uniprot	category	disease_name	cluster	position	WT	Mut
P04217	LB/B	-	A0A1U7UUV9	52	H	R
P04217	LB/B	-	A0A1U7UUV9	395	H	R
Q9NQ94	LB/B	-	V9KAZ0	555	V	M
Q9NQ94	LB/B	-	V9KAZ0	558	A	S
P01023	LB/B	-	A0A091S656	704	R	H
P01023	LB/B	-	A0A091S656	972	C	Y
P01023	LB/B	-	A0A091S656	1000	I	V
P01023	LB/B	-	A0A091S656	639	N	D
P01023	LB/B	-	A0A091S656	815	L	Q
A8K2U0	LB/B	-	A0A091S656	207	G	R
A8K2U0	LB/B	-	A0A091S656	970	C	Y
A8K2U0	LB/B	-	A0A091S656	1131	T	M
A8K2U0	LB/B	-	A0A091S656	1412	T	A
A8K2U0	LB/B	-	A0A091S656	850	D	E
A8K2U0	LB/B	-	A0A091S656	1229	H	R
A8K2U0	LB/B	-	A0A091S656	1122	R	W
A8K2U0	LB/B	-	A0A091S656	1257	M	V
A8K2U0	LB/B	-	A0A091S656	1312	T	M
A8K2U0	LB/B	-	A0A091S656	296	V	A
A8K2U0	LB/B	-	A0A091S656	356	P	R
A8K2U0	LB/B	-	A0A091S656	1001	R	W
A8K2U0	LB/B	-	A0A091S656	1431	A	V
Q9NPC4	LB/B	-	Q6RJV7	37	M	V
Q9NPC4	LB/B	-	Q6RJV7	183	M	K
Q9NPC4	LB/B	-	Q6RJV7	187	G	D
Q9NPC4	LB/B	-	Q6RJV7	251	P	L
Q9NPC4	LB/B	-	Q6RJV7	163	Q	R
Q9NPC4	LB/B	-	Q6RJV7	211	Q	E
Q9UNA3	LB/B	-	L9JDA8	218	A	D
Q86V21	LB/B	-	A0A2E9W6V8	118	I	V
Q86V21	LB/B	-	A0A2E9W6V8	470	A	V
P22760	LB/B	-	A0A2R8RW49	281	V	I
Q6P093	LB/B	-	A0A2R8RW49	186	A	S
Q6P093	LB/B	-	A0A2R8RW49	343	L	I
Q5VUY0	LB/B	-	A0A2Y9SUQ5	252	F	C
Q5VUY0	LB/B	-	A0A2Y9SUQ5	104	P	S
Q5VUY0	LB/B	-	A0A2Y9SUQ5	128	L	M
Q5VUY0	LB/B	-	A0A2Y9SUQ5	186	R	W
Q5VUY0	LB/B	-	A0A2Y9SUQ5	307	M	I
Q5VUY0	LB/B	-	A0A2Y9SUQ5	337	P	L
Q6PD74	LB/B	-	A0A2U3WY96	132	I	L
Q9H7C9	LB/B	-	A0A2Y9ID90	92	V	M
Q13685	LB/B	-	A0A151MCJ4	250	I	V
Q9Y312	LB/B	-	L5LU53	124	P	T
P49588	LB/B	-	V3ZQB6	275	G	D
P49588	LP/P	Charcot-Marie-Tooth disease, axonal, 2N (CMT2N) [MIM:613287]	V3ZQB6	329	R	H
P49588	LP/P	Charcot-Marie-Tooth disease, axonal, 2N (CMT2N) [MIM:613287]	V3ZQB6	71	N	Y
P49588	LP/P	Developmental and epileptic encephalopathy 29 (DEE29) [MIM:616339]	V3ZQB6	81	K	T
P49588	LP/P	Developmental and epileptic encephalopathy 29 (DEE29) [MIM:616339]	V3ZQB6	751	R	G
P49588	LP/P	Developmental and epileptic encephalopathy 29 (DEE29) [MIM:616339]	V3ZQB6	913	G	D
Q5JTZ9	LB/B	-	M1EF12	339	I	V
Q5JTZ9	LB/B	-	M1EF12	484	A	D
Q5JTZ9	LB/B	-	M1EF12	850	M	V
Q5JTZ9	LP/P	Combined oxidative phosphorylation deficiency 8 (COXPD8) [MIM:614096]	M1EF12	155	L	R
Q5JTZ9	LP/P	Combined oxidative phosphorylation deficiency 8 (COXPD8) [MIM:614096]	M1EF12	592	R	W
Q5JTZ9	LP/P	Leukoencephalopathy, progressive, with ovarian failure (LKENP) [MIM:615889]	M1EF12	50	F	C
Q5JTZ9	LP/P	Leukoencephalopathy, progressive, with ovarian failure (LKENP) [MIM:615889]	M1EF12	405	E	K
Q5JTZ9	LB/B	-	M1EF12	730	V	M
Q5JTZ9	LP/P	Leukoencephalopathy, progressive, with ovarian failure (LKENP) [MIM:615889]	M1EF12	965	G	R
Q4L235	LB/B	-	A0A091E212	368	K	R
Q4L235	LB/B	-	A0A091E212	747	A	V
Q4L235	LB/B	-	A0A091E212	774	V	I
Q4L235	LB/B	-	A0A091E212	865	T	A
Q4L235	LB/B	-	A0A091E212	1030	Y	D
Q4L235	LB/B	-	A0A091E212	61	I	V
Q4L235	LB/B	-	A0A091E212	93	P	R
Q6ZMQ8	LB/B	-	H2QE19	118	T	M
Q6ZMQ8	LB/B	-	H2QE19	703	G	C
Q6ZMQ8	LB/B	-	H2QE19	815	S	R
Q6ZMQ8	LB/B	-	H2QE19	923	S	L
Q6ZMQ8	LB/B	-	H2QE19	1160	E	K
Q6ZMQ8	LB/B	-	H2QE19	1192	P	S
Q6ZMQ8	LB/B	-	H2QE19	1266	F	S
Q6ZMQ8	LB/B	-	H2QE19	1332	A	T
P80404	LP/P	GABA transaminase deficiency (GABATD) [MIM:613163]	A0A2J8S0A4	220	R	K
P80404	LB/B	-	A0A2J8S0A4	56	Q	R
O95477	LB/B	-	N1PB02	399	V	A
O95477	LP/P	Tangier disease (TGD) [MIM:205400]	N1PB02	587	R	W
O95477	LP/P	Tangier disease (TGD) [MIM:205400]	N1PB02	590	W	S
O95477	LP/P	Tangier disease (TGD) [MIM:205400]	N1PB02	597	Q	R
O95477	LP/P	Tangier disease (TGD) [MIM:205400]	N1PB02	935	N	S
O95477	LP/P	Tangier disease (TGD) [MIM:205400]	N1PB02	937	A	V
O95477	LP/P	Tangier disease (TGD) [MIM:205400]	N1PB02	1289	D	N
O95477	LP/P	Tangier disease (TGD) [MIM:205400]	N1PB02	1477	C	R
O95477	LP/P	Tangier disease (TGD) [MIM:205400]	N1PB02	1517	I	R
O95477	LP/P	Tangier disease (TGD) [MIM:205400]	N1PB02	1800	N	H
O95477	LB/B	-	N1PB02	219	R	K
O95477	LB/B	-	N1PB02	230	R	C
O95477	LP/P	Tangier disease (TGD) [MIM:205400]	N1PB02	255	A	T
O95477	LB/B	-	N1PB02	771	V	M
O95477	LB/B	-	N1PB02	774	T	P
O95477	LB/B	-	N1PB02	776	K	N
O95477	LB/B	-	N1PB02	825	V	I
O95477	LB/B	-	N1PB02	883	I	M
O95477	LP/P	Tangier disease (TGD) [MIM:205400]	N1PB02	929	T	I
O95477	LP/P	Tangier disease (TGD) [MIM:205400]	N1PB02	1046	A	D
O95477	LP/P	Hypoalphalipoproteinemia, primary, 1 (FHA1) [MIM:604091]	N1PB02	1091	M	T
O95477	LB/B	-	N1PB02	1172	E	D
O95477	LP/P	Tangier disease (TGD) [MIM:205400]	N1PB02	1506	S	L
O95477	LB/B	-	N1PB02	1587	K	R
O95477	LP/P	-	N1PB02	1611	N	D
O95477	LB/B	-	N1PB02	1731	S	C
O95477	LP/P	Tangier disease (TGD) [MIM:205400]	N1PB02	2081	R	W
O95477	LP/P	Hypoalphalipoproteinemia, primary, 1 (FHA1) [MIM:604091]	N1PB02	2150	P	L
O95477	LB/B	-	N1PB02	2168	L	P
O95477	LB/B	-	N1PB02	1555	I	T
O95477	LB/B	-	N1PB02	1648	L	P
O95477	LB/B	-	N1PB02	1181	S	F
O95477	LP/P	Hypoalphalipoproteinemia, primary, 1 (FHA1) [MIM:604091]	N1PB02	85	P	L
O95477	LP/P	Hypoalphalipoproteinemia, primary, 1 (FHA1) [MIM:604091]	N1PB02	1099	D	Y
O95477	LP/P	Tangier disease (TGD) [MIM:205400]	N1PB02	935	N	H
O95477	LB/B	-	N1PB02	1054	V	I
O95477	LP/P	Tangier disease (TGD) [MIM:205400]	N1PB02	1680	R	W
O95477	LP/P	Hypoalphalipoproteinemia, primary, 1 (FHA1) [MIM:604091]	N1PB02	2009	F	S
O95477	LB/B	-	N1PB02	248	P	A
O95477	LP/P	Tangier disease (TGD) [MIM:205400]	N1PB02	284	E	K
O95477	LB/B	-	N1PB02	364	S	C
O95477	LB/B	-	N1PB02	401	K	Q
O95477	LP/P	Tangier disease (TGD) [MIM:205400]	N1PB02	482	Y	C
O95477	LB/B	-	N1PB02	496	R	W
O95477	LP/P	Tangier disease (TGD) [MIM:205400]	N1PB02	590	W	L
O95477	LB/B	-	N1PB02	638	R	Q
O95477	LB/B	-	N1PB02	774	T	S
O95477	LB/B	-	N1PB02	815	E	G
O95477	LP/P	Tangier disease (TGD) [MIM:205400]	N1PB02	840	W	R
O95477	LB/B	-	N1PB02	1065	P	S
O95477	LP/P	Tangier disease (TGD) [MIM:205400]	N1PB02	1068	R	C
O95477	LB/B	-	N1PB02	1216	G	V
O95477	LB/B	-	N1PB02	1341	R	T
O95477	LB/B	-	N1PB02	1376	S	G
O95477	LP/P	Tangier disease (TGD) [MIM:205400]	N1PB02	1379	L	F
O95477	LB/B	-	N1PB02	1615	R	Q
O95477	LB/B	-	N1PB02	1670	A	T
O95477	LB/B	-	N1PB02	1680	R	Q
O95477	LP/P	Tangier disease (TGD) [MIM:205400]	N1PB02	1704	V	D
O95477	LP/P	Tangier disease (TGD) [MIM:205400]	N1PB02	1851	R	Q
O95477	LP/P	Tangier disease (TGD) [MIM:205400]	N1PB02	1901	R	S
O95477	LB/B	-	N1PB02	1925	R	Q
O95477	LP/P	Tangier disease (TGD) [MIM:205400]	N1PB02	2196	Q	H
O95477	LB/B	-	N1PB02	2243	D	E
O95477	LB/B	-	N1PB02	2244	V	I
Q8WWZ4	LB/B	-	D3ZCF8	203	P	S
Q8WWZ4	LB/B	-	D3ZCF8	287	I	V
Q8WWZ4	LB/B	-	D3ZCF8	916	M	T
Q8WWZ4	LB/B	-	D3ZCF8	1322	R	W
Q86UK0	LB/B	-	D4A7J3	459	S	T
Q86UK0	LP/P	Ichthyosis, congenital, autosomal recessive 4A (ARCI4A) [MIM:601277]	D4A7J3	1380	N	S
Q86UK0	LP/P	Ichthyosis, congenital, autosomal recessive 4A (ARCI4A) [MIM:601277]	D4A7J3	1381	G	E
Q86UK0	LP/P	Ichthyosis, congenital, autosomal recessive 4A (ARCI4A) [MIM:601277]	D4A7J3	1514	R	H
Q86UK0	LP/P	Ichthyosis, congenital, autosomal recessive 4A (ARCI4A) [MIM:601277]	D4A7J3	1539	E	K
Q86UK0	LP/P	Ichthyosis, congenital, autosomal recessive 4A (ARCI4A) [MIM:601277]	D4A7J3	1651	G	S
Q86UK0	LB/B	-	D4A7J3	550	E	G
Q86UK0	LB/B	-	D4A7J3	777	S	T
Q86UK0	LB/B	-	D4A7J3	1251	G	D
Q86UK0	LB/B	-	D4A7J3	1546	R	C
Q86UK0	LB/B	-	D4A7J3	2064	E	K
Q86UK0	LB/B	-	D4A7J3	2365	D	N
Q86UK0	LB/B	-	D4A7J3	199	W	C
Q86UK0	LB/B	-	D4A7J3	237	N	H
Q86UK0	LB/B	-	D4A7J3	274	Q	R
Q86UK0	LB/B	-	D4A7J3	287	R	G
Q86UK0	LP/P	Ichthyosis, congenital, autosomal recessive 4A (ARCI4A) [MIM:601277]	D4A7J3	345	T	P
Q86UK0	LP/P	Ichthyosis, congenital, autosomal recessive 4B (ARCI4B) [MIM:242500]	D4A7J3	387	S	N
Q86UK0	LP/P	Ichthyosis, congenital, autosomal recessive 4A (ARCI4A) [MIM:601277]	D4A7J3	1136	G	D
Q86UK0	LP/P	Ichthyosis, congenital, autosomal recessive 4B (ARCI4B) [MIM:242500]	D4A7J3	1179	G	R
Q86UK0	LP/P	Ichthyosis, congenital, autosomal recessive 4A (ARCI4A) [MIM:601277]	D4A7J3	1235	W	S
Q86UK0	LP/P	Ichthyosis, congenital, autosomal recessive 4A (ARCI4A) [MIM:601277]	D4A7J3	1494	I	T
Q86UK0	LP/P	Ichthyosis, congenital, autosomal recessive 4A (ARCI4A) [MIM:601277]	D4A7J3	1559	G	V
Q86UK0	LP/P	Ichthyosis, congenital, autosomal recessive 4A (ARCI4A) [MIM:601277]	D4A7J3	1798	P	L
Q86UK0	LP/P	Ichthyosis, congenital, autosomal recessive 4A (ARCI4A) [MIM:601277]	D4A7J3	1980	T	K
Q86UQ4	LB/B	-	E1BK38	1508	T	I
Q86UQ4	LB/B	-	E1BK38	506	P	L
Q86UQ4	LB/B	-	E1BK38	555	R	H
Q86UQ4	LB/B	-	E1BK38	767	I	S
Q86UQ4	LB/B	-	E1BK38	799	E	K
Q86UQ4	LB/B	-	E1BK38	1434	I	V
Q86UQ4	LB/B	-	E1BK38	1540	F	L
Q86UQ4	LB/B	-	E1BK38	1889	I	K
Q86UQ4	LB/B	-	E1BK38	2033	N	D
Q86UQ4	LB/B	-	E1BK38	2154	S	L
Q86UQ4	LB/B	-	E1BK38	2178	A	E
Q86UQ4	LB/B	-	E1BK38	2212	L	S
Q86UQ4	LB/B	-	E1BK38	2436	K	R
Q86UQ4	LB/B	-	E1BK38	2537	S	A
Q86UQ4	LB/B	-	E1BK38	2674	R	W
Q86UQ4	LB/B	-	E1BK38	3142	A	V
Q86UQ4	LB/B	-	E1BK38	3851	Y	F
Q86UQ4	LB/B	-	E1BK38	4277	N	D
Q86UQ4	LB/B	-	E1BK38	4302	Q	R
Q86UQ4	LB/B	-	E1BK38	4335	P	A
Q8WWZ7	LB/B	-	A0A218UXB1	93	Q	K
Q8WWZ7	LB/B	-	A0A218UXB1	484	Q	R
Q8WWZ7	LB/B	-	A0A218UXB1	753	M	V
Q8WWZ7	LB/B	-	A0A218UXB1	832	A	S
Q8WWZ7	LB/B	-	A0A218UXB1	960	M	V
Q8WWZ7	LB/B	-	A0A218UXB1	178	A	T
Q8WWZ7	LB/B	-	A0A218UXB1	1260	D	G
Q8N139	LB/B	-	D3ZCF8	282	V	I
Q8N139	LB/B	-	D3ZCF8	610	N	Y
Q8N139	LB/B	-	D3ZCF8	698	M	I
Q8N139	LB/B	-	D3ZCF8	875	M	I
Q8N139	LB/B	-	D3ZCF8	1322	N	S
Q8IZY2	LB/B	-	F7DJZ7	188	E	G
Q8IZY2	LB/B	-	F7DJZ7	319	T	A
Q8IZY2	LB/B	-	F7DJZ7	395	H	R
Q8IZY2	LB/B	-	F7DJZ7	463	R	H
Q8IZY2	LB/B	-	F7DJZ7	718	N	T
Q8IZY2	LB/B	-	F7DJZ7	1349	R	Q
Q8IZY2	LB/B	-	F7DJZ7	1527	G	A
Q8IZY2	LB/B	-	F7DJZ7	1686	Q	R
Q8IZY2	LB/B	-	F7DJZ7	2045	A	S
Q8IZY2	LB/B	-	F7DJZ7	676	A	T
Q8IZY2	LP/P	Alzheimer disease 9 (AD9) [MIM:608907]	F7DJZ7	880	R	Q
O94911	LB/B	-	D3ZCF8	256	T	A
O94911	LB/B	-	D3ZCF8	331	G	S
O94911	LB/B	-	D3ZCF8	489	Y	F
O94911	LB/B	-	D3ZCF8	720	C	G
O94911	LB/B	-	D3ZCF8	416	A	V
O94911	LB/B	-	D3ZCF8	659	L	R
O94911	LB/B	-	D3ZCF8	1470	G	S
O94911	LB/B	-	D3ZCF8	649	P	R
Q8IUA7	LB/B	-	D3ZCF8	353	R	H
Q8IUA7	LB/B	-	D3ZCF8	785	N	S
Q8IUA7	LB/B	-	D3ZCF8	1306	K	T
Q8IUA7	LB/B	-	D3ZCF8	1356	G	S
P08183	LB/B	-	E7F1E3	893	S	A
P08183	LB/B	-	E7F1E3	893	S	T
P08183	LB/B	-	E7F1E3	21	N	D
P08183	LB/B	-	E7F1E3	103	F	L
P08183	LB/B	-	E7F1E3	185	G	V
P08183	LB/B	-	E7F1E3	400	S	N
P08183	LB/B	-	E7F1E3	999	A	T
P08183	LB/B	-	E7F1E3	1107	Q	P
P08183	LB/B	-	E7F1E3	108	E	K
P08183	LB/B	-	E7F1E3	986	M	V
P08183	LB/B	-	E7F1E3	1251	V	I
P08183	LB/B	-	E7F1E3	17	F	L
P08183	LB/B	-	E7F1E3	566	E	K
P08183	LB/B	-	E7F1E3	593	R	C
P08183	LB/B	-	E7F1E3	836	I	V
P08183	LB/B	-	E7F1E3	1051	P	A
P08183	LB/B	-	E7F1E3	1141	S	T
P08183	LB/B	-	E7F1E3	44	N	S
P08183	LB/B	-	E7F1E3	80	A	E
P08183	LB/B	-	E7F1E3	261	I	V
P08183	LB/B	-	E7F1E3	599	A	T
P08183	LB/B	-	E7F1E3	669	R	C
P08183	LB/B	-	E7F1E3	801	V	M
P08183	LB/B	-	E7F1E3	829	I	V
Q9NRK6	LB/B	-	M3W846	150	A	S
Q9NRK6	LB/B	-	M3W846	545	D	N
Q9NRK6	LB/B	-	M3W846	242	R	G
O95342	LP/P	Cholestasis, benign recurrent intrahepatic, 2 (BRIC2) [MIM:605479]	A0A067CQD7	297	E	G
O95342	LP/P	Cholestasis, progressive familial intrahepatic, 2 (PFIC2) [MIM:601847]	A0A067CQD7	297	E	G
O95342	LP/P	Cholestasis, progressive familial intrahepatic, 2 (PFIC2) [MIM:601847]	A0A067CQD7	284	V	L
O95342	LB/B	-	A0A067CQD7	444	V	A
O95342	LP/P	Cholestasis, progressive familial intrahepatic, 2 (PFIC2) [MIM:601847]	A0A067CQD7	461	K	E
O95342	LP/P	Cholestasis, progressive familial intrahepatic, 2 (PFIC2) [MIM:601847]	A0A067CQD7	482	D	G
O95342	LP/P	Cholestasis, progressive familial intrahepatic, 2 (PFIC2) [MIM:601847]	A0A067CQD7	982	G	R
O95342	LP/P	Cholestasis, progressive familial intrahepatic, 2 (PFIC2) [MIM:601847]	A0A067CQD7	1004	G	D
O95342	LP/P	Cholestasis, progressive familial intrahepatic, 2 (PFIC2) [MIM:601847]	A0A067CQD7	1153	R	C
O95342	LP/P	Cholestasis, progressive familial intrahepatic, 2 (PFIC2) [MIM:601847]	A0A067CQD7	1268	R	Q
O95342	LP/P	Cholestasis, benign recurrent intrahepatic, 2 (BRIC2) [MIM:605479]	A0A067CQD7	186	E	G
O95342	LB/B	-	A0A067CQD7	206	I	V
O95342	LP/P	Cholestasis, progressive familial intrahepatic, 2 (PFIC2) [MIM:601847]	A0A067CQD7	238	G	V
O95342	LB/B	-	A0A067CQD7	299	R	K
O95342	LP/P	Cholestasis, progressive familial intrahepatic, 2 (PFIC2) [MIM:601847]	A0A067CQD7	336	C	S
O95342	LP/P	Cholestasis, benign recurrent intrahepatic, 2 (BRIC2) [MIM:605479]	A0A067CQD7	432	R	T
O95342	LP/P	Cholestasis, benign recurrent intrahepatic, 2 (BRIC2) [MIM:605479]	A0A067CQD7	570	A	T
O95342	LB/B	-	A0A067CQD7	677	M	V
O95342	LP/P	Cholestasis, benign recurrent intrahepatic, 2 (BRIC2) [MIM:605479]	A0A067CQD7	923	T	P
O95342	LP/P	Cholestasis, benign recurrent intrahepatic, 2 (BRIC2) [MIM:605479]	A0A067CQD7	926	A	P
O95342	LP/P	Cholestasis, benign recurrent intrahepatic, 2 (BRIC2) [MIM:605479]	A0A067CQD7	1050	R	C
O95342	LP/P	Cholestasis, benign recurrent intrahepatic, 2 (BRIC2) [MIM:605479]	A0A067CQD7	1128	R	H
O95342	LB/B	-	A0A067CQD7	1186	E	K
O95342	LB/B	-	A0A067CQD7	284	V	A
O95342	LB/B	-	A0A067CQD7	616	R	G
O95342	LB/B	-	A0A067CQD7	619	T	A
O95342	LB/B	-	A0A067CQD7	698	R	H
O95342	LB/B	-	A0A067CQD7	865	A	V
O95342	LB/B	-	A0A067CQD7	958	R	Q
O95342	LB/B	-	A0A067CQD7	415	R	Q
O95342	LB/B	-	A0A067CQD7	591	N	S
O95342	LB/B	-	A0A067CQD7	56	S	L
O95342	LB/B	-	A0A067CQD7	444	V	D
O95342	LB/B	-	A0A067CQD7	444	V	G
O95342	LP/P	Cholestasis, progressive familial intrahepatic, 2 (PFIC2) [MIM:601847]	A0A067CQD7	472	Y	C
O95342	LP/P	Cholestasis, progressive familial intrahepatic, 2 (PFIC2) [MIM:601847]	A0A067CQD7	1131	D	V
O95342	LP/P	Cholestasis, progressive familial intrahepatic, 2 (PFIC2) [MIM:601847]	A0A067CQD7	129	C	Y
O95342	LB/B	-	A0A067CQD7	558	Q	H
O95342	LB/B	-	A0A067CQD7	592	E	Q
P21439	LB/B	-	E7F1E3	238	L	V
P21439	LB/B	-	E7F1E3	652	R	G
P21439	LP/P	Cholestasis of pregnancy, intrahepatic 3 (ICP3) [MIM:614972]	E7F1E3	546	A	D
P21439	LP/P	Gallbladder disease 1 (GBD1) [MIM:600803]	E7F1E3	1168	P	S
P21439	LB/B	Gallbladder disease 1 (GBD1) [MIM:600803]	E7F1E3	788	R	Q
P21439	LB/B	-	E7F1E3	263	I	V
P21439	LB/B	-	E7F1E3	651	T	N
P21439	LB/B	-	E7F1E3	87	D	E
P21439	LB/B	-	E7F1E3	95	P	S
P21439	LP/P	Cholestasis, progressive familial intrahepatic, 3 (PFIC3) [MIM:602347]	E7F1E3	138	W	R
P21439	LP/P	Cholestasis of pregnancy, intrahepatic 3 (ICP3) [MIM:614972]	E7F1E3	150	R	K
P21439	LP/P	Gallbladder disease 1 (GBD1) [MIM:600803]	E7F1E3	165	F	I
P21439	LP/P	Gallbladder disease 1 (GBD1) [MIM:600803]	E7F1E3	301	M	T
P21439	LP/P	Cholestasis, progressive familial intrahepatic, 3 (PFIC3) [MIM:602347]	E7F1E3	346	S	I
P21439	LB/B	-	E7F1E3	367	I	V
P21439	LP/P	Cholestasis, progressive familial intrahepatic, 3 (PFIC3) [MIM:602347]	E7F1E3	395	E	G
P21439	LP/P	Cholestasis, progressive familial intrahepatic, 3 (PFIC3) [MIM:602347]	E7F1E3	424	T	A
P21439	LP/P	Cholestasis, progressive familial intrahepatic, 3 (PFIC3) [MIM:602347]	E7F1E3	425	V	M
P21439	LB/B	-	E7F1E3	450	E	G
P21439	LP/P	Cholestasis, progressive familial intrahepatic, 3 (PFIC3) [MIM:602347]	E7F1E3	535	G	D
P21439	LP/P	Cholestasis, progressive familial intrahepatic, 3 (PFIC3) [MIM:602347]	E7F1E3	541	I	F
P21439	LP/P	Gallbladder disease 1 (GBD1) [MIM:600803]	E7F1E3	541	I	F
P21439	LP/P	Cholestasis, progressive familial intrahepatic, 3 (PFIC3) [MIM:602347]	E7F1E3	556	L	R
P21439	LP/P	Cholestasis, progressive familial intrahepatic, 3 (PFIC3) [MIM:602347]	E7F1E3	564	D	G
P21439	LP/P	Gallbladder disease 1 (GBD1) [MIM:600803]	E7F1E3	591	L	Q
P21439	LP/P	Cholestasis, progressive familial intrahepatic, 3 (PFIC3) [MIM:602347]	E7F1E3	711	F	S
P21439	LB/B	-	E7F1E3	742	G	S
P21439	LP/P	Cholestasis of pregnancy, intrahepatic 3 (ICP3) [MIM:614972]	E7F1E3	762	G	E
P21439	LP/P	Cholestasis, progressive familial intrahepatic, 3 (PFIC3) [MIM:602347]	E7F1E3	983	G	S
P21439	LB/B	-	E7F1E3	1082	L	Q
P21439	LP/P	Gallbladder disease 1 (GBD1) [MIM:600803]	E7F1E3	34	T	M
P21439	LP/P	Gallbladder disease 1 (GBD1) [MIM:600803]	E7F1E3	47	R	G
P21439	LP/P	Cholestasis, progressive familial intrahepatic, 3 (PFIC3) [MIM:602347]	E7F1E3	68	G	R
P21439	LP/P	Cholestasis, progressive familial intrahepatic, 3 (PFIC3) [MIM:602347]	E7F1E3	70	G	R
P21439	LP/P	Gallbladder disease 1 (GBD1) [MIM:600803]	E7F1E3	71	L	H
P21439	LP/P	Cholestasis, progressive familial intrahepatic, 3 (PFIC3) [MIM:602347]	E7F1E3	73	L	V
P21439	LP/P	Gallbladder disease 1 (GBD1) [MIM:600803]	E7F1E3	73	L	V
P21439	LP/P	Gallbladder disease 1 (GBD1) [MIM:600803]	E7F1E3	78	F	C
P21439	LP/P	Gallbladder disease 1 (GBD1) [MIM:600803]	E7F1E3	99	S	F
P21439	LP/P	Gallbladder disease 1 (GBD1) [MIM:600803]	E7F1E3	124	G	S
P21439	LP/P	Cholestasis, progressive familial intrahepatic, 3 (PFIC3) [MIM:602347]	E7F1E3	126	G	E
P21439	LP/P	Gallbladder disease 1 (GBD1) [MIM:600803]	E7F1E3	154	F	S
P21439	LP/P	Cholestasis, progressive familial intrahepatic, 3 (PFIC3) [MIM:602347]	E7F1E3	201	T	M
P21439	LP/P	Cholestasis, progressive familial intrahepatic, 3 (PFIC3) [MIM:602347]	E7F1E3	250	A	P
P21439	LP/P	Cholestasis, progressive familial intrahepatic, 3 (PFIC3) [MIM:602347]	E7F1E3	286	A	V
P21439	LP/P	Gallbladder disease 1 (GBD1) [MIM:600803]	E7F1E3	286	A	V
P21439	LP/P	Cholestasis, progressive familial intrahepatic, 3 (PFIC3) [MIM:602347]	E7F1E3	357	F	L
P21439	LP/P	Cholestasis, progressive familial intrahepatic, 3 (PFIC3) [MIM:602347]	E7F1E3	364	A	V
P21439	LP/P	Cholestasis, progressive familial intrahepatic, 3 (PFIC3) [MIM:602347]	E7F1E3	403	Y	H
P21439	LP/P	Gallbladder disease 1 (GBD1) [MIM:600803]	E7F1E3	406	R	G
P21439	LP/P	Cholestasis, progressive familial intrahepatic, 3 (PFIC3) [MIM:602347]	E7F1E3	459	D	H
P21439	LP/P	Cholestasis, progressive familial intrahepatic, 3 (PFIC3) [MIM:602347]	E7F1E3	475	V	A
P21439	LP/P	Cholestasis, progressive familial intrahepatic, 3 (PFIC3) [MIM:602347]	E7F1E3	479	P	L
P21439	LP/P	Cholestasis, progressive familial intrahepatic, 3 (PFIC3) [MIM:602347]	E7F1E3	481	L	R
P21439	LP/P	Gallbladder disease 1 (GBD1) [MIM:600803]	E7F1E3	510	N	S
P21439	LP/P	Cholestasis, progressive familial intrahepatic, 3 (PFIC3) [MIM:602347]	E7F1E3	511	A	T
P21439	LP/P	Gallbladder disease 1 (GBD1) [MIM:600803]	E7F1E3	511	A	T
P21439	LP/P	Gallbladder disease 1 (GBD1) [MIM:600803]	E7F1E3	513	E	K
P21439	LP/P	Gallbladder disease 1 (GBD1) [MIM:600803]	E7F1E3	545	R	H
P21439	LP/P	Gallbladder disease 1 (GBD1) [MIM:600803]	E7F1E3	549	R	H
P21439	LP/P	Cholestasis, progressive familial intrahepatic, 3 (PFIC3) [MIM:602347]	E7F1E3	558	E	K
P21439	LP/P	Gallbladder disease 1 (GBD1) [MIM:600803]	E7F1E3	589	H	T
P21439	LP/P	Cholestasis, progressive familial intrahepatic, 3 (PFIC3) [MIM:602347]	E7F1E3	593	T	A
P21439	LP/P	Gallbladder disease 1 (GBD1) [MIM:600803]	E7F1E3	593	T	M
P21439	LP/P	Cholestasis, progressive familial intrahepatic, 3 (PFIC3) [MIM:602347]	E7F1E3	630	M	V
P21439	LP/P	Gallbladder disease 1 (GBD1) [MIM:600803]	E7F1E3	647	E	K
P21439	LP/P	Cholestasis, progressive familial intrahepatic, 3 (PFIC3) [MIM:602347]	E7F1E3	701	L	P
P21439	LP/P	Cholestasis, progressive familial intrahepatic, 3 (PFIC3) [MIM:602347]	E7F1E3	715	T	I
P21439	LP/P	Cholestasis, progressive familial intrahepatic, 3 (PFIC3) [MIM:602347]	E7F1E3	723	G	E
P21439	LP/P	Gallbladder disease 1 (GBD1) [MIM:600803]	E7F1E3	726	P	L
P21439	LP/P	Cholestasis, progressive familial intrahepatic, 3 (PFIC3) [MIM:602347]	E7F1E3	726	P	T
P21439	LP/P	Gallbladder disease 1 (GBD1) [MIM:600803]	E7F1E3	729	S	L
P21439	LP/P	Cholestasis, progressive familial intrahepatic, 3 (PFIC3) [MIM:602347]	E7F1E3	737	A	V
P21439	LP/P	Cholestasis, progressive familial intrahepatic, 3 (PFIC3) [MIM:602347]	E7F1E3	840	A	D
P21439	LP/P	Cholestasis, progressive familial intrahepatic, 3 (PFIC3) [MIM:602347]	E7F1E3	954	G	S
P21439	LP/P	Gallbladder disease 1 (GBD1) [MIM:600803]	E7F1E3	975	L	V
P21439	LP/P	Cholestasis, progressive familial intrahepatic, 3 (PFIC3) [MIM:602347]	E7F1E3	978	S	P
P21439	LP/P	Gallbladder disease 1 (GBD1) [MIM:600803]	E7F1E3	1084	R	W
P21439	LP/P	Cholestasis, progressive familial intrahepatic, 3 (PFIC3) [MIM:602347]	E7F1E3	1125	E	K
P21439	LP/P	Cholestasis, progressive familial intrahepatic, 3 (PFIC3) [MIM:602347]	E7F1E3	1193	A	T
P21439	LP/P	Gallbladder disease 1 (GBD1) [MIM:600803]	E7F1E3	536	G	R
P21439	LP/P	Gallbladder disease 1 (GBD1) [MIM:600803]	E7F1E3	1183	S	L
P21439	LP/P	Gallbladder disease 1 (GBD1) [MIM:600803]	E7F1E3	1185	G	S
Q9NP58	LB/B	-	I3K2L8	648	R	Q
Q9NP58	LB/B	-	I3K2L8	293	L	V
Q9NP58	LB/B	-	I3K2L8	343	R	Q
Q9NP58	LP/P	Microphthalmia, isolated, with coloboma, 7 (MCOPCB7) [MIM:614497]	I3K2L8	811	L	V
Q9NP58	LP/P	Dyschromatosis universalis hereditaria 3 (DUH3) [MIM:615402]	I3K2L8	170	S	G
Q9NP58	LP/P	Dyschromatosis universalis hereditaria 3 (DUH3) [MIM:615402]	I3K2L8	356	L	P
Q9NP58	LP/P	Dyschromatosis universalis hereditaria 3 (DUH3) [MIM:615402]	I3K2L8	579	G	E
Q9NP58	LP/P	Pseudohyperkalemia, familial, 2, due to red cell leak (PSHK2) [MIM:609153]	I3K2L8	375	R	Q
Q9NP58	LP/P	Pseudohyperkalemia, familial, 2, due to red cell leak (PSHK2) [MIM:609153]	I3K2L8	375	R	W
Q9NP58	LP/P	Dyschromatosis universalis hereditaria 3 (DUH3) [MIM:615402]	I3K2L8	453	A	V
Q9NP58	LP/P	Dyschromatosis universalis hereditaria 3 (DUH3) [MIM:615402]	I3K2L8	555	Q	K
Q9NP58	LP/P	Dyschromatosis universalis hereditaria 3 (DUH3) [MIM:615402]	I3K2L8	322	S	R
Q9NP58	LP/P	Dyschromatosis universalis hereditaria 3 (DUH3) [MIM:615402]	I3K2L8	424	Y	H
Q9NP58	LP/P	Pseudohyperkalemia, familial, 2, due to red cell leak (PSHK2) [MIM:609153]	I3K2L8	723	R	Q
Q9NP58	LB/B	-	I3K2L8	192	R	Q
Q9NP58	LB/B	-	I3K2L8	276	R	W
Q9NP58	LB/B	-	I3K2L8	492	A	T
Q9NP58	LB/B	-	I3K2L8	521	T	S
Q9NP58	LB/B	-	I3K2L8	588	G	S
Q9NP58	LB/B	-	I3K2L8	681	A	T
O75027	LP/P	Anemia, sideroblastic, spinocerebellar ataxia (ASAT) [MIM:301310]	A0A2K6FDE3	400	I	M
O75027	LP/P	Anemia, sideroblastic, spinocerebellar ataxia (ASAT) [MIM:301310]	A0A2K6FDE3	433	E	K
O75027	LB/B	-	A0A2K6FDE3	315	R	G
O75027	LB/B	-	A0A2K6FDE3	346	F	I
O75027	LP/P	Anemia, sideroblastic, spinocerebellar ataxia (ASAT) [MIM:301310]	A0A2K6FDE3	411	V	L
O75027	LB/B	-	A0A2K6FDE3	581	V	A
O75027	LB/B	-	A0A2K6FDE3	580	A	V
O75027	LP/P	Anemia, sideroblastic, spinocerebellar ataxia (ASAT) [MIM:301310]	A0A2K6FDE3	208	E	D
Q9NUT2	LB/B	-	A0A212CJY6	152	V	I
P33527	LB/B	-	Q9UQ98	633	R	Q
P33527	LB/B	-	Q9UQ98	671	G	V
P33527	LB/B	-	Q9UQ98	43	C	S
P33527	LB/B	-	Q9UQ98	73	T	I
P33527	LB/B	-	Q9UQ98	117	M	T
P33527	LB/B	-	Q9UQ98	433	R	S
P33527	LB/B	-	Q9UQ98	723	R	Q
P33527	LB/B	-	Q9UQ98	1058	R	Q
P33527	LB/B	-	Q9UQ98	1512	S	L
P33527	LB/B	-	Q9UQ98	861	A	T
P33527	LB/B	-	Q9UQ98	1047	C	S
P33527	LB/B	-	Q9UQ98	1146	V	I
P33527	LB/B	-	Q9UQ98	242	W	C
P33527	LP/P	Deafness, autosomal dominant, 77 (DFNA77) [MIM:618915]	Q9UQ98	590	N	S
P33527	LB/B	-	Q9UQ98	886	V	I
P33527	LB/B	-	Q9UQ98	1007	G	R
P33527	LB/B	-	Q9UQ98	1086	M	T
Q5T3U5	LB/B	-	A0A060WUP0	948	I	T
Q96J66	LB/B	-	A0A210PT36	19	R	H
Q96J66	LB/B	-	A0A210PT36	180	G	R
Q96J66	LB/B	-	A0A210PT36	317	A	E
Q96J66	LB/B	-	A0A210PT36	546	T	M
Q96J66	LB/B	-	A0A210PT36	648	V	I
Q96J66	LB/B	-	A0A210PT36	687	V	I
Q96J66	LB/B	-	A0A210PT36	735	K	R
Q96J66	LB/B	-	A0A210PT36	1344	H	R
Q96J66	LB/B	-	A0A210PT36	630	R	W
Q96J66	LB/B	-	A0A210PT36	970	M	V
O15439	LB/B	-	A0A2K6EXJ9	184	M	T
O15439	LB/B	-	A0A2K6EXJ9	187	G	W
O15439	LB/B	-	A0A2K6EXJ9	498	K	E
O15439	LB/B	-	A0A2K6EXJ9	744	M	V
O15439	LB/B	-	A0A2K6EXJ9	860	V	M
O15439	LB/B	-	A0A2K6EXJ9	900	V	L
O15439	LB/B	-	A0A2K6EXJ9	304	K	N
O15439	LB/B	-	A0A2K6EXJ9	757	E	K
O15439	LB/B	-	A0A2K6EXJ9	78	P	A
O15439	LB/B	-	A0A2K6EXJ9	403	P	L
O15439	LB/B	-	A0A2K6EXJ9	487	G	E
O15439	LB/B	-	A0A2K6EXJ9	625	I	M
O15439	LB/B	-	A0A2K6EXJ9	667	P	L
O15439	LB/B	-	A0A2K6EXJ9	1142	T	M
O15439	LB/B	-	A0A2K6EXJ9	556	Y	C
O15439	LB/B	-	A0A2K6EXJ9	776	V	I
O15439	LB/B	-	A0A2K6EXJ9	820	R	I
O15439	LB/B	-	A0A2K6EXJ9	854	V	F
O15439	LB/B	-	A0A2K6EXJ9	866	I	V
O15439	LB/B	-	A0A2K6EXJ9	18	L	I
O15439	LB/B	-	A0A2K6EXJ9	171	C	G
O15439	LB/B	-	A0A2K6EXJ9	293	K	E
O15439	LB/B	-	A0A2K6EXJ9	356	T	M
O95255	LB/B	-	G1PKD2	614	V	A
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	1114	R	P
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	1138	R	Q
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	1138	R	W
O95255	LB/B	-	G1PKD2	1268	R	Q
O95255	LP/P	Arterial calcification of infancy, generalized, 2 (GACI2) [MIM:614473]	G1PKD2	1314	R	W
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	1314	R	W
O95255	LB/B	-	G1PKD2	61	G	D
O95255	LB/B	-	G1PKD2	64	R	W
O95255	LB/B	-	G1PKD2	207	G	R
O95255	LB/B	-	G1PKD2	265	R	G
O95255	LB/B	-	G1PKD2	281	K	E
O95255	LB/B	-	G1PKD2	319	I	V
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	364	T	R
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	411	N	K
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	455	A	P
O95255	LB/B	-	G1PKD2	497	N	K
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	518	R	Q
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	568	F	S
O95255	LB/B	-	G1PKD2	632	H	Q
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	673	L	P
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	765	R	Q
O95255	LB/B	-	G1PKD2	953	L	H
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	1121	S	W
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	1138	R	P
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	1203	G	D
O95255	LB/B	-	G1PKD2	1241	W	C
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	1298	V	F
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	1301	T	I
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	1302	G	R
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	1303	A	P
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	1314	R	Q
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	1321	G	S
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	1339	R	C
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	1347	Q	H
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	1354	G	R
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	1361	D	N
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	1424	I	T
O95255	LB/B	-	G1PKD2	665	V	A
O95255	LB/B	-	G1PKD2	848	M	V
O95255	LB/B	-	G1PKD2	1097	L	I
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	78	A	T
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	125	E	K
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	129	G	E
O95255	LB/B	-	G1PKD2	158	A	V
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	317	S	R
O95255	LP/P	Arterial calcification of infancy, generalized, 2 (GACI2) [MIM:614473]	G1PKD2	355	L	R
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	355	L	R
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	370	N	D
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	382	R	W
O95255	LP/P	Arterial calcification of infancy, generalized, 2 (GACI2) [MIM:614473]	G1PKD2	391	R	G
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	391	R	G
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	392	K	N
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	398	S	G
O95255	LB/B	-	G1PKD2	417	V	M
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	440	C	G
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	463	L	H
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	495	L	H
O95255	LB/B	-	G1PKD2	514	V	I
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	535	S	P
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	551	F	S
O95255	LP/P	Arterial calcification of infancy, generalized, 2 (GACI2) [MIM:614473]	G1PKD2	590	S	F
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	594	A	V
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	600	R	C
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	663	G	C
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	677	L	P
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	698	Q	P
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	699	E	D
O95255	LB/B	-	G1PKD2	724	R	K
O95255	LB/B	-	G1PKD2	724	R	L
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	726	L	P
O95255	LB/B	-	G1PKD2	742	I	V
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	751	M	K
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	755	G	R
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	760	R	W
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	766	A	D
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	777	D	N
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	807	R	Q
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	807	R	W
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	810	V	M
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	811	T	M
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	820	A	P
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	881	R	S
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	944	T	I
O95255	LB/B	-	G1PKD2	946	L	I
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	950	A	T
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	992	G	R
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	1056	D	E
O95255	LB/B	-	G1PKD2	1064	R	W
O95255	LP/P	Arterial calcification of infancy, generalized, 2 (GACI2) [MIM:614473]	G1PKD2	1114	R	C
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	1114	R	C
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	1121	S	L
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	1130	T	M
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	1133	G	A
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	1139	A	T
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	1164	R	Q
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	1221	R	C
O95255	LP/P	Arterial calcification of infancy, generalized, 2 (GACI2) [MIM:614473]	G1PKD2	1221	R	H
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	1226	L	I
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	1235	R	W
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	1238	D	H
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	1335	L	P
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	1335	L	Q
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	1339	R	L
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	1339	R	H
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	1346	P	S
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	1357	R	W
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	1400	E	K
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	1406	Q	K
O95255	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	G1PKD2	1459	R	C
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	716	G	V
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	1352	R	P
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	1420	R	C
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	1493	R	W
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	74	R	Q
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	125	H	Q
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	187	V	D
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	188	N	S
Q09428	LB/B	-	G3WN43	275	R	Q
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	406	N	D
Q09428	LB/B	-	G3WN43	560	V	M
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	591	F	L
Q09428	LB/B	-	G3WN43	810	D	N
Q09428	LB/B	-	G3WN43	834	R	C
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	1138	T	M
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	1214	R	Q
Q09428	LB/B	-	G3WN43	1360	V	G
Q09428	LB/B	-	G3WN43	1369	A	S
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	1378	G	R
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	1381	G	S
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	1393	R	H
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	1478	G	R
Q09428	LB/B	-	G3WN43	1572	V	I
Q09428	LB/B	-	G3WN43	673	D	N
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	1360	V	M
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	1436	R	Q
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	1506	E	K
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	1543	L	P
Q09428	LB/B	-	G3WN43	104	L	V
Q09428	LP/P	Diabetes mellitus, permanent neonatal, 3 (PNDM3) [MIM:618857]	G3WN43	132	F	L
Q09428	LP/P	Diabetes mellitus, permanent neonatal, 3 (PNDM3) [MIM:618857]	G3WN43	213	L	R
Q09428	LP/P	Transient neonatal diabetes mellitus 2 (TNDM2) [MIM:610374]	G3WN43	435	C	R
Q09428	LP/P	Transient neonatal diabetes mellitus 2 (TNDM2) [MIM:610374]	G3WN43	582	L	V
Q09428	LP/P	Transient neonatal diabetes mellitus 2 (TNDM2) [MIM:610374]	G3WN43	1023	H	Y
Q09428	LP/P	Transient neonatal diabetes mellitus 2 (TNDM2) [MIM:610374]	G3WN43	1182	R	Q
Q09428	LP/P	Leucine-induced hypoglycemia (LIH) [MIM:240800]	G3WN43	1352	R	H
Q09428	LP/P	Transient neonatal diabetes mellitus 2 (TNDM2) [MIM:610374]	G3WN43	1379	R	C
Q09428	LP/P	Diabetes mellitus, permanent neonatal, 3 (PNDM3) [MIM:618857]	G3WN43	1424	I	V
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	7	G	R
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	21	V	D
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	27	F	S
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	70	G	E
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	74	R	W
Q09428	LP/P	Diabetes mellitus, permanent neonatal, 3 (PNDM3) [MIM:618857]	G3WN43	86	V	A
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	111	G	R
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	116	A	P
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	233	M	R
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	310	D	N
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	418	C	R
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	495	R	Q
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	501	E	K
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	503	L	P
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	508	L	P
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	551	P	R
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	620	R	C
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	686	F	S
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	719	K	T
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	841	R	G
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	889	K	T
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	956	S	F
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	1130	T	P
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	1147	L	R
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	1214	R	W
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	1295	N	K
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	1336	K	N
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	1342	G	E
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	1349	L	Q
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	1384	K	Q
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	1386	S	F
Q09428	LP/P	Diabetes mellitus, permanent neonatal, 3 (PNDM3) [MIM:618857]	G3WN43	1400	G	R
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	1400	G	R
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	1418	R	H
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	1450	L	P
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	1457	A	T
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	1471	D	H
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	1471	D	N
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	1486	R	K
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	1493	R	Q
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	1550	V	D
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	1551	L	V
Q09428	LP/P	Diabetes mellitus, permanent neonatal, 3 (PNDM3) [MIM:618857]	G3WN43	45	P	L
Q09428	LP/P	Diabetes mellitus, permanent neonatal, 3 (PNDM3) [MIM:618857]	G3WN43	72	N	S
Q09428	LP/P	Diabetes mellitus, permanent neonatal, 3 (PNDM3) [MIM:618857]	G3WN43	86	V	G
Q09428	LP/P	Diabetes mellitus, permanent neonatal, 3 (PNDM3) [MIM:618857]	G3WN43	132	F	V
Q09428	LP/P	Diabetes mellitus, permanent neonatal, 3 (PNDM3) [MIM:618857]	G3WN43	207	P	S
Q09428	LP/P	Diabetes mellitus, permanent neonatal, 3 (PNDM3) [MIM:618857]	G3WN43	208	E	K
Q09428	LP/P	Diabetes mellitus, permanent neonatal, 3 (PNDM3) [MIM:618857]	G3WN43	209	D	E
Q09428	LP/P	Diabetes mellitus, permanent neonatal, 3 (PNDM3) [MIM:618857]	G3WN43	211	Q	K
Q09428	LP/P	Diabetes mellitus, permanent neonatal, 3 (PNDM3) [MIM:618857]	G3WN43	225	L	P
Q09428	LP/P	Diabetes mellitus, permanent neonatal, 3 (PNDM3) [MIM:618857]	G3WN43	229	T	I
Q09428	LP/P	Diabetes mellitus, permanent neonatal, 3 (PNDM3) [MIM:618857]	G3WN43	263	Y	D
Q09428	LP/P	Diabetes mellitus, permanent neonatal, 3 (PNDM3) [MIM:618857]	G3WN43	382	E	K
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	511	L	M
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	716	G	D
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	824	E	K
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	890	L	P
Q09428	LP/P	Diabetes mellitus, permanent neonatal, 3 (PNDM3) [MIM:618857]	G3WN43	1184	A	E
Q09428	LP/P	Diabetes mellitus, permanent neonatal, 3 (PNDM3) [MIM:618857]	G3WN43	1326	E	K
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	1378	G	S
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	1388	S	Y
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	1389	L	P
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	1457	A	V
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	1480	N	I
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	1505	D	E
Q09428	LP/P	Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]	G3WN43	1511	I	S
Q09428	LP/P	Diabetes mellitus, permanent neonatal, 3 (PNDM3) [MIM:618857]	G3WN43	1522	V	L
O60706	LP/P	Cardiomyopathy, dilated 1O (CMD1O) [MIM:608569]	G3WN43	1513	A	T
O60706	LB/B	-	G3WN43	1108	P	S
O60706	LP/P	Atrial fibrillation, familial, 12 (ATFB12) [MIM:614050]	G3WN43	1547	T	I
O60706	LP/P	Hypertrichotic osteochondrodysplasia (HTOCD) [MIM:239850]	G3WN43	60	H	Y
O60706	LP/P	Hypertrichotic osteochondrodysplasia (HTOCD) [MIM:239850]	G3WN43	207	D	E
O60706	LP/P	Hypertrichotic osteochondrodysplasia (HTOCD) [MIM:239850]	G3WN43	380	G	C
O60706	LP/P	Hypertrichotic osteochondrodysplasia (HTOCD) [MIM:239850]	G3WN43	432	P	L
O60706	LP/P	Hypertrichotic osteochondrodysplasia (HTOCD) [MIM:239850]	G3WN43	478	A	V
O60706	LP/P	Hypertrichotic osteochondrodysplasia (HTOCD) [MIM:239850]	G3WN43	1020	S	P
O60706	LP/P	Hypertrichotic osteochondrodysplasia (HTOCD) [MIM:239850]	G3WN43	1039	F	S
O60706	LP/P	Hypertrichotic osteochondrodysplasia (HTOCD) [MIM:239850]	G3WN43	1043	C	Y
O60706	LP/P	Hypertrichotic osteochondrodysplasia (HTOCD) [MIM:239850]	G3WN43	1054	S	Y
O60706	LP/P	Hypertrichotic osteochondrodysplasia (HTOCD) [MIM:239850]	G3WN43	1116	R	C
O60706	LP/P	Hypertrichotic osteochondrodysplasia (HTOCD) [MIM:239850]	G3WN43	1116	R	H
O60706	LP/P	Hypertrichotic osteochondrodysplasia (HTOCD) [MIM:239850]	G3WN43	1154	R	Q
O60706	LP/P	Hypertrichotic osteochondrodysplasia (HTOCD) [MIM:239850]	G3WN43	1154	R	W
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	98	S	L
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	104	R	C
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	104	R	H
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	105	T	I
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	107	L	P
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	108	S	W
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	116	G	R
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	141	A	T
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	148	N	S
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	149	S	N
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	152	R	P
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	163	R	H
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	174	Y	D
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	174	Y	S
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	178	Q	E
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	182	R	P
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	194	D	H
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	200	D	V
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	211	L	P
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	220	L	P
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	221	D	G
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	254	T	M
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	254	T	P
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	263	P	L
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	266	G	R
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	276	K	E
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	277	G	R
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	277	G	W
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	291	E	D
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	291	E	K
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	294	A	T
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	342	S	P
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	389	R	G
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	389	R	H
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	401	R	Q
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	418	R	W
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	484	P	R
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	507	G	V
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	512	G	S
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	515	S	F
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	518	R	Q
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	518	R	W
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	522	G	W
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	534	P	L
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	560	P	L
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	560	P	R
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	566	M	K
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	591	R	Q
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	606	S	L
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	606	S	P
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	609	E	G
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	609	E	K
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	617	R	C
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	617	R	G
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	617	R	H
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	626	A	T
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	629	D	H
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	660	R	W
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	679	W	R
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	90	E	K
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	103	S	R
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	105	T	P
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	108	S	L
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	113	R	C
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	143	P	S
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	152	R	L
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	152	R	S
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	161	S	P
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	163	R	P
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	174	Y	C
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	189	R	W
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	190	L	P
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	198	T	K
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	200	D	N
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	213	S	C
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	214	N	D
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	218	P	T
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	229	L	P
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	271	E	K
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	285	R	P
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	296	Y	C
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	298	G	D
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	302	E	K
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	322	L	P
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	336	K	M
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	401	R	W
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	529	G	S
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	540	F	S
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	543	P	L
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	544	Q	R
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	552	S	P
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	554	R	H
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	591	R	W
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	616	A	V
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	630	E	G
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	631	C	Y
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	633	S	R
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	636	S	I
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	638	D	Y
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	646	A	P
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	654	L	P
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	667	H	D
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	668	T	I
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	693	T	M
P33897	LB/B	-	A0A2Y9EC48	13	N	T
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	99	A	D
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	113	R	P
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	217	K	E
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	224	V	E
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	274	R	W
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	280	R	C
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	339	W	R
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	343	G	D
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	556	Q	R
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	560	P	S
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	591	R	P
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	608	G	D
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	626	A	D
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	632	T	I
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	633	S	I
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	635	V	M
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	660	R	P
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	198	T	R
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	266	G	E
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	523	L	F
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	540	F	C
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	632	T	P
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	640	E	K
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	677	G	D
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	516	L	P
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	660	R	Q
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	95	A	D
P33897	LP/P	Adrenoleukodystrophy (ALD) [MIM:300100]	A0A2Y9EC48	316	Q	P
P28288	LB/B	-	A0A1U7UKN4	17	G	D
O14678	LB/B	-	V8PEF8	368	E	K
O14678	LB/B	-	V8PEF8	304	A	T
O14678	LB/B	-	V8PEF8	172	V	I
O14678	LB/B	-	V8PEF8	350	T	R
O14678	LP/P	Methylmalonic aciduria and homocystinuria type cblJ (MAHCJ) [MIM:614857]	V8PEF8	319	Y	C
O14678	LP/P	Methylmalonic aciduria and homocystinuria type cblJ (MAHCJ) [MIM:614857]	V8PEF8	141	N	K
O14678	LP/P	Methylmalonic aciduria and homocystinuria type cblJ (MAHCJ) [MIM:614857]	V8PEF8	432	R	Q
P61221	LB/B	-	A0A2K3DFI2	489	S	C
Q8NE71	LB/B	-	H3A7X9	198	N	D
Q9NUQ8	LB/B	-	S7PSG2	503	P	L
Q9NUQ8	LB/B	-	S7PSG2	510	R	H
P45844	LB/B	-	A0A2I2V4C9	668	F	L
Q9UNQ0	LB/B	-	A0A091DDD4	431	F	L
Q9UNQ0	LB/B	-	A0A091DDD4	489	F	L
Q9UNQ0	LB/B	-	A0A091DDD4	12	V	M
Q9UNQ0	LB/B	-	A0A091DDD4	141	Q	K
Q9UNQ0	LB/B	-	A0A091DDD4	316	T	P
Q9UNQ0	LB/B	-	A0A091DDD4	166	Q	E
Q9UNQ0	LB/B	-	A0A091DDD4	206	I	L
Q9UNQ0	LB/B	-	A0A091DDD4	208	F	S
Q9UNQ0	LB/B	-	A0A091DDD4	248	S	P
Q9UNQ0	LB/B	-	A0A091DDD4	571	F	I
Q9UNQ0	LB/B	-	A0A091DDD4	620	D	N
Q9UNQ0	LB/B	-	A0A091DDD4	296	D	H
Q9UNQ0	LB/B	-	A0A091DDD4	528	A	T
Q9UNQ0	LB/B	-	A0A091DDD4	590	N	Y
Q9UNQ0	LB/B	-	A0A091DDD4	13	S	L
Q9UNQ0	LB/B	-	A0A091DDD4	160	R	Q
Q9UNQ0	LB/B	-	A0A091DDD4	354	G	R
Q9UNQ0	LB/B	-	A0A091DDD4	441	S	N
Q9UNQ0	LB/B	-	A0A091DDD4	147	R	W
Q9UNQ0	LB/B	-	A0A091DDD4	153	T	M
Q9UNQ0	LB/B	-	A0A091DDD4	373	F	C
Q9UNQ0	LB/B	-	A0A091DDD4	421	T	A
Q9UNQ0	LB/B	-	A0A091DDD4	434	T	M
Q9UNQ0	LB/B	-	A0A091DDD4	476	S	P
Q9UNQ0	LB/B	-	A0A091DDD4	572	S	R
Q9H172	LB/B	-	G1TCM8	352	P	L
Q9H222	LP/P	Sitosterolemia 2 (STSL2) [MIM:618666]	A0A091CN26	146	E	Q
Q9H222	LP/P	Sitosterolemia 2 (STSL2) [MIM:618666]	A0A091CN26	389	R	H
Q9H222	LP/P	Sitosterolemia 2 (STSL2) [MIM:618666]	A0A091CN26	419	R	H
Q9H222	LP/P	Sitosterolemia 2 (STSL2) [MIM:618666]	A0A091CN26	419	R	P
Q9H222	LP/P	Sitosterolemia 2 (STSL2) [MIM:618666]	A0A091CN26	550	R	S
Q9H222	LB/B	-	A0A091CN26	604	Q	E
Q9H222	LP/P	Sitosterolemia 2 (STSL2) [MIM:618666]	A0A091CN26	437	N	K
Q9H222	LB/B	-	A0A091CN26	523	I	V
Q9H222	LB/B	-	A0A091CN26	600	C	Y
Q9H222	LB/B	-	A0A091CN26	622	M	V
Q9H222	LB/B	-	A0A091CN26	517	T	S
Q9H222	LB/B	-	A0A091CN26	50	R	C
Q9H221	LB/B	-	A0A2D0QNY6	19	D	H
Q9H221	LB/B	-	A0A2D0QNY6	54	Y	C
Q9H221	LP/P	Sitosterolemia 1 (STSL1) [MIM:210250]	A0A2D0QNY6	184	R	H
Q9H221	LP/P	Sitosterolemia 1 (STSL1) [MIM:210250]	A0A2D0QNY6	231	P	T
Q9H221	LB/B	-	A0A2D0QNY6	259	A	V
Q9H221	LP/P	Sitosterolemia 1 (STSL1) [MIM:210250]	A0A2D0QNY6	263	R	Q
Q9H221	LB/B	-	A0A2D0QNY6	400	T	K
Q9H221	LP/P	Sitosterolemia 1 (STSL1) [MIM:210250]	A0A2D0QNY6	405	R	H
Q9H221	LP/P	Sitosterolemia 1 (STSL1) [MIM:210250]	A0A2D0QNY6	501	L	P
Q9H221	LP/P	Sitosterolemia 1 (STSL1) [MIM:210250]	A0A2D0QNY6	543	R	S
Q9H221	LP/P	Sitosterolemia 1 (STSL1) [MIM:210250]	A0A2D0QNY6	572	L	P
Q9H221	LP/P	Sitosterolemia 1 (STSL1) [MIM:210250]	A0A2D0QNY6	574	G	E
Q9H221	LP/P	Sitosterolemia 1 (STSL1) [MIM:210250]	A0A2D0QNY6	574	G	R
Q9H221	LB/B	-	A0A2D0QNY6	575	G	R
Q9H221	LP/P	Sitosterolemia 1 (STSL1) [MIM:210250]	A0A2D0QNY6	596	L	R
Q9H221	LB/B	-	A0A2D0QNY6	632	V	A
Q9H221	LB/B	-	A0A2D0QNY6	641	Y	F
Q9H221	LB/B	-	A0A2D0QNY6	210	V	M
Q9H221	LB/B	-	A0A2D0QNY6	655	M	V
Q96SE0	LB/B	-	A0A2U4BXW8	137	D	E
Q96SE0	LB/B	-	A0A2U4BXW8	371	W	C
Q96SE0	LB/B	-	A0A2U4BXW8	54	P	Q
Q9NUJ1	LB/B	-	A0A2R8ZVR0	251	I	V
Q8N2K0	LB/B	-	A0A2U3VT68	349	A	T
Q8N2K0	LP/P	Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract (PHARC) [MIM:612674]	A0A2U3VT68	253	T	R
Q7Z5M8	LB/B	-	G3TF36	334	F	L
Q9BUJ0	LB/B	-	A0A0K8S2U7	32	R	Q
Q9BUJ0	LB/B	-	A0A0K8S2U7	61	C	W
Q6UXT9	LB/B	-	A0A2K6NFK9	334	T	A
O95870	LP/P	Spastic paraplegia 86, autosomal recessive (SPG86) [MIM:619735]	A0A067QXZ6	118	R	H
O95870	LP/P	Spastic paraplegia 86, autosomal recessive (SPG86) [MIM:619735]	A0A067QXZ6	457	R	Q
Q9H3Z7	LB/B	-	A0A2K5ZDP5	10	L	Q
Q5VST6	LB/B	-	L9KPN9	169	Q	K
Q5VST6	LB/B	-	L9KPN9	154	R	K
P08910	LB/B	-	A0A1B6L2E9	253	R	Q
Q8WU67	LB/B	-	A7RIC9	3	R	C
Q8WTS1	LP/P	Chanarin-Dorfman syndrome (CDS) [MIM:275630]	A0A1U7UTT0	7	E	K
Q8WTS1	LP/P	Chanarin-Dorfman syndrome (CDS) [MIM:275630]	A0A1U7UTT0	130	Q	P
Q8WTS1	LP/P	Chanarin-Dorfman syndrome (CDS) [MIM:275630]	A0A1U7UTT0	260	E	K
Q8WTS1	LB/B	-	A0A1U7UTT0	72	I	T
Q8WTS1	LB/B	-	A0A1U7UTT0	82	H	R
Q8WTS1	LP/P	Chanarin-Dorfman syndrome (CDS) [MIM:275630]	A0A1U7UTT0	115	S	G
Q9BV23	LB/B	-	A0A0S7L748	113	R	H
Q9BV23	LB/B	-	A0A0S7L748	148	S	C
Q9BV23	LB/B	-	A0A0S7L748	204	P	L
Q9BV23	LB/B	-	A0A0S7L748	206	T	P
Q9BV23	LB/B	-	A0A0S7L748	231	G	V
Q8IZP0	LB/B	-	P62484	331	G	A
Q9P2A4	LB/B	-	A0A093GD29	44	R	Q
Q9P2A4	LB/B	-	A0A093GD29	203	S	F
Q9P2A4	LB/B	-	A0A093GD29	209	F	S
O94929	LB/B	-	A0A2Y9LZ25	125	G	D
P16442	LB/B	-	A0A2Y9E7R2	156	P	L
P16442	LB/B	-	A0A2Y9E7R2	176	R	G
P16442	LB/B	-	A0A2Y9E7R2	235	G	S
P16442	LB/B	-	A0A2Y9E7R2	266	L	M
P16442	LB/B	-	A0A2Y9E7R2	268	G	A
P16442	LB/B	-	A0A2Y9E7R2	352	R	W
P16442	LB/B	-	A0A2Y9E7R2	35	G	R
P16442	LB/B	-	A0A2Y9E7R2	36	V	F
P16442	LB/B	-	A0A2Y9E7R2	63	R	H
P16442	LB/B	-	A0A2Y9E7R2	74	P	S
P16442	LB/B	-	A0A2Y9E7R2	161	R	H
P16442	LB/B	-	A0A2Y9E7R2	199	R	C
P16442	LB/B	-	A0A2Y9E7R2	216	F	I
P16442	LB/B	-	A0A2Y9E7R2	277	V	M
P16442	LB/B	-	A0A2Y9E7R2	257	P	L
P16442	LB/B	-	A0A2Y9E7R2	268	G	R
P16442	LB/B	-	A0A2Y9E7R2	163	T	M
P16442	LB/B	-	A0A2Y9E7R2	198	R	W
P16442	LB/B	-	A0A2Y9E7R2	214	M	R
P16442	LB/B	-	A0A2Y9E7R2	223	E	D
P16442	LB/B	-	A0A2Y9E7R2	288	M	R
P16442	LB/B	-	A0A2Y9E7R2	291	D	N
P16442	LB/B	-	A0A2Y9E7R2	346	K	M
P16442	LB/B	-	A0A2Y9E7R2	352	R	G
P16442	LB/B	-	A0A2Y9E7R2	234	P	A
Q12979	LB/B	-	A0A2X0SFQ7	517	K	R
Q6UWZ7	LB/B	-	A0A0K8RXI3	239	A	T
Q6UWZ7	LB/B	-	A0A0K8RXI3	348	A	T
Q6UWZ7	LB/B	-	A0A0K8RXI3	373	D	N
Q6UWZ7	LP/P	Breast cancer (BC) [MIM:114480]	A0A0K8RXI3	361	R	Q
Q8N961	LB/B	-	A0A1B6KNY1	250	H	Q
Q8N961	LB/B	-	A0A1B6KNY1	918	T	A
A6QL63	LB/B	-	W5LLE4	1002	A	D
A6QL63	LB/B	-	W5LLE4	1076	G	S
A6QL63	LB/B	-	W5LLE4	448	G	S
P42765	LB/B	-	A0A1Q8V3R3	217	M	V
Q13085	LB/B	-	A0A2T7P3W9	2271	A	V
Q13085	LB/B	-	A0A2T7P3W9	838	R	W
O00763	LB/B	-	A0A2T7P3W9	552	I	V
O00763	LB/B	-	A0A2T7P3W9	651	A	T
O00763	LB/B	-	A0A2T7P3W9	2141	V	I
Q6JQN1	LB/B	-	L9KUV6	200	Q	R
Q6JQN1	LB/B	-	L9KUV6	216	T	P
Q6JQN1	LB/B	-	L9KUV6	463	D	N
Q6JQN1	LB/B	-	L9KUV6	880	A	V
Q709F0	LB/B	-	L5LI56	362	V	L
Q9H845	LB/B	-	A0A146UVR0	477	R	Q
Q9H845	LP/P	Mitochondrial complex I deficiency, nuclear type 20 (MC1DN20) [MIM:611126]	A0A146UVR0	44	F	I
Q9H845	LP/P	Mitochondrial complex I deficiency, nuclear type 20 (MC1DN20) [MIM:611126]	A0A146UVR0	127	R	K
Q9H845	LP/P	Mitochondrial complex I deficiency, nuclear type 20 (MC1DN20) [MIM:611126]	A0A146UVR0	220	A	V
Q9H845	LP/P	Mitochondrial complex I deficiency, nuclear type 20 (MC1DN20) [MIM:611126]	A0A146UVR0	266	R	Q
Q9H845	LP/P	Mitochondrial complex I deficiency, nuclear type 20 (MC1DN20) [MIM:611126]	A0A146UVR0	414	R	C
Q9H845	LP/P	Mitochondrial complex I deficiency, nuclear type 20 (MC1DN20) [MIM:611126]	A0A146UVR0	417	R	C
Q9H845	LP/P	Mitochondrial complex I deficiency, nuclear type 20 (MC1DN20) [MIM:611126]	A0A146UVR0	469	R	W
Q9H845	LP/P	Mitochondrial complex I deficiency, nuclear type 20 (MC1DN20) [MIM:611126]	A0A146UVR0	518	R	H
Q9H845	LP/P	Mitochondrial complex I deficiency, nuclear type 20 (MC1DN20) [MIM:611126]	A0A146UVR0	532	R	W
Q9H845	LP/P	Mitochondrial complex I deficiency, nuclear type 20 (MC1DN20) [MIM:611126]	A0A146UVR0	271	C	G
Q9H845	LP/P	Mitochondrial complex I deficiency, nuclear type 20 (MC1DN20) [MIM:611126]	A0A146UVR0	384	V	M
Q9H845	LP/P	Mitochondrial complex I deficiency, nuclear type 20 (MC1DN20) [MIM:611126]	A0A146UVR0	606	L	H
P11310	LP/P	Acyl-CoA dehydrogenase medium-chain deficiency (ACADMD) [MIM:201450]	U3KM39	53	R	C
P11310	LP/P	Acyl-CoA dehydrogenase medium-chain deficiency (ACADMD) [MIM:201450]	U3KM39	149	M	I
P11310	LP/P	Acyl-CoA dehydrogenase medium-chain deficiency (ACADMD) [MIM:201450]	U3KM39	193	T	A
P11310	LP/P	Acyl-CoA dehydrogenase medium-chain deficiency (ACADMD) [MIM:201450]	U3KM39	195	G	R
P11310	LP/P	Acyl-CoA dehydrogenase medium-chain deficiency (ACADMD) [MIM:201450]	U3KM39	244	C	R
P11310	LP/P	Acyl-CoA dehydrogenase medium-chain deficiency (ACADMD) [MIM:201450]	U3KM39	267	G	R
P11310	LP/P	Acyl-CoA dehydrogenase medium-chain deficiency (ACADMD) [MIM:201450]	U3KM39	326	M	T
P11310	LP/P	Acyl-CoA dehydrogenase medium-chain deficiency (ACADMD) [MIM:201450]	U3KM39	329	K	E
P11310	LP/P	Acyl-CoA dehydrogenase medium-chain deficiency (ACADMD) [MIM:201450]	U3KM39	336	S	R
P11310	LP/P	Acyl-CoA dehydrogenase medium-chain deficiency (ACADMD) [MIM:201450]	U3KM39	375	I	T
P11310	LP/P	Acyl-CoA dehydrogenase medium-chain deficiency (ACADMD) [MIM:201450]	U3KM39	67	Y	H
P11310	LP/P	Acyl-CoA dehydrogenase medium-chain deficiency (ACADMD) [MIM:201450]	U3KM39	245	S	L
P11310	LP/P	Acyl-CoA dehydrogenase medium-chain deficiency (ACADMD) [MIM:201450]	U3KM39	281	R	T
P11310	LP/P	Acyl-CoA dehydrogenase medium-chain deficiency (ACADMD) [MIM:201450]	U3KM39	78	I	T
P11310	LP/P	Acyl-CoA dehydrogenase medium-chain deficiency (ACADMD) [MIM:201450]	U3KM39	116	C	Y
P11310	LP/P	Acyl-CoA dehydrogenase medium-chain deficiency (ACADMD) [MIM:201450]	U3KM39	121	T	I
P11310	LP/P	Acyl-CoA dehydrogenase medium-chain deficiency (ACADMD) [MIM:201450]	U3KM39	206	R	L
P11310	LP/P	Acyl-CoA dehydrogenase medium-chain deficiency (ACADMD) [MIM:201450]	U3KM39	310	G	R
P11310	LP/P	Acyl-CoA dehydrogenase medium-chain deficiency (ACADMD) [MIM:201450]	U3KM39	352	Y	C
P16219	LP/P	Acyl-CoA dehydrogenase short-chain deficiency (ACADSD) [MIM:201470]	F7IGH4	46	R	W
P16219	LP/P	Acyl-CoA dehydrogenase short-chain deficiency (ACADSD) [MIM:201470]	F7IGH4	92	G	C
P16219	LP/P	Acyl-CoA dehydrogenase short-chain deficiency (ACADSD) [MIM:201470]	F7IGH4	107	R	C
P16219	LP/P	Acyl-CoA dehydrogenase short-chain deficiency (ACADSD) [MIM:201470]	F7IGH4	177	W	R
P16219	LB/B	-	F7IGH4	209	G	S
P16219	LP/P	Acyl-CoA dehydrogenase short-chain deficiency (ACADSD) [MIM:201470]	F7IGH4	383	R	C
P16219	LP/P	Acyl-CoA dehydrogenase short-chain deficiency (ACADSD) [MIM:201470]	F7IGH4	90	G	S
P16219	LB/B	-	F7IGH4	171	R	W
P16219	LP/P	Acyl-CoA dehydrogenase short-chain deficiency (ACADSD) [MIM:201470]	F7IGH4	192	A	V
P16219	LP/P	Acyl-CoA dehydrogenase short-chain deficiency (ACADSD) [MIM:201470]	F7IGH4	325	R	W
P16219	LP/P	Acyl-CoA dehydrogenase short-chain deficiency (ACADSD) [MIM:201470]	F7IGH4	353	S	L
P16219	LP/P	Acyl-CoA dehydrogenase short-chain deficiency (ACADSD) [MIM:201470]	F7IGH4	380	R	W
P16219	LB/B	-	F7IGH4	383	R	H
P16112	LB/B	-	H0YMF1	102	D	E
P16112	LB/B	-	H0YMF1	275	R	Q
P16112	LB/B	-	H0YMF1	2058	P	L
P16112	LB/B	-	H0YMF1	2120	S	R
P16112	LP/P	Spondyloepimetaphyseal dysplasia, aggrecan type (SEMDAG) [MIM:612813]	H0YMF1	2381	D	N
P16112	LP/P	Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans (SSOAOD) [MIM:165800]	H0YMF1	2418	V	M
P16112	LB/B	-	H0YMF1	864	P	L
P16112	LB/B	-	H0YMF1	913	P	T
P16112	LB/B	-	H0YMF1	930	S	I
P16112	LB/B	-	H0YMF1	939	S	T
P16112	LB/B	-	H0YMF1	1080	T	A
P16112	LB/B	-	H0YMF1	1403	T	A
P16112	LB/B	-	H0YMF1	1508	E	A
P16112	LB/B	-	H0YMF1	1765	I	V
P16112	LB/B	-	H0YMF1	2079	I	V
P16112	LB/B	-	H0YMF1	2373	D	E
P16112	LB/B	-	H0YMF1	2500	Q	R
Q15027	LB/B	-	L9KLJ9	68	R	C
Q15027	LB/B	-	L9KLJ9	533	R	W
P24752	LB/B	-	A0A2R7VSH8	5	A	P
P24752	LP/P	3-ketothiolase deficiency (3KTD) [MIM:203750]	A0A2R7VSH8	93	N	S
P24752	LP/P	3-ketothiolase deficiency (3KTD) [MIM:203750]	A0A2R7VSH8	152	G	A
P24752	LP/P	3-ketothiolase deficiency (3KTD) [MIM:203750]	A0A2R7VSH8	158	N	D
P24752	LP/P	3-ketothiolase deficiency (3KTD) [MIM:203750]	A0A2R7VSH8	183	G	R
P24752	LP/P	3-ketothiolase deficiency (3KTD) [MIM:203750]	A0A2R7VSH8	297	T	M
P24752	LP/P	3-ketothiolase deficiency (3KTD) [MIM:203750]	A0A2R7VSH8	301	A	P
P24752	LP/P	3-ketothiolase deficiency (3KTD) [MIM:203750]	A0A2R7VSH8	312	I	T
P24752	LP/P	3-ketothiolase deficiency (3KTD) [MIM:203750]	A0A2R7VSH8	333	A	P
P24752	LP/P	3-ketothiolase deficiency (3KTD) [MIM:203750]	A0A2R7VSH8	379	G	V
P24752	LP/P	3-ketothiolase deficiency (3KTD) [MIM:203750]	A0A2R7VSH8	380	A	T
Q9H3P7	LB/B	-	A0A2K6ENY8	187	E	D
Q5T8D3	LB/B	-	A0A286ZLW3	472	T	M
Q96QU6	LB/B	-	G3W3L0	421	P	L
Q96QU6	LB/B	-	G3W3L0	59	D	N
Q96QU6	LB/B	-	G3W3L0	134	D	E
P12821	LB/B	-	F6PS42	261	A	S
P12821	LB/B	-	F6PS42	561	R	W
P12821	LB/B	-	F6PS42	1286	R	S
P12821	LB/B	-	F6PS42	1018	I	T
P12821	LB/B	-	F6PS42	1051	F	V
P12821	LB/B	-	F6PS42	1279	R	Q
P12821	LB/B	-	F6PS42	1296	Q	P
P12821	LB/B	-	F6PS42	592	D	G
P12821	LB/B	-	F6PS42	244	Y	C
P12821	LB/B	-	F6PS42	351	P	L
P12821	LB/B	-	F6PS42	916	T	M
P12821	LB/B	-	F6PS42	1187	T	M
P12821	LB/B	-	F6PS42	1228	P	L
P12821	LB/B	-	F6PS42	154	A	T
P12821	LB/B	-	F6PS42	183	A	T
P12821	LB/B	-	F6PS42	379	R	Q
P12821	LB/B	-	F6PS42	524	V	A
P12821	LB/B	-	F6PS42	828	M	T
P12821	LB/B	-	F6PS42	354	G	R
P12821	LB/B	-	F6PS42	260	R	C
P12821	LB/B	-	F6PS42	260	R	L
P12821	LB/B	-	F6PS42	295	D	N
Q9BYF1	LB/B	-	R7VQ59	26	K	R
Q9BYF1	LB/B	-	R7VQ59	638	N	S
Q9BYF1	LB/B	-	R7VQ59	468	I	V
Q9BYF1	LB/B	-	R7VQ59	720	N	D
Q5QJU3	LB/B	-	S9X805	134	A	V
Q9NUN7	LP/P	Leukodystrophy, progressive, early childhood-onset (PLDECO) [MIM:617762]	S7PD34	33	E	G
P22303	LB/B	-	L9K1D4	353	H	N
P22303	LB/B	-	L9K1D4	333	V	E
P22303	LB/B	-	L9K1D4	34	R	Q
P22303	LB/B	-	L9K1D4	135	P	A
Q9UKV3	LB/B	-	A0A1A6H5H6	311	I	M
Q9UKV3	LB/B	-	A0A1A6H5H6	467	S	P
Q9UKV3	LB/B	-	A0A1A6H5H6	478	S	F
Q9UKV3	LB/B	-	A0A1A6H5H6	257	R	K
Q9UKV3	LB/B	-	A0A1A6H5H6	447	A	P
Q16570	LB/B	-	E2R629	42	G	D
Q16570	LB/B	-	E2R629	89	R	C
Q16570	LB/B	-	E2R629	100	A	T
Q16570	LB/B	-	E2R629	203	L	Q
Q16570	LB/B	-	E2R629	326	S	F
O00590	LB/B	-	L5KH70	373	Y	S
O00590	LB/B	-	L5KH70	41	V	A
O00590	LB/B	-	L5KH70	248	A	V
O00590	LB/B	-	L5KH70	311	L	V
P25106	LB/B	-	A0A0P7TWK2	219	L	W
P25106	LP/P	Oculomotor-abducens synkinesis (OCABSN) [MIM:619215]	A0A0P7TWK2	258	V	M
P53396	LB/B	-	K9J7M6	175	E	D
P21399	LB/B	-	A0A1Y1IIL8	395	A	D
P21399	LB/B	-	A0A1Y1IIL8	486	G	R
P21399	LB/B	-	A0A1Y1IIL8	318	T	M
Q99798	LB/B	-	L8H690	768	A	S
Q99798	LP/P	Infantile cerebellar-retinal degeneration (ICRD) [MIM:614559]	L8H690	112	S	R
Q99798	LP/P	Optic atrophy 9 (OPA9) [MIM:616289]	L8H690	74	L	V
Q99798	LP/P	Infantile cerebellar-retinal degeneration (ICRD) [MIM:614559]	L8H690	259	G	D
Q99798	LP/P	Optic atrophy 9 (OPA9) [MIM:616289]	L8H690	661	G	R
Q99798	LP/P	Infantile cerebellar-retinal degeneration (ICRD) [MIM:614559]	L8H690	736	K	N
A6NK06	LB/B	-	A0A2Y9NLZ3	97	T	M
A6NK06	LB/B	-	A0A2Y9NLZ3	159	H	R
A6NK06	LB/B	-	A0A2Y9NLZ3	272	K	Q
A6NK06	LB/B	-	A0A2Y9NLZ3	277	H	Y
A6NK06	LB/B	-	A0A2Y9NLZ3	331	R	H
Q86TX2	LB/B	-	A0A2R8Z7Z6	266	R	H
Q8WYK0	LB/B	-	H2PG07	230	V	I
Q8WYK0	LB/B	-	H2PG07	403	A	T
P49753	LB/B	-	A0A2R8Z7Z6	475	H	R
P49753	LB/B	-	A0A2R8Z7Z6	16	R	S
Q8N9L9	LB/B	-	A0A2R8Z7Z6	57	R	C
Q8N9L9	LB/B	-	A0A2R8Z7Z6	187	A	D
Q3I5F7	LB/B	-	A0A286XRC6	380	E	K
Q15067	LB/B	-	A0A0J7KMP9	312	I	M
Q15067	LP/P	Adrenoleukodystrophy, pseudoneonatal (Pseudo-NALD) [MIM:264470]	A0A0J7KMP9	178	G	C
Q15067	LP/P	Adrenoleukodystrophy, pseudoneonatal (Pseudo-NALD) [MIM:264470]	A0A0J7KMP9	278	M	V
Q15067	LB/B	-	A0A0J7KMP9	153	T	I
Q15067	LB/B	-	A0A0J7KMP9	101	G	S
Q15067	LP/P	Adrenoleukodystrophy, pseudoneonatal (Pseudo-NALD) [MIM:264470]	A0A0J7KMP9	184	S	L
Q15067	LP/P	Adrenoleukodystrophy, pseudoneonatal (Pseudo-NALD) [MIM:264470]	A0A0J7KMP9	231	G	V
Q15067	LP/P	Adrenoleukodystrophy, pseudoneonatal (Pseudo-NALD) [MIM:264470]	A0A0J7KMP9	309	Q	R
Q15067	LP/P	Adrenoleukodystrophy, pseudoneonatal (Pseudo-NALD) [MIM:264470]	A0A0J7KMP9	310	S	P
Q15067	LP/P	Mitchell syndrome (MITCH) [MIM:618960]	A0A0J7KMP9	237	N	S
Q99424	LP/P	Congenital bile acid synthesis defect 6 (CBAS6) [MIM:617308]	A0A0D2VH12	225	R	W
O15254	LB/B	-	Q4T5R1	34	E	A
O15254	LB/B	-	Q4T5R1	497	D	N
P11117	LB/B	-	A0A2D4LNX9	29	R	Q
P11117	LB/B	-	A0A2D4LNX9	320	S	F
P11117	LB/B	-	A0A2D4LNX9	402	V	I
P15309	LB/B	-	G3PM19	15	S	N
P15309	LB/B	-	G3PM19	124	F	V
P15309	LB/B	-	G3PM19	226	W	R
P15309	LB/B	-	G3PM19	330	Y	H
P15309	LB/B	-	G3PM19	360	V	A
Q9BZG2	LP/P	Amelogenesis imperfecta 1J (AI1J) [MIM:617297]	S7NFI8	76	R	C
Q9BZG2	LP/P	Amelogenesis imperfecta 1J (AI1J) [MIM:617297]	S7NFI8	111	R	C
Q9BZG2	LP/P	Amelogenesis imperfecta 1J (AI1J) [MIM:617297]	S7NFI8	238	S	L
P13686	LB/B	-	A0A1X7V516	148	V	M
P13686	LB/B	-	A0A1X7V516	200	V	M
P13686	LB/B	-	A0A1X7V516	221	V	I
P13686	LP/P	Spondyloenchondrodysplasia with immune dysregulation (SPENCDI) [MIM:607944]	A0A1X7V516	52	K	M
P13686	LP/P	Spondyloenchondrodysplasia with immune dysregulation (SPENCDI) [MIM:607944]	A0A1X7V516	89	T	I
P13686	LP/P	Spondyloenchondrodysplasia with immune dysregulation (SPENCDI) [MIM:607944]	A0A1X7V516	109	G	R
P13686	LP/P	Spondyloenchondrodysplasia with immune dysregulation (SPENCDI) [MIM:607944]	A0A1X7V516	201	L	P
P13686	LP/P	Spondyloenchondrodysplasia with immune dysregulation (SPENCDI) [MIM:607944]	A0A1X7V516	215	G	R
P13686	LP/P	Spondyloenchondrodysplasia with immune dysregulation (SPENCDI) [MIM:607944]	A0A1X7V516	241	D	N
P13686	LP/P	Spondyloenchondrodysplasia with immune dysregulation (SPENCDI) [MIM:607944]	A0A1X7V516	262	N	H
P13686	LP/P	Spondyloenchondrodysplasia with immune dysregulation (SPENCDI) [MIM:607944]	A0A1X7V516	264	M	K
Q9NPH0	LB/B	-	G3NHL0	316	M	V
P10323	LB/B	-	A0A2J8XTL1	120	L	V
P10323	LB/B	-	A0A2J8XTL1	166	F	L
Q4G176	LB/B	-	A0A2Y9K1R8	2	L	P
Q4G176	LB/B	-	A0A2Y9K1R8	17	A	P
Q4G176	LB/B	-	A0A2Y9K1R8	372	V	M
Q4G176	LP/P	Combined malonic and methylmalonic aciduria (CMAMMA) [MIM:614265]	A0A2Y9K1R8	198	M	R
Q4G176	LP/P	Combined malonic and methylmalonic aciduria (CMAMMA) [MIM:614265]	A0A2Y9K1R8	243	P	L
Q4G176	LP/P	Combined malonic and methylmalonic aciduria (CMAMMA) [MIM:614265]	A0A2Y9K1R8	358	T	I
Q4G176	LP/P	Combined malonic and methylmalonic aciduria (CMAMMA) [MIM:614265]	A0A2Y9K1R8	359	E	K
Q4G176	LP/P	Combined malonic and methylmalonic aciduria (CMAMMA) [MIM:614265]	A0A2Y9K1R8	462	K	T
Q4G176	LP/P	Combined malonic and methylmalonic aciduria (CMAMMA) [MIM:614265]	A0A2Y9K1R8	471	R	Q
Q4G176	LP/P	Combined malonic and methylmalonic aciduria (CMAMMA) [MIM:614265]	A0A2Y9K1R8	471	R	W
Q4G176	LP/P	Combined malonic and methylmalonic aciduria (CMAMMA) [MIM:614265]	A0A2Y9K1R8	480	G	S
Q4G176	LP/P	Combined malonic and methylmalonic aciduria (CMAMMA) [MIM:614265]	A0A2Y9K1R8	558	R	W
O95573	LB/B	-	A0A1L8F7I4	551	F	S
O60488	LP/P	Intellectual developmental disorder, X-linked 63 (XLID63) [MIM:300387]	A0A1L8F7I4	570	R	S
O60488	LB/B	-	A0A1L8F7I4	379	D	N
Q08AH1	LB/B	-	A0A257AJY6	479	I	V
Q08AH1	LB/B	-	A0A257AJY6	515	I	T
Q08AH1	LB/B	-	A0A257AJY6	272	I	M
Q08AH3	LB/B	-	A0A257AJY6	513	S	L
Q08AH3	LB/B	-	A0A257AJY6	561	A	T
Q08AH3	LB/B	-	A0A257AJY6	335	V	L
Q08AH3	LB/B	-	A0A257AJY6	337	V	G
Q53FZ2	LB/B	-	A0A257AJY6	100	L	P
Q53FZ2	LB/B	-	A0A257AJY6	308	P	T
Q53FZ2	LB/B	-	A0A257AJY6	367	K	N
Q53FZ2	LB/B	-	A0A257AJY6	270	D	H
P0C7M7	LB/B	-	A0A257AJY6	481	R	H
Q6NUN0	LB/B	-	A0A257AJY6	159	Q	H
Q6NUN0	LB/B	-	A0A257AJY6	352	P	R
Q6NUN0	LB/B	-	A0A257AJY6	360	H	R
Q6NUN0	LB/B	-	A0A257AJY6	533	T	M
Q6NUN0	LB/B	-	A0A257AJY6	65	R	Q
Q6NUN0	LB/B	-	A0A257AJY6	182	E	K
Q6NUN0	LB/B	-	A0A257AJY6	217	M	V
Q6P461	LB/B	-	S7N006	227	K	R
Q6P461	LB/B	-	S7N006	19	E	G
Q6P461	LB/B	-	S7N006	40	C	S
Q9NUB1	LB/B	-	A0A2U3ZDS7	488	V	M
P68133	LP/P	Myopathy, actin, congenital, with excess of thin myofilaments (MPCETM) [MIM:161800]	A0A2P6N765	17	G	R
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	96	L	P
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	117	N	S
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	138	I	M
P68133	LP/P	Myopathy, actin, congenital, with excess of thin myofilaments (MPCETM) [MIM:161800]	A0A2P6N765	165	V	L
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	261	E	V
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	270	G	C
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	372	V	F
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	134	M	V
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	271	M	R
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	42	H	Y
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	184	G	D
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	185	R	G
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	185	R	C
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	258	R	H
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	265	Q	L
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	282	N	K
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	288	D	G
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	359	I	L
P68133	LP/P	Myopathy, congenital, with fiber-type disproportion (CFTD) [MIM:255310]	A0A2P6N765	223	L	P
P68133	LP/P	Myopathy, congenital, with fiber-type disproportion (CFTD) [MIM:255310]	A0A2P6N765	294	D	V
P68133	LP/P	Myopathy, congenital, with fiber-type disproportion (CFTD) [MIM:255310]	A0A2P6N765	334	P	S
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	3	D	Y
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	27	D	N
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	37	V	L
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	40	P	L
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	43	Q	R
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	44	G	V
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	45	V	F
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	66	I	N
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	68	T	I
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	74	E	K
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	75	H	L
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	75	H	R
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	77	I	L
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	79	T	A
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	85	E	K
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	116	A	T
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	117	N	T
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	118	R	H
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	136	V	A
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	140	A	P
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	142	L	P
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	148	G	D
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	150	T	N
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	156	D	N
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	165	V	M
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	172	A	G
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	181	D	G
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	181	D	H
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	181	D	N
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	185	R	D
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	185	R	S
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	198	R	L
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	199	G	S
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	226	E	G
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	226	E	Q
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	227	N	V
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	229	M	I
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	229	M	T
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	229	M	V
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	243	E	K
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	248	Q	K
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	248	Q	R
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	253	G	D
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	258	R	L
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	270	G	D
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	270	G	R
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	274	A	E
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	281	Y	H
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	285	M	K
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	336	E	A
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	338	K	E
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	338	K	I
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	350	S	L
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	374	R	S
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	375	K	E
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	375	K	Q
P68133	LP/P	Myopathy, scapulohumeroperoneal (SHPM) [MIM:616852]	A0A2P6N765	197	E	D
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	328	K	N
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	358	W	C
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	72	P	R
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	116	A	V
P68133	LP/P	Nemaline myopathy 3 (NEM3) [MIM:161800]	A0A2P6N765	17	G	S
P62736	LB/B	-	A0A2P6N765	196	T	S
P62736	LB/B	-	A0A2P6N765	320	T	A
P62736	LB/B	-	A0A2P6N765	373	H	P
P62736	LP/P	Aortic aneurysm, familial thoracic 6 (AAT6) [MIM:611788]	A0A2P6N765	117	N	T
P62736	LP/P	Aortic aneurysm, familial thoracic 6 (AAT6) [MIM:611788]	A0A2P6N765	118	R	Q
P62736	LP/P	Aortic aneurysm, familial thoracic 6 (AAT6) [MIM:611788]	A0A2P6N765	135	Y	H
P62736	LP/P	Aortic aneurysm, familial thoracic 6 (AAT6) [MIM:611788]	A0A2P6N765	149	R	C
P62736	LP/P	Aortic aneurysm, familial thoracic 6 (AAT6) [MIM:611788]	A0A2P6N765	154	V	A
P62736	LP/P	Aortic aneurysm, familial thoracic 6 (AAT6) [MIM:611788]	A0A2P6N765	258	R	C
P62736	LP/P	Aortic aneurysm, familial thoracic 6 (AAT6) [MIM:611788]	A0A2P6N765	258	R	H
P62736	LP/P	Aortic aneurysm, familial thoracic 6 (AAT6) [MIM:611788]	A0A2P6N765	292	R	G
P62736	LP/P	Aortic aneurysm, familial thoracic 6 (AAT6) [MIM:611788]	A0A2P6N765	353	T	N
P62736	LP/P	Aortic aneurysm, familial thoracic 6 (AAT6) [MIM:611788]	A0A2P6N765	39	R	H
P62736	LP/P	Aortic aneurysm, familial thoracic 6 (AAT6) [MIM:611788]	A0A2P6N765	145	Y	C
P62736	LP/P	Aortic aneurysm, familial thoracic 6 (AAT6) [MIM:611788]	A0A2P6N765	185	R	Q
P62736	LP/P	Aortic aneurysm, familial thoracic 6 (AAT6) [MIM:611788]	A0A2P6N765	212	R	Q
P62736	LP/P	Aortic aneurysm, familial thoracic 6 (AAT6) [MIM:611788]	A0A2P6N765	326	T	N
P62736	LP/P	Moyamoya disease 5 (MYMY5) [MIM:614042]	A0A2P6N765	179	R	H
P62736	LP/P	Multisystemic smooth muscle dysfunction syndrome (MSMDS) [MIM:613834]	A0A2P6N765	179	R	H
P62736	LP/P	Multisystemic smooth muscle dysfunction syndrome (MSMDS) [MIM:613834]	A0A2P6N765	179	R	C
P60709	LP/P	Dystonia, juvenile-onset (DJO) [MIM:607371]	A0A2P6N765	183	R	W
P60709	LB/B	-	A0A2P6N765	243	P	L
P60709	LP/P	Baraitser-Winter syndrome 1 (BRWS1) [MIM:243310]	A0A2P6N765	12	N	D
P60709	LP/P	Baraitser-Winter syndrome 1 (BRWS1) [MIM:243310]	A0A2P6N765	65	L	V
P60709	LP/P	Baraitser-Winter syndrome 1 (BRWS1) [MIM:243310]	A0A2P6N765	196	R	C
P60709	LP/P	Baraitser-Winter syndrome 1 (BRWS1) [MIM:243310]	A0A2P6N765	196	R	H
P68032	LP/P	Cardiomyopathy, familial hypertrophic 11 (CMH11) [MIM:612098]	A0A2P6N765	101	E	K
P68032	LP/P	Cardiomyopathy, familial hypertrophic 11 (CMH11) [MIM:612098]	A0A2P6N765	166	P	A
P68032	LP/P	Cardiomyopathy, familial hypertrophic 11 (CMH11) [MIM:612098]	A0A2P6N765	297	A	S
P68032	LP/P	Cardiomyopathy, dilated 1R (CMD1R) [MIM:613424]	A0A2P6N765	314	R	H
P68032	LP/P	Cardiomyopathy, familial hypertrophic 11 (CMH11) [MIM:612098]	A0A2P6N765	333	A	P
P68032	LP/P	Cardiomyopathy, dilated 1R (CMD1R) [MIM:613424]	A0A2P6N765	363	E	G
P68032	LP/P	Cardiomyopathy, familial hypertrophic 11 (CMH11) [MIM:612098]	A0A2P6N765	90	H	Y
P68032	LP/P	Cardiomyopathy, familial hypertrophic 11 (CMH11) [MIM:612098]	A0A2P6N765	97	R	C
P68032	LP/P	Atrial septal defect 5 (ASD5) [MIM:612794]	A0A2P6N765	125	M	V
P68032	LP/P	Cardiomyopathy, familial hypertrophic 11 (CMH11) [MIM:612098]	A0A2P6N765	168	Y	C
P68032	LP/P	Cardiomyopathy, familial hypertrophic 11 (CMH11) [MIM:612098]	A0A2P6N765	307	M	L
P63267	LP/P	Megacystis-microcolon-intestinal hypoperistalsis syndrome 5 (MMIHS5) [MIM:619431]	A0A2P6N765	40	R	C
P63267	LP/P	Megacystis-microcolon-intestinal hypoperistalsis syndrome 5 (MMIHS5) [MIM:619431]	A0A2P6N765	40	R	H
P63267	LP/P	Visceral myopathy 1 (VSCM1) [MIM:155310]	A0A2P6N765	40	R	H
P63267	LP/P	Visceral myopathy 1 (VSCM1) [MIM:155310]	A0A2P6N765	45	M	T
P63267	LP/P	Visceral myopathy 1 (VSCM1) [MIM:155310]	A0A2P6N765	63	R	G
P63267	LP/P	Visceral myopathy 1 (VSCM1) [MIM:155310]	A0A2P6N765	110	P	L
P63267	LP/P	Megacystis-microcolon-intestinal hypoperistalsis syndrome 5 (MMIHS5) [MIM:619431]	A0A2P6N765	134	Y	N
P63267	LP/P	Visceral myopathy 1 (VSCM1) [MIM:155310]	A0A2P6N765	148	R	S
P63267	LP/P	Megacystis-microcolon-intestinal hypoperistalsis syndrome 5 (MMIHS5) [MIM:619431]	A0A2P6N765	178	R	C
P63267	LP/P	Megacystis-microcolon-intestinal hypoperistalsis syndrome 5 (MMIHS5) [MIM:619431]	A0A2P6N765	178	R	H
P63267	LP/P	Megacystis-microcolon-intestinal hypoperistalsis syndrome 5 (MMIHS5) [MIM:619431]	A0A2P6N765	178	R	L
P63267	LP/P	Visceral myopathy 1 (VSCM1) [MIM:155310]	A0A2P6N765	198	G	D
P63267	LP/P	Megacystis-microcolon-intestinal hypoperistalsis syndrome 5 (MMIHS5) [MIM:619431]	A0A2P6N765	257	R	C
P63267	LP/P	Visceral myopathy 1 (VSCM1) [MIM:155310]	A0A2P6N765	257	R	C
P63267	LP/P	Megacystis-microcolon-intestinal hypoperistalsis syndrome 5 (MMIHS5) [MIM:619431]	A0A2P6N765	63	R	Q
P63267	LP/P	Visceral myopathy 1 (VSCM1) [MIM:155310]	A0A2P6N765	143	L	F
P63267	LP/P	Visceral myopathy 1 (VSCM1) [MIM:155310]	A0A2P6N765	148	R	L
P63267	LP/P	Visceral myopathy 1 (VSCM1) [MIM:155310]	A0A2P6N765	149	T	R
P63267	LP/P	Visceral myopathy 1 (VSCM1) [MIM:155310]	A0A2P6N765	195	T	I
P63267	LP/P	Visceral myopathy 1 (VSCM1) [MIM:155310]	A0A2P6N765	196	E	D
P63267	LP/P	Megacystis-microcolon-intestinal hypoperistalsis syndrome 5 (MMIHS5) [MIM:619431]	A0A2P6N765	257	R	H
O96019	LP/P	-	L5LIH8	377	R	W
O94805	LP/P	Developmental and epileptic encephalopathy 76 (DEE76) [MIM:618468]	L9K4Y4	206	L	P
O94805	LP/P	Intellectual developmental disorder with severe speech and ambulation defects (IDDSSAD) [MIM:618470]	L9K4Y4	343	G	R
O94805	LP/P	Developmental and epileptic encephalopathy 76 (DEE76) [MIM:618468]	L9K4Y4	349	G	S
Q9Y615	LB/B	-	S9YIV4	340	V	M
Q9Y615	LB/B	-	S9YIV4	45	R	C
Q9Y615	LB/B	-	S9YIV4	161	A	P
Q9Y615	LB/B	-	S9YIV4	343	L	V
Q9Y615	LB/B	-	S9YIV4	245	A	T
Q9H568	LB/B	-	I3L747	3	A	S
Q9H568	LB/B	-	I3L747	245	R	C
P35609	LB/B	-	W2SGT5	604	M	V
P35609	LP/P	Cardiomyopathy, dilated 1AA, with or without left ventricular non-compaction (CMD1AA) [MIM:612158]	W2SGT5	9	Q	R
P35609	LP/P	Cardiomyopathy, dilated 1AA, with or without left ventricular non-compaction (CMD1AA) [MIM:612158]	W2SGT5	119	A	T
P35609	LP/P	Cardiomyopathy, familial hypertrophic 23, with or without left ventricular non-compaction (CMH23) [MIM:612158]	W2SGT5	119	A	T
P35609	LP/P	Cardiomyopathy, familial hypertrophic 23, with or without left ventricular non-compaction (CMH23) [MIM:612158]	W2SGT5	495	T	M
P35609	LP/P	Cardiomyopathy, familial hypertrophic 23, with or without left ventricular non-compaction (CMH23) [MIM:612158]	W2SGT5	583	E	A
P35609	LP/P	Cardiomyopathy, familial hypertrophic 23, with or without left ventricular non-compaction (CMH23) [MIM:612158]	W2SGT5	628	E	G
P35609	LP/P	Cardiomyopathy, familial hypertrophic 23, with or without left ventricular non-compaction (CMH23) [MIM:612158]	W2SGT5	228	M	T
P35609	LP/P	Myopathy, distal, 6, adult onset, autosomal dominant (MPD6) [MIM:618655]	W2SGT5	487	C	R
P35609	LP/P	Myopathy, congenital, with structured cores and Z-line abnormalities (MYOCOZ) [MIM:618654]	W2SGT5	727	L	R
Q08043	LB/B	-	W2SGT5	523	R	Q
Q08043	LB/B	-	W2SGT5	635	E	A
Q08043	LB/B	-	W2SGT5	628	C	R
Q08043	LB/B	-	W2SGT5	776	Q	R
O43707	LP/P	Focal segmental glomerulosclerosis 1 (FSGS1) [MIM:603278]	W2SGT5	255	K	E
O43707	LP/P	Focal segmental glomerulosclerosis 1 (FSGS1) [MIM:603278]	W2SGT5	259	T	I
O43707	LP/P	Focal segmental glomerulosclerosis 1 (FSGS1) [MIM:603278]	W2SGT5	262	S	P
O43707	LP/P	Focal segmental glomerulosclerosis 1 (FSGS1) [MIM:603278]	W2SGT5	262	S	F
O43707	LP/P	Focal segmental glomerulosclerosis 1 (FSGS1) [MIM:603278]	W2SGT5	427	A	T
O43707	LP/P	Focal segmental glomerulosclerosis 1 (FSGS1) [MIM:603278]	W2SGT5	748	N	D
O43707	LB/B	-	W2SGT5	786	G	R
O43707	LB/B	-	W2SGT5	787	P	L
O43707	LB/B	-	W2SGT5	787	P	S
O43707	LB/B	-	W2SGT5	801	V	M
O43707	LP/P	Focal segmental glomerulosclerosis 1 (FSGS1) [MIM:603278]	W2SGT5	59	W	R
O43707	LP/P	Focal segmental glomerulosclerosis 1 (FSGS1) [MIM:603278]	W2SGT5	72	E	Q
P42025	LB/B	-	L5K097	93	V	A
P42025	LB/B	-	L5K097	143	A	V
Q9H981	LB/B	-	A0A091UWN3	56	T	I
Q8TDY3	LB/B	-	Q58DT9	247	G	R
Q9BYD9	LB/B	-	M1T209	234	E	K
Q04771	LP/P	Fibrodysplasia ossificans progressiva (FOP) [MIM:135100]	K7GKU4	206	R	H
Q04771	LB/B	-	K7GKU4	15	A	G
Q04771	LB/B	-	K7GKU4	41	S	F
Q04771	LB/B	-	K7GKU4	47	H	Q
Q04771	LP/P	Fibrodysplasia ossificans progressiva (FOP) [MIM:135100]	K7GKU4	202	R	I
Q04771	LP/P	Fibrodysplasia ossificans progressiva (FOP) [MIM:135100]	K7GKU4	207	Q	E
Q04771	LP/P	Fibrodysplasia ossificans progressiva (FOP) [MIM:135100]	K7GKU4	328	G	E
Q04771	LP/P	Fibrodysplasia ossificans progressiva (FOP) [MIM:135100]	K7GKU4	328	G	R
Q04771	LP/P	Fibrodysplasia ossificans progressiva (FOP) [MIM:135100]	K7GKU4	328	G	W
Q04771	LP/P	Fibrodysplasia ossificans progressiva (FOP) [MIM:135100]	K7GKU4	356	G	D
Q04771	LP/P	Fibrodysplasia ossificans progressiva (FOP) [MIM:135100]	K7GKU4	375	R	P
Q8NER5	LB/B	-	A0A2U3YAI1	195	I	T
Q8NER5	LB/B	-	A0A2U3YAI1	216	G	R
Q8NER5	LB/B	-	A0A2U3YAI1	355	I	V
Q8NER5	LB/B	-	A0A2U3YAI1	482	I	V
Q13705	LP/P	Heterotaxy, visceral, 4, autosomal (HTX4) [MIM:613751]	S9YHM6	40	R	H
Q13705	LP/P	Heterotaxy, visceral, 4, autosomal (HTX4) [MIM:613751]	S9YHM6	494	V	I
Q13705	LB/B	-	S9YHM6	176	P	R
Q13705	LB/B	-	S9YHM6	459	E	D
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	50	W	C
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	51	C	Y
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	67	R	Q
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	77	C	W
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	96	N	D
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	333	S	I
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	374	R	W
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	376	M	R
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	411	R	Q
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	424	P	T
P37023	LB/B	-	K7GKU4	245	I	N
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	48	G	R
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	67	R	W
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	179	D	A
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	211	G	D
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	215	E	K
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	223	G	R
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	229	K	R
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	285	L	F
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	306	A	P
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	314	H	Y
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	337	L	P
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	344	C	Y
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	347	A	P
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	374	R	Q
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	376	M	V
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	378	P	L
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	379	E	K
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	397	D	G
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	398	I	N
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	399	W	S
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	407	E	D
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	411	R	P
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	411	R	W
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	425	F	L
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	425	F	V
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	479	R	L
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	482	A	V
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	484	R	W
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	487	K	T
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	34	C	Y
P37023	LB/B	-	K7GKU4	38	S	C
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	50	W	G
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	52	T	A
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	66	H	P
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	69	C	R
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	96	N	S
P37023	LB/B	-	K7GKU4	138	L	P
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	176	D	Y
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	197	T	I
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	217	W	G
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	219	G	D
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	226	V	E
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	233	S	L
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	237	Q	K
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	260	I	L
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	265	T	P
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	280	H	R
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	289	L	P
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	294	L	R
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	328	H	Q
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	335	N	H
P37023	LB/B	-	K7GKU4	342	L	P
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	344	C	R
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	347	A	D
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	378	P	S
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	403	L	P
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	416	G	S
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	424	P	R
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	426	Y	C
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	433	P	R
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	449	P	S
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	479	R	P
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	41	C	G
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	41	C	Y
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	46	C	G
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	47	R	P
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	66	H	Y
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	77	C	F
P37023	LB/B	-	K7GKU4	111	E	D
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	211	G	S
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	245	I	V
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	313	L	V
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	379	E	D
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	404	V	G
P37023	LB/B	-	K7GKU4	417	I	F
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	441	V	M
P37023	LP/P	Telangiectasia, hereditary hemorrhagic, 2 (HHT2) [MIM:600376]	K7GKU4	443	C	Y
P37023	LB/B	-	K7GKU4	8	K	N
Q03154	LP/P	Aminoacylase-1 deficiency (ACY1D) [MIM:609924]	S7NJ39	386	R	C
Q03154	LP/P	Aminoacylase-1 deficiency (ACY1D) [MIM:609924]	S7NJ39	233	E	D
Q03154	LP/P	Aminoacylase-1 deficiency (ACY1D) [MIM:609924]	S7NJ39	353	R	C
Q03154	LP/P	Aminoacylase-1 deficiency (ACY1D) [MIM:609924]	S7NJ39	197	R	W
Q03154	LP/P	Aminoacylase-1 deficiency (ACY1D) [MIM:609924]	S7NJ39	393	R	H
Q03154	LB/B	-	S7NJ39	179	N	S
Q03154	LP/P	Aminoacylase-1 deficiency (ACY1D) [MIM:609924]	S7NJ39	378	R	Q
Q03154	LP/P	Aminoacylase-1 deficiency (ACY1D) [MIM:609924]	S7NJ39	378	R	W
Q96HD9	LB/B	-	A0A060WG62	8	R	Q
Q96HD9	LB/B	-	A0A060WG62	281	V	M
P00813	LB/B	-	A0A1D5QEF0	8	D	N
P00813	LP/P	Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700]	A0A1D5QEF0	15	H	D
P00813	LP/P	Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700]	A0A1D5QEF0	20	G	R
P00813	LP/P	Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700]	A0A1D5QEF0	74	G	C
P00813	LP/P	Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700]	A0A1D5QEF0	76	R	W
P00813	LB/B	-	A0A1D5QEF0	80	K	R
P00813	LP/P	Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700]	A0A1D5QEF0	83	A	D
P00813	LP/P	Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700]	A0A1D5QEF0	101	R	L
P00813	LP/P	Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700]	A0A1D5QEF0	101	R	W
P00813	LP/P	Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700]	A0A1D5QEF0	101	R	Q
P00813	LP/P	Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700]	A0A1D5QEF0	107	L	P
P00813	LP/P	Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700]	A0A1D5QEF0	129	V	M
P00813	LP/P	Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700]	A0A1D5QEF0	140	G	E
P00813	LP/P	Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700]	A0A1D5QEF0	149	R	Q
P00813	LP/P	Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700]	A0A1D5QEF0	149	R	W
P00813	LB/B	-	A0A1D5QEF0	152	L	M
P00813	LP/P	Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700]	A0A1D5QEF0	156	R	C
P00813	LP/P	Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700]	A0A1D5QEF0	156	R	H
P00813	LP/P	Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700]	A0A1D5QEF0	177	V	M
P00813	LP/P	Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700]	A0A1D5QEF0	179	A	D
P00813	LP/P	Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700]	A0A1D5QEF0	199	Q	P
P00813	LP/P	Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700]	A0A1D5QEF0	211	R	C
P00813	LP/P	Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700]	A0A1D5QEF0	211	R	H
P00813	LP/P	Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700]	A0A1D5QEF0	215	A	T
P00813	LP/P	Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700]	A0A1D5QEF0	216	G	R
P00813	LB/B	-	A0A1D5QEF0	233	T	I
P00813	LP/P	Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700]	A0A1D5QEF0	274	P	L
P00813	LP/P	Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700]	A0A1D5QEF0	291	S	L
P00813	LP/P	Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700]	A0A1D5QEF0	297	P	Q
P00813	LP/P	Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700]	A0A1D5QEF0	304	L	R
P00813	LP/P	Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700]	A0A1D5QEF0	329	A	V
Q9NZK5	LB/B	-	A0A1Y1KT08	335	H	R
Q9NZK5	LP/P	Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome (VAIHS) [MIM:615688]	A0A1Y1KT08	47	G	R
Q9NZK5	LP/P	Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome (VAIHS) [MIM:615688]	A0A1Y1KT08	47	G	V
Q9NZK5	LP/P	Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome (VAIHS) [MIM:615688]	A0A1Y1KT08	109	A	D
Q9NZK5	LP/P	Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome (VAIHS) [MIM:615688]	A0A1Y1KT08	112	H	Q
Q9NZK5	LP/P	Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome (VAIHS) [MIM:615688]	A0A1Y1KT08	169	R	Q
Q9NZK5	LP/P	Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome (VAIHS) [MIM:615688]	A0A1Y1KT08	251	P	L
Q9NZK5	LP/P	Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome (VAIHS) [MIM:615688]	A0A1Y1KT08	264	W	S
Q9NZK5	LP/P	Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome (VAIHS) [MIM:615688]	A0A1Y1KT08	453	Y	C
Q9NZK5	LP/P	Sneddon syndrome (SNDNS) [MIM:182410]	A0A1Y1KT08	119	V	A
Q9NZK5	LP/P	Sneddon syndrome (SNDNS) [MIM:182410]	A0A1Y1KT08	142	G	S
Q8NCV1	LB/B	-	F7C2K2	44	G	E
Q8NCV1	LB/B	-	F7C2K2	235	G	R
O43184	LB/B	-	F6U591	48	G	R
Q13444	LB/B	-	A0A212CGI8	191	K	T
Q13444	LB/B	-	A0A212CGI8	294	P	H
Q13444	LB/B	-	A0A212CGI8	216	E	K
Q9Y3Q7	LB/B	-	A5A4F6	212	V	F
O43506	LB/B	-	A0A286ZYY7	19	F	L
Q9P0K1	LB/B	-	G1KS31	81	P	R
Q9P0K1	LB/B	-	G1KS31	119	H	Y
Q9P0K1	LB/B	-	G1KS31	207	V	I
Q9UKQ2	LB/B	-	W5NEC7	765	V	M
Q9UKQ2	LB/B	-	W5NEC7	219	R	M
Q9UKQ2	LB/B	-	W5NEC7	226	E	D
Q9UKQ2	LB/B	-	W5NEC7	493	N	S
Q9UKQ2	LB/B	-	W5NEC7	593	T	K
Q9UKQ2	LB/B	-	W5NEC7	604	T	P
Q9UKQ2	LB/B	-	W5NEC7	684	M	I
Q9UKF2	LB/B	-	G7NX71	359	L	P
Q9UKF2	LB/B	-	G7NX71	737	T	A
Q8TC27	LB/B	-	A5A4F6	467	T	S
Q8TC27	LB/B	-	A5A4F6	98	Q	R
Q8TC27	LB/B	-	A5A4F6	160	S	G
Q8TC27	LB/B	-	A5A4F6	327	L	V
Q8TC27	LB/B	-	A5A4F6	658	K	N
Q8TC27	LB/B	-	A5A4F6	778	D	E
Q9BZ11	LB/B	-	A0A2K6F113	764	M	T
Q9BZ11	LB/B	-	A0A2K6F113	178	T	A
Q9BZ11	LB/B	-	A0A2K6F113	774	P	S
Q9BZ11	LB/B	-	A0A2K6F113	109	N	S
Q9BZ11	LB/B	-	A0A2K6F113	272	T	M
Q9BZ11	LB/B	-	A0A2K6F113	316	V	I
Q9BZ11	LB/B	-	A0A2K6F113	336	P	S
Q9BZ11	LB/B	-	A0A2K6F113	365	A	S
Q9BZ11	LB/B	-	A0A2K6F113	441	D	E
Q9BZ11	LB/B	-	A0A2K6F113	515	W	R
Q9BZ11	LB/B	-	A0A2K6F113	612	L	H
Q9BZ11	LB/B	-	A0A2K6F113	710	V	I
Q9BZ11	LB/B	-	A0A2K6F113	739	C	G
Q9BZ11	LB/B	-	A0A2K6F113	742	D	Y
Q9H2U9	LB/B	-	M3WI75	25	E	Q
Q9H2U9	LB/B	-	M3WI75	205	I	V
Q9H2U9	LB/B	-	M3WI75	244	V	M
Q9H2U9	LB/B	-	M3WI75	453	I	T
Q9H2U9	LB/B	-	M3WI75	570	L	V
Q9H2U9	LB/B	-	M3WI75	638	N	H
Q9H2U9	LB/B	-	M3WI75	735	L	P
P78325	LB/B	-	S7NFL8	101	G	R
P78325	LB/B	-	S7NFL8	189	R	W
P78325	LB/B	-	S7NFL8	433	R	C
P78325	LB/B	-	S7NFL8	775	I	T
P78325	LB/B	-	S7NFL8	35	W	R
P78325	LB/B	-	S7NFL8	657	F	L
O15204	LB/B	-	L5LDJ1	444	N	S
O15204	LB/B	-	L5LDJ1	121	M	T
Q9UHI8	LB/B	-	A0A147AMB5	227	A	P
Q9H324	LP/P	Weill-Marchesani syndrome 1 (WMS1) [MIM:277600]	V4A015	25	A	T
Q9H324	LB/B	-	V4A015	119	R	Q
Q9H324	LB/B	-	V4A015	134	T	S
P58397	LB/B	-	G3T4G8	110	Q	E
P58397	LB/B	-	G3T4G8	1000	R	Q
P58397	LB/B	-	G3T4G8	1495	T	I
P58397	LB/B	-	G3T4G8	1177	W	R
P58397	LB/B	-	G3T4G8	1591	S	P
Q76LX8	LB/B	-	H0Z570	7	R	W
Q76LX8	LP/P	Thrombotic thrombocytopenic purpura, hereditary (TTP) [MIM:274150]	H0Z570	88	V	M
Q76LX8	LP/P	Thrombotic thrombocytopenic purpura, hereditary (TTP) [MIM:274150]	H0Z570	96	H	D
Q76LX8	LP/P	Thrombotic thrombocytopenic purpura, hereditary (TTP) [MIM:274150]	H0Z570	102	R	C
Q76LX8	LP/P	Thrombotic thrombocytopenic purpura, hereditary (TTP) [MIM:274150]	H0Z570	193	R	W
Q76LX8	LP/P	Thrombotic thrombocytopenic purpura, hereditary (TTP) [MIM:274150]	H0Z570	196	T	I
Q76LX8	LP/P	Thrombotic thrombocytopenic purpura, hereditary (TTP) [MIM:274150]	H0Z570	234	H	Q
Q76LX8	LP/P	Thrombotic thrombocytopenic purpura, hereditary (TTP) [MIM:274150]	H0Z570	250	A	V
Q76LX8	LP/P	Thrombotic thrombocytopenic purpura, hereditary (TTP) [MIM:274150]	H0Z570	268	R	P
Q76LX8	LP/P	Thrombotic thrombocytopenic purpura, hereditary (TTP) [MIM:274150]	H0Z570	390	W	C
Q76LX8	LP/P	Thrombotic thrombocytopenic purpura, hereditary (TTP) [MIM:274150]	H0Z570	398	R	H
Q76LX8	LB/B	-	H0Z570	448	Q	E
Q76LX8	LB/B	-	H0Z570	475	P	S
Q76LX8	LP/P	Thrombotic thrombocytopenic purpura, hereditary (TTP) [MIM:274150]	H0Z570	508	C	Y
Q76LX8	LP/P	Thrombotic thrombocytopenic purpura, hereditary (TTP) [MIM:274150]	H0Z570	528	R	G
Q76LX8	LB/B	-	H0Z570	618	P	A
Q76LX8	LB/B	-	H0Z570	625	R	H
Q76LX8	LP/P	Thrombotic thrombocytopenic purpura, hereditary (TTP) [MIM:274150]	H0Z570	673	I	F
Q76LX8	LP/P	Thrombotic thrombocytopenic purpura, hereditary (TTP) [MIM:274150]	H0Z570	692	R	C
Q76LX8	LB/B	-	H0Z570	732	A	V
Q76LX8	LB/B	-	H0Z570	900	A	V
Q76LX8	LB/B	-	H0Z570	903	S	L
Q76LX8	LP/P	Thrombotic thrombocytopenic purpura, hereditary (TTP) [MIM:274150]	H0Z570	908	C	Y
Q76LX8	LP/P	Thrombotic thrombocytopenic purpura, hereditary (TTP) [MIM:274150]	H0Z570	951	C	G
Q76LX8	LP/P	Thrombotic thrombocytopenic purpura, hereditary (TTP) [MIM:274150]	H0Z570	1024	C	G
Q76LX8	LB/B	-	H0Z570	1033	A	T
Q76LX8	LB/B	-	H0Z570	1095	R	W
Q76LX8	LP/P	Thrombotic thrombocytopenic purpura, hereditary (TTP) [MIM:274150]	H0Z570	1123	R	C
Q76LX8	LP/P	Thrombotic thrombocytopenic purpura, hereditary (TTP) [MIM:274150]	H0Z570	1213	C	Y
Q76LX8	LP/P	Thrombotic thrombocytopenic purpura, hereditary (TTP) [MIM:274150]	H0Z570	1239	G	V
Q76LX8	LP/P	Thrombotic thrombocytopenic purpura, hereditary (TTP) [MIM:274150]	H0Z570	1336	R	W
Q76LX8	LB/B	-	H0Z570	456	Q	H
Q76LX8	LB/B	-	H0Z570	457	P	L
Q76LX8	LB/B	-	H0Z570	740	E	K
Q76LX8	LB/B	-	H0Z570	982	G	R
Q76LX8	LB/B	-	H0Z570	1226	T	I
Q76LX8	LP/P	Thrombotic thrombocytopenic purpura, hereditary (TTP) [MIM:274150]	H0Z570	79	I	M
Q76LX8	LP/P	Thrombotic thrombocytopenic purpura, hereditary (TTP) [MIM:274150]	H0Z570	119	S	F
Q76LX8	LP/P	Thrombotic thrombocytopenic purpura, hereditary (TTP) [MIM:274150]	H0Z570	178	I	T
Q76LX8	LP/P	Thrombotic thrombocytopenic purpura, hereditary (TTP) [MIM:274150]	H0Z570	203	S	P
Q76LX8	LP/P	Thrombotic thrombocytopenic purpura, hereditary (TTP) [MIM:274150]	H0Z570	232	L	Q
Q76LX8	LP/P	Thrombotic thrombocytopenic purpura, hereditary (TTP) [MIM:274150]	H0Z570	235	D	H
Q76LX8	LP/P	Thrombotic thrombocytopenic purpura, hereditary (TTP) [MIM:274150]	H0Z570	263	S	C
Q76LX8	LP/P	Thrombotic thrombocytopenic purpura, hereditary (TTP) [MIM:274150]	H0Z570	304	Y	C
Q76LX8	LP/P	Thrombotic thrombocytopenic purpura, hereditary (TTP) [MIM:274150]	H0Z570	311	C	Y
Q76LX8	LB/B	-	H0Z570	339	T	R
Q76LX8	LP/P	Thrombotic thrombocytopenic purpura, hereditary (TTP) [MIM:274150]	H0Z570	347	C	S
Q76LX8	LP/P	Thrombotic thrombocytopenic purpura, hereditary (TTP) [MIM:274150]	H0Z570	349	R	C
Q76LX8	LP/P	Thrombotic thrombocytopenic purpura, hereditary (TTP) [MIM:274150]	H0Z570	353	P	L
Q76LX8	LP/P	Thrombotic thrombocytopenic purpura, hereditary (TTP) [MIM:274150]	H0Z570	507	R	Q
Q76LX8	LP/P	Thrombotic thrombocytopenic purpura, hereditary (TTP) [MIM:274150]	H0Z570	525	G	D
Q76LX8	LP/P	Thrombotic thrombocytopenic purpura, hereditary (TTP) [MIM:274150]	H0Z570	596	A	V
Q76LX8	LP/P	Thrombotic thrombocytopenic purpura, hereditary (TTP) [MIM:274150]	H0Z570	606	A	P
Q76LX8	LP/P	Thrombotic thrombocytopenic purpura, hereditary (TTP) [MIM:274150]	H0Z570	658	Y	C
Q76LX8	LP/P	Thrombotic thrombocytopenic purpura, hereditary (TTP) [MIM:274150]	H0Z570	671	P	L
Q76LX8	LP/P	Thrombotic thrombocytopenic purpura, hereditary (TTP) [MIM:274150]	H0Z570	758	C	R
Q76LX8	LP/P	Thrombotic thrombocytopenic purpura, hereditary (TTP) [MIM:274150]	H0Z570	908	C	S
Q76LX8	LP/P	Thrombotic thrombocytopenic purpura, hereditary (TTP) [MIM:274150]	H0Z570	1060	R	W
Q76LX8	LP/P	Thrombotic thrombocytopenic purpura, hereditary (TTP) [MIM:274150]	H0Z570	1219	R	W
Q76LX8	LB/B	-	H0Z570	1314	S	L
Q8TE58	LB/B	-	A0A147AMB5	623	N	S
Q8TE56	LB/B	-	G1NYZ6	216	S	L
Q8TE56	LB/B	-	G1NYZ6	482	M	T
Q8TE56	LB/B	-	G1NYZ6	1094	N	S
Q8TE56	LB/B	-	G1NYZ6	566	R	T
Q8TE60	LB/B	-	A0A1S2ZB84	769	L	I
Q8TE60	LB/B	-	A0A1S2ZB84	946	A	S
Q8TE60	LB/B	-	A0A1S2ZB84	1080	S	R
Q8TE60	LB/B	-	A0A1S2ZB84	1159	S	T
Q8TE60	LB/B	-	A0A1S2ZB84	191	Y	H
Q8TE60	LB/B	-	A0A1S2ZB84	626	L	I
Q8TE60	LB/B	-	A0A1S2ZB84	179	S	L
Q8TE60	LP/P	Microcornea, myopic chorioretinal atrophy, and telecanthus (MMCAT) [MIM:615458]	A0A1S2ZB84	202	L	P
Q8TE60	LP/P	Microcornea, myopic chorioretinal atrophy, and telecanthus (MMCAT) [MIM:615458]	A0A1S2ZB84	577	C	W
O15072	LB/B	-	S7NII0	138	R	K
O15072	LB/B	-	S7NII0	1074	S	P
O15072	LP/P	Hennekam lymphangiectasia-lymphedema syndrome 3 (HKLLS3) [MIM:618154]	S7NII0	168	L	P
O15072	LP/P	Hennekam lymphangiectasia-lymphedema syndrome 3 (HKLLS3) [MIM:618154]	S7NII0	291	I	T
O75173	LB/B	-	E2RFF5	626	Q	R
O75173	LB/B	-	E2RFF5	4	T	I
O75173	LB/B	-	E2RFF5	304	D	N
O75173	LB/B	-	E2RFF5	369	M	V
O75173	LB/B	-	E2RFF5	552	P	T
O75173	LB/B	-	E2RFF5	564	T	A
O75173	LB/B	-	E2RFF5	836	R	K
O75173	LB/B	-	E2RFF5	77	A	T
Q9UNA0	LB/B	-	H2TSQ5	614	R	H
Q9UNA0	LB/B	-	H2TSQ5	138	G	A
Q9UNA0	LB/B	-	H2TSQ5	692	L	P
Q9UKP4	LB/B	-	G3T4G8	214	S	P
Q9UKP4	LB/B	-	G3T4G8	307	T	M
Q9UKP4	LB/B	-	G3T4G8	1319	T	A
Q9UKP4	LB/B	-	G3T4G8	1414	G	S
Q9UKP4	LB/B	-	G3T4G8	1583	G	A
Q86TH1	LB/B	-	H2ZWM1	364	V	I
Q86TH1	LP/P	Geleophysic dysplasia 1 (GPHYSD1) [MIM:231050]	H2ZWM1	113	R	H
Q86TH1	LP/P	Geleophysic dysplasia 1 (GPHYSD1) [MIM:231050]	H2ZWM1	114	E	K
Q86TH1	LP/P	Geleophysic dysplasia 1 (GPHYSD1) [MIM:231050]	H2ZWM1	147	P	L
Q86TH1	LP/P	Geleophysic dysplasia 1 (GPHYSD1) [MIM:231050]	H2ZWM1	811	G	R
Q86TH1	LP/P	Geleophysic dysplasia 1 (GPHYSD1) [MIM:231050]	H2ZWM1	50	W	C
Q86TH1	LP/P	Geleophysic dysplasia 1 (GPHYSD1) [MIM:231050]	H2ZWM1	72	R	Q
Q86TH1	LP/P	Geleophysic dysplasia 1 (GPHYSD1) [MIM:231050]	H2ZWM1	159	R	W
Q86TH1	LP/P	Geleophysic dysplasia 1 (GPHYSD1) [MIM:231050]	H2ZWM1	165	A	T
Q86TH1	LP/P	Geleophysic dysplasia 1 (GPHYSD1) [MIM:231050]	H2ZWM1	171	C	R
Q86TH1	LP/P	Geleophysic dysplasia 1 (GPHYSD1) [MIM:231050]	H2ZWM1	221	R	C
Q86TH1	LP/P	Geleophysic dysplasia 1 (GPHYSD1) [MIM:231050]	H2ZWM1	239	A	T
Q86TH1	LP/P	Geleophysic dysplasia 1 (GPHYSD1) [MIM:231050]	H2ZWM1	593	R	C
Q86TH1	LP/P	Geleophysic dysplasia 1 (GPHYSD1) [MIM:231050]	H2ZWM1	635	S	L
Q86TH1	LP/P	Geleophysic dysplasia 1 (GPHYSD1) [MIM:231050]	H2ZWM1	906	P	L
O75689	LB/B	-	K7FAP0	241	G	S
P78563	LB/B	-	G3T033	224	V	A
P78563	LP/P	Neurodevelopmental disorder with hypotonia, microcephaly, and seizures (NEDHYMS) [MIM:618862]	G3T033	603	R	Q
Q9NS39	LB/B	-	G3T033	44	A	T
Q9NS39	LB/B	-	G3T033	626	A	T
Q9BUB4	LB/B	-	A0A1A7ZQI5	167	H	N
Q9BUB4	LB/B	-	A0A1A7ZQI5	203	T	N
Q9BUB4	LB/B	-	A0A1A7ZQI5	242	T	P
Q9BUB4	LB/B	-	A0A1A7ZQI5	226	I	V
Q3MIX3	LB/B	-	A0A1S3GKA4	17	S	R
Q96PN6	LB/B	-	H0XK44	234	T	M
Q96PN6	LB/B	-	H0XK44	697	I	V
Q08462	LB/B	-	H2U1J1	147	V	L
Q08462	LB/B	-	H2U1J1	163	V	I
O95622	LB/B	-	A0A1L8H9G3	726	A	T
O95622	LB/B	-	A0A1L8H9G3	418	R	W
O95622	LB/B	-	A0A1L8H9G3	10	P	L
O95622	LP/P	Dyskinesia with orofacial involvement, autosomal recessive (DSKOR) [MIM:619647]	A0A1L8H9G3	588	D	N
O95622	LB/B	-	A0A1L8H9G3	706	A	V
O95622	LP/P	Dyskinesia with orofacial involvement, autosomal recessive (DSKOR) [MIM:619647]	A0A1L8H9G3	1013	R	C
O95622	LP/P	Dyskinesia with orofacial involvement, autosomal recessive (DSKOR) [MIM:619647]	A0A1L8H9G3	1238	R	W
O43306	LB/B	-	A0A1L8H9G3	674	A	S
O43306	LP/P	Lethal congenital contracture syndrome 8 (LCCS8) [MIM:616287]	A0A1L8H9G3	1116	R	C
P40145	LB/B	-	A0A2U3YA04	80	A	T
O60503	LB/B	-	A0A1A8SGE7	772	I	M
O60503	LB/B	-	A0A1A8SGE7	1154	N	S
P18509	LB/B	-	B7Z222	54	D	G
P35611	LB/B	-	A1A5X4	460	G	W
P35611	LB/B	-	A1A5X4	586	S	C
P35611	LB/B	-	A1A5X4	270	Y	N
P35611	LB/B	-	A1A5X4	376	E	D
P35611	LB/B	-	A1A5X4	510	N	I
P35611	LB/B	-	A1A5X4	6	R	C
Q9UEY8	LP/P	Cerebral palsy, spastic quadriplegic 3 (CPSQ3) [MIM:617008]	A0A146WNE7	367	G	D
Q8N7X0	LB/B	-	A0A091E4C4	310	I	T
Q8N7X0	LB/B	-	A0A091E4C4	1637	T	A
Q86SQ6	LB/B	-	A0A2J8J1L3	183	A	S
Q86SQ6	LB/B	-	A0A2J8J1L3	214	Q	L
Q8IWK6	LB/B	-	H0X7U6	1043	V	M
Q8IWK6	LB/B	-	H0X7U6	1166	V	G
O60241	LP/P	-	I3JAE8	1465	R	W
O60242	LB/B	-	I3JAE8	503	N	S
Q6QNK2	LB/B	-	A0A087YHC6	508	V	M
Q6QNK2	LB/B	-	A0A087YHC6	523	S	L
Q6QNK2	LB/B	-	A0A087YHC6	18	Y	C
Q6QNK2	LB/B	-	A0A087YHC6	18	Y	H
Q6QNK2	LB/B	-	A0A087YHC6	32	D	N
Q6QNK2	LB/B	-	A0A087YHC6	78	E	K
Q6QNK2	LB/B	-	A0A087YHC6	82	T	M
Q6QNK2	LB/B	-	A0A087YHC6	85	Y	C
Q6QNK2	LB/B	-	A0A087YHC6	89	Y	D
Q6QNK2	LB/B	-	A0A087YHC6	110	F	L
Q6QNK2	LB/B	-	A0A087YHC6	138	S	F
Q6QNK2	LB/B	-	A0A087YHC6	140	G	S
Q6QNK2	LB/B	-	A0A087YHC6	141	G	D
Q6QNK2	LB/B	-	A0A087YHC6	145	V	L
Q6QNK2	LB/B	-	A0A087YHC6	150	R	W
Q6QNK2	LB/B	-	A0A087YHC6	174	W	S
Q6QNK2	LB/B	-	A0A087YHC6	178	E	K
Q6QNK2	LB/B	-	A0A087YHC6	184	V	I
Q6QNK2	LB/B	-	A0A087YHC6	195	G	R
Q6QNK2	LB/B	-	A0A087YHC6	199	R	C
Q6QNK2	LB/B	-	A0A087YHC6	199	R	H
Q6QNK2	LB/B	-	A0A087YHC6	203	E	D
Q6QNK2	LB/B	-	A0A087YHC6	209	V	M
Q6QNK2	LB/B	-	A0A087YHC6	226	D	N
Q6QNK2	LB/B	-	A0A087YHC6	233	R	W
Q6QNK2	LB/B	-	A0A087YHC6	241	A	T
Q6QNK2	LB/B	-	A0A087YHC6	242	M	T
Q6QNK2	LB/B	-	A0A087YHC6	245	T	I
Q6QNK2	LB/B	-	A0A087YHC6	257	T	A
Q6QNK2	LB/B	-	A0A087YHC6	259	P	Q
Q6QNK2	LB/B	-	A0A087YHC6	265	S	Y
Q6QNK2	LB/B	-	A0A087YHC6	268	S	N
Q6QNK2	LB/B	-	A0A087YHC6	270	V	A
Q6QNK2	LB/B	-	A0A087YHC6	270	V	M
Q6QNK2	LB/B	-	A0A087YHC6	293	P	A
Q6QNK2	LB/B	-	A0A087YHC6	294	G	R
Q6QNK2	LB/B	-	A0A087YHC6	308	P	S
Q6QNK2	LB/B	-	A0A087YHC6	318	L	F
Q6QNK2	LB/B	-	A0A087YHC6	349	S	N
Q6QNK2	LB/B	-	A0A087YHC6	364	N	S
Q6QNK2	LB/B	-	A0A087YHC6	369	T	M
Q6QNK2	LB/B	-	A0A087YHC6	383	F	S
Q6QNK2	LB/B	-	A0A087YHC6	393	V	M
Q6QNK2	LB/B	-	A0A087YHC6	397	H	Q
Q6QNK2	LB/B	-	A0A087YHC6	399	R	C
Q6QNK2	LB/B	-	A0A087YHC6	404	G	A
Q6QNK2	LB/B	-	A0A087YHC6	405	Q	P
Q6QNK2	LB/B	-	A0A087YHC6	410	I	V
Q6QNK2	LB/B	-	A0A087YHC6	411	P	S
Q6QNK2	LB/B	-	A0A087YHC6	413	E	K
Q6QNK2	LB/B	-	A0A087YHC6	419	A	V
Q6QNK2	LB/B	-	A0A087YHC6	425	G	S
Q6QNK2	LB/B	-	A0A087YHC6	441	A	T
Q6QNK2	LB/B	-	A0A087YHC6	448	A	D
Q6QNK2	LB/B	-	A0A087YHC6	450	H	R
Q6QNK2	LB/B	-	A0A087YHC6	453	D	N
Q6QNK2	LB/B	-	A0A087YHC6	454	C	Y
Q6QNK2	LB/B	-	A0A087YHC6	458	A	T
Q6QNK2	LB/B	-	A0A087YHC6	464	S	A
Q6QNK2	LB/B	-	A0A087YHC6	476	N	S
Q6QNK2	LB/B	-	A0A087YHC6	478	S	L
Q6QNK2	LB/B	-	A0A087YHC6	484	T	M
Q6QNK2	LB/B	-	A0A087YHC6	485	V	I
Q6QNK2	LB/B	-	A0A087YHC6	498	E	G
Q6QNK2	LB/B	-	A0A087YHC6	499	A	S
Q6QNK2	LB/B	-	A0A087YHC6	524	N	K
Q6QNK2	LB/B	-	A0A087YHC6	538	V	A
Q6QNK2	LB/B	-	A0A087YHC6	538	V	I
Q6QNK2	LB/B	-	A0A087YHC6	540	R	C
Q6QNK2	LB/B	-	A0A087YHC6	540	R	H
Q6QNK2	LB/B	-	A0A087YHC6	560	R	C
Q6QNK2	LB/B	-	A0A087YHC6	560	R	H
Q6QNK2	LB/B	-	A0A087YHC6	567	S	L
Q6QNK2	LB/B	-	A0A087YHC6	569	I	V
Q6QNK2	LB/B	-	A0A087YHC6	589	A	T
Q6QNK2	LB/B	-	A0A087YHC6	594	V	M
Q6QNK2	LB/B	-	A0A087YHC6	601	R	H
Q6QNK2	LB/B	-	A0A087YHC6	608	L	M
Q6QNK2	LB/B	-	A0A087YHC6	624	R	C
Q6QNK2	LB/B	-	A0A087YHC6	626	E	K
Q6QNK2	LB/B	-	A0A087YHC6	630	T	I
Q6QNK2	LB/B	-	A0A087YHC6	667	S	L
Q6QNK2	LB/B	-	A0A087YHC6	673	R	H
Q6QNK2	LB/B	-	A0A087YHC6	695	M	T
Q6QNK2	LB/B	-	A0A087YHC6	699	G	R
Q6QNK2	LB/B	-	A0A087YHC6	720	A	V
Q6QNK2	LB/B	-	A0A087YHC6	743	A	T
Q6QNK2	LB/B	-	A0A087YHC6	749	H	R
Q6QNK2	LB/B	-	A0A087YHC6	751	D	E
Q6QNK2	LB/B	-	A0A087YHC6	761	A	E
Q6QNK2	LB/B	-	A0A087YHC6	764	V	M
Q6QNK2	LB/B	-	A0A087YHC6	777	V	M
Q6QNK2	LB/B	-	A0A087YHC6	779	A	V
Q6QNK2	LB/B	-	A0A087YHC6	793	T	M
Q6QNK2	LB/B	-	A0A087YHC6	795	N	K
Q6QNK2	LB/B	-	A0A087YHC6	816	A	T
Q6QNK2	LB/B	-	A0A087YHC6	827	T	M
Q6QNK2	LB/B	-	A0A087YHC6	831	A	T
Q6QNK2	LB/B	-	A0A087YHC6	836	A	T
Q6QNK2	LB/B	-	A0A087YHC6	836	A	V
Q6QNK2	LB/B	-	A0A087YHC6	851	M	T
Q6QNK2	LB/B	-	A0A087YHC6	868	R	H
Q6QNK2	LB/B	-	A0A087YHC6	869	V	I
Q6QNK2	LB/B	-	A0A087YHC6	870	D	N
Q6QNK2	LB/B	-	A0A087YHC6	874	V	M
Q7Z7M1	LB/B	-	F1MYG4	170	P	S
Q7Z7M1	LB/B	-	F1MYG4	630	A	T
Q14246	LB/B	-	F7INW5	57	A	T
Q14246	LB/B	-	F7INW5	140	S	R
Q14246	LB/B	-	F7INW5	174	D	N
Q14246	LB/B	-	F7INW5	254	N	S
Q14246	LB/B	-	F7INW5	298	A	V
Q14246	LB/B	-	F7INW5	389	T	M
Q14246	LB/B	-	F7INW5	424	I	V
Q14246	LB/B	-	F7INW5	496	K	Q
Q14246	LB/B	-	F7INW5	539	I	V
Q14246	LB/B	-	F7INW5	589	V	I
Q14246	LB/B	-	F7INW5	691	F	C
Q14246	LB/B	-	F7INW5	724	V	L
Q14246	LB/B	-	F7INW5	2	R	L
Q14246	LB/B	-	F7INW5	663	M	T
Q8IZF7	LB/B	-	I3LB22	148	Q	R
Q8IZF7	LB/B	-	I3LB22	467	I	V
Q8IZF5	LB/B	-	F7FRZ2	404	A	T
Q8IZF3	LB/B	-	I3LB22	541	K	N
Q8IZF3	LB/B	-	I3LB22	507	R	C
Q8IZF2	LB/B	-	G3ULN2	856	M	T
Q8IZF2	LB/B	-	G3ULN2	604	T	M
Q8IZF2	LB/B	-	G3ULN2	801	V	I
Q8IZP9	LB/B	-	A0A091QEJ6	290	H	Q
Q8IZP9	LB/B	-	A0A091QEJ6	771	N	S
Q8IZP9	LB/B	-	A0A091QEJ6	224	P	S
Q86SQ4	LB/B	-	F6VSG8	230	K	Q
Q86SQ4	LB/B	-	F6VSG8	123	S	G
Q86SQ4	LB/B	-	F6VSG8	1127	Q	R
Q86SQ4	LP/P	Lethal congenital contracture syndrome 9 (LCCS9) [MIM:616503]	F6VSG8	741	V	E
Q86SQ4	LP/P	Lethal congenital contracture syndrome 9 (LCCS9) [MIM:616503]	F6VSG8	769	V	E
Q86SQ4	LB/B	-	F6VSG8	1057	R	Q
Q96K78	LB/B	-	G5BKT0	645	T	S
Q96K78	LB/B	-	G5BKT0	756	R	H
Q96K78	LB/B	-	G5BKT0	151	K	E
O94910	LB/B	-	G3P4U8	595	E	Q
O94910	LP/P	Developmental delay, behavioral abnormalities, and neuropsychiatric disorders (DEDBANP) [MIM:620065]	G3P4U8	1005	W	R
O94910	LP/P	Developmental delay, behavioral abnormalities, and neuropsychiatric disorders (DEDBANP) [MIM:620065]	G3P4U8	1152	M	T
O94910	LP/P	Developmental delay, behavioral abnormalities, and neuropsychiatric disorders (DEDBANP) [MIM:620065]	G3P4U8	1164	S	F
Q9HAR2	LB/B	-	G3P4U8	465	R	Q
Q9HAR2	LB/B	-	G3P4U8	247	A	S
Q9HAR2	LB/B	-	G3P4U8	770	T	M
Q9HAR2	LB/B	-	G3P4U8	915	L	V
Q9HBW9	LB/B	-	H2SDP5	300	V	L
Q9HBW9	LB/B	-	H2SDP5	599	H	Q
Q9HBW9	LB/B	-	H2SDP5	620	A	G
Q8WXG9	LB/B	-	F1N0A6	127	L	R
Q8WXG9	LB/B	-	F1N0A6	249	R	K
Q8WXG9	LB/B	-	F1N0A6	1093	L	F
Q8WXG9	LB/B	-	F1N0A6	1927	T	M
Q8WXG9	LB/B	-	F1N0A6	1951	V	I
Q8WXG9	LB/B	-	F1N0A6	1985	N	D
Q8WXG9	LB/B	-	F1N0A6	1987	P	L
Q8WXG9	LB/B	-	F1N0A6	2004	L	F
Q8WXG9	LB/B	-	F1N0A6	2232	Y	C
Q8WXG9	LB/B	-	F1N0A6	2345	N	S
Q8WXG9	LB/B	-	F1N0A6	2379	G	A
Q8WXG9	LB/B	-	F1N0A6	2584	N	S
Q8WXG9	LB/B	-	F1N0A6	2764	S	L
Q8WXG9	LB/B	-	F1N0A6	2803	A	T
Q8WXG9	LB/B	-	F1N0A6	3217	A	V
Q8WXG9	LB/B	-	F1N0A6	3248	G	D
Q8WXG9	LB/B	-	F1N0A6	3471	E	K
Q8WXG9	LB/B	-	F1N0A6	5344	E	G
Q8WXG9	LB/B	-	F1N0A6	5437	T	A
Q8WXG9	LB/B	-	F1N0A6	551	V	A
Q8WXG9	LB/B	-	F1N0A6	1187	I	V
Q8WXG9	LB/B	-	F1N0A6	1916	T	I
Q8WXG9	LB/B	-	F1N0A6	2097	R	C
Q8WXG9	LB/B	-	F1N0A6	3094	V	I
Q8WXG9	LB/B	-	F1N0A6	3347	F	L
Q8WXG9	LB/B	-	F1N0A6	3867	E	A
Q8WXG9	LB/B	-	F1N0A6	3868	E	A
Q8WXG9	LP/P	Usher syndrome 2C (USH2C) [MIM:605472]	F1N0A6	4789	R	W
Q8WXG9	LP/P	Usher syndrome 2C (USH2C) [MIM:605472]	F1N0A6	5978	H	R
P00325	LB/B	-	W0UF47	48	H	R
P00325	LB/B	-	W0UF47	370	R	C
P00325	LB/B	-	W0UF47	57	N	K
P00325	LB/B	-	W0UF47	60	T	S
P00326	LB/B	-	W0UF47	272	R	Q
P00326	LB/B	-	W0UF47	350	I	V
P00326	LB/B	-	W0UF47	48	R	H
P00326	LB/B	-	W0UF47	166	P	S
P00326	LB/B	-	W0UF47	352	P	T
P08319	LB/B	-	W0UF47	309	I	V
P08319	LB/B	-	W0UF47	318	R	H
P08319	LB/B	-	W0UF47	374	V	I
P11766	LB/B	-	L9KLJ6	163	L	S
P11766	LB/B	-	L9KLJ6	309	V	I
P11766	LB/B	-	L9KLJ6	353	D	E
P11766	LP/P	AMED syndrome, digenic (AMEDS) [MIM:619151]	L9KLJ6	278	A	P
P28332	LB/B	-	A0A2J8TQK4	102	C	G
P28332	LB/B	-	A0A2J8TQK4	114	I	V
P28332	LB/B	-	A0A2J8TQK4	151	T	P
P40394	LB/B	-	A0A1V4JTV7	92	G	A
Q8IWW8	LB/B	-	A0A2E7JS26	449	C	R
Q15848	LB/B	-	A0A226MU44	84	G	R
Q15848	LP/P	Adiponectin deficiency (ADPND) [MIM:612556]	A0A226MU44	112	R	C
Q15848	LB/B	-	A0A226MU44	117	V	M
Q15848	LB/B	-	A0A226MU44	164	I	T
Q15848	LB/B	-	A0A226MU44	221	R	S
Q15848	LB/B	-	A0A226MU44	241	H	P
Q15848	LB/B	-	A0A226MU44	90	G	S
Q15848	LB/B	-	A0A226MU44	111	Y	H
P55263	LP/P	Hypermethioninemia due to adenosine kinase deficiency (HMAKD) [MIM:614300]	A0A146NFW1	30	G	E
P55263	LP/P	Hypermethioninemia due to adenosine kinase deficiency (HMAKD) [MIM:614300]	A0A146NFW1	235	D	A
P55263	LP/P	Hypermethioninemia due to adenosine kinase deficiency (HMAKD) [MIM:614300]	A0A146NFW1	318	A	E
P29274	LB/B	-	L5LLR2	392	G	R
P29274	LB/B	-	L5LLR2	50	A	V
P29274	LB/B	-	L5LLR2	300	R	H
Q9BRR6	LB/B	-	H9GC23	184	K	R
Q8NDY3	LB/B	-	A0A2K6LQU0	7	A	V
Q3LIE5	LB/B	-	E2RJC7	92	L	R
Q3LIE5	LB/B	-	E2RJC7	337	E	G
P35348	LB/B	-	A0A218UB83	347	C	R
P35348	LB/B	-	A0A218UB83	200	I	S
P35348	LB/B	-	A0A218UB83	414	K	R
P35348	LB/B	-	A0A218UB83	465	E	D
P35368	LB/B	-	F7FUQ0	51	V	G
P08913	LB/B	-	A0A0P7TZT0	266	N	K
P08913	LB/B	-	A0A0P7TZT0	416	C	S
P18089	LB/B	-	A0A0U2VCL4	211	G	A
P18089	LB/B	-	A0A0U2VCL4	379	V	G
P18089	LB/B	-	A0A0U2VCL4	376	V	I
P18089	LB/B	-	A0A0U2VCL4	379	V	I
P08588	LB/B	-	H0W3H1	49	S	G
P08588	LB/B	-	H0W3H1	389	R	G
P08588	LB/B	-	H0W3H1	389	R	L
P08588	LB/B	-	H0W3H1	26	A	V
P08588	LB/B	-	H0W3H1	29	A	T
P08588	LB/B	-	H0W3H1	31	R	Q
P08588	LB/B	-	H0W3H1	399	R	H
P08588	LB/B	-	H0W3H1	405	H	Y
P08588	LB/B	-	H0W3H1	187	A	V
P13945	LB/B	-	A0A1V4KHI6	64	W	R
P13945	LB/B	-	A0A1V4KHI6	265	T	M
P13945	LB/B	-	A0A1V4KHI6	353	R	C
P13945	LB/B	-	A0A1V4KHI6	249	E	K
P30566	LP/P	Adenylosuccinase deficiency (ADSLD) [MIM:103050]	K3WKR3	438	S	P
P30566	LP/P	Adenylosuccinase deficiency (ADSLD) [MIM:103050]	K3WKR3	72	I	V
P30566	LP/P	Adenylosuccinase deficiency (ADSLD) [MIM:103050]	K3WKR3	141	R	W
P30566	LP/P	Adenylosuccinase deficiency (ADSLD) [MIM:103050]	K3WKR3	190	R	Q
P30566	LP/P	Adenylosuccinase deficiency (ADSLD) [MIM:103050]	K3WKR3	246	K	E
P30566	LP/P	Adenylosuccinase deficiency (ADSLD) [MIM:103050]	K3WKR3	303	R	C
P30566	LP/P	Adenylosuccinase deficiency (ADSLD) [MIM:103050]	K3WKR3	395	S	R
P30566	LP/P	Adenylosuccinase deficiency (ADSLD) [MIM:103050]	K3WKR3	426	R	H
P30566	LP/P	Adenylosuccinase deficiency (ADSLD) [MIM:103050]	K3WKR3	2	A	V
P30566	LP/P	Adenylosuccinase deficiency (ADSLD) [MIM:103050]	K3WKR3	26	M	L
P30566	LP/P	Adenylosuccinase deficiency (ADSLD) [MIM:103050]	K3WKR3	450	T	S
P30566	LP/P	Adenylosuccinase deficiency (ADSLD) [MIM:103050]	K3WKR3	3	A	V
P30566	LP/P	Adenylosuccinase deficiency (ADSLD) [MIM:103050]	K3WKR3	100	P	A
P30566	LP/P	Adenylosuccinase deficiency (ADSLD) [MIM:103050]	K3WKR3	114	Y	H
P30566	LP/P	Adenylosuccinase deficiency (ADSLD) [MIM:103050]	K3WKR3	194	R	C
P30566	LP/P	Adenylosuccinase deficiency (ADSLD) [MIM:103050]	K3WKR3	268	D	N
P30566	LP/P	Adenylosuccinase deficiency (ADSLD) [MIM:103050]	K3WKR3	311	L	V
P30566	LP/P	Adenylosuccinase deficiency (ADSLD) [MIM:103050]	K3WKR3	318	P	L
P30566	LP/P	Adenylosuccinase deficiency (ADSLD) [MIM:103050]	K3WKR3	364	V	M
P30566	LP/P	Adenylosuccinase deficiency (ADSLD) [MIM:103050]	K3WKR3	374	R	W
P30566	LP/P	Adenylosuccinase deficiency (ADSLD) [MIM:103050]	K3WKR3	396	R	C
P30566	LP/P	Adenylosuccinase deficiency (ADSLD) [MIM:103050]	K3WKR3	396	R	H
P30566	LP/P	Adenylosuccinase deficiency (ADSLD) [MIM:103050]	K3WKR3	422	D	Y
P30566	LP/P	Adenylosuccinase deficiency (ADSLD) [MIM:103050]	K3WKR3	423	L	V
P30566	LP/P	Adenylosuccinase deficiency (ADSLD) [MIM:103050]	K3WKR3	430	D	N
P30566	LP/P	Adenylosuccinase deficiency (ADSLD) [MIM:103050]	K3WKR3	447	S	P
P30566	LP/P	Adenylosuccinase deficiency (ADSLD) [MIM:103050]	K3WKR3	452	R	P
P30566	LB/B	-	K3WKR3	31	S	N
P30566	LB/B	-	K3WKR3	147	K	M
Q96IZ2	LB/B	-	F7EH87	202	V	I
Q8IUX7	LB/B	-	A0A1S3WCT9	273	P	T
Q8IUX7	LB/B	-	A0A1S3WCT9	648	D	E
Q8IUX7	LB/B	-	A0A1S3WCT9	1001	P	L
Q8IUX7	LB/B	-	A0A1S3WCT9	1133	K	E
Q8IUX7	LB/B	-	A0A1S3WCT9	1148	V	I
Q8N556	LB/B	-	A0A096NZB0	403	S	C
Q8N556	LB/B	-	A0A096NZB0	518	V	M
Q8N4X5	LB/B	-	G1P9D3	138	G	R
Q8N4X5	LB/B	-	G1P9D3	366	S	R
Q8N4X5	LB/B	-	G1P9D3	522	T	S
Q8N4X5	LB/B	-	G1P9D3	726	E	K
P51816	LB/B	-	A0A2U9CC94	1185	L	M
Q9Y4W6	LP/P	Spinocerebellar ataxia 28 (SCA28) [MIM:610246]	H0UVJ1	432	N	T
Q9Y4W6	LP/P	Spinocerebellar ataxia 28 (SCA28) [MIM:610246]	H0UVJ1	691	E	K
Q9Y4W6	LP/P	Spinocerebellar ataxia 28 (SCA28) [MIM:610246]	H0UVJ1	694	A	E
Q9Y4W6	LP/P	Spinocerebellar ataxia 28 (SCA28) [MIM:610246]	H0UVJ1	702	R	Q
Q9Y4W6	LP/P	Spinocerebellar ataxia 28 (SCA28) [MIM:610246]	H0UVJ1	654	T	I
Q9Y4W6	LP/P	Spinocerebellar ataxia 28 (SCA28) [MIM:610246]	H0UVJ1	666	M	R
Q9Y4W6	LP/P	Spinocerebellar ataxia 28 (SCA28) [MIM:610246]	H0UVJ1	666	M	T
Q9Y4W6	LP/P	Spinocerebellar ataxia 28 (SCA28) [MIM:610246]	H0UVJ1	666	M	V
Q9Y4W6	LP/P	Spinocerebellar ataxia 28 (SCA28) [MIM:610246]	H0UVJ1	671	G	E
Q9Y4W6	LP/P	Spinocerebellar ataxia 28 (SCA28) [MIM:610246]	H0UVJ1	671	G	R
Q9Y4W6	LP/P	Spinocerebellar ataxia 28 (SCA28) [MIM:610246]	H0UVJ1	700	E	K
Q9Y4W6	LP/P	Spastic ataxia 5, autosomal recessive (SPAX5) [MIM:614487]	H0UVJ1	616	Y	C
Q9Y4W6	LP/P	Spinocerebellar ataxia 28 (SCA28) [MIM:610246]	H0UVJ1	689	Y	H
Q9Y4W6	LP/P	Spinocerebellar ataxia 28 (SCA28) [MIM:610246]	H0UVJ1	689	Y	N
Q9Y4W6	LP/P	Optic atrophy 12 (OPA12) [MIM:618977]	H0UVJ1	337	G	E
Q9Y4W6	LP/P	Optic atrophy 12 (OPA12) [MIM:618977]	H0UVJ1	337	G	R
Q9Y4W6	LP/P	Optic atrophy 12 (OPA12) [MIM:618977]	H0UVJ1	462	A	V
Q9Y4W6	LP/P	Spastic ataxia 5, autosomal recessive (SPAX5) [MIM:614487]	H0UVJ1	462	A	V
Q9Y4W6	LP/P	Optic atrophy 12 (OPA12) [MIM:618977]	H0UVJ1	465	R	K
Q9Y4W6	LP/P	Optic atrophy 12 (OPA12) [MIM:618977]	H0UVJ1	468	R	C
Q9Y4W6	LP/P	Optic atrophy 12 (OPA12) [MIM:618977]	H0UVJ1	514	P	L
Q9Y4W6	LP/P	Spastic ataxia 5, autosomal recessive (SPAX5) [MIM:614487]	H0UVJ1	620	Q	K
P43652	LB/B	-	A0A091KH67	404	T	S
P43652	LB/B	-	A0A091KH67	395	R	H
P02771	LB/B	-	A0A091KH67	570	A	G
P02771	LB/B	-	A0A091KH67	187	K	Q
Q6ULP2	LB/B	-	A0A091PMG3	233	D	G
Q6ULP2	LB/B	-	A0A091PMG3	301	E	K
Q6ULP2	LB/B	-	A0A091PMG3	550	N	S
Q9UPQ3	LB/B	-	A0A2Y9MN88	829	E	K
Q9UPQ3	LB/B	-	A0A2Y9MN88	148	D	G
Q9UPQ3	LB/B	-	A0A2Y9MN88	671	V	I
Q9UPQ3	LB/B	-	A0A2Y9MN88	798	R	G
Q9UPQ3	LB/B	-	A0A2Y9MN88	854	P	T
Q8TF27	LB/B	-	A0A2J8R217	82	I	V
Q99490	LB/B	-	A0A2K6NM79	507	G	S
Q99490	LB/B	-	A0A2K6NM79	1124	G	V
Q96P64	LB/B	-	H2NAA1	661	K	E
Q5U5Z8	LB/B	-	F6W1D1	349	R	H
Q5U5Z8	LB/B	-	F6W1D1	90	I	R
Q5U5Z8	LB/B	-	F6W1D1	333	T	P
Q5U5Z8	LB/B	-	F6W1D1	368	D	G
Q5U5Z8	LB/B	-	F6W1D1	671	M	I
Q8NEM8	LB/B	-	A0A2Y9HA14	45	F	Y
Q8NEM8	LB/B	-	A0A2Y9HA14	122	E	Q
Q8NEM8	LB/B	-	A0A2Y9HA14	360	T	I
Q5VU57	LB/B	-	K1QF10	443	V	M
Q8NDL9	LB/B	-	G3GXS1	649	G	D
Q8NDL9	LP/P	Retinitis pigmentosa 75 (RP75) [MIM:617023]	G3GXS1	276	R	W
Q8NDL9	LP/P	Retinitis pigmentosa 75 (RP75) [MIM:617023]	G3GXS1	295	D	N
O95081	LB/B	-	A0A1W7RGT8	365	T	N
Q8N302	LP/P	Klippel-Trenaunay syndrome (KTS) [MIM:149000]	A0A091UH63	133	E	K
Q8N302	LB/B	-	A0A091UH63	698	P	T
Q8N302	LB/B	-	A0A091UH63	180	T	A
Q8N302	LB/B	-	A0A091UH63	471	L	P
P35573	LB/B	-	A0A2D0SVT0	1115	G	R
P35573	LP/P	Glycogen storage disease 3 (GSD3) [MIM:232400]	A0A2D0SVT0	1448	G	R
P35573	LB/B	-	A0A2D0SVT0	387	R	Q
P35573	LB/B	-	A0A2D0SVT0	1343	E	K
P35573	LB/B	-	A0A2D0SVT0	1067	P	S
P35573	LB/B	-	A0A2D0SVT0	229	Q	R
P35573	LB/B	-	A0A2D0SVT0	701	A	S
P35573	LB/B	-	A0A2D0SVT0	1144	I	N
P35573	LB/B	-	A0A2D0SVT0	1253	R	H
P35573	LB/B	-	A0A2D0SVT0	1487	R	G
P35573	LB/B	-	A0A2D0SVT0	38	T	A
P35573	LB/B	-	A0A2D0SVT0	962	S	C
P35573	LB/B	-	A0A2D0SVT0	1207	A	T
Q9BSE5	LB/B	-	F7EJR4	105	G	R
Q9BSE5	LB/B	-	F7EJR4	140	R	Q
Q6ZNB7	LB/B	-	M3YRG9	279	F	L
Q6ZNB7	LB/B	-	M3YRG9	280	S	Y
Q9UKV8	LP/P	Lessel-Kreienkamp syndrome (LESKRES) [MIM:619149]	A0A1X7V1N5	192	L	P
Q9UKV8	LP/P	Lessel-Kreienkamp syndrome (LESKRES) [MIM:619149]	A0A1X7V1N5	201	G	C
Q9UKV8	LP/P	Lessel-Kreienkamp syndrome (LESKRES) [MIM:619149]	A0A1X7V1N5	201	G	V
Q9UKV8	LP/P	Lessel-Kreienkamp syndrome (LESKRES) [MIM:619149]	A0A1X7V1N5	203	H	Q
Q9UKV8	LP/P	Lessel-Kreienkamp syndrome (LESKRES) [MIM:619149]	A0A1X7V1N5	357	T	M
Q9UKV8	LP/P	Lessel-Kreienkamp syndrome (LESKRES) [MIM:619149]	A0A1X7V1N5	364	M	T
Q9UKV8	LP/P	Lessel-Kreienkamp syndrome (LESKRES) [MIM:619149]	A0A1X7V1N5	367	A	P
Q9UKV8	LP/P	Lessel-Kreienkamp syndrome (LESKRES) [MIM:619149]	A0A1X7V1N5	573	G	S
Q9UKV8	LP/P	Lessel-Kreienkamp syndrome (LESKRES) [MIM:619149]	A0A1X7V1N5	733	G	R
Q9UKV8	LP/P	Lessel-Kreienkamp syndrome (LESKRES) [MIM:619149]	A0A1X7V1N5	751	C	Y
Q9UKV8	LP/P	Lessel-Kreienkamp syndrome (LESKRES) [MIM:619149]	A0A1X7V1N5	760	S	R
Q99943	LB/B	-	W4Z4S1	30	P	S
O15120	LP/P	Congenital generalized lipodystrophy 1 (CGL1) [MIM:608594]	A0A2K5NAQ6	239	A	V
O15120	LP/P	Congenital generalized lipodystrophy 1 (CGL1) [MIM:608594]	A0A2K5NAQ6	228	L	P
O15120	LP/P	Congenital generalized lipodystrophy 1 (CGL1) [MIM:608594]	A0A2K5NAQ6	136	G	R
Q9NUQ2	LB/B	-	A0A2K6GXJ6	77	Y	C
O00468	LB/B	-	A0A1S3LJG4	1666	V	I
O00468	LB/B	-	A0A1S3LJG4	23	V	L
O00468	LB/B	-	A0A1S3LJG4	58	D	N
O00468	LP/P	Myasthenic syndrome, congenital, 8 (CMS8) [MIM:615120]	A0A1S3LJG4	105	N	I
O00468	LB/B	-	A0A1S3LJG4	267	T	M
O00468	LB/B	-	A0A1S3LJG4	375	A	S
O00468	LB/B	-	A0A1S3LJG4	728	E	V
O00468	LB/B	-	A0A1S3LJG4	852	Q	R
O00468	LB/B	-	A0A1S3LJG4	984	V	M
O00468	LB/B	-	A0A1S3LJG4	1088	L	F
O00468	LB/B	-	A0A1S3LJG4	1118	T	K
O00468	LB/B	-	A0A1S3LJG4	1135	Q	R
O00468	LB/B	-	A0A1S3LJG4	1240	P	L
O00468	LB/B	-	A0A1S3LJG4	1341	G	R
O00468	LB/B	-	A0A1S3LJG4	1451	P	L
O00468	LB/B	-	A0A1S3LJG4	1514	A	T
O00468	LB/B	-	A0A1S3LJG4	1565	Q	H
O00468	LB/B	-	A0A1S3LJG4	1671	R	Q
O00468	LB/B	-	A0A1S3LJG4	1698	R	P
O00468	LP/P	Myasthenic syndrome, congenital, 8 (CMS8) [MIM:615120]	A0A1S3LJG4	1709	G	R
O00468	LB/B	-	A0A1S3LJG4	1734	R	H
O00468	LB/B	-	A0A1S3LJG4	1789	D	N
O00468	LB/B	-	A0A1S3LJG4	2046	G	V
O00468	LP/P	Myasthenic syndrome, congenital, 8 (CMS8) [MIM:615120]	A0A1S3LJG4	1727	V	F
O00468	LP/P	Myasthenic syndrome, congenital, 8 (CMS8) [MIM:615120]	A0A1S3LJG4	76	G	S
O00468	LB/B	-	A0A1S3LJG4	745	A	V
O00468	LP/P	Myasthenic syndrome, congenital, 8 (CMS8) [MIM:615120]	A0A1S3LJG4	1875	G	R
O00253	LB/B	-	A0A2I2UFI3	67	A	T
P01019	LB/B	-	M7BA81	207	T	M
P01019	LB/B	-	M7BA81	242	T	I
P01019	LB/B	-	M7BA81	244	L	R
P01019	LB/B	-	M7BA81	268	M	T
P01019	LB/B	-	M7BA81	281	Y	C
P01019	LB/B	-	M7BA81	392	L	M
P01019	LB/B	-	M7BA81	43	L	F
P01019	LB/B	-	M7BA81	98	E	K
P01019	LB/B	-	M7BA81	268	M	I
P01019	LB/B	-	M7BA81	137	T	M
P01019	LB/B	-	M7BA81	335	P	S
P01019	LP/P	Renal tubular dysgenesis (RTD) [MIM:267430]	M7BA81	375	R	Q
P01019	LB/B	-	M7BA81	114	G	C
P30556	LB/B	-	F7GE79	289	C	W
P30556	LB/B	-	F7GE79	336	T	P
P30556	LB/B	-	F7GE79	163	A	T
P30556	LB/B	-	F7GE79	244	A	S
P30556	LP/P	Renal tubular dysgenesis (RTD) [MIM:267430]	F7GE79	282	T	M
P30556	LB/B	-	F7GE79	222	L	V
P30556	LB/B	-	F7GE79	341	P	H
Q6RW13	LB/B	-	D7RF68	143	A	V
P21549	LB/B	-	A0A147ACD3	11	P	L
P21549	LP/P	Hyperoxaluria primary 1 (HP1) [MIM:259900]	A0A147ACD3	41	G	R
P21549	LP/P	Hyperoxaluria primary 1 (HP1) [MIM:259900]	A0A147ACD3	152	F	I
P21549	LP/P	Hyperoxaluria primary 1 (HP1) [MIM:259900]	A0A147ACD3	170	G	R
P21549	LP/P	Hyperoxaluria primary 1 (HP1) [MIM:259900]	A0A147ACD3	187	S	F
P21549	LP/P	Hyperoxaluria primary 1 (HP1) [MIM:259900]	A0A147ACD3	205	S	P
P21549	LB/B	-	A0A147ACD3	340	I	M
P21549	LP/P	Hyperoxaluria primary 1 (HP1) [MIM:259900]	A0A147ACD3	82	G	E
P21549	LP/P	Hyperoxaluria primary 1 (HP1) [MIM:259900]	A0A147ACD3	233	R	C
P21549	LP/P	Hyperoxaluria primary 1 (HP1) [MIM:259900]	A0A147ACD3	233	R	H
P21549	LP/P	Hyperoxaluria primary 1 (HP1) [MIM:259900]	A0A147ACD3	244	I	T
P21549	LP/P	Hyperoxaluria primary 1 (HP1) [MIM:259900]	A0A147ACD3	41	G	V
P21549	LP/P	Hyperoxaluria primary 1 (HP1) [MIM:259900]	A0A147ACD3	116	G	R
P21549	LP/P	Hyperoxaluria primary 1 (HP1) [MIM:259900]	A0A147ACD3	156	G	R
P21549	LP/P	Hyperoxaluria primary 1 (HP1) [MIM:259900]	A0A147ACD3	183	D	N
P21549	LB/B	-	A0A147ACD3	22	N	S
P21549	LB/B	-	A0A147ACD3	295	A	T
P21549	LB/B	-	A0A147ACD3	9	T	N
P21549	LP/P	Hyperoxaluria primary 1 (HP1) [MIM:259900]	A0A147ACD3	82	G	R
P21549	LP/P	Hyperoxaluria primary 1 (HP1) [MIM:259900]	A0A147ACD3	108	W	R
P21549	LP/P	Hyperoxaluria primary 1 (HP1) [MIM:259900]	A0A147ACD3	112	A	D
P21549	LP/P	Hyperoxaluria primary 1 (HP1) [MIM:259900]	A0A147ACD3	153	L	V
P21549	LP/P	Hyperoxaluria primary 1 (HP1) [MIM:259900]	A0A147ACD3	158	S	L
P21549	LP/P	Hyperoxaluria primary 1 (HP1) [MIM:259900]	A0A147ACD3	161	G	R
P21549	LP/P	Hyperoxaluria primary 1 (HP1) [MIM:259900]	A0A147ACD3	173	C	Y
P21549	LP/P	Hyperoxaluria primary 1 (HP1) [MIM:259900]	A0A147ACD3	190	G	R
P21549	LP/P	Hyperoxaluria primary 1 (HP1) [MIM:259900]	A0A147ACD3	195	M	R
P21549	LP/P	Hyperoxaluria primary 1 (HP1) [MIM:259900]	A0A147ACD3	201	D	E
P21549	LP/P	Hyperoxaluria primary 1 (HP1) [MIM:259900]	A0A147ACD3	218	S	L
P21549	LP/P	Hyperoxaluria primary 1 (HP1) [MIM:259900]	A0A147ACD3	233	R	L
P21549	LP/P	Hyperoxaluria primary 1 (HP1) [MIM:259900]	A0A147ACD3	243	D	H
P21549	LP/P	Hyperoxaluria primary 1 (HP1) [MIM:259900]	A0A147ACD3	253	C	R
P21549	LP/P	Hyperoxaluria primary 1 (HP1) [MIM:259900]	A0A147ACD3	279	I	M
P21549	LB/B	-	A0A147ACD3	279	I	T
P21549	LB/B	-	A0A147ACD3	280	A	V
P21549	LP/P	Hyperoxaluria primary 1 (HP1) [MIM:259900]	A0A147ACD3	287	S	T
P21549	LP/P	Hyperoxaluria primary 1 (HP1) [MIM:259900]	A0A147ACD3	289	R	C
P21549	LP/P	Hyperoxaluria primary 1 (HP1) [MIM:259900]	A0A147ACD3	298	L	P
P21549	LB/B	-	A0A147ACD3	326	V	I
P21549	LP/P	Hyperoxaluria primary 1 (HP1) [MIM:259900]	A0A147ACD3	336	V	D
P21549	LP/P	Hyperoxaluria primary 1 (HP1) [MIM:259900]	A0A147ACD3	350	G	D
P21549	LP/P	Hyperoxaluria primary 1 (HP1) [MIM:259900]	A0A147ACD3	36	R	C
P21549	LP/P	Hyperoxaluria primary 1 (HP1) [MIM:259900]	A0A147ACD3	41	G	E
P21549	LP/P	Hyperoxaluria primary 1 (HP1) [MIM:259900]	A0A147ACD3	47	G	R
P21549	LP/P	Hyperoxaluria primary 1 (HP1) [MIM:259900]	A0A147ACD3	150	L	P
P21549	LP/P	Hyperoxaluria primary 1 (HP1) [MIM:259900]	A0A147ACD3	161	G	C
P21549	LP/P	Hyperoxaluria primary 1 (HP1) [MIM:259900]	A0A147ACD3	161	G	S
P21549	LP/P	Hyperoxaluria primary 1 (HP1) [MIM:259900]	A0A147ACD3	166	L	P
Q9BYV1	LB/B	-	A0A2D7H056	140	V	I
Q9BYV1	LB/B	-	A0A2D7H056	212	T	I
Q9BYV1	LB/B	-	A0A2D7H056	102	S	N
Q9BYV1	LB/B	-	A0A2D7H056	498	V	L
Q9BYV1	LB/B	-	A0A2D7H056	132	G	R
Q9BYV1	LB/B	-	A0A2D7H056	492	P	R
Q9BYV1	LB/B	-	A0A2D7H056	102	S	I
Q9BYV1	LB/B	-	A0A2D7H056	102	S	T
Q8WYP5	LB/B	-	W5NIT8	874	N	S
Q8WYP5	LB/B	-	W5NIT8	2185	L	V
P23526	LB/B	-	L9L344	86	D	N
P23526	LB/B	-	L9L344	38	R	W
P23526	LP/P	Hypermethioninemia with S-adenosylhomocysteine hydrolase deficiency (HMAHCHD) [MIM:613752]	L9L344	49	R	C
P23526	LP/P	Hypermethioninemia with S-adenosylhomocysteine hydrolase deficiency (HMAHCHD) [MIM:613752]	L9L344	86	D	G
P23526	LP/P	Hypermethioninemia with S-adenosylhomocysteine hydrolase deficiency (HMAHCHD) [MIM:613752]	L9L344	89	A	V
P23526	LP/P	Hypermethioninemia with S-adenosylhomocysteine hydrolase deficiency (HMAHCHD) [MIM:613752]	L9L344	143	Y	C
Q5TGY3	LB/B	-	H9GPS0	935	A	T
Q5TGY3	LP/P	Xia-Gibbs syndrome (XIGIS) [MIM:615829]	H9GPS0	537	G	D
Q5TGY3	LP/P	Xia-Gibbs syndrome (XIGIS) [MIM:615829]	H9GPS0	1348	S	P
Q5TGY3	LP/P	Xia-Gibbs syndrome (XIGIS) [MIM:615829]	H9GPS0	1457	D	G
Q8N157	LP/P	Joubert syndrome 3 (JBTS3) [MIM:608629]	W5NH86	443	V	D
Q8N157	LB/B	-	W5NH86	49	I	N
Q8N157	LB/B	-	W5NH86	548	R	H
Q8N157	LP/P	Joubert syndrome 3 (JBTS3) [MIM:608629]	W5NH86	723	R	Q
Q8N157	LB/B	-	W5NH86	761	S	L
Q8N157	LB/B	-	W5NH86	830	R	W
Q8N157	LB/B	-	W5NH86	856	T	S
Q8N157	LB/B	-	W5NH86	933	Y	C
Q8N157	LB/B	-	W5NH86	1018	Q	P
Q8N157	LB/B	-	W5NH86	1123	S	F
Q8N157	LB/B	-	W5NH86	1140	P	S
Q8N157	LB/B	-	W5NH86	1086	E	G
Q8N157	LP/P	Joubert syndrome 3 (JBTS3) [MIM:608629]	W5NH86	351	R	L
Q8N157	LP/P	Joubert syndrome 3 (JBTS3) [MIM:608629]	W5NH86	671	T	I
Q8N157	LP/P	Joubert syndrome 3 (JBTS3) [MIM:608629]	W5NH86	719	D	G
Q8N157	LP/P	Joubert syndrome 3 (JBTS3) [MIM:608629]	W5NH86	896	H	R
P0C7V0	LB/B	-	P0C7V0	112	A	E
Q09666	LB/B	-	A0A2J8TXR7	962	G	V
Q09666	LB/B	-	A0A2J8TXR7	2114	A	T
Q09666	LB/B	-	A0A2J8TXR7	2439	P	L
Q09666	LB/B	-	A0A2J8TXR7	3003	Q	K
Q09666	LB/B	-	A0A2J8TXR7	3190	V	I
Q09666	LB/B	-	A0A2J8TXR7	3724	S	P
Q09666	LB/B	-	A0A2J8TXR7	4561	G	D
Q09666	LB/B	-	A0A2J8TXR7	4611	M	V
Q09666	LB/B	-	A0A2J8TXR7	4613	I	V
Q09666	LB/B	-	A0A2J8TXR7	4631	D	G
Q09666	LB/B	-	A0A2J8TXR7	5415	T	A
Q09666	LB/B	-	A0A2J8TXR7	2247	K	T
Q09666	LB/B	-	A0A2J8TXR7	4304	D	G
Q8IVF2	LB/B	-	A0A2K6R9C7	1266	V	M
Q8IVF2	LB/B	-	A0A2K6R9C7	1470	L	V
Q8IVF2	LB/B	-	A0A2K6R9C7	2115	S	R
Q8IVF2	LB/B	-	A0A2K6R9C7	2429	D	E
Q8IVF2	LB/B	-	A0A2K6R9C7	2430	L	V
Q8IVF2	LB/B	-	A0A2K6R9C7	2616	V	A
Q8IVF2	LB/B	-	A0A2K6R9C7	5028	L	M
Q8IVF2	LB/B	-	A0A2K6R9C7	5564	G	R
Q8IVF2	LB/B	-	A0A2K6R9C7	525	T	A
Q8IVF2	LB/B	-	A0A2K6R9C7	2107	M	V
Q8IVF2	LB/B	-	A0A2K6R9C7	2410	K	R
Q8IVF2	LB/B	-	A0A2K6R9C7	3796	V	L
Q8IVF2	LB/B	-	A0A2K6R9C7	3961	M	V
Q8IVF2	LB/B	-	A0A2K6R9C7	4071	I	M
Q8IVF2	LB/B	-	A0A2K6R9C7	4138	F	L
Q8IVF2	LB/B	-	A0A2K6R9C7	4232	K	N
Q8IVF2	LB/B	-	A0A2K6R9C7	4278	V	A
Q8IVF2	LB/B	-	A0A2K6R9C7	4536	M	L
Q8IVF2	LB/B	-	A0A2K6R9C7	4664	T	A
Q8IVF2	LB/B	-	A0A2K6R9C7	5072	G	R
Q8IVF2	LB/B	-	A0A2K6R9C7	5184	Y	D
Q8IVF2	LB/B	-	A0A2K6R9C7	5397	P	A
Q8IVF2	LB/B	-	A0A2K6R9C7	5732	T	M
Q8IVF2	LB/B	-	A0A2K6R9C7	1856	E	D
Q8IVF2	LB/B	-	A0A2K6R9C7	2146	L	V
Q8IVF2	LB/B	-	A0A2K6R9C7	2503	E	A
Q8IVF2	LB/B	-	A0A2K6R9C7	2862	R	S
Q8IVF2	LB/B	-	A0A2K6R9C7	3176	D	E
Q8IVF2	LB/B	-	A0A2K6R9C7	3177	L	V
Q8IVF2	LB/B	-	A0A2K6R9C7	3336	P	L
Q8IVF2	LB/B	-	A0A2K6R9C7	3363	V	A
Q8IVF2	LB/B	-	A0A2K6R9C7	3793	D	N
Q8IVF2	LB/B	-	A0A2K6R9C7	3869	M	V
Q8IVF2	LB/B	-	A0A2K6R9C7	3902	K	N
Q8IVF2	LB/B	-	A0A2K6R9C7	4085	A	V
Q8IVF2	LB/B	-	A0A2K6R9C7	4198	D	N
Q8IVF2	LB/B	-	A0A2K6R9C7	4326	L	P
Q8IVF2	LB/B	-	A0A2K6R9C7	4478	P	L
Q8IVF2	LB/B	-	A0A2K6R9C7	1298	M	I
Q8IVF2	LB/B	-	A0A2K6R9C7	3654	G	E
Q8IVF2	LB/B	-	A0A2K6R9C7	5139	G	E
P35869	LB/B	-	A0A0A0R877	554	R	K
P35869	LB/B	-	A0A0A0R877	570	V	I
P35869	LB/B	-	A0A0A0R877	517	P	S
P35869	LB/B	-	A0A0A0R877	786	M	V
A9YTQ3	LB/B	-	A0A093HR71	114	L	P
A9YTQ3	LB/B	-	A0A093HR71	189	P	A
A9YTQ3	LB/B	-	A0A093HR71	373	G	V
A9YTQ3	LB/B	-	A0A093HR71	627	D	H
Q9NZD4	LB/B	-	A0A2K6GTK6	100	P	T
Q9GZX7	LP/P	Immunodeficiency with hyper-IgM 2 (HIGM2) [MIM:605258]	L5LX78	24	R	W
Q9GZX7	LP/P	Immunodeficiency with hyper-IgM 2 (HIGM2) [MIM:605258]	L5LX78	80	W	R
Q9GZX7	LP/P	Immunodeficiency with hyper-IgM 2 (HIGM2) [MIM:605258]	L5LX78	106	L	P
Q9GZX7	LP/P	Immunodeficiency with hyper-IgM 2 (HIGM2) [MIM:605258]	L5LX78	139	M	V
Q9GZX7	LP/P	Immunodeficiency with hyper-IgM 2 (HIGM2) [MIM:605258]	L5LX78	151	F	S
Q9GZX7	LB/B	-	L5LX78	25	R	C
Q9GZX7	LP/P	Immunodeficiency with hyper-IgM 2 (HIGM2) [MIM:605258]	L5LX78	15	F	L
Q9GZX7	LP/P	Immunodeficiency with hyper-IgM 2 (HIGM2) [MIM:605258]	L5LX78	31	Y	H
Q9GZX7	LP/P	Immunodeficiency with hyper-IgM 2 (HIGM2) [MIM:605258]	L5LX78	130	H	P
P55008	LB/B	-	A0A0E9X8U2	14	G	R
Q9BRQ8	LB/B	-	L9KTA3	135	M	T
Q9BRQ8	LB/B	-	L9KTA3	288	D	N
Q96NN9	LB/B	-	A0A091DWM1	508	S	T
O14862	LB/B	-	A0A2Y9EMB9	32	E	K
O14862	LB/B	-	A0A2Y9EMB9	304	C	Y
Q12904	LB/B	-	A0A0D9QVF5	79	P	A
Q12904	LB/B	-	A0A0D9QVF5	104	T	A
Q12904	LB/B	-	A0A0D9QVF5	117	T	A
O00170	LB/B	-	A0A2C9JGD5	16	R	H
O00170	LB/B	-	A0A2C9JGD5	228	Q	K
O00170	LP/P	Pituitary adenoma 1, multiple types (PITA1) [MIM:102200]	A0A2C9JGD5	304	R	Q
O00170	LB/B	-	A0A2C9JGD5	307	R	Q
Q9NZN9	LP/P	Leber congenital amaurosis 4 (LCA4) [MIM:604393]	A0A2K6FWU7	239	C	R
Q9NZN9	LB/B	-	A0A2K6FWU7	90	D	H
Q9NZN9	LB/B	-	A0A2K6FWU7	33	V	A
Q9NZN9	LB/B	-	A0A2K6FWU7	134	Y	F
Q9NZN9	LP/P	Leber congenital amaurosis 4 (LCA4) [MIM:604393]	A0A2K6FWU7	270	R	H
Q9NZN9	LB/B	-	A0A2K6FWU7	302	R	L
Q9UKB5	LB/B	-	A0A1U7T218	263	G	R
P00568	LP/P	Hemolytic anemia due to adenylate kinase deficiency (HAAKD) [MIM:612631]	L9KH84	128	R	W
P00568	LB/B	-	L9KH84	123	E	Q
P00568	LP/P	Hemolytic anemia due to adenylate kinase deficiency (HAAKD) [MIM:612631]	L9KH84	40	G	R
P00568	LP/P	Hemolytic anemia due to adenylate kinase deficiency (HAAKD) [MIM:612631]	L9KH84	64	G	R
P00568	LP/P	Hemolytic anemia due to adenylate kinase deficiency (HAAKD) [MIM:612631]	L9KH84	164	Y	C
P54819	LB/B	-	S7Q2Y6	209	A	T
P54819	LP/P	Reticular dysgenesis (RDYS) [MIM:267500]	S7Q2Y6	103	R	W
P54819	LP/P	Reticular dysgenesis (RDYS) [MIM:267500]	S7Q2Y6	165	D	G
Q9Y6K8	LB/B	-	A0A2K6FVJ2	465	R	Q
Q96M32	LB/B	-	C3Z2C9	102	R	Q
Q96M32	LB/B	-	C3Z2C9	389	N	K
Q96M32	LP/P	Spermatogenic failure 27 (SPGF27) [MIM:617965]	C3Z2C9	673	L	P
Q92667	LB/B	-	A0A1U8DAE9	60	V	M
Q92667	LB/B	-	A0A1U8DAE9	18	A	V
Q92667	LB/B	-	A0A1U8DAE9	102	C	Y
Q92667	LB/B	-	A0A1U8DAE9	124	R	C
O43572	LB/B	-	U3JTP1	249	R	H
O43572	LB/B	-	U3JTP1	646	I	V
Q9UKA4	LB/B	-	A0A2I0U449	721	S	C
Q9UKA4	LB/B	-	A0A2I0U449	1070	H	R
Q9UKA4	LB/B	-	A0A2I0U449	1410	L	F
Q02952	LB/B	-	A0A1S2ZB56	117	K	E
Q02952	LB/B	-	A0A1S2ZB56	216	K	Q
Q02952	LB/B	-	A0A1S2ZB56	920	E	G
Q02952	LB/B	-	A0A1S2ZB56	1096	V	I
Q02952	LB/B	-	A0A1S2ZB56	1296	R	L
Q02952	LB/B	-	A0A1S2ZB56	1355	E	K
Q02952	LB/B	-	A0A1S2ZB56	1600	E	D
Q02952	LB/B	-	A0A1S2ZB56	1689	E	D
Q02952	LB/B	-	A0A1S2ZB56	987	A	S
Q12802	LB/B	-	A0A2I3M683	452	M	T
Q12802	LB/B	-	A0A2I3M683	494	W	R
Q12802	LB/B	-	A0A2I3M683	574	R	C
Q12802	LB/B	-	A0A2I3M683	624	G	V
Q12802	LB/B	-	A0A2I3M683	689	E	K
Q12802	LB/B	-	A0A2I3M683	845	V	A
Q12802	LB/B	-	A0A2I3M683	897	V	M
Q12802	LB/B	-	A0A2I3M683	1062	P	A
Q12802	LB/B	-	A0A2I3M683	1086	D	N
Q12802	LB/B	-	A0A2I3M683	1216	M	T
Q12802	LB/B	-	A0A2I3M683	2457	G	S
Q12802	LB/B	-	A0A2I3M683	2801	A	T
Q12802	LB/B	-	A0A2I3M683	526	K	Q
Q12802	LB/B	-	A0A2I3M683	1525	S	G
Q02040	LB/B	-	A0A2I0UKW0	194	P	S
Q9Y2D5	LB/B	-	K7FYL5	561	L	S
O75969	LB/B	-	A0A1S3GIL2	118	G	E
O75969	LB/B	-	A0A1S3GIL2	500	I	T
O75969	LB/B	-	A0A1S3GIL2	661	I	T
O75969	LB/B	-	A0A1S3GIL2	700	S	F
O75969	LB/B	-	A0A1S3GIL2	725	S	L
O75969	LB/B	-	A0A1S3GIL2	700	S	P
O75969	LB/B	-	A0A1S3GIL2	464	T	S
O75969	LB/B	-	A0A1S3GIL2	525	E	K
Q5JQC9	LB/B	-	A0A1S3GIL2	673	A	G
Q5JQC9	LB/B	-	A0A1S3GIL2	233	H	R
P24588	LB/B	-	G3W7A8	100	P	L
P24588	LB/B	-	G3W7A8	314	E	K
P24588	LB/B	-	G3W7A8	203	T	I
Q13023	LB/B	-	W5MTE4	337	A	V
Q13023	LB/B	-	W5MTE4	408	N	S
Q13023	LB/B	-	W5MTE4	1492	A	V
Q13023	LB/B	-	W5MTE4	2035	N	D
Q13023	LB/B	-	W5MTE4	2171	F	Y
Q13023	LB/B	-	W5MTE4	2209	D	H
Q13023	LB/B	-	W5MTE4	558	N	D
Q13023	LB/B	-	W5MTE4	892	E	K
Q13023	LB/B	-	W5MTE4	1516	T	A
Q13023	LB/B	-	W5MTE4	1522	V	I
Q13023	LB/B	-	W5MTE4	2267	E	D
Q9P0M2	LB/B	-	M3WG58	26	E	K
Q9P0M2	LB/B	-	M3WG58	215	S	N
Q9ULX6	LB/B	-	E2QX45	458	Q	H
Q99996	LB/B	-	F6V2R6	463	M	I
Q99996	LB/B	-	F6V2R6	2792	N	S
Q99996	LB/B	-	F6V2R6	2979	P	S
Q99996	LP/P	Long QT syndrome 11 (LQT11) [MIM:611820]	F6V2R6	1570	S	L
Q99996	LB/B	-	F6V2R6	2484	K	R
Q99996	LB/B	-	F6V2R6	3444	Q	R
Q99996	LB/B	-	F6V2R6	3614	M	V
Q7Z591	LB/B	-	H0WCT3	624	P	L
Q7Z591	LB/B	-	H0WCT3	1097	Q	R
Q7Z591	LB/B	-	H0WCT3	1119	R	Q
Q7Z591	LB/B	-	H0WCT3	1303	S	P
Q7Z591	LB/B	-	H0WCT3	1327	Y	C
P15121	LB/B	-	A0A2U4A373	15	I	F
P15121	LB/B	-	A0A2U4A373	42	H	L
P15121	LB/B	-	A0A2U4A373	73	L	V
P15121	LB/B	-	A0A2U4A373	204	G	S
P15121	LB/B	-	A0A2U4A373	288	T	I
P15121	LB/B	-	A0A2U4A373	90	K	E
Q04828	LB/B	-	A0A2K5NKG1	170	R	H
Q04828	LB/B	-	A0A2K5NKG1	172	Q	L
P52895	LB/B	-	A0A2K5NKG1	172	L	Q
P52895	LB/B	-	A0A2K5NKG1	46	F	Y
P52895	LP/P	46,XY sex reversal 8 (SRXY8) [MIM:614279]	A0A2K5NKG1	79	I	V
P52895	LP/P	46,XY sex reversal 8 (SRXY8) [MIM:614279]	A0A2K5NKG1	90	H	Q
P52895	LP/P	46,XY sex reversal 8 (SRXY8) [MIM:614279]	A0A2K5NKG1	222	H	Q
P52895	LP/P	46,XY sex reversal 8 (SRXY8) [MIM:614279]	A0A2K5NKG1	300	N	T
P42330	LB/B	-	A0A1W5A3F9	5	H	Q
P42330	LB/B	-	A0A1W5A3F9	175	M	I
P42330	LB/B	-	A0A1W5A3F9	66	R	Q
P42330	LB/B	-	A0A1W5A3F9	170	R	C
P42330	LB/B	-	A0A1W5A3F9	180	P	S
P42330	LB/B	-	A0A1W5A3F9	77	E	G
Q5T2L2	LB/B	-	A0A212CAP5	50	R	H
P51857	LP/P	Congenital bile acid synthesis defect 2 (CBAS2) [MIM:235555]	A0A1W5A3F9	106	L	F
P51857	LP/P	Congenital bile acid synthesis defect 2 (CBAS2) [MIM:235555]	A0A1W5A3F9	198	P	L
P51857	LP/P	Congenital bile acid synthesis defect 2 (CBAS2) [MIM:235555]	A0A1W5A3F9	133	P	R
P51857	LP/P	Congenital bile acid synthesis defect 2 (CBAS2) [MIM:235555]	A0A1W5A3F9	261	R	C
P51857	LP/P	Congenital bile acid synthesis defect 2 (CBAS2) [MIM:235555]	A0A1W5A3F9	223	G	E
P31749	LB/B	-	G5AWI7	167	V	A
P31749	LP/P	Breast cancer (BC) [MIM:114480]	G5AWI7	17	E	K
P31749	LP/P	Proteus syndrome (PROTEUSS) [MIM:176920]	G5AWI7	17	E	K
P31749	LP/P	Cowden syndrome 6 (CWS6) [MIM:615109]	G5AWI7	25	R	C
P31749	LP/P	Cowden syndrome 6 (CWS6) [MIM:615109]	G5AWI7	435	T	P
Q96B36	LB/B	-	E9QKI4	47	A	P
P31751	LB/B	-	M7B852	188	I	V
P31751	LB/B	-	M7B852	208	R	K
P31751	LP/P	Hypoinsulinemic hypoglycemia with hemihypertrophy (HIHGHH) [MIM:240900]	M7B852	17	E	K
P31751	LP/P	Type 2 diabetes mellitus (T2D) [MIM:125853]	M7B852	274	R	H
P13716	LB/B	-	A0A2J7RM73	59	K	N
P13716	LP/P	Acute hepatic porphyria (AHEPP) [MIM:612740]	A0A2J7RM73	133	G	R
P13716	LP/P	Acute hepatic porphyria (AHEPP) [MIM:612740]	A0A2J7RM73	240	R	W
P13716	LP/P	Acute hepatic porphyria (AHEPP) [MIM:612740]	A0A2J7RM73	274	A	T
P13716	LP/P	Acute hepatic porphyria (AHEPP) [MIM:612740]	A0A2J7RM73	275	V	M
P13716	LB/B	-	A0A2J7RM73	12	F	L
P13716	LP/P	Acute hepatic porphyria (AHEPP) [MIM:612740]	A0A2J7RM73	153	V	M
P22557	LP/P	Anemia, sideroblastic, 1 (SIDBA1) [MIM:300751]	A0A0P7THU6	388	T	S
P22557	LP/P	Anemia, sideroblastic, 1 (SIDBA1) [MIM:300751]	A0A0P7THU6	411	R	C
P22557	LP/P	Anemia, sideroblastic, 1 (SIDBA1) [MIM:300751]	A0A0P7THU6	476	I	N
P22557	LP/P	Anemia, sideroblastic, 1 (SIDBA1) [MIM:300751]	A0A0P7THU6	199	Y	H
P22557	LP/P	Anemia, sideroblastic, 1 (SIDBA1) [MIM:300751]	A0A0P7THU6	204	R	Q
P22557	LP/P	Anemia, sideroblastic, 1 (SIDBA1) [MIM:300751]	A0A0P7THU6	448	R	Q
P22557	LP/P	Anemia, sideroblastic, 1 (SIDBA1) [MIM:300751]	A0A0P7THU6	452	R	C
P22557	LP/P	Anemia, sideroblastic, 1 (SIDBA1) [MIM:300751]	A0A0P7THU6	159	D	Y
P22557	LP/P	Anemia, sideroblastic, 1 (SIDBA1) [MIM:300751]	A0A0P7THU6	560	R	H
P22557	LP/P	Anemia, sideroblastic, 1 (SIDBA1) [MIM:300751]	A0A0P7THU6	156	K	E
P22557	LP/P	Anemia, sideroblastic, 1 (SIDBA1) [MIM:300751]	A0A0P7THU6	170	R	H
P22557	LP/P	Anemia, sideroblastic, 1 (SIDBA1) [MIM:300751]	A0A0P7THU6	218	R	H
P22557	LP/P	Anemia, sideroblastic, 1 (SIDBA1) [MIM:300751]	A0A0P7THU6	242	E	K
P22557	LP/P	Anemia, sideroblastic, 1 (SIDBA1) [MIM:300751]	A0A0P7THU6	263	D	N
P22557	LP/P	Anemia, sideroblastic, 1 (SIDBA1) [MIM:300751]	A0A0P7THU6	339	P	L
P22557	LP/P	Anemia, sideroblastic, 1 (SIDBA1) [MIM:300751]	A0A0P7THU6	375	R	C
P22557	LP/P	Anemia, sideroblastic, 1 (SIDBA1) [MIM:300751]	A0A0P7THU6	411	R	H
P22557	LP/P	Anemia, sideroblastic, 1 (SIDBA1) [MIM:300751]	A0A0P7THU6	452	R	G
P22557	LP/P	Anemia, sideroblastic, 1 (SIDBA1) [MIM:300751]	A0A0P7THU6	452	R	H
P22557	LB/B	Anemia, sideroblastic, 1 (SIDBA1) [MIM:300751]	A0A0P7THU6	520	P	L
P22557	LP/P	Anemia, sideroblastic, 1 (SIDBA1) [MIM:300751]	A0A0P7THU6	572	R	H
P22557	LB/B	-	A0A0P7THU6	586	Y	F
P22557	LP/P	Anemia, sideroblastic, 1 (SIDBA1) [MIM:300751]	A0A0P7THU6	165	F	L
P22557	LP/P	Anemia, sideroblastic, 1 (SIDBA1) [MIM:300751]	A0A0P7THU6	170	R	C
P22557	LP/P	Anemia, sideroblastic, 1 (SIDBA1) [MIM:300751]	A0A0P7THU6	301	V	A
P22557	LP/P	Anemia, sideroblastic, 1 (SIDBA1) [MIM:300751]	A0A0P7THU6	517	R	G
P02768	LB/B	-	A0A091KH67	23	R	C
P02768	LB/B	-	A0A091KH67	23	R	H
P02768	LB/B	-	A0A091KH67	24	R	L
P02768	LB/B	-	A0A091KH67	24	R	P
P02768	LB/B	-	A0A091KH67	24	R	Q
P02768	LB/B	-	A0A091KH67	25	D	V
P02768	LB/B	-	A0A091KH67	27	H	Q
P02768	LB/B	-	A0A091KH67	27	H	Y
P02768	LB/B	-	A0A091KH67	84	E	K
P02768	LB/B	-	A0A091KH67	87	D	N
P02768	LB/B	-	A0A091KH67	106	E	K
P02768	LB/B	-	A0A091KH67	138	R	G
P02768	LB/B	-	A0A091KH67	143	E	K
P02768	LB/B	-	A0A091KH67	152	H	R
P02768	LB/B	-	A0A091KH67	201	C	F
P02768	LP/P	Hyperthyroxinemia, familial dysalbuminemic (FDAH) [MIM:615999]	A0A091KH67	242	R	H
P02768	LB/B	-	A0A091KH67	249	K	Q
P02768	LB/B	-	A0A091KH67	264	K	E
P02768	LB/B	-	A0A091KH67	292	Q	R
P02768	LB/B	-	A0A091KH67	293	D	G
P02768	LB/B	-	A0A091KH67	300	K	N
P02768	LB/B	-	A0A091KH67	337	K	N
P02768	LB/B	-	A0A091KH67	342	N	K
P02768	LB/B	-	A0A091KH67	344	A	T
P02768	LB/B	-	A0A091KH67	345	E	K
P02768	LB/B	-	A0A091KH67	357	E	K
P02768	LB/B	-	A0A091KH67	378	E	K
P02768	LB/B	-	A0A091KH67	382	E	K
P02768	LB/B	-	A0A091KH67	389	D	H
P02768	LB/B	-	A0A091KH67	389	D	V
P02768	LB/B	-	A0A091KH67	396	K	E
P02768	LB/B	-	A0A091KH67	399	D	N
P02768	LB/B	-	A0A091KH67	400	E	K
P02768	LB/B	-	A0A091KH67	400	E	Q
P02768	LB/B	-	A0A091KH67	406	E	K
P02768	LB/B	-	A0A091KH67	503	E	K
P02768	LB/B	-	A0A091KH67	518	D	N
P02768	LB/B	-	A0A091KH67	525	E	K
P02768	LB/B	-	A0A091KH67	529	E	K
P02768	LB/B	-	A0A091KH67	560	K	E
P02768	LB/B	-	A0A091KH67	565	K	E
P02768	LB/B	-	A0A091KH67	574	D	G
P02768	LB/B	-	A0A091KH67	574	D	A
P02768	LB/B	-	A0A091KH67	587	D	N
P02768	LB/B	-	A0A091KH67	589	E	K
P02768	LB/B	-	A0A091KH67	594	E	K
P02768	LB/B	-	A0A091KH67	597	K	E
P02768	LB/B	-	A0A091KH67	598	K	N
P02768	LB/B	-	A0A091KH67	73	F	Y
P02768	LP/P	Hyperthyroxinemia, familial dysalbuminemic (FDAH) [MIM:615999]	A0A091KH67	90	L	P
P02768	LB/B	-	A0A091KH67	146	V	E
P02768	LP/P	Hyperthyroxinemia, familial dysalbuminemic (FDAH) [MIM:615999]	A0A091KH67	242	R	P
P02768	LB/B	-	A0A091KH67	338	D	G
P02768	LB/B	-	A0A091KH67	338	D	V
P02768	LB/B	-	A0A091KH67	383	K	N
P02768	LB/B	-	A0A091KH67	434	R	C
P02768	LB/B	-	A0A091KH67	557	V	M
P02768	LB/B	-	A0A091KH67	584	K	E
P02768	LB/B	-	A0A091KH67	121	E	G
P02768	LB/B	-	A0A091KH67	215	A	T
P02768	LB/B	-	A0A091KH67	215	A	V
P02768	LB/B	-	A0A091KH67	220	Q	L
P02768	LB/B	-	A0A091KH67	420	E	K
P02768	LB/B	-	A0A091KH67	490	K	E
Q8IZ83	LB/B	-	D7CU76	110	E	K
Q8IZ83	LB/B	-	D7CU76	227	L	V
P54886	LP/P	Cutis laxa, autosomal recessive, 3A (ARCL3A) [MIM:219150]	A0A212CQA4	84	R	Q
P54886	LB/B	Cutis laxa, autosomal recessive, 3A (ARCL3A) [MIM:219150]	A0A212CQA4	299	T	I
P54886	LB/B	-	A0A212CQA4	372	S	Y
P54886	LP/P	Cutis laxa, autosomal recessive, 3A (ARCL3A) [MIM:219150]	A0A212CQA4	784	H	Y
P54886	LP/P	Cutis laxa, autosomal recessive, 3A (ARCL3A) [MIM:219150]	A0A212CQA4	93	G	R
P54886	LP/P	Spastic paraplegia 9A, autosomal dominant (SPG9A) [MIM:601162]	A0A212CQA4	120	V	A
P54886	LP/P	Spastic paraplegia 9B, autosomal recessive (SPG9B) [MIM:616586]	A0A212CQA4	128	R	H
P54886	LP/P	Cutis laxa, autosomal dominant, 3 (ADCL3) [MIM:616603]	A0A212CQA4	138	R	L
P54886	LP/P	Cutis laxa, autosomal dominant, 3 (ADCL3) [MIM:616603]	A0A212CQA4	138	R	Q
P54886	LP/P	Cutis laxa, autosomal dominant, 3 (ADCL3) [MIM:616603]	A0A212CQA4	138	R	W
P54886	LP/P	Spastic paraplegia 9A, autosomal dominant (SPG9A) [MIM:601162]	A0A212CQA4	243	V	L
P54886	LP/P	Spastic paraplegia 9A, autosomal dominant (SPG9A) [MIM:601162]	A0A212CQA4	252	R	Q
P54886	LP/P	Spastic paraplegia 9B, autosomal recessive (SPG9B) [MIM:616586]	A0A212CQA4	637	L	P
P54886	LP/P	Spastic paraplegia 9A, autosomal dominant (SPG9A) [MIM:601162]	A0A212CQA4	652	S	F
P54886	LP/P	Spastic paraplegia 9A, autosomal dominant (SPG9A) [MIM:601162]	A0A212CQA4	665	R	L
P54886	LP/P	Spastic paraplegia 9B, autosomal recessive (SPG9B) [MIM:616586]	A0A212CQA4	715	D	H
P54886	LP/P	Cutis laxa, autosomal recessive, 3A (ARCL3A) [MIM:219150]	A0A212CQA4	782	Y	C
P00352	LB/B	-	A0A2T2RTL7	177	I	F
P00352	LB/B	-	A0A2T2RTL7	121	N	S
P00352	LB/B	-	A0A2T2RTL7	125	G	R
O94788	LB/B	-	A0A2T2RTL7	50	E	G
O94788	LB/B	-	A0A2T2RTL7	110	A	V
O94788	LB/B	-	A0A2T2RTL7	348	V	I
O94788	LB/B	-	A0A2T2RTL7	436	E	K
O94788	LP/P	Diaphragmatic hernia 4, with cardiovascular defects (DIH4) [MIM:620025]	A0A2T2RTL7	182	Q	K
O94788	LP/P	Diaphragmatic hernia 4, with cardiovascular defects (DIH4) [MIM:620025]	A0A2T2RTL7	347	R	H
O94788	LP/P	Diaphragmatic hernia 4, with cardiovascular defects (DIH4) [MIM:620025]	A0A2T2RTL7	461	S	Y
P47895	LB/B	-	A0A2T2RTL7	386	M	V
P47895	LP/P	Microphthalmia, isolated, 8 (MCOP8) [MIM:615113]	A0A2T2RTL7	89	R	C
P47895	LP/P	Microphthalmia, isolated, 8 (MCOP8) [MIM:615113]	A0A2T2RTL7	145	A	V
P47895	LP/P	Microphthalmia, isolated, 8 (MCOP8) [MIM:615113]	A0A2T2RTL7	369	I	F
P47895	LP/P	Microphthalmia, isolated, 8 (MCOP8) [MIM:615113]	A0A2T2RTL7	493	A	P
P47895	LP/P	Microphthalmia, isolated, 8 (MCOP8) [MIM:615113]	A0A2T2RTL7	71	V	M
P47895	LP/P	Microphthalmia, isolated, 8 (MCOP8) [MIM:615113]	A0A2T2RTL7	174	C	Y
P47895	LP/P	Microphthalmia, isolated, 8 (MCOP8) [MIM:615113]	A0A2T2RTL7	355	P	R
P47895	LP/P	Microphthalmia, isolated, 8 (MCOP8) [MIM:615113]	A0A2T2RTL7	382	G	R
P47895	LP/P	Microphthalmia, isolated, 8 (MCOP8) [MIM:615113]	A0A2T2RTL7	411	E	K
P47895	LP/P	Microphthalmia, isolated, 8 (MCOP8) [MIM:615113]	A0A2T2RTL7	466	N	K
O75891	LB/B	-	H2YPW9	254	L	P
O75891	LB/B	-	H2YPW9	330	V	F
O75891	LB/B	-	H2YPW9	429	E	A
O75891	LB/B	-	H2YPW9	436	A	T
O75891	LB/B	-	H2YPW9	448	S	N
O75891	LB/B	-	H2YPW9	481	S	G
O75891	LB/B	-	H2YPW9	793	D	G
O75891	LB/B	-	H2YPW9	803	E	K
O75891	LB/B	-	H2YPW9	812	I	V
P05091	LP/P	AMED syndrome, digenic (AMEDS) [MIM:619151]	A0A2T2RTL7	504	E	K
P05091	LB/B	-	A0A2T2RTL7	496	E	K
P05091	LB/B	-	A0A2T2RTL7	337	E	V
P30838	LB/B	-	G7NGG7	329	P	A
P30838	LB/B	-	G7NGG7	134	S	A
P30838	LB/B	-	G7NGG7	309	G	E
P51648	LP/P	Sjoegren-Larsson syndrome (SLS) [MIM:270200]	A0A0F8AHW9	106	L	R
P51648	LP/P	Sjoegren-Larsson syndrome (SLS) [MIM:270200]	A0A0F8AHW9	214	C	Y
P51648	LP/P	Sjoegren-Larsson syndrome (SLS) [MIM:270200]	A0A0F8AHW9	226	C	W
P51648	LP/P	Sjoegren-Larsson syndrome (SLS) [MIM:270200]	A0A0F8AHW9	245	D	N
P51648	LP/P	Sjoegren-Larsson syndrome (SLS) [MIM:270200]	A0A0F8AHW9	315	P	S
P51648	LP/P	Sjoegren-Larsson syndrome (SLS) [MIM:270200]	A0A0F8AHW9	365	S	L
P51648	LP/P	Sjoegren-Larsson syndrome (SLS) [MIM:270200]	A0A0F8AHW9	412	G	R
P51648	LP/P	Sjoegren-Larsson syndrome (SLS) [MIM:270200]	A0A0F8AHW9	45	I	F
P51648	LP/P	Sjoegren-Larsson syndrome (SLS) [MIM:270200]	A0A0F8AHW9	64	V	D
P51648	LP/P	Sjoegren-Larsson syndrome (SLS) [MIM:270200]	A0A0F8AHW9	114	P	L
P51648	LP/P	Sjoegren-Larsson syndrome (SLS) [MIM:270200]	A0A0F8AHW9	121	P	L
P51648	LP/P	Sjoegren-Larsson syndrome (SLS) [MIM:270200]	A0A0F8AHW9	184	T	M
P51648	LP/P	Sjoegren-Larsson syndrome (SLS) [MIM:270200]	A0A0F8AHW9	184	T	R
P51648	LP/P	Sjoegren-Larsson syndrome (SLS) [MIM:270200]	A0A0F8AHW9	185	G	A
P51648	LP/P	Sjoegren-Larsson syndrome (SLS) [MIM:270200]	A0A0F8AHW9	228	R	C
P51648	LP/P	Sjoegren-Larsson syndrome (SLS) [MIM:270200]	A0A0F8AHW9	237	C	Y
P51648	LP/P	Sjoegren-Larsson syndrome (SLS) [MIM:270200]	A0A0F8AHW9	266	K	N
P51648	LP/P	Sjoegren-Larsson syndrome (SLS) [MIM:270200]	A0A0F8AHW9	279	Y	N
P51648	LP/P	Sjoegren-Larsson syndrome (SLS) [MIM:270200]	A0A0F8AHW9	328	M	I
P51648	LP/P	Sjoegren-Larsson syndrome (SLS) [MIM:270200]	A0A0F8AHW9	386	N	S
P51648	LP/P	Sjoegren-Larsson syndrome (SLS) [MIM:270200]	A0A0F8AHW9	406	G	R
P51648	LP/P	Sjoegren-Larsson syndrome (SLS) [MIM:270200]	A0A0F8AHW9	411	H	Y
P51648	LP/P	Sjoegren-Larsson syndrome (SLS) [MIM:270200]	A0A0F8AHW9	415	S	N
P51648	LP/P	Sjoegren-Larsson syndrome (SLS) [MIM:270200]	A0A0F8AHW9	419	F	S
P51648	LP/P	Sjoegren-Larsson syndrome (SLS) [MIM:270200]	A0A0F8AHW9	423	R	H
P51648	LP/P	Sjoegren-Larsson syndrome (SLS) [MIM:270200]	A0A0F8AHW9	447	K	E
P30038	LB/B	-	A0A2U3XM13	16	P	L
P30038	LP/P	Hyperprolinemia 2 (HYRPRO2) [MIM:239510]	A0A2U3XM13	352	S	L
P30038	LB/B	-	A0A2U3XM13	470	V	I
P30038	LB/B	-	A0A2U3XM13	473	T	A
P51649	LB/B	-	A0A2N2TZB7	180	H	Y
P51649	LB/B	-	A0A2N2TZB7	182	P	L
P51649	LP/P	Succinic semialdehyde dehydrogenase deficiency (SSADHD) [MIM:271980]	A0A2N2TZB7	93	C	F
P51649	LP/P	Succinic semialdehyde dehydrogenase deficiency (SSADHD) [MIM:271980]	A0A2N2TZB7	176	G	R
P51649	LP/P	Succinic semialdehyde dehydrogenase deficiency (SSADHD) [MIM:271980]	A0A2N2TZB7	223	C	Y
P51649	LP/P	Succinic semialdehyde dehydrogenase deficiency (SSADHD) [MIM:271980]	A0A2N2TZB7	233	T	M
P51649	LP/P	Succinic semialdehyde dehydrogenase deficiency (SSADHD) [MIM:271980]	A0A2N2TZB7	255	N	S
P51649	LP/P	Succinic semialdehyde dehydrogenase deficiency (SSADHD) [MIM:271980]	A0A2N2TZB7	268	G	E
P51649	LP/P	Succinic semialdehyde dehydrogenase deficiency (SSADHD) [MIM:271980]	A0A2N2TZB7	335	N	K
P51649	LP/P	Succinic semialdehyde dehydrogenase deficiency (SSADHD) [MIM:271980]	A0A2N2TZB7	382	P	L
P51649	LP/P	Succinic semialdehyde dehydrogenase deficiency (SSADHD) [MIM:271980]	A0A2N2TZB7	382	P	Q
P51649	LP/P	Succinic semialdehyde dehydrogenase deficiency (SSADHD) [MIM:271980]	A0A2N2TZB7	409	G	D
P51649	LP/P	Succinic semialdehyde dehydrogenase deficiency (SSADHD) [MIM:271980]	A0A2N2TZB7	487	V	E
P51649	LP/P	Succinic semialdehyde dehydrogenase deficiency (SSADHD) [MIM:271980]	A0A2N2TZB7	533	G	R
P51649	LB/B	-	A0A2N2TZB7	36	G	R
P51649	LB/B	-	A0A2N2TZB7	237	A	S
P51649	LB/B	-	A0A2N2TZB7	406	V	I
P51649	LB/B	-	A0A2N2TZB7	372	N	S
P49419	LB/B	-	F7FSZ3	412	T	A
P49419	LB/B	-	F7FSZ3	439	K	Q
P49419	LP/P	Pyridoxine-dependent epilepsy (PDE) [MIM:266100]	F7FSZ3	199	A	V
P49419	LP/P	Pyridoxine-dependent epilepsy (PDE) [MIM:266100]	F7FSZ3	427	E	Q
P49419	LP/P	Pyridoxine-dependent epilepsy (PDE) [MIM:266100]	F7FSZ3	202	G	V
P49419	LP/P	Pyridoxine-dependent epilepsy (PDE) [MIM:266100]	F7FSZ3	291	G	E
P49419	LP/P	Pyridoxine-dependent epilepsy (PDE) [MIM:266100]	F7FSZ3	301	N	I
P49419	LP/P	Pyridoxine-dependent epilepsy (PDE) [MIM:266100]	F7FSZ3	335	R	Q
P49419	LP/P	Pyridoxine-dependent epilepsy (PDE) [MIM:266100]	F7FSZ3	395	V	G
P49419	LP/P	Pyridoxine-dependent epilepsy (PDE) [MIM:266100]	F7FSZ3	458	S	N
P04075	LP/P	Glycogen storage disease 12 (GSD12) [MIM:611881]	F6SYJ3	129	D	G
P04075	LP/P	Glycogen storage disease 12 (GSD12) [MIM:611881]	F6SYJ3	207	E	K
P04075	LP/P	Glycogen storage disease 12 (GSD12) [MIM:611881]	F6SYJ3	339	C	Y
P04075	LB/B	Glycogen storage disease 12 (GSD12) [MIM:611881]	F6SYJ3	347	G	S
P04075	LB/B	-	F6SYJ3	82	E	Q
P04075	LB/B	-	F6SYJ3	142	G	V
P05062	LP/P	Hereditary fructose intolerance (HFI) [MIM:229600]	L5M8W7	135	C	R
P05062	LB/B	-	L5M8W7	148	W	R
P05062	LP/P	Hereditary fructose intolerance (HFI) [MIM:229600]	L5M8W7	150	A	P
P05062	LP/P	Hereditary fructose intolerance (HFI) [MIM:229600]	L5M8W7	175	A	D
P05062	LP/P	Hereditary fructose intolerance (HFI) [MIM:229600]	L5M8W7	257	L	P
P05062	LP/P	Hereditary fructose intolerance (HFI) [MIM:229600]	L5M8W7	304	R	W
P05062	LP/P	Hereditary fructose intolerance (HFI) [MIM:229600]	L5M8W7	335	N	K
P05062	LP/P	Hereditary fructose intolerance (HFI) [MIM:229600]	L5M8W7	338	A	V
P05062	LP/P	Hereditary fructose intolerance (HFI) [MIM:229600]	L5M8W7	74	I	T
P05062	LP/P	Hereditary fructose intolerance (HFI) [MIM:229600]	L5M8W7	185	P	R
P05062	LB/B	-	L5M8W7	207	E	Q
P05062	LP/P	Hereditary fructose intolerance (HFI) [MIM:229600]	L5M8W7	222	V	F
P05062	LP/P	Hereditary fructose intolerance (HFI) [MIM:229600]	L5M8W7	229	L	P
P05062	LP/P	Hereditary fructose intolerance (HFI) [MIM:229600]	L5M8W7	304	R	Q
P05062	LB/B	-	L5M8W7	134	R	S
P05062	LB/B	-	L5M8W7	268	I	N
P05062	LP/P	Hereditary fructose intolerance (HFI) [MIM:229600]	L5M8W7	178	C	R
P05062	LP/P	Hereditary fructose intolerance (HFI) [MIM:229600]	L5M8W7	284	L	P
P05062	LP/P	Hereditary fructose intolerance (HFI) [MIM:229600]	L5M8W7	46	R	W
P05062	LP/P	Hereditary fructose intolerance (HFI) [MIM:229600]	L5M8W7	343	Y	H
Q9BT22	LP/P	Congenital disorder of glycosylation 1K (CDG1K) [MIM:608540]	A0A1A8MJU6	150	S	R
Q9BT22	LP/P	Congenital disorder of glycosylation 1K (CDG1K) [MIM:608540]	A0A1A8MJU6	258	S	L
Q9BT22	LP/P	Congenital disorder of glycosylation 1K (CDG1K) [MIM:608540]	A0A1A8MJU6	342	Q	P
Q9BT22	LB/B	-	A0A1A8MJU6	429	D	E
Q9BT22	LB/B	-	A0A1A8MJU6	267	S	N
Q9BT22	LB/B	-	A0A1A8MJU6	325	L	M
Q9BT22	LB/B	-	A0A1A8MJU6	455	Q	R
Q9BT22	LP/P	Congenital disorder of glycosylation 1K (CDG1K) [MIM:608540]	A0A1A8MJU6	438	R	W
Q9BT22	LP/P	Congenital disorder of glycosylation 1K (CDG1K) [MIM:608540]	A0A1A8MJU6	50	Q	R
Q9BT22	LP/P	Congenital disorder of glycosylation 1K (CDG1K) [MIM:608540]	A0A1A8MJU6	71	S	F
Q9BT22	LP/P	Congenital disorder of glycosylation 1K (CDG1K) [MIM:608540]	A0A1A8MJU6	74	H	L
Q9BT22	LP/P	Congenital disorder of glycosylation 1K (CDG1K) [MIM:608540]	A0A1A8MJU6	88	L	V
Q9BT22	LP/P	Congenital disorder of glycosylation 1K (CDG1K) [MIM:608540]	A0A1A8MJU6	98	P	L
Q9BT22	LP/P	Congenital disorder of glycosylation 1K (CDG1K) [MIM:608540]	A0A1A8MJU6	114	L	F
Q9BT22	LP/P	Congenital disorder of glycosylation 1K (CDG1K) [MIM:608540]	A0A1A8MJU6	209	I	S
Q9BT22	LP/P	Congenital disorder of glycosylation 1K (CDG1K) [MIM:608540]	A0A1A8MJU6	276	R	W
Q9BT22	LP/P	Congenital disorder of glycosylation 1K (CDG1K) [MIM:608540]	A0A1A8MJU6	281	V	F
Q9BT22	LP/P	Congenital disorder of glycosylation 1K (CDG1K) [MIM:608540]	A0A1A8MJU6	289	D	G
Q9BT22	LP/P	Congenital disorder of glycosylation 1K (CDG1K) [MIM:608540]	A0A1A8MJU6	291	D	V
Q9BT22	LP/P	Congenital disorder of glycosylation 1K (CDG1K) [MIM:608540]	A0A1A8MJU6	353	Y	D
Q9BT22	LP/P	Congenital disorder of glycosylation 1K (CDG1K) [MIM:608540]	A0A1A8MJU6	358	G	R
Q9BT22	LP/P	Congenital disorder of glycosylation 1K (CDG1K) [MIM:608540]	A0A1A8MJU6	359	S	L
Q9BT22	LP/P	Congenital disorder of glycosylation 1K (CDG1K) [MIM:608540]	A0A1A8MJU6	360	A	V
Q9BT22	LP/P	Congenital disorder of glycosylation 1K (CDG1K) [MIM:608540]	A0A1A8MJU6	363	G	A
Q9BT22	LP/P	Congenital disorder of glycosylation 1K (CDG1K) [MIM:608540]	A0A1A8MJU6	366	L	Q
Q9BT22	LP/P	Congenital disorder of glycosylation 1K (CDG1K) [MIM:608540]	A0A1A8MJU6	367	H	Q
Q9BT22	LP/P	Congenital disorder of glycosylation 1K (CDG1K) [MIM:608540]	A0A1A8MJU6	382	M	K
Q9BT22	LP/P	Congenital disorder of glycosylation 1K (CDG1K) [MIM:608540]	A0A1A8MJU6	384	G	R
Q9BT22	LP/P	Congenital disorder of glycosylation 1K (CDG1K) [MIM:608540]	A0A1A8MJU6	388	P	S
Q5I7T1	LB/B	-	A0A091DFG1	446	I	V
Q5I7T1	LB/B	-	A0A091DFG1	84	A	G
Q5I7T1	LB/B	-	A0A091DFG1	383	S	N
Q9BV10	LP/P	Congenital disorder of glycosylation 1G (CDG1G) [MIM:607143]	A0A1S3FZJ3	67	T	M
Q9BV10	LP/P	Congenital disorder of glycosylation 1G (CDG1G) [MIM:607143]	A0A1S3FZJ3	142	F	V
Q9BV10	LP/P	Congenital disorder of glycosylation 1G (CDG1G) [MIM:607143]	A0A1S3FZJ3	146	R	Q
Q9BV10	LP/P	Congenital disorder of glycosylation 1G (CDG1G) [MIM:607143]	A0A1S3FZJ3	158	L	P
Q9BV10	LB/B	-	A0A1S3FZJ3	393	I	V
Q9BV10	LP/P	Congenital disorder of glycosylation 1G (CDG1G) [MIM:607143]	A0A1S3FZJ3	101	G	R
Q9NP73	LP/P	Developmental and epileptic encephalopathy 36 (DEE36) [MIM:300884]	Q9D8C3	94	K	E
Q9NP73	LP/P	Developmental and epileptic encephalopathy 36 (DEE36) [MIM:300884]	Q9D8C3	107	N	S
Q9H553	LB/B	-	M3X7Q7	11	S	P
Q9H553	LB/B	-	M3X7Q7	367	V	A
Q9H553	LP/P	Myasthenic syndrome, congenital, 14 (CMS14) [MIM:616228]	M3X7Q7	68	V	G
Q92685	LP/P	Congenital disorder of glycosylation 1D (CDG1D) [MIM:601110]	A0A226PQT9	118	G	D
Q92685	LB/B	-	A0A226PQT9	107	I	V
Q92685	LP/P	Congenital disorder of glycosylation 1D (CDG1D) [MIM:601110]	A0A226PQT9	171	R	Q
Q9Y673	LP/P	Polycystic kidney disease 7 (PKD7) [MIM:620056]	A0A182QSL6	208	R	H
Q9Y673	LP/P	Polycystic kidney disease 7 (PKD7) [MIM:620056]	A0A182QSL6	212	R	H
Q9Y672	LB/B	-	A0A1B0GIW4	304	S	F
Q9Y672	LP/P	Congenital disorder of glycosylation 1C (CDG1C) [MIM:603147]	A0A1B0GIW4	333	A	V
Q9Y672	LP/P	Congenital disorder of glycosylation 1C (CDG1C) [MIM:603147]	A0A1B0GIW4	478	S	P
Q9Y672	LP/P	Congenital disorder of glycosylation 1C (CDG1C) [MIM:603147]	A0A1B0GIW4	131	Y	H
Q9Y672	LP/P	Congenital disorder of glycosylation 1C (CDG1C) [MIM:603147]	A0A1B0GIW4	170	S	I
Q9Y672	LP/P	Congenital disorder of glycosylation 1C (CDG1C) [MIM:603147]	A0A1B0GIW4	227	G	E
Q9Y672	LP/P	Congenital disorder of glycosylation 1C (CDG1C) [MIM:603147]	A0A1B0GIW4	308	S	R
Q9Y672	LB/B	-	A0A1B0GIW4	226	K	N
Q9BVK2	LP/P	Congenital disorder of glycosylation 1H (CDG1H) [MIM:608104]	A0A010RDV2	47	T	P
Q9BVK2	LB/B	-	A0A010RDV2	222	N	S
Q9BVK2	LP/P	Congenital disorder of glycosylation 1H (CDG1H) [MIM:608104]	A0A010RDV2	275	G	D
Q9BVK2	LB/B	-	A0A010RDV2	439	I	T
Q9H6U8	LP/P	Congenital disorder of glycosylation 1L (CDG1L) [MIM:608776]	S7MDN1	287	Y	C
Q9H6U8	LB/B	-	S7MDN1	289	V	I
Q9H6U8	LB/B	-	S7MDN1	506	P	L
Q9H6U8	LP/P	Congenital disorder of glycosylation 1L (CDG1L) [MIM:608776]	S7MDN1	523	E	K
Q9H6U8	LB/B	-	S7MDN1	232	A	P
Q9H6U8	LB/B	-	S7MDN1	255	S	L
Q9H6U8	LB/B	-	S7MDN1	528	I	S
Q9UM73	LB/B	-	F1LRZ0	1461	I	V
Q9UM73	LB/B	-	F1LRZ0	1491	K	R
Q9UM73	LB/B	-	F1LRZ0	1529	D	E
Q9UM73	LB/B	-	F1LRZ0	90	S	L
Q9UM73	LB/B	-	F1LRZ0	163	V	L
Q9UM73	LB/B	-	F1LRZ0	296	E	Q
Q9UM73	LB/B	-	F1LRZ0	476	V	A
Q9UM73	LB/B	-	F1LRZ0	680	T	I
Q9UM73	LB/B	-	F1LRZ0	704	A	T
Q9UM73	LB/B	-	F1LRZ0	1012	T	M
Q9UM73	LB/B	-	F1LRZ0	1121	G	D
Q9UM73	LB/B	-	F1LRZ0	1274	A	T
Q9UM73	LB/B	-	F1LRZ0	1328	M	L
Q9UM73	LB/B	-	F1LRZ0	1416	K	N
Q9UM73	LB/B	-	F1LRZ0	1419	E	K
Q9UM73	LB/B	-	F1LRZ0	1429	Q	R
Q9UM73	LB/B	-	F1LRZ0	1376	F	S
Q9UM73	LB/B	-	F1LRZ0	1599	P	H
Q9UM73	LB/B	-	F1LRZ0	868	L	Q
Q9UM73	LP/P	Neuroblastoma 3 (NBLST3) [MIM:613014]	F1LRZ0	1091	D	N
Q9UM73	LP/P	Neuroblastoma 3 (NBLST3) [MIM:613014]	F1LRZ0	1128	G	A
Q9UM73	LP/P	Neuroblastoma 3 (NBLST3) [MIM:613014]	F1LRZ0	1151	T	M
Q9UM73	LP/P	Neuroblastoma 3 (NBLST3) [MIM:613014]	F1LRZ0	1166	M	R
Q9UM73	LP/P	Neuroblastoma 3 (NBLST3) [MIM:613014]	F1LRZ0	1171	I	N
Q9UM73	LP/P	Neuroblastoma 3 (NBLST3) [MIM:613014]	F1LRZ0	1174	F	C
Q9UM73	LP/P	Neuroblastoma 3 (NBLST3) [MIM:613014]	F1LRZ0	1174	F	I
Q9UM73	LP/P	Neuroblastoma 3 (NBLST3) [MIM:613014]	F1LRZ0	1174	F	L
Q9UM73	LP/P	Neuroblastoma 3 (NBLST3) [MIM:613014]	F1LRZ0	1174	F	V
Q9UM73	LP/P	Neuroblastoma 3 (NBLST3) [MIM:613014]	F1LRZ0	1192	R	P
Q9UM73	LP/P	Neuroblastoma 3 (NBLST3) [MIM:613014]	F1LRZ0	1234	A	T
Q9UM73	LP/P	Neuroblastoma 3 (NBLST3) [MIM:613014]	F1LRZ0	1245	F	C
Q9UM73	LP/P	Neuroblastoma 3 (NBLST3) [MIM:613014]	F1LRZ0	1245	F	V
Q9UM73	LP/P	Neuroblastoma 3 (NBLST3) [MIM:613014]	F1LRZ0	1250	I	T
Q9UM73	LB/B	-	F1LRZ0	1275	R	L
Q9UM73	LP/P	Neuroblastoma 3 (NBLST3) [MIM:613014]	F1LRZ0	1275	R	Q
Q9UM73	LP/P	Neuroblastoma 3 (NBLST3) [MIM:613014]	F1LRZ0	1278	Y	S
Q13686	LB/B	-	A0A2I0MPJ0	135	M	I
Q13686	LB/B	-	A0A2I0MPJ0	324	M	L
Q6NS38	LB/B	-	A0A1U7UYR6	203	R	H
Q6NS38	LB/B	-	A0A1U7UYR6	10	Q	K
Q96Q83	LB/B	-	V3YZ25	228	D	E
Q96Q83	LB/B	-	V3YZ25	164	R	C
Q9NXW9	LB/B	-	A0A2U4B7X3	247	A	V
Q9BT30	LB/B	-	A0A1A8E6P0	191	R	Q
P18054	LB/B	-	Q1ECU8	298	A	T
P18054	LB/B	-	Q1ECU8	261	Q	R
P18054	LB/B	-	Q1ECU8	322	N	S
P18054	LB/B	-	Q1ECU8	430	R	H
P18054	LB/B	-	Q1ECU8	259	E	K
P18054	LB/B	-	Q1ECU8	134	D	H
O75342	LP/P	Ichthyosis, congenital, autosomal recessive 2 (ARCI2) [MIM:242100]	G1PAI8	426	L	P
O75342	LP/P	Ichthyosis, congenital, autosomal recessive 2 (ARCI2) [MIM:242100]	G1PAI8	578	H	Q
O75342	LB/B	-	G1PAI8	94	G	S
O75342	LP/P	Ichthyosis, congenital, autosomal recessive 2 (ARCI2) [MIM:242100]	G1PAI8	24	L	P
O75342	LP/P	Ichthyosis, congenital, autosomal recessive 2 (ARCI2) [MIM:242100]	G1PAI8	67	I	F
O75342	LP/P	Ichthyosis, congenital, autosomal recessive 2 (ARCI2) [MIM:242100]	G1PAI8	114	R	W
O75342	LP/P	Ichthyosis, congenital, autosomal recessive 2 (ARCI2) [MIM:242100]	G1PAI8	127	P	S
O75342	LP/P	Ichthyosis, congenital, autosomal recessive 2 (ARCI2) [MIM:242100]	G1PAI8	195	F	L
O75342	LP/P	Ichthyosis, congenital, autosomal recessive 2 (ARCI2) [MIM:242100]	G1PAI8	318	Y	C
O75342	LP/P	Ichthyosis, congenital, autosomal recessive 2 (ARCI2) [MIM:242100]	G1PAI8	382	K	E
O75342	LP/P	Ichthyosis, congenital, autosomal recessive 2 (ARCI2) [MIM:242100]	G1PAI8	383	T	M
O75342	LP/P	Ichthyosis, congenital, autosomal recessive 2 (ARCI2) [MIM:242100]	G1PAI8	416	N	K
O75342	LP/P	Ichthyosis, congenital, autosomal recessive 2 (ARCI2) [MIM:242100]	G1PAI8	462	G	D
O75342	LP/P	Ichthyosis, congenital, autosomal recessive 2 (ARCI2) [MIM:242100]	G1PAI8	488	R	H
O75342	LP/P	Ichthyosis, congenital, autosomal recessive 2 (ARCI2) [MIM:242100]	G1PAI8	521	Y	C
O75342	LP/P	Ichthyosis, congenital, autosomal recessive 2 (ARCI2) [MIM:242100]	G1PAI8	527	V	M
O75342	LP/P	Ichthyosis, congenital, autosomal recessive 2 (ARCI2) [MIM:242100]	G1PAI8	597	A	E
O75342	LP/P	Ichthyosis, congenital, autosomal recessive 2 (ARCI2) [MIM:242100]	G1PAI8	664	A	P
O75342	LP/P	Ichthyosis, congenital, autosomal recessive 2 (ARCI2) [MIM:242100]	G1PAI8	679	R	L
P16050	LB/B	-	Q1ECU8	90	D	H
P16050	LB/B	-	Q1ECU8	103	N	K
P16050	LB/B	-	Q1ECU8	205	R	Q
P16050	LB/B	-	Q1ECU8	102	G	V
P16050	LB/B	-	Q1ECU8	239	V	M
P16050	LB/B	-	Q1ECU8	461	A	P
P16050	LB/B	-	Q1ECU8	560	T	M
O15296	LB/B	-	A0A1L8HJT5	656	Q	R
O15296	LB/B	-	A0A1L8HJT5	676	I	V
O15296	LB/B	-	A0A1L8HJT5	486	R	H
O15296	LB/B	-	A0A1L8HJT5	416	A	D
P09917	LB/B	-	Q1ECU8	254	E	K
Q9BYJ1	LP/P	Ichthyosis, congenital, autosomal recessive 3 (ARCI3) [MIM:606545]	G1PAI8	396	R	S
Q9BYJ1	LP/P	Ichthyosis, congenital, autosomal recessive 3 (ARCI3) [MIM:606545]	G1PAI8	500	V	F
Q9BYJ1	LP/P	Ichthyosis, congenital, autosomal recessive 3 (ARCI3) [MIM:606545]	G1PAI8	237	L	M
Q9BYJ1	LP/P	Ichthyosis, congenital, autosomal recessive 3 (ARCI3) [MIM:606545]	G1PAI8	281	G	V
Q9BYJ1	LP/P	Ichthyosis, congenital, autosomal recessive 3 (ARCI3) [MIM:606545]	G1PAI8	427	L	P
Q9BYJ1	LP/P	Ichthyosis, congenital, autosomal recessive 3 (ARCI3) [MIM:606545]	G1PAI8	630	P	L
P10696	LB/B	-	A0A1A6HVW2	273	L	M
P10696	LB/B	-	A0A1A6HVW2	316	L	R
P10696	LB/B	-	A0A1A6HVW2	527	G	E
P09923	LB/B	-	A0A1A6HVW2	298	H	L
P09923	LB/B	-	A0A1A6HVW2	144	R	H
Q96QP1	LB/B	-	A0A093Q212	175	N	D
Q96QP1	LB/B	-	A0A093Q212	565	G	D
Q96QP1	LB/B	-	A0A093Q212	642	H	R
Q96QP1	LB/B	-	A0A093Q212	732	M	I
Q96QP1	LB/B	-	A0A093Q212	861	M	T
Q96QP1	LB/B	-	A0A093Q212	870	G	S
Q96QP1	LB/B	-	A0A093Q212	916	N	D
Q96QP1	LB/B	-	A0A093Q212	67	Q	R
Q96QP1	LB/B	-	A0A093Q212	292	T	M
Q96QP1	LB/B	-	A0A093Q212	320	L	M
Q96QP1	LB/B	-	A0A093Q212	383	K	E
Q96QP1	LB/B	-	A0A093Q212	660	P	L
Q96QP1	LB/B	-	A0A093Q212	681	G	D
Q96QP1	LB/B	-	A0A093Q212	873	R	I
Q96QP1	LB/B	-	A0A093Q212	910	E	D
Q96QP1	LB/B	-	A0A093Q212	935	P	L
Q96QP1	LB/B	-	A0A093Q212	1084	R	Q
Q96QP1	LB/B	-	A0A093Q212	1117	L	P
Q96QP1	LB/B	-	A0A093Q212	1160	A	G
Q96QP1	LB/B	-	A0A093Q212	1008	H	P
Q96QP1	LP/P	Retinal dystrophy, optic nerve edema, splenomegaly, anhidrosis, and migraine headache syndrome (ROSAH) [MIM:614979]	A0A093Q212	237	T	M
Q96L96	LB/B	-	A0A151MAE9	414	T	S
Q96L96	LB/B	-	A0A151MAE9	579	G	E
Q96L96	LB/B	-	A0A151MAE9	761	T	M
Q96L96	LB/B	-	A0A151MAE9	1299	P	L
Q96L96	LB/B	-	A0A151MAE9	1622	L	P
Q96L96	LB/B	-	A0A151MAE9	336	R	H
Q96L96	LB/B	-	A0A151MAE9	338	T	I
Q96L96	LB/B	-	A0A151MAE9	602	Q	R
Q96L96	LB/B	-	A0A151MAE9	663	G	D
Q96L96	LB/B	-	A0A151MAE9	836	R	L
Q96L96	LB/B	-	A0A151MAE9	929	E	D
Q96L96	LB/B	-	A0A151MAE9	1412	R	W
Q96L96	LB/B	-	A0A151MAE9	1557	A	D
Q96L96	LB/B	-	A0A151MAE9	1013	E	K
Q96L96	LB/B	-	A0A151MAE9	1137	A	G
Q96L96	LB/B	-	A0A151MAE9	1873	A	V
P05187	LB/B	-	A0A1A6HVW2	25	P	L
P05187	LB/B	-	A0A1A6HVW2	89	I	L
P05187	LB/B	-	A0A1A6HVW2	231	R	P
P05187	LB/B	-	A0A1A6HVW2	263	R	H
P05187	LB/B	-	A0A1A6HVW2	451	E	G
Q96Q42	LB/B	-	A0A2I0UQH7	102	H	R
Q96Q42	LB/B	-	A0A2I0UQH7	368	V	M
Q96Q42	LB/B	-	A0A2I0UQH7	1406	R	K
Q96Q42	LB/B	-	A0A2I0UQH7	94	I	V
Q96Q42	LB/B	-	A0A2I0UQH7	159	E	K
Q96Q42	LB/B	-	A0A2I0UQH7	1255	S	F
Q60I27	LB/B	-	H0YPM0	45	E	Q
Q60I27	LB/B	-	H0YPM0	29	Q	R
O95076	LB/B	-	W5QDN7	234	P	A
O95076	LP/P	Frontonasal dysplasia 1 (FND1) [MIM:136760]	W5QDN7	168	L	V
O95076	LP/P	Frontonasal dysplasia 1 (FND1) [MIM:136760]	W5QDN7	183	R	W
O95076	LP/P	Frontonasal dysplasia 1 (FND1) [MIM:136760]	W5QDN7	196	R	W
O95076	LP/P	Frontonasal dysplasia 1 (FND1) [MIM:136760]	W5QDN7	203	N	S
Q9H161	LB/B	-	A0A023IUN3	35	R	T
Q9H161	LB/B	-	A0A023IUN3	102	P	S
Q9H161	LP/P	Parietal foramina 2 (PFM2) [MIM:609597]	A0A023IUN3	218	R	Q
Q9H161	LP/P	Parietal foramina 2 (PFM2) [MIM:609597]	A0A023IUN3	272	R	P
Q9H161	LB/B	-	A0A023IUN3	257	R	T
Q9H161	LP/P	Craniosynostosis 5 (CRS5) [MIM:615529]	A0A023IUN3	7	V	F
Q9H161	LP/P	Craniosynostosis 5 (CRS5) [MIM:615529]	A0A023IUN3	211	K	E
Q9H161	LB/B	-	A0A023IUN3	306	P	L
Q9UHK6	LB/B	-	A0A1F7M7E0	9	V	M
Q9UHK6	LP/P	Alpha-methylacyl-CoA racemase deficiency (AMACRD) [MIM:614307]	A0A1F7M7E0	52	S	P
Q9UHK6	LP/P	Congenital bile acid synthesis defect 4 (CBAS4) [MIM:214950]	A0A1F7M7E0	52	S	P
Q9UHK6	LB/B	-	A0A1F7M7E0	175	G	D
Q9UHK6	LB/B	-	A0A1F7M7E0	201	L	S
Q9UHK6	LB/B	-	A0A1F7M7E0	277	E	K
Q9UHK6	LP/P	Congenital bile acid synthesis defect 4 (CBAS4) [MIM:214950]	A0A1F7M7E0	107	L	P
Q9UHK6	LB/B	-	A0A1F7M7E0	118	R	Q
Q9UHK6	LB/B	-	A0A1F7M7E0	238	P	S
Q9UHK6	LB/B	-	A0A1F7M7E0	239	Q	H
Q9UHK6	LB/B	-	A0A1F7M7E0	261	M	I
Q9UHK6	LB/B	-	A0A1F7M7E0	261	M	T
Q99217	LP/P	Amelogenesis imperfecta 1E (AI1E) [MIM:301200]	H9G519	4	W	S
Q99217	LP/P	Amelogenesis imperfecta 1E (AI1E) [MIM:301200]	H9G519	37	T	I
Q99217	LP/P	Amelogenesis imperfecta 1E (AI1E) [MIM:301200]	H9G519	56	P	T
Q5JTC6	LB/B	-	F1NGE5	292	K	N
Q5JTC6	LB/B	-	F1NGE5	159	F	L
Q5JTC6	LB/B	-	F1NGE5	278	A	S
Q5JTC6	LB/B	-	F1NGE5	178	R	C
Q8N7J2	LB/B	-	L9JBF4	659	I	M
Q8N944	LB/B	-	A0A1U7TG87	340	S	P
P03971	LP/P	Persistent Muellerian duct syndrome 1 (PMDS1) [MIM:261550]	F6TR95	12	V	G
P03971	LB/B	-	F6TR95	49	S	I
P03971	LP/P	Persistent Muellerian duct syndrome 1 (PMDS1) [MIM:261550]	F6TR95	70	L	P
P03971	LP/P	Persistent Muellerian duct syndrome 1 (PMDS1) [MIM:261550]	F6TR95	101	G	V
P03971	LP/P	Persistent Muellerian duct syndrome 1 (PMDS1) [MIM:261550]	F6TR95	123	R	W
P03971	LP/P	Persistent Muellerian duct syndrome 1 (PMDS1) [MIM:261550]	F6TR95	167	Y	C
P03971	LB/B	-	F6TR95	185	Q	E
P03971	LP/P	Persistent Muellerian duct syndrome 1 (PMDS1) [MIM:261550]	F6TR95	194	R	C
P03971	LB/B	-	F6TR95	325	Q	R
P03971	LP/P	Persistent Muellerian duct syndrome 1 (PMDS1) [MIM:261550]	F6TR95	477	V	A
P03971	LP/P	Persistent Muellerian duct syndrome 1 (PMDS1) [MIM:261550]	F6TR95	506	H	Q
P03971	LP/P	Persistent Muellerian duct syndrome 1 (PMDS1) [MIM:261550]	F6TR95	525	C	Y
P03971	LB/B	-	F6TR95	515	V	A
Q16671	LP/P	Persistent Muellerian duct syndrome 2 (PMDS2) [MIM:261550]	A0A2Y9DH87	54	R	C
Q16671	LP/P	Persistent Muellerian duct syndrome 2 (PMDS2) [MIM:261550]	A0A2Y9DH87	142	G	V
Q16671	LP/P	Persistent Muellerian duct syndrome 2 (PMDS2) [MIM:261550]	A0A2Y9DH87	282	H	Q
Q16671	LP/P	Persistent Muellerian duct syndrome 2 (PMDS2) [MIM:261550]	A0A2Y9DH87	406	R	Q
Q16671	LP/P	Persistent Muellerian duct syndrome 2 (PMDS2) [MIM:261550]	A0A2Y9DH87	426	D	G
Q16671	LP/P	Persistent Muellerian duct syndrome 2 (PMDS2) [MIM:261550]	A0A2Y9DH87	458	V	A
Q16671	LP/P	Persistent Muellerian duct syndrome 2 (PMDS2) [MIM:261550]	A0A2Y9DH87	491	D	H
Q16671	LP/P	Persistent Muellerian duct syndrome 2 (PMDS2) [MIM:261550]	A0A2Y9DH87	504	R	C
Q16671	LB/B	-	A0A2Y9DH87	319	R	H
Q9Y4X0	LP/P	Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis (MFHIEN) [MIM:300990]	A0A2Y9GSU0	177	G	D
Q8IY63	LB/B	-	F1LZQ6	847	P	L
Q01433	LB/B	-	A0A2I4CTY3	522	I	V
Q01433	LP/P	Pontocerebellar hypoplasia 9 (PCH9) [MIM:615809]	A0A2I4CTY3	674	R	H
Q01433	LP/P	Pontocerebellar hypoplasia 9 (PCH9) [MIM:615809]	A0A2I4CTY3	793	D	Y
Q01433	LP/P	Pontocerebellar hypoplasia 9 (PCH9) [MIM:615809]	A0A2I4CTY3	778	E	D
Q01432	LP/P	Adenosine monophosphate deaminase deficiency erythrocyte type (AMPDDE) [MIM:612874]	U5ESH6	573	R	C
Q01432	LB/B	-	U5ESH6	185	R	W
Q01432	LP/P	Adenosine monophosphate deaminase deficiency erythrocyte type (AMPDDE) [MIM:612874]	U5ESH6	310	N	K
Q01432	LP/P	Adenosine monophosphate deaminase deficiency erythrocyte type (AMPDDE) [MIM:612874]	U5ESH6	311	V	L
Q01432	LP/P	Adenosine monophosphate deaminase deficiency erythrocyte type (AMPDDE) [MIM:612874]	U5ESH6	320	A	V
Q01432	LP/P	Adenosine monophosphate deaminase deficiency erythrocyte type (AMPDDE) [MIM:612874]	U5ESH6	324	M	T
Q01432	LP/P	Adenosine monophosphate deaminase deficiency erythrocyte type (AMPDDE) [MIM:612874]	U5ESH6	331	R	C
Q01432	LP/P	Adenosine monophosphate deaminase deficiency erythrocyte type (AMPDDE) [MIM:612874]	U5ESH6	402	R	C
Q01432	LP/P	Adenosine monophosphate deaminase deficiency erythrocyte type (AMPDDE) [MIM:612874]	U5ESH6	450	W	R
Q01432	LB/B	-	U5ESH6	455	Y	H
Q01432	LP/P	Adenosine monophosphate deaminase deficiency erythrocyte type (AMPDDE) [MIM:612874]	U5ESH6	585	P	L
Q01432	LP/P	Adenosine monophosphate deaminase deficiency erythrocyte type (AMPDDE) [MIM:612874]	U5ESH6	712	Q	P
P49418	LB/B	-	A0A1S3LUI0	218	K	E
P49418	LB/B	-	A0A1S3LUI0	376	M	I
P49418	LB/B	-	A0A1S3LUI0	496	K	T
P48728	LP/P	Non-ketotic hyperglycinemia (NKH) [MIM:605899]	Q00ZP0	42	H	R
P48728	LP/P	Non-ketotic hyperglycinemia (NKH) [MIM:605899]	Q00ZP0	47	G	R
P48728	LP/P	Non-ketotic hyperglycinemia (NKH) [MIM:605899]	Q00ZP0	269	G	D
P48728	LP/P	Non-ketotic hyperglycinemia (NKH) [MIM:605899]	Q00ZP0	276	D	H
P48728	LP/P	Non-ketotic hyperglycinemia (NKH) [MIM:605899]	Q00ZP0	320	R	H
P48728	LP/P	Non-ketotic hyperglycinemia (NKH) [MIM:605899]	Q00ZP0	145	N	I
P48728	LP/P	Non-ketotic hyperglycinemia (NKH) [MIM:605899]	Q00ZP0	211	E	K
P48728	LP/P	Non-ketotic hyperglycinemia (NKH) [MIM:605899]	Q00ZP0	265	R	C
P48728	LP/P	Non-ketotic hyperglycinemia (NKH) [MIM:605899]	Q00ZP0	94	R	W
P48728	LP/P	Non-ketotic hyperglycinemia (NKH) [MIM:605899]	Q00ZP0	222	R	C
P48728	LP/P	Non-ketotic hyperglycinemia (NKH) [MIM:605899]	Q00ZP0	296	R	C
Q6UX39	LB/B	-	G3X0Q5	45	N	S
Q6UX39	LB/B	-	G3X0Q5	50	S	P
Q400G9	LB/B	-	A0A2U4CBY4	491	R	H
Q86W34	LB/B	-	A0A1L8EUX6	30	N	D
Q86W34	LB/B	-	A0A1L8EUX6	146	H	Q
Q9UM13	LB/B	-	A0A226P7J7	46	R	Q
Q9UJX5	LB/B	-	A0A096NZK6	465	R	Q
Q9UJX5	LB/B	-	A0A096NZK6	800	E	G
Q9UNK9	LB/B	-	A0A212CTU3	141	G	W
Q9UNK9	LB/B	-	A0A212CTU3	515	F	C
Q9UNK9	LB/B	-	A0A212CTU3	383	V	L
Q15389	LB/B	-	L5MAA5	247	L	P
Q15389	LP/P	Angioedema, hereditary, 5 (HAE5) [MIM:619361]	L5MAA5	119	A	S
Q9Y264	LB/B	-	L5MAA5	395	E	K
Q9Y5C1	LB/B	-	I3KQP6	418	N	Y
Q9Y5C1	LB/B	-	I3KQP6	127	L	F
Q9Y5C1	LB/B	-	I3KQP6	63	K	T
Q9Y5C1	LB/B	-	I3KQP6	91	E	G
Q9Y5C1	LB/B	-	I3KQP6	164	L	F
Q9Y5C1	LB/B	-	I3KQP6	173	N	S
Q9Y5C1	LB/B	-	I3KQP6	259	M	T
Q9Y5C1	LB/B	-	I3KQP6	288	R	Q
Q9Y5C1	LB/B	-	I3KQP6	292	S	P
Q9Y5C1	LB/B	-	I3KQP6	344	Y	S
Q9Y5C1	LB/B	-	I3KQP6	375	E	K
Q9Y5C1	LB/B	-	I3KQP6	417	Y	C
Q9BY76	LB/B	-	A0A096N5Y2	266	T	M
Q9BY76	LB/B	-	A0A096N5Y2	5	P	L
Q9BY76	LB/B	-	A0A096N5Y2	40	E	K
Q9BY76	LB/B	-	A0A096N5Y2	41	M	I
Q9BY76	LB/B	-	A0A096N5Y2	67	S	R
Q9BY76	LB/B	-	A0A096N5Y2	72	R	L
Q9BY76	LB/B	-	A0A096N5Y2	77	G	R
Q9BY76	LB/B	-	A0A096N5Y2	167	E	K
Q9BY76	LB/B	-	A0A096N5Y2	174	P	S
Q9BY76	LB/B	-	A0A096N5Y2	190	E	Q
Q9BY76	LB/B	-	A0A096N5Y2	196	E	K
Q9BY76	LB/B	-	A0A096N5Y2	230	R	C
Q9BY76	LB/B	-	A0A096N5Y2	233	G	R
Q9BY76	LB/B	-	A0A096N5Y2	237	F	V
Q9BY76	LB/B	-	A0A096N5Y2	251	P	T
Q9BY76	LB/B	-	A0A096N5Y2	278	R	Q
Q9BY76	LB/B	-	A0A096N5Y2	291	V	M
Q9BY76	LB/B	-	A0A096N5Y2	293	L	M
Q9BY76	LB/B	-	A0A096N5Y2	296	E	V
Q9BY76	LB/B	-	A0A096N5Y2	307	P	S
Q9BY76	LB/B	-	A0A096N5Y2	308	V	M
Q9BY76	LB/B	-	A0A096N5Y2	336	R	C
Q9BY76	LB/B	-	A0A096N5Y2	338	D	E
Q9BY76	LB/B	-	A0A096N5Y2	349	W	C
Q9BY76	LB/B	-	A0A096N5Y2	361	G	R
Q9BY76	LB/B	-	A0A096N5Y2	361	G	S
Q9BY76	LB/B	-	A0A096N5Y2	371	R	Q
Q9BY76	LB/B	-	A0A096N5Y2	384	R	W
Q86XS5	LB/B	-	F7B2G0	175	S	P
Q6UXH0	LB/B	-	A0A1U7SXI1	59	R	W
Q6UXH0	LB/B	-	A0A1U7SXI1	147	R	Q
P16157	LB/B	-	A0A1L8H244	21	R	T
P16157	LP/P	Spherocytosis 1 (SPH1) [MIM:182900]	A0A1L8H244	463	V	I
P16157	LB/B	-	A0A1L8H244	619	R	H
P16157	LB/B	-	A0A1L8H244	750	V	A
P16157	LB/B	-	A0A1L8H244	845	D	E
P16157	LB/B	-	A0A1L8H244	1392	S	T
P16157	LB/B	-	A0A1L8H244	1286	E	D
P16157	LB/B	-	A0A1L8H244	1592	D	N
P16157	LB/B	-	A0A1L8H244	991	V	L
P16157	LB/B	-	A0A1L8H244	733	L	I
P16157	LB/B	-	A0A1L8H244	1126	A	P
P16157	LB/B	-	A0A1L8H244	1192	T	P
P16157	LB/B	-	A0A1L8H244	1325	M	V
P16157	LB/B	-	A0A1L8H244	1546	V	I
P16157	LB/B	-	A0A1L8H244	1075	T	I
P16157	LP/P	Spherocytosis 1 (SPH1) [MIM:182900]	A0A1L8H244	276	L	R
P16157	LP/P	Spherocytosis 1 (SPH1) [MIM:182900]	A0A1L8H244	1054	I	T
P16157	LB/B	-	A0A1L8H244	832	R	Q
Q01484	LP/P	Long QT syndrome 4 (LQT4) [MIM:600919]	A0A2I0U7C2	3740	L	I
Q01484	LP/P	Long QT syndrome 4 (LQT4) [MIM:600919]	A0A2I0U7C2	3744	T	N
Q01484	LP/P	Long QT syndrome 4 (LQT4) [MIM:600919]	A0A2I0U7C2	3906	R	W
Q01484	LP/P	Long QT syndrome 4 (LQT4) [MIM:600919]	A0A2I0U7C2	3931	E	K
Q01484	LB/B	-	A0A2I0U7C2	687	N	S
Q01484	LB/B	-	A0A2I0U7C2	2369	V	A
Q01484	LB/B	-	A0A2I0U7C2	1555	V	D
Q7Z5J8	LB/B	-	A7RY53	675	I	V
Q7Z5J8	LB/B	-	A7RY53	1077	L	F
Q495B1	LB/B	-	D3Z8Z7	355	K	E
Q9NU02	LB/B	-	A0A2I3HK16	324	L	Q
Q9NU02	LB/B	-	A0A2I3HK16	74	P	T
Q9NU02	LB/B	-	A0A2I3HK16	412	G	E
Q9NU02	LB/B	-	A0A2I3HK16	742	R	Q
Q8N957	LB/B	-	W5N360	442	V	I
Q9HCJ1	LP/P	Craniometaphyseal dysplasia, autosomal dominant (CMDD) [MIM:123000]	A0A1U8CBQ7	292	W	R
Q9HCJ1	LP/P	Craniometaphyseal dysplasia, autosomal dominant (CMDD) [MIM:123000]	A0A1U8CBQ7	331	C	R
Q9HCJ1	LP/P	Craniometaphyseal dysplasia, autosomal dominant (CMDD) [MIM:123000]	A0A1U8CBQ7	389	G	R
Q9HCJ1	LP/P	Chondrocalcinosis 2 (CCAL2) [MIM:118600]	A0A1U8CBQ7	48	M	T
Q9HCJ1	LP/P	Chondrocalcinosis 2 (CCAL2) [MIM:118600]	A0A1U8CBQ7	5	P	L
Q9HCJ1	LP/P	Chondrocalcinosis 2 (CCAL2) [MIM:118600]	A0A1U8CBQ7	5	P	T
Q8IWZ3	LB/B	-	A0A091CP42	175	L	M
Q8IWZ3	LB/B	-	A0A091CP42	228	G	C
Q8IWZ3	LB/B	-	A0A091CP42	1760	N	S
Q8IWZ3	LB/B	-	A0A091CP42	1586	G	S
Q9P2G1	LB/B	-	A0A2I0U4F7	1016	L	M
Q8NAG6	LB/B	-	L9KW76	94	L	Q
Q8NAG6	LB/B	-	L9KW76	184	L	W
Q8NAG6	LB/B	-	L9KW76	311	T	P
Q8NAG6	LB/B	-	L9KW76	435	Q	R
Q8NAG6	LB/B	-	L9KW76	447	V	M
Q8NAG6	LB/B	-	L9KW76	160	P	S
Q8NAG6	LB/B	-	L9KW76	31	A	T
Q8NAG6	LB/B	-	L9KW76	71	A	V
Q86XL3	LB/B	-	H0ZD49	122	H	Y
Q86XL3	LB/B	-	H0ZD49	148	Q	E
Q86XL3	LB/B	-	H0ZD49	720	R	H
Q86XL3	LP/P	Microcephaly 16, primary, autosomal recessive (MCPH16) [MIM:616681]	H0ZD49	109	A	P
Q86XL3	LP/P	Microcephaly 16, primary, autosomal recessive (MCPH16) [MIM:616681]	H0ZD49	201	G	W
Q6UB98	LB/B	-	A0A212C6K6	171	S	T
Q6UB98	LB/B	-	A0A212C6K6	818	S	N
Q6UB98	LB/B	-	A0A212C6K6	906	K	R
Q6UB98	LB/B	-	A0A212C6K6	277	P	A
Q6UB98	LB/B	-	A0A212C6K6	390	E	D
Q6UB98	LB/B	-	A0A212C6K6	507	T	I
Q6UB98	LB/B	-	A0A212C6K6	531	T	S
Q6UB98	LB/B	-	A0A212C6K6	998	L	S
Q6UB98	LB/B	-	A0A212C6K6	1758	S	P
Q8IZ07	LB/B	-	V4BRU0	505	L	P
Q8N6S4	LB/B	-	A0A1S3WES9	413	T	S
Q6P6B7	LB/B	-	E1C7B6	353	Q	R
Q6P6B7	LB/B	-	E1C7B6	128	A	G
O75179	LB/B	-	A0A2J8UTW5	2560	H	Y
O75179	LP/P	Chopra-Amiel-Gordon syndrome (CAGS) [MIM:619504]	A0A2J8UTW5	278	G	V
O75179	LP/P	Chopra-Amiel-Gordon syndrome (CAGS) [MIM:619504]	A0A2J8UTW5	377	A	T
O75179	LP/P	Chopra-Amiel-Gordon syndrome (CAGS) [MIM:619504]	A0A2J8UTW5	519	L	P
O75179	LP/P	Chopra-Amiel-Gordon syndrome (CAGS) [MIM:619504]	A0A2J8UTW5	716	L	R
O75179	LP/P	Chopra-Amiel-Gordon syndrome (CAGS) [MIM:619504]	A0A2J8UTW5	1120	L	R
O75179	LP/P	Chopra-Amiel-Gordon syndrome (CAGS) [MIM:619504]	A0A2J8UTW5	1186	P	R
O75179	LP/P	Chopra-Amiel-Gordon syndrome (CAGS) [MIM:619504]	A0A2J8UTW5	1364	G	A
O75179	LP/P	Chopra-Amiel-Gordon syndrome (CAGS) [MIM:619504]	A0A2J8UTW5	1880	S	P
O75179	LP/P	Chopra-Amiel-Gordon syndrome (CAGS) [MIM:619504]	A0A2J8UTW5	2434	R	G
Q8IVF6	LB/B	-	F6THX2	130	E	K
Q8IVF6	LB/B	-	F6THX2	277	A	E
Q8IVF6	LB/B	-	F6THX2	484	N	S
Q8IVF6	LB/B	-	F6THX2	688	Y	C
Q8IVF6	LB/B	-	F6THX2	942	T	I
Q8IVF6	LB/B	-	F6THX2	945	E	D
Q8IVF6	LB/B	-	F6THX2	838	E	D
Q5VYY1	LB/B	-	A0A087QZ15	73	E	G
Q5VYY1	LB/B	-	A0A087QZ15	79	Y	H
Q5VYY1	LB/B	-	A0A087QZ15	148	Q	P
Q5VYY1	LB/B	-	A0A087QZ15	177	R	I
Q9UPS8	LB/B	-	A0A2Y9P1R1	20	Q	R
Q9UPS8	LB/B	-	A0A2Y9P1R1	1305	V	I
Q9UPS8	LB/B	-	A0A2Y9P1R1	1514	F	L
Q9UPS8	LB/B	-	A0A2Y9P1R1	425	I	V
Q9UPS8	LB/B	-	A0A2Y9P1R1	1220	V	L
Q96NW4	LB/B	-	F7D8Q3	657	S	G
Q96NW4	LB/B	-	F7D8Q3	761	P	R
Q8N6D5	LB/B	-	A0A2K6KIC0	112	G	E
Q9BXX3	LB/B	-	A0A2K6UGA5	611	T	A
Q9BXX3	LB/B	-	A0A2K6UGA5	917	K	N
Q9BXX3	LB/B	-	A0A2K6UGA5	985	R	C
Q9BXX2	LB/B	-	A0A2K6UGA5	375	V	M
Q9BXX2	LB/B	-	A0A2K6UGA5	477	F	L
Q7Z3H0	LB/B	-	A0A060WYI1	140	Y	F
Q7Z3H0	LB/B	-	A0A060WYI1	257	Q	R
Q7Z3H0	LB/B	-	A0A060WYI1	313	T	N
A5PLL1	LB/B	-	A0A091E5N2	156	L	S
P0C6C1	LB/B	-	A0A091E5N2	369	P	R
P0C6C1	LB/B	-	A0A091E5N2	427	P	H
P0C6C1	LB/B	-	A0A091E5N2	442	L	I
Q8N283	LB/B	-	A0A1S3FCI3	428	P	S
Q8N283	LB/B	-	A0A1S3FCI3	978	N	D
Q8N283	LB/B	-	A0A1S3FCI3	53	N	K
Q8N283	LB/B	-	A0A1S3FCI3	592	R	Q
Q8N2N9	LB/B	-	A0A2K6UGA5	496	E	D
Q8N2N9	LB/B	-	A0A2K6UGA5	483	E	G
Q8N2N9	LB/B	-	A0A2K6UGA5	534	S	A
Q7Z713	LB/B	-	K7G8F9	152	T	S
Q53RE8	LB/B	-	L7MLY0	113	A	T
Q8N9B4	LB/B	-	E2RHA8	198	N	D
Q8N9V6	LB/B	-	A0A287BMK4	153	L	I
Q8N9V6	LB/B	-	A0A287BMK4	243	M	T
Q8N9V6	LB/B	-	A0A287BMK4	105	A	G
Q8N9V6	LB/B	-	A0A287BMK4	349	R	L
Q8N9V6	LB/B	-	A0A287BMK4	431	H	L
Q3KP44	LB/B	-	H0YWI8	345	V	M
Q3KP44	LB/B	-	H0YWI8	594	R	Q
Q9Y2G4	LB/B	-	A0A2K6U9V7	122	Q	E
Q9Y2G4	LB/B	-	A0A2K6U9V7	128	I	V
Q9Y2G4	LB/B	-	A0A2K6U9V7	233	T	M
Q9Y2G4	LB/B	-	A0A2K6U9V7	545	T	A
Q9Y2G4	LB/B	-	A0A2K6U9V7	550	A	T
Q9BZ19	LB/B	-	F7ISJ3	295	R	C
A6NC57	LB/B	-	E1BPJ3	188	A	S
A6NC57	LB/B	-	E1BPJ3	265	C	R
A6NC57	LB/B	-	E1BPJ3	406	E	K
A6NC57	LB/B	-	E1BPJ3	613	A	T
Q68DC2	LB/B	-	A0A2K6FLZ5	644	V	I
Q68DC2	LB/B	-	A0A2K6FLZ5	222	R	W
Q68DC2	LP/P	Nephronophthisis 16 (NPHP16) [MIM:615382]	A0A2K6FLZ5	312	A	P
Q68DC2	LB/B	-	A0A2K6FLZ5	440	R	Q
Q68DC2	LP/P	Nephronophthisis 16 (NPHP16) [MIM:615382]	A0A2K6FLZ5	441	Q	R
Q68DC2	LB/B	-	A0A2K6FLZ5	640	G	S
Q68DC2	LB/B	-	A0A2K6FLZ5	735	P	A
A6NFN9	LB/B	-	A0A1W5AXP0	217	R	W
A6NFN9	LB/B	-	A0A1W5AXP0	306	I	M
A6NFN9	LB/B	-	A0A1W5AXP0	386	S	G
Q9H8Y5	LB/B	-	S9WTB3	569	R	W
Q9H8Y5	LB/B	-	S9WTB3	676	P	L
Q9H8Y5	LB/B	-	S9WTB3	638	Q	P
Q5XXA6	LB/B	-	A0A1L8GR10	608	F	S
Q5XXA6	LB/B	-	A0A1L8GR10	983	G	R
Q9NW15	LB/B	-	A0A1V4KC76	462	R	Q
Q9NW15	LB/B	-	A0A1V4KC76	561	T	M
Q9NW15	LB/B	-	A0A1V4KC76	583	V	A
Q9NW15	LP/P	Spinocerebellar ataxia, autosomal recessive, 10 (SCAR10) [MIM:613728]	A0A1V4KC76	510	L	R
Q9NQ90	LB/B	-	H2V4Y2	505	S	A
Q9NQ90	LB/B	-	H2V4Y2	112	V	A
Q9NQ90	LB/B	-	H2V4Y2	147	P	S
Q9NQ90	LB/B	-	H2V4Y2	401	M	I
Q9BYT9	LB/B	-	L9JEC7	781	L	V
Q9BYT9	LP/P	Dystonia 24 (DYT24) [MIM:615034]	L9JEC7	490	W	C
Q9BYT9	LP/P	Dystonia 24 (DYT24) [MIM:615034]	L9JEC7	494	R	W
Q9BYT9	LP/P	Dystonia 24 (DYT24) [MIM:615034]	L9JEC7	685	S	G
Q9BYT9	LP/P	Dystonia 24 (DYT24) [MIM:615034]	L9JEC7	862	K	N
Q32M45	LB/B	-	A0A2U9B1K4	115	G	A
Q75V66	LP/P	Gnathodiaphyseal dysplasia (GDD) [MIM:166260]	G1SCV2	356	C	G
Q75V66	LP/P	Gnathodiaphyseal dysplasia (GDD) [MIM:166260]	G1SCV2	356	C	R
Q75V66	LB/B	-	G1SCV2	322	L	F
Q75V66	LB/B	-	G1SCV2	882	N	K
Q75V66	LP/P	Gnathodiaphyseal dysplasia (GDD) [MIM:166260]	G1SCV2	356	C	Y
Q4KMQ2	LB/B	-	H2V4Y2	128	A	T
Q6IWH7	LB/B	-	A0A2Y9E5H6	67	V	I
Q6IWH7	LB/B	-	A0A2Y9E5H6	912	E	K
A1A5B4	LB/B	-	A0A2K5U179	391	I	V
A1A5B4	LB/B	-	A0A2K5U179	399	C	R
A1A5B4	LB/B	-	A0A2K5U179	93	L	F
O43423	LB/B	-	H3CVZ7	71	R	K
O43423	LB/B	-	H3CVZ7	204	E	G
O43423	LB/B	-	H3CVZ7	23	A	V
O43423	LB/B	-	H3CVZ7	140	Y	H
O43423	LB/B	-	H3CVZ7	105	L	P
O95626	LB/B	-	A0A2K5DQ56	46	L	F
P15144	LB/B	-	F7CVV6	242	D	Y
P15144	LB/B	-	F7CVV6	243	L	P
P15144	LB/B	-	F7CVV6	86	R	Q
P15144	LB/B	-	F7CVV6	752	S	N
P15144	LB/B	-	F7CVV6	20	V	M
P15144	LB/B	-	F7CVV6	311	A	V
P15144	LB/B	-	F7CVV6	321	T	M
P15144	LB/B	-	F7CVV6	603	I	K
P15144	LB/B	-	F7CVV6	603	I	M
Q9H6X2	LB/B	-	A0A2Y9FNX1	7	R	K
Q9H6X2	LB/B	-	A0A2Y9FNX1	326	A	T
P58335	LP/P	Hyaline fibromatosis syndrome (HFS) [MIM:228600]	G3NVW6	45	L	P
P58335	LP/P	Hyaline fibromatosis syndrome (HFS) [MIM:228600]	G3NVW6	105	G	D
P58335	LP/P	Hyaline fibromatosis syndrome (HFS) [MIM:228600]	G3NVW6	189	I	T
P58335	LP/P	Hyaline fibromatosis syndrome (HFS) [MIM:228600]	G3NVW6	218	C	R
P58335	LP/P	Hyaline fibromatosis syndrome (HFS) [MIM:228600]	G3NVW6	329	L	R
P58335	LB/B	-	G3NVW6	357	A	P
P58335	LP/P	Hyaline fibromatosis syndrome (HFS) [MIM:228600]	G3NVW6	381	Y	C
A6NF34	LB/B	-	A0A1U7THL2	550	P	R
Q9UJ72	LB/B	-	A0A2U3X769	71	M	L
Q3ZCQ2	LB/B	-	G3UKB0	119	Q	R
Q3ZCQ2	LB/B	-	G3UKB0	186	R	W
P12429	LB/B	-	V9KKG3	19	S	N
P12429	LB/B	-	V9KKG3	219	I	N
P12429	LB/B	-	V9KKG3	251	P	L
P12429	LB/B	-	V9KKG3	291	F	S
P09525	LB/B	-	V9KKG3	85	T	M
P13928	LB/B	-	A0A091FPY8	6	S	A
P13928	LB/B	-	A0A091FPY8	177	G	A
Q5VT79	LB/B	-	A0A091FPY8	177	A	G
Q5VT79	LB/B	-	A0A091FPY8	134	A	V
Q5VT79	LB/B	-	A0A091FPY8	192	K	N
O76027	LB/B	-	A0A2K6S8B6	166	D	G
O76027	LB/B	-	A0A2K6S8B6	225	R	Q
O76027	LB/B	-	A0A2K6S8B6	28	A	T
O76027	LB/B	-	A0A2K6S8B6	114	T	A
O76027	LB/B	-	A0A2K6S8B6	119	A	T
O76027	LB/B	-	A0A2K6S8B6	232	R	Q
P28039	LB/B	-	A0A2R8ZDK2	166	A	T
P28039	LB/B	-	A0A2R8ZDK2	266	A	G
P28039	LB/B	-	A0A2R8ZDK2	28	D	N
P19801	LB/B	-	L5K341	645	H	D
P19801	LB/B	-	L5K341	16	T	M
P19801	LB/B	-	L5K341	332	S	F
P19801	LB/B	-	L5K341	479	M	I
P19801	LB/B	-	L5K341	659	N	H
O75106	LB/B	-	L5K341	5	I	V
O75106	LB/B	-	L5K341	22	Y	C
O75106	LB/B	-	L5K341	141	P	L
O75106	LB/B	-	L5K341	273	R	Q
O75106	LB/B	-	L5K341	427	E	D
Q16853	LB/B	-	L5K341	317	Y	H
Q16853	LB/B	-	L5K341	329	R	Q
Q16853	LB/B	-	L5K341	167	H	Y
Q16853	LB/B	-	L5K341	371	I	T
Q16853	LB/B	-	L5K341	408	A	S
Q16853	LB/B	-	L5K341	426	R	H
Q16853	LB/B	-	L5K341	441	R	W
Q16853	LB/B	-	L5K341	582	A	T
Q16853	LB/B	-	L5K341	700	G	S
Q16853	LB/B	-	L5K341	749	A	V
Q16853	LB/B	-	L5K341	5	T	R
Q16853	LB/B	-	L5K341	78	R	Q
Q16853	LB/B	-	L5K341	171	V	M
Q16853	LB/B	-	L5K341	203	H	R
Q8N6M6	LB/B	-	A0A099ZK94	179	V	A
Q8N6M6	LB/B	-	A0A099ZK94	179	V	I
Q8N6M6	LB/B	-	A0A099ZK94	255	R	Q
Q8N6M6	LB/B	-	A0A099ZK94	386	R	C
O43747	LB/B	-	L5MCZ0	685	P	H
O43747	LB/B	-	L5MCZ0	195	V	G
O43747	LP/P	Usmani-Riazuddin syndrome, autosomal dominant (USRISD) [MIM:619467]	L5MCZ0	15	R	Q
O43747	LP/P	Usmani-Riazuddin syndrome, autosomal dominant (USRISD) [MIM:619467]	L5MCZ0	35	R	Q
O43747	LP/P	Usmani-Riazuddin syndrome, autosomal dominant (USRISD) [MIM:619467]	L5MCZ0	35	R	W
O43747	LP/P	Usmani-Riazuddin syndrome, autosomal recessive (USRISR) [MIM:619548]	L5MCZ0	243	P	H
O43747	LP/P	Usmani-Riazuddin syndrome, autosomal recessive (USRISR) [MIM:619548]	L5MCZ0	366	M	V
O43747	LP/P	Usmani-Riazuddin syndrome, autosomal dominant (USRISD) [MIM:619467]	L5MCZ0	817	P	R
O75843	LB/B	-	A0A1S3EUP6	377	S	F
O95782	LB/B	-	A0A0B2VUF4	270	P	L
Q96CW1	LP/P	Intellectual developmental disorder, autosomal dominant 60, with seizures (MRD60) [MIM:618587]	A0A109FI91	170	R	W
P53680	LP/P	Hypocalciuric hypercalcemia, familial 3 (HHC3) [MIM:600740]	A0A1J1IGH5	15	R	C
P53680	LP/P	Hypocalciuric hypercalcemia, familial 3 (HHC3) [MIM:600740]	A0A1J1IGH5	15	R	H
P53680	LP/P	Hypocalciuric hypercalcemia, familial 3 (HHC3) [MIM:600740]	A0A1J1IGH5	15	R	L
O00203	LP/P	Hermansky-Pudlak syndrome 2 (HPS2) [MIM:608233]	S4RCD4	580	L	R
O00203	LB/B	-	S4RCD4	585	V	E
Q92572	LB/B	-	A0A2Y9SGN7	158	P	L
Q9H0R1	LB/B	-	A0A287DG71	226	G	R
Q9H0R1	LB/B	-	A0A287DG71	379	E	D
O43299	LB/B	-	G5BI69	94	S	C
Q02410	LB/B	-	L5K699	184	S	A
Q99767	LB/B	-	A0A2K6KDE9	311	L	P
O96018	LB/B	-	H0XGY4	527	I	F
O96018	LB/B	-	H0XGY4	276	K	T
O96018	LB/B	-	H0XGY4	376	C	R
O96018	LB/B	-	H0XGY4	154	W	L
O00213	LB/B	-	A0A218UH10	327	M	V
O00213	LB/B	-	A0A218UH10	396	N	S
Q7Z5R6	LB/B	-	G1L5A0	404	T	A
Q7Z5R6	LB/B	-	G1L5A0	617	A	T
Q92870	LB/B	-	A0A1V4JG82	179	R	Q
O95704	LB/B	-	A0A2Y9PFN1	231	C	R
O95704	LB/B	-	A0A2Y9PFN1	165	G	R
P25054	LP/P	Familial adenomatous polyposis 1 (FAP1) [MIM:175100]	F6YQA1	171	S	I
P25054	LP/P	Familial adenomatous polyposis 1 (FAP1) [MIM:175100]	F6YQA1	414	R	C
P25054	LP/P	Familial adenomatous polyposis 1 (FAP1) [MIM:175100]	F6YQA1	784	S	T
P25054	LP/P	Gastric cancer (GASC) [MIM:613659]	F6YQA1	817	G	C
P25054	LP/P	Gastric cancer (GASC) [MIM:613659]	F6YQA1	880	I	T
P25054	LP/P	Familial adenomatous polyposis 1 (FAP1) [MIM:175100]	F6YQA1	911	E	G
P25054	LP/P	Gastric cancer (GASC) [MIM:613659]	F6YQA1	942	N	D
P25054	LB/B	-	F6YQA1	1118	N	D
P25054	LP/P	Gastric cancer (GASC) [MIM:613659]	F6YQA1	1120	G	E
P25054	LP/P	Gastric cancer (GASC) [MIM:613659]	F6YQA1	1171	R	H
P25054	LP/P	Familial adenomatous polyposis 1 (FAP1) [MIM:175100]	F6YQA1	1176	P	L
P25054	LP/P	Gastric cancer (GASC) [MIM:613659]	F6YQA1	1197	F	S
P25054	LP/P	Gastric cancer (GASC) [MIM:613659]	F6YQA1	1259	I	T
P25054	LB/B	-	F6YQA1	1304	I	V
P25054	LB/B	-	F6YQA1	1307	I	K
P25054	LP/P	Gastric cancer (GASC) [MIM:613659]	F6YQA1	1312	G	E
P25054	LP/P	Familial adenomatous polyposis 1 (FAP1) [MIM:175100]	F6YQA1	1313	T	A
P25054	LP/P	Gastric cancer (GASC) [MIM:613659]	F6YQA1	1326	V	A
P25054	LP/P	Familial adenomatous polyposis 1 (FAP1) [MIM:175100]	F6YQA1	1348	R	W
P25054	LB/B	-	F6YQA1	2502	G	S
P25054	LP/P	Familial adenomatous polyposis 1 (FAP1) [MIM:175100]	F6YQA1	2839	L	F
P25054	LB/B	-	F6YQA1	1171	R	C
P25054	LB/B	-	F6YQA1	1822	V	D
P25054	LB/B	-	F6YQA1	2738	I	T
P25054	LP/P	Familial adenomatous polyposis 1 (FAP1) [MIM:175100]	F6YQA1	722	S	G
P25054	LP/P	Familial adenomatous polyposis 1 (FAP1) [MIM:175100]	F6YQA1	1184	A	P
P25054	LB/B	-	F6YQA1	1317	E	Q
P25054	LP/P	Medulloblastoma (MDB) [MIM:155255]	F6YQA1	1296	A	V
P25054	LP/P	Medulloblastoma (MDB) [MIM:155255]	F6YQA1	1472	V	I
P25054	LP/P	Medulloblastoma (MDB) [MIM:155255]	F6YQA1	1495	S	G
P25054	LB/B	-	F6YQA1	1496	T	S
P25054	LB/B	-	F6YQA1	1973	S	T
P25054	LB/B	-	F6YQA1	870	P	S
P25054	LB/B	-	F6YQA1	1882	R	T
P25054	LB/B	-	F6YQA1	2499	V	L
P25054	LB/B	-	F6YQA1	1395	S	C
O95996	LB/B	-	F6YQA1	2241	S	A
O95996	LB/B	-	F6YQA1	1921	H	N
Q8J025	LB/B	-	K7FMY1	150	V	I
Q8J025	LP/P	Hypotrichosis 1 (HYPT1) [MIM:605389]	K7FMY1	9	L	R
P13798	LB/B	-	K7GJV4	541	T	M
P27695	LB/B	-	F7FR04	51	Q	H
P27695	LB/B	-	F7FR04	64	I	V
P27695	LB/B	-	F7FR04	148	D	E
Q9UBZ4	LB/B	-	A0A2B4SLV2	141	R	C
Q9UBZ4	LB/B	-	A0A2B4SLV2	141	R	W
Q9UBZ4	LB/B	-	A0A2B4SLV2	269	H	Y
Q9UBZ4	LB/B	-	A0A2B4SLV2	392	N	H
Q9BZZ5	LB/B	-	A0A2K5KME9	276	P	S
Q9BZZ5	LB/B	-	A0A2K5KME9	300	M	V
Q9BZZ5	LB/B	-	A0A2K5KME9	493	G	S
Q96GX9	LB/B	-	A0A2B4S4W0	7	R	W
Q96GX9	LB/B	-	A0A2B4S4W0	23	H	R
Q96GX9	LB/B	-	A0A2B4S4W0	76	C	Y
Q96GX9	LB/B	-	A0A2B4S4W0	181	M	V
Q8IW19	LB/B	-	I3JI68	100	I	V
Q8IW19	LB/B	-	I3JI68	336	L	F
Q8IW19	LB/B	-	I3JI68	224	S	T
P35414	LB/B	-	A0A146ZQS0	300	V	I
Q06481	LB/B	-	A0A2U9AVQ0	632	D	N
P02647	LB/B	-	G5BQH5	27	P	H
P02647	LB/B	-	G5BQH5	27	P	R
P02647	LB/B	-	G5BQH5	28	P	R
P02647	LB/B	-	G5BQH5	34	R	L
P02647	LP/P	Amyloidosis 8 (AMYL8) [MIM:105200]	G5BQH5	50	G	R
P02647	LP/P	Amyloidosis 8 (AMYL8) [MIM:105200]	G5BQH5	84	L	R
P02647	LB/B	-	G5BQH5	113	D	E
P02647	LB/B	-	G5BQH5	127	D	N
P02647	LB/B	-	G5BQH5	131	K	M
P02647	LB/B	-	G5BQH5	160	E	K
P02647	LB/B	-	G5BQH5	163	E	G
P02647	LB/B	-	G5BQH5	167	P	R
P02647	LB/B	-	G5BQH5	171	E	V
P02647	LB/B	-	G5BQH5	189	P	R
P02647	LB/B	-	G5BQH5	197	R	C
P02647	LB/B	-	G5BQH5	222	E	K
P02647	LB/B	-	G5BQH5	184	R	P
P02647	LB/B	-	G5BQH5	126	D	H
P02647	LB/B	-	G5BQH5	92	T	I
P02647	LB/B	-	G5BQH5	180	V	E
P02647	LB/B	-	G5BQH5	61	A	T
P02647	LP/P	Amyloidosis 8 (AMYL8) [MIM:105200]	G5BQH5	198	L	S
Q6Q788	LB/B	-	L8IIZ3	19	S	W
Q6Q788	LB/B	-	L8IIZ3	153	V	M
Q6Q788	LB/B	-	L8IIZ3	185	G	C
Q6Q788	LB/B	-	L8IIZ3	37	D	E
P04114	LB/B	-	I3K0T7	1437	F	L
P04114	LB/B	-	I3K0T7	1914	N	S
P04114	LB/B	-	I3K0T7	1923	H	R
P04114	LB/B	-	I3K0T7	2566	E	K
P04114	LB/B	-	I3K0T7	2739	P	L
P04114	LB/B	-	I3K0T7	3121	A	T
P04114	LB/B	-	I3K0T7	3319	D	H
P04114	LB/B	-	I3K0T7	3427	T	K
P04114	LB/B	-	I3K0T7	3432	Q	E
P04114	LP/P	Hypercholesterolemia, familial, 2 (FHCL2) [MIM:144010]	I3K0T7	3527	R	Q
P04114	LP/P	Hypercholesterolemia, familial, 2 (FHCL2) [MIM:144010]	I3K0T7	3558	R	C
P04114	LB/B	-	I3K0T7	3921	V	I
P04114	LB/B	-	I3K0T7	3945	T	A
P04114	LB/B	-	I3K0T7	4128	V	M
P04114	LB/B	-	I3K0T7	4338	S	N
P04114	LB/B	-	I3K0T7	4481	A	T
P04114	LB/B	-	I3K0T7	98	T	I
P04114	LB/B	-	I3K0T7	733	V	I
P04114	LB/B	-	I3K0T7	3638	R	Q
P04114	LB/B	-	I3K0T7	4181	E	K
P04114	LB/B	-	I3K0T7	4270	R	T
P04114	LB/B	-	I3K0T7	273	K	N
P04114	LB/B	-	I3K0T7	618	A	V
P04114	LB/B	-	I3K0T7	1218	Q	E
P04114	LB/B	-	I3K0T7	2092	L	V
P04114	LB/B	-	I3K0T7	2365	A	T
P04114	LB/B	-	I3K0T7	2680	L	Q
P04114	LB/B	-	I3K0T7	3732	I	T
P04114	LB/B	-	I3K0T7	3949	F	L
P04114	LB/B	-	I3K0T7	3964	Y	F
P04114	LB/B	-	I3K0T7	554	P	L
P04114	LB/B	-	I3K0T7	730	V	I
P04114	LB/B	-	I3K0T7	741	T	N
P04114	LB/B	-	I3K0T7	2456	A	D
P04114	LB/B	-	I3K0T7	3294	S	P
P04114	LB/B	-	I3K0T7	4484	T	M
P04114	LB/B	-	I3K0T7	103	Y	H
P04114	LB/B	-	I3K0T7	145	P	S
P04114	LB/B	-	I3K0T7	2785	N	H
P04114	LP/P	Hypobetalipoproteinemia, familial, 1 (FHBL1) [MIM:615558]	I3K0T7	490	R	W
P04114	LB/B	-	I3K0T7	1128	R	H
P04114	LB/B	-	I3K0T7	408	I	T
P04114	LB/B	-	I3K0T7	877	P	L
P04114	LB/B	-	I3K0T7	1086	G	S
P04114	LB/B	-	I3K0T7	1113	D	H
P04114	LB/B	-	I3K0T7	1388	R	H
P04114	LB/B	-	I3K0T7	2299	D	H
P04114	LB/B	-	I3K0T7	3182	H	N
P04114	LB/B	-	I3K0T7	3279	S	G
P04114	LB/B	-	I3K0T7	3801	S	T
P04114	LB/B	-	I3K0T7	4394	V	A
P04114	LB/B	-	I3K0T7	194	T	M
P04114	LB/B	-	I3K0T7	955	P	S
P04114	LB/B	-	I3K0T7	2313	I	V
P04114	LB/B	-	I3K0T7	1422	Y	C
P04114	LB/B	-	I3K0T7	1613	S	T
P04114	LB/B	-	I3K0T7	3835	I	L
P04114	LB/B	-	I3K0T7	4314	I	V
P04114	LB/B	-	I3K0T7	4482	I	V
P04114	LB/B	-	I3K0T7	1670	E	D
P04114	LB/B	-	I3K0T7	2037	I	N
P04114	LB/B	-	I3K0T7	251	A	T
P41238	LB/B	-	G5BPM8	80	M	I
P41238	LB/B	-	G5BPM8	236	R	K
Q9Y235	LB/B	-	A0A061INR0	136	I	T
P31941	LB/B	-	A0A2K5RDN7	19	T	A
Q9UH17	LB/B	-	G1RYY7	62	K	E
Q9UH17	LB/B	-	G1RYY7	98	P	L
Q9UH17	LB/B	-	G1RYY7	146	T	K
Q9UH17	LB/B	-	G1RYY7	109	S	A
Q9UH17	LB/B	-	G1RYY7	351	R	H
Q8IUX4	LB/B	-	A0A2K5UEB6	61	Q	L
Q8IUX4	LB/B	-	A0A2K5UEB6	97	P	L
Q8IUX4	LB/B	-	A0A2K5UEB6	108	A	S
Q8IUX4	LB/B	-	A0A2K5UEB6	231	V	I
Q8IUX4	LB/B	-	A0A2K5UEB6	178	A	T
Q8IUX4	LB/B	-	A0A2K5UEB6	307	Y	C
Q8IUX4	LB/B	-	A0A2K5UEB6	48	R	P
Q9HC16	LB/B	-	A0A2R9AS24	186	H	R
Q9HC16	LB/B	-	A0A2R9AS24	275	Q	E
Q9HC16	LB/B	-	A0A2R9AS24	256	R	H
Q6NTF7	LB/B	-	A0A2K5RDN7	18	R	L
Q6NTF7	LB/B	-	A0A2K5RDN7	105	G	R
Q6NTF7	LB/B	-	A0A2K5RDN7	121	K	E
Q6NTF7	LB/B	-	A0A2K5RDN7	121	K	N
Q6NTF7	LB/B	-	A0A2K5RDN7	178	E	D
Q6NTF7	LB/B	-	A0A2K5RDN7	140	E	K
Q8WW27	LB/B	-	A0A2Y9EC74	75	S	F
Q8WW27	LB/B	-	A0A2Y9EC74	271	F	S
Q8WW27	LB/B	-	A0A2Y9EC74	275	P	S
Q8WW27	LB/B	-	A0A2Y9EC74	331	K	E
Q8WW27	LB/B	-	A0A2Y9EC74	345	V	M
Q8WW27	LB/B	-	A0A2Y9EC74	300	D	G
Q0VD83	LB/B	-	L5KK70	428	P	A
P02654	LB/B	-	A0A1U7QUM6	16	I	M
P02654	LB/B	-	A0A1U7QUM6	71	T	S
P02656	LP/P	Hyperalphalipoproteinemia 2 (HALP2) [MIM:614028]	L9KV54	78	K	E
P02656	LB/B	-	L9KV54	94	T	A
P55056	LB/B	-	L8IA55	96	L	R
P55056	LB/B	-	L8IA55	126	Q	L
P55056	LB/B	-	L8IA55	36	L	P
P55056	LB/B	-	L8IA55	52	G	D
P05090	LB/B	-	H2PCF2	15	F	S
P05090	LB/B	-	H2PCF2	115	S	L
P05090	LB/B	-	H2PCF2	178	T	K
P02649	LB/B	-	G3TD13	21	E	K
P02649	LP/P	Hyperlipoproteinemia 3 (HLPP3) [MIM:617347]	G3TD13	31	E	K
P02649	LB/B	-	G3TD13	60	T	A
P02649	LB/B	-	G3TD13	99	Q	K
P02649	LB/B	-	G3TD13	102	P	R
P02649	LB/B	-	G3TD13	117	A	T
P02649	LP/P	Alzheimer disease 2 (AD2) [MIM:104310]	G3TD13	130	C	R
P02649	LP/P	Hyperlipoproteinemia 3 (HLPP3) [MIM:617347]	G3TD13	130	C	R
P02649	LB/B	-	G3TD13	152	R	Q
P02649	LP/P	Hyperlipoproteinemia 3 (HLPP3) [MIM:617347]	G3TD13	154	R	S
P02649	LP/P	Hyperlipoproteinemia 3 (HLPP3) [MIM:617347]	G3TD13	154	R	C
P02649	LP/P	Hyperlipoproteinemia 3 (HLPP3) [MIM:617347]	G3TD13	160	R	C
P02649	LP/P	Hyperlipoproteinemia 3 (HLPP3) [MIM:617347]	G3TD13	163	R	C
P02649	LP/P	Hyperlipoproteinemia 3 (HLPP3) [MIM:617347]	G3TD13	164	K	Q
P02649	LP/P	Hyperlipoproteinemia 3 (HLPP3) [MIM:617347]	G3TD13	164	K	E
P02649	LB/B	-	G3TD13	170	A	P
P02649	LP/P	Hyperlipoproteinemia 3 (HLPP3) [MIM:617347]	G3TD13	176	R	C
P02649	LB/B	-	G3TD13	242	R	Q
P02649	LB/B	-	G3TD13	246	R	C
P02649	LB/B	-	G3TD13	254	V	E
P02649	LB/B	-	G3TD13	269	R	G
P02649	LB/B	-	G3TD13	292	R	H
P02649	LB/B	-	G3TD13	314	S	R
P02649	LB/B	-	G3TD13	64	Q	H
P02649	LB/B	-	G3TD13	124	A	V
P02649	LP/P	Lipoprotein glomerulopathy (LPG) [MIM:611771]	G3TD13	43	R	C
P02649	LP/P	Lipoprotein glomerulopathy (LPG) [MIM:611771]	G3TD13	163	R	P
P02749	LB/B	-	A0A2K6LD04	266	V	L
P02749	LB/B	-	A0A2K6LD04	107	S	N
P02749	LB/B	-	A0A2K6LD04	325	C	G
P02749	LB/B	-	A0A2K6LD04	335	W	S
P02749	LB/B	-	A0A2K6LD04	154	R	H
P02749	LB/B	-	A0A2K6LD04	5	V	A
O14791	LB/B	-	A5PL32	150	E	K
O14791	LB/B	-	A5PL32	228	M	I
O14791	LB/B	-	A5PL32	255	R	K
O14791	LB/B	-	A5PL32	337	D	N
O14791	LP/P	Focal segmental glomerulosclerosis 4 (FSGS4) [MIM:612551]	A5PL32	384	I	M
O14791	LP/P	Focal segmental glomerulosclerosis 4 (FSGS4) [MIM:612551]	A5PL32	342	S	G
Q9BQE5	LB/B	-	A5PL32	245	V	I
Q9BQE5	LB/B	-	A5PL32	182	R	C
O95236	LB/B	-	F6VUH9	135	A	V
O95236	LB/B	-	F6VUH9	39	S	R
Q9BPW4	LB/B	-	F6VUH9	9	I	V
Q9BPW4	LB/B	-	F6VUH9	12	V	L
Q9BPW4	LB/B	-	F6VUH9	159	M	V
Q9BPW4	LB/B	-	F6VUH9	223	R	H
Q9BPW4	LB/B	-	F6VUH9	319	A	E
Q9BPW4	LB/B	-	F6VUH9	326	S	L
Q9BWW9	LB/B	-	A0A2K6PE62	272	T	M
Q9BWW9	LB/B	-	A0A2K6PE62	323	T	M
Q9BWW9	LB/B	-	A0A2K6PE62	406	S	C
Q9BWW9	LB/B	-	A0A2K6PE62	81	E	K
Q9BWW8	LB/B	-	C4N380	173	N	K
Q92624	LB/B	-	A0A091DJ82	561	S	N
Q9UKG1	LB/B	-	E1C411	108	A	V
Q9UKG1	LB/B	-	E1C411	700	E	G
Q9UKG1	LP/P	Maturity-onset diabetes of the young 14 (MODY14) [MIM:616511]	E1C411	94	D	N
Q8NEU8	LB/B	-	G3HZP0	433	A	V
P07741	LP/P	Adenine phosphoribosyltransferase deficiency (APRTD) [MIM:614723]	A0A1A8FB40	65	D	V
P07741	LP/P	Adenine phosphoribosyltransferase deficiency (APRTD) [MIM:614723]	A0A1A8FB40	110	L	P
P07741	LP/P	Adenine phosphoribosyltransferase deficiency (APRTD) [MIM:614723]	A0A1A8FB40	136	M	T
P07741	LB/B	-	A0A1A8FB40	121	Q	R
P07741	LP/P	Adenine phosphoribosyltransferase deficiency (APRTD) [MIM:614723]	A0A1A8FB40	150	V	F
P07741	LP/P	Adenine phosphoribosyltransferase deficiency (APRTD) [MIM:614723]	A0A1A8FB40	153	C	R
P07741	LP/P	Adenine phosphoribosyltransferase deficiency (APRTD) [MIM:614723]	A0A1A8FB40	33	L	P
P07741	LP/P	Adenine phosphoribosyltransferase deficiency (APRTD) [MIM:614723]	A0A1A8FB40	84	V	M
P07741	LP/P	Adenine phosphoribosyltransferase deficiency (APRTD) [MIM:614723]	A0A1A8FB40	133	G	D
P29972	LB/B	-	A0A1S3WRQ5	45	A	V
P29972	LB/B	-	A0A1S3WRQ5	38	P	L
P29972	LB/B	-	A0A1S3WRQ5	165	G	D
Q96PS8	LB/B	-	A0A1A6HZZ2	15	R	Q
Q96PS8	LB/B	-	A0A1A6HZZ2	123	H	Y
Q8NBQ7	LB/B	-	G3I5E2	102	G	S
P41181	LP/P	Diabetes insipidus, nephrogenic, 2, autosomal (NDI2) [MIM:125800]	G3VJV2	64	G	R
P41181	LP/P	Diabetes insipidus, nephrogenic, 2, autosomal (NDI2) [MIM:125800]	G3VJV2	187	R	C
P41181	LP/P	Diabetes insipidus, nephrogenic, 2, autosomal (NDI2) [MIM:125800]	G3VJV2	216	S	P
P41181	LP/P	Diabetes insipidus, nephrogenic, 2, autosomal (NDI2) [MIM:125800]	G3VJV2	22	L	V
P41181	LP/P	Diabetes insipidus, nephrogenic, 2, autosomal (NDI2) [MIM:125800]	G3VJV2	28	L	P
P41181	LP/P	Diabetes insipidus, nephrogenic, 2, autosomal (NDI2) [MIM:125800]	G3VJV2	47	A	V
P41181	LP/P	Diabetes insipidus, nephrogenic, 2, autosomal (NDI2) [MIM:125800]	G3VJV2	68	N	S
P41181	LP/P	Diabetes insipidus, nephrogenic, 2, autosomal (NDI2) [MIM:125800]	G3VJV2	71	V	M
P41181	LP/P	Diabetes insipidus, nephrogenic, 2, autosomal (NDI2) [MIM:125800]	G3VJV2	125	T	M
P41181	LP/P	Diabetes insipidus, nephrogenic, 2, autosomal (NDI2) [MIM:125800]	G3VJV2	126	T	M
P41181	LP/P	Diabetes insipidus, nephrogenic, 2, autosomal (NDI2) [MIM:125800]	G3VJV2	147	A	T
P41181	LP/P	Diabetes insipidus, nephrogenic, 2, autosomal (NDI2) [MIM:125800]	G3VJV2	168	V	M
P41181	LP/P	Diabetes insipidus, nephrogenic, 2, autosomal (NDI2) [MIM:125800]	G3VJV2	175	G	R
P41181	LP/P	Diabetes insipidus, nephrogenic, 2, autosomal (NDI2) [MIM:125800]	G3VJV2	181	C	W
P41181	LP/P	Diabetes insipidus, nephrogenic, 2, autosomal (NDI2) [MIM:125800]	G3VJV2	185	P	A
P41181	LP/P	Diabetes insipidus, nephrogenic, 2, autosomal (NDI2) [MIM:125800]	G3VJV2	190	A	T
P41181	LB/B	-	G3VJV2	194	V	I
P41181	LP/P	Diabetes insipidus, nephrogenic, 2, autosomal (NDI2) [MIM:125800]	G3VJV2	202	W	C
P41181	LP/P	Diabetes insipidus, nephrogenic, 2, autosomal (NDI2) [MIM:125800]	G3VJV2	258	E	K
P41181	LP/P	Diabetes insipidus, nephrogenic, 2, autosomal (NDI2) [MIM:125800]	G3VJV2	262	P	L
P41181	LP/P	Diabetes insipidus, nephrogenic, 2, autosomal (NDI2) [MIM:125800]	G3VJV2	57	Q	P
P41181	LP/P	Diabetes insipidus, nephrogenic, 2, autosomal (NDI2) [MIM:125800]	G3VJV2	100	G	V
P41181	LB/B	-	G3VJV2	121	L	F
P41181	LP/P	Diabetes insipidus, nephrogenic, 2, autosomal (NDI2) [MIM:125800]	G3VJV2	70	A	D
P41181	LP/P	Diabetes insipidus, nephrogenic, 2, autosomal (NDI2) [MIM:125800]	G3VJV2	100	G	R
P41181	LP/P	Diabetes insipidus, nephrogenic, 2, autosomal (NDI2) [MIM:125800]	G3VJV2	180	G	S
P41181	LP/P	Diabetes insipidus, nephrogenic, 2, autosomal (NDI2) [MIM:125800]	G3VJV2	187	R	H
P41181	LP/P	Diabetes insipidus, nephrogenic, 2, autosomal (NDI2) [MIM:125800]	G3VJV2	254	R	L
P41181	LP/P	Diabetes insipidus, nephrogenic, 2, autosomal (NDI2) [MIM:125800]	G3VJV2	254	R	Q
P41181	LP/P	Diabetes insipidus, nephrogenic, 2, autosomal (NDI2) [MIM:125800]	G3VJV2	108	T	M
Q92482	LB/B	-	G3IAJ6	43	V	M
P55064	LP/P	Keratoderma, palmoplantar, Bothnian type (PPKB) [MIM:600231]	G1TZK9	38	A	E
P55064	LP/P	Keratoderma, palmoplantar, Bothnian type (PPKB) [MIM:600231]	G1TZK9	45	I	S
P55064	LP/P	Keratoderma, palmoplantar, Bothnian type (PPKB) [MIM:600231]	G1TZK9	123	N	D
P55064	LP/P	Keratoderma, palmoplantar, Bothnian type (PPKB) [MIM:600231]	G1TZK9	177	I	F
P55064	LP/P	Keratoderma, palmoplantar, Bothnian type (PPKB) [MIM:600231]	G1TZK9	188	R	C
Q13520	LB/B	-	A0A2Y9E8E9	234	V	I
O14520	LB/B	-	H0VL23	38	L	V
O14520	LB/B	-	H0VL23	63	K	T
O14520	LB/B	-	H0VL23	12	R	C
O14520	LB/B	-	H0VL23	59	V	L
O14520	LB/B	-	H0VL23	264	G	V
O94778	LB/B	-	A0A2Y9PE72	260	A	P
O43315	LB/B	-	W5N7Z3	279	T	A
Q96P48	LB/B	-	W5P7I6	358	R	Q
Q96P48	LB/B	-	W5P7I6	1047	Q	E
Q8WZ64	LB/B	-	A0A1W4YRK9	1523	R	Q
Q8WZ64	LB/B	-	A0A1W4YRK9	384	K	N
Q8WZ64	LB/B	-	A0A1W4YRK9	1006	F	L
Q8WWN8	LB/B	-	A0A2K6DAD7	218	D	H
P48444	LB/B	-	M7YK37	186	F	L
P48444	LB/B	-	M7YK37	309	K	N
P15514	LB/B	-	A0A212D5Y2	80	D	V
P15514	LB/B	-	A0A212D5Y2	81	Y	C
O15033	LB/B	-	A0A1D2NAS8	779	P	L
P84077	LP/P	Periventricular nodular heterotopia 8 (PVNH8) [MIM:618185]	A0A0N5E2Z0	35	Y	H
P84077	LP/P	Periventricular nodular heterotopia 8 (PVNH8) [MIM:618185]	A0A0N5E2Z0	127	K	E
P18085	LB/B	-	M7BH37	68	V	A
Q8N6H7	LB/B	-	H2ZZ94	411	S	N
Q8N6H7	LB/B	-	H2ZZ94	143	P	R
Q8N6H7	LB/B	-	H2ZZ94	339	R	H
Q8N6H7	LB/B	-	H2ZZ94	406	R	W
Q9NP61	LB/B	-	H2ZZ94	355	S	R
Q9NP61	LB/B	-	H2ZZ94	231	S	G
Q9NP61	LB/B	-	H2ZZ94	370	S	G
Q9NP61	LB/B	-	H2ZZ94	468	Q	H
Q9NP61	LB/B	-	H2ZZ94	482	A	T
Q9NP61	LB/B	-	H2ZZ94	490	Q	R
Q9Y6D6	LB/B	-	H2LWJ4	273	D	Y
Q9Y6D6	LP/P	Developmental delay, impaired speech, and behavioral abnormalities, with or without seizures (DEDISB) [MIM:619964]	H2LWJ4	798	D	N
Q9Y6D5	LB/B	-	L9L9Z1	527	A	V
Q9Y6D5	LB/B	-	L9L9Z1	802	R	Q
P05089	LP/P	Argininemia (ARGIN) [MIM:207800]	G1LUN3	235	G	R
P05089	LB/B	-	G1LUN3	290	T	S
P05089	LP/P	Argininemia (ARGIN) [MIM:207800]	G1LUN3	11	I	T
P05089	LP/P	Argininemia (ARGIN) [MIM:207800]	G1LUN3	138	G	V
P05089	LP/P	Argininemia (ARGIN) [MIM:207800]	G1LUN3	27	G	D
P05089	LP/P	Argininemia (ARGIN) [MIM:207800]	G1LUN3	74	G	V
P05089	LP/P	Argininemia (ARGIN) [MIM:207800]	G1LUN3	125	A	V
P05089	LP/P	Argininemia (ARGIN) [MIM:207800]	G1LUN3	134	T	I
P05089	LP/P	Argininemia (ARGIN) [MIM:207800]	G1LUN3	180	R	T
P05089	LP/P	Argininemia (ARGIN) [MIM:207800]	G1LUN3	308	R	Q
Q07960	LB/B	-	A0A2F0AYI1	369	R	C
A1A4S6	LB/B	-	A0A2K6KHZ7	684	M	V
A1A4S6	LB/B	-	A0A2K6KHZ7	488	P	S
Q8IWW6	LB/B	-	Q4SKK2	442	F	S
Q5T5U3	LB/B	-	V9K7V8	713	N	S
Q5T5U3	LB/B	-	V9K7V8	1594	T	A
Q5T5U3	LB/B	-	V9K7V8	1611	V	A
Q5T5U3	LB/B	-	V9K7V8	1629	E	K
Q5T5U3	LB/B	-	V9K7V8	1727	A	T
Q5T5U3	LB/B	-	V9K7V8	1950	S	N
Q7Z5H3	LB/B	-	H2U6Y0	410	T	K
Q7Z5H3	LB/B	-	H2U6Y0	612	R	C
P42331	LB/B	-	A2BGK1	192	R	W
P42331	LB/B	-	A2BGK1	555	R	S
P42331	LB/B	-	A2BGK1	556	M	T
Q9UNA1	LP/P	Leukemia, juvenile myelomonocytic (JMML) [MIM:607785]	Q4RIS0	417	N	S
Q9P2N2	LB/B	-	G5B1K9	190	T	S
Q9P2N2	LB/B	-	G5B1K9	727	Q	P
Q9P2N2	LB/B	-	G5B1K9	168	I	V
Q7Z6I6	LB/B	-	A0A212CGB0	70	F	L
Q7Z6I6	LB/B	-	A0A212CGB0	591	L	V
Q2M1Z3	LB/B	-	A0A1U7TCZ1	221	P	L
Q2M1Z3	LB/B	-	A0A1U7TCZ1	803	G	S
Q2M1Z3	LB/B	-	A0A1U7TCZ1	1115	I	L
Q2M1Z3	LB/B	-	A0A1U7TCZ1	1366	V	M
Q2M1Z3	LB/B	-	A0A1U7TCZ1	1380	T	I
Q2M1Z3	LB/B	-	A0A1U7TCZ1	727	T	I
P98171	LB/B	-	A0A061I0V3	104	A	V
Q17R89	LB/B	-	A0A1S3S091	463	V	M
Q92619	LB/B	-	A0A2I2UAN7	139	R	H
Q92619	LB/B	-	A0A2I2UAN7	259	E	D
Q92619	LB/B	-	A0A2I2UAN7	439	S	G
Q92619	LB/B	-	A0A2I2UAN7	515	M	I
Q92619	LB/B	-	A0A2I2UAN7	886	A	P
Q13017	LB/B	-	A0A2K6D5S0	17	I	V
O43182	LB/B	-	A0A1S2ZD29	791	D	E
Q92888	LB/B	-	G3T3K3	375	P	L
O15013	LP/P	Slowed nerve conduction velocity (SNCV) [MIM:608236]	A0A147ACJ2	357	T	I
O15013	LB/B	-	A0A147ACJ2	700	V	I
O15013	LB/B	-	A0A147ACJ2	725	V	I
Q9HCE6	LB/B	-	A0A2I0M386	69	D	N
Q9HCE6	LB/B	-	A0A2I0M386	991	R	W
Q9HCE6	LB/B	-	A0A2I0M386	1219	I	V
Q9HCE6	LB/B	-	A0A2I0M386	47	S	N
O15085	LB/B	-	A0A226NQR8	1427	H	R
O15085	LB/B	-	A0A226NQR8	1416	S	G
O94989	LB/B	-	I3LPE0	155	G	V
O94989	LB/B	-	I3LPE0	277	L	P
O94989	LB/B	-	I3LPE0	831	S	P
O94989	LB/B	-	I3LPE0	73	P	S
Q5VV41	LB/B	-	A0A287ANX2	137	V	M
Q5VV41	LB/B	-	A0A287ANX2	370	H	Y
Q5VV41	LB/B	-	A0A287ANX2	681	E	K
Q5VV41	LB/B	-	A0A287ANX2	24	R	W
Q96DR7	LB/B	-	F1NBE4	29	V	L
Q96DR7	LB/B	-	F1NBE4	203	F	S
Q96DR7	LB/B	-	F1NBE4	60	L	P
Q8N1W1	LB/B	-	G1SDQ4	98	R	M
Q8N1W1	LB/B	-	G1SDQ4	225	W	R
Q8N1W1	LB/B	-	G1SDQ4	284	P	Q
Q8N1W1	LB/B	-	G1SDQ4	544	S	L
Q8N1W1	LB/B	-	G1SDQ4	585	R	K
Q8N1W1	LB/B	-	G1SDQ4	780	H	N
Q8N1W1	LB/B	-	G1SDQ4	1548	P	S
Q8N1W1	LB/B	-	G1SDQ4	1640	H	Q
A1IGU5	LB/B	-	H2QRS0	421	M	L
A1IGU5	LB/B	-	H2QRS0	489	P	L
A1IGU5	LB/B	-	H2QRS0	518	S	R
A1IGU5	LB/B	-	H2QRS0	586	P	T
A1IGU5	LB/B	-	H2QRS0	604	M	V
Q9NXL2	LB/B	-	H3DNH5	88	M	V
Q8N4T4	LB/B	-	A0A1U7SBG8	306	H	R
Q8N4T4	LB/B	-	A0A1U7SBG8	5	C	F
Q9NR80	LB/B	-	H2QIQ7	33	D	H
O14497	LB/B	-	A0A218UN23	1658	R	W
O14497	LB/B	-	A0A218UN23	1907	I	F
O14497	LB/B	-	A0A218UN23	2087	G	R
O14497	LB/B	-	A0A218UN23	120	P	S
Q8NFD5	LB/B	-	G1KDQ1	165	Q	H
Q8NFD5	LB/B	-	G1KDQ1	329	G	S
Q8NFD5	LB/B	-	G1KDQ1	446	A	V
Q8NFD5	LB/B	-	G1KDQ1	479	G	A
Q8NFD5	LB/B	-	G1KDQ1	512	M	V
Q8NFD5	LB/B	-	G1KDQ1	580	S	N
Q8NFD5	LB/B	-	G1KDQ1	614	M	T
Q8NFD5	LB/B	-	G1KDQ1	959	Q	E
Q8NFD5	LB/B	-	G1KDQ1	1063	Q	L
Q8NFD5	LB/B	-	G1KDQ1	1175	V	I
Q8NFD5	LB/B	-	G1KDQ1	1332	Q	P
Q8NFD5	LB/B	-	G1KDQ1	1354	G	E
Q8NFD5	LB/B	-	G1KDQ1	1386	G	R
Q8NFD5	LB/B	-	G1KDQ1	1404	S	N
Q8NFD5	LB/B	-	G1KDQ1	1494	P	S
Q8NFD5	LB/B	-	G1KDQ1	1549	Q	K
Q8NFD5	LB/B	-	G1KDQ1	1589	R	H
Q8NFD5	LB/B	-	G1KDQ1	1656	T	M
Q8NFD5	LB/B	-	G1KDQ1	1742	N	S
Q8NFD5	LB/B	-	G1KDQ1	1856	K	R
Q8NFD5	LB/B	-	G1KDQ1	1934	D	N
Q8NFD5	LB/B	-	G1KDQ1	1981	K	R
Q8NFD5	LB/B	-	G1KDQ1	2037	K	R
Q8NFD5	LB/B	-	G1KDQ1	2246	Q	R
Q8NFD5	LP/P	-	G1KDQ1	1519	G	A
Q8NFD5	LP/P	-	G1KDQ1	2070	D	Y
Q99856	LB/B	-	M3X878	36	P	H
Q99856	LB/B	-	M3X878	320	K	E
Q99856	LB/B	-	M3X878	556	G	S
A6NKF2	LB/B	-	U3K5F6	310	R	Q
A6NKF2	LB/B	-	U3K5F6	335	C	G
Q9Y4X5	LP/P	-	A0A226MVJ7	15	E	Q
Q9Y4X5	LP/P	-	A0A226MVJ7	44	E	G
O95376	LB/B	-	L5KW92	24	E	K
O95376	LB/B	-	L5KW92	29	E	D
Q969Q4	LB/B	-	A0A2U4BG40	22	S	L
Q969Q4	LB/B	-	A0A2U4BG40	131	P	L
Q969Q4	LB/B	-	A0A2U4BG40	148	C	R
Q969Q4	LB/B	-	A0A2U4BG40	164	E	K
Q969Q4	LB/B	-	A0A2U4BG40	120	L	M
Q3SXY8	LB/B	-	M0RDU9	348	T	S
Q3SXY8	LP/P	Joubert syndrome 8 (JBTS8) [MIM:612291]	M0RDU9	79	R	Q
Q3SXY8	LP/P	Joubert syndrome 8 (JBTS8) [MIM:612291]	M0RDU9	200	R	C
Q3SXY8	LP/P	Joubert syndrome 8 (JBTS8) [MIM:612291]	M0RDU9	86	Y	C
Q8N4G2	LB/B	-	A0A2B4S1U4	83	D	N
Q8N4G2	LB/B	-	A0A2B4S1U4	117	P	T
Q8N8R7	LB/B	-	A0A1D5QMG3	180	T	P
P36404	LB/B	-	A0A2F0B8Q5	141	V	A
P36404	LP/P	Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma 1 (MRCS1) [MIM:619082]	A0A2F0B8Q5	15	R	L
P36405	LB/B	-	L5K097	34	L	M
P36405	LP/P	Joubert syndrome 35 (JBTS35) [MIM:618161]	L5K097	149	R	C
P36405	LP/P	Joubert syndrome 35 (JBTS35) [MIM:618161]	L5K097	149	R	H
P49703	LB/B	-	A0A2K5VRI8	91	T	N
Q9H0F7	LP/P	Bardet-Biedl syndrome 3 (BBS3) [MIM:600151]	L5JV56	31	T	M
Q9H0F7	LP/P	Bardet-Biedl syndrome 3 (BBS3) [MIM:600151]	L5JV56	31	T	R
Q9H0F7	LP/P	Bardet-Biedl syndrome 3 (BBS3) [MIM:600151]	L5JV56	169	G	A
Q9H0F7	LP/P	Bardet-Biedl syndrome 3 (BBS3) [MIM:600151]	L5JV56	170	L	W
Q9H0F7	LP/P	Retinitis pigmentosa 55 (RP55) [MIM:613575]	L5JV56	89	A	V
Q9H0F7	LP/P	Bardet-Biedl syndrome 3 (BBS3) [MIM:600151]	L5JV56	94	I	T
Q8NEN0	LB/B	-	G5B4I6	166	M	T
Q8NEN0	LB/B	-	G5B4I6	433	N	D
Q5W041	LB/B	-	A0A2K5NS62	345	E	G
Q5W041	LB/B	-	A0A2K5NS62	608	S	P
Q5W041	LB/B	-	A0A2K5NS62	626	R	Q
Q7Z3E5	LB/B	-	A0A2T7PPE1	108	L	F
Q7Z3E5	LB/B	-	A0A2T7PPE1	209	I	T
Q7Z3E5	LB/B	-	A0A2T7PPE1	222	R	H
Q7Z3E5	LB/B	-	A0A2T7PPE1	180	I	V
Q7Z3E5	LB/B	-	A0A2T7PPE1	330	D	N
Q5H9R4	LB/B	-	J9P1G5	84	R	G
Q86TY3	LB/B	-	H0X8R4	96	T	I
Q86TY3	LB/B	-	H0X8R4	391	A	V
Q86TY3	LB/B	-	H0X8R4	528	V	F
Q86TY3	LB/B	-	H0X8R4	613	Q	E
P0C7Q2	LB/B	-	A0A2J8W6G3	3	R	H
P0C7Q2	LB/B	-	A0A2J8W6G3	69	A	S
Q9H993	LB/B	-	A0A0F8BT26	77	P	R
Q9H993	LB/B	-	A0A0F8BT26	73	K	N
Q9H993	LB/B	-	A0A0F8BT26	150	G	E
Q9H993	LB/B	-	A0A0F8BT26	154	S	A
Q9H993	LB/B	-	A0A0F8BT26	161	H	P
Q9H993	LB/B	-	A0A0F8BT26	264	I	V
Q9H993	LB/B	-	A0A0F8BT26	317	A	T
P27540	LB/B	-	A0A061IK87	511	D	N
P27540	LB/B	-	A0A061IK87	517	D	E
P27540	LB/B	-	A0A061IK87	706	P	L
P27540	LB/B	-	A0A061IK87	430	R	Q
Q9HBZ2	LB/B	-	G1U1R7	679	G	S
Q9HBZ2	LB/B	-	G1U1R7	46	R	W
Q9HBZ2	LB/B	-	G1U1R7	107	R	H
Q9HBZ2	LB/B	-	G1U1R7	402	R	Q
Q9HBZ2	LB/B	-	G1U1R7	410	W	R
O15143	LB/B	-	A0A2K6S905	37	K	N
P59998	LP/P	Developmental delay, language impairment, and ocular abnormalities (DEVLO) [MIM:620141]	G5BX86	158	R	C
Q8N5I2	LB/B	-	L5K7G2	363	G	C
Q8TBH0	LB/B	-	A0A2I2V4A2	181	R	H
Q8TBH0	LB/B	-	A0A2I2V4A2	192	R	H
Q8TBH0	LB/B	-	A0A2I2V4A2	244	A	T
Q8TBH0	LB/B	-	A0A2I2V4A2	396	L	P
P15289	LB/B	-	A0A0P4WP99	76	L	P
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	82	P	L
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	84	R	Q
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	86	G	D
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	95	S	N
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	96	S	F
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	96	S	L
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	99	G	D
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	119	G	R
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	122	G	S
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	135	L	P
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	136	P	L
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	152	D	Y
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	154	G	D
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	155	P	R
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	167	P	R
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	169	D	N
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	172	C	Y
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	179	I	S
P15289	LB/B	-	A0A0P4WP99	193	W	C
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	201	Y	C
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	212	A	V
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	224	A	V
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	231	P	T
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	244	R	C
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	244	R	H
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	245	G	R
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	250	S	Y
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	274	T	M
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	288	R	C
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	295	S	Y
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	309	G	S
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	311	R	Q
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	314	A	T
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	335	D	V
P15289	LB/B	-	A0A0P4WP99	350	N	S
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	367	K	N
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	370	R	Q
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	370	R	W
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	377	P	L
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	382	E	K
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	384	R	C
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	390	R	Q
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	390	R	W
P15289	LB/B	-	A0A0P4WP99	391	T	S
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	397	H	Y
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	426	P	L
P15289	LB/B	-	A0A0P4WP99	464	A	V
P15289	LB/B	-	A0A0P4WP99	496	R	H
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	300	C	F
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	425	P	T
P15289	LB/B	-	A0A0P4WP99	356	F	V
P15289	LB/B	-	A0A0P4WP99	440	N	S
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	18	A	D
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	29	D	N
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	30	D	H
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	32	G	S
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	68	L	P
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	84	R	W
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	94	P	A
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	99	G	V
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	136	P	S
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	143	R	G
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	148	P	L
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	153	Q	H
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	155	P	L
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	156	C	R
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	181	L	Q
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	190	Q	H
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	191	P	T
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	212	A	P
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	217	R	H
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	219	F	V
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	227	H	Y
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	247	F	S
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	253	E	K
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	255	D	H
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	281	D	Y
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	282	N	S
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	286	T	P
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	288	R	H
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	293	G	D
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	293	G	S
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	294	C	Y
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	298	L	S
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	302	K	N
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	306	Y	H
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	308	G	D
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	308	G	V
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	312	E	D
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	325	G	S
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	327	T	I
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	376	Y	N
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	381	D	E
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	408	T	I
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	409	T	I
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	428	L	P
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	429	Y	S
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	469	A	G
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	489	C	G
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	52	L	P
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	138	H	D
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	304	T	M
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	307	E	K
P15289	LP/P	Metachromatic leukodystrophy (MLD) [MIM:250100]	A0A0P4WP99	406	S	G
P15848	LP/P	Mucopolysaccharidosis 6 (MPS6) [MIM:253200]	A0A146Y869	92	T	M
P15848	LP/P	Mucopolysaccharidosis 6 (MPS6) [MIM:253200]	A0A146Y869	95	R	Q
P15848	LP/P	Mucopolysaccharidosis 6 (MPS6) [MIM:253200]	A0A146Y869	117	C	R
P15848	LP/P	Mucopolysaccharidosis 6 (MPS6) [MIM:253200]	A0A146Y869	137	G	V
P15848	LP/P	Mucopolysaccharidosis 6 (MPS6) [MIM:253200]	A0A146Y869	152	R	W
P15848	LP/P	Mucopolysaccharidosis 6 (MPS6) [MIM:253200]	A0A146Y869	160	R	Q
P15848	LP/P	Mucopolysaccharidosis 6 (MPS6) [MIM:253200]	A0A146Y869	210	Y	C
P15848	LP/P	Mucopolysaccharidosis 6 (MPS6) [MIM:253200]	A0A146Y869	236	L	P
P15848	LP/P	Mucopolysaccharidosis 6 (MPS6) [MIM:253200]	A0A146Y869	302	G	R
P15848	LB/B	-	A0A146Y869	376	V	M
P15848	LP/P	Mucopolysaccharidosis 6 (MPS6) [MIM:253200]	A0A146Y869	393	H	P
P15848	LP/P	Mucopolysaccharidosis 6 (MPS6) [MIM:253200]	A0A146Y869	405	C	Y
P15848	LP/P	Mucopolysaccharidosis 6 (MPS6) [MIM:253200]	A0A146Y869	498	L	P
P15848	LB/B	-	A0A146Y869	358	V	M
P15848	LP/P	Mucopolysaccharidosis 6 (MPS6) [MIM:253200]	A0A146Y869	65	S	F
P15848	LP/P	Mucopolysaccharidosis 6 (MPS6) [MIM:253200]	A0A146Y869	116	P	H
P15848	LP/P	Mucopolysaccharidosis 6 (MPS6) [MIM:253200]	A0A146Y869	142	M	I
P15848	LP/P	Mucopolysaccharidosis 6 (MPS6) [MIM:253200]	A0A146Y869	144	G	R
P15848	LP/P	Mucopolysaccharidosis 6 (MPS6) [MIM:253200]	A0A146Y869	146	W	L
P15848	LP/P	Mucopolysaccharidosis 6 (MPS6) [MIM:253200]	A0A146Y869	146	W	R
P15848	LP/P	Mucopolysaccharidosis 6 (MPS6) [MIM:253200]	A0A146Y869	146	W	S
P15848	LP/P	Mucopolysaccharidosis 6 (MPS6) [MIM:253200]	A0A146Y869	192	C	R
P15848	LP/P	Mucopolysaccharidosis 6 (MPS6) [MIM:253200]	A0A146Y869	239	Q	R
P15848	LP/P	Mucopolysaccharidosis 6 (MPS6) [MIM:253200]	A0A146Y869	312	W	C
P15848	LP/P	Mucopolysaccharidosis 6 (MPS6) [MIM:253200]	A0A146Y869	315	R	Q
P15848	LP/P	Mucopolysaccharidosis 6 (MPS6) [MIM:253200]	A0A146Y869	321	L	P
P15848	LB/B	-	A0A146Y869	384	S	N
P15848	LP/P	Mucopolysaccharidosis 6 (MPS6) [MIM:253200]	A0A146Y869	399	F	L
P15848	LP/P	Mucopolysaccharidosis 6 (MPS6) [MIM:253200]	A0A146Y869	484	R	G
P15848	LP/P	Mucopolysaccharidosis 6 (MPS6) [MIM:253200]	A0A146Y869	521	C	Y
P15848	LP/P	Mucopolysaccharidosis 6 (MPS6) [MIM:253200]	A0A146Y869	531	P	R
P15848	LB/B	-	A0A146Y869	358	V	L
P15848	LP/P	Mucopolysaccharidosis 6 (MPS6) [MIM:253200]	A0A146Y869	82	L	R
P51689	LB/B	-	M7BKN4	224	S	C
P51689	LB/B	-	M7BKN4	500	V	I
P51689	LB/B	-	M7BKN4	564	M	T
P54793	LB/B	-	M7BKN4	527	H	Y
Q96EG1	LB/B	-	A0A2Y9R0L6	11	A	V
Q96EG1	LB/B	-	A0A2Y9R0L6	236	T	S
Q96EG1	LB/B	-	A0A2Y9R0L6	274	W	R
Q96EG1	LB/B	-	A0A2Y9R0L6	385	R	H
Q96EG1	LB/B	-	A0A2Y9R0L6	326	R	G
Q96EG1	LB/B	-	A0A2Y9R0L6	398	R	W
Q96EG1	LB/B	-	A0A2Y9R0L6	444	T	M
Q96EG1	LB/B	-	A0A2Y9R0L6	481	E	K
Q96EG1	LB/B	-	A0A2Y9R0L6	493	I	T
Q96EG1	LP/P	Usher syndrome 4 (USH4) [MIM:618144]	A0A2Y9R0L6	45	D	Y
Q6UWY0	LB/B	-	Q08CJ7	525	Q	R
Q6UWY0	LP/P	Mucopolysaccharidosis 10 (MPS10) [MIM:619698]	Q08CJ7	84	R	C
P51690	LP/P	Chondrodysplasia punctata 1, X-linked recessive (CDPX1) [MIM:302950]	A0A1V4JBR6	12	R	S
P51690	LP/P	Chondrodysplasia punctata 1, X-linked recessive (CDPX1) [MIM:302950]	A0A1V4JBR6	111	R	P
P51690	LP/P	Chondrodysplasia punctata 1, X-linked recessive (CDPX1) [MIM:302950]	A0A1V4JBR6	117	G	R
P51690	LP/P	Chondrodysplasia punctata 1, X-linked recessive (CDPX1) [MIM:302950]	A0A1V4JBR6	137	G	V
P51690	LP/P	Chondrodysplasia punctata 1, X-linked recessive (CDPX1) [MIM:302950]	A0A1V4JBR6	245	G	R
P51690	LP/P	Chondrodysplasia punctata 1, X-linked recessive (CDPX1) [MIM:302950]	A0A1V4JBR6	492	C	Y
P51690	LP/P	Chondrodysplasia punctata 1, X-linked recessive (CDPX1) [MIM:302950]	A0A1V4JBR6	80	I	N
P51690	LP/P	Chondrodysplasia punctata 1, X-linked recessive (CDPX1) [MIM:302950]	A0A1V4JBR6	481	T	M
P51690	LP/P	Chondrodysplasia punctata 1, X-linked recessive (CDPX1) [MIM:302950]	A0A1V4JBR6	578	P	S
P51690	LB/B	-	A0A1V4JBR6	183	R	H
P51690	LB/B	-	A0A1V4JBR6	424	G	S
P52961	LB/B	-	Q60935	105	P	L
P52961	LB/B	-	Q60935	126	P	R
P52961	LB/B	-	Q60935	257	L	P
Q93070	LB/B	-	G1LSN6	108	G	V
Q93070	LB/B	-	G1LSN6	117	T	I
Q93070	LB/B	-	G1LSN6	265	N	D
Q93070	LB/B	-	G1LSN6	300	L	V
Q93070	LB/B	-	G1LSN6	135	D	E
Q93070	LB/B	-	G1LSN6	189	T	M
Q5T4W7	LB/B	-	A0A2K6B3M7	19	Q	R
O00192	LB/B	-	A0A1L8HQG5	175	V	A
O00192	LB/B	-	A0A1L8HQG5	906	R	Q
O00192	LB/B	-	A0A1L8HQG5	220	P	L
O00192	LB/B	-	A0A1L8HQG5	909	R	W
O00192	LB/B	-	A0A1L8HQG5	909	R	Q
O00192	LB/B	-	A0A1L8HQG5	912	R	W
O00192	LB/B	-	A0A1L8HQG5	539	R	Q
Q9NR71	LB/B	-	A0A061ICG8	51	T	A
Q9NR71	LB/B	-	A0A061ICG8	346	A	S
O43150	LB/B	-	A0A1A8MZQ5	748	E	D
Q8WXI3	LB/B	-	A0A096MSP5	453	R	C
Q8WXI3	LB/B	-	A0A096MSP5	88	D	V
Q8WXI3	LB/B	-	A0A096MSP5	91	D	Y
Q8WXI3	LB/B	-	A0A096MSP5	172	A	V
Q8WXI3	LB/B	-	A0A096MSP5	189	R	W
Q8WXI3	LB/B	-	A0A096MSP5	237	R	G
Q8WXI3	LB/B	-	A0A096MSP5	304	R	C
Q8WXI3	LB/B	-	A0A096MSP5	329	T	M
Q8WXI3	LB/B	-	A0A096MSP5	372	R	C
Q8WXI3	LB/B	-	A0A096MSP5	402	P	T
Q8WXH4	LB/B	-	A0A226PLQ0	249	D	N
Q8WXH4	LB/B	-	A0A226PLQ0	263	S	G
Q8WXH4	LB/B	-	A0A226PLQ0	165	S	L
Q8WXK1	LB/B	-	A0A1W4ZGD7	57	P	L
Q8WXK1	LB/B	-	A0A1W4ZGD7	357	G	A
Q96NS5	LB/B	-	A0A287B699	240	T	I
Q6ZVZ8	LB/B	-	A0A2I0MIE0	127	A	P
Q6ZVZ8	LB/B	-	A0A2I0MIE0	104	A	T
Q6ZVZ8	LB/B	-	A0A2I0MIE0	407	H	N
Q6ZVZ8	LB/B	-	A0A2I0MIE0	261	G	S
Q9H1I8	LB/B	-	A0A2J7PDE4	509	R	Q
Q9H1I8	LB/B	-	A0A2J7PDE4	407	D	H
Q9H1I8	LB/B	-	A0A2J7PDE4	423	P	S
Q9H1I8	LB/B	-	A0A2J7PDE4	639	R	L
Q9H1I8	LB/B	-	A0A2J7PDE4	96	R	C
Q9H1I8	LB/B	-	A0A2J7PDE4	123	V	I
Q9H1I8	LB/B	-	A0A2J7PDE4	546	D	G
Q9H1I8	LB/B	-	A0A2J7PDE4	588	E	K
Q8N3C0	LB/B	-	G3T7C8	146	L	F
Q8N3C0	LB/B	-	G3T7C8	1050	V	I
Q8N3C0	LB/B	-	G3T7C8	1800	C	W
Q8N3C0	LB/B	-	G3T7C8	1930	V	M
Q8N3C0	LB/B	-	G3T7C8	1995	S	C
Q8N3C0	LB/B	-	G3T7C8	2176	Y	C
Q8N3C0	LB/B	-	G3T7C8	344	E	K
Q8N3C0	LB/B	-	G3T7C8	478	N	S
Q8N3C0	LB/B	-	G3T7C8	1425	V	A
Q8N3C0	LB/B	-	G3T7C8	1497	R	T
Q8N3C0	LB/B	-	G3T7C8	1016	S	C
P50553	LB/B	-	G1LIM7	158	E	G
P07307	LB/B	-	A0A1S2ZMT1	85	G	R
Q9NR48	LB/B	-	G1T8I1	1771	T	A
Q9NR48	LB/B	-	G1T8I1	1416	S	P
Q9NR48	LB/B	-	G1T8I1	277	S	G
Q9NR48	LP/P	Intellectual developmental disorder, autosomal dominant 52 (MRD52) [MIM:617796]	G1T8I1	2791	A	P
Q9UBL3	LB/B	-	L8Y0H8	478	S	F
Q96FT7	LB/B	-	L5L1L8	506	P	Q
Q96FT7	LB/B	-	L5L1L8	508	R	L
Q96FT7	LB/B	-	L5L1L8	511	V	A
P42127	LB/B	-	A0A1S7IYF7	61	Q	P
P42127	LB/B	-	A0A1S7IYF7	13	V	A
P46597	LB/B	-	A0A2K6BE11	17	N	K
P46597	LB/B	-	A0A2K6BE11	13	N	H
P46597	LB/B	-	A0A2K6BE11	61	E	Q
P46597	LB/B	-	A0A2K6BE11	81	K	E
P46597	LB/B	-	A0A2K6BE11	115	R	W
P46597	LB/B	-	A0A2K6BE11	151	G	S
P46597	LB/B	-	A0A2K6BE11	166	V	I
P46597	LB/B	-	A0A2K6BE11	171	V	M
P46597	LB/B	-	A0A2K6BE11	179	V	G
P46597	LB/B	-	A0A2K6BE11	210	D	G
P46597	LB/B	-	A0A2K6BE11	211	I	M
P46597	LB/B	-	A0A2K6BE11	217	T	M
P46597	LB/B	-	A0A2K6BE11	219	K	R
P46597	LB/B	-	A0A2K6BE11	243	P	L
P46597	LB/B	-	A0A2K6BE11	269	I	M
P46597	LB/B	-	A0A2K6BE11	273	C	S
P46597	LB/B	-	A0A2K6BE11	278	G	A
P46597	LB/B	-	A0A2K6BE11	288	E	D
P46597	LB/B	-	A0A2K6BE11	291	R	Q
P08243	LB/B	-	A0A2I2Y8A7	210	V	E
P08243	LP/P	Asparagine synthetase deficiency (ASNSD) [MIM:615574]	A0A2I2Y8A7	6	A	E
P08243	LP/P	Asparagine synthetase deficiency (ASNSD) [MIM:615574]	A0A2I2Y8A7	362	F	V
P08243	LP/P	Asparagine synthetase deficiency (ASNSD) [MIM:615574]	A0A2I2Y8A7	550	R	C
Q9NWL6	LB/B	-	A0A2C9JQF0	190	G	R
Q9NWL6	LB/B	-	A0A2C9JQF0	434	M	T
P45381	LP/P	Canavan disease (CAND) [MIM:271900]	A0A060WG62	143	I	T
P45381	LP/P	Canavan disease (CAND) [MIM:271900]	A0A060WG62	152	C	R
P45381	LP/P	Canavan disease (CAND) [MIM:271900]	A0A060WG62	274	G	R
P45381	LP/P	Canavan disease (CAND) [MIM:271900]	A0A060WG62	285	E	A
P45381	LP/P	Canavan disease (CAND) [MIM:271900]	A0A060WG62	295	F	S
P45381	LP/P	Canavan disease (CAND) [MIM:271900]	A0A060WG62	305	A	E
P45381	LP/P	Canavan disease (CAND) [MIM:271900]	A0A060WG62	21	H	P
P45381	LP/P	Canavan disease (CAND) [MIM:271900]	A0A060WG62	57	A	T
P45381	LP/P	Canavan disease (CAND) [MIM:271900]	A0A060WG62	168	R	H
P45381	LP/P	Canavan disease (CAND) [MIM:271900]	A0A060WG62	181	P	T
P45381	LP/P	Canavan disease (CAND) [MIM:271900]	A0A060WG62	24	E	G
P45381	LP/P	Canavan disease (CAND) [MIM:271900]	A0A060WG62	68	D	A
P45381	LP/P	Canavan disease (CAND) [MIM:271900]	A0A060WG62	114	D	Y
P45381	LP/P	Canavan disease (CAND) [MIM:271900]	A0A060WG62	152	C	W
P45381	LP/P	Canavan disease (CAND) [MIM:271900]	A0A060WG62	231	Y	C
P45381	LP/P	Canavan disease (CAND) [MIM:271900]	A0A060WG62	244	H	R
P45381	LP/P	Canavan disease (CAND) [MIM:271900]	A0A060WG62	249	D	V
P45381	LP/P	Canavan disease (CAND) [MIM:271900]	A0A060WG62	16	I	T
P45381	LP/P	Canavan disease (CAND) [MIM:271900]	A0A060WG62	27	G	R
P45381	LP/P	Canavan disease (CAND) [MIM:271900]	A0A060WG62	114	D	E
P45381	LP/P	Canavan disease (CAND) [MIM:271900]	A0A060WG62	123	G	E
P45381	LP/P	Canavan disease (CAND) [MIM:271900]	A0A060WG62	152	C	Y
P45381	LP/P	Canavan disease (CAND) [MIM:271900]	A0A060WG62	168	R	C
P45381	LP/P	Canavan disease (CAND) [MIM:271900]	A0A060WG62	183	P	H
P45381	LP/P	Canavan disease (CAND) [MIM:271900]	A0A060WG62	186	V	F
P45381	LP/P	Canavan disease (CAND) [MIM:271900]	A0A060WG62	195	M	R
P45381	LP/P	Canavan disease (CAND) [MIM:271900]	A0A060WG62	280	P	L
P45381	LP/P	Canavan disease (CAND) [MIM:271900]	A0A060WG62	280	P	S
P45381	LP/P	Canavan disease (CAND) [MIM:271900]	A0A060WG62	287	A	T
P45381	LB/B	-	A0A060WG62	310	C	G
P45381	LP/P	Canavan disease (CAND) [MIM:271900]	A0A060WG62	24	E	K
P45381	LP/P	Canavan disease (CAND) [MIM:271900]	A0A060WG62	30	L	P
P45381	LP/P	Canavan disease (CAND) [MIM:271900]	A0A060WG62	57	A	V
P45381	LP/P	Canavan disease (CAND) [MIM:271900]	A0A060WG62	63	R	T
P45381	LP/P	Canavan disease (CAND) [MIM:271900]	A0A060WG62	69	L	R
P45381	LP/P	Canavan disease (CAND) [MIM:271900]	A0A060WG62	101	G	V
P45381	LP/P	Canavan disease (CAND) [MIM:271900]	A0A060WG62	129	E	K
P45381	LP/P	Canavan disease (CAND) [MIM:271900]	A0A060WG62	170	I	T
P45381	LP/P	Canavan disease (CAND) [MIM:271900]	A0A060WG62	177	I	T
P45381	LP/P	Canavan disease (CAND) [MIM:271900]	A0A060WG62	180	G	V
P45381	LP/P	Canavan disease (CAND) [MIM:271900]	A0A060WG62	204	D	H
P45381	LP/P	Canavan disease (CAND) [MIM:271900]	A0A060WG62	248	Q	R
P45381	LP/P	Canavan disease (CAND) [MIM:271900]	A0A060WG62	286	A	D
Q12797	LB/B	-	G3VD33	354	R	M
Q12797	LP/P	Facial dysmorphism, lens dislocation, anterior segment abnormalities, and spontaneous filtering blebs (FDLAB) [MIM:601552]	G3VD33	735	R	W
Q6ICH7	LB/B	-	A0A2K5WFE4	235	N	S
Q8IZT6	LB/B	-	A0A1S3F903	2562	S	G
Q8IZT6	LB/B	-	A0A1S3F903	2647	L	I
Q8IZT6	LB/B	-	A0A1S3F903	3132	L	R
Q8IZT6	LB/B	-	A0A1S3F903	430	R	G
Q8IZT6	LB/B	-	A0A1S3F903	869	T	S
Q8IZT6	LB/B	-	A0A1S3F903	1090	S	F
Q8IZT6	LB/B	-	A0A1S3F903	2494	Y	H
Q8IZT6	LB/B	-	A0A1S3F903	2620	Q	H
Q8IZT6	LB/B	-	A0A1S3F903	3258	H	R
Q8IZT6	LB/B	-	A0A1S3F903	313	I	V
Q8IZT6	LB/B	-	A0A1S3F903	2526	N	D
Q8IZT6	LB/B	-	A0A1S3F903	3180	Q	P
Q9BZE9	LB/B	-	F6TDK8	252	L	Q
Q9BZE9	LB/B	-	F6TDK8	487	D	E
Q9BZE9	LB/B	-	F6TDK8	318	V	M
Q76L83	LB/B	-	B8XCX8	731	L	P
Q76L83	LB/B	-	B8XCX8	796	A	V
Q76L83	LB/B	-	B8XCX8	1210	T	P
Q76L83	LB/B	-	B8XCX8	1242	T	P
Q9C0F0	LB/B	-	A0A091U2P8	954	N	S
Q9C0F0	LB/B	-	A0A091U2P8	1415	M	R
Q9C0F0	LB/B	-	A0A091U2P8	1652	V	M
Q9C0F0	LB/B	-	A0A091U2P8	1708	M	V
Q6PL18	LB/B	-	W5MSH1	1280	I	T
Q9ULI0	LB/B	-	A0A2K6GYG9	118	S	P
Q96QE3	LB/B	-	A0A0Q3PF65	35	T	S
Q96QE3	LB/B	-	A0A0Q3PF65	87	P	S
Q96QE3	LB/B	-	A0A0Q3PF65	135	E	G
Q96QE3	LB/B	-	A0A0Q3PF65	249	R	K
Q96QE3	LB/B	-	A0A0Q3PF65	699	N	H
Q96QE3	LB/B	-	A0A0Q3PF65	1419	Y	H
Q96QE3	LB/B	-	A0A0Q3PF65	215	D	N
Q86WG3	LP/P	Cerebellar ataxia, cayman type (ATCAY) [MIM:601238]	A0A2Y9IBW6	301	S	R
P18847	LB/B	-	A0A1U7S414	38	T	M
P18848	LB/B	-	A0A2J8K781	322	E	D
P18848	LB/B	-	A0A2J8K781	22	Q	P
P18848	LB/B	-	A0A2J8K781	258	P	A
Q9Y2D1	LB/B	-	K7G7W7	121	P	L
P18850	LB/B	-	F1S1C8	67	M	L
P18850	LB/B	-	F1S1C8	67	M	V
P18850	LB/B	-	F1S1C8	145	A	P
P18850	LB/B	-	F1S1C8	157	P	S
P18850	LP/P	Achromatopsia 7 (ACHM7) [MIM:616517]	F1S1C8	324	R	C
P18850	LP/P	Achromatopsia 7 (ACHM7) [MIM:616517]	F1S1C8	567	Y	N
Q6VMQ6	LB/B	-	A0A1S3FW08	278	E	K
Q6VMQ6	LB/B	-	A0A1S3FW08	348	N	I
Q6VMQ6	LB/B	-	A0A1S3FW08	530	K	R
Q9H0Y0	LB/B	-	A0A1L8I1V5	212	T	M
Q9H0Y0	LB/B	-	A0A1L8I1V5	220	P	H
Q9H0Y0	LB/B	-	A0A1L8I1V5	62	S	P
Q676U5	LP/P	Inflammatory bowel disease 10 (IBD10) [MIM:611081]	L5M1T8	300	T	A
Q676U5	LB/B	-	L5M1T8	307	E	K
Q8NAA4	LB/B	-	W5P944	220	R	W
Q9H1Y0	LP/P	Spinocerebellar ataxia, autosomal recessive, 25 (SCAR25) [MIM:617584]	A0A2I4CAQ6	122	E	D
O95352	LB/B	-	G5C223	471	V	A
O95352	LP/P	Spinocerebellar ataxia, autosomal recessive, 31 (SCAR31) [MIM:619422]	G5C223	234	P	T
O95352	LP/P	Spinocerebellar ataxia, autosomal recessive, 31 (SCAR31) [MIM:619422]	G5C223	511	G	D
O95352	LP/P	Spinocerebellar ataxia, autosomal recessive, 31 (SCAR31) [MIM:619422]	G5C223	512	L	P
O95352	LP/P	Spinocerebellar ataxia, autosomal recessive, 31 (SCAR31) [MIM:619422]	G5C223	576	R	H
O95352	LP/P	Spinocerebellar ataxia, autosomal recessive, 31 (SCAR31) [MIM:619422]	G5C223	588	V	M
O95352	LP/P	Spinocerebellar ataxia, autosomal recessive, 31 (SCAR31) [MIM:619422]	G5C223	624	H	Y
Q674R7	LB/B	-	G3W5W6	166	P	L
P31939	LB/B	-	A0A1B6DMZ0	116	T	S
P31939	LP/P	AICA-ribosuria due to ATIC deficiency (AICAR) [MIM:608688]	A0A1B6DMZ0	426	K	R
Q8WXF7	LP/P	Spastic paraplegia 3, autosomal dominant (SPG3) [MIM:182600]	G1TE90	217	R	Q
Q8WXF7	LP/P	Spastic paraplegia 3, autosomal dominant (SPG3) [MIM:182600]	G1TE90	239	R	C
Q8WXF7	LP/P	Spastic paraplegia 3, autosomal dominant (SPG3) [MIM:182600]	G1TE90	258	H	R
Q8WXF7	LP/P	Spastic paraplegia 3, autosomal dominant (SPG3) [MIM:182600]	G1TE90	259	S	Y
Q8WXF7	LP/P	Spastic paraplegia 3, autosomal dominant (SPG3) [MIM:182600]	G1TE90	161	A	P
Q8WXF7	LP/P	Spastic paraplegia 3, autosomal dominant (SPG3) [MIM:182600]	G1TE90	247	H	P
Q8WXF7	LB/B	-	G1TE90	43	D	E
Q8WXF7	LB/B	-	G1TE90	193	F	C
Q8WXF7	LP/P	Neuropathy, hereditary sensory, 1D (HSN1D) [MIM:613708]	G1TE90	66	E	Q
Q8WXF7	LP/P	Spastic paraplegia 3, autosomal dominant (SPG3) [MIM:182600]	G1TE90	157	L	W
Q8WXF7	LP/P	Neuropathy, hereditary sensory, 1D (HSN1D) [MIM:613708]	G1TE90	355	N	K
Q8WXF7	LP/P	Spastic paraplegia 3, autosomal dominant (SPG3) [MIM:182600]	G1TE90	408	M	V
Q8WXF7	LP/P	Spastic paraplegia 3, autosomal dominant (SPG3) [MIM:182600]	G1TE90	415	R	W
Q8WXF7	LP/P	Spastic paraplegia 3, autosomal dominant (SPG3) [MIM:182600]	G1TE90	154	Q	E
Q8WXF7	LP/P	Spastic paraplegia 3, autosomal dominant (SPG3) [MIM:182600]	G1TE90	253	V	I
Q8WXF7	LP/P	Spastic paraplegia 3, autosomal dominant (SPG3) [MIM:182600]	G1TE90	413	F	V
Q8WXF7	LP/P	Spastic paraplegia 3, autosomal dominant (SPG3) [MIM:182600]	G1TE90	440	N	T
Q8WXF7	LP/P	Spastic paraplegia 3, autosomal dominant (SPG3) [MIM:182600]	G1TE90	495	R	W
Q8WXF7	LP/P	Spastic paraplegia 3, autosomal dominant (SPG3) [MIM:182600]	G1TE90	415	R	Q
Q8WXF7	LP/P	Spastic paraplegia 3, autosomal dominant (SPG3) [MIM:182600]	G1TE90	416	R	C
Q8WXF7	LP/P	Spastic paraplegia 3, autosomal dominant (SPG3) [MIM:182600]	G1TE90	118	R	Q
Q6DD88	LP/P	Neuropathy, hereditary sensory, 1F (HSN1F) [MIM:615632]	G5B6G6	192	Y	C
Q13315	LP/P	Ataxia telangiectasia (AT) [MIM:208900]	A0A2K6FTV4	49	S	C
Q13315	LB/B	-	A0A2K6FTV4	126	D	E
Q13315	LB/B	-	A0A2K6FTV4	182	V	L
Q13315	LP/P	Ataxia telangiectasia (AT) [MIM:208900]	A0A2K6FTV4	292	P	L
Q13315	LP/P	Ataxia telangiectasia (AT) [MIM:208900]	A0A2K6FTV4	323	I	V
Q13315	LB/B	-	A0A2K6FTV4	514	G	D
Q13315	LP/P	Ataxia telangiectasia (AT) [MIM:208900]	A0A2K6FTV4	570	F	S
Q13315	LB/B	-	A0A2K6FTV4	707	S	P
Q13315	LP/P	Ataxia telangiectasia (AT) [MIM:208900]	A0A2K6FTV4	768	N	D
Q13315	LP/P	Ataxia telangiectasia (AT) [MIM:208900]	A0A2K6FTV4	785	R	C
Q13315	LB/B	-	A0A2K6FTV4	858	F	L
Q13315	LP/P	Ataxia telangiectasia (AT) [MIM:208900]	A0A2K6FTV4	950	L	R
Q13315	LP/P	Ataxia telangiectasia (AT) [MIM:208900]	A0A2K6FTV4	1001	L	Q
Q13315	LP/P	Ataxia telangiectasia (AT) [MIM:208900]	A0A2K6FTV4	1054	P	R
Q13315	LP/P	Ataxia telangiectasia (AT) [MIM:208900]	A0A2K6FTV4	1091	E	D
Q13315	LB/B	-	A0A2K6FTV4	1420	L	F
Q13315	LP/P	Ataxia telangiectasia (AT) [MIM:208900]	A0A2K6FTV4	1420	L	P
Q13315	LP/P	Ataxia telangiectasia (AT) [MIM:208900]	A0A2K6FTV4	1465	L	P
Q13315	LP/P	Ataxia telangiectasia (AT) [MIM:208900]	A0A2K6FTV4	1566	P	R
Q13315	LB/B	-	A0A2K6FTV4	1570	V	A
Q13315	LP/P	Ataxia telangiectasia (AT) [MIM:208900]	A0A2K6FTV4	1691	S	R
Q13315	LP/P	Ataxia telangiectasia (AT) [MIM:208900]	A0A2K6FTV4	1743	T	I
Q13315	LB/B	-	A0A2K6FTV4	1853	D	N
Q13315	LB/B	-	A0A2K6FTV4	1853	D	V
Q13315	LP/P	Ataxia telangiectasia (AT) [MIM:208900]	A0A2K6FTV4	1913	V	G
Q13315	LP/P	Ataxia telangiectasia (AT) [MIM:208900]	A0A2K6FTV4	2067	A	D
Q13315	LB/B	-	A0A2K6FTV4	2079	V	I
Q13315	LP/P	Ataxia telangiectasia (AT) [MIM:208900]	A0A2K6FTV4	2218	S	C
Q13315	LP/P	Ataxia telangiectasia (AT) [MIM:208900]	A0A2K6FTV4	2424	V	G
Q13315	LB/B	-	A0A2K6FTV4	2438	T	I
Q13315	LP/P	Ataxia telangiectasia (AT) [MIM:208900]	A0A2K6FTV4	2470	Y	D
Q13315	LP/P	Ataxia telangiectasia (AT) [MIM:208900]	A0A2K6FTV4	2491	W	R
Q13315	LP/P	Ataxia telangiectasia (AT) [MIM:208900]	A0A2K6FTV4	2554	H	D
Q13315	LP/P	Ataxia telangiectasia (AT) [MIM:208900]	A0A2K6FTV4	2625	D	Q
Q13315	LP/P	Ataxia telangiectasia (AT) [MIM:208900]	A0A2K6FTV4	2656	L	P
Q13315	LP/P	Ataxia telangiectasia (AT) [MIM:208900]	A0A2K6FTV4	2702	I	R
Q13315	LB/B	-	A0A2K6FTV4	2765	G	S
Q13315	LP/P	Ataxia telangiectasia (AT) [MIM:208900]	A0A2K6FTV4	2824	C	Y
Q13315	LP/P	Ataxia telangiectasia (AT) [MIM:208900]	A0A2K6FTV4	2827	F	C
Q13315	LP/P	Ataxia telangiectasia (AT) [MIM:208900]	A0A2K6FTV4	2829	P	L
Q13315	LP/P	Ataxia telangiectasia (AT) [MIM:208900]	A0A2K6FTV4	2832	R	C
Q13315	LP/P	Ataxia telangiectasia (AT) [MIM:208900]	A0A2K6FTV4	2849	R	P
Q13315	LP/P	Ataxia telangiectasia (AT) [MIM:208900]	A0A2K6FTV4	2867	G	R
Q13315	LP/P	Ataxia telangiectasia (AT) [MIM:208900]	A0A2K6FTV4	2904	E	G
Q13315	LP/P	Ataxia telangiectasia (AT) [MIM:208900]	A0A2K6FTV4	2909	R	G
Q13315	LP/P	Ataxia telangiectasia (AT) [MIM:208900]	A0A2K6FTV4	3008	R	C
Q13315	LB/B	-	A0A2K6FTV4	140	D	H
Q13315	LB/B	-	A0A2K6FTV4	250	R	Q
Q13315	LB/B	-	A0A2K6FTV4	333	S	F
Q13315	LB/B	-	A0A2K6FTV4	410	V	A
Q13315	LB/B	-	A0A2K6FTV4	504	N	S
Q13315	LB/B	-	A0A2K6FTV4	546	L	V
Q13315	LB/B	-	A0A2K6FTV4	582	F	L
Q13315	LB/B	-	A0A2K6FTV4	872	P	S
Q13315	LB/B	-	A0A2K6FTV4	935	T	A
Q13315	LB/B	-	A0A2K6FTV4	1321	M	I
Q13315	LB/B	-	A0A2K6FTV4	1380	H	Y
Q13315	LB/B	-	A0A2K6FTV4	1382	P	S
Q13315	LB/B	-	A0A2K6FTV4	1475	Y	C
Q13315	LB/B	-	A0A2K6FTV4	1650	N	S
Q13315	LB/B	-	A0A2K6FTV4	1983	S	N
Q13315	LB/B	-	A0A2K6FTV4	2332	L	P
Q13315	LB/B	-	A0A2K6FTV4	2492	L	R
Q13315	LB/B	-	A0A2K6FTV4	2870	D	N
Q13315	LB/B	-	A0A2K6FTV4	761	T	S
Q13315	LB/B	-	A0A2K6FTV4	788	S	R
Q13315	LB/B	-	A0A2K6FTV4	814	D	E
Q13315	LB/B	-	A0A2K6FTV4	935	T	M
Q13315	LB/B	-	A0A2K6FTV4	942	L	F
Q13315	LB/B	-	A0A2K6FTV4	1313	E	Q
Q13315	LB/B	-	A0A2K6FTV4	1427	A	T
Q13315	LB/B	-	A0A2K6FTV4	1541	L	F
Q13315	LB/B	-	A0A2K6FTV4	1729	V	L
Q13315	LB/B	-	A0A2K6FTV4	2034	R	Q
Q13315	LB/B	-	A0A2K6FTV4	2335	T	K
Q13315	LB/B	-	A0A2K6FTV4	2570	E	G
Q13315	LB/B	-	A0A2K6FTV4	2640	T	I
Q13315	LB/B	-	A0A2K6FTV4	2709	G	S
Q13315	LP/P	Ataxia telangiectasia (AT) [MIM:208900]	A0A2K6FTV4	1046	L	P
Q13315	LP/P	Ataxia telangiectasia (AT) [MIM:208900]	A0A2K6FTV4	2023	G	R
Q13315	LP/P	Ataxia telangiectasia (AT) [MIM:208900]	A0A2K6FTV4	2068	L	S
Q13315	LP/P	Ataxia telangiectasia (AT) [MIM:208900]	A0A2K6FTV4	2080	Y	D
Q13315	LP/P	Ataxia telangiectasia (AT) [MIM:208900]	A0A2K6FTV4	2627	Y	H
Q13315	LP/P	Ataxia telangiectasia (AT) [MIM:208900]	A0A2K6FTV4	2834	F	L
Q13315	LP/P	Ataxia telangiectasia (AT) [MIM:208900]	A0A2K6FTV4	3003	N	D
Q13315	LB/B	-	A0A2K6FTV4	1322	L	I
O43313	LB/B	-	G1STU3	240	S	P
O43313	LB/B	-	G1STU3	305	K	E
P54259	LB/B	-	G3GUQ3	339	M	I
P54259	LP/P	Congenital hypotonia, epilepsy, developmental delay, and digital anomalies (CHEDDA) [MIM:618494]	G3GUQ3	1054	H	N
P54259	LP/P	Congenital hypotonia, epilepsy, developmental delay, and digital anomalies (CHEDDA) [MIM:618494]	G3GUQ3	1058	H	Y
P54259	LP/P	Congenital hypotonia, epilepsy, developmental delay, and digital anomalies (CHEDDA) [MIM:618494]	G3GUQ3	1060	H	Y
P54259	LP/P	Congenital hypotonia, epilepsy, developmental delay, and digital anomalies (CHEDDA) [MIM:618494]	G3GUQ3	1062	H	D
P54259	LP/P	Congenital hypotonia, epilepsy, developmental delay, and digital anomalies (CHEDDA) [MIM:618494]	G3GUQ3	1062	H	R
P54259	LP/P	Congenital hypotonia, epilepsy, developmental delay, and digital anomalies (CHEDDA) [MIM:618494]	G3GUQ3	1063	L	R
Q8N100	LP/P	Persistent hyperplastic primary vitreous, autosomal recessive (PHPVAR) [MIM:221900]	F6UQ92	46	N	H
Q8N100	LP/P	Persistent hyperplastic primary vitreous, autosomal recessive (PHPVAR) [MIM:221900]	F6UQ92	49	E	V
Q8N100	LB/B	-	F6UQ92	65	R	G
Q32MH5	LB/B	-	G5C9C9	135	Q	R
Q32MH5	LB/B	-	G5C9C9	560	V	I
O94823	LB/B	-	S9X9Y2	217	C	R
O94823	LB/B	-	S9X9Y2	393	G	W
P98196	LB/B	-	K1Q9M9	1091	V	I
P98196	LB/B	-	K1Q9M9	317	M	V
P98196	LP/P	Leukodystrophy, hypomyelinating, 24 (HLD24) [MIM:619851]	K1Q9M9	84	Q	E
Q8NB49	LB/B	-	A0A1W7REV0	114	C	W
Q8NB49	LB/B	-	A0A1W7REV0	522	Y	C
Q8NB49	LB/B	-	A0A1W7REV0	972	V	M
Q8NB49	LP/P	Hemolytic anemia, congenital, X-linked (HACXL) [MIM:301015]	A0A1W7REV0	418	T	N
P54707	LB/B	-	A0A0K0EHT4	863	P	L
Q9NQ11	LP/P	Kufor-Rakeb syndrome (KRS) [MIM:606693]	S7NZ80	12	T	M
Q9NQ11	LB/B	-	S7NZ80	49	G	S
Q9NQ11	LB/B	-	S7NZ80	294	R	Q
Q9NQ11	LB/B	-	S7NZ80	389	P	L
Q9NQ11	LP/P	Kufor-Rakeb syndrome (KRS) [MIM:606693]	S7NZ80	504	G	R
Q9NQ11	LP/P	Kufor-Rakeb syndrome (KRS) [MIM:606693]	S7NZ80	533	G	R
Q9NQ11	LB/B	-	S7NZ80	578	V	G
Q9NQ11	LP/P	Kufor-Rakeb syndrome (KRS) [MIM:606693]	S7NZ80	746	A	T
Q9NQ11	LB/B	-	S7NZ80	762	R	W
Q9NQ11	LB/B	-	S7NZ80	776	V	I
Q9NQ11	LB/B	-	S7NZ80	946	I	F
Q9NQ11	LP/P	Kufor-Rakeb syndrome (KRS) [MIM:606693]	S7NZ80	182	F	L
Q9NQ11	LP/P	Kufor-Rakeb syndrome (KRS) [MIM:606693]	S7NZ80	877	G	R
Q9NQ11	LP/P	Kufor-Rakeb syndrome (KRS) [MIM:606693]	S7NZ80	1059	L	R
Q9NQ11	LP/P	Kufor-Rakeb syndrome (KRS) [MIM:606693]	S7NZ80	854	M	R
Q9NQ11	LP/P	Spastic paraplegia 78, autosomal recessive (SPG78) [MIM:617225]	S7NZ80	517	T	I
Q4VNC1	LB/B	-	A0A0B7AE23	181	I	M
Q4VNC1	LB/B	-	A0A0B7AE23	353	V	A
Q4VNC1	LB/B	-	A0A0B7AE23	646	E	D
Q4VNC0	LB/B	-	A0A0B7AE23	133	E	Q
Q4VNC0	LB/B	-	A0A0B7AE23	739	G	S
Q4VNC0	LB/B	-	A0A0B7AE23	1053	I	V
Q4VNC0	LB/B	-	A0A0B7AE23	1131	V	A
Q4VNC0	LB/B	-	A0A0B7AE23	1204	K	Q
Q4VNC0	LB/B	-	A0A0B7AE23	96	S	Y
P05023	LB/B	-	A0A0K0EHT4	47	S	I
P05023	LP/P	Charcot-Marie-Tooth disease, axonal, 2DD (CMT2DD) [MIM:618036]	A0A0K0EHT4	48	L	R
P05023	LP/P	Charcot-Marie-Tooth disease, axonal, 2DD (CMT2DD) [MIM:618036]	A0A0K0EHT4	600	P	A
P05023	LP/P	Charcot-Marie-Tooth disease, axonal, 2DD (CMT2DD) [MIM:618036]	A0A0K0EHT4	811	D	A
P05023	LP/P	Hypomagnesemia, seizures, and impaired intellectual development 2 (HOMGSMR2) [MIM:618314]	A0A0K0EHT4	302	L	R
P05023	LP/P	Hypomagnesemia, seizures, and impaired intellectual development 2 (HOMGSMR2) [MIM:618314]	A0A0K0EHT4	303	G	R
P05023	LP/P	Hypomagnesemia, seizures, and impaired intellectual development 2 (HOMGSMR2) [MIM:618314]	A0A0K0EHT4	859	M	R
P50993	LP/P	Alternating hemiplegia of childhood 1 (AHC1) [MIM:104290]	S9XEY7	378	T	N
P50993	LP/P	Migraine, familial hemiplegic, 2 (FHM2) [MIM:602481]	S9XEY7	689	R	Q
P50993	LP/P	Migraine, familial hemiplegic, 2 (FHM2) [MIM:602481]	S9XEY7	731	M	T
P50993	LP/P	Migraine, familial hemiplegic, 2 (FHM2) [MIM:602481]	S9XEY7	764	L	P
P50993	LP/P	Migraine, familial hemiplegic, 2 (FHM2) [MIM:602481]	S9XEY7	887	W	R
P50993	LP/P	Migraine, familial hemiplegic, 2 (FHM2) [MIM:602481]	S9XEY7	715	G	R
P50993	LP/P	Migraine, familial hemiplegic, 2 (FHM2) [MIM:602481]	S9XEY7	874	G	S
P50993	LP/P	Migraine, familial hemiplegic, 2 (FHM2) [MIM:602481]	S9XEY7	1007	R	W
P50993	LP/P	Developmental and epileptic encephalopathy 98 (DEE98) [MIM:619605]	S9XEY7	366	G	A
P50993	LP/P	Developmental and epileptic encephalopathy 98 (DEE98) [MIM:619605]	S9XEY7	593	R	W
P50993	LP/P	Developmental and epileptic encephalopathy 98 (DEE98) [MIM:619605]	S9XEY7	293	I	M
P50993	LP/P	Developmental and epileptic encephalopathy 98 (DEE98) [MIM:619605]	S9XEY7	341	C	F
P50993	LP/P	-	S9XEY7	593	R	Q
P50993	LP/P	Developmental and epileptic encephalopathy 98 (DEE98) [MIM:619605]	S9XEY7	908	R	Q
P13637	LP/P	Dystonia 12 (DYT12) [MIM:128235]	L5L7K9	274	I	T
P13637	LP/P	Dystonia 12 (DYT12) [MIM:128235]	L5L7K9	277	E	K
P13637	LP/P	Dystonia 12 (DYT12) [MIM:128235]	L5L7K9	613	T	M
P13637	LP/P	Dystonia 12 (DYT12) [MIM:128235]	L5L7K9	758	I	S
P13637	LP/P	Dystonia 12 (DYT12) [MIM:128235]	L5L7K9	780	F	L
P13637	LP/P	Dystonia 12 (DYT12) [MIM:128235]	L5L7K9	801	D	Y
P13637	LP/P	Alternating hemiplegia of childhood 2 (AHC2) [MIM:614820]	L5L7K9	137	S	F
P13637	LP/P	Alternating hemiplegia of childhood 2 (AHC2) [MIM:614820]	L5L7K9	137	S	Y
P13637	LP/P	Alternating hemiplegia of childhood 2 (AHC2) [MIM:614820]	L5L7K9	140	Q	L
P13637	LP/P	Alternating hemiplegia of childhood 2 (AHC2) [MIM:614820]	L5L7K9	220	D	N
P13637	LP/P	Alternating hemiplegia of childhood 2 (AHC2) [MIM:614820]	L5L7K9	274	I	N
P13637	LP/P	Alternating hemiplegia of childhood 2 (AHC2) [MIM:614820]	L5L7K9	333	C	F
P13637	LP/P	Alternating hemiplegia of childhood 2 (AHC2) [MIM:614820]	L5L7K9	755	G	S
P13637	LP/P	Alternating hemiplegia of childhood 2 (AHC2) [MIM:614820]	L5L7K9	773	N	S
P13637	LP/P	Alternating hemiplegia of childhood 2 (AHC2) [MIM:614820]	L5L7K9	801	D	N
P13637	LP/P	Developmental and epileptic encephalopathy 99 (DEE99) [MIM:619606]	L5L7K9	801	D	N
P13637	LP/P	Alternating hemiplegia of childhood 2 (AHC2) [MIM:614820]	L5L7K9	806	M	R
P13637	LP/P	Alternating hemiplegia of childhood 2 (AHC2) [MIM:614820]	L5L7K9	810	I	S
P13637	LP/P	Alternating hemiplegia of childhood 2 (AHC2) [MIM:614820]	L5L7K9	811	S	P
P13637	LP/P	Alternating hemiplegia of childhood 2 (AHC2) [MIM:614820]	L5L7K9	815	E	K
P13637	LP/P	Dystonia 12 (DYT12) [MIM:128235]	L5L7K9	923	D	N
P13637	LP/P	Alternating hemiplegia of childhood 2 (AHC2) [MIM:614820]	L5L7K9	947	G	R
P13637	LP/P	Alternating hemiplegia of childhood 2 (AHC2) [MIM:614820]	L5L7K9	955	A	D
P13637	LP/P	Alternating hemiplegia of childhood 2 (AHC2) [MIM:614820]	L5L7K9	992	D	Y
P13637	LP/P	Alternating hemiplegia of childhood 2 (AHC2) [MIM:614820]	L5L7K9	322	V	D
P13637	LP/P	Alternating hemiplegia of childhood 2 (AHC2) [MIM:614820]	L5L7K9	371	L	P
P13637	LP/P	Alternating hemiplegia of childhood 2 (AHC2) [MIM:614820]	L5L7K9	755	G	C
P13637	LP/P	Alternating hemiplegia of childhood 2 (AHC2) [MIM:614820]	L5L7K9	772	S	R
P13637	LP/P	Alternating hemiplegia of childhood 2 (AHC2) [MIM:614820]	L5L7K9	773	N	I
P13637	LP/P	Cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss (CAPOS) [MIM:601338]	L5L7K9	818	E	K
P13637	LP/P	Alternating hemiplegia of childhood 2 (AHC2) [MIM:614820]	L5L7K9	923	D	Y
P13637	LP/P	Alternating hemiplegia of childhood 2 (AHC2) [MIM:614820]	L5L7K9	927	C	Y
P13637	LP/P	-	L5L7K9	320	A	T
P13637	LP/P	Developmental and epileptic encephalopathy 99 (DEE99) [MIM:619606]	L5L7K9	292	L	R
P13637	LP/P	Developmental and epileptic encephalopathy 99 (DEE99) [MIM:619606]	L5L7K9	316	G	V
P13637	LP/P	Developmental and epileptic encephalopathy 99 (DEE99) [MIM:619606]	L5L7K9	361	S	P
P13637	LP/P	Developmental and epileptic encephalopathy 99 (DEE99) [MIM:619606]	L5L7K9	609	D	Y
P13637	LP/P	Developmental and epileptic encephalopathy 99 (DEE99) [MIM:619606]	L5L7K9	775	P	R
P13637	LP/P	Developmental and epileptic encephalopathy 99 (DEE99) [MIM:619606]	L5L7K9	887	D	Y
P13637	LP/P	Developmental and epileptic encephalopathy 99 (DEE99) [MIM:619606]	L5L7K9	888	L	P
P13637	LP/P	Developmental and epileptic encephalopathy 99 (DEE99) [MIM:619606]	L5L7K9	893	G	W
P13637	LP/P	Developmental and epileptic encephalopathy 99 (DEE99) [MIM:619606]	L5L7K9	924	L	P
Q13733	LB/B	-	A0A0K0EHT4	83	G	D
Q13733	LB/B	-	A0A0K0EHT4	297	E	K
Q13733	LB/B	-	A0A0K0EHT4	541	M	R
Q13733	LB/B	-	A0A0K0EHT4	586	M	I
P14415	LB/B	-	B5G4P6	199	T	A
P14415	LB/B	-	B5G4P6	124	Q	L
Q9UN42	LB/B	-	A0A2Y9GV80	48	V	A
O14983	LP/P	Brody disease (BROD) [MIM:601003]	G3I7M5	789	P	L
P20020	LB/B	-	H3DBG2	267	M	R
P20020	LP/P	Intellectual developmental disorder, autosomal dominant 66 (MRD66) [MIM:619910]	H3DBG2	239	D	G
P20020	LP/P	Intellectual developmental disorder, autosomal dominant 66 (MRD66) [MIM:619910]	H3DBG2	264	T	I
P20020	LP/P	Intellectual developmental disorder, autosomal dominant 66 (MRD66) [MIM:619910]	H3DBG2	425	T	K
P20020	LP/P	Intellectual developmental disorder, autosomal dominant 66 (MRD66) [MIM:619910]	H3DBG2	459	H	R
P20020	LP/P	Intellectual developmental disorder, autosomal dominant 66 (MRD66) [MIM:619910]	H3DBG2	763	R	P
P20020	LB/B	-	H3DBG2	779	G	S
P20020	LP/P	Intellectual developmental disorder, autosomal dominant 66 (MRD66) [MIM:619910]	H3DBG2	789	R	C
P20020	LP/P	Intellectual developmental disorder, autosomal dominant 66 (MRD66) [MIM:619910]	H3DBG2	824	E	K
P20020	LP/P	Intellectual developmental disorder, autosomal dominant 66 (MRD66) [MIM:619910]	H3DBG2	857	Q	R
P20020	LP/P	Intellectual developmental disorder, autosomal dominant 66 (MRD66) [MIM:619910]	H3DBG2	991	R	Q
Q16720	LB/B	-	H3DBG2	198	I	M
Q16720	LP/P	Spinocerebellar ataxia, X-linked 1 (SCAX1) [MIM:302500]	H3DBG2	1107	G	D
Q16720	LP/P	Spinocerebellar ataxia, X-linked 1 (SCAX1) [MIM:302500]	H3DBG2	482	R	H
O75185	LB/B	-	S7P5G9	411	G	S
O75185	LB/B	-	S7P5G9	466	M	L
O75185	LB/B	-	S7P5G9	907	L	P
O75185	LB/B	-	S7P5G9	165	L	M
O75185	LB/B	-	S7P5G9	604	L	Q
P20648	LB/B	-	A0A0K0EHT4	265	V	A
P25705	LB/B	-	L9L2H2	32	A	S
P25705	LP/P	Mitochondrial complex V deficiency, nuclear type 4 (MC5DN4) [MIM:615228]	L9L2H2	329	R	C
P25705	LP/P	Combined oxidative phosphorylation deficiency 22 (COXPD22) [MIM:616045]	L9L2H2	321	Y	C
P06576	LB/B	-	L5KVR4	274	E	Q
P06576	LB/B	-	L5KVR4	130	A	V
P06576	LP/P	Hypermetabolism due to uncoupled mitochondrial oxidative phosphorylation 2 (HUMOP2) [MIM:620085]	L5KVR4	335	L	P
P56381	LP/P	Mitochondrial complex V deficiency, nuclear type 3 (MC5DN3) [MIM:614053]	G1PR27	12	Y	C
Q06055	LB/B	-	I3LMW2	58	S	I
Q06055	LB/B	-	I3LMW2	141	M	K
P48201	LB/B	-	A0A1V4K6L9	93	G	E
P48201	LP/P	Dystonia, early-onset, and/or spastic paraplegia (DYTSPG) [MIM:619681]	A0A1V4K6L9	106	N	K
P56378	LB/B	-	F7CEF1	9	I	V
P24539	LB/B	-	J9JWZ4	152	T	N
P24539	LB/B	-	J9JWZ4	152	T	M
P18859	LB/B	-	F7E138	39	I	T
P48047	LB/B	-	H3ASH2	98	K	R
Q15904	LP/P	Immunodeficiency 47 (IMD47) [MIM:300972]	B0KWX0	144	L	P
Q15904	LP/P	Immunodeficiency 47 (IMD47) [MIM:300972]	B0KWX0	313	Y	C
Q15904	LP/P	Immunodeficiency 47 (IMD47) [MIM:300972]	B0KWX0	346	E	K
Q15904	LP/P	Immunodeficiency 47 (IMD47) [MIM:300972]	B0KWX0	428	M	I
Q93050	LP/P	Neurodevelopmental disorder with epilepsy and brain atrophy (NEDEBA) [MIM:619971]	A0A077Z165	505	A	P
Q93050	LP/P	Developmental and epileptic encephalopathy 104 (DEE104) [MIM:619970]	A0A077Z165	740	R	Q
Q93050	LP/P	Developmental and epileptic encephalopathy 104 (DEE104) [MIM:619970]	A0A077Z165	804	R	H
Q8N8Y2	LB/B	-	A0A137PFU6	272	G	R
Q8N8Y2	LB/B	-	A0A137PFU6	295	E	K
P38606	LP/P	Cutis laxa, autosomal recessive, 2D (ARCL2D) [MIM:617403]	A0A2U9B845	72	G	D
P38606	LP/P	Cutis laxa, autosomal recessive, 2D (ARCL2D) [MIM:617403]	A0A2U9B845	338	R	C
P38606	LP/P	Epileptic encephalopathy, infantile or early childhood, 3 (IECEE3) [MIM:618012]	A0A2U9B845	100	D	Y
P38606	LP/P	Epileptic encephalopathy, infantile or early childhood, 3 (IECEE3) [MIM:618012]	A0A2U9B845	349	D	N
P15313	LP/P	Renal tubular acidosis, distal, 2, with progressive sensorineural hearing loss (DRTA2) [MIM:267300]	A0A2K5QZN8	81	L	P
P15313	LP/P	Renal tubular acidosis, distal, 2, with progressive sensorineural hearing loss (DRTA2) [MIM:267300]	A0A2K5QZN8	124	R	W
P15313	LP/P	Renal tubular acidosis, distal, 2, with progressive sensorineural hearing loss (DRTA2) [MIM:267300]	A0A2K5QZN8	174	M	R
P15313	LP/P	Renal tubular acidosis, distal, 2, with progressive sensorineural hearing loss (DRTA2) [MIM:267300]	A0A2K5QZN8	275	T	P
P15313	LP/P	Renal tubular acidosis, distal, 2, with progressive sensorineural hearing loss (DRTA2) [MIM:267300]	A0A2K5QZN8	316	G	E
P15313	LP/P	Renal tubular acidosis, distal, 2, with progressive sensorineural hearing loss (DRTA2) [MIM:267300]	A0A2K5QZN8	346	P	R
P15313	LP/P	Renal tubular acidosis, distal, 2, with progressive sensorineural hearing loss (DRTA2) [MIM:267300]	A0A2K5QZN8	364	G	S
P15313	LB/B	-	A0A2K5QZN8	30	T	I
P15313	LP/P	Renal tubular acidosis, distal, 2, with progressive sensorineural hearing loss (DRTA2) [MIM:267300]	A0A2K5QZN8	123	G	V
P15313	LP/P	Renal tubular acidosis, distal, 2, with progressive sensorineural hearing loss (DRTA2) [MIM:267300]	A0A2K5QZN8	157	R	C
P15313	LB/B	-	A0A2K5QZN8	161	E	K
P15313	LB/B	-	A0A2K5QZN8	465	R	H
P21281	LP/P	Zimmermann-Laband syndrome 2 (ZLS2) [MIM:616455]	A0A2I2UNH0	485	R	P
P36543	LP/P	Cutis laxa, autosomal recessive, 2C (ARCL2C) [MIM:617402]	A0A1W7RBL6	128	L	P
P36543	LP/P	Cutis laxa, autosomal recessive, 2C (ARCL2C) [MIM:617402]	A0A1W7RBL6	212	R	W
Q16864	LB/B	-	S9WYC7	24	G	V
Q96LB4	LB/B	-	A0A2Y9GL96	54	E	Q
Q04656	LP/P	Menkes disease (MNK) [MIM:309400]	A0A2I3H680	629	A	P
Q04656	LP/P	Menkes disease (MNK) [MIM:309400]	A0A2I3H680	727	G	R
Q04656	LP/P	Menkes disease (MNK) [MIM:309400]	A0A2I3H680	1006	L	P
Q04656	LP/P	Menkes disease (MNK) [MIM:309400]	A0A2I3H680	1019	G	D
Q04656	LP/P	Occipital horn syndrome (OHS) [MIM:304150]	A0A2I3H680	637	S	L
Q04656	LB/B	-	A0A2I3H680	767	V	L
Q04656	LP/P	Menkes disease (MNK) [MIM:309400]	A0A2I3H680	873	L	R
Q04656	LP/P	Menkes disease (MNK) [MIM:309400]	A0A2I3H680	876	G	E
Q04656	LP/P	Menkes disease (MNK) [MIM:309400]	A0A2I3H680	1000	C	R
Q04656	LP/P	Menkes disease (MNK) [MIM:309400]	A0A2I3H680	1300	G	E
Q04656	LP/P	Menkes disease (MNK) [MIM:309400]	A0A2I3H680	1302	G	R
Q04656	LP/P	Menkes disease (MNK) [MIM:309400]	A0A2I3H680	1302	G	V
Q04656	LP/P	Menkes disease (MNK) [MIM:309400]	A0A2I3H680	1305	D	A
Q04656	LP/P	Menkes disease (MNK) [MIM:309400]	A0A2I3H680	1362	A	V
Q04656	LB/B	-	A0A2I3H680	669	I	T
Q04656	LB/B	-	A0A2I3H680	703	R	H
Q04656	LB/B	-	A0A2I3H680	1464	I	V
Q04656	LP/P	Menkes disease (MNK) [MIM:309400]	A0A2I3H680	706	L	R
Q04656	LP/P	Menkes disease (MNK) [MIM:309400]	A0A2I3H680	844	R	H
Q04656	LP/P	Menkes disease (MNK) [MIM:309400]	A0A2I3H680	853	G	R
Q04656	LP/P	Menkes disease (MNK) [MIM:309400]	A0A2I3H680	860	G	V
Q04656	LP/P	Menkes disease (MNK) [MIM:309400]	A0A2I3H680	876	G	R
Q04656	LP/P	Occipital horn syndrome (OHS) [MIM:304150]	A0A2I3H680	924	Q	R
Q04656	LP/P	Menkes disease (MNK) [MIM:309400]	A0A2I3H680	1007	A	V
Q04656	LP/P	Menkes disease (MNK) [MIM:309400]	A0A2I3H680	1015	G	D
Q04656	LP/P	Menkes disease (MNK) [MIM:309400]	A0A2I3H680	1044	D	G
Q04656	LP/P	Menkes disease (MNK) [MIM:309400]	A0A2I3H680	1100	L	P
Q04656	LP/P	Menkes disease (MNK) [MIM:309400]	A0A2I3H680	1118	G	D
Q04656	LP/P	Menkes disease (MNK) [MIM:309400]	A0A2I3H680	1255	G	R
Q04656	LP/P	Menkes disease (MNK) [MIM:309400]	A0A2I3H680	1282	K	E
Q04656	LP/P	Menkes disease (MNK) [MIM:309400]	A0A2I3H680	1304	N	K
Q04656	LP/P	Menkes disease (MNK) [MIM:309400]	A0A2I3H680	1315	G	R
Q04656	LP/P	Menkes disease (MNK) [MIM:309400]	A0A2I3H680	1325	A	V
Q04656	LP/P	Menkes disease (MNK) [MIM:309400]	A0A2I3H680	1344	S	R
Q04656	LP/P	Menkes disease (MNK) [MIM:309400]	A0A2I3H680	1345	I	F
Q04656	LP/P	Menkes disease (MNK) [MIM:309400]	A0A2I3H680	1369	G	R
Q04656	LP/P	Menkes disease (MNK) [MIM:309400]	A0A2I3H680	1397	S	F
Q04656	LP/P	Distal spinal muscular atrophy, X-linked, 3 (DSMAX3) [MIM:300489]	A0A2I3H680	994	T	I
Q04656	LP/P	Occipital horn syndrome (OHS) [MIM:304150]	A0A2I3H680	1304	N	S
Q04656	LP/P	Distal spinal muscular atrophy, X-linked, 3 (DSMAX3) [MIM:300489]	A0A2I3H680	1386	P	S
Q04656	LP/P	Menkes disease (MNK) [MIM:309400]	A0A2I3H680	1048	T	I
Q04656	LB/B	-	A0A2I3H680	1350	K	E
Q04656	LP/P	Menkes disease (MNK) [MIM:309400]	A0A2I3H680	628	E	V
Q04656	LP/P	Menkes disease (MNK) [MIM:309400]	A0A2I3H680	633	K	R
Q04656	LP/P	Menkes disease (MNK) [MIM:309400]	A0A2I3H680	653	S	Y
Q04656	LP/P	Menkes disease (MNK) [MIM:309400]	A0A2I3H680	666	G	R
Q04656	LP/P	Menkes disease (MNK) [MIM:309400]	A0A2I3H680	728	G	D
Q04656	LP/P	Menkes disease (MNK) [MIM:309400]	A0A2I3H680	761	S	P
Q04656	LP/P	Menkes disease (MNK) [MIM:309400]	A0A2I3H680	802	K	N
Q04656	LP/P	Menkes disease (MNK) [MIM:309400]	A0A2I3H680	1005	G	R
Q04656	LP/P	Menkes disease (MNK) [MIM:309400]	A0A2I3H680	1037	K	N
Q04656	LP/P	Menkes disease (MNK) [MIM:309400]	A0A2I3H680	1301	D	G
Q04656	LP/P	Menkes disease (MNK) [MIM:309400]	A0A2I3H680	1302	G	E
Q04656	LP/P	Menkes disease (MNK) [MIM:309400]	A0A2I3H680	1305	D	G
Q04656	LP/P	Menkes disease (MNK) [MIM:309400]	A0A2I3H680	1308	A	D
Q04656	LP/P	Menkes disease (MNK) [MIM:309400]	A0A2I3H680	1373	A	P
Q04656	LP/P	Menkes disease (MNK) [MIM:309400]	A0A2I3H680	1393	M	T
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	85	G	V
P35670	LB/B	-	A0A1U8DHE0	96	G	D
P35670	LB/B	-	A0A1U8DHE0	390	I	V
P35670	LB/B	-	A0A1U8DHE0	406	S	A
P35670	LB/B	-	A0A1U8DHE0	446	V	L
P35670	LB/B	-	A0A1U8DHE0	456	V	L
P35670	LB/B	-	A0A1U8DHE0	466	L	V
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	492	L	S
P35670	LB/B	-	A0A1U8DHE0	565	N	S
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	645	M	R
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	691	G	R
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	708	L	P
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	710	G	R
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	710	G	S
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	711	G	E
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	713	Y	C
P35670	LB/B	-	A0A1U8DHE0	723	R	G
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	747	I	F
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	765	D	N
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	769	M	V
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	778	R	G
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	778	R	L
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	778	R	Q
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	778	R	W
P35670	LB/B	-	A0A1U8DHE0	832	K	R
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	840	P	L
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	857	I	T
P35670	LB/B	-	A0A1U8DHE0	864	V	I
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	869	G	R
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	874	A	V
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	918	D	N
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	919	R	G
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	919	R	W
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	921	S	N
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	935	T	M
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	943	G	D
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	943	G	S
P35670	LB/B	-	A0A1U8DHE0	952	R	K
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	969	R	Q
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	977	T	M
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	992	P	L
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1003	A	T
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1018	A	V
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1035	G	V
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1043	L	P
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1064	E	A
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1064	E	K
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1069	H	Q
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1083	L	F
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1089	G	E
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1089	G	V
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1101	G	R
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1102	I	T
P35670	LB/B	-	A0A1U8DHE0	1109	V	M
P35670	LB/B	-	A0A1U8DHE0	1140	V	A
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1142	Q	H
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1146	V	M
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1148	I	T
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1153	W	C
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1169	M	V
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1183	A	G
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1186	G	C
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1213	G	V
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1216	V	M
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1220	T	M
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1222	D	Y
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1266	G	V
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1267	D	A
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1270	N	S
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1273	P	L
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1310	S	R
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1322	R	P
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1341	G	D
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1353	W	R
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1358	A	S
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	711	G	R
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	711	G	W
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	744	S	P
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	769	M	R
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	795	L	R
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	869	G	V
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	985	C	Y
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1003	A	V
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1033	T	A
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1041	R	P
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1052	P	L
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1061	G	E
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1063	A	V
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1068	E	G
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1095	Q	P
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1104	C	F
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1151	R	H
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1169	M	T
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1173	E	K
P35670	LB/B	-	A0A1U8DHE0	1207	H	R
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1239	V	G
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1262	V	F
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1266	G	R
P35670	LB/B	-	A0A1U8DHE0	1297	V	I
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1327	L	V
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1363	S	F
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	710	G	A
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	741	Y	C
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	891	G	V
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	967	I	F
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1031	T	I
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1038	R	K
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1106	V	D
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1153	W	R
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1176	G	R
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1222	D	V
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1355	G	S
P35670	LB/B	-	A0A1U8DHE0	14	A	D
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	41	N	S
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	616	R	W
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	690	P	L
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	693	S	C
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	721	S	P
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	760	P	L
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	765	D	G
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	768	P	H
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	769	M	I
P35670	LB/B	-	A0A1U8DHE0	875	G	R
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	890	V	M
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	898	Q	R
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	918	D	E
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	949	V	G
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	975	S	Y
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1033	T	S
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1094	F	L
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1098	P	R
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1099	G	S
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1111	G	D
P35670	LB/B	-	A0A1U8DHE0	1143	T	N
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1168	A	S
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1232	T	P
P35670	LB/B	-	A0A1U8DHE0	1245	P	S
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1248	K	N
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1255	L	I
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1271	D	N
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1279	D	G
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1305	L	P
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1336	I	T
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1355	G	C
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1373	L	P
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1373	L	R
P35670	LB/B	-	A0A1U8DHE0	290	V	L
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	591	G	D
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	703	C	Y
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	710	G	V
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	756	A	G
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	766	T	M
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	766	T	R
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	776	L	P
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	861	A	T
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	875	G	V
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	943	G	C
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	988	G	R
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	991	T	M
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	992	P	H
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	996	M	T
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1000	G	R
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1029	T	I
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1065	A	P
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1104	C	Y
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1176	G	E
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1221	G	E
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1222	D	N
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1252	V	I
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1256	Q	R
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1279	D	Y
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1287	G	S
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1296	D	N
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1331	Y	S
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1341	G	S
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1341	G	V
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1352	P	S
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1368	L	P
P35670	LB/B	-	A0A1U8DHE0	1407	D	E
P35670	LB/B	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	536	V	A
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	971	A	V
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	974	T	M
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1004	Q	P
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1149	G	A
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1164	D	N
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1173	E	G
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1228	R	T
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1230	I	V
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1267	D	V
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1328	A	T
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1359	M	I
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	998	G	D
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1332	N	D
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1341	G	R
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	788	T	I
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1036	V	I
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1151	R	C
P35670	LB/B	-	A0A1U8DHE0	1243	V	L
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1245	P	T
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	827	R	W
P35670	LB/B	-	A0A1U8DHE0	929	I	V
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1010	K	T
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1295	A	D
P35670	LB/B	-	A0A1U8DHE0	149	V	L
P35670	LB/B	-	A0A1U8DHE0	825	V	L
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	939	W	C
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	1104	C	S
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	539	P	L
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	779	W	G
P35670	LP/P	Wilson disease (WD) [MIM:277900]	A0A1U8DHE0	816	R	S
Q9Y2Q0	LB/B	-	H2ZKG3	673	T	M
Q9NTI2	LB/B	-	A0A2I0UKF7	1069	A	T
Q9NTI2	LP/P	Cerebellar ataxia, impaired intellectual development, and dysequilibrium syndrome 4 (CAMRQ4) [MIM:615268]	A0A2I0UKF7	376	I	M
O43520	LP/P	Cholestasis, progressive familial intrahepatic, 1 (PFIC1) [MIM:211600]	A0A226PB80	288	L	S
O43520	LP/P	Cholestasis, progressive familial intrahepatic, 1 (PFIC1) [MIM:211600]	A0A226PB80	308	G	V
O43520	LP/P	Cholestasis, benign recurrent intrahepatic, 1 (BRIC1) [MIM:243300]	A0A226PB80	661	I	T
O43520	LP/P	Cholestasis, progressive familial intrahepatic, 1 (PFIC1) [MIM:211600]	A0A226PB80	661	I	T
O43520	LP/P	Cholestasis, benign recurrent intrahepatic, 1 (BRIC1) [MIM:243300]	A0A226PB80	892	G	R
O43520	LP/P	Cholestasis, progressive familial intrahepatic, 1 (PFIC1) [MIM:211600]	A0A226PB80	892	G	R
O43520	LP/P	Cholestasis, progressive familial intrahepatic, 1 (PFIC1) [MIM:211600]	A0A226PB80	554	D	N
O43520	LB/B	-	A0A226PB80	78	H	Q
O43520	LB/B	-	A0A226PB80	577	I	V
O43520	LB/B	-	A0A226PB80	952	R	Q
O43520	LP/P	Cholestasis of pregnancy, intrahepatic 1 (ICP1) [MIM:147480]	A0A226PB80	45	N	T
O43520	LP/P	Cholestasis, progressive familial intrahepatic, 1 (PFIC1) [MIM:211600]	A0A226PB80	127	L	P
O43520	LB/B	-	A0A226PB80	305	F	I
O43520	LP/P	Cholestasis, benign recurrent intrahepatic, 1 (BRIC1) [MIM:243300]	A0A226PB80	308	G	D
O43520	LP/P	Cholestasis, benign recurrent intrahepatic, 1 (BRIC1) [MIM:243300]	A0A226PB80	344	I	F
O43520	LB/B	-	A0A226PB80	384	R	H
O43520	LB/B	-	A0A226PB80	393	I	V
O43520	LP/P	Cholestasis, progressive familial intrahepatic, 1 (PFIC1) [MIM:211600]	A0A226PB80	403	S	Y
O43520	LP/P	Cholestasis, progressive familial intrahepatic, 1 (PFIC1) [MIM:211600]	A0A226PB80	412	R	P
O43520	LB/B	-	A0A226PB80	429	E	A
O43520	LP/P	Cholestasis, benign recurrent intrahepatic, 1 (BRIC1) [MIM:243300]	A0A226PB80	453	S	Y
O43520	LP/P	Cholestasis, benign recurrent intrahepatic, 1 (BRIC1) [MIM:243300]	A0A226PB80	454	D	G
O43520	LP/P	Cholestasis, progressive familial intrahepatic, 1 (PFIC1) [MIM:211600]	A0A226PB80	456	T	M
O43520	LP/P	Cholestasis, progressive familial intrahepatic, 1 (PFIC1) [MIM:211600]	A0A226PB80	500	Y	H
O43520	LP/P	Cholestasis, progressive familial intrahepatic, 1 (PFIC1) [MIM:211600]	A0A226PB80	535	H	L
O43520	LB/B	-	A0A226PB80	580	S	N
O43520	LP/P	Cholestasis, benign recurrent intrahepatic, 1 (BRIC1) [MIM:243300]	A0A226PB80	600	R	Q
O43520	LP/P	Cholestasis, benign recurrent intrahepatic, 1 (BRIC1) [MIM:243300]	A0A226PB80	600	R	W
O43520	LP/P	Cholestasis, benign recurrent intrahepatic, 1 (BRIC1) [MIM:243300]	A0A226PB80	628	R	W
O43520	LB/B	-	A0A226PB80	674	M	T
O43520	LP/P	Cholestasis, progressive familial intrahepatic, 1 (PFIC1) [MIM:211600]	A0A226PB80	688	D	G
O43520	LP/P	Cholestasis, benign recurrent intrahepatic, 1 (BRIC1) [MIM:243300]	A0A226PB80	694	I	T
O43520	LP/P	Cholestasis, progressive familial intrahepatic, 1 (PFIC1) [MIM:211600]	A0A226PB80	733	G	R
O43520	LB/B	-	A0A226PB80	814	K	N
O43520	LP/P	Cholestasis, progressive familial intrahepatic, 1 (PFIC1) [MIM:211600]	A0A226PB80	853	F	S
O43520	LP/P	Cholestasis of pregnancy, intrahepatic 1 (ICP1) [MIM:147480]	A0A226PB80	867	R	C
O43520	LP/P	Cholestasis, progressive familial intrahepatic, 1 (PFIC1) [MIM:211600]	A0A226PB80	1040	G	R
O43520	LB/B	-	A0A226PB80	1152	A	T
O43520	LP/P	Cholestasis, progressive familial intrahepatic, 1 (PFIC1) [MIM:211600]	A0A226PB80	209	P	T
O43520	LP/P	Cholestasis, progressive familial intrahepatic, 1 (PFIC1) [MIM:211600]	A0A226PB80	1012	S	I
Q8TF62	LB/B	-	A0A0F8B1V1	225	N	S
Q8TF62	LB/B	-	A0A0F8B1V1	452	H	N
Q8TF62	LB/B	-	A0A0F8B1V1	1165	N	K
Q8TF62	LB/B	-	A0A0F8B1V1	1190	V	G
O43861	LB/B	-	A0A2U3TVM1	39	S	G
O43861	LB/B	-	A0A2U3TVM1	504	D	N
O43861	LB/B	-	A0A2U3TVM1	732	M	L
O43861	LB/B	-	A0A2U3TVM1	108	R	Q
Q8N5M1	LP/P	Mitochondrial complex V deficiency, nuclear type 1 (MC5DN1) [MIM:604273]	A0A1S3WFI5	94	W	R
Q6P4H8	LB/B	-	F1MWX0	75	T	M
Q6P4H8	LB/B	-	F1MWX0	105	A	V
Q6P4H8	LB/B	-	F1MWX0	114	V	A
Q6P4H8	LB/B	-	F1MWX0	229	L	M
Q6UW56	LB/B	-	H9FVG6	209	A	S
P46100	LP/P	Alpha-thalassemia/impaired intellectual development syndrome, X-linked (ATRX) [MIM:301040]	A0A061HUQ5	190	P	A
P46100	LP/P	Alpha-thalassemia/impaired intellectual development syndrome, X-linked (ATRX) [MIM:301040]	A0A061HUQ5	192	L	F
P46100	LP/P	Alpha-thalassemia/impaired intellectual development syndrome, X-linked (ATRX) [MIM:301040]	A0A061HUQ5	200	C	S
P46100	LP/P	Alpha-thalassemia/impaired intellectual development syndrome, X-linked (ATRX) [MIM:301040]	A0A061HUQ5	220	C	R
P46100	LP/P	Alpha-thalassemia/impaired intellectual development syndrome, X-linked (ATRX) [MIM:301040]	A0A061HUQ5	222	W	S
P46100	LP/P	Alpha-thalassemia/impaired intellectual development syndrome, X-linked (ATRX) [MIM:301040]	A0A061HUQ5	243	C	F
P46100	LP/P	Alpha-thalassemia/impaired intellectual development syndrome, X-linked (ATRX) [MIM:301040]	A0A061HUQ5	246	R	C
P46100	LP/P	Alpha-thalassemia/impaired intellectual development syndrome, X-linked (ATRX) [MIM:301040]	A0A061HUQ5	249	G	D
P46100	LP/P	Alpha-thalassemia/impaired intellectual development syndrome, X-linked (ATRX) [MIM:301040]	A0A061HUQ5	1609	H	R
P46100	LP/P	Alpha-thalassemia/impaired intellectual development syndrome, X-linked (ATRX) [MIM:301040]	A0A061HUQ5	1614	C	R
P46100	LP/P	Alpha-thalassemia/impaired intellectual development syndrome, X-linked (ATRX) [MIM:301040]	A0A061HUQ5	1650	K	N
P46100	LB/B	-	A0A061HUQ5	1860	N	S
P46100	LP/P	Alpha-thalassemia/impaired intellectual development syndrome, X-linked (ATRX) [MIM:301040]	A0A061HUQ5	2035	D	V
P46100	LP/P	Alpha-thalassemia/impaired intellectual development syndrome, X-linked (ATRX) [MIM:301040]	A0A061HUQ5	2084	Y	H
P46100	LP/P	Intellectual disability-hypotonic facies syndrome, X-linked, 1 (MRXHF1) [MIM:309580]	A0A061HUQ5	2131	R	Q
P46100	LP/P	Alpha-thalassemia/impaired intellectual development syndrome, X-linked (ATRX) [MIM:301040]	A0A061HUQ5	2163	Y	C
P46100	LP/P	Alpha-thalassemia/impaired intellectual development syndrome, X-linked (ATRX) [MIM:301040]	A0A061HUQ5	246	R	L
P46100	LP/P	Alpha-thalassemia/impaired intellectual development syndrome, X-linked (ATRX) [MIM:301040]	A0A061HUQ5	175	G	E
P46100	LP/P	Alpha-thalassemia/impaired intellectual development syndrome, X-linked (ATRX) [MIM:301040]	A0A061HUQ5	179	N	S
P46100	LP/P	Alpha-thalassemia/impaired intellectual development syndrome, X-linked (ATRX) [MIM:301040]	A0A061HUQ5	190	P	L
P46100	LP/P	Alpha-thalassemia/impaired intellectual development syndrome, X-linked (ATRX) [MIM:301040]	A0A061HUQ5	190	P	S
P46100	LP/P	Alpha-thalassemia/impaired intellectual development syndrome, X-linked (ATRX) [MIM:301040]	A0A061HUQ5	194	V	I
P46100	LP/P	Alpha-thalassemia/impaired intellectual development syndrome, X-linked (ATRX) [MIM:301040]	A0A061HUQ5	219	Q	P
P46100	LP/P	Alpha-thalassemia/impaired intellectual development syndrome, X-linked (ATRX) [MIM:301040]	A0A061HUQ5	249	G	C
P46100	LP/P	Alpha-thalassemia/impaired intellectual development syndrome, X-linked (ATRX) [MIM:301040]	A0A061HUQ5	1552	V	F
P46100	LP/P	Alpha-thalassemia/impaired intellectual development syndrome, X-linked (ATRX) [MIM:301040]	A0A061HUQ5	1645	L	S
P46100	LP/P	Alpha-thalassemia/impaired intellectual development syndrome, X-linked (ATRX) [MIM:301040]	A0A061HUQ5	1713	P	S
P46100	LP/P	Alpha-thalassemia/impaired intellectual development syndrome, X-linked (ATRX) [MIM:301040]	A0A061HUQ5	1742	R	K
P46100	LP/P	Alpha-thalassemia/impaired intellectual development syndrome, X-linked (ATRX) [MIM:301040]	A0A061HUQ5	1847	Y	C
P46100	LP/P	Intellectual disability-hypotonic facies syndrome, X-linked, 1 (MRXHF1) [MIM:309580]	A0A061HUQ5	2050	I	T
P46100	LB/B	-	A0A061HUQ5	596	S	P
P46100	LB/B	-	A0A061HUQ5	740	E	G
P46100	LP/P	Alpha-thalassemia/impaired intellectual development syndrome, X-linked (ATRX) [MIM:301040]	A0A061HUQ5	1621	T	M
P46100	LB/B	-	A0A061HUQ5	929	E	Q
P46100	LP/P	Intellectual disability-hypotonic facies syndrome, X-linked, 1 (MRXHF1) [MIM:309580]	A0A061HUQ5	220	C	Y
P46100	LP/P	Intellectual disability-hypotonic facies syndrome, X-linked, 1 (MRXHF1) [MIM:309580]	A0A061HUQ5	409	L	S
P46100	LP/P	Intellectual disability-hypotonic facies syndrome, X-linked, 1 (MRXHF1) [MIM:309580]	A0A061HUQ5	2271	R	G
P46100	LB/B	-	A0A061HUQ5	545	Q	E
P54253	LB/B	-	A0A2K5D0Z9	209	H	Q
P54253	LB/B	-	A0A2K5D0Z9	753	P	S
P0C7T5	LB/B	-	A0A087XB80	313	S	P
Q99700	LB/B	-	E9QM77	107	L	V
Q99700	LB/B	-	E9QM77	248	S	N
P54252	LB/B	-	A0A2J8W4V6	212	V	M
Q5T6C5	LB/B	-	F6T5P7	495	P	S
Q13825	LP/P	3-methylglutaconic aciduria 1 (MGCA1) [MIM:250950]	F7ISD5	240	A	V
Q9NWT8	LB/B	-	G1TFB1	107	Q	H
Q96GD4	LB/B	-	S9XEU2	100	H	Q
Q96GD4	LB/B	-	S9XEU2	298	M	T
Q96GD4	LB/B	-	S9XEU2	52	A	V
Q96GD4	LB/B	-	S9XEU2	179	T	M
Q8WXX7	LB/B	-	A0A091W4Q1	303	A	S
O75366	LB/B	-	F1QQQ5	204	K	E
O75366	LP/P	Nephrotic syndrome 21 (NPHS21) [MIM:618594]	F1QQQ5	135	R	Q
O75366	LP/P	Nephrotic syndrome 21 (NPHS21) [MIM:618594]	F1QQQ5	425	L	M
Q8NBF6	LB/B	-	A0A084VH11	257	C	S
Q5T686	LB/B	-	A0A2U3ZPX8	41	A	G
P47901	LB/B	-	Q5MZ03	65	K	N
P47901	LB/B	-	Q5MZ03	191	G	R
P47901	LB/B	-	Q5MZ03	267	S	G
P47901	LB/B	-	Q5MZ03	364	R	H
P47901	LB/B	-	Q5MZ03	224	H	Q
Q9Y2T1	LB/B	-	A0A147AUL7	50	P	S
P30530	LB/B	-	H2UTI6	515	S	G
P30530	LB/B	-	H2UTI6	112	T	M
P30530	LB/B	-	H2UTI6	266	D	N
P61769	LP/P	Immunodeficiency 43 (IMD43) [MIM:241600]	A0A287B7B9	11	A	P
P61769	LP/P	Amyloidosis 8 (AMYL8) [MIM:105200]	A0A287B7B9	96	D	N
O75752	LB/B	-	S9W518	266	E	A
O75752	LB/B	-	S9W518	271	G	R
O75752	LB/B	-	S9W518	126	D	N
Q9Y2C3	LB/B	-	L9JDB8	85	M	T
Q9Y2C3	LB/B	-	L9JDB8	144	R	H
Q9Y2C3	LB/B	-	L9JDB8	27	S	R
Q9P2W7	LB/B	-	G3HW23	131	A	T
O94766	LP/P	Multiple joint dislocations, short stature, and craniofacial dysmorphism with or without congenital heart defects (JDSCD) [MIM:245600]	A0A2K6AXP6	277	R	Q
O94766	LP/P	Multiple joint dislocations, short stature, and craniofacial dysmorphism with or without congenital heart defects (JDSCD) [MIM:245600]	A0A2K6AXP6	140	P	L
Q9Y2A9	LB/B	-	D3ZC66	328	R	H
Q9Y2A9	LB/B	-	D3ZC66	317	I	F
Q9C0J1	LB/B	-	W5P3F5	6	P	A
Q9C0J1	LB/B	-	W5P3F5	83	S	T
Q9C0J1	LB/B	-	W5P3F5	87	L	P
Q8NFL0	LB/B	-	A0A1S3GPB9	233	V	I
Q6L9W6	LB/B	-	R0LNF4	59	G	S
Q6L9W6	LB/B	-	R0LNF4	265	R	Q
Q6L9W6	LB/B	-	R0LNF4	411	K	R
Q6L9W6	LB/B	-	R0LNF4	768	R	Q
Q6L9W6	LB/B	-	R0LNF4	992	R	H
Q76KP1	LB/B	-	A0A091D5P5	67	A	V
Q76KP1	LB/B	-	A0A091D5P5	88	G	V
P15291	LB/B	-	S9X2V0	21	R	W
P15291	LB/B	-	S9X2V0	257	H	R
O60909	LB/B	-	F6PK94	122	Q	H
O60909	LB/B	-	F6PK94	338	G	R
O60513	LB/B	-	A0A1Y3E903	116	Q	E
O43286	LB/B	-	A0A2R8MEY9	61	G	S
O43286	LB/B	-	A0A2R8MEY9	371	Y	D
O43286	LB/B	-	A0A2R8MEY9	368	D	N
Q9UBX8	LB/B	-	G3UDN7	379	I	V
Q9UBV7	LP/P	Ehlers-Danlos syndrome, spondylodysplastic type, 1 (EDSSPD1) [MIM:130070]	A0A2R9CS16	186	A	D
Q9UBV7	LP/P	Ehlers-Danlos syndrome, spondylodysplastic type, 1 (EDSSPD1) [MIM:130070]	A0A2R9CS16	206	L	P
O43505	LB/B	-	T0NQ84	253	T	S
O43505	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A13 (MDDGA13) [MIM:615287]	T0NQ84	390	N	D
O43505	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A13 (MDDGA13) [MIM:615287]	T0NQ84	406	A	V
Q9UPM9	LB/B	-	T1G780	61	R	W
Q9UPM9	LB/B	-	T1G780	51	S	P
Q9UPM9	LP/P	Joubert syndrome 27 (JBTS27) [MIM:617120]	T1G780	32	Y	C
Q9UPM9	LP/P	Joubert syndrome 27 (JBTS27) [MIM:617120]	T1G780	156	R	Q
Q9BPU9	LP/P	Meckel syndrome 10 (MKS10) [MIM:614175]	L8Y6Y6	101	S	R
Q9BPU9	LB/B	-	L8Y6Y6	11	I	M
Q8WXS3	LB/B	-	A0A1L8FTP0	129	S	T
Q14032	LP/P	Bile acid conjugation defect 1 (BACD1) [MIM:619232]	H0V8L4	76	M	V
Q14032	LB/B	-	H0V8L4	20	R	Q
P56817	LB/B	-	L8YFG8	481	R	C
P56817	LB/B	-	L8YFG8	265	V	A
O14867	LB/B	-	F6W359	314	S	P
Q9BYV9	LB/B	-	A0A2K6D2I5	418	A	T
Q9BYV9	LP/P	Immunodeficiency 60 and autoimmunity (IMD60) [MIM:618394]	A0A2K6D2I5	24	L	P
Q92934	LB/B	-	L8IPQ0	107	A	S
O95817	LB/B	-	A0A0Q3USJ5	71	R	Q
O95817	LB/B	-	A0A0Q3USJ5	151	C	R
O95817	LB/B	-	A0A0Q3USJ5	405	A	V
O95817	LB/B	-	A0A0Q3USJ5	407	P	L
O95817	LP/P	Myopathy, myofibrillar, 6 (MFM6) [MIM:612954]	A0A0Q3USJ5	209	P	L
O95817	LP/P	Cardiomyopathy, dilated 1HH (CMD1HH) [MIM:613881]	A0A0Q3USJ5	71	R	W
O95817	LP/P	Cardiomyopathy, dilated 1HH (CMD1HH) [MIM:613881]	A0A0Q3USJ5	477	R	H
O95817	LB/B	-	A0A0Q3USJ5	77	P	L
O95817	LB/B	-	A0A0Q3USJ5	94	I	F
O95817	LB/B	-	A0A0Q3USJ5	115	P	S
O95817	LB/B	-	A0A0Q3USJ5	155	A	T
O95817	LP/P	Cardiomyopathy, dilated 1HH (CMD1HH) [MIM:613881]	A0A0Q3USJ5	218	R	W
O95817	LB/B	-	A0A0Q3USJ5	258	R	W
O95817	LB/B	-	A0A0Q3USJ5	300	D	N
O95817	LB/B	-	A0A0Q3USJ5	380	P	S
O95817	LP/P	Cardiomyopathy, dilated 1HH (CMD1HH) [MIM:613881]	A0A0Q3USJ5	455	E	K
O95817	LP/P	Cardiomyopathy, dilated 1HH (CMD1HH) [MIM:613881]	A0A0Q3USJ5	462	L	P
O95817	LP/P	Cardiomyopathy, dilated 1HH (CMD1HH) [MIM:613881]	A0A0Q3USJ5	468	V	M
O95817	LB/B	-	A0A0Q3USJ5	553	E	D
Q9UL15	LB/B	-	A0A099ZRJ6	157	C	W
Q86Y30	LB/B	-	Q86Y30	95	R	T
Q86Y30	LB/B	-	Q86Y30	106	R	Q
Q86Y29	LB/B	-	Q86Y30	95	R	T
Q86Y29	LB/B	-	Q86Y30	106	Q	R
Q8TBE0	LB/B	-	W5NBZ9	26	E	G
Q8TBE0	LB/B	-	W5NBZ9	182	D	H
Q8TBE0	LB/B	-	W5NBZ9	298	Q	K
O94812	LB/B	-	S9XLI9	582	D	A
O94812	LB/B	-	S9XLI9	879	S	I
Q16611	LB/B	-	A0A1S3GNV3	28	A	V
Q16611	LB/B	-	A0A1S3GNV3	69	S	R
Q16611	LB/B	-	A0A1S3GNV3	42	R	H
Q9H503	LB/B	-	A0A146ZBL7	78	T	S
Q9H503	LB/B	-	A0A146ZBL7	3	N	D
Q8NDB2	LB/B	-	W5PV80	61	R	H
Q8NDB2	LB/B	-	W5PV80	383	A	T
Q8NDB2	LB/B	-	W5PV80	650	C	R
Q92560	LB/B	-	A0A146NV16	616	V	E
Q92560	LB/B	-	A0A146NV16	63	S	C
Q92560	LB/B	-	A0A146NV16	315	E	A
Q92560	LP/P	Kury-Isidor syndrome (KURIS) [MIM:619762]	A0A146NV16	12	P	A
Q92560	LP/P	Kury-Isidor syndrome (KURIS) [MIM:619762]	A0A146NV16	12	P	T
Q92560	LP/P	Kury-Isidor syndrome (KURIS) [MIM:619762]	A0A146NV16	91	C	G
Q92560	LP/P	Kury-Isidor syndrome (KURIS) [MIM:619762]	A0A146NV16	91	C	R
Q92560	LP/P	Kury-Isidor syndrome (KURIS) [MIM:619762]	A0A146NV16	91	C	S
Q92560	LP/P	Kury-Isidor syndrome (KURIS) [MIM:619762]	A0A146NV16	169	H	R
Q92560	LP/P	Tumor predisposition syndrome 1 (TPDS1) [MIM:614327]	A0A146NV16	93	T	A
Q99728	LB/B	-	A0A091HNV6	24	P	S
Q99728	LB/B	-	A0A091HNV6	153	K	E
Q99728	LB/B	-	A0A091HNV6	507	V	M
Q99728	LB/B	-	A0A091HNV6	557	C	S
Q99728	LB/B	-	A0A091HNV6	658	R	C
Q99728	LB/B	-	A0A091HNV6	241	S	C
Q99728	LB/B	-	A0A091HNV6	378	R	S
Q99728	LB/B	-	A0A091HNV6	728	S	F
Q99728	LB/B	-	A0A091HNV6	186	S	G
Q99728	LB/B	-	A0A091HNV6	645	C	R
Q9HBU1	LB/B	-	G1S3S6	48	A	T
P80723	LB/B	-	A0A2Y9K4V9	76	A	V
Q8N1L9	LB/B	-	Q8R1H8	6	G	S
Q9NR55	LB/B	-	G1L3F1	11	V	I
Q9NRL2	LB/B	-	G3NJG6	344	D	E
Q9NRL2	LB/B	-	G3NJG6	1366	N	K
Q9UIF8	LB/B	-	A0A2U4ABB2	71	M	T
Q9UIF8	LB/B	-	A0A2U4ABB2	422	L	S
Q9UIF8	LB/B	-	A0A2U4ABB2	530	P	L
Q9UIF8	LB/B	-	A0A2U4ABB2	702	G	V
Q9UIF8	LB/B	-	A0A2U4ABB2	2024	S	N
Q8ND07	LB/B	-	A0A1U8D007	496	K	E
Q8ND07	LB/B	-	A0A1U8D007	58	R	Q
Q8ND07	LB/B	-	A0A1U8D007	183	R	K
Q8ND07	LB/B	-	A0A1U8D007	230	D	V
Q8NFJ9	LP/P	Bardet-Biedl syndrome 1 (BBS1) [MIM:209900]	A0A1S3I1L6	234	E	K
Q8NFJ9	LP/P	Bardet-Biedl syndrome 1 (BBS1) [MIM:209900]	A0A1S3I1L6	390	M	R
Q8NFJ9	LP/P	Bardet-Biedl syndrome 1 (BBS1) [MIM:209900]	A0A1S3I1L6	518	L	P
Q8NFJ9	LP/P	Bardet-Biedl syndrome 1 (BBS1) [MIM:209900]	A0A1S3I1L6	35	H	R
Q8NFJ9	LP/P	Bardet-Biedl syndrome 1 (BBS1) [MIM:209900]	A0A1S3I1L6	53	K	E
Q8NFJ9	LP/P	Bardet-Biedl syndrome 1 (BBS1) [MIM:209900]	A0A1S3I1L6	148	D	N
Q8NFJ9	LP/P	Bardet-Biedl syndrome 1 (BBS1) [MIM:209900]	A0A1S3I1L6	160	R	Q
Q8NFJ9	LP/P	Bardet-Biedl syndrome 1 (BBS1) [MIM:209900]	A0A1S3I1L6	305	G	S
Q8NFJ9	LP/P	Bardet-Biedl syndrome 1 (BBS1) [MIM:209900]	A0A1S3I1L6	434	Y	S
Q8NFJ9	LP/P	Bardet-Biedl syndrome 1 (BBS1) [MIM:209900]	A0A1S3I1L6	503	L	H
Q8NFJ9	LP/P	Bardet-Biedl syndrome 1 (BBS1) [MIM:209900]	A0A1S3I1L6	518	L	Q
Q8NFJ9	LB/B	-	A0A1S3I1L6	559	G	D
Q8NFJ9	LP/P	Bardet-Biedl syndrome 1 (BBS1) [MIM:209900]	A0A1S3I1L6	330	I	T
Q8NFJ9	LB/B	-	A0A1S3I1L6	206	L	V
Q8NFJ9	LB/B	-	A0A1S3I1L6	245	P	L
Q8TAM1	LP/P	Bardet-Biedl syndrome 10 (BBS10) [MIM:615987]	A0A0P7WKC5	34	R	P
Q8TAM1	LP/P	Bardet-Biedl syndrome 10 (BBS10) [MIM:615987]	A0A0P7WKC5	49	R	W
Q8TAM1	LP/P	Bardet-Biedl syndrome 10 (BBS10) [MIM:615987]	A0A0P7WKC5	91	C	W
Q8TAM1	LP/P	Bardet-Biedl syndrome 10 (BBS10) [MIM:615987]	A0A0P7WKC5	170	L	S
Q8TAM1	LP/P	Bardet-Biedl syndrome 10 (BBS10) [MIM:615987]	A0A0P7WKC5	195	C	W
Q8TAM1	LP/P	Bardet-Biedl syndrome 10 (BBS10) [MIM:615987]	A0A0P7WKC5	197	Y	C
Q8TAM1	LP/P	Bardet-Biedl syndrome 10 (BBS10) [MIM:615987]	A0A0P7WKC5	240	V	G
Q8TAM1	LP/P	Bardet-Biedl syndrome 10 (BBS10) [MIM:615987]	A0A0P7WKC5	308	L	F
Q8TAM1	LP/P	Bardet-Biedl syndrome 10 (BBS10) [MIM:615987]	A0A0P7WKC5	311	S	A
Q8TAM1	LP/P	Bardet-Biedl syndrome 10 (BBS10) [MIM:615987]	A0A0P7WKC5	329	S	L
Q8TAM1	LP/P	Bardet-Biedl syndrome 10 (BBS10) [MIM:615987]	A0A0P7WKC5	363	P	L
Q8TAM1	LB/B	-	A0A0P7WKC5	376	L	F
Q8TAM1	LP/P	Bardet-Biedl syndrome 10 (BBS10) [MIM:615987]	A0A0P7WKC5	414	L	S
Q8TAM1	LP/P	Bardet-Biedl syndrome 10 (BBS10) [MIM:615987]	A0A0P7WKC5	579	K	R
Q8TAM1	LP/P	Bardet-Biedl syndrome 10 (BBS10) [MIM:615987]	A0A0P7WKC5	613	Y	C
Q8TAM1	LP/P	Bardet-Biedl syndrome 10 (BBS10) [MIM:615987]	A0A0P7WKC5	613	Y	H
Q8TAM1	LP/P	Bardet-Biedl syndrome 10 (BBS10) [MIM:615987]	A0A0P7WKC5	677	G	V
Q8TAM1	LP/P	Bardet-Biedl syndrome 10 (BBS10) [MIM:615987]	A0A0P7WKC5	689	T	P
Q8TAM1	LB/B	-	A0A0P7WKC5	539	P	L
Q8TAM1	LP/P	Bardet-Biedl syndrome 10 (BBS10) [MIM:615987]	A0A0P7WKC5	55	L	P
Q8TAM1	LB/B	-	A0A0P7WKC5	142	D	N
Q8TAM1	LP/P	Bardet-Biedl syndrome 10 (BBS10) [MIM:615987]	A0A0P7WKC5	188	K	T
Q8TAM1	LP/P	Bardet-Biedl syndrome 10 (BBS10) [MIM:615987]	A0A0P7WKC5	410	H	Q
Q8TAM1	LP/P	Bardet-Biedl syndrome 10 (BBS10) [MIM:615987]	A0A0P7WKC5	600	L	S
Q8TAM1	LP/P	Bardet-Biedl syndrome 10 (BBS10) [MIM:615987]	A0A0P7WKC5	636	A	V
Q8TAM1	LP/P	Bardet-Biedl syndrome 10 (BBS10) [MIM:615987]	A0A0P7WKC5	687	L	P
Q8TAM1	LB/B	-	A0A0P7WKC5	715	H	R
Q8TAM1	LP/P	Bardet-Biedl syndrome 10 (BBS10) [MIM:615987]	A0A0P7WKC5	11	V	G
Q6ZW61	LB/B	-	F7E5E6	39	I	T
Q6ZW61	LB/B	-	F7E5E6	126	E	D
Q6ZW61	LB/B	-	F7E5E6	170	I	V
Q6ZW61	LB/B	-	F7E5E6	195	K	R
Q6ZW61	LB/B	-	F7E5E6	238	N	K
Q6ZW61	LP/P	Bardet-Biedl syndrome 12 (BBS12) [MIM:615989]	F7E5E6	289	A	P
Q6ZW61	LB/B	-	F7E5E6	386	R	Q
Q6ZW61	LB/B	-	F7E5E6	429	S	T
Q6ZW61	LB/B	-	F7E5E6	461	N	H
Q6ZW61	LB/B	-	F7E5E6	467	D	N
Q6ZW61	LB/B	-	F7E5E6	484	R	K
Q6ZW61	LP/P	Bardet-Biedl syndrome 12 (BBS12) [MIM:615989]	F7E5E6	540	G	V
Q6ZW61	LB/B	-	F7E5E6	615	A	V
Q6ZW61	LP/P	Bardet-Biedl syndrome 12 (BBS12) [MIM:615989]	F7E5E6	346	I	T
Q6ZW61	LP/P	Bardet-Biedl syndrome 12 (BBS12) [MIM:615989]	F7E5E6	501	T	M
Q6ZW61	LP/P	Bardet-Biedl syndrome 12 (BBS12) [MIM:615989]	F7E5E6	88	L	R
Q6ZW61	LB/B	-	F7E5E6	119	G	S
Q6ZW61	LB/B	-	F7E5E6	263	Y	H
Q6ZW61	LP/P	Bardet-Biedl syndrome 12 (BBS12) [MIM:615989]	F7E5E6	293	Q	E
Q6ZW61	LP/P	Bardet-Biedl syndrome 12 (BBS12) [MIM:615989]	F7E5E6	355	R	Q
Q6ZW61	LP/P	Bardet-Biedl syndrome 12 (BBS12) [MIM:615989]	F7E5E6	400	V	M
Q6ZW61	LP/P	Bardet-Biedl syndrome 12 (BBS12) [MIM:615989]	F7E5E6	539	G	D
Q6ZW61	LP/P	Bardet-Biedl syndrome 12 (BBS12) [MIM:615989]	F7E5E6	674	R	C
Q9BXC9	LB/B	-	U3IYU1	70	S	N
Q9BXC9	LP/P	Bardet-Biedl syndrome 2 (BBS2) [MIM:615981]	U3IYU1	75	V	G
Q9BXC9	LP/P	Bardet-Biedl syndrome 2 (BBS2) [MIM:615981]	U3IYU1	104	D	A
Q9BXC9	LP/P	Retinitis pigmentosa 74 (RP74) [MIM:616562]	U3IYU1	104	D	A
Q9BXC9	LB/B	-	U3IYU1	123	I	V
Q9BXC9	LP/P	Bardet-Biedl syndrome 2 (BBS2) [MIM:615981]	U3IYU1	315	R	Q
Q9BXC9	LP/P	Bardet-Biedl syndrome 2 (BBS2) [MIM:615981]	U3IYU1	315	R	W
Q9BXC9	LP/P	Bardet-Biedl syndrome 2 (BBS2) [MIM:615981]	U3IYU1	558	T	I
Q9BXC9	LP/P	Bardet-Biedl syndrome 2 (BBS2) [MIM:615981]	U3IYU1	632	R	P
Q9BXC9	LP/P	Retinitis pigmentosa 74 (RP74) [MIM:616562]	U3IYU1	632	R	P
Q9BXC9	LB/B	-	U3IYU1	122	A	V
Q9BXC9	LB/B	-	U3IYU1	504	A	V
Q9BXC9	LP/P	Bardet-Biedl syndrome 2 (BBS2) [MIM:615981]	U3IYU1	23	R	P
Q9BXC9	LP/P	Bardet-Biedl syndrome 2 (BBS2) [MIM:615981]	U3IYU1	174	D	E
Q9BXC9	LP/P	Bardet-Biedl syndrome 2 (BBS2) [MIM:615981]	U3IYU1	349	L	W
Q9BXC9	LP/P	Bardet-Biedl syndrome 2 (BBS2) [MIM:615981]	U3IYU1	643	R	H
Q9BXC9	LP/P	Bardet-Biedl syndrome 2 (BBS2) [MIM:615981]	U3IYU1	81	G	C
Q9BXC9	LP/P	Bardet-Biedl syndrome 2 (BBS2) [MIM:615981]	U3IYU1	125	L	R
Q9BXC9	LP/P	Bardet-Biedl syndrome 2 (BBS2) [MIM:615981]	U3IYU1	136	A	P
Q9BXC9	LP/P	Bardet-Biedl syndrome 2 (BBS2) [MIM:615981]	U3IYU1	307	C	W
Q9BXC9	LP/P	Bardet-Biedl syndrome 2 (BBS2) [MIM:615981]	U3IYU1	317	Y	C
Q9BXC9	LB/B	-	U3IYU1	629	E	K
Q9BXC9	LP/P	Retinitis pigmentosa 74 (RP74) [MIM:616562]	U3IYU1	33	A	D
Q9BXC9	LP/P	Retinitis pigmentosa 74 (RP74) [MIM:616562]	U3IYU1	134	P	R
Q9BXC9	LP/P	Bardet-Biedl syndrome 2 (BBS2) [MIM:615981]	U3IYU1	139	G	V
Q96RK4	LP/P	Bardet-Biedl syndrome 4 (BBS4) [MIM:615982]	A0A287AKX1	295	R	P
Q96RK4	LP/P	Bardet-Biedl syndrome 4 (BBS4) [MIM:615982]	A0A287AKX1	165	N	H
Q96RK4	LP/P	Bardet-Biedl syndrome 4 (BBS4) [MIM:615982]	A0A287AKX1	327	L	P
Q96RK4	LP/P	Bardet-Biedl syndrome 4 (BBS4) [MIM:615982]	A0A287AKX1	364	A	E
Q96RK4	LP/P	Bardet-Biedl syndrome 4 (BBS4) [MIM:615982]	A0A287AKX1	457	S	I
Q96RK4	LP/P	Bardet-Biedl syndrome 4 (BBS4) [MIM:615982]	A0A287AKX1	472	M	V
Q96RK4	LB/B	-	A0A287AKX1	354	I	T
Q96RK4	LB/B	-	A0A287AKX1	268	E	K
Q96RK4	LB/B	-	A0A287AKX1	393	A	V
Q96RK4	LB/B	-	A0A287AKX1	46	K	R
Q96RK4	LP/P	Bardet-Biedl syndrome 4 (BBS4) [MIM:615982]	A0A287AKX1	351	L	R
Q96RK4	LP/P	Bardet-Biedl syndrome 4 (BBS4) [MIM:615982]	A0A287AKX1	368	D	G
Q96RK4	LP/P	Bardet-Biedl syndrome 4 (BBS4) [MIM:615982]	A0A287AKX1	503	P	L
Q96RK4	LB/B	-	A0A287AKX1	61	E	K
Q96RK4	LB/B	-	A0A287AKX1	412	E	D
Q96RK4	LB/B	-	A0A287AKX1	488	T	K
Q8WY36	LB/B	-	A0A2H6N548	576	P	S
Q96GW7	LB/B	-	G1Q3N1	504	E	K
Q96GW7	LB/B	-	G1Q3N1	356	S	L
P56945	LB/B	-	A0A147ARX0	491	R	L
P56945	LB/B	-	A0A147ARX0	558	H	R
P56945	LB/B	-	A0A147ARX0	76	P	S
O75815	LB/B	-	G1KE33	464	E	G
O75815	LB/B	-	G1KE33	593	Q	H
O75363	LB/B	-	A0A1U8CXC6	255	G	E
O75363	LB/B	-	A0A1U8CXC6	24	Q	K
O75363	LB/B	-	A0A1U8CXC6	163	V	A
O75363	LB/B	-	A0A1U8CXC6	583	S	P
O75363	LB/B	-	A0A1U8CXC6	472	Q	H
P54687	LB/B	-	G1SKT0	321	E	K
P54687	LB/B	-	G1SKT0	59	T	M
P54687	LB/B	-	G1SKT0	330	G	S
O15382	LB/B	-	A9JS68	186	T	R
O15382	LP/P	Hypervalinemia and hyperleucine-isoleucinemia (HVLI) [MIM:618850]	A9JS68	170	R	Q
O15382	LP/P	Hypervalinemia and hyperleucine-isoleucinemia (HVLI) [MIM:618850]	A9JS68	264	E	K
Q9P287	LB/B	-	K7JA50	254	E	Q
Q7Z5W3	LB/B	-	A0A1S3A332	288	S	R
P06276	LP/P	Butyrylcholinesterase deficiency (BCHED) [MIM:617936]	A0A1S2ZS42	98	D	G
P06276	LP/P	Butyrylcholinesterase deficiency (BCHED) [MIM:617936]	A0A1S2ZS42	358	L	I
P06276	LP/P	Butyrylcholinesterase deficiency (BCHED) [MIM:617936]	A0A1S2ZS42	567	A	T
P06276	LP/P	Butyrylcholinesterase deficiency (BCHED) [MIM:617936]	A0A1S2ZS42	52	T	M
P06276	LP/P	Butyrylcholinesterase deficiency (BCHED) [MIM:617936]	A0A1S2ZS42	56	F	I
P06276	LP/P	Butyrylcholinesterase deficiency (BCHED) [MIM:617936]	A0A1S2ZS42	61	Y	C
P06276	LP/P	Butyrylcholinesterase deficiency (BCHED) [MIM:617936]	A0A1S2ZS42	65	P	S
P06276	LP/P	Butyrylcholinesterase deficiency (BCHED) [MIM:617936]	A0A1S2ZS42	98	D	H
P06276	LP/P	Butyrylcholinesterase deficiency (BCHED) [MIM:617936]	A0A1S2ZS42	124	N	Y
P06276	LP/P	Butyrylcholinesterase deficiency (BCHED) [MIM:617936]	A0A1S2ZS42	128	P	S
P06276	LP/P	Butyrylcholinesterase deficiency (BCHED) [MIM:617936]	A0A1S2ZS42	143	G	D
P06276	LP/P	Butyrylcholinesterase deficiency (BCHED) [MIM:617936]	A0A1S2ZS42	153	L	F
P06276	LP/P	Butyrylcholinesterase deficiency (BCHED) [MIM:617936]	A0A1S2ZS42	156	Y	C
P06276	LP/P	Butyrylcholinesterase deficiency (BCHED) [MIM:617936]	A0A1S2ZS42	170	V	M
P06276	LP/P	Butyrylcholinesterase deficiency (BCHED) [MIM:617936]	A0A1S2ZS42	198	D	E
P06276	LP/P	Butyrylcholinesterase deficiency (BCHED) [MIM:617936]	A0A1S2ZS42	226	S	G
P06276	LP/P	Butyrylcholinesterase deficiency (BCHED) [MIM:617936]	A0A1S2ZS42	227	A	V
P06276	LP/P	Butyrylcholinesterase deficiency (BCHED) [MIM:617936]	A0A1S2ZS42	229	A	T
P06276	LP/P	Butyrylcholinesterase deficiency (BCHED) [MIM:617936]	A0A1S2ZS42	271	T	M
P06276	LP/P	Butyrylcholinesterase deficiency (BCHED) [MIM:617936]	A0A1S2ZS42	278	T	P
P06276	LB/B	-	A0A1S2ZS42	283	E	D
P06276	LP/P	Butyrylcholinesterase deficiency (BCHED) [MIM:617936]	A0A1S2ZS42	295	K	R
P06276	LP/P	Butyrylcholinesterase deficiency (BCHED) [MIM:617936]	A0A1S2ZS42	335	L	P
P06276	LP/P	Butyrylcholinesterase deficiency (BCHED) [MIM:617936]	A0A1S2ZS42	356	A	D
P06276	LP/P	Butyrylcholinesterase deficiency (BCHED) [MIM:617936]	A0A1S2ZS42	393	G	R
P06276	LP/P	Butyrylcholinesterase deficiency (BCHED) [MIM:617936]	A0A1S2ZS42	414	R	C
P06276	LP/P	Butyrylcholinesterase deficiency (BCHED) [MIM:617936]	A0A1S2ZS42	418	G	V
P06276	LP/P	Butyrylcholinesterase deficiency (BCHED) [MIM:617936]	A0A1S2ZS42	446	F	S
P06276	LP/P	Butyrylcholinesterase deficiency (BCHED) [MIM:617936]	A0A1S2ZS42	488	E	K
P06276	LP/P	Butyrylcholinesterase deficiency (BCHED) [MIM:617936]	A0A1S2ZS42	499	W	R
P06276	LP/P	Butyrylcholinesterase deficiency (BCHED) [MIM:617936]	A0A1S2ZS42	502	F	L
P06276	LP/P	Butyrylcholinesterase deficiency (BCHED) [MIM:617936]	A0A1S2ZS42	525	E	V
P06276	LP/P	Butyrylcholinesterase deficiency (BCHED) [MIM:617936]	A0A1S2ZS42	543	R	C
P06276	LP/P	Butyrylcholinesterase deficiency (BCHED) [MIM:617936]	A0A1S2ZS42	546	Q	L
P06276	LB/B	-	A0A1S2ZS42	40	K	R
P06276	LP/P	Butyrylcholinesterase deficiency (BCHED) [MIM:617936]	A0A1S2ZS42	103	G	R
P06276	LP/P	Butyrylcholinesterase deficiency (BCHED) [MIM:617936]	A0A1S2ZS42	118	E	D
P06276	LB/B	-	A0A1S2ZS42	127	I	M
P06276	LP/P	Butyrylcholinesterase deficiency (BCHED) [MIM:617936]	A0A1S2ZS42	232	V	D
P06276	LB/B	-	A0A1S2ZS42	322	V	M
P06276	LP/P	Butyrylcholinesterase deficiency (BCHED) [MIM:617936]	A0A1S2ZS42	361	G	C
P06276	LB/B	-	A0A1S2ZS42	498	R	W
P06276	LP/P	Butyrylcholinesterase deficiency (BCHED) [MIM:617936]	A0A1S2ZS42	62	A	V
P12694	LP/P	Maple syrup urine disease 1A (MSUD1A) [MIM:248600]	E2RPW4	159	R	W
P12694	LP/P	Maple syrup urine disease 1A (MSUD1A) [MIM:248600]	E2RPW4	190	Q	K
P12694	LP/P	Maple syrup urine disease 1A (MSUD1A) [MIM:248600]	E2RPW4	253	A	T
P12694	LP/P	Maple syrup urine disease 1A (MSUD1A) [MIM:248600]	E2RPW4	326	I	T
P12694	LP/P	Maple syrup urine disease 1A (MSUD1A) [MIM:248600]	E2RPW4	413	Y	C
P12694	LP/P	Maple syrup urine disease 1A (MSUD1A) [MIM:248600]	E2RPW4	438	Y	N
P12694	LP/P	Maple syrup urine disease 1A (MSUD1A) [MIM:248600]	E2RPW4	290	G	R
P12694	LP/P	Maple syrup urine disease 1A (MSUD1A) [MIM:248600]	E2RPW4	409	F	C
P12694	LB/B	-	E2RPW4	39	P	H
P12694	LB/B	-	E2RPW4	151	T	M
P12694	LP/P	Maple syrup urine disease 1A (MSUD1A) [MIM:248600]	E2RPW4	211	T	M
P12694	LP/P	Maple syrup urine disease 1A (MSUD1A) [MIM:248600]	E2RPW4	220	A	V
P12694	LP/P	Maple syrup urine disease 1A (MSUD1A) [MIM:248600]	E2RPW4	346	R	C
P21953	LP/P	Maple syrup urine disease 1B (MSUD1B) [MIM:248600]	L5JMG3	206	H	R
P21953	LP/P	Maple syrup urine disease 1B (MSUD1B) [MIM:248600]	L5JMG3	183	R	P
P21953	LP/P	Maple syrup urine disease 1B (MSUD1B) [MIM:248600]	L5JMG3	278	G	S
P21953	LB/B	-	L5JMG3	41	T	I
P21953	LP/P	Maple syrup urine disease 1B (MSUD1B) [MIM:248600]	L5JMG3	170	R	H
P21953	LP/P	Maple syrup urine disease 1B (MSUD1B) [MIM:248600]	L5JMG3	346	Q	R
O14874	LP/P	Branched-chain ketoacid dehydrogenase kinase deficiency (BCKDKD) [MIM:614923]	W5PFM0	224	R	P
O14874	LP/P	Branched-chain ketoacid dehydrogenase kinase deficiency (BCKDKD) [MIM:614923]	W5PFM0	174	R	G
O14874	LP/P	Branched-chain ketoacid dehydrogenase kinase deficiency (BCKDKD) [MIM:614923]	W5PFM0	389	L	P
O95999	LB/B	-	A0A2K5S741	45	K	Q
O95999	LB/B	-	A0A2K5S741	58	R	Q
O95999	LB/B	-	A0A2K5S741	93	N	S
O95999	LB/B	-	A0A2K5S741	153	M	V
O95999	LB/B	-	A0A2K5S741	162	T	M
Q9H165	LP/P	Intellectual developmental disorder with persistence of fetal hemoglobin (IDPFH) [MIM:617101]	W5LFR4	47	T	P
Q9H165	LP/P	Intellectual developmental disorder with persistence of fetal hemoglobin (IDPFH) [MIM:617101]	W5LFR4	48	C	F
Q9H165	LP/P	Intellectual developmental disorder with persistence of fetal hemoglobin (IDPFH) [MIM:617101]	W5LFR4	66	H	Q
Q9C0K0	LB/B	-	W5LFR4	229	P	S
Q9C0K0	LP/P	Immunodeficiency 49 (IMD49) [MIM:617237]	W5LFR4	441	N	K
Q9C0K0	LP/P	Immunodeficiency 49 (IMD49) [MIM:617237]	W5LFR4	807	N	K
Q16548	LB/B	-	G3T8E6	19	C	Y
Q16548	LB/B	-	G3T8E6	39	N	K
Q16548	LB/B	-	G3T8E6	82	G	D
Q16548	LB/B	-	G3T8E6	117	E	D
Q9HD36	LB/B	-	A0A2U3XPI4	21	L	R
Q9HB09	LB/B	-	A0A2K5IYR0	47	G	V
Q9BXK5	LB/B	-	G3S1J2	55	I	V
Q9BXK5	LB/B	-	G3S1J2	360	P	S
Q9BXK5	LB/B	-	G3S1J2	46	I	R
Q9BXK5	LB/B	-	G3S1J2	46	I	T
Q5TBC7	LB/B	-	A0A091PMC0	90	D	N
P41182	LB/B	-	A0A146XBE5	676	H	Y
P41182	LB/B	-	A0A146XBE5	493	A	T
P41182	LB/B	-	A0A146XBE5	252	N	S
O00512	LB/B	-	A0A151P231	671	P	S
O00512	LB/B	-	A0A151P231	782	R	K
Q9NYF8	LB/B	-	W5M529	209	S	C
Q9NYF8	LB/B	-	W5M529	459	Y	D
Q9NYF8	LB/B	-	W5M529	461	L	H
Q9NYF8	LB/B	-	W5M529	629	N	S
Q9NYF8	LB/B	-	W5M529	875	R	C
Q9NYF8	LB/B	-	W5M529	66	G	A
Q9BYV7	LB/B	-	A0A151NFX9	231	L	P
Q9BYV7	LB/B	-	A0A151NFX9	289	G	E
Q9BYV7	LB/B	-	A0A151NFX9	548	I	L
Q6W2J9	LP/P	Microphthalmia, syndromic, 2 (MCOPS2) [MIM:300166]	H9A532	85	P	L
Q5H9F3	LB/B	-	H0XX72	209	G	S
Q5H9F3	LB/B	-	H0XX72	111	L	F
P11274	LB/B	-	A0A2X0SFQ7	796	N	S
P11274	LB/B	-	A0A2X0SFQ7	1037	E	K
P11274	LB/B	-	A0A2X0SFQ7	1127	T	M
P11274	LB/B	-	A0A2X0SFQ7	413	I	M
P11274	LB/B	-	A0A2X0SFQ7	752	D	E
P11274	LB/B	-	A0A2X0SFQ7	910	Y	C
P11274	LB/B	-	A0A2X0SFQ7	949	V	I
P11274	LB/B	-	A0A2X0SFQ7	1091	V	M
P11274	LB/B	-	A0A2X0SFQ7	1096	T	A
P11274	LB/B	-	A0A2X0SFQ7	1104	A	G
P11274	LB/B	-	A0A2X0SFQ7	1106	D	N
P11274	LB/B	-	A0A2X0SFQ7	1149	A	T
P11274	LB/B	-	A0A2X0SFQ7	1161	E	K
P11274	LB/B	-	A0A2X0SFQ7	1187	K	E
P11274	LB/B	-	A0A2X0SFQ7	1189	V	M
P11274	LB/B	-	A0A2X0SFQ7	1204	A	G
P11274	LB/B	-	A0A2X0SFQ7	1235	W	R
P11274	LB/B	-	A0A2X0SFQ7	558	K	T
Q9Y276	LP/P	GRACILE syndrome (GRACILE) [MIM:603358]	S9WTA2	78	S	G
Q9Y276	LP/P	Mitochondrial complex III deficiency, nuclear type 1 (MC3DN1) [MIM:124000]	S9WTA2	99	P	L
Q9Y276	LP/P	GRACILE syndrome (GRACILE) [MIM:603358]	S9WTA2	144	R	Q
Q9Y276	LP/P	Mitochondrial complex III deficiency, nuclear type 1 (MC3DN1) [MIM:124000]	S9WTA2	155	R	P
Q9Y276	LP/P	Mitochondrial complex III deficiency, nuclear type 1 (MC3DN1) [MIM:124000]	S9WTA2	277	S	N
Q9Y276	LP/P	GRACILE syndrome (GRACILE) [MIM:603358]	S9WTA2	327	V	A
Q9Y276	LP/P	Mitochondrial complex III deficiency, nuclear type 1 (MC3DN1) [MIM:124000]	S9WTA2	353	V	M
Q9Y276	LP/P	Bjoernstad syndrome (BJS) [MIM:262000]	S9WTA2	35	G	R
Q9Y276	LP/P	Mitochondrial complex III deficiency, nuclear type 1 (MC3DN1) [MIM:124000]	S9WTA2	45	R	C
Q9Y276	LP/P	Bjoernstad syndrome (BJS) [MIM:262000]	S9WTA2	114	R	W
Q9Y276	LP/P	Bjoernstad syndrome (BJS) [MIM:262000]	S9WTA2	183	R	H
Q9Y276	LP/P	Bjoernstad syndrome (BJS) [MIM:262000]	S9WTA2	184	R	C
Q9Y276	LP/P	Mitochondrial complex III deficiency, nuclear type 1 (MC3DN1) [MIM:124000]	S9WTA2	184	R	C
Q9Y276	LP/P	Bjoernstad syndrome (BJS) [MIM:262000]	S9WTA2	302	Q	E
Q9Y276	LP/P	Bjoernstad syndrome (BJS) [MIM:262000]	S9WTA2	306	R	H
Q9Y276	LP/P	Mitochondrial complex III deficiency, nuclear type 1 (MC3DN1) [MIM:124000]	S9WTA2	50	T	A
Q9Y276	LP/P	Mitochondrial complex III deficiency, nuclear type 1 (MC3DN1) [MIM:124000]	S9WTA2	73	R	C
Q9Y276	LP/P	Mitochondrial complex III deficiency, nuclear type 1 (MC3DN1) [MIM:124000]	S9WTA2	183	R	C
Q9Y276	LP/P	Mitochondrial complex III deficiency, nuclear type 1 (MC3DN1) [MIM:124000]	S9WTA2	368	F	I
Q9Y276	LP/P	Mitochondrial complex III deficiency, nuclear type 1 (MC3DN1) [MIM:124000]	S9WTA2	129	G	R
Q9Y276	LP/P	Bjoernstad syndrome (BJS) [MIM:262000]	S9WTA2	301	Y	N
Q9BUT1	LB/B	-	A0A1F4F7G3	70	N	S
P46663	LB/B	-	A0A1L8F9L7	250	A	V
P46663	LB/B	-	A0A1L8F9L7	317	R	Q
P30411	LB/B	-	I3LMT9	14	R	C
P30411	LB/B	-	I3LMT9	354	G	E
P23560	LB/B	-	S7N7A0	66	V	M
P23560	LB/B	-	S7N7A0	75	Q	H
P23560	LB/B	-	S7N7A0	125	R	M
P23560	LB/B	-	S7N7A0	127	R	L
A6H8Y1	LB/B	-	G1L9I5	38	D	E
A6H8Y1	LB/B	-	G1L9I5	757	R	C
A6H8Y1	LB/B	-	G1L9I5	778	V	M
A6H8Y1	LB/B	-	G1L9I5	1264	I	M
A6H8Y1	LB/B	-	G1L9I5	1347	V	M
A6H8Y1	LB/B	-	G1L9I5	1469	K	E
A6H8Y1	LB/B	-	G1L9I5	2013	I	L
A6H8Y1	LB/B	-	G1L9I5	26	N	S
A6H8Y1	LB/B	-	G1L9I5	125	A	V
A6H8Y1	LB/B	-	G1L9I5	722	K	E
A6H8Y1	LB/B	-	G1L9I5	1180	G	S
A6H8Y1	LB/B	-	G1L9I5	1244	F	I
A6H8Y1	LB/B	-	G1L9I5	1676	Q	E
A6H8Y1	LB/B	-	G1L9I5	2555	N	S
Q14457	LB/B	-	A0A2P4TA77	403	I	T
Q14457	LB/B	-	A0A2P4TA77	103	A	V
Q8NDZ0	LB/B	-	A0A2K5R0Z7	154	F	L
Q8NDZ0	LB/B	-	A0A2K5R0Z7	188	S	F
Q8N7W2	LB/B	-	A0A2K6KWX8	341	N	S
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	6	T	P
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	9	V	A
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	9	V	M
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	10	A	T
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	21	L	V
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	24	W	C
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	25	R	Q
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	25	R	W
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	27	S	R
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	58	Q	L
O76090	LB/B	-	G3RQQ6	67	L	V
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	85	Y	H
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	92	R	S
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	93	W	C
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	99	N	K
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	100	L	R
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	104	D	E
O76090	LP/P	Bestrophinopathy, autosomal recessive (ARB) [MIM:611809]	G3RQQ6	141	R	H
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	141	R	H
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	209	S	N
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	218	R	C
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	218	R	Q
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	218	R	S
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	224	L	M
O76090	LP/P	Retinitis pigmentosa 50 (RP50) [MIM:613194]	G3RQQ6	227	Y	C
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	227	Y	N
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	231	S	R
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	235	V	M
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	237	T	R
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	243	A	V
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	297	P	A
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	299	G	E
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	300	E	K
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	301	D	E
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	301	D	N
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	305	F	S
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	310	I	T
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	311	V	G
O76090	LP/P	Bestrophinopathy, autosomal recessive (ARB) [MIM:611809]	G3RQQ6	312	D	N
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	312	D	N
O76090	LB/B	-	G3RQQ6	578	E	V
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	10	A	V
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	13	R	H
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	16	S	F
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	17	F	C
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	73	I	N
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	82	L	V
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	92	R	C
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	92	R	H
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	96	Q	H
O76090	LB/B	-	G3RQQ6	119	E	Q
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	135	G	S
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	146	A	K
O76090	LB/B	-	G3RQQ6	216	T	I
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	218	R	H
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	235	V	L
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	293	Q	K
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	296	N	S
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	297	P	S
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	300	E	D
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	307	T	I
O76090	LB/B	-	G3RQQ6	525	E	A
O76090	LB/B	-	G3RQQ6	557	E	K
O76090	LB/B	-	G3RQQ6	561	T	A
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	6	T	R
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	11	N	I
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	26	G	R
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	29	Y	H
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	30	K	R
O76090	LP/P	Bestrophinopathy, autosomal recessive (ARB) [MIM:611809]	G3RQQ6	41	L	P
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	41	L	P
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	47	R	H
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	80	F	L
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	89	V	A
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	91	T	I
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	101	P	T
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	102	W	R
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	104	D	H
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	133	N	K
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	140	L	R
O76090	LP/P	Bestrophinopathy, autosomal recessive (ARB) [MIM:611809]	G3RQQ6	195	A	V
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	195	A	V
O76090	LB/B	-	G3RQQ6	105	R	C
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	113	F	L
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	201	I	T
O76090	LB/B	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	207	L	I
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	221	C	W
O76090	LB/B	-	G3RQQ6	222	G	V
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	224	L	P
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	241	T	N
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	243	A	T
O76090	LB/B	-	G3RQQ6	275	V	I
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	276	F	L
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	294	L	V
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	295	I	T
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	296	N	H
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	298	F	S
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	302	D	G
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	302	D	H
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	302	D	V
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	303	D	E
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	306	E	D
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	306	E	G
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	307	T	A
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	308	N	S
O76090	LP/P	Bestrophinopathy, autosomal recessive (ARB) [MIM:611809]	G3RQQ6	152	P	A
O76090	LP/P	Bestrophinopathy, autosomal recessive (ARB) [MIM:611809]	G3RQQ6	317	V	M
O76090	LP/P	Bestrophinopathy, autosomal recessive (ARB) [MIM:611809]	G3RQQ6	325	M	T
O76090	LB/B	-	G3RQQ6	357	A	V
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	3	I	T
O76090	LP/P	Vitreoretinochoroidopathy (VRCP) [MIM:193220]	G3RQQ6	86	V	M
O76090	LP/P	Vitreoretinochoroidopathy (VRCP) [MIM:193220]	G3RQQ6	236	Y	C
O76090	LP/P	Vitreoretinochoroidopathy (VRCP) [MIM:193220]	G3RQQ6	239	V	M
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	242	V	M
O76090	LP/P	Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]	G3RQQ6	299	G	A
O76090	LP/P	Bestrophinopathy, autosomal recessive (ARB) [MIM:611809]	G3RQQ6	140	L	V
O76090	LP/P	Retinitis pigmentosa 50 (RP50) [MIM:613194]	G3RQQ6	140	L	V
O76090	LP/P	Retinitis pigmentosa 50 (RP50) [MIM:613194]	G3RQQ6	205	I	T
O76090	LP/P	Retinitis pigmentosa 50 (RP50) [MIM:613194]	G3RQQ6	228	D	N
O76090	LP/P	Bestrophinopathy, autosomal recessive (ARB) [MIM:611809]	G3RQQ6	202	R	W
Q9HBH7	LB/B	-	A0A2K5CT53	40	A	V
Q9HBH7	LB/B	-	A0A2K5CT53	66	M	I
Q9HBH7	LB/B	-	A0A2K5CT53	9	V	L
Q9HBH7	LB/B	-	A0A2K5CT53	11	S	N
Q9HBH7	LB/B	-	A0A2K5CT53	13	S	I
Q9HBH7	LB/B	-	A0A2K5CT53	14	M	V
Q9HBH7	LB/B	-	A0A2K5CT53	17	A	V
Q9NZS9	LB/B	-	S7PKA4	140	M	R
Q9NZS9	LB/B	-	S7PKA4	245	R	H
Q13515	LP/P	Cataract 12, multiple types (CTRCT12) [MIM:611597]	L5M629	287	R	W
P02818	LB/B	-	A0A1S3GW65	94	R	Q
P21810	LP/P	Spondyloepimetaphyseal dysplasia, X-linked (SEMDX) [MIM:300106]	F7ESZ3	147	K	E
P21810	LP/P	Spondyloepimetaphyseal dysplasia, X-linked (SEMDX) [MIM:300106]	F7ESZ3	259	G	V
Q7RTU4	LP/P	Syndactyly, mesoaxial synostotic, with phalangeal reduction (MSSD) [MIM:609432]	A0A2Y9DKP5	71	N	D
Q7RTU4	LP/P	Syndactyly, mesoaxial synostotic, with phalangeal reduction (MSSD) [MIM:609432]	A0A2Y9DKP5	73	R	P
Q7RTU4	LP/P	Syndactyly, mesoaxial synostotic, with phalangeal reduction (MSSD) [MIM:609432]	A0A2Y9DKP5	75	R	L
Q8NFJ8	LB/B	-	G1TRN6	28	S	A
Q93088	LB/B	-	A0A1D5R1Z9	239	R	Q
Q93088	LB/B	-	A0A1D5R1Z9	199	G	S
Q9H694	LB/B	-	H9G5Q6	8	G	D
Q9H694	LB/B	-	H9G5Q6	943	S	P
Q9H694	LB/B	-	H9G5Q6	945	N	S
Q9H694	LB/B	-	H9G5Q6	711	N	T
Q9H694	LP/P	Renal dysplasia, cystic (CYSRD) [MIM:601331]	H9G5Q6	932	E	G
Q96G01	LB/B	-	L5KKG0	778	T	A
Q8TD16	LB/B	-	F6PIY7	90	K	R
Q8TD16	LP/P	Spinal muscular atrophy, lower extremity-predominant 2A, childhood onset, autosomal dominant (SMALED2A) [MIM:615290]	F6PIY7	107	S	L
Q8TD16	LP/P	Spinal muscular atrophy, lower extremity-predominant 2A, childhood onset, autosomal dominant (SMALED2A) [MIM:615290]	F6PIY7	188	N	T
Q8TD16	LP/P	Spinal muscular atrophy, lower extremity-predominant 2A, childhood onset, autosomal dominant (SMALED2A) [MIM:615290]	F6PIY7	189	I	F
Q8TD16	LP/P	Spinal muscular atrophy, lower extremity-predominant 2A, childhood onset, autosomal dominant (SMALED2A) [MIM:615290]	F6PIY7	501	R	P
Q8TD16	LP/P	Spinal muscular atrophy, lower extremity-predominant 2A, childhood onset, autosomal dominant (SMALED2A) [MIM:615290]	F6PIY7	508	K	T
Q8TD16	LP/P	Spinal muscular atrophy, lower extremity-predominant 2A, childhood onset, autosomal dominant (SMALED2A) [MIM:615290]	F6PIY7	703	T	M
Q8TD16	LP/P	Spinal muscular atrophy, lower extremity-predominant 2A, childhood onset, autosomal dominant (SMALED2A) [MIM:615290]	F6PIY7	774	E	G
Q8TD16	LP/P	Spinal muscular atrophy, lower extremity-predominant, 2B, prenatal onset, autosomal dominant (SMALED2B) [MIM:618291]	F6PIY7	194	Q	R
Q8TD16	LP/P	Spinal muscular atrophy, lower extremity-predominant, 2B, prenatal onset, autosomal dominant (SMALED2B) [MIM:618291]	F6PIY7	542	C	W
Q8TD16	LP/P	Spinal muscular atrophy, lower extremity-predominant, 2B, prenatal onset, autosomal dominant (SMALED2B) [MIM:618291]	F6PIY7	694	R	C
A1A5D9	LB/B	-	A0A2K6ANW8	273	Q	R
A1A5D9	LB/B	-	A0A2K6ANW8	55	Q	E
Q9NZM4	LB/B	-	F8VPZ9	1044	T	A
Q9NZM4	LB/B	-	F8VPZ9	683	P	S
Q13323	LB/B	-	A0A2J8TWC9	19	E	K
Q13323	LB/B	-	A0A2J8TWC9	148	L	P
Q13323	LB/B	-	A0A2J8TWC9	26	T	I
O00499	LP/P	Myopathy, centronuclear, 2 (CNM2) [MIM:255200]	A0A1U8CMK6	35	K	N
O00499	LP/P	Myopathy, centronuclear, 2 (CNM2) [MIM:255200]	A0A1U8CMK6	151	D	N
O00499	LP/P	-	A0A1U8CMK6	24	R	C
O00499	LP/P	Myopathy, centronuclear, 2 (CNM2) [MIM:255200]	A0A1U8CMK6	145	R	C
O00499	LP/P	Myopathy, centronuclear, 2 (CNM2) [MIM:255200]	A0A1U8CMK6	154	R	Q
O00499	LP/P	Myopathy, centronuclear, 2 (CNM2) [MIM:255200]	A0A1U8CMK6	234	R	C
Q9UBW5	LB/B	-	F7ED00	48	S	N
Q9UBW5	LB/B	-	F7ED00	529	N	D
O15392	LB/B	-	Q4R7L4	129	K	E
Q96CA5	LB/B	-	A0A2I2UF10	223	E	Q
Q96P09	LB/B	-	H2M1B6	196	H	Y
Q96P09	LB/B	-	H2M1B6	156	A	T
Q96P09	LB/B	-	H2M1B6	165	L	S
Q96P09	LB/B	-	H2M1B6	225	A	T
Q96P09	LB/B	-	H2M1B6	225	A	V
P62952	LB/B	-	A0A2I0TK86	2	Y	C
P62952	LB/B	-	A0A2I0TK86	15	K	R
Q8IZY5	LB/B	-	A0A2K6TZ24	76	A	D
P51451	LB/B	-	Q05D26	48	T	I
P51451	LB/B	-	Q05D26	71	A	T
Q2LD37	LB/B	-	A0A139WGJ2	978	I	T
Q2LD37	LB/B	-	A0A139WGJ2	4352	T	A
Q2LD37	LB/B	-	A0A139WGJ2	4786	T	A
Q2LD37	LB/B	-	A0A139WGJ2	1951	D	E
Q2LD37	LB/B	-	A0A139WGJ2	2521	S	R
Q6BDS2	LB/B	-	G1K9J8	404	K	N
Q6BDS2	LB/B	-	G1K9J8	454	Q	R
Q6BDS2	LB/B	-	G1K9J8	854	K	E
Q6BDS2	LB/B	-	G1K9J8	984	Q	H
Q6BDS2	LB/B	-	G1K9J8	1098	M	T
A0JNW5	LB/B	-	G1K9J8	1147	S	L
A0JNW5	LB/B	-	G1K9J8	1175	I	V
A0JNW5	LB/B	-	G1K9J8	1111	M	L
P53004	LB/B	-	S9YLC2	56	Q	R
P53004	LB/B	-	S9YLC2	3	A	T
P53004	LB/B	-	S9YLC2	37	L	V
P30043	LB/B	-	E9PZC3	46	R	Q
Q9H2G9	LB/B	-	A0A1W5ANT6	40	Q	R
Q9H2G9	LB/B	-	A0A1W5ANT6	196	R	Q
Q8WYA1	LB/B	-	A0A0D9R5L8	340	N	S
Q8WYA1	LB/B	-	A0A0D9R5L8	574	A	V
P35226	LB/B	-	R4GMX3	18	C	Y
P13497	LB/B	-	G3GUX9	719	V	I
P13497	LP/P	Osteogenesis imperfecta 13 (OI13) [MIM:614856]	G3GUX9	249	F	L
P13497	LP/P	Osteogenesis imperfecta 13 (OI13) [MIM:614856]	G3GUX9	12	G	R
P13497	LP/P	Osteogenesis imperfecta 13 (OI13) [MIM:614856]	G3GUX9	270	M	V
O95393	LB/B	-	A0A2I0T8R7	200	T	S
O95393	LB/B	-	A0A2I0T8R7	250	N	K
Q9NSY1	LB/B	-	A0A1S2ZIJ0	212	D	V
Q9NSY1	LB/B	-	A0A1S2ZIJ0	288	R	H
Q9NSY1	LB/B	-	A0A1S2ZIJ0	405	G	S
Q9NSY1	LB/B	-	A0A1S2ZIJ0	1002	T	S
Q9NSY1	LB/B	-	A0A1S2ZIJ0	486	Q	H
P22003	LB/B	-	A0A226P9Y7	2	H	Y
P22003	LB/B	-	A0A226P9Y7	121	N	S
P18075	LB/B	-	A0A2U4C1V4	198	L	P
P18075	LB/B	-	A0A2U4C1V4	321	N	S
Q7Z5Y6	LB/B	-	A0A2I0U2D1	293	R	H
Q7Z5Y6	LB/B	-	A0A2I0U2D1	84	M	V
P34820	LB/B	-	A0A2I0U2D1	293	H	R
P36894	LP/P	Juvenile polyposis syndrome (JPS) [MIM:174900]	H9JHY6	124	C	R
P36894	LP/P	Juvenile polyposis syndrome (JPS) [MIM:174900]	H9JHY6	338	A	D
P36894	LP/P	Juvenile polyposis syndrome (JPS) [MIM:174900]	H9JHY6	376	C	Y
P36894	LP/P	Juvenile polyposis syndrome (JPS) [MIM:174900]	H9JHY6	62	Y	D
P36894	LP/P	Juvenile polyposis syndrome (JPS) [MIM:174900]	H9JHY6	82	C	Y
P36894	LP/P	Juvenile polyposis syndrome (JPS) [MIM:174900]	H9JHY6	130	C	R
P36894	LP/P	Juvenile polyposis syndrome (JPS) [MIM:174900]	H9JHY6	443	R	C
P36894	LP/P	Juvenile polyposis syndrome (JPS) [MIM:174900]	H9JHY6	470	M	T
P36894	LB/B	-	H9JHY6	2	P	T
P36894	LB/B	-	H9JHY6	450	V	M
O00238	LP/P	Brachydactyly A2 (BDA2) [MIM:112600]	A0A2I4AUJ9	200	I	K
O00238	LP/P	Brachydactyly A2 (BDA2) [MIM:112600]	A0A2I4AUJ9	486	R	W
O00238	LP/P	Brachydactyly A2 (BDA2) [MIM:112600]	A0A2I4AUJ9	486	R	Q
O00238	LB/B	-	A0A2I4AUJ9	149	R	W
O00238	LB/B	-	A0A2I4AUJ9	224	R	H
O00238	LB/B	-	A0A2I4AUJ9	371	R	Q
O00238	LP/P	Acromesomelic dysplasia 3 (AMD3) [MIM:609441]	A0A2I4AUJ9	53	C	R
O00238	LP/P	Brachydactyly A1, D (BDA1D) [MIM:616849]	A0A2I4AUJ9	325	K	N
P51813	LB/B	-	A0A2U9C741	284	S	L
Q12981	LB/B	-	A0A212C815	14	Q	H
Q12982	LB/B	-	A0A2U3ZM79	24	S	T
P0C671	LB/B	-	H0XN27	582	L	V
Q9BWV1	LB/B	-	A0A218VD41	883	K	N
Q9BWV1	LB/B	-	A0A218VD41	915	Q	H
Q9Y3E2	LB/B	-	A0A1U7THN7	98	G	A
Q6PGQ7	LB/B	-	A0A091V016	210	S	L
Q6PGQ7	LB/B	-	A0A091V016	308	S	F
Q969J3	LB/B	-	F6PG67	41	S	C
Q969J3	LB/B	-	F6PG67	191	D	N
P07738	LP/P	Erythrocytosis, familial, 8 (ECYT8) [MIM:222800]	L8I1X0	62	R	Q
P07738	LP/P	Erythrocytosis, familial, 8 (ECYT8) [MIM:222800]	L8I1X0	90	R	C
P17213	LB/B	-	Q67E05	16	A	V
P17213	LB/B	-	Q67E05	196	A	V
P17213	LB/B	-	Q67E05	216	E	K
P17213	LB/B	-	Q67E05	12	A	T
P17213	LB/B	-	Q67E05	12	A	V
P17213	LB/B	-	Q67E05	90	R	C
P17213	LB/B	-	Q67E05	140	E	Q
P17213	LB/B	-	Q67E05	280	A	V
P17213	LB/B	-	Q67E05	377	V	I
P17213	LB/B	-	Q67E05	404	N	D
P17213	LB/B	-	Q67E05	451	K	E
Q96DR5	LB/B	-	M3Z2D3	43	G	R
Q96DR5	LB/B	-	M3Z2D3	113	K	E
Q96DR5	LB/B	-	M3Z2D3	221	R	C
Q9BQP9	LB/B	-	G5BPV4	41	A	E
Q9BQP9	LB/B	-	G5BPV4	136	V	I
Q8TDL5	LB/B	-	A0A2K5H923	84	I	V
Q8TDL5	LB/B	-	A0A2K5H923	479	S	T
Q8TDL5	LB/B	-	A0A2K5H923	298	S	P
Q8TDL5	LB/B	-	A0A2K5H923	313	S	I
Q8TDL5	LB/B	-	A0A2K5H923	140	T	A
Q8TDL5	LB/B	-	A0A2K5H923	284	V	M
Q8TDL5	LB/B	-	A0A2K5H923	287	D	H
Q8TDL5	LB/B	-	A0A2K5H923	464	T	S
Q8N4F0	LB/B	-	A0A1U7R2I3	31	K	M
Q8N4F0	LB/B	-	A0A1U7R2I3	63	A	V
P59826	LB/B	-	A0A2I2V4X8	224	V	M
P59826	LB/B	-	A0A2I2V4X8	286	T	M
P59826	LB/B	-	A0A2I2V4X8	330	H	Q
P59826	LB/B	-	A0A2I2V4X8	365	Y	C
P59826	LB/B	-	A0A2I2V4X8	445	P	S
P59827	LB/B	-	A0A2F0B633	199	D	G
P59827	LB/B	-	A0A2F0B633	206	G	W
P59827	LB/B	-	A0A2F0B633	268	I	V
P59827	LB/B	-	A0A2F0B633	320	N	T
P59827	LB/B	-	A0A2F0B633	167	G	W
P59827	LB/B	-	A0A2F0B633	229	I	V
P59827	LB/B	-	A0A2F0B633	527	F	L
P59827	LB/B	-	A0A2F0B633	533	T	I
Q8NFQ5	LB/B	-	S9X9G4	97	V	I
Q8NFQ5	LB/B	-	S9X9G4	16	T	M
Q8NFQ5	LB/B	-	S9X9G4	149	P	T
Q8NFQ5	LB/B	-	S9X9G4	347	S	G
Q8NFQ5	LB/B	-	S9X9G4	296	R	H
Q8NFQ6	LB/B	-	W5M054	269	V	A
Q8NFQ6	LB/B	-	W5M054	451	S	P
Q8NFQ6	LB/B	-	W5M054	302	V	L
Q8NFQ6	LB/B	-	W5M054	479	E	A
Q9NX62	LP/P	Chondrodysplasia with joint dislocations, GPAPP type (CDP-GPAPP) [MIM:614078]	A0A1L8FZ44	177	D	N
Q9NX62	LP/P	Chondrodysplasia with joint dislocations, GPAPP type (CDP-GPAPP) [MIM:614078]	A0A1L8FZ44	183	T	P
Q12830	LP/P	Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies (NEDDFL) [MIM:617755]	A0A287B9K5	1924	A	T
Q12830	LP/P	Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies (NEDDFL) [MIM:617755]	A0A287B9K5	2996	M	R
Q6PJG6	LB/B	-	A0A1S3FR14	20	R	G
Q6PJG6	LB/B	-	A0A1S3FR14	737	R	W
P51587	LP/P	Breast cancer (BC) [MIM:114480]	A4ZZ89	32	F	L
P51587	LP/P	Breast cancer (BC) [MIM:114480]	A4ZZ89	53	K	R
P51587	LP/P	Breast cancer (BC) [MIM:114480]	A4ZZ89	81	F	L
P51587	LP/P	Breast cancer (BC) [MIM:114480]	A4ZZ89	201	P	R
P51587	LP/P	Breast cancer (BC) [MIM:114480]	A4ZZ89	211	V	A
P51587	LP/P	Breast cancer (BC) [MIM:114480]	A4ZZ89	222	P	S
P51587	LB/B	-	A4ZZ89	289	N	H
P51587	LB/B	-	A4ZZ89	372	N	H
P51587	LP/P	Breast cancer (BC) [MIM:114480]	A4ZZ89	554	C	W
P51587	LP/P	Breast cancer (BC) [MIM:114480]	A4ZZ89	728	D	A
P51587	LB/B	-	A4ZZ89	991	N	D
P51587	LB/B	-	A4ZZ89	1147	N	S
P51587	LB/B	-	A4ZZ89	1880	N	K
P51587	LB/B	-	A4ZZ89	1915	T	M
P51587	LB/B	-	A4ZZ89	2034	R	C
P51587	LP/P	Breast cancer (BC) [MIM:114480]	A4ZZ89	2274	G	V
P51587	LP/P	Breast cancer (BC) [MIM:114480]	A4ZZ89	2415	H	N
P51587	LP/P	Breast cancer (BC) [MIM:114480]	A4ZZ89	2421	Q	H
P51587	LP/P	Breast cancer (BC) [MIM:114480]	A4ZZ89	3118	M	T
P51587	LP/P	Breast cancer (BC) [MIM:114480]	A4ZZ89	3357	T	R
P51587	LB/B	-	A4ZZ89	3412	I	V
P51587	LB/B	-	A4ZZ89	108	N	H
P51587	LB/B	-	A4ZZ89	582	T	P
P51587	LB/B	-	A4ZZ89	707	D	Y
P51587	LB/B	-	A4ZZ89	784	M	V
P51587	LB/B	-	A4ZZ89	886	N	I
P51587	LB/B	-	A4ZZ89	1290	C	Y
P51587	LB/B	-	A4ZZ89	1414	T	M
P51587	LB/B	-	A4ZZ89	1420	D	Y
P51587	LB/B	-	A4ZZ89	1513	D	N
P51587	LB/B	-	A4ZZ89	1593	E	D
P51587	LB/B	-	A4ZZ89	1805	N	S
P51587	LB/B	-	A4ZZ89	1902	D	N
P51587	LB/B	-	A4ZZ89	2074	H	N
P51587	LP/P	Breast cancer (BC) [MIM:114480]	A4ZZ89	2089	E	D
P51587	LB/B	-	A4ZZ89	2138	V	F
P51587	LB/B	Breast cancer (BC) [MIM:114480]	A4ZZ89	2466	V	A
P51587	LB/B	-	A4ZZ89	2480	L	V
P51587	LB/B	-	A4ZZ89	2490	I	T
P51587	LB/B	-	A4ZZ89	2944	I	F
P51587	LB/B	-	A4ZZ89	2969	V	M
P51587	LB/B	-	A4ZZ89	3257	K	R
P51587	LB/B	-	A4ZZ89	3276	R	S
P51587	LP/P	Breast cancer (BC) [MIM:114480]	A4ZZ89	2722	T	R
P51587	LB/B	-	A4ZZ89	322	K	Q
P51587	LB/B	-	A4ZZ89	929	L	S
P51587	LB/B	-	A4ZZ89	976	S	F
P51587	LB/B	-	A4ZZ89	987	N	I
P51587	LB/B	-	A4ZZ89	1561	H	N
P51587	LB/B	-	A4ZZ89	2162	K	R
P51587	LB/B	-	A4ZZ89	2440	H	R
P51587	LB/B	-	A4ZZ89	2835	S	P
P51587	LB/B	-	A4ZZ89	3244	V	I
P51587	LB/B	-	A4ZZ89	598	T	A
P51587	LP/P	Breast cancer (BC) [MIM:114480]	A4ZZ89	1179	S	N
P51587	LB/B	-	A4ZZ89	1279	N	S
P51587	LP/P	Breast cancer (BC) [MIM:114480]	A4ZZ89	1580	C	Y
P51587	LP/P	Breast cancer (BC) [MIM:114480]	A4ZZ89	1679	T	I
P51587	LP/P	Breast cancer (BC) [MIM:114480]	A4ZZ89	1804	V	A
P51587	LP/P	Breast cancer (BC) [MIM:114480]	A4ZZ89	1901	E	K
P51587	LP/P	Breast cancer (BC) [MIM:114480]	A4ZZ89	2072	S	C
P51587	LP/P	Breast cancer (BC) [MIM:114480]	A4ZZ89	2094	Y	C
P51587	LP/P	Breast cancer (BC) [MIM:114480]	A4ZZ89	2096	P	L
P51587	LP/P	Breast cancer (BC) [MIM:114480]	A4ZZ89	2128	K	N
P51587	LB/B	-	A4ZZ89	2706	N	S
P51587	LP/P	Breast cancer (BC) [MIM:114480]	A4ZZ89	2728	V	I
P51587	LP/P	Breast cancer (BC) [MIM:114480]	A4ZZ89	3076	G	E
P51587	LP/P	Breast cancer (BC) [MIM:114480]	A4ZZ89	3124	N	I
P51587	LP/P	Breast cancer (BC) [MIM:114480]	A4ZZ89	3196	K	E
P51587	LB/B	-	A4ZZ89	3374	T	I
P51587	LP/P	Breast cancer (BC) [MIM:114480]	A4ZZ89	25	G	R
P51587	LP/P	Breast cancer (BC) [MIM:114480]	A4ZZ89	31	W	C
P51587	LP/P	Breast cancer (BC) [MIM:114480]	A4ZZ89	31	W	R
P51587	LP/P	Breast cancer (BC) [MIM:114480]	A4ZZ89	64	T	I
P51587	LB/B	-	A4ZZ89	225	T	A
P51587	LP/P	Breast cancer (BC) [MIM:114480]	A4ZZ89	326	S	R
P51587	LP/P	Breast cancer (BC) [MIM:114480]	A4ZZ89	505	I	T
P51587	LP/P	Breast cancer (BC) [MIM:114480]	A4ZZ89	729	I	M
P51587	LB/B	-	A4ZZ89	1522	L	F
P51587	LP/P	Breast cancer (BC) [MIM:114480]	A4ZZ89	1690	K	N
P51587	LP/P	Breast cancer (BC) [MIM:114480]	A4ZZ89	1730	N	Y
P51587	LP/P	Breast cancer (BC) [MIM:114480]	A4ZZ89	1887	T	M
P51587	LB/B	-	A4ZZ89	2044	G	V
P51587	LB/B	-	A4ZZ89	2108	R	C
P51587	LP/P	Breast cancer (BC) [MIM:114480]	A4ZZ89	2135	N	H
P51587	LP/P	Breast cancer (BC) [MIM:114480]	A4ZZ89	2222	Y	C
P51587	LP/P	Fanconi anemia complementation group D1 (FANCD1) [MIM:605724]	A4ZZ89	2336	R	H
P51587	LP/P	Breast cancer (BC) [MIM:114480]	A4ZZ89	2456	Q	E
P51587	LP/P	Fanconi anemia complementation group D1 (FANCD1) [MIM:605724]	A4ZZ89	2510	L	P
P51587	LP/P	Fanconi anemia complementation group D1 (FANCD1) [MIM:605724]	A4ZZ89	2626	W	C
P51587	LB/B	-	A4ZZ89	599	S	F
P51587	LB/B	-	A4ZZ89	513	K	R
P51587	LB/B	-	A4ZZ89	982	I	L
P51587	LB/B	-	A4ZZ89	1542	V	M
P51587	LB/B	-	A4ZZ89	1643	V	A
P51587	LB/B	-	A4ZZ89	1979	S	R
P51587	LB/B	-	A4ZZ89	2238	D	E
P51587	LB/B	-	A4ZZ89	2336	R	Q
P51587	LB/B	-	A4ZZ89	2447	N	D
P51587	LB/B	-	A4ZZ89	2686	L	P
P51587	LB/B	-	A4ZZ89	3101	L	R
P51587	LB/B	-	A4ZZ89	2116	H	R
P51587	LP/P	-	A4ZZ89	2663	E	V
P51587	LP/P	Breast cancer (BC) [MIM:114480]	A4ZZ89	2723	D	G
P51587	LP/P	Breast cancer (BC) [MIM:114480]	A4ZZ89	3052	R	W
P51587	LB/B	-	A4ZZ89	606	P	L
P46736	LB/B	-	A0A210Q288	74	I	V
O60885	LB/B	-	H3CFD6	37	P	S
O60885	LB/B	-	H3CFD6	371	A	G
O60885	LB/B	-	H3CFD6	563	S	N
O60885	LB/B	-	H3CFD6	598	T	S
O60885	LB/B	-	H3CFD6	669	R	H
O60885	LB/B	-	H3CFD6	1097	R	H
Q9H0E9	LB/B	-	R0KS33	490	T	M
Q9H0E9	LB/B	-	R0KS33	896	L	P
Q9H0E9	LB/B	-	R0KS33	1198	Q	R
Q9H8M2	LB/B	-	W5Q364	266	A	T
Q9H8M2	LB/B	-	W5Q364	389	A	T
Q9H8M2	LB/B	-	W5Q364	170	A	T
Q58F21	LB/B	-	A0A091JVA6	62	Q	K
Q58F21	LB/B	-	A0A091JVA6	238	K	N
Q58F21	LB/B	-	A0A091JVA6	410	N	K
Q58F21	LB/B	-	A0A091JVA6	2	S	F
Q58F21	LB/B	-	A0A091JVA6	6	R	Q
Q58F21	LB/B	-	A0A091JVA6	357	E	K
Q58F21	LB/B	-	A0A091JVA6	542	P	A
Q58F21	LB/B	-	A0A091JVA6	336	K	T
Q58F21	LB/B	-	A0A091JVA6	605	R	Q
Q58F21	LB/B	-	A0A091JVA6	696	P	L
Q92994	LP/P	Cerebellofaciodental syndrome (CFDS) [MIM:616202]	H3CGT4	223	R	W
Q92994	LP/P	Cerebellofaciodental syndrome (CFDS) [MIM:616202]	H3CGT4	226	S	L
Q92994	LP/P	Cerebellofaciodental syndrome (CFDS) [MIM:616202]	H3CGT4	259	T	M
Q92994	LP/P	Cerebellofaciodental syndrome (CFDS) [MIM:616202]	H3CGT4	292	P	H
O95415	LB/B	-	A0A287AK24	123	T	A
Q6PL45	LB/B	-	A0A2Y9PXP1	46	V	I
Q6PL45	LB/B	-	A0A2Y9PXP1	31	S	G
Q6PL45	LB/B	-	A0A2Y9PXP1	122	H	Y
O60477	LB/B	-	A0A1L8F247	437	A	T
O60477	LB/B	-	A0A1L8F247	347	S	R
O60477	LB/B	-	A0A1L8F247	358	R	H
Q9C0B6	LB/B	-	A0A1L8F247	71	Y	C
Q9C0B6	LB/B	-	A0A1L8F247	390	L	V
Q9BX63	LP/P	Breast cancer (BC) [MIM:114480]	A0A091N4E0	47	P	A
Q9BX63	LB/B	-	A0A091N4E0	173	R	C
Q9BX63	LB/B	-	A0A091N4E0	193	V	I
Q9BX63	LB/B	-	A0A091N4E0	195	L	P
Q9BX63	LP/P	Breast cancer (BC) [MIM:114480]	A0A091N4E0	299	M	I
Q9BX63	LB/B	-	A0A091N4E0	419	R	W
Q9BX63	LB/B	-	A0A091N4E0	531	F	V
Q9BX63	LB/B	-	A0A091N4E0	540	Q	L
Q9BX63	LB/B	-	A0A091N4E0	832	C	Y
Q9BX63	LB/B	-	A0A091N4E0	919	S	P
Q9BX63	LB/B	-	A0A091N4E0	935	V	G
Q9BX63	LP/P	Fanconi anemia complementation group J (FANCJ) [MIM:609054]	A0A091N4E0	255	Q	H
Q9BX63	LB/B	-	A0A091N4E0	264	R	W
Q9BX63	LP/P	Fanconi anemia complementation group J (FANCJ) [MIM:609054]	A0A091N4E0	349	A	P
Q9BX63	LP/P	Fanconi anemia complementation group J (FANCJ) [MIM:609054]	A0A091N4E0	647	W	C
Q9BX63	LP/P	Fanconi anemia complementation group J (FANCJ) [MIM:609054]	A0A091N4E0	707	R	C
Q9BX63	LB/B	-	A0A091N4E0	633	I	M
Q9BX63	LB/B	-	A0A091N4E0	1148	D	E
Q0VDD7	LB/B	-	H0XIC9	267	G	R
Q0VDD7	LB/B	-	H0XIC9	500	Q	R
Q9ULD4	LB/B	-	F6YZW8	278	A	G
Q9ULD4	LB/B	-	F6YZW8	177	S	G
P32247	LB/B	-	A0A091DYU6	53	T	P
P32247	LB/B	-	A0A091DYU6	162	L	Q
Q9NSI6	LB/B	-	G1RRQ8	83	Q	E
Q9NSI6	LB/B	-	G1RRQ8	1511	S	P
Q9NSI6	LB/B	-	G1RRQ8	1699	L	P
Q9NSI6	LB/B	-	G1RRQ8	2156	K	R
Q6RI45	LB/B	-	H3AWA4	1288	K	R
Q96G97	LP/P	Neuronopathy, distal hereditary motor, 5C (HMN5C) [MIM:619112]	A0A2Y9PWI4	88	N	S
Q96G97	LP/P	Spastic paraplegia 17, autosomal dominant (SPG17) [MIM:270685]	A0A2Y9PWI4	88	N	S
Q96G97	LP/P	Neuronopathy, distal hereditary motor, 5C (HMN5C) [MIM:619112]	A0A2Y9PWI4	90	S	L
Q96G97	LP/P	Spastic paraplegia 17, autosomal dominant (SPG17) [MIM:270685]	A0A2Y9PWI4	90	S	L
Q96G97	LP/P	Congenital generalized lipodystrophy 2 (CGL2) [MIM:269700]	A0A2Y9PWI4	212	A	P
Q9UPA5	LB/B	-	K7GJV4	741	A	T
Q9UPA5	LB/B	-	K7GJV4	1213	G	D
Q9UPA5	LB/B	-	K7GJV4	3863	A	T
Q8WZ55	LP/P	Bartter syndrome 4A, neonatal, with sensorineural deafness (BARTS4A) [MIM:602522]	I3LR58	8	R	L
Q8WZ55	LP/P	Bartter syndrome 4A, neonatal, with sensorineural deafness (BARTS4A) [MIM:602522]	I3LR58	8	R	W
Q8WZ55	LP/P	Bartter syndrome 4A, neonatal, with sensorineural deafness (BARTS4A) [MIM:602522]	I3LR58	10	G	S
Q8WZ55	LP/P	Bartter syndrome 4A, neonatal, with sensorineural deafness (BARTS4A) [MIM:602522]	I3LR58	47	G	R
Q8WZ55	LB/B	-	I3LR58	43	V	I
Q10588	LB/B	-	A0A1S2ZE10	125	R	H
Q10588	LB/B	-	A0A1S2ZE10	145	R	Q
Q10588	LB/B	-	A0A1S2ZE10	77	A	V
Q10588	LB/B	-	A0A1S2ZE10	101	I	V
Q9BSF8	LB/B	-	M3XKJ1	145	T	A
Q5XKL5	LB/B	-	M7C7Q5	136	K	R
Q5XKL5	LB/B	-	M7C7Q5	60	V	I
Q5XKL5	LB/B	-	M7C7Q5	805	H	R
Q5XKL5	LB/B	-	M7C7Q5	825	S	I
Q5XKL5	LB/B	-	M7C7Q5	905	V	L
Q5XKL5	LB/B	-	M7C7Q5	985	Q	R
Q5XKL5	LB/B	-	M7C7Q5	1064	D	G
Q5XKL5	LB/B	-	M7C7Q5	1098	N	Y
Q5XKL5	LB/B	-	M7C7Q5	1209	K	E
Q5XKL5	LB/B	-	M7C7Q5	1328	N	S
Q5XKL5	LB/B	-	M7C7Q5	1431	T	N
Q5XKL5	LB/B	-	M7C7Q5	1466	F	V
Q5XKL5	LB/B	-	M7C7Q5	1541	V	I
P35070	LB/B	-	A0A1U7TEE3	7	C	G
P35070	LB/B	-	A0A1U7TEE3	124	L	M
P35070	LB/B	-	A0A1U7TEE3	44	L	F
P43251	LP/P	Biotinidase deficiency (BTD deficiency) [MIM:253260]	V8NR44	128	F	V
P43251	LP/P	Biotinidase deficiency (BTD deficiency) [MIM:253260]	V8NR44	171	A	T
P43251	LP/P	Biotinidase deficiency (BTD deficiency) [MIM:253260]	V8NR44	228	D	Y
P43251	LP/P	Biotinidase deficiency (BTD deficiency) [MIM:253260]	V8NR44	323	H	R
P43251	LP/P	Biotinidase deficiency (BTD deficiency) [MIM:253260]	V8NR44	444	D	H
P43251	LP/P	Biotinidase deficiency (BTD deficiency) [MIM:253260]	V8NR44	451	G	D
P43251	LP/P	Biotinidase deficiency (BTD deficiency) [MIM:253260]	V8NR44	456	Q	H
P43251	LP/P	Biotinidase deficiency (BTD deficiency) [MIM:253260]	V8NR44	532	T	M
P43251	LP/P	Biotinidase deficiency (BTD deficiency) [MIM:253260]	V8NR44	538	R	C
P43251	LB/B	-	V8NR44	391	P	S
P62324	LB/B	-	A0A2R8NAS5	139	N	S
P62324	LB/B	-	A0A2R8NAS5	141	Q	E
P78543	LB/B	-	G1SLS5	153	V	M
Q9NY30	LP/P	Oocyte maturation defect 8 (OOMD8) [MIM:619009]	A0A1A6H096	56	A	T
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	11	L	P
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	12	K	R
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	14	S	F
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	25	F	S
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	28	R	H
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	28	R	P
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	33	T	P
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	64	V	F
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	113	V	D
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	288	R	W
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	295	L	P
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	302	G	E
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	307	R	G
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	334	Y	S
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	358	L	F
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	361	Y	C
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	362	H	Q
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	364	H	P
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	365	N	Y
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	370	I	M
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	408	L	P
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	418	Y	H
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	429	I	N
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	430	K	E
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	476	Y	D
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	477	M	R
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	502	C	F
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	502	C	W
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	506	C	R
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	506	C	Y
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	509	M	V
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	520	R	Q
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	521	D	H
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	521	D	N
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	525	R	P
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	525	R	Q
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	526	N	K
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	542	L	P
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	544	R	K
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	562	R	P
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	562	R	W
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	567	E	K
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	581	W	R
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	582	A	V
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	587	M	L
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	589	E	G
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	592	S	P
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	594	G	E
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	594	G	R
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	598	Y	C
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	607	A	D
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	613	G	D
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	619	P	S
Q06187	LB/B	-	A0A2U9C741	630	M	I
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	630	M	K
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	633	C	Y
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	641	R	C
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	641	R	H
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	644	F	S
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	647	L	P
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	652	L	P
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	19	K	E
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	27	K	R
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	28	R	C
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	40	Y	C
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	40	Y	N
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	61	I	N
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	64	V	D
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	115	S	F
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	117	T	P
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	127	Q	H
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	154	C	S
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	155	C	G
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	155	C	R
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	184	T	P
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	288	R	Q
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	302	G	R
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	307	R	T
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	308	D	E
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	319	V	A
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	366	S	F
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	369	L	F
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	372	R	G
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	414	G	R
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	430	K	R
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	445	E	D
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	462	G	D
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	462	G	V
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	508	A	D
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	509	M	I
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	518	L	R
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	521	D	G
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	523	A	E
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	525	R	G
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	535	V	F
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	559	F	S
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	563	W	L
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	583	F	S
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	589	E	D
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	619	P	A
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	619	P	T
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	622	A	P
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	626	V	G
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	630	M	T
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	644	F	L
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	39	Y	S
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	512	L	P
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	512	L	Q
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	544	R	G
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	578	S	Y
Q06187	LP/P	X-linked agammaglobulinemia (XLA) [MIM:300755]	A0A2U9C741	589	E	K
Q06187	LB/B	-	A0A2U9C741	82	R	K
Q13410	LB/B	-	L5LUK5	213	A	T
Q13410	LB/B	-	L5LUK5	503	D	E
Q13410	LB/B	-	L5LUK5	303	V	A
Q13410	LB/B	-	L5LUK5	521	P	S
Q7KYR7	LB/B	-	A0A2R9CJ86	124	R	C
Q7KYR7	LB/B	-	A0A2R9CJ86	207	V	M
Q7KYR7	LB/B	-	A0A2R9CJ86	378	R	Q
Q7KYR7	LB/B	-	A0A2R9CJ86	451	G	A
Q7KYR7	LB/B	-	A0A2R9CJ86	178	W	C
Q7KYR7	LB/B	-	A0A2R9CJ86	178	W	L
Q8WVV5	LB/B	-	A0A2R9CJ86	479	P	S
Q96KV6	LB/B	-	A0A2R9CJ86	79	G	D
Q96KV6	LB/B	-	A0A2R9CJ86	148	V	I
Q96KV6	LB/B	-	A0A2R9CJ86	300	N	S
O00481	LB/B	-	A0A2K5SFM9	224	S	N
O00481	LB/B	-	A0A2K5SFM9	456	P	T
O00481	LB/B	-	A0A2K5SFM9	15	R	H
O00481	LB/B	-	A0A2K5SFM9	282	R	T
P78410	LB/B	-	F7HH27	181	N	D
P78410	LB/B	-	F7HH27	167	R	T
P78410	LB/B	-	F7HH27	182	A	T
P78410	LB/B	-	F7HH27	211	R	K
P78410	LB/B	-	F7HH27	307	S	N
Q9UIR0	LB/B	-	A0A2K5CPJ7	196	K	E
Q9UIR0	LB/B	-	A0A2K5CPJ7	334	S	L
Q9UIR0	LB/B	-	A0A2K5CPJ7	94	W	R
Q9UIR0	LB/B	-	A0A2K5CPJ7	283	D	V
Q9UIR0	LB/B	-	A0A2K5CPJ7	352	A	T
Q9UIR0	LB/B	-	A0A2K5CPJ7	379	P	L
Q9UIR0	LB/B	-	A0A2K5CPJ7	380	M	I
Q9UIR0	LB/B	-	A0A2K5CPJ7	393	P	Q
Q9UIR0	LB/B	-	A0A2K5CPJ7	188	V	M
Q9UIR0	LB/B	-	A0A2K5CPJ7	360	S	G
Q9UIR0	LB/B	-	A0A2K5CPJ7	181	R	Q
Q9UIR0	LB/B	-	A0A2K5CPJ7	202	A	V
Q6UX41	LB/B	-	F7GSG8	143	T	A
Q6UX41	LB/B	-	F7GSG8	229	E	K
Q6UX41	LB/B	-	F7GSG8	311	H	Q
Q6UX41	LB/B	-	F7GSG8	326	T	K
Q6UX41	LB/B	-	F7GSG8	477	A	T
Q6UXG8	LB/B	-	A0A2K6DB64	511	G	R
Q9Y297	LB/B	-	A0A0F8CA48	592	P	H
Q9Y297	LB/B	-	A0A0F8CA48	543	A	S
O43683	LB/B	-	A0A091H0Y4	20	G	D
O43683	LB/B	-	A0A091H0Y4	534	N	D
O60566	LB/B	-	S7P8C3	349	R	Q
O60566	LB/B	-	S7P8C3	618	V	A
O60566	LP/P	Premature chromatid separation trait (PCS) [MIM:176430]	S7P8C3	36	R	Q
O60566	LB/B	-	S7P8C3	390	E	D
O60566	LP/P	Mosaic variegated aneuploidy syndrome 1 (MVA1) [MIM:257300]	S7P8C3	550	R	Q
O60566	LP/P	Mosaic variegated aneuploidy syndrome 1 (MVA1) [MIM:257300]	S7P8C3	814	R	H
O60566	LP/P	Mosaic variegated aneuploidy syndrome 1 (MVA1) [MIM:257300]	S7P8C3	844	L	F
O60566	LP/P	Mosaic variegated aneuploidy syndrome 1 (MVA1) [MIM:257300]	S7P8C3	909	I	T
O60566	LP/P	Mosaic variegated aneuploidy syndrome 1 (MVA1) [MIM:257300]	S7P8C3	921	Q	H
O60566	LP/P	Mosaic variegated aneuploidy syndrome 1 (MVA1) [MIM:257300]	S7P8C3	1012	L	P
O60566	LB/B	-	S7P8C3	40	T	M
O60566	LB/B	-	S7P8C3	378	P	S
Q9Y6E2	LB/B	-	A0A091D278	44	D	A
Q5T681	LB/B	-	A0A286XNJ7	121	E	D
Q96M02	LB/B	-	A0A091NBA7	134	R	H
Q96M02	LB/B	-	A0A091NBA7	262	D	N
Q96M02	LB/B	-	A0A091NBA7	57	M	I
Q96M02	LB/B	-	A0A091NBA7	531	D	E
Q9NQ32	LB/B	-	G3T621	144	P	L
Q9NQ32	LB/B	-	G3T621	210	V	L
Q96F05	LB/B	-	G3SXY6	97	G	V
Q96F05	LB/B	-	G3SXY6	150	A	T
Q8WZ69	LB/B	-	G3RYH7	100	F	S
Q96A22	LB/B	-	Q9D8L0	23	T	R
Q9H3H3	LB/B	-	A0A2Y9RFI3	195	Q	R
Q7Z7L8	LB/B	-	A0A1D5R6V8	26	T	A
Q7Z7L8	LB/B	-	A0A1D5R6V8	47	S	P
Q7Z7L8	LB/B	-	A0A1D5R6V8	110	R	S
Q7Z7L8	LB/B	-	A0A1D5R6V8	144	R	C
Q7Z7L8	LB/B	-	A0A1D5R6V8	151	F	S
Q7Z7L8	LB/B	-	A0A1D5R6V8	352	P	S
Q8N999	LB/B	-	A0A2Y9LES6	23	P	L
Q8N999	LB/B	-	A0A2Y9LES6	238	V	L
Q86WS4	LB/B	-	G1SM94	13	I	L
Q8NA57	LB/B	-	A0A091DK75	306	Q	R
Q8NA57	LB/B	-	A0A091DK75	322	R	H
Q99622	LP/P	Temtamy syndrome (TEMTYS) [MIM:218340]	H3AB67	51	L	Q
Q5U649	LB/B	-	G1Q508	51	K	R
Q5U649	LB/B	-	G1Q508	65	K	R
Q5U649	LB/B	-	G1Q508	103	N	K
Q9NWQ9	LB/B	-	A0A2R8MEY1	16	L	V
Q9H972	LB/B	-	F7HFD6	190	A	V
Q32M92	LB/B	-	Q32M92	17	A	T
Q6ZRI6	LB/B	-	A0A061I3Q1	119	A	P
Q6ZRI6	LB/B	-	A0A061I3Q1	491	G	D
Q6ZRI6	LB/B	-	A0A061I3Q1	536	S	A
Q6ZRI6	LB/B	-	A0A061I3Q1	945	G	D
Q8WUR7	LB/B	-	H0UWU4	89	A	T
Q6P387	LB/B	-	G3VPH6	77	T	S
Q6P387	LB/B	-	G3VPH6	288	I	T
Q6P387	LB/B	-	G3VPH6	335	Y	H
Q6P387	LB/B	-	G3VPH6	357	K	E
Q6P387	LB/B	-	G3VPH6	388	P	S
Q6UX73	LB/B	-	A0A2K6N4I0	296	L	S
Q6UX73	LB/B	-	A0A2K6N4I0	363	Y	H
Q6UX73	LB/B	-	A0A2K6N4I0	215	G	A
Q8WW18	LB/B	-	A0A2Y9E268	22	D	E
Q2M2W7	LB/B	-	A0A2R8MHJ0	334	I	V
Q8N4C9	LB/B	-	G3WHL2	152	T	S
Q9BSJ5	LB/B	-	A0A2Y9PQ60	226	G	S
Q9BSJ5	LB/B	-	A0A2Y9PQ60	322	K	Q
Q9BSJ5	LB/B	-	A0A2Y9PQ60	356	F	L
Q9BSJ5	LB/B	-	A0A2Y9PQ60	395	H	N
Q9BSJ5	LB/B	-	A0A2Y9PQ60	396	C	R
Q9BSJ5	LB/B	-	A0A2Y9PQ60	420	Q	H
Q9BSJ5	LB/B	-	A0A2Y9PQ60	522	A	T
Q6UX52	LB/B	-	A0A0D9S433	101	W	R
Q32NC0	LB/B	-	G3WVQ8	132	T	A
Q8TCD1	LB/B	-	W5N121	37	P	H
Q9NSK7	LP/P	Neurodegeneration with brain iron accumulation 4 (NBIA4) [MIM:614298]	K9IY92	11	T	M
Q9NSK7	LP/P	Neurodegeneration with brain iron accumulation 4 (NBIA4) [MIM:614298]	K9IY92	53	G	R
Q9NSK7	LP/P	Neurodegeneration with brain iron accumulation 4 (NBIA4) [MIM:614298]	K9IY92	65	G	E
Q9NSK7	LP/P	Neurodegeneration with brain iron accumulation 4 (NBIA4) [MIM:614298]	K9IY92	69	G	R
Q9NSK7	LB/B	-	K9IY92	142	K	T
Q9NSK7	LP/P	Neurodegeneration with brain iron accumulation 4 (NBIA4) [MIM:614298]	K9IY92	39	S	F
Q9NSK7	LP/P	Neurodegeneration with brain iron accumulation 4 (NBIA4) [MIM:614298]	K9IY92	48	A	P
Q9NSK7	LP/P	Neurodegeneration with brain iron accumulation 4 (NBIA4) [MIM:614298]	K9IY92	60	P	L
Q9NSK7	LP/P	Neurodegeneration with brain iron accumulation 4 (NBIA4) [MIM:614298]	K9IY92	65	G	V
Q9NSK7	LP/P	Neurodegeneration with brain iron accumulation 4 (NBIA4) [MIM:614298]	K9IY92	83	P	L
Q9NSK7	LP/P	Neurodegeneration with brain iron accumulation 4 (NBIA4) [MIM:614298]	K9IY92	98	R	S
Q9NSK7	LP/P	Neurodegeneration with brain iron accumulation 4 (NBIA4) [MIM:614298]	K9IY92	121	L	Q
Q9NSK7	LB/B	-	K9IY92	149	Q	R
Q9NSK7	LP/P	Neurodegeneration with brain iron accumulation 4 (NBIA4) [MIM:614298]	K9IY92	63	A	P
Q9NSK7	LP/P	Spastic paraplegia 43, autosomal recessive (SPG43) [MIM:615043]	K9IY92	63	A	P
Q9NSK7	LP/P	Neurodegeneration with brain iron accumulation 4 (NBIA4) [MIM:614298]	K9IY92	58	G	S
Q9NSK7	LP/P	Neurodegeneration with brain iron accumulation 4 (NBIA4) [MIM:614298]	K9IY92	96	Q	P
Q8NEA5	LB/B	-	F7CY99	208	H	Y
Q9UNZ5	LB/B	-	M3XW18	39	K	R
Q9NVV2	LB/B	-	G3QZA2	106	S	G
Q13901	LB/B	-	A0A1A7Y1Z7	127	S	P
O95561	LB/B	-	A0A2I2UMS6	97	M	V
O95561	LB/B	-	A0A2I2UMS6	137	S	N
Q8N9H9	LB/B	-	G3TJM8	530	A	V
Q8N9H9	LB/B	-	G3TJM8	256	R	Q
Q8N9H9	LB/B	-	G3TJM8	366	V	D
Q5JVX7	LB/B	-	A0A2Y9SIP7	85	E	G
Q5JVX7	LB/B	-	A0A2Y9SIP7	189	V	I
Q8NEQ5	LB/B	-	A0A2K5Q3F5	3	G	S
Q5SNV9	LB/B	-	G1PIY5	453	P	S
Q5SNV9	LB/B	-	G1PIY5	544	R	Q
Q5SNV9	LB/B	-	G1PIY5	602	R	W
Q5SNV9	LB/B	-	G1PIY5	782	W	R
Q5SNV9	LB/B	-	G1PIY5	800	R	C
Q5SNV9	LB/B	-	G1PIY5	848	S	I
Q5SNV9	LB/B	-	G1PIY5	944	R	H
Q5SNV9	LB/B	-	G1PIY5	955	W	R
Q5SNV9	LB/B	-	G1PIY5	1215	R	H
Q5SNV9	LB/B	-	G1PIY5	1295	C	S
Q5SNV9	LB/B	-	G1PIY5	1451	R	G
Q9H425	LB/B	-	A0A2K6H0E5	274	A	S
Q9H425	LB/B	-	A0A2K6H0E5	306	K	R
Q8IVY1	LB/B	-	A0A1U7TIP7	12	S	L
Q9BV19	LB/B	-	A0A2I2Y2F1	178	T	M
Q96LT6	LB/B	-	L5KYP7	146	L	F
P02746	LP/P	Complement component C1q deficiency (C1QD) [MIM:613652]	V8NE44	42	G	D
Q07021	LP/P	Combined oxidative phosphorylation deficiency 33 (COXPD33) [MIM:617713]	A0A1S3EMT8	247	G	W
Q07021	LP/P	Combined oxidative phosphorylation deficiency 33 (COXPD33) [MIM:617713]	A0A1S3EMT8	275	L	P
P02747	LP/P	Complement component C1q deficiency (C1QD) [MIM:613652]	V8NE44	34	G	R
Q9BXJ1	LB/B	-	A0A2K5E5B3	241	R	Q
Q9BXJ0	LB/B	-	A0A1S2ZRZ7	44	Q	R
Q9BXJ0	LP/P	Late-onset retinal degeneration (LORD) [MIM:605670]	A0A1S2ZRZ7	163	S	R
Q9BXI9	LB/B	-	W5MZD8	21	G	V
Q9BXI9	LB/B	-	W5MZD8	42	P	R
Q9BXI9	LB/B	-	W5MZD8	55	G	D
Q9BXI9	LB/B	-	W5MZD8	138	P	L
Q9BXI9	LB/B	-	W5MZD8	226	R	H
P0C862	LB/B	-	A0A094L6G4	219	M	V
P0C862	LB/B	-	A0A094L6G4	301	V	M
P0C862	LB/B	-	A0A094L6G4	6	L	F
P06681	LP/P	Complement component 2 deficiency (C2D) [MIM:217000]	M3ZKU0	131	C	Y
P06681	LP/P	Complement component 2 deficiency (C2D) [MIM:217000]	M3ZKU0	209	S	F
P06681	LP/P	Complement component 2 deficiency (C2D) [MIM:217000]	M3ZKU0	464	G	R
P06681	LB/B	-	M3ZKU0	533	F	L
P06681	LB/B	-	M3ZKU0	318	E	D
P06681	LB/B	-	M3ZKU0	734	R	C
Q9BQM9	LB/B	-	A0A2I2ZJR0	62	Q	R
Q96LM9	LB/B	-	A0A2J8JYP4	141	K	E
Q9H1P6	LB/B	-	A0A2I3SWI8	26	R	H
Q9H1P6	LB/B	-	A0A2I3SWI8	99	I	V
Q9H1P6	LB/B	-	A0A2I3SWI8	34	R	Q
Q9NUD7	LB/B	-	F1PQS1	305	I	F
Q9BZE7	LB/B	-	A0A2I3G9H0	136	M	L
Q9Y426	LB/B	-	U3CPD9	211	V	A
Q9Y426	LB/B	-	U3CPD9	618	T	A
O14523	LB/B	-	A0A091K480	413	R	W
Q4AC94	LB/B	-	I3K653	773	P	R
Q4AC94	LB/B	-	I3K653	997	R	Q
Q4AC94	LB/B	-	I3K653	1219	R	Q
Q4AC94	LB/B	-	I3K653	1297	Y	C
Q4AC94	LB/B	-	I3K653	1663	S	N
Q4AC94	LB/B	-	I3K653	1831	G	W
Q4AC94	LB/B	-	I3K653	1832	R	G
Q4AC94	LP/P	Orofaciodigital syndrome 14 (OFD14) [MIM:615948]	I3K653	1029	C	G
Q4AC94	LB/B	-	I3K653	1743	G	C
Q68DN1	LB/B	-	A0A2K6EXA6	357	R	G
Q68DN1	LB/B	-	A0A2K6EXA6	505	D	V
Q68DN1	LB/B	-	A0A2K6EXA6	655	T	S
Q68DN1	LB/B	-	A0A2K6EXA6	660	A	E
Q68DN1	LB/B	-	A0A2K6EXA6	685	V	A
Q68DN1	LB/B	-	A0A2K6EXA6	767	I	T
Q68DN1	LB/B	-	A0A2K6EXA6	774	I	V
Q68DN1	LB/B	-	A0A2K6EXA6	1500	S	F
Q68DN1	LB/B	-	A0A2K6EXA6	1559	H	Y
Q68DN1	LB/B	-	A0A2K6EXA6	1613	N	S
Q68DN1	LB/B	-	A0A2K6EXA6	1665	S	P
Q9NWW7	LB/B	-	A0A099Z4G3	314	Q	P
Q96LS8	LB/B	-	Q96LS8	90	P	L
Q96LS8	LB/B	-	Q96LS8	119	W	S
Q9BVC5	LB/B	-	A0A212CW25	185	G	D
Q8N5S3	LB/B	-	H0XCN3	254	P	L
Q8N5S3	LB/B	-	H0XCN3	275	R	T
Q8N5S3	LB/B	-	H0XCN3	29	H	N
Q3KRA6	LB/B	-	S7N9W5	46	I	V
Q3KRA6	LB/B	-	S7N9W5	116	K	R
Q0P641	LB/B	-	A0A1S3W8N9	82	R	H
Q0P641	LB/B	-	A0A1S3W8N9	130	C	R
Q0P641	LB/B	-	A0A1S3W8N9	152	S	G
Q53S99	LB/B	-	A0A2K5IAC7	104	E	Q
Q53S99	LB/B	-	A0A2K5IAC7	45	S	L
Q9BSF0	LB/B	-	G3TLQ9	56	T	I
P01024	LB/B	-	A0A068B2R5	102	R	G
P01024	LB/B	-	A0A068B2R5	314	P	L
P01024	LP/P	Complement component 3 deficiency (C3D) [MIM:613779]	A0A068B2R5	549	D	N
P01024	LB/B	-	A0A068B2R5	863	R	K
P01024	LB/B	-	A0A068B2R5	1224	G	D
P01024	LB/B	-	A0A068B2R5	1367	I	T
P01024	LB/B	-	A0A068B2R5	469	E	D
P01024	LB/B	-	A0A068B2R5	1619	S	R
P01024	LB/B	-	A0A068B2R5	1521	Q	R
P01024	LB/B	-	A0A068B2R5	1601	H	N
P01024	LP/P	Hemolytic uremic syndrome atypical 5 (AHUS5) [MIM:612925]	A0A068B2R5	592	R	Q
P01024	LP/P	Hemolytic uremic syndrome atypical 5 (AHUS5) [MIM:612925]	A0A068B2R5	592	R	W
P01024	LP/P	Hemolytic uremic syndrome atypical 5 (AHUS5) [MIM:612925]	A0A068B2R5	735	R	W
P01024	LP/P	Hemolytic uremic syndrome atypical 5 (AHUS5) [MIM:612925]	A0A068B2R5	1094	A	V
P01024	LP/P	Hemolytic uremic syndrome atypical 5 (AHUS5) [MIM:612925]	A0A068B2R5	1115	D	N
P01024	LP/P	Hemolytic uremic syndrome atypical 5 (AHUS5) [MIM:612925]	A0A068B2R5	1158	C	W
P01024	LP/P	Hemolytic uremic syndrome atypical 5 (AHUS5) [MIM:612925]	A0A068B2R5	1161	Q	K
P01024	LP/P	Hemolytic uremic syndrome atypical 5 (AHUS5) [MIM:612925]	A0A068B2R5	1464	H	D
P01024	LP/P	Hemolytic uremic syndrome atypical 5 (AHUS5) [MIM:612925]	A0A068B2R5	603	F	V
P01024	LP/P	Hemolytic uremic syndrome atypical 5 (AHUS5) [MIM:612925]	A0A068B2R5	1042	R	L
P01024	LP/P	Macular degeneration, age-related, 9 (ARMD9) [MIM:611378]	A0A068B2R5	155	K	Q
Q16581	LB/B	-	A0A2Y9KVW2	136	V	A
Q8ND61	LB/B	-	G3WXI3	176	A	T
Q8ND61	LB/B	-	G3WXI3	42	G	D
Q8ND61	LB/B	-	G3WXI3	65	D	N
Q8ND61	LB/B	-	G3WXI3	230	S	Y
Q8ND61	LB/B	-	G3WXI3	298	A	T
Q8ND61	LB/B	-	G3WXI3	407	I	V
Q8ND61	LB/B	-	G3WXI3	422	L	V
Q8ND61	LB/B	-	G3WXI3	205	Q	R
Q8ND61	LB/B	-	G3WXI3	689	A	V
Q6ZUJ4	LB/B	-	L5KUF4	110	E	K
P0C0L4	LB/B	-	S9YD43	477	R	W
P0C0L4	LB/B	-	S9YD43	726	P	L
P0C0L4	LB/B	-	S9YD43	1201	T	S
P0C0L4	LB/B	-	S9YD43	1207	V	A
P0C0L4	LB/B	-	S9YD43	1210	L	R
P0C0L4	LB/B	-	S9YD43	1286	S	A
P0C0L4	LB/B	-	S9YD43	347	S	Y
P0C0L4	LB/B	-	S9YD43	727	D	N
P0C0L4	LB/B	-	S9YD43	907	A	T
P0C0L4	LB/B	-	S9YD43	141	L	V
P0C0L4	LB/B	-	S9YD43	418	V	A
P0C0L4	LB/B	-	S9YD43	549	H	P
P0C0L4	LB/B	-	S9YD43	1073	D	G
P0C0L4	LB/B	-	S9YD43	1176	N	S
P0C0L5	LB/B	-	S9YD43	347	S	Y
P0C0L5	LB/B	-	S9YD43	907	T	A
P0C0L5	LB/B	-	S9YD43	1073	G	D
P0C0L5	LB/B	-	S9YD43	1176	S	N
P0C0L5	LB/B	-	S9YD43	1207	A	V
P0C0L5	LB/B	-	S9YD43	1210	R	L
P0C0L5	LB/B	-	S9YD43	478	P	L
P0C0L5	LB/B	-	S9YD43	1317	I	F
P04003	LB/B	-	G1T7A2	357	Y	H
P04003	LB/B	-	G1T7A2	473	W	L
P04003	LB/B	-	G1T7A2	300	I	T
P04003	LB/B	-	G1T7A2	60	A	V
P04003	LB/B	-	G1T7A2	4	P	Q
P04003	LB/B	-	G1T7A2	240	R	H
P20851	LB/B	-	A0A2Y9DIM5	198	P	S
P20851	LB/B	-	A0A2Y9DIM5	102	K	Q
Q53FE4	LB/B	-	A0A212CM14	64	G	E
Q53FE4	LB/B	-	A0A212CM14	85	S	P
Q53FE4	LB/B	-	A0A212CM14	91	E	K
Q8IY42	LB/B	-	F7ENJ8	151	A	T
Q8IY42	LB/B	-	F7ENJ8	274	E	G
Q8IY42	LB/B	-	F7ENJ8	39	D	E
Q8N1A6	LB/B	-	A0A1S3RE09	40	R	M
Q8N1A6	LB/B	-	A0A1S3RE09	104	S	L
Q8N1A6	LB/B	-	A0A1S3RE09	107	M	V
Q8N1A6	LB/B	-	A0A1S3RE09	166	H	R
Q96KX1	LB/B	-	L8HUL9	36	S	Y
Q96KX1	LB/B	-	L8HUL9	18	S	N
Q96LM5	LB/B	-	A0A2K6EF25	46	A	V
Q96LM5	LB/B	-	A0A2K6EF25	75	S	G
Q96LM5	LB/B	-	A0A2K6EF25	84	Y	C
Q96LM5	LB/B	-	A0A2K6EF25	93	G	E
Q96LM5	LB/B	-	A0A2K6EF25	134	R	H
Q6ZRC1	LB/B	-	A0A2I2ZEE7	86	R	W
Q6ZRC1	LB/B	-	A0A2I2ZEE7	177	I	V
Q6ZRC1	LB/B	-	A0A2I2ZEE7	199	V	M
P01031	LB/B	-	A0A1S3G9Q2	518	F	S
P01031	LB/B	-	A0A1S3G9Q2	802	V	I
P01031	LB/B	-	A0A1S3G9Q2	1053	M	L
P01031	LB/B	-	A0A1S3G9Q2	1310	S	N
P01031	LB/B	-	A0A1S3G9Q2	1437	E	D
P01031	LB/B	-	A0A1S3G9Q2	389	T	I
P01031	LB/B	-	A0A1S3G9Q2	145	V	I
P01031	LB/B	-	A0A1S3G9Q2	449	R	G
P01031	LB/B	-	A0A1S3G9Q2	928	R	Q
P01031	LB/B	-	A0A1S3G9Q2	933	G	V
P01031	LB/B	-	A0A1S3G9Q2	1033	I	T
P01031	LB/B	-	A0A1S3G9Q2	1037	D	N
P01031	LB/B	-	A0A1S3G9Q2	1043	Q	K
P01031	LB/B	-	A0A1S3G9Q2	354	L	M
P01031	LB/B	-	A0A1S3G9Q2	966	D	Y
P01031	LB/B	-	A0A1S3G9Q2	1365	V	A
P01031	LB/B	-	A0A1S3G9Q2	885	R	C
P01031	LB/B	-	A0A1S3G9Q2	885	R	H
P21730	LB/B	-	A0A2Y9P492	2	D	N
P21730	LB/B	-	A0A2Y9P492	279	K	N
Q9P296	LB/B	-	Q5XPY4	233	P	L
A6NFR6	LB/B	-	A0A0D9R5N2	55	R	C
A6NFR6	LB/B	-	A0A0D9R5N2	56	L	P
Q2M2E5	LB/B	-	G7P7L2	57	A	T
Q2M2E5	LB/B	-	G7P7L2	101	R	W
P13671	LB/B	-	I3MBA4	119	A	E
P13671	LB/B	-	I3MBA4	397	K	E
P13671	LB/B	-	I3MBA4	470	S	F
Q5T0Z8	LB/B	-	A0A2K6SZM8	4	K	N
Q6UXA7	LB/B	-	U3KPP3	40	L	F
Q6UXA7	LB/B	-	U3KPP3	43	N	D
Q6UXA7	LB/B	-	U3KPP3	83	A	P
Q6UXA7	LB/B	-	U3KPP3	165	K	E
Q6UXA7	LB/B	-	U3KPP3	81	V	A
Q6UXA7	LB/B	-	U3KPP3	145	A	P
Q6UXA7	LB/B	-	U3KPP3	291	G	D
Q6UXA7	LB/B	-	U3KPP3	48	G	R
Q6UXA7	LB/B	-	U3KPP3	232	M	I
Q6UXA7	LB/B	-	U3KPP3	5	V	M
Q9GZU0	LB/B	-	A0A0Q3MCB0	116	W	C
Q9GZU0	LB/B	-	A0A0Q3MCB0	140	R	S
Q9BPX7	LB/B	-	A0A182GKB5	265	G	E
P07357	LB/B	-	F1S788	93	Q	K
P07357	LB/B	-	F1S788	407	T	I
P07357	LB/B	-	F1S788	485	R	L
P07357	LB/B	-	F1S788	561	E	Q
P07357	LB/B	-	F1S788	458	D	N
P07357	LB/B	-	F1S788	575	P	L
P07358	LB/B	-	F1S788	117	R	G
P07358	LB/B	-	F1S788	108	E	K
P07358	LB/B	-	F1S788	261	P	L
P07360	LB/B	-	G3TZT8	69	R	Q
P07360	LB/B	-	G3TZT8	124	H	N
P07360	LB/B	-	G3TZT8	118	D	G
Q96CB5	LB/B	-	A0A2K6B8T1	131	Q	R
Q96CB5	LB/B	-	A0A2K6B8T1	148	F	S
Q6P047	LB/B	-	W5NJA5	15	L	F
Q6P047	LB/B	-	W5NJA5	222	I	V
P02748	LP/P	Complement component 9 deficiency (C9D) [MIM:613825]	A0A2Y9RTB1	119	C	G
P02748	LB/B	-	A0A2Y9RTB1	5	R	W
P02748	LB/B	-	A0A2Y9RTB1	203	I	V
P02748	LB/B	-	A0A2Y9RTB1	279	T	S
P02748	LB/B	-	A0A2Y9RTB1	127	D	Y
P02748	LB/B	-	A0A2Y9RTB1	427	S	T
P02748	LP/P	Macular degeneration, age-related, 15 (ARMD15) [MIM:615591]	A0A2Y9RTB1	167	P	S
Q5VYM1	LB/B	-	G5BXB8	222	W	L
Q5VYM1	LB/B	-	G5BXB8	285	L	F
Q5VYM1	LB/B	-	G5BXB8	437	L	V
Q5VYM1	LB/B	-	G5BXB8	623	S	T
Q5VYM1	LB/B	-	G5BXB8	916	P	S
Q8N9P6	LB/B	-	Q8N9P6	5	L	P
Q8TAL5	LB/B	-	F6TI52	252	D	G
Q5SZB4	LB/B	-	G3N0H9	248	R	K
Q5SZB4	LB/B	-	G3N0H9	312	R	Q
Q5SZB4	LB/B	-	G3N0H9	381	R	Q
Q5SZB4	LB/B	-	G3N0H9	415	K	R
Q9NZ63	LB/B	-	A0A091DIG4	70	Q	H
P00915	LB/B	-	E3TBT6	68	H	R
P00915	LB/B	-	E3TBT6	254	G	R
P00915	LB/B	-	E3TBT6	143	A	V
O43570	LP/P	Hyperchlorhidrosis, isolated (HYCHL) [MIM:143860]	A0A2Y9QTS8	143	E	K
O43570	LP/P	Hyperchlorhidrosis, isolated (HYCHL) [MIM:143860]	A0A2Y9QTS8	121	H	Q
Q8N1Q1	LB/B	-	E3TBT6	68	N	S
P00918	LB/B	-	A0A1U7UDS6	18	K	E
P00918	LP/P	Osteopetrosis, autosomal recessive 3 (OPTB3) [MIM:259730]	A0A1U7UDS6	92	Q	P
P00918	LP/P	Osteopetrosis, autosomal recessive 3 (OPTB3) [MIM:259730]	A0A1U7UDS6	107	H	Y
P00918	LB/B	-	A0A1U7UDS6	236	P	H
P00918	LB/B	-	A0A1U7UDS6	252	N	D
P00918	LP/P	Osteopetrosis, autosomal recessive 3 (OPTB3) [MIM:259730]	A0A1U7UDS6	94	H	Y
P00918	LP/P	Osteopetrosis, autosomal recessive 3 (OPTB3) [MIM:259730]	A0A1U7UDS6	144	G	R
P07451	LB/B	-	A0A2I3S2V9	31	V	I
P22748	LP/P	Retinitis pigmentosa 17 (RP17) [MIM:600852]	Q3U3I1	14	R	W
P22748	LP/P	Retinitis pigmentosa 17 (RP17) [MIM:600852]	Q3U3I1	219	R	S
P22748	LB/B	-	Q3U3I1	237	V	L
P22748	LP/P	Retinitis pigmentosa 17 (RP17) [MIM:600852]	Q3U3I1	12	A	T
P22748	LP/P	Retinitis pigmentosa 17 (RP17) [MIM:600852]	Q3U3I1	69	R	H
P22748	LB/B	-	Q3U3I1	177	N	K
P23280	LB/B	-	M7ASX7	55	T	M
P23280	LB/B	-	M7ASX7	68	M	L
P23280	LB/B	-	M7ASX7	70	G	A
P23280	LB/B	-	M7ASX7	90	S	G
P23280	LB/B	-	M7ASX7	37	Q	L
P23280	LB/B	-	M7ASX7	58	R	W
Q16790	LB/B	-	A0A2Y9QA85	33	V	M
Q16790	LB/B	-	A0A2Y9QA85	326	Q	R
Q9H8G2	LB/B	-	A0A2Y9L9S8	233	V	M
Q9NPB3	LB/B	-	A0A2U3YIY2	94	R	Q
P57796	LP/P	Cone-rod synaptic disorder, congenital non-progressive (CRSD) [MIM:610427]	W5PRH7	124	R	C
Q9NP86	LB/B	-	A0A2K6RAH1	128	V	A
Q9NP86	LB/B	-	A0A2K6RAH1	65	T	R
Q9NP86	LB/B	-	A0A2K6RAH1	80	L	P
Q9NP86	LB/B	-	A0A2K6RAH1	140	E	K
Q9NP86	LB/B	-	A0A2K6RAH1	147	I	S
O75952	LB/B	-	A0A2K5QKS9	490	S	A
O75952	LB/B	-	A0A2K5QKS9	74	T	M
O75952	LB/B	-	A0A2K5QKS9	448	K	R
O75952	LB/B	-	A0A2K5QKS9	186	I	V
Q9UGQ2	LB/B	-	H2ZWM1	58	I	M
Q5VU97	LB/B	-	A0A091CZ88	414	M	T
Q00975	LB/B	-	H0V358	167	N	K
Q00975	LB/B	-	H0V358	1436	E	K
Q00975	LB/B	-	H0V358	1500	E	K
Q00975	LB/B	-	H0V358	862	A	S
Q00975	LB/B	-	H0V358	996	T	A
Q15878	LB/B	-	I3M4N4	859	D	E
Q15878	LB/B	-	I3M4N4	1955	A	T
Q15878	LP/P	Developmental and epileptic encephalopathy 69 (DEE69) [MIM:618285]	I3M4N4	228	L	P
Q15878	LP/P	Developmental and epileptic encephalopathy 69 (DEE69) [MIM:618285]	I3M4N4	348	G	R
Q15878	LP/P	Developmental and epileptic encephalopathy 69 (DEE69) [MIM:618285]	I3M4N4	352	G	R
Q15878	LP/P	Developmental and epileptic encephalopathy 69 (DEE69) [MIM:618285]	I3M4N4	603	I	L
Q15878	LP/P	Developmental and epileptic encephalopathy 69 (DEE69) [MIM:618285]	I3M4N4	690	G	D
Q15878	LP/P	Developmental and epileptic encephalopathy 69 (DEE69) [MIM:618285]	I3M4N4	698	F	S
Q15878	LP/P	Developmental and epileptic encephalopathy 69 (DEE69) [MIM:618285]	I3M4N4	700	A	T
Q15878	LP/P	Developmental and epileptic encephalopathy 69 (DEE69) [MIM:618285]	I3M4N4	701	I	V
Q15878	LP/P	Developmental and epileptic encephalopathy 69 (DEE69) [MIM:618285]	I3M4N4	702	A	P
Q15878	LP/P	Developmental and epileptic encephalopathy 69 (DEE69) [MIM:618285]	I3M4N4	702	A	T
Q15878	LP/P	Developmental and epileptic encephalopathy 69 (DEE69) [MIM:618285]	I3M4N4	1422	I	F
Q15878	LP/P	Developmental and epileptic encephalopathy 69 (DEE69) [MIM:618285]	I3M4N4	1425	T	N
Q15878	LP/P	Developmental and epileptic encephalopathy 69 (DEE69) [MIM:618285]	I3M4N4	1430	G	R
Q15878	LP/P	Developmental and epileptic encephalopathy 69 (DEE69) [MIM:618285]	I3M4N4	1720	A	G
O60840	LP/P	Night blindness, congenital stationary, 2A (CSNB2A) [MIM:300071]	A0A091DIQ3	369	G	D
O60840	LP/P	Night blindness, congenital stationary, 2A (CSNB2A) [MIM:300071]	A0A091DIQ3	519	R	Q
O60840	LP/P	Night blindness, congenital stationary, 2A (CSNB2A) [MIM:300071]	A0A091DIQ3	1060	R	W
O60840	LP/P	Night blindness, congenital stationary, 2A (CSNB2A) [MIM:300071]	A0A091DIQ3	1375	L	H
O60840	LB/B	-	A0A091DIQ3	746	N	T
O60840	LB/B	-	A0A091DIQ3	14	P	L
O60840	LP/P	Night blindness, congenital stationary, 2A (CSNB2A) [MIM:300071]	A0A091DIQ3	74	C	R
O60840	LP/P	Night blindness, congenital stationary, 2A (CSNB2A) [MIM:300071]	A0A091DIQ3	150	G	R
O60840	LP/P	Night blindness, congenital stationary, 2A (CSNB2A) [MIM:300071]	A0A091DIQ3	229	S	P
O60840	LP/P	Night blindness, congenital stationary, 2A (CSNB2A) [MIM:300071]	A0A091DIQ3	261	G	R
O60840	LP/P	Night blindness, congenital stationary, 2A (CSNB2A) [MIM:300071]	A0A091DIQ3	674	G	D
O60840	LP/P	Night blindness, congenital stationary, 2A (CSNB2A) [MIM:300071]	A0A091DIQ3	753	F	C
O60840	LP/P	Night blindness, congenital stationary, 2A (CSNB2A) [MIM:300071]	A0A091DIQ3	756	I	T
O60840	LP/P	Night blindness, congenital stationary, 2A (CSNB2A) [MIM:300071]	A0A091DIQ3	860	L	P
O60840	LP/P	Night blindness, congenital stationary, 2A (CSNB2A) [MIM:300071]	A0A091DIQ3	928	A	D
O60840	LP/P	Night blindness, congenital stationary, 2A (CSNB2A) [MIM:300071]	A0A091DIQ3	1018	G	R
O60840	LP/P	Night blindness, congenital stationary, 2A (CSNB2A) [MIM:300071]	A0A091DIQ3	1079	L	P
O60840	LP/P	Night blindness, congenital stationary, 2A (CSNB2A) [MIM:300071]	A0A091DIQ3	1499	C	R
O60840	LP/P	Night blindness, congenital stationary, 2A (CSNB2A) [MIM:300071]	A0A091DIQ3	1500	P	R
O60840	LP/P	Night blindness, congenital stationary, 2A (CSNB2A) [MIM:300071]	A0A091DIQ3	1508	L	P
O60840	LB/B	-	A0A091DIQ3	1270	A	T
O60840	LB/B	-	A0A091DIQ3	1930	R	H
O60840	LB/B	-	A0A091DIQ3	1259	A	T
O60840	LP/P	Aaland island eye disease (AIED) [MIM:300600]	A0A091DIQ3	603	G	R
O60840	LP/P	Night blindness, congenital stationary, 2A (CSNB2A) [MIM:300071]	A0A091DIQ3	603	G	R
Q9P0X4	LB/B	-	G1RZ76	1040	I	V
Q9P0X4	LB/B	-	G1RZ76	1782	G	A
Q9P0X4	LB/B	-	G1RZ76	1782	G	R
Q9P0X4	LB/B	-	G1RZ76	1513	T	M
Q9P0X4	LP/P	Neurodevelopmental disorder with speech impairment and with or without seizures (NEDSIS) [MIM:620114]	G1RZ76	860	I	M
Q9P0X4	LP/P	Neurodevelopmental disorder with speech impairment and with or without seizures (NEDSIS) [MIM:620114]	G1RZ76	860	I	N
Q9P0X4	LP/P	Neurodevelopmental disorder with speech impairment and with or without seizures (NEDSIS) [MIM:620114]	G1RZ76	1306	I	T
Q9P0X4	LP/P	Neurodevelopmental disorder with speech impairment and with or without seizures (NEDSIS) [MIM:620114]	G1RZ76	1425	M	I
Q13698	LB/B	-	L9K8G5	458	L	H
Q13698	LP/P	Periodic paralysis hypokalemic 1 (HOKPP1) [MIM:170400]	L9K8G5	528	R	H
Q13698	LP/P	Malignant hyperthermia 5 (MHS5) [MIM:601887]	L9K8G5	1086	R	H
Q13698	LP/P	Periodic paralysis hypokalemic 1 (HOKPP1) [MIM:170400]	L9K8G5	1239	R	G
Q13698	LP/P	Periodic paralysis hypokalemic 1 (HOKPP1) [MIM:170400]	L9K8G5	1239	R	H
Q13698	LB/B	-	L9K8G5	1539	R	C
Q13698	LB/B	-	L9K8G5	69	A	G
Q13698	LB/B	-	L9K8G5	1658	R	H
Q13698	LB/B	-	L9K8G5	1800	L	S
Q13698	LB/B	-	L9K8G5	1840	E	D
Q13698	LP/P	Periodic paralysis hypokalemic 1 (HOKPP1) [MIM:170400]	L9K8G5	528	R	G
Q13698	LP/P	Periodic paralysis hypokalemic 1 (HOKPP1) [MIM:170400]	L9K8G5	900	R	S
P54289	LB/B	-	F7C1C8	1057	D	A
P54289	LB/B	-	F7C1C8	1019	E	D
P54289	LP/P	Developmental and epileptic encephalopathy 110 (DEE110) [MIM:620149]	F7C1C8	209	G	D
Q9NY47	LB/B	-	A0A1V4K8V4	138	A	V
Q9NY47	LB/B	-	A0A1V4K8V4	334	E	K
Q9NY47	LP/P	Cerebellar atrophy with seizures and variable developmental delay (CASVDD) [MIM:618501]	A0A1V4K8V4	1047	L	P
Q7Z3S7	LB/B	-	A0A1S3W403	327	I	V
Q7Z3S7	LB/B	-	A0A1S3W403	863	R	H
Q7Z3S7	LB/B	-	A0A1S3W403	869	T	M
Q06432	LB/B	-	A0A2K5YV94	196	G	S
Q9Y698	LP/P	Intellectual developmental disorder, autosomal dominant 10 (MRD10) [MIM:614256]	A0A1U7TN61	143	V	L
Q9BXT2	LB/B	-	H3A7G5	252	C	S
P27708	LP/P	Developmental and epileptic encephalopathy 50 (DEE50) [MIM:616457]	G7PLV5	2024	R	Q
Q8N126	LB/B	-	G1TBI5	162	R	W
Q8N126	LP/P	Charcot-Marie-Tooth disease, axonal, 2FF (CMT2FF) [MIM:619519]	G1TBI5	138	Y	C
Q86UW7	LB/B	-	H3CYI5	298	A	T
Q8TC20	LB/B	-	A0A2I3HRL4	169	T	I
Q8TC20	LB/B	-	A0A2I3HRL4	282	E	A
P01258	LB/B	-	A0A151MC14	57	D	N
P01258	LB/B	-	A0A151MC14	76	S	R
P01258	LB/B	-	A0A151MC14	2	G	R
P01258	LB/B	-	A0A151MC14	67	E	K
P01258	LB/B	-	A0A151MC14	123	S	T
P01258	LB/B	-	A0A151MC14	138	Q	P
P06881	LB/B	-	A0A1S3KVI1	57	D	N
P30988	LB/B	-	A0A1S2ZPI0	447	L	P
Q16602	LB/B	-	Q1LYA6	16	F	L
Q16602	LB/B	-	Q1LYA6	274	R	I
Q16602	LB/B	-	Q1LYA6	8	Y	N
Q05682	LB/B	-	A0A0G2JTV2	397	H	R
Q5R3K3	LB/B	-	A0A2Y9LU54	80	G	R
Q5R3K3	LB/B	-	A0A2Y9LU54	293	E	K
Q5R3K3	LB/B	-	A0A2Y9LU54	100	T	A
P0DP23	LP/P	Ventricular tachycardia, catecholaminergic polymorphic, 4 (CPVT4) [MIM:614916]	A0A0V1EE01	54	N	I
P0DP23	LP/P	Long QT syndrome 14 (LQT14) [MIM:616247]	A0A0V1EE01	90	F	L
P0DP23	LP/P	Long QT syndrome 14 (LQT14) [MIM:616247]	A0A0V1EE01	142	F	L
P0DP23	LP/P	Long QT syndrome 14 (LQT14) [MIM:616247]	A0A0V1EE01	141	E	G
P0DP23	LP/P	Ventricular tachycardia, catecholaminergic polymorphic, 4 (CPVT4) [MIM:614916]	A0A0V1EE01	98	N	S
P0DP23	LP/P	Long QT syndrome 14 (LQT14) [MIM:616247]	A0A0V1EE01	130	D	G
P0DP23	LP/P	Long QT syndrome 14 (LQT14) [MIM:616247]	A0A0V1EE01	141	E	V
P0DP24	LP/P	Long QT syndrome 15 (LQT15) [MIM:616249]	A0A0V1EE01	96	D	V
P0DP24	LP/P	Long QT syndrome 15 (LQT15) [MIM:616249]	A0A0V1EE01	98	N	I
P0DP24	LP/P	Long QT syndrome 15 (LQT15) [MIM:616249]	A0A0V1EE01	132	D	E
P0DP24	LP/P	Long QT syndrome 15 (LQT15) [MIM:616249]	A0A0V1EE01	134	D	H
P0DP24	LP/P	Long QT syndrome 15 (LQT15) [MIM:616249]	A0A0V1EE01	136	Q	P
P0DP24	LP/P	Long QT syndrome 15 (LQT15) [MIM:616249]	A0A0V1EE01	130	D	V
P0DP24	LP/P	Long QT syndrome 15 (LQT15) [MIM:616249]	A0A0V1EE01	98	N	S
P0DP24	LP/P	Long QT syndrome 15 (LQT15) [MIM:616249]	A0A0V1EE01	130	D	G
P0DP25	LP/P	Ventricular tachycardia, catecholaminergic polymorphic, 6 (CPVT6) [MIM:618782]	A0A0V1EE01	103	A	V
P0DP25	LP/P	Long QT syndrome 16 (LQT16) [MIM:618782]	A0A0V1EE01	130	D	G
P0DP25	LP/P	Long QT syndrome 16 (LQT16) [MIM:618782]	A0A0V1EE01	141	E	K
Q96GE6	LB/B	-	A0A2U3Z8V7	28	R	C
Q96GE6	LB/B	-	A0A2U3Z8V7	154	T	K
Q9NZT1	LB/B	-	D4ABY7	58	S	G
Q9NZT1	LB/B	-	D4ABY7	74	K	R
Q8TD86	LB/B	-	A0A2Y9ED85	60	W	R
O43852	LB/B	-	A0A146ZIY9	4	R	Q
Q14012	LB/B	-	A0A1A6HLQ2	361	E	K
Q8IU85	LB/B	-	W5LF90	66	I	M
Q96NX5	LB/B	-	G3H2M6	329	V	I
Q96NX5	LB/B	-	G3H2M6	259	E	Q
Q13554	LB/B	-	H9GIS3	510	E	K
Q13554	LP/P	Intellectual developmental disorder, autosomal dominant 54 (MRD54) [MIM:617799]	H9GIS3	110	E	K
Q13554	LP/P	Intellectual developmental disorder, autosomal dominant 54 (MRD54) [MIM:617799]	H9GIS3	139	P	L
Q13554	LP/P	Intellectual developmental disorder, autosomal dominant 54 (MRD54) [MIM:617799]	H9GIS3	237	E	K
Q13554	LP/P	Intellectual developmental disorder, autosomal dominant 54 (MRD54) [MIM:617799]	H9GIS3	301	K	E
Q13554	LP/P	Intellectual developmental disorder, autosomal dominant 54 (MRD54) [MIM:617799]	H9GIS3	213	P	L
Q13554	LP/P	Intellectual developmental disorder, autosomal dominant 54 (MRD54) [MIM:617799]	H9GIS3	284	R	S
Q13557	LB/B	-	A0A1S3W7H6	463	Q	E
Q13557	LB/B	-	A0A1S3W7H6	167	D	E
Q13557	LB/B	-	A0A1S3W7H6	493	T	I
Q13555	LB/B	-	A0A1S3W7H6	36	S	P
Q13555	LP/P	Intellectual developmental disorder, autosomal dominant 59 (MRD59) [MIM:618522]	A0A1S3W7H6	292	R	P
Q16566	LB/B	-	A0A2Y9PMY3	178	D	N
Q16566	LB/B	-	A0A2Y9PMY3	465	Q	R
Q8N5S9	LB/B	-	F6QSP1	375	E	G
Q96RR4	LB/B	-	A0A2K6BSU9	85	T	S
Q96RR4	LB/B	-	A0A2K6BSU9	363	R	C
Q96RR4	LB/B	-	A0A2K6BSU9	10	S	N
Q96RR4	LB/B	-	A0A2K6BSU9	123	C	Y
Q96RR4	LB/B	-	A0A2K6BSU9	492	R	H
Q08AD1	LB/B	-	G1PV00	958	P	L
Q08AD1	LB/B	-	G1PV00	1028	R	P
Q08AD1	LB/B	-	G1PV00	969	P	L
Q08AD1	LB/B	-	G1PV00	1039	P	R
Q9P1Y5	LB/B	-	G1PV00	335	P	S
Q86VP6	LB/B	-	F1RYI3	952	A	V
Q86VP6	LB/B	-	F1RYI3	803	V	A
O75155	LB/B	-	A0A2P2I5E0	408	Q	R
O75155	LB/B	-	A0A2P2I5E0	476	P	L
O75155	LB/B	-	A0A2P2I5E0	533	S	P
O75155	LB/B	-	A0A2P2I5E0	655	H	R
O75155	LB/B	-	A0A2P2I5E0	845	L	F
O75155	LB/B	-	A0A2P2I5E0	858	H	P
O75155	LB/B	-	A0A2P2I5E0	990	V	I
O75155	LB/B	-	A0A2P2I5E0	1225	A	T
Q8WVQ1	LP/P	Desbuquois dysplasia 1 (DBQD1) [MIM:251450]	V9K8K2	299	P	L
Q8WVQ1	LP/P	Desbuquois dysplasia 1 (DBQD1) [MIM:251450]	V9K8K2	300	R	C
Q8WVQ1	LP/P	Desbuquois dysplasia 1 (DBQD1) [MIM:251450]	V9K8K2	300	R	H
Q8WVQ1	LP/P	Desbuquois dysplasia 1 (DBQD1) [MIM:251450]	V9K8K2	112	D	E
Q8WVQ1	LP/P	Desbuquois dysplasia 1 (DBQD1) [MIM:251450]	V9K8K2	125	W	C
Q8WVQ1	LP/P	Desbuquois dysplasia 1 (DBQD1) [MIM:251450]	V9K8K2	165	M	T
Q8WVQ1	LP/P	Desbuquois dysplasia 1 (DBQD1) [MIM:251450]	V9K8K2	224	L	P
Q8WVQ1	LP/P	Desbuquois dysplasia 1 (DBQD1) [MIM:251450]	V9K8K2	226	V	M
Q8WVQ1	LP/P	Epiphyseal dysplasia, multiple, 7 (EDM7) [MIM:617719]	V9K8K2	226	V	M
Q8WVQ1	LP/P	Desbuquois dysplasia 1 (DBQD1) [MIM:251450]	V9K8K2	303	S	R
Q8WVQ1	LB/B	-	V9K8K2	323	A	T
Q8WVQ1	LP/P	Desbuquois dysplasia 1 (DBQD1) [MIM:251450]	V9K8K2	360	A	D
Q8WVQ1	LP/P	Desbuquois dysplasia 1 (DBQD1) [MIM:251450]	V9K8K2	374	I	N
Q8WVQ1	LB/B	-	V9K8K2	391	G	E
Q01518	LB/B	-	M3WFC4	229	C	G
Q01518	LB/B	-	M3WFC4	236	C	G
Q01518	LB/B	-	M3WFC4	245	I	S
Q01518	LB/B	-	M3WFC4	247	C	G
Q01518	LB/B	-	M3WFC4	249	Y	D
Q01518	LB/B	-	M3WFC4	256	S	A
P40123	LB/B	-	M3WFC4	311	T	A
P40123	LB/B	-	M3WFC4	316	Y	C
P40121	LB/B	-	A0A2K5S936	41	V	I
P40121	LB/B	-	A0A2K5S936	198	R	W
P40121	LB/B	-	A0A2K5S936	335	H	R
P07384	LB/B	-	A0A2K6B5L3	103	T	A
P07384	LB/B	-	A0A2K6B5L3	433	R	P
P07384	LB/B	-	A0A2K6B5L3	492	G	R
P07384	LB/B	-	A0A2K6B5L3	676	V	I
P07384	LP/P	Spastic paraplegia 76, autosomal recessive (SPG76) [MIM:616907]	A0A2K6B5L3	295	R	P
Q9HC96	LB/B	-	A0A2Y9RY55	200	P	T
Q9HC96	LB/B	-	A0A2Y9RY55	202	R	H
Q9HC96	LB/B	-	A0A2Y9RY55	341	A	V
Q9HC96	LB/B	-	A0A2Y9RY55	504	T	A
Q9HC96	LB/B	-	A0A2Y9RY55	529	A	S
Q9HC96	LB/B	-	A0A2Y9RY55	613	S	N
Q9HC96	LB/B	-	A0A2Y9RY55	666	I	V
Q9UMQ6	LB/B	-	A0A2K6B5L3	728	S	N
Q9UMQ6	LB/B	-	A0A2K6B5L3	266	V	M
Q9UMQ6	LB/B	-	A0A2K6B5L3	441	V	A
Q9UMQ6	LB/B	-	A0A2K6B5L3	521	I	V
Q9UMQ6	LB/B	-	A0A2K6B5L3	544	S	R
Q6ZSI9	LB/B	-	A0A2K6B5L3	287	C	R
Q6MZZ7	LB/B	-	A0A2Y9SF98	249	H	Y
Q6MZZ7	LB/B	-	A0A2Y9SF98	280	A	T
Q6MZZ7	LB/B	-	A0A2Y9SF98	596	I	T
P17655	LB/B	-	A0A2K6B5L3	22	D	E
P17655	LB/B	-	A0A2K6B5L3	568	K	Q
P17655	LB/B	-	A0A2K6B5L3	68	S	G
P17655	LB/B	-	A0A2K6B5L3	476	K	R
P17655	LB/B	-	A0A2K6B5L3	521	E	Q
P17655	LB/B	-	A0A2K6B5L3	677	K	Q
P20807	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) [MIM:253600]	C0H9F2	182	L	Q
P20807	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) [MIM:253600]	C0H9F2	234	G	E
P20807	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) [MIM:253600]	C0H9F2	354	V	G
P20807	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) [MIM:253600]	C0H9F2	490	R	W
P20807	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) [MIM:253600]	C0H9F2	572	R	Q
P20807	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) [MIM:253600]	C0H9F2	744	S	G
P20807	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) [MIM:253600]	C0H9F2	769	R	Q
P20807	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) [MIM:253600]	C0H9F2	4	V	I
P20807	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) [MIM:253600]	C0H9F2	26	P	L
P20807	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) [MIM:253600]	C0H9F2	77	D	N
P20807	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) [MIM:253600]	C0H9F2	86	S	F
P20807	LB/B	-	C0H9F2	107	E	K
P20807	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) [MIM:253600]	C0H9F2	118	R	G
P20807	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) [MIM:253600]	C0H9F2	137	C	R
P20807	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) [MIM:253600]	C0H9F2	162	I	L
P20807	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) [MIM:253600]	C0H9F2	183	P	L
P20807	LB/B	-	C0H9F2	184	T	M
P20807	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) [MIM:253600]	C0H9F2	189	L	P
P20807	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) [MIM:253600]	C0H9F2	214	G	S
P20807	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) [MIM:253600]	C0H9F2	215	S	P
P20807	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) [MIM:253600]	C0H9F2	217	E	K
P20807	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) [MIM:253600]	C0H9F2	222	G	R
P20807	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) [MIM:253600]	C0H9F2	226	E	K
P20807	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) [MIM:253600]	C0H9F2	232	T	I
P20807	LB/B	-	C0H9F2	236	A	T
P20807	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) [MIM:253600]	C0H9F2	319	P	L
P20807	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) [MIM:253600]	C0H9F2	334	H	Q
P20807	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) [MIM:253600]	C0H9F2	336	Y	N
P20807	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) [MIM:253600]	C0H9F2	360	W	C
P20807	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) [MIM:253600]	C0H9F2	437	R	C
P20807	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) [MIM:253600]	C0H9F2	440	R	W
P20807	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) [MIM:253600]	C0H9F2	441	G	D
P20807	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) [MIM:253600]	C0H9F2	445	G	R
P20807	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) [MIM:253600]	C0H9F2	448	R	C
P20807	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) [MIM:253600]	C0H9F2	448	R	G
P20807	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) [MIM:253600]	C0H9F2	448	R	H
P20807	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) [MIM:253600]	C0H9F2	479	S	G
P20807	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) [MIM:253600]	C0H9F2	486	Q	E
P20807	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) [MIM:253600]	C0H9F2	489	R	Q
P20807	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) [MIM:253600]	C0H9F2	489	R	W
P20807	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) [MIM:253600]	C0H9F2	490	R	Q
P20807	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) [MIM:253600]	C0H9F2	493	R	W
P20807	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) [MIM:253600]	C0H9F2	496	G	R
P20807	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) [MIM:253600]	C0H9F2	502	I	T
P20807	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) [MIM:253600]	C0H9F2	541	R	Q
P20807	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) [MIM:253600]	C0H9F2	567	G	W
P20807	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) [MIM:253600]	C0H9F2	572	R	W
P20807	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) [MIM:253600]	C0H9F2	606	S	L
P20807	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) [MIM:253600]	C0H9F2	638	Q	P
P20807	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) [MIM:253600]	C0H9F2	698	R	P
P20807	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) [MIM:253600]	C0H9F2	702	A	V
P20807	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) [MIM:253600]	C0H9F2	705	D	G
P20807	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) [MIM:253600]	C0H9F2	705	D	H
P20807	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) [MIM:253600]	C0H9F2	731	F	S
P20807	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) [MIM:253600]	C0H9F2	748	R	Q
P20807	LB/B	-	C0H9F2	160	A	G
P20807	LB/B	-	C0H9F2	21	G	E
P20807	LB/B	-	C0H9F2	622	E	A
O15484	LP/P	Vitreoretinopathy, neovascular inflammatory (VRNI) [MIM:193235]	L5JLY9	243	R	L
O15484	LP/P	Vitreoretinopathy, neovascular inflammatory (VRNI) [MIM:193235]	L5JLY9	244	L	P
Q9Y6Q1	LB/B	-	A0A1S3NRU4	277	V	L
Q9Y6Q1	LB/B	-	A0A1S3NRU4	518	T	I
O14815	LB/B	-	A0A1A8U8S2	102	A	V
O14815	LB/B	-	A0A1A8U8S2	122	S	R
O14815	LB/B	-	A0A1A8U8S2	164	D	N
O14815	LB/B	-	A0A1A8U8S2	234	I	T
O14815	LB/B	-	A0A1A8U8S2	239	A	T
O14815	LB/B	-	A0A1A8U8S2	277	R	W
O14815	LB/B	-	A0A1A8U8S2	322	K	Q
O14815	LB/B	-	A0A1A8U8S2	327	H	Q
O14815	LB/B	-	A0A1A8U8S2	342	E	K
O14815	LB/B	-	A0A1A8U8S2	458	R	W
O14815	LB/B	-	A0A1A8U8S2	522	R	W
O14815	LB/B	-	A0A1A8U8S2	611	M	I
P04632	LB/B	-	A0A2K6FTT2	224	M	V
Q6IMN6	LB/B	-	A0A151NIE0	519	M	V
Q6IMN6	LB/B	-	A0A151NIE0	114	P	S
Q6IMN6	LB/B	-	A0A151NIE0	237	K	R
Q6IMN6	LB/B	-	A0A151NIE0	655	S	L
Q13938	LB/B	-	A0A2K6N0K0	125	R	G
Q9BXL7	LB/B	-	A0A0Q3U6D1	670	T	M
Q9BXL7	LB/B	-	A0A0Q3U6D1	694	S	L
Q9BXL7	LP/P	B-cell expansion with NFKB and T-cell anergy (BENTA) [MIM:616452]	A0A0Q3U6D1	123	G	S
Q9BXL7	LP/P	B-cell expansion with NFKB and T-cell anergy (BENTA) [MIM:616452]	A0A0Q3U6D1	134	E	G
Q9BXL7	LP/P	Immunodeficiency 11B with atopic dermatitis (IMD11B) [MIM:617638]	A0A0Q3U6D1	57	E	D
Q9BXL7	LP/P	Immunodeficiency 11B with atopic dermatitis (IMD11B) [MIM:617638]	A0A0Q3U6D1	194	L	P
Q9BXL7	LP/P	Immunodeficiency 11B with atopic dermatitis (IMD11B) [MIM:617638]	A0A0Q3U6D1	975	R	W
Q5EG05	LB/B	-	Q5EG05	33	R	S
Q5EG05	LB/B	-	Q5EG05	37	Q	K
Q5EG05	LB/B	-	Q5EG05	56	A	D
Q5EG05	LB/B	-	Q5EG05	167	N	I
Q9BX69	LB/B	-	G3SS93	86	S	L
Q9BX69	LB/B	-	G3SS93	93	R	K
Q9BX69	LB/B	-	G3SS93	395	M	K
Q9BX69	LB/B	-	G3SS93	426	D	V
Q9BX69	LB/B	-	G3SS93	575	A	D
Q9BX69	LB/B	-	G3SS93	576	I	V
Q9Y2G2	LB/B	-	A0A2I3RB11	173	I	V
Q9Y2G2	LB/B	-	A0A2I3RB11	204	E	A
Q9Y2G2	LP/P	Inflammatory bowel disease 30 (IBD30) [MIM:619079]	A0A2I3RB11	102	F	I
Q9H257	LB/B	-	H0ZY39	12	S	N
Q9H257	LP/P	Immunodeficiency 103, susceptibility to fungal infections (IMD103) [MIM:212050]	H0ZY39	72	G	S
Q9H257	LP/P	Immunodeficiency 103, susceptibility to fungal infections (IMD103) [MIM:212050]	H0ZY39	101	R	C
Q9H257	LP/P	Immunodeficiency 103, susceptibility to fungal infections (IMD103) [MIM:212050]	H0ZY39	373	R	P
Q9H257	LP/P	Immunodeficiency 103, susceptibility to fungal infections (IMD103) [MIM:212050]	H0ZY39	18	R	W
Q9H257	LP/P	Immunodeficiency 103, susceptibility to fungal infections (IMD103) [MIM:212050]	H0ZY39	35	R	Q
Q9H257	LP/P	Immunodeficiency 103, susceptibility to fungal infections (IMD103) [MIM:212050]	H0ZY39	57	R	H
Q9H257	LP/P	Immunodeficiency 103, susceptibility to fungal infections (IMD103) [MIM:212050]	H0ZY39	70	R	W
Q9H257	LP/P	Immunodeficiency 103, susceptibility to fungal infections (IMD103) [MIM:212050]	H0ZY39	91	Y	H
Q9H257	LP/P	Immunodeficiency 103, susceptibility to fungal infections (IMD103) [MIM:212050]	H0ZY39	101	R	L
Q9H257	LP/P	Immunodeficiency 103, susceptibility to fungal infections (IMD103) [MIM:212050]	H0ZY39	196	K	E
Q9H257	LP/P	Immunodeficiency 103, susceptibility to fungal infections (IMD103) [MIM:212050]	H0ZY39	380	A	P
Q8ND23	LB/B	-	A0A212CUA7	1022	L	M
P49589	LP/P	Microcephaly, developmental delay, and brittle hair syndrome (MDBH) [MIM:618891]	L9LB79	341	R	H
P49589	LP/P	Microcephaly, developmental delay, and brittle hair syndrome (MDBH) [MIM:618891]	L9LB79	359	S	L
P49589	LP/P	Microcephaly, developmental delay, and brittle hair syndrome (MDBH) [MIM:618891]	L9LB79	400	L	Q
Q96PB1	LB/B	-	A0A1S3H9M8	386	R	S
O14936	LP/P	FG syndrome 4 (FGS4) [MIM:300422]	U5ENN4	28	R	L
O14936	LP/P	Intellectual developmental disorder with microcephaly and pontine and cerebellar hypoplasia (MICPCH) [MIM:300749]	U5ENN4	268	Y	H
O14936	LP/P	Intellectual developmental disorder with microcephaly and pontine and cerebellar hypoplasia (MICPCH) [MIM:300749]	U5ENN4	396	P	S
O14936	LP/P	Intellectual developmental disorder with microcephaly and pontine and cerebellar hypoplasia (MICPCH) [MIM:300749]	U5ENN4	710	D	G
Q8WXE0	LB/B	-	W5PLD0	891	E	G
Q92851	LP/P	Autoimmune lymphoproliferative syndrome 2A (ALPS2A) [MIM:603909]	A0A1W4XZR3	285	L	F
Q92851	LB/B	-	A0A1W4XZR3	410	V	I
Q92851	LP/P	Gastric cancer (GASC) [MIM:613659]	A0A1W4XZR3	147	M	T
Q92851	LB/B	-	A0A1W4XZR3	406	I	L
Q92851	LP/P	Familial non-Hodgkin lymphoma (NHL) [MIM:605027]	A0A1W4XZR3	414	A	V
Q92851	LB/B	-	A0A1W4XZR3	446	Y	C
Q92851	LB/B	-	A0A1W4XZR3	239	S	C
Q92851	LB/B	-	A0A1W4XZR3	444	P	S
Q92851	LB/B	-	A0A1W4XZR3	21	R	C
P42575	LB/B	-	A0A1S3N276	172	V	L
P42575	LB/B	-	A0A1S3N276	178	P	A
P42575	LB/B	-	A0A1S3N276	441	R	G
P42575	LB/B	-	A0A1S3N276	105	A	G
P42574	LB/B	-	W5N8J1	190	E	D
P42574	LB/B	-	W5N8J1	22	H	R
P49662	LB/B	-	G5BVT8	47	D	N
P49662	LB/B	-	G5BVT8	284	E	D
P49662	LB/B	-	G5BVT8	134	R	C
P51878	LB/B	-	A0A2K6LQE6	29	F	L
P51878	LB/B	-	A0A2K6LQE6	168	R	H
P51878	LB/B	-	A0A2K6LQE6	217	V	L
P51878	LB/B	-	A0A2K6LQE6	19	K	N
P51878	LB/B	-	A0A2K6LQE6	26	L	W
P51878	LB/B	-	A0A2K6LQE6	106	T	A
P51878	LB/B	-	A0A2K6LQE6	334	L	V
P51878	LB/B	-	A0A2K6LQE6	353	E	K
P51878	LB/B	-	A0A2K6LQE6	75	L	R
P51878	LB/B	-	A0A2K6LQE6	298	R	H
P51878	LB/B	-	A0A2K6LQE6	382	E	Q
P55212	LB/B	-	A0A1U7S1Q9	109	A	T
P55212	LB/B	-	A0A1U7S1Q9	182	T	S
P55212	LB/B	-	A0A1U7S1Q9	35	E	K
P55210	LB/B	-	A0A1D5RGZ3	4	D	E
P55210	LB/B	-	A0A1D5RGZ3	255	D	E
Q14790	LP/P	Caspase-8 deficiency (CASP8D) [MIM:607271]	A0A1W4XZR3	248	R	W
Q14790	LB/B	-	A0A1W4XZR3	285	D	H
Q14790	LB/B	-	A0A1W4XZR3	219	S	T
P55211	LB/B	-	H2V834	28	A	V
P55211	LB/B	-	H2V834	99	S	L
P55211	LB/B	-	H2V834	102	T	I
P55211	LB/B	-	H2V834	106	L	V
P55211	LB/B	-	H2V834	114	E	D
P55211	LB/B	-	H2V834	173	R	H
P55211	LB/B	-	H2V834	221	Q	R
P55211	LB/B	-	H2V834	176	G	R
P55211	LB/B	-	H2V834	192	R	C
P55211	LB/B	-	H2V834	185	I	M
P55211	LB/B	-	H2V834	136	F	L
P31415	LB/B	-	A0A1A8CM97	140	Y	F
P31415	LP/P	Myopathy, vacuolar, with CASQ1 aggregates (VMCQA) [MIM:616231]	A0A1A8CM97	244	D	G
P31415	LP/P	Myopathy, tubular aggregate, 1 (TAM1) [MIM:160565]	A0A1A8CM97	44	D	N
P31415	LP/P	Myopathy, tubular aggregate, 1 (TAM1) [MIM:160565]	A0A1A8CM97	103	G	D
P31415	LP/P	Myopathy, tubular aggregate, 1 (TAM1) [MIM:160565]	A0A1A8CM97	385	I	T
O14958	LP/P	Ventricular tachycardia, catecholaminergic polymorphic, 2 (CPVT2) [MIM:611938]	M3XRE8	307	D	H
O14958	LB/B	-	M3XRE8	66	T	A
O14958	LB/B	-	M3XRE8	76	V	M
O14958	LP/P	Ventricular tachycardia, catecholaminergic polymorphic, 2 (CPVT2) [MIM:611938]	M3XRE8	167	L	H
O14958	LP/P	Ventricular tachycardia, catecholaminergic polymorphic, 2 (CPVT2) [MIM:611938]	M3XRE8	33	R	Q
O14958	LB/B	-	M3XRE8	244	H	R
O14958	LB/B	-	M3XRE8	335	N	K
O14958	LP/P	Ventricular tachycardia, catecholaminergic polymorphic, 2 (CPVT2) [MIM:611938]	M3XRE8	180	K	R
Q86V15	LP/P	-	A0A096N0F6	38	L	P
Q7Z7H3	LP/P	Spermatogenic failure 54 (SPGF54) [MIM:619379]	A0A1S3LZU7	35	F	I
Q86XQ3	LB/B	-	H9G511	204	N	K
Q7RTX7	LB/B	-	A0A2Y9K9Z0	77	Q	R
Q7RTX7	LB/B	-	A0A2Y9K9Z0	124	L	F
Q7RTX7	LB/B	-	A0A2Y9K9Z0	293	I	V
Q7RTX7	LB/B	-	A0A2Y9K9Z0	436	D	N
Q9H7T0	LB/B	-	F7FIN7	318	F	Y
Q86XM0	LB/B	-	F1SBU6	504	T	A
Q86XM0	LB/B	-	F1SBU6	743	T	S
Q86XM0	LB/B	-	F1SBU6	212	M	T
Q5SY80	LB/B	-	E1BME4	66	T	K
Q5SY80	LB/B	-	E1BME4	56	T	S
Q6ZRH7	LB/B	-	A0A212DE91	29	L	P
Q6ZRH7	LB/B	-	A0A212DE91	650	S	R
Q6ZRH7	LB/B	-	A0A212DE91	1137	M	T
Q9NTU4	LB/B	-	A0A2Y9JQI9	68	P	L
P51636	LB/B	-	F1PFX6	130	Q	E
P56539	LP/P	Rippling muscle disease 2 (RMD2) [MIM:606072]	S9WAD2	105	P	L
P56539	LP/P	HyperCKmia (HYPCK) [MIM:123320]	S9WAD2	57	V	M
P56539	LB/B	-	S9WAD2	72	C	W
P56539	LP/P	HyperCKmia (HYPCK) [MIM:123320]	S9WAD2	27	R	Q
P56539	LP/P	Myopathy, distal, Tateyama type (MPDT) [MIM:614321]	S9WAD2	27	R	Q
P56539	LP/P	Rippling muscle disease 2 (RMD2) [MIM:606072]	S9WAD2	27	R	Q
P56539	LP/P	Rippling muscle disease 2 (RMD2) [MIM:606072]	S9WAD2	46	A	T
P56539	LP/P	Rippling muscle disease 2 (RMD2) [MIM:606072]	S9WAD2	46	A	V
P56539	LP/P	Rippling muscle disease 2 (RMD2) [MIM:606072]	S9WAD2	28	D	E
P56539	LP/P	Rippling muscle disease 2 (RMD2) [MIM:606072]	S9WAD2	87	L	P
P56539	LP/P	Rippling muscle disease 2 (RMD2) [MIM:606072]	S9WAD2	93	A	T
P56539	LP/P	Myopathy, distal, Tateyama type (MPDT) [MIM:614321]	S9WAD2	33	N	K
P56539	LP/P	Rippling muscle disease 2 (RMD2) [MIM:606072]	S9WAD2	33	N	K
P56539	LP/P	Rippling muscle disease 2 (RMD2) [MIM:606072]	S9WAD2	44	V	E
P56539	LP/P	Rippling muscle disease 2 (RMD2) [MIM:606072]	S9WAD2	64	T	P
P56539	LB/B	-	S9WAD2	61	S	R
P56539	LP/P	HyperCKmia (HYPCK) [MIM:123320]	S9WAD2	29	P	L
P56539	LP/P	Rippling muscle disease 2 (RMD2) [MIM:606072]	S9WAD2	53	S	G
P56539	LB/B	-	S9WAD2	56	G	S
P56539	LP/P	Cardiomyopathy, familial hypertrophic (CMH) [MIM:192600]	S9WAD2	64	T	S
P56539	LB/B	-	S9WAD2	126	R	H
P56539	LP/P	Sudden infant death syndrome (SIDS) [MIM:272120]	S9WAD2	14	V	L
P56539	LP/P	Long QT syndrome 9 (LQT9) [MIM:611818]	S9WAD2	78	T	M
P56539	LP/P	Sudden infant death syndrome (SIDS) [MIM:272120]	S9WAD2	78	T	M
P56539	LP/P	Long QT syndrome 9 (LQT9) [MIM:611818]	S9WAD2	79	L	R
P56539	LP/P	Sudden infant death syndrome (SIDS) [MIM:272120]	S9WAD2	79	L	R
P56539	LP/P	Long QT syndrome 9 (LQT9) [MIM:611818]	S9WAD2	85	A	T
P56539	LP/P	Long QT syndrome 9 (LQT9) [MIM:611818]	S9WAD2	97	F	C
P56539	LP/P	Long QT syndrome 9 (LQT9) [MIM:611818]	S9WAD2	141	S	R
Q6NZI2	LB/B	-	A0A0D9S1T8	193	E	Q
O95810	LB/B	-	G1PT38	130	E	D
O75081	LB/B	-	A0A2K6CHW0	429	E	G
P22681	LB/B	-	A0A093QV69	620	L	F
P22681	LB/B	-	A0A093QV69	782	P	L
P22681	LB/B	-	A0A093QV69	904	V	I
P22681	LP/P	Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia (NSLL) [MIM:613563]	A0A093QV69	367	Q	P
P22681	LP/P	Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia (NSLL) [MIM:613563]	A0A093QV69	382	K	E
P22681	LP/P	Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia (NSLL) [MIM:613563]	A0A093QV69	390	D	Y
P22681	LP/P	Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia (NSLL) [MIM:613563]	A0A093QV69	420	R	Q
Q13191	LB/B	-	G3RS61	584	R	K
Q13191	LB/B	-	G3RS61	883	N	D
Q9ULV8	LB/B	-	A0A2I3GQ14	405	H	Y
P16152	LB/B	-	G3W3S2	131	P	S
P16152	LB/B	-	G3W3S2	88	V	I
O75828	LB/B	-	G3W3S2	4	C	Y
O75828	LB/B	-	G3W3S2	84	L	V
O75828	LB/B	-	G3W3S2	93	V	I
O75828	LB/B	-	G3W3S2	131	P	S
O75828	LB/B	-	G3W3S2	235	M	L
O75828	LB/B	-	G3W3S2	244	V	M
Q8N4T8	LB/B	-	A0A0Q3P4U6	70	L	M
Q14781	LP/P	46,XY sex reversal 5 (SRXY5) [MIM:613080]	M4AEQ5	98	P	L
Q14781	LP/P	46,XY sex reversal 5 (SRXY5) [MIM:613080]	M4AEQ5	443	R	P
Q9HC52	LB/B	-	G1KS06	317	G	V
Q8NA61	LB/B	-	G3W232	329	K	E
Q6P1N0	LB/B	-	A0A2K5CVI5	339	T	P
Q6P1N0	LB/B	-	A0A2K5CVI5	635	T	S
Q6P1N0	LB/B	-	A0A2K5CVI5	801	T	M
Q5T0F9	LB/B	-	Q4RWW9	35	M	T
Q68D86	LB/B	-	W5P4K1	346	C	F
Q68D86	LB/B	-	W5P4K1	429	A	P
Q68D86	LB/B	-	W5P4K1	153	K	N
Q68D86	LB/B	-	W5P4K1	298	K	R
Q68D86	LB/B	-	W5P4K1	370	E	G
Q68D86	LB/B	-	W5P4K1	425	N	K
Q8IYK2	LB/B	-	G5BYQ8	434	D	E
Q8IYK2	LB/B	-	G5BYQ8	444	S	T
Q8IYK2	LB/B	-	G5BYQ8	499	P	T
Q8IYK2	LB/B	-	G5BYQ8	245	V	M
Q8IYK2	LB/B	-	G5BYQ8	248	M	T
Q8NEF3	LB/B	-	L8Y5Q0	32	H	L
Q8NEF3	LB/B	-	L8Y5Q0	144	S	N
Q8NEF3	LB/B	-	L8Y5Q0	341	K	N
Q8NEF3	LB/B	-	L8Y5Q0	354	E	G
Q9H0I3	LB/B	-	A7SJZ5	4	D	E
Q9H0I3	LB/B	-	A7SJZ5	6	S	T
Q8IYX3	LB/B	-	A0A2K6EWB2	96	R	C
Q8IYX3	LB/B	-	A0A2K6EWB2	121	G	R
Q8IYX3	LB/B	-	A0A2K6EWB2	122	R	W
Q8IYX3	LB/B	-	A0A2K6EWB2	199	R	W
Q8IYX3	LB/B	-	A0A2K6EWB2	436	A	T
Q8IYX3	LB/B	-	A0A2K6EWB2	293	P	L
Q96CT7	LB/B	-	A0A2Y9LYI5	138	E	Q
Q86Z20	LB/B	-	A0A093LW23	13	V	M
Q96BQ5	LB/B	-	E2QWH7	60	R	H
Q96JN2	LB/B	-	A0A2U3YPB2	218	D	H
Q96JN2	LB/B	-	A0A2U3YPB2	1049	Q	E
Q6PK04	LB/B	-	A0A2I3GBL9	127	H	Q
Q6PK04	LB/B	-	A0A2I3GBL9	177	R	W
Q6PK04	LB/B	-	A0A2I3GBL9	229	R	Q
Q6PK04	LB/B	-	A0A2I3GBL9	282	R	W
Q49A88	LB/B	-	A0A061I608	365	T	P
Q6ZP82	LB/B	-	A0A151LZR1	828	R	W
Q6ZP82	LB/B	-	A0A151LZR1	935	R	W
Q6ZP82	LB/B	-	A0A151LZR1	1170	N	S
Q17RM4	LB/B	-	W5PT41	534	R	Q
Q8NFR7	LB/B	-	V3ZJD3	75	Q	R
Q8NFR7	LB/B	-	V3ZJD3	157	M	V
Q8NFR7	LB/B	-	V3ZJD3	329	K	R
Q0P6D6	LB/B	-	G3TYA2	529	G	D
Q0P6D6	LB/B	-	G3TYA2	813	C	R
Q0P6D6	LB/B	-	G3TYA2	166	F	C
Q8NCX0	LB/B	-	A0A2K6KWI7	156	E	K
Q4G0S7	LB/B	-	R4GJU0	251	R	H
Q494R4	LB/B	-	A0A2K5QJZ4	101	R	H
Q569K6	LB/B	-	F6Z7W8	191	P	L
Q569K6	LB/B	-	F6Z7W8	587	S	A
Q569K6	LB/B	-	F6Z7W8	51	D	N
Q5M9N0	LB/B	-	W5M869	232	E	D
Q5M9N0	LB/B	-	W5M869	297	I	V
A6NNP5	LB/B	-	A0A2Y9KRK6	120	K	R
Q96LX7	LB/B	-	M3WV38	353	P	L
Q96LX7	LB/B	-	M3WV38	557	I	V
Q96LX7	LB/B	-	M3WV38	470	V	I
Q96LX7	LB/B	-	M3WV38	580	S	N
Q8IYT3	LB/B	-	H2ZVX3	269	A	V
Q8IYT3	LB/B	-	H2ZVX3	324	F	S
Q8IYT3	LB/B	-	H2ZVX3	331	A	T
Q8IYT3	LB/B	-	H2ZVX3	604	V	I
Q8IYT3	LB/B	-	H2ZVX3	683	V	I
Q8IYT3	LB/B	-	H2ZVX3	479	N	K
Q8IYT3	LB/B	-	H2ZVX3	553	R	Q
Q8IYT3	LB/B	-	H2ZVX3	345	E	K
Q6PII3	LB/B	-	A0A091HJP8	436	T	M
P0C221	LB/B	-	F1PNX7	164	G	R
P0C221	LB/B	-	F1PNX7	507	G	E
P0C221	LB/B	-	F1PNX7	689	S	N
P0C221	LB/B	-	F1PNX7	689	S	R
Q5BJE1	LB/B	-	A0A2Y9GRP2	42	A	T
Q5BJE1	LB/B	-	A0A2Y9GRP2	465	V	E
Q5BJE1	LB/B	-	A0A2Y9GRP2	600	L	R
Q5BJE1	LB/B	-	A0A2Y9GRP2	601	D	N
Q5BJE1	LB/B	-	A0A2Y9GRP2	420	D	N
Q5TID7	LB/B	-	Q1LY09	172	F	S
Q5TID7	LB/B	-	Q1LY09	238	F	I
Q5TID7	LB/B	-	Q1LY09	323	S	C
Q5T5S1	LB/B	-	A0A2K6FCX0	38	M	T
Q5T5S1	LB/B	-	A0A2K6FCX0	113	L	R
Q5T5S1	LB/B	-	A0A2K6FCX0	129	D	A
Q5T5S1	LB/B	-	A0A2K6FCX0	342	W	R
Q5T5S1	LB/B	-	A0A2K6FCX0	421	N	T
Q52MB2	LB/B	-	A0A091DWS4	140	E	D
Q8N715	LB/B	-	Q2KIK1	195	V	A
Q8N715	LB/B	-	Q2KIK1	329	G	D
Q8N715	LB/B	-	Q2KIK1	331	R	W
Q8N715	LB/B	-	Q2KIK1	380	R	L
Q7Z3E2	LB/B	-	A0A0Q3USF9	85	T	I
Q7Z3E2	LB/B	-	A0A0Q3USF9	179	R	Q
Q7Z3E2	LB/B	-	A0A0Q3USF9	271	Q	K
Q8NCU4	LB/B	-	K7F3D1	374	R	W
Q8NCU4	LB/B	-	K7F3D1	696	E	D
Q9NVL8	LB/B	-	K7FZ06	235	Y	C
Q2M243	LB/B	-	A0A1S3GE70	54	Q	E
Q2M243	LB/B	-	A0A1S3GE70	267	M	T
Q2M243	LB/B	-	A0A1S3GE70	353	T	M
Q2M243	LB/B	-	A0A1S3GE70	390	P	L
Q9BUN5	LB/B	-	A0A2K6NT96	25	R	W
Q9BV29	LB/B	-	G8F3P6	2	K	I
Q8N5R6	LB/B	-	J9NUG8	683	S	N
Q8N5R6	LB/B	-	J9NUG8	635	M	V
Q8N5R6	LB/B	-	J9NUG8	640	R	L
Q96HJ3	LB/B	-	A0A286XPZ1	53	P	S
Q96HJ3	LB/B	-	A0A286XPZ1	264	E	A
Q96HJ3	LB/B	-	A0A286XPZ1	319	I	V
Q96HJ3	LB/B	-	A0A286XPZ1	192	H	N
Q502W7	LB/B	-	L5MAZ2	36	V	F
Q502W7	LB/B	-	L5MAZ2	227	M	V
Q8IVM0	LB/B	-	G1PLB3	121	L	F
Q8IVM0	LB/B	-	G1PLB3	156	M	T
Q8NEL0	LB/B	-	A0A1U7QLP5	38	R	Q
Q2TAC2	LB/B	-	F6PXD4	237	E	Q
Q2TAC2	LB/B	-	F6PXD4	321	Q	R
Q2TAC2	LB/B	-	F6PXD4	480	V	M
Q2TAC2	LB/B	-	F6PXD4	774	R	G
Q2TAC2	LB/B	-	F6PXD4	776	D	N
Q2TAC2	LB/B	-	F6PXD4	777	A	T
Q2TAC2	LB/B	-	F6PXD4	810	Q	K
Q2TAC2	LB/B	-	F6PXD4	833	M	T
Q16204	LB/B	-	H3DI15	470	P	T
Q8IWA6	LB/B	-	H0X3I3	46	I	V
Q8IWA6	LB/B	-	H0X3I3	115	T	A
Q8IWA6	LB/B	-	H0X3I3	393	V	I
Q6P9F0	LB/B	-	E2R320	394	T	K
Q6P9F0	LB/B	-	E2R320	141	T	M
Q8NA47	LB/B	-	F6XGI5	212	L	S
Q8IXS2	LB/B	-	R7UDN7	133	H	R
Q8IXS2	LB/B	-	R7UDN7	408	Y	C
A2RUB6	LB/B	-	H0Z9Q8	383	Q	R
A2RUB6	LB/B	-	H0Z9Q8	460	R	Q
A2RUB6	LB/B	-	H0Z9Q8	592	E	K
A2RUB6	LB/B	-	H0Z9Q8	592	E	Q
A2RUB6	LB/B	-	H0Z9Q8	681	C	Y
Q96M83	LB/B	-	A0A2K5HH49	1267	M	T
Q96M83	LB/B	-	A0A2K5HH49	1117	G	A
Q96M83	LB/B	-	A0A2K5HH49	1364	V	I
Q96M83	LB/B	-	A0A2K5HH49	449	K	T
Q96M83	LB/B	-	A0A2K5HH49	148	K	Q
Q6NSX1	LB/B	-	A0A2K6M8G3	206	I	V
Q6NSX1	LB/B	-	A0A2K6M8G3	126	R	C
Q8IV32	LB/B	-	A0A0Q3RG43	317	Q	L
Q8IV32	LB/B	-	A0A0Q3RG43	339	W	R
Q96AQ1	LB/B	-	A0A2K5JX76	302	G	R
Q96LY2	LB/B	-	A0A2K5JX76	169	T	M
Q96LY2	LB/B	-	A0A2K5JX76	346	R	H
Q9BR77	LB/B	-	A0A2D0SDS4	25	S	R
Q9BR77	LB/B	-	A0A2D0SDS4	335	M	T
Q9H0W5	LB/B	-	L5KMK7	507	K	N
Q9H0W5	LB/B	-	L5KMK7	296	G	R
Q9H0W5	LB/B	-	L5KMK7	383	H	Y
Q6ZN84	LB/B	-	G7PNE1	449	Y	C
Q8N4S0	LB/B	-	M7BK87	149	Q	E
Q8N4S0	LB/B	-	M7BK87	327	Q	R
Q8N4S0	LB/B	-	M7BK87	128	K	R
Q9H6F5	LB/B	-	A0A2Y9GMX8	153	Q	H
Q9NVE4	LB/B	-	K7F6I2	217	F	L
Q9NVE4	LB/B	-	K7F6I2	156	A	T
A6NC98	LB/B	-	A0A2K6F602	193	D	E
A6NC98	LB/B	-	A0A2K6F602	639	W	R
A6NC98	LB/B	-	A0A2K6F602	886	D	A
Q9P219	LB/B	-	A0A1A6HQ16	811	A	E
Q9P219	LB/B	-	A0A1A6HQ16	1028	A	V
Q9P219	LB/B	-	A0A1A6HQ16	1992	L	P
Q9P219	LB/B	-	A0A1A6HQ16	637	L	V
Q9P219	LP/P	Spinocerebellar ataxia 40 (SCA40) [MIM:616053]	A0A1A6HQ16	464	R	H
Q9Y3X0	LB/B	-	A0A2K5L4P4	215	E	D
Q9Y3X0	LB/B	-	A0A2K5L4P4	456	A	V
Q9Y3X0	LB/B	-	A0A2K5L4P4	478	L	P
Q567U6	LB/B	-	F1NF62	179	R	C
Q567U6	LB/B	-	F1NF62	213	R	C
Q567U6	LB/B	-	F1NF62	228	P	L
Q567U6	LB/B	-	F1NF62	465	Y	H
Q8TC90	LB/B	-	A0A2Y9FY19	379	I	M
Q8TC90	LB/B	-	A0A2Y9FY19	286	D	E
I3L3R5	LB/B	-	A0A061HTU9	33	E	D
I3L3R5	LB/B	-	A0A061HTU9	39	L	P
I3L3R5	LB/B	-	A0A061HTU9	64	E	D
I3L3R5	LB/B	-	A0A061HTU9	80	G	V
I3L3R5	LB/B	-	A0A061HTU9	160	E	K
I3L3R5	LB/B	-	A0A061HTU9	195	R	C
I3L3R5	LB/B	-	A0A061HTU9	224	A	T
I3L3R5	LB/B	-	A0A061HTU9	232	E	A
I3L3R5	LB/B	-	A0A061HTU9	249	D	G
Q13939	LB/B	-	H3A1A7	75	S	N
P32239	LB/B	-	W5K8H8	37	L	F
P32239	LB/B	-	W5K8H8	125	V	I
P32239	LB/B	-	W5K8H8	215	R	H
P32239	LB/B	-	W5K8H8	319	R	Q
P32239	LB/B	-	W5K8H8	77	V	G
Q16663	LB/B	-	A0A286XAQ7	24	T	I
Q92583	LB/B	-	A0A2Y9M2N7	5	K	N
Q92583	LB/B	-	A0A2Y9M2N7	67	V	M
P78556	LB/B	-	R4G9F3	47	V	M
P55773	LB/B	-	A0A286XAQ7	106	M	V
O15444	LB/B	-	A0A2I3LKM1	23	T	A
O15444	LB/B	-	A0A2I3LKM1	101	H	R
O15444	LB/B	-	A0A2I3LKM1	104	T	M
P13501	LB/B	-	A0A2R8MQF5	24	S	F
Q9BSQ5	LB/B	-	H2MPA5	53	V	I
Q9BSQ5	LB/B	-	H2MPA5	120	V	I
Q9BSQ5	LP/P	Cerebral cavernous malformations 2 (CCM2) [MIM:603284]	H2MPA5	198	L	R
Q9BSQ5	LB/B	-	H2MPA5	289	S	N
Q9BSQ5	LP/P	Cerebral cavernous malformations 2 (CCM2) [MIM:603284]	H2MPA5	215	Q	H
Q9BSQ5	LP/P	Cerebral cavernous malformations 2 (CCM2) [MIM:603284]	H2MPA5	229	L	Q
O00622	LB/B	-	A0A0P7U0P1	334	R	W
P29279	LB/B	-	A0A2K6RTE7	83	H	D
P48745	LB/B	-	A0A2K6RTE7	42	R	Q
P48745	LB/B	-	A0A2K6RTE7	233	R	H
O76076	LB/B	-	U3JS02	59	R	Q
O95389	LB/B	-	L5JR98	56	Q	H
O95389	LP/P	Progressive pseudorheumatoid dysplasia (PPRD) [MIM:208230]	L5JR98	78	C	R
O95389	LB/B	-	L5JR98	60	R	C
O95389	LP/P	Progressive pseudorheumatoid dysplasia (PPRD) [MIM:208230]	L5JR98	78	C	Y
O95389	LB/B	-	L5JR98	83	G	E
O95389	LP/P	Progressive pseudorheumatoid dysplasia (PPRD) [MIM:208230]	L5JR98	114	C	R
O95389	LP/P	Progressive pseudorheumatoid dysplasia (PPRD) [MIM:208230]	L5JR98	114	C	W
O95389	LP/P	Progressive pseudorheumatoid dysplasia (PPRD) [MIM:208230]	L5JR98	223	C	G
O95389	LP/P	Progressive pseudorheumatoid dysplasia (PPRD) [MIM:208230]	L5JR98	337	C	Y
O95389	LP/P	Progressive pseudorheumatoid dysplasia (PPRD) [MIM:208230]	L5JR98	114	C	Y
O95389	LP/P	Progressive pseudorheumatoid dysplasia (PPRD) [MIM:208230]	L5JR98	226	G	V
O95389	LP/P	Progressive pseudorheumatoid dysplasia (PPRD) [MIM:208230]	L5JR98	334	S	P
Q8WWL7	LB/B	-	H9A532	1001	G	R
P30279	LB/B	-	G1T9R9	268	G	R
P30279	LP/P	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3 (MPPH3) [MIM:615938]	G1T9R9	280	T	A
P30279	LP/P	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3 (MPPH3) [MIM:615938]	G1T9R9	280	T	N
P30279	LP/P	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3 (MPPH3) [MIM:615938]	G1T9R9	281	P	L
P30279	LP/P	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3 (MPPH3) [MIM:615938]	G1T9R9	281	P	R
P30279	LP/P	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3 (MPPH3) [MIM:615938]	G1T9R9	284	V	G
P30281	LB/B	-	F1PC17	259	S	A
P30281	LB/B	-	F1PC17	134	P	S
P30281	LB/B	-	F1PC17	253	E	D
O96020	LB/B	-	A0A1V4KGW3	387	N	S
Q16589	LB/B	-	A0A091DX80	4	L	V
Q16589	LB/B	-	A0A091DX80	28	E	G
P51946	LB/B	-	A0A2U9BTQ4	28	R	L
P51946	LB/B	-	A0A2U9BTQ4	54	M	V
P51946	LB/B	-	A0A2U9BTQ4	138	K	R
P51946	LB/B	-	A0A2U9BTQ4	270	V	A
Q14094	LB/B	-	A0A091H378	207	V	I
Q6ZMN8	LB/B	-	B1MTN7	91	A	P
Q8IV13	LB/B	-	F6TN79	234	H	Y
O75909	LP/P	Intellectual developmental disorder with hypertelorism and distinctive facies (IDDHDF) [MIM:618147]	A0A1S3RE73	111	K	E
Q8N1B3	LB/B	-	A0A2K6LHK0	183	C	S
O60563	LB/B	-	A0A151MUI7	362	H	R
O60563	LB/B	-	A0A151MUI7	541	R	C
O43303	LB/B	-	A0A151N1I6	252	I	M
O43303	LB/B	-	A0A151N1I6	375	M	I
O43303	LB/B	-	A0A151N1I6	69	R	S
O43303	LB/B	-	A0A151N1I6	171	P	L
O43303	LB/B	-	A0A151N1I6	347	F	I
Q9ULG6	LB/B	-	G1N2R4	44	S	P
Q9ULG6	LB/B	-	G1N2R4	161	E	V
Q9ULG6	LB/B	-	G1N2R4	418	Y	H
Q9ULG6	LB/B	-	G1N2R4	436	R	L
Q9ULG6	LB/B	-	G1N2R4	477	A	V
Q9ULG6	LB/B	-	G1N2R4	517	A	D
Q9ULG6	LB/B	-	G1N2R4	553	G	D
Q9ULG6	LB/B	-	G1N2R4	553	G	S
Q9ULG6	LB/B	-	G1N2R4	590	N	K
Q9ULG6	LB/B	-	G1N2R4	627	K	E
Q9ULG6	LB/B	-	G1N2R4	646	T	I
Q9ULG6	LB/B	-	G1N2R4	673	H	R
P41597	LB/B	-	H3A7J6	64	V	I
P41597	LB/B	-	H3A7J6	355	G	E
P41597	LB/B	-	H3A7J6	45	L	V
P51677	LB/B	-	H3A7J6	218	C	S
P51677	LB/B	-	H3A7J6	21	G	D
P51677	LB/B	-	H3A7J6	39	P	L
P51679	LB/B	-	S9WH51	130	L	V
P51679	LB/B	-	S9WH51	178	C	S
P51681	LB/B	-	H3A7J6	31	R	H
P51681	LB/B	-	H3A7J6	68	Y	H
P51681	LB/B	-	H3A7J6	95	D	N
P51681	LB/B	-	H3A7J6	246	L	P
P51681	LB/B	-	H3A7J6	288	T	M
P51681	LB/B	-	H3A7J6	335	A	V
P51681	LB/B	-	H3A7J6	339	Y	F
P51681	LB/B	-	H3A7J6	29	A	S
P51681	LB/B	-	H3A7J6	55	L	Q
P51681	LB/B	-	H3A7J6	60	R	S
P51681	LB/B	-	H3A7J6	223	R	Q
P51681	LB/B	-	H3A7J6	301	G	V
P51681	LB/B	-	H3A7J6	178	C	R
P51681	LB/B	-	H3A7J6	12	I	L
P51681	LB/B	-	H3A7J6	20	C	S
P51681	LB/B	-	H3A7J6	42	I	F
P51681	LB/B	-	H3A7J6	73	A	V
P51681	LB/B	-	H3A7J6	215	S	L
P51681	LB/B	-	H3A7J6	106	G	R
P32248	LB/B	-	W5NLW3	7	M	V
P51685	LB/B	-	H3A7J6	27	A	G
O00421	LB/B	-	M3YV26	167	F	Y
O00421	LB/B	-	M3YV26	168	V	M
O00421	LB/B	-	M3YV26	243	I	V
O00421	LB/B	-	M3YV26	4	Y	C
O14618	LB/B	-	T0MEE5	163	R	W
Q6IQ19	LB/B	-	Q6P3G4	123	A	V
P50991	LB/B	-	L9KQ79	112	I	V
P40227	LB/B	-	A0A151N5P4	229	Y	C
Q92526	LB/B	-	A0A1Y1Y365	247	G	A
Q92526	LB/B	-	A0A1Y1Y365	17	R	Q
Q92526	LB/B	-	A0A1Y1Y365	48	V	A
Q99832	LB/B	-	A0A1B6CDI9	259	T	A
P50990	LB/B	-	J9NRN0	4	H	Q
P50990	LB/B	-	J9NRN0	409	V	I
A6NM43	LB/B	-	A0A2I3TXI9	217	C	S
A6NM43	LB/B	-	A0A2I3TXI9	308	D	N
A6NM43	LB/B	-	A0A2I3TXI9	395	S	G
Q96SF2	LB/B	-	A0A2I3TXI9	320	W	R
Q93033	LB/B	-	M3XRA4	225	N	S
Q93033	LB/B	-	M3XRA4	415	M	V
Q93033	LB/B	-	M3XRA4	518	R	Q
Q93033	LB/B	-	M3XRA4	525	S	R
Q93033	LB/B	-	M3XRA4	965	V	I
Q93033	LB/B	-	M3XRA4	988	R	C
Q93033	LB/B	-	M3XRA4	157	G	S
Q93033	LB/B	-	M3XRA4	631	T	S
Q93033	LB/B	-	M3XRA4	933	R	Q
Q93033	LB/B	-	M3XRA4	955	L	F
Q93033	LB/B	-	M3XRA4	992	R	W
Q6YHK3	LB/B	-	A0A1A7ZAN9	45	G	V
Q6YHK3	LB/B	-	A0A1A7ZAN9	703	Y	S
Q6YHK3	LB/B	-	A0A1A7ZAN9	797	N	S
Q6YHK3	LB/B	-	A0A1A7ZAN9	845	V	I
Q6YHK3	LB/B	-	A0A1A7ZAN9	1241	T	M
Q6YHK3	LB/B	-	A0A1A7ZAN9	377	G	D
Q6YHK3	LB/B	-	A0A1A7ZAN9	641	L	F
Q6YHK3	LB/B	-	A0A1A7ZAN9	1009	V	M
Q6YHK3	LB/B	-	A0A1A7ZAN9	1296	H	R
Q6YHK3	LB/B	-	A0A1A7ZAN9	791	D	G
P08571	LB/B	-	A0A2F0B0T0	204	N	D
P08571	LB/B	-	A0A2F0B0T0	341	E	K
O95971	LB/B	-	A0A2Y9LEG8	91	I	V
Q86VB7	LB/B	-	F7ENX8	342	I	V
Q9NR16	LB/B	-	G3Q5G5	578	D	N
Q9NR16	LB/B	-	G3Q5G5	582	G	A
Q9NR16	LB/B	-	G3Q5G5	1055	G	S
Q9NR16	LB/B	-	G3Q5G5	1108	M	T
Q9NR16	LB/B	-	G3Q5G5	523	L	M
Q6UWJ8	LB/B	-	W5P017	76	V	M
Q8N6Q3	LB/B	-	A0A212DCM0	3	A	P
Q8N6Q3	LB/B	-	A0A212DCM0	251	L	I
Q8N6Q3	LB/B	-	A0A212DCM0	348	A	T
Q8N6Q3	LB/B	-	A0A212DCM0	119	L	F
Q8N6Q3	LB/B	-	A0A212DCM0	323	R	Q
Q8N6Q3	LB/B	-	A0A212DCM0	379	F	S
Q8N6Q3	LB/B	-	A0A212DCM0	31	H	L
Q8N6Q3	LB/B	-	A0A212DCM0	261	G	A
Q8N6Q3	LB/B	-	A0A212DCM0	431	G	R
Q99467	LB/B	-	A0A099ZEG7	53	N	K
Q99467	LB/B	-	A0A099ZEG7	99	S	R
Q99467	LB/B	-	A0A099ZEG7	20	V	L
Q99467	LB/B	-	A0A099ZEG7	259	D	N
Q99467	LB/B	-	A0A099ZEG7	430	T	A
Q99467	LB/B	-	A0A099ZEG7	648	F	L
Q99467	LB/B	-	A0A099ZEG7	356	V	M
P15391	LB/B	-	S7N010	174	L	V
P15391	LB/B	-	S7N010	514	R	H
P06126	LB/B	-	G3U2H9	30	T	I
P06126	LB/B	-	G3U2H9	68	C	W
P06126	LB/B	-	G3U2H9	22	K	N
P29017	LB/B	-	G3U2H9	70	N	T
P29017	LB/B	-	G3U2H9	300	F	S
P15813	LB/B	-	A0A2Y9ICT2	64	T	S
P15812	LB/B	-	A0A2Y9ICT2	106	Q	R
P15812	LB/B	-	A0A2Y9ICT2	164	R	W
P15812	LB/B	-	A0A2Y9ICT2	194	L	P
P15812	LB/B	-	A0A2Y9ICT2	15	G	E
P15812	LB/B	-	A0A2Y9ICT2	102	H	R
P15812	LB/B	-	A0A2Y9ICT2	149	S	N
P06729	LB/B	-	A0A1U7TXE5	266	H	Q
P06729	LB/B	-	A0A1U7TXE5	339	H	N
P41217	LB/B	-	G3TPI1	11	S	C
P41217	LB/B	-	G3TPI1	46	P	T
P41217	LB/B	-	G3TPI1	76	V	G
Q9NNX6	LB/B	-	H2NXB8	214	E	D
Q9NNX6	LB/B	-	H2NXB8	242	L	V
Q9NNX6	LB/B	-	H2NXB8	168	E	D
Q9NNX6	LB/B	-	H2NXB8	382	A	S
Q15762	LB/B	-	A0A1U7U1D2	307	S	G
P25063	LB/B	-	A0A1S3FGM7	57	A	V
P25063	LB/B	-	A0A1S3FGM7	44	S	T
Q9BZW8	LB/B	-	F1PPB5	89	N	D
Q9BZW8	LB/B	-	F1PPB5	323	S	F
Q9HCU0	LB/B	-	A0A0F8AYX7	457	H	R
P26842	LB/B	-	U6CW22	59	A	T
P26842	LB/B	-	U6CW22	233	H	R
P26842	LP/P	Lymphoproliferative syndrome 2 (LPFS2) [MIM:615122]	U6CW22	53	C	Y
Q5ZPR3	LB/B	-	A0A2Y9T998	97	P	L
Q5ZPR3	LB/B	-	A0A2Y9T998	111	R	S
Q5ZPR3	LB/B	-	A0A2Y9T998	137	Q	L
Q5ZPR3	LB/B	-	A0A2Y9T998	160	T	M
Q5ZPR3	LB/B	-	A0A2Y9T998	267	R	H
Q5ZPR3	LB/B	-	A0A2Y9T998	279	A	T
Q5ZPR3	LB/B	-	A0A2Y9T998	315	P	L
Q5ZPR3	LB/B	-	A0A2Y9T998	329	R	S
Q5ZPR3	LB/B	-	A0A2Y9T998	378	T	M
O95400	LB/B	-	Q6DIK3	231	G	D
O95400	LB/B	-	Q6DIK3	262	T	I
Q9UGN4	LB/B	-	A0A2K5R6V4	111	R	Q
Q96MU5	LB/B	-	Q96MU5	47	R	S
Q8TDQ1	LB/B	-	A0A2Y9PRB5	218	Q	R
Q8TDQ1	LB/B	-	A0A2Y9PRB5	19	V	A
Q6UXG3	LB/B	-	A0A2J8J496	221	D	N
Q6UXG3	LB/B	-	A0A2J8J496	228	T	A
P20138	LB/B	-	L5L434	69	R	G
P20138	LB/B	-	L5L434	202	R	W
P20138	LB/B	-	L5L434	242	I	L
P20138	LB/B	-	L5L434	243	F	L
P20138	LB/B	-	L5L434	294	V	L
P20138	LB/B	-	L5L434	14	A	V
P20138	LB/B	-	L5L434	22	W	R
P20138	LB/B	-	L5L434	128	S	N
P20138	LB/B	-	L5L434	304	G	R
P20138	LB/B	-	L5L434	331	T	A
P20138	LB/B	-	L5L434	267	V	I
P28906	LB/B	-	A0A2Y9PVI6	367	A	S
P16671	LB/B	-	A0A146Y6K9	154	V	F
P16671	LP/P	Platelet glycoprotein IV deficiency (PG4D) [MIM:608404]	A0A146Y6K9	90	P	S
P16671	LB/B	-	A0A146Y6K9	123	E	K
P16671	LB/B	-	A0A146Y6K9	174	T	A
P16671	LP/P	Platelet glycoprotein IV deficiency (PG4D) [MIM:608404]	A0A146Y6K9	254	F	L
P16671	LB/B	-	A0A146Y6K9	271	I	T
P16671	LP/P	Platelet glycoprotein IV deficiency (PG4D) [MIM:608404]	A0A146Y6K9	413	I	L
P16671	LB/B	-	A0A146Y6K9	127	S	L
P16671	LB/B	-	A0A146Y6K9	386	R	W
P16671	LB/B	-	A0A146Y6K9	470	T	I
P28907	LB/B	-	F1S5D9	140	R	W
P09693	LB/B	-	Q3UZ65	131	V	F
P25942	LP/P	Immunodeficiency with hyper-IgM 3 (HIGM3) [MIM:606843]	Q8SQ34	83	C	R
P25942	LB/B	-	Q8SQ34	124	S	L
P25942	LB/B	-	Q8SQ34	227	P	A
P25942	LP/P	Immunodeficiency with hyper-IgM 3 (HIGM3) [MIM:606843]	Q8SQ34	37	C	G
P29965	LP/P	Immunodeficiency with hyper-IgM, type 1 (HIGM1) [MIM:308230]	L8HWN5	36	M	R
P29965	LP/P	Immunodeficiency with hyper-IgM, type 1 (HIGM1) [MIM:308230]	L8HWN5	123	A	E
P29965	LP/P	Immunodeficiency with hyper-IgM, type 1 (HIGM1) [MIM:308230]	L8HWN5	126	V	A
P29965	LP/P	Immunodeficiency with hyper-IgM, type 1 (HIGM1) [MIM:308230]	L8HWN5	140	W	C
P29965	LP/P	Immunodeficiency with hyper-IgM, type 1 (HIGM1) [MIM:308230]	L8HWN5	140	W	G
P29965	LP/P	Immunodeficiency with hyper-IgM, type 1 (HIGM1) [MIM:308230]	L8HWN5	140	W	R
P29965	LP/P	Immunodeficiency with hyper-IgM, type 1 (HIGM1) [MIM:308230]	L8HWN5	144	G	E
P29965	LP/P	Immunodeficiency with hyper-IgM, type 1 (HIGM1) [MIM:308230]	L8HWN5	155	L	P
P29965	LP/P	Immunodeficiency with hyper-IgM, type 1 (HIGM1) [MIM:308230]	L8HWN5	211	T	N
P29965	LB/B	-	L8HWN5	219	G	R
P29965	LP/P	Immunodeficiency with hyper-IgM, type 1 (HIGM1) [MIM:308230]	L8HWN5	227	G	V
P29965	LP/P	Immunodeficiency with hyper-IgM, type 1 (HIGM1) [MIM:308230]	L8HWN5	231	L	S
P29965	LP/P	Immunodeficiency with hyper-IgM, type 1 (HIGM1) [MIM:308230]	L8HWN5	235	A	P
P29965	LP/P	Immunodeficiency with hyper-IgM, type 1 (HIGM1) [MIM:308230]	L8HWN5	254	T	M
P29965	LP/P	Immunodeficiency with hyper-IgM, type 1 (HIGM1) [MIM:308230]	L8HWN5	147	T	N
P29965	LP/P	Immunodeficiency with hyper-IgM, type 1 (HIGM1) [MIM:308230]	L8HWN5	170	Y	C
P29965	LP/P	Immunodeficiency with hyper-IgM, type 1 (HIGM1) [MIM:308230]	L8HWN5	258	L	S
P29965	LP/P	Immunodeficiency with hyper-IgM, type 1 (HIGM1) [MIM:308230]	L8HWN5	38	G	R
P29965	LP/P	Immunodeficiency with hyper-IgM, type 1 (HIGM1) [MIM:308230]	L8HWN5	125	H	R
P29965	LP/P	Immunodeficiency with hyper-IgM, type 1 (HIGM1) [MIM:308230]	L8HWN5	174	Q	R
P29965	LP/P	Immunodeficiency with hyper-IgM, type 1 (HIGM1) [MIM:308230]	L8HWN5	257	G	S
P29965	LP/P	Immunodeficiency with hyper-IgM, type 1 (HIGM1) [MIM:308230]	L8HWN5	116	G	R
P29965	LP/P	Immunodeficiency with hyper-IgM, type 1 (HIGM1) [MIM:308230]	L8HWN5	116	G	S
P29965	LP/P	Immunodeficiency with hyper-IgM, type 1 (HIGM1) [MIM:308230]	L8HWN5	126	V	D
P29965	LP/P	Immunodeficiency with hyper-IgM, type 1 (HIGM1) [MIM:308230]	L8HWN5	143	K	T
P29965	LP/P	Immunodeficiency with hyper-IgM, type 1 (HIGM1) [MIM:308230]	L8HWN5	173	A	D
P29965	LP/P	Immunodeficiency with hyper-IgM, type 1 (HIGM1) [MIM:308230]	L8HWN5	176	T	I
P29965	LP/P	Immunodeficiency with hyper-IgM, type 1 (HIGM1) [MIM:308230]	L8HWN5	195	L	P
P29965	LP/P	Immunodeficiency with hyper-IgM, type 1 (HIGM1) [MIM:308230]	L8HWN5	208	A	D
P29965	LP/P	Immunodeficiency with hyper-IgM, type 1 (HIGM1) [MIM:308230]	L8HWN5	224	H	Y
P29965	LP/P	Immunodeficiency with hyper-IgM, type 1 (HIGM1) [MIM:308230]	L8HWN5	226	G	A
P29965	LP/P	Immunodeficiency with hyper-IgM, type 1 (HIGM1) [MIM:308230]	L8HWN5	237	V	E
P29965	LP/P	Immunodeficiency with hyper-IgM, type 1 (HIGM1) [MIM:308230]	L8HWN5	257	G	D
P16070	LB/B	-	H0VAV9	46	R	P
P16070	LB/B	-	H0VAV9	417	K	R
P16070	LB/B	-	H0VAV9	393	T	M
P16070	LB/B	-	H0VAV9	479	I	T
P16070	LB/B	-	H0VAV9	494	D	H
P15529	LB/B	-	A0A2Y9PUL2	266	D	N
P15529	LB/B	-	A0A2Y9PUL2	324	P	L
P15529	LB/B	-	A0A2Y9PUL2	353	A	V
P15529	LB/B	-	A0A2Y9PUL2	355	V	G
P15529	LB/B	-	A0A2Y9PUL2	13	S	F
P15529	LB/B	-	A0A2Y9PUL2	59	R	Q
P15529	LP/P	Hemolytic uremic syndrome atypical 2 (AHUS2) [MIM:612922]	A0A2Y9PUL2	165	P	S
P15529	LP/P	Hemolytic uremic syndrome atypical 2 (AHUS2) [MIM:612922]	A0A2Y9PUL2	240	S	P
P15529	LP/P	Hemolytic uremic syndrome atypical 2 (AHUS2) [MIM:612922]	A0A2Y9PUL2	35	C	Y
P15529	LP/P	Hemolytic uremic syndrome atypical 2 (AHUS2) [MIM:612922]	A0A2Y9PUL2	216	W	C
P15529	LP/P	Hemolytic uremic syndrome atypical 2 (AHUS2) [MIM:612922]	A0A2Y9PUL2	231	P	R
P08174	LB/B	-	A0A1U7U1M7	52	R	L
P08174	LB/B	-	A0A1U7U1M7	52	R	P
P08174	LB/B	-	A0A1U7U1M7	82	L	R
P08174	LB/B	-	A0A1U7U1M7	199	S	L
P08174	LB/B	-	A0A1U7U1M7	227	A	P
P08174	LB/B	-	A0A1U7U1M7	240	R	H
P08174	LP/P	Complement hyperactivation, angiopathic thrombosis, and protein-losing enteropathy (CHAPLE) [MIM:226300]	A0A1U7U1M7	267	C	S
P19256	LB/B	-	A0A0D9S645	15	S	G
P13987	LP/P	Hemolytic anemia, CD59-mediated, with or without polyneuropathy (HACD59) [MIM:612300]	S7P8T8	89	C	Y
O43866	LB/B	-	A0A212CI17	117	D	E
P30203	LB/B	-	A0A1S2ZI44	225	R	W
P30203	LB/B	-	A0A1S2ZI44	271	A	T
P30203	LB/B	-	A0A1S2ZI44	351	S	N
P30203	LB/B	-	A0A1S2ZI44	606	G	S
P30203	LB/B	-	A0A1S2ZI44	217	T	M
P30203	LB/B	-	A0A1S2ZI44	257	A	V
P34810	LB/B	-	W5PZB2	254	Q	K
P34810	LB/B	-	W5PZB2	340	A	T
P34810	LB/B	-	W5PZB2	329	I	T
P34810	LB/B	-	W5PZB2	350	A	T
P09564	LB/B	-	A0A2J8XZJ2	113	T	A
P27701	LB/B	-	Q7T2E0	241	I	V
Q01151	LB/B	-	G3WQ92	182	R	Q
P42081	LB/B	-	A0A2K5Q1G6	310	A	T
P42081	LB/B	-	A0A2K5Q1G6	170	S	N
P42081	LB/B	-	A0A2K5Q1G6	323	D	N
P42081	LB/B	-	A0A2K5Q1G6	185	V	I
P01732	LP/P	CD8 deficiency, familial (CD8 deficiency) [MIM:608957]	F7BJE5	111	G	S
Q9NPY3	LB/B	-	V8NY71	318	V	A
Q9NPY3	LB/B	-	V8NY71	541	P	S
P32320	LB/B	-	K7FC96	27	K	Q
Q8IWY9	LP/P	Anemia, congenital dyserythropoietic, 1A (CDAN1A) [MIM:224120]	F7DMB3	599	N	S
Q8IWY9	LP/P	Anemia, congenital dyserythropoietic, 1A (CDAN1A) [MIM:224120]	F7DMB3	672	P	L
Q8IWY9	LP/P	Anemia, congenital dyserythropoietic, 1A (CDAN1A) [MIM:224120]	F7DMB3	698	E	K
Q8IWY9	LP/P	Anemia, congenital dyserythropoietic, 1A (CDAN1A) [MIM:224120]	F7DMB3	714	R	W
Q8IWY9	LP/P	Anemia, congenital dyserythropoietic, 1A (CDAN1A) [MIM:224120]	F7DMB3	868	F	I
Q8IWY9	LP/P	Anemia, congenital dyserythropoietic, 1A (CDAN1A) [MIM:224120]	F7DMB3	869	V	M
Q8IWY9	LP/P	Anemia, congenital dyserythropoietic, 1A (CDAN1A) [MIM:224120]	F7DMB3	1042	R	W
Q8IWY9	LP/P	Anemia, congenital dyserythropoietic, 1A (CDAN1A) [MIM:224120]	F7DMB3	1043	D	V
Q8IWY9	LP/P	Anemia, congenital dyserythropoietic, 1A (CDAN1A) [MIM:224120]	F7DMB3	1130	P	L
Q8IWY9	LB/B	-	F7DMB3	596	Q	R
Q8IWY9	LB/B	-	F7DMB3	891	R	C
Q8IWY9	LB/B	-	F7DMB3	107	Q	L
Q9UNH5	LB/B	-	A0A1S3GFX0	345	R	Q
Q9UNH5	LB/B	-	A0A1S3GFX0	589	S	F
Q9UNH5	LP/P	Deafness, autosomal recessive, 32, with or without immotile sperm (DFNB32) [MIM:608653]	A0A1S3GFX0	312	R	G
Q9UNH5	LP/P	Deafness, autosomal recessive, 32, with or without immotile sperm (DFNB32) [MIM:608653]	A0A1S3GFX0	312	R	Q
Q9UNH5	LP/P	Deafness, autosomal recessive, 32, with or without immotile sperm (DFNB32) [MIM:608653]	A0A1S3GFX0	320	Q	P
A4D256	LB/B	-	F1M567	131	P	S
A4D256	LB/B	-	F1M567	189	I	L
Q12834	LB/B	-	V9KNW4	402	V	M
Q12834	LB/B	-	V9KNW4	479	R	Q
Q86Y33	LB/B	-	H0WVN5	8	T	P
Q86Y33	LB/B	-	H0WVN5	17	E	K
Q86Y33	LB/B	-	H0WVN5	97	T	S
Q86Y33	LB/B	-	H0WVN5	121	R	C
Q86Y33	LB/B	-	H0WVN5	496	S	A
Q86Y33	LB/B	-	H0WVN5	503	R	W
Q9UJX2	LB/B	-	A0A1S3L1K7	78	E	Q
Q9UJX2	LB/B	-	A0A1S3L1K7	9	P	L
P30307	LB/B	-	D4ADT2	297	G	R
P30307	LB/B	-	D4ADT2	14	S	N
P30307	LB/B	-	D4ADT2	70	R	C
P30307	LB/B	-	D4ADT2	78	S	N
P30260	LB/B	-	E2AD66	496	Y	H
P49427	LB/B	-	A0A287DFR4	227	D	H
Q16543	LB/B	-	A0A146MPU1	360	G	E
Q7L3B6	LB/B	-	A0A2Y9QSI6	291	S	F
O60508	LP/P	Pontocerebellar hypoplasia 15 (PCH15) [MIM:619302]	A0A2B7XYL6	502	F	C
P60953	LP/P	Takenouchi-Kosaki syndrome (TKS) [MIM:616737]	A0A1I7S981	64	Y	C
Q5VT25	LB/B	-	K7G3M3	231	T	M
Q5VT25	LB/B	-	K7G3M3	537	I	T
Q5VT25	LB/B	-	K7G3M3	1418	I	K
Q5VT25	LB/B	-	K7G3M3	780	T	M
Q5VT25	LB/B	-	K7G3M3	790	Y	C
Q5VT25	LB/B	-	K7G3M3	1148	A	T
Q5VT25	LB/B	-	K7G3M3	1211	R	H
Q5VT25	LB/B	-	K7G3M3	1317	V	I
Q5VT25	LB/B	-	K7G3M3	1469	A	V
Q5VT25	LB/B	-	K7G3M3	1618	T	A
Q5VT25	LB/B	-	K7G3M3	1699	A	V
Q5VT25	LB/B	-	K7G3M3	1712	A	V
Q9Y5S2	LB/B	-	K7G3M3	1077	I	V
Q9Y5S2	LB/B	-	K7G3M3	555	R	Q
Q9Y5S2	LB/B	-	K7G3M3	671	R	Q
Q9Y5S2	LP/P	Chilton-Okur-Chung neurodevelopmental syndrome (CHOCNS) [MIM:619841]	K7G3M3	876	R	W
Q9Y5S2	LB/B	-	K7G3M3	1633	S	Y
Q9Y5S2	LB/B	-	K7G3M3	1203	R	K
Q9Y5S2	LP/P	Chilton-Okur-Chung neurodevelopmental syndrome (CHOCNS) [MIM:619841]	K7G3M3	867	R	C
Q9Y5S2	LP/P	Chilton-Okur-Chung neurodevelopmental syndrome (CHOCNS) [MIM:619841]	K7G3M3	876	R	P
Q6DT37	LB/B	-	K7G3M3	168	P	L
Q6DT37	LB/B	-	K7G3M3	362	T	P
Q6DT37	LB/B	-	K7G3M3	537	A	D
Q6DT37	LB/B	-	K7G3M3	1135	Q	R
O75419	LB/B	-	C5NS93	81	V	I
O75419	LB/B	-	C5NS93	376	V	M
O75419	LB/B	-	C5NS93	356	M	R
O75419	LP/P	Meier-Gorlin syndrome 7 (MGORS7) [MIM:617063]	C5NS93	68	Q	R
O75419	LP/P	Meier-Gorlin syndrome 7 (MGORS7) [MIM:617063]	C5NS93	76	N	H
O75419	LP/P	Meier-Gorlin syndrome 7 (MGORS7) [MIM:617063]	C5NS93	157	R	C
O75419	LP/P	Meier-Gorlin syndrome 7 (MGORS7) [MIM:617063]	C5NS93	226	D	G
O75419	LP/P	Meier-Gorlin syndrome 7 (MGORS7) [MIM:617063]	C5NS93	298	A	V
Q99741	LB/B	-	Q28FT2	238	T	A
Q99741	LB/B	-	Q28FT2	295	D	N
Q99741	LB/B	-	Q28FT2	299	T	M
Q99741	LB/B	-	Q28FT2	378	R	H
Q99741	LB/B	-	Q28FT2	441	V	I
Q99741	LP/P	Meier-Gorlin syndrome 5 (MGORS5) [MIM:613805]	Q28FT2	323	T	R
Q6P1J9	LP/P	Hyperparathyroidism 1 (HRPT1) [MIM:145000]	A0A0A9WF39	64	L	P
Q6P1J9	LB/B	-	A0A0A9WF39	384	L	P
Q6P1J9	LB/B	-	A0A0A9WF39	272	N	S
Q6P1J9	LP/P	Hyperparathyroidism 2 with jaw tumors (HRPT2) [MIM:145001]	A0A0A9WF39	379	D	N
Q96FF9	LB/B	-	B0BMM7	156	S	Y
Q9BWT1	LP/P	Immunodeficiency-centromeric instability-facial anomalies syndrome 3 (ICF3) [MIM:616910]	A0A2K5S3Z2	274	R	C
Q9BWT1	LP/P	Immunodeficiency-centromeric instability-facial anomalies syndrome 3 (ICF3) [MIM:616910]	A0A2K5S3Z2	274	R	H
Q53HL2	LB/B	-	A0A2K6K843	12	K	N
Q9H5V8	LB/B	-	A0A061I2E7	525	Q	R
Q9H5V8	LB/B	-	A0A061I2E7	709	D	G
Q9H5V8	LB/B	-	A0A061I2E7	673	A	V
Q5VXM1	LB/B	-	H3C0B5	244	G	R
P55291	LP/P	Intellectual developmental disorder, autosomal dominant 3 (MRD3) [MIM:612580]	A0A2K5JSB5	60	R	C
P55291	LP/P	Intellectual developmental disorder, autosomal dominant 3 (MRD3) [MIM:612580]	A0A2K5JSB5	92	R	W
P55291	LP/P	Intellectual developmental disorder, autosomal dominant 3 (MRD3) [MIM:612580]	A0A2K5JSB5	122	A	V
Q12864	LB/B	-	A0A146YV43	446	I	T
Q12864	LB/B	-	A0A146YV43	734	E	D
Q12864	LB/B	-	A0A146YV43	739	E	A
Q12864	LB/B	-	A0A146YV43	115	K	E
P19022	LB/B	-	A0A1U7UV72	21	A	T
P19022	LB/B	-	A0A1U7UV72	118	A	T
P19022	LB/B	-	A0A1U7UV72	196	S	T
P19022	LB/B	-	A0A1U7UV72	212	I	L
P19022	LB/B	-	A0A1U7UV72	845	N	S
P19022	LB/B	-	A0A1U7UV72	454	T	A
P19022	LP/P	Agenesis of corpus callosum, cardiac, ocular, and genital syndrome (ACOGS) [MIM:618929]	A0A1U7UV72	353	D	N
P19022	LP/P	Agenesis of corpus callosum, cardiac, ocular, and genital syndrome (ACOGS) [MIM:618929]	A0A1U7UV72	597	D	N
P19022	LP/P	Agenesis of corpus callosum, cardiac, ocular, and genital syndrome (ACOGS) [MIM:618929]	A0A1U7UV72	597	D	Y
P19022	LP/P	Agenesis of corpus callosum, cardiac, ocular, and genital syndrome (ACOGS) [MIM:618929]	A0A1U7UV72	601	N	T
P19022	LP/P	Agenesis of corpus callosum, cardiac, ocular, and genital syndrome (ACOGS) [MIM:618929]	A0A1U7UV72	613	C	W
P19022	LP/P	Agenesis of corpus callosum, cardiac, ocular, and genital syndrome (ACOGS) [MIM:618929]	A0A1U7UV72	627	D	G
P19022	LP/P	Agenesis of corpus callosum, cardiac, ocular, and genital syndrome (ACOGS) [MIM:618929]	A0A1U7UV72	676	Y	C
P19022	LP/P	Attention deficit-hyperactivity disorder 8 (ADHD8) [MIM:619957]	A0A1U7UV72	150	H	Y
Q9H251	LB/B	-	F1LPE5	3	R	C
Q9H251	LB/B	-	F1LPE5	490	G	A
Q9H251	LB/B	-	F1LPE5	496	S	N
Q9H251	LP/P	Deafness, autosomal recessive, 12 (DFNB12) [MIM:601386]	F1LPE5	990	D	N
Q9H251	LB/B	-	F1LPE5	1222	A	T
Q9H251	LB/B	-	F1LPE5	1349	R	C
Q9H251	LB/B	-	F1LPE5	1351	N	D
Q9H251	LP/P	Usher syndrome 1D (USH1D) [MIM:601067]	F1LPE5	1496	Q	H
Q9H251	LB/B	-	F1LPE5	1575	A	T
Q9H251	LB/B	-	F1LPE5	1671	T	S
Q9H251	LB/B	-	F1LPE5	1675	V	I
Q9H251	LP/P	Usher syndrome 1D (USH1D) [MIM:601067]	F1LPE5	1746	R	Q
Q9H251	LB/B	-	F1LPE5	1804	R	Q
Q9H251	LP/P	Deafness, autosomal recessive, 12 (DFNB12) [MIM:601386]	F1LPE5	1999	T	S
Q9H251	LB/B	-	F1LPE5	2044	E	K
Q9H251	LP/P	Deafness, autosomal recessive, 12 (DFNB12) [MIM:601386]	F1LPE5	2045	D	N
Q9H251	LP/P	Deafness, autosomal recessive, 12 (DFNB12) [MIM:601386]	F1LPE5	2202	D	N
Q9H251	LB/B	-	F1LPE5	2358	R	Q
Q9H251	LB/B	-	F1LPE5	2380	P	L
Q9H251	LB/B	-	F1LPE5	2588	E	Q
Q9H251	LP/P	Deafness, autosomal recessive, 12 (DFNB12) [MIM:601386]	F1LPE5	2950	I	N
Q9H251	LP/P	Deafness, autosomal recessive, 12 (DFNB12) [MIM:601386]	F1LPE5	2956	R	C
Q9H251	LP/P	Deafness, autosomal recessive, 12 (DFNB12) [MIM:601386]	F1LPE5	3059	P	T
Q9H251	LB/B	-	F1LPE5	3125	F	L
Q9H251	LB/B	Usher syndrome 1D (USH1D) [MIM:601067]	F1LPE5	366	A	T
Q9H251	LP/P	Usher syndrome 1D (USH1D) [MIM:601067]	F1LPE5	1209	T	A
Q9H251	LP/P	Usher syndrome 1D (USH1D) [MIM:601067]	F1LPE5	1507	R	Q
Q9H251	LP/P	Usher syndrome 1D (USH1D) [MIM:601067]	F1LPE5	3189	R	W
Q9H251	LP/P	Usher syndrome 1D/F (USH1DF) [MIM:601067]	F1LPE5	3189	R	W
Q9H251	LP/P	Usher syndrome 1D (USH1D) [MIM:601067]	F1LPE5	3245	S	F
Q9H251	LP/P	Deafness, autosomal recessive, 12 (DFNB12) [MIM:601386]	F1LPE5	124	D	G
Q9H251	LP/P	Usher syndrome 1D (USH1D) [MIM:601067]	F1LPE5	247	E	K
Q9H251	LP/P	Deafness, autosomal recessive, 12 (DFNB12) [MIM:601386]	F1LPE5	452	N	S
Q9H251	LP/P	Deafness, autosomal recessive, 12 (DFNB12) [MIM:601386]	F1LPE5	480	L	Q
Q9H251	LP/P	Usher syndrome 1D (USH1D) [MIM:601067]	F1LPE5	484	A	P
Q9H251	LP/P	Deafness, autosomal recessive, 12 (DFNB12) [MIM:601386]	F1LPE5	582	R	Q
Q9H251	LP/P	Deafness, autosomal recessive, 12 (DFNB12) [MIM:601386]	F1LPE5	1060	R	W
Q9H251	LP/P	Deafness, autosomal recessive, 12 (DFNB12) [MIM:601386]	F1LPE5	1186	G	D
Q9H251	LP/P	Usher syndrome 1D (USH1D) [MIM:601067]	F1LPE5	1206	P	R
Q9H251	LP/P	Deafness, autosomal recessive, 12 (DFNB12) [MIM:601386]	F1LPE5	1341	D	N
Q9H251	LB/B	-	F1LPE5	1437	R	Q
Q9H251	LP/P	Deafness, autosomal recessive, 12 (DFNB12) [MIM:601386]	F1LPE5	1586	A	P
Q9H251	LP/P	Deafness, autosomal recessive, 12 (DFNB12) [MIM:601386]	F1LPE5	1595	E	K
Q9H251	LB/B	-	F1LPE5	1620	V	M
Q9H251	LP/P	Deafness, autosomal recessive, 12 (DFNB12) [MIM:601386]	F1LPE5	1846	D	N
Q9H251	LB/B	-	F1LPE5	1887	T	I
Q9H251	LP/P	Deafness, autosomal recessive, 12 (DFNB12) [MIM:601386]	F1LPE5	1888	F	S
Q9H251	LP/P	Usher syndrome 1D (USH1D) [MIM:601067]	F1LPE5	2017	G	S
Q9H251	LB/B	-	F1LPE5	2066	R	Q
Q9H251	LP/P	Deafness, autosomal recessive, 12 (DFNB12) [MIM:601386]	F1LPE5	2148	D	N
Q9H251	LB/B	-	F1LPE5	2283	V	I
Q9H251	LB/B	-	F1LPE5	2376	D	N
Q9H251	LP/P	Deafness, autosomal recessive, 12 (DFNB12) [MIM:601386]	F1LPE5	2465	R	W
Q9H251	LP/P	Usher syndrome 1D (USH1D) [MIM:601067]	F1LPE5	2517	S	G
Q9H251	LP/P	Deafness, autosomal recessive, 12 (DFNB12) [MIM:601386]	F1LPE5	2608	R	H
Q9H251	LP/P	Usher syndrome 1D (USH1D) [MIM:601067]	F1LPE5	2744	G	S
Q9H251	LP/P	Usher syndrome 1D (USH1D) [MIM:601067]	F1LPE5	2833	R	G
Q9H251	LB/B	-	F1LPE5	2933	V	E
Q9H251	LB/B	-	F1LPE5	2954	D	N
Q9H251	LB/B	-	F1LPE5	2962	N	S
Q9H251	LP/P	Usher syndrome 1D (USH1D) [MIM:601067]	F1LPE5	3175	R	H
Q9H251	LP/P	Deafness, autosomal recessive, 12 (DFNB12) [MIM:601386]	F1LPE5	240	P	L
Q9H251	LP/P	Deafness, autosomal recessive, 12 (DFNB12) [MIM:601386]	F1LPE5	301	R	Q
Q9H251	LB/B	-	F1LPE5	746	V	I
Q9H251	LP/P	Usher syndrome 1D (USH1D) [MIM:601067]	F1LPE5	755	H	Y
Q9H251	LB/B	-	F1LPE5	944	S	G
Q9H251	LB/B	-	F1LPE5	960	E	K
Q9H251	LP/P	Usher syndrome 1D (USH1D) [MIM:601067]	F1LPE5	1090	V	I
Q9H251	LP/P	Usher syndrome 1D (USH1D) [MIM:601067]	F1LPE5	1098	N	S
Q9H251	LB/B	-	F1LPE5	1236	R	Q
Q9H251	LB/B	-	F1LPE5	1282	N	S
Q9H251	LP/P	Deafness, autosomal recessive, 12 (DFNB12) [MIM:601386]	F1LPE5	1417	R	W
Q9H251	LB/B	-	F1LPE5	1520	I	M
Q9H251	LB/B	-	F1LPE5	1574	M	T
Q9H251	LB/B	-	F1LPE5	1711	V	I
Q9H251	LP/P	Deafness, autosomal recessive, 12 (DFNB12) [MIM:601386]	F1LPE5	1716	Q	P
Q9H251	LP/P	Usher syndrome 1D (USH1D) [MIM:601067]	F1LPE5	1788	P	L
Q9H251	LB/B	-	F1LPE5	1807	V	M
Q9H251	LB/B	-	F1LPE5	1876	S	N
Q9H251	LB/B	-	F1LPE5	1908	V	I
Q9H251	LP/P	Usher syndrome 1D (USH1D) [MIM:601067]	F1LPE5	1912	R	W
Q9H251	LP/P	Usher syndrome 1D (USH1D) [MIM:601067]	F1LPE5	1930	D	N
Q9H251	LP/P	Deafness, autosomal recessive, 12 (DFNB12) [MIM:601386]	F1LPE5	2029	R	W
Q9H251	LB/B	-	F1LPE5	2125	I	M
Q9H251	LB/B	-	F1LPE5	2171	R	C
Q9H251	LB/B	-	F1LPE5	2227	Q	P
Q9H251	LP/P	Usher syndrome 1D (USH1D) [MIM:601067]	F1LPE5	2376	D	V
Q9H251	LB/B	-	F1LPE5	2473	L	P
Q9H251	LB/B	-	F1LPE5	2489	R	H
Q9H251	LP/P	Usher syndrome 1D (USH1D) [MIM:601067]	F1LPE5	2530	T	I
Q9H251	LB/B	-	F1LPE5	2669	I	V
Q9H251	LP/P	Usher syndrome 1D (USH1D) [MIM:601067]	F1LPE5	2771	G	S
Q9H251	LB/B	-	F1LPE5	2801	F	V
Q9H251	LP/P	Usher syndrome 1D (USH1D) [MIM:601067]	F1LPE5	2968	V	A
Q9H251	LB/B	-	F1LPE5	3175	R	C
Q9H251	LB/B	-	F1LPE5	160	D	N
Q9H251	LP/P	Deafness, autosomal recessive, 12 (DFNB12) [MIM:601386]	F1LPE5	342	N	S
Q9H251	LB/B	-	F1LPE5	361	A	S
Q9H251	LB/B	-	F1LPE5	424	V	M
Q9H251	LB/B	-	F1LPE5	428	D	N
Q9H251	LB/B	-	F1LPE5	803	V	I
Q9H251	LP/P	Deafness, autosomal recessive, 12 (DFNB12) [MIM:601386]	F1LPE5	956	E	K
Q9H251	LB/B	-	F1LPE5	964	R	Q
Q9H251	LB/B	-	F1LPE5	1010	R	H
Q9H251	LB/B	-	F1LPE5	1118	G	S
Q9H251	LB/B	-	F1LPE5	1335	V	A
Q9H251	LP/P	Deafness, autosomal recessive, 12 (DFNB12) [MIM:601386]	F1LPE5	1368	T	M
Q9H251	LB/B	-	F1LPE5	1415	S	I
Q9H251	LB/B	-	F1LPE5	1443	A	G
Q9H251	LB/B	-	F1LPE5	1588	R	W
Q9H251	LP/P	Deafness, autosomal recessive, 12 (DFNB12) [MIM:601386]	F1LPE5	1626	D	A
Q9H251	LB/B	-	F1LPE5	1806	D	E
Q9H251	LB/B	-	F1LPE5	2130	A	V
Q9H251	LP/P	Deafness, autosomal recessive, 12 (DFNB12) [MIM:601386]	F1LPE5	2287	N	K
Q9H251	LP/P	Deafness, autosomal recessive, 12 (DFNB12) [MIM:601386]	F1LPE5	2438	E	K
Q9H251	LB/B	-	F1LPE5	2531	M	V
Q9H251	LB/B	-	F1LPE5	2912	G	S
Q9H251	LB/B	-	F1LPE5	3080	A	T
Q9H251	LB/B	-	F1LPE5	192	E	Q
Q9H251	LB/B	-	F1LPE5	3062	M	T
Q9H251	LB/B	-	F1LPE5	187	V	I
Q9H251	LP/P	Pituitary adenoma 5, multiple types (PITA5) [MIM:617540]	F1LPE5	1379	R	L
P22223	LP/P	Hypotrichosis congenital with juvenile macular dystrophy (HJMD) [MIM:601553]	A0A093SQ13	503	R	H
P22223	LB/B	-	A0A093SQ13	237	V	M
P22223	LB/B	-	A0A093SQ13	477	R	H
P22223	LB/B	-	A0A093SQ13	563	Q	H
P22223	LP/P	Ectodermal dysplasia, ectrodactyly, and macular dystrophy syndrome (EEMS) [MIM:225280]	A0A093SQ13	322	N	I
P55283	LB/B	-	A0A093SQ13	625	K	R
P55283	LB/B	-	A0A093SQ13	141	A	V
P33151	LB/B	-	A0A2I3HI79	503	I	T
P33151	LB/B	-	A0A2I3HI79	517	I	T
Q96JP9	LB/B	-	G1MTE1	53	H	Q
Q96JP9	LB/B	-	G1MTE1	212	A	T
Q96JP9	LB/B	-	G1MTE1	243	A	V
Q96JP9	LB/B	-	G1MTE1	532	P	A
Q96JP9	LP/P	Cone-rod dystrophy 15 (CORD15) [MIM:613660]	G1MTE1	574	P	A
Q96JP9	LB/B	-	G1MTE1	171	T	S
Q9BYE9	LB/B	-	L9JBQ8	1164	L	M
Q9BYE9	LB/B	-	L9JBQ8	107	Q	H
Q9BYE9	LB/B	-	L9JBQ8	415	A	G
Q9BYE9	LB/B	-	L9JBQ8	424	V	A
Q9BYE9	LB/B	-	L9JBQ8	766	L	P
Q9BYE9	LB/B	-	L9JBQ8	901	T	M
Q9BYE9	LB/B	-	L9JBQ8	948	V	M
Q9BYE9	LB/B	-	L9JBQ8	1128	T	M
Q9BYE9	LB/B	-	L9JBQ8	1004	P	L
A6H8M9	LB/B	-	T0MFB0	5	R	K
Q9HBB8	LB/B	-	Q9JIK1	357	R	S
Q9HBB8	LB/B	-	Q9JIK1	389	D	N
Q9HBB8	LB/B	-	Q9JIK1	702	C	S
Q9HBB8	LB/B	-	Q9JIK1	165	Q	P
Q9HBB8	LB/B	-	Q9JIK1	521	P	S
Q14004	LB/B	-	F6VYH1	356	P	A
Q14004	LB/B	-	F6VYH1	403	L	F
Q14004	LB/B	-	F6VYH1	410	R	Q
Q14004	LB/B	-	F6VYH1	500	T	A
Q14004	LB/B	-	F6VYH1	624	S	G
Q14004	LB/B	-	F6VYH1	700	R	L
Q14004	LB/B	-	F6VYH1	1062	V	M
Q14004	LB/B	-	F6VYH1	494	T	A
Q14004	LB/B	-	F6VYH1	670	T	R
Q14004	LB/B	-	F6VYH1	1170	V	M
Q14004	LB/B	-	F6VYH1	340	S	F
Q14004	LP/P	Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder (CHDFIDD) [MIM:617360]	F6VYH1	714	G	R
Q14004	LP/P	Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder (CHDFIDD) [MIM:617360]	F6VYH1	717	G	R
Q14004	LP/P	Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder (CHDFIDD) [MIM:617360]	F6VYH1	751	R	Q
Q14004	LP/P	Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder (CHDFIDD) [MIM:617360]	F6VYH1	842	N	S
Q14004	LP/P	Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder (CHDFIDD) [MIM:617360]	F6VYH1	734	K	E
Q14004	LP/P	Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder (CHDFIDD) [MIM:617360]	F6VYH1	842	N	D
O94921	LB/B	-	A0A1W4ZZA3	463	S	R
Q96Q40	LB/B	-	H3AW41	64	R	G
Q96Q40	LB/B	-	H3AW41	127	Q	R
Q96Q40	LB/B	-	H3AW41	255	T	I
Q00537	LB/B	-	A0A146V459	214	T	I
Q9BWU1	LP/P	Developmental and epileptic encephalopathy 87 (DEE87) [MIM:618916]	R0K1S8	28	G	A
Q9BWU1	LP/P	Developmental and epileptic encephalopathy 87 (DEE87) [MIM:618916]	R0K1S8	28	G	R
Q9BWU1	LP/P	Developmental and epileptic encephalopathy 87 (DEE87) [MIM:618916]	R0K1S8	32	Y	C
Q9BWU1	LP/P	Developmental and epileptic encephalopathy 87 (DEE87) [MIM:618916]	R0K1S8	32	Y	H
Q9BWU1	LP/P	Developmental and epileptic encephalopathy 87 (DEE87) [MIM:618916]	R0K1S8	196	T	A
Q9BWU1	LP/P	Developmental and epileptic encephalopathy 87 (DEE87) [MIM:618916]	R0K1S8	197	F	L
Q9BWU1	LP/P	Developmental and epileptic encephalopathy 87 (DEE87) [MIM:618916]	R0K1S8	198	W	C
Q9BWU1	LP/P	Developmental and epileptic encephalopathy 87 (DEE87) [MIM:618916]	R0K1S8	200	R	W
Q8IZL9	LB/B	-	A0A2K6K5F6	86	S	L
Q8IZL9	LB/B	-	A0A2K6K5F6	137	A	T
Q8IZL9	LB/B	-	A0A2K6K5F6	281	K	R
Q8IZL9	LB/B	-	A0A2K6K5F6	106	S	N
P11802	LP/P	Melanoma, cutaneous malignant 3 (CMM3) [MIM:609048]	A0A1D2N3C7	24	R	C
P11802	LP/P	Melanoma, cutaneous malignant 3 (CMM3) [MIM:609048]	A0A1D2N3C7	24	R	H
P11802	LP/P	Melanoma, cutaneous malignant 3 (CMM3) [MIM:609048]	A0A1D2N3C7	41	N	S
P11802	LB/B	-	A0A1D2N3C7	82	R	Q
P11802	LB/B	-	A0A1D2N3C7	122	R	H
Q00535	LB/B	-	A0A0N5DMZ8	225	E	D
Q96SN8	LB/B	-	M7BQW5	289	E	Q
Q96SN8	LB/B	-	M7BQW5	1540	V	L
Q96SN8	LB/B	-	M7BQW5	1045	R	T
Q96SN8	LB/B	-	M7BQW5	183	A	P
Q96SN8	LB/B	-	M7BQW5	1607	R	S
Q96SN8	LB/B	-	M7BQW5	1330	N	I
Q96JB5	LB/B	-	B3S8S3	324	L	V
P50613	LB/B	-	A0A023G468	163	G	A
P50613	LB/B	-	A0A023G468	285	T	M
P49336	LP/P	Intellectual developmental disorder with hypotonia and behavioral abnormalities (IDDHBA) [MIM:618748]	A0A147AN47	27	V	L
P49336	LP/P	Intellectual developmental disorder with hypotonia and behavioral abnormalities (IDDHBA) [MIM:618748]	A0A147AN47	29	R	G
P49336	LP/P	Intellectual developmental disorder with hypotonia and behavioral abnormalities (IDDHBA) [MIM:618748]	A0A147AN47	30	G	S
P49336	LP/P	Intellectual developmental disorder with hypotonia and behavioral abnormalities (IDDHBA) [MIM:618748]	A0A147AN47	62	S	L
P49336	LP/P	Intellectual developmental disorder with hypotonia and behavioral abnormalities (IDDHBA) [MIM:618748]	A0A147AN47	178	R	Q
P49336	LP/P	Intellectual developmental disorder with hypotonia and behavioral abnormalities (IDDHBA) [MIM:618748]	A0A147AN47	193	V	G
P49336	LP/P	Intellectual developmental disorder with hypotonia and behavioral abnormalities (IDDHBA) [MIM:618748]	A0A147AN47	223	I	M
P50750	LB/B	-	L9KH40	231	G	A
P50750	LB/B	-	L9KH40	59	F	L
Q5VV42	LB/B	-	L5KVD8	484	K	R
Q5MAI5	LB/B	-	A0A1A9X053	38	S	P
Q5MAI5	LB/B	-	A0A1A9X053	53	R	H
Q5MAI5	LB/B	-	A0A1A9X053	228	F	C
Q5MAI5	LB/B	-	A0A1A9X053	288	S	Y
Q5MAI5	LB/B	-	A0A1A9X053	307	R	C
Q5MAI5	LB/B	-	A0A1A9X053	118	H	Y
O76039	LP/P	Developmental and epileptic encephalopathy 2 (DEE2) [MIM:300672]	A0A2I0MLC2	152	C	F
O76039	LP/P	Developmental and epileptic encephalopathy 2 (DEE2) [MIM:300672]	A0A2I0MLC2	175	R	S
O76039	LB/B	-	A0A2I0MLC2	791	Q	P
O76039	LP/P	Developmental and epileptic encephalopathy 2 (DEE2) [MIM:300672]	A0A2I0MLC2	180	P	L
O76039	LB/B	-	A0A2I0MLC2	734	T	A
O76039	LP/P	Developmental and epileptic encephalopathy 2 (DEE2) [MIM:300672]	A0A2I0MLC2	40	A	V
O76039	LP/P	Developmental and epileptic encephalopathy 2 (DEE2) [MIM:300672]	A0A2I0MLC2	72	I	N
O76039	LP/P	Developmental and epileptic encephalopathy 2 (DEE2) [MIM:300672]	A0A2I0MLC2	72	I	T
O76039	LP/P	Developmental and epileptic encephalopathy 2 (DEE2) [MIM:300672]	A0A2I0MLC2	127	H	R
O76039	LP/P	Developmental and epileptic encephalopathy 2 (DEE2) [MIM:300672]	A0A2I0MLC2	178	R	P
O76039	LP/P	Developmental and epileptic encephalopathy 2 (DEE2) [MIM:300672]	A0A2I0MLC2	220	L	P
O76039	LP/P	Developmental and epileptic encephalopathy 2 (DEE2) [MIM:300672]	A0A2I0MLC2	288	T	I
O76039	LP/P	Developmental and epileptic encephalopathy 2 (DEE2) [MIM:300672]	A0A2I0MLC2	291	C	Y
O76039	LP/P	Developmental and epileptic encephalopathy 2 (DEE2) [MIM:300672]	A0A2I0MLC2	399	N	T
O76039	LB/B	-	A0A2I0MLC2	444	R	C
O76039	LP/P	Developmental and epileptic encephalopathy 2 (DEE2) [MIM:300672]	A0A2I0MLC2	718	V	M
O76039	LP/P	Developmental and epileptic encephalopathy 2 (DEE2) [MIM:300672]	A0A2I0MLC2	178	R	Q
O76039	LP/P	Developmental and epileptic encephalopathy 2 (DEE2) [MIM:300672]	A0A2I0MLC2	196	S	L
O76039	LP/P	Developmental and epileptic encephalopathy 2 (DEE2) [MIM:300672]	A0A2I0MLC2	182	L	P
O76039	LP/P	Developmental and epileptic encephalopathy 2 (DEE2) [MIM:300672]	A0A2I0MLC2	207	G	E
O76039	LP/P	Developmental and epileptic encephalopathy 2 (DEE2) [MIM:300672]	A0A2I0MLC2	178	R	W
O76039	LP/P	-	A0A2I0MLC2	647	P	L
P46527	LB/B	-	A0A2I4CFI0	15	R	W
P46527	LB/B	-	A0A2I4CFI0	109	V	G
P46527	LB/B	-	A0A2I4CFI0	69	P	L
P49918	LP/P	Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies (IMAGE) [MIM:614732]	A0A2K5Q1P5	274	D	N
P49918	LP/P	Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies (IMAGE) [MIM:614732]	A0A2K5Q1P5	276	F	S
P49918	LP/P	Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies (IMAGE) [MIM:614732]	A0A2K5Q1P5	276	F	V
P49918	LP/P	Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies (IMAGE) [MIM:614732]	A0A2K5Q1P5	278	K	E
P49918	LP/P	Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies (IMAGE) [MIM:614732]	A0A2K5Q1P5	279	R	P
P49918	LP/P	Beckwith-Wiedemann syndrome (BWS) [MIM:130650]	A0A2K5Q1P5	53	L	P
P49918	LP/P	Beckwith-Wiedemann syndrome (BWS) [MIM:130650]	A0A2K5Q1P5	70	P	L
P42771	LP/P	Melanoma, cutaneous malignant 2 (CMM2) [MIM:155601]	A0A1A6GSL6	24	R	C
P42771	LP/P	Melanoma, cutaneous malignant 2 (CMM2) [MIM:155601]	A0A1A6GSL6	24	R	P
P42771	LP/P	Melanoma, cutaneous malignant 2 (CMM2) [MIM:155601]	A0A1A6GSL6	32	L	P
P42771	LP/P	Melanoma, cutaneous malignant 2 (CMM2) [MIM:155601]	A0A1A6GSL6	35	G	A
P42771	LP/P	Melanoma, cutaneous malignant 2 (CMM2) [MIM:155601]	A0A1A6GSL6	35	G	E
P42771	LP/P	Melanoma, cutaneous malignant 2 (CMM2) [MIM:155601]	A0A1A6GSL6	48	P	L
P42771	LB/B	-	A0A1A6GSL6	49	I	T
P42771	LP/P	Melanoma, cutaneous malignant 2 (CMM2) [MIM:155601]	A0A1A6GSL6	50	Q	R
P42771	LP/P	Melanoma, cutaneous malignant 2 (CMM2) [MIM:155601]	A0A1A6GSL6	53	M	I
P42771	LB/B	-	A0A1A6GSL6	56	S	I
P42771	LP/P	Melanoma, cutaneous malignant 2 (CMM2) [MIM:155601]	A0A1A6GSL6	59	V	G
P42771	LB/B	-	A0A1A6GSL6	60	A	T
P42771	LP/P	Melanoma, cutaneous malignant 2 (CMM2) [MIM:155601]	A0A1A6GSL6	62	L	P
P42771	LP/P	Melanoma, cutaneous malignant 2 (CMM2) [MIM:155601]	A0A1A6GSL6	68	A	L
P42771	LB/B	-	A0A1A6GSL6	68	A	V
P42771	LP/P	Melanoma, cutaneous malignant 2 (CMM2) [MIM:155601]	A0A1A6GSL6	71	N	K
P42771	LB/B	-	A0A1A6GSL6	71	N	S
P42771	LP/P	Melanoma, cutaneous malignant 2 (CMM2) [MIM:155601]	A0A1A6GSL6	84	D	Y
P42771	LB/B	-	A0A1A6GSL6	85	A	T
P42771	LP/P	Melanoma, cutaneous malignant 2 (CMM2) [MIM:155601]	A0A1A6GSL6	87	R	P
P42771	LP/P	Melanoma, cutaneous malignant 2 (CMM2) [MIM:155601]	A0A1A6GSL6	89	G	D
P42771	LP/P	Melanoma, cutaneous malignant 2 (CMM2) [MIM:155601]	A0A1A6GSL6	89	G	S
P42771	LP/P	Melanoma, cutaneous malignant 2 (CMM2) [MIM:155601]	A0A1A6GSL6	97	L	R
P42771	LP/P	Melanoma, cutaneous malignant 2 (CMM2) [MIM:155601]	A0A1A6GSL6	98	H	P
P42771	LP/P	Melanoma, cutaneous malignant 2 (CMM2) [MIM:155601]	A0A1A6GSL6	98	H	Q
P42771	LP/P	Melanoma, cutaneous malignant 2 (CMM2) [MIM:155601]	A0A1A6GSL6	99	R	P
P42771	LP/P	Melanoma, cutaneous malignant 2 (CMM2) [MIM:155601]	A0A1A6GSL6	100	A	L
P42771	LB/B	-	A0A1A6GSL6	100	A	P
P42771	LP/P	Familial atypical multiple mole melanoma-pancreatic carcinoma syndrome (FAMMMPC) [MIM:606719]	A0A1A6GSL6	101	G	W
P42771	LP/P	Melanoma, cutaneous malignant 2 (CMM2) [MIM:155601]	A0A1A6GSL6	101	G	W
P42771	LP/P	Melanoma, cutaneous malignant 2 (CMM2) [MIM:155601]	A0A1A6GSL6	107	R	C
P42771	LB/B	-	A0A1A6GSL6	107	R	H
P42771	LP/P	Melanoma, cutaneous malignant 2 (CMM2) [MIM:155601]	A0A1A6GSL6	117	L	M
P42771	LP/P	Melanoma, cutaneous malignant 2 (CMM2) [MIM:155601]	A0A1A6GSL6	118	A	T
P42771	LP/P	Melanoma, cutaneous malignant 2 (CMM2) [MIM:155601]	A0A1A6GSL6	126	V	D
P42771	LB/B	-	A0A1A6GSL6	148	A	T
P42771	LP/P	Melanoma, cutaneous malignant 2 (CMM2) [MIM:155601]	A0A1A6GSL6	87	R	W
P42771	LB/B	-	A0A1A6GSL6	102	A	E
P42771	LP/P	Melanoma, cutaneous malignant 2 (CMM2) [MIM:155601]	A0A1A6GSL6	94	L	Q
P42771	LP/P	Melanoma, cutaneous malignant 2 (CMM2) [MIM:155601]	A0A1A6GSL6	122	G	R
P42771	LB/B	-	A0A1A6GSL6	83	H	Q
P42771	LB/B	-	A0A1A6GSL6	99	R	W
P42771	LB/B	-	A0A1A6GSL6	102	A	T
P42771	LB/B	-	A0A1A6GSL6	124	R	C
P42771	LB/B	-	A0A1A6GSL6	24	R	Q
P42771	LP/P	Melanoma, cutaneous malignant 2 (CMM2) [MIM:155601]	A0A1A6GSL6	35	G	V
P42771	LP/P	Melanoma, cutaneous malignant 2 (CMM2) [MIM:155601]	A0A1A6GSL6	67	G	R
P42771	LB/B	-	A0A1A6GSL6	69	E	G
P42771	LP/P	Melanoma, cutaneous malignant 2 (CMM2) [MIM:155601]	A0A1A6GSL6	74	D	Y
P42771	LP/P	Melanoma, cutaneous malignant 2 (CMM2) [MIM:155601]	A0A1A6GSL6	77	T	P
P42771	LP/P	Melanoma, cutaneous malignant 2 (CMM2) [MIM:155601]	A0A1A6GSL6	80	R	P
P42771	LP/P	Melanoma, cutaneous malignant 2 (CMM2) [MIM:155601]	A0A1A6GSL6	81	P	T
P42771	LB/B	-	A0A1A6GSL6	114	P	S
Q8N726	LB/B	-	H2PS13	17	P	S
Q8N726	LB/B	-	H2PS13	106	G	R
Q8N726	LB/B	-	H2PS13	113	P	L
Q8N726	LB/B	-	H2PS13	116	G	D
Q16667	LP/P	Hepatocellular carcinoma (HCC) [MIM:114550]	U3JMH5	31	W	R
Q16667	LP/P	Hepatocellular carcinoma (HCC) [MIM:114550]	U3JMH5	78	F	L
Q16667	LP/P	Hepatocellular carcinoma (HCC) [MIM:114550]	U3JMH5	79	C	Y
Q16667	LP/P	Hepatocellular carcinoma (HCC) [MIM:114550]	U3JMH5	91	N	K
Q16667	LP/P	Hepatocellular carcinoma (HCC) [MIM:114550]	U3JMH5	94	D	V
Q16667	LP/P	Hepatocellular carcinoma (HCC) [MIM:114550]	U3JMH5	95	L	F
Q16667	LP/P	Hepatocellular carcinoma (HCC) [MIM:114550]	U3JMH5	108	I	V
Q16667	LP/P	Hepatocellular carcinoma (HCC) [MIM:114550]	U3JMH5	187	N	S
Q16667	LP/P	Hepatocellular carcinoma (HCC) [MIM:114550]	U3JMH5	195	K	I
Q16667	LB/B	-	U3JMH5	159	S	F
Q16878	LB/B	-	L5KJR3	45	T	I
Q4KMG0	LB/B	-	S7N3E4	66	K	R
Q4KMG0	LB/B	-	S7N3E4	162	E	K
Q4KMG0	LB/B	-	S7N3E4	351	P	A
Q4KMG0	LB/B	-	S7N3E4	686	A	V
Q4KMG0	LB/B	Holoprosencephaly 11 (HPE11) [MIM:614226]	S7N3E4	684	T	S
Q4KMG0	LP/P	Holoprosencephaly 11 (HPE11) [MIM:614226]	S7N3E4	689	P	A
Q4KMG0	LP/P	Holoprosencephaly 11 (HPE11) [MIM:614226]	S7N3E4	691	V	M
Q4KMG0	LP/P	Holoprosencephaly 11 (HPE11) [MIM:614226]	S7N3E4	780	V	E
Q4KMG0	LP/P	Holoprosencephaly 11 (HPE11) [MIM:614226]	S7N3E4	790	T	A
Q4KMG0	LP/P	Holoprosencephaly 11 (HPE11) [MIM:614226]	S7N3E4	940	S	R
Q6NVV7	LB/B	-	K7GK23	5	V	A
Q6NVV7	LB/B	-	K7GK23	70	L	R
Q96T59	LB/B	-	A0A2I3HVD6	24	R	Q
Q8N9R6	LB/B	-	A0A2R8ZQ30	73	V	I
Q8N9R6	LB/B	-	A0A2R8ZQ30	122	H	Q
Q92903	LB/B	-	S7PP50	99	L	F
Q15517	LB/B	-	F6U7J3	18	M	L
Q15517	LB/B	-	F6U7J3	143	N	S
Q15517	LB/B	-	F6U7J3	202	S	F
Q15517	LB/B	-	F6U7J3	408	S	A
Q15517	LB/B	-	F6U7J3	410	S	L
Q15517	LB/B	-	F6U7J3	527	D	N
Q15517	LB/B	-	F6U7J3	56	L	F
Q15517	LB/B	-	F6U7J3	150	S	N
Q15517	LB/B	-	F6U7J3	401	S	G
Q15517	LB/B	-	F6U7J3	145	G	S
Q9H211	LB/B	-	G1L0I8	537	A	V
Q9H211	LB/B	-	G1L0I8	135	A	V
Q9H211	LB/B	-	G1L0I8	172	R	C
Q9H211	LB/B	-	G1L0I8	456	E	A
Q9H211	LB/B	-	G1L0I8	234	C	R
Q9H211	LB/B	-	G1L0I8	262	T	A
Q9H211	LP/P	Meier-Gorlin syndrome 4 (MGORS4) [MIM:613804]	G1L0I8	66	A	T
Q9H211	LP/P	Meier-Gorlin syndrome 4 (MGORS4) [MIM:613804]	G1L0I8	117	Q	H
Q9H211	LP/P	Meier-Gorlin syndrome 4 (MGORS4) [MIM:613804]	G1L0I8	453	R	W
Q9H211	LP/P	Meier-Gorlin syndrome 4 (MGORS4) [MIM:613804]	G1L0I8	462	R	Q
Q9H211	LP/P	Meier-Gorlin syndrome 4 (MGORS4) [MIM:613804]	G1L0I8	468	E	K
P47902	LB/B	-	A0A2K6K4D1	130	P	R
Q9Y232	LB/B	-	A0A1S2ZRB1	2	T	A
Q9Y232	LB/B	-	A0A1S2ZRB1	9	S	P
Q9Y232	LB/B	-	A0A1S2ZRB1	48	V	A
Q9Y232	LB/B	-	A0A1S2ZRB1	60	A	G
P13688	LB/B	-	A0A2K6FK42	35	Q	K
P13688	LB/B	-	A0A2K6FK42	83	A	V
P13688	LB/B	-	A0A2K6FK42	123	Q	H
P13688	LB/B	-	A0A2K6FK42	376	Q	R
Q2WEN9	LP/P	Deafness, autosomal dominant, 4B (DFNA4B) [MIM:614614]	H0W5K3	140	T	P
Q2WEN9	LP/P	Deafness, autosomal dominant, 4B (DFNA4B) [MIM:614614]	H0W5K3	169	G	R
A8MTB9	LB/B	-	L8IH60	160	L	H
A8MTB9	LB/B	-	L8IH60	161	T	A
Q6UY09	LB/B	-	A0A2U3ZG87	41	A	V
Q6UY09	LB/B	-	A0A2U3ZG87	113	R	H
Q6UY09	LB/B	-	A0A2U3ZG87	127	I	V
Q6UY09	LB/B	-	A0A2U3ZG87	355	S	L
Q6UY09	LB/B	-	A0A2U3ZG87	369	S	F
Q6UY09	LB/B	-	A0A2U3ZG87	512	R	C
Q6UY09	LB/B	-	A0A2U3ZG87	87	T	I
Q3KPI0	LB/B	-	F7BL07	121	N	T
Q3KPI0	LB/B	-	F7BL07	198	V	M
P40198	LB/B	-	A0A2U3XKN9	7	S	P
O75871	LB/B	-	A0A2U3XKN9	29	H	D
O75871	LB/B	-	A0A2U3XKN9	69	K	R
P40199	LB/B	-	A0A2K5PZW6	239	V	G
Q14002	LB/B	-	F1RMX1	120	I	F
Q14002	LB/B	-	F1RMX1	263	A	V
Q14002	LB/B	-	F1RMX1	236	Y	H
P31997	LB/B	-	A0A2K5PZW6	114	R	K
P31997	LB/B	-	A0A2K5PZW6	17	G	V
P31997	LB/B	-	A0A2K5PZW6	45	A	V
P31997	LB/B	-	A0A2K5PZW6	322	L	V
P31997	LB/B	-	A0A2K5PZW6	340	I	M
P49715	LP/P	Leukemia, acute myelogenous (AML) [MIM:601626]	G3WQ59	84	H	L
P49716	LB/B	-	W5NMR1	248	R	W
Q15744	LP/P	Specific granule deficiency 1 (SGD1) [MIM:245480]	A0A2Y9IG80	218	V	A
Q15744	LP/P	Immunodeficiency 108 with autoinflammation (IMD108) [MIM:260570]	A0A2Y9IG80	219	R	H
Q03701	LB/B	-	Q5ZIQ7	102	V	I
Q03701	LB/B	-	Q5ZIQ7	15	P	S
Q03701	LB/B	-	Q5ZIQ7	303	K	R
Q03701	LB/B	-	Q5ZIQ7	639	N	S
Q9BXF3	LB/B	-	A0A151NIJ3	293	R	H
Q9BXF3	LB/B	-	A0A151NIJ3	674	P	L
Q711Q0	LB/B	-	G3X3I0	208	N	K
Q711Q0	LB/B	-	G3X3I0	666	H	Q
Q711Q0	LB/B	-	G3X3I0	698	F	S
Q711Q0	LB/B	-	G3X3I0	741	D	G
Q711Q0	LB/B	-	G3X3I0	883	D	N
Q711Q0	LB/B	-	G3X3I0	958	F	Y
Q711Q0	LB/B	-	G3X3I0	1084	G	A
Q711Q0	LB/B	-	G3X3I0	1254	V	I
Q711Q0	LB/B	-	G3X3I0	1337	G	S
Q711Q0	LB/B	-	G3X3I0	320	R	L
Q711Q0	LB/B	-	G3X3I0	461	D	A
Q711Q0	LB/B	-	G3X3I0	522	V	G
Q9UNI1	LB/B	-	G1N1Z6	10	Q	H
Q9UNI1	LB/B	-	G1N1Z6	44	R	W
Q9UNI1	LB/B	-	G1N1Z6	59	M	V
Q9UNI1	LB/B	-	G1N1Z6	243	Q	R
P08217	LB/B	-	G1N1Z6	257	N	S
P08217	LP/P	Abdominal obesity-metabolic syndrome 4 (AOMS4) [MIM:618620]	G1N1Z6	70	T	M
P08217	LP/P	Abdominal obesity-metabolic syndrome 4 (AOMS4) [MIM:618620]	G1N1Z6	121	D	N
P08218	LB/B	-	G1N1Z6	79	G	R
P08218	LB/B	-	G1N1Z6	114	D	N
P08218	LB/B	-	G1N1Z6	177	Q	R
P08218	LB/B	-	G1N1Z6	235	G	S
P09093	LB/B	-	A0A1U8CLS1	241	A	G
P09093	LB/B	-	A0A1U8CLS1	24	H	R
P09093	LB/B	-	A0A1U8CLS1	25	S	P
P09093	LB/B	-	A0A1U8CLS1	31	H	N
P08861	LB/B	-	A0A1U8CLS1	79	R	W
Q9BZC1	LB/B	-	G5BZ33	388	G	S
Q96J87	LB/B	-	A0A2U3ZW03	152	R	P
Q8WUJ3	LB/B	-	F7AG84	187	R	C
Q8WUJ3	LB/B	-	F7AG84	187	R	H
Q8WUJ3	LB/B	-	F7AG84	783	H	R
Q8WUJ3	LB/B	-	F7AG84	783	H	Y
Q8WUJ3	LB/B	-	F7AG84	1109	V	I
Q8WUJ3	LB/B	-	F7AG84	1169	P	A
Q9UHN6	LB/B	-	F7AG84	245	R	K
Q9UHN6	LB/B	-	F7AG84	291	R	H
Q9UHN6	LB/B	-	F7AG84	423	D	E
Q9UHN6	LB/B	-	F7AG84	765	P	S
Q9UHN6	LB/B	-	F7AG84	1010	I	V
Q9UHN6	LB/B	-	F7AG84	1254	S	N
Q9UHN6	LB/B	-	F7AG84	1280	G	D
Q9UHN6	LB/B	-	F7AG84	291	R	L
Q9UHN6	LB/B	-	F7AG84	291	R	P
Q6PRD7	LB/B	-	H2RAE3	55	K	E
Q86UT8	LB/B	-	H3CAL0	244	W	G
Q03188	LB/B	-	E9PSW8	341	L	F
Q03188	LB/B	-	E9PSW8	389	G	D
P49454	LB/B	-	A0A1S3AM78	3106	N	K
P49454	LB/B	-	A0A1S3AM78	300	R	C
P49454	LB/B	-	A0A1S3AM78	494	H	Q
P49454	LB/B	-	A0A1S3AM78	701	M	V
P49454	LB/B	-	A0A1S3AM78	754	Q	E
P49454	LB/B	-	A0A1S3AM78	815	R	H
P49454	LB/B	-	A0A1S3AM78	1018	Y	D
P49454	LB/B	-	A0A1S3AM78	1033	G	R
P49454	LB/B	-	A0A1S3AM78	1105	T	I
P49454	LB/B	-	A0A1S3AM78	1412	L	S
P49454	LB/B	-	A0A1S3AM78	1915	E	A
P49454	LB/B	-	A0A1S3AM78	250	Q	L
P49454	LB/B	-	A0A1S3AM78	272	D	G
P49454	LB/B	-	A0A1S3AM78	1768	D	N
Q8N0S6	LB/B	-	A0A151MIH9	117	I	F
Q96H22	LB/B	-	A0A2K6FRQ1	84	E	D
Q96H22	LB/B	-	A0A2K6FRQ1	223	Q	R
Q96H22	LB/B	-	A0A2K6FRQ1	288	E	K
Q9BU64	LB/B	-	A0A093J5Q4	34	Q	R
Q7L2Z9	LB/B	-	A0A2K6L6C8	63	G	R
Q7L2Z9	LB/B	-	A0A2K6L6C8	266	D	G
Q96BT3	LB/B	-	F7C6J9	115	P	L
O60308	LB/B	-	A0A2J7PSH2	686	A	V
O60308	LB/B	-	A0A2J7PSH2	414	L	I
Q8N8E3	LB/B	-	F7BE59	551	K	E
Q8N960	LB/B	-	A0A087RBI5	602	L	V
Q8N960	LB/B	-	A0A087RBI5	879	Q	H
Q8N960	LB/B	-	A0A087RBI5	936	V	I
Q8N960	LB/B	-	A0A087RBI5	947	R	H
Q8N960	LP/P	Short-rib thoracic dysplasia 13 with or without polydactyly (SRTD13) [MIM:616300]	A0A087RBI5	199	A	P
Q9P2H0	LB/B	-	K7G0F3	178	A	T
Q9P2H0	LB/B	-	K7G0F3	238	G	C
Q9P2H0	LB/B	-	K7G0F3	275	S	Y
Q9P2H0	LB/B	-	K7G0F3	281	I	T
Q9P2H0	LB/B	-	K7G0F3	302	A	T
Q9P2H0	LB/B	-	K7G0F3	710	P	S
Q9P2H0	LB/B	-	K7G0F3	1021	M	T
Q9P2H0	LB/B	-	K7G0F3	1077	S	N
Q9P2H0	LB/B	-	K7G0F3	668	G	S
Q6ZU80	LB/B	-	S4RKU9	16	R	L
Q6ZU80	LB/B	-	S4RKU9	732	H	R
Q9UPN4	LB/B	-	A0A0S3NTU0	43	V	I
Q9UPN4	LB/B	-	A0A0S3NTU0	70	I	V
Q9UPN4	LB/B	-	A0A0S3NTU0	272	T	A
Q9UPN4	LB/B	-	A0A0S3NTU0	397	T	A
Q9UPN4	LB/B	-	A0A0S3NTU0	473	V	A
Q66GS9	LB/B	-	E1C7U7	769	I	L
Q5TB80	LB/B	-	H3B0S9	266	C	S
Q5TB80	LB/B	-	H3B0S9	272	E	Q
Q5TB80	LB/B	-	H3B0S9	342	S	C
Q5TB80	LB/B	-	H3B0S9	348	E	Q
Q9UPV0	LB/B	-	A0A2K6F3W0	94	S	N
Q9UPV0	LB/B	-	A0A2K6F3W0	988	T	S
Q9UPV0	LB/B	-	A0A2K6F3W0	1119	Q	R
Q9UPV0	LP/P	Nephronophthisis 15 (NPHP15) [MIM:614845]	A0A2K6F3W0	11	Q	P
Q9UPV0	LP/P	Nephronophthisis 15 (NPHP15) [MIM:614845]	A0A2K6F3W0	93	R	W
Q5SW79	LB/B	-	A0A146WBF3	213	G	S
O15078	LP/P	Joubert syndrome 5 (JBTS5) [MIM:610188]	A0A091RD53	7	W	C
O15078	LP/P	Senior-Loken syndrome 6 (SLSN6) [MIM:610189]	A0A091RD53	7	W	C
O15078	LB/B	-	A0A091RD53	838	K	E
O15078	LB/B	-	A0A091RD53	906	L	W
O15078	LB/B	-	A0A091RD53	1237	R	H
O15078	LB/B	-	A0A091RD53	1836	I	V
O15078	LB/B	-	A0A091RD53	277	E	Q
O15078	LB/B	-	A0A091RD53	664	D	G
O15078	LB/B	-	A0A091RD53	2228	N	K
O15078	LB/B	-	A0A091RD53	2210	R	C
O15078	LP/P	Joubert syndrome 5 (JBTS5) [MIM:610188]	A0A091RD53	534	E	K
O15078	LB/B	Joubert syndrome 5 (JBTS5) [MIM:610188]	A0A091RD53	2134	I	T
Q9C0D2	LB/B	-	F1N4A0	80	Q	K
Q9C0D2	LB/B	-	F1N4A0	208	R	Q
Q9C0D2	LB/B	-	F1N4A0	499	A	E
Q9C0D2	LB/B	-	F1N4A0	1026	E	K
Q9C0D2	LB/B	-	F1N4A0	1270	A	G
Q9C0D2	LB/B	-	F1N4A0	1441	G	E
Q9C0D2	LB/B	-	F1N4A0	1459	L	R
Q9BYV8	LP/P	-	A0A1L8GZK0	36	M	T
Q9BYV8	LP/P	-	A0A1L8GZK0	179	R	H
Q9BYV8	LP/P	-	A0A1L8GZK0	360	R	C
O95684	LB/B	-	Q3KPN4	271	K	N
O95684	LB/B	-	Q3KPN4	190	A	G
Q9C0F1	LB/B	-	A0A2K6EZ20	147	G	S
Q53EZ4	LB/B	-	A0A060XD11	99	T	A
Q53EZ4	LB/B	-	A0A060XD11	378	H	L
Q53EZ4	LB/B	-	A0A060XD11	57	H	Q
Q53EZ4	LB/B	-	A0A060XD11	236	C	R
Q76N32	LB/B	-	E2QY20	74	G	S
Q76N32	LB/B	-	E2QY20	27	R	G
Q76N32	LB/B	-	E2QY20	397	L	P
Q76N32	LB/B	-	E2QY20	462	R	C
Q76N32	LB/B	-	E2QY20	473	E	Q
Q8NHQ1	LB/B	-	Q4RY86	135	S	N
Q8NHQ1	LB/B	-	Q4RY86	537	N	S
Q9P209	LB/B	-	K7FAE6	238	P	L
Q9P209	LB/B	-	K7FAE6	412	P	T
Q9P209	LB/B	-	K7FAE6	509	T	A
Q96ST8	LB/B	-	G1MAJ1	194	R	W
Q96ST8	LB/B	-	G1MAJ1	398	V	A
O95813	LB/B	-	A0A2K6CB62	19	R	W
O95813	LB/B	-	A0A2K6CB62	65	A	G
O95813	LB/B	-	A0A2K6CB62	179	V	I
Q8TCT0	LB/B	-	F1Q445	191	I	V
Q8TCT0	LB/B	-	F1Q445	211	T	M
Q8TCT0	LB/B	-	F1Q445	306	L	F
Q49MI3	LB/B	-	A0A151LZT4	232	L	F
Q49MI3	LB/B	-	A0A151LZT4	514	E	G
Q49MI3	LP/P	Retinitis pigmentosa 26 (RP26) [MIM:608380]	A0A151LZT4	106	R	S
P27544	LP/P	Epilepsy, progressive myoclonic 8 (EPM8) [MIM:616230]	A4FUG2	183	H	Q
Q96G23	LB/B	-	L8Y6Z2	115	E	A
Q8IU89	LB/B	-	A0A091CNI8	370	R	G
Q8IU89	LB/B	-	A0A091CNI8	342	D	G
Q8IU89	LB/B	-	A0A091CNI8	45	Y	C
Q9HA82	LB/B	-	H2NXD5	301	G	S
Q9HA82	LB/B	-	H2NXD5	366	A	T
Q9HA82	LB/B	-	H2NXD5	119	R	Q
Q9HA82	LB/B	-	H2NXD5	353	A	V
Q9HA82	LB/B	-	H2NXD5	379	R	Q
Q8N5B7	LB/B	-	H0WQE6	75	C	R
Q9Y5P4	LB/B	-	A0A074Z6Q0	599	K	R
Q9Y5P4	LP/P	Intellectual developmental disorder, autosomal dominant 34 (MRD34) [MIM:616351]	A0A074Z6Q0	132	S	L
Q9Y5P4	LP/P	Intellectual developmental disorder, autosomal dominant 34 (MRD34) [MIM:616351]	A0A074Z6Q0	243	G	R
P23141	LB/B	-	A0A212DBT2	75	S	N
P23141	LB/B	-	A0A212DBT2	199	R	H
P23141	LB/B	-	A0A212DBT2	203	D	E
P23141	LB/B	-	A0A212DBT2	143	G	E
O00748	LB/B	-	A0A2K6KFU9	34	R	W
O00748	LB/B	-	A0A2K6KFU9	206	R	H
Q6UWW8	LB/B	-	G3VZX8	129	V	I
Q6UWW8	LB/B	-	G3VZX8	151	A	T
Q6UWW8	LB/B	-	G3VZX8	160	Y	H
Q6UWW8	LB/B	-	G3VZX8	191	E	K
Q6UWW8	LB/B	-	G3VZX8	213	I	N
Q6UWW8	LB/B	-	G3VZX8	367	R	W
Q6UWW8	LB/B	-	G3VZX8	523	A	V
Q6UWW8	LB/B	-	G3VZX8	555	I	V
Q6NT32	LB/B	-	A0A2K6BJC5	71	R	Q
Q6NT32	LB/B	-	A0A2K6BJC5	261	E	K
Q6NT32	LB/B	-	A0A2K6BJC5	344	H	Q
Q6NT32	LB/B	-	A0A2K6BJC5	499	G	R
Q6NT32	LB/B	-	A0A2K6BJC5	537	D	E
O15182	LB/B	-	A0A2U4AWE1	10	V	L
Q5JU67	LB/B	-	G3X1G7	483	Y	S
Q6P656	LB/B	-	Q5PQ12	284	P	S
Q6ZVT6	LB/B	-	Q6P2K3	158	S	R
Q6ZVT6	LB/B	-	Q6P2K3	304	D	E
Q6ZVT6	LB/B	-	Q6P2K3	387	V	M
Q6ZVT6	LB/B	-	Q6P2K3	404	S	N
Q8TBY9	LB/B	-	A0A2K6F3J4	61	E	G
Q8TBY9	LB/B	-	A0A2K6F3J4	383	T	M
Q8TBY9	LB/B	-	A0A2K6F3J4	445	L	F
Q8TBY9	LB/B	-	A0A2K6F3J4	66	G	E
Q5T5A4	LB/B	-	A0A060XFR5	28	K	I
Q5T5A4	LP/P	-	A0A060XFR5	122	I	N
P57076	LB/B	-	G8XV63	33	R	W
P57076	LB/B	-	G8XV63	173	D	Y
Q6V702	LB/B	-	A0A0G4FLI9	138	T	M
Q6V702	LB/B	-	A0A0G4FLI9	220	V	I
Q9BRQ4	LP/P	Ciliary dyskinesia, primary, 38 (CILD38) [MIM:618063]	A0A2Y9HKJ5	259	H	R
O43822	LB/B	-	A0A2Y9KDP9	150	T	I
O43822	LB/B	-	A0A2Y9KDP9	153	G	S
O43822	LP/P	Spondylometaphyseal dysplasia, axial (SMDAX) [MIM:602271]	A0A2Y9KDP9	73	R	P
O43822	LP/P	Spondylometaphyseal dysplasia, axial (SMDAX) [MIM:602271]	A0A2Y9KDP9	107	Y	H
O43822	LP/P	Spondylometaphyseal dysplasia, axial (SMDAX) [MIM:602271]	A0A2Y9KDP9	116	P	L
O43822	LP/P	Spondylometaphyseal dysplasia, axial (SMDAX) [MIM:602271]	A0A2Y9KDP9	224	L	P
O43822	LP/P	Retinal dystrophy with or without macular staphyloma (RDMS) [MIM:617547]	A0A2Y9KDP9	61	C	Y
O43822	LP/P	Retinal dystrophy with or without macular staphyloma (RDMS) [MIM:617547]	A0A2Y9KDP9	107	Y	C
O43822	LP/P	Spondylometaphyseal dysplasia, axial (SMDAX) [MIM:602271]	A0A2Y9KDP9	111	V	M
Q8NDM7	LB/B	-	K7FST4	393	I	T
Q8NDM7	LB/B	-	K7FST4	616	L	F
Q8NDM7	LB/B	-	K7FST4	634	V	I
Q8NDM7	LB/B	-	K7FST4	835	A	S
Q96MT7	LB/B	-	A0A210PY39	284	K	N
Q96MT7	LB/B	-	A0A210PY39	53	K	E
Q8IYW2	LB/B	-	A0A2Y9MP71	2331	A	T
Q8IYW2	LB/B	-	A0A2Y9MP71	2540	S	G
Q8IYW2	LB/B	-	A0A2Y9MP71	264	S	N
Q8IYW2	LB/B	-	A0A2Y9MP71	2125	C	R
Q8IYW2	LB/B	-	A0A2Y9MP71	2249	E	K
Q8IYW2	LB/B	-	A0A2Y9MP71	2499	L	F
Q8IYW2	LB/B	-	A0A2Y9MP71	2658	K	Q
Q8N1V2	LB/B	-	A0A0R3W720	336	E	K
Q8N1V2	LP/P	Heterotaxy, visceral, 10, autosomal, with male infertility (HTX10) [MIM:619607]	A0A0R3W720	271	G	R
Q96M91	LB/B	-	W5N579	231	R	C
Q96M91	LB/B	-	W5N579	294	E	K
Q96N23	LB/B	-	A0A151LZ89	11	P	S
Q96N23	LB/B	-	A0A151LZ89	558	T	A
Q96N23	LB/B	-	A0A151LZ89	562	L	F
Q5T655	LB/B	-	A0A2B4S422	496	S	T
Q5T655	LB/B	-	A0A2B4S422	804	Q	H
Q6ZU64	LB/B	-	A0A1S3JQ72	66	M	L
Q6ZU64	LB/B	-	A0A1S3JQ72	672	V	I
Q6ZU64	LB/B	-	A0A1S3JQ72	806	K	M
Q6ZU64	LB/B	-	A0A1S3JQ72	1858	N	S
Q6ZU64	LB/B	-	A0A1S3JQ72	639	D	E
Q6ZU64	LB/B	-	A0A1S3JQ72	1240	I	F
Q9H5F2	LB/B	-	A0A1S3WXI1	49	K	Q
Q9H5F2	LB/B	-	A0A1S3WXI1	85	Q	H
Q9H5F2	LB/B	-	A0A1S3WXI1	40	V	A
A5D8W1	LB/B	-	A0A091FX36	22	S	R
A5D8W1	LB/B	-	A0A091FX36	306	R	C
A5D8W1	LB/B	-	A0A091FX36	459	P	L
A5D8W1	LB/B	-	A0A091FX36	490	V	M
A5D8W1	LB/B	-	A0A091FX36	885	T	M
Q6ZQR2	LB/B	-	Q6ZQR2	137	G	R
Q6ZQR2	LB/B	-	Q6ZQR2	184	R	H
Q6ZQR2	LB/B	-	Q6ZQR2	244	K	Q
Q7Z4T9	LB/B	-	U3KMB6	207	A	P
Q7Z4T9	LB/B	-	U3KMB6	253	S	T
Q7Z4T9	LB/B	-	U3KMB6	320	S	C
P00751	LB/B	-	A0A2J8R4H2	28	W	R
P00751	LB/B	-	A0A2J8R4H2	28	W	Q
P00751	LB/B	-	A0A2J8R4H2	32	R	Q
P00751	LB/B	-	A0A2J8R4H2	736	A	S
P00751	LB/B	-	A0A2J8R4H2	9	L	H
P00751	LB/B	-	A0A2J8R4H2	32	R	W
P00751	LB/B	-	A0A2J8R4H2	252	G	S
P00751	LB/B	-	A0A2J8R4H2	565	K	E
P00751	LB/B	-	A0A2J8R4H2	651	D	E
P00751	LP/P	Hemolytic uremic syndrome atypical 4 (AHUS4) [MIM:612924]	A0A2J8R4H2	286	F	L
P00751	LP/P	Hemolytic uremic syndrome atypical 4 (AHUS4) [MIM:612924]	A0A2J8R4H2	323	K	E
P00751	LP/P	Hemolytic uremic syndrome atypical 4 (AHUS4) [MIM:612924]	A0A2J8R4H2	166	S	P
P00751	LP/P	Hemolytic uremic syndrome atypical 4 (AHUS4) [MIM:612924]	A0A2J8R4H2	203	R	Q
P00751	LP/P	Hemolytic uremic syndrome atypical 4 (AHUS4) [MIM:612924]	A0A2J8R4H2	242	I	L
P00751	LP/P	Hemolytic uremic syndrome atypical 4 (AHUS4) [MIM:612924]	A0A2J8R4H2	323	K	Q
P00751	LP/P	Hemolytic uremic syndrome atypical 4 (AHUS4) [MIM:612924]	A0A2J8R4H2	458	M	I
P00751	LB/B	Hemolytic uremic syndrome atypical 4 (AHUS4) [MIM:612924]	A0A2J8R4H2	533	K	R
P00746	LP/P	Complement factor D deficiency (CFDD) [MIM:613912]	M3W7H5	213	V	G
P00746	LP/P	Complement factor D deficiency (CFDD) [MIM:613912]	M3W7H5	214	C	R
P00746	LB/B	-	M3W7H5	248	I	M
Q9UEE9	LB/B	-	L5MC35	60	A	T
P08603	LB/B	-	A0A099ZKY6	402	Y	H
P08603	LP/P	Complement factor H deficiency (CFHD) [MIM:609814]	A0A099ZKY6	536	C	R
P08603	LP/P	Complement factor H deficiency (CFHD) [MIM:609814]	A0A099ZKY6	959	C	Y
P08603	LP/P	Hemolytic uremic syndrome atypical 1 (AHUS1) [MIM:235400]	A0A099ZKY6	1189	L	R
P08603	LP/P	Hemolytic uremic syndrome atypical 1 (AHUS1) [MIM:235400]	A0A099ZKY6	1191	S	L
P08603	LB/B	-	A0A099ZKY6	936	E	D
P08603	LB/B	-	A0A099ZKY6	62	V	I
P08603	LB/B	-	A0A099ZKY6	551	I	T
P08603	LB/B	-	A0A099ZKY6	890	S	I
P08603	LB/B	-	A0A099ZKY6	1007	V	I
P08603	LB/B	-	A0A099ZKY6	1017	T	I
P08603	LB/B	-	A0A099ZKY6	1050	N	Y
P08603	LB/B	-	A0A099ZKY6	1059	I	T
P08603	LP/P	Hemolytic uremic syndrome atypical 1 (AHUS1) [MIM:235400]	A0A099ZKY6	78	R	G
P08603	LP/P	Hemolytic uremic syndrome atypical 1 (AHUS1) [MIM:235400]	A0A099ZKY6	630	C	W
P08603	LP/P	Hemolytic uremic syndrome atypical 1 (AHUS1) [MIM:235400]	A0A099ZKY6	850	E	K
P08603	LP/P	Hemolytic uremic syndrome atypical 1 (AHUS1) [MIM:235400]	A0A099ZKY6	950	Q	H
P08603	LP/P	Hemolytic uremic syndrome atypical 1 (AHUS1) [MIM:235400]	A0A099ZKY6	951	Y	H
P08603	LP/P	Hemolytic uremic syndrome atypical 1 (AHUS1) [MIM:235400]	A0A099ZKY6	956	T	M
P08603	LP/P	Hemolytic uremic syndrome atypical 1 (AHUS1) [MIM:235400]	A0A099ZKY6	978	W	C
P08603	LP/P	Hemolytic uremic syndrome atypical 1 (AHUS1) [MIM:235400]	A0A099ZKY6	1021	Y	F
P08603	LP/P	Hemolytic uremic syndrome atypical 1 (AHUS1) [MIM:235400]	A0A099ZKY6	1043	C	R
P08603	LP/P	Complement factor H deficiency (CFHD) [MIM:609814]	A0A099ZKY6	1076	Q	E
P08603	LP/P	Complement factor H deficiency (CFHD) [MIM:609814]	A0A099ZKY6	1119	D	G
P08603	LP/P	Hemolytic uremic syndrome atypical 1 (AHUS1) [MIM:235400]	A0A099ZKY6	1134	V	G
P08603	LP/P	Hemolytic uremic syndrome atypical 1 (AHUS1) [MIM:235400]	A0A099ZKY6	1142	Y	D
P08603	LP/P	Hemolytic uremic syndrome atypical 1 (AHUS1) [MIM:235400]	A0A099ZKY6	1157	W	R
P08603	LP/P	Hemolytic uremic syndrome atypical 1 (AHUS1) [MIM:235400]	A0A099ZKY6	1163	C	W
P08603	LP/P	Hemolytic uremic syndrome atypical 1 (AHUS1) [MIM:235400]	A0A099ZKY6	1183	W	L
P08603	LP/P	Hemolytic uremic syndrome atypical 1 (AHUS1) [MIM:235400]	A0A099ZKY6	1183	W	R
P08603	LP/P	Complement factor H deficiency (CFHD) [MIM:609814]	A0A099ZKY6	1184	T	R
P08603	LP/P	Hemolytic uremic syndrome atypical 1 (AHUS1) [MIM:235400]	A0A099ZKY6	1194	G	D
P08603	LP/P	Hemolytic uremic syndrome atypical 1 (AHUS1) [MIM:235400]	A0A099ZKY6	1197	V	A
P08603	LP/P	Hemolytic uremic syndrome atypical 1 (AHUS1) [MIM:235400]	A0A099ZKY6	1198	E	A
P08603	LP/P	Complement factor H deficiency (CFHD) [MIM:609814]	A0A099ZKY6	1210	R	C
P08603	LP/P	Macular degeneration, age-related, 4 (ARMD4) [MIM:610698]	A0A099ZKY6	1210	R	C
P08603	LP/P	Hemolytic uremic syndrome atypical 1 (AHUS1) [MIM:235400]	A0A099ZKY6	1215	R	G
P08603	LP/P	Complement factor H deficiency (CFHD) [MIM:609814]	A0A099ZKY6	1215	R	Q
P08603	LP/P	Hemolytic uremic syndrome atypical 1 (AHUS1) [MIM:235400]	A0A099ZKY6	1226	P	S
P08603	LP/P	Complement factor H deficiency (CFHD) [MIM:609814]	A0A099ZKY6	127	R	L
P08603	LP/P	Hemolytic uremic syndrome atypical 1 (AHUS1) [MIM:235400]	A0A099ZKY6	400	Q	K
P08603	LP/P	Complement factor H deficiency (CFHD) [MIM:609814]	A0A099ZKY6	431	C	S
P08603	LP/P	Complement factor H deficiency (CFHD) [MIM:609814]	A0A099ZKY6	673	C	S
P08603	LP/P	Hemolytic uremic syndrome atypical 1 (AHUS1) [MIM:235400]	A0A099ZKY6	673	C	Y
P08603	LP/P	Hemolytic uremic syndrome atypical 1 (AHUS1) [MIM:235400]	A0A099ZKY6	893	H	R
P08603	LP/P	Hemolytic uremic syndrome atypical 1 (AHUS1) [MIM:235400]	A0A099ZKY6	915	C	S
P08603	LP/P	Hemolytic uremic syndrome atypical 1 (AHUS1) [MIM:235400]	A0A099ZKY6	1199	F	S
P08603	LB/B	-	A0A099ZKY6	493	T	R
P08603	LB/B	-	A0A099ZKY6	567	R	G
P08603	LB/B	-	A0A099ZKY6	1007	V	L
P08603	LB/B	-	A0A099ZKY6	1078	R	S
P08603	LB/B	-	A0A099ZKY6	1143	Q	E
P08603	LB/B	-	A0A099ZKY6	997	N	T
P08603	LB/B	-	A0A099ZKY6	1010	A	T
P08603	LP/P	Hemolytic uremic syndrome atypical 1 (AHUS1) [MIM:235400]	A0A099ZKY6	325	C	Y
P08603	LP/P	Hemolytic uremic syndrome atypical 1 (AHUS1) [MIM:235400]	A0A099ZKY6	609	V	I
P08603	LP/P	Hemolytic uremic syndrome atypical 1 (AHUS1) [MIM:235400]	A0A099ZKY6	1169	I	L
P08603	LP/P	Hemolytic uremic syndrome atypical 1 (AHUS1) [MIM:235400]	A0A099ZKY6	1183	W	C
Q03591	LB/B	-	A0A2Y9FYS4	157	H	Y
Q03591	LB/B	-	A0A2Y9FYS4	159	L	V
Q03591	LB/B	-	A0A2Y9FYS4	175	E	Q
Q03591	LB/B	-	A0A2Y9FYS4	296	A	V
Q92496	LB/B	-	F7E8D2	553	G	E
Q92496	LB/B	-	F7E8D2	125	E	D
Q92496	LB/B	-	F7E8D2	210	N	S
Q9BXR6	LB/B	-	H9H3P5	46	P	S
Q9BXR6	LB/B	-	H9H3P5	356	R	H
Q9BXR6	LB/B	-	H9H3P5	521	L	I
Q9BXR6	LB/B	-	H9H3P5	529	L	R
Q9BXR6	LB/B	-	H9H3P5	277	Y	N
Q9BXR6	LB/B	-	H9H3P5	379	V	L
Q9BXR6	LB/B	-	H9H3P5	105	L	R
Q9BXR6	LB/B	-	H9H3P5	195	S	T
Q9BXR6	LB/B	-	H9H3P5	436	W	C
P05156	LP/P	Complement factor I deficiency (CFI deficiency) [MIM:610984]	A0A2J8XQ72	418	H	L
P05156	LP/P	Hemolytic uremic syndrome atypical 3 (AHUS3) [MIM:612923]	A0A2J8XQ72	340	I	T
P05156	LP/P	Hemolytic uremic syndrome atypical 3 (AHUS3) [MIM:612923]	A0A2J8XQ72	524	D	V
P05156	LP/P	Complement factor I deficiency (CFI deficiency) [MIM:610984]	A0A2J8XQ72	243	G	D
P05156	LB/B	-	A0A2J8XQ72	300	T	A
P05156	LP/P	Hemolytic uremic syndrome atypical 3 (AHUS3) [MIM:612923]	A0A2J8XQ72	64	P	L
P05156	LP/P	Hemolytic uremic syndrome atypical 3 (AHUS3) [MIM:612923]	A0A2J8XQ72	119	G	R
P05156	LP/P	Macular degeneration, age-related, 13 (ARMD13) [MIM:615439]	A0A2J8XQ72	119	G	R
P05156	LP/P	Hemolytic uremic syndrome atypical 3 (AHUS3) [MIM:612923]	A0A2J8XQ72	183	H	R
P05156	LP/P	Hemolytic uremic syndrome atypical 3 (AHUS3) [MIM:612923]	A0A2J8XQ72	287	G	R
P05156	LP/P	Hemolytic uremic syndrome atypical 3 (AHUS3) [MIM:612923]	A0A2J8XQ72	317	R	W
P05156	LP/P	Hemolytic uremic syndrome atypical 3 (AHUS3) [MIM:612923]	A0A2J8XQ72	416	I	L
P05156	LP/P	Hemolytic uremic syndrome atypical 3 (AHUS3) [MIM:612923]	A0A2J8XQ72	519	D	N
P05156	LP/P	Hemolytic uremic syndrome atypical 3 (AHUS3) [MIM:612923]	A0A2J8XQ72	522	K	T
P05156	LB/B	-	A0A2J8XQ72	188	G	A
Q9Y281	LP/P	Nemaline myopathy 7 (NEM7) [MIM:610687]	A0A061I383	35	A	T
O15519	LB/B	-	F2X056	203	L	I
Q8N884	LB/B	-	G3T540	261	P	H
Q8N884	LB/B	-	G3T540	35	T	N
P0DN86	LB/B	-	A0A2I2Z3G3	137	D	A
P0DN86	LB/B	-	A0A2I2Z3G3	4	F	L
P0DN86	LB/B	-	A0A2I2Z3G3	22	K	R
P0DN86	LB/B	-	A0A2I2Z3G3	35	T	I
P0DN86	LB/B	-	A0A2I2Z3G3	18	T	A
P0DN86	LB/B	-	A0A2I2Z3G3	28	R	W
P0DN86	LB/B	-	A0A2I2Z3G3	30	R	H
P0DN86	LB/B	-	A0A2I2Z3G3	147	S	C
Q9P2M7	LB/B	-	A0A0F7Z9F8	485	R	Q
Q0VF96	LB/B	-	A0A087XCT3	380	T	P
Q0VF96	LB/B	-	A0A087XCT3	459	S	F
Q0VF96	LB/B	-	A0A087XCT3	511	T	A
Q0VF96	LB/B	-	A0A087XCT3	1101	L	V
Q0VF96	LB/B	-	A0A087XCT3	1270	M	V
Q99674	LB/B	-	G1L509	212	A	V
Q99674	LB/B	-	G1L509	232	K	N
Q99674	LB/B	-	G1L509	243	G	E
Q99674	LB/B	-	G1L509	116	I	M
Q99674	LB/B	-	G1L509	226	E	G
Q99674	LB/B	-	G1L509	232	K	E
Q99675	LB/B	-	A0A2K6KBT6	117	C	Y
O95992	LB/B	-	A0A287BRJ1	133	L	P
O15335	LB/B	-	A0A2Y9K6R3	350	T	I
O15335	LB/B	-	A0A2Y9K6R3	312	R	Q
Q6NUI6	LB/B	-	A0A146YD37	710	Q	R
Q6NUI6	LB/B	-	A0A146YD37	721	D	N
Q13111	LB/B	-	A0A091GX49	167	D	V
Q13111	LB/B	-	A0A091GX49	239	M	V
Q13111	LB/B	-	A0A091GX49	850	K	R
Q13111	LB/B	-	A0A091GX49	923	A	V
Q13111	LB/B	-	A0A091GX49	950	A	S
Q96JM3	LB/B	-	A0A1S3WW36	568	L	V
Q96JM3	LB/B	-	A0A1S3WW36	604	P	R
Q96JM3	LB/B	-	A0A1S3WW36	591	K	R
P28329	LP/P	Myasthenic syndrome, congenital, 6, presynaptic (CMS6) [MIM:254210]	C3Z4L6	210	L	P
P28329	LP/P	Myasthenic syndrome, congenital, 6, presynaptic (CMS6) [MIM:254210]	C3Z4L6	211	P	A
P28329	LP/P	Myasthenic syndrome, congenital, 6, presynaptic (CMS6) [MIM:254210]	C3Z4L6	305	I	T
P28329	LP/P	Myasthenic syndrome, congenital, 6, presynaptic (CMS6) [MIM:254210]	C3Z4L6	420	R	C
P28329	LP/P	Myasthenic syndrome, congenital, 6, presynaptic (CMS6) [MIM:254210]	C3Z4L6	441	E	K
P28329	LP/P	Myasthenic syndrome, congenital, 6, presynaptic (CMS6) [MIM:254210]	C3Z4L6	482	R	G
P28329	LP/P	Myasthenic syndrome, congenital, 6, presynaptic (CMS6) [MIM:254210]	C3Z4L6	498	S	L
P28329	LP/P	Myasthenic syndrome, congenital, 6, presynaptic (CMS6) [MIM:254210]	C3Z4L6	506	V	L
P28329	LP/P	Myasthenic syndrome, congenital, 6, presynaptic (CMS6) [MIM:254210]	C3Z4L6	560	R	H
P28329	LB/B	-	C3Z4L6	120	A	T
P28329	LB/B	-	C3Z4L6	392	A	G
P28329	LP/P	Myasthenic syndrome, congenital, 6, presynaptic (CMS6) [MIM:254210]	C3Z4L6	336	I	T
P28329	LB/B	-	C3Z4L6	47	D	E
P28329	LB/B	-	C3Z4L6	222	R	P
P28329	LB/B	-	C3Z4L6	243	L	F
P28329	LB/B	-	C3Z4L6	299	P	L
P28329	LB/B	-	C3Z4L6	400	D	N
P28329	LB/B	-	C3Z4L6	461	V	M
Q8WYQ3	LP/P	Frontotemporal dementia and/or amyotrophic lateral sclerosis 2 (FTDALS2) [MIM:615911]	H9KWQ3	34	P	S
Q8WYQ3	LP/P	Frontotemporal dementia and/or amyotrophic lateral sclerosis 2 (FTDALS2) [MIM:615911]	H9KWQ3	59	S	L
Q8WYQ3	LP/P	Myopathy, isolated mitochondrial, autosomal dominant (IMMD) [MIM:616209]	H9KWQ3	58	G	R
Q8WYQ3	LP/P	Spinal muscular atrophy, Jokela type (SMAJ) [MIM:615048]	H9KWQ3	66	G	V
Q9BRQ6	LB/B	-	A0A1U7UI48	95	A	S
O14646	LB/B	-	A0A226MGR4	264	P	T
O14646	LP/P	Pilarowski-Bjornsson syndrome (PILBOS) [MIM:617682]	A0A226MGR4	141	R	G
O14646	LP/P	Pilarowski-Bjornsson syndrome (PILBOS) [MIM:617682]	A0A226MGR4	460	R	K
O14646	LP/P	Pilarowski-Bjornsson syndrome (PILBOS) [MIM:617682]	A0A226MGR4	618	R	Q
O14646	LP/P	Pilarowski-Bjornsson syndrome (PILBOS) [MIM:617682]	A0A226MGR4	1708	R	Q
Q86WJ1	LB/B	-	A0A2I3SNB5	25	R	P
Q86WJ1	LB/B	-	A0A2I3SNB5	350	H	Q
Q86WJ1	LB/B	-	A0A2I3SNB5	649	E	A
Q86WJ1	LB/B	-	A0A2I3SNB5	743	S	C
Q86WJ1	LB/B	-	A0A2I3SNB5	885	S	A
Q86WJ1	LB/B	-	A0A2I3SNB5	852	W	C
Q86WJ1	LB/B	-	A0A2I3SNB5	857	R	Q
Q86WJ1	LB/B	-	A0A2I3SNB5	860	R	W
O14647	LB/B	-	A0A1S3ESG9	1574	G	A
O14647	LP/P	Developmental and epileptic encephalopathy 94 (DEE94) [MIM:615369]	A0A1S3ESG9	548	W	R
O14647	LP/P	Developmental and epileptic encephalopathy 94 (DEE94) [MIM:615369]	A0A1S3ESG9	823	L	P
Q14839	LB/B	-	A0A2I0U4B3	139	E	D
Q14839	LB/B	-	A0A2I0U4B3	1648	S	L
Q14839	LB/B	-	A0A2I0U4B3	1655	I	V
Q14839	LP/P	Sifrim-Hitz-Weiss syndrome (SIHIWES) [MIM:617159]	A0A2I0U4B3	851	S	Y
Q14839	LP/P	Sifrim-Hitz-Weiss syndrome (SIHIWES) [MIM:617159]	A0A2I0U4B3	1003	G	D
Q14839	LP/P	Sifrim-Hitz-Weiss syndrome (SIHIWES) [MIM:617159]	A0A2I0U4B3	1068	R	H
Q14839	LP/P	Sifrim-Hitz-Weiss syndrome (SIHIWES) [MIM:617159]	A0A2I0U4B3	1127	R	Q
Q14839	LP/P	Sifrim-Hitz-Weiss syndrome (SIHIWES) [MIM:617159]	A0A2I0U4B3	1148	W	L
Q14839	LP/P	Sifrim-Hitz-Weiss syndrome (SIHIWES) [MIM:617159]	A0A2I0U4B3	1173	R	L
Q8TDI0	LB/B	-	A0A091IJH1	1253	S	I
Q8TDI0	LB/B	-	A0A091IJH1	1539	S	P
Q8TDI0	LP/P	Parenti-Mignot neurodevelopmental syndrome (PMNDS) [MIM:619873]	A0A091IJH1	193	R	Q
Q8TDI0	LP/P	Parenti-Mignot neurodevelopmental syndrome (PMNDS) [MIM:619873]	A0A091IJH1	193	R	W
Q8TDI0	LP/P	Parenti-Mignot neurodevelopmental syndrome (PMNDS) [MIM:619873]	A0A091IJH1	427	E	K
Q8TDI0	LP/P	Parenti-Mignot neurodevelopmental syndrome (PMNDS) [MIM:619873]	A0A091IJH1	912	S	F
Q8TDI0	LP/P	Parenti-Mignot neurodevelopmental syndrome (PMNDS) [MIM:619873]	A0A091IJH1	1084	D	N
Q8TDI0	LP/P	Parenti-Mignot neurodevelopmental syndrome (PMNDS) [MIM:619873]	A0A091IJH1	1124	P	L
Q8TDI0	LP/P	Parenti-Mignot neurodevelopmental syndrome (PMNDS) [MIM:619873]	A0A091IJH1	1136	R	H
Q8TDI0	LP/P	Parenti-Mignot neurodevelopmental syndrome (PMNDS) [MIM:619873]	A0A091IJH1	1140	N	I
Q8TDI0	LP/P	Parenti-Mignot neurodevelopmental syndrome (PMNDS) [MIM:619873]	A0A091IJH1	1419	I	M
Q8TDI0	LP/P	Parenti-Mignot neurodevelopmental syndrome (PMNDS) [MIM:619873]	A0A091IJH1	1488	D	V
Q8TDI0	LP/P	Parenti-Mignot neurodevelopmental syndrome (PMNDS) [MIM:619873]	A0A091IJH1	1714	E	G
Q8TD26	LB/B	-	M7BZP9	2161	H	Q
Q8TD26	LB/B	-	M7BZP9	780	Q	H
Q9P2D1	LP/P	CHARGE syndrome (CHARGES) [MIM:214800]	A0A1A7Y172	1028	I	V
Q9P2D1	LP/P	CHARGE syndrome (CHARGES) [MIM:214800]	A0A1A7Y172	1257	L	R
Q9P2D1	LP/P	CHARGE syndrome (CHARGES) [MIM:214800]	A0A1A7Y172	1031	W	G
Q9P2D1	LP/P	CHARGE syndrome (CHARGES) [MIM:214800]	A0A1A7Y172	1214	Q	R
Q9P2D1	LP/P	CHARGE syndrome (CHARGES) [MIM:214800]	A0A1A7Y172	1294	L	P
Q9P2D1	LP/P	CHARGE syndrome (CHARGES) [MIM:214800]	A0A1A7Y172	1815	L	P
Q9P2D1	LP/P	CHARGE syndrome (CHARGES) [MIM:214800]	A0A1A7Y172	2096	H	R
Q9P2D1	LP/P	CHARGE syndrome (CHARGES) [MIM:214800]	A0A1A7Y172	2319	R	S
Q9P2D1	LB/B	-	A0A1A7Y172	2750	F	L
Q9P2D1	LB/B	-	A0A1A7Y172	340	M	V
Q9P2D1	LP/P	Hypogonadotropic hypogonadism 5 with or without anosmia (HH5) [MIM:612370]	A0A1A7Y172	55	H	R
Q9P2D1	LP/P	Hypogonadotropic hypogonadism 5 with or without anosmia (HH5) [MIM:612370]	A0A1A7Y172	834	S	F
Q9P2D1	LB/B	-	A0A1A7Y172	2789	A	T
Q9P2D1	LP/P	Hypogonadotropic hypogonadism 5 with or without anosmia (HH5) [MIM:612370]	A0A1A7Y172	2880	P	L
Q9P2D1	LP/P	Hypogonadotropic hypogonadism 5 with or without anosmia (HH5) [MIM:612370]	A0A1A7Y172	2948	K	E
Q9P2D1	LB/B	-	A0A1A7Y172	103	S	T
Q9P2D1	LB/B	-	A0A1A7Y172	201	Q	R
Q9P2D1	LB/B	-	A0A1A7Y172	369	P	A
Q9P2D1	LB/B	-	A0A1A7Y172	466	S	L
Q9P2D1	LB/B	-	A0A1A7Y172	522	G	V
Q9P2D1	LB/B	-	A0A1A7Y172	636	G	V
Q9P2D1	LB/B	-	A0A1A7Y172	744	G	S
Q9P2D1	LP/P	CHARGE syndrome (CHARGES) [MIM:214800]	A0A1A7Y172	871	E	D
Q9P2D1	LP/P	CHARGE syndrome (CHARGES) [MIM:214800]	A0A1A7Y172	1020	L	S
Q9P2D1	LP/P	CHARGE syndrome (CHARGES) [MIM:214800]	A0A1A7Y172	1395	Q	H
Q9P2D1	LP/P	CHARGE syndrome (CHARGES) [MIM:214800]	A0A1A7Y172	1684	G	S
Q9P2D1	LP/P	Hypogonadotropic hypogonadism 5 with or without anosmia (HH5) [MIM:612370]	A0A1A7Y172	1684	G	S
Q9P2D1	LP/P	CHARGE syndrome (CHARGES) [MIM:214800]	A0A1A7Y172	1739	L	R
Q9P2D1	LP/P	CHARGE syndrome (CHARGES) [MIM:214800]	A0A1A7Y172	1802	G	D
Q9P2D1	LP/P	CHARGE syndrome (CHARGES) [MIM:214800]	A0A1A7Y172	2065	R	S
Q9P2D1	LP/P	CHARGE syndrome (CHARGES) [MIM:214800]	A0A1A7Y172	2108	G	R
Q9P2D1	LP/P	Hypogonadotropic hypogonadism 5 with or without anosmia (HH5) [MIM:612370]	A0A1A7Y172	2108	G	R
Q9P2D1	LP/P	CHARGE syndrome (CHARGES) [MIM:214800]	A0A1A7Y172	2116	I	N
Q9P2D1	LB/B	-	A0A1A7Y172	2160	A	T
Q9P2D1	LB/B	-	A0A1A7Y172	2225	A	T
Q9P2D1	LB/B	-	A0A1A7Y172	2330	G	A
Q9P2D1	LP/P	CHARGE syndrome (CHARGES) [MIM:214800]	A0A1A7Y172	2418	R	G
Q9P2D1	LB/B	-	A0A1A7Y172	2527	M	L
Q9P2D1	LB/B	-	A0A1A7Y172	2653	R	Q
Q9P2D1	LB/B	-	A0A1A7Y172	2806	L	V
Q9P2D1	LB/B	-	A0A1A7Y172	2857	S	A
Q9P2D1	LB/B	-	A0A1A7Y172	2984	L	F
Q9P2D1	LB/B	-	A0A1A7Y172	37	M	L
Q9P2D1	LB/B	-	A0A1A7Y172	93	T	A
Q9P2D1	LB/B	-	A0A1A7Y172	167	P	L
Q9P2D1	LB/B	-	A0A1A7Y172	238	V	L
Q9P2D1	LB/B	-	A0A1A7Y172	286	R	G
Q9P2D1	LB/B	-	A0A1A7Y172	524	H	P
Q9P2D1	LB/B	-	A0A1A7Y172	596	Q	K
Q9P2D1	LB/B	-	A0A1A7Y172	812	K	N
Q9P2D1	LP/P	CHARGE syndrome (CHARGES) [MIM:214800]	A0A1A7Y172	840	W	C
Q9P2D1	LP/P	CHARGE syndrome (CHARGES) [MIM:214800]	A0A1A7Y172	1031	W	R
Q9P2D1	LP/P	CHARGE syndrome (CHARGES) [MIM:214800]	A0A1A7Y172	1082	T	N
Q9P2D1	LP/P	CHARGE syndrome (CHARGES) [MIM:214800]	A0A1A7Y172	1101	C	R
Q9P2D1	LP/P	CHARGE syndrome (CHARGES) [MIM:214800]	A0A1A7Y172	1292	L	P
Q9P2D1	LP/P	CHARGE syndrome (CHARGES) [MIM:214800]	A0A1A7Y172	1318	C	R
Q9P2D1	LP/P	CHARGE syndrome (CHARGES) [MIM:214800]	A0A1A7Y172	1345	R	H
Q9P2D1	LB/B	-	A0A1A7Y172	1594	P	S
Q9P2D1	LB/B	-	A0A1A7Y172	1672	A	V
Q9P2D1	LP/P	CHARGE syndrome (CHARGES) [MIM:214800]	A0A1A7Y172	1797	G	V
Q9P2D1	LP/P	CHARGE syndrome (CHARGES) [MIM:214800]	A0A1A7Y172	1812	D	G
Q9P2D1	LP/P	CHARGE syndrome (CHARGES) [MIM:214800]	A0A1A7Y172	1812	D	H
Q9P2D1	LB/B	-	A0A1A7Y172	1972	A	G
Q9P2D1	LB/B	-	A0A1A7Y172	2062	R	W
Q9P2D1	LP/P	CHARGE syndrome (CHARGES) [MIM:214800]	A0A1A7Y172	2091	W	R
Q9P2D1	LB/B	-	A0A1A7Y172	2118	N	D
Q9P2D1	LP/P	CHARGE syndrome (CHARGES) [MIM:214800]	A0A1A7Y172	2286	G	A
Q9P2D1	LB/B	-	A0A1A7Y172	2415	A	S
Q9P2D1	LB/B	-	A0A1A7Y172	2488	G	D
Q9P2D1	LB/B	-	A0A1A7Y172	2491	R	C
Q9P2D1	LB/B	-	A0A1A7Y172	2725	I	V
Q9P2D1	LB/B	-	A0A1A7Y172	2780	A	V
Q9P2D1	LB/B	-	A0A1A7Y172	511	L	V
Q9P2D1	LB/B	-	A0A1A7Y172	527	S	A
Q9P2D1	LB/B	-	A0A1A7Y172	117	G	D
Q9P2D1	LP/P	Hypogonadotropic hypogonadism 5 with or without anosmia (HH5) [MIM:612370]	A0A1A7Y172	758	R	H
Q9P2D1	LP/P	Hypogonadotropic hypogonadism 5 with or without anosmia (HH5) [MIM:612370]	A0A1A7Y172	886	R	W
Q9P2D1	LP/P	Hypogonadotropic hypogonadism 5 with or without anosmia (HH5) [MIM:612370]	A0A1A7Y172	944	R	S
Q9P2D1	LP/P	Hypogonadotropic hypogonadism 5 with or without anosmia (HH5) [MIM:612370]	A0A1A7Y172	1030	N	S
Q9P2D1	LP/P	Hypogonadotropic hypogonadism 5 with or without anosmia (HH5) [MIM:612370]	A0A1A7Y172	1291	K	E
Q9P2D1	LP/P	CHARGE syndrome (CHARGES) [MIM:214800]	A0A1A7Y172	1302	L	P
Q9P2D1	LP/P	Hypogonadotropic hypogonadism 5 with or without anosmia (HH5) [MIM:612370]	A0A1A7Y172	1375	L	F
Q9P2D1	LP/P	CHARGE syndrome (CHARGES) [MIM:214800]	A0A1A7Y172	1742	V	D
Q9P2D1	LP/P	Hypogonadotropic hypogonadism 5 with or without anosmia (HH5) [MIM:612370]	A0A1A7Y172	1838	M	V
Q9P2D1	LP/P	Hypogonadotropic hypogonadism 5 with or without anosmia (HH5) [MIM:612370]	A0A1A7Y172	1912	R	G
Q9P2D1	LP/P	Hypogonadotropic hypogonadism 5 with or without anosmia (HH5) [MIM:612370]	A0A1A7Y172	2065	R	C
Q9P2D1	LP/P	Hypogonadotropic hypogonadism 5 with or without anosmia (HH5) [MIM:612370]	A0A1A7Y172	2398	R	G
Q9P2D1	LP/P	Hypogonadotropic hypogonadism 5 with or without anosmia (HH5) [MIM:612370]	A0A1A7Y172	2833	Q	P
Q9P2D1	LP/P	CHARGE syndrome (CHARGES) [MIM:214800]	A0A1A7Y172	2108	G	W
Q8NE62	LB/B	-	I3LWR6	40	E	A
Q8NE62	LB/B	-	I3LWR6	441	N	S
Q8NE62	LB/B	-	I3LWR6	78	L	R
O14757	LB/B	-	A0A0D9S4F3	156	R	Q
O14757	LB/B	-	A0A0D9S4F3	471	I	V
O14757	LB/B	-	A0A0D9S4F3	223	E	V
O14757	LB/B	-	A0A0D9S4F3	312	V	M
Q8IWX8	LB/B	-	A0A212D0G8	199	N	H
Q96EP1	LB/B	-	U3EPZ8	270	G	R
Q96EP1	LB/B	-	U3EPZ8	497	A	V
Q96EP1	LB/B	-	U3EPZ8	580	V	M
P10645	LB/B	-	A0A2K6GIM3	176	E	K
P10645	LB/B	-	A0A2K6GIM3	264	E	D
P10645	LB/B	-	A0A2K6GIM3	271	R	W
P10645	LB/B	-	A0A2K6GIM3	274	A	G
P10645	LB/B	-	A0A2K6GIM3	315	G	S
P10645	LB/B	-	A0A2K6GIM3	332	L	P
P10645	LB/B	-	A0A2K6GIM3	369	D	N
P10645	LB/B	-	A0A2K6GIM3	382	G	S
P10645	LB/B	-	A0A2K6GIM3	388	P	L
P10645	LB/B	-	A0A2K6GIM3	399	R	W
P10645	LB/B	-	A0A2K6GIM3	61	R	Q
P10645	LB/B	-	A0A2K6GIM3	392	R	Q
P05060	LB/B	-	H0UTY9	178	R	Q
P05060	LB/B	-	H0UTY9	417	R	H
P05060	LB/B	-	H0UTY9	117	K	N
P05060	LB/B	-	H0UTY9	243	T	A
P05060	LB/B	-	H0UTY9	353	A	G
P05060	LB/B	-	H0UTY9	145	D	N
P05060	LB/B	-	H0UTY9	200	N	H
P05060	LB/B	-	H0UTY9	232	R	Q
P05060	LB/B	-	H0UTY9	413	P	L
P05060	LB/B	-	H0UTY9	93	S	T
Q15782	LB/B	-	H0VXV9	184	V	I
Q15782	LB/B	-	H0VXV9	182	A	V
Q15782	LB/B	-	H0VXV9	318	R	W
Q9BZP6	LB/B	-	U3KAU6	324	V	G
Q9BZP6	LB/B	-	U3KAU6	102	G	R
Q9BZP6	LB/B	-	U3KAU6	339	I	V
Q9BZP6	LB/B	-	U3KAU6	354	F	S
Q9BZP6	LB/B	-	U3KAU6	377	F	L
Q9BZP6	LB/B	-	U3KAU6	432	V	G
Q9BZP6	LB/B	-	U3KAU6	45	N	D
Q9BZP6	LB/B	-	U3KAU6	47	D	N
Q9BZP6	LB/B	-	U3KAU6	61	R	M
Q9BZP6	LB/B	-	U3KAU6	125	K	R
Q9BWS9	LB/B	-	H2LQ71	331	R	Q
Q9BWS9	LB/B	-	H2LQ71	338	A	V
Q13231	LB/B	-	U3KAU6	102	G	S
Q13231	LB/B	-	U3KAU6	442	A	G
Q13231	LB/B	-	U3KAU6	40	R	H
Q13231	LB/B	-	U3KAU6	171	Q	H
Q13231	LB/B	-	U3KAU6	74	E	K
P35790	LB/B	-	A0A2R9BJN2	220	S	G
P35790	LB/B	-	A0A2R9BJN2	422	L	Q
P35790	LP/P	Neurodevelopmental disorder with microcephaly, movement abnormalities, and seizures (NEDMIMS) [MIM:620023]	A0A2R9BJN2	141	R	W
P35790	LP/P	Neurodevelopmental disorder with microcephaly, movement abnormalities, and seizures (NEDMIMS) [MIM:620023]	A0A2R9BJN2	194	P	S
P35790	LP/P	Neurodevelopmental disorder with microcephaly, movement abnormalities, and seizures (NEDMIMS) [MIM:620023]	A0A2R9BJN2	341	F	L
Q9Y259	LP/P	Muscular dystrophy, congenital, megaconial type (MDCMC) [MIM:602541]	G3TBJ6	283	E	K
Q9Y259	LB/B	-	G3TBJ6	301	T	I
Q9Y259	LB/B	-	G3TBJ6	328	Q	R
Q9Y259	LP/P	Muscular dystrophy, congenital, megaconial type (MDCMC) [MIM:602541]	G3TBJ6	377	R	L
O00533	LB/B	-	G1P6E9	17	L	F
O00533	LB/B	-	G1P6E9	287	T	A
O00533	LB/B	-	G1P6E9	1034	I	V
Q9UQN3	LP/P	Frontotemporal dementia and/or amyotrophic lateral sclerosis 7 (FTDALS7) [MIM:600795]	A0A147AYX1	148	D	Y
Q9UQN3	LP/P	Frontotemporal dementia and/or amyotrophic lateral sclerosis 7 (FTDALS7) [MIM:600795]	A0A147AYX1	29	I	V
Q9UQN3	LP/P	Frontotemporal dementia and/or amyotrophic lateral sclerosis 7 (FTDALS7) [MIM:600795]	A0A147AYX1	206	Q	H
Q9UQN3	LP/P	Frontotemporal dementia and/or amyotrophic lateral sclerosis 7 (FTDALS7) [MIM:600795]	A0A147AYX1	104	T	N
Q96CF2	LB/B	-	I3J0N1	232	A	T
P15882	LP/P	Duane retraction syndrome 2 (DURS2) [MIM:604356]	F6TGZ5	20	L	F
P15882	LP/P	Duane retraction syndrome 2 (DURS2) [MIM:604356]	F6TGZ5	126	I	M
P15882	LP/P	Duane retraction syndrome 2 (DURS2) [MIM:604356]	F6TGZ5	143	Y	H
P15882	LP/P	Duane retraction syndrome 2 (DURS2) [MIM:604356]	F6TGZ5	223	A	V
P15882	LP/P	Duane retraction syndrome 2 (DURS2) [MIM:604356]	F6TGZ5	228	G	S
P15882	LP/P	Duane retraction syndrome 2 (DURS2) [MIM:604356]	F6TGZ5	252	P	Q
P15882	LP/P	Duane retraction syndrome 2 (DURS2) [MIM:604356]	F6TGZ5	313	E	K
P52757	LB/B	-	F6TGZ5	204	H	R
P52757	LB/B	-	F6TGZ5	438	P	S
Q9UHD1	LB/B	-	X1ZAF4	329	A	D
O43745	LB/B	-	A0A146NF92	127	R	P
Q8IZ52	LB/B	-	Q4SYQ2	371	Q	R
Q9H2X0	LB/B	-	A0A1A7WUY7	630	M	L
Q9H2X0	LB/B	-	A0A1A7WUY7	94	P	S
Q9BU40	LP/P	Megalocornea 1, X-linked (MGC1) [MIM:309300]	F1RXG9	260	C	F
P20309	LB/B	-	A0A2I0URD0	65	V	I
P20309	LB/B	-	A0A2I0URD0	431	L	P
Q9GZZ6	LB/B	-	F7D6N1	355	E	A
P43681	LP/P	Epilepsy, nocturnal frontal lobe, 1 (ENFL1) [MIM:600513]	A0A1U7UL54	280	S	F
P43681	LP/P	Epilepsy, nocturnal frontal lobe, 1 (ENFL1) [MIM:600513]	A0A1U7UL54	280	S	L
P43681	LB/B	-	A0A1U7UL54	387	E	G
P43681	LB/B	-	A0A1U7UL54	517	S	L
Q9UGM1	LB/B	-	I3K8W1	442	N	S
Q9UGM1	LB/B	-	I3K8W1	96	R	Q
Q9UGM1	LB/B	-	I3K8W1	315	A	V
P11230	LP/P	Myasthenic syndrome, congenital, 2A, slow-channel (CMS2A) [MIM:616313]	A0A091M555	285	L	M
P11230	LP/P	Myasthenic syndrome, congenital, 2A, slow-channel (CMS2A) [MIM:616313]	A0A091M555	289	V	M
P11230	LB/B	-	A0A091M555	32	E	G
P11230	LB/B	-	A0A091M555	124	D	Y
P11230	LP/P	Myasthenic syndrome, congenital, 2A, slow-channel (CMS2A) [MIM:616313]	A0A091M555	289	V	A
Q05901	LB/B	-	A0A1A8FTL8	451	K	E
P30926	LB/B	-	A0A091M555	136	R	W
P30926	LB/B	-	A0A091M555	140	S	G
P30926	LB/B	-	A0A091M555	467	M	V
P30926	LB/B	-	A0A091M555	91	T	I
Q07001	LP/P	Myasthenic syndrome, congenital, 3A, slow-channel (CMS3A) [MIM:616321]	L5L100	289	S	F
Q07001	LP/P	Myasthenic syndrome, congenital, 3B, fast-channel (CMS3B) [MIM:616322]	L5L100	80	E	K
Q07001	LP/P	Myasthenic syndrome, congenital, 3B, fast-channel (CMS3B) [MIM:616322]	L5L100	271	P	Q
Q07001	LB/B	-	L5L100	288	Q	E
Q07001	LP/P	Multiple pterygium syndrome, lethal type (LMPS) [MIM:253290]	L5L100	95	F	L
Q07001	LP/P	Myasthenic syndrome, congenital, 3B, fast-channel (CMS3B) [MIM:616322]	L5L100	42	L	P
Q07001	LP/P	Myasthenic syndrome, congenital, 3B, fast-channel (CMS3B) [MIM:616322]	L5L100	79	I	K
Q07001	LB/B	-	L5L100	114	V	L
Q07001	LP/P	Myasthenic syndrome, congenital, 3C, associated with acetylcholine receptor deficiency (CMS3C) [MIM:616323]	L5L100	402	E	K
Q04844	LP/P	Myasthenic syndrome, congenital, 4B, fast-channel (CMS4B) [MIM:616324]	A0A2D0QB90	141	P	L
Q04844	LP/P	Myasthenic syndrome, congenital, 4C, associated with acetylcholine receptor deficiency (CMS4C) [MIM:608931]	A0A2D0QB90	167	R	L
Q04844	LP/P	Myasthenic syndrome, congenital, 4C, associated with acetylcholine receptor deficiency (CMS4C) [MIM:608931]	A0A2D0QB90	265	P	L
Q04844	LP/P	Myasthenic syndrome, congenital, 4A, slow-channel (CMS4A) [MIM:605809]	A0A2D0QB90	284	T	P
Q04844	LP/P	Myasthenic syndrome, congenital, 4A, slow-channel (CMS4A) [MIM:605809]	A0A2D0QB90	289	L	F
Q04844	LP/P	Myasthenic syndrome, congenital, 4C, associated with acetylcholine receptor deficiency (CMS4C) [MIM:608931]	A0A2D0QB90	331	R	W
Q04844	LP/P	Myasthenic syndrome, congenital, 4A, slow-channel (CMS4A) [MIM:605809]	A0A2D0QB90	98	L	P
Q04844	LP/P	Myasthenic syndrome, congenital, 4A, slow-channel (CMS4A) [MIM:605809]	A0A2D0QB90	241	L	F
Q04844	LP/P	Myasthenic syndrome, congenital, 4B, fast-channel (CMS4B) [MIM:616324]	A0A2D0QB90	13	G	R
Q04844	LP/P	Myasthenic syndrome, congenital, 4B, fast-channel (CMS4B) [MIM:616324]	A0A2D0QB90	163	S	L
Q04844	LP/P	Myasthenic syndrome, congenital, 4B, fast-channel (CMS4B) [MIM:616324]	A0A2D0QB90	431	A	P
Q04844	LB/B	-	A0A2D0QB90	18	G	V
Q04844	LP/P	Myasthenic syndrome, congenital, 4B, fast-channel (CMS4B) [MIM:616324]	A0A2D0QB90	75	W	R
Q04844	LP/P	Myasthenic syndrome, congenital, 4A, slow-channel (CMS4A) [MIM:605809]	A0A2D0QB90	285	V	A
P07510	LP/P	Multiple pterygium syndrome, Escobar variant (EVMPS) [MIM:265000]	A0A2D0QB90	107	V	G
P07510	LP/P	Multiple pterygium syndrome, lethal type (LMPS) [MIM:253290]	A0A2D0QB90	107	V	G
P07510	LB/B	-	A0A2D0QB90	149	A	T
P07510	LP/P	Multiple pterygium syndrome, Escobar variant (EVMPS) [MIM:265000]	A0A2D0QB90	239	R	C
P07510	LP/P	Multiple pterygium syndrome, lethal type (LMPS) [MIM:253290]	A0A2D0QB90	239	R	C
Q8NET6	LB/B	-	V8P0G2	271	A	V
Q8NET6	LB/B	-	V8P0G2	317	R	Q
Q8NET6	LB/B	-	V8P0G2	146	P	S
Q8NCH0	LP/P	Ehlers-Danlos syndrome, musculocontractural type 1 (EDSMC1) [MIM:601776]	H2ZTS0	135	R	G
Q8NCH0	LP/P	Ehlers-Danlos syndrome, musculocontractural type 1 (EDSMC1) [MIM:601776]	H2ZTS0	137	L	Q
Q8NCH0	LP/P	Ehlers-Danlos syndrome, musculocontractural type 1 (EDSMC1) [MIM:601776]	H2ZTS0	213	R	P
Q8NCH0	LP/P	Ehlers-Danlos syndrome, musculocontractural type 1 (EDSMC1) [MIM:601776]	H2ZTS0	293	Y	C
Q8NCH0	LP/P	Ehlers-Danlos syndrome, musculocontractural type 1 (EDSMC1) [MIM:601776]	H2ZTS0	281	P	L
Q8NCH0	LP/P	Ehlers-Danlos syndrome, musculocontractural type 1 (EDSMC1) [MIM:601776]	H2ZTS0	289	C	S
Q7LGC8	LP/P	Spondyloepiphyseal dysplasia with congenital joint dislocations (SEDCJD) [MIM:143095]	A0A2K6NZV8	304	R	Q
Q7LGC8	LB/B	-	A0A2K6NZV8	348	I	M
Q7LGC8	LB/B	-	A0A2K6NZV8	357	R	Q
Q7LGC8	LP/P	Spondyloepiphyseal dysplasia with congenital joint dislocations (SEDCJD) [MIM:143095]	A0A2K6NZV8	222	R	W
Q7LGC8	LP/P	Spondyloepiphyseal dysplasia with congenital joint dislocations (SEDCJD) [MIM:143095]	A0A2K6NZV8	259	L	P
Q7LGC8	LP/P	Spondyloepiphyseal dysplasia with congenital joint dislocations (SEDCJD) [MIM:143095]	A0A2K6NZV8	307	L	P
Q7LGC8	LP/P	Spondyloepiphyseal dysplasia with congenital joint dislocations (SEDCJD) [MIM:143095]	A0A2K6NZV8	372	E	K
Q8NCG5	LB/B	-	H0XYQ4	361	H	Q
Q9GZS9	LB/B	-	A0A0D9QUL1	318	T	M
Q9GZS9	LB/B	-	A0A0D9QUL1	311	A	T
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	15	L	P
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	22	L	R
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	31	P	S
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	42	H	Y
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	50	R	C
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	51	S	L
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	52	G	D
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	53	S	L
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	59	L	P
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	61	N	T
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	66	V	L
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	68	Y	H
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	70	M	L
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	72	P	S
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	76	V	M
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	93	R	H
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	97	R	P
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	98	S	W
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	102	C	G
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	102	C	Y
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	104	M	V
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	107	F	S
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	110	Y	C
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	121	F	L
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	122	Q	P
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	127	R	C
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	128	A	V
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	131	S	P
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	152	L	P
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	162	R	G
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	166	R	P
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	174	K	R
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	177	R	H
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	198	V	E
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	200	L	R
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	202	R	S
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	203	D	E
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	204	P	Q
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	205	R	L
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	205	R	Q
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	206	A	T
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	206	A	V
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	210	S	F
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	211	R	Q
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	211	R	W
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	217	A	T
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	221	D	E
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	221	D	Y
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	249	H	P
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	268	Y	C
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	274	E	K
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	276	L	P
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	358	Y	D
Q9GZX3	LB/B	-	A0A0D9QUL1	369	N	D
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	177	R	G
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	186	P	R
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	205	R	W
Q9GZX3	LP/P	Macular dystrophy, corneal (MCD) [MIM:217800]	A0A0D9QUL1	358	Y	H
Q7L1S5	LB/B	-	F1M862	122	S	N
Q7L1S5	LB/B	-	F1M862	378	N	S
Q86X52	LB/B	-	A0A1L8H129	359	P	S
Q86X52	LB/B	-	A0A1L8H129	652	Q	H
Q86X52	LP/P	Temtamy preaxial brachydactyly syndrome (TPBS) [MIM:605282]	A0A1L8H129	539	P	R
O15111	LB/B	-	K1QZ46	268	V	I
O15111	LB/B	-	K1QZ46	126	S	C
O15111	LB/B	-	K1QZ46	155	V	A
Q6FI81	LB/B	-	A0A093J1X1	34	A	E
Q6FI81	LB/B	-	A0A093J1X1	52	Q	E
Q99828	LB/B	-	A0A2I2Z4F1	44	S	T
Q99828	LB/B	-	A0A2I2Z4F1	106	I	T
O75838	LP/P	Deafness, autosomal recessive, 48 (DFNB48) [MIM:609439]	G3TQG5	64	E	D
O75838	LP/P	Usher syndrome 1J (USH1J) [MIM:614869]	G3TQG5	64	E	D
O75838	LP/P	Deafness, autosomal recessive, 48 (DFNB48) [MIM:609439]	G3TQG5	91	F	S
O75838	LP/P	Deafness, autosomal recessive, 48 (DFNB48) [MIM:609439]	G3TQG5	99	C	W
O75838	LP/P	Deafness, autosomal recessive, 48 (DFNB48) [MIM:609439]	G3TQG5	123	I	T
O75838	LP/P	Deafness, autosomal recessive, 48 (DFNB48) [MIM:609439]	G3TQG5	186	R	W
Q96Q77	LB/B	-	A0A2I0M6W4	139	G	E
A0PJX0	LB/B	-	K4GG65	181	H	R
A1XBS5	LB/B	-	A0A1U7QF05	222	R	Q
Q9UPZ9	LB/B	-	A0A1A6HKA5	320	V	I
Q9UPZ9	LB/B	-	A0A1A6HKA5	471	T	K
Q9UPZ9	LB/B	-	A0A1A6HKA5	476	R	Q
Q9UPZ9	LB/B	-	A0A1A6HKA5	98	P	L
Q9UPZ9	LP/P	Endocrine-cerebroosteodysplasia (ECO) [MIM:612651]	A0A1A6HKA5	272	R	Q
Q9UPZ9	LP/P	Juvenile myoclonic epilepsy 10 (EJM10) [MIM:617924]	A0A1A6HKA5	220	K	E
Q9UPZ9	LP/P	Juvenile myoclonic epilepsy 10 (EJM10) [MIM:617924]	A0A1A6HKA5	305	K	T
O75339	LB/B	-	H9GJM4	59	W	L
O75339	LB/B	-	H9GJM4	327	S	F
O75339	LB/B	-	H9GJM4	395	I	T
O75339	LB/B	-	H9GJM4	575	K	E
O75339	LB/B	-	H9GJM4	895	A	V
O75339	LB/B	-	H9GJM4	979	Q	R
O75339	LB/B	-	H9GJM4	1101	D	N
O75339	LB/B	-	H9GJM4	1166	G	S
O75339	LB/B	-	H9GJM4	1168	V	A
O75339	LB/B	-	H9GJM4	495	R	H
O75339	LB/B	-	H9GJM4	1032	S	T
Q9C0C6	LB/B	-	G9L426	31	L	F
Q9C0C6	LB/B	-	G9L426	203	T	A
O14578	LB/B	-	G3UM73	7	G	E
O14578	LB/B	-	G3UM73	9	R	Q
O14578	LB/B	-	G3UM73	183	L	F
O14578	LP/P	Microcephaly 17, primary, autosomal recessive (MCPH17) [MIM:617090]	G3UM73	106	G	V
O14578	LP/P	Microcephaly 17, primary, autosomal recessive (MCPH17) [MIM:617090]	G3UM73	126	K	Q
O14578	LP/P	Microcephaly 17, primary, autosomal recessive (MCPH17) [MIM:617090]	G3UM73	230	D	V
Q99966	LB/B	-	H2PW07	96	H	Q
Q9ULV3	LB/B	-	A0A2K6GSQ3	219	A	T
Q9ULV3	LB/B	-	A0A2K6GSQ3	578	S	F
Q9ULV3	LB/B	-	A0A2K6GSQ3	638	V	M
Q9ULV3	LB/B	-	A0A2K6GSQ3	370	E	G
Q9ULV3	LB/B	-	A0A2K6GSQ3	847	R	Q
Q9ULV3	LP/P	-	A0A2K6GSQ3	47	P	S
Q9ULV3	LB/B	-	A0A2K6GSQ3	50	P	L
Q9ULV3	LP/P	-	A0A2K6GSQ3	264	S	G
Q9ULV3	LB/B	-	A0A2K6GSQ3	394	Q	E
Q9ULV3	LB/B	-	A0A2K6GSQ3	577	S	F
Q9ULV3	LP/P	-	A0A2K6GSQ3	672	R	M
Q8IYA6	LB/B	-	H0WRY0	19	L	F
Q8IYA6	LB/B	-	H0WRY0	26	K	R
Q8IYA6	LB/B	-	H0WRY0	62	N	S
Q8IYA6	LB/B	-	H0WRY0	104	T	I
Q8IYA6	LB/B	-	H0WRY0	263	R	S
Q8IYA6	LB/B	-	H0WRY0	375	I	V
Q8IYA6	LB/B	-	H0WRY0	379	P	A
Q8IYA6	LB/B	-	H0WRY0	519	S	G
Q8IYA6	LB/B	-	H0WRY0	614	L	S
Q8IYA6	LB/B	-	H0WRY0	706	E	D
Q14008	LB/B	-	A0A0N8K2Q7	785	Y	C
P06732	LB/B	-	G3UTB0	83	E	G
P06732	LB/B	-	G3UTB0	127	L	V
P06732	LB/B	-	G3UTB0	243	G	A
P06732	LB/B	-	G3UTB0	166	T	M
Q7Z460	LB/B	-	I3J9R3	233	I	T
Q8N2M8	LB/B	-	A0A2Y9L7F8	174	K	E
Q05315	LB/B	-	G1QE01	28	A	V
Q96S66	LB/B	-	A0A2K6UXX2	368	S	R
Q96S66	LP/P	Retinitis pigmentosa 32 (RP32) [MIM:609913]	A0A2K6UXX2	25	D	E
Q9UBD9	LP/P	Crisponi/Cold-induced sweating syndrome 2 (CISS2) [MIM:610313]	A0A2K6RVW7	197	R	L
P35523	LP/P	Myotonia congenita, autosomal recessive (MCAR) [MIM:255700]	W5Q934	105	R	C
P35523	LB/B	-	W5Q934	118	G	W
P35523	LP/P	Myotonia congenita, autosomal recessive (MCAR) [MIM:255700]	W5Q934	136	D	G
P35523	LP/P	Myotonia congenita, autosomal recessive (MCAR) [MIM:255700]	W5Q934	150	Y	C
P35523	LP/P	Myotonia congenita, autosomal dominant (MCAD) [MIM:160800]	W5Q934	161	F	V
P35523	LP/P	Myotonia congenita, autosomal recessive (MCAR) [MIM:255700]	W5Q934	161	F	V
P35523	LP/P	Myotonia congenita, autosomal recessive (MCAR) [MIM:255700]	W5Q934	165	V	G
P35523	LP/P	Myotonia congenita, autosomal recessive (MCAR) [MIM:255700]	W5Q934	167	F	L
P35523	LP/P	Myotonia congenita, autosomal dominant (MCAD) [MIM:160800]	W5Q934	200	G	R
P35523	LP/P	Myotonia congenita, autosomal recessive (MCAR) [MIM:255700]	W5Q934	200	G	R
P35523	LP/P	Myotonia congenita, autosomal dominant (MCAD) [MIM:160800]	W5Q934	230	G	E
P35523	LP/P	Myotonia congenita, autosomal recessive (MCAR) [MIM:255700]	W5Q934	230	G	E
P35523	LP/P	Myotonia congenita, autosomal recessive (MCAR) [MIM:255700]	W5Q934	236	V	L
P35523	LP/P	Myotonia congenita, autosomal recessive (MCAR) [MIM:255700]	W5Q934	261	Y	C
P35523	LP/P	Myotonia congenita, autosomal recessive (MCAR) [MIM:255700]	W5Q934	285	G	E
P35523	LP/P	Myotonia congenita, autosomal dominant (MCAD) [MIM:160800]	W5Q934	286	V	A
P35523	LP/P	Myotonia congenita, autosomal dominant (MCAD) [MIM:160800]	W5Q934	290	I	M
P35523	LP/P	Myotonia congenita, autosomal recessive (MCAR) [MIM:255700]	W5Q934	291	E	K
P35523	LB/B	-	W5Q934	300	R	Q
P35523	LP/P	Myotonia congenita, autosomal dominant (MCAD) [MIM:160800]	W5Q934	307	F	S
P35523	LP/P	Myotonia congenita, autosomal dominant (MCAD) [MIM:160800]	W5Q934	313	A	T
P35523	LP/P	Myotonia congenita, autosomal recessive (MCAR) [MIM:255700]	W5Q934	313	A	T
P35523	LP/P	Myotonia congenita, autosomal dominant (MCAD) [MIM:160800]	W5Q934	317	R	Q
P35523	LP/P	Myotonia congenita, autosomal recessive (MCAR) [MIM:255700]	W5Q934	327	V	I
P35523	LP/P	Myotonia congenita, autosomal recessive (MCAR) [MIM:255700]	W5Q934	329	I	T
P35523	LP/P	Myotonia congenita, autosomal dominant (MCAD) [MIM:160800]	W5Q934	338	R	Q
P35523	LP/P	Myotonia congenita, autosomal recessive (MCAR) [MIM:255700]	W5Q934	338	R	Q
P35523	LP/P	Myotonia congenita, autosomal recessive (MCAR) [MIM:255700]	W5Q934	413	F	C
P35523	LP/P	Myotonia congenita, autosomal recessive (MCAR) [MIM:255700]	W5Q934	415	A	V
P35523	LB/B	-	W5Q934	437	A	T
P35523	LP/P	Myotonia congenita, autosomal dominant (MCAD) [MIM:160800]	W5Q934	480	P	L
P35523	LP/P	Myotonia congenita, autosomal recessive (MCAR) [MIM:255700]	W5Q934	482	G	R
P35523	LP/P	Myotonia congenita, autosomal recessive (MCAR) [MIM:255700]	W5Q934	485	M	V
P35523	LP/P	Myotonia congenita, autosomal recessive (MCAR) [MIM:255700]	W5Q934	496	R	S
P35523	LP/P	Myotonia congenita, autosomal dominant (MCAD) [MIM:160800]	W5Q934	552	Q	R
P35523	LP/P	Myotonia congenita, autosomal recessive (MCAR) [MIM:255700]	W5Q934	552	Q	R
P35523	LP/P	Myotonia congenita, autosomal dominant (MCAD) [MIM:160800]	W5Q934	556	I	N
P35523	LP/P	Myotonia congenita, autosomal recessive (MCAR) [MIM:255700]	W5Q934	556	I	N
P35523	LP/P	Myotonia congenita, autosomal recessive (MCAR) [MIM:255700]	W5Q934	563	V	I
P35523	LP/P	Myotonia congenita, autosomal recessive (MCAR) [MIM:255700]	W5Q934	708	F	L
P35523	LB/B	-	W5Q934	727	P	L
P35523	LP/P	Myotonia congenita, autosomal recessive (MCAR) [MIM:255700]	W5Q934	43	Q	R
P35523	LP/P	Myotonia congenita, autosomal dominant (MCAD) [MIM:160800]	W5Q934	128	M	V
P35523	LP/P	Myotonia congenita, autosomal recessive (MCAR) [MIM:255700]	W5Q934	137	Y	D
P35523	LB/B	-	W5Q934	154	Q	R
P35523	LP/P	Myotonia congenita, autosomal recessive (MCAR) [MIM:255700]	W5Q934	160	Q	H
P35523	LP/P	Myotonia congenita, autosomal recessive (MCAR) [MIM:255700]	W5Q934	164	W	R
P35523	LP/P	Myotonia congenita, autosomal recessive (MCAR) [MIM:255700]	W5Q934	190	G	S
P35523	LP/P	Myotonia congenita, autosomal dominant (MCAD) [MIM:160800]	W5Q934	193	E	K
P35523	LP/P	Myotonia congenita, autosomal recessive (MCAR) [MIM:255700]	W5Q934	197	I	R
P35523	LP/P	Myotonia congenita, autosomal dominant (MCAD) [MIM:160800]	W5Q934	198	L	P
P35523	LP/P	Myotonia congenita, autosomal recessive (MCAR) [MIM:255700]	W5Q934	270	G	V
P35523	LP/P	Myotonia congenita, autosomal recessive (MCAR) [MIM:255700]	W5Q934	277	C	R
P35523	LP/P	Myotonia congenita, autosomal recessive (MCAR) [MIM:255700]	W5Q934	277	C	Y
P35523	LP/P	Myotonia congenita, autosomal recessive (MCAR) [MIM:255700]	W5Q934	412	Q	P
P35523	LP/P	Myotonia congenita, autosomal dominant (MCAD) [MIM:160800]	W5Q934	484	F	L
P35523	LP/P	Myotonia congenita, autosomal recessive (MCAR) [MIM:255700]	W5Q934	499	G	R
P35523	LB/B	-	W5Q934	614	K	N
P35523	LP/P	Myotonia congenita, autosomal recessive (MCAR) [MIM:255700]	W5Q934	640	V	G
P35523	LP/P	Myotonia congenita, autosomal dominant (MCAD) [MIM:160800]	W5Q934	480	P	H
P51788	LB/B	-	A0A2I4D2Z8	668	T	S
P51788	LB/B	-	A0A2I4D2Z8	718	E	D
P51788	LB/B	-	A0A2I4D2Z8	48	P	R
P51788	LB/B	-	A0A2I4D2Z8	68	R	H
P51788	LB/B	-	A0A2I4D2Z8	199	G	A
P51788	LP/P	Juvenile myoclonic epilepsy 8 (EJM8) [MIM:607628]	A0A2I4D2Z8	235	R	Q
P51788	LP/P	Epilepsy, idiopathic generalized 11 (EIG11) [MIM:607628]	A0A2I4D2Z8	577	R	Q
P51788	LB/B	-	A0A2I4D2Z8	644	R	C
P51788	LB/B	-	A0A2I4D2Z8	646	R	Q
P51788	LB/B	-	A0A2I4D2Z8	725	R	W
P51788	LB/B	-	A0A2I4D2Z8	747	R	H
P51788	LP/P	Leukoencephalopathy with ataxia (LKPAT) [MIM:615651]	A0A2I4D2Z8	500	A	V
P51788	LP/P	Hyperaldosteronism, familial, 2 (HALD2) [MIM:605635]	A0A2I4D2Z8	22	M	K
P51788	LP/P	Hyperaldosteronism, familial, 2 (HALD2) [MIM:605635]	A0A2I4D2Z8	24	G	D
P51788	LP/P	Hyperaldosteronism, familial, 2 (HALD2) [MIM:605635]	A0A2I4D2Z8	26	Y	N
P51788	LP/P	Hyperaldosteronism, familial, 2 (HALD2) [MIM:605635]	A0A2I4D2Z8	172	R	Q
P51788	LP/P	Hyperaldosteronism, familial, 2 (HALD2) [MIM:605635]	A0A2I4D2Z8	865	S	R
P51790	LP/P	Neurodevelopmental disorder with hypotonia and brain abnormalities (NEDHYBA) [MIM:619512]	A0A0F8ANX7	85	Y	C
P51790	LP/P	Neurodevelopmental disorder with hypotonia and brain abnormalities (NEDHYBA) [MIM:619512]	A0A0F8ANX7	252	I	T
P51790	LP/P	Neurodevelopmental disorder with hypotonia and brain abnormalities (NEDHYBA) [MIM:619512]	A0A0F8ANX7	324	V	A
P51790	LP/P	Neurodevelopmental disorder with hypotonia and brain abnormalities (NEDHYBA) [MIM:619512]	A0A0F8ANX7	453	S	R
P51790	LP/P	Neurodevelopmental disorder with hypotonia and brain abnormalities (NEDHYBA) [MIM:619512]	A0A0F8ANX7	570	T	I
P51790	LP/P	Neurodevelopmental disorder with hypotonia and brain abnormalities (NEDHYBA) [MIM:619512]	A0A0F8ANX7	607	I	T
P51790	LP/P	Neurodevelopmental disorder with hypotonia and brain abnormalities (NEDHYBA) [MIM:619512]	A0A0F8ANX7	772	V	A
P51793	LP/P	Raynaud-Claes syndrome (MRXSRC) [MIM:300114]	A0A0Q3MG38	78	G	S
P51793	LP/P	Raynaud-Claes syndrome (MRXSRC) [MIM:300114]	A0A0Q3MG38	221	L	V
P51793	LP/P	Raynaud-Claes syndrome (MRXSRC) [MIM:300114]	A0A0Q3MG38	536	V	M
P51793	LP/P	Raynaud-Claes syndrome (MRXSRC) [MIM:300114]	A0A0Q3MG38	544	G	R
P51793	LP/P	Raynaud-Claes syndrome (MRXSRC) [MIM:300114]	A0A0Q3MG38	731	G	R
P51793	LP/P	Raynaud-Claes syndrome (MRXSRC) [MIM:300114]	A0A0Q3MG38	212	V	G
P51793	LP/P	Raynaud-Claes syndrome (MRXSRC) [MIM:300114]	A0A0Q3MG38	221	L	P
P51793	LP/P	Raynaud-Claes syndrome (MRXSRC) [MIM:300114]	A0A0Q3MG38	275	V	M
P51793	LP/P	Raynaud-Claes syndrome (MRXSRC) [MIM:300114]	A0A0Q3MG38	534	S	L
P51793	LP/P	Raynaud-Claes syndrome (MRXSRC) [MIM:300114]	A0A0Q3MG38	555	A	V
P51793	LP/P	Raynaud-Claes syndrome (MRXSRC) [MIM:300114]	A0A0Q3MG38	718	R	W
P51797	LB/B	-	R7TX20	198	E	G
P51797	LP/P	Neurodegeneration, childhood-onset, with hypotonia, respiratory insufficiency, and brain imaging abnormalities (CONRIBA) [MIM:619173]	R7TX20	553	Y	C
P51800	LB/B	-	A0A087RJ30	447	A	T
P51800	LB/B	-	A0A087RJ30	83	R	G
P51800	LB/B	-	A0A087RJ30	315	Y	F
P51800	LB/B	-	A0A087RJ30	67	M	I
P51800	LB/B	-	A0A087RJ30	45	R	H
P51800	LB/B	-	A0A087RJ30	8	R	H
P51800	LB/B	-	A0A087RJ30	534	R	W
P51800	LB/B	-	A0A087RJ30	683	P	L
P51800	LP/P	Bartter syndrome 4B, neonatal, with sensorineural deafness (BARTS4B) [MIM:613090]	A0A087RJ30	80	W	C
P51800	LB/B	-	A0A087RJ30	357	H	Q
P51801	LP/P	Bartter syndrome 3 (BARTS3) [MIM:607364]	A0A087RJ30	124	P	L
P51801	LP/P	Bartter syndrome 3 (BARTS3) [MIM:607364]	A0A087RJ30	204	A	T
P51801	LP/P	Bartter syndrome 3 (BARTS3) [MIM:607364]	A0A087RJ30	349	A	D
P51801	LP/P	Bartter syndrome 3 (BARTS3) [MIM:607364]	A0A087RJ30	432	Y	H
P51801	LP/P	Bartter syndrome 3 (BARTS3) [MIM:607364]	A0A087RJ30	438	R	C
P51801	LB/B	-	A0A087RJ30	88	S	R
P51801	LB/B	-	A0A087RJ30	143	N	H
P51801	LB/B	-	A0A087RJ30	334	V	L
P51801	LB/B	-	A0A087RJ30	562	M	T
P51801	LB/B	-	A0A087RJ30	578	K	E
P51801	LB/B	-	A0A087RJ30	4	F	L
P51801	LB/B	-	A0A087RJ30	104	V	I
P51801	LB/B	-	A0A087RJ30	214	A	G
P51801	LB/B	-	A0A087RJ30	419	I	V
P51801	LB/B	-	A0A087RJ30	27	R	L
P51801	LB/B	-	A0A087RJ30	395	R	W
P51801	LB/B	-	A0A087RJ30	481	T	S
P51801	LB/B	-	A0A087RJ30	660	S	L
P51801	LB/B	-	A0A087RJ30	287	A	V
P78369	LP/P	HELIX syndrome (HELIX) [MIM:617671]	A0A060XED2	48	N	K
P78369	LP/P	HELIX syndrome (HELIX) [MIM:617671]	A0A060XED2	131	S	L
Q8N6F1	LB/B	-	G1U697	13	L	F
Q8N6F1	LP/P	Hypomagnesemia 5, renal, with or without ocular involvement (HOMG5) [MIM:248190]	G1U697	20	G	D
Q8N6F1	LP/P	Hypomagnesemia 5, renal, with or without ocular involvement (HOMG5) [MIM:248190]	G1U697	57	Q	E
Q8N6F1	LP/P	Hypomagnesemia 5, renal, with or without ocular involvement (HOMG5) [MIM:248190]	G1U697	90	L	P
P56747	LB/B	-	Q5XIT8	143	I	V
P56748	LB/B	-	A0A1U7RWC5	151	S	P
P56748	LB/B	-	A0A1U7RWC5	129	T	A
P56748	LB/B	-	A0A1U7RWC5	25	T	A
Q8IUN9	LB/B	-	A0A1S2ZMT1	35	C	R
Q8IUN9	LB/B	-	A0A1S2ZMT1	73	R	K
Q8IUN9	LB/B	-	A0A1S2ZMT1	100	T	M
Q8IUN9	LB/B	-	A0A1S2ZMT1	203	A	G
Q5QGZ9	LB/B	-	W5QIP5	244	K	Q
Q2HXU8	LB/B	-	G1PIT6	6	T	N
Q2HXU8	LB/B	-	G1PIT6	116	V	L
Q6UVW9	LB/B	-	W5QIQ2	136	G	D
Q9UHP7	LB/B	-	A0A1S3W2B0	19	N	K
Q9UHP7	LB/B	-	A0A1S3W2B0	23	L	V
O75596	LB/B	-	A0A1S3EWH7	197	Q	K
Q8WXI8	LB/B	-	A0A2Y9RZV3	32	S	G
Q9H2X3	LB/B	-	H2NXB8	291	D	N
Q9H2X3	LB/B	-	H2NXB8	164	R	Q
Q9H2X3	LB/B	-	H2NXB8	205	Y	C
Q9H2X3	LB/B	-	H2NXB8	251	Y	C
Q96NY7	LB/B	-	A0A2U3Z5Z9	632	D	G
P30622	LB/B	-	A0A091U9P7	1080	D	E
P30622	LB/B	-	A0A091U9P7	780	R	W
P30622	LB/B	-	A0A091U9P7	941	S	P
P30622	LB/B	-	A0A091U9P7	1224	A	S
P30622	LB/B	-	A0A091U9P7	162	S	P
Q9UDT6	LB/B	-	W5PQ21	977	R	P
Q9UDT6	LB/B	-	W5PQ21	961	D	E
Q96DZ5	LB/B	-	A0A091DD30	175	D	V
Q8N3C7	LB/B	-	F1S3X7	486	R	L
Q8N3C7	LB/B	-	F1S3X7	613	T	P
P49759	LB/B	-	A0A091DVW7	61	S	F
P49759	LB/B	-	A0A091DVW7	118	R	G
P49759	LB/B	-	A0A091DVW7	307	P	S
P49759	LB/B	-	A0A091DVW7	440	M	T
P49759	LB/B	-	A0A091DVW7	99	N	D
P49759	LB/B	-	A0A091DVW7	459	E	G
Q9H6B4	LB/B	-	L9KTN4	69	R	H
Q9H6B4	LP/P	Congenital short bowel syndrome (CSBS) [MIM:615237]	L9KTN4	124	V	D
Q13286	LP/P	Ceroid lipofuscinosis, neuronal, 3 (CLN3) [MIM:204200]	A0A091DTE8	101	L	P
Q13286	LP/P	Ceroid lipofuscinosis, neuronal, 3 (CLN3) [MIM:204200]	A0A091DTE8	170	L	P
Q13286	LP/P	Ceroid lipofuscinosis, neuronal, 3 (CLN3) [MIM:204200]	A0A091DTE8	295	E	K
Q13286	LP/P	Ceroid lipofuscinosis, neuronal, 3 (CLN3) [MIM:204200]	A0A091DTE8	330	V	F
Q13286	LP/P	Ceroid lipofuscinosis, neuronal, 3 (CLN3) [MIM:204200]	A0A091DTE8	334	R	C
Q13286	LP/P	Ceroid lipofuscinosis, neuronal, 3 (CLN3) [MIM:204200]	A0A091DTE8	334	R	H
Q13286	LP/P	Ceroid lipofuscinosis, neuronal, 3 (CLN3) [MIM:204200]	A0A091DTE8	134	C	R
Q13286	LP/P	Ceroid lipofuscinosis, neuronal, 3 (CLN3) [MIM:204200]	A0A091DTE8	187	G	A
Q13286	LP/P	Ceroid lipofuscinosis, neuronal, 3 (CLN3) [MIM:204200]	A0A091DTE8	189	G	R
Q9NWW5	LP/P	Ceroid lipofuscinosis, neuronal, 6 (CLN6) [MIM:601780]	A0A1U7TJ57	123	G	D
Q9NWW5	LP/P	Ceroid lipofuscinosis, neuronal, 6 (CLN6) [MIM:601780]	A0A1U7TJ57	300	W	R
Q9NWW5	LP/P	Ceroid lipofuscinosis, neuronal, 6 (CLN6) [MIM:601780]	A0A1U7TJ57	62	R	H
Q9NWW5	LB/B	-	A0A1U7TJ57	72	E	Q
Q9NWW5	LP/P	Ceroid lipofuscinosis, neuronal, 6 (CLN6) [MIM:601780]	A0A1U7TJ57	221	Y	S
Q9NWW5	LP/P	Ceroid lipofuscinosis, neuronal, 6 (CLN6) [MIM:601780]	A0A1U7TJ57	241	M	T
Q9NWW5	LP/P	Ceroid lipofuscinosis, neuronal, 6 (CLN6) [MIM:601780]	A0A1U7TJ57	299	P	L
Q9NWW5	LP/P	Ceroid lipofuscinosis, neuronal, 6 (CLN6) [MIM:601780]	A0A1U7TJ57	159	P	L
Q9NWW5	LP/P	Ceroid lipofuscinosis, neuronal, 6 (CLN6) [MIM:601780]	A0A1U7TJ57	221	Y	C
Q9NWW5	LP/P	Ceroid lipofuscinosis, neuronal, 4A (Kufs type), autosomal recessive (CLN4A) [MIM:204300]	A0A1U7TJ57	6	R	T
Q9NWW5	LB/B	-	A0A1U7TJ57	34	A	T
Q9NWW5	LP/P	Ceroid lipofuscinosis, neuronal, 4A (Kufs type), autosomal recessive (CLN4A) [MIM:204300]	A0A1U7TJ57	47	L	F
Q9NWW5	LP/P	Ceroid lipofuscinosis, neuronal, 4A (Kufs type), autosomal recessive (CLN4A) [MIM:204300]	A0A1U7TJ57	67	L	P
Q9NWW5	LP/P	Ceroid lipofuscinosis, neuronal, 4A (Kufs type), autosomal recessive (CLN4A) [MIM:204300]	A0A1U7TJ57	77	N	K
Q9NWW5	LP/P	Ceroid lipofuscinosis, neuronal, 4A (Kufs type), autosomal recessive (CLN4A) [MIM:204300]	A0A1U7TJ57	103	R	Q
Q9NWW5	LP/P	Ceroid lipofuscinosis, neuronal, 4A (Kufs type), autosomal recessive (CLN4A) [MIM:204300]	A0A1U7TJ57	149	R	H
Q9NWW5	LP/P	Ceroid lipofuscinosis, neuronal, 4A (Kufs type), autosomal recessive (CLN4A) [MIM:204300]	A0A1U7TJ57	238	F	T
Q9NWW5	LB/B	-	A0A1U7TJ57	308	S	T
Q9NWW5	LB/B	-	A0A1U7TJ57	12	A	T
Q9NWW5	LP/P	Ceroid lipofuscinosis, neuronal, 6 (CLN6) [MIM:601780]	A0A1U7TJ57	90	N	K
Q9NWW5	LP/P	Ceroid lipofuscinosis, neuronal, 6 (CLN6) [MIM:601780]	A0A1U7TJ57	104	S	F
Q9NWW5	LP/P	Ceroid lipofuscinosis, neuronal, 6 (CLN6) [MIM:601780]	A0A1U7TJ57	149	R	C
Q9NWW5	LP/P	Ceroid lipofuscinosis, neuronal, 6 (CLN6) [MIM:601780]	A0A1U7TJ57	169	L	P
Q9NWW5	LP/P	Ceroid lipofuscinosis, neuronal, 6 (CLN6) [MIM:601780]	A0A1U7TJ57	186	F	S
Q9NWW5	LP/P	Ceroid lipofuscinosis, neuronal, 6 (CLN6) [MIM:601780]	A0A1U7TJ57	234	F	L
Q9NWW5	LP/P	Ceroid lipofuscinosis, neuronal, 6 (CLN6) [MIM:601780]	A0A1U7TJ57	252	R	H
Q9NWW5	LP/P	Ceroid lipofuscinosis, neuronal, 6 (CLN6) [MIM:601780]	A0A1U7TJ57	259	G	S
Q9NWW5	LP/P	Ceroid lipofuscinosis, neuronal, 6 (CLN6) [MIM:601780]	A0A1U7TJ57	297	P	T
Q9UBY8	LP/P	Ceroid lipofuscinosis, neuronal, 8, Northern epilepsy variant (CLN8NE) [MIM:610003]	A0A2U3V0B8	24	R	G
Q9UBY8	LB/B	-	A0A2U3V0B8	155	A	V
Q9UBY8	LP/P	Ceroid lipofuscinosis, neuronal, 8 (CLN8) [MIM:600143]	A0A2U3V0B8	16	L	M
Q9UBY8	LP/P	Ceroid lipofuscinosis, neuronal, 8 (CLN8) [MIM:600143]	A0A2U3V0B8	170	T	M
Q9UBY8	LP/P	Ceroid lipofuscinosis, neuronal, 8 (CLN8) [MIM:600143]	A0A2U3V0B8	204	R	C
Q9UBY8	LP/P	Ceroid lipofuscinosis, neuronal, 8 (CLN8) [MIM:600143]	A0A2U3V0B8	263	W	C
Q9UBY8	LB/B	-	A0A2U3V0B8	92	H	Y
Q9UBY8	LP/P	Ceroid lipofuscinosis, neuronal, 8 (CLN8) [MIM:600143]	A0A2U3V0B8	158	Y	C
Q9UBY8	LP/P	Ceroid lipofuscinosis, neuronal, 8 (CLN8) [MIM:600143]	A0A2U3V0B8	237	G	R
Q9UBY8	LP/P	Ceroid lipofuscinosis, neuronal, 8 (CLN8) [MIM:600143]	A0A2U3V0B8	30	A	P
Q9UBY8	LP/P	Ceroid lipofuscinosis, neuronal, 8 (CLN8) [MIM:600143]	A0A2U3V0B8	194	Q	R
Q9UBY8	LP/P	Ceroid lipofuscinosis, neuronal, 8 (CLN8) [MIM:600143]	A0A2U3V0B8	70	R	H
Q9UBY8	LP/P	Ceroid lipofuscinosis, neuronal, 8 (CLN8) [MIM:600143]	A0A2U3V0B8	76	Q	R
Q9UBY8	LP/P	Ceroid lipofuscinosis, neuronal, 8 (CLN8) [MIM:600143]	A0A2U3V0B8	107	I	S
Q9UBY8	LB/B	-	A0A2U3V0B8	125	N	S
Q9UBY8	LP/P	Ceroid lipofuscinosis, neuronal, 8 (CLN8) [MIM:600143]	A0A2U3V0B8	139	H	Y
Q9UBY8	LP/P	Ceroid lipofuscinosis, neuronal, 8 (CLN8) [MIM:600143]	A0A2U3V0B8	221	G	S
Q9UBY8	LB/B	-	A0A2U3V0B8	229	P	A
Q9UBY8	LP/P	Ceroid lipofuscinosis, neuronal, 8 (CLN8) [MIM:600143]	A0A2U3V0B8	269	E	V
Q9UBY8	LP/P	Ceroid lipofuscinosis, neuronal, 8 (CLN8) [MIM:600143]	A0A2U3V0B8	204	R	L
Q7Z7G1	LB/B	-	A0A2K6G8B8	65	S	G
P54105	LB/B	-	I3IYX7	20	Q	H
P54105	LB/B	-	I3IYX7	218	M	T
O15516	LB/B	-	A0A146N9R0	395	L	I
O15516	LB/B	-	A0A146N9R0	542	H	R
O15516	LB/B	-	A0A146N9R0	208	S	C
O15516	LB/B	-	A0A146N9R0	380	E	K
Q92989	LP/P	Pontocerebellar hypoplasia 10 (PCH10) [MIM:615803]	A0A2I2UE52	140	R	H
Q9H078	LB/B	-	I3M4U9	295	R	T
Q9H078	LP/P	3-methylglutaconic aciduria 7B (MGCA7B) [MIM:616271]	I3M4U9	268	T	M
Q9H078	LP/P	3-methylglutaconic aciduria 7B (MGCA7B) [MIM:616271]	I3M4U9	272	Y	C
Q9H078	LP/P	3-methylglutaconic aciduria 7B (MGCA7B) [MIM:616271]	I3M4U9	408	R	G
Q9H078	LP/P	3-methylglutaconic aciduria 7B (MGCA7B) [MIM:616271]	I3M4U9	411	M	I
Q9H078	LP/P	3-methylglutaconic aciduria 7B (MGCA7B) [MIM:616271]	I3M4U9	486	C	R
Q9H078	LP/P	3-methylglutaconic aciduria 7B (MGCA7B) [MIM:616271]	I3M4U9	501	E	K
Q9H078	LP/P	3-methylglutaconic aciduria 7B (MGCA7B) [MIM:616271]	I3M4U9	567	Y	C
Q9H078	LP/P	3-methylglutaconic aciduria 7B (MGCA7B) [MIM:616271]	I3M4U9	591	A	V
Q9H078	LP/P	3-methylglutaconic aciduria 7B (MGCA7B) [MIM:616271]	I3M4U9	617	Y	C
Q9H078	LP/P	3-methylglutaconic aciduria 7B (MGCA7B) [MIM:616271]	I3M4U9	646	G	V
Q9H078	LP/P	3-methylglutaconic aciduria 7B (MGCA7B) [MIM:616271]	I3M4U9	682	I	N
Q9H078	LB/B	-	I3M4U9	327	R	W
Q9H078	LP/P	Neutropenia, severe congenital 9, autosomal dominant (SCN9) [MIM:619813]	I3M4U9	388	T	K
Q9H078	LP/P	3-methylglutaconic aciduria 7A (MGCA7A) [MIM:619835]	I3M4U9	404	K	T
Q9H078	LP/P	3-methylglutaconic aciduria 7A (MGCA7A) [MIM:619835]	I3M4U9	427	P	L
Q9H078	LP/P	Neutropenia, severe congenital 9, autosomal dominant (SCN9) [MIM:619813]	I3M4U9	496	N	K
Q9H078	LP/P	Neutropenia, severe congenital 9, autosomal dominant (SCN9) [MIM:619813]	I3M4U9	557	E	K
Q9H078	LP/P	3-methylglutaconic aciduria 7A (MGCA7A) [MIM:619835]	I3M4U9	560	G	R
Q9H078	LP/P	Neutropenia, severe congenital 9, autosomal dominant (SCN9) [MIM:619813]	I3M4U9	561	R	G
Q9H078	LP/P	Neutropenia, severe congenital 9, autosomal dominant (SCN9) [MIM:619813]	I3M4U9	561	R	Q
Q9H078	LP/P	3-methylglutaconic aciduria 7A (MGCA7A) [MIM:619835]	I3M4U9	561	R	W
Q9H078	LP/P	Neutropenia, severe congenital 9, autosomal dominant (SCN9) [MIM:619813]	I3M4U9	620	R	C
P04118	LB/B	-	P42889	109	R	C
P04118	LB/B	-	P42889	8	L	P
O96005	LB/B	-	A0A0D9S1S1	478	Y	C
O76031	LB/B	-	A0A2K5Y5N2	488	I	T
O76031	LP/P	Protoporphyria, erythropoietic, 2 (EPP2) [MIM:618015]	A0A2K5Y5N2	298	G	D
P58418	LP/P	Usher syndrome 3A (USH3A) [MIM:276902]	A0A093GHV1	120	M	K
P58418	LP/P	Usher syndrome 3A (USH3A) [MIM:276902]	A0A093GHV1	48	N	K
P58418	LP/P	Usher syndrome 3A (USH3A) [MIM:276902]	A0A093GHV1	150	L	P
P58418	LB/B	-	A0A093GHV1	7	K	I
P58418	LP/P	Usher syndrome 3A (USH3A) [MIM:276902]	A0A093GHV1	40	C	G
P58418	LP/P	Usher syndrome 3A (USH3A) [MIM:276902]	A0A093GHV1	105	S	P
P58418	LP/P	Retinitis pigmentosa 61 (RP61) [MIM:614180]	A0A093GHV1	31	P	L
P58418	LP/P	Retinitis pigmentosa 61 (RP61) [MIM:614180]	A0A093GHV1	154	L	W
P58418	LP/P	Usher syndrome 3A (USH3A) [MIM:276902]	A0A093GHV1	168	I	N
A0PK11	LB/B	-	A0A093GHV1	113	L	V
A0PK11	LB/B	-	A0A093GHV1	153	A	T
A0PK11	LP/P	Deafness, autosomal recessive, 117 (DFNB117) [MIM:619174]	A0A093GHV1	165	T	K
O94985	LB/B	-	A0A1W7RAU6	474	V	A
O94985	LB/B	-	A0A1W7RAU6	524	S	C
O94985	LB/B	-	A0A1W7RAU6	583	P	R
O94985	LB/B	-	A0A1W7RAU6	857	P	H
O94985	LB/B	-	A0A1W7RAU6	870	F	S
O94985	LB/B	-	A0A1W7RAU6	332	A	T
Q9H4D0	LB/B	-	A0A1W7RAU6	366	V	I
Q9H4D0	LB/B	-	A0A1W7RAU6	331	I	T
Q9BQT9	LB/B	-	S9XGX7	209	S	G
Q00610	LP/P	Intellectual developmental disorder, autosomal dominant 56 (MRD56) [MIM:617854]	A0A2I0TU86	890	P	L
P53675	LB/B	-	A0A2I0UA42	61	P	L
P53675	LB/B	-	A0A2I0UA42	205	K	R
P53675	LB/B	-	A0A2I0UA42	279	Y	C
P53675	LB/B	-	A0A2I0UA42	691	E	K
P53675	LB/B	-	A0A2I0UA42	941	K	R
P53675	LB/B	-	A0A2I0UA42	945	R	H
P53675	LB/B	-	A0A2I0UA42	1046	R	C
P53675	LB/B	-	A0A2I0UA42	1195	N	S
P53675	LB/B	-	A0A2I0UA42	1316	M	V
P53675	LB/B	-	A0A2I0UA42	1394	I	T
P53675	LB/B	-	A0A2I0UA42	1592	V	M
P53675	LB/B	-	A0A2I0UA42	1620	R	H
P10909	LB/B	-	W5PZI0	317	N	H
P10909	LB/B	-	W5PZI0	328	D	N
P10909	LB/B	-	W5PZI0	396	S	L
Q96AJ1	LB/B	-	A0A2K6L578	68	A	S
Q96AJ1	LB/B	-	A0A2K6L578	401	R	W
Q8N0X4	LB/B	-	A0A2U4A6Q5	28	D	Y
Q8N0X4	LB/B	-	A0A2U4A6Q5	128	V	I
Q8N0X4	LB/B	-	A0A2U4A6Q5	241	I	V
Q96DG6	LB/B	-	A0A093P0L7	155	Y	C
Q5EBM0	LB/B	-	F7DGE1	433	K	R
Q9BQ75	LB/B	-	A0A2U4ABF3	166	V	I
Q9BQ75	LB/B	-	A0A2U4ABF3	138	E	G
Q8IZ96	LB/B	-	A0A2K5J9E8	10	S	T
Q8TAZ6	LB/B	-	F6TWG9	122	I	T
Q9NX76	LB/B	-	H3AZK6	91	T	A
Q8N3K9	LB/B	-	F7DZY3	64	Y	C
Q8N3K9	LB/B	-	F7DZY3	175	Q	H
Q8N3K9	LB/B	-	F7DZY3	190	D	G
Q8N3K9	LB/B	-	F7DZY3	349	G	D
Q8N3K9	LB/B	-	F7DZY3	591	G	D
Q8N3K9	LB/B	-	F7DZY3	1006	V	A
Q8N3K9	LB/B	-	F7DZY3	1295	A	V
Q8N3K9	LB/B	-	F7DZY3	1309	I	V
Q8N3K9	LB/B	-	F7DZY3	1333	A	V
Q8N3K9	LB/B	-	F7DZY3	1380	I	V
Q8N3K9	LB/B	-	F7DZY3	1567	A	E
Q8N3K9	LB/B	-	F7DZY3	1599	S	A
Q8N3K9	LB/B	-	F7DZY3	1669	L	S
Q8N3K9	LB/B	-	F7DZY3	1713	I	N
Q8N3K9	LB/B	-	F7DZY3	1721	I	V
Q8N3K9	LB/B	-	F7DZY3	1875	A	V
Q8N3K9	LB/B	-	F7DZY3	1917	D	G
Q8N3K9	LB/B	-	F7DZY3	1920	S	G
Q8N3K9	LB/B	-	F7DZY3	2262	V	L
Q8N3K9	LB/B	-	F7DZY3	2383	K	E
Q8N3K9	LB/B	-	F7DZY3	2693	T	I
Q8N3K9	LB/B	-	F7DZY3	2906	K	N
Q8N3K9	LB/B	-	F7DZY3	2935	G	R
Q8N3K9	LB/B	-	F7DZY3	3358	H	Q
Q8N3K9	LB/B	-	F7DZY3	3583	K	E
Q8N3K9	LB/B	-	F7DZY3	3927	R	Q
Q8N3K9	LB/B	-	F7DZY3	4063	P	L
Q8N3K9	LB/B	-	F7DZY3	651	S	R
Q8NA66	LB/B	-	M3YHQ1	64	D	N
Q8NA66	LB/B	-	M3YHQ1	69	Q	K
Q8NA66	LB/B	-	M3YHQ1	257	M	V
Q96M20	LB/B	-	F6QFE6	37	R	H
Q96M20	LB/B	-	F6QFE6	208	T	A
Q96M20	LB/B	-	F6QFE6	375	P	S
Q14028	LB/B	-	A0A151MSJ1	100	R	H
Q14028	LB/B	-	A0A151MSJ1	479	L	I
Q14028	LB/B	-	A0A151MSJ1	535	V	A
Q14028	LB/B	-	A0A151MSJ1	731	N	K
Q14028	LB/B	-	A0A151MSJ1	745	L	I
Q14028	LB/B	-	A0A151MSJ1	911	K	R
Q14028	LB/B	-	A0A151MSJ1	961	A	S
Q14028	LP/P	Retinitis pigmentosa 45 (RP45) [MIM:613767]	A0A151MSJ1	993	G	V
Q9NQW8	LB/B	-	K7GE96	234	C	W
Q9NQW8	LB/B	-	K7GE96	298	T	P
Q9NQW8	LP/P	Achromatopsia 3 (ACHM3) [MIM:262300]	K7GE96	435	S	F
Q9NQW8	LB/B	-	K7GE96	755	E	G
Q9NQW8	LB/B	-	K7GE96	307	I	V
Q9NQW8	LB/B	-	K7GE96	203	R	Q
Q9NQW8	LB/B	-	K7GE96	750	P	S
Q9NQW8	LB/B	-	K7GE96	25	R	H
Q9NQW8	LB/B	-	K7GE96	27	N	S
Q9NQW8	LP/P	Achromatopsia 3 (ACHM3) [MIM:262300]	K7GE96	148	K	E
Q9NQW8	LP/P	Achromatopsia 3 (ACHM3) [MIM:262300]	K7GE96	156	S	F
Q9NQW8	LP/P	Achromatopsia 3 (ACHM3) [MIM:262300]	K7GE96	309	P	L
Q9NQW8	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	K7GE96	469	Y	D
Q9NQW8	LP/P	Achromatopsia 3 (ACHM3) [MIM:262300]	K7GE96	525	F	N
Q9NQW8	LP/P	Achromatopsia 3 (ACHM3) [MIM:262300]	K7GE96	558	G	C
Q9NQW8	LP/P	Achromatopsia 3 (ACHM3) [MIM:262300]	K7GE96	595	L	F
Q9P003	LB/B	-	A0A0P4W6W7	3	A	G
Q969H4	LB/B	-	H9GPP2	662	R	W
Q9NRU3	LB/B	-	W5MRP1	819	R	Q
Q9H8M5	LB/B	-	I3JZ43	38	R	Q
Q9H8M5	LP/P	Hypomagnesemia 6 (HOMG6) [MIM:613882]	I3JZ43	568	T	I
Q9H8M5	LP/P	Hypomagnesemia, seizures, and impaired intellectual development 1 (HOMGSMR1) [MIM:616418]	I3JZ43	122	E	K
Q9H8M5	LP/P	Hypomagnesemia, seizures, and impaired intellectual development 1 (HOMGSMR1) [MIM:616418]	I3JZ43	269	S	W
Q9H8M5	LP/P	Hypomagnesemia, seizures, and impaired intellectual development 1 (HOMGSMR1) [MIM:616418]	I3JZ43	330	L	F
Q9H8M5	LP/P	Hypomagnesemia, seizures, and impaired intellectual development 1 (HOMGSMR1) [MIM:616418]	I3JZ43	357	E	K
Q6P4Q7	LB/B	-	I3JZ43	126	G	R
Q6P4Q7	LP/P	Jalili syndrome (JALIS) [MIM:217080]	I3JZ43	196	S	P
Q6P4Q7	LP/P	Jalili syndrome (JALIS) [MIM:217080]	I3JZ43	200	S	Y
Q6P4Q7	LP/P	Jalili syndrome (JALIS) [MIM:217080]	I3JZ43	236	R	Q
Q6P4Q7	LP/P	Jalili syndrome (JALIS) [MIM:217080]	I3JZ43	324	L	P
A5YKK6	LB/B	-	T1ISW7	603	D	A
A5YKK6	LP/P	Holoprosencephaly 12 with or without pancreatic agenesis (HPE12) [MIM:618500]	T1ISW7	535	R	C
A5YKK6	LP/P	Vissers-Bodmer syndrome (VIBOS) [MIM:619033]	T1ISW7	897	E	K
A5YKK6	LP/P	Vissers-Bodmer syndrome (VIBOS) [MIM:619033]	T1ISW7	900	R	C
A5YKK6	LP/P	Vissers-Bodmer syndrome (VIBOS) [MIM:619033]	T1ISW7	1148	L	P
A5YKK6	LP/P	Vissers-Bodmer syndrome (VIBOS) [MIM:619033]	T1ISW7	1188	D	G
A5YKK6	LP/P	Vissers-Bodmer syndrome (VIBOS) [MIM:619033]	T1ISW7	1241	K	R
A5YKK6	LP/P	Vissers-Bodmer syndrome (VIBOS) [MIM:619033]	T1ISW7	1419	T	A
A5YKK6	LP/P	Vissers-Bodmer syndrome (VIBOS) [MIM:619033]	T1ISW7	1428	F	S
A5YKK6	LP/P	Vissers-Bodmer syndrome (VIBOS) [MIM:619033]	T1ISW7	1478	R	C
A5YKK6	LP/P	Vissers-Bodmer syndrome (VIBOS) [MIM:619033]	T1ISW7	1494	Q	H
A5YKK6	LP/P	Vissers-Bodmer syndrome (VIBOS) [MIM:619033]	T1ISW7	1572	Y	D
A5YKK6	LP/P	Vissers-Bodmer syndrome (VIBOS) [MIM:619033]	T1ISW7	2216	N	S
Q9H9A5	LB/B	-	F6V3V4	736	P	S
Q9H9A5	LB/B	-	F6V3V4	348	T	S
O75175	LP/P	Intellectual developmental disorder with speech delay, autism and dysmorphic facies (IDDSADF) [MIM:618672]	H2SZM8	20	E	Q
O75175	LP/P	Intellectual developmental disorder with speech delay, autism and dysmorphic facies (IDDSADF) [MIM:618672]	H2SZM8	48	L	V
O75175	LP/P	Intellectual developmental disorder with speech delay, autism and dysmorphic facies (IDDSADF) [MIM:618672]	H2SZM8	188	R	C
O75175	LP/P	Intellectual developmental disorder with speech delay, autism and dysmorphic facies (IDDSADF) [MIM:618672]	H2SZM8	188	R	H
Q9UFF9	LB/B	-	A0A091D659	32	L	P
P09543	LB/B	-	G1KTD6	207	Q	R
Q9BT09	LB/B	-	G1PJS7	145	M	I
Q9BT09	LB/B	-	G1PJS7	231	S	I
Q8N129	LB/B	-	Q8BQ47	168	G	R
P34972	LB/B	-	M1EKQ8	316	H	Y
P34972	LB/B	-	M1EKQ8	63	Q	R
Q6PJW8	LB/B	-	A0A091D4N2	28	S	N
Q6PJW8	LB/B	-	A0A091D4N2	87	L	S
Q6PJW8	LB/B	-	A0A091D4N2	399	R	C
Q6PJW8	LB/B	-	A0A091D4N2	183	Q	R
Q8N815	LB/B	-	S7PRT1	145	T	P
P26441	LB/B	-	E1BFH9	182	H	R
P26441	LB/B	-	E1BFH9	49	N	S
Q9NXG0	LB/B	-	G5E6V4	562	R	C
Q9NXG0	LB/B	-	G5E6V4	695	T	I
Q9NXG0	LB/B	-	G5E6V4	1376	T	A
Q9NXG0	LB/B	-	G5E6V4	284	T	A
Q9NXG0	LB/B	-	G5E6V4	291	E	D
P78357	LB/B	-	M3WIA1	522	V	L
P78357	LP/P	Lethal congenital contracture syndrome 7 (LCCS7) [MIM:616286]	M3WIA1	323	C	R
P78357	LP/P	Neuropathy, congenital hypomyelinating, 3 (CHN3) [MIM:618186]	M3WIA1	388	R	P
P78357	LP/P	Neuropathy, congenital hypomyelinating, 3 (CHN3) [MIM:618186]	M3WIA1	764	R	C
P78357	LP/P	Neuropathy, congenital hypomyelinating, 3 (CHN3) [MIM:618186]	M3WIA1	50	P	Q
P78357	LP/P	Neuropathy, congenital hypomyelinating, 3 (CHN3) [MIM:618186]	M3WIA1	212	L	P
P78357	LP/P	Neuropathy, congenital hypomyelinating, 3 (CHN3) [MIM:618186]	M3WIA1	714	R	P
Q9UHC6	LB/B	-	G1KP51	114	R	Q
Q9UHC6	LB/B	-	G1KP51	218	T	M
Q9UHC6	LB/B	-	G1KP51	226	L	M
Q9UHC6	LB/B	-	G1KP51	283	R	C
Q9UHC6	LB/B	-	G1KP51	382	S	N
Q9UHC6	LB/B	-	G1KP51	407	N	S
Q9UHC6	LB/B	-	G1KP51	418	N	D
Q9UHC6	LB/B	-	G1KP51	680	E	K
Q9UHC6	LB/B	-	G1KP51	699	P	Q
Q9UHC6	LB/B	-	G1KP51	716	Y	C
Q9UHC6	LB/B	-	G1KP51	731	G	S
Q9UHC6	LB/B	-	G1KP51	779	G	D
Q9UHC6	LB/B	-	G1KP51	869	I	T
Q9UHC6	LB/B	-	G1KP51	906	R	H
Q9UHC6	LB/B	-	G1KP51	1038	D	N
Q9UHC6	LB/B	-	G1KP51	1102	V	A
Q9UHC6	LB/B	-	G1KP51	1114	S	G
Q9UHC6	LB/B	-	G1KP51	1119	R	H
Q9UHC6	LB/B	-	G1KP51	1129	D	H
Q9UHC6	LB/B	-	G1KP51	1227	A	T
Q9UHC6	LB/B	-	G1KP51	1253	I	T
Q9UHC6	LB/B	-	G1KP51	1278	T	I
Q9BZ76	LB/B	-	H2QXB2	628	A	S
Q9BZ76	LB/B	-	H2QXB2	845	R	H
Q9C0A0	LB/B	-	H2QXB2	513	Q	H
Q9C0A0	LB/B	-	H2QXB2	1155	D	E
Q9C0A0	LB/B	-	H2QXB2	1300	N	S
Q9C0A0	LB/B	-	H2QXB2	276	L	V
Q9C0A0	LB/B	-	H2QXB2	786	Q	R
Q8WYK1	LB/B	-	G1KP51	452	S	L
Q8WYK1	LB/B	-	G1KP51	1195	T	M
Q7Z7A1	LB/B	-	U3IAR0	56	V	I
Q7Z7A1	LB/B	-	U3IAR0	216	P	L
Q7Z7A1	LB/B	-	U3IAR0	889	A	T
Q7Z7A1	LB/B	-	U3IAR0	1146	M	V
Q8N137	LB/B	-	A0A2I3N5E6	578	P	Q
Q8N137	LB/B	-	A0A2I3N5E6	439	R	Q
Q86WW8	LP/P	Mitochondrial complex IV deficiency, nuclear type 9 (MC4DN9) [MIM:616500]	A0A2I3RHV0	53	A	P
Q5JTJ3	LP/P	Mitochondrial complex IV deficiency, nuclear type 13 (MC4DN13) [MIM:616501]	G1TDM9	59	W	C
Q5JTJ3	LP/P	Mitochondrial complex IV deficiency, nuclear type 13 (MC4DN13) [MIM:616501]	G1TDM9	66	W	R
Q96BR5	LB/B	-	C1C421	219	K	R
Q96BR5	LP/P	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3 (SCAN3) [MIM:618387]	C1C421	6	D	G
Q96BR5	LP/P	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3 (SCAN3) [MIM:618387]	C1C421	137	Y	C
Q8WTW3	LB/B	-	K7GJU2	392	N	S
Q8WTW3	LB/B	-	K7GJU2	744	Y	C
Q8WTW3	LB/B	-	K7GJU2	357	M	L
Q14746	LB/B	-	L5MAT2	304	N	K
Q14746	LB/B	-	L5MAT2	288	R	H
Q14746	LB/B	-	L5MAT2	589	V	I
Q14746	LP/P	Congenital disorder of glycosylation 2Q (CDG2Q) [MIM:617395]	L5MAT2	634	W	G
Q96JB2	LB/B	-	C3ZDX1	747	N	S
Q9Y2V7	LB/B	-	F2UBY0	10	A	T
Q9Y2V7	LB/B	-	F2UBY0	32	C	S
Q9Y2V7	LB/B	-	F2UBY0	300	H	Y
Q9Y2V7	LB/B	-	F2UBY0	447	M	T
Q9Y2V7	LP/P	Congenital disorder of glycosylation 2L (CDG2L) [MIM:614576]	F2UBY0	549	G	V
P83436	LB/B	-	L9KYP4	605	T	M
Q03692	LP/P	Schmid type metaphyseal chondrodysplasia (SMCD) [MIM:156500]	W5K583	18	G	E
Q03692	LP/P	Schmid type metaphyseal chondrodysplasia (SMCD) [MIM:156500]	W5K583	18	G	R
Q03692	LB/B	-	W5K583	545	G	R
Q03692	LP/P	Schmid type metaphyseal chondrodysplasia (SMCD) [MIM:156500]	W5K583	591	C	R
Q03692	LP/P	Schmid type metaphyseal chondrodysplasia (SMCD) [MIM:156500]	W5K583	595	G	E
Q03692	LP/P	Schmid type metaphyseal chondrodysplasia (SMCD) [MIM:156500]	W5K583	597	Y	H
Q03692	LP/P	Schmid type metaphyseal chondrodysplasia (SMCD) [MIM:156500]	W5K583	598	Y	D
Q03692	LP/P	Schmid type metaphyseal chondrodysplasia (SMCD) [MIM:156500]	W5K583	600	S	P
Q03692	LP/P	Schmid type metaphyseal chondrodysplasia (SMCD) [MIM:156500]	W5K583	614	L	P
Q03692	LP/P	Schmid type metaphyseal chondrodysplasia (SMCD) [MIM:156500]	W5K583	617	N	K
Q03692	LP/P	Schmid type metaphyseal chondrodysplasia (SMCD) [MIM:156500]	W5K583	618	G	V
Q03692	LP/P	Schmid type metaphyseal chondrodysplasia (SMCD) [MIM:156500]	W5K583	644	L	R
Q03692	LP/P	Schmid type metaphyseal chondrodysplasia (SMCD) [MIM:156500]	W5K583	648	D	G
Q03692	LP/P	Schmid type metaphyseal chondrodysplasia (SMCD) [MIM:156500]	W5K583	597	Y	C
Q03692	LB/B	-	W5K583	27	M	T
Q03692	LB/B	-	W5K583	198	R	H
Q03692	LP/P	Schmid type metaphyseal chondrodysplasia (SMCD) [MIM:156500]	W5K583	582	Y	D
Q03692	LP/P	Schmid type metaphyseal chondrodysplasia (SMCD) [MIM:156500]	W5K583	595	G	R
Q03692	LB/B	-	W5K583	603	V	M
Q03692	LP/P	Schmid type metaphyseal chondrodysplasia (SMCD) [MIM:156500]	W5K583	651	W	R
Q03692	LP/P	Schmid type metaphyseal chondrodysplasia (SMCD) [MIM:156500]	W5K583	653	Q	P
Q03692	LP/P	Schmid type metaphyseal chondrodysplasia (SMCD) [MIM:156500]	W5K583	671	S	P
Q03692	LB/B	-	W5K583	98	G	R
P12107	LP/P	Stickler syndrome 2 (STL2) [MIM:604841]	A0A1L8F3N8	625	G	V
P12107	LP/P	Stickler syndrome 2 (STL2) [MIM:604841]	A0A1L8F3N8	676	G	R
P12107	LP/P	Stickler syndrome 2 (STL2) [MIM:604841]	A0A1L8F3N8	1516	G	V
P12107	LB/B	-	A0A1L8F3N8	8	W	G
P12107	LB/B	-	A0A1L8F3N8	46	D	E
P12107	LB/B	-	A0A1L8F3N8	559	G	S
P12107	LB/B	-	A0A1L8F3N8	1323	P	L
P12107	LB/B	-	A0A1L8F3N8	1535	S	P
P12107	LB/B	-	A0A1L8F3N8	1805	L	F
P12107	LP/P	Stickler syndrome 2 (STL2) [MIM:604841]	A0A1L8F3N8	565	G	V
P12107	LP/P	Stickler syndrome 2 (STL2) [MIM:604841]	A0A1L8F3N8	1027	G	R
P12107	LP/P	Stickler syndrome 2 (STL2) [MIM:604841]	A0A1L8F3N8	1513	G	D
P12107	LP/P	Fibrochondrogenesis 1 (FBCG1) [MIM:228520]	A0A1L8F3N8	796	G	R
P12107	LP/P	Fibrochondrogenesis 1 (FBCG1) [MIM:228520]	A0A1L8F3N8	1042	G	R
P13942	LP/P	Otospondylomegaepiphyseal dysplasia, autosomal recessive (OSMEDB) [MIM:215150]	A0A1L8F3N8	661	G	R
P13942	LP/P	Deafness, autosomal dominant, 13 (DFNA13) [MIM:601868]	A0A1L8F3N8	808	G	E
P13942	LP/P	Deafness, autosomal dominant, 13 (DFNA13) [MIM:601868]	A0A1L8F3N8	1034	R	C
P13942	LB/B	-	A0A1L8F3N8	593	D	G
P13942	LB/B	-	A0A1L8F3N8	824	E	K
P13942	LB/B	-	A0A1L8F3N8	879	P	L
P13942	LP/P	Otospondylomegaepiphyseal dysplasia, autosomal dominant (OSMEDA) [MIM:184840]	A0A1L8F3N8	1441	G	E
P13942	LB/B	-	A0A1L8F3N8	1316	P	T
P13942	LB/B	-	A0A1L8F3N8	1600	R	Q
P13942	LP/P	Deafness, autosomal recessive, 53 (DFNB53) [MIM:609706]	A0A1L8F3N8	621	P	T
P13942	LB/B	-	A0A1L8F3N8	1628	E	D
P13942	LB/B	-	A0A1L8F3N8	236	P	S
P13942	LB/B	-	A0A1L8F3N8	276	E	K
P13942	LB/B	-	A0A1L8F3N8	894	L	P
P13942	LB/B	-	A0A1L8F3N8	1722	P	L
P13942	LP/P	Deafness, autosomal recessive, 53 (DFNB53) [MIM:609706]	A0A1L8F3N8	37	A	S
P13942	LP/P	Deafness, autosomal recessive, 53 (DFNB53) [MIM:609706]	A0A1L8F3N8	888	P	T
P13942	LB/B	-	A0A1L8F3N8	1422	P	L
Q99715	LB/B	-	G3PDH7	461	A	P
Q99715	LB/B	-	G3PDH7	1738	I	T
Q99715	LB/B	-	G3PDH7	2160	E	V
Q99715	LB/B	-	G3PDH7	2596	I	V
Q99715	LB/B	-	G3PDH7	2021	R	Q
Q99715	LB/B	-	G3PDH7	3048	Q	H
Q99715	LP/P	Bethlem myopathy 2 (BTHLM2) [MIM:616471]	G3PDH7	2334	I	T
Q99715	LP/P	Bethlem myopathy 2 (BTHLM2) [MIM:616471]	G3PDH7	2786	G	D
Q99715	LB/B	-	G3PDH7	3058	G	S
Q5TAT6	LB/B	-	F1PJH3	531	H	Q
Q05707	LB/B	-	A0A0F8BNK2	563	N	H
Q05707	LB/B	-	A0A0F8BNK2	855	P	L
Q05707	LB/B	-	A0A0F8BNK2	922	V	I
Q05707	LB/B	-	A0A0F8BNK2	1342	V	L
Q05707	LB/B	-	A0A0F8BNK2	636	T	A
P39059	LB/B	-	A0A2Y9GAT7	163	R	H
P39059	LB/B	-	A0A2Y9GAT7	204	M	V
P39059	LB/B	-	A0A2Y9GAT7	391	T	M
P39059	LB/B	-	A0A2Y9GAT7	442	A	T
P39059	LB/B	-	A0A2Y9GAT7	446	G	R
P39059	LB/B	-	A0A2Y9GAT7	506	E	D
P39059	LB/B	-	A0A2Y9GAT7	531	P	R
P39059	LB/B	-	A0A2Y9GAT7	989	K	R
P39059	LB/B	-	A0A2Y9GAT7	1001	K	R
P39059	LB/B	-	A0A2Y9GAT7	1332	V	I
P39059	LB/B	-	A0A2Y9GAT7	504	G	V
P39059	LB/B	-	A0A2Y9GAT7	705	P	L
Q07092	LB/B	-	L9JEA6	62	T	K
Q07092	LB/B	-	L9JEA6	418	R	Q
Q07092	LB/B	-	L9JEA6	745	G	S
Q9UMD9	LB/B	-	A0A1L8FEH4	210	T	M
Q9UMD9	LB/B	-	A0A1L8FEH4	231	M	I
Q9UMD9	LB/B	-	A0A1L8FEH4	238	M	T
Q9UMD9	LP/P	Epidermolysis bullosa, junctional 4, intermediate (JEB4) [MIM:619787]	A0A1L8FEH4	265	S	C
Q9UMD9	LB/B	-	A0A1L8FEH4	428	G	S
Q9UMD9	LP/P	Epidermolysis bullosa, junctional 4, intermediate (JEB4) [MIM:619787]	A0A1L8FEH4	627	G	V
Q9UMD9	LP/P	Epidermolysis bullosa, junctional 4, intermediate (JEB4) [MIM:619787]	A0A1L8FEH4	633	G	D
Q9UMD9	LB/B	-	A0A1L8FEH4	703	M	V
Q9UMD9	LP/P	Epidermolysis bullosa, junctional 4, intermediate (JEB4) [MIM:619787]	A0A1L8FEH4	1303	R	Q
Q9UMD9	LB/B	-	A0A1L8FEH4	1370	D	G
Q9UMD9	LB/B	-	A0A1L8FEH4	4	T	A
Q9UMD9	LP/P	Epithelial recurrent erosion dystrophy (ERED) [MIM:122400]	A0A1L8FEH4	939	T	I
P39060	LB/B	-	A0A2Y9GAT7	1675	D	N
P39060	LB/B	-	A0A2Y9GAT7	49	Q	L
P39060	LB/B	-	A0A2Y9GAT7	111	G	R
P39060	LB/B	-	A0A2Y9GAT7	1076	V	I
P39060	LB/B	-	A0A2Y9GAT7	1121	P	R
P39060	LB/B	-	A0A2Y9GAT7	288	A	T
P39060	LB/B	-	A0A2Y9GAT7	1195	Q	H
P39060	LB/B	-	A0A2Y9GAT7	379	T	M
Q14993	LB/B	-	G5ALV0	352	A	G
Q14993	LB/B	-	G5ALV0	406	G	E
Q14993	LB/B	-	G5ALV0	496	E	G
Q8NFW1	LB/B	-	Q4S053	320	S	G
Q8NFW1	LB/B	-	Q4S053	703	P	T
Q8NFW1	LB/B	-	Q4S053	938	A	D
Q86Y22	LB/B	-	A0A2Y9S091	287	T	A
Q17RW2	LB/B	-	H3DN34	1423	G	R
Q17RW2	LB/B	-	H3DN34	151	P	L
Q17RW2	LB/B	-	H3DN34	293	I	T
Q17RW2	LB/B	-	H3DN34	481	M	L
Q17RW2	LB/B	-	H3DN34	546	P	S
Q17RW2	LB/B	-	H3DN34	731	P	S
Q17RW2	LB/B	-	H3DN34	641	R	H
Q17RW2	LB/B	-	H3DN34	61	A	V
Q96A83	LB/B	-	A0A1W4Z0H7	427	P	L
Q8IZC6	LB/B	-	H3DN34	89	V	I
Q8IZC6	LB/B	-	H3DN34	120	Q	R
Q8IZC6	LB/B	-	H3DN34	265	A	T
Q8IZC6	LB/B	-	H3DN34	349	R	C
Q8IZC6	LB/B	-	H3DN34	422	A	T
Q8IZC6	LB/B	-	H3DN34	537	I	T
Q8IZC6	LB/B	-	H3DN34	611	I	F
Q8IZC6	LB/B	-	H3DN34	720	P	R
Q8IZC6	LB/B	-	H3DN34	1116	P	Q
Q8IZC6	LB/B	-	H3DN34	1348	R	Q
Q8IZC6	LB/B	-	H3DN34	1354	R	Q
Q8IZC6	LB/B	-	H3DN34	1808	M	V
Q8IZC6	LP/P	Steel syndrome (STLS) [MIM:615155]	H3DN34	697	G	R
Q2UY09	LB/B	-	U3II46	189	A	G
Q2UY09	LB/B	-	U3II46	239	I	V
Q2UY09	LB/B	-	U3II46	327	T	S
Q2UY09	LB/B	-	U3II46	433	E	D
Q2UY09	LB/B	-	U3II46	472	A	P
Q2UY09	LB/B	-	U3II46	741	R	Q
Q2UY09	LB/B	-	U3II46	437	I	M
P02461	LB/B	-	G1T4A5	169	L	F
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	183	G	C
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	201	G	R
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	228	G	E
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	303	G	R
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	540	G	R
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	567	G	E
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	582	G	S
P02461	LB/B	-	G1T4A5	602	P	T
P02461	LB/B	-	G1T4A5	635	P	L
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	666	G	D
P02461	LB/B	-	G1T4A5	698	A	T
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	726	G	R
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	756	G	E
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	762	G	C
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	786	G	R
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	804	G	S
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	828	G	R
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	909	G	D
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	936	G	R
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	936	G	S
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	939	G	D
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	957	G	S
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	960	G	V
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	996	G	E
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	1014	G	E
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	1050	G	D
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	1071	G	V
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	1077	G	V
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	1101	G	E
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	1104	G	A
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	1167	G	V
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	1170	G	D
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	1173	G	E
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	1176	G	V
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	1182	G	E
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	1185	G	D
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	1185	G	V
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	1188	G	E
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	1188	G	R
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	183	G	D
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	183	G	S
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	192	G	V
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	204	G	D
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	204	G	S
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	210	G	D
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	219	G	C
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	225	G	V
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	240	G	R
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	243	G	V
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	249	G	D
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	249	G	V
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	252	G	D
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	252	G	R
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	252	G	V
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	255	G	V
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	264	G	R
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	267	G	V
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	321	G	V
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	327	G	D
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	345	G	R
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	417	G	R
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	444	G	R
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	489	G	E
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	501	G	R
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	519	G	V
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	549	G	E
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	552	G	E
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	588	G	D
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	636	G	R
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	657	G	E
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	660	G	D
P02461	LB/B	-	G1T4A5	668	P	T
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	699	G	R
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	738	G	S
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	738	G	V
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	744	G	V
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	828	G	W
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	852	G	C
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	879	G	V
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	882	G	D
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	900	G	D
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	903	G	E
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	909	G	V
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	918	G	E
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	924	G	C
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	942	G	E
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	966	G	V
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	972	G	A
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	984	G	T
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	999	G	R
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	1011	G	E
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	1032	G	V
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	1035	G	C
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	1044	G	D
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	1050	G	V
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	1089	G	D
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	1098	G	D
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	1098	G	V
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	1161	G	V
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	1164	G	E
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	1164	G	R
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	1170	G	V
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	1173	G	R
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	1179	G	R
P02461	LB/B	-	G1T4A5	1205	I	V
P02461	LB/B	-	G1T4A5	1353	H	Q
P02461	LP/P	Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]	G1T4A5	297	G	R
P02461	LB/B	-	G1T4A5	534	G	E
P02461	LB/B	-	G1T4A5	679	A	T
P02461	LB/B	-	G1T4A5	686	P	A
P02461	LP/P	Polymicrogyria with or without vascular-type Ehlers-Danlos syndrome (PMGEDSV) [MIM:618343]	G1T4A5	49	P	A
P02461	LP/P	Polymicrogyria with or without vascular-type Ehlers-Danlos syndrome (PMGEDSV) [MIM:618343]	G1T4A5	1284	G	E
P02462	LB/B	-	K1RH30	1334	Q	H
P02462	LB/B	-	K1RH30	7	V	L
P02462	LP/P	Brain small vessel disease 1 with or without ocular anomalies (BSVD1) [MIM:175780]	K1RH30	562	G	E
P02462	LP/P	Brain small vessel disease 1 with or without ocular anomalies (BSVD1) [MIM:175780]	K1RH30	749	G	S
P02462	LP/P	Brain small vessel disease 1 with or without ocular anomalies (BSVD1) [MIM:175780]	K1RH30	1130	G	D
P02462	LP/P	Brain small vessel disease 1 with or without ocular anomalies (BSVD1) [MIM:175780]	K1RH30	1236	G	R
P02462	LP/P	Brain small vessel disease 1 with or without ocular anomalies (BSVD1) [MIM:175780]	K1RH30	1423	G	R
P02462	LB/B	-	K1RH30	555	P	T
P02462	LB/B	-	K1RH30	304	P	L
P02462	LP/P	Hereditary angiopathy with nephropathy aneurysms and muscle cramps (HANAC) [MIM:611773]	K1RH30	498	G	V
P02462	LP/P	Hereditary angiopathy with nephropathy aneurysms and muscle cramps (HANAC) [MIM:611773]	K1RH30	519	G	R
P02462	LP/P	Hereditary angiopathy with nephropathy aneurysms and muscle cramps (HANAC) [MIM:611773]	K1RH30	528	G	E
P02462	LP/P	Hereditary angiopathy with nephropathy aneurysms and muscle cramps (HANAC) [MIM:611773]	K1RH30	498	G	R
P02462	LP/P	Hereditary angiopathy with nephropathy aneurysms and muscle cramps (HANAC) [MIM:611773]	K1RH30	510	G	R
P02462	LP/P	Tortuosity of retinal arteries (RATOR) [MIM:180000]	K1RH30	510	G	R
P02462	LP/P	Hereditary angiopathy with nephropathy aneurysms and muscle cramps (HANAC) [MIM:611773]	K1RH30	525	G	L
P02462	LP/P	Brain small vessel disease 1 with or without ocular anomalies (BSVD1) [MIM:175780]	K1RH30	720	G	D
P02462	LP/P	Brain small vessel disease 1 with or without ocular anomalies (BSVD1) [MIM:175780]	K1RH30	755	G	R
P02462	LP/P	Brain small vessel disease 1 with or without ocular anomalies (BSVD1) [MIM:175780]	K1RH30	805	G	R
P02462	LP/P	Brain small vessel disease 1 with or without ocular anomalies (BSVD1) [MIM:175780]	K1RH30	1580	G	R
P02462	LB/B	-	K1RH30	144	A	V
P02462	LP/P	Intracerebral hemorrhage (ICH) [MIM:614519]	K1RH30	352	P	L
P02462	LP/P	Intracerebral hemorrhage (ICH) [MIM:614519]	K1RH30	538	R	G
P02462	LP/P	Schizencephaly (SCHZC) [MIM:269160]	K1RH30	655	G	R
P02462	LP/P	Brain small vessel disease 1 with or without ocular anomalies (BSVD1) [MIM:175780]	K1RH30	708	G	R
P02462	LP/P	Brain small vessel disease 1 with or without ocular anomalies (BSVD1) [MIM:175780]	K1RH30	773	G	R
P02462	LP/P	Schizencephaly (SCHZC) [MIM:269160]	K1RH30	870	G	R
P02462	LP/P	Brain small vessel disease 1 with or without ocular anomalies (BSVD1) [MIM:175780]	K1RH30	882	G	D
P02462	LP/P	Schizencephaly (SCHZC) [MIM:269160]	K1RH30	897	G	S
P02462	LP/P	Schizencephaly (SCHZC) [MIM:269160]	K1RH30	948	G	S
P02462	LP/P	Schizencephaly (SCHZC) [MIM:269160]	K1RH30	1041	G	E
P02462	LP/P	Schizencephaly (SCHZC) [MIM:269160]	K1RH30	1082	G	E
P02462	LP/P	Brain small vessel disease 1 with or without ocular anomalies (BSVD1) [MIM:175780]	K1RH30	1266	G	R
P02462	LP/P	Schizencephaly (SCHZC) [MIM:269160]	K1RH30	1326	G	R
P02462	LP/P	Schizencephaly (SCHZC) [MIM:269160]	K1RH30	1332	G	D
P02462	LB/B	-	K1RH30	1531	M	V
P02462	LP/P	Schizencephaly (SCHZC) [MIM:269160]	K1RH30	1615	E	K
P02462	LP/P	Brain small vessel disease 1 with or without ocular anomalies (BSVD1) [MIM:175780]	K1RH30	1627	N	K
P08572	LB/B	-	K1RH30	517	R	K
P08572	LB/B	-	K1RH30	683	G	A
P08572	LB/B	-	K1RH30	192	V	F
P08572	LB/B	-	K1RH30	701	K	R
P08572	LB/B	-	K1RH30	1109	R	Q
P08572	LB/B	-	K1RH30	1123	E	G
P08572	LB/B	-	K1RH30	1150	Q	K
P08572	LP/P	-	K1RH30	1389	G	R
P08572	LB/B	-	K1RH30	1399	V	I
P08572	LB/B	-	K1RH30	1690	A	T
P08572	LB/B	-	K1RH30	718	P	S
P08572	LP/P	Brain small vessel disease 2 (BSVD2) [MIM:614483]	K1RH30	1037	G	E
P08572	LP/P	Brain small vessel disease 2 (BSVD2) [MIM:614483]	K1RH30	1152	G	D
Q01955	LB/B	-	K1RH30	1474	L	P
Q01955	LB/B	-	K1RH30	1495	Q	R
Q01955	LB/B	-	K1RH30	43	G	R
Q01955	LB/B	-	K1RH30	162	E	G
Q01955	LP/P	Alport syndrome 2, autosomal recessive (ATS2) [MIM:203780]	K1RH30	297	G	E
Q01955	LB/B	-	K1RH30	326	D	Y
Q01955	LP/P	Alport syndrome 2, autosomal recessive (ATS2) [MIM:203780]	K1RH30	407	G	R
Q01955	LB/B	-	K1RH30	408	R	H
Q01955	LB/B	-	K1RH30	451	H	R
Q01955	LB/B	-	K1RH30	574	P	L
Q01955	LP/P	Alport syndrome 2, autosomal recessive (ATS2) [MIM:203780]	K1RH30	640	G	R
Q01955	LP/P	Alport syndrome 3, autosomal dominant (ATS3) [MIM:104200]	K1RH30	1167	G	R
Q01955	LP/P	Alport syndrome 2, autosomal recessive (ATS2) [MIM:203780]	K1RH30	1207	G	E
Q01955	LB/B	-	K1RH30	1269	D	E
Q01955	LP/P	Alport syndrome 2, autosomal recessive (ATS2) [MIM:203780]	K1RH30	1277	G	S
Q01955	LP/P	Alport syndrome 2, autosomal recessive (ATS2) [MIM:203780]	K1RH30	1334	G	E
Q01955	LB/B	-	K1RH30	141	L	P
Q01955	LP/P	Alport syndrome 2, autosomal recessive (ATS2) [MIM:203780]	K1RH30	532	G	D
Q01955	LP/P	Alport syndrome 2, autosomal recessive (ATS2) [MIM:203780]	K1RH30	739	G	R
Q01955	LP/P	Alport syndrome 2, autosomal recessive (ATS2) [MIM:203780]	K1RH30	853	G	R
Q01955	LP/P	Hematuria, benign familial (BFH) [MIM:141200]	K1RH30	985	G	V
Q01955	LP/P	Hematuria, benign familial (BFH) [MIM:141200]	K1RH30	1015	G	E
Q01955	LP/P	Alport syndrome 2, autosomal recessive (ATS2) [MIM:203780]	K1RH30	1216	G	R
Q01955	LB/B	-	K1RH30	834	K	R
P53420	LP/P	Hematuria, benign familial (BFH) [MIM:141200]	K1RH30	897	G	E
P53420	LP/P	Alport syndrome 2, autosomal recessive (ATS2) [MIM:203780]	K1RH30	1201	G	S
P53420	LB/B	-	K1RH30	545	G	A
P53420	LB/B	-	K1RH30	570	E	Q
P53420	LB/B	-	K1RH30	931	A	T
P53420	LB/B	-	K1RH30	1004	P	L
P53420	LP/P	Alport syndrome 2, autosomal recessive (ATS2) [MIM:203780]	K1RH30	1030	G	V
P53420	LB/B	-	K1RH30	1402	P	S
P53420	LP/P	Alport syndrome 2, autosomal recessive (ATS2) [MIM:203780]	K1RH30	1572	P	L
P53420	LB/B	-	K1RH30	482	P	S
P53420	LB/B	-	K1RH30	6	I	T
P53420	LP/P	Hematuria, benign familial (BFH) [MIM:141200]	K1RH30	116	G	E
P53420	LP/P	Hematuria, benign familial (BFH) [MIM:141200]	K1RH30	960	G	R
P53420	LP/P	Hematuria, benign familial (BFH) [MIM:141200]	K1RH30	999	G	E
P53420	LP/P	Hematuria, benign familial (BFH) [MIM:141200]	K1RH30	1132	P	L
P53420	LB/B	-	K1RH30	1327	V	M
P53420	LB/B	-	K1RH30	1403	S	P
P53420	LB/B	-	K1RH30	594	E	G
P53420	LB/B	-	K1RH30	670	V	I
P53420	LB/B	-	K1RH30	759	P	L
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	54	G	D
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	129	G	E
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	129	G	V
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	174	G	R
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	177	G	R
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	216	G	R
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	219	G	S
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	289	G	V
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	292	G	V
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	325	G	E
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	325	G	R
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	365	G	E
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	371	G	E
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	374	G	A
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	383	G	D
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	400	G	E
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	406	G	V
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	409	G	D
P29400	LB/B	-	K1RH30	430	A	D
P29400	LB/B	-	K1RH30	444	I	S
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	466	G	E
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	494	G	D
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	521	G	C
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	521	G	S
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	567	G	A
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	609	G	V
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	638	G	V
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	638	G	A
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	653	G	R
P29400	LB/B	-	K1RH30	664	K	N
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	684	G	V
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	740	G	E
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	772	G	D
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	796	G	R
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	852	G	R
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	866	G	E
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	869	G	R
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	872	G	R
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1104	G	V
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1143	G	D
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1143	G	S
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1182	G	R
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1241	G	C
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1270	G	S
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1379	G	V
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1410	R	C
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1421	G	W
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1422	R	C
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1451	G	S
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1498	A	D
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1517	P	T
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1538	W	S
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1563	R	Q
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1564	C	S
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1596	G	D
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1649	L	R
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1677	R	Q
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	114	G	S
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	331	G	V
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	472	G	R
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	545	G	R
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	545	G	V
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	561	G	R
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	579	G	R
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	635	G	D
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	638	G	S
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	669	G	A
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	687	G	E
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	743	G	D
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	808	G	E
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	852	G	E
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	878	G	R
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1107	G	R
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1161	G	R
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1211	G	R
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1220	G	D
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1333	G	S
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1427	G	V
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1442	G	D
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1486	G	A
P29400	LB/B	-	K1RH30	1559	P	A
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	177	G	C
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	192	G	R
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	204	G	V
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	230	G	R
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	239	G	E
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	264	G	R
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	292	G	R
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	295	G	D
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	298	G	S
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	319	G	R
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	412	G	V
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	415	G	R
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	420	G	E
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	420	G	V
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	423	G	E
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	491	G	E
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	497	G	C
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	524	G	D
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	558	G	R
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	573	G	D
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	579	G	E
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	603	G	V
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	609	G	R
P29400	LB/B	-	K1RH30	619	P	S
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	621	G	C
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	624	G	D
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	629	G	D
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	632	G	D
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	633	E	K
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	681	G	D
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	722	G	E
P29400	LB/B	-	K1RH30	739	P	A
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	739	P	S
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	802	G	R
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	811	G	V
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	822	G	R
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	898	M	V
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	902	G	V
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	911	G	E
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	941	G	C
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	947	G	D
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	953	G	V
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1006	G	A
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1006	G	V
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1015	G	E
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1015	G	V
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1030	G	S
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1036	G	V
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1039	G	S
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1045	G	E
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1066	G	R
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1066	G	S
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1086	G	D
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1158	G	R
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1167	G	S
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1170	G	S
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1196	G	R
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1205	G	C
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1211	G	E
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1229	G	D
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1244	G	D
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1252	G	S
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1261	G	E
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1357	G	S
P29400	LB/B	-	K1RH30	1428	L	M
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1488	S	F
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1567	C	R
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1677	R	P
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	1678	C	W
P29400	LP/P	Alport syndrome 1, X-linked (ATS1) [MIM:301050]	K1RH30	123	G	E
Q14031	LB/B	-	K1RH30	455	S	A
Q14031	LB/B	-	K1RH30	1110	N	K
Q14031	LB/B	-	K1RH30	1126	P	S
Q14031	LB/B	-	K1RH30	1162	I	V
Q14031	LB/B	-	K1RH30	1362	L	P
Q14031	LB/B	-	K1RH30	455	S	P
Q14031	LP/P	Deafness, X-linked, 6 (DFNX6) [MIM:300914]	K1RH30	591	G	S
P20908	LP/P	Ehlers-Danlos syndrome, classic type, 1 (EDSCL1) [MIM:130000]	A0A1L8F3N8	1639	C	S
P20908	LP/P	Ehlers-Danlos syndrome, classic type, 1 (EDSCL1) [MIM:130000]	A0A1L8F3N8	530	G	S
P20908	LP/P	Ehlers-Danlos syndrome, classic type, 1 (EDSCL1) [MIM:130000]	A0A1L8F3N8	1489	G	D
P20908	LP/P	Ehlers-Danlos syndrome, classic type, 1 (EDSCL1) [MIM:130000]	A0A1L8F3N8	25	L	P
P20908	LP/P	Ehlers-Danlos syndrome, classic type, 1 (EDSCL1) [MIM:130000]	A0A1L8F3N8	25	L	R
P20908	LB/B	-	A0A1L8F3N8	114	A	D
P20908	LB/B	-	A0A1L8F3N8	192	D	N
P20908	LB/B	-	A0A1L8F3N8	951	N	S
P20908	LP/P	Ehlers-Danlos syndrome, classic type, 1 (EDSCL1) [MIM:130000]	A0A1L8F3N8	1486	G	C
P20908	LB/B	-	A0A1L8F3N8	908	P	L
P20908	LB/B	-	A0A1L8F3N8	863	E	V
P20908	LB/B	-	A0A1L8F3N8	1140	V	M
P20908	LP/P	Fibromuscular dysplasia, multifocal (FMDMF) [MIM:619329]	A0A1L8F3N8	514	G	S
P25940	LB/B	-	A0A2J8UIU7	134	R	H
P25940	LB/B	-	A0A2J8UIU7	1207	R	P
P25940	LB/B	-	A0A2J8UIU7	1428	V	M
P25940	LB/B	-	A0A2J8UIU7	1594	I	M
P25940	LB/B	-	A0A2J8UIU7	1691	V	I
P25940	LB/B	-	A0A2J8UIU7	1042	R	P
P25940	LB/B	-	A0A2J8UIU7	1488	A	P
P25940	LB/B	-	A0A2J8UIU7	322	R	G
P12109	LP/P	Bethlem myopathy 1 (BTHLM1) [MIM:158810]	A0A0Q3PF17	121	K	R
P12109	LP/P	Bethlem myopathy 1 (BTHLM1) [MIM:158810]	A0A0Q3PF17	305	G	V
P12109	LP/P	Bethlem myopathy 1 (BTHLM1) [MIM:158810]	A0A0Q3PF17	341	G	D
P12109	LB/B	-	A0A0Q3PF17	439	R	Q
P12109	LB/B	-	A0A0Q3PF17	850	R	H
P12109	LB/B	-	A0A0Q3PF17	116	S	N
P12109	LP/P	Bethlem myopathy 1 (BTHLM1) [MIM:158810]	A0A0Q3PF17	272	G	D
P12109	LP/P	Bethlem myopathy 1 (BTHLM1) [MIM:158810]	A0A0Q3PF17	274	P	L
P12109	LP/P	Bethlem myopathy 1 (BTHLM1) [MIM:158810]	A0A0Q3PF17	275	G	R
P12109	LP/P	Ullrich congenital muscular dystrophy 1 (UCMD1) [MIM:254090]	A0A0Q3PF17	281	G	R
P12109	LP/P	Ullrich congenital muscular dystrophy 1 (UCMD1) [MIM:254090]	A0A0Q3PF17	284	G	R
P12109	LP/P	Bethlem myopathy 1 (BTHLM1) [MIM:158810]	A0A0Q3PF17	290	G	R
P12109	LP/P	Ullrich congenital muscular dystrophy 1 (UCMD1) [MIM:254090]	A0A0Q3PF17	290	G	R
P12109	LB/B	-	A0A0Q3PF17	332	G	S
P12109	LP/P	Bethlem myopathy 1 (BTHLM1) [MIM:158810]	A0A0Q3PF17	341	G	V
P12109	LP/P	Bethlem myopathy 1 (BTHLM1) [MIM:158810]	A0A0Q3PF17	571	K	T
P12109	LB/B	-	A0A0Q3PF17	881	T	M
P12109	LB/B	-	A0A0Q3PF17	890	S	L
P12109	LP/P	-	A0A0Q3PF17	43	D	A
P12110	LP/P	Bethlem myopathy 1 (BTHLM1) [MIM:158810]	A0A1V4L0R0	271	G	S
P12110	LP/P	Bethlem myopathy 1 (BTHLM1) [MIM:158810]	A0A1V4L0R0	621	D	N
P12110	LB/B	-	A0A1V4L0R0	399	S	N
P12110	LB/B	-	A0A1V4L0R0	680	R	H
P12110	LB/B	-	A0A1V4L0R0	227	D	N
P12110	LB/B	-	A0A1V4L0R0	935	G	R
P12110	LB/B	-	A0A1V4L0R0	1015	I	L
P12110	LB/B	-	A0A1V4L0R0	106	E	K
P12110	LP/P	Ullrich congenital muscular dystrophy 1 (UCMD1) [MIM:254090]	A0A1V4L0R0	283	G	R
P12110	LB/B	-	A0A1V4L0R0	489	R	Q
P12110	LP/P	Ullrich congenital muscular dystrophy 1 (UCMD1) [MIM:254090]	A0A1V4L0R0	498	R	H
P12110	LB/B	-	A0A1V4L0R0	518	P	S
P12110	LP/P	Ullrich congenital muscular dystrophy 1 (UCMD1) [MIM:254090]	A0A1V4L0R0	531	G	R
P12110	LP/P	Bethlem myopathy 1 (BTHLM1) [MIM:158810]	A0A1V4L0R0	700	G	S
P12110	LB/B	-	A0A1V4L0R0	724	R	C
P12110	LP/P	Bethlem myopathy 1 (BTHLM1) [MIM:158810]	A0A1V4L0R0	777	C	R
P12110	LB/B	-	A0A1V4L0R0	784	R	H
P12110	LB/B	-	A0A1V4L0R0	804	V	G
P12110	LP/P	Ullrich congenital muscular dystrophy 1 (UCMD1) [MIM:254090]	A0A1V4L0R0	837	L	P
P12110	LB/B	-	A0A1V4L0R0	853	R	Q
P12110	LP/P	Ullrich congenital muscular dystrophy 1 (UCMD1) [MIM:254090]	A0A1V4L0R0	876	R	S
P12110	LB/B	-	A0A1V4L0R0	895	S	R
P12110	LP/P	Bethlem myopathy 1 (BTHLM1) [MIM:158810]	A0A1V4L0R0	932	P	L
P12110	LB/B	-	A0A1V4L0R0	377	R	C
P12110	LB/B	-	A0A1V4L0R0	446	D	N
P12110	LB/B	-	A0A1V4L0R0	728	V	M
P12110	LB/B	-	A0A1V4L0R0	843	R	Q
P12110	LB/B	-	A0A1V4L0R0	1010	F	C
P12111	LP/P	Bethlem myopathy 1 (BTHLM1) [MIM:158810]	A0A1L8EWL1	1679	G	E
P12111	LB/B	-	A0A1L8EWL1	2831	D	H
P12111	LB/B	-	A0A1L8EWL1	538	T	M
P12111	LB/B	-	A0A1L8EWL1	659	R	H
P12111	LB/B	-	A0A1L8EWL1	886	V	E
P12111	LB/B	-	A0A1L8EWL1	1088	K	Q
P12111	LB/B	-	A0A1L8EWL1	2218	P	L
P12111	LB/B	-	A0A1L8EWL1	2805	N	T
P12111	LB/B	-	A0A1L8EWL1	2927	M	T
P12111	LB/B	-	A0A1L8EWL1	2988	M	V
P12111	LB/B	-	A0A1L8EWL1	3012	A	P
P12111	LB/B	-	A0A1L8EWL1	3069	T	I
P12111	LB/B	-	A0A1L8EWL1	411	L	V
P12111	LB/B	-	A0A1L8EWL1	491	D	H
P12111	LB/B	-	A0A1L8EWL1	492	T	S
P12111	LB/B	-	A0A1L8EWL1	677	R	H
P12111	LB/B	-	A0A1L8EWL1	807	A	T
P12111	LB/B	-	A0A1L8EWL1	830	A	S
P12111	LP/P	Bethlem myopathy 1 (BTHLM1) [MIM:158810]	A0A1L8EWL1	1014	K	E
P12111	LB/B	-	A0A1L8EWL1	1064	R	Q
P12111	LP/P	Bethlem myopathy 1 (BTHLM1) [MIM:158810]	A0A1L8EWL1	1386	E	K
P12111	LB/B	-	A0A1L8EWL1	1395	R	Q
P12111	LP/P	Bethlem myopathy 1 (BTHLM1) [MIM:158810]	A0A1L8EWL1	1467	N	D
P12111	LB/B	-	A0A1L8EWL1	1576	R	Q
P12111	LB/B	-	A0A1L8EWL1	1632	R	Q
P12111	LP/P	Ullrich congenital muscular dystrophy 1 (UCMD1) [MIM:254090]	A0A1L8EWL1	1674	D	N
P12111	LB/B	-	A0A1L8EWL1	1687	P	S
P12111	LP/P	Bethlem myopathy 1 (BTHLM1) [MIM:158810]	A0A1L8EWL1	1726	L	R
P12111	LP/P	Bethlem myopathy 1 (BTHLM1) [MIM:158810]	A0A1L8EWL1	1985	V	M
P12111	LP/P	Bethlem myopathy 1 (BTHLM1) [MIM:158810]	A0A1L8EWL1	2047	G	D
P12111	LP/P	Bethlem myopathy 1 (BTHLM1) [MIM:158810]	A0A1L8EWL1	2056	G	R
P12111	LP/P	Bethlem myopathy 1 (BTHLM1) [MIM:158810]	A0A1L8EWL1	2080	G	D
P12111	LB/B	-	A0A1L8EWL1	2431	D	V
P12111	LB/B	-	A0A1L8EWL1	2453	E	K
P12111	LB/B	-	A0A1L8EWL1	2941	A	V
P12111	LP/P	Dystonia 27 (DYT27) [MIM:616411]	A0A1L8EWL1	2501	R	H
P12111	LP/P	Dystonia 27 (DYT27) [MIM:616411]	A0A1L8EWL1	2554	A	T
P12111	LP/P	Dystonia 27 (DYT27) [MIM:616411]	A0A1L8EWL1	3043	R	H
P12111	LP/P	Dystonia 27 (DYT27) [MIM:616411]	A0A1L8EWL1	3082	P	R
Q14055	LP/P	Intervertebral disc disease (IDD) [MIM:603932]	A0A087YFF2	326	Q	W
Q14055	LB/B	-	A0A087YFF2	326	Q	R
Q14055	LB/B	-	A0A087YFF2	581	V	I
Q14055	LB/B	-	A0A087YFF2	246	T	M
Q14055	LB/B	-	A0A087YFF2	335	L	V
Q14050	LB/B	-	A0A087YFF2	103	R	Q
Q14050	LB/B	-	A0A087YFF2	103	R	W
Q14050	LB/B	-	A0A087YFF2	296	P	L
Q14050	LB/B	-	A0A087YFF2	402	R	Q
Q14050	LB/B	-	A0A087YFF2	435	A	E
Q14050	LB/B	-	A0A087YFF2	94	P	S
Q14050	LP/P	Multiple epiphyseal dysplasia 3 (EDM3) [MIM:600969]	A0A087YFF2	35	G	D
Q9Y6Z7	LP/P	3MC syndrome 3 (3MC3) [MIM:248340]	L9LCR2	176	C	W
Q9BWP8	LB/B	-	V8PI97	219	H	R
Q9BWP8	LP/P	3MC syndrome 2 (3MC2) [MIM:265050]	V8PI97	169	S	P
Q9BWP8	LP/P	3MC syndrome 2 (3MC2) [MIM:265050]	V8PI97	204	G	S
Q8NBJ5	LP/P	Brain small vessel disease 3 (BSVD3) [MIM:618360]	A0A091IPP8	151	L	R
Q8NBJ5	LP/P	Brain small vessel disease 3 (BSVD3) [MIM:618360]	A0A091IPP8	154	A	P
Q8NBJ5	LP/P	Brain small vessel disease 3 (BSVD3) [MIM:618360]	A0A091IPP8	377	G	R
Q9Y215	LP/P	Myasthenic syndrome, congenital, 5 (CMS5) [MIM:603034]	F7E8L6	59	P	Q
Q9Y215	LP/P	Myasthenic syndrome, congenital, 5 (CMS5) [MIM:603034]	F7E8L6	342	D	E
Q9Y215	LP/P	Myasthenic syndrome, congenital, 5 (CMS5) [MIM:603034]	F7E8L6	410	R	Q
Q9Y215	LP/P	Myasthenic syndrome, congenital, 5 (CMS5) [MIM:603034]	F7E8L6	430	Y	S
Q9Y215	LP/P	Myasthenic syndrome, congenital, 5 (CMS5) [MIM:603034]	F7E8L6	444	C	Y
Q9Y215	LB/B	-	F7E8L6	312	S	G
Q9Y215	LP/P	Myasthenic syndrome, congenital, 5 (CMS5) [MIM:603034]	F7E8L6	337	I	T
Q9Y6G5	LB/B	-	G1SPX7	128	I	S
Q86X83	LB/B	-	Q4SRW0	113	I	L
Q86X83	LB/B	-	Q4SRW0	177	Q	H
Q9UBI1	LB/B	-	A0A087XJM5	18	R	G
Q9GZQ3	LB/B	-	A0A2K6NR98	6	A	T
Q9GZQ3	LB/B	-	A0A2K6NR98	69	Q	H
Q7Z4G1	LB/B	-	J9P2Y7	52	H	N
Q9NX08	LB/B	-	H0VSK8	17	A	P
P21964	LB/B	-	A0A2K6UJS9	158	V	M
P21964	LB/B	-	A0A2K6UJS9	34	C	S
P21964	LB/B	-	A0A2K6UJS9	72	A	S
P21964	LB/B	-	A0A2K6UJS9	102	A	T
P21964	LB/B	-	A0A2K6UJS9	146	A	V
P53621	LB/B	-	A0A0A0LM21	1040	V	G
P53621	LP/P	Autoimmune interstitial lung, joint, and kidney disease (AILJK) [MIM:616414]	A0A0A0LM21	230	K	N
P53621	LP/P	Autoimmune interstitial lung, joint, and kidney disease (AILJK) [MIM:616414]	A0A0A0LM21	233	R	H
P53621	LP/P	Autoimmune interstitial lung, joint, and kidney disease (AILJK) [MIM:616414]	A0A0A0LM21	241	E	K
P53621	LP/P	Autoimmune interstitial lung, joint, and kidney disease (AILJK) [MIM:616414]	A0A0A0LM21	243	D	G
P53618	LP/P	Baralle-Macken syndrome (BARMACS) [MIM:619255]	A0A2I0UIW5	551	F	V
Q9UBF2	LB/B	-	A0A091E2R0	547	I	L
Q9UBF2	LB/B	-	A0A091E2R0	626	P	L
Q9NQ92	LB/B	-	F7AE33	43	S	G
Q9H8M1	LB/B	-	K7GI63	48	L	F
Q96H96	LP/P	Coenzyme Q10 deficiency, primary, 1 (COQ10D1) [MIM:607426]	K7ET43	247	Y	C
Q96H96	LP/P	Coenzyme Q10 deficiency, primary, 1 (COQ10D1) [MIM:607426]	K7ET43	96	S	N
Q96H96	LP/P	Coenzyme Q10 deficiency, primary, 1 (COQ10D1) [MIM:607426]	K7ET43	147	R	H
Q96H96	LP/P	Coenzyme Q10 deficiency, primary, 1 (COQ10D1) [MIM:607426]	K7ET43	178	N	S
Q96H96	LB/B	-	K7ET43	16	V	L
Q96H96	LB/B	-	K7ET43	22	P	L
Q96H96	LP/P	Multiple system atrophy 1 (MSA1) [MIM:146500]	K7ET43	29	F	L
Q96H96	LP/P	Multiple system atrophy 1 (MSA1) [MIM:146500]	K7ET43	49	P	H
Q96H96	LP/P	Multiple system atrophy 1 (MSA1) [MIM:146500]	K7ET43	57	S	T
Q96H96	LB/B	-	K7ET43	69	R	H
Q96H96	LP/P	Multiple system atrophy 1 (MSA1) [MIM:146500]	K7ET43	78	M	V
Q96H96	LP/P	Multiple system atrophy 1 (MSA1) [MIM:146500]	K7ET43	97	I	T
Q96H96	LP/P	Multiple system atrophy 1 (MSA1) [MIM:146500]	K7ET43	107	P	S
Q96H96	LP/P	Multiple system atrophy 1 (MSA1) [MIM:146500]	K7ET43	113	S	F
Q96H96	LP/P	Multiple system atrophy 1 (MSA1) [MIM:146500]	K7ET43	267	T	A
Q96H96	LP/P	Multiple system atrophy 1 (MSA1) [MIM:146500]	K7ET43	297	S	C
Q96H96	LB/B	-	K7ET43	336	N	H
Q96H96	LP/P	Multiple system atrophy 1 (MSA1) [MIM:146500]	K7ET43	337	R	Q
Q96H96	LP/P	Multiple system atrophy 1 (MSA1) [MIM:146500]	K7ET43	343	V	A
Q96H96	LP/P	Coenzyme Q10 deficiency, primary, 1 (COQ10D1) [MIM:607426]	K7ET43	132	M	R
Q96H96	LP/P	Coenzyme Q10 deficiency, primary, 1 (COQ10D1) [MIM:607426]	K7ET43	252	A	V
Q9NZJ6	LB/B	-	A0A2K6EJ66	272	S	G
Q9NZJ6	LB/B	-	A0A2K6EJ66	329	Y	H
Q9NZJ6	LB/B	-	A0A2K6EJ66	134	K	E
Q5HYK3	LB/B	-	A0A1U7ZLS2	152	A	T
Q99807	LB/B	-	A0A2K5YTZ7	103	T	M
Q99807	LP/P	Coenzyme Q10 deficiency, primary, 8 (COQ10D8) [MIM:616733]	A0A2K5YTZ7	141	V	E
Q8NI60	LB/B	-	A0A1S3S8N5	85	H	Q
Q8NI60	LP/P	Coenzyme Q10 deficiency, primary, 4 (COQ10D4) [MIM:612016]	A0A1S3S8N5	213	R	W
Q8NI60	LP/P	Coenzyme Q10 deficiency, primary, 4 (COQ10D4) [MIM:612016]	A0A1S3S8N5	272	G	D
Q8NI60	LP/P	Coenzyme Q10 deficiency, primary, 4 (COQ10D4) [MIM:612016]	A0A1S3S8N5	272	G	V
Q8NI60	LP/P	Coenzyme Q10 deficiency, primary, 4 (COQ10D4) [MIM:612016]	A0A1S3S8N5	514	Y	C
Q8NI60	LP/P	Coenzyme Q10 deficiency, primary, 4 (COQ10D4) [MIM:612016]	A0A1S3S8N5	549	G	S
Q8NI60	LP/P	Coenzyme Q10 deficiency, primary, 4 (COQ10D4) [MIM:612016]	A0A1S3S8N5	551	E	K
Q8NI60	LB/B	-	A0A1S3S8N5	341	I	T
Q8NI60	LP/P	Coenzyme Q10 deficiency, primary, 4 (COQ10D4) [MIM:612016]	A0A1S3S8N5	271	R	C
Q8NI60	LP/P	Coenzyme Q10 deficiency, primary, 4 (COQ10D4) [MIM:612016]	A0A1S3S8N5	299	R	W
Q8NI60	LP/P	Coenzyme Q10 deficiency, primary, 4 (COQ10D4) [MIM:612016]	A0A1S3S8N5	304	A	T
Q8NI60	LP/P	Coenzyme Q10 deficiency, primary, 4 (COQ10D4) [MIM:612016]	A0A1S3S8N5	304	A	V
Q8NI60	LP/P	Coenzyme Q10 deficiency, primary, 4 (COQ10D4) [MIM:612016]	A0A1S3S8N5	429	Y	C
Q8NI60	LP/P	Coenzyme Q10 deficiency, primary, 4 (COQ10D4) [MIM:612016]	A0A1S3S8N5	602	P	R
P31146	LB/B	-	V9KL47	415	R	K
P31146	LP/P	Immunodeficiency 8 (IMD8) [MIM:615401]	V9KL47	134	V	M
Q9BR76	LB/B	-	S9YJI2	476	R	L
Q92828	LB/B	-	S9Y3Q9	296	R	H
Q92828	LB/B	-	S9Y3Q9	495	R	L
P57737	LB/B	-	A0A1D5PRU5	174	A	V
P57737	LB/B	-	A0A1D5PRU5	193	R	Q
P57737	LB/B	-	A0A1D5PRU5	257	L	S
P57737	LB/B	-	A0A1D5PRU5	403	A	T
Q12887	LP/P	Mitochondrial complex IV deficiency, nuclear type 3 (MC4DN3) [MIM:619046]	G1KU55	196	T	K
Q12887	LP/P	Mitochondrial complex IV deficiency, nuclear type 3 (MC4DN3) [MIM:619046]	G1KU55	204	N	K
Q12887	LP/P	Mitochondrial complex IV deficiency, nuclear type 3 (MC4DN3) [MIM:619046]	G1KU55	225	P	L
Q12887	LP/P	Mitochondrial complex IV deficiency, nuclear type 3 (MC4DN3) [MIM:619046]	G1KU55	336	D	G
Q12887	LP/P	Mitochondrial complex IV deficiency, nuclear type 3 (MC4DN3) [MIM:619046]	G1KU55	336	D	V
Q12887	LB/B	-	G1KU55	28	T	I
Q12887	LB/B	-	G1KU55	62	T	S
Q12887	LB/B	-	G1KU55	97	Y	C
Q12887	LB/B	-	G1KU55	159	R	Q
Q12887	LB/B	-	G1KU55	340	G	D
Q12887	LB/B	-	G1KU55	258	L	H
Q12887	LP/P	Mitochondrial complex IV deficiency, nuclear type 3 (MC4DN3) [MIM:619046]	G1KU55	288	G	R
Q12887	LP/P	Mitochondrial complex IV deficiency, nuclear type 3 (MC4DN3) [MIM:619046]	G1KU55	420	P	L
Q96I36	LP/P	Mitochondrial complex IV deficiency, nuclear type 10 (MC4DN10) [MIM:619053]	L5M1F3	19	M	I
Q7KZN9	LP/P	Mitochondrial complex IV deficiency, nuclear type 6 (MC4DN6) [MIM:615119]	F7CSQ7	217	R	W
Q7KZN9	LP/P	Mitochondrial complex IV deficiency, nuclear type 6 (MC4DN6) [MIM:615119]	F7CSQ7	344	S	P
Q5RI15	LP/P	Mitochondrial complex IV deficiency, nuclear type 11 (MC4DN11) [MIM:619054]	A0A2I2ZXJ9	52	T	P
Q5RI15	LB/B	-	A0A2I2ZXJ9	118	N	S
P13073	LB/B	-	A0A2I2U2Z5	38	Y	F
P13073	LB/B	-	A0A2I2U2Z5	3	A	T
P13073	LP/P	Mitochondrial complex IV deficiency, nuclear type 16 (MC4DN16) [MIM:619060]	A0A2I2U2Z5	152	P	T
Q96KJ9	LB/B	-	G3CJT5	161	R	H
Q96KJ9	LP/P	Exocrine pancreatic insufficiency dyserythropoietic anemia and calvarial hyperostosis (EPIDACH) [MIM:612714]	G3CJT5	138	E	K
P14854	LP/P	Mitochondrial complex IV deficiency, nuclear type 7 (MC4DN7) [MIM:619051]	L5LUZ2	20	R	H
P14854	LP/P	Mitochondrial complex IV deficiency, nuclear type 7 (MC4DN7) [MIM:619051]	L5LUZ2	20	R	C
Q8TF08	LB/B	-	A0A091K3T1	27	H	Q
P00450	LB/B	-	A0A226MNU6	63	I	T
P00450	LB/B	-	A0A226MNU6	477	P	L
P00450	LB/B	-	A0A226MNU6	544	D	E
P00450	LB/B	-	A0A226MNU6	551	T	I
P00450	LB/B	-	A0A226MNU6	793	R	H
P00450	LB/B	-	A0A226MNU6	841	T	R
P00450	LB/B	-	A0A226MNU6	367	R	C
P15085	LB/B	-	G5BH75	208	A	T
P15085	LB/B	-	G5BH75	276	H	R
P48052	LB/B	-	G5BH75	82	E	G
P15088	LB/B	-	W5MLT5	171	T	M
P15088	LB/B	-	W5MLT5	81	A	S
Q9UI42	LB/B	-	W5MLT5	157	P	T
Q9UI42	LB/B	-	W5MLT5	303	G	C
Q9UI42	LB/B	-	W5MLT5	27	L	F
Q9UI42	LB/B	-	W5MLT5	183	R	L
Q8WXQ8	LB/B	-	G5BH75	79	P	S
Q8WXQ8	LB/B	-	G5BH75	336	L	S
Q8WXQ8	LB/B	-	G5BH75	338	E	D
Q8WXQ8	LB/B	-	G5BH75	378	S	G
Q8N4T0	LB/B	-	W5MLT5	45	F	L
Q8N4T0	LB/B	-	W5MLT5	173	S	C
Q8N4T0	LB/B	-	W5MLT5	249	N	S
Q8N4T0	LP/P	Epilepsy, familial temporal lobe, 5 (ETL5) [MIM:614417]	W5MLT5	267	G	R
Q8N4T0	LP/P	Febrile seizures, familial, 11 (FEB11) [MIM:614418]	W5MLT5	270	A	V
Q8IZJ3	LB/B	-	A0A226MUC3	251	R	W
Q8IZJ3	LB/B	-	A0A226MUC3	265	M	T
Q8IZJ3	LB/B	-	A0A226MUC3	294	R	Q
Q8IZJ3	LB/B	-	A0A226MUC3	539	D	E
Q8IZJ3	LB/B	-	A0A226MUC3	546	H	R
Q8IZJ3	LB/B	-	A0A226MUC3	736	P	H
Q8IZJ3	LB/B	-	A0A226MUC3	1156	V	I
Q8IZJ3	LB/B	-	A0A226MUC3	1268	T	I
Q8IZJ3	LB/B	-	A0A226MUC3	1843	Q	R
Q8IZJ3	LP/P	Anterior segment dysgenesis 8 (ASGD8) [MIM:617319]	A0A226MUC3	1404	S	P
P15086	LB/B	-	G5BSK3	208	D	N
Q96IY4	LB/B	-	W5MLT5	347	I	T
Q96IY4	LB/B	-	W5MLT5	169	A	T
O75976	LB/B	-	G1QU52	36	K	E
O75976	LB/B	-	G1QU52	454	E	G
O75976	LB/B	-	G1QU52	505	H	N
O75976	LB/B	-	G1QU52	899	T	I
P16870	LB/B	-	W5MZG2	235	W	R
Q9BZB8	LB/B	-	F6Q2X6	233	M	I
Q8NE35	LB/B	-	G3NEV0	324	R	W
A4D0V7	LB/B	-	A0A091T6C4	326	I	T
A4D0V7	LB/B	-	A0A091T6C4	551	A	G
A4D0V7	LB/B	-	A0A091T6C4	708	E	G
A4D0V7	LB/B	-	A0A091T6C4	949	K	T
Q9BU20	LB/B	-	L5KIY5	86	E	G
Q9BU20	LB/B	-	L5KIY5	161	I	L
P15169	LP/P	Carboxypeptidase N deficiency (CPND) [MIM:212070]	W5MZG2	178	G	D
P22792	LB/B	-	G3IAV7	536	V	M
P22792	LB/B	-	G3IAV7	305	A	T
P22792	LB/B	-	G3IAV7	509	Q	R
Q99829	LB/B	-	V8NHS8	211	Q	R
Q99829	LB/B	-	V8NHS8	347	P	R
Q99829	LB/B	-	V8NHS8	535	P	L
O75131	LB/B	-	A7MBS0	412	T	M
O75131	LB/B	-	A7MBS0	252	E	D
Q9HCH3	LB/B	-	A0A146ZZV6	33	N	S
Q9HCH3	LB/B	-	A0A146ZZV6	582	R	H
Q9UBL6	LB/B	-	A0A060WAW8	77	F	L
Q9UBL6	LB/B	-	A0A060WAW8	633	P	L
Q9UBL6	LB/B	-	A0A060WAW8	397	R	Q
Q9UBL6	LB/B	-	A0A060WAW8	507	K	E
Q8IVL8	LB/B	-	H0XGL7	85	M	I
Q8IVL8	LB/B	-	H0XGL7	134	S	R
Q9BRF8	LB/B	-	A0A0Q5TCK1	19	A	D
Q9BRF8	LB/B	-	A0A0Q5TCK1	86	V	I
Q9BRF8	LB/B	-	A0A0Q5TCK1	241	K	R
Q9BRF8	LB/B	-	A0A0Q5TCK1	290	H	P
Q9Y646	LB/B	-	A0A1W5ASB0	138	S	N
P31327	LB/B	-	A0A2K6PK26	344	T	A
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	544	T	M
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	337	H	R
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	457	V	G
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	810	Q	R
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	843	L	S
P31327	LB/B	-	A0A2K6PK26	875	K	E
P31327	LB/B	-	A0A2K6PK26	1266	F	S
P31327	LB/B	-	A0A2K6PK26	1283	M	L
P31327	LB/B	-	A0A2K6PK26	1376	G	S
P31327	LB/B	-	A0A2K6PK26	1406	T	N
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	850	R	H
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	918	S	P
P31327	LB/B	-	A0A2K6PK26	344	T	S
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	79	G	E
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	212	Y	N
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	280	K	N
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	438	A	P
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	587	R	H
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	593	G	R
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	651	E	K
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	674	N	I
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	780	R	H
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	850	R	C
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	982	G	D
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	1103	Q	R
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	1141	V	G
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	1195	H	P
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	1241	N	K
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	123	S	F
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	471	T	N
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	678	Q	P
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	774	P	L
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	1411	P	L
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	1453	R	Q
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	1453	R	W
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	1491	Y	H
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	301	G	E
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	389	Y	C
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	390	L	R
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	718	R	K
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	721	R	Q
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	724	A	P
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	726	A	T
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	767	D	V
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	792	M	I
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	978	V	E
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	982	G	V
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	984	Y	H
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	986	I	T
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	987	G	C
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	992	F	S
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	1016	N	S
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	1017	P	L
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	1022	T	I
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	1034	E	G
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	1045	H	R
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	1059	Q	R
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	1065	A	E
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	1089	R	C
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	1155	A	E
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	1155	A	V
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	1203	S	L
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	1228	R	Q
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	1255	E	D
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	1262	R	P
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	1262	R	Q
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	1274	D	H
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	1327	C	R
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	1333	G	E
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	1371	R	L
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	1391	T	M
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	1398	L	V
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	1439	P	L
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	1462	P	R
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	589	A	T
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	640	A	S
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	716	N	K
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	803	R	C
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	803	R	G
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	803	R	S
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	805	F	L
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	805	F	S
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	814	R	W
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	816	C	R
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	911	G	E
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	911	G	V
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	913	S	L
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	914	D	G
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	914	D	H
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	932	R	T
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	949	A	T
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	958	L	P
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	959	Y	C
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	962	Y	C
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	982	G	S
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	998	S	F
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	1054	I	R
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	1089	R	L
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	1203	S	P
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	1205	D	N
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	1331	S	P
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	1378	A	T
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	1443	T	A
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	43	A	V
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	58	G	D
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	65	S	F
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	71	V	G
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	87	P	S
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	89	Y	D
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	165	D	G
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	224	D	V
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	233	R	C
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	243	H	P
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	258	G	E
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	263	G	E
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	304	A	V
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	317	G	E
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	358	D	H
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	382	P	L
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	431	G	R
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	432	G	V
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	438	A	T
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	450	K	E
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	498	A	P
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	531	V	E
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	531	V	G
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	587	R	C
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	587	R	L
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	597	S	L
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	622	V	M
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	628	G	D
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	632	I	R
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	638	R	P
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	648	C	Y
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	654	D	V
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	674	N	K
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	698	N	S
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	355	N	D
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	871	T	P
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	937	I	N
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	964	G	D
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	1194	E	D
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	1381	L	S
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	341	L	S
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	661	G	R
P31327	LP/P	Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300]	A0A2K6PK26	1167	T	R
Q9UKF6	LB/B	-	A0A0P5UET1	142	E	G
Q9UKF6	LP/P	Neurodevelopmental disorder with microcephaly, hypotonia, nystagmus, and seizures (NEDMHS) [MIM:619876]	A0A0P5UET1	468	G	E
P23786	LP/P	Carnitine palmitoyltransferase 2 deficiency, myopathic, stress-induced (CPT2D) [MIM:255110]	A0A058ZF16	50	P	H
P23786	LP/P	Carnitine palmitoyltransferase 2 deficiency, myopathic, stress-induced (CPT2D) [MIM:255110]	A0A058ZF16	113	S	L
P23786	LP/P	Carnitine palmitoyltransferase 2 deficiency, myopathic, stress-induced (CPT2D) [MIM:255110]	A0A058ZF16	174	E	K
P23786	LB/B	-	A0A058ZF16	352	F	C
P23786	LB/B	-	A0A058ZF16	368	V	I
P23786	LP/P	Carnitine palmitoyltransferase 2 deficiency, myopathic, stress-induced (CPT2D) [MIM:255110]	A0A058ZF16	383	F	Y
P23786	LP/P	Carnitine palmitoyltransferase 2 deficiency, myopathic, stress-induced (CPT2D) [MIM:255110]	A0A058ZF16	553	D	N
P23786	LP/P	Carnitine palmitoyltransferase 2 deficiency, infantile (CPT2DI) [MIM:600649]	A0A058ZF16	628	Y	S
P23786	LP/P	Carnitine palmitoyltransferase 2 deficiency, infantile (CPT2DI) [MIM:600649]	A0A058ZF16	631	R	C
P23786	LP/P	Carnitine palmitoyltransferase 2 deficiency, myopathic, stress-induced (CPT2D) [MIM:255110]	A0A058ZF16	631	R	C
P23786	LB/B	-	A0A058ZF16	647	M	V
P23786	LP/P	Carnitine palmitoyltransferase 2 deficiency, myopathic, stress-induced (CPT2D) [MIM:255110]	A0A058ZF16	214	M	T
P23786	LP/P	Carnitine palmitoyltransferase 2 deficiency, myopathic, stress-induced (CPT2D) [MIM:255110]	A0A058ZF16	227	P	L
P23786	LP/P	Carnitine palmitoyltransferase 2 deficiency, myopathic, stress-induced (CPT2D) [MIM:255110]	A0A058ZF16	448	F	L
P23786	LP/P	Carnitine palmitoyltransferase 2 deficiency, myopathic, stress-induced (CPT2D) [MIM:255110]	A0A058ZF16	479	Y	F
P23786	LP/P	Carnitine palmitoyltransferase 2 deficiency, myopathic, stress-induced (CPT2D) [MIM:255110]	A0A058ZF16	503	R	C
P23786	LP/P	Carnitine palmitoyltransferase 2 deficiency, myopathic, stress-induced (CPT2D) [MIM:255110]	A0A058ZF16	549	G	D
P23786	LB/B	-	A0A058ZF16	588	S	C
P23786	LP/P	Carnitine palmitoyltransferase 2 deficiency, myopathic, stress-induced (CPT2D) [MIM:255110]	A0A058ZF16	151	R	Q
P23786	LP/P	Carnitine palmitoyltransferase 2 deficiency, myopathic, stress-induced (CPT2D) [MIM:255110]	A0A058ZF16	210	Y	D
P23786	LP/P	Carnitine palmitoyltransferase 2 deficiency, myopathic, stress-induced (CPT2D) [MIM:255110]	A0A058ZF16	296	R	Q
P23786	LP/P	Carnitine palmitoyltransferase 2 deficiency, myopathic, stress-induced (CPT2D) [MIM:255110]	A0A058ZF16	550	Q	R
P23786	LP/P	Carnitine palmitoyltransferase 2 deficiency, myopathic, stress-induced (CPT2D) [MIM:255110]	A0A058ZF16	600	G	R
P23786	LP/P	Carnitine palmitoyltransferase 2 deficiency, myopathic, stress-induced (CPT2D) [MIM:255110]	A0A058ZF16	604	P	S
P23786	LP/P	Carnitine palmitoyltransferase 2 deficiency, myopathic, stress-induced (CPT2D) [MIM:255110]	A0A058ZF16	213	D	G
P23786	LB/B	-	A0A058ZF16	504	P	L
P23786	LB/B	-	A0A058ZF16	605	V	L
Q9H3G5	LB/B	-	A0A091DMN8	435	A	V
Q9H3G5	LB/B	-	A0A091DMN8	11	S	L
Q9H3G5	LB/B	-	A0A091DMN8	25	R	H
Q9H3G5	LB/B	-	A0A091DMN8	398	R	H
Q8N123	LB/B	-	A0A1S3ANX4	3	Y	S
Q8N123	LB/B	-	A0A1S3ANX4	131	R	H
P17927	LB/B	-	G1QKA7	1208	H	R
P17927	LB/B	-	G1QKA7	1408	T	I
P17927	LB/B	-	G1QKA7	1590	K	E
P17927	LB/B	-	G1QKA7	1601	R	G
P17927	LB/B	-	G1QKA7	1610	S	T
P17927	LB/B	-	G1QKA7	1615	I	V
P17927	LB/B	-	G1QKA7	1827	P	R
P17927	LB/B	-	G1QKA7	1850	H	D
P17927	LB/B	-	G1QKA7	1408	T	M
P17927	LB/B	-	G1QKA7	1540	N	S
P17927	LB/B	-	G1QKA7	1969	T	A
Q2VPA4	LB/B	-	G3QLR1	116	R	G
Q2VPA4	LB/B	-	G3QLR1	139	I	V
Q2VPA4	LB/B	-	G3QLR1	402	N	D
Q2VPA4	LB/B	-	G3QLR1	455	I	V
Q2VPA4	LB/B	-	G3QLR1	491	L	P
Q6ZU35	LB/B	-	A0A099YS58	269	L	I
Q6ZU35	LB/B	-	A0A099YS58	655	R	P
Q6ZU35	LB/B	-	A0A099YS58	710	R	Q
Q6ZU35	LB/B	-	A0A099YS58	776	S	L
Q6ZU35	LB/B	-	A0A099YS58	249	E	Q
Q9BSW2	LB/B	-	G1N9Z1	7	R	G
Q9BSW2	LB/B	-	G1N9Z1	98	A	T
Q9BSW2	LB/B	-	G1N9Z1	128	A	V
Q9BSW2	LB/B	-	G1N9Z1	136	H	P
Q9BSW2	LB/B	-	G1N9Z1	154	E	K
Q9BSW2	LB/B	-	G1N9Z1	212	H	Q
P78560	LP/P	Intellectual developmental disorder, autosomal recessive 34, with variant lissencephaly (MRT34) [MIM:614499]	A0A1S2ZR55	128	G	R
P43155	LB/B	-	J9P075	372	L	M
P43155	LB/B	-	J9P075	624	A	P
P82279	LP/P	Retinitis pigmentosa 12 (RP12) [MIM:600105]	H0Z9G5	161	A	V
P82279	LP/P	Retinitis pigmentosa 12 (RP12) [MIM:600105]	H0Z9G5	250	C	W
P82279	LP/P	Leber congenital amaurosis 8 (LCA8) [MIM:613835]	H0Z9G5	745	T	M
P82279	LP/P	Retinitis pigmentosa 12 (RP12) [MIM:600105]	H0Z9G5	745	T	M
P82279	LP/P	Leber congenital amaurosis 8 (LCA8) [MIM:613835]	H0Z9G5	764	R	C
P82279	LP/P	Retinitis pigmentosa 12 (RP12) [MIM:600105]	H0Z9G5	764	R	C
P82279	LP/P	Leber congenital amaurosis 8 (LCA8) [MIM:613835]	H0Z9G5	948	C	Y
P82279	LP/P	Retinitis pigmentosa 12 (RP12) [MIM:600105]	H0Z9G5	948	C	Y
P82279	LP/P	Retinitis pigmentosa 12 (RP12) [MIM:600105]	H0Z9G5	1041	M	T
P82279	LP/P	Retinitis pigmentosa 12 (RP12) [MIM:600105]	H0Z9G5	1071	L	P
P82279	LP/P	Leber congenital amaurosis 8 (LCA8) [MIM:613835]	H0Z9G5	1100	I	R
P82279	LP/P	Retinitis pigmentosa 12 (RP12) [MIM:600105]	H0Z9G5	1181	C	R
P82279	LP/P	Leber congenital amaurosis 8 (LCA8) [MIM:613835]	H0Z9G5	144	F	V
P82279	LP/P	Pigmented paravenous chorioretinal atrophy (PPCRA) [MIM:172870]	H0Z9G5	162	V	M
P82279	LP/P	Retinitis pigmentosa 12 (RP12) [MIM:600105]	H0Z9G5	195	C	F
P82279	LB/B	-	H0Z9G5	289	T	M
P82279	LP/P	Leber congenital amaurosis 8 (LCA8) [MIM:613835]	H0Z9G5	383	C	Y
P82279	LP/P	Retinitis pigmentosa 12 (RP12) [MIM:600105]	H0Z9G5	433	Y	C
P82279	LP/P	Leber congenital amaurosis 8 (LCA8) [MIM:613835]	H0Z9G5	480	C	G
P82279	LP/P	Leber congenital amaurosis 8 (LCA8) [MIM:613835]	H0Z9G5	480	C	R
P82279	LP/P	Retinitis pigmentosa 12 (RP12) [MIM:600105]	H0Z9G5	578	V	E
P82279	LP/P	Leber congenital amaurosis 8 (LCA8) [MIM:613835]	H0Z9G5	584	D	Y
P82279	LP/P	Retinitis pigmentosa 12 (RP12) [MIM:600105]	H0Z9G5	587	C	Y
P82279	LB/B	-	H0Z9G5	679	Q	E
P82279	LP/P	Leber congenital amaurosis 8 (LCA8) [MIM:613835]	H0Z9G5	681	C	Y
P82279	LP/P	Leber congenital amaurosis 8 (LCA8) [MIM:613835]	H0Z9G5	710	E	Q
P82279	LP/P	Leber congenital amaurosis 8 (LCA8) [MIM:613835]	H0Z9G5	741	M	T
P82279	LB/B	-	H0Z9G5	769	R	H
P82279	LB/B	-	H0Z9G5	769	R	Q
P82279	LP/P	Retinitis pigmentosa 12 (RP12) [MIM:600105]	H0Z9G5	836	P	T
P82279	LP/P	Retinitis pigmentosa 12 (RP12) [MIM:600105]	H0Z9G5	837	D	H
P82279	LP/P	Retinitis pigmentosa 12 (RP12) [MIM:600105]	H0Z9G5	846	G	R
P82279	LP/P	Leber congenital amaurosis 8 (LCA8) [MIM:613835]	H0Z9G5	850	G	S
P82279	LP/P	Retinitis pigmentosa 12 (RP12) [MIM:600105]	H0Z9G5	850	G	S
P82279	LP/P	Leber congenital amaurosis 8 (LCA8) [MIM:613835]	H0Z9G5	852	I	T
P82279	LP/P	Retinitis pigmentosa 12 (RP12) [MIM:600105]	H0Z9G5	891	C	G
P82279	LB/B	-	H0Z9G5	905	R	Q
P82279	LP/P	Retinitis pigmentosa 12 (RP12) [MIM:600105]	H0Z9G5	986	N	I
P82279	LP/P	Leber congenital amaurosis 8 (LCA8) [MIM:613835]	H0Z9G5	989	I	T
P82279	LP/P	Leber congenital amaurosis 8 (LCA8) [MIM:613835]	H0Z9G5	1025	S	I
P82279	LP/P	Retinitis pigmentosa 12 (RP12) [MIM:600105]	H0Z9G5	1100	I	T
P82279	LP/P	Leber congenital amaurosis 8 (LCA8) [MIM:613835]	H0Z9G5	1103	G	R
P82279	LP/P	Retinitis pigmentosa 12 (RP12) [MIM:600105]	H0Z9G5	1103	G	R
P82279	LP/P	Leber congenital amaurosis 8 (LCA8) [MIM:613835]	H0Z9G5	1107	L	P
P82279	LP/P	Leber congenital amaurosis 8 (LCA8) [MIM:613835]	H0Z9G5	1107	L	R
P82279	LP/P	Retinitis pigmentosa 12 (RP12) [MIM:600105]	H0Z9G5	1107	L	R
P82279	LP/P	Leber congenital amaurosis 8 (LCA8) [MIM:613835]	H0Z9G5	1205	G	R
P82279	LP/P	Leber congenital amaurosis 8 (LCA8) [MIM:613835]	H0Z9G5	1218	C	F
P82279	LP/P	Leber congenital amaurosis 8 (LCA8) [MIM:613835]	H0Z9G5	1317	N	H
P82279	LP/P	Leber congenital amaurosis 8 (LCA8) [MIM:613835]	H0Z9G5	1321	C	S
P82279	LB/B	-	H0Z9G5	1331	R	H
P82279	LP/P	Retinitis pigmentosa 12 (RP12) [MIM:600105]	H0Z9G5	1354	A	T
P82279	LP/P	Retinitis pigmentosa 12 (RP12) [MIM:600105]	H0Z9G5	1383	R	H
P82279	LP/P	Retinitis pigmentosa 12 (RP12) [MIM:600105]	H0Z9G5	27	C	F
P82279	LP/P	Retinitis pigmentosa 12 (RP12) [MIM:600105]	H0Z9G5	1165	C	W
P82279	LP/P	Retinitis pigmentosa 12 (RP12) [MIM:600105]	H0Z9G5	45	C	W
P82279	LP/P	Retinitis pigmentosa 12 (RP12) [MIM:600105]	H0Z9G5	157	C	S
P82279	LB/B	-	H0Z9G5	222	E	K
P82279	LP/P	-	H0Z9G5	310	C	Y
P82279	LP/P	Retinitis pigmentosa 12 (RP12) [MIM:600105]	H0Z9G5	312	N	K
P82279	LP/P	Leber congenital amaurosis 8 (LCA8) [MIM:613835]	H0Z9G5	333	G	D
P82279	LP/P	Leber congenital amaurosis 8 (LCA8) [MIM:613835]	H0Z9G5	438	C	Y
P82279	LP/P	Leber congenital amaurosis 8 (LCA8) [MIM:613835]	H0Z9G5	454	G	R
P82279	LB/B	-	H0Z9G5	488	F	S
P82279	LP/P	Leber congenital amaurosis 8 (LCA8) [MIM:613835]	H0Z9G5	535	L	P
P82279	LP/P	Leber congenital amaurosis 8 (LCA8) [MIM:613835]	H0Z9G5	564	D	Y
P82279	LP/P	Retinitis pigmentosa 12 (RP12) [MIM:600105]	H0Z9G5	675	W	C
P82279	LP/P	Retinitis pigmentosa 12 (RP12) [MIM:600105]	H0Z9G5	710	E	V
P82279	LP/P	Retinitis pigmentosa 12 (RP12) [MIM:600105]	H0Z9G5	740	S	F
P82279	LP/P	Leber congenital amaurosis 8 (LCA8) [MIM:613835]	H0Z9G5	753	L	P
P82279	LB/B	-	H0Z9G5	821	T	M
P82279	LP/P	Leber congenital amaurosis 8 (LCA8) [MIM:613835]	H0Z9G5	939	C	Y
P82279	LP/P	Leber congenital amaurosis 8 (LCA8) [MIM:613835]	H0Z9G5	1003	I	T
P82279	LP/P	Retinitis pigmentosa 12 (RP12) [MIM:600105]	H0Z9G5	1012	L	S
P82279	LP/P	Retinitis pigmentosa 12 (RP12) [MIM:600105]	H0Z9G5	1025	S	N
P82279	LP/P	Retinitis pigmentosa 12 (RP12) [MIM:600105]	H0Z9G5	1099	T	K
P82279	LP/P	Leber congenital amaurosis 8 (LCA8) [MIM:613835]	H0Z9G5	1161	Y	C
P82279	LP/P	Leber congenital amaurosis 8 (LCA8) [MIM:613835]	H0Z9G5	1174	C	G
P82279	LP/P	Retinitis pigmentosa 12 (RP12) [MIM:600105]	H0Z9G5	1174	C	G
P82279	LP/P	-	H0Z9G5	1198	Y	C
P82279	LP/P	-	H0Z9G5	1223	C	S
P82279	LP/P	Retinitis pigmentosa 12 (RP12) [MIM:600105]	H0Z9G5	1305	P	L
P82279	LP/P	Leber congenital amaurosis 8 (LCA8) [MIM:613835]	H0Z9G5	1332	C	F
P82279	LP/P	-	H0Z9G5	1365	A	D
P82279	LP/P	Leber congenital amaurosis 8 (LCA8) [MIM:613835]	H0Z9G5	1381	P	L
P82279	LP/P	Retinitis pigmentosa 12 (RP12) [MIM:600105]	H0Z9G5	534	K	N
P82279	LP/P	-	H0Z9G5	479	L	P
P82279	LP/P	-	H0Z9G5	921	A	P
P82279	LP/P	Leber congenital amaurosis 8 (LCA8) [MIM:613835]	H0Z9G5	948	C	R
P82279	LP/P	-	H0Z9G5	1031	D	N
Q5IJ48	LB/B	-	H0Z9G5	46	P	L
Q5IJ48	LB/B	-	H0Z9G5	97	V	L
Q5IJ48	LB/B	-	H0Z9G5	116	P	L
Q5IJ48	LB/B	-	H0Z9G5	145	M	T
Q5IJ48	LB/B	-	H0Z9G5	159	G	A
Q5IJ48	LB/B	-	H0Z9G5	187	E	D
Q5IJ48	LB/B	-	H0Z9G5	351	A	T
Q5IJ48	LB/B	-	H0Z9G5	534	R	Q
Q5IJ48	LB/B	-	H0Z9G5	610	R	W
Q5IJ48	LB/B	-	H0Z9G5	746	H	Q
Q5IJ48	LB/B	-	H0Z9G5	1110	T	M
Q5IJ48	LB/B	-	H0Z9G5	90	T	N
Q5IJ48	LB/B	-	H0Z9G5	709	V	A
Q5IJ48	LP/P	Focal segmental glomerulosclerosis 9 (FSGS9) [MIM:616220]	H0Z9G5	620	C	S
Q5IJ48	LP/P	Focal segmental glomerulosclerosis 9 (FSGS9) [MIM:616220]	H0Z9G5	628	R	C
Q5IJ48	LP/P	Focal segmental glomerulosclerosis 9 (FSGS9) [MIM:616220]	H0Z9G5	629	C	S
Q5IJ48	LP/P	Ventriculomegaly with cystic kidney disease (VMCKD) [MIM:219730]	H0Z9G5	633	R	W
Q5IJ48	LP/P	Focal segmental glomerulosclerosis 9 (FSGS9) [MIM:616220]	H0Z9G5	1249	R	Q
Q96SW2	LP/P	Intellectual developmental disorder, autosomal recessive 2 (MRT2) [MIM:607417]	T1JIH3	391	C	R
Q9UGL9	LB/B	-	G1QBD5	96	C	Y
P16220	LB/B	-	K7GBZ8	102	D	G
Q70SY1	LB/B	-	A0A093FYD8	130	V	I
Q68CJ9	LB/B	-	A0A091DEZ3	105	G	R
Q68CJ9	LP/P	Hypertriglyceridemia 2 (HYTG2) [MIM:619324]	A0A091DEZ3	240	E	K
Q8TEY5	LB/B	-	A0A1S3F296	95	P	S
Q96HD1	LP/P	Atrioventricular septal defect 2 (AVSD2) [MIM:606217]	A0A2K5D8V0	107	R	H
Q96HD1	LP/P	Atrioventricular septal defect 2 (AVSD2) [MIM:606217]	A0A2K5D8V0	162	P	A
Q96HD1	LP/P	Atrioventricular septal defect 2 (AVSD2) [MIM:606217]	A0A2K5D8V0	311	T	I
Q96HD1	LP/P	Atrioventricular septal defect 2 (AVSD2) [MIM:606217]	A0A2K5D8V0	329	R	C
Q96HD1	LB/B	-	A0A2K5D8V0	13	M	V
Q96HD1	LB/B	-	A0A2K5D8V0	128	P	R
Q6UXH1	LB/B	-	A0A2Y9KPH3	182	D	E
Q6UXH1	LB/B	-	A0A2Y9KPH3	295	S	A
Q6UXH1	LB/B	-	A0A2Y9KPH3	325	E	G
Q03060	LB/B	-	A0A1V4KLS3	254	Q	R
Q13324	LB/B	-	A0A2Y9PCV2	220	E	D
Q9NZV1	LB/B	-	A0A1D5P8H3	502	E	K
Q9NZV1	LB/B	-	A0A1D5P8H3	781	V	I
P16562	LB/B	-	G1TFA5	131	N	S
P54108	LB/B	-	A0A2K6GG24	106	S	P
P54108	LB/B	-	A0A2K6GG24	134	A	S
O75462	LP/P	Crisponi/Cold-induced sweating syndrome 1 (CISS1) [MIM:272430]	A0A2Y9TKY5	81	R	H
O75462	LP/P	Crisponi/Cold-induced sweating syndrome 1 (CISS1) [MIM:272430]	A0A2Y9TKY5	374	L	R
O75462	LB/B	-	A0A2Y9TKY5	176	R	K
O75462	LP/P	Crisponi/Cold-induced sweating syndrome 1 (CISS1) [MIM:272430]	A0A2Y9TKY5	76	W	G
O75462	LP/P	Crisponi/Cold-induced sweating syndrome 1 (CISS1) [MIM:272430]	A0A2Y9TKY5	74	L	P
O75462	LP/P	Crisponi/Cold-induced sweating syndrome 1 (CISS1) [MIM:272430]	A0A2Y9TKY5	75	Y	D
O75462	LP/P	Crisponi/Cold-induced sweating syndrome 1 (CISS1) [MIM:272430]	A0A2Y9TKY5	113	N	I
O75462	LP/P	Crisponi/Cold-induced sweating syndrome 1 (CISS1) [MIM:272430]	A0A2Y9TKY5	114	L	P
O75462	LP/P	Crisponi/Cold-induced sweating syndrome 1 (CISS1) [MIM:272430]	A0A2Y9TKY5	138	P	L
O75462	LP/P	Crisponi/Cold-induced sweating syndrome 1 (CISS1) [MIM:272430]	A0A2Y9TKY5	145	S	P
O75462	LP/P	Crisponi/Cold-induced sweating syndrome 1 (CISS1) [MIM:272430]	A0A2Y9TKY5	216	R	C
O75462	LP/P	Crisponi/Cold-induced sweating syndrome 1 (CISS1) [MIM:272430]	A0A2Y9TKY5	268	F	S
O75462	LP/P	Crisponi/Cold-induced sweating syndrome 1 (CISS1) [MIM:272430]	A0A2Y9TKY5	284	W	C
O75462	LP/P	Crisponi/Cold-induced sweating syndrome 1 (CISS1) [MIM:272430]	A0A2Y9TKY5	312	R	P
O75462	LP/P	Crisponi/Cold-induced sweating syndrome 1 (CISS1) [MIM:272430]	A0A2Y9TKY5	340	R	C
Q8IUI8	LB/B	-	H3BBR5	389	L	P
Q8IUI8	LB/B	-	H3BBR5	202	V	M
Q14194	LB/B	-	L9KUG1	461	V	I
Q9BZJ0	LB/B	-	G1T9K0	35	G	R
Q9BZJ0	LB/B	-	G1T9K0	51	F	L
Q9BZJ0	LB/B	-	G1T9K0	111	Q	H
Q9BZJ0	LB/B	-	G1T9K0	158	T	A
Q9BZJ0	LB/B	-	G1T9K0	843	V	I
Q9UBG3	LB/B	-	A0A212CH91	27	A	V
Q9UBG3	LB/B	-	A0A212CH91	374	Q	H
Q9UBG3	LP/P	Esophageal cancer (ESCR) [MIM:133239]	A0A212CH91	480	G	S
Q5TZA2	LB/B	-	A0A1U7S042	439	A	V
Q5TZA2	LB/B	-	A0A1U7S042	586	D	H
Q5TZA2	LB/B	-	A0A1U7S042	1097	R	P
Q5TZA2	LB/B	-	A0A1U7S042	7	G	R
Q5TZA2	LB/B	-	A0A1U7S042	372	R	Q
Q5TZA2	LB/B	-	A0A1U7S042	1216	R	W
Q5TZA2	LB/B	-	A0A1U7S042	1866	R	C
Q6UUV9	LB/B	-	A0A093BKJ9	286	T	A
Q6UUV9	LB/B	-	A0A093BKJ9	311	V	I
Q6UUV9	LB/B	-	A0A093BKJ9	328	T	A
Q53ET0	LB/B	-	A0A061IQI8	147	M	V
Q53ET0	LB/B	-	A0A061IQI8	379	R	C
Q6UUV7	LB/B	-	F1PL33	72	S	N
Q6UUV7	LB/B	-	F1PL33	346	L	S
O43186	LP/P	Cone-rod dystrophy 2 (CORD2) [MIM:120970]	A0A2D0PYF0	41	R	W
O43186	LP/P	Cone-rod dystrophy 2 (CORD2) [MIM:120970]	A0A2D0PYF0	80	E	A
O43186	LP/P	Retinitis pigmentosa (RP) [MIM:268000]	A0A2D0PYF0	41	R	Q
O43186	LB/B	-	A0A2D0PYF0	158	A	T
O43186	LP/P	Cone-rod dystrophy 2 (CORD2) [MIM:120970]	A0A2D0PYF0	242	V	M
O43186	LB/B	-	A0A2D0PYF0	122	G	D
O43186	LP/P	Leber congenital amaurosis 7 (LCA7) [MIM:613829]	A0A2D0PYF0	90	R	W
O43186	LP/P	Leber congenital amaurosis 7 (LCA7) [MIM:613829]	A0A2D0PYF0	88	K	N
O43186	LB/B	-	A0A2D0PYF0	154	T	A
O43186	LB/B	-	A0A2D0PYF0	10	H	D
O43186	LB/B	-	A0A2D0PYF0	66	V	I
P02511	LP/P	Myopathy, myofibrillar, 2 (MFM2) [MIM:608810]	S9XYV9	120	R	G
P02511	LB/B	-	S9XYV9	41	S	Y
P02511	LB/B	-	S9XYV9	51	P	L
P02511	LP/P	Myopathy, myofibrillar, 2 (MFM2) [MIM:608810]	S9XYV9	109	D	H
P02511	LP/P	Cardiomyopathy, dilated 1II (CMD1II) [MIM:615184]	S9XYV9	154	G	S
P02511	LP/P	Cardiomyopathy, dilated 1II (CMD1II) [MIM:615184]	S9XYV9	157	R	H
P02511	LP/P	-	S9XYV9	109	D	G
P53672	LP/P	Cataract 42 (CTRCT42) [MIM:115900]	A0A0P7USE7	50	V	M
P53672	LB/B	-	A0A0P7USE7	7	P	S
P53673	LB/B	-	A0A061I9L7	84	T	M
P53673	LP/P	Cataract 23, multiple types (CTRCT23) [MIM:610425]	A0A061I9L7	69	L	P
P53673	LP/P	Cataract 23, multiple types (CTRCT23) [MIM:610425]	A0A061I9L7	94	F	S
P53673	LB/B	-	A0A061I9L7	36	V	M
P53673	LP/P	Cataract 23, multiple types (CTRCT23) [MIM:610425]	A0A061I9L7	64	G	W
P43320	LB/B	-	S9WXY6	65	A	S
Q8N1P7	LB/B	-	E7ET48	1294	S	N
Q68DQ2	LB/B	-	A0A1U8C2D8	2381	R	H
Q68DQ2	LB/B	-	A0A1U8C2D8	2709	Y	C
Q68DQ2	LB/B	-	A0A1U8C2D8	2874	N	H
P11844	LB/B	-	I3K815	148	P	L
P07316	LB/B	-	I3K815	73	S	I
P07316	LB/B	-	I3K815	111	I	L
P07316	LB/B	-	I3K815	90	R	T
P07315	LP/P	Cataract 2, multiple types (CTRCT2) [MIM:604307]	I3K815	5	T	P
P07315	LB/B	-	I3K815	48	R	H
P07315	LB/B	-	I3K815	6	F	L
P07315	LP/P	Cataract 2, multiple types (CTRCT2) [MIM:604307]	I3K815	129	G	C
P07320	LP/P	Cataract 4, multiple types (CTRCT4) [MIM:115700]	I3K815	15	R	C
P07320	LP/P	Cataract 4, multiple types (CTRCT4) [MIM:115700]	I3K815	37	R	S
P07320	LP/P	Cataract 4, multiple types (CTRCT4) [MIM:115700]	I3K815	59	R	H
P07320	LB/B	-	I3K815	102	M	V
P07320	LP/P	Cataract 4, multiple types (CTRCT4) [MIM:115700]	I3K815	24	P	S
P07320	LP/P	Cataract 4, multiple types (CTRCT4) [MIM:115700]	I3K815	107	E	A
P07320	LP/P	Cataract 4, multiple types (CTRCT4) [MIM:115700]	I3K815	43	W	R
P22914	LP/P	Cataract 20, multiple types (CTRCT20) [MIM:116100]	A0A091DQ34	18	G	V
Q14894	LP/P	Deafness, autosomal dominant, 40 (DFNA40) [MIM:616357]	A0A0Q3XAB7	314	K	T
O95825	LB/B	-	A0A146NMH8	39	A	T
P55060	LB/B	-	L9L9Z1	754	I	V
P55060	LB/B	-	L9L9Z1	968	V	L
P07333	LB/B	-	Q2PP56	969	Y	C
P07333	LB/B	-	Q2PP56	32	V	G
P07333	LB/B	-	Q2PP56	362	H	R
P07333	LB/B	-	Q2PP56	413	G	S
P07333	LB/B	-	Q2PP56	536	L	V
P07333	LB/B	-	Q2PP56	920	E	D
P07333	LB/B	-	Q2PP56	921	R	Q
P07333	LB/B	-	Q2PP56	279	V	M
P07333	LB/B	-	Q2PP56	245	A	S
P07333	LP/P	Leukoencephalopathy, hereditary diffuse, with spheroids 1 (HDLS1) [MIM:221820]	Q2PP56	589	G	E
P07333	LP/P	Leukoencephalopathy, hereditary diffuse, with spheroids 1 (HDLS1) [MIM:221820]	Q2PP56	633	E	K
P07333	LB/B	-	Q2PP56	710	R	H
P07333	LB/B	-	Q2PP56	747	G	R
P07333	LP/P	Leukoencephalopathy, hereditary diffuse, with spheroids 1 (HDLS1) [MIM:221820]	Q2PP56	766	M	T
P07333	LP/P	Leukoencephalopathy, hereditary diffuse, with spheroids 1 (HDLS1) [MIM:221820]	Q2PP56	770	A	P
P07333	LP/P	Leukoencephalopathy, hereditary diffuse, with spheroids 1 (HDLS1) [MIM:221820]	Q2PP56	775	I	N
P07333	LP/P	Leukoencephalopathy, hereditary diffuse, with spheroids 1 (HDLS1) [MIM:221820]	Q2PP56	794	I	T
P07333	LP/P	Leukoencephalopathy, hereditary diffuse, with spheroids 1 (HDLS1) [MIM:221820]	Q2PP56	837	D	Y
P07333	LP/P	Leukoencephalopathy, hereditary diffuse, with spheroids 1 (HDLS1) [MIM:221820]	Q2PP56	849	F	S
P07333	LP/P	Leukoencephalopathy, hereditary diffuse, with spheroids 1 (HDLS1) [MIM:221820]	Q2PP56	868	L	P
P07333	LP/P	Leukoencephalopathy, hereditary diffuse, with spheroids 1 (HDLS1) [MIM:221820]	Q2PP56	875	M	T
P07333	LP/P	Leukoencephalopathy, hereditary diffuse, with spheroids 1 (HDLS1) [MIM:221820]	Q2PP56	878	P	T
P07333	LP/P	Leukoencephalopathy, hereditary diffuse, with spheroids 1 (HDLS1) [MIM:221820]	Q2PP56	653	C	R
P07333	LP/P	Leukoencephalopathy, hereditary diffuse, with spheroids 1 (HDLS1) [MIM:221820]	Q2PP56	843	I	F
P07333	LP/P	Leukoencephalopathy, hereditary diffuse, with spheroids 1 (HDLS1) [MIM:221820]	Q2PP56	906	I	T
P07333	LP/P	Brain abnormalities, neurodegeneration, and dysosteosclerosis (BANDDOS) [MIM:618476]	Q2PP56	132	P	L
P07333	LP/P	Brain abnormalities, neurodegeneration, and dysosteosclerosis (BANDDOS) [MIM:618476]	Q2PP56	643	H	Q
P07333	LP/P	Leukoencephalopathy, hereditary diffuse, with spheroids 1 (HDLS1) [MIM:221820]	Q2PP56	765	G	D
P07333	LP/P	Leukoencephalopathy, hereditary diffuse, with spheroids 1 (HDLS1) [MIM:221820]	Q2PP56	781	A	E
P07333	LP/P	Leukoencephalopathy, hereditary diffuse, with spheroids 1 (HDLS1) [MIM:221820]	Q2PP56	782	R	H
P07333	LP/P	Leukoencephalopathy, hereditary diffuse, with spheroids 1 (HDLS1) [MIM:221820]	Q2PP56	824	P	S
P15509	LP/P	Pulmonary surfactant metabolism dysfunction 4 (SMDP4) [MIM:300770]	A0A2Y9RUA9	196	G	R
P32927	LB/B	-	L5KF02	603	P	T
P32927	LB/B	-	L5KF02	647	G	V
P32927	LB/B	-	L5KF02	652	V	M
P32927	LB/B	-	L5KF02	249	E	Q
P32927	LB/B	-	L5KF02	696	P	S
P09919	LB/B	-	L5JTJ0	157	L	M
P09919	LB/B	-	L5JTJ0	174	A	T
Q99062	LB/B	-	M7BAB9	231	M	T
Q99062	LB/B	-	M7BAB9	320	D	N
Q99062	LB/B	-	M7BAB9	346	Q	R
Q99062	LB/B	-	M7BAB9	405	E	K
Q99062	LB/B	-	M7BAB9	440	R	Q
Q99062	LB/B	-	M7BAB9	510	D	H
Q99062	LB/B	-	M7BAB9	562	Y	H
Q99062	LB/B	-	M7BAB9	583	R	C
Q99062	LP/P	-	M7BAB9	229	P	H
Q99062	LP/P	Hereditary neutrophilia (NEUTROPHILIA) [MIM:162830]	M7BAB9	640	T	N
Q99062	LP/P	Neutropenia, severe congenital 7, autosomal recessive (SCN7) [MIM:617014]	M7BAB9	308	R	C
Q8TDX6	LB/B	-	A0A146ZML8	137	V	I
Q8TDX6	LB/B	-	A0A146ZML8	473	F	Y
Q8TDX6	LB/B	-	A0A146ZML8	193	S	N
Q8TDX6	LP/P	Skeletal dysplasia, mild, with joint laxity and advanced bone age (SDJLABA) [MIM:618870]	A0A146ZML8	384	P	R
Q8TDX6	LP/P	Skeletal dysplasia, mild, with joint laxity and advanced bone age (SDJLABA) [MIM:618870]	A0A146ZML8	264	N	S
Q8TDX6	LP/P	Skeletal dysplasia, mild, with joint laxity and advanced bone age (SDJLABA) [MIM:618870]	A0A146ZML8	432	D	Y
Q8N6G5	LB/B	-	A0A146ZML8	215	E	K
Q8N6G5	LB/B	-	A0A146ZML8	479	P	S
Q14406	LB/B	-	F7H8S0	141	D	E
P41240	LB/B	-	A0A091E3Q0	287	G	D
P41240	LB/B	-	A0A091E3Q0	398	R	Q
P41240	LB/B	-	A0A091E3Q0	442	H	R
P41240	LB/B	-	A0A091E3Q0	45	P	L
A8MUP2	LB/B	-	F6Z7E7	125	G	S
Q96PZ7	LB/B	-	A0A1L8H821	3311	G	W
Q96PZ7	LB/B	-	A0A1L8H821	2040	M	I
Q96PZ7	LB/B	-	A0A1L8H821	3369	Q	H
Q96PZ7	LB/B	-	A0A1L8H821	3478	S	N
Q96PZ7	LB/B	-	A0A1L8H821	2260	P	A
Q96PZ7	LB/B	-	A0A1L8H821	3539	Y	C
Q7Z408	LB/B	-	A0A1L8H821	538	H	R
Q7Z408	LB/B	-	A0A1L8H821	167	L	P
Q7Z408	LB/B	-	A0A1L8H821	2096	R	K
Q7Z408	LB/B	-	A0A1L8H821	2117	A	V
Q7Z408	LB/B	-	A0A1L8H821	2554	M	V
Q7Z408	LB/B	-	A0A1L8H821	2661	L	R
Q7Z408	LB/B	-	A0A1L8H821	3406	S	F
Q7Z408	LB/B	-	A0A1L8H821	2661	L	V
Q7Z407	LB/B	-	A0A1L8H821	219	I	M
Q7Z407	LB/B	-	A0A1L8H821	3000	V	L
Q7Z407	LB/B	-	A0A1L8H821	3621	N	H
Q8N752	LB/B	-	A0A2D4Q772	170	R	S
Q8N752	LB/B	-	A0A2D4Q772	5	S	G
Q8N752	LB/B	-	A0A2D4Q772	21	R	W
Q8N752	LB/B	-	A0A2D4Q772	42	D	E
Q8N752	LB/B	-	A0A2D4Q772	177	E	K
Q8N752	LB/B	-	A0A2D4Q772	220	P	L
Q8N752	LB/B	-	A0A2D4Q772	230	K	N
Q8N752	LB/B	-	A0A2D4Q772	257	A	T
P78368	LB/B	-	A0A1A8F9X6	189	F	L
P78368	LB/B	-	A0A1A8F9X6	194	E	G
P78368	LB/B	-	A0A1A8F9X6	196	I	T
P78368	LB/B	-	A0A1A8F9X6	206	Y	C
P78368	LB/B	-	A0A1A8F9X6	206	Y	H
P78368	LB/B	-	A0A1A8F9X6	207	R	S
P78368	LB/B	-	A0A1A8F9X6	208	E	Q
P78368	LB/B	-	A0A1A8F9X6	217	R	C
P78368	LB/B	-	A0A1A8F9X6	223	T	M
P19784	LB/B	-	A0A0B7AHR9	188	E	A
Q6UVK1	LB/B	-	H2L8T3	1703	R	H
O95196	LB/B	-	A0A1S3G427	188	G	V
O95196	LB/B	-	A0A1S3G427	417	T	P
Q1MSJ5	LB/B	-	A0A091T4D1	907	R	H
Q1MSJ5	LB/B	-	A0A091T4D1	1135	W	R
Q96S65	LB/B	-	A0A0P7V027	453	V	I
Q9H175	LB/B	-	S7MYG7	436	T	M
Q5W186	LB/B	-	A0A2K5QDQ0	48	L	F
Q9H4G1	LB/B	-	G3SR66	109	H	P
P01040	LB/B	-	A0A2P4SQF1	96	T	M
P04080	LP/P	Epilepsy, progressive myoclonic 1 (EPM1) [MIM:254800]	A0A0E9U8S8	4	G	R
Q8NHU0	LB/B	-	A0A2I3T3H5	55	E	A
O75638	LB/B	-	A0A2K6UH01	6	R	Q
O75638	LB/B	-	A0A2K6UH01	89	E	Q
O75638	LB/B	-	A0A2K6UH01	99	P	A
Q96RT6	LB/B	-	A0A1S3R9Z4	682	I	V
Q13363	LP/P	Hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome (HADDTS) [MIM:617915]	A0A151PA46	342	R	W
Q01459	LB/B	-	L9KSB6	310	D	Y
Q01459	LB/B	-	L9KSB6	274	V	I
P49711	LP/P	Intellectual developmental disorder, autosomal dominant 21 (MRD21) [MIM:615502]	W5MIX9	567	R	W
Q8NI51	LB/B	-	M3XB11	50	E	Q
Q8NI51	LB/B	-	M3XB11	177	T	A
Q8NI51	LB/B	-	M3XB11	525	Q	E
Q8NI51	LB/B	-	M3XB11	448	R	H
O95476	LB/B	-	L9KKY9	12	T	A
Q9Y5B0	LB/B	-	H2ZXN9	340	T	M
Q9Y5B0	LB/B	-	H2ZXN9	755	L	S
Q9Y5B0	LB/B	-	H2ZXN9	282	S	F
Q9Y5B0	LB/B	-	H2ZXN9	519	P	H
Q9GZU7	LB/B	-	A0A2K5IGT1	56	A	T
O15194	LB/B	-	L8Y872	121	S	P
O15194	LB/B	-	L8Y872	127	N	S
O15194	LB/B	-	L8Y872	132	V	G
Q05D32	LB/B	-	A0A091ECF4	244	A	V
Q16619	LB/B	-	A0A2R8MAV4	92	A	T
P32929	LP/P	Cystathioninuria (CSTNU) [MIM:219500]	A0A061IMK1	67	T	I
P32929	LP/P	Cystathioninuria (CSTNU) [MIM:219500]	A0A061IMK1	240	Q	E
P32929	LB/B	-	A0A061IMK1	403	S	I
Q96CG8	LB/B	-	A0A2U3V987	44	Q	P
O43310	LB/B	-	H0YP34	82	P	L
P35221	LB/B	-	A0A146ZAT2	179	A	V
P35221	LB/B	-	A0A146ZAT2	219	P	S
P35221	LP/P	Macular dystrophy, patterned, 2 (MDPT2) [MIM:608970]	A0A146ZAT2	54	R	C
P35221	LP/P	Macular dystrophy, patterned, 2 (MDPT2) [MIM:608970]	A0A146ZAT2	307	E	K
P35221	LP/P	Macular dystrophy, patterned, 2 (MDPT2) [MIM:608970]	A0A146ZAT2	318	L	S
P35221	LP/P	Macular dystrophy, patterned, 2 (MDPT2) [MIM:608970]	A0A146ZAT2	431	I	M
Q9UI47	LB/B	-	A0A146ZAT2	596	S	N
Q9UI47	LB/B	-	A0A146ZAT2	535	R	C
Q9UI47	LP/P	Arrhythmogenic right ventricular dysplasia, familial, 13 (ARVD13) [MIM:615616]	A0A146ZAT2	94	V	D
Q8WYA6	LB/B	-	A0A2I0LJU2	507	N	D
Q8WYA6	LP/P	Immunodeficiency 99 with hypogammaglobulinemia and autoimmune cytopenias (IMD99) [MIM:619846]	A0A2I0LJU2	466	M	V
O60716	LB/B	-	A0A1Z5L386	217	Y	C
O60716	LB/B	-	A0A1Z5L386	464	R	C
O60716	LB/B	-	A0A1Z5L386	915	R	K
O60716	LB/B	-	A0A1Z5L386	171	S	F
Q9UQB3	LB/B	-	A0A2I0URG9	482	A	T
Q9UQB3	LB/B	-	A0A2I0URG9	810	G	R
Q9UQB3	LP/P	-	A0A2I0URG9	34	G	S
Q9UQB3	LP/P	-	A0A2I0URG9	189	P	L
Q9UQB3	LP/P	-	A0A2I0URG9	224	P	L
Q9UQB3	LB/B	-	A0A2I0URG9	330	R	H
Q9UQB3	LP/P	-	A0A2I0URG9	454	R	H
Q9UQB3	LB/B	-	A0A2I0URG9	465	D	N
Q9UQB3	LP/P	-	A0A2I0URG9	507	Q	P
Q9UQB3	LP/P	-	A0A2I0URG9	713	R	C
O60931	LB/B	-	H2S484	42	V	I
O60931	LP/P	Cystinosis, nephropathic type (CTNS) [MIM:219800]	H2S484	169	G	D
O60931	LP/P	Cystinosis, late-onset juvenile or adolescent nephropathic type (CTNSJAN) [MIM:219900]	H2S484	280	K	R
O60931	LP/P	Cystinosis, late-onset juvenile or adolescent nephropathic type (CTNSJAN) [MIM:219900]	H2S484	323	N	K
O60931	LP/P	Cystinosis, nephropathic type (CTNS) [MIM:219800]	H2S484	133	I	F
O60931	LP/P	Cystinosis, nephropathic type (CTNS) [MIM:219800]	H2S484	139	S	F
O60931	LP/P	Cystinosis, nephropathic type (CTNS) [MIM:219800]	H2S484	158	L	P
O60931	LP/P	Cystinosis, nephropathic type (CTNS) [MIM:219800]	H2S484	182	W	R
O60931	LP/P	Cystinosis, adult, non-nephropathic type (CTNSANN) [MIM:219750]	H2S484	197	G	R
O60931	LP/P	Cystinosis, nephropathic type (CTNS) [MIM:219800]	H2S484	205	D	N
O60931	LP/P	Cystinosis, nephropathic type (CTNS) [MIM:219800]	H2S484	305	D	G
O60931	LP/P	Cystinosis, nephropathic type (CTNS) [MIM:219800]	H2S484	305	D	Y
O60931	LP/P	Cystinosis, nephropathic type (CTNS) [MIM:219800]	H2S484	308	G	R
O60931	LP/P	Cystinosis, nephropathic type (CTNS) [MIM:219800]	H2S484	338	L	P
O60931	LP/P	Cystinosis, nephropathic type (CTNS) [MIM:219800]	H2S484	339	G	R
O60931	LP/P	Cystinosis, nephropathic type (CTNS) [MIM:219800]	H2S484	346	D	N
O60931	LP/P	Cystinosis, nephropathic type (CTNS) [MIM:219800]	H2S484	298	S	N
O60931	LP/P	Cystinosis, nephropathic type (CTNS) [MIM:219800]	H2S484	110	G	V
O60931	LP/P	Cystinosis, late-onset juvenile or adolescent nephropathic type (CTNSJAN) [MIM:219900]	H2S484	177	N	T
O60931	LP/P	Cystinosis, late-onset juvenile or adolescent nephropathic type (CTNSJAN) [MIM:219900]	H2S484	200	P	L
O60931	LP/P	Cystinosis, nephropathic type (CTNS) [MIM:219800]	H2S484	222	Q	R
O60931	LP/P	Cystinosis, nephropathic type (CTNS) [MIM:219800]	H2S484	288	N	K
O60931	LB/B	-	H2S484	260	T	I
O60931	LP/P	Cystinosis, nephropathic type (CTNS) [MIM:219800]	H2S484	151	R	G
O60931	LP/P	Cystinosis, nephropathic type (CTNS) [MIM:219800]	H2S484	157	G	D
O60931	LP/P	Cystinosis, nephropathic type (CTNS) [MIM:219800]	H2S484	173	Y	C
O60931	LP/P	Cystinosis, nephropathic type (CTNS) [MIM:219800]	H2S484	177	N	S
O60931	LP/P	Cystinosis, nephropathic type (CTNS) [MIM:219800]	H2S484	287	M	I
O60931	LP/P	Cystinosis, nephropathic type (CTNS) [MIM:219800]	H2S484	308	G	V
O60931	LP/P	Cystinosis, nephropathic type (CTNS) [MIM:219800]	H2S484	309	G	D
O60931	LP/P	Cystinosis, nephropathic type (CTNS) [MIM:219800]	H2S484	337	G	R
O60931	LP/P	Cystinosis, nephropathic type (CTNS) [MIM:219800]	H2S484	338	L	R
O60931	LP/P	Cystinosis, nephropathic type (CTNS) [MIM:219800]	H2S484	141	S	F
P17812	LB/B	-	A0A0Q3U459	571	S	I
P17538	LB/B	-	A0A0P7TWG0	250	T	A
P17538	LB/B	-	A0A0P7TWG0	222	D	H
Q6GPI1	LB/B	-	A0A0P7TWG0	250	A	T
Q99895	LB/B	-	G1N1Z6	80	R	W
Q99895	LB/B	-	G1N1Z6	35	D	H
Q99895	LB/B	-	G1N1Z6	35	D	N
Q99895	LB/B	-	G1N1Z6	37	R	Q
Q99895	LB/B	-	G1N1Z6	48	Q	R
Q99895	LP/P	Pancreatitis, hereditary (PCTT) [MIM:167800]	G1N1Z6	73	A	T
Q99895	LB/B	-	G1N1Z6	172	K	E
Q99895	LP/P	Pancreatitis, hereditary (PCTT) [MIM:167800]	G1N1Z6	217	G	R
Q99895	LP/P	Pancreatitis, hereditary (PCTT) [MIM:167800]	G1N1Z6	217	G	S
Q99895	LB/B	-	G1N1Z6	218	G	S
Q99895	LB/B	-	G1N1Z6	225	E	A
Q99895	LP/P	Pancreatitis, hereditary (PCTT) [MIM:167800]	G1N1Z6	235	V	I
Q99895	LP/P	Pancreatitis, hereditary (PCTT) [MIM:167800]	G1N1Z6	249	P	L
Q99895	LP/P	Pancreatitis, hereditary (PCTT) [MIM:167800]	G1N1Z6	254	R	W
Q99895	LB/B	-	G1N1Z6	260	D	N
Q99895	LP/P	Pancreatitis, hereditary (PCTT) [MIM:167800]	G1N1Z6	32	G	V
Q99895	LP/P	Pancreatitis, hereditary (PCTT) [MIM:167800]	G1N1Z6	155	C	Y
Q99895	LP/P	Pancreatitis, hereditary (PCTT) [MIM:167800]	G1N1Z6	178	Q	R
Q99895	LB/B	-	G1N1Z6	209	I	M
Q99895	LB/B	-	G1N1Z6	227	G	S
Q99895	LB/B	-	G1N1Z6	246	R	C
Q99895	LP/P	Pancreatitis, hereditary (PCTT) [MIM:167800]	G1N1Z6	250	V	E
P40313	LB/B	-	A0A0P7TWG0	173	H	R
P40313	LB/B	-	A0A0P7TWG0	150	T	I
P10619	LP/P	Galactosialidosis (GSL) [MIM:256540]	A0A2U9BCE5	49	Q	R
P10619	LP/P	Galactosialidosis (GSL) [MIM:256540]	A0A2U9BCE5	65	W	R
P10619	LP/P	Galactosialidosis (GSL) [MIM:256540]	A0A2U9BCE5	90	S	L
P10619	LP/P	Galactosialidosis (GSL) [MIM:256540]	A0A2U9BCE5	249	Y	N
P10619	LP/P	Galactosialidosis (GSL) [MIM:256540]	A0A2U9BCE5	395	Y	C
P10619	LP/P	Galactosialidosis (GSL) [MIM:256540]	A0A2U9BCE5	440	F	V
P10619	LP/P	Galactosialidosis (GSL) [MIM:256540]	A0A2U9BCE5	51	S	Y
P10619	LP/P	Galactosialidosis (GSL) [MIM:256540]	A0A2U9BCE5	132	V	M
P10619	LP/P	Galactosialidosis (GSL) [MIM:256540]	A0A2U9BCE5	236	L	P
P10619	LP/P	Galactosialidosis (GSL) [MIM:256540]	A0A2U9BCE5	406	M	T
P10619	LP/P	Galactosialidosis (GSL) [MIM:256540]	A0A2U9BCE5	439	G	S
P10619	LP/P	Galactosialidosis (GSL) [MIM:256540]	A0A2U9BCE5	453	K	E
P07858	LB/B	-	H2ZCH5	26	L	V
P07858	LB/B	-	H2ZCH5	235	S	N
P07858	LB/B	-	H2ZCH5	53	S	G
P07858	LB/B	-	H2ZCH5	91	P	L
P53634	LP/P	Papillon-Lefevre syndrome (PLS) [MIM:245000]	A0A1W4ZJH1	249	V	F
P53634	LP/P	Papillon-Lefevre syndrome (PLS) [MIM:245000]	A0A1W4ZJH1	252	Q	L
P53634	LP/P	Papillon-Lefevre syndrome (PLS) [MIM:245000]	A0A1W4ZJH1	272	R	P
P53634	LP/P	Papillon-Lefevre syndrome (PLS) [MIM:245000]	A0A1W4ZJH1	301	G	S
P53634	LP/P	Papillon-Lefevre syndrome (PLS) [MIM:245000]	A0A1W4ZJH1	339	R	C
P53634	LP/P	Papillon-Lefevre syndrome (PLS) [MIM:245000]	A0A1W4ZJH1	347	Y	C
P53634	LP/P	Periodontititis, aggressive, 1 (AP1) [MIM:170650]	A0A1W4ZJH1	347	Y	C
P53634	LP/P	Papillon-Lefevre syndrome (PLS) [MIM:245000]	A0A1W4ZJH1	39	W	S
P53634	LP/P	Papillon-Lefevre syndrome (PLS) [MIM:245000]	A0A1W4ZJH1	127	H	P
P53634	LP/P	Haim-Munk syndrome (HMS) [MIM:245010]	A0A1W4ZJH1	286	Q	R
P53634	LP/P	Papillon-Lefevre syndrome (PLS) [MIM:245000]	A0A1W4ZJH1	286	Q	R
P53634	LP/P	Papillon-Lefevre syndrome (PLS) [MIM:245000]	A0A1W4ZJH1	429	W	C
P53634	LB/B	-	A0A1W4ZJH1	153	I	T
P53634	LP/P	Papillon-Lefevre syndrome (PLS) [MIM:245000]	A0A1W4ZJH1	340	Y	C
P53634	LB/B	-	A0A1W4ZJH1	401	E	K
P53634	LB/B	-	A0A1W4ZJH1	453	I	V
P53634	LP/P	Papillon-Lefevre syndrome (PLS) [MIM:245000]	A0A1W4ZJH1	129	V	E
P53634	LP/P	Papillon-Lefevre syndrome (PLS) [MIM:245000]	A0A1W4ZJH1	139	G	R
P53634	LP/P	Papillon-Lefevre syndrome (PLS) [MIM:245000]	A0A1W4ZJH1	236	D	Y
P53634	LP/P	Papillon-Lefevre syndrome (PLS) [MIM:245000]	A0A1W4ZJH1	272	R	H
P53634	LP/P	Papillon-Lefevre syndrome (PLS) [MIM:245000]	A0A1W4ZJH1	291	C	Y
P53634	LP/P	Papillon-Lefevre syndrome (PLS) [MIM:245000]	A0A1W4ZJH1	300	G	D
P53634	LP/P	Papillon-Lefevre syndrome (PLS) [MIM:245000]	A0A1W4ZJH1	300	G	S
P53634	LP/P	Papillon-Lefevre syndrome (PLS) [MIM:245000]	A0A1W4ZJH1	301	G	V
P53634	LP/P	Papillon-Lefevre syndrome (PLS) [MIM:245000]	A0A1W4ZJH1	304	Y	N
P53634	LP/P	Papillon-Lefevre syndrome (PLS) [MIM:245000]	A0A1W4ZJH1	312	Q	R
P53634	LP/P	Papillon-Lefevre syndrome (PLS) [MIM:245000]	A0A1W4ZJH1	319	E	G
P53634	LP/P	Periodontititis, aggressive, 1 (AP1) [MIM:170650]	A0A1W4ZJH1	412	Y	C
P53634	LP/P	Papillon-Lefevre syndrome (PLS) [MIM:245000]	A0A1W4ZJH1	447	E	G
P53634	LP/P	Papillon-Lefevre syndrome (PLS) [MIM:245000]	A0A1W4ZJH1	405	H	N
P53634	LP/P	Papillon-Lefevre syndrome (PLS) [MIM:245000]	A0A1W4ZJH1	405	H	R
P53634	LP/P	Papillon-Lefevre syndrome (PLS) [MIM:245000]	A0A1W4ZJH1	294	Y	H
P14091	LB/B	-	A0A0A0APU1	324	T	I
P14091	LB/B	-	A0A0A0APU1	82	I	V
Q9UBX1	LB/B	-	W5KTA6	153	Q	R
Q9UBX1	LP/P	Ceroid lipofuscinosis, neuronal, 13 (Kufs type) (CLN13) [MIM:615362]	W5KTA6	231	Y	C
Q9UBX1	LP/P	Ceroid lipofuscinosis, neuronal, 13 (Kufs type) (CLN13) [MIM:615362]	W5KTA6	321	Q	R
Q9UBX1	LP/P	Ceroid lipofuscinosis, neuronal, 13 (Kufs type) (CLN13) [MIM:615362]	W5KTA6	458	G	A
Q9UBX1	LP/P	Ceroid lipofuscinosis, neuronal, 13 (Kufs type) (CLN13) [MIM:615362]	W5KTA6	480	S	L
P43235	LP/P	Pycnodysostosis (PKND) [MIM:265800]	F1Q8A0	146	G	R
P43235	LP/P	Pycnodysostosis (PKND) [MIM:265800]	F1Q8A0	309	L	P
P43235	LP/P	Pycnodysostosis (PKND) [MIM:265800]	F1Q8A0	79	G	E
P43235	LP/P	Pycnodysostosis (PKND) [MIM:265800]	F1Q8A0	277	A	V
P43235	LP/P	Pycnodysostosis (PKND) [MIM:265800]	F1Q8A0	122	R	P
P43235	LP/P	Pycnodysostosis (PKND) [MIM:265800]	F1Q8A0	283	Y	C
Q5NE16	LB/B	-	Q5NE16	123	S	G
P56202	LB/B	-	A0A2K6BQL0	218	Q	R
P56202	LB/B	-	A0A2K6BQL0	139	S	G
Q9UBR2	LB/B	-	F7HZF6	36	P	S
Q9UBR2	LB/B	-	F7HZF6	286	A	T
Q8WZ74	LB/B	-	A0A093FWQ6	1213	L	V
Q8WZ74	LB/B	-	A0A093FWQ6	1148	Q	K
Q7Z7A3	LB/B	-	A0A2Y9PGV9	107	A	V
Q2VPK5	LB/B	-	A0A2I3GQ77	253	M	V
Q2VPK5	LB/B	-	A0A2I3GQ77	332	V	I
Q2VPK5	LB/B	-	A0A2I3GQ77	416	Q	R
Q2VPK5	LB/B	-	A0A2I3GQ77	186	H	Y
Q4LDR2	LB/B	-	G1KAX4	17	E	V
Q4LDR2	LB/B	-	G1KAX4	23	M	I
Q9NWM3	LB/B	-	A0A2U3Z2M1	205	P	S
Q9NWM3	LB/B	-	A0A2U3Z2M1	316	R	Q
Q9NWM3	LB/B	-	A0A2U3Z2M1	169	R	H
Q13617	LB/B	-	A0A091D7T8	109	N	S
Q13618	LB/B	-	R1EPB6	13	D	H
Q13618	LB/B	-	R1EPB6	567	V	I
Q13618	LB/B	-	R1EPB6	184	R	S
Q13618	LP/P	Pseudohypoaldosteronism 2E (PHA2E) [MIM:614496]	R1EPB6	413	D	G
Q13618	LP/P	Pseudohypoaldosteronism 2E (PHA2E) [MIM:614496]	R1EPB6	459	K	R
Q13618	LP/P	Neurodevelopmental disorder with or without autism or seizures (NEDAUS) [MIM:619239]	R1EPB6	285	V	A
Q8IWT3	LB/B	-	L9KU90	2058	H	P
Q8IWT3	LB/B	-	L9KU90	2180	T	I
Q96C57	LB/B	-	G3R8U7	44	G	R
O14529	LB/B	-	A0A2I0TJC7	1472	V	L
O14529	LP/P	Developmental and epileptic encephalopathy 67 (DEE67) [MIM:618141]	A0A2I0TJC7	590	E	K
Q6UX04	LB/B	-	Q6GLX7	256	P	A
Q69YN2	LB/B	-	U3IV67	160	C	Y
Q69YN2	LB/B	-	U3IV67	259	P	L
Q69YN2	LB/B	-	U3IV67	523	R	H
Q69YN2	LB/B	-	U3IV67	526	R	Q
Q2TBE0	LB/B	-	G3NZP6	210	P	T
Q2TBE0	LB/B	-	G3NZP6	443	H	Y
Q2TBE0	LB/B	-	G3NZP6	445	H	Q
Q2TBE0	LB/B	-	G3NZP6	537	G	R
Q2TBE0	LB/B	-	G3NZP6	894	Y	C
Q9H720	LB/B	-	I1C4J3	2	P	T
Q9H720	LB/B	-	I1C4J3	689	H	N
P78423	LB/B	-	G1ST53	240	A	V
P49238	LB/B	-	A0A2Y9MCB7	57	T	A
P49238	LB/B	-	A0A2Y9MCB7	122	V	I
P49238	LB/B	-	A0A2Y9MCB7	249	V	I
P49238	LB/B	-	A0A2Y9MCB7	280	T	M
P49238	LB/B	-	A0A2Y9MCB7	147	V	I
P49238	LB/B	-	A0A2Y9MCB7	13	E	D
P78310	LB/B	-	A0A2I3H4M6	323	S	R
P19876	LB/B	-	A0A286XWF2	3	H	R
P25024	LB/B	-	A0A1S3GWT9	276	S	T
P25024	LB/B	-	A0A1S3GWT9	71	R	C
P25024	LB/B	-	A0A1S3GWT9	306	A	T
P25024	LB/B	-	A0A1S3GWT9	335	R	C
P25024	LB/B	-	A0A1S3GWT9	31	M	R
P25024	LB/B	-	A0A1S3GWT9	342	S	L
P25024	LB/B	-	A0A1S3GWT9	268	M	L
P25025	LB/B	-	A0A1S3GWT9	80	R	C
P49682	LB/B	-	A0A1U7UG55	292	R	Q
P49682	LB/B	-	A0A1U7UG55	363	A	T
P32302	LB/B	-	A0A1U7QL65	344	G	S
O00574	LB/B	-	A0A1S3GWT9	3	E	K
A6NEN9	LB/B	-	A0A2Y9GAR5	156	R	H
P00167	LP/P	Methemoglobinemia and ambiguous genitalia (METAG) [MIM:250790]	A0A2R8PN64	44	H	L
Q6P9G0	LB/B	-	A0A183AUA7	20	F	L
Q9UHQ9	LB/B	-	L9JAX6	44	N	S
P00387	LP/P	Methemoglobinemia CYB5R3-related (METHB-CYB5R3) [MIM:250800]	A0A2F0AVR8	58	R	Q
P00387	LP/P	Methemoglobinemia CYB5R3-related (METHB-CYB5R3) [MIM:250800]	A0A2F0AVR8	106	V	M
P00387	LP/P	Methemoglobinemia CYB5R3-related (METHB-CYB5R3) [MIM:250800]	A0A2F0AVR8	128	S	P
P00387	LP/P	Methemoglobinemia CYB5R3-related (METHB-CYB5R3) [MIM:250800]	A0A2F0AVR8	149	L	P
P00387	LP/P	Methemoglobinemia CYB5R3-related (METHB-CYB5R3) [MIM:250800]	A0A2F0AVR8	73	L	P
P00387	LB/B	-	A0A2F0AVR8	117	T	S
P00387	LP/P	Methemoglobinemia CYB5R3-related (METHB-CYB5R3) [MIM:250800]	A0A2F0AVR8	179	A	V
P00387	LP/P	Methemoglobinemia CYB5R3-related (METHB-CYB5R3) [MIM:250800]	A0A2F0AVR8	204	C	R
P00387	LP/P	Methemoglobinemia CYB5R3-related (METHB-CYB5R3) [MIM:250800]	A0A2F0AVR8	204	C	Y
P00387	LB/B	-	A0A2F0AVR8	66	S	P
P00387	LP/P	Methemoglobinemia CYB5R3-related (METHB-CYB5R3) [MIM:250800]	A0A2F0AVR8	292	G	D
P13498	LB/B	-	F7DJ13	72	Y	H
P13498	LP/P	Granulomatous disease, chronic, autosomal recessive, 4 (CGD4) [MIM:233690]	F7DJ13	90	R	Q
P13498	LP/P	Granulomatous disease, chronic, autosomal recessive, 4 (CGD4) [MIM:233690]	F7DJ13	94	H	R
P13498	LP/P	Granulomatous disease, chronic, autosomal recessive, 4 (CGD4) [MIM:233690]	F7DJ13	118	S	R
P13498	LP/P	Granulomatous disease, chronic, autosomal recessive, 4 (CGD4) [MIM:233690]	F7DJ13	156	P	Q
P13498	LP/P	Granulomatous disease, chronic, autosomal recessive, 4 (CGD4) [MIM:233690]	F7DJ13	24	G	R
P13498	LB/B	-	F7DJ13	174	V	A
P13498	LP/P	Granulomatous disease, chronic, autosomal recessive, 4 (CGD4) [MIM:233690]	F7DJ13	25	G	V
P13498	LP/P	Granulomatous disease, chronic, autosomal recessive, 4 (CGD4) [MIM:233690]	F7DJ13	52	L	P
P13498	LP/P	Granulomatous disease, chronic, autosomal recessive, 4 (CGD4) [MIM:233690]	F7DJ13	53	E	V
P13498	LP/P	Granulomatous disease, chronic, autosomal recessive, 4 (CGD4) [MIM:233690]	F7DJ13	90	R	W
P13498	LP/P	Granulomatous disease, chronic, autosomal recessive, 4 (CGD4) [MIM:233690]	F7DJ13	124	A	V
P13498	LP/P	Granulomatous disease, chronic, autosomal recessive, 4 (CGD4) [MIM:233690]	F7DJ13	125	A	T
P13498	LB/B	-	F7DJ13	171	E	G
P13498	LB/B	-	F7DJ13	193	E	D
P13498	LP/P	Granulomatous disease, chronic, autosomal recessive, 4 (CGD4) [MIM:233690]	F7DJ13	25	G	D
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	101	H	R
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	156	A	T
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	209	H	Y
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	225	E	V
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	244	C	S
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	244	C	Y
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	339	P	H
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	389	G	A
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	415	P	H
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	500	D	G
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	20	G	R
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	54	R	S
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	59	C	R
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	101	H	Y
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	119	H	R
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	209	H	Q
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	222	H	N
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	222	H	R
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	222	H	Y
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	223	G	L
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	244	C	R
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	309	E	K
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	322	G	E
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	325	I	F
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	333	S	P
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	356	R	P
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	405	M	R
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	408	G	E
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	408	G	R
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	415	P	L
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	422	S	P
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	453	W	R
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	516	W	C
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	534	V	D
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	537	C	R
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	57	A	E
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	303	H	N
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	304	P	R
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	41	Y	D
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	54	R	M
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	55	A	D
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	209	H	R
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	224	A	G
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	338	H	Y
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	344	S	F
P04839	LB/B	-	A0A1A6GIP4	364	G	R
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	389	G	E
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	420	L	P
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	516	W	R
P04839	LB/B	-	A0A1A6GIP4	517	D	E
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	18	W	C
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	59	C	W
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	179	G	R
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	193	S	F
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	205	F	I
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	307	T	P
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	342	L	Q
P04839	LB/B	-	A0A1A6GIP4	472	G	S
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	505	L	R
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	546	L	P
P04839	LP/P	Immunodeficiency 34 (IMD34) [MIM:300645]	A0A1A6GIP4	178	T	P
P04839	LP/P	Immunodeficiency 34 (IMD34) [MIM:300645]	A0A1A6GIP4	231	Q	P
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	488	A	D
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	500	D	E
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	299	K	N
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	338	H	D
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	412	G	E
P04839	LP/P	Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400]	A0A1A6GIP4	409	A	G
P08574	LB/B	-	V9KR85	89	L	V
P08574	LB/B	-	V9KR85	76	M	V
P08574	LP/P	Mitochondrial complex III deficiency, nuclear type 6 (MC3DN6) [MIM:615453]	V9KR85	96	W	C
P08574	LP/P	Mitochondrial complex III deficiency, nuclear type 6 (MC3DN6) [MIM:615453]	V9KR85	215	L	F
P99999	LB/B	-	W9W6J3	66	M	L
P99999	LP/P	Thrombocytopenia 4 (THC4) [MIM:612004]	W9W6J3	42	G	S
P99999	LB/B	-	W9W6J3	56	K	R
Q7L576	LB/B	-	Q4SD94	532	A	P
Q7L576	LB/B	-	Q4SD94	820	G	D
Q7L576	LB/B	-	Q4SD94	820	G	S
P35663	LB/B	-	M3WHC4	399	D	H
Q14093	LB/B	-	A0A1U7TQ72	190	K	E
Q14093	LB/B	-	A0A1U7TQ72	208	G	D
Q14093	LB/B	-	A0A1U7TQ72	319	A	E
Q14093	LB/B	-	A0A1U7TQ72	146	D	Y
Q14093	LB/B	-	A0A1U7TQ72	184	G	D
Q9NQC7	LP/P	Brooke-Spiegler syndrome (BRSS) [MIM:605041]	L5KX70	747	E	G
Q9NQC7	LP/P	Multiple familial trichoepithelioma 1 (MFT1) [MIM:601606]	L5KX70	747	E	G
Q9NQC7	LP/P	Frontotemporal dementia and/or amyotrophic lateral sclerosis 8 (FTDALS8) [MIM:619132]	L5KX70	719	M	V
P11511	LP/P	Aromatase deficiency (AROD) [MIM:613546]	A0A0Q3XBY1	365	R	Q
P11511	LP/P	Aromatase deficiency (AROD) [MIM:613546]	A0A0Q3XBY1	375	R	C
P11511	LP/P	Aromatase deficiency (AROD) [MIM:613546]	A0A0Q3XBY1	435	R	C
P11511	LP/P	Aromatase deficiency (AROD) [MIM:613546]	A0A0Q3XBY1	437	C	Y
P11511	LB/B	-	A0A0Q3XBY1	264	R	C
P11511	LB/B	-	A0A0Q3XBY1	39	W	R
P11511	LB/B	-	A0A0Q3XBY1	201	T	M
P11511	LB/B	-	A0A0Q3XBY1	375	R	L
P11511	LP/P	Aromatase deficiency (AROD) [MIM:613546]	A0A0Q3XBY1	192	R	H
P11511	LB/B	-	A0A0Q3XBY1	264	R	H
P05177	LB/B	-	A0A1A6H2K5	21	F	L
P05177	LB/B	-	A0A1A6H2K5	348	D	N
P05177	LB/B	-	A0A1A6H2K5	386	I	F
P05177	LB/B	-	A0A1A6H2K5	406	C	Y
P05177	LB/B	-	A0A1A6H2K5	431	R	W
P05177	LB/B	-	A0A1A6H2K5	83	T	M
P05177	LB/B	-	A0A1A6H2K5	168	E	Q
P05177	LB/B	-	A0A1A6H2K5	186	F	L
P05177	LB/B	-	A0A1A6H2K5	212	S	C
P05177	LB/B	-	A0A1A6H2K5	299	G	S
P05177	LB/B	-	A0A1A6H2K5	438	T	I
P05177	LB/B	-	A0A1A6H2K5	18	S	C
P05177	LB/B	-	A0A1A6H2K5	298	S	R
P05177	LB/B	-	A0A1A6H2K5	314	I	V
P05177	LB/B	-	A0A1A6H2K5	42	P	R
P05177	LB/B	-	A0A1A6H2K5	73	G	R
P05177	LB/B	-	A0A1A6H2K5	104	D	N
P05177	LB/B	-	A0A1A6H2K5	111	L	F
P05177	LB/B	-	A0A1A6H2K5	205	F	V
P05177	LB/B	-	A0A1A6H2K5	281	R	W
P05177	LB/B	-	A0A1A6H2K5	377	R	Q
P05177	LB/B	-	A0A1A6H2K5	456	R	H
P05177	LB/B	-	A0A1A6H2K5	457	R	W
Q6UW02	LB/B	-	A0A146VH29	97	S	L
Q6UW02	LB/B	-	A0A146VH29	346	L	F
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	30	P	L
P08686	LB/B	-	A0A1A8IM47	98	K	R
P08686	LB/B	-	A0A1A8IM47	102	K	R
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	105	P	L
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	169	C	Y
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	172	I	N
P08686	LB/B	-	A0A1A8IM47	183	D	E
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	236	I	N
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	237	V	E
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	239	M	K
P08686	LB/B	-	A0A1A8IM47	268	S	T
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	281	V	L
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	291	G	S
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	339	R	H
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	341	R	W
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	356	R	P
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	356	R	Q
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	356	R	W
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	380	E	D
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	453	P	S
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	483	R	P
P08686	LB/B	-	A0A1A8IM47	493	N	S
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	64	G	E
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	362	A	V
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	62	H	L
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	291	G	R
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	301	S	Y
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	341	R	P
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	483	R	Q
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	30	P	Q
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	90	G	V
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	124	R	H
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	178	G	A
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	211	V	L
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	261	L	P
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	281	V	G
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	283	M	L
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	291	G	C
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	300	L	F
P08686	LB/B	-	A0A1A8IM47	304	V	M
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	317	L	M
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	354	R	C
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	354	R	H
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	363	L	W
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	365	H	Y
P08686	LB/B	-	A0A1A8IM47	375	G	S
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	408	R	C
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	424	G	S
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	426	R	H
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	435	R	C
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	479	R	L
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	482	P	S
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	483	R	W
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	56	G	R
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	77	I	T
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	107	L	R
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	121	K	Q
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	142	L	P
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	167	L	P
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	230	I	T
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	233	R	K
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	292	G	D
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	320	E	K
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	369	R	W
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	169	C	R
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	178	G	R
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	191	Y	H
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	198	L	F
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	282	H	N
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	302	W	R
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	426	R	C
P08686	LB/B	-	A0A1A8IM47	16	R	C
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	113	S	F
P08686	LB/B	-	A0A1A8IM47	202	S	G
P08686	LB/B	-	A0A1A8IM47	267	P	L
P08686	LB/B	-	A0A1A8IM47	450	T	M
P08686	LP/P	Adrenal hyperplasia 3 (AH3) [MIM:201910]	A0A1A8IM47	450	T	P
Q07973	LB/B	-	G1SMU5	157	R	Q
Q07973	LB/B	-	G1SMU5	374	M	T
Q07973	LP/P	Hypercalcemia, infantile, 1 (HCINF1) [MIM:143880]	G1SMU5	409	L	S
Q07973	LP/P	Hypercalcemia, infantile, 1 (HCINF1) [MIM:143880]	G1SMU5	159	R	Q
Q07973	LP/P	Hypercalcemia, infantile, 1 (HCINF1) [MIM:143880]	G1SMU5	322	E	K
Q07973	LP/P	Hypercalcemia, infantile, 1 (HCINF1) [MIM:143880]	G1SMU5	396	R	W
Q9NR63	LB/B	-	A0A146ZRI8	264	L	S
Q9NR63	LB/B	-	A0A146ZRI8	181	V	M
Q9NR63	LB/B	-	A0A146ZRI8	185	A	V
Q9NR63	LB/B	-	A0A146ZRI8	191	R	H
Q9NR63	LB/B	-	A0A146ZRI8	227	D	N
Q9NR63	LB/B	-	A0A146ZRI8	380	E	K
Q9NR63	LB/B	-	A0A146ZRI8	420	A	G
Q9NR63	LB/B	-	A0A146ZRI8	473	R	C
Q9NR63	LB/B	-	A0A146ZRI8	479	V	I
Q9NR63	LP/P	Radiohumeral fusions with other skeletal and craniofacial anomalies (RHFCA) [MIM:614416]	A0A146ZRI8	146	S	P
Q9NR63	LP/P	Radiohumeral fusions with other skeletal and craniofacial anomalies (RHFCA) [MIM:614416]	A0A146ZRI8	363	R	L
Q9NR63	LB/B	-	A0A146ZRI8	64	H	R
Q6V0L0	LB/B	-	A0A146ZRI8	245	R	Q
Q02318	LP/P	Cerebrotendinous xanthomatosis (CTX) [MIM:213700]	M3XKF7	395	R	C
Q02318	LP/P	Cerebrotendinous xanthomatosis (CTX) [MIM:213700]	M3XKF7	479	R	C
Q02318	LP/P	Cerebrotendinous xanthomatosis (CTX) [MIM:213700]	M3XKF7	395	R	S
Q02318	LP/P	Cerebrotendinous xanthomatosis (CTX) [MIM:213700]	M3XKF7	405	R	Q
Q02318	LP/P	Cerebrotendinous xanthomatosis (CTX) [MIM:213700]	M3XKF7	474	R	Q
Q02318	LP/P	Cerebrotendinous xanthomatosis (CTX) [MIM:213700]	M3XKF7	474	R	W
Q02318	LP/P	Cerebrotendinous xanthomatosis (CTX) [MIM:213700]	M3XKF7	145	G	E
Q02318	LB/B	-	M3XKF7	175	T	M
Q02318	LB/B	-	M3XKF7	169	A	V
O15528	LP/P	Rickets vitamin D-dependent 1A (VDDR1A) [MIM:264700]	M3XKF7	107	R	H
O15528	LP/P	Rickets vitamin D-dependent 1A (VDDR1A) [MIM:264700]	M3XKF7	125	G	E
O15528	LP/P	Rickets vitamin D-dependent 1A (VDDR1A) [MIM:264700]	M3XKF7	189	E	G
O15528	LP/P	Rickets vitamin D-dependent 1A (VDDR1A) [MIM:264700]	M3XKF7	321	T	R
O15528	LP/P	Rickets vitamin D-dependent 1A (VDDR1A) [MIM:264700]	M3XKF7	335	R	P
O15528	LP/P	Rickets vitamin D-dependent 1A (VDDR1A) [MIM:264700]	M3XKF7	343	L	F
O15528	LP/P	Rickets vitamin D-dependent 1A (VDDR1A) [MIM:264700]	M3XKF7	382	P	S
O15528	LP/P	Rickets vitamin D-dependent 1A (VDDR1A) [MIM:264700]	M3XKF7	389	R	H
O15528	LP/P	Rickets vitamin D-dependent 1A (VDDR1A) [MIM:264700]	M3XKF7	389	R	G
O15528	LP/P	Rickets vitamin D-dependent 1A (VDDR1A) [MIM:264700]	M3XKF7	409	T	I
O15528	LP/P	Rickets vitamin D-dependent 1A (VDDR1A) [MIM:264700]	M3XKF7	189	E	K
O15528	LP/P	Rickets vitamin D-dependent 1A (VDDR1A) [MIM:264700]	M3XKF7	389	R	C
O15528	LP/P	Rickets vitamin D-dependent 1A (VDDR1A) [MIM:264700]	M3XKF7	65	Q	H
O15528	LP/P	Rickets vitamin D-dependent 1A (VDDR1A) [MIM:264700]	M3XKF7	323	S	Y
O15528	LP/P	Rickets vitamin D-dependent 1A (VDDR1A) [MIM:264700]	M3XKF7	429	R	P
O15528	LP/P	Rickets vitamin D-dependent 1A (VDDR1A) [MIM:264700]	M3XKF7	453	R	C
O15528	LP/P	Rickets vitamin D-dependent 1A (VDDR1A) [MIM:264700]	M3XKF7	478	V	G
O15528	LP/P	Rickets vitamin D-dependent 1A (VDDR1A) [MIM:264700]	M3XKF7	497	P	R
O15528	LB/B	-	M3XKF7	166	V	L
Q4G0S4	LB/B	-	M3XKF7	529	T	M
Q16696	LB/B	-	A0A1D5PM10	257	R	C
Q16696	LB/B	-	A0A1D5PM10	25	R	Q
Q16696	LB/B	-	A0A1D5PM10	101	R	Q
Q16696	LB/B	-	A0A1D5PM10	158	D	E
Q16696	LB/B	-	A0A1D5PM10	453	F	Y
Q16696	LB/B	-	A0A1D5PM10	494	R	C
Q16696	LB/B	-	A0A1D5PM10	323	V	L
P11509	LB/B	-	A0A1D5PM10	160	L	H
P11509	LB/B	-	A0A1D5PM10	479	G	V
P11509	LB/B	-	A0A1D5PM10	128	R	Q
P11509	LB/B	-	A0A1D5PM10	471	I	T
P11509	LB/B	-	A0A1D5PM10	485	R	L
P11509	LB/B	-	A0A1D5PM10	5	G	R
P11509	LB/B	-	A0A1D5PM10	29	S	N
P11509	LB/B	-	A0A1D5PM10	194	K	E
P11509	LB/B	-	A0A1D5PM10	203	R	S
P11509	LB/B	-	A0A1D5PM10	419	E	D
P11509	LB/B	-	A0A1D5PM10	118	F	L
P11509	LB/B	-	A0A1D5PM10	224	S	P
P11509	LB/B	-	A0A1D5PM10	365	V	M
P11509	LB/B	-	A0A1D5PM10	418	N	D
P11509	LB/B	-	A0A1D5PM10	476	K	R
P11509	LB/B	-	A0A1D5PM10	294	T	S
P11509	LB/B	-	A0A1D5PM10	392	Y	F
P11509	LB/B	-	A0A1D5PM10	203	R	C
P11509	LB/B	-	A0A1D5PM10	110	V	L
P11509	LB/B	-	A0A1D5PM10	128	R	L
P11509	LB/B	-	A0A1D5PM10	131	S	A
P11509	LB/B	-	A0A1D5PM10	438	N	Y
P11509	LB/B	-	A0A1D5PM10	292	V	M
P20853	LB/B	-	A0A1D5PM10	61	F	I
P20853	LB/B	-	A0A1D5PM10	64	C	R
P20853	LB/B	-	A0A1D5PM10	274	H	R
P20853	LB/B	-	A0A1D5PM10	301	A	G
P20853	LB/B	-	A0A1D5PM10	311	R	C
P20853	LB/B	-	A0A1D5PM10	368	M	T
P20853	LB/B	-	A0A1D5PM10	169	D	E
P20853	LB/B	-	A0A1D5PM10	479	V	G
P20813	LB/B	-	F7I7T9	167	P	A
P20813	LB/B	-	F7I7T9	172	Q	H
P20813	LB/B	-	F7I7T9	262	K	R
P20813	LB/B	-	F7I7T9	22	R	C
P20813	LB/B	-	F7I7T9	259	S	R
P20813	LB/B	-	F7I7T9	487	R	C
P20813	LB/B	-	F7I7T9	139	K	E
P20813	LB/B	-	F7I7T9	21	Q	L
P20813	LB/B	-	F7I7T9	46	M	V
P20813	LB/B	-	F7I7T9	99	G	E
P20813	LB/B	-	F7I7T9	140	R	Q
P20813	LB/B	-	F7I7T9	391	I	N
P20813	LB/B	-	F7I7T9	328	I	T
P20813	LB/B	-	F7I7T9	26	T	S
P20813	LB/B	-	F7I7T9	28	D	G
P20813	LB/B	-	F7I7T9	29	R	S
P20813	LB/B	-	F7I7T9	289	N	K
P20813	LB/B	-	F7I7T9	306	T	S
P20813	LB/B	-	F7I7T9	29	R	P
P33260	LB/B	-	F7I7T9	385	T	M
P33261	LB/B	-	F7I7T9	331	I	V
P33261	LB/B	-	F7I7T9	120	W	R
P33261	LB/B	-	F7I7T9	132	R	Q
P33261	LB/B	-	F7I7T9	433	R	W
P33261	LB/B	-	F7I7T9	227	P	L
P33261	LB/B	-	F7I7T9	17	L	P
P33261	LB/B	-	F7I7T9	19	I	L
P33261	LB/B	-	F7I7T9	92	E	D
P33261	LB/B	-	F7I7T9	122	E	A
P33261	LB/B	-	F7I7T9	144	R	H
P33261	LB/B	-	F7I7T9	150	R	H
P33261	LB/B	-	F7I7T9	410	R	C
P33261	LB/B	-	F7I7T9	442	R	C
P33261	LB/B	-	F7I7T9	51	S	G
P33261	LB/B	-	F7I7T9	161	A	P
P33261	LB/B	-	F7I7T9	329	R	H
P33261	LB/B	-	F7I7T9	74	M	T
P33261	LB/B	-	F7I7T9	168	F	L
P10632	LB/B	-	F7I7T9	154	E	D
P10632	LB/B	-	F7I7T9	193	N	K
P10632	LB/B	-	F7I7T9	249	K	R
P10632	LB/B	-	F7I7T9	411	H	L
P10632	LB/B	-	F7I7T9	264	I	M
P10632	LB/B	-	F7I7T9	139	R	K
P10632	LB/B	-	F7I7T9	269	I	F
P10632	LB/B	-	F7I7T9	399	K	R
P10632	LB/B	-	F7I7T9	390	L	S
P10632	LB/B	-	F7I7T9	244	I	V
P10632	LB/B	-	F7I7T9	171	G	S
P10632	LB/B	-	F7I7T9	186	R	G
P10632	LB/B	-	F7I7T9	223	I	M
P10632	LB/B	-	F7I7T9	238	A	P
P10632	LB/B	-	F7I7T9	247	K	R
P10632	LB/B	-	F7I7T9	383	K	N
P11712	LB/B	-	F7I7T9	144	R	C
P11712	LB/B	-	F7I7T9	358	Y	C
P11712	LB/B	-	F7I7T9	359	I	L
P11712	LB/B	-	F7I7T9	417	G	D
P11712	LB/B	-	F7I7T9	359	I	T
P11712	LB/B	-	F7I7T9	360	D	E
P11712	LB/B	-	F7I7T9	19	L	I
P11712	LB/B	-	F7I7T9	150	R	H
P11712	LB/B	-	F7I7T9	251	H	R
P11712	LB/B	-	F7I7T9	272	E	G
P11712	LB/B	-	F7I7T9	335	R	W
P11712	LB/B	-	F7I7T9	489	P	S
P11712	LB/B	-	F7I7T9	413	L	P
P11712	LB/B	-	F7I7T9	125	R	H
P11712	LB/B	-	F7I7T9	125	R	L
P11712	LB/B	-	F7I7T9	204	N	H
P11712	LB/B	-	F7I7T9	434	I	F
P10635	LB/B	-	G1S165	42	G	R
P10635	LB/B	-	G1S165	34	P	S
P10635	LB/B	-	G1S165	107	T	I
P10635	LB/B	-	G1S165	169	G	R
P10635	LB/B	-	G1S165	212	G	E
P10635	LB/B	-	G1S165	296	R	C
P10635	LB/B	-	G1S165	486	S	T
P10635	LB/B	-	G1S165	324	H	P
P10635	LB/B	-	G1S165	11	V	M
P10635	LB/B	-	G1S165	26	R	H
P10635	LB/B	-	G1S165	28	R	C
P10635	LB/B	-	G1S165	85	A	V
P10635	LB/B	-	G1S165	237	A	S
P10635	LB/B	-	G1S165	297	I	L
P10635	LB/B	-	G1S165	343	R	G
P10635	LB/B	-	G1S165	369	I	T
P10635	LB/B	-	G1S165	410	E	K
P10635	LB/B	-	G1S165	311	S	L
P10635	LB/B	-	G1S165	91	L	M
P10635	LB/B	-	G1S165	94	H	R
P10635	LB/B	-	G1S165	120	F	I
P10635	LB/B	-	G1S165	155	E	K
P10635	LB/B	-	G1S165	418	E	K
P10635	LB/B	-	G1S165	469	P	A
P10635	LB/B	-	G1S165	478	H	Y
P10635	LB/B	-	G1S165	231	L	P
P10635	LB/B	-	G1S165	300	A	G
P10635	LB/B	-	G1S165	365	R	H
P10635	LB/B	-	G1S165	329	R	L
P10635	LB/B	-	G1S165	373	G	S
P10635	LB/B	-	G1S165	5	A	V
P10635	LB/B	-	G1S165	25	R	Q
P10635	LB/B	-	G1S165	104	V	A
P10635	LB/B	-	G1S165	142	L	S
P10635	LB/B	-	G1S165	147	K	R
P10635	LB/B	-	G1S165	161	C	S
P10635	LB/B	-	G1S165	164	F	L
P10635	LB/B	-	G1S165	215	E	K
P10635	LB/B	-	G1S165	219	F	S
P10635	LB/B	-	G1S165	249	T	P
P10635	LB/B	-	G1S165	327	V	M
P10635	LB/B	-	G1S165	336	D	N
P10635	LB/B	-	G1S165	337	D	G
P10635	LB/B	-	G1S165	342	V	M
P10635	LB/B	-	G1S165	344	R	Q
P10635	LB/B	-	G1S165	440	R	C
P10635	LB/B	-	G1S165	457	F	L
P10635	LB/B	-	G1S165	463	H	D
P10635	LB/B	-	G1S165	497	R	C
A0A087X1C5	LB/B	-	G1S165	70	S	N
A0A087X1C5	LB/B	-	G1S165	311	S	L
A0A087X1C5	LB/B	-	G1S165	383	H	R
A0A087X1C5	LB/B	-	G1S165	428	K	E
P24903	LB/B	-	A0A2K6UHS7	38	S	P
P24903	LB/B	-	A0A2K6UHS7	98	R	P
P24903	LB/B	-	A0A2K6UHS7	218	D	N
P24903	LB/B	-	A0A2K6UHS7	266	Q	H
P24903	LB/B	-	A0A2K6UHS7	391	L	P
P24903	LB/B	-	A0A2K6UHS7	490	P	L
P51589	LB/B	-	G1PR49	143	T	A
P51589	LB/B	-	G1PR49	158	R	C
P51589	LB/B	-	G1PR49	192	I	N
P51589	LB/B	-	G1PR49	342	D	N
P51589	LB/B	-	G1PR49	404	N	Y
P51589	LB/B	-	G1PR49	124	N	S
P51589	LB/B	-	G1PR49	49	R	S
P51589	LB/B	-	G1PR49	113	V	M
Q6VVX0	LP/P	Rickets vitamin D-dependent 1B (VDDR1B) [MIM:600081]	A0A0D9QXG6	99	L	P
Q7Z449	LP/P	Spastic paraplegia 56, autosomal recessive, with or without pseudoxanthoma elasticum (SPG56) [MIM:615030]	C3ZLD1	262	C	R
Q7Z449	LP/P	Spastic paraplegia 56, autosomal recessive, with or without pseudoxanthoma elasticum (SPG56) [MIM:615030]	C3ZLD1	316	D	V
Q7Z449	LP/P	Spastic paraplegia 56, autosomal recessive, with or without pseudoxanthoma elasticum (SPG56) [MIM:615030]	C3ZLD1	380	E	G
Q7Z449	LP/P	Spastic paraplegia 56, autosomal recessive, with or without pseudoxanthoma elasticum (SPG56) [MIM:615030]	C3ZLD1	488	R	W
Q8TAV3	LB/B	-	A0A2R9BPY6	181	A	T
Q8TAV3	LB/B	-	A0A2R9BPY6	58	E	A
Q8TAV3	LB/B	-	A0A2R9BPY6	432	V	I
Q8TAV3	LB/B	-	A0A2R9BPY6	482	Q	H
Q8TAV3	LB/B	-	A0A2R9BPY6	488	P	L
Q9NYL5	LB/B	-	A0A1W4YW00	23	R	P
Q9NYL5	LB/B	-	A0A1W4YW00	103	R	H
Q9NYL5	LB/B	-	A0A1W4YW00	288	Y	H
Q9NYL5	LB/B	-	A0A1W4YW00	324	N	K
Q9NYL5	LB/B	-	A0A1W4YW00	329	K	Q
P08684	LB/B	-	A0A0H4IV15	222	S	P
P08684	LB/B	-	A0A0H4IV15	445	M	T
P08684	LB/B	-	A0A0H4IV15	15	L	P
P08684	LB/B	-	A0A0H4IV15	56	G	D
P08684	LB/B	-	A0A0H4IV15	118	I	V
P08684	LB/B	-	A0A0H4IV15	130	R	Q
P08684	LB/B	-	A0A0H4IV15	162	R	Q
P08684	LB/B	-	A0A0H4IV15	170	V	I
P08684	LB/B	-	A0A0H4IV15	174	D	H
P08684	LB/B	-	A0A0H4IV15	185	T	S
P08684	LB/B	-	A0A0H4IV15	218	P	R
P08684	LB/B	-	A0A0H4IV15	363	T	M
P08684	LB/B	-	A0A0H4IV15	373	L	F
P08684	LB/B	-	A0A0H4IV15	416	P	L
P08684	LB/B	-	A0A0H4IV15	189	F	S
P08684	LB/B	-	A0A0H4IV15	293	L	P
P08684	LB/B	-	A0A0H4IV15	467	P	S
P08684	LB/B	-	A0A0H4IV15	96	K	E
P08684	LB/B	-	A0A0H4IV15	252	S	A
P08684	LB/B	-	A0A0H4IV15	349	T	N
P08684	LB/B	-	A0A0H4IV15	431	I	T
P08684	LP/P	Vitamin D-dependent rickets 3 (VDDR3) [MIM:619073]	A0A0H4IV15	301	I	T
Q9HB55	LB/B	-	A0A0H4IV15	340	P	A
Q9HB55	LB/B	-	A0A0H4IV15	27	T	A
Q9HB55	LB/B	-	A0A0H4IV15	145	M	I
Q9HB55	LB/B	-	A0A0H4IV15	275	M	I
P20815	LB/B	-	A0A0H4IV15	398	T	N
P20815	LB/B	-	A0A0H4IV15	30	H	Y
P20815	LB/B	-	A0A0H4IV15	277	D	E
P20815	LB/B	-	A0A0H4IV15	337	A	T
P20815	LB/B	-	A0A0H4IV15	28	R	C
P20815	LB/B	-	A0A0H4IV15	200	Q	R
P20815	LB/B	-	A0A0H4IV15	446	F	S
P20815	LB/B	-	A0A0H4IV15	371	I	V
P20815	LB/B	-	A0A0H4IV15	488	I	T
P24462	LB/B	-	A0A0H4IV15	409	T	R
P24462	LB/B	-	A0A0H4IV15	71	V	A
Q9HBI6	LB/B	-	A0A2K6CAF1	146	R	C
Q9HBI6	LB/B	-	A0A2K6CAF1	276	C	R
Q9HBI6	LB/B	-	A0A2K6CAF1	446	D	N
Q9HCS2	LB/B	-	A0A2K6CAF1	13	P	L
Q9HCS2	LB/B	-	A0A2K6CAF1	76	N	D
Q9HCS2	LB/B	-	A0A2K6CAF1	90	V	I
Q9HCS2	LB/B	-	A0A2K6CAF1	188	R	C
Q9HCS2	LB/B	-	A0A2K6CAF1	16	T	M
Q9HCS2	LB/B	-	A0A2K6CAF1	522	S	G
P78329	LB/B	-	A0A2K6CAF1	7	S	Y
P78329	LB/B	-	A0A2K6CAF1	12	W	G
P78329	LB/B	-	A0A2K6CAF1	185	G	V
P78329	LB/B	-	A0A2K6CAF1	433	V	M
P78329	LB/B	-	A0A2K6CAF1	519	L	M
P78329	LB/B	-	A0A2K6CAF1	269	A	D
Q08477	LB/B	-	A0A2K6CAF1	269	A	D
Q08477	LB/B	-	A0A2K6CAF1	270	V	I
Q08477	LB/B	-	A0A2K6CAF1	271	I	T
Q08477	LB/B	-	A0A2K6CAF1	96	H	Q
Q08477	LB/B	-	A0A2K6CAF1	106	Y	C
P98187	LB/B	-	H0X5F8	125	Y	F
P98187	LB/B	-	H0X5F8	447	P	Q
Q6ZWL3	LP/P	Bietti crystalline corneoretinal dystrophy (BCD) [MIM:210370]	A0A2Y9NBX2	44	W	R
Q6ZWL3	LP/P	Bietti crystalline corneoretinal dystrophy (BCD) [MIM:210370]	A0A2Y9NBX2	61	G	S
Q6ZWL3	LP/P	Bietti crystalline corneoretinal dystrophy (BCD) [MIM:210370]	A0A2Y9NBX2	79	E	D
Q6ZWL3	LP/P	Bietti crystalline corneoretinal dystrophy (BCD) [MIM:210370]	A0A2Y9NBX2	111	I	T
Q6ZWL3	LP/P	Bietti crystalline corneoretinal dystrophy (BCD) [MIM:210370]	A0A2Y9NBX2	123	M	V
Q6ZWL3	LP/P	Bietti crystalline corneoretinal dystrophy (BCD) [MIM:210370]	A0A2Y9NBX2	331	H	P
Q6ZWL3	LP/P	Bietti crystalline corneoretinal dystrophy (BCD) [MIM:210370]	A0A2Y9NBX2	341	S	P
Q6ZWL3	LP/P	Bietti crystalline corneoretinal dystrophy (BCD) [MIM:210370]	A0A2Y9NBX2	508	R	H
Q6ZWL3	LB/B	-	A0A2Y9NBX2	259	Q	K
Q6ZWL3	LB/B	-	A0A2Y9NBX2	22	L	V
Q6ZWL3	LB/B	-	A0A2Y9NBX2	213	S	N
Q6ZWL3	LB/B	-	A0A2Y9NBX2	275	E	K
Q6ZWL3	LB/B	-	A0A2Y9NBX2	372	V	I
Q6ZWL3	LB/B	-	A0A2Y9NBX2	443	R	Q
Q86W10	LB/B	-	M3YLY5	393	P	L
Q16850	LB/B	-	A0A1S3K5U1	19	V	A
P22680	LB/B	-	A0A1W5AIV6	100	F	S
P22680	LB/B	-	A0A1W5AIV6	233	N	S
P22680	LB/B	-	A0A1W5AIV6	347	D	N
P22680	LB/B	-	A0A1W5AIV6	86	H	N
O75881	LP/P	Spastic paraplegia 5A, autosomal recessive (SPG5A) [MIM:270800]	A0A212CE01	57	G	R
O75881	LP/P	Spastic paraplegia 5A, autosomal recessive (SPG5A) [MIM:270800]	A0A212CE01	216	F	S
O75881	LP/P	Spastic paraplegia 5A, autosomal recessive (SPG5A) [MIM:270800]	A0A212CE01	363	S	F
O75881	LP/P	Spastic paraplegia 5A, autosomal recessive (SPG5A) [MIM:270800]	A0A212CE01	417	R	H
O75881	LB/B	-	A0A212CE01	19	L	P
O75881	LP/P	Spastic paraplegia 5A, autosomal recessive (SPG5A) [MIM:270800]	A0A212CE01	87	G	V
O75881	LB/B	-	A0A212CE01	106	H	Y
O75881	LP/P	Spastic paraplegia 5A, autosomal recessive (SPG5A) [MIM:270800]	A0A212CE01	285	H	L
O75881	LB/B	-	A0A212CE01	287	L	S
O75881	LP/P	Spastic paraplegia 5A, autosomal recessive (SPG5A) [MIM:270800]	A0A212CE01	297	T	A
O75881	LB/B	-	A0A212CE01	324	R	H
O75881	LP/P	Spastic paraplegia 5A, autosomal recessive (SPG5A) [MIM:270800]	A0A212CE01	417	R	C
O75881	LP/P	Spastic paraplegia 5A, autosomal recessive (SPG5A) [MIM:270800]	A0A212CE01	443	G	A
O75881	LP/P	Spastic paraplegia 5A, autosomal recessive (SPG5A) [MIM:270800]	A0A212CE01	470	F	I
O75881	LP/P	Spastic paraplegia 5A, autosomal recessive (SPG5A) [MIM:270800]	A0A212CE01	486	R	C
Q9UNU6	LB/B	-	A0A1W5AIV6	234	R	H
Q9UNU6	LB/B	-	A0A1W5AIV6	88	S	P
Q9UNU6	LB/B	-	A0A1W5AIV6	238	K	R
Q9UNU6	LB/B	-	A0A1W5AIV6	357	L	F
Q9UIA0	LB/B	-	A0A2K5EFR0	74	M	V
Q9NRR1	LB/B	-	L5LQ03	51	S	L
Q9NRR1	LB/B	-	L5LQ03	136	R	C
Q96J86	LB/B	-	A0A2U4ABG7	95	R	H
Q96J86	LB/B	-	A0A2U4ABG7	111	P	S
Q86T65	LB/B	-	F7E0S9	105	R	H
Q86T65	LB/B	-	F7E0S9	617	R	H
O75553	LB/B	-	A0A091D0Y4	71	V	I
Q5VWQ8	LB/B	-	F6YHP5	59	S	F
Q9NYF0	LB/B	-	M7BRB4	446	D	N
Q9NYF0	LB/B	-	M7BRB4	464	A	V
Q9NYF0	LB/B	-	M7BRB4	628	S	A
Q9NYF0	LB/B	-	M7BRB4	697	G	S
Q9NYF0	LP/P	Neural tube defects (NTD) [MIM:182940]	M7BRB4	356	N	K
Q9NYF0	LB/B	-	M7BRB4	800	D	G
Q5SW24	LB/B	-	G1KHV8	351	E	G
Q5SW24	LB/B	-	G1KHV8	541	T	P
Q14118	LB/B	-	B7QJQ0	14	S	W
Q14118	LP/P	Muscular dystrophy-dystroglycanopathy limb-girdle C9 (MDDGC9) [MIM:613818]	B7QJQ0	192	T	M
Q14118	LP/P	Muscular dystrophy-dystroglycanopathy limb-girdle C9 (MDDGC9) [MIM:613818]	B7QJQ0	74	V	I
Q14118	LP/P	Muscular dystrophy-dystroglycanopathy limb-girdle C9 (MDDGC9) [MIM:613818]	B7QJQ0	111	D	N
Q14118	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A9 (MDDGA9) [MIM:616538]	B7QJQ0	669	C	F
Q8NCG7	LB/B	-	R7UIW4	664	Q	R
Q5D0E6	LB/B	-	G3WPF8	299	Q	R
P53355	LB/B	-	F6Y048	416	V	I
P53355	LB/B	-	F6Y048	461	A	S
P53355	LB/B	-	F6Y048	519	S	A
P53355	LB/B	-	F6Y048	540	C	Y
P53355	LB/B	-	F6Y048	941	M	T
P53355	LB/B	-	F6Y048	977	R	W
P53355	LB/B	-	F6Y048	978	K	N
P53355	LB/B	-	F6Y048	993	Y	C
P53355	LB/B	-	F6Y048	994	D	E
P53355	LB/B	-	F6Y048	1005	E	Q
P53355	LB/B	-	F6Y048	1007	D	Y
P53355	LB/B	-	F6Y048	1008	L	P
P53355	LB/B	-	F6Y048	1010	R	C
P53355	LB/B	-	F6Y048	1018	T	A
P53355	LB/B	-	F6Y048	1272	M	I
P53355	LB/B	-	F6Y048	1346	S	N
P53355	LB/B	-	F6Y048	1405	G	V
P53355	LB/B	-	F6Y048	591	P	L
P53355	LB/B	-	F6Y048	622	I	M
Q9UIK4	LB/B	-	F7EDV0	60	R	W
Q9UIK4	LB/B	-	F7EDV0	271	R	W
Q6PI48	LB/B	-	A0A146UUB7	10	L	V
Q6PI48	LB/B	-	A0A146UUB7	196	K	R
Q6PI48	LP/P	Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL) [MIM:611105]	A0A146UUB7	45	S	G
Q6PI48	LP/P	Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL) [MIM:611105]	A0A146UUB7	152	C	F
Q6PI48	LP/P	Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL) [MIM:611105]	A0A146UUB7	179	R	H
Q6PI48	LP/P	Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL) [MIM:611105]	A0A146UUB7	184	Q	K
Q6PI48	LP/P	Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL) [MIM:611105]	A0A146UUB7	248	Q	K
Q6PI48	LP/P	Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL) [MIM:611105]	A0A146UUB7	263	R	Q
Q6PI48	LP/P	Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL) [MIM:611105]	A0A146UUB7	560	D	V
Q6PI48	LP/P	Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL) [MIM:611105]	A0A146UUB7	613	L	F
Q6PI48	LP/P	Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL) [MIM:611105]	A0A146UUB7	626	L	Q
Q6PI48	LP/P	Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL) [MIM:611105]	A0A146UUB7	626	L	V
Q6PI48	LP/P	Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL) [MIM:611105]	A0A146UUB7	629	Y	C
Q15038	LB/B	-	A0A091DH07	102	S	A
Q9UBU7	LB/B	-	A0A1U7QYZ3	112	Y	N
Q9UBU7	LB/B	-	A0A1U7QYZ3	575	H	R
P09172	LB/B	-	G5B8I2	318	A	S
P09172	LB/B	-	G5B8I2	211	A	T
P09172	LB/B	-	G5B8I2	549	R	C
P09172	LB/B	-	G5B8I2	181	E	Q
P09172	LB/B	-	G5B8I2	239	K	N
P09172	LB/B	-	G5B8I2	250	E	Q
P09172	LB/B	-	G5B8I2	290	D	N
P09172	LB/B	-	G5B8I2	317	L	P
P09172	LP/P	Orthostatic hypotension 1 (ORTHYP1) [MIM:223360]	G5B8I2	101	V	M
P09172	LP/P	Orthostatic hypotension 1 (ORTHYP1) [MIM:223360]	G5B8I2	114	D	E
P09172	LP/P	Orthostatic hypotension 1 (ORTHYP1) [MIM:223360]	G5B8I2	345	D	N
P09172	LB/B	-	G5B8I2	12	G	S
P07108	LB/B	-	A0A2K5FA48	39	D	N
P07108	LB/B	-	A0A2K5FA48	71	M	V
P07108	LB/B	-	A0A2K5FA48	86	G	R
Q16643	LB/B	-	F6URX7	446	I	V
Q16643	LB/B	-	F6URX7	553	S	P
P11182	LP/P	Maple syrup urine disease 2 (MSUD2) [MIM:248600]	F7FPX4	276	F	C
P11182	LP/P	Maple syrup urine disease 2 (MSUD2) [MIM:248600]	F7FPX4	98	I	M
P11182	LP/P	Maple syrup urine disease 2 (MSUD2) [MIM:248600]	F7FPX4	384	G	S
Q6ZNG2	LB/B	-	A0A2I0URS1	171	M	V
Q9Y4B6	LB/B	-	T1J9J0	267	N	D
Q9Y4B6	LB/B	-	T1J9J0	378	L	F
Q9Y4B6	LB/B	-	T1J9J0	1031	L	P
Q8TEB1	LB/B	-	A0A1S3WT18	207	R	H
Q5T6F0	LB/B	-	A0A2I2YB32	131	R	Q
Q5VU92	LB/B	-	G1THK7	19	D	G
Q5VW00	LB/B	-	G1THK7	147	H	Q
Q9NV06	LB/B	-	A0A2K5LU86	42	I	V
Q9NV06	LB/B	-	A0A2K5LU86	70	N	S
Q5H9S7	LB/B	-	V8P4Y8	185	H	Q
Q58WW2	LB/B	-	H3D8R6	547	V	A
Q5TAQ9	LP/P	Giant axonal neuropathy 2, autosomal dominant (GAN2) [MIM:610100]	M7BP98	317	R	C
A6NGE4	LB/B	-	M7BP98	549	R	W
P0C7V8	LB/B	-	M7BP98	345	T	A
Q8WVC6	LB/B	-	A0A2K6TR62	84	N	I
Q8TF63	LB/B	-	A0A2I3HVC9	75	T	P
Q8TF63	LB/B	-	A0A2I3HVC9	97	N	D
Q96PD2	LB/B	-	W5NKM7	144	I	M
Q96PD2	LB/B	-	W5NKM7	723	D	N
P43146	LB/B	-	H2SLV3	201	R	G
P43146	LB/B	-	H2SLV3	1017	M	V
P43146	LB/B	-	H2SLV3	759	I	M
P43146	LB/B	-	H2SLV3	23	F	L
P43146	LB/B	-	H2SLV3	679	L	R
P43146	LB/B	-	H2SLV3	1191	H	L
P43146	LP/P	Mirror movements 1 (MRMV1) [MIM:157600]	H2SLV3	793	V	G
P43146	LP/P	Mirror movements 1 (MRMV1) [MIM:157600]	H2SLV3	805	G	E
Q9UHG0	LB/B	-	A0A2K5NRS6	221	S	G
Q9UHG0	LB/B	-	A0A2K5NRS6	152	P	A
Q9UHG0	LB/B	-	A0A2K5NRS6	456	K	N
Q9UHG0	LP/P	Deafness, autosomal recessive, 66 (DFNB66) [MIM:610212]	A0A2K5NRS6	424	Q	P
Q9UHG0	LP/P	Sclerosing cholangitis, neonatal (NSC) [MIM:617394]	A0A2K5NRS6	17	K	N
Q96JQ0	LB/B	-	Q4SRZ9	1949	T	M
Q96JQ0	LB/B	-	Q4SRZ9	2331	V	I
Q96JQ0	LB/B	-	Q4SRZ9	2359	R	C
Q96JQ0	LB/B	-	Q4SRZ9	2172	L	Q
Q96JQ0	LP/P	Van Maldergem syndrome 1 (VMLDS1) [MIM:601390]	Q4SRZ9	2370	N	I
Q96JQ0	LB/B	-	Q4SRZ9	197	P	L
Q96JQ0	LP/P	Mitral valve prolapse 2 (MVP2) [MIM:607829]	Q4SRZ9	2330	R	C
Q96JQ0	LP/P	Mitral valve prolapse 2 (MVP2) [MIM:607829]	Q4SRZ9	2513	R	H
O15075	LB/B	-	H3DK37	292	R	H
Q8N568	LB/B	-	H3DK37	119	G	C
Q8N568	LB/B	-	H3DK37	372	R	H
Q8N568	LB/B	-	H3DK37	583	I	V
Q6PJP8	LB/B	-	G1NEW4	58	K	E
Q6PJP8	LB/B	-	G1NEW4	59	E	D
Q6PJP8	LB/B	-	G1NEW4	71	G	D
Q6PJP8	LB/B	-	G1NEW4	287	P	L
Q6PJP8	LB/B	-	G1NEW4	317	D	H
Q6PJP8	LB/B	-	G1NEW4	859	I	F
Q6PJP8	LB/B	-	G1NEW4	582	G	W
Q9H816	LB/B	-	G3WJ97	46	R	L
Q9H816	LB/B	-	G3WJ97	61	H	Y
Q9H816	LB/B	-	G3WJ97	462	D	N
Q9H816	LB/B	-	G3WJ97	510	N	Y
Q9H816	LP/P	Dyskeratosis congenita, autosomal recessive, 8 (DKCB8) [MIM:620133]	G3WJ97	142	L	F
Q9H816	LP/P	Dyskeratosis congenita, autosomal recessive, 8 (DKCB8) [MIM:620133]	G3WJ97	142	L	S
Q96SD1	LP/P	Omenn syndrome (OS) [MIM:603554]	H2MSA9	35	H	D
Q96SD1	LP/P	Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-positive with sensitivity to ionizing radiation (RSSCID) [MIM:602450]	H2MSA9	118	G	V
Q96SD1	LP/P	Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-positive with sensitivity to ionizing radiation (RSSCID) [MIM:602450]	H2MSA9	135	G	E
Q96SD1	LB/B	-	H2MSA9	171	P	R
Q96SD1	LB/B	-	H2MSA9	243	H	R
Q96SD1	LB/B	-	H2MSA9	320	S	C
Q96SD1	LB/B	-	H2MSA9	140	A	V
Q96SD1	LB/B	-	H2MSA9	153	G	R
Q96SD1	LB/B	-	H2MSA9	329	L	M
P07585	LB/B	-	S9Y9F3	273	E	Q
P07585	LB/B	-	S9Y9F3	268	T	M
Q8IZD4	LB/B	-	V8PHM6	195	N	D
Q8IZD4	LB/B	-	V8PHM6	216	N	S
Q8IZD4	LB/B	-	V8PHM6	301	S	T
Q8IZD4	LB/B	-	V8PHM6	344	R	H
Q96C86	LB/B	-	A0A182Y9N3	73	G	E
Q96C86	LP/P	Al-Raqad syndrome (ARS) [MIM:616459]	A0A182Y9N3	316	T	M
Q5T197	LB/B	-	H2N5I6	512	M	L
Q5T197	LB/B	-	H2N5I6	158	T	I
Q14203	LB/B	-	A0A2D0QEP4	163	A	P
Q14203	LP/P	Neuronopathy, distal hereditary motor, 7B (HMN7B) [MIM:607641]	A0A2D0QEP4	59	G	S
Q14203	LB/B	-	A0A2D0QEP4	287	L	M
Q14203	LB/B	-	A0A2D0QEP4	495	R	Q
Q14203	LP/P	Perry syndrome (PERRYS) [MIM:168605]	A0A2D0QEP4	71	G	A
Q14203	LP/P	Perry syndrome (PERRYS) [MIM:168605]	A0A2D0QEP4	71	G	E
Q14203	LP/P	Perry syndrome (PERRYS) [MIM:168605]	A0A2D0QEP4	71	G	R
Q14203	LP/P	Perry syndrome (PERRYS) [MIM:168605]	A0A2D0QEP4	72	T	P
Q14203	LP/P	Perry syndrome (PERRYS) [MIM:168605]	A0A2D0QEP4	74	Q	P
Q14203	LP/P	Amyotrophic lateral sclerosis (ALS) [MIM:105400]	A0A2D0QEP4	571	M	T
Q14203	LP/P	Amyotrophic lateral sclerosis (ALS) [MIM:105400]	A0A2D0QEP4	785	R	W
Q14203	LP/P	Amyotrophic lateral sclerosis (ALS) [MIM:105400]	A0A2D0QEP4	1101	R	K
Q14203	LP/P	Perry syndrome (PERRYS) [MIM:168605]	A0A2D0QEP4	52	F	L
Q14203	LP/P	Perry syndrome (PERRYS) [MIM:168605]	A0A2D0QEP4	78	Y	C
Q14203	LB/B	-	A0A2D0QEP4	196	I	V
Q9UJW0	LB/B	-	A0A287BK24	342	F	L
Q9UJW0	LB/B	-	A0A287BK24	438	S	N
Q9UJW0	LB/B	-	A0A287BK24	263	Y	C
Q9UJW0	LB/B	-	A0A287BK24	95	P	T
Q16531	LB/B	-	A0A146WF39	427	L	F
Q16531	LP/P	White-Kernohan syndrome (WHIKERS) [MIM:619426]	A0A146WF39	188	R	Q
Q16531	LP/P	White-Kernohan syndrome (WHIKERS) [MIM:619426]	A0A146WF39	188	R	W
Q16531	LP/P	White-Kernohan syndrome (WHIKERS) [MIM:619426]	A0A146WF39	213	E	K
Q16531	LP/P	White-Kernohan syndrome (WHIKERS) [MIM:619426]	A0A146WF39	429	F	V
Q92466	LP/P	Xeroderma pigmentosum complementation group E (XP-E) [MIM:278740]	G5BPC2	244	K	E
Q92466	LP/P	Xeroderma pigmentosum complementation group E (XP-E) [MIM:278740]	G5BPC2	273	R	H
Q92466	LB/B	-	G5BPC2	215	M	T
Q92466	LB/B	-	G5BPC2	293	A	T
O94830	LB/B	-	G3WYH6	186	T	M
O94830	LP/P	Spastic paraplegia 54, autosomal recessive (SPG54) [MIM:615033]	G3WYH6	660	D	H
Q8WTU0	LB/B	-	L5LNF1	136	G	S
Q8WTU0	LB/B	-	L5LNF1	142	S	G
Q8WTU0	LB/B	-	L5LNF1	239	G	E
Q96D03	LB/B	-	G3INL0	161	S	F
Q99489	LB/B	-	F7EJR8	189	Q	E
Q99489	LB/B	-	F7EJR8	230	H	Y
Q99489	LB/B	-	F7EJR8	255	L	R
Q08345	LB/B	-	Q4SNG7	17	S	G
Q08345	LB/B	-	Q4SNG7	100	V	A
Q08345	LB/B	-	Q4SNG7	169	R	Q
Q08345	LB/B	-	Q4SNG7	170	A	D
Q08345	LB/B	-	Q4SNG7	306	R	W
Q08345	LB/B	-	Q4SNG7	833	L	V
Q16832	LB/B	-	A0A226MS34	441	M	I
Q16832	LB/B	-	A0A226MS34	478	R	C
Q16832	LB/B	-	A0A226MS34	543	V	F
Q16832	LP/P	Spondyloepimetaphyseal dysplasia, short limb-hand type (SEMD-SL) [MIM:271665]	A0A226MS34	713	T	I
Q16832	LP/P	Spondyloepimetaphyseal dysplasia, short limb-hand type (SEMD-SL) [MIM:271665]	A0A226MS34	726	I	R
Q16832	LP/P	Spondyloepimetaphyseal dysplasia, short limb-hand type (SEMD-SL) [MIM:271665]	A0A226MS34	752	R	C
Q16832	LP/P	Spondyloepimetaphyseal dysplasia, short limb-hand type (SEMD-SL) [MIM:271665]	A0A226MS34	113	E	K
Q16832	LP/P	Spondyloepimetaphyseal dysplasia, short limb-hand type (SEMD-SL) [MIM:271665]	A0A226MS34	124	R	W
Q16832	LP/P	Warburg-Cinotti syndrome (WRCN) [MIM:618175]	A0A226MS34	610	L	P
Q16832	LP/P	Warburg-Cinotti syndrome (WRCN) [MIM:618175]	A0A226MS34	740	Y	C
Q96HY6	LB/B	-	A0A2I2YBE1	303	A	T
Q9NVP1	LB/B	-	Q8K363	94	T	S
Q9NVP1	LB/B	-	Q8K363	647	K	R
Q9UMR2	LB/B	-	A0A2K6LV91	149	V	L
Q9UHI6	LB/B	-	A0A091SKB1	636	I	T
Q9UHI6	LB/B	-	A0A091SKB1	693	R	S
Q9UHI6	LB/B	-	A0A091SKB1	762	I	T
Q9NR30	LB/B	-	A0A1S3WCH1	27	T	I
Q9GZR7	LB/B	-	A0A091L1V5	316	E	K
Q96GQ7	LB/B	-	A0A1S3HZP9	766	G	S
Q9NUL7	LB/B	-	A0A1A6FYS2	4	T	A
Q9H8H2	LB/B	-	G3X3H2	799	I	V
Q9H8H2	LB/B	-	G3X3H2	843	R	Q
Q9H8H2	LB/B	-	G3X3H2	153	E	K
Q9H8H2	LB/B	-	G3X3H2	687	R	Q
O00148	LB/B	-	A0A060XUI5	142	V	I
O00571	LP/P	Intellectual developmental disorder, X-linked, syndromic, Snijders Blok type (MRXSSB) [MIM:300958]	A0A226NLW5	214	I	T
O00571	LP/P	Intellectual developmental disorder, X-linked, syndromic, Snijders Blok type (MRXSSB) [MIM:300958]	A0A226NLW5	233	A	V
O00571	LP/P	Intellectual developmental disorder, X-linked, syndromic, Snijders Blok type (MRXSSB) [MIM:300958]	A0A226NLW5	235	L	P
O00571	LP/P	Intellectual developmental disorder, X-linked, syndromic, Snijders Blok type (MRXSSB) [MIM:300958]	A0A226NLW5	300	V	F
O00571	LP/P	Intellectual developmental disorder, X-linked, syndromic, Snijders Blok type (MRXSSB) [MIM:300958]	A0A226NLW5	326	R	H
O00571	LP/P	Intellectual developmental disorder, X-linked, syndromic, Snijders Blok type (MRXSSB) [MIM:300958]	A0A226NLW5	351	R	Q
O00571	LP/P	Intellectual developmental disorder, X-linked, syndromic, Snijders Blok type (MRXSSB) [MIM:300958]	A0A226NLW5	362	R	C
O00571	LP/P	Intellectual developmental disorder, X-linked, syndromic, Snijders Blok type (MRXSSB) [MIM:300958]	A0A226NLW5	376	R	C
O00571	LP/P	Intellectual developmental disorder, X-linked, syndromic, Snijders Blok type (MRXSSB) [MIM:300958]	A0A226NLW5	392	L	P
O00571	LP/P	Intellectual developmental disorder, X-linked, syndromic, Snijders Blok type (MRXSSB) [MIM:300958]	A0A226NLW5	417	Q	P
O00571	LP/P	Intellectual developmental disorder, X-linked, syndromic, Snijders Blok type (MRXSSB) [MIM:300958]	A0A226NLW5	475	R	G
O00571	LP/P	Intellectual developmental disorder, X-linked, syndromic, Snijders Blok type (MRXSSB) [MIM:300958]	A0A226NLW5	480	R	S
O00571	LP/P	Intellectual developmental disorder, X-linked, syndromic, Snijders Blok type (MRXSSB) [MIM:300958]	A0A226NLW5	488	R	H
O00571	LP/P	Intellectual developmental disorder, X-linked, syndromic, Snijders Blok type (MRXSSB) [MIM:300958]	A0A226NLW5	507	I	T
O00571	LP/P	Intellectual developmental disorder, X-linked, syndromic, Snijders Blok type (MRXSSB) [MIM:300958]	A0A226NLW5	509	N	I
O00571	LP/P	Intellectual developmental disorder, X-linked, syndromic, Snijders Blok type (MRXSSB) [MIM:300958]	A0A226NLW5	514	I	T
O00571	LP/P	Intellectual developmental disorder, X-linked, syndromic, Snijders Blok type (MRXSSB) [MIM:300958]	A0A226NLW5	534	R	H
O00571	LP/P	Intellectual developmental disorder, X-linked, syndromic, Snijders Blok type (MRXSSB) [MIM:300958]	A0A226NLW5	568	P	L
Q9NQI0	LB/B	-	G1KQJ8	148	G	D
Q9NQI0	LB/B	-	G1KQJ8	287	I	V
Q9UJV9	LP/P	Myeloproliferative/lymphoproliferative neoplasms, familial (MPLPF) [MIM:616871]	M7BS62	525	R	H
Q9NXZ2	LB/B	-	D2H4I8	625	K	E
Q9NXZ2	LB/B	-	D2H4I8	629	Q	R
Q7L014	LB/B	-	L5JUC1	207	E	Q
Q9Y6V7	LB/B	-	A0A085MA14	222	R	H
Q9Y6V7	LB/B	-	A0A085MA14	296	S	A
Q9Y6V7	LB/B	-	A0A085MA14	413	R	W
Q8N8A6	LB/B	-	W5PQS9	41	R	Q
Q8N8A6	LB/B	-	W5PQS9	134	E	V
Q8N8A6	LB/B	-	W5PQS9	175	Q	K
Q8N8A6	LB/B	-	W5PQS9	249	P	L
Q8N8A6	LB/B	-	W5PQS9	295	Q	R
Q8N8A6	LB/B	-	W5PQS9	406	Q	K
Q8N8A6	LB/B	-	W5PQS9	652	Q	K
Q8N8A6	LB/B	-	W5PQS9	322	A	V
Q9Y2R4	LB/B	-	A0A1D5PUB0	403	V	M
Q86TM3	LB/B	-	D2H4I8	62	V	A
Q86TM3	LB/B	-	D2H4I8	381	M	I
Q86TM3	LB/B	-	D2H4I8	391	R	M
Q8TDD1	LB/B	-	C3Y4L5	821	P	L
Q8TDD1	LB/B	-	C3Y4L5	570	R	H
Q8TDD1	LB/B	-	C3Y4L5	693	R	Q
Q8TDD1	LB/B	-	C3Y4L5	712	V	A
Q8NHQ9	LB/B	-	A0A210Q3N6	101	V	L
Q8NHQ9	LB/B	-	A0A210Q3N6	154	E	G
Q8NHQ9	LB/B	-	A0A210Q3N6	264	N	S
Q8NHQ9	LB/B	-	A0A210Q3N6	556	N	S
Q5T1V6	LB/B	-	H3CXJ2	107	I	V
Q5T1V6	LB/B	-	H3CXJ2	472	S	R
Q5T1V6	LP/P	Orofaciodigital syndrome 5 (OFD5) [MIM:174300]	H3CXJ2	367	V	G
Q5T1V6	LP/P	Orofaciodigital syndrome 5 (OFD5) [MIM:174300]	H3CXJ2	534	G	R
P26196	LP/P	Intellectual developmental disorder with impaired language and dysmorphic facies (IDDILF) [MIM:618653]	A0A146TPJ7	372	H	R
P26196	LP/P	Intellectual developmental disorder with impaired language and dysmorphic facies (IDDILF) [MIM:618653]	A0A146TPJ7	373	R	Q
P26196	LP/P	Intellectual developmental disorder with impaired language and dysmorphic facies (IDDILF) [MIM:618653]	A0A146TPJ7	390	C	R
P26196	LP/P	Intellectual developmental disorder with impaired language and dysmorphic facies (IDDILF) [MIM:618653]	A0A146TPJ7	391	T	I
P26196	LP/P	Intellectual developmental disorder with impaired language and dysmorphic facies (IDDILF) [MIM:618653]	A0A146TPJ7	391	T	P
Q8IY21	LB/B	-	L5MHT7	672	V	M
Q8IY21	LB/B	-	L5MHT7	998	I	V
Q5H9U9	LB/B	-	L5MHT7	336	C	Y
Q5H9U9	LB/B	-	L5MHT7	355	N	K
Q5H9U9	LB/B	-	L5MHT7	409	V	L
Q5H9U9	LB/B	-	L5MHT7	583	A	T
Q5H9U9	LB/B	-	L5MHT7	1080	S	C
O75398	LP/P	Vulto-van Silfout-de Vries syndrome (VSVS) [MIM:615828]	A0A2U3YDP3	228	I	S
O75398	LP/P	Vulto-van Silfout-de Vries syndrome (VSVS) [MIM:615828]	A0A2U3YDP3	224	R	W
O75398	LB/B	-	A0A2U3YDP3	226	R	W
O75398	LP/P	Vulto-van Silfout-de Vries syndrome (VSVS) [MIM:615828]	A0A2U3YDP3	254	R	S
O75398	LP/P	Vulto-van Silfout-de Vries syndrome (VSVS) [MIM:615828]	A0A2U3YDP3	264	Q	P
Q6ZN54	LB/B	-	A0A2K6GIT5	90	Q	E
P12838	LB/B	-	A0A1U7UBZ8	8	A	P
P12838	LB/B	-	A0A1U7UBZ8	8	A	V
Q01523	LB/B	-	A0A1U7UBZ8	71	R	H
P60022	LB/B	-	A0A2K6F365	48	A	V
P60022	LB/B	-	A0A2K6F365	67	C	S
P60022	LB/B	-	A0A2K6F365	38	V	I
Q8WTQ1	LB/B	-	A0A2K6ER89	10	I	V
Q8NET1	LB/B	-	F6RM81	36	R	W
Q8NET1	LB/B	-	F6RM81	27	I	V
Q8NET1	LB/B	-	F6RM81	45	H	L
Q8NET1	LB/B	-	F6RM81	53	Q	R
Q96PH6	LB/B	-	A0A2R8MX32	56	I	V
Q8N687	LB/B	-	A0A2J8VIG5	62	H	Y
Q9H1M3	LB/B	-	A0A2Y9PPA0	149	T	S
O15121	LP/P	Leukodystrophy, hypomyelinating, 18 (HLD18) [MIM:618404]	A0A146WXG3	113	N	D
O15121	LP/P	Leukodystrophy, hypomyelinating, 18 (HLD18) [MIM:618404]	A0A146WXG3	133	R	W
O15121	LP/P	Leukodystrophy, hypomyelinating, 18 (HLD18) [MIM:618404]	A0A146WXG3	255	N	S
O15121	LP/P	Leukodystrophy, hypomyelinating, 18 (HLD18) [MIM:618404]	A0A146WXG3	280	A	V
Q6QHC5	LB/B	-	A0A146WXG3	57	A	T
Q6QHC5	LB/B	-	A0A146WXG3	8	S	N
P35659	LB/B	-	F1P9G4	140	V	A
Q14154	LB/B	-	A0A1L8GR41	128	F	L
Q14154	LB/B	-	A0A1L8GR41	247	A	T
Q14154	LB/B	-	A0A1L8GR41	95	A	T
Q14154	LB/B	-	A0A1L8GR41	468	R	C
Q14154	LB/B	-	A0A1L8GR41	60	G	D
Q9P2X7	LB/B	-	F6UQG0	60	A	V
Q6P3S1	LB/B	-	F1S5G7	216	V	M
Q8IV53	LB/B	-	G1SZP2	23	A	T
Q8IV53	LB/B	-	G1SZP2	489	R	C
Q8IV53	LB/B	-	G1SZP2	542	A	V
Q9ULE3	LB/B	-	G3WS54	156	P	H
Q9ULE3	LB/B	-	G3WS54	729	E	K
Q9ULE3	LB/B	-	G3WS54	777	I	T
Q68D51	LB/B	-	A0A091NHL4	2	D	E
Q68D51	LB/B	-	A0A091NHL4	170	D	G
Q9H6A0	LB/B	-	H0V1F5	282	S	N
A2RUS2	LB/B	-	F6PV42	143	S	N
A2RUS2	LB/B	-	F6PV42	364	Q	R
Q7Z401	LB/B	-	A0A2U9BVS8	284	L	P
Q5VZ89	LB/B	-	A0A2U9BVS8	1266	T	A
Q5VZ89	LB/B	-	A0A2U9BVS8	1343	N	H
Q5VZ89	LB/B	-	A0A2U9BVS8	1227	V	G
Q6IQ26	LB/B	-	A0A2J7R2K5	224	E	Q
Q6ZUT9	LB/B	-	A0A2J7R2K5	52	R	K
Q6ZUT9	LB/B	-	A0A2J7R2K5	487	H	N
Q5TB30	LB/B	-	A0A2Y9D749	404	I	R
Q8WUY9	LB/B	-	W5MLV6	332	R	M
Q8WUY9	LB/B	-	W5MLV6	395	V	L
Q8N2C3	LB/B	-	F7E3H4	122	H	R
Q96QD5	LB/B	-	A0A1W5AT70	192	A	T
Q96QD5	LB/B	-	A0A1W5AT70	464	T	I
Q9NTK1	LB/B	-	A0A1U7TCK1	44	I	M
Q8TB45	LB/B	-	G1STH6	148	N	S
Q8TB45	LB/B	-	G1STH6	204	N	S
Q8TB45	LB/B	-	G1STH6	389	S	N
Q9BUN8	LB/B	-	G3MLT5	171	I	V
P17661	LP/P	Myopathy, myofibrillar, 1 (MFM1) [MIM:601419]	F7AWR3	337	A	P
P17661	LP/P	Myopathy, myofibrillar, 1 (MFM1) [MIM:601419]	F7AWR3	360	A	P
P17661	LP/P	Myopathy, myofibrillar, 1 (MFM1) [MIM:601419]	F7AWR3	393	N	I
P17661	LP/P	Myopathy, myofibrillar, 1 (MFM1) [MIM:601419]	F7AWR3	345	L	P
P17661	LP/P	Myopathy, myofibrillar, 1 (MFM1) [MIM:601419]	F7AWR3	385	L	P
P17661	LP/P	Myopathy, myofibrillar, 1 (MFM1) [MIM:601419]	F7AWR3	389	Q	P
P17661	LP/P	Cardiomyopathy, dilated 1I (CMD1I) [MIM:604765]	F7AWR3	451	I	M
P17661	LP/P	Myopathy, myofibrillar, 1 (MFM1) [MIM:601419]	F7AWR3	451	I	M
P17661	LP/P	Myopathy, myofibrillar, 1 (MFM1) [MIM:601419]	F7AWR3	2	S	I
P17661	LP/P	Myopathy, myofibrillar, 1 (MFM1) [MIM:601419]	F7AWR3	46	S	F
P17661	LP/P	Myopathy, myofibrillar, 1 (MFM1) [MIM:601419]	F7AWR3	46	S	Y
P17661	LB/B	-	F7AWR3	213	A	V
P17661	LP/P	Myopathy, myofibrillar, 1 (MFM1) [MIM:601419]	F7AWR3	245	E	D
P17661	LP/P	Myopathy, myofibrillar, 1 (MFM1) [MIM:601419]	F7AWR3	342	N	D
P17661	LP/P	Myopathy, myofibrillar, 1 (MFM1) [MIM:601419]	F7AWR3	350	R	P
P17661	LP/P	Neurogenic scapuloperoneal syndrome Kaeser type (Kaeser syndrome) [MIM:181400]	F7AWR3	350	R	P
P17661	LP/P	Myopathy, myofibrillar, 1 (MFM1) [MIM:601419]	F7AWR3	355	R	P
P17661	LP/P	Myopathy, myofibrillar, 1 (MFM1) [MIM:601419]	F7AWR3	357	A	P
P17661	LP/P	Myopathy, myofibrillar, 1 (MFM1) [MIM:601419]	F7AWR3	370	L	P
P17661	LP/P	Myopathy, myofibrillar, 1 (MFM1) [MIM:601419]	F7AWR3	406	R	W
P17661	LP/P	Myopathy, myofibrillar, 1 (MFM1) [MIM:601419]	F7AWR3	442	T	I
P17661	LP/P	Myopathy, myofibrillar, 1 (MFM1) [MIM:601419]	F7AWR3	449	K	M
P17661	LP/P	Myopathy, myofibrillar, 1 (MFM1) [MIM:601419]	F7AWR3	449	K	T
P17661	LP/P	Myopathy, myofibrillar, 1 (MFM1) [MIM:601419]	F7AWR3	454	R	W
P17661	LP/P	Myopathy, myofibrillar, 1 (MFM1) [MIM:601419]	F7AWR3	460	S	I
P17661	LP/P	Myopathy, myofibrillar, 1 (MFM1) [MIM:601419]	F7AWR3	7	S	F
P17661	LP/P	Myopathy, myofibrillar, 1 (MFM1) [MIM:601419]	F7AWR3	13	S	F
P17661	LP/P	Myopathy, myofibrillar, 1 (MFM1) [MIM:601419]	F7AWR3	338	L	R
P17661	LP/P	Myopathy, myofibrillar, 1 (MFM1) [MIM:601419]	F7AWR3	399	D	Y
P17661	LP/P	Myopathy, myofibrillar, 1 (MFM1) [MIM:601419]	F7AWR3	401	E	K
P17661	LP/P	Myopathy, myofibrillar, 1 (MFM1) [MIM:601419]	F7AWR3	419	P	S
P17661	LP/P	Myopathy, myofibrillar, 1 (MFM1) [MIM:601419]	F7AWR3	116	N	S
P17661	LB/B	-	F7AWR3	241	K	E
P17661	LP/P	Cardiomyopathy, dilated 1I (CMD1I) [MIM:604765]	F7AWR3	120	A	D
P17661	LP/P	Cardiomyopathy, dilated 1I (CMD1I) [MIM:604765]	F7AWR3	136	L	P
P17661	LP/P	Myopathy, myofibrillar, 1 (MFM1) [MIM:601419]	F7AWR3	16	R	C
P17661	LP/P	Myopathy, myofibrillar, 1 (MFM1) [MIM:601419]	F7AWR3	453	T	I
Q05D60	LB/B	-	A0A091GN66	175	S	F
Q05D60	LB/B	-	A0A091GN66	440	E	Q
Q05D60	LB/B	-	A0A091GN66	504	Q	K
Q05D60	LB/B	-	A0A091GN66	440	E	G
O76075	LB/B	-	A0A1S3GDW4	196	R	K
O76075	LB/B	-	A0A1S3GDW4	277	K	R
P98153	LB/B	-	A0A2Y9QGF5	473	V	A
Q8WYQ5	LB/B	-	A0A2P4TAZ1	174	I	V
Q8WYQ5	LB/B	-	A0A2P4TAZ1	725	N	D
P52429	LP/P	Hemolytic uremic syndrome atypical 7 (AHUS7) [MIM:615008]	W5P9H9	63	R	P
P52429	LP/P	Hemolytic uremic syndrome atypical 7 (AHUS7) [MIM:615008]	W5P9H9	273	R	P
Q86XP1	LB/B	-	A0A2Y9MS27	1201	V	A
O75912	LB/B	-	A0A226PQ98	153	L	F
Q5KSL6	LB/B	-	A0A2U3YP03	1118	D	N
Q13574	LB/B	-	A0A226PQ98	523	Q	K
Q16854	LP/P	Mitochondrial DNA depletion syndrome 3 (MTDPS3) [MIM:251880]	A0A2K6MSG9	142	R	K
Q16854	LP/P	Mitochondrial DNA depletion syndrome 3 (MTDPS3) [MIM:251880]	A0A2K6MSG9	227	E	K
Q16854	LP/P	Mitochondrial DNA depletion syndrome 3 (MTDPS3) [MIM:251880]	A0A2K6MSG9	250	L	S
Q16854	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4 (PEOB4) [MIM:617070]	A0A2K6MSG9	44	E	K
Q16854	LP/P	Portal hypertension, non-cirrhotic, 1 (NCPH1) [MIM:617068]	A0A2K6MSG9	46	N	S
Q16854	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4 (PEOB4) [MIM:617070]	A0A2K6MSG9	154	N	K
Q16854	LB/B	-	A0A2K6MSG9	266	L	R
Q15392	LP/P	Desmosterolosis (DESMOS) [MIM:602398]	F6ZHE7	191	E	K
Q15392	LP/P	Desmosterolosis (DESMOS) [MIM:602398]	F6ZHE7	294	N	T
Q15392	LP/P	Desmosterolosis (DESMOS) [MIM:602398]	F6ZHE7	306	K	N
Q15392	LP/P	Desmosterolosis (DESMOS) [MIM:602398]	F6ZHE7	471	Y	S
Q15392	LP/P	Desmosterolosis (DESMOS) [MIM:602398]	F6ZHE7	94	R	H
Q15392	LP/P	Desmosterolosis (DESMOS) [MIM:602398]	F6ZHE7	480	E	K
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	51	P	S
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	93	T	M
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	99	L	P
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	119	H	L
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	157	L	P
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	244	G	R
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	247	A	V
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	248	W	C
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	289	T	I
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	326	V	L
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	352	R	W
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	380	C	S
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	404	R	C
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	410	G	S
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	448	E	K
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	68	L	P
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	107	Q	H
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	109	L	P
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	113	S	C
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	138	G	V
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	145	I	L
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	147	G	D
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	154	T	M
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	169	S	L
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	182	W	C
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	182	W	L
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	183	C	Y
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	198	K	E
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	235	F	S
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	242	R	C
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	242	R	H
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	255	F	L
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	281	V	M
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	297	I	T
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	311	C	G
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	311	C	Y
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	324	Y	H
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	344	G	R
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	352	R	Q
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	353	V	A
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	362	R	C
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	380	C	R
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	380	C	Y
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	397	S	L
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	404	R	S
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	405	H	Y
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	408	Y	H
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	410	G	R
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	426	H	P
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	443	R	C
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	446	R	Q
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	448	E	Q
Q9UBM7	LP/P	Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]	Q5RCV4	450	R	L
Q9UBM7	LB/B	-	Q5RCV4	425	G	S
Q9UBM7	LB/B	-	Q5RCV4	5	S	L
Q9UBM7	LB/B	-	Q5RCV4	118	C	R
Q9UQ10	LB/B	-	A0A1S3KDT8	2	A	P
Q9UQ10	LB/B	-	A0A1S3KDT8	66	S	N
Q9UQ10	LB/B	-	A0A1S3KDT8	200	V	M
Q9UQ10	LB/B	-	A0A1S3KDT8	247	V	A
Q9UQ10	LB/B	-	A0A1S3KDT8	282	G	R
P00374	LP/P	Megaloblastic anemia due to dihydrofolate reductase deficiency (DHFRD) [MIM:613839]	A0A024RAQ3	80	L	F
P00374	LP/P	Megaloblastic anemia due to dihydrofolate reductase deficiency (DHFRD) [MIM:613839]	A0A024RAQ3	153	D	V
Q86XF0	LB/B	-	A0A024RAQ3	166	V	I
O43323	LP/P	46,XY sex reversal 7 (SRXY7) [MIM:233420]	L8Y929	162	L	P
Q02127	LB/B	-	A0A2Y9F1S1	7	K	Q
Q02127	LP/P	Postaxial acrofacial dysostosis (POADS) [MIM:263750]	A0A2Y9F1S1	19	G	E
Q02127	LP/P	Postaxial acrofacial dysostosis (POADS) [MIM:263750]	A0A2Y9F1S1	135	R	C
Q02127	LP/P	Postaxial acrofacial dysostosis (POADS) [MIM:263750]	A0A2Y9F1S1	152	G	R
Q02127	LP/P	Postaxial acrofacial dysostosis (POADS) [MIM:263750]	A0A2Y9F1S1	199	R	C
Q02127	LP/P	Postaxial acrofacial dysostosis (POADS) [MIM:263750]	A0A2Y9F1S1	202	G	A
Q02127	LP/P	Postaxial acrofacial dysostosis (POADS) [MIM:263750]	A0A2Y9F1S1	202	G	D
Q02127	LP/P	Postaxial acrofacial dysostosis (POADS) [MIM:263750]	A0A2Y9F1S1	244	R	W
Q02127	LP/P	Postaxial acrofacial dysostosis (POADS) [MIM:263750]	A0A2Y9F1S1	284	T	I
Q02127	LP/P	Postaxial acrofacial dysostosis (POADS) [MIM:263750]	A0A2Y9F1S1	346	R	W
Q02127	LP/P	Postaxial acrofacial dysostosis (POADS) [MIM:263750]	A0A2Y9F1S1	392	D	G
Q96LJ7	LB/B	-	W4Y9Y0	241	T	I
Q9BTZ2	LB/B	-	L9L3D4	31	A	T
Q9BTZ2	LB/B	-	L9L3D4	202	P	S
Q9Y394	LB/B	-	H0YJ66	218	R	Q
Q8N5I4	LB/B	-	V9KU50	297	E	K
Q8N5I4	LB/B	-	V9KU50	247	V	L
Q8N5I4	LB/B	-	V9KU50	292	H	R
Q96HY7	LB/B	-	A0A2K5CIA6	20	F	L
Q96HY7	LB/B	-	A0A2K5CIA6	272	Y	D
Q96HY7	LB/B	-	A0A2K5CIA6	308	R	L
Q96HY7	LB/B	-	A0A2K5CIA6	350	N	D
Q96HY7	LB/B	-	A0A2K5CIA6	607	I	M
Q96HY7	LP/P	Alpha-aminoadipic and alpha-ketoadipic aciduria (AAKAD) [MIM:204750]	A0A2K5CIA6	729	G	R
Q96HY7	LP/P	Alpha-aminoadipic and alpha-ketoadipic aciduria (AAKAD) [MIM:204750]	A0A2K5CIA6	715	R	C
O60231	LB/B	-	A0A091CZ40	352	K	E
O60231	LB/B	-	A0A091CZ40	502	L	F
O60231	LB/B	-	A0A091CZ40	566	D	G
O60231	LP/P	Neuromuscular oculoauditory syndrome (NMOAS) [MIM:618733]	A0A091CZ40	427	G	E
Q7L2E3	LP/P	Neurodevelopmental disorder with severe motor impairment and absent language (NEDMIAL) [MIM:617804]	A0A2P6KSK5	493	R	H
Q7L2E3	LP/P	Neurodevelopmental disorder with severe motor impairment and absent language (NEDMIAL) [MIM:617804]	A0A2P6KSK5	562	H	R
Q7L2E3	LP/P	Neurodevelopmental disorder with severe motor impairment and absent language (NEDMIAL) [MIM:617804]	A0A2P6KSK5	781	G	D
Q7L2E3	LP/P	Neurodevelopmental disorder with severe motor impairment and absent language (NEDMIAL) [MIM:617804]	A0A2P6KSK5	782	R	W
Q7L2E3	LP/P	Neurodevelopmental disorder with severe motor impairment and absent language (NEDMIAL) [MIM:617804]	A0A2P6KSK5	785	R	C
Q7L2E3	LP/P	Neurodevelopmental disorder with severe motor impairment and absent language (NEDMIAL) [MIM:617804]	A0A2P6KSK5	785	R	H
Q7L7V1	LB/B	-	A0A0D9QNZ7	271	E	D
Q7L7V1	LB/B	-	A0A0D9QNZ7	301	D	A
Q7L7V1	LB/B	-	A0A0D9QNZ7	430	V	L
Q9H6R0	LB/B	-	A0A1S2ZR26	118	R	C
Q9H6R0	LB/B	-	A0A1S2ZR26	483	H	D
Q8IY37	LB/B	-	H2UYQ2	458	R	Q
Q8IY37	LB/B	-	H2UYQ2	508	K	N
Q8IY37	LB/B	-	H2UYQ2	717	V	I
Q8IY37	LB/B	-	H2UYQ2	869	S	G
Q8IY37	LB/B	-	H2UYQ2	1081	R	Q
Q8IY37	LB/B	-	H2UYQ2	96	M	I
Q8IY37	LP/P	46,XY sex reversal 11 (SRXY11) [MIM:273250]	H2UYQ2	304	T	M
Q8IY37	LP/P	46,XY sex reversal 11 (SRXY11) [MIM:273250]	H2UYQ2	308	R	Q
Q8IY37	LP/P	46,XY sex reversal 11 (SRXY11) [MIM:273250]	H2UYQ2	595	S	F
Q8IY37	LP/P	46,XY sex reversal 11 (SRXY11) [MIM:273250]	H2UYQ2	674	R	Q
Q8IY37	LP/P	46,XY sex reversal 11 (SRXY11) [MIM:273250]	H2UYQ2	674	R	W
Q6P158	LB/B	-	A0A093PMV8	433	S	G
Q6P158	LB/B	-	A0A093PMV8	410	S	F
Q6P158	LB/B	-	A0A093PMV8	587	N	S
Q96C10	LB/B	-	A0A091L9L9	425	Q	R
Q96C10	LB/B	-	A0A091L9L9	523	R	Q
Q96C10	LB/B	-	A0A091L9L9	76	T	A
Q96C10	LB/B	-	A0A091L9L9	95	R	Q
Q14562	LB/B	-	A0A061RXB0	1069	A	G
Q9NR28	LP/P	Deafness, autosomal dominant, 64 (DFNA64) [MIM:614152]	G1TZ19	126	S	L
O60610	LP/P	Deafness, autosomal dominant 1, with or without thrombocytopenia (DFNA1) [MIM:124900]	U3JMW0	678	P	S
O60879	LB/B	-	U3JMW0	425	F	L
O60879	LB/B	-	U3JMW0	426	L	V
Q9NSV4	LB/B	-	U3JMW0	363	N	S
Q9NSV4	LB/B	-	U3JMW0	773	F	L
Q9NSV4	LB/B	-	U3JMW0	1041	E	G
Q9BTC0	LB/B	-	W5M8J1	13	P	L
Q9BTC0	LB/B	-	W5M8J1	276	P	L
Q9BTC0	LB/B	-	W5M8J1	544	M	T
Q9BTC0	LB/B	-	W5M8J1	556	A	T
Q9BTC0	LB/B	-	W5M8J1	793	A	G
Q9BTC0	LB/B	-	W5M8J1	1220	P	Q
Q9BTC0	LB/B	-	W5M8J1	1708	S	C
Q92813	LB/B	-	V8PBL1	92	T	A
Q92813	LB/B	-	V8PBL1	81	A	D
Q5VUD6	LB/B	-	A0A1L8GG90	158	S	G
Q9H7Y0	LB/B	-	A0A2Y9DLQ6	128	R	K
Q9H7Y0	LB/B	-	A0A2Y9DLQ6	146	R	Q
Q969H9	LB/B	-	A0A2K6BHR6	51	S	A
Q969H9	LB/B	-	A0A2K6BHR6	92	L	S
Q9Y2L1	LB/B	-	A0A1D1VWS9	269	N	S
Q9Y2L1	LB/B	-	A0A1D1VWS9	326	T	R
Q8TF46	LB/B	-	A0A151M8W6	518	I	V
Q8TF46	LB/B	-	A0A151M8W6	614	D	G
Q8TF46	LB/B	-	A0A151M8W6	747	N	S
Q8IYB7	LB/B	-	D3K5M4	12	P	S
Q8IYB7	LP/P	-	D3K5M4	483	R	G
Q8IYB7	LP/P	Perlman syndrome (PRLMNS) [MIM:267000]	D3K5M4	489	C	Y
Q8IYB7	LP/P	-	D3K5M4	576	R	H
Q96F81	LB/B	-	L5M0F3	103	E	K
A7MBM2	LB/B	-	G1MWP4	47	P	A
A7MBM2	LB/B	-	G1MWP4	56	C	S
A7MBM2	LB/B	-	G1MWP4	388	G	E
A7MBM2	LB/B	-	G1MWP4	1145	G	S
A7MBM2	LB/B	-	G1MWP4	1247	R	W
Q9P2K9	LB/B	-	H2S9Q5	51	L	V
Q9P2K9	LB/B	-	H2S9Q5	182	G	S
Q9P2K9	LB/B	-	H2S9Q5	650	A	T
Q9P2K9	LB/B	-	H2S9Q5	661	G	A
Q9P2K9	LB/B	-	H2S9Q5	948	R	H
Q9P2K9	LB/B	-	H2S9Q5	39	G	R
Q155Q3	LB/B	-	G3T5H8	300	K	R
O60832	LP/P	Dyskeratosis congenita, X-linked (DKCX) [MIM:305000]	A0A0P5RZR4	36	F	V
O60832	LP/P	Dyskeratosis congenita, X-linked (DKCX) [MIM:305000]	A0A0P5RZR4	40	P	R
O60832	LP/P	Dyskeratosis congenita, X-linked (DKCX) [MIM:305000]	A0A0P5RZR4	72	L	Y
O60832	LP/P	Dyskeratosis congenita, X-linked (DKCX) [MIM:305000]	A0A0P5RZR4	402	G	E
O60832	LP/P	Dyskeratosis congenita, X-linked (DKCX) [MIM:305000]	A0A0P5RZR4	353	A	V
O60832	LP/P	Hoyeraal-Hreidarsson syndrome (HHS) [MIM:305000]	A0A0P5RZR4	353	A	V
O60832	LP/P	Dyskeratosis congenita, X-linked (DKCX) [MIM:305000]	A0A0P5RZR4	2	A	V
O60832	LP/P	Dyskeratosis congenita, X-linked (DKCX) [MIM:305000]	A0A0P5RZR4	39	K	E
O60832	LP/P	Dyskeratosis congenita, X-linked (DKCX) [MIM:305000]	A0A0P5RZR4	41	E	K
O60832	LP/P	Dyskeratosis congenita, X-linked (DKCX) [MIM:305000]	A0A0P5RZR4	65	R	T
O60832	LP/P	Dyskeratosis congenita, X-linked (DKCX) [MIM:305000]	A0A0P5RZR4	66	T	A
O60832	LP/P	Dyskeratosis congenita, X-linked (DKCX) [MIM:305000]	A0A0P5RZR4	321	L	V
O60832	LP/P	Dyskeratosis congenita, X-linked (DKCX) [MIM:305000]	A0A0P5RZR4	350	M	I
O60832	LP/P	Dyskeratosis congenita, X-linked (DKCX) [MIM:305000]	A0A0P5RZR4	350	M	T
O60832	LP/P	Dyskeratosis congenita, X-linked (DKCX) [MIM:305000]	A0A0P5RZR4	402	G	R
O60832	LP/P	Hoyeraal-Hreidarsson syndrome (HHS) [MIM:305000]	A0A0P5RZR4	38	I	T
O60832	LP/P	Hoyeraal-Hreidarsson syndrome (HHS) [MIM:305000]	A0A0P5RZR4	49	T	M
O60832	LP/P	Hoyeraal-Hreidarsson syndrome (HHS) [MIM:305000]	A0A0P5RZR4	121	S	G
O60832	LB/B	-	A0A0P5RZR4	223	G	D
O60832	LP/P	Dyskeratosis congenita, X-linked (DKCX) [MIM:305000]	A0A0P5RZR4	56	L	S
O60832	LP/P	Dyskeratosis congenita, X-linked (DKCX) [MIM:305000]	A0A0P5RZR4	72	L	F
O60832	LP/P	Dyskeratosis congenita, X-linked (DKCX) [MIM:305000]	A0A0P5RZR4	317	L	F
O60832	LP/P	Dyskeratosis congenita, X-linked (DKCX) [MIM:305000]	A0A0P5RZR4	322	R	Q
O60832	LP/P	Dyskeratosis congenita, X-linked (DKCX) [MIM:305000]	A0A0P5RZR4	409	P	L
O60832	LP/P	Dyskeratosis congenita, X-linked (DKCX) [MIM:305000]	A0A0P5RZR4	54	L	V
Q9UBU2	LB/B	-	V8NY19	146	R	Q
Q9UBP4	LB/B	-	A0A2I3TJP2	335	R	G
Q9UBP4	LB/B	-	A0A2I3TJP2	49	E	D
Q9UK85	LB/B	-	G3RJT6	109	M	R
Q9UK85	LB/B	-	G3RJT6	214	E	K
Q9UK85	LB/B	-	G3RJT6	29	A	T
Q9UK85	LB/B	-	G3RJT6	24	L	R
Q9UK85	LB/B	-	G3RJT6	104	L	I
Q9UK85	LB/B	-	G3RJT6	187	G	S
P10515	LB/B	-	L9KP42	43	A	V
P10515	LB/B	-	L9KP42	98	S	F
P10515	LB/B	-	L9KP42	99	L	F
P10515	LB/B	-	L9KP42	209	Q	R
P10515	LB/B	-	L9KP42	313	D	V
P10515	LB/B	-	L9KP42	318	V	A
P10515	LB/B	-	L9KP42	451	D	N
Q96QB1	LB/B	-	M3WML3	712	N	S
Q96QB1	LB/B	-	M3WML3	791	V	M
Q96QB1	LB/B	-	M3WML3	959	T	A
Q96QB1	LB/B	-	M3WML3	998	H	Q
Q96QB1	LB/B	-	M3WML3	1025	V	A
Q96QB1	LB/B	-	M3WML3	1199	E	V
Q96QB1	LB/B	-	M3WML3	1209	S	C
Q96QB1	LB/B	-	M3WML3	27	R	C
Q96QB1	LB/B	-	M3WML3	81	L	V
Q96QB1	LB/B	-	M3WML3	254	Q	H
Q96QB1	LB/B	-	M3WML3	255	N	D
Q96QB1	LB/B	-	M3WML3	260	T	I
Q96QB1	LB/B	-	M3WML3	320	Q	H
Q9Y238	LB/B	-	H3B754	79	L	R
Q9Y238	LB/B	-	H3B754	192	S	F
Q9Y238	LB/B	-	H3B754	1022	K	N
Q9Y238	LB/B	-	H3B754	1150	N	D
Q9Y238	LB/B	-	H3B754	1227	L	P
Q6UYE1	LB/B	-	F1RK27	83	A	V
Q8TDM6	LB/B	-	A0A2J7Q990	140	Q	R
Q8TDM6	LB/B	-	A0A2J7Q990	1481	P	Q
Q8TDM6	LB/B	-	A0A2J7Q990	1600	A	V
P80370	LB/B	-	A0A2I0MPR7	73	Q	L
P80370	LB/B	-	A0A2I0MPR7	104	V	M
P80370	LB/B	-	A0A2I0MPR7	260	S	N
P80370	LB/B	-	A0A2I0MPR7	101	R	G
P80370	LB/B	-	A0A2I0MPR7	108	D	G
O00548	LB/B	-	G1KB45	444	V	M
O00548	LP/P	Neurodevelopmental disorder with non-specific brain abnormalities and with or without seizures (NEDBAS) [MIM:618709]	G1KB45	179	C	F
Q9NYJ7	LP/P	Spondylocostal dysostosis 1, autosomal recessive (SCDO1) [MIM:277300]	H0VNI5	385	G	D
Q9NYJ7	LB/B	-	H0VNI5	218	L	P
Q9NYJ7	LB/B	-	H0VNI5	115	A	T
Q9NYJ7	LB/B	-	H0VNI5	142	L	Q
Q9NYJ7	LB/B	-	H0VNI5	172	F	C
P36957	LB/B	-	A0A087XPU4	213	P	A
P36957	LB/B	-	A0A087XPU4	384	P	T
P36957	LB/B	-	A0A087XPU4	304	D	N
P36957	LP/P	Paragangliomas 7 (PGL7) [MIM:618475]	A0A087XPU4	374	G	E
P56177	LB/B	-	H2UZF4	136	S	C
P56178	LB/B	-	L9JJ26	234	S	R
P56178	LP/P	Split-hand/foot malformation 1 with sensorineural hearing loss, autosomal recessive (SHFM1D) [MIM:220600]	L9JJ26	178	Q	P
Q9NW81	LB/B	-	G1LYN7	9	R	C
Q9NW81	LB/B	-	G1LYN7	23	H	R
Q9NW81	LB/B	-	G1LYN7	34	N	S
Q9NW81	LB/B	-	G1LYN7	230	E	K
Q9NW81	LB/B	-	G1LYN7	159	C	S
Q9UGM3	LB/B	-	A0A2Y9J4D5	42	P	T
Q9UGM3	LB/B	-	A0A2Y9J4D5	52	S	W
Q9UGM3	LB/B	-	A0A2Y9J4D5	54	S	L
Q9UGM3	LB/B	-	A0A2Y9J4D5	60	V	A
Q9UGM3	LB/B	-	A0A2Y9J4D5	65	P	L
Q9UGM3	LB/B	-	A0A2Y9J4D5	337	Q	L
Q9UGM3	LB/B	-	A0A2Y9J4D5	357	P	S
Q9UGM3	LB/B	-	A0A2Y9J4D5	364	R	G
Q9UGM3	LB/B	-	A0A2Y9J4D5	649	T	M
Q9UGM3	LB/B	-	A0A2Y9J4D5	656	R	W
Q9UGM3	LB/B	-	A0A2Y9J4D5	780	T	M
Q9UGM3	LB/B	-	A0A2Y9J4D5	856	P	S
Q9UGM3	LB/B	-	A0A2Y9J4D5	1084	H	Y
Q9UGM3	LB/B	-	A0A2Y9J4D5	1169	M	T
Q9UGM3	LB/B	-	A0A2Y9J4D5	1176	R	W
Q9UGM3	LB/B	-	A0A2Y9J4D5	1545	V	M
Q9UGM3	LB/B	-	A0A2Y9J4D5	1961	T	P
Q9UGM3	LB/B	-	A0A2Y9J4D5	322	N	D
Q9UGM3	LB/B	-	A0A2Y9J4D5	1860	R	L
Q9UGM3	LB/B	-	A0A2Y9J4D5	670	R	C
Q9UGM3	LB/B	-	A0A2Y9J4D5	719	T	M
Q9UGM3	LB/B	-	A0A2Y9J4D5	1095	S	P
Q9UGM3	LB/B	-	A0A2Y9J4D5	1102	S	T
Q9UGM3	LB/B	-	A0A2Y9J4D5	1434	R	W
Q9UGM3	LB/B	-	A0A2Y9J4D5	2255	V	M
Q8NFW5	LB/B	-	A0A212CHS4	205	A	P
Q9UI17	LP/P	DMGDH deficiency (DMGDHD) [MIM:605850]	A0A1F8L8R1	109	H	R
Q9UI17	LB/B	-	A0A1F8L8R1	279	S	P
Q9UI17	LB/B	-	A0A1F8L8R1	530	A	G
Q9UI17	LB/B	-	A0A1F8L8R1	646	S	P
Q6E0U4	LB/B	-	A0A1S3WW61	415	A	S
Q6E0U4	LB/B	-	A0A1S3WW61	427	D	A
Q6E0U4	LB/B	-	A0A1S3WW61	69	E	D
Q6E0U4	LB/B	-	A0A1S3WW61	139	N	S
Q6E0U4	LB/B	-	A0A1S3WW61	91	V	A
Q6E0U4	LB/B	-	A0A1S3WW61	280	G	S
Q13316	LB/B	-	G5CXG0	69	S	C
Q13316	LB/B	-	G5CXG0	272	R	H
Q13316	LB/B	-	G5CXG0	463	K	R
Q9Y5R6	LB/B	-	A0A2Y9N3M6	45	S	T
Q9Y5R6	LB/B	-	A0A2Y9N3M6	221	Y	S
Q9Y5R6	LB/B	-	A0A2Y9N3M6	281	R	S
Q9Y5R6	LB/B	-	A0A2Y9N3M6	295	P	L
Q9NQL9	LB/B	-	A0A2K5HG76	164	A	T
Q9NQL9	LB/B	-	A0A2K5HG76	261	N	T
Q9NQL9	LB/B	-	A0A2K5HG76	356	G	V
Q9Y222	LB/B	-	A0A226NZP4	479	V	I
Q9Y485	LB/B	-	H3AQ68	221	I	M
Q9Y485	LB/B	-	H3AQ68	851	S	N
Q9Y485	LB/B	-	H3AQ68	2067	V	M
Q9Y485	LB/B	-	H3AQ68	2107	T	S
Q8TDJ6	LB/B	-	H3AQ68	497	T	M
Q8TDJ6	LB/B	-	H3AQ68	903	N	D
Q8TDJ6	LB/B	-	H3AQ68	1288	S	P
Q8TDJ6	LB/B	-	H3AQ68	1481	D	G
Q8TDJ6	LB/B	-	H3AQ68	144	E	Q
Q8TDJ6	LB/B	-	H3AQ68	1698	N	S
Q8TDJ6	LP/P	Deafness, autosomal dominant, 71 (DFNA71) [MIM:617605]	H3AQ68	2417	R	H
Q8TDJ6	LP/P	Developmental and epileptic encephalopathy 81 (DEE81) [MIM:618663]	H3AQ68	1712	A	V
P51530	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 6 (PEOA6) [MIM:615156]	A0A1S2ZTC8	198	R	H
P51530	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 6 (PEOA6) [MIM:615156]	A0A1S2ZTC8	227	K	E
P51530	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 6 (PEOA6) [MIM:615156]	A0A1S2ZTC8	637	V	I
Q8NEP3	LB/B	-	A0A2J8T9R5	387	D	E
Q8NEP3	LB/B	-	A0A2J8T9R5	393	K	R
Q8NEP3	LB/B	-	A0A2J8T9R5	432	E	D
Q8NEP3	LB/B	-	A0A2J8T9R5	502	P	L
Q8NEP3	LB/B	-	A0A2J8T9R5	545	F	C
Q8NEP3	LB/B	-	A0A2J8T9R5	633	L	S
Q8NEP3	LB/B	-	A0A2J8T9R5	659	L	P
Q8NEP3	LB/B	-	A0A2J8T9R5	659	L	V
Q8NEP3	LB/B	-	A0A2J8T9R5	675	S	T
Q8NEP3	LB/B	-	A0A2J8T9R5	703	G	R
Q8NEP3	LB/B	-	A0A2J8T9R5	712	P	A
Q8NEP3	LP/P	Ciliary dyskinesia, primary, 13 (CILD13) [MIM:613193]	A0A2J8T9R5	175	L	R
Q96MX6	LB/B	-	H2P604	241	M	V
Q9NVR5	LB/B	-	G1QBT2	768	D	G
Q9NVR5	LB/B	-	G1QBT2	62	E	D
Q8N9W5	LB/B	-	A0A2Y9PG93	292	E	G
Q8N9W5	LB/B	-	A0A2Y9PG93	331	G	W
Q8N9W5	LB/B	-	A0A2Y9PG93	365	N	D
Q8N9W5	LP/P	Ciliary dyskinesia, primary, 2 (CILD2) [MIM:606763]	A0A2Y9PG93	61	L	P
Q8N9W5	LB/B	-	A0A2Y9PG93	278	A	T
Q8WXU2	LB/B	-	A0A1S3J8Z5	2	P	S
Q8WXU2	LB/B	-	A0A1S3J8Z5	91	V	I
Q8WXU2	LB/B	-	A0A1S3J8Z5	191	E	G
Q8WXU2	LB/B	-	A0A1S3J8Z5	420	S	C
Q8WXU2	LB/B	-	A0A1S3J8Z5	38	N	K
Q8WXU2	LB/B	-	A0A1S3J8Z5	332	A	V
Q86Y56	LB/B	-	A0A146YB08	632	V	A
Q86Y56	LB/B	-	A0A146YB08	560	R	C
Q86Y56	LB/B	-	A0A146YB08	743	R	K
Q86Y56	LP/P	Ciliary dyskinesia, primary, 18 (CILD18) [MIM:614874]	A0A146YB08	795	L	P
Q9NQM4	LP/P	Ciliary dyskinesia, primary, 36, X-linked (CILD36) [MIM:300991]	A0A2K6NAY0	133	D	Y
Q8IYS4	LB/B	-	A0A2K6QSP7	88	E	D
Q8IYS4	LB/B	-	A0A2K6QSP7	143	P	S
Q8IYS4	LB/B	-	A0A2K6QSP7	190	S	L
Q8IYS4	LB/B	-	A0A2K6QSP7	232	E	K
Q8IYS4	LB/B	-	A0A2K6QSP7	241	A	V
Q8IYS4	LB/B	-	A0A2K6QSP7	302	R	C
Q8IYS4	LB/B	-	A0A2K6QSP7	354	Q	R
Q8IYS4	LB/B	-	A0A2K6QSP7	465	P	L
Q5TEA3	LB/B	-	A0A1S3K925	481	T	P
Q5TEA3	LB/B	-	A0A1S3K925	577	R	G
Q5TEA3	LB/B	-	A0A1S3K925	86	T	M
Q5TEA3	LB/B	-	A0A1S3K925	265	F	L
Q96DT5	LB/B	-	A0A146Z7T2	34	E	L
Q96DT5	LB/B	-	A0A146Z7T2	639	Q	R
Q96DT5	LB/B	-	A0A146Z7T2	654	S	C
Q96DT5	LB/B	-	A0A146Z7T2	1023	V	A
Q96DT5	LB/B	-	A0A146Z7T2	1038	T	A
Q96DT5	LB/B	-	A0A146Z7T2	1635	D	G
Q96DT5	LB/B	-	A0A146Z7T2	2634	N	S
Q96DT5	LB/B	-	A0A146Z7T2	2675	I	V
Q96DT5	LB/B	-	A0A146Z7T2	3467	A	T
Q96DT5	LB/B	-	A0A146Z7T2	3708	V	L
Q96DT5	LB/B	-	A0A146Z7T2	3758	S	P
Q96DT5	LB/B	-	A0A146Z7T2	4170	T	I
Q96DT5	LB/B	-	A0A146Z7T2	34	E	V
Q96DT5	LB/B	-	A0A146Z7T2	1316	M	V
Q96DT5	LB/B	-	A0A146Z7T2	4165	M	V
Q96DT5	LB/B	-	A0A146Z7T2	2586	Y	H
Q96DT5	LP/P	Ciliary dyskinesia, primary, 7 (CILD7) [MIM:611884]	A0A146Z7T2	117	E	V
Q96DT5	LP/P	Ciliary dyskinesia, primary, 7 (CILD7) [MIM:611884]	A0A146Z7T2	2383	L	P
Q96DT5	LP/P	Ciliary dyskinesia, primary, 7 (CILD7) [MIM:611884]	A0A146Z7T2	4327	L	S
Q6ZR08	LB/B	-	A0A2U3Y0W3	32	V	A
Q6ZR08	LB/B	-	A0A2U3Y0W3	139	S	N
Q6ZR08	LB/B	-	A0A2U3Y0W3	224	D	E
Q6ZR08	LB/B	-	A0A2U3Y0W3	231	T	A
Q6ZR08	LB/B	-	A0A2U3Y0W3	2740	Y	F
Q6ZR08	LB/B	-	A0A2U3Y0W3	2893	G	S
Q6ZR08	LB/B	-	A0A2U3Y0W3	467	T	P
Q6ZR08	LB/B	-	A0A2U3Y0W3	1549	D	N
Q6ZR08	LB/B	-	A0A2U3Y0W3	1704	Y	H
Q6ZR08	LB/B	-	A0A2U3Y0W3	1748	R	C
Q6ZR08	LB/B	-	A0A2U3Y0W3	1754	K	N
Q6ZR08	LB/B	-	A0A2U3Y0W3	1763	T	I
Q0VDD8	LB/B	-	A0A287B324	220	T	S
Q0VDD8	LB/B	-	A0A287B324	274	P	L
Q0VDD8	LB/B	-	A0A287B324	2671	K	E
Q9UFH2	LB/B	-	A0A146Z7T2	492	D	N
Q9UFH2	LB/B	-	A0A146Z7T2	792	I	V
Q9UFH2	LB/B	-	A0A146Z7T2	963	I	T
Q9UFH2	LB/B	-	A0A146Z7T2	1972	M	V
Q9UFH2	LP/P	Spermatogenic failure 39 (SPGF39) [MIM:618643]	A0A146Z7T2	1829	C	Y
Q9UFH2	LP/P	Spermatogenic failure 39 (SPGF39) [MIM:618643]	A0A146Z7T2	3499	P	L
Q9UFH2	LP/P	Spermatogenic failure 39 (SPGF39) [MIM:618643]	A0A146Z7T2	3595	L	P
Q8TD57	LB/B	-	V3ZUH2	545	R	W
Q8TD57	LB/B	-	V3ZUH2	1565	I	M
Q8TD57	LB/B	-	V3ZUH2	1583	V	I
Q8TD57	LB/B	-	V3ZUH2	1752	T	M
Q8TD57	LB/B	-	V3ZUH2	2399	I	N
Q8TD57	LB/B	-	V3ZUH2	2804	I	V
Q8TD57	LB/B	-	V3ZUH2	2949	K	T
Q8TD57	LB/B	-	V3ZUH2	3457	E	K
Q8TD57	LB/B	-	V3ZUH2	3639	L	I
Q8TD57	LB/B	-	V3ZUH2	3645	R	C
Q8TD57	LB/B	-	V3ZUH2	3744	R	W
Q8WXX0	LB/B	-	G1P9P6	169	H	P
Q8WXX0	LB/B	-	G1P9P6	280	A	T
Q8WXX0	LB/B	-	G1P9P6	315	I	V
Q8WXX0	LB/B	-	G1P9P6	438	S	N
Q8WXX0	LB/B	-	G1P9P6	545	R	C
Q8WXX0	LB/B	-	G1P9P6	565	D	H
Q8WXX0	LB/B	-	G1P9P6	675	K	E
Q8WXX0	LB/B	-	G1P9P6	825	K	E
Q8WXX0	LB/B	-	G1P9P6	1422	P	T
Q8WXX0	LB/B	-	G1P9P6	1525	E	K
Q8WXX0	LB/B	-	G1P9P6	1886	R	Q
Q8WXX0	LB/B	-	G1P9P6	1940	P	L
Q8WXX0	LB/B	-	G1P9P6	1971	P	L
Q8WXX0	LB/B	-	G1P9P6	2020	M	T
Q8WXX0	LB/B	-	G1P9P6	2459	N	K
Q8WXX0	LB/B	-	G1P9P6	2569	T	I
Q8WXX0	LB/B	-	G1P9P6	2809	I	V
Q8WXX0	LB/B	-	G1P9P6	3319	L	P
Q8WXX0	LB/B	-	G1P9P6	3386	R	H
Q96JB1	LB/B	-	A0A1Q3FSU3	71	N	S
Q96JB1	LB/B	-	A0A1Q3FSU3	473	G	R
Q96JB1	LB/B	-	A0A1Q3FSU3	573	I	V
Q96JB1	LB/B	-	A0A1Q3FSU3	727	A	T
Q96JB1	LB/B	-	A0A1Q3FSU3	807	G	E
Q96JB1	LB/B	-	A0A1Q3FSU3	1202	E	K
Q96JB1	LB/B	-	A0A1Q3FSU3	2444	T	N
Q96JB1	LB/B	-	A0A1Q3FSU3	4106	T	M
Q96JB1	LB/B	-	A0A1Q3FSU3	4271	I	V
Q96JB1	LB/B	-	A0A1Q3FSU3	3707	T	M
Q9NYC9	LB/B	-	A0A146Z7T2	151	R	H
Q9NYC9	LB/B	-	A0A146Z7T2	445	Q	R
Q9NYC9	LB/B	-	A0A146Z7T2	842	R	W
Q9NYC9	LB/B	-	A0A146Z7T2	1158	R	W
Q9NYC9	LB/B	-	A0A146Z7T2	1221	T	A
Q9NYC9	LB/B	-	A0A146Z7T2	2087	M	V
Q9NYC9	LB/B	-	A0A146Z7T2	2195	N	S
Q9NYC9	LB/B	-	A0A146Z7T2	2438	Q	H
Q9NYC9	LB/B	-	A0A146Z7T2	2961	K	R
Q9NYC9	LB/B	-	A0A146Z7T2	2968	K	N
Q9NYC9	LB/B	-	A0A146Z7T2	3726	R	Q
Q9NYC9	LB/B	-	A0A146Z7T2	3726	R	W
Q9NYC9	LB/B	-	A0A146Z7T2	4036	D	N
Q9NYC9	LB/B	-	A0A146Z7T2	4374	M	I
Q9NYC9	LB/B	-	A0A146Z7T2	4443	R	C
Q9NYC9	LB/B	-	A0A146Z7T2	4462	W	R
Q9NYC9	LP/P	Ciliary dyskinesia, primary, 40 (CILD40) [MIM:618300]	A0A146Z7T2	1881	K	E
Q9NYC9	LP/P	Ciliary dyskinesia, primary, 40 (CILD40) [MIM:618300]	A0A146Z7T2	2965	R	H
Q9NYC9	LP/P	Ciliary dyskinesia, primary, 40 (CILD40) [MIM:618300]	A0A146Z7T2	3398	R	L
Q9NYC9	LP/P	Ciliary dyskinesia, primary, 40 (CILD40) [MIM:618300]	A0A146Z7T2	4123	D	N
Q5VTH9	LB/B	-	A0A2K6SRK5	16	G	A
Q5VTH9	LB/B	-	A0A2K6SRK5	33	C	W
Q5VTH9	LB/B	-	A0A2K6SRK5	832	R	Q
Q6TDU7	LB/B	-	A0A2I3T461	33	R	S
Q6TDU7	LB/B	-	A0A2I3T461	633	A	E
Q9NXW2	LB/B	-	A0A1A6GRA5	304	E	K
P59910	LP/P	Ciliary dyskinesia, primary, 34 (CILD34) [MIM:617091]	S9WYJ1	278	M	R
P25686	LB/B	-	A0A2K5Q951	270	G	R
P25686	LP/P	Distal spinal muscular atrophy, autosomal recessive, 5 (DSMA5) [MIM:614881]	A0A2K5Q951	5	Y	C
Q8WWF6	LB/B	-	F8WCZ4	85	D	E
Q8WWF6	LB/B	-	F8WCZ4	98	D	E
O75190	LP/P	Muscular dystrophy, limb-girdle, autosomal dominant 1 (LGMDD1) [MIM:603511]	A0A218UT19	89	F	I
O75190	LP/P	Muscular dystrophy, limb-girdle, autosomal dominant 1 (LGMDD1) [MIM:603511]	A0A218UT19	93	F	L
O75190	LP/P	Muscular dystrophy, limb-girdle, autosomal dominant 1 (LGMDD1) [MIM:603511]	A0A218UT19	96	P	R
Q8NHS0	LB/B	-	A0A1S3WWF7	153	M	L
Q9UBS3	LB/B	-	M7CMU0	136	R	H
Q9NVH1	LB/B	-	A0A098M0M6	267	V	M
Q9NVH1	LB/B	-	A0A098M0M6	290	T	A
Q9NVH1	LB/B	-	A0A098M0M6	290	T	S
Q9Y5T4	LB/B	-	A0A1L8HHI8	35	R	G
Q5F1R6	LB/B	-	U5EYP5	433	E	K
Q5F1R6	LP/P	Bone marrow failure syndrome 3 (BMFS3) [MIM:617052]	U5EYP5	32	P	A
Q4LDG9	LP/P	Ciliary dyskinesia, primary, 16 (CILD16) [MIM:614017]	F7FTD0	150	N	S
P24855	LB/B	-	A0A2Y9F0H5	31	Q	E
P24855	LB/B	-	A0A2Y9F0H5	154	P	A
P24855	LB/B	-	A0A2Y9F0H5	244	R	Q
P24855	LB/B	-	A0A2Y9F0H5	114	V	M
P24855	LB/B	-	A0A2Y9F0H5	207	R	C
P24855	LB/B	-	A0A2Y9F0H5	2	R	S
P24855	LB/B	-	A0A2Y9F0H5	127	G	R
P24855	LB/B	-	A0A2Y9F0H5	107	R	G
P24855	LB/B	-	A0A2Y9F0H5	231	C	Y
P24855	LB/B	-	A0A2Y9F0H5	246	A	P
P24855	LB/B	-	A0A2Y9F0H5	262	G	D
P49184	LB/B	-	S9WND3	122	V	I
Q13609	LB/B	-	A0A2Y9F0H5	96	N	K
Q13609	LB/B	-	A0A2Y9F0H5	243	I	M
Q13609	LB/B	-	A0A2Y9F0H5	206	R	C
O00115	LB/B	-	A0A2K6D5C9	314	R	L
O00115	LB/B	-	A0A2K6D5C9	39	R	I
O00115	LB/B	-	A0A2K6D5C9	204	H	R
O00115	LP/P	Autoinflammatory-pancytopenia syndrome (AIPCS) [MIM:619858]	A0A2K6D5C9	95	Y	C
O00115	LP/P	Autoinflammatory-pancytopenia syndrome (AIPCS) [MIM:619858]	A0A2K6D5C9	116	G	A
O00115	LP/P	Autoinflammatory-pancytopenia syndrome (AIPCS) [MIM:619858]	A0A2K6D5C9	121	D	V
Q8WZ79	LB/B	-	A0A0L8FW50	47	K	R
Q8WZ79	LB/B	-	A0A0L8FW50	3	Q	H
Q8WZ79	LB/B	-	A0A0L8FW50	51	R	K
Q8NFT8	LB/B	-	A0A091CRM0	433	P	L
Q5SXM8	LB/B	-	A0A2K5HR56	169	P	H
Q5SXM8	LB/B	-	A0A2K5HR56	178	S	T
O00429	LB/B	-	A0A158QX48	71	S	T
O00429	LB/B	-	A0A158QX48	426	E	D
O00429	LP/P	Encephalopathy due to defective mitochondrial and peroxisomal fission 1 (EMPF1) [MIM:614388]	A0A158QX48	395	A	D
O00429	LP/P	Encephalopathy due to defective mitochondrial and peroxisomal fission 1 (EMPF1) [MIM:614388]	A0A158QX48	362	G	S
O00429	LP/P	Encephalopathy due to defective mitochondrial and peroxisomal fission 1 (EMPF1) [MIM:614388]	A0A158QX48	403	R	C
O00429	LP/P	Optic atrophy 5 (OPA5) [MIM:610708]	A0A158QX48	2	E	A
O00429	LP/P	Encephalopathy due to defective mitochondrial and peroxisomal fission 1 (EMPF1) [MIM:614388]	A0A158QX48	36	S	G
O00429	LP/P	Optic atrophy 5 (OPA5) [MIM:610708]	A0A158QX48	192	A	E
O00429	LP/P	Encephalopathy due to defective mitochondrial and peroxisomal fission 1 (EMPF1) [MIM:614388]	A0A158QX48	406	L	S
Q6XZF7	LB/B	-	W5N2R5	1413	C	W
Q6XZF7	LB/B	-	W5N2R5	81	E	D
Q6XZF7	LB/B	-	W5N2R5	373	N	K
Q6XZF7	LB/B	-	W5N2R5	914	N	K
P26358	LB/B	-	A0A1A6HN46	97	H	R
P26358	LB/B	-	A0A1A6HN46	311	I	V
P26358	LP/P	Neuropathy, hereditary sensory, 1E (HSN1E) [MIM:614116]	A0A1A6HN46	495	Y	C
P26358	LP/P	Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant (ADCADN) [MIM:604121]	A0A1A6HN46	554	A	V
P26358	LP/P	Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant (ADCADN) [MIM:604121]	A0A1A6HN46	589	G	A
P26358	LP/P	Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant (ADCADN) [MIM:604121]	A0A1A6HN46	590	V	F
Q9Y6K1	LP/P	Leukemia, acute myelogenous (AML) [MIM:601626]	W5NHN0	882	R	C
Q9Y6K1	LP/P	Tatton-Brown-Rahman syndrome (TBRS) [MIM:615879]	W5NHN0	882	R	C
Q9Y6K1	LP/P	Leukemia, acute myelogenous (AML) [MIM:601626]	W5NHN0	882	R	H
Q9Y6K1	LP/P	Tatton-Brown-Rahman syndrome (TBRS) [MIM:615879]	W5NHN0	882	R	H
Q9Y6K1	LP/P	Tatton-Brown-Rahman syndrome (TBRS) [MIM:615879]	W5NHN0	310	I	N
Q9Y6K1	LP/P	Tatton-Brown-Rahman syndrome (TBRS) [MIM:615879]	W5NHN0	532	G	S
Q9Y6K1	LP/P	Tatton-Brown-Rahman syndrome (TBRS) [MIM:615879]	W5NHN0	548	M	K
Q9Y6K1	LP/P	Tatton-Brown-Rahman syndrome (TBRS) [MIM:615879]	W5NHN0	549	C	R
Q9Y6K1	LP/P	Tatton-Brown-Rahman syndrome (TBRS) [MIM:615879]	W5NHN0	648	L	P
Q9Y6K1	LP/P	Tatton-Brown-Rahman syndrome (TBRS) [MIM:615879]	W5NHN0	700	P	L
Q9Y6K1	LP/P	Tatton-Brown-Rahman syndrome (TBRS) [MIM:615879]	W5NHN0	749	R	C
Q9Y6K1	LP/P	Tatton-Brown-Rahman syndrome (TBRS) [MIM:615879]	W5NHN0	838	N	D
Q9Y6K1	LP/P	Tatton-Brown-Rahman syndrome (TBRS) [MIM:615879]	W5NHN0	902	F	S
Q9Y6K1	LP/P	Tatton-Brown-Rahman syndrome (TBRS) [MIM:615879]	W5NHN0	904	P	L
Q9Y6K1	LP/P	Heyn-Sproul-Jackson syndrome (HESJAS) [MIM:618724]	W5NHN0	330	W	R
Q9Y6K1	LP/P	Heyn-Sproul-Jackson syndrome (HESJAS) [MIM:618724]	W5NHN0	333	D	N
Q9UBC3	LP/P	Immunodeficiency-centromeric instability-facial anomalies syndrome 1 (ICF1) [MIM:242860]	A0A2K5QV97	603	A	T
Q9UBC3	LP/P	Immunodeficiency-centromeric instability-facial anomalies syndrome 1 (ICF1) [MIM:242860]	A0A2K5QV97	663	G	S
Q9UBC3	LP/P	Immunodeficiency-centromeric instability-facial anomalies syndrome 1 (ICF1) [MIM:242860]	A0A2K5QV97	726	V	G
Q9UBC3	LP/P	Immunodeficiency-centromeric instability-facial anomalies syndrome 1 (ICF1) [MIM:242860]	A0A2K5QV97	817	D	G
Q9UBC3	LP/P	Immunodeficiency-centromeric instability-facial anomalies syndrome 1 (ICF1) [MIM:242860]	A0A2K5QV97	818	V	M
Q9UBC3	LP/P	Immunodeficiency-centromeric instability-facial anomalies syndrome 1 (ICF1) [MIM:242860]	A0A2K5QV97	585	A	V
Q9UBC3	LP/P	Immunodeficiency-centromeric instability-facial anomalies syndrome 1 (ICF1) [MIM:242860]	A0A2K5QV97	606	V	A
Q9UBC3	LP/P	Immunodeficiency-centromeric instability-facial anomalies syndrome 1 (ICF1) [MIM:242860]	A0A2K5QV97	699	V	G
Q9UBC3	LP/P	Immunodeficiency-centromeric instability-facial anomalies syndrome 1 (ICF1) [MIM:242860]	A0A2K5QV97	766	A	P
Q9UBC3	LP/P	Immunodeficiency-centromeric instability-facial anomalies syndrome 1 (ICF1) [MIM:242860]	A0A2K5QV97	814	H	R
Q9UBC3	LP/P	Immunodeficiency-centromeric instability-facial anomalies syndrome 1 (ICF1) [MIM:242860]	A0A2K5QV97	270	S	P
Q9UBC3	LP/P	Immunodeficiency-centromeric instability-facial anomalies syndrome 1 (ICF1) [MIM:242860]	A0A2K5QV97	664	L	P
Q9UBC3	LP/P	Immunodeficiency-centromeric instability-facial anomalies syndrome 1 (ICF1) [MIM:242860]	A0A2K5QV97	840	R	Q
Q9UBC3	LB/B	-	A0A2K5QV97	54	R	P
Q9UBC3	LP/P	Facioscapulohumeral muscular dystrophy 4, digenic (FSHD4) [MIM:619478]	A0A2K5QV97	527	C	R
Q9UBC3	LP/P	Immunodeficiency-centromeric instability-facial anomalies syndrome 1 (ICF1) [MIM:242860]	A0A2K5QV97	585	A	T
Q9UBC3	LP/P	Facioscapulohumeral muscular dystrophy 4, digenic (FSHD4) [MIM:619478]	A0A2K5QV97	691	P	L
P04053	LB/B	-	G5ASQ9	112	R	G
Q9H147	LB/B	-	A0A2P4T0H6	183	A	T
Q5QJE6	LB/B	-	A0A093I507	309	E	D
Q5QJE6	LB/B	-	A0A093I507	341	T	A
Q5QJE6	LB/B	-	A0A093I507	430	A	V
Q5QJE6	LB/B	-	A0A093I507	676	Y	F
Q5QJE6	LB/B	-	A0A093I507	477	G	E
Q14183	LB/B	-	A0A2K6MAP8	48	G	S
Q14184	LB/B	-	A0A2K6MAP8	209	R	L
Q14185	LB/B	-	A0A087XHU8	1793	A	T
Q5JSL3	LB/B	-	H3A612	813	I	F
Q92608	LB/B	-	A0A087XHU8	1746	S	T
Q92608	LB/B	-	A0A087XHU8	1779	T	S
Q92608	LB/B	-	A0A087XHU8	1558	D	A
Q92608	LP/P	Immunodeficiency 40 (IMD40) [MIM:616433]	A0A087XHU8	751	R	S
Q92608	LP/P	Immunodeficiency 40 (IMD40) [MIM:616433]	A0A087XHU8	1104	R	W
Q8N1I0	LB/B	-	F8W4T6	87	T	I
Q8N1I0	LB/B	-	F8W4T6	606	E	Q
Q8N1I0	LB/B	-	F8W4T6	1733	P	A
Q8N1I0	LB/B	-	F8W4T6	1884	V	M
Q8N1I0	LB/B	-	F8W4T6	1914	V	I
Q8N1I0	LB/B	-	F8W4T6	1917	P	L
Q8N1I0	LB/B	-	F8W4T6	1926	S	L
Q8N1I0	LB/B	-	F8W4T6	535	N	D
Q8N1I0	LB/B	-	F8W4T6	853	R	H
Q8N1I0	LB/B	-	F8W4T6	1570	R	K
Q8N1I0	LB/B	-	F8W4T6	1580	F	L
Q8N1I0	LB/B	-	F8W4T6	1822	Q	K
Q9H7D0	LB/B	-	A0A087XHU8	250	Q	R
Q9H7D0	LB/B	-	A0A087XHU8	1836	E	K
Q9H7D0	LB/B	-	A0A087XHU8	1023	Q	R
Q9H7D0	LB/B	-	A0A087XHU8	1285	K	R
Q96HP0	LB/B	-	A0A087SWU2	250	P	L
Q96HP0	LB/B	-	A0A087SWU2	555	P	L
Q96HP0	LB/B	-	A0A087SWU2	665	G	R
Q96HP0	LB/B	-	A0A087SWU2	1420	V	L
Q96HP0	LB/B	-	A0A087SWU2	826	R	C
Q96HP0	LB/B	-	A0A087SWU2	1442	A	T
Q96N67	LB/B	-	A0A087SWU2	824	I	T
Q8NF50	LB/B	-	A0A087SWU2	97	P	T
Q8NF50	LB/B	-	A0A087SWU2	237	E	K
Q8NF50	LB/B	-	A0A087SWU2	413	N	S
Q8NF50	LB/B	-	A0A087SWU2	597	A	V
Q8NF50	LB/B	-	A0A087SWU2	1008	R	W
Q8NF50	LB/B	-	A0A087SWU2	1970	A	P
Q8NF50	LB/B	-	A0A087SWU2	169	E	K
Q8NF50	LP/P	Hyper-IgE recurrent infection syndrome 2, autosomal recessive (HIES2) [MIM:243700]	A0A087SWU2	473	K	R
Q8NF50	LB/B	-	A0A087SWU2	652	I	V
Q5T8R8	LB/B	-	A0A2K6MK14	43	L	R
Q5T8R8	LB/B	-	A0A2K6MK14	178	R	Q
Q5T8R8	LB/B	-	A0A2K6MK14	231	R	G
Q9BZ29	LB/B	-	L5MG53	1416	K	E
Q9BZ29	LB/B	-	L5MG53	455	A	T
Q7L591	LB/B	-	L5JVS0	12	R	P
Q7L591	LB/B	-	L5JVS0	22	G	R
Q18PE1	LP/P	Myasthenic syndrome, congenital, 10 (CMS10) [MIM:254300]	A0A1U8BWJ8	180	G	A
Q18PE1	LB/B	-	A0A1U8BWJ8	197	D	N
Q18PE1	LB/B	-	A0A1U8BWJ8	261	R	H
Q18PE1	LB/B	-	A0A1U8BWJ8	296	Q	R
Q18PE1	LB/B	-	A0A1U8BWJ8	415	P	S
Q18PE1	LB/B	-	A0A1U8BWJ8	427	G	D
Q18PE1	LB/B	-	A0A1U8BWJ8	451	R	W
Q18PE1	LB/B	-	A0A1U8BWJ8	461	G	D
Q18PE1	LP/P	Myasthenic syndrome, congenital, 10 (CMS10) [MIM:254300]	A0A1U8BWJ8	158	R	Q
Q18PE1	LB/B	-	A0A1U8BWJ8	379	G	R
Q18PE1	LP/P	Myasthenic syndrome, congenital, 10 (CMS10) [MIM:254300]	A0A1U8BWJ8	3	E	K
Q18PE1	LP/P	Myasthenic syndrome, congenital, 10 (CMS10) [MIM:254300]	A0A1U8BWJ8	31	P	T
Q18PE1	LP/P	Myasthenic syndrome, congenital, 10 (CMS10) [MIM:254300]	A0A1U8BWJ8	33	A	V
Q18PE1	LB/B	-	A0A1U8BWJ8	45	S	L
Q18PE1	LP/P	Myasthenic syndrome, congenital, 10 (CMS10) [MIM:254300]	A0A1U8BWJ8	77	T	M
Q18PE1	LB/B	-	A0A1U8BWJ8	99	A	V
Q18PE1	LP/P	Myasthenic syndrome, congenital, 10 (CMS10) [MIM:254300]	A0A1U8BWJ8	109	G	C
Q18PE1	LP/P	Myasthenic syndrome, congenital, 10 (CMS10) [MIM:254300]	A0A1U8BWJ8	116	V	M
Q18PE1	LP/P	Myasthenic syndrome, congenital, 10 (CMS10) [MIM:254300]	A0A1U8BWJ8	132	H	Q
Q18PE1	LP/P	Myasthenic syndrome, congenital, 10 (CMS10) [MIM:254300]	A0A1U8BWJ8	139	V	L
Q18PE1	LP/P	Myasthenic syndrome, congenital, 10 (CMS10) [MIM:254300]	A0A1U8BWJ8	146	P	L
Q18PE1	LP/P	Myasthenic syndrome, congenital, 10 (CMS10) [MIM:254300]	A0A1U8BWJ8	157	L	R
Q18PE1	LP/P	Myasthenic syndrome, congenital, 10 (CMS10) [MIM:254300]	A0A1U8BWJ8	161	G	R
Q18PE1	LP/P	Myasthenic syndrome, congenital, 10 (CMS10) [MIM:254300]	A0A1U8BWJ8	166	G	R
Q18PE1	LP/P	Myasthenic syndrome, congenital, 10 (CMS10) [MIM:254300]	A0A1U8BWJ8	171	G	D
Q18PE1	LP/P	Myasthenic syndrome, congenital, 10 (CMS10) [MIM:254300]	A0A1U8BWJ8	171	G	R
Q18PE1	LP/P	Myasthenic syndrome, congenital, 10 (CMS10) [MIM:254300]	A0A1U8BWJ8	172	G	R
Q18PE1	LP/P	Myasthenic syndrome, congenital, 10 (CMS10) [MIM:254300]	A0A1U8BWJ8	180	G	V
Q18PE1	LB/B	-	A0A1U8BWJ8	272	H	Q
Q18PE1	LB/B	-	A0A1U8BWJ8	323	R	C
Q18PE1	LB/B	-	A0A1U8BWJ8	382	E	K
Q18PE1	LB/B	-	A0A1U8BWJ8	402	R	Q
Q18PE1	LB/B	-	A0A1U8BWJ8	440	A	T
Q18PE1	LP/P	Myasthenic syndrome, congenital, 10 (CMS10) [MIM:254300]	A0A1U8BWJ8	469	P	H
Q18PE1	LB/B	-	A0A1U8BWJ8	503	P	T
Q9UPQ8	LP/P	Congenital disorder of glycosylation 1M (CDG1M) [MIM:610768]	A0A146NPU0	99	C	S
Q9UPQ8	LP/P	Congenital disorder of glycosylation 1M (CDG1M) [MIM:610768]	A0A146NPU0	441	Y	S
Q9UPQ8	LB/B	-	A0A146NPU0	224	D	V
Q9NYP3	LB/B	-	G1K3N1	28	S	R
Q9NYP3	LP/P	Microcephaly, short stature, and limb abnormalities (MISSLA) [MIM:617604]	G1K3N1	278	C	R
Q9NYP3	LP/P	Microcephaly, short stature, and limb abnormalities (MISSLA) [MIM:617604]	G1K3N1	282	Y	C
Q9NYP3	LP/P	Microcephaly, short stature, and limb abnormalities (MISSLA) [MIM:617604]	G1K3N1	292	F	L
Q9NYP3	LP/P	Microcephaly, short stature, and limb abnormalities (MISSLA) [MIM:617604]	G1K3N1	433	P	S
Q9NYP3	LP/P	Microcephaly, short stature, and limb abnormalities (MISSLA) [MIM:617604]	G1K3N1	446	M	T
Q9NYP3	LP/P	Microcephaly, short stature, and limb abnormalities (MISSLA) [MIM:617604]	G1K3N1	504	E	K
Q5JWR5	LB/B	-	H0XB58	596	R	Q
Q5JWR5	LB/B	-	H0XB58	1781	Q	L
Q9Y3R5	LB/B	-	H0XB58	1118	C	G
Q9Y3R5	LB/B	-	H0XB58	1149	P	H
Q9Y3R5	LB/B	-	H0XB58	1217	R	S
Q9Y3R5	LB/B	-	H0XB58	2139	G	E
Q9Y3R5	LB/B	-	H0XB58	1021	S	W
Q8TEK3	LB/B	-	A0A1L8HWP3	726	L	M
Q8TEK3	LB/B	-	A0A1L8HWP3	1386	G	S
Q8TEK3	LB/B	-	A0A1L8HWP3	1418	V	L
Q9H3H5	LB/B	-	A0A1Y3N7M2	393	I	V
Q9H3H5	LP/P	Congenital disorder of glycosylation 1J (CDG1J) [MIM:608093]	A0A1Y3N7M2	170	Y	C
Q9H3H5	LP/P	Myasthenic syndrome, congenital, 13 (CMS13) [MIM:614750]	A0A1Y3N7M2	108	M	I
Q9H3H5	LP/P	Myasthenic syndrome, congenital, 13 (CMS13) [MIM:614750]	A0A1Y3N7M2	117	V	I
Q9H3H5	LP/P	Myasthenic syndrome, congenital, 13 (CMS13) [MIM:614750]	A0A1Y3N7M2	120	L	M
Q9H3H5	LP/P	Myasthenic syndrome, congenital, 13 (CMS13) [MIM:614750]	A0A1Y3N7M2	160	G	S
Q9H3H5	LP/P	Myasthenic syndrome, congenital, 13 (CMS13) [MIM:614750]	A0A1Y3N7M2	192	G	S
Q9H3H5	LP/P	Myasthenic syndrome, congenital, 13 (CMS13) [MIM:614750]	A0A1Y3N7M2	264	V	G
Q9BVM2	LB/B	-	Q0P448	56	S	R
Q9BVM2	LB/B	-	Q0P448	156	L	S
P16444	LB/B	-	A0A2Y9KDL9	351	E	K
P16444	LB/B	-	A0A2Y9KDL9	351	E	Q
Q92785	LP/P	Coffin-Siris syndrome 7 (CSS7) [MIM:618027]	J9JQG4	276	C	F
Q92785	LP/P	Coffin-Siris syndrome 7 (CSS7) [MIM:618027]	J9JQG4	330	C	W
Q92785	LP/P	Coffin-Siris syndrome 7 (CSS7) [MIM:618027]	J9JQG4	346	D	G
Q92785	LP/P	Coffin-Siris syndrome 7 (CSS7) [MIM:618027]	J9JQG4	350	R	H
Q92785	LP/P	Coffin-Siris syndrome 7 (CSS7) [MIM:618027]	J9JQG4	369	W	R
Q92784	LB/B	-	A0A016UD05	177	R	H
Q9BZG8	LB/B	-	A0A2Y9DK99	221	K	R
Q9BZG8	LB/B	-	A0A2Y9DK99	46	I	M
Q9BZG8	LP/P	Developmental delay with short stature, dysmorphic facial features, and sparse hair 1 (DEDSSH1) [MIM:616901]	A0A2Y9DK99	229	L	P
Q9BZG8	LP/P	Developmental delay with short stature, dysmorphic facial features, and sparse hair 1 (DEDSSH1) [MIM:616901]	A0A2Y9DK99	107	Y	C
Q9BZG8	LP/P	Developmental delay with short stature, dysmorphic facial features, and sparse hair 1 (DEDSSH1) [MIM:616901]	A0A2Y9DK99	120	L	P
Q9BZG8	LP/P	Developmental delay with short stature, dysmorphic facial features, and sparse hair 1 (DEDSSH1) [MIM:616901]	A0A2Y9DK99	159	L	P
Q9BQC3	LP/P	Developmental delay with short stature, dysmorphic facial features, and sparse hair 2 (DEDSSH2) [MIM:620062]	A0A293MDJ7	201	R	C
Q9H2P9	LP/P	Neurodevelopmental disorder with short stature, prominent forehead, and feeding difficulties (NEDSFF) [MIM:620070]	M3ZTM8	110	N	S
Q9H2P9	LP/P	Neurodevelopmental disorder with short stature, prominent forehead, and feeding difficulties (NEDSFF) [MIM:620070]	M3ZTM8	260	H	R
Q7L8W6	LB/B	-	A0A059D3Z0	41	G	E
Q7L8W6	LB/B	-	A0A059D3Z0	236	P	R
Q9BTV6	LB/B	-	Q4TBF1	158	G	R
O60762	LP/P	Congenital disorder of glycosylation 1E (CDG1E) [MIM:608799]	A0A074ZAA1	92	R	G
O60762	LP/P	Congenital disorder of glycosylation 1E (CDG1E) [MIM:608799]	A0A074ZAA1	248	S	P
O60762	LP/P	Congenital disorder of glycosylation 1E (CDG1E) [MIM:608799]	A0A074ZAA1	152	G	V
O94777	LB/B	-	L5K777	76	T	S
O94777	LP/P	Congenital disorder of glycosylation 1U (CDG1U) [MIM:615042]	L5K777	23	Y	C
Q9NY33	LB/B	-	A0A091DD02	678	R	H
Q9NY33	LB/B	-	A0A091DD02	76	R	H
Q9NY33	LB/B	-	A0A091DD02	145	Q	H
Q9NY33	LB/B	-	A0A091DD02	690	E	K
Q9UHL4	LB/B	-	A0A226NG76	89	A	G
Q7L190	LB/B	-	A0A1U7QLQ8	55	I	V
Q7L190	LB/B	-	A0A1U7QLQ8	226	S	F
Q2PZI1	LB/B	-	H3CDE8	502	G	V
Q6NUT2	LB/B	-	A0A096P046	37	M	V
Q6NUT2	LB/B	-	A0A096P046	41	A	V
Q6NUT2	LB/B	-	A0A096P046	51	S	A
Q6NUT2	LB/B	-	A0A096P046	757	V	I
Q6NUT2	LP/P	Spermatogenic failure 9 (SPGF9) [MIM:613958]	A0A096P046	290	R	H
Q6NUT2	LP/P	Spermatogenic failure 9 (SPGF9) [MIM:613958]	A0A096P046	298	R	C
Q6NUT2	LP/P	Spermatogenic failure 9 (SPGF9) [MIM:613958]	A0A096P046	298	R	H
Q6ZN68	LB/B	-	G3WU00	66	M	V
Q6ZN68	LB/B	-	G3WU00	333	N	I
Q6ZPD9	LB/B	-	M3XDV1	350	M	V
Q16555	LB/B	-	L9KUG1	118	A	T
Q14195	LB/B	-	L9KUG1	442	A	S
Q9BPU6	LP/P	Ritscher-Schinzel syndrome 4 (RTSC4) [MIM:619435]	L9KUG1	41	E	K
Q9BPU6	LP/P	Ritscher-Schinzel syndrome 4 (RTSC4) [MIM:619435]	L9KUG1	47	G	R
Q6UX65	LP/P	Cone-rod dystrophy 21 (CORD21) [MIM:616502]	A0A0P7TWV9	27	Y	H
Q6UX65	LP/P	Cone-rod dystrophy 21 (CORD21) [MIM:616502]	A0A0P7TWV9	44	S	N
Q6UX65	LP/P	Cone-rod dystrophy 21 (CORD21) [MIM:616502]	A0A0P7TWV9	121	H	L
Q9H069	LB/B	-	D1LX59	191	R	W
Q9H069	LB/B	-	D1LX59	159	R	Q
Q9H069	LB/B	-	D1LX59	364	A	V
P21728	LB/B	-	L9JCI8	37	T	P
P21728	LB/B	-	L9JCI8	37	T	R
P21728	LB/B	-	L9JCI8	50	R	S
P21728	LB/B	-	L9JCI8	199	S	A
P21728	LB/B	-	L9JCI8	81	K	R
P21728	LB/B	-	L9JCI8	259	S	Y
P14416	LB/B	-	G3SYC1	311	S	C
P14416	LB/B	-	G3SYC1	310	P	S
P14416	LB/B	-	G3SYC1	327	K	E
P35462	LB/B	-	G3SYC1	9	G	S
P21918	LB/B	-	H3CD49	269	A	V
P21918	LB/B	-	H3CD49	330	P	Q
P21918	LB/B	-	H3CD49	351	N	D
P21918	LB/B	-	H3CD49	453	S	C
P21918	LB/B	-	H3CD49	88	L	R
P21918	LB/B	-	H3CD49	238	V	I
P21918	LB/B	-	H3CD49	62	C	S
P21918	LB/B	-	H3CD49	110	G	E
P21918	LB/B	-	H3CD49	207	F	V
P21918	LB/B	-	H3CD49	233	S	N
P21918	LB/B	-	H3CD49	286	A	V
P21918	LB/B	-	H3CD49	297	T	P
Q6PGQ1	LB/B	-	A0A2I3H7J6	4	I	T
Q13474	LB/B	-	A0A091DR55	68	V	L
Q08554	LB/B	-	A0A287B6Z6	460	V	I
Q08554	LB/B	-	A0A287B6Z6	848	C	F
Q08554	LB/B	-	A0A287B6Z6	93	S	F
Q02487	LB/B	-	A0A287B6Z6	776	I	V
Q02487	LB/B	-	A0A287B6Z6	11	N	S
Q02487	LB/B	-	A0A287B6Z6	358	T	I
Q02487	LB/B	-	A0A287B6Z6	798	R	Q
Q02487	LP/P	Arrhythmogenic right ventricular dysplasia, familial, 11 (ARVD11) [MIM:610476]	A0A287B6Z6	203	R	C
Q02487	LP/P	Arrhythmogenic right ventricular dysplasia, familial, 11 (ARVD11) [MIM:610476]	A0A287B6Z6	231	I	T
Q02487	LP/P	Arrhythmogenic right ventricular dysplasia, familial, 11 (ARVD11) [MIM:610476]	A0A287B6Z6	275	T	M
Q02487	LP/P	Arrhythmogenic right ventricular dysplasia, familial, 11 (ARVD11) [MIM:610476]	A0A287B6Z6	340	T	A
Q02487	LB/B	-	A0A287B6Z6	596	A	V
Q02487	LB/B	-	A0A287B6Z6	638	Q	H
Q02487	LP/P	Arrhythmogenic right ventricular dysplasia, familial, 11 (ARVD11) [MIM:610476]	A0A287B6Z6	364	V	M
Q14574	LB/B	-	A0A287B6Z6	28	A	D
Q14574	LB/B	-	A0A287B6Z6	78	S	T
Q14574	LB/B	-	A0A287B6Z6	102	R	K
Q14574	LB/B	-	A0A287B6Z6	180	K	Q
Q14574	LB/B	-	A0A287B6Z6	199	R	W
Q14574	LB/B	-	A0A287B6Z6	239	N	S
O60469	LB/B	-	W5KKG3	232	D	E
Q9BVC3	LB/B	-	A0A024R9J7	376	H	R
P59020	LB/B	-	P59021	76	R	L
P59020	LB/B	-	P59021	23	G	V
Q9UL01	LB/B	-	V9KET0	25	T	I
Q9UL01	LB/B	-	V9KET0	34	P	L
Q9UL01	LB/B	-	V9KET0	282	I	V
Q9UL01	LP/P	Ehlers-Danlos syndrome, musculocontractural type 2 (EDSMC2) [MIM:615539]	V9KET0	268	S	L
Q8IZU8	LB/B	-	H3AJN0	673	P	S
Q8IZU8	LB/B	-	H3AJN0	730	Y	C
Q8IZU8	LB/B	-	H3AJN0	832	T	S
Q02413	LB/B	-	L5LQG8	841	Y	F
Q02413	LB/B	-	L5LQG8	493	N	T
Q02413	LB/B	-	L5LQG8	498	T	N
Q02413	LB/B	-	L5LQG8	395	T	S
Q02413	LB/B	-	L5LQG8	528	Y	S
Q02413	LB/B	-	L5LQG8	538	D	N
Q02413	LB/B	-	L5LQG8	665	M	I
Q02413	LB/B	-	L5LQG8	821	L	Q
Q02413	LB/B	-	L5LQG8	11	M	V
Q02413	LB/B	-	L5LQG8	828	D	N
P32926	LB/B	-	A0A212C6J2	509	V	M
P32926	LB/B	-	A0A212C6J2	912	T	A
Q86SJ6	LB/B	-	A0A212C6J2	644	I	L
Q86SJ6	LB/B	-	A0A212C6J2	535	I	T
Q86SJ6	LB/B	-	A0A212C6J2	154	A	T
P15924	LP/P	Skin fragility-woolly hair syndrome (SFWHS) [MIM:607655]	E1BKT9	287	N	K
P15924	LP/P	Skin fragility-woolly hair syndrome (SFWHS) [MIM:607655]	E1BKT9	2366	R	C
P15924	LB/B	-	E1BKT9	2375	G	R
P15924	LB/B	-	E1BKT9	1512	Y	C
P15924	LP/P	Arrhythmogenic right ventricular dysplasia, familial, 8 (ARVD8) [MIM:607450]	E1BKT9	1255	R	K
P15924	LB/B	-	E1BKT9	1738	R	Q
P15924	LB/B	-	E1BKT9	305	I	F
P15924	LP/P	Arrhythmogenic right ventricular dysplasia, familial, 8 (ARVD8) [MIM:607450]	E1BKT9	445	I	V
P15924	LB/B	-	E1BKT9	1505	A	V
P15924	LB/B	-	E1BKT9	1526	N	K
P15924	LB/B	-	E1BKT9	1537	R	C
P15924	LB/B	-	E1BKT9	1833	E	V
P15924	LP/P	Cardiomyopathy, dilated, with woolly hair, keratoderma, and tooth agenesis (DCWHKTA) [MIM:615821]	E1BKT9	564	T	I
P15924	LP/P	Cardiomyopathy, dilated, with woolly hair, keratoderma, and tooth agenesis (DCWHKTA) [MIM:615821]	E1BKT9	597	S	L
Q9NZW4	LP/P	Deafness, autosomal dominant, 39, with dentinogenesis imperfecta 1 (DFNA39/DGI1) [MIM:605594]	A0A2R8MY29	17	P	T
Q9NZW4	LP/P	Deafness, autosomal dominant, 39, with dentinogenesis imperfecta 1 (DFNA39/DGI1) [MIM:605594]	A0A2R8MY29	18	V	F
Q9NZW4	LP/P	Dentinogenesis imperfecta, Shields type 3 (DGI3) [MIM:125500]	A0A2R8MY29	18	V	F
Q9NZW4	LP/P	Dentinogenesis imperfecta, Shields type 2 (DGI2) [MIM:125490]	A0A2R8MY29	68	R	W
Q9NZW4	LP/P	Dentin dysplasia 2 (DTDP2) [MIM:125420]	A0A2R8MY29	6	Y	D
Q9NZW4	LP/P	Dentinogenesis imperfecta, Shields type 2 (DGI2) [MIM:125490]	A0A2R8MY29	15	A	V
Q9NZW4	LB/B	-	A0A2R8MY29	243	D	N
Q9NZW4	LP/P	Dentinogenesis imperfecta, Shields type 2 (DGI2) [MIM:125490]	A0A2R8MY29	17	P	S
Q9NZW4	LP/P	Dentinogenesis imperfecta, Shields type 3 (DGI3) [MIM:125500]	A0A2R8MY29	17	P	S
Q9NZW4	LP/P	Dentinogenesis imperfecta, Shields type 3 (DGI3) [MIM:125500]	A0A2R8MY29	17	P	L
Q9NZW4	LP/P	Dentinogenesis imperfecta, Shields type 2 (DGI2) [MIM:125490]	A0A2R8MY29	18	V	D
Q03001	LB/B	-	L5JMM3	1319	N	K
Q03001	LB/B	-	L5JMM3	2332	Q	R
Q03001	LB/B	-	L5JMM3	3720	Q	R
Q03001	LB/B	-	L5JMM3	5138	T	A
Q6XUX3	LB/B	-	A0A2U3ZYN6	432	L	V
Q6XUX3	LP/P	Congenital anomalies of the kidney and urinary tract 1 (CAKUT1) [MIM:610805]	A0A2U3ZYN6	200	D	G
Q6XUX3	LP/P	Congenital anomalies of the kidney and urinary tract 1 (CAKUT1) [MIM:610805]	A0A2U3ZYN6	843	S	L
Q6ZMT9	LB/B	-	A0A2Y9I000	26	G	R
Q6ZMT9	LB/B	-	A0A2Y9I000	179	V	D
Q6ZMT9	LB/B	-	A0A2Y9I000	552	R	C
Q6ZMT9	LB/B	-	A0A2Y9I000	662	R	H
Q9NZJ0	LB/B	-	A0A1L8G1C0	436	A	V
Q9NZJ0	LB/B	-	A0A1L8G1C0	694	K	T
Q9NZJ0	LB/B	-	A0A1L8G1C0	425	S	N
Q9Y4J8	LB/B	-	M7BXA4	180	A	E
O60941	LB/B	-	A0A091DKP3	97	P	H
O60941	LB/B	-	A0A091DKP3	116	I	T
Q96EV8	LB/B	-	F6PQR7	272	P	S
Q96EV8	LB/B	-	F6PQR7	214	G	D
Q8N5C7	LB/B	-	A0A1A6H0E4	9	L	P
Q8N5C7	LB/B	-	A0A1A6H0E4	13	E	K
Q8N5C7	LB/B	-	A0A1A6H0E4	25	S	P
Q86UW9	LB/B	-	A0A2J8IK24	94	A	T
Q86UW9	LB/B	-	A0A2J8IK24	384	G	E
Q86UW9	LB/B	-	A0A2J8IK24	421	T	A
P23919	LP/P	Neurodegeneration, childhood-onset, with progressive microcephaly (CONPM) [MIM:619847]	A0A2I3GHJ2	81	P	L
P23919	LP/P	Neurodegeneration, childhood-onset, with progressive microcephaly (CONPM) [MIM:619847]	A0A2I3GHJ2	128	D	N
Q1HG43	LB/B	-	H0X7P9	313	S	G
Q1HG43	LB/B	-	H0X7P9	19	P	L
Q1HG44	LB/B	-	L5K1A4	100	R	G
O95620	LB/B	-	A0A1Y2CV51	230	R	Q
O95620	LB/B	-	A0A1Y2CV51	178	T	A
Q9UNI6	LB/B	-	A0A1S3WPT0	51	A	E
Q6B8I1	LB/B	-	U3JWV6	73	K	R
Q9UII6	LB/B	-	A0A0P6K6J0	156	C	Y
Q9UII6	LB/B	-	A0A0P6K6J0	62	R	Q
Q9UII6	LB/B	-	A0A0P6K6J0	190	R	G
Q8WTR2	LB/B	-	A0A2L2XX69	216	S	R
Q16690	LB/B	-	A0A2I3S8P7	154	E	D
Q16690	LB/B	-	A0A2I3S8P7	322	P	L
Q16690	LB/B	-	A0A2I3S8P7	220	A	T
Q16690	LB/B	-	A0A2I3S8P7	220	A	V
Q16828	LB/B	-	A0A2U9C3F6	114	V	L
Q16828	LB/B	-	A0A2U9C3F6	144	S	A
Q16828	LB/B	-	A0A2U9C3F6	313	N	I
Q16828	LP/P	Hypogonadotropic hypogonadism 19 with or without anosmia (HH19) [MIM:615269]	A0A2U9C3F6	77	F	I
Q16828	LP/P	Hypogonadotropic hypogonadism 19 with or without anosmia (HH19) [MIM:615269]	A0A2U9C3F6	182	S	F
Q16828	LP/P	Hypogonadotropic hypogonadism 19 with or without anosmia (HH19) [MIM:615269]	A0A2U9C3F6	189	N	S
Q16828	LP/P	Hypogonadotropic hypogonadism 19 with or without anosmia (HH19) [MIM:615269]	A0A2U9C3F6	346	T	M
Q16829	LB/B	-	A0A2U9C3F6	235	S	N
Q96PT3	LB/B	-	A0A2R8Z5V9	60	A	V
Q96PT3	LB/B	-	A0A2R8Z5V9	118	P	L
Q96PT3	LB/B	-	A0A2R8Z5V9	119	Q	P
Q96PT3	LB/B	-	A0A2R8Z5V9	180	S	A
Q96PT3	LB/B	-	A0A2R8Z5V9	180	S	T
Q92997	LB/B	-	B5THN3	433	W	L
Q14204	LB/B	-	A0A0C9QIL6	3902	D	N
Q14204	LB/B	-	A0A0C9QIL6	4029	H	Q
Q14204	LP/P	Intellectual developmental disorder, autosomal dominant 13 (MRD13) [MIM:614563]	A0A0C9QIL6	3822	H	P
Q14204	LP/P	Charcot-Marie-Tooth disease, axonal, 2O (CMT2O) [MIM:614228]	A0A0C9QIL6	306	H	R
Q14204	LP/P	Spinal muscular atrophy, lower extremity-predominant 1, autosomal dominant (SMALED1) [MIM:158600]	A0A0C9QIL6	306	H	R
Q14204	LP/P	Spinal muscular atrophy, lower extremity-predominant 1, autosomal dominant (SMALED1) [MIM:158600]	A0A0C9QIL6	584	I	L
Q14204	LP/P	Spinal muscular atrophy, lower extremity-predominant 1, autosomal dominant (SMALED1) [MIM:158600]	A0A0C9QIL6	671	K	E
Q14204	LP/P	Spinal muscular atrophy, lower extremity-predominant 1, autosomal dominant (SMALED1) [MIM:158600]	A0A0C9QIL6	970	Y	C
Q14204	LP/P	Intellectual developmental disorder, autosomal dominant 13 (MRD13) [MIM:614563]	A0A0C9QIL6	1518	E	K
Q14204	LB/B	-	A0A0C9QIL6	142	E	A
Q14204	LB/B	-	A0A0C9QIL6	1250	V	L
Q14204	LB/B	-	A0A0C9QIL6	2247	V	M
Q14204	LB/B	-	A0A0C9QIL6	4143	R	C
Q14204	LB/B	-	A0A0C9QIL6	4285	A	S
Q14204	LB/B	-	A0A0C9QIL6	4421	A	T
Q14204	LB/B	-	A0A0C9QIL6	4507	I	S
Q14204	LB/B	-	A0A0C9QIL6	4603	S	G
Q14204	LP/P	Intellectual developmental disorder, autosomal dominant 13 (MRD13) [MIM:614563]	A0A0C9QIL6	129	K	I
Q14204	LP/P	Intellectual developmental disorder, autosomal dominant 13 (MRD13) [MIM:614563]	A0A0C9QIL6	1567	R	Q
Q14204	LP/P	Intellectual developmental disorder, autosomal dominant 13 (MRD13) [MIM:614563]	A0A0C9QIL6	1962	R	C
Q14204	LP/P	Intellectual developmental disorder, autosomal dominant 13 (MRD13) [MIM:614563]	A0A0C9QIL6	3241	K	T
Q14204	LP/P	Intellectual developmental disorder, autosomal dominant 13 (MRD13) [MIM:614563]	A0A0C9QIL6	3336	K	N
Q14204	LP/P	Intellectual developmental disorder, autosomal dominant 13 (MRD13) [MIM:614563]	A0A0C9QIL6	3344	R	Q
Q14204	LP/P	Intellectual developmental disorder, autosomal dominant 13 (MRD13) [MIM:614563]	A0A0C9QIL6	3384	R	Q
Q14204	LP/P	Charcot-Marie-Tooth disease, axonal, 2O (CMT2O) [MIM:614228]	A0A0C9QIL6	1194	Q	R
Q14204	LP/P	Charcot-Marie-Tooth disease, axonal, 2O (CMT2O) [MIM:614228]	A0A0C9QIL6	3048	E	K
Q14204	LP/P	Spinal muscular atrophy, lower extremity-predominant 1, autosomal dominant (SMALED1) [MIM:158600]	A0A0C9QIL6	264	R	L
Q14204	LP/P	Charcot-Marie-Tooth disease, axonal, 2O (CMT2O) [MIM:614228]	A0A0C9QIL6	598	R	C
Q14204	LP/P	Spinal muscular atrophy, lower extremity-predominant 1, autosomal dominant (SMALED1) [MIM:158600]	A0A0C9QIL6	598	R	C
Q14204	LP/P	Spinal muscular atrophy, lower extremity-predominant 1, autosomal dominant (SMALED1) [MIM:158600]	A0A0C9QIL6	776	P	L
Q14204	LP/P	Spinal muscular atrophy, lower extremity-predominant 1, autosomal dominant (SMALED1) [MIM:158600]	A0A0C9QIL6	1132	G	E
O14576	LB/B	-	H2MGX6	582	N	T
Q13409	LP/P	Neurodevelopmental disorder with microcephaly and structural brain anomalies (NEDMIBA) [MIM:618492]	H2MGX6	247	Y	C
Q13409	LB/B	-	H2MGX6	516	P	A
Q9Y6G9	LB/B	-	A0A2U4CAR3	277	Q	R
Q9Y6G9	LB/B	-	A0A2U4CAR3	147	M	T
Q8WVS4	LB/B	-	G1PNV0	91	E	G
Q8WVS4	LB/B	-	G1PNV0	273	Q	R
Q8WVS4	LP/P	Short-rib thoracic dysplasia 8 with or without polydactyly (SRTD8) [MIM:615503]	G1PNV0	749	T	M
Q96EX3	LB/B	-	F7FDN0	22	A	V
Q96EX3	LP/P	Short-rib thoracic dysplasia 11 with or without polydactyly (SRTD11) [MIM:615633]	F7FDN0	148	C	F
Q96EX3	LB/B	-	F7FDN0	206	R	C
Q96EX3	LP/P	Short-rib thoracic dysplasia 11 with or without polydactyly (SRTD11) [MIM:615633]	F7FDN0	341	A	V
Q96EX3	LP/P	Short-rib thoracic dysplasia 11 with or without polydactyly (SRTD11) [MIM:615633]	F7FDN0	354	T	M
Q96EX3	LP/P	Short-rib thoracic dysplasia 11 with or without polydactyly (SRTD11) [MIM:615633]	F7FDN0	390	P	L
Q96EX3	LP/P	Short-rib thoracic dysplasia 11 with or without polydactyly (SRTD11) [MIM:615633]	F7FDN0	393	G	S
Q96EX3	LP/P	Short-rib thoracic dysplasia 11 with or without polydactyly (SRTD11) [MIM:615633]	F7FDN0	410	S	I
Q96EX3	LP/P	Short-rib thoracic dysplasia 11 with or without polydactyly (SRTD11) [MIM:615633]	F7FDN0	436	K	R
Q96EX3	LP/P	Short-rib thoracic dysplasia 11 with or without polydactyly (SRTD11) [MIM:615633]	F7FDN0	447	R	Q
Q96EX3	LP/P	Short-rib thoracic dysplasia 11 with or without polydactyly (SRTD11) [MIM:615633]	F7FDN0	447	R	W
Q96EX3	LP/P	Short-rib thoracic dysplasia 11 with or without polydactyly (SRTD11) [MIM:615633]	F7FDN0	182	R	W
Q8TCX1	LB/B	-	A7RNJ9	33	F	S
Q8TCX1	LB/B	-	A7RNJ9	58	P	S
Q8TCX1	LB/B	-	A7RNJ9	230	I	L
Q8TCX1	LP/P	Short-rib thoracic dysplasia 15 with polydactyly (SRTD15) [MIM:617088]	A7RNJ9	117	L	V
Q8TCX1	LP/P	Short-rib thoracic dysplasia 15 with polydactyly (SRTD15) [MIM:617088]	A7RNJ9	220	T	I
Q8TF09	LB/B	-	A0A091DEL9	14	H	R
Q5JR98	LB/B	-	G7MGN7	47	P	L
Q92630	LB/B	-	L5JSV2	98	S	G
Q92630	LB/B	-	L5JSV2	245	H	N
Q92630	LB/B	-	L5JSV2	295	N	S
Q92630	LB/B	-	L5JSV2	451	R	Q
Q92630	LB/B	-	L5JSV2	455	F	Y
O75923	LP/P	Miyoshi muscular dystrophy 1 (MMD1) [MIM:254130]	M7BWA8	791	P	R
O75923	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 2 (LGMDR2) [MIM:253601]	M7BWA8	791	P	R
O75923	LP/P	Miyoshi muscular dystrophy 1 (MMD1) [MIM:254130]	M7BWA8	1298	I	V
O75923	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 2 (LGMDR2) [MIM:253601]	M7BWA8	1298	I	V
O75923	LP/P	Miyoshi muscular dystrophy 1 (MMD1) [MIM:254130]	M7BWA8	1857	H	R
O75923	LP/P	Miyoshi muscular dystrophy 1 (MMD1) [MIM:254130]	M7BWA8	2042	R	C
O75923	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 2 (LGMDR2) [MIM:253601]	M7BWA8	2042	R	C
O75923	LB/B	-	M7BWA8	1242	R	H
O75923	LB/B	-	M7BWA8	170	A	E
O75923	LB/B	-	M7BWA8	189	L	V
O75923	LB/B	-	M7BWA8	253	R	W
O75923	LP/P	Miyoshi muscular dystrophy 1 (MMD1) [MIM:254130]	M7BWA8	299	G	E
O75923	LP/P	Miyoshi muscular dystrophy 1 (MMD1) [MIM:254130]	M7BWA8	456	C	W
O75923	LP/P	Miyoshi muscular dystrophy 1 (MMD1) [MIM:254130]	M7BWA8	555	R	W
O75923	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 2 (LGMDR2) [MIM:253601]	M7BWA8	555	R	W
O75923	LP/P	Miyoshi muscular dystrophy 1 (MMD1) [MIM:254130]	M7BWA8	959	R	W
O75923	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 2 (LGMDR2) [MIM:253601]	M7BWA8	959	R	W
O75923	LB/B	-	M7BWA8	1022	R	Q
O75923	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 2 (LGMDR2) [MIM:253601]	M7BWA8	1038	R	Q
O75923	LP/P	Miyoshi muscular dystrophy 1 (MMD1) [MIM:254130]	M7BWA8	1046	R	H
O75923	LB/B	-	M7BWA8	1331	R	L
O75923	LP/P	Miyoshi muscular dystrophy 1 (MMD1) [MIM:254130]	M7BWA8	1335	E	K
O75923	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 2 (LGMDR2) [MIM:253601]	M7BWA8	1335	E	K
O75923	LB/B	-	M7BWA8	1351	N	S
O75923	LP/P	Miyoshi muscular dystrophy 1 (MMD1) [MIM:254130]	M7BWA8	1693	R	Q
O75923	LP/P	Miyoshi muscular dystrophy 1 (MMD1) [MIM:254130]	M7BWA8	2000	R	Q
O75923	LB/B	-	M7BWA8	834	I	V
O75923	LB/B	-	M7BWA8	1072	A	P
O75923	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 2 (LGMDR2) [MIM:253601]	M7BWA8	52	W	R
O75923	LP/P	Miyoshi muscular dystrophy 1 (MMD1) [MIM:254130]	M7BWA8	67	V	D
O75923	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 2 (LGMDR2) [MIM:253601]	M7BWA8	67	V	D
O75923	LB/B	-	M7BWA8	84	A	V
O75923	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 2 (LGMDR2) [MIM:253601]	M7BWA8	155	G	R
O75923	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 2 (LGMDR2) [MIM:253601]	M7BWA8	234	G	E
O75923	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 2 (LGMDR2) [MIM:253601]	M7BWA8	284	I	T
O75923	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 2 (LGMDR2) [MIM:253601]	M7BWA8	299	G	R
O75923	LP/P	Miyoshi muscular dystrophy 1 (MMD1) [MIM:254130]	M7BWA8	299	G	W
O75923	LB/B	-	M7BWA8	335	G	A
O75923	LB/B	-	M7BWA8	340	S	R
O75923	LB/B	-	M7BWA8	374	V	L
O75923	LP/P	Miyoshi muscular dystrophy 1 (MMD1) [MIM:254130]	M7BWA8	389	E	Q
O75923	LB/B	-	M7BWA8	390	D	N
O75923	LP/P	Miyoshi muscular dystrophy 1 (MMD1) [MIM:254130]	M7BWA8	426	G	R
O75923	LP/P	Miyoshi muscular dystrophy 1 (MMD1) [MIM:254130]	M7BWA8	426	G	V
O75923	LP/P	Miyoshi muscular dystrophy 1 (MMD1) [MIM:254130]	M7BWA8	519	G	R
O75923	LP/P	Miyoshi muscular dystrophy 1 (MMD1) [MIM:254130]	M7BWA8	618	G	R
O75923	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 2 (LGMDR2) [MIM:253601]	M7BWA8	618	G	R
O75923	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 2 (LGMDR2) [MIM:253601]	M7BWA8	621	G	R
O75923	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 2 (LGMDR2) [MIM:253601]	M7BWA8	625	D	Y
O75923	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 2 (LGMDR2) [MIM:253601]	M7BWA8	731	P	R
O75923	LB/B	-	M7BWA8	819	R	Q
O75923	LP/P	Miyoshi muscular dystrophy 1 (MMD1) [MIM:254130]	M7BWA8	999	W	C
O75923	LP/P	Miyoshi muscular dystrophy 1 (MMD1) [MIM:254130]	M7BWA8	1029	P	L
O75923	LP/P	Miyoshi muscular dystrophy 1 (MMD1) [MIM:254130]	M7BWA8	1041	R	C
O75923	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 2 (LGMDR2) [MIM:253601]	M7BWA8	1228	L	P
O75923	LB/B	-	M7BWA8	1325	I	V
O75923	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 2 (LGMDR2) [MIM:253601]	M7BWA8	1341	L	P
O75923	LP/P	Miyoshi muscular dystrophy 1 (MMD1) [MIM:254130]	M7BWA8	1361	C	R
O75923	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 2 (LGMDR2) [MIM:253601]	M7BWA8	1505	Y	C
O75923	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 2 (LGMDR2) [MIM:253601]	M7BWA8	1526	K	T
O75923	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 2 (LGMDR2) [MIM:253601]	M7BWA8	1543	G	D
O75923	LB/B	-	M7BWA8	1581	R	H
O75923	LP/P	Miyoshi muscular dystrophy 1 (MMD1) [MIM:254130]	M7BWA8	1662	T	R
O75923	LB/B	-	M7BWA8	1678	C	S
O75923	LP/P	Miyoshi muscular dystrophy 1 (MMD1) [MIM:254130]	M7BWA8	1679	G	E
O75923	LP/P	Miyoshi muscular dystrophy 1 (MMD1) [MIM:254130]	M7BWA8	1693	R	W
O75923	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 2 (LGMDR2) [MIM:253601]	M7BWA8	1734	E	G
O75923	LP/P	Miyoshi muscular dystrophy 1 (MMD1) [MIM:254130]	M7BWA8	1837	D	N
O75923	LP/P	Miyoshi muscular dystrophy 1 (MMD1) [MIM:254130]	M7BWA8	1842	G	D
O75923	LP/P	Miyoshi muscular dystrophy 1 (MMD1) [MIM:254130]	M7BWA8	1922	L	P
O75923	LP/P	Miyoshi muscular dystrophy 1 (MMD1) [MIM:254130]	M7BWA8	1942	C	G
O75923	LB/B	-	M7BWA8	1967	G	S
O75923	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 2 (LGMDR2) [MIM:253601]	M7BWA8	1970	P	S
O75923	LP/P	Miyoshi muscular dystrophy 1 (MMD1) [MIM:254130]	M7BWA8	2068	P	L
O75923	LB/B	-	M7BWA8	1096	R	H
A2CJ06	LB/B	-	A0A2K6FRB2	241	Y	C
A2CJ06	LB/B	-	A0A2K6FRB2	474	Q	K
Q86YF9	LB/B	-	W5MCM1	736	P	S
Q86YF9	LB/B	-	W5MCM1	172	T	M
Q86YF9	LB/B	-	W5MCM1	664	M	L
Q86YF9	LP/P	Mitral valve prolapse 3 (MVP3) [MIM:610840]	W5MCM1	24	S	R
Q86YF9	LP/P	Spermatogenic failure 47 (SPGF47) [MIM:619102]	W5MCM1	63	R	Q
Q8IYY4	LB/B	-	A0A2Y9ER26	321	R	W
Q8IYY4	LB/B	-	A0A2Y9ER26	545	T	A
Q8IYY4	LB/B	-	A0A2Y9ER26	551	A	V
Q8IYY4	LB/B	-	A0A2Y9ER26	593	R	H
Q8IYY4	LB/B	-	A0A2Y9ER26	645	K	E
Q8IYY4	LP/P	Polycystic kidney disease 5 (PKD5) [MIM:617610]	A0A2Y9ER26	90	A	V
Q8IYY4	LP/P	Polycystic kidney disease 5 (PKD5) [MIM:617610]	A0A2Y9ER26	91	Q	H
Q01094	LB/B	-	Q90977	252	R	H
Q01094	LB/B	-	Q90977	276	V	M
Q01094	LB/B	-	Q90977	311	T	N
Q01094	LB/B	-	Q90977	393	G	S
Q01094	LB/B	-	Q90977	200	G	S
Q14209	LB/B	-	A0A1U7TUB5	205	G	R
Q14209	LB/B	-	A0A1U7TUB5	226	Q	H
O00716	LB/B	-	F6WI20	344	G	R
O00716	LB/B	-	F6WI20	389	D	N
Q16254	LB/B	-	M7AV50	293	T	P
A0AVK6	LB/B	-	H3B8S1	674	I	V
Q66K89	LB/B	-	H3AGM1	167	R	H
Q66K89	LB/B	-	H3AGM1	355	V	I
Q56P03	LB/B	-	F6PGH7	168	Q	E
Q9HAK2	LB/B	-	A0A1A8FG46	559	G	S
Q9H4W6	LP/P	Hypotonia, ataxia, and delayed development syndrome (HADDS) [MIM:617330]	A0A1A8FG46	66	N	D
Q9H4W6	LP/P	Hypotonia, ataxia, and delayed development syndrome (HADDS) [MIM:617330]	A0A1A8FG46	141	Y	C
Q9H4W6	LP/P	Hypotonia, ataxia, and delayed development syndrome (HADDS) [MIM:617330]	A0A1A8FG46	163	R	L
Q9H4W6	LP/P	Hypotonia, ataxia, and delayed development syndrome (HADDS) [MIM:617330]	A0A1A8FG46	163	R	P
Q9H4W6	LP/P	Hypotonia, ataxia, and delayed development syndrome (HADDS) [MIM:617330]	A0A1A8FG46	163	R	Q
Q9H4W6	LP/P	Hypotonia, ataxia, and delayed development syndrome (HADDS) [MIM:617330]	A0A1A8FG46	171	G	D
Q9H4W6	LP/P	Hypotonia, ataxia, and delayed development syndrome (HADDS) [MIM:617330]	A0A1A8FG46	177	P	L
Q9H4W6	LP/P	Hypotonia, ataxia, and delayed development syndrome (HADDS) [MIM:617330]	A0A1A8FG46	193	K	N
Q9H4W6	LP/P	Hypotonia, ataxia, and delayed development syndrome (HADDS) [MIM:617330]	A0A1A8FG46	209	R	W
Q15125	LP/P	Chondrodysplasia punctata 2, X-linked dominant (CDPX2) [MIM:302960]	A0A146Z760	80	E	K
Q15125	LP/P	Chondrodysplasia punctata 2, X-linked dominant (CDPX2) [MIM:302960]	A0A146Z760	110	R	Q
Q15125	LP/P	Chondrodysplasia punctata 2, X-linked dominant (CDPX2) [MIM:302960]	A0A146Z760	147	R	G
Q15125	LP/P	Chondrodysplasia punctata 2, X-linked dominant (CDPX2) [MIM:302960]	A0A146Z760	147	R	H
Q15125	LP/P	MEND syndrome (MEND) [MIM:300960]	A0A146Z760	18	L	P
Q15125	LP/P	MEND syndrome (MEND) [MIM:300960]	A0A146Z760	47	W	C
Q15125	LP/P	MEND syndrome (MEND) [MIM:300960]	A0A146Z760	47	W	R
Q15125	LP/P	MEND syndrome (MEND) [MIM:300960]	A0A146Z760	75	I	N
Q15125	LP/P	Chondrodysplasia punctata 2, X-linked dominant (CDPX2) [MIM:302960]	A0A146Z760	103	E	K
P42892	LB/B	-	A0A1U7QP63	341	T	I
P42892	LP/P	Hirschsprung disease, cardiac defects, and autonomic dysfunction (HCAD) [MIM:613870]	A0A1U7QP63	754	R	C
P0DPD6	LB/B	-	A0A1U7QP63	499	R	Q
Q13011	LB/B	-	A0A287AE42	41	E	A
Q13011	LB/B	-	A0A287AE42	217	G	R
Q86YB7	LB/B	-	A0A2U4BJT8	119	N	D
P30084	LB/B	-	N6V8P2	11	V	A
P30084	LB/B	-	N6V8P2	75	T	I
P30084	LP/P	Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency (ECHS1D) [MIM:616277]	N6V8P2	2	A	V
P30084	LP/P	Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency (ECHS1D) [MIM:616277]	N6V8P2	158	A	D
P30084	LP/P	Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency (ECHS1D) [MIM:616277]	N6V8P2	33	F	S
P30084	LP/P	Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency (ECHS1D) [MIM:616277]	N6V8P2	54	R	H
P30084	LP/P	Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency (ECHS1D) [MIM:616277]	N6V8P2	59	N	S
P30084	LP/P	Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency (ECHS1D) [MIM:616277]	N6V8P2	66	I	T
P30084	LP/P	Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency (ECHS1D) [MIM:616277]	N6V8P2	77	E	Q
P30084	LP/P	Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency (ECHS1D) [MIM:616277]	N6V8P2	132	A	T
P30084	LP/P	Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency (ECHS1D) [MIM:616277]	N6V8P2	150	D	G
P30084	LP/P	Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency (ECHS1D) [MIM:616277]	N6V8P2	159	Q	R
P30084	LP/P	Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency (ECHS1D) [MIM:616277]	N6V8P2	195	G	S
P30084	LP/P	Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency (ECHS1D) [MIM:616277]	N6V8P2	225	C	R
P30084	LP/P	Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency (ECHS1D) [MIM:616277]	N6V8P2	273	K	E
P30084	LP/P	Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency (ECHS1D) [MIM:616277]	N6V8P2	138	A	V
O75521	LB/B	-	A0A2K5N334	47	M	I
O75521	LB/B	-	A0A2K5N334	344	A	V
Q16610	LB/B	-	M3X2V7	415	G	S
Q16610	LB/B	-	M3X2V7	528	G	R
Q16610	LB/B	-	M3X2V7	535	S	F
Q16610	LB/B	-	M3X2V7	130	T	M
Q16610	LP/P	Lipoid proteinosis (LiP) [MIM:247100]	M3X2V7	167	F	I
O94769	LB/B	-	L5JVQ8	56	Q	P
O94769	LB/B	-	L5JVQ8	109	T	S
O94769	LB/B	-	L5JVQ8	204	R	Q
Q5VYK3	LB/B	-	K1RL00	472	T	S
Q9H1Z8	LB/B	-	V9L0T2	52	A	T
Q9H8V3	LB/B	-	I3KSR6	15	S	T
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	61	Y	H
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	63	E	K
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	69	R	L
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	155	R	C
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	156	R	C
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	156	R	H
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	209	P	L
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	224	G	A
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	252	H	L
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	299	G	S
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	349	A	T
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	356	A	D
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	357	R	P
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	54	H	Y
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	55	L	R
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	291	G	R
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	291	G	W
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	298	D	H
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	255	G	C
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	255	G	D
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	274	W	G
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	332	C	Y
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	60	C	R
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	252	H	Y
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	269	G	V
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	302	F	S
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	378	T	M
Q92838	LP/P	Tooth agenesis, selective, X-linked, 1 (STHAGX1) [MIM:313500]	Q50D54	65	R	G
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	153	R	C
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	156	R	S
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	158	K	N
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	189	G	E
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	198	G	A
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	207	G	R
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	218	G	D
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	298	D	Y
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	306	Q	H
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	307	V	G
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	320	Y	C
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	343	Y	C
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	358	Q	E
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	360	I	N
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	372	N	D
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	373	M	I
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	374	S	R
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	378	T	P
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	156	R	G
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	207	G	V
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	211	T	R
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	266	L	R
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	274	W	R
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	293	L	P
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	296	L	V
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	299	G	D
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	323	V	G
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	338	T	M
Q92838	LP/P	Tooth agenesis, selective, X-linked, 1 (STHAGX1) [MIM:313500]	Q50D54	338	T	M
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	346	C	Y
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	356	A	V
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	381	G	R
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	354	L	P
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	319	S	R
Q92838	LP/P	Tooth agenesis, selective, X-linked, 1 (STHAGX1) [MIM:313500]	Q50D54	259	A	E
Q92838	LP/P	Tooth agenesis, selective, X-linked, 1 (STHAGX1) [MIM:313500]	Q50D54	260	I	S
Q92838	LP/P	Tooth agenesis, selective, X-linked, 1 (STHAGX1) [MIM:313500]	Q50D54	289	R	C
Q92838	LP/P	Tooth agenesis, selective, X-linked, 1 (STHAGX1) [MIM:313500]	Q50D54	289	R	L
Q92838	LP/P	Tooth agenesis, selective, X-linked, 1 (STHAGX1) [MIM:313500]	Q50D54	334	R	H
Q92838	LP/P	Tooth agenesis, selective, X-linked, 1 (STHAGX1) [MIM:313500]	Q50D54	379	F	V
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	289	R	P
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	290	S	C
Q92838	LP/P	Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100]	Q50D54	379	F	S
Q9UNE0	LP/P	Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive (ECTD10B) [MIM:224900]	G3VCB6	87	C	R
Q9UNE0	LP/P	Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive (ECTD10B) [MIM:224900]	G3VCB6	89	R	H
Q9UNE0	LP/P	Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant (ECTD10A) [MIM:129490]	G3VCB6	420	R	Q
Q9UNE0	LP/P	Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive (ECTD10B) [MIM:224900]	G3VCB6	420	R	Q
Q9UNE0	LB/B	-	G3VCB6	370	V	A
Q9UNE0	LP/P	Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive (ECTD10B) [MIM:224900]	G3VCB6	47	C	Y
Q9UNE0	LP/P	Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive (ECTD10B) [MIM:224900]	G3VCB6	110	D	A
Q9UNE0	LP/P	Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive (ECTD10B) [MIM:224900]	G3VCB6	148	C	R
Q9UNE0	LP/P	Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive (ECTD10B) [MIM:224900]	G3VCB6	375	R	H
Q9UNE0	LP/P	Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive (ECTD10B) [MIM:224900]	G3VCB6	377	L	F
Q9UNE0	LP/P	Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive (ECTD10B) [MIM:224900]	G3VCB6	382	G	S
Q9UNE0	LP/P	Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive (ECTD10B) [MIM:224900]	G3VCB6	403	T	M
Q9UNE0	LP/P	Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive (ECTD10B) [MIM:224900]	G3VCB6	413	T	P
Q9UNE0	LP/P	Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive (ECTD10B) [MIM:224900]	G3VCB6	418	I	T
Q9UNE0	LP/P	Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive (ECTD10B) [MIM:224900]	G3VCB6	434	W	C
Q9UNE0	LP/P	Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive (ECTD10B) [MIM:224900]	G3VCB6	98	R	Q
Q9UNE0	LP/P	Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive (ECTD10B) [MIM:224900]	G3VCB6	358	R	Q
Q9UNE0	LP/P	Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive (ECTD10B) [MIM:224900]	G3VCB6	408	I	F
Q9UNE0	LP/P	Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive (ECTD10B) [MIM:224900]	G3VCB6	434	W	R
Q9UNE0	LB/B	-	G3VCB6	370	V	L
Q96F86	LP/P	Intellectual developmental disorder, autosomal recessive 50 (MRT50) [MIM:616460]	W5K217	54	F	S
Q14507	LB/B	-	A0A1S3GQJ0	62	G	C
P56851	LB/B	-	A0A1S3GQJ0	5	L	V
Q9BV94	LB/B	-	R7TBC6	456	A	T
Q9BV94	LB/B	-	R7TBC6	510	R	Q
Q9BV94	LB/B	-	R7TBC6	556	L	F
Q9BZQ6	LB/B	-	A0A068XCP9	820	I	S
P05305	LB/B	-	A0A1V4JX18	198	K	N
P05305	LB/B	-	A0A1V4JX18	186	V	I
P05305	LP/P	Question mark ears, isolated (QME) [MIM:612798]	A0A1V4JX18	64	V	D
P05305	LP/P	Auriculocondylar syndrome 3 (ARCND3) [MIM:615706]	A0A1V4JX18	77	P	H
P05305	LP/P	Auriculocondylar syndrome 3 (ARCND3) [MIM:615706]	A0A1V4JX18	91	K	E
P20800	LB/B	-	F7ICB2	168	P	L
P20800	LB/B	-	F7ICB2	131	F	L
P14138	LP/P	Waardenburg syndrome 4B (WS4B) [MIM:613265]	A0A2Y9IWZ1	159	C	F
P14138	LB/B	-	A0A2Y9IWZ1	17	A	T
P14138	LP/P	Hirschsprung disease 4 (HSCR4) [MIM:613712]	A0A2Y9IWZ1	224	A	T
P14138	LP/P	Waardenburg syndrome 4B (WS4B) [MIM:613265]	A0A2Y9IWZ1	127	Y	C
P24530	LB/B	-	A0A2K6UV82	57	G	S
P24530	LP/P	Waardenburg syndrome 4A (WS4A) [MIM:277580]	A0A2K6UV82	183	A	G
P24530	LP/P	Hirschsprung disease 2 (HSCR2) [MIM:600155]	A0A2K6UV82	276	W	C
P24530	LB/B	-	A0A2K6UV82	305	S	N
P24530	LP/P	Hirschsprung disease 2 (HSCR2) [MIM:600155]	A0A2K6UV82	319	R	W
P24530	LP/P	Hirschsprung disease 2 (HSCR2) [MIM:600155]	A0A2K6UV82	374	M	I
P24530	LP/P	Hirschsprung disease 2 (HSCR2) [MIM:600155]	A0A2K6UV82	383	P	L
P24530	LB/B	-	A0A2K6UV82	7	L	Q
P24530	LB/B	-	A0A2K6UV82	17	L	F
P24530	LB/B	-	A0A2K6UV82	112	F	V
P24530	LB/B	-	A0A2K6UV82	244	T	M
P24530	LP/P	Waardenburg syndrome 4A (WS4A) [MIM:277580]	A0A2K6UV82	292	F	L
P24530	LB/B	-	A0A2K6UV82	5	P	T
P24530	LB/B	-	A0A2K6UV82	76	R	M
P24530	LP/P	-	A0A2K6UV82	17	L	P
P24530	LP/P	-	A0A2K6UV82	137	N	Y
P24530	LP/P	-	A0A2K6UV82	156	P	R
Q05639	LP/P	Developmental and epileptic encephalopathy 33 (DEE33) [MIM:616409]	L8Y4G7	70	G	S
Q05639	LP/P	Intellectual developmental disorder, autosomal dominant 38 (MRD38) [MIM:616393]	L8Y4G7	122	E	K
Q05639	LP/P	Intellectual developmental disorder, autosomal dominant 38 (MRD38) [MIM:616393]	L8Y4G7	252	D	H
P13639	LP/P	Spinocerebellar ataxia 26 (SCA26) [MIM:609306]	S7MI30	596	P	H
O00418	LB/B	-	A0A293M251	23	H	R
O00418	LB/B	-	A0A293M251	75	P	A
O00418	LB/B	-	A0A293M251	433	R	W
O00418	LB/B	-	A0A293M251	609	D	H
O00418	LB/B	-	A0A293M251	361	Q	R
Q96G04	LB/B	-	A0A2Y9FVL3	123	S	C
Q96G04	LB/B	-	A0A2Y9FVL3	270	R	W
Q96G04	LB/B	-	A0A2Y9FVL3	230	V	I
Q96G04	LB/B	-	A0A2Y9FVL3	272	H	D
Q96G04	LB/B	-	A0A2Y9FVL3	329	T	I
Q7L9B9	LB/B	-	T1ISV2	358	A	S
Q7L9B9	LB/B	-	T1ISV2	416	P	S
Q7L9B9	LB/B	-	T1ISV2	343	S	N
O75071	LB/B	-	A0A2K5JLY2	337	L	P
O75071	LB/B	-	A0A2K5JLY2	239	P	S
Q8N7B9	LB/B	-	A0A1U7QB67	341	G	R
Q8N7B9	LB/B	-	A0A1U7QB67	364	M	I
Q8N7B9	LB/B	-	A0A1U7QB67	370	S	A
A4FU69	LB/B	-	L5JUC5	237	L	V
A4FU69	LB/B	-	L5JUC5	278	I	K
A4FU69	LB/B	-	L5JUC5	561	R	S
A4FU69	LB/B	-	L5JUC5	1145	A	D
A4FU69	LB/B	-	L5JUC5	1252	V	A
A4FU69	LB/B	-	L5JUC5	1274	R	T
Q5THR3	LB/B	-	I3M3I3	166	V	A
Q5THR3	LB/B	-	I3M3I3	199	R	G
Q5THR3	LB/B	-	I3M3I3	351	T	A
Q5THR3	LB/B	-	I3M3I3	384	S	A
Q5THR3	LB/B	-	I3M3I3	400	H	Y
Q5THR3	LB/B	-	I3M3I3	680	T	A
Q5THR3	LB/B	-	I3M3I3	780	D	N
Q5THR3	LB/B	-	I3M3I3	800	R	W
Q5THR3	LB/B	-	I3M3I3	1059	A	V
A8K855	LB/B	-	W5MI58	27	F	I
A8K855	LB/B	-	W5MI58	186	S	G
A8K855	LB/B	-	W5MI58	248	T	I
A8K855	LB/B	-	W5MI58	262	M	T
A8K855	LB/B	-	W5MI58	375	R	K
Q12805	LB/B	-	G1KCE9	220	I	F
Q12805	LP/P	Doyne honeycomb retinal dystrophy (DHRD) [MIM:126600]	G1KCE9	345	R	W
O95967	LP/P	Cutis laxa, autosomal recessive, 1B (ARCL1B) [MIM:614437]	G1KCE9	57	E	K
O95967	LB/B	-	G1KCE9	259	I	V
O95967	LP/P	Cutis laxa, autosomal recessive, 1B (ARCL1B) [MIM:614437]	G1KCE9	267	C	Y
O95967	LP/P	Cutis laxa, autosomal recessive, 1B (ARCL1B) [MIM:614437]	G1KCE9	279	R	C
O95967	LP/P	Cutis laxa, autosomal recessive, 1B (ARCL1B) [MIM:614437]	G1KCE9	126	E	K
O95967	LP/P	Cutis laxa, autosomal recessive, 1B (ARCL1B) [MIM:614437]	G1KCE9	126	E	V
O95967	LP/P	Cutis laxa, autosomal recessive, 1B (ARCL1B) [MIM:614437]	G1KCE9	203	D	A
O95967	LP/P	Cutis laxa, autosomal recessive, 1B (ARCL1B) [MIM:614437]	G1KCE9	227	R	C
O95967	LP/P	Cutis laxa, autosomal recessive, 1B (ARCL1B) [MIM:614437]	G1KCE9	397	A	T
Q8N7U6	LB/B	-	A0A1S3FMI3	331	V	I
Q8N7U6	LB/B	-	A0A1S3FMI3	382	T	I
Q8N7U6	LB/B	-	A0A1S3FMI3	663	Q	P
Q8N7U6	LB/B	-	A0A1S3FMI3	99	G	V
Q8N7U6	LB/B	-	A0A1S3FMI3	269	P	S
Q8N7U6	LB/B	-	A0A1S3FMI3	826	R	W
Q5JST6	LB/B	-	A0A2U9CC20	31	N	S
Q5JST6	LB/B	-	A0A2U9CC20	208	E	K
Q5JST6	LB/B	-	A0A2U9CC20	430	S	Y
Q5JST6	LB/B	-	A0A2U9CC20	507	E	Q
Q5JST6	LB/B	-	A0A2U9CC20	57	C	Y
Q7Z2Z2	LB/B	-	A0A099YQQ8	478	E	D
Q7Z2Z2	LB/B	-	A0A099YQQ8	617	I	V
Q7Z2Z2	LB/B	-	A0A099YQQ8	711	K	R
P20827	LB/B	-	H2SXZ8	159	D	V
P52803	LB/B	-	A0A1D5PII3	55	N	K
P98172	LP/P	Craniofrontonasal syndrome (CFNS) [MIM:304110]	A0A147A105	27	P	R
P98172	LP/P	Craniofrontonasal syndrome (CFNS) [MIM:304110]	A0A147A105	54	P	L
P98172	LP/P	Craniofrontonasal syndrome (CFNS) [MIM:304110]	A0A147A105	62	I	T
P98172	LP/P	Craniofrontonasal syndrome (CFNS) [MIM:304110]	A0A147A105	98	L	S
P98172	LP/P	Craniofrontonasal syndrome (CFNS) [MIM:304110]	A0A147A105	111	T	I
P98172	LP/P	Craniofrontonasal syndrome (CFNS) [MIM:304110]	A0A147A105	115	Q	P
P98172	LP/P	Craniofrontonasal syndrome (CFNS) [MIM:304110]	A0A147A105	119	P	H
P98172	LP/P	Craniofrontonasal syndrome (CFNS) [MIM:304110]	A0A147A105	119	P	S
P98172	LP/P	Craniofrontonasal syndrome (CFNS) [MIM:304110]	A0A147A105	119	P	T
P98172	LP/P	Craniofrontonasal syndrome (CFNS) [MIM:304110]	A0A147A105	137	T	A
P98172	LP/P	Craniofrontonasal syndrome (CFNS) [MIM:304110]	A0A147A105	138	S	F
P98172	LP/P	Craniofrontonasal syndrome (CFNS) [MIM:304110]	A0A147A105	151	G	S
P98172	LP/P	Craniofrontonasal syndrome (CFNS) [MIM:304110]	A0A147A105	151	G	V
P98172	LP/P	Craniofrontonasal syndrome (CFNS) [MIM:304110]	A0A147A105	153	C	S
P98172	LP/P	Craniofrontonasal syndrome (CFNS) [MIM:304110]	A0A147A105	153	C	Y
P98172	LB/B	-	A0A147A105	154	R	H
P98172	LP/P	Craniofrontonasal syndrome (CFNS) [MIM:304110]	A0A147A105	155	T	P
P98172	LP/P	Craniofrontonasal syndrome (CFNS) [MIM:304110]	A0A147A105	158	M	I
P98172	LP/P	Craniofrontonasal syndrome (CFNS) [MIM:304110]	A0A147A105	158	M	V
P98172	LP/P	Craniofrontonasal syndrome (CFNS) [MIM:304110]	A0A147A105	182	S	R
P98172	LB/B	-	A0A147A105	189	V	A
P98172	LB/B	-	A0A147A105	172	T	M
Q15768	LB/B	-	G3N9M0	166	R	Q
O43281	LB/B	-	A0A1S3AL11	7	T	A
O43281	LB/B	-	A0A1S3AL11	100	V	M
P01133	LB/B	-	A0A091D5S5	708	M	I
P01133	LB/B	-	A0A091D5S5	16	S	R
P01133	LB/B	-	A0A091D5S5	431	R	K
P01133	LB/B	-	A0A091D5S5	723	G	R
P01133	LB/B	-	A0A091D5S5	784	D	V
P01133	LB/B	-	A0A091D5S5	842	M	T
P01133	LB/B	-	A0A091D5S5	1043	L	F
P01133	LB/B	-	A0A091D5S5	257	D	H
P01133	LB/B	-	A0A091D5S5	638	S	R
P01133	LB/B	-	A0A091D5S5	920	E	V
P01133	LB/B	-	A0A091D5S5	981	D	E
P01133	LB/B	-	A0A091D5S5	1084	A	G
P01133	LB/B	-	A0A091D5S5	151	H	Y
P01133	LB/B	-	A0A091D5S5	292	L	H
P01133	LP/P	Hypomagnesemia 4 (HOMG4) [MIM:611718]	A0A091D5S5	1070	P	L
Q0D2K5	LB/B	-	Q0D2K5	59	G	D
Q0D2K5	LB/B	-	Q0D2K5	157	P	L
Q8IUX8	LB/B	-	A0A2K5VVY6	66	E	K
Q8IUX8	LB/B	-	A0A2K5VVY6	164	R	C
Q8IUX8	LB/B	-	A0A2K5VVY6	508	L	F
Q8IUX8	LB/B	-	A0A2K5VVY6	535	D	N
Q9UHF1	LB/B	-	A0A2J8N9V4	153	V	I
Q9UHF1	LB/B	-	A0A2J8N9V4	183	P	S
Q9UHF1	LB/B	-	A0A2J8N9V4	186	A	G
Q9UHF1	LB/B	-	A0A2J8N9V4	114	G	R
Q63HQ2	LB/B	-	H9GQ01	111	R	H
Q63HQ2	LB/B	-	H9GQ01	229	W	R
Q63HQ2	LB/B	-	H9GQ01	473	T	M
Q63HQ2	LB/B	-	H9GQ01	576	H	N
Q63HQ2	LB/B	-	H9GQ01	26	R	P
Q63HQ2	LB/B	-	H9GQ01	745	V	M
P00533	LB/B	-	A0A2I0U5X7	98	R	Q
P00533	LB/B	-	A0A2I0U5X7	266	P	R
P00533	LB/B	-	A0A2I0U5X7	521	R	K
P00533	LB/B	-	A0A2I0U5X7	674	V	I
P00533	LB/B	-	A0A2I0U5X7	719	G	S
P00533	LB/B	-	A0A2I0U5X7	858	L	R
P00533	LB/B	-	A0A2I0U5X7	962	R	G
P00533	LB/B	-	A0A2I0U5X7	988	H	P
P00533	LB/B	-	A0A2I0U5X7	709	E	A
P00533	LB/B	-	A0A2I0U5X7	709	E	K
P00533	LB/B	-	A0A2I0U5X7	719	G	A
P00533	LB/B	-	A0A2I0U5X7	719	G	C
P00533	LB/B	-	A0A2I0U5X7	719	G	D
P00533	LB/B	-	A0A2I0U5X7	724	G	S
P00533	LB/B	-	A0A2I0U5X7	734	E	K
P00533	LB/B	-	A0A2I0U5X7	790	T	M
P00533	LB/B	-	A0A2I0U5X7	833	L	V
P00533	LB/B	-	A0A2I0U5X7	834	V	L
P00533	LB/B	-	A0A2I0U5X7	858	L	M
P00533	LB/B	-	A0A2I0U5X7	861	L	Q
P00533	LB/B	-	A0A2I0U5X7	1034	L	R
P00533	LB/B	-	A0A2I0U5X7	1210	A	V
P00533	LB/B	-	A0A2I0U5X7	709	E	G
P00533	LB/B	-	A0A2I0U5X7	768	S	I
P00533	LB/B	-	A0A2I0U5X7	769	V	M
P00533	LB/B	-	A0A2I0U5X7	835	H	L
P00533	LB/B	-	A0A2I0U5X7	838	L	V
P00533	LP/P	Inflammatory skin and bowel disease, neonatal, 2 (NISBD2) [MIM:616069]	A0A2I0U5X7	428	G	D
Q9GZT9	LP/P	Erythrocytosis, familial, 3 (ECYT3) [MIM:609820]	A0A2Y9HQ61	317	P	R
Q9GZT9	LP/P	Erythrocytosis, familial, 3 (ECYT3) [MIM:609820]	A0A2Y9HQ61	371	R	H
Q9GZT9	LB/B	-	A0A2Y9HQ61	4	D	E
Q9GZT9	LB/B	-	A0A2Y9HQ61	127	C	S
Q9H6Z9	LB/B	-	W5P9P5	136	V	L
Q9H6Z9	LB/B	-	W5P9P5	234	S	T
P18146	LB/B	-	G3UAH9	144	N	K
P18146	LB/B	-	G3UAH9	145	S	R
P18146	LB/B	-	G3UAH9	219	E	D
P18146	LB/B	-	G3UAH9	28	T	I
P11161	LP/P	Neuropathy, congenital hypomyelinating, 1, autosomal recessive (CHN1) [MIM:605253]	A0A2I4D3V5	268	I	N
P11161	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1D (CMT1D) [MIM:607678]	A0A2I4D3V5	355	D	V
P11161	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1D (CMT1D) [MIM:607678]	A0A2I4D3V5	409	R	W
P11161	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1D (CMT1D) [MIM:607678]	A0A2I4D3V5	359	R	W
P11161	LP/P	Dejerine-Sottas syndrome (DSS) [MIM:145900]	A0A2I4D3V5	359	R	W
P11161	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1D (CMT1D) [MIM:607678]	A0A2I4D3V5	381	R	H
P11161	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1D (CMT1D) [MIM:607678]	A0A2I4D3V5	381	R	C
P11161	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1D (CMT1D) [MIM:607678]	A0A2I4D3V5	383	D	Y
P11161	LP/P	Dejerine-Sottas syndrome (DSS) [MIM:145900]	A0A2I4D3V5	411	D	G
P11161	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1D (CMT1D) [MIM:607678]	A0A2I4D3V5	412	E	G
P11161	LP/P	Dejerine-Sottas syndrome (DSS) [MIM:145900]	A0A2I4D3V5	412	E	K
Q8NDI1	LB/B	-	A0A2R8QED9	755	K	Q
Q8N3D4	LB/B	-	A0A2K6SZH8	307	R	Q
Q8N3D4	LB/B	-	A0A2K6SZH8	538	V	G
Q8N3D4	LB/B	-	A0A2K6SZH8	569	D	V
Q8N3D4	LB/B	-	A0A2K6SZH8	599	T	I
Q8N3D4	LB/B	-	A0A2K6SZH8	648	T	I
Q8N3D4	LB/B	-	A0A2K6SZH8	133	V	L
Q9NZN4	LB/B	-	S9X9D0	57	G	S
Q9H223	LB/B	-	A0A0L7QXR0	154	V	I
Q9NZC4	LB/B	-	G3W8E1	96	A	V
Q08426	LB/B	-	P55100	75	T	I
Q08426	LB/B	-	P55100	274	A	T
Q08426	LB/B	-	P55100	606	T	P
Q08426	LB/B	-	P55100	685	Q	K
Q08426	LB/B	-	P55100	715	L	S
Q08426	LB/B	-	P55100	40	V	G
Q08426	LB/B	-	P55100	41	I	R
Q08426	LB/B	-	P55100	325	A	G
Q08426	LB/B	-	P55100	598	K	T
Q08426	LP/P	Fanconi renotubular syndrome 3 (FRTS3) [MIM:615605]	P55100	3	E	K
Q9H9B1	LB/B	-	H2R5Y8	388	A	T
Q9H9B1	LP/P	Kleefstra syndrome 1 (KLEFS1) [MIM:610253]	H2R5Y8	1075	C	Y
Q96KQ7	LB/B	-	A0A2D0SDU4	55	T	N
Q96KQ7	LB/B	-	A0A2D0SDU4	1165	Y	F
Q8N9N8	LB/B	-	W5KTA9	23	D	N
Q8N9N8	LB/B	-	W5KTA9	159	S	N
Q9BY44	LB/B	-	A0A0D2WK52	97	T	S
Q9BY44	LB/B	-	A0A0D2WK52	582	E	K
P19525	LB/B	-	A0A2K6DCU6	428	V	E
P19525	LB/B	-	A0A2K6DCU6	506	I	V
P19525	LP/P	Dystonia 33 (DYT33) [MIM:619687]	A0A2K6DCU6	130	G	R
Q9P2K8	LB/B	-	K7JC97	137	H	R
Q9P2K8	LB/B	-	K7JC97	166	R	W
Q9P2K8	LB/B	-	K7JC97	441	I	L
Q9P2K8	LB/B	-	K7JC97	872	D	V
Q9P2K8	LB/B	-	K7JC97	1060	T	R
Q9P2K8	LB/B	-	K7JC97	1306	G	C
Q9P2K8	LB/B	-	K7JC97	1336	K	R
Q9P2K8	LB/B	-	K7JC97	1406	Q	H
Q9P2K8	LP/P	Pulmonary venoocclusive disease 2, autosomal recessive (PVOD2) [MIM:234810]	K7JC97	585	R	Q
Q9P2K8	LP/P	Pulmonary venoocclusive disease 2, autosomal recessive (PVOD2) [MIM:234810]	K7JC97	643	L	R
P49770	LP/P	Leukodystrophy with vanishing white matter (VWM) [MIM:603896]	M7B0Y2	213	E	G
P49770	LP/P	Leukodystrophy with vanishing white matter (VWM) [MIM:603896]	M7B0Y2	316	V	D
P49770	LP/P	Leukodystrophy with vanishing white matter (VWM) [MIM:603896]	M7B0Y2	273	K	R
P49770	LP/P	Leukodystrophy with vanishing white matter (VWM) [MIM:603896]	M7B0Y2	329	G	V
P49770	LP/P	Leukodystrophy with vanishing white matter (VWM) [MIM:603896]	M7B0Y2	171	S	F
P49770	LP/P	Leukodystrophy with vanishing white matter (VWM) [MIM:603896]	M7B0Y2	85	V	E
P49770	LP/P	Leukodystrophy with vanishing white matter (VWM) [MIM:603896]	M7B0Y2	196	P	S
P49770	LP/P	Leukodystrophy with vanishing white matter (VWM) [MIM:603896]	M7B0Y2	200	G	V
P49770	LP/P	Leukodystrophy with vanishing white matter (VWM) [MIM:603896]	M7B0Y2	268	C	Y
Q9UI10	LP/P	Leukodystrophy with vanishing white matter (VWM) [MIM:603896]	A0A0Q3R5E5	228	A	V
Q9UI10	LB/B	-	A0A0Q3R5E5	306	R	G
Q9UI10	LP/P	Leukodystrophy with vanishing white matter (VWM) [MIM:603896]	A0A0Q3R5E5	357	R	Q
Q9UI10	LP/P	Leukodystrophy with vanishing white matter (VWM) [MIM:603896]	A0A0Q3R5E5	374	R	C
Q9UI10	LP/P	Leukodystrophy with vanishing white matter (VWM) [MIM:603896]	A0A0Q3R5E5	465	C	R
Q9UI10	LP/P	Leukodystrophy with vanishing white matter (VWM) [MIM:603896]	A0A0Q3R5E5	489	Y	H
Q9UI10	LB/B	-	A0A0Q3R5E5	93	A	V
Q9UI10	LP/P	Leukodystrophy with vanishing white matter (VWM) [MIM:603896]	A0A0Q3R5E5	209	R	Q
Q9UI10	LP/P	Leukodystrophy with vanishing white matter (VWM) [MIM:603896]	A0A0Q3R5E5	269	L	R
Q13144	LP/P	Leukodystrophy with vanishing white matter (VWM) [MIM:603896]	W5LKI8	91	T	A
Q13144	LP/P	Leukodystrophy with vanishing white matter (VWM) [MIM:603896]	W5LKI8	113	R	H
Q13144	LP/P	Leukodystrophy with vanishing white matter (VWM) [MIM:603896]	W5LKI8	386	G	V
Q13144	LP/P	Leukodystrophy with vanishing white matter (VWM) [MIM:603896]	W5LKI8	628	W	R
Q13144	LP/P	Leukodystrophy with vanishing white matter (VWM) [MIM:603896]	W5LKI8	73	V	G
Q13144	LP/P	Leukodystrophy with vanishing white matter (VWM) [MIM:603896]	W5LKI8	106	L	F
Q13144	LP/P	Leukodystrophy with vanishing white matter (VWM) [MIM:603896]	W5LKI8	299	R	H
Q13144	LP/P	Leukodystrophy with vanishing white matter (VWM) [MIM:603896]	W5LKI8	315	R	G
Q13144	LP/P	Leukodystrophy with vanishing white matter (VWM) [MIM:603896]	W5LKI8	315	R	H
Q13144	LP/P	Leukodystrophy with vanishing white matter (VWM) [MIM:603896]	W5LKI8	339	R	P
Q13144	LP/P	Leukodystrophy with vanishing white matter (VWM) [MIM:603896]	W5LKI8	339	R	Q
Q13144	LP/P	Leukodystrophy with vanishing white matter (VWM) [MIM:603896]	W5LKI8	339	R	W
Q13144	LP/P	Leukodystrophy with vanishing white matter (VWM) [MIM:603896]	W5LKI8	430	V	A
Q13144	LB/B	-	W5LKI8	587	I	V
Q13144	LP/P	Leukodystrophy with vanishing white matter (VWM) [MIM:603896]	W5LKI8	650	E	K
Q13144	LP/P	Leukodystrophy with vanishing white matter (VWM) [MIM:603896]	W5LKI8	195	R	C
Q13144	LP/P	Leukodystrophy with vanishing white matter (VWM) [MIM:603896]	W5LKI8	195	R	H
Q13144	LB/B	-	W5LKI8	200	N	T
Q13144	LP/P	Leukodystrophy with vanishing white matter (VWM) [MIM:603896]	W5LKI8	62	D	V
Q13144	LP/P	Leukodystrophy with vanishing white matter (VWM) [MIM:603896]	W5LKI8	68	L	S
Q13144	LP/P	Leukodystrophy with vanishing white matter (VWM) [MIM:603896]	W5LKI8	74	A	T
Q13144	LP/P	Leukodystrophy with vanishing white matter (VWM) [MIM:603896]	W5LKI8	113	R	C
Q13144	LP/P	Leukodystrophy with vanishing white matter (VWM) [MIM:603896]	W5LKI8	269	R	G
Q13144	LP/P	Leukodystrophy with vanishing white matter (VWM) [MIM:603896]	W5LKI8	269	R	Q
Q13144	LP/P	Leukodystrophy with vanishing white matter (VWM) [MIM:603896]	W5LKI8	270	D	H
Q13144	LP/P	Leukodystrophy with vanishing white matter (VWM) [MIM:603896]	W5LKI8	310	C	F
Q13144	LP/P	Leukodystrophy with vanishing white matter (VWM) [MIM:603896]	W5LKI8	315	R	C
Q13144	LP/P	Leukodystrophy with vanishing white matter (VWM) [MIM:603896]	W5LKI8	335	C	R
Q13144	LP/P	Leukodystrophy with vanishing white matter (VWM) [MIM:603896]	W5LKI8	335	C	S
Q13144	LP/P	Leukodystrophy with vanishing white matter (VWM) [MIM:603896]	W5LKI8	376	N	D
Q13144	LP/P	Leukodystrophy with vanishing white matter (VWM) [MIM:603896]	W5LKI8	447	S	L
P41214	LB/B	-	G3WZU7	210	T	I
P41091	LB/B	-	A0A2I0TSZ3	125	K	R
P41091	LP/P	MEHMO syndrome (MEHMO) [MIM:300148]	A0A2I0TSZ3	222	I	T
Q14152	LB/B	-	A0A1U8CNK1	386	E	K
Q14152	LB/B	-	A0A1U8CNK1	694	K	N
Q14152	LB/B	-	A0A1U8CNK1	993	D	E
P55884	LB/B	-	A0A2R9AWG7	64	S	P
P55884	LB/B	-	A0A2R9AWG7	793	D	E
O15371	LB/B	-	A0A0P6J4V1	310	R	C
P60228	LB/B	-	A0A2I0UU01	185	A	V
O00303	LB/B	-	U3KNL5	172	W	L
O00303	LB/B	-	U3KNL5	39	P	L
O00303	LP/P	Intellectual developmental disorder, autosomal recessive 67 (MRT67) [MIM:618295]	U3KNL5	232	F	V
O75822	LB/B	-	A0A060WIJ3	141	A	T
Q7L2H7	LB/B	-	K1R0D7	37	G	R
Q7L2H7	LB/B	-	K1R0D7	346	Q	R
Q14240	LB/B	-	T0NNB1	93	Q	H
A6NMX2	LB/B	-	A0A2K6FQM6	227	D	Y
Q04637	LB/B	-	A0A091EYW2	311	Y	C
Q04637	LB/B	-	A0A091EYW2	1233	L	P
Q04637	LB/B	-	A0A091EYW2	161	T	A
Q04637	LB/B	-	A0A091EYW2	1229	P	A
Q04637	LB/B	-	A0A091EYW2	432	M	V
Q04637	LB/B	-	A0A091EYW2	71	P	S
Q04637	LP/P	Parkinson disease 18 (PARK18) [MIM:614251]	A0A091EYW2	502	A	V
Q04637	LB/B	-	A0A091EYW2	806	I	V
Q04637	LB/B	-	A0A091EYW2	829	T	S
Q04637	LP/P	Parkinson disease 18 (PARK18) [MIM:614251]	A0A091EYW2	1205	R	H
Q04637	LB/B	-	A0A091EYW2	1257	N	S
P78344	LB/B	-	A0A2K5PR52	236	L	M
O43432	LB/B	-	A0A1S3WQD7	496	P	A
O43432	LB/B	-	A0A1S3WQD7	378	Q	R
O43432	LB/B	-	A0A1S3WQD7	1185	D	E
P63241	LP/P	Faundes-Banka syndrome (FABAS) [MIM:619376]	A0A061IN17	48	T	N
P63241	LP/P	Faundes-Banka syndrome (FABAS) [MIM:619376]	A0A061IN17	106	G	R
P63241	LP/P	Faundes-Banka syndrome (FABAS) [MIM:619376]	A0A061IN17	109	R	G
P63241	LP/P	Faundes-Banka syndrome (FABAS) [MIM:619376]	A0A061IN17	115	P	S
P63241	LP/P	Faundes-Banka syndrome (FABAS) [MIM:619376]	A0A061IN17	122	E	K
Q9GZV4	LB/B	-	F6ZHM6	42	E	D
Q9H777	LB/B	-	A0A0L0HDL4	355	M	V
Q9BQ52	LP/P	Prostate cancer, hereditary, 2 (HPC2) [MIM:614731]	S9X5C4	211	R	Q
Q9BQ52	LP/P	Prostate cancer, hereditary, 2 (HPC2) [MIM:614731]	S9X5C4	217	S	L
Q9BQ52	LP/P	Prostate cancer, hereditary, 2 (HPC2) [MIM:614731]	S9X5C4	487	G	R
Q9BQ52	LP/P	Prostate cancer, hereditary, 2 (HPC2) [MIM:614731]	S9X5C4	541	A	T
Q9BQ52	LP/P	Prostate cancer, hereditary, 2 (HPC2) [MIM:614731]	S9X5C4	622	E	V
Q9BQ52	LB/B	-	S9X5C4	627	S	L
Q9BQ52	LP/P	Prostate cancer, hereditary, 2 (HPC2) [MIM:614731]	S9X5C4	781	R	H
Q9BQ52	LP/P	Prostate cancer, hereditary, 2 (HPC2) [MIM:614731]	S9X5C4	806	G	R
Q9BQ52	LB/B	-	S9X5C4	52	S	F
Q9BQ52	LB/B	-	S9X5C4	436	D	N
Q9BQ52	LP/P	Combined oxidative phosphorylation deficiency 17 (COXPD17) [MIM:615440]	S9X5C4	154	F	L
Q9BQ52	LP/P	Combined oxidative phosphorylation deficiency 17 (COXPD17) [MIM:615440]	S9X5C4	423	L	F
Q9BQ52	LP/P	Combined oxidative phosphorylation deficiency 17 (COXPD17) [MIM:615440]	S9X5C4	520	T	I
P08246	LB/B	-	G7NL32	219	V	I
P08246	LB/B	-	G7NL32	257	P	L
P08246	LB/B	-	G7NL32	262	P	L
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	55	C	Y
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	57	A	T
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	60	I	T
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	71	C	R
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	71	C	S
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	85	G	E
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	98	V	L
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	101	V	L
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	101	V	M
P08246	LP/P	Cyclic haematopoiesis (CH) [MIM:162800]	G7NL32	126	S	L
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	126	S	L
P08246	LP/P	Cyclic haematopoiesis (CH) [MIM:162800]	G7NL32	139	P	L
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	139	P	L
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	151	C	S
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	205	P	R
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	210	G	V
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	214	G	R
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	25	A	V
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	166	A	T
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	42	P	L
P08246	LP/P	Cyclic haematopoiesis (CH) [MIM:162800]	G7NL32	43	F	L
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	43	F	L
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	44	M	R
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	45	V	E
P08246	LP/P	Cyclic haematopoiesis (CH) [MIM:162800]	G7NL32	45	V	L
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	46	S	C
P08246	LP/P	Cyclic haematopoiesis (CH) [MIM:162800]	G7NL32	46	S	F
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	46	S	F
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	47	L	P
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	47	L	R
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	49	L	P
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	53	H	L
P08246	LP/P	Cyclic haematopoiesis (CH) [MIM:162800]	G7NL32	53	H	Q
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	53	H	Y
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	55	C	S
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	56	G	R
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	57	A	S
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	57	A	V
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	59	L	P
P08246	LP/P	Cyclic haematopoiesis (CH) [MIM:162800]	G7NL32	61	A	V
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	61	A	V
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	67	S	W
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	71	C	F
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	71	C	Y
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	72	V	G
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	80	V	G
P08246	LP/P	Cyclic haematopoiesis (CH) [MIM:162800]	G7NL32	81	R	P
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	81	R	P
P08246	LP/P	Cyclic haematopoiesis (CH) [MIM:162800]	G7NL32	82	V	M
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	82	V	M
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	84	L	P
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	85	G	R
P08246	LP/P	Cyclic haematopoiesis (CH) [MIM:162800]	G7NL32	97	Q	L
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	98	V	M
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	103	R	L
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	103	R	P
P08246	LP/P	Cyclic haematopoiesis (CH) [MIM:162800]	G7NL32	104	I	N
P08246	LB/B	-	G7NL32	118	I	V
P08246	LP/P	Cyclic haematopoiesis (CH) [MIM:162800]	G7NL32	120	I	F
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	120	I	F
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	120	I	N
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	120	I	S
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	121	L	P
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	123	L	H
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	124	N	I
P08246	LB/B	-	G7NL32	125	G	R
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	127	A	D
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	127	A	P
P08246	LB/B	-	G7NL32	135	V	M
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	136	A	D
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	139	P	R
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	151	C	F
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	151	C	W
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	152	L	P
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	153	A	D
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	153	A	P
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	156	W	C
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	156	W	R
P08246	LP/P	Cyclic haematopoiesis (CH) [MIM:162800]	G7NL32	203	G	C
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	203	G	C
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	203	G	R
P08246	LP/P	Cyclic haematopoiesis (CH) [MIM:162800]	G7NL32	206	L	F
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	206	L	S
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	208	C	G
P08246	LP/P	Cyclic haematopoiesis (CH) [MIM:162800]	G7NL32	209	N	I
P08246	LP/P	Cyclic haematopoiesis (CH) [MIM:162800]	G7NL32	210	G	W
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	214	G	E
P08246	LP/P	Cyclic haematopoiesis (CH) [MIM:162800]	G7NL32	220	R	Q
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	220	R	Q
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	233	A	P
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	235	V	E
P08246	LP/P	Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700]	G7NL32	235	V	G
Q6UXG2	LB/B	-	A0A1D5PPQ9	86	I	V
Q6UXG2	LB/B	-	A0A1D5PPQ9	623	T	P
Q6UXG2	LB/B	-	A0A1D5PPQ9	1009	L	P
A8MWY0	LB/B	-	A0A1D5PPQ9	539	N	Y
A8MWY0	LB/B	-	A0A1D5PPQ9	729	L	V
A8MWY0	LB/B	-	A0A1D5PPQ9	767	S	R
P26378	LB/B	-	A0A2I4BPP4	275	P	S
P26378	LB/B	-	A0A2I4BPP4	171	D	G
P26378	LB/B	-	A0A2I4BPP4	361	A	T
P32519	LB/B	-	G1SZL5	58	N	S
P32519	LB/B	-	G1SZL5	343	T	S
P32519	LB/B	-	G1SZL5	403	T	I
P19419	LB/B	-	A0A2K5LWV6	144	G	S
P19419	LB/B	-	A0A2K5LWV6	183	S	N
P41970	LB/B	-	S7Q342	169	P	L
P55199	LB/B	-	A0A218UCL1	297	S	N
P55199	LB/B	-	A0A218UCL1	387	R	W
O00472	LB/B	-	A0A218UCL1	298	A	T
Q9HB65	LB/B	-	H0VBS8	11	Q	E
Q9HB65	LB/B	-	H0VBS8	140	W	R
Q92556	LB/B	-	B7Q7M8	362	I	S
Q96JJ3	LB/B	-	B7Q7M8	695	E	D
Q96BJ8	LB/B	-	B7Q7M8	13	K	Q
Q96BJ8	LB/B	-	B7Q7M8	95	N	D
Q96BJ8	LB/B	-	B7Q7M8	316	R	C
Q96FG2	LB/B	-	H0VBA5	66	R	C
Q96FG2	LB/B	-	H0VBA5	70	T	I
Q96FG2	LP/P	Deafness, autosomal recessive, 88 (DFNB88) [MIM:615429]	H0VBA5	265	L	S
Q96FG2	LP/P	Deafness, autosomal dominant, 81 (DFNA81) [MIM:619500]	H0VBA5	171	H	R
P15502	LB/B	-	A0A2K6BHN6	422	G	S
P15502	LB/B	-	A0A2K6BHN6	610	G	R
Q9BW60	LP/P	Ichthyotic keratoderma, spasticity, hypomyelination, and dysmorphic facies (IKSHD) [MIM:618527]	A0A1S3NPX6	165	S	F
Q9NXB9	LB/B	-	A0A2R8MBJ5	216	T	A
Q9NXB9	LB/B	-	A0A2R8MBJ5	225	V	M
Q9GZR5	LB/B	-	A0A151I3W1	299	M	V
Q9GZR5	LB/B	-	A0A151I3W1	267	I	T
Q9GZR5	LP/P	Spinocerebellar ataxia 34 (SCA34) [MIM:133190]	A0A151I3W1	168	L	F
Q9NYP7	LP/P	Spinocerebellar ataxia 38 (SCA38) [MIM:615957]	S7NF24	72	L	V
Q9NYP7	LP/P	Spinocerebellar ataxia 38 (SCA38) [MIM:615957]	S7NF24	230	G	V
Q8TE02	LB/B	-	A0A1S3EXZ3	303	D	Y
Q8TE02	LB/B	-	A0A1S3EXZ3	14	E	K
Q96BH3	LB/B	-	H0WH14	100	C	W
Q96BH3	LB/B	-	H0WH14	170	D	N
Q96BH3	LB/B	-	H0WH14	199	E	K
Q96BH3	LB/B	-	H0WH14	215	D	N
Q8N766	LB/B	-	A0A2P6KDE2	295	L	S
Q8N766	LB/B	-	A0A2P6KDE2	345	S	T
Q8N766	LB/B	-	A0A2P6KDE2	347	S	N
Q8N766	LP/P	Cerebellar atrophy, visual impairment, and psychomotor retardation (CAVIPMR) [MIM:616875]	A0A2P6KDE2	82	T	M
Q8N766	LP/P	Cerebellar atrophy, visual impairment, and psychomotor retardation (CAVIPMR) [MIM:616875]	A0A2P6KDE2	868	G	R
Q5J8M3	LB/B	-	A0A2T3AZK6	98	P	T
Q9Y3B6	LB/B	-	A0A2Y9KZI7	97	A	V
P50402	LP/P	Emery-Dreifuss muscular dystrophy 1, X-linked (EDMD1) [MIM:310300]	Q6PCU4	54	S	F
P50402	LP/P	Emery-Dreifuss muscular dystrophy 1, X-linked (EDMD1) [MIM:310300]	Q6PCU4	183	P	H
P50402	LP/P	Emery-Dreifuss muscular dystrophy 1, X-linked (EDMD1) [MIM:310300]	Q6PCU4	183	P	T
P50402	LP/P	Emery-Dreifuss muscular dystrophy 1, X-linked (EDMD1) [MIM:310300]	Q6PCU4	133	Q	H
P50402	LB/B	-	Q6PCU4	149	D	H
Q96AY2	LB/B	-	G7PUA4	49	I	V
Q96AY2	LB/B	-	G7PUA4	69	E	D
Q96AY2	LB/B	-	G7PUA4	350	I	T
Q96AY2	LB/B	-	G7PUA4	5	K	N
Q96AY2	LB/B	-	G7PUA4	63	F	L
Q96AY2	LB/B	-	G7PUA4	347	V	I
Q92979	LB/B	-	A0A0L0HFA2	34	A	G
Q92979	LP/P	Bowen-Conradi syndrome (BWCNS) [MIM:211180]	A0A0L0HFA2	86	D	G
Q96A84	LB/B	-	A0A2K6DJA1	107	A	G
Q9BXX0	LB/B	-	A0A1U7V5G1	215	A	T
Q9BXX0	LB/B	-	A0A1U7V5G1	259	M	V
Q9BXX0	LB/B	-	A0A1U7V5G1	903	P	S
O00423	LB/B	-	W5NC26	377	A	V
O00423	LB/B	-	W5NC26	552	H	N
O00423	LB/B	-	W5NC26	556	S	P
O00423	LP/P	Band heterotopia (BH) [MIM:600348]	W5NC26	225	W	R
O00423	LP/P	Band heterotopia (BH) [MIM:600348]	W5NC26	243	T	A
O95834	LB/B	-	W5NC26	357	R	H
O95834	LB/B	-	W5NC26	235	E	D
O95834	LB/B	-	W5NC26	33	M	V
O95834	LB/B	-	W5NC26	187	L	F
Q32P44	LB/B	-	W5NC26	620	Q	K
Q9HC35	LB/B	-	A0A1S3FBN4	283	K	E
Q9HC35	LB/B	-	A0A1S3FBN4	382	I	V
Q9HC35	LB/B	-	A0A1S3FBN4	398	K	R
Q9HC35	LB/B	-	A0A1S3FBN4	978	S	L
Q05BV3	LB/B	-	A0A1S3I092	269	I	V
P54849	LB/B	-	E6ZHV5	57	S	N
P54852	LB/B	-	L5L5N9	125	I	V
P19622	LB/B	-	W5M5W5	121	L	F
Q9NRM1	LB/B	-	L5K8J3	724	P	L
Q9NRM1	LB/B	-	L5K8J3	576	F	L
Q9NRM1	LB/B	-	L5K8J3	648	I	T
Q9NRM1	LB/B	-	L5K8J3	763	R	Q
Q9NRM1	LB/B	-	L5K8J3	767	D	G
Q9NRM1	LP/P	Amelogenesis imperfecta 1B (AI1B) [MIM:104500]	L5K8J3	216	S	L
Q9NRM1	LP/P	Amelogenesis imperfecta 1C (AI1C) [MIM:204650]	L5K8J3	216	S	L
O94919	LB/B	-	Q69ZY2	350	V	M
O94919	LB/B	-	Q69ZY2	446	G	V
Q8N8Q3	LB/B	-	A0A2K5HNR9	29	V	I
Q8N8Q3	LB/B	-	A0A2K5HNR9	112	R	Q
Q8N8Q3	LB/B	-	A0A2K5HNR9	114	K	R
Q8N8Q3	LB/B	-	A0A2K5HNR9	141	H	Y
Q8N8Q3	LB/B	-	A0A2K5HNR9	201	D	N
P17813	LB/B	-	A0A2P4SKH3	5	T	M
P17813	LP/P	Telangiectasia, hereditary hemorrhagic, 1 (HHT1) [MIM:187300]	A0A2P4SKH3	52	G	V
P17813	LP/P	Telangiectasia, hereditary hemorrhagic, 1 (HHT1) [MIM:187300]	A0A2P4SKH3	53	C	R
P17813	LP/P	Telangiectasia, hereditary hemorrhagic, 1 (HHT1) [MIM:187300]	A0A2P4SKH3	149	W	C
P17813	LP/P	Telangiectasia, hereditary hemorrhagic, 1 (HHT1) [MIM:187300]	A0A2P4SKH3	306	L	P
P17813	LP/P	Telangiectasia, hereditary hemorrhagic, 1 (HHT1) [MIM:187300]	A0A2P4SKH3	160	A	D
P17813	LP/P	Telangiectasia, hereditary hemorrhagic, 1 (HHT1) [MIM:187300]	A0A2P4SKH3	221	L	P
P17813	LB/B	-	A0A2P4SKH3	366	D	H
P17813	LP/P	Telangiectasia, hereditary hemorrhagic, 1 (HHT1) [MIM:187300]	A0A2P4SKH3	8	L	P
P17813	LP/P	Telangiectasia, hereditary hemorrhagic, 1 (HHT1) [MIM:187300]	A0A2P4SKH3	49	V	F
P17813	LP/P	Telangiectasia, hereditary hemorrhagic, 1 (HHT1) [MIM:187300]	A0A2P4SKH3	107	L	R
P17813	LP/P	Telangiectasia, hereditary hemorrhagic, 1 (HHT1) [MIM:187300]	A0A2P4SKH3	263	I	T
P17813	LP/P	Telangiectasia, hereditary hemorrhagic, 1 (HHT1) [MIM:187300]	A0A2P4SKH3	412	C	S
P17813	LP/P	Telangiectasia, hereditary hemorrhagic, 1 (HHT1) [MIM:187300]	A0A2P4SKH3	504	V	M
P17813	LB/B	-	A0A2P4SKH3	615	S	L
P17813	LP/P	Telangiectasia, hereditary hemorrhagic, 1 (HHT1) [MIM:187300]	A0A2P4SKH3	413	G	V
P17813	LP/P	Telangiectasia, hereditary hemorrhagic, 1 (HHT1) [MIM:187300]	A0A2P4SKH3	11	A	D
P17813	LP/P	Telangiectasia, hereditary hemorrhagic, 1 (HHT1) [MIM:187300]	A0A2P4SKH3	105	V	D
P17813	LP/P	Telangiectasia, hereditary hemorrhagic, 1 (HHT1) [MIM:187300]	A0A2P4SKH3	175	A	E
P17813	LB/B	-	A0A2P4SKH3	205	R	P
P17813	LP/P	Telangiectasia, hereditary hemorrhagic, 1 (HHT1) [MIM:187300]	A0A2P4SKH3	220	I	T
P17813	LP/P	Telangiectasia, hereditary hemorrhagic, 1 (HHT1) [MIM:187300]	A0A2P4SKH3	221	L	Q
P17813	LP/P	Telangiectasia, hereditary hemorrhagic, 1 (HHT1) [MIM:187300]	A0A2P4SKH3	238	V	E
P17813	LP/P	Telangiectasia, hereditary hemorrhagic, 1 (HHT1) [MIM:187300]	A0A2P4SKH3	263	I	S
P17813	LP/P	Telangiectasia, hereditary hemorrhagic, 1 (HHT1) [MIM:187300]	A0A2P4SKH3	269	M	R
P17813	LP/P	Telangiectasia, hereditary hemorrhagic, 1 (HHT1) [MIM:187300]	A0A2P4SKH3	308	A	D
P17813	LP/P	Telangiectasia, hereditary hemorrhagic, 1 (HHT1) [MIM:187300]	A0A2P4SKH3	363	C	S
P17813	LP/P	Telangiectasia, hereditary hemorrhagic, 1 (HHT1) [MIM:187300]	A0A2P4SKH3	394	C	Y
P17813	LP/P	Telangiectasia, hereditary hemorrhagic, 1 (HHT1) [MIM:187300]	A0A2P4SKH3	437	R	W
P17813	LP/P	Telangiectasia, hereditary hemorrhagic, 1 (HHT1) [MIM:187300]	A0A2P4SKH3	490	L	S
P17813	LP/P	Telangiectasia, hereditary hemorrhagic, 1 (HHT1) [MIM:187300]	A0A2P4SKH3	529	R	H
P17813	LP/P	Telangiectasia, hereditary hemorrhagic, 1 (HHT1) [MIM:187300]	A0A2P4SKH3	529	R	P
P17813	LP/P	Telangiectasia, hereditary hemorrhagic, 1 (HHT1) [MIM:187300]	A0A2P4SKH3	545	G	D
P17813	LB/B	-	A0A2P4SKH3	545	G	S
P17813	LP/P	Telangiectasia, hereditary hemorrhagic, 1 (HHT1) [MIM:187300]	A0A2P4SKH3	547	L	P
P17813	LB/B	-	A0A2P4SKH3	561	D	A
P17813	LP/P	Telangiectasia, hereditary hemorrhagic, 1 (HHT1) [MIM:187300]	A0A2P4SKH3	603	G	R
P17813	LP/P	Telangiectasia, hereditary hemorrhagic, 1 (HHT1) [MIM:187300]	A0A2P4SKH3	604	A	D
Q8NFI3	LB/B	-	G7PT22	596	S	N
Q8NFI3	LB/B	-	G7PT22	731	E	K
P06733	LB/B	-	T1K662	177	N	K
P06733	LB/B	-	T1K662	325	P	Q
P09104	LB/B	-	A0A151MCQ7	264	P	A
P09104	LB/B	-	A0A151MCQ7	395	T	A
P13929	LB/B	-	A0A2F0B1I9	71	N	S
P13929	LB/B	-	A0A2F0B1I9	85	V	A
P13929	LP/P	Glycogen storage disease 13 (GSD13) [MIM:612932]	A0A2F0B1I9	156	G	D
P13929	LP/P	Glycogen storage disease 13 (GSD13) [MIM:612932]	A0A2F0B1I9	374	G	E
Q16206	LB/B	-	I3J2F3	202	V	I
Q07075	LB/B	-	H3CIK3	213	Q	R
Q07075	LB/B	-	H3CIK3	218	V	A
Q07075	LB/B	-	H3CIK3	437	R	H
Q07075	LB/B	-	H3CIK3	861	S	R
Q13822	LB/B	-	F7BIY1	577	N	S
Q13822	LB/B	-	F7BIY1	726	S	L
Q13822	LB/B	-	F7BIY1	493	S	P
O14638	LB/B	-	F7BIY1	620	V	M
O14638	LB/B	-	F7BIY1	786	S	N
O14638	LB/B	-	F7BIY1	744	N	H
Q6UWR7	LB/B	-	A0A1D2NK49	419	S	G
Q6UWR7	LB/B	-	A0A1D2NK49	357	D	N
Q6UWV6	LB/B	-	A0A2Y9L048	4	P	L
P49961	LB/B	-	F6XDT4	293	V	I
P49961	LP/P	Spastic paraplegia 64, autosomal recessive (SPG64) [MIM:615683]	F6XDT4	210	G	R
O75355	LB/B	-	A0A2K5M247	440	E	D
O75355	LB/B	-	A0A2K5M247	496	A	V
O75355	LB/B	-	A0A2K5M247	505	L	F
O75355	LB/B	-	A0A2K5M247	264	R	Q
O75355	LB/B	-	A0A2K5M247	24	I	V
Q9Y227	LB/B	-	L9LB66	354	K	E
Q9Y227	LB/B	-	L9LB66	341	I	V
O75356	LB/B	-	F7BUY1	314	K	R
O75354	LB/B	-	A0A0T6B3V8	138	L	V
O75354	LB/B	-	A0A0T6B3V8	14	S	N
O75354	LB/B	-	A0A0T6B3V8	202	K	E
O75354	LB/B	-	A0A0T6B3V8	323	S	N
O75354	LB/B	-	A0A0T6B3V8	157	R	Q
Q9NQZ7	LB/B	-	A0A146X060	276	V	A
Q5MY95	LB/B	-	F6XDT4	62	L	P
Q5MY95	LB/B	-	F6XDT4	428	E	K
Q96C92	LB/B	-	F6QT44	157	L	V
Q96C92	LB/B	-	F6QT44	176	E	G
Q96C92	LB/B	-	F6QT44	304	R	Q
Q96C92	LB/B	-	F6QT44	379	V	M
Q96C92	LB/B	-	F6QT44	428	V	I
Q5NDL2	LP/P	Adams-Oliver syndrome 4 (AOS4) [MIM:615297]	A0A1S3EN55	207	W	S
Q5NDL2	LP/P	Adams-Oliver syndrome 4 (AOS4) [MIM:615297]	A0A1S3EN55	377	R	Q
O95936	LB/B	-	B7Z4K0	120	A	G
Q99814	LP/P	Erythrocytosis, familial, 4 (ECYT4) [MIM:611783]	G3PBW9	537	G	W
Q99814	LB/B	-	G3PBW9	766	T	P
Q99814	LB/B	-	G3PBW9	785	P	T
Q99814	LP/P	Erythrocytosis, familial, 4 (ECYT4) [MIM:611783]	G3PBW9	534	P	L
Q99814	LP/P	Erythrocytosis, familial, 4 (ECYT4) [MIM:611783]	G3PBW9	535	M	T
Q99814	LP/P	Erythrocytosis, familial, 4 (ECYT4) [MIM:611783]	G3PBW9	535	M	V
Q99814	LP/P	Erythrocytosis, familial, 4 (ECYT4) [MIM:611783]	G3PBW9	537	G	R
Q99814	LP/P	Erythrocytosis, familial, 4 (ECYT4) [MIM:611783]	G3PBW9	540	F	L
P11171	LB/B	-	A0A287A1W8	214	V	I
Q9H4G0	LP/P	Intellectual developmental disorder, autosomal dominant 11 (MRD11) [MIM:614257]	A0A2U3Y3R2	854	P	S
O43491	LB/B	-	A0A2R8ML65	17	Q	H
Q9Y2J2	LB/B	-	A0A2K6DME0	555	A	T
Q9Y2J2	LB/B	-	A0A2K6DME0	575	Y	C
Q9Y2J2	LB/B	-	A0A2K6DME0	859	E	Q
Q9HCM4	LB/B	-	K7E3J9	462	A	T
Q9HCM4	LB/B	-	K7E3J9	334	H	Y
P16452	LP/P	Spherocytosis 5 (SPH5) [MIM:612690]	F6YVB3	112	A	T
P16452	LP/P	Spherocytosis 5 (SPH5) [MIM:612690]	F6YVB3	280	R	Q
P16452	LP/P	Spherocytosis 5 (SPH5) [MIM:612690]	F6YVB3	145	D	Y
P16452	LP/P	Spherocytosis 5 (SPH5) [MIM:612690]	F6YVB3	287	R	C
Q9H2F5	LB/B	-	A0A147A1Y8	123	V	L
Q9HCE0	LB/B	-	M7BQE1	844	E	D
Q9HCE0	LB/B	-	M7BQE1	1058	V	A
Q9HCE0	LB/B	-	M7BQE1	1131	I	V
Q9HCE0	LB/B	-	M7BQE1	1511	A	V
Q9HCE0	LB/B	-	M7BQE1	1864	S	N
Q9HCE0	LB/B	-	M7BQE1	1985	R	Q
Q9HCE0	LB/B	-	M7BQE1	182	K	E
Q9HCE0	LP/P	Vici syndrome (VICIS) [MIM:242840]	M7BQE1	336	Q	R
Q9HCE0	LP/P	Vici syndrome (VICIS) [MIM:242840]	M7BQE1	1827	P	A
P21709	LB/B	-	A0A2U9B0L5	160	V	A
P21709	LB/B	-	A0A2U9B0L5	492	R	Q
P21709	LB/B	-	A0A2U9B0L5	900	M	V
P21709	LB/B	-	A0A2U9B0L5	351	R	C
P21709	LB/B	-	A0A2U9B0L5	575	R	Q
P21709	LB/B	-	A0A2U9B0L5	585	A	T
P21709	LB/B	-	A0A2U9B0L5	697	P	L
P21709	LB/B	-	A0A2U9B0L5	807	S	R
P54764	LB/B	-	A0A2J8TUS4	269	R	Q
P54764	LB/B	-	A0A2J8TUS4	953	R	K
P29323	LP/P	Prostate cancer (PC) [MIM:176807]	M3ZYZ8	199	R	H
P29323	LP/P	Prostate cancer (PC) [MIM:176807]	M3ZYZ8	279	A	S
P29323	LP/P	Prostate cancer (PC) [MIM:176807]	M3ZYZ8	650	V	A
P29323	LP/P	Prostate cancer (PC) [MIM:176807]	M3ZYZ8	679	H	N
P29323	LP/P	Prostate cancer (PC) [MIM:176807]	M3ZYZ8	883	M	V
P29323	LP/P	Prostate cancer (PC) [MIM:176807]	M3ZYZ8	909	I	M
P29323	LB/B	-	M3ZYZ8	289	C	G
P29323	LB/B	-	M3ZYZ8	361	I	V
P29323	LB/B	-	M3ZYZ8	678	D	N
P29323	LB/B	-	M3ZYZ8	844	R	W
P29323	LP/P	Bleeding disorder, platelet-type, 22 (BDPLT22) [MIM:618462]	M3ZYZ8	745	R	C
P54753	LB/B	-	M3ZYZ8	440	R	C
P54753	LB/B	-	M3ZYZ8	579	I	V
P54753	LB/B	-	M3ZYZ8	601	I	L
P54760	LB/B	-	A0A286XZH1	67	P	L
P54760	LB/B	-	A0A286XZH1	113	V	I
P54760	LB/B	-	A0A286XZH1	371	A	V
P54760	LB/B	-	A0A286XZH1	576	D	E
P54760	LB/B	-	A0A286XZH1	678	R	H
P54760	LB/B	-	A0A286XZH1	882	A	T
P54760	LB/B	-	A0A286XZH1	890	E	D
P54760	LB/B	-	A0A286XZH1	162	K	R
P54760	LP/P	Lymphatic malformation 7 (LMPHM7) [MIM:617300]	A0A286XZH1	739	R	Q
P54760	LP/P	Lymphatic malformation 7 (LMPHM7) [MIM:617300]	A0A286XZH1	782	I	S
P54760	LB/B	-	A0A286XZH1	509	A	G
P54760	LP/P	Capillary malformation-arteriovenous malformation 2 (CMAVM2) [MIM:618196]	A0A286XZH1	650	K	N
P54760	LP/P	Capillary malformation-arteriovenous malformation 2 (CMAVM2) [MIM:618196]	A0A286XZH1	664	E	K
P54760	LP/P	Capillary malformation-arteriovenous malformation 2 (CMAVM2) [MIM:618196]	A0A286XZH1	745	N	D
P54760	LP/P	Capillary malformation-arteriovenous malformation 2 (CMAVM2) [MIM:618196]	A0A286XZH1	802	D	G
P54760	LP/P	Capillary malformation-arteriovenous malformation 2 (CMAVM2) [MIM:618196]	A0A286XZH1	838	R	W
P54760	LP/P	Capillary malformation-arteriovenous malformation 2 (CMAVM2) [MIM:618196]	A0A286XZH1	845	C	R
P54760	LP/P	Capillary malformation-arteriovenous malformation 2 (CMAVM2) [MIM:618196]	A0A286XZH1	856	C	Y
P54760	LP/P	Capillary malformation-arteriovenous malformation 2 (CMAVM2) [MIM:618196]	A0A286XZH1	864	R	W
P54760	LP/P	Capillary malformation-arteriovenous malformation 2 (CMAVM2) [MIM:618196]	A0A286XZH1	867	F	L
O15197	LB/B	-	M3ZYZ8	122	G	S
O15197	LB/B	-	M3ZYZ8	282	P	R
O15197	LB/B	-	M3ZYZ8	324	S	A
O15197	LB/B	-	M3ZYZ8	499	R	Q
O15197	LB/B	-	M3ZYZ8	170	S	T
O15197	LB/B	-	M3ZYZ8	221	A	V
O15197	LB/B	-	M3ZYZ8	282	P	H
O15197	LB/B	-	M3ZYZ8	309	R	Q
O15197	LB/B	-	M3ZYZ8	332	S	L
O15197	LB/B	-	M3ZYZ8	662	A	V
O15197	LB/B	-	M3ZYZ8	813	R	H
O15197	LB/B	-	M3ZYZ8	993	I	V
P34913	LB/B	-	A0A091G7I7	287	R	Q
P34913	LB/B	-	A0A091G7I7	103	R	C
P34913	LB/B	-	A0A091G7I7	55	K	R
P34913	LB/B	-	A0A091G7I7	21	G	A
P34913	LB/B	-	A0A091G7I7	52	R	Q
P34913	LB/B	-	A0A091G7I7	154	C	Y
P34913	LB/B	-	A0A091G7I7	225	P	L
P34913	LB/B	-	A0A091G7I7	369	M	V
P34913	LB/B	-	A0A091G7I7	470	E	G
Q8IUS5	LB/B	-	A0A1B6FEJ8	321	Y	F
Q7L775	LB/B	-	H0XLQ1	333	V	F
Q7L775	LB/B	-	H0XLQ1	360	A	S
O95208	LB/B	-	A0A091G3L7	531	P	T
O95208	LB/B	-	A0A091G3L7	401	V	A
O95208	LB/B	-	A0A091G3L7	532	P	T
Q9H201	LB/B	-	B4DK18	544	P	T
P01588	LP/P	Diamond-Blackfan anemia-like (DBAL) [MIM:617911]	P49157	177	R	Q
P19235	LP/P	Erythrocytosis, familial, 1 (ECYT1) [MIM:133100]	G3NT94	487	N	S
P19235	LB/B	-	G3NT94	488	P	S
P19235	LB/B	-	G3NT94	380	P	A
O95925	LB/B	-	H0V038	92	H	R
O95925	LB/B	-	H0V038	128	K	T
P07814	LB/B	-	U3I6C2	296	A	P
P07814	LB/B	-	U3I6C2	308	D	E
P07814	LB/B	-	U3I6C2	334	Q	H
P07814	LB/B	-	U3I6C2	893	P	H
P07814	LB/B	-	U3I6C2	1043	I	V
P07814	LB/B	-	U3I6C2	1107	S	F
P07814	LB/B	-	U3I6C2	1399	T	N
P07814	LB/B	-	U3I6C2	913	E	G
P07814	LP/P	Leukodystrophy, hypomyelinating, 15 (HLD15) [MIM:617951]	U3I6C2	1115	P	R
P42566	LB/B	-	A0A099YUR6	822	I	M
Q12929	LB/B	-	A0A2J8QQ03	761	D	E
Q12929	LB/B	-	A0A2J8QQ03	806	A	S
Q8TE68	LB/B	-	A0A1B8Y223	457	Q	E
Q8TE68	LB/B	-	A0A1B8Y223	4	A	T
Q8TE68	LB/B	-	A0A1B8Y223	288	R	G
Q8TE68	LB/B	-	A0A1B8Y223	669	K	R
Q8TE68	LB/B	-	A0A1B8Y223	703	L	P
Q8TE67	LB/B	-	A0A1U8CCK5	163	G	S
Q8TE67	LB/B	-	A0A1U8CCK5	293	H	Y
Q8TE67	LB/B	-	A0A1U8CCK5	356	P	S
Q8TE67	LB/B	-	A0A1U8CCK5	35	M	I
Q8TE67	LB/B	-	A0A1U8CCK5	581	R	Q
P11678	LP/P	Eosinophil peroxidase deficiency (EPXD) [MIM:261500]	A0A091QVF8	286	R	H
P11678	LB/B	-	A0A091QVF8	572	N	Y
P11678	LB/B	-	A0A091QVF8	40	I	M
P11678	LB/B	-	A0A091QVF8	122	Q	H
P11678	LB/B	-	A0A091QVF8	249	A	E
P11678	LB/B	-	A0A091QVF8	276	K	R
P11678	LB/B	-	A0A091QVF8	292	P	L
P11678	LB/B	-	A0A091QVF8	326	R	P
P11678	LB/B	-	A0A091QVF8	358	P	L
P11678	LB/B	-	A0A091QVF8	364	R	H
P11678	LB/B	-	A0A091QVF8	441	K	T
P11678	LB/B	-	A0A091QVF8	496	H	Q
P11678	LB/B	-	A0A091QVF8	35	V	I
P11678	LB/B	-	A0A091QVF8	458	V	M
P11678	LB/B	-	A0A091QVF8	326	R	H
P11678	LB/B	-	A0A091QVF8	326	R	L
Q9NQ60	LB/B	-	F6TY72	101	N	D
Q9NQ60	LB/B	-	F6TY72	274	T	K
Q9NQ60	LB/B	-	F6TY72	110	I	T
O75616	LP/P	Perrault syndrome 6 (PRLTS6) [MIM:617565]	A0A2Y9T2M1	236	N	I
Q9NZ08	LB/B	-	V8P2K1	127	R	P
Q9NZ08	LB/B	-	V8P2K1	276	I	M
Q9NZ08	LB/B	-	V8P2K1	346	G	D
Q9NZ08	LB/B	-	V8P2K1	349	M	V
Q9NZ08	LB/B	-	V8P2K1	528	K	R
Q9NZ08	LB/B	-	V8P2K1	730	Q	E
Q9NZ08	LB/B	-	V8P2K1	575	D	N
Q9NZ08	LB/B	-	V8P2K1	725	R	Q
Q9NZ08	LB/B	-	V8P2K1	56	E	K
Q9NZ08	LB/B	-	V8P2K1	575	D	G
P04626	LB/B	-	A0A2D0R5J2	654	I	V
P04626	LB/B	-	A0A2D0R5J2	655	I	V
P04626	LB/B	-	A0A2D0R5J2	452	W	C
P04626	LB/B	-	A0A2D0R5J2	1170	P	A
P04626	LB/B	-	A0A2D0R5J2	768	L	S
P04626	LB/B	-	A0A2D0R5J2	1216	A	D
P04626	LP/P	Visceral neuropathy, familial, 2, autosomal recessive (VSCN2) [MIM:619465]	A0A2D0R5J2	710	A	V
P21860	LB/B	-	Q5G254	20	S	Y
P21860	LB/B	-	Q5G254	30	P	L
P21860	LB/B	-	Q5G254	204	T	I
P21860	LB/B	-	Q5G254	683	R	W
P21860	LB/B	-	Q5G254	717	S	L
P21860	LB/B	-	Q5G254	744	I	T
P21860	LB/B	-	Q5G254	998	K	R
P21860	LB/B	-	Q5G254	1119	S	C
P21860	LB/B	-	Q5G254	1127	R	H
P21860	LB/B	-	Q5G254	1177	L	I
P21860	LB/B	-	Q5G254	1254	T	K
P21860	LB/B	-	Q5G254	385	N	S
P21860	LB/B	-	Q5G254	1271	G	S
P21860	LP/P	Erythroleukemia, familial (FERLK) [MIM:133180]	Q5G254	1337	A	T
P21860	LP/P	Visceral neuropathy, familial, 1, autosomal recessive (VSCN1) [MIM:243180]	Q5G254	787	T	P
P21860	LP/P	Visceral neuropathy, familial, 1, autosomal recessive (VSCN1) [MIM:243180]	Q5G254	899	V	M
Q15303	LP/P	Amyotrophic lateral sclerosis 19 (ALS19) [MIM:615515]	A0A2D0R5J2	927	R	Q
Q15303	LP/P	Amyotrophic lateral sclerosis 19 (ALS19) [MIM:615515]	A0A2D0R5J2	1275	R	W
Q96RT1	LB/B	-	A0A099ZKT9	274	S	L
Q96RT1	LB/B	-	A0A099ZKT9	1112	S	L
Q96RT1	LB/B	-	A0A099ZKT9	1207	K	E
Q96RT1	LB/B	-	A0A099ZKT9	746	K	E
Q96RT1	LB/B	-	A0A099ZKT9	914	K	R
Q96RT1	LB/B	-	A0A099ZKT9	1089	G	V
Q96RT1	LB/B	-	A0A099ZKT9	313	A	V
Q8IUD2	LB/B	-	H2U2Q5	50	S	G
Q8IUD2	LB/B	-	H2U2Q5	1032	T	A
O15083	LB/B	-	H2U2Q5	542	N	S
P07992	LB/B	-	F6ZLN3	266	A	T
P07992	LP/P	Cerebro-oculo-facio-skeletal syndrome 4 (COFS4) [MIM:610758]	F6ZLN3	231	F	L
P18074	LP/P	Trichothiodystrophy 1, photosensitive (TTD1) [MIM:601675]	A0A0N5AKA0	112	R	H
P18074	LP/P	Xeroderma pigmentosum complementation group D (XP-D) [MIM:278730]	A0A0N5AKA0	112	R	H
P18074	LP/P	Trichothiodystrophy 1, photosensitive (TTD1) [MIM:601675]	A0A0N5AKA0	461	L	V
P18074	LP/P	Xeroderma pigmentosum complementation group D (XP-D) [MIM:278730]	A0A0N5AKA0	461	L	V
P18074	LP/P	Xeroderma pigmentosum complementation group D (XP-D) [MIM:278730]	A0A0N5AKA0	541	S	R
P18074	LP/P	Trichothiodystrophy 1, photosensitive (TTD1) [MIM:601675]	A0A0N5AKA0	616	R	P
P18074	LP/P	Xeroderma pigmentosum complementation group D (XP-D) [MIM:278730]	A0A0N5AKA0	616	R	P
P18074	LP/P	Xeroderma pigmentosum complementation group D (XP-D) [MIM:278730]	A0A0N5AKA0	602	G	D
P18074	LP/P	Trichothiodystrophy 1, photosensitive (TTD1) [MIM:601675]	A0A0N5AKA0	722	R	W
P18074	LP/P	Trichothiodystrophy 1, photosensitive (TTD1) [MIM:601675]	A0A0N5AKA0	725	A	P
P18074	LP/P	Xeroderma pigmentosum complementation group D (XP-D) [MIM:278730]	A0A0N5AKA0	47	G	R
P18074	LP/P	Xeroderma pigmentosum complementation group D (XP-D) [MIM:278730]	A0A0N5AKA0	234	D	N
P18074	LP/P	Trichothiodystrophy 1, photosensitive (TTD1) [MIM:601675]	A0A0N5AKA0	259	C	Y
P18074	LP/P	Xeroderma pigmentosum complementation group D (XP-D) [MIM:278730]	A0A0N5AKA0	542	Y	C
P18074	LP/P	Xeroderma pigmentosum complementation group D (XP-D) [MIM:278730]	A0A0N5AKA0	601	R	L
P18074	LP/P	Cerebro-oculo-facio-skeletal syndrome 2 (COFS2) [MIM:610756]	A0A0N5AKA0	616	R	W
P18074	LP/P	Xeroderma pigmentosum complementation group D (XP-D) [MIM:278730]	A0A0N5AKA0	616	R	W
P18074	LP/P	Trichothiodystrophy 1, photosensitive (TTD1) [MIM:601675]	A0A0N5AKA0	658	R	C
P18074	LP/P	Trichothiodystrophy 1, photosensitive (TTD1) [MIM:601675]	A0A0N5AKA0	658	R	H
P18074	LP/P	Trichothiodystrophy 1, photosensitive (TTD1) [MIM:601675]	A0A0N5AKA0	673	D	G
P18074	LP/P	Xeroderma pigmentosum complementation group D (XP-D) [MIM:278730]	A0A0N5AKA0	683	R	Q
P18074	LP/P	Xeroderma pigmentosum complementation group D (XP-D) [MIM:278730]	A0A0N5AKA0	683	R	W
P18074	LP/P	Trichothiodystrophy 1, photosensitive (TTD1) [MIM:601675]	A0A0N5AKA0	713	G	R
P18074	LB/B	-	A0A0N5AKA0	199	I	M
P18074	LB/B	-	A0A0N5AKA0	201	H	Y
P18074	LB/B	-	A0A0N5AKA0	312	D	N
P18074	LB/B	-	A0A0N5AKA0	616	R	C
P18074	LB/B	-	A0A0N5AKA0	751	K	Q
P18074	LP/P	Xeroderma pigmentosum complementation group D (XP-D) [MIM:278730]	A0A0N5AKA0	76	T	A
P18074	LP/P	Xeroderma pigmentosum complementation group D (XP-D) [MIM:278730]	A0A0N5AKA0	485	L	P
P18074	LP/P	Trichothiodystrophy 1, photosensitive (TTD1) [MIM:601675]	A0A0N5AKA0	487	R	G
P18074	LP/P	Xeroderma pigmentosum complementation group D (XP-D) [MIM:278730]	A0A0N5AKA0	511	R	Q
P18074	LP/P	Trichothiodystrophy 1, photosensitive (TTD1) [MIM:601675]	A0A0N5AKA0	592	R	P
P18074	LP/P	Trichothiodystrophy 1, photosensitive (TTD1) [MIM:601675]	A0A0N5AKA0	594	A	P
P18074	LP/P	Xeroderma pigmentosum complementation group D (XP-D) [MIM:278730]	A0A0N5AKA0	601	R	W
P18074	LP/P	Trichothiodystrophy 1, photosensitive (TTD1) [MIM:601675]	A0A0N5AKA0	658	R	G
P18074	LP/P	Trichothiodystrophy 1, photosensitive (TTD1) [MIM:601675]	A0A0N5AKA0	663	C	R
P18074	LP/P	Xeroderma pigmentosum complementation group D (XP-D) [MIM:278730]	A0A0N5AKA0	666	R	W
P18074	LP/P	Cerebro-oculo-facio-skeletal syndrome 2 (COFS2) [MIM:610756]	A0A0N5AKA0	681	D	N
P18074	LP/P	Xeroderma pigmentosum complementation group D (XP-D) [MIM:278730]	A0A0N5AKA0	681	D	N
P19447	LP/P	Xeroderma pigmentosum complementation group B (XP-B) [MIM:610651]	A0A067QZB7	99	F	S
P19447	LP/P	Trichothiodystrophy 2, photosensitive (TTD2) [MIM:616390]	A0A067QZB7	119	T	P
P19447	LB/B	-	A0A067QZB7	735	S	P
P19447	LB/B	-	A0A067QZB7	117	K	R
P19447	LB/B	-	A0A067QZB7	402	G	C
P19447	LB/B	-	A0A067QZB7	704	S	L
Q92889	LB/B	-	U3I5F6	703	G	D
Q92889	LP/P	Xeroderma pigmentosum complementation group F (XP-F) [MIM:278760]	U3I5F6	799	R	W
Q92889	LP/P	Xeroderma pigmentosum complementation group F (XP-F) [MIM:278760]	U3I5F6	225	I	M
Q92889	LP/P	Xeroderma pigmentosum complementation group F (XP-F) [MIM:278760]	U3I5F6	454	R	W
Q92889	LP/P	Xeroderma pigmentosum complementation group F (XP-F) [MIM:278760]	U3I5F6	490	R	Q
Q92889	LP/P	Xeroderma pigmentosum complementation group F (XP-F) [MIM:278760]	U3I5F6	502	E	K
Q92889	LP/P	Xeroderma pigmentosum complementation group F (XP-F) [MIM:278760]	U3I5F6	513	G	R
Q92889	LP/P	Xeroderma pigmentosum complementation group F (XP-F) [MIM:278760]	U3I5F6	529	I	T
Q92889	LP/P	Xeroderma pigmentosum complementation group F (XP-F) [MIM:278760]	U3I5F6	567	T	A
Q92889	LB/B	-	U3I5F6	379	P	S
Q92889	LB/B	-	U3I5F6	415	R	Q
Q92889	LB/B	-	U3I5F6	576	R	T
Q92889	LP/P	Xeroderma pigmentosum complementation group F (XP-F) [MIM:278760]	U3I5F6	608	L	P
Q92889	LB/B	-	U3I5F6	717	I	T
Q92889	LB/B	-	U3I5F6	875	E	G
Q92889	LB/B	-	U3I5F6	168	A	V
Q92889	LB/B	-	U3I5F6	662	S	P
Q92889	LB/B	-	U3I5F6	706	I	T
Q92889	LB/B	-	U3I5F6	912	G	E
Q92889	LB/B	-	U3I5F6	873	I	V
Q92889	LP/P	XFE progeroid syndrome (XFEPS) [MIM:610965]	U3I5F6	153	R	P
Q92889	LB/B	-	U3I5F6	33	V	L
Q92889	LB/B	-	U3I5F6	768	S	F
Q92889	LB/B	-	U3I5F6	860	A	D
Q92889	LP/P	Fanconi anemia complementation group Q (FANCQ) [MIM:615272]	U3I5F6	230	L	P
Q92889	LP/P	Xeroderma pigmentosum type F/Cockayne syndrome (XPF/CS) [MIM:278760]	U3I5F6	236	C	R
Q92889	LP/P	Xeroderma pigmentosum type F/Cockayne syndrome (XPF/CS) [MIM:278760]	U3I5F6	589	R	W
Q92889	LP/P	Fanconi anemia complementation group Q (FANCQ) [MIM:615272]	U3I5F6	689	R	S
Q92889	LB/B	-	U3I5F6	150	R	C
Q92889	LB/B	-	U3I5F6	267	R	H
Q92889	LB/B	-	U3I5F6	621	T	A
Q92889	LP/P	Fanconi anemia complementation group Q (FANCQ) [MIM:615272]	U3I5F6	786	S	F
P28715	LB/B	-	H0ZKQ6	254	M	V
P28715	LP/P	Xeroderma pigmentosum complementation group G (XP-G) [MIM:278780]	H0ZKQ6	792	A	V
P28715	LB/B	-	H0ZKQ6	1104	D	H
P28715	LB/B	-	H0ZKQ6	311	S	C
P28715	LP/P	Xeroderma pigmentosum complementation group G (XP-G) [MIM:278780]	H0ZKQ6	72	P	H
P28715	LP/P	Xeroderma pigmentosum complementation group G (XP-G) [MIM:278780]	H0ZKQ6	874	A	T
P28715	LP/P	Xeroderma pigmentosum complementation group G (XP-G) [MIM:278780]	H0ZKQ6	858	L	P
P28715	LB/B	-	H0ZKQ6	145	V	I
P28715	LB/B	-	H0ZKQ6	256	Q	R
P28715	LB/B	-	H0ZKQ6	529	C	S
P28715	LB/B	-	H0ZKQ6	680	Q	R
P28715	LB/B	-	H0ZKQ6	879	N	S
P28715	LB/B	-	H0ZKQ6	1119	A	V
P28715	LB/B	-	H0ZKQ6	181	H	R
P28715	LB/B	-	H0ZKQ6	399	E	K
P28715	LB/B	-	H0ZKQ6	590	V	I
P28715	LB/B	-	H0ZKQ6	597	V	L
P28715	LB/B	-	H0ZKQ6	1009	R	H
P28715	LB/B	-	H0ZKQ6	1080	G	Q
P28715	LB/B	-	H0ZKQ6	670	F	L
P28715	LB/B	-	H0ZKQ6	1053	G	R
P28715	LB/B	-	H0ZKQ6	1080	G	R
P28715	LP/P	Xeroderma pigmentosum complementation group G (XP-G) [MIM:278780]	H0ZKQ6	28	A	D
P28715	LP/P	Xeroderma pigmentosum complementation group G (XP-G) [MIM:278780]	H0ZKQ6	968	W	C
P0DP91	LP/P	Premature ovarian failure 11 (POF11) [MIM:616946]	A0A2K5QFQ3	746	G	D
P0DP91	LB/B	-	A0A2K5QFQ3	850	R	K
P0DP91	LP/P	Premature ovarian failure 11 (POF11) [MIM:616946]	A0A2K5QFQ3	1056	V	I
Q5T890	LB/B	-	L5MJ87	592	V	A
Q13216	LB/B	-	H3AYS3	200	Y	C
Q13216	LP/P	Cockayne syndrome A (CSA) [MIM:216400]	H3AYS3	160	A	V
Q13216	LP/P	Cockayne syndrome A (CSA) [MIM:216400]	H3AYS3	205	A	P
Q13216	LB/B	-	H3AYS3	150	S	C
Q13216	LP/P	Cockayne syndrome A (CSA) [MIM:216400]	H3AYS3	160	A	T
Q13216	LP/P	Cockayne syndrome A (CSA) [MIM:216400]	H3AYS3	194	W	C
Q13216	LP/P	Cockayne syndrome A (CSA) [MIM:216400]	H3AYS3	202	L	S
Q13216	LP/P	Cockayne syndrome A (CSA) [MIM:216400]	H3AYS3	266	D	G
Q13216	LP/P	UV-sensitive syndrome 2 (UVSS2) [MIM:614621]	H3AYS3	361	W	C
O14944	LB/B	-	G3QMK4	147	R	Q
P50548	LB/B	-	A0A151N0M9	205	R	H
P50548	LP/P	Craniosynostosis 4 (CRS4) [MIM:600775]	A0A151N0M9	65	R	Q
P50548	LP/P	Craniosynostosis 4 (CRS4) [MIM:600775]	A0A151N0M9	86	R	C
P50548	LP/P	Chitayat syndrome (CHYTS) [MIM:617180]	A0A151N0M9	89	Y	C
Q86X53	LB/B	-	A0A2R9BNG1	403	R	S
Q5RHP9	LB/B	-	G7MHK8	264	P	A
Q5RHP9	LB/B	-	G7MHK8	555	R	H
Q5RHP9	LB/B	-	G7MHK8	636	I	V
Q5RHP9	LB/B	-	G7MHK8	691	H	R
Q5RHP9	LB/B	-	G7MHK8	1056	L	V
Q5RHP9	LB/B	-	G7MHK8	1528	V	M
Q6P6B1	LB/B	-	J9NTW2	59	R	H
Q6P6B1	LB/B	-	J9NTW2	244	Q	P
Q6P6B1	LB/B	-	J9NTW2	287	H	R
Q7L0X2	LB/B	-	A0A1U7QP66	9	G	V
Q7L0X2	LB/B	-	A0A1U7QP66	433	G	R
Q7L0X2	LB/B	-	A0A1U7QP66	604	R	H
Q5W0A0	LB/B	-	A0A2K5QYH8	63	E	D
Q5W0A0	LB/B	-	A0A2K5QYH8	99	E	G
Q5W0A0	LB/B	-	A0A2K5QYH8	174	S	T
Q5W0A0	LB/B	-	A0A2K5QYH8	178	E	K
Q5W0A0	LB/B	-	A0A2K5QYH8	303	L	P
Q5W0A0	LB/B	-	A0A2K5QYH8	427	T	I
Q5W0A0	LB/B	-	A0A2K5QYH8	439	P	R
Q5W0A0	LB/B	-	A0A2K5QYH8	453	H	R
Q5W0A0	LB/B	-	A0A2K5QYH8	565	R	C
Q5W0A0	LB/B	-	A0A2K5QYH8	653	V	F
Q96DZ1	LB/B	-	D6WC47	318	V	L
O75477	LP/P	Spastic paraplegia 62, autosomal recessive (SPG62) [MIM:615681]	M3WVS2	50	G	V
O94905	LB/B	-	M3WVS2	71	V	A
Q96PL5	LB/B	-	A0A1U7UET8	4	A	V
Q96PL5	LB/B	-	A0A1U7UET8	26	H	Y
Q96PL5	LB/B	-	A0A1U7UET8	35	G	S
Q96PL5	LB/B	-	A0A1U7UET8	47	E	K
Q96PL5	LB/B	-	A0A1U7UET8	57	G	R
Q96PL5	LB/B	-	A0A1U7UET8	60	P	A
Q96PL5	LB/B	-	A0A1U7UET8	81	R	Q
Q96PL5	LB/B	-	A0A1U7UET8	259	C	R
Q96PL5	LB/B	-	A0A1U7UET8	263	G	E
Q5T6L9	LB/B	-	U3JKL1	540	S	G
Q5T6L9	LP/P	Periventricular nodular heterotopia 6 (PVNH6) [MIM:615544]	U3JKL1	377	I	N
Q7Z2K6	LB/B	-	F1SMM0	44	S	N
Q76MJ5	LB/B	-	A0A286ZX60	69	V	I
Q76MJ5	LB/B	-	A0A286ZX60	118	R	C
Q76MJ5	LB/B	-	A0A286ZX60	184	R	C
Q76MJ5	LB/B	-	A0A286ZX60	271	R	Q
Q76MJ5	LB/B	-	A0A286ZX60	318	A	T
Q76MJ5	LB/B	-	A0A286ZX60	410	L	F
Q76MJ5	LB/B	-	A0A286ZX60	487	S	T
Q76MJ5	LB/B	-	A0A286ZX60	504	L	F
Q76MJ5	LB/B	-	A0A286ZX60	537	R	Q
Q76MJ5	LB/B	-	A0A286ZX60	858	H	Y
Q86YB8	LB/B	-	C3Z2H2	465	H	Q
Q86YB8	LB/B	-	C3Z2H2	129	D	V
Q9UJM3	LB/B	-	G3WU52	158	I	L
Q9UJM3	LB/B	-	G3WU52	109	D	N
Q14264	LB/B	-	G3KGU3	90	T	I
Q14264	LB/B	-	G3KGU3	192	C	Y
Q14264	LB/B	-	G3KGU3	236	Y	C
Q14264	LB/B	-	G3KGU3	481	N	S
Q14264	LB/B	-	G3KGU3	522	L	P
Q14264	LB/B	-	G3KGU3	569	N	S
O42043	LB/B	-	P63135	97	C	Y
O42043	LB/B	-	P63135	272	V	I
O42043	LB/B	-	P63135	348	V	I
O42043	LB/B	-	P63135	534	V	I
Q5FWF5	LB/B	-	A0A2J8XGX0	221	T	M
Q5FWF5	LB/B	-	A0A2J8XGX0	191	N	S
Q9H501	LB/B	-	A0A2I3M716	550	I	T
Q9H501	LB/B	-	A0A2I3M716	386	P	L
Q9H501	LB/B	-	A0A2I3M716	824	I	L
Q14674	LB/B	-	W5MJW9	614	S	R
Q14674	LB/B	-	W5MJW9	699	R	Q
Q14674	LB/B	-	W5MJW9	1136	I	V
Q14674	LB/B	-	W5MJW9	1157	T	A
Q14674	LB/B	-	W5MJW9	1237	Q	H
Q14674	LB/B	-	W5MJW9	1435	K	M
B1AK53	LB/B	-	A0A226PDF6	322	R	H
B1AK53	LB/B	-	A0A226PDF6	323	Y	C
B1AK53	LP/P	Deafness, autosomal recessive, 36, with or without vestibular involvement (DFNB36) [MIM:609006]	A0A226PDF6	719	S	R
B1AK53	LP/P	Deafness, autosomal recessive, 36, with or without vestibular involvement (DFNB36) [MIM:609006]	A0A226PDF6	744	D	N
Q6ZVH7	LB/B	-	L8HYD3	167	R	Q
Q6ZVH7	LB/B	-	L8HYD3	568	I	V
Q6ZVH7	LB/B	-	L8HYD3	574	A	S
Q6ZVH7	LB/B	-	L8HYD3	761	V	A
Q6ZVH7	LB/B	-	L8HYD3	829	Q	R
P03372	LB/B	-	A0A0U5C4L9	160	G	C
P03372	LB/B	-	A0A0U5C4L9	77	G	S
P03372	LP/P	Estrogen resistance (ESTRR) [MIM:615363]	A0A0U5C4L9	375	Q	H
P03372	LP/P	Estrogen resistance (ESTRR) [MIM:615363]	A0A0U5C4L9	394	R	H
Q92731	LP/P	Ovarian dysgenesis 8 (ODG8) [MIM:618187]	Q90ZE6	314	K	R
Q6NXG1	LB/B	-	D7PBN3	196	Y	C
Q6NXG1	LP/P	Deafness, autosomal recessive, 109 (DFNB109) [MIM:618013]	D7PBN3	259	L	V
O95718	LP/P	Deafness, autosomal recessive, 35 (DFNB35) [MIM:608565]	A0A2D0RRY2	110	A	V
O95718	LP/P	Deafness, autosomal recessive, 35 (DFNB35) [MIM:608565]	A0A2D0RRY2	320	L	P
O95718	LP/P	Deafness, autosomal recessive, 35 (DFNB35) [MIM:608565]	A0A2D0RRY2	342	V	L
O95718	LP/P	Deafness, autosomal recessive, 35 (DFNB35) [MIM:608565]	A0A2D0RRY2	347	L	P
O95718	LB/B	-	A0A2D0RRY2	386	P	S
P62508	LB/B	-	A0A2D0RRY2	50	T	M
Q96DF8	LB/B	-	C3YXY9	31	A	V
Q96DF8	LB/B	-	C3YXY9	336	V	M
Q96DF8	LB/B	-	C3YXY9	423	A	V
Q8N693	LB/B	-	A0A2I3TTD7	314	T	P
Q9BSJ8	LB/B	-	A0A2G9S0B7	764	R	C
A0FGR8	LB/B	-	A0A087YE72	210	C	S
A0FGR8	LB/B	-	A0A087YE72	638	S	G
A0FGR9	LB/B	-	A0A087YE72	246	P	Q
A0FGR9	LB/B	-	A0A087YE72	416	G	R
A0FGR9	LB/B	-	A0A087YE72	590	G	R
A0FGR9	LB/B	-	A0A087YE72	662	T	S
P13804	LP/P	Glutaric aciduria 2A (GA2A) [MIM:231680]	L5L525	116	G	R
P13804	LP/P	Glutaric aciduria 2A (GA2A) [MIM:231680]	L5L525	157	V	G
P13804	LP/P	Glutaric aciduria 2A (GA2A) [MIM:231680]	L5L525	266	T	M
P13804	LB/B	-	L5L525	171	T	I
P38117	LP/P	Glutaric aciduria 2B (GA2B) [MIM:231680]	E2QYD2	164	R	Q
P38117	LB/B	-	E2QYD2	154	T	M
P38117	LP/P	Glutaric aciduria 2B (GA2B) [MIM:231680]	E2QYD2	128	D	N
Q16134	LB/B	-	A0A2I2KDU9	94	H	R
Q16134	LB/B	-	A0A2I2KDU9	31	T	I
Q16134	LB/B	-	A0A2I2KDU9	16	F	C
Q16134	LP/P	Glutaric aciduria 2C (GA2C) [MIM:231680]	A0A2I2KDU9	82	S	F
Q16134	LP/P	Glutaric aciduria 2C (GA2C) [MIM:231680]	A0A2I2KDU9	82	S	P
Q16134	LP/P	Glutaric aciduria 2C (GA2C) [MIM:231680]	A0A2I2KDU9	84	A	T
Q16134	LP/P	Glutaric aciduria 2C (GA2C) [MIM:231680]	A0A2I2KDU9	112	H	Y
Q16134	LP/P	Glutaric aciduria 2C (GA2C) [MIM:231680]	A0A2I2KDU9	127	L	H
Q16134	LP/P	Glutaric aciduria 2C (GA2C) [MIM:231680]	A0A2I2KDU9	175	R	H
Q16134	LP/P	Glutaric aciduria 2C (GA2C) [MIM:231680]	A0A2I2KDU9	175	R	L
Q16134	LP/P	Glutaric aciduria 2C (GA2C) [MIM:231680]	A0A2I2KDU9	456	P	L
Q16134	LP/P	Glutaric aciduria 2C (GA2C) [MIM:231680]	A0A2I2KDU9	456	P	T
Q16134	LP/P	Glutaric aciduria 2C (GA2C) [MIM:231680]	A0A2I2KDU9	562	P	L
Q16134	LP/P	Glutaric aciduria 2C (GA2C) [MIM:231680]	A0A2I2KDU9	590	K	E
Q16134	LP/P	Glutaric aciduria 2C (GA2C) [MIM:231680]	A0A2I2KDU9	611	G	E
O95571	LP/P	Ethylmalonic encephalopathy (EE) [MIM:602473]	A0A2P6S0E1	38	Y	C
O95571	LP/P	Ethylmalonic encephalopathy (EE) [MIM:602473]	A0A2P6S0E1	136	T	A
O95571	LP/P	Ethylmalonic encephalopathy (EE) [MIM:602473]	A0A2P6S0E1	163	R	W
O95571	LP/P	Ethylmalonic encephalopathy (EE) [MIM:602473]	A0A2P6S0E1	185	L	R
O95571	LP/P	Ethylmalonic encephalopathy (EE) [MIM:602473]	A0A2P6S0E1	55	L	P
O95571	LP/P	Ethylmalonic encephalopathy (EE) [MIM:602473]	A0A2P6S0E1	152	T	I
O95571	LP/P	Ethylmalonic encephalopathy (EE) [MIM:602473]	A0A2P6S0E1	163	R	Q
O95571	LP/P	Ethylmalonic encephalopathy (EE) [MIM:602473]	A0A2P6S0E1	164	T	K
O95571	LP/P	Ethylmalonic encephalopathy (EE) [MIM:602473]	A0A2P6S0E1	196	D	N
Q9NVF9	LB/B	-	A0A1S3WC26	227	R	Q
Q8TBG4	LB/B	-	A0A2U9B183	185	S	P
O00321	LB/B	-	Q5EP41	90	D	N
Q6ZN32	LB/B	-	A0A2U3W4F8	19	S	A
Q6ZN32	LB/B	-	A0A2U3W4F8	263	G	A
Q6ZN32	LB/B	-	A0A2U3W4F8	318	M	V
Q6ZN32	LB/B	-	A0A2U3W4F8	151	R	W
P41212	LP/P	Thrombocytopenia 5 (THC5) [MIM:616216]	A0A146WK59	214	P	L
P41212	LP/P	Thrombocytopenia 5 (THC5) [MIM:616216]	A0A146WK59	369	R	Q
P41212	LP/P	Thrombocytopenia 5 (THC5) [MIM:616216]	A0A146WK59	399	R	C
Q9Y603	LB/B	-	A0A093ND04	212	P	L
Q9Y603	LB/B	-	A0A093ND04	138	H	Y
Q9Y603	LB/B	-	A0A093ND04	199	G	S
Q9Y603	LB/B	-	A0A093ND04	250	A	V
Q9Y603	LB/B	-	A0A093ND04	86	A	T
Q9H8M9	LB/B	-	H2P5P9	150	R	H
P57679	LB/B	-	G5B317	74	Q	P
P57679	LB/B	-	G5B317	258	Y	H
P57679	LP/P	Acrofacial dysostosis, Weyers type (WAD) [MIM:193530]	G5B317	307	S	P
P57679	LB/B	-	G5B317	403	G	S
P57679	LP/P	Ellis-van Creveld syndrome (EVC) [MIM:225500]	G5B317	443	R	Q
P57679	LB/B	-	G5B317	449	T	K
P57679	LB/B	-	G5B317	576	R	Q
P57679	LB/B	-	G5B317	760	R	Q
P57679	LB/B	-	G5B317	953	D	G
P57679	LB/B	-	G5B317	114	A	V
P57679	LB/B	-	G5B317	372	T	M
P57679	LP/P	Ellis-van Creveld syndrome (EVC) [MIM:225500]	G5B317	206	S	N
P57679	LP/P	Ellis-van Creveld syndrome (EVC) [MIM:225500]	G5B317	623	L	P
P34910	LB/B	-	A0A2Y9E2Z9	53	G	R
O60447	LB/B	-	A0A1U8CEM8	336	I	V
O60447	LB/B	-	A0A1U8CEM8	612	Q	H
O60447	LB/B	-	A0A1U8CEM8	82	D	V
Q92817	LB/B	-	K7G376	49	N	S
Q92817	LB/B	-	K7G376	433	Q	R
Q92817	LB/B	-	K7G376	168	Y	C
Q92817	LB/B	-	K7G376	1814	P	S
A8MZ36	LB/B	-	A0A1D5RJ55	4	S	N
Q8NHP7	LB/B	-	G1T664	489	T	A
Q9NVH0	LB/B	-	A0A096M877	231	D	N
Q9NVH0	LB/B	-	A0A096M877	518	Q	H
Q8N9H8	LB/B	-	A0A1U8D3X9	220	R	Q
Q8N9H8	LB/B	-	A0A1U8D3X9	20	R	Q
Q9UQ84	LB/B	-	A0A2U4A5C5	27	V	A
Q9UQ84	LB/B	-	A0A2U4A5C5	76	V	I
Q9UQ84	LB/B	-	A0A2U4A5C5	93	R	G
Q9UQ84	LB/B	-	A0A2U4A5C5	109	E	K
Q9UQ84	LB/B	-	A0A2U4A5C5	137	A	S
Q9UQ84	LB/B	-	A0A2U4A5C5	279	N	S
Q9UQ84	LB/B	-	A0A2U4A5C5	299	N	S
Q9UQ84	LB/B	-	A0A2U4A5C5	354	H	R
Q9UQ84	LB/B	-	A0A2U4A5C5	410	L	R
Q9UQ84	LB/B	-	A0A2U4A5C5	428	D	N
Q9UQ84	LB/B	-	A0A2U4A5C5	438	F	C
Q9UQ84	LB/B	-	A0A2U4A5C5	439	T	M
Q9UQ84	LB/B	-	A0A2U4A5C5	456	S	Y
Q9UQ84	LB/B	-	A0A2U4A5C5	458	V	M
Q9UQ84	LB/B	-	A0A2U4A5C5	460	V	L
Q9UQ84	LB/B	-	A0A2U4A5C5	503	R	T
Q9UQ84	LB/B	-	A0A2U4A5C5	589	E	K
Q9UQ84	LB/B	-	A0A2U4A5C5	610	S	G
Q9UQ84	LB/B	-	A0A2U4A5C5	634	R	Q
Q9UQ84	LB/B	-	A0A2U4A5C5	640	P	A
Q9UQ84	LB/B	-	A0A2U4A5C5	640	P	S
Q9UQ84	LB/B	-	A0A2U4A5C5	670	E	G
Q9UQ84	LB/B	-	A0A2U4A5C5	723	R	C
Q9UQ84	LB/B	-	A0A2U4A5C5	726	H	P
Q9UQ84	LB/B	-	A0A2U4A5C5	757	P	L
Q9UQ84	LB/B	-	A0A2U4A5C5	759	G	E
Q9UQ84	LB/B	-	A0A2U4A5C5	770	P	L
Q9UQ84	LB/B	-	A0A2U4A5C5	827	A	V
Q9UQ84	LB/B	-	A0A2U4A5C5	153	A	V
Q96KP1	LB/B	-	E9G6B5	195	N	T
Q8N2X6	LB/B	-	Q8N2X6	50	P	S
Q8N2X6	LB/B	-	Q8N2X6	118	R	G
Q86VI1	LB/B	-	W5NXR3	561	Q	E
Q86VI1	LB/B	-	W5NXR3	634	S	G
Q8TAG9	LB/B	-	A0A0P5V262	396	T	I
Q8TAG9	LB/B	-	A0A0P5V262	523	L	V
Q8TAG9	LB/B	-	A0A0P5V262	578	T	I
Q9Y2C4	LB/B	-	F7DTX1	277	G	V
Q13868	LP/P	Short stature, hearing loss, retinitis pigmentosa, and distinctive facies (SHRF) [MIM:617763]	A0A2Y9DJJ5	30	G	V
Q13868	LP/P	Short stature, hearing loss, retinitis pigmentosa, and distinctive facies (SHRF) [MIM:617763]	A0A2Y9DJJ5	198	G	D
Q9NQT5	LB/B	-	F6WQK8	225	Y	H
Q9NQT5	LP/P	Pontocerebellar hypoplasia 1B (PCH1B) [MIM:614678]	F6WQK8	31	G	A
Q9NQT5	LP/P	Pontocerebellar hypoplasia 1B (PCH1B) [MIM:614678]	F6WQK8	132	D	A
Q9NQT5	LP/P	Pontocerebellar hypoplasia 1B (PCH1B) [MIM:614678]	F6WQK8	139	A	P
Q9NQT5	LP/P	Pontocerebellar hypoplasia 1B (PCH1B) [MIM:614678]	F6WQK8	238	W	R
Q9NQT5	LB/B	-	F6WQK8	80	V	F
Q96B26	LP/P	Pontocerebellar hypoplasia 1C (PCH1C) [MIM:616081]	A0A091E0Y0	2	A	V
Q96B26	LP/P	Pontocerebellar hypoplasia 1C (PCH1C) [MIM:616081]	A0A091E0Y0	272	S	T
Q06265	LB/B	-	Q6GQJ3	425	S	T
Q06265	LB/B	-	Q6GQJ3	366	I	V
Q06265	LP/P	Pontocerebellar hypoplasia 1D (PCH1D) [MIM:618065]	Q6GQJ3	14	L	P
Q8NEV8	LB/B	-	H0XT80	19	R	G
Q8NEV8	LB/B	-	H0XT80	118	R	L
Q8NEV8	LB/B	-	H0XT80	137	E	V
Q8NEV8	LB/B	-	H0XT80	328	R	Q
Q8NEV8	LB/B	-	H0XT80	512	M	L
Q8NEV8	LB/B	-	H0XT80	525	V	F
Q8NEV8	LB/B	-	H0XT80	676	S	N
Q8NEV8	LB/B	-	H0XT80	777	D	N
Q8NEV8	LB/B	-	H0XT80	853	L	P
Q8NEV8	LB/B	-	H0XT80	892	N	Y
Q8NEV8	LB/B	-	H0XT80	899	V	A
Q8NEV8	LB/B	-	H0XT80	1240	D	N
Q8NEV8	LB/B	-	H0XT80	1311	C	R
Q8NEV8	LB/B	-	H0XT80	1663	G	R
Q8NEV8	LB/B	-	H0XT80	1967	D	N
Q8NEV8	LB/B	-	H0XT80	1147	M	I
Q8NEV8	LB/B	-	H0XT80	1236	S	A
Q8NEV8	LB/B	-	H0XT80	1343	T	A
Q8NEV8	LB/B	-	H0XT80	1656	E	K
Q8NEV8	LB/B	-	H0XT80	1735	I	F
Q93063	LP/P	Hereditary multiple exostoses 2 (EXT2) [MIM:133701]	L5KY03	227	D	N
Q93063	LP/P	Hereditary multiple exostoses 2 (EXT2) [MIM:133701]	L5KY03	85	C	R
Q93063	LP/P	Hereditary multiple exostoses 2 (EXT2) [MIM:133701]	L5KY03	152	L	R
Q93063	LP/P	Hereditary multiple exostoses 2 (EXT2) [MIM:133701]	L5KY03	179	R	S
Q93063	LP/P	Hereditary multiple exostoses 2 (EXT2) [MIM:133701]	L5KY03	202	A	V
Q93063	LP/P	Hereditary multiple exostoses 2 (EXT2) [MIM:133701]	L5KY03	223	R	P
Q93063	LP/P	Hereditary multiple exostoses 2 (EXT2) [MIM:133701]	L5KY03	380	I	T
Q93063	LB/B	-	L5KY03	576	E	K
Q93063	LB/B	-	L5KY03	42	M	V
Q93063	LP/P	Seizures, scoliosis, and macrocephaly/microcephaly syndrome (SSMS) [MIM:616682]	L5KY03	87	M	R
Q93063	LP/P	Seizures, scoliosis, and macrocephaly/microcephaly syndrome (SSMS) [MIM:616682]	L5KY03	95	R	C
O43909	LB/B	-	A0A1W4WTE2	706	L	P
O43909	LB/B	-	A0A1W4WTE2	550	A	V
O43909	LP/P	Immunoskeletal dysplasia with neurodevelopmental abnormalities (ISDNA) [MIM:617425]	A0A1W4WTE2	339	R	W
O43909	LB/B	-	A0A1W4WTE2	442	V	L
O43909	LP/P	Immunoskeletal dysplasia with neurodevelopmental abnormalities (ISDNA) [MIM:617425]	A0A1W4WTE2	461	P	L
O43909	LP/P	Immunoskeletal dysplasia with neurodevelopmental abnormalities (ISDNA) [MIM:617425]	A0A1W4WTE2	513	R	C
O43909	LP/P	Immunoskeletal dysplasia with neurodevelopmental abnormalities (ISDNA) [MIM:617425]	A0A1W4WTE2	657	N	S
O43909	LP/P	Immunoskeletal dysplasia with neurodevelopmental abnormalities (ISDNA) [MIM:617425]	A0A1W4WTE2	670	Y	D
Q99502	LP/P	Branchiootorenal syndrome 1 (BOR1) [MIM:113650]	A0A1L8G927	487	S	P
Q99502	LP/P	Branchiootorenal syndrome 1 (BOR1) [MIM:113650]	A0A1L8G927	505	L	R
Q99502	LP/P	Anterior segment anomalies with or without cataract (ASA) [MIM:602588]	A0A1L8G927	363	E	K
Q99502	LP/P	Branchiootorenal syndrome 1 (BOR1) [MIM:113650]	A0A1L8G927	426	G	S
Q99502	LP/P	Branchiootorenal syndrome 1 (BOR1) [MIM:113650]	A0A1L8G927	429	D	G
Q99502	LP/P	Branchiootorenal syndrome 1 (BOR1) [MIM:113650]	A0A1L8G927	440	R	Q
Q99502	LP/P	Anterior segment anomalies with or without cataract (ASA) [MIM:602588]	A0A1L8G927	547	R	G
Q99502	LP/P	Branchiootorenal syndrome 1 (BOR1) [MIM:113650]	A0A1L8G927	583	L	P
Q99502	LB/B	-	A0A1L8G927	20	P	A
Q99502	LP/P	Branchiootic syndrome 1 (BOS1) [MIM:602588]	A0A1L8G927	242	S	G
Q99502	LP/P	Branchiootorenal syndrome 1 (BOR1) [MIM:113650]	A0A1L8G927	95	P	S
Q99502	LP/P	Branchiootorenal syndrome 1 (BOR1) [MIM:113650]	A0A1L8G927	140	G	S
Q99502	LP/P	Branchiootorenal syndrome 1 (BOR1) [MIM:113650]	A0A1L8G927	363	E	V
Q99502	LP/P	Branchiootorenal syndrome 1 (BOR1) [MIM:113650]	A0A1L8G927	514	L	P
Q99502	LP/P	Branchiootorenal syndrome 1 (BOR1) [MIM:113650]	A0A1L8G927	527	Y	C
Q99502	LP/P	Branchiootorenal syndrome 1 (BOR1) [MIM:113650]	A0A1L8G927	569	M	T
Q99502	LB/B	-	A0A1L8G927	41	E	K
O95677	LB/B	-	A0A1L8G927	277	G	S
O95677	LP/P	Deafness, autosomal dominant, 10 (DFNA10) [MIM:601316]	A0A1L8G927	171	G	R
O95677	LP/P	Deafness, autosomal dominant, 10 (DFNA10) [MIM:601316]	A0A1L8G927	548	T	R
Q5T1H1	LB/B	-	A0A2I4BF64	120	T	M
Q5T1H1	LB/B	-	A0A2I4BF64	852	L	P
Q5T1H1	LB/B	-	A0A2I4BF64	94	P	Q
Q5T1H1	LB/B	-	A0A2I4BF64	112	V	I
Q5T1H1	LB/B	-	A0A2I4BF64	136	V	F
Q5T1H1	LB/B	-	A0A2I4BF64	326	S	N
Q5T1H1	LB/B	-	A0A2I4BF64	532	K	N
Q5T1H1	LB/B	-	A0A2I4BF64	551	R	L
Q5T1H1	LB/B	-	A0A2I4BF64	571	Q	R
Q5T1H1	LP/P	Retinitis pigmentosa 25 (RP25) [MIM:602772]	A0A2I4BF64	618	G	S
Q5T1H1	LB/B	-	A0A2I4BF64	631	G	S
Q5T1H1	LB/B	-	A0A2I4BF64	641	E	V
Q5T1H1	LB/B	-	A0A2I4BF64	834	V	I
Q5T1H1	LB/B	-	A0A2I4BF64	938	K	R
Q5T1H1	LP/P	Retinitis pigmentosa 25 (RP25) [MIM:602772]	A0A2I4BF64	1110	T	S
Q5T1H1	LB/B	-	A0A2I4BF64	1163	N	K
Q5T1H1	LP/P	Retinitis pigmentosa 25 (RP25) [MIM:602772]	A0A2I4BF64	1176	C	R
Q5T1H1	LP/P	Retinitis pigmentosa 25 (RP25) [MIM:602772]	A0A2I4BF64	1232	I	F
Q5T1H1	LB/B	-	A0A2I4BF64	1263	I	V
Q5T1H1	LB/B	-	A0A2I4BF64	1325	Q	E
Q5T1H1	LB/B	-	A0A2I4BF64	1361	I	V
Q5T1H1	LB/B	-	A0A2I4BF64	1365	K	E
Q5T1H1	LB/B	-	A0A2I4BF64	1419	L	S
Q5T1H1	LB/B	-	A0A2I4BF64	1451	I	T
Q5T1H1	LB/B	-	A0A2I4BF64	1515	R	W
Q5T1H1	LB/B	-	A0A2I4BF64	1517	S	G
Q5T1H1	LB/B	-	A0A2I4BF64	1662	D	V
Q5T1H1	LB/B	-	A0A2I4BF64	1664	T	I
Q5T1H1	LP/P	Retinitis pigmentosa 25 (RP25) [MIM:602772]	A0A2I4BF64	1682	D	Y
Q5T1H1	LB/B	-	A0A2I4BF64	1739	P	L
Q5T1H1	LP/P	Retinitis pigmentosa 25 (RP25) [MIM:602772]	A0A2I4BF64	1747	E	G
Q5T1H1	LB/B	-	A0A2I4BF64	1748	L	F
Q5T1H1	LB/B	-	A0A2I4BF64	1837	W	S
Q5T1H1	LP/P	Retinitis pigmentosa 25 (RP25) [MIM:602772]	A0A2I4BF64	1869	L	M
Q5T1H1	LB/B	-	A0A2I4BF64	1873	L	V
Q5T1H1	LB/B	-	A0A2I4BF64	1902	N	I
Q5T1H1	LB/B	-	A0A2I4BF64	1915	S	G
Q5T1H1	LB/B	-	A0A2I4BF64	1987	T	P
Q5T1H1	LB/B	-	A0A2I4BF64	1993	T	A
Q5T1H1	LB/B	-	A0A2I4BF64	1999	I	V
Q5T1H1	LB/B	-	A0A2I4BF64	2040	V	D
Q5T1H1	LP/P	Retinitis pigmentosa 25 (RP25) [MIM:602772]	A0A2I4BF64	2139	C	Y
Q5T1H1	LB/B	-	A0A2I4BF64	2151	N	S
Q5T1H1	LP/P	Retinitis pigmentosa 25 (RP25) [MIM:602772]	A0A2I4BF64	2189	L	P
Q5T1H1	LB/B	-	A0A2I4BF64	2326	R	Q
Q5T1H1	LB/B	-	A0A2I4BF64	2556	S	C
Q5T1H1	LB/B	-	A0A2I4BF64	2599	H	R
Q5T1H1	LB/B	-	A0A2I4BF64	2757	A	P
Q5T1H1	LP/P	Retinitis pigmentosa 25 (RP25) [MIM:602772]	A0A2I4BF64	2829	A	T
Q5T1H1	LB/B	-	A0A2I4BF64	2831	T	I
Q5T1H1	LP/P	Retinitis pigmentosa 25 (RP25) [MIM:602772]	A0A2I4BF64	2911	C	Y
Q5T1H1	LP/P	Retinitis pigmentosa 25 (RP25) [MIM:602772]	A0A2I4BF64	2928	G	E
Q5T1H1	LP/P	Retinitis pigmentosa 25 (RP25) [MIM:602772]	A0A2I4BF64	1484	W	R
Q5T1H1	LP/P	Retinitis pigmentosa 25 (RP25) [MIM:602772]	A0A2I4BF64	2017	G	V
Q5T1H1	LP/P	Retinitis pigmentosa 25 (RP25) [MIM:602772]	A0A2I4BF64	2503	E	K
Q5T1H1	LP/P	Retinitis pigmentosa 25 (RP25) [MIM:602772]	A0A2I4BF64	2945	Q	E
Q86X51	LB/B	-	D2I6K1	470	R	K
P15311	LB/B	-	A0A091DL41	532	L	V
P15311	LB/B	-	A0A091DL41	180	R	C
P15311	LB/B	-	A0A091DL41	494	A	P
P00742	LB/B	-	G1U6I7	7	L	I
P00742	LB/B	-	G1U6I7	30	Q	H
P00742	LB/B	-	G1U6I7	152	A	T
P00742	LB/B	-	G1U6I7	192	G	R
P00742	LP/P	Factor X deficiency (FA10D) [MIM:227600]	G1U6I7	47	E	G
P00742	LP/P	Factor X deficiency (FA10D) [MIM:227600]	G1U6I7	51	G	V
P00742	LP/P	Factor X deficiency (FA10D) [MIM:227600]	G1U6I7	54	E	G
P00742	LP/P	Factor X deficiency (FA10D) [MIM:227600]	G1U6I7	54	E	K
P00742	LP/P	Factor X deficiency (FA10D) [MIM:227600]	G1U6I7	72	E	Q
P00742	LP/P	Factor X deficiency (FA10D) [MIM:227600]	G1U6I7	91	E	K
P00742	LP/P	Factor X deficiency (FA10D) [MIM:227600]	G1U6I7	149	C	Y
P00742	LP/P	Factor X deficiency (FA10D) [MIM:227600]	G1U6I7	151	C	Y
P00742	LP/P	Factor X deficiency (FA10D) [MIM:227600]	G1U6I7	289	G	R
P00742	LP/P	Factor X deficiency (FA10D) [MIM:227600]	G1U6I7	304	E	K
P00742	LP/P	Factor X deficiency (FA10D) [MIM:227600]	G1U6I7	322	D	N
P00742	LP/P	Factor X deficiency (FA10D) [MIM:227600]	G1U6I7	327	R	W
P00742	LP/P	Factor X deficiency (FA10D) [MIM:227600]	G1U6I7	338	V	M
P00742	LP/P	Factor X deficiency (FA10D) [MIM:227600]	G1U6I7	350	E	K
P00742	LP/P	Factor X deficiency (FA10D) [MIM:227600]	G1U6I7	358	T	M
P00742	LP/P	Factor X deficiency (FA10D) [MIM:227600]	G1U6I7	363	G	S
P00742	LP/P	Factor X deficiency (FA10D) [MIM:227600]	G1U6I7	366	R	C
P00742	LP/P	Factor X deficiency (FA10D) [MIM:227600]	G1U6I7	374	S	P
P00742	LP/P	Factor X deficiency (FA10D) [MIM:227600]	G1U6I7	383	P	S
P00742	LP/P	Factor X deficiency (FA10D) [MIM:227600]	G1U6I7	390	C	F
P00742	LP/P	Factor X deficiency (FA10D) [MIM:227600]	G1U6I7	404	C	R
P00742	LP/P	Factor X deficiency (FA10D) [MIM:227600]	G1U6I7	406	G	S
P00742	LP/P	Factor X deficiency (FA10D) [MIM:227600]	G1U6I7	420	G	R
P00742	LP/P	Factor X deficiency (FA10D) [MIM:227600]	G1U6I7	448	K	N
P00742	LP/P	Factor X deficiency (FA10D) [MIM:227600]	G1U6I7	382	V	A
P00742	LP/P	Factor X deficiency (FA10D) [MIM:227600]	G1U6I7	421	G	D
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	301	F	L
P03951	LB/B	-	G3VQX8	66	P	L
P03951	LB/B	-	G3VQX8	244	Q	R
P03951	LB/B	-	G3VQX8	308	I	F
P03951	LB/B	-	G3VQX8	339	C	F
P03951	LB/B	-	G3VQX8	399	W	R
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	34	D	H
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	246	W	C
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	266	S	N
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	320	L	P
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	322	T	I
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	326	R	C
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	341	E	K
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	404	T	N
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	430	A	V
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	460	F	V
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	493	T	I
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	594	S	R
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	46	C	F
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	56	C	R
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	101	K	R
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	151	Y	C
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	255	C	Y
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	263	G	E
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	270	K	I
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	418	G	V
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	511	Y	H
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	538	P	L
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	565	E	K
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	587	W	S
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	618	I	S
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	32	G	R
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	43	A	T
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	51	T	I
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	51	T	P
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	53	H	Q
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	63	A	V
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	140	C	Y
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	222	D	Y
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	228	R	Q
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	241	F	L
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	252	R	T
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	276	S	C
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	277	G	D
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	315	E	K
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	331	T	I
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	360	L	P
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	401	W	R
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	403	V	M
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	454	I	K
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	481	I	S
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	503	S	P
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	506	D	G
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	514	C	F
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	526	D	E
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	575	S	L
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	597	E	K
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	608	Y	H
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	30	F	S
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	109	A	T
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	216	D	N
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	543	E	K
P03951	LP/P	Factor XI deficiency (FA11D) [MIM:612416]	G3VQX8	552	H	R
P00748	LP/P	Factor XII deficiency (FA12D) [MIM:234000]	A0A061IBV4	372	R	P
P00748	LP/P	Factor XII deficiency (FA12D) [MIM:234000]	A0A061IBV4	590	C	S
P00748	LB/B	-	A0A061IBV4	207	A	P
P00748	LB/B	-	A0A061IBV4	545	G	D
P00748	LB/B	-	A0A061IBV4	605	Y	H
P00748	LP/P	Factor XII deficiency (FA12D) [MIM:234000]	A0A061IBV4	53	Y	C
P00748	LB/B	-	A0A061IBV4	342	P	Q
P00748	LP/P	Factor XII deficiency (FA12D) [MIM:234000]	A0A061IBV4	142	R	P
P00748	LP/P	Angioedema, hereditary, 3 (HAE3) [MIM:610618]	A0A061IBV4	328	T	K
P00748	LP/P	Angioedema, hereditary, 3 (HAE3) [MIM:610618]	A0A061IBV4	328	T	R
P00748	LP/P	Factor XII deficiency (FA12D) [MIM:234000]	A0A061IBV4	411	A	T
P00748	LP/P	Factor XII deficiency (FA12D) [MIM:234000]	A0A061IBV4	414	L	M
P00748	LP/P	Factor XII deficiency (FA12D) [MIM:234000]	A0A061IBV4	417	R	Q
P00748	LP/P	Factor XII deficiency (FA12D) [MIM:234000]	A0A061IBV4	440	Q	K
P00748	LP/P	Factor XII deficiency (FA12D) [MIM:234000]	A0A061IBV4	461	D	N
P00748	LP/P	Factor XII deficiency (FA12D) [MIM:234000]	A0A061IBV4	505	W	C
P00748	LP/P	Factor XII deficiency (FA12D) [MIM:234000]	A0A061IBV4	589	G	R
P00734	LP/P	Factor II deficiency (FA2D) [MIM:613679]	H3BHN3	200	E	K
P00734	LP/P	Factor II deficiency (FA2D) [MIM:613679]	H3BHN3	314	R	C
P00734	LP/P	Factor II deficiency (FA2D) [MIM:613679]	H3BHN3	314	R	H
P00734	LP/P	Factor II deficiency (FA2D) [MIM:613679]	H3BHN3	380	M	T
P00734	LP/P	Factor II deficiency (FA2D) [MIM:613679]	H3BHN3	425	R	C
P00734	LP/P	Factor II deficiency (FA2D) [MIM:613679]	H3BHN3	431	R	H
P00734	LP/P	Factor II deficiency (FA2D) [MIM:613679]	H3BHN3	461	R	W
P00734	LP/P	Factor II deficiency (FA2D) [MIM:613679]	H3BHN3	509	E	A
P00734	LP/P	Factor II deficiency (FA2D) [MIM:613679]	H3BHN3	601	G	V
P00734	LB/B	-	H3BHN3	165	T	M
P00734	LB/B	-	H3BHN3	386	P	T
P00734	LP/P	Factor II deficiency (FA2D) [MIM:613679]	H3BHN3	72	E	G
P00734	LB/B	-	H3BHN3	532	E	Q
P25116	LB/B	-	A0A212CU33	166	S	G
P25116	LB/B	-	A0A212CU33	187	Y	N
P25116	LB/B	-	A0A212CU33	257	V	L
P25116	LB/B	-	A0A212CU33	412	S	Y
P25116	LB/B	-	A0A212CU33	268	A	P
P25116	LB/B	-	A0A212CU33	335	A	V
P55085	LB/B	-	A0A2F0BLI9	21	S	F
P55085	LB/B	-	A0A2F0BLI9	270	R	Q
P55085	LB/B	-	A0A2F0BLI9	291	T	A
P55085	LB/B	-	A0A2F0BLI9	30	N	S
O00254	LB/B	-	Q28BQ5	15	L	S
O00254	LB/B	-	Q28BQ5	177	M	V
O00254	LB/B	-	Q28BQ5	250	N	D
Q96RI0	LB/B	-	A0A2K6FRG1	296	F	V
Q96RI0	LB/B	-	A0A2K6FRG1	310	P	L
Q96RI0	LB/B	-	A0A2K6FRG1	120	A	T
Q96RI0	LB/B	-	A0A2K6FRG1	215	R	Q
P13726	LB/B	-	A0A212CGD7	163	R	W
P13726	LB/B	-	A0A212CGD7	36	T	A
P13726	LB/B	-	A0A212CGD7	145	I	V
P13726	LB/B	-	A0A212CGD7	281	G	E
P12259	LP/P	Thrombophilia due to activated protein C resistance (THPH2) [MIM:188055]	Q7TPK2	534	R	Q
P12259	LB/B	-	Q7TPK2	858	K	R
P12259	LB/B	-	Q7TPK2	865	H	R
P12259	LB/B	-	Q7TPK2	334	R	G
P12259	LP/P	Thrombophilia due to activated protein C resistance (THPH2) [MIM:188055]	Q7TPK2	334	R	T
P12259	LB/B	-	Q7TPK2	513	R	K
P12259	LB/B	-	Q7TPK2	107	D	H
P12259	LB/B	-	Q7TPK2	413	M	T
P12259	LB/B	-	Q7TPK2	809	P	S
P12259	LB/B	-	Q7TPK2	817	N	T
P12259	LB/B	-	Q7TPK2	925	K	E
P12259	LB/B	-	Q7TPK2	1146	H	Q
P12259	LB/B	-	Q7TPK2	1285	L	I
P12259	LB/B	-	Q7TPK2	1327	H	R
P12259	LB/B	-	Q7TPK2	1530	E	A
P12259	LB/B	-	Q7TPK2	1685	T	S
P12259	LB/B	-	Q7TPK2	1749	L	V
P12259	LB/B	-	Q7TPK2	1764	M	V
P12259	LB/B	-	Q7TPK2	1820	M	I
P12259	LB/B	-	Q7TPK2	2222	D	G
P12259	LP/P	Thrombophilia due to activated protein C resistance (THPH2) [MIM:188055]	Q7TPK2	2102	R	H
P12259	LB/B	-	Q7TPK2	15	G	S
P12259	LB/B	-	Q7TPK2	915	T	S
P12259	LB/B	-	Q7TPK2	969	N	S
P12259	LB/B	-	Q7TPK2	980	R	L
P12259	LB/B	-	Q7TPK2	1404	P	S
P12259	LB/B	-	Q7TPK2	2148	M	T
P12259	LP/P	Thrombophilia due to activated protein C resistance (THPH2) [MIM:188055]	Q7TPK2	387	I	T
P12259	LP/P	Thrombophilia due to activated protein C resistance (THPH2) [MIM:188055]	Q7TPK2	613	C	R
P12259	LP/P	Factor V deficiency (FA5D) [MIM:227400]	Q7TPK2	1730	Y	C
P12259	LP/P	Factor V deficiency (FA5D) [MIM:227400]	Q7TPK2	2102	R	C
P12259	LB/B	-	Q7TPK2	2185	K	R
P12259	LB/B	-	Q7TPK2	781	S	R
P12259	LB/B	-	Q7TPK2	1397	L	F
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	139	R	K
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	139	R	Q
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	139	R	W
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	157	G	S
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	157	G	C
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	160	Q	R
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	194	P	T
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	197	K	E
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	212	R	Q
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	238	C	Y
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	283	R	W
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	304	A	V
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	307	R	H
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	325	E	K
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	354	A	V
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	358	M	I
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	358	M	V
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	364	R	Q
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	370	C	F
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	402	G	R
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	402	G	E
P08709	LB/B	-	A0A1S3FNQ1	413	R	Q
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	419	T	M
P08709	LB/B	-	A0A1S3FNQ1	352	A	T
P08709	LB/B	-	A0A1S3FNQ1	445	E	K
P08709	LB/B	-	A0A1S3FNQ1	295	V	D
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	13	L	P
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	389	C	G
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	73	L	Q
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	79	E	Q
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	121	C	F
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	125	L	P
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	128	Y	C
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	151	C	S
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	157	G	V
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	195	C	R
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	241	T	N
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	302	D	H
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	302	D	N
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	304	A	T
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	307	R	C
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	332	T	M
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	391	G	S
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	435	G	E
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	64	F	L
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	120	S	P
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	154	E	K
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	216	G	D
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	254	C	Y
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	266	A	T
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	312	V	M
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	341	V	F
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	363	P	R
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	403	D	H
P08709	LB/B	-	A0A1S3FNQ1	367	T	S
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	82	C	F
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	82	C	R
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	85	E	K
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	88	R	G
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	88	R	P
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	117	N	D
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	138	G	D
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	156	G	S
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	171	S	F
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	177	G	R
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	181	L	P
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	183	D	N
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	186	S	F
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	189	P	S
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	194	P	L
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	198	I	T
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	240	G	R
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	250	S	F
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	251	A	P
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	251	A	T
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	254	C	R
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	264	L	P
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	272	D	N
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	277	D	N
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	298	T	I
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	301	H	Q
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	314	L	V
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	321	L	F
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	323	L	R
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	326	R	Q
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	337	R	C
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	343	G	S
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	344	W	R
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	345	G	S
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	350	R	C
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	360	L	P
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	363	P	H
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	364	R	W
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	375	R	W
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	384	T	M
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	387	M	T
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	387	M	V
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	388	F	S
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	391	G	C
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	398	D	E
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	401	K	E
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	404	S	N
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	408	H	Q
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	408	H	R
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	413	R	G
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	414	G	C
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	422	V	F
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	425	G	A
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	425	G	C
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	429	A	T
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	432	G	D
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	437	Y	F
P08709	LP/P	Factor VII deficiency (FA7D) [MIM:227500]	A0A1S3FNQ1	344	W	G
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	26	L	R
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	30	E	V
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	41	G	C
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	48	R	C
P00451	LB/B	-	A0A093HXT5	75	D	V
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	89	G	D
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	89	G	V
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	99	V	D
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	104	V	D
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	108	K	T
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	110	M	V
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	117	L	R
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	129	E	V
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	130	G	R
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	132	E	D
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	133	Y	C
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	135	D	G
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	137	T	I
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	164	G	V
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	165	P	S
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	181	V	M
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	185	K	T
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	189	S	L
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	222	D	V
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	224	G	W
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	253	V	F
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	266	G	E
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	278	G	R
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	285	V	G
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	291	E	G
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	294	T	I
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	299	N	I
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	301	R	H
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	301	R	L
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	308	S	L
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	312	F	S
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	314	T	A
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	314	T	I
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	327	L	P
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	331	I	V
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	345	V	L
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	348	C	R
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	348	C	S
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	348	C	Y
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	391	R	C
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	391	R	H
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	391	R	P
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	392	S	L
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	392	S	P
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	405	I	S
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	409	E	G
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	431	L	F
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	439	G	V
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	444	K	R
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	450	Y	N
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	474	G	R
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	488	A	G
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	492	Y	H
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	492	Y	C
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	494	I	T
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	498	G	R
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	544	D	N
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	546	R	W
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	550	R	C
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	550	R	G
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	550	R	H
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	554	S	G
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	556	V	D
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	577	S	F
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	584	Q	K
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	585	I	T
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	596	S	P
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	603	S	I
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	604	W	C
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	605	Y	S
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	612	R	C
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	631	N	K
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	631	N	S
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	644	L	V
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	653	V	A
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	653	V	M
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	663	A	V
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	677	F	L
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	699	M	V
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	717	R	W
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	720	G	D
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	723	A	T
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	727	V	F
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	739	E	K
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1057	E	K
P00451	LB/B	-	A0A093HXT5	1260	D	E
P00451	LB/B	-	A0A093HXT5	1481	L	P
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1699	Y	C
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1699	Y	F
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1708	R	C
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1708	R	H
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1715	R	G
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1723	E	K
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1728	Y	C
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1769	G	R
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1775	L	V
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1775	L	F
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1779	G	E
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1791	M	T
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1800	R	H
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1800	R	C
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1800	R	G
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1803	S	Y
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1808	L	F
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1842	M	I
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1844	P	S
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1845	T	P
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1853	A	T
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1853	A	V
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1865	D	N
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1865	D	Y
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1867	H	R
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1869	G	V
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1873	P	R
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1888	R	I
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1894	E	G
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1904	E	K
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1941	N	D
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1941	N	S
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1960	R	Q
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1960	R	L
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1967	G	D
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1979	G	V
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1980	H	Y
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2016	R	W
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2038	N	S
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2065	W	R
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2088	S	F
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2093	D	G
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2105	T	N
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2107	G	S
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2120	F	L
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2124	Y	C
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2135	R	P
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2138	S	Y
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2148	N	S
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2169	R	H
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2172	P	Q
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2173	T	I
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2178	R	C
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2178	R	H
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2178	R	L
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2182	R	C
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2182	R	H
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2183	M	V
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2185	L	S
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2204	I	T
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2209	I	N
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2211	A	P
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2228	R	G
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2228	R	L
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2228	R	Q
P00451	LB/B	-	A0A093HXT5	2242	V	M
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2248	W	C
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2265	Q	R
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2319	P	L
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2319	P	S
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2323	R	C
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2323	R	H
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2326	R	L
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2326	R	Q
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	202	S	R
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	561	D	Y
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2344	G	C
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	255	G	V
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	323	G	E
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	586	M	V
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1942	G	A
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1963	L	P
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2036	Y	C
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2172	P	R
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2307	D	A
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	72	E	K
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	97	A	P
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	155	Y	H
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	181	V	E
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	254	N	I
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	439	G	S
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	529	K	E
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	567	I	T
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1804	F	S
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2051	I	S
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2141	T	N
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2193	C	G
P00451	LB/B	-	A0A093HXT5	2257	M	V
P00451	LB/B	-	A0A093HXT5	795	R	G
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	19	S	R
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	22	R	T
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	24	Y	C
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	25	Y	C
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	26	L	P
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	33	W	G
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	35	Y	C
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	35	Y	H
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	48	R	K
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	67	K	E
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	67	K	N
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	69	L	P
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	75	D	E
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	75	D	Y
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	92	G	A
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	92	G	V
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	98	E	K
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	101	D	G
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	101	D	H
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	101	D	V
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	111	A	T
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	111	A	V
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	113	H	R
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	113	H	Y
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	117	L	F
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	121	G	S
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	135	D	Y
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	137	T	A
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	138	S	R
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	141	E	K
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	145	D	H
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	147	V	D
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	159	V	A
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	163	N	K
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	164	G	D
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	172	C	W
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	176	S	P
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	179	S	P
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	186	D	G
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	186	D	Y
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	193	G	R
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	198	C	G
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	202	S	N
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	214	F	V
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	217	L	H
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	219	A	D
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	219	A	T
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	220	V	G
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	223	E	K
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	252	T	I
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	262	P	L
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	263	G	S
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	267	C	Y
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	274	W	C
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	275	H	L
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	284	E	K
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	291	E	K
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	295	F	L
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	297	V	A
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	301	R	C
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	303	A	E
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	303	A	P
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	307	I	S
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	315	A	V
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	326	L	P
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	327	L	V
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	329	C	F
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	339	M	T
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	340	E	K
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	345	V	A
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	365	Y	C
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	401	W	G
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	405	I	F
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	412	W	G
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	412	W	R
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	427	K	I
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	431	L	S
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	437	R	P
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	437	R	W
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	438	I	F
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	439	G	D
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	442	Y	C
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	450	Y	D
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	454	T	I
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	455	F	C
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	466	G	E
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	470	P	L
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	470	P	R
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	470	P	T
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	474	G	E
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	475	E	K
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	477	G	V
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	478	D	N
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	479	T	R
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	484	F	C
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	490	R	G
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	503	R	H
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	513	G	S
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	522	I	Y
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	532	W	G
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	540	P	T
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	541	T	S
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	553	S	P
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	554	S	C
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	560	R	T
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	561	D	G
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	561	D	H
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	578	V	A
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	579	D	A
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	579	D	H
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	583	N	S
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	584	Q	H
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	584	Q	R
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	585	I	R
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	588	D	G
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	588	D	Y
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	594	L	Q
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	601	N	D
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	601	N	K
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	602	R	G
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	603	S	R
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	605	Y	H
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	609	N	I
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	633	M	I
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	635	S	N
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	637	N	D
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	637	N	S
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	639	Y	C
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	650	L	F
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	659	L	P
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	664	Q	P
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	681	M	I
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	682	V	F
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	683	Y	C
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	683	Y	N
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	686	T	R
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	698	F	L
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	699	M	T
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	701	M	I
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	705	G	V
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	710	G	W
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	713	N	I
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	717	R	L
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	720	G	S
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	721	M	I
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	721	M	L
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	725	L	Q
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	742	Y	C
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	947	P	R
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1012	V	L
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1066	H	Y
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1336	Q	K
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1460	N	K
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1610	A	S
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1698	I	T
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1701	E	K
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1705	Q	H
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1714	T	S
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1727	D	V
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1740	R	G
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1751	K	Q
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1768	R	H
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1771	L	P
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1777	L	P
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1779	G	R
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1780	P	L
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1782	I	R
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1788	D	H
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1798	A	P
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1799	S	H
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1801	P	A
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1802	Y	C
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1848	E	G
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1858	S	C
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1864	K	E
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1867	H	P
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1869	G	D
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1872	G	E
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1875	L	P
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1876	V	L
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1877	C	R
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1882	L	P
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1901	I	F
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1904	E	D
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1907	S	C
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1907	S	R
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1908	W	L
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1909	Y	C
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1939	A	T
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1945	M	V
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1951	L	F
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1965	S	I
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1966	M	I
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1966	M	V
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1968	S	R
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1971	N	T
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1973	H	L
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1980	H	P
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1982	F	I
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1985	R	Q
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1994	L	P
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1998	Y	C
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2000	G	A
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2004	T	R
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2007	M	I
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2015	W	C
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2016	R	P
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2018	E	G
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2022	G	D
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2028	G	R
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2030	S	N
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2035	V	A
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2040	C	Y
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2045	G	E
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2045	G	V
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2056	I	N
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2058	A	P
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2067	P	L
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2070	A	V
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2082	S	N
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2093	D	Y
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2106	Q	E
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2106	Q	R
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2109	R	C
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2117	I	F
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2117	I	S
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2119	Q	R
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2120	F	C
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2145	F	C
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2157	N	D
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2162	P	L
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2169	R	C
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2173	T	A
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2174	H	D
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2182	R	P
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2183	M	R
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2185	L	W
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2192	S	I
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2196	P	R
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2198	G	V
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2200	E	D
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2220	A	P
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2224	P	L
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2228	R	P
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2229	L	F
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2248	W	S
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2251	V	A
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2251	V	E
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2264	T	A
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2279	F	C
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2279	F	I
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2281	I	T
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2290	W	L
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2304	G	V
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2323	R	G
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2323	R	L
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2326	R	G
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2326	R	P
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2330	Q	P
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2332	W	R
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2339	R	T
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2344	G	S
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2345	C	S
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2345	C	Y
P00451	LB/B	-	A0A093HXT5	1289	K	Q
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	83	P	R
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	186	D	N
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	191	L	F
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	195	L	P
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	261	L	P
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	280	G	D
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	394	A	S
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	474	G	V
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	496	P	R
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	513	G	V
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	569	P	R
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	637	N	I
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1720	A	V
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1762	F	L
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	1877	C	Y
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2013	G	R
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2101	H	D
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2106	Q	P
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2143	M	V
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2172	P	L
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2286	D	G
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2336	I	F
P00451	LP/P	Hemophilia A (HEMA) [MIM:306700]	A0A093HXT5	2344	G	D
P00740	LB/B	-	A0A226PHB5	7	I	F
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	17	I	N
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	28	C	R
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	30	V	I
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	43	R	Q
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	43	R	L
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	43	R	W
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	45	K	N
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	46	R	S
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	46	R	T
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	48	N	I
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	49	S	P
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	53	E	A
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	54	E	G
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	55	F	C
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	58	G	A
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	58	G	R
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	66	E	V
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	67	E	K
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	71	F	S
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	73	E	K
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	73	E	V
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	91	Y	C
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	93	D	G
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	96	Q	P
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	97	C	S
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	101	P	R
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	102	C	R
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	106	G	S
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	108	C	S
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	110	D	N
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	112	I	S
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	113	N	K
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	115	Y	C
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	119	C	F
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	119	C	R
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	125	G	E
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	125	G	V
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	136	I	T
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	139	G	D
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	139	G	S
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	155	C	F
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	160	G	E
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	167	Q	H
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	178	C	R
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	178	C	W
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	191	R	H
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	191	R	C
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	226	R	W
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	226	R	G
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	226	R	Q
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	227	V	D
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	228	V	L
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	241	Q	H
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	253	G	E
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	253	G	R
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	265	A	T
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	279	A	T
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	283	N	D
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	294	R	G
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	294	R	Q
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	302	H	R
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	316	I	F
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	321	L	Q
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	333	P	H
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	342	T	K
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	342	T	M
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	351	G	D
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	356	W	C
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	357	G	E
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	362	K	E
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	363	G	W
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	366	A	D
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	379	R	G
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	379	R	Q
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	382	C	Y
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	387	K	E
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	390	I	F
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	394	M	K
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	396	C	S
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	404	R	T
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	407	C	S
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	413	G	R
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	419	V	E
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	424	F	V
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	426	T	P
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	430	S	T
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	431	W	G
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	431	W	R
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	432	G	S
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	432	G	V
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	433	E	A
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	433	E	K
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	436	A	V
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	449	R	Q
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	449	R	W
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	450	Y	C
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	454	I	T
P00740	LB/B	-	A0A226PHB5	194	T	A
P00740	LB/B	-	A0A226PHB5	461	T	P
P00740	LP/P	Warfarin sensitivity, X-linked (WARFS) [MIM:301052]	A0A226PHB5	37	A	T
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	75	R	Q
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	79	E	D
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	227	V	F
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	228	V	F
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	252	C	S
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	268	C	W
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	291	E	V
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	306	N	S
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	357	G	R
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	397	A	P
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	410	D	H
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	411	S	I
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	411	S	G
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	414	P	T
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	442	G	R
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	443	I	T
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	453	W	R
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	28	C	Y
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	52	L	S
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	84	T	R
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	106	G	D
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	124	E	K
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	125	G	R
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	134	C	Y
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	169	S	C
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	170	C	F
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	241	Q	K
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	252	C	Y
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	318	L	R
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	333	P	T
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	344	I	L
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	383	L	I
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	383	L	F
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	395	F	I
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	395	F	L
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	396	C	F
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	407	C	R
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	412	G	E
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	435	C	Y
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	442	G	E
P00740	LP/P	Thrombophilia, X-linked, due to factor IX defect (THPH8) [MIM:300807]	A0A226PHB5	384	R	L
P00740	LP/P	Hemophilia B (HEMB) [MIM:306900]	A0A226PHB5	328	N	Y
P00740	LP/P	Warfarin sensitivity, X-linked (WARFS) [MIM:301052]	A0A226PHB5	37	A	V
O00519	LB/B	-	F7HAB1	129	P	T
Q6NZ36	LB/B	-	A0A2K6F2F8	126	P	S
P07148	LB/B	-	F7AW92	54	A	T
P07148	LB/B	-	F7AW92	94	T	A
P12104	LB/B	-	D5LL08	55	A	T
P05413	LB/B	-	A0A087Y865	53	K	R
P51161	LB/B	-	F7IFS1	33	R	H
P51161	LB/B	-	F7IFS1	55	S	Y
P51161	LB/B	-	F7IFS1	79	T	M
O15540	LB/B	-	A0A087Y865	61	T	M
Q13158	LP/P	Infections, recurrent, associated with encephalopathy, hepatic dysfunction and cardiovascular malformations (IEHDCM) [MIM:613759]	G7PNY6	105	C	W
P16930	LP/P	Tyrosinemia 1 (TYRSN1) [MIM:276700]	C3YKG9	16	N	I
P16930	LP/P	Tyrosinemia 1 (TYRSN1) [MIM:276700]	C3YKG9	62	F	C
P16930	LP/P	Tyrosinemia 1 (TYRSN1) [MIM:276700]	C3YKG9	64	Q	H
P16930	LP/P	Tyrosinemia 1 (TYRSN1) [MIM:276700]	C3YKG9	134	A	D
P16930	LP/P	Tyrosinemia 1 (TYRSN1) [MIM:276700]	C3YKG9	158	G	D
P16930	LP/P	Tyrosinemia 1 (TYRSN1) [MIM:276700]	C3YKG9	166	V	G
P16930	LP/P	Tyrosinemia 1 (TYRSN1) [MIM:276700]	C3YKG9	193	C	R
P16930	LP/P	Tyrosinemia 1 (TYRSN1) [MIM:276700]	C3YKG9	207	G	D
P16930	LP/P	Tyrosinemia 1 (TYRSN1) [MIM:276700]	C3YKG9	233	D	V
P16930	LP/P	Tyrosinemia 1 (TYRSN1) [MIM:276700]	C3YKG9	234	W	G
P16930	LP/P	Tyrosinemia 1 (TYRSN1) [MIM:276700]	C3YKG9	249	P	T
P16930	LP/P	Tyrosinemia 1 (TYRSN1) [MIM:276700]	C3YKG9	261	P	L
P16930	LP/P	Tyrosinemia 1 (TYRSN1) [MIM:276700]	C3YKG9	294	T	P
P16930	LP/P	Tyrosinemia 1 (TYRSN1) [MIM:276700]	C3YKG9	337	G	S
P16930	LB/B	-	C3YKG9	341	R	W
P16930	LP/P	Tyrosinemia 1 (TYRSN1) [MIM:276700]	C3YKG9	342	P	L
P16930	LP/P	Tyrosinemia 1 (TYRSN1) [MIM:276700]	C3YKG9	369	G	V
P16930	LP/P	Tyrosinemia 1 (TYRSN1) [MIM:276700]	C3YKG9	381	R	G
P16930	LP/P	Tyrosinemia 1 (TYRSN1) [MIM:276700]	C3YKG9	405	F	H
P16930	LP/P	Tyrosinemia 1 (TYRSN1) [MIM:276700]	C3YKG9	35	A	T
P16930	LP/P	Tyrosinemia 1 (TYRSN1) [MIM:276700]	C3YKG9	279	Q	R
Q6P587	LB/B	-	A0A2K5CPE4	110	D	N
Q96GK7	LB/B	-	A0A2I3T937	198	M	T
Q5XKR9	LB/B	-	A0A2I2ZE67	60	S	G
O95990	LB/B	-	A0A151MKK1	89	A	S
O95990	LB/B	-	A0A151MKK1	141	E	Q
Q8TAY7	LB/B	-	A0A212D3B6	53	H	R
Q96PZ2	LP/P	Gracile bone dysplasia (GCLEB) [MIM:602361]	H0WN61	338	T	A
Q96PZ2	LP/P	Kenny-Caffey syndrome 2 (KCS2) [MIM:127000]	H0WN61	511	Y	H
Q96PZ2	LP/P	Gracile bone dysplasia (GCLEB) [MIM:602361]	H0WN61	527	P	T
Q96PZ2	LP/P	Gracile bone dysplasia (GCLEB) [MIM:602361]	H0WN61	528	D	G
Q96PZ2	LP/P	Kenny-Caffey syndrome 2 (KCS2) [MIM:127000]	H0WN61	569	R	H
Q6SJ93	LB/B	-	J9P3W6	731	P	A
Q6SJ93	LB/B	-	J9P3W6	218	G	D
Q6SJ93	LP/P	Poikiloderma, hereditary fibrosing, with tendon contractures, myopathy, and pulmonary fibrosis (POIKTMP) [MIM:615704]	J9P3W6	621	Y	D
Q6SJ93	LP/P	Poikiloderma, hereditary fibrosing, with tendon contractures, myopathy, and pulmonary fibrosis (POIKTMP) [MIM:615704]	J9P3W6	627	R	G
Q6SJ93	LP/P	Poikiloderma, hereditary fibrosing, with tendon contractures, myopathy, and pulmonary fibrosis (POIKTMP) [MIM:615704]	J9P3W6	628	S	N
Q9NZB2	LB/B	-	A0A1S3P8L0	327	Y	H
Q96EK7	LB/B	-	A0A250YL85	370	D	Y
Q96EK7	LB/B	-	A0A250YL85	379	M	T
Q96EK7	LB/B	-	A0A250YL85	428	Y	C
Q96EK7	LB/B	-	A0A250YL85	430	D	G
Q96EK7	LB/B	-	A0A250YL85	431	S	P
Q96EK7	LB/B	-	A0A250YL85	433	P	A
Q96EK7	LB/B	-	A0A250YL85	440	Y	C
Q96EK7	LB/B	-	A0A250YL85	511	C	G
Q9NX05	LB/B	-	H9H7Q6	82	I	T
Q9NX05	LB/B	-	H9H7Q6	934	M	I
Q86V42	LB/B	-	G3TAP1	181	D	H
Q9H5Z6	LB/B	-	G3VQJ5	257	I	T
Q86XD5	LB/B	-	F6XV51	307	A	T
Q96AQ9	LB/B	-	S7NSY4	48	K	E
Q96AQ9	LB/B	-	S7NSY4	107	R	Q
Q96AQ9	LB/B	-	S7NSY4	123	P	R
Q96AQ9	LB/B	-	S7NSY4	215	S	I
Q96AQ9	LB/B	-	S7NSY4	226	E	D
Q9P2D6	LB/B	-	G7MPP6	725	I	V
Q9P2D6	LB/B	-	G7MPP6	954	P	S
Q9P2D6	LB/B	-	G7MPP6	1242	D	G
Q49AJ0	LB/B	-	G3HSU0	477	I	V
Q49AJ0	LB/B	-	G3HSU0	846	D	N
Q49AJ0	LB/B	-	G3HSU0	578	S	N
Q49AJ0	LB/B	-	G3HSU0	1142	V	I
O94988	LB/B	-	H0WMJ0	769	V	I
Q9NYF5	LB/B	-	H0WMJ0	802	M	V
Q8NE31	LB/B	-	A0A1S3W460	82	P	H
Q6UXP7	LB/B	-	A0A1S3M6H7	155	I	T
Q3B820	LB/B	-	H0UXQ4	236	I	V
Q3B820	LB/B	-	H0UXQ4	273	E	K
Q3B820	LB/B	-	H0UXQ4	107	I	M
Q96MY7	LB/B	-	A0A151NK93	11	G	A
Q96MY7	LB/B	-	A0A151NK93	622	L	P
Q96MY7	LB/B	-	A0A151NK93	487	K	R
Q96A26	LB/B	-	A0A2Y9DGM3	50	A	V
Q5T6X4	LB/B	-	A0A2R9C9Q9	71	Q	H
A6NJV1	LB/B	-	A0A151NJS0	66	Q	H
A6NJV1	LB/B	-	A0A151NJS0	177	Q	L
Q96KS9	LB/B	-	A0A1A7ZPN9	56	H	Q
Q96KS9	LB/B	-	A0A1A7ZPN9	107	T	S
Q8N8A8	LB/B	-	A0A2K6EVH6	115	S	P
A1A519	LB/B	-	A0A2K6TEA9	173	P	S
A6NMN3	LB/B	-	M3W7N5	69	R	L
Q5VUB5	LB/B	-	H2R7T1	465	P	S
Q6P995	LB/B	-	A0A1S3MWJ7	302	V	I
Q8WUF8	LB/B	-	Q6DIP8	131	S	N
Q3ZCQ3	LB/B	-	G3WAZ0	116	S	L
Q6P0A1	LB/B	-	J9NT50	145	A	T
Q8N9Y4	LB/B	-	W5PX95	28	A	T
Q8N9Y4	LB/B	-	W5PX95	162	L	M
A6NEQ2	LB/B	-	A0A146RFW2	186	V	L
A6NEQ2	LB/B	-	A0A146RFW2	367	R	P
Q8NB25	LB/B	-	A0A2K5WW15	174	Q	H
Q8NB25	LB/B	-	A0A2K5WW15	177	V	G
Q8NB25	LB/B	-	A0A2K5WW15	599	D	N
Q8N0U4	LB/B	-	A0A1S3GR22	60	G	A
Q8N0U4	LB/B	-	A0A1S3GR22	15	L	F
A6NE01	LB/B	-	A0A2K5RDU1	187	K	Q
A6NE01	LB/B	-	A0A2K5RDU1	1204	R	G
A6NE01	LB/B	-	A0A2K5RDU1	1233	L	P
A6NE01	LB/B	-	A0A2K5RDU1	2166	H	Y
A6NE01	LB/B	-	A0A2K5RDU1	2193	M	I
A6NE01	LB/B	-	A0A2K5RDU1	2228	H	Q
A6NE01	LB/B	-	A0A2K5RDU1	2316	Q	E
Q17R55	LB/B	-	A0A2Y9E884	3	P	S
Q17R55	LB/B	-	A0A2Y9E884	160	C	R
Q17R55	LB/B	-	A0A2Y9E884	216	V	I
P78312	LB/B	-	A0A1U7S4C9	192	M	V
P78312	LB/B	-	A0A1U7S4C9	1115	I	V
Q96PV7	LB/B	-	G1KEL5	816	S	P
Q8IZ13	LB/B	-	J9JRH8	523	A	S
Q5JX71	LB/B	-	H2P2D0	66	V	A
Q5JX71	LB/B	-	H2P2D0	117	M	K
Q5JX71	LB/B	-	H2P2D0	135	R	G
Q5JX71	LB/B	-	H2P2D0	146	R	K
Q5JX71	LB/B	-	H2P2D0	95	L	F
Q96MK3	LB/B	-	F6VRT0	332	N	K
Q96MK3	LB/B	-	F6VRT0	530	L	S
Q96MK3	LP/P	Amelogenesis imperfecta 1G (AI1G) [MIM:204690]	F6VRT0	173	L	R
Q96MK3	LP/P	Amelogenesis imperfecta 1G (AI1G) [MIM:204690]	F6VRT0	331	G	D
Q96MK3	LP/P	Amelogenesis imperfecta 1G (AI1G) [MIM:204690]	F6VRT0	403	D	N
Q8IXL6	LP/P	Raine syndrome (RNS) [MIM:259775]	G3TFS7	379	G	E
Q8IXL6	LP/P	Raine syndrome (RNS) [MIM:259775]	G3TFS7	379	G	R
Q8IXL6	LP/P	Raine syndrome (RNS) [MIM:259775]	G3TFS7	388	L	R
Q8IXL6	LP/P	Raine syndrome (RNS) [MIM:259775]	G3TFS7	549	R	W
Q8IXL6	LP/P	Raine syndrome (RNS) [MIM:259775]	G3TFS7	258	I	N
Q8IXL6	LP/P	Raine syndrome (RNS) [MIM:259775]	G3TFS7	268	T	M
Q8IXL6	LP/P	Raine syndrome (RNS) [MIM:259775]	G3TFS7	280	G	R
Q8IXL6	LP/P	Raine syndrome (RNS) [MIM:259775]	G3TFS7	328	P	S
Q8IXL6	LP/P	Raine syndrome (RNS) [MIM:259775]	G3TFS7	451	D	N
Q8WUB2	LB/B	-	M3W1M6	225	R	G
Q8N7L0	LB/B	-	L5KGY8	134	R	C
Q9NTX9	LB/B	-	I3NGI1	380	Y	C
Q96MZ4	LB/B	-	A0A2K5QBW3	54	H	R
Q7Z4H9	LB/B	-	S9XLS3	71	G	R
Q7Z4H9	LB/B	-	S9XLS3	127	R	Q
Q7Z4H9	LB/B	-	S9XLS3	161	V	L
Q7Z4H9	LB/B	-	S9XLS3	198	V	M
Q7Z4H9	LB/B	-	S9XLS3	237	G	S
B1ANY3	LB/B	-	S9XLS3	162	W	R
B1ANY3	LB/B	-	S9XLS3	199	K	N
B1ANY3	LB/B	-	S9XLS3	203	K	N
A4D161	LB/B	-	A0A287BQD3	20	Y	H
A4D161	LB/B	-	A0A287BQD3	90	A	T
A4D161	LB/B	-	A0A287BQD3	95	C	R
A4D161	LB/B	-	A0A287BQD3	128	H	R
A4D161	LB/B	-	A0A287BQD3	240	S	G
Q8WU58	LB/B	-	H0XLK8	471	L	S
Q8WU58	LB/B	-	H0XLK8	542	G	S
Q8N8J7	LB/B	-	F6QDW0	46	P	Q
Q8N5W8	LB/B	-	A0A1S3FMW8	2	P	L
B3EWG3	LB/B	-	A0A2K6QD06	35	V	L
P98173	LB/B	-	A0A061HUL7	213	W	C
P98173	LB/B	-	A0A061HUL7	21	I	M
Q96BQ1	LB/B	-	G1KL39	60	P	S
Q96BQ1	LB/B	-	G1KL39	118	A	S
Q5JRC9	LB/B	-	A0A2K5ICJ6	50	F	L
Q5JRC9	LB/B	-	A0A2K5ICJ6	232	V	E
Q5JRC9	LB/B	-	A0A2K5ICJ6	377	A	S
Q5JRC9	LB/B	-	A0A2K5ICJ6	531	G	R
Q5HY64	LB/B	-	A0A2K5ICJ6	924	N	T
Q86X60	LB/B	-	A0A1Y1XIT5	82	G	V
Q86X60	LB/B	-	A0A1Y1XIT5	94	P	L
Q96LP2	LB/B	-	A0A2Y9JI04	150	R	G
Q96LP2	LB/B	-	A0A2Y9JI04	187	A	V
Q96LP2	LB/B	-	A0A2Y9JI04	239	R	Q
Q96LP2	LB/B	-	A0A2Y9JI04	275	S	P
Q86UY5	LB/B	-	W5PM83	237	A	T
Q9BQN1	LB/B	-	A0A2Y9EHQ3	621	R	Q
Q9BQN1	LB/B	-	A0A2Y9EHQ3	134	E	K
Q9BQN1	LB/B	-	A0A2Y9EHQ3	600	Y	H
Q9BQN1	LB/B	-	A0A2Y9EHQ3	645	R	C
Q2M2I3	LB/B	-	A0A2K6C8Q4	91	T	A
Q2M2I3	LB/B	-	A0A2K6C8Q4	311	P	L
Q2M2I3	LB/B	-	A0A2K6C8Q4	372	R	H
Q8NEG4	LB/B	-	U3IQ44	245	R	S
Q8NEG4	LB/B	-	U3IQ44	353	G	S
Q8NEG4	LB/B	-	U3IQ44	436	R	G
Q6ZRV2	LB/B	-	A0A2G9SLH4	201	Q	H
Q6ZRV2	LP/P	Amelogenesis imperfecta 3A (AI3A) [MIM:130900]	A0A2G9SLH4	557	G	C
P0C5J1	LB/B	-	A0A2Y9FVL3	43	D	Y
P0C5J1	LB/B	-	A0A2Y9FVL3	285	R	S
Q9NVL1	LB/B	-	H2RAB5	7	A	S
Q9NVL1	LB/B	-	H2RAB5	30	R	P
Q9NVL1	LB/B	-	H2RAB5	70	V	A
Q9NVL1	LB/B	-	H2RAB5	135	P	L
Q658Y4	LB/B	-	A0A2D0S4R3	704	I	V
Q658Y4	LB/B	-	A0A2D0S4R3	800	C	Y
Q17RN3	LB/B	-	A0A2J8QF29	240	T	K
Q9Y2M0	LB/B	-	A0A093I0H1	233	G	E
Q9Y2M0	LP/P	Interstitial nephritis, karyomegalic (KMIN) [MIM:614817]	A0A093I0H1	871	C	R
Q9Y2M0	LP/P	Interstitial nephritis, karyomegalic (KMIN) [MIM:614817]	A0A093I0H1	929	Q	P
Q9Y2M0	LP/P	Interstitial nephritis, karyomegalic (KMIN) [MIM:614817]	A0A093I0H1	937	G	D
Q9Y2M0	LP/P	Interstitial nephritis, karyomegalic (KMIN) [MIM:614817]	A0A093I0H1	960	D	N
O15360	LB/B	-	U3JK75	6	V	D
O15360	LB/B	Fanconi anemia, complementation group A (FANCA) [MIM:227650]	U3JK75	8	N	K
O15360	LB/B	Fanconi anemia, complementation group A (FANCA) [MIM:227650]	U3JK75	181	A	V
O15360	LP/P	Fanconi anemia, complementation group A (FANCA) [MIM:227650]	U3JK75	244	L	F
O15360	LB/B	Fanconi anemia, complementation group A (FANCA) [MIM:227650]	U3JK75	252	D	G
O15360	LP/P	Fanconi anemia, complementation group A (FANCA) [MIM:227650]	U3JK75	435	R	C
O15360	LP/P	Fanconi anemia, complementation group A (FANCA) [MIM:227650]	U3JK75	492	H	R
O15360	LB/B	-	U3JK75	501	G	S
O15360	LB/B	-	U3JK75	739	P	L
O15360	LB/B	-	U3JK75	809	G	D
O15360	LP/P	Fanconi anemia, complementation group A (FANCA) [MIM:227650]	U3JK75	817	L	P
O15360	LP/P	Fanconi anemia, complementation group A (FANCA) [MIM:227650]	U3JK75	845	L	P
O15360	LP/P	Fanconi anemia, complementation group A (FANCA) [MIM:227650]	U3JK75	1055	R	L
O15360	LP/P	Fanconi anemia, complementation group A (FANCA) [MIM:227650]	U3JK75	1110	H	P
O15360	LP/P	Fanconi anemia, complementation group A (FANCA) [MIM:227650]	U3JK75	1117	R	G
O15360	LP/P	Fanconi anemia, complementation group A (FANCA) [MIM:227650]	U3JK75	1128	Q	E
O15360	LP/P	Fanconi anemia, complementation group A (FANCA) [MIM:227650]	U3JK75	1131	T	A
O15360	LB/B	-	U3JK75	1287	V	I
O15360	LP/P	Fanconi anemia, complementation group A (FANCA) [MIM:227650]	U3JK75	1302	W	R
O15360	LB/B	-	U3JK75	1328	T	A
O15360	LP/P	Fanconi anemia, complementation group A (FANCA) [MIM:227650]	U3JK75	1417	H	D
O15360	LB/B	-	U3JK75	266	T	A
O15360	LP/P	Fanconi anemia, complementation group A (FANCA) [MIM:227650]	U3JK75	598	D	N
O15360	LP/P	Fanconi anemia, complementation group A (FANCA) [MIM:227650]	U3JK75	858	S	R
O15360	LP/P	Fanconi anemia, complementation group A (FANCA) [MIM:227650]	U3JK75	1055	R	W
O15360	LP/P	Fanconi anemia, complementation group A (FANCA) [MIM:227650]	U3JK75	1082	L	P
O15360	LP/P	Fanconi anemia, complementation group A (FANCA) [MIM:227650]	U3JK75	1088	S	F
O15360	LP/P	Fanconi anemia, complementation group A (FANCA) [MIM:227650]	U3JK75	1262	F	L
O15360	LP/P	Fanconi anemia, complementation group A (FANCA) [MIM:227650]	U3JK75	1359	D	Y
O15360	LP/P	Fanconi anemia, complementation group A (FANCA) [MIM:227650]	U3JK75	1360	M	I
O15360	LP/P	Fanconi anemia, complementation group A (FANCA) [MIM:227650]	U3JK75	1324	P	L
O15360	LP/P	Fanconi anemia, complementation group A (FANCA) [MIM:227650]	U3JK75	210	L	R
O15360	LP/P	Fanconi anemia, complementation group A (FANCA) [MIM:227650]	U3JK75	660	L	P
O15360	LB/B	-	U3JK75	761	V	E
O15360	LP/P	Fanconi anemia, complementation group A (FANCA) [MIM:227650]	U3JK75	843	Y	D
O15360	LP/P	Fanconi anemia, complementation group A (FANCA) [MIM:227650]	U3JK75	869	Q	P
O15360	LB/B	-	U3JK75	951	R	Q
O15360	LB/B	-	U3JK75	951	R	W
O15360	LP/P	Fanconi anemia, complementation group A (FANCA) [MIM:227650]	U3JK75	1249	L	P
O15360	LB/B	Fanconi anemia, complementation group A (FANCA) [MIM:227650]	U3JK75	1346	A	T
O15360	LP/P	Fanconi anemia, complementation group A (FANCA) [MIM:227650]	U3JK75	1400	R	H
O15360	LB/B	-	U3JK75	131	T	S
O15360	LB/B	-	U3JK75	176	S	F
O15360	LB/B	-	U3JK75	277	A	G
O15360	LB/B	-	U3JK75	286	Q	R
O15360	LB/B	-	U3JK75	412	A	V
O15360	LB/B	-	U3JK75	643	P	A
O15360	LB/B	-	U3JK75	717	M	I
Q9HB96	LB/B	-	S9YJE3	89	R	L
Q9HB96	LB/B	-	S9YJE3	204	S	L
Q9HB96	LB/B	-	S9YJE3	340	G	R
Q9HB96	LB/B	-	S9YJE3	343	R	Q
Q9HB96	LB/B	-	S9YJE3	502	A	T
Q9NPI8	LB/B	-	H3A681	320	P	L
Q9NPI8	LB/B	-	H3A681	295	V	I
O15287	LP/P	Fanconi anemia complementation group G (FANCG) [MIM:614082]	A0A2Y9JE40	71	L	P
O15287	LB/B	-	A0A2Y9JE40	297	T	I
O15287	LB/B	-	A0A2Y9JE40	294	G	E
O15287	LB/B	-	A0A2Y9JE40	330	P	S
O15287	LB/B	-	A0A2Y9JE40	378	S	L
O15287	LB/B	-	A0A2Y9JE40	430	K	E
O15287	LB/B	-	A0A2Y9JE40	513	R	Q
O15287	LB/B	-	A0A2Y9JE40	603	S	F
Q9NVI1	LB/B	-	A0A151M9A6	686	Q	K
Q9NVI1	LB/B	-	A0A151M9A6	742	C	S
Q9NVI1	LB/B	Fanconi anemia complementation group I (FANCI) [MIM:609053]	A0A151M9A6	55	P	L
Q9NVI1	LB/B	-	A0A151M9A6	86	A	V
Q9NVI1	LP/P	Fanconi anemia complementation group I (FANCI) [MIM:609053]	A0A151M9A6	858	H	Y
Q9NVI1	LP/P	Fanconi anemia complementation group I (FANCI) [MIM:609053]	A0A151M9A6	1285	R	Q
Q9NW38	LB/B	-	A0A2Y9FY24	144	S	F
Q8IYD8	LB/B	-	A0A2J8V9N2	175	S	F
Q8IYD8	LB/B	-	A0A2J8V9N2	878	V	L
Q8IYD8	LB/B	-	A0A2J8V9N2	1812	P	A
Q8IYD8	LB/B	-	A0A2J8V9N2	208	I	M
Q8TC84	LB/B	-	A0A0D9QWT2	329	L	V
Q8TC84	LB/B	-	A0A0D9QWT2	46	R	S
Q8TC84	LB/B	-	A0A0D9QWT2	12	P	L
Q8TC84	LB/B	-	A0A0D9QWT2	343	C	F
Q8WVX9	LB/B	-	H3AHH5	96	E	K
Q8WVX9	LP/P	Peroxisomal fatty acyl-CoA reductase 1 disorder (PFCRD) [MIM:616154]	H3AHH5	365	D	G
Q8WVX9	LP/P	Cataracts, spastic paraparesis, and speech delay (CSPSD) [MIM:619338]	H3AHH5	480	R	C
Q8WVX9	LP/P	Cataracts, spastic paraparesis, and speech delay (CSPSD) [MIM:619338]	H3AHH5	480	R	H
Q8WVX9	LP/P	Cataracts, spastic paraparesis, and speech delay (CSPSD) [MIM:619338]	H3AHH5	480	R	L
Q9Y4F1	LB/B	-	A0A2R5L889	8	P	L
O94887	LB/B	-	V8NJW7	185	K	N
O94887	LB/B	-	V8NJW7	260	T	I
O94887	LB/B	-	V8NJW7	643	V	I
Q9NSD9	LB/B	-	A0A287FIW3	585	V	I
Q9NSD9	LP/P	Rajab interstitial lung disease with brain calcifications 1 (RILDBC1) [MIM:613658]	A0A287FIW3	76	C	R
Q9NSD9	LP/P	Rajab interstitial lung disease with brain calcifications 1 (RILDBC1) [MIM:613658]	A0A287FIW3	252	F	S
Q9NSD9	LP/P	Rajab interstitial lung disease with brain calcifications 1 (RILDBC1) [MIM:613658]	A0A287FIW3	256	T	M
Q9NSD9	LP/P	Rajab interstitial lung disease with brain calcifications 1 (RILDBC1) [MIM:613658]	A0A287FIW3	262	K	E
Q9NSD9	LP/P	Rajab interstitial lung disease with brain calcifications 1 (RILDBC1) [MIM:613658]	A0A287FIW3	285	E	K
Q9NSD9	LP/P	Rajab interstitial lung disease with brain calcifications 1 (RILDBC1) [MIM:613658]	A0A287FIW3	305	R	Q
Q9NSD9	LP/P	Rajab interstitial lung disease with brain calcifications 1 (RILDBC1) [MIM:613658]	A0A287FIW3	401	R	Q
Q9NSD9	LP/P	Rajab interstitial lung disease with brain calcifications 1 (RILDBC1) [MIM:613658]	A0A287FIW3	461	T	P
P25445	LP/P	Autoimmune lymphoproliferative syndrome 1A (ALPS1A) [MIM:601859]	O77736	28	T	A
P25445	LP/P	Autoimmune lymphoproliferative syndrome 1A (ALPS1A) [MIM:601859]	O77736	82	C	R
P25445	LP/P	Autoimmune lymphoproliferative syndrome 1A (ALPS1A) [MIM:601859]	O77736	121	R	W
P25445	LP/P	Autoimmune lymphoproliferative syndrome 1A (ALPS1A) [MIM:601859]	O77736	232	Y	C
P25445	LP/P	Autoimmune lymphoproliferative syndrome 1A (ALPS1A) [MIM:601859]	O77736	241	T	K
P25445	LP/P	Autoimmune lymphoproliferative syndrome 1A (ALPS1A) [MIM:601859]	O77736	241	T	P
P25445	LP/P	Autoimmune lymphoproliferative syndrome 1A (ALPS1A) [MIM:601859]	O77736	250	R	P
P25445	LP/P	Autoimmune lymphoproliferative syndrome 1A (ALPS1A) [MIM:601859]	O77736	250	R	Q
P25445	LP/P	Autoimmune lymphoproliferative syndrome 1A (ALPS1A) [MIM:601859]	O77736	257	A	D
P25445	LP/P	Autoimmune lymphoproliferative syndrome 1A (ALPS1A) [MIM:601859]	O77736	260	D	G
P25445	LP/P	Autoimmune lymphoproliferative syndrome 1A (ALPS1A) [MIM:601859]	O77736	260	D	Y
P25445	LP/P	Autoimmune lymphoproliferative syndrome 1A (ALPS1A) [MIM:601859]	O77736	260	D	V
P25445	LP/P	Autoimmune lymphoproliferative syndrome 1A (ALPS1A) [MIM:601859]	O77736	270	T	I
P25445	LP/P	Autoimmune lymphoproliferative syndrome 1A (ALPS1A) [MIM:601859]	O77736	272	E	G
P25445	LP/P	Autoimmune lymphoproliferative syndrome 1A (ALPS1A) [MIM:601859]	O77736	272	E	K
P25445	LP/P	Autoimmune lymphoproliferative syndrome 1A (ALPS1A) [MIM:601859]	O77736	310	I	S
P25445	LB/B	-	O77736	16	A	T
P25445	LB/B	-	O77736	122	T	I
P25445	LB/B	-	O77736	305	T	I
P25445	LB/B	-	O77736	184	I	V
P25445	LP/P	Autoimmune lymphoproliferative syndrome 1A (ALPS1A) [MIM:601859]	O77736	262	I	S
P25445	LP/P	Autoimmune lymphoproliferative syndrome 1A (ALPS1A) [MIM:601859]	O77736	249	V	L
P25445	LP/P	Autoimmune lymphoproliferative syndrome 1A (ALPS1A) [MIM:601859]	O77736	253	G	D
P25445	LP/P	Autoimmune lymphoproliferative syndrome 1A (ALPS1A) [MIM:601859]	O77736	253	G	S
P25445	LP/P	Autoimmune lymphoproliferative syndrome 1A (ALPS1A) [MIM:601859]	O77736	259	I	R
P25445	LP/P	Autoimmune lymphoproliferative syndrome 1A (ALPS1A) [MIM:601859]	O77736	270	T	K
P48023	LB/B	-	A0A093GF86	189	Y	S
P48023	LP/P	Autoimmune lymphoproliferative syndrome 1B (ALPS1B) [MIM:601859]	A0A093GF86	202	C	S
P49327	LB/B	-	F6W5Y2	1483	V	I
P49327	LB/B	-	F6W5Y2	1694	R	H
P49327	LB/B	-	F6W5Y2	1888	I	V
P49327	LB/B	-	F6W5Y2	477	R	H
Q53R41	LB/B	-	W5MMX3	384	E	Q
Q53R41	LB/B	-	W5MMX3	446	C	G
Q53R41	LB/B	-	W5MMX3	467	M	V
Q14CZ7	LB/B	-	A0A1S3W7S8	56	K	R
Q14CZ7	LB/B	-	A0A1S3W7S8	459	E	G
Q14CZ7	LB/B	-	A0A1S3W7S8	3	L	F
Q7L8L6	LB/B	-	E2RHP5	256	R	C
Q7L8L6	LB/B	-	E2RHP5	288	I	T
Q7L8L6	LB/B	-	E2RHP5	377	I	V
Q14517	LB/B	-	M7B901	131	A	V
Q14517	LB/B	-	M7B901	1330	N	S
Q14517	LB/B	-	M7B901	1564	A	T
Q14517	LB/B	-	M7B901	1605	N	D
Q14517	LB/B	-	M7B901	3800	P	H
Q14517	LB/B	-	M7B901	902	R	S
Q14517	LB/B	-	M7B901	1393	I	V
Q14517	LB/B	-	M7B901	3732	N	S
Q9NYQ8	LB/B	-	M7B901	201	G	A
Q9NYQ8	LB/B	-	M7B901	248	P	S
Q9NYQ8	LB/B	-	M7B901	574	R	C
Q9NYQ8	LB/B	-	M7B901	686	F	S
Q9NYQ8	LB/B	-	M7B901	992	R	Q
Q9NYQ8	LB/B	-	M7B901	1004	G	S
Q9NYQ8	LB/B	-	M7B901	1164	P	L
Q9NYQ8	LB/B	-	M7B901	1462	V	M
Q9NYQ8	LB/B	-	M7B901	1515	G	S
Q9NYQ8	LB/B	-	M7B901	1571	G	S
Q9NYQ8	LB/B	-	M7B901	1895	R	W
Q9NYQ8	LB/B	-	M7B901	2054	G	A
Q9NYQ8	LB/B	-	M7B901	2907	A	T
Q9NYQ8	LB/B	-	M7B901	3318	R	Q
Q9NYQ8	LB/B	-	M7B901	3318	R	W
Q9NYQ8	LB/B	-	M7B901	3514	L	S
Q9NYQ8	LB/B	-	M7B901	3631	M	I
Q9NYQ8	LB/B	-	M7B901	3664	A	G
Q9NYQ8	LB/B	-	M7B901	3953	Q	H
Q9NYQ8	LB/B	-	M7B901	4117	P	L
Q9NYQ8	LB/B	-	M7B901	1295	L	P
Q9NYQ8	LB/B	-	M7B901	1181	Y	H
Q9NYQ8	LB/B	-	M7B901	2428	F	S
Q8TDW7	LB/B	-	A0A2U9B7D4	412	S	F
Q8TDW7	LB/B	-	A0A2U9B7D4	462	I	V
Q8TDW7	LB/B	-	A0A2U9B7D4	1167	V	G
Q8TDW7	LB/B	-	A0A2U9B7D4	1726	Q	R
Q8TDW7	LB/B	-	A0A2U9B7D4	2293	N	S
Q8TDW7	LB/B	-	A0A2U9B7D4	2622	V	F
Q8TDW7	LB/B	-	A0A2U9B7D4	2755	I	V
Q8TDW7	LB/B	-	A0A2U9B7D4	3518	V	L
Q8TDW7	LB/B	-	A0A2U9B7D4	3812	S	G
Q6V0I7	LB/B	-	A0A195D885	2826	D	N
Q6V0I7	LB/B	-	A0A195D885	3524	G	D
Q6V0I7	LB/B	-	A0A195D885	3828	K	E
Q6V0I7	LB/B	-	A0A195D885	3873	S	N
Q6V0I7	LB/B	-	A0A195D885	4374	E	K
Q6V0I7	LB/B	-	A0A195D885	4972	P	S
Q6V0I7	LB/B	-	A0A195D885	4977	A	T
Q6V0I7	LB/B	-	A0A195D885	453	Q	L
Q6V0I7	LB/B	-	A0A195D885	807	A	V
Q6V0I7	LP/P	Hennekam lymphangiectasia-lymphedema syndrome 2 (HKLLS2) [MIM:616006]	A0A195D885	2375	E	K
Q6V0I7	LP/P	Van Maldergem syndrome 2 (VMLDS2) [MIM:615546]	A0A195D885	2375	E	K
Q6V0I7	LP/P	Van Maldergem syndrome 2 (VMLDS2) [MIM:615546]	A0A195D885	4159	C	F
Q6V0I7	LP/P	Van Maldergem syndrome 2 (VMLDS2) [MIM:615546]	A0A195D885	4398	C	Y
Q6V0I7	LP/P	Hennekam lymphangiectasia-lymphedema syndrome 2 (HKLLS2) [MIM:616006]	A0A195D885	475	F	L
Q6V0I7	LP/P	Hennekam lymphangiectasia-lymphedema syndrome 2 (HKLLS2) [MIM:616006]	A0A195D885	486	E	Q
Q6V0I7	LP/P	Hennekam lymphangiectasia-lymphedema syndrome 2 (HKLLS2) [MIM:616006]	A0A195D885	4282	S	F
Q969F0	LB/B	-	F6TST4	10	A	V
Q969F0	LB/B	-	F6TST4	125	S	R
P62861	LB/B	-	A0A164R027	93	V	M
P62861	LB/B	-	A0A164R027	53	T	I
Q96IV6	LB/B	-	M4AWG7	133	R	H
Q8TES7	LB/B	-	A0A2Y9GCE3	65	G	V
Q8TES7	LB/B	-	A0A2Y9GCE3	151	R	G
Q8TES7	LB/B	-	A0A2Y9GCE3	371	P	S
Q8TES7	LB/B	-	A0A2Y9GCE3	574	C	S
P98095	LB/B	-	A0A1A8RHD2	1114	G	R
P98095	LB/B	-	A0A1A8RHD2	361	S	G
P98095	LB/B	-	A0A1A8RHD2	387	N	T
P98095	LB/B	-	A0A1A8RHD2	854	T	A
P98095	LB/B	-	A0A1A8RHD2	45	I	V
P98095	LB/B	-	A0A1A8RHD2	144	H	R
Q53RD9	LB/B	-	A0A2Y9QB27	119	V	M
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	111	C	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	122	R	C
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	129	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	166	C	F
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	166	C	S
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	217	W	G
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	476	C	G
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	490	D	Y
P35555	LP/P	Ectopia lentis 1, isolated, autosomal dominant (ECTOL1) [MIM:129600]	A0A060XAT7	545	R	C
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	545	R	C
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	548	N	I
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	587	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	627	R	C
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	661	C	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	705	A	T
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	711	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	723	D	A
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	746	Y	C
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	750	C	G
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	862	C	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	926	C	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	984	V	I
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	996	C	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1013	G	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1023	K	N
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1043	K	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1048	I	T
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1053	C	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1055	C	G
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1072	D	G
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1073	E	K
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1074	C	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1086	C	W
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1117	C	G
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1117	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1127	G	S
P35555	LB/B	-	A0A060XAT7	1131	N	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1137	R	P
P35555	LB/B	-	A0A060XAT7	1148	P	A
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1153	C	Y
P35555	LP/P	Ectopia lentis 1, isolated, autosomal dominant (ECTOL1) [MIM:129600]	A0A060XAT7	1155	D	N
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1155	D	N
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1170	R	H
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1171	C	W
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1173	N	K
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1223	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1242	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1249	C	S
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1382	N	S
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1404	D	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1513	C	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1589	C	F
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1610	C	G
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1663	C	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1837	P	S
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1893	N	K
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1928	C	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2099	C	W
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2111	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2127	D	E
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2144	N	S
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2151	C	W
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2221	C	S
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2258	C	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2282	R	W
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2307	C	S
P35555	LP/P	Ectopia lentis 1, isolated, autosomal dominant (ECTOL1) [MIM:129600]	A0A060XAT7	2447	E	K
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2447	E	K
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2489	C	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2511	C	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2623	H	P
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2627	G	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2680	R	C
P35555	LP/P	-	A0A060XAT7	2726	R	W
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	504	C	F
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1129	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1261	Y	C
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1833	C	S
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2142	C	Y
P35555	LB/B	-	A0A060XAT7	27	A	T
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	62	R	C
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	89	C	F
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	114	R	C
P35555	LP/P	Ectopia lentis 1, isolated, autosomal dominant (ECTOL1) [MIM:129600]	A0A060XAT7	115	S	C
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	154	C	S
P35555	LP/P	Ectopia lentis 1, isolated, autosomal dominant (ECTOL1) [MIM:129600]	A0A060XAT7	240	R	C
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	240	R	C
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	366	W	C
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	560	G	S
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	570	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	592	G	D
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	596	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	598	C	W
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	652	C	S
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	654	D	N
P35555	LP/P	Ectopia lentis 1, isolated, autosomal dominant (ECTOL1) [MIM:129600]	A0A060XAT7	661	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	681	S	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	683	C	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	685	C	W
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	723	D	V
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	734	C	F
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	748	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	776	C	G
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	776	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	781	C	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	816	C	S
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	890	C	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	908	C	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	913	E	G
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	921	C	G
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	985	G	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1044	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1055	C	W
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1055	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1101	Y	C
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1200	E	G
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1325	E	Q
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1337	A	P
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1339	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1366	E	K
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1374	C	S
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1389	C	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1424	P	A
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1429	C	S
P35555	LP/P	Ectopia lentis 1, isolated, autosomal dominant (ECTOL1) [MIM:129600]	A0A060XAT7	1530	R	C
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1530	R	C
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1564	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1770	C	F
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1790	R	P
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1791	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1793	C	W
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1796	G	E
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1806	C	S
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1835	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1909	I	T
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1915	R	S
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1971	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1977	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1998	C	Y
P35555	LB/B	-	A0A060XAT7	2101	T	M
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2111	C	R
P35555	LP/P	Ectopia lentis 1, isolated, autosomal dominant (ECTOL1) [MIM:129600]	A0A060XAT7	2154	P	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2221	C	G
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2223	N	H
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2269	I	T
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2335	R	W
P35555	LP/P	Ectopia lentis 1, isolated, autosomal dominant (ECTOL1) [MIM:129600]	A0A060XAT7	2339	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2406	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2442	C	W
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2474	Y	C
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2581	C	F
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2585	I	T
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2624	N	K
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2652	C	G
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2668	G	C
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	985	G	E
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1265	C	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	20	Y	C
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	123	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	177	C	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	224	C	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	439	R	G
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	541	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	635	Y	C
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	636	R	I
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	781	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	832	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	890	C	G
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1058	G	D
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1113	D	V
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1153	C	S
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1219	Y	C
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1261	Y	D
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1278	C	S
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1284	C	G
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1333	C	S
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1402	C	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1424	P	S
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1475	G	E
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1475	G	S
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1564	C	F
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1576	M	T
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1631	C	G
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1663	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1791	C	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1806	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1876	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1887	T	I
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1895	C	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1900	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1928	C	G
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1928	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2038	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2085	C	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2160	A	P
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2221	C	F
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2251	C	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2385	A	T
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2500	C	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2500	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2535	C	W
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2536	G	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2570	E	K
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2571	C	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2592	C	S
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2605	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2610	E	K
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2629	Y	C
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2663	C	S
P35555	LB/B	-	A0A060XAT7	133	H	Q
P35555	LB/B	-	A0A060XAT7	329	I	T
P35555	LB/B	-	A0A060XAT7	363	G	S
P35555	LB/B	-	A0A060XAT7	1048	I	V
P35555	LB/B	-	A0A060XAT7	1113	D	G
P35555	LB/B	-	A0A060XAT7	1282	N	S
P35555	LB/B	-	A0A060XAT7	1672	C	F
P35555	LB/B	-	A0A060XAT7	2018	V	I
P35555	LB/B	-	A0A060XAT7	2053	C	F
P35555	LB/B	-	A0A060XAT7	2113	Y	F
P35555	LB/B	-	A0A060XAT7	2170	C	F
P35555	LB/B	-	A0A060XAT7	2278	P	S
P35555	LB/B	-	A0A060XAT7	2329	D	E
P35555	LB/B	-	A0A060XAT7	472	Y	C
P35555	LP/P	Stiff skin syndrome (SSKS) [MIM:184900]	A0A060XAT7	1564	C	S
P35555	LP/P	Stiff skin syndrome (SSKS) [MIM:184900]	A0A060XAT7	1570	W	C
P35555	LP/P	Stiff skin syndrome (SSKS) [MIM:184900]	A0A060XAT7	1577	C	G
P35555	LP/P	Stiff skin syndrome (SSKS) [MIM:184900]	A0A060XAT7	1594	G	D
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1068	C	G
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	80	C	G
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	499	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	611	C	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	617	C	G
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	685	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	790	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	811	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	853	C	S
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	926	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1090	P	S
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1185	G	D
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1284	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1350	C	F
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1401	T	A
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1431	C	W
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1431	C	Y
P35555	LB/B	-	A0A060XAT7	1481	S	G
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1487	D	A
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1489	N	K
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1838	G	C
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1934	C	S
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1976	E	G
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1984	C	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2166	D	N
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2185	I	T
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2247	D	G
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2318	C	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2442	C	S
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2646	C	R
P35555	LP/P	-	A0A060XAT7	2793	Y	H
P35555	LP/P	Geleophysic dysplasia 2 (GPHYSD2) [MIM:614185]	A0A060XAT7	1696	Y	C
P35555	LP/P	Acromicric dysplasia (ACMICD) [MIM:102370]	A0A060XAT7	1699	Y	C
P35555	LP/P	Geleophysic dysplasia 2 (GPHYSD2) [MIM:614185]	A0A060XAT7	1699	Y	C
P35555	LP/P	Geleophysic dysplasia 2 (GPHYSD2) [MIM:614185]	A0A060XAT7	1699	Y	D
P35555	LP/P	Acromicric dysplasia (ACMICD) [MIM:102370]	A0A060XAT7	1700	Y	C
P35555	LP/P	Geleophysic dysplasia 2 (GPHYSD2) [MIM:614185]	A0A060XAT7	1706	C	Y
P35555	LP/P	Acromicric dysplasia (ACMICD) [MIM:102370]	A0A060XAT7	1714	M	R
P35555	LP/P	Geleophysic dysplasia 2 (GPHYSD2) [MIM:614185]	A0A060XAT7	1719	C	W
P35555	LP/P	Acromicric dysplasia (ACMICD) [MIM:102370]	A0A060XAT7	1722	S	C
P35555	LP/P	Acromicric dysplasia (ACMICD) [MIM:102370]	A0A060XAT7	1726	G	V
P35555	LP/P	Acromicric dysplasia (ACMICD) [MIM:102370]	A0A060XAT7	1728	A	T
P35555	LP/P	Geleophysic dysplasia 2 (GPHYSD2) [MIM:614185]	A0A060XAT7	1728	A	T
P35555	LP/P	Geleophysic dysplasia 2 (GPHYSD2) [MIM:614185]	A0A060XAT7	1728	A	V
P35555	LP/P	Geleophysic dysplasia 2 (GPHYSD2) [MIM:614185]	A0A060XAT7	1733	C	Y
P35555	LP/P	Acromicric dysplasia (ACMICD) [MIM:102370]	A0A060XAT7	1750	S	R
P35555	LP/P	Acromicric dysplasia (ACMICD) [MIM:102370]	A0A060XAT7	1758	D	V
P35555	LP/P	Geleophysic dysplasia 2 (GPHYSD2) [MIM:614185]	A0A060XAT7	1762	G	S
P35555	LP/P	-	A0A060XAT7	39	A	P
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	55	G	E
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	57	N	D
P35555	LP/P	Ectopia lentis 1, isolated, autosomal dominant (ECTOL1) [MIM:129600]	A0A060XAT7	63	Y	C
P35555	LP/P	Ectopia lentis 1, isolated, autosomal dominant (ECTOL1) [MIM:129600]	A0A060XAT7	68	C	S
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	100	C	Y
P35555	LP/P	-	A0A060XAT7	127	G	D
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	136	C	S
P35555	LP/P	-	A0A060XAT7	160	C	R
P35555	LP/P	-	A0A060XAT7	164	N	S
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	177	C	S
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	177	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	214	G	S
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	219	H	Q
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	365	C	R
P35555	LP/P	Ectopia lentis 1, isolated, autosomal dominant (ECTOL1) [MIM:129600]	A0A060XAT7	365	C	W
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	449	V	I
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	474	C	W
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	488	C	R
P35555	LP/P	-	A0A060XAT7	504	C	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	546	C	W
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	576	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	582	C	R
P35555	LP/P	Ectopia lentis 1, isolated, autosomal dominant (ECTOL1) [MIM:129600]	A0A060XAT7	596	C	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	623	C	F
P35555	LP/P	Ectopia lentis 1, isolated, autosomal dominant (ECTOL1) [MIM:129600]	A0A060XAT7	634	S	P
P35555	LP/P	-	A0A060XAT7	652	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	684	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	699	C	S
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	721	G	C
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	727	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	816	C	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	828	F	C
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	880	G	S
P35555	LP/P	Ectopia lentis 1, isolated, autosomal dominant (ECTOL1) [MIM:129600]	A0A060XAT7	882	A	V
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	882	A	V
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	884	G	E
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	908	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	910	D	H
P35555	LP/P	-	A0A060XAT7	937	C	R
P35555	LP/P	-	A0A060XAT7	954	R	C
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	974	R	C
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	976	R	H
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1008	C	Y
P35555	LP/P	-	A0A060XAT7	1020	T	A
P35555	LP/P	-	A0A060XAT7	1028	D	G
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1032	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1042	G	S
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1074	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1088	N	I
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1117	C	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1130	H	P
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1138	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1158	E	G
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1182	C	W
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1199	D	A
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1223	C	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1249	C	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1265	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1307	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1320	C	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1326	C	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1346	F	L
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1402	C	Y
P35555	LP/P	-	A0A060XAT7	1406	D	G
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1427	Y	D
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1485	C	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1528	D	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1622	C	R
P35555	LP/P	-	A0A060XAT7	1633	C	S
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1642	D	G
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1672	C	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1672	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1674	C	G
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1720	C	Y
P35555	LP/P	-	A0A060XAT7	1777	C	F
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1793	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1796	G	V
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1811	E	K
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1812	C	R
P35555	LP/P	-	A0A060XAT7	1812	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1826	N	S
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1830	S	C
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1835	C	F
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1847	C	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1847	C	W
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1860	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1865	C	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1879	G	D
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1894	E	K
P35555	LP/P	-	A0A060XAT7	1907	N	S
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1908	T	I
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1919	G	D
P35555	LP/P	-	A0A060XAT7	1930	D	H
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1934	C	G
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1977	C	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1977	C	W
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	1987	G	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2084	C	W
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2084	C	Y
P35555	LP/P	-	A0A060XAT7	2105	E	K
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2118	I	M
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2130	E	K
P35555	LP/P	-	A0A060XAT7	2136	V	D
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2144	N	D
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2145	T	P
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2153	C	Y
P35555	LP/P	-	A0A060XAT7	2195	G	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2221	C	R
P35555	LP/P	-	A0A060XAT7	2224	T	P
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2232	C	Y
P35555	LP/P	-	A0A060XAT7	2234	V	M
P35555	LP/P	Ectopia lentis 1, isolated, autosomal dominant (ECTOL1) [MIM:129600]	A0A060XAT7	2250	E	G
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2258	C	Y
P35555	LP/P	Ectopia lentis 1, isolated, autosomal dominant (ECTOL1) [MIM:129600]	A0A060XAT7	2272	Y	C
P35555	LP/P	-	A0A060XAT7	2273	M	T
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2274	C	W
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2284	P	T
P35555	LP/P	-	A0A060XAT7	2289	C	W
P35555	LP/P	-	A0A060XAT7	2302	C	Y
P35555	LP/P	-	A0A060XAT7	2365	C	Y
P35555	LP/P	Ectopia lentis 1, isolated, autosomal dominant (ECTOL1) [MIM:129600]	A0A060XAT7	2448	C	R
P35555	LP/P	-	A0A060XAT7	2470	C	W
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2470	C	Y
P35555	LP/P	-	A0A060XAT7	2516	T	I
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2520	T	M
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2522	C	Y
P35555	LP/P	-	A0A060XAT7	2526	N	S
P35555	LP/P	-	A0A060XAT7	2541	C	F
P35555	LP/P	-	A0A060XAT7	2554	R	W
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2555	G	V
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2561	T	P
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2577	C	R
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2577	C	Y
P35555	LP/P	Marfan syndrome (MFS) [MIM:154700]	A0A060XAT7	2708	N	S
P35555	LP/P	Marfanoid-progeroid-lipodystrophy syndrome (MFLS) [MIM:616914]	A0A060XAT7	2741	I	T
P35555	LP/P	-	A0A060XAT7	2780	L	P
P35556	LB/B	-	A0A060XAT7	965	V	I
P35556	LP/P	Contractural arachnodactyly, congenital (CCA) [MIM:121050]	A0A060XAT7	1253	C	Y
P35556	LP/P	Contractural arachnodactyly, congenital (CCA) [MIM:121050]	A0A060XAT7	1434	C	S
P35556	LP/P	Contractural arachnodactyly, congenital (CCA) [MIM:121050]	A0A060XAT7	1115	D	H
P35556	LP/P	Contractural arachnodactyly, congenital (CCA) [MIM:121050]	A0A060XAT7	1142	C	F
P35556	LP/P	Contractural arachnodactyly, congenital (CCA) [MIM:121050]	A0A060XAT7	1253	C	W
P35556	LB/B	-	A0A060XAT7	2771	S	P
P35556	LP/P	Contractural arachnodactyly, congenital (CCA) [MIM:121050]	A0A060XAT7	391	E	K
P35556	LB/B	-	A0A060XAT7	2428	P	T
P35556	LB/B	-	A0A060XAT7	594	T	S
P35556	LB/B	-	A0A060XAT7	681	R	H
P35556	LP/P	Contractural arachnodactyly, congenital (CCA) [MIM:121050]	A0A060XAT7	1057	G	D
P35556	LP/P	Contractural arachnodactyly, congenital (CCA) [MIM:121050]	A0A060XAT7	1093	I	T
P35556	LP/P	Contractural arachnodactyly, congenital (CCA) [MIM:121050]	A0A060XAT7	1179	G	C
P35556	LP/P	Contractural arachnodactyly, congenital (CCA) [MIM:121050]	A0A060XAT7	1198	C	Y
P35556	LP/P	Contractural arachnodactyly, congenital (CCA) [MIM:121050]	A0A060XAT7	1240	C	R
P35556	LP/P	Contractural arachnodactyly, congenital (CCA) [MIM:121050]	A0A060XAT7	1257	C	W
P35556	LP/P	Contractural arachnodactyly, congenital (CCA) [MIM:121050]	A0A060XAT7	1268	C	R
P35556	LB/B	-	A0A060XAT7	1772	W	G
P35556	LB/B	-	A0A060XAT7	2266	F	L
P35556	LB/B	-	A0A060XAT7	2581	L	S
P35556	LB/B	-	A0A060XAT7	2278	T	M
P35556	LB/B	-	A0A060XAT7	2311	M	V
P35556	LB/B	-	A0A060XAT7	2580	S	L
P35556	LP/P	Contractural arachnodactyly, congenital (CCA) [MIM:121050]	A0A060XAT7	754	G	S
P35556	LP/P	Contractural arachnodactyly, congenital (CCA) [MIM:121050]	A0A060XAT7	1091	N	S
P35556	LP/P	Contractural arachnodactyly, congenital (CCA) [MIM:121050]	A0A060XAT7	1122	S	P
P35556	LP/P	Contractural arachnodactyly, congenital (CCA) [MIM:121050]	A0A060XAT7	1142	C	R
P35556	LP/P	Contractural arachnodactyly, congenital (CCA) [MIM:121050]	A0A060XAT7	1146	Y	C
P35556	LP/P	Contractural arachnodactyly, congenital (CCA) [MIM:121050]	A0A060XAT7	1156	C	F
P35556	LP/P	Contractural arachnodactyly, congenital (CCA) [MIM:121050]	A0A060XAT7	1161	E	K
P35556	LP/P	Contractural arachnodactyly, congenital (CCA) [MIM:121050]	A0A060XAT7	1246	C	F
P35556	LP/P	Contractural arachnodactyly, congenital (CCA) [MIM:121050]	A0A060XAT7	1384	C	F
P35556	LP/P	Contractural arachnodactyly, congenital (CCA) [MIM:121050]	A0A060XAT7	1384	C	Y
P35556	LP/P	Contractural arachnodactyly, congenital (CCA) [MIM:121050]	A0A060XAT7	1408	D	N
P35556	LP/P	Contractural arachnodactyly, congenital (CCA) [MIM:121050]	A0A060XAT7	1425	C	R
P35556	LP/P	Macular degeneration, early-onset (EOMD) [MIM:616118]	A0A060XAT7	1144	E	K
P35556	LP/P	Macular degeneration, early-onset (EOMD) [MIM:616118]	A0A060XAT7	1247	M	T
P35556	LP/P	Contractural arachnodactyly, congenital (CCA) [MIM:121050]	A0A060XAT7	1259	N	K
P35556	LB/B	-	A0A060XAT7	1381	H	N
P35556	LB/B	-	A0A060XAT7	1416	T	A
P35556	LB/B	-	A0A060XAT7	1438	E	K
P35556	LP/P	Contractural arachnodactyly, congenital (CCA) [MIM:121050]	A0A060XAT7	1406	C	R
P35556	LP/P	Contractural arachnodactyly, congenital (CCA) [MIM:121050]	A0A060XAT7	1257	C	R
Q75N90	LB/B	-	A0A060XAT7	119	G	A
Q75N90	LB/B	-	A0A060XAT7	473	R	Q
Q75N90	LB/B	-	A0A060XAT7	662	D	N
Q75N90	LB/B	-	A0A060XAT7	935	R	L
Q75N90	LB/B	-	A0A060XAT7	938	V	F
Q75N90	LB/B	-	A0A060XAT7	1083	R	W
Q75N90	LB/B	-	A0A060XAT7	1293	S	N
Q75N90	LB/B	-	A0A060XAT7	1326	V	I
Q75N90	LB/B	-	A0A060XAT7	1614	G	S
Q75N90	LB/B	-	A0A060XAT7	1806	R	Q
Q75N90	LB/B	-	A0A060XAT7	1869	N	K
Q75N90	LB/B	-	A0A060XAT7	1904	L	P
Q75N90	LB/B	-	A0A060XAT7	1958	P	H
Q75N90	LB/B	-	A0A060XAT7	2610	E	D
Q75N90	LB/B	-	A0A060XAT7	329	P	L
Q75N90	LB/B	-	A0A060XAT7	371	M	I
Q75N90	LB/B	-	A0A060XAT7	542	V	I
Q75N90	LB/B	-	A0A060XAT7	868	D	N
Q75N90	LB/B	-	A0A060XAT7	1209	Q	R
Q75N90	LB/B	-	A0A060XAT7	1293	S	G
Q75N90	LB/B	-	A0A060XAT7	1431	N	I
Q75N90	LB/B	-	A0A060XAT7	1850	E	K
Q75N90	LB/B	-	A0A060XAT7	1904	L	F
Q75N90	LB/B	-	A0A060XAT7	1939	T	N
Q75N90	LB/B	-	A0A060XAT7	1966	H	D
Q75N90	LB/B	-	A0A060XAT7	2005	N	T
Q75N90	LB/B	-	A0A060XAT7	2314	S	N
Q75N90	LB/B	-	A0A060XAT7	2471	R	H
Q75N90	LB/B	-	A0A060XAT7	2540	H	Q
Q75N90	LB/B	-	A0A060XAT7	2594	V	I
P09467	LP/P	Fructose-1,6-bisphosphatase deficiency (FBP1D) [MIM:229700]	A0A2K6QKP4	164	G	S
P09467	LP/P	Fructose-1,6-bisphosphatase deficiency (FBP1D) [MIM:229700]	A0A2K6QKP4	177	A	D
P09467	LB/B	-	A0A2K6QKP4	325	V	A
P09467	LB/B	-	A0A2K6QKP4	218	R	K
P09467	LB/B	-	A0A2K6QKP4	233	F	I
P09467	LB/B	-	A0A2K6QKP4	255	R	L
P09467	LP/P	Fructose-1,6-bisphosphatase deficiency (FBP1D) [MIM:229700]	A0A2K6QKP4	194	F	S
P09467	LP/P	Fructose-1,6-bisphosphatase deficiency (FBP1D) [MIM:229700]	A0A2K6QKP4	284	P	R
O00757	LB/B	-	A0A2K6QKP4	86	V	L
O00757	LP/P	Leukodystrophy, childhood-onset, remitting (CORLK) [MIM:619864]	A0A2K6QKP4	115	V	M
Q9HCM7	LB/B	-	E1BD01	367	L	P
Q8NEE6	LB/B	-	L8IJP6	74	I	M
Q8NEE6	LB/B	-	L8IJP6	313	G	A
Q8NEE6	LB/B	-	L8IJP6	535	I	V
Q8NEE6	LB/B	-	L8IJP6	565	Y	C
Q8NEE6	LB/B	-	L8IJP6	692	D	G
Q8N461	LB/B	-	A0A2D0PUJ5	429	L	P
Q96ME1	LB/B	-	I3J527	552	N	K
Q9UKT6	LB/B	-	A0A1S3AD35	76	F	L
Q9UKT6	LB/B	-	A0A1S3AD35	209	P	L
Q9UKT7	LP/P	Intellectual developmental disorder with short stature, facial anomalies, and speech defects (IDDSFAS) [MIM:606220]	L9LCZ5	358	C	R
Q8N531	LB/B	-	A0A2Y9LVQ7	496	G	S
Q9UK96	LB/B	-	A0A091LL11	212	H	N
Q9UK96	LB/B	-	A0A091LL11	44	R	H
Q9UK96	LB/B	-	A0A091LL11	825	R	W
Q86XK2	LB/B	-	A0A1D2N499	126	T	S
Q86XK2	LB/B	-	A0A1D2N499	206	Y	C
Q86XK2	LB/B	-	A0A1D2N499	715	K	N
Q86XK2	LP/P	Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities (IDDFBA) [MIM:618089]	A0A1D2N499	138	R	S
Q86XK2	LP/P	Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities (IDDFBA) [MIM:618089]	A0A1D2N499	156	Q	R
Q86XK2	LP/P	Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities (IDDFBA) [MIM:618089]	A0A1D2N499	538	I	V
Q86XK2	LP/P	Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities (IDDFBA) [MIM:618089]	A0A1D2N499	623	T	R
Q86XK2	LP/P	Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities (IDDFBA) [MIM:618089]	A0A1D2N499	840	S	P
Q86XK2	LP/P	Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities (IDDFBA) [MIM:618089]	A0A1D2N499	892	A	D
Q86XK2	LP/P	Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities (IDDFBA) [MIM:618089]	A0A1D2N499	905	P	R
Q86XK2	LP/P	Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities (IDDFBA) [MIM:618089]	A0A1D2N499	910	D	G
Q8NCQ5	LB/B	-	K7F591	496	Y	H
O75426	LB/B	-	A0A151M8W0	302	R	H
Q8TCJ0	LB/B	-	F6PGM4	36	N	D
Q8TCJ0	LB/B	-	F6PGM4	38	R	H
Q9UK99	LB/B	-	F1SGR6	221	V	I
Q8TB52	LB/B	-	H2QTV7	583	H	Q
Q8TB52	LB/B	-	H2QTV7	375	V	M
Q8TB52	LB/B	-	H2QTV7	382	S	C
Q969P5	LB/B	-	A0A2R8MIH7	56	N	S
Q969P5	LB/B	-	A0A2R8MIH7	89	G	A
Q969P5	LP/P	-	A0A2R8MIH7	243	G	R
Q9NWN3	LB/B	-	G1U8U8	470	I	N
Q9NWN3	LB/B	-	G1U8U8	533	L	P
Q9NWN3	LB/B	-	G1U8U8	432	V	A
Q9NWN3	LB/B	-	G1U8U8	704	G	V
Q8NEA4	LB/B	-	A0A2U4ADE6	86	L	F
Q6PIJ6	LB/B	-	A0A2D0RI34	592	S	P
Q6PIJ6	LB/B	-	A0A2D0RI34	894	A	T
Q6PIJ6	LP/P	Neuronopathy, distal hereditary motor, 2D (HMN2D) [MIM:615575]	A0A2D0RI34	206	C	R
Q8N4B4	LB/B	-	A0A2U4AN69	10	P	S
Q8N4B4	LB/B	-	A0A2U4AN69	231	L	F
Q8N4B4	LB/B	-	A0A2U4AN69	363	I	M
Q8N4B4	LB/B	-	A0A2U4AN69	166	Y	C
Q8N4B4	LB/B	-	A0A2U4AN69	221	S	T
Q9UH90	LB/B	-	F6SX77	87	V	A
Q6P3S6	LB/B	-	C3XQ14	471	P	A
Q4G163	LB/B	-	A0A2Y9P239	139	P	L
Q4G163	LB/B	-	A0A2Y9P239	139	P	R
Q5MNV8	LB/B	-	F6X1T6	209	Q	R
Q5FWF7	LB/B	-	E1C0I6	16	T	I
Q9UKT4	LB/B	-	G1PBE7	107	Q	E
Q9UKT4	LB/B	-	G1PBE7	164	L	F
Q9NRD1	LB/B	-	G5C512	201	P	T
Q9NRD1	LB/B	-	G5C512	60	R	Q
Q9Y3I1	LB/B	-	A0A2Y9GVE9	115	M	I
Q9Y3I1	LP/P	Parkinson disease 15 (PARK15) [MIM:260300]	A0A2Y9GVE9	378	R	G
Q9Y3I1	LB/B	-	A0A2Y9GVE9	481	R	C
Q9NRD0	LB/B	-	A0A151PAW6	51	I	M
Q9NRD0	LB/B	-	A0A151PAW6	156	Y	H
Q5XX13	LB/B	-	M3XW60	23	I	N
Q5XX13	LB/B	-	M3XW60	821	A	T
Q5XX13	LB/B	-	M3XW60	372	R	G
Q9UKB1	LP/P	Neurodevelopmental, jaw, eye, and digital syndrome (NEDJED) [MIM:618914]	A0A0F8CA48	242	G	R
Q9UKB1	LP/P	Neurodevelopmental, jaw, eye, and digital syndrome (NEDJED) [MIM:618914]	A0A0F8CA48	363	R	W
Q9UKB1	LP/P	Neurodevelopmental, jaw, eye, and digital syndrome (NEDJED) [MIM:618914]	A0A0F8CA48	364	A	D
Q9UKB1	LP/P	Neurodevelopmental, jaw, eye, and digital syndrome (NEDJED) [MIM:618914]	A0A0F8CA48	365	A	T
Q9UKB1	LP/P	Neurodevelopmental, jaw, eye, and digital syndrome (NEDJED) [MIM:618914]	A0A0F8CA48	444	E	K
Q9UKB1	LP/P	Neurodevelopmental, jaw, eye, and digital syndrome (NEDJED) [MIM:618914]	A0A0F8CA48	447	R	L
Q9UKB1	LP/P	Neurodevelopmental, jaw, eye, and digital syndrome (NEDJED) [MIM:618914]	A0A0F8CA48	447	R	Q
Q6X9E4	LB/B	-	I3N5U6	6	P	L
Q6X9E4	LB/B	-	I3N5U6	166	R	W
Q6X9E4	LB/B	-	I3N5U6	273	V	D
Q969U6	LB/B	-	A0A2I4BUS1	340	E	K
Q969H0	LB/B	-	F6YR23	115	E	K
Q969H0	LB/B	-	F6YR23	133	R	G
Q969H0	LB/B	-	F6YR23	144	T	R
Q969H0	LB/B	-	F6YR23	668	S	G
Q969H0	LP/P	Developmental delay, hypotonia, and impaired language (DEDHIL) [MIM:620012]	F6YR23	465	R	H
Q969H0	LP/P	Developmental delay, hypotonia, and impaired language (DEDHIL) [MIM:620012]	F6YR23	416	T	A
Q969H0	LP/P	Developmental delay, hypotonia, and impaired language (DEDHIL) [MIM:620012]	F6YR23	416	T	I
Q969H0	LP/P	Developmental delay, hypotonia, and impaired language (DEDHIL) [MIM:620012]	F6YR23	420	H	L
Q969H0	LP/P	Developmental delay, hypotonia, and impaired language (DEDHIL) [MIM:620012]	F6YR23	423	G	R
Q969H0	LP/P	Developmental delay, hypotonia, and impaired language (DEDHIL) [MIM:620012]	F6YR23	441	R	G
Q969H0	LP/P	Developmental delay, hypotonia, and impaired language (DEDHIL) [MIM:620012]	F6YR23	462	S	P
Q969H0	LP/P	Developmental delay, hypotonia, and impaired language (DEDHIL) [MIM:620012]	F6YR23	479	R	Q
Q969H0	LP/P	Developmental delay, hypotonia, and impaired language (DEDHIL) [MIM:620012]	F6YR23	480	D	G
Q969H0	LP/P	Developmental delay, hypotonia, and impaired language (DEDHIL) [MIM:620012]	F6YR23	505	R	H
Q969H0	LP/P	Developmental delay, hypotonia, and impaired language (DEDHIL) [MIM:620012]	F6YR23	544	V	G
Q969H0	LP/P	Developmental delay, hypotonia, and impaired language (DEDHIL) [MIM:620012]	F6YR23	580	H	Y
Q969H0	LP/P	Developmental delay, hypotonia, and impaired language (DEDHIL) [MIM:620012]	F6YR23	582	S	A
Q969H0	LP/P	Developmental delay, hypotonia, and impaired language (DEDHIL) [MIM:620012]	F6YR23	599	A	V
Q969H0	LP/P	Developmental delay, hypotonia, and impaired language (DEDHIL) [MIM:620012]	F6YR23	626	A	V
Q969H0	LP/P	Developmental delay, hypotonia, and impaired language (DEDHIL) [MIM:620012]	F6YR23	640	S	R
Q969H0	LP/P	Developmental delay, hypotonia, and impaired language (DEDHIL) [MIM:620012]	F6YR23	674	R	P
Q969H0	LP/P	Developmental delay, hypotonia, and impaired language (DEDHIL) [MIM:620012]	F6YR23	674	R	W
Q969H0	LP/P	Developmental delay, hypotonia, and impaired language (DEDHIL) [MIM:620012]	F6YR23	689	R	Q
Q969H0	LP/P	Developmental delay, hypotonia, and impaired language (DEDHIL) [MIM:620012]	F6YR23	689	R	W
Q8N3Y1	LB/B	-	H2L5P8	211	T	A
Q8N3Y1	LB/B	-	H2L5P8	536	T	M
Q8N3Y1	LB/B	-	H2L5P8	192	R	Q
Q8N3Y1	LB/B	-	H2L5P8	563	V	M
P12319	LB/B	-	A0A2J8K5T8	84	K	R
P12319	LB/B	-	A0A2J8K5T8	101	S	N
Q9Y6R7	LB/B	-	H2NYU0	1340	V	L
Q9Y6R7	LB/B	-	H2NYU0	1616	G	V
Q9Y6R7	LB/B	-	H2NYU0	1617	M	V
Q9Y6R7	LB/B	-	H2NYU0	2089	N	D
Q9Y6R7	LB/B	-	H2NYU0	2646	E	D
Q9Y6R7	LB/B	-	H2NYU0	2647	E	K
Q9Y6R7	LB/B	-	H2NYU0	2793	A	V
Q9Y6R7	LB/B	-	H2NYU0	2814	V	A
Q9Y6R7	LB/B	-	H2NYU0	3264	G	S
Q9Y6R7	LB/B	-	H2NYU0	3920	H	Q
Q9Y6R7	LB/B	-	H2NYU0	4015	V	A
Q9Y6R7	LB/B	-	H2NYU0	4095	G	D
Q9Y6R7	LB/B	-	H2NYU0	4465	G	S
Q9Y6R7	LB/B	-	H2NYU0	4906	D	H
Q9Y6R7	LB/B	-	H2NYU0	732	V	A
Q9Y6R7	LB/B	-	H2NYU0	770	N	S
Q9Y6R7	LB/B	-	H2NYU0	929	G	R
Q9Y6R7	LB/B	-	H2NYU0	971	V	M
Q9Y6R7	LB/B	-	H2NYU0	1019	G	R
Q9Y6R7	LB/B	-	H2NYU0	1436	P	L
Q9Y6R7	LB/B	-	H2NYU0	1445	H	D
Q9Y6R7	LB/B	-	H2NYU0	1524	T	N
Q9Y6R7	LB/B	-	H2NYU0	5017	A	V
P12314	LB/B	-	G1PIK2	105	L	P
P12318	LB/B	-	A0A2K6KH16	167	H	R
P12318	LB/B	-	A0A2K6KH16	63	Q	R
P12318	LB/B	-	A0A2K6KH16	140	M	V
P12318	LB/B	-	A0A2K6KH16	218	I	V
P08637	LB/B	-	A0A2K6D7M8	176	F	V
P08637	LB/B	-	A0A2K6D7M8	66	L	R
P08637	LP/P	Immunodeficiency 20 (IMD20) [MIM:615707]	A0A2K6D7M8	66	L	H
P08637	LB/B	-	A0A2K6D7M8	147	G	D
P08637	LB/B	-	A0A2K6D7M8	158	Y	H
P08637	LB/B	-	A0A2K6D7M8	203	F	S
O75015	LB/B	-	A0A2K6D7M8	36	S	R
O75015	LB/B	-	A0A2K6D7M8	82	N	D
O75015	LB/B	-	A0A2K6D7M8	65	S	N
O75015	LB/B	-	A0A2K6D7M8	106	I	V
O75015	LB/B	-	A0A2K6D7M8	78	A	D
O14526	LP/P	Immunodeficiency 76 (IMD76) [MIM:619164]	V9KHS2	34	A	P
O14526	LP/P	Immunodeficiency 76 (IMD76) [MIM:619164]	V9KHS2	679	R	P
Q0JRZ9	LB/B	-	V9KHS2	371	M	V
Q96LA6	LB/B	-	A0A2K6TJA1	124	V	M
Q96LA5	LB/B	-	A0A2K6KDS5	202	I	N
Q96P31	LB/B	-	A0A1U7T5X0	28	N	D
Q96P31	LB/B	-	A0A1U7T5X0	307	L	F
Q96P31	LB/B	-	A0A1U7T5X0	660	P	L
Q96P31	LB/B	-	A0A1U7T5X0	721	N	S
Q96PJ5	LB/B	-	A0A212CHH6	60	R	Q
Q96PJ5	LB/B	-	A0A212CHH6	255	N	S
Q96PJ5	LB/B	-	A0A212CHH6	457	K	R
Q96PJ5	LB/B	-	A0A212CHH6	493	Y	C
Q96RD9	LB/B	-	A0A1U7T5X0	267	Y	H
Q96RD9	LB/B	-	A0A1U7T5X0	269	V	I
Q96RD9	LB/B	-	A0A1U7T5X0	418	G	D
Q96RD9	LB/B	-	A0A1U7T5X0	466	V	I
Q96RD9	LB/B	-	A0A1U7T5X0	427	N	K
Q96RD9	LB/B	-	A0A1U7T5X0	457	Q	R
Q7L513	LB/B	-	A0A1U7V3T8	349	R	Q
Q8N0W3	LB/B	-	A0A091IFQ5	146	V	M
Q8N0W3	LB/B	-	A0A091IFQ5	521	A	T
Q8N0W3	LB/B	-	A0A091IFQ5	571	R	H
Q8N0W3	LB/B	-	A0A091IFQ5	701	P	L
Q8N0W3	LB/B	-	A0A091IFQ5	858	A	T
Q8N0W3	LB/B	-	A0A091IFQ5	861	V	M
Q8N0W3	LB/B	-	A0A091IFQ5	901	R	W
Q8N0W3	LB/B	-	A0A091IFQ5	939	R	Q
Q8N0W3	LB/B	-	A0A091IFQ5	939	R	W
P14324	LB/B	-	A0A091CYM3	391	I	V
P14324	LB/B	-	A0A091CYM3	364	V	A
P14324	LP/P	Porokeratosis 9, multiple types (POROK9) [MIM:616631]	A0A091CYM3	179	R	Q
Q6P4F2	LP/P	Mitochondrial myopathy, episodic, with optic atrophy and reversible leukoencephalopathy (MEOAL) [MIM:251900]	L8YFZ7	144	P	L
P22570	LB/B	-	A0A2Y9GBW8	123	R	Q
P22570	LB/B	-	A0A2Y9GBW8	7	R	L
P22570	LB/B	-	A0A2Y9GBW8	213	G	V
P22570	LB/B	-	A0A2Y9GBW8	248	P	L
P22570	LB/B	-	A0A2Y9GBW8	251	R	W
P22570	LB/B	-	A0A2Y9GBW8	301	R	C
P22570	LB/B	-	A0A2Y9GBW8	345	T	M
P22570	LB/B	-	A0A2Y9GBW8	352	P	S
P22570	LB/B	-	A0A2Y9GBW8	472	T	A
P22570	LP/P	Auditory neuropathy and optic atrophy (ANOA) [MIM:617717]	A0A2Y9GBW8	215	L	V
P22570	LP/P	Auditory neuropathy and optic atrophy (ANOA) [MIM:617717]	A0A2Y9GBW8	242	R	W
P22570	LP/P	Auditory neuropathy and optic atrophy (ANOA) [MIM:617717]	A0A2Y9GBW8	306	R	C
P22570	LP/P	Auditory neuropathy and optic atrophy (ANOA) [MIM:617717]	A0A2Y9GBW8	327	R	S
P22830	LP/P	Protoporphyria, erythropoietic, 1 (EPP1) [MIM:177000]	A0A2K5UGZ8	55	G	C
P22830	LP/P	Protoporphyria, erythropoietic, 1 (EPP1) [MIM:177000]	A0A2K5UGZ8	186	I	T
P22830	LP/P	Protoporphyria, erythropoietic, 1 (EPP1) [MIM:177000]	A0A2K5UGZ8	267	M	I
P22830	LP/P	Protoporphyria, erythropoietic, 1 (EPP1) [MIM:177000]	A0A2K5UGZ8	386	H	P
P22830	LP/P	Protoporphyria, erythropoietic, 1 (EPP1) [MIM:177000]	A0A2K5UGZ8	417	F	S
P22830	LB/B	-	A0A2K5UGZ8	96	R	Q
P22830	LP/P	Protoporphyria, erythropoietic, 1 (EPP1) [MIM:177000]	A0A2K5UGZ8	62	P	R
P22830	LP/P	Protoporphyria, erythropoietic, 1 (EPP1) [MIM:177000]	A0A2K5UGZ8	71	I	K
P22830	LP/P	Protoporphyria, erythropoietic, 1 (EPP1) [MIM:177000]	A0A2K5UGZ8	139	Q	L
P22830	LP/P	Protoporphyria, erythropoietic, 1 (EPP1) [MIM:177000]	A0A2K5UGZ8	151	S	P
P22830	LP/P	Protoporphyria, erythropoietic, 1 (EPP1) [MIM:177000]	A0A2K5UGZ8	178	E	K
P22830	LP/P	Protoporphyria, erythropoietic, 1 (EPP1) [MIM:177000]	A0A2K5UGZ8	182	L	R
P22830	LP/P	Protoporphyria, erythropoietic, 1 (EPP1) [MIM:177000]	A0A2K5UGZ8	191	Y	H
P22830	LP/P	Protoporphyria, erythropoietic, 1 (EPP1) [MIM:177000]	A0A2K5UGZ8	192	P	T
P22830	LP/P	Protoporphyria, erythropoietic, 1 (EPP1) [MIM:177000]	A0A2K5UGZ8	236	C	Y
P22830	LP/P	Protoporphyria, erythropoietic, 1 (EPP1) [MIM:177000]	A0A2K5UGZ8	260	F	L
P22830	LP/P	Protoporphyria, erythropoietic, 1 (EPP1) [MIM:177000]	A0A2K5UGZ8	283	T	I
P22830	LP/P	Protoporphyria, erythropoietic, 1 (EPP1) [MIM:177000]	A0A2K5UGZ8	288	M	K
P22830	LP/P	Protoporphyria, erythropoietic, 1 (EPP1) [MIM:177000]	A0A2K5UGZ8	334	P	L
P22830	LP/P	Protoporphyria, erythropoietic, 1 (EPP1) [MIM:177000]	A0A2K5UGZ8	362	V	G
P22830	LP/P	Protoporphyria, erythropoietic, 1 (EPP1) [MIM:177000]	A0A2K5UGZ8	379	K	N
P22830	LP/P	Protoporphyria, erythropoietic, 1 (EPP1) [MIM:177000]	A0A2K5UGZ8	406	C	S
P22830	LP/P	Protoporphyria, erythropoietic, 1 (EPP1) [MIM:177000]	A0A2K5UGZ8	406	C	Y
P22830	LP/P	Protoporphyria, erythropoietic, 1 (EPP1) [MIM:177000]	A0A2K5UGZ8	264	S	L
Q96JP0	LP/P	-	A0A250YKB7	126	D	H
P16591	LB/B	-	A0A151PI67	439	L	V
P16591	LB/B	-	A0A151PI67	128	V	F
P16591	LB/B	-	A0A151PI67	412	M	V
P16591	LB/B	-	A0A151PI67	443	A	P
P16591	LB/B	-	A0A151PI67	813	E	Q
P16591	LB/B	-	A0A151PI67	507	I	T
A0AVI2	LB/B	-	M7BWA8	354	I	T
A0AVI2	LB/B	-	M7BWA8	687	T	A
Q2WGJ9	LB/B	-	F6YX48	1110	D	E
Q9BQL6	LB/B	-	Q6DJA9	526	R	K
Q9BQL6	LB/B	-	Q6DJA9	534	A	T
Q9BQL6	LB/B	-	Q6DJA9	160	I	T
Q9BQL6	LB/B	-	Q6DJA9	241	V	A
Q9BQL6	LP/P	Kindler syndrome (KNDLRS) [MIM:173650]	Q6DJA9	400	S	P
Q9BQL6	LP/P	Kindler syndrome (KNDLRS) [MIM:173650]	Q6DJA9	559	W	R
P07332	LB/B	-	G1NDE7	85	R	C
P07332	LB/B	-	G1NDE7	246	R	Q
P07332	LB/B	-	G1NDE7	323	M	V
Q99689	LB/B	-	A0A091DGW8	123	D	E
Q9UHY8	LB/B	-	G1S1W2	50	P	L
Q9UHY8	LB/B	-	G1S1W2	329	R	C
Q8TBJ5	LB/B	-	A0A2R8N5Z1	164	P	T
Q8TBJ5	LB/B	-	A0A2R8N5Z1	250	S	W
Q8TBJ5	LB/B	-	A0A2R8N5Z1	188	G	D
O14842	LB/B	-	A0A151MUN5	211	R	H
O15552	LB/B	-	A0A2F0BKT2	211	L	H
O14843	LB/B	-	A0A2U3YGS2	44	Q	R
O14843	LB/B	-	A0A2U3YGS2	45	R	C
O14843	LB/B	-	A0A2U3YGS2	174	R	W
O14843	LB/B	-	A0A2U3YGS2	227	L	V
O14843	LB/B	-	A0A2U3YGS2	256	A	V
O14843	LB/B	-	A0A2U3YGS2	346	S	N
P02671	LB/B	-	A0A2K5VSR8	26	D	N
P02671	LB/B	-	A0A2K5VSR8	31	G	V
P02671	LP/P	Dysfibrinogenemia, congenital (DYSFIBRIN) [MIM:616004]	A0A2K5VSR8	35	R	C
P02671	LB/B	-	A0A2K5VSR8	35	R	H
P02671	LB/B	-	A0A2K5VSR8	37	P	L
P02671	LB/B	-	A0A2K5VSR8	38	R	S
P02671	LB/B	-	A0A2K5VSR8	38	R	G
P02671	LB/B	-	A0A2K5VSR8	66	S	T
P02671	LB/B	-	A0A2K5VSR8	453	S	N
P02671	LP/P	Dysfibrinogenemia, congenital (DYSFIBRIN) [MIM:616004]	A0A2K5VSR8	573	R	C
P02671	LB/B	-	A0A2K5VSR8	39	V	D
P02671	LP/P	Amyloidosis 8 (AMYL8) [MIM:105200]	A0A2K5VSR8	545	E	V
P02671	LP/P	Amyloidosis 8 (AMYL8) [MIM:105200]	A0A2K5VSR8	573	R	L
P02671	LB/B	-	A0A2K5VSR8	6	I	V
P02671	LB/B	-	A0A2K5VSR8	331	T	A
P02671	LB/B	-	A0A2K5VSR8	456	T	A
P02671	LB/B	-	A0A2K5VSR8	446	K	E
P02671	LP/P	Congenital afibrinogenemia (CAFBN) [MIM:202400]	A0A2K5VSR8	55	C	R
P02671	LP/P	Congenital afibrinogenemia (CAFBN) [MIM:202400]	A0A2K5VSR8	129	R	P
P02671	LP/P	Congenital afibrinogenemia (CAFBN) [MIM:202400]	A0A2K5VSR8	184	C	W
P02675	LB/B	-	F7CST7	44	R	C
P02675	LB/B	-	F7CST7	74	R	C
P02675	LP/P	Dysfibrinogenemia, congenital (DYSFIBRIN) [MIM:616004]	F7CST7	98	A	T
P02675	LB/B	-	F7CST7	365	A	T
P02675	LB/B	-	F7CST7	478	R	K
P02675	LB/B	-	F7CST7	100	P	S
P02675	LB/B	-	F7CST7	170	N	H
P02675	LB/B	-	F7CST7	265	P	L
P02675	LB/B	-	F7CST7	2	K	E
P02675	LP/P	Congenital afibrinogenemia (CAFBN) [MIM:202400]	F7CST7	196	R	C
P02675	LP/P	Congenital afibrinogenemia (CAFBN) [MIM:202400]	F7CST7	383	L	R
P02675	LP/P	Congenital afibrinogenemia (CAFBN) [MIM:202400]	F7CST7	430	G	D
P02675	LP/P	Congenital afibrinogenemia (CAFBN) [MIM:202400]	F7CST7	202	L	Q
P02675	LP/P	Congenital afibrinogenemia (CAFBN) [MIM:202400]	F7CST7	95	C	R
P02675	LP/P	Congenital afibrinogenemia (CAFBN) [MIM:202400]	F7CST7	407	T	K
P98174	LP/P	Aarskog-Scott syndrome (AAS) [MIM:305400]	F7F4V1	522	R	H
P98174	LP/P	Aarskog-Scott syndrome (AAS) [MIM:305400]	F7F4V1	610	R	Q
P98174	LP/P	Aarskog-Scott syndrome (AAS) [MIM:305400]	F7F4V1	205	S	I
P98174	LB/B	-	F7F4V1	312	P	L
P98174	LP/P	Aarskog-Scott syndrome (AAS) [MIM:305400]	F7F4V1	380	E	A
P98174	LP/P	Aarskog-Scott syndrome (AAS) [MIM:305400]	F7F4V1	443	R	H
Q7Z6J4	LB/B	-	A0A2K5CJV8	32	Q	H
Q96M96	LP/P	Charcot-Marie-Tooth disease 4H (CMT4H) [MIM:609311]	A0A2K6GHB0	298	M	R
Q96M96	LP/P	Charcot-Marie-Tooth disease 4H (CMT4H) [MIM:609311]	A0A2K6GHB0	298	M	T
P05230	LB/B	-	A0A067R335	21	G	E
O15520	LP/P	Lacrimo-auriculo-dento-digital syndrome 3 (LADD3) [MIM:620193]	S4RK08	106	C	F
O15520	LP/P	Lacrimo-auriculo-dento-digital syndrome 3 (LADD3) [MIM:620193]	S4RK08	156	I	R
O60258	LP/P	Hypogonadotropic hypogonadism 20 with or without anosmia (HH20) [MIM:615270]	M7BBX3	108	I	T
O60258	LP/P	Hypogonadotropic hypogonadism 20 with or without anosmia (HH20) [MIM:615270]	M7BBX3	177	R	H
O60258	LP/P	Hypogonadotropic hypogonadism 20 with or without anosmia (HH20) [MIM:615270]	M7BBX3	187	N	S
Q9NP95	LB/B	-	W5PIL4	116	G	R
Q9NP95	LB/B	-	W5PIL4	175	P	A
Q9NP95	LB/B	-	W5PIL4	206	D	N
Q9GZV9	LP/P	Hypophosphatemic rickets, autosomal dominant (ADHR) [MIM:193100]	A0A2K6ESX2	176	R	Q
Q9GZV9	LP/P	Hypophosphatemic rickets, autosomal dominant (ADHR) [MIM:193100]	A0A2K6ESX2	179	R	W
Q9GZV9	LP/P	Hypophosphatemic rickets, autosomal dominant (ADHR) [MIM:193100]	A0A2K6ESX2	179	R	Q
Q9GZV9	LB/B	-	A0A2K6ESX2	239	T	M
Q9GZV9	LB/B	-	A0A2K6ESX2	195	P	S
Q9GZV9	LP/P	Tumoral calcinosis, hyperphosphatemic, familial, 2 (HFTC2) [MIM:617993]	A0A2K6ESX2	71	S	G
Q9GZV9	LP/P	Tumoral calcinosis, hyperphosphatemic, familial, 2 (HFTC2) [MIM:617993]	A0A2K6ESX2	96	M	T
Q9GZV9	LP/P	Tumoral calcinosis, hyperphosphatemic, familial, 2 (HFTC2) [MIM:617993]	A0A2K6ESX2	129	S	F
Q9GZV9	LP/P	Tumoral calcinosis, hyperphosphatemic, familial, 2 (HFTC2) [MIM:617993]	A0A2K6ESX2	157	F	L
P12034	LB/B	-	A0A091E5M9	54	M	V
P12034	LP/P	Trichomegaly (TCMGLY) [MIM:190330]	A0A091E5M9	174	Y	H
P10767	LB/B	-	Q9DFC9	36	V	A
P10767	LB/B	-	Q9DFC9	63	A	V
P10767	LB/B	-	Q9DFC9	174	D	V
P10767	LB/B	-	Q9DFC9	191	R	W
P21781	LB/B	-	A0A061I1H6	59	M	T
P21781	LB/B	-	A0A061I1H6	62	G	E
Q9BYJ0	LB/B	-	A0A1U7SYY2	90	P	S
Q9BYJ0	LB/B	-	A0A1U7SYY2	84	F	L
Q9BYJ0	LB/B	-	A0A1U7SYY2	28	S	N
Q8TAT2	LB/B	-	D2H3E0	206	E	V
Q8TAT2	LB/B	-	D2H3E0	107	A	T
P22607	LP/P	Bladder cancer (BLC) [MIM:109800]	F6VBA5	248	R	C
P22607	LP/P	Keratinocytic non-epidermolytic nevus (KNEN) [MIM:162900]	F6VBA5	248	R	C
P22607	LP/P	Keratosis, seborrheic (KERSEB) [MIM:182000]	F6VBA5	248	R	C
P22607	LP/P	Thanatophoric dysplasia 1 (TD1) [MIM:187600]	F6VBA5	248	R	C
P22607	LP/P	Bladder cancer (BLC) [MIM:109800]	F6VBA5	249	S	C
P22607	LP/P	Cervical cancer (CERCA) [MIM:603956]	F6VBA5	249	S	C
P22607	LP/P	Keratosis, seborrheic (KERSEB) [MIM:182000]	F6VBA5	249	S	C
P22607	LP/P	Thanatophoric dysplasia 1 (TD1) [MIM:187600]	F6VBA5	249	S	C
P22607	LP/P	Muenke syndrome (MNKS) [MIM:602849]	F6VBA5	250	P	R
P22607	LP/P	Bladder cancer (BLC) [MIM:109800]	F6VBA5	370	G	C
P22607	LP/P	Keratinocytic non-epidermolytic nevus (KNEN) [MIM:162900]	F6VBA5	370	G	C
P22607	LP/P	Keratosis, seborrheic (KERSEB) [MIM:182000]	F6VBA5	370	G	C
P22607	LP/P	Thanatophoric dysplasia 1 (TD1) [MIM:187600]	F6VBA5	370	G	C
P22607	LP/P	Keratosis, seborrheic (KERSEB) [MIM:182000]	F6VBA5	371	S	C
P22607	LP/P	Thanatophoric dysplasia 1 (TD1) [MIM:187600]	F6VBA5	371	S	C
P22607	LP/P	Keratosis, seborrheic (KERSEB) [MIM:182000]	F6VBA5	373	Y	C
P22607	LP/P	Thanatophoric dysplasia 1 (TD1) [MIM:187600]	F6VBA5	373	Y	C
P22607	LP/P	Achondroplasia (ACH) [MIM:100800]	F6VBA5	375	G	C
P22607	LP/P	Achondroplasia (ACH) [MIM:100800]	F6VBA5	380	G	R
P22607	LP/P	Keratinocytic non-epidermolytic nevus (KNEN) [MIM:162900]	F6VBA5	380	G	R
P22607	LP/P	Crouzon syndrome with acanthosis nigricans (CAN) [MIM:612247]	F6VBA5	391	A	E
P22607	LP/P	Hypochondroplasia (HCH) [MIM:146000]	F6VBA5	538	I	V
P22607	LP/P	Hypochondroplasia (HCH) [MIM:146000]	F6VBA5	540	N	K
P22607	LP/P	Hypochondroplasia (HCH) [MIM:146000]	F6VBA5	540	N	T
P22607	LP/P	Bladder cancer (BLC) [MIM:109800]	F6VBA5	650	K	E
P22607	LP/P	Keratosis, seborrheic (KERSEB) [MIM:182000]	F6VBA5	650	K	E
P22607	LP/P	Testicular germ cell tumor (TGCT) [MIM:273300]	F6VBA5	650	K	E
P22607	LP/P	Thanatophoric dysplasia 2 (TD2) [MIM:187601]	F6VBA5	650	K	E
P22607	LP/P	Achondroplasia (ACH) [MIM:100800]	F6VBA5	650	K	M
P22607	LP/P	Achondroplasia, severe, with developmental delay and acanthosis nigricans (SADDAN) [MIM:616482]	F6VBA5	650	K	M
P22607	LP/P	Keratosis, seborrheic (KERSEB) [MIM:182000]	F6VBA5	650	K	M
P22607	LP/P	Thanatophoric dysplasia 1 (TD1) [MIM:187600]	F6VBA5	650	K	M
P22607	LP/P	Hypochondroplasia (HCH) [MIM:146000]	F6VBA5	540	N	S
P22607	LP/P	Bladder cancer (BLC) [MIM:109800]	F6VBA5	650	K	Q
P22607	LP/P	Hypochondroplasia (HCH) [MIM:146000]	F6VBA5	650	K	Q
P22607	LB/B	-	F6VBA5	65	G	R
P22607	LB/B	-	F6VBA5	384	F	L
P22607	LB/B	-	F6VBA5	441	A	T
P22607	LB/B	-	F6VBA5	717	A	T
P22607	LB/B	-	F6VBA5	726	I	F
P22607	LP/P	Camptodactyly, tall stature, and hearing loss syndrome (CATSHLS) [MIM:610474]	F6VBA5	621	R	H
P22607	LB/B	-	F6VBA5	338	T	M
P22607	LB/B	-	F6VBA5	646	D	N
P22455	LB/B	-	A0A2K6LN08	10	V	I
P22455	LB/B	-	A0A2K6LN08	136	P	L
P22455	LB/B	-	A0A2K6LN08	179	T	A
P22455	LB/B	-	A0A2K6LN08	516	D	N
P22455	LB/B	-	A0A2K6LN08	426	G	S
P22455	LB/B	-	A0A2K6LN08	550	V	M
P22455	LB/B	-	A0A2K6LN08	529	R	Q
Q8N441	LB/B	-	I3IXH5	362	P	Q
Q8N441	LB/B	-	I3IXH5	464	P	L
Q96C11	LB/B	-	Q6NUW9	134	L	V
Q96C11	LB/B	-	Q6NUW9	43	N	K
Q96C11	LB/B	-	Q6NUW9	246	L	V
Q08830	LB/B	-	G1NG76	15	T	I
Q08830	LB/B	-	G1NG76	72	I	V
Q08830	LB/B	-	G1NG76	105	P	L
Q08830	LB/B	-	G1NG76	111	Y	H
Q08830	LB/B	-	G1NG76	121	T	S
Q08830	LB/B	-	G1NG76	140	Y	F
Q08830	LB/B	-	G1NG76	114	M	V
Q08830	LB/B	-	G1NG76	256	W	L
Q14314	LB/B	-	L9LB25	53	G	E
P07954	LP/P	Fumarase deficiency (FMRD) [MIM:606812]	A0A1U7U9Z2	230	K	R
P07954	LP/P	Hereditary leiomyomatosis and renal cell cancer (HLRCC) [MIM:150800]	A0A1U7U9Z2	230	K	R
P07954	LP/P	Fumarase deficiency (FMRD) [MIM:606812]	A0A1U7U9Z2	308	A	T
P07954	LP/P	Fumarase deficiency (FMRD) [MIM:606812]	A0A1U7U9Z2	312	F	C
P07954	LP/P	Fumarase deficiency (FMRD) [MIM:606812]	A0A1U7U9Z2	425	D	V
P07954	LP/P	Hereditary leiomyomatosis and renal cell cancer (HLRCC) [MIM:150800]	A0A1U7U9Z2	107	N	T
P07954	LP/P	Hereditary leiomyomatosis and renal cell cancer (HLRCC) [MIM:150800]	A0A1U7U9Z2	117	A	P
P07954	LP/P	Hereditary leiomyomatosis and renal cell cancer (HLRCC) [MIM:150800]	A0A1U7U9Z2	180	H	R
P07954	LP/P	Hereditary leiomyomatosis and renal cell cancer (HLRCC) [MIM:150800]	A0A1U7U9Z2	185	Q	R
P07954	LP/P	Hereditary leiomyomatosis and renal cell cancer (HLRCC) [MIM:150800]	A0A1U7U9Z2	233	R	H
P07954	LP/P	Hereditary leiomyomatosis and renal cell cancer (HLRCC) [MIM:150800]	A0A1U7U9Z2	282	G	V
P07954	LP/P	Hereditary leiomyomatosis and renal cell cancer (HLRCC) [MIM:150800]	A0A1U7U9Z2	328	M	R
P07954	LP/P	Hereditary leiomyomatosis and renal cell cancer (HLRCC) [MIM:150800]	A0A1U7U9Z2	362	E	Q
Q9C0D6	LB/B	-	A0A099YWH1	639	R	C
Q9C0D6	LB/B	-	A0A099YWH1	297	L	F
Q8N612	LB/B	-	A0A2I3HBK2	491	T	M
Q8N612	LB/B	-	A0A2I3HBK2	619	R	L
Q8N612	LB/B	-	A0A2I3HBK2	754	Q	H
Q8N612	LB/B	-	A0A2I3HBK2	462	R	W
Q5W0V3	LB/B	-	T1IIV5	408	L	I
Q5W0V3	LB/B	-	T1IIV5	631	F	L
Q86V87	LB/B	-	H9G411	315	T	A
Q86V87	LB/B	-	H9G411	667	G	R
Q13642	LP/P	Scapuloperoneal myopathy, X-linked dominant (SPM) [MIM:300695]	A0A1S3FAQ7	122	W	S
Q13642	LP/P	Myopathy, X-linked, with postural muscle atrophy (XMPMA) [MIM:300696]	A0A1S3FAQ7	224	C	W
Q13642	LP/P	Reducing body myopathy, X-linked 1A, severe, with infantile or early childhood onset (RBMX1A) [MIM:300717]	A0A1S3FAQ7	123	H	Y
Q13642	LP/P	Reducing body myopathy, X-linked 1A, severe, with infantile or early childhood onset (RBMX1A) [MIM:300717]	A0A1S3FAQ7	132	C	F
Q13642	LP/P	Reducing body myopathy, X-linked 1B, with late childhood or adult onset (RBMX1B) [MIM:300718]	A0A1S3FAQ7	153	C	R
Q13642	LP/P	Reducing body myopathy, X-linked 1B, with late childhood or adult onset (RBMX1B) [MIM:300718]	A0A1S3FAQ7	153	C	Y
Q13642	LP/P	Reducing body myopathy, X-linked 1A, severe, with infantile or early childhood onset (RBMX1A) [MIM:300717]	A0A1S3FAQ7	123	H	L
Q13642	LP/P	Reducing body myopathy, X-linked 1A, severe, with infantile or early childhood onset (RBMX1A) [MIM:300717]	A0A1S3FAQ7	123	H	Q
Q13642	LP/P	Reducing body myopathy, X-linked 1B, with late childhood or adult onset (RBMX1B) [MIM:300718]	A0A1S3FAQ7	150	C	S
Q13642	LP/P	Emery-Dreifuss muscular dystrophy 6, X-linked (EDMD6) [MIM:300696]	A0A1S3FAQ7	209	C	R
Q13642	LP/P	Emery-Dreifuss muscular dystrophy 6, X-linked (EDMD6) [MIM:300696]	A0A1S3FAQ7	276	C	Y
Q13642	LP/P	Myopathy, X-linked, with postural muscle atrophy (XMPMA) [MIM:300696]	A0A1S3FAQ7	280	V	M
Q13642	LP/P	Scapuloperoneal myopathy, X-linked dominant (SPM) [MIM:300695]	A0A1S3FAQ7	154	H	P
Q14192	LB/B	-	A0A2K5DZT1	167	K	M
Q5TD97	LB/B	-	F7AM23	211	V	M
Q5TD97	LB/B	-	F7AM23	35	R	H
Q5TD97	LB/B	-	F7AM23	204	R	G
Q5TD97	LB/B	-	F7AM23	243	S	R
Q2V2M9	LB/B	-	F7BDD0	475	R	W
O43427	LB/B	-	F7DUG7	152	R	W
O43427	LB/B	-	F7DUG7	351	M	V
O43427	LB/B	-	F7DUG7	359	L	R
Q92562	LB/B	-	M7BJD5	364	M	L
Q92562	LB/B	-	M7BJD5	654	V	A
Q92562	LP/P	Charcot-Marie-Tooth disease 4J (CMT4J) [MIM:611228]	M7BJD5	41	I	T
Q92562	LB/B	-	M7BJD5	48	D	G
Q92562	LP/P	Amyotrophic lateral sclerosis 11 (ALS11) [MIM:612577]	M7BJD5	53	D	Y
Q92562	LB/B	-	M7BJD5	388	R	G
Q92562	LB/B	-	M7BJD5	411	I	V
Q92562	LB/B	-	M7BJD5	647	Y	C
Q92562	LB/B	-	M7BJD5	902	I	T
Q92562	LP/P	Yunis-Varon syndrome (YVS) [MIM:216340]	M7BJD5	104	G	D
Q92562	LP/P	Yunis-Varon syndrome (YVS) [MIM:216340]	M7BJD5	175	L	P
Q92562	LP/P	Charcot-Marie-Tooth disease 4J (CMT4J) [MIM:611228]	M7BJD5	17	L	P
Q92562	LP/P	Charcot-Marie-Tooth disease 4J (CMT4J) [MIM:611228]	M7BJD5	302	E	K
Q92562	LP/P	Polymicrogyria, bilateral temporooccipital (BTOP) [MIM:612691]	M7BJD5	783	D	V
Q6QHK4	LB/B	-	H0XYF1	4	A	E
Q6QHK4	LB/B	-	H0XYF1	141	S	T
Q5HY92	LB/B	-	G3NPJ7	96	S	L
Q5HY92	LB/B	-	G3NPJ7	448	R	C
Q5HY92	LB/B	-	G3NPJ7	565	K	R
Q6PIW4	LB/B	-	A0A1B6L4J3	137	V	M
Q6PIW4	LB/B	-	A0A1B6L4J3	216	H	Y
A6NMB9	LB/B	-	G3NPJ7	366	T	P
Q7Z7B0	LB/B	-	I3NH23	1003	P	S
Q4L180	LB/B	-	I3NH23	168	R	H
Q4L180	LB/B	-	I3NH23	884	A	P
Q8N6M3	LP/P	Siddiqi syndrome (SIDDIS) [MIM:618635]	A0A2U3WX48	232	G	R
Q96SL8	LB/B	-	A0A2Y9S435	391	T	A
Q86VR8	LB/B	-	H0W295	153	M	L
Q86VR8	LB/B	-	H0W295	415	R	H
Q96AY3	LB/B	-	A0A091QVV8	197	K	R
Q96AY3	LP/P	Bruck syndrome 1 (BRKS1) [MIM:259450]	A0A091QVV8	113	E	K
Q96AY3	LP/P	Bruck syndrome 1 (BRKS1) [MIM:259450]	A0A091QVV8	115	R	Q
Q96AY3	LP/P	Bruck syndrome 1 (BRKS1) [MIM:259450]	A0A091QVV8	136	P	L
Q5T1M5	LB/B	-	G3HI06	106	A	T
Q5T1M5	LB/B	-	G3HI06	413	H	Q
Q5T1M5	LB/B	-	G3HI06	434	L	F
Q5T1M5	LB/B	-	G3HI06	847	A	S
Q5T1M5	LB/B	-	G3HI06	993	P	T
P26885	LB/B	-	A0A1D5QSN2	25	A	T
P26885	LB/B	-	A0A1D5QSN2	97	C	Y
P26885	LB/B	-	A0A1D5QSN2	7	R	Q
O75344	LB/B	-	A0A2R8MVV5	183	R	C
Q9UIM3	LB/B	-	A0A1A6G410	90	A	T
O75072	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A4 (MDDGA4) [MIM:253800]	F7EQC4	250	C	G
O75072	LB/B	-	F7EQC4	446	N	D
O75072	LB/B	-	F7EQC4	125	G	S
O75072	LB/B	-	F7EQC4	203	R	Q
O75072	LP/P	Cardiomyopathy, dilated 1X (CMD1X) [MIM:611615]	F7EQC4	179	R	T
O75072	LP/P	Muscular dystrophy-dystroglycanopathy congenital without impaired intellectual development B4 (MDDGB4) [MIM:613152]	F7EQC4	307	R	Q
O75072	LP/P	Muscular dystrophy-dystroglycanopathy limb-girdle C4 (MDDGC4) [MIM:611588]	F7EQC4	307	R	Q
O75072	LP/P	Cardiomyopathy, dilated 1X (CMD1X) [MIM:611615]	F7EQC4	358	Q	P
O75072	LB/B	-	F7EQC4	56	R	C
O75072	LP/P	Muscular dystrophy-dystroglycanopathy limb-girdle C4 (MDDGC4) [MIM:611588]	F7EQC4	114	A	T
O75072	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A4 (MDDGA4) [MIM:253800]	F7EQC4	170	A	E
O75072	LP/P	Muscular dystrophy-dystroglycanopathy limb-girdle C4 (MDDGC4) [MIM:611588]	F7EQC4	176	F	S
O75072	LP/P	Muscular dystrophy-dystroglycanopathy congenital without impaired intellectual development B4 (MDDGB4) [MIM:613152]	F7EQC4	246	R	G
O75072	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A4 (MDDGA4) [MIM:253800]	F7EQC4	371	Y	C
Q8NFF5	LB/B	-	A0A147A6D7	107	P	L
Q8NFF5	LP/P	Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency (LSMFLAD) [MIM:255100]	A0A147A6D7	530	R	C
Q8NFG4	LP/P	Birt-Hogg-Dube syndrome (BHD) [MIM:135150]	A0A096P314	108	S	I
Q8NFG4	LP/P	Primary spontaneous pneumothorax (PSP) [MIM:173600]	A0A096P314	132	E	K
Q8NFG4	LP/P	Renal cell carcinoma (RCC) [MIM:144700]	A0A096P314	239	R	C
Q8NFG4	LB/B	-	A0A096P314	362	R	C
Q8NFG4	LP/P	Primary spontaneous pneumothorax (PSP) [MIM:173600]	A0A096P314	429	H	Y
Q8NFG4	LP/P	Birt-Hogg-Dube syndrome (BHD) [MIM:135150]	A0A096P314	508	K	R
P20930	LB/B	-	P20930	3436	G	A
P20930	LB/B	-	P20930	1184	S	L
P20930	LB/B	-	P20930	1376	R	G
P20930	LB/B	-	P20930	1437	R	C
P20930	LB/B	-	P20930	1805	A	V
P20930	LB/B	-	P20930	1961	H	Q
P20930	LB/B	-	P20930	2022	I	T
P20930	LB/B	-	P20930	2507	H	Q
P20930	LB/B	-	P20930	2540	R	Q
P20930	LB/B	-	P20930	2781	D	Y
P20930	LB/B	-	P20930	3371	S	F
P20930	LB/B	-	P20930	3396	S	P
P20930	LB/B	-	P20930	3415	H	Y
P20930	LB/B	-	P20930	3427	S	Y
P20930	LB/B	-	P20930	3437	H	Q
P20930	LB/B	-	P20930	3490	R	C
P20930	LB/B	-	P20930	3512	Q	R
P20930	LB/B	-	P20930	3584	D	N
P20930	LB/B	-	P20930	3695	S	F
P20930	LB/B	-	P20930	3696	T	A
P20930	LB/B	-	P20930	3720	S	P
P20930	LB/B	-	P20930	3739	H	Y
P20930	LB/B	-	P20930	3751	S	Y
P20930	LB/B	-	P20930	3760	G	A
P20930	LB/B	-	P20930	3761	H	Q
P20930	LB/B	-	P20930	3814	R	C
P20930	LB/B	-	P20930	3827	G	W
P20930	LB/B	-	P20930	3908	D	N
P20930	LB/B	-	P20930	3935	S	P
P20930	LB/B	-	P20930	3970	S	L
P20930	LB/B	-	P20930	454	T	A
P20930	LB/B	-	P20930	478	P	S
P20930	LB/B	-	P20930	725	T	I
P20930	LB/B	-	P20930	1482	S	Y
P20930	LB/B	-	P20930	1699	R	C
P20930	LB/B	-	P20930	1750	S	F
P20930	LB/B	-	P20930	1816	H	Q
P20930	LB/B	-	P20930	1891	R	Q
P20930	LB/B	-	P20930	2108	A	V
P20930	LB/B	-	P20930	2119	Y	H
P20930	LB/B	-	P20930	2194	Y	H
P20930	LB/B	-	P20930	2545	G	R
P20930	LB/B	-	P20930	3105	Y	D
P20930	LB/B	-	P20930	3179	V	G
P20930	LB/B	-	P20930	3503	W	G
P20930	LB/B	-	P20930	3564	R	H
P20930	LB/B	-	P20930	3593	E	D
P20930	LB/B	-	P20930	3630	H	Y
P20930	LB/B	-	P20930	332	G	V
P20930	LB/B	-	P20930	444	G	R
P20930	LB/B	-	P20930	742	S	Y
P20930	LB/B	-	P20930	1684	R	H
Q01543	LP/P	Bleeding disorder, platelet-type, 21 (BDPLT21) [MIM:617443]	A0A091H6M2	324	R	W
Q01543	LP/P	Bleeding disorder, platelet-type, 21 (BDPLT21) [MIM:617443]	A0A091H6M2	337	R	Q
Q01543	LP/P	Bleeding disorder, platelet-type, 21 (BDPLT21) [MIM:617443]	A0A091H6M2	337	R	W
Q01543	LP/P	Bleeding disorder, platelet-type, 21 (BDPLT21) [MIM:617443]	A0A091H6M2	343	Y	C
Q01543	LP/P	Bleeding disorder, platelet-type, 21 (BDPLT21) [MIM:617443]	A0A091H6M2	345	K	E
Q13045	LB/B	-	T1J3P6	1243	R	H
P21333	LB/B	-	K1PW06	320	V	A
P21333	LB/B	-	K1PW06	370	F	L
P21333	LB/B	-	K1PW06	552	V	A
P21333	LP/P	Periventricular nodular heterotopia 1 (PVNH1) [MIM:300049]	K1PW06	656	L	F
P21333	LB/B	-	K1PW06	1764	A	T
P21333	LP/P	Periventricular nodular heterotopia 1 (PVNH1) [MIM:300049]	K1PW06	82	E	V
P21333	LP/P	Otopalatodigital syndrome 1 (OPD1) [MIM:311300]	K1PW06	207	P	L
P21333	LP/P	Otopalatodigital syndrome 2 (OPD2) [MIM:304120]	K1PW06	254	E	K
P21333	LP/P	Frontometaphyseal dysplasia 1 (FMD1) [MIM:305620]	K1PW06	1159	D	A
P21333	LP/P	Melnick-Needles syndrome (MNS) [MIM:309350]	K1PW06	1188	A	T
P21333	LP/P	Melnick-Needles syndrome (MNS) [MIM:309350]	K1PW06	1199	S	L
P21333	LP/P	Otopalatodigital syndrome 2 (OPD2) [MIM:304120]	K1PW06	170	Q	P
P21333	LP/P	Otopalatodigital syndrome 1 (OPD1) [MIM:311300]	K1PW06	172	L	F
P21333	LP/P	Otopalatodigital syndrome 2 (OPD2) [MIM:304120]	K1PW06	196	R	G
P21333	LP/P	Otopalatodigital syndrome 1 (OPD1) [MIM:311300]	K1PW06	196	R	W
P21333	LP/P	Otopalatodigital syndrome 2 (OPD2) [MIM:304120]	K1PW06	200	A	S
P21333	LP/P	Otopalatodigital syndrome 2 (OPD2) [MIM:304120]	K1PW06	273	A	P
P21333	LP/P	Otopalatodigital syndrome 2 (OPD2) [MIM:304120]	K1PW06	555	T	K
P21333	LP/P	Melnick-Needles syndrome (MNS) [MIM:309350]	K1PW06	1184	D	E
P21333	LP/P	Frontometaphyseal dysplasia 1 (FMD1) [MIM:305620]	K1PW06	1186	S	L
P21333	LP/P	Otopalatodigital syndrome 2 (OPD2) [MIM:304120]	K1PW06	1645	C	F
P21333	LP/P	Periventricular nodular heterotopia 1 (PVNH1) [MIM:300049]	K1PW06	39	A	G
P21333	LP/P	Periventricular nodular heterotopia 1 (PVNH1) [MIM:300049]	K1PW06	102	M	V
P21333	LP/P	Periventricular nodular heterotopia 1 (PVNH1) [MIM:300049]	K1PW06	128	A	V
P21333	LP/P	Periventricular nodular heterotopia 1 (PVNH1) [MIM:300049]	K1PW06	149	S	F
P21333	LP/P	Otopalatodigital syndrome 1 (OPD1) [MIM:311300]	K1PW06	203	D	Y
P21333	LB/B	-	K1PW06	528	V	M
P21333	LB/B	-	K1PW06	1012	S	L
P21333	LP/P	Frontometaphyseal dysplasia 1 (FMD1) [MIM:305620]	K1PW06	1728	G	C
P21333	LB/B	-	K1PW06	1419	A	G
P21333	LP/P	Otopalatodigital syndrome 2 (OPD2) [MIM:304120]	K1PW06	210	C	F
P21333	LP/P	FG syndrome 2 (FGS2) [MIM:300321]	K1PW06	1291	P	L
P21333	LP/P	Cardiac valvular dysplasia, X-linked (CVDPX) [MIM:314400]	K1PW06	288	G	R
P21333	LP/P	Cardiac valvular dysplasia, X-linked (CVDPX) [MIM:314400]	K1PW06	637	P	Q
P21333	LP/P	Cardiac valvular dysplasia, X-linked (CVDPX) [MIM:314400]	K1PW06	711	V	D
P21333	LP/P	-	K1PW06	1803	E	K
P21333	LB/B	-	K1PW06	429	T	M
O75369	LB/B	-	K1PW06	1018	V	M
O75369	LB/B	-	K1PW06	1157	D	N
O75369	LB/B	-	K1PW06	1179	E	K
O75369	LB/B	-	K1PW06	1471	V	M
O75369	LP/P	Larsen syndrome (LRS) [MIM:150250]	K1PW06	161	F	C
O75369	LP/P	Larsen syndrome (LRS) [MIM:150250]	K1PW06	168	G	S
O75369	LP/P	Boomerang dysplasia (BOOMD) [MIM:112310]	K1PW06	171	L	R
O75369	LP/P	Atelosteogenesis 1 (AO1) [MIM:108720]	K1PW06	173	A	V
O75369	LP/P	Atelosteogenesis 1 (AO1) [MIM:108720]	K1PW06	188	S	P
O75369	LP/P	Atelosteogenesis 1 (AO1) [MIM:108720]	K1PW06	202	M	V
O75369	LP/P	Atelosteogenesis 3 (AO3) [MIM:108721]	K1PW06	202	M	V
O75369	LP/P	Larsen syndrome (LRS) [MIM:150250]	K1PW06	227	E	K
O75369	LP/P	Larsen syndrome (LRS) [MIM:150250]	K1PW06	234	L	V
O75369	LP/P	Boomerang dysplasia (BOOMD) [MIM:112310]	K1PW06	235	S	P
O75369	LP/P	Larsen syndrome (LRS) [MIM:150250]	K1PW06	361	G	S
O75369	LP/P	Larsen syndrome (LRS) [MIM:150250]	K1PW06	363	G	E
O75369	LP/P	Atelosteogenesis 3 (AO3) [MIM:108721]	K1PW06	751	G	R
O75369	LP/P	Larsen syndrome (LRS) [MIM:150250]	K1PW06	1431	L	R
O75369	LP/P	Larsen syndrome (LRS) [MIM:150250]	K1PW06	1586	G	R
O75369	LP/P	Larsen syndrome (LRS) [MIM:150250]	K1PW06	1592	V	D
O75369	LP/P	Larsen syndrome (LRS) [MIM:150250]	K1PW06	1603	P	L
O75369	LP/P	Larsen syndrome (LRS) [MIM:150250]	K1PW06	1691	G	S
O75369	LP/P	Larsen syndrome (LRS) [MIM:150250]	K1PW06	1834	G	R
Q14315	LB/B	-	K1PW06	1567	R	Q
Q14315	LB/B	-	K1PW06	1580	D	G
Q14315	LB/B	-	K1PW06	1599	T	A
Q14315	LB/B	-	K1PW06	2135	K	R
Q14315	LB/B	-	K1PW06	2203	R	P
Q14315	LB/B	-	K1PW06	2626	S	N
Q14315	LB/B	-	K1PW06	2637	K	Q
Q14315	LP/P	Myopathy, distal, 4 (MPD4) [MIM:614065]	K1PW06	193	A	T
Q14315	LP/P	Myopathy, distal, 4 (MPD4) [MIM:614065]	K1PW06	251	M	T
Q14315	LP/P	Cardiomyopathy, familial hypertrophic 26 (CMH26) [MIM:617047]	K1PW06	123	V	A
Q14315	LP/P	Cardiomyopathy, familial hypertrophic 26 (CMH26) [MIM:617047]	K1PW06	1539	A	T
Q14315	LP/P	Cardiomyopathy, familial restrictive 5 (RCM5) [MIM:617047]	K1PW06	1624	S	L
Q14315	LP/P	Cardiomyopathy, familial hypertrophic 26 (CMH26) [MIM:617047]	K1PW06	2133	R	H
Q14315	LP/P	Cardiomyopathy, familial restrictive 5 (RCM5) [MIM:617047]	K1PW06	2160	I	F
Q14315	LB/B	-	K1PW06	1674	G	S
Q14254	LB/B	-	L8YAW6	328	A	T
O43155	LB/B	-	F7D0D5	486	R	Q
Q9NZU0	LB/B	-	F7D0D5	400	H	Q
Q9NZU0	LB/B	-	F7D0D5	377	A	T
Q9NZU0	LB/B	-	F7D0D5	460	E	D
Q9NZU0	LB/B	-	F7D0D5	452	I	V
Q9NZU0	LP/P	Hypogonadotropic hypogonadism 21 with or without anosmia (HH21) [MIM:615271]	F7D0D5	69	Q	K
Q9NZU0	LP/P	Hypogonadotropic hypogonadism 21 with or without anosmia (HH21) [MIM:615271]	F7D0D5	97	E	G
Q9NZU0	LP/P	Hypogonadotropic hypogonadism 21 with or without anosmia (HH21) [MIM:615271]	F7D0D5	144	S	I
Q9NZU0	LP/P	Hypogonadotropic hypogonadism 21 with or without anosmia (HH21) [MIM:615271]	F7D0D5	339	K	R
P17948	LB/B	-	M7BK51	60	K	T
P17948	LB/B	-	M7BK51	144	E	K
P17948	LB/B	-	M7BK51	281	R	Q
P17948	LB/B	-	M7BK51	938	M	V
P17948	LB/B	-	M7BK51	982	E	A
P17948	LB/B	-	M7BK51	128	I	L
P36888	LB/B	-	A0A151MSD7	7	D	G
P36888	LB/B	-	A0A151MSD7	227	T	M
P36888	LB/B	-	A0A151MSD7	158	V	A
P36888	LB/B	-	A0A151MSD7	324	D	N
P36888	LB/B	-	A0A151MSD7	358	D	V
P36888	LB/B	-	A0A151MSD7	557	V	I
P36888	LB/B	-	A0A151MSD7	194	V	M
P36888	LB/B	-	A0A151MSD7	417	I	L
P35916	LB/B	-	L9L0E5	494	T	A
P35916	LB/B	-	L9L0E5	641	P	S
P35916	LP/P	Lymphatic malformation 1 (LMPHM1) [MIM:153100]	L9L0E5	857	G	R
P35916	LB/B	-	L9L0E5	890	H	Q
P35916	LP/P	Hemangioma, capillary infantile (HCI) [MIM:602089]	L9L0E5	954	P	S
P35916	LP/P	Lymphatic malformation 1 (LMPHM1) [MIM:153100]	L9L0E5	1035	H	R
P35916	LP/P	Lymphatic malformation 1 (LMPHM1) [MIM:153100]	L9L0E5	1041	R	P
P35916	LP/P	Lymphatic malformation 1 (LMPHM1) [MIM:153100]	L9L0E5	1044	L	P
P35916	LP/P	Lymphatic malformation 1 (LMPHM1) [MIM:153100]	L9L0E5	1114	P	L
P35916	LP/P	Hemangioma, capillary infantile (HCI) [MIM:602089]	L9L0E5	1137	P	S
P35916	LB/B	-	L9L0E5	1146	R	H
P35916	LB/B	-	L9L0E5	527	N	S
P35916	LB/B	-	L9L0E5	149	N	D
P35916	LB/B	-	L9L0E5	868	H	Y
P35916	LB/B	-	L9L0E5	1031	R	Q
P35916	LB/B	-	L9L0E5	1049	D	N
P35916	LB/B	-	L9L0E5	1075	R	Q
P35916	LP/P	Lymphatic malformation 1 (LMPHM1) [MIM:153100]	L9L0E5	855	A	T
P35916	LP/P	Lymphatic malformation 1 (LMPHM1) [MIM:153100]	L9L0E5	878	V	M
P35916	LP/P	Lymphatic malformation 1 (LMPHM1) [MIM:153100]	L9L0E5	1020	Q	L
P35916	LP/P	-	L9L0E5	1035	H	Q
P35916	LP/P	Lymphatic malformation 1 (LMPHM1) [MIM:153100]	L9L0E5	1086	I	T
P35916	LP/P	Lymphatic malformation 1 (LMPHM1) [MIM:153100]	L9L0E5	1106	E	K
P35916	LP/P	Lymphatic malformation 1 (LMPHM1) [MIM:153100]	L9L0E5	1235	S	C
Q9UPI3	LB/B	-	H0X208	16	V	A
Q9UPI3	LB/B	-	H0X208	481	A	T
Q9UPI3	LP/P	Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome (PVHH) [MIM:225790]	H0X208	280	P	R
Q9UPI3	LP/P	Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome (PVHH) [MIM:225790]	H0X208	398	L	V
Q9UPI3	LP/P	Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome (PVHH) [MIM:225790]	H0X208	430	T	R
Q9UPI3	LP/P	Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome (PVHH) [MIM:225790]	H0X208	84	R	H
Q9UPI3	LP/P	Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome (PVHH) [MIM:225790]	H0X208	326	A	V
Q9UPI3	LP/P	Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome (PVHH) [MIM:225790]	H0X208	352	T	R
Q9UPI3	LP/P	Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome (PVHH) [MIM:225790]	H0X208	412	G	R
Q9UPI3	LP/P	Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome (PVHH) [MIM:225790]	H0X208	430	T	M
Q68DA7	LB/B	-	A0A1W4ZAD7	686	L	P
Q9NZ56	LB/B	-	G1KC54	1468	R	H
Q9NZ56	LB/B	-	G1KC54	1291	R	G
Q9NZ56	LB/B	-	G1KC54	1148	R	G
Q01740	LB/B	-	F6Y3T2	97	H	Q
Q01740	LB/B	-	F6Y3T2	303	I	T
Q01740	LB/B	-	F6Y3T2	303	I	V
Q01740	LB/B	-	F6Y3T2	223	R	Q
Q01740	LB/B	-	F6Y3T2	227	S	T
Q01740	LB/B	-	F6Y3T2	322	I	V
Q01740	LB/B	-	F6Y3T2	327	F	L
Q01740	LB/B	-	F6Y3T2	373	K	R
Q01740	LB/B	-	F6Y3T2	474	R	H
Q99518	LB/B	-	F6Y3T2	36	D	G
Q99518	LB/B	-	F6Y3T2	81	F	S
Q99518	LB/B	-	F6Y3T2	182	F	S
Q99518	LB/B	-	F6Y3T2	195	S	L
Q99518	LB/B	-	F6Y3T2	413	N	K
Q99518	LB/B	-	F6Y3T2	59	V	I
Q99518	LB/B	-	F6Y3T2	238	R	Q
Q99518	LB/B	-	F6Y3T2	391	R	T
Q99518	LB/B	-	F6Y3T2	69	F	Y
Q99518	LB/B	-	F6Y3T2	314	E	G
P31513	LP/P	Trimethylaminuria (TMAU) [MIM:602079]	F6Y3T2	66	M	I
P31513	LP/P	Trimethylaminuria (TMAU) [MIM:602079]	F6Y3T2	153	P	L
P31513	LB/B	-	F6Y3T2	158	E	K
P31513	LB/B	-	F6Y3T2	257	V	M
P31513	LB/B	-	F6Y3T2	308	E	G
P31513	LP/P	Trimethylaminuria (TMAU) [MIM:602079]	F6Y3T2	492	R	W
P31513	LP/P	Trimethylaminuria (TMAU) [MIM:602079]	F6Y3T2	52	A	T
P31513	LP/P	Trimethylaminuria (TMAU) [MIM:602079]	F6Y3T2	387	R	L
P31513	LB/B	-	F6Y3T2	277	V	A
P31513	LB/B	-	F6Y3T2	362	E	Q
P31513	LB/B	-	F6Y3T2	132	D	H
P31513	LB/B	-	F6Y3T2	360	L	P
P31513	LB/B	-	F6Y3T2	503	G	R
P31513	LB/B	-	F6Y3T2	198	D	E
P31513	LB/B	-	F6Y3T2	205	R	C
P31513	LP/P	Trimethylaminuria (TMAU) [MIM:602079]	F6Y3T2	32	E	K
P31513	LP/P	Trimethylaminuria (TMAU) [MIM:602079]	F6Y3T2	61	N	S
P31513	LP/P	Trimethylaminuria (TMAU) [MIM:602079]	F6Y3T2	434	M	I
P31513	LB/B	-	F6Y3T2	416	K	N
P31512	LB/B	-	F6Y3T2	37	I	T
P31512	LB/B	-	F6Y3T2	323	V	A
P31512	LB/B	-	F6Y3T2	339	E	Q
P31512	LB/B	-	F6Y3T2	372	G	S
P31512	LB/B	-	F6Y3T2	536	F	L
P31512	LB/B	-	F6Y3T2	544	L	R
P31512	LB/B	-	F6Y3T2	308	T	S
P49326	LB/B	-	F6Y3T2	457	P	L
P49326	LB/B	-	F6Y3T2	400	P	A
P49326	LB/B	-	F6Y3T2	506	R	S
O60774	LB/B	-	F6Y3T2	127	V	I
O60774	LB/B	-	F6Y3T2	257	V	I
Q06787	LP/P	Fragile X syndrome (FXS) [MIM:300624]	S9WE94	304	I	N
Q06787	LB/B	-	S9WE94	546	R	H
Q06787	LB/B	-	S9WE94	145	A	S
Q06787	LP/P	Fragile X syndrome (FXS) [MIM:300624]	S9WE94	138	R	Q
Q06787	LP/P	Fragile X syndrome (FXS) [MIM:300624]	S9WE94	266	G	E
Q8N0W7	LB/B	-	G7Q1V6	142	A	V
P02751	LB/B	-	H3A822	15	Q	L
P02751	LP/P	Glomerulopathy with fibronectin deposits 2 (GFND2) [MIM:601894]	H3A822	973	Y	C
P02751	LP/P	Glomerulopathy with fibronectin deposits 2 (GFND2) [MIM:601894]	H3A822	1925	W	R
P02751	LP/P	Glomerulopathy with fibronectin deposits 2 (GFND2) [MIM:601894]	H3A822	1974	L	R
P02751	LB/B	-	H3A822	2051	I	V
P02751	LB/B	-	H3A822	1558	S	R
P02751	LB/B	-	H3A822	2212	I	V
P02751	LB/B	-	H3A822	817	T	P
P02751	LB/B	-	H3A822	2261	V	I
P02751	LP/P	Spondylometaphyseal dysplasia, corner fracture type (SMDCF) [MIM:184255]	H3A822	87	C	F
P02751	LP/P	Spondylometaphyseal dysplasia, corner fracture type (SMDCF) [MIM:184255]	H3A822	123	C	R
P02751	LP/P	Spondylometaphyseal dysplasia, corner fracture type (SMDCF) [MIM:184255]	H3A822	225	C	W
P02751	LP/P	Spondylometaphyseal dysplasia, corner fracture type (SMDCF) [MIM:184255]	H3A822	240	Y	D
P02751	LP/P	Spondylometaphyseal dysplasia, corner fracture type (SMDCF) [MIM:184255]	H3A822	260	C	G
Q9HA64	LB/B	-	L5MJ80	57	A	V
Q8N3X1	LB/B	-	A0A2K6F655	125	E	G
Q8N3X1	LB/B	-	A0A2K6F655	794	T	A
Q4ZHG4	LB/B	-	A0A2Y9FXW9	438	T	A
Q4ZHG4	LB/B	-	A0A2Y9FXW9	463	E	Q
Q4ZHG4	LB/B	-	A0A2Y9FXW9	1003	Q	E
Q4ZHG4	LB/B	-	A0A2Y9FXW9	1180	D	E
Q4ZHG4	LB/B	-	A0A2Y9FXW9	1261	L	P
Q4ZHG4	LB/B	-	A0A2Y9FXW9	1280	Q	R
Q4ZHG4	LB/B	-	A0A2Y9FXW9	1504	T	K
Q4ZHG4	LB/B	-	A0A2Y9FXW9	1574	T	A
Q8TC99	LB/B	-	H0W706	36	S	P
Q8TC99	LB/B	-	H0W706	127	A	T
Q8TBE3	LB/B	-	A0A2K6D2S6	50	H	N
Q8TBE3	LB/B	-	A0A2K6D2S6	138	V	I
Q8TBE3	LB/B	-	A0A2K6D2S6	166	P	A
Q8TF40	LB/B	-	A0A1A6H2B1	76	G	C
Q8TF40	LB/B	-	A0A1A6H2B1	354	S	L
Q8TF40	LB/B	-	A0A1A6H2B1	648	Q	R
Q8TF40	LB/B	-	A0A1A6H2B1	738	V	L
Q8TF40	LB/B	-	A0A1A6H2B1	844	I	V
Q9P278	LB/B	-	A0A1A6H2B1	298	T	S
Q04609	LB/B	-	H2Z0Q3	475	H	Y
Q04609	LB/B	-	H2Z0Q3	75	Y	H
Q04609	LB/B	-	H2Z0Q3	627	V	L
Q9HBA9	LB/B	-	H2Z0Q3	151	N	K
P53539	LB/B	-	A0A2J8PYM2	33	G	S
P55317	LB/B	-	A0A2U9B3Q4	83	A	T
P55317	LB/B	-	A0A2U9B3Q4	448	S	N
P55317	LB/B	-	A0A2U9B3Q4	72	G	A
P55317	LB/B	-	A0A2U9B3Q4	185	Q	R
P55317	LB/B	-	A0A2U9B3Q4	87	G	E
Q12948	LP/P	Anterior segment dysgenesis 3 (ASGD3) [MIM:601631]	A0A0P7UG87	112	F	S
Q12948	LP/P	Axenfeld-Rieger syndrome 3 (RIEG3) [MIM:602482]	A0A0P7UG87	112	F	S
Q12948	LP/P	Anterior segment dysgenesis 3 (ASGD3) [MIM:601631]	A0A0P7UG87	126	I	M
Q12948	LP/P	Axenfeld-Rieger syndrome 3 (RIEG3) [MIM:602482]	A0A0P7UG87	126	I	M
Q12948	LP/P	Anterior segment dysgenesis 3 (ASGD3) [MIM:601631]	A0A0P7UG87	131	S	L
Q12948	LP/P	Axenfeld-Rieger syndrome 3 (RIEG3) [MIM:602482]	A0A0P7UG87	131	S	L
Q12948	LP/P	Axenfeld-Rieger syndrome 3 (RIEG3) [MIM:602482]	A0A0P7UG87	82	S	T
Q12948	LP/P	Axenfeld-Rieger syndrome 3 (RIEG3) [MIM:602482]	A0A0P7UG87	87	I	M
Q12948	LP/P	Anterior segment dysgenesis 3 (ASGD3) [MIM:601631]	A0A0P7UG87	161	M	K
Q12948	LP/P	Axenfeld-Rieger syndrome 3 (RIEG3) [MIM:602482]	A0A0P7UG87	161	M	K
Q12948	LP/P	Axenfeld-Rieger syndrome 3 (RIEG3) [MIM:602482]	A0A0P7UG87	79	P	L
Q12948	LP/P	Axenfeld-Rieger syndrome 3 (RIEG3) [MIM:602482]	A0A0P7UG87	79	P	R
Q12948	LP/P	Axenfeld-Rieger syndrome 3 (RIEG3) [MIM:602482]	A0A0P7UG87	79	P	T
Q12948	LP/P	Axenfeld-Rieger syndrome 3 (RIEG3) [MIM:602482]	A0A0P7UG87	86	L	F
Q12948	LP/P	Axenfeld-Rieger syndrome 3 (RIEG3) [MIM:602482]	A0A0P7UG87	91	I	S
Q12948	LP/P	Axenfeld-Rieger syndrome 3 (RIEG3) [MIM:602482]	A0A0P7UG87	91	I	T
Q12948	LP/P	Axenfeld-Rieger syndrome 3 (RIEG3) [MIM:602482]	A0A0P7UG87	115	Y	S
Q12948	LP/P	Axenfeld-Rieger syndrome 3 (RIEG3) [MIM:602482]	A0A0P7UG87	127	R	H
Q12948	LP/P	Axenfeld-Rieger syndrome 3 (RIEG3) [MIM:602482]	A0A0P7UG87	130	L	F
Q12948	LP/P	Axenfeld-Rieger syndrome 3 (RIEG3) [MIM:602482]	A0A0P7UG87	149	G	D
Q12948	LP/P	Axenfeld-Rieger syndrome 3 (RIEG3) [MIM:602482]	A0A0P7UG87	161	M	V
Q12948	LP/P	Axenfeld-Rieger syndrome 3 (RIEG3) [MIM:602482]	A0A0P7UG87	165	G	R
Q12948	LP/P	Axenfeld-Rieger syndrome 3 (RIEG3) [MIM:602482]	A0A0P7UG87	169	R	P
Q12948	LP/P	Anterior segment dysgenesis 3 (ASGD3) [MIM:601631]	A0A0P7UG87	109	M	V
Q12948	LP/P	Axenfeld-Rieger syndrome 3 (RIEG3) [MIM:602482]	A0A0P7UG87	126	I	S
Q12948	LP/P	Axenfeld-Rieger syndrome 3 (RIEG3) [MIM:602482]	A0A0P7UG87	127	R	L
Q12948	LP/P	Axenfeld-Rieger syndrome 3 (RIEG3) [MIM:602482]	A0A0P7UG87	128	H	R
Q12948	LP/P	Anterior segment dysgenesis 3 (ASGD3) [MIM:601631]	A0A0P7UG87	131	S	W
Q12948	LP/P	Axenfeld-Rieger syndrome 3 (RIEG3) [MIM:602482]	A0A0P7UG87	135	C	Y
Q12948	LP/P	Anterior segment dysgenesis 3 (ASGD3) [MIM:601631]	A0A0P7UG87	138	K	E
Q12948	LP/P	Anterior segment dysgenesis 3 (ASGD3) [MIM:601631]	A0A0P7UG87	152	W	G
Q12948	LP/P	Anterior segment dysgenesis 3 (ASGD3) [MIM:601631]	A0A0P7UG87	297	P	S
Q99958	LP/P	Lymphedema-distichiasis syndrome (LPHDST) [MIM:153400]	A0A0P7UG87	125	S	L
Q99958	LB/B	-	A0A0P7UG87	191	S	F
Q16676	LB/B	-	A0A0Q3RDD9	55	R	P
Q16676	LB/B	-	A0A0Q3RDD9	88	A	G
Q16676	LB/B	-	A0A0Q3RDD9	228	P	L
Q16676	LB/B	-	A0A0Q3RDD9	326	A	T
Q16676	LB/B	-	A0A0Q3RDD9	336	A	V
Q16676	LB/B	-	A0A0Q3RDD9	352	P	R
Q16676	LB/B	-	A0A0Q3RDD9	356	A	G
Q16676	LB/B	-	A0A0Q3RDD9	364	I	M
Q16676	LB/B	-	A0A0Q3RDD9	396	P	L
Q16676	LB/B	-	A0A0Q3RDD9	437	V	I
Q16676	LB/B	-	A0A0Q3RDD9	442	A	S
Q12950	LB/B	-	L5K6Q2	134	I	F
Q12950	LB/B	-	L5K6Q2	136	D	G
Q12950	LB/B	-	L5K6Q2	152	I	V
Q9NU39	LB/B	-	L5K6Q2	29	V	I
O00358	LP/P	Bamforth-Lazarus syndrome (BAMLAZ) [MIM:241850]	A0A0P7UXW0	65	A	V
O00358	LP/P	Bamforth-Lazarus syndrome (BAMLAZ) [MIM:241850]	A0A0P7UXW0	57	S	N
O00358	LB/B	-	A0A0P7UXW0	102	R	C
O00358	LP/P	Bamforth-Lazarus syndrome (BAMLAZ) [MIM:241850]	A0A0P7UXW0	73	R	S
O00358	LB/B	-	A0A0P7UXW0	132	N	D
O00358	LP/P	Thyroid cancer, non-medullary, 4 (NMTC4) [MIM:616534]	A0A0P7UXW0	248	A	G
Q13461	LB/B	-	A0A0B5J4B6	196	G	A
Q13461	LB/B	-	A0A0B5J4B6	300	S	G
Q13461	LB/B	-	A0A0B5J4B6	49	G	A
Q13461	LP/P	Anterior segment dysgenesis 2 (ASGD2) [MIM:610256]	A0A0B5J4B6	90	R	L
Q13461	LP/P	Anterior segment dysgenesis 2 (ASGD2) [MIM:610256]	A0A0B5J4B6	120	R	G
Q13461	LP/P	Cataract 34, multiple types (CTRCT34) [MIM:612968]	A0A0B5J4B6	103	E	K
Q13461	LP/P	Cataract 34, multiple types (CTRCT34) [MIM:612968]	A0A0B5J4B6	117	N	K
Q13461	LP/P	Aortic aneurysm, familial thoracic 11 (AAT11) [MIM:617349]	A0A0B5J4B6	137	G	D
Q13461	LP/P	Aortic aneurysm, familial thoracic 11 (AAT11) [MIM:617349]	A0A0B5J4B6	153	D	H
Q12946	LP/P	Alveolar capillary dysplasia with misalignment of pulmonary veins (ACDMPV) [MIM:265380]	A0A2I4CWI4	49	P	Q
Q12946	LP/P	Alveolar capillary dysplasia with misalignment of pulmonary veins (ACDMPV) [MIM:265380]	A0A2I4CWI4	49	P	S
Q12946	LP/P	Alveolar capillary dysplasia with misalignment of pulmonary veins (ACDMPV) [MIM:265380]	A0A2I4CWI4	52	S	F
Q12946	LP/P	Alveolar capillary dysplasia with misalignment of pulmonary veins (ACDMPV) [MIM:265380]	A0A2I4CWI4	53	Y	C
Q12946	LP/P	Alveolar capillary dysplasia with misalignment of pulmonary veins (ACDMPV) [MIM:265380]	A0A2I4CWI4	74	I	N
Q12946	LP/P	Alveolar capillary dysplasia with misalignment of pulmonary veins (ACDMPV) [MIM:265380]	A0A2I4CWI4	85	F	I
Q12946	LP/P	Alveolar capillary dysplasia with misalignment of pulmonary veins (ACDMPV) [MIM:265380]	A0A2I4CWI4	85	F	L
Q12946	LP/P	Alveolar capillary dysplasia with misalignment of pulmonary veins (ACDMPV) [MIM:265380]	A0A2I4CWI4	85	F	S
Q12946	LP/P	Alveolar capillary dysplasia with misalignment of pulmonary veins (ACDMPV) [MIM:265380]	A0A2I4CWI4	86	R	W
Q12946	LP/P	Alveolar capillary dysplasia with misalignment of pulmonary veins (ACDMPV) [MIM:265380]	A0A2I4CWI4	91	G	E
Q12946	LP/P	Alveolar capillary dysplasia with misalignment of pulmonary veins (ACDMPV) [MIM:265380]	A0A2I4CWI4	91	G	V
Q12946	LP/P	Alveolar capillary dysplasia with misalignment of pulmonary veins (ACDMPV) [MIM:265380]	A0A2I4CWI4	96	V	M
Q12946	LP/P	Alveolar capillary dysplasia with misalignment of pulmonary veins (ACDMPV) [MIM:265380]	A0A2I4CWI4	97	R	H
Q12946	LP/P	Alveolar capillary dysplasia with misalignment of pulmonary veins (ACDMPV) [MIM:265380]	A0A2I4CWI4	98	H	Q
Q12946	LP/P	Alveolar capillary dysplasia with misalignment of pulmonary veins (ACDMPV) [MIM:265380]	A0A2I4CWI4	101	S	L
Q12946	LP/P	Alveolar capillary dysplasia with misalignment of pulmonary veins (ACDMPV) [MIM:265380]	A0A2I4CWI4	106	F	L
Q12946	LP/P	Alveolar capillary dysplasia with misalignment of pulmonary veins (ACDMPV) [MIM:265380]	A0A2I4CWI4	119	G	D
Q12946	LP/P	Alveolar capillary dysplasia with misalignment of pulmonary veins (ACDMPV) [MIM:265380]	A0A2I4CWI4	126	P	L
Q12946	LP/P	Alveolar capillary dysplasia with misalignment of pulmonary veins (ACDMPV) [MIM:265380]	A0A2I4CWI4	139	R	L
Q12946	LP/P	Alveolar capillary dysplasia with misalignment of pulmonary veins (ACDMPV) [MIM:265380]	A0A2I4CWI4	77	F	L
P55316	LP/P	Rett syndrome congenital variant (RTTCV) [MIM:613454]	H3AYM5	215	F	L
P55316	LB/B	-	H3AYM5	109	P	L
P55316	LP/P	Rett syndrome congenital variant (RTTCV) [MIM:613454]	H3AYM5	244	R	C
P55316	LP/P	-	H3AYM5	232	N	S
Q12951	LB/B	-	L5LS67	243	P	S
Q12951	LB/B	-	L5LS67	362	N	S
Q9P0K8	LB/B	-	U3FZI2	310	P	S
Q9P0K8	LB/B	-	U3FZI2	229	P	R
Q9UPW0	LB/B	-	A0A091EPX2	162	V	A
Q9UPW0	LB/B	-	A0A091EPX2	377	T	P
P58012	LP/P	Premature ovarian failure 3 (POF3) [MIM:608996]	A0A2K6KLZ5	187	G	D
P58012	LB/B	-	A0A2K6KLZ5	285	P	S
P58012	LP/P	Blepharophimosis, ptosis, and epicanthus inversus syndrome (BPES) [MIM:110100]	A0A2K6KLZ5	84	I	S
P58012	LP/P	Blepharophimosis, ptosis, and epicanthus inversus syndrome (BPES) [MIM:110100]	A0A2K6KLZ5	106	L	F
P58012	LP/P	Blepharophimosis, ptosis, and epicanthus inversus syndrome (BPES) [MIM:110100]	A0A2K6KLZ5	109	N	K
P58012	LP/P	Blepharophimosis, ptosis, and epicanthus inversus syndrome (BPES) [MIM:110100]	A0A2K6KLZ5	217	S	F
P58012	LP/P	Blepharophimosis, ptosis, and epicanthus inversus syndrome (BPES) [MIM:110100]	A0A2K6KLZ5	58	S	L
P58012	LP/P	Blepharophimosis, ptosis, and epicanthus inversus syndrome (BPES) [MIM:110100]	A0A2K6KLZ5	66	A	V
P58012	LP/P	Blepharophimosis, ptosis, and epicanthus inversus syndrome (BPES) [MIM:110100]	A0A2K6KLZ5	69	E	K
P58012	LP/P	Blepharophimosis, ptosis, and epicanthus inversus syndrome (BPES) [MIM:110100]	A0A2K6KLZ5	104	H	R
P58012	LP/P	Blepharophimosis, ptosis, and epicanthus inversus syndrome (BPES) [MIM:110100]	A0A2K6KLZ5	105	N	S
P58012	LB/B	-	A0A2K6KLZ5	179	A	G
P58012	LP/P	Blepharophimosis, ptosis, and epicanthus inversus syndrome (BPES) [MIM:110100]	A0A2K6KLZ5	193	K	R
P58012	LP/P	Blepharophimosis, ptosis, and epicanthus inversus syndrome (BPES) [MIM:110100]	A0A2K6KLZ5	215	Y	C
P58012	LP/P	Premature ovarian failure 3 (POF3) [MIM:608996]	A0A2K6KLZ5	258	Y	N
P58012	LP/P	Blepharophimosis, ptosis, and epicanthus inversus syndrome (BPES) [MIM:110100]	A0A2K6KLZ5	65	M	V
P58012	LP/P	Blepharophimosis, ptosis, and epicanthus inversus syndrome (BPES) [MIM:110100]	A0A2K6KLZ5	80	I	T
P58012	LP/P	Blepharophimosis, ptosis, and epicanthus inversus syndrome (BPES) [MIM:110100]	A0A2K6KLZ5	84	I	N
P58012	LP/P	Blepharophimosis, ptosis, and epicanthus inversus syndrome (BPES) [MIM:110100]	A0A2K6KLZ5	90	F	S
P58012	LP/P	Blepharophimosis, ptosis, and epicanthus inversus syndrome (BPES) [MIM:110100]	A0A2K6KLZ5	98	W	G
P58012	LP/P	Blepharophimosis, ptosis, and epicanthus inversus syndrome (BPES) [MIM:110100]	A0A2K6KLZ5	101	S	R
P58012	LP/P	Blepharophimosis, ptosis, and epicanthus inversus syndrome (BPES) [MIM:110100]	A0A2K6KLZ5	102	I	T
P58012	LP/P	Blepharophimosis, ptosis, and epicanthus inversus syndrome (BPES) [MIM:110100]	A0A2K6KLZ5	103	R	C
P58012	LP/P	Blepharophimosis, ptosis, and epicanthus inversus syndrome (BPES) [MIM:110100]	A0A2K6KLZ5	106	L	P
P58012	LP/P	Blepharophimosis, ptosis, and epicanthus inversus syndrome (BPES) [MIM:110100]	A0A2K6KLZ5	63	I	T
P58012	LP/P	Blepharophimosis, ptosis, and epicanthus inversus syndrome (BPES) [MIM:110100]	A0A2K6KLZ5	98	W	R
P58012	LP/P	Blepharophimosis, ptosis, and epicanthus inversus syndrome (BPES) [MIM:110100]	A0A2K6KLZ5	108	L	P
P58012	LP/P	Blepharophimosis, ptosis, and epicanthus inversus syndrome (BPES) [MIM:110100]	A0A2K6KLZ5	217	S	C
P58012	LB/B	-	A0A2K6KLZ5	349	R	G
Q96NZ1	LB/B	-	W5KHG4	137	P	L
Q9H334	LB/B	-	R4GBW0	5	S	P
Q9H334	LB/B	-	R4GBW0	101	M	V
Q9H334	LB/B	-	R4GBW0	215	P	A
Q9H334	LB/B	-	R4GBW0	261	S	P
Q9H334	LB/B	-	R4GBW0	390	T	S
Q9H334	LB/B	-	R4GBW0	445	V	M
Q9H334	LB/B	-	R4GBW0	570	N	S
Q9H334	LB/B	-	R4GBW0	613	T	N
Q9H334	LB/B	-	R4GBW0	107	I	T
Q9H334	LP/P	Intellectual developmental disorder with language impairment and with or without autistic features (MRLIAF) [MIM:613670]	R4GBW0	465	R	G
Q9H334	LP/P	Intellectual developmental disorder with language impairment and with or without autistic features (MRLIAF) [MIM:613670]	R4GBW0	514	R	C
Q9H334	LP/P	Intellectual developmental disorder with language impairment and with or without autistic features (MRLIAF) [MIM:613670]	R4GBW0	534	W	R
O15409	LP/P	Speech-language disorder 1 (SPCH1) [MIM:602081]	A0A1A8KH00	553	R	H
Q9BZS1	LP/P	Immunodeficiency polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) [MIM:304790]	F7FW29	371	F	C
Q9BZS1	LP/P	Immunodeficiency polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) [MIM:304790]	F7FW29	384	A	T
Q9BZS1	LP/P	Immunodeficiency polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) [MIM:304790]	F7FW29	397	R	W
Q9BZS1	LP/P	Immunodeficiency polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) [MIM:304790]	F7FW29	363	I	V
Q9BZS1	LP/P	Immunodeficiency polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) [MIM:304790]	F7FW29	242	L	P
Q9BZS1	LP/P	Immunodeficiency polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) [MIM:304790]	F7FW29	324	F	L
Q9BZS1	LP/P	Immunodeficiency polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) [MIM:304790]	F7FW29	339	P	A
Q9BZS1	LP/P	Immunodeficiency polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) [MIM:304790]	F7FW29	347	R	H
Q9BZS1	LP/P	Immunodeficiency polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) [MIM:304790]	F7FW29	373	F	A
Q9BZS1	LP/P	Immunodeficiency polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) [MIM:304790]	F7FW29	374	F	C
Q96CU9	LB/B	-	A0A0V0TK76	343	A	P
Q96CU9	LB/B	-	A0A0V0TK76	145	V	I
Q96CU9	LB/B	-	A0A0V0TK76	380	H	R
Q96CU9	LP/P	Mitochondrial complex I deficiency, nuclear type 19 (MC1DN19) [MIM:618241]	A0A0V0TK76	430	N	S
Q96CU9	LP/P	Mitochondrial complex I deficiency, nuclear type 19 (MC1DN19) [MIM:618241]	A0A0V0TK76	352	R	W
O43638	LB/B	-	G1Q0G1	292	P	A
P21462	LB/B	-	A0A2K5SIE2	101	V	L
P21462	LB/B	-	A0A2K5SIE2	192	N	K
P21462	LB/B	-	A0A2K5SIE2	346	E	A
P21462	LB/B	-	A0A2K5SIE2	11	I	T
P21462	LB/B	-	A0A2K5SIE2	190	R	W
Q70Z53	LB/B	-	H2LKE3	16	R	H
Q70Z53	LB/B	-	H2LKE3	78	T	R
Q70Z53	LB/B	-	H2LKE3	251	S	F
Q86XX4	LB/B	-	S7NX18	54	D	H
Q86XX4	LB/B	-	S7NX18	209	P	S
Q86XX4	LB/B	-	S7NX18	228	Y	H
Q86XX4	LB/B	-	S7NX18	243	I	V
Q86XX4	LB/B	-	S7NX18	429	S	Y
Q86XX4	LB/B	-	S7NX18	466	L	I
Q86XX4	LB/B	-	S7NX18	590	M	T
Q86XX4	LB/B	-	S7NX18	817	A	V
Q86XX4	LB/B	-	S7NX18	954	T	M
Q86XX4	LB/B	-	S7NX18	1023	G	E
Q86XX4	LB/B	-	S7NX18	1136	E	K
Q86XX4	LB/B	-	S7NX18	1626	A	V
Q86XX4	LB/B	-	S7NX18	32	D	G
Q86XX4	LB/B	-	S7NX18	687	D	G
Q86XX4	LB/B	-	S7NX18	710	I	L
Q86XX4	LB/B	-	S7NX18	2545	D	N
P0C091	LB/B	-	A0A2I0MS33	412	D	N
P0C091	LB/B	-	A0A2I0MS33	417	D	N
Q14331	LB/B	-	L9KRU9	19	T	A
Q8N878	LB/B	-	A0A2K5KBS3	274	R	C
Q8N878	LB/B	-	A0A2K5KBS3	456	Q	E
A2A2Y4	LB/B	-	A0A2U3XGN3	485	D	Y
Q9P2Q2	LB/B	-	L5LRU1	242	Q	H
Q7Z6J6	LP/P	Neurodevelopmental disorder with eye movement abnormalities and ataxia (NEDEMA) [MIM:620094]	A0A093BKN9	351	S	G
Q7Z6J6	LP/P	Neurodevelopmental disorder with eye movement abnormalities and ataxia (NEDEMA) [MIM:620094]	A0A093BKN9	351	S	R
Q7Z6J6	LP/P	Neurodevelopmental disorder with eye movement abnormalities and ataxia (NEDEMA) [MIM:620094]	A0A093BKN9	352	C	R
P0C7T7	LB/B	-	P0C7T7	115	G	R
Q6ZUT3	LP/P	Nystagmus congenital X-linked 1 (NYS1) [MIM:310700]	H9GLF8	24	G	E
Q6ZUT3	LP/P	Nystagmus congenital X-linked 1 (NYS1) [MIM:310700]	H9GLF8	24	G	R
Q6ZUT3	LP/P	Nystagmus congenital X-linked 1 (NYS1) [MIM:310700]	H9GLF8	142	L	R
Q6ZUT3	LP/P	Nystagmus congenital X-linked 1 (NYS1) [MIM:310700]	H9GLF8	221	N	D
Q6ZUT3	LP/P	Nystagmus congenital X-linked 1 (NYS1) [MIM:310700]	H9GLF8	226	A	T
Q6ZUT3	LP/P	Nystagmus congenital X-linked 1 (NYS1) [MIM:310700]	H9GLF8	231	L	V
Q6ZUT3	LP/P	Nystagmus congenital X-linked 1 (NYS1) [MIM:310700]	H9GLF8	266	A	P
Q6ZUT3	LP/P	Nystagmus congenital X-linked 1 (NYS1) [MIM:310700]	H9GLF8	271	C	Y
Q6ZUT3	LB/B	-	H9GLF8	281	S	L
Q6ZUT3	LP/P	Nystagmus congenital X-linked 1 (NYS1) [MIM:310700]	H9GLF8	301	Y	C
Q6ZUT3	LP/P	Nystagmus congenital X-linked 1 (NYS1) [MIM:310700]	H9GLF8	340	S	L
Q6ZUT3	LB/B	-	H9GLF8	468	R	H
Q6ZUT3	LP/P	Nystagmus congenital X-linked 1 (NYS1) [MIM:310700]	H9GLF8	24	G	W
Q6ZUT3	LP/P	Nystagmus congenital X-linked 1 (NYS1) [MIM:310700]	H9GLF8	146	R	W
Q6ZUT3	LP/P	Nystagmus congenital X-linked 1 (NYS1) [MIM:310700]	H9GLF8	225	W	G
Q6ZUT3	LP/P	Nystagmus congenital X-linked 1 (NYS1) [MIM:310700]	H9GLF8	229	R	C
Q6ZUT3	LP/P	Nystagmus congenital X-linked 1 (NYS1) [MIM:310700]	H9GLF8	229	R	G
Q6ZUT3	LP/P	Nystagmus congenital X-linked 1 (NYS1) [MIM:310700]	H9GLF8	261	R	G
Q6ZUT3	LP/P	Nystagmus congenital X-linked 1 (NYS1) [MIM:310700]	H9GLF8	261	R	Q
Q6ZUT3	LP/P	Nystagmus congenital X-linked 1 (NYS1) [MIM:310700]	H9GLF8	271	C	F
Q6ZUT3	LP/P	Nystagmus congenital X-linked 1 (NYS1) [MIM:310700]	H9GLF8	275	H	P
Q6ZUT3	LP/P	Nystagmus congenital X-linked 1 (NYS1) [MIM:310700]	H9GLF8	296	G	R
Q6ZUT3	LP/P	Nystagmus congenital X-linked 1 (NYS1) [MIM:310700]	H9GLF8	16	F	S
Q6ZUT3	LP/P	Nystagmus congenital X-linked 1 (NYS1) [MIM:310700]	H9GLF8	208	H	R
Q6ZUT3	LP/P	Nystagmus congenital X-linked 1 (NYS1) [MIM:310700]	H9GLF8	212	L	P
Q6ZUT3	LP/P	Nystagmus congenital X-linked 1 (NYS1) [MIM:310700]	H9GLF8	271	C	S
Q6ZUT3	LP/P	Nystagmus congenital X-linked 1 (NYS1) [MIM:310700]	H9GLF8	306	Q	R
Q5SYB0	LB/B	-	A0A212C4V5	6	T	P
Q5SYB0	LB/B	-	A0A212C4V5	44	A	T
Q5SYB0	LB/B	-	A0A212C4V5	50	T	N
Q5SYB0	LB/B	-	A0A212C4V5	225	A	V
Q5SYB0	LB/B	-	A0A212C4V5	846	Y	D
Q5SYB0	LB/B	-	A0A212C4V5	1092	G	E
Q14CM0	LP/P	Intellectual developmental disorder, X-linked 104 (XLID104) [MIM:300983]	A0A1A8GLL9	553	C	R
Q8WU20	LB/B	-	M7BXC5	303	K	N
Q8WU20	LB/B	-	M7BXC5	449	N	D
O43559	LB/B	-	A0A1L8GYJ1	221	P	L
Q5TBA9	LB/B	-	A0A146M8X4	1968	G	S
O94915	LB/B	-	A0A146M8X4	1878	I	V
O94915	LB/B	-	A0A146M8X4	890	P	S
Q92765	LP/P	Osteoarthritis 1 (OS1) [MIM:165720]	A0A1S3GDR1	324	R	G
Q92765	LB/B	-	A0A1S3GDR1	200	R	W
O95073	LB/B	-	A0A1A8RDZ4	226	R	K
Q5H9T9	LB/B	-	B3KW45	119	P	S
Q5H9T9	LB/B	-	B3KW45	195	H	Q
Q5H9T9	LB/B	-	B3KW45	380	L	P
Q5H9T9	LB/B	-	B3KW45	409	P	S
Q5H9T9	LB/B	-	B3KW45	423	D	E
Q5H9T9	LB/B	-	B3KW45	642	A	T
Q9NQT6	LB/B	-	K7FFI0	24	A	S
Q9NQT6	LB/B	-	K7FFI0	428	H	L
Q9BTV5	LB/B	-	W5MHW8	232	L	V
A1L4K1	LB/B	-	W5N5Q8	333	K	T
A1L4K1	LB/B	-	W5N5Q8	720	E	K
P01225	LB/B	-	A0A0A0MQ67	20	S	I
P01225	LP/P	Hypogonadotropic hypogonadism 24 with or without anosmia (HH24) [MIM:229070]	A0A0A0MQ67	69	C	G
Q5CZC0	LB/B	-	A0A2I3M713	306	M	V
Q5CZC0	LB/B	-	A0A2I3M713	700	L	F
Q5CZC0	LB/B	-	A0A2I3M713	2764	P	T
P19883	LB/B	-	A0A0C9RTQ0	152	E	Q
O95954	LP/P	Glutamate formiminotransferase deficiency (FIGLU-URIA) [MIM:229100]	F7DDZ6	135	R	C
O95954	LP/P	Glutamate formiminotransferase deficiency (FIGLU-URIA) [MIM:229100]	F7DDZ6	299	R	P
O95954	LB/B	-	F7DDZ6	438	A	E
P0C7X4	LB/B	-	P0C7X4	17	R	H
P0C7X4	LB/B	-	P0C7X4	106	A	P
Q9BXU8	LB/B	-	A0A2K6NP59	120	Q	H
Q9BXU8	LB/B	-	A0A2K6NP59	138	Y	H
P02792	LP/P	Neurodegeneration with brain iron accumulation 3 (NBIA3) [MIM:606159]	I3MUG1	96	A	T
P02792	LP/P	Hyperferritinemia with or without cataract (HRFTC) [MIM:600886]	I3MUG1	30	T	I
Q9C0B1	LB/B	-	L5KWP6	405	A	V
Q9C0B1	LP/P	Growth retardation, developmental delay, and facial dysmorphism (GDFD) [MIM:612938]	L5KWP6	316	R	Q
Q9C0B1	LP/P	Growth retardation, developmental delay, and facial dysmorphism (GDFD) [MIM:612938]	L5KWP6	319	S	F
Q9C0B1	LP/P	Growth retardation, developmental delay, and facial dysmorphism (GDFD) [MIM:612938]	L5KWP6	322	R	Q
Q8IY81	LB/B	-	Q5ZKM1	91	Q	E
Q8IY81	LB/B	-	Q5ZKM1	424	S	C
Q96AE4	LB/B	-	A0A1S3M0U8	399	I	K
P04066	LP/P	Fucosidosis (FUCA1D) [MIM:230000]	A0A2U4CP59	65	G	D
P04066	LP/P	Fucosidosis (FUCA1D) [MIM:230000]	A0A2U4CP59	68	S	L
P04066	LB/B	-	A0A2U4CP59	286	Q	R
P04066	LB/B	-	A0A2U4CP59	10	P	R
P04066	LB/B	-	A0A2U4CP59	269	C	S
P04066	LP/P	Fucosidosis (FUCA1D) [MIM:230000]	A0A2U4CP59	410	L	R
P04066	LB/B	-	A0A2U4CP59	2	R	W
P04066	LB/B	-	A0A2U4CP59	146	P	L
P04066	LB/B	-	A0A2U4CP59	260	V	I
Q9BTY2	LB/B	-	A0A2U4CP59	356	M	V
Q9BTY2	LB/B	-	A0A2U4CP59	371	H	Y
Q9BTY2	LB/B	-	A0A2U4CP59	233	A	E
P19526	LB/B	-	A0A2K6LZ36	349	W	C
P19526	LB/B	-	A0A2K6LZ36	164	L	H
P19526	LB/B	-	A0A2K6LZ36	242	L	R
P19526	LB/B	-	A0A2K6LZ36	148	D	Y
P19526	LB/B	-	A0A2K6LZ36	154	Y	H
P19526	LB/B	-	A0A2K6LZ36	241	Y	H
P19526	LB/B	-	A0A2K6LZ36	348	E	K
P19526	LB/B	-	A0A2K6LZ36	12	A	V
Q6P4F1	LB/B	-	G7MZ27	59	L	F
Q6P4F1	LB/B	-	G7MZ27	268	Y	H
Q6P4F1	LB/B	-	G7MZ27	368	L	V
Q6P4F1	LB/B	-	G7MZ27	371	R	P
Q495W5	LB/B	-	S9YPW1	51	S	A
Q10981	LB/B	-	A0A2U3WZL2	25	I	V
Q10981	LB/B	-	A0A2U3WZL2	138	R	C
Q10981	LB/B	-	A0A2U3WZL2	140	I	F
Q10981	LB/B	-	A0A2U3WZL2	172	D	N
Q10981	LB/B	-	A0A2U3WZL2	258	G	S
P21217	LB/B	-	A0A2K6G1Z4	20	L	R
P21217	LB/B	-	A0A2K6G1Z4	105	T	M
P21217	LB/B	-	A0A2K6G1Z4	170	G	S
P21217	LB/B	-	A0A2K6G1Z4	336	D	A
P21217	LB/B	-	A0A2K6G1Z4	356	I	K
P21217	LB/B	-	A0A2K6G1Z4	68	W	R
P21217	LB/B	-	A0A2K6G1Z4	102	Q	K
P21217	LB/B	-	A0A2K6G1Z4	124	S	A
P21217	LB/B	-	A0A2K6G1Z4	162	D	N
P21217	LB/B	-	A0A2K6G1Z4	223	G	R
P21217	LB/B	-	A0A2K6G1Z4	270	V	M
P21217	LB/B	-	A0A2K6G1Z4	5	G	S
P21217	LB/B	-	A0A2K6G1Z4	160	R	C
P21217	LB/B	-	A0A2K6G1Z4	325	T	M
P21217	LB/B	-	A0A2K6G1Z4	327	R	Q
Q11128	LB/B	-	A0A2K6G1Z4	187	P	L
Q11128	LB/B	-	A0A2K6G1Z4	338	T	M
P51993	LB/B	-	A0A2K6G1Z4	124	P	S
P51993	LB/B	-	A0A2K6G1Z4	230	Q	K
P51993	LB/B	-	A0A2K6G1Z4	247	E	K
P51993	LB/B	-	A0A2K6G1Z4	303	R	G
Q11130	LB/B	-	L5K7D8	110	R	Q
Q9BYC5	LB/B	-	A0A293MSG4	267	T	K
Q9BYC5	LB/B	-	A0A293MSG4	101	K	Q
Q9BYC5	LP/P	Congenital disorder of glycosylation with defective fucosylation 1 (CDGF1) [MIM:618005]	A0A293MSG4	337	R	G
Q9BT04	LB/B	-	A0A2I3H104	34	A	S
Q9BT04	LB/B	-	A0A2I3H104	175	G	D
Q9BT04	LB/B	-	A0A2I3H104	400	T	I
P51114	LB/B	-	A0A1U8DLM4	614	A	V
P51114	LB/B	-	A0A1U8DLM4	429	D	N
P51116	LB/B	-	L9KM93	591	R	P
P51116	LB/B	-	L9KM93	252	Q	H
P54710	LP/P	Hypomagnesemia 2 (HOMG2) [MIM:154020]	H0XPH7	41	G	R
Q14802	LB/B	-	A0A1S5UZ23	40	G	S
Q96DB9	LB/B	-	G3TAS1	35	S	A
Q96DB9	LB/B	-	G3TAS1	176	R	H
Q9BQS8	LB/B	-	L5KHA2	250	R	Q
Q9BQS8	LB/B	-	L5KHA2	282	R	H
Q9BQS8	LB/B	-	L5KHA2	321	G	A
Q9BQS8	LB/B	-	L5KHA2	381	T	M
Q9BQS8	LB/B	-	L5KHA2	679	A	V
Q9BQS8	LB/B	-	L5KHA2	1001	N	D
Q9BQS8	LB/B	-	L5KHA2	447	R	C
Q9BQS8	LB/B	-	L5KHA2	994	E	K
Q9BQS8	LP/P	Cataract 18 (CTRCT18) [MIM:610019]	L5KHA2	1376	L	P
P06241	LB/B	-	F6T9G2	445	I	F
P06241	LB/B	-	F6T9G2	506	D	E
Q96QD9	LB/B	-	A0A2K5V7T3	87	R	H
Q14332	LP/P	Omodysplasia 2 (OMOD2) [MIM:164745]	A0A2R7WR03	434	G	V
Q14332	LP/P	-	A0A2R7WR03	434	G	S
Q9NPG1	LB/B	-	A0A2I4BY42	4	T	S
Q9NPG1	LB/B	-	A0A2I4BY42	199	L	M
Q9NPG1	LB/B	-	A0A2I4BY42	545	I	V
Q9ULV1	LP/P	Vitreoretinopathy, exudative 1 (EVR1) [MIM:133780]	A0A1U7UJD3	105	M	V
Q9ULV1	LP/P	Vitreoretinopathy, exudative 1 (EVR1) [MIM:133780]	A0A1U7UJD3	157	M	V
Q9ULV1	LB/B	Vitreoretinopathy, exudative 1 (EVR1) [MIM:133780]	A0A1U7UJD3	33	P	S
Q9ULV1	LP/P	Vitreoretinopathy, exudative 1 (EVR1) [MIM:133780]	A0A1U7UJD3	36	G	D
Q9ULV1	LP/P	Vitreoretinopathy, exudative 1 (EVR1) [MIM:133780]	A0A1U7UJD3	40	E	Q
Q9ULV1	LP/P	Vitreoretinopathy, exudative 1 (EVR1) [MIM:133780]	A0A1U7UJD3	69	H	Y
Q9ULV1	LP/P	Vitreoretinopathy, exudative 1 (EVR1) [MIM:133780]	A0A1U7UJD3	105	M	T
Q9ULV1	LP/P	Vitreoretinopathy, exudative 1 (EVR1) [MIM:133780]	A0A1U7UJD3	114	I	T
Q9ULV1	LB/B	-	A0A1U7UJD3	168	P	S
Q9ULV1	LP/P	Vitreoretinopathy, exudative 1 (EVR1) [MIM:133780]	A0A1U7UJD3	181	C	R
Q9ULV1	LB/B	-	A0A1U7UJD3	203	K	N
Q9ULV1	LP/P	Vitreoretinopathy, exudative 1 (EVR1) [MIM:133780]	A0A1U7UJD3	204	C	R
Q9ULV1	LP/P	Vitreoretinopathy, exudative 1 (EVR1) [MIM:133780]	A0A1U7UJD3	204	C	Y
Q9ULV1	LP/P	Vitreoretinopathy, exudative 1 (EVR1) [MIM:133780]	A0A1U7UJD3	223	M	K
Q9ULV1	LP/P	Vitreoretinopathy, exudative 1 (EVR1) [MIM:133780]	A0A1U7UJD3	256	I	V
Q9ULV1	LP/P	Vitreoretinopathy, exudative 1 (EVR1) [MIM:133780]	A0A1U7UJD3	335	W	C
Q9ULV1	LP/P	Vitreoretinopathy, exudative 1 (EVR1) [MIM:133780]	A0A1U7UJD3	342	M	V
Q9ULV1	LP/P	Vitreoretinopathy, exudative 1 (EVR1) [MIM:133780]	A0A1U7UJD3	417	R	Q
Q9ULV1	LP/P	Vitreoretinopathy, exudative 1 (EVR1) [MIM:133780]	A0A1U7UJD3	445	T	P
Q9ULV1	LP/P	Vitreoretinopathy, exudative 1 (EVR1) [MIM:133780]	A0A1U7UJD3	488	G	D
Q9ULV1	LP/P	Vitreoretinopathy, exudative 1 (EVR1) [MIM:133780]	A0A1U7UJD3	497	S	F
Q9ULV1	LP/P	Vitreoretinopathy, exudative 1 (EVR1) [MIM:133780]	A0A1U7UJD3	525	G	R
O75084	LB/B	-	A0A091CKW2	24	G	S
O75084	LB/B	-	A0A091CKW2	196	G	E
O75084	LB/B	-	A0A091CKW2	487	A	V
O75084	LB/B	-	A0A091CKW2	24	G	D
Q9UM11	LP/P	Developmental and epileptic encephalopathy 109 (DEE109) [MIM:620145]	S7MI48	187	D	G
Q9UM11	LP/P	Developmental and epileptic encephalopathy 109 (DEE109) [MIM:620145]	S7MI48	187	D	N
Q9UM11	LP/P	Developmental and epileptic encephalopathy 109 (DEE109) [MIM:620145]	S7MI48	333	N	K
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	38	D	V
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	77	W	R
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	83	R	C
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	83	R	H
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	83	R	I
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	110	E	K
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	124	A	T
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	166	V	G
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	184	G	E
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	188	G	R
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	211	L	P
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	222	G	R
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	266	G	V
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	270	G	V
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	295	R	C
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	338	V	F
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	341	I	N
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	20	Q	R
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	54	Q	P
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	81	G	R
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	108	T	I
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	156	W	L
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	188	G	D
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	5	M	R
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	16	T	A
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	16	T	R
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	63	W	R
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	65	A	P
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	68	G	R
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	76	K	N
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	111	T	I
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	113	P	L
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	119	H	L
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	122	G	D
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	166	V	A
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	170	R	Q
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	177	F	C
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	178	P	S
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	179	H	P
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	184	G	V
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	188	G	S
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	209	Y	C
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	236	W	R
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	241	A	T
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	257	P	L
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	264	N	K
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	265	L	P
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	270	G	R
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	270	G	W
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	298	S	P
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	322	F	L
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	345	L	R
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	178	P	A
P35575	LP/P	Glycogen storage disease 1A (GSD1A) [MIM:232200]	A0A2C9M310	255	T	I
Q9NQR9	LB/B	-	A0A2C9M310	171	I	V
Q9NQR9	LB/B	-	A0A2C9M310	207	Y	S
Q9NQR9	LB/B	-	A0A2C9M310	219	V	L
Q9NQR9	LB/B	-	A0A2C9M310	324	S	P
Q9NQR9	LB/B	-	A0A2C9M310	340	P	L
Q9NQR9	LB/B	-	A0A2C9M310	342	S	C
Q9BUM1	LB/B	-	A0A151PBT7	216	T	I
Q9BUM1	LP/P	Neutropenia, severe congenital 4, autosomal recessive (SCN4) [MIM:612541]	A0A151PBT7	185	L	P
Q9BUM1	LP/P	Neutropenia, severe congenital 4, autosomal recessive (SCN4) [MIM:612541]	A0A151PBT7	253	R	H
Q9BUM1	LP/P	Neutropenia, severe congenital 4, autosomal recessive (SCN4) [MIM:612541]	A0A151PBT7	262	G	R
Q9BUM1	LP/P	Neutropenia, severe congenital 4, autosomal recessive (SCN4) [MIM:612541]	A0A151PBT7	116	M	K
Q9BUM1	LP/P	Dursun syndrome (DURSS) [MIM:612541]	A0A151PBT7	116	M	V
Q9BUM1	LP/P	Neutropenia, severe congenital 4, autosomal recessive (SCN4) [MIM:612541]	A0A151PBT7	116	M	V
Q9BUM1	LP/P	Neutropenia, severe congenital 4, autosomal recessive (SCN4) [MIM:612541]	A0A151PBT7	189	R	Q
Q9BUM1	LP/P	Neutropenia, severe congenital 4, autosomal recessive (SCN4) [MIM:612541]	A0A151PBT7	260	G	R
Q9BUM1	LP/P	Neutropenia, severe congenital 4, autosomal recessive (SCN4) [MIM:612541]	A0A151PBT7	44	P	S
Q9BUM1	LP/P	Neutropenia, severe congenital 4, autosomal recessive (SCN4) [MIM:612541]	A0A151PBT7	59	W	R
Q9BUM1	LP/P	Neutropenia, severe congenital 4, autosomal recessive (SCN4) [MIM:612541]	A0A151PBT7	116	M	T
Q9BUM1	LP/P	Neutropenia, severe congenital 4, autosomal recessive (SCN4) [MIM:612541]	A0A151PBT7	139	S	I
Q9BUM1	LP/P	Neutropenia, severe congenital 4, autosomal recessive (SCN4) [MIM:612541]	A0A151PBT7	154	L	P
Q9BUM1	LP/P	Neutropenia, severe congenital 4, autosomal recessive (SCN4) [MIM:612541]	A0A151PBT7	208	L	R
Q9BUM1	LP/P	Neutropenia, severe congenital 4, autosomal recessive (SCN4) [MIM:612541]	A0A151PBT7	260	G	D
Q9BUM1	LP/P	Neutropenia, severe congenital 4, autosomal recessive (SCN4) [MIM:612541]	A0A151PBT7	325	L	R
Q9BUM1	LP/P	Neutropenia, severe congenital 4, autosomal recessive (SCN4) [MIM:612541]	A0A151PBT7	44	P	L
Q9BUM1	LP/P	Neutropenia, severe congenital 4, autosomal recessive (SCN4) [MIM:612541]	A0A151PBT7	116	M	I
Q9BUM1	LP/P	Neutropenia, severe congenital 4, autosomal recessive (SCN4) [MIM:612541]	A0A151PBT7	118	T	R
Q9BUM1	LP/P	Neutropenia, severe congenital 4, autosomal recessive (SCN4) [MIM:612541]	A0A151PBT7	161	R	Q
Q9BUM1	LP/P	Neutropenia, severe congenital 4, autosomal recessive (SCN4) [MIM:612541]	A0A151PBT7	253	R	C
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	32	H	R
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	44	A	G
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	48	I	T
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	58	D	N
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	68	V	M
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	70	Y	H
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	75	L	P
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	81	R	H
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	81	R	C
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	106	S	C
P11413	LB/B	-	A0A061HUL7	126	N	D
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	128	L	P
P11413	LB/B	-	A0A061HUL7	131	G	V
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	156	E	K
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	163	G	S
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	163	G	D
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	165	N	D
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	166	R	H
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	176	D	G
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	181	D	V
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	182	R	W
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	188	S	F
P11413	LB/B	-	A0A061HUL7	198	R	C
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	198	R	P
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	212	M	V
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	213	V	L
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	216	F	L
P11413	LB/B	-	A0A061HUL7	227	R	Q
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	227	R	L
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	257	R	G
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	274	E	K
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	278	S	F
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	279	T	S
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	282	D	H
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	285	R	H
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	291	V	M
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	317	E	K
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	323	L	P
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	335	A	T
P11413	LB/B	-	A0A061HUL7	342	L	F
P11413	LB/B	-	A0A061HUL7	353	P	S
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	363	N	K
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	385	C	R
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	386	K	E
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	387	R	H
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	387	R	C
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	393	R	H
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	394	V	L
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	396	P	L
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	398	E	K
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	410	G	C
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	410	G	D
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	416	E	K
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	439	R	P
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	440	L	F
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	447	G	R
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	449	Q	H
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	454	R	C
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	454	R	H
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	459	R	L
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	459	R	P
P11413	LB/B	-	A0A061HUL7	463	R	H
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	488	G	V
P11413	LB/B	-	A0A061HUL7	322	Y	H
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	198	R	S
P11413	LB/B	-	A0A061HUL7	184	S	F
P11413	LB/B	-	A0A061HUL7	198	R	H
P11413	LP/P	Anemia, non-spherocytic hemolytic, due to G6PD deficiency (NSHA) [MIM:300908]	A0A061HUL7	321	G	V
P10253	LB/B	-	A0A2Y9FWA5	91	D	N
P10253	LB/B	-	A0A2Y9FWA5	199	H	R
P10253	LB/B	-	A0A2Y9FWA5	223	R	H
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	299	L	R
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	318	M	T
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	402	W	R
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	478	G	R
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	481	W	R
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	519	M	T
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	519	M	V
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	521	E	K
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	529	S	V
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	545	P	L
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	566	S	P
P10253	LB/B	-	A0A2Y9FWA5	576	G	A
P10253	LB/B	-	A0A2Y9FWA5	576	G	S
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	643	G	R
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	645	D	E
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	645	D	H
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	645	D	N
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	647	C	W
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	648	G	S
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	672	R	Q
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	672	R	W
P10253	LB/B	-	A0A2Y9FWA5	689	E	K
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	725	R	W
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	746	W	C
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	768	P	R
P10253	LB/B	-	A0A2Y9FWA5	780	V	I
P10253	LB/B	-	A0A2Y9FWA5	816	V	I
P10253	LB/B	-	A0A2Y9FWA5	927	T	I
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	949	V	D
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	600	R	H
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	615	G	R
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	103	C	G
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	219	G	R
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	285	P	R
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	292	Y	C
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	293	G	R
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	308	H	P
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	309	G	R
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	312	L	R
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	355	L	P
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	374	C	R
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	405	L	P
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	455	Y	F
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	549	G	R
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	552	L	P
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	575	Y	S
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	579	E	K
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	600	R	C
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	607	G	D
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	880	A	D
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	208	L	P
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	224	R	W
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	237	A	V
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	262	E	K
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	324	P	L
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	330	W	G
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	361	P	L
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	377	G	R
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	404	D	N
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	408	M	V
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	437	R	C
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	445	A	P
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	489	D	N
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	612	H	Q
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	901	L	Q
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	457	P	L
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	191	Y	C
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	308	H	L
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	375	R	L
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	401	Q	R
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	522	P	A
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	585	R	M
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	599	S	Y
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	619	S	R
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	638	G	W
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	660	R	H
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	672	R	T
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	702	R	C
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	46	S	P
P10253	LB/B	-	A0A2Y9FWA5	74	R	H
P10253	LB/B	-	A0A2Y9FWA5	89	R	H
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	103	C	R
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	108	C	G
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	127	C	F
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	190	R	H
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	217	P	L
P10253	LB/B	-	A0A2Y9FWA5	220	V	L
P10253	LB/B	-	A0A2Y9FWA5	222	V	M
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	224	R	P
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	224	R	Q
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	234	T	K
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	234	T	R
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	251	S	L
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	254	S	L
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	266	P	S
P10253	LB/B	-	A0A2Y9FWA5	271	T	A
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	285	P	S
P10253	LB/B	-	A0A2Y9FWA5	290	N	D
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	291	L	F
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	291	L	P
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	316	N	I
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	318	M	K
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	335	G	E
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	335	G	R
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	347	P	R
P10253	LB/B	-	A0A2Y9FWA5	359	G	R
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	397	P	L
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	419	D	V
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	457	P	H
P10253	LB/B	-	A0A2Y9FWA5	458	Y	C
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	482	P	R
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	483	G	V
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	486	A	P
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	521	E	Q
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	522	P	S
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	523	S	Y
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	525	F	Y
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	557	I	F
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	558	C	S
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	570	N	K
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	572	H	Q
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	575	Y	C
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	576	G	R
P10253	LB/B	-	A0A2Y9FWA5	585	R	K
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	594	R	H
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	594	R	P
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	601	S	L
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	602	T	A
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	610	A	V
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	612	H	Y
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	614	T	K
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	627	S	P
P10253	LB/B	-	A0A2Y9FWA5	629	P	L
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	635	N	K
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	638	G	V
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	648	G	D
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	702	R	L
P10253	LB/B	-	A0A2Y9FWA5	711	T	R
P10253	LB/B	-	A0A2Y9FWA5	718	V	I
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	737	T	N
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	743	Q	K
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	746	W	G
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	746	W	S
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	819	R	P
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	916	V	F
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	935	L	P
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	568	H	L
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	766	Y	C
P10253	LP/P	Glycogen storage disease 2 (GSD2) [MIM:232300]	A0A2Y9FWA5	913	P	R
P60520	LB/B	-	A0A2U9BB57	51	V	A
O75899	LB/B	-	A0A2I2UQN0	628	Y	F
O75899	LB/B	-	A0A2I2UQN0	869	T	A
O75899	LB/B	-	A0A2I2UQN0	163	L	P
O75899	LP/P	Neurodevelopmental disorder with poor language and loss of hand skills (NDPLHS) [MIM:617903]	A0A2I2UQN0	567	A	T
O75899	LP/P	Developmental and epileptic encephalopathy 59 (DEE59) [MIM:617904]	A0A2I2UQN0	695	S	I
O75899	LP/P	Developmental and epileptic encephalopathy 59 (DEE59) [MIM:617904]	A0A2I2UQN0	705	I	N
O75899	LP/P	Neurodevelopmental disorder with poor language and loss of hand skills (NDPLHS) [MIM:617903]	A0A2I2UQN0	707	A	T
Q06546	LB/B	-	A0A091CU92	291	A	V
Q06546	LB/B	-	A0A091CU92	345	E	K
Q8TAK5	LB/B	-	S9WVP0	62	V	I
P14867	LP/P	Juvenile myoclonic epilepsy 5 (EJM5) [MIM:611136]	A0A1U7QGV7	322	A	D
P14867	LP/P	Developmental and epileptic encephalopathy 19 (DEE19) [MIM:615744]	A0A1U7QGV7	112	R	Q
P14867	LP/P	Epilepsy, idiopathic generalized 13 (EIG13) [MIM:611136]	A0A1U7QGV7	219	D	N
P14867	LP/P	Developmental and epileptic encephalopathy 19 (DEE19) [MIM:615744]	A0A1U7QGV7	251	G	S
P14867	LP/P	Developmental and epileptic encephalopathy 19 (DEE19) [MIM:615744]	A0A1U7QGV7	306	K	T
P14867	LP/P	Developmental and epileptic encephalopathy 19 (DEE19) [MIM:615744]	A0A1U7QGV7	146	L	M
P47869	LP/P	Developmental and epileptic encephalopathy 78 (DEE78) [MIM:618557]	F6U2C0	263	M	T
P47869	LP/P	Developmental and epileptic encephalopathy 78 (DEE78) [MIM:618557]	F6U2C0	284	V	A
P47869	LP/P	Developmental and epileptic encephalopathy 78 (DEE78) [MIM:618557]	F6U2C0	291	L	V
P47869	LP/P	Developmental and epileptic encephalopathy 78 (DEE78) [MIM:618557]	F6U2C0	292	T	K
P47869	LP/P	Developmental and epileptic encephalopathy 78 (DEE78) [MIM:618557]	F6U2C0	325	F	L
P34903	LP/P	Epilepsy, X-linked 2, with or without impaired intellectual development and dysmorphic features (EPILX2) [MIM:301091]	A0A1S3G751	166	T	M
P34903	LP/P	Epilepsy, X-linked 2, with or without impaired intellectual development and dysmorphic features (EPILX2) [MIM:301091]	A0A1S3G751	474	Y	C
P31644	LP/P	Developmental and epileptic encephalopathy 79 (DEE79) [MIM:618559]	F6U2C0	294	V	F
P31644	LP/P	Developmental and epileptic encephalopathy 79 (DEE79) [MIM:618559]	F6U2C0	294	V	L
P31644	LP/P	Developmental and epileptic encephalopathy 79 (DEE79) [MIM:618559]	F6U2C0	413	S	F
Q16445	LB/B	-	A0A1S3G751	187	T	M
Q16445	LB/B	-	A0A1S3G751	404	P	S
P18505	LB/B	-	F1QPW7	421	H	Q
P18505	LB/B	-	F1QPW7	429	I	N
P18505	LP/P	Developmental and epileptic encephalopathy 45 (DEE45) [MIM:617153]	F1QPW7	246	F	S
P18505	LP/P	Developmental and epileptic encephalopathy 45 (DEE45) [MIM:617153]	F1QPW7	287	T	I
P47870	LP/P	Epileptic encephalopathy, infantile or early childhood, 2 (IECEE2) [MIM:617829]	F1QPW7	287	T	P
P28472	LP/P	Epilepsy, childhood absence 5 (ECA5) [MIM:612269]	F1QPW7	32	G	R
P28472	LB/B	-	F1QPW7	173	Q	L
P28472	LB/B	-	F1QPW7	217	R	H
P28472	LP/P	Developmental and epileptic encephalopathy 43 (DEE43) [MIM:617113]	F1QPW7	120	D	N
P28472	LP/P	Developmental and epileptic encephalopathy 43 (DEE43) [MIM:617113]	F1QPW7	182	Y	F
P28472	LP/P	Developmental and epileptic encephalopathy 43 (DEE43) [MIM:617113]	F1QPW7	249	Q	K
P28472	LP/P	Developmental and epileptic encephalopathy 43 (DEE43) [MIM:617113]	F1QPW7	256	L	Q
P28472	LP/P	Developmental and epileptic encephalopathy 43 (DEE43) [MIM:617113]	F1QPW7	305	A	T
P28472	LP/P	Developmental and epileptic encephalopathy 43 (DEE43) [MIM:617113]	F1QPW7	124	L	F
P28472	LP/P	Developmental and epileptic encephalopathy 43 (DEE43) [MIM:617113]	F1QPW7	254	S	F
P28472	LP/P	Developmental and epileptic encephalopathy 43 (DEE43) [MIM:617113]	F1QPW7	287	T	I
O14764	LP/P	Generalized epilepsy with febrile seizures plus 5 (GEFSP5) [MIM:613060]	A0A218V8D5	177	E	A
O14764	LB/B	-	A0A218V8D5	220	R	H
O14764	LB/B	-	A0A218V8D5	62	P	S
O00591	LB/B	-	L5L154	391	F	L
Q9UN88	LB/B	-	A0A2K6G689	15	L	I
Q9UN88	LB/B	-	A0A2K6G689	478	I	F
P24046	LB/B	-	W5NJY2	27	H	R
P24046	LB/B	-	W5NJY2	26	M	V
Q99259	LB/B	-	A0A1U7UEN6	474	V	G
Q99259	LB/B	-	A0A1U7UEN6	532	R	Q
Q99259	LB/B	-	A0A1U7UEN6	565	F	L
Q99259	LB/B	-	A0A1U7UEN6	228	I	L
Q99259	LB/B	-	A0A1U7UEN6	12	S	C
Q99259	LP/P	Developmental and epileptic encephalopathy 89 (DEE89) [MIM:619124]	A0A1U7UEN6	509	E	K
Q05329	LB/B	-	S9XRT2	12	G	R
Q05329	LB/B	-	S9XRT2	124	K	N
Q05329	LB/B	-	S9XRT2	286	K	R
Q05329	LB/B	-	S9XRT2	375	R	Q
Q05329	LB/B	-	S9XRT2	153	P	Q
Q05329	LB/B	-	S9XRT2	232	G	E
Q05329	LB/B	-	S9XRT2	326	G	A
A6NGK3	LB/B	-	A0A0D9RK61	11	P	S
A6NGK3	LB/B	-	A0A0D9RK61	15	R	L
P22466	LB/B	-	F6YII8	16	A	V
P22466	LP/P	Epilepsy, familial temporal lobe, 8 (ETL8) [MIM:616461]	F6YII8	39	A	E
Q99999	LB/B	-	A0A1S3F0K6	29	V	M
Q96A11	LB/B	-	M4A1Q3	221	A	D
Q96A11	LB/B	-	M4A1Q3	410	E	A
Q96RP7	LB/B	-	G1M9L7	353	R	Q
Q96RP7	LB/B	-	G1M9L7	467	A	V
P54803	LP/P	Krabbe disease (KRB) [MIM:245200]	A0A1A6GPW1	111	G	D
P54803	LP/P	Krabbe disease (KRB) [MIM:245200]	A0A1A6GPW1	111	G	S
P54803	LP/P	Krabbe disease (KRB) [MIM:245200]	A0A1A6GPW1	112	T	A
P54803	LP/P	Krabbe disease (KRB) [MIM:245200]	A0A1A6GPW1	117	M	L
P54803	LP/P	Krabbe disease (KRB) [MIM:245200]	A0A1A6GPW1	187	D	V
P54803	LP/P	Krabbe disease (KRB) [MIM:245200]	A0A1A6GPW1	194	G	A
P54803	LB/B	-	A0A1A6GPW1	248	D	N
P54803	LP/P	Krabbe disease (KRB) [MIM:245200]	A0A1A6GPW1	250	I	T
P54803	LP/P	Krabbe disease (KRB) [MIM:245200]	A0A1A6GPW1	263	A	T
P54803	LP/P	Krabbe disease (KRB) [MIM:245200]	A0A1A6GPW1	284	G	S
P54803	LP/P	Krabbe disease (KRB) [MIM:245200]	A0A1A6GPW1	286	G	D
P54803	LP/P	Krabbe disease (KRB) [MIM:245200]	A0A1A6GPW1	295	N	T
P54803	LP/P	Krabbe disease (KRB) [MIM:245200]	A0A1A6GPW1	303	S	F
P54803	LP/P	Krabbe disease (KRB) [MIM:245200]	A0A1A6GPW1	318	P	A
P54803	LP/P	Krabbe disease (KRB) [MIM:245200]	A0A1A6GPW1	396	R	W
P54803	LP/P	Krabbe disease (KRB) [MIM:245200]	A0A1A6GPW1	400	P	L
P54803	LP/P	Krabbe disease (KRB) [MIM:245200]	A0A1A6GPW1	514	F	S
P54803	LP/P	Krabbe disease (KRB) [MIM:245200]	A0A1A6GPW1	529	T	M
P54803	LP/P	Krabbe disease (KRB) [MIM:245200]	A0A1A6GPW1	531	R	C
P54803	LP/P	Krabbe disease (KRB) [MIM:245200]	A0A1A6GPW1	544	D	N
P54803	LB/B	-	A0A1A6GPW1	562	I	T
P54803	LP/P	Krabbe disease (KRB) [MIM:245200]	A0A1A6GPW1	566	V	G
P54803	LP/P	Krabbe disease (KRB) [MIM:245200]	A0A1A6GPW1	567	Y	S
P54803	LP/P	Krabbe disease (KRB) [MIM:245200]	A0A1A6GPW1	592	A	S
P54803	LP/P	Krabbe disease (KRB) [MIM:245200]	A0A1A6GPW1	599	I	S
P54803	LB/B	-	A0A1A6GPW1	641	T	A
P54803	LP/P	Krabbe disease (KRB) [MIM:245200]	A0A1A6GPW1	645	L	R
P54803	LP/P	Krabbe disease (KRB) [MIM:245200]	A0A1A6GPW1	59	G	R
P54803	LP/P	Krabbe disease (KRB) [MIM:245200]	A0A1A6GPW1	68	S	F
P54803	LP/P	Krabbe disease (KRB) [MIM:245200]	A0A1A6GPW1	79	R	H
P54803	LP/P	Krabbe disease (KRB) [MIM:245200]	A0A1A6GPW1	82	I	M
P54803	LB/B	-	A0A1A6GPW1	184	R	C
P54803	LP/P	Krabbe disease (KRB) [MIM:245200]	A0A1A6GPW1	278	T	I
P54803	LB/B	-	A0A1A6GPW1	305	I	V
P54803	LP/P	Krabbe disease (KRB) [MIM:245200]	A0A1A6GPW1	314	Y	C
P54803	LP/P	Krabbe disease (KRB) [MIM:245200]	A0A1A6GPW1	335	Y	C
P54803	LP/P	Krabbe disease (KRB) [MIM:245200]	A0A1A6GPW1	426	W	G
P54803	LP/P	Krabbe disease (KRB) [MIM:245200]	A0A1A6GPW1	531	R	H
P54803	LP/P	Krabbe disease (KRB) [MIM:245200]	A0A1A6GPW1	553	G	R
P54803	LP/P	Krabbe disease (KRB) [MIM:245200]	A0A1A6GPW1	634	L	S
P54803	LP/P	Krabbe disease (KRB) [MIM:245200]	A0A1A6GPW1	668	T	R
P54803	LB/B	-	A0A1A6GPW1	21	A	P
P54803	LP/P	Krabbe disease (KRB) [MIM:245200]	A0A1A6GPW1	41	G	S
P54803	LP/P	Krabbe disease (KRB) [MIM:245200]	A0A1A6GPW1	130	E	K
P54803	LP/P	Krabbe disease (KRB) [MIM:245200]	A0A1A6GPW1	318	P	R
P54803	LP/P	Krabbe disease (KRB) [MIM:245200]	A0A1A6GPW1	323	G	R
P54803	LP/P	Krabbe disease (KRB) [MIM:245200]	A0A1A6GPW1	384	I	T
P54803	LP/P	Krabbe disease (KRB) [MIM:245200]	A0A1A6GPW1	396	R	L
P54803	LP/P	Krabbe disease (KRB) [MIM:245200]	A0A1A6GPW1	490	Y	N
P54803	LP/P	Krabbe disease (KRB) [MIM:245200]	A0A1A6GPW1	681	V	M
Q14376	LP/P	Galactosemia 3 (GALAC3) [MIM:230350]	L9JAK5	34	N	S
Q14376	LP/P	Galactosemia 3 (GALAC3) [MIM:230350]	L9JAK5	90	G	E
Q14376	LP/P	Galactosemia 3 (GALAC3) [MIM:230350]	L9JAK5	103	D	G
Q14376	LB/B	-	L9JAK5	180	A	V
Q14376	LP/P	Galactosemia 3 (GALAC3) [MIM:230350]	L9JAK5	183	L	P
Q14376	LP/P	Galactosemia 3 (GALAC3) [MIM:230350]	L9JAK5	257	K	R
Q14376	LP/P	Galactosemia 3 (GALAC3) [MIM:230350]	L9JAK5	313	L	M
Q14376	LP/P	Galactosemia 3 (GALAC3) [MIM:230350]	L9JAK5	319	G	E
Q14376	LP/P	Galactosemia 3 (GALAC3) [MIM:230350]	L9JAK5	94	V	M
Q14376	LP/P	Galactosemia 3 (GALAC3) [MIM:230350]	L9JAK5	25	A	V
Q14376	LP/P	Galactosemia 3 (GALAC3) [MIM:230350]	L9JAK5	40	R	C
Q14376	LP/P	Galactosemia 3 (GALAC3) [MIM:230350]	L9JAK5	69	D	E
Q14376	LP/P	Galactosemia 3 (GALAC3) [MIM:230350]	L9JAK5	165	E	K
Q14376	LP/P	Galactosemia 3 (GALAC3) [MIM:230350]	L9JAK5	169	R	W
Q14376	LP/P	Galactosemia 3 (GALAC3) [MIM:230350]	L9JAK5	239	R	W
Q14376	LP/P	Galactosemia 3 (GALAC3) [MIM:230350]	L9JAK5	302	G	D
Q14376	LP/P	Galactosemia 3 (GALAC3) [MIM:230350]	L9JAK5	335	R	H
P51570	LP/P	Galactosemia 2 (GALAC2) [MIM:230200]	F6X2B4	32	V	M
P51570	LP/P	Galactosemia 2 (GALAC2) [MIM:230200]	F6X2B4	28	P	T
P51570	LP/P	Galactosemia 2 (GALAC2) [MIM:230200]	F6X2B4	198	A	V
P51570	LP/P	Galactosemia 2 (GALAC2) [MIM:230200]	F6X2B4	36	G	R
P51570	LP/P	Galactosemia 2 (GALAC2) [MIM:230200]	F6X2B4	44	H	Y
P51570	LP/P	Galactosemia 2 (GALAC2) [MIM:230200]	F6X2B4	68	R	C
P51570	LB/B	-	F6X2B4	184	I	M
P51570	LP/P	Galactosemia 2 (GALAC2) [MIM:230200]	F6X2B4	239	R	Q
P51570	LB/B	-	F6X2B4	274	G	D
P51570	LP/P	Galactosemia 2 (GALAC2) [MIM:230200]	F6X2B4	288	T	M
P51570	LB/B	-	F6X2B4	338	V	A
P51570	LP/P	Galactosemia 2 (GALAC2) [MIM:230200]	F6X2B4	346	G	S
P51570	LP/P	Galactosemia 2 (GALAC2) [MIM:230200]	F6X2B4	349	G	S
P51570	LP/P	Galactosemia 2 (GALAC2) [MIM:230200]	F6X2B4	384	A	P
Q01415	LB/B	-	I3JNU8	182	I	V
Q96C23	LB/B	-	A0A1S2ZL41	190	N	Y
Q96C23	LP/P	Galactosemia 4 (GALAC4) [MIM:618881]	A0A1S2ZL41	267	R	G
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	47	G	R
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	60	D	N
P34059	LB/B	-	A0A2K5DL51	67	L	M
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	77	P	R
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	80	S	L
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	90	R	W
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	94	R	C
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	94	R	G
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	96	G	C
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	96	G	V
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	97	F	V
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	111	Q	R
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	113	I	F
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	125	P	L
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	135	S	R
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	138	V	A
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	139	G	S
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	141	W	R
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	151	P	L
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	151	P	S
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	155	G	R
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	156	F	C
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	156	F	S
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	166	H	Q
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	168	G	R
P34059	LB/B	-	A0A2K5DL51	178	I	V
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	179	P	H
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	179	P	L
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	185	E	G
P34059	LB/B	-	A0A2K5DL51	200	T	M
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	204	N	K
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	230	W	G
P34059	LB/B	-	A0A2K5DL51	231	A	G
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	247	G	D
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	257	A	T
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	259	R	Q
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	284	F	V
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	287	S	L
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	290	G	S
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	291	A	D
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	291	A	T
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	295	S	F
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	301	G	C
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	309	G	R
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	312	T	S
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	318	M	R
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	343	M	R
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	344	D	E
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	344	D	N
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	346	F	L
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	351	A	V
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	361	R	G
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	376	R	Q
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	386	R	C
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	391	M	V
P34059	LB/B	-	A0A2K5DL51	393	A	S
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	395	L	P
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	395	L	V
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	407	N	H
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	409	W	S
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	450	E	V
P34059	LB/B	-	A0A2K5DL51	459	A	V
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	487	N	S
P34059	LB/B	-	A0A2K5DL51	488	V	M
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	494	M	V
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	15	L	M
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	23	G	R
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	36	L	P
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	41	M	L
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	42	G	E
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	53	S	F
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	61	R	W
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	69	F	V
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	79	C	Y
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	94	R	L
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	107	A	T
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	116	G	S
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	141	W	C
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	150	H	Y
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	155	G	E
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	162	S	F
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	164	N	T
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	167	F	V
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	171	D	A
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	179	P	S
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	203	A	V
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	233	D	N
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	239	V	F
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	253	R	W
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	260	E	D
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	307	L	P
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	310	K	N
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	325	W	C
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	340	G	D
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	341	S	R
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	345	L	P
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	352	L	P
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	357	P	L
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	369	L	P
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	380	R	S
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	380	R	T
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	386	R	H
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	388	D	N
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	392	A	V
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	398	H	D
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	401	H	Y
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	452	F	I
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	470	S	P
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	484	P	S
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	16	V	E
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	36	L	R
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	40	D	N
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	48	V	G
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	51	E	K
P34059	LB/B	-	A0A2K5DL51	74	S	F
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	81	P	L
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	84	A	E
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	91	L	P
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	116	G	V
P34059	LB/B	-	A0A2K5DL51	121	E	D
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	145	H	Y
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	156	F	L
P34059	LB/B	-	A0A2K5DL51	159	W	C
P34059	LB/B	-	A0A2K5DL51	165	C	Y
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	166	H	R
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	201	G	E
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	214	L	P
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	216	F	S
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	235	T	K
P34059	LB/B	-	A0A2K5DL51	251	R	Q
P34059	LB/B	-	A0A2K5DL51	254	Y	C
P34059	LB/B	-	A0A2K5DL51	260	E	K
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	264	S	T
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	380	R	G
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	415	G	V
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	416	I	T
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	420	P	R
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	492	A	T
P34059	LB/B	-	A0A2K5DL51	495	N	K
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	500	G	S
P34059	LP/P	Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]	A0A2K5DL51	507	C	F
Q10472	LB/B	-	A0A1W2WCJ1	414	Y	D
Q8IXK2	LB/B	-	A0A1A6H2L4	3	G	E
Q8IXK2	LB/B	-	A0A1A6H2L4	46	G	R
Q8IXK2	LB/B	-	A0A1A6H2L4	119	E	V
Q8IXK2	LB/B	-	A0A1A6H2L4	261	D	N
Q8IXK2	LB/B	-	A0A1A6H2L4	272	G	R
Q8IXK2	LP/P	Colorectal cancer 1 (CRCS1) [MIM:608812]	A0A1A6H2L4	297	R	W
Q8IXK2	LP/P	Colorectal cancer 1 (CRCS1) [MIM:608812]	A0A1A6H2L4	303	D	N
Q8IXK2	LP/P	Colorectal cancer 1 (CRCS1) [MIM:608812]	A0A1A6H2L4	341	E	D
Q8IXK2	LP/P	Colorectal cancer 1 (CRCS1) [MIM:608812]	A0A1A6H2L4	373	R	H
Q8IXK2	LP/P	Colorectal cancer 1 (CRCS1) [MIM:608812]	A0A1A6H2L4	382	R	H
Q8IXK2	LP/P	Colorectal cancer 1 (CRCS1) [MIM:608812]	A0A1A6H2L4	479	C	F
Q8IXK2	LP/P	Colorectal cancer 1 (CRCS1) [MIM:608812]	A0A1A6H2L4	491	T	M
Q8IXK2	LB/B	-	A0A1A6H2L4	552	R	K
Q8IXK2	LP/P	Colorectal cancer 1 (CRCS1) [MIM:608812]	A0A1A6H2L4	396	Y	C
Q8IUC8	LB/B	-	A0A2G8JIE6	59	E	D
Q8N3T1	LB/B	-	I3J9Z5	510	H	Y
Q8N3T1	LB/B	-	I3J9Z5	68	V	G
Q8N3T1	LB/B	-	I3J9Z5	151	P	L
Q8N3T1	LB/B	-	I3J9Z5	324	P	A
Q8N3T1	LB/B	-	I3J9Z5	432	A	T
Q8N428	LB/B	-	A0A146S679	201	V	M
Q8N428	LB/B	-	A0A146S679	497	P	S
Q8N4A0	LB/B	-	A0A1A6H2L4	270	I	T
Q8N4A0	LB/B	-	A0A1A6H2L4	506	V	I
Q8N4A0	LB/B	-	A0A1A6H2L4	51	D	G
Q8NCL4	LB/B	-	A0A1L8HI83	423	V	I
Q9UBC7	LB/B	-	A0A2K5HHD0	72	I	M
P47211	LB/B	-	A0A1A8BRJ5	15	W	C
P47211	LB/B	-	A0A1A8BRJ5	334	S	N
P47211	LB/B	-	A0A1A8BRJ5	342	P	L
O60755	LB/B	-	G3UMG4	342	R	G
O60755	LB/B	-	G3UMG4	349	Q	R
Q14353	LB/B	-	G3HF75	209	T	M
Q14353	LP/P	Cerebral creatine deficiency syndrome 2 (CCDS2) [MIM:612736]	G3HF75	20	W	S
Q14353	LP/P	Cerebral creatine deficiency syndrome 2 (CCDS2) [MIM:612736]	G3HF75	50	M	L
Q14353	LP/P	Cerebral creatine deficiency syndrome 2 (CCDS2) [MIM:612736]	G3HF75	51	H	P
Q14353	LP/P	Cerebral creatine deficiency syndrome 2 (CCDS2) [MIM:612736]	G3HF75	54	A	P
Q14353	LP/P	Cerebral creatine deficiency syndrome 2 (CCDS2) [MIM:612736]	G3HF75	169	C	Y
Q14353	LP/P	Cerebral creatine deficiency syndrome 2 (CCDS2) [MIM:612736]	G3HF75	197	L	P
Q14353	LB/B	-	G3HF75	8	P	T
Q14353	LB/B	-	G3HF75	27	Y	H
Q14353	LP/P	Cerebral creatine deficiency syndrome 2 (CCDS2) [MIM:612736]	G3HF75	45	W	R
Q14353	LP/P	Cerebral creatine deficiency syndrome 2 (CCDS2) [MIM:612736]	G3HF75	68	G	C
Q14353	LP/P	Cerebral creatine deficiency syndrome 2 (CCDS2) [MIM:612736]	G3HF75	75	A	V
Q14353	LP/P	Cerebral creatine deficiency syndrome 2 (CCDS2) [MIM:612736]	G3HF75	78	V	E
Q14353	LP/P	Cerebral creatine deficiency syndrome 2 (CCDS2) [MIM:612736]	G3HF75	110	V	F
Q14353	LP/P	Cerebral creatine deficiency syndrome 2 (CCDS2) [MIM:612736]	G3HF75	135	D	N
Q14353	LP/P	Cerebral creatine deficiency syndrome 2 (CCDS2) [MIM:612736]	G3HF75	147	H	Y
Q14353	LP/P	Cerebral creatine deficiency syndrome 2 (CCDS2) [MIM:612736]	G3HF75	159	L	P
Q14353	LP/P	Cerebral creatine deficiency syndrome 2 (CCDS2) [MIM:612736]	G3HF75	164	G	D
Q14353	LP/P	Cerebral creatine deficiency syndrome 2 (CCDS2) [MIM:612736]	G3HF75	166	L	P
Q14353	LP/P	Cerebral creatine deficiency syndrome 2 (CCDS2) [MIM:612736]	G3HF75	169	C	R
Q14353	LP/P	Cerebral creatine deficiency syndrome 2 (CCDS2) [MIM:612736]	G3HF75	208	R	P
Q14353	LB/B	-	G3HF75	44	R	L
Q14353	LB/B	-	G3HF75	71	M	V
Q14353	LB/B	-	G3HF75	76	S	L
Q14353	LB/B	-	G3HF75	78	V	M
Q14353	LB/B	-	G3HF75	95	V	I
Q14353	LB/B	-	G3HF75	105	R	Q
Q14353	LB/B	-	G3HF75	106	Q	P
Q14353	LB/B	-	G3HF75	146	T	R
Q14353	LB/B	-	G3HF75	156	A	D
Q14353	LB/B	-	G3HF75	157	F	L
Q14353	LB/B	-	G3HF75	167	T	I
Q14353	LB/B	-	G3HF75	196	A	T
Q14353	LB/B	-	G3HF75	196	A	V
Q14353	LB/B	-	G3HF75	224	A	T
Q9H2C0	LP/P	Giant axonal neuropathy 1, autosomal recessive (GAN1) [MIM:256850]	F6WU31	486	E	K
Q9H2C0	LP/P	Giant axonal neuropathy 1, autosomal recessive (GAN1) [MIM:256850]	F6WU31	15	R	S
Q9H2C0	LP/P	Giant axonal neuropathy 1, autosomal recessive (GAN1) [MIM:256850]	F6WU31	52	S	G
Q9H2C0	LP/P	Giant axonal neuropathy 1, autosomal recessive (GAN1) [MIM:256850]	F6WU31	79	S	L
Q9H2C0	LP/P	Giant axonal neuropathy 1, autosomal recessive (GAN1) [MIM:256850]	F6WU31	82	V	F
Q9H2C0	LP/P	Giant axonal neuropathy 1, autosomal recessive (GAN1) [MIM:256850]	F6WU31	138	R	H
Q9H2C0	LP/P	Giant axonal neuropathy 1, autosomal recessive (GAN1) [MIM:256850]	F6WU31	269	R	Q
Q9H2C0	LP/P	Giant axonal neuropathy 1, autosomal recessive (GAN1) [MIM:256850]	F6WU31	309	L	R
Q9H2C0	LP/P	Giant axonal neuropathy 1, autosomal recessive (GAN1) [MIM:256850]	F6WU31	545	R	C
Q9H2C0	LP/P	Giant axonal neuropathy 1, autosomal recessive (GAN1) [MIM:256850]	F6WU31	570	C	Y
Q9H2C0	LP/P	Giant axonal neuropathy 1, autosomal recessive (GAN1) [MIM:256850]	F6WU31	423	I	T
Q9H2C0	LP/P	Giant axonal neuropathy 1, autosomal recessive (GAN1) [MIM:256850]	F6WU31	86	I	F
Q9H2C0	LP/P	Giant axonal neuropathy 1, autosomal recessive (GAN1) [MIM:256850]	F6WU31	368	G	R
Q9H2C0	LP/P	Giant axonal neuropathy 1, autosomal recessive (GAN1) [MIM:256850]	F6WU31	51	A	P
Q9H2C0	LP/P	Giant axonal neuropathy 1, autosomal recessive (GAN1) [MIM:256850]	F6WU31	89	Y	C
Q9H2C0	LP/P	Giant axonal neuropathy 1, autosomal recessive (GAN1) [MIM:256850]	F6WU31	195	V	F
Q9H2C0	LP/P	Giant axonal neuropathy 1, autosomal recessive (GAN1) [MIM:256850]	F6WU31	315	P	L
Q9H2C0	LP/P	Giant axonal neuropathy 1, autosomal recessive (GAN1) [MIM:256850]	F6WU31	474	G	R
Q9H2C0	LP/P	Giant axonal neuropathy 1, autosomal recessive (GAN1) [MIM:256850]	F6WU31	545	R	H
Q9H2C0	LP/P	-	F6WU31	102	I	T
Q9H2C0	LP/P	-	F6WU31	438	V	I
P17677	LB/B	-	A0A1V4J368	59	V	I
P17677	LB/B	-	A0A1V4J368	162	K	E
O14556	LB/B	-	I3M9K1	110	D	N
Q8N292	LB/B	-	D4ACG3	83	A	T
Q6NXP2	LB/B	-	S7PM83	112	P	T
Q6NXP2	LB/B	-	S7PM83	114	D	V
Q6NXP2	LB/B	-	S7PM83	136	R	W
Q6NXP2	LB/B	-	S7PM83	251	I	V
Q96KD3	LB/B	-	H0X1B3	228	S	L
Q96KD3	LB/B	-	H0X1B3	242	E	K
Q8TC56	LB/B	-	S9WF68	543	A	V
Q8TC56	LB/B	-	S9WF68	564	M	T
Q8TC56	LB/B	-	S9WF68	599	V	I
Q8IYT1	LB/B	-	S9WF68	22	N	D
Q8IYT1	LB/B	-	S9WF68	253	N	S
Q8IYT1	LB/B	-	S9WF68	319	G	D
Q8IYT1	LB/B	-	S9WF68	551	N	D
Q8IYT1	LB/B	-	S9WF68	577	T	M
Q6IPT2	LB/B	-	A0A2K5EYC8	206	S	I
Q5VVW2	LB/B	-	A0A226P1L9	108	H	R
Q5VVW2	LB/B	-	A0A226P1L9	752	A	S
P41250	LP/P	Charcot-Marie-Tooth disease, axonal, 2D (CMT2D) [MIM:601472]	A0A1V4KLA7	125	E	G
P41250	LP/P	Neuronopathy, distal hereditary motor, 5A (HMN5A) [MIM:600794]	A0A1V4KLA7	183	L	P
P41250	LP/P	Charcot-Marie-Tooth disease, axonal, 2D (CMT2D) [MIM:601472]	A0A1V4KLA7	294	G	R
P41250	LP/P	Neuronopathy, distal hereditary motor, 5A (HMN5A) [MIM:600794]	A0A1V4KLA7	580	G	R
P41250	LB/B	-	A0A1V4KLA7	42	P	A
P41250	LB/B	-	A0A1V4KLA7	388	R	Q
P41250	LP/P	Charcot-Marie-Tooth disease, axonal, 2D (CMT2D) [MIM:601472]	A0A1V4KLA7	111	A	V
P41250	LP/P	Charcot-Marie-Tooth disease, axonal, 2D (CMT2D) [MIM:601472]	A0A1V4KLA7	200	D	N
P41250	LP/P	Neuronopathy, distal hereditary motor, 5A (HMN5A) [MIM:600794]	A0A1V4KLA7	200	D	N
P41250	LP/P	Charcot-Marie-Tooth disease, axonal, 2D (CMT2D) [MIM:601472]	A0A1V4KLA7	265	S	F
P41250	LP/P	Neuronopathy, distal hereditary motor, 5A (HMN5A) [MIM:600794]	A0A1V4KLA7	265	S	F
P41250	LP/P	Charcot-Marie-Tooth disease, axonal, 2D (CMT2D) [MIM:601472]	A0A1V4KLA7	298	P	L
P41250	LP/P	Neuronopathy, distal hereditary motor, 5A (HMN5A) [MIM:600794]	A0A1V4KLA7	472	H	R
P41250	LP/P	Charcot-Marie-Tooth disease, axonal, 2D (CMT2D) [MIM:601472]	A0A1V4KLA7	554	D	N
P41250	LB/B	-	A0A1V4KLA7	635	S	L
P41250	LP/P	Charcot-Marie-Tooth disease, axonal, 2D (CMT2D) [MIM:601472]	A0A1V4KLA7	652	G	A
P41250	LP/P	Charcot-Marie-Tooth disease, axonal, 2D (CMT2D) [MIM:601472]	A0A1V4KLA7	200	D	Y
P41250	LP/P	Charcot-Marie-Tooth disease, axonal, 2D (CMT2D) [MIM:601472]	A0A1V4KLA7	292	M	R
P41250	LP/P	-	A0A1V4KLA7	310	R	Q
P41250	LP/P	Spinal muscular atrophy, infantile, James type (SMAJI) [MIM:619042]	A0A1V4KLA7	334	I	N
P41250	LP/P	Spinal muscular atrophy, infantile, James type (SMAJI) [MIM:619042]	A0A1V4KLA7	652	G	R
P22102	LB/B	-	A0A146SUR0	21	L	F
P22102	LB/B	-	A0A146SUR0	421	V	I
P22102	LB/B	-	A0A146SUR0	752	D	G
P22102	LB/B	-	A0A146SUR0	510	D	G
P22102	LB/B	-	A0A146SUR0	641	P	A
Q8NHY3	LB/B	-	A0A1L8HPX9	540	A	T
Q8NHY3	LB/B	-	A0A1L8HPX9	654	A	V
Q8NHY3	LB/B	-	A0A1L8HPX9	164	A	V
Q8NHY3	LB/B	-	A0A1L8HPX9	829	R	W
Q14393	LB/B	-	H2V4I6	41	F	L
Q14393	LB/B	-	H2V4I6	231	S	Y
Q14393	LB/B	-	H2V4I6	347	V	M
Q14393	LB/B	-	H2V4I6	500	G	R
Q14393	LB/B	-	H2V4I6	580	S	L
Q14393	LB/B	-	H2V4I6	612	E	K
Q14393	LB/B	-	H2V4I6	616	R	Q
O95995	LB/B	-	B3RVB6	199	E	K
O95995	LB/B	-	B3RVB6	259	R	Q
O95995	LP/P	Ciliary dyskinesia, primary, 33 (CILD33) [MIM:616726]	B3RVB6	391	A	V
Q6UWH4	LB/B	-	A0A2Y9NV53	432	G	S
P01350	LB/B	-	P55885	3	R	P
P15976	LP/P	X-linked dyserythropoietic anemia and thrombocytopenia (XDAT) [MIM:300367]	A0A212CHU5	205	V	M
P15976	LP/P	X-linked dyserythropoietic anemia and thrombocytopenia (XDAT) [MIM:300367]	A0A212CHU5	208	G	S
P15976	LP/P	X-linked dyserythropoietic anemia and thrombocytopenia (XDAT) [MIM:300367]	A0A212CHU5	218	D	G
P15976	LP/P	Thrombocytopenia with beta-thalassemia, X-linked (XLTT) [MIM:314050]	A0A212CHU5	216	R	Q
P15976	LP/P	X-linked dyserythropoietic anemia and thrombocytopenia (XDAT) [MIM:300367]	A0A212CHU5	218	D	Y
P15976	LP/P	Hemolytic anemia due to elevated adenosine deaminase (HAEADA) [MIM:301083]	A0A212CHU5	307	R	C
P15976	LP/P	Hemolytic anemia due to elevated adenosine deaminase (HAEADA) [MIM:301083]	A0A212CHU5	307	R	H
P23769	LB/B	-	G1SUL8	164	A	T
P23769	LB/B	-	G1SUL8	235	T	N
P23769	LP/P	Immunodeficiency 21 (IMD21) [MIM:614172]	G1SUL8	254	P	L
P23769	LP/P	Immunodeficiency 21 (IMD21) [MIM:614172]	G1SUL8	354	T	M
P23769	LP/P	Myelodysplastic syndrome (MDS) [MIM:614286]	G1SUL8	354	T	M
P23769	LP/P	Immunodeficiency 21 (IMD21) [MIM:614172]	G1SUL8	398	R	W
P23769	LP/P	Lymphedema, primary, with myelodysplasia (LMPM) [MIM:614038]	G1SUL8	361	R	P
P23769	LP/P	Lymphedema, primary, with myelodysplasia (LMPM) [MIM:614038]	G1SUL8	373	C	R
P23771	LP/P	Hypoparathyroidism, sensorineural deafness, and renal disease (HDR) [MIM:146255]	A0A2Y9R3R7	274	W	R
P23771	LB/B	-	A0A2Y9R3R7	242	G	S
P23771	LP/P	Hypoparathyroidism, sensorineural deafness, and renal disease (HDR) [MIM:146255]	A0A2Y9R3R7	298	R	Q
Q9BWX5	LP/P	Congenital heart defects, multiple types, 5 (CHTD5) [MIM:617912]	A0A2I2UGX5	187	R	G
Q9BWX5	LP/P	Congenital heart defects, multiple types, 5 (CHTD5) [MIM:617912]	A0A2I2UGX5	199	L	V
Q9BWX5	LP/P	Congenital heart defects, multiple types, 5 (CHTD5) [MIM:617912]	A0A2I2UGX5	200	W	G
Q9BWX5	LP/P	Congenital heart defects, multiple types, 5 (CHTD5) [MIM:617912]	A0A2I2UGX5	207	H	R
Q9BWX5	LB/B	-	A0A2I2UGX5	3	Q	R
Q9BWX5	LP/P	Congenital heart defects, multiple types, 5 (CHTD5) [MIM:617912]	A0A2I2UGX5	16	Y	D
Q9BWX5	LB/B	-	A0A2I2UGX5	19	S	W
Q9BWX5	LP/P	Congenital heart defects, multiple types, 5 (CHTD5) [MIM:617912]	A0A2I2UGX5	138	Y	F
Q9BWX5	LB/B	-	A0A2I2UGX5	166	G	S
Q9BWX5	LP/P	Congenital heart defects, multiple types, 5 (CHTD5) [MIM:617912]	A0A2I2UGX5	210	C	G
Q9BWX5	LP/P	Congenital heart defects, multiple types, 5 (CHTD5) [MIM:617912]	A0A2I2UGX5	240	G	D
Q9BWX5	LP/P	Congenital heart defects, multiple types, 5 (CHTD5) [MIM:617912]	A0A2I2UGX5	252	T	P
Q9BWX5	LB/B	-	A0A2I2UGX5	67	T	P
Q92908	LB/B	-	A0A1A6HR43	15	G	R
Q92908	LP/P	Atrioventricular septal defect 5 (AVSD5) [MIM:614474]	A0A1A6HR43	178	A	V
Q92908	LP/P	Atrial septal defect 9 (ASD9) [MIM:614475]	A0A1A6HR43	184	S	N
Q92908	LP/P	Tetralogy of Fallot (TOF) [MIM:187500]	A0A1A6HR43	184	S	N
Q92908	LP/P	Pancreatic agenesis and congenital heart defects (PACHD) [MIM:600001]	A0A1A6HR43	452	T	A
Q92908	LP/P	Pancreatic agenesis and congenital heart defects (PACHD) [MIM:600001]	A0A1A6HR43	456	R	C
Q92908	LP/P	Pancreatic agenesis and congenital heart defects (PACHD) [MIM:600001]	A0A1A6HR43	456	R	H
Q92908	LP/P	Pancreatic agenesis and congenital heart defects (PACHD) [MIM:600001]	A0A1A6HR43	466	N	D
Q92908	LP/P	Conotruncal heart malformations (CTHM) [MIM:217095]	A0A1A6HR43	466	N	H
Q92908	LP/P	Pancreatic agenesis and congenital heart defects (PACHD) [MIM:600001]	A0A1A6HR43	467	A	T
Q92908	LP/P	Pancreatic agenesis and congenital heart defects (PACHD) [MIM:600001]	A0A1A6HR43	473	K	Q
Q92908	LP/P	-	A0A1A6HR43	91	P	S
Q92908	LP/P	-	A0A1A6HR43	177	A	T
Q92908	LP/P	-	A0A1A6HR43	235	Y	S
Q92908	LP/P	-	A0A1A6HR43	469	G	V
Q92908	LP/P	-	A0A1A6HR43	543	A	G
Q92908	LP/P	-	A0A1A6HR43	585	R	L
Q8WUU5	LB/B	-	K7JA43	54	G	S
Q8WUU5	LP/P	Cardiomyopathy, dilated 2B (CMD2B) [MIM:614672]	K7JA43	102	S	P
Q8WUU5	LB/B	-	K7JA43	233	R	W
O43716	LB/B	-	F7I2M5	3	S	L
O43716	LP/P	Combined oxidative phosphorylation deficiency 42 (COXPD42) [MIM:618839]	F7I2M5	78	M	R
P50440	LB/B	-	A0A2G9SGU6	110	Q	H
P50440	LP/P	Cerebral creatine deficiency syndrome 3 (CCDS3) [MIM:612718]	A0A2G9SGU6	203	Y	S
P50440	LP/P	Cerebral creatine deficiency syndrome 3 (CCDS3) [MIM:612718]	A0A2G9SGU6	413	R	Q
P50440	LP/P	Cerebral creatine deficiency syndrome 3 (CCDS3) [MIM:612718]	A0A2G9SGU6	413	R	W
P50440	LP/P	Cerebral creatine deficiency syndrome 3 (CCDS3) [MIM:612718]	A0A2G9SGU6	105	P	L
P50440	LP/P	Cerebral creatine deficiency syndrome 3 (CCDS3) [MIM:612718]	A0A2G9SGU6	181	E	K
P50440	LP/P	Cerebral creatine deficiency syndrome 3 (CCDS3) [MIM:612718]	A0A2G9SGU6	185	A	P
P50440	LP/P	Cerebral creatine deficiency syndrome 3 (CCDS3) [MIM:612718]	A0A2G9SGU6	189	R	C
P50440	LP/P	Cerebral creatine deficiency syndrome 3 (CCDS3) [MIM:612718]	A0A2G9SGU6	208	A	T
P50440	LB/B	-	A0A2G9SGU6	231	S	C
P50440	LB/B	-	A0A2G9SGU6	234	D	G
P50440	LP/P	Cerebral creatine deficiency syndrome 3 (CCDS3) [MIM:612718]	A0A2G9SGU6	282	R	H
P50440	LP/P	Cerebral creatine deficiency syndrome 3 (CCDS3) [MIM:612718]	A0A2G9SGU6	329	L	V
P50440	LP/P	Cerebral creatine deficiency syndrome 3 (CCDS3) [MIM:612718]	A0A2G9SGU6	346	P	L
P50440	LP/P	Fanconi renotubular syndrome 1 (FRTS1) [MIM:134600]	A0A2G9SGU6	320	P	S
P50440	LP/P	Fanconi renotubular syndrome 1 (FRTS1) [MIM:134600]	A0A2G9SGU6	336	T	A
P50440	LP/P	Fanconi renotubular syndrome 1 (FRTS1) [MIM:134600]	A0A2G9SGU6	336	T	I
P50440	LP/P	Fanconi renotubular syndrome 1 (FRTS1) [MIM:134600]	A0A2G9SGU6	341	P	L
Q9H227	LB/B	-	R7TDT2	106	D	N
Q9H227	LB/B	-	R7TDT2	213	R	P
Q9H227	LB/B	-	R7TDT2	354	C	R
Q9H227	LB/B	-	R7TDT2	172	M	I
Q04446	LB/B	-	G7E255	190	R	G
Q04446	LP/P	Glycogen storage disease 4 (GSD4) [MIM:232500]	G7E255	224	L	P
Q04446	LP/P	Glycogen storage disease 4 (GSD4) [MIM:232500]	G7E255	257	F	L
Q04446	LP/P	Glycogen storage disease 4 (GSD4) [MIM:232500]	G7E255	329	Y	S
Q04446	LP/P	Glycogen storage disease 4 (GSD4) [MIM:232500]	G7E255	515	R	C
Q04446	LP/P	Polyglucosan body neuropathy, adult form (APBN) [MIM:263570]	G7E255	515	R	H
Q04446	LP/P	Glycogen storage disease 4 (GSD4) [MIM:232500]	G7E255	524	R	Q
Q04446	LP/P	Polyglucosan body neuropathy, adult form (APBN) [MIM:263570]	G7E255	524	R	Q
Q04446	LP/P	Glycogen storage disease 4 (GSD4) [MIM:232500]	G7E255	545	H	R
Q04446	LP/P	Glycogen storage disease 4 (GSD4) [MIM:232500]	G7E255	628	H	R
Q04446	LB/B	-	G7E255	265	T	S
Q04446	LB/B	-	G7E255	334	I	V
Q04446	LB/B	-	G7E255	507	T	A
Q92538	LB/B	-	A0A2U9CDC5	1693	G	S
P32455	LB/B	-	G1PFH1	349	T	S
P32455	LB/B	-	G1PFH1	78	I	V
P32455	LB/B	-	G1PFH1	166	E	D
P32455	LB/B	-	G1PFH1	409	A	G
P32456	LB/B	-	G1PFH1	281	S	P
P32456	LB/B	-	G1PFH1	285	P	A
P32456	LB/B	-	G1PFH1	303	S	G
Q9H0R5	LB/B	-	G1PFH1	469	V	M
Q9H0R5	LB/B	-	G1PFH1	491	C	R
Q9H0R5	LB/B	-	G1PFH1	558	V	A
Q9H0R5	LB/B	-	G1PFH1	221	R	Q
Q9H0R5	LB/B	-	G1PFH1	225	R	W
Q9H0R5	LB/B	-	G1PFH1	347	T	S
Q96PP9	LB/B	-	G1PFH1	125	K	E
Q96PP9	LB/B	-	G1PFH1	379	I	V
Q96PP9	LB/B	-	G1PFH1	541	Y	N
Q96PP9	LB/B	-	G1PFH1	549	L	M
Q96PP9	LB/B	-	G1PFH1	551	E	K
Q96PP9	LB/B	-	G1PFH1	551	E	G
Q96PP9	LB/B	-	G1PFH1	542	M	I
Q96PP9	LB/B	-	G1PFH1	545	M	I
Q96PP9	LB/B	-	G1PFH1	545	M	L
Q96PP9	LB/B	-	G1PFH1	546	E	K
Q96PP8	LB/B	-	G1PFH1	35	T	M
Q96PP8	LB/B	-	G1PFH1	4	E	Q
Q6ZN66	LB/B	-	K7GK68	278	T	I
Q6ZN66	LB/B	-	K7GK68	331	A	S
Q6ZN66	LB/B	-	K7GK68	344	L	F
Q6ZN66	LB/B	-	K7GK68	355	M	V
Q6ZN66	LB/B	-	K7GK68	520	D	V
Q8N8V2	LB/B	-	K7GK68	14	T	I
Q8N8V2	LB/B	-	K7GK68	618	G	R
P02774	LB/B	-	F7G172	432	D	E
P02774	LB/B	-	F7G172	436	T	K
P02774	LB/B	-	F7G172	445	H	C
P02774	LB/B	-	F7G172	445	H	R
P28676	LB/B	-	A0A2I3LU27	80	S	A
Q96CN9	LB/B	-	Q4T8W1	87	C	W
Q96CN9	LB/B	-	Q4T8W1	86	R	W
Q96CN9	LB/B	-	Q4T8W1	122	A	V
Q96CN9	LB/B	-	Q4T8W1	262	Q	R
Q96CN9	LB/B	-	Q4T8W1	274	A	T
Q96CN9	LB/B	-	Q4T8W1	618	R	C
Q8IWJ2	LB/B	-	L9LB91	1298	R	G
Q8IWJ2	LB/B	-	L9LB91	1134	Q	E
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	88	R	C
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	94	R	L
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	101	G	R
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	115	C	Y
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	122	A	V
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	128	R	G
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	138	R	G
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	139	S	L
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	148	V	I
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	161	R	Q
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	178	G	R
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	179	L	R
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	191	M	T
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	195	A	T
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	227	R	P
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	236	F	L
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	257	R	Q
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	257	R	W
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	266	M	V
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	278	P	S
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	283	L	P
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	293	A	T
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	294	R	W
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	295	Y	H
Q92947	LB/B	-	H2T7M2	298	A	T
Q92947	LB/B	-	H2T7M2	298	A	V
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	305	S	L
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	308	C	S
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	309	L	W
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	313	R	W
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	333	Q	E
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	349	A	T
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	354	G	R
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	354	G	S
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	355	R	C
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	355	R	H
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	365	E	K
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	375	C	R
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	382	A	T
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	383	R	C
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	383	R	H
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	386	R	Q
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	390	G	R
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	390	G	A
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	392	N	D
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	400	V	M
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	402	R	W
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	402	R	Q
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	403	H	R
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	406	N	K
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	407	L	P
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	414	E	K
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	416	T	I
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	421	A	T
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	421	A	V
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	429	T	M
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	433	A	E
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	263	M	V
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	64	E	D
Q92947	LP/P	Glutaric aciduria 1 (GA1) [MIM:231670]	H2T7M2	268	G	V
P16383	LB/B	-	A0A1U7T133	32	P	A
P16383	LB/B	-	A0A1U7T133	249	N	S
P16383	LB/B	-	A0A1U7T133	316	Q	E
P16383	LB/B	-	A0A1U7T133	594	T	A
P16383	LB/B	-	A0A1U7T133	724	E	D
P01275	LB/B	-	G3HZV5	115	A	V
P47871	LB/B	-	F6Q776	40	G	S
P47871	LB/B	-	F6Q776	114	P	A
P47871	LB/B	-	F6Q776	303	F	C
P47871	LP/P	Mahvash disease (MVAH) [MIM:619290]	F6Q776	86	P	S
P47871	LP/P	Mahvash disease (MVAH) [MIM:619290]	F6Q776	63	D	N
P47871	LP/P	Mahvash disease (MVAH) [MIM:619290]	F6Q776	225	R	H
P47871	LP/P	Mahvash disease (MVAH) [MIM:619290]	F6Q776	368	V	M
P30793	LP/P	Dystonia, dopa-responsive (DRD) [MIM:128230]	G5BF79	23	P	L
P30793	LP/P	Dystonia, dopa-responsive (DRD) [MIM:128230]	G5BF79	79	L	P
P30793	LP/P	Dystonia, dopa-responsive (DRD) [MIM:128230]	G5BF79	88	R	P
P30793	LP/P	Dystonia, dopa-responsive (DRD) [MIM:128230]	G5BF79	88	R	W
P30793	LP/P	Dystonia, dopa-responsive (DRD) [MIM:128230]	G5BF79	102	M	K
P30793	LP/P	Dystonia, dopa-responsive (DRD) [MIM:128230]	G5BF79	134	D	V
P30793	LP/P	Dystonia, dopa-responsive (DRD) [MIM:128230]	G5BF79	141	C	W
P30793	LP/P	Dystonia, dopa-responsive (DRD) [MIM:128230]	G5BF79	144	H	P
P30793	LP/P	Dystonia, dopa-responsive (DRD) [MIM:128230]	G5BF79	153	H	P
P30793	LP/P	Dystonia, dopa-responsive (DRD) [MIM:128230]	G5BF79	178	R	S
P30793	LP/P	Hyperphenylalaninemia, BH4-deficient, B (HPABH4B) [MIM:233910]	G5BF79	184	R	H
P30793	LP/P	Dystonia, dopa-responsive (DRD) [MIM:128230]	G5BF79	186	T	K
P30793	LP/P	Dystonia, dopa-responsive (DRD) [MIM:128230]	G5BF79	201	G	E
P30793	LP/P	Dystonia, dopa-responsive (DRD) [MIM:128230]	G5BF79	203	G	R
P30793	LP/P	Hyperphenylalaninemia, BH4-deficient, B (HPABH4B) [MIM:233910]	G5BF79	211	M	I
P30793	LP/P	Dystonia, dopa-responsive (DRD) [MIM:128230]	G5BF79	224	K	R
P30793	LP/P	Hyperphenylalaninemia, BH4-deficient, B (HPABH4B) [MIM:233910]	G5BF79	224	K	R
P30793	LP/P	Dystonia, dopa-responsive (DRD) [MIM:128230]	G5BF79	234	F	S
P30793	LP/P	Dystonia, dopa-responsive (DRD) [MIM:128230]	G5BF79	71	L	Q
P30793	LP/P	Dystonia, dopa-responsive (DRD) [MIM:128230]	G5BF79	74	A	V
P30793	LP/P	Dystonia, dopa-responsive (DRD) [MIM:128230]	G5BF79	83	G	A
P30793	LP/P	Dystonia, dopa-responsive (DRD) [MIM:128230]	G5BF79	90	G	V
P30793	LP/P	Dystonia, dopa-responsive (DRD) [MIM:128230]	G5BF79	102	M	R
P30793	LP/P	Hyperphenylalaninemia, BH4-deficient, B (HPABH4B) [MIM:233910]	G5BF79	108	G	D
P30793	LP/P	Dystonia, dopa-responsive (DRD) [MIM:128230]	G5BF79	115	D	N
P30793	LP/P	Dystonia, dopa-responsive (DRD) [MIM:128230]	G5BF79	135	I	K
P30793	LP/P	Dystonia, dopa-responsive (DRD) [MIM:128230]	G5BF79	141	C	R
P30793	LP/P	Dystonia, dopa-responsive (DRD) [MIM:128230]	G5BF79	163	L	R
P30793	LP/P	Dystonia, dopa-responsive (DRD) [MIM:128230]	G5BF79	176	S	T
P30793	LP/P	Dystonia, dopa-responsive (DRD) [MIM:128230]	G5BF79	180	Q	R
P30793	LP/P	Dystonia, dopa-responsive (DRD) [MIM:128230]	G5BF79	191	V	I
P30793	LP/P	Dystonia, dopa-responsive (DRD) [MIM:128230]	G5BF79	199	P	L
P30793	LP/P	Dystonia, dopa-responsive (DRD) [MIM:128230]	G5BF79	211	M	V
P30793	LP/P	Dystonia, dopa-responsive (DRD) [MIM:128230]	G5BF79	213	M	V
P30793	LP/P	Hyperphenylalaninemia, BH4-deficient, B (HPABH4B) [MIM:233910]	G5BF79	221	M	T
P30793	LP/P	Dystonia, dopa-responsive (DRD) [MIM:128230]	G5BF79	241	R	W
P30793	LP/P	Dystonia, dopa-responsive (DRD) [MIM:128230]	G5BF79	249	R	S
P30793	LP/P	Dystonia, dopa-responsive (DRD) [MIM:128230]	G5BF79	106	T	I
P30793	LB/B	-	G5BF79	98	A	V
P30793	LB/B	-	G5BF79	135	I	T
P35557	LB/B	-	A0A091DRF5	4	D	N
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	70	E	K
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	80	G	A
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	80	G	S
P35557	LB/B	-	A0A091DRF5	107	M	T
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	131	S	P
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	175	G	R
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	182	V	M
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	188	A	T
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	203	V	A
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	221	E	K
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	226	V	M
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	227	G	C
P35557	LP/P	Diabetes mellitus, permanent neonatal, 1 (PNDM1) [MIM:606176]	A0A091DRF5	228	T	M
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	228	T	M
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	256	E	K
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	257	W	R
P35557	LP/P	Diabetes mellitus, permanent neonatal, 1 (PNDM1) [MIM:606176]	A0A091DRF5	261	G	R
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	261	G	R
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	279	E	Q
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	299	G	R
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	300	E	Q
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	300	E	K
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	309	L	P
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	414	K	E
P35557	LP/P	Familial hyperinsulinemic hypoglycemia 3 (HHF3) [MIM:602485]	A0A091DRF5	455	V	M
P35557	LB/B	-	A0A091DRF5	11	A	T
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	36	R	W
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	53	A	S
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	108	Y	H
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	137	H	R
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	150	F	S
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	168	T	P
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	209	T	M
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	210	M	T
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	213	C	R
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	259	A	T
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	261	G	E
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	336	S	L
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	367	V	M
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	382	C	Y
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	384	A	T
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	392	R	C
P35557	LP/P	Diabetes mellitus, permanent neonatal, 1 (PNDM1) [MIM:606176]	A0A091DRF5	164	L	P
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	164	L	P
P35557	LP/P	Diabetes mellitus, permanent neonatal, 1 (PNDM1) [MIM:606176]	A0A091DRF5	210	M	K
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	210	M	K
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	110	I	T
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	119	A	D
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	385	G	V
P35557	LB/B	-	A0A091DRF5	342	T	P
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	217	D	N
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	225	I	M
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	248	E	K
P35557	LP/P	Familial hyperinsulinemic hypoglycemia 3 (HHF3) [MIM:602485]	A0A091DRF5	65	T	I
P35557	LP/P	Familial hyperinsulinemic hypoglycemia 3 (HHF3) [MIM:602485]	A0A091DRF5	91	V	L
P35557	LP/P	Familial hyperinsulinemic hypoglycemia 3 (HHF3) [MIM:602485]	A0A091DRF5	99	W	C
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	129	C	Y
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	188	A	V
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	191	R	W
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	202	M	R
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	223	G	S
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	378	A	T
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	441	S	W
P35557	LP/P	Familial hyperinsulinemic hypoglycemia 3 (HHF3) [MIM:602485]	A0A091DRF5	442	E	K
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	447	R	Q
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	16	V	E
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	19	I	N
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	20	L	P
P35557	LP/P	Diabetes mellitus, permanent neonatal, 1 (PNDM1) [MIM:606176]	A0A091DRF5	40	E	K
P35557	LP/P	Diabetes mellitus, permanent neonatal, 1 (PNDM1) [MIM:606176]	A0A091DRF5	43	R	C
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	43	R	S
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	44	G	S
P35557	LP/P	Diabetes mellitus, permanent neonatal, 1 (PNDM1) [MIM:606176]	A0A091DRF5	50	H	D
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	61	Y	S
P35557	LP/P	Diabetes mellitus, permanent neonatal, 1 (PNDM1) [MIM:606176]	A0A091DRF5	72	G	R
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	72	G	R
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	77	L	P
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	78	D	E
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	80	G	D
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	82	T	I
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	116	T	P
P35557	LP/P	Diabetes mellitus, permanent neonatal, 1 (PNDM1) [MIM:606176]	A0A091DRF5	151	S	T
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	160	D	N
P35557	LP/P	Diabetes mellitus, permanent neonatal, 1 (PNDM1) [MIM:606176]	A0A091DRF5	168	T	A
P35557	LP/P	Diabetes mellitus, permanent neonatal, 1 (PNDM1) [MIM:606176]	A0A091DRF5	169	K	R
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	182	V	L
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	187	D	Y
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	200	V	L
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	202	M	T
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	206	T	M
P35557	LP/P	Familial hyperinsulinemic hypoglycemia 3 (HHF3) [MIM:602485]	A0A091DRF5	214	Y	C
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	224	M	R
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	227	G	S
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	233	C	R
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	252	C	G
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	255	T	A
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	265	E	K
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	298	M	K
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	308	R	W
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	377	R	H
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	379	A	V
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	383	S	L
P35557	LP/P	Diabetes mellitus, permanent neonatal, 1 (PNDM1) [MIM:606176]	A0A091DRF5	393	M	T
P35557	LP/P	Diabetes mellitus, permanent neonatal, 1 (PNDM1) [MIM:606176]	A0A091DRF5	397	R	L
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	411	S	F
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	416	H	P
P35557	LP/P	Maturity-onset diabetes of the young 2 (MODY2) [MIM:125851]	A0A091DRF5	420	K	E
P35557	LP/P	Diabetes mellitus, permanent neonatal, 1 (PNDM1) [MIM:606176]	A0A091DRF5	441	S	L
P35557	LP/P	Diabetes mellitus, permanent neonatal, 1 (PNDM1) [MIM:606176]	A0A091DRF5	449	A	T
P35557	LP/P	Familial hyperinsulinemic hypoglycemia 3 (HHF3) [MIM:602485]	A0A091DRF5	456	A	V
P48506	LP/P	Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency (HAGGSD) [MIM:230450]	A0A165GRN9	370	H	L
P48506	LB/B	-	A0A165GRN9	55	L	S
P48506	LP/P	Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency (HAGGSD) [MIM:230450]	A0A165GRN9	158	P	L
P48506	LB/B	-	A0A165GRN9	462	P	S
P48506	LP/P	Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency (HAGGSD) [MIM:230450]	A0A165GRN9	127	R	C
Q92616	LB/B	-	A0A2K5H876	2155	D	Y
Q02742	LB/B	-	K7EYA9	152	I	V
Q02742	LB/B	-	K7EYA9	158	S	C
Q8N0V5	LB/B	-	A0A286Y3Y9	169	A	T
Q8N0V5	LB/B	-	A0A286Y3Y9	228	R	Q
Q9P109	LB/B	-	K7EYA9	321	V	I
Q9P109	LB/B	-	K7EYA9	439	P	S
Q9P109	LB/B	-	K7EYA9	321	V	L
P23434	LB/B	-	G1TTR4	21	S	L
P23434	LB/B	-	G1TTR4	73	N	S
P27539	LB/B	-	A0A2U9CA91	118	A	V
P27539	LP/P	Tetralogy of Fallot (TOF) [MIM:187500]	A0A2U9CA91	162	G	D
P27539	LP/P	Conotruncal heart malformations (CTHM) [MIM:217095]	A0A2U9CA91	267	C	Y
P27539	LP/P	Tetralogy of Fallot (TOF) [MIM:187500]	A0A2U9CA91	309	S	P
P27539	LP/P	Tetralogy of Fallot (TOF) [MIM:187500]	A0A2U9CA91	312	P	T
P27539	LP/P	Congenital heart defects, multiple types, 6 (CHTD6) [MIM:613854]	A0A2U9CA91	318	A	T
P27539	LP/P	Congenital heart defects, multiple types, 6 (CHTD6) [MIM:613854]	A0A2U9CA91	364	M	T
Q99988	LB/B	-	F1PDK9	48	S	T
Q99988	LB/B	-	F1PDK9	9	V	L
Q99988	LB/B	-	F1PDK9	202	H	D
Q9UK05	LP/P	Telangiectasia, hereditary hemorrhagic, 5 (HHT5) [MIM:615506]	A0A2I0T8R7	68	R	L
Q9UK05	LP/P	Telangiectasia, hereditary hemorrhagic, 5 (HHT5) [MIM:615506]	A0A2I0T8R7	85	P	L
Q9UK05	LP/P	Telangiectasia, hereditary hemorrhagic, 5 (HHT5) [MIM:615506]	A0A2I0T8R7	333	R	W
Q9NR23	LB/B	-	A0A1S3AQP4	328	V	L
Q9NR23	LB/B	-	A0A1S3AQP4	213	G	R
Q9NR23	LP/P	Microphthalmia, isolated, 7 (MCOP7) [MIM:613704]	A0A1S3AQP4	195	R	Q
Q9NR23	LP/P	Klippel-Feil syndrome 3, autosomal dominant (KFS3) [MIM:613702]	A0A1S3AQP4	266	R	C
Q9NR23	LP/P	Microphthalmia, isolated, with coloboma, 6 (MCOPCB6) [MIM:613703]	A0A1S3AQP4	266	R	C
Q9NR23	LP/P	Microphthalmia, isolated, with coloboma, 6 (MCOPCB6) [MIM:613703]	A0A1S3AQP4	274	R	W
Q9NR23	LP/P	Microphthalmia, isolated, 7 (MCOP7) [MIM:613704]	A0A1S3AQP4	305	L	P
Q6KF10	LB/B	-	G1SUH3	110	K	E
Q6KF10	LP/P	Klippel-Feil syndrome 1, autosomal dominant (KFS1) [MIM:118100]	G1SUH3	249	A	E
Q6KF10	LP/P	Leber congenital amaurosis 17 (LCA17) [MIM:615360]	G1SUH3	249	A	E
Q6KF10	LP/P	Microphthalmia, isolated, 4 (MCOP4) [MIM:613094]	G1SUH3	249	A	E
Q6KF10	LP/P	Klippel-Feil syndrome 1, autosomal dominant (KFS1) [MIM:118100]	G1SUH3	289	L	P
Q6KF10	LP/P	Klippel-Feil syndrome 1, autosomal dominant (KFS1) [MIM:118100]	G1SUH3	42	G	V
Q6KF10	LP/P	Microphthalmia, isolated, 4 (MCOP4) [MIM:613094]	G1SUH3	119	Q	R
Q6KF10	LP/P	Microphthalmia, isolated, 4 (MCOP4) [MIM:613094]	G1SUH3	216	D	G
Q6KF10	LP/P	Microphthalmia, isolated, 4 (MCOP4) [MIM:613094]	G1SUH3	253	Q	L
Q6KF10	LP/P	Microphthalmia, isolated, 4 (MCOP4) [MIM:613094]	G1SUH3	327	P	H
Q6KF10	LP/P	Klippel-Feil syndrome 1, autosomal dominant (KFS1) [MIM:118100]	G1SUH3	424	K	R
Q6KF10	LP/P	Leber congenital amaurosis 17 (LCA17) [MIM:615360]	G1SUH3	199	A	T
Q6KF10	LP/P	Leber congenital amaurosis 17 (LCA17) [MIM:615360]	G1SUH3	57	D	H
Q6KF10	LP/P	Leber congenital amaurosis 17 (LCA17) [MIM:615360]	G1SUH3	292	E	D
Q6KF10	LP/P	Multiple synostoses syndrome 4 (SYNS4) [MIM:617898]	G1SUH3	444	Y	N
O60383	LB/B	-	A0A096ND35	121	T	I
O60383	LB/B	-	A0A096ND35	374	P	L
O60383	LB/B	-	A0A096ND35	454	R	C
P31150	LP/P	Intellectual developmental disorder, X-linked 41 (XLID41) [MIM:300849]	B0KWX0	92	L	P
P31150	LP/P	Intellectual developmental disorder, X-linked 41 (XLID41) [MIM:300849]	B0KWX0	423	R	P
P39905	LB/B	-	A0A1U8C4V4	93	R	W
P39905	LB/B	-	A0A1U8C4V4	150	D	N
P39905	LP/P	Hirschsprung disease 3 (HSCR3) [MIM:613711]	A0A1U8C4V4	154	T	S
P39905	LP/P	Hirschsprung disease 3 (HSCR3) [MIM:613711]	A0A1U8C4V4	211	I	M
Q6W3E5	LB/B	-	A0A1S3EZQ3	220	K	R
Q6W3E5	LB/B	-	A0A1S3EZQ3	383	H	Y
Q6W3E5	LB/B	-	A0A1S3EZQ3	390	I	V
Q6W3E5	LB/B	-	A0A1S3EZQ3	396	N	K
Q8WTR4	LB/B	-	A0A091DMK8	480	A	T
Q6ZNW5	LB/B	-	S7PWF3	37	M	T
Q6ZNW5	LB/B	-	S7PWF3	264	P	T
Q6ZNW5	LB/B	-	S7PWF3	307	T	I
P55040	LB/B	-	A0A147B0H0	43	R	G
P57678	LB/B	-	F6ZFB1	1033	R	C
P57678	LB/B	-	F6ZFB1	684	R	Q
P57678	LB/B	-	F6ZFB1	579	A	G
P57678	LB/B	-	F6ZFB1	182	F	L
P57678	LB/B	-	F6ZFB1	502	I	V
P57678	LB/B	-	F6ZFB1	739	I	T
P57678	LB/B	-	F6ZFB1	749	P	L
P57678	LB/B	-	F6ZFB1	782	F	L
P57678	LB/B	-	F6ZFB1	824	V	F
P57678	LB/B	-	F6ZFB1	913	V	I
Q8WXD5	LB/B	-	A0A1S3FBG1	140	G	D
Q17RS7	LB/B	-	G1P9K8	92	S	T
Q17RS7	LB/B	-	G1P9K8	143	N	S
Q17RS7	LB/B	-	G1P9K8	203	I	V
Q17RS7	LB/B	-	G1P9K8	310	S	N
Q17RS7	LB/B	-	G1P9K8	680	T	I
Q17RS7	LB/B	-	G1P9K8	898	R	C
O43681	LB/B	-	A0A094DQA8	332	N	S
P55789	LB/B	-	A0A250YC34	166	F	L
P55789	LP/P	Myopathy, mitochondrial progressive, with congenital cataract, hearing loss and developmental delay (MPMCD) [MIM:613076]	A0A250YC34	194	R	H
Q99684	LP/P	Neutropenia, severe congenital 2, autosomal dominant (SCN2) [MIM:613107]	H2LK28	382	N	S
Q99684	LP/P	Dominant nonimmune chronic idiopathic neutropenia of adults (NI-CINA) [MIM:607847]	H2LK28	403	K	R
Q99684	LB/B	-	H2LK28	36	S	N
Q96RP9	LP/P	Combined oxidative phosphorylation deficiency 1 (COXPD1) [MIM:609060]	A0A096M2Z6	174	N	S
Q96RP9	LB/B	-	A0A096M2Z6	215	V	I
Q96RP9	LP/P	Combined oxidative phosphorylation deficiency 1 (COXPD1) [MIM:609060]	A0A096M2Z6	496	M	R
Q96RP9	LP/P	Combined oxidative phosphorylation deficiency 1 (COXPD1) [MIM:609060]	A0A096M2Z6	57	S	Y
Q96RP9	LP/P	Combined oxidative phosphorylation deficiency 1 (COXPD1) [MIM:609060]	A0A096M2Z6	250	R	W
Q969S9	LB/B	-	T1HV44	64	N	S
Q969S9	LB/B	-	T1HV44	300	S	C
Q969S9	LB/B	-	T1HV44	774	R	Q
Q969S9	LB/B	-	T1HV44	425	P	H
Q969S9	LB/B	-	T1HV44	594	E	G
Q969S9	LB/B	-	T1HV44	735	E	G
Q969S9	LP/P	Combined oxidative phosphorylation deficiency 39 (COXPD39) [MIM:618397]	T1HV44	92	Y	S
Q969S9	LP/P	Combined oxidative phosphorylation deficiency 39 (COXPD39) [MIM:618397]	T1HV44	190	R	Q
Q3B7J2	LB/B	-	G1QY52	231	G	V
P56159	LB/B	-	A0A2K6KH32	85	Y	N
P56159	LB/B	-	A0A2K6KH32	366	T	A
P56159	LB/B	-	A0A2K6KH32	371	L	R
Q6UXV0	LB/B	-	L8I4F2	33	R	C
Q6UXV0	LB/B	-	L8I4F2	387	S	P
Q9NZ52	LB/B	-	A0A0F8B6N4	132	K	R
Q9NZ52	LB/B	-	A0A0F8B6N4	321	S	G
Q92820	LB/B	-	A0A067R906	6	C	R
Q92820	LB/B	-	A0A067R906	31	A	T
Q92820	LB/B	-	A0A067R906	151	T	I
O95749	LP/P	Muscular dystrophy, congenital hearing loss, and ovarian insufficiency syndrome (MDHLO) [MIM:619518]	A0A0L0FXB4	257	F	C
O95749	LP/P	Muscular dystrophy, congenital hearing loss, and ovarian insufficiency syndrome (MDHLO) [MIM:619518]	A0A0L0FXB4	259	Y	C
O95749	LP/P	Muscular dystrophy, congenital hearing loss, and ovarian insufficiency syndrome (MDHLO) [MIM:619518]	A0A0L0FXB4	261	R	G
O95749	LP/P	Muscular dystrophy, congenital hearing loss, and ovarian insufficiency syndrome (MDHLO) [MIM:619518]	A0A0L0FXB4	261	R	H
P19440	LB/B	-	A0A2Y9ITH0	272	V	A
P19440	LB/B	-	A0A2Y9ITH0	52	K	E
P19440	LB/B	-	A0A2Y9ITH0	177	A	V
P19440	LB/B	-	A0A2Y9ITH0	51	S	L
P19440	LB/B	-	A0A2Y9ITH0	419	N	D
P19440	LB/B	-	A0A2Y9ITH0	435	V	A
Q6P531	LB/B	-	Q6IE08	40	R	W
Q6P531	LB/B	-	Q6IE08	58	A	V
Q14390	LB/B	-	B5MC34	70	E	G
Q14390	LB/B	-	B5MC34	75	D	N
P01241	LB/B	-	F7H8S0	3	T	A
P01241	LB/B	-	F7H8S0	105	S	C
P01241	LB/B	-	F7H8S0	136	V	I
P01241	LP/P	Growth hormone deficiency, isolated, 1B (IGHD1B) [MIM:612781]	F7H8S0	16	L	P
P01241	LP/P	Growth hormone deficiency, isolated, 1B (IGHD1B) [MIM:612781]	F7H8S0	37	D	N
P01241	LP/P	Growth hormone deficiency, isolated, 1B (IGHD1B) [MIM:612781]	F7H8S0	42	R	C
P01241	LP/P	Growth hormone deficiency, isolated, 1B (IGHD1B) [MIM:612781]	F7H8S0	53	T	I
P01241	LP/P	Growth hormone deficiency, isolated, 1B (IGHD1B) [MIM:612781]	F7H8S0	67	K	R
P01241	LP/P	Growth hormone deficiency, isolated, 1B (IGHD1B) [MIM:612781]	F7H8S0	73	N	D
P01241	LP/P	Growth hormone deficiency, isolated, 1B (IGHD1B) [MIM:612781]	F7H8S0	97	S	F
P01241	LP/P	Growth hormone deficiency, isolated, 1B (IGHD1B) [MIM:612781]	F7H8S0	100	E	K
P01241	LP/P	Kowarski syndrome (KWKS) [MIM:262650]	F7H8S0	103	R	C
P01241	LP/P	Growth hormone deficiency, isolated, 1B (IGHD1B) [MIM:612781]	F7H8S0	117	Q	L
P01241	LP/P	Growth hormone deficiency, isolated, 1B (IGHD1B) [MIM:612781]	F7H8S0	134	S	C
P01241	LP/P	Growth hormone deficiency, isolated, 1B (IGHD1B) [MIM:612781]	F7H8S0	134	S	R
P01241	LP/P	Kowarski syndrome (KWKS) [MIM:262650]	F7H8S0	138	D	G
P01241	LP/P	Growth hormone deficiency, isolated, 1B (IGHD1B) [MIM:612781]	F7H8S0	201	T	A
P01241	LP/P	Growth hormone deficiency, isolated, 2 (IGHD2) [MIM:173100]	F7H8S0	209	R	H
P01241	LB/B	-	F7H8S0	79	C	S
P01241	LB/B	-	F7H8S0	205	I	M
P01242	LB/B	-	F7H8S0	90	R	W
P10912	LP/P	Growth hormone insensitivity, partial (GHIP) [MIM:604271]	M3YSM8	62	E	K
P10912	LP/P	Laron syndrome (LARS) [MIM:262500]	M3YSM8	89	R	K
P10912	LP/P	Laron syndrome (LARS) [MIM:262500]	M3YSM8	114	F	S
P10912	LP/P	Laron syndrome (LARS) [MIM:262500]	M3YSM8	143	V	A
P10912	LP/P	Laron syndrome (LARS) [MIM:262500]	M3YSM8	162	V	D
P10912	LP/P	Laron syndrome (LARS) [MIM:262500]	M3YSM8	170	D	H
P10912	LP/P	Growth hormone insensitivity, partial (GHIP) [MIM:604271]	M3YSM8	179	R	C
P10912	LP/P	Laron syndrome (LARS) [MIM:262500]	M3YSM8	179	R	C
P10912	LP/P	Laron syndrome (LARS) [MIM:262500]	M3YSM8	229	R	G
P10912	LB/B	-	M3YSM8	179	R	H
P10912	LB/B	-	M3YSM8	440	C	F
P10912	LB/B	-	M3YSM8	495	P	T
P10912	LB/B	-	M3YSM8	544	I	L
P10912	LB/B	-	M3YSM8	579	P	T
P10912	LP/P	Laron syndrome (LARS) [MIM:262500]	M3YSM8	56	C	S
P10912	LP/P	Laron syndrome (LARS) [MIM:262500]	M3YSM8	58	S	L
P10912	LP/P	Laron syndrome (LARS) [MIM:262500]	M3YSM8	68	W	R
P10912	LP/P	Laron syndrome (LARS) [MIM:262500]	M3YSM8	149	P	Q
P10912	LP/P	Laron syndrome (LARS) [MIM:262500]	M3YSM8	171	I	T
P10912	LP/P	Laron syndrome (LARS) [MIM:262500]	M3YSM8	172	Q	P
P10912	LP/P	Laron syndrome (LARS) [MIM:262500]	M3YSM8	173	V	G
P10912	LP/P	Laron syndrome (LARS) [MIM:262500]	M3YSM8	226	Y	C
P10912	LP/P	Laron syndrome (LARS) [MIM:262500]	M3YSM8	244	S	I
P10912	LP/P	Laron syndrome (LARS) [MIM:262500]	M3YSM8	262	D	N
P10912	LB/B	-	M3YSM8	162	V	F
P10912	LB/B	-	M3YSM8	465	E	K
P01286	LB/B	-	F7IJ93	75	L	F
P01286	LB/B	-	F7IJ93	32	Y	C
Q02643	LP/P	Growth hormone deficiency, isolated, 4 (IGHD4) [MIM:618157]	K7GGM6	144	L	H
Q02643	LP/P	Growth hormone deficiency, isolated, 4 (IGHD4) [MIM:618157]	K7GGM6	176	A	V
Q02643	LP/P	Growth hormone deficiency, isolated, 4 (IGHD4) [MIM:618157]	K7GGM6	222	A	E
Q02643	LP/P	Growth hormone deficiency, isolated, 4 (IGHD4) [MIM:618157]	K7GGM6	242	F	C
Q02643	LP/P	Growth hormone deficiency, isolated, 4 (IGHD4) [MIM:618157]	K7GGM6	329	K	E
Q02643	LB/B	-	K7GGM6	57	A	T
Q02643	LB/B	-	K7GGM6	121	E	D
Q02643	LB/B	-	K7GGM6	225	V	I
Q02643	LB/B	-	K7GGM6	422	M	T
Q9UBU3	LB/B	-	A0A2K6NEJ5	90	Q	L
Q9UBU3	LB/B	-	A0A2K6NEJ5	72	L	M
Q92847	LP/P	Growth hormone deficiency, isolated partial (GHDP) [MIM:615925]	G1UDG4	204	A	E
Q92847	LB/B	-	G1UDG4	5	T	I
Q92847	LP/P	Growth hormone deficiency, isolated partial (GHDP) [MIM:615925]	G1UDG4	237	R	W
Q6Y7W6	LB/B	-	G5ASX0	56	N	S
Q6Y7W6	LP/P	Parkinson disease 11 (PARK11) [MIM:607688]	G5ASX0	112	T	A
Q6Y7W6	LP/P	Parkinson disease 11 (PARK11) [MIM:607688]	G5ASX0	278	I	V
Q6Y7W6	LP/P	Parkinson disease 11 (PARK11) [MIM:607688]	G5ASX0	335	S	T
Q6Y7W6	LB/B	-	G5ASX0	460	P	T
Q6Y7W6	LP/P	Parkinson disease 11 (PARK11) [MIM:607688]	G5ASX0	606	D	E
Q6Y7W6	LB/B	-	G5ASX0	1171	H	R
Q6Y7W6	LP/P	Parkinson disease 11 (PARK11) [MIM:607688]	G5ASX0	1242	V	I
Q6Y7W6	LB/B	-	G5ASX0	423	P	L
Q6Y7W6	LB/B	-	G5ASX0	560	A	V
Q6Y7W6	LP/P	Parkinson disease 11 (PARK11) [MIM:607688]	G5ASX0	589	R	G
Q6Y7W6	LB/B	-	G5ASX0	1131	A	V
Q9UG22	LB/B	-	A0A2K5DYA7	161	H	R
Q9UG22	LB/B	-	A0A2K5DYA7	74	V	F
Q9UG22	LB/B	-	A0A2K5DYA7	152	N	S
Q6P9H5	LB/B	-	F6W176	170	G	D
Q6P9H5	LB/B	-	F6W176	171	G	S
Q6P9H5	LB/B	-	F6W176	237	Q	R
Q6P9H5	LB/B	-	F6W176	65	V	I
Q8NHV1	LB/B	-	F7CKT4	83	R	C
Q8ND71	LB/B	-	M3Y7V9	301	I	T
Q9NXP7	LB/B	-	A0A226MP74	22	G	C
Q9NXP7	LB/B	-	A0A226MP74	239	T	M
Q14691	LB/B	-	A0A2G9GXY8	97	V	I
Q14691	LP/P	Immunodeficiency 55 (IMD55) [MIM:617827]	A0A2G9GXY8	83	R	C
Q14691	LP/P	Immunodeficiency 55 (IMD55) [MIM:617827]	A0A2G9GXY8	152	C	Y
P09681	LB/B	-	A0A2F0AY13	103	S	G
P09681	LB/B	-	A0A2F0AY13	146	N	S
P48546	LB/B	-	A0A1U7RDC8	207	A	V
P48546	LB/B	-	A0A1U7RDC8	262	L	V
P48546	LB/B	-	A0A1U7RDC8	354	E	Q
P48546	LB/B	-	A0A1U7RDC8	136	R	W
Q14161	LB/B	-	H2UM78	387	N	S
Q14161	LB/B	-	H2UM78	338	N	S
Q14161	LB/B	-	H2UM78	552	A	V
P17302	LP/P	Oculodentodigital dysplasia (ODDD) [MIM:164200]	O73863	148	R	Q
P17302	LB/B	-	O73863	168	A	T
P17302	LP/P	Oculodentodigital dysplasia (ODDD) [MIM:164200]	O73863	17	Y	S
P17302	LP/P	Oculodentodigital dysplasia (ODDD) [MIM:164200]	O73863	18	S	P
P17302	LP/P	Oculodentodigital dysplasia (ODDD) [MIM:164200]	O73863	21	G	R
P17302	LP/P	Oculodentodigital dysplasia (ODDD) [MIM:164200]	O73863	22	G	E
P17302	LP/P	Oculodentodigital dysplasia (ODDD) [MIM:164200]	O73863	23	K	T
P17302	LP/P	Oculodentodigital dysplasia (ODDD) [MIM:164200]	O73863	40	A	V
P17302	LP/P	Oculodentodigital dysplasia (ODDD) [MIM:164200]	O73863	49	Q	K
P17302	LP/P	Oculodentodigital dysplasia (ODDD) [MIM:164200]	O73863	76	R	S
P17302	LP/P	Oculodentodigital dysplasia (ODDD) [MIM:164200]	O73863	90	L	V
P17302	LP/P	Oculodentodigital dysplasia (ODDD) [MIM:164200]	O73863	98	Y	C
P17302	LP/P	Oculodentodigital dysplasia (ODDD) [MIM:164200]	O73863	102	K	N
P17302	LP/P	Oculodentodigital dysplasia (ODDD) [MIM:164200]	O73863	130	I	T
P17302	LP/P	Oculodentodigital dysplasia (ODDD) [MIM:164200]	O73863	134	K	E
P17302	LP/P	Oculodentodigital dysplasia (ODDD) [MIM:164200]	O73863	138	G	R
P17302	LP/P	Oculodentodigital dysplasia (ODDD) [MIM:164200]	O73863	202	R	H
P17302	LP/P	Oculodentodigital dysplasia (ODDD) [MIM:164200]	O73863	216	V	L
P17302	LB/B	-	O73863	253	A	V
P17302	LP/P	Oculodentodigital dysplasia (ODDD) [MIM:164200]	O73863	27	S	P
P17302	LP/P	Oculodentodigital dysplasia (ODDD) [MIM:164200]	O73863	31	I	M
P17302	LP/P	Oculodentodigital dysplasia (ODDD) [MIM:164200]	O73863	69	S	Y
P17302	LP/P	Oculodentodigital dysplasia (ODDD) [MIM:164200]	O73863	113	L	P
P17302	LP/P	Oculodentodigital dysplasia (ODDD) [MIM:164200]	O73863	134	K	N
P17302	LP/P	Syndactyly 3 (SDTY3) [MIM:186100]	O73863	143	G	S
P17302	LP/P	Oculodentodigital dysplasia (ODDD) [MIM:164200]	O73863	2	G	V
P17302	LP/P	Oculodentodigital dysplasia (ODDD) [MIM:164200]	O73863	7	L	V
P17302	LP/P	Oculodentodigital dysplasia (ODDD) [MIM:164200]	O73863	11	L	P
P17302	LP/P	Oculodentodigital dysplasia (ODDD) [MIM:164200]	O73863	49	Q	P
P17302	LP/P	Oculodentodigital dysplasia (ODDD) [MIM:164200]	O73863	59	P	H
P17302	LP/P	Hallermann-Streiff syndrome (HSS) [MIM:234100]	O73863	76	R	H
P17302	LP/P	Oculodentodigital dysplasia (ODDD) [MIM:164200]	O73863	95	H	R
P17302	LP/P	Oculodentodigital dysplasia (ODDD) [MIM:164200]	O73863	96	V	A
P17302	LP/P	Oculodentodigital dysplasia (ODDD) [MIM:164200]	O73863	96	V	E
P17302	LP/P	Oculodentodigital dysplasia (ODDD) [MIM:164200]	O73863	96	V	M
P17302	LP/P	Oculodentodigital dysplasia (ODDD) [MIM:164200]	O73863	106	L	P
P17302	LP/P	Oculodentodigital dysplasia (ODDD) [MIM:164200]	O73863	110	E	D
P17302	LP/P	Oculodentodigital dysplasia (ODDD) [MIM:164200]	O73863	147	M	T
P17302	LP/P	Oculodentodigital dysplasia (ODDD) [MIM:164200]	O73863	154	T	A
P17302	LP/P	Oculodentodigital dysplasia (ODDD) [MIM:164200]	O73863	154	T	N
P17302	LP/P	Oculodentodigital dysplasia (ODDD) [MIM:164200]	O73863	194	H	P
P17302	LP/P	Oculodentodigital dysplasia (ODDD) [MIM:164200]	O73863	201	S	F
P17302	LP/P	Oculodentodigital dysplasia (ODDD) [MIM:164200]	O73863	220	S	Y
P17302	LB/B	-	O73863	326	T	A
P17302	LB/B	-	O73863	373	S	G
P17302	LP/P	Oculodentodigital dysplasia (ODDD) [MIM:164200]	O73863	206	K	R
P17302	LP/P	Craniometaphyseal dysplasia, autosomal recessive (CMDR) [MIM:218400]	O73863	239	R	Q
P17302	LP/P	Oculodentodigital dysplasia (ODDD) [MIM:164200]	O73863	47	D	H
P17302	LP/P	Oculodentodigital dysplasia (ODDD) [MIM:164200]	O73863	86	S	Y
P17302	LP/P	Oculodentodigital dysplasia (ODDD) [MIM:164200]	O73863	106	L	R
P17302	LP/P	Palmoplantar keratoderma and congenital alopecia 1 (PPKCA1) [MIM:104100]	O73863	8	G	V
P17302	LP/P	Erythrokeratodermia variabilis et progressiva 3 (EKVP3) [MIM:617525]	O73863	44	A	V
P17302	LP/P	Erythrokeratodermia variabilis et progressiva 3 (EKVP3) [MIM:617525]	O73863	227	E	D
P17302	LP/P	Oculodentodigital dysplasia (ODDD) [MIM:164200]	O73863	11	L	I
Q9Y6H8	LP/P	Cataract 14, multiple types (CTRCT14) [MIM:601885]	A0A1S3GWX6	63	N	S
Q9Y6H8	LB/B	-	A0A1S3GWX6	299	L	M
Q9Y6H8	LP/P	Cataract 14, multiple types (CTRCT14) [MIM:601885]	A0A1S3GWX6	187	P	L
Q9Y6H8	LP/P	Cataract 14, multiple types (CTRCT14) [MIM:601885]	A0A1S3GWX6	11	L	S
Q9Y6H8	LP/P	Cataract 14, multiple types (CTRCT14) [MIM:601885]	A0A1S3GWX6	32	F	L
Q9Y6H8	LP/P	Cataract 14, multiple types (CTRCT14) [MIM:601885]	A0A1S3GWX6	59	P	L
Q9Y6H8	LP/P	Cataract 14, multiple types (CTRCT14) [MIM:601885]	A0A1S3GWX6	76	R	H
Q9Y6H8	LP/P	Cataract 14, multiple types (CTRCT14) [MIM:601885]	A0A1S3GWX6	45	W	S
Q9Y6H8	LP/P	Cataract 14, multiple types (CTRCT14) [MIM:601885]	A0A1S3GWX6	2	G	D
Q9Y6H8	LP/P	Cataract 14, multiple types (CTRCT14) [MIM:601885]	A0A1S3GWX6	3	D	Y
Q9Y6H8	LP/P	Cataract 14, multiple types (CTRCT14) [MIM:601885]	A0A1S3GWX6	28	V	M
Q9Y6H8	LP/P	Cataract 14, multiple types (CTRCT14) [MIM:601885]	A0A1S3GWX6	33	R	L
Q9Y6H8	LP/P	Cataract 14, multiple types (CTRCT14) [MIM:601885]	A0A1S3GWX6	44	V	M
Q9Y6H8	LP/P	Cataract 14, multiple types (CTRCT14) [MIM:601885]	A0A1S3GWX6	47	D	N
Q9Y6H8	LP/P	Cataract 14, multiple types (CTRCT14) [MIM:601885]	A0A1S3GWX6	76	R	G
Q9Y6H8	LP/P	Cataract 14, multiple types (CTRCT14) [MIM:601885]	A0A1S3GWX6	87	T	M
Q9Y6H8	LP/P	Cataract 14, multiple types (CTRCT14) [MIM:601885]	A0A1S3GWX6	187	P	S
Q9Y6H8	LP/P	Cataract 14, multiple types (CTRCT14) [MIM:601885]	A0A1S3GWX6	188	N	T
Q9Y6H8	LP/P	Cataract 14, multiple types (CTRCT14) [MIM:601885]	A0A1S3GWX6	143	G	E
Q9Y6H8	LP/P	Cataract 14, multiple types (CTRCT14) [MIM:601885]	A0A1S3GWX6	188	N	I
Q9Y6H8	LP/P	Cataract 14, multiple types (CTRCT14) [MIM:601885]	A0A1S3GWX6	48	E	G
P35212	LB/B	-	H0WMY4	71	P	S
P35212	LB/B	-	H0WMY4	128	A	V
P35212	LB/B	-	H0WMY4	130	V	I
P35212	LB/B	-	H0WMY4	319	P	S
P36382	LP/P	Atrial standstill 1 (ATRST1) [MIM:108770]	A0A1S3GWL5	88	P	S
P36382	LP/P	Atrial standstill 1 (ATRST1) [MIM:108770]	A0A1S3GWL5	96	A	S
P36382	LP/P	Atrial fibrillation, familial, 11 (ATFB11) [MIM:614049]	A0A1S3GWL5	85	V	I
P36382	LP/P	Atrial fibrillation, familial, 11 (ATFB11) [MIM:614049]	A0A1S3GWL5	221	L	I
P36382	LP/P	Atrial fibrillation, familial, 11 (ATFB11) [MIM:614049]	A0A1S3GWL5	229	L	M
P48165	LP/P	Cataract 1, multiple types (CTRCT1) [MIM:116200]	F6QCF2	88	P	S
P48165	LP/P	Cataract 1, multiple types (CTRCT1) [MIM:116200]	F6QCF2	64	V	G
P48165	LP/P	Cataract 1, multiple types (CTRCT1) [MIM:116200]	F6QCF2	23	R	T
P48165	LP/P	Cataract 1, multiple types (CTRCT1) [MIM:116200]	F6QCF2	44	V	E
P48165	LP/P	Cataract 1, multiple types (CTRCT1) [MIM:116200]	F6QCF2	48	E	K
P48165	LP/P	Cataract 1, multiple types (CTRCT1) [MIM:116200]	F6QCF2	198	R	Q
P48165	LB/B	-	F6QCF2	247	I	M
P48165	LP/P	Cataract 1, multiple types (CTRCT1) [MIM:116200]	F6QCF2	67	D	G
P48165	LP/P	Cataract 1, multiple types (CTRCT1) [MIM:116200]	F6QCF2	76	R	C
P48165	LP/P	Cataract 1, multiple types (CTRCT1) [MIM:116200]	F6QCF2	73	S	F
P48165	LP/P	Cataract 1, multiple types (CTRCT1) [MIM:116200]	F6QCF2	88	P	L
P48165	LP/P	Cataract 1, multiple types (CTRCT1) [MIM:116200]	F6QCF2	88	P	Q
P29033	LB/B	-	A0A1A6H6Q9	27	V	I
P29033	LP/P	Deafness, autosomal recessive, 1A (DFNB1A) [MIM:220290]	A0A1A6H6Q9	34	M	T
P29033	LP/P	Deafness, autosomal recessive, 1A (DFNB1A) [MIM:220290]	A0A1A6H6Q9	37	V	I
P29033	LP/P	Deafness, autosomal dominant, 3A (DFNA3A) [MIM:601544]	A0A1A6H6Q9	75	R	W
P29033	LP/P	Keratoderma, palmoplantar, with deafness (PPKDFN) [MIM:148350]	A0A1A6H6Q9	75	R	W
P29033	LP/P	Deafness, autosomal recessive, 1A (DFNB1A) [MIM:220290]	A0A1A6H6Q9	77	W	R
P29033	LB/B	-	A0A1A6H6Q9	83	F	L
P29033	LP/P	Deafness, autosomal recessive, 1A (DFNB1A) [MIM:220290]	A0A1A6H6Q9	84	V	L
P29033	LP/P	Deafness, autosomal recessive, 1A (DFNB1A) [MIM:220290]	A0A1A6H6Q9	95	V	M
P29033	LP/P	Deafness, autosomal recessive, 1A (DFNB1A) [MIM:220290]	A0A1A6H6Q9	113	S	R
P29033	LB/B	-	A0A1A6H6Q9	160	G	S
P29033	LP/P	Deafness, autosomal dominant, 3A (DFNA3A) [MIM:601544]	A0A1A6H6Q9	44	W	C
P29033	LP/P	Keratoderma, palmoplantar, with deafness (PPKDFN) [MIM:148350]	A0A1A6H6Q9	66	D	H
P29033	LP/P	Vohwinkel syndrome (VOWNKL) [MIM:124500]	A0A1A6H6Q9	66	D	H
P29033	LP/P	Keratoderma, palmoplantar, with deafness (PPKDFN) [MIM:148350]	A0A1A6H6Q9	59	G	A
P29033	LB/B	-	A0A1A6H6Q9	114	E	G
P29033	LB/B	-	A0A1A6H6Q9	153	V	I
P29033	LB/B	-	A0A1A6H6Q9	169	C	Y
P29033	LP/P	Deafness, autosomal recessive, 1A (DFNB1A) [MIM:220290]	A0A1A6H6Q9	184	R	W
P29033	LB/B	-	A0A1A6H6Q9	203	I	T
P29033	LP/P	Keratitis-ichthyosis-deafness syndrome, autosomal dominant (KIDAD) [MIM:148210]	A0A1A6H6Q9	12	G	R
P29033	LP/P	Keratitis-ichthyosis-deafness syndrome, autosomal dominant (KIDAD) [MIM:148210]	A0A1A6H6Q9	17	S	F
P29033	LB/B	-	A0A1A6H6Q9	45	G	E
P29033	LP/P	Ichthyosis hystrix-like with deafness syndrome (HID syndrome) [MIM:602540]	A0A1A6H6Q9	50	D	N
P29033	LP/P	Keratitis-ichthyosis-deafness syndrome, autosomal dominant (KIDAD) [MIM:148210]	A0A1A6H6Q9	50	D	N
P29033	LB/B	-	A0A1A6H6Q9	71	I	T
P29033	LP/P	Deafness, autosomal recessive, 1A (DFNB1A) [MIM:220290]	A0A1A6H6Q9	86	T	R
P29033	LB/B	-	A0A1A6H6Q9	123	T	N
P29033	LP/P	Deafness, autosomal recessive, 1A (DFNB1A) [MIM:220290]	A0A1A6H6Q9	143	R	W
P29033	LB/B	-	A0A1A6H6Q9	191	F	L
P29033	LP/P	Keratitis-ichthyosis-deafness syndrome, autosomal dominant (KIDAD) [MIM:148210]	A0A1A6H6Q9	50	D	Y
P29033	LP/P	Keratoderma, palmoplantar, with deafness (PPKDFN) [MIM:148350]	A0A1A6H6Q9	75	R	Q
P29033	LP/P	Deafness, autosomal recessive, 1A (DFNB1A) [MIM:220290]	A0A1A6H6Q9	90	L	P
P29033	LB/B	-	A0A1A6H6Q9	111	I	T
P29033	LB/B	-	A0A1A6H6Q9	127	R	H
P29033	LP/P	Deafness, autosomal dominant, 3A (DFNA3A) [MIM:601544]	A0A1A6H6Q9	143	R	Q
P29033	LP/P	Deafness, autosomal recessive, 1A (DFNB1A) [MIM:220290]	A0A1A6H6Q9	159	D	V
P29033	LB/B	-	A0A1A6H6Q9	165	R	W
P29033	LP/P	Deafness, autosomal recessive, 1A (DFNB1A) [MIM:220290]	A0A1A6H6Q9	184	R	P
P29033	LP/P	Deafness, autosomal dominant, 3A (DFNA3A) [MIM:601544]	A0A1A6H6Q9	202	C	F
P29033	LB/B	-	A0A1A6H6Q9	32	R	L
P29033	LP/P	Deafness, autosomal recessive, 1A (DFNB1A) [MIM:220290]	A0A1A6H6Q9	32	R	H
P29033	LP/P	Deafness, autosomal recessive, 1A (DFNB1A) [MIM:220290]	A0A1A6H6Q9	79	L	P
P29033	LP/P	Deafness, autosomal recessive, 1A (DFNB1A) [MIM:220290]	A0A1A6H6Q9	80	Q	K
P29033	LP/P	Deafness, autosomal recessive, 1A (DFNB1A) [MIM:220290]	A0A1A6H6Q9	93	M	I
P29033	LP/P	Deafness, autosomal recessive, 1A (DFNB1A) [MIM:220290]	A0A1A6H6Q9	129	E	K
P29033	LB/B	-	A0A1A6H6Q9	167	V	M
P29033	LP/P	Deafness, autosomal recessive, 1A (DFNB1A) [MIM:220290]	A0A1A6H6Q9	178	V	A
P29033	LP/P	Deafness, autosomal dominant, 3A (DFNA3A) [MIM:601544]	A0A1A6H6Q9	184	R	Q
P29033	LP/P	Deafness, autosomal dominant, 3A (DFNA3A) [MIM:601544]	A0A1A6H6Q9	197	A	S
P29033	LP/P	Deafness, autosomal recessive, 1A (DFNB1A) [MIM:220290]	A0A1A6H6Q9	203	I	K
P29033	LP/P	Deafness, autosomal recessive, 1A (DFNB1A) [MIM:220290]	A0A1A6H6Q9	214	L	P
P29033	LP/P	Deafness, autosomal dominant, 3A (DFNA3A) [MIM:601544]	A0A1A6H6Q9	44	W	S
P29033	LP/P	Bart-Pumphrey syndrome (BAPS) [MIM:149200]	A0A1A6H6Q9	54	N	K
P29033	LP/P	Bart-Pumphrey syndrome (BAPS) [MIM:149200]	A0A1A6H6Q9	59	G	S
P29033	LP/P	Deafness, autosomal dominant, 3A (DFNA3A) [MIM:601544]	A0A1A6H6Q9	179	D	N
P29033	LP/P	Deafness, autosomal dominant, 3A (DFNA3A) [MIM:601544]	A0A1A6H6Q9	46	D	E
P29033	LP/P	Keratoderma, palmoplantar, with deafness (PPKDFN) [MIM:148350]	A0A1A6H6Q9	73	H	R
P29033	LP/P	Deafness, autosomal recessive, 1A (DFNB1A) [MIM:220290]	A0A1A6H6Q9	84	V	M
P29033	LB/B	-	A0A1A6H6Q9	117	D	H
P29033	LP/P	Deafness, autosomal recessive, 1A (DFNB1A) [MIM:220290]	A0A1A6H6Q9	130	G	A
P29033	LP/P	Deafness, autosomal recessive, 1A (DFNB1A) [MIM:220290]	A0A1A6H6Q9	130	G	D
P29033	LP/P	Vohwinkel syndrome (VOWNKL) [MIM:124500]	A0A1A6H6Q9	130	G	V
P29033	LB/B	-	A0A1A6H6Q9	148	A	P
O75712	LP/P	Erythrokeratodermia variabilis et progressiva 1 (EKVP1) [MIM:133200]	Q6GQC4	12	G	D
O75712	LP/P	Erythrokeratodermia variabilis et progressiva 1 (EKVP1) [MIM:133200]	Q6GQC4	12	G	R
O75712	LP/P	Erythrokeratodermia variabilis et progressiva 1 (EKVP1) [MIM:133200]	Q6GQC4	86	C	S
O75712	LB/B	-	Q6GQC4	32	R	W
O75712	LP/P	Erythrokeratodermia variabilis et progressiva 1 (EKVP1) [MIM:133200]	Q6GQC4	42	R	P
O75712	LP/P	Erythrokeratodermia variabilis et progressiva 1 (EKVP1) [MIM:133200]	Q6GQC4	137	F	L
O75712	LP/P	Deafness, autosomal dominant, 2B (DFNA2B) [MIM:612644]	Q6GQC4	141	I	V
O75712	LB/B	-	Q6GQC4	200	V	I
Q9NTQ9	LP/P	Erythrokeratodermia variabilis et progressiva 2 (EKVP2) [MIM:617524]	Q6GQC4	137	F	L
Q9NTQ9	LB/B	-	Q6GQC4	103	R	C
Q9NTQ9	LB/B	-	Q6GQC4	124	R	Q
Q9NTQ9	LB/B	-	Q6GQC4	160	R	C
Q9NTQ9	LB/B	-	Q6GQC4	169	C	W
Q9NTQ9	LB/B	-	Q6GQC4	204	E	A
Q9NTQ9	LP/P	Erythrokeratodermia variabilis et progressiva 2 (EKVP2) [MIM:617524]	Q6GQC4	12	G	D
Q9NTQ9	LP/P	Erythrokeratodermia variabilis et progressiva 2 (EKVP2) [MIM:617524]	Q6GQC4	22	R	H
Q9NTQ9	LP/P	Erythrokeratodermia variabilis et progressiva 2 (EKVP2) [MIM:617524]	Q6GQC4	85	T	P
Q9NTQ9	LP/P	Erythrokeratodermia variabilis et progressiva 2 (EKVP2) [MIM:617524]	Q6GQC4	189	F	Y
O95452	LP/P	Deafness, autosomal dominant, 3B (DFNA3B) [MIM:612643]	Q6GQC4	5	T	M
O95452	LP/P	Ectodermal dysplasia 2, Clouston type (ECTD2) [MIM:129500]	Q6GQC4	11	G	R
O95452	LP/P	Ectodermal dysplasia 2, Clouston type (ECTD2) [MIM:129500]	Q6GQC4	88	A	V
O95452	LP/P	Ectodermal dysplasia 2, Clouston type (ECTD2) [MIM:129500]	Q6GQC4	37	V	E
O95452	LB/B	-	Q6GQC4	139	S	G
O95452	LB/B	-	Q6GQC4	199	S	T
O95452	LB/B	-	Q6GQC4	159	N	S
Q6PEY0	LB/B	-	Q6GQC4	20	T	I
Q6PEY0	LB/B	-	Q6GQC4	206	F	L
Q6PEY0	LB/B	-	Q6GQC4	177	T	M
Q96KN9	LB/B	-	F7CCT5	90	A	V
P32189	LB/B	-	Q4RK70	185	S	N
P32189	LB/B	-	Q4RK70	232	N	H
P32189	LB/B	-	Q4RK70	382	A	T
P32189	LP/P	Glycerol kinase deficiency (GKD) [MIM:307030]	Q4RK70	446	D	V
P32189	LP/P	Glycerol kinase deficiency (GKD) [MIM:307030]	Q4RK70	509	W	R
P32189	LP/P	Glycerol kinase deficiency (GKD) [MIM:307030]	Q4RK70	294	N	D
P32189	LB/B	-	Q4RK70	79	N	K
P32189	LB/B	-	Q4RK70	131	P	T
Q8NCI6	LB/B	-	A0A0D9S4Z0	163	R	P
Q8NCI6	LB/B	-	A0A0D9S4Z0	474	V	M
O94923	LB/B	-	A0A151M8U9	65	M	V
O94923	LB/B	-	A0A151M8U9	597	V	I
Q6ZMI3	LB/B	-	W5N6Y1	141	S	N
Q6ZMI3	LB/B	-	W5N6Y1	265	S	N
Q6ZMI3	LB/B	-	W5N6Y1	351	D	N
Q6ZMI3	LP/P	Lethal congenital contracture syndrome 11 (LCCS11) [MIM:617194]	W5N6Y1	32	A	E
Q6ZMI3	LP/P	Lethal congenital contracture syndrome 11 (LCCS11) [MIM:617194]	W5N6Y1	475	A	P
Q53GS7	LB/B	-	Q8R322	130	G	D
Q53GS7	LB/B	-	Q8R322	243	I	V
Q53GS7	LB/B	-	Q8R322	590	R	Q
Q53GS7	LP/P	Lethal congenital contracture syndrome 1 (LCCS1) [MIM:253310]	Q8R322	569	R	H
Q53GS7	LP/P	Congenital arthrogryposis with anterior horn cell disease (CAAHD) [MIM:611890]	Q8R322	617	V	M
Q53GS7	LP/P	Congenital arthrogryposis with anterior horn cell disease (CAAHD) [MIM:611890]	Q8R322	684	I	T
P10070	LB/B	-	A0A212C227	1444	M	I
P10070	LB/B	-	A0A212C227	449	D	H
P10070	LB/B	-	A0A212C227	579	S	I
P10070	LB/B	-	A0A212C227	625	P	S
P10070	LB/B	-	A0A212C227	1156	A	S
P10070	LB/B	-	A0A212C227	1306	D	N
P10070	LP/P	Culler-Jones syndrome (CJS) [MIM:615849]	A0A212C227	608	P	L
P10070	LP/P	Culler-Jones syndrome (CJS) [MIM:615849]	A0A212C227	516	R	P
P10070	LB/B	-	A0A212C227	1352	M	V
P10070	LB/B	-	A0A212C227	1520	D	N
P10070	LB/B	-	A0A212C227	1543	R	H
P10071	LP/P	Polydactyly, postaxial A1 (PAPA1) [MIM:174200]	A0A212C227	727	G	R
P10071	LP/P	Polydactyly, postaxial B (PAPB) [MIM:174200]	A0A212C227	727	G	R
P10071	LB/B	-	A0A212C227	440	D	E
P10071	LP/P	Greig cephalo-poly-syndactyly syndrome (GCPS) [MIM:175700]	A0A212C227	515	C	G
P10071	LP/P	Greig cephalo-poly-syndactyly syndrome (GCPS) [MIM:175700]	A0A212C227	520	C	Y
P10071	LP/P	Greig cephalo-poly-syndactyly syndrome (GCPS) [MIM:175700]	A0A212C227	707	P	S
P10071	LB/B	-	A0A212C227	808	I	M
P10071	LB/B	-	A0A212C227	1537	R	C
P10071	LP/P	Greig cephalo-poly-syndactyly syndrome (GCPS) [MIM:175700]	A0A212C227	625	R	W
P10071	LP/P	Greig cephalo-poly-syndactyly syndrome (GCPS) [MIM:175700]	A0A212C227	934	A	P
P10071	LB/B	-	A0A212C227	183	T	A
P10071	LB/B	-	A0A212C227	998	P	L
P10071	LB/B	-	A0A212C227	1336	G	E
P48060	LB/B	-	Q5FVN7	211	R	Q
P48060	LB/B	-	Q5FVN7	163	D	E
Q8NBF1	LB/B	-	A0A151M4G3	157	F	L
Q8NBF1	LB/B	-	A0A151M4G3	110	T	A
Q8NBF1	LB/B	-	A0A151M4G3	187	A	G
Q92990	LB/B	-	A0A1W4Y3E5	336	L	S
Q8WWB7	LB/B	-	H2RM90	94	V	I
Q8WWB7	LB/B	-	H2RM90	203	P	S
Q8WWB7	LB/B	-	H2RM90	223	I	V
Q9HC38	LB/B	-	A0A146PBB2	282	M	I
O95838	LB/B	-	A0A2Y9Q7U8	22	H	L
O95838	LB/B	-	A0A2Y9Q7U8	470	D	N
O95838	LB/B	-	A0A2Y9Q7U8	523	R	H
P23415	LP/P	Hyperekplexia 1 (HKPX1) [MIM:149400]	A0A2S1WM10	272	I	N
P23415	LP/P	Hyperekplexia 1 (HKPX1) [MIM:149400]	A0A2S1WM10	294	Q	H
P23415	LP/P	Hyperekplexia 1 (HKPX1) [MIM:149400]	A0A2S1WM10	299	R	L
P23415	LP/P	Hyperekplexia 1 (HKPX1) [MIM:149400]	A0A2S1WM10	299	R	Q
P23415	LP/P	Hyperekplexia 1 (HKPX1) [MIM:149400]	A0A2S1WM10	304	K	E
P23415	LP/P	Hyperekplexia 1 (HKPX1) [MIM:149400]	A0A2S1WM10	307	Y	C
P23415	LP/P	Hyperekplexia 1 (HKPX1) [MIM:149400]	A0A2S1WM10	278	P	T
P23415	LP/P	Hyperekplexia 1 (HKPX1) [MIM:149400]	A0A2S1WM10	280	R	H
P23415	LP/P	Hyperekplexia 1 (HKPX1) [MIM:149400]	A0A2S1WM10	428	R	H
P23415	LP/P	Hyperekplexia 1 (HKPX1) [MIM:149400]	A0A2S1WM10	93	R	W
P23415	LP/P	Hyperekplexia 1 (HKPX1) [MIM:149400]	A0A2S1WM10	100	R	C
P23415	LP/P	Hyperekplexia 1 (HKPX1) [MIM:149400]	A0A2S1WM10	246	R	W
P23415	LP/P	Hyperekplexia 1 (HKPX1) [MIM:149400]	A0A2S1WM10	254	Q	E
P23415	LP/P	Hyperekplexia 1 (HKPX1) [MIM:149400]	A0A2S1WM10	258	P	S
P23415	LP/P	Hyperekplexia 1 (HKPX1) [MIM:149400]	A0A2S1WM10	308	V	M
P23415	LP/P	Hyperekplexia 1 (HKPX1) [MIM:149400]	A0A2S1WM10	319	L	P
P23415	LP/P	Hyperekplexia 1 (HKPX1) [MIM:149400]	A0A2S1WM10	424	D	A
P23415	LP/P	Hyperekplexia 1 (HKPX1) [MIM:149400]	A0A2S1WM10	450	R	H
P23416	LP/P	Intellectual developmental disorder, X-linked, syndromic, Pilorge type (MRXSP) [MIM:301076]	F1Q832	136	N	S
P23416	LP/P	Intellectual developmental disorder, X-linked, syndromic, Pilorge type (MRXSP) [MIM:301076]	F1Q832	153	R	Q
P23416	LP/P	Intellectual developmental disorder, X-linked, syndromic, Pilorge type (MRXSP) [MIM:301076]	F1Q832	296	T	M
P23416	LP/P	Intellectual developmental disorder, X-linked, syndromic, Pilorge type (MRXSP) [MIM:301076]	F1Q832	350	R	L
P48167	LP/P	Hyperekplexia 2 (HKPX2) [MIM:614619]	A0A0Q3MS51	251	G	D
P48167	LP/P	Hyperekplexia 2 (HKPX2) [MIM:614619]	A0A0Q3MS51	199	M	R
P48167	LP/P	Hyperekplexia 2 (HKPX2) [MIM:614619]	A0A0Q3MS51	307	L	R
P48167	LP/P	Hyperekplexia 2 (HKPX2) [MIM:614619]	A0A0Q3MS51	332	W	C
P35754	LB/B	-	A0A2I3GGR2	47	D	Y
Q9NS18	LB/B	-	A0A2K5RMN9	95	K	E
O76003	LB/B	-	A0A2U4BRI8	21	Q	H
O76003	LB/B	-	A0A2U4BRI8	123	P	S
Q9UI32	LB/B	-	A0A087Y275	581	L	P
Q7Z4J2	LB/B	-	L9KP07	195	H	R
Q7Z4J2	LB/B	-	L9KP07	219	P	S
Q68CQ7	LB/B	-	A0A2I4D176	210	R	H
P00367	LP/P	Familial hyperinsulinemic hypoglycemia 6 (HHF6) [MIM:606762]	A0A2K5VI50	498	S	L
P00367	LP/P	Familial hyperinsulinemic hypoglycemia 6 (HHF6) [MIM:606762]	A0A2K5VI50	499	G	D
P00367	LP/P	Familial hyperinsulinemic hypoglycemia 6 (HHF6) [MIM:606762]	A0A2K5VI50	499	G	S
P00367	LP/P	Familial hyperinsulinemic hypoglycemia 6 (HHF6) [MIM:606762]	A0A2K5VI50	501	S	P
P00367	LP/P	Familial hyperinsulinemic hypoglycemia 6 (HHF6) [MIM:606762]	A0A2K5VI50	507	H	Y
P00367	LP/P	Familial hyperinsulinemic hypoglycemia 6 (HHF6) [MIM:606762]	A0A2K5VI50	318	R	K
P00367	LP/P	Familial hyperinsulinemic hypoglycemia 6 (HHF6) [MIM:606762]	A0A2K5VI50	349	E	A
P00367	LP/P	Familial hyperinsulinemic hypoglycemia 6 (HHF6) [MIM:606762]	A0A2K5VI50	270	S	C
P00367	LP/P	Familial hyperinsulinemic hypoglycemia 6 (HHF6) [MIM:606762]	A0A2K5VI50	274	R	C
P00367	LP/P	Familial hyperinsulinemic hypoglycemia 6 (HHF6) [MIM:606762]	A0A2K5VI50	318	R	T
P00367	LP/P	Familial hyperinsulinemic hypoglycemia 6 (HHF6) [MIM:606762]	A0A2K5VI50	319	Y	C
P00367	LP/P	Familial hyperinsulinemic hypoglycemia 6 (HHF6) [MIM:606762]	A0A2K5VI50	322	R	C
P00367	LP/P	Familial hyperinsulinemic hypoglycemia 6 (HHF6) [MIM:606762]	A0A2K5VI50	322	R	H
P49448	LB/B	-	A0A2K5VI50	498	S	A
Q6IB77	LB/B	-	A0A0D9R143	17	S	T
Q6IB77	LB/B	-	A0A0D9R143	156	N	S
Q49A26	LB/B	-	A0A2R5L8C0	103	N	D
Q49A26	LB/B	-	A0A2R5L8C0	459	Q	H
Q49A26	LB/B	-	A0A2R5L8C0	531	Y	C
P17900	LP/P	GM2-gangliosidosis AB (GM2GAB) [MIM:272750]	G1TZT5	138	C	R
P17900	LP/P	GM2-gangliosidosis AB (GM2GAB) [MIM:272750]	G1TZT5	169	R	P
P17900	LB/B	-	G1TZT5	19	A	T
P17900	LB/B	-	G1TZT5	59	I	V
P17900	LB/B	-	G1TZT5	69	M	V
Q9Y692	LB/B	-	F6WTH0	14	V	A
O60234	LB/B	-	A0A2U3VNB1	122	E	K
O60234	LB/B	-	A0A2U3VNB1	136	E	K
Q9P107	LB/B	-	A0A1S3AR77	641	D	N
Q99445	LB/B	-	H2PRB8	54	R	C
O75496	LB/B	-	H2PI31	18	N	T
O75496	LB/B	-	H2PI31	15	N	H
O75496	LB/B	-	H2PI31	48	L	F
O75496	LB/B	-	H2PI31	54	R	W
O75496	LB/B	-	H2PI31	60	S	P
O75496	LB/B	-	H2PI31	203	T	M
O75496	LP/P	Meier-Gorlin syndrome 6 (MGORS6) [MIM:616835]	H2PI31	17	K	R
Q9Y5P6	LB/B	-	A0A023RCI4	126	H	D
Q9Y5P6	LB/B	-	A0A023RCI4	184	Q	R
Q9Y5P6	LP/P	Muscular dystrophy-dystroglycanopathy limb-girdle C14 (MDDGC14) [MIM:615352]	A0A023RCI4	22	P	S
Q9Y5P6	LP/P	Muscular dystrophy-dystroglycanopathy limb-girdle C14 (MDDGC14) [MIM:615352]	A0A023RCI4	27	D	H
Q9Y5P6	LP/P	Muscular dystrophy-dystroglycanopathy congenital with impaired intellectual development B14 (MDDGB14) [MIM:615351]	A0A023RCI4	32	P	L
Q9Y5P6	LP/P	Muscular dystrophy-dystroglycanopathy congenital with impaired intellectual development B14 (MDDGB14) [MIM:615351]	A0A023RCI4	185	R	C
Q9Y5P6	LP/P	Muscular dystrophy-dystroglycanopathy congenital with impaired intellectual development B14 (MDDGB14) [MIM:615351]	A0A023RCI4	287	R	Q
Q9Y5P6	LP/P	Muscular dystrophy-dystroglycanopathy limb-girdle C14 (MDDGC14) [MIM:615352]	A0A023RCI4	287	R	Q
Q9Y5P6	LP/P	Muscular dystrophy-dystroglycanopathy limb-girdle C14 (MDDGC14) [MIM:615352]	A0A023RCI4	330	V	I
Q9Y5P6	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A14 (MDDGA14) [MIM:615350]	A0A023RCI4	334	D	N
Q9Y5P6	LP/P	Muscular dystrophy-dystroglycanopathy limb-girdle C14 (MDDGC14) [MIM:615352]	A0A023RCI4	32	P	S
Q9Y5P6	LP/P	Muscular dystrophy-dystroglycanopathy limb-girdle C14 (MDDGC14) [MIM:615352]	A0A023RCI4	132	S	C
Q9Y5P6	LP/P	Muscular dystrophy-dystroglycanopathy limb-girdle C14 (MDDGC14) [MIM:615352]	A0A023RCI4	219	I	T
Q9Y5P6	LP/P	Muscular dystrophy-dystroglycanopathy limb-girdle C14 (MDDGC14) [MIM:615352]	A0A023RCI4	241	P	S
Q9Y5P6	LP/P	Muscular dystrophy-dystroglycanopathy limb-girdle C14 (MDDGC14) [MIM:615352]	A0A023RCI4	254	V	M
Q9Y5P6	LP/P	Muscular dystrophy-dystroglycanopathy limb-girdle C14 (MDDGC14) [MIM:615352]	A0A023RCI4	287	R	W
Q9Y5P6	LP/P	Muscular dystrophy-dystroglycanopathy limb-girdle C14 (MDDGC14) [MIM:615352]	A0A023RCI4	293	R	W
Q9Y5P6	LP/P	Muscular dystrophy-dystroglycanopathy limb-girdle C14 (MDDGC14) [MIM:615352]	A0A023RCI4	318	V	A
Q9Y5P6	LP/P	Muscular dystrophy-dystroglycanopathy limb-girdle C14 (MDDGC14) [MIM:615352]	A0A023RCI4	322	N	K
Q9Y5P6	LP/P	Muscular dystrophy-dystroglycanopathy limb-girdle C14 (MDDGC14) [MIM:615352]	A0A023RCI4	340	G	R
Q9Y5P6	LP/P	Muscular dystrophy-dystroglycanopathy limb-girdle C14 (MDDGC14) [MIM:615352]	A0A023RCI4	357	R	H
Q9P2T1	LB/B	-	A0A2U3W256	242	G	D
P29992	LP/P	Hypocalcemia, autosomal dominant 2 (HYPOC2) [MIM:615361]	A0A0B8RUJ3	60	R	C
P29992	LP/P	Hypocalciuric hypercalcemia, familial 2 (HHC2) [MIM:145981]	A0A0B8RUJ3	135	L	Q
P29992	LP/P	Hypocalcemia, autosomal dominant 2 (HYPOC2) [MIM:615361]	A0A0B8RUJ3	181	R	Q
P29992	LP/P	Hypocalcemia, autosomal dominant 2 (HYPOC2) [MIM:615361]	A0A0B8RUJ3	211	S	W
P29992	LP/P	Hypocalcemia, autosomal dominant 2 (HYPOC2) [MIM:615361]	A0A0B8RUJ3	341	F	L
Q03113	LB/B	-	W5J919	242	F	L
Q03113	LB/B	-	W5J919	330	Y	H
Q03113	LB/B	-	W5J919	68	S	G
Q14344	LB/B	-	W5J919	221	V	L
P30679	LB/B	-	Q4SQ90	147	C	Y
P63096	LP/P	Neurodevelopmental disorder with hypotonia, impaired speech, and behavioral abnormalities (NEDHISB) [MIM:619854]	A0A2U9BWC3	40	G	C
P63096	LP/P	Neurodevelopmental disorder with hypotonia, impaired speech, and behavioral abnormalities (NEDHISB) [MIM:619854]	A0A2U9BWC3	40	G	R
P63096	LP/P	Neurodevelopmental disorder with hypotonia, impaired speech, and behavioral abnormalities (NEDHISB) [MIM:619854]	A0A2U9BWC3	45	G	D
P63096	LP/P	Neurodevelopmental disorder with hypotonia, impaired speech, and behavioral abnormalities (NEDHISB) [MIM:619854]	A0A2U9BWC3	48	T	I
P63096	LP/P	Neurodevelopmental disorder with hypotonia, impaired speech, and behavioral abnormalities (NEDHISB) [MIM:619854]	A0A2U9BWC3	48	T	K
P63096	LP/P	Neurodevelopmental disorder with hypotonia, impaired speech, and behavioral abnormalities (NEDHISB) [MIM:619854]	A0A2U9BWC3	52	Q	P
P63096	LP/P	Neurodevelopmental disorder with hypotonia, impaired speech, and behavioral abnormalities (NEDHISB) [MIM:619854]	A0A2U9BWC3	173	D	V
P63096	LP/P	Neurodevelopmental disorder with hypotonia, impaired speech, and behavioral abnormalities (NEDHISB) [MIM:619854]	A0A2U9BWC3	224	C	Y
P63096	LP/P	Neurodevelopmental disorder with hypotonia, impaired speech, and behavioral abnormalities (NEDHISB) [MIM:619854]	A0A2U9BWC3	270	K	N
P63096	LP/P	Neurodevelopmental disorder with hypotonia, impaired speech, and behavioral abnormalities (NEDHISB) [MIM:619854]	A0A2U9BWC3	270	K	R
P63096	LP/P	Neurodevelopmental disorder with hypotonia, impaired speech, and behavioral abnormalities (NEDHISB) [MIM:619854]	A0A2U9BWC3	272	D	G
P63096	LP/P	Neurodevelopmental disorder with hypotonia, impaired speech, and behavioral abnormalities (NEDHISB) [MIM:619854]	A0A2U9BWC3	326	A	P
P08754	LP/P	Auriculocondylar syndrome 1 (ARCND1) [MIM:602483]	A0A2U9BWC3	40	G	R
P38405	LB/B	-	A0A2D0QK63	16	V	F
P38405	LP/P	Dystonia 25 (DYT25) [MIM:615073]	A0A2D0QK63	137	V	M
P38405	LP/P	Dystonia 25 (DYT25) [MIM:615073]	A0A2D0QK63	155	E	K
P50148	LB/B	-	A0A0B8RUJ3	355	E	D
P50148	LP/P	Sturge-Weber syndrome (SWS) [MIM:185300]	A0A0B8RUJ3	183	R	Q
P50148	LB/B	-	A0A0B8RUJ3	209	Q	L
P63092	LP/P	Albright hereditary osteodystrophy (AHO) [MIM:103580]	F6Y6T1	99	L	P
P63092	LP/P	Albright hereditary osteodystrophy (AHO) [MIM:103580]	F6Y6T1	165	R	C
P63092	LP/P	ACTH-independent macronodular adrenal hyperplasia 1 (AIMAH1) [MIM:219080]	F6Y6T1	201	R	H
P63092	LP/P	McCune-Albright syndrome (MAS) [MIM:174800]	F6Y6T1	201	R	H
P63092	LP/P	McCune-Albright syndrome (MAS) [MIM:174800]	F6Y6T1	201	R	C
P63092	LB/B	-	F6Y6T1	227	Q	R
P63092	LP/P	Albright hereditary osteodystrophy (AHO) [MIM:103580]	F6Y6T1	385	R	H
P63092	LP/P	Albright hereditary osteodystrophy (AHO) [MIM:103580]	F6Y6T1	258	R	W
P63092	LP/P	Albright hereditary osteodystrophy (AHO) [MIM:103580]	F6Y6T1	115	P	L
P63092	LP/P	McCune-Albright syndrome (MAS) [MIM:174800]	F6Y6T1	201	R	G
P63092	LP/P	ACTH-independent macronodular adrenal hyperplasia 1 (AIMAH1) [MIM:219080]	F6Y6T1	201	R	S
P63092	LB/B	-	F6Y6T1	227	Q	H
P63092	LP/P	Albright hereditary osteodystrophy (AHO) [MIM:103580]	F6Y6T1	231	R	H
P63092	LP/P	Albright hereditary osteodystrophy (AHO) [MIM:103580]	F6Y6T1	250	S	R
P63092	LP/P	Pseudohypoparathyroidism 1A (PHP1A) [MIM:103580]	F6Y6T1	366	A	S
P63092	LP/P	Pseudohypoparathyroidism 1A (PHP1A) [MIM:103580]	F6Y6T1	156	D	N
P63092	LP/P	Pseudohypoparathyroidism 1A (PHP1A) [MIM:103580]	F6Y6T1	159	V	M
P63092	LP/P	Albright hereditary osteodystrophy (AHO) [MIM:103580]	F6Y6T1	242	T	I
P63092	LP/P	Albright hereditary osteodystrophy (AHO) [MIM:103580]	F6Y6T1	246	F	S
P63092	LP/P	Albright hereditary osteodystrophy (AHO) [MIM:103580]	F6Y6T1	259	E	V
P63092	LP/P	Pseudohypoparathyroidism 1A (PHP1A) [MIM:103580]	F6Y6T1	280	R	G
P63092	LP/P	Pseudohypoparathyroidism 1A (PHP1A) [MIM:103580]	F6Y6T1	280	R	K
P63092	LP/P	Progressive osseous heteroplasia (POH) [MIM:166350]	F6Y6T1	281	W	R
P63092	LP/P	Pseudohypoparathyroidism 1A (PHP1A) [MIM:103580]	F6Y6T1	338	K	N
P63092	LB/B	-	F6Y6T1	380	R	L
P63092	LP/P	Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462]	F6Y6T1	388	L	R
P63092	LP/P	Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462]	F6Y6T1	392	E	K
P84996	LP/P	GNAS hyperfunction (GNASHYP) [MIM:139320]	A0A1D5QZG0	374	P	T
P84996	LP/P	GNAS hyperfunction (GNASHYP) [MIM:139320]	A0A1D5QZG0	397	L	V
Q5JWF2	LP/P	GNAS hyperfunction (GNASHYP) [MIM:139320]	F6Y6T1	436	A	D
Q5JWF2	LP/P	GNAS hyperfunction (GNASHYP) [MIM:139320]	F6Y6T1	459	P	R
Q5JWF2	LB/B	-	F6Y6T1	1023	R	L
P11488	LP/P	Night blindness, congenital stationary, autosomal dominant 3 (CSNBAD3) [MIM:610444]	A0A0Q3P2C2	38	G	D
P11488	LP/P	Night blindness, congenital stationary, 1G (CSNB1G) [MIM:616389]	A0A0Q3P2C2	129	D	G
P11488	LP/P	Night blindness, congenital stationary, autosomal dominant 3 (CSNBAD3) [MIM:610444]	A0A0Q3P2C2	200	Q	E
P19087	LB/B	-	A0A091E2J1	183	G	D
P19087	LB/B	-	A0A091E2J1	107	L	I
P19087	LB/B	-	A0A091E2J1	124	V	M
P62873	LP/P	Intellectual developmental disorder, autosomal dominant 42 (MRD42) [MIM:616973]	A0A2R8MQ29	76	D	G
P62873	LP/P	Intellectual developmental disorder, autosomal dominant 42 (MRD42) [MIM:616973]	A0A2R8MQ29	76	D	E
P62873	LP/P	Intellectual developmental disorder, autosomal dominant 42 (MRD42) [MIM:616973]	A0A2R8MQ29	77	G	S
P62873	LP/P	Intellectual developmental disorder, autosomal dominant 42 (MRD42) [MIM:616973]	A0A2R8MQ29	78	K	R
P62873	LP/P	Intellectual developmental disorder, autosomal dominant 42 (MRD42) [MIM:616973]	A0A2R8MQ29	80	I	N
P62873	LP/P	Intellectual developmental disorder, autosomal dominant 42 (MRD42) [MIM:616973]	A0A2R8MQ29	80	I	T
P62873	LP/P	Intellectual developmental disorder, autosomal dominant 42 (MRD42) [MIM:616973]	A0A2R8MQ29	95	L	P
P62873	LP/P	Intellectual developmental disorder, autosomal dominant 42 (MRD42) [MIM:616973]	A0A2R8MQ29	101	M	V
P62873	LP/P	Intellectual developmental disorder, autosomal dominant 42 (MRD42) [MIM:616973]	A0A2R8MQ29	326	A	T
P62873	LP/P	Intellectual developmental disorder, autosomal dominant 42 (MRD42) [MIM:616973]	A0A2R8MQ29	52	R	G
P62873	LP/P	Intellectual developmental disorder, autosomal dominant 42 (MRD42) [MIM:616973]	A0A2R8MQ29	64	G	V
P62873	LP/P	Intellectual developmental disorder, autosomal dominant 42 (MRD42) [MIM:616973]	A0A2R8MQ29	92	A	T
P62873	LP/P	Intellectual developmental disorder, autosomal dominant 42 (MRD42) [MIM:616973]	A0A2R8MQ29	94	P	S
P62873	LP/P	Intellectual developmental disorder, autosomal dominant 42 (MRD42) [MIM:616973]	A0A2R8MQ29	96	R	L
P62873	LP/P	Intellectual developmental disorder, autosomal dominant 42 (MRD42) [MIM:616973]	A0A2R8MQ29	106	A	T
P62873	LP/P	Intellectual developmental disorder, autosomal dominant 42 (MRD42) [MIM:616973]	A0A2R8MQ29	118	D	G
Q9BYB4	LB/B	-	K7FMB5	239	W	G
Q9BYB4	LB/B	-	K7FMB5	30	E	K
Q9BYB4	LB/B	-	K7FMB5	37	R	H
P62879	LP/P	Sick sinus syndrome 4 (SSS4) [MIM:619464]	A0A147A4M8	52	R	L
P62879	LP/P	Neurodevelopmental disorder with hypotonia and dysmorphic facies (NEDHYDF) [MIM:619503]	A0A147A4M8	73	A	T
P62879	LP/P	Neurodevelopmental disorder with hypotonia and dysmorphic facies (NEDHYDF) [MIM:619503]	A0A147A4M8	77	G	R
P62879	LP/P	Neurodevelopmental disorder with hypotonia and dysmorphic facies (NEDHYDF) [MIM:619503]	A0A147A4M8	77	G	W
P62879	LP/P	Neurodevelopmental disorder with hypotonia and dysmorphic facies (NEDHYDF) [MIM:619503]	A0A147A4M8	89	K	E
P62879	LP/P	Neurodevelopmental disorder with hypotonia and dysmorphic facies (NEDHYDF) [MIM:619503]	A0A147A4M8	89	K	T
P62879	LP/P	Neurodevelopmental disorder with hypotonia and dysmorphic facies (NEDHYDF) [MIM:619503]	A0A147A4M8	147	S	L
Q9HAV0	LP/P	Charcot-Marie-Tooth disease, dominant intermediate F (CMTDIF) [MIM:615185]	A0A1E3QFC9	53	G	D
Q9HAV0	LP/P	Charcot-Marie-Tooth disease, dominant intermediate F (CMTDIF) [MIM:615185]	A0A1E3QFC9	89	K	E
O14775	LB/B	-	A0A151M9L4	213	A	V
O14775	LP/P	Language delay and attention deficit-hyperactivity disorder/cognitive impairment with or without cardiac arrhythmia (LADCI) [MIM:617182]	A0A151M9L4	123	S	L
Q9Y223	LP/P	Nonaka myopathy (NM) [MIM:605820]	W5MZ88	36	P	L
Q9Y223	LP/P	Nonaka myopathy (NM) [MIM:605820]	W5MZ88	225	D	N
Q9Y223	LP/P	Nonaka myopathy (NM) [MIM:605820]	W5MZ88	246	R	Q
Q9Y223	LP/P	Nonaka myopathy (NM) [MIM:605820]	W5MZ88	246	R	W
Q9Y223	LP/P	Sialuria (SIALURIA) [MIM:269921]	W5MZ88	263	R	L
Q9Y223	LP/P	Sialuria (SIALURIA) [MIM:269921]	W5MZ88	266	R	Q
Q9Y223	LP/P	Sialuria (SIALURIA) [MIM:269921]	W5MZ88	266	R	W
Q9Y223	LP/P	Nonaka myopathy (NM) [MIM:605820]	W5MZ88	303	C	V
Q9Y223	LP/P	Nonaka myopathy (NM) [MIM:605820]	W5MZ88	378	D	Y
Q9Y223	LP/P	Nonaka myopathy (NM) [MIM:605820]	W5MZ88	460	A	V
Q9Y223	LP/P	Nonaka myopathy (NM) [MIM:605820]	W5MZ88	524	A	V
Q9Y223	LP/P	Nonaka myopathy (NM) [MIM:605820]	W5MZ88	528	F	C
Q9Y223	LP/P	Nonaka myopathy (NM) [MIM:605820]	W5MZ88	557	I	T
Q9Y223	LP/P	Nonaka myopathy (NM) [MIM:605820]	W5MZ88	572	V	L
Q9Y223	LP/P	Nonaka myopathy (NM) [MIM:605820]	W5MZ88	576	G	E
Q9Y223	LP/P	Nonaka myopathy (NM) [MIM:605820]	W5MZ88	587	I	T
Q9Y223	LP/P	Nonaka myopathy (NM) [MIM:605820]	W5MZ88	631	A	T
Q9Y223	LP/P	Nonaka myopathy (NM) [MIM:605820]	W5MZ88	631	A	V
Q9Y223	LP/P	Nonaka myopathy (NM) [MIM:605820]	W5MZ88	675	Y	H
Q9Y223	LP/P	Nonaka myopathy (NM) [MIM:605820]	W5MZ88	696	V	M
Q9Y223	LP/P	Nonaka myopathy (NM) [MIM:605820]	W5MZ88	712	M	T
Q9Y223	LP/P	Nonaka myopathy (NM) [MIM:605820]	W5MZ88	27	P	S
Q9Y223	LP/P	Nonaka myopathy (NM) [MIM:605820]	W5MZ88	132	H	Q
Q9Y223	LP/P	Nonaka myopathy (NM) [MIM:605820]	W5MZ88	162	R	C
Q9Y223	LP/P	Nonaka myopathy (NM) [MIM:605820]	W5MZ88	171	M	V
Q9Y223	LP/P	Nonaka myopathy (NM) [MIM:605820]	W5MZ88	176	D	V
Q9Y223	LP/P	Nonaka myopathy (NM) [MIM:605820]	W5MZ88	177	R	C
Q9Y223	LP/P	Nonaka myopathy (NM) [MIM:605820]	W5MZ88	206	G	S
Q9Y223	LP/P	Nonaka myopathy (NM) [MIM:605820]	W5MZ88	216	V	A
Q9Y223	LP/P	Nonaka myopathy (NM) [MIM:605820]	W5MZ88	306	R	Q
Q9Y223	LP/P	Nonaka myopathy (NM) [MIM:605820]	W5MZ88	331	V	A
Q9Y223	LP/P	Nonaka myopathy (NM) [MIM:605820]	W5MZ88	472	I	T
Q9Y223	LP/P	Nonaka myopathy (NM) [MIM:605820]	W5MZ88	519	N	S
Q9Y223	LP/P	Nonaka myopathy (NM) [MIM:605820]	W5MZ88	600	A	T
Q9Y223	LP/P	Nonaka myopathy (NM) [MIM:605820]	W5MZ88	630	A	T
Q9Y223	LP/P	Nonaka myopathy (NM) [MIM:605820]	W5MZ88	13	C	S
Q9Y223	LP/P	Nonaka myopathy (NM) [MIM:605820]	W5MZ88	708	G	S
P63211	LB/B	-	F6RKF1	50	E	K
Q13823	LB/B	-	W5QEV4	452	Q	H
Q9BVP2	LB/B	-	A0A2Y9IZ20	39	R	Q
Q9BVP2	LB/B	-	A0A2Y9IZ20	367	V	M
Q9NVN8	LB/B	-	A0A1S3WW19	320	R	H
P22749	LB/B	-	A0A2S2A406	119	T	I
Q14749	LP/P	Glycine N-methyltransferase deficiency (GNMT deficiency) [MIM:606664]	A0A1U7UGA9	50	L	P
Q14749	LP/P	Glycine N-methyltransferase deficiency (GNMT deficiency) [MIM:606664]	A0A1U7UGA9	177	H	N
Q14749	LP/P	Glycine N-methyltransferase deficiency (GNMT deficiency) [MIM:606664]	A0A1U7UGA9	141	N	S
O15228	LP/P	Rhizomelic chondrodysplasia punctata 2 (RCDP2) [MIM:222765]	H2MT96	211	R	C
O15228	LP/P	Rhizomelic chondrodysplasia punctata 2 (RCDP2) [MIM:222765]	H2MT96	211	R	H
O15228	LP/P	Rhizomelic chondrodysplasia punctata 2 (RCDP2) [MIM:222765]	H2MT96	519	D	G
O15228	LB/B	-	H2MT96	495	V	I
O15228	LB/B	-	H2MT96	586	Y	H
Q8TDQ7	LB/B	-	S7MDZ8	182	P	S
Q3T906	LP/P	Mucolipidosis type III complementation group A (MLIIIA) [MIM:252600]	A0A1A6G0M6	407	D	A
Q3T906	LB/B	-	A0A1A6G0M6	662	A	G
Q3T906	LP/P	Mucolipidosis type III complementation group A (MLIIIA) [MIM:252600]	A0A1A6G0M6	4	K	Q
Q3T906	LP/P	Mucolipidosis type II (MLII) [MIM:252500]	A0A1A6G0M6	1236	K	M
Q3T906	LP/P	Mucolipidosis type II (MLII) [MIM:252500]	A0A1A6G0M6	374	F	L
Q3T906	LP/P	Mucolipidosis type III complementation group A (MLIIIA) [MIM:252600]	A0A1A6G0M6	374	F	L
Q3T906	LP/P	Mucolipidosis type III complementation group A (MLIIIA) [MIM:252600]	A0A1A6G0M6	399	S	F
Q3T906	LP/P	Mucolipidosis type III complementation group A (MLIIIA) [MIM:252600]	A0A1A6G0M6	403	I	T
Q3T906	LP/P	Mucolipidosis type III complementation group A (MLIIIA) [MIM:252600]	A0A1A6G0M6	442	C	Y
Q3T906	LP/P	Mucolipidosis type III complementation group A (MLIIIA) [MIM:252600]	A0A1A6G0M6	461	C	G
Q3T906	LP/P	Mucolipidosis type III complementation group A (MLIIIA) [MIM:252600]	A0A1A6G0M6	926	Q	P
Q3T906	LP/P	Mucolipidosis type III complementation group A (MLIIIA) [MIM:252600]	A0A1A6G0M6	956	H	Y
Q3T906	LP/P	Mucolipidosis type II (MLII) [MIM:252500]	A0A1A6G0M6	1001	L	P
Q3T906	LP/P	Mucolipidosis type III complementation group A (MLIIIA) [MIM:252600]	A0A1A6G0M6	1153	N	S
Q3T906	LP/P	Mucolipidosis type II (MLII) [MIM:252500]	A0A1A6G0M6	81	W	L
Q3T906	LP/P	Mucolipidosis type III complementation group A (MLIIIA) [MIM:252600]	A0A1A6G0M6	81	W	L
Q3T906	LP/P	Mucolipidosis type II (MLII) [MIM:252500]	A0A1A6G0M6	732	K	N
Q3T906	LP/P	Mucolipidosis type II (MLII) [MIM:252500]	A0A1A6G0M6	986	R	C
Q3T906	LP/P	Mucolipidosis type II (MLII) [MIM:252500]	A0A1A6G0M6	334	R	L
Q3T906	LP/P	Mucolipidosis type III complementation group A (MLIIIA) [MIM:252600]	A0A1A6G0M6	334	R	Q
Q3T906	LP/P	Mucolipidosis type III complementation group A (MLIIIA) [MIM:252600]	A0A1A6G0M6	468	C	S
Q3T906	LP/P	Mucolipidosis type III complementation group A (MLIIIA) [MIM:252600]	A0A1A6G0M6	587	R	P
Q3T906	LB/B	-	A0A1A6G0M6	1200	E	K
Q3T906	LP/P	Mucolipidosis type III complementation group A (MLIIIA) [MIM:252600]	A0A1A6G0M6	575	G	R
Q3T906	LP/P	Mucolipidosis type III complementation group A (MLIIIA) [MIM:252600]	A0A1A6G0M6	644	T	M
Q3T906	LP/P	Mucolipidosis type II (MLII) [MIM:252500]	A0A1A6G0M6	76	D	G
Q3T906	LP/P	Mucolipidosis type II (MLII) [MIM:252500]	A0A1A6G0M6	385	S	L
P15586	LP/P	Mucopolysaccharidosis 3D (MPS3D) [MIM:252940]	A0A182JMF2	94	S	I
P15586	LP/P	Mucopolysaccharidosis 3D (MPS3D) [MIM:252940]	A0A182JMF2	340	K	R
P15586	LP/P	Mucopolysaccharidosis 3D (MPS3D) [MIM:252940]	A0A182JMF2	418	G	E
Q92805	LB/B	-	A0A094NGX0	220	N	S
Q92805	LB/B	-	A0A094NGX0	317	L	V
Q92805	LB/B	-	A0A094NGX0	425	T	M
Q08379	LB/B	-	G3TBL0	902	R	G
Q08378	LB/B	-	H0ZD32	70	G	E
Q08378	LB/B	-	H0ZD32	1185	K	R
Q08378	LB/B	-	H0ZD32	264	P	L
Q8TBA6	LB/B	-	H0UVL9	67	A	G
Q8TBA6	LB/B	-	H0UVL9	486	M	V
Q9NYA3	LB/B	-	A0A2K5H780	200	W	R
A6NDN3	LB/B	-	A0A2K5H780	200	R	W
Q8N9W4	LB/B	-	Q8N9W4	43	R	G
Q8N9W4	LB/B	-	Q8N9W4	54	N	H
Q8N9W4	LB/B	-	Q8N9W4	64	E	G
Q8N9W4	LB/B	-	Q8N9W4	191	W	R
Q8N9W4	LB/B	-	Q8N9W4	235	R	P
A7E2F4	LB/B	-	A0A2K5H780	480	K	N
A7E2F4	LB/B	-	A0A2K5H780	530	S	N
A7E2F4	LB/B	-	A0A2K5H780	541	R	Q
Q14789	LB/B	-	A0A061I3D6	911	T	S
Q14789	LB/B	-	A0A061I3D6	1212	Y	C
Q14789	LB/B	-	A0A061I3D6	1249	P	S
Q14789	LB/B	-	A0A061I3D6	1713	C	F
Q14789	LB/B	-	A0A061I3D6	1765	G	D
Q3T8J9	LB/B	-	A0A2K5ZTA3	1418	M	V
Q3T8J9	LB/B	-	A0A2K5ZTA3	150	L	F
Q3T8J9	LB/B	-	A0A2K5ZTA3	416	T	A
Q3T8J9	LB/B	-	A0A2K5ZTA3	1197	S	P
Q3T8J9	LB/B	-	A0A2K5ZTA3	1539	Q	E
Q5T7V8	LB/B	-	A0A2K6GC52	295	E	K
Q9BQQ3	LB/B	-	S9YHN8	425	T	M
Q9H8Y8	LB/B	-	L5LQB9	432	S	F
O14653	LB/B	-	A0A0P7XH85	67	R	K
O14653	LP/P	Epilepsy, progressive myoclonic 6 (EPM6) [MIM:614018]	A0A0P7XH85	144	G	W
O14653	LP/P	Muscular dystrophy, congenital, with or without seizures (MYOS) [MIM:620166]	A0A0P7XH85	144	G	W
P13224	LP/P	Bernard-Soulier syndrome (BSS) [MIM:231200]	G1QDF4	113	Y	C
P13224	LP/P	Bernard-Soulier syndrome (BSS) [MIM:231200]	G1QDF4	133	A	P
P14770	LP/P	Bernard-Soulier syndrome (BSS) [MIM:231200]	G1TJM7	37	D	G
P14770	LP/P	Bernard-Soulier syndrome (BSS) [MIM:231200]	G1TJM7	61	N	S
P14770	LP/P	Bernard-Soulier syndrome (BSS) [MIM:231200]	G1TJM7	7	L	P
P14770	LP/P	Bernard-Soulier syndrome (BSS) [MIM:231200]	G1TJM7	24	C	R
P14770	LP/P	Bernard-Soulier syndrome (BSS) [MIM:231200]	G1TJM7	56	L	P
P14770	LP/P	Bernard-Soulier syndrome (BSS) [MIM:231200]	G1TJM7	71	F	S
P14770	LP/P	Bernard-Soulier syndrome (BSS) [MIM:231200]	G1TJM7	113	C	Y
P14770	LB/B	-	G1TJM7	156	A	T
Q99795	LB/B	-	H0UT56	20	D	N
Q99795	LB/B	-	H0UT56	165	K	N
Q9HCL2	LB/B	-	Q05B36	4	S	Y
Q9HCL2	LB/B	-	Q05B36	43	I	V
Q9HCL2	LB/B	-	Q05B36	131	E	G
Q9HCL2	LB/B	-	Q05B36	386	I	T
O95872	LB/B	-	A0A2K6KLQ6	235	A	V
O95872	LB/B	-	A0A2K6KLQ6	41	R	L
O95872	LB/B	-	A0A2K6KLQ6	112	A	V
O95872	LB/B	-	A0A2K6KLQ6	210	S	A
Q9NWQ4	LB/B	-	F7CZT6	132	V	E
Q9UKJ3	LB/B	-	G7NIY1	1043	R	Q
Q9UKJ3	LB/B	-	G7NIY1	1161	C	W
Q9UKJ3	LB/B	-	G7NIY1	979	A	P
Q9UKJ3	LB/B	-	G7NIY1	1012	H	Q
Q9UKJ3	LB/B	-	G7NIY1	1259	S	G
Q9HC44	LB/B	-	L5K5P5	192	P	S
Q9HC44	LB/B	-	L5K5P5	439	R	H
O75487	LB/B	-	W5MBQ3	391	E	D
O75487	LB/B	-	W5MBQ3	442	A	V
P78333	LB/B	-	A0A2Y9HIS9	155	A	V
Q9Y625	LB/B	-	W5MBQ3	412	V	M
Q9NPB8	LB/B	-	A0A0K8TR97	273	T	I
P43304	LB/B	-	A0A146ZRE8	525	R	H
P43304	LB/B	-	A0A146ZRE8	264	R	H
P43304	LB/B	-	A0A146ZRE8	453	K	Q
P51674	LB/B	-	G3PV14	242	V	L
Q14956	LB/B	-	U3K4V2	195	S	C
Q14956	LB/B	-	U3K4V2	197	N	H
Q14956	LB/B	-	U3K4V2	294	S	F
Q14956	LB/B	-	U3K4V2	324	P	L
Q14956	LB/B	-	U3K4V2	538	S	R
Q5VW38	LB/B	-	A0A1S3FJN4	189	A	P
Q8TDV5	LB/B	-	A0A2I0M1J7	309	S	L
Q8IZ08	LB/B	-	A0A2Y9G4M9	5	Q	P
Q8IZ08	LB/B	-	A0A2Y9G4M9	481	V	A
Q7Z602	LB/B	-	A0A091K658	72	R	H
Q7Z601	LB/B	-	A0A2R8M9N0	132	H	N
P51810	LP/P	Albinism ocular 1 (OA1) [MIM:300500]	A0A091HZ44	35	G	D
P51810	LP/P	Albinism ocular 1 (OA1) [MIM:300500]	A0A091HZ44	84	G	D
P51810	LP/P	Albinism ocular 1 (OA1) [MIM:300500]	A0A091HZ44	84	G	R
P51810	LP/P	Albinism ocular 1 (OA1) [MIM:300500]	A0A091HZ44	116	C	R
P51810	LP/P	Albinism ocular 1 (OA1) [MIM:300500]	A0A091HZ44	118	G	E
P51810	LP/P	Albinism ocular 1 (OA1) [MIM:300500]	A0A091HZ44	133	W	R
P51810	LP/P	Albinism ocular 1 (OA1) [MIM:300500]	A0A091HZ44	138	A	V
P51810	LP/P	Albinism ocular 1 (OA1) [MIM:300500]	A0A091HZ44	152	S	N
P51810	LP/P	Albinism ocular 1 (OA1) [MIM:300500]	A0A091HZ44	173	A	D
P51810	LP/P	Albinism ocular 1 (OA1) [MIM:300500]	A0A091HZ44	232	T	K
P51810	LP/P	Albinism ocular 1 (OA1) [MIM:300500]	A0A091HZ44	235	E	K
P51810	LP/P	Albinism ocular 1 (OA1) [MIM:300500]	A0A091HZ44	292	W	G
P51810	LP/P	Albinism ocular 1 (OA1) [MIM:300500]	A0A091HZ44	5	R	C
P51810	LP/P	Albinism ocular 1 (OA1) [MIM:300500]	A0A091HZ44	39	L	R
P51810	LP/P	Albinism ocular 1 (OA1) [MIM:300500]	A0A091HZ44	78	D	N
P51810	LP/P	Albinism ocular 1 (OA1) [MIM:300500]	A0A091HZ44	78	D	V
P51810	LP/P	Albinism ocular 1 (OA1) [MIM:300500]	A0A091HZ44	116	C	S
P51810	LP/P	Albinism ocular 1 (OA1) [MIM:300500]	A0A091HZ44	124	Q	R
P51810	LP/P	Albinism ocular 1 (OA1) [MIM:300500]	A0A091HZ44	229	G	V
P51810	LP/P	Albinism ocular 1 (OA1) [MIM:300500]	A0A091HZ44	233	E	K
P51810	LP/P	Albinism ocular 1 (OA1) [MIM:300500]	A0A091HZ44	244	I	V
P51810	LP/P	Albinism ocular 1 (OA1) [MIM:300500]	A0A091HZ44	261	I	N
P51810	LP/P	Albinism ocular 1 (OA1) [MIM:300500]	A0A091HZ44	271	E	G
P51810	LP/P	Albinism ocular 1 (OA1) [MIM:300500]	A0A091HZ44	292	W	C
P51810	LP/P	Albinism ocular 1 (OA1) [MIM:300500]	A0A091HZ44	81	G	V
P51810	LP/P	Nystagmus congenital X-linked 6 (NYS6) [MIM:300814]	A0A091HZ44	89	S	F
P51810	LP/P	Albinism ocular 1 (OA1) [MIM:300500]	A0A091HZ44	116	C	G
P51810	LP/P	Albinism ocular 1 (OA1) [MIM:300500]	A0A091HZ44	116	C	W
P51810	LP/P	Albinism ocular 1 (OA1) [MIM:300500]	A0A091HZ44	132	W	R
P51810	LP/P	Albinism ocular 1 (OA1) [MIM:300500]	A0A091HZ44	134	L	P
P51810	LP/P	Albinism ocular 1 (OA1) [MIM:300500]	A0A091HZ44	166	T	N
P51810	LP/P	Albinism ocular 1 (OA1) [MIM:300500]	A0A091HZ44	185	E	K
P51810	LP/P	Albinism ocular 1 (OA1) [MIM:300500]	A0A091HZ44	186	R	P
P51810	LP/P	Albinism ocular 1 (OA1) [MIM:300500]	A0A091HZ44	186	R	W
Q8TDV0	LB/B	-	F7A698	40	P	L
Q8TDV0	LB/B	-	F7A698	144	A	V
Q8TDV0	LB/B	-	F7A698	261	L	V
Q8TDT2	LB/B	-	A0A2R8ZA72	317	L	V
Q8NFN8	LB/B	-	A0A2I0MLE3	516	E	D
Q5T848	LB/B	-	H2TFZ6	425	A	G
Q5T848	LB/B	-	H2TFZ6	1209	I	V
Q16538	LB/B	-	A0A1U7SBR6	459	R	G
O14626	LB/B	-	A0A2I0TV49	283	I	V
O15218	LB/B	-	H0W9Y4	349	C	R
P46089	LB/B	-	F7G113	222	R	H
O00270	LB/B	-	A0A2Y9EUC9	91	H	R
Q9HC97	LB/B	-	Q6ZMP9	25	A	T
Q9HC97	LB/B	-	Q6ZMP9	29	V	I
Q9HC97	LB/B	-	Q6ZMP9	108	T	M
Q9HC97	LB/B	-	Q6ZMP9	125	R	S
Q9HC97	LB/B	-	Q6ZMP9	253	T	M
Q9HC97	LB/B	-	Q6ZMP9	294	S	R
Q9HC97	LB/B	-	Q6ZMP9	76	V	M
O60883	LB/B	-	A0A0N8ESR8	81	P	A
O60883	LB/B	-	A0A0N8ESR8	90	G	D
O60883	LB/B	-	A0A0N8ESR8	91	K	R
P46093	LB/B	-	L9L7N2	295	S	N
O15529	LB/B	-	A0A2U3YGS2	45	C	R
O15529	LB/B	-	A0A2U3YGS2	227	V	L
O15529	LB/B	-	A0A2U3YGS2	256	V	A
O15529	LB/B	-	A0A2U3YGS2	44	R	Q
O15529	LB/B	-	A0A2U3YGS2	174	W	R
O15529	LB/B	-	A0A2U3YGS2	346	N	S
Q9Y5Y3	LB/B	-	A0A1U8DC59	312	L	F
Q13585	LB/B	-	L8Y5D2	532	T	A
Q13585	LB/B	-	L8Y5D2	606	I	V
Q9Y2T6	LB/B	-	A0A0P6J2I8	195	G	V
Q9Y2T6	LB/B	-	A0A0P6J2I8	215	T	N
Q9BZJ6	LB/B	-	I3JZH0	21	V	M
Q8IYL9	LB/B	-	A0A2I3N193	231	I	L
Q15743	LB/B	-	W5NMG8	53	R	Q
Q15743	LP/P	Amelogenesis imperfecta, hypomaturation type, 2A6 (AI2A6) [MIM:617217]	W5NMG8	74	L	P
Q96P69	LB/B	-	E7FGY4	201	R	S
Q96P69	LB/B	-	E7FGY4	330	A	T
Q96P69	LB/B	-	E7FGY4	342	R	H
Q9NYM4	LB/B	-	W5NBP2	374	P	Q
Q9NQS5	LB/B	-	G3N6I7	37	G	D
Q9NQS5	LB/B	-	G3N6I7	367	P	R
Q9BY21	LB/B	-	F7DD20	205	T	M
Q9GZN0	LB/B	-	A0A1A6FWW9	190	V	I
Q9GZN0	LB/B	-	A0A1A6FWW9	318	Q	H
Q5JY77	LB/B	-	H9G2E0	315	A	G
Q5JY77	LB/B	-	H9G2E0	779	I	V
Q5JY77	LB/B	-	H9G2E0	1093	P	S
Q96D09	LB/B	-	A0A091DWZ9	173	R	S
Q96D09	LP/P	Deafness, X-linked, 7 (DFNX7) [MIM:301018]	A0A091DWZ9	573	A	N
Q6PI77	LB/B	-	A0A250Y2P2	132	S	G
Q6PI77	LB/B	-	A0A250Y2P2	318	C	R
Q8NFJ5	LB/B	-	G3TF88	118	S	G
Q8NFJ5	LB/B	-	G3TF88	9	C	F
Q8NFJ5	LB/B	-	G3TF88	182	T	A
Q9NZD1	LB/B	-	G3TF88	18	A	D
Q7Z2K8	LB/B	-	F1S3A2	337	G	A
Q7Z2K8	LB/B	-	F1S3A2	357	S	P
Q7Z2K8	LB/B	-	F1S3A2	121	P	T
Q7Z2K8	LB/B	-	F1S3A2	300	M	V
O60269	LB/B	-	F7CY44	39	L	V
O60269	LB/B	-	F7CY44	104	S	G
O60269	LB/B	-	F7CY44	5	R	H
O60269	LB/B	-	F7CY44	40	R	H
O60269	LB/B	-	F7CY44	47	V	M
O60269	LB/B	-	F7CY44	91	W	R
O60269	LB/B	-	F7CY44	400	L	P
O60269	LB/B	-	F7CY44	100	T	P
O60269	LB/B	-	F7CY44	202	G	W
O60269	LB/B	-	F7CY44	233	A	S
O60269	LB/B	-	F7CY44	241	V	M
O60269	LB/B	-	F7CY44	242	R	G
O60269	LB/B	-	F7CY44	328	S	C
O60269	LB/B	-	F7CY44	375	V	A
Q6ZVF9	LB/B	-	A0A1S3A724	39	L	V
Q6ZVF9	LB/B	-	A0A1S3A724	378	A	V
Q6ZVF9	LB/B	-	A0A1S3A724	382	S	P
Q6ZVF9	LB/B	-	A0A1S3A724	390	P	S
Q6ZVF9	LB/B	-	A0A1S3A724	446	V	A
Q6ZVF9	LB/B	-	A0A1S3A724	746	R	K
Q13227	LB/B	-	L9KMB0	306	T	A
Q8TD30	LP/P	Neurodevelopmental disorder with spastic paraplegia and microcephaly (NEDSPM) [MIM:616281]	A0A1Y1XV76	153	S	R
P22352	LB/B	-	A0A212D0K9	128	F	L
P59796	LB/B	-	G5C444	6	Q	L
P59796	LB/B	-	G5C444	13	F	L
P59796	LB/B	-	G5C444	53	Y	H
P59796	LB/B	-	G5C444	58	Q	H
P59796	LB/B	-	G5C444	72	Y	N
P59796	LB/B	-	G5C444	136	E	D
P59796	LB/B	-	G5C444	140	V	M
P59796	LB/B	-	G5C444	157	P	S
P59796	LB/B	-	G5C444	161	D	G
P59796	LB/B	-	G5C444	188	V	A
Q8TED1	LB/B	-	H2MD54	182	K	R
Q8IYS0	LB/B	-	A0A226N4Q5	644	L	P
Q6IC98	LB/B	-	A0A1S3SF90	159	S	I
Q13588	LP/P	Deafness, autosomal recessive, 114 (DFNB114) [MIM:618456]	M3XLU3	104	Q	L
O75791	LB/B	-	A0A1V4J9E5	319	L	F
Q13322	LB/B	-	A0A2Y9I698	36	P	L
Q13322	LB/B	-	A0A2Y9I698	558	D	H
Q13322	LB/B	-	A0A2Y9I698	95	P	S
Q9H772	LB/B	-	S4S1R9	131	V	I
Q9H772	LP/P	Tooth agenesis, selective, 9 (STHAG9) [MIM:617275]	S4S1R9	13	A	V
Q9H772	LP/P	Tooth agenesis, selective, 9 (STHAG9) [MIM:617275]	S4S1R9	76	Q	E
Q9H772	LP/P	Tooth agenesis, selective, 9 (STHAG9) [MIM:617275]	S4S1R9	136	E	D
Q9UBQ7	LB/B	-	A0A2R8MJX5	170	R	Q
Q9ULK0	LB/B	-	A0A2U9CQS4	529	V	I
Q13003	LB/B	-	A0A1U7R2L0	310	S	A
Q05586	LB/B	-	Q4SWJ9	540	I	M
Q05586	LP/P	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant (NDHMSD) [MIM:614254]	Q4SWJ9	662	E	K
Q05586	LB/B	-	Q4SWJ9	682	A	S
Q05586	LP/P	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive (NDHMSR) [MIM:617820]	Q4SWJ9	217	R	W
Q05586	LB/B	-	Q4SWJ9	349	A	S
Q05586	LB/B	-	Q4SWJ9	419	T	A
Q05586	LP/P	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant (NDHMSD) [MIM:614254]	Q4SWJ9	552	D	E
Q05586	LP/P	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant (NDHMSD) [MIM:614254]	Q4SWJ9	557	P	R
Q05586	LP/P	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant (NDHMSD) [MIM:614254]	Q4SWJ9	618	G	R
Q05586	LP/P	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant (NDHMSD) [MIM:614254]	Q4SWJ9	620	G	R
Q05586	LP/P	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant (NDHMSD) [MIM:614254]	Q4SWJ9	647	Y	S
Q05586	LP/P	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant (NDHMSD) [MIM:614254]	Q4SWJ9	688	S	Y
Q05586	LP/P	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant (NDHMSD) [MIM:614254]	Q4SWJ9	815	G	R
Q05586	LP/P	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant (NDHMSD) [MIM:614254]	Q4SWJ9	815	G	V
Q05586	LP/P	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant (NDHMSD) [MIM:614254]	Q4SWJ9	817	F	L
Q05586	LP/P	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant (NDHMSD) [MIM:614254]	Q4SWJ9	827	G	R
Q05586	LP/P	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant (NDHMSD) [MIM:614254]	Q4SWJ9	844	R	C
Q8TCU5	LB/B	-	A0A1L8HWN4	362	V	M
Q8TCU5	LB/B	-	A0A1L8HWN4	487	G	R
Q8TCU5	LB/B	-	A0A1L8HWN4	835	D	N
Q8TCU5	LB/B	-	A0A1L8HWN4	1041	R	Q
Q8TCU5	LB/B	-	A0A1L8HWN4	480	R	H
Q8TCU5	LB/B	-	A0A1L8HWN4	72	S	I
Q8TCU5	LB/B	-	A0A1L8HWN4	116	G	S
Q8TCU5	LB/B	-	A0A1L8HWN4	337	R	W
Q8TCU5	LB/B	-	A0A1L8HWN4	375	I	T
Q8TCU5	LB/B	-	A0A1L8HWN4	434	S	P
Q8TCU5	LB/B	-	A0A1L8HWN4	493	Y	F
Q8TCU5	LB/B	-	A0A1L8HWN4	565	N	S
Q8TCU5	LB/B	-	A0A1L8HWN4	586	K	N
Q8TCU5	LB/B	-	A0A1L8HWN4	793	R	S
Q8TCU5	LB/B	-	A0A1L8HWN4	921	T	M
Q8TCU5	LB/B	-	A0A1L8HWN4	956	Y	H
O60391	LB/B	-	L8IXX4	157	T	M
O60391	LB/B	-	L8IXX4	404	R	W
O60391	LB/B	-	L8IXX4	414	W	R
O60391	LB/B	-	L8IXX4	577	T	M
O60391	LB/B	-	L8IXX4	845	A	T
O60391	LB/B	-	L8IXX4	612	T	A
O60391	LB/B	-	L8IXX4	180	R	C
O60391	LB/B	-	L8IXX4	194	R	W
O60391	LB/B	-	L8IXX4	247	R	Q
O60391	LB/B	-	L8IXX4	247	R	W
O60391	LB/B	-	L8IXX4	332	E	K
O60391	LB/B	-	L8IXX4	350	R	H
O60391	LB/B	-	L8IXX4	515	G	S
O60391	LB/B	-	L8IXX4	583	A	V
O60391	LB/B	-	L8IXX4	598	R	C
O60391	LB/B	-	L8IXX4	608	R	H
O60391	LB/B	-	L8IXX4	678	S	L
O60391	LB/B	-	L8IXX4	928	V	M
Q7Z429	LB/B	-	A0A1A8SJZ7	107	S	N
Q9Y3R0	LB/B	-	A0A2J7QRV6	322	A	T
Q4V328	LB/B	-	H2UAU8	179	L	P
P25098	LB/B	-	W5PIZ3	184	I	T
P35626	LB/B	-	A0A0R3RGV6	409	V	M
P35626	LB/B	-	A0A0R3RGV6	50	R	S
P35626	LB/B	-	A0A0R3RGV6	60	N	S
P32298	LB/B	-	A0A0A9ZGM9	247	V	I
P32298	LB/B	-	A0A0A9ZGM9	65	R	L
P32298	LB/B	-	A0A0A9ZGM9	142	A	V
P32298	LB/B	-	A0A0A9ZGM9	486	V	A
P32298	LB/B	-	A0A0A9ZGM9	425	L	P
P32298	LB/B	-	A0A0A9ZGM9	116	A	T
P32298	LB/B	-	A0A0A9ZGM9	383	H	Q
P32298	LB/B	-	A0A0A9ZGM9	473	V	I
P32298	LB/B	-	A0A0A9ZGM9	495	A	T
P32298	LB/B	-	A0A0A9ZGM9	95	D	H
P32298	LB/B	-	A0A0A9ZGM9	183	T	R
P32298	LB/B	-	A0A0A9ZGM9	440	A	V
P34947	LB/B	-	A0A0A9ZGM9	41	Q	L
P34947	LB/B	-	A0A0A9ZGM9	119	A	V
P34947	LB/B	-	A0A0A9ZGM9	122	G	S
P34947	LB/B	-	A0A0A9ZGM9	129	T	M
P34947	LB/B	-	A0A0A9ZGM9	141	L	I
P34947	LB/B	-	A0A0A9ZGM9	304	R	H
Q8WTQ7	LB/B	-	A0A0A9ZGM9	81	R	H
Q8WTQ7	LB/B	-	A0A0A9ZGM9	113	C	W
Q8WTQ7	LB/B	-	A0A0A9ZGM9	115	S	C
Q8WTQ7	LB/B	-	A0A0A9ZGM9	127	S	T
Q8WTQ7	LB/B	-	A0A0A9ZGM9	196	V	G
Q8WTQ7	LB/B	-	A0A0A9ZGM9	196	V	M
Q8WTQ7	LB/B	-	A0A0A9ZGM9	226	R	W
Q8WTQ7	LB/B	-	A0A0A9ZGM9	309	E	Q
Q8WTQ7	LB/B	-	A0A0A9ZGM9	313	V	I
Q8WTQ7	LB/B	-	A0A0A9ZGM9	443	E	G
Q8WTQ7	LB/B	-	A0A0A9ZGM9	460	P	T
Q8WTQ7	LB/B	-	A0A0A9ZGM9	461	R	C
Q13255	LB/B	-	A0A093JH78	929	V	I
Q13255	LB/B	-	A0A093JH78	34	S	Y
Q13255	LB/B	-	A0A093JH78	285	R	K
Q13255	LB/B	-	A0A093JH78	741	E	D
Q13255	LB/B	-	A0A093JH78	884	G	E
Q13255	LB/B	-	A0A093JH78	993	S	P
Q13255	LB/B	-	A0A093JH78	593	S	P
Q13255	LP/P	Spinocerebellar ataxia 44 (SCA44) [MIM:617691]	A0A093JH78	262	Y	C
Q13255	LP/P	Spinocerebellar ataxia 44 (SCA44) [MIM:617691]	A0A093JH78	792	Y	C
Q13255	LP/P	Spinocerebellar ataxia, autosomal recessive, 13 (SCAR13) [MIM:614831]	A0A093JH78	454	L	F
Q14833	LB/B	-	A0A091CUD5	797	V	I
Q14833	LB/B	-	A0A091CUD5	169	L	F
O15303	LP/P	Night blindness, congenital stationary, 1B (CSNB1B) [MIM:257270]	A0A091CUD5	150	G	S
O15303	LP/P	Night blindness, congenital stationary, 1B (CSNB1B) [MIM:257270]	A0A091CUD5	781	E	K
O15303	LB/B	-	A0A091CUD5	227	E	V
O15303	LB/B	-	A0A091CUD5	236	I	F
O15303	LB/B	-	A0A091CUD5	712	M	V
O15303	LB/B	-	A0A091CUD5	807	A	V
O15303	LB/B	-	A0A091CUD5	817	T	S
O15303	LB/B	-	A0A091CUD5	59	Q	P
O15303	LP/P	Night blindness, congenital stationary, 1B (CSNB1B) [MIM:257270]	A0A091CUD5	46	P	L
O15303	LP/P	Night blindness, congenital stationary, 1B (CSNB1B) [MIM:257270]	A0A091CUD5	58	G	R
O15303	LP/P	Night blindness, congenital stationary, 1B (CSNB1B) [MIM:257270]	A0A091CUD5	405	I	T
O15303	LP/P	Night blindness, congenital stationary, 1B (CSNB1B) [MIM:257270]	A0A091CUD5	522	C	Y
Q14831	LB/B	-	A0A091CUD5	433	Y	F
Q14831	LB/B	-	A0A091CUD5	495	I	V
Q14831	LB/B	-	A0A091CUD5	745	G	E
Q14831	LP/P	Neurodevelopmental disorder with seizures, hypotonia, and brain imaging abnormalities (NEDSHBA) [MIM:618922]	A0A091CUD5	154	I	T
O00222	LB/B	-	M7B366	10	S	C
O00222	LB/B	-	M7B366	21	F	C
O00222	LB/B	-	M7B366	392	R	Q
O00222	LB/B	-	M7B366	548	V	G
O00222	LB/B	-	M7B366	265	I	T
O00222	LB/B	-	M7B366	362	F	Y
O00222	LB/B	-	M7B366	368	G	D
O00222	LB/B	-	M7B366	430	L	F
O00222	LB/B	-	M7B366	343	R	Q
O00222	LB/B	-	M7B366	768	I	N
O00222	LB/B	-	M7B366	902	S	I
P28799	LB/B	-	A0A2I3LZ88	515	G	A
P28799	LP/P	Ubiquitin-positive frontotemporal dementia (UP-FTD) [MIM:607485]	A0A2I3LZ88	9	A	D
P28799	LB/B	-	A0A2I3LZ88	19	R	W
P28799	LB/B	-	A0A2I3LZ88	55	R	W
P28799	LB/B	-	A0A2I3LZ88	69	A	T
P28799	LB/B	-	A0A2I3LZ88	120	S	Y
P28799	LB/B	-	A0A2I3LZ88	182	T	M
P28799	LB/B	-	A0A2I3LZ88	221	C	S
P28799	LB/B	-	A0A2I3LZ88	275	P	L
P28799	LB/B	-	A0A2I3LZ88	376	D	N
P28799	LB/B	-	A0A2I3LZ88	398	S	L
P28799	LB/B	-	A0A2I3LZ88	433	R	Q
P28799	LB/B	-	A0A2I3LZ88	564	R	H
Q12849	LB/B	-	A0A2I3RCK5	277	D	Y
A8MXD5	LB/B	-	M3Y581	9	E	K
A8MXD5	LP/P	Deafness, autosomal recessive, 25 (DFNB25) [MIM:613285]	M3Y581	38	P	L
A8MXD5	LB/B	-	M3Y581	51	G	E
A8MXD5	LP/P	Deafness, autosomal recessive, 25 (DFNB25) [MIM:613285]	M3Y581	64	G	S
A8MXD5	LB/B	-	M3Y581	91	G	V
A8MXD5	LP/P	Deafness, autosomal recessive, 25 (DFNB25) [MIM:613285]	M3Y581	138	R	C
A8MXD5	LP/P	Deafness, autosomal recessive, 25 (DFNB25) [MIM:613285]	M3Y581	153	F	V
A6NFK2	LB/B	-	A0A2K6SR50	181	L	F
A4D1B5	LB/B	-	F1P0Z8	47	H	R
A4D1B5	LB/B	-	F1P0Z8	305	G	E
A4D1B5	LB/B	-	F1P0Z8	649	V	I
A4D1B5	LB/B	-	F1P0Z8	653	W	L
Q96QA5	LB/B	-	A0A1U7TTN0	18	R	Q
Q96QA5	LB/B	-	A0A1U7TTN0	128	V	L
Q96QA5	LB/B	-	A0A1U7TTN0	130	E	K
Q96QA5	LB/B	-	A0A1U7TTN0	314	T	N
Q8TAX9	LB/B	-	L8IGZ1	122	E	G
Q8TAX9	LB/B	-	L8IGZ1	132	T	A
Q8TAX9	LB/B	-	L8IGZ1	304	G	R
Q8TAX9	LB/B	-	L8IGZ1	311	P	S
Q8TAX9	LB/B	-	L8IGZ1	330	R	C
Q9BYG8	LB/B	-	A0A1U7R0Y3	23	P	S
Q9BYG8	LB/B	-	A0A1U7R0Y3	150	R	K
Q9BYG8	LB/B	-	A0A1U7R0Y3	475	M	T
Q14687	LB/B	-	A0A287CWI7	936	V	A
Q14687	LB/B	-	A0A287CWI7	1153	R	Q
Q2KHT4	LB/B	-	G1PJM9	39	F	L
Q2KHT4	LB/B	-	G1PJM9	67	G	V
P06396	LP/P	Amyloidosis 5 (AMYL5) [MIM:105120]	F1QQQ5	214	D	N
P06396	LP/P	Amyloidosis 5 (AMYL5) [MIM:105120]	F1QQQ5	214	D	Y
P06396	LB/B	-	F1QQQ5	129	A	T
P06396	LB/B	-	F1QQQ5	668	R	L
P06396	LB/B	-	F1QQQ5	231	N	D
Q8IYD1	LB/B	-	Q8R050	23	P	T
P08263	LB/B	-	A0A2P4T471	19	T	I
P08263	LB/B	-	A0A2P4T471	113	P	Q
P08263	LB/B	-	A0A2P4T471	117	K	Q
P09210	LB/B	-	A0A2P4T471	112	S	T
P09210	LB/B	-	A0A2P4T471	210	E	A
P09210	LB/B	-	A0A2P4T471	110	P	S
P09210	LB/B	-	A0A2P4T471	149	V	A
Q16772	LB/B	-	A0A2P4T471	71	I	L
Q16772	LB/B	-	A0A2P4T471	73	N	D
Q16772	LB/B	-	A0A2P4T471	36	G	E
Q16772	LB/B	-	A0A2P4T471	113	R	Q
Q16772	LB/B	-	A0A2P4T471	208	A	T
O15217	LB/B	-	A0A2Y9E978	100	L	P
O15217	LB/B	-	A0A2Y9E978	163	T	A
Q7RTV2	LB/B	-	A0A2P4T471	55	V	I
P21266	LB/B	-	G1SXQ0	224	V	I
P78417	LB/B	-	F1QN72	140	A	D
P78417	LB/B	-	F1QN72	208	E	K
P78417	LB/B	-	F1QN72	236	A	V
P78417	LB/B	-	F1QN72	86	S	C
P78417	LB/B	-	F1QN72	32	C	Y
Q9H4Y5	LB/B	-	F1QN72	142	N	D
Q9H4Y5	LB/B	-	F1QN72	130	C	Y
P30711	LB/B	-	A0A1D5PX81	21	A	T
P30711	LB/B	-	A0A1D5PX81	141	D	N
P30711	LB/B	-	A0A1D5PX81	169	V	I
P30711	LB/B	-	A0A1D5PX81	173	E	K
O43708	LB/B	-	A0A2K5TJ90	32	K	E
O43708	LB/B	-	A0A2K5TJ90	42	R	G
O43708	LB/B	-	A0A2K5TJ90	82	M	T
O43708	LB/B	-	A0A2K5TJ90	133	N	H
O43708	LP/P	Maleylacetoacetate isomerase deficiency (MAAID) [MIM:617596]	A0A2K5TJ90	99	V	M
O43708	LP/P	Maleylacetoacetate isomerase deficiency (MAAID) [MIM:617596]	A0A2K5TJ90	150	A	V
Q9BZM3	LB/B	-	E2RAL5	107	G	S
Q9BZM3	LP/P	Diencephalic-mesencephalic junction dysplasia syndrome 2 (DMJDS2) [MIM:618646]	E2RAL5	251	Q	R
Q4AE62	LB/B	-	A0A147AZL8	137	M	I
P29084	LB/B	-	A0A146XQ13	183	K	R
P29084	LB/B	-	A0A146XQ13	133	I	T
P29084	LP/P	Trichothiodystrophy 6, non-photosensitive (TTD6) [MIM:616943]	A0A146XQ13	150	A	P
P29084	LP/P	Trichothiodystrophy 6, non-photosensitive (TTD6) [MIM:616943]	A0A146XQ13	187	D	Y
P32780	LB/B	-	A0A0K2U2E3	234	R	W
P32780	LB/B	-	A0A0K2U2E3	285	S	F
P32780	LB/B	-	A0A0K2U2E3	517	L	V
Q92759	LB/B	-	A0A061IKW4	337	R	Q
Q6ZYL4	LP/P	Trichothiodystrophy 3, photosensitive (TTD3) [MIM:616395]	A0A2I0MTL9	21	L	P
P78347	LB/B	-	F6VVV6	174	L	V
Q86UP8	LB/B	-	L5LER6	514	N	H
Q92664	LB/B	-	A0A2K5ZT85	245	V	L
Q12789	LB/B	-	H9GNA3	1889	Q	E
Q12789	LB/B	-	H9GNA3	1959	F	S
Q12789	LB/B	-	H9GNA3	2077	E	K
A4D1E9	LB/B	-	H2M071	88	C	W
A4D1E9	LB/B	-	H2M071	110	N	S
A4D1E9	LB/B	-	H2M071	164	L	F
A4D1E9	LB/B	-	H2M071	368	M	I
Q9BZE4	LB/B	-	A0A2G8KKJ0	525	R	H
Q9NYZ3	LB/B	-	A0A2Y9Q4W8	470	S	L
Q9NYZ3	LB/B	-	A0A2Y9Q4W8	506	W	R
Q9NYZ3	LB/B	-	A0A2Y9Q4W8	181	T	A
Q9NYZ3	LB/B	-	A0A2Y9Q4W8	200	A	V
Q9NYZ3	LB/B	-	A0A2Y9Q4W8	274	A	T
Q9NYZ3	LB/B	-	A0A2Y9Q4W8	322	S	N
Q9NYZ3	LB/B	-	A0A2Y9Q4W8	463	D	E
Q9NYZ3	LB/B	-	A0A2Y9Q4W8	635	A	T
Q9NYZ3	LB/B	-	A0A2Y9Q4W8	303	S	N
Q9H1H1	LB/B	-	H0VBT4	56	L	V
P43080	LP/P	Cone dystrophy 3 (COD3) [MIM:602093]	A0A0P6K6T4	99	Y	C
P43080	LP/P	Cone dystrophy 3 (COD3) [MIM:602093]	A0A0P6K6T4	155	E	G
P43080	LP/P	Cone dystrophy 3 (COD3) [MIM:602093]	A0A0P6K6T4	89	E	K
P43080	LP/P	Cone dystrophy 3 (COD3) [MIM:602093]	A0A0P6K6T4	100	D	E
P43080	LP/P	Cone dystrophy 3 (COD3) [MIM:602093]	A0A0P6K6T4	151	L	F
P43080	LP/P	Cone-rod dystrophy 14 (CORD14) [MIM:602093]	A0A0P6K6T4	151	L	F
P43080	LP/P	Cone dystrophy 3 (COD3) [MIM:602093]	A0A0P6K6T4	159	G	V
P43080	LB/B	Cone dystrophy 3 (COD3) [MIM:602093]	A0A0P6K6T4	42	F	I
P43080	LP/P	Cone-rod dystrophy 14 (CORD14) [MIM:602093]	A0A0P6K6T4	84	L	F
P43080	LP/P	Cone-rod dystrophy 14 (CORD14) [MIM:602093]	A0A0P6K6T4	86	G	R
P43080	LP/P	Cone dystrophy 3 (COD3) [MIM:602093]	A0A0P6K6T4	99	Y	N
P43080	LP/P	Cone dystrophy 3 (COD3) [MIM:602093]	A0A0P6K6T4	99	Y	S
P43080	LP/P	Cone-rod dystrophy 14 (CORD14) [MIM:602093]	A0A0P6K6T4	100	D	G
P43080	LP/P	Cone dystrophy 3 (COD3) [MIM:602093]	A0A0P6K6T4	104	N	K
P43080	LP/P	Cone-rod dystrophy 14 (CORD14) [MIM:602093]	A0A0P6K6T4	107	I	T
P43080	LP/P	Cone-rod dystrophy 14 (CORD14) [MIM:602093]	A0A0P6K6T4	111	E	V
P43080	LP/P	Cone dystrophy 3 (COD3) [MIM:602093]	A0A0P6K6T4	120	R	L
P43080	LP/P	Cone dystrophy 3 (COD3) [MIM:602093]	A0A0P6K6T4	144	D	G
P43080	LB/B	Cone dystrophy 3 (COD3) [MIM:602093]	A0A0P6K6T4	184	Q	R
Q9UMX6	LB/B	-	A0A1S3PX39	155	E	D
Q9UMX6	LP/P	Retinitis pigmentosa 48 (RP48) [MIM:613827]	A0A1S3PX39	157	G	R
O95843	LB/B	-	U3IQB5	72	V	I
O95843	LB/B	-	U3IQB5	85	M	V
O95843	LB/B	-	U3IQB5	119	A	V
O95843	LB/B	-	U3IQB5	159	M	V
Q02747	LB/B	-	L8YDC4	7	S	F
Q16661	LB/B	-	A0A1W4XYR0	11	P	T
O75343	LB/B	-	V8PEM4	316	N	H
O75343	LB/B	-	V8PEM4	55	Y	C
O75343	LB/B	-	V8PEM4	128	M	I
P25092	LB/B	-	Q4T9J5	30	C	R
P25092	LB/B	-	Q4T9J5	114	R	Q
P25092	LB/B	-	Q4T9J5	464	R	L
P25092	LB/B	-	Q4T9J5	610	E	K
P25092	LB/B	-	Q4T9J5	859	I	V
P25092	LB/B	-	Q4T9J5	1045	Q	R
P25092	LB/B	-	Q4T9J5	1072	Y	C
P25092	LB/B	-	Q4T9J5	281	F	L
P25092	LP/P	Diarrhea 6 (DIAR6) [MIM:614616]	Q4T9J5	840	S	I
P25092	LP/P	Meconium ileus (MECIL) [MIM:614665]	Q4T9J5	387	D	G
Q8N442	LB/B	-	A0A0P5D6E5	58	L	P
Q8N442	LB/B	-	A0A0P5D6E5	329	T	I
Q8N442	LP/P	Developmental and epileptic encephalopathy 40 (DEE40) [MIM:617065]	A0A0P5D6E5	609	A	S
P08236	LP/P	Mucopolysaccharidosis 7 (MPS7) [MIM:253220]	A0A1R1HVW8	216	R	W
P08236	LP/P	Mucopolysaccharidosis 7 (MPS7) [MIM:253220]	A0A1R1HVW8	354	A	V
P08236	LP/P	Mucopolysaccharidosis 7 (MPS7) [MIM:253220]	A0A1R1HVW8	382	R	C
P08236	LP/P	Mucopolysaccharidosis 7 (MPS7) [MIM:253220]	A0A1R1HVW8	611	R	W
P08236	LP/P	Mucopolysaccharidosis 7 (MPS7) [MIM:253220]	A0A1R1HVW8	619	A	V
P08236	LP/P	Mucopolysaccharidosis 7 (MPS7) [MIM:253220]	A0A1R1HVW8	627	W	C
P08236	LB/B	-	A0A1R1HVW8	649	L	P
P08236	LP/P	Mucopolysaccharidosis 7 (MPS7) [MIM:253220]	A0A1R1HVW8	38	C	G
P08236	LP/P	Mucopolysaccharidosis 7 (MPS7) [MIM:253220]	A0A1R1HVW8	52	S	F
P08236	LP/P	Mucopolysaccharidosis 7 (MPS7) [MIM:253220]	A0A1R1HVW8	136	G	R
P08236	LP/P	Mucopolysaccharidosis 7 (MPS7) [MIM:253220]	A0A1R1HVW8	148	P	S
P08236	LP/P	Mucopolysaccharidosis 7 (MPS7) [MIM:253220]	A0A1R1HVW8	150	E	K
P08236	LB/B	-	A0A1R1HVW8	152	D	N
P08236	LP/P	Mucopolysaccharidosis 7 (MPS7) [MIM:253220]	A0A1R1HVW8	176	L	F
P08236	LP/P	Mucopolysaccharidosis 7 (MPS7) [MIM:253220]	A0A1R1HVW8	320	Y	C
P08236	LP/P	Mucopolysaccharidosis 7 (MPS7) [MIM:253220]	A0A1R1HVW8	320	Y	S
P08236	LP/P	Mucopolysaccharidosis 7 (MPS7) [MIM:253220]	A0A1R1HVW8	350	K	N
P08236	LP/P	Mucopolysaccharidosis 7 (MPS7) [MIM:253220]	A0A1R1HVW8	351	H	Y
P08236	LP/P	Mucopolysaccharidosis 7 (MPS7) [MIM:253220]	A0A1R1HVW8	374	R	C
P08236	LP/P	Mucopolysaccharidosis 7 (MPS7) [MIM:253220]	A0A1R1HVW8	382	R	H
P08236	LP/P	Mucopolysaccharidosis 7 (MPS7) [MIM:253220]	A0A1R1HVW8	408	P	S
P08236	LP/P	Mucopolysaccharidosis 7 (MPS7) [MIM:253220]	A0A1R1HVW8	415	P	L
P08236	LP/P	Mucopolysaccharidosis 7 (MPS7) [MIM:253220]	A0A1R1HVW8	435	R	P
P08236	LP/P	Mucopolysaccharidosis 7 (MPS7) [MIM:253220]	A0A1R1HVW8	477	R	W
P08236	LP/P	Mucopolysaccharidosis 7 (MPS7) [MIM:253220]	A0A1R1HVW8	495	Y	C
P08236	LP/P	Mucopolysaccharidosis 7 (MPS7) [MIM:253220]	A0A1R1HVW8	508	Y	C
P08236	LP/P	Mucopolysaccharidosis 7 (MPS7) [MIM:253220]	A0A1R1HVW8	572	G	D
P08236	LP/P	Mucopolysaccharidosis 7 (MPS7) [MIM:253220]	A0A1R1HVW8	577	R	L
P08236	LP/P	Mucopolysaccharidosis 7 (MPS7) [MIM:253220]	A0A1R1HVW8	606	K	N
P08236	LP/P	Mucopolysaccharidosis 7 (MPS7) [MIM:253220]	A0A1R1HVW8	626	Y	H
P08236	LB/B	-	A0A1R1HVW8	376	L	F
P08236	LP/P	Mucopolysaccharidosis 7 (MPS7) [MIM:253220]	A0A1R1HVW8	30	P	S
P08236	LP/P	Mucopolysaccharidosis 7 (MPS7) [MIM:253220]	A0A1R1HVW8	152	D	G
P08236	LP/P	Mucopolysaccharidosis 7 (MPS7) [MIM:253220]	A0A1R1HVW8	243	L	P
P08236	LP/P	Mucopolysaccharidosis 7 (MPS7) [MIM:253220]	A0A1R1HVW8	339	N	S
P08236	LP/P	Mucopolysaccharidosis 7 (MPS7) [MIM:253220]	A0A1R1HVW8	362	D	N
P08236	LP/P	Mucopolysaccharidosis 7 (MPS7) [MIM:253220]	A0A1R1HVW8	364	P	L
P08236	LP/P	Mucopolysaccharidosis 7 (MPS7) [MIM:253220]	A0A1R1HVW8	540	E	K
P08236	LP/P	Mucopolysaccharidosis 7 (MPS7) [MIM:253220]	A0A1R1HVW8	607	G	A
P46976	LP/P	Glycogen storage disease 15 (GSD15) [MIM:613507]	A0A0P5KYC9	83	T	M
P46976	LP/P	Polyglucosan body myopathy 2 (PGBM2) [MIM:616199]	A0A0P5KYC9	16	A	P
P46976	LP/P	Polyglucosan body myopathy 2 (PGBM2) [MIM:616199]	A0A0P5KYC9	102	D	H
O15488	LB/B	-	W5PEP4	270	A	V
O15488	LB/B	-	W5PEP4	313	H	R
O15488	LB/B	-	W5PEP4	373	R	C
O15488	LB/B	-	W5PEP4	7	H	Y
O15488	LB/B	-	W5PEP4	194	G	R
P02724	LB/B	-	A0A2K6LM38	20	S	L
P02724	LB/B	-	A0A2K6LM38	24	G	E
P02724	LB/B	-	A0A2K6LM38	13	E	A
P02724	LB/B	-	A0A2K6LM38	23	T	N
P02724	LB/B	-	A0A2K6LM38	24	G	D
P02724	LB/B	-	A0A2K6LM38	46	D	E
P02724	LB/B	-	A0A2K6LM38	47	T	K
P02724	LB/B	-	A0A2K6LM38	47	T	M
P02724	LB/B	-	A0A2K6LM38	50	R	W
P02724	LB/B	-	A0A2K6LM38	66	S	Y
P02724	LB/B	-	A0A2K6LM38	73	P	S
P02724	LB/B	-	A0A2K6LM38	76	E	K
P02724	LB/B	-	A0A2K6LM38	77	T	I
P02724	LB/B	-	A0A2K6LM38	78	G	R
P02724	LB/B	-	A0A2K6LM38	82	Q	K
P02724	LB/B	-	A0A2K6LM38	84	A	P
P02724	LB/B	-	A0A2K6LM38	13	E	G
P06028	LB/B	-	A0A2J8MU86	48	T	M
P06028	LB/B	-	A0A2J8MU86	84	S	T
P06028	LB/B	-	A0A2J8MU86	22	T	S
P06028	LB/B	-	A0A2J8MU86	54	R	H
P06028	LB/B	-	A0A2J8MU86	58	P	R
P04921	LB/B	-	A0A2K5WD65	8	N	S
P04921	LB/B	-	A0A2K5WD65	14	L	F
P04921	LB/B	-	A0A2K5WD65	23	A	S
P04921	LB/B	-	A0A2K5WD65	124	K	E
P15421	LB/B	-	A0A2R9CCI4	78	R	P
P15421	LB/B	-	A0A2R9CCI4	13	G	E
P13807	LB/B	-	G1QXU3	464	G	S
P13807	LB/B	-	G1QXU3	130	K	E
P13807	LB/B	-	G1QXU3	283	N	S
P13807	LB/B	-	G1QXU3	359	E	G
P13807	LB/B	-	G1QXU3	416	M	V
P13807	LB/B	-	G1QXU3	619	E	Q
P13807	LB/B	-	G1QXU3	691	P	A
P13807	LB/B	-	G1QXU3	108	I	M
P54840	LP/P	Glycogen storage disease 0 (GSD0) [MIM:240600]	G1QXU3	39	N	S
P54840	LP/P	Glycogen storage disease 0 (GSD0) [MIM:240600]	G1QXU3	339	A	P
P54840	LP/P	Glycogen storage disease 0 (GSD0) [MIM:240600]	G1QXU3	446	H	D
P54840	LP/P	Glycogen storage disease 0 (GSD0) [MIM:240600]	G1QXU3	479	P	Q
P54840	LP/P	Glycogen storage disease 0 (GSD0) [MIM:240600]	G1QXU3	483	S	P
P54840	LP/P	Glycogen storage disease 0 (GSD0) [MIM:240600]	G1QXU3	491	M	R
P54840	LB/B	-	G1QXU3	193	A	T
P54840	LB/B	-	G1QXU3	415	D	E
P54840	LB/B	-	G1QXU3	363	M	V
P12544	LB/B	-	G1KR50	121	M	T
P51124	LB/B	-	S9YJ00	221	R	G
Q8IZA3	LB/B	-	A0A2Y9STM2	296	N	S
Q99880	LB/B	-	A0A1A6FVE5	4	L	P
P62807	LB/B	-	A0A1S3GRR9	27	G	S
Q7Z2G1	LB/B	-	E2RH15	87	R	W
Q7Z2G1	LB/B	-	E2RH15	123	H	R
Q6NXT2	LB/B	-	A0A164U858	39	H	R
O95479	LB/B	-	K9IMY8	151	D	A
O95479	LB/B	-	K9IMY8	218	R	Q
O95479	LB/B	-	K9IMY8	484	N	D
O95479	LB/B	-	K9IMY8	554	P	L
O95479	LP/P	Cortisone reductase deficiency 1 (CORTRD1) [MIM:604931]	K9IMY8	146	P	L
O95479	LP/P	Cortisone reductase deficiency 1 (CORTRD1) [MIM:604931]	K9IMY8	359	G	D
P46952	LB/B	-	F7HZQ0	37	I	V
P46952	LB/B	-	F7HZQ0	42	T	S
Q9P035	LB/B	-	E2RSN5	56	E	K
Q9P035	LB/B	-	E2RSN5	269	M	L
Q16836	LP/P	3-alpha-hydroxyacyl-CoA dehydrogenase deficiency (HADH deficiency) [MIM:231530]	A0A2J8XQE3	40	A	T
Q16836	LP/P	3-alpha-hydroxyacyl-CoA dehydrogenase deficiency (HADH deficiency) [MIM:231530]	A0A2J8XQE3	57	D	E
Q16836	LP/P	Familial hyperinsulinemic hypoglycemia 4 (HHF4) [MIM:609975]	A0A2J8XQE3	258	P	L
Q16836	LB/B	-	A0A2J8XQE3	86	L	P
Q16836	LB/B	-	A0A2J8XQE3	152	Q	H
Q16836	LB/B	-	A0A2J8XQE3	226	Y	H
P40939	LP/P	Long-chain 3-hydroxyl-CoA dehydrogenase deficiency (LCHAD deficiency) [MIM:609016]	A0A1I8MXU8	510	E	Q
P40939	LP/P	Maternal acute fatty liver of pregnancy (AFLP) [MIM:609016]	A0A1I8MXU8	510	E	Q
P40939	LP/P	Mitochondrial trifunctional protein deficiency (MTPD) [MIM:609015]	A0A1I8MXU8	282	V	D
P40939	LP/P	Mitochondrial trifunctional protein deficiency (MTPD) [MIM:609015]	A0A1I8MXU8	305	I	N
P40939	LP/P	Long-chain 3-hydroxyl-CoA dehydrogenase deficiency (LCHAD deficiency) [MIM:609016]	A0A1I8MXU8	342	L	P
P40939	LB/B	-	A0A1I8MXU8	358	Q	K
P81172	LP/P	Hemochromatosis 2B (HFE2B) [MIM:613313]	A0A1S3FZD4	71	G	D
P81172	LP/P	Hemochromatosis 2B (HFE2B) [MIM:613313]	A0A1S3FZD4	59	R	G
P81172	LP/P	Hemochromatosis 2B (HFE2B) [MIM:613313]	A0A1S3FZD4	70	C	R
P81172	LP/P	Hemochromatosis 2B (HFE2B) [MIM:613313]	A0A1S3FZD4	78	C	Y
P10915	LB/B	-	S7Q575	281	N	S
Q14CZ0	LB/B	-	A0A2U3W055	221	N	S
P12081	LB/B	-	L9JUN1	399	A	V
P12081	LP/P	Usher syndrome 3B (USH3B) [MIM:614504]	L9JUN1	454	Y	S
P12081	LB/B	-	L9JUN1	5	A	E
P12081	LP/P	Charcot-Marie-Tooth disease, axonal, 2W (CMT2W) [MIM:616625]	L9JUN1	137	R	Q
P12081	LB/B	-	L9JUN1	205	G	D
P12081	LB/B	-	L9JUN1	376	K	R
P12081	LP/P	Charcot-Marie-Tooth disease, axonal, 2W (CMT2W) [MIM:616625]	L9JUN1	132	T	I
P12081	LP/P	Charcot-Marie-Tooth disease, axonal, 2W (CMT2W) [MIM:616625]	L9JUN1	134	P	H
P12081	LP/P	Charcot-Marie-Tooth disease, axonal, 2W (CMT2W) [MIM:616625]	L9JUN1	175	D	E
P12081	LP/P	Charcot-Marie-Tooth disease, axonal, 2W (CMT2W) [MIM:616625]	L9JUN1	364	D	Y
P12081	LP/P	Charcot-Marie-Tooth disease, axonal, 2W (CMT2W) [MIM:616625]	L9JUN1	330	Y	C
P49590	LP/P	Perrault syndrome 2 (PRLTS2) [MIM:614926]	A0A0D2WSV6	200	L	V
P49590	LP/P	Perrault syndrome 2 (PRLTS2) [MIM:614926]	A0A0D2WSV6	368	V	L
Q92839	LB/B	-	G5B3D3	14	C	R
O00219	LB/B	-	A0A2U4BD98	173	R	H
Q8TF76	LB/B	-	F1MG77	204	G	D
Q8TF76	LB/B	-	F1MG77	328	I	T
Q8TF76	LB/B	-	F1MG77	378	V	A
Q8TF76	LB/B	-	F1MG77	422	N	D
Q8TF76	LB/B	-	F1MG77	76	V	E
Q8TF76	LB/B	-	F1MG77	82	R	C
Q8TF76	LB/B	-	F1MG77	145	R	H
Q8TF76	LB/B	-	F1MG77	283	G	S
Q8TF76	LB/B	-	F1MG77	301	Q	L
Q8TF76	LB/B	-	F1MG77	706	M	V
Q68CZ6	LB/B	-	A0A093FD63	586	I	T
O94927	LB/B	-	A0A091DPI9	213	P	L
O94927	LB/B	-	A0A091DPI9	277	A	D
Q9BT25	LB/B	-	A0A2Y9LX64	83	G	R
Q8TDQ0	LB/B	-	A0A2Y9QG57	140	R	L
Q8TDQ0	LP/P	T-cell lymphoma, subcutaneous panniculitis-like (SPTCL) [MIM:618398]	A0A2Y9QG57	82	Y	C
Q8TDQ0	LP/P	T-cell lymphoma, subcutaneous panniculitis-like (SPTCL) [MIM:618398]	A0A2Y9QG57	97	I	M
Q8TDQ0	LP/P	T-cell lymphoma, subcutaneous panniculitis-like (SPTCL) [MIM:618398]	A0A2Y9QG57	101	T	I
O00165	LB/B	-	A0A1S2ZW10	49	P	S
O00165	LP/P	Neutropenia, severe congenital 3, autosomal recessive (SCN3) [MIM:610738]	A0A1S2ZW10	141	F	L
O00165	LB/B	-	A0A1S2ZW10	151	S	G
O00165	LB/B	-	A0A1S2ZW10	278	S	P
O00165	LP/P	Neutropenia, severe congenital 3, autosomal recessive (SCN3) [MIM:610738]	A0A1S2ZW10	130	L	R
O00165	LB/B	Neutropenia, severe congenital 3, autosomal recessive (SCN3) [MIM:610738]	A0A1S2ZW10	172	V	I
P68871	LB/B	-	A0A212DIB2	2	V	A
P68871	LB/B	-	A0A212DIB2	3	H	L
P68871	LB/B	-	A0A212DIB2	3	H	Q
P68871	LB/B	-	A0A212DIB2	3	H	R
P68871	LB/B	-	A0A212DIB2	3	H	Y
P68871	LB/B	-	A0A212DIB2	6	P	R
P68871	LB/B	-	A0A212DIB2	7	E	A
P68871	LP/P	Sickle cell anemia (SKCA) [MIM:603903]	A0A212DIB2	7	E	V
P68871	LB/B	-	A0A212DIB2	7	E	K
P68871	LB/B	-	A0A212DIB2	7	E	Q
P68871	LB/B	-	A0A212DIB2	8	E	G
P68871	LB/B	-	A0A212DIB2	8	E	K
P68871	LB/B	-	A0A212DIB2	9	K	E
P68871	LB/B	-	A0A212DIB2	9	K	Q
P68871	LB/B	-	A0A212DIB2	9	K	T
P68871	LB/B	-	A0A212DIB2	10	S	C
P68871	LB/B	-	A0A212DIB2	11	A	D
P68871	LB/B	-	A0A212DIB2	12	V	D
P68871	LB/B	-	A0A212DIB2	12	V	I
P68871	LB/B	-	A0A212DIB2	14	A	D
P68871	LB/B	-	A0A212DIB2	15	L	P
P68871	LB/B	-	A0A212DIB2	15	L	R
P68871	LB/B	-	A0A212DIB2	16	W	G
P68871	LB/B	-	A0A212DIB2	16	W	R
P68871	LB/B	-	A0A212DIB2	17	G	D
P68871	LB/B	-	A0A212DIB2	17	G	R
P68871	LB/B	-	A0A212DIB2	18	K	E
P68871	LB/B	-	A0A212DIB2	18	K	N
P68871	LB/B	-	A0A212DIB2	18	K	Q
P68871	LB/B	-	A0A212DIB2	19	V	M
P68871	LB/B	-	A0A212DIB2	20	N	D
P68871	LB/B	-	A0A212DIB2	20	N	K
P68871	LB/B	-	A0A212DIB2	20	N	S
P68871	LB/B	-	A0A212DIB2	21	V	M
P68871	LB/B	-	A0A212DIB2	22	D	G
P68871	LB/B	-	A0A212DIB2	22	D	N
P68871	LB/B	-	A0A212DIB2	22	D	H
P68871	LB/B	-	A0A212DIB2	22	D	Y
P68871	LB/B	-	A0A212DIB2	23	E	A
P68871	LB/B	-	A0A212DIB2	23	E	G
P68871	LB/B	-	A0A212DIB2	23	E	K
P68871	LB/B	-	A0A212DIB2	23	E	Q
P68871	LB/B	-	A0A212DIB2	23	E	V
P68871	LB/B	-	A0A212DIB2	24	V	D
P68871	LB/B	-	A0A212DIB2	24	V	F
P68871	LB/B	-	A0A212DIB2	24	V	G
P68871	LB/B	-	A0A212DIB2	25	G	D
P68871	LB/B	-	A0A212DIB2	25	G	R
P68871	LB/B	-	A0A212DIB2	25	G	V
P68871	LB/B	-	A0A212DIB2	26	G	D
P68871	LB/B	-	A0A212DIB2	26	G	R
P68871	LP/P	Beta-thalassemia (B-THAL) [MIM:613985]	A0A212DIB2	27	E	K
P68871	LB/B	-	A0A212DIB2	27	E	V
P68871	LB/B	-	A0A212DIB2	28	A	D
P68871	LB/B	-	A0A212DIB2	28	A	S
P68871	LB/B	-	A0A212DIB2	28	A	V
P68871	LB/B	-	A0A212DIB2	29	L	P
P68871	LB/B	-	A0A212DIB2	30	G	D
P68871	LB/B	-	A0A212DIB2	31	R	S
P68871	LB/B	-	A0A212DIB2	32	L	P
P68871	LB/B	-	A0A212DIB2	33	L	R
P68871	LB/B	-	A0A212DIB2	33	L	V
P68871	LB/B	-	A0A212DIB2	35	V	F
P68871	LB/B	-	A0A212DIB2	36	Y	F
P68871	LB/B	-	A0A212DIB2	37	P	R
P68871	LB/B	-	A0A212DIB2	37	P	S
P68871	LB/B	-	A0A212DIB2	37	P	T
P68871	LB/B	-	A0A212DIB2	38	W	G
P68871	LB/B	-	A0A212DIB2	38	W	S
P68871	LB/B	-	A0A212DIB2	38	W	R
P68871	LB/B	-	A0A212DIB2	39	T	N
P68871	LB/B	-	A0A212DIB2	40	Q	E
P68871	LB/B	-	A0A212DIB2	40	Q	K
P68871	LB/B	-	A0A212DIB2	40	Q	R
P68871	LB/B	-	A0A212DIB2	42	F	Y
P68871	LB/B	-	A0A212DIB2	43	F	L
P68871	LB/B	-	A0A212DIB2	44	E	Q
P68871	LB/B	-	A0A212DIB2	45	S	C
P68871	LB/B	-	A0A212DIB2	46	F	S
P68871	LB/B	-	A0A212DIB2	47	G	E
P68871	LB/B	-	A0A212DIB2	48	D	A
P68871	LB/B	-	A0A212DIB2	48	D	G
P68871	LB/B	-	A0A212DIB2	48	D	Y
P68871	LB/B	-	A0A212DIB2	49	L	P
P68871	LB/B	-	A0A212DIB2	50	S	F
P68871	LB/B	-	A0A212DIB2	52	P	R
P68871	LB/B	-	A0A212DIB2	53	D	A
P68871	LB/B	-	A0A212DIB2	53	D	H
P68871	LB/B	-	A0A212DIB2	55	V	D
P68871	LB/B	-	A0A212DIB2	56	M	K
P68871	LB/B	-	A0A212DIB2	57	G	R
P68871	LB/B	-	A0A212DIB2	58	N	K
P68871	LB/B	-	A0A212DIB2	59	P	R
P68871	LB/B	-	A0A212DIB2	60	K	E
P68871	LB/B	-	A0A212DIB2	61	V	A
P68871	LB/B	-	A0A212DIB2	62	K	E
P68871	LB/B	-	A0A212DIB2	62	K	M
P68871	LB/B	-	A0A212DIB2	62	K	N
P68871	LB/B	-	A0A212DIB2	63	A	D
P68871	LB/B	-	A0A212DIB2	63	A	P
P68871	LB/B	-	A0A212DIB2	64	H	Y
P68871	LB/B	-	A0A212DIB2	66	K	M
P68871	LB/B	-	A0A212DIB2	66	K	N
P68871	LB/B	-	A0A212DIB2	66	K	Q
P68871	LB/B	-	A0A212DIB2	67	K	T
P68871	LB/B	-	A0A212DIB2	68	V	A
P68871	LB/B	-	A0A212DIB2	68	V	M
P68871	LB/B	-	A0A212DIB2	69	L	H
P68871	LB/B	-	A0A212DIB2	69	L	P
P68871	LB/B	-	A0A212DIB2	70	G	D
P68871	LB/B	-	A0A212DIB2	70	G	R
P68871	LB/B	-	A0A212DIB2	70	G	S
P68871	LB/B	-	A0A212DIB2	71	A	D
P68871	LB/B	-	A0A212DIB2	72	F	S
P68871	LB/B	-	A0A212DIB2	74	D	G
P68871	LB/B	-	A0A212DIB2	74	D	V
P68871	LB/B	-	A0A212DIB2	74	D	Y
P68871	LB/B	-	A0A212DIB2	75	G	R
P68871	LB/B	-	A0A212DIB2	75	G	V
P68871	LB/B	-	A0A212DIB2	76	L	P
P68871	LB/B	-	A0A212DIB2	76	L	R
P68871	LB/B	-	A0A212DIB2	77	A	D
P68871	LB/B	-	A0A212DIB2	78	H	D
P68871	LB/B	-	A0A212DIB2	78	H	R
P68871	LB/B	-	A0A212DIB2	78	H	Y
P68871	LB/B	-	A0A212DIB2	79	L	R
P68871	LB/B	-	A0A212DIB2	80	D	Y
P68871	LB/B	-	A0A212DIB2	81	N	K
P68871	LB/B	-	A0A212DIB2	82	L	R
P68871	LB/B	-	A0A212DIB2	83	K	M
P68871	LB/B	-	A0A212DIB2	84	G	R
P68871	LB/B	-	A0A212DIB2	85	T	I
P68871	LB/B	-	A0A212DIB2	87	A	D
P68871	LB/B	-	A0A212DIB2	88	T	I
P68871	LB/B	-	A0A212DIB2	88	T	K
P68871	LB/B	-	A0A212DIB2	88	T	P
P68871	LB/B	-	A0A212DIB2	89	L	P
P68871	LB/B	-	A0A212DIB2	89	L	R
P68871	LB/B	-	A0A212DIB2	90	S	N
P68871	LB/B	-	A0A212DIB2	90	S	R
P68871	LB/B	-	A0A212DIB2	91	E	D
P68871	LB/B	-	A0A212DIB2	91	E	K
P68871	LB/B	-	A0A212DIB2	92	L	P
P68871	LB/B	-	A0A212DIB2	92	L	R
P68871	LB/B	-	A0A212DIB2	93	H	D
P68871	LB/B	-	A0A212DIB2	93	H	N
P68871	LB/B	-	A0A212DIB2	93	H	P
P68871	LB/B	-	A0A212DIB2	93	H	Q
P68871	LB/B	-	A0A212DIB2	94	C	R
P68871	LB/B	-	A0A212DIB2	95	D	G
P68871	LB/B	-	A0A212DIB2	95	D	H
P68871	LB/B	-	A0A212DIB2	95	D	N
P68871	LB/B	-	A0A212DIB2	96	K	M
P68871	LB/B	-	A0A212DIB2	96	K	N
P68871	LB/B	-	A0A212DIB2	97	L	P
P68871	LB/B	-	A0A212DIB2	97	L	V
P68871	LB/B	-	A0A212DIB2	98	H	L
P68871	LB/B	-	A0A212DIB2	98	H	P
P68871	LB/B	-	A0A212DIB2	98	H	Q
P68871	LB/B	-	A0A212DIB2	98	H	Y
P68871	LB/B	-	A0A212DIB2	99	V	G
P68871	LB/B	-	A0A212DIB2	100	D	E
P68871	LB/B	-	A0A212DIB2	101	P	L
P68871	LB/B	-	A0A212DIB2	101	P	R
P68871	LB/B	-	A0A212DIB2	102	E	D
P68871	LB/B	-	A0A212DIB2	102	E	G
P68871	LB/B	-	A0A212DIB2	102	E	K
P68871	LB/B	-	A0A212DIB2	102	E	Q
P68871	LB/B	-	A0A212DIB2	103	N	S
P68871	LB/B	-	A0A212DIB2	103	N	Y
P68871	LB/B	-	A0A212DIB2	104	F	L
P68871	LB/B	-	A0A212DIB2	105	R	S
P68871	LB/B	-	A0A212DIB2	105	R	T
P68871	LB/B	-	A0A212DIB2	108	G	R
P68871	LB/B	-	A0A212DIB2	109	N	K
P68871	LB/B	-	A0A212DIB2	110	V	M
P68871	LB/B	-	A0A212DIB2	111	L	P
P68871	LB/B	-	A0A212DIB2	112	V	A
P68871	LB/B	-	A0A212DIB2	113	C	R
P68871	LB/B	-	A0A212DIB2	113	C	Y
P68871	LP/P	Beta-thalassemia (B-THAL) [MIM:613985]	A0A212DIB2	116	A	D
P68871	LB/B	-	A0A212DIB2	116	A	P
P68871	LB/B	-	A0A212DIB2	117	H	Q
P68871	LB/B	-	A0A212DIB2	118	H	P
P68871	LB/B	-	A0A212DIB2	118	H	R
P68871	LB/B	-	A0A212DIB2	120	G	A
P68871	LB/B	-	A0A212DIB2	121	K	E
P68871	LB/B	-	A0A212DIB2	121	K	I
P68871	LB/B	-	A0A212DIB2	121	K	Q
P68871	LB/B	-	A0A212DIB2	122	E	A
P68871	LB/B	-	A0A212DIB2	122	E	G
P68871	LB/B	-	A0A212DIB2	122	E	Q
P68871	LB/B	-	A0A212DIB2	122	E	K
P68871	LB/B	-	A0A212DIB2	122	E	V
P68871	LB/B	-	A0A212DIB2	124	T	I
P68871	LB/B	-	A0A212DIB2	125	P	R
P68871	LB/B	-	A0A212DIB2	125	P	Q
P68871	LB/B	-	A0A212DIB2	125	P	S
P68871	LB/B	-	A0A212DIB2	127	V	A
P68871	LP/P	Beta-thalassemia (B-THAL) [MIM:613985]	A0A212DIB2	127	V	G
P68871	LB/B	-	A0A212DIB2	127	V	E
P68871	LB/B	-	A0A212DIB2	128	Q	E
P68871	LB/B	-	A0A212DIB2	128	Q	K
P68871	LB/B	-	A0A212DIB2	129	A	D
P68871	LB/B	-	A0A212DIB2	130	A	P
P68871	LB/B	-	A0A212DIB2	130	A	V
P68871	LB/B	-	A0A212DIB2	131	Y	D
P68871	LB/B	-	A0A212DIB2	131	Y	S
P68871	LB/B	-	A0A212DIB2	132	Q	E
P68871	LB/B	-	A0A212DIB2	132	Q	K
P68871	LB/B	-	A0A212DIB2	132	Q	P
P68871	LB/B	-	A0A212DIB2	132	Q	R
P68871	LB/B	-	A0A212DIB2	133	K	N
P68871	LB/B	-	A0A212DIB2	133	K	Q
P68871	LB/B	-	A0A212DIB2	134	V	L
P68871	LB/B	-	A0A212DIB2	135	V	E
P68871	LB/B	-	A0A212DIB2	136	A	D
P68871	LB/B	-	A0A212DIB2	136	A	P
P68871	LB/B	-	A0A212DIB2	137	G	D
P68871	LB/B	-	A0A212DIB2	139	A	P
P68871	LB/B	-	A0A212DIB2	140	N	D
P68871	LB/B	-	A0A212DIB2	140	N	K
P68871	LB/B	-	A0A212DIB2	140	N	Y
P68871	LB/B	-	A0A212DIB2	141	A	D
P68871	LB/B	-	A0A212DIB2	141	A	T
P68871	LB/B	-	A0A212DIB2	141	A	V
P68871	LB/B	-	A0A212DIB2	142	L	R
P68871	LB/B	-	A0A212DIB2	143	A	D
P68871	LB/B	-	A0A212DIB2	144	H	D
P68871	LB/B	-	A0A212DIB2	144	H	Q
P68871	LB/B	-	A0A212DIB2	144	H	P
P68871	LB/B	-	A0A212DIB2	144	H	R
P68871	LB/B	-	A0A212DIB2	145	K	E
P68871	LB/B	-	A0A212DIB2	146	Y	C
P68871	LB/B	-	A0A212DIB2	146	Y	H
P68871	LB/B	-	A0A212DIB2	147	H	D
P68871	LB/B	-	A0A212DIB2	147	H	L
P68871	LB/B	-	A0A212DIB2	147	H	P
P68871	LB/B	-	A0A212DIB2	147	H	Q
P68871	LB/B	-	A0A212DIB2	115	L	M
P68871	LP/P	Beta-thalassemia (B-THAL) [MIM:613985]	A0A212DIB2	115	L	P
P68871	LB/B	-	A0A212DIB2	82	L	H
P68871	LB/B	-	A0A212DIB2	83	K	N
P68871	LB/B	-	A0A212DIB2	11	A	V
P68871	LB/B	-	A0A212DIB2	35	V	D
P68871	LB/B	-	A0A212DIB2	35	V	L
P68871	LB/B	-	A0A212DIB2	84	G	D
P68871	LB/B	-	A0A212DIB2	113	C	F
P68871	LB/B	-	A0A212DIB2	117	H	L
P68871	LB/B	-	A0A212DIB2	118	H	Y
P68871	LB/B	-	A0A212DIB2	29	L	Q
P68871	LB/B	-	A0A212DIB2	43	F	S
P68871	LB/B	-	A0A212DIB2	68	V	G
P68871	LB/B	-	A0A212DIB2	82	L	V
P02042	LB/B	-	A0A212DIB2	2	V	A
P02042	LB/B	-	A0A212DIB2	3	H	R
P02042	LB/B	-	A0A212DIB2	13	N	K
P02042	LB/B	-	A0A212DIB2	17	G	R
P02042	LB/B	-	A0A212DIB2	21	V	E
P02042	LB/B	-	A0A212DIB2	23	A	E
P02042	LB/B	-	A0A212DIB2	25	G	D
P02042	LB/B	-	A0A212DIB2	26	G	D
P02042	LB/B	-	A0A212DIB2	27	E	D
P02042	LB/B	-	A0A212DIB2	28	A	S
P02042	LB/B	-	A0A212DIB2	44	E	G
P02042	LB/B	-	A0A212DIB2	44	E	K
P02042	LB/B	-	A0A212DIB2	48	D	V
P02042	LB/B	-	A0A212DIB2	52	P	R
P02042	LB/B	-	A0A212DIB2	70	G	R
P02042	LB/B	-	A0A212DIB2	76	L	V
P02042	LB/B	-	A0A212DIB2	91	E	V
P02042	LB/B	-	A0A212DIB2	99	V	M
P02042	LB/B	-	A0A212DIB2	100	D	N
P02042	LB/B	-	A0A212DIB2	117	R	C
P02042	LB/B	-	A0A212DIB2	117	R	H
P02042	LB/B	-	A0A212DIB2	118	N	D
P02042	LB/B	-	A0A212DIB2	122	E	V
P02042	LB/B	-	A0A212DIB2	126	Q	E
P02042	LB/B	-	A0A212DIB2	137	G	D
P02042	LB/B	-	A0A212DIB2	142	L	P
P02042	LB/B	-	A0A212DIB2	143	A	D
P02042	LB/B	-	A0A212DIB2	94	C	G
P02042	LB/B	-	A0A212DIB2	147	H	R
P02042	LB/B	-	A0A212DIB2	5	T	I
P02042	LB/B	-	A0A212DIB2	5	T	S
P02042	LB/B	-	A0A212DIB2	3	H	L
P02042	LB/B	-	A0A212DIB2	12	V	G
P02042	LB/B	-	A0A212DIB2	37	P	H
P02042	LB/B	-	A0A212DIB2	58	N	K
P02042	LB/B	-	A0A212DIB2	71	A	G
P02042	LB/B	-	A0A212DIB2	86	F	S
P02042	LB/B	-	A0A212DIB2	88	Q	K
P02042	LB/B	-	A0A212DIB2	89	L	V
P02042	LB/B	-	A0A212DIB2	105	R	S
P02042	LB/B	-	A0A212DIB2	134	V	A
P02042	LB/B	-	A0A212DIB2	141	A	V
P69891	LB/B	-	P10060	3	H	Q
P69891	LB/B	-	P10060	6	E	K
P69891	LB/B	-	P10060	7	E	G
P69891	LB/B	-	P10060	7	E	Q
P69891	LB/B	-	P10060	13	T	R
P69891	LB/B	-	P10060	23	D	G
P69891	LB/B	-	P10060	26	G	R
P69891	LB/B	-	P10060	37	P	R
P69891	LB/B	-	P10060	38	W	G
P69891	LB/B	-	P10060	40	Q	R
P69891	LB/B	-	P10060	41	R	K
P69891	LB/B	-	P10060	44	D	N
P69891	LB/B	-	P10060	54	A	D
P69891	LB/B	-	P10060	62	K	E
P69891	LB/B	-	P10060	73	G	R
P69891	LB/B	-	P10060	74	D	N
P69891	LB/B	-	P10060	74	D	H
P69891	LB/B	-	P10060	76	I	T
P69891	LB/B	-	P10060	80	D	N
P69891	LB/B	-	P10060	81	D	Y
P69891	LB/B	-	P10060	81	D	N
P69891	LB/B	-	P10060	98	H	R
P69891	LB/B	-	P10060	122	E	K
P69891	LB/B	-	P10060	129	A	T
P69891	LB/B	-	P10060	135	V	M
P69892	LB/B	-	P10060	2	G	C
P69892	LB/B	-	P10060	6	E	G
P69892	LB/B	-	P10060	8	D	N
P69892	LB/B	-	P10060	16	W	R
P69892	LB/B	-	P10060	17	G	R
P69892	LB/B	-	P10060	22	E	K
P69892	LB/B	-	P10060	22	E	Q
P69892	LB/B	-	P10060	23	D	V
P69892	LB/B	-	P10060	26	G	E
P69892	LB/B	-	P10060	27	E	K
P69892	LB/B	-	P10060	35	V	I
P69892	LB/B	-	P10060	41	R	G
P69892	LP/P	Cyanosis transient neonatal (TNCY) [MIM:613977]	P10060	42	F	S
P69892	LB/B	-	P10060	45	S	R
P69892	LB/B	-	P10060	56	M	R
P69892	LB/B	-	P10060	60	K	E
P69892	LB/B	-	P10060	60	K	Q
P69892	LP/P	Cyanosis transient neonatal (TNCY) [MIM:613977]	P10060	64	H	Y
P69892	LB/B	-	P10060	66	K	N
P69892	LB/B	-	P10060	67	K	R
P69892	LB/B	-	P10060	67	K	Q
P69892	LB/B	-	P10060	78	H	R
P69892	LP/P	Cyanosis transient neonatal (TNCY) [MIM:613977]	P10060	93	H	Y
P69892	LB/B	-	P10060	95	D	N
P69892	LB/B	-	P10060	102	E	K
P69892	LB/B	-	P10060	105	K	N
P69892	LB/B	-	P10060	118	H	R
P69892	LB/B	-	P10060	121	K	Q
P69892	LB/B	-	P10060	126	E	A
P69892	LB/B	-	P10060	131	W	G
P69892	LB/B	-	P10060	147	H	Y
P69892	LB/B	-	P10060	119	F	L
P69892	LB/B	-	P10060	9	K	E
P69892	LB/B	-	P10060	9	K	Q
P69892	LB/B	-	P10060	13	T	R
P69892	LB/B	-	P10060	18	K	N
P69892	LB/B	-	P10060	20	N	K
P69892	LB/B	-	P10060	23	D	G
P69892	LB/B	-	P10060	41	R	K
P69892	LB/B	-	P10060	73	G	R
P69892	LB/B	-	P10060	76	I	T
P69892	LB/B	-	P10060	81	D	N
P69892	LB/B	-	P10060	122	E	K
P69892	LP/P	Cyanosis transient neonatal (TNCY) [MIM:613977]	P10060	64	H	L
P69892	LB/B	-	P10060	21	V	A
P69892	LB/B	-	P10060	39	T	P
P69892	LB/B	-	P10060	76	I	V
P69892	LP/P	Cyanosis transient neonatal (TNCY) [MIM:613977]	P10060	68	V	M
P69892	LP/P	Cyanosis transient neonatal (TNCY) [MIM:613977]	P10060	106	L	H
Q9Y450	LB/B	-	T2M2X7	440	G	S
Q9BXC0	LB/B	-	G3TUA1	43	H	Q
Q9BXC0	LB/B	-	G3TUA1	253	D	E
Q9BXC0	LB/B	-	G3TUA1	253	D	H
Q8TDS4	LB/B	-	G3TUA1	311	R	C
Q8TDS4	LB/B	-	G3TUA1	317	M	I
Q8TDS4	LB/B	-	G3TUA1	187	Q	R
Q8TDS4	LB/B	-	G3TUA1	198	F	L
P49019	LB/B	-	G3TUA1	173	T	P
P49019	LB/B	-	G3TUA1	198	F	L
P49019	LB/B	-	G3TUA1	253	H	R
P49019	LB/B	-	G3TUA1	317	I	M
P49019	LB/B	-	G3TUA1	346	I	M
P49019	LB/B	-	G3TUA1	350	G	S
P53701	LP/P	Linear skin defects with multiple congenital anomalies 1 (LSDMCA1) [MIM:309801]	A0A287BJQ4	217	R	C
P51610	LB/B	-	V8NZA6	1164	S	P
P51610	LB/B	-	V8NZA6	2004	S	I
Q9NWW0	LB/B	-	Q9CYQ5	92	P	Q
Q9Y5Z7	LB/B	-	R7V1A3	268	G	A
Q9Y5Z7	LB/B	-	R7V1A3	46	A	S
Q9P1Z3	LB/B	-	G1RVI6	630	P	L
Q6MZN7	LB/B	-	Q6MZN7	32	W	R
Q6MZN7	LB/B	-	Q6MZN7	82	W	C
Q6MZN7	LB/B	-	Q6MZN7	93	G	E
Q6MZN7	LB/B	-	Q6MZN7	112	V	G
Q6MZN7	LB/B	-	Q6MZN7	123	H	R
O43612	LP/P	Narcolepsy 1 (NRCLP1) [MIM:161400]	A0A1S3GYE2	16	L	R
O43614	LB/B	-	A0A218VCP3	10	P	S
O43614	LB/B	-	A0A218VCP3	11	P	T
O43614	LB/B	-	A0A218VCP3	293	I	V
O43614	LB/B	-	A0A218VCP3	308	I	V
Q969S8	LB/B	-	G5B2I1	429	V	I
O15379	LB/B	-	A0A1X0R7M8	411	N	S
Q9UQL6	LB/B	-	A0A091D4W5	137	R	Q
Q9UQL6	LB/B	-	A0A091D4W5	565	G	A
P51858	LB/B	-	G3WTY7	201	P	L
Q9H0R4	LB/B	-	T1EI66	85	R	Q
Q9BSH5	LB/B	-	S8CAX6	146	G	E
Q9BXW7	LB/B	-	F6XBN5	369	R	S
Q9BXW7	LB/B	-	F6XBN5	179	T	M
Q9BXW7	LB/B	-	F6XBN5	416	R	C
Q7Z4Q2	LB/B	-	A0A1S3GZM8	302	R	S
Q7Z4Q2	LP/P	Diamond-Blackfan anemia 21 (DBA21) [MIM:620072]	A0A1S3GZM8	446	C	Y
Q7Z4Q2	LP/P	Diamond-Blackfan anemia 21 (DBA21) [MIM:620072]	A0A1S3GZM8	584	G	E
Q86WZ0	LB/B	-	A0A1L8EZZ9	634	L	H
Q86WZ0	LB/B	-	A0A1L8EZZ9	643	W	G
Q86WZ0	LB/B	-	A0A1L8EZZ9	660	V	A
Q6AI08	LB/B	-	A0A2J7PU54	71	A	V
Q6AI08	LB/B	-	A0A2J7PU54	1006	S	L
Q9NRV9	LB/B	-	A0A151LYZ5	183	E	D
Q9Y5Z4	LB/B	-	A0A2R9C6L5	140	R	Q
Q9Y5Z4	LB/B	-	A0A2R9C6L5	191	E	A
Q9P2P5	LP/P	Neurodevelopmental disorder with hypotonia, seizures, and absent language (NDHSAL) [MIM:617268]	H3A600	1191	R	Q
Q9P2P5	LP/P	Neurodevelopmental disorder with hypotonia, seizures, and absent language (NDHSAL) [MIM:617268]	H3A600	1193	F	V
Q9P2P5	LP/P	Neurodevelopmental disorder with hypotonia, seizures, and absent language (NDHSAL) [MIM:617268]	H3A600	1330	R	W
Q9P2P5	LP/P	Neurodevelopmental disorder with hypotonia, seizures, and absent language (NDHSAL) [MIM:617268]	H3A600	1445	E	G
Q9ULI3	LB/B	-	A0A1U8C2U3	602	F	S
Q9ULI3	LB/B	-	A0A1U8C2U3	980	V	L
Q9ULI3	LB/B	-	A0A1U8C2U3	1039	M	T
Q9ULI3	LB/B	-	A0A1U8C2U3	145	Q	R
Q9ULI3	LB/B	-	A0A1U8C2U3	305	S	P
Q8NG08	LB/B	-	A0A226P6R7	172	E	K
Q8NG08	LB/B	-	A0A226P6R7	191	L	P
Q8NG08	LB/B	-	A0A226P6R7	267	L	F
Q8NG08	LB/B	-	A0A226P6R7	966	P	L
Q8NG08	LB/B	-	A0A226P6R7	980	T	I
Q8NG08	LB/B	-	A0A226P6R7	575	T	A
Q8TDG4	LB/B	-	A0A151P1F9	235	L	P
Q8TDG4	LB/B	-	A0A151P1F9	585	P	S
Q8TDG4	LB/B	-	A0A151P1F9	1094	V	M
Q8TDG4	LB/B	-	A0A151P1F9	35	V	E
Q9BYK8	LB/B	-	A0A091JTC9	788	S	N
Q9BYK8	LB/B	-	A0A091JTC9	1123	H	R
Q9BYK8	LB/B	-	A0A091JTC9	2016	P	L
Q9BYK8	LB/B	-	A0A091JTC9	2049	Q	E
Q9BYK8	LB/B	-	A0A091JTC9	1152	S	L
Q9BYK8	LB/B	-	A0A091JTC9	1308	V	L
Q9BYK8	LB/B	-	A0A091JTC9	1381	R	K
Q9BYK8	LB/B	-	A0A091JTC9	1821	L	R
Q9BYK8	LB/B	-	A0A091JTC9	1889	T	A
Q9BYK8	LB/B	-	A0A091JTC9	2170	T	M
Q9Y5R4	LB/B	-	T0NMV0	192	R	Q
Q9Y5R4	LB/B	-	T0NMV0	200	H	Q
Q5T8I9	LB/B	-	M3Y4S9	129	T	A
Q5T8I9	LB/B	-	M3Y4S9	230	R	Q
Q5T8I9	LB/B	-	M3Y4S9	361	M	I
Q14CZ8	LB/B	-	G1Q2G8	218	M	V
Q14CZ8	LP/P	Leukoencephalopathy, megalencephalic, with subcortical cysts, 2A (MLC2A) [MIM:613925]	G1Q2G8	23	L	H
Q14CZ8	LP/P	Megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without impaired intellectual development (MLC2B) [MIM:613926]	G1Q2G8	89	G	D
Q14CZ8	LP/P	Megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without impaired intellectual development (MLC2B) [MIM:613926]	G1Q2G8	89	G	S
Q14CZ8	LP/P	Leukoencephalopathy, megalencephalic, with subcortical cysts, 2A (MLC2A) [MIM:613925]	G1Q2G8	92	R	Q
Q14CZ8	LP/P	Megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without impaired intellectual development (MLC2B) [MIM:613926]	G1Q2G8	92	R	W
Q14CZ8	LP/P	Leukoencephalopathy, megalencephalic, with subcortical cysts, 2A (MLC2A) [MIM:613925]	G1Q2G8	98	R	C
Q14CZ8	LP/P	Megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without impaired intellectual development (MLC2B) [MIM:613926]	G1Q2G8	128	D	N
Q14CZ8	LP/P	Leukoencephalopathy, megalencephalic, with subcortical cysts, 2A (MLC2A) [MIM:613925]	G1Q2G8	148	P	S
Q14CZ8	LP/P	Leukoencephalopathy, megalencephalic, with subcortical cysts, 2A (MLC2A) [MIM:613925]	G1Q2G8	196	S	Y
Q14CZ8	LP/P	Leukoencephalopathy, megalencephalic, with subcortical cysts, 2A (MLC2A) [MIM:613925]	G1Q2G8	211	D	N
Q14CZ8	LP/P	Megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without impaired intellectual development (MLC2B) [MIM:613926]	G1Q2G8	288	R	C
A8MVW5	LB/B	-	A0A093HGW0	86	K	T
A8MVW5	LB/B	-	A0A093HGW0	114	F	L
Q9BQS7	LB/B	-	A0A1S3L330	595	A	T
Q6MZM0	LB/B	-	A0A1S3L330	251	N	D
Q6MZM0	LB/B	-	A0A1S3L330	381	R	C
Q6MZM0	LP/P	Abnormal hair, joint laxity, and developmental delay (HJDD) [MIM:261990]	A0A1S3L330	355	A	T
Q6MZM0	LP/P	Abnormal hair, joint laxity, and developmental delay (HJDD) [MIM:261990]	A0A1S3L330	1059	M	T
Q6WQI6	LB/B	-	A0A2K5DR50	37	W	R
Q15751	LB/B	-	A0A0Q3M6R5	1088	L	F
Q15751	LB/B	-	A0A0Q3M6R5	1278	L	F
Q15751	LB/B	-	A0A0Q3M6R5	1411	G	V
Q15751	LB/B	-	A0A0Q3M6R5	1447	H	N
Q15751	LB/B	-	A0A0Q3M6R5	1572	S	A
Q15751	LB/B	-	A0A0Q3M6R5	1696	G	A
Q15751	LB/B	-	A0A0Q3M6R5	1995	T	A
Q15751	LB/B	-	A0A0Q3M6R5	2220	I	V
Q15751	LB/B	-	A0A0Q3M6R5	2816	A	T
Q15751	LB/B	-	A0A0Q3M6R5	3152	S	F
Q15751	LB/B	-	A0A0Q3M6R5	3517	G	R
Q15751	LB/B	-	A0A0Q3M6R5	3722	E	D
Q15751	LB/B	-	A0A0Q3M6R5	4394	I	V
Q15751	LP/P	Macrocephaly, dysmorphic facies, and psychomotor retardation (MDFPMR) [MIM:617011]	A0A0Q3M6R5	4520	G	E
O95714	LP/P	Intellectual developmental disorder, autosomal recessive 38 (MRT38) [MIM:615516]	G3W6N5	594	P	L
Q15034	LB/B	-	A0A2I4AZH9	946	E	Q
Q9UII4	LB/B	-	A0A2I4AZH9	301	A	T
Q8IVU3	LB/B	-	A0A2I4AZH9	123	M	T
Q8IVU3	LB/B	-	A0A2I4AZH9	199	C	R
Q8IVU3	LB/B	-	A0A2I4AZH9	343	F	L
Q8IVU3	LB/B	-	A0A2I4AZH9	614	T	I
Q15011	LB/B	-	G1SYG9	50	R	H
Q9Y543	LB/B	-	H0XTX3	139	P	S
Q96HZ4	LB/B	-	K9IGT9	218	R	Q
Q9BYE0	LP/P	Spondylocostal dysostosis 4, autosomal recessive (SCDO4) [MIM:613686]	F7I1Z0	25	R	W
Q9BYE0	LP/P	Spondylocostal dysostosis 4, autosomal recessive (SCDO4) [MIM:613686]	F7I1Z0	58	I	V
Q9BYE0	LP/P	Spondylocostal dysostosis 4, autosomal recessive (SCDO4) [MIM:613686]	F7I1Z0	186	D	Y
Q9UBX0	LP/P	Septooptic dysplasia (SOD) [MIM:182230]	A0A1U7QNQ6	160	R	C
Q9UBX0	LB/B	-	A0A1U7QNQ6	125	N	S
Q9UBX0	LP/P	Pituitary hormone deficiency, combined, 5 (CPHD5) [MIM:182230]	A0A1U7QNQ6	6	Q	H
Q9UBX0	LP/P	Pituitary hormone deficiency, combined, 5 (CPHD5) [MIM:182230]	A0A1U7QNQ6	26	I	T
Q9UBX0	LP/P	Growth hormone deficiency with pituitary anomalies (GHDPA) [MIM:182230]	A0A1U7QNQ6	149	E	K
Q9UBX0	LP/P	Septooptic dysplasia (SOD) [MIM:182230]	A0A1U7QNQ6	170	S	L
Q9UBX0	LP/P	Growth hormone deficiency with pituitary anomalies (GHDPA) [MIM:182230]	A0A1U7QNQ6	181	T	A
P06865	LP/P	GM2-gangliosidosis 1 (GM2G1) [MIM:272800]	G1PPV3	25	P	S
P06865	LP/P	GM2-gangliosidosis 1 (GM2G1) [MIM:272800]	G1PPV3	39	L	R
P06865	LP/P	GM2-gangliosidosis 1 (GM2G1) [MIM:272800]	G1PPV3	127	L	R
P06865	LP/P	GM2-gangliosidosis 1 (GM2G1) [MIM:272800]	G1PPV3	166	R	G
P06865	LP/P	GM2-gangliosidosis 1 (GM2G1) [MIM:272800]	G1PPV3	170	R	Q
P06865	LP/P	GM2-gangliosidosis 1 (GM2G1) [MIM:272800]	G1PPV3	170	R	W
P06865	LP/P	GM2-gangliosidosis 1 (GM2G1) [MIM:272800]	G1PPV3	178	R	C
P06865	LP/P	GM2-gangliosidosis 1 (GM2G1) [MIM:272800]	G1PPV3	178	R	H
P06865	LP/P	GM2-gangliosidosis 1 (GM2G1) [MIM:272800]	G1PPV3	178	R	L
P06865	LP/P	GM2-gangliosidosis 1 (GM2G1) [MIM:272800]	G1PPV3	180	Y	H
P06865	LP/P	GM2-gangliosidosis 1 (GM2G1) [MIM:272800]	G1PPV3	192	V	L
P06865	LP/P	GM2-gangliosidosis 1 (GM2G1) [MIM:272800]	G1PPV3	196	N	S
P06865	LP/P	GM2-gangliosidosis 1 (GM2G1) [MIM:272800]	G1PPV3	197	K	T
P06865	LP/P	GM2-gangliosidosis 1 (GM2G1) [MIM:272800]	G1PPV3	200	V	M
P06865	LP/P	GM2-gangliosidosis 1 (GM2G1) [MIM:272800]	G1PPV3	204	H	R
P06865	LP/P	GM2-gangliosidosis 1 (GM2G1) [MIM:272800]	G1PPV3	210	S	F
P06865	LP/P	GM2-gangliosidosis 1 (GM2G1) [MIM:272800]	G1PPV3	211	F	S
P06865	LB/B	-	G1PPV3	247	R	W
P06865	LB/B	-	G1PPV3	249	R	W
P06865	LP/P	GM2-gangliosidosis 1 (GM2G1) [MIM:272800]	G1PPV3	250	G	D
P06865	LP/P	GM2-gangliosidosis 1 (GM2G1) [MIM:272800]	G1PPV3	250	G	S
P06865	LP/P	GM2-gangliosidosis 1 (GM2G1) [MIM:272800]	G1PPV3	252	R	H
P06865	LP/P	GM2-gangliosidosis 1 (GM2G1) [MIM:272800]	G1PPV3	258	D	H
P06865	LP/P	GM2-gangliosidosis 1 (GM2G1) [MIM:272800]	G1PPV3	269	G	S
P06865	LP/P	GM2-gangliosidosis 1 (GM2G1) [MIM:272800]	G1PPV3	279	S	P
P06865	LP/P	GM2-gangliosidosis 1 (GM2G1) [MIM:272800]	G1PPV3	301	M	R
P06865	LP/P	GM2-gangliosidosis 1 (GM2G1) [MIM:272800]	G1PPV3	335	I	F
P06865	LP/P	GM2-gangliosidosis 1 (GM2G1) [MIM:272800]	G1PPV3	391	V	M
P06865	LB/B	-	G1PPV3	399	N	D
P06865	LP/P	GM2-gangliosidosis 1 (GM2G1) [MIM:272800]	G1PPV3	420	W	C
P06865	LB/B	-	G1PPV3	436	I	V
P06865	LP/P	GM2-gangliosidosis 1 (GM2G1) [MIM:272800]	G1PPV3	454	G	S
P06865	LP/P	GM2-gangliosidosis 1 (GM2G1) [MIM:272800]	G1PPV3	455	G	R
P06865	LP/P	GM2-gangliosidosis 1 (GM2G1) [MIM:272800]	G1PPV3	458	C	Y
P06865	LP/P	GM2-gangliosidosis 1 (GM2G1) [MIM:272800]	G1PPV3	474	W	C
P06865	LP/P	GM2-gangliosidosis 1 (GM2G1) [MIM:272800]	G1PPV3	482	E	K
P06865	LP/P	GM2-gangliosidosis 1 (GM2G1) [MIM:272800]	G1PPV3	484	L	Q
P06865	LP/P	GM2-gangliosidosis 1 (GM2G1) [MIM:272800]	G1PPV3	485	W	R
P06865	LP/P	GM2-gangliosidosis 1 (GM2G1) [MIM:272800]	G1PPV3	499	R	C
P06865	LP/P	GM2-gangliosidosis 1 (GM2G1) [MIM:272800]	G1PPV3	499	R	H
P06865	LP/P	GM2-gangliosidosis 1 (GM2G1) [MIM:272800]	G1PPV3	504	R	C
P06865	LP/P	GM2-gangliosidosis 1 (GM2G1) [MIM:272800]	G1PPV3	504	R	H
P06865	LP/P	GM2-gangliosidosis 1 (GM2G1) [MIM:272800]	G1PPV3	252	R	L
P06865	LP/P	GM2-gangliosidosis 1 (GM2G1) [MIM:272800]	G1PPV3	295	N	S
P06865	LP/P	GM2-gangliosidosis 1 (GM2G1) [MIM:272800]	G1PPV3	127	L	F
P06865	LP/P	GM2-gangliosidosis 1 (GM2G1) [MIM:272800]	G1PPV3	226	S	F
P06865	LP/P	GM2-gangliosidosis 1 (GM2G1) [MIM:272800]	G1PPV3	269	G	D
P06865	LP/P	GM2-gangliosidosis 1 (GM2G1) [MIM:272800]	G1PPV3	314	D	V
P06865	LB/B	-	G1PPV3	293	S	I
P06865	LP/P	GM2-gangliosidosis 1 (GM2G1) [MIM:272800]	G1PPV3	322	D	N
P06865	LP/P	GM2-gangliosidosis 1 (GM2G1) [MIM:272800]	G1PPV3	322	D	Y
P06865	LP/P	GM2-gangliosidosis 1 (GM2G1) [MIM:272800]	G1PPV3	393	R	P
P06865	LP/P	GM2-gangliosidosis 1 (GM2G1) [MIM:272800]	G1PPV3	462	E	V
P06865	LP/P	GM2-gangliosidosis 1 (GM2G1) [MIM:272800]	G1PPV3	478	G	R
P07686	LP/P	GM2-gangliosidosis 2 (GM2G2) [MIM:268800]	A0A2Y9JLC6	62	L	S
P07686	LB/B	-	A0A2Y9JLC6	121	K	R
P07686	LB/B	-	A0A2Y9JLC6	207	I	V
P07686	LP/P	GM2-gangliosidosis 2 (GM2G2) [MIM:268800]	A0A2Y9JLC6	309	C	Y
P07686	LP/P	GM2-gangliosidosis 2 (GM2G2) [MIM:268800]	A0A2Y9JLC6	417	P	L
P07686	LP/P	GM2-gangliosidosis 2 (GM2G2) [MIM:268800]	A0A2Y9JLC6	456	Y	S
P07686	LP/P	GM2-gangliosidosis 2 (GM2G2) [MIM:268800]	A0A2Y9JLC6	505	R	Q
P07686	LP/P	GM2-gangliosidosis 2 (GM2G2) [MIM:268800]	A0A2Y9JLC6	534	C	Y
P07686	LP/P	GM2-gangliosidosis 2 (GM2G2) [MIM:268800]	A0A2Y9JLC6	255	S	R
P07686	LP/P	GM2-gangliosidosis 2 (GM2G2) [MIM:268800]	A0A2Y9JLC6	504	P	S
P07686	LP/P	GM2-gangliosidosis 2 (GM2G2) [MIM:268800]	A0A2Y9JLC6	543	A	T
Q8WVB3	LB/B	-	F7BFL1	145	I	V
Q8WVB3	LB/B	-	F7BFL1	232	H	Y
Q9UBP5	LB/B	-	U3I5Y0	96	T	A
Q9UBP5	LB/B	-	U3I5Y0	140	V	M
Q9NQ87	LB/B	-	G1SDJ4	47	H	R
Q30201	LB/B	-	A0A287BPR3	63	H	D
Q30201	LP/P	Hemochromatosis 1 (HFE1) [MIM:235200]	A0A287BPR3	65	S	C
Q30201	LP/P	Hemochromatosis 1 (HFE1) [MIM:235200]	A0A287BPR3	282	C	Y
Q30201	LB/B	-	A0A287BPR3	53	V	M
Q30201	LB/B	-	A0A287BPR3	59	V	M
Q30201	LP/P	Hemochromatosis 1 (HFE1) [MIM:235200]	A0A287BPR3	127	Q	H
Q30201	LP/P	Hemochromatosis 1 (HFE1) [MIM:235200]	A0A287BPR3	330	R	M
Q30201	LP/P	Hemochromatosis 1 (HFE1) [MIM:235200]	A0A287BPR3	93	G	R
Q30201	LP/P	Hemochromatosis 1 (HFE1) [MIM:235200]	A0A287BPR3	105	I	T
Q30201	LB/B	-	A0A287BPR3	277	E	K
Q30201	LB/B	-	A0A287BPR3	217	T	I
Q30201	LP/P	Hemochromatosis 1 (HFE1) [MIM:235200]	A0A287BPR3	283	Q	P
Q30201	LP/P	Hemochromatosis 1 (HFE1) [MIM:235200]	A0A287BPR3	43	G	D
Q30201	LP/P	Hemochromatosis 1 (HFE1) [MIM:235200]	A0A287BPR3	66	R	C
Q30201	LP/P	Hemochromatosis 1 (HFE1) [MIM:235200]	A0A287BPR3	224	R	G
Q30201	LP/P	Hemochromatosis 1 (HFE1) [MIM:235200]	A0A287BPR3	295	V	A
Q30201	LB/B	-	A0A287BPR3	224	R	Q
A2PYH4	LB/B	-	A0A1U8D2R7	115	S	P
A2PYH4	LB/B	-	A0A1U8D2R7	117	I	V
A2PYH4	LB/B	-	A0A1U8D2R7	939	I	V
A2PYH4	LP/P	Premature ovarian failure 9 (POF9) [MIM:615724]	A0A1U8D2R7	736	G	S
A2PYH4	LP/P	Premature ovarian failure 9 (POF9) [MIM:615724]	A0A1U8D2R7	884	I	S
P14210	LB/B	-	G3HGQ6	304	E	K
P14210	LB/B	-	G3HGQ6	330	D	Y
Q04756	LB/B	-	L9KJT5	509	R	H
Q04756	LB/B	-	L9KJT5	644	R	Q
Q04756	LB/B	-	L9KJT5	225	V	M
Q04756	LB/B	-	L9KJT5	231	F	L
Q04756	LB/B	-	L9KJT5	218	A	S
Q68CP4	LP/P	Mucopolysaccharidosis 3C (MPS3C) [MIM:252930]	I3JQL1	311	P	L
Q68CP4	LP/P	Mucopolysaccharidosis 3C (MPS3C) [MIM:252930]	I3JQL1	372	R	C
Q68CP4	LP/P	Mucopolysaccharidosis 3C (MPS3C) [MIM:252930]	I3JQL1	452	G	S
Q68CP4	LP/P	Mucopolysaccharidosis 3C (MPS3C) [MIM:252930]	I3JQL1	499	E	K
Q68CP4	LP/P	Mucopolysaccharidosis 3C (MPS3C) [MIM:252930]	I3JQL1	510	M	K
Q68CP4	LP/P	Mucopolysaccharidosis 3C (MPS3C) [MIM:252930]	I3JQL1	569	S	L
Q68CP4	LP/P	Mucopolysaccharidosis 3C (MPS3C) [MIM:252930]	I3JQL1	590	D	V
Q68CP4	LP/P	Mucopolysaccharidosis 3C (MPS3C) [MIM:252930]	I3JQL1	599	P	L
Q68CP4	LP/P	Mucopolysaccharidosis 3C (MPS3C) [MIM:252930]	I3JQL1	104	C	F
Q68CP4	LP/P	Mucopolysaccharidosis 3C (MPS3C) [MIM:252930]	I3JQL1	165	L	P
Q68CP4	LB/B	-	I3JQL1	265	P	Q
Q68CP4	LP/P	Mucopolysaccharidosis 3C (MPS3C) [MIM:252930]	I3JQL1	280	I	R
Q68CP4	LP/P	Mucopolysaccharidosis 3C (MPS3C) [MIM:252930]	I3JQL1	290	G	R
Q68CP4	LP/P	Mucopolysaccharidosis 3C (MPS3C) [MIM:252930]	I3JQL1	301	N	K
Q68CP4	LP/P	Mucopolysaccharidosis 3C (MPS3C) [MIM:252930]	I3JQL1	372	R	H
Q68CP4	LP/P	Mucopolysaccharidosis 3C (MPS3C) [MIM:252930]	I3JQL1	431	W	C
Q68CP4	LB/B	-	I3JQL1	509	V	L
Q68CP4	LP/P	Mucopolysaccharidosis 3C (MPS3C) [MIM:252930]	I3JQL1	514	G	E
Q68CP4	LP/P	Mucopolysaccharidosis 3C (MPS3C) [MIM:252930]	I3JQL1	517	A	E
Q68CP4	LP/P	Mucopolysaccharidosis 3C (MPS3C) [MIM:252930]	I3JQL1	546	S	F
Q68CP4	LB/B	-	I3JQL1	551	K	Q
Q68CP4	LP/P	Mucopolysaccharidosis 3C (MPS3C) [MIM:252930]	I3JQL1	567	S	C
Q68CP4	LP/P	Mucopolysaccharidosis 3C (MPS3C) [MIM:252930]	I3JQL1	82	A	V
Q68CP4	LP/P	Mucopolysaccharidosis 3C (MPS3C) [MIM:252930]	I3JQL1	141	L	P
Q68CP4	LP/P	Retinitis pigmentosa 73 (RP73) [MIM:616544]	I3JQL1	152	R	W
Q68CP4	LP/P	Retinitis pigmentosa 73 (RP73) [MIM:616544]	I3JQL1	161	G	A
Q68CP4	LP/P	Mucopolysaccharidosis 3C (MPS3C) [MIM:252930]	I3JQL1	452	G	V
Q68CP4	LP/P	Mucopolysaccharidosis 3C (MPS3C) [MIM:252930]	I3JQL1	473	L	P
Q5VTY9	LB/B	-	A0A1W4Z4Z2	182	S	N
Q5VTY9	LB/B	-	A0A1W4Z4Z2	165	E	G
Q5VTY9	LB/B	-	A0A1W4Z4Z2	188	C	R
Q5VTY9	LP/P	Nivelon-Nivelon-Mabille syndrome (NNMS) [MIM:600092]	A0A1W4Z4Z2	287	G	V
Q9HCP6	LB/B	-	A0A2I4AQ70	403	M	V
Q96JK4	LB/B	-	A0A146YIB4	692	V	A
Q6UWX4	LB/B	-	H2RXM1	241	V	M
Q6UWX4	LB/B	-	H2RXM1	391	H	D
Q6UWX4	LB/B	-	H2RXM1	394	R	Q
Q6UWX4	LB/B	-	H2RXM1	434	R	L
Q9UM44	LB/B	-	A0A2Y9SCG1	30	I	T
Q9UM44	LB/B	-	A0A2Y9SCG1	344	N	K
Q9UM44	LB/B	-	A0A2Y9SCG1	364	S	R
Q6NVY1	LB/B	-	A0A151JQI3	46	T	A
Q6NVY1	LP/P	3-hydroxyisobutryl-CoA hydrolase deficiency (HIBCHD) [MIM:250620]	A0A151JQI3	122	Y	C
Q9NWT6	LB/B	-	A0A2K6CQ80	41	P	A
Q9Y2N7	LB/B	-	M3WK84	343	Q	R
Q9Y2N7	LB/B	-	M3WK84	463	F	L
Q9P298	LB/B	-	G5BJ05	86	S	N
Q9P298	LB/B	-	G5BJ05	87	D	N
Q53FT3	LB/B	-	T1K1V8	47	P	A
Q53FT3	LP/P	Leukodystrophy, hypomyelinating, 13 (HLD13) [MIM:616881]	T1K1V8	54	V	L
Q9BQA5	LB/B	-	G5BHN8	493	A	V
Q9BQA5	LB/B	-	G5BHN8	4	P	S
Q9BQA5	LB/B	-	G5BHN8	78	S	C
Q9BQA5	LB/B	-	G5BHN8	352	K	R
P49773	LP/P	Neuromyotonia and axonal neuropathy, autosomal recessive (NMAN) [MIM:137200]	A0A2P8Z914	37	R	P
P49773	LP/P	Neuromyotonia and axonal neuropathy, autosomal recessive (NMAN) [MIM:137200]	A0A2P8Z914	51	H	R
P49773	LP/P	Neuromyotonia and axonal neuropathy, autosomal recessive (NMAN) [MIM:137200]	A0A2P8Z914	84	C	R
P49773	LP/P	Neuromyotonia and axonal neuropathy, autosomal recessive (NMAN) [MIM:137200]	A0A2P8Z914	89	G	V
P49773	LP/P	Neuromyotonia and axonal neuropathy, autosomal recessive (NMAN) [MIM:137200]	A0A2P8Z914	93	G	D
P49773	LP/P	Neuromyotonia and axonal neuropathy, autosomal recessive (NMAN) [MIM:137200]	A0A2P8Z914	112	H	N
Q9NQE9	LB/B	-	A0A2Y9FXE0	36	G	A
O00291	LB/B	-	L7M6R8	263	M	K
Q86Z02	LB/B	-	Q5XGV3	310	G	C
Q86Z02	LB/B	-	Q5XGV3	1165	L	V
Q86Z02	LB/B	-	Q5XGV3	6	Q	R
Q9H2X6	LB/B	-	Q5XGV3	792	R	Q
Q9H2X6	LB/B	-	Q5XGV3	1027	R	Q
Q9H422	LB/B	-	A0A096LXY8	142	Q	R
Q9H422	LB/B	-	A0A096LXY8	170	G	E
Q9H422	LB/B	-	A0A096LXY8	191	C	R
Q9H422	LB/B	-	A0A096LXY8	500	S	N
Q9H422	LB/B	-	A0A096LXY8	729	P	L
Q9H422	LB/B	-	A0A096LXY8	474	V	I
Q9BW71	LB/B	-	L9KV69	521	G	W
Q9BW71	LB/B	-	L9KV69	496	A	V
P15822	LB/B	-	A0A0A0ADN4	187	T	M
P15822	LB/B	-	A0A0A0ADN4	362	P	L
P15822	LB/B	-	A0A0A0ADN4	716	T	A
P15822	LB/B	-	A0A0A0ADN4	828	V	I
P15822	LB/B	-	A0A0A0ADN4	873	A	T
P15822	LB/B	-	A0A0A0ADN4	1074	N	S
P15822	LB/B	-	A0A0A0ADN4	1170	K	N
P15822	LB/B	-	A0A0A0ADN4	1520	A	G
P15822	LB/B	-	A0A0A0ADN4	1609	M	I
P15822	LB/B	-	A0A0A0ADN4	1915	Q	R
P15822	LB/B	-	A0A0A0ADN4	2444	T	M
P15822	LB/B	-	A0A0A0ADN4	2692	A	G
Q5T1R4	LB/B	-	A0A1A8N4W5	35	V	I
Q5T1R4	LB/B	-	A0A1A8N4W5	575	H	R
Q5T1R4	LB/B	-	A0A1A8N4W5	1087	Q	H
Q5T1R4	LB/B	-	A0A1A8N4W5	2023	A	P
Q5T1R4	LB/B	-	A0A1A8N4W5	2109	D	A
Q5T1R4	LB/B	-	A0A1A8N4W5	2272	G	R
Q5T1R4	LB/B	-	A0A1A8N4W5	2339	T	A
Q5T1R4	LB/B	-	A0A1A8N4W5	2348	P	L
Q6ZVN8	LP/P	Hemochromatosis 2A (HFE2A) [MIM:602390]	H2LIE1	80	C	R
Q6ZVN8	LP/P	Hemochromatosis 2A (HFE2A) [MIM:602390]	H2LIE1	85	S	P
Q6ZVN8	LP/P	Hemochromatosis 2A (HFE2A) [MIM:602390]	H2LIE1	99	G	R
Q6ZVN8	LP/P	Hemochromatosis 2A (HFE2A) [MIM:602390]	H2LIE1	101	L	P
Q6ZVN8	LP/P	Hemochromatosis 2A (HFE2A) [MIM:602390]	H2LIE1	168	A	D
Q6ZVN8	LP/P	Hemochromatosis 2A (HFE2A) [MIM:602390]	H2LIE1	170	F	S
Q6ZVN8	LP/P	Hemochromatosis 2A (HFE2A) [MIM:602390]	H2LIE1	172	D	E
Q6ZVN8	LP/P	Hemochromatosis 2A (HFE2A) [MIM:602390]	H2LIE1	191	W	C
Q6ZVN8	LP/P	Hemochromatosis 2A (HFE2A) [MIM:602390]	H2LIE1	205	S	R
Q6ZVN8	LP/P	Hemochromatosis 2A (HFE2A) [MIM:602390]	H2LIE1	222	I	N
Q6ZVN8	LP/P	Hemochromatosis 2A (HFE2A) [MIM:602390]	H2LIE1	250	G	V
Q6ZVN8	LP/P	Hemochromatosis 2A (HFE2A) [MIM:602390]	H2LIE1	288	R	W
Q6ZVN8	LP/P	Hemochromatosis 2A (HFE2A) [MIM:602390]	H2LIE1	320	G	V
Q6ZVN8	LP/P	Hemochromatosis 2A (HFE2A) [MIM:602390]	H2LIE1	321	C	W
Q6ZVN8	LB/B	-	H2LIE1	310	A	G
P19367	LP/P	Hexokinase deficiency (HK deficiency) [MIM:235700]	A0A2I3GFD7	529	L	S
P19367	LP/P	Hexokinase deficiency (HK deficiency) [MIM:235700]	A0A2I3GFD7	680	T	S
P19367	LB/B	-	A0A2I3GFD7	776	L	M
P19367	LP/P	Neurodevelopmental disorder with visual defects and brain anomalies (NEDVIBA) [MIM:618547]	A0A2I3GFD7	414	G	E
P19367	LP/P	Neurodevelopmental disorder with visual defects and brain anomalies (NEDVIBA) [MIM:618547]	A0A2I3GFD7	418	K	E
P19367	LP/P	Neurodevelopmental disorder with visual defects and brain anomalies (NEDVIBA) [MIM:618547]	A0A2I3GFD7	445	S	L
P19367	LP/P	Neurodevelopmental disorder with visual defects and brain anomalies (NEDVIBA) [MIM:618547]	A0A2I3GFD7	457	T	M
P52789	LB/B	-	A0A2I3GFD7	142	Q	H
P52789	LB/B	-	A0A2I3GFD7	148	L	F
P52789	LB/B	-	A0A2I3GFD7	314	A	V
P52789	LB/B	-	A0A2I3GFD7	353	R	C
P52789	LB/B	-	A0A2I3GFD7	497	R	Q
P52789	LB/B	-	A0A2I3GFD7	775	R	Q
P52789	LB/B	-	A0A2I3GFD7	844	R	K
P52789	LB/B	-	A0A2I3GFD7	274	R	C
P52789	LB/B	-	A0A2I3GFD7	314	A	P
P52789	LB/B	-	A0A2I3GFD7	331	T	I
P52789	LB/B	-	A0A2I3GFD7	387	A	S
P52789	LB/B	-	A0A2I3GFD7	801	R	Q
P52789	LB/B	-	A0A2I3GFD7	881	D	N
Q2TB90	LB/B	-	A0A2I3GFD7	54	D	G
Q2TB90	LB/B	-	A0A2I3GFD7	124	T	I
Q2TB90	LB/B	-	A0A2I3GFD7	204	L	P
Q2TB90	LB/B	-	A0A2I3GFD7	721	W	R
Q2TB90	LB/B	-	A0A2I3GFD7	917	N	K
P01889	LB/B	-	A0A2K5DCC3	2	L	R
P01889	LB/B	-	A0A2K5DCC3	4	M	T
P01889	LB/B	-	A0A2K5DCC3	9	V	L
P01889	LB/B	-	A0A2K5DCC3	14	S	W
P01889	LB/B	-	A0A2K5DCC3	15	A	G
P01889	LB/B	-	A0A2K5DCC3	17	L	V
P01889	LB/B	-	A0A2K5DCC3	33	Y	D
P01889	LB/B	-	A0A2K5DCC3	33	Y	H
P01889	LB/B	-	A0A2K5DCC3	35	S	A
P01889	LB/B	-	A0A2K5DCC3	36	V	M
P01889	LB/B	-	A0A2K5DCC3	48	S	A
P01889	LB/B	-	A0A2K5DCC3	48	S	T
P01889	LB/B	-	A0A2K5DCC3	54	D	G
P01889	LB/B	-	A0A2K5DCC3	56	Q	L
P01889	LB/B	-	A0A2K5DCC3	65	A	T
P01889	LB/B	-	A0A2K5DCC3	69	E	G
P01889	LB/B	-	A0A2K5DCC3	69	E	K
P01889	LB/B	-	A0A2K5DCC3	69	E	M
P01889	LB/B	-	A0A2K5DCC3	69	E	T
P01889	LB/B	-	A0A2K5DCC3	70	E	A
P01889	LB/B	-	A0A2K5DCC3	76	I	V
P01889	LB/B	-	A0A2K5DCC3	86	R	G
P01889	LB/B	-	A0A2K5DCC3	87	N	E
P01889	LB/B	-	A0A2K5DCC3	89	Q	R
P01889	LB/B	-	A0A2K5DCC3	90	I	K
P01889	LB/B	-	A0A2K5DCC3	90	I	N
P01889	LB/B	-	A0A2K5DCC3	91	Y	C
P01889	LB/B	-	A0A2K5DCC3	91	Y	F
P01889	LB/B	-	A0A2K5DCC3	91	Y	M
P01889	LB/B	-	A0A2K5DCC3	91	Y	S
P01889	LB/B	-	A0A2K5DCC3	93	A	R
P01889	LB/B	-	A0A2K5DCC3	93	A	T
P01889	LB/B	-	A0A2K5DCC3	94	Q	K
P01889	LB/B	-	A0A2K5DCC3	94	Q	N
P01889	LB/B	-	A0A2K5DCC3	94	Q	S
P01889	LB/B	-	A0A2K5DCC3	95	A	T
P01889	LB/B	-	A0A2K5DCC3	98	D	Y
P01889	LB/B	-	A0A2K5DCC3	100	E	V
P01889	LB/B	-	A0A2K5DCC3	101	S	D
P01889	LB/B	-	A0A2K5DCC3	101	S	G
P01889	LB/B	-	A0A2K5DCC3	101	S	N
P01889	LB/B	-	A0A2K5DCC3	104	N	I
P01889	LB/B	-	A0A2K5DCC3	104	N	T
P01889	LB/B	-	A0A2K5DCC3	105	L	A
P01889	LB/B	-	A0A2K5DCC3	106	R	L
P01889	LB/B	-	A0A2K5DCC3	107	G	R
P01889	LB/B	-	A0A2K5DCC3	114	A	D
P01889	LB/B	-	A0A2K5DCC3	118	T	I
P01889	LB/B	-	A0A2K5DCC3	119	L	I
P01889	LB/B	-	A0A2K5DCC3	119	L	W
P01889	LB/B	-	A0A2K5DCC3	121	S	N
P01889	LB/B	-	A0A2K5DCC3	121	S	R
P01889	LB/B	-	A0A2K5DCC3	121	S	T
P01889	LB/B	-	A0A2K5DCC3	121	S	V
P01889	LB/B	-	A0A2K5DCC3	121	S	W
P01889	LB/B	-	A0A2K5DCC3	123	Y	F
P01889	LB/B	-	A0A2K5DCC3	123	Y	S
P01889	LB/B	-	A0A2K5DCC3	127	V	L
P01889	LB/B	-	A0A2K5DCC3	127	V	M
P01889	LB/B	-	A0A2K5DCC3	137	H	Y
P01889	LB/B	-	A0A2K5DCC3	138	D	H
P01889	LB/B	-	A0A2K5DCC3	138	D	N
P01889	LB/B	-	A0A2K5DCC3	140	Y	D
P01889	LB/B	-	A0A2K5DCC3	140	Y	F
P01889	LB/B	-	A0A2K5DCC3	140	Y	L
P01889	LB/B	-	A0A2K5DCC3	140	Y	S
P01889	LB/B	-	A0A2K5DCC3	155	R	S
P01889	LB/B	-	A0A2K5DCC3	167	T	S
P01889	LB/B	-	A0A2K5DCC3	169	R	L
P01889	LB/B	-	A0A2K5DCC3	171	W	L
P01889	LB/B	-	A0A2K5DCC3	176	E	V
P01889	LB/B	-	A0A2K5DCC3	180	R	D
P01889	LB/B	-	A0A2K5DCC3	180	R	L
P01889	LB/B	-	A0A2K5DCC3	180	R	W
P01889	LB/B	-	A0A2K5DCC3	182	A	T
P01889	LB/B	-	A0A2K5DCC3	186	G	D
P01889	LB/B	-	A0A2K5DCC3	187	E	L
P01889	LB/B	-	A0A2K5DCC3	187	E	T
P01889	LB/B	-	A0A2K5DCC3	191	W	S
P01889	LB/B	-	A0A2K5DCC3	195	Y	H
P01889	LB/B	-	A0A2K5DCC3	201	D	E
P01889	LB/B	-	A0A2K5DCC3	202	K	T
P01889	LB/B	-	A0A2K5DCC3	204	E	Q
P01889	LB/B	-	A0A2K5DCC3	218	I	V
P01889	LB/B	-	A0A2K5DCC3	223	A	V
P01889	LB/B	-	A0A2K5DCC3	263	R	G
P01889	LB/B	-	A0A2K5DCC3	269	A	T
P01889	LB/B	-	A0A2K5DCC3	277	E	Q
P01889	LB/B	-	A0A2K5DCC3	291	P	Q
P01889	LB/B	-	A0A2K5DCC3	292	K	E
P01889	LB/B	-	A0A2K5DCC3	294	L	C
P01889	LB/B	-	A0A2K5DCC3	299	E	K
P01889	LB/B	-	A0A2K5DCC3	306	V	I
P01889	LB/B	-	A0A2K5DCC3	329	A	T
P01889	LB/B	-	A0A2K5DCC3	331	M	V
P01889	LB/B	-	A0A2K5DCC3	349	C	S
P10321	LB/B	-	A0A2K4X4G7	7	R	Q
P10321	LB/B	-	A0A2K4X4G7	8	A	T
P10321	LB/B	-	A0A2K4X4G7	10	L	I
P10321	LB/B	-	A0A2K4X4G7	16	G	A
P10321	LB/B	-	A0A2K4X4G7	20	T	I
P10321	LB/B	-	A0A2K4X4G7	25	C	G
P10321	LB/B	-	A0A2K4X4G7	30	R	K
P10321	LB/B	-	A0A2K4X4G7	33	D	F
P10321	LB/B	-	A0A2K4X4G7	33	D	S
P10321	LB/B	-	A0A2K4X4G7	33	D	Y
P10321	LB/B	-	A0A2K4X4G7	35	A	S
P10321	LB/B	-	A0A2K4X4G7	38	R	W
P10321	LB/B	-	A0A2K4X4G7	40	G	S
P10321	LB/B	-	A0A2K4X4G7	45	R	H
P10321	LB/B	-	A0A2K4X4G7	48	S	A
P10321	LB/B	-	A0A2K4X4G7	59	R	Q
P10321	LB/B	-	A0A2K4X4G7	73	A	E
P10321	LB/B	-	A0A2K4X4G7	90	K	N
P10321	LB/B	-	A0A2K4X4G7	97	A	T
P10321	LB/B	-	A0A2K4X4G7	101	S	N
P10321	LB/B	-	A0A2K4X4G7	104	N	K
P10321	LB/B	-	A0A2K4X4G7	114	D	A
P10321	LB/B	-	A0A2K4X4G7	118	T	I
P10321	LB/B	-	A0A2K4X4G7	119	L	F
P10321	LB/B	-	A0A2K4X4G7	119	L	I
P10321	LB/B	-	A0A2K4X4G7	121	R	W
P10321	LB/B	-	A0A2K4X4G7	123	S	C
P10321	LB/B	-	A0A2K4X4G7	123	S	F
P10321	LB/B	-	A0A2K4X4G7	123	S	Y
P10321	LB/B	-	A0A2K4X4G7	127	L	V
P10321	LB/B	-	A0A2K4X4G7	137	Y	H
P10321	LB/B	-	A0A2K4X4G7	138	D	N
P10321	LB/B	-	A0A2K4X4G7	140	S	F
P10321	LB/B	-	A0A2K4X4G7	140	S	L
P10321	LB/B	-	A0A2K4X4G7	140	S	Y
P10321	LB/B	-	A0A2K4X4G7	162	T	K
P10321	LB/B	-	A0A2K4X4G7	167	T	S
P10321	LB/B	-	A0A2K4X4G7	171	L	W
P10321	LB/B	-	A0A2K4X4G7	176	A	E
P10321	LB/B	-	A0A2K4X4G7	176	A	T
P10321	LB/B	-	A0A2K4X4G7	180	L	D
P10321	LB/B	-	A0A2K4X4G7	180	L	Q
P10321	LB/B	-	A0A2K4X4G7	180	L	R
P10321	LB/B	-	A0A2K4X4G7	180	L	W
P10321	LB/B	-	A0A2K4X4G7	187	T	E
P10321	LB/B	-	A0A2K4X4G7	187	T	L
P10321	LB/B	-	A0A2K4X4G7	194	R	G
P10321	LB/B	-	A0A2K4X4G7	197	E	K
P10321	LB/B	-	A0A2K4X4G7	201	E	K
P10321	LB/B	-	A0A2K4X4G7	208	P	H
P10321	LB/B	-	A0A2K4X4G7	208	P	R
P10321	LB/B	-	A0A2K4X4G7	217	P	L
P10321	LB/B	-	A0A2K4X4G7	218	L	V
P10321	LB/B	-	A0A2K4X4G7	235	A	T
P10321	LB/B	-	A0A2K4X4G7	243	R	W
P10321	LB/B	-	A0A2K4X4G7	272	V	M
P10321	LB/B	-	A0A2K4X4G7	277	Q	E
P10321	LB/B	-	A0A2K4X4G7	285	M	V
P10321	LB/B	-	A0A2K4X4G7	291	Q	P
P10321	LB/B	-	A0A2K4X4G7	294	L	C
P10321	LB/B	-	A0A2K4X4G7	297	S	R
P10321	LB/B	-	A0A2K4X4G7	299	E	G
P10321	LB/B	-	A0A2K4X4G7	299	E	K
P10321	LB/B	-	A0A2K4X4G7	309	M	V
P10321	LB/B	-	A0A2K4X4G7	319	V	A
P10321	LB/B	-	A0A2K4X4G7	327	V	M
P10321	LB/B	-	A0A2K4X4G7	328	V	M
P10321	LB/B	-	A0A2K4X4G7	329	T	A
P10321	LB/B	-	A0A2K4X4G7	330	A	V
P10321	LB/B	-	A0A2K4X4G7	331	M	V
P10321	LB/B	-	A0A2K4X4G7	332	M	I
P10321	LB/B	-	A0A2K4X4G7	333	C	H
P10321	LB/B	-	A0A2K4X4G7	350	C	S
P10321	LB/B	-	A0A2K4X4G7	363	T	A
P28068	LB/B	-	A0A2Y9ETV2	45	S	F
P28068	LB/B	-	A0A2Y9ETV2	162	A	E
P28068	LB/B	-	A0A2Y9ETV2	162	A	V
P28068	LB/B	-	A0A2Y9ETV2	197	T	I
P28068	LB/B	-	A0A2Y9ETV2	28	T	A
P28068	LB/B	-	A0A2Y9ETV2	49	D	V
P28068	LB/B	-	A0A2Y9ETV2	71	S	N
P06340	LB/B	-	A0A2Y9K3E0	99	L	V
P06340	LB/B	-	A0A2Y9K3E0	105	R	C
P13765	LB/B	-	Q56JZ6	18	R	Q
P13765	LB/B	-	Q56JZ6	244	V	I
P13765	LB/B	-	Q56JZ6	234	L	F
P13765	LB/B	-	Q56JZ6	210	V	I
P20036	LB/B	-	M3WGL1	42	A	T
P20036	LB/B	-	M3WGL1	42	A	V
P20036	LB/B	-	M3WGL1	62	M	L
P20036	LB/B	-	M3WGL1	81	Q	R
P20036	LB/B	-	M3WGL1	97	L	S
P20036	LB/B	-	M3WGL1	114	T	A
P20036	LB/B	-	M3WGL1	142	K	R
P20036	LB/B	-	M3WGL1	191	F	V
P20036	LB/B	-	M3WGL1	42	A	M
P20036	LB/B	-	M3WGL1	49	P	T
P20036	LB/B	-	M3WGL1	54	M	T
P20036	LB/B	-	M3WGL1	59	E	D
P20036	LB/B	-	M3WGL1	62	M	K
P20036	LB/B	-	M3WGL1	74	W	C
P20036	LB/B	-	M3WGL1	82	A	T
P20036	LB/B	-	M3WGL1	100	N	D
P20036	LB/B	-	M3WGL1	103	T	I
P20036	LB/B	-	M3WGL1	104	L	A
P20036	LB/B	-	M3WGL1	127	P	A
P20036	LB/B	-	M3WGL1	158	L	P
P20036	LB/B	-	M3WGL1	221	T	A
P20036	LB/B	-	M3WGL1	259	T	P
P20036	LB/B	-	M3WGL1	62	M	Q
P01909	LB/B	-	A0A2K6C993	57	Q	E
P01909	LB/B	-	A0A2K6C993	8	M	L
P01909	LB/B	-	A0A2K6C993	11	A	T
P01909	LB/B	-	A0A2K6C993	41	S	F
P01909	LB/B	-	A0A2K6C993	48	Y	F
P01909	LB/B	-	A0A2K6C993	49	T	S
P01909	LB/B	-	A0A2K6C993	70	C	Y
P01909	LB/B	-	A0A2K6C993	73	V	L
P01909	LB/B	-	A0A2K6C993	73	V	D
P01909	LB/B	-	A0A2K6C993	86	T	R
P01909	LB/B	-	A0A2K6C993	88	I	M
P01909	LB/B	-	A0A2K6C993	229	V	M
P01909	LB/B	-	A0A2K6C993	237	F	L
P01909	LB/B	-	A0A2K6C993	240	R	Q
P01909	LB/B	-	A0A2K6C993	17	V	M
P01909	LB/B	-	A0A2K6C993	18	M	T
P01909	LB/B	-	A0A2K6C993	25	D	G
P01909	LB/B	-	A0A2K6C993	64	R	K
P01909	LB/B	-	A0A2K6C993	102	S	Y
P01909	LB/B	-	A0A2K6C993	129	I	T
P01909	LB/B	-	A0A2K6C993	151	H	Q
P01909	LB/B	-	A0A2K6C993	209	A	T
P01909	LB/B	-	A0A2K6C993	221	A	T
P01909	LB/B	-	A0A2K6C993	24	E	K
P01909	LB/B	-	A0A2K6C993	34	Y	C
P01909	LB/B	-	A0A2K6C993	44	P	L
P01909	LB/B	-	A0A2K6C993	63	G	E
P01909	LB/B	-	A0A2K6C993	67	T	A
P01909	LB/B	-	A0A2K6C993	68	V	A
P01909	LB/B	-	A0A2K6C993	70	C	K
P01909	LB/B	-	A0A2K6C993	70	C	Q
P01909	LB/B	-	A0A2K6C993	70	C	R
P01909	LB/B	-	A0A2K6C993	71	L	W
P01909	LB/B	-	A0A2K6C993	73	V	E
P01909	LB/B	-	A0A2K6C993	74	L	F
P01909	LB/B	-	A0A2K6C993	75	R	H
P01909	LB/B	-	A0A2K6C993	75	R	S
P01909	LB/B	-	A0A2K6C993	76	Q	K
P01909	LB/B	-	A0A2K6C993	76	Q	R
P01909	LB/B	-	A0A2K6C993	77	F	L
P01909	LB/B	-	A0A2K6C993	81	P	R
P01909	LB/B	-	A0A2K6C993	83	F	G
P01909	LB/B	-	A0A2K6C993	91	L	A
P01909	LB/B	-	A0A2K6C993	91	L	T
P01909	LB/B	-	A0A2K6C993	97	S	I
P01909	LB/B	-	A0A2K6C993	98	L	M
P01909	LB/B	-	A0A2K6C993	98	L	V
P01909	LB/B	-	A0A2K6C993	101	R	C
P01909	LB/B	-	A0A2K6C993	124	L	V
P01909	LB/B	-	A0A2K6C993	152	S	A
P01909	LB/B	-	A0A2K6C993	160	T	I
P01909	LB/B	-	A0A2K6C993	161	S	R
P01909	LB/B	-	A0A2K6C993	161	S	I
P01909	LB/B	-	A0A2K6C993	175	Y	H
P01909	LB/B	-	A0A2K6C993	178	L	F
P01909	LB/B	-	A0A2K6C993	182	A	D
P01909	LB/B	-	A0A2K6C993	182	A	S
P01909	LB/B	-	A0A2K6C993	183	E	D
P01909	LB/B	-	A0A2K6C993	185	S	I
P01909	LB/B	-	A0A2K6C993	197	K	E
P01909	LB/B	-	A0A2K6C993	197	K	Q
P01909	LB/B	-	A0A2K6C993	230	G	C
P01906	LB/B	-	A0A2K6C993	227	V	A
P01906	LB/B	-	A0A2K6C993	247	G	D
P01920	LB/B	-	Q56JZ6	6	A	S
P01920	LB/B	-	Q56JZ6	148	V	I
P01920	LB/B	-	Q56JZ6	194	E	D
P01920	LB/B	-	Q56JZ6	197	P	L
P01920	LB/B	-	Q56JZ6	45	A	G
P01920	LB/B	-	Q56JZ6	46	M	L
P01920	LB/B	-	Q56JZ6	256	Q	R
P01920	LB/B	-	Q56JZ6	12	G	D
P01920	LB/B	-	Q56JZ6	15	A	V
P01920	LB/B	-	Q56JZ6	23	A	S
P01920	LB/B	-	Q56JZ6	24	M	I
P01920	LB/B	-	Q56JZ6	27	T	A
P01920	LB/B	-	Q56JZ6	27	T	S
P01920	LB/B	-	Q56JZ6	28	P	L
P01920	LB/B	-	Q56JZ6	28	P	S
P01920	LB/B	-	Q56JZ6	29	V	L
P01920	LB/B	-	Q56JZ6	35	S	P
P01920	LB/B	-	Q56JZ6	41	Y	F
P01920	LB/B	-	Q56JZ6	41	Y	L
P01920	LB/B	-	Q56JZ6	43	F	L
P01920	LB/B	-	Q56JZ6	55	R	L
P01920	LB/B	-	Q56JZ6	58	Y	G
P01920	LB/B	-	Q56JZ6	58	Y	L
P01920	LB/B	-	Q56JZ6	59	V	L
P01920	LB/B	-	Q56JZ6	60	T	S
P01920	LB/B	-	Q56JZ6	62	Y	H
P01920	LB/B	-	Q56JZ6	62	Y	S
P01920	LB/B	-	Q56JZ6	69	Y	D
P01920	LB/B	-	Q56JZ6	69	Y	I
P01920	LB/B	-	Q56JZ6	70	A	T
P01920	LB/B	-	Q56JZ6	70	A	V
P01920	LB/B	-	Q56JZ6	77	E	G
P01920	LB/B	-	Q56JZ6	78	V	E
P01920	LB/B	-	Q56JZ6	79	Y	F
P01920	LB/B	-	Q56JZ6	81	A	V
P01920	LB/B	-	Q56JZ6	84	P	L
P01920	LB/B	-	Q56JZ6	85	L	Q
P01920	LB/B	-	Q56JZ6	87	P	L
P01920	LB/B	-	Q56JZ6	87	P	Q
P01920	LB/B	-	Q56JZ6	87	P	R
P01920	LB/B	-	Q56JZ6	88	P	L
P01920	LB/B	-	Q56JZ6	89	D	A
P01920	LB/B	-	Q56JZ6	89	D	S
P01920	LB/B	-	Q56JZ6	89	D	V
P01920	LB/B	-	Q56JZ6	92	Y	N
P01920	LB/B	-	Q56JZ6	94	N	K
P01920	LB/B	-	Q56JZ6	95	S	R
P01920	LB/B	-	Q56JZ6	98	E	D
P01920	LB/B	-	Q56JZ6	99	V	D
P01920	LB/B	-	Q56JZ6	99	V	I
P01920	LB/B	-	Q56JZ6	102	R	E
P01920	LB/B	-	Q56JZ6	102	R	G
P01920	LB/B	-	Q56JZ6	103	T	A
P01920	LB/B	-	Q56JZ6	103	T	D
P01920	LB/B	-	Q56JZ6	103	T	K
P01920	LB/B	-	Q56JZ6	106	E	A
P01920	LB/B	-	Q56JZ6	106	E	S
P01920	LB/B	-	Q56JZ6	107	L	V
P01920	LB/B	-	Q56JZ6	109	T	R
P01920	LB/B	-	Q56JZ6	116	Q	E
P01920	LB/B	-	Q56JZ6	117	L	V
P01920	LB/B	-	Q56JZ6	118	E	A
P01920	LB/B	-	Q56JZ6	118	E	G
P01920	LB/B	-	Q56JZ6	119	L	F
P01920	LB/B	-	Q56JZ6	119	L	Y
P01920	LB/B	-	Q56JZ6	121	T	G
P01920	LB/B	-	Q56JZ6	122	T	I
P01920	LB/B	-	Q56JZ6	157	A	G
P01920	LB/B	-	Q56JZ6	157	A	S
P01920	LB/B	-	Q56JZ6	158	Q	H
P01920	LB/B	-	Q56JZ6	162	R	Q
P01920	LB/B	-	Q56JZ6	165	R	W
P01920	LB/B	-	Q56JZ6	165	R	Q
P01920	LB/B	-	Q56JZ6	167	D	G
P01920	LB/B	-	Q56JZ6	168	Q	E
P01920	LB/B	-	Q56JZ6	172	T	A
P01920	LB/B	-	Q56JZ6	199	H	R
P01920	LB/B	-	Q56JZ6	202	V	I
P01920	LB/B	-	Q56JZ6	214	N	S
P01920	LB/B	-	Q56JZ6	217	T	I
P01920	LB/B	-	Q56JZ6	218	V	A
P01920	LB/B	-	Q56JZ6	229	S	N
P01920	LB/B	-	Q56JZ6	235	I	V
P01920	LB/B	-	Q56JZ6	252	H	R
P01920	LB/B	-	Q56JZ6	253	H	Q
P05538	LB/B	-	Q56JZ6	161	R	Q
P05538	LB/B	-	Q56JZ6	232	S	G
P05538	LB/B	-	Q56JZ6	234	I	V
P01903	LB/B	-	A0A2K6C993	242	L	V
P01903	LB/B	-	A0A2K6C993	16	V	L
P01911	LB/B	-	A0A2K5NF78	5	K	R
P01911	LB/B	-	A0A2K5NF78	6	L	F
P01911	LB/B	-	A0A2K5NF78	13	T	A
P01911	LB/B	-	A0A2K5NF78	14	A	V
P01911	LB/B	-	A0A2K5NF78	29	S	A
P01911	LB/B	-	A0A2K5NF78	33	R	Q
P01911	LB/B	-	A0A2K5NF78	38	W	E
P01911	LB/B	-	A0A2K5NF78	38	W	K
P01911	LB/B	-	A0A2K5NF78	39	Q	E
P01911	LB/B	-	A0A2K5NF78	39	Q	Y
P01911	LB/B	-	A0A2K5NF78	40	P	D
P01911	LB/B	-	A0A2K5NF78	40	P	G
P01911	LB/B	-	A0A2K5NF78	40	P	L
P01911	LB/B	-	A0A2K5NF78	40	P	S
P01911	LB/B	-	A0A2K5NF78	40	P	V
P01911	LB/B	-	A0A2K5NF78	41	K	T
P01911	LB/B	-	A0A2K5NF78	42	R	F
P01911	LB/B	-	A0A2K5NF78	42	R	G
P01911	LB/B	-	A0A2K5NF78	42	R	H
P01911	LB/B	-	A0A2K5NF78	42	R	S
P01911	LB/B	-	A0A2K5NF78	42	R	Y
P01911	LB/B	-	A0A2K5NF78	43	E	K
P01911	LB/B	-	A0A2K5NF78	45	H	Q
P01911	LB/B	-	A0A2K5NF78	45	H	Y
P01911	LB/B	-	A0A2K5NF78	54	R	Q
P01911	LB/B	-	A0A2K5NF78	55	F	L
P01911	LB/B	-	A0A2K5NF78	55	F	Y
P01911	LB/B	-	A0A2K5NF78	57	D	E
P01911	LB/B	-	A0A2K5NF78	57	D	H
P01911	LB/B	-	A0A2K5NF78	59	Y	C
P01911	LB/B	-	A0A2K5NF78	59	Y	G
P01911	LB/B	-	A0A2K5NF78	59	Y	H
P01911	LB/B	-	A0A2K5NF78	59	Y	L
P01911	LB/B	-	A0A2K5NF78	59	Y	R
P01911	LB/B	-	A0A2K5NF78	60	F	I
P01911	LB/B	-	A0A2K5NF78	60	F	V
P01911	LB/B	-	A0A2K5NF78	61	Y	H
P01911	LB/B	-	A0A2K5NF78	62	N	H
P01911	LB/B	-	A0A2K5NF78	66	S	F
P01911	LB/B	-	A0A2K5NF78	66	S	L
P01911	LB/B	-	A0A2K5NF78	66	S	N
P01911	LB/B	-	A0A2K5NF78	66	S	Y
P01911	LB/B	-	A0A2K5NF78	67	V	A
P01911	LB/B	-	A0A2K5NF78	67	V	L
P01911	LB/B	-	A0A2K5NF78	69	F	Y
P01911	LB/B	-	A0A2K5NF78	76	F	Y
P01911	LB/B	-	A0A2K5NF78	86	D	A
P01911	LB/B	-	A0A2K5NF78	86	D	S
P01911	LB/B	-	A0A2K5NF78	86	D	V
P01911	LB/B	-	A0A2K5NF78	87	A	E
P01911	LB/B	-	A0A2K5NF78	89	Y	H
P01911	LB/B	-	A0A2K5NF78	89	Y	S
P01911	LB/B	-	A0A2K5NF78	96	I	F
P01911	LB/B	-	A0A2K5NF78	96	I	L
P01911	LB/B	-	A0A2K5NF78	99	Q	D
P01911	LB/B	-	A0A2K5NF78	99	Q	R
P01911	LB/B	-	A0A2K5NF78	100	A	E
P01911	LB/B	-	A0A2K5NF78	100	A	K
P01911	LB/B	-	A0A2K5NF78	100	A	R
P01911	LB/B	-	A0A2K5NF78	102	A	G
P01911	LB/B	-	A0A2K5NF78	103	A	E
P01911	LB/B	-	A0A2K5NF78	103	A	L
P01911	LB/B	-	A0A2K5NF78	103	A	Q
P01911	LB/B	-	A0A2K5NF78	103	A	R
P01911	LB/B	-	A0A2K5NF78	106	T	N
P01911	LB/B	-	A0A2K5NF78	107	Y	V
P01911	LB/B	-	A0A2K5NF78	114	V	A
P01911	LB/B	-	A0A2K5NF78	115	V	G
P01911	LB/B	-	A0A2K5NF78	125	Q	E
P01911	LB/B	-	A0A2K5NF78	125	Q	H
P01911	LB/B	-	A0A2K5NF78	125	Q	Y
P01911	LB/B	-	A0A2K5NF78	127	K	E
P01911	LB/B	-	A0A2K5NF78	133	S	A
P01911	LB/B	-	A0A2K5NF78	141	H	Y
P01911	LB/B	-	A0A2K5NF78	149	S	N
P01911	LB/B	-	A0A2K5NF78	162	L	R
P01911	LB/B	-	A0A2K5NF78	169	A	T
P01911	LB/B	-	A0A2K5NF78	171	M	V
P01911	LB/B	-	A0A2K5NF78	178	Q	H
P01911	LB/B	-	A0A2K5NF78	195	R	Q
P01911	LB/B	-	A0A2K5NF78	209	V	L
P01911	LB/B	-	A0A2K5NF78	210	T	M
P01911	LB/B	-	A0A2K5NF78	218	R	S
P01911	LB/B	-	A0A2K5NF78	260	Q	P
P01911	LB/B	-	A0A2K5NF78	262	T	R
P79483	LB/B	-	A0A2K5NF78	40	R	C
P79483	LB/B	-	A0A2K5NF78	102	G	A
P79483	LB/B	-	A0A2K5NF78	114	V	A
P79483	LB/B	-	A0A2K5NF78	37	L	S
P79483	LB/B	-	A0A2K5NF78	38	E	Q
P79483	LB/B	-	A0A2K5NF78	39	L	Y
P79483	LB/B	-	A0A2K5NF78	40	R	L
P79483	LB/B	-	A0A2K5NF78	40	R	S
P79483	LB/B	-	A0A2K5NF78	41	K	T
P79483	LB/B	-	A0A2K5NF78	55	Y	L
P79483	LB/B	-	A0A2K5NF78	55	Y	F
P79483	LB/B	-	A0A2K5NF78	57	D	E
P79483	LB/B	-	A0A2K5NF78	57	D	N
P79483	LB/B	-	A0A2K5NF78	58	R	I
P79483	LB/B	-	A0A2K5NF78	59	Y	H
P79483	LB/B	-	A0A2K5NF78	66	F	S
P79483	LB/B	-	A0A2K5NF78	66	F	L
P79483	LB/B	-	A0A2K5NF78	66	F	N
P79483	LB/B	-	A0A2K5NF78	66	F	Y
P79483	LB/B	-	A0A2K5NF78	67	L	A
P79483	LB/B	-	A0A2K5NF78	67	L	V
P79483	LB/B	-	A0A2K5NF78	68	R	S
P79483	LB/B	-	A0A2K5NF78	80	T	R
P79483	LB/B	-	A0A2K5NF78	84	R	L
P79483	LB/B	-	A0A2K5NF78	86	V	A
P79483	LB/B	-	A0A2K5NF78	86	V	S
P79483	LB/B	-	A0A2K5NF78	86	V	D
P79483	LB/B	-	A0A2K5NF78	87	A	E
P79483	LB/B	-	A0A2K5NF78	89	S	H
P79483	LB/B	-	A0A2K5NF78	89	S	Y
P79483	LB/B	-	A0A2K5NF78	96	L	F
P79483	LB/B	-	A0A2K5NF78	96	L	I
P79483	LB/B	-	A0A2K5NF78	103	R	Q
P79483	LB/B	-	A0A2K5NF78	106	N	T
P79483	LB/B	-	A0A2K5NF78	113	G	R
P79483	LB/B	-	A0A2K5NF78	115	G	A
P79483	LB/B	-	A0A2K5NF78	115	G	V
P79483	LB/B	-	A0A2K5NF78	169	A	T
P79483	LB/B	-	A0A2K5NF78	178	Q	H
P79483	LB/B	-	A0A2K5NF78	193	V	F
P79483	LB/B	-	A0A2K5NF78	212	A	P
P79483	LB/B	-	A0A2K5NF78	218	R	S
P13747	LB/B	-	A0A2K4X4G7	128	G	R
P13747	LB/B	-	A0A2K4X4G7	178	R	G
P13747	LB/B	-	A0A2K4X4G7	98	N	K
P30511	LB/B	-	A0A2J8NX11	272	P	S
P30511	LB/B	-	A0A2J8NX11	13	A	V
P30511	LB/B	-	A0A2J8NX11	71	P	Q
Q14774	LB/B	-	D2HDH6	116	S	P
Q14774	LB/B	-	D2HDH6	356	P	L
Q14774	LB/B	-	D2HDH6	387	A	G
Q8TCT9	LB/B	-	A0A2K6QG27	259	A	P
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	22	R	C
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	26	R	H
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	31	A	T
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	34	Q	K
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	55	A	S
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	93	V	F
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	98	K	R
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	111	G	R
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	116	R	Q
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	116	R	W
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	119	P	L
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	149	R	L
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	149	R	Q
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	167	R	Q
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	167	R	W
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	173	R	Q
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	173	R	W
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	177	L	R
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	195	R	C
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	201	R	W
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	222	V	M
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	223	E	K
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	225	R	G
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	238	L	R
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	245	L	R
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	247	C	F
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	247	C	R
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	250	E	A
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	250	E	K
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	252	A	T
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	252	A	V
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	256	H	N
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	269	T	I
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	274	G	R
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	278	L	P
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	280	G	R
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	24	G	S
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	26	R	C
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	28	S	N
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	31	A	P
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	34	Q	P
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	35	T	M
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	42	L	S
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	61	D	N
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	85	L	R
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	90	V	G
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	124	V	D
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	202	V	L
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	209	E	K
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	216	G	D
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	217	Q	H
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	217	Q	L
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	219	A	D
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	250	E	Q
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	250	E	V
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	256	H	Y
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	267	V	M
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	270	A	D
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	270	A	G
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	335	G	D
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	335	G	S
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	18	M	I
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	34	Q	R
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	61	D	Y
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	78	T	P
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	80	E	G
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	81	L	P
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	86	E	V
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	92	L	P
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	96	S	F
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	99	D	G
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	99	D	H
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	99	D	N
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	113	I	T
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	122	A	G
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	212	M	V
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	236	G	S
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	244	L	P
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	254	L	P
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	260	G	D
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	261	C	Y
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	343	L	P
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	32	R	P
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	204	Q	K
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	215	V	M
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	250	E	D
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	330	A	P
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	338	L	P
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	30	L	F
P08397	LP/P	Acute intermittent porphyria (AIP) [MIM:176000]	A0A2A2TKV5	235	V	E
Q96RW7	LB/B	-	U3JKT4	1624	A	V
Q96RW7	LB/B	-	U3JKT4	2327	M	I
Q96RW7	LB/B	-	U3JKT4	2418	I	T
Q96RW7	LB/B	-	U3JKT4	2893	E	G
Q96RW7	LB/B	-	U3JKT4	4084	H	Y
Q96RW7	LB/B	-	U3JKT4	4720	A	T
Q96RW7	LB/B	-	U3JKT4	5087	D	V
Q96RW7	LP/P	Macular degeneration, age-related, 1 (ARMD1) [MIM:603075]	U3JKT4	5345	Q	R
Q96RW7	LB/B	-	U3JKT4	1056	T	A
Q96RW7	LB/B	-	U3JKT4	1184	V	F
Q96RW7	LB/B	-	U3JKT4	4437	Q	R
P09429	LB/B	-	L9LE73	156	E	Q
O15347	LB/B	-	A0A0Q3X7L2	51	T	A
O15347	LB/B	-	A0A0Q3X7L2	56	E	Q
Q8WW32	LB/B	-	F1M106	59	K	R
Q8WW32	LB/B	-	F1M106	92	E	A
Q8WW32	LB/B	-	F1M106	170	Y	H
P35914	LP/P	3-hydroxy-3-methylglutaryl-CoA lyase deficiency (HMGCLD) [MIM:246450]	H2PJF5	41	R	Q
P35914	LP/P	3-hydroxy-3-methylglutaryl-CoA lyase deficiency (HMGCLD) [MIM:246450]	H2PJF5	42	D	E
P35914	LP/P	3-hydroxy-3-methylglutaryl-CoA lyase deficiency (HMGCLD) [MIM:246450]	H2PJF5	42	D	G
P35914	LP/P	3-hydroxy-3-methylglutaryl-CoA lyase deficiency (HMGCLD) [MIM:246450]	H2PJF5	42	D	H
P35914	LP/P	3-hydroxy-3-methylglutaryl-CoA lyase deficiency (HMGCLD) [MIM:246450]	H2PJF5	70	V	L
P35914	LP/P	3-hydroxy-3-methylglutaryl-CoA lyase deficiency (HMGCLD) [MIM:246450]	H2PJF5	233	H	R
P35914	LP/P	3-hydroxy-3-methylglutaryl-CoA lyase deficiency (HMGCLD) [MIM:246450]	H2PJF5	279	E	K
P35914	LP/P	3-hydroxy-3-methylglutaryl-CoA lyase deficiency (HMGCLD) [MIM:246450]	H2PJF5	37	E	K
P35914	LP/P	3-hydroxy-3-methylglutaryl-CoA lyase deficiency (HMGCLD) [MIM:246450]	H2PJF5	48	K	N
P35914	LP/P	3-hydroxy-3-methylglutaryl-CoA lyase deficiency (HMGCLD) [MIM:246450]	H2PJF5	75	S	R
P35914	LP/P	3-hydroxy-3-methylglutaryl-CoA lyase deficiency (HMGCLD) [MIM:246450]	H2PJF5	142	S	F
P35914	LP/P	3-hydroxy-3-methylglutaryl-CoA lyase deficiency (HMGCLD) [MIM:246450]	H2PJF5	174	C	Y
P35914	LP/P	3-hydroxy-3-methylglutaryl-CoA lyase deficiency (HMGCLD) [MIM:246450]	H2PJF5	192	F	S
P35914	LP/P	3-hydroxy-3-methylglutaryl-CoA lyase deficiency (HMGCLD) [MIM:246450]	H2PJF5	200	I	F
P35914	LP/P	3-hydroxy-3-methylglutaryl-CoA lyase deficiency (HMGCLD) [MIM:246450]	H2PJF5	201	S	Y
P35914	LP/P	3-hydroxy-3-methylglutaryl-CoA lyase deficiency (HMGCLD) [MIM:246450]	H2PJF5	203	G	E
P35914	LP/P	3-hydroxy-3-methylglutaryl-CoA lyase deficiency (HMGCLD) [MIM:246450]	H2PJF5	204	D	N
P35914	LP/P	3-hydroxy-3-methylglutaryl-CoA lyase deficiency (HMGCLD) [MIM:246450]	H2PJF5	263	L	P
P35914	LP/P	3-hydroxy-3-methylglutaryl-CoA lyase deficiency (HMGCLD) [MIM:246450]	H2PJF5	165	R	Q
P04035	LB/B	-	A0A024BSN1	638	I	V
Q86SG4	LB/B	-	A0A0D9RD44	91	C	R
Q9UGU5	LB/B	-	A0A2I4B9A0	165	G	V
O97980	LB/B	-	A0A2K5VC72	16	H	Y
O75330	LB/B	-	A0A2Y9QSQ5	368	V	A
O75330	LB/B	-	A0A2Y9QSQ5	92	R	C
O75330	LB/B	-	A0A2Y9QSQ5	332	R	H
O75330	LB/B	-	A0A2Y9QSQ5	484	A	V
O75330	LB/B	-	A0A2Y9QSQ5	305	N	K
O75330	LB/B	-	A0A2Y9QSQ5	320	N	K
O75330	LB/B	-	A0A2Y9QSQ5	557	D	H
O75330	LB/B	-	A0A2Y9QSQ5	595	L	I
P09601	LB/B	-	Q3U5U6	7	D	H
P09601	LB/B	-	Q3U5U6	106	P	L
P30519	LB/B	-	H2NQ09	137	R	Q
P30519	LB/B	-	H2NQ09	146	P	L
P20823	LP/P	Maturity-onset diabetes of the young 3 (MODY3) [MIM:600496]	G1SK71	122	Y	C
P20823	LP/P	Maturity-onset diabetes of the young 3 (MODY3) [MIM:600496]	G1SK71	142	S	F
P20823	LP/P	Maturity-onset diabetes of the young 3 (MODY3) [MIM:600496]	G1SK71	159	R	Q
P20823	LP/P	Maturity-onset diabetes of the young 3 (MODY3) [MIM:600496]	G1SK71	272	R	H
P20823	LP/P	Type 1 diabetes mellitus 20 (T1D20) [MIM:612520]	G1SK71	272	R	H
P20823	LP/P	Maturity-onset diabetes of the young 3 (MODY3) [MIM:600496]	G1SK71	447	P	L
P20823	LP/P	Type 1 diabetes mellitus 20 (T1D20) [MIM:612520]	G1SK71	583	R	G
P20823	LB/B	-	G1SK71	27	I	L
P20823	LB/B	-	G1SK71	487	S	N
P20823	LP/P	Maturity-onset diabetes of the young 3 (MODY3) [MIM:600496]	G1SK71	12	L	H
P20823	LP/P	Maturity-onset diabetes of the young 3 (MODY3) [MIM:600496]	G1SK71	31	G	D
P20823	LP/P	Type 1 diabetes mellitus 20 (T1D20) [MIM:612520]	G1SK71	48	E	K
P20823	LB/B	-	G1SK71	98	A	V
P20823	LP/P	Maturity-onset diabetes of the young 3 (MODY3) [MIM:600496]	G1SK71	107	L	R
P20823	LP/P	Maturity-onset diabetes of the young 3 (MODY3) [MIM:600496]	G1SK71	117	K	E
P20823	LP/P	Maturity-onset diabetes of the young 3 (MODY3) [MIM:600496]	G1SK71	128	I	N
P20823	LP/P	Maturity-onset diabetes of the young 3 (MODY3) [MIM:600496]	G1SK71	129	P	T
P20823	LP/P	Maturity-onset diabetes of the young 3 (MODY3) [MIM:600496]	G1SK71	131	R	Q
P20823	LP/P	Maturity-onset diabetes of the young 3 (MODY3) [MIM:600496]	G1SK71	131	R	W
P20823	LP/P	Maturity-onset diabetes of the young 3 (MODY3) [MIM:600496]	G1SK71	133	V	M
P20823	LP/P	Maturity-onset diabetes of the young 3 (MODY3) [MIM:600496]	G1SK71	143	H	Y
P20823	LP/P	Maturity-onset diabetes of the young 3 (MODY3) [MIM:600496]	G1SK71	158	K	N
P20823	LP/P	Maturity-onset diabetes of the young 3 (MODY3) [MIM:600496]	G1SK71	159	R	W
P20823	LP/P	Maturity-onset diabetes of the young 3 (MODY3) [MIM:600496]	G1SK71	161	A	T
P20823	LP/P	Maturity-onset diabetes of the young 3 (MODY3) [MIM:600496]	G1SK71	203	R	C
P20823	LP/P	Maturity-onset diabetes of the young 3 (MODY3) [MIM:600496]	G1SK71	205	K	Q
P20823	LP/P	Maturity-onset diabetes of the young 3 (MODY3) [MIM:600496]	G1SK71	229	R	Q
P20823	LP/P	Maturity-onset diabetes of the young 3 (MODY3) [MIM:600496]	G1SK71	241	C	G
P20823	LP/P	Type 1 diabetes mellitus 20 (T1D20) [MIM:612520]	G1SK71	241	C	G
P20823	LP/P	Maturity-onset diabetes of the young 3 (MODY3) [MIM:600496]	G1SK71	259	V	D
P20823	LP/P	Maturity-onset diabetes of the young 3 (MODY3) [MIM:600496]	G1SK71	260	T	M
P20823	LP/P	Maturity-onset diabetes of the young 3 (MODY3) [MIM:600496]	G1SK71	263	R	C
P20823	LP/P	Maturity-onset diabetes of the young 3 (MODY3) [MIM:600496]	G1SK71	271	R	W
P20823	LP/P	Type 1 diabetes mellitus 20 (T1D20) [MIM:612520]	G1SK71	415	G	R
P20823	LB/B	-	G1SK71	514	H	R
P20823	LP/P	Maturity-onset diabetes of the young 3 (MODY3) [MIM:600496]	G1SK71	519	P	L
P20823	LP/P	Maturity-onset diabetes of the young 3 (MODY3) [MIM:600496]	G1SK71	537	T	R
P20823	LB/B	-	G1SK71	574	G	S
P20823	LP/P	Maturity-onset diabetes of the young 3 (MODY3) [MIM:600496]	G1SK71	594	S	I
P20823	LP/P	Maturity-onset diabetes of the young 3 (MODY3) [MIM:600496]	G1SK71	619	E	K
P20823	LP/P	Maturity-onset diabetes of the young 3 (MODY3) [MIM:600496]	G1SK71	620	T	I
P20823	LP/P	Maturity-onset diabetes of the young 3 (MODY3) [MIM:600496]	G1SK71	20	G	R
P20823	LP/P	Maturity-onset diabetes of the young 3 (MODY3) [MIM:600496]	G1SK71	203	R	H
P20823	LP/P	Maturity-onset diabetes of the young 3 (MODY3) [MIM:600496]	G1SK71	432	S	C
P20823	LP/P	Maturity-onset diabetes of the young 3 (MODY3) [MIM:600496]	G1SK71	618	I	M
P20823	LP/P	Maturity-onset diabetes of the young 3 (MODY3) [MIM:600496]	G1SK71	200	R	W
P20823	LP/P	Maturity-onset diabetes of the young 3 (MODY3) [MIM:600496]	G1SK71	271	R	G
P35680	LP/P	Type 2 diabetes mellitus (T2D) [MIM:125853]	G1SK71	465	S	R
P35680	LP/P	Renal cysts and diabetes syndrome (RCAD) [MIM:137920]	G1SK71	36	S	F
P35680	LP/P	Renal cysts and diabetes syndrome (RCAD) [MIM:137920]	G1SK71	61	V	G
P35680	LP/P	Renal cysts and diabetes syndrome (RCAD) [MIM:137920]	G1SK71	110	V	G
P35680	LP/P	Renal cysts and diabetes syndrome (RCAD) [MIM:137920]	G1SK71	112	R	P
P35680	LP/P	Renal cysts and diabetes syndrome (RCAD) [MIM:137920]	G1SK71	136	Q	E
P35680	LP/P	Renal cysts and diabetes syndrome (RCAD) [MIM:137920]	G1SK71	148	S	L
P35680	LP/P	Renal cysts and diabetes syndrome (RCAD) [MIM:137920]	G1SK71	148	S	W
P35680	LP/P	Renal cysts and diabetes syndrome (RCAD) [MIM:137920]	G1SK71	151	S	P
P35680	LP/P	Renal cysts and diabetes syndrome (RCAD) [MIM:137920]	G1SK71	153	H	N
P35680	LP/P	Renal cysts and diabetes syndrome (RCAD) [MIM:137920]	G1SK71	156	K	E
P35680	LP/P	Renal cysts and diabetes syndrome (RCAD) [MIM:137920]	G1SK71	164	K	Q
P35680	LP/P	Renal cysts and diabetes syndrome (RCAD) [MIM:137920]	G1SK71	165	R	H
P35680	LP/P	Renal cysts and diabetes syndrome (RCAD) [MIM:137920]	G1SK71	235	R	Q
P35680	LP/P	Renal cysts and diabetes syndrome (RCAD) [MIM:137920]	G1SK71	241	A	T
P35680	LP/P	Renal cysts and diabetes syndrome (RCAD) [MIM:137920]	G1SK71	260	E	D
P35680	LP/P	Renal cysts and diabetes syndrome (RCAD) [MIM:137920]	G1SK71	276	R	G
P35680	LP/P	Renal cysts and diabetes syndrome (RCAD) [MIM:137920]	G1SK71	276	R	Q
P35680	LP/P	Renal cysts and diabetes syndrome (RCAD) [MIM:137920]	G1SK71	285	G	D
P35680	LP/P	Renal cysts and diabetes syndrome (RCAD) [MIM:137920]	G1SK71	295	R	C
P35680	LP/P	Renal cysts and diabetes syndrome (RCAD) [MIM:137920]	G1SK71	295	R	H
P35680	LP/P	Renal cysts and diabetes syndrome (RCAD) [MIM:137920]	G1SK71	295	R	P
P35680	LP/P	Renal cysts and diabetes syndrome (RCAD) [MIM:137920]	G1SK71	370	G	S
P41235	LP/P	Maturity-onset diabetes of the young 1 (MODY1) [MIM:125850]	A0A1S3MGS7	136	R	W
P41235	LB/B	-	A0A1S3MGS7	139	T	I
P41235	LP/P	Type 2 diabetes mellitus (T2D) [MIM:125853]	A0A1S3MGS7	402	V	I
P41235	LB/B	-	A0A1S3MGS7	264	V	M
P41235	LP/P	Maturity-onset diabetes of the young 1 (MODY1) [MIM:125850]	A0A1S3MGS7	285	E	Q
P41235	LB/B	-	A0A1S3MGS7	445	P	S
P41235	LB/B	-	A0A1S3MGS7	453	V	I
P41235	LP/P	Fanconi renotubular syndrome 4 with maturity-onset diabetes of the young (FRTS4) [MIM:616026]	A0A1S3MGS7	85	R	W
P41235	LP/P	Maturity-onset diabetes of the young 1 (MODY1) [MIM:125850]	A0A1S3MGS7	373	M	R
Q14541	LB/B	-	A0A1S3MGS7	190	M	I
P50135	LB/B	-	A0A0E9XKR4	105	T	I
P50135	LP/P	Intellectual developmental disorder, autosomal recessive 51 (MRT51) [MIM:616739]	A0A0E9XKR4	60	G	D
P50135	LP/P	Intellectual developmental disorder, autosomal recessive 51 (MRT51) [MIM:616739]	A0A0E9XKR4	208	L	P
P09651	LP/P	Amyotrophic lateral sclerosis 20 (ALS20) [MIM:615426]	A0A2Y9LRA4	314	D	N
P09651	LP/P	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 3 (IBMPFD3) [MIM:615424]	A0A2Y9LRA4	314	D	V
P09651	LP/P	Amyotrophic lateral sclerosis 20 (ALS20) [MIM:615426]	A0A2Y9LRA4	319	N	S
P09651	LB/B	-	A0A2Y9LRA4	283	G	R
P09651	LP/P	Amyotrophic lateral sclerosis 20 (ALS20) [MIM:615426]	A0A2Y9LRA4	340	P	S
Q32P51	LB/B	-	A0A2Y9LRA4	215	N	D
P22626	LP/P	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2 (IBMPFD2) [MIM:615422]	A0A2U4AMA3	302	D	V
O60812	LB/B	-	H0XX05	258	V	D
O60812	LB/B	-	H0XX05	208	Q	H
O60812	LB/B	-	H0XX05	81	D	V
O14979	LP/P	Muscular dystrophy, limb-girdle, autosomal dominant 3 (LGMDD3) [MIM:609115]	A0A2K6PVB3	378	D	H
O14979	LP/P	Muscular dystrophy, limb-girdle, autosomal dominant 3 (LGMDD3) [MIM:609115]	A0A2K6PVB3	378	D	N
P52597	LB/B	-	A0A091DS70	87	K	R
Q00839	LB/B	-	H3BD92	712	F	L
Q86XE5	LP/P	Hyperoxaluria primary 3 (HP3) [MIM:613616]	A0A0P5VD64	257	C	G
Q86XE5	LP/P	Hyperoxaluria primary 3 (HP3) [MIM:613616]	A0A0P5VD64	287	G	V
Q8IX15	LB/B	-	A0A1A6H672	278	A	T
Q9UJC3	LB/B	-	A0A1S3JYV2	689	G	S
Q96ED9	LB/B	-	A0A1S3JYV2	10	G	R
Q96ED9	LB/B	-	A0A1S3JYV2	488	H	Q
Q8N7B1	LB/B	-	A0A2K5EEK1	2	A	T
Q8N7B1	LB/B	-	A0A2K5EEK1	20	V	L
P49639	LB/B	-	K7FIU0	73	H	R
P49639	LB/B	-	K7FIU0	189	E	A
P31271	LP/P	Guttmacher syndrome (GUTTS) [MIM:176305]	G9HPP6	371	Q	L
P31271	LP/P	Hand-foot-genital syndrome (HFG) [MIM:140000]	G9HPP6	372	N	H
P31271	LP/P	Hand-foot-genital syndrome (HFG) [MIM:140000]	G9HPP6	368	I	F
P31271	LP/P	Hand-foot-genital syndrome (HFG) [MIM:140000]	G9HPP6	375	V	F
O43364	LP/P	Microtia, hearing impairment, and cleft palate (MHICP) [MIM:612290]	A0A2K6T4P0	186	Q	K
Q00056	LB/B	-	H9GGC5	70	T	P
Q00056	LB/B	-	H9GGC5	140	L	P
Q00056	LB/B	-	H9GGC5	178	L	F
Q00056	LB/B	-	H9GGC5	251	T	P
Q00056	LB/B	-	H9GGC5	317	P	S
P14653	LB/B	-	K7FIU0	71	T	N
P14653	LB/B	-	K7FIU0	103	Q	H
P14653	LB/B	-	K7FIU0	265	E	G
P14653	LP/P	Facial paresis, hereditary congenital, 3 (HCFP3) [MIM:614744]	K7FIU0	207	R	C
Q92826	LB/B	-	E3TFF5	41	T	M
Q92826	LP/P	Prostate cancer (PC) [MIM:176807]	E3TFF5	84	G	E
Q92826	LB/B	-	E3TFF5	217	R	C
P14651	LB/B	-	M7B9E9	82	P	T
O43248	LB/B	-	A0A091E7P9	130	P	S
O43248	LB/B	-	A0A091E7P9	222	A	V
P31276	LB/B	-	G1SEV3	50	S	I
P09017	LB/B	-	A0A147A5L8	158	R	L
P09017	LB/B	-	A0A147A5L8	178	N	S
Q9GZZ0	LB/B	-	A0A2R9AII6	296	A	T
P28358	LP/P	Vertical talus, congenital (CVT) [MIM:192950]	A0A1A6GGW7	319	M	K
P31277	LB/B	-	A0A091E7P9	245	G	D
P31249	LB/B	-	M7B9E9	129	S	C
P09016	LB/B	-	I3JPN3	123	S	P
P00738	LB/B	-	H2RB63	129	N	D
P00738	LB/B	-	H2RB63	130	E	K
P00738	LB/B	-	H2RB63	397	D	H
P00738	LP/P	Anhaptoglobinemia (AHP) [MIM:614081]	H2RB63	247	I	T
P32754	LB/B	-	A0A2K6T2P9	33	A	T
P32754	LP/P	Tyrosinemia 3 (TYRSN3) [MIM:276710]	A0A2K6T2P9	160	Y	C
P32754	LB/B	-	A0A2K6T2P9	267	I	F
P32754	LP/P	Tyrosinemia 3 (TYRSN3) [MIM:276710]	A0A2K6T2P9	268	A	V
P32754	LP/P	Tyrosinemia 3 (TYRSN3) [MIM:276710]	A0A2K6T2P9	335	I	M
P32754	LB/B	-	A0A2K6T2P9	340	V	L
P32754	LB/B	-	A0A2K6T2P9	113	R	Q
Q96IR7	LP/P	Spastic paraplegia 83, autosomal recessive (SPG83) [MIM:619027]	A0A091DDI6	50	G	D
Q96IR7	LP/P	Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities (NEDSWMA) [MIM:619026]	A0A091DDI6	176	L	P
Q9NWY4	LB/B	-	T1K1U1	174	R	K
Q9NWY4	LB/B	-	T1K1U1	331	E	D
P15428	LB/B	-	I3KL42	217	Y	C
P15428	LP/P	Cranioosteoarthropathy (COA) [MIM:259100]	I3KL42	140	A	P
P15428	LP/P	Digital clubbing, isolated congenital (DIGC) [MIM:119900]	I3KL42	193	S	P
P00739	LB/B	-	B3GQZ2	339	H	D
P00739	LB/B	-	B3GQZ2	27	T	M
P00739	LB/B	-	B3GQZ2	42	N	H
P00739	LB/B	-	B3GQZ2	58	R	K
P00739	LB/B	-	B3GQZ2	203	R	K
P00739	LB/B	-	B3GQZ2	283	V	A
P00739	LB/B	-	B3GQZ2	156	A	V
Q92902	LB/B	-	S9WR90	283	G	W
Q92902	LB/B	-	S9WR90	491	P	R
Q92902	LB/B	-	S9WR90	603	Q	R
Q92902	LB/B	-	S9WR90	630	V	I
Q92902	LB/B	-	S9WR90	100	E	D
Q92902	LB/B	-	S9WR90	186	A	V
Q92902	LB/B	-	S9WR90	480	A	T
Q9NQG7	LB/B	-	A0A2K6DW89	625	Q	H
Q9NQG7	LB/B	-	A0A2K6DW89	443	L	V
Q9NQG7	LB/B	-	A0A2K6DW89	606	H	Y
Q9NQG7	LB/B	-	A0A2K6DW89	229	E	G
Q9NQG7	LB/B	-	A0A2K6DW89	552	V	M
Q8WWQ2	LB/B	-	A0A2I0LV27	579	Y	F
Q8WWQ2	LB/B	-	A0A2I0LV27	315	A	T
P02790	LB/B	-	B1GS20	83	R	W
P02790	LB/B	-	B1GS20	52	D	N
P01112	LP/P	Congenital myopathy with excess of muscle spindles (CMEMS) [MIM:218040]	A0A226P1W1	12	G	V
P01112	LP/P	Costello syndrome (CSTLO) [MIM:218040]	A0A226P1W1	12	G	V
P01112	LP/P	Congenital myopathy with excess of muscle spindles (CMEMS) [MIM:218040]	A0A226P1W1	12	G	S
P01112	LP/P	Costello syndrome (CSTLO) [MIM:218040]	A0A226P1W1	12	G	S
P01112	LP/P	Costello syndrome (CSTLO) [MIM:218040]	A0A226P1W1	12	G	A
P01112	LP/P	Costello syndrome (CSTLO) [MIM:218040]	A0A226P1W1	13	G	C
P01112	LP/P	Costello syndrome (CSTLO) [MIM:218040]	A0A226P1W1	13	G	D
P01112	LP/P	Costello syndrome (CSTLO) [MIM:218040]	A0A226P1W1	12	G	C
P01112	LP/P	Costello syndrome (CSTLO) [MIM:218040]	A0A226P1W1	12	G	E
P01112	LP/P	Congenital myopathy with excess of muscle spindles (CMEMS) [MIM:218040]	A0A226P1W1	22	Q	K
P01112	LP/P	Costello syndrome (CSTLO) [MIM:218040]	A0A226P1W1	58	T	I
P01112	LP/P	Thyroid cancer, non-medullary, 2 (NMTC2) [MIM:188470]	A0A226P1W1	61	Q	K
P01112	LP/P	Congenital myopathy with excess of muscle spindles (CMEMS) [MIM:218040]	A0A226P1W1	63	E	K
P01112	LP/P	Costello syndrome (CSTLO) [MIM:218040]	A0A226P1W1	117	K	R
P01112	LP/P	Costello syndrome (CSTLO) [MIM:218040]	A0A226P1W1	146	A	T
P01112	LP/P	Costello syndrome (CSTLO) [MIM:218040]	A0A226P1W1	146	A	V
P01112	LP/P	Costello syndrome (CSTLO) [MIM:218040]	A0A226P1W1	12	G	D
P01112	LP/P	Schimmelpenning-Feuerstein-Mims syndrome (SFM) [MIM:163200]	A0A226P1W1	13	G	R
P23327	LB/B	-	A0A2K5C8D2	96	S	A
P23327	LB/B	-	A0A2K5C8D2	43	S	N
P04196	LB/B	-	A0A2K6GSF8	204	P	S
P04196	LB/B	-	A0A2K6GSF8	118	D	G
P04196	LB/B	-	A0A2K6GSF8	340	H	R
P04196	LB/B	-	A0A2K6GSF8	180	I	T
P04196	LB/B	-	A0A2K6GSF8	436	G	R
P04196	LB/B	-	A0A2K6GSF8	448	R	C
P04196	LB/B	-	A0A2K6GSF8	493	N	I
P04196	LB/B	-	A0A2K6GSF8	79	S	L
P04196	LP/P	Thrombophilia due to histidine-rich glycoprotein deficiency (THPH11) [MIM:613116]	A0A2K6GSF8	103	G	E
P04196	LP/P	Thrombophilia due to histidine-rich glycoprotein deficiency (THPH11) [MIM:613116]	A0A2K6GSF8	241	C	R
P35367	LB/B	-	A0A060YIH0	270	G	E
P35367	LB/B	-	A0A060YIH0	19	K	N
Q9H3N8	LB/B	-	H2L7A7	138	A	V
Q9H3N8	LB/B	-	H2L7A7	206	H	R
Q86YZ3	LB/B	-	W5QIW7	85	R	H
Q86YZ3	LB/B	-	W5QIW7	167	G	D
Q86YZ3	LB/B	-	W5QIW7	473	E	G
Q86YZ3	LB/B	-	W5QIW7	492	G	R
Q86YZ3	LB/B	-	W5QIW7	664	R	Q
Q86YZ3	LB/B	-	W5QIW7	799	S	T
Q86YZ3	LB/B	-	W5QIW7	273	H	Q
Q86YZ3	LB/B	-	W5QIW7	2435	S	G
Q86YZ3	LB/B	-	W5QIW7	2461	G	S
Q86YZ3	LB/B	-	W5QIW7	122	R	W
Q86YZ3	LB/B	-	W5QIW7	376	Q	R
Q86YZ3	LB/B	-	W5QIW7	427	G	D
Q86YZ3	LB/B	-	W5QIW7	517	Y	C
Q7LGA3	LP/P	Neurofacioskeletal syndrome with or without renal agenesis (NFSRA) [MIM:619194]	A0A146N5I4	165	D	Y
Q7LGA3	LP/P	Neurofacioskeletal syndrome with or without renal agenesis (NFSRA) [MIM:619194]	A0A146N5I4	176	F	S
Q7LGA3	LP/P	Neurofacioskeletal syndrome with or without renal agenesis (NFSRA) [MIM:619194]	A0A146N5I4	189	R	S
O14792	LB/B	-	L8Y7F4	22	P	T
O14792	LB/B	-	L8Y7F4	295	K	R
Q9Y661	LB/B	-	A0A2Y9LKZ6	136	Q	R
Q8IZT8	LB/B	-	A0A195EN96	247	I	N
O60243	LP/P	Hypogonadotropic hypogonadism 15 with or without anosmia (HH15) [MIM:614880]	H2UR45	306	R	Q
O60243	LP/P	Hypogonadotropic hypogonadism 15 with or without anosmia (HH15) [MIM:614880]	H2UR45	306	R	W
O60243	LP/P	Hypogonadotropic hypogonadism 15 with or without anosmia (HH15) [MIM:614880]	H2UR45	323	R	Q
O60243	LP/P	Hypogonadotropic hypogonadism 15 with or without anosmia (HH15) [MIM:614880]	H2UR45	382	R	W
O60243	LP/P	Hypogonadotropic hypogonadism 15 with or without anosmia (HH15) [MIM:614880]	H2UR45	404	M	V
O60243	LP/P	Hypogonadotropic hypogonadism 15 with or without anosmia (HH15) [MIM:614880]	H2UR45	218	P	S
Q8IWL3	LB/B	-	A0A287D973	73	Y	C
Q8IWL3	LB/B	-	A0A287D973	163	I	M
P80365	LP/P	Apparent mineralocorticoid excess (AME) [MIM:218030]	W5NYD1	208	R	C
P80365	LP/P	Apparent mineralocorticoid excess (AME) [MIM:218030]	W5NYD1	213	R	C
P80365	LP/P	Apparent mineralocorticoid excess (AME) [MIM:218030]	W5NYD1	179	L	R
P80365	LP/P	Apparent mineralocorticoid excess (AME) [MIM:218030]	W5NYD1	180	S	F
P80365	LP/P	Apparent mineralocorticoid excess (AME) [MIM:218030]	W5NYD1	186	R	C
P80365	LP/P	Apparent mineralocorticoid excess (AME) [MIM:218030]	W5NYD1	208	R	H
P80365	LB/B	-	W5NYD1	227	P	L
P80365	LP/P	Apparent mineralocorticoid excess (AME) [MIM:218030]	W5NYD1	237	A	V
P80365	LP/P	Apparent mineralocorticoid excess (AME) [MIM:218030]	W5NYD1	244	D	N
P80365	LP/P	Apparent mineralocorticoid excess (AME) [MIM:218030]	W5NYD1	250	L	R
P80365	LP/P	Apparent mineralocorticoid excess (AME) [MIM:218030]	W5NYD1	279	R	C
P80365	LP/P	Apparent mineralocorticoid excess (AME) [MIM:218030]	W5NYD1	328	A	V
P80365	LP/P	Apparent mineralocorticoid excess (AME) [MIM:218030]	W5NYD1	338	Y	H
P80365	LB/B	-	W5NYD1	147	R	H
P80365	LP/P	Apparent mineralocorticoid excess (AME) [MIM:218030]	W5NYD1	223	D	N
P80365	LP/P	Apparent mineralocorticoid excess (AME) [MIM:218030]	W5NYD1	337	R	C
P14061	LB/B	-	A0A2Y9GE79	238	A	V
P14061	LB/B	-	A0A2Y9GE79	313	G	S
Q99714	LP/P	HDS10 mitochondrial disease (HSD10MD) [MIM:300438]	A0A136NW80	122	L	V
Q99714	LP/P	HDS10 mitochondrial disease (HSD10MD) [MIM:300438]	A0A136NW80	130	R	C
Q99714	LP/P	HDS10 mitochondrial disease (HSD10MD) [MIM:300438]	A0A136NW80	247	N	S
Q99714	LP/P	HDS10 mitochondrial disease (HSD10MD) [MIM:300438]	A0A136NW80	86	D	G
Q99714	LP/P	HDS10 mitochondrial disease (HSD10MD) [MIM:300438]	A0A136NW80	165	Q	H
Q99714	LP/P	HDS10 mitochondrial disease (HSD10MD) [MIM:300438]	A0A136NW80	212	K	E
Q99714	LP/P	HDS10 mitochondrial disease (HSD10MD) [MIM:300438]	A0A136NW80	249	E	Q
Q99714	LP/P	HDS10 mitochondrial disease (HSD10MD) [MIM:300438]	A0A136NW80	12	V	L
Q99714	LP/P	HDS10 mitochondrial disease (HSD10MD) [MIM:300438]	A0A136NW80	176	V	M
Q99714	LP/P	HDS10 mitochondrial disease (HSD10MD) [MIM:300438]	A0A136NW80	210	P	S
Q99714	LP/P	HDS10 mitochondrial disease (HSD10MD) [MIM:300438]	A0A136NW80	226	R	Q
Q7Z5P4	LB/B	-	A0A2I2YYP8	260	P	S
P37059	LB/B	-	A0A286ZXK4	121	A	T
P37058	LP/P	Male pseudohermaphrodism with gynecomastia (MPH) [MIM:264300]	A0A1S3AS55	80	R	Q
P37058	LP/P	Male pseudohermaphrodism with gynecomastia (MPH) [MIM:264300]	A0A1S3AS55	80	R	W
P37058	LP/P	Male pseudohermaphrodism with gynecomastia (MPH) [MIM:264300]	A0A1S3AS55	203	A	V
P37058	LP/P	Male pseudohermaphrodism with gynecomastia (MPH) [MIM:264300]	A0A1S3AS55	232	S	L
P37058	LP/P	Male pseudohermaphrodism with gynecomastia (MPH) [MIM:264300]	A0A1S3AS55	235	M	V
P37058	LB/B	-	A0A1S3AS55	31	V	I
P37058	LB/B	-	A0A1S3AS55	289	G	S
P37058	LP/P	Male pseudohermaphrodism with gynecomastia (MPH) [MIM:264300]	A0A1S3AS55	56	A	T
P37058	LP/P	Male pseudohermaphrodism with gynecomastia (MPH) [MIM:264300]	A0A1S3AS55	65	S	L
P37058	LP/P	Male pseudohermaphrodism with gynecomastia (MPH) [MIM:264300]	A0A1S3AS55	130	N	S
P37058	LP/P	Male pseudohermaphrodism with gynecomastia (MPH) [MIM:264300]	A0A1S3AS55	176	Q	P
P37058	LP/P	Male pseudohermaphrodism with gynecomastia (MPH) [MIM:264300]	A0A1S3AS55	205	V	E
P37058	LP/P	Male pseudohermaphrodism with gynecomastia (MPH) [MIM:264300]	A0A1S3AS55	208	F	I
P37058	LP/P	Male pseudohermaphrodism with gynecomastia (MPH) [MIM:264300]	A0A1S3AS55	268	C	Y
P37058	LP/P	Male pseudohermaphrodism with gynecomastia (MPH) [MIM:264300]	A0A1S3AS55	282	P	L
P37058	LP/P	Male pseudohermaphrodism with gynecomastia (MPH) [MIM:264300]	A0A1S3AS55	215	E	D
P37058	LB/B	-	A0A1S3AS55	289	G	C
P37058	LB/B	-	A0A1S3AS55	289	G	R
P37058	LP/P	Male pseudohermaphrodism with gynecomastia (MPH) [MIM:264300]	A0A1S3AS55	133	G	R
P51659	LB/B	-	A0A0N0U600	106	R	H
P51659	LB/B	-	A0A0N0U600	511	W	R
P51659	LB/B	-	A0A0N0U600	559	I	V
P51659	LB/B	-	A0A0N0U600	292	T	S
P51659	LP/P	D-bifunctional protein deficiency (DBPD) [MIM:261515]	A0A0N0U600	16	G	S
P51659	LB/B	-	A0A0N0U600	90	F	L
P51659	LB/B	-	A0A0N0U600	140	K	N
P51659	LB/B	-	A0A0N0U600	427	A	V
P51659	LB/B	-	A0A0N0U600	491	A	T
P51659	LB/B	-	A0A0N0U600	606	A	S
P51659	LB/B	-	A0A0N0U600	687	T	I
P51659	LB/B	-	A0A0N0U600	728	M	V
P51659	LP/P	D-bifunctional protein deficiency (DBPD) [MIM:261515]	A0A0N0U600	106	R	P
P51659	LP/P	Perrault syndrome 1 (PRLTS1) [MIM:233400]	A0A0N0U600	217	Y	C
P51659	LP/P	D-bifunctional protein deficiency (DBPD) [MIM:261515]	A0A0N0U600	457	N	Y
Q92506	LB/B	-	A0A2R8MEJ8	190	H	R
P14060	LB/B	-	A0A2R9A4F7	367	T	N
P14060	LB/B	-	A0A2R9A4F7	79	I	V
P14060	LB/B	-	A0A2R9A4F7	286	F	L
P14060	LB/B	-	A0A2R9A4F7	54	T	I
P14060	LB/B	-	A0A2R9A4F7	71	R	I
P14060	LB/B	-	A0A2R9A4F7	90	G	S
P26439	LP/P	Adrenal hyperplasia 2 (AH2) [MIM:201810]	A0A2R9A4F7	142	E	K
P26439	LP/P	Adrenal hyperplasia 2 (AH2) [MIM:201810]	A0A2R9A4F7	205	L	P
P26439	LP/P	Adrenal hyperplasia 2 (AH2) [MIM:201810]	A0A2R9A4F7	245	A	P
P26439	LP/P	Adrenal hyperplasia 2 (AH2) [MIM:201810]	A0A2R9A4F7	253	Y	N
P26439	LP/P	Adrenal hyperplasia 2 (AH2) [MIM:201810]	A0A2R9A4F7	254	Y	D
P26439	LP/P	Adrenal hyperplasia 2 (AH2) [MIM:201810]	A0A2R9A4F7	259	T	R
P26439	LP/P	Adrenal hyperplasia 2 (AH2) [MIM:201810]	A0A2R9A4F7	10	A	E
P26439	LP/P	Adrenal hyperplasia 2 (AH2) [MIM:201810]	A0A2R9A4F7	10	A	V
P26439	LP/P	Adrenal hyperplasia 2 (AH2) [MIM:201810]	A0A2R9A4F7	15	G	D
P26439	LP/P	Adrenal hyperplasia 2 (AH2) [MIM:201810]	A0A2R9A4F7	82	A	T
P26439	LP/P	Adrenal hyperplasia 2 (AH2) [MIM:201810]	A0A2R9A4F7	100	N	S
P26439	LP/P	Adrenal hyperplasia 2 (AH2) [MIM:201810]	A0A2R9A4F7	108	L	W
P26439	LP/P	Adrenal hyperplasia 2 (AH2) [MIM:201810]	A0A2R9A4F7	129	G	R
P26439	LP/P	Adrenal hyperplasia 2 (AH2) [MIM:201810]	A0A2R9A4F7	155	P	L
P26439	LP/P	Adrenal hyperplasia 2 (AH2) [MIM:201810]	A0A2R9A4F7	167	A	V
P26439	LP/P	Adrenal hyperplasia 2 (AH2) [MIM:201810]	A0A2R9A4F7	173	L	R
P26439	LP/P	Adrenal hyperplasia 2 (AH2) [MIM:201810]	A0A2R9A4F7	186	P	L
P26439	LP/P	Adrenal hyperplasia 2 (AH2) [MIM:201810]	A0A2R9A4F7	213	S	G
P26439	LP/P	Adrenal hyperplasia 2 (AH2) [MIM:201810]	A0A2R9A4F7	216	K	E
P26439	LP/P	Adrenal hyperplasia 2 (AH2) [MIM:201810]	A0A2R9A4F7	222	P	H
P26439	LP/P	Adrenal hyperplasia 2 (AH2) [MIM:201810]	A0A2R9A4F7	222	P	Q
P26439	LP/P	Adrenal hyperplasia 2 (AH2) [MIM:201810]	A0A2R9A4F7	236	L	S
P26439	LP/P	Adrenal hyperplasia 2 (AH2) [MIM:201810]	A0A2R9A4F7	259	T	M
P26439	LP/P	Adrenal hyperplasia 2 (AH2) [MIM:201810]	A0A2R9A4F7	294	G	V
P26439	LB/B	-	A0A2R9A4F7	94	E	Q
P26439	LP/P	Adrenal hyperplasia 2 (AH2) [MIM:201810]	A0A2R9A4F7	222	P	T
P26439	LB/B	-	A0A2R9A4F7	74	D	N
P26439	LP/P	Adrenal hyperplasia 2 (AH2) [MIM:201810]	A0A2R9A4F7	341	P	L
P26439	LP/P	Adrenal hyperplasia 2 (AH2) [MIM:201810]	A0A2R9A4F7	82	A	P
P26439	LP/P	Adrenal hyperplasia 2 (AH2) [MIM:201810]	A0A2R9A4F7	250	G	V
Q9H2F3	LB/B	-	A0A212CYC9	250	T	A
Q9H2F3	LB/B	-	A0A212CYC9	347	L	P
Q9H2F3	LP/P	Congenital bile acid synthesis defect 1 (CBAS1) [MIM:607765]	A0A212CYC9	19	G	S
Q9H2F3	LP/P	Congenital bile acid synthesis defect 1 (CBAS1) [MIM:607765]	A0A212CYC9	147	E	K
Q3SXM5	LB/B	-	G1T8E7	248	P	S
Q3SXM5	LB/B	-	G1T8E7	327	S	C
O75031	LP/P	Premature ovarian failure 19 (POF19) [MIM:619245]	A0A226MTH1	167	S	L
Q9ULV5	LP/P	Cataract 5, multiple types (CTRCT5) [MIM:116800]	W5MMT2	19	A	D
Q9ULV5	LP/P	Cataract 5, multiple types (CTRCT5) [MIM:116800]	W5MMT2	86	I	V
Q9ULV5	LP/P	Cataract 5, multiple types (CTRCT5) [MIM:116800]	W5MMT2	114	L	P
Q9ULV5	LP/P	Cataract 5, multiple types (CTRCT5) [MIM:116800]	W5MMT2	73	R	H
Q14568	LB/B	-	A0A146Y753	235	T	A
Q14568	LB/B	-	A0A146Y753	312	C	Y
P08238	LB/B	-	A0A1C8EG93	349	K	E
Q96MM6	LB/B	-	A0A151MP74	23	V	L
Q96MM6	LB/B	-	A0A151MP74	270	R	H
P0DMV8	LB/B	-	A0A223APY3	110	E	D
P0DMV9	LB/B	-	A0A223APY3	499	N	S
P0DMV9	LB/B	-	A0A223APY3	95	I	V
P0DMV9	LB/B	-	A0A223APY3	467	A	V
P34931	LB/B	-	A0A223APY3	493	T	M
P34931	LB/B	-	A0A223APY3	8	A	P
P34931	LB/B	-	A0A223APY3	268	A	T
P34931	LB/B	-	A0A223APY3	294	D	G
P34931	LB/B	-	A0A223APY3	479	T	M
P34931	LB/B	-	A0A223APY3	558	E	A
P34931	LB/B	-	A0A223APY3	602	E	K
P54652	LB/B	-	L9L765	191	C	S
P54652	LB/B	-	L9L765	496	K	E
O95757	LB/B	-	S9YNI4	211	L	S
O95757	LB/B	-	S9YNI4	216	N	T
O95757	LB/B	-	S9YNI4	601	I	T
P17066	LB/B	-	A0A223APY3	198	L	F
P17066	LB/B	-	A0A223APY3	562	D	E
P17066	LB/B	-	A0A223APY3	150	A	T
P17066	LB/B	-	A0A223APY3	153	N	S
P17066	LB/B	-	A0A223APY3	154	D	N
P17066	LB/B	-	A0A223APY3	170	N	K
P17066	LB/B	-	A0A223APY3	173	R	P
P17066	LB/B	-	A0A223APY3	178	P	A
P17066	LB/B	-	A0A223APY3	194	E	K
P17066	LB/B	-	A0A223APY3	260	R	H
P17066	LB/B	-	A0A223APY3	464	S	I
P17066	LB/B	-	A0A223APY3	471	R	H
P17066	LB/B	-	A0A223APY3	528	K	E
P17066	LB/B	-	A0A223APY3	572	M	V
P17066	LB/B	-	A0A223APY3	577	R	Q
P17066	LB/B	-	A0A223APY3	626	T	A
P17066	LB/B	-	A0A223APY3	336	V	F
P17066	LB/B	-	A0A223APY3	528	K	R
P17066	LB/B	-	A0A223APY3	65	P	T
P17066	LB/B	-	A0A223APY3	95	R	Q
P17066	LB/B	-	A0A223APY3	159	A	V
P17066	LB/B	-	A0A223APY3	297	T	K
P11142	LB/B	-	A0A1V4J7W8	32	D	Y
P11142	LB/B	-	A0A1V4J7W8	459	F	L
P38646	LB/B	-	A0A0P7U623	74	Q	R
P38646	LB/B	-	A0A0P7U623	184	H	Y
P38646	LB/B	-	A0A0P7U623	127	R	G
P38646	LB/B	-	A0A0P7U623	225	A	G
P38646	LP/P	Even-plus syndrome (EVPLS) [MIM:616854]	A0A0P7U623	126	R	W
P38646	LP/P	Even-plus syndrome (EVPLS) [MIM:616854]	A0A0P7U623	128	Y	C
P38646	LB/B	-	A0A0P7U623	200	S	L
P38646	LB/B	-	A0A0P7U623	539	T	K
P38646	LB/B	-	A0A0P7U623	573	R	W
P38646	LB/B	-	A0A0P7U623	577	E	K
P04792	LP/P	Neuronopathy, distal hereditary motor, 2B (HMN2B) [MIM:608634]	G1TRF1	127	R	W
P04792	LP/P	Charcot-Marie-Tooth disease, axonal, 2F (CMT2F) [MIM:606595]	G1TRF1	135	S	F
P04792	LP/P	Neuronopathy, distal hereditary motor, 2B (HMN2B) [MIM:608634]	G1TRF1	135	S	F
P04792	LP/P	Charcot-Marie-Tooth disease, axonal, 2F (CMT2F) [MIM:606595]	G1TRF1	136	R	W
P04792	LP/P	Neuronopathy, distal hereditary motor, 2B (HMN2B) [MIM:608634]	G1TRF1	151	T	I
P04792	LP/P	Neuronopathy, distal hereditary motor, 2B (HMN2B) [MIM:608634]	G1TRF1	182	P	L
P04792	LP/P	Charcot-Marie-Tooth disease, axonal, 2F (CMT2F) [MIM:606595]	G1TRF1	164	T	A
P04792	LP/P	Neuronopathy, distal hereditary motor, 2B (HMN2B) [MIM:608634]	G1TRF1	34	G	R
P04792	LP/P	Charcot-Marie-Tooth disease, axonal, 2F (CMT2F) [MIM:606595]	G1TRF1	39	P	L
P04792	LP/P	Neuronopathy, distal hereditary motor, 2B (HMN2B) [MIM:608634]	G1TRF1	39	P	L
P04792	LP/P	Neuronopathy, distal hereditary motor, 2B (HMN2B) [MIM:608634]	G1TRF1	41	E	K
P04792	LP/P	Neuronopathy, distal hereditary motor, 2B (HMN2B) [MIM:608634]	G1TRF1	84	G	R
P04792	LP/P	Neuronopathy, distal hereditary motor, 2B (HMN2B) [MIM:608634]	G1TRF1	99	L	M
P04792	LP/P	Charcot-Marie-Tooth disease, axonal, 2F (CMT2F) [MIM:606595]	G1TRF1	136	R	L
P04792	LP/P	Neuronopathy, distal hereditary motor, 2B (HMN2B) [MIM:608634]	G1TRF1	136	R	L
P04792	LP/P	Neuronopathy, distal hereditary motor, 2B (HMN2B) [MIM:608634]	G1TRF1	140	R	G
P04792	LP/P	Neuronopathy, distal hereditary motor, 2B (HMN2B) [MIM:608634]	G1TRF1	141	K	Q
P04792	LB/B	-	G1TRF1	156	S	Y
P04792	LP/P	Neuronopathy, distal hereditary motor, 2B (HMN2B) [MIM:608634]	G1TRF1	7	P	S
P04792	LP/P	Neuronopathy, distal hereditary motor, 2B (HMN2B) [MIM:608634]	G1TRF1	53	G	D
P04792	LP/P	Neuronopathy, distal hereditary motor, 2B (HMN2B) [MIM:608634]	G1TRF1	187	S	L
Q12988	LB/B	-	L9KRX5	67	G	S
Q12988	LP/P	Neuronopathy, distal hereditary motor, 2C (HMN2C) [MIM:613376]	L9KRX5	7	R	S
O14558	LB/B	-	A0A0P6K1Q0	20	P	L
Q9UJY1	LP/P	Neuronopathy, distal hereditary motor, 2A (HMN2A) [MIM:158590]	A0A1W4YP37	141	K	E
Q9UJY1	LP/P	Neuronopathy, distal hereditary motor, 2A (HMN2A) [MIM:158590]	A0A1W4YP37	141	K	N
Q9UJY1	LB/B	-	A0A1W4YP37	78	R	M
Q9UJY1	LP/P	Neuronopathy, distal hereditary motor, 2A (HMN2A) [MIM:158590]	A0A1W4YP37	90	P	L
Q9UJY1	LP/P	Neuronopathy, distal hereditary motor, 2A (HMN2A) [MIM:158590]	A0A1W4YP37	138	N	T
Q9UJY1	LP/P	Neuronopathy, distal hereditary motor, 2A (HMN2A) [MIM:158590]	A0A1W4YP37	141	K	M
Q9BQS6	LB/B	-	A0A2U3WND7	2	Q	P
Q96EW2	LB/B	-	G7MKK2	64	S	A
Q9NZL4	LB/B	-	A0A2Y9INH7	25	G	V
P10809	LP/P	Spastic paraplegia 13, autosomal dominant (SPG13) [MIM:605280]	L5K231	98	V	I
P10809	LP/P	Leukodystrophy, hypomyelinating, 4 (HLD4) [MIM:612233]	L5K231	29	D	G
P98160	LP/P	Schwartz-Jampel syndrome (SJS1) [MIM:255800]	H3D4F8	1532	C	Y
P98160	LB/B	-	H3D4F8	68	D	E
P98160	LB/B	-	H3D4F8	638	M	V
P98160	LB/B	-	H3D4F8	765	N	S
P98160	LB/B	-	H3D4F8	1186	R	Q
P98160	LB/B	-	H3D4F8	1503	A	V
P98160	LB/B	-	H3D4F8	1758	R	Q
P98160	LB/B	-	H3D4F8	1919	R	C
P98160	LB/B	-	H3D4F8	1967	V	I
P98160	LB/B	-	H3D4F8	2980	L	H
P98160	LB/B	-	H3D4F8	2981	V	I
P98160	LB/B	-	H3D4F8	2995	S	G
P98160	LB/B	-	H3D4F8	3168	A	T
P98160	LB/B	-	H3D4F8	3256	H	Y
P98160	LB/B	-	H3D4F8	3530	R	W
P98160	LB/B	-	H3D4F8	3632	R	Q
P98160	LB/B	-	H3D4F8	3640	V	I
P98160	LB/B	-	H3D4F8	4331	S	N
P98160	LB/B	-	H3D4F8	303	L	H
P98160	LB/B	-	H3D4F8	1323	L	V
Q9BUP3	LB/B	-	L9L1U7	197	S	R
O43719	LB/B	-	A0A096NAK0	478	G	A
O43719	LB/B	-	A0A096NAK0	526	N	T
O43719	LB/B	-	A0A096NAK0	678	D	G
P08908	LB/B	-	A0A0A7DQA3	16	P	L
P08908	LB/B	-	A0A0A7DQA3	22	G	S
P08908	LB/B	-	A0A0A7DQA3	28	I	V
P08908	LB/B	-	A0A0A7DQA3	184	P	L
P08908	LB/B	-	A0A0A7DQA3	220	R	L
P08908	LB/B	-	A0A0A7DQA3	273	G	D
P28222	LB/B	-	A0A146SIE7	124	F	C
P28222	LB/B	-	A0A146SIE7	219	F	L
P28222	LB/B	-	A0A146SIE7	367	I	V
P28222	LB/B	-	A0A146SIE7	374	E	K
P28221	LB/B	-	A0A146SIE7	265	S	L
P28566	LB/B	-	A0A146SIE7	262	S	F
P28566	LB/B	-	A0A146SIE7	208	A	T
P41595	LB/B	-	A0A212D3H5	421	M	V
P41595	LB/B	-	A0A212D3H5	45	Q	E
P41595	LB/B	-	A0A212D3H5	173	F	L
P41595	LB/B	-	A0A212D3H5	388	R	W
P28335	LB/B	-	A0A1U7S513	23	S	C
P28335	LB/B	-	A0A1U7S513	160	I	V
P46098	LB/B	-	A0A091IUL5	33	A	T
P46098	LB/B	-	A0A091IUL5	253	S	N
P46098	LB/B	-	A0A091IUL5	344	R	H
P46098	LB/B	-	A0A091IUL5	391	P	R
P46098	LB/B	-	A0A091IUL5	409	R	Q
Q92743	LP/P	Cerebral arteriopathy, autosomal recessive, with subcortical infarcts and leukoencephalopathy (CARASIL) [MIM:600142]	A0A147A7J3	252	A	T
Q92743	LP/P	Cerebral arteriopathy, autosomal recessive, with subcortical infarcts and leukoencephalopathy (CARASIL) [MIM:600142]	A0A147A7J3	297	V	M
Q92743	LB/B	-	A0A147A7J3	20	A	V
Q92743	LB/B	-	A0A147A7J3	51	E	G
Q92743	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 2 (CADASIL2) [MIM:616779]	A0A147A7J3	121	S	R
Q92743	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 2 (CADASIL2) [MIM:616779]	A0A147A7J3	123	A	S
Q92743	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 2 (CADASIL2) [MIM:616779]	A0A147A7J3	133	R	G
Q92743	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 2 (CADASIL2) [MIM:616779]	A0A147A7J3	166	R	L
Q92743	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 2 (CADASIL2) [MIM:616779]	A0A147A7J3	173	A	P
Q92743	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 2 (CADASIL2) [MIM:616779]	A0A147A7J3	284	S	G
Q92743	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 2 (CADASIL2) [MIM:616779]	A0A147A7J3	284	S	R
Q92743	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 2 (CADASIL2) [MIM:616779]	A0A147A7J3	285	P	Q
Q92743	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 2 (CADASIL2) [MIM:616779]	A0A147A7J3	286	F	V
P42858	LB/B	-	A0A210Q9D5	1382	E	A
P42858	LB/B	-	A0A210Q9D5	893	G	R
P42858	LB/B	-	A0A210Q9D5	1064	V	I
P42858	LB/B	-	A0A210Q9D5	1091	I	M
P42858	LB/B	-	A0A210Q9D5	1173	T	A
P42858	LB/B	-	A0A210Q9D5	1385	N	H
P42858	LB/B	-	A0A210Q9D5	1720	T	N
P42858	LB/B	-	A0A210Q9D5	2113	D	Y
P42858	LB/B	-	A0A210Q9D5	2309	Y	H
P42858	LB/B	-	A0A210Q9D5	2786	V	I
P42858	LP/P	Lopes-Maciel-Rodan syndrome (LOMARS) [MIM:617435]	A0A210Q9D5	703	P	L
P42858	LP/P	Lopes-Maciel-Rodan syndrome (LOMARS) [MIM:617435]	A0A210Q9D5	2717	F	L
P42858	LB/B	-	A0A210Q9D5	551	G	E
P57058	LB/B	-	A0A2K6KU20	157	R	W
P57058	LB/B	-	A0A2K6KU20	591	R	C
P57058	LB/B	-	A0A2K6KU20	625	E	K
P57058	LB/B	-	A0A2K6KU20	648	M	T
Q7Z6Z7	LP/P	Intellectual developmental disorder, X-linked, syndromic, Turner type (MRXST) [MIM:309590]	A0A0P5LLH5	2981	R	H
Q7Z6Z7	LP/P	Intellectual developmental disorder, X-linked, syndromic, Turner type (MRXST) [MIM:309590]	A0A0P5LLH5	4013	R	W
Q7Z6Z7	LP/P	Intellectual developmental disorder, X-linked, syndromic, Turner type (MRXST) [MIM:309590]	A0A0P5LLH5	4187	R	C
Q7Z6Z7	LB/B	-	A0A0P5LLH5	483	N	S
Q7Z6Z7	LP/P	Intellectual developmental disorder, X-linked, syndromic, Turner type (MRXST) [MIM:309590]	A0A0P5LLH5	110	R	Q
Q7Z6Z7	LP/P	Intellectual developmental disorder, X-linked, syndromic, Turner type (MRXST) [MIM:309590]	A0A0P5LLH5	110	R	W
Q7Z6Z7	LP/P	Intellectual developmental disorder, X-linked, syndromic, Turner type (MRXST) [MIM:309590]	A0A0P5LLH5	115	S	F
Q7Z6Z7	LP/P	Intellectual developmental disorder, X-linked, syndromic, Turner type (MRXST) [MIM:309590]	A0A0P5LLH5	660	G	R
Q7Z6Z7	LP/P	Intellectual developmental disorder, X-linked, syndromic, Turner type (MRXST) [MIM:309590]	A0A0P5LLH5	669	H	Q
Q7Z6Z7	LP/P	Intellectual developmental disorder, X-linked, syndromic, Turner type (MRXST) [MIM:309590]	A0A0P5LLH5	1328	M	V
Q7Z6Z7	LP/P	Intellectual developmental disorder, X-linked, syndromic, Turner type (MRXST) [MIM:309590]	A0A0P5LLH5	2089	I	M
Q7Z6Z7	LP/P	Intellectual developmental disorder, X-linked, syndromic, Turner type (MRXST) [MIM:309590]	A0A0P5LLH5	3070	R	C
Q7Z6Z7	LP/P	Intellectual developmental disorder, X-linked, syndromic, Turner type (MRXST) [MIM:309590]	A0A0P5LLH5	3194	F	S
Q7Z6Z7	LP/P	Intellectual developmental disorder, X-linked, syndromic, Turner type (MRXST) [MIM:309590]	A0A0P5LLH5	4023	R	C
Q7Z6Z7	LP/P	Intellectual developmental disorder, X-linked, syndromic, Turner type (MRXST) [MIM:309590]	A0A0P5LLH5	4063	R	Q
Q7Z6Z7	LP/P	Intellectual developmental disorder, X-linked, syndromic, Turner type (MRXST) [MIM:309590]	A0A0P5LLH5	4069	I	F
Q7Z6Z7	LP/P	Intellectual developmental disorder, X-linked, syndromic, Turner type (MRXST) [MIM:309590]	A0A0P5LLH5	4075	N	K
Q7Z6Z7	LP/P	Intellectual developmental disorder, X-linked, syndromic, Turner type (MRXST) [MIM:309590]	A0A0P5LLH5	4106	Y	C
Q7Z6Z7	LP/P	Intellectual developmental disorder, X-linked, syndromic, Turner type (MRXST) [MIM:309590]	A0A0P5LLH5	4157	L	V
Q7Z6Z7	LP/P	Intellectual developmental disorder, X-linked, syndromic, Turner type (MRXST) [MIM:309590]	A0A0P5LLH5	4244	E	D
Q7Z6Z7	LP/P	Intellectual developmental disorder, X-linked, syndromic, Turner type (MRXST) [MIM:309590]	A0A0P5LLH5	4295	K	N
Q7Z6Z7	LP/P	Intellectual developmental disorder, X-linked, syndromic, Turner type (MRXST) [MIM:309590]	A0A0P5LLH5	4310	G	R
Q12794	LP/P	Mucopolysaccharidosis 9 (MPS9) [MIM:601492]	A0A091KCX3	268	E	K
Q12891	LB/B	-	H3A0D6	18	S	A
Q12891	LB/B	-	H3A0D6	418	I	L
O43820	LB/B	-	A0A091KCX3	113	H	Y
Q2M3T9	LB/B	-	H3A0D6	346	A	S
Q4G0P3	LB/B	-	A0A1U7TND8	451	R	P
Q4G0P3	LB/B	-	A0A1U7TND8	584	T	N
Q4G0P3	LB/B	-	A0A1U7TND8	690	T	A
Q4G0P3	LB/B	-	A0A1U7TND8	724	N	D
Q4G0P3	LB/B	-	A0A1U7TND8	1718	V	M
Q4G0P3	LB/B	-	A0A1U7TND8	1892	R	H
Q4G0P3	LB/B	-	A0A1U7TND8	1952	R	Q
Q4G0P3	LB/B	-	A0A1U7TND8	2099	V	M
Q4G0P3	LB/B	-	A0A1U7TND8	2276	Q	R
Q4G0P3	LB/B	-	A0A1U7TND8	2306	E	G
Q4G0P3	LB/B	-	A0A1U7TND8	2445	N	I
Q4G0P3	LB/B	-	A0A1U7TND8	2502	L	S
Q4G0P3	LB/B	-	A0A1U7TND8	2558	G	E
Q4G0P3	LB/B	-	A0A1U7TND8	2589	K	R
Q4G0P3	LB/B	-	A0A1U7TND8	2932	P	L
Q4G0P3	LB/B	-	A0A1U7TND8	2937	E	K
Q4G0P3	LB/B	-	A0A1U7TND8	2939	R	K
Q4G0P3	LB/B	-	A0A1U7TND8	2994	E	G
Q4G0P3	LB/B	-	A0A1U7TND8	3116	T	R
Q4G0P3	LB/B	-	A0A1U7TND8	3269	Y	D
Q4G0P3	LB/B	-	A0A1U7TND8	3811	R	H
Q4G0P3	LB/B	-	A0A1U7TND8	3899	V	M
Q4G0P3	LB/B	-	A0A1U7TND8	4026	A	T
Q4G0P3	LB/B	-	A0A1U7TND8	4088	K	R
Q4G0P3	LB/B	-	A0A1U7TND8	4270	H	Y
Q4G0P3	LB/B	-	A0A1U7TND8	4606	N	K
Q4G0P3	LB/B	-	A0A1U7TND8	1077	I	V
Q4G0P3	LB/B	-	A0A1U7TND8	1228	V	L
Q4G0P3	LB/B	-	A0A1U7TND8	1534	I	V
Q4G0P3	LB/B	-	A0A1U7TND8	2087	R	C
Q4G0P3	LB/B	-	A0A1U7TND8	2242	Q	R
Q4G0P3	LB/B	-	A0A1U7TND8	2298	R	G
Q4G0P3	LB/B	-	A0A1U7TND8	2530	K	E
Q4G0P3	LB/B	-	A0A1U7TND8	2570	D	N
Q4G0P3	LB/B	-	A0A1U7TND8	2694	I	S
Q4G0P3	LB/B	-	A0A1U7TND8	3291	A	P
Q4G0P3	LB/B	-	A0A1U7TND8	3316	L	P
Q4G0P3	LB/B	-	A0A1U7TND8	3739	A	T
Q4G0P3	LB/B	-	A0A1U7TND8	3742	V	I
Q4G0P3	LB/B	-	A0A1U7TND8	3840	V	L
Q4G0P3	LB/B	-	A0A1U7TND8	3869	M	R
Q4G0P3	LB/B	-	A0A1U7TND8	4005	T	A
Q4G0P3	LB/B	-	A0A1U7TND8	4160	E	Q
Q4G0P3	LB/B	-	A0A1U7TND8	4363	S	C
Q4G0P3	LB/B	-	A0A1U7TND8	4412	K	E
Q4G0P3	LB/B	-	A0A1U7TND8	4552	M	L
Q4G0P3	LB/B	-	A0A1U7TND8	4869	R	Q
Q4G0P3	LB/B	-	A0A1U7TND8	2455	P	Q
Q5T013	LB/B	-	A0A2K6RDZ7	239	D	N
Q96M11	LB/B	-	L9LBE9	31	C	R
Q96M11	LP/P	Hydrolethalus syndrome 1 (HLS1) [MIM:236680]	L9LBE9	211	D	G
Q9NX55	LB/B	-	A0A2Y9PCE6	97	S	P
P10997	LB/B	-	A0A1S3AP15	53	S	G
Q9NSE4	LB/B	-	G4ZSJ7	522	I	V
Q9NSE4	LB/B	-	G4ZSJ7	14	A	V
Q5T440	LB/B	-	F7DYG6	211	G	S
Q5T440	LP/P	Multiple mitochondrial dysfunctions syndrome 3 (MMDS3) [MIM:615330]	F7DYG6	314	Q	P
P05362	LB/B	-	W5Q263	56	K	M
P05362	LB/B	-	W5Q263	241	G	R
P05362	LB/B	-	W5Q263	469	K	E
P05362	LB/B	-	W5Q263	155	K	N
P05362	LB/B	-	W5Q263	315	V	M
P05362	LB/B	-	W5Q263	352	P	L
P05362	LB/B	-	W5Q263	397	R	Q
P05362	LB/B	-	W5Q263	478	R	W
P13598	LB/B	-	G1L825	37	A	T
P13598	LB/B	-	G1L825	199	R	H
P13598	LB/B	-	G1L825	256	R	Q
P32942	LB/B	-	W5Q263	525	S	T
P32942	LB/B	-	W5Q263	63	I	V
P32942	LB/B	-	W5Q263	143	D	G
P32942	LB/B	-	W5Q263	115	R	G
Q14773	LB/B	-	H0X405	100	Q	R
Q14773	LB/B	-	H0X405	208	V	L
Q9UMF0	LB/B	-	G3TS88	301	V	I
Q9UMF0	LB/B	-	G3TS88	348	A	T
Q9Y2F5	LB/B	-	A0A151NCY4	391	C	S
Q9Y2F5	LB/B	-	A0A151NCY4	596	K	E
Q9Y2F5	LB/B	-	A0A151NCY4	901	V	I
Q9Y2F5	LB/B	-	A0A151NCY4	1054	T	A
Q9Y2F5	LB/B	-	A0A151NCY4	1058	G	D
Q9Y2F5	LB/B	-	A0A151NCY4	1597	Q	P
Q9Y2F5	LB/B	-	A0A151NCY4	1618	P	L
O75144	LB/B	-	A0A2I3TNW5	128	V	I
Q02535	LB/B	-	A0A2U3V254	105	T	A
Q02535	LB/B	-	A0A2U3V254	111	S	A
O75874	LB/B	-	L5K352	178	V	I
P48735	LP/P	D-2-hydroxyglutaric aciduria 2 (D2HGA2) [MIM:613657]	H2NP64	140	R	G
P48735	LP/P	D-2-hydroxyglutaric aciduria 2 (D2HGA2) [MIM:613657]	H2NP64	140	R	Q
P48735	LP/P	Glioma (GLM) [MIM:137800]	H2NP64	158	P	L
P48735	LP/P	Glioma (GLM) [MIM:137800]	H2NP64	162	P	S
P48735	LP/P	Glioma (GLM) [MIM:137800]	H2NP64	172	R	G
P48735	LP/P	Glioma (GLM) [MIM:137800]	H2NP64	172	R	K
P48735	LP/P	Glioma (GLM) [MIM:137800]	H2NP64	172	R	M
P48735	LB/B	-	H2NP64	172	R	S
P48735	LB/B	-	H2NP64	172	R	W
O43837	LB/B	-	A0A0L1HS29	3	A	V
O43837	LB/B	-	A0A0L1HS29	166	Q	H
O43837	LP/P	Retinitis pigmentosa 46 (RP46) [MIM:612572]	A0A0L1HS29	132	L	P
O43837	LB/B	-	A0A0L1HS29	360	T	A
Q5T6J7	LB/B	-	G5BP05	185	K	T
P14902	LB/B	-	D2H9Q4	4	A	T
Q6ZQW0	LB/B	-	D2H9Q4	248	R	W
P35475	LB/B	-	K7G2W8	33	H	Q
P35475	LP/P	Mucopolysaccharidosis 1H (MPS1H) [MIM:607014]	K7G2W8	51	G	D
P35475	LP/P	Mucopolysaccharidosis 1H (MPS1H) [MIM:607014]	K7G2W8	75	A	T
P35475	LP/P	Mucopolysaccharidosis 1H/S (MPS1H/S) [MIM:607015]	K7G2W8	82	H	P
P35475	LP/P	Mucopolysaccharidosis 1S (MPS1S) [MIM:607016]	K7G2W8	89	R	Q
P35475	LP/P	Mucopolysaccharidosis 1S (MPS1S) [MIM:607016]	K7G2W8	89	R	W
P35475	LB/B	-	K7G2W8	105	R	Q
P35475	LB/B	-	K7G2W8	116	G	R
P35475	LP/P	Mucopolysaccharidosis 1H (MPS1H) [MIM:607014]	K7G2W8	218	L	P
P35475	LB/B	-	K7G2W8	279	V	A
P35475	LP/P	Mucopolysaccharidosis 1H (MPS1H) [MIM:607014]	K7G2W8	315	D	Y
P35475	LP/P	Mucopolysaccharidosis 1H (MPS1H) [MIM:607014]	K7G2W8	327	A	P
P35475	LP/P	Mucopolysaccharidosis 1H (MPS1H) [MIM:607014]	K7G2W8	349	D	N
P35475	LB/B	-	K7G2W8	361	A	T
P35475	LP/P	Mucopolysaccharidosis 1H (MPS1H) [MIM:607014]	K7G2W8	366	T	P
P35475	LP/P	Mucopolysaccharidosis 1H/S (MPS1H/S) [MIM:607015]	K7G2W8	380	Q	R
P35475	LP/P	Mucopolysaccharidosis 1S (MPS1S) [MIM:607016]	K7G2W8	380	Q	R
P35475	LP/P	Mucopolysaccharidosis 1S (MPS1S) [MIM:607016]	K7G2W8	383	R	H
P35475	LP/P	Mucopolysaccharidosis 1H (MPS1H) [MIM:607014]	K7G2W8	388	T	R
P35475	LP/P	Mucopolysaccharidosis 1H (MPS1H) [MIM:607014]	K7G2W8	409	G	R
P35475	LB/B	-	K7G2W8	454	V	I
P35475	LP/P	Mucopolysaccharidosis 1H (MPS1H) [MIM:607014]	K7G2W8	489	R	P
P35475	LP/P	Mucopolysaccharidosis 1H/S (MPS1H/S) [MIM:607015]	K7G2W8	490	L	P
P35475	LP/P	Mucopolysaccharidosis 1S (MPS1S) [MIM:607016]	K7G2W8	490	L	P
P35475	LP/P	Mucopolysaccharidosis 1S (MPS1S) [MIM:607016]	K7G2W8	492	R	P
P35475	LP/P	Mucopolysaccharidosis 1H/S (MPS1H/S) [MIM:607015]	K7G2W8	496	P	L
P35475	LP/P	Mucopolysaccharidosis 1H/S (MPS1H/S) [MIM:607015]	K7G2W8	504	M	T
P35475	LP/P	Mucopolysaccharidosis 1H (MPS1H) [MIM:607014]	K7G2W8	533	P	R
P35475	LP/P	Mucopolysaccharidosis 1H/S (MPS1H/S) [MIM:607015]	K7G2W8	533	P	R
P35475	LP/P	Mucopolysaccharidosis 1H/S (MPS1H/S) [MIM:607015]	K7G2W8	626	W	R
P35475	LB/B	-	K7G2W8	300	A	T
P35475	LP/P	Mucopolysaccharidosis 1H/S (MPS1H/S) [MIM:607015]	K7G2W8	346	L	R
P35475	LP/P	Mucopolysaccharidosis 1H/S (MPS1H/S) [MIM:607015]	K7G2W8	619	R	G
P35475	LP/P	Mucopolysaccharidosis 1H/S (MPS1H/S) [MIM:607015]	K7G2W8	79	A	V
P35475	LB/B	-	K7G2W8	82	H	Q
P35475	LP/P	Mucopolysaccharidosis 1H (MPS1H) [MIM:607014]	K7G2W8	133	M	I
P35475	LP/P	Mucopolysaccharidosis 1H (MPS1H) [MIM:607014]	K7G2W8	182	E	K
P35475	LP/P	Mucopolysaccharidosis 1H (MPS1H) [MIM:607014]	K7G2W8	208	G	D
P35475	LP/P	Mucopolysaccharidosis 1H/S (MPS1H/S) [MIM:607015]	K7G2W8	238	L	Q
P35475	LP/P	Mucopolysaccharidosis 1H/S (MPS1H/S) [MIM:607015]	K7G2W8	260	S	F
P35475	LP/P	Mucopolysaccharidosis 1H (MPS1H) [MIM:607014]	K7G2W8	349	D	Y
P35475	LP/P	Mucopolysaccharidosis 1S (MPS1S) [MIM:607016]	K7G2W8	350	N	I
P35475	LP/P	Mucopolysaccharidosis 1H/S (MPS1H/S) [MIM:607015]	K7G2W8	363	R	C
P35475	LP/P	Mucopolysaccharidosis 1H/S (MPS1H/S) [MIM:607015]	K7G2W8	423	S	R
P35475	LP/P	Mucopolysaccharidosis 1S (MPS1S) [MIM:607016]	K7G2W8	423	S	R
P35475	LP/P	Mucopolysaccharidosis 1H/S (MPS1H/S) [MIM:607015]	K7G2W8	602	F	I
P35475	LP/P	Mucopolysaccharidosis 1H/S (MPS1H/S) [MIM:607015]	K7G2W8	628	R	P
P35475	LP/P	Mucopolysaccharidosis 1S (MPS1S) [MIM:607016]	K7G2W8	76	Y	C
P35475	LP/P	Mucopolysaccharidosis 1H/S (MPS1H/S) [MIM:607015]	K7G2W8	84	G	R
P35475	LP/P	Mucopolysaccharidosis 1H (MPS1H) [MIM:607014]	K7G2W8	103	T	P
P35475	LP/P	Mucopolysaccharidosis 1H/S (MPS1H/S) [MIM:607015]	K7G2W8	178	E	K
P35475	LP/P	Mucopolysaccharidosis 1H/S (MPS1H/S) [MIM:607015]	K7G2W8	188	F	L
P35475	LP/P	Mucopolysaccharidosis 1S (MPS1S) [MIM:607016]	K7G2W8	219	G	E
P35475	LP/P	Mucopolysaccharidosis 1H/S (MPS1H/S) [MIM:607015]	K7G2W8	265	G	R
P35475	LP/P	Mucopolysaccharidosis 1H/S (MPS1H/S) [MIM:607015]	K7G2W8	276	E	K
P35475	LP/P	Mucopolysaccharidosis 1S (MPS1S) [MIM:607016]	K7G2W8	276	E	K
P35475	LP/P	Mucopolysaccharidosis 1S (MPS1S) [MIM:607016]	K7G2W8	306	W	L
P35475	LP/P	Mucopolysaccharidosis 1S (MPS1S) [MIM:607016]	K7G2W8	348	N	K
P35475	LP/P	Mucopolysaccharidosis 1H (MPS1H) [MIM:607014]	K7G2W8	385	P	R
P35475	LP/P	Mucopolysaccharidosis 1H/S (MPS1H/S) [MIM:607015]	K7G2W8	396	L	P
P35475	LP/P	Mucopolysaccharidosis 1H/S (MPS1H/S) [MIM:607015]	K7G2W8	436	A	P
P35475	LB/B	-	K7G2W8	449	H	N
P35475	LP/P	Mucopolysaccharidosis 1H/S (MPS1H/S) [MIM:607015]	K7G2W8	496	P	R
P35475	LP/P	Mucopolysaccharidosis 1H/S (MPS1H/S) [MIM:607015]	K7G2W8	535	L	F
P35475	LB/B	-	K7G2W8	591	A	T
P35475	LP/P	Mucopolysaccharidosis 1S (MPS1S) [MIM:607016]	K7G2W8	18	L	P
P35475	LP/P	Mucopolysaccharidosis 1H (MPS1H) [MIM:607014]	K7G2W8	620	V	F
Q9BTL4	LB/B	-	G5BYV3	133	A	V
P46695	LB/B	-	A0A250YAI5	127	A	P
Q5VY09	LB/B	-	J9P9J9	92	R	H
Q5VY09	LB/B	-	J9P9J9	168	V	I
Q5VY09	LB/B	-	J9P9J9	194	R	G
Q5VY09	LB/B	-	J9P9J9	202	Q	R
Q5VY09	LB/B	-	J9P9J9	285	P	S
Q5T953	LB/B	-	A0A2J8UJJ2	105	P	S
P40305	LB/B	-	A0A2K5ZER2	109	S	F
Q96BM0	LB/B	-	A0A2Y9JJG9	35	G	S
P80217	LB/B	-	H0V1Z2	126	M	V
Q8TCB0	LB/B	-	H2LXD9	9	W	R
Q53G44	LB/B	-	H2LXD9	390	M	I
Q53G44	LB/B	-	H2LXD9	73	H	R
Q53G44	LB/B	-	H2LXD9	104	A	T
Q53G44	LB/B	-	H2LXD9	148	R	C
Q53G44	LB/B	-	H2LXD9	217	V	I
Q53G44	LB/B	-	H2LXD9	235	I	T
Q53G44	LB/B	-	H2LXD9	296	R	C
P09914	LB/B	-	A0A093STR1	131	P	H
Q5T764	LB/B	-	A0A093STR1	188	L	P
P09913	LB/B	-	A0A093STR1	352	D	E
P09913	LB/B	-	A0A093STR1	79	E	A
P09913	LB/B	-	A0A093STR1	121	K	R
P13164	LB/B	-	A0A1U8BX49	13	P	A
Q01629	LB/B	-	A0A1D5RF05	41	M	T
Q01629	LB/B	-	A0A1D5RF05	121	I	V
Q01629	LB/B	-	A0A1D5RF05	33	V	A
Q01628	LB/B	-	A0A2K5HPU3	3	H	Q
A6NNB3	LB/B	-	W5PEG2	27	G	A
A6NNB3	LP/P	Osteogenesis imperfecta 5 (OI5) [MIM:610967]	W5PEG2	40	S	L
P01562	LB/B	-	W5PYA2	137	A	V
P01562	LB/B	-	W5PYA2	10	V	A
P01562	LB/B	-	W5PYA2	163	A	G
P01566	LB/B	-	W5PYA2	42	G	A
P01571	LB/B	-	W5PYA2	184	I	R
P01563	LB/B	-	W5PYA2	46	R	K
P01563	LB/B	-	W5PYA2	57	H	R
P01563	LB/B	-	W5PYA2	6	A	D
P01568	LB/B	-	W5PYA2	179	K	E
P01568	LB/B	-	W5PYA2	119	L	M
P05014	LB/B	-	W5PYA2	74	A	T
P05014	LB/B	-	W5PYA2	137	E	V
P05014	LB/B	-	W5PYA2	49	H	P
P32881	LB/B	-	W5PYA2	137	E	K
P17181	LB/B	-	K7G121	168	V	L
P17181	LB/B	-	K7G121	307	V	I
P17181	LB/B	-	K7G121	359	T	M
P17181	LB/B	-	K7G121	24	A	V
P17181	LB/B	-	K7G121	57	G	R
P17181	LB/B	-	K7G121	73	W	C
P17181	LB/B	-	K7G121	80	Q	H
P17181	LB/B	-	K7G121	88	N	S
P17181	LB/B	-	K7G121	169	I	M
P17181	LB/B	-	K7G121	183	I	V
P17181	LB/B	-	K7G121	306	R	C
P17181	LB/B	-	K7G121	422	S	R
P17181	LB/B	-	K7G121	424	A	T
P17181	LB/B	-	K7G121	515	E	K
P48551	LB/B	-	A0A2U3WCW2	8	F	S
P48551	LB/B	-	A0A2U3WCW2	10	F	V
P48551	LB/B	-	A0A2U3WCW2	196	I	V
P48551	LB/B	-	A0A2U3WCW2	37	E	Q
P48551	LB/B	-	A0A2U3WCW2	73	M	V
P48551	LB/B	-	A0A2U3WCW2	215	S	G
P48551	LB/B	-	A0A2U3WCW2	283	H	R
P48551	LB/B	-	A0A2U3WCW2	295	P	L
P48551	LB/B	-	A0A2U3WCW2	318	Y	C
P48551	LB/B	-	A0A2U3WCW2	324	S	N
P48551	LB/B	-	A0A2U3WCW2	346	P	S
P48551	LB/B	-	A0A2U3WCW2	362	P	S
P48551	LB/B	-	A0A2U3WCW2	385	P	L
P48551	LB/B	-	A0A2U3WCW2	450	S	L
Q86WN2	LB/B	-	M3WZS7	46	Q	H
P01579	LB/B	-	Q2PE75	29	K	Q
P01579	LB/B	-	Q2PE75	160	R	Q
P15260	LP/P	Immunodeficiency 27A (IMD27A) [MIM:209950]	M3XA82	77	C	Y
P15260	LP/P	Immunodeficiency 27A (IMD27A) [MIM:209950]	M3XA82	87	I	T
P15260	LB/B	-	M3XA82	61	V	I
P15260	LB/B	-	M3XA82	335	H	P
P15260	LB/B	-	M3XA82	467	L	P
P15260	LB/B	-	M3XA82	14	V	M
P15260	LP/P	Immunodeficiency 27A (IMD27A) [MIM:209950]	M3XA82	37	I	T
P15260	LP/P	Immunodeficiency 27A (IMD27A) [MIM:209950]	M3XA82	61	V	E
P15260	LP/P	Immunodeficiency 27A (IMD27A) [MIM:209950]	M3XA82	63	V	G
P15260	LP/P	Immunodeficiency 27A (IMD27A) [MIM:209950]	M3XA82	66	Y	C
P15260	LP/P	Immunodeficiency 27A (IMD27A) [MIM:209950]	M3XA82	77	C	F
P15260	LP/P	Immunodeficiency 27A (IMD27A) [MIM:209950]	M3XA82	85	C	Y
P15260	LB/B	-	M3XA82	149	S	L
P15260	LB/B	-	M3XA82	180	G	R
P15260	LB/B	-	M3XA82	197	E	K
P15260	LP/P	Immunodeficiency 27A (IMD27A) [MIM:209950]	M3XA82	219	G	R
P15260	LB/B	-	M3XA82	352	I	M
P15260	LB/B	-	M3XA82	397	Y	C
P15260	LP/P	Immunodeficiency 27A (IMD27A) [MIM:209950]	M3XA82	485	S	F
P38484	LB/B	-	A0A2K5ZHM6	64	Q	R
P38484	LB/B	-	A0A2K5ZHM6	58	T	R
P38484	LB/B	-	A0A2K5ZHM6	147	E	K
P38484	LB/B	-	A0A2K5ZHM6	182	K	E
P38484	LP/P	Immunodeficiency 28 (IMD28) [MIM:614889]	A0A2K5ZHM6	168	T	N
P38484	LP/P	Immunodeficiency 28 (IMD28) [MIM:614889]	A0A2K5ZHM6	114	R	C
P38484	LP/P	Immunodeficiency 28 (IMD28) [MIM:614889]	A0A2K5ZHM6	124	S	F
P38484	LP/P	Immunodeficiency 28 (IMD28) [MIM:614889]	A0A2K5ZHM6	141	G	R
P38484	LP/P	Immunodeficiency 28 (IMD28) [MIM:614889]	A0A2K5ZHM6	227	G	R
Q9P0W0	LB/B	-	A0A2Y9E5X3	133	K	E
Q9P0W0	LB/B	-	A0A2Y9E5X3	97	I	N
P05000	LB/B	-	W5PYA2	95	R	S
Q9HBG6	LP/P	Cranioectodermal dysplasia 1 (CED1) [MIM:218330]	A0A0P7UQI7	7	W	C
Q9HBG6	LP/P	Cranioectodermal dysplasia 1 (CED1) [MIM:218330]	A0A0P7UQI7	322	S	F
Q9HBG6	LP/P	Cranioectodermal dysplasia 1 (CED1) [MIM:218330]	A0A0P7UQI7	502	V	G
Q9HBG6	LP/P	Cranioectodermal dysplasia 1 (CED1) [MIM:218330]	A0A0P7UQI7	495	G	R
Q9HBG6	LP/P	Cranioectodermal dysplasia 1 (CED1) [MIM:218330]	A0A0P7UQI7	572	G	V
Q96RY7	LB/B	-	A0A2B4SRW8	165	D	A
Q96RY7	LB/B	-	A0A2B4SRW8	279	R	P
Q96RY7	LB/B	-	A0A2B4SRW8	280	R	Q
Q96RY7	LB/B	-	A0A2B4SRW8	398	V	I
Q96RY7	LB/B	-	A0A2B4SRW8	451	A	V
Q96RY7	LB/B	-	A0A2B4SRW8	621	R	Q
Q96RY7	LB/B	-	A0A2B4SRW8	670	P	S
Q96RY7	LB/B	-	A0A2B4SRW8	1070	A	V
Q96RY7	LB/B	-	A0A2B4SRW8	561	S	N
Q96RY7	LP/P	Short-rib thoracic dysplasia 9 with or without polydactyly (SRTD9) [MIM:266920]	A0A2B4SRW8	212	G	R
Q96RY7	LP/P	Short-rib thoracic dysplasia 9 with or without polydactyly (SRTD9) [MIM:266920]	A0A2B4SRW8	233	I	M
Q96RY7	LP/P	Short-rib thoracic dysplasia 9 with or without polydactyly (SRTD9) [MIM:266920]	A0A2B4SRW8	292	V	M
Q96RY7	LP/P	Short-rib thoracic dysplasia 9 with or without polydactyly (SRTD9) [MIM:266920]	A0A2B4SRW8	311	Y	C
Q96RY7	LP/P	Short-rib thoracic dysplasia 9 with or without polydactyly (SRTD9) [MIM:266920]	A0A2B4SRW8	522	G	E
Q96RY7	LP/P	Short-rib thoracic dysplasia 9 with or without polydactyly (SRTD9) [MIM:266920]	A0A2B4SRW8	576	R	Q
Q96RY7	LB/B	-	A0A2B4SRW8	110	R	H
Q96RY7	LP/P	Short-rib thoracic dysplasia 9 with or without polydactyly (SRTD9) [MIM:266920]	A0A2B4SRW8	152	L	F
Q96RY7	LB/B	-	A0A2B4SRW8	161	P	T
Q96RY7	LB/B	-	A0A2B4SRW8	243	E	G
Q96RY7	LP/P	Short-rib thoracic dysplasia 9 with or without polydactyly (SRTD9) [MIM:266920]	A0A2B4SRW8	267	E	G
Q96RY7	LB/B	-	A0A2B4SRW8	459	W	S
Q96RY7	LB/B	-	A0A2B4SRW8	514	L	H
Q96RY7	LB/B	-	A0A2B4SRW8	787	D	G
Q96RY7	LB/B	-	A0A2B4SRW8	1353	P	R
Q96RY7	LP/P	Short-rib thoracic dysplasia 9 with or without polydactyly (SRTD9) [MIM:266920]	A0A2B4SRW8	1360	C	R
Q96RY7	LP/P	Short-rib thoracic dysplasia 9 with or without polydactyly (SRTD9) [MIM:266920]	A0A2B4SRW8	280	R	W
Q96RY7	LB/B	-	A0A2B4SRW8	777	L	R
Q9BW83	LP/P	Bardet-Biedl syndrome 19 (BBS19) [MIM:615996]	B3S9A2	100	C	Y
Q96FT9	LB/B	-	Q28CW2	85	R	H
Q96FT9	LP/P	Retinitis pigmentosa 81 (RP81) [MIM:617871]	Q28CW2	34	E	K
Q96FT9	LP/P	Short-rib thoracic dysplasia 18 with polydactyly (SRTD18) [MIM:617866]	Q28CW2	174	W	R
Q9NQC8	LB/B	-	A0A2K6T453	9	C	Y
Q9Y366	LP/P	Short-rib thoracic dysplasia 16 with or without polydactyly (SRTD16) [MIM:617102]	A0A146NW43	199	A	T
Q8WYA0	LP/P	Short-rib thoracic dysplasia 19 with or without polydactyly (SRTD19) [MIM:617895]	A0A1W4YFB0	29	L	F
Q13099	LB/B	-	W5MY88	374	M	I
Q13099	LB/B	-	W5MY88	446	S	N
Q13099	LB/B	-	W5MY88	662	S	G
P78318	LB/B	-	Q6NTJ9	20	R	K
Q8IVU1	LB/B	-	G1L812	751	V	L
Q8TDY8	LB/B	-	A0A1S3WN46	52	A	P
Q8TDY8	LB/B	-	A0A1S3WN46	301	N	S
Q8TDY8	LB/B	-	A0A1S3WN46	1102	T	A
Q8TDY8	LB/B	-	A0A1S3WN46	1125	C	Y
Q8TDY8	LB/B	-	A0A1S3WN46	803	S	C
P05019	LB/B	-	H0WMK4	187	A	D
P05019	LB/B	-	H0WMK4	115	A	T
P01344	LB/B	-	A0A096MVH6	120	K	N
P01344	LB/B	-	A0A096MVH6	173	P	Q
P01344	LB/B	-	A0A096MVH6	180	K	N
Q6U949	LB/B	-	A0A2I2ZVG8	106	S	I
Q6U949	LB/B	-	A0A2I2ZVG8	112	P	T
Q6U949	LB/B	-	A0A2I2ZVG8	125	F	V
Q6U949	LB/B	-	A0A2I2ZVG8	150	T	A
P11717	LB/B	-	C3ZMD5	2020	N	S
P11717	LB/B	-	C3ZMD5	203	P	L
P11717	LB/B	-	C3ZMD5	252	L	V
P11717	LB/B	-	C3ZMD5	529	R	Q
P11717	LB/B	-	C3ZMD5	604	G	S
P11717	LB/B	-	C3ZMD5	724	A	T
P11717	LB/B	-	C3ZMD5	856	G	S
P11717	LB/B	-	C3ZMD5	1107	T	M
P11717	LB/B	-	C3ZMD5	1184	T	S
P11717	LB/B	-	C3ZMD5	91	R	H
P11717	LB/B	-	C3ZMD5	231	G	D
P11717	LB/B	-	C3ZMD5	273	D	G
P11717	LB/B	-	C3ZMD5	512	K	Q
P11717	LB/B	-	C3ZMD5	817	L	V
P11717	LB/B	-	C3ZMD5	1124	V	I
P11717	LB/B	-	C3ZMD5	1315	G	E
P11717	LB/B	-	C3ZMD5	1335	R	H
P11717	LB/B	-	C3ZMD5	1619	R	G
P11717	LB/B	-	C3ZMD5	1832	R	H
P11717	LB/B	-	C3ZMD5	1860	G	D
P11717	LB/B	-	C3ZMD5	1908	I	M
P11717	LB/B	-	C3ZMD5	2459	A	V
P11717	LB/B	-	C3ZMD5	1254	E	A
P11717	LB/B	-	C3ZMD5	1395	T	S
P11717	LB/B	-	C3ZMD5	1696	Q	R
P35858	LB/B	-	A0A2I2UQC9	498	P	S
P35858	LB/B	-	A0A2I2UQC9	548	R	W
P35858	LB/B	-	A0A2I2UQC9	97	L	F
P35858	LB/B	-	A0A2I2UQC9	307	P	L
P35858	LP/P	Acid-labile subunit deficiency (ACLSD) [MIM:615961]	A0A2I2UQC9	60	C	S
P35858	LP/P	Acid-labile subunit deficiency (ACLSD) [MIM:615961]	A0A2I2UQC9	73	P	L
P35858	LP/P	Acid-labile subunit deficiency (ACLSD) [MIM:615961]	A0A2I2UQC9	134	L	Q
P35858	LP/P	Acid-labile subunit deficiency (ACLSD) [MIM:615961]	A0A2I2UQC9	244	L	F
P35858	LP/P	Acid-labile subunit deficiency (ACLSD) [MIM:615961]	A0A2I2UQC9	276	N	S
P35858	LP/P	Acid-labile subunit deficiency (ACLSD) [MIM:615961]	A0A2I2UQC9	440	D	N
P35858	LP/P	Acid-labile subunit deficiency (ACLSD) [MIM:615961]	A0A2I2UQC9	540	C	R
P35858	LP/P	Acid-labile subunit deficiency (ACLSD) [MIM:615961]	A0A2I2UQC9	127	L	P
P08833	LB/B	-	A0A1U8CFE9	253	I	M
P08833	LB/B	-	A0A1U8CFE9	183	V	I
P08833	LB/B	-	A0A1U8CFE9	114	H	D
P18065	LB/B	-	F7I8E0	137	A	D
P17936	LB/B	-	Q6ZSD0	158	H	P
P17936	LB/B	-	Q6ZSD0	32	A	G
P17936	LB/B	-	Q6ZSD0	56	A	T
P17936	LB/B	-	Q6ZSD0	234	G	S
P22692	LB/B	-	A0A2K5R4H9	42	V	G
P24593	LB/B	-	Q6ZSD0	138	R	W
Q16270	LB/B	-	G3WTE8	11	L	F
Q16270	LB/B	-	G3WTE8	78	R	G
Q16270	LB/B	-	G3WTE8	95	K	R
Q6UXB1	LB/B	-	F1PNN0	66	T	S
Q6B9Z1	LB/B	-	A0A0D9S275	25	L	P
Q6B9Z1	LB/B	-	A0A0D9S275	60	R	Q
Q9H665	LB/B	-	A0A2K5N9B8	189	W	R
P01854	LB/B	-	H9GQF6	359	W	L
P01854	LB/B	-	H9GQF6	43	W	C
P01857	LB/B	-	Q6MZX7	97	K	R
P01857	LB/B	-	Q6MZX7	239	D	E
P01857	LB/B	-	Q6MZX7	241	L	M
P01859	LB/B	-	Q6MZX7	60	S	A
P01859	LB/B	-	Q6MZX7	257	S	A
P01871	LB/B	-	F7AB23	191	G	S
P01871	LB/B	-	F7AB23	215	V	G
P01871	LB/B	-	F7AB23	40	F	L
P01871	LB/B	-	F7AB23	418	E	D
P38935	LB/B	-	A0A2L2YGK6	671	T	A
P38935	LB/B	-	A0A2L2YGK6	694	R	W
P38935	LB/B	-	A0A2L2YGK6	928	E	K
P38935	LP/P	Neuronopathy, distal hereditary motor, 6 (HMN6) [MIM:604320]	A0A2L2YGK6	192	L	P
P38935	LP/P	Neuronopathy, distal hereditary motor, 6 (HMN6) [MIM:604320]	A0A2L2YGK6	213	H	R
P38935	LP/P	Neuronopathy, distal hereditary motor, 6 (HMN6) [MIM:604320]	A0A2L2YGK6	221	T	A
P38935	LP/P	Neuronopathy, distal hereditary motor, 6 (HMN6) [MIM:604320]	A0A2L2YGK6	241	C	R
P38935	LP/P	Neuronopathy, distal hereditary motor, 6 (HMN6) [MIM:604320]	A0A2L2YGK6	334	E	K
P38935	LP/P	Neuronopathy, distal hereditary motor, 6 (HMN6) [MIM:604320]	A0A2L2YGK6	361	L	P
P38935	LP/P	Neuronopathy, distal hereditary motor, 6 (HMN6) [MIM:604320]	A0A2L2YGK6	364	L	P
P38935	LP/P	Neuronopathy, distal hereditary motor, 6 (HMN6) [MIM:604320]	A0A2L2YGK6	382	E	K
P38935	LP/P	Neuronopathy, distal hereditary motor, 6 (HMN6) [MIM:604320]	A0A2L2YGK6	426	L	P
P38935	LP/P	Neuronopathy, distal hereditary motor, 6 (HMN6) [MIM:604320]	A0A2L2YGK6	514	E	K
P38935	LP/P	Neuronopathy, distal hereditary motor, 6 (HMN6) [MIM:604320]	A0A2L2YGK6	565	D	N
P38935	LP/P	Neuronopathy, distal hereditary motor, 6 (HMN6) [MIM:604320]	A0A2L2YGK6	577	L	P
P38935	LP/P	Neuronopathy, distal hereditary motor, 6 (HMN6) [MIM:604320]	A0A2L2YGK6	580	V	I
P38935	LP/P	Neuronopathy, distal hereditary motor, 6 (HMN6) [MIM:604320]	A0A2L2YGK6	583	N	I
P38935	LP/P	Neuronopathy, distal hereditary motor, 6 (HMN6) [MIM:604320]	A0A2L2YGK6	586	G	C
P38935	LP/P	Neuronopathy, distal hereditary motor, 6 (HMN6) [MIM:604320]	A0A2L2YGK6	603	R	H
P38935	LP/P	Neuronopathy, distal hereditary motor, 6 (HMN6) [MIM:604320]	A0A2L2YGK6	637	R	C
P38935	LB/B	-	A0A2L2YGK6	879	T	K
P38935	LB/B	-	A0A2L2YGK6	201	L	S
P38935	LB/B	-	A0A2L2YGK6	275	I	V
P38935	LB/B	-	A0A2L2YGK6	75	A	T
P38935	LB/B	-	A0A2L2YGK6	557	P	A
P38935	LP/P	Neuronopathy, distal hereditary motor, 6 (HMN6) [MIM:604320]	A0A2L2YGK6	17	L	P
P38935	LP/P	Neuronopathy, distal hereditary motor, 6 (HMN6) [MIM:604320]	A0A2L2YGK6	196	Q	R
P38935	LP/P	Neuronopathy, distal hereditary motor, 6 (HMN6) [MIM:604320]	A0A2L2YGK6	216	P	L
P38935	LP/P	Neuronopathy, distal hereditary motor, 6 (HMN6) [MIM:604320]	A0A2L2YGK6	251	L	P
P38935	LP/P	Neuronopathy, distal hereditary motor, 6 (HMN6) [MIM:604320]	A0A2L2YGK6	386	W	R
P38935	LP/P	Neuronopathy, distal hereditary motor, 6 (HMN6) [MIM:604320]	A0A2L2YGK6	445	H	P
P38935	LP/P	Neuronopathy, distal hereditary motor, 6 (HMN6) [MIM:604320]	A0A2L2YGK6	472	L	P
P38935	LP/P	Neuronopathy, distal hereditary motor, 6 (HMN6) [MIM:604320]	A0A2L2YGK6	493	T	I
P38935	LP/P	Neuronopathy, distal hereditary motor, 6 (HMN6) [MIM:604320]	A0A2L2YGK6	581	R	S
P38935	LP/P	Neuronopathy, distal hereditary motor, 6 (HMN6) [MIM:604320]	A0A2L2YGK6	603	R	C
P38935	LP/P	Charcot-Marie-Tooth disease, axonal, 2S (CMT2S) [MIM:616155]	A0A2L2YGK6	202	F	V
P38935	LP/P	Neuronopathy, distal hereditary motor, 6 (HMN6) [MIM:604320]	A0A2L2YGK6	369	F	L
P38935	LP/P	Charcot-Marie-Tooth disease, axonal, 2S (CMT2S) [MIM:616155]	A0A2L2YGK6	373	V	G
P38935	LP/P	Charcot-Marie-Tooth disease, axonal, 2S (CMT2S) [MIM:616155]	A0A2L2YGK6	528	A	T
P01743	LB/B	-	Q9Z1C4	49	T	N
A0A0C4DH32	LB/B	-	A0A2K6DIY4	41	C	F
P01764	LB/B	-	G3RUG5	24	V	L
P01764	LB/B	-	G3RUG5	80	A	G
P01834	LB/B	-	A0A291NGZ4	84	V	L
P01834	LP/P	Immunoglobulin kappa light chain deficiency (IGKCD) [MIM:614102]	A0A291NGZ4	41	W	R
P01602	LB/B	-	A0A287AA42	72	K	D
P01601	LB/B	-	A0A291NGZ4	48	S	R
P0DOY3	LB/B	-	G1TKP3	83	K	R
A0M8Q6	LB/B	-	A0A291NHA6	34	N	Y
P15814	LP/P	Agammaglobulinemia 2, autosomal recessive (AGM2) [MIM:613500]	G1T2Z9	142	P	L
P15814	LB/B	-	G1T2Z9	189	R	H
Q6WRI0	LB/B	-	A0A2D0R6D4	124	T	I
Q6WRI0	LB/B	-	A0A2D0R6D4	150	Y	D
Q6WRI0	LB/B	-	A0A2D0R6D4	571	P	S
Q6WRI0	LB/B	-	A0A2D0R6D4	1199	S	A
Q6WRI0	LB/B	-	A0A2D0R6D4	1370	T	I
Q6WRI0	LB/B	-	A0A2D0R6D4	1875	Y	H
Q6WRI0	LB/B	-	A0A2D0R6D4	2476	R	W
Q6WRI0	LB/B	-	A0A2D0R6D4	2579	H	Y
Q6WRI0	LB/B	-	A0A2D0R6D4	795	D	N
Q6WRI0	LP/P	-	A0A2D0R6D4	156	R	L
Q6WRI0	LP/P	-	A0A2D0R6D4	161	E	K
Q5DX21	LB/B	-	A0A1S3FE83	39	P	T
Q5DX21	LB/B	-	A0A1S3FE83	333	E	D
Q5DX21	LB/B	-	A0A1S3FE83	388	S	N
Q8N9C0	LB/B	-	H2S4Y8	94	A	P
Q8N9C0	LB/B	-	H2S4Y8	130	L	R
Q8N9C0	LB/B	-	H2S4Y8	414	V	I
Q8N9C0	LB/B	-	H2S4Y8	472	R	Q
Q8N9C0	LB/B	-	H2S4Y8	503	S	I
Q8N9C0	LB/B	-	H2S4Y8	559	M	V
Q8N9C0	LB/B	-	H2S4Y8	677	L	F
Q8N9C0	LB/B	-	H2S4Y8	7	R	W
O75054	LB/B	-	H2N684	51	S	P
O75054	LB/B	-	H2N684	1020	D	E
O75054	LB/B	-	H2N684	1073	Q	R
Q9NSI5	LB/B	-	Q5VJ70	49	R	T
Q9NSI5	LB/B	-	Q5VJ70	156	N	K
Q9NSI5	LB/B	-	Q5VJ70	170	R	W
Q9NSI5	LB/B	-	Q5VJ70	350	D	E
O95976	LB/B	-	A0A1U8BYL8	74	Q	R
O95976	LB/B	-	A0A1U8BYL8	173	F	S
O95976	LB/B	-	A0A1U8BYL8	186	N	K
Q9UPX0	LB/B	-	L9KQI2	178	T	M
Q9UPX0	LB/B	-	L9KQI2	268	E	K
Q14623	LP/P	Acrocapitofemoral dysplasia (ACFD) [MIM:607778]	A0A2U9NKQ0	46	P	L
Q14623	LP/P	Brachydactyly A1 (BDA1) [MIM:112500]	A0A2U9NKQ0	95	E	K
Q14623	LP/P	Brachydactyly A1 (BDA1) [MIM:112500]	A0A2U9NKQ0	100	D	E
Q14623	LP/P	Brachydactyly A1 (BDA1) [MIM:112500]	A0A2U9NKQ0	100	D	N
Q14623	LP/P	Brachydactyly A1 (BDA1) [MIM:112500]	A0A2U9NKQ0	131	E	K
Q14623	LP/P	Acrocapitofemoral dysplasia (ACFD) [MIM:607778]	A0A2U9NKQ0	190	V	A
Q8IYA8	LB/B	-	F7C7L7	440	D	E
Q70UQ0	LB/B	-	A0A2Y9DUP2	265	G	S
O14920	LB/B	-	A0A1D5PFV1	554	R	W
O14920	LB/B	-	A0A1D5PFV1	369	Q	R
O14920	LB/B	-	A0A1D5PFV1	526	R	Q
O14920	LB/B	-	A0A1D5PFV1	710	A	T
O14920	LB/B	-	A0A1D5PFV1	734	F	L
O14920	LB/B	-	A0A1D5PFV1	736	A	T
O14920	LP/P	Immunodeficiency 15A (IMD15A) [MIM:618204]	A0A1D5PFV1	203	V	I
Q14164	LB/B	-	H3ARH4	713	P	L
Q14164	LB/B	-	H3ARH4	128	E	K
Q14164	LB/B	-	H3ARH4	371	A	T
Q14164	LB/B	-	H3ARH4	515	E	D
Q14164	LB/B	-	H3ARH4	543	I	M
Q14164	LB/B	-	H3ARH4	602	A	V
Q14164	LB/B	-	H3ARH4	483	T	M
Q14164	LB/B	-	H3ARH4	660	G	E
Q96MC9	LB/B	-	H2N3Y2	213	G	A
Q96MC9	LB/B	-	H2N3Y2	233	P	S
Q96MC9	LB/B	-	H2N3Y2	259	T	M
Q9Y6K9	LP/P	Incontinentia pigmenti (IP) [MIM:308300]	A0A212D8P4	407	M	V
Q9Y6K9	LP/P	Ectodermal dysplasia and immunodeficiency 1 (EDAID1) [MIM:300291]	A0A212D8P4	175	R	P
Q9Y6K9	LP/P	Ectodermal dysplasia and immunodeficiency 1 (EDAID1) [MIM:300291]	A0A212D8P4	227	L	P
Q9Y6K9	LP/P	Ectodermal dysplasia and immunodeficiency 1 (EDAID1) [MIM:300291]	A0A212D8P4	288	A	G
Q9Y6K9	LP/P	Ectodermal dysplasia and immunodeficiency 1 (EDAID1) [MIM:300291]	A0A212D8P4	311	D	N
Q9Y6K9	LP/P	Ectodermal dysplasia and immunodeficiency 1 (EDAID1) [MIM:300291]	A0A212D8P4	406	D	V
Q9Y6K9	LP/P	Ectodermal dysplasia and immunodeficiency 1 (EDAID1) [MIM:300291]	A0A212D8P4	417	C	F
Q9Y6K9	LP/P	Ectodermal dysplasia and immunodeficiency 1 (EDAID1) [MIM:300291]	A0A212D8P4	417	C	R
Q9Y6K9	LP/P	Incontinentia pigmenti (IP) [MIM:308300]	A0A212D8P4	57	E	K
Q9Y6K9	LB/B	-	A0A212D8P4	113	D	N
Q9Y6K9	LP/P	Incontinentia pigmenti (IP) [MIM:308300]	A0A212D8P4	123	R	W
Q9Y6K9	LP/P	Ectodermal dysplasia and immunodeficiency 1 (EDAID1) [MIM:300291]	A0A212D8P4	153	L	R
Q9Y6K9	LP/P	Immunodeficiency 33 (IMD33) [MIM:300636]	A0A212D8P4	417	C	Y
Q9Y6K9	LP/P	Immunodeficiency 33 (IMD33) [MIM:300636]	A0A212D8P4	173	R	G
Q9Y6K9	LP/P	Immunodeficiency 33 (IMD33) [MIM:300636]	A0A212D8P4	315	E	A
Q9Y6K9	LP/P	Immunodeficiency 33 (IMD33) [MIM:300636]	A0A212D8P4	319	R	Q
Q9Y6K9	LP/P	Incontinentia pigmenti (IP) [MIM:308300]	A0A212D8P4	323	A	P
Q9Y6K9	LP/P	Incontinentia pigmenti (IP) [MIM:308300]	A0A212D8P4	170	L	P
Q9Y6K9	LP/P	Incontinentia pigmenti (IP) [MIM:308300]	A0A212D8P4	173	R	Q
Q9Y6K9	LP/P	Incontinentia pigmenti (IP) [MIM:308300]	A0A212D8P4	183	Q	H
Q9Y6K9	LP/P	Incontinentia pigmenti (IP) [MIM:308300]	A0A212D8P4	314	A	P
Q9Y6K9	LP/P	Incontinentia pigmenti (IP) [MIM:308300]	A0A212D8P4	322	L	P
Q9Y6K9	LP/P	Incontinentia pigmenti (IP) [MIM:308300]	A0A212D8P4	413	H	Y
Q13422	LP/P	Immunodeficiency, common variable, 13 (CVID13) [MIM:616873]	W5K2N4	162	R	L
Q13422	LP/P	Immunodeficiency, common variable, 13 (CVID13) [MIM:616873]	W5K2N4	162	R	Q
Q13422	LP/P	Immunodeficiency, common variable, 13 (CVID13) [MIM:616873]	W5K2N4	167	H	R
Q13422	LP/P	Immunodeficiency, common variable, 13 (CVID13) [MIM:616873]	W5K2N4	184	R	Q
Q13422	LP/P	Immunodeficiency, common variable, 13 (CVID13) [MIM:616873]	W5K2N4	210	Y	C
Q9UKS7	LB/B	-	A0A091ULK7	93	N	S
Q9UKT9	LP/P	Immunodeficiency 84 (IMD84) [MIM:619437]	G1KBS5	159	G	R
P22301	LB/B	-	M3YEY4	15	G	R
Q13651	LB/B	-	F6SGX7	61	L	V
Q13651	LB/B	-	F6SGX7	113	V	I
Q13651	LB/B	-	F6SGX7	159	S	G
Q13651	LB/B	-	F6SGX7	212	R	Q
Q13651	LB/B	-	F6SGX7	351	R	G
Q13651	LB/B	-	F6SGX7	420	S	L
Q13651	LB/B	-	F6SGX7	224	I	V
Q13651	LB/B	-	F6SGX7	353	P	S
Q13651	LP/P	Inflammatory bowel disease 28, autosomal recessive (IBD28) [MIM:613148]	F6SGX7	84	T	I
Q13651	LP/P	Inflammatory bowel disease 28, autosomal recessive (IBD28) [MIM:613148]	F6SGX7	141	G	R
Q13651	LP/P	Inflammatory bowel disease 28, autosomal recessive (IBD28) [MIM:613148]	F6SGX7	69	W	R
Q13651	LP/P	Inflammatory bowel disease 28, autosomal recessive (IBD28) [MIM:613148]	F6SGX7	91	Y	C
Q13651	LP/P	Inflammatory bowel disease 28, autosomal recessive (IBD28) [MIM:613148]	F6SGX7	101	R	W
Q13651	LP/P	Inflammatory bowel disease 28, autosomal recessive (IBD28) [MIM:613148]	F6SGX7	117	R	H
Q13651	LP/P	Inflammatory bowel disease 28, autosomal recessive (IBD28) [MIM:613148]	F6SGX7	262	R	C
Q08334	LB/B	-	A0A2K6UCD6	47	K	E
Q99665	LB/B	-	G5BSQ2	185	I	V
Q99665	LB/B	-	G5BSQ2	420	G	R
Q99665	LB/B	-	G5BSQ2	426	Q	H
Q99665	LB/B	-	G5BSQ2	465	G	D
Q99665	LB/B	-	G5BSQ2	625	A	V
Q99665	LB/B	-	G5BSQ2	201	T	I
Q99665	LB/B	-	G5BSQ2	313	R	G
Q99665	LB/B	-	G5BSQ2	720	H	R
Q99665	LB/B	-	G5BSQ2	13	M	V
Q99665	LB/B	-	G5BSQ2	149	R	Q
Q99665	LB/B	-	G5BSQ2	808	L	R
Q99665	LB/B	-	G5BSQ2	420	G	S
P35225	LB/B	-	L8IYT3	144	R	Q
Q14627	LB/B	-	H2PWJ0	111	W	R
Q13261	LB/B	-	A0A2J8KTR3	182	N	T
Q14005	LB/B	-	D4A4I9	889	R	Q
Q14005	LB/B	-	D4A4I9	906	S	L
Q14005	LB/B	-	D4A4I9	1147	N	K
Q14005	LB/B	-	D4A4I9	1027	S	T
Q14005	LB/B	-	D4A4I9	1176	H	R
Q14005	LB/B	-	D4A4I9	434	P	S
Q9P0M4	LB/B	-	A0A091DN07	25	R	G
Q96PD4	LB/B	-	H2QT65	126	E	G
Q96PD4	LB/B	-	H2QT65	155	V	I
Q96PD4	LB/B	-	H2QT65	161	H	R
Q96PD4	LP/P	Candidiasis, familial, 6 (CANDF6) [MIM:613956]	H2QT65	95	S	L
Q96F46	LB/B	-	U3IYI2	367	A	V
Q96F46	LB/B	-	U3IYI2	580	R	H
Q96F46	LB/B	-	U3IYI2	562	P	Q
Q8NAC3	LB/B	-	F7D217	182	S	L
Q8NFM7	LB/B	-	G3NIB5	255	T	M
Q8NFM7	LB/B	-	G3NIB5	301	V	M
Q8NFM7	LP/P	Hypogonadotropic hypogonadism 18 with or without anosmia (HH18) [MIM:615267]	G3NIB5	131	K	T
Q8NFM7	LP/P	Hypogonadotropic hypogonadism 18 with or without anosmia (HH18) [MIM:615267]	G3NIB5	162	K	R
Q8NFM7	LP/P	Hypogonadotropic hypogonadism 18 with or without anosmia (HH18) [MIM:615267]	G3NIB5	306	P	S
Q8NFM7	LP/P	Hypogonadotropic hypogonadism 18 with or without anosmia (HH18) [MIM:615267]	G3NIB5	379	Y	C
Q8NFM7	LP/P	Hypogonadotropic hypogonadism 18 with or without anosmia (HH18) [MIM:615267]	G3NIB5	468	S	L
Q8NFM7	LP/P	Hypogonadotropic hypogonadism 18 with or without anosmia (HH18) [MIM:615267]	G3NIB5	577	P	Q
Q8NFM7	LP/P	Hypogonadotropic hypogonadism 18 with or without anosmia (HH18) [MIM:615267]	G3NIB5	735	A	V
Q6ZVW7	LB/B	-	G3TN29	333	L	P
Q6ZVW7	LB/B	-	G3TN29	70	G	R
O95998	LB/B	-	A0A1U7TW96	121	R	Q
O95998	LB/B	-	A0A1U7TW96	91	R	H
Q13478	LB/B	-	L5K2Q4	210	R	H
Q13478	LB/B	-	L5K2Q4	232	N	K
Q13478	LB/B	-	L5K2Q4	310	S	N
Q13478	LB/B	-	L5K2Q4	423	G	R
O95256	LB/B	-	H0ZHV1	350	V	I
Q9UHD0	LB/B	-	M3W5Z2	175	F	S
P01583	LB/B	-	O46612	85	R	Q
P01583	LB/B	-	O46612	114	A	S
P01583	LB/B	-	O46612	138	D	N
P01583	LB/B	-	O46612	125	N	D
P01583	LB/B	-	O46612	176	D	H
P01584	LB/B	-	Q712K7	141	E	N
P14778	LB/B	-	A0A212CXK3	124	A	G
P14778	LB/B	-	A0A212CXK3	344	T	M
P27930	LB/B	-	I3MBR5	181	E	K
P27930	LB/B	-	I3MBR5	292	E	K
Q9NPH3	LB/B	-	U3JY07	473	V	M
Q9NZN1	LB/B	-	U3IZL0	379	K	R
Q9NZN1	LB/B	-	U3IZL0	618	Q	H
Q9NZN1	LB/B	-	U3IZL0	637	T	S
Q9NZN1	LB/B	-	U3IZL0	643	I	V
Q01638	LB/B	-	A0A093JCH6	78	A	E
Q01638	LB/B	-	A0A093JCH6	433	A	T
Q01638	LB/B	-	A0A093JCH6	501	Q	K
Q01638	LB/B	-	A0A093JCH6	501	Q	R
Q01638	LB/B	-	A0A093JCH6	549	T	I
Q01638	LB/B	-	A0A093JCH6	551	L	S
Q9NYY1	LB/B	-	F7AQ09	107	R	Q
Q9UHF4	LB/B	-	L9L3F9	259	V	I
Q9UHF4	LB/B	-	L9L3F9	382	L	F
Q9HBE4	LP/P	Immunodeficiency, common variable, 11 (CVID11) [MIM:615767]	A0A061III4	56	L	P
Q9HBE5	LB/B	-	G1P3X4	191	R	C
Q9HBE5	LB/B	-	G1P3X4	318	S	R
Q9HBE5	LB/B	-	G1P3X4	484	G	S
Q9HBE5	LP/P	Immunodeficiency 56 (IMD56) [MIM:615207]	G1P3X4	201	R	L
Q9GZX6	LB/B	-	A0A1S3FC05	158	S	G
Q8N6P7	LB/B	-	H0XNQ7	130	S	P
Q8N6P7	LB/B	-	H0XNQ7	205	V	I
Q8N6P7	LB/B	-	H0XNQ7	209	A	S
Q8N6P7	LB/B	-	H0XNQ7	222	L	P
Q8N6P7	LB/B	-	H0XNQ7	407	M	V
Q8N6P7	LB/B	-	H0XNQ7	518	R	G
Q969J5	LB/B	-	H2PKF4	16	L	P
Q969J5	LB/B	-	H2PKF4	190	E	K
Q5VWK5	LB/B	-	K7FH25	3	Q	H
Q5VWK5	LB/B	-	K7FH25	310	L	P
Q5VWK5	LB/B	-	K7FH25	381	R	Q
Q5VWK5	LB/B	-	K7FH25	175	T	N
Q13007	LB/B	-	A0A287D857	124	Y	H
Q13007	LB/B	-	A0A287D857	125	H	R
Q13007	LB/B	-	A0A287D857	131	V	L
Q8NEV9	LB/B	-	A0A2Y9ER57	59	S	A
Q8NEV9	LB/B	-	A0A2Y9ER57	119	L	P
P31785	LP/P	Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400]	W5Q3K9	39	D	N
P31785	LP/P	Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400]	W5Q3K9	62	C	G
P31785	LP/P	Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400]	W5Q3K9	68	E	G
P31785	LP/P	Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400]	W5Q3K9	68	E	K
P31785	LP/P	Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400]	W5Q3K9	84	N	K
P31785	LP/P	Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400]	W5Q3K9	89	Y	C
P31785	LP/P	Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400]	W5Q3K9	105	Y	C
P31785	LP/P	Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400]	W5Q3K9	114	G	D
P31785	LP/P	Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400]	W5Q3K9	115	C	F
P31785	LP/P	Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400]	W5Q3K9	115	C	R
P31785	LP/P	Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400]	W5Q3K9	123	H	P
P31785	LP/P	Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400]	W5Q3K9	125	Y	N
P31785	LP/P	Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400]	W5Q3K9	144	Q	P
P31785	LP/P	Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400]	W5Q3K9	153	I	N
P31785	LP/P	Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400]	W5Q3K9	156	A	V
P31785	LP/P	Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400]	W5Q3K9	162	L	H
P31785	LP/P	Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400]	W5Q3K9	172	L	P
P31785	LP/P	Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400]	W5Q3K9	172	L	Q
P31785	LP/P	Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400]	W5Q3K9	182	C	R
P31785	LP/P	Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400]	W5Q3K9	183	L	S
P31785	LP/P	X-linked combined immunodeficiency (XCID) [MIM:312863]	W5Q3K9	222	R	C
P31785	LP/P	Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400]	W5Q3K9	224	R	W
P31785	LP/P	Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400]	W5Q3K9	226	R	C
P31785	LP/P	Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400]	W5Q3K9	226	R	H
P31785	LP/P	Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400]	W5Q3K9	227	F	C
P31785	LP/P	Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400]	W5Q3K9	230	L	P
P31785	LP/P	Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400]	W5Q3K9	231	C	Y
P31785	LP/P	Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400]	W5Q3K9	232	G	R
P31785	LP/P	Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400]	W5Q3K9	240	W	C
P31785	LP/P	Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400]	W5Q3K9	241	S	I
P31785	LP/P	Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400]	W5Q3K9	270	M	R
P31785	LP/P	Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400]	W5Q3K9	285	R	Q
P31785	LP/P	X-linked combined immunodeficiency (XCID) [MIM:312863]	W5Q3K9	293	L	Q
P31785	LB/B	-	W5Q3K9	109	E	K
P31785	LB/B	-	W5Q3K9	44	T	S
P08700	LB/B	-	Q9BDX4	15	R	H
P08700	LB/B	-	Q9BDX4	27	P	S
P08700	LB/B	-	Q9BDX4	3	R	C
P08700	LB/B	-	Q9BDX4	60	N	S
Q8NI17	LB/B	-	A0A2K5CW85	155	D	N
Q8NI17	LB/B	-	A0A2K5CW85	497	S	N
Q8NI17	LP/P	Amyloidosis, primary localized cutaneous, 2 (PLCA2) [MIM:613955]	A0A2K5CW85	489	S	F
P24001	LB/B	-	A0A2J8S7U4	152	D	N
O95760	LB/B	-	A0A2K6FKE8	263	I	M
Q6ZMJ4	LB/B	-	A0A2Y9E7F5	123	E	Q
Q6ZMJ4	LB/B	-	A0A2Y9E7F5	195	S	T
Q9UHA7	LB/B	-	A0A2Y9FIJ6	12	Q	R
Q9UHA7	LB/B	-	A0A2Y9FIJ6	63	I	T
Q9UHA7	LB/B	-	A0A2Y9FIJ6	134	G	R
Q9NZH8	LB/B	-	H2P5G4	69	Q	K
Q9NZH6	LB/B	-	A0A2K6LBU2	31	G	V
Q9NZH6	LB/B	-	A0A2K6LBU2	42	T	A
Q9NZH6	LB/B	-	A0A2K6LBU2	108	P	L
Q9NZH6	LB/B	-	A0A2K6LBU2	152	R	W
Q9NZH6	LB/B	-	A0A2K6LBU2	164	W	R
Q9NZH6	LB/B	-	A0A2K6LBU2	218	D	N
Q9NZH6	LB/B	-	A0A2K6LBU2	50	P	R
Q9NZH6	LB/B	-	A0A2K6LBU2	54	N	S
Q9NZH6	LP/P	Inflammatory bowel disease 31, autosomal recessive (IBD31) [MIM:619398]	A0A2K6LBU2	177	I	T
P26951	LB/B	-	A0A2I2ZRX5	12	A	T
P26951	LB/B	-	A0A2I2ZRX5	77	E	G
P26951	LB/B	-	A0A2I2ZRX5	123	S	T
P26951	LB/B	-	A0A2I2ZRX5	323	V	L
P05112	LB/B	-	Q04745	27	C	R
Q96RQ9	LB/B	-	D3Z4E0	501	A	S
Q96RQ9	LB/B	-	D3Z4E0	92	N	D
P24394	LB/B	-	A0A2U4A9J3	75	I	V
P24394	LB/B	-	A0A2U4A9J3	576	Q	R
P24394	LB/B	-	A0A2U4A9J3	400	E	A
P24394	LB/B	-	A0A2U4A9J3	431	C	R
P24394	LB/B	-	A0A2U4A9J3	436	S	L
P24394	LB/B	-	A0A2U4A9J3	503	S	P
P24394	LB/B	-	A0A2U4A9J3	579	V	I
P24394	LB/B	-	A0A2U4A9J3	752	S	A
P24394	LB/B	-	A0A2U4A9J3	786	S	P
P24394	LB/B	-	A0A2U4A9J3	387	S	L
P24394	LB/B	-	A0A2U4A9J3	675	P	S
P24394	LB/B	-	A0A2U4A9J3	492	A	T
P24394	LB/B	-	A0A2U4A9J3	492	A	V
P24394	LB/B	-	A0A2U4A9J3	75	I	F
P24394	LB/B	-	A0A2U4A9J3	75	I	L
Q01344	LB/B	-	A0A091IDH5	129	I	V
Q01344	LB/B	-	A0A091IDH5	262	V	A
P05231	LB/B	-	A0A2I3HU53	32	P	S
P05231	LB/B	-	A0A2I3HU53	162	D	V
P05231	LB/B	-	A0A2I3HU53	162	D	E
P16871	LB/B	-	A0A1U7RZD3	66	I	T
P16871	LB/B	-	A0A1U7RZD3	113	E	D
P16871	LB/B	-	A0A1U7RZD3	138	V	I
P16871	LB/B	-	A0A1U7RZD3	244	T	I
P16871	LB/B	-	A0A1U7RZD3	356	I	V
P16871	LP/P	Immunodeficiency 104 (IMD104) [MIM:608971]	A0A1U7RZD3	132	P	S
P16871	LB/B	-	A0A1U7RZD3	414	T	M
P15248	LB/B	-	G5BX09	117	T	M
Q01113	LB/B	-	A0A2K6U1Y9	239	E	Q
Q01113	LB/B	-	A0A2K6U1Y9	288	Y	C
Q01113	LB/B	-	A0A2K6U1Y9	63	R	K
Q01113	LB/B	-	A0A2K6U1Y9	331	G	R
Q01113	LB/B	-	A0A2K6U1Y9	365	R	H
Q86SU0	LP/P	Deafness, autosomal recessive, 42 (DFNB42) [MIM:609646]	W5MTT1	97	R	Q
Q86SU0	LB/B	-	W5MTT1	463	R	C
Q86SU0	LB/B	-	W5MTT1	357	I	V
Q71H61	LB/B	-	W5PQK5	202	V	I
Q12906	LB/B	-	H0ZU10	50	D	H
Q12906	LB/B	-	H0ZU10	501	A	S
Q9H0C8	LB/B	-	A0A2Y9E523	66	I	M
Q16891	LB/B	-	I3KLN2	124	P	S
Q16891	LB/B	-	I3KLN2	294	A	V
O14732	LB/B	-	F1PPN3	88	A	T
Q9P2X3	LB/B	-	A0A0N4W4A5	125	D	E
Q9P2X3	LB/B	-	A0A0N4W4A5	151	L	V
Q9P2X3	LB/B	-	A0A0N4W4A5	74	A	V
Q17R60	LB/B	-	A0A0P7XK50	518	H	D
Q17R60	LB/B	-	A0A0P7XK50	704	R	W
Q17R60	LB/B	-	A0A0P7XK50	463	G	V
Q17R60	LB/B	-	A0A0P7XK50	569	K	R
Q17R60	LB/B	-	A0A0P7XK50	711	R	H
Q17R60	LB/B	-	A0A0P7XK50	761	S	N
Q17R60	LP/P	Macular dystrophy, vitelliform, 4 (VMD4) [MIM:616151]	A0A0P7XK50	238	L	R
Q17R60	LP/P	Retinitis pigmentosa 91 (RP91) [MIM:153870]	A0A0P7XK50	579	L	P
Q16352	LB/B	-	P79933	149	D	H
Q16352	LB/B	-	P79933	92	T	S
Q27J81	LB/B	-	A0A2I3GSV3	1096	P	S
Q27J81	LB/B	-	A0A2I3GSV3	1135	T	M
Q27J81	LP/P	Focal segmental glomerulosclerosis 5 (FSGS5) [MIM:613237]	A0A2I3GSV3	13	A	T
Q27J81	LP/P	Focal segmental glomerulosclerosis 5 (FSGS5) [MIM:613237]	A0A2I3GSV3	42	L	P
Q27J81	LP/P	Charcot-Marie-Tooth disease, dominant intermediate E (CMTDIE) [MIM:614455]	A0A2I3GSV3	184	E	K
Q27J81	LP/P	Focal segmental glomerulosclerosis 5 (FSGS5) [MIM:613237]	A0A2I3GSV3	184	E	K
Q27J81	LP/P	Focal segmental glomerulosclerosis 5 (FSGS5) [MIM:613237]	A0A2I3GSV3	186	S	P
Q27J81	LP/P	Focal segmental glomerulosclerosis 5 (FSGS5) [MIM:613237]	A0A2I3GSV3	198	L	R
Q27J81	LP/P	Focal segmental glomerulosclerosis 5 (FSGS5) [MIM:613237]	A0A2I3GSV3	214	R	H
Q27J81	LP/P	Focal segmental glomerulosclerosis 5 (FSGS5) [MIM:613237]	A0A2I3GSV3	218	R	Q
Q27J81	LP/P	Focal segmental glomerulosclerosis 5 (FSGS5) [MIM:613237]	A0A2I3GSV3	218	R	W
Q27J81	LP/P	Focal segmental glomerulosclerosis 5 (FSGS5) [MIM:613237]	A0A2I3GSV3	220	E	K
Q27J81	LP/P	Charcot-Marie-Tooth disease, dominant intermediate E (CMTDIE) [MIM:614455]	A0A2I3GSV3	104	C	F
Q27J81	LP/P	Charcot-Marie-Tooth disease, dominant intermediate E (CMTDIE) [MIM:614455]	A0A2I3GSV3	104	C	R
Q27J81	LP/P	Charcot-Marie-Tooth disease, dominant intermediate E (CMTDIE) [MIM:614455]	A0A2I3GSV3	104	C	W
Q27J81	LP/P	Charcot-Marie-Tooth disease, dominant intermediate E (CMTDIE) [MIM:614455]	A0A2I3GSV3	128	L	P
Q27J81	LP/P	Charcot-Marie-Tooth disease, dominant intermediate E (CMTDIE) [MIM:614455]	A0A2I3GSV3	132	L	R
Q27J81	LP/P	Focal segmental glomerulosclerosis 5 (FSGS5) [MIM:613237]	A0A2I3GSV3	245	L	P
Q27J81	LP/P	Focal segmental glomerulosclerosis 5 (FSGS5) [MIM:613237]	A0A2I3GSV3	76	L	P
Q27J81	LP/P	Focal segmental glomerulosclerosis 5 (FSGS5) [MIM:613237]	A0A2I3GSV3	177	R	H
Q27J81	LB/B	-	A0A2I3GSV3	183	N	K
Q27J81	LP/P	Focal segmental glomerulosclerosis 5 (FSGS5) [MIM:613237]	A0A2I3GSV3	184	E	Q
Q27J81	LP/P	Focal segmental glomerulosclerosis 5 (FSGS5) [MIM:613237]	A0A2I3GSV3	193	Y	H
Q27J81	LP/P	Focal segmental glomerulosclerosis 5 (FSGS5) [MIM:613237]	A0A2I3GSV3	202	N	D
Q27J81	LP/P	Focal segmental glomerulosclerosis 5 (FSGS5) [MIM:613237]	A0A2I3GSV3	203	A	D
Q27J81	LP/P	Focal segmental glomerulosclerosis 5 (FSGS5) [MIM:613237]	A0A2I3GSV3	214	R	C
Q27J81	LB/B	-	A0A2I3GSV3	547	G	D
Q27J81	LB/B	-	A0A2I3GSV3	1160	G	S
Q27J81	LP/P	Charcot-Marie-Tooth disease, dominant intermediate E (CMTDIE) [MIM:614455]	A0A2I3GSV3	105	V	G
Q27J81	LB/B	-	A0A2I3GSV3	114	G	D
Q27J81	LP/P	Charcot-Marie-Tooth disease, dominant intermediate E (CMTDIE) [MIM:614455]	A0A2I3GSV3	132	L	P
Q27J81	LP/P	Focal segmental glomerulosclerosis 5 (FSGS5) [MIM:613237]	A0A2I3GSV3	162	L	R
Q27J81	LP/P	Focal segmental glomerulosclerosis 5 (FSGS5) [MIM:613237]	A0A2I3GSV3	81	L	P
Q27J81	LP/P	Focal segmental glomerulosclerosis 5 (FSGS5) [MIM:613237]	A0A2I3GSV3	151	C	R
Q27J81	LP/P	Focal segmental glomerulosclerosis 5 (FSGS5) [MIM:613237]	A0A2I3GSV3	158	H	D
Q27J81	LP/P	Focal segmental glomerulosclerosis 5 (FSGS5) [MIM:613237]	A0A2I3GSV3	177	R	C
Q9NXR8	LP/P	Squamous cell carcinoma of the head and neck (HNSCC) [MIM:275355]	A0A0V0GC48	20	D	G
P05111	LB/B	-	F6WBP4	257	A	T
P05111	LB/B	-	F6WBP4	227	G	R
P08476	LB/B	-	A0A2I0UEJ6	299	Q	P
P55103	LB/B	-	A0A060X7S6	322	R	Q
O95050	LB/B	-	A0A1U7SYP5	205	M	V
O95050	LB/B	-	A0A1U7SYP5	219	E	G
O95050	LB/B	-	A0A1U7SYP5	28	D	N
O95050	LB/B	-	A0A1U7SYP5	246	N	S
O95050	LB/B	-	A0A1U7SYP5	254	F	C
O95050	LB/B	-	A0A1U7SYP5	258	R	H
O95050	LB/B	-	A0A1U7SYP5	214	V	M
Q9ULG1	LB/B	-	Q4SC15	882	I	V
Q9ULG1	LB/B	-	Q4SC15	1108	V	G
Q96PE3	LB/B	-	F1Q736	604	T	A
O15327	LB/B	-	A0A091D646	311	Y	F
Q14642	LB/B	-	V9KRP0	45	K	R
P32019	LB/B	-	A0A060XWR8	745	M	T
P32019	LB/B	-	A0A060XWR8	46	G	S
Q92835	LB/B	-	G5BXG5	1169	H	Y
Q9NRR6	LB/B	-	A0A2Y9J6Q9	201	I	M
Q9NRR6	LP/P	Joubert syndrome 1 (JBTS1) [MIM:213300]	A0A2Y9J6Q9	378	R	C
Q9NRR6	LP/P	Joubert syndrome 1 (JBTS1) [MIM:213300]	A0A2Y9J6Q9	435	R	Q
Q9NRR6	LP/P	Joubert syndrome 1 (JBTS1) [MIM:213300]	A0A2Y9J6Q9	512	R	W
Q9NRR6	LP/P	Joubert syndrome 1 (JBTS1) [MIM:213300]	A0A2Y9J6Q9	515	R	W
Q9NRR6	LP/P	Joubert syndrome 1 (JBTS1) [MIM:213300]	A0A2Y9J6Q9	563	R	H
Q9NRR6	LP/P	Joubert syndrome 1 (JBTS1) [MIM:213300]	A0A2Y9J6Q9	580	K	E
Q9NRR6	LP/P	Joubert syndrome 1 (JBTS1) [MIM:213300]	A0A2Y9J6Q9	621	R	Q
Q9NRR6	LP/P	Joubert syndrome 1 (JBTS1) [MIM:213300]	A0A2Y9J6Q9	286	G	R
Q9NRR6	LP/P	Joubert syndrome 1 (JBTS1) [MIM:213300]	A0A2Y9J6Q9	303	V	M
Q9NRR6	LP/P	Joubert syndrome 1 (JBTS1) [MIM:213300]	A0A2Y9J6Q9	345	R	S
Q9NRR6	LP/P	Joubert syndrome 1 (JBTS1) [MIM:213300]	A0A2Y9J6Q9	426	T	N
Q9NRR6	LP/P	Joubert syndrome 1 (JBTS1) [MIM:213300]	A0A2Y9J6Q9	534	Y	D
Q9NRR6	LP/P	Joubert syndrome 1 (JBTS1) [MIM:213300]	A0A2Y9J6Q9	585	R	C
Q9NRR6	LP/P	Joubert syndrome 1 (JBTS1) [MIM:213300]	A0A2Y9J6Q9	641	C	R
Q9NRR6	LP/P	Joubert syndrome 1 (JBTS1) [MIM:213300]	A0A2Y9J6Q9	522	G	A
Q9Y2H2	LB/B	-	U3JHJ6	453	I	V
Q9Y2H2	LB/B	-	U3JHJ6	997	N	D
Q15735	LB/B	-	A0A2K6SXA3	333	S	I
Q9BT40	LP/P	Muscular dystrophy, congenital, with cataracts and intellectual disability (MDCCAID) [MIM:617404]	G3NPM8	23	V	M
Q9BT40	LP/P	Muscular dystrophy, congenital, with cataracts and intellectual disability (MDCCAID) [MIM:617404]	G3NPM8	50	I	T
Q9BT40	LP/P	Muscular dystrophy, congenital, with cataracts and intellectual disability (MDCCAID) [MIM:617404]	G3NPM8	93	M	V
Q9BT40	LP/P	Muscular dystrophy, congenital, with cataracts and intellectual disability (MDCCAID) [MIM:617404]	G3NPM8	140	G	S
Q9BT40	LP/P	Muscular dystrophy, congenital, with cataracts and intellectual disability (MDCCAID) [MIM:617404]	G3NPM8	269	D	N
Q9BT40	LP/P	Muscular dystrophy, congenital, with cataracts and intellectual disability (MDCCAID) [MIM:617404]	G3NPM8	300	Y	C
Q9BT40	LP/P	Muscular dystrophy, congenital, with cataracts and intellectual disability (MDCCAID) [MIM:617404]	G3NPM8	363	I	T
P01308	LP/P	Hyperproinsulinemia (HPRI) [MIM:616214]	A0A1A6FUB4	34	H	D
P01308	LB/B	-	A0A1A6FUB4	48	F	S
P01308	LB/B	-	A0A1A6FUB4	49	F	L
P01308	LP/P	Hyperproinsulinemia (HPRI) [MIM:616214]	A0A1A6FUB4	89	R	H
P01308	LP/P	Hyperproinsulinemia (HPRI) [MIM:616214]	A0A1A6FUB4	89	R	L
P01308	LB/B	-	A0A1A6FUB4	92	V	L
P01308	LP/P	Maturity-onset diabetes of the young 10 (MODY10) [MIM:613370]	A0A1A6FUB4	6	R	C
P01308	LP/P	Maturity-onset diabetes of the young 10 (MODY10) [MIM:613370]	A0A1A6FUB4	6	R	H
P01308	LP/P	Diabetes mellitus, permanent neonatal, 4 (PNDM4) [MIM:618858]	A0A1A6FUB4	24	A	D
P01308	LP/P	Diabetes mellitus, permanent neonatal, 4 (PNDM4) [MIM:618858]	A0A1A6FUB4	29	H	D
P01308	LP/P	Diabetes mellitus, permanent neonatal, 4 (PNDM4) [MIM:618858]	A0A1A6FUB4	32	G	R
P01308	LP/P	Diabetes mellitus, permanent neonatal, 4 (PNDM4) [MIM:618858]	A0A1A6FUB4	32	G	S
P01308	LP/P	Diabetes mellitus, permanent neonatal, 4 (PNDM4) [MIM:618858]	A0A1A6FUB4	35	L	P
P01308	LP/P	Diabetes mellitus, permanent neonatal, 4 (PNDM4) [MIM:618858]	A0A1A6FUB4	43	C	G
P01308	LP/P	Maturity-onset diabetes of the young 10 (MODY10) [MIM:613370]	A0A1A6FUB4	46	R	Q
P01308	LP/P	Diabetes mellitus, permanent neonatal, 4 (PNDM4) [MIM:618858]	A0A1A6FUB4	47	G	V
P01308	LP/P	Diabetes mellitus, permanent neonatal, 4 (PNDM4) [MIM:618858]	A0A1A6FUB4	48	F	C
P01308	LP/P	Type 1 diabetes mellitus 2 (T1D2) [MIM:125852]	A0A1A6FUB4	55	R	C
P01308	LB/B	-	A0A1A6FUB4	68	L	M
P01308	LP/P	Diabetes mellitus, permanent neonatal, 4 (PNDM4) [MIM:618858]	A0A1A6FUB4	89	R	C
P01308	LP/P	Diabetes mellitus, permanent neonatal, 4 (PNDM4) [MIM:618858]	A0A1A6FUB4	90	G	C
P01308	LP/P	Diabetes mellitus, permanent neonatal, 4 (PNDM4) [MIM:618858]	A0A1A6FUB4	96	C	S
P01308	LP/P	Diabetes mellitus, permanent neonatal, 4 (PNDM4) [MIM:618858]	A0A1A6FUB4	96	C	Y
P01308	LP/P	Diabetes mellitus, permanent neonatal, 4 (PNDM4) [MIM:618858]	A0A1A6FUB4	101	S	C
P01308	LP/P	Diabetes mellitus, permanent neonatal, 4 (PNDM4) [MIM:618858]	A0A1A6FUB4	103	Y	C
P01308	LP/P	Diabetes mellitus, permanent neonatal, 4 (PNDM4) [MIM:618858]	A0A1A6FUB4	108	Y	C
O15503	LB/B	-	A0A146YC77	27	A	T
P51460	LB/B	-	Q9WUK0	24	A	G
P51460	LB/B	-	Q9WUK0	43	V	L
P51460	LB/B	-	Q9WUK0	60	T	A
P51460	LP/P	Cryptorchidism (CRYPTO) [MIM:219050]	Q9WUK0	93	P	L
P51460	LP/P	Cryptorchidism (CRYPTO) [MIM:219050]	Q9WUK0	102	R	C
P51460	LB/B	-	Q9WUK0	102	R	H
P51460	LP/P	Cryptorchidism (CRYPTO) [MIM:219050]	Q9WUK0	110	N	K
Q9Y5Q6	LB/B	-	W5PM23	50	Q	L
Q96T92	LB/B	-	A0A146XA68	206	D	G
P06213	LP/P	Rabson-Mendenhall syndrome (RMS) [MIM:262190]	A0A224XI01	42	N	K
P06213	LP/P	Leprechaunism (LEPRCH) [MIM:246200]	A0A224XI01	55	V	A
P06213	LP/P	Leprechaunism (LEPRCH) [MIM:246200]	A0A224XI01	58	G	R
P06213	LP/P	Leprechaunism (LEPRCH) [MIM:246200]	A0A224XI01	113	R	P
P06213	LB/B	-	A0A224XI01	220	P	L
P06213	LP/P	Leprechaunism (LEPRCH) [MIM:246200]	A0A224XI01	236	H	R
P06213	LP/P	Rabson-Mendenhall syndrome (RMS) [MIM:262190]	A0A224XI01	236	H	R
P06213	LP/P	Leprechaunism (LEPRCH) [MIM:246200]	A0A224XI01	260	L	P
P06213	LP/P	Leprechaunism (LEPRCH) [MIM:246200]	A0A224XI01	393	G	R
P06213	LP/P	Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549]	A0A224XI01	409	F	V
P06213	LP/P	Leprechaunism (LEPRCH) [MIM:246200]	A0A224XI01	487	K	E
P06213	LP/P	Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549]	A0A224XI01	489	N	S
P06213	LP/P	Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549]	A0A224XI01	762	R	S
P06213	LB/B	-	A0A224XI01	1012	V	M
P06213	LP/P	Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549]	A0A224XI01	1020	R	Q
P06213	LP/P	Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549]	A0A224XI01	1035	G	V
P06213	LP/P	Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549]	A0A224XI01	1075	A	D
P06213	LP/P	Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549]	A0A224XI01	1161	A	T
P06213	LP/P	Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549]	A0A224XI01	1162	A	E
P06213	LB/B	-	A0A224XI01	1180	M	I
P06213	LP/P	Type 2 diabetes mellitus (T2D) [MIM:125853]	A0A224XI01	1191	R	Q
P06213	LP/P	Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549]	A0A224XI01	1205	P	L
P06213	LP/P	Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549]	A0A224XI01	1220	W	L
P06213	LP/P	Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549]	A0A224XI01	1227	W	S
P06213	LP/P	Leprechaunism (LEPRCH) [MIM:246200]	A0A224XI01	146	I	M
P06213	LP/P	Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549]	A0A224XI01	279	R	C
P06213	LP/P	Leprechaunism (LEPRCH) [MIM:246200]	A0A224XI01	439	W	S
P06213	LP/P	Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549]	A0A224XI01	86	D	G
P06213	LP/P	Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549]	A0A224XI01	89	L	P
P06213	LP/P	Leprechaunism (LEPRCH) [MIM:246200]	A0A224XI01	119	A	V
P06213	LP/P	Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549]	A0A224XI01	167	V	L
P06213	LP/P	Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549]	A0A224XI01	280	C	Y
P06213	LP/P	Leprechaunism (LEPRCH) [MIM:246200]	A0A224XI01	301	C	Y
P06213	LP/P	Leprechaunism (LEPRCH) [MIM:246200]	A0A224XI01	350	S	L
P06213	LP/P	Rabson-Mendenhall syndrome (RMS) [MIM:262190]	A0A224XI01	350	S	L
P06213	LB/B	-	A0A224XI01	448	I	T
P06213	LB/B	-	A0A224XI01	492	Q	K
P06213	LP/P	Type 2 diabetes mellitus (T2D) [MIM:125853]	A0A224XI01	858	T	A
P06213	LP/P	Leprechaunism (LEPRCH) [MIM:246200]	A0A224XI01	925	I	T
P06213	LP/P	Leprechaunism (LEPRCH) [MIM:246200]	A0A224XI01	926	R	W
P06213	LP/P	Leprechaunism (LEPRCH) [MIM:246200]	A0A224XI01	937	T	M
P06213	LP/P	Rabson-Mendenhall syndrome (RMS) [MIM:262190]	A0A224XI01	997	P	T
P06213	LB/B	-	A0A224XI01	1023	I	F
P06213	LP/P	Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549]	A0A224XI01	1055	A	V
P06213	LB/B	-	A0A224XI01	1095	K	E
P06213	LP/P	Leprechaunism (LEPRCH) [MIM:246200]	A0A224XI01	1119	R	W
P06213	LP/P	Rabson-Mendenhall syndrome (RMS) [MIM:262190]	A0A224XI01	1143	I	T
P06213	LP/P	Type 2 diabetes mellitus (T2D) [MIM:125853]	A0A224XI01	1158	R	Q
P06213	LP/P	Rabson-Mendenhall syndrome (RMS) [MIM:262190]	A0A224XI01	1158	R	W
P06213	LP/P	Familial hyperinsulinemic hypoglycemia 5 (HHF5) [MIM:609968]	A0A224XI01	1201	R	Q
P06213	LP/P	Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549]	A0A224XI01	1201	R	Q
P06213	LP/P	Leprechaunism (LEPRCH) [MIM:246200]	A0A224XI01	1201	R	W
P06213	LP/P	Rabson-Mendenhall syndrome (RMS) [MIM:262190]	A0A224XI01	1201	R	W
P06213	LP/P	Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549]	A0A224XI01	1206	E	D
P06213	LP/P	Leprechaunism (LEPRCH) [MIM:246200]	A0A224XI01	1206	E	K
P06213	LB/B	-	A0A224XI01	1361	Y	C
P06213	LP/P	Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549]	A0A224XI01	1378	R	Q
P06213	LP/P	Leprechaunism (LEPRCH) [MIM:246200]	A0A224XI01	120	L	Q
P06213	LP/P	Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549]	A0A224XI01	279	R	H
P06213	LP/P	Rabson-Mendenhall syndrome (RMS) [MIM:262190]	A0A224XI01	386	G	S
P06213	LP/P	Leprechaunism (LEPRCH) [MIM:246200]	A0A224XI01	458	N	D
P06213	LB/B	-	A0A224XI01	695	Q	R
P06213	LB/B	-	A0A224XI01	811	G	S
P06213	LB/B	-	A0A224XI01	1065	L	V
P06213	LB/B	-	A0A224XI01	1282	T	A
P06213	LB/B	-	A0A224XI01	830	P	L
P06213	LB/B	-	A0A224XI01	2	A	G
P06213	LB/B	-	A0A224XI01	171	Y	H
P06213	LP/P	Leprechaunism (LEPRCH) [MIM:246200]	A0A224XI01	56	I	T
P06213	LP/P	Rabson-Mendenhall syndrome (RMS) [MIM:262190]	A0A224XI01	256	R	C
P06213	LP/P	Leprechaunism (LEPRCH) [MIM:246200]	A0A224XI01	286	C	Y
P06213	LP/P	Rabson-Mendenhall syndrome (RMS) [MIM:262190]	A0A224XI01	635	S	L
P06213	LP/P	Leprechaunism (LEPRCH) [MIM:246200]	A0A224XI01	657	V	F
P06213	LP/P	Leprechaunism (LEPRCH) [MIM:246200]	A0A224XI01	659	W	R
P06213	LP/P	Leprechaunism (LEPRCH) [MIM:246200]	A0A224XI01	818	Y	C
P06213	LP/P	Rabson-Mendenhall syndrome (RMS) [MIM:262190]	A0A224XI01	835	S	I
P06213	LP/P	Rabson-Mendenhall syndrome (RMS) [MIM:262190]	A0A224XI01	842	A	V
P06213	LP/P	Rabson-Mendenhall syndrome (RMS) [MIM:262190]	A0A224XI01	874	P	L
P06213	LP/P	Rabson-Mendenhall syndrome (RMS) [MIM:262190]	A0A224XI01	878	N	S
P14616	LB/B	-	A0A0A9XLS6	127	A	E
P14616	LB/B	-	A0A0A9XLS6	161	A	V
P14616	LB/B	-	A0A0A9XLS6	244	R	H
P14616	LB/B	-	A0A0A9XLS6	246	C	R
P14616	LB/B	-	A0A0A9XLS6	554	R	C
P14616	LB/B	-	A0A0A9XLS6	928	P	L
Q8N201	LB/B	-	A0A2A3EK45	172	P	L
Q8N201	LP/P	Neurodevelopmental disorder with cataracts, poor growth, and dysmorphic facies (NDCAGF) [MIM:618571]	A0A2A3EK45	549	M	V
Q96CB8	LB/B	-	H2LQD2	323	T	A
Q96N11	LB/B	-	A0A061I5G1	245	R	C
Q9H0H0	LB/B	-	A7RVD7	768	N	H
Q5JSJ4	LB/B	-	A0A1S3P0H8	769	I	V
Q9NVH2	LB/B	-	A0A023EXU1	425	H	R
Q9Y283	LP/P	Nephronophthisis 2 (NPHP2) [MIM:602088]	L5KPW4	482	P	R
Q9Y283	LP/P	Nephronophthisis 2 (NPHP2) [MIM:602088]	L5KPW4	493	L	S
Q9Y283	LB/B	-	L5KPW4	242	S	L
Q9Y283	LB/B	-	L5KPW4	888	S	R
Q96PC2	LB/B	-	H3B9U4	60	R	W
Q96PC2	LB/B	-	H3B9U4	308	A	V
Q96PC2	LB/B	-	H3B9U4	312	V	I
Q96PC2	LB/B	-	H3B9U4	378	Y	S
Q8WWN9	LB/B	-	G9CGD6	194	S	P
Q9UI26	LB/B	-	G1MYF0	260	N	D
Q9UI26	LB/B	-	G1MYF0	937	I	V
Q8TEX9	LB/B	-	D6WIB4	513	A	V
Q8TEX9	LB/B	-	D6WIB4	580	P	A
A8MXQ7	LB/B	-	H3AUA0	465	T	R
Q86XH1	LB/B	-	V4AB81	452	K	R
Q86XH1	LB/B	-	V4AB81	8	K	M
Q86XH1	LB/B	-	V4AB81	362	Q	R
Q15051	LB/B	-	U3I511	142	F	L
Q15051	LB/B	-	U3I511	393	I	N
Q15051	LB/B	-	U3I511	435	R	C
Q15051	LB/B	-	U3I511	434	C	Y
Q4KMZ1	LB/B	-	M3WH15	209	F	C
Q4KMZ1	LB/B	-	M3WH15	217	C	Y
Q4KMZ1	LB/B	-	M3WH15	464	P	L
Q6IPM2	LB/B	-	F6Y5V9	101	H	N
Q6IPM2	LB/B	-	F6Y5V9	546	A	V
Q6IPM2	LB/B	-	F6Y5V9	587	R	H
Q6IPM2	LB/B	-	F6Y5V9	596	T	A
Q6IPM2	LB/B	-	F6Y5V9	666	L	V
Q6IPM2	LB/B	-	F6Y5V9	690	T	M
Q9H095	LB/B	-	A0A2K5P598	112	A	D
Q8N0W5	LB/B	-	A0A2K6RYL8	220	L	P
Q9H0B3	LB/B	-	A0A2K5PXH9	44	L	P
Q9H0B3	LB/B	-	A0A2K5PXH9	235	L	V
Q9H0B3	LB/B	-	A0A2K5PXH9	285	S	T
Q9H0B3	LB/B	-	A0A2K5PXH9	359	M	T
Q9H0B3	LB/B	-	A0A2K5PXH9	908	P	H
Q9H0B3	LB/B	-	A0A2K5PXH9	648	Y	F
Q9H0B3	LB/B	-	A0A2K5PXH9	823	P	R
Q9H0B3	LB/B	-	A0A2K5PXH9	50	A	V
Q9H0B3	LB/B	-	A0A2K5PXH9	197	C	R
Q9H0B3	LB/B	-	A0A2K5PXH9	524	T	A
Q9H0B3	LB/B	-	A0A2K5PXH9	610	T	P
Q9H0B3	LB/B	-	A0A2K5PXH9	614	A	V
Q9H0B3	LB/B	-	A0A2K5PXH9	835	P	L
P46940	LB/B	-	S7Q358	256	S	A
Q6DN90	LB/B	-	A0A146W3B3	882	V	I
Q6DN90	LB/B	-	A0A146W3B3	640	P	S
Q6DN90	LP/P	Intellectual developmental disorder with short stature and behavioral abnormalities (IDDSSBA) [MIM:618687]	A0A146W3B3	335	R	Q
Q6DN90	LP/P	Intellectual developmental disorder with short stature and behavioral abnormalities (IDDSSBA) [MIM:618687]	A0A146W3B3	357	T	M
Q9UPP2	LB/B	-	M3ZNX4	558	A	G
Q8NA54	LB/B	-	A0A2K6FA58	126	V	M
Q8NA54	LB/B	-	A0A2K6FA58	691	D	N
Q8NA54	LB/B	-	A0A2K6FA58	735	R	P
Q9Y6F6	LB/B	-	A0A093SPY2	11	I	V
Q9Y6F6	LB/B	-	A0A093SPY2	28	A	T
Q9Y6F6	LB/B	-	A0A093SPY2	70	A	T
Q9Y6F6	LB/B	-	A0A093SPY2	186	P	S
Q9Y6F6	LB/B	-	A0A093SPY2	289	Q	H
Q12912	LB/B	-	A0A0Q3X885	94	T	A
Q12912	LB/B	-	A0A0Q3X885	197	L	V
Q12912	LB/B	-	A0A0Q3X885	241	L	W
Q12912	LB/B	-	A0A0Q3X885	253	C	S
O43187	LB/B	-	H0UVM5	47	S	Y
O43187	LB/B	-	H0UVM5	392	L	V
O43187	LB/B	-	H0UVM5	431	D	E
O43187	LB/B	-	H0UVM5	439	L	V
O43187	LB/B	-	H0UVM5	503	L	I
O43187	LB/B	-	H0UVM5	574	D	H
O43187	LB/B	-	H0UVM5	43	R	Q
O43187	LB/B	-	H0UVM5	99	I	V
O43187	LB/B	-	H0UVM5	147	R	T
O43187	LB/B	-	H0UVM5	214	R	G
O43187	LB/B	-	H0UVM5	469	D	N
O43187	LB/B	-	H0UVM5	566	R	W
Q9Y616	LB/B	-	A0A2K5D2L2	147	I	V
Q9Y616	LB/B	-	A0A2K5D2L2	270	I	V
Q9Y616	LB/B	-	A0A2K5D2L2	269	G	S
Q9Y616	LB/B	-	A0A2K5D2L2	22	P	L
Q9Y616	LB/B	-	A0A2K5D2L2	111	P	A
Q9Y616	LB/B	-	A0A2K5D2L2	134	V	M
Q9Y616	LB/B	-	A0A2K5D2L2	400	L	V
Q9Y616	LB/B	-	A0A2K5D2L2	429	R	Q
Q9Y616	LB/B	-	A0A2K5D2L2	57	H	R
Q9Y616	LB/B	-	A0A2K5D2L2	84	G	S
Q9Y616	LB/B	-	A0A2K5D2L2	171	I	V
Q9Y616	LB/B	-	A0A2K5D2L2	288	S	L
Q9Y616	LB/B	-	A0A2K5D2L2	384	R	Q
Q9Y616	LB/B	-	A0A2K5D2L2	391	M	T
Q9Y616	LB/B	-	A0A2K5D2L2	482	D	N
Q9NWZ3	LB/B	-	V4A4B0	98	S	R
Q9NWZ3	LB/B	-	V4A4B0	390	H	R
Q9NWZ3	LB/B	-	V4A4B0	428	A	T
Q9NWZ3	LB/B	-	V4A4B0	5	I	V
Q9NWZ3	LB/B	-	V4A4B0	355	M	V
Q9NWZ3	LB/B	-	V4A4B0	391	R	H
Q9NWZ3	LP/P	Immunodeficiency 67 (IMD67) [MIM:607676]	V4A4B0	12	R	C
Q9NWZ3	LB/B	-	V4A4B0	20	R	W
Q9NWZ3	LB/B	-	V4A4B0	26	I	T
Q9NWZ3	LB/B	-	V4A4B0	39	I	V
Q9NWZ3	LP/P	Immunodeficiency 67 (IMD67) [MIM:607676]	V4A4B0	298	G	D
P48200	LB/B	-	A0A146X5T7	580	I	T
Q7Z5L9	LB/B	-	A0A1L8G830	254	A	V
Q7Z5L9	LP/P	Immunodeficiency, common variable, 14 (CVID14) [MIM:617765]	A0A1L8G830	551	S	N
Q14653	LB/B	-	A0A2Y9GG29	96	R	Q
Q14653	LB/B	-	A0A2Y9GG29	377	E	K
Q14653	LB/B	-	A0A2Y9GG29	427	S	T
Q14653	LB/B	-	A0A2Y9GG29	107	Y	F
Q14653	LP/P	Encephalopathy, acute, infection-induced, 7, herpes-specific (IIAE7) [MIM:616532]	A0A2Y9GG29	285	R	Q
O14896	LP/P	Van der Woude syndrome 1 (VWS1) [MIM:119300]	H3BH00	2	A	V
O14896	LP/P	Van der Woude syndrome 1 (VWS1) [MIM:119300]	H3BH00	18	V	A
O14896	LP/P	Van der Woude syndrome 1 (VWS1) [MIM:119300]	H3BH00	18	V	M
O14896	LP/P	Van der Woude syndrome 1 (VWS1) [MIM:119300]	H3BH00	39	P	A
O14896	LP/P	Popliteal pterygium syndrome (PPS) [MIM:119500]	H3BH00	60	W	G
O14896	LP/P	Van der Woude syndrome 1 (VWS1) [MIM:119300]	H3BH00	61	A	G
O14896	LP/P	Popliteal pterygium syndrome (PPS) [MIM:119500]	H3BH00	66	K	T
O14896	LP/P	Van der Woude syndrome 1 (VWS1) [MIM:119300]	H3BH00	70	G	R
O14896	LP/P	Van der Woude syndrome 1 (VWS1) [MIM:119300]	H3BH00	76	P	S
O14896	LP/P	Popliteal pterygium syndrome (PPS) [MIM:119500]	H3BH00	82	Q	K
O14896	LP/P	Popliteal pterygium syndrome (PPS) [MIM:119500]	H3BH00	84	R	C
O14896	LP/P	Popliteal pterygium syndrome (PPS) [MIM:119500]	H3BH00	84	R	H
O14896	LP/P	Van der Woude syndrome 1 (VWS1) [MIM:119300]	H3BH00	88	N	H
O14896	LP/P	Popliteal pterygium syndrome (PPS) [MIM:119500]	H3BH00	89	K	E
O14896	LP/P	Van der Woude syndrome 1 (VWS1) [MIM:119300]	H3BH00	90	S	G
O14896	LP/P	Van der Woude syndrome 1 (VWS1) [MIM:119300]	H3BH00	98	D	H
O14896	LP/P	Van der Woude syndrome 1 (VWS1) [MIM:119300]	H3BH00	250	R	Q
O14896	LP/P	Van der Woude syndrome 1 (VWS1) [MIM:119300]	H3BH00	273	Q	R
O14896	LB/B	-	H3BH00	274	V	I
O14896	LP/P	Van der Woude syndrome 1 (VWS1) [MIM:119300]	H3BH00	294	L	P
O14896	LP/P	Van der Woude syndrome 1 (VWS1) [MIM:119300]	H3BH00	297	V	I
O14896	LP/P	Van der Woude syndrome 1 (VWS1) [MIM:119300]	H3BH00	320	K	E
O14896	LP/P	Van der Woude syndrome 1 (VWS1) [MIM:119300]	H3BH00	321	V	M
O14896	LP/P	Van der Woude syndrome 1 (VWS1) [MIM:119300]	H3BH00	325	G	E
O14896	LP/P	Van der Woude syndrome 1 (VWS1) [MIM:119300]	H3BH00	345	L	P
O14896	LP/P	Van der Woude syndrome 1 (VWS1) [MIM:119300]	H3BH00	347	C	F
O14896	LP/P	Non-syndromic orofacial cleft 6 (OFC6) [MIM:608864]	H3BH00	369	F	S
O14896	LP/P	Van der Woude syndrome 1 (VWS1) [MIM:119300]	H3BH00	369	F	S
O14896	LP/P	Van der Woude syndrome 1 (VWS1) [MIM:119300]	H3BH00	374	C	W
O14896	LP/P	Van der Woude syndrome 1 (VWS1) [MIM:119300]	H3BH00	388	K	E
O14896	LP/P	Popliteal pterygium syndrome (PPS) [MIM:119500]	H3BH00	430	D	N
O14896	LP/P	Van der Woude syndrome 1 (VWS1) [MIM:119300]	H3BH00	6	R	C
O14896	LP/P	Van der Woude syndrome 1 (VWS1) [MIM:119300]	H3BH00	16	A	V
O14896	LP/P	Popliteal pterygium syndrome (PPS) [MIM:119500]	H3BH00	22	L	P
O14896	LP/P	Van der Woude syndrome 1 (VWS1) [MIM:119300]	H3BH00	22	L	P
O14896	LP/P	Van der Woude syndrome 1 (VWS1) [MIM:119300]	H3BH00	45	R	Q
O14896	LP/P	Van der Woude syndrome 1 (VWS1) [MIM:119300]	H3BH00	64	T	I
O14896	LP/P	Van der Woude syndrome 1 (VWS1) [MIM:119300]	H3BH00	84	R	G
O14896	LP/P	Van der Woude syndrome 1 (VWS1) [MIM:119300]	H3BH00	100	T	A
O14896	LP/P	Van der Woude syndrome 1 (VWS1) [MIM:119300]	H3BH00	251	L	P
O14896	LP/P	Van der Woude syndrome 1 (VWS1) [MIM:119300]	H3BH00	349	E	V
O14896	LP/P	Van der Woude syndrome 1 (VWS1) [MIM:119300]	H3BH00	396	P	S
O14896	LP/P	Van der Woude syndrome 1 (VWS1) [MIM:119300]	H3BH00	400	R	W
O14896	LP/P	Van der Woude syndrome 1 (VWS1) [MIM:119300]	H3BH00	339	R	I
O14896	LP/P	Popliteal pterygium syndrome (PPS) [MIM:119500]	H3BH00	84	R	L
O14896	LP/P	Popliteal pterygium syndrome (PPS) [MIM:119500]	H3BH00	424	S	L
Q92985	LB/B	-	A0A0A0AQD2	179	K	E
Q92985	LB/B	-	A0A0A0AQD2	412	Q	R
Q92985	LB/B	-	A0A0A0AQD2	204	D	N
Q92985	LP/P	Immunodeficiency 39 (IMD39) [MIM:616345]	A0A0A0AQD2	410	F	V
Q02556	LP/P	Immunodeficiency 32A (IMD32A) [MIM:614893]	H3BH00	80	T	A
Q02556	LP/P	Immunodeficiency 32B (IMD32B) [MIM:226990]	H3BH00	108	K	E
Q00978	LB/B	-	A0A2K5J6P6	127	Q	H
Q00978	LB/B	-	A0A2K5J6P6	292	R	C
Q6NXR0	LB/B	-	A0A2U4B5W8	135	D	N
A1A4Y4	LB/B	-	C3UZU9	17	E	D
A1A4Y4	LB/B	-	C3UZU9	94	T	K
Q9Y4H2	LB/B	-	A0A2Y9G2Q0	1057	G	D
Q9Y4H2	LB/B	-	A0A2Y9G2Q0	879	G	S
Q9Y4H2	LB/B	-	A0A2Y9G2Q0	882	G	A
Q9Y4H2	LB/B	-	A0A2Y9G2Q0	789	H	Y
Q9Y4H2	LB/B	-	A0A2Y9G2Q0	999	V	M
O14654	LB/B	-	L5KFS6	34	L	F
O14654	LB/B	-	L5KFS6	508	N	K
O14654	LB/B	-	L5KFS6	879	H	D
O14654	LB/B	-	L5KFS6	1230	D	Y
P78415	LB/B	-	A0A0P7UM27	479	Q	H
P78415	LB/B	-	A0A0P7UM27	422	L	P
P78413	LB/B	-	A0A2I3GYZ3	119	A	T
Q86U28	LP/P	Multiple mitochondrial dysfunctions syndrome 4 (MMDS4) [MIM:616370]	A0A093KSF8	77	G	S
P05161	LB/B	-	F7D6U2	83	S	N
Q9H9L3	LB/B	-	A0A226NRU2	130	N	S
B1AKI9	LB/B	-	G3W569	193	P	R
Q6H9L7	LB/B	-	G3SWN4	94	A	T
Q6H9L7	LB/B	-	G3SWN4	133	P	A
P56199	LB/B	-	H2RPL1	480	T	M
P56199	LB/B	-	H2RPL1	961	I	M
P56199	LB/B	-	H2RPL1	1108	E	G
P56199	LB/B	-	H2RPL1	670	V	I
O75578	LB/B	-	H3B732	381	R	Q
O75578	LB/B	-	H3B732	691	R	H
O75578	LB/B	-	H3B732	725	R	Q
O75578	LB/B	-	H3B732	668	R	W
O75578	LB/B	-	H3B732	702	A	T
Q9UKX5	LB/B	-	H3B732	433	V	M
Q9UKX5	LB/B	-	H3B732	524	L	R
Q9UKX5	LB/B	-	H3B732	972	P	L
Q9UKX5	LB/B	-	H3B732	1003	M	I
Q9UKX5	LB/B	-	H3B732	1093	L	V
Q9UKX5	LB/B	-	H3B732	471	M	L
Q9UKX5	LB/B	-	H3B732	891	Q	K
P17301	LB/B	-	A0A2I0U216	534	E	K
P17301	LB/B	-	A0A2I0U216	1127	K	Q
P17301	LB/B	-	A0A2I0U216	927	N	S
P17301	LB/B	-	A0A2I0U216	691	N	K
P17301	LB/B	-	A0A2I0U216	532	I	L
P08514	LP/P	Glanzmann thrombasthenia 1 (GT1) [MIM:273800]	A0A1U7UF24	273	G	D
P08514	LP/P	Glanzmann thrombasthenia 1 (GT1) [MIM:273800]	A0A1U7UF24	358	R	H
P08514	LP/P	Glanzmann thrombasthenia 1 (GT1) [MIM:273800]	A0A1U7UF24	449	G	D
P08514	LP/P	Glanzmann thrombasthenia 1 (GT1) [MIM:273800]	A0A1U7UF24	778	Q	P
P08514	LB/B	-	A0A1U7UF24	874	I	S
P08514	LP/P	Glanzmann thrombasthenia 1 (GT1) [MIM:273800]	A0A1U7UF24	176	P	A
P08514	LP/P	Glanzmann thrombasthenia 1 (GT1) [MIM:273800]	A0A1U7UF24	176	P	L
P08514	LP/P	Glanzmann thrombasthenia 1 (GT1) [MIM:273800]	A0A1U7UF24	320	F	S
P08514	LP/P	Glanzmann thrombasthenia 1 (GT1) [MIM:273800]	A0A1U7UF24	355	E	K
P08514	LB/B	-	A0A1U7UF24	40	T	I
P08514	LB/B	-	A0A1U7UF24	968	Y	N
P08514	LP/P	Glanzmann thrombasthenia 1 (GT1) [MIM:273800]	A0A1U7UF24	86	L	P
P08514	LP/P	Glanzmann thrombasthenia 1 (GT1) [MIM:273800]	A0A1U7UF24	139	A	V
P08514	LP/P	Glanzmann thrombasthenia 1 (GT1) [MIM:273800]	A0A1U7UF24	161	C	W
P08514	LP/P	Glanzmann thrombasthenia 1 (GT1) [MIM:273800]	A0A1U7UF24	174	Y	H
P08514	LP/P	Glanzmann thrombasthenia 1 (GT1) [MIM:273800]	A0A1U7UF24	202	F	C
P08514	LP/P	Glanzmann thrombasthenia 1 (GT1) [MIM:273800]	A0A1U7UF24	207	T	I
P08514	LP/P	Glanzmann thrombasthenia 1 (GT1) [MIM:273800]	A0A1U7UF24	214	L	P
P08514	LP/P	Glanzmann thrombasthenia 1 (GT1) [MIM:273800]	A0A1U7UF24	222	F	L
P08514	LP/P	Glanzmann thrombasthenia 1 (GT1) [MIM:273800]	A0A1U7UF24	267	G	E
P08514	LP/P	Glanzmann thrombasthenia 1 (GT1) [MIM:273800]	A0A1U7UF24	329	V	F
P08514	LP/P	Glanzmann thrombasthenia 1 (GT1) [MIM:273800]	A0A1U7UF24	380	G	D
P08514	LP/P	Glanzmann thrombasthenia 1 (GT1) [MIM:273800]	A0A1U7UF24	405	I	T
P08514	LP/P	Glanzmann thrombasthenia 1 (GT1) [MIM:273800]	A0A1U7UF24	412	G	R
P08514	LP/P	Glanzmann thrombasthenia 1 (GT1) [MIM:273800]	A0A1U7UF24	581	A	D
P08514	LP/P	Glanzmann thrombasthenia 1 (GT1) [MIM:273800]	A0A1U7UF24	596	I	T
P08514	LP/P	Glanzmann thrombasthenia 1 (GT1) [MIM:273800]	A0A1U7UF24	705	C	R
P08514	LP/P	Glanzmann thrombasthenia 1 (GT1) [MIM:273800]	A0A1U7UF24	752	L	V
P08514	LP/P	Glanzmann thrombasthenia 1 (GT1) [MIM:273800]	A0A1U7UF24	755	R	P
P08514	LP/P	Glanzmann thrombasthenia 1 (GT1) [MIM:273800]	A0A1U7UF24	847	L	P
P08514	LP/P	Glanzmann thrombasthenia 1 (GT1) [MIM:273800]	A0A1U7UF24	943	P	L
P08514	LP/P	Glanzmann thrombasthenia 1 (GT1) [MIM:273800]	A0A1U7UF24	982	V	M
P08514	LB/B	-	A0A1U7UF24	989	A	T
P08514	LP/P	Bleeding disorder, platelet-type, 16 (BDPLT16) [MIM:187800]	A0A1U7UF24	1026	R	Q
P08514	LP/P	Glanzmann thrombasthenia 1 (GT1) [MIM:273800]	A0A1U7UF24	1026	R	Q
P08514	LB/B	-	A0A1U7UF24	313	G	A
P08514	LB/B	-	A0A1U7UF24	649	V	L
P08514	LP/P	Glanzmann thrombasthenia 1 (GT1) [MIM:273800]	A0A1U7UF24	934	V	F
P08514	LP/P	Glanzmann thrombasthenia 1 (GT1) [MIM:273800]	A0A1U7UF24	957	S	L
P08514	LP/P	Bleeding disorder, platelet-type, 16 (BDPLT16) [MIM:187800]	A0A1U7UF24	1026	R	W
P13612	LB/B	-	A0A091DCK5	878	R	Q
P13612	LB/B	-	A0A091DCK5	634	S	T
P13612	LB/B	-	A0A091DCK5	824	V	A
P08648	LB/B	-	A0A1U7UF24	585	R	I
P53708	LB/B	-	H0YSX9	216	V	L
P53708	LB/B	-	H0YSX9	577	S	F
P53708	LB/B	-	H0YSX9	581	Q	P
P53708	LB/B	-	H0YSX9	748	R	H
P53708	LB/B	-	H0YSX9	993	I	V
P53708	LB/B	-	H0YSX9	994	V	A
P53708	LB/B	-	H0YSX9	567	V	L
P53708	LP/P	Renal hypodysplasia/aplasia 1 (RHDA1) [MIM:191830]	H0YSX9	407	G	R
Q13797	LB/B	-	A0A091DCK5	507	G	E
P20701	LB/B	-	K7FSG9	144	R	H
P20701	LB/B	-	K7FSG9	214	R	W
P20701	LB/B	-	K7FSG9	746	Q	K
P20701	LB/B	-	K7FSG9	791	R	T
P11215	LB/B	-	K7FSG9	77	R	H
P11215	LB/B	-	K7FSG9	441	M	T
P11215	LB/B	-	K7FSG9	858	A	V
P11215	LB/B	-	K7FSG9	1146	P	S
P06756	LB/B	-	A0A1U7UF24	405	I	V
P06756	LB/B	-	A0A1U7UF24	783	V	I
P06756	LB/B	-	A0A1U7UF24	548	S	A
P20702	LB/B	-	K7FSG9	48	W	R
P20702	LB/B	-	K7FSG9	251	A	T
P20702	LB/B	-	K7FSG9	517	P	R
P20702	LB/B	-	K7FSG9	547	E	K
P20702	LB/B	-	K7FSG9	971	F	L
P20702	LB/B	-	K7FSG9	201	F	L
P20702	LB/B	-	K7FSG9	564	I	V
P20702	LB/B	-	K7FSG9	1012	A	V
P05106	LB/B	-	G3HGD1	59	L	P
P05106	LB/B	-	G3HGD1	169	R	Q
P05106	LB/B	-	G3HGD1	433	P	A
P05106	LB/B	-	G3HGD1	515	R	Q
P05106	LB/B	-	G3HGD1	662	R	C
P05106	LP/P	Glanzmann thrombasthenia 2 (GT2) [MIM:619267]	G3HGD1	145	D	Y
P05106	LP/P	Glanzmann thrombasthenia 2 (GT2) [MIM:619267]	G3HGD1	240	R	Q
P05106	LP/P	Glanzmann thrombasthenia 2 (GT2) [MIM:619267]	G3HGD1	240	R	W
P05106	LP/P	Glanzmann thrombasthenia 2 (GT2) [MIM:619267]	G3HGD1	306	H	P
P05106	LP/P	Glanzmann thrombasthenia 2 (GT2) [MIM:619267]	G3HGD1	400	C	Y
P05106	LP/P	Glanzmann thrombasthenia 2 (GT2) [MIM:619267]	G3HGD1	586	C	F
P05106	LP/P	Glanzmann thrombasthenia 2 (GT2) [MIM:619267]	G3HGD1	598	G	S
P05106	LP/P	Glanzmann thrombasthenia 2 (GT2) [MIM:619267]	G3HGD1	778	S	P
P05106	LP/P	Glanzmann thrombasthenia 2 (GT2) [MIM:619267]	G3HGD1	143	L	W
P05106	LP/P	Glanzmann thrombasthenia 2 (GT2) [MIM:619267]	G3HGD1	188	S	L
P05106	LP/P	Glanzmann thrombasthenia 2 (GT2) [MIM:619267]	G3HGD1	568	C	R
P05106	LP/P	Glanzmann thrombasthenia 2 (GT2) [MIM:619267]	G3HGD1	605	G	S
P05106	LB/B	-	G3HGD1	453	V	I
P05106	LP/P	Glanzmann thrombasthenia 2 (GT2) [MIM:619267]	G3HGD1	119	R	W
P05106	LP/P	Glanzmann thrombasthenia 2 (GT2) [MIM:619267]	G3HGD1	141	Y	C
P05106	LP/P	Glanzmann thrombasthenia 2 (GT2) [MIM:619267]	G3HGD1	145	D	N
P05106	LP/P	Glanzmann thrombasthenia 2 (GT2) [MIM:619267]	G3HGD1	150	M	V
P05106	LB/B	-	G3HGD1	166	T	I
P05106	LP/P	Glanzmann thrombasthenia 2 (GT2) [MIM:619267]	G3HGD1	222	L	P
P05106	LP/P	Glanzmann thrombasthenia 2 (GT2) [MIM:619267]	G3HGD1	242	R	Q
P05106	LP/P	Glanzmann thrombasthenia 2 (GT2) [MIM:619267]	G3HGD1	243	D	V
P05106	LP/P	Glanzmann thrombasthenia 2 (GT2) [MIM:619267]	G3HGD1	288	L	P
P05106	LP/P	Glanzmann thrombasthenia 2 (GT2) [MIM:619267]	G3HGD1	321	M	L
P05106	LP/P	Glanzmann thrombasthenia 2 (GT2) [MIM:619267]	G3HGD1	330	I	N
P05106	LP/P	Glanzmann thrombasthenia 2 (GT2) [MIM:619267]	G3HGD1	532	C	Y
P05106	LP/P	Glanzmann thrombasthenia 2 (GT2) [MIM:619267]	G3HGD1	586	C	R
P05106	LP/P	Glanzmann thrombasthenia 2 (GT2) [MIM:619267]	G3HGD1	601	C	R
P05106	LB/B	-	G3HGD1	66	L	R
P05106	LP/P	Glanzmann thrombasthenia 2 (GT2) [MIM:619267]	G3HGD1	64	C	Y
P05106	LP/P	Glanzmann thrombasthenia 2 (GT2) [MIM:619267]	G3HGD1	144	M	R
P05106	LP/P	Glanzmann thrombasthenia 2 (GT2) [MIM:619267]	G3HGD1	247	G	D
P05106	LP/P	Glanzmann thrombasthenia 2 (GT2) [MIM:619267]	G3HGD1	279	K	M
P05106	LP/P	Bleeding disorder, platelet-type, 24 (BDPLT24) [MIM:619271]	G3HGD1	749	D	H
Q13352	LB/B	-	A0A1L1RJV0	30	I	V
P16144	LP/P	Epidermolysis bullosa, junctional 5B, with pyloric atresia (JEB5B) [MIM:226730]	H2SP23	61	C	Y
P16144	LP/P	Epidermolysis bullosa, junctional 5B, with pyloric atresia (JEB5B) [MIM:226730]	H2SP23	156	L	P
P16144	LP/P	Epidermolysis bullosa, junctional 5B, with pyloric atresia (JEB5B) [MIM:226730]	H2SP23	245	C	G
P16144	LP/P	Epidermolysis bullosa, junctional 5B, with pyloric atresia (JEB5B) [MIM:226730]	H2SP23	252	R	C
P16144	LP/P	Epidermolysis bullosa, junctional 5B, with pyloric atresia (JEB5B) [MIM:226730]	H2SP23	562	C	R
P16144	LP/P	Epidermolysis bullosa, junctional 5B, with pyloric atresia (JEB5B) [MIM:226730]	H2SP23	1281	R	W
P16144	LP/P	Epidermolysis bullosa, junctional 5B, with pyloric atresia (JEB5B) [MIM:226730]	H2SP23	38	C	R
P16144	LB/B	-	H2SP23	98	R	H
P16144	LP/P	Epidermolysis bullosa, junctional 5B, with pyloric atresia (JEB5B) [MIM:226730]	H2SP23	131	D	Y
P16144	LP/P	Epidermolysis bullosa, junctional 5B, with pyloric atresia (JEB5B) [MIM:226730]	H2SP23	273	G	D
P16144	LP/P	Epidermolysis bullosa, junctional 5B, with pyloric atresia (JEB5B) [MIM:226730]	H2SP23	283	R	C
P16144	LP/P	Epidermolysis bullosa, junctional 5B, with pyloric atresia (JEB5B) [MIM:226730]	H2SP23	325	V	D
P16144	LP/P	Epidermolysis bullosa, junctional 5B, with pyloric atresia (JEB5B) [MIM:226730]	H2SP23	336	L	P
P16144	LB/B	-	H2SP23	844	R	L
P16144	LP/P	Epidermolysis bullosa, junctional 5A, intermediate (JEB5A) [MIM:619816]	H2SP23	931	G	D
P16144	LB/B	-	H2SP23	1216	H	Q
P16144	LP/P	Epidermolysis bullosa, junctional 5B, with pyloric atresia (JEB5B) [MIM:226730]	H2SP23	1225	R	H
P16144	LB/B	-	H2SP23	478	Q	H
P16144	LB/B	-	H2SP23	1779	L	P
P16144	LB/B	-	H2SP23	1764	T	S
P18084	LB/B	-	A0A0P7WB83	428	L	V
P18084	LB/B	-	A0A0P7WB83	431	R	Q
P18084	LB/B	-	A0A0P7WB83	477	N	S
P18564	LB/B	-	C3YNY6	437	P	T
P18564	LP/P	Amelogenesis imperfecta 1H (AI1H) [MIM:616221]	C3YNY6	143	A	T
P18564	LP/P	Amelogenesis imperfecta 1H (AI1H) [MIM:616221]	C3YNY6	196	P	T
P18564	LP/P	Amelogenesis imperfecta 1H (AI1H) [MIM:616221]	C3YNY6	275	H	Q
P26010	LB/B	-	C3YNY6	672	H	Y
O95965	LB/B	-	A0A1A7WJ91	154	A	S
Q14624	LB/B	-	G3GSF1	86	I	N
Q14624	LB/B	-	G3GSF1	85	I	N
Q14624	LB/B	-	G3GSF1	669	Q	L
Q14624	LB/B	-	G3GSF1	698	P	T
Q14624	LB/B	-	G3GSF1	714	M	I
Q14624	LB/B	-	G3GSF1	791	L	P
Q86UX2	LB/B	-	Q4S5G0	139	E	K
Q86UX2	LB/B	-	Q4S5G0	207	N	H
Q86UX2	LB/B	-	Q4S5G0	570	T	P
Q86UX2	LB/B	-	Q4S5G0	629	R	C
Q86UX2	LB/B	-	Q4S5G0	421	N	H
Q86UX2	LB/B	-	Q4S5G0	925	F	S
Q86UX2	LB/B	-	Q4S5G0	496	V	M
Q6UXX5	LB/B	-	A0A1A6GW33	387	G	R
Q6UXX5	LB/B	-	A0A1A6GW33	561	R	C
Q6UXX5	LB/B	-	A0A1A6GW33	1041	W	S
Q6UXX5	LB/B	-	A0A1A6GW33	1170	G	A
Q08881	LB/B	-	A0A2I0UA01	581	R	W
Q08881	LB/B	-	A0A2I0UA01	587	V	I
Q08881	LB/B	-	A0A2I0UA01	193	R	Q
Q08881	LP/P	Lymphoproliferative syndrome 1 (LPFS1) [MIM:613011]	A0A2I0UA01	335	R	W
Q8WWA0	LB/B	-	G1T503	109	V	D
Q8WWA0	LB/B	-	G1T503	313	R	P
Q8WWU7	LB/B	-	G1T503	103	R	H
Q8WWU7	LB/B	-	G1T503	171	Q	R
O43736	LB/B	-	G3HWB2	72	A	V
O43736	LB/B	-	G3HWB2	230	R	T
Q9Y287	LB/B	-	H3AEX3	15	A	T
Q9Y287	LP/P	Retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities (RDGCA) [MIM:616079]	H3AEX3	261	E	A
Q9NQX7	LB/B	-	H3AEX3	53	G	S
P27987	LB/B	-	I3ND56	552	P	Q
P27987	LB/B	-	I3ND56	408	S	A
P27987	LB/B	-	I3ND56	322	A	T
Q14643	LB/B	-	A0A0C9RIJ7	769	M	V
Q14643	LB/B	-	A0A0C9RIJ7	1430	I	V
Q14643	LP/P	Spinocerebellar ataxia 29 (SCA29) [MIM:117360]	A0A0C9RIJ7	602	N	D
Q14643	LP/P	Spinocerebellar ataxia 29 (SCA29) [MIM:117360]	A0A0C9RIJ7	1562	V	M
Q14643	LP/P	Gillespie syndrome (GLSP) [MIM:206700]	A0A0C9RIJ7	2109	E	Q
Q14643	LP/P	Gillespie syndrome (GLSP) [MIM:206700]	A0A0C9RIJ7	2554	G	R
Q14643	LP/P	Gillespie syndrome (GLSP) [MIM:206700]	A0A0C9RIJ7	2601	F	L
Q14643	LP/P	Spinocerebellar ataxia 15 (SCA15) [MIM:606658]	A0A0C9RIJ7	1083	P	L
Q14571	LB/B	-	A0A0C9RIJ7	453	A	V
Q14571	LB/B	-	A0A0C9RIJ7	1143	E	D
Q14571	LB/B	-	A0A0C9RIJ7	1898	A	V
Q14571	LP/P	Anhidrosis, isolated, with normal sweat glands (ANHD) [MIM:106190]	A0A0C9RIJ7	2498	G	S
Q14573	LB/B	-	A0A0C9RIJ7	667	R	Q
Q14573	LB/B	-	A0A0C9RIJ7	742	D	E
Q14573	LB/B	-	A0A0C9RIJ7	1029	G	V
Q14573	LB/B	-	A0A0C9RIJ7	1552	L	V
Q14573	LB/B	-	A0A0C9RIJ7	1850	R	Q
Q14573	LB/B	-	A0A0C9RIJ7	2398	E	Q
Q14573	LB/B	-	A0A0C9RIJ7	2436	L	V
Q14573	LB/B	-	A0A0C9RIJ7	374	L	W
Q14573	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1J (CMT1J) [MIM:620111]	A0A0C9RIJ7	615	V	M
Q14573	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1J (CMT1J) [MIM:620111]	A0A0C9RIJ7	2524	R	C
Q6ZRS4	LB/B	-	G3HJL2	32	A	D
Q6ZRS4	LB/B	-	G3HJL2	490	A	V
Q6ZRS4	LB/B	-	G3HJL2	809	C	Y
Q6ZRS4	LB/B	-	G3HJL2	887	H	Y
Q6ZRS4	LB/B	-	G3HJL2	377	H	R
P28290	LB/B	-	A0A091L5E7	833	R	W
P28290	LB/B	-	A0A091L5E7	836	P	L
P28290	LB/B	-	A0A091L5E7	817	A	V
P28290	LB/B	-	A0A091L5E7	1258	Y	N
Q3MIP1	LB/B	-	W5NNJ9	237	C	S
Q3MIP1	LB/B	-	W5NNJ9	522	P	S
Q15811	LB/B	-	A0A091Q7R7	1137	S	N
Q9NZM3	LB/B	-	A0A091Q7R7	1287	I	T
Q9NZM3	LB/B	-	A0A091Q7R7	1534	A	T
Q9NZM3	LB/B	-	A0A091Q7R7	254	T	A
Q9NZM3	LB/B	-	A0A091Q7R7	291	V	I
P26440	LP/P	Isovaleric acidemia (IVA) [MIM:243500]	G1SW97	45	L	P
P26440	LP/P	Isovaleric acidemia (IVA) [MIM:243500]	G1SW97	202	G	V
P26440	LP/P	Isovaleric acidemia (IVA) [MIM:243500]	G1SW97	53	R	P
P26440	LP/P	Isovaleric acidemia (IVA) [MIM:243500]	G1SW97	72	D	N
P26440	LP/P	Isovaleric acidemia (IVA) [MIM:243500]	G1SW97	314	A	V
P26440	LP/P	Isovaleric acidemia (IVA) [MIM:243500]	G1SW97	360	C	R
P26440	LP/P	Isovaleric acidemia (IVA) [MIM:243500]	G1SW97	374	V	A
P26440	LP/P	Isovaleric acidemia (IVA) [MIM:243500]	G1SW97	395	R	C
P26440	LP/P	Isovaleric acidemia (IVA) [MIM:243500]	G1SW97	414	R	L
P26440	LP/P	Isovaleric acidemia (IVA) [MIM:243500]	G1SW97	97	A	G
P26440	LP/P	Isovaleric acidemia (IVA) [MIM:243500]	G1SW97	123	G	R
P26440	LP/P	Isovaleric acidemia (IVA) [MIM:243500]	G1SW97	199	I	M
P26440	LP/P	Isovaleric acidemia (IVA) [MIM:243500]	G1SW97	279	L	P
P26440	LP/P	Isovaleric acidemia (IVA) [MIM:243500]	G1SW97	403	Y	C
P07476	LB/B	-	P17941	113	T	A
P07476	LB/B	-	P17941	166	L	P
P07476	LB/B	-	P17941	174	K	E
P07476	LB/B	-	P17941	237	Q	E
P07476	LB/B	-	P17941	312	Q	K
P07476	LB/B	-	P17941	480	V	L
P07476	LB/B	-	P17941	227	E	Q
P07476	LB/B	-	P17941	236	P	S
Q6PHW0	LB/B	-	G1T5C1	260	L	P
Q6PHW0	LP/P	Thyroid dyshormonogenesis 4 (TDH4) [MIM:274800]	G1T5C1	101	R	W
Q6PHW0	LP/P	Thyroid dyshormonogenesis 4 (TDH4) [MIM:274800]	G1T5C1	116	I	T
Q6PHW0	LB/B	-	G1T5C1	271	E	K
Q8IYV9	LB/B	-	L8IM63	333	A	V
Q6UXV1	LB/B	-	H0WU63	139	R	C
P78504	LP/P	Alagille syndrome 1 (ALGS1) [MIM:118450]	A0A093CED4	37	L	S
P78504	LP/P	Alagille syndrome 1 (ALGS1) [MIM:118450]	A0A093CED4	79	L	H
P78504	LP/P	Alagille syndrome 1 (ALGS1) [MIM:118450]	A0A093CED4	127	A	T
P78504	LP/P	Alagille syndrome 1 (ALGS1) [MIM:118450]	A0A093CED4	129	P	R
P78504	LP/P	Alagille syndrome 1 (ALGS1) [MIM:118450]	A0A093CED4	152	I	T
P78504	LP/P	Alagille syndrome 1 (ALGS1) [MIM:118450]	A0A093CED4	163	P	L
P78504	LP/P	Alagille syndrome 1 (ALGS1) [MIM:118450]	A0A093CED4	184	R	C
P78504	LP/P	Alagille syndrome 1 (ALGS1) [MIM:118450]	A0A093CED4	184	R	G
P78504	LP/P	Alagille syndrome 1 (ALGS1) [MIM:118450]	A0A093CED4	184	R	H
P78504	LP/P	Alagille syndrome 1 (ALGS1) [MIM:118450]	A0A093CED4	184	R	L
P78504	LP/P	Alagille syndrome 1 (ALGS1) [MIM:118450]	A0A093CED4	187	C	S
P78504	LP/P	Alagille syndrome 1 (ALGS1) [MIM:118450]	A0A093CED4	220	C	F
P78504	LP/P	Alagille syndrome 1 (ALGS1) [MIM:118450]	A0A093CED4	229	C	G
P78504	LP/P	Alagille syndrome 1 (ALGS1) [MIM:118450]	A0A093CED4	229	C	Y
P78504	LP/P	Tetralogy of Fallot (TOF) [MIM:187500]	A0A093CED4	274	G	D
P78504	LP/P	Alagille syndrome 1 (ALGS1) [MIM:118450]	A0A093CED4	284	C	F
P78504	LP/P	Alagille syndrome 1 (ALGS1) [MIM:118450]	A0A093CED4	288	W	C
P78504	LP/P	Alagille syndrome 1 (ALGS1) [MIM:118450]	A0A093CED4	386	G	R
P78504	LP/P	Alagille syndrome 1 (ALGS1) [MIM:118450]	A0A093CED4	438	C	F
P78504	LP/P	Alagille syndrome 1 (ALGS1) [MIM:118450]	A0A093CED4	731	C	S
P78504	LP/P	Alagille syndrome 1 (ALGS1) [MIM:118450]	A0A093CED4	740	C	R
P78504	LP/P	Alagille syndrome 1 (ALGS1) [MIM:118450]	A0A093CED4	753	C	R
P78504	LP/P	Alagille syndrome 1 (ALGS1) [MIM:118450]	A0A093CED4	31	A	V
P78504	LP/P	Alagille syndrome 1 (ALGS1) [MIM:118450]	A0A093CED4	33	G	D
P78504	LP/P	Alagille syndrome 1 (ALGS1) [MIM:118450]	A0A093CED4	33	G	S
P78504	LP/P	Alagille syndrome 1 (ALGS1) [MIM:118450]	A0A093CED4	33	G	V
P78504	LP/P	Alagille syndrome 1 (ALGS1) [MIM:118450]	A0A093CED4	39	I	S
P78504	LP/P	Alagille syndrome 1 (ALGS1) [MIM:118450]	A0A093CED4	40	L	P
P78504	LB/B	-	A0A093CED4	45	V	L
P78504	LP/P	Alagille syndrome 1 (ALGS1) [MIM:118450]	A0A093CED4	75	F	S
P78504	LP/P	Alagille syndrome 1 (ALGS1) [MIM:118450]	A0A093CED4	78	C	S
P78504	LP/P	Alagille syndrome 1 (ALGS1) [MIM:118450]	A0A093CED4	92	C	R
P78504	LP/P	Alagille syndrome 1 (ALGS1) [MIM:118450]	A0A093CED4	92	C	Y
P78504	LP/P	Alagille syndrome 1 (ALGS1) [MIM:118450]	A0A093CED4	120	I	N
P78504	LP/P	Alagille syndrome 1 (ALGS1) [MIM:118450]	A0A093CED4	123	P	S
P78504	LP/P	Alagille syndrome 1 (ALGS1) [MIM:118450]	A0A093CED4	155	A	P
P78504	LP/P	Alagille syndrome 1 (ALGS1) [MIM:118450]	A0A093CED4	163	P	R
P78504	LP/P	Alagille syndrome 1 (ALGS1) [MIM:118450]	A0A093CED4	181	Y	N
P78504	LP/P	Alagille syndrome 1 (ALGS1) [MIM:118450]	A0A093CED4	187	C	Y
P78504	LP/P	Alagille syndrome 1 (ALGS1) [MIM:118450]	A0A093CED4	224	W	C
P78504	LP/P	Deafness, congenital heart defects, and posterior embryotoxon (DCHE) [MIM:617992]	A0A093CED4	234	C	Y
P78504	LP/P	Alagille syndrome 1 (ALGS1) [MIM:118450]	A0A093CED4	252	R	G
P78504	LP/P	Alagille syndrome 1 (ALGS1) [MIM:118450]	A0A093CED4	256	G	S
P78504	LP/P	Alagille syndrome 1 (ALGS1) [MIM:118450]	A0A093CED4	269	P	L
P78504	LP/P	Alagille syndrome 1 (ALGS1) [MIM:118450]	A0A093CED4	271	C	R
P78504	LP/P	Alagille syndrome 1 (ALGS1) [MIM:118450]	A0A093CED4	504	N	S
P78504	LP/P	Alagille syndrome 1 (ALGS1) [MIM:118450]	A0A093CED4	693	C	Y
P78504	LP/P	Alagille syndrome 1 (ALGS1) [MIM:118450]	A0A093CED4	714	C	Y
P78504	LB/B	-	A0A093CED4	818	R	K
P78504	LB/B	-	A0A093CED4	871	P	R
P78504	LP/P	Alagille syndrome 1 (ALGS1) [MIM:118450]	A0A093CED4	902	C	S
P78504	LP/P	Alagille syndrome 1 (ALGS1) [MIM:118450]	A0A093CED4	911	C	Y
P78504	LP/P	Alagille syndrome 1 (ALGS1) [MIM:118450]	A0A093CED4	913	S	R
P78504	LB/B	-	A0A093CED4	921	L	P
P78504	LB/B	-	A0A093CED4	937	R	Q
P78504	LB/B	-	A0A093CED4	1213	R	Q
P78504	LB/B	-	A0A093CED4	146	V	I
P78504	LP/P	Alagille syndrome 1 (ALGS1) [MIM:118450]	A0A093CED4	436	C	W
P78504	LP/P	Tetralogy of Fallot (TOF) [MIM:187500]	A0A093CED4	810	P	L
P78504	LP/P	Charcot-Marie-Tooth disease, axonal, 2HH (CMT2HH) [MIM:619574]	A0A093CED4	577	S	R
P78504	LP/P	Charcot-Marie-Tooth disease, axonal, 2HH (CMT2HH) [MIM:619574]	A0A093CED4	650	S	P
Q8N5M9	LP/P	Neutropenia, severe congenital 6, autosomal recessive (SCN6) [MIM:616022]	L9KKN6	14	G	S
Q8N5M9	LP/P	Neutropenia, severe congenital 6, autosomal recessive (SCN6) [MIM:616022]	L9KKN6	20	R	Q
Q8N5M9	LP/P	Neutropenia, severe congenital 6, autosomal recessive (SCN6) [MIM:616022]	L9KKN6	21	E	D
Q8N5M9	LP/P	Neutropenia, severe congenital 6, autosomal recessive (SCN6) [MIM:616022]	L9KKN6	44	H	Y
Q8N5M9	LP/P	Neutropenia, severe congenital 6, autosomal recessive (SCN6) [MIM:616022]	L9KKN6	162	Q	R
P23458	LB/B	-	V9KBV7	973	N	K
P23458	LP/P	Autoinflammation, immune dysregulation, and eosinophilia (AIIDE) [MIM:618999]	V9KBV7	634	A	D
P23458	LP/P	Autoinflammation, immune dysregulation, and eosinophilia (AIIDE) [MIM:618999]	V9KBV7	703	S	I
O60674	LB/B	-	V9KBV7	539	K	L
O60674	LP/P	Leukemia, acute myelogenous (AML) [MIM:601626]	V9KBV7	607	K	N
O60674	LP/P	Leukemia, acute myelogenous (AML) [MIM:601626]	V9KBV7	617	V	F
O60674	LP/P	Polycythemia vera (PV) [MIM:263300]	V9KBV7	617	V	F
O60674	LP/P	Thrombocythemia 3 (THCYT3) [MIM:614521]	V9KBV7	617	V	F
O60674	LB/B	-	V9KBV7	127	G	D
O60674	LB/B	-	V9KBV7	346	K	R
O60674	LB/B	-	V9KBV7	377	A	E
O60674	LB/B	-	V9KBV7	393	L	V
O60674	LB/B	-	V9KBV7	1063	R	H
O60674	LB/B	-	V9KBV7	584	D	E
O60674	LP/P	Thrombocythemia 3 (THCYT3) [MIM:614521]	V9KBV7	617	V	I
P52333	LP/P	Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-positive/NK-cell-negative (T(-)B(+)NK(-) SCID) [MIM:600802]	V9KBV7	100	Y	C
P52333	LB/B	Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-positive/NK-cell-negative (T(-)B(+)NK(-) SCID) [MIM:600802]	V9KBV7	151	P	R
P52333	LP/P	Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-positive/NK-cell-negative (T(-)B(+)NK(-) SCID) [MIM:600802]	V9KBV7	481	E	G
P52333	LP/P	Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-positive/NK-cell-negative (T(-)B(+)NK(-) SCID) [MIM:600802]	V9KBV7	582	R	W
P52333	LB/B	-	V9KBV7	722	V	I
P52333	LP/P	Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-positive/NK-cell-negative (T(-)B(+)NK(-) SCID) [MIM:600802]	V9KBV7	759	C	R
P52333	LP/P	Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-positive/NK-cell-negative (T(-)B(+)NK(-) SCID) [MIM:600802]	V9KBV7	910	L	S
P52333	LB/B	-	V9KBV7	132	P	T
P52333	LP/P	Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-positive/NK-cell-negative (T(-)B(+)NK(-) SCID) [MIM:600802]	V9KBV7	169	D	E
P52333	LP/P	Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-positive/NK-cell-negative (T(-)B(+)NK(-) SCID) [MIM:600802]	V9KBV7	589	G	S
P52333	LB/B	-	V9KBV7	12	P	L
P52333	LB/B	-	V9KBV7	40	R	H
P52333	LB/B	-	V9KBV7	521	L	V
P52333	LB/B	-	V9KBV7	688	I	F
Q96N16	LB/B	-	A0A091D5K9	251	K	R
Q96AA8	LB/B	-	A0A1S3WPK2	106	V	I
Q5VZ66	LB/B	-	A0A1S3WPK2	493	M	V
Q15652	LB/B	-	G3PRN0	272	A	T
Q15652	LB/B	-	G3PRN0	394	E	D
Q15652	LB/B	-	G3PRN0	464	S	T
Q15652	LB/B	-	G3PRN0	1393	N	Y
Q15652	LB/B	-	G3PRN0	2400	D	E
Q15652	LB/B	-	G3PRN0	2535	E	D
Q15652	LB/B	-	G3PRN0	591	M	V
Q9H9V9	LB/B	-	A0A2K6TIN7	11	A	V
Q9H9V9	LB/B	-	A0A2K6TIN7	16	G	C
Q9H9V9	LB/B	-	A0A2K6TIN7	65	D	E
Q9H9V9	LB/B	-	A0A2K6TIN7	461	A	V
P0C870	LB/B	-	A0A2J8IJV8	28	A	G
P0C870	LB/B	-	A0A2J8IJV8	160	M	V
Q15040	LB/B	-	W5N0M2	48	S	R
Q9HDC5	LB/B	-	A0A0P7V827	507	T	M
Q9HDC5	LB/B	-	A0A0P7V827	624	D	H
Q9BR39	LB/B	-	G3SP46	396	A	T
Q9BR39	LP/P	Cardiomyopathy, familial hypertrophic 17 (CMH17) [MIM:613873]	G3SP46	101	S	R
Q9BR39	LP/P	Cardiomyopathy, familial hypertrophic 17 (CMH17) [MIM:613873]	G3SP46	141	Y	H
Q9BR39	LP/P	Cardiomyopathy, familial hypertrophic 17 (CMH17) [MIM:613873]	G3SP46	165	S	F
Q9BR39	LB/B	-	G3SP46	436	R	C
Q9BR39	LB/B	-	G3SP46	505	G	S
Q9BR39	LP/P	-	G3SP46	85	E	K
Q9BR39	LP/P	Cardiomyopathy, familial hypertrophic 17 (CMH17) [MIM:613873]	G3SP46	161	T	K
Q9BR39	LP/P	-	G3SP46	169	E	K
Q96MG2	LB/B	-	G3T6T6	92	V	A
Q96MG2	LB/B	-	G3T6T6	233	R	Q
Q96MG2	LB/B	-	G3T6T6	108	P	L
Q96MG2	LB/B	-	G3T6T6	150	G	A
O76095	LB/B	-	A0A2K5R7E1	16	L	F
P17275	LB/B	-	A0A0S7J976	230	L	V
P17535	LB/B	-	W8C3W7	20	G	V
P14923	LB/B	-	L9JXK7	697	M	L
P14923	LB/B	-	L9JXK7	142	R	H
P14923	LB/B	-	L9JXK7	648	V	I
O60229	LB/B	-	A0A2K6RUH1	1326	E	D
O60229	LB/B	-	A0A2K6RUH1	196	S	L
O60229	LB/B	-	A0A2K6RUH1	1930	R	M
Q63ZY3	LB/B	-	G3W4D3	118	G	S
Q63ZY3	LB/B	-	G3W4D3	401	M	T
Q63ZY3	LP/P	Palmoplantar keratoderma and woolly hair (PPKWH) [MIM:616099]	G3W4D3	670	A	V
Q63ZY3	LP/P	Nephrotic syndrome 16 (NPHS16) [MIM:617783]	G3W4D3	181	S	G
Q63ZY3	LP/P	Nephrotic syndrome 16 (NPHS16) [MIM:617783]	G3W4D3	676	S	F
Q6NY19	LB/B	-	G3W4D3	288	D	Y
Q6NY19	LB/B	-	G3W4D3	359	R	H
Q6NY19	LB/B	-	G3W4D3	485	A	T
Q5T7N3	LB/B	-	A0A0P7XAD8	822	H	R
Q5T7N3	LB/B	-	A0A0P7XAD8	840	V	A
Q5T7N3	LB/B	-	A0A0P7XAD8	935	V	L
Q5T7N3	LB/B	-	A0A0P7XAD8	701	G	S
Q5T7N3	LB/B	-	A0A0P7XAD8	768	T	A
Q5T7N3	LB/B	-	A0A0P7XAD8	987	A	V
Q7Z3B3	LB/B	-	A0A2Y9PN76	1010	P	L
Q7Z3B3	LB/B	-	A0A2Y9PN76	104	K	T
Q7Z3B3	LB/B	-	A0A2Y9PN76	221	T	I
Q7Z3B3	LB/B	-	A0A2Y9PN76	225	N	D
Q7Z3B3	LB/B	-	A0A2Y9PN76	718	S	P
Q7Z3B3	LB/B	-	A0A2Y9PN76	1085	I	T
Q9P2N6	LB/B	-	A0A2Y9HYV9	707	V	I
Q8N6L0	LB/B	-	A0A212DDX0	116	L	P
Q8N6L0	LB/B	-	A0A212DDX0	129	R	Q
Q9H8E8	LB/B	-	A0A146XZ53	442	R	T
Q9H8E8	LB/B	-	A0A146XZ53	214	P	L
Q9H8E8	LB/B	-	A0A146XZ53	400	V	G
Q9H8E8	LB/B	-	A0A146XZ53	600	P	R
Q9H8E8	LB/B	-	A0A146XZ53	738	A	S
Q92831	LB/B	-	K1PM97	386	N	S
Q92993	LB/B	-	A0A0L0ST48	78	P	T
Q92993	LP/P	Neurodevelopmental disorder with dysmorphic facies, sleep disturbance, and brain abnormalities (NEDFASB) [MIM:619103]	A0A0L0ST48	53	R	H
Q92993	LP/P	Neurodevelopmental disorder with dysmorphic facies, sleep disturbance, and brain abnormalities (NEDFASB) [MIM:619103]	A0A0L0ST48	369	C	S
Q92993	LP/P	Neurodevelopmental disorder with dysmorphic facies, sleep disturbance, and brain abnormalities (NEDFASB) [MIM:619103]	A0A0L0ST48	413	S	A
Q92794	LB/B	-	A0A2J8TNW8	134	L	S
Q8WYB5	LB/B	-	A0A2J8TNW8	1499	V	I
Q8WYB5	LB/B	-	A0A2J8TNW8	1217	A	S
Q8WYB5	LB/B	-	A0A2J8TNW8	360	E	K
Q8IYT4	LB/B	-	L5K2R1	160	S	N
Q674X7	LB/B	-	A0A096MB21	706	A	T
Q674X7	LB/B	-	A0A096MB21	763	R	C
Q8IY47	LB/B	-	W5UF44	166	Q	K
Q8IY47	LB/B	-	W5UF44	189	E	G
Q8IY47	LB/B	-	W5UF44	193	T	P
Q8IY47	LB/B	-	W5UF44	254	P	R
Q8IY47	LB/B	-	W5UF44	301	P	R
Q8IY47	LB/B	-	W5UF44	534	L	I
Q8IY47	LB/B	-	W5UF44	594	S	Y
Q8NAB2	LB/B	-	H2SWP9	193	M	V
Q8NFY9	LB/B	-	A0A0F8ASB3	420	C	R
P16389	LP/P	Developmental and epileptic encephalopathy 32 (DEE32) [MIM:616366]	A0A2Y9PBI8	263	I	T
P16389	LP/P	Developmental and epileptic encephalopathy 32 (DEE32) [MIM:616366]	A0A2Y9PBI8	297	R	Q
P16389	LP/P	Developmental and epileptic encephalopathy 32 (DEE32) [MIM:616366]	A0A2Y9PBI8	298	L	F
P16389	LP/P	Developmental and epileptic encephalopathy 32 (DEE32) [MIM:616366]	A0A2Y9PBI8	405	P	L
P16389	LP/P	-	A0A2Y9PBI8	324	S	T
P16389	LP/P	Developmental and epileptic encephalopathy 32 (DEE32) [MIM:616366]	A0A2Y9PBI8	236	E	K
P22460	LB/B	-	W5NN04	228	P	S
P22460	LB/B	-	W5NN04	578	R	K
P22460	LB/B	-	W5NN04	85	L	M
Q96RP8	LB/B	-	M3WAG0	189	P	R
Q96RP8	LB/B	-	M3WAG0	418	M	T
Q14721	LB/B	-	A0A1U7R6N3	825	P	S
Q14721	LB/B	-	A0A1U7R6N3	616	T	N
Q14721	LB/B	-	A0A1U7R6N3	616	T	S
Q14721	LB/B	-	A0A1U7R6N3	857	S	N
Q14721	LP/P	Developmental and epileptic encephalopathy 26 (DEE26) [MIM:616056]	A0A1U7R6N3	347	S	R
Q14721	LP/P	Developmental and epileptic encephalopathy 26 (DEE26) [MIM:616056]	A0A1U7R6N3	374	T	I
Q14721	LP/P	Developmental and epileptic encephalopathy 26 (DEE26) [MIM:616056]	A0A1U7R6N3	379	G	R
Q14721	LP/P	Developmental and epileptic encephalopathy 26 (DEE26) [MIM:616056]	A0A1U7R6N3	306	R	C
Q14721	LP/P	Developmental and epileptic encephalopathy 26 (DEE26) [MIM:616056]	A0A1U7R6N3	378	V	A
Q14721	LP/P	Developmental and epileptic encephalopathy 26 (DEE26) [MIM:616056]	A0A1U7R6N3	401	G	R
Q92953	LB/B	-	A0A1U7R6N3	657	E	G
P48547	LP/P	Epilepsy, progressive myoclonic 7 (EPM7) [MIM:616187]	T0NNK3	320	R	H
Q96PR1	LP/P	Developmental and epileptic encephalopathy 103 (DEE103) [MIM:619913]	A0A2I0MHY4	125	C	W
Q96PR1	LP/P	Developmental and epileptic encephalopathy 103 (DEE103) [MIM:619913]	A0A2I0MHY4	135	E	G
Q96PR1	LP/P	Developmental and epileptic encephalopathy 103 (DEE103) [MIM:619913]	A0A2I0MHY4	167	D	Y
Q96PR1	LP/P	-	A0A2I0MHY4	219	F	S
Q96PR1	LP/P	Developmental and epileptic encephalopathy 103 (DEE103) [MIM:619913]	A0A2I0MHY4	351	R	K
Q96PR1	LP/P	Developmental and epileptic encephalopathy 103 (DEE103) [MIM:619913]	A0A2I0MHY4	405	R	G
Q96PR1	LP/P	Developmental and epileptic encephalopathy 103 (DEE103) [MIM:619913]	A0A2I0MHY4	437	T	A
Q96PR1	LP/P	Developmental and epileptic encephalopathy 103 (DEE103) [MIM:619913]	A0A2I0MHY4	471	V	L
Q03721	LB/B	-	A0A2I0MHY4	520	C	Y
Q03721	LB/B	-	A0A2I0MHY4	318	D	Y
Q03721	LB/B	-	A0A2I0MHY4	516	R	Q
Q9NZV8	LP/P	-	A0A1A6HRN6	404	V	M
Q9UK17	LP/P	Spinocerebellar ataxia 19 (SCA19) [MIM:607346]	A0A1A6HRN6	338	V	E
Q9UK17	LP/P	Spinocerebellar ataxia 19 (SCA19) [MIM:607346]	A0A1A6HRN6	345	G	V
Q9UK17	LP/P	Spinocerebellar ataxia 19 (SCA19) [MIM:607346]	A0A1A6HRN6	352	T	P
Q9UK17	LP/P	Spinocerebellar ataxia 19 (SCA19) [MIM:607346]	A0A1A6HRN6	377	T	M
Q9UK17	LP/P	Spinocerebellar ataxia 19 (SCA19) [MIM:607346]	A0A1A6HRN6	384	G	S
P15382	LB/B	-	A0A093HDQ6	38	S	G
P15382	LP/P	Jervell and Lange-Nielsen syndrome 2 (JLNS2) [MIM:612347]	A0A093HDQ6	7	T	I
P15382	LP/P	Jervell and Lange-Nielsen syndrome 2 (JLNS2) [MIM:612347]	A0A093HDQ6	47	V	F
P15382	LP/P	Jervell and Lange-Nielsen syndrome 2 (JLNS2) [MIM:612347]	A0A093HDQ6	51	L	H
P15382	LP/P	Long QT syndrome 5 (LQT5) [MIM:613695]	A0A093HDQ6	74	S	L
P15382	LP/P	Jervell and Lange-Nielsen syndrome 2 (JLNS2) [MIM:612347]	A0A093HDQ6	76	D	N
P15382	LP/P	Long QT syndrome 5 (LQT5) [MIM:613695]	A0A093HDQ6	76	D	N
P15382	LB/B	-	A0A093HDQ6	85	D	N
P15382	LP/P	Long QT syndrome 5 (LQT5) [MIM:613695]	A0A093HDQ6	87	W	R
P15382	LP/P	Long QT syndrome 5 (LQT5) [MIM:613695]	A0A093HDQ6	98	R	W
P15382	LP/P	Long QT syndrome 5 (LQT5) [MIM:613695]	A0A093HDQ6	127	P	T
P15382	LB/B	-	A0A093HDQ6	52	G	A
Q8WWG9	LB/B	-	G3RLT2	196	D	E
Q8WWG9	LB/B	-	G3RLT2	98	G	S
Q9UJ90	LB/B	-	A0A2Y9EN53	114	E	Q
Q9UJ90	LB/B	-	A0A2Y9EN53	33	P	S
O95259	LP/P	Temple-Baraitser syndrome (TMBTS) [MIM:611816]	R4GA28	217	K	N
O95259	LP/P	Temple-Baraitser syndrome (TMBTS) [MIM:611816]	R4GA28	489	L	F
O95259	LP/P	Temple-Baraitser syndrome (TMBTS) [MIM:611816]	R4GA28	494	I	V
O95259	LP/P	Zimmermann-Laband syndrome 1 (ZLS1) [MIM:135500]	R4GA28	494	I	V
O95259	LP/P	Temple-Baraitser syndrome (TMBTS) [MIM:611816]	R4GA28	503	Q	R
O95259	LP/P	Zimmermann-Laband syndrome 1 (ZLS1) [MIM:135500]	R4GA28	352	S	Y
O95259	LP/P	Zimmermann-Laband syndrome 1 (ZLS1) [MIM:135500]	R4GA28	375	G	R
O95259	LP/P	Zimmermann-Laband syndrome 1 (ZLS1) [MIM:135500]	R4GA28	379	L	V
O95259	LP/P	Zimmermann-Laband syndrome 1 (ZLS1) [MIM:135500]	R4GA28	383	V	L
O95259	LP/P	Zimmermann-Laband syndrome 1 (ZLS1) [MIM:135500]	R4GA28	496	G	R
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	470	N	D
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	534	R	C
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	561	A	V
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	582	R	C
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	593	I	R
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	628	G	S
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	822	V	M
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	29	F	L
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	33	N	T
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	53	G	R
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	56	R	Q
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	66	C	G
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	70	H	R
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	78	A	P
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	86	L	R
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	176	R	W
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	436	T	M
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	474	T	I
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	552	L	S
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	558	A	P
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	564	L	P
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	569	Y	H
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	572	G	R
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	572	G	C
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	584	G	S
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	588	N	D
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	601	G	S
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	604	G	S
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	611	Y	H
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	612	V	L
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	613	T	M
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	614	A	V
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	629	N	D
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	629	N	K
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	630	V	L
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	630	V	A
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	633	N	S
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	640	F	L
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	818	S	L
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	629	N	S
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	47	G	V
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	347	P	S
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	531	R	Q
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	593	I	T
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	609	D	N
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	65	T	P
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	451	P	L
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	561	A	T
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	615	L	V
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	626	G	S
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	627	F	L
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	632	P	S
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	637	E	K
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	638	K	E
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	645	M	L
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	752	R	W
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	805	F	C
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	805	F	S
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	861	N	I
Q12809	LB/B	-	A0A2J8JZ79	897	K	T
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	917	P	L
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	922	R	W
Q12809	LP/P	Short QT syndrome 1 (SQT1) [MIM:609620]	A0A2J8JZ79	588	N	K
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	100	R	G
Q12809	LB/B	-	A0A2J8JZ79	181	R	Q
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	490	A	T
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	525	K	N
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	528	R	P
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	696	R	C
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	752	R	Q
Q12809	LB/B	-	A0A2J8JZ79	784	R	W
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	948	R	C
Q12809	LB/B	-	A0A2J8JZ79	1016	P	S
Q12809	LB/B	-	A0A2J8JZ79	1016	P	L
Q12809	LB/B	-	A0A2J8JZ79	1020	P	S
Q12809	LB/B	-	A0A2J8JZ79	1026	P	L
Q12809	LB/B	-	A0A2J8JZ79	1055	R	Q
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	26	S	I
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	31	I	S
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	55	S	L
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	85	A	V
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	100	R	Q
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	238	G	S
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	306	G	W
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	320	S	L
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	328	R	C
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	420	Y	C
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	421	T	M
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	422	A	T
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	427	Y	S
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	456	D	Y
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	562	H	P
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	571	I	L
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	572	G	S
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	596	P	R
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	622	L	F
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	623	T	I
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	628	G	V
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	635	N	I
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	640	F	V
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	641	S	F
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	721	P	L
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	744	R	P
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	774	D	Y
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	788	E	D
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	820	G	R
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	837	D	G
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	887	R	H
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	913	A	V
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	925	G	R
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	983	T	I
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	996	N	I
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	1036	G	D
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	413	L	P
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	444	E	D
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	559	L	H
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	74	T	M
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	427	Y	H
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	534	R	L
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	572	G	D
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	637	E	D
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	644	V	F
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	660	S	L
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	1115	M	V
Q12809	LP/P	Long QT syndrome 2 (LQT2) [MIM:613688]	A0A2J8JZ79	64	C	Y
Q8NCM2	LB/B	-	R4GA28	745	A	T
Q9H252	LB/B	-	A0A2J8JZ79	165	G	R
Q9H252	LB/B	-	A0A2J8JZ79	925	T	M
Q9NS40	LB/B	-	I3ITL7	958	G	A
Q96L42	LB/B	-	A0A2Y9LTJ8	893	Q	R
Q96L42	LB/B	-	A0A2Y9LTJ8	984	E	Q
Q9Y2W7	LB/B	-	A0A1W4ZLN8	119	A	V
P48048	LP/P	Bartter syndrome 2, antenatal (BARTS2) [MIM:241200]	L5KEJ7	72	V	E
P48048	LP/P	Bartter syndrome 2, antenatal (BARTS2) [MIM:241200]	L5KEJ7	74	D	Y
P48048	LP/P	Bartter syndrome 2, antenatal (BARTS2) [MIM:241200]	L5KEJ7	99	W	C
P48048	LP/P	Bartter syndrome 2, antenatal (BARTS2) [MIM:241200]	L5KEJ7	108	D	H
P48048	LP/P	Bartter syndrome 2, antenatal (BARTS2) [MIM:241200]	L5KEJ7	110	P	L
P48048	LP/P	Bartter syndrome 2, antenatal (BARTS2) [MIM:241200]	L5KEJ7	122	V	E
P48048	LP/P	Bartter syndrome 2, antenatal (BARTS2) [MIM:241200]	L5KEJ7	167	G	E
P48048	LP/P	Bartter syndrome 2, antenatal (BARTS2) [MIM:241200]	L5KEJ7	198	A	T
P48048	LP/P	Bartter syndrome 2, antenatal (BARTS2) [MIM:241200]	L5KEJ7	315	V	G
P48048	LP/P	Bartter syndrome 2, antenatal (BARTS2) [MIM:241200]	L5KEJ7	124	N	K
P48048	LP/P	Bartter syndrome 2, antenatal (BARTS2) [MIM:241200]	L5KEJ7	214	A	V
P48048	LP/P	Bartter syndrome 2, antenatal (BARTS2) [MIM:241200]	L5KEJ7	219	S	R
P48048	LP/P	Bartter syndrome 2, antenatal (BARTS2) [MIM:241200]	L5KEJ7	357	M	T
P48048	LB/B	-	L5KEJ7	6	R	W
P78508	LB/B	-	Q499F6	271	R	H
P78508	LB/B	-	Q499F6	271	R	C
P78508	LP/P	Seizures, sensorineural deafness, ataxia, impaired intellectual development, and electrolyte imbalance (SESAMES) [MIM:612780]	Q499F6	65	R	P
P78508	LP/P	Seizures, sensorineural deafness, ataxia, impaired intellectual development, and electrolyte imbalance (SESAMES) [MIM:612780]	Q499F6	77	G	R
P78508	LP/P	Seizures, sensorineural deafness, ataxia, impaired intellectual development, and electrolyte imbalance (SESAMES) [MIM:612780]	Q499F6	140	C	R
P78508	LP/P	Seizures, sensorineural deafness, ataxia, impaired intellectual development, and electrolyte imbalance (SESAMES) [MIM:612780]	Q499F6	164	T	I
P78508	LP/P	Seizures, sensorineural deafness, ataxia, impaired intellectual development, and electrolyte imbalance (SESAMES) [MIM:612780]	Q499F6	167	A	V
P78508	LP/P	Seizures, sensorineural deafness, ataxia, impaired intellectual development, and electrolyte imbalance (SESAMES) [MIM:612780]	Q499F6	297	R	C
P78508	LP/P	Seizures, sensorineural deafness, ataxia, impaired intellectual development, and electrolyte imbalance (SESAMES) [MIM:612780]	Q499F6	68	L	P
P78508	LP/P	Seizures, sensorineural deafness, ataxia, impaired intellectual development, and electrolyte imbalance (SESAMES) [MIM:612780]	Q499F6	129	I	V
Q14654	LP/P	Familial hyperinsulinemic hypoglycemia 2 (HHF2) [MIM:601820]	A0A093R0S0	147	L	P
Q14654	LB/B	-	A0A093R0S0	10	E	K
Q14654	LB/B	-	A0A093R0S0	23	K	E
Q14654	LB/B	-	A0A093R0S0	270	L	V
Q14654	LB/B	-	A0A093R0S0	337	V	I
Q14654	LB/B	-	A0A093R0S0	355	L	P
Q14654	LB/B	-	A0A093R0S0	385	S	C
Q14654	LB/B	-	A0A093R0S0	195	R	H
Q14654	LP/P	Diabetes mellitus, permanent neonatal, 2 (PNDM2) [MIM:618856]	A0A093R0S0	35	F	L
Q14654	LP/P	Diabetes mellitus, permanent neonatal, 2 (PNDM2) [MIM:618856]	A0A093R0S0	35	F	V
Q14654	LP/P	Diabetes mellitus, permanent neonatal, 2 (PNDM2) [MIM:618856]	A0A093R0S0	50	R	P
Q14654	LP/P	Diabetes mellitus, permanent neonatal, 2 (PNDM2) [MIM:618856]	A0A093R0S0	52	Q	R
Q14654	LP/P	Transient neonatal diabetes mellitus 3 (TNDM3) [MIM:610582]	A0A093R0S0	53	G	R
Q14654	LP/P	Transient neonatal diabetes mellitus 3 (TNDM3) [MIM:610582]	A0A093R0S0	53	G	S
Q14654	LP/P	Diabetes mellitus, permanent neonatal, 2 (PNDM2) [MIM:618856]	A0A093R0S0	59	V	G
Q14654	LP/P	Diabetes mellitus, permanent neonatal, 2 (PNDM2) [MIM:618856]	A0A093R0S0	59	V	M
Q14654	LP/P	Familial hyperinsulinemic hypoglycemia 2 (HHF2) [MIM:601820]	A0A093R0S0	67	K	N
Q14654	LP/P	Familial hyperinsulinemic hypoglycemia 2 (HHF2) [MIM:601820]	A0A093R0S0	91	W	R
Q14654	LP/P	Diabetes mellitus, permanent neonatal, 2 (PNDM2) [MIM:618856]	A0A093R0S0	170	K	N
Q14654	LP/P	Diabetes mellitus, permanent neonatal, 2 (PNDM2) [MIM:618856]	A0A093R0S0	170	K	R
Q14654	LP/P	Transient neonatal diabetes mellitus 3 (TNDM3) [MIM:610582]	A0A093R0S0	182	I	V
Q14654	LP/P	Diabetes mellitus, permanent neonatal, 2 (PNDM2) [MIM:618856]	A0A093R0S0	201	R	C
Q14654	LP/P	Diabetes mellitus, permanent neonatal, 2 (PNDM2) [MIM:618856]	A0A093R0S0	201	R	H
Q14654	LP/P	Familial hyperinsulinemic hypoglycemia 2 (HHF2) [MIM:601820]	A0A093R0S0	254	P	L
Q14654	LP/P	Diabetes mellitus, permanent neonatal, 2 (PNDM2) [MIM:618856]	A0A093R0S0	296	I	L
Q14654	LP/P	Diabetes mellitus, permanent neonatal, 2 (PNDM2) [MIM:618856]	A0A093R0S0	322	E	K
Q14654	LP/P	Diabetes mellitus, permanent neonatal, 2 (PNDM2) [MIM:618856]	A0A093R0S0	330	Y	C
Q14654	LP/P	Diabetes mellitus, permanent neonatal, 2 (PNDM2) [MIM:618856]	A0A093R0S0	333	F	I
Q14654	LP/P	Familial hyperinsulinemic hypoglycemia 2 (HHF2) [MIM:601820]	A0A093R0S0	34	R	H
Q14654	LP/P	Familial hyperinsulinemic hypoglycemia 2 (HHF2) [MIM:601820]	A0A093R0S0	40	G	D
Q14654	LP/P	Transient neonatal diabetes mellitus 3 (TNDM3) [MIM:610582]	A0A093R0S0	42	C	R
Q14654	LP/P	Diabetes mellitus, permanent neonatal, 2 (PNDM2) [MIM:618856]	A0A093R0S0	46	H	Y
Q14654	LP/P	Diabetes mellitus, permanent neonatal, 2 (PNDM2) [MIM:618856]	A0A093R0S0	50	R	Q
Q14654	LP/P	Diabetes mellitus, permanent neonatal, 2 (PNDM2) [MIM:618856]	A0A093R0S0	53	G	D
Q14654	LP/P	Familial hyperinsulinemic hypoglycemia 2 (HHF2) [MIM:601820]	A0A093R0S0	55	F	L
Q14654	LP/P	Familial hyperinsulinemic hypoglycemia 2 (HHF2) [MIM:601820]	A0A093R0S0	101	A	D
Q14654	LP/P	Familial hyperinsulinemic hypoglycemia 2 (HHF2) [MIM:601820]	A0A093R0S0	116	S	P
Q14654	LP/P	Familial hyperinsulinemic hypoglycemia 2 (HHF2) [MIM:601820]	A0A093R0S0	134	G	A
Q14654	LP/P	Familial hyperinsulinemic hypoglycemia 2 (HHF2) [MIM:601820]	A0A093R0S0	136	R	L
Q14654	LB/B	-	A0A093R0S0	148	I	S
Q14654	LP/P	Diabetes mellitus, permanent neonatal, 2 (PNDM2) [MIM:618856]	A0A093R0S0	164	L	P
Q14654	LP/P	Diabetes mellitus, permanent neonatal, 2 (PNDM2) [MIM:618856]	A0A093R0S0	166	C	Y
Q14654	LP/P	Diabetes mellitus, permanent neonatal, 2 (PNDM2) [MIM:618856]	A0A093R0S0	170	K	T
Q14654	LP/P	Diabetes mellitus, permanent neonatal, 2 (PNDM2) [MIM:618856]	A0A093R0S0	201	R	L
Q14654	LP/P	Familial hyperinsulinemic hypoglycemia 2 (HHF2) [MIM:601820]	A0A093R0S0	259	H	R
Q14654	LP/P	Familial hyperinsulinemic hypoglycemia 2 (HHF2) [MIM:601820]	A0A093R0S0	266	P	L
Q14654	LP/P	Familial hyperinsulinemic hypoglycemia 2 (HHF2) [MIM:601820]	A0A093R0S0	301	R	H
Q14654	LP/P	Diabetes mellitus, permanent neonatal, 2 (PNDM2) [MIM:618856]	A0A093R0S0	330	Y	S
Q14654	LB/B	-	A0A093R0S0	18	A	G
Q14654	LP/P	Diabetes mellitus, permanent neonatal, 2 (PNDM2) [MIM:618856]	A0A093R0S0	60	F	Y
Q14654	LP/P	Familial hyperinsulinemic hypoglycemia 2 (HHF2) [MIM:601820]	A0A093R0S0	156	G	R
Q14654	LP/P	Diabetes mellitus, permanent neonatal, 2 (PNDM2) [MIM:618856]	A0A093R0S0	167	I	L
Q14654	LP/P	Familial hyperinsulinemic hypoglycemia 2 (HHF2) [MIM:601820]	A0A093R0S0	204	D	E
Q14654	LP/P	Maturity-onset diabetes of the young 13 (MODY13) [MIM:616329]	A0A093R0S0	227	E	K
Q14654	LP/P	Familial hyperinsulinemic hypoglycemia 2 (HHF2) [MIM:601820]	A0A093R0S0	282	E	K
O60928	LB/B	-	A0A2G9RGF6	175	T	I
O60928	LP/P	Snowflake vitreoretinal degeneration (SVD) [MIM:193230]	A0A2G9RGF6	162	R	W
O60928	LB/B	-	A0A2G9RGF6	290	P	Q
O60928	LB/B	-	A0A2G9RGF6	309	G	C
O60928	LP/P	Leber congenital amaurosis 16 (LCA16) [MIM:614186]	A0A2G9RGF6	117	Q	R
O60928	LB/B	-	A0A2G9RGF6	162	R	Q
O60928	LP/P	Leber congenital amaurosis 16 (LCA16) [MIM:614186]	A0A2G9RGF6	241	L	P
O60928	LB/B	-	A0A2G9RGF6	276	E	A
Q9UNX9	LB/B	-	S9X6J9	289	R	C
Q99712	LB/B	-	S7MKI2	98	G	D
Q99712	LB/B	-	S7MKI2	30	M	L
Q9NPI9	LB/B	-	A0A218UY71	11	I	V
Q9NPI9	LP/P	Hypokalemic tubulopathy and deafness (HKTD) [MIM:619406]	A0A218UY71	64	T	I
Q9NPI9	LP/P	Hypokalemic tubulopathy and deafness (HKTD) [MIM:619406]	A0A218UY71	132	I	R
Q9NPI9	LP/P	Hypokalemic tubulopathy and deafness (HKTD) [MIM:619406]	A0A218UY71	135	G	A
Q9NPI9	LP/P	Hypokalemic tubulopathy and deafness (HKTD) [MIM:619406]	A0A218UY71	137	R	C
Q9NPI9	LP/P	Hypokalemic tubulopathy and deafness (HKTD) [MIM:619406]	A0A218UY71	250	P	L
P48549	LB/B	-	H2UZV0	40	K	R
P48544	LB/B	-	F1QR82	282	Q	E
P48544	LP/P	Long QT syndrome 13 (LQT13) [MIM:613485]	F1QR82	387	G	R
P48544	LB/B	-	F1QR82	39	R	H
P48544	LP/P	Hyperaldosteronism, familial, 3 (HALD3) [MIM:613677]	F1QR82	151	G	R
P48544	LP/P	Hyperaldosteronism, familial, 3 (HALD3) [MIM:613677]	F1QR82	158	T	A
P48544	LB/B	-	F1QR82	168	L	R
P48544	LB/B	-	F1QR82	210	M	I
P48544	LP/P	Hyperaldosteronism, familial, 3 (HALD3) [MIM:613677]	F1QR82	151	G	E
P48544	LP/P	Hyperaldosteronism, familial, 3 (HALD3) [MIM:613677]	F1QR82	152	Y	C
P48544	LP/P	Hyperaldosteronism, familial, 3 (HALD3) [MIM:613677]	F1QR82	157	I	S
P48544	LP/P	-	F1QR82	348	Y	N
Q15842	LB/B	-	A0A1A8NCK5	334	V	A
Q15842	LP/P	Sudden infant death syndrome (SIDS) [MIM:272120]	A0A1A8NCK5	346	V	I
Q92806	LB/B	-	A0A2K5HPQ4	366	A	V
P57789	LB/B	-	M0QT03	512	A	T
P57789	LB/B	-	M0QT03	70	K	Q
Q9HB14	LB/B	-	A0A2I4B2U1	389	G	A
Q9HB14	LB/B	-	A0A2I4B2U1	305	G	R
Q96T55	LB/B	-	M3W5V3	301	P	H
Q96T55	LB/B	-	M3W5V3	215	F	L
Q96T55	LB/B	-	M3W5V3	275	A	G
Q96T54	LB/B	-	H0WL62	296	R	Q
Q96T54	LB/B	-	H0WL62	21	S	G
Q96T54	LB/B	-	H0WL62	253	M	L
Q9NYG8	LB/B	-	F7BJ57	328	P	L
Q9NYG8	LP/P	Facial dysmorphism, hypertrichosis, epilepsy, intellectual and developmental delay, and gingival overgrowth syndrome (FHEIG) [MIM:618381]	F7BJ57	172	A	E
Q9NYG8	LP/P	Facial dysmorphism, hypertrichosis, epilepsy, intellectual and developmental delay, and gingival overgrowth syndrome (FHEIG) [MIM:618381]	F7BJ57	244	A	P
O95279	LB/B	-	W5NKS2	465	P	T
Q9NPC2	LP/P	Birk-Barel syndrome (BIBARS) [MIM:612292]	A0A1S3M415	236	G	R
Q9NPC2	LP/P	Birk-Barel syndrome (BIBARS) [MIM:612292]	A0A1S3M415	237	A	D
Q12791	LP/P	Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy (PNKD3) [MIM:609446]	Q5QJC5	434	D	G
Q12791	LP/P	Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy (PNKD3) [MIM:609446]	Q5QJC5	884	E	K
Q12791	LP/P	Epilepsy, idiopathic generalized 16 (EIG16) [MIM:618596]	Q5QJC5	1053	N	S
Q12791	LP/P	Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy (PNKD3) [MIM:609446]	Q5QJC5	1053	N	S
Q12791	LP/P	Liang-Wang syndrome (LIWAS) [MIM:618729]	Q5QJC5	375	G	R
Q16558	LB/B	-	A0A2K6QSM3	65	E	K
Q16558	LB/B	-	A0A2K6QSM3	110	V	L
Q9NPA1	LB/B	-	A0A1S3W537	44	D	G
Q9NPA1	LB/B	-	A0A1S3W537	53	A	T
Q9NPA1	LB/B	-	A0A1S3W537	75	L	V
Q9NPA1	LB/B	-	A0A1S3W537	165	N	S
Q9NPA1	LB/B	-	A0A1S3W537	230	M	T
Q9UGI6	LP/P	Zimmermann-Laband syndrome 3 (ZLS3) [MIM:618658]	A0A0Q3X826	269	K	E
Q9UGI6	LP/P	Zimmermann-Laband syndrome 3 (ZLS3) [MIM:618658]	A0A0Q3X826	350	G	D
Q9UGI6	LP/P	Zimmermann-Laband syndrome 3 (ZLS3) [MIM:618658]	A0A0Q3X826	436	S	C
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	168	G	R
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	174	R	C
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	178	A	P
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	189	G	R
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	190	R	Q
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	216	G	R
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	254	V	M
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	261	E	K
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	269	G	D
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	273	L	F
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	300	A	T
P51787	LP/P	Jervell and Lange-Nielsen syndrome 1 (JLNS1) [MIM:220400]	A0A1A8AJJ0	305	W	S
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	309	T	R
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	312	T	I
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	313	I	M
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	314	G	S
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	315	Y	S
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	317	D	N
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	320	P	A
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	325	G	R
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	341	A	E
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	341	A	V
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	342	L	F
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	344	A	V
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	345	G	E
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	366	R	P
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	371	A	T
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	555	R	C
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	157	F	C
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	184	Y	S
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	345	G	R
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	373	S	P
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	392	W	R
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	174	R	H
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	242	D	N
P51787	LP/P	Jervell and Lange-Nielsen syndrome 1 (JLNS1) [MIM:220400]	A0A1A8AJJ0	243	R	H
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	248	W	R
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	250	L	H
P51787	LP/P	Jervell and Lange-Nielsen syndrome 1 (JLNS1) [MIM:220400]	A0A1A8AJJ0	261	E	D
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	281	Y	C
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	315	Y	C
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	318	K	N
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	366	R	W
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	533	R	W
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	539	R	W
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	587	T	M
P51787	LP/P	Jervell and Lange-Nielsen syndrome 1 (JLNS1) [MIM:220400]	A0A1A8AJJ0	589	G	D
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	589	G	D
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	591	R	H
P51787	LB/B	-	A0A1A8AJJ0	643	G	S
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	353	L	P
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	525	A	T
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	160	E	K
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	178	A	T
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	194	A	P
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	225	S	L
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	266	L	P
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	269	G	S
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	310	V	I
P51787	LP/P	Jervell and Lange-Nielsen syndrome 1 (JLNS1) [MIM:220400]	A0A1A8AJJ0	311	T	I
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	311	T	I
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	349	S	W
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	366	R	Q
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	391	T	I
P51787	LB/B	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	448	P	R
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	566	S	F
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	583	R	C
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	594	R	Q
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	243	R	C
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	417	V	M
P51787	LP/P	Atrial fibrillation, familial, 3 (ATFB3) [MIM:607554]	A0A1A8AJJ0	140	S	G
P51787	LP/P	Short QT syndrome 2 (SQT2) [MIM:609621]	A0A1A8AJJ0	307	V	L
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	362	K	R
P51787	LB/B	-	A0A1A8AJJ0	393	K	N
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	277	S	L
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	320	P	H
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	115	E	G
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	122	C	Y
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	133	V	I
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	136	C	F
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	204	I	F
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	235	I	N
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	259	R	C
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	259	R	L
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	273	L	R
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	278	Y	H
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	290	E	K
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	292	G	D
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	293	R	C
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	302	A	V
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	304	W	R
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	314	G	D
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	314	G	R
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	316	G	R
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	322	T	A
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	343	P	S
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	344	A	E
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	380	R	S
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	389	S	Y
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	524	V	G
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	526	K	E
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	546	S	L
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	555	R	H
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	566	S	Y
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	567	I	S
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	568	G	R
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	590	A	T
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	619	L	M
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	626	G	S
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	191	L	P
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	243	R	P
P51787	LP/P	Jervell and Lange-Nielsen syndrome 1 (JLNS1) [MIM:220400]	A0A1A8AJJ0	248	W	F
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	275	F	S
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	306	G	V
P51787	LP/P	Jervell and Lange-Nielsen syndrome 1 (JLNS1) [MIM:220400]	A0A1A8AJJ0	322	T	M
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	322	T	M
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	557	K	E
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	586	N	D
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	173	V	D
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	204	I	M
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	215	V	M
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	231	R	C
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	231	R	H
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	262	L	V
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	272	G	D
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	280	V	E
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	316	G	E
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	343	P	L
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	350	G	R
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	351	F	S
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	567	I	T
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	296	F	S
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	339	F	S
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	360	R	G
P51787	LP/P	Long QT syndrome 1 (LQT1) [MIM:192500]	A0A1A8AJJ0	455	H	Y
O43525	LP/P	Seizures, benign familial neonatal 2 (BFNS2) [MIM:121201]	S9WNY3	310	G	V
O43525	LP/P	Seizures, benign familial neonatal 2 (BFNS2) [MIM:121201]	S9WNY3	309	W	R
O43525	LP/P	Seizures, benign familial neonatal 2 (BFNS2) [MIM:121201]	S9WNY3	305	D	G
O43525	LB/B	-	S9WNY3	468	N	S
O43525	LB/B	-	S9WNY3	414	E	G
P56696	LP/P	Deafness, autosomal dominant, 2A (DFNA2A) [MIM:600101]	W5LMN5	285	G	S
P56696	LP/P	Deafness, autosomal dominant, 2A (DFNA2A) [MIM:600101]	W5LMN5	276	W	S
P56696	LP/P	Deafness, autosomal dominant, 2A (DFNA2A) [MIM:600101]	W5LMN5	285	G	C
P56696	LP/P	Deafness, autosomal dominant, 2A (DFNA2A) [MIM:600101]	W5LMN5	321	G	S
P56696	LP/P	Deafness, autosomal dominant, 2A (DFNA2A) [MIM:600101]	W5LMN5	274	L	H
P56696	LP/P	Deafness, autosomal dominant, 2A (DFNA2A) [MIM:600101]	W5LMN5	281	L	S
P56696	LB/B	-	W5LMN5	455	H	Q
P56696	LP/P	Deafness, autosomal dominant, 2A (DFNA2A) [MIM:600101]	W5LMN5	287	G	R
Q96KK3	LB/B	-	L5JYS0	489	I	V
Q96KK3	LB/B	-	L5JYS0	508	Q	R
Q9BQ31	LB/B	-	F1PGB8	450	T	A
Q9BQ31	LB/B	-	F1PGB8	225	V	L
A8MYU2	LB/B	-	Q5QJC5	768	W	R
A8MYU2	LB/B	-	Q5QJC5	916	N	S
A8MYU2	LB/B	-	Q5QJC5	175	D	N
Q6PIU1	LB/B	-	S9WTI0	22	D	G
Q6ZWJ8	LB/B	-	A0A1U8CFD9	47	G	E
Q6ZWJ8	LB/B	-	A0A1U8CFD9	459	K	E
Q6ZWJ8	LB/B	-	A0A1U8CFD9	688	D	V
Q6ZWJ8	LB/B	-	A0A1U8CFD9	1193	P	R
Q719H9	LB/B	-	L5LTJ6	107	L	W
Q719H9	LP/P	Scalp-ear-nipple syndrome (SENS) [MIM:181270]	L5LTJ6	30	A	E
Q719H9	LP/P	Scalp-ear-nipple syndrome (SENS) [MIM:181270]	L5LTJ6	31	P	L
Q719H9	LP/P	Scalp-ear-nipple syndrome (SENS) [MIM:181270]	L5LTJ6	31	P	R
Q719H9	LP/P	Scalp-ear-nipple syndrome (SENS) [MIM:181270]	L5LTJ6	31	P	S
Q719H9	LP/P	Scalp-ear-nipple syndrome (SENS) [MIM:181270]	L5LTJ6	33	H	P
Q719H9	LP/P	Scalp-ear-nipple syndrome (SENS) [MIM:181270]	L5LTJ6	33	H	Q
Q719H9	LP/P	Scalp-ear-nipple syndrome (SENS) [MIM:181270]	L5LTJ6	62	G	D
Q719H9	LP/P	Scalp-ear-nipple syndrome (SENS) [MIM:181270]	L5LTJ6	74	H	P
Q693B1	LB/B	-	T0M3P5	22	G	S
Q96SI1	LB/B	-	A0A2U9C002	64	G	S
Q8N5Z5	LB/B	-	A0A2K5MDF3	51	R	G
Q8N5Z5	LP/P	Dystonia 26, myoclonic (DYT26) [MIM:616398]	A0A2K5MDF3	145	R	H
Q6PI47	LB/B	-	M7ANM6	333	A	V
Q6PI47	LB/B	-	M7ANM6	336	G	C
Q6PI47	LB/B	-	M7ANM6	390	C	S
Q6PI47	LB/B	-	M7ANM6	413	A	V
Q17RG1	LB/B	-	L5LHE0	750	E	K
Q7Z5Y7	LB/B	-	M3XKJ1	171	S	T
Q9Y597	LB/B	-	A0A2I4DD73	9	F	V
Q96MP8	LP/P	-	A0A2Y9TL61	84	R	W
Q96MP8	LP/P	Epilepsy, progressive myoclonic 3, with or without intracellular inclusions (EPM3) [MIM:611726]	A0A2Y9TL61	94	R	W
Q96MP8	LP/P	Epilepsy, progressive myoclonic 3, with or without intracellular inclusions (EPM3) [MIM:611726]	A0A2Y9TL61	108	L	M
Q96MP8	LP/P	Epilepsy, progressive myoclonic 3, with or without intracellular inclusions (EPM3) [MIM:611726]	A0A2Y9TL61	184	R	C
Q96MP8	LP/P	Epilepsy, progressive myoclonic 3, with or without intracellular inclusions (EPM3) [MIM:611726]	A0A2Y9TL61	273	N	I
P33947	LP/P	Osteogenesis imperfecta 21 (OI21) [MIM:619131]	M7BCS2	12	H	D
O43731	LB/B	-	L9K753	199	V	G
Q8NAX2	LB/B	-	A0A2U4BLH7	100	Q	R
Q8NAX2	LB/B	-	A0A2U4BLH7	107	R	W
Q8NAX2	LB/B	-	A0A2U4BLH7	189	K	R
O60341	LP/P	Cleft palate, psychomotor retardation, and distinctive facial features (CPRF) [MIM:616728]	A0A182GCT0	379	E	K
O60341	LP/P	Cleft palate, psychomotor retardation, and distinctive facial features (CPRF) [MIM:616728]	A0A182GCT0	556	D	G
O60341	LP/P	Cleft palate, psychomotor retardation, and distinctive facial features (CPRF) [MIM:616728]	A0A182GCT0	761	Y	H
Q9Y4C1	LB/B	-	G3WJ43	212	I	V
Q9Y4C1	LB/B	-	G3WJ43	194	E	K
Q9Y4C1	LB/B	-	G3WJ43	710	V	E
Q9Y4C1	LB/B	-	G3WJ43	447	S	P
Q7LBC6	LB/B	-	A0A2Y9RHA5	256	A	T
Q7LBC6	LB/B	-	A0A2Y9RHA5	1201	S	N
Q7LBC6	LP/P	Diets-Jongmans syndrome (DIJOS) [MIM:618846]	A0A2Y9RHA5	117	W	R
Q7LBC6	LP/P	Diets-Jongmans syndrome (DIJOS) [MIM:618846]	A0A2Y9RHA5	943	R	Q
Q7LBC6	LP/P	Diets-Jongmans syndrome (DIJOS) [MIM:618846]	A0A2Y9RHA5	943	R	W
Q7LBC6	LP/P	Diets-Jongmans syndrome (DIJOS) [MIM:618846]	A0A2Y9RHA5	1028	R	Q
Q7LBC6	LP/P	Diets-Jongmans syndrome (DIJOS) [MIM:618846]	A0A2Y9RHA5	1032	D	V
Q7LBC6	LP/P	Diets-Jongmans syndrome (DIJOS) [MIM:618846]	A0A2Y9RHA5	1509	L	P
Q7LBC6	LP/P	Diets-Jongmans syndrome (DIJOS) [MIM:618846]	A0A2Y9RHA5	1734	L	R
O94953	LB/B	-	H3C124	29	N	T
O94953	LB/B	-	H3C124	710	K	E
O94953	LP/P	Intellectual developmental disorder, autosomal dominant 65 (MRD65) [MIM:619320]	H3C124	220	L	P
O94953	LP/P	Intellectual developmental disorder, autosomal dominant 65 (MRD65) [MIM:619320]	H3C124	222	R	W
O94953	LP/P	Intellectual developmental disorder, autosomal dominant 65 (MRD65) [MIM:619320]	H3C124	768	H	R
Q9H3R0	LB/B	-	H3C124	396	D	N
Q9H3R0	LB/B	-	H3C124	767	Q	E
Q9H3R0	LB/B	-	H3C124	1039	V	I
Q9H3R0	LB/B	-	H3C124	206	E	D
Q9H3R0	LB/B	-	H3C124	492	S	T
Q9H3R0	LB/B	-	H3C124	697	N	S
Q9H3R0	LB/B	-	H3C124	772	K	R
Q6B0I6	LB/B	-	A0A2U4CFI6	408	R	Q
Q6B0I6	LB/B	-	A0A2U4CFI6	355	S	R
Q6B0I6	LB/B	-	A0A2U4CFI6	471	A	S
B2RXH2	LB/B	-	A0A2U4CFI6	26	A	T
B2RXH2	LB/B	-	A0A2U4CFI6	42	Q	R
B2RXH2	LB/B	-	A0A2U4CFI6	113	Q	R
B2RXH2	LB/B	-	A0A2U4CFI6	258	F	S
P29375	LB/B	-	G1NL10	865	M	T
P29375	LB/B	-	G1NL10	1190	P	A
P41229	LP/P	Intellectual developmental disorder, X-linked, syndromic, Claes-Jensen type (MRXSCJ) [MIM:300534]	G3VQR9	388	A	P
P41229	LP/P	Intellectual developmental disorder, X-linked, syndromic, Claes-Jensen type (MRXSCJ) [MIM:300534]	G3VQR9	402	D	Y
P41229	LP/P	Intellectual developmental disorder, X-linked, syndromic, Claes-Jensen type (MRXSCJ) [MIM:300534]	G3VQR9	698	E	K
P41229	LP/P	Intellectual developmental disorder, X-linked, syndromic, Claes-Jensen type (MRXSCJ) [MIM:300534]	G3VQR9	731	L	F
P41229	LP/P	Intellectual developmental disorder, X-linked, syndromic, Claes-Jensen type (MRXSCJ) [MIM:300534]	G3VQR9	87	D	G
P41229	LP/P	Intellectual developmental disorder, X-linked, syndromic, Claes-Jensen type (MRXSCJ) [MIM:300534]	G3VQR9	451	S	R
P41229	LP/P	Intellectual developmental disorder, X-linked, syndromic, Claes-Jensen type (MRXSCJ) [MIM:300534]	G3VQR9	642	F	L
P41229	LP/P	Intellectual developmental disorder, X-linked, syndromic, Claes-Jensen type (MRXSCJ) [MIM:300534]	G3VQR9	750	R	W
P41229	LP/P	Intellectual developmental disorder, X-linked, syndromic, Claes-Jensen type (MRXSCJ) [MIM:300534]	G3VQR9	751	Y	C
P41229	LP/P	Intellectual developmental disorder, X-linked, syndromic, Claes-Jensen type (MRXSCJ) [MIM:300534]	G3VQR9	480	P	L
Q9BY66	LB/B	-	G3VQR9	1186	V	L
Q8N371	LB/B	-	H2KP05	302	E	D
P35968	LB/B	-	F6R1G7	472	Q	H
P35968	LB/B	-	F6R1G7	297	V	I
P35968	LB/B	-	F6R1G7	136	V	M
P35968	LB/B	-	F6R1G7	462	L	V
P35968	LP/P	Hemangioma, capillary infantile (HCI) [MIM:602089]	F6R1G7	482	C	R
P35968	LB/B	-	F6R1G7	539	G	R
P35968	LB/B	-	F6R1G7	689	T	M
P35968	LB/B	-	F6R1G7	814	D	N
P35968	LB/B	-	F6R1G7	1065	A	T
P35968	LB/B	-	F6R1G7	848	V	E
P35968	LB/B	-	F6R1G7	952	V	I
P35968	LP/P	Hemangioma, capillary infantile (HCI) [MIM:602089]	F6R1G7	1147	P	S
Q06136	LP/P	Erythrokeratodermia variabilis et progressiva 4 (EKVP4) [MIM:617526]	A0A1A7XFJ5	186	Y	F
O60938	LP/P	Cornea plana 2, autosomal recessive (CNA2) [MIM:217300]	A0A2G9S605	215	T	K
O60938	LP/P	Cornea plana 2, autosomal recessive (CNA2) [MIM:217300]	A0A2G9S605	247	N	S
O60938	LB/B	-	A0A2G9S605	235	V	G
Q5VWX1	LB/B	-	F6VEI6	308	G	A
O15037	LB/B	-	F6UFC4	261	K	T
O15037	LB/B	-	F6UFC4	270	W	L
Q14695	LB/B	-	A0A2K6B5X7	85	S	N
Q5VV43	LB/B	-	G5BJY4	142	T	P
Q5VV43	LB/B	-	G5BJY4	311	A	T
Q5VV43	LB/B	-	G5BJY4	919	G	A
Q5VV43	LB/B	-	G5BJY4	567	G	S
Q5VV43	LB/B	-	G5BJY4	773	S	G
Q5VV43	LB/B	-	G5BJY4	774	V	A
Q5VV43	LB/B	-	G5BJY4	1013	Y	C
Q6ZU52	LB/B	-	A0A091VVD9	61	S	R
Q6ZU52	LB/B	-	A0A091VVD9	331	S	L
O60268	LB/B	-	H2MFR0	100	R	H
Q9BVV6	LB/B	-	A0A091LLN9	828	L	P
Q9BVV6	LP/P	Joubert syndrome 23 (JBTS23) [MIM:616490]	A0A091LLN9	566	D	V
Q2KHM9	LB/B	-	J9P8V3	201	H	Q
Q2KHM9	LB/B	-	J9P8V3	375	E	D
Q2KHM9	LB/B	-	J9P8V3	375	E	G
Q2KHM9	LB/B	-	J9P8V3	444	D	N
Q2KHM9	LB/B	-	J9P8V3	466	L	P
Q2KHM9	LB/B	-	J9P8V3	501	V	M
Q2KHM9	LB/B	-	J9P8V3	566	P	L
Q2KHM9	LB/B	-	J9P8V3	896	Q	R
Q8IV33	LB/B	-	G3P827	46	K	E
Q96AT1	LB/B	-	A0A2K5QA08	139	I	M
Q5T5P2	LB/B	-	A0A1S2ZYC7	145	A	G
Q5T5P2	LB/B	-	A0A1S2ZYC7	887	A	T
Q5T5P2	LB/B	-	A0A1S2ZYC7	1362	P	A
Q9P206	LB/B	-	A0A2K6FFM1	57	P	S
Q9P206	LB/B	-	A0A2K6FFM1	114	S	P
Q9P206	LB/B	-	A0A2K6FFM1	232	M	V
Q9P206	LB/B	-	A0A2K6FFM1	310	L	I
Q9P206	LB/B	-	A0A2K6FFM1	770	P	L
Q9P206	LB/B	-	A0A2K6FFM1	1021	E	K
Q5VZ46	LB/B	-	G1S1M4	214	H	Y
Q5VZ46	LB/B	-	G1S1M4	740	R	W
Q5VZ46	LB/B	-	G1S1M4	801	L	F
Q5VZ46	LB/B	-	G1S1M4	1078	N	D
Q5VZ46	LB/B	-	G1S1M4	64	L	P
Q5JYT7	LB/B	-	A0A1U8CRA2	339	K	N
Q5JYT7	LB/B	-	A0A1U8CRA2	415	P	L
Q5JYT7	LB/B	-	A0A1U8CRA2	633	A	V
Q5JYT7	LB/B	-	A0A1U8CRA2	940	E	K
Q5JYT7	LB/B	-	A0A1U8CRA2	1045	R	W
Q9ULH0	LB/B	-	A0A2I4D5C6	1307	R	H
Q9ULH0	LB/B	-	A0A2I4D5C6	1608	Q	H
Q9ULH0	LB/B	-	A0A2I4D5C6	538	I	T
Q9NQT8	LB/B	-	A0A2Y9K303	1471	V	I
Q15058	LB/B	-	A0A2U3YA14	1633	P	A
Q15058	LP/P	Microcephaly 20, primary, autosomal recessive (MCPH20) [MIM:617914]	A0A2U3YA14	849	H	D
Q15058	LP/P	Microcephaly 20, primary, autosomal recessive (MCPH20) [MIM:617914]	A0A2U3YA14	1221	G	V
Q9NS87	LB/B	-	A0A1L8FWL3	211	A	V
Q9NS87	LB/B	-	A0A1L8FWL3	996	T	S
Q9NS87	LB/B	-	A0A1L8FWL3	1206	L	M
Q9NS87	LB/B	-	A0A1L8FWL3	1272	E	D
Q9P2E2	LB/B	-	U3KPK1	402	V	M
Q9P2E2	LB/B	-	U3KPK1	933	D	E
Q9P2E2	LB/B	-	U3KPK1	341	I	V
Q9P2E2	LB/B	-	U3KPK1	675	V	I
Q9P2E2	LB/B	-	U3KPK1	735	V	I
Q9P2E2	LB/B	-	U3KPK1	369	S	R
Q8NI77	LB/B	-	S7N4J4	735	I	V
Q8NI77	LB/B	-	S7N4J4	273	T	A
Q8NI77	LB/B	-	S7N4J4	334	P	S
Q86Y91	LB/B	-	D2HCX0	506	Q	R
Q2TAC6	LB/B	-	G3TXY2	471	R	W
Q2TAC6	LB/B	-	G3TXY2	937	L	P
Q2TAC6	LB/B	-	G3TXY2	807	R	H
Q2TAC6	LB/B	-	G3TXY2	974	R	Q
O60333	LP/P	Charcot-Marie-Tooth disease, axonal, 2A1 (CMT2A1) [MIM:118210]	A0A0Q3PTX7	98	Q	L
O60333	LB/B	-	A0A0Q3PTX7	34	S	L
O60333	LB/B	-	A0A0Q3PTX7	692	E	V
O60333	LB/B	-	A0A0Q3PTX7	873	T	I
O60333	LB/B	-	A0A0Q3PTX7	1133	Y	C
O60333	LB/B	-	A0A0Q3PTX7	1263	P	S
O60333	LB/B	-	A0A0Q3PTX7	1527	S	N
O60333	LB/B	-	A0A0Q3PTX7	1600	V	M
O60333	LB/B	-	A0A0Q3PTX7	1674	E	K
O43896	LP/P	Spastic ataxia 2, autosomal recessive (SPAX2) [MIM:611302]	A0A096MEW2	169	R	W
Q96Q89	LB/B	-	G5B0Z5	50	A	G
Q96Q89	LB/B	-	G5B0Z5	490	E	D
Q96Q89	LB/B	-	G5B0Z5	756	N	I
Q96Q89	LB/B	-	G5B0Z5	789	H	L
Q96Q89	LB/B	-	G5B0Z5	1011	D	E
Q96Q89	LB/B	-	G5B0Z5	1127	E	Q
Q96Q89	LB/B	-	G5B0Z5	1177	C	R
Q96Q89	LB/B	-	G5B0Z5	1219	N	S
Q96Q89	LB/B	-	G5B0Z5	1789	I	V
Q96Q89	LB/B	-	G5B0Z5	1148	A	V
Q96Q89	LB/B	-	G5B0Z5	1589	F	Y
Q7Z4S6	LP/P	Fibrosis of extraocular muscles, congenital, 1 (CFEOM1) [MIM:135700]	A0A1U8BSW1	356	M	T
Q7Z4S6	LP/P	Fibrosis of extraocular muscles, congenital, 1 (CFEOM1) [MIM:135700]	A0A1U8BSW1	947	M	R
Q7Z4S6	LP/P	Fibrosis of extraocular muscles, congenital, 1 (CFEOM1) [MIM:135700]	A0A1U8BSW1	947	M	V
Q7Z4S6	LP/P	Fibrosis of extraocular muscles, congenital, 1 (CFEOM1) [MIM:135700]	A0A1U8BSW1	954	R	Q
Q7Z4S6	LP/P	Fibrosis of extraocular muscles, congenital, 1 (CFEOM1) [MIM:135700]	A0A1U8BSW1	954	R	W
Q7Z4S6	LP/P	Fibrosis of extraocular muscles, congenital, 1 (CFEOM1) [MIM:135700]	A0A1U8BSW1	1010	I	T
Q7Z4S6	LP/P	Fibrosis of extraocular muscles, congenital, 1 (CFEOM1) [MIM:135700]	A0A1U8BSW1	947	M	T
Q7Z4S6	LP/P	Fibrosis of extraocular muscles, congenital, 1 (CFEOM1) [MIM:135700]	A0A1U8BSW1	352	D	E
Q7Z4S6	LP/P	Fibrosis of extraocular muscles, congenital, 1 (CFEOM1) [MIM:135700]	A0A1U8BSW1	944	E	Q
Q7Z4S6	LP/P	Fibrosis of extraocular muscles, congenital, 1 (CFEOM1) [MIM:135700]	A0A1U8BSW1	954	R	L
Q7Z4S6	LP/P	Fibrosis of extraocular muscles, congenital, 1 (CFEOM1) [MIM:135700]	A0A1U8BSW1	1008	A	P
Q14807	LP/P	Spondyloepimetaphyseal dysplasia with joint laxity, 2 (SEMDJL2) [MIM:603546]	A0A2J8ISH9	148	P	L
Q14807	LP/P	Spondyloepimetaphyseal dysplasia with joint laxity, 2 (SEMDJL2) [MIM:603546]	A0A2J8ISH9	148	P	S
Q14807	LP/P	Spondyloepimetaphyseal dysplasia with joint laxity, 2 (SEMDJL2) [MIM:603546]	A0A2J8ISH9	149	R	L
Q14807	LP/P	Spondyloepimetaphyseal dysplasia with joint laxity, 2 (SEMDJL2) [MIM:603546]	A0A2J8ISH9	149	R	Q
Q14807	LB/B	-	A0A2J8ISH9	232	R	Q
Q02241	LB/B	-	G7P903	515	F	L
Q02241	LP/P	Anemia, congenital dyserythropoietic, 3A (CDAN3A) [MIM:105600]	G7P903	916	P	R
Q9Y6Z4	LB/B	-	Q9Y6Z4	23	H	D
Q9Y6Z4	LB/B	-	Q9Y6Z4	24	C	R
Q9Y6Z4	LB/B	-	Q9Y6Z4	57	Q	E
O00139	LP/P	Cortical dysplasia, complex, with other brain malformations 3 (CDCBM3) [MIM:615411]	J9P9X3	317	S	N
O00139	LP/P	Cortical dysplasia, complex, with other brain malformations 3 (CDCBM3) [MIM:615411]	J9P9X3	321	H	D
Q99661	LB/B	-	G1NCL3	449	I	L
O15066	LP/P	Retinitis pigmentosa 89 (RP89) [MIM:618955]	W5K2F5	250	E	Q
O15066	LP/P	Retinitis pigmentosa 89 (RP89) [MIM:618955]	W5K2F5	523	L	P
O14782	LB/B	-	W5K2F5	370	R	Q
O14782	LP/P	-	W5K2F5	571	R	Q
O95239	LB/B	-	A0A1S3IN85	422	L	W
O95239	LB/B	-	A0A1S3IN85	491	A	V
O95239	LB/B	-	A0A1S3IN85	1193	L	S
Q2VIQ3	LB/B	-	A0A1S3IN85	494	E	Q
Q2VIQ3	LB/B	-	A0A1S3IN85	580	R	L
Q2VIQ3	LB/B	-	A0A1S3IN85	680	R	H
Q2VIQ3	LB/B	-	A0A1S3IN85	684	Y	C
Q12840	LP/P	Spastic paraplegia 10, autosomal dominant (SPG10) [MIM:604187]	S7PXE1	256	N	S
Q12840	LP/P	Spastic paraplegia 10, autosomal dominant (SPG10) [MIM:604187]	S7PXE1	280	R	C
Q12840	LP/P	Spastic paraplegia 10, autosomal dominant (SPG10) [MIM:604187]	S7PXE1	361	A	V
Q12840	LP/P	Spastic paraplegia 10, autosomal dominant (SPG10) [MIM:604187]	S7PXE1	276	Y	C
Q12840	LP/P	Spastic paraplegia 10, autosomal dominant (SPG10) [MIM:604187]	S7PXE1	253	K	N
Q12840	LP/P	Spastic paraplegia 10, autosomal dominant (SPG10) [MIM:604187]	S7PXE1	63	Y	C
Q12840	LP/P	Spastic paraplegia 10, autosomal dominant (SPG10) [MIM:604187]	S7PXE1	198	M	T
Q12840	LP/P	Spastic paraplegia 10, autosomal dominant (SPG10) [MIM:604187]	S7PXE1	204	R	Q
Q12840	LP/P	Spastic paraplegia 10, autosomal dominant (SPG10) [MIM:604187]	S7PXE1	251	E	K
Q12840	LP/P	Spastic paraplegia 10, autosomal dominant (SPG10) [MIM:604187]	S7PXE1	257	K	N
Q12840	LP/P	Spastic paraplegia 10, autosomal dominant (SPG10) [MIM:604187]	S7PXE1	280	R	H
Q12840	LP/P	Spastic paraplegia 10, autosomal dominant (SPG10) [MIM:604187]	S7PXE1	280	R	L
Q12840	LP/P	Spastic paraplegia 10, autosomal dominant (SPG10) [MIM:604187]	S7PXE1	203	S	C
Q12840	LP/P	Amyotrophic lateral sclerosis 25 (ALS25) [MIM:617921]	S7PXE1	1007	R	G
O60282	LP/P	Cortical dysplasia, complex, with other brain malformations 2 (CDCBM2) [MIM:615282]	A0A0F8CUN4	237	E	K
O60282	LP/P	Cortical dysplasia, complex, with other brain malformations 2 (CDCBM2) [MIM:615282]	A0A0F8CUN4	237	E	V
Q6ZMV9	LB/B	-	A8KBG9	719	W	R
Q6ZMV9	LB/B	-	A8KBG9	512	R	H
Q9HAQ2	LB/B	-	F6TSW9	96	G	A
Q9HAQ2	LB/B	-	F6TSW9	78	V	I
Q9HAQ2	LB/B	-	F6TSW9	638	R	W
Q96EK5	LB/B	-	U3KF26	66	G	S
Q9BW19	LB/B	-	A0A2K5L1N2	219	R	Q
Q9BVG8	LB/B	-	G1T2J7	391	G	V
P43632	LB/B	-	Q8MK27	65	K	M
P43632	LB/B	-	Q8MK27	68	N	D
P43632	LB/B	-	Q8MK27	71	H	R
P43632	LB/B	-	Q8MK27	89	P	R
P43632	LB/B	-	Q8MK27	92	P	H
P43632	LB/B	-	Q8MK27	93	V	D
P43632	LB/B	-	Q8MK27	103	S	C
P43632	LB/B	-	Q8MK27	178	N	H
P43632	LB/B	-	Q8MK27	205	A	S
P43632	LB/B	-	Q8MK27	254	K	N
Q14953	LB/B	-	Q8MK27	2	S	L
Q14953	LB/B	-	Q8MK27	22	H	R
Q14953	LB/B	-	Q8MK27	132	S	P
Q14953	LB/B	-	Q8MK27	144	S	N
Q14953	LB/B	-	Q8MK27	148	S	F
Q14953	LB/B	-	Q8MK27	175	P	T
Q14953	LB/B	-	Q8MK27	179	R	G
Q14953	LB/B	-	Q8MK27	185	F	S
Q14953	LB/B	-	Q8MK27	195	T	A
Q14953	LB/B	-	Q8MK27	197	R	T
Q14953	LB/B	-	Q8MK27	203	R	H
Q14953	LB/B	-	Q8MK27	237	E	K
P43630	LB/B	-	A0A2I3N113	40	P	A
P43630	LB/B	-	A0A2I3N113	113	L	V
P43630	LB/B	-	A0A2I3N113	158	E	D
P43630	LB/B	-	A0A2I3N113	166	R	H
P43630	LB/B	-	A0A2I3N113	228	A	P
P43630	LB/B	-	A0A2I3N113	252	I	T
P43630	LB/B	-	A0A2I3N113	397	T	M
P43630	LB/B	-	A0A2I3N113	439	K	Q
Q96J84	LB/B	-	A0A091D6M1	78	A	T
Q96J84	LP/P	Nephrotic syndrome 23 (NPHS23) [MIM:619201]	A0A091D6M1	440	R	C
Q6UWL6	LB/B	-	A0A2U3VNH4	19	R	S
Q6UWL6	LB/B	-	A0A2U3VNH4	170	A	T
Q6UWL6	LB/B	-	A0A2U3VNH4	353	V	M
Q6UWL6	LB/B	-	A0A2U3VNH4	556	S	N
Q6UWL6	LB/B	-	A0A2U3VNH4	591	E	K
Q15726	LB/B	-	A0A0D9RPT6	20	E	K
Q15726	LB/B	-	A0A0D9RPT6	36	Q	R
Q15726	LB/B	-	A0A0D9RPT6	81	P	R
Q15726	LP/P	Hypogonadotropic hypogonadism 13 with or without anosmia (HH13) [MIM:614842]	A0A0D9RPT6	115	N	K
Q969F8	LP/P	Hypogonadotropic hypogonadism 8 with or without anosmia (HH8) [MIM:614837]	A0A2Y9MHF2	148	L	S
Q969F8	LP/P	Hypogonadotropic hypogonadism 8 with or without anosmia (HH8) [MIM:614837]	A0A2Y9MHF2	223	C	R
Q969F8	LP/P	Hypogonadotropic hypogonadism 8 with or without anosmia (HH8) [MIM:614837]	A0A2Y9MHF2	297	R	L
Q969F8	LB/B	-	A0A2Y9MHF2	364	L	H
Q969F8	LP/P	Hypogonadotropic hypogonadism 8 with or without anosmia (HH8) [MIM:614837]	A0A2Y9MHF2	102	L	P
Q969F8	LP/P	Precocious puberty, central 1 (CPPB1) [MIM:176400]	A0A2Y9MHF2	386	R	P
Q969F8	LB/B	Hypogonadotropic hypogonadism 8 with or without anosmia (HH8) [MIM:614837]	A0A2Y9MHF2	189	A	T
Q969F8	LP/P	Hypogonadotropic hypogonadism 8 with or without anosmia (HH8) [MIM:614837]	A0A2Y9MHF2	194	A	D
Q969F8	LP/P	Hypogonadotropic hypogonadism 8 with or without anosmia (HH8) [MIM:614837]	A0A2Y9MHF2	262	S	L
P10721	LP/P	Piebald trait (PBT) [MIM:172800]	Q2PP56	583	E	K
P10721	LP/P	Piebald trait (PBT) [MIM:172800]	Q2PP56	584	F	L
P10721	LP/P	Piebald trait (PBT) [MIM:172800]	Q2PP56	664	G	R
P10721	LP/P	Piebald trait (PBT) [MIM:172800]	Q2PP56	791	R	G
P10721	LP/P	Piebald trait (PBT) [MIM:172800]	Q2PP56	812	G	V
P10721	LP/P	Mastocytosis, cutaneous (MASTC) [MIM:154800]	Q2PP56	816	D	V
P10721	LP/P	Mastocytosis, systemic (MASTSYS) [MIM:154800]	Q2PP56	816	D	V
P10721	LP/P	Mastocytosis, cutaneous (MASTC) [MIM:154800]	Q2PP56	816	D	Y
P10721	LP/P	Mastocytosis, systemic (MASTSYS) [MIM:154800]	Q2PP56	816	D	Y
P10721	LP/P	Gastrointestinal stromal tumor (GIST) [MIM:606764]	Q2PP56	550	K	I
P10721	LP/P	Gastrointestinal stromal tumor (GIST) [MIM:606764]	Q2PP56	559	V	A
P10721	LP/P	Gastrointestinal stromal tumor (GIST) [MIM:606764]	Q2PP56	559	V	D
P10721	LP/P	Piebald trait (PBT) [MIM:172800]	Q2PP56	584	F	C
P10721	LP/P	Piebald trait (PBT) [MIM:172800]	Q2PP56	601	G	R
P10721	LP/P	Piebald trait (PBT) [MIM:172800]	Q2PP56	656	L	P
P10721	LP/P	Piebald trait (PBT) [MIM:172800]	Q2PP56	796	R	G
P10721	LP/P	Mastocytosis, cutaneous (MASTC) [MIM:154800]	Q2PP56	816	D	F
P10721	LB/B	-	Q2PP56	820	D	G
P10721	LP/P	Mastocytosis, cutaneous (MASTC) [MIM:154800]	Q2PP56	839	E	K
P10721	LP/P	Piebald trait (PBT) [MIM:172800]	Q2PP56	847	T	P
P10721	LB/B	-	Q2PP56	532	V	I
P10721	LB/B	-	Q2PP56	541	M	L
P10721	LB/B	-	Q2PP56	691	C	S
P10721	LB/B	-	Q2PP56	715	S	N
P10721	LB/B	-	Q2PP56	541	M	V
P10721	LP/P	Mastocytosis, cutaneous (MASTC) [MIM:154800]	Q2PP56	816	D	I
P10721	LP/P	Mastocytosis, cutaneous (MASTC) [MIM:154800]	Q2PP56	822	N	I
Q9H0B6	LB/B	-	A0A091DD11	517	P	S
Q9NSK0	LB/B	-	A0A2Y9ERN2	72	R	H
Q13118	LB/B	-	A0A1L8FZP9	249	S	F
Q8TD94	LB/B	-	I3MZD8	173	A	P
Q9Y5W3	LB/B	-	H3DBP9	104	L	P
Q9Y5W3	LB/B	-	H3DBP9	145	R	P
P57682	LB/B	-	G1K9V5	207	R	S
O43474	LB/B	-	H0XZC9	315	T	S
O43474	LB/B	-	H0XZC9	321	L	F
Q99612	LB/B	-	A0A212CBU3	64	W	R
Q99612	LB/B	-	A0A212CBU3	116	S	P
Q99612	LB/B	-	A0A212CBU3	123	A	D
Q99612	LB/B	-	A0A212CBU3	155	S	R
Q99612	LB/B	-	A0A212CBU3	169	L	P
Q99612	LB/B	-	A0A212CBU3	180	S	L
Q6PID8	LB/B	-	A0A2K6T3B8	2	S	L
Q6PID8	LB/B	-	A0A2K6T3B8	183	D	G
Q6PID8	LB/B	-	A0A2K6T3B8	274	I	V
Q6PID8	LB/B	-	A0A2K6T3B8	295	E	G
Q6PID8	LB/B	-	A0A2K6T3B8	437	L	I
Q8TBB5	LB/B	-	A0A1A7Y9B7	56	L	V
Q8TBB5	LB/B	-	A0A1A7Y9B7	155	L	V
Q8TBB5	LB/B	-	A0A1A7Y9B7	102	T	I
Q8TBB5	LB/B	-	A0A1A7Y9B7	130	G	V
Q5VTJ3	LB/B	-	A0A2P4TGU4	147	T	P
Q5VTJ3	LB/B	-	A0A2P4TGU4	273	H	N
Q5VTJ3	LB/B	-	A0A2P4TGU4	21	V	L
Q5VTJ3	LB/B	-	A0A2P4TGU4	194	R	P
Q5VTJ3	LB/B	-	A0A2P4TGU4	160	R	S
Q5VTJ3	LB/B	-	A0A2P4TGU4	351	T	P
Q5VTJ3	LB/B	-	A0A2P4TGU4	94	G	S
Q5VTJ3	LB/B	-	A0A2P4TGU4	141	P	R
Q8NEP7	LB/B	-	G7NX98	171	S	R
Q8NEP7	LB/B	-	G7NX98	288	N	S
Q8NEP7	LB/B	-	G7NX98	282	A	T
Q6JEL2	LP/P	Spermatogenic failure 11 (SPGF11) [MIM:615081]	K1R9Z0	216	Q	P
Q6JEL2	LP/P	Spermatogenic failure 11 (SPGF11) [MIM:615081]	K1R9Z0	313	A	T
Q9P2N7	LB/B	-	A0A151N7I7	261	T	S
Q53HC5	LB/B	-	C3ZDQ3	542	V	M
Q9NXS3	LB/B	-	A7RMV8	349	I	V
Q9UH77	LP/P	Pseudohypoaldosteronism 2D (PHA2D) [MIM:614495]	A0A226MNH4	77	A	E
Q9UH77	LP/P	Pseudohypoaldosteronism 2D (PHA2D) [MIM:614495]	A0A226MNH4	78	M	V
Q9UH77	LP/P	Pseudohypoaldosteronism 2D (PHA2D) [MIM:614495]	A0A226MNH4	85	E	A
Q9UH77	LP/P	Pseudohypoaldosteronism 2D (PHA2D) [MIM:614495]	A0A226MNH4	164	C	F
Q9UH77	LP/P	Pseudohypoaldosteronism 2D (PHA2D) [MIM:614495]	A0A226MNH4	228	R	G
Q9UH77	LP/P	Pseudohypoaldosteronism 2D (PHA2D) [MIM:614495]	A0A226MNH4	309	Q	R
Q9UH77	LP/P	Pseudohypoaldosteronism 2D (PHA2D) [MIM:614495]	A0A226MNH4	322	F	C
Q9UH77	LP/P	Pseudohypoaldosteronism 2D (PHA2D) [MIM:614495]	A0A226MNH4	336	R	I
Q9UH77	LP/P	Pseudohypoaldosteronism 2D (PHA2D) [MIM:614495]	A0A226MNH4	340	A	V
Q9UH77	LP/P	Pseudohypoaldosteronism 2D (PHA2D) [MIM:614495]	A0A226MNH4	361	V	M
Q9UH77	LP/P	Pseudohypoaldosteronism 2D (PHA2D) [MIM:614495]	A0A226MNH4	362	R	W
Q9UH77	LP/P	Pseudohypoaldosteronism 2D (PHA2D) [MIM:614495]	A0A226MNH4	384	R	Q
Q9UH77	LP/P	Pseudohypoaldosteronism 2D (PHA2D) [MIM:614495]	A0A226MNH4	384	R	W
Q9UH77	LP/P	Pseudohypoaldosteronism 2D (PHA2D) [MIM:614495]	A0A226MNH4	387	L	P
Q9UH77	LP/P	Pseudohypoaldosteronism 2D (PHA2D) [MIM:614495]	A0A226MNH4	398	A	V
Q9UH77	LP/P	Pseudohypoaldosteronism 2D (PHA2D) [MIM:614495]	A0A226MNH4	410	S	L
Q9UH77	LP/P	Pseudohypoaldosteronism 2D (PHA2D) [MIM:614495]	A0A226MNH4	426	P	L
Q9UH77	LP/P	Pseudohypoaldosteronism 2D (PHA2D) [MIM:614495]	A0A226MNH4	427	M	T
Q9UH77	LP/P	Pseudohypoaldosteronism 2D (PHA2D) [MIM:614495]	A0A226MNH4	431	R	Q
Q9UH77	LP/P	Pseudohypoaldosteronism 2D (PHA2D) [MIM:614495]	A0A226MNH4	432	S	N
Q9UH77	LP/P	Pseudohypoaldosteronism 2D (PHA2D) [MIM:614495]	A0A226MNH4	433	S	G
Q9UH77	LP/P	Pseudohypoaldosteronism 2D (PHA2D) [MIM:614495]	A0A226MNH4	433	S	N
Q9UH77	LP/P	Pseudohypoaldosteronism 2D (PHA2D) [MIM:614495]	A0A226MNH4	494	A	T
Q9UH77	LP/P	Pseudohypoaldosteronism 2D (PHA2D) [MIM:614495]	A0A226MNH4	500	G	V
Q9UH77	LP/P	Pseudohypoaldosteronism 2D (PHA2D) [MIM:614495]	A0A226MNH4	501	P	T
Q9UH77	LP/P	Pseudohypoaldosteronism 2D (PHA2D) [MIM:614495]	A0A226MNH4	528	R	C
Q9UH77	LP/P	Pseudohypoaldosteronism 2D (PHA2D) [MIM:614495]	A0A226MNH4	528	R	H
Q9UH77	LP/P	Pseudohypoaldosteronism 2D (PHA2D) [MIM:614495]	A0A226MNH4	529	N	K
Q9UH77	LP/P	Pseudohypoaldosteronism 2D (PHA2D) [MIM:614495]	A0A226MNH4	557	Y	C
Q9UH77	LP/P	Pseudohypoaldosteronism 2D (PHA2D) [MIM:614495]	A0A226MNH4	575	R	W
Q9UH77	LP/P	Pseudohypoaldosteronism 2D (PHA2D) [MIM:614495]	A0A226MNH4	498	H	Y
Q9UH77	LP/P	Pseudohypoaldosteronism 2D (PHA2D) [MIM:614495]	A0A226MNH4	553	S	L
Q9H511	LB/B	-	A0A0N8JVS2	11	N	S
Q9H511	LB/B	-	A0A0N8JVS2	156	V	I
Q9H511	LB/B	-	A0A0N8JVS2	508	A	T
A6NCF5	LB/B	-	A0A087X7E5	163	R	H
A6NCF5	LB/B	-	A0A087X7E5	176	R	Q
A6NCF5	LB/B	-	A0A087X7E5	345	E	G
A6NCF5	LB/B	-	A0A087X7E5	516	A	T
Q2WGJ6	LB/B	-	A0A2D0S0M7	310	G	S
Q2WGJ6	LB/B	-	A0A2D0S0M7	352	N	Y
Q2WGJ6	LB/B	-	A0A2D0S0M7	394	G	R
Q2WGJ6	LB/B	-	A0A2D0S0M7	504	C	Y
Q2WGJ6	LB/B	-	A0A2D0S0M7	334	I	V
Q2WGJ6	LB/B	-	A0A2D0S0M7	346	R	K
Q2TBA0	LB/B	-	A0A2U3YWB9	345	N	S
Q2TBA0	LB/B	-	A0A2U3YWB9	617	C	R
Q2TBA0	LP/P	Nemaline myopathy 8 (NEM8) [MIM:615348]	A0A2U3YWB9	34	D	H
Q2TBA0	LP/P	Nemaline myopathy 8 (NEM8) [MIM:615348]	A0A2U3YWB9	86	L	P
Q2TBA0	LP/P	Nemaline myopathy 8 (NEM8) [MIM:615348]	A0A2U3YWB9	194	V	E
Q2TBA0	LP/P	Nemaline myopathy 8 (NEM8) [MIM:615348]	A0A2U3YWB9	201	W	L
Q2TBA0	LP/P	Nemaline myopathy 8 (NEM8) [MIM:615348]	A0A2U3YWB9	311	R	L
Q2TBA0	LP/P	Nemaline myopathy 8 (NEM8) [MIM:615348]	A0A2U3YWB9	397	P	L
Q2TBA0	LP/P	Nemaline myopathy 8 (NEM8) [MIM:615348]	A0A2U3YWB9	455	H	R
Q2TBA0	LP/P	Nemaline myopathy 8 (NEM8) [MIM:615348]	A0A2U3YWB9	469	G	C
Q2TBA0	LP/P	Nemaline myopathy 8 (NEM8) [MIM:615348]	A0A2U3YWB9	506	T	P
Q2TBA0	LP/P	Nemaline myopathy 8 (NEM8) [MIM:615348]	A0A2U3YWB9	528	E	K
Q2TBA0	LP/P	Nemaline myopathy 8 (NEM8) [MIM:615348]	A0A2U3YWB9	538	A	P
Q2TBA0	LP/P	Nemaline myopathy 8 (NEM8) [MIM:615348]	A0A2U3YWB9	588	E	K
Q2TBA0	LP/P	Nemaline myopathy 8 (NEM8) [MIM:615348]	A0A2U3YWB9	505	A	P
Q8IXQ5	LP/P	Retinitis pigmentosa 42 (RP42) [MIM:612943]	A0A287BFW2	150	S	N
Q8IXQ5	LP/P	Retinitis pigmentosa 42 (RP42) [MIM:612943]	A0A287BFW2	153	A	T
Q8IXQ5	LP/P	Retinitis pigmentosa 42 (RP42) [MIM:612943]	A0A287BFW2	153	A	V
Q8IXQ5	LB/B	-	A0A287BFW2	423	H	Y
Q8IXQ5	LP/P	Perching syndrome (PERCHING) [MIM:617055]	A0A287BFW2	372	R	Q
Q8IXQ5	LP/P	Perching syndrome (PERCHING) [MIM:617055]	A0A287BFW2	420	R	C
Q8IXQ5	LP/P	Perching syndrome (PERCHING) [MIM:617055]	A0A287BFW2	421	C	S
Q9P2G9	LB/B	-	G3PVG9	520	P	R
P06870	LB/B	-	H0V5Y0	145	E	Q
P06870	LB/B	-	H0V5Y0	186	K	E
P06870	LB/B	-	H0V5Y0	77	R	H
P06870	LB/B	-	H0V5Y0	193	V	E
Q9UBX7	LB/B	-	I3M3U1	49	G	E
Q9UBX7	LB/B	-	I3M3U1	166	R	C
Q9UBX7	LB/B	-	I3M3U1	32	A	T
Q9UKR3	LB/B	-	L5L4C5	109	H	Y
Q9P0G3	LB/B	-	I3M3U1	33	Q	R
Q9P0G3	LB/B	-	I3M3U1	45	H	Y
Q9P0G3	LB/B	-	I3M3U1	64	R	H
Q9H2R5	LB/B	-	L5L4C5	134	P	L
P20151	LB/B	-	H0V5Y0	18	V	L
P20151	LB/B	-	H0V5Y0	250	R	W
P20151	LB/B	-	H0V5Y0	255	D	A
Q9Y5K2	LB/B	-	I3M3U1	22	S	A
Q9Y5K2	LB/B	-	I3M3U1	197	H	Q
Q9Y5K2	LB/B	-	I3M3U1	159	G	D
Q9Y337	LB/B	-	A0A286ZS23	55	G	R
Q9Y337	LB/B	-	A0A286ZS23	153	D	N
Q92876	LB/B	-	L5L4C5	78	R	W
O60259	LB/B	-	A0A2K6EQN9	154	V	I
P03952	LP/P	Prekallikrein deficiency (PKKD) [MIM:612423]	G3VQX8	143	N	S
P03952	LB/B	-	G3VQX8	202	H	Q
P03952	LB/B	-	G3VQX8	208	H	P
P03952	LB/B	-	G3VQX8	178	A	T
P03952	LB/B	-	G3VQX8	269	S	C
P03952	LB/B	-	G3VQX8	311	F	V
P03952	LB/B	-	G3VQX8	358	T	A
P03952	LB/B	-	G3VQX8	381	S	A
P03952	LB/B	-	G3VQX8	442	Q	P
P03952	LB/B	-	G3VQX8	560	R	Q
P03952	LB/B	-	G3VQX8	210	A	E
P03952	LP/P	Prekallikrein deficiency (PKKD) [MIM:612423]	G3VQX8	123	G	R
P03952	LP/P	Prekallikrein deficiency (PKKD) [MIM:612423]	G3VQX8	548	C	Y
Q12918	LB/B	-	A0A287B3E8	168	I	T
O43908	LB/B	-	Q9GME6	29	I	S
O43908	LB/B	-	Q9GME6	104	N	S
Q9NZS2	LB/B	-	W5QIS8	67	L	F
Q96E93	LB/B	-	G1TEI4	58	W	R
A4D1S0	LB/B	-	A0A1U7R202	152	K	T
A4D1S0	LB/B	-	A0A1U7R202	339	G	A
P26718	LB/B	-	G7N650	72	T	A
P26718	LB/B	-	G7N650	177	N	S
Q03164	LB/B	-	A0A091DLB6	30	A	G
Q03164	LB/B	-	A0A091DLB6	53	A	V
Q03164	LB/B	-	A0A091DLB6	502	E	K
Q03164	LB/B	-	A0A091DLB6	2319	S	T
Q03164	LB/B	-	A0A091DLB6	2354	P	R
Q03164	LB/B	-	A0A091DLB6	2387	Q	R
Q03164	LB/B	-	A0A091DLB6	3714	V	I
Q03164	LB/B	-	A0A091DLB6	3773	S	A
Q03164	LB/B	-	A0A091DLB6	1975	Q	P
Q9UMN6	LB/B	-	M3W5T8	587	P	R
Q9UMN6	LB/B	-	M3W5T8	754	P	L
Q9UMN6	LB/B	-	M3W5T8	1097	P	L
Q9UMN6	LB/B	-	M3W5T8	1829	P	L
Q9UMN6	LB/B	-	M3W5T8	2364	D	G
Q9UMN6	LB/B	-	M3W5T8	2408	K	N
Q9UMN6	LB/B	-	M3W5T8	172	T	I
Q9UMN6	LB/B	-	M3W5T8	215	T	N
Q9UMN6	LP/P	Intellectual developmental disorder, autosomal dominant 68 (MRD68) [MIM:619934]	M3W5T8	1222	C	Y
Q9UMN6	LP/P	Intellectual developmental disorder, autosomal dominant 68 (MRD68) [MIM:619934]	M3W5T8	1597	R	W
Q9UMN6	LP/P	Intellectual developmental disorder, autosomal dominant 68 (MRD68) [MIM:619934]	M3W5T8	1682	C	W
O14686	LB/B	-	A0A0G2JVD6	5224	R	H
O14686	LB/B	-	A0A0G2JVD6	476	A	T
O14686	LP/P	Kabuki syndrome 1 (KABUK1) [MIM:147920]	A0A0G2JVD6	5109	C	F
O14686	LP/P	Kabuki syndrome 1 (KABUK1) [MIM:147920]	A0A0G2JVD6	5179	R	H
O14686	LP/P	Kabuki syndrome 1 (KABUK1) [MIM:147920]	A0A0G2JVD6	5214	R	H
O14686	LP/P	Kabuki syndrome 1 (KABUK1) [MIM:147920]	A0A0G2JVD6	5340	R	L
O14686	LP/P	Kabuki syndrome 1 (KABUK1) [MIM:147920]	A0A0G2JVD6	5464	T	M
O14686	LB/B	-	A0A0G2JVD6	692	P	T
O14686	LB/B	-	A0A0G2JVD6	813	P	L
O14686	LB/B	-	A0A0G2JVD6	2382	P	S
O14686	LB/B	-	A0A0G2JVD6	2460	R	C
O14686	LB/B	-	A0A0G2JVD6	2557	P	L
O14686	LB/B	-	A0A0G2JVD6	3398	M	V
O14686	LB/B	-	A0A0G2JVD6	3419	D	G
O14686	LB/B	-	A0A0G2JVD6	4357	R	S
O14686	LP/P	Kabuki syndrome 1 (KABUK1) [MIM:147920]	A0A0G2JVD6	647	P	Q
O14686	LB/B	-	A0A0G2JVD6	2652	M	L
O14686	LB/B	-	A0A0G2JVD6	4010	S	P
O14686	LP/P	Kabuki syndrome 1 (KABUK1) [MIM:147920]	A0A0G2JVD6	5030	R	C
O14686	LP/P	Kabuki syndrome 1 (KABUK1) [MIM:147920]	A0A0G2JVD6	5048	R	C
O14686	LP/P	Kabuki syndrome 1 (KABUK1) [MIM:147920]	A0A0G2JVD6	5048	R	H
O14686	LP/P	Kabuki syndrome 1 (KABUK1) [MIM:147920]	A0A0G2JVD6	5154	R	Q
O14686	LP/P	Kabuki syndrome 1 (KABUK1) [MIM:147920]	A0A0G2JVD6	5214	R	C
O14686	LP/P	Kabuki syndrome 1 (KABUK1) [MIM:147920]	A0A0G2JVD6	5471	R	T
O14686	LP/P	Kabuki syndrome 1 (KABUK1) [MIM:147920]	A0A0G2JVD6	5498	S	F
Q8IZD2	LB/B	-	G7P2E3	1424	S	P
Q8IZD2	LP/P	O'Donnell-Luria-Rodan syndrome (ODLURO) [MIM:618512]	G7P2E3	140	V	I
Q8IZD2	LP/P	O'Donnell-Luria-Rodan syndrome (ODLURO) [MIM:618512]	G7P2E3	284	Y	H
Q8IZD2	LP/P	O'Donnell-Luria-Rodan syndrome (ODLURO) [MIM:618512]	G7P2E3	907	D	V
Q8IZD2	LB/B	-	G7P2E3	1376	P	L
Q8IZD2	LP/P	O'Donnell-Luria-Rodan syndrome (ODLURO) [MIM:618512]	G7P2E3	1376	P	S
Q76NI1	LB/B	-	A0A091PN93	436	E	G
Q76NI1	LB/B	-	A0A091PN93	581	G	S
Q76NI1	LB/B	-	A0A091PN93	717	L	P
Q76NI1	LB/B	-	A0A091PN93	1332	A	T
Q76NI1	LB/B	-	A0A091PN93	1038	R	W
Q1ED39	LB/B	-	A0A2U3WMU8	266	A	V
Q1ED39	LB/B	-	A0A2U3WMU8	28	R	Q
Q1ED39	LB/B	-	A0A2U3WMU8	276	V	A
Q9Y448	LB/B	-	A0A1U7QEN7	40	A	E
Q9Y448	LB/B	-	A0A1U7QEN7	75	R	L
Q9Y448	LB/B	-	A0A1U7QEN7	92	P	S
Q9Y448	LB/B	-	A0A1U7QEN7	24	S	F
P52294	LB/B	-	L5MDH8	73	S	N
P52292	LB/B	-	S9XDZ0	165	P	R
P52292	LB/B	-	S9XDZ0	157	A	V
P52292	LB/B	-	S9XDZ0	365	G	S
P52292	LB/B	-	S9XDZ0	453	K	N
O00505	LB/B	-	A0A1I8CGF3	291	P	S
O00505	LP/P	Spastic paraplegia 88, autosomal dominant (SPG88) [MIM:620106]	A0A1I8CGF3	315	T	I
O00505	LP/P	Spastic paraplegia 88, autosomal dominant (SPG88) [MIM:620106]	A0A1I8CGF3	328	L	M
O00505	LP/P	Spastic paraplegia 88, autosomal dominant (SPG88) [MIM:620106]	A0A1I8CGF3	328	L	P
O00505	LP/P	Spastic paraplegia 88, autosomal dominant (SPG88) [MIM:620106]	A0A1I8CGF3	334	L	R
O00505	LP/P	Spastic paraplegia 88, autosomal dominant (SPG88) [MIM:620106]	A0A1I8CGF3	350	L	P
O00505	LP/P	Spastic paraplegia 88, autosomal dominant (SPG88) [MIM:620106]	A0A1I8CGF3	415	P	L
Q5T749	LB/B	-	A0A2U3X1C3	14	Q	H
Q5T749	LB/B	-	A0A2U3X1C3	37	V	A
Q5T749	LB/B	-	A0A2U3X1C3	113	C	R
Q5T749	LB/B	-	A0A2U3X1C3	168	R	H
Q5T749	LB/B	-	A0A2U3X1C3	413	C	S
Q5T749	LB/B	-	A0A2U3X1C3	532	P	T
A5PL33	LB/B	-	A0A2K6MF61	320	H	R
A5PL33	LB/B	-	A0A2K6MF61	661	D	E
Q96MU8	LP/P	Ectodermal dysplasia 13, hair/tooth type (ECTD13) [MIM:617392]	A0A2D0PNQ6	207	F	S
Q8NCW0	LB/B	-	A0A2K5YWY1	408	A	P
Q8N9T8	LB/B	-	K7BJR8	138	G	R
Q8N9T8	LB/B	-	K7BJR8	179	E	A
Q8N9T8	LB/B	-	K7BJR8	266	E	K
Q8N9T8	LB/B	-	K7BJR8	309	S	L
Q8N9T8	LB/B	-	K7BJR8	336	R	W
Q8N9T8	LB/B	-	K7BJR8	349	E	Q
Q8N9T8	LB/B	-	K7BJR8	445	L	P
Q8N9T8	LB/B	-	K7BJR8	703	S	P
O00522	LP/P	Cerebral cavernous malformations 1 (CCM1) [MIM:116860]	A0A091CYW7	97	F	S
O00522	LP/P	Cerebral cavernous malformations 1 (CCM1) [MIM:116860]	A0A091CYW7	569	K	E
Q13601	LB/B	-	A0A091D8B4	134	R	Q
P04264	LP/P	Epidermolytic hyperkeratosis (EHK) [MIM:113800]	F7AGY4	155	V	G
P04264	LP/P	Epidermolytic hyperkeratosis (EHK) [MIM:113800]	F7AGY4	161	L	P
P04264	LP/P	Epidermolytic hyperkeratosis (EHK) [MIM:113800]	F7AGY4	186	S	P
P04264	LP/P	Epidermolytic hyperkeratosis (EHK) [MIM:113800]	F7AGY4	188	N	S
P04264	LP/P	Epidermolytic hyperkeratosis (EHK) [MIM:113800]	F7AGY4	193	S	P
P04264	LB/B	-	F7AGY4	312	I	V
P04264	LB/B	-	F7AGY4	330	I	T
P04264	LB/B	-	F7AGY4	358	Y	N
P04264	LP/P	Epidermolytic hyperkeratosis (EHK) [MIM:113800]	F7AGY4	490	E	Q
P04264	LB/B	-	F7AGY4	537	G	C
P04264	LB/B	-	F7AGY4	633	K	R
P04264	LP/P	Keratoderma, palmoplantar, non-epidermolytic (NEPPK) [MIM:600962]	F7AGY4	74	K	I
P04264	LP/P	Epidermolytic hyperkeratosis (EHK) [MIM:113800]	F7AGY4	155	V	D
P04264	LP/P	Epidermolytic hyperkeratosis (EHK) [MIM:113800]	F7AGY4	188	N	K
P04264	LP/P	Epidermolytic hyperkeratosis (EHK) [MIM:113800]	F7AGY4	188	N	T
P04264	LP/P	Epidermolytic hyperkeratosis (EHK) [MIM:113800]	F7AGY4	214	L	P
P04264	LP/P	Epidermolytic hyperkeratosis (EHK) [MIM:113800]	F7AGY4	340	D	V
P04264	LP/P	Ichthyosis, annular epidermolytic, 2 (AEI2) [MIM:620148]	F7AGY4	479	I	F
P04264	LP/P	Epidermolytic hyperkeratosis (EHK) [MIM:113800]	F7AGY4	479	I	T
P04264	LP/P	Ichthyosis, annular epidermolytic, 2 (AEI2) [MIM:620148]	F7AGY4	479	I	T
P04264	LP/P	Epidermolytic hyperkeratosis (EHK) [MIM:113800]	F7AGY4	482	Y	C
P04264	LP/P	Epidermolytic hyperkeratosis (EHK) [MIM:113800]	F7AGY4	486	L	P
P04264	LB/B	-	F7AGY4	454	A	S
P04264	LP/P	Epidermolytic hyperkeratosis (EHK) [MIM:113800]	F7AGY4	478	E	Q
P04264	LP/P	Epidermolytic hyperkeratosis (EHK) [MIM:113800]	F7AGY4	485	L	P
P04264	LP/P	Epidermolytic hyperkeratosis (EHK) [MIM:113800]	F7AGY4	490	E	K
P13645	LP/P	Epidermolytic hyperkeratosis (EHK) [MIM:113800]	F7B5G7	154	N	H
P13645	LP/P	Epidermolytic hyperkeratosis (EHK) [MIM:113800]	F7B5G7	156	R	H
P13645	LP/P	Epidermolytic hyperkeratosis (EHK) [MIM:113800]	F7B5G7	156	R	C
P13645	LP/P	Epidermolytic hyperkeratosis (EHK) [MIM:113800]	F7B5G7	156	R	P
P13645	LP/P	Epidermolytic hyperkeratosis (EHK) [MIM:113800]	F7B5G7	156	R	S
P13645	LP/P	Epidermolytic hyperkeratosis (EHK) [MIM:113800]	F7B5G7	160	Y	D
P13645	LP/P	Epidermolytic hyperkeratosis (EHK) [MIM:113800]	F7B5G7	161	L	S
P13645	LP/P	Epidermolytic hyperkeratosis (EHK) [MIM:113800]	F7B5G7	442	L	Q
P13645	LB/B	-	F7B5G7	126	G	S
P13645	LP/P	Epidermolytic hyperkeratosis (EHK) [MIM:113800]	F7B5G7	150	M	R
P13645	LP/P	Epidermolytic hyperkeratosis (EHK) [MIM:113800]	F7B5G7	150	M	T
P13645	LP/P	Epidermolytic hyperkeratosis (EHK) [MIM:113800]	F7B5G7	160	Y	N
P13645	LP/P	Epidermolytic hyperkeratosis (EHK) [MIM:113800]	F7B5G7	160	Y	S
P13645	LP/P	Epidermolytic hyperkeratosis (EHK) [MIM:113800]	F7B5G7	439	K	E
P13645	LP/P	Ichthyosis, annular epidermolytic, 1 (AEI1) [MIM:607602]	F7B5G7	446	I	T
P13645	LP/P	Ichthyosis, annular epidermolytic, 1 (AEI1) [MIM:607602]	F7B5G7	422	R	E
P13645	LB/B	-	F7B5G7	101	I	S
P13645	LB/B	-	F7B5G7	487	H	Y
P13645	LP/P	Epidermolytic hyperkeratosis (EHK) [MIM:113800]	F7B5G7	449	Y	C
Q99456	LP/P	Corneal dystrophy, Meesmann 1 (MECD1) [MIM:122100]	H0YVX6	135	R	T
Q99456	LP/P	Corneal dystrophy, Meesmann 1 (MECD1) [MIM:122100]	H0YVX6	143	V	L
Q99456	LP/P	Corneal dystrophy, Meesmann 1 (MECD1) [MIM:122100]	H0YVX6	135	R	I
Q99456	LP/P	Corneal dystrophy, Meesmann 1 (MECD1) [MIM:122100]	H0YVX6	135	R	G
Q99456	LP/P	Corneal dystrophy, Meesmann 1 (MECD1) [MIM:122100]	H0YVX6	140	L	R
Q99456	LP/P	Corneal dystrophy, Meesmann 1 (MECD1) [MIM:122100]	H0YVX6	429	Y	D
Q99456	LB/B	-	H0YVX6	20	R	W
Q99456	LP/P	Corneal dystrophy, Meesmann 1 (MECD1) [MIM:122100]	H0YVX6	129	M	T
Q99456	LP/P	Corneal dystrophy, Meesmann 1 (MECD1) [MIM:122100]	H0YVX6	130	Q	P
Q99456	LP/P	Corneal dystrophy, Meesmann 1 (MECD1) [MIM:122100]	H0YVX6	135	R	S
Q99456	LP/P	Corneal dystrophy, Meesmann 1 (MECD1) [MIM:122100]	H0YVX6	137	A	P
Q99456	LP/P	Corneal dystrophy, Meesmann 1 (MECD1) [MIM:122100]	H0YVX6	426	I	S
Q99456	LP/P	Corneal dystrophy, Meesmann 1 (MECD1) [MIM:122100]	H0YVX6	429	Y	C
Q99456	LB/B	-	H0YVX6	15	P	S
Q99456	LP/P	Corneal dystrophy, Meesmann 1 (MECD1) [MIM:122100]	H0YVX6	129	M	V
Q99456	LP/P	Corneal dystrophy, Meesmann 1 (MECD1) [MIM:122100]	H0YVX6	132	L	P
Q99456	LP/P	Corneal dystrophy, Meesmann 1 (MECD1) [MIM:122100]	H0YVX6	140	L	Q
Q99456	LP/P	Corneal dystrophy, Meesmann 1 (MECD1) [MIM:122100]	H0YVX6	430	R	P
Q99456	LP/P	Corneal dystrophy, Meesmann 1 (MECD1) [MIM:122100]	H0YVX6	433	L	R
Q99456	LP/P	Corneal dystrophy, Meesmann 1 (MECD1) [MIM:122100]	H0YVX6	132	L	V
P19012	LB/B	-	A0A2Y9LY56	147	T	A
P19012	LB/B	-	A0A2Y9LY56	416	K	R
P19012	LB/B	-	A0A2Y9LY56	421	A	G
Q04695	LP/P	Pachyonychia congenita 2 (PC2) [MIM:167210]	A0A2Y9LY56	92	N	D
Q04695	LP/P	Steatocystoma multiplex (SM) [MIM:184500]	A0A2Y9LY56	92	N	H
Q04695	LP/P	Pachyonychia congenita 2 (PC2) [MIM:167210]	A0A2Y9LY56	92	N	S
Q04695	LP/P	Pachyonychia congenita 2 (PC2) [MIM:167210]	A0A2Y9LY56	94	R	H
Q04695	LP/P	Steatocystoma multiplex (SM) [MIM:184500]	A0A2Y9LY56	94	R	H
Q04695	LP/P	Pachyonychia congenita 2 (PC2) [MIM:167210]	A0A2Y9LY56	98	Y	D
Q04695	LP/P	Pachyonychia congenita 2 (PC2) [MIM:167210]	A0A2Y9LY56	88	M	T
Q04695	LP/P	Steatocystoma multiplex (SM) [MIM:184500]	A0A2Y9LY56	88	M	T
Q04695	LP/P	Pachyonychia congenita 2 (PC2) [MIM:167210]	A0A2Y9LY56	94	R	C
Q04695	LP/P	Steatocystoma multiplex (SM) [MIM:184500]	A0A2Y9LY56	94	R	C
Q04695	LP/P	Pachyonychia congenita 2 (PC2) [MIM:167210]	A0A2Y9LY56	94	R	P
Q04695	LP/P	Pachyonychia congenita 2 (PC2) [MIM:167210]	A0A2Y9LY56	95	L	Q
Q04695	LP/P	Pachyonychia congenita 2 (PC2) [MIM:167210]	A0A2Y9LY56	95	L	P
Q04695	LP/P	Pachyonychia congenita 2 (PC2) [MIM:167210]	A0A2Y9LY56	99	L	P
Q04695	LP/P	Pachyonychia congenita 2 (PC2) [MIM:167210]	A0A2Y9LY56	102	V	M
Q04695	LP/P	Pachyonychia congenita 2 (PC2) [MIM:167210]	A0A2Y9LY56	109	N	D
Q04695	LP/P	Pachyonychia congenita 2 (PC2) [MIM:167210]	A0A2Y9LY56	88	M	K
Q04695	LP/P	Pachyonychia congenita 2 (PC2) [MIM:167210]	A0A2Y9LY56	91	L	P
Q04695	LP/P	Pachyonychia congenita 2 (PC2) [MIM:167210]	A0A2Y9LY56	388	L	P
Q04695	LP/P	Pachyonychia congenita 2 (PC2) [MIM:167210]	A0A2Y9LY56	388	L	R
P05783	LP/P	Cirrhosis (CIRRH) [MIM:215600]	A1KQY9	128	H	L
P05783	LP/P	Cirrhosis (CIRRH) [MIM:215600]	A1KQY9	103	T	A
P05783	LB/B	-	A1KQY9	230	S	T
P05783	LP/P	Cirrhosis (CIRRH) [MIM:215600]	A1KQY9	261	R	Q
P05783	LP/P	Cirrhosis (CIRRH) [MIM:215600]	A1KQY9	340	G	R
P08727	LB/B	-	A0A2Y9LY56	60	A	G
P35908	LP/P	Ichthyosis bullosa of Siemens (IBS) [MIM:146800]	A0A286XI76	181	Q	P
P35908	LP/P	Ichthyosis bullosa of Siemens (IBS) [MIM:146800]	A0A286XI76	487	E	D
P35908	LP/P	Ichthyosis bullosa of Siemens (IBS) [MIM:146800]	A0A286XI76	487	E	K
P35908	LP/P	Ichthyosis bullosa of Siemens (IBS) [MIM:146800]	A0A286XI76	186	N	Y
P35908	LP/P	Ichthyosis bullosa of Siemens (IBS) [MIM:146800]	A0A286XI76	476	E	K
P35908	LP/P	Ichthyosis bullosa of Siemens (IBS) [MIM:146800]	A0A286XI76	479	T	P
P35908	LP/P	Ichthyosis bullosa of Siemens (IBS) [MIM:146800]	A0A286XI76	182	I	N
P35908	LP/P	Ichthyosis bullosa of Siemens (IBS) [MIM:146800]	A0A286XI76	186	N	D
P35908	LP/P	Ichthyosis bullosa of Siemens (IBS) [MIM:146800]	A0A286XI76	484	L	P
P35908	LP/P	Ichthyosis bullosa of Siemens (IBS) [MIM:146800]	A0A286XI76	186	N	K
P35908	LP/P	Ichthyosis bullosa of Siemens (IBS) [MIM:146800]	A0A286XI76	465	E	D
P35908	LP/P	Ichthyosis bullosa of Siemens (IBS) [MIM:146800]	A0A286XI76	465	E	K
P35908	LP/P	Ichthyosis bullosa of Siemens (IBS) [MIM:146800]	A0A286XI76	476	E	V
P35908	LP/P	Ichthyosis bullosa of Siemens (IBS) [MIM:146800]	A0A286XI76	477	I	N
P35908	LP/P	Ichthyosis bullosa of Siemens (IBS) [MIM:146800]	A0A286XI76	488	E	K
P35908	LB/B	-	A0A286XI76	101	S	G
P35908	LB/B	-	A0A286XI76	219	G	D
Q2M2I5	LB/B	-	H0YVX6	115	A	T
Q2M2I5	LB/B	-	H0YVX6	250	G	D
Q2M2I5	LB/B	-	H0YVX6	267	M	I
Q2M2I5	LB/B	-	H0YVX6	366	R	C
Q2M2I5	LB/B	-	H0YVX6	415	C	Y
Q2M2I5	LB/B	-	H0YVX6	418	W	R
Q2M2I5	LB/B	-	H0YVX6	429	K	E
Q7Z3Z0	LB/B	-	Q6ZPD6	54	S	L
Q7Z3Z0	LP/P	Woolly hair autosomal recessive 3 (ARWH3) [MIM:616760]	Q6ZPD6	238	V	L
Q7Z3Z0	LP/P	Woolly hair autosomal recessive 3 (ARWH3) [MIM:616760]	Q6ZPD6	317	L	P
Q7Z3Z0	LP/P	Woolly hair autosomal recessive 3 (ARWH3) [MIM:616760]	Q6ZPD6	376	L	R
Q7Z3Y9	LB/B	-	Q6ZPD6	118	W	R
Q7Z3Y8	LB/B	-	Q6ZPD6	193	G	S
Q7Z3Y8	LB/B	-	Q6ZPD6	284	A	T
Q7Z3Y8	LB/B	-	Q6ZPD6	52	S	T
Q7Z3Y8	LB/B	-	Q6ZPD6	144	E	K
Q7Z3Y8	LB/B	-	Q6ZPD6	305	I	T
Q7Z3Y7	LB/B	-	H0YVX6	52	G	D
Q7Z3Y7	LB/B	-	H0YVX6	286	A	T
Q7Z3Y7	LB/B	-	H0YVX6	62	A	V
P12035	LP/P	Corneal dystrophy, Meesmann 2 (MECD2) [MIM:618767]	W5Q6B8	509	E	K
P12035	LP/P	Corneal dystrophy, Meesmann 2 (MECD2) [MIM:618767]	W5Q6B8	503	R	P
P12035	LB/B	-	W5Q6B8	375	R	G
P12035	LB/B	-	W5Q6B8	44	G	A
Q15323	LB/B	-	A0A2K6FF88	39	A	G
Q15323	LB/B	-	A0A2K6FF88	82	A	V
Q15323	LB/B	-	A0A2K6FF88	377	A	V
Q14532	LB/B	-	A0A2K6FF88	72	Q	R
Q14532	LB/B	-	A0A2K6FF88	171	I	T
Q14532	LB/B	-	A0A2K6FF88	222	S	Y
Q14532	LB/B	-	A0A2K6FF88	339	T	M
Q14532	LB/B	-	A0A2K6FF88	395	T	M
Q14532	LB/B	-	A0A2K6FF88	428	R	C
Q14532	LB/B	-	A0A2K6FF88	151	E	D
Q14532	LB/B	-	A0A2K6FF88	280	R	H
Q14532	LB/B	-	A0A2K6FF88	402	N	S
Q14532	LB/B	-	A0A2K6FF88	427	P	T
Q14532	LB/B	-	A0A2K6FF88	89	E	K
O76009	LB/B	-	A0A2K6FF88	270	A	V
O76011	LB/B	-	A0A2K6FF88	280	I	T
O76011	LB/B	-	A0A2K6FF88	348	H	R
O76014	LB/B	-	A0A2K6CH58	13	G	C
O76014	LB/B	-	A0A2K6CH58	39	N	S
O76014	LB/B	-	A0A2K6CH58	72	T	A
O76014	LB/B	-	A0A2K6CH58	73	S	C
O76014	LB/B	-	A0A2K6CH58	217	A	V
O76014	LB/B	-	A0A2K6CH58	306	A	D
O76014	LB/B	-	A0A2K6CH58	421	S	F
O76014	LB/B	-	A0A2K6CH58	422	T	M
O76014	LB/B	-	A0A2K6CH58	434	P	S
O76015	LB/B	-	A0A2K6CH58	423	S	P
Q6A163	LB/B	-	H0VIA1	341	T	M
Q6A163	LB/B	-	H0VIA1	383	L	M
Q6A163	LB/B	-	H0VIA1	456	R	Q
P19013	LB/B	-	F7AGY4	72	A	V
P19013	LP/P	White sponge nevus 1 (WSN1) [MIM:193900]	F7AGY4	435	E	K
Q6A162	LB/B	-	A0A2K6FF88	37	T	A
Q6A162	LB/B	-	A0A2K6FF88	85	F	S
Q6A162	LB/B	-	A0A2K6FF88	102	S	N
Q6A162	LB/B	-	A0A2K6FF88	153	T	M
Q6A162	LB/B	-	A0A2K6FF88	235	R	H
Q6A162	LB/B	-	A0A2K6FF88	265	C	Y
Q6A162	LB/B	-	A0A2K6FF88	286	E	D
Q6A162	LB/B	-	A0A2K6FF88	303	M	T
Q6A162	LB/B	-	A0A2K6FF88	406	S	L
P13647	LB/B	-	F7AGY4	138	G	E
P13647	LP/P	Epidermolysis bullosa simplex 2C, localized (EBS2C) [MIM:619594]	F7AGY4	161	I	S
P13647	LP/P	Epidermolysis bullosa simplex 2A, generalized severe (EBS2A) [MIM:619555]	F7AGY4	193	N	K
P13647	LP/P	Epidermolysis bullosa simplex 2C, localized (EBS2C) [MIM:619594]	F7AGY4	193	N	K
P13647	LP/P	Epidermolysis bullosa simplex 2C, localized (EBS2C) [MIM:619594]	F7AGY4	327	M	T
P13647	LP/P	Epidermolysis bullosa simplex 2C, localized (EBS2C) [MIM:619594]	F7AGY4	331	R	C
P13647	LP/P	Epidermolysis bullosa simplex 2B, generalized intermediate (EBS2B) [MIM:619588]	F7AGY4	463	L	P
P13647	LP/P	Epidermolysis bullosa simplex 2A, generalized severe (EBS2A) [MIM:619555]	F7AGY4	475	E	G
P13647	LP/P	Epidermolysis bullosa simplex 2F, with mottled pigmentation (EBS2F) [MIM:131960]	F7AGY4	25	P	L
P13647	LP/P	Epidermolysis bullosa simplex 2C, localized (EBS2C) [MIM:619594]	F7AGY4	152	P	L
P13647	LP/P	Epidermolysis bullosa simplex 2B, generalized intermediate (EBS2B) [MIM:619588]	F7AGY4	173	K	N
P13647	LP/P	Epidermolysis bullosa simplex 2A, generalized severe (EBS2A) [MIM:619555]	F7AGY4	175	L	F
P13647	LP/P	Epidermolysis bullosa simplex 2A, generalized severe (EBS2A) [MIM:619555]	F7AGY4	176	N	S
P13647	LP/P	Epidermolysis bullosa simplex 2A, generalized severe (EBS2A) [MIM:619555]	F7AGY4	179	F	S
P13647	LP/P	Epidermolysis bullosa simplex 2A, generalized severe (EBS2A) [MIM:619555]	F7AGY4	181	S	P
P13647	LP/P	Epidermolysis bullosa simplex 2B, generalized intermediate (EBS2B) [MIM:619588]	F7AGY4	323	V	A
P13647	LP/P	Epidermolysis bullosa simplex 2B, generalized intermediate (EBS2B) [MIM:619588]	F7AGY4	325	L	P
P13647	LP/P	Epidermolysis bullosa simplex 2C, localized (EBS2C) [MIM:619594]	F7AGY4	327	M	K
P13647	LP/P	Epidermolysis bullosa simplex 2C, localized (EBS2C) [MIM:619594]	F7AGY4	328	D	H
P13647	LP/P	Epidermolysis bullosa simplex 2C, localized (EBS2C) [MIM:619594]	F7AGY4	328	D	V
P13647	LP/P	Epidermolysis bullosa simplex 2C, localized (EBS2C) [MIM:619594]	F7AGY4	329	N	K
P13647	LP/P	Epidermolysis bullosa simplex 2A, generalized severe (EBS2A) [MIM:619555]	F7AGY4	467	I	T
P13647	LP/P	Epidermolysis bullosa simplex 2A, generalized severe (EBS2A) [MIM:619555]	F7AGY4	477	E	K
P13647	LP/P	Epidermolysis bullosa simplex 2B, generalized intermediate (EBS2B) [MIM:619588]	F7AGY4	186	V	L
P13647	LP/P	Epidermolysis bullosa simplex 2B, generalized intermediate (EBS2B) [MIM:619588]	F7AGY4	475	E	K
P13647	LP/P	Epidermolysis bullosa simplex 2C, localized (EBS2C) [MIM:619594]	F7AGY4	167	E	K
P13647	LP/P	Epidermolysis bullosa simplex 2B, generalized intermediate (EBS2B) [MIM:619588]	F7AGY4	170	E	K
P13647	LP/P	Epidermolysis bullosa simplex 2C, localized (EBS2C) [MIM:619594]	F7AGY4	170	E	K
P13647	LP/P	Epidermolysis bullosa simplex 2D, generalized, intermediate or severe, autosomal recessive (EBS2D) [MIM:619599]	F7AGY4	170	E	K
P13647	LP/P	Epidermolysis bullosa simplex 2C, localized (EBS2C) [MIM:619594]	F7AGY4	177	N	S
P13647	LP/P	Epidermolysis bullosa simplex 2C, localized (EBS2C) [MIM:619594]	F7AGY4	199	K	T
P13647	LP/P	Epidermolysis bullosa simplex 2C, localized (EBS2C) [MIM:619594]	F7AGY4	311	L	P
P13647	LP/P	Epidermolysis bullosa simplex 2C, localized (EBS2C) [MIM:619594]	F7AGY4	324	V	D
P13647	LP/P	Epidermolysis bullosa simplex 2C, localized (EBS2C) [MIM:619594]	F7AGY4	328	D	E
P13647	LP/P	Epidermolysis bullosa simplex 2C, localized (EBS2C) [MIM:619594]	F7AGY4	328	D	G
P13647	LP/P	Epidermolysis bullosa simplex 2A, generalized severe (EBS2A) [MIM:619555]	F7AGY4	168	E	K
P13647	LP/P	Epidermolysis bullosa simplex 2A, generalized severe (EBS2A) [MIM:619555]	F7AGY4	169	R	P
P13647	LP/P	Epidermolysis bullosa simplex 2C, localized (EBS2C) [MIM:619594]	F7AGY4	331	R	H
P13647	LP/P	Epidermolysis bullosa simplex 2A, generalized severe (EBS2A) [MIM:619555]	F7AGY4	469	T	P
P13647	LB/B	-	F7AGY4	79	S	R
P13647	LB/B	-	F7AGY4	197	D	E
P13647	LB/B	-	F7AGY4	232	S	N
P13647	LB/B	-	F7AGY4	387	S	T
P13647	LB/B	-	F7AGY4	528	S	G
P13647	LB/B	-	F7AGY4	543	G	S
P13647	LP/P	Epidermolysis bullosa simplex 2B, generalized intermediate (EBS2B) [MIM:619588]	F7AGY4	143	V	D
P13647	LP/P	Epidermolysis bullosa simplex 2C, localized (EBS2C) [MIM:619594]	F7AGY4	352	R	S
P13647	LP/P	Epidermolysis bullosa simplex 2B, generalized intermediate (EBS2B) [MIM:619588]	F7AGY4	517	G	D
P13647	LP/P	Epidermolysis bullosa simplex 2A, generalized severe (EBS2A) [MIM:619555]	F7AGY4	165	R	S
P13647	LP/P	Epidermolysis bullosa simplex 2C, localized (EBS2C) [MIM:619594]	F7AGY4	186	V	E
P13647	LP/P	Epidermolysis bullosa simplex 2C, localized (EBS2C) [MIM:619594]	F7AGY4	321	T	P
P13647	LP/P	Epidermolysis bullosa simplex 2C, localized (EBS2C) [MIM:619594]	F7AGY4	428	A	T
P13647	LP/P	Epidermolysis bullosa simplex 2B, generalized intermediate (EBS2B) [MIM:619588]	F7AGY4	143	V	A
P13647	LP/P	-	F7AGY4	143	V	F
P13647	LP/P	Epidermolysis bullosa simplex 2B, generalized intermediate (EBS2B) [MIM:619588]	F7AGY4	180	A	D
P13647	LP/P	Epidermolysis bullosa simplex 2D, generalized, intermediate or severe, autosomal recessive (EBS2D) [MIM:619599]	F7AGY4	183	I	T
P13647	LP/P	Epidermolysis bullosa simplex 2C, localized (EBS2C) [MIM:619594]	F7AGY4	323	V	G
P13647	LP/P	Epidermolysis bullosa simplex 2C, localized (EBS2C) [MIM:619594]	F7AGY4	325	L	F
P13647	LP/P	Epidermolysis bullosa simplex 2D, generalized, intermediate or severe, autosomal recessive (EBS2D) [MIM:619599]	F7AGY4	418	E	K
P13647	LP/P	Epidermolysis bullosa simplex 2C, localized (EBS2C) [MIM:619594]	F7AGY4	428	A	D
P13647	LP/P	Epidermolysis bullosa simplex 2A, generalized severe (EBS2A) [MIM:619555]	F7AGY4	467	I	M
P02538	LP/P	Pachyonychia congenita 3 (PC3) [MIM:615726]	A0A287AZL3	174	F	V
P02538	LP/P	Pachyonychia congenita 3 (PC3) [MIM:615726]	A0A287AZL3	469	L	R
P02538	LP/P	Pachyonychia congenita 3 (PC3) [MIM:615726]	A0A287AZL3	472	E	K
P02538	LB/B	-	A0A287AZL3	21	N	S
P02538	LB/B	-	A0A287AZL3	111	G	D
P02538	LP/P	Pachyonychia congenita 3 (PC3) [MIM:615726]	A0A287AZL3	164	R	P
P02538	LP/P	Pachyonychia congenita 3 (PC3) [MIM:615726]	A0A287AZL3	166	Q	P
P02538	LP/P	Pachyonychia congenita 3 (PC3) [MIM:615726]	A0A287AZL3	167	I	N
P02538	LP/P	Pachyonychia congenita 3 (PC3) [MIM:615726]	A0A287AZL3	170	L	F
P02538	LP/P	Pachyonychia congenita 3 (PC3) [MIM:615726]	A0A287AZL3	171	N	D
P02538	LP/P	Pachyonychia congenita 3 (PC3) [MIM:615726]	A0A287AZL3	171	N	K
P02538	LP/P	Pachyonychia congenita 3 (PC3) [MIM:615726]	A0A287AZL3	171	N	S
P02538	LP/P	Pachyonychia congenita 3 (PC3) [MIM:615726]	A0A287AZL3	171	N	Y
P02538	LP/P	Pachyonychia congenita 3 (PC3) [MIM:615726]	A0A287AZL3	174	F	C
P02538	LP/P	Pachyonychia congenita 3 (PC3) [MIM:615726]	A0A287AZL3	174	F	S
P02538	LP/P	Pachyonychia congenita 3 (PC3) [MIM:615726]	A0A287AZL3	176	S	P
P02538	LP/P	Pachyonychia congenita 3 (PC3) [MIM:615726]	A0A287AZL3	178	I	N
P02538	LP/P	Pachyonychia congenita 3 (PC3) [MIM:615726]	A0A287AZL3	462	I	N
P02538	LP/P	Pachyonychia congenita 3 (PC3) [MIM:615726]	A0A287AZL3	462	I	S
P02538	LP/P	Pachyonychia congenita 3 (PC3) [MIM:615726]	A0A287AZL3	463	A	P
P02538	LP/P	Pachyonychia congenita 3 (PC3) [MIM:615726]	A0A287AZL3	464	T	P
P02538	LP/P	Pachyonychia congenita 3 (PC3) [MIM:615726]	A0A287AZL3	465	Y	H
P02538	LP/P	Pachyonychia congenita 3 (PC3) [MIM:615726]	A0A287AZL3	465	Y	S
P02538	LP/P	Pachyonychia congenita 3 (PC3) [MIM:615726]	A0A287AZL3	468	L	P
P02538	LP/P	Pachyonychia congenita 3 (PC3) [MIM:615726]	A0A287AZL3	468	L	Q
P02538	LP/P	Pachyonychia congenita 3 (PC3) [MIM:615726]	A0A287AZL3	469	L	P
P04259	LB/B	-	A0A287AZL3	21	N	S
P04259	LB/B	-	A0A287AZL3	227	N	S
P04259	LB/B	-	A0A287AZL3	365	I	V
P04259	LP/P	Pachyonychia congenita 4 (PC4) [MIM:615728]	A0A287AZL3	472	E	K
P48668	LB/B	-	A0A287AZL3	182	R	Q
P48668	LB/B	-	A0A287AZL3	227	S	N
P48668	LB/B	-	A0A287AZL3	481	V	I
P48668	LP/P	Palmoplantar keratoderma, non-epidermolytic, focal or diffuse (PPKNEFD) [MIM:615735]	A0A287AZL3	472	E	K
P08729	LB/B	-	A0A1U7TRE7	364	G	A
P08729	LB/B	-	A0A1U7TRE7	186	H	R
Q3SY84	LB/B	-	G3WRS6	107	V	I
Q3SY84	LB/B	-	G3WRS6	122	E	K
Q3SY84	LB/B	-	G3WRS6	355	I	F
Q3SY84	LB/B	-	G3WRS6	464	V	G
Q3SY84	LB/B	-	G3WRS6	523	R	Q
Q3SY84	LP/P	Hypotrichosis 13 (HYPT13) [MIM:615896]	G3WRS6	141	F	C
Q14CN4	LB/B	-	G3WRS6	171	N	D
Q14CN4	LB/B	-	G3WRS6	264	Y	C
Q14CN4	LB/B	-	G3WRS6	366	D	E
Q14CN4	LB/B	-	G3WRS6	428	R	L
Q14CN4	LB/B	-	G3WRS6	326	Q	E
Q86Y46	LB/B	-	G3WRS6	61	V	M
Q86Y46	LB/B	-	G3WRS6	96	P	L
Q86Y46	LB/B	-	G3WRS6	365	E	G
O95678	LB/B	-	A0A287AZL3	39	R	C
O95678	LB/B	-	A0A287AZL3	91	R	G
O95678	LB/B	-	A0A287AZL3	117	P	A
O95678	LB/B	-	A0A287AZL3	161	A	T
O95678	LB/B	-	A0A287AZL3	209	R	Q
O95678	LB/B	-	A0A287AZL3	242	E	G
O95678	LP/P	Loose anagen hair syndrome (LAHS) [MIM:600628]	A0A287AZL3	337	E	K
O95678	LB/B	-	A0A287AZL3	367	I	V
O95678	LB/B	-	A0A287AZL3	427	M	T
O95678	LB/B	-	A0A287AZL3	432	R	C
O95678	LB/B	-	A0A287AZL3	485	S	R
Q01546	LB/B	-	A0A287AZL3	283	A	T
Q01546	LB/B	-	A0A287AZL3	359	A	T
Q01546	LB/B	-	A0A287AZL3	629	T	M
Q7Z794	LB/B	-	A0A2U3YQ73	10	A	T
Q8N1N4	LB/B	-	A0A2Y9DGC1	25	R	H
Q8N1N4	LB/B	-	A0A2Y9DGC1	92	L	P
Q8N1N4	LB/B	-	A0A2Y9DGC1	224	G	A
Q8N1N4	LB/B	-	A0A2Y9DGC1	238	A	T
Q5XKE5	LB/B	-	G3WRS6	81	L	S
Q5XKE5	LB/B	-	G3WRS6	195	F	L
Q5XKE5	LB/B	-	G3WRS6	266	H	R
Q5XKE5	LB/B	-	G3WRS6	393	A	V
P05787	LP/P	Cirrhosis (CIRRH) [MIM:215600]	A0A2I3M7V3	53	G	V
P05787	LP/P	Cirrhosis (CIRRH) [MIM:215600]	A0A2I3M7V3	54	Y	C
P05787	LP/P	Cirrhosis (CIRRH) [MIM:215600]	A0A2I3M7V3	62	G	C
P05787	LB/B	-	A0A2I3M7V3	63	I	V
P05787	LB/B	-	A0A2I3M7V3	401	R	W
P05787	LB/B	-	A0A2I3M7V3	417	S	G
P05787	LB/B	-	A0A2I3M7V3	429	G	D
Q14533	LB/B	-	A0A2K6PEK6	52	G	R
Q14533	LB/B	-	A0A2K6PEK6	248	L	R
Q14533	LB/B	-	A0A2K6PEK6	316	R	C
Q14533	LP/P	Monilethrix (MNLIX) [MIM:158000]	A0A2K6PEK6	402	E	K
Q14533	LP/P	Monilethrix (MNLIX) [MIM:158000]	A0A2K6PEK6	413	E	K
Q14533	LP/P	Monilethrix (MNLIX) [MIM:158000]	A0A2K6PEK6	408	R	C
Q9NSB4	LB/B	-	A0A2K6PEK6	458	T	M
Q9NSB4	LB/B	-	A0A2K6PEK6	219	E	Q
Q9NSB4	LB/B	-	A0A2K6PEK6	452	E	D
P78385	LB/B	-	A0A2K6PEK6	149	R	C
P78385	LB/B	-	A0A2K6PEK6	279	I	M
P78385	LB/B	-	A0A2K6PEK6	493	H	Y
P78385	LP/P	Monilethrix (MNLIX) [MIM:158000]	A0A2K6PEK6	407	E	K
P78385	LP/P	Monilethrix (MNLIX) [MIM:158000]	A0A2K6PEK6	418	E	K
P78386	LP/P	Ectodermal dysplasia 4, hair/nail type (ECTD4) [MIM:602032]	A0A2K6PEK6	78	R	H
P78386	LB/B	-	A0A2K6PEK6	155	W	L
O43790	LP/P	Monilethrix (MNLIX) [MIM:158000]	A0A2K6PEK6	114	N	D
O43790	LP/P	Monilethrix (MNLIX) [MIM:158000]	A0A2K6PEK6	402	E	Q
O43790	LP/P	Monilethrix (MNLIX) [MIM:158000]	A0A2K6PEK6	402	E	K
O43790	LP/P	Monilethrix (MNLIX) [MIM:158000]	A0A2K6PEK6	413	E	K
O43790	LP/P	Monilethrix (MNLIX) [MIM:158000]	A0A2K6PEK6	413	E	D
O43790	LP/P	Monilethrix (MNLIX) [MIM:158000]	A0A2K6PEK6	114	N	H
O43790	LP/P	Monilethrix (MNLIX) [MIM:158000]	A0A2K6PEK6	409	L	P
O43790	LP/P	Monilethrix (MNLIX) [MIM:158000]	A0A2K6PEK6	410	L	P
P35527	LP/P	Keratoderma, palmoplantar, epidermolytic (EPPK) [MIM:144200]	M3WGY3	161	N	K
P35527	LP/P	Keratoderma, palmoplantar, epidermolytic (EPPK) [MIM:144200]	M3WGY3	163	R	Q
P35527	LP/P	Keratoderma, palmoplantar, epidermolytic (EPPK) [MIM:144200]	M3WGY3	163	R	W
P35527	LP/P	Keratoderma, palmoplantar, epidermolytic (EPPK) [MIM:144200]	M3WGY3	168	L	S
P35527	LP/P	Keratoderma, palmoplantar, epidermolytic (EPPK) [MIM:144200]	M3WGY3	157	M	T
P35527	LP/P	Keratoderma, palmoplantar, epidermolytic (EPPK) [MIM:144200]	M3WGY3	157	M	V
P35527	LP/P	Keratoderma, palmoplantar, epidermolytic (EPPK) [MIM:144200]	M3WGY3	160	L	V
P35527	LP/P	Keratoderma, palmoplantar, epidermolytic (EPPK) [MIM:144200]	M3WGY3	161	N	S
P35527	LP/P	Keratoderma, palmoplantar, epidermolytic (EPPK) [MIM:144200]	M3WGY3	161	N	Y
P35527	LP/P	Keratoderma, palmoplantar, epidermolytic (EPPK) [MIM:144200]	M3WGY3	172	Q	P
P35527	LP/P	Keratoderma, palmoplantar, epidermolytic (EPPK) [MIM:144200]	M3WGY3	160	L	F
P35527	LP/P	Keratoderma, palmoplantar, epidermolytic (EPPK) [MIM:144200]	M3WGY3	171	V	M
P35527	LP/P	Keratoderma, palmoplantar, epidermolytic (EPPK) [MIM:144200]	M3WGY3	157	M	R
P35527	LP/P	Keratoderma, palmoplantar, epidermolytic (EPPK) [MIM:144200]	M3WGY3	161	N	H
P35527	LP/P	Keratoderma, palmoplantar, epidermolytic (EPPK) [MIM:144200]	M3WGY3	161	N	I
P35527	LP/P	Keratoderma, palmoplantar, epidermolytic (EPPK) [MIM:144200]	M3WGY3	163	R	P
P35527	LP/P	Keratoderma, palmoplantar, epidermolytic (EPPK) [MIM:144200]	M3WGY3	458	L	F
P35527	LP/P	Keratoderma, palmoplantar, epidermolytic (EPPK) [MIM:144200]	M3WGY3	157	M	K
P35527	LP/P	Keratoderma, palmoplantar, epidermolytic (EPPK) [MIM:144200]	M3WGY3	406	C	R
P35527	LP/P	Keratoderma, palmoplantar, epidermolytic (EPPK) [MIM:144200]	M3WGY3	454	Y	H
P35527	LP/P	Keratoderma, palmoplantar, epidermolytic (EPPK) [MIM:144200]	M3WGY3	458	L	P
Q8IUG1	LB/B	-	A0A2Y9JV76	34	C	S
Q8IUG1	LB/B	-	A0A2Y9JV76	82	G	R
P60331	LB/B	-	A0A2K6UVH2	39	P	L
P60331	LB/B	-	A0A2K6UVH2	101	V	M
P60331	LB/B	-	A0A2K6UVH2	241	R	Q
P60331	LB/B	-	A0A2K6UVH2	280	P	L
P60014	LB/B	-	F6Y931	72	T	P
P60014	LB/B	-	F6Y931	20	V	D
P60014	LB/B	-	F6Y931	158	V	M
P60014	LB/B	-	F6Y931	86	T	S
P60014	LB/B	-	F6Y931	126	C	S
P60014	LB/B	-	F6Y931	129	Q	P
P60014	LB/B	-	F6Y931	116	V	M
P60412	LB/B	-	A0A2K6UVH2	130	S	F
P60413	LB/B	-	F6Y931	146	P	Q
P60413	LB/B	-	F6Y931	226	G	S
P60368	LB/B	-	A0A2K6UVH2	15	N	D
P60368	LB/B	-	A0A2K6UVH2	107	P	T
P60368	LB/B	-	A0A2K6UVH2	117	A	P
P60368	LB/B	-	A0A2K6UVH2	241	R	G
P60368	LB/B	-	A0A2K6UVH2	177	P	L
P60369	LB/B	-	F6Y931	3	T	A
P60369	LB/B	-	F6Y931	170	C	Y
P60372	LB/B	-	G3VR13	62	R	C
P60372	LB/B	-	G3VR13	159	I	V
P60372	LB/B	-	G3VR13	285	G	C
P60370	LB/B	-	A0A2K6UVH2	20	D	N
P60370	LB/B	-	A0A2K6UVH2	235	L	V
P60370	LB/B	-	A0A2K6UVH2	183	C	F
P60370	LB/B	-	A0A2K6UVH2	247	Y	C
P60370	LB/B	-	A0A2K6UVH2	268	P	R
P60370	LB/B	-	A0A2K6UVH2	4	C	S
P60371	LB/B	-	G3VR13	159	V	I
P60371	LB/B	-	G3VR13	68	C	S
P60371	LB/B	-	G3VR13	74	P	S
P60371	LB/B	-	G3VR13	300	S	P
P60409	LB/B	-	G3VR13	111	V	M
P60409	LB/B	-	G3VR13	215	K	Q
P60409	LB/B	-	G3VR13	285	T	S
P60409	LB/B	-	G3VR13	320	A	T
P60409	LB/B	-	G3VR13	124	Y	C
P60410	LB/B	-	F6Y931	26	H	R
P60411	LB/B	-	A0A2K6UVH2	182	Y	C
P60411	LB/B	-	A0A2K6UVH2	257	R	C
Q3LI76	LB/B	-	S9XPG8	43	L	M
Q3LI73	LB/B	-	A0A0D9RAG7	48	Y	C
Q3LI54	LB/B	-	J9JHL6	61	A	T
Q3MIV0	LB/B	-	F7GV25	29	Y	C
Q3MIV0	LB/B	-	F7GV25	26	L	H
Q3LHN0	LB/B	-	H2RHG7	40	S	P
Q6PEX3	LB/B	-	A0A2Y9ED16	26	S	Y
Q6PEX3	LB/B	-	A0A2Y9ED16	188	P	T
Q3LI81	LB/B	-	A0A2Y9KQV4	99	A	V
Q9BYQ7	LB/B	-	G3ULF6	66	H	R
Q9BYQ7	LB/B	-	G3ULF6	115	S	R
Q9BYQ7	LB/B	-	G3ULF6	134	A	T
Q9BYR4	LB/B	-	G3ULF6	122	P	S
Q9BYR4	LB/B	-	G3ULF6	152	P	S
Q9BYR3	LB/B	-	A0A2K6T9E5	25	Y	C
Q9BYR3	LB/B	-	A0A2K6T9E5	35	C	S
Q9BYR3	LB/B	-	A0A2K6T9E5	154	R	S
Q9BYR2	LB/B	-	G3ULF6	6	C	R
Q9BYR2	LB/B	-	G3ULF6	22	R	C
Q9BYR2	LB/B	-	G3ULF6	67	R	H
Q9BYR2	LB/B	-	G3ULF6	125	C	Y
Q9BYR0	LB/B	-	G3ULF6	16	S	G
Q9BYR0	LB/B	-	G3ULF6	18	D	V
Q9BYR0	LB/B	-	G3ULF6	68	T	S
Q9BYR0	LB/B	-	G3ULF6	168	S	C
Q6L8H2	LB/B	-	H2NCE1	27	G	S
Q6L8H2	LB/B	-	H2NCE1	28	Y	C
Q6L8H2	LB/B	-	H2NCE1	73	C	S
Q6L8H2	LB/B	-	H2NCE1	76	G	V
Q6L8H2	LB/B	-	H2NCE1	83	S	C
O75690	LB/B	-	A0A2K6S5E9	28	C	R
P26371	LB/B	-	A0A2K6S5E9	8	G	R
P26371	LB/B	-	A0A2K6S5E9	40	Y	C
Q3LI67	LB/B	-	G7P1K1	51	Y	S
Q3LI67	LB/B	-	G7P1K1	44	Y	S
Q9BYQ4	LB/B	-	A0A1U7SM58	36	P	S
Q9BYQ4	LB/B	-	A0A1U7SM58	56	C	S
Q9BYQ2	LB/B	-	A0A1U7SM58	146	S	Y
A8MVA2	LB/B	-	A0A1U7SM58	86	Y	C
A8MTY7	LB/B	-	A0A1U7SM58	23	T	I
A8MTY7	LB/B	-	A0A1U7SM58	130	S	N
Q9BYP9	LB/B	-	A0A1U7SM58	36	P	S
Q9BYP9	LB/B	-	A0A1U7SM58	56	C	S
Q96EK9	LB/B	-	L8IL65	191	D	E
Q9BQD3	LB/B	-	A0A091CWM2	157	P	A
Q6YP21	LB/B	-	A0A146Z484	206	S	P
P32004	LP/P	Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000]	A0A0F8CA97	9	W	S
P32004	LP/P	Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000]	A0A0F8CA97	121	G	S
P32004	LP/P	Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000]	A0A0F8CA97	179	I	S
P32004	LP/P	MASA syndrome (MASA) [MIM:303350]	A0A0F8CA97	179	I	S
P32004	LP/P	Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000]	A0A0F8CA97	184	R	Q
P32004	LP/P	Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000]	A0A0F8CA97	194	Y	C
P32004	LP/P	MASA syndrome (MASA) [MIM:303350]	A0A0F8CA97	210	H	Q
P32004	LP/P	Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000]	A0A0F8CA97	219	I	T
P32004	LP/P	Agenesis of the corpus callosum, X-linked, partial (ACCPX) [MIM:304100]	A0A0F8CA97	240	P	L
P32004	LP/P	Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000]	A0A0F8CA97	240	P	L
P32004	LP/P	Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000]	A0A0F8CA97	264	C	Y
P32004	LP/P	MASA syndrome (MASA) [MIM:303350]	A0A0F8CA97	309	E	K
P32004	LP/P	Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000]	A0A0F8CA97	335	W	R
P32004	LP/P	MASA syndrome (MASA) [MIM:303350]	A0A0F8CA97	335	W	R
P32004	LP/P	Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000]	A0A0F8CA97	370	G	R
P32004	LP/P	MASA syndrome (MASA) [MIM:303350]	A0A0F8CA97	370	G	R
P32004	LP/P	Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000]	A0A0F8CA97	386	R	C
P32004	LP/P	Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000]	A0A0F8CA97	452	G	R
P32004	LP/P	Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000]	A0A0F8CA97	473	R	C
P32004	LP/P	MASA syndrome (MASA) [MIM:303350]	A0A0F8CA97	473	R	C
P32004	LP/P	MASA syndrome (MASA) [MIM:303350]	A0A0F8CA97	598	D	N
P32004	LP/P	MASA syndrome (MASA) [MIM:303350]	A0A0F8CA97	632	R	P
P32004	LP/P	MASA syndrome (MASA) [MIM:303350]	A0A0F8CA97	691	A	D
P32004	LP/P	Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000]	A0A0F8CA97	698	G	R
P32004	LP/P	MASA syndrome (MASA) [MIM:303350]	A0A0F8CA97	698	G	R
P32004	LP/P	Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000]	A0A0F8CA97	768	V	F
P32004	LP/P	Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000]	A0A0F8CA97	784	Y	C
P32004	LP/P	Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000]	A0A0F8CA97	935	L	P
P32004	LP/P	Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000]	A0A0F8CA97	941	P	L
P32004	LP/P	MASA syndrome (MASA) [MIM:303350]	A0A0F8CA97	941	P	L
P32004	LP/P	Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000]	A0A0F8CA97	1070	Y	C
P32004	LP/P	Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000]	A0A0F8CA97	1194	S	L
P32004	LP/P	MASA syndrome (MASA) [MIM:303350]	A0A0F8CA97	1194	S	L
P32004	LP/P	Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000]	A0A0F8CA97	1224	S	L
P32004	LP/P	Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000]	A0A0F8CA97	752	V	M
P32004	LP/P	MASA syndrome (MASA) [MIM:303350]	A0A0F8CA97	752	V	M
P32004	LP/P	Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000]	A0A0F8CA97	415	A	P
P32004	LP/P	MASA syndrome (MASA) [MIM:303350]	A0A0F8CA97	674	S	C
P32004	LP/P	MASA syndrome (MASA) [MIM:303350]	A0A0F8CA97	770	D	N
P32004	LB/B	-	A0A0F8CA97	30	H	N
P32004	LP/P	Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000]	A0A0F8CA97	184	R	W
P32004	LP/P	MASA syndrome (MASA) [MIM:303350]	A0A0F8CA97	202	D	Y
P32004	LP/P	MASA syndrome (MASA) [MIM:303350]	A0A0F8CA97	268	G	D
P32004	LP/P	Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000]	A0A0F8CA97	335	W	C
P32004	LP/P	Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000]	A0A0F8CA97	408	N	I
P32004	LP/P	Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000]	A0A0F8CA97	421	V	D
P32004	LP/P	MASA syndrome (MASA) [MIM:303350]	A0A0F8CA97	426	A	D
P32004	LP/P	MASA syndrome (MASA) [MIM:303350]	A0A0F8CA97	482	L	P
P32004	LP/P	Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000]	A0A0F8CA97	497	C	Y
P32004	LP/P	Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000]	A0A0F8CA97	542	S	P
P32004	LP/P	Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000]	A0A0F8CA97	655	K	E
P32004	LP/P	Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000]	A0A0F8CA97	691	A	T
P32004	LB/B	-	A0A0F8CA97	739	R	W
P32004	LP/P	Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000]	A0A0F8CA97	741	M	T
P32004	LP/P	Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000]	A0A0F8CA97	751	R	P
P32004	LB/B	-	A0A0F8CA97	768	V	I
P32004	LB/B	-	A0A0F8CA97	1239	G	E
P32004	LB/B	-	A0A0F8CA97	958	L	V
P32004	LP/P	-	A0A0F8CA97	37	I	N
P32004	LB/B	-	A0A0F8CA97	38	T	M
P32004	LB/B	-	A0A0F8CA97	120	L	V
P32004	LP/P	-	A0A0F8CA97	172	M	I
P32004	LP/P	-	A0A0F8CA97	184	R	G
P32004	LP/P	-	A0A0F8CA97	254	A	D
P32004	LP/P	-	A0A0F8CA97	276	W	R
P32004	LP/P	-	A0A0F8CA97	313	L	P
P32004	LP/P	-	A0A0F8CA97	369	N	K
P32004	LP/P	-	A0A0F8CA97	480	G	R
P32004	LB/B	-	A0A0F8CA97	627	T	M
P32004	LP/P	-	A0A0F8CA97	635	W	C
P32004	LP/P	-	A0A0F8CA97	645	I	P
P32004	LP/P	-	A0A0F8CA97	714	P	S
P32004	LP/P	-	A0A0F8CA97	754	W	R
P32004	LP/P	Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000]	A0A0F8CA97	1036	W	L
P32004	LP/P	-	A0A0F8CA97	1080	L	Q
Q5T7N2	LB/B	-	Q587J6	27	R	S
Q5T7N2	LB/B	-	Q587J6	246	V	A
Q5T7N2	LB/B	-	Q587J6	309	V	M
Q5T7N2	LB/B	-	Q587J6	329	K	N
Q5T7N2	LB/B	-	Q587J6	549	P	T
Q5T7N2	LB/B	-	Q587J6	613	T	I
Q5T7N2	LB/B	-	Q587J6	860	L	V
Q9H9P8	LB/B	-	A0A2U3XI81	18	L	R
Q9H9P8	LP/P	L-2-hydroxyglutaric aciduria (L2HGA) [MIM:236792]	A0A2U3XI81	55	G	D
Q9H9P8	LP/P	L-2-hydroxyglutaric aciduria (L2HGA) [MIM:236792]	A0A2U3XI81	57	G	R
Q9H9P8	LP/P	L-2-hydroxyglutaric aciduria (L2HGA) [MIM:236792]	A0A2U3XI81	81	K	E
Q9H9P8	LP/P	L-2-hydroxyglutaric aciduria (L2HGA) [MIM:236792]	A0A2U3XI81	98	H	R
Q9H9P8	LP/P	L-2-hydroxyglutaric aciduria (L2HGA) [MIM:236792]	A0A2U3XI81	98	H	Y
Q9H9P8	LP/P	L-2-hydroxyglutaric aciduria (L2HGA) [MIM:236792]	A0A2U3XI81	176	E	D
Q9H9P8	LB/B	-	A0A2U3XI81	178	Y	F
Q9H9P8	LP/P	L-2-hydroxyglutaric aciduria (L2HGA) [MIM:236792]	A0A2U3XI81	302	P	L
Q9H9P8	LP/P	L-2-hydroxyglutaric aciduria (L2HGA) [MIM:236792]	A0A2U3XI81	434	H	P
Q9H9P8	LB/B	-	A0A2U3XI81	33	R	S
Q96EM0	LB/B	-	A0A2P8C9K3	42	V	A
Q96EM0	LB/B	-	A0A2P8C9K3	315	A	V
Q96EM0	LB/B	-	A0A2P8C9K3	341	I	V
Q96EM0	LB/B	-	A0A2P8C9K3	125	P	S
Q8NA19	LB/B	-	G3N850	489	G	S
Q8NA19	LB/B	-	G3N850	618	G	D
Q8IV20	LB/B	-	A0A226MU63	254	I	V
Q8IV20	LP/P	Juvenile arthritis (JUVAR) [MIM:618795]	A0A226MU63	284	C	R
P83111	LB/B	-	A0A286XMZ4	469	R	K
O00515	LB/B	-	A0A287BSQ4	56	A	S
O00515	LB/B	-	A0A287BSQ4	155	A	P
O00515	LB/B	-	A0A287BSQ4	243	L	P
O00515	LB/B	-	A0A287BSQ4	279	P	Q
O00515	LB/B	-	A0A287BSQ4	323	K	E
O00515	LB/B	-	A0A287BSQ4	503	T	S
Q14657	LP/P	Galloway-Mowat syndrome 2, X-linked (GAMOS2) [MIM:301006]	A0A096P1D2	106	V	F
Q14657	LP/P	Galloway-Mowat syndrome 2, X-linked (GAMOS2) [MIM:301006]	A0A096P1D2	137	F	S
Q6GTX8	LB/B	-	A0A2K5TN08	63	D	E
Q6GTX8	LB/B	-	A0A2K5TN08	92	R	S
Q6GTX8	LB/B	-	A0A2K5TN08	98	L	P
Q6GTX8	LB/B	-	A0A2K5TN08	123	S	T
P25391	LB/B	-	G1LRK8	349	L	S
P25391	LB/B	-	G1LRK8	559	V	I
P25391	LB/B	-	G1LRK8	1577	S	A
P25391	LB/B	-	G1LRK8	1591	L	V
P25391	LB/B	-	G1LRK8	1632	K	E
P25391	LB/B	-	G1LRK8	1682	D	V
P25391	LB/B	-	G1LRK8	2076	I	T
P25391	LB/B	-	G1LRK8	2611	T	A
P25391	LB/B	-	G1LRK8	674	N	T
P25391	LB/B	-	G1LRK8	1340	M	V
P25391	LB/B	-	G1LRK8	1876	A	T
P25391	LB/B	-	G1LRK8	2002	K	E
P25391	LB/B	-	G1LRK8	2511	L	M
Q16787	LB/B	-	A0A146V5U0	2702	T	A
Q16787	LB/B	-	A0A146V5U0	2815	N	K
Q16787	LB/B	-	A0A146V5U0	796	T	N
Q16787	LB/B	-	A0A146V5U0	1206	V	A
Q16787	LB/B	-	A0A146V5U0	1208	P	T
Q16787	LB/B	-	A0A146V5U0	1774	F	L
Q16787	LB/B	-	A0A146V5U0	2834	G	S
Q16363	LB/B	-	A0A1L8G2U4	498	Y	H
Q16363	LB/B	-	A0A1L8G2U4	1117	G	S
Q16363	LB/B	-	A0A1L8G2U4	1119	P	R
Q16363	LB/B	-	A0A1L8G2U4	94	G	S
Q16363	LB/B	-	A0A1L8G2U4	154	R	W
Q16363	LB/B	-	A0A1L8G2U4	492	L	H
Q16363	LB/B	-	A0A1L8G2U4	1549	N	S
Q16363	LB/B	-	A0A1L8G2U4	1815	V	I
Q16363	LB/B	-	A0A1L8G2U4	283	A	E
Q16363	LP/P	Cardiomyopathy, dilated 1JJ (CMD1JJ) [MIM:615235]	A0A1L8G2U4	950	P	L
O15230	LB/B	-	A0A1A6H509	889	V	M
O15230	LB/B	-	A0A1A6H509	1258	M	T
O15230	LB/B	-	A0A1A6H509	1367	K	E
O15230	LB/B	-	A0A1A6H509	1434	G	A
O15230	LB/B	-	A0A1A6H509	1667	R	W
O15230	LB/B	-	A0A1A6H509	1717	H	Y
O15230	LB/B	-	A0A1A6H509	1807	F	S
O15230	LB/B	-	A0A1A6H509	1900	V	M
O15230	LB/B	-	A0A1A6H509	1908	A	T
O15230	LB/B	-	A0A1A6H509	2036	H	R
O15230	LB/B	-	A0A1A6H509	2053	R	H
O15230	LB/B	-	A0A1A6H509	2062	D	N
O15230	LB/B	-	A0A1A6H509	2226	R	H
O15230	LB/B	-	A0A1A6H509	3079	R	W
O15230	LB/B	-	A0A1A6H509	401	T	A
O15230	LB/B	-	A0A1A6H509	1671	T	M
O15230	LP/P	Nephrotic syndrome 26 (NPHS26) [MIM:620049]	A0A1A6H509	286	R	L
P07942	LB/B	-	A0A2D0T5K1	670	V	A
P07942	LB/B	-	A0A2D0T5K1	1022	Q	R
P07942	LB/B	-	A0A2D0T5K1	860	G	S
P07942	LB/B	-	A0A2D0T5K1	379	P	S
P55268	LP/P	Pierson syndrome (PIERS) [MIM:609049]	A0A2D0T5K1	246	R	Q
P55268	LP/P	Pierson syndrome (PIERS) [MIM:609049]	A0A2D0T5K1	246	R	W
P55268	LP/P	Nephrotic syndrome 5 with or without ocular abnormalities (NPHS5) [MIM:614199]	A0A2D0T5K1	321	C	R
P55268	LP/P	Pierson syndrome (PIERS) [MIM:609049]	A0A2D0T5K1	321	C	R
P55268	LB/B	-	A0A2D0T5K1	987	E	K
P55268	LP/P	Nephrotic syndrome 5 with or without ocular abnormalities (NPHS5) [MIM:614199]	A0A2D0T5K1	1380	N	K
P55268	LP/P	Pierson syndrome (PIERS) [MIM:609049]	A0A2D0T5K1	1380	N	K
P55268	LP/P	Nephrotic syndrome 5 with or without ocular abnormalities (NPHS5) [MIM:614199]	A0A2D0T5K1	1393	L	F
P55268	LP/P	Pierson syndrome (PIERS) [MIM:609049]	A0A2D0T5K1	1393	L	F
P55268	LP/P	Nephrotic syndrome 5 with or without ocular abnormalities (NPHS5) [MIM:614199]	A0A2D0T5K1	147	H	R
P55268	LB/B	-	A0A2D0T5K1	700	G	E
P55268	LB/B	-	A0A2D0T5K1	1148	R	H
P55268	LB/B	-	A0A2D0T5K1	1765	A	T
A4D0S4	LB/B	-	A0A2D0T5K1	44	M	T
A4D0S4	LB/B	-	A0A2D0T5K1	234	H	Y
A4D0S4	LB/B	-	A0A2D0T5K1	591	V	F
A4D0S4	LB/B	-	A0A2D0T5K1	866	N	S
A4D0S4	LB/B	-	A0A2D0T5K1	1350	T	N
A4D0S4	LB/B	-	A0A2D0T5K1	1510	H	Y
A4D0S4	LB/B	-	A0A2D0T5K1	1612	R	S
A4D0S4	LB/B	-	A0A2D0T5K1	1028	G	C
Q9Y6N6	LB/B	-	A0A2U4A4T3	522	P	S
Q9Y6N6	LB/B	-	A0A2U4A4T3	544	E	G
Q9Y6N6	LB/B	-	A0A2U4A4T3	770	R	G
Q9Y6N6	LB/B	-	A0A2U4A4T3	1082	S	G
Q9Y6N6	LB/B	-	A0A2U4A4T3	1264	R	W
Q9Y6N6	LP/P	Cortical malformations occipital (OCCM) [MIM:614115]	A0A2U4A4T3	350	G	R
P11279	LB/B	-	A0A2D0Q3D3	309	I	T
P13473	LB/B	-	A0A2D0Q3D3	256	P	H
P13473	LP/P	Danon disease (DAND) [MIM:300257]	A0A2D0Q3D3	321	W	R
Q9UQV4	LB/B	-	G3TQL3	318	I	V
Q9UQV4	LB/B	-	G3TQL3	32	E	G
Q9UJQ1	LB/B	-	A0A1S3ARR7	12	D	G
Q9UJQ1	LB/B	-	A0A1S3ARR7	81	I	V
Q9UJQ1	LB/B	-	A0A1S3ARR7	103	Q	E
Q9UJQ1	LB/B	-	A0A1S3ARR7	158	S	G
Q9NS86	LB/B	-	A0A287AQ33	74	I	V
Q9NS86	LB/B	-	A0A287AQ33	56	T	P
O95461	LB/B	-	A0A1V4KER1	68	R	G
O95461	LB/B	-	A0A1V4KER1	68	R	P
O95461	LB/B	-	A0A1V4KER1	665	R	H
O95461	LP/P	Muscular dystrophy-dystroglycanopathy congenital with impaired intellectual development B6 (MDDGB6) [MIM:608840]	A0A1V4KER1	509	E	K
O95461	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A6 (MDDGA6) [MIM:613154]	A0A1V4KER1	331	S	F
O95461	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A6 (MDDGA6) [MIM:613154]	A0A1V4KER1	495	W	R
O95461	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A6 (MDDGA6) [MIM:613154]	A0A1V4KER1	443	C	Y
Q8N3Y3	LB/B	-	A0A1S2ZGY7	677	R	C
Q8N3Y3	LB/B	-	A0A1S2ZGY7	37	E	K
Q8N3Y3	LB/B	-	A0A1S2ZGY7	546	R	W
Q659C4	LB/B	-	K7G252	462	P	R
Q659C4	LB/B	-	K7G252	660	R	H
Q9P2J5	LB/B	-	A0A151M6T5	1088	R	K
Q9P2J5	LB/B	-	A0A151M6T5	82	K	R
Q9P2J5	LP/P	Infantile liver failure syndrome 1 (ILFS1) [MIM:615438]	A0A151M6T5	373	Y	C
Q15031	LB/B	-	B4KXC0	727	K	N
Q15031	LB/B	-	B4KXC0	831	E	D
Q15031	LP/P	Hydrops, lactic acidosis, and sideroblastic anemia (HLASA) [MIM:617021]	B4KXC0	522	T	N
Q15031	LP/P	Perrault syndrome 4 (PRLTS4) [MIM:615300]	B4KXC0	522	T	N
Q15031	LP/P	Hydrops, lactic acidosis, and sideroblastic anemia (HLASA) [MIM:617021]	B4KXC0	430	A	V
O95835	LB/B	-	L9LCK0	96	R	W
O95835	LB/B	-	L9LCK0	204	S	G
O95835	LB/B	-	L9LCK0	237	P	Q
O95835	LB/B	-	L9LCK0	370	R	W
O95835	LB/B	-	L9LCK0	531	P	S
O95835	LB/B	-	L9LCK0	641	F	L
O95835	LB/B	-	L9LCK0	1000	G	S
Q9NRM7	LB/B	-	F6YGK3	324	A	V
Q9NRM7	LB/B	-	F6YGK3	91	S	L
Q9NRM7	LB/B	-	F6YGK3	799	I	V
Q9NRM7	LB/B	-	F6YGK3	1014	A	G
Q9NRM7	LB/B	-	F6YGK3	1025	L	P
Q9NRM7	LB/B	-	F6YGK3	363	G	S
Q6UX15	LB/B	-	H0W8N1	66	E	K
P18428	LB/B	-	H2P1W4	9	P	L
P18428	LB/B	-	H2P1W4	125	L	I
P18428	LB/B	-	H2P1W4	166	V	M
P18428	LB/B	-	H2P1W4	242	M	I
P18428	LB/B	-	H2P1W4	283	D	G
P18428	LB/B	-	H2P1W4	294	H	R
P18428	LB/B	-	H2P1W4	333	P	L
P18428	LB/B	-	H2P1W4	339	L	F
P18428	LB/B	-	H2P1W4	436	F	L
P18428	LB/B	-	H2P1W4	445	A	T
P18428	LB/B	-	H2P1W4	111	R	Q
P18428	LB/B	-	H2P1W4	147	E	K
P18428	LB/B	-	H2P1W4	364	I	T
P18428	LB/B	-	H2P1W4	157	S	C
Q6XYB7	LB/B	-	D4A7L0	158	S	F
O95447	LB/B	-	G7P0Z6	17	G	S
O95447	LB/B	-	G7P0Z6	547	G	S
P04180	LP/P	Fish-eye disease (FED) [MIM:136120]	S9YJ86	34	P	L
P04180	LP/P	Lecithin-cholesterol acyltransferase deficiency (LCATD) [MIM:245900]	S9YJ86	54	G	S
P04180	LP/P	Lecithin-cholesterol acyltransferase deficiency (LCATD) [MIM:245900]	S9YJ86	57	G	R
P04180	LP/P	Lecithin-cholesterol acyltransferase deficiency (LCATD) [MIM:245900]	S9YJ86	117	A	T
P04180	LP/P	Fish-eye disease (FED) [MIM:136120]	S9YJ86	147	T	I
P04180	LP/P	Lecithin-cholesterol acyltransferase deficiency (LCATD) [MIM:245900]	S9YJ86	159	R	W
P04180	LP/P	Lecithin-cholesterol acyltransferase deficiency (LCATD) [MIM:245900]	S9YJ86	164	R	H
P04180	LP/P	Lecithin-cholesterol acyltransferase deficiency (LCATD) [MIM:245900]	S9YJ86	171	R	W
P04180	LP/P	Lecithin-cholesterol acyltransferase deficiency (LCATD) [MIM:245900]	S9YJ86	180	Y	N
P04180	LB/B	-	S9YJ86	182	R	C
P04180	LP/P	Lecithin-cholesterol acyltransferase deficiency (LCATD) [MIM:245900]	S9YJ86	233	L	P
P04180	LP/P	Lecithin-cholesterol acyltransferase deficiency (LCATD) [MIM:245900]	S9YJ86	252	N	K
P04180	LP/P	Fish-eye disease (FED) [MIM:136120]	S9YJ86	276	M	K
P04180	LP/P	Lecithin-cholesterol acyltransferase deficiency (LCATD) [MIM:245900]	S9YJ86	317	M	I
P04180	LP/P	Lecithin-cholesterol acyltransferase deficiency (LCATD) [MIM:245900]	S9YJ86	345	T	M
P04180	LP/P	Fish-eye disease (FED) [MIM:136120]	S9YJ86	371	T	M
P04180	LB/B	-	S9YJ86	232	S	T
P04180	LP/P	Lecithin-cholesterol acyltransferase deficiency (LCATD) [MIM:245900]	S9YJ86	29	N	I
P04180	LP/P	Fish-eye disease (FED) [MIM:136120]	S9YJ86	34	P	Q
P04180	LP/P	Lecithin-cholesterol acyltransferase deficiency (LCATD) [MIM:245900]	S9YJ86	37	T	M
P04180	LP/P	Fish-eye disease (FED) [MIM:136120]	S9YJ86	70	V	E
P04180	LB/B	-	S9YJ86	115	S	P
P04180	LP/P	Fish-eye disease (FED) [MIM:136120]	S9YJ86	123	R	C
P04180	LP/P	Fish-eye disease (FED) [MIM:136120]	S9YJ86	159	R	Q
P04180	LP/P	Lecithin-cholesterol acyltransferase deficiency (LCATD) [MIM:245900]	S9YJ86	164	R	C
P04180	LB/B	-	S9YJ86	165	A	T
P04180	LP/P	Lecithin-cholesterol acyltransferase deficiency (LCATD) [MIM:245900]	S9YJ86	205	S	N
P04180	LP/P	Lecithin-cholesterol acyltransferase deficiency (LCATD) [MIM:245900]	S9YJ86	242	K	N
P04180	LP/P	Lecithin-cholesterol acyltransferase deficiency (LCATD) [MIM:245900]	S9YJ86	268	R	H
P04180	LP/P	Fish-eye disease (FED) [MIM:136120]	S9YJ86	298	T	A
P04180	LP/P	Lecithin-cholesterol acyltransferase deficiency (LCATD) [MIM:245900]	S9YJ86	298	T	A
P04180	LP/P	Lecithin-cholesterol acyltransferase deficiency (LCATD) [MIM:245900]	S9YJ86	298	T	I
P04180	LP/P	Lecithin-cholesterol acyltransferase deficiency (LCATD) [MIM:245900]	S9YJ86	331	P	S
P04180	LP/P	Lecithin-cholesterol acyltransferase deficiency (LCATD) [MIM:245900]	S9YJ86	333	V	M
P04180	LP/P	Lecithin-cholesterol acyltransferase deficiency (LCATD) [MIM:245900]	S9YJ86	406	F	V
P04180	LP/P	Fish-eye disease (FED) [MIM:136120]	S9YJ86	99	W	S
P04180	LB/B	-	S9YJ86	268	R	C
P04180	LB/B	-	S9YJ86	322	R	C
P04180	LP/P	Fish-eye disease (FED) [MIM:136120]	S9YJ86	338	L	F
P04180	LP/P	Fish-eye disease (FED) [MIM:136120]	S9YJ86	347	R	C
Q5T751	LB/B	-	A0A0D9SAR5	16	C	Y
Q5T752	LB/B	-	A0A0D9SAR5	59	N	S
Q5T752	LB/B	-	A0A0D9SAR5	78	R	H
Q5T753	LB/B	-	A0A0D9SAR5	59	S	G
Q5T753	LB/B	-	A0A0D9SAR5	111	G	S
Q5TA79	LB/B	-	A0A0D9SAR5	20	C	Y
O14633	LB/B	-	A0A0D9SAR5	51	I	S
O14633	LB/B	-	A0A0D9SAR5	83	R	Q
Q5TA82	LB/B	-	A0A0D9SAR5	92	C	Y
Q5TA76	LB/B	-	A0A0D9SAR5	59	R	C
Q9BYE3	LB/B	-	A0A0D9SAR5	43	G	V
Q9BYE3	LB/B	-	A0A0D9SAR5	81	G	V
Q5TA78	LB/B	-	A0A0D9SAR5	95	G	V
Q5TCM9	LB/B	-	A0A0D9SAR5	40	C	Y
Q6UWP7	LB/B	-	W5KMZ8	290	I	V
O60294	LB/B	-	A0A091HPV1	141	R	S
O60294	LB/B	-	A0A091HPV1	67	V	L
O60294	LB/B	-	A0A091HPV1	149	C	Y
O60294	LB/B	-	A0A091HPV1	518	T	A
Q6UWW0	LB/B	-	I3N1X2	152	S	A
Q6UWW0	LB/B	-	I3N1X2	164	K	E
Q6ZST4	LB/B	-	A0A2R9AKP6	68	A	T
P13796	LB/B	-	G3H8N1	24	D	E
P13796	LB/B	-	G3H8N1	533	K	E
P13796	LB/B	-	G3H8N1	544	P	A
Q13094	LB/B	-	G3QCK7	410	S	C
Q6UWM7	LB/B	-	A0A212CUQ9	240	A	T
Q6UWM7	LB/B	-	A0A212CUQ9	212	T	M
Q96B96	LB/B	-	A0A286XEA8	107	G	S
Q96B96	LB/B	-	A0A286XEA8	154	E	D
Q96B96	LB/B	-	A0A286XEA8	97	F	L
O75112	LB/B	-	H2UCF1	55	V	I
O75112	LP/P	Cardiomyopathy, dilated 1C, with or without left ventricular non-compaction (CMD1C) [MIM:601493]	H2UCF1	189	S	L
O75112	LP/P	Cardiomyopathy, dilated 1C, with or without left ventricular non-compaction (CMD1C) [MIM:601493]	H2UCF1	206	T	I
O75112	LP/P	Cardiomyopathy, dilated 1C, with or without left ventricular non-compaction (CMD1C) [MIM:601493]	H2UCF1	345	I	M
O75112	LB/B	-	H2UCF1	635	V	I
O75112	LP/P	Cardiomyopathy, dilated 1C, with or without left ventricular non-compaction (CMD1C) [MIM:601493]	H2UCF1	673	D	N
O75112	LB/B	-	H2UCF1	101	P	L
Q86WU2	LB/B	-	A0A2I3HIC1	233	R	K
Q86WU2	LP/P	D-lactic aciduria with gout (DLACD) [MIM:245450]	A0A2I3HIC1	374	W	C
Q86WU2	LP/P	D-lactic aciduria with gout (DLACD) [MIM:245450]	A0A2I3HIC1	463	T	M
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	27	C	W
P01130	LB/B	-	A0A2J8S0N9	52	C	Y
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	78	R	C
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	87	W	G
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	89	C	Y
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	90	D	G
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	90	D	N
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	90	D	Y
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	92	Q	E
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	95	C	G
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	101	E	K
P01130	LB/B	-	A0A2J8S0N9	109	C	R
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	116	C	R
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	140	E	K
P01130	LB/B	-	A0A2J8S0N9	155	C	G
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	168	D	H
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	168	D	N
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	168	D	Y
P01130	LB/B	-	A0A2J8S0N9	173	C	R
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	173	C	W
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	175	D	N
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	177	S	L
P01130	LB/B	-	A0A2J8S0N9	197	C	F
P01130	LB/B	-	A0A2J8S0N9	197	C	Y
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	197	C	R
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	221	D	G
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	221	D	Y
P01130	LB/B	-	A0A2J8S0N9	224	D	N
P01130	LB/B	-	A0A2J8S0N9	224	D	G
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	224	D	V
P01130	LB/B	-	A0A2J8S0N9	226	S	P
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	227	D	E
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	228	E	Q
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	228	E	K
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	231	C	G
P01130	LB/B	-	A0A2J8S0N9	240	E	K
P01130	LB/B	-	A0A2J8S0N9	248	C	F
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	248	C	Y
P01130	LB/B	-	A0A2J8S0N9	256	D	G
P01130	LB/B	-	A0A2J8S0N9	270	C	Y
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	276	C	Y
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	301	D	A
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	302	C	Y
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	302	C	W
P01130	LB/B	-	A0A2J8S0N9	304	D	N
P01130	LB/B	-	A0A2J8S0N9	304	D	E
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	313	C	Y
P01130	LB/B	-	A0A2J8S0N9	318	C	Y
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	318	C	F
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	327	H	Y
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	329	C	Y
P01130	LB/B	-	A0A2J8S0N9	335	G	S
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	338	C	S
P01130	LB/B	-	A0A2J8S0N9	342	D	E
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	350	R	P
P01130	LB/B	-	A0A2J8S0N9	352	C	Y
P01130	LB/B	-	A0A2J8S0N9	354	D	G
P01130	LB/B	-	A0A2J8S0N9	354	D	V
P01130	LB/B	-	A0A2J8S0N9	357	E	K
P01130	LB/B	-	A0A2J8S0N9	364	C	R
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	368	C	R
P01130	LB/B	-	A0A2J8S0N9	379	C	R
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	399	A	D
P01130	LB/B	-	A0A2J8S0N9	401	L	H
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	414	L	R
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	416	R	Q
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	416	R	W
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	423	I	T
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	429	V	M
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	433	D	H
P01130	LB/B	-	A0A2J8S0N9	441	I	N
P01130	LB/B	-	A0A2J8S0N9	441	I	M
P01130	LB/B	-	A0A2J8S0N9	443	W	C
P01130	LB/B	-	A0A2J8S0N9	478	G	R
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	482	D	H
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	483	W	R
P01130	LB/B	-	A0A2J8S0N9	485	H	R
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	523	V	M
P01130	LB/B	-	A0A2J8S0N9	546	G	D
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	549	G	D
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	564	N	H
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	564	N	S
P01130	LB/B	-	A0A2J8S0N9	565	G	V
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	579	D	N
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	592	G	E
P01130	LB/B	-	A0A2J8S0N9	599	L	S
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	633	R	C
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	649	P	L
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	667	C	Y
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	677	C	R
P01130	LB/B	-	A0A2J8S0N9	682	L	P
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	685	P	L
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	700	D	E
P01130	LB/B	-	A0A2J8S0N9	792	I	F
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	797	V	M
P01130	LB/B	-	A0A2J8S0N9	827	V	I
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	828	Y	C
P01130	LB/B	-	A0A2J8S0N9	844	G	D
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	50	A	S
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	56	S	P
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	175	D	Y
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	221	D	N
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	288	E	K
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	356	D	Y
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	366	Q	R
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	379	C	Y
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	401	L	V
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	432	L	V
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	608	P	S
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	403	F	L
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	568	L	V
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	714	E	K
P01130	LB/B	-	A0A2J8S0N9	2	G	R
P01130	LB/B	-	A0A2J8S0N9	468	V	I
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	46	C	S
P01130	LB/B	-	A0A2J8S0N9	172	D	H
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	184	C	Y
P01130	LB/B	-	A0A2J8S0N9	253	R	W
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	261	C	F
P01130	LB/B	-	A0A2J8S0N9	406	R	Q
P01130	LB/B	-	A0A2J8S0N9	391	A	T
P01130	LB/B	-	A0A2J8S0N9	105	P	S
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	134	C	F
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	134	C	W
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	222	C	Y
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	254	Q	P
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	276	C	R
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	318	C	R
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	358	C	Y
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	370	N	T
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	415	D	G
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	451	I	T
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	479	L	P
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	579	D	Y
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	826	P	S
P01130	LB/B	-	A0A2J8S0N9	139	D	H
P01130	LB/B	-	A0A2J8S0N9	201	E	K
P01130	LB/B	-	A0A2J8S0N9	255	C	S
P01130	LB/B	-	A0A2J8S0N9	471	R	G
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	329	C	F
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	143	C	R
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	148	C	Y
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	155	C	Y
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	172	D	N
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	184	C	W
P01130	LB/B	-	A0A2J8S0N9	257	R	W
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	300	R	G
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	301	D	G
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	454	T	N
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	574	R	C
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	577	W	G
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	639	V	D
P01130	LB/B	-	A0A2J8S0N9	742	T	I
P01130	LP/P	Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890]	A0A2J8S0N9	825	N	K
Q5SZI1	LB/B	-	M3YX84	134	N	T
Q5SW96	LP/P	Hypercholesterolemia, familial, 4 (FHCL4) [MIM:603813]	F6QKE5	202	S	H
Q5SW96	LB/B	-	F6QKE5	202	S	P
Q5SW96	LP/P	-	F6QKE5	56	T	M
O14960	LB/B	-	B0FFI8	58	I	V
O75610	LB/B	-	A0A093NAS7	322	D	A
O75610	LB/B	-	A0A093NAS7	57	V	M
O75610	LB/B	-	A0A093NAS7	92	L	S
O75610	LB/B	-	A0A093NAS7	142	R	Q
O00292	LP/P	Left-right axis malformations (LRAM) [MIM:601877]	A0A093NAS7	342	S	N
O00292	LB/B	-	A0A093NAS7	92	S	L
O00292	LB/B	-	A0A093NAS7	286	P	L
Q6P5S2	LB/B	-	A0A2Y9FUD8	308	C	G
Q9Y2U8	LB/B	-	W5NYJ7	260	D	Y
Q96BZ8	LB/B	-	A0A1S3J6J0	97	K	E
Q96PV6	LB/B	-	F6QQ05	279	R	P
Q96PV6	LB/B	-	F6QQ05	557	I	V
P41159	LB/B	-	M7BYR5	94	V	M
P41159	LP/P	Leptin deficiency (LEPD) [MIM:614962]	M7BYR5	105	R	W
P41159	LB/B	-	M7BYR5	110	V	M
P41159	LP/P	Leptin deficiency (LEPD) [MIM:614962]	M7BYR5	100	D	Y
P48357	LB/B	-	M7B9Z4	109	K	R
P48357	LB/B	-	M7B9Z4	204	K	R
P48357	LB/B	-	M7B9Z4	223	Q	R
P48357	LB/B	-	M7B9Z4	656	K	N
P48357	LB/B	-	M7B9Z4	675	S	T
P48357	LB/B	-	M7B9Z4	503	I	V
P48357	LB/B	-	M7B9Z4	124	D	G
P48357	LB/B	-	M7B9Z4	699	T	M
O95202	LP/P	Neurodegeneration, childhood-onset, with multisystem involvement due to mitochondrial dysfunction (CONDMIM) [MIM:620089]	A0A2K5F352	293	I	N
O95202	LP/P	Neurodegeneration, childhood-onset, with multisystem involvement due to mitochondrial dysfunction (CONDMIM) [MIM:620089]	A0A2K5F352	294	R	Q
O95202	LP/P	Neurodegeneration, childhood-onset, with multisystem involvement due to mitochondrial dysfunction (CONDMIM) [MIM:620089]	A0A2K5F352	300	P	S
O95202	LP/P	Neurodegeneration, childhood-onset, with multisystem involvement due to mitochondrial dysfunction (CONDMIM) [MIM:620089]	A0A2K5F352	358	D	N
O95202	LB/B	-	A0A2K5F352	587	K	R
Q6P1Q0	LB/B	-	B0K026	84	V	I
Q3ZCV2	LB/B	-	A0A2Y9QMX3	126	G	C
Q3ZCV2	LB/B	-	A0A2Y9QMX3	205	H	Y
P17931	LB/B	-	H9GN28	64	P	H
P17931	LB/B	-	H9GN28	98	T	P
P17931	LB/B	-	H9GN28	183	R	K
P56470	LB/B	-	C3Y0M7	16	T	M
O00214	LB/B	-	V8P692	36	R	C
O00214	LB/B	-	V8P692	19	F	Y
O00214	LB/B	-	V8P692	56	M	V
O00214	LB/B	-	V8P692	184	R	S
O95970	LP/P	Epilepsy, familial temporal lobe, 1 (ETL1) [MIM:600512]	A0A1U8CCW5	26	L	R
O95970	LP/P	Epilepsy, familial temporal lobe, 1 (ETL1) [MIM:600512]	A0A1U8CCW5	46	C	R
O95970	LP/P	Epilepsy, familial temporal lobe, 1 (ETL1) [MIM:600512]	A0A1U8CCW5	383	E	A
O95970	LP/P	Epilepsy, familial temporal lobe, 1 (ETL1) [MIM:600512]	A0A1U8CCW5	318	F	C
O95970	LP/P	Epilepsy, familial temporal lobe, 1 (ETL1) [MIM:600512]	A0A1U8CCW5	42	C	G
O95970	LP/P	Epilepsy, familial temporal lobe, 1 (ETL1) [MIM:600512]	A0A1U8CCW5	473	S	L
O95970	LP/P	Epilepsy, familial temporal lobe, 1 (ETL1) [MIM:600512]	A0A1U8CCW5	42	C	R
O95970	LP/P	Epilepsy, familial temporal lobe, 1 (ETL1) [MIM:600512]	A0A1U8CCW5	110	A	D
O95970	LP/P	Epilepsy, familial temporal lobe, 1 (ETL1) [MIM:600512]	A0A1U8CCW5	122	I	K
O95970	LP/P	Epilepsy, familial temporal lobe, 1 (ETL1) [MIM:600512]	A0A1U8CCW5	123	E	K
O95970	LP/P	Epilepsy, familial temporal lobe, 1 (ETL1) [MIM:600512]	A0A1U8CCW5	136	R	W
O95970	LP/P	Epilepsy, familial temporal lobe, 1 (ETL1) [MIM:600512]	A0A1U8CCW5	145	S	R
O95970	LP/P	Epilepsy, familial temporal lobe, 1 (ETL1) [MIM:600512]	A0A1U8CCW5	154	L	P
O95970	LP/P	Epilepsy, familial temporal lobe, 1 (ETL1) [MIM:600512]	A0A1U8CCW5	200	C	R
O95970	LP/P	Epilepsy, familial temporal lobe, 1 (ETL1) [MIM:600512]	A0A1U8CCW5	232	L	P
O95970	LP/P	Epilepsy, familial temporal lobe, 1 (ETL1) [MIM:600512]	A0A1U8CCW5	298	I	T
O95970	LP/P	Epilepsy, familial temporal lobe, 1 (ETL1) [MIM:600512]	A0A1U8CCW5	432	V	E
Q8N0V4	LB/B	-	A0A1U8CCW5	444	R	Q
Q8N0V4	LB/B	-	A0A1U8CCW5	452	Q	R
Q8N145	LB/B	-	A0A146WQT0	524	A	T
Q8N145	LP/P	Intellectual developmental disorder with muscle tone abnormalities and distal skeletal defects (IDDMDS) [MIM:620007]	A0A146WQT0	141	L	H
Q8N145	LP/P	Intellectual developmental disorder with muscle tone abnormalities and distal skeletal defects (IDDMDS) [MIM:620007]	A0A146WQT0	331	D	N
Q8N135	LP/P	Arthrogryposis multiplex congenita 1, neurogenic, with myelin defect (AMC1) [MIM:617468]	A0A1U8CCW5	258	R	P
Q8N135	LP/P	Arthrogryposis multiplex congenita 1, neurogenic, with myelin defect (AMC1) [MIM:617468]	A0A1U8CCW5	434	V	D
Q99538	LB/B	-	A0A2J8TLU8	18	V	I
O75473	LB/B	-	A0A2Y9G3T2	383	H	R
O75473	LB/B	-	A0A2Y9G3T2	666	V	A
Q9HBX8	LB/B	-	A0A2Y9G3T2	516	A	S
Q9HBX8	LB/B	-	A0A2Y9G3T2	267	N	K
Q9HBX8	LB/B	-	A0A2Y9G3T2	592	V	A
P22888	LB/B	-	G3H5R6	284	N	S
P22888	LB/B	-	G3H5R6	306	S	N
P22888	LP/P	Luteinizing hormone resistance (LHR) [MIM:238320]	G3H5R6	354	E	K
P22888	LP/P	Familial male precocious puberty (FMPP) [MIM:176410]	G3H5R6	373	A	V
P22888	LP/P	Familial male precocious puberty (FMPP) [MIM:176410]	G3H5R6	398	M	T
P22888	LP/P	Familial male precocious puberty (FMPP) [MIM:176410]	G3H5R6	568	A	V
P22888	LP/P	Familial male precocious puberty (FMPP) [MIM:176410]	G3H5R6	571	M	I
P22888	LP/P	Familial male precocious puberty (FMPP) [MIM:176410]	G3H5R6	572	A	V
P22888	LP/P	Familial male precocious puberty (FMPP) [MIM:176410]	G3H5R6	577	T	I
P22888	LP/P	Familial male precocious puberty (FMPP) [MIM:176410]	G3H5R6	578	D	G
P22888	LP/P	Luteinizing hormone resistance (LHR) [MIM:238320]	G3H5R6	593	A	P
P22888	LP/P	Luteinizing hormone resistance (LHR) [MIM:238320]	G3H5R6	616	S	Y
P22888	LP/P	Luteinizing hormone resistance (LHR) [MIM:238320]	G3H5R6	625	I	K
P22888	LP/P	Luteinizing hormone resistance (LHR) [MIM:238320]	G3H5R6	131	C	R
P22888	LP/P	Luteinizing hormone resistance (LHR) [MIM:238320]	G3H5R6	343	C	S
P22888	LP/P	Familial male precocious puberty (FMPP) [MIM:176410]	G3H5R6	457	L	R
P22888	LP/P	Familial male precocious puberty (FMPP) [MIM:176410]	G3H5R6	542	I	L
P22888	LP/P	Luteinizing hormone resistance (LHR) [MIM:238320]	G3H5R6	543	C	R
P22888	LP/P	Familial male precocious puberty (FMPP) [MIM:176410]	G3H5R6	564	D	G
P22888	LP/P	Familial male precocious puberty (FMPP) [MIM:176410]	G3H5R6	575	I	L
P22888	LP/P	Familial male precocious puberty (FMPP) [MIM:176410]	G3H5R6	578	D	E
P22888	LP/P	Familial male precocious puberty (FMPP) [MIM:176410]	G3H5R6	578	D	Y
P22888	LP/P	Familial male precocious puberty (FMPP) [MIM:176410]	G3H5R6	581	C	R
P22888	LB/B	-	G3H5R6	291	N	S
P22888	LB/B	-	G3H5R6	312	N	S
P22888	LP/P	Luteinizing hormone resistance (LHR) [MIM:238320]	G3H5R6	144	V	F
P22888	LP/P	Luteinizing hormone resistance (LHR) [MIM:238320]	G3H5R6	152	I	T
P22888	LP/P	Familial male precocious puberty (FMPP) [MIM:176410]	G3H5R6	368	L	P
P22888	LP/P	Luteinizing hormone resistance (LHR) [MIM:238320]	G3H5R6	502	L	P
Q6ZUX7	LB/B	-	A0A1A8IPL7	102	I	V
Q9H008	LB/B	-	A0A2K6U5P6	94	Q	R
Q9UBR4	LP/P	Pituitary hormone deficiency, combined, 3 (CPHD3) [MIM:221750]	A0A2K6FRA8	111	Y	C
Q9UBR4	LP/P	Pituitary hormone deficiency, combined, 3 (CPHD3) [MIM:221750]	A0A2K6FRA8	210	A	V
Q969G2	LB/B	-	A0A0K1LYQ0	328	N	S
Q969G2	LP/P	Pituitary hormone deficiency, combined, 4 (CPHD4) [MIM:262700]	A0A0K1LYQ0	84	R	C
Q969G2	LP/P	Pituitary hormone deficiency, combined, 4 (CPHD4) [MIM:262700]	A0A0K1LYQ0	190	L	R
Q969G2	LP/P	Pituitary hormone deficiency, combined, 4 (CPHD4) [MIM:262700]	A0A0K1LYQ0	210	A	P
Q969G2	LP/P	Pituitary hormone deficiency, combined, 4 (CPHD4) [MIM:262700]	A0A0K1LYQ0	389	P	T
O43766	LP/P	Hyperglycinemia, lactic acidosis, and seizures (HGCLAS) [MIM:614462]	A7S733	249	R	H
Q6ZQX7	LB/B	-	A0A2R9A3F6	56	E	K
Q6ZQX7	LB/B	-	A0A2R9A3F6	220	D	E
P42702	LB/B	-	A0A099ZDF8	633	I	M
P42702	LP/P	Stuve-Wiedemann syndrome 1 (STWS1) [MIM:601559]	A0A099ZDF8	279	S	P
P42702	LB/B	-	A0A099ZDF8	116	H	Y
P42702	LB/B	-	A0A099ZDF8	578	D	N
P42702	LB/B	-	A0A099ZDF8	785	V	I
P42702	LB/B	-	A0A099ZDF8	664	S	L
P18858	LP/P	Immunodeficiency 96 (IMD96) [MIM:619774]	M3W7P3	566	E	K
P18858	LP/P	Immunodeficiency 96 (IMD96) [MIM:619774]	M3W7P3	771	R	W
P18858	LB/B	-	M3W7P3	249	G	E
P18858	LB/B	-	M3W7P3	267	N	S
P18858	LB/B	-	M3W7P3	409	R	H
P18858	LB/B	-	M3W7P3	480	M	V
P18858	LB/B	-	M3W7P3	614	T	I
P18858	LB/B	-	M3W7P3	24	A	V
P18858	LB/B	-	M3W7P3	62	R	W
P18858	LB/B	-	M3W7P3	349	V	M
P18858	LB/B	-	M3W7P3	369	V	I
P18858	LB/B	-	M3W7P3	677	R	L
P18858	LB/B	-	M3W7P3	52	P	L
P18858	LB/B	-	M3W7P3	72	D	G
P18858	LB/B	-	M3W7P3	529	P	L
P18858	LP/P	Immunodeficiency 96 (IMD96) [MIM:619774]	M3W7P3	641	R	L
P18858	LB/B	-	M3W7P3	753	V	M
P49916	LB/B	-	A0A2Y9I6E8	867	R	H
P49916	LB/B	-	A0A2Y9I6E8	224	R	W
P49916	LB/B	-	A0A2Y9I6E8	986	P	S
P49916	LB/B	-	A0A2Y9I6E8	898	K	T
P49916	LB/B	-	A0A2Y9I6E8	768	Y	H
P49916	LP/P	Mitochondrial DNA depletion syndrome 20, MNGIE type (MTDPS20) [MIM:619780]	A0A2Y9I6E8	537	K	N
P49916	LP/P	Mitochondrial DNA depletion syndrome 20, MNGIE type (MTDPS20) [MIM:619780]	A0A2Y9I6E8	609	P	L
P49916	LP/P	Mitochondrial DNA depletion syndrome 20, MNGIE type (MTDPS20) [MIM:619780]	A0A2Y9I6E8	964	G	R
P49916	LP/P	Mitochondrial DNA depletion syndrome 20, MNGIE type (MTDPS20) [MIM:619780]	A0A2Y9I6E8	999	C	Y
P49917	LP/P	LIG4 syndrome (LIG4S) [MIM:606593]	A0A1B6DNN2	278	R	H
P49917	LP/P	LIG4 syndrome (LIG4S) [MIM:606593]	A0A1B6DNN2	469	G	E
P49917	LB/B	-	A0A1B6DNN2	539	L	F
P49917	LB/B	-	A0A1B6DNN2	658	I	V
P49917	LB/B	-	A0A1B6DNN2	857	A	T
P49917	LB/B	-	A0A1B6DNN2	231	P	S
P49917	LB/B	-	A0A1B6DNN2	3	A	V
P49917	LB/B	-	A0A1B6DNN2	62	D	H
P49917	LB/B	-	A0A1B6DNN2	9	T	I
P49917	LB/B	-	A0A1B6DNN2	461	E	G
O75019	LB/B	-	A0A0A0MTY4	153	S	G
O75019	LB/B	-	A0A0A0MTY4	220	L	P
O75019	LB/B	-	A0A0A0MTY4	12	R	G
Q8N149	LB/B	-	A0A0A0MTY4	25	H	L
Q8N149	LB/B	-	A0A0A0MTY4	25	H	N
Q8N149	LB/B	-	A0A0A0MTY4	331	V	G
Q8N149	LB/B	-	A0A0A0MTY4	361	G	A
Q8N149	LB/B	-	A0A0A0MTY4	381	R	C
Q8N6C8	LB/B	-	A0A0A0MTY4	3	P	S
Q8N6C8	LB/B	-	A0A0A0MTY4	107	L	R
Q8N6C8	LB/B	-	A0A0A0MTY4	301	Y	H
P59901	LB/B	-	A0A0A0MTY4	27	L	P
P59901	LB/B	-	A0A0A0MTY4	155	I	V
Q8NHJ6	LB/B	-	A0A2K5HYQ0	223	D	G
Q8NHJ6	LB/B	-	A0A2K5HYQ0	362	K	E
Q8NHJ6	LB/B	-	A0A2K5HYQ0	5	F	L
Q8NHJ6	LB/B	-	A0A2K5HYQ0	18	R	S
Q8NHJ6	LB/B	-	A0A2K5HYQ0	330	C	Y
Q8NHJ6	LB/B	-	A0A2K5HYQ0	335	N	D
Q8NHJ6	LB/B	-	A0A2K5HYQ0	414	Q	R
Q8NHJ6	LB/B	-	A0A2K5HYQ0	362	K	T
Q8NHJ6	LB/B	-	A0A2K5HYQ0	20	H	D
Q9UPQ0	LB/B	-	I3IYP0	759	M	T
Q9H400	LB/B	-	A0A2Y9G2G5	211	P	L
P53667	LB/B	-	F7B2P9	190	G	A
P53667	LB/B	-	F7B2P9	247	S	N
P53667	LB/B	-	F7B2P9	422	R	Q
P53667	LB/B	-	F7B2P9	580	F	Y
P53671	LB/B	-	M7BQ30	35	G	S
P53671	LB/B	-	M7BQ30	45	D	N
P53671	LB/B	-	M7BQ30	213	R	C
P53671	LB/B	-	M7BQ30	296	P	R
P53671	LB/B	-	M7BQ30	418	R	C
P53671	LB/B	-	M7BQ30	381	R	H
Q3SY05	LB/B	-	Q3SY05	98	V	A
Q6ZN03	LB/B	-	Q6ZN03	116	L	F
Q6ZN03	LB/B	-	Q6ZN03	149	A	T
Q6ZUF6	LB/B	-	Q6ZUF6	13	S	R
Q6ZUF6	LB/B	-	Q6ZUF6	73	L	P
Q6ZUF6	LB/B	-	Q6ZUF6	84	P	S
Q8N8I6	LB/B	-	H2NV11	50	V	L
Q8N8I6	LB/B	-	H2NV11	119	R	C
Q8N0U6	LB/B	-	G7P4D7	106	Y	C
Q86TU6	LB/B	-	Q86TU6	21	E	D
Q52M75	LB/B	-	H2PG49	85	R	C
Q8NAE3	LB/B	-	G7NTK1	96	F	V
Q5JQF7	LB/B	-	Q5JQF7	41	G	E
Q495D7	LB/B	-	Q495D7	38	P	L
Q495D7	LB/B	-	Q495D7	76	A	E
Q495D7	LB/B	-	Q495D7	84	I	V
Q99440	LB/B	-	A0A2K5EX52	15	N	K
Q96MT4	LB/B	-	H2PHR1	2	I	F
Q96MT4	LB/B	-	H2PHR1	43	P	S
Q86X59	LB/B	-	A0A2R8ZBK1	186	L	P
Q6ZV77	LB/B	-	Q6ZV77	168	K	E
Q8N8G6	LB/B	-	Q8N8G6	59	T	M
Q8N8G6	LB/B	-	Q8N8G6	77	E	K
Q8N319	LB/B	-	A0A2K6U2B6	48	K	E
Q8N319	LB/B	-	A0A2K6U2B6	107	V	M
Q6ZUL3	LB/B	-	H2PQ39	81	R	H
Q96FE5	LB/B	-	H0V7K5	183	S	F
Q96FE5	LP/P	Intellectual developmental disorder, autosomal recessive 64 (MRT64) [MIM:618103]	H0V7K5	288	Y	C
Q96FE5	LP/P	Intellectual developmental disorder, autosomal recessive 64 (MRT64) [MIM:618103]	H0V7K5	290	R	H
Q7L985	LB/B	-	H0V7K5	507	R	H
P0C6S8	LB/B	-	H0V7K5	426	R	H
Q8NG48	LB/B	-	S7N104	29	I	V
Q8NG48	LB/B	-	S7N104	331	A	V
Q8NG48	LB/B	-	S7N104	406	V	M
Q8NG48	LB/B	-	S7N104	472	S	T
Q8NG48	LB/B	-	S7N104	541	I	V
Q8NG48	LB/B	-	S7N104	641	E	D
Q8NG48	LB/B	-	S7N104	680	R	S
P38571	LB/B	-	L8IIS2	16	T	P
P38571	LP/P	Cholesteryl ester storage disease (CESD) [MIM:278000]	L8IIS2	129	H	P
P38571	LP/P	Cholesteryl ester storage disease (CESD) [MIM:278000]	L8IIS2	129	H	R
P38571	LP/P	Cholesteryl ester storage disease (CESD) [MIM:278000]	L8IIS2	200	L	P
P38571	LP/P	Wolman disease (WOD) [MIM:278000]	L8IIS2	200	L	P
P38571	LB/B	-	L8IIS2	23	G	R
P38571	LB/B	-	L8IIS2	29	V	L
P38571	LB/B	-	L8IIS2	228	F	S
P11150	LB/B	-	U3IMP7	95	V	M
P11150	LB/B	-	U3IMP7	215	N	S
P11150	LP/P	Hepatic lipase deficiency (HL deficiency) [MIM:614025]	U3IMP7	289	S	F
P11150	LP/P	Hepatic lipase deficiency (HL deficiency) [MIM:614025]	U3IMP7	405	T	M
P11150	LB/B	-	U3IMP7	440	S	N
P11150	LB/B	-	U3IMP7	342	V	I
P11150	LB/B	-	U3IMP7	356	F	L
P11150	LB/B	-	U3IMP7	409	D	A
P07098	LB/B	-	L8IIS2	161	T	A
P07098	LB/B	-	L8IIS2	224	F	I
P07098	LB/B	-	L8IIS2	348	P	T
Q9Y5X9	LB/B	-	A0A1S2Z9N2	96	G	S
Q9Y5X9	LB/B	-	A0A1S2Z9N2	111	T	I
Q9Y5X9	LB/B	-	A0A1S2Z9N2	312	R	H
Q9Y5X9	LB/B	-	A0A1S2Z9N2	26	G	S
Q8WWY8	LP/P	Hypotrichosis 7 (HYPT7) [MIM:604379]	A0A1V4J2X0	108	W	R
Q8WWY8	LP/P	Woolly hair autosomal recessive 2 (ARWH2) [MIM:604379]	A0A1V4J2X0	108	W	R
Q6XZB0	LB/B	-	A0A1V4J2X0	55	C	Y
Q6XZB0	LB/B	-	A0A1V4J2X0	364	G	E
Q6XZB0	LB/B	-	A0A1V4J2X0	431	E	K
Q6XZB0	LB/B	-	A0A1V4J2X0	444	D	E
Q5W064	LB/B	-	L8IIS2	210	I	V
Q5VXJ0	LB/B	-	L8IIS2	331	M	I
Q5VXJ0	LB/B	-	L8IIS2	391	I	T
Q5VYY2	LB/B	-	L8IIS2	418	R	W
Q5VYY2	LB/B	-	L8IIS2	274	L	S
Q5VXI9	LB/B	-	L8IIS2	244	T	N
A6NK58	LP/P	Encephalopathy, neonatal severe, with lactic acidosis and brain abnormalities (NELABA) [MIM:617668]	A0A2R8MAY2	30	L	P
A6NK58	LP/P	Encephalopathy, neonatal severe, with lactic acidosis and brain abnormalities (NELABA) [MIM:617668]	A0A2R8MAY2	105	L	R
A6NK58	LP/P	Encephalopathy, neonatal severe, with lactic acidosis and brain abnormalities (NELABA) [MIM:617668]	A0A2R8MAY2	126	L	R
Q99732	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1C (CMT1C) [MIM:601098]	A0A1S3ABF8	49	T	M
Q99732	LB/B	-	A0A1S3ABF8	92	I	V
Q99732	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1C (CMT1C) [MIM:601098]	A0A1S3ABF8	112	G	S
Q99732	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1C (CMT1C) [MIM:601098]	A0A1S3ABF8	115	T	N
Q99732	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1C (CMT1C) [MIM:601098]	A0A1S3ABF8	116	W	G
Q99732	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1C (CMT1C) [MIM:601098]	A0A1S3ABF8	122	L	V
Q8N485	LB/B	-	A0A2D0PL95	3	R	I
Q8TD35	LB/B	-	H2P2P2	9	G	W
Q8TD35	LB/B	-	H2P2P2	85	E	D
P49257	LB/B	-	K7FHL4	14	R	Q
P49257	LB/B	-	K7FHL4	39	V	A
P49257	LB/B	-	K7FHL4	410	M	L
P49257	LB/B	-	K7FHL4	355	I	T
P49257	LP/P	Factor V and factor VIII combined deficiency 1 (F5F8D1) [MIM:227300]	K7FHL4	67	W	S
Q9HAT1	LB/B	-	A0A2K5XGW0	105	R	Q
Q9HAT1	LB/B	-	A0A2K5XGW0	517	R	S
Q9H0V9	LP/P	Intellectual developmental disorder, autosomal recessive 52 (MRT52) [MIM:616887]	W4ZAR9	53	R	Q
Q8WVP7	LB/B	-	A0A1U7T718	228	T	A
Q68DH5	LP/P	Developmental delay with variable neurologic and brain abnormalities (DENBA) [MIM:619694]	A0A146Z480	123	W	R
Q68DH5	LP/P	Developmental delay with variable neurologic and brain abnormalities (DENBA) [MIM:619694]	A0A146Z480	483	R	H
Q96S06	LB/B	-	A0A1W4ZJJ4	203	S	P
Q96S06	LB/B	-	A0A1W4ZJJ4	562	P	R
Q96S06	LB/B	-	A0A1W4ZJJ4	164	V	A
Q96S06	LB/B	-	A0A1W4ZJJ4	364	R	Q
Q9BU23	LB/B	-	G3PHL5	479	T	M
Q96KR4	LB/B	-	A0A091DRK0	106	E	D
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	45	Y	C
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	50	R	P
P02545	LP/P	Muscular dystrophy congenital LMNA-related (MDCL) [MIM:613205]	A0A1U7SLJ6	50	R	P
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	63	I	S
P02545	LP/P	Cardiomyopathy, dilated 1A (CMD1A) [MIM:115200]	A0A1U7SLJ6	85	L	R
P02545	LP/P	Cardiomyopathy, dilated 1A (CMD1A) [MIM:115200]	A0A1U7SLJ6	195	N	K
P02545	LP/P	Cardiomyopathy, dilated 1A (CMD1A) [MIM:115200]	A0A1U7SLJ6	203	E	G
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	222	H	Y
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	249	R	Q
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	294	Q	P
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	336	R	Q
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	343	R	Q
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	358	E	K
P02545	LP/P	Muscular dystrophy congenital LMNA-related (MDCL) [MIM:613205]	A0A1U7SLJ6	358	E	K
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	371	M	K
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	386	R	K
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	453	R	W
P02545	LP/P	Lipodystrophy, familial partial, 2 (FPLD2) [MIM:151660]	A0A1U7SLJ6	465	G	D
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	469	I	T
P02545	LP/P	Lipodystrophy, familial partial, 2 (FPLD2) [MIM:151660]	A0A1U7SLJ6	482	R	L
P02545	LP/P	Lipodystrophy, familial partial, 2 (FPLD2) [MIM:151660]	A0A1U7SLJ6	482	R	Q
P02545	LP/P	Lipodystrophy, familial partial, 2 (FPLD2) [MIM:151660]	A0A1U7SLJ6	482	R	W
P02545	LP/P	Lipodystrophy, familial partial, 2 (FPLD2) [MIM:151660]	A0A1U7SLJ6	486	K	N
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	527	R	P
P02545	LP/P	Lipodystrophy, familial partial, 2 (FPLD2) [MIM:151660]	A0A1U7SLJ6	527	R	P
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	528	T	K
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	530	L	P
P02545	LP/P	Lipodystrophy, familial partial, 2 (FPLD2) [MIM:151660]	A0A1U7SLJ6	582	R	H
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	377	R	H
P02545	LP/P	Lipodystrophy, familial partial, 2 (FPLD2) [MIM:151660]	A0A1U7SLJ6	133	R	L
P02545	LP/P	Cardiomyopathy, dilated, with hypergonadotropic hypogonadism (CMDHH) [MIM:212112]	A0A1U7SLJ6	57	A	P
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	133	R	P
P02545	LP/P	Hutchinson-Gilford progeria syndrome (HGPS) [MIM:176670]	A0A1U7SLJ6	140	L	R
P02545	LP/P	Hutchinson-Gilford progeria syndrome (HGPS) [MIM:176670]	A0A1U7SLJ6	145	E	K
P02545	LP/P	Cardiomyopathy, dilated 1A (CMD1A) [MIM:115200]	A0A1U7SLJ6	161	E	K
P02545	LP/P	Charcot-Marie-Tooth disease, axonal, 2B1 (CMT2B1) [MIM:605588]	A0A1U7SLJ6	298	R	C
P02545	LP/P	Hutchinson-Gilford progeria syndrome (HGPS) [MIM:176670]	A0A1U7SLJ6	471	R	C
P02545	LP/P	Hutchinson-Gilford progeria syndrome (HGPS) [MIM:176670]	A0A1U7SLJ6	527	R	C
P02545	LP/P	Hutchinson-Gilford progeria syndrome (HGPS) [MIM:176670]	A0A1U7SLJ6	608	G	S
P02545	LP/P	Mandibuloacral dysplasia with type A lipodystrophy (MADA) [MIM:248370]	A0A1U7SLJ6	527	R	H
P02545	LP/P	Cardiomyopathy, dilated 1A (CMD1A) [MIM:115200]	A0A1U7SLJ6	60	R	G
P02545	LP/P	Lipodystrophy, familial partial, 2 (FPLD2) [MIM:151660]	A0A1U7SLJ6	60	R	G
P02545	LP/P	Hutchinson-Gilford progeria syndrome (HGPS) [MIM:176670]	A0A1U7SLJ6	143	S	F
P02545	LP/P	Mandibuloacral dysplasia with type A lipodystrophy (MADA) [MIM:248370]	A0A1U7SLJ6	529	A	V
P02545	LP/P	Hutchinson-Gilford progeria syndrome (HGPS) [MIM:176670]	A0A1U7SLJ6	542	K	N
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	25	R	G
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	25	R	P
P02545	LP/P	Lipodystrophy, familial partial, 2 (FPLD2) [MIM:151660]	A0A1U7SLJ6	28	R	W
P02545	LB/B	-	A0A1U7SLJ6	33	E	D
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	33	E	G
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	35	L	V
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	43	A	T
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	50	R	S
P02545	LP/P	Lipodystrophy, familial partial, 2 (FPLD2) [MIM:151660]	A0A1U7SLJ6	62	R	G
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	63	I	N
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	65	E	G
P02545	LP/P	Cardiomyopathy, dilated 1A (CMD1A) [MIM:115200]	A0A1U7SLJ6	89	R	L
P02545	LP/P	Cardiomyopathy, dilated 1A (CMD1A) [MIM:115200]	A0A1U7SLJ6	97	K	E
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	140	L	P
P02545	LP/P	Cardiomyopathy, dilated 1A (CMD1A) [MIM:115200]	A0A1U7SLJ6	143	S	P
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	150	T	P
P02545	LP/P	Cardiomyopathy, dilated 1A (CMD1A) [MIM:115200]	A0A1U7SLJ6	190	R	Q
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	190	R	Q
P02545	LP/P	Cardiomyopathy, dilated 1A (CMD1A) [MIM:115200]	A0A1U7SLJ6	190	R	W
P02545	LP/P	Cardiomyopathy, dilated 1A (CMD1A) [MIM:115200]	A0A1U7SLJ6	192	D	G
P02545	LP/P	Cardiomyopathy, dilated 1A (CMD1A) [MIM:115200]	A0A1U7SLJ6	203	E	K
P02545	LP/P	Cardiomyopathy, dilated 1A (CMD1A) [MIM:115200]	A0A1U7SLJ6	215	L	P
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	222	H	P
P02545	LP/P	Lipodystrophy, familial partial, 2 (FPLD2) [MIM:151660]	A0A1U7SLJ6	230	D	N
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	232	G	E
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	248	L	P
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	267	Y	C
P02545	LP/P	Cardiomyopathy, dilated 1A (CMD1A) [MIM:115200]	A0A1U7SLJ6	317	E	K
P02545	LP/P	Cardiomyopathy, dilated 1A (CMD1A) [MIM:115200]	A0A1U7SLJ6	349	R	L
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	377	R	L
P02545	LP/P	Cardiomyopathy, dilated 1A (CMD1A) [MIM:115200]	A0A1U7SLJ6	399	R	C
P02545	LP/P	Lipodystrophy, familial partial, 2 (FPLD2) [MIM:151660]	A0A1U7SLJ6	399	R	C
P02545	LP/P	Cardiomyopathy, dilated 1A (CMD1A) [MIM:115200]	A0A1U7SLJ6	435	R	C
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	446	D	V
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	456	N	I
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	456	N	K
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	481	Y	H
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	520	W	S
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	528	T	R
P02545	LP/P	Cardiomyopathy, dilated 1A (CMD1A) [MIM:115200]	A0A1U7SLJ6	541	R	C
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	541	R	H
P02545	LP/P	Cardiomyopathy, dilated 1A (CMD1A) [MIM:115200]	A0A1U7SLJ6	541	R	S
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	541	R	S
P02545	LP/P	Cardiomyopathy, dilated 1A (CMD1A) [MIM:115200]	A0A1U7SLJ6	573	S	L
P02545	LP/P	Lipodystrophy, familial partial, 2 (FPLD2) [MIM:151660]	A0A1U7SLJ6	573	S	L
P02545	LP/P	Mandibuloacral dysplasia with type A lipodystrophy (MADA) [MIM:248370]	A0A1U7SLJ6	573	S	L
P02545	LB/B	-	A0A1U7SLJ6	578	E	V
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	624	R	H
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	39	N	S
P02545	LP/P	Muscular dystrophy congenital LMNA-related (MDCL) [MIM:613205]	A0A1U7SLJ6	39	N	S
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	249	R	W
P02545	LP/P	Muscular dystrophy congenital LMNA-related (MDCL) [MIM:613205]	A0A1U7SLJ6	249	R	W
P02545	LP/P	Muscular dystrophy congenital LMNA-related (MDCL) [MIM:613205]	A0A1U7SLJ6	302	L	P
P02545	LP/P	Muscular dystrophy congenital LMNA-related (MDCL) [MIM:613205]	A0A1U7SLJ6	380	L	S
P02545	LP/P	Muscular dystrophy congenital LMNA-related (MDCL) [MIM:613205]	A0A1U7SLJ6	453	R	P
P02545	LP/P	Muscular dystrophy congenital LMNA-related (MDCL) [MIM:613205]	A0A1U7SLJ6	455	R	P
P02545	LP/P	Muscular dystrophy congenital LMNA-related (MDCL) [MIM:613205]	A0A1U7SLJ6	456	N	D
P02545	LP/P	Cardiomyopathy, dilated, with hypergonadotropic hypogonadism (CMDHH) [MIM:212112]	A0A1U7SLJ6	59	L	R
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	189	R	P
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	206	F	L
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	268	S	P
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	271	L	P
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	295	S	P
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	303	S	P
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	361	E	K
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	449	G	D
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	454	L	P
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	461	D	Y
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	467	W	R
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	541	R	P
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	602	G	S
P02545	LP/P	Cardiomyopathy, dilated 1A (CMD1A) [MIM:115200]	A0A1U7SLJ6	92	L	F
P02545	LP/P	Emery-Dreifuss muscular dystrophy 3, autosomal recessive (EDMD3) [MIM:616516]	A0A1U7SLJ6	225	R	Q
P02545	LP/P	Cardiomyopathy, dilated 1A (CMD1A) [MIM:115200]	A0A1U7SLJ6	101	R	P
P02545	LP/P	Hutchinson-Gilford progeria syndrome (HGPS) [MIM:176670]	A0A1U7SLJ6	138	E	K
P02545	LP/P	Cardiomyopathy, dilated 1A (CMD1A) [MIM:115200]	A0A1U7SLJ6	166	R	P
P02545	LP/P	Cardiomyopathy, dilated 1A (CMD1A) [MIM:115200]	A0A1U7SLJ6	210	I	S
P02545	LP/P	Hutchinson-Gilford progeria syndrome (HGPS) [MIM:176670]	A0A1U7SLJ6	300	D	G
P02545	LP/P	Cardiomyopathy, dilated 1A (CMD1A) [MIM:115200]	A0A1U7SLJ6	318	A	T
P02545	LP/P	Cardiomyopathy, dilated 1A (CMD1A) [MIM:115200]	A0A1U7SLJ6	388	R	H
P02545	LP/P	Lipodystrophy, familial partial, 2 (FPLD2) [MIM:151660]	A0A1U7SLJ6	439	R	C
P02545	LP/P	Cardiomyopathy, dilated 1A (CMD1A) [MIM:115200]	A0A1U7SLJ6	471	R	H
P02545	LP/P	Lipodystrophy, familial partial, 2 (FPLD2) [MIM:151660]	A0A1U7SLJ6	515	K	E
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	401	R	C
P02545	LP/P	-	A0A1U7SLJ6	411	G	D
P02545	LB/B	-	A0A1U7SLJ6	413	G	C
P02545	LB/B	-	A0A1U7SLJ6	419	R	C
P02545	LP/P	-	A0A1U7SLJ6	421	L	P
P02545	LB/B	-	A0A1U7SLJ6	488	T	P
P02545	LP/P	-	A0A1U7SLJ6	631	G	D
P02545	LP/P	Emery-Dreifuss muscular dystrophy 3, autosomal recessive (EDMD3) [MIM:616516]	A0A1U7SLJ6	24	T	S
P02545	LP/P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]	A0A1U7SLJ6	259	Y	C
P20700	LB/B	-	A0A287ADV8	501	A	V
P20700	LP/P	Microcephaly 26, primary, autosomal dominant (MCPH26) [MIM:619179]	A0A287ADV8	33	K	E
P20700	LB/B	-	A0A287ADV8	33	K	T
P20700	LP/P	Microcephaly 26, primary, autosomal dominant (MCPH26) [MIM:619179]	A0A287ADV8	42	R	W
P20700	LP/P	Microcephaly 26, primary, autosomal dominant (MCPH26) [MIM:619179]	A0A287ADV8	90	R	P
P20700	LP/P	Microcephaly 26, primary, autosomal dominant (MCPH26) [MIM:619179]	A0A287ADV8	152	A	G
Q03252	LB/B	-	A0A287ADV8	235	R	Q
Q03252	LP/P	Partial acquired lipodystrophy (APLD) [MIM:608709]	A0A287ADV8	427	A	T
Q03252	LP/P	Epilepsy, progressive myoclonic 9 (EPM9) [MIM:616540]	A0A287ADV8	157	H	Y
Q03252	LP/P	Partial acquired lipodystrophy (APLD) [MIM:608709]	A0A287ADV8	252	Y	H
Q03252	LP/P	Microcephaly 27, primary, autosomal dominant (MCPH27) [MIM:619180]	A0A287ADV8	54	N	H
Q03252	LP/P	Microcephaly 27, primary, autosomal dominant (MCPH27) [MIM:619180]	A0A287ADV8	398	E	K
Q8IXW0	LB/B	-	A0A2K6QDE0	44	A	T
Q8WWI1	LB/B	-	M3XVS3	1547	P	Q
P29536	LB/B	-	A0A1U7UJ38	295	T	M
Q0VAK6	LB/B	-	L5KB61	560	A	V
Q0VAK6	LB/B	-	L5KB61	438	K	M
Q0VAK6	LB/B	-	L5KB61	263	I	T
Q0VAK6	LB/B	-	L5KB61	83	R	H
Q0VAK6	LP/P	Nemaline myopathy 10 (NEM10) [MIM:616165]	L5KB61	326	G	R
Q8IWU2	LB/B	-	S9XF05	30	P	A
Q8IWU2	LB/B	-	S9XF05	780	L	M
Q8IWU2	LB/B	-	S9XF05	1061	D	N
Q8IWU2	LB/B	-	S9XF05	595	V	I
Q8IWU2	LB/B	-	S9XF05	624	V	M
Q8IWU2	LB/B	-	S9XF05	693	I	T
Q8IWU2	LB/B	-	S9XF05	849	V	F
Q8IWU2	LB/B	-	S9XF05	862	A	T
Q8IWU2	LB/B	-	S9XF05	916	S	R
Q8IWU2	LB/B	-	S9XF05	1220	D	N
Q8IWU2	LB/B	-	S9XF05	1341	A	G
Q8IWU2	LB/B	-	S9XF05	1401	S	N
Q96Q04	LB/B	-	L9J9B2	929	L	V
Q96Q04	LB/B	-	L9J9B2	900	V	L
Q8TE12	LB/B	-	H3DMH9	126	E	K
Q8TE12	LP/P	Deafness, autosomal dominant, 7 (DFNA7) [MIM:601412]	H3DMH9	241	V	L
O60663	LP/P	Nail-patella syndrome (NPS) [MIM:161200]	W5PSU1	118	C	F
O60663	LP/P	Nail-patella syndrome (NPS) [MIM:161200]	W5PSU1	165	C	W
O60663	LP/P	Nail-patella syndrome (NPS) [MIM:161200]	W5PSU1	223	R	Q
O60663	LP/P	Nail-patella syndrome (NPS) [MIM:161200]	W5PSU1	236	A	P
O60663	LP/P	Nail-patella syndrome (NPS) [MIM:161200]	W5PSU1	241	S	P
O60663	LP/P	Nail-patella syndrome (NPS) [MIM:161200]	W5PSU1	249	R	P
O60663	LP/P	Nail-patella syndrome (NPS) [MIM:161200]	W5PSU1	253	A	V
O60663	LP/P	Nail-patella syndrome (NPS) [MIM:161200]	W5PSU1	269	N	K
O60663	LP/P	Nail-patella syndrome (NPS) [MIM:161200]	W5PSU1	77	H	N
O60663	LP/P	Nail-patella syndrome (NPS) [MIM:161200]	W5PSU1	81	L	W
O60663	LP/P	Nail-patella syndrome (NPS) [MIM:161200]	W5PSU1	83	C	F
O60663	LP/P	Nail-patella syndrome (NPS) [MIM:161200]	W5PSU1	83	C	W
O60663	LP/P	Nail-patella syndrome (NPS) [MIM:161200]	W5PSU1	103	C	W
O60663	LP/P	Nail-patella syndrome (NPS) [MIM:161200]	W5PSU1	118	C	Y
O60663	LP/P	Nail-patella syndrome (NPS) [MIM:161200]	W5PSU1	137	H	Y
O60663	LP/P	Nail-patella syndrome (NPS) [MIM:161200]	W5PSU1	140	C	Y
O60663	LP/P	Nail-patella syndrome (NPS) [MIM:161200]	W5PSU1	266	W	C
O60663	LP/P	Nail-patella syndrome (NPS) [MIM:161200]	W5PSU1	59	C	R
O60663	LP/P	Nail-patella syndrome (NPS) [MIM:161200]	W5PSU1	59	C	S
O60663	LP/P	Nail-patella syndrome (NPS) [MIM:161200]	W5PSU1	77	H	Q
O60663	LP/P	Nail-patella syndrome (NPS) [MIM:161200]	W5PSU1	77	H	Y
O60663	LP/P	Nail-patella syndrome (NPS) [MIM:161200]	W5PSU1	80	C	R
O60663	LP/P	Nail-patella syndrome (NPS) [MIM:161200]	W5PSU1	83	C	G
O60663	LP/P	Nail-patella syndrome (NPS) [MIM:161200]	W5PSU1	83	C	Y
O60663	LP/P	Nail-patella syndrome (NPS) [MIM:161200]	W5PSU1	86	C	R
O60663	LP/P	Nail-patella syndrome (NPS) [MIM:161200]	W5PSU1	106	D	G
O60663	LP/P	Nail-patella syndrome (NPS) [MIM:161200]	W5PSU1	143	C	S
O60663	LP/P	Nail-patella syndrome (NPS) [MIM:161200]	W5PSU1	146	C	F
O60663	LP/P	Nail-patella syndrome (NPS) [MIM:161200]	W5PSU1	146	C	Y
O60663	LP/P	Nail-patella syndrome (NPS) [MIM:161200]	W5PSU1	252	L	P
O60663	LB/B	-	W5PSU1	75	S	F
O60663	LP/P	Focal segmental glomerulosclerosis 10 (FSGS10) [MIM:256020]	W5PSU1	246	R	P
O60663	LP/P	Focal segmental glomerulosclerosis 10 (FSGS10) [MIM:256020]	W5PSU1	246	R	Q
Q8N448	LB/B	-	H3DJW3	198	S	P
P36776	LB/B	-	A0A2T3AKG8	87	E	D
P36776	LB/B	-	A0A2T3AKG8	241	R	Q
P36776	LB/B	-	A0A2T3AKG8	829	A	T
P36776	LB/B	-	A0A2T3AKG8	911	V	I
P36776	LP/P	CODAS syndrome (CODASS) [MIM:600373]	A0A2T3AKG8	476	E	A
P36776	LP/P	CODAS syndrome (CODASS) [MIM:600373]	A0A2T3AKG8	631	S	Y
P36776	LP/P	CODAS syndrome (CODASS) [MIM:600373]	A0A2T3AKG8	670	A	V
P36776	LP/P	CODAS syndrome (CODASS) [MIM:600373]	A0A2T3AKG8	672	R	C
P36776	LP/P	CODAS syndrome (CODASS) [MIM:600373]	A0A2T3AKG8	676	P	S
P36776	LP/P	CODAS syndrome (CODASS) [MIM:600373]	A0A2T3AKG8	679	R	H
P36776	LP/P	CODAS syndrome (CODASS) [MIM:600373]	A0A2T3AKG8	721	R	G
P36776	LP/P	CODAS syndrome (CODASS) [MIM:600373]	A0A2T3AKG8	724	A	V
P36776	LP/P	CODAS syndrome (CODASS) [MIM:600373]	A0A2T3AKG8	749	P	S
P36776	LP/P	CODAS syndrome (CODASS) [MIM:600373]	A0A2T3AKG8	767	G	E
Q17RB8	LB/B	-	F6Z118	265	I	L
Q1L5Z9	LB/B	-	F6Z118	183	L	P
Q1L5Z9	LB/B	-	F6Z118	426	L	P
Q08397	LB/B	-	A0A0P7YIH7	153	G	D
Q08397	LB/B	-	A0A0P7YIH7	141	R	L
Q9Y4K0	LB/B	-	A0A2R8MID5	570	M	L
Q9Y4K0	LB/B	-	A0A2R8MID5	359	S	W
Q96JB6	LB/B	-	F7EVU7	154	R	Q
Q96JB6	LB/B	-	F7EVU7	405	D	A
Q96JB6	LB/B	-	F7EVU7	372	P	T
P08519	LB/B	-	P08519	1685	W	R
P08519	LB/B	-	P08519	990	R	Q
P08519	LB/B	-	P08519	1358	L	V
P08519	LB/B	-	P08519	1372	L	V
P08519	LB/B	-	P08519	1399	T	P
P08519	LB/B	-	P08519	1421	R	Q
P08519	LB/B	-	P08519	1598	M	T
P08519	LB/B	-	P08519	1679	M	T
P08519	LB/B	-	P08519	1822	G	A
P08519	LB/B	-	P08519	1891	I	M
P08519	LB/B	-	P08519	2016	R	C
Q16609	LB/B	-	Q28911	91	T	M
Q9UBY5	LB/B	-	A0A2U4A446	231	R	Q
P43657	LB/B	-	G3PDY2	137	C	W
P43657	LB/B	-	G3PDY2	33	I	V
P43657	LP/P	Woolly hair autosomal recessive 1 with or without hypotrichosis (ARWH1) [MIM:278150]	G3PDY2	63	D	V
P43657	LP/P	Woolly hair autosomal recessive 1 with or without hypotrichosis (ARWH1) [MIM:278150]	G3PDY2	188	I	F
P43657	LP/P	Woolly hair autosomal recessive 1 with or without hypotrichosis (ARWH1) [MIM:278150]	G3PDY2	189	E	K
P43657	LB/B	-	G3PDY2	307	W	C
Q7L5N7	LB/B	-	F7CN60	163	M	I
Q6P1A2	LB/B	-	E2RKK9	63	F	L
Q6P1A2	LB/B	-	E2RKK9	217	I	T
Q92539	LP/P	Majeed syndrome (MJDS) [MIM:609628]	A0A146V8I9	734	S	L
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	102	R	S
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	113	W	G
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	113	W	R
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	163	H	R
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	169	G	E
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	181	G	S
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	183	D	G
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	183	D	N
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	184	P	R
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	185	A	T
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	199	S	C
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	203	A	T
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	207	D	E
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	210	H	Q
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	215	G	E
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	220	S	R
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	221	I	T
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	222	G	E
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	231	D	E
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	232	I	S
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	234	P	L
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	243	C	S
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	270	R	H
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	271	S	T
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	277	D	N
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	278	S	C
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	286	S	G
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	286	S	R
P06858	LP/P	Hyperlipidemia, familial combined, 3 (FCHL3) [MIM:144250]	A0A2I0UNJ9	318	N	S
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	328	M	T
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	330	L	P
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	361	A	T
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	392	L	V
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	437	E	K
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	437	E	V
P06858	LP/P	Hyperlipidemia, familial combined, 3 (FCHL3) [MIM:144250]	A0A2I0UNJ9	36	D	N
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	288	A	T
P06858	LB/B	-	A0A2I0UNJ9	370	V	M
P06858	LB/B	-	A0A2I0UNJ9	379	T	A
P06858	LB/B	-	A0A2I0UNJ9	427	A	T
P06858	LB/B	-	A0A2I0UNJ9	71	H	Q
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	70	N	S
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	96	V	L
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	98	A	T
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	128	T	A
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	132	G	R
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	181	G	V
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	183	D	H
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	186	G	E
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	190	E	G
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	201	D	V
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	208	V	I
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	210	H	D
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	215	G	R
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	225	K	R
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	227	V	A
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	252	I	T
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	266	C	W
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	270	R	C
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	279	L	R
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	279	L	V
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	289	Y	H
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	297	F	L
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	303	L	F
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	305	C	R
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	310	C	Y
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	313	L	P
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	325	S	R
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	328	M	R
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	330	L	F
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	365	S	F
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	445	C	Y
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	448	E	K
P06858	LP/P	Hyperlipoproteinemia 1 (HLPP1) [MIM:238600]	A0A2I0UNJ9	404	M	R
P22079	LB/B	-	A0A091QVF8	105	T	I
P22079	LB/B	-	A0A091QVF8	244	A	T
P22079	LB/B	-	A0A091QVF8	414	R	Q
P22079	LB/B	-	A0A091QVF8	421	V	M
P22079	LB/B	-	A0A091QVF8	514	R	Q
P22079	LB/B	-	A0A091QVF8	614	I	T
P22079	LB/B	-	A0A091QVF8	700	D	N
Q93052	LB/B	-	G3NI89	346	Y	H
Q93052	LB/B	-	G3NI89	146	T	A
Q93052	LB/B	-	G3NI89	259	S	P
O60711	LB/B	-	M7AQT6	148	P	T
O95237	LP/P	Leber congenital amaurosis 14 (LCA14) [MIM:613341]	S7P8N6	175	S	R
O95237	LB/B	-	S7P8N6	173	P	L
P50851	LB/B	-	U3B0C7	2809	S	L
P50851	LB/B	-	U3B0C7	1090	A	G
P50851	LB/B	-	U3B0C7	1230	G	D
P50851	LB/B	-	U3B0C7	1677	N	S
P50851	LB/B	-	U3B0C7	1997	R	C
P50851	LB/B	-	U3B0C7	2704	A	T
P50851	LB/B	-	U3B0C7	2713	L	F
P50851	LP/P	Immunodeficiency, common variable, 8, with autoimmunity (CVID8) [MIM:614700]	U3B0C7	2657	I	S
Q9Y2L9	LB/B	-	L5KBH4	234	S	P
Q9Y2L9	LB/B	-	L5KBH4	486	A	S
Q9ULH4	LB/B	-	A0A060WGV2	770	D	N
Q9BTN0	LB/B	-	F6YV83	14	A	V
P02750	LB/B	-	A0A2K5DW42	133	P	S
P02750	LB/B	-	A0A2K5DW42	64	G	S
Q96M69	LB/B	-	A0A1S2ZYL5	302	D	Y
Q96M69	LB/B	-	A0A1S2ZYL5	661	A	V
Q9P2V4	LB/B	-	A0A087XKE6	591	S	G
Q9P2V4	LB/B	-	A0A087XKE6	154	L	M
Q9P2V4	LB/B	-	A0A087XKE6	258	P	Q
Q9P2V4	LB/B	-	A0A087XKE6	389	P	T
Q3SXY7	LB/B	-	F6T1L6	336	M	L
Q3SXY7	LB/B	-	F6T1L6	486	A	T
Q3SXY7	LB/B	-	F6T1L6	503	T	M
Q3SXY7	LB/B	-	F6T1L6	175	S	N
Q3SXY7	LP/P	Night blindness, congenital stationary, 1F (CSNB1F) [MIM:615058]	F6T1L6	328	C	Y
Q3SXY7	LP/P	Night blindness, congenital stationary, 1F (CSNB1F) [MIM:615058]	F6T1L6	203	W	L
Q9H2I8	LB/B	-	A0A0K8RTL2	153	S	F
Q07954	LB/B	-	A0A146VE76	217	A	V
Q07954	LB/B	-	A0A146VE76	166	N	D
Q07954	LB/B	-	A0A146VE76	2059	V	L
Q07954	LB/B	-	A0A146VE76	2080	D	N
Q07954	LB/B	-	A0A146VE76	2900	Q	P
Q07954	LB/B	-	A0A146VE76	4536	E	G
Q07954	LB/B	-	A0A146VE76	3258	H	Q
Q07954	LP/P	Keratosis pilaris atrophicans (KPA) [MIM:604093]	A0A146VE76	1245	K	R
Q7Z4F1	LB/B	-	F7GLB7	48	R	W
Q7Z4F1	LB/B	-	F7GLB7	139	M	V
Q9Y561	LB/B	-	M3YUG5	694	S	G
Q9NZR2	LB/B	-	A0A146VE76	3157	R	C
Q9NZR2	LB/B	-	A0A146VE76	48	Q	R
Q9NZR2	LB/B	-	A0A146VE76	3140	Q	R
Q9NZR2	LB/B	-	A0A146VE76	3458	E	K
Q9NZR2	LB/B	-	A0A146VE76	3734	Q	K
Q9NZR2	LB/B	-	A0A146VE76	4264	V	L
O75096	LB/B	-	A0A1S3IHV0	1086	I	V
O75096	LB/B	-	A0A1S3IHV0	1554	S	G
O75096	LB/B	-	A0A1S3IHV0	1646	R	Q
O75096	LB/B	-	A0A1S3IHV0	314	L	S
O75096	LB/B	-	A0A1S3IHV0	1203	A	V
O75096	LB/B	-	A0A1S3IHV0	1238	A	T
O75096	LP/P	Cenani-Lenz syndactyly syndrome (CLSS) [MIM:212780]	A0A1S3IHV0	137	D	N
O75096	LP/P	Cenani-Lenz syndactyly syndrome (CLSS) [MIM:212780]	A0A1S3IHV0	160	C	Y
O75096	LP/P	Cenani-Lenz syndactyly syndrome (CLSS) [MIM:212780]	A0A1S3IHV0	449	D	N
O75096	LP/P	Cenani-Lenz syndactyly syndrome (CLSS) [MIM:212780]	A0A1S3IHV0	461	T	P
O75096	LP/P	Cenani-Lenz syndactyly syndrome (CLSS) [MIM:212780]	A0A1S3IHV0	473	L	F
O75096	LP/P	Cenani-Lenz syndactyly syndrome (CLSS) [MIM:212780]	A0A1S3IHV0	529	D	N
O75096	LP/P	Cenani-Lenz syndactyly syndrome (CLSS) [MIM:212780]	A0A1S3IHV0	1017	C	R
O75096	LP/P	Sclerosteosis 2 (SOST2) [MIM:614305]	A0A1S3IHV0	1170	R	W
O75096	LP/P	Sclerosteosis 2 (SOST2) [MIM:614305]	A0A1S3IHV0	1186	W	S
O75096	LP/P	Myasthenic syndrome, congenital, 17 (CMS17) [MIM:616304]	A0A1S3IHV0	1233	E	K
O75096	LP/P	Myasthenic syndrome, congenital, 17 (CMS17) [MIM:616304]	A0A1S3IHV0	1277	R	H
Q14114	LB/B	-	H3K2Y7	46	D	E
Q14114	LB/B	-	H3K2Y7	952	R	Q
Q14114	LB/B	-	H3K2Y7	453	V	M
Q14114	LB/B	-	H3K2Y7	466	W	C
Q14114	LB/B	-	H3K2Y7	607	Q	R
Q14114	LB/B	-	H3K2Y7	611	I	L
Q14114	LB/B	-	H3K2Y7	653	S	T
Q14114	LB/B	-	H3K2Y7	25	Q	R
Q14114	LB/B	-	H3K2Y7	736	R	Q
P30533	LB/B	-	A0A2K6LWA2	311	V	M
P30533	LB/B	-	A0A2K6LWA2	114	N	S
P42704	LP/P	Mitochondrial complex IV deficiency, nuclear type 5 (MC4DN5) [MIM:220111]	H0UTE6	354	A	V
P42704	LB/B	-	H0UTE6	478	T	A
Q9BTT6	LB/B	-	A0A1S3Q6W0	193	I	V
Q15048	LB/B	-	V9KI72	437	G	D
Q8TF66	LB/B	-	A0A2P4STM5	264	V	I
Q8TF66	LB/B	-	A0A2P4STM5	286	P	L
Q8N6Y2	LB/B	-	A0A0Q3UQ67	95	T	I
Q8N6Y2	LB/B	-	A0A0Q3UQ67	119	K	E
Q8N6Y2	LB/B	-	A0A0Q3UQ67	187	G	A
Q8N456	LB/B	-	J9PWA1	7	G	V
Q8N456	LB/B	-	J9PWA1	31	R	H
Q9BYS8	LB/B	-	F7CP65	32	V	A
Q9BYS8	LB/B	-	F7CP65	83	T	A
Q9BYS8	LB/B	-	F7CP65	145	A	E
Q53EV4	LB/B	-	H0X3P4	65	N	H
Q53EV4	LB/B	-	H0X3P4	124	R	L
Q53EV4	LB/B	-	H0X3P4	317	V	E
Q8N386	LB/B	-	A0A2U3V792	294	P	S
Q8N386	LB/B	-	A0A2U3V792	234	P	T
Q86X40	LB/B	-	H2USE0	168	R	H
Q6UY01	LB/B	-	G3WTF0	322	L	F
Q6UY01	LB/B	-	G3WTF0	324	A	E
Q6UY01	LB/B	-	G3WTF0	378	L	F
Q1X8D7	LB/B	-	A0A1U7TXY3	222	R	P
Q1X8D7	LB/B	-	A0A1U7TXY3	509	G	S
Q1X8D7	LB/B	-	A0A1U7TXY3	744	S	G
A6NM11	LB/B	-	A0A2K5LC72	1141	F	L
A6NM11	LB/B	-	A0A2K5LC72	1281	I	T
A6NM11	LB/B	-	A0A2K5LC72	1385	N	K
A6NM11	LB/B	-	A0A2K5LC72	1423	H	P
O60309	LB/B	-	A0A2K5LC72	1215	K	E
O60309	LB/B	-	A0A2K5LC72	1590	G	A
Q96DD0	LB/B	-	A0A1U7QE68	121	I	L
Q9H9A6	LB/B	-	A0A093HAI3	53	Q	P
Q9H9A6	LB/B	-	A0A093HAI3	500	I	V
Q15345	LB/B	-	A0A091HQH5	609	V	I
Q8N1G4	LB/B	-	A0A146WLB6	545	P	L
Q8N1G4	LB/B	-	A0A146WLB6	581	V	I
Q8N7C0	LB/B	-	G3WTY4	209	D	E
Q8IYG6	LB/B	-	F6SQV1	507	R	G
Q8IYG6	LB/B	-	F6SQV1	523	D	H
Q8IYG6	LB/B	-	F6SQV1	12	R	Q
Q8IYG6	LB/B	-	F6SQV1	300	R	H
Q8IYG6	LB/B	-	F6SQV1	467	R	Q
Q8IYG6	LP/P	Ciliary dyskinesia, primary, 39 (CILD39) [MIM:618254]	F6SQV1	140	L	P
Q9BV99	LB/B	-	A0A1W5AYY8	143	N	S
Q68CR7	LB/B	-	A0A2Y9TBP3	342	G	A
Q6ZNQ3	LB/B	-	A0A2U4AIB3	64	T	I
Q8N4P6	LB/B	-	G1SZV2	483	R	H
Q8N4P6	LB/B	-	G1SZV2	503	S	A
Q8N4P6	LB/B	-	G1SZV2	533	A	T
Q6ZQY2	LB/B	-	G1Q5I8	3	G	R
Q6ZQY2	LB/B	-	G1Q5I8	77	R	C
Q2VPJ9	LB/B	-	F6YDL7	140	S	R
Q6P9F7	LB/B	-	L9LD76	419	Q	K
Q6P9F7	LB/B	-	L9LD76	288	D	N
Q6P9F7	LB/B	-	L9LD76	469	R	H
Q6P9F7	LB/B	-	L9LD76	689	N	S
Q8TDW0	LB/B	-	A0A0P7XT20	205	D	G
Q8TDW0	LB/B	-	A0A0P7XT20	468	N	S
Q8TDW0	LB/B	-	A0A0P7XT20	800	M	I
Q7L1W4	LB/B	-	A0A0P7XT20	371	S	Y
Q6NSJ5	LB/B	-	A0A0P7XT20	433	V	I
Q6NSJ5	LB/B	-	A0A0P7XT20	181	E	G
Q6NSJ5	LB/B	-	A0A0P7XT20	190	M	T
Q6NSJ5	LB/B	-	A0A0P7XT20	160	P	L
Q9C099	LB/B	-	A0A1S3LWL6	69	H	Q
Q9C099	LB/B	-	A0A1S3LWL6	210	T	A
Q9C099	LB/B	-	A0A1S3LWL6	613	K	N
Q32MZ4	LB/B	-	A0A2K6SRJ3	275	Q	R
Q32MZ4	LB/B	-	A0A2K6SRJ3	418	N	S
Q32MZ4	LB/B	-	A0A2K6SRJ3	609	E	K
Q32MZ4	LB/B	-	A0A2K6SRJ3	645	P	L
Q32MZ4	LB/B	-	A0A2K6SRJ3	779	R	G
Q32MZ4	LB/B	-	A0A2K6SRJ3	783	H	D
Q32MZ4	LB/B	-	A0A2K6SRJ3	633	K	E
Q96JM4	LB/B	-	A0A1U7TVA2	29	I	N
Q96JM4	LB/B	-	A0A1U7TVA2	83	C	Y
Q96JM4	LB/B	-	A0A1U7TVA2	912	A	T
Q38SD2	LB/B	-	A0A091CNI4	1803	A	T
Q38SD2	LB/B	-	A0A091CNI4	1824	L	F
Q38SD2	LB/B	-	A0A091CNI4	1847	S	N
Q38SD2	LB/B	-	A0A091CNI4	1927	D	G
Q5S007	LB/B	-	A0A093CNU7	50	R	H
Q5S007	LB/B	-	A0A093CNU7	119	L	P
Q5S007	LB/B	-	A0A093CNU7	551	N	K
Q5S007	LB/B	-	A0A093CNU7	723	I	V
Q5S007	LB/B	-	A0A093CNU7	944	D	Y
Q5S007	LP/P	Parkinson disease 8 (PARK8) [MIM:607060]	A0A093CNU7	1067	R	Q
Q5S007	LP/P	Parkinson disease 8 (PARK8) [MIM:607060]	A0A093CNU7	1122	I	V
Q5S007	LP/P	Parkinson disease 8 (PARK8) [MIM:607060]	A0A093CNU7	1228	S	T
Q5S007	LB/B	-	A0A093CNU7	1262	P	A
Q5S007	LB/B	-	A0A093CNU7	1398	R	H
Q5S007	LP/P	Parkinson disease 8 (PARK8) [MIM:607060]	A0A093CNU7	1441	R	C
Q5S007	LP/P	Parkinson disease 8 (PARK8) [MIM:607060]	A0A093CNU7	1441	R	G
Q5S007	LP/P	Parkinson disease 8 (PARK8) [MIM:607060]	A0A093CNU7	1441	R	H
Q5S007	LB/B	-	A0A093CNU7	1628	R	P
Q5S007	LB/B	-	A0A093CNU7	1646	M	T
Q5S007	LB/B	-	A0A093CNU7	1647	S	T
Q5S007	LP/P	Parkinson disease 8 (PARK8) [MIM:607060]	A0A093CNU7	1699	Y	C
Q5S007	LP/P	Parkinson disease 8 (PARK8) [MIM:607060]	A0A093CNU7	1941	R	H
Q5S007	LP/P	Parkinson disease 8 (PARK8) [MIM:607060]	A0A093CNU7	2019	G	S
Q5S007	LP/P	Parkinson disease 8 (PARK8) [MIM:607060]	A0A093CNU7	2020	I	T
Q5S007	LB/B	-	A0A093CNU7	2081	N	D
Q5S007	LB/B	-	A0A093CNU7	2119	P	L
Q5S007	LB/B	-	A0A093CNU7	2261	N	I
Q5S007	LP/P	Parkinson disease 8 (PARK8) [MIM:607060]	A0A093CNU7	2356	T	I
Q5S007	LP/P	Parkinson disease 8 (PARK8) [MIM:607060]	A0A093CNU7	2385	G	R
Q5S007	LB/B	-	A0A093CNU7	2397	M	T
Q5S007	LB/B	-	A0A093CNU7	419	A	V
Q5S007	LB/B	-	A0A093CNU7	755	P	L
Q5S007	LB/B	-	A0A093CNU7	1375	D	E
Q5S007	LB/B	-	A0A093CNU7	228	C	S
Q5S007	LP/P	Parkinson disease 8 (PARK8) [MIM:607060]	A0A093CNU7	712	M	V
Q5S007	LB/B	-	A0A093CNU7	716	A	V
Q5S007	LB/B	-	A0A093CNU7	871	K	E
Q5S007	LP/P	Parkinson disease 8 (PARK8) [MIM:607060]	A0A093CNU7	1728	R	H
Q5S007	LP/P	Parkinson disease 8 (PARK8) [MIM:607060]	A0A093CNU7	1728	R	L
Q5S007	LB/B	-	A0A093CNU7	1870	L	F
Q5S007	LP/P	Parkinson disease 8 (PARK8) [MIM:607060]	A0A093CNU7	2141	T	M
Q5S007	LP/P	Parkinson disease 8 (PARK8) [MIM:607060]	A0A093CNU7	2143	R	H
Q5S007	LB/B	-	A0A093CNU7	2395	E	K
Q5S007	LP/P	Parkinson disease 8 (PARK8) [MIM:607060]	A0A093CNU7	2466	L	H
Q5S007	LP/P	Parkinson disease 8 (PARK8) [MIM:607060]	A0A093CNU7	2031	T	S
Q5S007	LP/P	Parkinson disease 8 (PARK8) [MIM:607060]	A0A093CNU7	2175	D	H
Q5S007	LP/P	Parkinson disease 8 (PARK8) [MIM:607060]	A0A093CNU7	2189	Y	C
Q5S007	LP/P	Parkinson disease 8 (PARK8) [MIM:607060]	A0A093CNU7	2390	V	M
Q5S007	LP/P	Parkinson disease 8 (PARK8) [MIM:607060]	A0A093CNU7	2439	L	I
Q8WUT4	LB/B	-	H0X836	138	P	L
Q8WUT4	LB/B	-	H0X836	141	T	A
Q9HBL6	LB/B	-	A0A1S3GD58	43	E	K
Q9HBL6	LB/B	-	A0A1S3GD58	117	L	V
Q8N967	LB/B	-	H2UYN5	161	D	N
Q13449	LB/B	-	H0YR05	225	K	E
Q9H089	LB/B	-	W5KLP4	92	L	P
Q9H089	LB/B	-	W5KLP4	267	K	E
P83369	LP/P	Aicardi-Goutieres syndrome 8 (AGS8) [MIM:619486]	F1MKH0	211	G	S
Q3MHD2	LB/B	-	W5JYH8	77	P	R
Q3MHD2	LB/B	-	W5JYH8	173	V	L
P33241	LB/B	-	A0A2K6SHQ1	100	A	T
P33241	LB/B	-	A0A2K6SHQ1	229	Q	K
P33241	LB/B	-	A0A2K6SHQ1	108	Q	L
Q86X29	LB/B	-	A0A2K5IK15	363	S	N
P48449	LB/B	-	A0A1S4CH62	642	L	V
P48449	LB/B	-	A0A1S4CH62	175	R	Q
P48449	LB/B	-	A0A1S4CH62	310	H	R
P48449	LB/B	-	A0A1S4CH62	614	R	W
P48449	LB/B	-	A0A1S4CH62	688	P	L
P48449	LP/P	Cataract 44 (CTRCT44) [MIM:616509]	A0A1S4CH62	581	W	R
P48449	LP/P	Cataract 44 (CTRCT44) [MIM:616509]	A0A1S4CH62	588	G	S
P48449	LP/P	Hypotrichosis 14 (HYPT14) [MIM:618275]	A0A1S4CH62	102	L	V
P48449	LP/P	Alopecia-intellectual disability syndrome 4 (APMR4) [MIM:618840]	A0A1S4CH62	209	N	Y
P48449	LP/P	Hypotrichosis 14 (HYPT14) [MIM:618275]	A0A1S4CH62	248	L	P
P48449	LP/P	Hypotrichosis 14 (HYPT14) [MIM:618275]	A0A1S4CH62	391	F	S
Q14767	LB/B	-	G3X2N6	319	P	Q
Q14767	LB/B	-	G3X2N6	37	R	M
Q14767	LB/B	-	G3X2N6	591	P	S
Q14767	LP/P	Weill-Marchesani syndrome 3 (WMS3) [MIM:614819]	G3X2N6	1177	V	M
Q16873	LB/B	-	A0A1S2ZZW4	142	R	Q
P29376	LB/B	-	F7I974	42	R	Q
P29376	LB/B	-	F7I974	384	C	R
P29376	LB/B	-	F7I974	535	D	N
P29376	LB/B	-	F7I974	569	R	S
P29376	LB/B	-	F7I974	673	R	Q
P29376	LB/B	-	F7I974	745	P	S
P29376	LB/B	-	F7I974	838	P	S
P29376	LB/B	-	F7I974	763	E	K
O94822	LB/B	-	H0V8N1	403	L	S
O94822	LB/B	-	H0V8N1	500	A	V
O94822	LB/B	-	H0V8N1	565	G	C
O94822	LB/B	-	H0V8N1	761	V	I
Q8WV07	LB/B	-	F1PPQ8	3	G	S
Q9Y383	LB/B	-	L5KPV9	361	D	E
P51884	LB/B	-	Q640B1	199	L	P
Q86V48	LB/B	-	M7BCR2	458	G	S
Q86V48	LB/B	-	M7BCR2	461	Q	K
Q86V48	LB/B	-	M7BCR2	868	D	N
Q86V48	LB/B	-	M7BCR2	317	S	A
Q86V48	LB/B	-	M7BCR2	491	T	I
Q86V48	LB/B	-	M7BCR2	1034	S	N
Q86TE4	LB/B	-	S7N4K0	308	E	Q
Q9P127	LB/B	-	A0A096NGN2	14	P	S
Q9P127	LB/B	-	A0A096NGN2	306	T	A
Q6Q4G3	LB/B	-	A0A2U4BTJ3	640	V	F
Q6Q4G3	LB/B	-	A0A2U4BTJ3	689	L	F
Q6Q4G3	LB/B	-	A0A2U4BTJ3	936	V	I
Q14210	LB/B	-	A0A091DVJ4	10	A	T
Q8NDX9	LB/B	-	A0A2Y9MLT1	102	D	N
Q8NDX9	LB/B	-	A0A2Y9MLT1	131	S	Y
Q8NDX9	LB/B	-	A0A2Y9MLT1	176	R	C
O95867	LB/B	-	G5C3F6	63	L	M
Q5SQ64	LB/B	-	G1PDR2	34	P	Q
Q5SQ64	LB/B	-	G1PDR2	39	P	S
Q5SQ64	LB/B	-	G1PDR2	107	A	T
Q5SQ64	LB/B	-	G1PDR2	167	R	K
O60449	LB/B	-	H9GHS9	692	D	N
O60449	LB/B	-	H9GHS9	268	E	D
O60449	LB/B	-	H9GHS9	486	K	M
O60449	LB/B	-	H9GHS9	807	D	E
O60449	LB/B	-	H9GHS9	884	D	A
O60449	LB/B	-	H9GHS9	1202	T	S
O60449	LB/B	-	H9GHS9	1321	K	N
O60449	LB/B	-	H9GHS9	1347	K	R
O60449	LB/B	-	H9GHS9	1391	Y	H
O60449	LB/B	-	H9GHS9	20	W	R
O60449	LB/B	-	H9GHS9	666	V	A
O60449	LB/B	-	H9GHS9	1393	T	I
O95711	LB/B	-	A0A2J8MTV3	160	M	V
O95711	LB/B	-	A0A2J8MTV3	93	S	P
O95711	LB/B	-	A0A2J8MTV3	121	Y	C
Q9HBG7	LB/B	-	A0A2Y9M8I3	602	M	V
Q9Y6Y9	LB/B	-	A0A091WJX9	157	P	S
Q9Y6Y9	LB/B	-	A0A091WJX9	56	R	G
Q9NX58	LB/B	-	K1PGF7	151	D	Y
Q9NX58	LB/B	-	K1PGF7	265	R	H
Q6UXB3	LB/B	-	E2RBN2	5	R	Q
Q6UXB3	LB/B	-	E2RBN2	7	A	V
Q6UWN0	LB/B	-	A0A2Y9E993	184	T	S
O75608	LB/B	-	A0A0K8TPS1	153	P	S
Q5VWZ2	LB/B	-	A0A1U8CE79	131	I	M
Q5VWZ2	LB/B	-	A0A1U8CE79	197	L	V
Q9NU23	LB/B	-	A0A2U3UYN7	46	K	E
Q9NU23	LB/B	-	A0A2U3UYN7	34	R	W
Q9NU23	LB/B	-	A0A2U3UYN7	60	T	P
Q9HD34	LB/B	-	F7H9P8	11	S	A
Q9HD34	LP/P	Combined oxidative phosphorylation deficiency 19 (COXPD19) [MIM:615595]	F7H9P8	68	R	L
Q5XG99	LB/B	-	A0A2I0MD69	157	A	V
Q5XG99	LB/B	-	A0A2I0MD69	161	A	V
Q5XG99	LB/B	-	A0A2I0MD69	180	A	G
Q99698	LP/P	Chediak-Higashi syndrome (CHS) [MIM:214500]	S4RE65	1563	R	H
Q99698	LP/P	Chediak-Higashi syndrome (CHS) [MIM:214500]	S4RE65	1999	V	D
Q99698	LB/B	-	S4RE65	123	H	R
Q99698	LB/B	-	S4RE65	192	L	V
Q99698	LB/B	-	S4RE65	702	E	G
Q99698	LB/B	-	S4RE65	1017	S	N
Q99698	LB/B	-	S4RE65	1949	Q	H
Q99698	LB/B	-	S4RE65	2598	F	Y
Q99698	LB/B	-	S4RE65	2804	G	D
Q99698	LB/B	-	S4RE65	2936	V	I
Q99698	LB/B	-	S4RE65	2116	T	M
Q99698	LP/P	Chediak-Higashi syndrome (CHS) [MIM:214500]	S4RE65	1397	F	V
Q99698	LP/P	Chediak-Higashi syndrome (CHS) [MIM:214500]	S4RE65	1907	I	V
Q6UWQ5	LB/B	-	A0A096P406	62	Q	P
Q7Z4W2	LB/B	-	A0A096P406	144	D	G
O75951	LB/B	-	G5BCS8	139	F	S
Q8N653	LP/P	Schwannomatosis 2 (SWNTS2) [MIM:615670]	A0A287BFU1	122	S	L
Q8N653	LP/P	Schwannomatosis 2 (SWNTS2) [MIM:615670]	A0A287BFU1	404	G	R
Q8N653	LP/P	Schwannomatosis 2 (SWNTS2) [MIM:615670]	A0A287BFU1	456	V	G
Q8N653	LP/P	Schwannomatosis 2 (SWNTS2) [MIM:615670]	A0A287BFU1	466	R	Q
Q8N653	LP/P	Schwannomatosis 2 (SWNTS2) [MIM:615670]	A0A287BFU1	520	P	L
Q8N653	LP/P	Schwannomatosis 2 (SWNTS2) [MIM:615670]	A0A287BFU1	688	R	C
Q8N653	LP/P	Schwannomatosis 2 (SWNTS2) [MIM:615670]	A0A287BFU1	813	S	I
Q8N653	LP/P	Noonan syndrome 10 (NS10) [MIM:616564]	A0A287BFU1	119	Y	C
Q8N653	LP/P	Noonan syndrome 10 (NS10) [MIM:616564]	A0A287BFU1	247	S	N
Q8N653	LP/P	Glioma (GLM) [MIM:137800]	A0A287BFU1	248	G	R
Q8N653	LP/P	Noonan syndrome 10 (NS10) [MIM:616564]	A0A287BFU1	248	G	R
Q8N653	LP/P	Noonan syndrome 10 (NS10) [MIM:616564]	A0A287BFU1	284	R	C
Q8N653	LP/P	Schwannomatosis 2 (SWNTS2) [MIM:615670]	A0A287BFU1	284	R	C
Q8N653	LP/P	Noonan syndrome 10 (NS10) [MIM:616564]	A0A287BFU1	287	H	Y
Q8N653	LB/B	-	A0A287BFU1	447	F	L
Q8N653	LB/B	-	A0A287BFU1	647	I	V
Q8N653	LP/P	Glioma (GLM) [MIM:137800]	A0A287BFU1	105	W	R
Q8N653	LP/P	Schwannomatosis 2 (SWNTS2) [MIM:615670]	A0A287BFU1	170	R	Q
Q8N653	LP/P	Noonan syndrome 2 (NS2) [MIM:605275]	A0A287BFU1	170	R	W
Q8N653	LP/P	Schwannomatosis 2 (SWNTS2) [MIM:615670]	A0A287BFU1	187	L	R
Q8N653	LP/P	Glioma (GLM) [MIM:137800]	A0A287BFU1	198	R	G
Q8N653	LP/P	Schwannomatosis 2 (SWNTS2) [MIM:615670]	A0A287BFU1	202	M	R
Q8N653	LP/P	Noonan syndrome 10 (NS10) [MIM:616564]	A0A287BFU1	283	R	Q
Q8N653	LP/P	Glioma (GLM) [MIM:137800]	A0A287BFU1	288	T	I
Q8N653	LP/P	Noonan syndrome 2 (NS2) [MIM:605275]	A0A287BFU1	697	R	Q
Q8N653	LP/P	Noonan syndrome 2 (NS2) [MIM:605275]	A0A287BFU1	701	P	H
Q8N653	LP/P	Glioma (GLM) [MIM:137800]	A0A287BFU1	810	R	W
Q8N653	LP/P	Schwannomatosis 2 (SWNTS2) [MIM:615670]	A0A287BFU1	812	L	P
Q9Y250	LB/B	-	H2ZY04	29	S	P
Q9Y250	LB/B	-	H2ZY04	119	K	E
Q9Y250	LB/B	-	H2ZY04	475	L	V
Q9Y250	LB/B	-	H2ZY04	50	S	F
Q13394	LB/B	-	V8P4C1	70	S	P
Q9Y586	LP/P	Microphthalmia/coloboma and skeletal dysplasia syndrome (MCSKS) [MIM:615877]	V8P4C1	49	E	K
Q9Y586	LP/P	Microphthalmia/coloboma and skeletal dysplasia syndrome (MCSKS) [MIM:615877]	V8P4C1	51	R	C
Q9Y586	LP/P	Microphthalmia/coloboma and skeletal dysplasia syndrome (MCSKS) [MIM:615877]	V8P4C1	51	R	H
Q9Y586	LP/P	Microphthalmia/coloboma and skeletal dysplasia syndrome (MCSKS) [MIM:615877]	V8P4C1	247	R	Q
Q9Y586	LP/P	Microphthalmia/coloboma and skeletal dysplasia syndrome (MCSKS) [MIM:615877]	V8P4C1	51	R	G
Q08AI8	LB/B	-	F1PJC0	309	L	P
Q08AI8	LB/B	-	F1PJC0	170	A	T
Q6ZN28	LB/B	-	V8N9W5	31	L	V
Q6ZN28	LB/B	-	V8N9W5	50	P	L
Q6ZN28	LB/B	-	V8N9W5	515	S	L
Q6ZN28	LB/B	-	V8N9W5	728	E	A
Q6ZN28	LB/B	-	V8N9W5	804	R	T
O94854	LB/B	-	A0A2Y9SUR7	960	I	V
O94854	LB/B	-	A0A2Y9SUR7	1105	T	A
O94854	LB/B	-	A0A2Y9SUR7	1194	E	K
Q9UPN3	LB/B	-	G1LVE7	4357	M	V
Q9UPN3	LB/B	-	G1LVE7	6201	K	R
Q9UPN3	LB/B	-	G1LVE7	6308	A	T
Q9UPN3	LB/B	-	G1LVE7	6628	S	T
Q9UPN3	LB/B	-	G1LVE7	6752	T	I
Q9UPN3	LB/B	-	G1LVE7	6855	I	V
Q9UPN3	LP/P	Lissencephaly 9 with complex brainstem malformation (LIS9) [MIM:618325]	G1LVE7	7135	C	F
Q9UPN3	LP/P	Lissencephaly 9 with complex brainstem malformation (LIS9) [MIM:618325]	G1LVE7	7186	D	Y
Q9UPN3	LP/P	Lissencephaly 9 with complex brainstem malformation (LIS9) [MIM:618325]	G1LVE7	7188	C	F
Q9UPN3	LP/P	Lissencephaly 9 with complex brainstem malformation (LIS9) [MIM:618325]	G1LVE7	7188	C	G
A1Z1Q3	LB/B	-	I7GIN3	58	T	I
A1Z1Q3	LB/B	-	I7GIN3	335	T	M
Q13477	LB/B	-	A0A2J8QUW2	300	P	H
Q8WXG6	LB/B	-	A0A2I0MNE9	696	P	T
Q8WXG6	LB/B	-	A0A2I0MNE9	751	V	M
Q8WXG6	LB/B	-	A0A2I0MNE9	968	R	G
Q8WXG6	LB/B	-	A0A2I0MNE9	1040	L	F
Q8WXG6	LB/B	-	A0A2I0MNE9	765	R	Q
Q8WXG6	LB/B	-	A0A2I0MNE9	1518	L	P
Q8WXG6	LP/P	DEEAH syndrome (DEEAH) [MIM:619004]	A0A2I0MNE9	257	S	F
Q8WXG6	LP/P	DEEAH syndrome (DEEAH) [MIM:619004]	A0A2I0MNE9	305	G	V
Q8WXG6	LP/P	Neurodevelopmental disorder with dysmorphic facies, impaired speech, and hypotonia (NEDDISH) [MIM:619005]	A0A2I0MNE9	354	P	L
Q8WXG6	LP/P	DEEAH syndrome (DEEAH) [MIM:619004]	A0A2I0MNE9	1040	L	R
Q96JY0	LB/B	-	M3WB55	41	S	A
P20916	LB/B	-	A0A2I3LCF0	202	L	M
P20916	LP/P	Spastic paraplegia 75, autosomal recessive (SPG75) [MIM:616680]	A0A2I3LCF0	133	S	R
P43363	LB/B	-	S7N4S6	166	R	K
P43363	LB/B	-	S7N4S6	234	V	I
P43364	LB/B	-	A0A2K6SAT6	191	S	R
P43358	LB/B	-	A0A2K6SAT6	173	A	T
P43358	LB/B	-	A0A2K6SAT6	137	L	Q
P43358	LB/B	-	A0A2K6SAT6	230	G	E
P43366	LB/B	-	G3T6D9	267	R	C
Q96LZ2	LB/B	-	G3T6D9	65	R	Q
Q96LZ2	LB/B	-	G3T6D9	50	F	S
A2A368	LB/B	-	Q9CWV4	38	L	F
A2A368	LB/B	-	Q9CWV4	128	C	Y
A2A368	LB/B	-	Q9CWV4	161	H	R
A2A368	LB/B	-	Q9CWV4	248	M	V
A2A368	LB/B	-	Q9CWV4	248	M	K
Q96M61	LB/B	-	G3T6D9	40	P	S
O60732	LB/B	-	A0A0D9R4Q1	25	C	Y
O60732	LB/B	-	A0A0D9R4Q1	151	T	I
O60732	LB/B	-	A0A0D9R4Q1	257	Q	H
O60732	LB/B	-	A0A0D9R4Q1	276	F	S
O60732	LB/B	-	A0A0D9R4Q1	327	H	Q
O60732	LB/B	-	A0A0D9R4Q1	709	H	Y
Q8TD91	LB/B	-	A0A096ML53	165	L	M
Q8TD91	LB/B	-	A0A096ML53	307	A	T
Q8TD91	LB/B	-	A0A096ML53	328	A	T
Q8TD91	LB/B	-	A0A096ML53	155	S	P
Q9UNF1	LB/B	-	G3QIN6	266	Q	R
Q9UNF1	LB/B	-	G3QIN6	187	E	D
Q9UNF1	LP/P	Bartter syndrome 5, antenatal, transient (BARTS5) [MIM:300971]	G3QIN6	446	R	C
Q9HCI5	LB/B	-	Q6PCZ4	339	E	D
Q9HCI5	LB/B	-	Q6PCZ4	305	S	C
Q9H6Y5	LB/B	-	M3W113	53	R	H
Q9H6Y5	LB/B	-	M3W113	112	R	H
Q9H6Y5	LB/B	-	M3W113	173	L	V
Q9H6Y5	LB/B	-	M3W113	323	L	F
Q9H0U3	LP/P	Congenital disorder of glycosylation 1CC (CDG1CC) [MIM:301031]	A0A061HUQ5	324	K	N
Q8WWC4	LB/B	-	A0A1A6FVQ0	290	L	I
P20794	LB/B	-	L9L9F3	189	I	V
P20794	LB/B	-	L9L9F3	384	N	S
P20794	LB/B	-	L9L9F3	520	P	S
P20794	LB/B	-	L9L9F3	550	F	L
P20794	LB/B	-	L9L9F3	329	D	E
P20794	LP/P	Retinitis pigmentosa 62 (RP62) [MIM:614181]	L9L9F3	13	G	S
P20794	LP/P	Retinitis pigmentosa 62 (RP62) [MIM:614181]	L9L9F3	27	G	R
P20794	LP/P	Retinitis pigmentosa 62 (RP62) [MIM:614181]	L9L9F3	130	N	H
P20794	LP/P	Retinitis pigmentosa 62 (RP62) [MIM:614181]	L9L9F3	166	R	H
P20794	LP/P	Retinitis pigmentosa 62 (RP62) [MIM:614181]	L9L9F3	181	I	T
P20794	LB/B	-	L9L9F3	325	P	L
Q9BXY0	LB/B	-	A0A1Y1XNS4	277	Q	R
Q969L2	LB/B	-	W5KIN9	92	A	T
Q5VYJ5	LB/B	-	A0A1U8DKK5	1266	D	A
Q5VYJ5	LB/B	-	A0A1U8DKK5	1277	I	V
Q5VYJ5	LB/B	-	A0A1U8DKK5	1357	K	N
Q5VYJ5	LB/B	-	A0A1U8DKK5	1417	V	A
Q5VYJ5	LB/B	-	A0A1U8DKK5	1513	D	G
Q5VYJ5	LB/B	-	A0A1U8DKK5	1516	E	K
Q5VYJ5	LB/B	-	A0A1U8DKK5	1602	V	I
Q5VYJ5	LB/B	-	A0A1U8DKK5	1683	L	I
Q5VYJ5	LB/B	-	A0A1U8DKK5	1721	H	Q
Q5VYJ5	LB/B	-	A0A1U8DKK5	1807	M	T
Q5VYJ5	LB/B	-	A0A1U8DKK5	1895	P	S
Q5VYJ5	LB/B	-	A0A1U8DKK5	1941	S	N
Q5VYJ5	LB/B	-	A0A1U8DKK5	2013	M	R
Q5VYJ5	LB/B	-	A0A1U8DKK5	666	A	V
Q5VYJ5	LB/B	-	A0A1U8DKK5	793	D	H
Q5VYJ5	LB/B	-	A0A1U8DKK5	887	S	N
Q9UDY8	LB/B	-	F7AR74	641	I	V
Q9UDY8	LP/P	Immunodeficiency 12 (IMD12) [MIM:615468]	F7AR74	89	S	I
Q92585	LB/B	-	A0A2Y9RZL6	1007	S	N
Q92585	LB/B	-	A0A2Y9RZL6	583	S	N
Q8IZL2	LB/B	-	H0VCJ5	896	P	T
P33908	LB/B	-	A0A2R9BFB5	651	R	G
Q9UKM7	LB/B	-	A0A2K5LXP8	59	N	S
Q9UKM7	LP/P	Rafiq syndrome (RAFQS) [MIM:614202]	A0A2K5LXP8	334	R	C
Q9UKM7	LP/P	Rafiq syndrome (RAFQS) [MIM:614202]	A0A2K5LXP8	397	E	K
Q16706	LB/B	-	V4AK03	1012	L	V
P49641	LB/B	-	V4AK03	412	Q	R
P49641	LB/B	-	V4AK03	665	S	F
O00754	LP/P	Mannosidosis, alpha B, lysosomal (MANSA) [MIM:248500]	F1QTT0	72	H	L
O00754	LB/B	-	F1QTT0	278	L	V
O00754	LB/B	-	F1QTT0	312	T	I
O00754	LB/B	-	F1QTT0	337	R	Q
O00754	LP/P	Mannosidosis, alpha B, lysosomal (MANSA) [MIM:248500]	F1QTT0	355	T	P
O00754	LP/P	Mannosidosis, alpha B, lysosomal (MANSA) [MIM:248500]	F1QTT0	356	P	R
O00754	LB/B	-	F1QTT0	413	N	S
O00754	LP/P	Mannosidosis, alpha B, lysosomal (MANSA) [MIM:248500]	F1QTT0	714	W	R
O00754	LP/P	Mannosidosis, alpha B, lysosomal (MANSA) [MIM:248500]	F1QTT0	750	R	W
O00754	LP/P	Mannosidosis, alpha B, lysosomal (MANSA) [MIM:248500]	F1QTT0	809	L	P
O00754	LP/P	Mannosidosis, alpha B, lysosomal (MANSA) [MIM:248500]	F1QTT0	200	H	L
O00754	LP/P	Mannosidosis, alpha B, lysosomal (MANSA) [MIM:248500]	F1QTT0	453	S	Y
O00754	LP/P	Mannosidosis, alpha B, lysosomal (MANSA) [MIM:248500]	F1QTT0	801	G	D
O00754	LB/B	-	F1QTT0	250	A	S
O00754	LB/B	-	F1QTT0	481	A	S
O00754	LP/P	Mannosidosis, alpha B, lysosomal (MANSA) [MIM:248500]	F1QTT0	55	C	F
O00754	LP/P	Mannosidosis, alpha B, lysosomal (MANSA) [MIM:248500]	F1QTT0	74	D	E
O00754	LP/P	Mannosidosis, alpha B, lysosomal (MANSA) [MIM:248500]	F1QTT0	95	A	P
O00754	LP/P	Mannosidosis, alpha B, lysosomal (MANSA) [MIM:248500]	F1QTT0	99	Y	H
O00754	LP/P	Mannosidosis, alpha B, lysosomal (MANSA) [MIM:248500]	F1QTT0	159	D	N
O00754	LP/P	Mannosidosis, alpha B, lysosomal (MANSA) [MIM:248500]	F1QTT0	197	P	R
O00754	LP/P	Mannosidosis, alpha B, lysosomal (MANSA) [MIM:248500]	F1QTT0	200	H	N
O00754	LP/P	Mannosidosis, alpha B, lysosomal (MANSA) [MIM:248500]	F1QTT0	202	R	P
O00754	LP/P	Mannosidosis, alpha B, lysosomal (MANSA) [MIM:248500]	F1QTT0	229	R	W
O00754	LB/B	-	F1QTT0	248	P	L
O00754	LP/P	Mannosidosis, alpha B, lysosomal (MANSA) [MIM:248500]	F1QTT0	263	P	L
O00754	LB/B	-	F1QTT0	282	P	S
O00754	LP/P	Mannosidosis, alpha B, lysosomal (MANSA) [MIM:248500]	F1QTT0	318	S	L
O00754	LP/P	Mannosidosis, alpha B, lysosomal (MANSA) [MIM:248500]	F1QTT0	352	L	P
O00754	LP/P	Mannosidosis, alpha B, lysosomal (MANSA) [MIM:248500]	F1QTT0	379	P	L
O00754	LP/P	Mannosidosis, alpha B, lysosomal (MANSA) [MIM:248500]	F1QTT0	390	G	C
O00754	LP/P	Mannosidosis, alpha B, lysosomal (MANSA) [MIM:248500]	F1QTT0	420	G	V
O00754	LP/P	Mannosidosis, alpha B, lysosomal (MANSA) [MIM:248500]	F1QTT0	445	H	Y
O00754	LP/P	Mannosidosis, alpha B, lysosomal (MANSA) [MIM:248500]	F1QTT0	451	G	C
O00754	LP/P	Mannosidosis, alpha B, lysosomal (MANSA) [MIM:248500]	F1QTT0	453	S	F
O00754	LP/P	Mannosidosis, alpha B, lysosomal (MANSA) [MIM:248500]	F1QTT0	457	V	E
O00754	LP/P	Mannosidosis, alpha B, lysosomal (MANSA) [MIM:248500]	F1QTT0	501	C	S
O00754	LP/P	Mannosidosis, alpha B, lysosomal (MANSA) [MIM:248500]	F1QTT0	565	L	P
O00754	LB/B	-	F1QTT0	669	P	L
O00754	LP/P	Mannosidosis, alpha B, lysosomal (MANSA) [MIM:248500]	F1QTT0	745	T	R
O00754	LP/P	Mannosidosis, alpha B, lysosomal (MANSA) [MIM:248500]	F1QTT0	800	G	R
O00754	LP/P	Mannosidosis, alpha B, lysosomal (MANSA) [MIM:248500]	F1QTT0	800	G	W
O00754	LP/P	Mannosidosis, alpha B, lysosomal (MANSA) [MIM:248500]	F1QTT0	891	G	R
O00754	LP/P	Mannosidosis, alpha B, lysosomal (MANSA) [MIM:248500]	F1QTT0	892	L	P
O00754	LP/P	Mannosidosis, alpha B, lysosomal (MANSA) [MIM:248500]	F1QTT0	916	R	C
O00754	LP/P	Mannosidosis, alpha B, lysosomal (MANSA) [MIM:248500]	F1QTT0	916	R	H
O00754	LP/P	Mannosidosis, alpha B, lysosomal (MANSA) [MIM:248500]	F1QTT0	950	R	P
O00754	LP/P	Mannosidosis, alpha B, lysosomal (MANSA) [MIM:248500]	F1QTT0	956	L	R
O00754	LP/P	Mannosidosis, alpha B, lysosomal (MANSA) [MIM:248500]	F1QTT0	1000	F	S
Q9Y2E5	LB/B	-	A0A2Y9RQ94	243	Q	P
Q9Y2E5	LB/B	-	A0A2Y9RQ94	320	V	M
Q9Y2E5	LB/B	-	A0A2Y9RQ94	446	M	V
Q9Y2E5	LB/B	-	A0A2Y9RQ94	541	N	S
Q9Y2E5	LB/B	-	A0A2Y9RQ94	365	R	C
Q9NTJ4	LB/B	-	L5JWP9	960	V	I
Q9NTJ4	LB/B	-	L5JWP9	950	V	M
Q9NTJ4	LB/B	-	L5JWP9	975	R	K
Q9NTJ4	LB/B	-	L5JWP9	818	R	H
Q9NTJ4	LB/B	-	L5JWP9	323	R	C
Q9H8J5	LB/B	-	K7FQF9	55	V	I
Q9H8J5	LB/B	-	K7FQF9	375	N	Y
Q9H8J5	LB/B	-	K7FQF9	165	D	N
Q9H8J5	LB/B	-	K7FQF9	141	L	V
P78559	LB/B	-	A0A2P4TCQ0	72	F	L
P78559	LB/B	-	A0A2P4TCQ0	335	A	S
P78559	LB/B	-	A0A2P4TCQ0	336	K	T
P78559	LB/B	-	A0A2P4TCQ0	353	A	S
P78559	LB/B	-	A0A2P4TCQ0	357	A	S
P78559	LB/B	-	A0A2P4TCQ0	364	K	Q
P78559	LB/B	-	A0A2P4TCQ0	485	K	Q
P78559	LB/B	-	A0A2P4TCQ0	830	T	A
P78559	LB/B	-	A0A2P4TCQ0	1078	N	S
P78559	LB/B	-	A0A2P4TCQ0	1102	I	T
P78559	LB/B	-	A0A2P4TCQ0	1185	R	H
P78559	LB/B	-	A0A2P4TCQ0	1245	D	N
P78559	LB/B	-	A0A2P4TCQ0	1461	D	N
P78559	LB/B	-	A0A2P4TCQ0	1553	Q	H
P78559	LB/B	-	A0A2P4TCQ0	1605	K	N
P78559	LB/B	-	A0A2P4TCQ0	1650	W	C
P78559	LB/B	-	A0A2P4TCQ0	1690	A	S
P78559	LB/B	-	A0A2P4TCQ0	1827	P	A
P78559	LB/B	-	A0A2P4TCQ0	1881	A	P
P78559	LB/B	-	A0A2P4TCQ0	1912	A	V
P78559	LB/B	-	A0A2P4TCQ0	1938	S	R
P78559	LB/B	-	A0A2P4TCQ0	2056	S	R
P78559	LB/B	-	A0A2P4TCQ0	2214	H	Y
P78559	LB/B	-	A0A2P4TCQ0	2327	D	V
P78559	LB/B	-	A0A2P4TCQ0	2461	I	T
P78559	LB/B	-	A0A2P4TCQ0	2405	T	I
P78559	LB/B	-	A0A2P4TCQ0	2465	D	N
P46821	LB/B	-	A0A1A7WRG4	594	I	V
P46821	LB/B	-	A0A1A7WRG4	869	E	G
P46821	LB/B	-	A0A1A7WRG4	1296	P	L
P46821	LB/B	-	A0A1A7WRG4	1917	S	R
P46821	LB/B	-	A0A1A7WRG4	923	I	T
P46821	LB/B	-	A0A1A7WRG4	1838	F	L
Q66K74	LB/B	-	A0A146T6H3	411	S	C
Q66K74	LB/B	-	A0A146T6H3	538	P	Q
Q66K74	LB/B	-	A0A146T6H3	372	L	V
P11137	LB/B	-	F7F0B6	82	A	G
P11137	LB/B	-	F7F0B6	423	R	K
P11137	LB/B	-	F7F0B6	179	E	G
P11137	LB/B	-	F7F0B6	976	H	L
P11137	LB/B	-	F7F0B6	991	G	R
P11137	LB/B	-	F7F0B6	1099	M	V
Q02750	LP/P	Cardiofaciocutaneous syndrome 3 (CFC3) [MIM:615279]	D6W868	53	F	S
Q02750	LP/P	Cardiofaciocutaneous syndrome 3 (CFC3) [MIM:615279]	D6W868	130	Y	C
Q02750	LP/P	Cardiofaciocutaneous syndrome 3 (CFC3) [MIM:615279]	D6W868	128	G	V
Q02750	LP/P	Melorheostosis, isolated (MEL) [MIM:155950]	D6W868	56	Q	P
Q02750	LP/P	Melorheostosis, isolated (MEL) [MIM:155950]	D6W868	57	K	E
Q02750	LP/P	Melorheostosis, isolated (MEL) [MIM:155950]	D6W868	57	K	N
P36507	LP/P	Cardiofaciocutaneous syndrome 4 (CFC4) [MIM:615280]	D6W868	57	F	C
P36507	LP/P	Cardiofaciocutaneous syndrome 4 (CFC4) [MIM:615280]	D6W868	57	F	V
P36507	LP/P	Cardiofaciocutaneous syndrome 4 (CFC4) [MIM:615280]	D6W868	128	P	Q
P36507	LP/P	Cardiofaciocutaneous syndrome 4 (CFC4) [MIM:615280]	D6W868	134	Y	H
P46734	LB/B	-	K7GNK7	26	R	T
P46734	LB/B	-	K7GNK7	40	P	T
P46734	LB/B	-	K7GNK7	68	S	P
P46734	LB/B	-	K7GNK7	84	A	T
P46734	LB/B	-	K7GNK7	90	M	I
P46734	LB/B	-	K7GNK7	94	R	L
P46734	LB/B	-	K7GNK7	96	R	W
P46734	LB/B	-	K7GNK7	293	R	H
P46734	LB/B	-	K7GNK7	339	V	M
P46734	LB/B	-	K7GNK7	55	R	T
P45985	LB/B	-	F7BGB2	16	S	R
O14733	LB/B	-	A0A212D251	259	L	F
O14733	LB/B	-	A0A212D251	118	N	S
O14733	LB/B	-	A0A212D251	138	R	C
O14733	LB/B	-	A0A212D251	195	A	T
Q12852	LB/B	-	H2MP03	628	G	R
Q12852	LB/B	-	H2MP03	640	G	S
O43283	LB/B	-	H2MP03	915	R	H
O43283	LB/B	-	H2MP03	517	R	G
O43283	LB/B	-	H2MP03	712	E	K
O43283	LB/B	-	H2MP03	44	E	K
Q99558	LB/B	-	G7PV20	140	S	N
Q99558	LB/B	-	G7PV20	764	T	A
Q99558	LB/B	-	G7PV20	928	P	H
Q99558	LB/B	-	G7PV20	255	T	M
Q99558	LB/B	-	G7PV20	674	H	Y
Q6ZN16	LB/B	-	H2SSQ5	192	A	T
Q6ZN16	LB/B	-	H2SSQ5	199	S	N
Q6ZN16	LB/B	-	H2SSQ5	226	D	H
Q6ZN16	LB/B	-	H2SSQ5	456	S	G
Q6ZN16	LB/B	-	H2SSQ5	494	R	C
Q6ZN16	LB/B	-	H2SSQ5	838	G	S
Q6ZN16	LB/B	-	H2SSQ5	993	S	L
Q6ZN16	LB/B	-	H2SSQ5	1029	N	H
Q6ZN16	LB/B	-	H2SSQ5	1251	Q	E
Q9NYL2	LB/B	-	F7EFG9	531	S	L
Q9NYL2	LB/B	-	F7EFG9	267	T	M
Q9NYL2	LB/B	-	F7EFG9	281	A	V
Q9NYL2	LB/B	-	F7EFG9	580	R	W
Q9NYL2	LB/B	-	F7EFG9	740	P	T
Q9NYL2	LB/B	-	F7EFG9	773	Y	H
Q9NYL2	LB/B	-	F7EFG9	784	K	T
Q9NYL2	LP/P	Split-foot malformation with mesoaxial polydactyly (SFMMP) [MIM:616890]	F7EFG9	368	F	C
Q9NYL2	LP/P	Split-foot malformation with mesoaxial polydactyly (SFMMP) [MIM:616890]	F7EFG9	505	A	S
Q5TCX8	LB/B	-	A0A2K6RHT2	420	D	N
Q5TCX8	LB/B	-	A0A2K6RHT2	563	E	D
Q5TCX8	LB/B	-	A0A2K6RHT2	597	S	F
Q5TCX8	LB/B	-	A0A2K6RHT2	728	V	I
Q5TCX8	LB/B	-	A0A2K6RHT2	741	E	D
Q5TCX8	LB/B	-	A0A2K6RHT2	784	C	G
Q5TCX8	LB/B	-	A0A2K6RHT2	892	R	W
Q5TCX8	LB/B	-	A0A2K6RHT2	900	T	I
Q5TCX8	LB/B	-	A0A2K6RHT2	977	R	C
Q5TCX8	LB/B	-	A0A2K6RHT2	982	P	L
Q99759	LB/B	-	A0A0Q3RFR3	325	A	G
Q99759	LB/B	-	A0A0Q3RFR3	435	A	G
Q99759	LB/B	-	A0A0Q3RFR3	281	V	M
Q9Y6R4	LB/B	-	M7B005	294	I	T
Q9Y6R4	LB/B	-	M7B005	335	V	I
Q9Y6R4	LB/B	-	M7B005	566	R	H
Q9Y6R4	LB/B	-	M7B005	584	Q	H
Q9Y6R4	LB/B	-	M7B005	906	H	P
Q9Y6R4	LB/B	-	M7B005	1492	A	V
Q9Y6R4	LB/B	-	M7B005	157	R	H
Q99683	LB/B	-	H2SSQ5	1006	G	R
Q99683	LB/B	-	H2SSQ5	1214	I	T
Q99683	LB/B	-	H2SSQ5	1250	I	V
Q99683	LB/B	-	H2SSQ5	1314	T	I
Q99683	LB/B	-	H2SSQ5	1315	D	N
O95382	LB/B	-	A0A091SH86	455	T	I
O95382	LB/B	-	A0A091SH86	622	N	K
O95382	LB/B	-	A0A091SH86	969	S	N
O95382	LB/B	-	A0A091SH86	499	R	C
O95382	LB/B	-	A0A091SH86	544	R	W
O95382	LB/B	-	A0A091SH86	668	R	G
O95382	LB/B	-	A0A091SH86	673	R	L
O95382	LB/B	-	A0A091SH86	1061	A	T
O95382	LB/B	-	A0A091SH86	1233	G	A
P41279	LB/B	-	E7F4L2	214	S	F
P27816	LB/B	-	F6WJS4	427	S	Y
P27816	LB/B	-	F6WJS4	441	E	Q
P27816	LB/B	-	F6WJS4	23	R	Q
P27816	LB/B	-	F6WJS4	366	P	L
P27816	LB/B	-	F6WJS4	367	S	P
P27816	LB/B	-	F6WJS4	409	D	G
P27816	LB/B	-	F6WJS4	628	V	I
P27816	LB/B	-	F6WJS4	994	I	V
Q96JE9	LB/B	-	A0A1U8C033	247	I	M
Q96T17	LB/B	-	H3BA58	182	N	S
Q8IWC1	LB/B	-	A0A2J8WX95	502	E	A
Q8IWC1	LB/B	-	A0A2J8WX95	628	Q	R
Q8IWC1	LB/B	-	A0A2J8WX95	561	K	R
Q49MG5	LB/B	-	K7FUL2	177	R	W
Q49MG5	LB/B	-	K7FUL2	146	M	V
Q49MG5	LB/B	-	K7FUL2	499	K	R
Q49MG5	LB/B	-	K7FUL2	601	N	D
P28482	LP/P	Noonan syndrome 13 (NS13) [MIM:619087]	F7FMZ6	74	I	N
P28482	LP/P	Noonan syndrome 13 (NS13) [MIM:619087]	F7FMZ6	80	H	Y
P28482	LP/P	Noonan syndrome 13 (NS13) [MIM:619087]	F7FMZ6	174	A	V
P28482	LP/P	Noonan syndrome 13 (NS13) [MIM:619087]	F7FMZ6	318	D	G
P28482	LP/P	Noonan syndrome 13 (NS13) [MIM:619087]	F7FMZ6	318	D	N
P28482	LP/P	Noonan syndrome 13 (NS13) [MIM:619087]	F7FMZ6	322	E	Q
P28482	LP/P	Noonan syndrome 13 (NS13) [MIM:619087]	F7FMZ6	323	P	R
Q15759	LB/B	-	A0A1U8BH43	275	R	H
P53778	LB/B	-	A0A1V4KWS3	244	T	M
P53778	LB/B	-	A0A1V4KWS3	103	T	M
P53778	LB/B	-	A0A1V4KWS3	230	D	N
O15264	LB/B	-	F7I5F4	41	S	L
O15264	LB/B	-	F7I5F4	282	A	V
O15264	LB/B	-	F7I5F4	300	A	T
Q8TD08	LB/B	-	A0A287AXJ5	221	T	K
Q8TD08	LB/B	-	A0A287AXJ5	505	S	P
P27361	LB/B	-	A0A2U3Z2Q3	323	E	K
Q16659	LB/B	-	A0A212CUV4	290	L	V
Q13387	LB/B	-	A0A286XZA0	743	P	L
Q9UPT6	LB/B	-	A0A091DUJ5	753	T	A
Q9UPT6	LP/P	Neurodevelopmental disorder with or without variable brain abnormalities (NEDBA) [MIM:618443]	A0A091DUJ5	444	L	P
Q9UPT6	LP/P	Neurodevelopmental disorder with or without variable brain abnormalities (NEDBA) [MIM:618443]	A0A091DUJ5	578	R	C
Q9UPT6	LP/P	Neurodevelopmental disorder with or without variable brain abnormalities (NEDBA) [MIM:618443]	A0A091DUJ5	1146	R	C
Q16644	LB/B	-	A0A2K5M297	276	D	Y
Q16644	LP/P	Macular dystrophy, patterned, 3 (MDPT3) [MIM:617111]	A0A2K5M297	173	L	P
Q8IW41	LB/B	-	A0A0S7H1E7	67	M	I
Q8IW41	LB/B	-	A0A0S7H1E7	282	R	K
O60336	LB/B	-	L9JCQ8	204	Y	S
O60336	LB/B	-	L9JCQ8	313	L	V
O60336	LB/B	-	L9JCQ8	1240	R	P
Q15555	LB/B	-	A0A091DA92	162	Y	C
Q15555	LP/P	Skin creases, congenital symmetric circumferential, 2 (CSCSC2) [MIM:616734]	A0A091DA92	68	N	S
Q15555	LP/P	Skin creases, congenital symmetric circumferential, 2 (CSCSC2) [MIM:616734]	A0A091DA92	87	Y	C
Q15555	LP/P	Skin creases, congenital symmetric circumferential, 2 (CSCSC2) [MIM:616734]	A0A091DA92	143	R	C
P10636	LB/B	-	A0A091DB38	285	D	N
P10636	LB/B	-	A0A091DB38	289	V	A
P10636	LB/B	-	A0A091DB38	441	Y	H
P10636	LB/B	-	A0A091DB38	447	S	P
P10636	LP/P	Pick disease of the brain (PIDB) [MIM:172700]	A0A091DB38	574	K	T
P10636	LP/P	Frontotemporal dementia (FTD) [MIM:600274]	A0A091DB38	589	G	V
P10636	LP/P	Frontotemporal dementia (FTD) [MIM:600274]	A0A091DB38	596	N	K
P10636	LP/P	Frontotemporal dementia (FTD) [MIM:600274]	A0A091DB38	618	P	L
P10636	LP/P	Frontotemporal dementia (FTD) [MIM:600274]	A0A091DB38	618	P	S
P10636	LP/P	Frontotemporal dementia (FTD) [MIM:600274]	A0A091DB38	622	S	N
P10636	LP/P	Frontotemporal dementia (FTD) [MIM:600274]	A0A091DB38	654	V	M
P10636	LP/P	Pick disease of the brain (PIDB) [MIM:172700]	A0A091DB38	706	G	R
P10636	LB/B	-	A0A091DB38	723	R	W
P10636	LP/P	Frontotemporal dementia (FTD) [MIM:600274]	A0A091DB38	5	R	H
P10636	LP/P	Progressive supranuclear palsy 1 (PSNP1) [MIM:601104]	A0A091DB38	5	R	L
P10636	LP/P	Frontotemporal dementia (FTD) [MIM:600274]	A0A091DB38	583	L	V
P10636	LP/P	Frontotemporal dementia (FTD) [MIM:600274]	A0A091DB38	613	N	H
P10636	LP/P	Pick disease of the brain (PIDB) [MIM:172700]	A0A091DB38	637	S	F
P10636	LP/P	Frontotemporal dementia (FTD) [MIM:600274]	A0A091DB38	659	E	V
P10636	LB/B	-	A0A091DB38	669	S	L
P10636	LP/P	Pick disease of the brain (PIDB) [MIM:172700]	A0A091DB38	686	K	I
P10636	LP/P	Progressive supranuclear palsy 1 (PSNP1) [MIM:601104]	A0A091DB38	620	G	V
P10636	LP/P	Frontotemporal dementia (FTD) [MIM:600274]	A0A091DB38	634	K	M
P10636	LB/B	-	A0A091DB38	370	R	W
P10636	LB/B	-	A0A091DB38	17	T	M
P10636	LB/B	-	A0A091DB38	30	T	A
P10636	LB/B	-	A0A091DB38	617	V	I
P10636	LP/P	Frontotemporal dementia (FTD) [MIM:600274]	A0A091DB38	590	G	R
Q9P0N8	LB/B	-	T0NLB8	54	A	T
Q9P0N8	LB/B	-	T0NLB8	219	R	P
O60337	LB/B	-	A0A2D4FEU4	622	P	L
Q9H992	LB/B	-	F7E7Y0	100	T	S
Q9H992	LB/B	-	F7E7Y0	193	T	I
Q9H992	LB/B	-	F7E7Y0	379	G	S
P29966	LB/B	-	A0A2K6PYD8	250	P	L
P29966	LB/B	-	A0A2K6PYD8	274	A	V
Q9UEW3	LB/B	-	H0V108	282	F	S
Q9P0L2	LB/B	-	G5AQS8	645	R	G
Q9P0L2	LB/B	-	G5AQS8	530	V	M
Q9P0L2	LB/B	-	G5AQS8	578	P	L
Q9P0L2	LB/B	-	G5AQS8	691	E	G
P27448	LB/B	-	A0A0P7VFW0	429	V	A
P27448	LB/B	-	A0A0P7VFW0	443	S	G
P27448	LB/B	-	A0A0P7VFW0	410	S	F
P27448	LP/P	Visual impairment and progressive phthisis bulbi (VIPB) [MIM:618283]	A0A0P7VFW0	570	R	G
Q96L34	LB/B	-	I3MHI3	377	R	Q
P56192	LB/B	-	A0A146WDL2	683	A	D
P56192	LP/P	Interstitial lung and liver disease (ILLD) [MIM:615486]	A0A146WDL2	370	F	L
P56192	LP/P	Interstitial lung and liver disease (ILLD) [MIM:615486]	A0A146WDL2	523	I	T
P56192	LP/P	Charcot-Marie-Tooth disease, axonal, 2U (CMT2U) [MIM:616280]	A0A146WDL2	618	R	C
P56192	LP/P	Charcot-Marie-Tooth disease, axonal, 2U (CMT2U) [MIM:616280]	A0A146WDL2	800	P	T
P56192	LB/B	-	A0A146WDL2	206	P	L
P56192	LP/P	Interstitial lung and liver disease (ILLD) [MIM:615486]	A0A146WDL2	344	Y	C
P56192	LP/P	Interstitial lung and liver disease (ILLD) [MIM:615486]	A0A146WDL2	393	A	T
P56192	LP/P	Interstitial lung and liver disease (ILLD) [MIM:615486]	A0A146WDL2	567	S	L
P56192	LP/P	Interstitial lung and liver disease (ILLD) [MIM:615486]	A0A146WDL2	605	D	V
P56192	LB/B	-	A0A146WDL2	727	R	Q
Q96GW9	LP/P	Combined oxidative phosphorylation deficiency 25 (COXPD25) [MIM:616430]	B4N9J4	142	R	W
Q8N4S9	LB/B	-	F1QIE2	33	T	I
Q96A59	LB/B	-	A0A2I2UKH4	60	E	K
Q9Y2H9	LB/B	-	W5PLB2	1292	P	S
Q9Y2H9	LB/B	-	W5PLB2	1048	A	S
Q9Y2H9	LP/P	Mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations (MCCCHCM) [MIM:618273]	W5PLB2	517	G	S
Q6P0Q8	LB/B	-	A0A096NEK1	69	L	F
Q6P0Q8	LB/B	-	A0A096NEK1	388	D	E
Q6P0Q8	LB/B	-	A0A096NEK1	659	I	M
Q6P0Q8	LB/B	-	A0A096NEK1	991	R	L
Q6P0Q8	LB/B	-	A0A096NEK1	1197	K	R
Q6P0Q8	LB/B	-	A0A096NEK1	1221	D	E
Q6P0Q8	LB/B	-	A0A096NEK1	1246	R	L
Q6P0Q8	LB/B	-	A0A096NEK1	1304	V	M
Q6P0Q8	LB/B	-	A0A096NEK1	1463	A	T
Q6P0Q8	LB/B	-	A0A096NEK1	1468	G	A
Q6P0Q8	LB/B	-	A0A096NEK1	1551	D	G
Q6P0Q8	LB/B	-	A0A096NEK1	1673	K	R
Q6P0Q8	LB/B	-	A0A096NEK1	1703	G	E
Q6P0Q8	LB/B	-	A0A096NEK1	1608	T	I
O60307	LB/B	-	A0A1U8DKS7	883	G	S
O60307	LB/B	-	A0A1U8DKS7	203	R	Q
O60307	LB/B	-	A0A1U8DKS7	861	G	S
O60307	LP/P	Developmental and epileptic encephalopathy 108 (DEE108) [MIM:620115]	A0A1U8DKS7	104	S	L
O60307	LP/P	Developmental and epileptic encephalopathy 108 (DEE108) [MIM:620115]	A0A1U8DKS7	406	R	P
O60307	LP/P	Developmental and epileptic encephalopathy 108 (DEE108) [MIM:620115]	A0A1U8DKS7	510	G	S
O60307	LP/P	Developmental and epileptic encephalopathy 108 (DEE108) [MIM:620115]	A0A1U8DKS7	515	G	S
O60307	LP/P	Developmental and epileptic encephalopathy 108 (DEE108) [MIM:620115]	A0A1U8DKS7	516	L	P
Q00266	LP/P	Methionine adenosyltransferase deficiency (MATD) [MIM:250850]	A0A060TA33	55	A	D
Q00266	LP/P	Methionine adenosyltransferase deficiency (MATD) [MIM:250850]	A0A060TA33	199	R	C
Q00266	LP/P	Methionine adenosyltransferase deficiency (MATD) [MIM:250850]	A0A060TA33	264	R	H
Q00266	LP/P	Methionine adenosyltransferase deficiency (MATD) [MIM:250850]	A0A060TA33	305	L	P
Q00266	LP/P	Methionine adenosyltransferase deficiency (MATD) [MIM:250850]	A0A060TA33	322	I	M
Q00266	LP/P	Methionine adenosyltransferase deficiency (MATD) [MIM:250850]	A0A060TA33	356	R	Q
Q00266	LP/P	Methionine adenosyltransferase deficiency (MATD) [MIM:250850]	A0A060TA33	357	P	L
Q00266	LP/P	Methionine adenosyltransferase deficiency (MATD) [MIM:250850]	A0A060TA33	378	G	S
Q00266	LB/B	-	A0A060TA33	119	Q	H
Q00266	LP/P	Methionine adenosyltransferase deficiency (MATD) [MIM:250850]	A0A060TA33	38	S	N
Q00266	LP/P	Methionine adenosyltransferase deficiency (MATD) [MIM:250850]	A0A060TA33	264	R	C
Q00266	LP/P	Methionine adenosyltransferase deficiency (MATD) [MIM:250850]	A0A060TA33	336	G	R
Q00266	LP/P	Methionine adenosyltransferase deficiency (MATD) [MIM:250850]	A0A060TA33	344	E	A
Q9NZL9	LB/B	-	L9JJA9	293	A	T
P42679	LB/B	-	A0A2Y9M2A1	496	A	T
O00339	LB/B	-	K7G476	356	K	E
O00339	LB/B	-	K7G476	14	G	A
O00339	LB/B	-	K7G476	187	T	M
O00339	LB/B	-	K7G476	599	A	T
O00339	LB/B	-	K7G476	855	T	M
O00339	LB/B	-	K7G476	932	V	I
O15232	LP/P	Multiple epiphyseal dysplasia 5 (EDM5) [MIM:607078]	A0A2K5VF97	121	R	W
O15232	LP/P	Multiple epiphyseal dysplasia 5 (EDM5) [MIM:607078]	A0A2K5VF97	194	V	D
O15232	LB/B	-	A0A2K5VF97	303	T	M
O15232	LB/B	-	A0A2K5VF97	11	P	S
O15232	LP/P	Multiple epiphyseal dysplasia 5 (EDM5) [MIM:607078]	A0A2K5VF97	120	T	M
O15232	LP/P	Multiple epiphyseal dysplasia 5 (EDM5) [MIM:607078]	A0A2K5VF97	128	A	P
O15232	LP/P	Multiple epiphyseal dysplasia 5 (EDM5) [MIM:607078]	A0A2K5VF97	134	E	K
O15232	LP/P	Multiple epiphyseal dysplasia 5 (EDM5) [MIM:607078]	A0A2K5VF97	192	I	N
O15232	LP/P	Multiple epiphyseal dysplasia 5 (EDM5) [MIM:607078]	A0A2K5VF97	219	A	D
O15232	LB/B	-	A0A2K5VF97	252	E	K
O15232	LP/P	Spondyloepimetaphyseal dysplasia, Borochowitz-Cormier-Daire type (SEMDBCD) [MIM:608728]	A0A2K5VF97	304	C	S
O15232	LP/P	Multiple epiphyseal dysplasia 5 (EDM5) [MIM:607078]	A0A2K5VF97	105	F	S
O15232	LP/P	Multiple epiphyseal dysplasia 5 (EDM5) [MIM:607078]	A0A2K5VF97	70	R	H
O15232	LP/P	Multiple epiphyseal dysplasia 5 (EDM5) [MIM:607078]	A0A2K5VF97	195	T	K
O15232	LP/P	Multiple epiphyseal dysplasia 5 (EDM5) [MIM:607078]	A0A2K5VF97	218	Y	N
O15232	LP/P	Multiple epiphyseal dysplasia 5 (EDM5) [MIM:607078]	A0A2K5VF97	173	A	D
O15232	LP/P	Multiple epiphyseal dysplasia 5 (EDM5) [MIM:607078]	A0A2K5VF97	209	R	P
O15232	LP/P	Multiple epiphyseal dysplasia 5 (EDM5) [MIM:607078]	A0A2K5VF97	231	K	N
O15232	LP/P	Multiple epiphyseal dysplasia 5 (EDM5) [MIM:607078]	A0A2K5VF97	245	V	M
O95460	LB/B	-	H2RM06	13	L	F
O95460	LB/B	-	H2RM06	164	R	S
Q7Z434	LB/B	-	M1P2Z4	409	S	F
Q7Z434	LB/B	-	M1P2Z4	79	C	F
Q7Z434	LB/B	-	M1P2Z4	93	Q	E
Q7Z434	LB/B	-	M1P2Z4	198	Q	K
Q7Z434	LB/B	-	M1P2Z4	79	C	S
P02144	LB/B	-	A0A146ZR58	55	E	K
P02144	LB/B	-	A0A146ZR58	134	K	N
P02144	LB/B	-	A0A146ZR58	140	R	Q
P02144	LB/B	-	A0A146ZR58	140	R	W
Q9UIS9	LB/B	-	A0A286YDI1	401	P	A
Q8WWY6	LB/B	-	A0A1S3GJS1	190	R	C
O95243	LB/B	-	L5K8S1	273	A	S
O95243	LB/B	-	L5K8S1	342	S	P
O95243	LB/B	-	L5K8S1	346	E	K
O95243	LB/B	-	L5K8S1	568	D	H
O95243	LB/B	-	L5K8S1	273	A	T
O95243	LB/B	-	L5K8S1	358	I	T
O95243	LB/B	-	L5K8S1	61	C	R
O95243	LP/P	Melanoma, uveal, 1 (UVM1) [MIM:606660]	L5K8S1	468	R	W
Q9P267	LB/B	-	A0A1L8ENV6	677	S	N
Q9NS73	LB/B	-	A0A2I3NI65	7	L	H
Q9NS73	LB/B	-	A0A2I3NI65	22	R	S
A4D2B0	LB/B	-	A0A0F8CFL9	79	P	H
A4D2B0	LB/B	-	A0A0F8CFL9	114	H	N
Q68D91	LB/B	-	A0A2T1DSF4	128	T	A
Q6ZNC8	LB/B	-	M7BR90	450	I	V
Q6ZWT7	LB/B	-	A0A2K6EN99	501	T	A
Q96T53	LB/B	-	A0A226PXC0	231	G	E
Q96T53	LB/B	-	A0A226PXC0	46	T	A
Q96N66	LB/B	-	A0A1A6FW49	261	F	L
Q96N66	LB/B	-	A0A1A6FW49	415	V	L
Q01726	LB/B	-	E1UXX8	84	D	E
Q01726	LB/B	-	E1UXX8	92	V	M
Q01726	LB/B	-	E1UXX8	151	R	C
Q01726	LB/B	-	E1UXX8	160	R	W
Q01726	LB/B	-	E1UXX8	294	D	H
Q01726	LB/B	-	E1UXX8	67	R	Q
Q01726	LB/B	-	E1UXX8	163	R	Q
Q01726	LB/B	-	E1UXX8	40	I	T
Q01726	LB/B	-	E1UXX8	60	V	L
Q01726	LB/B	-	E1UXX8	122	V	M
Q01726	LB/B	-	E1UXX8	155	I	T
Q01726	LB/B	-	E1UXX8	156	V	L
Q01726	LB/B	-	E1UXX8	196	F	L
Q01726	LB/B	-	E1UXX8	162	R	P
Q01726	LB/B	-	E1UXX8	89	G	R
Q01726	LB/B	-	E1UXX8	95	T	M
Q01726	LB/B	-	E1UXX8	104	G	S
Q01726	LB/B	-	E1UXX8	120	I	T
Q01726	LB/B	-	E1UXX8	157	T	I
Q01726	LB/B	-	E1UXX8	159	P	T
Q01726	LB/B	-	E1UXX8	166	A	G
Q01726	LB/B	-	E1UXX8	171	A	S
Q01726	LP/P	Melanoma, cutaneous malignant 5 (CMM5) [MIM:613099]	E1UXX8	38	V	M
Q01726	LP/P	Melanoma, cutaneous malignant 5 (CMM5) [MIM:613099]	E1UXX8	41	S	F
Q01726	LP/P	Melanoma, cutaneous malignant 5 (CMM5) [MIM:613099]	E1UXX8	51	V	A
Q01726	LP/P	Melanoma, cutaneous malignant 5 (CMM5) [MIM:613099]	E1UXX8	128	M	T
Q01726	LB/B	-	E1UXX8	142	R	H
Q01726	LB/B	-	E1UXX8	281	N	S
Q01726	LP/P	Melanoma, cutaneous malignant 5 (CMM5) [MIM:613099]	E1UXX8	289	C	R
Q01718	LB/B	-	E1UXX8	27	P	R
Q01718	LP/P	Glucocorticoid deficiency 1 (GCCD1) [MIM:202200]	E1UXX8	74	S	I
Q01718	LP/P	Glucocorticoid deficiency 1 (GCCD1) [MIM:202200]	E1UXX8	120	S	R
Q01718	LP/P	Glucocorticoid deficiency 1 (GCCD1) [MIM:202200]	E1UXX8	128	R	C
Q01718	LP/P	Glucocorticoid deficiency 1 (GCCD1) [MIM:202200]	E1UXX8	146	R	H
Q01718	LP/P	Glucocorticoid deficiency 1 (GCCD1) [MIM:202200]	E1UXX8	103	D	N
Q01718	LP/P	Glucocorticoid deficiency 1 (GCCD1) [MIM:202200]	E1UXX8	137	R	W
Q01718	LP/P	Glucocorticoid deficiency 1 (GCCD1) [MIM:202200]	E1UXX8	107	D	N
Q01718	LP/P	Glucocorticoid deficiency 1 (GCCD1) [MIM:202200]	E1UXX8	251	C	F
Q01718	LP/P	Glucocorticoid deficiency 1 (GCCD1) [MIM:202200]	E1UXX8	254	Y	C
Q01718	LB/B	-	E1UXX8	278	F	C
Q01718	LB/B	-	E1UXX8	137	R	P
P41968	LB/B	-	D1GLS5	44	V	I
P41968	LB/B	-	D1GLS5	146	I	N
P41968	LB/B	-	D1GLS5	298	I	S
P32245	LP/P	Obesity (OBESITY) [MIM:601665]	A0A1A6H0R7	30	S	F
P32245	LP/P	Obesity (OBESITY) [MIM:601665]	A0A1A6H0R7	37	D	V
P32245	LP/P	Obesity (OBESITY) [MIM:601665]	A0A1A6H0R7	78	P	L
P32245	LB/B	-	A0A1A6H0R7	103	V	I
P32245	LB/B	-	A0A1A6H0R7	112	T	M
P32245	LP/P	Obesity (OBESITY) [MIM:601665]	A0A1A6H0R7	165	R	W
P32245	LB/B	-	A0A1A6H0R7	251	I	L
P32245	LP/P	Obesity (OBESITY) [MIM:601665]	A0A1A6H0R7	252	G	S
P32245	LP/P	Obesity (OBESITY) [MIM:601665]	A0A1A6H0R7	317	I	T
P32245	LP/P	Obesity (OBESITY) [MIM:601665]	A0A1A6H0R7	274	N	S
P32245	LP/P	Obesity (OBESITY) [MIM:601665]	A0A1A6H0R7	11	T	A
P32245	LP/P	Obesity (OBESITY) [MIM:601665]	A0A1A6H0R7	36	S	Y
P32245	LP/P	Obesity (OBESITY) [MIM:601665]	A0A1A6H0R7	50	V	M
P32245	LP/P	Obesity (OBESITY) [MIM:601665]	A0A1A6H0R7	58	S	C
P32245	LP/P	Obesity (OBESITY) [MIM:601665]	A0A1A6H0R7	62	N	S
P32245	LP/P	Obesity (OBESITY) [MIM:601665]	A0A1A6H0R7	97	N	D
P32245	LP/P	Obesity (OBESITY) [MIM:601665]	A0A1A6H0R7	102	I	S
P32245	LP/P	Obesity (OBESITY) [MIM:601665]	A0A1A6H0R7	102	I	T
P32245	LP/P	Obesity (OBESITY) [MIM:601665]	A0A1A6H0R7	106	L	P
P32245	LP/P	Obesity (OBESITY) [MIM:601665]	A0A1A6H0R7	125	I	K
P32245	LP/P	Obesity (OBESITY) [MIM:601665]	A0A1A6H0R7	127	S	L
P32245	LP/P	Obesity (OBESITY) [MIM:601665]	A0A1A6H0R7	165	R	Q
P32245	LP/P	Obesity (OBESITY) [MIM:601665]	A0A1A6H0R7	170	I	V
P32245	LP/P	Obesity (OBESITY) [MIM:601665]	A0A1A6H0R7	175	A	T
P32245	LP/P	Obesity (OBESITY) [MIM:601665]	A0A1A6H0R7	181	G	D
P32245	LP/P	Obesity (OBESITY) [MIM:601665]	A0A1A6H0R7	219	A	V
P32245	LB/B	-	A0A1A6H0R7	226	I	T
P32245	LP/P	Obesity (OBESITY) [MIM:601665]	A0A1A6H0R7	253	V	I
P32245	LP/P	Obesity (OBESITY) [MIM:601665]	A0A1A6H0R7	271	C	R
P32245	LP/P	Obesity (OBESITY) [MIM:601665]	A0A1A6H0R7	271	C	Y
P32245	LP/P	Obesity (OBESITY) [MIM:601665]	A0A1A6H0R7	316	I	S
P32245	LP/P	Obesity (OBESITY) [MIM:601665]	A0A1A6H0R7	325	L	F
P32245	LP/P	Obesity (OBESITY) [MIM:601665]	A0A1A6H0R7	72	N	K
Q8IVS2	LB/B	-	A0A2P4THJ7	303	A	G
Q9HCC0	LP/P	3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]	W8KTK2	99	E	Q
Q9HCC0	LP/P	3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]	W8KTK2	155	R	Q
Q9HCC0	LP/P	3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]	W8KTK2	167	C	R
Q9HCC0	LP/P	3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]	W8KTK2	173	S	L
Q9HCC0	LP/P	3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]	W8KTK2	193	R	C
Q9HCC0	LP/P	3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]	W8KTK2	218	A	T
Q9HCC0	LP/P	3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]	W8KTK2	268	R	T
Q9HCC0	LP/P	3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]	W8KTK2	310	P	R
Q9HCC0	LP/P	3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]	W8KTK2	339	V	M
Q9HCC0	LP/P	3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]	W8KTK2	437	I	V
Q9HCC0	LB/B	-	W8KTK2	478	A	G
Q9HCC0	LP/P	3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]	W8KTK2	280	D	Y
Q9HCC0	LP/P	3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]	W8KTK2	459	P	S
Q9HCC0	LP/P	3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]	W8KTK2	39	S	F
Q9HCC0	LP/P	3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]	W8KTK2	101	S	F
Q9HCC0	LP/P	3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]	W8KTK2	131	C	F
Q9HCC0	LP/P	3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]	W8KTK2	146	Y	N
Q9HCC0	LP/P	3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]	W8KTK2	152	K	T
Q9HCC0	LP/P	3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]	W8KTK2	155	R	W
Q9HCC0	LP/P	3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]	W8KTK2	169	Y	D
Q9HCC0	LP/P	3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]	W8KTK2	190	H	R
Q9HCC0	LP/P	3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]	W8KTK2	190	H	Y
Q9HCC0	LP/P	3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]	W8KTK2	193	R	H
Q9HCC0	LP/P	3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]	W8KTK2	218	A	V
Q9HCC0	LP/P	3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]	W8KTK2	220	G	E
Q9HCC0	LP/P	3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]	W8KTK2	224	P	L
Q9HCC0	LP/P	3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]	W8KTK2	237	G	D
Q9HCC0	LP/P	3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]	W8KTK2	266	H	L
Q9HCC0	LP/P	3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]	W8KTK2	282	H	R
Q9HCC0	LP/P	3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]	W8KTK2	340	D	V
Q9HCC0	LP/P	3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]	W8KTK2	352	G	R
Q9HCC0	LP/P	3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]	W8KTK2	355	L	F
Q9HCC0	LP/P	3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]	W8KTK2	375	V	F
Q9HCC0	LP/P	3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]	W8KTK2	403	N	T
Q9HCC0	LP/P	3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]	W8KTK2	434	V	L
Q9HCC0	LP/P	3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]	W8KTK2	456	A	V
Q9HCC0	LP/P	3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]	W8KTK2	475	G	R
Q9HCC0	LP/P	3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]	W8KTK2	477	Q	R
Q9HCC0	LP/P	3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]	W8KTK2	517	G	R
Q9HCC0	LP/P	3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]	W8KTK2	520	Y	S
Q9HCC0	LP/P	3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]	W8KTK2	523	S	G
Q9HCC0	LP/P	3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]	W8KTK2	555	K	E
Q9HCC0	LP/P	3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]	W8KTK2	139	T	I
Q9HCC0	LP/P	3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]	W8KTK2	214	G	A
Q9HCC0	LP/P	3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]	W8KTK2	216	C	W
Q9HCC0	LP/P	3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]	W8KTK2	230	N	D
Q9HCC0	LP/P	3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]	W8KTK2	318	Y	C
Q9HCC0	LP/P	3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]	W8KTK2	319	G	R
Q9HCC0	LP/P	3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]	W8KTK2	393	Q	P
Q9HCC0	LP/P	3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]	W8KTK2	410	G	D
Q9HCC0	LP/P	3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]	W8KTK2	410	G	R
Q9HCC0	LP/P	3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]	W8KTK2	461	F	V
Q9HCC0	LP/P	3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]	W8KTK2	524	A	T
P59942	LB/B	-	L8I112	42	E	K
P59942	LB/B	-	L8I112	45	S	N
P59942	LB/B	-	L8I112	53	T	M
Q96PE7	LB/B	-	G1QAH5	104	R	L
Q96PE7	LB/B	-	G1QAH5	76	A	V
Q8IX19	LB/B	-	A0A2Y9M1L7	167	I	V
Q8IX19	LB/B	-	A0A2Y9M1L7	175	L	V
Q8IX19	LB/B	-	A0A2Y9M1L7	129	V	I
Q86YR7	LB/B	-	A0A2Y9DXS4	159	T	M
Q86YR7	LB/B	-	A0A2Y9DXS4	277	N	S
Q86YR7	LB/B	-	A0A2Y9DXS4	359	I	L
Q86YR7	LB/B	-	A0A2Y9DXS4	378	Q	L
Q86YR7	LB/B	-	A0A2Y9DXS4	589	F	S
Q86YR7	LB/B	-	A0A2Y9DXS4	772	F	L
Q86YR7	LB/B	-	A0A2Y9DXS4	902	T	A
Q86YR7	LB/B	-	A0A2Y9DXS4	1015	M	T
Q8NI22	LP/P	Factor V and factor VIII combined deficiency 2 (F5F8D2) [MIM:613625]	A0A0A0MXQ5	129	D	E
Q8NI22	LP/P	Factor V and factor VIII combined deficiency 2 (F5F8D2) [MIM:613625]	A0A0A0MXQ5	136	I	T
Q8NI22	LP/P	Factor V and factor VIII combined deficiency 2 (F5F8D2) [MIM:613625]	A0A0A0MXQ5	81	D	H
Q8NI22	LP/P	Factor V and factor VIII combined deficiency 2 (F5F8D2) [MIM:613625]	A0A0A0MXQ5	135	Y	N
Q99705	LB/B	-	G1M5I7	32	N	D
Q99705	LB/B	-	G1M5I7	25	T	M
Q99705	LB/B	-	G1M5I7	28	D	V
Q99705	LB/B	-	G1M5I7	34	G	R
Q99705	LB/B	-	G1M5I7	210	R	H
Q99705	LB/B	-	G1M5I7	250	Y	H
Q99705	LB/B	-	G1M5I7	305	T	M
Q99705	LB/B	-	G1M5I7	317	R	Q
Q99705	LB/B	-	G1M5I7	377	P	S
Q99705	LB/B	-	G1M5I7	411	T	M
Q99705	LB/B	-	G1M5I7	103	G	R
D6RGH6	LP/P	Ciliary dyskinesia, primary, 42 (CILD42) [MIM:618695]	A0A2Y9FB72	366	G	D
D6RGH6	LP/P	Ciliary dyskinesia, primary, 42 (CILD42) [MIM:618695]	A0A2Y9FB72	381	R	H
Q07820	LB/B	-	A0A1L1RUS7	173	E	D
Q07820	LB/B	-	A0A1L1RUS7	227	A	V
Q07820	LB/B	-	A0A1L1RUS7	231	M	L
Q7L590	LB/B	-	A0A087Y6X2	134	K	R
Q7L590	LB/B	-	A0A087Y6X2	541	T	S
Q7L590	LB/B	-	A0A087Y6X2	669	K	R
Q7L590	LB/B	-	A0A087Y6X2	195	A	P
Q7L590	LB/B	-	A0A087Y6X2	418	A	V
Q7L590	LP/P	Immunodeficiency 80 with or without congenital cardiomyopathy (IMD80) [MIM:619313]	A0A087Y6X2	427	R	C
P49736	LB/B	-	A0A1A9Y6F9	396	A	T
P49736	LB/B	-	A0A1A9Y6F9	667	V	M
P49736	LB/B	-	A0A1A9Y6F9	727	A	T
P49736	LB/B	-	A0A1A9Y6F9	68	D	E
P49736	LB/B	-	A0A1A9Y6F9	135	L	F
P49736	LB/B	-	A0A1A9Y6F9	166	E	Q
P49736	LB/B	-	A0A1A9Y6F9	501	G	R
P49736	LP/P	Deafness, autosomal dominant, 70 (DFNA70) [MIM:616968]	A0A1A9Y6F9	44	R	C
P25205	LB/B	-	B4I0Q6	105	S	G
P25205	LB/B	-	B4I0Q6	280	D	V
P25205	LB/B	-	B4I0Q6	287	F	L
P25205	LB/B	-	B4I0Q6	777	E	K
P25205	LB/B	-	B4I0Q6	590	I	L
P25205	LB/B	-	B4I0Q6	774	R	W
P33992	LB/B	-	A0A091CL01	136	S	T
P33992	LB/B	-	A0A091CL01	180	T	S
P33992	LB/B	-	A0A091CL01	258	V	I
P33992	LP/P	Meier-Gorlin syndrome 8 (MGORS8) [MIM:617564]	A0A091CL01	466	T	I
Q14566	LB/B	-	D8QT69	35	E	V
Q14566	LB/B	-	D8QT69	806	E	K
P33993	LB/B	-	K7E231	144	N	S
P33993	LB/B	-	K7E231	473	G	S
P33993	LB/B	-	K7E231	114	R	Q
Q9UJA3	LB/B	-	A0A1U8BWX8	63	Q	K
Q9UJA3	LB/B	-	A0A1U8BWX8	101	K	N
Q9UJA3	LB/B	-	A0A1U8BWX8	183	N	S
Q9UJA3	LB/B	-	A0A1U8BWX8	341	E	K
Q9UJA3	LB/B	-	A0A1U8BWX8	365	S	N
Q9UJA3	LB/B	-	A0A1U8BWX8	785	N	S
Q9UJA3	LP/P	Premature ovarian failure 10 (POF10) [MIM:612885]	A0A1U8BWX8	149	P	R
Q4G0Z9	LB/B	-	C3ZP69	137	M	K
Q4G0Z9	LB/B	-	C3ZP69	322	L	V
Q4G0Z9	LB/B	-	C3ZP69	583	S	A
Q9GZU1	LP/P	Mucolipidosis 4 (ML4) [MIM:252650]	A0A061I3P6	106	L	P
Q9GZU1	LP/P	Mucolipidosis 4 (ML4) [MIM:252650]	A0A061I3P6	232	T	P
Q9GZU1	LP/P	Mucolipidosis 4 (ML4) [MIM:252650]	A0A061I3P6	362	D	Y
Q9GZU1	LP/P	Mucolipidosis 4 (ML4) [MIM:252650]	A0A061I3P6	446	V	L
Q9GZU1	LP/P	Mucolipidosis 4 (ML4) [MIM:252650]	A0A061I3P6	447	L	P
Q9GZU1	LP/P	Mucolipidosis 4 (ML4) [MIM:252650]	A0A061I3P6	465	F	L
Q9GZU1	LP/P	Mucolipidosis 4 (ML4) [MIM:252650]	A0A061I3P6	403	R	C
Q8IZK6	LB/B	-	A0A146PRS0	365	M	V
Q8IZK6	LB/B	-	A0A146PRS0	370	K	Q
Q6DN14	LB/B	-	V8PD35	612	R	K
Q6DN12	LB/B	-	U3IT52	877	A	T
Q9ULC4	LB/B	-	A0A1A6GQF3	106	L	H
Q9NWR8	LB/B	-	M3WPT1	253	Y	F
Q9NWR8	LB/B	-	M3WPT1	255	I	V
Q9NWR8	LB/B	-	M3WPT1	63	I	N
Q14676	LB/B	-	A0A2K5XPV0	251	E	K
Q14676	LB/B	-	A0A2K5XPV0	268	R	K
Q14676	LB/B	-	A0A2K5XPV0	371	E	K
Q14676	LB/B	-	A0A2K5XPV0	586	S	A
Q14676	LB/B	-	A0A2K5XPV0	1509	E	D
Q14676	LB/B	-	A0A2K5XPV0	1540	S	P
Q14676	LB/B	-	A0A2K5XPV0	536	I	M
Q14676	LB/B	-	A0A2K5XPV0	1545	Q	R
Q14676	LB/B	-	A0A2K5XPV0	179	R	C
Q14676	LB/B	-	A0A2K5XPV0	386	P	L
Q14676	LB/B	-	A0A2K5XPV0	917	R	S
Q14676	LB/B	-	A0A2K5XPV0	1100	P	A
Q14676	LB/B	-	A0A2K5XPV0	1112	S	F
Q14676	LB/B	-	A0A2K5XPV0	1180	S	P
Q14676	LB/B	-	A0A2K5XPV0	1745	P	R
Q14676	LB/B	-	A0A2K5XPV0	1791	V	E
Q14676	LB/B	-	A0A2K5XPV0	1855	D	E
Q14676	LB/B	-	A0A2K5XPV0	1883	R	Q
Q14676	LB/B	-	A0A2K5XPV0	1904	R	Q
Q8NFP4	LB/B	-	G1NZL8	61	L	P
Q8NFP4	LB/B	-	G1NZL8	935	P	S
Q7Z553	LB/B	-	G1NZL8	608	V	F
P40925	LP/P	Developmental and epileptic encephalopathy 88 (DEE88) [MIM:618959]	A0A1J1IYL1	120	A	V
Q5I0G3	LB/B	-	V8PFU9	510	E	D
Q5I0G3	LB/B	-	V8PFU9	515	T	A
P40926	LB/B	-	L9K4S9	9	A	V
P40926	LP/P	Developmental and epileptic encephalopathy 51 (DEE51) [MIM:617339]	L9K4S9	37	G	R
P40926	LP/P	Developmental and epileptic encephalopathy 51 (DEE51) [MIM:617339]	L9K4S9	133	P	L
P40926	LP/P	Developmental and epileptic encephalopathy 51 (DEE51) [MIM:617339]	L9K4S9	207	P	L
Q8TC05	LB/B	-	A0A2I0MJ27	103	T	I
Q8TC05	LB/B	-	A0A2I0MJ27	383	V	I
Q8TC05	LB/B	-	A0A2I0MJ27	489	R	H
Q8TC05	LB/B	-	A0A2I0MJ27	552	P	L
O15151	LB/B	-	W5QG42	175	I	T
O15151	LB/B	-	W5QG42	406	T	I
O15151	LP/P	Bone marrow failure syndrome 6 (BMFS6) [MIM:618849]	W5QG42	454	T	M
Q9NU22	LB/B	-	S7PSE7	440	F	V
Q9NU22	LB/B	-	S7PSE7	1559	S	N
Q9NU22	LB/B	-	S7PSE7	4044	A	S
Q9NU22	LB/B	-	S7PSE7	660	I	V
Q9NU22	LB/B	-	S7PSE7	1044	A	V
Q9NU22	LB/B	-	S7PSE7	1929	H	D
Q9NU22	LB/B	-	S7PSE7	2972	H	P
Q9NU22	LB/B	-	S7PSE7	3004	E	K
Q9NU22	LB/B	-	S7PSE7	3423	H	Y
Q9NU22	LB/B	-	S7PSE7	3794	A	G
Q9NU22	LB/B	-	S7PSE7	3986	R	L
Q9NU22	LB/B	-	S7PSE7	4167	A	T
Q9NU22	LB/B	-	S7PSE7	4720	I	T
Q9NU22	LB/B	-	S7PSE7	4783	D	E
Q9NU22	LB/B	-	S7PSE7	5251	N	K
P23368	LB/B	-	F6QV43	114	P	L
P23368	LB/B	-	F6QV43	450	G	E
Q16626	LB/B	-	G3T451	183	A	D
Q6P9B6	LB/B	-	L8ITB9	10	R	L
Q6P9B6	LB/B	-	L8ITB9	97	H	Q
Q6P9B6	LB/B	-	L8ITB9	172	D	E
Q6P9B6	LB/B	-	L8ITB9	220	I	V
Q6P9B6	LB/B	-	L8ITB9	233	E	D
Q6P9B6	LB/B	-	L8ITB9	267	C	R
Q6P9B6	LB/B	-	L8ITB9	443	S	L
Q03112	LB/B	-	L8IY26	120	P	S
Q03112	LB/B	-	L8IY26	295	Q	R
Q03112	LP/P	Radioulnar synostosis with amegakaryocytic thrombocytopenia 2 (RUSAT2) [MIM:616738]	L8IY26	929	R	W
Q03112	LP/P	Radioulnar synostosis with amegakaryocytic thrombocytopenia 2 (RUSAT2) [MIM:616738]	L8IY26	930	H	R
Q03112	LP/P	Radioulnar synostosis with amegakaryocytic thrombocytopenia 2 (RUSAT2) [MIM:616738]	L8IY26	935	T	A
P51608	LP/P	Rett syndrome (RTT) [MIM:312750]	G3TGQ2	106	R	W
P51608	LP/P	Rett syndrome (RTT) [MIM:312750]	G3TGQ2	133	R	C
P51608	LP/P	Rett syndrome (RTT) [MIM:312750]	G3TGQ2	155	F	S
P51608	LP/P	Rett syndrome (RTT) [MIM:312750]	G3TGQ2	158	T	M
P51608	LP/P	Rett syndrome (RTT) [MIM:312750]	G3TGQ2	101	P	R
P51608	LP/P	Rett syndrome (RTT) [MIM:312750]	G3TGQ2	124	L	F
P51608	LP/P	Rett syndrome (RTT) [MIM:312750]	G3TGQ2	134	S	C
P51608	LP/P	Intellectual developmental disorder, X-linked, syndromic 13 (MRXS13) [MIM:300055]	G3TGQ2	140	A	V
P51608	LP/P	Rett syndrome (RTT) [MIM:312750]	G3TGQ2	152	P	R
P51608	LB/B	-	G3TGQ2	201	A	V
P51608	LP/P	Rett syndrome (RTT) [MIM:312750]	G3TGQ2	306	R	C
P51608	LB/B	-	G3TGQ2	397	E	K
P51608	LP/P	Rett syndrome (RTT) [MIM:312750]	G3TGQ2	100	L	V
P51608	LP/P	Intellectual developmental disorder, X-linked, syndromic 13 (MRXS13) [MIM:300055]	G3TGQ2	137	E	G
P51608	LP/P	Rett syndrome (RTT) [MIM:312750]	G3TGQ2	10	E	Q
P51608	LB/B	-	G3TGQ2	86	S	C
P51608	LP/P	Rett syndrome (RTT) [MIM:312750]	G3TGQ2	97	D	Y
P51608	LP/P	Rett syndrome (RTT) [MIM:312750]	G3TGQ2	101	P	H
P51608	LP/P	Rett syndrome (RTT) [MIM:312750]	G3TGQ2	101	P	L
P51608	LP/P	Rett syndrome (RTT) [MIM:312750]	G3TGQ2	101	P	T
P51608	LP/P	Rett syndrome (RTT) [MIM:312750]	G3TGQ2	106	R	Q
P51608	LP/P	Rett syndrome (RTT) [MIM:312750]	G3TGQ2	111	R	G
P51608	LP/P	Rett syndrome (RTT) [MIM:312750]	G3TGQ2	128	Q	P
P51608	LP/P	Rett syndrome (RTT) [MIM:312750]	G3TGQ2	133	R	H
P51608	LP/P	Rett syndrome (RTT) [MIM:312750]	G3TGQ2	135	K	E
P51608	LP/P	Rett syndrome (RTT) [MIM:312750]	G3TGQ2	156	D	G
P51608	LP/P	Intellectual developmental disorder, X-linked, syndromic 13 (MRXS13) [MIM:300055]	G3TGQ2	167	R	W
P51608	LB/B	-	G3TGQ2	181	A	V
P51608	LB/B	-	G3TGQ2	196	T	S
P51608	LB/B	-	G3TGQ2	197	T	M
P51608	LB/B	-	G3TGQ2	203	T	M
P51608	LP/P	Rett syndrome (RTT) [MIM:312750]	G3TGQ2	210	K	I
P51608	LP/P	Rett syndrome (RTT) [MIM:312750]	G3TGQ2	225	P	R
P51608	LB/B	-	G3TGQ2	228	T	S
P51608	LB/B	-	G3TGQ2	229	S	L
P51608	LB/B	-	G3TGQ2	232	G	A
P51608	LB/B	-	G3TGQ2	251	P	L
P51608	LP/P	Intellectual developmental disorder, X-linked, syndromic 13 (MRXS13) [MIM:300055]	G3TGQ2	284	K	E
P51608	LB/B	-	G3TGQ2	287	A	P
P51608	LB/B	-	G3TGQ2	291	S	A
P51608	LP/P	Rett syndrome (RTT) [MIM:312750]	G3TGQ2	302	P	A
P51608	LP/P	Rett syndrome (RTT) [MIM:312750]	G3TGQ2	302	P	H
P51608	LP/P	Rett syndrome (RTT) [MIM:312750]	G3TGQ2	302	P	L
P51608	LP/P	Rett syndrome (RTT) [MIM:312750]	G3TGQ2	302	P	R
P51608	LP/P	Rett syndrome (RTT) [MIM:312750]	G3TGQ2	305	K	R
P51608	LP/P	Rett syndrome (RTT) [MIM:312750]	G3TGQ2	306	R	H
P51608	LP/P	Rett syndrome (RTT) [MIM:312750]	G3TGQ2	322	P	A
P51608	LP/P	Rett syndrome (RTT) [MIM:312750]	G3TGQ2	322	P	L
P51608	LP/P	Rett syndrome (RTT) [MIM:312750]	G3TGQ2	344	R	W
P51608	LB/B	-	G3TGQ2	359	S	P
P51608	LB/B	-	G3TGQ2	376	P	S
P51608	LB/B	-	G3TGQ2	394	E	K
P51608	LB/B	-	G3TGQ2	402	P	L
P51608	LB/B	-	G3TGQ2	412	V	I
P51608	LB/B	-	G3TGQ2	439	A	T
P51608	LB/B	-	G3TGQ2	444	A	T
P51608	LP/P	Intellectual developmental disorder, X-linked, syndromic 13 (MRXS13) [MIM:300055]	G3TGQ2	453	R	Q
P51608	LB/B	-	G3TGQ2	480	P	S
P51608	LP/P	Rett syndrome (RTT) [MIM:312750]	G3TGQ2	97	D	E
P51608	LP/P	Rett syndrome (RTT) [MIM:312750]	G3TGQ2	100	L	R
P51608	LP/P	Rett syndrome (RTT) [MIM:312750]	G3TGQ2	101	P	S
P51608	LP/P	Rett syndrome (RTT) [MIM:312750]	G3TGQ2	120	Y	D
P51608	LP/P	Rett syndrome (RTT) [MIM:312750]	G3TGQ2	155	F	I
P51608	LP/P	Rett syndrome (RTT) [MIM:312750]	G3TGQ2	158	T	A
P51608	LP/P	Rett syndrome (RTT) [MIM:312750]	G3TGQ2	161	G	V
P51608	LB/B	-	G3TGQ2	388	P	L
P51608	LP/P	Intellectual developmental disorder, X-linked, syndromic 13 (MRXS13) [MIM:300055]	G3TGQ2	225	P	L
P51608	LP/P	Intellectual developmental disorder, X-linked, syndromic 13 (MRXS13) [MIM:300055]	G3TGQ2	322	P	S
P51608	LP/P	-	G3TGQ2	305	K	N
Q9BV79	LB/B	-	U3KN23	96	F	L
Q9BV79	LB/B	-	U3KN23	227	R	K
Q9BV79	LB/B	-	U3KN23	258	R	L
Q9BV79	LP/P	Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities (DYTOABG) [MIM:617282]	U3KN23	232	G	E
Q9BV79	LP/P	Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities (DYTOABG) [MIM:617282]	U3KN23	258	R	W
Q9BV79	LP/P	Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities (DYTOABG) [MIM:617282]	U3KN23	285	Y	C
Q93074	LP/P	Opitz-Kaveggia syndrome (OKS) [MIM:305450]	H9GMB7	961	R	W
Q93074	LP/P	Intellectual developmental disorder, X-linked, syndromic, Lujan-Fryns type (MRXSLF) [MIM:309520]	H9GMB7	1007	N	S
Q93074	LB/B	-	H9GMB7	1392	Q	R
Q93074	LP/P	Ohdo syndrome, X-linked (OHDOX) [MIM:300895]	H9GMB7	1148	R	H
Q93074	LP/P	Ohdo syndrome, X-linked (OHDOX) [MIM:300895]	H9GMB7	1165	S	P
Q93074	LP/P	Ohdo syndrome, X-linked (OHDOX) [MIM:300895]	H9GMB7	1729	H	N
Q86YW9	LB/B	-	H9GMB7	401	Q	P
Q86YW9	LB/B	-	H9GMB7	464	E	K
Q86YW9	LB/B	-	H9GMB7	903	Q	H
Q86YW9	LB/B	-	H9GMB7	1210	R	Q
Q86YW9	LB/B	-	H9GMB7	1698	R	Q
Q9Y2X0	LB/B	-	A0A2J7QX62	770	L	F
Q9Y2X0	LB/B	-	A0A2J7QX62	874	E	K
Q9ULK4	LP/P	Intellectual developmental disorder, autosomal recessive 18, with or without epilepsy (MRT18) [MIM:614249]	R7TT05	611	R	Q
Q71SY5	LP/P	Charcot-Marie-Tooth disease, axonal, 2B2 (CMT2B2) [MIM:605589]	L5L527	335	A	V
Q71SY5	LP/P	Basel-Vanagaite-Smirin-Yosef syndrome (BVSYS) [MIM:616449]	L5L527	39	Y	C
Q14814	LB/B	-	A0A0F8AVZ6	434	P	S
Q7Z7M0	LP/P	Carpenter syndrome 2 (CRPT2) [MIM:614976]	A0A1W4Y7R9	199	G	R
Q7Z7M0	LP/P	Carpenter syndrome 2 (CRPT2) [MIM:614976]	A0A1W4Y7R9	1566	R	H
Q7Z7M0	LP/P	Carpenter syndrome 2 (CRPT2) [MIM:614976]	A0A1W4Y7R9	2434	S	G
Q5TIA1	LB/B	-	S9XK58	657	E	Q
Q5TIA1	LB/B	-	S9XK58	853	S	T
Q5TIA1	LB/B	-	S9XK58	1049	K	E
Q8N635	LB/B	-	F6Y9C7	261	I	T
Q8N635	LB/B	-	F6Y9C7	75	K	T
Q8N635	LB/B	-	F6Y9C7	18	T	P
Q8N635	LP/P	Spermatogenic failure 22 (SPGF22) [MIM:617706]	F6Y9C7	64	N	I
A2RUB1	LB/B	-	G1KMF1	311	M	L
A2RUB1	LB/B	-	G1KMF1	320	N	T
O00470	LB/B	-	H0VBR2	272	R	H
Q14680	LB/B	-	A0A091UVW4	56	T	M
Q14680	LB/B	-	A0A091UVW4	219	K	R
Q14680	LB/B	-	A0A091UVW4	333	R	K
Q14680	LB/B	-	A0A091UVW4	348	T	I
P08582	LB/B	-	H3BCZ0	294	R	W
P08582	LB/B	-	H3BCZ0	559	A	T
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	12	P	L
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	22	L	R
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	26	E	K
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	39	L	W
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	42	G	D
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	45	E	G
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	139	H	D
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	139	H	Y
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	135	K	I
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	144	F	V
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	165	A	P
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	169	A	D
O00255	LB/B	-	L5LFE9	176	R	Q
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	177	D	Y
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	181	A	P
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	184	E	D
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	188	W	S
O00255	LP/P	-	L5LFE9	189	V	E
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	228	L	P
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	247	A	V
O00255	LP/P	-	L5LFE9	260	E	K
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	269	L	P
O00255	LP/P	-	L5LFE9	272	L	P
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	289	A	E
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	291	L	P
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	314	A	P
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	319	R	P
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	342	A	D
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	346	W	R
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	349	T	R
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	364	E	K
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	373	A	D
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	423	D	N
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	441	W	R
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	452	F	S
O00255	LB/B	-	L5LFE9	546	T	A
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	560	S	N
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	161	G	D
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	246	C	R
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	45	E	K
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	98	R	L
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	110	G	E
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	139	H	P
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	139	H	R
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	158	D	V
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	159	S	I
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	160	S	F
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	165	A	T
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	167	V	F
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	170	C	R
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	173	L	P
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	184	E	K
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	184	E	Q
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	186	H	R
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	188	W	R
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	220	V	M
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	230	G	R
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	234	R	L
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	245	V	F
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	246	C	F
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	246	C	Y
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	258	S	P
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	264	L	R
O00255	LP/P	-	L5LFE9	265	Q	P
O00255	LP/P	-	L5LFE9	282	P	H
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	286	G	R
O00255	LP/P	-	L5LFE9	310	G	D
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	316	T	P
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	322	H	R
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	322	H	Y
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	325	P	L
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	325	P	R
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	330	A	P
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	342	A	P
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	347	A	P
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	353	I	N
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	358	Y	D
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	360	R	W
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	362	D	H
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	377	I	M
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	378	P	S
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	390	A	V
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	416	A	P
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	419	L	P
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	420	R	P
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	423	D	H
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	426	C	Y
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	428	W	S
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	432	S	R
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	441	W	C
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	449	L	P
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	532	R	C
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	545	P	S
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	549	P	S
O00255	LB/B	-	L5LFE9	557	T	S
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	560	S	R
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	147	I	F
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	418	L	R
O00255	LP/P	Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100]	L5LFE9	476	W	C
P50221	LB/B	-	A0A218UM87	27	S	L
Q16819	LB/B	-	S7MK32	469	V	L
Q16819	LB/B	-	S7MK32	634	M	V
Q16819	LB/B	-	S7MK32	476	R	G
Q16819	LB/B	-	S7MK32	726	T	M
Q16819	LB/B	-	S7MK32	606	T	S
Q16820	LB/B	-	A0A1S2ZL20	326	V	M
Q16820	LB/B	-	A0A1S2ZL20	695	P	L
Q16820	LB/B	-	A0A1S2ZL20	324	T	A
Q9NQ76	LB/B	-	H0X4A0	330	V	I
Q9BRJ9	LB/B	-	F6UUJ2	53	A	P
P08581	LB/B	-	H3B042	320	A	V
P08581	LP/P	Renal cell carcinoma papillary (RCCP) [MIM:605074]	H3B042	1131	M	T
P08581	LP/P	Renal cell carcinoma papillary (RCCP) [MIM:605074]	H3B042	1188	V	L
P08581	LP/P	Renal cell carcinoma papillary (RCCP) [MIM:605074]	H3B042	1195	L	V
P08581	LP/P	Renal cell carcinoma papillary (RCCP) [MIM:605074]	H3B042	1220	V	I
P08581	LP/P	Renal cell carcinoma papillary (RCCP) [MIM:605074]	H3B042	1228	D	N
P08581	LP/P	Renal cell carcinoma papillary (RCCP) [MIM:605074]	H3B042	1228	D	H
P08581	LP/P	Renal cell carcinoma papillary (RCCP) [MIM:605074]	H3B042	1230	Y	C
P08581	LP/P	Renal cell carcinoma papillary (RCCP) [MIM:605074]	H3B042	1230	Y	H
P08581	LP/P	Renal cell carcinoma papillary (RCCP) [MIM:605074]	H3B042	1250	M	T
P08581	LB/B	-	H3B042	238	L	S
P08581	LB/B	-	H3B042	316	I	M
P08581	LB/B	-	H3B042	375	N	S
P08581	LB/B	-	H3B042	970	R	C
P08581	LB/B	-	H3B042	992	T	I
P08581	LP/P	Renal cell carcinoma papillary (RCCP) [MIM:605074]	H3B042	1092	V	I
P08581	LP/P	Renal cell carcinoma papillary (RCCP) [MIM:605074]	H3B042	1094	H	L
P08581	LP/P	Renal cell carcinoma papillary (RCCP) [MIM:605074]	H3B042	1094	H	R
P08581	LP/P	Renal cell carcinoma papillary (RCCP) [MIM:605074]	H3B042	1094	H	Y
P08581	LP/P	Renal cell carcinoma papillary (RCCP) [MIM:605074]	H3B042	1106	H	D
P08581	LP/P	Hepatocellular carcinoma (HCC) [MIM:114550]	H3B042	1173	T	I
P08581	LP/P	Renal cell carcinoma papillary (RCCP) [MIM:605074]	H3B042	1230	Y	D
P08581	LP/P	Hepatocellular carcinoma (HCC) [MIM:114550]	H3B042	1244	K	R
P08581	LP/P	Hepatocellular carcinoma (HCC) [MIM:114550]	H3B042	1250	M	I
P08581	LB/B	-	H3B042	143	R	Q
P08581	LB/B	-	H3B042	156	S	L
P08581	LB/B	-	H3B042	168	E	D
P08581	LB/B	-	H3B042	150	H	Y
P08581	LB/B	-	H3B042	385	C	Y
P08581	LB/B	-	H3B042	1294	V	I
P08581	LP/P	Deafness, autosomal recessive, 97 (DFNB97) [MIM:616705]	H3B042	841	F	V
P08581	LP/P	-	H3B042	1003	Y	S
P08581	LP/P	Arthrogryposis, distal, 11 (DA11) [MIM:620019]	H3B042	1234	Y	C
Q6UB28	LB/B	-	A0A2U4ACK6	14	G	V
Q8N6R0	LB/B	-	A0A1S3F4U4	105	M	V
Q8N6R0	LB/B	-	A0A1S3F4U4	359	M	I
Q8N6R0	LB/B	-	A0A1S3F4U4	16	Y	C
Q8N6R0	LB/B	-	A0A1S3F4U4	544	R	Q
A6NJ78	LB/B	-	A0A286XR54	31	N	K
A6NJ78	LB/B	-	A0A286XR54	149	A	T
A6NJ78	LB/B	-	A0A286XR54	267	I	F
Q9H7H0	LB/B	-	A0A0R4IJY0	289	G	A
Q9H7H0	LB/B	-	A0A0R4IJY0	346	A	P
Q9H7H0	LB/B	-	A0A0R4IJY0	173	A	S
O95568	LB/B	-	A0A0Q3QNI8	10	E	D
O95568	LB/B	-	A0A0Q3QNI8	325	A	V
O95568	LB/B	-	A0A0Q3QNI8	360	K	M
O95568	LB/B	-	A0A0Q3QNI8	309	F	L
O95568	LB/B	-	A0A0Q3QNI8	318	R	H
Q8WXB1	LB/B	-	I3K6S3	192	T	I
Q9BUU2	LB/B	-	A0A2U4ATK0	59	W	S
Q9BUU2	LB/B	-	A0A2U4ATK0	219	A	T
Q9BUU2	LB/B	-	A0A2U4ATK0	366	A	T
Q9BUU2	LB/B	-	A0A2U4ATK0	375	E	K
Q86XA0	LB/B	-	A0A2Y9GFW2	141	L	V
Q5JXM2	LB/B	-	A0A2K6PEV4	281	L	F
Q8N6Q8	LB/B	-	L5JU14	249	Q	K
Q96FB5	LB/B	-	V5H7Y4	400	V	L
Q96S19	LB/B	-	A0A146L2X7	136	L	P
Q8N6F8	LB/B	-	A0A250YDB6	107	Q	R
Q8N6F8	LB/B	-	A0A250YDB6	171	S	W
Q6P1Q9	LB/B	-	R7TTQ9	124	C	R
Q6P1Q9	LB/B	-	R7TTQ9	129	N	H
Q6P1Q9	LB/B	-	R7TTQ9	169	E	K
Q6P1Q9	LB/B	-	R7TTQ9	266	V	I
Q6P1Q9	LB/B	-	R7TTQ9	68	V	I
Q8N3J2	LB/B	-	E2RJ25	163	L	F
Q8N3J2	LB/B	-	E2RJ25	310	Q	K
Q8N3J2	LB/B	-	E2RJ25	468	V	L
Q8N3J2	LB/B	-	E2RJ25	230	E	D
Q9NRN9	LB/B	-	A0A2K5LHC1	202	V	G
Q5U5Q3	LB/B	-	A0A2K5LQE4	412	T	P
P55083	LB/B	-	S7PHK4	173	A	V
Q13361	LP/P	Aortic aneurysm, familial thoracic 9 (AAT9) [MIM:616166]	A0A2K6D1M2	21	W	L
Q08431	LB/B	-	I3LZ50	76	L	M
Q08431	LB/B	-	I3LZ50	3	R	S
Q9H3U5	LB/B	-	A0A2K6UCV4	24	P	S
Q9H3U5	LB/B	-	A0A2K6UCV4	168	K	E
Q9H3U5	LB/B	-	A0A2K6UCV4	220	I	V
Q9H3U5	LB/B	-	A0A2K6UCV4	271	I	T
O43934	LB/B	-	A0A1S4FYZ9	428	S	F
Q6NUT3	LB/B	-	A0A2D0QVM8	182	Y	H
Q6NUT3	LB/B	-	A0A2D0QVM8	243	R	H
Q6NUT3	LB/B	-	A0A2D0QVM8	476	R	C
Q6NUT3	LB/B	-	A0A2D0QVM8	203	I	V
Q6NUT3	LB/B	-	A0A2D0QVM8	395	G	S
Q5SR56	LB/B	-	A0A1B6CFG6	406	V	L
Q96ES6	LB/B	-	A0A210Q317	292	G	R
Q8N468	LB/B	-	H2ZW39	228	L	I
Q8N468	LB/B	-	H2ZW39	314	G	A
Q5TF39	LB/B	-	A0A1S3GH78	93	S	P
Q6ZSS7	LB/B	-	A0A151NA67	205	R	G
Q8IWD5	LB/B	-	V9KLI8	486	R	H
Q8NHS3	LB/B	-	A0A1S3HJE7	109	V	G
Q8NHS3	LP/P	Ceroid lipofuscinosis, neuronal, 7 (CLN7) [MIM:610951]	A0A1S3HJE7	310	G	D
Q8NHS3	LB/B	-	A0A1S3HJE7	385	G	R
Q8NHS3	LB/B	-	A0A1S3HJE7	423	A	V
Q8NHS3	LP/P	Ceroid lipofuscinosis, neuronal, 7 (CLN7) [MIM:610951]	A0A1S3HJE7	429	G	D
Q8NHS3	LP/P	Ceroid lipofuscinosis, neuronal, 7 (CLN7) [MIM:610951]	A0A1S3HJE7	52	G	R
Q8NHS3	LP/P	Ceroid lipofuscinosis, neuronal, 7 (CLN7) [MIM:610951]	A0A1S3HJE7	121	Y	C
Q8NHS3	LP/P	Ceroid lipofuscinosis, neuronal, 7 (CLN7) [MIM:610951]	A0A1S3HJE7	139	R	H
Q8NHS3	LP/P	Ceroid lipofuscinosis, neuronal, 7 (CLN7) [MIM:610951]	A0A1S3HJE7	157	A	P
Q8NHS3	LP/P	Ceroid lipofuscinosis, neuronal, 7 (CLN7) [MIM:610951]	A0A1S3HJE7	294	T	K
Q8NHS3	LP/P	Ceroid lipofuscinosis, neuronal, 7 (CLN7) [MIM:610951]	A0A1S3HJE7	447	P	L
Q8NHS3	LP/P	Ceroid lipofuscinosis, neuronal, 7 (CLN7) [MIM:610951]	A0A1S3HJE7	465	R	W
Q8NHS3	LP/P	Ceroid lipofuscinosis, neuronal, 7 (CLN7) [MIM:610951]	A0A1S3HJE7	160	T	I
Q8NHS3	LP/P	Ceroid lipofuscinosis, neuronal, 7 (CLN7) [MIM:610951]	A0A1S3HJE7	160	T	N
Q8NHS3	LP/P	Ceroid lipofuscinosis, neuronal, 7 (CLN7) [MIM:610951]	A0A1S3HJE7	458	T	K
Q8NHS3	LP/P	Ceroid lipofuscinosis, neuronal, 7 (CLN7) [MIM:610951]	A0A1S3HJE7	465	R	Q
Q8NHS3	LP/P	Ceroid lipofuscinosis, neuronal, 7 (CLN7) [MIM:610951]	A0A1S3HJE7	470	M	V
Q8NHS3	LP/P	Macular dystrophy with central cone involvement (CCMD) [MIM:616170]	A0A1S3HJE7	336	E	Q
Q8NHS3	LP/P	Ceroid lipofuscinosis, neuronal, 7 (CLN7) [MIM:610951]	A0A1S3HJE7	412	P	L
O43451	LB/B	-	A0A2C9KG08	404	Q	H
O43451	LB/B	-	A0A2C9KG08	542	S	L
O43451	LB/B	-	A0A2C9KG08	858	N	D
O43451	LB/B	-	A0A2C9KG08	2534	L	I
Q8TDB4	LB/B	-	A0A2Y9LZF1	128	A	T
P26572	LB/B	-	W5UBY9	223	R	Q
P26572	LB/B	-	W5UBY9	435	L	P
Q10469	LP/P	Congenital disorder of glycosylation 2A (CDG2A) [MIM:212066]	A0A1A8MS27	262	H	R
Q10469	LP/P	Congenital disorder of glycosylation 2A (CDG2A) [MIM:212066]	A0A1A8MS27	290	S	F
Q10469	LP/P	Congenital disorder of glycosylation 2A (CDG2A) [MIM:212066]	A0A1A8MS27	318	N	D
Q9UQ53	LB/B	-	U3JQQ7	491	L	F
Q9UQ53	LB/B	-	U3JQQ7	257	Q	H
Q9UBM8	LB/B	-	D3ZEV3	428	T	S
Q9BQP7	LB/B	-	A0A1S2ZWM7	15	S	C
Q9BQP7	LP/P	Mitochondrial DNA depletion syndrome 11 (MTDPS11) [MIM:615084]	A0A1S2ZWM7	233	Y	C
P16455	LB/B	-	A0A2Y9MT89	30	E	K
P16455	LB/B	-	A0A2Y9MT89	84	L	F
P16455	LB/B	-	A0A2Y9MT89	143	I	V
P16455	LB/B	-	A0A2Y9MT89	160	G	R
P16455	LB/B	-	A0A2Y9MT89	166	E	D
P16455	LB/B	-	A0A2Y9MT89	178	K	R
P16455	LB/B	-	A0A2Y9MT89	65	W	C
P16455	LB/B	-	A0A2Y9MT89	58	P	S
P16455	LB/B	-	A0A2Y9MT89	53	L	F
P16455	LB/B	-	A0A2Y9MT89	112	I	V
P08493	LB/B	-	S7PJ97	53	K	E
P08493	LB/B	-	S7PJ97	102	T	A
Q99735	LB/B	-	I3M482	101	A	V
O14880	LB/B	-	A0A2K6G0Z9	15	G	C
O14880	LB/B	-	A0A2K6G0Z9	48	P	S
Q96PC5	LB/B	-	A0A091GAM2	813	K	N
Q96PC5	LB/B	-	A0A091GAM2	858	K	E
Q96PC5	LB/B	-	A0A091GAM2	968	E	Q
Q96PC5	LB/B	-	A0A091GAM2	983	N	S
Q96PC5	LB/B	-	A0A091GAM2	1307	I	V
Q96PC5	LB/B	-	A0A091GAM2	1346	G	R
Q86YT6	LB/B	-	A0A1U7SR96	174	R	H
Q86YT6	LP/P	Left ventricular non-compaction 7 (LVNC7) [MIM:615092]	A0A1U7SR96	943	V	F
Q29983	LB/B	-	A0A096NPI4	29	R	P
Q29983	LB/B	-	A0A096NPI4	37	W	G
Q29983	LB/B	-	A0A096NPI4	47	T	A
Q29983	LB/B	-	A0A096NPI4	49	V	G
Q29983	LB/B	-	A0A096NPI4	59	C	Y
Q29983	LB/B	-	A0A096NPI4	114	Q	R
Q29983	LB/B	-	A0A096NPI4	128	R	K
Q29983	LB/B	-	A0A096NPI4	137	G	R
Q29983	LB/B	-	A0A096NPI4	145	L	V
Q29983	LB/B	-	A0A096NPI4	147	T	S
Q29983	LB/B	-	A0A096NPI4	148	K	E
Q29983	LB/B	-	A0A096NPI4	152	M	V
Q29983	LB/B	-	A0A096NPI4	165	V	I
Q29983	LB/B	-	A0A096NPI4	174	M	V
Q29983	LB/B	-	A0A096NPI4	179	H	L
Q29983	LB/B	-	A0A096NPI4	196	K	E
Q29983	LB/B	-	A0A096NPI4	198	G	S
Q29983	LB/B	-	A0A096NPI4	199	V	I
Q29983	LB/B	-	A0A096NPI4	204	T	R
Q29983	LB/B	-	A0A096NPI4	229	G	S
Q29983	LB/B	-	A0A096NPI4	231	Y	C
Q29983	LB/B	-	A0A096NPI4	233	W	R
Q29983	LB/B	-	A0A096NPI4	236	T	I
Q29983	LB/B	-	A0A096NPI4	238	S	T
Q29983	LB/B	-	A0A096NPI4	244	V	L
Q29983	LB/B	-	A0A096NPI4	274	Q	R
Q29983	LB/B	-	A0A096NPI4	279	R	S
Q29983	LB/B	-	A0A096NPI4	291	S	G
Q29983	LB/B	-	A0A096NPI4	294	P	A
Q29983	LB/B	-	A0A096NPI4	328	V	I
Q29983	LB/B	-	A0A096NPI4	329	R	C
Q29983	LB/B	-	A0A096NPI4	356	T	M
Q29983	LB/B	-	A0A096NPI4	373	D	A
Q29983	LB/B	-	A0A096NPI4	377	T	A
Q29983	LB/B	-	A0A096NPI4	383	A	T
Q29983	LB/B	-	A0A096NPI4	253	W	S
Q8TDZ2	LB/B	-	W5N104	758	A	E
Q8TDZ2	LB/B	-	W5N104	12	A	T
Q8TDZ2	LB/B	-	W5N104	153	D	A
Q8TDZ2	LB/B	-	W5N104	758	A	T
Q8TDZ2	LB/B	-	W5N104	12	A	S
Q8TDZ2	LB/B	-	W5N104	195	R	H
Q8TDZ2	LB/B	-	W5N104	453	R	C
Q8TDZ2	LB/B	-	W5N104	624	A	T
Q8TDZ2	LB/B	-	W5N104	758	A	K
Q8TDZ2	LB/B	-	W5N104	758	A	S
O94851	LB/B	-	A0A1L8GDY6	1089	R	Q
O94851	LB/B	-	A0A1L8GDY6	220	I	V
O94851	LB/B	-	A0A1L8GDY6	1106	L	P
O94851	LB/B	-	A0A1L8GDY6	145	F	L
O94851	LB/B	-	A0A1L8GDY6	687	D	E
O94851	LB/B	-	A0A1L8GDY6	1110	P	S
O94851	LB/B	-	A0A1L8GDY6	1332	V	I
O94851	LB/B	-	A0A1L8GDY6	1355	Y	S
O94851	LB/B	-	A0A1L8GDY6	1567	A	T
O94851	LB/B	-	A0A1L8GDY6	1575	S	G
O94851	LB/B	-	A0A1L8GDY6	1631	D	E
O94851	LB/B	-	A0A1L8GDY6	1733	T	P
Q7RTP6	LB/B	-	D3ZGN7	750	M	L
Q7RTP6	LB/B	-	D3ZGN7	11	P	A
Q7RTP6	LB/B	-	D3ZGN7	745	R	Q
Q8N3F8	LB/B	-	E1BBG2	519	A	S
Q8N3F8	LB/B	-	E1BBG2	583	P	L
Q8N3F8	LB/B	-	E1BBG2	685	H	R
Q8IY33	LB/B	-	F1PHR8	480	A	P
Q8IY33	LB/B	-	F1PHR8	519	P	L
Q8IY33	LB/B	-	F1PHR8	711	L	V
Q8IY33	LB/B	-	F1PHR8	623	K	R
Q29980	LB/B	-	A0A096NPI4	39	G	E
Q29980	LB/B	-	A0A096NPI4	68	P	H
Q29980	LB/B	-	A0A096NPI4	75	N	D
Q29980	LB/B	-	A0A096NPI4	80	K	E
Q29980	LB/B	-	A0A096NPI4	88	D	G
Q29980	LB/B	-	A0A096NPI4	105	D	G
Q29980	LB/B	-	A0A096NPI4	121	I	M
Q29980	LB/B	-	A0A096NPI4	136	D	N
Q29980	LB/B	-	A0A096NPI4	212	T	I
Q29980	LB/B	-	A0A096NPI4	215	E	K
Q29980	LB/B	-	A0A096NPI4	279	R	K
Q29980	LB/B	-	A0A096NPI4	291	G	S
Q29980	LB/B	-	A0A096NPI4	300	A	V
Q29980	LB/B	-	A0A096NPI4	383	T	A
Q29980	LB/B	-	A0A096NPI4	136	D	H
Q8IYU8	LB/B	-	A0A250Y0T9	260	Q	L
Q8N344	LB/B	-	A0A2I3SG18	68	D	N
Q8N344	LB/B	-	A0A2I3SG18	104	D	N
Q8N344	LB/B	-	A0A2I3SG18	464	P	S
Q8N344	LB/B	-	A0A2I3SG18	485	S	G
Q7Z3K6	LB/B	-	F7E538	126	D	G
Q7Z3K6	LB/B	-	F7E538	414	N	K
Q7Z3K6	LB/B	-	F7E538	432	N	D
Q7Z3K6	LB/B	-	F7E538	530	N	S
Q5JXC2	LB/B	-	Q6AYH0	99	K	N
Q5JXC2	LB/B	-	Q6AYH0	142	P	S
Q5JXC2	LB/B	-	Q6AYH0	167	K	E
Q5JXC2	LB/B	-	Q6AYH0	247	R	W
Q5JXC2	LB/B	-	Q6AYH0	288	S	L
Q5JXC2	LB/B	-	Q6AYH0	381	P	S
Q8N5J2	LB/B	-	F1PUK8	385	T	K
Q4G0A6	LB/B	-	Q3UQI9	183	D	A
Q4G0A6	LB/B	-	Q3UQI9	262	S	L
Q4G0A6	LB/B	-	Q3UQI9	322	T	M
Q4G0A6	LB/B	-	Q3UQI9	324	R	K
Q4G0A6	LB/B	-	Q3UQI9	355	A	V
Q4G0A6	LB/B	-	Q3UQI9	655	M	V
Q4G0A6	LB/B	-	Q3UQI9	465	C	Y
Q9UNW1	LP/P	Thyroid cancer, non-medullary, 2 (NMTC2) [MIM:188470]	A0A2D4KAH8	41	S	L
Q9UNW1	LP/P	Thyroid cancer, non-medullary, 2 (NMTC2) [MIM:188470]	A0A2D4KAH8	270	Q	R
Q9UNW1	LP/P	Pontocerebellar hypoplasia 16 (PCH16) [MIM:619527]	A0A2D4KAH8	53	Y	D
P30301	LP/P	Cataract 15, multiple types (CTRCT15) [MIM:615274]	G3VJV2	134	E	G
P30301	LP/P	Cataract 15, multiple types (CTRCT15) [MIM:615274]	G3VJV2	138	T	R
P30301	LP/P	Cataract 15, multiple types (CTRCT15) [MIM:615274]	G3VJV2	33	R	C
P30301	LB/B	Cataract 15, multiple types (CTRCT15) [MIM:615274]	G3VJV2	107	V	I
P30301	LP/P	Cataract 15, multiple types (CTRCT15) [MIM:615274]	G3VJV2	187	R	C
P30301	LP/P	Cataract 15, multiple types (CTRCT15) [MIM:615274]	G3VJV2	233	R	K
P30301	LP/P	Cataract 15, multiple types (CTRCT15) [MIM:615274]	G3VJV2	150	D	H
Q8TD10	LB/B	-	I3MGN1	141	Q	L
Q9H1L0	LB/B	-	Q9H1L0	27	V	A
Q5T4H9	LB/B	-	A0A2I2UPM8	73	R	P
Q8N6C7	LB/B	-	Q8N6C7	73	R	S
Q8N6C7	LB/B	-	Q8N6C7	91	H	Q
Q8IVT2	LB/B	-	G3VZI6	156	S	G
Q8IVT2	LB/B	-	G3VZI6	232	K	R
Q8IVT2	LB/B	-	G3VZI6	653	E	G
Q8IVT2	LB/B	-	G3VZI6	269	S	N
Q8IVT2	LB/B	-	G3VZI6	99	A	T
Q96FF7	LB/B	-	A0A2K5DM06	198	V	A
O75030	LP/P	Tietz albinism-deafness syndrome (TADS) [MIM:103500]	A0A151MKJ3	317	N	K
O75030	LP/P	Waardenburg syndrome 2A (WS2A) [MIM:193510]	A0A151MKJ3	357	S	P
O75030	LP/P	Waardenburg syndrome 2A (WS2A) [MIM:193510]	A0A151MKJ3	385	N	D
O75030	LP/P	Waardenburg syndrome 2A (WS2A) [MIM:193510]	A0A151MKJ3	405	S	P
O75030	LP/P	Melanoma, cutaneous malignant 8 (CMM8) [MIM:614456]	A0A151MKJ3	425	E	K
O75030	LP/P	Coloboma, osteopetrosis, microphthalmia, macrocephaly, albinism, and deafness (COMMAD) [MIM:617306]	A0A151MKJ3	313	K	N
O75030	LP/P	Coloboma, osteopetrosis, microphthalmia, macrocephaly, albinism, and deafness (COMMAD) [MIM:617306]	A0A151MKJ3	324	R	G
P46013	LB/B	-	A0A1U8BT99	3150	T	S
P46013	LB/B	-	A0A1U8BT99	3217	K	E
P46013	LB/B	-	A0A1U8BT99	1403	E	V
P46013	LB/B	-	A0A1U8BT99	1247	T	I
P46013	LB/B	-	A0A1U8BT99	631	I	L
P46013	LB/B	-	A0A1U8BT99	854	L	V
P46013	LB/B	-	A0A1U8BT99	1042	G	S
P46013	LB/B	-	A0A1U8BT99	2337	T	N
P46013	LB/B	-	A0A1U8BT99	2608	P	L
P46013	LB/B	-	A0A1U8BT99	2720	T	P
P46013	LB/B	-	A0A1U8BT99	2868	T	S
P46013	LB/B	-	A0A1U8BT99	104	N	S
P46013	LB/B	-	A0A1U8BT99	238	W	R
P46013	LB/B	-	A0A1U8BT99	497	E	D
P46013	LB/B	-	A0A1U8BT99	574	Q	P
P46013	LB/B	-	A0A1U8BT99	872	A	V
P46013	LB/B	-	A0A1U8BT99	1120	T	S
P46013	LB/B	-	A0A1U8BT99	1470	L	W
P46013	LB/B	-	A0A1U8BT99	1559	V	M
P46013	LB/B	-	A0A1U8BT99	1622	P	L
P46013	LB/B	-	A0A1U8BT99	1849	T	A
P46013	LB/B	-	A0A1U8BT99	1876	R	Q
P46013	LB/B	-	A0A1U8BT99	2101	I	T
P46013	LB/B	-	A0A1U8BT99	2363	N	S
P46013	LB/B	-	A0A1U8BT99	2649	R	H
P46013	LB/B	-	A0A1U8BT99	2760	D	G
P46013	LB/B	-	A0A1U8BT99	2786	R	Q
P46013	LB/B	-	A0A1U8BT99	2793	S	N
P46013	LB/B	-	A0A1U8BT99	2845	R	H
P46013	LB/B	-	A0A1U8BT99	2904	Q	R
P46013	LB/B	-	A0A1U8BT99	3097	N	D
P46013	LB/B	-	A0A1U8BT99	832	R	W
P46013	LB/B	-	A0A1U8BT99	1951	L	I
P46013	LB/B	-	A0A1U8BT99	3102	E	G
P46013	LB/B	-	A0A1U8BT99	2607	R	H
Q9NPJ1	LP/P	Bardet-Biedl syndrome 6 (BBS6) [MIM:605231]	A0A093GSR9	37	Y	C
Q9NPJ1	LP/P	McKusick-Kaufman syndrome (MKKS) [MIM:236700]	A0A093GSR9	37	Y	C
Q9NPJ1	LB/B	-	A0A093GSR9	49	G	V
Q9NPJ1	LP/P	McKusick-Kaufman syndrome (MKKS) [MIM:236700]	A0A093GSR9	84	H	Y
Q9NPJ1	LB/B	-	A0A093GSR9	517	R	C
Q9NPJ1	LB/B	-	A0A093GSR9	532	G	V
Q9NPJ1	LP/P	Bardet-Biedl syndrome 6 (BBS6) [MIM:605231]	A0A093GSR9	52	G	D
Q9NPJ1	LP/P	Bardet-Biedl syndrome 6 (BBS6) [MIM:605231]	A0A093GSR9	57	T	A
Q9NPJ1	LP/P	Bardet-Biedl syndrome 6 (BBS6) [MIM:605231]	A0A093GSR9	277	L	P
Q9NPJ1	LP/P	Bardet-Biedl syndrome 6 (BBS6) [MIM:605231]	A0A093GSR9	499	C	S
Q9NPJ1	LP/P	Bardet-Biedl syndrome 6 (BBS6) [MIM:605231]	A0A093GSR9	32	I	M
Q9NPJ1	LP/P	Bardet-Biedl syndrome 6 (BBS6) [MIM:605231]	A0A093GSR9	236	S	P
Q9NPJ1	LP/P	Bardet-Biedl syndrome 6 (BBS6) [MIM:605231]	A0A093GSR9	286	D	A
Q9NPJ1	LP/P	Bardet-Biedl syndrome 6 (BBS6) [MIM:605231]	A0A093GSR9	511	S	A
Q9NPJ1	LP/P	Bardet-Biedl syndrome 6 (BBS6) [MIM:605231]	A0A093GSR9	518	R	H
Q9NPJ1	LP/P	Bardet-Biedl syndrome 6 (BBS6) [MIM:605231]	A0A093GSR9	155	R	L
Q9NPJ1	LB/B	-	A0A093GSR9	339	I	V
Q9NPJ1	LP/P	Bardet-Biedl syndrome 6 (BBS6) [MIM:605231]	A0A093GSR9	345	G	E
Q9NPJ1	LP/P	Bardet-Biedl syndrome 6 (BBS6) [MIM:605231]	A0A093GSR9	181	A	P
Q9NPJ1	LP/P	Bardet-Biedl syndrome 6 (BBS6) [MIM:605231]	A0A093GSR9	237	T	A
Q9NPJ1	LP/P	Bardet-Biedl syndrome 6 (BBS6) [MIM:605231]	A0A093GSR9	237	T	P
Q9NPJ1	LB/B	-	A0A093GSR9	325	T	P
Q9NPJ1	LP/P	Bardet-Biedl syndrome 6 (BBS6) [MIM:605231]	A0A093GSR9	460	S	P
Q9NPJ1	LP/P	Bardet-Biedl syndrome 6 (BBS6) [MIM:605231]	A0A093GSR9	41	G	R
Q9NPJ1	LP/P	Bardet-Biedl syndrome 6 (BBS6) [MIM:605231]	A0A093GSR9	99	C	R
Q9NPJ1	LP/P	Bardet-Biedl syndrome 6 (BBS6) [MIM:605231]	A0A093GSR9	299	P	L
Q9NPJ1	LB/B	-	A0A093GSR9	488	A	T
Q9NPJ1	LP/P	Bardet-Biedl syndrome 6 (BBS6) [MIM:605231]	A0A093GSR9	395	H	R
Q9UL63	LB/B	-	A0A1S8W0T0	469	C	G
Q9HBH9	LB/B	-	A0A2Y9IAK3	73	D	N
Q9HBH9	LB/B	-	A0A2Y9IAK3	10	Q	K
Q9HBH9	LB/B	-	A0A2Y9IAK3	428	R	Q
Q9UHC7	LB/B	-	A0A2Y9MIZ0	243	V	L
Q9UHC7	LB/B	-	A0A2Y9MIZ0	439	V	A
Q13064	LP/P	Precocious puberty, central 2 (CPPB2) [MIM:615346]	A0A2Y9MIZ0	365	R	S
Q13064	LP/P	Precocious puberty, central 2 (CPPB2) [MIM:615346]	A0A2Y9MIZ0	340	C	G
Q13064	LP/P	Precocious puberty, central 2 (CPPB2) [MIM:615346]	A0A2Y9MIZ0	417	F	I
Q13064	LP/P	Precocious puberty, central 2 (CPPB2) [MIM:615346]	A0A2Y9MIZ0	420	H	Q
Q8IYA7	LB/B	-	A0A1L8FQR3	40	R	H
Q15049	LP/P	Leukoencephalopathy, megalencephalic, with subcortical cysts, 1 (MLC1) [MIM:604004]	B7Z4G9	93	S	L
Q15049	LP/P	Leukoencephalopathy, megalencephalic, with subcortical cysts, 1 (MLC1) [MIM:604004]	B7Z4G9	118	T	R
Q15049	LP/P	Leukoencephalopathy, megalencephalic, with subcortical cysts, 1 (MLC1) [MIM:604004]	B7Z4G9	212	G	R
Q15049	LP/P	Leukoencephalopathy, megalencephalic, with subcortical cysts, 1 (MLC1) [MIM:604004]	B7Z4G9	280	S	L
Q15049	LB/B	-	B7Z4G9	309	L	M
Q15049	LP/P	Leukoencephalopathy, megalencephalic, with subcortical cysts, 1 (MLC1) [MIM:604004]	B7Z4G9	59	G	E
Q15049	LP/P	Leukoencephalopathy, megalencephalic, with subcortical cysts, 1 (MLC1) [MIM:604004]	B7Z4G9	92	P	S
Q15049	LP/P	Leukoencephalopathy, megalencephalic, with subcortical cysts, 1 (MLC1) [MIM:604004]	B7Z4G9	141	N	K
Q15049	LP/P	Leukoencephalopathy, megalencephalic, with subcortical cysts, 1 (MLC1) [MIM:604004]	B7Z4G9	141	N	S
Q15049	LB/B	-	B7Z4G9	171	C	F
Q15049	LB/B	-	B7Z4G9	344	N	S
Q15049	LP/P	Leukoencephalopathy, megalencephalic, with subcortical cysts, 1 (MLC1) [MIM:604004]	B7Z4G9	69	S	L
Q15049	LP/P	Leukoencephalopathy, megalencephalic, with subcortical cysts, 1 (MLC1) [MIM:604004]	B7Z4G9	80	M	I
Q15049	LP/P	Leukoencephalopathy, megalencephalic, with subcortical cysts, 1 (MLC1) [MIM:604004]	B7Z4G9	84	R	C
Q15049	LP/P	Leukoencephalopathy, megalencephalic, with subcortical cysts, 1 (MLC1) [MIM:604004]	B7Z4G9	125	C	R
Q15049	LP/P	Leukoencephalopathy, megalencephalic, with subcortical cysts, 1 (MLC1) [MIM:604004]	B7Z4G9	245	A	P
Q15049	LP/P	Leukoencephalopathy, megalencephalic, with subcortical cysts, 1 (MLC1) [MIM:604004]	B7Z4G9	246	S	R
Q15049	LP/P	Leukoencephalopathy, megalencephalic, with subcortical cysts, 1 (MLC1) [MIM:604004]	B7Z4G9	320	T	K
P58340	LB/B	-	A0A091DBQ1	226	P	T
Q9UHC1	LB/B	-	H2NLT5	494	H	R
Q9UHC1	LP/P	Hereditary non-polyposis colorectal cancer 7 (HNPCC7) [MIM:614385]	H2NLT5	24	Q	E
Q9UHC1	LP/P	Hereditary non-polyposis colorectal cancer 7 (HNPCC7) [MIM:614385]	H2NLT5	499	N	S
Q9UHC1	LP/P	Hereditary non-polyposis colorectal cancer 7 (HNPCC7) [MIM:614385]	H2NLT5	624	E	Q
Q9UHC1	LP/P	Hereditary non-polyposis colorectal cancer 7 (HNPCC7) [MIM:614385]	H2NLT5	647	R	C
Q9UHC1	LP/P	Hereditary non-polyposis colorectal cancer 7 (HNPCC7) [MIM:614385]	H2NLT5	817	S	G
Q9UHC1	LP/P	Hereditary non-polyposis colorectal cancer 7 (HNPCC7) [MIM:614385]	H2NLT5	981	G	S
Q9UHC1	LP/P	Hereditary non-polyposis colorectal cancer 7 (HNPCC7) [MIM:614385]	H2NLT5	1007	N	S
Q9UHC1	LP/P	Hereditary non-polyposis colorectal cancer 7 (HNPCC7) [MIM:614385]	H2NLT5	1394	A	T
Q9UHC1	LP/P	Hereditary non-polyposis colorectal cancer 7 (HNPCC7) [MIM:614385]	H2NLT5	1451	E	K
Q9UHC1	LB/B	-	H2NLT5	93	R	G
Q9UHC1	LB/B	-	H2NLT5	120	F	S
Q9UHC1	LB/B	-	H2NLT5	231	K	Q
Q9UHC1	LB/B	-	H2NLT5	420	V	I
Q9UHC1	LB/B	-	H2NLT5	492	L	V
Q9UHC1	LB/B	-	H2NLT5	600	R	Q
Q9UHC1	LB/B	-	H2NLT5	606	T	P
Q9UHC1	LB/B	-	H2NLT5	720	Y	C
Q9UHC1	LB/B	-	H2NLT5	723	V	I
Q9UHC1	LB/B	-	H2NLT5	741	V	F
Q9UHC1	LB/B	-	H2NLT5	797	R	H
Q9UHC1	LB/B	-	H2NLT5	844	P	L
Q9UHC1	LB/B	-	H2NLT5	845	S	G
Q9UHC1	LB/B	-	H2NLT5	942	T	I
Q9UHC1	LB/B	-	H2NLT5	966	S	P
Q9UHC1	LB/B	-	H2NLT5	1073	D	N
Q9UHC1	LB/B	-	H2NLT5	1105	D	E
Q9UHC1	LB/B	-	H2NLT5	1163	G	D
Q9UHC1	LB/B	-	H2NLT5	1319	G	R
Q9UHC1	LB/B	-	H2NLT5	826	N	D
Q5VWP3	LB/B	-	A0A087RJV2	170	V	I
Q5VWP3	LB/B	-	A0A087RJV2	855	S	T
Q5VWP3	LB/B	-	A0A087RJV2	911	P	S
Q8NB16	LB/B	-	A0A1A6HUG0	52	S	T
Q8NB16	LB/B	-	A0A1A6HUG0	100	D	E
Q8NB16	LB/B	-	A0A1A6HUG0	132	S	P
Q8NB16	LB/B	-	A0A1A6HUG0	146	R	Q
Q8NB16	LB/B	-	A0A1A6HUG0	169	M	L
Q8NB16	LB/B	-	A0A1A6HUG0	364	T	M
Q8NB16	LB/B	-	A0A1A6HUG0	421	R	H
P55198	LB/B	-	A0A093Q4Z5	198	A	T
P55198	LB/B	-	A0A093Q4Z5	33	A	V
P12872	LB/B	-	H2PIR3	15	V	A
Q9BV36	LB/B	-	L9KKU2	139	R	W
Q9BV36	LB/B	-	L9KKU2	153	L	P
Q9BV36	LB/B	-	L9KKU2	163	D	N
Q9BV36	LB/B	-	L9KKU2	172	G	D
Q9BV36	LB/B	-	L9KKU2	347	H	R
Q9BV36	LB/B	-	L9KKU2	374	V	A
Q9BV36	LP/P	Griscelli syndrome 3 (GS3) [MIM:609227]	L9KKU2	35	R	W
Q9BV36	LB/B	-	L9KKU2	289	T	I
Q9BV36	LB/B	-	L9KKU2	451	P	S
Q9UH92	LB/B	-	A0A2Y9JUQ2	223	Q	R
Q9HAP2	LB/B	-	I3LZ59	396	E	G
Q9HAP2	LB/B	-	I3LZ59	539	V	L
Q9NP71	LB/B	-	I3LZ59	241	Q	H
Q9NP71	LB/B	-	I3LZ59	244	D	E
Q8IVH4	LP/P	Methylmalonic aciduria type cblA (MMAA) [MIM:251100]	G3VR08	207	Y	C
Q8IVH4	LB/B	-	G3VR08	363	Q	H
Q8IVH4	LP/P	Methylmalonic aciduria type cblA (MMAA) [MIM:251100]	G3VR08	89	L	P
Q8IVH4	LP/P	Methylmalonic aciduria type cblA (MMAA) [MIM:251100]	G3VR08	145	R	Q
Q8IVH4	LP/P	Methylmalonic aciduria type cblA (MMAA) [MIM:251100]	G3VR08	218	G	E
Q8IVH4	LP/P	Methylmalonic aciduria type cblA (MMAA) [MIM:251100]	G3VR08	359	R	Q
Q8IVH4	LP/P	Methylmalonic aciduria type cblA (MMAA) [MIM:251100]	G3VR08	359	R	G
Q8IVH4	LP/P	Methylmalonic aciduria type cblA (MMAA) [MIM:251100]	G3VR08	209	R	S
Q8IVH4	LP/P	Methylmalonic aciduria type cblA (MMAA) [MIM:251100]	G3VR08	250	E	K
Q8IVH4	LP/P	Methylmalonic aciduria type cblA (MMAA) [MIM:251100]	G3VR08	274	G	D
Q8IVH4	LP/P	Methylmalonic aciduria type cblA (MMAA) [MIM:251100]	G3VR08	274	G	S
Q8IVH4	LP/P	Methylmalonic aciduria type cblA (MMAA) [MIM:251100]	G3VR08	276	K	E
Q8IVH4	LP/P	Methylmalonic aciduria type cblA (MMAA) [MIM:251100]	G3VR08	98	R	G
Q8IVH4	LP/P	Methylmalonic aciduria type cblA (MMAA) [MIM:251100]	G3VR08	147	G	E
Q8IVH4	LP/P	Methylmalonic aciduria type cblA (MMAA) [MIM:251100]	G3VR08	188	G	R
Q8IVH4	LP/P	Methylmalonic aciduria type cblA (MMAA) [MIM:251100]	G3VR08	192	G	D
Q8IVH4	LP/P	Methylmalonic aciduria type cblA (MMAA) [MIM:251100]	G3VR08	220	V	M
Q8IVH4	LP/P	Methylmalonic aciduria type cblA (MMAA) [MIM:251100]	G3VR08	241	I	F
Q8IVH4	LP/P	Methylmalonic aciduria type cblA (MMAA) [MIM:251100]	G3VR08	243	T	N
Q8IVH4	LP/P	Methylmalonic aciduria type cblA (MMAA) [MIM:251100]	G3VR08	258	D	N
Q8IVH4	LP/P	Methylmalonic aciduria type cblA (MMAA) [MIM:251100]	G3VR08	287	A	D
Q8IVH4	LP/P	Methylmalonic aciduria type cblA (MMAA) [MIM:251100]	G3VR08	292	D	V
Q8IVH4	LP/P	Methylmalonic aciduria type cblA (MMAA) [MIM:251100]	G3VR08	399	G	V
Q9Y4U1	LP/P	Methylmalonic aciduria and homocystinuria, cblC type (MAHCC) [MIM:277400]	A0A2D4P5K6	27	Q	R
Q9Y4U1	LP/P	Methylmalonic aciduria and homocystinuria, cblC type (MAHCC) [MIM:277400]	A0A2D4P5K6	116	L	P
Q9Y4U1	LP/P	Methylmalonic aciduria and homocystinuria, cblC type (MAHCC) [MIM:277400]	A0A2D4P5K6	122	H	R
Q9Y4U1	LP/P	Methylmalonic aciduria and homocystinuria, cblC type (MAHCC) [MIM:277400]	A0A2D4P5K6	130	Y	H
Q9Y4U1	LP/P	Methylmalonic aciduria and homocystinuria, cblC type (MAHCC) [MIM:277400]	A0A2D4P5K6	147	G	A
Q9Y4U1	LP/P	Methylmalonic aciduria and homocystinuria, cblC type (MAHCC) [MIM:277400]	A0A2D4P5K6	147	G	D
Q9Y4U1	LP/P	Methylmalonic aciduria and homocystinuria, cblC type (MAHCC) [MIM:277400]	A0A2D4P5K6	156	G	D
Q9Y4U1	LP/P	Methylmalonic aciduria and homocystinuria, cblC type (MAHCC) [MIM:277400]	A0A2D4P5K6	157	W	C
Q9Y4U1	LP/P	Methylmalonic aciduria and homocystinuria, cblC type (MAHCC) [MIM:277400]	A0A2D4P5K6	161	R	G
Q9Y4U1	LP/P	Methylmalonic aciduria and homocystinuria, cblC type (MAHCC) [MIM:277400]	A0A2D4P5K6	161	R	Q
Q9Y4U1	LP/P	Methylmalonic aciduria and homocystinuria, cblC type (MAHCC) [MIM:277400]	A0A2D4P5K6	189	R	S
Q9Y4U1	LP/P	Methylmalonic aciduria and homocystinuria, cblC type (MAHCC) [MIM:277400]	A0A2D4P5K6	193	L	P
Q9Y4U1	LP/P	Methylmalonic aciduria and homocystinuria, cblC type (MAHCC) [MIM:277400]	A0A2D4P5K6	206	R	P
Q9Y4U1	LP/P	Methylmalonic aciduria and homocystinuria, cblC type (MAHCC) [MIM:277400]	A0A2D4P5K6	206	R	W
Q9Y4U1	LB/B	-	A0A2D4P5K6	271	S	G
P08473	LP/P	Spinocerebellar ataxia 43 (SCA43) [MIM:617018]	A0A0L7RAY4	143	C	Y
P08473	LP/P	Charcot-Marie-Tooth disease, axonal, 2T (CMT2T) [MIM:617017]	A0A0L7RAY4	347	Y	C
P08473	LP/P	Charcot-Marie-Tooth disease, axonal, 2T (CMT2T) [MIM:617017]	A0A0L7RAY4	422	A	D
P08473	LB/B	-	A0A0L7RAY4	497	Y	H
P08473	LP/P	Charcot-Marie-Tooth disease, axonal, 2T (CMT2T) [MIM:617017]	A0A0L7RAY4	621	C	R
Q495T6	LB/B	-	A0A182NBV0	518	M	T
P03956	LB/B	-	A0A2K6G508	29	Q	P
P03956	LB/B	-	A0A2K6G508	252	D	G
P03956	LB/B	-	A0A2K6G508	191	I	V
P03956	LB/B	-	A0A2K6G508	405	R	Q
P03956	LB/B	-	A0A2K6G508	406	S	T
P03956	LB/B	-	A0A2K6G508	262	R	S
P24347	LB/B	-	A0A2F0B6D8	38	A	V
P24347	LB/B	-	A0A2F0B6D8	44	E	K
P24347	LB/B	-	A0A2F0B6D8	61	P	L
P24347	LB/B	-	A0A2F0B6D8	86	S	P
P24347	LB/B	-	A0A2F0B6D8	182	F	S
P45452	LB/B	-	A0A2K6G508	2	H	L
P45452	LB/B	-	A0A2K6G508	390	D	G
P45452	LP/P	Spondyloepimetaphyseal dysplasia, Missouri type (SEMDM) [MIM:602111]	A0A2K6G508	75	F	S
P45452	LP/P	Metaphyseal anadysplasia 1 (MANDP1) [MIM:602111]	A0A2K6G508	74	F	S
P45452	LP/P	Metaphyseal anadysplasia 1 (MANDP1) [MIM:602111]	A0A2K6G508	91	M	T
P45452	LP/P	Metaphyseal anadysplasia 1 (MANDP1) [MIM:602111]	A0A2K6G508	232	H	N
P45452	LP/P	Metaphyseal dysplasia, Spahr type (MDST) [MIM:250400]	A0A2K6G508	207	W	G
P50281	LB/B	-	A0A099ZJJ4	4	A	T
P50281	LB/B	-	A0A099ZJJ4	6	R	K
P50281	LB/B	-	A0A099ZJJ4	8	P	S
P50281	LB/B	-	A0A099ZJJ4	233	I	V
P50281	LB/B	-	A0A099ZJJ4	273	D	N
P50281	LB/B	-	A0A099ZJJ4	302	R	W
P50281	LB/B	-	A0A099ZJJ4	355	M	I
P50281	LB/B	-	A0A099ZJJ4	431	R	H
P50281	LP/P	Winchester syndrome (WNCHRS) [MIM:277950]	A0A099ZJJ4	17	T	R
Q99542	LB/B	-	V4B204	103	R	C
Q99542	LB/B	-	V4B204	488	P	T
Q99542	LB/B	-	V4B204	491	T	M
Q99542	LB/B	-	V4B204	245	P	S
P08253	LB/B	-	E7D7N7	447	A	V
P08253	LB/B	-	E7D7N7	621	V	L
P08253	LP/P	Multicentric osteolysis, nodulosis, and arthropathy (MONA) [MIM:259600]	E7D7N7	101	R	H
P08253	LB/B	-	E7D7N7	210	D	Y
P08253	LP/P	Multicentric osteolysis, nodulosis, and arthropathy (MONA) [MIM:259600]	E7D7N7	404	E	K
O60882	LB/B	-	A0A2K6G508	18	K	T
O60882	LB/B	-	A0A2K6G508	139	D	N
O60882	LB/B	-	A0A2K6G508	169	I	L
O60882	LB/B	-	A0A2K6G508	275	V	A
O60882	LB/B	-	A0A2K6G508	281	T	N
Q8N119	LB/B	-	G3TB04	191	V	A
Q8N119	LB/B	-	G3TB04	95	A	E
Q8N119	LB/B	-	G3TB04	115	P	Q
Q8N119	LB/B	-	G3TB04	349	E	G
Q8N119	LB/B	-	G3TB04	454	A	V
Q8N119	LB/B	-	G3TB04	263	D	E
Q8N119	LB/B	-	G3TB04	311	A	T
Q8N119	LB/B	-	G3TB04	360	R	H
Q8N119	LP/P	Heterotaxy, visceral, 7, autosomal (HTX7) [MIM:616749]	G3TB04	31	R	W
Q8N119	LP/P	Heterotaxy, visceral, 7, autosomal (HTX7) [MIM:616749]	G3TB04	215	E	K
Q8N119	LP/P	Heterotaxy, visceral, 7, autosomal (HTX7) [MIM:616749]	G3TB04	226	I	T
Q8N119	LP/P	Heterotaxy, visceral, 7, autosomal (HTX7) [MIM:616749]	G3TB04	283	H	Y
Q8N119	LP/P	Heterotaxy, visceral, 7, autosomal (HTX7) [MIM:616749]	G3TB04	285	I	T
Q8N119	LP/P	Heterotaxy, visceral, 7, autosomal (HTX7) [MIM:616749]	G3TB04	321	A	P
Q8N119	LP/P	Heterotaxy, visceral, 7, autosomal (HTX7) [MIM:616749]	G3TB04	360	R	C
Q8N119	LP/P	Heterotaxy, visceral, 7, autosomal (HTX7) [MIM:616749]	G3TB04	375	R	H
O75900	LB/B	-	I3N937	91	F	L
Q9Y5R2	LB/B	-	A0A099ZJJ4	564	R	H
Q9NRE1	LB/B	-	A0A2I4C9C3	43	K	E
Q9NRE1	LB/B	-	A0A2I4C9C3	260	I	M
P09237	LB/B	-	Q9TV55	77	R	H
P09237	LB/B	-	Q9TV55	137	G	D
P09237	LB/B	-	Q9TV55	241	P	L
P22894	LB/B	-	A0A2K6G508	87	K	E
P22894	LB/B	-	A0A2K6G508	3	S	C
P22894	LB/B	-	A0A2K6G508	32	T	I
P22894	LB/B	-	A0A2K6G508	154	G	E
P22894	LB/B	-	A0A2K6G508	193	D	V
P22894	LB/B	-	A0A2K6G508	246	N	Y
P22894	LB/B	-	A0A2K6G508	436	V	A
P22894	LB/B	-	A0A2K6G508	460	K	T
P14780	LB/B	-	E7D7N7	20	A	V
P14780	LB/B	-	E7D7N7	82	E	K
P14780	LB/B	-	E7D7N7	279	Q	R
P14780	LB/B	-	E7D7N7	668	R	Q
P14780	LB/B	-	E7D7N7	127	N	K
P14780	LB/B	-	E7D7N7	574	R	P
P14780	LB/B	-	E7D7N7	239	R	H
P14780	LB/B	-	E7D7N7	571	F	V
P14780	LB/B	-	E7D7N7	38	N	S
Q6ZRQ5	LB/B	-	A0A091DY43	419	N	D
Q6ZRQ5	LB/B	-	A0A091DY43	564	T	M
Q6ZRQ5	LB/B	-	A0A091DY43	875	V	A
Q6ZRQ5	LB/B	-	A0A091DY43	1015	P	L
Q10571	LB/B	-	A0A1S3A5K8	382	Q	H
P51948	LB/B	-	A0A1B0CU32	282	D	A
P41218	LB/B	-	A0A2Y9EMB9	286	V	L
P41218	LB/B	-	A0A2Y9EMB9	357	H	Y
P41218	LB/B	-	A0A2Y9EMB9	156	S	R
Q99583	LB/B	-	E1BCU5	109	A	T
Q96EN8	LP/P	Xanthinuria 2 (XAN2) [MIM:603592]	G7PWN8	57	A	P
Q96EN8	LB/B	-	G7PWN8	120	S	N
Q96EN8	LB/B	-	G7PWN8	170	T	I
Q96EN8	LB/B	-	G7PWN8	184	S	G
Q96EN8	LB/B	-	G7PWN8	225	H	R
Q96EN8	LP/P	Xanthinuria 2 (XAN2) [MIM:603592]	G7PWN8	294	T	I
Q96EN8	LB/B	-	G7PWN8	358	V	M
Q96EN8	LB/B	-	G7PWN8	495	D	N
Q96EN8	LB/B	-	G7PWN8	541	V	L
Q96EN8	LB/B	-	G7PWN8	703	H	N
Q96EN8	LB/B	-	G7PWN8	867	V	A
Q96EN8	LP/P	Xanthinuria 2 (XAN2) [MIM:603592]	G7PWN8	776	R	C
O96007	LP/P	Molybdenum cofactor deficiency, complementation group B (MOCODB) [MIM:252160]	A0A2K5E742	168	E	K
O96007	LB/B	-	A0A2K5E742	50	T	A
O96007	LB/B	-	A0A2K5E742	77	T	A
O96007	LB/B	-	A0A2K5E742	123	H	Y
O96007	LB/B	-	A0A2K5E742	187	N	S
O96033	LB/B	-	A0A212C898	51	V	A
O96033	LP/P	Molybdenum cofactor deficiency, complementation group B (MOCODB) [MIM:252160]	A0A212C898	7	V	F
O95396	LB/B	-	B4N7R4	429	S	A
Q16653	LB/B	-	L9JDQ2	171	V	L
Q16653	LB/B	-	L9JDQ2	174	I	V
Q16653	LP/P	Narcolepsy 7 (NRCLP7) [MIM:614250]	L9JDQ2	133	S	C
Q96PD6	LB/B	-	G5BGY4	163	S	P
Q96PD6	LB/B	-	G5BGY4	13	A	T
Q13724	LP/P	Type IIb congenital disorder of glycosylation (CDGIIb) [MIM:606056]	Q0JGI9	486	R	T
Q13724	LP/P	Type IIb congenital disorder of glycosylation (CDGIIb) [MIM:606056]	Q0JGI9	652	F	L
Q13724	LB/B	-	Q0JGI9	236	E	Q
Q13724	LB/B	-	Q0JGI9	239	D	N
Q13724	LB/B	-	Q0JGI9	222	G	R
Q13724	LB/B	-	Q0JGI9	293	P	S
Q13724	LB/B	-	Q0JGI9	495	R	P
Q13724	LB/B	-	Q0JGI9	785	G	S
Q7Z3U7	LB/B	-	D6W829	548	A	T
Q86VD1	LB/B	-	A0A2K6AMS1	153	T	P
Q86VD1	LB/B	-	A0A2K6AMS1	322	K	M
Q86VD1	LB/B	-	A0A2K6AMS1	470	F	I
Q86VD1	LB/B	-	A0A2K6AMS1	478	M	V
Q86VD1	LB/B	-	A0A2K6AMS1	649	M	I
Q86VD1	LB/B	-	A0A2K6AMS1	767	S	N
Q86VD1	LB/B	-	A0A2K6AMS1	836	H	Y
Q86VD1	LB/B	-	A0A2K6AMS1	982	S	C
Q86VD1	LB/B	-	A0A2K6AMS1	982	S	W
Q86VD1	LB/B	-	A0A2K6AMS1	462	D	E
Q9Y6X9	LP/P	Charcot-Marie-Tooth disease, axonal, 2Z (CMT2Z) [MIM:616688]	A0A226P8Q3	87	S	L
Q9Y6X9	LP/P	Developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy (DIGFAN) [MIM:619090]	A0A226P8Q3	87	S	L
Q9Y6X9	LP/P	Charcot-Marie-Tooth disease, axonal, 2Z (CMT2Z) [MIM:616688]	A0A226P8Q3	236	E	G
Q9Y6X9	LB/B	-	A0A226P8Q3	248	Y	C
Q9Y6X9	LP/P	Charcot-Marie-Tooth disease, axonal, 2Z (CMT2Z) [MIM:616688]	A0A226P8Q3	252	R	W
Q9Y6X9	LB/B	-	A0A226P8Q3	283	R	H
Q9Y6X9	LB/B	-	A0A226P8Q3	466	D	H
Q9Y6X9	LB/B	-	A0A226P8Q3	585	R	C
Q9Y6X9	LB/B	-	A0A226P8Q3	757	E	G
Q9Y6X9	LP/P	-	A0A226P8Q3	424	T	R
Q9Y6X9	LP/P	Developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy (DIGFAN) [MIM:619090]	A0A226P8Q3	24	T	I
Q9Y6X9	LP/P	Developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy (DIGFAN) [MIM:619090]	A0A226P8Q3	27	E	K
Q9Y6X9	LP/P	Developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy (DIGFAN) [MIM:619090]	A0A226P8Q3	88	A	V
Q9Y6X9	LP/P	Developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy (DIGFAN) [MIM:619090]	A0A226P8Q3	132	R	C
Q9Y6X9	LB/B	-	A0A226P8Q3	163	E	D
Q9Y6X9	LB/B	-	A0A226P8Q3	209	N	S
Q9Y6X9	LB/B	-	A0A226P8Q3	228	T	M
Q9Y6X9	LP/P	Developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy (DIGFAN) [MIM:619090]	A0A226P8Q3	266	R	S
Q9Y6X9	LP/P	Developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy (DIGFAN) [MIM:619090]	A0A226P8Q3	388	S	R
Q9Y6X9	LP/P	Charcot-Marie-Tooth disease, axonal, 2Z (CMT2Z) [MIM:616688]	A0A226P8Q3	394	Y	C
Q9Y6X9	LP/P	Developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy (DIGFAN) [MIM:619090]	A0A226P8Q3	394	Y	C
Q9Y6X9	LP/P	Charcot-Marie-Tooth disease, axonal, 2Z (CMT2Z) [MIM:616688]	A0A226P8Q3	400	Q	R
Q9Y6X9	LP/P	Charcot-Marie-Tooth disease, axonal, 2Z (CMT2Z) [MIM:616688]	A0A226P8Q3	407	C	Y
Q9Y6X9	LP/P	Developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy (DIGFAN) [MIM:619090]	A0A226P8Q3	413	V	F
Q9Y6X9	LP/P	Charcot-Marie-Tooth disease, axonal, 2Z (CMT2Z) [MIM:616688]	A0A226P8Q3	431	A	V
Q9Y6X9	LB/B	-	A0A226P8Q3	906	E	K
Q5T089	LB/B	-	A0A1S3LMB3	330	H	Y
Q5T089	LB/B	-	A0A1S3LMB3	124	L	V
Q502X0	LB/B	-	A0A1S3FAR6	48	E	K
P00540	LB/B	-	S9WKR5	96	R	L
P00540	LB/B	-	S9WKR5	105	A	S
P00540	LB/B	-	S9WKR5	300	S	P
Q8NHP6	LB/B	-	T1DAK2	240	S	N
Q9BXT6	LB/B	-	F6YK83	454	I	L
Q9BXT6	LB/B	-	F6YK83	650	V	I
Q9BXT6	LB/B	-	F6YK83	820	Q	R
Q9BXT6	LB/B	-	F6YK83	1179	A	E
Q9BXT6	LB/B	-	F6YK83	182	R	C
Q9BXT6	LB/B	-	F6YK83	57	M	L
Q9BXT6	LB/B	-	F6YK83	683	S	G
Q9BXT6	LB/B	-	F6YK83	18	T	S
Q9BXT6	LP/P	Spermatogenic failure 73 (SPGF73) [MIM:619878]	F6YK83	816	S	I
Q6UVY6	LB/B	-	A0A091D9B1	488	E	Q
Q6UVY6	LB/B	-	A0A091D9B1	539	K	E
Q9Y5U8	LB/B	-	A0A182P2E7	36	L	I
Q9Y5U8	LP/P	Mitochondrial pyruvate carrier deficiency (MPYCD) [MIM:614741]	A0A182P2E7	79	L	H
Q9Y5U8	LP/P	Mitochondrial pyruvate carrier deficiency (MPYCD) [MIM:614741]	A0A182P2E7	97	R	W
O75970	LB/B	-	U3J252	92	S	L
O75970	LB/B	-	U3J252	351	L	F
O75970	LB/B	-	U3J252	702	E	K
O75970	LB/B	-	U3J252	702	E	V
O75970	LB/B	-	U3J252	1604	T	A
O75970	LB/B	-	U3J252	1663	G	R
Q2M385	LB/B	-	H2LJB3	467	A	T
Q2M385	LB/B	-	H2LJB3	552	P	L
Q2M385	LB/B	-	H2LJB3	694	Q	R
Q2M385	LB/B	-	H2LJB3	316	P	S
O00566	LB/B	-	S4RQW0	634	E	K
O00566	LB/B	-	S4RQW0	425	L	M
O00566	LB/B	-	S4RQW0	229	E	D
O00566	LB/B	-	S4RQW0	69	E	A
O00566	LB/B	-	S4RQW0	115	R	H
O00566	LB/B	-	S4RQW0	140	D	N
O00566	LB/B	-	S4RQW0	639	A	T
Q99547	LB/B	-	A0A061IDT6	58	I	V
P34949	LP/P	Congenital disorder of glycosylation 1B (CDG1B) [MIM:602579]	A0A2U4CIV3	102	S	L
P34949	LP/P	Congenital disorder of glycosylation 1B (CDG1B) [MIM:602579]	A0A2U4CIV3	138	M	T
P34949	LP/P	Congenital disorder of glycosylation 1B (CDG1B) [MIM:602579]	A0A2U4CIV3	219	R	Q
P34949	LP/P	Congenital disorder of glycosylation 1B (CDG1B) [MIM:602579]	A0A2U4CIV3	140	I	T
P34949	LP/P	Congenital disorder of glycosylation 1B (CDG1B) [MIM:602579]	A0A2U4CIV3	51	M	T
P34949	LP/P	Congenital disorder of glycosylation 1B (CDG1B) [MIM:602579]	A0A2U4CIV3	129	Y	C
P34949	LP/P	Congenital disorder of glycosylation 1B (CDG1B) [MIM:602579]	A0A2U4CIV3	131	D	N
P34949	LP/P	Congenital disorder of glycosylation 1B (CDG1B) [MIM:602579]	A0A2U4CIV3	152	R	Q
P34949	LP/P	Congenital disorder of glycosylation 1B (CDG1B) [MIM:602579]	A0A2U4CIV3	250	G	S
P34949	LP/P	Congenital disorder of glycosylation 1B (CDG1B) [MIM:602579]	A0A2U4CIV3	255	Y	C
P34949	LP/P	Congenital disorder of glycosylation 1B (CDG1B) [MIM:602579]	A0A2U4CIV3	295	R	H
P34949	LP/P	Congenital disorder of glycosylation 1B (CDG1B) [MIM:602579]	A0A2U4CIV3	398	I	T
P34949	LP/P	Congenital disorder of glycosylation 1B (CDG1B) [MIM:602579]	A0A2U4CIV3	418	R	H
O95866	LB/B	-	H0X2E0	175	R	G
P40238	LB/B	-	A0A1S3F6K9	58	A	V
P40238	LB/B	-	A0A1S3F6K9	168	E	K
P40238	LB/B	-	A0A1S3F6K9	39	K	N
P40238	LB/B	-	A0A1S3F6K9	114	V	M
P40238	LP/P	Thrombocythemia 2 (THCYT2) [MIM:601977]	A0A1S3F6K9	505	S	N
P40238	LP/P	Myelofibrosis with myeloid metaplasia (MMM) [MIM:254450]	A0A1S3F6K9	515	W	K
P40238	LP/P	Myelofibrosis with myeloid metaplasia (MMM) [MIM:254450]	A0A1S3F6K9	515	W	L
P40238	LP/P	Thrombocythemia 2 (THCYT2) [MIM:601977]	A0A1S3F6K9	515	W	L
P40238	LP/P	Congenital amegakaryocytic thrombocytopenia (CAMT) [MIM:604498]	A0A1S3F6K9	102	R	C
P40238	LP/P	Congenital amegakaryocytic thrombocytopenia (CAMT) [MIM:604498]	A0A1S3F6K9	102	R	P
P40238	LP/P	Congenital amegakaryocytic thrombocytopenia (CAMT) [MIM:604498]	A0A1S3F6K9	104	F	S
P40238	LP/P	Thrombocythemia 2 (THCYT2) [MIM:601977]	A0A1S3F6K9	106	P	L
P40238	LP/P	Congenital amegakaryocytic thrombocytopenia (CAMT) [MIM:604498]	A0A1S3F6K9	136	P	L
P40238	LP/P	Congenital amegakaryocytic thrombocytopenia (CAMT) [MIM:604498]	A0A1S3F6K9	154	W	R
P40238	LP/P	Congenital amegakaryocytic thrombocytopenia (CAMT) [MIM:604498]	A0A1S3F6K9	257	R	L
P40238	LP/P	Congenital amegakaryocytic thrombocytopenia (CAMT) [MIM:604498]	A0A1S3F6K9	275	P	T
P40238	LP/P	Congenital amegakaryocytic thrombocytopenia (CAMT) [MIM:604498]	A0A1S3F6K9	435	W	C
P40238	LP/P	Congenital amegakaryocytic thrombocytopenia (CAMT) [MIM:604498]	A0A1S3F6K9	594	L	W
Q8TAP9	LP/P	Trichothiodystrophy 4, non-photosensitive (TTD4) [MIM:234050]	A0A1U7QS34	144	M	V
P05164	LB/B	-	A0A146VKC3	717	I	V
P05164	LP/P	Myeloperoxidase deficiency (MPOD) [MIM:254600]	A0A146VKC3	173	Y	C
P05164	LP/P	Myeloperoxidase deficiency (MPOD) [MIM:254600]	A0A146VKC3	251	M	T
P05164	LP/P	Myeloperoxidase deficiency (MPOD) [MIM:254600]	A0A146VKC3	569	R	W
P05164	LB/B	-	A0A146VKC3	53	V	F
P05164	LB/B	-	A0A146VKC3	604	R	C
P05164	LB/B	-	A0A146VKC3	683	E	Q
Q00013	LB/B	-	W5NYU9	448	E	Q
Q13368	LB/B	-	T1JH09	585	R	G
Q96JB8	LB/B	-	T1JH09	44	G	S
Q96JB8	LB/B	-	T1JH09	562	V	I
Q15777	LB/B	-	W5QD26	67	H	R
Q6WCQ1	LB/B	-	A0A087RG16	327	P	Q
Q567V2	LB/B	-	A0A2Y9IXU9	72	M	V
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	30	I	M
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	32	V	F
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	34	T	I
P25189	LP/P	Charcot-Marie-Tooth disease, axonal, 2I (CMT2I) [MIM:607677]	L8YBJ5	44	S	F
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	44	S	F
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	54	S	C
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	54	S	P
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	58	V	F
P25189	LP/P	Dejerine-Sottas syndrome (DSS) [MIM:145900]	L8YBJ5	63	S	C
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	63	S	F
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	68	Y	C
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	78	S	L
P25189	LP/P	Charcot-Marie-Tooth disease, axonal, 2I (CMT2I) [MIM:607677]	L8YBJ5	81	H	R
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	81	H	R
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	82	Y	C
P25189	LP/P	Dejerine-Sottas syndrome (DSS) [MIM:145900]	L8YBJ5	82	Y	C
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	90	D	E
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	93	G	E
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	96	K	E
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	98	R	C
P25189	LP/P	Dejerine-Sottas syndrome (DSS) [MIM:145900]	L8YBJ5	98	R	C
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	98	R	H
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	98	R	P
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	98	R	S
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	99	I	T
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	101	W	C
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	112	I	T
P25189	LP/P	Dejerine-Sottas syndrome (DSS) [MIM:145900]	L8YBJ5	114	I	T
P25189	LP/P	Dejerine-Sottas syndrome (DSS) [MIM:145900]	L8YBJ5	116	N	H
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	122	N	S
P25189	LP/P	Charcot-Marie-Tooth disease, axonal, 2I (CMT2I) [MIM:607677]	L8YBJ5	124	T	M
P25189	LP/P	Charcot-Marie-Tooth disease, axonal, 2J (CMT2J) [MIM:607736]	L8YBJ5	124	T	M
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	124	T	M
P25189	LP/P	Dejerine-Sottas syndrome (DSS) [MIM:145900]	L8YBJ5	127	C	Y
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	128	D	E
P25189	LP/P	Dejerine-Sottas syndrome (DSS) [MIM:145900]	L8YBJ5	128	D	N
P25189	LP/P	Charcot-Marie-Tooth disease, axonal, 2I (CMT2I) [MIM:607677]	L8YBJ5	130	K	R
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	130	K	R
P25189	LP/P	Dejerine-Sottas syndrome (DSS) [MIM:145900]	L8YBJ5	130	K	R
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	132	P	L
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	134	D	E
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	134	D	N
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	135	I	L
P25189	LP/P	Dejerine-Sottas syndrome (DSS) [MIM:145900]	L8YBJ5	135	I	L
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	135	I	T
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	137	G	S
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	143	T	M
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	163	G	R
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	167	G	A
P25189	LP/P	Dejerine-Sottas syndrome (DSS) [MIM:145900]	L8YBJ5	167	G	A
P25189	LP/P	Charcot-Marie-Tooth disease, axonal, 2I (CMT2I) [MIM:607677]	L8YBJ5	167	G	R
P25189	LP/P	Dejerine-Sottas syndrome (DSS) [MIM:145900]	L8YBJ5	167	G	R
P25189	LB/B	-	L8YBJ5	244	R	L
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	35	D	Y
P25189	LP/P	Charcot-Marie-Tooth disease, dominant intermediate D (CMTDID) [MIM:607791]	L8YBJ5	35	D	Y
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	62	I	F
P25189	LP/P	Charcot-Marie-Tooth disease, axonal, 2I (CMT2I) [MIM:607677]	L8YBJ5	75	D	V
P25189	LP/P	Charcot-Marie-Tooth disease, axonal, 2J (CMT2J) [MIM:607736]	L8YBJ5	75	D	V
P25189	LP/P	Charcot-Marie-Tooth disease, axonal, 2I (CMT2I) [MIM:607677]	L8YBJ5	89	I	N
P25189	LP/P	Charcot-Marie-Tooth disease, axonal, 2I (CMT2I) [MIM:607677]	L8YBJ5	92	V	M
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	103	G	E
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	123	G	C
P25189	LP/P	Dejerine-Sottas syndrome (DSS) [MIM:145900]	L8YBJ5	123	G	C
P25189	LP/P	Roussy-Levy syndrome (ROULS) [MIM:180800]	L8YBJ5	131	N	K
P25189	LP/P	Dejerine-Sottas syndrome (DSS) [MIM:145900]	L8YBJ5	136	V	E
P25189	LP/P	Charcot-Marie-Tooth disease, axonal, 2I (CMT2I) [MIM:607677]	L8YBJ5	162	I	M
P25189	LP/P	Charcot-Marie-Tooth disease, axonal, 2I (CMT2I) [MIM:607677]	L8YBJ5	118	D	N
P25189	LP/P	Charcot-Marie-Tooth disease, axonal, 2I (CMT2I) [MIM:607677]	L8YBJ5	236	K	E
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	51	S	F
P25189	LP/P	Charcot-Marie-Tooth disease, axonal, 2I (CMT2I) [MIM:607677]	L8YBJ5	60	D	H
P25189	LP/P	Charcot-Marie-Tooth disease, axonal, 2I (CMT2I) [MIM:607677]	L8YBJ5	62	I	M
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	65	T	I
P25189	LP/P	Charcot-Marie-Tooth disease, axonal, 2J (CMT2J) [MIM:607736]	L8YBJ5	97	E	V
P25189	LP/P	Dejerine-Sottas syndrome (DSS) [MIM:145900]	L8YBJ5	110	G	D
P25189	LP/P	Neuropathy, congenital hypomyelinating, 2 (CHN2) [MIM:618184]	L8YBJ5	124	T	K
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	134	D	G
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	138	K	N
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	139	T	N
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	140	S	T
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	145	Y	S
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	146	V	F
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	170	L	R
P25189	LP/P	Charcot-Marie-Tooth disease, axonal, 2I (CMT2I) [MIM:607677]	L8YBJ5	61	D	G
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	65	T	A
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	78	S	W
P25189	LB/B	-	L8YBJ5	81	H	Y
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	109	D	N
P25189	LB/B	-	L8YBJ5	113	V	F
P25189	LP/P	Charcot-Marie-Tooth disease, axonal, 2I (CMT2I) [MIM:607677]	L8YBJ5	119	Y	C
P25189	LP/P	Dejerine-Sottas syndrome (DSS) [MIM:145900]	L8YBJ5	221	A	T
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	39	H	P
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	224	D	Y
P25189	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1B (CMT1B) [MIM:118200]	L8YBJ5	227	R	S
Q95460	LB/B	-	A0A2K4X4G7	39	H	R
Q95460	LB/B	-	A0A2K4X4G7	63	R	Q
Q95460	LB/B	-	A0A2K4X4G7	77	A	V
P22897	LB/B	-	A0A0Q3M5N2	167	T	I
P22897	LB/B	-	A0A0Q3M5N2	396	G	S
P22897	LB/B	-	A0A0Q3M5N2	399	T	A
P22897	LB/B	-	A0A0Q3M5N2	407	L	F
Q9UBG0	LB/B	-	G1KNV4	43	V	I
Q9UBG0	LB/B	-	G1KNV4	1156	R	H
Q8N565	LB/B	-	D4A9U9	15	G	R
Q86SM8	LB/B	-	A0A2Y9RHI5	16	G	S
Q86SM8	LB/B	-	A0A2Y9RHI5	160	G	S
Q96AM1	LB/B	-	G5BSR7	16	K	R
Q2M3A8	LB/B	-	A0A024RCF0	6	E	A
Q2M3A8	LB/B	-	A0A024RCF0	135	S	F
Q2M3A8	LB/B	-	A0A024RCF0	142	G	V
Q96LB2	LB/B	-	A0A2K5HDQ8	36	I	V
Q96LB2	LB/B	-	A0A2K5HDQ8	46	A	T
Q96LB2	LB/B	-	A0A2K5HDQ8	55	R	L
Q96LB2	LB/B	-	A0A2K5HDQ8	131	R	S
Q96LB2	LB/B	-	A0A2K5HDQ8	133	H	R
Q96LB2	LB/B	-	A0A2K5HDQ8	137	H	R
Q96LB2	LB/B	-	A0A2K5HDQ8	273	F	L
Q96LB1	LB/B	-	A0A2K5HDQ8	62	N	S
Q96LB1	LB/B	-	A0A2K5HDQ8	16	N	H
Q96LB1	LB/B	-	A0A2K5HDQ8	78	F	L
Q96LB1	LB/B	-	A0A2K5HDQ8	43	V	I
Q96LB0	LB/B	-	A0A2K5HDQ8	169	N	D
Q96LB0	LB/B	-	A0A2K5HDQ8	82	C	R
Q96LA9	LB/B	-	A0A2K5HDQ8	8	F	L
Q96LA9	LB/B	-	A0A2K5HDQ8	25	N	K
Q96LA9	LB/B	-	A0A2K5HDQ8	54	Y	C
Q96LA9	LB/B	-	A0A2K5HDQ8	83	L	S
Q96LA9	LB/B	-	A0A2K5HDQ8	182	A	V
Q96LA9	LB/B	-	A0A2K5HDQ8	245	N	S
Q9BV20	LB/B	-	A0A2K6KDK7	235	M	V
Q9BV20	LB/B	-	A0A2K6KDK7	319	G	A
Q6IN84	LB/B	-	A0A1U7UIL2	98	P	S
Q6NTE8	LB/B	-	A0A2K5R2Q3	97	Q	R
Q6NTE8	LB/B	-	A0A2K5R2Q3	154	R	G
Q6NTE8	LB/B	-	A0A2K5R2Q3	231	Q	R
Q6NTE8	LB/B	-	A0A2K5R2Q3	42	Q	R
Q9BYG7	LB/B	-	D3ZXW1	39	R	S
Q9BYG7	LB/B	-	D3ZXW1	134	T	A
Q8NDA8	LB/B	-	M3Y6J9	38	A	V
Q7Z745	LB/B	-	H2PFF5	11	M	V
Q7Z745	LB/B	-	H2PFF5	191	W	R
Q7Z745	LB/B	-	H2PFF5	263	L	I
Q7Z745	LB/B	-	H2PFF5	468	E	V
Q7Z745	LB/B	-	H2PFF5	496	V	I
Q7Z745	LB/B	-	H2PFF5	526	R	H
Q7Z745	LB/B	-	H2PFF5	617	K	N
Q7Z745	LB/B	-	H2PFF5	648	D	V
Q7Z745	LB/B	-	H2PFF5	781	M	V
Q7Z745	LB/B	-	H2PFF5	918	N	K
Q7Z745	LB/B	-	H2PFF5	1179	L	P
Q68CQ1	LB/B	-	F1S770	182	H	R
Q68CQ1	LB/B	-	F1S770	290	V	M
Q68CQ1	LB/B	-	F1S770	306	Y	D
Q68CQ1	LB/B	-	F1S770	312	S	F
Q68CQ1	LB/B	-	F1S770	316	E	G
Q68CQ1	LB/B	-	F1S770	352	T	M
Q68CQ1	LB/B	-	F1S770	455	K	R
Q68CQ1	LB/B	-	F1S770	509	V	A
Q68CQ1	LB/B	-	F1S770	618	H	R
Q9BYD6	LB/B	-	A0A2K5ERW1	47	T	K
Q9BYD6	LB/B	-	A0A2K5ERW1	177	F	S
P52815	LB/B	-	G1MGN5	105	S	P
P52815	LP/P	Combined oxidative phosphorylation deficiency 45 (COXPD45) [MIM:618951]	G1MGN5	181	A	V
Q9H0U6	LB/B	-	G1NTZ8	6	R	Q
Q5T653	LB/B	-	A0A2K5JFH5	300	S	F
Q9P0M9	LB/B	-	K7EFC7	24	T	A
Q13084	LB/B	-	M7AVG6	160	D	E
Q13084	LB/B	-	M7AVG6	27	H	Y
Q13084	LB/B	-	M7AVG6	230	Y	C
P09001	LB/B	-	A0A2K5CNT9	261	M	T
P09001	LP/P	Combined oxidative phosphorylation deficiency 9 (COXPD9) [MIM:614582]	A0A2K5CNT9	317	P	R
Q8TCC3	LB/B	-	A0A0P6JM75	130	A	T
Q9BZE1	LB/B	-	A0A2K6T3Z7	322	L	V
Q9BZE1	LB/B	-	A0A2K6T3Z7	366	C	S
Q96DV4	LB/B	-	H2ZUN8	371	D	H
Q96DV4	LB/B	-	H2ZUN8	99	R	W
Q9NYK5	LB/B	-	A0A2U3YK37	31	S	P
Q9NQ50	LB/B	-	A0A2Y9QNA9	129	R	H
Q9NQ50	LB/B	-	A0A2Y9QNA9	11	L	P
Q9H9J2	LB/B	-	M3YZ25	138	T	I
Q9H9J2	LP/P	Combined oxidative phosphorylation deficiency 16 (COXPD16) [MIM:615395]	M3YZ25	156	L	R
Q96GC5	LB/B	-	G1TS94	6	E	G
Q8N5N7	LB/B	-	A0A2K5MBZ5	127	L	F
Q4U2R6	LB/B	-	Q4SNE2	102	M	I
Q7Z7F7	LB/B	-	A0A2K6AF69	24	R	C
Q7Z7F7	LB/B	-	A0A2K6AF69	42	R	H
Q14197	LB/B	-	A0A2K5Z4G3	8	R	P
Q14197	LB/B	-	A0A2K5Z4G3	77	L	F
Q14197	LB/B	-	A0A2K5Z4G3	122	T	M
Q9BYD2	LB/B	-	Q3UK02	67	E	G
Q9BYD2	LB/B	-	Q3UK02	210	E	A
P82912	LB/B	-	H0WQK4	10	R	W
P82912	LB/B	-	H0WQK4	51	Q	H
O15235	LB/B	-	K7G751	8	H	R
O60783	LP/P	Combined oxidative phosphorylation deficiency 38 (COXPD38) [MIM:618378]	K7G8U4	108	R	C
Q9Y676	LB/B	-	F6ZQK1	230	P	A
Q9Y399	LB/B	-	G3TQ92	294	H	R
Q9Y399	LB/B	-	G3TQ92	112	D	G
Q9Y399	LB/B	-	G3TQ92	158	M	V
Q9Y399	LP/P	Combined oxidative phosphorylation deficiency 36 (COXPD36) [MIM:617950]	G3TQ92	110	R	C
Q9Y399	LP/P	Combined oxidative phosphorylation deficiency 36 (COXPD36) [MIM:617950]	G3TQ92	114	D	N
Q9Y399	LP/P	Combined oxidative phosphorylation deficiency 36 (COXPD36) [MIM:617950]	G3TQ92	138	R	H
P82650	LP/P	Combined oxidative phosphorylation deficiency 5 (COXPD5) [MIM:611719]	I3MMH8	170	R	H
Q96EL2	LB/B	-	G5ASR4	97	W	R
P82663	LP/P	Combined oxidative phosphorylation deficiency 50 (COXPD50) [MIM:619025]	B4JL43	72	P	L
Q9NP92	LB/B	-	H0YVT7	33	C	S
Q9NP92	LB/B	-	H0YVT7	102	A	V
P82930	LB/B	-	A0A1S3WHK9	33	L	I
P82930	LP/P	Combined oxidative phosphorylation deficiency 32 (COXPD32) [MIM:617664]	A0A1S3WHK9	13	E	K
P82933	LB/B	-	A0A096NPD8	13	S	L
Q96PG2	LB/B	-	G3UIB2	219	P	L
Q96JA4	LB/B	-	A0A2K5KAG4	177	N	Y
Q96JA4	LB/B	-	A0A2K5KAG4	584	G	R
Q01362	LB/B	-	A0A1S2ZHT0	237	E	G
Q01362	LB/B	-	A0A1S2ZHT0	143	T	M
Q01362	LB/B	-	A0A1S2ZHT0	211	N	K
Q96JQ5	LB/B	-	A0A1D5RJZ7	178	M	V
Q96JQ5	LB/B	-	A0A1D5RJZ7	52	K	E
Q96JQ5	LB/B	-	A0A1D5RJZ7	191	L	I
Q9H2W1	LB/B	-	Q99N09	183	A	S
Q9H2W1	LB/B	-	Q99N09	185	T	S
Q96DS6	LB/B	-	B4DW64	47	V	F
Q96DS6	LB/B	-	B4DW64	6	I	V
Q96DS6	LB/B	-	B4DW64	10	T	A
Q9BY19	LB/B	-	F7DS45	95	V	L
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	46	H	Q
P43246	LB/B	-	A0A293M7T2	96	R	H
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	139	N	S
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	167	D	H
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	305	A	T
P43246	LB/B	-	A0A293M7T2	322	G	D
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	524	R	P
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	562	E	V
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	622	P	L
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	639	H	Y
P43246	LB/B	-	A0A293M7T2	641	C	G
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	674	G	S
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	697	C	F
P43246	LB/B	-	A0A293M7T2	770	I	V
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	834	A	T
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	692	G	R
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	697	C	R
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	161	V	D
P43246	LP/P	Colorectal cancer (CRC) [MIM:114500]	A0A293M7T2	506	D	Y
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	506	D	Y
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	636	A	P
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	688	M	I
P43246	LB/B	-	A0A293M7T2	8	T	M
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	845	K	E
P43246	LB/B	-	A0A293M7T2	43	Y	C
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	127	N	S
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	163	V	G
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	660	D	G
P43246	LB/B	-	A0A293M7T2	106	R	K
P43246	LB/B	-	A0A293M7T2	670	P	L
P43246	LB/B	-	A0A293M7T2	779	M	I
P43246	LB/B	-	A0A293M7T2	807	T	S
P43246	LB/B	-	A0A293M7T2	835	N	H
P43246	LB/B	-	A0A293M7T2	911	L	R
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	33	T	P
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	93	L	F
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	102	V	I
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	110	K	T
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	162	G	R
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	163	V	D
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	164	G	R
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	173	L	P
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	175	L	P
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	187	L	P
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	283	D	Y
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	333	C	Y
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	336	P	S
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	349	P	L
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	359	R	S
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	393	K	M
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	492	M	V
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	552	T	P
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	583	N	S
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	600	A	V
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	603	D	N
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	639	H	R
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	647	E	K
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	656	Y	H
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	679	I	T
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	723	S	F
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	729	M	V
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	732	T	I
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	749	E	K
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	813	M	V
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	839	H	R
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	931	K	T
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	2	A	T
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	162	G	A
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	198	E	G
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	331	N	D
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	470	V	E
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	610	H	N
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	638	R	G
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	645	Q	E
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	696	P	L
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	748	D	Y
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	839	H	Q
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	674	G	R
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	669	G	R
P43246	LB/B	-	A0A293M7T2	205	E	Q
P43246	LB/B	-	A0A293M7T2	328	A	P
P43246	LB/B	-	A0A293M7T2	367	V	I
P43246	LB/B	-	A0A293M7T2	487	D	E
P43246	LB/B	-	A0A293M7T2	909	K	I
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	187	L	R
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	674	G	A
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	688	M	V
P43246	LP/P	Lynch syndrome 1 (LYNCH1) [MIM:120435]	A0A293M7T2	722	V	I
P43246	LB/B	-	A0A293M7T2	5	P	Q
P43246	LB/B	-	A0A293M7T2	55	R	G
P43246	LB/B	-	A0A293M7T2	534	R	P
P43246	LB/B	-	A0A293M7T2	813	M	I
P20585	LB/B	-	A0A151PI60	709	F	L
P20585	LB/B	-	A0A151PI60	949	Q	R
P20585	LB/B	-	A0A151PI60	1045	A	T
P20585	LB/B	-	A0A151PI60	1054	T	A
P20585	LB/B	-	A0A151PI60	79	I	V
P20585	LB/B	-	A0A151PI60	789	Y	F
O15457	LB/B	-	W5MZK1	60	A	V
O15457	LB/B	-	W5MZK1	90	A	T
O15457	LB/B	-	W5MZK1	97	A	T
O15457	LB/B	-	W5MZK1	162	E	K
O15457	LB/B	-	W5MZK1	589	Y	C
O15457	LB/B	-	W5MZK1	914	S	N
O15457	LP/P	Spermatogenic failure 2 (SPGF2) [MIM:108420]	W5MZK1	638	P	L
O15457	LP/P	Premature ovarian failure 20 (POF20) [MIM:619938]	W5MZK1	754	S	L
O15457	LP/P	Spermatogenic failure 2 (SPGF2) [MIM:108420]	W5MZK1	754	S	L
O43196	LB/B	-	A0A061IN66	29	P	S
O43196	LB/B	-	A0A061IN66	85	L	F
O43196	LB/B	-	A0A061IN66	202	Y	C
O43196	LB/B	-	A0A061IN66	206	V	F
O43196	LB/B	-	A0A061IN66	351	R	G
O43196	LB/B	-	A0A061IN66	377	L	F
O43196	LB/B	-	A0A061IN66	786	P	S
O43196	LP/P	Premature ovarian failure 13 (POF13) [MIM:617442]	A0A061IN66	487	D	Y
Q8N5Y2	LB/B	-	G5BRL3	199	K	Q
Q8N5Y2	LB/B	-	G5BRL3	2	S	T
Q13421	LB/B	-	A0A2J8J874	72	A	V
Q13421	LB/B	-	A0A2J8J874	309	R	P
Q13421	LB/B	-	A0A2J8J874	601	M	V
Q13421	LB/B	-	A0A2J8J874	497	G	E
Q96KJ4	LB/B	-	A0A2K5EJZ7	463	D	V
Q96KJ4	LB/B	-	A0A2K5EJZ7	597	S	G
P08118	LB/B	-	F7A7E0	17	L	S
P08118	LB/B	-	F7A7E0	25	I	M
P08118	LB/B	-	F7A7E0	52	W	R
P08118	LB/B	-	F7A7E0	53	Q	R
P08118	LB/B	-	F7A7E0	80	D	A
P08118	LB/B	-	F7A7E0	87	I	T
P08118	LB/B	-	F7A7E0	91	E	G
P08118	LB/B	-	F7A7E0	92	D	G
P08118	LB/B	-	F7A7E0	98	V	L
Q1L6U9	LB/B	-	A0A1U7QTJ6	116	G	V
P26038	LP/P	Immunodeficiency 50 (IMD50) [MIM:300988]	A0A091DL41	171	R	W
P21757	LB/B	-	A0A2I3GU51	23	F	C
P21757	LB/B	-	A0A2I3GU51	275	P	A
P21757	LB/B	-	A0A2I3GU51	269	T	I
P21757	LB/B	-	A0A2I3GU51	36	P	A
P21757	LB/B	-	A0A2I3GU51	41	S	Y
P21757	LB/B	-	A0A2I3GU51	113	V	A
P21757	LB/B	-	A0A2I3GU51	174	D	Y
P21757	LB/B	-	A0A2I3GU51	254	L	V
P21757	LB/B	-	A0A2I3GU51	369	G	S
P21757	LB/B	-	A0A2I3GU51	441	H	R
Q8IXL7	LP/P	Deafness, autosomal recessive, 74 (DFNB74) [MIM:613718]	A0A1U7RYK4	89	C	G
P26927	LB/B	-	A0A091EJ05	13	C	Y
P26927	LB/B	-	A0A091EJ05	212	C	F
P26927	LB/B	-	A0A091EJ05	551	S	G
P26927	LB/B	-	A0A091EJ05	689	R	C
Q04912	LB/B	-	H3B042	322	R	Q
Q04912	LB/B	-	H3B042	1335	R	G
Q04912	LB/B	-	H3B042	434	S	L
Q04912	LB/B	-	H3B042	440	N	S
Q04912	LB/B	-	H3B042	75	R	S
Q04912	LB/B	-	H3B042	95	P	T
Q04912	LB/B	-	H3B042	185	R	C
Q04912	LB/B	-	H3B042	356	G	D
Q04912	LB/B	-	H3B042	465	G	D
Q04912	LB/B	-	H3B042	504	R	C
Q04912	LB/B	-	H3B042	523	Q	R
Q04912	LB/B	-	H3B042	613	Q	P
Q04912	LB/B	-	H3B042	900	V	M
Q04912	LB/B	-	H3B042	1304	R	G
Q04912	LB/B	-	H3B042	1360	Y	C
Q04912	LB/B	-	H3B042	1195	G	S
Q04912	LP/P	Nasopharyngeal carcinoma, 3 (NPCA3) [MIM:617075]	H3B042	306	R	H
P28360	LP/P	Tooth agenesis, selective, 1 (STHAG1) [MIM:106600]	Q3B8L1	202	R	P
P28360	LP/P	Tooth agenesis, selective, 1 (STHAG1) [MIM:106600]	Q3B8L1	67	M	K
P28360	LP/P	Non-syndromic orofacial cleft 5 (OFC5) [MIM:608874]	Q3B8L1	84	E	V
P28360	LP/P	Non-syndromic orofacial cleft 5 (OFC5) [MIM:608874]	Q3B8L1	97	G	D
P28360	LP/P	Non-syndromic orofacial cleft 5 (OFC5) [MIM:608874]	Q3B8L1	120	V	G
P28360	LP/P	Non-syndromic orofacial cleft 5 (OFC5) [MIM:608874]	Q3B8L1	122	G	E
P28360	LP/P	Non-syndromic orofacial cleft 5 (OFC5) [MIM:608874]	Q3B8L1	157	R	S
P03928	LB/B	-	R9Y6A5	17	L	P
P03928	LB/B	-	R9Y6A5	21	F	S
P03928	LB/B	-	R9Y6A5	28	M	T
P03928	LP/P	Cardiomyopathy, infantile hypertrophic (CMHI) [MIM:500006]	R9Y6A5	55	W	R
P03928	LP/P	Mitochondrial complex V deficiency, mitochondrial 2 (MC5DM2) [MIM:516070]	R9Y6A5	55	W	R
P00395	LB/B	-	C3UPN2	273	M	T
P00395	LB/B	-	C3UPN2	280	I	T
P00395	LB/B	-	C3UPN2	10	T	A
P00395	LB/B	-	C3UPN2	94	F	C
P00395	LB/B	-	C3UPN2	155	V	L
P00395	LB/B	-	C3UPN2	224	G	A
P00395	LB/B	-	C3UPN2	305	F	L
P00395	LB/B	-	C3UPN2	235	F	S
P00395	LB/B	-	C3UPN2	415	T	A
P00395	LP/P	Mitochondrial complex IV deficiency (MT-C4D) [MIM:220110]	C3UPN2	142	S	F
P00395	LP/P	Mitochondrial complex IV deficiency (MT-C4D) [MIM:220110]	C3UPN2	196	L	I
P00395	LP/P	Colorectal cancer (CRC) [MIM:114500]	C3UPN2	125	G	D
P00395	LP/P	Colorectal cancer (CRC) [MIM:114500]	C3UPN2	458	S	P
P00403	LB/B	-	A0A1W5T2N1	123	L	P
P00403	LB/B	-	A0A1W5T2N1	187	T	M
P00403	LB/B	-	A0A1W5T2N1	11	D	A
P00403	LB/B	-	A0A1W5T2N1	30	I	V
P00403	LB/B	-	A0A1W5T2N1	148	A	T
P00403	LP/P	Mitochondrial complex IV deficiency (MT-C4D) [MIM:220110]	A0A1W5T2N1	29	M	K
P00414	LP/P	Leber hereditary optic neuropathy (LHON) [MIM:535000]	Q8LX42	78	G	S
P00414	LP/P	Leber hereditary optic neuropathy (LHON) [MIM:535000]	Q8LX42	200	A	T
P00414	LB/B	-	Q8LX42	3	H	R
P00414	LB/B	-	Q8LX42	35	F	S
P00414	LB/B	-	Q8LX42	91	V	I
P00414	LB/B	-	Q8LX42	177	Q	R
P00414	LB/B	-	Q8LX42	254	V	I
P00156	LP/P	Leber hereditary optic neuropathy (LHON) [MIM:535000]	A0A172QDM1	171	D	N
P00156	LP/P	Leber hereditary optic neuropathy (LHON) [MIM:535000]	A0A172QDM1	356	V	M
P00156	LB/B	-	A0A172QDM1	7	T	I
P00156	LB/B	-	A0A172QDM1	87	A	P
P00156	LB/B	-	A0A172QDM1	191	A	T
P00156	LB/B	-	A0A172QDM1	194	T	A
P00156	LB/B	-	A0A172QDM1	229	A	T
P00156	LB/B	-	A0A172QDM1	8	N	S
P00156	LB/B	-	A0A172QDM1	18	F	L
P00156	LB/B	-	A0A172QDM1	34	G	S
P00156	LB/B	-	A0A172QDM1	39	A	V
P00156	LB/B	-	A0A172QDM1	78	I	T
P00156	LB/B	-	A0A172QDM1	122	A	T
P00156	LB/B	-	A0A172QDM1	123	T	A
P00156	LB/B	-	A0A172QDM1	151	S	P
P00156	LB/B	-	A0A172QDM1	153	I	T
P00156	LB/B	-	A0A172QDM1	164	I	V
P00156	LB/B	-	A0A172QDM1	166	G	E
P00156	LB/B	-	A0A172QDM1	236	L	I
P00156	LP/P	Cardiomyopathy, infantile histiocytoid (CMIH) [MIM:500000]	A0A172QDM1	251	G	D
P00156	LB/B	-	A0A172QDM1	278	Y	C
P00156	LB/B	-	A0A172QDM1	290	G	D
P00156	LB/B	-	A0A172QDM1	306	I	T
P00156	LB/B	-	A0A172QDM1	316	M	T
P00156	LB/B	-	A0A172QDM1	329	A	T
P00156	LB/B	-	A0A172QDM1	330	A	T
P00156	LB/B	-	A0A172QDM1	334	I	V
P00156	LB/B	-	A0A172QDM1	353	V	M
P00156	LB/B	-	A0A172QDM1	360	T	A
P00156	LB/B	-	A0A172QDM1	368	T	I
P00156	LB/B	-	A0A172QDM1	39	A	T
P00156	LB/B	-	A0A172QDM1	78	I	V
P00156	LB/B	-	A0A172QDM1	260	N	D
P00156	LB/B	-	A0A172QDM1	35	S	P
P00156	LB/B	-	A0A172QDM1	251	G	S
P03891	LP/P	Leber hereditary optic neuropathy (LHON) [MIM:535000]	A0A1B1PEN7	150	N	D
P03891	LP/P	Leber hereditary optic neuropathy (LHON) [MIM:535000]	A0A1B1PEN7	259	G	S
P03891	LB/B	-	A0A1B1PEN7	331	A	T
P03891	LP/P	Alzheimer disease mitochondrial (AD-MT) [MIM:502500]	A0A1B1PEN7	331	A	S
P03891	LB/B	-	A0A1B1PEN7	42	P	L
P03891	LB/B	-	A0A1B1PEN7	57	I	T
P03891	LB/B	-	A0A1B1PEN7	63	Q	R
P03891	LB/B	-	A0A1B1PEN7	119	T	A
P03891	LB/B	-	A0A1B1PEN7	148	S	P
P03891	LB/B	-	A0A1B1PEN7	150	N	S
P03891	LB/B	-	A0A1B1PEN7	159	I	T
P03891	LB/B	-	A0A1B1PEN7	185	T	A
P03891	LB/B	-	A0A1B1PEN7	43	V	I
P03891	LB/B	-	A0A1B1PEN7	69	I	V
P03891	LB/B	-	A0A1B1PEN7	88	N	S
P03891	LB/B	-	A0A1B1PEN7	237	L	M
P03891	LB/B	-	A0A1B1PEN7	265	A	T
P03891	LB/B	-	A0A1B1PEN7	265	A	V
P03891	LB/B	-	A0A1B1PEN7	278	I	T
P03891	LB/B	-	A0A1B1PEN7	325	F	L
P03891	LB/B	-	A0A1B1PEN7	333	T	A
P03897	LB/B	-	A0A059RNS3	10	N	D
P03897	LB/B	-	A0A059RNS3	114	T	A
P03897	LB/B	-	A0A059RNS3	53	M	V
P03897	LP/P	Mitochondrial complex I deficiency, mitochondrial type 1 (MC1DM1) [MIM:500014]	A0A059RNS3	45	S	P
P03897	LP/P	Leigh syndrome (LS) [MIM:256000]	A0A059RNS3	47	A	T
P03897	LP/P	Mitochondrial complex I deficiency, mitochondrial type 1 (MC1DM1) [MIM:500014]	A0A059RNS3	47	A	T
P03897	LP/P	Mitochondrial complex I deficiency, mitochondrial type 1 (MC1DM1) [MIM:500014]	A0A059RNS3	34	S	P
P03915	LP/P	Leber hereditary optic neuropathy (LHON) [MIM:535000]	A0A140IMP4	458	A	T
P03915	LP/P	Leber hereditary optic neuropathy (LHON) [MIM:535000]	A0A140IMP4	465	G	E
P03915	LB/B	-	A0A140IMP4	475	A	T
P03915	LB/B	-	A0A140IMP4	17	P	S
P03915	LB/B	-	A0A140IMP4	95	F	S
P03915	LB/B	-	A0A140IMP4	99	S	P
P03915	LB/B	-	A0A140IMP4	146	G	D
P03915	LB/B	-	A0A140IMP4	160	A	V
P03915	LB/B	-	A0A140IMP4	165	N	S
P03915	LB/B	-	A0A140IMP4	304	F	S
P03915	LB/B	-	A0A140IMP4	331	T	A
P03915	LB/B	-	A0A140IMP4	503	D	G
P03915	LB/B	-	A0A140IMP4	211	T	P
P03915	LB/B	-	A0A140IMP4	257	I	V
P03915	LB/B	-	A0A140IMP4	314	M	V
P03915	LP/P	Leigh syndrome (LS) [MIM:256000]	A0A140IMP4	124	F	L
P03915	LP/P	Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes syndrome (MELAS) [MIM:540000]	A0A140IMP4	145	E	G
P03915	LP/P	Leber hereditary optic neuropathy (LHON) [MIM:535000]	A0A140IMP4	171	A	V
P03915	LP/P	Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes syndrome (MELAS) [MIM:540000]	A0A140IMP4	236	A	T
P03915	LP/P	Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes syndrome (MELAS) [MIM:540000]	A0A140IMP4	237	M	L
P03915	LP/P	Leigh syndrome (LS) [MIM:256000]	A0A140IMP4	250	S	C
P03915	LP/P	Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes syndrome (MELAS) [MIM:540000]	A0A140IMP4	393	D	N
P03923	LP/P	Leber hereditary optic neuropathy (LHON) [MIM:535000]	A0A1S6YGE6	64	M	V
P03923	LP/P	Leber hereditary optic neuropathy with dystonia (LDYT) [MIM:500001]	A0A1S6YGE6	72	A	V
P03923	LP/P	Leber hereditary optic neuropathy with dystonia (LDYT) [MIM:500001]	A0A1S6YGE6	26	I	M
P03923	LP/P	Leber hereditary optic neuropathy (LHON) [MIM:535000]	A0A1S6YGE6	36	G	S
P03923	LP/P	Leber hereditary optic neuropathy (LHON) [MIM:535000]	A0A1S6YGE6	59	Y	C
P03923	LP/P	Leber hereditary optic neuropathy (LHON) [MIM:535000]	A0A1S6YGE6	64	M	I
P03923	LB/B	-	A0A1S6YGE6	165	Y	C
P03923	LB/B	-	A0A1S6YGE6	31	V	A
P03923	LB/B	-	A0A1S6YGE6	33	I	V
P03923	LB/B	-	A0A1S6YGE6	58	I	V
P03923	LP/P	Leber hereditary optic neuropathy (LHON) [MIM:535000]	A0A1S6YGE6	60	L	S
P03923	LP/P	Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes syndrome (MELAS) [MIM:540000]	A0A1S6YGE6	74	A	V
P03923	LP/P	Leigh syndrome (LS) [MIM:256000]	A0A1S6YGE6	63	M	V
P04731	LB/B	-	A0A2K6PDN9	51	K	R
P04731	LB/B	-	A0A2K6PDN9	27	T	N
Q8N339	LB/B	-	A0A2K6PDN9	20	T	K
P02795	LB/B	-	M3XWU8	42	A	V
P47944	LB/B	-	N0DX17	30	Y	C
P47944	LB/B	-	N0DX17	31	W	R
P47944	LB/B	-	N0DX17	48	G	D
Q13330	LB/B	-	A0A2Y9JMI1	372	V	I
Q13330	LB/B	-	A0A2Y9JMI1	612	A	T
Q13126	LB/B	-	A0A1S3FHZ6	56	V	I
Q9Y6C9	LB/B	-	A0A0A0MXN1	68	R	S
Q9Y6C9	LB/B	-	A0A0A0MXN1	290	P	A
Q9Y4B5	LB/B	-	F6PS31	861	Q	R
Q9Y4B5	LB/B	-	F6PS31	898	D	G
Q9Y4B5	LB/B	-	F6PS31	1097	G	S
Q9Y4B5	LB/B	-	F6PS31	1211	K	Q
Q9Y4B5	LB/B	-	F6PS31	602	M	T
Q99551	LB/B	-	A0A287A9T5	294	A	T
Q99551	LB/B	-	A0A287A9T5	231	A	T
Q49AM1	LB/B	-	M4AYW7	14	L	V
Q49AM1	LB/B	-	M4AYW7	81	A	G
Q49AM1	LB/B	-	M4AYW7	31	A	V
Q49AM1	LB/B	-	M4AYW7	198	V	I
Q7Z6M4	LB/B	-	G1ME26	45	T	A
Q7Z6M4	LB/B	-	G1ME26	189	M	T
Q7Z6M4	LB/B	-	G1ME26	339	L	V
Q7Z6M4	LB/B	-	G1ME26	347	D	E
Q7Z6M4	LB/B	-	G1ME26	378	D	E
Q9Y483	LB/B	-	M7BLL4	140	S	C
Q96DP5	LB/B	-	F6U0S0	5	V	A
Q96DP5	LP/P	Combined oxidative phosphorylation deficiency 15 (COXPD15) [MIM:614947]	F6U0S0	125	S	L
Q96DP5	LP/P	Combined oxidative phosphorylation deficiency 15 (COXPD15) [MIM:614947]	F6U0S0	209	S	L
Q96DP5	LP/P	Mitochondrial complex I deficiency, nuclear type 27 (MC1DN27) [MIM:618248]	F6U0S0	209	S	L
Q9H019	LB/B	-	H2T598	58	P	S
Q9H4K7	LB/B	-	A0A2U9C0X2	47	G	S
Q9H4K7	LB/B	-	A0A2U9C0X2	93	H	R
Q9H4K7	LB/B	-	A0A2U9C0X2	337	A	V
P11586	LP/P	Neural tube defects, folate-sensitive (NTDFS) [MIM:601634]	A0A1S8W6H3	293	R	H
P11586	LP/P	Neural tube defects, folate-sensitive (NTDFS) [MIM:601634]	A0A1S8W6H3	653	R	Q
P11586	LB/B	-	A0A1S8W6H3	134	K	R
P11586	LB/B	-	A0A1S8W6H3	761	T	M
P11586	LB/B	-	A0A1S8W6H3	769	L	F
P11586	LB/B	-	A0A1S8W6H3	162	P	L
P11586	LP/P	Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia (CIMAH) [MIM:617780]	A0A1S8W6H3	49	S	F
P11586	LP/P	Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia (CIMAH) [MIM:617780]	A0A1S8W6H3	173	R	C
P11586	LP/P	Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia (CIMAH) [MIM:617780]	A0A1S8W6H3	269	T	I
P11586	LP/P	Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia (CIMAH) [MIM:617780]	A0A1S8W6H3	51	L	P
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	69	R	C
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	70	L	F
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	87	L	P
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	184	R	G
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	189	N	S
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	198	Y	N
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	205	P	L
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	229	S	P
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	241	R	C
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	241	R	L
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	317	M	R
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	376	S	N
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	378	G	R
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	397	Y	C
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	402	G	A
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	404	E	K
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	406	L	P
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	421	R	Q
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	431	D	N
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	433	D	N
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	469	H	P
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	499	W	R
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	179	P	S
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	225	I	T
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	264	I	S
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	510	K	N
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	49	V	F
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	68	Y	D
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	69	R	P
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	69	R	S
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	157	E	K
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	180	N	K
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	184	R	L
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	186	T	I
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	197	T	I
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	199	P	S
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	202	L	S
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	226	P	T
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	227	V	M
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	228	L	P
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	230	W	C
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	232	H	R
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	279	A	G
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	346	W	C
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	346	W	S
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	364	V	G
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	374	H	D
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	378	G	E
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	389	A	D
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	391	L	P
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	402	G	R
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	402	G	V
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	411	W	C
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	444	C	Y
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	470	L	P
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	481	N	Y
Q13496	LP/P	Myopathy, centronuclear, X-linked (CNMX) [MIM:310400]	A0A2I3S224	387	S	Y
Q9NXD2	LB/B	-	H9G6M0	648	R	H
A4FU01	LB/B	-	S7PDE8	159	M	V
A4FU01	LB/B	-	S7PDE8	531	Q	P
Q8NCE2	LP/P	Myopathy, centronuclear, 1 (CNM1) [MIM:160150]	A0A287B6C9	336	R	Q
Q8NCE2	LP/P	Myopathy, centronuclear, 1 (CNM1) [MIM:160150]	A0A287B6C9	462	Y	C
Q13614	LB/B	-	M3XJT6	3	K	T
Q13614	LB/B	-	M3XJT6	545	N	S
Q13614	LP/P	Charcot-Marie-Tooth disease 4B1 (CMT4B1) [MIM:601382]	M3XJT6	283	R	W
Q9NYA4	LB/B	-	S9YH98	170	L	V
Q9NYA4	LB/B	-	S9YH98	280	S	G
Q9NYA4	LB/B	-	S9YH98	297	V	G
Q9Y217	LB/B	-	V9KJB9	319	I	V
Q9Y217	LB/B	-	V9KJB9	131	A	T
P48039	LB/B	-	A0A2Y9DYL9	54	R	W
P48039	LB/B	-	A0A2Y9DYL9	157	A	V
P48039	LB/B	-	A0A2Y9DYL9	212	I	T
Q9Y2Z2	LP/P	Combined oxidative phosphorylation deficiency 10 (COXPD10) [MIM:614702]	A0A061I817	453	A	T
Q99707	LB/B	-	L9L3Z9	61	R	K
Q99707	LB/B	-	L9L3Z9	255	C	Y
Q99707	LB/B	-	L9L3Z9	919	D	G
Q99707	LP/P	Homocystinuria-megaloblastic anemia, cblG complementation type (HMAG) [MIM:250940]	L9L3Z9	920	H	D
Q99707	LP/P	Homocystinuria-megaloblastic anemia, cblG complementation type (HMAG) [MIM:250940]	L9L3Z9	1173	P	L
Q99707	LB/B	-	L9L3Z9	52	R	Q
Q99707	LB/B	-	L9L3Z9	314	D	N
P42285	LB/B	-	A0A0D2WGZ0	346	A	P
O75570	LB/B	-	A0A226MT49	2	N	S
O75570	LB/B	-	A0A226MT49	324	L	V
O75570	LB/B	-	A0A226MT49	407	I	V
Q9H3J6	LB/B	-	M3WMD9	134	A	T
P0CJ72	LB/B	-	A0A2I3T3Y2	13	T	I
Q9UBK8	LB/B	-	H3CRV8	22	I	M
Q9UBK8	LP/P	Homocystinuria-megaloblastic anemia, cblE complementation type (HMAE) [MIM:236270]	H3CRV8	56	V	M
Q9UBK8	LP/P	Homocystinuria-megaloblastic anemia, cblE complementation type (HMAE) [MIM:236270]	H3CRV8	129	A	T
Q9UBK8	LB/B	-	H3CRV8	333	L	V
Q9UBK8	LP/P	Homocystinuria-megaloblastic anemia, cblE complementation type (HMAE) [MIM:236270]	H3CRV8	405	C	R
Q9UBK8	LP/P	Homocystinuria-megaloblastic anemia, cblE complementation type (HMAE) [MIM:236270]	H3CRV8	487	G	R
Q9UBK8	LB/B	-	H3CRV8	595	H	Y
Q9UBK8	LP/P	Homocystinuria-megaloblastic anemia, cblE complementation type (HMAE) [MIM:236270]	H3CRV8	554	G	R
Q9UBK8	LB/B	-	H3CRV8	175	S	L
Q9UBK8	LB/B	-	H3CRV8	257	S	T
Q9UBK8	LB/B	-	H3CRV8	350	K	R
Q9UBK8	LB/B	-	H3CRV8	415	R	C
Q9UBK8	LB/B	-	H3CRV8	450	P	R
Q9UBK8	LB/B	-	H3CRV8	515	A	V
O43312	LB/B	-	F6WHM5	305	N	I
O43312	LB/B	-	F6WHM5	725	T	A
Q765P7	LP/P	Intellectual developmental disorder with ocular anomalies and distinctive facial features (IDDOF) [MIM:620086]	F6WHM5	671	R	W
P55157	LB/B	-	C3Z5A2	297	H	Q
P55157	LB/B	-	C3Z5A2	384	D	A
P55157	LP/P	Abetalipoproteinemia (ABL) [MIM:200100]	C3Z5A2	540	R	H
P55157	LP/P	Abetalipoproteinemia (ABL) [MIM:200100]	C3Z5A2	590	S	I
P55157	LP/P	Abetalipoproteinemia (ABL) [MIM:200100]	C3Z5A2	746	G	E
P55157	LB/B	-	C3Z5A2	95	Q	H
P55157	LB/B	-	C3Z5A2	128	I	T
P55157	LB/B	-	C3Z5A2	244	Q	E
P55157	LP/P	Abetalipoproteinemia (ABL) [MIM:200100]	C3Z5A2	780	N	Y
P55157	LB/B	-	C3Z5A2	168	V	I
P55157	LB/B	-	C3Z5A2	98	E	D
P55157	LB/B	-	C3Z5A2	166	N	S
P55157	LP/P	Abetalipoproteinemia (ABL) [MIM:200100]	C3Z5A2	169	D	V
P55157	LP/P	Abetalipoproteinemia (ABL) [MIM:200100]	C3Z5A2	435	L	H
P55157	LP/P	Abetalipoproteinemia (ABL) [MIM:200100]	C3Z5A2	528	Y	H
P55157	LP/P	Abetalipoproteinemia (ABL) [MIM:200100]	C3Z5A2	540	R	C
Q9ULD2	LP/P	Hepatocellular carcinoma (HCC) [MIM:114550]	G3T4C7	75	Q	K
Q9ULD2	LB/B	-	G3T4C7	148	C	R
Q9ULD2	LB/B	-	G3T4C7	186	T	S
Q9ULD2	LB/B	-	G3T4C7	425	T	M
Q9ULD2	LB/B	-	G3T4C7	453	K	T
Q9ULD2	LP/P	Hepatocellular carcinoma (HCC) [MIM:114550]	G3T4C7	563	A	S
Q9ULD2	LB/B	-	G3T4C7	575	H	R
Q9ULD2	LP/P	Hepatocellular carcinoma (HCC) [MIM:114550]	G3T4C7	873	N	H
Q9ULD2	LB/B	-	G3T4C7	911	K	T
Q9ULD2	LB/B	-	G3T4C7	1063	K	T
Q9ULD2	LB/B	-	G3T4C7	1105	E	Q
Q9ULD2	LP/P	Hepatocellular carcinoma (HCC) [MIM:114550]	G3T4C7	1201	Q	R
Q5JR59	LB/B	-	A0A2Y9DZG7	955	P	H
Q5JR59	LB/B	-	A0A2Y9DZG7	1071	L	Q
Q13505	LB/B	-	A0A2Y9E7Z7	63	S	T
Q5HYI7	LB/B	-	W5MFV1	238	S	R
Q9H3R2	LB/B	-	E1BAQ3	18	A	V
Q9H3R2	LB/B	-	E1BAQ3	364	S	G
Q9H3R2	LB/B	-	E1BAQ3	503	R	S
Q9H3R2	LB/B	-	E1BAQ3	100	I	T
Q8N387	LB/B	-	A0A2Y9NZN8	184	I	T
Q8N387	LB/B	-	A0A2Y9NZN8	202	T	I
Q8N387	LB/B	-	A0A2Y9NZN8	19	S	W
Q7Z5P9	LB/B	-	Q7Z5P9	717	G	E
Q7Z5P9	LB/B	-	Q7Z5P9	783	T	K
Q7Z5P9	LB/B	-	Q7Z5P9	790	V	I
Q7Z5P9	LB/B	-	Q7Z5P9	791	R	L
Q7Z5P9	LB/B	-	Q7Z5P9	803	D	H
Q7Z5P9	LB/B	-	Q7Z5P9	843	V	I
Q7Z5P9	LB/B	-	Q7Z5P9	869	V	I
Q7Z5P9	LB/B	-	Q7Z5P9	883	V	I
Q7Z5P9	LB/B	-	Q7Z5P9	1010	L	F
Q7Z5P9	LB/B	-	Q7Z5P9	1151	I	T
Q7Z5P9	LB/B	-	Q7Z5P9	1226	S	F
Q7Z5P9	LB/B	-	Q7Z5P9	1278	I	M
Q7Z5P9	LB/B	-	Q7Z5P9	1296	G	S
Q7Z5P9	LB/B	-	Q7Z5P9	1315	R	H
Q7Z5P9	LB/B	-	Q7Z5P9	1327	G	W
Q7Z5P9	LB/B	-	Q7Z5P9	1367	A	T
Q7Z5P9	LB/B	-	Q7Z5P9	1411	C	Y
Q7Z5P9	LB/B	-	Q7Z5P9	1451	A	T
Q7Z5P9	LB/B	-	Q7Z5P9	1493	A	V
Q7Z5P9	LB/B	-	Q7Z5P9	1621	N	S
Q7Z5P9	LB/B	-	Q7Z5P9	1688	T	A
Q7Z5P9	LB/B	-	Q7Z5P9	1762	E	A
Q7Z5P9	LB/B	-	Q7Z5P9	1770	S	R
Q7Z5P9	LB/B	-	Q7Z5P9	2029	A	S
Q02817	LB/B	-	F7CZT4	58	L	P
Q02817	LB/B	-	F7CZT4	116	V	M
Q02817	LB/B	-	F7CZT4	832	G	S
Q02817	LB/B	-	F7CZT4	1619	S	R
Q02817	LB/B	-	F7CZT4	1689	P	L
Q02817	LB/B	-	F7CZT4	2243	I	T
Q02817	LB/B	-	F7CZT4	2613	T	P
Q02817	LB/B	-	F7CZT4	2613	T	S
Q02817	LB/B	-	F7CZT4	2742	Q	L
Q02817	LB/B	-	F7CZT4	2742	Q	P
Q02817	LB/B	-	F7CZT4	1768	P	H
Q5SSG8	LB/B	-	A0A2J8NXH5	139	D	E
Q5SSG8	LB/B	-	A0A2J8NXH5	161	E	G
Q5SSG8	LB/B	-	A0A2J8NXH5	244	E	D
Q5SSG8	LB/B	-	A0A2J8NXH5	253	G	S
Q5SSG8	LB/B	-	A0A2J8NXH5	285	V	A
Q5SSG8	LB/B	-	A0A2J8NXH5	289	E	D
Q5SSG8	LB/B	-	A0A2J8NXH5	313	N	S
Q5SSG8	LB/B	-	A0A2J8NXH5	315	A	V
Q5SSG8	LB/B	-	A0A2J8NXH5	319	D	E
Q5SSG8	LB/B	-	A0A2J8NXH5	323	T	P
Q5SSG8	LB/B	-	A0A2J8NXH5	328	S	N
Q5SSG8	LB/B	-	A0A2J8NXH5	98	V	A
Q5SSG8	LB/B	-	A0A2J8NXH5	282	I	T
Q5SSG8	LB/B	-	A0A2J8NXH5	282	I	V
E2RYF6	LB/B	-	A0A2K5DRX0	1712	N	D
Q9H195	LB/B	-	A0A2Y9PK65	1034	A	V
Q9H195	LB/B	-	A0A2Y9PK65	1213	H	Y
Q99102	LB/B	-	F6VIZ0	37	G	D
Q99102	LB/B	-	F6VIZ0	156	T	A
Q99102	LB/B	-	F6VIZ0	580	S	A
Q99102	LB/B	-	F6VIZ0	716	A	T
Q99102	LB/B	-	F6VIZ0	4448	A	T
Q99102	LB/B	-	F6VIZ0	4821	A	S
Q99102	LB/B	-	F6VIZ0	41	A	P
Q99102	LB/B	-	F6VIZ0	4324	G	D
P98088	LB/B	-	F7CZT4	5521	P	L
Q9HC84	LB/B	-	F7CZT4	5196	S	T
Q9HC84	LB/B	-	F7CZT4	51	R	W
Q9HC84	LB/B	-	F7CZT4	1360	T	M
Q9HC84	LB/B	-	F7CZT4	1401	R	H
Q9HC84	LB/B	-	F7CZT4	2027	A	T
Q9HC84	LB/B	-	F7CZT4	2559	T	M
Q9HC84	LB/B	-	F7CZT4	34	E	G
Q9HC84	LB/B	-	F7CZT4	1805	G	S
Q9HC84	LB/B	-	F7CZT4	1889	P	L
Q9HC84	LB/B	-	F7CZT4	2025	A	T
Q9HC84	LB/B	-	F7CZT4	2194	M	T
Q9HC84	LB/B	-	F7CZT4	2238	L	P
Q9HC84	LB/B	-	F7CZT4	2425	M	T
Q9HC84	LB/B	-	F7CZT4	3072	F	S
Q9HC84	LB/B	-	F7CZT4	3284	T	A
Q9HC84	LB/B	-	F7CZT4	3468	R	P
Q9HC84	LB/B	-	F7CZT4	3816	T	M
Q9HC84	LB/B	-	F7CZT4	4404	A	G
Q9HC84	LB/B	-	F7CZT4	4440	P	L
Q9HC84	LB/B	-	F7CZT4	4706	T	P
Q9HC84	LB/B	-	F7CZT4	4712	T	M
Q9HC84	LB/B	-	F7CZT4	4867	A	T
Q9HC84	LB/B	-	F7CZT4	4882	T	A
Q6W4X9	LB/B	-	A0A2K5LE70	1578	P	S
Q6W4X9	LB/B	-	A0A2K5LE70	1794	P	T
Q96NY9	LB/B	-	A0A2J8TZM9	189	L	F
Q96NY9	LB/B	-	A0A2J8TZM9	37	R	H
Q96NY9	LB/B	-	A0A2J8TZM9	481	Q	H
Q96NY9	LB/B	-	A0A2J8TZM9	180	R	P
Q96NY9	LB/B	-	A0A2J8TZM9	350	R	W
Q96NY9	LB/B	-	A0A2J8TZM9	115	S	F
O15146	LB/B	-	H2PT09	413	M	I
O15146	LP/P	Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency (CMS9) [MIM:616325]	H2PT09	790	V	M
O15146	LB/B	-	H2PT09	829	V	L
O15146	LB/B	-	H2PT09	27	A	G
O15146	LB/B	-	H2PT09	100	T	M
O15146	LB/B	-	H2PT09	107	G	E
O15146	LB/B	-	H2PT09	159	S	G
O15146	LB/B	-	H2PT09	222	N	S
O15146	LB/B	-	H2PT09	629	L	F
O15146	LB/B	-	H2PT09	644	V	A
O15146	LB/B	-	H2PT09	664	N	S
O15146	LB/B	-	H2PT09	696	P	L
O15146	LB/B	-	H2PT09	782	E	D
O15146	LB/B	-	H2PT09	858	R	H
O15146	LP/P	Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency (CMS9) [MIM:616325]	H2PT09	605	M	I
O15146	LP/P	Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency (CMS9) [MIM:616325]	H2PT09	727	A	V
O15146	LP/P	Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency (CMS9) [MIM:616325]	H2PT09	38	D	E
O15146	LP/P	Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency (CMS9) [MIM:616325]	H2PT09	344	P	R
O15146	LP/P	Fetal akinesia deformation sequence 1 (FADS1) [MIM:208150]	H2PT09	575	I	T
O15146	LP/P	Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency (CMS9) [MIM:616325]	H2PT09	835	M	V
Q9UIF7	LB/B	-	A0A1S3A8K4	22	V	M
Q9UIF7	LP/P	Familial adenomatous polyposis 2 (FAP2) [MIM:608456]	A0A1S3A8K4	176	Y	C
Q9UIF7	LB/B	-	A0A1S3A8K4	335	Q	H
Q9UIF7	LP/P	Familial adenomatous polyposis 2 (FAP2) [MIM:608456]	A0A1S3A8K4	393	G	D
Q9UIF7	LB/B	-	A0A1S3A8K4	500	G	E
Q9UIF7	LB/B	-	A0A1S3A8K4	526	L	M
Q9UIF7	LB/B	-	A0A1S3A8K4	531	R	Q
Q9UIF7	LP/P	Familial adenomatous polyposis 2 (FAP2) [MIM:608456]	A0A1S3A8K4	125	Y	H
Q9UIF7	LP/P	Familial adenomatous polyposis 2 (FAP2) [MIM:608456]	A0A1S3A8K4	128	W	R
Q9UIF7	LP/P	Familial adenomatous polyposis 2 (FAP2) [MIM:608456]	A0A1S3A8K4	179	R	H
Q9UIF7	LP/P	Gastric cancer (GASC) [MIM:613659]	A0A1S3A8K4	402	P	S
Q9UIF7	LB/B	-	A0A1S3A8K4	512	S	F
Q9UIF7	LB/B	-	A0A1S3A8K4	370	A	V
Q9UIF7	LP/P	Familial adenomatous polyposis 2 (FAP2) [MIM:608456]	A0A1S3A8K4	179	R	C
Q9UIF7	LP/P	Familial adenomatous polyposis 2 (FAP2) [MIM:608456]	A0A1S3A8K4	182	R	W
Q9UIF7	LB/B	-	A0A1S3A8K4	25	G	D
Q9UIF7	LB/B	-	A0A1S3A8K4	72	V	E
Q9UIF7	LB/B	-	A0A1S3A8K4	121	D	G
Q9UIF7	LP/P	Familial adenomatous polyposis 2 (FAP2) [MIM:608456]	A0A1S3A8K4	154	P	L
Q9UIF7	LP/P	Familial adenomatous polyposis 2 (FAP2) [MIM:608456]	A0A1S3A8K4	177	Y	S
Q9UIF7	LP/P	Familial adenomatous polyposis 2 (FAP2) [MIM:608456]	A0A1S3A8K4	182	R	Q
Q9UIF7	LP/P	Familial adenomatous polyposis 2 (FAP2) [MIM:608456]	A0A1S3A8K4	186	G	E
Q9UIF7	LP/P	Familial adenomatous polyposis 2 (FAP2) [MIM:608456]	A0A1S3A8K4	213	G	E
Q9UIF7	LB/B	-	A0A1S3A8K4	224	A	V
Q9UIF7	LP/P	-	A0A1S3A8K4	231	V	M
Q9UIF7	LP/P	Familial adenomatous polyposis 2 (FAP2) [MIM:608456]	A0A1S3A8K4	235	N	S
Q9UIF7	LP/P	-	A0A1S3A8K4	242	R	C
Q9UIF7	LP/P	Familial adenomatous polyposis 2 (FAP2) [MIM:608456]	A0A1S3A8K4	242	R	H
Q9UIF7	LB/B	-	A0A1S3A8K4	243	V	F
Q9UIF7	LB/B	-	A0A1S3A8K4	244	R	G
Q9UIF7	LP/P	Familial adenomatous polyposis 2 (FAP2) [MIM:608456]	A0A1S3A8K4	271	R	W
Q9UIF7	LP/P	Familial adenomatous polyposis 2 (FAP2) [MIM:608456]	A0A1S3A8K4	280	M	V
Q9UIF7	LP/P	Familial adenomatous polyposis 2 (FAP2) [MIM:608456]	A0A1S3A8K4	292	P	L
Q9UIF7	LB/B	-	A0A1S3A8K4	319	S	N
Q9UIF7	LP/P	Familial adenomatous polyposis 2 (FAP2) [MIM:608456]	A0A1S3A8K4	377	P	T
Q9UIF7	LP/P	Familial adenomatous polyposis 2 (FAP2) [MIM:608456]	A0A1S3A8K4	385	L	P
Q9UIF7	LP/P	Familial adenomatous polyposis 2 (FAP2) [MIM:608456]	A0A1S3A8K4	402	P	L
Q9UIF7	LB/B	-	A0A1S3A8K4	434	R	Q
Q9UIF7	LP/P	Familial adenomatous polyposis 2 (FAP2) [MIM:608456]	A0A1S3A8K4	470	A	D
Q9UIF7	LP/P	Familial adenomatous polyposis 2 (FAP2) [MIM:608456]	A0A1S3A8K4	486	A	T
Q9UIF7	LB/B	-	A0A1S3A8K4	513	P	L
Q9UIF7	LB/B	-	A0A1S3A8K4	520	R	H
Q9UIF7	LB/B	-	A0A1S3A8K4	536	T	A
P53602	LB/B	-	A0A1E4RGH9	278	N	H
P53602	LP/P	Porokeratosis 7, multiple types (POROK7) [MIM:614714]	A0A1E4RGH9	161	R	Q
P53602	LP/P	Porokeratosis 7, multiple types (POROK7) [MIM:614714]	A0A1E4RGH9	249	F	S
P53602	LP/P	Porokeratosis 7, multiple types (POROK7) [MIM:614714]	A0A1E4RGH9	292	N	S
Q14764	LB/B	-	G4Z1M3	635	V	I
Q14764	LB/B	-	G4Z1M3	651	R	Q
Q14764	LB/B	-	G4Z1M3	87	D	E
Q9BW11	LB/B	-	A0A1U7R0B6	114	Q	H
P50539	LP/P	Prostate cancer (PC) [MIM:176807]	F7F0X4	152	E	A
Q9NR99	LB/B	-	A0A2D0R6D4	2531	L	V
Q9NR99	LB/B	-	A0A2D0R6D4	764	V	L
Q9NR99	LB/B	-	A0A2D0R6D4	1484	T	A
Q9NR99	LB/B	-	A0A2D0R6D4	1665	P	S
Q9NR99	LB/B	-	A0A2D0R6D4	824	I	V
Q9NR99	LB/B	-	A0A2D0R6D4	1128	A	V
Q9NR99	LB/B	-	A0A2D0R6D4	1394	G	D
Q9NR99	LB/B	-	A0A2D0R6D4	2000	G	S
Q9NR99	LP/P	Lung cancer (LNCR) [MIM:211980]	A0A2D0R6D4	862	S	N
Q9NR99	LB/B	-	A0A2D0R6D4	1163	R	H
Q9NR99	LB/B	-	A0A2D0R6D4	2663	G	W
Q9NR99	LB/B	-	A0A2D0R6D4	2426	E	D
Q9BRK3	LB/B	-	G3VXG2	396	D	N
P10242	LB/B	-	G7MQB1	336	T	I
P10242	LB/B	-	G7MQB1	422	T	N
Q9BQG0	LB/B	-	Q6DRL5	8	Q	E
Q9BQG0	LB/B	-	Q6DRL5	680	H	Y
Q9BQG0	LB/B	-	Q6DRL5	958	H	P
Q9BQG0	LB/B	-	Q6DRL5	1208	M	L
P10244	LB/B	-	G7MQB1	427	S	G
P10244	LB/B	-	G7MQB1	341	N	S
P10244	LB/B	-	G7MQB1	595	V	M
P10244	LB/B	-	G7MQB1	624	I	M
Q00872	LB/B	-	S7NJG0	481	H	Q
Q00872	LP/P	Arthrogryposis, distal, 1B (DA1B) [MIM:614335]	S7NJG0	211	W	R
Q00872	LP/P	Arthrogryposis, distal, 1B (DA1B) [MIM:614335]	S7NJG0	849	Y	H
Q00872	LP/P	Arthrogryposis, distal, 1B (DA1B) [MIM:614335]	S7NJG0	161	E	K
Q00872	LP/P	Myopathy, congenital, with tremor (MYOTREM) [MIM:618524]	S7NJG0	222	Y	H
Q00872	LP/P	Myopathy, congenital, with tremor (MYOTREM) [MIM:618524]	S7NJG0	223	E	K
Q00872	LP/P	Myopathy, congenital, with tremor (MYOTREM) [MIM:618524]	S7NJG0	234	L	P
Q00872	LP/P	Myopathy, congenital, with tremor (MYOTREM) [MIM:618524]	S7NJG0	238	L	R
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	542	E	Q
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	755	N	K
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	257	H	P
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	258	E	K
Q14896	LB/B	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	278	G	E
Q14896	LB/B	-	S9WMN0	326	R	Q
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	352	L	P
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	502	R	W
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	811	K	R
Q14896	LB/B	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	833	A	V
Q14896	LB/B	-	S9WMN0	896	V	M
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	1194	A	T
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	1255	A	T
Q14896	LB/B	-	S9WMN0	158	V	M
Q14896	LB/B	-	S9WMN0	236	S	G
Q14896	LB/B	-	S9WMN0	189	V	I
Q14896	LB/B	-	S9WMN0	281	R	Q
Q14896	LB/B	-	S9WMN0	382	R	W
Q14896	LB/B	-	S9WMN0	383	L	V
Q14896	LB/B	-	S9WMN0	522	A	T
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	998	Q	E
Q14896	LB/B	-	S9WMN0	1048	R	C
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	451	E	Q
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	495	R	Q
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	502	R	Q
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	5	G	R
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	59	T	A
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	161	P	S
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	219	V	L
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	228	D	N
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	237	Y	S
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	256	V	I
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	282	R	W
Q14896	LB/B	-	S9WMN0	416	G	S
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	458	R	H
Q14896	LP/P	Cardiomyopathy, dilated 1MM (CMD1MM) [MIM:615396]	S9WMN0	490	G	R
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	490	G	R
Q14896	LP/P	Left ventricular non-compaction 10 (LVNC10) [MIM:615396]	S9WMN0	490	G	R
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	507	G	R
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	523	G	W
Q14896	LB/B	-	S9WMN0	545	L	M
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	566	C	R
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	604	D	V
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	608	P	L
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	668	R	H
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	668	R	P
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	770	D	N
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	792	W	R
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	810	R	H
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	820	R	Q
Q14896	LP/P	Cardiomyopathy, dilated 1MM (CMD1MM) [MIM:615396]	S9WMN0	833	A	T
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	833	A	T
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	834	R	T
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	873	P	H
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	948	N	T
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	998	Q	R
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	1002	R	Q
Q14896	LB/B	-	S9WMN0	1002	R	W
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	1003	P	Q
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	1113	F	I
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	1115	V	I
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	263	G	R
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	417	A	S
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	669	L	H
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	759	E	D
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	495	R	G
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	1028	T	S
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	336	I	V
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	490	G	V
Q14896	LP/P	Left ventricular non-compaction 10 (LVNC10) [MIM:615396]	S9WMN0	873	P	L
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	957	T	S
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	958	T	I
Q14896	LP/P	Cardiomyopathy, dilated 1MM (CMD1MM) [MIM:615396]	S9WMN0	1264	C	F
Q14896	LB/B	-	S9WMN0	147	P	L
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	334	E	K
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	342	V	D
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	627	A	V
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	771	V	M
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	1046	T	M
Q14896	LB/B	-	S9WMN0	1138	R	H
Q14896	LP/P	Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]	S9WMN0	562	A	V
Q13203	LB/B	-	M3WI89	48	Q	H
Q13203	LB/B	-	M3WI89	49	A	G
Q13203	LB/B	-	M3WI89	114	A	G
P01106	LB/B	-	A0A1S3S6U6	26	N	S
P01106	LB/B	-	A0A1S3S6U6	175	G	C
P01106	LB/B	-	A0A1S3S6U6	185	V	I
P01106	LB/B	-	A0A1S3S6U6	337	A	V
O75592	LB/B	-	A0A2T7PNH1	2626	V	M
O75592	LB/B	-	A0A2T7PNH1	1919	A	S
Q8TBZ2	LB/B	-	W5N999	387	A	T
Q8TBZ2	LB/B	-	W5N999	688	R	W
Q8TBZ2	LB/B	-	W5N999	910	S	R
P04198	LP/P	Feingold syndrome 1 (FGLDS1) [MIM:164280]	A0A218VBD5	393	R	H
P04198	LP/P	Feingold syndrome 1 (FGLDS1) [MIM:164280]	A0A218VBD5	393	R	S
P04198	LP/P	Feingold syndrome 1 (FGLDS1) [MIM:164280]	A0A218VBD5	394	R	H
Q8N699	LB/B	-	A0A2R8M4T5	119	G	S
Q8N699	LB/B	-	A0A2R8M4T5	127	R	G
Q969H8	LB/B	-	A0A2U3VKP8	12	G	R
Q9P2K5	LB/B	-	G1P7U3	91	A	T
Q9P2K5	LB/B	-	G1P7U3	465	S	G
Q9P2K5	LB/B	-	G1P7U3	426	Q	R
Q96EZ4	LB/B	-	A0A2K5K1I8	159	V	A
Q96EZ4	LB/B	-	A0A2K5K1I8	198	R	Q
Q96EZ4	LB/B	-	A0A2K5K1I8	271	G	R
Q96EZ4	LB/B	-	A0A2K5K1I8	284	P	T
Q9HB07	LB/B	-	A0A2K6L4L3	349	T	I
P12882	LB/B	-	R0LU47	1341	R	C
P12882	LB/B	-	R0LU47	1539	Q	H
P12882	LB/B	-	R0LU47	1716	R	C
P12882	LB/B	-	R0LU47	640	G	S
Q9Y2K3	LB/B	-	A0A0R3X3Q2	454	R	Q
Q9Y2K3	LB/B	-	A0A0R3X3Q2	504	H	Y
Q9Y2K3	LB/B	-	A0A0R3X3Q2	949	T	I
Q9Y2K3	LB/B	-	A0A0R3X3Q2	1125	T	A
Q9Y2K3	LB/B	-	A0A0R3X3Q2	1467	D	N
Q9UKX2	LP/P	Myopathy, proximal, with ophthalmoplegia (MYPOP) [MIM:605637]	R0LU47	706	E	K
Q9UKX2	LB/B	-	R0LU47	1061	L	V
Q9UKX2	LB/B	-	R0LU47	1927	R	Q
P11055	LB/B	-	V8PIZ1	1137	R	C
P11055	LB/B	-	V8PIZ1	1192	A	T
P11055	LP/P	Arthrogryposis, distal, 2A (DA2A) [MIM:193700]	V8PIZ1	178	T	I
P11055	LP/P	Arthrogryposis, distal, 2B3 (DA2B3) [MIM:618436]	V8PIZ1	178	T	I
P11055	LP/P	Arthrogryposis, distal, 2B3 (DA2B3) [MIM:618436]	V8PIZ1	261	S	F
P11055	LP/P	Arthrogryposis, distal, 2A (DA2A) [MIM:193700]	V8PIZ1	498	E	G
P11055	LP/P	Arthrogryposis, distal, 2A (DA2A) [MIM:193700]	V8PIZ1	583	Y	S
P11055	LP/P	Arthrogryposis, distal, 2A (DA2A) [MIM:193700]	V8PIZ1	672	R	C
P11055	LP/P	Arthrogryposis, distal, 2A (DA2A) [MIM:193700]	V8PIZ1	672	R	H
P11055	LP/P	Arthrogryposis, distal, 2B3 (DA2B3) [MIM:618436]	V8PIZ1	769	G	V
P11055	LP/P	Arthrogryposis, distal, 2A (DA2A) [MIM:193700]	V8PIZ1	825	V	D
P11055	LP/P	Arthrogryposis, distal, 2B3 (DA2B3) [MIM:618436]	V8PIZ1	838	K	E
P11055	LB/B	-	V8PIZ1	1622	D	A
P11055	LB/B	-	V8PIZ1	1637	A	V
P11055	LB/B	-	V8PIZ1	1003	A	V
P11055	LB/B	-	V8PIZ1	1313	T	I
P11055	LP/P	Contractures, pterygia, and spondylocarpotarsal fusion syndrome 1A (CPSFS1A) [MIM:178110]	V8PIZ1	1075	Q	P
P11055	LP/P	Arthrogryposis, distal, 2B3 (DA2B3) [MIM:618436]	V8PIZ1	234	A	T
P11055	LP/P	Contractures, pterygia, and spondylocarpotarsal fusion syndrome 1A (CPSFS1A) [MIM:178110]	V8PIZ1	287	F	V
P11055	LP/P	Contractures, pterygia, and spondylocarpotarsal fusion syndrome 1A (CPSFS1A) [MIM:178110]	V8PIZ1	333	T	R
Q9Y623	LB/B	-	R0LU47	883	T	M
Q9Y623	LB/B	-	R0LU47	1911	K	E
Q9Y623	LB/B	-	R0LU47	594	A	T
Q9Y623	LB/B	-	R0LU47	1106	I	M
Q9Y623	LB/B	-	R0LU47	1117	A	D
Q9Y623	LB/B	-	R0LU47	1209	E	K
Q9Y623	LB/B	-	R0LU47	1802	D	G
Q9Y623	LB/B	-	R0LU47	1862	R	C
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	26	A	V
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	59	V	I
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	143	R	Q
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	249	R	Q
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	256	G	E
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	263	I	T
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	349	M	T
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	403	R	L
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	403	R	Q
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	403	R	W
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	453	R	C
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	513	F	C
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	584	G	R
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	587	D	V
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	602	N	S
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	606	V	M
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	615	K	N
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	716	G	R
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	719	R	W
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	723	R	C
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	731	P	L
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	736	I	M
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	741	G	R
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	741	G	W
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	778	D	G
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	797	A	T
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	870	R	H
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	908	L	V
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	924	E	K
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	930	E	K
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	935	E	K
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	949	E	K
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	743	E	D
P12883	LB/B	-	S7NJQ2	107	D	E
P12883	LP/P	Cardiomyopathy, dilated 1S (CMD1S) [MIM:613426]	S7NJQ2	223	A	T
P12883	LP/P	Cardiomyopathy, dilated 1S (CMD1S) [MIM:613426]	S7NJQ2	532	S	P
P12883	LP/P	Cardiomyopathy, dilated 1S (CMD1S) [MIM:613426]	S7NJQ2	642	S	L
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	719	R	Q
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	728	A	V
P12883	LP/P	Cardiomyopathy, dilated 1S (CMD1S) [MIM:613426]	S7NJQ2	764	F	L
P12883	LB/B	-	S7NJQ2	1124	A	S
P12883	LP/P	Myopathy, myosin storage, autosomal dominant (MSMA) [MIM:608358]	S7NJQ2	1845	R	W
P12883	LP/P	Scapuloperoneal myopathy MYH7-related (SPMM) [MIM:181430]	S7NJQ2	1845	R	W
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	39	V	M
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	188	T	N
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	204	R	H
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	232	N	S
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	355	A	T
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	428	A	V
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	443	I	T
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	479	N	S
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	483	E	K
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	659	M	I
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	663	R	H
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	663	R	S
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	671	R	C
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	733	G	E
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	768	G	R
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	778	D	E
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	787	R	H
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	852	M	T
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	869	R	G
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	1135	L	R
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	1218	E	Q
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	1377	T	M
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	1379	A	T
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	1382	R	W
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	1777	A	T
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	124	T	I
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	162	Y	C
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	187	N	K
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	190	R	T
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	222	Q	K
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	244	F	L
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	320	V	M
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	390	L	V
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	406	V	M
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	499	E	K
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	595	Q	R
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	601	L	V
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	694	R	C
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	696	N	S
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	712	R	L
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	723	R	G
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	782	S	N
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	846	E	Q
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	869	R	C
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	870	R	C
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	877	M	K
P12883	LB/B	-	S7NJQ2	1491	S	C
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	1555	E	K
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	1776	S	G
P12883	LP/P	Myopathy, distal, 1 (MPD1) [MIM:160500]	S7NJQ2	1500	R	P
P12883	LP/P	Myopathy, distal, 1 (MPD1) [MIM:160500]	S7NJQ2	1663	A	P
P12883	LP/P	Myopathy, distal, 1 (MPD1) [MIM:160500]	S7NJQ2	1706	L	P
P12883	LB/B	-	S7NJQ2	3	D	A
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	143	R	W
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	411	V	I
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	430	A	E
P12883	LB/B	-	S7NJQ2	466	E	Q
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	517	L	M
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	584	G	S
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	694	R	H
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	734	Q	E
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	736	I	T
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	796	L	F
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	824	V	I
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	905	C	F
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	924	E	Q
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	928	D	N
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	515	M	V
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	858	R	C
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	115	Y	H
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	143	R	G
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	146	K	N
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	148	S	I
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	186	V	L
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	196	A	T
P12883	LP/P	Cardiomyopathy, dilated 1S (CMD1S) [MIM:613426]	S7NJQ2	201	I	T
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	207	K	Q
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	211	P	L
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	227	L	V
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	263	I	M
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	312	F	C
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	328	E	G
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	351	K	E
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	383	K	N
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	385	A	V
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	404	V	L
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	404	V	M
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	407	G	V
P12883	LP/P	Cardiomyopathy, dilated 1S (CMD1S) [MIM:613426]	S7NJQ2	412	T	N
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	425	G	R
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	435	M	T
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	440	V	M
P12883	LP/P	Myopathy, distal, 1 (MPD1) [MIM:160500]	S7NJQ2	441	T	M
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	450	K	E
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	450	K	T
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	453	R	H
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	500	E	A
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	501	Y	C
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	511	I	F
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	511	I	T
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	515	M	R
P12883	LP/P	Cardiomyopathy, dilated 1S (CMD1S) [MIM:613426]	S7NJQ2	550	A	V
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	571	G	R
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	576	H	R
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	615	K	Q
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	663	R	C
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	698	V	A
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	734	Q	P
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	742	A	E
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	763	V	G
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	774	E	V
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	778	D	V
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	822	M	L
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	822	M	T
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	823	G	E
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	858	R	H
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	869	R	H
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	882	Q	E
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	894	E	G
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	901	A	G
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	906	D	G
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	921	E	K
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	927	E	K
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	931	E	K
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	953	D	H
P12883	LP/P	Cardiomyopathy, dilated 1S (CMD1S) [MIM:613426]	S7NJQ2	1019	T	N
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	1057	G	D
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	1057	G	S
P12883	LP/P	Cardiomyopathy, dilated 1S (CMD1S) [MIM:613426]	S7NJQ2	1193	R	S
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	1327	N	K
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	1356	E	K
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	1420	R	W
P12883	LP/P	Cardiomyopathy, dilated 1S (CMD1S) [MIM:613426]	S7NJQ2	1426	E	K
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	1454	A	T
P12883	LP/P	Cardiomyopathy, dilated 1S (CMD1S) [MIM:613426]	S7NJQ2	1459	K	N
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	1459	K	N
P12883	LB/B	-	S7NJQ2	1475	R	C
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	1513	T	S
P12883	LB/B	-	S7NJQ2	1519	S	C
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	1712	R	W
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	1753	E	K
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	1768	E	K
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	1854	T	M
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	1883	E	K
P12883	LP/P	Myopathy, myosin storage, autosomal dominant (MSMA) [MIM:608358]	S7NJQ2	1901	H	L
P12883	LB/B	-	S7NJQ2	1919	K	N
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	763	V	M
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	787	R	C
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	1414	L	M
P12883	LP/P	Cardiomyopathy, dilated 1S (CMD1S) [MIM:613426]	S7NJQ2	1044	V	A
P12883	LP/P	Cardiomyopathy, dilated 1S (CMD1S) [MIM:613426]	S7NJQ2	1263	A	E
P12883	LP/P	Cardiomyopathy, dilated 1S (CMD1S) [MIM:613426]	S7NJQ2	1297	L	V
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	1752	E	K
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	243	R	H
P12883	LP/P	Left ventricular non-compaction 5 (LVNC5) [MIM:613426]	S7NJQ2	243	R	H
P12883	LP/P	Cardiomyopathy, dilated 1S (CMD1S) [MIM:613426]	S7NJQ2	283	Y	D
P12883	LP/P	Cardiomyopathy, dilated 1S (CMD1S) [MIM:613426]	S7NJQ2	350	Y	N
P12883	LP/P	Cardiomyopathy, dilated 1S (CMD1S) [MIM:613426]	S7NJQ2	390	L	P
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	453	R	S
P12883	LP/P	Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]	S7NJQ2	497	E	D
P12883	LP/P	Left ventricular non-compaction 5 (LVNC5) [MIM:613426]	S7NJQ2	1776	S	T
P12883	LP/P	Myopathy, myosin storage, autosomal dominant (MSMA) [MIM:608358]	S7NJQ2	1793	L	P
P12883	LP/P	Myopathy, myosin storage, autosomal recessive (MSMB) [MIM:255160]	S7NJQ2	1820	R	W
P12883	LP/P	Cardiomyopathy, dilated 1S (CMD1S) [MIM:613426]	S7NJQ2	1918	N	K
P12883	LP/P	Left ventricular non-compaction 5 (LVNC5) [MIM:613426]	S7NJQ2	252	F	L
P13535	LP/P	Arthrogryposis, distal, 7 (DA7) [MIM:158300]	R0LU47	674	R	Q
P13535	LP/P	Carney complex variant (CACOV) [MIM:608837]	R0LU47	674	R	Q
P13535	LB/B	-	R0LU47	924	E	G
P13535	LB/B	-	R0LU47	1261	E	G
P13535	LB/B	-	R0LU47	1692	W	R
P13535	LB/B	-	R0LU47	326	I	T
P13535	LB/B	-	R0LU47	636	A	V
P13535	LB/B	-	R0LU47	1229	M	T
P05976	LP/P	Myopathy, congenital, with fast-twitch type II fiber atrophy (MYOFTA) [MIM:618414]	A0A2K5RS73	163	M	R
Q9BUA6	LB/B	-	L5LJZ4	46	M	T
P10916	LP/P	Cardiomyopathy, familial hypertrophic 10 (CMH10) [MIM:608758]	L5LJZ4	13	A	T
P10916	LP/P	Cardiomyopathy, familial hypertrophic 10 (CMH10) [MIM:608758]	L5LJZ4	18	F	L
P10916	LP/P	Cardiomyopathy, familial hypertrophic 10 (CMH10) [MIM:608758]	L5LJZ4	22	E	K
P10916	LP/P	Cardiomyopathy, familial hypertrophic 10 (CMH10) [MIM:608758]	L5LJZ4	58	R	Q
P10916	LP/P	Cardiomyopathy, familial hypertrophic 10 (CMH10) [MIM:608758]	L5LJZ4	95	P	A
P10916	LP/P	Cardiomyopathy, familial hypertrophic 10 (CMH10) [MIM:608758]	L5LJZ4	166	D	V
P10916	LB/B	-	L5LJZ4	57	G	R
P08590	LP/P	Cardiomyopathy, familial hypertrophic 8 (CMH8) [MIM:608751]	A0A2K5RS73	149	M	V
P08590	LP/P	Cardiomyopathy, familial hypertrophic 8 (CMH8) [MIM:608751]	A0A2K5RS73	154	R	H
P08590	LP/P	Cardiomyopathy, familial hypertrophic 8 (CMH8) [MIM:608751]	A0A2K5RS73	56	E	G
P08590	LP/P	Cardiomyopathy, familial hypertrophic 8 (CMH8) [MIM:608751]	A0A2K5RS73	143	E	K
P08590	LP/P	Cardiomyopathy, familial hypertrophic 8 (CMH8) [MIM:608751]	A0A2K5RS73	177	E	G
P12829	LB/B	-	A0A2K5RS73	186	N	Y
P12829	LP/P	Atrial fibrillation, familial, 18 (ATFB18) [MIM:617280]	A0A2K5RS73	11	E	K
Q02045	LB/B	-	L5LJZ4	88	F	S
P60660	LB/B	-	A0A2R8ZD38	103	T	P
P60660	LB/B	-	A0A2R8ZD38	85	T	I
Q8WY64	LB/B	-	A0A1U7UEW2	342	N	S
Q15746	LB/B	-	A0A287A9M0	861	L	P
Q15746	LB/B	-	A0A287A9M0	914	D	E
Q15746	LB/B	-	A0A287A9M0	261	V	A
Q15746	LB/B	-	A0A287A9M0	276	T	A
Q15746	LB/B	-	A0A287A9M0	378	R	H
Q15746	LB/B	-	A0A287A9M0	405	M	V
Q15746	LB/B	-	A0A287A9M0	443	P	S
Q15746	LB/B	-	A0A287A9M0	607	R	G
Q15746	LB/B	-	A0A287A9M0	652	P	A
Q15746	LB/B	-	A0A287A9M0	656	W	C
Q15746	LB/B	-	A0A287A9M0	692	T	M
Q15746	LB/B	-	A0A287A9M0	701	A	T
Q15746	LB/B	-	A0A287A9M0	709	V	M
Q15746	LB/B	-	A0A287A9M0	1527	A	V
Q15746	LB/B	-	A0A287A9M0	21	P	H
Q15746	LB/B	-	A0A287A9M0	336	P	L
Q15746	LB/B	-	A0A287A9M0	845	R	C
Q15746	LB/B	-	A0A287A9M0	877	V	M
Q15746	LB/B	-	A0A287A9M0	128	A	V
Q15746	LB/B	-	A0A287A9M0	133	Q	H
Q15746	LB/B	-	A0A287A9M0	160	P	R
Q15746	LB/B	-	A0A287A9M0	1085	T	A
Q15746	LB/B	-	A0A287A9M0	1399	E	K
Q15746	LP/P	Aortic aneurysm, familial thoracic 7 (AAT7) [MIM:613780]	A0A287A9M0	1754	A	T
Q15746	LP/P	Aortic aneurysm, familial thoracic 7 (AAT7) [MIM:613780]	A0A287A9M0	1759	S	P
Q15746	LP/P	Aortic aneurysm, familial thoracic 7 (AAT7) [MIM:613780]	A0A287A9M0	1491	A	S
Q9H1R3	LP/P	Cardiomyopathy, familial hypertrophic (CMH) [MIM:192600]	L5LM66	87	A	V
Q9H1R3	LP/P	Cardiomyopathy, familial hypertrophic (CMH) [MIM:192600]	L5LM66	95	A	E
Q9H1R3	LB/B	-	L5LM66	142	G	V
Q9H1R3	LB/B	-	L5LM66	144	P	A
Q9H1R3	LB/B	-	L5LM66	324	K	N
Q86YV6	LB/B	-	G5BKF4	50	G	R
Q86YV6	LB/B	-	G5BKF4	126	T	M
Q86YV6	LB/B	-	G5BKF4	318	C	Y
Q86YV6	LB/B	-	G5BKF4	373	Q	R
Q86YV6	LB/B	-	G5BKF4	39	E	A
A6NI61	LP/P	Carey-Fineman-Ziter syndrome 1 (CFZS1) [MIM:254940]	G5B8H9	100	G	S
A6NI61	LP/P	Carey-Fineman-Ziter syndrome 1 (CFZS1) [MIM:254940]	G5B8H9	154	I	T
A6NI61	LP/P	Carey-Fineman-Ziter syndrome 1 (CFZS1) [MIM:254940]	G5B8H9	185	C	R
Q96JP2	LB/B	-	R0M2K0	547	R	W
Q9Y6X6	LB/B	-	H0WUE7	385	M	T
Q9Y6X6	LB/B	-	H0WUE7	831	P	A
Q9Y6X6	LB/B	-	H0WUE7	181	D	E
Q9Y6X6	LB/B	-	H0WUE7	339	V	I
Q9Y6X6	LB/B	-	H0WUE7	1171	I	M
Q96H55	LB/B	-	A0A1U7TVR9	176	N	S
Q96H55	LB/B	-	A0A1U7TVR9	203	Q	H
Q96H55	LB/B	-	A0A1U7TVR9	475	L	I
Q9UBC5	LB/B	-	A0A087QXU0	662	G	E
Q9UBC5	LB/B	-	A0A087QXU0	797	S	F
Q9UBC5	LB/B	-	A0A087QXU0	600	F	L
Q9UBC5	LB/B	-	A0A087QXU0	426	P	L
Q9UBC5	LB/B	-	A0A087QXU0	506	C	S
Q9UBC5	LB/B	-	A0A087QXU0	996	T	I
O94832	LB/B	-	T1KN30	765	P	S
O94832	LB/B	-	T1KN30	771	R	H
B0I1T2	LB/B	-	T1KN30	49	V	M
B0I1T2	LB/B	-	T1KN30	489	M	T
B0I1T2	LB/B	-	T1KN30	861	Q	R
B0I1T2	LB/B	-	T1KN30	798	R	Q
Q8N1T3	LB/B	-	S9XGS3	37	S	R
Q8N1T3	LB/B	-	S9XGS3	705	H	Y
Q8N1T3	LB/B	-	S9XGS3	1011	L	P
Q8WXR4	LB/B	-	A0A2I2UX35	275	I	V
Q8WXR4	LB/B	-	A0A2I2UX35	309	K	E
Q8WXR4	LB/B	-	A0A2I2UX35	406	A	T
Q8WXR4	LB/B	-	A0A2I2UX35	770	V	I
Q8WXR4	LB/B	-	A0A2I2UX35	798	E	K
Q8WXR4	LB/B	-	A0A2I2UX35	1082	R	K
Q8WXR4	LB/B	-	A0A2I2UX35	21	P	S
Q8WXR4	LB/B	-	A0A2I2UX35	185	R	H
Q8WXR4	LB/B	-	A0A2I2UX35	267	N	S
Q8WXR4	LB/B	-	A0A2I2UX35	316	H	L
Q8WXR4	LB/B	-	A0A2I2UX35	352	E	Q
Q8WXR4	LB/B	-	A0A2I2UX35	388	N	S
Q8WXR4	LB/B	-	A0A2I2UX35	638	Q	P
Q8WXR4	LB/B	-	A0A2I2UX35	773	E	G
Q8WXR4	LB/B	-	A0A2I2UX35	918	R	Q
Q8WXR4	LB/B	-	A0A2I2UX35	969	S	C
Q8WXR4	LB/B	-	A0A2I2UX35	990	R	C
Q8WXR4	LB/B	-	A0A2I2UX35	1092	I	V
Q8WXR4	LB/B	-	A0A2I2UX35	1137	V	I
Q8WXR4	LB/B	-	A0A2I2UX35	1165	R	C
Q9Y4I1	LB/B	-	A0A2U9CGC0	1246	R	C
Q9Y4I1	LB/B	-	A0A2U9CGC0	627	M	T
Q9Y4I1	LB/B	-	A0A2U9CGC0	1673	S	L
Q9ULV0	LP/P	Diarrhea 2, with microvillus atrophy, with or without cholestasis (DIAR2) [MIM:251850]	A0A2I0M0L1	108	V	G
Q9ULV0	LP/P	Diarrhea 2, with microvillus atrophy, with or without cholestasis (DIAR2) [MIM:251850]	A0A2I0M0L1	219	R	H
Q9ULV0	LP/P	Diarrhea 2, with microvillus atrophy, with or without cholestasis (DIAR2) [MIM:251850]	A0A2I0M0L1	656	R	C
Q9ULV0	LB/B	-	A0A2I0M0L1	10	C	G
Q9ULV0	LB/B	-	A0A2I0M0L1	307	K	N
Q9ULV0	LB/B	-	A0A2I0M0L1	918	R	H
Q9ULV0	LB/B	-	A0A2I0M0L1	942	K	R
Q9ULV0	LB/B	-	A0A2I0M0L1	126	T	A
Q9ULV0	LP/P	Diarrhea 2, with microvillus atrophy, with or without cholestasis (DIAR2) [MIM:251850]	A0A2I0M0L1	143	A	E
Q9ULV0	LP/P	Diarrhea 2, with microvillus atrophy, with or without cholestasis (DIAR2) [MIM:251850]	A0A2I0M0L1	168	G	R
Q9ULV0	LP/P	Diarrhea 2, with microvillus atrophy, with or without cholestasis (DIAR2) [MIM:251850]	A0A2I0M0L1	316	G	R
Q9ULV0	LP/P	Diarrhea 2, with microvillus atrophy, with or without cholestasis (DIAR2) [MIM:251850]	A0A2I0M0L1	401	R	H
Q9ULV0	LP/P	Diarrhea 2, with microvillus atrophy, with or without cholestasis (DIAR2) [MIM:251850]	A0A2I0M0L1	435	G	R
Q9ULV0	LP/P	Diarrhea 2, with microvillus atrophy, with or without cholestasis (DIAR2) [MIM:251850]	A0A2I0M0L1	456	N	S
Q9ULV0	LP/P	Diarrhea 2, with microvillus atrophy, with or without cholestasis (DIAR2) [MIM:251850]	A0A2I0M0L1	514	C	R
Q9ULV0	LP/P	Diarrhea 2, with microvillus atrophy, with or without cholestasis (DIAR2) [MIM:251850]	A0A2I0M0L1	660	P	L
Q9ULV0	LP/P	Diarrhea 2, with microvillus atrophy, with or without cholestasis (DIAR2) [MIM:251850]	A0A2I0M0L1	1556	L	R
Q9ULV0	LB/B	-	A0A2I0M0L1	1688	M	V
Q9ULV0	LP/P	Diarrhea 2, with microvillus atrophy, with or without cholestasis (DIAR2) [MIM:251850]	A0A2I0M0L1	538	F	S
Q9ULV0	LP/P	Diarrhea 2, with microvillus atrophy, with or without cholestasis (DIAR2) [MIM:251850]	A0A2I0M0L1	550	I	F
Q9ULV0	LP/P	Diarrhea 2, with microvillus atrophy, with or without cholestasis (DIAR2) [MIM:251850]	A0A2I0M0L1	81	H	R
Q9ULV0	LP/P	Diarrhea 2, with microvillus atrophy, with or without cholestasis (DIAR2) [MIM:251850]	A0A2I0M0L1	82	E	K
Q9ULV0	LP/P	Cholestasis, progressive familial intrahepatic, 10 (PFIC10) [MIM:619868]	A0A2I0M0L1	92	R	C
Q9ULV0	LP/P	Cholestasis, progressive familial intrahepatic, 10 (PFIC10) [MIM:619868]	A0A2I0M0L1	266	C	R
Q9ULV0	LP/P	Cholestasis, progressive familial intrahepatic, 10 (PFIC10) [MIM:619868]	A0A2I0M0L1	392	M	T
Q9ULV0	LP/P	Diarrhea 2, with microvillus atrophy, with or without cholestasis (DIAR2) [MIM:251850]	A0A2I0M0L1	392	M	T
Q9ULV0	LP/P	Cholestasis, progressive familial intrahepatic, 10 (PFIC10) [MIM:619868]	A0A2I0M0L1	401	R	C
Q9ULV0	LP/P	Cholestasis, progressive familial intrahepatic, 10 (PFIC10) [MIM:619868]	A0A2I0M0L1	654	Y	C
Q9ULV0	LP/P	Cholestasis, progressive familial intrahepatic, 10 (PFIC10) [MIM:619868]	A0A2I0M0L1	824	R	C
Q9NQX4	LB/B	-	A0A151M9L4	522	L	P
Q9NQX4	LB/B	-	A0A151M9L4	634	L	S
Q9NQX4	LB/B	-	A0A151M9L4	1075	E	K
Q9NQX4	LB/B	-	A0A151M9L4	1396	P	L
Q9NQX4	LB/B	-	A0A151M9L4	172	R	C
Q9UM54	LP/P	Deafness, autosomal dominant, 22 (DFNA22) [MIM:606346]	A0A1B6FAM9	442	C	Y
Q9UM54	LP/P	Deafness, autosomal recessive, 37 (DFNB37) [MIM:607821]	A0A1B6FAM9	216	E	V
Q9UM54	LP/P	Deafness, autosomal dominant 22, with hypertrophic cardiomyopathy (DFNHCM) [MIM:606346]	A0A1B6FAM9	246	H	R
Q6PIF6	LB/B	-	A0A2K5L8S8	21	G	S
Q6PIF6	LB/B	-	A0A2K5L8S8	1264	R	Q
Q6PIF6	LB/B	-	A0A2K5L8S8	1647	E	D
Q6PIF6	LB/B	-	A0A2K5L8S8	2105	Q	R
B2RTY4	LB/B	-	A0A091N447	37	R	K
B2RTY4	LB/B	-	A0A091N447	85	R	Q
B2RTY4	LB/B	-	A0A091N447	161	T	I
B2RTY4	LB/B	-	A0A091N447	168	N	D
B2RTY4	LB/B	-	A0A091N447	211	L	P
B2RTY4	LB/B	-	A0A091N447	946	R	Q
B2RTY4	LB/B	-	A0A091N447	1193	G	E
B2RTY4	LB/B	-	A0A091N447	1362	S	P
B2RTY4	LB/B	-	A0A091N447	1476	P	R
B2RTY4	LB/B	-	A0A091N447	1795	H	Y
B2RTY4	LB/B	-	A0A091N447	1805	H	Q
B2RTY4	LB/B	-	A0A091N447	1834	R	C
B2RTY4	LB/B	-	A0A091N447	2390	I	V
B2RTY4	LB/B	-	A0A091N447	825	A	V
Q9NZM1	LB/B	-	M7BWA8	1198	Y	F
Q9NZM1	LB/B	-	M7BWA8	1399	R	C
Q9NZM1	LB/B	-	M7BWA8	1783	R	Q
Q9NZM1	LB/B	-	M7BWA8	1136	V	I
Q9NZM1	LB/B	-	M7BWA8	1701	G	A
P54296	LB/B	-	K7GHV4	776	T	M
P54296	LB/B	-	K7GHV4	1022	L	F
P54296	LB/B	-	K7GHV4	81	E	K
P54296	LB/B	-	K7GHV4	182	T	M
P54296	LB/B	-	K7GHV4	321	V	L
P54296	LB/B	-	K7GHV4	363	V	I
P54296	LB/B	-	K7GHV4	601	S	Y
P54296	LB/B	-	K7GHV4	701	V	I
P54296	LB/B	-	K7GHV4	1284	E	D
P54296	LB/B	-	K7GHV4	869	S	N
P54296	LB/B	-	K7GHV4	1168	V	A
Q5VTT5	LB/B	-	K7GHV4	266	T	M
Q5VTT5	LB/B	-	K7GHV4	344	M	T
Q5VTT5	LB/B	-	K7GHV4	435	Q	R
Q5VTT5	LB/B	-	K7GHV4	528	D	G
Q5VTT5	LB/B	-	K7GHV4	662	G	R
Q5VTT5	LB/B	-	K7GHV4	775	R	Q
Q5VTT5	LB/B	-	K7GHV4	853	P	S
Q5VTT5	LB/B	-	K7GHV4	892	D	A
Q5VTT5	LB/B	-	K7GHV4	1041	F	L
Q5VTT5	LB/B	-	K7GHV4	1066	I	T
Q5VTT5	LB/B	-	K7GHV4	1124	R	Q
Q5VTT5	LB/B	-	K7GHV4	258	D	H
Q9UBF9	LP/P	Myopathy, myofibrillar, 3 (MFM3) [MIM:609200]	A0A2D4P3I4	55	S	F
Q9UBF9	LP/P	Myopathy, myofibrillar, 3 (MFM3) [MIM:609200]	A0A2D4P3I4	55	S	F
Q9UBF9	LP/P	Myopathy, myofibrillar, 3 (MFM3) [MIM:609200]	A0A2D4P3I4	57	T	I
Q9UBF9	LP/P	Myopathy, myofibrillar, 3 (MFM3) [MIM:609200]	A0A2D4P3I4	60	S	C
Q9UBF9	LP/P	Myopathy, myofibrillar, 3 (MFM3) [MIM:609200]	A0A2D4P3I4	60	S	F
Q9UBF9	LP/P	Myopathy, myofibrillar, 3 (MFM3) [MIM:609200]	A0A2D4P3I4	95	S	I
Q9UBF9	LP/P	Spheroid body myopathy (SBM) [MIM:182920]	A0A2D4P3I4	39	S	F
Q9UBF9	LB/B	-	A0A2D4P3I4	74	K	Q
Q9UBF9	LB/B	-	A0A2D4P3I4	50	Q	R
Q9NPC6	LP/P	Cardiomyopathy, familial hypertrophic 16 (CMH16) [MIM:613838]	V9KTU9	48	S	P
Q9NPC6	LP/P	Cardiomyopathy, familial hypertrophic 16 (CMH16) [MIM:613838]	V9KTU9	246	I	M
Q8TDC0	LB/B	-	F6PL78	209	T	N
Q8TDC0	LB/B	-	F6PL78	161	S	P
Q86TC9	LB/B	-	H2UIL9	691	S	N
Q86TC9	LB/B	-	H2UIL9	707	S	N
Q86TC9	LB/B	-	H2UIL9	803	S	R
Q86TC9	LB/B	-	H2UIL9	393	V	A
Q86TC9	LB/B	-	H2UIL9	628	F	L
Q86TC9	LB/B	-	H2UIL9	1135	P	T
Q86TC9	LP/P	Cardiomyopathy, dilated 1KK (CMD1KK) [MIM:615248]	H2UIL9	20	Y	C
Q86TC9	LP/P	Cardiomyopathy, familial hypertrophic 22 (CMH22) [MIM:615248]	H2UIL9	20	Y	C
Q86TC9	LP/P	Cardiomyopathy, familial hypertrophic 22 (CMH22) [MIM:615248]	H2UIL9	153	K	R
Q86TC9	LP/P	Cardiomyopathy, dilated 1KK (CMD1KK) [MIM:615248]	H2UIL9	213	I	V
Q86TC9	LP/P	Cardiomyopathy, familial hypertrophic 22 (CMH22) [MIM:615248]	H2UIL9	217	A	E
Q86TC9	LP/P	Cardiomyopathy, dilated 1KK (CMD1KK) [MIM:615248]	H2UIL9	339	Y	F
Q86TC9	LP/P	Cardiomyopathy, familial hypertrophic 22 (CMH22) [MIM:615248]	H2UIL9	410	V	A
Q86TC9	LB/B	-	H2UIL9	467	E	K
Q86TC9	LP/P	Cardiomyopathy, dilated 1KK (CMD1KK) [MIM:615248]	H2UIL9	611	A	T
Q86TC9	LB/B	-	H2UIL9	614	E	K
Q86TC9	LB/B	-	H2UIL9	804	G	R
Q86TC9	LP/P	Cardiomyopathy, familial hypertrophic 22 (CMH22) [MIM:615248]	H2UIL9	841	P	T
Q86TC9	LP/P	Cardiomyopathy, dilated 1KK (CMD1KK) [MIM:615248]	H2UIL9	882	A	T
Q86TC9	LP/P	Cardiomyopathy, dilated 1KK (CMD1KK) [MIM:615248]	H2UIL9	954	F	L
Q86TC9	LB/B	-	H2UIL9	955	R	Q
Q86TC9	LP/P	Cardiomyopathy, dilated 1KK (CMD1KK) [MIM:615248]	H2UIL9	961	P	L
Q86TC9	LP/P	Cardiomyopathy, dilated 1KK (CMD1KK) [MIM:615248]	H2UIL9	1088	R	H
Q86TC9	LP/P	Cardiomyopathy, dilated 1KK (CMD1KK) [MIM:615248]	H2UIL9	1112	P	L
Q86TC9	LP/P	Cardiomyopathy, familial hypertrophic 22 (CMH22) [MIM:615248]	H2UIL9	1112	P	L
Q86TC9	LB/B	-	H2UIL9	1161	L	I
Q86TC9	LP/P	Cardiomyopathy, dilated 1KK (CMD1KK) [MIM:615248]	H2UIL9	1195	V	M
Q86TC9	LP/P	Cardiomyopathy, familial hypertrophic 22 (CMH22) [MIM:615248]	H2UIL9	1265	A	P
Q86TC9	LB/B	-	H2UIL9	1306	V	G
Q86TC9	LB/B	-	H2UIL9	698	N	S
Q9Y2G1	LB/B	-	A0A1W5B0V9	723	A	T
Q9Y2G1	LP/P	Encephalitis/encephalopathy, mild, with reversible myelin vacuolization (MMERV) [MIM:618113]	A0A1W5B0V9	403	Q	R
Q9Y2G1	LP/P	Cardiac-urogenital syndrome (CUGS) [MIM:618280]	A0A1W5B0V9	435	G	R
Q8NFW9	LB/B	-	H9G951	673	P	S
Q8NFW9	LB/B	-	H9G951	312	A	T
Q8NFW9	LB/B	-	H9G951	365	P	L
Q5VVJ2	LB/B	-	I3J3Q5	200	C	S
Q5VVJ2	LB/B	-	I3J3Q5	264	T	A
Q5VVJ2	LB/B	-	I3J3Q5	825	E	K
Q5VVJ2	LP/P	Bone marrow failure syndrome 4 (BMFS4) [MIM:618116]	I3J3Q5	656	H	R
P0CAP1	LB/B	-	A0A1V4JEL3	277	A	V
Q08AG7	LB/B	-	H2TKH6	5	S	G
Q6NZ67	LB/B	-	H9KX44	118	A	V
Q6NZ67	LB/B	-	H9KX44	155	R	Q
Q92802	LB/B	-	F7B8U4	272	Y	H
Q9Y5N5	LB/B	-	A0A2Y9MYZ7	34	D	N
Q9Y5N5	LB/B	-	A0A2Y9MYZ7	146	R	K
Q9Y5N5	LB/B	-	A0A2Y9MYZ7	166	R	K
P41227	LP/P	N-terminal acetyltransferase deficiency (NATD) [MIM:300855]	L8Y500	37	S	P
P41227	LP/P	N-terminal acetyltransferase deficiency (NATD) [MIM:300855]	L8Y500	43	Y	S
P41227	LP/P	N-terminal acetyltransferase deficiency (NATD) [MIM:300855]	L8Y500	83	R	H
Q9BSU3	LB/B	-	A0A2Y9G2S5	6	A	T
Q9BSU3	LB/B	-	A0A2Y9G2S5	19	L	F
Q14CX7	LB/B	-	D2A4T4	876	K	R
Q14CX7	LB/B	-	D2A4T4	426	L	F
Q14CX7	LB/B	-	D2A4T4	915	L	I
Q9H7X0	LB/B	-	A0A287AIC0	218	H	Q
Q02083	LB/B	-	G1KMR5	151	V	I
Q02083	LB/B	-	G1KMR5	107	N	K
Q02083	LB/B	-	G1KMR5	334	F	L
Q9Y3Q0	LB/B	-	S8C3H3	101	V	I
Q9Y3Q0	LB/B	-	S8C3H3	446	I	V
Q9UQQ1	LB/B	-	G1TWK4	2	Q	H
Q9UQQ1	LB/B	-	G1TWK4	398	K	T
Q9UQQ1	LB/B	-	G1TWK4	611	L	V
Q96AH0	LB/B	-	H7C0W4	154	T	S
E9PAV3	LB/B	-	A0A2K5Q884	336	V	E
E9PAV3	LB/B	-	A0A2K5Q884	405	F	S
E9PAV3	LB/B	-	A0A2K5Q884	519	P	S
E9PAV3	LB/B	-	A0A2K5Q884	1795	S	T
E9PAV3	LB/B	-	A0A2K5Q884	1841	L	P
Q9H009	LB/B	-	A0A2K5SHY3	64	V	I
O15069	LB/B	-	A0A2Y9S093	438	D	E
O15069	LB/B	-	A0A2Y9S093	498	V	A
O15069	LB/B	-	A0A2Y9S093	591	K	E
O15069	LB/B	-	A0A2Y9S093	1105	D	E
O15069	LB/B	-	A0A2Y9S093	1152	C	F
Q96RE7	LP/P	Neurodevelopmental disorder with epilepsy, cataracts, feeding difficulties, and delayed brain myelination (NECFM) [MIM:617393]	H2LQF5	298	R	W
O95544	LB/B	-	L5L775	262	N	K
Q6IA69	LB/B	-	A7SR86	74	V	L
Q6IA69	LB/B	-	A7SR86	297	P	L
Q6IA69	LB/B	-	A7SR86	591	M	I
Q6IA69	LB/B	-	A7SR86	704	G	S
Q6IA69	LB/B	-	A7SR86	204	Q	H
Q6IA69	LP/P	Vertebral, cardiac, renal, and limb defects syndrome 3 (VCRL3) [MIM:618845]	A7SR86	49	C	R
Q6IA69	LP/P	Vertebral, cardiac, renal, and limb defects syndrome 3 (VCRL3) [MIM:618845]	A7SR86	132	W	L
Q6IA69	LP/P	Vertebral, cardiac, renal, and limb defects syndrome 3 (VCRL3) [MIM:618845]	A7SR86	573	A	T
Q13564	LB/B	-	A0A197JTS1	101	S	F
Q96HR8	LB/B	-	A0A1U7T7E2	43	P	S
Q96HR8	LB/B	-	A0A1U7T7E2	162	I	V
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	92	Y	H
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	115	P	S
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	140	Y	C
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	153	E	K
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	358	P	L
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	643	R	H
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	664	A	V
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	674	R	H
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	682	L	R
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	79	G	C
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	100	H	R
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	243	P	L
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	277	C	F
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	280	L	P
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	292	G	R
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	452	E	K
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	482	R	W
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	561	L	R
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	565	R	Q
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	705	E	K
P54802	LB/B	-	A0A2W5WZ12	737	R	G
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	48	F	L
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	314	F	L
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	521	P	L
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	565	R	P
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	565	R	W
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	643	R	C
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	35	L	F
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	38	R	W
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	48	F	C
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	69	G	S
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	77	V	G
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	79	G	S
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	82	G	D
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	130	R	C
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	154	I	R
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	156	W	C
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	227	H	P
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	234	R	C
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	241	V	M
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	242	L	P
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	246	A	P
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	248	H	R
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	268	W	R
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	309	Y	C
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	334	V	F
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	335	Y	C
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	410	F	S
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	412	G	E
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	414	H	R
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	437	T	I
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	446	E	K
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	455	Y	C
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	474	W	G
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	482	R	Q
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	501	V	G
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	516	P	L
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	520	R	W
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	534	S	Y
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	560	L	P
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	591	L	P
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	612	S	G
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	617	L	F
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	649	W	C
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	650	G	E
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	658	Y	F
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	674	R	C
P54802	LP/P	Mucopolysaccharidosis 3B (MPS3B) [MIM:252920]	A0A2W5WZ12	676	R	P
P54802	LP/P	Charcot-Marie-Tooth disease, axonal, 2V (CMT2V) [MIM:616491]	A0A2W5WZ12	403	I	T
Q9UK23	LB/B	-	V8NJR8	465	T	I
Q8N159	LP/P	N-acetylglutamate synthase deficiency (NAGSD) [MIM:237310]	L8Y4P3	200	C	R
Q8N159	LP/P	N-acetylglutamate synthase deficiency (NAGSD) [MIM:237310]	L8Y4P3	279	A	P
Q8N159	LP/P	N-acetylglutamate synthase deficiency (NAGSD) [MIM:237310]	L8Y4P3	410	S	P
Q8N159	LP/P	N-acetylglutamate synthase deficiency (NAGSD) [MIM:237310]	L8Y4P3	430	L	P
Q8N159	LP/P	N-acetylglutamate synthase deficiency (NAGSD) [MIM:237310]	L8Y4P3	484	W	R
Q8N159	LP/P	N-acetylglutamate synthase deficiency (NAGSD) [MIM:237310]	L8Y4P3	518	A	T
Q13075	LB/B	-	G1KJP5	535	V	M
O75949	LB/B	-	H2SM68	172	L	P
Q9H9S0	LB/B	-	A0A2K6P942	82	K	N
Q6NSW7	LB/B	-	A0A2K6P942	13	C	R
Q6NSW7	LB/B	-	A0A2K6P942	16	E	A
Q6NSW7	LB/B	-	A0A2K6P942	37	S	P
Q6NSW7	LB/B	-	A0A2K6P942	64	D	Y
Q6NSW7	LB/B	-	A0A2K6P942	68	S	Y
Q6NSW7	LB/B	-	A0A2K6P942	96	Q	R
Q6NSW7	LB/B	-	A0A2K6P942	107	L	P
Q6NSW7	LB/B	-	A0A2K6P942	127	E	G
Q6NSW7	LB/B	-	A0A2K6P942	146	Q	R
Q6NSW7	LB/B	-	A0A2K6P942	207	S	G
Q6NSW7	LB/B	-	A0A2K6P942	208	N	S
Q6NSW7	LB/B	-	A0A2K6P942	210	T	I
Q6NSW7	LB/B	-	A0A2K6P942	218	N	S
Q6NSW7	LB/B	-	A0A2K6P942	262	D	G
Q6NSW7	LB/B	-	A0A2K6P942	301	Q	R
Q8WY41	LB/B	-	A0A2K5KHQ0	34	P	T
Q9NR45	LB/B	-	D6WCA5	68	E	D
Q9NR45	LP/P	Spondyloepimetaphyseal dysplasia, Genevieve type (SEMDG) [MIM:610442]	D6WCA5	29	H	N
Q9NR45	LP/P	Spondyloepimetaphyseal dysplasia, Genevieve type (SEMDG) [MIM:610442]	D6WCA5	133	G	V
Q9NR45	LP/P	Spondyloepimetaphyseal dysplasia, Genevieve type (SEMDG) [MIM:610442]	D6WCA5	151	R	H
Q9NR45	LP/P	Spondyloepimetaphyseal dysplasia, Genevieve type (SEMDG) [MIM:610442]	D6WCA5	188	Y	H
Q9NR45	LP/P	Spondyloepimetaphyseal dysplasia, Genevieve type (SEMDG) [MIM:610442]	D6WCA5	189	P	L
Q9NR45	LP/P	Spondyloepimetaphyseal dysplasia, Genevieve type (SEMDG) [MIM:610442]	D6WCA5	237	R	C
Q96NT1	LB/B	-	A0A2U3V8B8	154	E	Q
Q6IQ20	LB/B	-	A0A1U8DN62	389	D	N
Q6IQ20	LB/B	-	A0A1U8DN62	152	S	A
Q6XQN6	LB/B	-	A0A2K5ZU21	57	A	V
O96009	LB/B	-	I3MHV8	310	A	T
O96009	LB/B	-	I3MHV8	40	I	T
O43776	LP/P	Neurodevelopmental disorder with microcephaly, impaired language, and gait abnormalities (NEDMILG) [MIM:619091]	F1LML0	17	T	M
O43776	LP/P	Neurodevelopmental disorder with microcephaly, impaired language, epilepsy, and gait abnormalities (NEDMILEG) [MIM:619092]	F1LML0	322	R	L
O43776	LP/P	Neurodevelopmental disorder with microcephaly, impaired language, and gait abnormalities (NEDMILG) [MIM:619091]	F1LML0	356	D	A
O43776	LP/P	Neurodevelopmental disorder with microcephaly, impaired language, and gait abnormalities (NEDMILG) [MIM:619091]	F1LML0	545	R	C
Q96I59	LB/B	-	M5WCI5	87	N	T
Q96I59	LP/P	Combined oxidative phosphorylation deficiency 24 (COXPD24) [MIM:616239]	M5WCI5	214	P	L
Q96I59	LP/P	Deafness, autosomal recessive, 94 (DFNB94) [MIM:618434]	M5WCI5	213	V	F
Q96I59	LP/P	Combined oxidative phosphorylation deficiency 24 (COXPD24) [MIM:616239]	M5WCI5	381	N	S
P18440	LB/B	-	H2MG64	64	R	W
P18440	LB/B	-	H2MG64	149	V	I
P18440	LB/B	-	H2MG64	187	R	Q
P18440	LB/B	-	H2MG64	205	M	V
P18440	LB/B	-	H2MG64	214	S	A
P18440	LB/B	-	H2MG64	251	D	V
P18440	LB/B	-	H2MG64	261	E	K
P18440	LB/B	-	H2MG64	263	I	V
P18440	LB/B	-	H2MG64	117	R	T
P18440	LB/B	-	H2MG64	207	T	I
P11245	LB/B	-	H2MG64	64	R	Q
P11245	LB/B	-	H2MG64	114	I	T
P11245	LB/B	-	H2MG64	197	R	Q
P11245	LB/B	-	H2MG64	268	R	K
P11245	LB/B	-	H2MG64	286	G	E
P11245	LB/B	-	H2MG64	64	R	W
P11245	LB/B	-	H2MG64	145	Q	P
P11245	LB/B	-	H2MG64	282	K	T
P11245	LB/B	-	H2MG64	24	L	I
P11245	LB/B	-	H2MG64	228	P	L
P11245	LB/B	-	H2MG64	122	D	N
P11245	LB/B	-	H2MG64	137	L	F
P11245	LB/B	-	H2MG64	193	T	M
P11245	LB/B	-	H2MG64	208	Y	H
P11245	LB/B	-	H2MG64	135	L	V
P11245	LB/B	-	H2MG64	280	V	M
Q9UHE5	LB/B	-	S7PP16	143	F	S
Q9UHE5	LB/B	-	S7PP16	104	E	K
Q8N6N6	LB/B	-	A0A151N218	42	V	I
Q8IVL1	LB/B	-	L9KXC3	109	R	K
Q8IVL1	LB/B	-	L9KXC3	491	Q	H
Q8IVL1	LB/B	-	L9KXC3	1041	E	D
Q8IVL1	LB/B	-	L9KXC3	1077	P	A
Q8IVL1	LB/B	-	L9KXC3	2374	V	I
Q8IVL0	LB/B	-	V8NQZ6	45	T	A
Q8IVL0	LB/B	-	V8NQZ6	210	S	W
Q8IW45	LB/B	-	A0A2Y9SJW0	140	K	E
Q8IW45	LB/B	-	A0A2Y9SJW0	149	V	I
Q8IW45	LB/B	-	A0A2Y9SJW0	152	P	T
Q8IW45	LP/P	Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 2 (PEBEL2) [MIM:618321]	A0A2Y9SJW0	81	G	S
Q8IW45	LP/P	Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 2 (PEBEL2) [MIM:618321]	A0A2Y9SJW0	326	R	C
Q8NCW5	LB/B	-	A0A2K6DAT6	19	V	L
Q8NCW5	LP/P	Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy 1 (PEBEL1) [MIM:617186]	A0A2K6DAT6	94	A	D
Q8NCW5	LP/P	Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy 1 (PEBEL1) [MIM:617186]	A0A2K6DAT6	218	D	V
A2RRP1	LB/B	-	A0A0F8BDT1	243	I	V
A2RRP1	LB/B	-	A0A0F8BDT1	655	K	R
A2RRP1	LB/B	-	A0A0F8BDT1	1004	R	Q
A2RRP1	LB/B	-	A0A0F8BDT1	1178	S	N
A2RRP1	LB/B	-	A0A0F8BDT1	2074	A	T
A2RRP1	LB/B	-	A0A0F8BDT1	44	Q	E
A2RRP1	LB/B	-	A0A0F8BDT1	949	V	L
A2RRP1	LB/B	-	A0A0F8BDT1	1009	C	S
A2RRP1	LP/P	-	A0A0F8BDT1	95	A	V
A2RRP1	LP/P	-	A0A0F8BDT1	137	R	W
A2RRP1	LP/P	Infantile liver failure syndrome 2 (ILFS2) [MIM:616483]	A0A0F8BDT1	348	P	S
A2RRP1	LP/P	-	A0A0F8BDT1	396	W	R
A2RRP1	LP/P	Infantile liver failure syndrome 2 (ILFS2) [MIM:616483]	A0A0F8BDT1	777	P	H
A2RRP1	LP/P	Infantile liver failure syndrome 2 (ILFS2) [MIM:616483]	A0A0F8BDT1	842	V	F
A2RRP1	LP/P	Infantile liver failure syndrome 2 (ILFS2) [MIM:616483]	A0A0F8BDT1	984	I	S
A2RRP1	LP/P	Infantile liver failure syndrome 2 (ILFS2) [MIM:616483]	A0A0F8BDT1	1055	L	P
Q8NFP9	LB/B	-	U3B0C7	569	A	P
Q8NFP9	LB/B	-	U3B0C7	2501	I	V
Q8NFP9	LP/P	Neurodevelopmental disorder with or without early-onset generalized epilepsy (NEDEGE) [MIM:619157]	U3B0C7	483	A	V
Q8NFP9	LP/P	Neurodevelopmental disorder with or without early-onset generalized epilepsy (NEDEGE) [MIM:619157]	U3B0C7	1332	P	S
Q8NFP9	LP/P	Neurodevelopmental disorder with or without early-onset generalized epilepsy (NEDEGE) [MIM:619157]	U3B0C7	2801	E	K
Q8NFP9	LP/P	Neurodevelopmental disorder with or without early-onset generalized epilepsy (NEDEGE) [MIM:619157]	U3B0C7	946	H	Y
Q3BBV0	LB/B	-	Q3BBV0	20	I	M
Q3BBV0	LB/B	-	Q3BBV0	31	N	K
Q3BBV0	LB/B	-	Q3BBV0	510	A	T
Q3BBV0	LB/B	-	Q3BBV0	591	C	G
Q3BBV0	LB/B	-	Q3BBV0	612	M	V
Q3BBV0	LB/B	-	Q3BBV0	663	C	R
Q3BBV0	LB/B	-	Q3BBV0	712	D	H
Q3BBV0	LB/B	-	Q3BBV0	726	K	E
Q3BBV0	LB/B	-	Q3BBV0	734	P	Q
Q3BBV0	LB/B	-	Q3BBV0	850	K	Q
Q5TI25	LB/B	-	G3SAK4	243	S	G
P0C2Y1	LB/B	-	F1SB06	170	E	D
Q14596	LB/B	-	A0A087V920	923	H	R
P13591	LB/B	-	H2MIC7	260	D	N
P13591	LB/B	-	H2MIC7	679	E	D
P13591	LB/B	-	H2MIC7	834	T	M
P13591	LB/B	-	H2MIC7	7	L	F
O15394	LB/B	-	H2MIC7	347	D	N
O15394	LB/B	-	H2MIC7	350	L	P
Q15021	LB/B	-	A0A1A6GID0	83	Q	E
Q15021	LB/B	-	A0A1A6GID0	797	V	M
Q15021	LB/B	-	A0A1A6GID0	580	K	R
Q15021	LB/B	-	A0A1A6GID0	1321	T	S
P42695	LB/B	-	F7CYV5	622	R	Q
P42695	LB/B	-	F7CYV5	907	P	T
P42695	LB/B	-	F7CYV5	1034	S	R
P42695	LP/P	Microcephaly 22, primary, autosomal recessive (MCPH22) [MIM:617984]	F7CYV5	1153	E	A
Q9BPX3	LB/B	-	A0A1U7TK83	64	A	P
Q9BPX3	LB/B	-	A0A1U7TK83	581	M	I
Q86XI2	LB/B	-	A0A091S9Z0	794	T	M
Q86XI2	LB/B	-	A0A091S9Z0	867	E	D
Q86XI2	LP/P	Khan-Khan-Katsanis syndrome (3KS) [MIM:618460]	A0A091S9Z0	609	K	E
Q86XI2	LP/P	Khan-Khan-Katsanis syndrome (3KS) [MIM:618460]	A0A091S9Z0	693	T	M
Q86XI2	LP/P	Khan-Khan-Katsanis syndrome (3KS) [MIM:618460]	A0A091S9Z0	850	T	P
Q15003	LB/B	-	V8NG82	539	V	A
Q15003	LP/P	Microcephaly 23, primary, autosomal recessive (MCPH23) [MIM:617985]	V8NG82	243	P	L
Q6PIU2	LB/B	-	L5KPA1	19	V	F
Q6PIU2	LB/B	-	L5KPA1	71	K	Q
Q6PIU2	LB/B	-	L5KPA1	343	L	M
Q15080	LB/B	-	A0A2R8ZMX4	147	L	I
Q15080	LB/B	-	A0A2R8ZMX4	153	R	H
Q15080	LP/P	Granulomatous disease, chronic, autosomal recessive, 3 (CGD3) [MIM:613960]	A0A2R8ZMX4	105	R	Q
P16333	LB/B	-	A0A1W4Y9R7	180	A	V
P55160	LB/B	-	G1T5L6	402	S	L
P55160	LB/B	-	G1T5L6	391	T	A
P55160	LP/P	Immunodeficiency 72 with autoinflammation (IMD72) [MIM:618982]	G1T5L6	258	R	L
P55160	LP/P	Immunodeficiency 72 with autoinflammation (IMD72) [MIM:618982]	G1T5L6	359	P	L
P55160	LP/P	Immunodeficiency 72 with autoinflammation (IMD72) [MIM:618982]	G1T5L6	371	M	V
P55160	LP/P	Immunodeficiency 72 with autoinflammation (IMD72) [MIM:618982]	G1T5L6	519	V	L
O14513	LB/B	-	A0A094K5S6	600	S	T
O14513	LB/B	-	A0A094K5S6	937	V	I
O14513	LB/B	-	A0A094K5S6	977	I	T
O14513	LB/B	-	A0A094K5S6	1093	N	Y
O14513	LB/B	-	A0A094K5S6	1260	P	Q
O14513	LB/B	-	A0A094K5S6	1403	V	A
O14513	LB/B	-	A0A094K5S6	250	R	Q
P19338	LB/B	-	G3P2Q4	68	P	L
P19338	LB/B	-	G3P2Q4	122	P	L
P19338	LB/B	-	G3P2Q4	174	A	V
Q15788	LB/B	-	A0A2K6FTY0	457	Q	K
Q15788	LB/B	-	A0A2K6FTY0	466	N	K
Q15788	LB/B	-	A0A2K6FTY0	474	S	P
Q15788	LB/B	-	A0A2K6FTY0	591	I	T
Q15788	LB/B	-	A0A2K6FTY0	685	E	A
Q15788	LB/B	-	A0A2K6FTY0	794	P	A
Q15788	LB/B	-	A0A2K6FTY0	999	S	F
Q15788	LB/B	-	A0A2K6FTY0	1154	M	T
Q15788	LB/B	-	A0A2K6FTY0	1272	P	S
Q15788	LB/B	-	A0A2K6FTY0	1238	V	I
Q13772	LB/B	-	Q3UJ63	94	S	L
Q13772	LB/B	-	Q3UJ63	154	F	L
Q13772	LB/B	-	Q3UJ63	350	C	R
Q13772	LB/B	-	Q3UJ63	561	L	P
Q13772	LB/B	-	Q3UJ63	474	P	R
Q9HCD5	LB/B	-	L9JCB0	326	E	G
Q14686	LB/B	-	A0A1D5R718	512	P	L
Q14686	LB/B	-	A0A1D5R718	955	N	S
Q14686	LB/B	-	A0A1D5R718	1995	I	V
Q8NI08	LB/B	-	S9XQM4	399	S	A
Q8NI08	LB/B	-	S9XQM4	942	D	E
Q8NI08	LB/B	-	S9XQM4	533	G	R
Q9Y618	LB/B	-	A0A2Y9QDI0	1699	A	T
Q9Y618	LB/B	-	A0A2Y9QDI0	781	G	E
Q9Y618	LB/B	-	A0A2Y9QDI0	2001	P	S
O76036	LB/B	-	A0A286XP88	82	K	Q
O14931	LB/B	-	A0A2K6FW66	103	A	T
O14931	LB/B	-	A0A2K6FW66	174	R	S
Q92542	LB/B	-	A0A093PSY9	75	V	I
Q92542	LB/B	-	A0A093PSY9	77	E	D
Q92542	LP/P	Acne inversa, familial, 1 (ACNINV1) [MIM:142690]	A0A093PSY9	211	P	R
Q9BTX1	LB/B	-	A0A2I4B5B4	154	G	D
O14777	LB/B	-	G3SUD9	66	S	A
O14777	LB/B	-	G3SUD9	348	E	D
O14777	LB/B	-	G3SUD9	605	A	P
Q99608	LB/B	-	A0A2K5NUU4	318	V	A
Q9UHB4	LB/B	-	A0A2Y9T2H4	522	V	I
Q92597	LB/B	-	G7N056	67	M	V
Q92597	LB/B	-	G7N056	111	M	L
Q9UN36	LB/B	-	A0A075B7H3	48	G	V
Q9UN36	LB/B	-	A0A075B7H3	45	T	S
P52848	LP/P	Intellectual developmental disorder, autosomal recessive 46 (MRT46) [MIM:616116]	A0A093FST1	611	G	S
P52848	LP/P	Intellectual developmental disorder, autosomal recessive 46 (MRT46) [MIM:616116]	A0A093FST1	640	F	L
P52848	LP/P	Intellectual developmental disorder, autosomal recessive 46 (MRT46) [MIM:616116]	A0A093FST1	642	E	D
P52848	LP/P	Intellectual developmental disorder, autosomal recessive 46 (MRT46) [MIM:616116]	A0A093FST1	709	R	Q
Q9H3R1	LB/B	-	A0A093FST1	12	R	Q
O15239	LB/B	-	A0A1S3WBG3	32	G	R
O15239	LP/P	Mitochondrial complex I deficiency, nuclear type 12 (MC1DN12) [MIM:301020]	A0A1S3WBG3	8	G	R
O15239	LP/P	Mitochondrial complex I deficiency, nuclear type 12 (MC1DN12) [MIM:301020]	A0A1S3WBG3	37	R	S
O95299	LB/B	-	H0WR55	2	A	G
O95299	LP/P	Mitochondrial complex I deficiency, nuclear type 22 (MC1DN22) [MIM:618243]	H0WR55	142	Q	R
Q9UI09	LB/B	-	M3Y7J0	104	T	A
Q9P0J0	LP/P	Mitochondrial complex I deficiency, nuclear type 28 (MC1DN28) [MIM:618249]	A0A1A6FWR6	57	R	H
P56556	LB/B	-	A0A2Y9EDV0	9	A	V
P56556	LP/P	Mitochondrial complex I deficiency, nuclear type 33 (MC1DN33) [MIM:618253]	A0A2Y9EDV0	64	R	P
P51970	LP/P	Mitochondrial complex I deficiency, nuclear type 37 (MC1DN37) [MIM:619272]	F1SLR1	47	R	C
P51970	LP/P	Mitochondrial complex I deficiency, nuclear type 37 (MC1DN37) [MIM:619272]	F1SLR1	98	R	L
Q16795	LP/P	Mitochondrial complex I deficiency, nuclear type 26 (MC1DN26) [MIM:618247]	A0A1X7TME2	321	R	P
Q16795	LP/P	Mitochondrial complex I deficiency, nuclear type 26 (MC1DN26) [MIM:618247]	A0A1X7TME2	360	R	C
Q9BU61	LP/P	Mitochondrial complex I deficiency, nuclear type 18 (MC1DN18) [MIM:618240]	G3WPQ4	77	G	R
Q9BU61	LP/P	Mitochondrial complex I deficiency, nuclear type 18 (MC1DN18) [MIM:618240]	G3WPQ4	122	R	P
Q9BU61	LP/P	Mitochondrial complex I deficiency, nuclear type 18 (MC1DN18) [MIM:618240]	G3WPQ4	165	A	V
Q9P032	LP/P	Mitochondrial complex I deficiency, nuclear type 15 (MC1DN15) [MIM:618237]	F6UT45	65	L	P
Q9P032	LP/P	Mitochondrial complex I deficiency, nuclear type 15 (MC1DN15) [MIM:618237]	F6UT45	3	A	P
Q330K2	LP/P	Mitochondrial complex I deficiency, nuclear type 17 (MC1DN17) [MIM:618239]	G1SRD8	99	Q	R
Q330K2	LP/P	Mitochondrial complex I deficiency, nuclear type 17 (MC1DN17) [MIM:618239]	G1SRD8	69	D	V
Q330K2	LP/P	Mitochondrial complex I deficiency, nuclear type 17 (MC1DN17) [MIM:618239]	G1SRD8	76	S	P
Q330K2	LP/P	Mitochondrial complex I deficiency, nuclear type 17 (MC1DN17) [MIM:618239]	G1SRD8	124	I	T
Q330K2	LP/P	Mitochondrial complex I deficiency, nuclear type 17 (MC1DN17) [MIM:618239]	G1SRD8	269	H	D
Q330K2	LP/P	Mitochondrial complex I deficiency, nuclear type 17 (MC1DN17) [MIM:618239]	G1SRD8	274	R	G
Q330K2	LP/P	Mitochondrial complex I deficiency, nuclear type 17 (MC1DN17) [MIM:618239]	G1SRD8	178	A	P
O96000	LP/P	Mitochondrial complex I deficiency, nuclear type 35 (MC1DN35) [MIM:619003]	A0A1U7RIM1	107	C	S
Q9NX14	LP/P	Mitochondrial complex I deficiency, nuclear type 30 (MC1DN30) [MIM:301021]	A0A0D9RMS4	121	E	K
O43676	LP/P	Mitochondrial complex I deficiency, nuclear type 25 (MC1DN25) [MIM:618246]	A0A2K5CGH5	22	W	R
P17568	LB/B	-	A0A0E9WI03	106	R	G
O95169	LP/P	Mitochondrial complex I deficiency, nuclear type 32 (MC1DN32) [MIM:618252]	Q6P5L5	62	Y	H
O95169	LP/P	Mitochondrial complex I deficiency, nuclear type 32 (MC1DN32) [MIM:618252]	Q6P5L5	76	P	Q
O95169	LP/P	Mitochondrial complex I deficiency, nuclear type 32 (MC1DN32) [MIM:618252]	Q6P5L5	144	C	W
Q9Y6M9	LB/B	-	A0A2K6D599	146	P	S
Q9Y6M9	LP/P	Mitochondrial complex I deficiency, nuclear type 24 (MC1DN24) [MIM:618245]	A0A2K6D599	64	L	P
O95298	LB/B	-	A0A1D5RHW4	46	L	V
O95298	LP/P	Mitochondrial complex I deficiency, nuclear type 36 (MC1DN36) [MIM:619170]	A0A1D5RHW4	58	H	Y
P28331	LB/B	-	H3B728	649	V	F
P28331	LP/P	Mitochondrial complex I deficiency, nuclear type 5 (MC1DN5) [MIM:618226]	H3B728	252	D	G
P28331	LB/B	-	H3B728	241	R	Q
P28331	LB/B	-	H3B728	253	V	G
P28331	LP/P	Mitochondrial complex I deficiency, nuclear type 5 (MC1DN5) [MIM:618226]	H3B728	228	V	A
O75306	LP/P	Mitochondrial complex I deficiency, nuclear type 6 (MC1DN6) [MIM:618228]	A0A1D5P3B3	228	R	Q
O75306	LP/P	Mitochondrial complex I deficiency, nuclear type 6 (MC1DN6) [MIM:618228]	A0A1D5P3B3	229	P	Q
O75306	LP/P	Mitochondrial complex I deficiency, nuclear type 6 (MC1DN6) [MIM:618228]	A0A1D5P3B3	413	S	P
O75306	LB/B	-	A0A1D5P3B3	20	P	T
O75306	LB/B	-	A0A1D5P3B3	229	P	A
O75306	LB/B	-	A0A1D5P3B3	352	P	A
O75306	LB/B	-	A0A1D5P3B3	224	A	V
O75306	LP/P	Mitochondrial complex I deficiency, nuclear type 6 (MC1DN6) [MIM:618228]	A0A1D5P3B3	446	D	N
O75489	LB/B	-	A0A0P6JBI8	249	P	Q
O75489	LP/P	Mitochondrial complex I deficiency, nuclear type 8 (MC1DN8) [MIM:618230]	A0A0P6JBI8	145	T	I
O75489	LP/P	Mitochondrial complex I deficiency, nuclear type 8 (MC1DN8) [MIM:618230]	A0A0P6JBI8	199	R	W
O43181	LB/B	-	A0A1S3FBY0	174	T	P
O43181	LP/P	Mitochondrial complex I deficiency, nuclear type 1 (MC1DN1) [MIM:252010]	A0A1S3FBY0	119	D	H
O75380	LP/P	Mitochondrial complex I deficiency, nuclear type 9 (MC1DN9) [MIM:618232]	A0A1V4J9F0	115	C	Y
O75251	LP/P	Mitochondrial complex I deficiency, nuclear type 3 (MC1DN3) [MIM:618224]	A0A286XHE4	122	V	M
O75251	LB/B	-	A0A286XHE4	23	P	L
O00217	LP/P	Mitochondrial complex I deficiency, nuclear type 2 (MC1DN2) [MIM:618222]	A0A026WYP1	79	P	L
O00217	LP/P	Mitochondrial complex I deficiency, nuclear type 2 (MC1DN2) [MIM:618222]	A0A026WYP1	102	R	H
O00217	LP/P	Mitochondrial complex I deficiency, nuclear type 2 (MC1DN2) [MIM:618222]	A0A026WYP1	63	E	Q
Q7Z6G3	LB/B	-	A0A286ZTK3	233	G	S
Q7Z6G3	LB/B	-	A0A286ZTK3	235	T	S
Q7Z6G3	LB/B	-	A0A286ZTK3	308	Q	H
Q7Z6G3	LB/B	-	A0A286ZTK3	353	L	V
Q96P71	LB/B	-	A0A1A8IC45	254	P	L
Q8NC96	LB/B	-	A0A091CVE9	224	D	N
Q9NVZ3	LB/B	-	A0A2J8S973	149	D	A
P46934	LB/B	-	A0A2D0QT83	679	R	Q
P46934	LB/B	-	A0A2D0QT83	698	N	S
P46934	LB/B	-	A0A2D0QT83	33	M	V
Q96PU5	LB/B	-	A0A2D0QT83	355	P	L
Q96PU5	LB/B	-	A0A2D0QT83	497	S	R
Q96PU5	LP/P	Periventricular nodular heterotopia 7 (PVNH7) [MIM:617201]	A0A2D0QT83	679	Y	C
Q96PU5	LP/P	Periventricular nodular heterotopia 7 (PVNH7) [MIM:617201]	A0A2D0QT83	694	Q	H
Q96PU5	LP/P	Periventricular nodular heterotopia 7 (PVNH7) [MIM:617201]	A0A2D0QT83	893	E	K
Q96PU5	LP/P	Periventricular nodular heterotopia 7 (PVNH7) [MIM:617201]	A0A2D0QT83	897	R	Q
Q14511	LB/B	-	W5MMK1	577	T	M
Q14511	LB/B	-	W5MMK1	178	D	N
Q14511	LB/B	-	W5MMK1	304	P	L
P12036	LB/B	-	A0A287CRV9	811	E	A
P12036	LB/B	-	A0A287CRV9	575	P	S
P12036	LB/B	-	A0A287CRV9	615	P	L
P07196	LP/P	Charcot-Marie-Tooth disease, axonal, 2E (CMT2E) [MIM:607684]	V8P128	332	Q	P
P07196	LB/B	-	V8P128	7	E	K
P07196	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1F (CMT1F) [MIM:607734]	V8P128	8	P	L
P07196	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1F (CMT1F) [MIM:607734]	V8P128	8	P	Q
P07196	LP/P	Charcot-Marie-Tooth disease, axonal, 2E (CMT2E) [MIM:607684]	V8P128	8	P	R
P07196	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1F (CMT1F) [MIM:607734]	V8P128	8	P	R
P07196	LP/P	Charcot-Marie-Tooth disease, axonal, 2E (CMT2E) [MIM:607684]	V8P128	22	P	S
P07196	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1F (CMT1F) [MIM:607734]	V8P128	90	E	K
P07196	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1F (CMT1F) [MIM:607734]	V8P128	98	N	S
P07196	LP/P	Charcot-Marie-Tooth disease, dominant intermediate G (CMTDIG) [MIM:617882]	V8P128	98	N	S
P07196	LB/B	-	V8P128	468	D	N
P07196	LP/P	Charcot-Marie-Tooth disease, axonal, 2E (CMT2E) [MIM:607684]	V8P128	396	E	K
P07196	LP/P	Charcot-Marie-Tooth disease, dominant intermediate G (CMTDIG) [MIM:617882]	V8P128	396	E	K
P07196	LB/B	-	V8P128	213	I	M
P07196	LP/P	Charcot-Marie-Tooth disease, axonal, 2E (CMT2E) [MIM:607684]	V8P128	268	L	P
Q96FI4	LB/B	-	A0A1S3WF60	82	S	C
Q96FI4	LB/B	-	A0A1S3WF60	83	G	D
Q96FI4	LB/B	-	A0A1S3WF60	136	C	R
Q96FI4	LB/B	-	A0A1S3WF60	182	I	M
Q96FI4	LB/B	-	A0A1S3WF60	252	D	N
Q96FI4	LB/B	-	A0A1S3WF60	159	R	Q
Q96FI4	LB/B	-	A0A1S3WF60	181	E	K
Q969S2	LB/B	-	A0A091S4U6	70	T	S
Q969S2	LB/B	-	A0A091S4U6	103	R	Q
Q969S2	LB/B	-	A0A091S4U6	103	R	W
Q969S2	LB/B	-	A0A091S4U6	257	R	L
Q969S2	LB/B	-	A0A091S4U6	304	P	T
Q6ZWH5	LB/B	-	A0A2Y9MTV8	50	F	L
Q6ZWH5	LB/B	-	A0A2Y9MTV8	67	G	S
Q6ZWH5	LB/B	-	A0A2Y9MTV8	513	L	S
Q6ZWH5	LB/B	-	A0A2Y9MTV8	659	N	S
Q6ZWH5	LB/B	-	A0A2Y9MTV8	701	L	V
P51955	LB/B	-	Q91XQ1	354	N	S
P51955	LB/B	-	Q91XQ1	410	C	Y
P51957	LB/B	-	W5NV64	225	P	A
P51957	LB/B	-	W5NV64	239	R	G
P51957	LB/B	-	W5NV64	250	P	L
P51957	LB/B	-	W5NV64	357	T	I
P51957	LB/B	-	W5NV64	456	Q	E
P51957	LB/B	-	W5NV64	567	F	L
Q6P3R8	LB/B	-	A0A1U7UK07	290	R	H
Q6P3R8	LB/B	-	A0A1U7UK07	531	C	R
Q6P3R8	LB/B	-	A0A1U7UK07	255	K	Q
Q8TDX7	LB/B	-	A0A091DEB9	35	R	G
Q86SG6	LP/P	Nephronophthisis 9 (NPHP9) [MIM:613824]	A0A2I4CHT9	330	L	F
Q86SG6	LP/P	Nephronophthisis 9 (NPHP9) [MIM:613824]	A0A2I4CHT9	425	H	Y
Q86SG6	LP/P	Nephronophthisis 9 (NPHP9) [MIM:613824]	A0A2I4CHT9	497	A	P
Q8TD19	LB/B	-	K7GHM8	429	R	H
Q8TD19	LB/B	-	K7GHM8	828	P	T
Q8TD19	LP/P	Nevus comedonicus (NC) [MIM:617025]	K7GHM8	167	I	T
Q8TD19	LP/P	Nevus comedonicus (NC) [MIM:617025]	K7GHM8	573	I	T
Q8TD19	LP/P	Arthrogryposis, Perthes disease, and upward gaze palsy (APUG) [MIM:614262]	K7GHM8	681	R	H
Q9H3P2	LB/B	-	A0A1S3I1B3	335	S	A
Q92832	LB/B	-	V9KCM9	354	R	W
Q92832	LB/B	-	V9KCM9	82	R	Q
Q92832	LB/B	-	V9KCM9	211	F	V
Q92832	LB/B	-	V9KCM9	287	V	I
Q99435	LB/B	-	V9KCM9	5	V	I
Q99435	LB/B	-	V9KCM9	347	N	D
Q99435	LB/B	-	V9KCM9	631	P	L
O60524	LB/B	-	A0A0P4VQU8	257	S	C
O14524	LB/B	-	A0A1S3AHC7	217	I	V
Q92859	LB/B	-	H2SLV3	534	P	L
Q6NW34	LB/B	-	U3E767	101	E	K
Q6NW34	LB/B	-	U3E767	352	P	S
Q6NW34	LB/B	-	U3E767	357	F	I
Q6NW34	LB/B	-	U3E767	476	T	A
Q6NW34	LB/B	-	U3E767	490	S	P
P48681	LB/B	-	A0A1S3WS33	815	V	I
P48681	LB/B	-	A0A1S3WS33	1016	S	N
P48681	LB/B	-	A0A1S3WS33	1101	P	L
P48681	LB/B	-	A0A1S3WS33	1133	R	S
P48681	LB/B	-	A0A1S3WS33	1275	P	L
P48681	LB/B	-	A0A1S3WS33	130	V	A
Q7Z628	LB/B	-	F7DXT9	417	T	I
Q8NC67	LB/B	-	F6SWB8	456	S	T
Q9Y3R4	LB/B	-	K0Q567	11	S	R
Q9Y3R4	LB/B	-	K0Q567	41	R	Q
Q9Y3R4	LB/B	-	K0Q567	145	A	T
Q9Y3R4	LB/B	-	K0Q567	168	H	N
Q9Y3R4	LB/B	-	K0Q567	182	R	Q
Q9UQ49	LB/B	-	L8I5X4	15	R	Q
Q8WWR8	LB/B	-	A0A146PCP0	301	G	R
Q9BR09	LB/B	-	A0A2F0B8J1	211	E	K
Q13562	LP/P	Type 2 diabetes mellitus (T2D) [MIM:125853]	A0A226MML7	111	R	L
Q13562	LB/B	-	A0A226MML7	45	T	A
Q13562	LB/B	-	A0A226MML7	197	P	H
Q13562	LP/P	Maturity-onset diabetes of the young 6 (MODY6) [MIM:606394]	A0A226MML7	103	R	P
Q15784	LP/P	Developmental and epileptic encephalopathy 72 (DEE72) [MIM:618374]	A0A1U8C0Q6	130	E	Q
Q15784	LP/P	Developmental and epileptic encephalopathy 72 (DEE72) [MIM:618374]	A0A1U8C0Q6	134	M	T
Q9HD90	LB/B	-	A0A226MML7	68	K	T
Q9Y4Z2	LP/P	Diarrhea 4, malabsorptive, congenital (DIAR4) [MIM:610370]	A0A287AZY9	93	R	L
Q9Y4Z2	LP/P	Diarrhea 4, malabsorptive, congenital (DIAR4) [MIM:610370]	A0A287AZY9	107	R	S
Q9Y4Z2	LB/B	-	A0A287AZY9	199	F	S
Q5QGS0	LB/B	-	A0A2D0REH7	1112	I	T
Q0ZGT2	LB/B	-	A0A2R8Q6F9	245	G	R
Q0ZGT2	LB/B	-	A0A2R8Q6F9	335	R	K
Q0ZGT2	LP/P	Cardiomyopathy, dilated 1CC (CMD1CC) [MIM:613122]	A0A2R8Q6F9	611	P	T
Q0ZGT2	LP/P	Cardiomyopathy, dilated 1CC (CMD1CC) [MIM:613122]	A0A2R8Q6F9	652	Y	C
Q0ZGT2	LP/P	Cardiomyopathy, familial hypertrophic 20 (CMH20) [MIM:613876]	A0A2R8Q6F9	131	Q	E
Q0ZGT2	LP/P	Cardiomyopathy, familial hypertrophic 20 (CMH20) [MIM:613876]	A0A2R8Q6F9	279	R	C
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	629	G	R
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	844	L	R
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	898	L	P
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	1035	M	R
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	1440	K	R
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	1444	K	E
P21359	LP/P	Neurofibromatosis-Noonan syndrome (NFNS) [MIM:601321]	A0A0P5UGN0	1444	K	E
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	1611	R	W
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	1952	W	R
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	1953	L	P
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	2164	L	M
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	2192	Y	N
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	2631	T	A
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	1446	L	P
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	117	I	S
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	338	D	G
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	508	L	P
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	844	L	F
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	1166	G	D
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	1204	R	W
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	1276	R	P
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	1412	R	S
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	1440	K	Q
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	1489	S	G
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	93	C	Y
P21359	LB/B	-	A0A0P5UGN0	176	D	E
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	604	L	V
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	1276	R	Q
P21359	LP/P	Familial spinal neurofibromatosis (FSNF) [MIM:162210]	A0A0P5UGN0	2088	L	P
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	82	S	F
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	157	I	N
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	216	L	P
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	357	L	P
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	491	Y	C
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	549	L	P
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	578	L	R
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	581	I	T
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	583	K	R
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	695	L	P
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	763	L	P
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	777	W	S
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	780	T	K
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	781	H	P
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	784	W	C
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	784	W	R
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	847	L	P
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	848	G	E
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	920	L	P
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	968	M	R
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	1147	L	P
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	1156	N	S
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	1193	F	C
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	1204	R	G
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	1250	R	P
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	1444	K	N
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	1444	K	R
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	1605	I	V
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	1785	A	S
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	2001	G	R
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	2012	D	N
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	2221	P	A
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	2357	E	K
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	2507	T	I
P21359	LB/B	-	A0A0P5UGN0	80	Y	C
P21359	LB/B	-	A0A0P5UGN0	678	P	L
P21359	LB/B	-	A0A0P5UGN0	1422	Y	H
P21359	LB/B	-	A0A0P5UGN0	2511	V	L
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	31	H	R
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	145	L	P
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	186	D	V
P21359	LP/P	Neurofibromatosis-Noonan syndrome (NFNS) [MIM:601321]	A0A0P5UGN0	194	L	R
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	324	C	R
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	337	E	V
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	489	Y	C
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	532	L	P
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	574	S	R
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	844	L	P
P21359	LB/B	-	A0A0P5UGN0	873	R	C
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	1073	M	V
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	1196	L	R
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	1243	L	P
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	1276	R	G
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	1430	K	E
P21359	LP/P	Neurofibromatosis-Noonan syndrome (NFNS) [MIM:601321]	A0A0P5UGN0	1451	N	T
P21359	LP/P	Neurofibromatosis-Noonan syndrome (NFNS) [MIM:601321]	A0A0P5UGN0	1453	V	L
P21359	LB/B	-	A0A0P5UGN0	80	Y	S
P21359	LP/P	Neurofibromatosis-Noonan syndrome (NFNS) [MIM:601321]	A0A0P5UGN0	1411	L	F
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	160	R	T
P21359	LB/B	-	A0A0P5UGN0	330	A	T
P21359	LB/B	-	A0A0P5UGN0	393	H	D
P21359	LB/B	-	A0A0P5UGN0	393	H	L
P21359	LB/B	-	A0A0P5UGN0	519	Q	P
P21359	LB/B	-	A0A0P5UGN0	776	A	T
P21359	LB/B	-	A0A0P5UGN0	1484	S	F
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	93	C	W
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	1048	W	R
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	1189	Q	R
P21359	LP/P	Neurofibromatosis 1 (NF1) [MIM:162200]	A0A0P5UGN0	2125	L	P
P35240	LP/P	Neurofibromatosis 2 (NF2) [MIM:101000]	A0A091CZF1	62	F	S
P35240	LP/P	Neurofibromatosis 2 (NF2) [MIM:101000]	A0A091CZF1	106	E	G
P35240	LB/B	-	A0A091CZF1	219	V	M
P35240	LP/P	Neurofibromatosis 2 (NF2) [MIM:101000]	A0A091CZF1	220	N	Y
P35240	LP/P	Neurofibromatosis 2 (NF2) [MIM:101000]	A0A091CZF1	352	T	M
P35240	LP/P	Neurofibromatosis 2 (NF2) [MIM:101000]	A0A091CZF1	360	L	P
P35240	LB/B	-	A0A091CZF1	418	R	C
P35240	LP/P	Neurofibromatosis 2 (NF2) [MIM:101000]	A0A091CZF1	535	L	P
P35240	LP/P	Neurofibromatosis 2 (NF2) [MIM:101000]	A0A091CZF1	538	Q	P
P35240	LP/P	Neurofibromatosis 2 (NF2) [MIM:101000]	A0A091CZF1	234	L	R
P35240	LB/B	-	A0A091CZF1	351	R	H
P35240	LP/P	Neurofibromatosis 2 (NF2) [MIM:101000]	A0A091CZF1	77	M	V
P35240	LP/P	Neurofibromatosis 2 (NF2) [MIM:101000]	A0A091CZF1	141	L	P
P35240	LP/P	Neurofibromatosis 2 (NF2) [MIM:101000]	A0A091CZF1	197	G	C
P35240	LP/P	Neurofibromatosis 2 (NF2) [MIM:101000]	A0A091CZF1	413	K	E
P35240	LP/P	Neurofibromatosis 2 (NF2) [MIM:101000]	A0A091CZF1	533	K	T
P35240	LP/P	Neurofibromatosis 2 (NF2) [MIM:101000]	A0A091CZF1	539	L	H
P35240	LP/P	Neurofibromatosis 2 (NF2) [MIM:101000]	A0A091CZF1	579	K	M
P35240	LP/P	Neurofibromatosis 2 (NF2) [MIM:101000]	A0A091CZF1	133	C	R
Q8NET5	LB/B	-	G3TM31	137	H	Y
Q8NET5	LB/B	-	G3TM31	187	N	K
O94856	LB/B	-	A0A0F8CA97	159	T	M
O95644	LB/B	-	S9Y8V2	68	P	T
O95644	LB/B	-	S9Y8V2	751	C	G
Q13469	LB/B	-	Q4S657	446	H	R
Q8NCF5	LB/B	-	G1MB43	33	R	W
Q14934	LB/B	-	A0A2I4BL58	160	G	A
Q14934	LB/B	-	A0A2I4BL58	246	S	N
Q14934	LB/B	-	A0A2I4BL58	800	S	P
Q16236	LB/B	-	A0A1K0K0M1	99	S	P
Q16236	LB/B	-	A0A1K0K0M1	43	R	Q
Q16236	LB/B	-	A0A1K0K0M1	268	V	M
Q16236	LP/P	Immunodeficiency, developmental delay, and hypohomocysteinemia (IMDDHH) [MIM:617744]	A0A1K0K0M1	31	G	R
Q16236	LP/P	Immunodeficiency, developmental delay, and hypohomocysteinemia (IMDDHH) [MIM:617744]	A0A1K0K0M1	79	E	K
Q16236	LP/P	Immunodeficiency, developmental delay, and hypohomocysteinemia (IMDDHH) [MIM:617744]	A0A1K0K0M1	80	T	K
Q16236	LP/P	Immunodeficiency, developmental delay, and hypohomocysteinemia (IMDDHH) [MIM:617744]	A0A1K0K0M1	81	G	S
Q9Y4A8	LB/B	-	A0A1S3FVM3	441	V	E
O00712	LP/P	Macrocephaly, acquired, with impaired intellectual development (MACID) [MIM:618286]	H2RTL1	114	K	T
O00712	LP/P	Macrocephaly, acquired, with impaired intellectual development (MACID) [MIM:618286]	H2RTL1	126	K	E
O00712	LP/P	Macrocephaly, acquired, with impaired intellectual development (MACID) [MIM:618286]	H2RTL1	132	L	P
O00712	LB/B	Macrocephaly, acquired, with impaired intellectual development (MACID) [MIM:618286]	H2RTL1	356	S	L
P08651	LB/B	-	V9KS27	417	A	S
Q14938	LP/P	Malan syndrome (MALNS) [MIM:614753]	V9KS27	60	L	P
Q14938	LP/P	Malan syndrome (MALNS) [MIM:614753]	V9KS27	121	R	P
Q14938	LP/P	Malan syndrome (MALNS) [MIM:614753]	V9KS27	38	R	C
Q14938	LP/P	Malan syndrome (MALNS) [MIM:614753]	V9KS27	54	R	P
Q14938	LP/P	Malan syndrome (MALNS) [MIM:614753]	V9KS27	116	R	P
Q14938	LP/P	Malan syndrome (MALNS) [MIM:614753]	V9KS27	125	K	E
P19838	LB/B	-	F1LQH2	489	T	I
P19838	LB/B	-	F1LQH2	506	M	V
P19838	LB/B	-	F1LQH2	566	T	I
P19838	LB/B	-	F1LQH2	578	R	K
P19838	LB/B	-	F1LQH2	711	H	Q
P19838	LB/B	-	F1LQH2	901	A	T
Q15653	LB/B	-	G3TL44	339	R	W
Q9Y697	LP/P	Combined oxidative phosphorylation deficiency 52 (COXPD52) [MIM:619386]	A0A2I3N5E4	72	R	Q
Q9UMS0	LB/B	-	A0A091MGW6	25	M	K
Q9UMS0	LP/P	Multiple mitochondrial dysfunctions syndrome 1 (MMDS1) [MIM:605711]	A0A091MGW6	208	G	C
Q9UMS0	LP/P	Multiple mitochondrial dysfunctions syndrome 1 (MMDS1) [MIM:605711]	A0A091MGW6	21	R	P
Q9UMS0	LP/P	Multiple mitochondrial dysfunctions syndrome 1 (MMDS1) [MIM:605711]	A0A091MGW6	182	R	W
Q9UMS0	LP/P	Multiple mitochondrial dysfunctions syndrome 1 (MMDS1) [MIM:605711]	A0A091MGW6	189	G	R
Q12986	LB/B	-	A0A0F7Z825	731	H	Y
Q12986	LB/B	-	A0A0F7Z825	760	P	S
Q12986	LB/B	-	A0A0F7Z825	1086	P	Q
Q6ZNB6	LB/B	-	A0A1I8M6C6	246	P	L
Q8NEJ9	LB/B	-	A0A2K6GUG3	15	V	L
Q8NEJ9	LB/B	-	A0A2K6GUG3	308	K	I
Q8N5V2	LB/B	-	A0A2X0SG27	78	R	G
Q8N5V2	LB/B	-	A0A2X0SG27	111	M	T
P08138	LB/B	-	A0A1W4Z620	205	S	L
Q9H9Q4	LP/P	Severe combined immunodeficiency due to NHEJ1 deficiency (NHEJ1-SCID) [MIM:611291]	F1SRW5	57	R	G
Q9H9Q4	LP/P	Severe combined immunodeficiency due to NHEJ1 deficiency (NHEJ1-SCID) [MIM:611291]	F1SRW5	123	C	R
Q9H9Q4	LB/B	-	F1SRW5	14	A	T
Q9H9Q4	LB/B	-	F1SRW5	89	H	R
Q9H9Q4	LB/B	-	F1SRW5	256	Q	L
O14745	LP/P	Nephrolithiasis/osteoporosis, hypophosphatemic, 2 (NPHLOP2) [MIM:612287]	A0A226NN43	110	L	V
O14745	LP/P	Nephrolithiasis/osteoporosis, hypophosphatemic, 2 (NPHLOP2) [MIM:612287]	A0A226NN43	153	R	Q
O14745	LP/P	Nephrolithiasis/osteoporosis, hypophosphatemic, 2 (NPHLOP2) [MIM:612287]	A0A226NN43	225	E	K
O14745	LP/P	Nephrolithiasis/osteoporosis, hypophosphatemic, 2 (NPHLOP2) [MIM:612287]	A0A226NN43	68	E	A
Q6VVB1	LP/P	Epilepsy, progressive myoclonic 2 (EPM2) [MIM:254780]	F6ZZ74	26	C	S
Q6VVB1	LP/P	Epilepsy, progressive myoclonic 2 (EPM2) [MIM:254780]	F6ZZ74	33	F	S
Q6VVB1	LP/P	Epilepsy, progressive myoclonic 2 (EPM2) [MIM:254780]	F6ZZ74	69	P	A
Q6VVB1	LP/P	Epilepsy, progressive myoclonic 2 (EPM2) [MIM:254780]	F6ZZ74	87	L	P
Q6VVB1	LB/B	-	F6ZZ74	111	P	L
Q6VVB1	LP/P	Epilepsy, progressive myoclonic 2 (EPM2) [MIM:254780]	F6ZZ74	146	D	N
Q6VVB1	LP/P	Epilepsy, progressive myoclonic 2 (EPM2) [MIM:254780]	F6ZZ74	302	Q	P
Q6VVB1	LP/P	Epilepsy, progressive myoclonic 2 (EPM2) [MIM:254780]	F6ZZ74	22	S	R
Q6VVB1	LP/P	Epilepsy, progressive myoclonic 2 (EPM2) [MIM:254780]	F6ZZ74	67	E	Q
Q6VVB1	LP/P	Epilepsy, progressive myoclonic 2 (EPM2) [MIM:254780]	F6ZZ74	68	C	Y
Q6VVB1	LP/P	Epilepsy, progressive myoclonic 2 (EPM2) [MIM:254780]	F6ZZ74	126	L	P
Q6VVB1	LP/P	Epilepsy, progressive myoclonic 2 (EPM2) [MIM:254780]	F6ZZ74	153	I	M
Q6VVB1	LP/P	Epilepsy, progressive myoclonic 2 (EPM2) [MIM:254780]	F6ZZ74	160	C	R
Q6VVB1	LP/P	Epilepsy, progressive myoclonic 2 (EPM2) [MIM:254780]	F6ZZ74	198	I	N
Q6VVB1	LP/P	Epilepsy, progressive myoclonic 2 (EPM2) [MIM:254780]	F6ZZ74	219	W	R
Q6VVB1	LP/P	Epilepsy, progressive myoclonic 2 (EPM2) [MIM:254780]	F6ZZ74	233	D	A
Q6VVB1	LP/P	Epilepsy, progressive myoclonic 2 (EPM2) [MIM:254780]	F6ZZ74	245	D	N
Q6VVB1	LP/P	Epilepsy, progressive myoclonic 2 (EPM2) [MIM:254780]	F6ZZ74	253	R	K
Q6VVB1	LP/P	Epilepsy, progressive myoclonic 2 (EPM2) [MIM:254780]	F6ZZ74	264	P	H
Q6VVB1	LP/P	Epilepsy, progressive myoclonic 2 (EPM2) [MIM:254780]	F6ZZ74	279	L	P
Q6VVB1	LP/P	Epilepsy, progressive myoclonic 2 (EPM2) [MIM:254780]	F6ZZ74	308	D	A
Q6VVB1	LP/P	Epilepsy, progressive myoclonic 2 (EPM2) [MIM:254780]	F6ZZ74	46	C	Y
Q6VVB1	LP/P	Epilepsy, progressive myoclonic 2 (EPM2) [MIM:254780]	F6ZZ74	261	L	P
Q8NBF2	LB/B	-	A0A1B0D1V0	314	V	I
Q9NX24	LB/B	-	A0A1U7T697	118	A	T
Q9NX24	LP/P	Dyskeratosis congenita, autosomal recessive, 2 (DKCB2) [MIM:613987]	A0A1U7T697	126	V	M
Q9NX24	LP/P	Dyskeratosis congenita, autosomal recessive, 2 (DKCB2) [MIM:613987]	A0A1U7T697	139	Y	H
Q6T4R5	LB/B	-	H2V388	1340	F	L
Q6T4R5	LB/B	-	H2V388	1556	S	T
Q6T4R5	LB/B	-	H2V388	1531	S	T
Q6T4R5	LB/B	-	H2V388	1628	A	P
Q6T4R5	LB/B	-	H2V388	583	R	C
Q5SYE7	LB/B	-	A0A0Q3PJ65	1085	V	M
Q5SYE7	LB/B	-	A0A0Q3PJ65	1585	G	S
Q5HYW2	LB/B	-	A0A2Y9RER0	901	T	I
Q9BZQ8	LB/B	-	A0A1S2ZSI2	633	S	L
Q9BZQ8	LB/B	-	A0A1S2ZSI2	692	D	N
Q9BZQ8	LB/B	-	A0A1S2ZSI2	720	V	M
Q9BZQ8	LB/B	-	A0A1S2ZSI2	830	G	S
Q86XR2	LB/B	-	A0A2K5XZK6	229	I	T
Q86XR2	LB/B	-	A0A2K5XZK6	543	L	F
Q86XR2	LB/B	-	A0A2K5XZK6	603	G	S
Q86XR2	LB/B	-	A0A2K5XZK6	493	T	M
P14543	LB/B	-	F1LM84	669	Q	R
P14543	LB/B	-	F1LM84	246	V	I
P14543	LB/B	-	F1LM84	31	R	L
P14543	LB/B	-	F1LM84	302	R	H
P14543	LB/B	-	F1LM84	335	R	H
P14543	LB/B	-	F1LM84	387	R	H
P14543	LB/B	-	F1LM84	970	K	E
P14543	LB/B	-	F1LM84	1163	L	V
P14543	LB/B	-	F1LM84	1226	T	I
P14543	LB/B	-	F1LM84	60	S	R
P14543	LB/B	-	F1LM84	807	Q	H
P14543	LB/B	-	F1LM84	1246	Q	R
Q14112	LB/B	-	X1WE42	313	D	G
Q14112	LB/B	-	X1WE42	354	P	H
Q14112	LB/B	-	X1WE42	529	P	S
Q14112	LB/B	-	X1WE42	726	V	M
Q14112	LB/B	-	X1WE42	775	R	Q
Q14112	LB/B	-	X1WE42	830	R	Q
Q14112	LB/B	-	X1WE42	866	R	Q
Q14112	LB/B	-	X1WE42	22	P	Q
Q14112	LB/B	-	X1WE42	453	G	D
Q14112	LB/B	-	X1WE42	656	S	P
Q14112	LB/B	-	X1WE42	760	G	V
Q9GZT8	LB/B	-	A0A2I4BNS2	324	T	I
Q8IY84	LB/B	-	A0A2P4T600	21	R	W
Q8IY84	LB/B	-	A0A2P4T600	64	E	Q
Q8IY84	LB/B	-	A0A2P4T600	260	L	I
Q8IY84	LB/B	-	A0A2P4T600	320	M	I
Q92982	LB/B	-	A0A091CWH1	110	A	D
Q9Y2I6	LB/B	-	W5PS53	969	R	G
Q9Y2I6	LB/B	-	W5PS53	1366	R	H
Q9Y2I6	LB/B	-	W5PS53	79	G	V
Q9Y2I6	LB/B	-	W5PS53	191	S	R
Q9Y2I6	LB/B	-	W5PS53	276	R	W
Q9Y2I6	LB/B	-	W5PS53	296	T	A
Q9Y2I6	LB/B	-	W5PS53	973	E	K
Q9Y2I6	LB/B	-	W5PS53	1077	D	N
Q9Y2I6	LB/B	-	W5PS53	1276	R	C
Q7RTP0	LP/P	Spastic paraplegia 6, autosomal dominant (SPG6) [MIM:600363]	A0A1I7ZKV4	45	T	R
Q7RTP0	LP/P	Spastic paraplegia 6, autosomal dominant (SPG6) [MIM:600363]	A0A1I7ZKV4	106	G	R
Q6KC79	LB/B	-	A0A1S3FDB0	135	S	N
Q6KC79	LP/P	Cornelia de Lange syndrome 1 (CDLS1) [MIM:122470]	A0A1S3FDB0	1311	C	R
Q6KC79	LP/P	Cornelia de Lange syndrome 1 (CDLS1) [MIM:122470]	A0A1S3FDB0	1348	L	R
Q6KC79	LP/P	Cornelia de Lange syndrome 1 (CDLS1) [MIM:122470]	A0A1S3FDB0	2430	Y	C
Q6KC79	LB/B	-	A0A1S3FDB0	674	N	S
Q6KC79	LB/B	-	A0A1S3FDB0	1206	I	V
Q6KC79	LP/P	Cornelia de Lange syndrome 1 (CDLS1) [MIM:122470]	A0A1S3FDB0	1246	A	G
Q6KC79	LP/P	Cornelia de Lange syndrome 1 (CDLS1) [MIM:122470]	A0A1S3FDB0	1312	L	P
Q6KC79	LP/P	Cornelia de Lange syndrome 1 (CDLS1) [MIM:122470]	A0A1S3FDB0	1789	R	L
Q6KC79	LP/P	Cornelia de Lange syndrome 1 (CDLS1) [MIM:122470]	A0A1S3FDB0	1803	D	V
Q6KC79	LP/P	Cornelia de Lange syndrome 1 (CDLS1) [MIM:122470]	A0A1S3FDB0	1856	R	T
Q6KC79	LP/P	Cornelia de Lange syndrome 1 (CDLS1) [MIM:122470]	A0A1S3FDB0	2298	R	C
Q6KC79	LP/P	Cornelia de Lange syndrome 1 (CDLS1) [MIM:122470]	A0A1S3FDB0	2298	R	H
Q6KC79	LP/P	Cornelia de Lange syndrome 1 (CDLS1) [MIM:122470]	A0A1S3FDB0	2312	G	R
Q6KC79	LP/P	Cornelia de Lange syndrome 1 (CDLS1) [MIM:122470]	A0A1S3FDB0	2381	G	A
Q6KC79	LP/P	Cornelia de Lange syndrome 1 (CDLS1) [MIM:122470]	A0A1S3FDB0	2390	A	T
Q6KC79	LP/P	Cornelia de Lange syndrome 1 (CDLS1) [MIM:122470]	A0A1S3FDB0	2440	Y	H
Q6KC79	LB/B	-	A0A1S3FDB0	261	S	A
Q6KC79	LB/B	-	A0A1S3FDB0	384	N	S
Q6KC79	LP/P	Cornelia de Lange syndrome 1 (CDLS1) [MIM:122470]	A0A1S3FDB0	2081	G	A
Q6KC79	LP/P	Cornelia de Lange syndrome 1 (CDLS1) [MIM:122470]	A0A1S3FDB0	2090	S	I
Q6KC79	LP/P	Cornelia de Lange syndrome 1 (CDLS1) [MIM:122470]	A0A1S3FDB0	2150	L	P
Q6KC79	LP/P	Cornelia de Lange syndrome 1 (CDLS1) [MIM:122470]	A0A1S3FDB0	15	G	R
Q6KC79	LP/P	Cornelia de Lange syndrome 1 (CDLS1) [MIM:122470]	A0A1S3FDB0	29	P	Q
Q6KC79	LP/P	Cornelia de Lange syndrome 1 (CDLS1) [MIM:122470]	A0A1S3FDB0	70	N	I
Q6KC79	LP/P	Cornelia de Lange syndrome 1 (CDLS1) [MIM:122470]	A0A1S3FDB0	111	S	T
Q6KC79	LP/P	Cornelia de Lange syndrome 1 (CDLS1) [MIM:122470]	A0A1S3FDB0	179	A	S
Q6KC79	LB/B	Cornelia de Lange syndrome 1 (CDLS1) [MIM:122470]	A0A1S3FDB0	179	A	T
Q6KC79	LP/P	Cornelia de Lange syndrome 1 (CDLS1) [MIM:122470]	A0A1S3FDB0	192	P	L
Q6KC79	LP/P	Cornelia de Lange syndrome 1 (CDLS1) [MIM:122470]	A0A1S3FDB0	246	D	G
Q6KC79	LP/P	Cornelia de Lange syndrome 1 (CDLS1) [MIM:122470]	A0A1S3FDB0	254	L	V
Q6KC79	LP/P	Cornelia de Lange syndrome 1 (CDLS1) [MIM:122470]	A0A1S3FDB0	351	P	T
Q6KC79	LP/P	Cornelia de Lange syndrome 1 (CDLS1) [MIM:122470]	A0A1S3FDB0	357	K	N
Q6KC79	LP/P	Cornelia de Lange syndrome 1 (CDLS1) [MIM:122470]	A0A1S3FDB0	868	R	Q
Q6KC79	LP/P	Cornelia de Lange syndrome 1 (CDLS1) [MIM:122470]	A0A1S3FDB0	1207	E	K
Q6KC79	LP/P	Cornelia de Lange syndrome 1 (CDLS1) [MIM:122470]	A0A1S3FDB0	1343	H	P
Q6KC79	LP/P	Cornelia de Lange syndrome 1 (CDLS1) [MIM:122470]	A0A1S3FDB0	1441	V	L
Q6KC79	LP/P	Cornelia de Lange syndrome 1 (CDLS1) [MIM:122470]	A0A1S3FDB0	1625	V	F
Q6KC79	LP/P	Cornelia de Lange syndrome 1 (CDLS1) [MIM:122470]	A0A1S3FDB0	1637	I	L
Q6KC79	LP/P	Cornelia de Lange syndrome 1 (CDLS1) [MIM:122470]	A0A1S3FDB0	1722	N	H
Q6KC79	LP/P	Cornelia de Lange syndrome 1 (CDLS1) [MIM:122470]	A0A1S3FDB0	2091	C	F
Q6KC79	LP/P	Cornelia de Lange syndrome 1 (CDLS1) [MIM:122470]	A0A1S3FDB0	2312	G	V
Q6KC79	LP/P	Cornelia de Lange syndrome 1 (CDLS1) [MIM:122470]	A0A1S3FDB0	2433	D	N
Q9BPW8	LB/B	-	A0A2Y9R1J3	245	E	K
Q9UFN0	LB/B	-	V9L826	100	R	Q
Q9BS92	LB/B	-	V9L826	94	A	P
Q9BS92	LB/B	-	V9L826	154	K	E
Q9BS92	LB/B	-	V9L826	159	A	G
Q9Y2I1	LB/B	-	A0A2K6FLU9	299	V	I
Q9Y2I1	LB/B	-	A0A2K6FLU9	1056	A	V
Q9NQR4	LB/B	-	L7M2A5	231	V	A
Q8IVV8	LB/B	-	Q6DEX3	91	K	Q
Q8IVV8	LB/B	-	Q6DEX3	131	A	D
Q8IVV8	LB/B	-	Q6DEX3	151	C	G
Q8IVV8	LB/B	-	Q6DEX3	173	E	D
Q8N5F7	LB/B	-	G5BU77	115	P	H
Q8N5F7	LP/P	Intellectual developmental disorder, X-linked, syndromic, Hackman-Di Donato type (MRXSHD) [MIM:301039]	G5BU77	330	R	C
Q8N5F7	LP/P	Intellectual developmental disorder, X-linked, syndromic, Hackman-Di Donato type (MRXSHD) [MIM:301039]	G5BU77	330	R	H
Q8N5F7	LP/P	Intellectual developmental disorder, X-linked, syndromic, Hackman-Di Donato type (MRXSHD) [MIM:301039]	G5BU77	337	I	T
Q969F2	LB/B	-	A0A2U3WRA6	257	T	K
P30414	LB/B	-	A0A226P6G7	861	L	V
P30414	LB/B	-	A0A226P6G7	935	S	L
P30414	LB/B	-	A0A226P6G7	271	V	G
P30414	LB/B	-	A0A226P6G7	1182	M	T
P43699	LP/P	Chorea, hereditary benign (BHC) [MIM:118700]	A0A2Y9IIW5	208	W	L
P43699	LP/P	Chorea, hereditary benign (BHC) [MIM:118700]	A0A2Y9IIW5	213	R	S
P43699	LP/P	Choreoathetosis and congenital hypothyroidism with or without pulmonary dysfunction (CAHTP) [MIM:610978]	A0A2Y9IIW5	205	V	F
P43699	LP/P	Choreoathetosis and congenital hypothyroidism with or without pulmonary dysfunction (CAHTP) [MIM:610978]	A0A2Y9IIW5	203	T	R
P43699	LP/P	Chorea, hereditary benign (BHC) [MIM:118700]	A0A2Y9IIW5	172	Q	H
P43699	LP/P	Chorea, hereditary benign (BHC) [MIM:118700]	A0A2Y9IIW5	208	W	S
P43699	LP/P	Thyroid cancer, non-medullary, 1 (NMTC1) [MIM:188550]	A0A2Y9IIW5	339	A	V
P52952	LP/P	Atrial septal defect 7, with or without atrioventricular conduction defects (ASD7) [MIM:108900]	A0A0P7WU15	178	T	M
P52952	LP/P	Atrial septal defect 7, with or without atrioventricular conduction defects (ASD7) [MIM:108900]	A0A0P7WU15	188	N	K
P52952	LP/P	Atrial septal defect 7, with or without atrioventricular conduction defects (ASD7) [MIM:108900]	A0A0P7WU15	189	R	G
P52952	LP/P	Atrial septal defect 7, with or without atrioventricular conduction defects (ASD7) [MIM:108900]	A0A0P7WU15	191	Y	C
P52952	LP/P	Atrial septal defect 7, with or without atrioventricular conduction defects (ASD7) [MIM:108900]	A0A0P7WU15	7	L	P
P52952	LP/P	Atrial septal defect 7, with or without atrioventricular conduction defects (ASD7) [MIM:108900]	A0A0P7WU15	15	K	I
P52952	LP/P	Atrial septal defect 7, with or without atrioventricular conduction defects (ASD7) [MIM:108900]	A0A0P7WU15	19	N	S
P52952	LP/P	Atrial septal defect 7, with or without atrioventricular conduction defects (ASD7) [MIM:108900]	A0A0P7WU15	21	E	Q
P52952	LP/P	Tetralogy of Fallot (TOF) [MIM:187500]	A0A0P7WU15	21	E	Q
P52952	LP/P	Atrial septal defect 7, with or without atrioventricular conduction defects (ASD7) [MIM:108900]	A0A0P7WU15	22	Q	P
P52952	LP/P	Tetralogy of Fallot (TOF) [MIM:187500]	A0A0P7WU15	22	Q	P
P52952	LP/P	Atrial septal defect 7, with or without atrioventricular conduction defects (ASD7) [MIM:108900]	A0A0P7WU15	45	S	P
P52952	LP/P	Atrial septal defect 7, with or without atrioventricular conduction defects (ASD7) [MIM:108900]	A0A0P7WU15	51	F	L
P52952	LP/P	Atrial septal defect 7, with or without atrioventricular conduction defects (ASD7) [MIM:108900]	A0A0P7WU15	63	A	V
P52952	LP/P	Atrial septal defect 7, with or without atrioventricular conduction defects (ASD7) [MIM:108900]	A0A0P7WU15	69	L	P
P52952	LP/P	Atrial septal defect 7, with or without atrioventricular conduction defects (ASD7) [MIM:108900]	A0A0P7WU15	77	P	L
P52952	LP/P	Atrial septal defect 7, with or without atrioventricular conduction defects (ASD7) [MIM:108900]	A0A0P7WU15	114	C	R
P52952	LP/P	Atrial septal defect 7, with or without atrioventricular conduction defects (ASD7) [MIM:108900]	A0A0P7WU15	114	C	S
P52952	LP/P	Atrial septal defect 7, with or without atrioventricular conduction defects (ASD7) [MIM:108900]	A0A0P7WU15	118	K	R
P52952	LP/P	Atrial septal defect 7, with or without atrioventricular conduction defects (ASD7) [MIM:108900]	A0A0P7WU15	124	K	R
P52952	LP/P	Atrial septal defect 7, with or without atrioventricular conduction defects (ASD7) [MIM:108900]	A0A0P7WU15	126	E	V
P52952	LP/P	Atrial septal defect 7, with or without atrioventricular conduction defects (ASD7) [MIM:108900]	A0A0P7WU15	127	A	E
P52952	LP/P	Atrial septal defect 7, with or without atrioventricular conduction defects (ASD7) [MIM:108900]	A0A0P7WU15	133	P	S
P52952	LP/P	Atrial septal defect 7, with or without atrioventricular conduction defects (ASD7) [MIM:108900]	A0A0P7WU15	135	A	T
P52952	LP/P	Atrial septal defect 7, with or without atrioventricular conduction defects (ASD7) [MIM:108900]	A0A0P7WU15	142	R	C
P52952	LP/P	Atrial septal defect 7, with or without atrioventricular conduction defects (ASD7) [MIM:108900]	A0A0P7WU15	144	L	P
P52952	LP/P	Atrial septal defect 7, with or without atrioventricular conduction defects (ASD7) [MIM:108900]	A0A0P7WU15	183	K	E
P52952	LP/P	Atrial septal defect 7, with or without atrioventricular conduction defects (ASD7) [MIM:108900]	A0A0P7WU15	187	Q	H
P52952	LP/P	Atrial septal defect 7, with or without atrioventricular conduction defects (ASD7) [MIM:108900]	A0A0P7WU15	190	R	C
P52952	LP/P	Atrial septal defect 7, with or without atrioventricular conduction defects (ASD7) [MIM:108900]	A0A0P7WU15	192	K	R
P52952	LP/P	Atrial septal defect 7, with or without atrioventricular conduction defects (ASD7) [MIM:108900]	A0A0P7WU15	192	K	T
P52952	LP/P	Atrial septal defect 7, with or without atrioventricular conduction defects (ASD7) [MIM:108900]	A0A0P7WU15	194	K	R
P52952	LP/P	Atrial septal defect 7, with or without atrioventricular conduction defects (ASD7) [MIM:108900]	A0A0P7WU15	205	V	E
P52952	LP/P	Atrial septal defect 7, with or without atrioventricular conduction defects (ASD7) [MIM:108900]	A0A0P7WU15	216	R	C
P52952	LP/P	Tetralogy of Fallot (TOF) [MIM:187500]	A0A0P7WU15	216	R	C
P52952	LP/P	Atrial septal defect 7, with or without atrioventricular conduction defects (ASD7) [MIM:108900]	A0A0P7WU15	219	A	V
P52952	LP/P	Tetralogy of Fallot (TOF) [MIM:187500]	A0A0P7WU15	219	A	V
P52952	LP/P	Atrial septal defect 7, with or without atrioventricular conduction defects (ASD7) [MIM:108900]	A0A0P7WU15	226	D	N
P52952	LP/P	Atrial septal defect 7, with or without atrioventricular conduction defects (ASD7) [MIM:108900]	A0A0P7WU15	248	Y	H
P52952	LP/P	Atrial septal defect 7, with or without atrioventricular conduction defects (ASD7) [MIM:108900]	A0A0P7WU15	275	P	T
P52952	LP/P	Atrial septal defect 7, with or without atrioventricular conduction defects (ASD7) [MIM:108900]	A0A0P7WU15	279	S	F
P52952	LP/P	Atrial septal defect 7, with or without atrioventricular conduction defects (ASD7) [MIM:108900]	A0A0P7WU15	279	S	P
P52952	LP/P	Atrial septal defect 7, with or without atrioventricular conduction defects (ASD7) [MIM:108900]	A0A0P7WU15	281	A	V
P52952	LP/P	Atrial septal defect 7, with or without atrioventricular conduction defects (ASD7) [MIM:108900]	A0A0P7WU15	286	A	V
P52952	LP/P	Atrial septal defect 7, with or without atrioventricular conduction defects (ASD7) [MIM:108900]	A0A0P7WU15	294	N	H
P52952	LP/P	Atrial septal defect 7, with or without atrioventricular conduction defects (ASD7) [MIM:108900]	A0A0P7WU15	299	D	G
P52952	LP/P	Atrial septal defect 7, with or without atrioventricular conduction defects (ASD7) [MIM:108900]	A0A0P7WU15	305	S	G
P52952	LP/P	Atrial septal defect 7, with or without atrioventricular conduction defects (ASD7) [MIM:108900]	A0A0P7WU15	320	G	S
P52952	LP/P	Atrial septal defect 7, with or without atrioventricular conduction defects (ASD7) [MIM:108900]	A0A0P7WU15	322	R	Q
P52952	LP/P	Atrial septal defect 7, with or without atrioventricular conduction defects (ASD7) [MIM:108900]	A0A0P7WU15	323	A	T
P52952	LP/P	Tetralogy of Fallot (TOF) [MIM:187500]	A0A0P7WU15	323	A	T
P52952	LP/P	Hypothyroidism, congenital, non-goitrous, 5 (CHNG5) [MIM:225250]	A0A0P7WU15	119	A	S
P52952	LP/P	Hypothyroidism, congenital, non-goitrous, 5 (CHNG5) [MIM:225250]	A0A0P7WU15	161	R	P
P52952	LB/B	-	A0A0P7WU15	16	D	A
P52952	LP/P	Ventricular septal defect 3 (VSD3) [MIM:614432]	A0A0P7WU15	59	P	A
P52952	LP/P	Ventricular septal defect 3 (VSD3) [MIM:614432]	A0A0P7WU15	283	P	Q
P52952	LB/B	-	A0A0P7WU15	74	G	D
A6NCS4	LP/P	Conotruncal heart malformations (CTHM) [MIM:217095]	L9LBA9	151	F	L
A6NCS4	LP/P	Conotruncal heart malformations (CTHM) [MIM:217095]	L9LBA9	152	K	Q
A6NCS4	LP/P	Conotruncal heart malformations (CTHM) [MIM:217095]	L9LBA9	176	V	A
Q99801	LB/B	-	A0A2K6UDD4	52	R	C
Q9C056	LB/B	-	H0XLR0	209	V	A
Q8N2Q7	LP/P	Autism 20 (AUTS20) [MIM:618830]	A0A1W4Y558	89	P	L
Q8N2Q7	LP/P	Autism 20 (AUTS20) [MIM:618830]	A0A1W4Y558	309	L	P
Q8N2Q7	LP/P	Autism 20 (AUTS20) [MIM:618830]	A0A1W4Y558	337	G	E
Q8N2Q7	LB/B	-	A0A1W4Y558	756	R	H
Q8N2Q7	LP/P	Autism 20 (AUTS20) [MIM:618830]	A0A1W4Y558	835	H	Y
Q9NZ94	LP/P	Asperger syndrome, X-linked, 1 (ASPGX1) [MIM:300494]	M7C405	451	R	C
Q9NZ94	LP/P	Autism, X-linked 1 (AUTSX1) [MIM:300425]	M7C405	451	R	C
Q9NZ94	LB/B	-	M7C405	92	S	Y
Q9NZ94	LB/B	-	M7C405	718	L	I
Q9NZ94	LB/B	-	M7C405	751	G	W
Q9NZ94	LB/B	-	M7C405	778	G	S
Q9BYT8	LB/B	-	F7E621	704	P	S
Q9BYT8	LB/B	-	F7E621	323	S	G
Q9BYT8	LB/B	-	F7E621	372	K	R
Q9BYT8	LB/B	-	F7E621	417	S	G
Q9BYT8	LB/B	-	F7E621	79	G	S
Q7RTR2	LB/B	-	S7N4N5	567	V	M
Q9C000	LB/B	-	A0A1S3EZG5	1366	R	C
Q9C000	LB/B	-	A0A1S3EZG5	404	R	Q
Q9C000	LB/B	-	A0A1S3EZG5	246	T	S
Q9C000	LB/B	-	A0A1S3EZG5	1059	V	M
Q9C000	LP/P	Vitiligo-associated multiple autoimmune disease 1 (VAMAS1) [MIM:606579]	A0A1S3EZG5	155	L	H
Q9C000	LB/B	-	A0A1S3EZG5	878	T	M
Q9C000	LB/B	-	A0A1S3EZG5	1069	H	Y
Q9C000	LB/B	-	A0A1S3EZG5	1119	M	V
Q9C000	LB/B	-	A0A1S3EZG5	1184	M	V
Q9C000	LB/B	-	A0A1S3EZG5	1241	V	L
Q9C000	LP/P	Palmoplantar carcinoma, multiple self-healing (MSPC) [MIM:615225]	A0A1S3EZG5	77	M	T
Q9C000	LP/P	Palmoplantar carcinoma, multiple self-healing (MSPC) [MIM:615225]	A0A1S3EZG5	54	A	T
Q9C000	LP/P	Palmoplantar carcinoma, multiple self-healing (MSPC) [MIM:615225]	A0A1S3EZG5	66	A	V
Q9C000	LP/P	Autoinflammation with arthritis and dyskeratosis (AIADK) [MIM:617388]	A0A1S3EZG5	1214	P	R
Q9C000	LP/P	Respiratory papillomatosis, juvenile recurrent, congenital (JRRP) [MIM:618803]	A0A1S3EZG5	755	T	N
P59045	LB/B	-	F6WD23	438	P	L
P59045	LB/B	-	F6WD23	188	A	S
P59045	LB/B	-	F6WD23	233	N	D
Q86W25	LB/B	-	F6WD23	247	Q	R
Q86W25	LB/B	-	F6WD23	781	N	S
Q86W24	LB/B	-	F6WD23	808	E	K
Q86W24	LB/B	-	F6WD23	48	N	T
Q86W24	LB/B	-	F6WD23	55	R	Q
Q86W24	LB/B	-	F6WD23	86	D	V
Q86W24	LB/B	-	F6WD23	92	K	R
Q86W24	LB/B	-	F6WD23	98	S	L
Q86W24	LB/B	-	F6WD23	375	A	T
Q86W24	LB/B	-	F6WD23	397	T	I
Q86W24	LB/B	-	F6WD23	441	V	M
Q86W24	LB/B	-	F6WD23	522	D	G
Q86W24	LB/B	-	F6WD23	951	S	T
Q86W24	LB/B	-	F6WD23	954	L	S
Q86W24	LB/B	-	F6WD23	1010	L	F
Q86W24	LB/B	-	F6WD23	1019	M	I
Q86W24	LB/B	-	F6WD23	21	E	K
Q86W24	LB/B	-	F6WD23	511	L	F
Q9NX02	LB/B	-	A0A2K6DR93	1052	A	E
Q9NX02	LB/B	-	A0A2K6DR93	364	R	K
Q9NX02	LB/B	-	A0A2K6DR93	302	E	Q
Q9NX02	LB/B	-	A0A2K6DR93	884	G	R
Q9NX02	LB/B	-	A0A2K6DR93	516	T	A
Q9NX02	LB/B	-	A0A2K6DR93	522	E	G
Q9NX02	LB/B	-	A0A2K6DR93	529	T	A
Q96MN2	LB/B	-	F6WD23	925	Q	L
Q96MN2	LB/B	-	F6WD23	144	A	T
Q96MN2	LB/B	-	F6WD23	383	E	D
Q96MN2	LB/B	-	F6WD23	390	P	Q
Q96MN2	LB/B	-	F6WD23	774	L	M
Q96MN2	LB/B	-	F6WD23	708	R	H
P59047	LB/B	-	A0A1S3GMN9	459	M	I
P59047	LB/B	-	A0A1S3GMN9	584	H	P
P59047	LB/B	-	A0A1S3GMN9	761	R	L
P59047	LB/B	-	A0A1S3GMN9	912	M	T
P59047	LB/B	-	A0A1S3GMN9	1097	A	T
P59047	LB/B	-	A0A1S3GMN9	1108	S	C
P59047	LB/B	-	A0A1S3GMN9	1181	V	I
P59047	LB/B	-	A0A1S3GMN9	1195	R	Q
Q8WX94	LP/P	Hydatidiform mole, recurrent, 1 (HYDM1) [MIM:231090]	A0A2K6DR93	693	R	P
Q8WX94	LP/P	Hydatidiform mole, recurrent, 1 (HYDM1) [MIM:231090]	A0A2K6DR93	693	R	W
Q8WX94	LP/P	Hydatidiform mole, recurrent, 1 (HYDM1) [MIM:231090]	A0A2K6DR93	913	N	S
Q8WX94	LB/B	-	A0A2K6DR93	971	T	A
Q8WX94	LP/P	Hydatidiform mole, recurrent, 1 (HYDM1) [MIM:231090]	A0A2K6DR93	398	L	R
Q8WX94	LP/P	Hydatidiform mole, recurrent, 1 (HYDM1) [MIM:231090]	A0A2K6DR93	651	P	S
Q8WX94	LP/P	Hydatidiform mole, recurrent, 1 (HYDM1) [MIM:231090]	A0A2K6DR93	693	R	Q
Q8WX94	LP/P	Hydatidiform mole, recurrent, 1 (HYDM1) [MIM:231090]	A0A2K6DR93	716	P	A
Q8WX94	LP/P	Hydatidiform mole, recurrent, 1 (HYDM1) [MIM:231090]	A0A2K6DR93	721	R	W
Q8WX94	LP/P	Hydatidiform mole, recurrent, 1 (HYDM1) [MIM:231090]	A0A2K6DR93	761	C	Y
Q8WX94	LB/B	-	A0A2K6DR93	487	G	E
Q86W28	LB/B	-	F6WD23	25	P	L
Q86W28	LB/B	-	F6WD23	116	V	L
Q86W28	LB/B	-	F6WD23	234	A	T
Q86W28	LB/B	-	F6WD23	268	Q	R
Q86W28	LB/B	-	F6WD23	367	Q	E
Q86W28	LB/B	-	F6WD23	782	V	A
Q86W28	LB/B	-	F6WD23	937	K	R
Q86W28	LB/B	-	F6WD23	543	A	V
Q86W28	LB/B	-	F6WD23	651	R	W
Q86UT6	LB/B	-	H2RXZ7	63	P	S
Q86UT6	LB/B	-	H2RXZ7	125	R	L
Q86UT6	LB/B	-	H2RXZ7	793	A	E
Q86UT6	LB/B	-	H2RXZ7	843	A	S
P08949	LB/B	-	A0A2R8ZTY6	73	P	T
Q96D46	LB/B	-	A0A0K8TRM1	6	E	K
P15531	LB/B	-	M7BLZ6	120	S	G
Q8N427	LB/B	-	A0A1U7RV61	208	C	R
Q8N427	LB/B	-	A0A1U7RV61	43	R	K
Q8N427	LB/B	-	A0A1U7RV61	493	I	T
Q13287	LB/B	-	A0A2Y9F397	16	S	L
Q9HAN9	LP/P	Leber congenital amaurosis 9 (LCA9) [MIM:608553]	L5KG64	9	V	M
Q9HAN9	LP/P	Leber congenital amaurosis 9 (LCA9) [MIM:608553]	L5KG64	13	A	T
Q9HAN9	LP/P	Leber congenital amaurosis 9 (LCA9) [MIM:608553]	L5KG64	20	I	N
Q9HAN9	LP/P	Leber congenital amaurosis 9 (LCA9) [MIM:608553]	L5KG64	33	D	G
Q9HAN9	LP/P	Leber congenital amaurosis 9 (LCA9) [MIM:608553]	L5KG64	35	M	T
Q9HAN9	LP/P	Leber congenital amaurosis 9 (LCA9) [MIM:608553]	L5KG64	54	A	V
Q9HAN9	LP/P	Leber congenital amaurosis 9 (LCA9) [MIM:608553]	L5KG64	66	R	W
Q9HAN9	LP/P	Leber congenital amaurosis 9 (LCA9) [MIM:608553]	L5KG64	67	V	F
Q9HAN9	LP/P	Leber congenital amaurosis 9 (LCA9) [MIM:608553]	L5KG64	69	M	V
Q9HAN9	LP/P	Leber congenital amaurosis 9 (LCA9) [MIM:608553]	L5KG64	72	L	H
Q9HAN9	LP/P	Leber congenital amaurosis 9 (LCA9) [MIM:608553]	L5KG64	98	V	G
Q9HAN9	LP/P	Leber congenital amaurosis 9 (LCA9) [MIM:608553]	L5KG64	147	A	P
Q9HAN9	LP/P	Leber congenital amaurosis 9 (LCA9) [MIM:608553]	L5KG64	151	V	F
Q9HAN9	LP/P	Leber congenital amaurosis 9 (LCA9) [MIM:608553]	L5KG64	153	L	P
Q9HAN9	LP/P	Leber congenital amaurosis 9 (LCA9) [MIM:608553]	L5KG64	153	L	V
Q9HAN9	LP/P	Leber congenital amaurosis 9 (LCA9) [MIM:608553]	L5KG64	156	G	R
Q9HAN9	LP/P	Leber congenital amaurosis 9 (LCA9) [MIM:608553]	L5KG64	173	D	G
Q9HAN9	LP/P	Leber congenital amaurosis 9 (LCA9) [MIM:608553]	L5KG64	178	V	M
Q9HAN9	LP/P	Leber congenital amaurosis 9 (LCA9) [MIM:608553]	L5KG64	181	Y	C
Q9HAN9	LP/P	Leber congenital amaurosis 9 (LCA9) [MIM:608553]	L5KG64	184	I	M
Q9HAN9	LP/P	Leber congenital amaurosis 9 (LCA9) [MIM:608553]	L5KG64	207	R	W
Q9HAN9	LP/P	Leber congenital amaurosis 9 (LCA9) [MIM:608553]	L5KG64	217	I	N
Q9HAN9	LP/P	Leber congenital amaurosis 9 (LCA9) [MIM:608553]	L5KG64	237	R	C
Q9HAN9	LP/P	Leber congenital amaurosis 9 (LCA9) [MIM:608553]	L5KG64	237	R	L
Q9HAN9	LP/P	Leber congenital amaurosis 9 (LCA9) [MIM:608553]	L5KG64	239	L	S
Q9HAN9	LP/P	Leber congenital amaurosis 9 (LCA9) [MIM:608553]	L5KG64	251	H	P
Q9HAN9	LP/P	Leber congenital amaurosis 9 (LCA9) [MIM:608553]	L5KG64	257	E	K
Q9HAN9	LP/P	Leber congenital amaurosis 9 (LCA9) [MIM:608553]	L5KG64	273	N	D
Q9HBL8	LB/B	-	A0A1V4KT64	23	T	I
Q9HBL8	LB/B	-	A0A1V4KT64	252	P	L
Q9NPI5	LB/B	-	G7NLV9	178	E	K
P30419	LB/B	-	G1SRL3	61	Q	K
P48645	LB/B	-	A0A2I2ZFQ2	79	E	G
P48645	LB/B	-	A0A2I2ZFQ2	148	F	L
Q9GZQ4	LB/B	-	F7CAM3	298	S	T
Q9GZQ4	LB/B	-	F7CAM3	315	F	L
Q9GZQ4	LB/B	-	F7CAM3	388	M	V
Q9GZQ4	LB/B	-	F7CAM3	395	A	T
Q9GZQ4	LB/B	-	F7CAM3	383	P	L
Q13423	LP/P	Glucocorticoid deficiency 4 with or without mineralocorticoid deficiency (GCCD4) [MIM:614736]	H2ZIS3	193	S	N
Q13423	LP/P	Glucocorticoid deficiency 4 with or without mineralocorticoid deficiency (GCCD4) [MIM:614736]	H2ZIS3	357	T	A
Q13423	LP/P	Glucocorticoid deficiency 4 with or without mineralocorticoid deficiency (GCCD4) [MIM:614736]	H2ZIS3	365	H	P
Q13423	LP/P	Glucocorticoid deficiency 4 with or without mineralocorticoid deficiency (GCCD4) [MIM:614736]	H2ZIS3	437	P	L
Q13423	LP/P	Glucocorticoid deficiency 4 with or without mineralocorticoid deficiency (GCCD4) [MIM:614736]	H2ZIS3	533	A	V
Q13423	LP/P	Glucocorticoid deficiency 4 with or without mineralocorticoid deficiency (GCCD4) [MIM:614736]	H2ZIS3	664	G	R
Q13423	LP/P	Glucocorticoid deficiency 4 with or without mineralocorticoid deficiency (GCCD4) [MIM:614736]	H2ZIS3	678	G	R
Q13423	LP/P	Glucocorticoid deficiency 4 with or without mineralocorticoid deficiency (GCCD4) [MIM:614736]	H2ZIS3	862	G	D
Q13423	LP/P	Glucocorticoid deficiency 4 with or without mineralocorticoid deficiency (GCCD4) [MIM:614736]	H2ZIS3	977	L	P
Q13423	LP/P	Glucocorticoid deficiency 4 with or without mineralocorticoid deficiency (GCCD4) [MIM:614736]	H2ZIS3	1008	A	P
Q13423	LP/P	Glucocorticoid deficiency 4 with or without mineralocorticoid deficiency (GCCD4) [MIM:614736]	H2ZIS3	1009	N	K
Q8NC60	LB/B	-	A0A060WAU1	153	A	S
Q8NC60	LB/B	-	A0A060WAU1	450	K	R
Q9Y3T9	LB/B	-	A0A2I4BTW6	271	A	V
Q9Y3T9	LB/B	-	A0A2I4BTW6	300	I	V
Q9Y3T9	LB/B	-	A0A2I4BTW6	556	S	L
Q8WTT2	LB/B	-	A0A2I0LY21	194	P	L
Q8WTT2	LB/B	-	A0A2I0LY21	472	E	A
Q8WTT2	LB/B	-	A0A2I0LY21	444	P	R
Q8WTT2	LB/B	-	A0A2I0LY21	504	R	I
Q8WTT2	LB/B	-	A0A2I0LY21	655	T	S
Q8WTT2	LB/B	-	A0A2I0LY21	695	A	T
Q9HC29	LB/B	-	S9Y3V7	189	T	M
Q9HC29	LB/B	-	S9Y3V7	268	P	S
Q9HC29	LB/B	-	S9Y3V7	289	N	S
Q9HC29	LP/P	Blau syndrome (BLAUS) [MIM:186580]	S9Y3V7	334	R	Q
Q9HC29	LP/P	Blau syndrome (BLAUS) [MIM:186580]	S9Y3V7	334	R	W
Q9HC29	LP/P	Blau syndrome (BLAUS) [MIM:186580]	S9Y3V7	469	L	F
Q9HC29	LP/P	Inflammatory bowel disease 1 (IBD1) [MIM:266600]	S9Y3V7	702	R	W
Q9HC29	LP/P	Yao syndrome (YAOS) [MIM:617321]	S9Y3V7	702	R	W
Q9HC29	LP/P	Inflammatory bowel disease 1 (IBD1) [MIM:266600]	S9Y3V7	908	G	R
Q9HC29	LP/P	Yao syndrome (YAOS) [MIM:617321]	S9Y3V7	908	G	R
Q9HC29	LB/B	-	S9Y3V7	918	A	D
Q9HC29	LB/B	-	S9Y3V7	955	V	I
Q9HC29	LP/P	Blau syndrome (BLAUS) [MIM:186580]	S9Y3V7	382	D	E
Q9HC29	LP/P	Blau syndrome (BLAUS) [MIM:186580]	S9Y3V7	383	E	K
Q9HC29	LP/P	Blau syndrome (BLAUS) [MIM:186580]	S9Y3V7	496	H	L
Q9HC29	LB/B	-	S9Y3V7	790	R	Q
Q9HC29	LB/B	-	S9Y3V7	81	L	V
Q9HC29	LB/B	-	S9Y3V7	471	R	C
Q9HC29	LP/P	Blau syndrome (BLAUS) [MIM:186580]	S9Y3V7	605	T	N
Q9HC29	LP/P	Blau syndrome (BLAUS) [MIM:186580]	S9Y3V7	507	P	S
Q9HC29	LB/B	-	S9Y3V7	391	R	C
Q9HC29	LB/B	-	S9Y3V7	463	P	A
Q9HC29	LB/B	-	S9Y3V7	464	G	W
Q9HC29	LP/P	Blau syndrome (BLAUS) [MIM:186580]	S9Y3V7	513	M	T
Q9HC29	LP/P	Blau syndrome (BLAUS) [MIM:186580]	S9Y3V7	605	T	P
Q9HC29	LP/P	Blau syndrome (BLAUS) [MIM:186580]	S9Y3V7	670	N	K
Q9HC29	LB/B	-	S9Y3V7	791	R	W
Q9HC29	LB/B	-	S9Y3V7	825	N	K
Q9HC29	LB/B	-	S9Y3V7	849	A	V
Q13253	LP/P	Symphalangism, proximal 1A (SYM1A) [MIM:185800]	W5LSL3	35	P	R
Q13253	LP/P	Tarsal-carpal coalition syndrome (TCC) [MIM:186570]	W5LSL3	35	P	R
Q13253	LP/P	Symphalangism, proximal 1A (SYM1A) [MIM:185800]	W5LSL3	189	G	C
Q13253	LP/P	Multiple synostoses syndrome 1 (SYNS1) [MIM:186500]	W5LSL3	217	W	G
Q13253	LP/P	Symphalangism, proximal 1A (SYM1A) [MIM:185800]	W5LSL3	220	I	N
Q13253	LP/P	Symphalangism, proximal 1A (SYM1A) [MIM:185800]	W5LSL3	222	Y	C
Q13253	LP/P	Tarsal-carpal coalition syndrome (TCC) [MIM:186570]	W5LSL3	222	Y	C
Q13253	LP/P	Symphalangism, proximal 1A (SYM1A) [MIM:185800]	W5LSL3	222	Y	D
Q13253	LP/P	Symphalangism, proximal 1A (SYM1A) [MIM:185800]	W5LSL3	223	P	L
Q13253	LP/P	Brachydactyly B2 (BDB2) [MIM:611377]	W5LSL3	35	P	S
Q13253	LP/P	Symphalangism, proximal 1A (SYM1A) [MIM:185800]	W5LSL3	35	P	S
Q13253	LP/P	Symphalangism, proximal 1A (SYM1A) [MIM:185800]	W5LSL3	184	C	Y
Q13253	LP/P	Tarsal-carpal coalition syndrome (TCC) [MIM:186570]	W5LSL3	204	R	L
Q13253	LP/P	Brachydactyly B2 (BDB2) [MIM:611377]	W5LSL3	35	P	A
Q13253	LP/P	Brachydactyly B2 (BDB2) [MIM:611377]	W5LSL3	36	A	P
Q13253	LP/P	Brachydactyly B2 (BDB2) [MIM:611377]	W5LSL3	48	E	K
Q13253	LP/P	Brachydactyly B2 (BDB2) [MIM:611377]	W5LSL3	167	R	G
Q13253	LP/P	Brachydactyly B2 (BDB2) [MIM:611377]	W5LSL3	187	P	S
Q13253	LP/P	Symphalangism, proximal 1A (SYM1A) [MIM:185800]	W5LSL3	205	W	C
Q13253	LP/P	Multiple synostoses syndrome 1 (SYNS1) [MIM:186500]	W5LSL3	232	C	W
Q9BSC4	LB/B	-	A0A1A9WBW8	635	D	N
O60936	LP/P	Myoclonus, familial, 1 (MYOCL1) [MIM:614937]	A0A2J8Q4V5	21	E	Q
O60936	LP/P	Myoclonus, familial, 1 (MYOCL1) [MIM:614937]	A0A2J8Q4V5	80	A	T
Q9H6R4	LB/B	-	H9GJA7	52	P	S
Q9H6R4	LB/B	-	H9GJA7	723	R	W
Q76FK4	LB/B	-	A0A2R9AQ24	748	V	L
Q76FK4	LB/B	-	A0A2R9AQ24	841	D	E
Q76FK4	LB/B	-	A0A2R9AQ24	988	E	D
Q76FK4	LB/B	-	A0A2R9AQ24	1021	G	S
Q76FK4	LB/B	-	A0A2R9AQ24	470	G	E
Q14978	LB/B	-	V8NXS4	412	G	V
Q14978	LB/B	-	V8NXS4	456	S	P
Q5C9Z4	LB/B	-	A0A2U3W5Y4	122	H	P
Q5C9Z4	LB/B	-	A0A2U3W5Y4	779	R	H
Q5C9Z4	LB/B	-	A0A2U3W5Y4	804	V	L
Q5C9Z4	LB/B	-	A0A2U3W5Y4	812	V	M
Q5C9Z4	LB/B	-	A0A2U3W5Y4	723	M	V
Q5C9Z4	LB/B	-	A0A2U3W5Y4	24	R	G
P78316	LB/B	-	S9YI91	380	L	S
P78316	LB/B	-	S9YI91	716	Q	R
O00567	LB/B	-	A0A2Y9RFV3	576	V	A
O00567	LB/B	-	A0A2Y9RFV3	121	I	V
O00567	LB/B	-	A0A2Y9RFV3	475	M	T
Q9Y2X3	LB/B	-	A0A1S3ISU2	387	N	T
Q9Y2X3	LB/B	-	A0A1S3ISU2	389	A	P
Q9Y2X3	LB/B	-	A0A1S3ISU2	400	D	A
Q9Y2X3	LB/B	-	A0A1S3ISU2	508	T	P
Q86U38	LB/B	-	Q6PCF6	308	S	N
Q86U38	LB/B	-	Q6PCF6	51	P	S
Q8N5I9	LB/B	-	A0A2K6K645	5	G	S
Q8N5I9	LB/B	-	A0A2K6K645	8	K	Q
O75052	LP/P	Nephrotic syndrome 22 (NPHS22) [MIM:619155]	F7CSF2	143	C	Y
P35228	LB/B	-	A0A2U4AP23	608	S	L
P35228	LB/B	-	A0A2U4AP23	221	R	W
P35228	LB/B	-	A0A2U4AP23	747	T	A
P35228	LB/B	-	A0A2U4AP23	1009	R	C
P29474	LB/B	-	A0A2I0U3N9	298	D	E
P29474	LB/B	-	A0A2I0U3N9	112	R	Q
P29474	LB/B	-	A0A2I0U3N9	827	V	M
P29474	LB/B	-	A0A2I0U3N9	885	R	M
P29474	LB/B	-	A0A2I0U3N9	982	Q	L
P29474	LB/B	-	A0A2I0U3N9	474	R	C
P29474	LB/B	-	A0A2I0U3N9	602	R	Q
P29474	LB/B	-	A0A2I0U3N9	665	R	H
Q9Y314	LB/B	-	A0A0P6JUY6	168	T	M
Q8IVI9	LB/B	-	G1SPJ1	473	G	E
Q7Z3S9	LB/B	-	A0A226PXJ8	67	S	P
Q7Z3S9	LB/B	-	A0A226PXJ8	158	T	I
Q7Z3S9	LB/B	-	A0A226PXJ8	196	T	S
Q7Z3S9	LB/B	-	A0A226PXJ8	226	E	Q
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	49	C	Y
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	71	W	C
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	90	R	C
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	110	R	C
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	133	R	C
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	141	R	C
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	146	C	R
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	153	R	C
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	169	R	C
Q9UM47	LB/B	-	G3W2W7	170	H	R
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	171	G	C
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	182	R	C
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	185	C	R
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	212	C	S
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	222	C	G
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	224	C	Y
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	258	Y	C
Q9UM47	LB/B	-	G3W2W7	496	P	L
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	542	C	Y
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	558	R	C
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	578	R	C
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	728	R	C
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	985	R	C
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	1006	R	C
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	1031	R	C
Q9UM47	LB/B	-	G3W2W7	1133	H	Q
Q9UM47	LB/B	-	G3W2W7	1183	V	M
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	1231	R	C
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	1261	C	R
Q9UM47	LB/B	-	G3W2W7	2223	A	V
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	43	C	G
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	49	C	F
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	54	R	C
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	60	S	C
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	65	C	S
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	67	C	Y
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	76	C	R
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	76	C	W
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	87	C	R
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	87	C	Y
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	93	C	F
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	93	C	Y
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	106	C	W
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	108	C	W
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	108	C	Y
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	117	C	F
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	118	S	C
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	123	C	F
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	123	C	Y
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	128	C	Y
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	134	C	W
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	142	F	C
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	144	C	F
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	144	C	S
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	144	C	Y
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	145	S	C
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	149	G	C
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	150	Y	C
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	155	C	S
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	162	C	S
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	174	C	F
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	174	C	R
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	174	C	Y
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	180	S	C
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	183	C	F
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	183	C	R
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	183	C	S
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	185	C	G
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	189	Y	C
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	194	C	F
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	194	C	R
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	194	C	S
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	194	C	Y
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	201	C	Y
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	206	C	Y
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	207	R	C
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	213	R	K
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	222	C	Y
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	233	C	S
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	233	C	Y
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	240	C	S
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	245	C	R
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	251	C	R
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	260	C	Y
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	319	A	C
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	332	R	C
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	335	S	C
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	337	Y	C
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	379	C	S
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	395	C	R
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	420	G	C
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	421	R	C
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	428	C	S
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	428	C	Y
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	440	C	G
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	440	C	R
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	446	C	S
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	449	R	C
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	455	C	R
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	484	C	F
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	484	C	Y
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	495	C	Y
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	511	C	R
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	544	R	C
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	549	C	Y
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	607	R	C
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	775	C	S
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	953	G	C
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	984	F	C
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	1015	C	R
Q9UM47	LB/B	-	G3W2W7	1020	A	P
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	1021	Y	C
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	1063	D	C
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	1261	C	Y
Q9UM47	LP/P	Myofibromatosis, infantile 2 (IMF2) [MIM:615293]	G3W2W7	1519	L	P
Q9UM47	LP/P	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310]	G3W2W7	710	Y	C
Q99466	LB/B	-	G3HZC0	117	K	Q
Q99466	LB/B	-	G3HZC0	272	D	G
Q99466	LB/B	-	G3HZC0	317	E	Q
Q99466	LB/B	-	G3HZC0	320	T	A
Q99466	LB/B	-	G3HZC0	851	K	R
Q99466	LB/B	-	G3HZC0	204	P	L
Q99466	LB/B	-	G3HZC0	206	P	L
Q99466	LB/B	-	G3HZC0	244	S	L
Q99466	LB/B	-	G3HZC0	534	G	S
Q99466	LB/B	-	G3HZC0	809	S	I
Q99466	LB/B	-	G3HZC0	942	G	R
Q99466	LB/B	-	G3HZC0	1346	R	P
Q99466	LB/B	-	G3HZC0	284	Q	H
A8MTQ0	LB/B	-	W5PQ09	5	R	T
A8MTQ0	LB/B	-	W5PQ09	164	N	K
Q9HBY0	LB/B	-	A0A1A6GIP4	171	T	K
Q9NPH5	LB/B	-	C3YUJ9	315	M	I
Q9NZP6	LB/B	-	F1PM39	212	V	A
Q9NZP6	LB/B	-	F1PM39	253	G	R
Q9NZP6	LB/B	-	F1PM39	282	N	S
Q9NZP6	LB/B	-	F1PM39	406	Q	E
Q9NZP6	LB/B	-	F1PM39	34	P	Q
Q9NZP6	LB/B	-	F1PM39	152	W	R
Q9NZP6	LB/B	-	F1PM39	343	P	A
Q9NZP6	LB/B	-	F1PM39	757	A	T
Q9NZP6	LB/B	-	F1PM39	929	T	P
Q8IUM7	LB/B	-	G3PY63	147	F	S
Q8IUM7	LB/B	-	G3PY63	208	G	C
Q8IUM7	LB/B	-	G3PY63	257	E	K
Q8IUM7	LB/B	-	G3PY63	293	W	R
Q8IUM7	LB/B	-	G3PY63	296	C	R
Q8IUM7	LB/B	-	G3PY63	317	M	L
Q8IUM7	LB/B	-	G3PY63	344	P	A
Q8IUM7	LB/B	-	G3PY63	359	T	I
Q8IUM7	LB/B	-	G3PY63	472	P	S
Q8IUM7	LB/B	-	G3PY63	500	Q	K
Q8IUM7	LB/B	-	G3PY63	587	T	M
Q8IUM7	LB/B	-	G3PY63	702	N	D
Q8IUM7	LB/B	-	G3PY63	750	D	Y
Q8IUM7	LB/B	-	G3PY63	777	T	I
P48145	LB/B	-	Q2Q1V0	135	Y	F
P48145	LB/B	-	Q2Q1V0	319	R	C
P48146	LB/B	-	A0A2Y9IQJ1	206	Q	R
Q9UHC9	LB/B	-	L5KNZ8	55	V	L
Q9UHC9	LB/B	-	L5KNZ8	1233	I	N
Q9UHC9	LB/B	-	L5KNZ8	510	M	I
Q9UHC9	LB/B	-	L5KNZ8	1308	E	K
O15130	LB/B	-	G1U784	88	W	R
Q9GZQ6	LB/B	-	F7CY91	145	I	L
O15259	LP/P	Nephronophthisis 1 (NPHP1) [MIM:256100]	A0A091JCX7	342	G	R
O15259	LB/B	-	A0A091JCX7	5	R	L
Q7Z494	LP/P	Nephronophthisis 3 (NPHP3) [MIM:604387]	A0A1A8KWY8	360	S	T
Q7Z494	LP/P	Nephronophthisis 3 (NPHP3) [MIM:604387]	A0A1A8KWY8	386	N	S
Q7Z494	LP/P	Nephronophthisis 3 (NPHP3) [MIM:604387]	A0A1A8KWY8	397	R	H
Q7Z494	LP/P	Nephronophthisis 3 (NPHP3) [MIM:604387]	A0A1A8KWY8	1141	L	P
Q7Z494	LP/P	Nephronophthisis 3 (NPHP3) [MIM:604387]	A0A1A8KWY8	1221	A	V
Q7Z494	LP/P	Nephronophthisis 3 (NPHP3) [MIM:604387]	A0A1A8KWY8	1252	S	R
Q7Z494	LB/B	Nephronophthisis 3 (NPHP3) [MIM:604387]	A0A1A8KWY8	1314	S	T
Q7Z494	LP/P	Renal-hepatic-pancreatic dysplasia 1 (RHPD1) [MIM:208540]	A0A1A8KWY8	973	R	Q
Q7Z494	LB/B	-	A0A1A8KWY8	1305	R	C
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	64	W	S
O60500	LB/B	-	G1TR14	117	E	K
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	171	I	N
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	173	I	N
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	270	G	C
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	350	S	P
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	366	S	R
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	367	R	C
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	368	P	S
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	376	L	V
O60500	LB/B	-	G1TR14	408	R	Q
O60500	LB/B	-	G1TR14	447	E	K
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	465	C	Y
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	528	C	F
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	610	L	Q
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	623	C	F
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	724	S	C
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	743	R	C
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	802	R	W
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	802	R	P
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	806	A	D
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	819	D	V
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	831	R	C
O60500	LB/B	-	G1TR14	1077	N	S
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	1140	R	C
O60500	LB/B	-	G1TR14	233	T	A
O60500	LB/B	-	G1TR14	392	L	P
O60500	LB/B	-	G1TR14	991	V	L
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	96	L	V
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	107	A	T
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	107	A	V
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	167	P	L
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	256	R	W
O60500	LB/B	-	G1TR14	264	P	R
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	265	C	R
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	299	R	C
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	340	P	H
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	347	G	E
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	368	P	L
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	379	R	W
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	407	R	W
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	412	G	C
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	417	C	F
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	460	R	Q
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	519	P	S
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	558	R	C
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	569	S	R
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	572	S	N
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	575	P	Q
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	586	R	G
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	587	L	R
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	673	N	K
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	681	W	C
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	709	V	G
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	739	A	V
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	822	V	M
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	832	L	P
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	834	V	F
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	910	S	P
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	976	R	S
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	742	I	T
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	237	L	P
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	912	A	T
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	1020	G	V
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	188	N	I
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	189	E	K
O60500	LB/B	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	294	T	I
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	608	V	I
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	1016	S	N
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	107	A	E
O60500	LP/P	Nephrotic syndrome 1 (NPHS1) [MIM:256300]	G1TR14	567	C	S
Q9NP85	LB/B	-	A0A2R9A9B9	20	P	L
Q9NP85	LP/P	Nephrotic syndrome 2 (NPHS2) [MIM:600995]	A0A2R9A9B9	92	G	C
Q9NP85	LP/P	Nephrotic syndrome 2 (NPHS2) [MIM:600995]	A0A2R9A9B9	138	R	Q
Q9NP85	LP/P	Nephrotic syndrome 2 (NPHS2) [MIM:600995]	A0A2R9A9B9	160	D	G
Q9NP85	LP/P	Nephrotic syndrome 2 (NPHS2) [MIM:600995]	A0A2R9A9B9	180	V	M
Q9NP85	LP/P	Nephrotic syndrome 2 (NPHS2) [MIM:600995]	A0A2R9A9B9	291	R	W
Q9NP85	LP/P	Nephrotic syndrome 2 (NPHS2) [MIM:600995]	A0A2R9A9B9	29	A	T
Q9NP85	LB/B	-	A0A2R9A9B9	34	G	E
Q9NP85	LB/B	-	A0A2R9A9B9	44	E	A
Q9NP85	LB/B	-	A0A2R9A9B9	61	A	V
Q9NP85	LP/P	Nephrotic syndrome 2 (NPHS2) [MIM:600995]	A0A2R9A9B9	107	L	P
Q9NP85	LP/P	Nephrotic syndrome 2 (NPHS2) [MIM:600995]	A0A2R9A9B9	116	T	P
Q9NP85	LP/P	Nephrotic syndrome 2 (NPHS2) [MIM:600995]	A0A2R9A9B9	118	P	L
Q9NP85	LP/P	Nephrotic syndrome 2 (NPHS2) [MIM:600995]	A0A2R9A9B9	122	W	S
Q9NP85	LP/P	Nephrotic syndrome 2 (NPHS2) [MIM:600995]	A0A2R9A9B9	168	R	C
Q9NP85	LP/P	Nephrotic syndrome 2 (NPHS2) [MIM:600995]	A0A2R9A9B9	168	R	H
Q9NP85	LP/P	Nephrotic syndrome 2 (NPHS2) [MIM:600995]	A0A2R9A9B9	168	R	S
Q9NP85	LP/P	Nephrotic syndrome 2 (NPHS2) [MIM:600995]	A0A2R9A9B9	175	P	V
Q9NP85	LP/P	Nephrotic syndrome 2 (NPHS2) [MIM:600995]	A0A2R9A9B9	183	D	Y
Q9NP85	LP/P	Nephrotic syndrome 2 (NPHS2) [MIM:600995]	A0A2R9A9B9	208	A	T
Q9NP85	LP/P	Nephrotic syndrome 2 (NPHS2) [MIM:600995]	A0A2R9A9B9	221	T	I
Q9NP85	LB/B	-	A0A2R9A9B9	237	E	Q
Q9NP85	LP/P	Nephrotic syndrome 2 (NPHS2) [MIM:600995]	A0A2R9A9B9	238	R	S
Q9NP85	LB/B	-	A0A2R9A9B9	242	A	V
Q9NP85	LP/P	Nephrotic syndrome 2 (NPHS2) [MIM:600995]	A0A2R9A9B9	260	V	E
Q9NP85	LB/B	-	A0A2R9A9B9	264	E	Q
Q9NP85	LP/P	Nephrotic syndrome 2 (NPHS2) [MIM:600995]	A0A2R9A9B9	281	E	A
Q9NP85	LP/P	Nephrotic syndrome 2 (NPHS2) [MIM:600995]	A0A2R9A9B9	281	E	K
Q9NP85	LP/P	Nephrotic syndrome 2 (NPHS2) [MIM:600995]	A0A2R9A9B9	290	V	M
Q9NP85	LP/P	Nephrotic syndrome 2 (NPHS2) [MIM:600995]	A0A2R9A9B9	296	E	K
Q9NP85	LP/P	Nephrotic syndrome 2 (NPHS2) [MIM:600995]	A0A2R9A9B9	309	A	V
Q9NP85	LP/P	Nephrotic syndrome 2 (NPHS2) [MIM:600995]	A0A2R9A9B9	3	R	G
Q9NP85	LP/P	Nephrotic syndrome 2 (NPHS2) [MIM:600995]	A0A2R9A9B9	18	R	T
Q9NP85	LP/P	Nephrotic syndrome 2 (NPHS2) [MIM:600995]	A0A2R9A9B9	26	R	M
Q9NP85	LP/P	Nephrotic syndrome 2 (NPHS2) [MIM:600995]	A0A2R9A9B9	28	K	M
Q9NP85	LP/P	Nephrotic syndrome 2 (NPHS2) [MIM:600995]	A0A2R9A9B9	30	E	K
Q9NP85	LP/P	Nephrotic syndrome 2 (NPHS2) [MIM:600995]	A0A2R9A9B9	30	E	Q
Q9NP85	LP/P	Nephrotic syndrome 2 (NPHS2) [MIM:600995]	A0A2R9A9B9	39	Q	L
Q9NP85	LP/P	Nephrotic syndrome 2 (NPHS2) [MIM:600995]	A0A2R9A9B9	89	P	T
Q9NP85	LP/P	Nephrotic syndrome 2 (NPHS2) [MIM:600995]	A0A2R9A9B9	115	M	T
Q9NP85	LP/P	Nephrotic syndrome 2 (NPHS2) [MIM:600995]	A0A2R9A9B9	122	W	L
Q9NP85	LP/P	Nephrotic syndrome 2 (NPHS2) [MIM:600995]	A0A2R9A9B9	124	C	W
Q9NP85	LP/P	Nephrotic syndrome 2 (NPHS2) [MIM:600995]	A0A2R9A9B9	126	K	N
Q9NP85	LP/P	Nephrotic syndrome 2 (NPHS2) [MIM:600995]	A0A2R9A9B9	139	L	R
Q9NP85	LP/P	Nephrotic syndrome 2 (NPHS2) [MIM:600995]	A0A2R9A9B9	142	L	P
Q9NP85	LP/P	Nephrotic syndrome 2 (NPHS2) [MIM:600995]	A0A2R9A9B9	192	I	V
Q9NP85	LP/P	Nephrotic syndrome 2 (NPHS2) [MIM:600995]	A0A2R9A9B9	211	S	A
Q9NP85	LP/P	Nephrotic syndrome 2 (NPHS2) [MIM:600995]	A0A2R9A9B9	213	A	T
Q9NP85	LP/P	Nephrotic syndrome 2 (NPHS2) [MIM:600995]	A0A2R9A9B9	218	V	G
Q9NP85	LP/P	Nephrotic syndrome 2 (NPHS2) [MIM:600995]	A0A2R9A9B9	228	H	D
Q9NP85	LP/P	Nephrotic syndrome 2 (NPHS2) [MIM:600995]	A0A2R9A9B9	229	R	L
Q9NP85	LP/P	Nephrotic syndrome 2 (NPHS2) [MIM:600995]	A0A2R9A9B9	267	D	N
Q9NP85	LP/P	Nephrotic syndrome 2 (NPHS2) [MIM:600995]	A0A2R9A9B9	268	V	L
Q9NP85	LP/P	Nephrotic syndrome 2 (NPHS2) [MIM:600995]	A0A2R9A9B9	276	H	L
Q9NP85	LP/P	Nephrotic syndrome 2 (NPHS2) [MIM:600995]	A0A2R9A9B9	322	R	Q
Q9NP85	LP/P	Nephrotic syndrome 2 (NPHS2) [MIM:600995]	A0A2R9A9B9	341	P	S
Q9NP85	LP/P	Nephrotic syndrome 2 (NPHS2) [MIM:600995]	A0A2R9A9B9	370	V	G
Q9NP85	LB/B	-	A0A2R9A9B9	297	A	V
Q9NP85	LP/P	Nephrotic syndrome 2 (NPHS2) [MIM:600995]	A0A2R9A9B9	138	R	P
Q9UND3	LB/B	-	H2RHR7	93	R	C
O75607	LB/B	-	F1P694	16	S	N
O75607	LB/B	-	F1P694	80	N	I
Q6UXI9	LB/B	-	I3LXI9	159	Q	H
Q6UXI9	LB/B	-	I3LXI9	234	I	V
Q6UXI9	LB/B	-	I3LXI9	473	G	S
Q6UXI9	LB/B	-	I3LXI9	476	M	T
P01160	LB/B	-	A0A1U7RNV0	32	V	M
P01160	LP/P	Atrial standstill 2 (ATRST2) [MIM:615745]	A0A1U7RNV0	150	R	Q
P16860	LB/B	-	G7MGW0	25	R	L
P16860	LB/B	-	G7MGW0	47	R	H
P16860	LB/B	-	G7MGW0	93	M	L
P23582	LB/B	-	G1T785	82	R	Q
P16066	LB/B	-	A0A2K6PQI1	182	A	V
P16066	LB/B	-	A0A2K6PQI1	755	V	M
P16066	LB/B	-	A0A2K6PQI1	939	R	Q
P16066	LB/B	-	A0A2K6PQI1	967	E	K
P20594	LB/B	-	A0A212C506	771	Q	E
P20594	LP/P	Acromesomelic dysplasia 1 (AMD1) [MIM:602875]	A0A212C506	32	P	T
P20594	LP/P	Acromesomelic dysplasia 1 (AMD1) [MIM:602875]	A0A212C506	115	W	G
P20594	LP/P	Acromesomelic dysplasia 1 (AMD1) [MIM:602875]	A0A212C506	176	D	E
P20594	LP/P	Acromesomelic dysplasia 1 (AMD1) [MIM:602875]	A0A212C506	297	T	M
P20594	LP/P	Acromesomelic dysplasia 1 (AMD1) [MIM:602875]	A0A212C506	338	Y	C
P20594	LP/P	Acromesomelic dysplasia 1 (AMD1) [MIM:602875]	A0A212C506	409	A	T
P20594	LP/P	Acromesomelic dysplasia 1 (AMD1) [MIM:602875]	A0A212C506	413	G	E
P20594	LP/P	Acromesomelic dysplasia 1 (AMD1) [MIM:602875]	A0A212C506	708	Y	C
P20594	LP/P	Acromesomelic dysplasia 1 (AMD1) [MIM:602875]	A0A212C506	776	R	W
P20594	LP/P	Acromesomelic dysplasia 1 (AMD1) [MIM:602875]	A0A212C506	957	R	C
P20594	LP/P	Acromesomelic dysplasia 1 (AMD1) [MIM:602875]	A0A212C506	959	G	A
P20594	LB/B	-	A0A212C506	232	M	I
P20594	LB/B	-	A0A212C506	882	V	I
P20594	LP/P	Epiphyseal chondrodysplasia, Miura type (ECDM) [MIM:615923]	A0A212C506	488	A	P
P20594	LP/P	Epiphyseal chondrodysplasia, Miura type (ECDM) [MIM:615923]	A0A212C506	655	R	C
P20594	LP/P	Epiphyseal chondrodysplasia, Miura type (ECDM) [MIM:615923]	A0A212C506	882	V	M
P20594	LP/P	Short stature with non-specific skeletal abnormalities (SNSK) [MIM:616255]	A0A212C506	76	S	P
P20594	LP/P	Short stature with non-specific skeletal abnormalities (SNSK) [MIM:616255]	A0A212C506	110	R	C
P20594	LB/B	-	A0A212C506	187	V	I
P20594	LP/P	Short stature with non-specific skeletal abnormalities (SNSK) [MIM:616255]	A0A212C506	263	R	P
P20594	LP/P	Short stature with non-specific skeletal abnormalities (SNSK) [MIM:616255]	A0A212C506	417	Q	E
P20594	LP/P	Short stature with non-specific skeletal abnormalities (SNSK) [MIM:616255]	A0A212C506	819	R	C
P20594	LP/P	Acromesomelic dysplasia 1 (AMD1) [MIM:602875]	A0A212C506	658	L	F
P17342	LP/P	Boudin-Mortier syndrome (BOMOS) [MIM:619543]	A0A2I4CT33	148	S	P
P17342	LP/P	Boudin-Mortier syndrome (BOMOS) [MIM:619543]	A0A2I4CT33	363	D	V
P0C0P6	LB/B	-	A0A1U8BKC8	14	S	L
P0C0P6	LB/B	-	A0A1U8BKC8	75	V	L
Q6W5P4	LB/B	-	A0A1D5PKZ0	107	N	I
Q6W5P4	LB/B	-	A0A1D5PKZ0	241	S	R
Q6W5P4	LB/B	-	A0A1D5PKZ0	344	Q	R
Q6W5P4	LB/B	-	A0A1D5PKZ0	122	R	Q
Q6W5P4	LB/B	-	A0A1D5PKZ0	143	S	G
Q6W5P4	LB/B	-	A0A1D5PKZ0	197	C	F
Q6W5P4	LB/B	-	A0A1D5PKZ0	212	T	I
Q6W5P4	LB/B	-	A0A1D5PKZ0	315	I	T
Q9HCQ7	LB/B	-	G5AY58	32	M	I
Q9HCQ7	LB/B	-	G5AY58	42	D	G
Q9HCQ7	LB/B	-	G5AY58	121	V	M
P01303	LB/B	-	A0A091DK89	7	L	P
P01303	LB/B	-	A0A091DK89	22	L	M
P25929	LB/B	-	Q6Y6A4	374	K	T
P50391	LB/B	-	Q6Y6A4	99	A	S
P50391	LB/B	-	Q6Y6A4	240	R	C
P15559	LB/B	-	M3ZPV4	187	P	S
P15559	LB/B	-	M3ZPV4	139	R	W
P15559	LB/B	-	M3ZPV4	269	Q	H
P16083	LB/B	-	A0A2R8MHW3	16	K	R
P16083	LB/B	-	A0A2R8MHW3	29	E	G
P16083	LB/B	-	A0A2R8MHW3	47	L	F
P16083	LB/B	-	A0A2R8MHW3	58	G	D
P16083	LB/B	-	A0A2R8MHW3	184	V	A
P51843	LP/P	Adrenal hypoplasia, congenital (AHC) [MIM:300200]	A0A1S2ZG71	267	R	P
P51843	LP/P	Adrenal hypoplasia, congenital (AHC) [MIM:300200]	A0A1S2ZG71	287	V	G
P51843	LP/P	Adrenal hypoplasia, congenital (AHC) [MIM:300200]	A0A1S2ZG71	300	A	V
P51843	LP/P	Adrenal hypoplasia, congenital (AHC) [MIM:300200]	A0A1S2ZG71	377	E	K
P51843	LP/P	Adrenal hypoplasia, congenital (AHC) [MIM:300200]	A0A1S2ZG71	382	K	N
P51843	LP/P	Adrenal hypoplasia, congenital (AHC) [MIM:300200]	A0A1S2ZG71	385	V	G
P51843	LP/P	Adrenal hypoplasia, congenital (AHC) [MIM:300200]	A0A1S2ZG71	425	R	G
P51843	LP/P	Adrenal hypoplasia, congenital (AHC) [MIM:300200]	A0A1S2ZG71	440	N	I
P51843	LP/P	Adrenal hypoplasia, congenital (AHC) [MIM:300200]	A0A1S2ZG71	380	Y	D
P51843	LP/P	Adrenal hypoplasia, congenital (AHC) [MIM:300200]	A0A1S2ZG71	381	L	H
P51843	LP/P	Adrenal hypoplasia, congenital (AHC) [MIM:300200]	A0A1S2ZG71	439	I	S
P51843	LP/P	Adrenal hypoplasia, congenital (AHC) [MIM:300200]	A0A1S2ZG71	295	L	P
P51843	LP/P	Adrenal hypoplasia, congenital (AHC) [MIM:300200]	A0A1S2ZG71	300	A	P
P51843	LP/P	Adrenal hypoplasia, congenital (AHC) [MIM:300200]	A0A1S2ZG71	425	R	T
P51843	LP/P	Adrenal hypoplasia, congenital (AHC) [MIM:300200]	A0A1S2ZG71	466	L	R
P51843	LP/P	Adrenal hypoplasia, congenital (AHC) [MIM:300200]	A0A1S2ZG71	278	L	P
P51843	LP/P	Adrenal hypoplasia, congenital (AHC) [MIM:300200]	A0A1S2ZG71	291	W	C
P51843	LP/P	Adrenal hypoplasia, congenital (AHC) [MIM:300200]	A0A1S2ZG71	297	L	P
Q15466	LB/B	-	A0A087XW02	57	R	W
Q15466	LB/B	-	A0A087XW02	189	G	E
Q15466	LB/B	-	A0A087XW02	195	A	S
Q15466	LB/B	-	A0A087XW02	213	R	C
Q15466	LB/B	-	A0A087XW02	216	R	H
Q15466	LB/B	-	A0A087XW02	171	G	A
Q14995	LB/B	-	A0A060XNU4	21	P	H
Q14995	LB/B	-	A0A060XNU4	282	Q	K
Q14995	LB/B	-	A0A060XNU4	288	P	R
Q14995	LB/B	-	A0A060XNU4	386	M	L
P55055	LB/B	-	H2NZR6	2	S	F
Q13133	LB/B	-	H2NZR6	52	G	V
O75469	LB/B	-	M7ANR0	27	P	S
O75469	LB/B	-	M7ANR0	36	G	R
O75469	LB/B	-	M7ANR0	122	R	Q
O75469	LB/B	-	M7ANR0	98	R	C
O75469	LB/B	-	M7ANR0	148	R	Q
O75469	LB/B	-	M7ANR0	381	R	W
O75469	LB/B	-	M7ANR0	403	I	V
O75469	LB/B	-	M7ANR0	18	E	K
O75469	LB/B	-	M7ANR0	370	A	T
O75469	LB/B	-	M7ANR0	12	A	T
P24468	LP/P	Congenital heart defects, multiple types, 4 (CHTD4) [MIM:615779]	W5Q5F6	170	D	V
P24468	LP/P	Congenital heart defects, multiple types, 4 (CHTD4) [MIM:615779]	W5Q5F6	205	N	I
P24468	LP/P	Congenital heart defects, multiple types, 4 (CHTD4) [MIM:615779]	W5Q5F6	251	E	D
P24468	LP/P	Congenital heart defects, multiple types, 4 (CHTD4) [MIM:615779]	W5Q5F6	341	S	Y
P24468	LP/P	Congenital heart defects, multiple types, 4 (CHTD4) [MIM:615779]	W5Q5F6	412	A	S
P08235	LB/B	-	A0A2I4CD75	180	V	I
P08235	LB/B	-	A0A2I4CD75	444	N	T
P08235	LB/B	-	A0A2I4CD75	537	R	Q
P08235	LB/B	-	A0A2I4CD75	554	N	S
P08235	LP/P	Early-onset hypertension with severe exacerbation in pregnancy (EOHSEP) [MIM:605115]	A0A2I4CD75	810	S	L
P08235	LP/P	Pseudohypoaldosteronism 1, autosomal dominant (PHA1A) [MIM:177735]	A0A2I4CD75	924	L	P
P08235	LB/B	-	A0A2I4CD75	826	F	Y
P08235	LP/P	Pseudohypoaldosteronism 1, autosomal dominant (PHA1A) [MIM:177735]	A0A2I4CD75	633	G	R
P08235	LP/P	Pseudohypoaldosteronism 1, autosomal dominant (PHA1A) [MIM:177735]	A0A2I4CD75	645	C	S
P08235	LP/P	Pseudohypoaldosteronism 1, autosomal dominant (PHA1A) [MIM:177735]	A0A2I4CD75	659	R	S
P08235	LP/P	Pseudohypoaldosteronism 1, autosomal dominant (PHA1A) [MIM:177735]	A0A2I4CD75	759	P	S
P08235	LP/P	Pseudohypoaldosteronism 1, autosomal dominant (PHA1A) [MIM:177735]	A0A2I4CD75	769	L	P
P08235	LP/P	Pseudohypoaldosteronism 1, autosomal dominant (PHA1A) [MIM:177735]	A0A2I4CD75	770	N	K
P08235	LP/P	Pseudohypoaldosteronism 1, autosomal dominant (PHA1A) [MIM:177735]	A0A2I4CD75	776	Q	R
P08235	LP/P	Pseudohypoaldosteronism 1, autosomal dominant (PHA1A) [MIM:177735]	A0A2I4CD75	805	S	P
P08235	LP/P	Pseudohypoaldosteronism 1, autosomal dominant (PHA1A) [MIM:177735]	A0A2I4CD75	815	S	R
P08235	LP/P	Pseudohypoaldosteronism 1, autosomal dominant (PHA1A) [MIM:177735]	A0A2I4CD75	818	S	L
P08235	LP/P	Pseudohypoaldosteronism 1, autosomal dominant (PHA1A) [MIM:177735]	A0A2I4CD75	972	E	G
P08235	LP/P	Pseudohypoaldosteronism 1, autosomal dominant (PHA1A) [MIM:177735]	A0A2I4CD75	979	L	P
P22736	LB/B	-	A0A091DLS1	26	L	V
P43354	LP/P	Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism (IDLDP) [MIM:619911]	V9KL30	280	C	Y
P43354	LP/P	Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism (IDLDP) [MIM:619911]	V9KL30	305	C	Y
P43354	LP/P	Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism (IDLDP) [MIM:619911]	V9KL30	319	R	Q
Q9UHY1	LB/B	-	S9WMG3	365	V	I
Q9UHY1	LB/B	-	S9WMG3	460	H	R
Q92823	LB/B	-	A0A0F8CA97	545	P	A
O43847	LB/B	-	A0A091SDC3	832	Y	S
Q02297	LB/B	-	G3WL15	38	R	Q
Q02297	LB/B	-	G3WL15	463	M	K
Q02297	LB/B	-	G3WL15	289	M	T
P56975	LB/B	-	A0A1S3N4D0	472	S	R
P56975	LB/B	-	A0A1S3N4D0	552	K	N
P48552	LB/B	-	A0A1W4ZV39	221	H	R
P48552	LB/B	-	A0A1W4ZV39	441	I	V
P48552	LB/B	-	A0A1W4ZV39	448	R	G
P48552	LB/B	-	A0A1W4ZV39	803	S	L
P48552	LB/B	-	A0A1W4ZV39	1079	V	F
P48552	LB/B	-	A0A1W4ZV39	315	Y	F
P48552	LB/B	-	A0A1W4ZV39	37	V	I
P48552	LB/B	-	A0A1W4ZV39	567	N	S
Q7Z2Y5	LB/B	-	S7PNP0	358	V	M
Q7Z2Y5	LB/B	-	S7PNP0	993	A	E
Q7Z2Y5	LB/B	-	S7PNP0	355	Q	H
Q7Z2Y5	LB/B	-	S7PNP0	426	P	A
Q7Z2Y5	LB/B	-	S7PNP0	579	E	G
Q7Z2Y5	LB/B	-	S7PNP0	679	E	G
Q7Z2Y5	LB/B	-	S7PNP0	971	D	G
Q7Z2Y5	LB/B	-	S7PNP0	1106	P	S
Q7Z2Y5	LB/B	-	S7PNP0	1121	A	P
Q7Z2Y5	LB/B	-	S7PNP0	1276	H	L
Q7Z2Y5	LB/B	-	S7PNP0	1471	G	A
Q7Z2Y5	LB/B	-	S7PNP0	1472	M	L
Q7Z2Y5	LB/B	-	S7PNP0	727	R	H
P54845	LP/P	Retinitis pigmentosa 27 (RP27) [MIM:613750]	A0A2U3V179	50	S	T
P54845	LP/P	Retinal degeneration autosomal recessive clumped pigment type (RDCP) [MIM:613750]	A0A2U3V179	160	L	P
P54845	LP/P	Retinitis pigmentosa 27 (RP27) [MIM:613750]	A0A2U3V179	170	R	S
P54845	LP/P	Retinitis pigmentosa 27 (RP27) [MIM:613750]	A0A2U3V179	50	S	L
P54845	LP/P	Retinitis pigmentosa 27 (RP27) [MIM:613750]	A0A2U3V179	50	S	P
P54845	LP/P	Retinitis pigmentosa 27 (RP27) [MIM:613750]	A0A2U3V179	51	P	L
P54845	LP/P	Retinitis pigmentosa 27 (RP27) [MIM:613750]	A0A2U3V179	51	P	S
P54845	LP/P	Retinitis pigmentosa 27 (RP27) [MIM:613750]	A0A2U3V179	51	P	T
P54845	LP/P	Retinitis pigmentosa 27 (RP27) [MIM:613750]	A0A2U3V179	67	P	S
P54845	LP/P	Retinitis pigmentosa 27 (RP27) [MIM:613750]	A0A2U3V179	96	M	T
O14786	LB/B	-	A0A093CX29	179	V	A
O14786	LB/B	-	A0A093CX29	561	F	L
O14786	LB/B	-	A0A093CX29	733	V	I
O60462	LB/B	-	A0A093CX29	123	K	R
O60462	LB/B	-	A0A093CX29	602	E	K
O60462	LB/B	-	A0A093CX29	334	R	C
O60462	LB/B	-	A0A093CX29	428	R	W
Q8IZ57	LB/B	-	M7BML1	41	I	V
Q8IZ57	LB/B	-	M7BML1	104	H	Y
Q9GZP1	LB/B	-	M7BML1	41	L	V
Q9GZP1	LB/B	-	M7BML1	65	S	C
Q9GZP1	LB/B	-	M7BML1	160	E	Q
Q99748	LB/B	-	E1BD76	96	A	S
Q96L73	LB/B	-	D4AA06	614	V	L
Q96L73	LB/B	-	D4AA06	691	A	T
Q96L73	LB/B	-	D4AA06	726	S	P
Q96L73	LB/B	-	D4AA06	1036	A	P
Q96L73	LB/B	-	D4AA06	1091	L	I
Q96L73	LP/P	Sotos syndrome (SOTOS) [MIM:117550]	D4AA06	1616	H	L
Q96L73	LP/P	Sotos syndrome (SOTOS) [MIM:117550]	D4AA06	1637	L	P
Q96L73	LP/P	Sotos syndrome (SOTOS) [MIM:117550]	D4AA06	1674	C	W
Q96L73	LP/P	Sotos syndrome (SOTOS) [MIM:117550]	D4AA06	1687	I	N
Q96L73	LP/P	Sotos syndrome (SOTOS) [MIM:117550]	D4AA06	1792	G	V
Q96L73	LP/P	Sotos syndrome (SOTOS) [MIM:117550]	D4AA06	1925	C	R
Q96L73	LP/P	Sotos syndrome (SOTOS) [MIM:117550]	D4AA06	1955	G	D
Q96L73	LP/P	Sotos syndrome (SOTOS) [MIM:117550]	D4AA06	1984	R	Q
Q96L73	LP/P	Sotos syndrome (SOTOS) [MIM:117550]	D4AA06	1997	Y	C
Q96L73	LP/P	Sotos syndrome (SOTOS) [MIM:117550]	D4AA06	2005	R	Q
Q96L73	LP/P	Sotos syndrome (SOTOS) [MIM:117550]	D4AA06	2017	R	Q
Q96L73	LP/P	Sotos syndrome (SOTOS) [MIM:117550]	D4AA06	2017	R	W
Q96L73	LP/P	Sotos syndrome (SOTOS) [MIM:117550]	D4AA06	2143	H	Q
Q96L73	LP/P	Sotos syndrome (SOTOS) [MIM:117550]	D4AA06	2183	C	S
Q96L73	LB/B	-	D4AA06	2250	M	I
Q96L73	LB/B	-	D4AA06	2261	M	T
O96028	LP/P	Rauch-Steindl syndrome (RAUST) [MIM:619695]	A0A091R109	869	C	Y
O96028	LP/P	Rauch-Steindl syndrome (RAUST) [MIM:619695]	A0A091R109	895	P	L
O96028	LP/P	Rauch-Steindl syndrome (RAUST) [MIM:619695]	A0A091R109	1019	K	R
O96028	LP/P	Rauch-Steindl syndrome (RAUST) [MIM:619695]	A0A091R109	1091	E	K
O96028	LP/P	Rauch-Steindl syndrome (RAUST) [MIM:619695]	A0A091R109	1137	S	F
Q9BZ95	LB/B	-	A0A091R109	383	R	P
Q9BZ95	LB/B	-	A0A091R109	186	T	M
Q9UNZ2	LB/B	-	A0A1Y1YJX0	290	D	N
Q92636	LB/B	-	A0A212CEF0	626	Y	C
Q8WV22	LB/B	-	G1SFK0	38	T	R
Q8WV22	LB/B	-	G1SFK0	47	N	S
Q9H0G5	LB/B	-	A0A2Y9R0E5	86	K	T
Q08J23	LB/B	-	F6Y791	627	V	I
Q08J23	LP/P	Intellectual developmental disorder, autosomal recessive 5 (MRT5) [MIM:611091]	F6Y791	679	G	R
Q9H649	LB/B	-	A0A061I1Q8	295	A	V
Q96CB9	LB/B	-	A0A151NGB6	51	T	A
Q96CB9	LB/B	-	A0A151NGB6	128	N	K
Q96CB9	LB/B	-	A0A151NGB6	325	I	T
Q96CB9	LB/B	-	A0A151NGB6	365	I	V
Q96P11	LB/B	-	L9KFA4	183	P	S
Q63ZY6	LB/B	-	Q63ZY6	47	W	S
Q63ZY6	LB/B	-	Q63ZY6	90	A	V
Q63ZY6	LB/B	-	Q63ZY6	272	C	R
Q63ZY6	LB/B	-	Q63ZY6	303	K	R
Q8NE18	LB/B	-	A0A2K6UUD5	308	S	A
Q8NE18	LB/B	-	A0A2K6UUD5	622	T	A
Q8TCD5	LB/B	-	R4GBS3	68	P	L
P49902	LB/B	-	A0A1L8FEI6	3	T	A
P49902	LB/B	-	A0A1L8FEI6	136	Q	R
Q9H0P0	LP/P	P5N deficiency (P5ND) [MIM:266120]	A0A151P2D5	137	D	V
Q9H0P0	LP/P	P5N deficiency (P5ND) [MIM:266120]	A0A151P2D5	181	L	P
Q9H0P0	LP/P	P5N deficiency (P5ND) [MIM:266120]	A0A151P2D5	229	N	S
Q9H0P0	LP/P	P5N deficiency (P5ND) [MIM:266120]	A0A151P2D5	280	G	R
Q9H0P0	LP/P	P5N deficiency (P5ND) [MIM:266120]	A0A151P2D5	95	R	G
Q9H0P0	LP/P	P5N deficiency (P5ND) [MIM:266120]	A0A151P2D5	113	C	R
Q9H0P0	LP/P	P5N deficiency (P5ND) [MIM:266120]	A0A151P2D5	207	G	R
Q9H0P0	LP/P	P5N deficiency (P5ND) [MIM:266120]	A0A151P2D5	297	I	T
Q969T7	LB/B	-	W5Q8F4	209	A	V
Q969T7	LB/B	-	W5Q8F4	213	S	C
Q86UY8	LB/B	-	A0A2Y9N1T9	266	A	E
P21589	LB/B	-	A0A1L8EEA5	376	T	A
P21589	LB/B	-	A0A1L8EEA5	379	M	T
P21589	LP/P	Calcification of joints and arteries (CALJA) [MIM:211800]	A0A1L8EEA5	358	C	Y
Q96HA8	LB/B	-	A0A232F4M8	32	I	V
Q96HA8	LB/B	-	A0A232F4M8	93	N	S
Q96HA8	LB/B	-	A0A232F4M8	116	F	I
Q96HA8	LB/B	-	A0A232F4M8	134	R	C
P34130	LB/B	-	L5LRC1	88	A	V
P34130	LB/B	-	L5LRC1	89	S	N
P34130	LB/B	-	L5LRC1	90	R	C
P34130	LB/B	-	L5LRC1	114	R	G
P34130	LB/B	-	L5LRC1	133	R	H
P34130	LB/B	-	L5LRC1	140	R	C
P34130	LB/B	-	L5LRC1	207	T	I
P34130	LB/B	-	L5LRC1	207	T	S
Q5VVY1	LB/B	-	A0A1S2ZSH7	150	S	P
Q5VVY1	LB/B	-	A0A1S2ZSH7	72	A	G
Q5VVY1	LB/B	-	A0A1S2ZSH7	247	S	R
O95631	LB/B	-	A0A1U7UPJ7	351	R	H
O95631	LP/P	Mirror movements 4 (MRMV4) [MIM:618264]	A0A1U7UPJ7	601	C	R
O95631	LP/P	Mirror movements 4 (MRMV4) [MIM:618264]	A0A1U7UPJ7	601	C	S
O00634	LB/B	-	A0A1S3JDN1	425	P	S
Q9HB63	LB/B	-	G1KP45	205	Y	H
Q96CW9	LB/B	-	A0A2D0T169	346	T	A
Q96CW9	LP/P	Neurodevelopmental disorder with behavioral abnormalities, absent speech, and hypotonia (NEDBASH) [MIM:618718]	A0A2D0T169	81	C	Y
Q96CW9	LP/P	Neurodevelopmental disorder with behavioral abnormalities, absent speech, and hypotonia (NEDBASH) [MIM:618718]	A0A2D0T169	107	W	G
Q96CW9	LP/P	Neurodevelopmental disorder with behavioral abnormalities, absent speech, and hypotonia (NEDBASH) [MIM:618718]	A0A2D0T169	149	M	T
Q96CW9	LP/P	Neurodevelopmental disorder with behavioral abnormalities, absent speech, and hypotonia (NEDBASH) [MIM:618718]	A0A2D0T169	200	S	L
Q96CW9	LP/P	Neurodevelopmental disorder with behavioral abnormalities, absent speech, and hypotonia (NEDBASH) [MIM:618718]	A0A2D0T169	355	C	W
Q96CW9	LP/P	Neurodevelopmental disorder with behavioral abnormalities, absent speech, and hypotonia (NEDBASH) [MIM:618718]	A0A2D0T169	359	S	C
Q96CW9	LP/P	Neurodevelopmental disorder with behavioral abnormalities, absent speech, and hypotonia (NEDBASH) [MIM:618718]	A0A2D0T169	456	C	Y
Q9BSD7	LB/B	-	R4GB86	106	G	E
P04629	LP/P	Congenital insensitivity to pain with anhidrosis (CIPA) [MIM:256800]	H2MI35	577	G	R
P04629	LB/B	-	H2MI35	85	R	S
P04629	LP/P	Congenital insensitivity to pain with anhidrosis (CIPA) [MIM:256800]	H2MI35	93	L	P
P04629	LP/P	Congenital insensitivity to pain with anhidrosis (CIPA) [MIM:256800]	H2MI35	213	L	P
P04629	LP/P	Congenital insensitivity to pain with anhidrosis (CIPA) [MIM:256800]	H2MI35	522	G	R
P04629	LP/P	Congenital insensitivity to pain with anhidrosis (CIPA) [MIM:256800]	H2MI35	587	M	V
P04629	LB/B	-	H2MI35	604	H	Y
P04629	LB/B	-	H2MI35	613	G	V
P04629	LP/P	Congenital insensitivity to pain with anhidrosis (CIPA) [MIM:256800]	H2MI35	649	R	W
P04629	LP/P	Congenital insensitivity to pain with anhidrosis (CIPA) [MIM:256800]	H2MI35	654	R	C
P04629	LP/P	Congenital insensitivity to pain with anhidrosis (CIPA) [MIM:256800]	H2MI35	674	D	Y
P04629	LP/P	Congenital insensitivity to pain with anhidrosis (CIPA) [MIM:256800]	H2MI35	695	P	L
P04629	LP/P	Congenital insensitivity to pain with anhidrosis (CIPA) [MIM:256800]	H2MI35	714	G	S
P04629	LP/P	Congenital insensitivity to pain with anhidrosis (CIPA) [MIM:256800]	H2MI35	780	R	P
P04629	LB/B	-	H2MI35	780	R	Q
P04629	LB/B	-	H2MI35	80	Q	R
P04629	LB/B	-	H2MI35	237	T	M
P04629	LB/B	-	H2MI35	238	V	G
P04629	LB/B	-	H2MI35	260	R	G
P04629	LB/B	-	H2MI35	444	R	Q
P04629	LB/B	-	H2MI35	452	R	C
P04629	LB/B	-	H2MI35	566	M	T
P04629	LB/B	-	H2MI35	790	V	I
P04629	LB/B	-	H2MI35	18	G	E
P04629	LB/B	-	H2MI35	6	R	W
P04629	LP/P	Congenital insensitivity to pain with anhidrosis (CIPA) [MIM:256800]	H2MI35	359	Y	C
P04629	LP/P	Congenital insensitivity to pain with anhidrosis (CIPA) [MIM:256800]	H2MI35	492	E	K
P04629	LP/P	Congenital insensitivity to pain with anhidrosis (CIPA) [MIM:256800]	H2MI35	517	G	E
P04629	LP/P	Congenital insensitivity to pain with anhidrosis (CIPA) [MIM:256800]	H2MI35	522	G	E
P04629	LP/P	Congenital insensitivity to pain with anhidrosis (CIPA) [MIM:256800]	H2MI35	572	I	S
P04629	LP/P	Congenital insensitivity to pain with anhidrosis (CIPA) [MIM:256800]	H2MI35	657	L	P
P04629	LP/P	Congenital insensitivity to pain with anhidrosis (CIPA) [MIM:256800]	H2MI35	699	I	T
P04629	LP/P	Congenital insensitivity to pain with anhidrosis (CIPA) [MIM:256800]	H2MI35	717	L	R
P04629	LP/P	Congenital insensitivity to pain with anhidrosis (CIPA) [MIM:256800]	H2MI35	763	C	S
P04629	LP/P	Congenital insensitivity to pain with anhidrosis (CIPA) [MIM:256800]	H2MI35	771	R	C
P04629	LP/P	Congenital insensitivity to pain with anhidrosis (CIPA) [MIM:256800]	H2MI35	110	A	D
P04629	LP/P	Congenital insensitivity to pain with anhidrosis (CIPA) [MIM:256800]	H2MI35	596	D	N
P04629	LP/P	Congenital insensitivity to pain with anhidrosis (CIPA) [MIM:256800]	H2MI35	649	R	Q
P04629	LP/P	Congenital insensitivity to pain with anhidrosis (CIPA) [MIM:256800]	H2MI35	700	L	P
Q16620	LB/B	-	H2MI35	338	N	Y
Q16620	LB/B	-	H2MI35	309	G	R
Q16620	LB/B	-	H2MI35	545	G	V
Q16620	LP/P	Obesity, hyperphagia, and developmental delay (OBHD) [MIM:613886]	H2MI35	706	Y	C
Q16288	LB/B	-	A0A2I0UGV0	306	R	C
Q16288	LB/B	-	A0A2I0UGV0	678	R	Q
Q16288	LB/B	-	A0A2I0UGV0	768	K	R
Q16288	LB/B	-	A0A2I0UGV0	781	E	K
Q16288	LB/B	-	A0A2I0UGV0	21	V	F
Q16288	LP/P	-	A0A2I0UGV0	93	T	M
Q16288	LP/P	-	A0A2I0UGV0	533	I	F
Q16288	LP/P	-	A0A2I0UGV0	817	I	M
O60285	LB/B	-	A0A151MAS9	543	P	R
O60285	LB/B	-	A0A151MAS9	419	G	D
Q9H093	LB/B	-	A0A151MAS9	309	T	S
Q9H093	LB/B	-	A0A151MAS9	341	R	L
Q9H093	LB/B	-	A0A151MAS9	516	A	V
Q9Y5A7	LB/B	-	A0A1S3HNS7	13	Q	R
P53384	LB/B	-	H0X2W8	39	P	A
Q9Y5Y2	LB/B	-	L5KHL6	250	P	S
Q9Y5Y2	LB/B	-	L5KHL6	266	T	M
Q9Y5Y2	LB/B	-	L5KHL6	200	T	A
Q8TB37	LB/B	-	A0A2Y9QV69	198	N	T
Q8TB37	LP/P	Mitochondrial complex I deficiency, nuclear type 21 (MC1DN21) [MIM:618242]	A0A2Y9QV69	105	D	Y
Q8TB37	LP/P	Mitochondrial complex I deficiency, nuclear type 21 (MC1DN21) [MIM:618242]	A0A2Y9QV69	193	L	F
Q02818	LB/B	-	A0A2K6CEN4	399	R	Q
Q02818	LB/B	-	A0A2K6CEN4	338	M	V
P80303	LB/B	-	A0A147AY43	338	Q	E
Q9H1E3	LB/B	-	A0A1U8DFC2	119	E	G
Q9H1E3	LB/B	-	A0A1U8DFC2	137	L	P
Q96RS6	LB/B	-	A0A2P8XMS7	252	L	F
Q96RS6	LB/B	-	A0A2P8XMS7	269	I	V
Q96RS6	LB/B	-	A0A2P8XMS7	394	N	H
Q96RS6	LB/B	-	A0A2P8XMS7	426	N	S
Q8IVD9	LB/B	-	A0A091M898	235	R	C
Q8IVD9	LB/B	-	A0A091M898	3	T	P
P36639	LB/B	-	H9GEQ8	83	V	M
P36639	LB/B	-	H9GEQ8	36	G	W
Q96G61	LB/B	-	A0A182KGK4	39	S	N
Q9BQG2	LB/B	-	R7U2G6	129	K	E
Q9BQG2	LB/B	-	R7U2G6	235	I	V
Q86X67	LB/B	-	H3AMU0	81	G	D
Q86X67	LB/B	-	H3AMU0	273	M	V
A8MXV4	LB/B	-	H2M8D9	43	R	Q
Q9BRQ3	LB/B	-	G1T969	36	G	C
Q9BRQ3	LB/B	-	G1T969	260	Q	R
Q9BRQ3	LB/B	-	G1T969	263	L	P
Q9BRQ3	LB/B	-	G1T969	129	T	R
P0C024	LB/B	-	D3ZV74	100	R	H
P0C024	LB/B	-	D3ZV74	181	E	G
Q9BZD4	LB/B	-	K7GJG4	229	S	L
Q9BZD4	LB/B	-	K7GJG4	239	S	R
Q9UHK0	LB/B	-	F7FVR1	36	S	R
Q68CJ6	LB/B	-	A0A091E124	23	R	P
Q68CJ6	LB/B	-	A0A091E124	180	S	G
Q68CJ6	LB/B	-	A0A091E124	328	Q	R
Q68CJ6	LB/B	-	A0A091E124	474	S	N
Q68CJ6	LB/B	-	A0A091E124	492	R	W
P49757	LB/B	-	F6UX32	387	V	I
P49757	LB/B	-	F6UX32	595	G	D
P57740	LP/P	Nephrotic syndrome 11 (NPHS11) [MIM:616730]	L5JW22	157	D	Y
P57740	LP/P	Nephrotic syndrome 11 (NPHS11) [MIM:616730]	L5JW22	831	D	A
P57740	LP/P	Ovarian dysgenesis 6 (ODG6) [MIM:618078]	L5JW22	447	D	N
P57740	LP/P	Galloway-Mowat syndrome 7 (GAMOS7) [MIM:618348]	L5JW22	101	M	I
P57740	LP/P	Nephrotic syndrome 11 (NPHS11) [MIM:616730]	L5JW22	889	Y	C
P49790	LB/B	-	G3GUG1	90	D	N
P49790	LB/B	-	G3GUG1	248	I	V
P49790	LB/B	-	G3GUG1	402	N	K
P49790	LB/B	-	G3GUG1	821	P	L
P49790	LB/B	-	G3GUG1	827	A	T
P49790	LB/B	-	G3GUG1	1388	T	A
P49790	LB/B	-	G3GUG1	381	V	F
O75694	LP/P	Atrial fibrillation, familial, 15 (ATFB15) [MIM:615770]	A0A293N4B5	391	R	H
Q12769	LB/B	-	V8PFQ6	40	A	T
Q12769	LB/B	-	V8PFQ6	351	T	A
Q5SRE5	LB/B	-	F6WXT2	1419	A	V
Q5SRE5	LB/B	-	F6WXT2	1587	N	K
O15504	LB/B	-	U3K4W5	391	D	N
O15504	LB/B	-	U3K4W5	392	K	N
Q9BVL2	LB/B	-	A0A2I4B868	34	A	T
Q9BVL2	LB/B	-	A0A2I4B868	166	S	P
P37198	LB/B	-	U3K9P3	233	A	S
P37198	LB/B	-	U3K9P3	139	G	S
P37198	LB/B	-	U3K9P3	283	S	T
P37198	LP/P	Infantile striatonigral degeneration (SNDI) [MIM:271930]	U3K9P3	391	Q	P
Q9H1M0	LB/B	-	A0A2K5PEC0	177	I	T
Q9H1M0	LB/B	-	A0A2K5PEC0	54	F	L
Q9BW27	LP/P	Nephrotic syndrome 17 (NPHS17) [MIM:618176]	A0A1A6G1V4	581	A	P
Q9BW27	LP/P	Nephrotic syndrome 17 (NPHS17) [MIM:618176]	A0A1A6G1V4	645	R	W
Q99567	LB/B	-	A0A1A6HJT1	289	N	S
Q99567	LP/P	Fetal akinesia deformation sequence 4 (FADS4) [MIM:618393]	A0A1A6HJT1	434	D	Y
Q8N1F7	LB/B	-	R7TV42	509	S	R
Q8N1F7	LP/P	Nephrotic syndrome 12 (NPHS12) [MIM:616892]	R7TV42	388	R	W
Q8N1F7	LP/P	Nephrotic syndrome 12 (NPHS12) [MIM:616892]	R7TV42	591	G	V
Q8N1F7	LP/P	Nephrotic syndrome 12 (NPHS12) [MIM:616892]	R7TV42	629	Y	C
Q96E22	LB/B	-	Q6DHR8	175	N	Y
Q96E22	LB/B	-	Q6DHR8	179	D	E
Q96E22	LB/B	-	Q6DHR8	216	K	R
Q96E22	LB/B	-	Q6DHR8	219	T	K
Q96E22	LP/P	Congenital disorder of glycosylation 1AA (CDG1AA) [MIM:617082]	Q6DHR8	290	R	H
Q96E22	LP/P	-	Q6DHR8	91	G	C
Q9BXS6	LB/B	-	G9KEF1	33	T	A
Q9BXS6	LB/B	-	G9KEF1	33	T	N
Q86Y26	LB/B	-	F6XP92	22	P	L
Q86Y26	LB/B	-	F6XP92	781	T	M
Q86Y26	LB/B	-	F6XP92	785	V	E
Q86Y26	LB/B	-	F6XP92	973	T	N
Q86Y26	LB/B	-	F6XP92	985	P	R
Q86Y26	LB/B	-	F6XP92	1113	R	H
A1L443	LB/B	-	A0A2J8WNQ4	137	S	C
A1L443	LB/B	-	A0A2J8WNQ4	176	R	G
O15381	LB/B	-	A0A250Y4N4	359	C	G
O15381	LB/B	-	A0A250Y4N4	295	V	I
O15381	LB/B	-	A0A250Y4N4	404	V	I
Q149M9	LB/B	-	A0A1L8HXH8	174	S	G
Q149M9	LB/B	-	A0A1L8HXH8	211	L	F
Q149M9	LB/B	-	A0A1L8HXH8	218	A	T
Q149M9	LB/B	-	A0A1L8HXH8	900	Q	E
Q149M9	LB/B	-	A0A1L8HXH8	926	N	I
Q149M9	LB/B	-	A0A1L8HXH8	935	H	R
Q149M9	LB/B	-	A0A1L8HXH8	1541	D	V
Q5VZ03	LB/B	-	F6URM9	76	S	C
Q8N323	LB/B	-	A0A2U3XIH3	353	G	R
Q8N323	LB/B	-	A0A2U3XIH3	423	I	T
Q96DL1	LB/B	-	A0A2U3XIH3	103	V	A
Q969Y0	LB/B	-	L5LD74	507	T	I
Q6UWF7	LB/B	-	A0A2U3XIH3	398	Y	H
Q6UWF7	LB/B	-	A0A2U3XIH3	451	A	V
Q9P242	LB/B	-	L5L0I0	205	T	A
Q9P242	LB/B	-	L5L0I0	586	T	P
Q9P2P1	LB/B	-	Q5DTZ0	457	T	M
Q9P2P1	LB/B	-	Q5DTZ0	659	A	V
Q9P2P1	LB/B	-	Q5DTZ0	978	A	T
Q9P2P1	LB/B	-	Q5DTZ0	997	E	K
Q9P2P1	LB/B	-	Q5DTZ0	1551	I	V
Q86UD1	LB/B	-	S9XCJ0	210	H	R
Q86UD1	LB/B	-	S9XCJ0	217	R	H
P00973	LB/B	-	A0A2K5UGH8	162	G	S
P00973	LB/B	-	A0A2K5UGH8	354	D	G
P00973	LB/B	-	A0A2K5UGH8	361	R	T
P00973	LB/B	-	A0A2K5UGH8	31	N	D
P00973	LB/B	-	A0A2K5UGH8	127	G	R
P00973	LB/B	-	A0A2K5UGH8	352	A	T
P00973	LP/P	Immunodeficiency 100 with pulmonary alveolar proteinosis and hypogammaglobulinemia (IMD100) [MIM:618042]	A0A2K5UGH8	76	A	V
P00973	LP/P	Immunodeficiency 100 with pulmonary alveolar proteinosis and hypogammaglobulinemia (IMD100) [MIM:618042]	A0A2K5UGH8	109	C	Y
P00973	LP/P	Immunodeficiency 100 with pulmonary alveolar proteinosis and hypogammaglobulinemia (IMD100) [MIM:618042]	A0A2K5UGH8	121	V	G
P00973	LP/P	Immunodeficiency 100 with pulmonary alveolar proteinosis and hypogammaglobulinemia (IMD100) [MIM:618042]	A0A2K5UGH8	198	L	V
Q9Y6K5	LB/B	-	A0A2K5PJD6	65	R	W
Q9Y6K5	LB/B	-	A0A2K5PJD6	381	S	R
Q9Y6K5	LB/B	-	A0A2K5PJD6	869	R	H
Q9Y6K5	LB/B	-	A0A2K5PJD6	18	R	K
Q9Y6K5	LB/B	-	A0A2K5PJD6	18	R	M
Q9Y6K5	LB/B	-	A0A2K5PJD6	18	R	T
Q9Y6K5	LB/B	-	A0A2K5PJD6	378	R	K
Q15646	LB/B	-	A0A2Y9DR41	341	N	I
P04181	LP/P	Hyperornithinemia with gyrate atrophy of choroid and retina (HOGA) [MIM:258870]	A0A1L8FEA2	54	N	K
P04181	LP/P	Hyperornithinemia with gyrate atrophy of choroid and retina (HOGA) [MIM:258870]	A0A1L8FEA2	55	Y	H
P04181	LP/P	Hyperornithinemia with gyrate atrophy of choroid and retina (HOGA) [MIM:258870]	A0A1L8FEA2	89	N	K
P04181	LP/P	Hyperornithinemia with gyrate atrophy of choroid and retina (HOGA) [MIM:258870]	A0A1L8FEA2	93	C	F
P04181	LP/P	Hyperornithinemia with gyrate atrophy of choroid and retina (HOGA) [MIM:258870]	A0A1L8FEA2	154	R	L
P04181	LP/P	Hyperornithinemia with gyrate atrophy of choroid and retina (HOGA) [MIM:258870]	A0A1L8FEA2	180	R	T
P04181	LP/P	Hyperornithinemia with gyrate atrophy of choroid and retina (HOGA) [MIM:258870]	A0A1L8FEA2	226	A	V
P04181	LP/P	Hyperornithinemia with gyrate atrophy of choroid and retina (HOGA) [MIM:258870]	A0A1L8FEA2	241	P	L
P04181	LP/P	Hyperornithinemia with gyrate atrophy of choroid and retina (HOGA) [MIM:258870]	A0A1L8FEA2	245	Y	C
P04181	LP/P	Hyperornithinemia with gyrate atrophy of choroid and retina (HOGA) [MIM:258870]	A0A1L8FEA2	250	R	P
P04181	LP/P	Hyperornithinemia with gyrate atrophy of choroid and retina (HOGA) [MIM:258870]	A0A1L8FEA2	267	T	I
P04181	LB/B	-	A0A1L8FEA2	270	A	P
P04181	LP/P	Hyperornithinemia with gyrate atrophy of choroid and retina (HOGA) [MIM:258870]	A0A1L8FEA2	271	R	K
P04181	LP/P	Hyperornithinemia with gyrate atrophy of choroid and retina (HOGA) [MIM:258870]	A0A1L8FEA2	319	H	Y
P04181	LP/P	Hyperornithinemia with gyrate atrophy of choroid and retina (HOGA) [MIM:258870]	A0A1L8FEA2	332	V	M
P04181	LP/P	Hyperornithinemia with gyrate atrophy of choroid and retina (HOGA) [MIM:258870]	A0A1L8FEA2	353	G	D
P04181	LP/P	Hyperornithinemia with gyrate atrophy of choroid and retina (HOGA) [MIM:258870]	A0A1L8FEA2	375	G	A
P04181	LP/P	Hyperornithinemia with gyrate atrophy of choroid and retina (HOGA) [MIM:258870]	A0A1L8FEA2	394	C	R
P04181	LP/P	Hyperornithinemia with gyrate atrophy of choroid and retina (HOGA) [MIM:258870]	A0A1L8FEA2	402	L	P
P04181	LP/P	Hyperornithinemia with gyrate atrophy of choroid and retina (HOGA) [MIM:258870]	A0A1L8FEA2	417	P	L
P04181	LP/P	Hyperornithinemia with gyrate atrophy of choroid and retina (HOGA) [MIM:258870]	A0A1L8FEA2	437	L	F
P04181	LP/P	Hyperornithinemia with gyrate atrophy of choroid and retina (HOGA) [MIM:258870]	A0A1L8FEA2	90	Q	E
P04181	LP/P	Hyperornithinemia with gyrate atrophy of choroid and retina (HOGA) [MIM:258870]	A0A1L8FEA2	51	G	D
P04181	LP/P	Hyperornithinemia with gyrate atrophy of choroid and retina (HOGA) [MIM:258870]	A0A1L8FEA2	104	Q	R
P04181	LP/P	Hyperornithinemia with gyrate atrophy of choroid and retina (HOGA) [MIM:258870]	A0A1L8FEA2	199	P	Q
P04181	LP/P	Hyperornithinemia with gyrate atrophy of choroid and retina (HOGA) [MIM:258870]	A0A1L8FEA2	318	E	K
P04181	LP/P	Hyperornithinemia with gyrate atrophy of choroid and retina (HOGA) [MIM:258870]	A0A1L8FEA2	394	C	Y
P04181	LP/P	Hyperornithinemia with gyrate atrophy of choroid and retina (HOGA) [MIM:258870]	A0A1L8FEA2	436	I	N
Q04671	LP/P	Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]	F7BCB0	27	G	R
Q04671	LP/P	Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]	F7BCB0	86	S	R
Q04671	LP/P	Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]	F7BCB0	112	C	F
Q04671	LB/B	-	F7BCB0	257	A	D
Q04671	LB/B	-	F7BCB0	305	R	W
Q04671	LP/P	Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]	F7BCB0	368	A	V
Q04671	LP/P	Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]	F7BCB0	385	F	I
Q04671	LP/P	Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]	F7BCB0	395	M	L
Q04671	LP/P	Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]	F7BCB0	404	T	M
Q04671	LB/B	-	F7BCB0	419	R	Q
Q04671	LP/P	Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]	F7BCB0	419	R	W
Q04671	LB/B	-	F7BCB0	440	L	H
Q04671	LP/P	Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]	F7BCB0	443	V	I
Q04671	LP/P	Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]	F7BCB0	446	M	V
Q04671	LP/P	Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]	F7BCB0	473	I	S
Q04671	LP/P	Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]	F7BCB0	489	N	D
Q04671	LP/P	Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]	F7BCB0	549	H	Q
Q04671	LP/P	Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]	F7BCB0	592	T	I
Q04671	LP/P	Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]	F7BCB0	614	K	N
Q04671	LB/B	-	F7BCB0	615	H	R
Q04671	LP/P	Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]	F7BCB0	652	W	R
Q04671	LP/P	Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]	F7BCB0	679	W	R
Q04671	LB/B	-	F7BCB0	722	I	T
Q04671	LP/P	Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]	F7BCB0	724	A	P
Q04671	LP/P	Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]	F7BCB0	736	S	L
Q04671	LP/P	Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]	F7BCB0	743	P	L
Q04671	LP/P	Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]	F7BCB0	787	A	V
Q04671	LB/B	-	F7BCB0	440	L	F
Q04671	LP/P	Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]	F7BCB0	481	A	T
Q04671	LP/P	Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]	F7BCB0	10	R	W
Q04671	LP/P	Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]	F7BCB0	198	P	L
Q04671	LP/P	Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]	F7BCB0	211	P	L
Q04671	LP/P	Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]	F7BCB0	290	R	G
Q04671	LP/P	Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]	F7BCB0	334	A	V
Q04671	LB/B	-	F7BCB0	350	V	M
Q04671	LB/B	-	F7BCB0	370	I	T
Q04671	LB/B	-	F7BCB0	387	T	M
Q04671	LP/P	Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]	F7BCB0	394	M	I
Q04671	LP/P	Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]	F7BCB0	614	K	E
Q04671	LP/P	Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]	F7BCB0	617	I	L
Q04671	LP/P	Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]	F7BCB0	679	W	C
Q04671	LP/P	Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]	F7BCB0	720	R	C
Q04671	LP/P	Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]	F7BCB0	795	G	R
Q04671	LP/P	Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]	F7BCB0	799	Q	H
Q04671	LB/B	-	F7BCB0	241	P	R
Q04671	LB/B	-	F7BCB0	266	R	W
Q04671	LB/B	-	F7BCB0	336	A	V
Q04671	LB/B	-	F7BCB0	519	V	A
Q04671	LB/B	-	F7BCB0	560	R	H
Q04671	LP/P	Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]	F7BCB0	476	N	D
Q04671	LP/P	Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]	F7BCB0	775	G	R
Q04671	LP/P	Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]	F7BCB0	827	Y	H
Q04671	LP/P	Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]	F7BCB0	633	V	I
Q04671	LP/P	Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]	F7BCB0	684	F	C
Q56VL3	LB/B	-	A0A2Y9RNL6	44	R	Q
Q16625	LP/P	Pseudo-TORCH syndrome 1 (PTORCH1) [MIM:251290]	W5M9U1	219	F	S
Q01968	LP/P	Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000]	F6PHM6	337	R	P
Q01968	LP/P	Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000]	F6PHM6	372	V	G
Q01968	LP/P	Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000]	F6PHM6	375	H	Y
Q01968	LP/P	Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000]	F6PHM6	421	G	E
Q01968	LP/P	Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000]	F6PHM6	424	N	D
Q01968	LP/P	Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000]	F6PHM6	451	D	G
Q01968	LP/P	Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000]	F6PHM6	463	F	S
Q01968	LP/P	Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000]	F6PHM6	498	C	Y
Q01968	LP/P	Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000]	F6PHM6	500	R	G
Q01968	LP/P	Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000]	F6PHM6	500	R	Q
Q01968	LP/P	Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000]	F6PHM6	508	V	D
Q01968	LP/P	Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000]	F6PHM6	513	Y	C
Q01968	LP/P	Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000]	F6PHM6	522	S	R
Q01968	LP/P	Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000]	F6PHM6	524	H	Q
Q01968	LP/P	Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000]	F6PHM6	524	H	R
Q01968	LP/P	Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000]	F6PHM6	533	I	S
Q01968	LP/P	Dent disease 2 (DENT2) [MIM:300555]	F6PHM6	318	R	C
Q01968	LP/P	Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000]	F6PHM6	318	R	C
Q01968	LP/P	Dent disease 2 (DENT2) [MIM:300555]	F6PHM6	479	Y	C
Q01968	LP/P	Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000]	F6PHM6	526	P	L
Q01968	LP/P	Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000]	F6PHM6	242	F	S
Q01968	LP/P	Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000]	F6PHM6	274	I	T
Q01968	LP/P	Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000]	F6PHM6	277	Q	R
Q01968	LP/P	Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000]	F6PHM6	337	R	C
Q01968	LP/P	Dent disease 2 (DENT2) [MIM:300555]	F6PHM6	354	N	H
Q01968	LP/P	Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000]	F6PHM6	361	R	I
Q01968	LP/P	Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000]	F6PHM6	373	N	Y
Q01968	LP/P	Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000]	F6PHM6	374	S	F
Q01968	LP/P	Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000]	F6PHM6	414	H	R
Q01968	LP/P	Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000]	F6PHM6	451	D	N
Q01968	LP/P	Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000]	F6PHM6	457	R	G
Q01968	LP/P	Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000]	F6PHM6	468	E	G
Q01968	LP/P	Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000]	F6PHM6	468	E	K
Q01968	LP/P	Dent disease 2 (DENT2) [MIM:300555]	F6PHM6	493	R	W
Q01968	LP/P	Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000]	F6PHM6	495	P	L
Q01968	LP/P	Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000]	F6PHM6	499	D	H
Q01968	LP/P	Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000]	F6PHM6	503	W	R
Q01968	LP/P	Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000]	F6PHM6	591	N	K
Q01968	LP/P	Dent disease 2 (DENT2) [MIM:300555]	F6PHM6	799	P	L
Q01968	LP/P	Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000]	F6PHM6	801	P	L
Q01968	LP/P	Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000]	F6PHM6	891	L	R
Q9BR26	LB/B	-	A0A2Y9MUA1	565	P	S
Q5T2S8	LB/B	-	A0A1S3F086	935	N	K
Q5T2S8	LB/B	-	A0A1S3F086	343	I	T
Q5T2S8	LB/B	-	A0A1S3F086	1041	A	S
Q5T2S8	LP/P	Ciliary dyskinesia, primary, 23 (CILD23) [MIM:615451]	A0A1S3F086	927	L	W
A5D8V7	LB/B	-	A0A2K6DK86	545	R	P
Q96NG3	LB/B	-	A0A2Y9LWQ3	4	P	S
Q96NG3	LB/B	-	A0A2Y9LWQ3	18	A	G
A1E959	LB/B	-	Q003G9	222	I	T
Q17RF5	LB/B	-	A0A096MS97	30	P	L
Q17RF5	LB/B	-	A0A096MS97	109	R	H
Q14990	LB/B	-	A0A2K6GF64	216	S	N
Q14990	LB/B	-	A0A2K6GF64	243	F	L
Q5BJF6	LB/B	-	A0A226NXS5	710	T	S
Q8IXM7	LB/B	-	L9L6Y1	41	P	L
Q2M2E3	LB/B	-	A0A2F0BBZ4	34	W	R
Q2M2E3	LB/B	-	A0A2F0BBZ4	98	V	M
Q2M2E3	LB/B	-	A0A2F0BBZ4	139	Y	C
Q8IZS5	LB/B	-	H0WIE1	21	S	L
Q8IZS5	LB/B	-	H0WIE1	123	R	Q
Q8IZS5	LB/B	-	H0WIE1	145	T	I
O75665	LP/P	Orofaciodigital syndrome 1 (OFD1) [MIM:311200]	A0A1V4JBL8	435	S	R
O75665	LP/P	Orofaciodigital syndrome 1 (OFD1) [MIM:311200]	A0A1V4JBL8	74	S	F
O75665	LP/P	Orofaciodigital syndrome 1 (OFD1) [MIM:311200]	A0A1V4JBL8	79	A	T
O75665	LP/P	Orofaciodigital syndrome 1 (OFD1) [MIM:311200]	A0A1V4JBL8	138	G	S
O75665	LP/P	Orofaciodigital syndrome 1 (OFD1) [MIM:311200]	A0A1V4JBL8	141	M	R
Q02218	LB/B	-	A0A1S8VVM7	1018	V	I
Q9ULD0	LB/B	-	A0A1S8VVM7	511	P	L
Q9ULD0	LB/B	-	A0A1S8VVM7	573	D	N
Q9ULD0	LB/B	-	A0A1S8VVM7	623	S	C
Q9ULD0	LB/B	-	A0A1S8VVM7	637	T	M
Q9ULD0	LB/B	-	A0A1S8VVM7	725	N	S
Q9ULD0	LB/B	-	A0A1S8VVM7	220	W	C
Q9ULD0	LB/B	-	A0A1S8VVM7	734	F	S
Q6PK18	LB/B	-	B5X0R6	67	D	E
Q6PK18	LB/B	-	B5X0R6	272	P	R
Q5TC84	LB/B	-	A0A2Y9JZV7	47	S	P
O15527	LB/B	-	E5KPM6	46	R	Q
O15527	LB/B	-	E5KPM6	154	R	H
O15527	LB/B	-	E5KPM6	326	S	C
O15527	LB/B	-	E5KPM6	229	R	Q
O15527	LB/B	-	E5KPM6	320	S	T
O15527	LB/B	-	E5KPM6	288	A	V
O15527	LB/B	-	E5KPM6	322	D	N
O15527	LB/B	-	E5KPM6	12	G	E
O15527	LB/B	-	E5KPM6	85	A	S
O15527	LB/B	-	E5KPM6	131	R	Q
O15294	LP/P	Intellectual developmental disorder, X-linked 106 (XLID106) [MIM:300997]	A0A0L7L8G3	284	R	P
O15294	LP/P	Intellectual developmental disorder, X-linked 106 (XLID106) [MIM:300997]	A0A0L7L8G3	254	L	F
Q8WWZ8	LB/B	-	W5MPX3	237	S	P
Q6UX06	LB/B	-	A0A093PKB5	36	S	P
Q6UWY5	LB/B	-	A0A2I0UNS5	113	E	V
Q6UWY5	LB/B	-	A0A2I0UNS5	259	A	T
P78380	LB/B	-	S7MU65	167	K	N
Q96E52	LB/B	-	M7BH07	67	N	K
Q96E52	LB/B	-	M7BH07	117	P	L
Q96E52	LB/B	-	M7BH07	211	F	C
Q96E52	LB/B	-	M7BH07	329	I	L
Q96E52	LB/B	-	M7BH07	69	H	Y
Q96E52	LB/B	-	M7BH07	272	E	G
Q96E52	LB/B	-	M7BH07	365	D	Y
Q99983	LB/B	-	W5N8Y0	200	D	G
Q99983	LB/B	-	W5N8Y0	212	E	G
Q99983	LB/B	-	W5N8Y0	221	S	N
Q99983	LB/B	-	W5N8Y0	282	I	T
Q99983	LB/B	-	W5N8Y0	353	C	W
P23515	LB/B	-	A0A1U7RNI3	21	G	D
P23515	LB/B	-	A0A1U7RNI3	435	V	A
P47874	LB/B	-	S9WFZ3	26	R	W
P47874	LB/B	-	S9WFZ3	36	G	R
Q9UBC0	LB/B	-	Q5MD19	75	P	A
A6NGQ2	LB/B	-	A0A0A0MPZ2	18	A	T
A6NGQ2	LB/B	-	A0A0A0MPZ2	92	V	A
Q9H6K4	LP/P	Optic atrophy 3 (OPA3) [MIM:165300]	A0A250XVJ4	93	G	S
Q9H6K4	LP/P	Optic atrophy 3 (OPA3) [MIM:165300]	A0A250XVJ4	105	Q	E
Q14982	LP/P	Ovarian cancer (OC) [MIM:167000]	A0A2Y9LQ53	95	P	R
O60890	LB/B	-	A0A218V3H2	45	A	T
O60890	LB/B	-	A0A218V3H2	301	T	M
O60890	LB/B	-	A0A218V3H2	693	M	I
O60890	LB/B	-	A0A218V3H2	39	V	I
O14841	LB/B	-	A0A0N0U4T8	284	S	R
P04000	LB/B	-	A0A2C9F1E8	180	A	S
P04000	LP/P	Blue cone monochromacy (BCM) [MIM:303700]	A0A2C9F1E8	203	C	R
P04000	LP/P	Blue cone monochromacy (BCM) [MIM:303700]	A0A2C9F1E8	307	P	L
P04000	LB/B	-	A0A2C9F1E8	111	I	V
P04000	LB/B	-	A0A2C9F1E8	116	S	Y
P04000	LB/B	-	A0A2C9F1E8	153	M	L
P04000	LB/B	-	A0A2C9F1E8	230	I	T
P04000	LB/B	-	A0A2C9F1E8	298	A	P
P04000	LB/B	-	A0A2C9F1E8	274	I	V
P04000	LP/P	Colorblindness, partial, protan series (CBP) [MIM:303900]	A0A2C9F1E8	338	G	E
P04001	LP/P	Blue cone monochromacy (BCM) [MIM:303700]	A0A2C9F1E8	203	C	R
P04001	LP/P	Colorblindness, partial, deutan series (CBD) [MIM:303800]	A0A2C9F1E8	203	C	R
P04001	LP/P	Colorblindness, partial, deutan series (CBD) [MIM:303800]	A0A2C9F1E8	94	N	K
P04001	LP/P	Cone dystrophy 5 (COD5) [MIM:303700]	A0A2C9F1E8	177	W	R
P04001	LP/P	Colorblindness, partial, deutan series (CBD) [MIM:303800]	A0A2C9F1E8	330	R	Q
P03999	LP/P	Tritan color blindness (CBT) [MIM:190900]	Q9PUA9	79	G	R
P03999	LP/P	Tritan color blindness (CBT) [MIM:190900]	Q9PUA9	214	S	P
P03999	LP/P	Tritan color blindness (CBT) [MIM:190900]	Q9PUA9	264	P	S
P03999	LP/P	Tritan color blindness (CBT) [MIM:190900]	Q9PUA9	190	T	I
Q9UHM6	LB/B	-	G5APG0	394	T	I
Q9UHM6	LB/B	-	G5APG0	10	P	L
Q9UHM6	LB/B	-	G5APG0	444	G	D
P41143	LB/B	-	W5NXE0	27	C	F
P41145	LB/B	-	G3NJZ4	374	D	N
P35372	LB/B	-	F7CDR6	40	N	D
P35372	LB/B	-	F7CDR6	6	A	V
P35372	LB/B	-	F7CDR6	147	S	C
P35372	LB/B	-	F7CDR6	260	R	H
P35372	LB/B	-	F7CDR6	152	N	D
P35372	LB/B	-	F7CDR6	265	R	C
P35372	LB/B	-	F7CDR6	274	D	N
P35372	LB/B	-	F7CDR6	63	G	V
P35372	LB/B	-	F7CDR6	66	S	F
Q9UBM4	LB/B	-	A0A2K5NGT7	182	I	T
Q9UBM4	LB/B	-	A0A2K5NGT7	229	R	C
Q9UBM4	LB/B	-	A0A2K5NGT7	325	R	W
Q9H208	LB/B	-	E1BJ73	207	H	R
Q9H208	LB/B	-	E1BJ73	240	I	T
Q9H208	LB/B	-	E1BJ73	258	K	T
Q9H208	LB/B	-	E1BJ73	134	A	T
Q9H208	LB/B	-	E1BJ73	43	H	R
P58181	LB/B	-	E1BJ73	20	F	V
Q9H209	LB/B	-	E1BJ73	262	R	Q
Q9H209	LB/B	-	E1BJ73	221	R	H
Q9H209	LB/B	-	E1BJ73	246	L	F
Q9H209	LB/B	-	E1BJ73	206	L	P
Q9H207	LB/B	-	E1BJ73	41	K	M
Q8NH74	LB/B	-	H0VB95	117	A	V
Q8NH74	LB/B	-	H0VB95	140	V	G
Q8NH74	LB/B	-	H0VB95	287	L	P
Q8NGE0	LB/B	-	G3TT24	279	Y	H
Q8NGE0	LB/B	-	G3TT24	8	V	A
Q8NGE0	LB/B	-	G3TT24	166	R	Q
Q8NGE0	LB/B	-	G3TT24	275	F	V
Q96KK4	LB/B	-	F6RAV9	57	P	S
Q96KK4	LB/B	-	F6RAV9	60	F	L
Q96KK4	LB/B	-	F6RAV9	89	R	S
Q96KK4	LB/B	-	F6RAV9	100	M	V
Q96KK4	LB/B	-	F6RAV9	121	R	C
Q96KK4	LB/B	-	F6RAV9	138	R	W
Q96KK4	LB/B	-	F6RAV9	160	P	S
Q96KK4	LB/B	-	F6RAV9	161	F	L
Q96KK4	LB/B	-	F6RAV9	174	P	Q
Q96KK4	LB/B	-	F6RAV9	246	M	V
Q96KK4	LB/B	-	F6RAV9	255	L	I
Q96KK4	LB/B	-	F6RAV9	310	M	R
Q8NGC3	LB/B	-	A0A1U8DLS2	67	L	F
Q8NGC3	LB/B	-	A0A1U8DLS2	85	L	R
Q8NGC3	LB/B	-	A0A1U8DLS2	187	P	R
Q8NGC3	LB/B	-	A0A1U8DLS2	209	G	R
Q8NGC3	LB/B	-	A0A1U8DLS2	136	R	H
Q8NGC3	LB/B	-	A0A1U8DLS2	228	N	H
Q8NGC3	LB/B	-	A0A1U8DLS2	236	T	A
Q8NGC4	LB/B	-	F6RAV9	73	S	G
Q8NGN3	LB/B	-	A0A1A6H8B9	195	V	E
Q8NGN3	LB/B	-	A0A1A6H8B9	235	R	G
Q8NGN3	LB/B	-	A0A1A6H8B9	24	L	P
Q8NGN3	LB/B	-	A0A1A6H8B9	134	M	V
Q8NGN3	LB/B	-	A0A1A6H8B9	181	P	S
Q8NGN3	LB/B	-	A0A1A6H8B9	226	R	Q
Q8NGN3	LB/B	-	A0A1A6H8B9	295	K	Q
Q8NGN3	LB/B	-	A0A1A6H8B9	101	Y	C
Q8NGN3	LB/B	-	A0A1A6H8B9	146	G	C
Q8NGN3	LB/B	-	A0A1A6H8B9	146	G	R
Q8NGN3	LB/B	-	A0A1A6H8B9	146	G	S
Q8NGN6	LB/B	-	L9KX95	5	T	S
Q8NGN6	LB/B	-	L9KX95	136	T	S
Q8NGN6	LB/B	-	L9KX95	13	T	M
Q8NGN6	LB/B	-	L9KX95	18	A	V
Q8NGN6	LB/B	-	L9KX95	20	G	A
Q8NGN6	LB/B	-	L9KX95	28	I	V
Q8NGN6	LB/B	-	L9KX95	90	T	A
Q8NGN4	LB/B	-	A0A1A6H8B9	136	S	T
Q8NGN4	LB/B	-	A0A1A6H8B9	172	Q	R
Q8NGN4	LB/B	-	A0A1A6H8B9	134	M	V
Q8NGN4	LB/B	-	A0A1A6H8B9	228	H	R
Q9Y4A9	LB/B	-	A0A2Y9J339	16	G	R
Q9Y4A9	LB/B	-	A0A2Y9J339	65	A	V
Q9Y4A9	LB/B	-	A0A2Y9J339	175	H	Q
O60403	LB/B	-	A0A2Y9J339	171	S	F
O60403	LB/B	-	A0A2Y9J339	40	L	Q
O60404	LB/B	-	H0VB95	224	V	M
O60404	LB/B	-	H0VB95	293	S	N
O60404	LB/B	-	H0VB95	7	R	S
O60404	LB/B	-	H0VB95	14	L	I
O60404	LB/B	-	H0VB95	54	R	H
Q8NGA5	LB/B	-	H0VB95	100	N	K
Q8NGA5	LB/B	-	H0VB95	144	H	R
Q8NGA5	LB/B	-	H0VB95	281	T	A
Q5JRS4	LB/B	-	H0VB95	235	Q	R
Q6IF99	LB/B	-	H0VB95	208	A	T
Q8NGE3	LB/B	-	E1BJ73	88	P	L
Q8NGE3	LB/B	-	E1BJ73	200	V	M
Q8NGQ4	LB/B	-	A0A1U8DLS2	12	E	D
Q8NGQ4	LB/B	-	A0A1U8DLS2	191	R	C
Q8NGX6	LB/B	-	A0A2U3ZWE3	191	A	T
Q8NGX6	LB/B	-	A0A2U3ZWE3	216	E	G
Q8NGX6	LB/B	-	A0A2U3ZWE3	239	L	F
Q8NGN2	LB/B	-	A0A2I2UC95	63	G	S
Q8NGN2	LB/B	-	A0A2I2UC95	93	K	R
Q8NGN2	LB/B	-	A0A2I2UC95	112	A	V
Q8NGX3	LB/B	-	H0VB95	16	V	A
Q8NGX3	LB/B	-	H0VB95	65	F	L
Q8NGX3	LB/B	-	H0VB95	78	I	V
Q8NGX3	LB/B	-	H0VB95	137	I	M
Q8NGX3	LB/B	-	H0VB95	155	F	L
Q8NGX3	LB/B	-	H0VB95	312	K	N
Q8NGI7	LB/B	-	H0VB95	123	Q	R
Q8NGI7	LB/B	-	H0VB95	117	V	A
Q8NGY0	LB/B	-	H0VB95	60	I	T
Q8NGY0	LB/B	-	H0VB95	81	A	S
Q8NGY0	LB/B	-	H0VB95	172	S	P
Q8NGY0	LB/B	-	H0VB95	180	F	L
Q8NGY1	LB/B	-	H0VB95	294	N	T
Q9GZK7	LB/B	-	A0A1S3FBW6	165	A	T
Q9GZK7	LB/B	-	A0A1S3FBW6	121	Y	C
Q8NGC1	LB/B	-	G1LDP0	99	I	N
Q8NGC1	LB/B	-	G1LDP0	116	V	I
Q8NGX0	LB/B	-	G1LQV3	117	F	L
Q8NGX0	LB/B	-	G1LQV3	108	G	S
Q8NGX0	LB/B	-	G1LQV3	142	A	T
Q8NGX0	LB/B	-	G1LQV3	171	R	P
P58182	LB/B	-	M7BCE2	47	V	F
P58182	LB/B	-	M7BCE2	56	L	P
P58182	LB/B	-	M7BCE2	113	F	L
P58182	LB/B	-	M7BCE2	120	L	R
P58182	LB/B	-	M7BCE2	121	S	C
P58182	LB/B	-	M7BCE2	132	V	G
P58182	LB/B	-	M7BCE2	159	V	I
P58182	LB/B	-	M7BCE2	104	S	F
Q9UGF7	LB/B	-	M7BCE2	97	T	I
Q9UGF7	LB/B	-	M7BCE2	277	Y	H
Q8NGS6	LB/B	-	A0A1U8DLS2	293	K	T
Q8NGV5	LB/B	-	A0A1U8DLS2	21	F	L
Q8NGV5	LB/B	-	A0A1U8DLS2	64	L	V
Q8NGV5	LB/B	-	A0A1U8DLS2	191	Q	H
Q8NGV5	LB/B	-	A0A1U8DLS2	277	S	L
Q8NG92	LB/B	-	G1TS95	266	Y	S
Q8NHC5	LB/B	-	A0A1S3APF9	238	I	T
Q8NHC7	LB/B	-	A0A1U8DQX9	141	Q	R
Q8NHC7	LB/B	-	A0A1U8DQX9	225	G	R
Q8NHC7	LB/B	-	A0A1U8DQX9	231	D	Y
A6ND48	LB/B	-	A0A1U8DQX9	36	V	A
A6ND48	LB/B	-	A0A1U8DQX9	50	D	N
A6ND48	LB/B	-	A0A1U8DQX9	170	S	N
A6ND48	LB/B	-	A0A1U8DQX9	84	L	M
A6ND48	LB/B	-	A0A1U8DQX9	216	Y	C
Q9UGF5	LB/B	-	A0A1U8DQX9	7	M	T
Q9UGF5	LB/B	-	A0A1U8DQX9	278	V	M
Q9P1Q5	LB/B	-	A0A091D2P5	285	P	S
Q9P1Q5	LB/B	-	A0A091D2P5	233	V	M
Q9P1Q5	LB/B	-	A0A091D2P5	128	R	H
Q9Y585	LB/B	-	A0A091D2P5	256	G	C
Q9Y585	LB/B	-	A0A091D2P5	260	R	C
Q9Y585	LB/B	-	A0A091D2P5	293	W	C
Q9Y585	LB/B	-	A0A091D2P5	244	L	F
Q8NGR6	LB/B	-	A0A091D2P5	149	L	S
Q8NGR6	LB/B	-	A0A091D2P5	230	A	T
Q8NGR6	LB/B	-	A0A091D2P5	263	C	W
Q8NGR6	LB/B	-	A0A091D2P5	314	V	G
Q15619	LB/B	-	A0A091D2P5	209	T	M
P34982	LB/B	-	H2QFL0	25	R	Q
P34982	LB/B	-	H2QFL0	31	F	Y
P34982	LB/B	-	H2QFL0	240	T	I
P34982	LB/B	-	H2QFL0	214	V	M
O43749	LB/B	-	A0A091D2P5	75	F	S
O43749	LB/B	-	A0A091D2P5	126	V	M
P47890	LB/B	-	M3Z7M9	88	Q	H
O60431	LB/B	-	G1QZ74	139	P	R
O60431	LB/B	-	G1QZ74	211	F	L
O60431	LB/B	-	G1QZ74	252	Y	S
O60431	LB/B	-	G1QZ74	292	I	T
O60431	LB/B	-	G1QZ74	50	I	F
O60431	LB/B	-	G1QZ74	163	M	L
O60431	LB/B	-	G1QZ74	282	I	F
Q8NGS3	LB/B	-	A0A091D2P5	318	N	S
Q8NGR3	LB/B	-	A0A091D2P5	271	W	R
Q8NH94	LB/B	-	A0A091D2P5	145	S	G
Q8NH94	LB/B	-	A0A091D2P5	149	T	A
Q8NH94	LB/B	-	A0A091D2P5	308	L	V
Q8NH94	LB/B	-	A0A091D2P5	349	G	R
Q8NH93	LB/B	-	A0A091D2P5	106	V	A
Q8NH93	LB/B	-	A0A091D2P5	121	N	D
Q8NH93	LB/B	-	A0A091D2P5	54	R	G
Q8NGR5	LB/B	-	A0A091D2P5	234	G	R
Q8NGR5	LB/B	-	A0A091D2P5	310	Y	H
Q8NGR2	LB/B	-	A0A091D2P5	59	Q	K
Q8NGR2	LB/B	-	A0A091D2P5	186	C	Y
Q8NGR2	LB/B	-	A0A091D2P5	251	I	T
Q8NGR2	LB/B	-	A0A091D2P5	259	M	I
Q8NGR8	LB/B	-	A0A091D2P5	27	T	P
Q8NGR8	LB/B	-	A0A091D2P5	211	R	P
Q8NGS0	LB/B	-	A0A091D2P5	18	P	S
Q8NGS0	LB/B	-	A0A091D2P5	227	R	Q
Q8NGR9	LB/B	-	A0A091D2P5	37	W	R
Q8NGR9	LB/B	-	A0A091D2P5	244	V	G
Q8NGR9	LB/B	-	A0A091D2P5	301	T	M
Q8NGR9	LB/B	-	A0A091D2P5	237	R	C
Q15612	LB/B	-	M3Z7M9	163	I	M
Q15612	LB/B	-	M3Z7M9	24	Q	R
Q15612	LB/B	-	M3Z7M9	240	T	A
Q8NH92	LB/B	-	A0A2Y9GSS2	5	S	G
Q8NH92	LB/B	-	A0A2Y9GSS2	123	I	T
Q8NH92	LB/B	-	A0A2Y9GSS2	135	H	R
Q8NH92	LB/B	-	A0A2Y9GSS2	183	N	D
Q8NH92	LB/B	-	A0A2Y9GSS2	206	L	M
Q8NH92	LB/B	-	A0A2Y9GSS2	227	S	I
Q8NGQ3	LB/B	-	A0A2Y9GSS2	225	V	A
Q8NGQ3	LB/B	-	A0A2Y9GSS2	225	V	I
Q8NGQ3	LB/B	-	A0A2Y9GSS2	59	I	T
Q8NHA4	LB/B	-	F6YW40	77	I	T
Q8NHA4	LB/B	-	F6YW40	267	L	V
Q8NHA4	LB/B	-	F6YW40	217	Y	C
Q9H205	LB/B	-	F6YW40	187	V	L
Q9H205	LB/B	-	F6YW40	299	R	G
Q9H205	LB/B	-	F6YW40	299	R	W
A6NM03	LB/B	-	F6YW40	28	Y	C
A6NM03	LB/B	-	F6YW40	54	R	P
A6NM03	LB/B	-	F6YW40	87	R	L
A6NM03	LB/B	-	F6YW40	299	R	G
Q8NG84	LB/B	-	F6YW40	99	S	N
Q8NG84	LB/B	-	F6YW40	203	V	M
Q5JQS5	LB/B	-	A0A1U8DLS2	198	V	M
Q5JQS5	LB/B	-	A0A1U8DLS2	223	G	D
Q5JQS5	LB/B	-	A0A1U8DLS2	293	T	I
Q5JQS5	LB/B	-	A0A1U8DLS2	300	D	G
Q5JQS5	LB/B	-	A0A1U8DLS2	130	I	S
Q9GZK3	LB/B	-	A0A1U8DLS2	234	Q	R
Q9GZK3	LB/B	-	A0A1U8DLS2	183	A	P
Q9GZK3	LB/B	-	A0A1U8DLS2	300	A	S
P58173	LB/B	-	A0A1U8DLS2	270	Q	R
P58173	LB/B	-	A0A1U8DLS2	117	V	I
O95371	LB/B	-	A0A1U8DLS2	16	G	S
O95371	LB/B	-	A0A1U8DLS2	149	C	W
O95371	LB/B	-	A0A1U8DLS2	229	R	H
Q9H210	LB/B	-	A0A1U8DLS2	148	S	P
Q9H210	LB/B	-	A0A1U8DLS2	163	I	M
Q9H210	LB/B	-	A0A1U8DLS2	163	I	T
Q9H210	LB/B	-	A0A1U8DLS2	202	M	T
Q9H210	LB/B	-	A0A1U8DLS2	84	H	Y
Q9H210	LB/B	-	A0A1U8DLS2	220	R	G
Q8NGH3	LB/B	-	A0A1U8DLS2	82	L	I
Q8NGH3	LB/B	-	A0A1U8DLS2	155	R	W
Q8NGH3	LB/B	-	A0A1U8DLS2	165	W	S
Q13607	LB/B	-	A0A1U8DLS2	122	R	C
Q13607	LB/B	-	A0A1U8DLS2	137	H	R
O95006	LB/B	-	A0A1U8DLS2	98	A	V
O95006	LB/B	-	A0A1U8DLS2	170	T	A
O95006	LB/B	-	A0A1U8DLS2	278	Y	H
Q8NGZ5	LB/B	-	A0A2K5KC93	24	P	A
Q8NGZ5	LB/B	-	A0A2K5KC93	120	V	L
Q8NGZ5	LB/B	-	A0A2K5KC93	167	L	P
Q8NGZ5	LB/B	-	A0A2K5KC93	236	R	G
Q8NGZ4	LB/B	-	A0A1U8DLS2	258	V	M
Q8NGZ4	LB/B	-	A0A1U8DLS2	164	L	S
Q5TZ20	LB/B	-	A0A1U8DLS2	258	M	L
Q5TZ20	LB/B	-	A0A1U8DLS2	59	M	V
Q9GZK4	LB/B	-	A0A1U8DLS2	63	D	N
Q9GZK4	LB/B	-	A0A1U8DLS2	223	V	M
O95918	LB/B	-	A0A1U8DLS2	30	L	S
O95918	LB/B	-	A0A1U8DLS2	48	A	V
O95918	LB/B	-	A0A1U8DLS2	220	T	A
O95918	LB/B	-	A0A1U8DLS2	30	L	I
O95918	LB/B	-	A0A1U8DLS2	38	V	M
O95918	LB/B	-	A0A1U8DLS2	30	L	F
Q9GZK6	LB/B	-	A0A1U8DLS2	14	L	I
O76002	LB/B	-	A0A1U8DLS2	74	H	Y
O76002	LB/B	-	A0A1U8DLS2	111	A	T
O76002	LB/B	-	A0A1U8DLS2	146	A	V
O76002	LB/B	-	A0A1U8DLS2	218	A	T
O76001	LB/B	-	A0A1U8DLS2	113	T	A
O76001	LB/B	-	A0A1U8DLS2	226	R	Q
O76001	LB/B	-	A0A1U8DLS2	228	V	I
O76001	LB/B	-	A0A1U8DLS2	261	I	M
Q8N349	LB/B	-	A0A2K5ZI03	156	L	F
Q8N349	LB/B	-	A0A2K5ZI03	265	R	H
Q8NH16	LB/B	-	A0A2K5ZI03	249	F	L
Q8NH16	LB/B	-	A0A2K5ZI03	259	V	L
Q8NG85	LB/B	-	A0A2K5ZI03	104	S	L
Q8NG85	LB/B	-	A0A2K5ZI03	39	I	T
Q8NG85	LB/B	-	A0A2K5ZI03	78	P	L
Q8NG85	LB/B	-	A0A2K5ZI03	139	M	V
Q8NGY9	LB/B	-	A0A2K5ZI03	217	Y	C
Q8NGY9	LB/B	-	A0A2K5ZI03	196	G	C
Q8NGY9	LB/B	-	A0A2K5ZI03	202	A	T
Q8NGY9	LB/B	-	A0A2K5ZI03	294	K	R
Q8NGY9	LB/B	-	A0A2K5ZI03	226	H	R
Q8NGY9	LB/B	-	A0A2K5ZI03	301	T	K
Q96R28	LB/B	-	F6YW40	237	A	T
Q96R28	LB/B	-	F6YW40	220	R	G
Q96R28	LB/B	-	F6YW40	235	C	R
Q96R28	LB/B	-	F6YW40	87	S	C
Q8NG81	LB/B	-	F6YW40	78	V	A
Q8NG81	LB/B	-	F6YW40	178	C	F
Q8NG81	LB/B	-	F6YW40	35	F	L
Q8NG81	LB/B	-	F6YW40	191	D	N
O43869	LB/B	-	F6YW40	25	H	R
Q8NH01	LB/B	-	F6YW40	119	C	R
Q8NH01	LB/B	-	F6YW40	309	Q	R
Q8NG77	LB/B	-	A0A2I3RDV7	296	K	N
Q8NG77	LB/B	-	A0A2I3RDV7	41	A	S
Q8NG77	LB/B	-	A0A2I3RDV7	69	M	V
Q8NG77	LB/B	-	A0A2I3RDV7	104	T	S
Q8NG77	LB/B	-	A0A2I3RDV7	301	R	L
Q8NH04	LB/B	-	F6YW40	36	L	V
Q8NH04	LB/B	-	F6YW40	45	K	M
Q8NH03	LB/B	-	F6YW40	204	M	T
Q8NG76	LB/B	-	A0A2I3RDV7	169	A	V
Q8NGX1	LB/B	-	F6YW40	267	R	P
Q8NH00	LB/B	-	F6YW40	31	N	S
Q6IEZ7	LB/B	-	F6YW40	13	K	R
Q8NHC8	LB/B	-	F6YW40	57	T	N
Q8NHC8	LB/B	-	F6YW40	159	L	P
Q8NHC8	LB/B	-	F6YW40	243	S	A
Q8NHC8	LB/B	-	F6YW40	21	N	D
Q8NHC8	LB/B	-	F6YW40	23	C	G
A6NH00	LB/B	-	A0A2I3RDV7	39	G	S
A6NH00	LB/B	-	A0A2I3RDV7	49	W	R
A6NH00	LB/B	-	A0A2I3RDV7	179	T	A
A6NH00	LB/B	-	A0A2I3RDV7	197	M	R
A6NH00	LB/B	-	A0A2I3RDV7	221	A	S
A6NH00	LB/B	-	A0A2I3RDV7	305	R	W
A6NH00	LB/B	-	A0A2I3RDV7	69	V	M
A6NH00	LB/B	-	A0A2I3RDV7	311	R	H
Q96R30	LB/B	-	F6YW40	34	A	V
Q96R30	LB/B	-	F6YW40	221	H	R
Q9Y3N9	LB/B	-	A0A1U8DLS2	81	M	V
Q9Y3N9	LB/B	-	A0A1U8DLS2	296	D	N
Q8NGV0	LB/B	-	A0A2Y9E6C5	200	V	L
Q8NGV0	LB/B	-	A0A2Y9E6C5	128	R	C
Q8NGV0	LB/B	-	A0A2Y9E6C5	154	V	M
Q8NG97	LB/B	-	F6YW40	138	R	C
Q8NH70	LB/B	-	M3X309	188	L	I
Q8NH70	LB/B	-	M3X309	303	K	M
Q8NH70	LB/B	-	M3X309	232	H	R
Q6IF82	LB/B	-	A0A287D735	82	G	D
Q6IF82	LB/B	-	A0A287D735	104	I	L
Q6IF82	LB/B	-	A0A287D735	145	V	M
Q6IF82	LB/B	-	A0A287D735	192	A	D
Q8NH83	LB/B	-	A0A287D735	6	N	S
Q8NH83	LB/B	-	A0A287D735	23	K	N
Q8NH83	LB/B	-	A0A287D735	219	L	Q
Q8NGF8	LB/B	-	A0A287D735	63	C	Y
Q8NGF8	LB/B	-	A0A287D735	237	T	N
Q6IEV9	LB/B	-	M3X309	8	P	T
Q6IEV9	LB/B	-	M3X309	15	L	I
Q6IEV9	LB/B	-	M3X309	277	T	P
Q8NGL9	LB/B	-	A0A287D735	76	T	A
Q8NGL9	LB/B	-	A0A287D735	25	V	L
Q8NGL9	LB/B	-	A0A287D735	49	T	A
Q8NGL9	LB/B	-	A0A287D735	203	A	T
Q8NGL9	LB/B	-	A0A287D735	259	L	P
Q8NH72	LB/B	-	A0A287D735	133	I	T
Q15615	LB/B	-	A0A287D735	54	R	Q
Q15615	LB/B	-	A0A287D735	174	L	I
Q8NGI4	LB/B	-	A0A287D735	197	F	L
P58180	LB/B	-	A0A287D735	29	L	I
Q8NGJ1	LB/B	-	A0A287D735	96	D	G
Q8NGJ1	LB/B	-	A0A287D735	151	S	T
Q8NGJ1	LB/B	-	A0A287D735	263	M	T
Q8NGJ1	LB/B	-	A0A287D735	11	E	Q
Q8NGJ1	LB/B	-	A0A287D735	102	F	S
Q8NGJ1	LB/B	-	A0A287D735	111	D	A
Q8NGJ1	LB/B	-	A0A287D735	59	M	V
Q8NGE8	LB/B	-	A0A287D735	159	Q	R
P0C645	LB/B	-	M3X309	199	I	L
P0C645	LB/B	-	M3X309	238	R	W
P0C645	LB/B	-	M3X309	274	V	A
Q8NGC2	LB/B	-	M3X309	118	V	M
Q8NGC2	LB/B	-	M3X309	234	Q	R
Q8NGD4	LB/B	-	A0A287B774	89	R	H
Q8NGD4	LB/B	-	A0A287B774	138	R	Q
Q8NGD4	LB/B	-	A0A287B774	304	R	H
Q8NH42	LB/B	-	A0A287B774	292	Q	K
Q8NGD5	LB/B	-	A0A287B774	119	M	V
Q8NGD5	LB/B	-	A0A287B774	145	L	R
Q8NH41	LB/B	-	A0A287B774	65	N	S
Q8NH41	LB/B	-	A0A287B774	88	E	V
Q8NH41	LB/B	-	A0A287B774	93	S	A
Q8NH41	LB/B	-	A0A287B774	231	A	E
Q8NH41	LB/B	-	A0A287B774	280	L	P
Q8NH41	LB/B	-	A0A287B774	286	I	M
Q8NGD2	LB/B	-	A0A287B774	307	N	I
Q8NGD3	LB/B	-	A0A287B774	319	R	K
Q8NH43	LB/B	-	A0A287B774	52	R	S
Q8NH43	LB/B	-	A0A287B774	2	D	N
Q8NH43	LB/B	-	A0A287B774	40	M	V
Q8NH43	LB/B	-	A0A287B774	93	S	F
Q8NH43	LB/B	-	A0A287B774	101	M	K
Q8NH43	LB/B	-	A0A287B774	109	G	S
Q8NH43	LB/B	-	A0A287B774	16	G	V
Q8NH43	LB/B	-	A0A287B774	160	I	T
Q8NGD0	LB/B	-	S7Q966	116	T	I
Q8NGD0	LB/B	-	S7Q966	232	G	D
Q8NGB6	LB/B	-	S7Q966	96	G	E
Q8NGB6	LB/B	-	S7Q966	121	D	N
Q8NGB6	LB/B	-	S7Q966	225	F	L
Q8NGB6	LB/B	-	S7Q966	239	M	V
Q8NGB6	LB/B	-	S7Q966	284	R	H
Q8NGD1	LB/B	-	A0A287D735	135	V	L
Q8NGD1	LB/B	-	A0A287D735	76	I	T
Q8NGD1	LB/B	-	A0A287D735	133	P	S
Q8N0Y3	LB/B	-	A0A287D735	61	L	F
Q8N0Y3	LB/B	-	A0A287D735	86	L	F
Q8N0Y3	LB/B	-	A0A287D735	239	T	M
Q8N0Y3	LB/B	-	A0A287D735	274	F	L
Q8IXE1	LB/B	-	A0A287D735	191	N	D
Q8IXE1	LB/B	-	A0A287D735	234	S	T
Q8IXE1	LB/B	-	A0A287D735	260	C	R
Q8IXE1	LB/B	-	A0A287D735	290	R	H
Q8NH05	LB/B	-	A0A287B774	135	T	A
Q8NH05	LB/B	-	A0A287B774	238	F	L
Q8NH73	LB/B	-	M3X309	72	S	T
Q8NH73	LB/B	-	M3X309	195	V	G
Q8NH49	LB/B	-	A0A287D735	165	P	L
Q8NH49	LB/B	-	A0A287D735	246	D	N
Q8NH49	LB/B	-	A0A287D735	282	P	S
Q8NH49	LB/B	-	A0A287D735	144	R	G
Q8NH49	LB/B	-	A0A287D735	196	L	Q
Q8NH64	LB/B	-	M7AII8	8	E	K
Q8NH64	LB/B	-	M7AII8	81	M	T
Q8NH64	LB/B	-	M7AII8	196	V	A
Q9Y5P1	LB/B	-	L5MCE2	283	P	S
Q9Y5P1	LB/B	-	L5MCE2	120	C	R
Q9Y5P1	LB/B	-	L5MCE2	134	L	F
Q9Y5P1	LB/B	-	L5MCE2	209	C	S
Q9Y5P1	LB/B	-	L5MCE2	312	S	R
Q9H339	LB/B	-	L5MCE2	5	G	S
Q9H339	LB/B	-	L5MCE2	102	I	T
Q9H339	LB/B	-	L5MCE2	154	V	I
Q9H339	LB/B	-	L5MCE2	160	P	L
Q9H339	LB/B	-	L5MCE2	220	L	F
Q9H339	LB/B	-	L5MCE2	78	T	K
Q9H339	LB/B	-	L5MCE2	88	R	G
Q9H340	LB/B	-	L5MCE2	5	K	T
Q9H340	LB/B	-	L5MCE2	40	N	S
Q9H340	LB/B	-	L5MCE2	90	I	T
Q9H340	LB/B	-	L5MCE2	123	T	A
Q9H340	LB/B	-	L5MCE2	131	T	I
Q9H340	LB/B	-	L5MCE2	145	R	G
Q9H340	LB/B	-	L5MCE2	169	S	A
Q9H340	LB/B	-	L5MCE2	172	L	F
Q9H340	LB/B	-	L5MCE2	192	F	L
Q9H340	LB/B	-	L5MCE2	254	V	L
Q9H340	LB/B	-	L5MCE2	275	S	R
Q9H340	LB/B	-	L5MCE2	125	R	H
Q9H340	LB/B	-	L5MCE2	126	S	N
Q8NGF3	LB/B	-	H0XTV5	89	I	V
Q8TCB6	LB/B	-	A0A2F0B5I9	10	S	N
Q8TCB6	LB/B	-	A0A2F0B5I9	9	S	N
A6NGY5	LB/B	-	M7AII8	20	T	A
A6NGY5	LB/B	-	M7AII8	73	F	S
A6NGY5	LB/B	-	M7AII8	74	R	M
A6NGY5	LB/B	-	M7AII8	232	H	R
A6NGY5	LB/B	-	M7AII8	301	D	Y
A6NGY5	LB/B	-	M7AII8	202	R	Q
A6NGY5	LB/B	-	M7AII8	258	A	V
A6NGY5	LB/B	-	M7AII8	233	S	F
Q8NGK1	LB/B	-	L5MCE2	125	Y	S
Q8NGK1	LB/B	-	L5MCE2	114	S	L
Q8NGK1	LB/B	-	L5MCE2	124	R	H
Q8NGK1	LB/B	-	L5MCE2	195	I	T
Q8NGK1	LB/B	-	L5MCE2	303	Q	H
Q8NGK0	LB/B	-	M7AII8	96	E	Q
Q8NGK0	LB/B	-	M7AII8	94	A	E
Q8NGJ5	LB/B	-	B0VXA2	196	T	I
Q8NGJ5	LB/B	-	B0VXA2	207	A	V
Q9H341	LB/B	-	A0A2U3XLG4	102	H	Q
Q9H341	LB/B	-	A0A2U3XLG4	135	L	F
Q9H341	LB/B	-	A0A2U3XLG4	204	I	T
Q9H341	LB/B	-	A0A2U3XLG4	256	P	H
Q9H341	LB/B	-	A0A2U3XLG4	257	L	R
Q9H341	LB/B	-	A0A2U3XLG4	318	F	L
Q8NH59	LB/B	-	M7AII8	211	V	M
Q8NH59	LB/B	-	M7AII8	146	T	I
Q8NH59	LB/B	-	M7AII8	153	C	R
Q8NH59	LB/B	-	M7AII8	178	R	H
Q8NH59	LB/B	-	M7AII8	155	V	I
Q8NH59	LB/B	-	M7AII8	308	F	S
Q8NGJ8	LB/B	-	A0A2U3WG00	178	L	R
Q8NGJ8	LB/B	-	A0A2U3WG00	57	I	N
Q8NGJ8	LB/B	-	A0A2U3WG00	60	Q	E
Q8NGJ8	LB/B	-	A0A2U3WG00	264	L	F
A6NMU1	LB/B	-	A0A2I2YI30	87	D	G
A6NMU1	LB/B	-	A0A2I2YI30	180	Y	S
A6NMU1	LB/B	-	A0A2I2YI30	277	C	R
A6NMU1	LB/B	-	A0A2I2YI30	303	T	A
Q9H346	LB/B	-	M7AII8	251	I	T
Q9H346	LB/B	-	M7AII8	154	R	C
Q9H346	LB/B	-	M7AII8	213	D	E
Q9H346	LB/B	-	M7AII8	221	Y	F
Q9H346	LB/B	-	M7AII8	304	R	W
Q8NGJ2	LB/B	-	L8YBF1	47	V	I
Q8NGJ2	LB/B	-	L8YBF1	89	A	T
Q8NGJ2	LB/B	-	L8YBF1	130	H	R
Q8NGJ2	LB/B	-	L8YBF1	235	G	C
Q8NGJ2	LB/B	-	L8YBF1	242	C	R
Q8NGJ2	LB/B	-	L8YBF1	283	M	T
Q8NGJ2	LB/B	-	L8YBF1	45	V	A
Q8NGK4	LB/B	-	M7AII8	52	Q	R
Q8NGK4	LB/B	-	M7AII8	153	R	W
Q8NGK3	LB/B	-	M7AII8	124	R	C
Q8NGK3	LB/B	-	M7AII8	302	R	C
Q8NGK3	LB/B	-	M7AII8	236	R	H
Q8NGK5	LB/B	-	M7AII8	9	S	L
Q8NGK5	LB/B	-	M7AII8	305	S	R
Q8NGI0	LB/B	-	M7AII8	249	S	A
Q8NGI0	LB/B	-	M7AII8	264	H	R
Q8NGI2	LB/B	-	M7AII8	106	T	I
Q8NGI2	LB/B	-	M7AII8	218	N	I
Q8NGI2	LB/B	-	M7AII8	167	L	R
Q8NGI2	LB/B	-	M7AII8	209	W	G
Q8NH56	LB/B	-	M7AII8	133	V	I
Q6IF63	LB/B	-	M7AII8	239	H	R
Q6IF63	LB/B	-	M7AII8	254	L	Q
Q6IF63	LB/B	-	M7AII8	266	T	A
Q8NH54	LB/B	-	A0A2Y9KTS1	51	M	T
Q8NGI3	LB/B	-	A0A2K6APP0	106	C	R
Q8NH76	LB/B	-	L8YFN7	277	P	S
Q9NZP5	LB/B	-	A0A2R9AS76	200	M	I
Q8NH90	LB/B	-	G5AK70	4	G	V
Q8NH90	LB/B	-	G5AK70	92	M	I
Q8NH90	LB/B	-	G5AK70	43	S	T
Q8NGC0	LB/B	-	A0A2Y9PC23	80	V	M
Q8NGC0	LB/B	-	A0A2Y9PC23	117	L	F
Q8NGC0	LB/B	-	A0A2Y9PC23	299	I	V
Q8NGC0	LB/B	-	A0A2Y9PC23	194	S	L
Q8NGC0	LB/B	-	A0A2Y9PC23	274	N	K
Q96R08	LB/B	-	F6YQW7	141	C	R
Q96R08	LB/B	-	F6YQW7	141	C	Y
Q8NGF7	LB/B	-	M3WWY3	80	L	I
Q8NGF7	LB/B	-	M3WWY3	308	Y	C
A6NL26	LB/B	-	F6YQW7	272	S	Y
Q8NH48	LB/B	-	M3WWY3	30	P	L
Q8NH48	LB/B	-	M3WWY3	35	I	F
Q8NH48	LB/B	-	M3WWY3	49	W	R
Q8NH48	LB/B	-	M3WWY3	170	N	S
Q8NH48	LB/B	-	M3WWY3	181	A	T
Q8NH48	LB/B	-	M3WWY3	198	I	V
Q8NH48	LB/B	-	M3WWY3	247	G	A
Q8NH48	LB/B	-	M3WWY3	296	K	R
Q8NGL4	LB/B	-	A0A091CPK9	62	C	Y
Q8NGL4	LB/B	-	A0A091CPK9	124	R	H
Q8NGL4	LB/B	-	A0A091CPK9	236	R	L
Q8NGL3	LB/B	-	A0A091CPK9	249	S	A
Q8NGL3	LB/B	-	A0A091CPK9	290	L	P
Q8NGK9	LB/B	-	A0A091CPK9	156	A	T
Q8NGL1	LB/B	-	A0A091CPK9	118	V	M
Q8NGL1	LB/B	-	A0A091CPK9	36	Y	C
Q8NGL1	LB/B	-	A0A091CPK9	136	N	D
Q8NGL1	LB/B	-	A0A091CPK9	270	H	R
A6NKK0	LB/B	-	F6YQW7	148	S	T
A6NKK0	LB/B	-	F6YQW7	153	I	L
A6NKK0	LB/B	-	F6YQW7	181	T	I
A6NKK0	LB/B	-	F6YQW7	230	S	T
A6NHG9	LB/B	-	Q8VG51	64	G	R
A6NHG9	LB/B	-	Q8VG51	189	Y	C
A6NDH6	LB/B	-	F6YQW7	108	V	I
A6NDH6	LB/B	-	F6YQW7	148	S	T
A6NDH6	LB/B	-	F6YQW7	167	T	S
Q8NGV7	LB/B	-	A0A2R9AS76	230	I	V
Q8NGV7	LB/B	-	A0A2R9AS76	266	R	C
Q8NGV7	LB/B	-	A0A2R9AS76	286	I	V
Q8NGV6	LB/B	-	A0A2R9AS76	46	A	E
Q8NGV6	LB/B	-	A0A2R9AS76	145	A	P
Q8NGV6	LB/B	-	A0A2R9AS76	179	S	L
Q8NGV6	LB/B	-	A0A2R9AS76	195	C	R
Q8NGV6	LB/B	-	A0A2R9AS76	272	T	A
Q8NGV6	LB/B	-	A0A2R9AS76	285	D	N
Q8NGV6	LB/B	-	A0A2R9AS76	88	S	L
Q8NGV6	LB/B	-	A0A2R9AS76	88	S	W
A6NMS3	LB/B	-	F6YQW7	206	I	V
Q8NGP4	LB/B	-	L5KAE8	84	L	F
Q8NGP4	LB/B	-	L5KAE8	163	G	S
Q8NGP3	LB/B	-	A0A286YEX6	270	K	R
O95007	LB/B	-	M3WVQ8	143	R	C
Q96RD1	LB/B	-	S7MP30	130	C	Y
Q96RD1	LB/B	-	S7MP30	165	H	D
Q96RD1	LB/B	-	S7MP30	222	T	I
Q96RD1	LB/B	-	S7MP30	246	V	I
Q9NZP2	LB/B	-	A0A1S3FII9	181	P	A
Q9NZP2	LB/B	-	A0A1S3FII9	209	L	P
Q9NZP0	LB/B	-	M3YN99	234	A	S
Q9NZP0	LB/B	-	M3YN99	69	S	L
Q9NZP0	LB/B	-	M3YN99	133	M	T
Q8NGE1	LB/B	-	M3YN99	37	I	V
Q8NGE1	LB/B	-	M3YN99	83	M	T
A6NF89	LB/B	-	M3YN99	190	T	I
A6NJZ3	LB/B	-	M3YN99	13	L	Q
A6NJZ3	LB/B	-	M3YN99	222	T	A
A6NIJ9	LB/B	-	M3YN99	181	L	P
A6NIJ9	LB/B	-	M3YN99	233	K	N
A6NCV1	LB/B	-	M3YN99	2	R	G
A6NCV1	LB/B	-	M3YN99	61	L	F
A6NCV1	LB/B	-	M3YN99	75	Y	C
A6NCV1	LB/B	-	M3YN99	86	G	D
A6NCV1	LB/B	-	M3YN99	120	R	C
A6NL08	LB/B	-	M3YN99	141	L	F
A6NL08	LB/B	-	M3YN99	235	A	D
O76100	LB/B	-	M3Z7M9	183	Q	E
O76100	LB/B	-	M3Z7M9	151	M	T
O76100	LB/B	-	M3Z7M9	225	I	L
O76100	LB/B	-	M3Z7M9	273	A	T
O14581	LB/B	-	G1MMG0	37	V	A
O14581	LB/B	-	G1MMG0	46	I	T
O14581	LB/B	-	G1MMG0	69	A	S
O14581	LB/B	-	G1MMG0	237	A	T
O76099	LB/B	-	H2QFL0	126	V	I
O76099	LB/B	-	H2QFL0	210	S	P
O76099	LB/B	-	H2QFL0	99	S	G
O76099	LB/B	-	H2QFL0	171	E	K
O60412	LB/B	-	H2QFL0	118	T	M
O60412	LB/B	-	H2QFL0	122	R	H
Q96RA2	LB/B	-	M3Z7M9	197	T	M
Q8NG98	LB/B	-	M3Z7M9	52	D	G
Q8NG98	LB/B	-	M3Z7M9	75	S	C
Q8NG98	LB/B	-	M3Z7M9	79	P	L
Q8NG98	LB/B	-	M3Z7M9	84	S	N
Q8NG98	LB/B	-	M3Z7M9	88	R	W
Q8NG98	LB/B	-	M3Z7M9	131	H	Q
Q8NG98	LB/B	-	M3Z7M9	133	T	M
Q8NG98	LB/B	-	M3Z7M9	136	M	I
Q8NG98	LB/B	-	M3Z7M9	139	C	R
Q8NG98	LB/B	-	M3Z7M9	139	C	Y
Q8NG98	LB/B	-	M3Z7M9	162	L	P
Q8NG98	LB/B	-	M3Z7M9	279	A	D
Q8NG98	LB/B	-	M3Z7M9	292	L	M
Q8NG98	LB/B	-	M3Z7M9	17	L	F
Q6IFN5	LB/B	-	A0A2Y9IBS0	193	S	F
Q6IFN5	LB/B	-	A0A2Y9IBS0	242	P	S
Q8NGA0	LB/B	-	G5AMN6	141	W	C
Q8NGA0	LB/B	-	G5AMN6	252	Y	C
Q8NGA0	LB/B	-	G5AMN6	83	V	A
Q8NGA0	LB/B	-	G5AMN6	156	A	V
Q8NGA0	LB/B	-	G5AMN6	167	S	F
Q8NG99	LB/B	-	G5AMN6	281	F	V
Q8NG95	LB/B	-	M3Z7M9	29	M	V
Q8NGG7	LB/B	-	G1TS95	218	S	L
Q8NGG7	LB/B	-	G1TS95	133	T	R
Q96RD0	LB/B	-	Q8VG51	27	L	F
Q96RD0	LB/B	-	Q8VG51	164	L	F
Q96RD0	LB/B	-	Q8VG51	20	H	R
Q96RD0	LB/B	-	Q8VG51	273	S	F
Q8NGG8	LB/B	-	Q8VG51	20	H	R
Q8NGG8	LB/B	-	Q8VG51	114	M	I
Q96RC9	LB/B	-	L5KH16	131	Y	H
Q96RC9	LB/B	-	L5KH16	22	E	G
Q96RC9	LB/B	-	L5KH16	140	C	F
Q96RC9	LB/B	-	L5KH16	178	C	R
Q8WZ84	LB/B	-	Q8VG51	194	L	P
Q8WZ84	LB/B	-	Q8VG51	102	F	V
Q8WZ84	LB/B	-	Q8VG51	127	C	W
Q9GZM6	LB/B	-	Q8VG51	122	R	H
Q9GZM6	LB/B	-	Q8VG51	263	P	L
Q8NGM9	LB/B	-	Q8VG51	133	R	K
Q8NGM9	LB/B	-	Q8VG51	200	F	L
Q8NGM9	LB/B	-	Q8VG51	283	L	P
Q8NGM9	LB/B	-	Q8VG51	298	R	K
Q8NGM9	LB/B	-	Q8VG51	55	L	R
Q8NGM9	LB/B	-	Q8VG51	92	I	V
Q8NGM9	LB/B	-	Q8VG51	205	F	S
Q8NGM9	LB/B	-	Q8VG51	120	C	Y
Q15617	LB/B	-	Q8VG51	247	A	V
Q8N0Y5	LB/B	-	G1TS95	124	I	V
Q8N0Y5	LB/B	-	G1TS95	139	K	N
Q8NGG0	LB/B	-	A0A091E323	57	N	T
Q8NGG0	LB/B	-	A0A091E323	87	V	I
Q8NGG0	LB/B	-	A0A091E323	208	V	F
Q8NGG0	LB/B	-	A0A091E323	271	D	E
Q8NGG5	LB/B	-	G1TS95	21	M	V
Q8NGG5	LB/B	-	G1TS95	27	P	T
Q8NGG5	LB/B	-	G1TS95	84	A	T
Q8NH51	LB/B	-	G1TS95	122	L	R
Q8NH51	LB/B	-	G1TS95	173	V	I
Q8NH51	LB/B	-	G1TS95	275	I	M
Q8NH50	LB/B	-	A0A091E323	68	F	S
Q8NH10	LB/B	-	F6YQW7	20	H	R
Q8NH10	LB/B	-	F6YQW7	109	I	V
Q8NH10	LB/B	-	F6YQW7	112	S	C
Q8NH10	LB/B	-	F6YQW7	165	R	C
Q8NH10	LB/B	-	F6YQW7	288	L	V
Q8NH10	LB/B	-	F6YQW7	293	Q	R
Q8NH10	LB/B	-	F6YQW7	137	T	S
Q8NH10	LB/B	-	F6YQW7	206	M	I
Q8NH10	LB/B	-	F6YQW7	206	M	T
Q13415	LB/B	-	A0A093CQ73	19	R	S
Q13415	LB/B	-	A0A093CQ73	180	Q	H
Q13415	LB/B	-	A0A093CQ73	190	V	M
Q13415	LB/B	-	A0A093CQ73	372	A	V
Q13415	LB/B	-	A0A093CQ73	441	R	M
Q13415	LB/B	-	A0A093CQ73	456	K	E
Q13415	LB/B	-	A0A093CQ73	466	T	M
Q13415	LB/B	-	A0A093CQ73	469	C	Y
Q13415	LB/B	-	A0A093CQ73	816	M	T
Q13415	LP/P	Meier-Gorlin syndrome 1 (MGORS1) [MIM:224690]	A0A093CQ73	89	F	S
Q13415	LP/P	Meier-Gorlin syndrome 1 (MGORS1) [MIM:224690]	A0A093CQ73	105	R	Q
Q13415	LP/P	Meier-Gorlin syndrome 1 (MGORS1) [MIM:224690]	A0A093CQ73	127	E	G
Q13415	LP/P	Meier-Gorlin syndrome 1 (MGORS1) [MIM:224690]	A0A093CQ73	666	R	W
Q13415	LP/P	Meier-Gorlin syndrome 1 (MGORS1) [MIM:224690]	A0A093CQ73	720	R	Q
Q13416	LB/B	-	A0A210QDX7	106	M	K
Q13416	LB/B	-	A0A210QDX7	521	R	Q
Q9UBD5	LB/B	-	A0A1S3I245	94	Q	K
Q9UBD5	LB/B	-	A0A1S3I245	126	Q	R
Q9UBD5	LB/B	-	A0A1S3I245	217	V	I
Q9UBD5	LB/B	-	A0A1S3I245	247	I	V
Q9UBD5	LB/B	-	A0A1S3I245	287	T	M
Q9UBD5	LB/B	-	A0A1S3I245	389	T	P
Q9UBD5	LB/B	-	A0A1S3I245	588	R	C
Q9UBD5	LB/B	-	A0A1S3I245	626	A	T
O43929	LB/B	-	H3CCT0	56	L	V
O43929	LB/B	-	H3CCT0	78	N	S
O43929	LP/P	Meier-Gorlin syndrome 2 (MGORS2) [MIM:613800]	H3CCT0	174	Y	C
Q9Y5N6	LB/B	-	A0A226NJ70	32	R	W
Q9Y5N6	LB/B	-	A0A226NJ70	138	P	Q
Q9Y5N6	LP/P	Meier-Gorlin syndrome 3 (MGORS3) [MIM:613803]	A0A226NJ70	232	Y	S
P02763	LB/B	-	B9EIY6	38	R	Q
P02763	LB/B	-	B9EIY6	174	V	M
P02763	LB/B	-	B9EIY6	167	R	C
P19652	LB/B	-	B9EIY6	38	R	Q
P19652	LB/B	-	B9EIY6	99	V	A
P19652	LB/B	-	B9EIY6	141	G	R
P19652	LB/B	-	B9EIY6	167	C	R
P19652	LB/B	-	B9EIY6	174	M	V
Q13438	LB/B	-	H2U776	398	R	W
Q13438	LB/B	-	H2U776	454	S	L
Q13438	LB/B	-	H2U776	305	D	N
Q969R2	LB/B	-	A0A2I2U3G6	760	M	V
Q9BXW6	LB/B	-	T2M5M8	810	S	P
Q9H4L5	LB/B	-	W5N174	354	M	V
Q9H0X9	LB/B	-	A0A1V4JNN6	774	A	T
Q9H0X9	LB/B	-	A0A1V4JNN6	90	T	I
Q9BZF3	LB/B	-	W5N174	58	P	L
Q9BZF3	LB/B	-	W5N174	53	R	Q
Q9BZF2	LB/B	-	A0A218UCH3	156	T	I
Q9BZF2	LB/B	-	A0A218UCH3	148	M	I
Q9BZF2	LB/B	-	A0A218UCH3	169	A	E
Q8IYS5	LB/B	-	E1B8Y2	97	I	S
Q8IYS5	LB/B	-	E1B8Y2	229	S	Y
Q8WVF1	LB/B	-	G5C6G3	31	P	R
Q8WVF1	LB/B	-	G5C6G3	242	K	E
Q8WVF1	LB/B	-	G5C6G3	141	T	A
Q9NX31	LB/B	-	S9WCT7	74	V	G
Q9NPF4	LP/P	Galloway-Mowat syndrome 3 (GAMOS3) [MIM:617729]	A0A2R7W870	14	I	F
Q9NPF4	LP/P	Galloway-Mowat syndrome 3 (GAMOS3) [MIM:617729]	A0A2R7W870	78	K	E
Q9NPF4	LP/P	Galloway-Mowat syndrome 3 (GAMOS3) [MIM:617729]	A0A2R7W870	107	V	M
Q9NPF4	LP/P	Galloway-Mowat syndrome 3 (GAMOS3) [MIM:617729]	A0A2R7W870	110	C	R
Q9NPF4	LP/P	Galloway-Mowat syndrome 3 (GAMOS3) [MIM:617729]	A0A2R7W870	111	I	T
Q9NPF4	LP/P	Galloway-Mowat syndrome 3 (GAMOS3) [MIM:617729]	A0A2R7W870	139	I	T
Q9NPF4	LP/P	Galloway-Mowat syndrome 3 (GAMOS3) [MIM:617729]	A0A2R7W870	177	G	A
Q9NPF4	LP/P	Galloway-Mowat syndrome 3 (GAMOS3) [MIM:617729]	A0A2R7W870	198	K	R
Q9NPF4	LP/P	Galloway-Mowat syndrome 3 (GAMOS3) [MIM:617729]	A0A2R7W870	247	R	Q
Q9NPF4	LP/P	Galloway-Mowat syndrome 3 (GAMOS3) [MIM:617729]	A0A2R7W870	280	R	C
Q9NPF4	LP/P	Galloway-Mowat syndrome 3 (GAMOS3) [MIM:617729]	A0A2R7W870	280	R	H
Q9NPF4	LP/P	Galloway-Mowat syndrome 3 (GAMOS3) [MIM:617729]	A0A2R7W870	280	R	L
Q9NPF4	LP/P	Galloway-Mowat syndrome 3 (GAMOS3) [MIM:617729]	A0A2R7W870	325	R	Q
Q9NPF4	LP/P	Galloway-Mowat syndrome 3 (GAMOS3) [MIM:617729]	A0A2R7W870	325	R	W
Q9H4B0	LB/B	-	Q6AYN7	229	A	P
P13725	LB/B	-	M3YP54	9	T	M
Q99650	LB/B	-	S7PLA2	210	G	W
Q99650	LB/B	-	S7PLA2	527	E	K
Q99650	LB/B	-	S7PLA2	553	D	N
Q99650	LB/B	-	S7PLA2	936	P	S
Q99650	LB/B	-	S7PLA2	187	H	Q
Q99650	LP/P	Amyloidosis, primary localized cutaneous, 1 (PLCA1) [MIM:105250]	S7PLA2	618	G	A
Q99650	LP/P	Amyloidosis, primary localized cutaneous, 1 (PLCA1) [MIM:105250]	S7PLA2	691	I	T
Q99650	LB/B	-	S7PLA2	959	P	R
Q99650	LP/P	Amyloidosis, primary localized cutaneous, 1 (PLCA1) [MIM:105250]	S7PLA2	647	D	V
Q99650	LP/P	Amyloidosis, primary localized cutaneous, 1 (PLCA1) [MIM:105250]	S7PLA2	694	P	L
Q99650	LP/P	Amyloidosis, primary localized cutaneous, 1 (PLCA1) [MIM:105250]	S7PLA2	697	K	T
Q92882	LB/B	-	S7PF11	159	L	F
Q92882	LB/B	-	S7PF11	48	N	S
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	26	R	Q
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	39	G	C
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	40	R	C
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	40	R	H
P00480	LB/B	-	F6ZKS9	43	L	F
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	44	T	I
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	45	L	P
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	45	L	V
P00480	LB/B	-	F6ZKS9	46	K	R
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	47	N	I
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	50	G	R
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	55	Y	D
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	56	M	T
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	60	S	L
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	63	L	P
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	79	G	E
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	83	G	D
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	83	G	R
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	87	E	K
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	88	K	N
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	90	S	R
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	92	R	Q
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	93	T	A
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	94	R	T
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	100	G	D
P00480	LB/B	-	F6ZKS9	101	F	L
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	102	A	E
P00480	LB/B	-	F6ZKS9	111	L	P
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	117	H	L
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	117	H	R
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	125	T	M
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	126	D	G
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	129	R	H
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	139	L	S
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	141	R	P
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	141	R	Q
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	148	L	F
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	159	I	T
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	161	N	S
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	162	G	R
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	168	H	Q
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	168	H	R
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	172	I	M
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	174	A	P
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	175	D	V
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	176	Y	C
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	178	T	M
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	180	Q	H
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	181	E	G
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	182	H	L
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	183	Y	C
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	183	Y	D
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	188	G	R
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	192	S	R
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	195	G	R
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	196	D	V
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	196	D	Y
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	197	G	E
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	201	L	P
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	202	H	Y
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	203	S	C
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	206	M	R
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	207	S	R
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	208	A	T
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	209	A	V
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	213	M	K
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	216	Q	E
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	220	P	A
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	225	P	L
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	225	P	R
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	225	P	T
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	242	T	I
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	244	L	Q
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	247	T	K
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	255	H	P
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	263	D	G
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	263	D	N
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	264	T	A
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	264	T	I
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	267	S	R
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	268	M	T
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	269	G	E
P00480	LB/B	-	F6ZKS9	270	Q	R
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	277	R	Q
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	277	R	W
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	302	H	L
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	302	H	Q
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	302	H	Y
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	303	C	R
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	303	C	Y
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	304	L	F
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	320	R	L
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	330	R	G
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	336	A	S
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	337	V	L
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	339	V	L
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	340	S	P
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	343	T	K
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	345	Y	C
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	345	Y	D
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	354	F	C
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	172	I	F
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	188	G	V
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	197	G	R
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	140	A	P
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	198	N	K
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	214	H	Y
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	262	T	K
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	265	W	L
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	326	E	K
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	160	I	S
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	191	L	F
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	206	M	I
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	301	L	F
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	305	P	H
P00480	LB/B	-	F6ZKS9	333	T	A
P00480	LP/P	Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]	F6ZKS9	341	L	P
Q6ZRI0	LB/B	-	A0A099Z6D8	375	T	S
Q6ZRI0	LB/B	-	A0A099Z6D8	659	T	M
Q6ZRI0	LB/B	-	A0A099Z6D8	692	S	P
Q6ZRI0	LB/B	-	A0A099Z6D8	919	A	T
Q6ZRI0	LB/B	-	A0A099Z6D8	1075	R	Q
Q6ZRI0	LB/B	-	A0A099Z6D8	1112	A	V
Q6ZRI0	LB/B	-	A0A099Z6D8	1129	P	L
Q6ZRI0	LB/B	-	A0A099Z6D8	1399	A	G
Q6ZRI0	LB/B	-	A0A099Z6D8	1646	P	L
Q6ZRI0	LB/B	-	A0A099Z6D8	1832	A	V
Q6ZRI0	LB/B	-	A0A099Z6D8	1947	T	M
Q6ZRI0	LB/B	-	A0A099Z6D8	2750	R	Q
Q6ZRI0	LB/B	-	A0A099Z6D8	2909	W	S
Q6ZRI0	LB/B	-	A0A099Z6D8	2006	A	V
Q6ZRI0	LB/B	-	A0A099Z6D8	391	A	D
Q6ZRI0	LP/P	Deafness, autosomal recessive, 18B (DFNB18B) [MIM:614945]	A0A099Z6D8	2116	P	L
Q6ZRI0	LB/B	-	A0A099Z6D8	1089	I	V
Q3ZCN5	LB/B	-	F7FIY8	1387	C	R
A6NHN0	LB/B	-	A0A1A8APF9	470	E	A
Q7RTM1	LB/B	-	A0A1L8HTB1	241	I	V
Q7RTM1	LB/B	-	A0A1L8HTB1	309	D	E
Q7RTM1	LB/B	-	A0A1L8HTB1	434	V	M
Q7RTM1	LB/B	-	A0A1L8HTB1	493	K	T
Q7RTM1	LB/B	-	A0A1L8HTB1	516	Q	H
Q9NRC9	LB/B	-	A0A091WJB9	31	L	P
Q01804	LB/B	-	V8P067	194	A	G
Q01804	LB/B	-	V8P067	216	A	T
Q01804	LB/B	-	V8P067	398	G	V
Q8N6M0	LB/B	-	J9NW98	283	R	Q
Q96BN8	LB/B	-	H0ZAP5	227	S	N
Q96BN8	LB/B	-	H0ZAP5	155	M	L
Q96BN8	LB/B	-	H0ZAP5	311	N	S
Q96BN8	LP/P	Autoinflammation, panniculitis, and dermatosis syndrome (AIPDS) [MIM:617099]	H0ZAP5	244	Y	C
Q96BN8	LP/P	Immunodeficiency 107, susceptibility to invasive Staphylococcus aureus infection (IMD107) [MIM:619986]	H0ZAP5	244	Y	C
Q96BN8	LP/P	Autoinflammation, panniculitis, and dermatosis syndrome (AIPDS) [MIM:617099]	H0ZAP5	272	L	P
Q96BN8	LP/P	Immunodeficiency 107, susceptibility to invasive Staphylococcus aureus infection (IMD107) [MIM:619986]	H0ZAP5	272	L	P
Q96BN8	LP/P	Autoinflammation, panniculitis, and dermatosis syndrome (AIPDS) [MIM:617099]	H0ZAP5	86	M	I
Q96BN8	LB/B	-	H0ZAP5	115	Q	H
Q96BN8	LP/P	Autoinflammation, panniculitis, and dermatosis syndrome (AIPDS) [MIM:617099]	H0ZAP5	167	W	S
Q96BN8	LP/P	Immunodeficiency 107, susceptibility to invasive Staphylococcus aureus infection (IMD107) [MIM:619986]	H0ZAP5	246	D	V
Q96BN8	LP/P	Immunodeficiency 107, susceptibility to invasive Staphylococcus aureus infection (IMD107) [MIM:619986]	H0ZAP5	263	R	Q
Q9NUU6	LB/B	-	F1PSU1	319	F	L
Q7RTY7	LB/B	-	A0A2K6U3B5	133	R	C
Q7RTY7	LB/B	-	A0A2K6U3B5	228	W	G
Q7RTY7	LB/B	-	A0A2K6U3B5	330	K	E
Q7RTY7	LB/B	-	A0A2K6U3B5	444	I	T
Q7RTY7	LB/B	-	A0A2K6U3B5	672	S	F
Q7RTY7	LB/B	-	A0A2K6U3B5	754	G	R
Q7RTY7	LB/B	-	A0A2K6U3B5	881	P	A
Q7RTY7	LB/B	-	A0A2K6U3B5	934	P	S
Q7RTY7	LB/B	-	A0A2K6U3B5	557	L	V
Q7RTZ1	LB/B	-	W5Q1W6	19	R	Q
Q7RTZ1	LB/B	-	W5Q1W6	292	P	S
Q7RTZ1	LB/B	-	W5Q1W6	381	G	E
Q7RTZ1	LB/B	-	W5Q1W6	410	N	T
Q7RTZ1	LB/B	-	W5Q1W6	413	R	G
Q7RTZ1	LB/B	-	W5Q1W6	526	H	Q
Q7RTZ1	LB/B	-	W5Q1W6	539	T	I
Q7RTZ1	LB/B	-	W5Q1W6	410	N	Y
Q7RTZ1	LB/B	-	W5Q1W6	24	T	A
Q12889	LB/B	-	A0A1U7UP84	676	E	Q
Q12889	LB/B	-	A0A1U7UP84	477	M	T
Q12889	LB/B	-	A0A1U7UP84	604	H	Q
Q12889	LB/B	-	A0A1U7UP84	332	D	E
Q12889	LB/B	-	A0A1U7UP84	479	M	V
Q12889	LB/B	-	A0A1U7UP84	514	Y	H
Q12889	LB/B	-	A0A1U7UP84	536	S	G
Q12889	LB/B	-	A0A1U7UP84	526	P	S
Q15070	LB/B	-	Q3U3X8	44	V	A
Q15070	LB/B	-	Q3U3X8	91	V	I
P55809	LB/B	-	S7PYY2	58	T	M
P55809	LP/P	Succinyl-CoA:3-oxoacid CoA transferase deficiency (SCOTD) [MIM:245050]	S7PYY2	133	V	E
P55809	LP/P	Succinyl-CoA:3-oxoacid CoA transferase deficiency (SCOTD) [MIM:245050]	S7PYY2	456	C	F
P55809	LP/P	Succinyl-CoA:3-oxoacid CoA transferase deficiency (SCOTD) [MIM:245050]	S7PYY2	219	G	E
P55809	LP/P	Succinyl-CoA:3-oxoacid CoA transferase deficiency (SCOTD) [MIM:245050]	S7PYY2	221	V	M
P55809	LP/P	Succinyl-CoA:3-oxoacid CoA transferase deficiency (SCOTD) [MIM:245050]	S7PYY2	324	G	E
P55809	LP/P	Succinyl-CoA:3-oxoacid CoA transferase deficiency (SCOTD) [MIM:245050]	S7PYY2	215	A	V
P55809	LP/P	Succinyl-CoA:3-oxoacid CoA transferase deficiency (SCOTD) [MIM:245050]	S7PYY2	226	S	N
P55809	LP/P	Succinyl-CoA:3-oxoacid CoA transferase deficiency (SCOTD) [MIM:245050]	S7PYY2	327	L	P
P55809	LP/P	Succinyl-CoA:3-oxoacid CoA transferase deficiency (SCOTD) [MIM:245050]	S7PYY2	404	V	F
P55809	LP/P	Succinyl-CoA:3-oxoacid CoA transferase deficiency (SCOTD) [MIM:245050]	S7PYY2	405	S	P
P55809	LP/P	Succinyl-CoA:3-oxoacid CoA transferase deficiency (SCOTD) [MIM:245050]	S7PYY2	468	R	C
Q9BYC2	LB/B	-	A0A2I3M0Y9	250	E	D
Q9BYC2	LB/B	-	A0A2I3M0Y9	285	L	R
Q8TDS5	LB/B	-	A0A2Y9D7Y2	407	L	V
Q8TDS5	LB/B	-	A0A2Y9D7Y2	316	M	L
Q96HP4	LB/B	-	A0A0D9RCD7	59	R	Q
Q96HP4	LB/B	-	A0A0D9RCD7	64	S	A
Q96HP4	LB/B	-	A0A0D9RCD7	82	R	C
Q8N573	LB/B	-	S4RDD4	100	E	G
Q8N573	LB/B	-	S4RDD4	360	Q	P
Q8N573	LB/B	-	S4RDD4	516	K	R
O95747	LB/B	-	W8AZ88	304	T	I
O95747	LB/B	-	W8AZ88	425	S	T
P30559	LB/B	-	W5MXC6	16	A	S
P30559	LB/B	-	W5MXC6	218	A	T
P51575	LB/B	-	A0A091PEC9	396	M	V
Q9UBL9	LP/P	Deafness, autosomal dominant, 41 (DFNA41) [MIM:608224]	A0A2U3YPZ4	60	V	L
Q9UBL9	LP/P	Deafness, autosomal dominant, 41 (DFNA41) [MIM:608224]	A0A2U3YPZ4	353	G	R
O15547	LB/B	-	A0A091PEC9	242	R	H
O15547	LB/B	-	A0A091PEC9	38	V	G
Q99572	LB/B	-	A0A096NC25	270	R	H
Q99572	LB/B	-	A0A096NC25	155	Y	H
Q99572	LB/B	-	A0A096NC25	357	T	S
Q99572	LB/B	-	A0A096NC25	460	Q	R
Q99572	LB/B	-	A0A096NC25	496	E	A
Q99572	LB/B	-	A0A096NC25	76	V	A
Q99572	LB/B	-	A0A096NC25	150	G	R
Q99572	LB/B	-	A0A096NC25	270	R	C
Q99572	LB/B	-	A0A096NC25	276	R	H
Q99572	LB/B	-	A0A096NC25	307	R	Q
Q99572	LB/B	-	A0A096NC25	348	A	T
Q99572	LB/B	-	A0A096NC25	430	P	R
Q99572	LB/B	-	A0A096NC25	433	A	V
Q99572	LB/B	-	A0A096NC25	521	H	Q
Q99572	LB/B	-	A0A096NC25	522	V	I
Q99572	LB/B	-	A0A096NC25	578	R	Q
Q99572	LB/B	-	A0A096NC25	568	I	N
Q99572	LB/B	-	A0A096NC25	117	R	W
Q99572	LB/B	-	A0A096NC25	125	R	L
Q99572	LB/B	-	A0A096NC25	148	Q	R
Q99572	LB/B	-	A0A096NC25	205	T	M
Q99572	LB/B	-	A0A096NC25	264	R	H
Q99572	LB/B	-	A0A096NC25	288	Y	H
Q99572	LB/B	-	A0A096NC25	361	N	S
Q99572	LB/B	-	A0A096NC25	535	A	V
Q99572	LB/B	-	A0A096NC25	544	R	Q
O00398	LB/B	-	H9G4C0	3	N	H
Q96G91	LB/B	-	A0A2Y9L9D4	87	A	T
Q9H244	LP/P	Bleeding disorder, platelet-type, 8 (BDPLT8) [MIM:609821]	A0A2F0BIQ5	256	R	Q
Q9H244	LP/P	Bleeding disorder, platelet-type, 8 (BDPLT8) [MIM:609821]	A0A2F0BIQ5	265	R	W
Q9H244	LB/B	-	A0A2F0BIQ5	330	E	G
Q9H244	LP/P	Bleeding disorder, platelet-type, 8 (BDPLT8) [MIM:609821]	A0A2F0BIQ5	187	H	Q
Q9BPV8	LB/B	-	F7DD20	179	T	M
Q32P28	LB/B	-	A0A287A6G5	349	G	R
Q32P28	LB/B	-	A0A287A6G5	506	P	R
Q32P28	LB/B	-	A0A287A6G5	549	M	I
Q32P28	LB/B	-	A0A287A6G5	644	Q	K
Q8IVL5	LP/P	Myopia, high, with cataract and vitreoretinal degeneration (MCVD) [MIM:614292]	G3PAK4	508	G	V
Q92791	LB/B	-	H9GK74	186	Q	R
O15460	LP/P	Myopia 25, autosomal dominant (MYP25) [MIM:617238]	A0A2I0TMH6	140	Q	R
O15460	LP/P	Myopia 25, autosomal dominant (MYP25) [MIM:617238]	A0A2I0TMH6	291	E	K
Q7Z4N8	LB/B	-	A0A1Q3FP39	400	D	N
P07237	LP/P	Cole-Carpenter syndrome 1 (CLCRP1) [MIM:112240]	G7PT54	393	Y	C
Q9NXG6	LP/P	Hypotonia, hyperventilation, impaired intellectual development, dysautonomia, epilepsy, and eye abnormalities (HIDEA) [MIM:618493]	A0A2Y9D6P8	161	H	P
Q9BRP4	LB/B	-	A0A2K6SSN7	53	A	V
Q9BRP4	LB/B	-	A0A2K6SSN7	209	A	G
Q9BRP4	LB/B	-	A0A2K6SSN7	139	C	S
Q4VXU2	LB/B	-	A0A2K6KFV2	212	S	A
Q4VXU2	LB/B	-	A0A2K6KFV2	492	S	G
Q13310	LB/B	-	A0A2K6AE68	382	Y	F
Q96DU9	LB/B	-	A0A2Y9G7R1	314	N	S
Q6VY07	LB/B	-	A0A2K6AQ36	302	F	L
Q6VY07	LP/P	Schuurs-Hoeijmakers syndrome (SHMS) [MIM:615009]	A0A2K6AQ36	203	R	W
Q9BY11	LB/B	-	W5MUY1	334	A	V
Q9UNF0	LB/B	-	W5MUY1	294	M	I
Q9UNF0	LB/B	-	W5MUY1	324	V	F
Q9UNF0	LB/B	-	W5MUY1	175	N	S
Q9UKS6	LB/B	-	W5MUY1	61	A	V
Q9ULC6	LB/B	-	A0A093Q481	649	V	M
Q9ULW8	LB/B	-	A0A093Q481	52	I	V
Q9ULW8	LB/B	-	A0A093Q481	171	V	M
Q9ULW8	LB/B	-	A0A093Q481	582	A	T
Q9ULW8	LB/B	-	A0A093Q481	618	R	Q
Q9ULW8	LP/P	Uncombable hair syndrome 1 (UHS1) [MIM:191480]	A0A093Q481	112	L	H
Q9ULW8	LP/P	Uncombable hair syndrome 1 (UHS1) [MIM:191480]	A0A093Q481	294	A	V
Q9ULW8	LP/P	Uncombable hair syndrome 1 (UHS1) [MIM:191480]	A0A093Q481	605	P	T
Q9UM07	LB/B	-	A0A093Q481	55	G	S
Q9UM07	LB/B	-	A0A093Q481	82	V	A
Q9UM07	LB/B	-	A0A093Q481	112	G	A
Q9UM07	LB/B	-	A0A093Q481	275	S	F
Q9UM07	LB/B	-	A0A093Q481	89	D	N
Q9UM07	LB/B	-	A0A093Q481	102	P	T
Q9UM07	LB/B	-	A0A093Q481	131	R	T
Q9UM07	LB/B	-	A0A093Q481	164	M	T
Q9UM07	LB/B	-	A0A093Q481	8	R	H
Q9UM07	LB/B	-	A0A093Q481	79	T	M
Q9UM07	LB/B	-	A0A093Q481	260	D	N
Q6TGC4	LP/P	Preimplantation embryonic lethality 2 (PREMBL2) [MIM:617234]	A0A093Q481	211	H	Q
Q6TGC4	LP/P	Preimplantation embryonic lethality 2 (PREMBL2) [MIM:617234]	A0A093Q481	540	G	R
P09466	LB/B	-	A0A2R9AM86	126	Q	K
P09466	LB/B	-	A0A2R9AM86	28	L	V
Q15102	LB/B	-	S9YW38	214	R	G
Q7Z2X7	LB/B	-	A0A2K5I426	5	L	V
Q5JUK9	LB/B	-	M3WNW6	35	N	D
Q5JUK9	LB/B	-	M3WNW6	53	G	S
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	16	S	P
P00439	LP/P	Hyperphenylalaninemia (HPA) [MIM:261600]	F6XY00	39	F	L
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	39	F	L
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	40	S	L
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	41	L	F
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	42	K	I
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	46	G	S
P00439	LP/P	Non-phenylketonuria hyperphenylalaninemia (Non-PKU HPA) [MIM:261600]	F6XY00	47	A	V
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	48	L	S
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	53	R	H
P00439	LP/P	Hyperphenylalaninemia (HPA) [MIM:261600]	F6XY00	55	F	L
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	55	F	L
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	56	E	D
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	65	I	N
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	65	I	T
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	67	S	P
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	68	R	S
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	76	E	A
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	84	D	Y
P00439	LP/P	Non-phenylketonuria hyperphenylalaninemia (Non-PKU HPA) [MIM:261600]	F6XY00	87	S	R
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	92	T	I
P00439	LP/P	Non-phenylketonuria hyperphenylalaninemia (Non-PKU HPA) [MIM:261600]	F6XY00	98	L	S
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	104	A	D
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	124	T	I
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	129	D	Y
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	143	D	G
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	146	H	Y
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	148	G	S
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	151	D	H
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	154	Y	N
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	157	R	N
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	158	R	Q
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	158	R	W
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	160	Q	P
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	161	F	S
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	164	I	T
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	167	N	I
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	170	H	R
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	171	G	A
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	171	G	R
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	173	P	T
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	174	I	T
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	175	P	A
P00439	LP/P	Non-phenylketonuria hyperphenylalaninemia (Non-PKU HPA) [MIM:261600]	F6XY00	176	R	L
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	176	R	P
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	177	V	L
P00439	LP/P	Non-phenylketonuria hyperphenylalaninemia (Non-PKU HPA) [MIM:261600]	F6XY00	178	E	G
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	190	V	A
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	194	L	P
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	201	H	R
P00439	LP/P	Non-phenylketonuria hyperphenylalaninemia (Non-PKU HPA) [MIM:261600]	F6XY00	201	H	Y
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	204	Y	C
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	206	Y	D
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	207	N	D
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	207	N	S
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	211	P	T
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	212	L	P
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	213	L	P
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	217	C	G
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	218	G	V
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	221	E	G
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	222	D	V
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	224	I	M
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	225	P	R
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	225	P	T
P00439	LP/P	Non-phenylketonuria hyperphenylalaninemia (Non-PKU HPA) [MIM:261600]	F6XY00	230	V	I
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	231	S	P
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	233	F	L
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	238	T	P
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	239	G	S
P00439	LP/P	Non-phenylketonuria hyperphenylalaninemia (Non-PKU HPA) [MIM:261600]	F6XY00	241	R	C
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	241	R	C
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	241	R	H
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	241	R	L
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	242	L	F
P00439	LP/P	Non-phenylketonuria hyperphenylalaninemia (Non-PKU HPA) [MIM:261600]	F6XY00	243	R	Q
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	243	R	Q
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	244	P	L
P00439	LP/P	Hyperphenylalaninemia (HPA) [MIM:261600]	F6XY00	245	V	A
P00439	LP/P	Non-phenylketonuria hyperphenylalaninemia (Non-PKU HPA) [MIM:261600]	F6XY00	245	V	A
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	245	V	A
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	245	V	E
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	245	V	L
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	246	A	D
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	247	G	V
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	248	L	P
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	249	L	F
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	252	R	G
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	252	R	Q
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	252	R	W
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	255	L	V
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	255	L	S
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	257	G	C
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	259	A	T
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	259	A	V
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	261	R	P
P00439	LP/P	Hyperphenylalaninemia (HPA) [MIM:261600]	F6XY00	261	R	Q
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	261	R	Q
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	263	F	L
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	264	H	L
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	265	C	G
P00439	LP/P	Non-phenylketonuria hyperphenylalaninemia (Non-PKU HPA) [MIM:261600]	F6XY00	269	I	L
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	270	R	K
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	270	R	S
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	271	H	Y
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	273	S	F
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	276	M	I
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	276	M	V
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	277	Y	C
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	277	Y	D
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	278	T	A
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	278	T	N
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	280	E	K
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	281	P	L
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	282	D	N
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	283	I	F
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	283	I	N
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	297	R	C
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	297	R	H
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	299	F	C
P00439	LP/P	Hyperphenylalaninemia (HPA) [MIM:261600]	F6XY00	300	A	S
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	300	A	S
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	300	A	V
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	303	S	P
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	304	Q	R
P00439	LP/P	Non-phenylketonuria hyperphenylalaninemia (Non-PKU HPA) [MIM:261600]	F6XY00	306	I	V
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	309	A	D
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	309	A	V
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	310	S	F
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	311	L	P
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	314	P	H
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	322	A	G
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	322	A	T
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	331	F	L
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	333	L	F
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	334	C	S
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	337	G	V
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	338	D	Y
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	341	K	R
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	341	K	T
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	342	A	T
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	343	Y	C
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	345	A	S
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	345	A	T
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	347	L	F
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	348	L	V
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	349	S	L
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	349	S	P
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	350	S	T
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	362	P	T
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	366	P	H
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	372	T	S
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	377	Y	C
P00439	LP/P	Non-phenylketonuria hyperphenylalaninemia (Non-PKU HPA) [MIM:261600]	F6XY00	380	T	M
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	386	Y	C
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	387	Y	H
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	388	V	L
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	388	V	M
P00439	LP/P	Non-phenylketonuria hyperphenylalaninemia (Non-PKU HPA) [MIM:261600]	F6XY00	390	E	G
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	390	E	G
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	394	D	A
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	394	D	H
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	395	A	G
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	395	A	P
P00439	LP/P	Non-phenylketonuria hyperphenylalaninemia (Non-PKU HPA) [MIM:261600]	F6XY00	403	A	V
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	403	A	V
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	408	R	Q
P00439	LP/P	Hyperphenylalaninemia (HPA) [MIM:261600]	F6XY00	408	R	W
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	408	R	W
P00439	LP/P	Non-phenylketonuria hyperphenylalaninemia (Non-PKU HPA) [MIM:261600]	F6XY00	413	R	P
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	413	R	P
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	413	R	S
P00439	LP/P	Hyperphenylalaninemia (HPA) [MIM:261600]	F6XY00	414	Y	C
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	414	Y	C
P00439	LP/P	Hyperphenylalaninemia (HPA) [MIM:261600]	F6XY00	415	D	N
P00439	LP/P	Non-phenylketonuria hyperphenylalaninemia (Non-PKU HPA) [MIM:261600]	F6XY00	415	D	N
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	415	D	N
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	418	T	P
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	430	L	P
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	447	A	D
P00439	LP/P	Hyperphenylalaninemia (HPA) [MIM:261600]	F6XY00	20	Q	L
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	41	L	P
P00439	LP/P	Hyperphenylalaninemia (HPA) [MIM:261600]	F6XY00	110	S	C
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	155	R	P
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	183	E	Q
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	231	S	F
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	325	Y	C
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	330	E	D
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	344	G	R
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	344	G	V
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	410	F	S
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	145	D	V
P00439	LP/P	Hyperphenylalaninemia (HPA) [MIM:261600]	F6XY00	167	N	S
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	169	R	H
P00439	LP/P	Hyperphenylalaninemia (HPA) [MIM:261600]	F6XY00	170	H	D
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	174	I	V
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	205	E	A
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	240	F	S
P00439	LB/B	-	F6XY00	274	K	E
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	318	I	T
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	357	C	G
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	407	P	S
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	290	H	Y
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	322	A	V
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	421	I	S
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	45	V	A
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	61	N	D
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	62	L	P
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	65	I	S
P00439	LP/P	Hyperphenylalaninemia (HPA) [MIM:261600]	F6XY00	65	I	V
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	65	I	V
P00439	LP/P	Non-phenylketonuria hyperphenylalaninemia (Non-PKU HPA) [MIM:261600]	F6XY00	76	E	G
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	157	R	S
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	170	H	Q
P00439	LP/P	Hyperphenylalaninemia (HPA) [MIM:261600]	F6XY00	177	V	M
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	226	Q	H
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	275	P	L
P00439	LP/P	Hyperphenylalaninemia (HPA) [MIM:261600]	F6XY00	310	S	Y
P00439	LP/P	Hyperphenylalaninemia (HPA) [MIM:261600]	F6XY00	314	P	S
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	407	P	L
P00439	LP/P	Phenylketonuria (PKU) [MIM:261600]	F6XY00	417	Y	H
P00439	LP/P	Hyperphenylalaninemia (HPA) [MIM:261600]	F6XY00	121	F	L
P00439	LP/P	Hyperphenylalaninemia (HPA) [MIM:261600]	F6XY00	196	S	Y
P22234	LB/B	-	M7AQM2	201	K	N
O96013	LB/B	-	A0A151MGV3	135	R	Q
O96013	LB/B	-	A0A151MGV3	139	A	T
Q9P286	LB/B	-	V5HV49	511	S	N
Q9P286	LB/B	-	V5HV49	118	G	D
Q9P286	LB/B	-	V5HV49	187	P	A
Q9P286	LB/B	-	V5HV49	335	R	P
Q9P286	LB/B	-	V5HV49	555	A	S
Q9NQU5	LB/B	-	A0A226MLU1	76	M	V
Q9NQU5	LB/B	-	A0A226MLU1	215	H	R
Q9NQU5	LB/B	-	A0A226MLU1	337	P	L
Q9NQU5	LB/B	-	A0A226MLU1	184	E	K
Q9NQU5	LB/B	-	A0A226MLU1	205	G	E
Q9NQU5	LB/B	-	A0A226MLU1	208	P	T
Q9NQU5	LB/B	-	A0A226MLU1	210	T	M
Q9NQU5	LB/B	-	A0A226MLU1	376	A	V
Q9NQU5	LB/B	-	A0A226MLU1	103	R	C
Q9NQU5	LB/B	-	A0A226MLU1	151	T	I
Q9NQU5	LB/B	-	A0A226MLU1	475	E	K
Q86YC2	LB/B	-	G3VMC4	309	I	V
Q86YC2	LB/B	-	G3VMC4	864	P	S
Q86YC2	LB/B	-	G3VMC4	46	H	Y
Q86YC2	LB/B	-	G3VMC4	219	D	G
Q86YC2	LB/B	-	G3VMC4	334	Y	C
Q86YC2	LB/B	-	G3VMC4	337	L	S
Q86YC2	LB/B	-	G3VMC4	414	R	Q
Q86YC2	LB/B	-	G3VMC4	425	V	M
Q86YC2	LB/B	-	G3VMC4	491	A	T
Q86YC2	LB/B	-	G3VMC4	515	K	R
Q86YC2	LB/B	-	G3VMC4	559	Q	R
Q86YC2	LB/B	-	G3VMC4	672	E	Q
Q86YC2	LB/B	-	G3VMC4	712	A	V
Q86YC2	LB/B	-	G3VMC4	728	F	L
Q86YC2	LB/B	-	G3VMC4	917	V	A
Q86YC2	LB/B	-	G3VMC4	932	V	M
Q86YC2	LB/B	-	G3VMC4	939	L	W
Q86YC2	LB/B	-	G3VMC4	966	I	V
Q86YC2	LB/B	-	G3VMC4	998	G	E
Q86YC2	LB/B	-	G3VMC4	1025	A	T
Q86YC2	LB/B	-	G3VMC4	1043	G	A
Q86YC2	LB/B	-	G3VMC4	1075	S	G
Q86YC2	LB/B	-	G3VMC4	1105	V	A
Q86YC2	LB/B	-	G3VMC4	1114	Q	H
Q86YC2	LB/B	-	G3VMC4	1143	L	P
Q86YC2	LB/B	-	G3VMC4	1170	H	Y
Q86YC2	LB/B	-	G3VMC4	18	K	R
Q86YC2	LB/B	-	G3VMC4	28	Y	C
Q86YC2	LP/P	Breast cancer (BC) [MIM:114480]	G3VMC4	35	L	P
Q86YC2	LB/B	-	G3VMC4	37	R	H
Q8WX93	LB/B	-	H2UIL9	224	M	I
Q8WX93	LB/B	-	H2UIL9	224	M	T
O75781	LB/B	-	W5M0X8	107	T	A
A6NDB9	LB/B	-	A0A2Y9LXU8	440	A	T
Q9NP74	LB/B	-	A0A1U7QQN8	73	H	Q
Q9NP74	LB/B	-	A0A1U7QQN8	229	N	S
Q9NP74	LB/B	-	A0A1U7QQN8	459	E	D
Q9Y3D7	LB/B	-	A0A1D5PRU5	114	Q	K
Q9Y3D7	LP/P	Spondylometaphyseal dysplasia, Megarbane-Dagher-Melike type (SMDMDM) [MIM:613320]	A0A1D5PRU5	76	N	D
Q6UXH9	LB/B	-	V8PEJ3	305	A	T
Q504Q3	LB/B	-	A0A0L0CMD5	32	S	N
Q504Q3	LB/B	-	A0A0L0CMD5	179	I	L
Q9BZ23	LB/B	-	G1R7Z7	111	L	Q
Q9BZ23	LB/B	-	G1R7Z7	126	G	A
Q9BZ23	LP/P	Neurodegeneration with brain iron accumulation 1 (NBIA1) [MIM:234200]	G1R7Z7	219	G	V
Q9BZ23	LP/P	Neurodegeneration with brain iron accumulation 1 (NBIA1) [MIM:234200]	G1R7Z7	234	T	A
Q9BZ23	LP/P	Neurodegeneration with brain iron accumulation 1 (NBIA1) [MIM:234200]	G1R7Z7	264	R	W
Q9BZ23	LP/P	Neurodegeneration with brain iron accumulation 1 (NBIA1) [MIM:234200]	G1R7Z7	278	R	C
Q9BZ23	LP/P	Neurodegeneration with brain iron accumulation 1 (NBIA1) [MIM:234200]	G1R7Z7	282	L	V
Q9BZ23	LP/P	Neurodegeneration with brain iron accumulation 1 (NBIA1) [MIM:234200]	G1R7Z7	286	R	C
Q9BZ23	LP/P	Neurodegeneration with brain iron accumulation 1 (NBIA1) [MIM:234200]	G1R7Z7	327	T	I
Q9BZ23	LP/P	Neurodegeneration with brain iron accumulation 1 (NBIA1) [MIM:234200]	G1R7Z7	351	S	P
Q9BZ23	LP/P	Neurodegeneration with brain iron accumulation 1 (NBIA1) [MIM:234200]	G1R7Z7	355	N	S
Q9BZ23	LP/P	Neurodegeneration with brain iron accumulation 1 (NBIA1) [MIM:234200]	G1R7Z7	404	N	I
Q9BZ23	LP/P	Neurodegeneration with brain iron accumulation 1 (NBIA1) [MIM:234200]	G1R7Z7	413	L	P
Q9BZ23	LP/P	Neurodegeneration with brain iron accumulation 1 (NBIA1) [MIM:234200]	G1R7Z7	471	S	N
Q9BZ23	LP/P	Neurodegeneration with brain iron accumulation 1 (NBIA1) [MIM:234200]	G1R7Z7	497	I	T
Q9BZ23	LP/P	Neurodegeneration with brain iron accumulation 1 (NBIA1) [MIM:234200]	G1R7Z7	500	N	I
Q9BZ23	LP/P	Neurodegeneration with brain iron accumulation 1 (NBIA1) [MIM:234200]	G1R7Z7	521	G	R
Q9BZ23	LB/B	-	G1R7Z7	94	R	P
Q9BZ23	LP/P	Neurodegeneration with brain iron accumulation 1 (NBIA1) [MIM:234200]	G1R7Z7	134	E	G
Q9BZ23	LP/P	Neurodegeneration with brain iron accumulation 1 (NBIA1) [MIM:234200]	G1R7Z7	249	R	P
Q9BZ23	LP/P	Neurodegeneration with brain iron accumulation 1 (NBIA1) [MIM:234200]	G1R7Z7	278	R	L
Q9BZ23	LP/P	Neurodegeneration with brain iron accumulation 1 (NBIA1) [MIM:234200]	G1R7Z7	322	E	D
Q9BZ23	LP/P	Neurodegeneration with brain iron accumulation 1 (NBIA1) [MIM:234200]	G1R7Z7	322	E	G
Q9BZ23	LP/P	Neurodegeneration with brain iron accumulation 1 (NBIA1) [MIM:234200]	G1R7Z7	357	R	Q
Q9BZ23	LP/P	Neurodegeneration with brain iron accumulation 1 (NBIA1) [MIM:234200]	G1R7Z7	398	A	T
Q9BZ23	LP/P	Neurodegeneration with brain iron accumulation 1 (NBIA1) [MIM:234200]	G1R7Z7	428	C	Y
Q9BZ23	LP/P	Neurodegeneration with brain iron accumulation 1 (NBIA1) [MIM:234200]	G1R7Z7	447	D	N
Q9BZ23	LP/P	Neurodegeneration with brain iron accumulation 1 (NBIA1) [MIM:234200]	G1R7Z7	501	I	T
Q9BZ23	LP/P	Neurodegeneration with brain iron accumulation 1 (NBIA1) [MIM:234200]	G1R7Z7	509	A	V
Q9BZ23	LP/P	Neurodegeneration with brain iron accumulation 1 (NBIA1) [MIM:234200]	G1R7Z7	511	N	D
Q9BZ23	LP/P	Neurodegeneration with brain iron accumulation 1 (NBIA1) [MIM:234200]	G1R7Z7	532	R	W
Q9BZ23	LP/P	Neurodegeneration with brain iron accumulation 1 (NBIA1) [MIM:234200]	G1R7Z7	563	L	P
Q9BZ23	LP/P	Neurodegeneration with brain iron accumulation 1 (NBIA1) [MIM:234200]	G1R7Z7	570	P	L
Q96QZ0	LB/B	-	L9LC01	95	G	R
Q96QZ0	LB/B	-	L9LC01	208	T	A
O95428	LB/B	-	G3HNF5	33	S	G
O95428	LB/B	-	G3HNF5	191	A	T
O95428	LB/B	-	G3HNF5	356	N	H
O95428	LB/B	-	G3HNF5	443	V	I
O95428	LB/B	-	G3HNF5	461	A	V
O95428	LB/B	-	G3HNF5	628	H	R
O95428	LB/B	-	G3HNF5	723	Q	H
O95428	LB/B	-	G3HNF5	896	G	R
O95428	LB/B	-	G3HNF5	1192	L	V
O95428	LB/B	-	G3HNF5	1201	T	M
O95428	LB/B	-	G3HNF5	1260	S	T
Q9BXP8	LB/B	-	L5MFI7	171	T	S
Q9BXP8	LB/B	-	L5MFI7	1657	P	R
Q9BXP8	LP/P	Short stature, Dauber-Argente type (SSDA) [MIM:619489]	L5MFI7	1033	A	V
O43252	LB/B	-	F6QI65	587	S	L
O43252	LB/B	-	F6QI65	270	L	F
O95340	LB/B	-	F6QI65	291	V	M
O95340	LB/B	-	F6QI65	10	E	K
O95340	LB/B	-	F6QI65	281	M	L
O95340	LB/B	-	F6QI65	432	R	K
O95340	LP/P	Brachyolmia type 4 with mild epiphyseal and metaphyseal changes (BCYM4) [MIM:612847]	F6QI65	48	T	R
O95340	LP/P	Brachyolmia type 4 with mild epiphyseal and metaphyseal changes (BCYM4) [MIM:612847]	F6QI65	43	C	Y
O95340	LP/P	Brachyolmia type 4 with mild epiphyseal and metaphyseal changes (BCYM4) [MIM:612847]	F6QI65	76	L	Q
O95340	LB/B	-	F6QI65	183	E	K
O95340	LP/P	Brachyolmia type 4 with mild epiphyseal and metaphyseal changes (BCYM4) [MIM:612847]	F6QI65	270	G	D
Q9NXK6	LB/B	-	G1T8N2	24	I	T
Q86WK9	LB/B	-	S9Y0B8	272	G	R
Q86WK9	LB/B	-	S9Y0B8	227	V	M
Q8TEW0	LB/B	-	A0A2I0UEF9	107	E	D
Q8TEW0	LB/B	-	A0A2I0UEF9	575	D	N
Q8TEW0	LP/P	Neural tube defects (NTD) [MIM:182940]	A0A2I0UEF9	783	D	G
Q8TEW0	LP/P	Neural tube defects (NTD) [MIM:182940]	A0A2I0UEF9	913	P	Q
Q9H300	LB/B	-	A0A2R8MV14	262	V	L
Q9H300	LB/B	-	A0A2R8MV14	137	A	G
O95453	LP/P	Dyskeratosis congenita, autosomal recessive, 6 (DKCB6) [MIM:616353]	S7PS41	383	A	V
O95453	LP/P	Pulmonary fibrosis, and/or bone marrow failure, telomere-related, 4 (PFBMFT4) [MIM:616371]	S7PS41	421	K	R
P09874	LB/B	-	A0A0L8GGW2	188	A	T
P09874	LB/B	-	A0A0L8GGW2	762	V	A
P09874	LB/B	-	A0A0L8GGW2	334	V	I
P09874	LB/B	-	A0A0L8GGW2	383	S	Y
P09874	LB/B	-	A0A0L8GGW2	940	K	R
P09874	LB/B	-	A0A0L8GGW2	54	F	L
P09874	LB/B	-	A0A0L8GGW2	377	P	S
Q53GL7	LB/B	-	A0A2F0BJX4	249	I	V
Q53GL7	LB/B	-	A0A2F0BJX4	395	L	P
Q53GL7	LB/B	-	A0A2F0BJX4	630	V	A
Q9H0J9	LB/B	-	R0JRY4	293	V	I
Q9H0J9	LB/B	-	R0JRY4	463	V	M
Q9H0J9	LB/B	-	R0JRY4	620	A	V
Q460N3	LB/B	-	I3J9Z6	337	R	K
Q460N3	LB/B	-	I3J9Z6	628	G	R
Q460N3	LB/B	-	I3J9Z6	521	A	T
Q8N5Y8	LB/B	-	A0A2K5U405	280	S	P
Q9UGN5	LB/B	-	A0A146XZ15	161	S	N
Q9UGN5	LB/B	-	A0A146XZ15	168	N	S
Q9UGN5	LB/B	-	A0A146XZ15	235	D	G
Q9UGN5	LB/B	-	A0A146XZ15	285	I	V
Q9UGN5	LB/B	-	A0A146XZ15	296	R	Q
Q9UGN5	LB/B	-	A0A146XZ15	331	I	T
Q9Y6F1	LB/B	-	H0Z7N3	100	R	H
Q9Y6F1	LB/B	-	H0Z7N3	91	S	N
Q9Y6F1	LB/B	-	H0Z7N3	269	Q	R
Q9UKK3	LB/B	-	A0A2K6G5Y5	1265	G	A
Q9UKK3	LB/B	-	A0A2K6G5Y5	1280	G	R
Q9UKK3	LB/B	-	A0A2K6G5Y5	81	I	V
Q9UKK3	LB/B	-	A0A2K6G5Y5	122	S	N
Q9UKK3	LB/B	-	A0A2K6G5Y5	215	F	Y
Q9UKK3	LB/B	-	A0A2K6G5Y5	792	P	L
Q9UKK3	LB/B	-	A0A2K6G5Y5	873	S	N
Q9UKK3	LB/B	-	A0A2K6G5Y5	899	A	T
Q9UKK3	LB/B	-	A0A2K6G5Y5	991	K	R
Q9UKK3	LB/B	-	A0A2K6G5Y5	1012	V	I
Q9UKK3	LB/B	-	A0A2K6G5Y5	1253	S	T
Q9NWS1	LB/B	-	L5LKT3	400	V	M
Q7L3T8	LB/B	-	G1Q3P4	235	N	S
Q7L3T8	LB/B	-	G1Q3P4	28	R	S
Q8IV76	LB/B	-	A0A2K5IWR9	213	Q	E
Q96RG2	LB/B	-	A0A091CXE3	250	V	I
Q96RG2	LB/B	-	A0A091CXE3	514	L	S
Q96RG2	LB/B	-	A0A091CXE3	694	V	M
Q96RG2	LB/B	-	A0A091CXE3	725	G	D
Q96RG2	LB/B	-	A0A091CXE3	1210	V	M
Q96RG2	LB/B	-	A0A091CXE3	1266	F	C
Q96RG2	LB/B	-	A0A091CXE3	426	Q	R
Q96RG2	LB/B	-	A0A091CXE3	512	T	A
Q96RG2	LB/B	-	A0A091CXE3	684	P	R
Q96RG2	LB/B	-	A0A091CXE3	796	E	K
Q96RG2	LB/B	-	A0A091CXE3	844	P	Q
Q96RG2	LB/B	-	A0A091CXE3	937	R	H
Q96RG2	LB/B	-	A0A091CXE3	1301	P	S
Q8WXA2	LB/B	-	A0A2K6UF45	46	V	I
Q8WXA2	LB/B	-	A0A2K6UF45	47	Q	R
Q8NI35	LB/B	-	A0A091CUI0	744	C	R
Q8NI35	LB/B	-	A0A091CUI0	303	G	R
Q8NI35	LB/B	-	A0A091CUI0	362	E	A
Q8NI35	LB/B	-	A0A091CUI0	400	I	V
Q8NI35	LB/B	-	A0A091CUI0	599	Q	H
Q8NI35	LB/B	-	A0A091CUI0	779	E	K
Q8NI35	LB/B	-	A0A091CUI0	780	E	K
Q8NI35	LB/B	-	A0A091CUI0	870	I	M
Q8NI35	LB/B	-	A0A091CUI0	1178	G	S
Q8NI35	LB/B	-	A0A091CUI0	1282	R	H
Q8NI35	LB/B	-	A0A091CUI0	1360	V	L
Q8NI35	LB/B	-	A0A091CUI0	1504	A	P
C9JE40	LB/B	-	G3UDA9	88	M	L
C9JE40	LP/P	Oocyte maturation defect 4 (OOMD4) [MIM:617743]	G3UDA9	189	L	R
C9JE40	LP/P	Oocyte maturation defect 4 (OOMD4) [MIM:617743]	G3UDA9	217	Y	N
Q96IZ0	LB/B	-	Q62627	42	P	L
Q96IZ0	LB/B	-	Q62627	78	P	R
Q96IZ0	LB/B	-	Q62627	137	G	A
Q96IZ0	LB/B	-	Q62627	202	E	A
P15863	LB/B	-	F1PB32	439	T	R
P15863	LB/B	-	F1PB32	453	P	L
P15863	LB/B	-	F1PB32	504	P	L
P15863	LP/P	Otofaciocervical syndrome 2, with T-cell deficiency (OTFCS2) [MIM:615560]	F1PB32	166	G	V
P23760	LP/P	Waardenburg syndrome 1 (WS1) [MIM:193500]	F6VTJ2	45	F	L
P23760	LP/P	Waardenburg syndrome 3 (WS3) [MIM:148820]	F6VTJ2	47	N	H
P23760	LP/P	Craniofacial-deafness-hand syndrome (CDHS) [MIM:122880]	F6VTJ2	47	N	K
P23760	LP/P	Waardenburg syndrome 1 (WS1) [MIM:193500]	F6VTJ2	50	P	L
P23760	LP/P	Waardenburg syndrome 1 (WS1) [MIM:193500]	F6VTJ2	56	R	L
P23760	LP/P	Waardenburg syndrome 1 (WS1) [MIM:193500]	F6VTJ2	59	I	F
P23760	LP/P	Waardenburg syndrome 1 (WS1) [MIM:193500]	F6VTJ2	59	I	N
P23760	LP/P	Waardenburg syndrome 1 (WS1) [MIM:193500]	F6VTJ2	60	V	M
P23760	LP/P	Waardenburg syndrome 1 (WS1) [MIM:193500]	F6VTJ2	62	M	V
P23760	LP/P	Waardenburg syndrome 1 (WS1) [MIM:193500]	F6VTJ2	81	G	A
P23760	LP/P	Waardenburg syndrome 3 (WS3) [MIM:148820]	F6VTJ2	84	S	F
P23760	LP/P	Waardenburg syndrome 1 (WS1) [MIM:193500]	F6VTJ2	85	K	E
P23760	LP/P	Waardenburg syndrome 1 (WS1) [MIM:193500]	F6VTJ2	99	G	D
P23760	LP/P	Waardenburg syndrome 1 (WS1) [MIM:193500]	F6VTJ2	238	F	S
P23760	LP/P	Waardenburg syndrome 1 (WS1) [MIM:193500]	F6VTJ2	265	V	F
P23760	LP/P	Waardenburg syndrome 1 (WS1) [MIM:193500]	F6VTJ2	271	R	G
P23760	LB/B	-	F6VTJ2	315	T	K
P23760	LP/P	Waardenburg syndrome 1 (WS1) [MIM:193500]	F6VTJ2	270	R	C
P23760	LP/P	Waardenburg syndrome 3 (WS3) [MIM:148820]	F6VTJ2	270	R	C
P23760	LP/P	Waardenburg syndrome 1 (WS1) [MIM:193500]	F6VTJ2	73	S	L
P23760	LP/P	Waardenburg syndrome 1 (WS1) [MIM:193500]	F6VTJ2	391	Q	H
P23760	LP/P	Waardenburg syndrome 1 (WS1) [MIM:193500]	F6VTJ2	48	G	R
P23760	LP/P	Waardenburg syndrome 1 (WS1) [MIM:193500]	F6VTJ2	78	V	M
P23760	LP/P	Waardenburg syndrome 3 (WS3) [MIM:148820]	F6VTJ2	90	Y	H
P23760	LP/P	Waardenburg syndrome 1 (WS1) [MIM:193500]	F6VTJ2	266	W	C
P23760	LP/P	Waardenburg syndrome 1 (WS1) [MIM:193500]	F6VTJ2	271	R	C
P23760	LP/P	Waardenburg syndrome 1 (WS1) [MIM:193500]	F6VTJ2	271	R	H
P23760	LP/P	Waardenburg syndrome 1 (WS1) [MIM:193500]	F6VTJ2	80	H	D
P23760	LP/P	Waardenburg syndrome 1 (WS1) [MIM:193500]	F6VTJ2	234	L	P
O43316	LB/B	-	G1Q5W7	39	R	Q
O43316	LP/P	Diabetes mellitus, ketosis-prone (KPD) [MIM:612227]	G1Q5W7	45	R	W
O43316	LP/P	Type 2 diabetes mellitus (T2D) [MIM:125853]	G1Q5W7	129	R	W
O43316	LP/P	Diabetes mellitus, ketosis-prone (KPD) [MIM:612227]	G1Q5W7	141	R	W
O43316	LP/P	Maturity-onset diabetes of the young 9 (MODY9) [MIM:612225]	G1Q5W7	172	R	W
O43316	LB/B	-	G1Q5W7	191	R	C
O43316	LB/B	-	G1Q5W7	200	R	H
O43316	LB/B	-	G1Q5W7	200	R	S
Q02548	LB/B	-	A0A2I3GTQ1	322	A	T
Q02548	LB/B	-	A0A2I3GTQ1	24	G	R
Q02548	LB/B	-	A0A2I3GTQ1	26	V	G
Q02548	LB/B	-	A0A2I3GTQ1	34	P	Q
Q02548	LB/B	-	A0A2I3GTQ1	53	D	V
Q02548	LB/B	-	A0A2I3GTQ1	59	R	G
Q02548	LB/B	-	A0A2I3GTQ1	66	S	N
Q02548	LB/B	-	A0A2I3GTQ1	75	T	R
Q02548	LB/B	-	A0A2I3GTQ1	80	P	R
Q02548	LB/B	-	A0A2I3GTQ1	139	I	T
Q02548	LB/B	-	A0A2I3GTQ1	151	V	I
Q02548	LP/P	Leukemia, acute lymphoblastic, 3 (ALL3) [MIM:613065]	A0A2I3GTQ1	183	G	S
Q02548	LB/B	-	A0A2I3GTQ1	183	G	V
Q02548	LB/B	-	A0A2I3GTQ1	213	S	L
Q02548	LB/B	-	A0A2I3GTQ1	301	I	T
Q02548	LB/B	-	A0A2I3GTQ1	338	G	V
P23759	LP/P	Myopathy, congenital, progressive, with scoliosis (MYOSCO) [MIM:618578]	F6VTJ2	56	R	C
P55771	LP/P	Tooth agenesis, selective, 3 (STHAG3) [MIM:604625]	A0A2I0MPC7	51	G	S
P55771	LB/B	-	A0A2I0MPC7	240	A	P
Q6ZW49	LB/B	-	A0A0D9R2H9	1013	M	V
Q96KB5	LB/B	-	A0A1S2ZCM0	107	N	S
Q96KB5	LB/B	-	A0A1S2ZCM0	241	M	L
Q96KB5	LB/B	-	A0A1S2ZCM0	220	E	D
Q86U86	LB/B	-	A0A139WMA9	56	T	A
Q86U86	LB/B	-	A0A139WMA9	66	R	G
Q86U86	LB/B	-	A0A139WMA9	202	R	C
Q86U86	LB/B	-	A0A139WMA9	206	E	K
Q86U86	LB/B	-	A0A139WMA9	228	I	V
Q86U86	LB/B	-	A0A139WMA9	256	A	T
Q86U86	LB/B	-	A0A139WMA9	340	G	A
Q86U86	LB/B	-	A0A139WMA9	678	R	C
Q86U86	LB/B	-	A0A139WMA9	893	Y	C
Q86U86	LB/B	-	A0A139WMA9	1098	A	S
Q86U86	LB/B	-	A0A139WMA9	1120	R	Q
Q86U86	LB/B	-	A0A139WMA9	1647	R	C
P40424	LB/B	-	A0A2I3R9S9	31	G	S
P11498	LP/P	Pyruvate carboxylase deficiency (PC deficiency) [MIM:266150]	A0A2K6NY08	610	A	T
P11498	LP/P	Pyruvate carboxylase deficiency (PC deficiency) [MIM:266150]	A0A2K6NY08	743	M	I
P11498	LP/P	Pyruvate carboxylase deficiency (PC deficiency) [MIM:266150]	A0A2K6NY08	145	V	A
P11498	LP/P	Pyruvate carboxylase deficiency (PC deficiency) [MIM:266150]	A0A2K6NY08	451	R	C
P11498	LB/B	-	A0A2K6NY08	76	H	L
P11498	LP/P	Pyruvate carboxylase deficiency (PC deficiency) [MIM:266150]	A0A2K6NY08	156	R	Q
P11498	LP/P	Pyruvate carboxylase deficiency (PC deficiency) [MIM:266150]	A0A2K6NY08	270	R	W
P11498	LP/P	Pyruvate carboxylase deficiency (PC deficiency) [MIM:266150]	A0A2K6NY08	304	Y	C
P11498	LP/P	Pyruvate carboxylase deficiency (PC deficiency) [MIM:266150]	A0A2K6NY08	583	R	L
P11498	LP/P	Pyruvate carboxylase deficiency (PC deficiency) [MIM:266150]	A0A2K6NY08	631	R	Q
A6NGG8	LB/B	-	K7EW87	13	S	C
A6NGG8	LB/B	-	K7EW87	421	K	R
A6NGG8	LB/B	-	K7EW87	580	T	M
A6NGG8	LB/B	-	K7EW87	792	L	V
A6NGG8	LB/B	-	K7EW87	1254	P	L
A6NGG8	LP/P	Retinitis pigmentosa 54 (RP54) [MIM:613428]	K7EW87	201	I	F
A6NGG8	LB/B	-	K7EW87	867	P	L
A6NGG8	LB/B	-	K7EW87	227	E	K
A6NGG8	LB/B	-	K7EW87	247	V	A
A6NGG8	LB/B	-	K7EW87	252	A	D
A6NGG8	LB/B	-	K7EW87	258	R	I
A6NGG8	LB/B	-	K7EW87	312	S	N
A6NGG8	LP/P	Retinitis pigmentosa 54 (RP54) [MIM:613428]	K7EW87	372	D	N
A6NGG8	LB/B	-	K7EW87	378	E	K
A6NGG8	LP/P	Retinitis pigmentosa 54 (RP54) [MIM:613428]	K7EW87	612	L	P
A6NGG8	LP/P	Retinitis pigmentosa 54 (RP54) [MIM:613428]	K7EW87	615	V	D
A6NGG8	LB/B	-	K7EW87	628	A	T
A6NGG8	LB/B	-	K7EW87	648	A	P
A6NGG8	LB/B	-	K7EW87	688	C	Y
A6NGG8	LB/B	-	K7EW87	954	P	S
A6NGG8	LB/B	-	K7EW87	955	R	Q
A6NGG8	LB/B	-	K7EW87	959	A	T
A6NGG8	LB/B	-	K7EW87	1020	Q	R
A6NGG8	LB/B	-	K7EW87	1160	A	T
A6NGG8	LB/B	-	K7EW87	1177	R	Q
A6NGG8	LB/B	-	K7EW87	1247	G	S
P61457	LP/P	Hyperphenylalaninemia, BH4-deficient, D (HPABH4D) [MIM:264070]	A0A091E2M6	79	T	I
P61457	LP/P	Hyperphenylalaninemia, BH4-deficient, D (HPABH4D) [MIM:264070]	A0A091E2M6	82	C	R
P61457	LP/P	Hyperphenylalaninemia, BH4-deficient, D (HPABH4D) [MIM:264070]	A0A091E2M6	97	E	K
P57723	LB/B	-	S9X8H6	198	G	S
P05165	LP/P	Propionic acidemia type I (PA-1) [MIM:606054]	I3TNU8	75	A	P
P05165	LP/P	Propionic acidemia type I (PA-1) [MIM:606054]	I3TNU8	77	R	W
P05165	LP/P	Propionic acidemia type I (PA-1) [MIM:606054]	I3TNU8	138	A	T
P05165	LP/P	Propionic acidemia type I (PA-1) [MIM:606054]	I3TNU8	164	I	T
P05165	LP/P	Propionic acidemia type I (PA-1) [MIM:606054]	I3TNU8	229	M	K
P05165	LP/P	Propionic acidemia type I (PA-1) [MIM:606054]	I3TNU8	297	Q	R
P05165	LP/P	Propionic acidemia type I (PA-1) [MIM:606054]	I3TNU8	368	D	G
P05165	LP/P	Propionic acidemia type I (PA-1) [MIM:606054]	I3TNU8	373	M	K
P05165	LP/P	Propionic acidemia type I (PA-1) [MIM:606054]	I3TNU8	379	G	V
P05165	LP/P	Propionic acidemia type I (PA-1) [MIM:606054]	I3TNU8	399	R	Q
P05165	LP/P	Propionic acidemia type I (PA-1) [MIM:606054]	I3TNU8	423	P	L
P05165	LB/B	-	I3TNU8	475	I	V
P05165	LP/P	Propionic acidemia type I (PA-1) [MIM:606054]	I3TNU8	559	W	L
P05165	LP/P	Propionic acidemia type I (PA-1) [MIM:606054]	I3TNU8	631	G	R
P05165	LP/P	Propionic acidemia type I (PA-1) [MIM:606054]	I3TNU8	668	G	R
P05165	LP/P	Propionic acidemia type I (PA-1) [MIM:606054]	I3TNU8	197	G	E
P05165	LP/P	Propionic acidemia type I (PA-1) [MIM:606054]	I3TNU8	398	C	R
P05165	LB/B	-	I3TNU8	551	V	F
Q08174	LB/B	-	A0A1U7TUU5	15	L	F
Q08174	LB/B	-	A0A1U7TUU5	25	H	P
Q08174	LB/B	-	A0A1U7TUU5	514	A	T
Q96QU1	LP/P	Deafness, autosomal recessive, 23 (DFNB23) [MIM:609533]	B1MTB2	134	R	G
Q96QU1	LP/P	Deafness, autosomal recessive, 23 (DFNB23) [MIM:609533]	B1MTB2	262	G	D
Q96QU1	LB/B	Usher syndrome 1F (USH1F) [MIM:602083]	B1MTB2	1342	Q	K
Q96QU1	LB/B	-	B1MTB2	19	S	A
Q96QU1	LB/B	-	B1MTB2	380	G	S
Q96QU1	LB/B	-	B1MTB2	435	D	A
Q96QU1	LB/B	-	B1MTB2	929	R	Q
Q96QU1	LP/P	Usher syndrome 1D/F (USH1DF) [MIM:601067]	B1MTB2	178	D	G
Q96QU1	LP/P	Usher syndrome 1F (USH1F) [MIM:602083]	B1MTB2	134	R	Q
Q96QU1	LB/B	-	B1MTB2	174	N	S
Q96QU1	LB/B	-	B1MTB2	1273	R	S
Q8TAB3	LP/P	Developmental and epileptic encephalopathy 9 (DEE9) [MIM:300088]	A0A0Q3LSW0	441	V	E
Q8TAB3	LP/P	Developmental and epileptic encephalopathy 9 (DEE9) [MIM:300088]	A0A0Q3LSW0	557	N	K
Q8TAB3	LP/P	Developmental and epileptic encephalopathy 9 (DEE9) [MIM:300088]	A0A0Q3LSW0	121	D	N
Q8TAB3	LP/P	Developmental and epileptic encephalopathy 9 (DEE9) [MIM:300088]	A0A0Q3LSW0	199	E	Q
Q8TAB3	LP/P	Developmental and epileptic encephalopathy 9 (DEE9) [MIM:300088]	A0A0Q3LSW0	203	H	P
Q8TAB3	LP/P	Developmental and epileptic encephalopathy 9 (DEE9) [MIM:300088]	A0A0Q3LSW0	206	F	C
Q8TAB3	LP/P	Developmental and epileptic encephalopathy 9 (DEE9) [MIM:300088]	A0A0Q3LSW0	276	S	P
Q8TAB3	LP/P	Developmental and epileptic encephalopathy 9 (DEE9) [MIM:300088]	A0A0Q3LSW0	340	N	S
Q8TAB3	LP/P	Developmental and epileptic encephalopathy 9 (DEE9) [MIM:300088]	A0A0Q3LSW0	377	D	H
Q8TAB3	LP/P	Developmental and epileptic encephalopathy 9 (DEE9) [MIM:300088]	A0A0Q3LSW0	404	T	I
Q8TAB3	LP/P	Developmental and epileptic encephalopathy 9 (DEE9) [MIM:300088]	A0A0Q3LSW0	414	E	Q
Q8TAB3	LP/P	Developmental and epileptic encephalopathy 9 (DEE9) [MIM:300088]	A0A0Q3LSW0	543	L	P
Q8TAB3	LB/B	-	A0A0Q3LSW0	958	R	Q
Q8TAB3	LB/B	-	A0A0Q3LSW0	1107	R	G
Q8TAB3	LP/P	Developmental and epileptic encephalopathy 9 (DEE9) [MIM:300088]	A0A0Q3LSW0	81	L	R
Q8TAB3	LP/P	Developmental and epileptic encephalopathy 9 (DEE9) [MIM:300088]	A0A0Q3LSW0	146	T	R
Q8TAB3	LP/P	Developmental and epileptic encephalopathy 9 (DEE9) [MIM:300088]	A0A0Q3LSW0	206	F	Y
Q8TAB3	LP/P	Developmental and epileptic encephalopathy 9 (DEE9) [MIM:300088]	A0A0Q3LSW0	249	E	D
Q8TAB3	LP/P	Developmental and epileptic encephalopathy 9 (DEE9) [MIM:300088]	A0A0Q3LSW0	341	D	E
Q8TAB3	LP/P	Developmental and epileptic encephalopathy 9 (DEE9) [MIM:300088]	A0A0Q3LSW0	561	P	R
Q8TAB3	LP/P	Developmental and epileptic encephalopathy 9 (DEE9) [MIM:300088]	A0A0Q3LSW0	567	P	L
Q8TAB3	LP/P	Developmental and epileptic encephalopathy 9 (DEE9) [MIM:300088]	A0A0Q3LSW0	618	D	N
Q8TAB3	LP/P	Developmental and epileptic encephalopathy 9 (DEE9) [MIM:300088]	A0A0Q3LSW0	25	L	P
Q8TAB3	LP/P	Developmental and epileptic encephalopathy 9 (DEE9) [MIM:300088]	A0A0Q3LSW0	72	V	G
Q8TAB3	LP/P	Developmental and epileptic encephalopathy 9 (DEE9) [MIM:300088]	A0A0Q3LSW0	153	A	T
Q8TAB3	LP/P	Developmental and epileptic encephalopathy 9 (DEE9) [MIM:300088]	A0A0Q3LSW0	190	L	R
Q8TAB3	LP/P	Developmental and epileptic encephalopathy 9 (DEE9) [MIM:300088]	A0A0Q3LSW0	191	V	L
Q8TAB3	LP/P	Developmental and epileptic encephalopathy 9 (DEE9) [MIM:300088]	A0A0Q3LSW0	232	N	S
Q8TAB3	LP/P	Developmental and epileptic encephalopathy 9 (DEE9) [MIM:300088]	A0A0Q3LSW0	234	N	S
Q8TAB3	LP/P	Developmental and epileptic encephalopathy 9 (DEE9) [MIM:300088]	A0A0Q3LSW0	236	P	S
Q8TAB3	LP/P	Developmental and epileptic encephalopathy 9 (DEE9) [MIM:300088]	A0A0Q3LSW0	262	A	D
Q8TAB3	LP/P	Developmental and epileptic encephalopathy 9 (DEE9) [MIM:300088]	A0A0Q3LSW0	344	P	R
Q8TAB3	LP/P	Developmental and epileptic encephalopathy 9 (DEE9) [MIM:300088]	A0A0Q3LSW0	377	D	E
Q8TAB3	LP/P	Developmental and epileptic encephalopathy 9 (DEE9) [MIM:300088]	A0A0Q3LSW0	433	L	P
Q8TAB3	LP/P	Developmental and epileptic encephalopathy 9 (DEE9) [MIM:300088]	A0A0Q3LSW0	513	G	R
Q8TAB3	LP/P	Developmental and epileptic encephalopathy 9 (DEE9) [MIM:300088]	A0A0Q3LSW0	642	V	M
Q8TAB3	LB/B	-	A0A0Q3LSW0	980	R	C
Q8TAB3	LB/B	-	A0A0Q3LSW0	1094	L	V
Q8TAB3	LB/B	-	A0A0Q3LSW0	1107	R	H
Q8TAB3	LB/B	-	A0A0Q3LSW0	1134	N	H
Q8TAB3	LP/P	-	A0A0Q3LSW0	447	N	H
Q8TAB3	LP/P	Developmental and epileptic encephalopathy 9 (DEE9) [MIM:300088]	A0A0Q3LSW0	236	P	L
O95206	LB/B	-	A0A091FA22	7	W	R
O95206	LB/B	-	A0A091FA22	39	E	A
O95206	LB/B	-	A0A091FA22	743	V	A
O95206	LB/B	-	A0A091FA22	367	T	A
Q9Y5H7	LB/B	-	G5BMG7	691	A	V
Q9H158	LB/B	-	D2GUM8	498	L	V
Q9Y5F3	LB/B	-	F7D549	385	F	L
Q9Y5F3	LB/B	-	F7D549	390	L	F
Q9Y5F3	LB/B	-	F7D549	524	A	V
Q9Y5F3	LB/B	-	F7D549	611	T	I
Q9Y5F3	LB/B	-	F7D549	712	I	T
Q9Y5F3	LB/B	-	F7D549	719	K	I
Q9Y5F3	LB/B	-	F7D549	778	F	L
Q9Y5F2	LB/B	-	G3TN72	4	Q	R
Q9Y5F2	LB/B	-	G3TN72	7	R	H
Q9Y5F2	LB/B	-	G3TN72	528	D	E
Q9Y5F1	LB/B	-	G3TN72	420	T	I
Q9Y5F1	LB/B	-	G3TN72	763	K	E
Q9Y5F0	LB/B	-	G3TN72	471	R	G
Q9Y5E8	LB/B	-	G3TN72	474	S	R
Q9Y5E8	LB/B	-	G3TN72	494	R	Q
Q9NRJ7	LB/B	-	G3TN72	525	Q	R
Q9NRJ7	LB/B	-	G3TN72	532	G	S
Q9NRJ7	LB/B	-	G3TN72	91	D	E
Q9NRJ7	LB/B	-	G3TN72	347	V	L
Q9NRJ7	LB/B	-	G3TN72	508	A	T
Q9Y5E7	LB/B	-	G3TN72	128	V	I
Q9Y5E7	LB/B	-	G3TN72	674	L	P
Q9Y5E7	LB/B	-	G3TN72	760	G	D
Q9Y5E6	LB/B	-	G3TN72	414	R	S
Q9Y5E6	LB/B	-	G3TN72	41	K	R
Q9Y5E6	LB/B	-	G3TN72	207	E	K
Q9Y5E5	LB/B	-	G3TN72	421	A	T
Q9Y5E5	LB/B	-	G3TN72	168	K	R
Q9Y5E5	LB/B	-	G3TN72	255	P	L
Q9Y5E5	LB/B	-	G3TN72	255	P	S
Q9Y5E5	LB/B	-	G3TN72	553	T	A
Q9Y5E4	LB/B	-	G3TN72	156	I	T
Q9Y5E4	LB/B	-	G3TN72	720	P	S
Q9Y5E3	LB/B	-	G3TN72	231	V	I
Q9Y5E3	LB/B	-	G3TN72	232	L	F
Q9Y5E3	LB/B	-	G3TN72	636	H	Q
Q9Y5E3	LB/B	-	G3TN72	747	Y	H
Q9Y5E3	LB/B	-	G3TN72	446	V	A
Q9Y5E3	LB/B	-	G3TN72	776	G	D
Q9Y5E2	LB/B	-	G3TN72	389	V	L
Q9Y5E2	LB/B	-	G3TN72	120	E	K
Q9Y5E2	LB/B	-	G3TN72	187	E	K
Q9Y5E2	LB/B	-	G3TN72	575	P	L
Q9Y5E2	LB/B	-	G3TN72	576	L	V
Q9Y5E2	LB/B	-	G3TN72	716	R	W
Q9UN66	LB/B	-	G3TN72	305	K	E
Q9UN66	LB/B	-	G3TN72	322	A	V
Q9UN66	LB/B	-	G3TN72	767	L	F
Q9UN66	LB/B	-	G3TN72	199	K	N
Q9UN66	LB/B	-	G3TN72	244	E	Q
Q9UN66	LB/B	-	G3TN72	232	E	G
Q9UN66	LB/B	-	G3TN72	382	I	T
Q9UN66	LB/B	-	G3TN72	639	Q	H
Q9UN66	LB/B	-	G3TN72	661	V	L
Q9UN66	LB/B	-	G3TN72	745	S	N
Q9UN66	LB/B	-	G3TN72	759	G	V
Q9Y5E1	LB/B	-	G3TN72	174	S	P
Q9Y5E1	LB/B	-	G3TN72	239	V	A
Q9Y5E1	LB/B	-	G3TN72	124	R	S
Q9Y5E1	LB/B	-	G3TN72	185	S	G
Q9Y5E1	LB/B	-	G3TN72	414	K	E
Q9Y5E1	LB/B	-	G3TN72	426	L	M
Q9Y5H4	LB/B	-	F7D549	152	V	I
Q9Y5H4	LB/B	-	F7D549	282	H	Q
Q9Y5H3	LB/B	-	F7D549	89	I	V
Q9Y5H3	LB/B	-	F7D549	796	S	P
Q9Y5H2	LB/B	-	F7D549	104	F	L
Q9Y5H1	LB/B	-	F7D549	5	Q	R
Q9Y5H0	LB/B	-	F7D549	79	P	S
Q9Y5H0	LB/B	-	F7D549	154	I	L
Q9Y5H0	LB/B	-	F7D549	743	A	V
Q9Y5G9	LB/B	-	F7D549	181	A	T
Q9Y5G9	LB/B	-	F7D549	672	R	K
Q9Y5G9	LB/B	-	F7D549	714	D	H
Q9Y5G7	LB/B	-	F7D549	248	R	S
Q9Y5G6	LB/B	-	F7D549	188	E	G
Q9Y5G6	LB/B	-	F7D549	212	L	F
Q9Y5G6	LB/B	-	F7D549	239	T	M
Q9Y5G5	LB/B	-	F7D549	16	L	R
Q9Y5G5	LB/B	-	F7D549	187	N	K
Q9Y5G4	LB/B	-	F7D549	791	L	F
Q9Y5G2	LB/B	-	A0A2U3XJF6	26	P	R
Q9Y5G2	LB/B	-	A0A2U3XJF6	58	V	I
Q9Y5G2	LB/B	-	A0A2U3XJF6	687	K	E
Q9Y5G1	LB/B	-	A0A2U3XJF6	20	F	Y
Q9Y5G1	LB/B	-	A0A2U3XJF6	389	N	K
Q9Y5G1	LB/B	-	A0A2U3XJF6	28	A	V
Q9Y5G0	LB/B	-	A0A2U3XJF6	188	G	S
Q9Y5F9	LB/B	-	A0A2U3XJF6	684	P	S
Q9Y5F9	LB/B	-	A0A2U3XJF6	722	A	T
Q9Y5F9	LB/B	-	A0A2U3XJF6	775	S	A
Q9Y5F8	LB/B	-	A0A2U3XJF6	405	V	L
Q9H1Q7	LB/B	-	A0A212CBY0	22	Q	H
Q96HM7	LB/B	-	G3TVB5	429	P	A
O94913	LB/B	-	A0A061I8P9	651	Q	H
O94913	LB/B	-	A0A061I8P9	1119	H	Y
O94913	LB/B	-	A0A061I8P9	1402	E	K
P35227	LP/P	Turnpenny-Fry syndrome (TPFS) [MIM:618371]	A0A2Y9I770	65	P	L
P35227	LP/P	Turnpenny-Fry syndrome (TPFS) [MIM:618371]	A0A2Y9I770	65	P	S
P35558	LB/B	-	A0A2E5YGM6	267	I	V
P35558	LB/B	-	A0A2E5YGM6	55	R	Q
P35558	LB/B	-	A0A2E5YGM6	60	M	T
P35558	LB/B	-	A0A2E5YGM6	138	T	I
P35558	LB/B	-	A0A2E5YGM6	184	V	L
P35558	LB/B	-	A0A2E5YGM6	276	E	K
P35558	LB/B	-	A0A2E5YGM6	368	V	I
P35558	LB/B	-	A0A2E5YGM6	427	P	S
P35558	LB/B	-	A0A2E5YGM6	586	E	D
P35558	LP/P	Phosphoenolpyruvate carboxykinase deficiency, cytosolic (PCKDC) [MIM:261680]	A0A2E5YGM6	45	I	T
Q9Y6V0	LB/B	-	K7GHK3	2671	T	P
Q9Y6V0	LB/B	-	K7GHK3	2804	A	T
P22061	LB/B	-	G5BMD3	120	V	I
Q96MG8	LB/B	-	U3K6E8	312	N	I
Q96RV3	LB/B	-	G1KD95	809	L	I
Q96RV3	LB/B	-	G1KD95	814	L	I
Q96RV3	LB/B	-	G1KD95	594	A	T
A6NKB5	LB/B	-	R0J817	454	T	A
A6NKB5	LB/B	-	R0J817	117	R	K
A6NKB5	LB/B	-	R0J817	1901	S	N
A6NKB5	LB/B	-	R0J817	1984	R	Q
Q9UKZ9	LB/B	-	A0A0P7XY18	292	P	T
Q9UKZ9	LB/B	-	A0A0P7XY18	280	V	A
P29120	LB/B	-	A0A1V4L147	80	R	Q
P29120	LB/B	-	A0A1V4L147	221	N	D
P29120	LB/B	-	A0A1V4L147	665	Q	E
P29120	LB/B	-	A0A1V4L147	690	S	T
P29120	LP/P	Proprotein convertase 1 deficiency (PC1 deficiency) [MIM:600955]	A0A1V4L147	483	G	R
P29120	LP/P	Proprotein convertase 1 deficiency (PC1 deficiency) [MIM:600955]	A0A1V4L147	307	S	L
Q9UHG2	LB/B	-	G1SWD0	31	A	T
P16519	LB/B	-	A0A2S2QMX9	244	P	Q
P16519	LB/B	-	A0A2S2QMX9	484	K	E
P16519	LB/B	-	A0A2S2QMX9	77	A	D
P16519	LB/B	-	A0A2S2QMX9	267	A	T
P16519	LB/B	-	A0A2S2QMX9	430	R	W
P16519	LB/B	-	A0A2S2QMX9	525	M	V
Q6UW60	LB/B	-	A0A2K6B4W1	267	T	M
P29122	LB/B	-	K7G5Q1	502	C	R
P49585	LP/P	Spondylometaphyseal dysplasia with cone-rod dystrophy (SMDCRD) [MIM:608940]	W5UC53	99	A	T
P49585	LP/P	Spondylometaphyseal dysplasia with cone-rod dystrophy (SMDCRD) [MIM:608940]	W5UC53	99	A	V
P49585	LP/P	Spondylometaphyseal dysplasia with cone-rod dystrophy (SMDCRD) [MIM:608940]	W5UC53	129	E	K
P49585	LP/P	Spondylometaphyseal dysplasia with cone-rod dystrophy (SMDCRD) [MIM:608940]	W5UC53	150	P	A
P49585	LP/P	Spondylometaphyseal dysplasia with cone-rod dystrophy (SMDCRD) [MIM:608940]	W5UC53	191	F	L
P49585	LP/P	Spondylometaphyseal dysplasia with cone-rod dystrophy (SMDCRD) [MIM:608940]	W5UC53	223	R	S
Q15116	LB/B	-	F6U6N6	215	A	V
Q9BUL8	LB/B	-	T1G6T4	102	D	A
Q14690	LB/B	-	S9WVU3	1871	D	A
Q14690	LB/B	-	S9WVU3	623	A	S
Q14690	LB/B	-	S9WVU3	1216	L	F
Q14690	LB/B	-	S9WVU3	397	S	N
Q14690	LB/B	-	S9WVU3	780	A	S
Q14690	LB/B	-	S9WVU3	1453	P	S
Q14690	LB/B	-	S9WVU3	45	K	E
Q53EL6	LB/B	-	A0A212CNX5	36	I	V
Q53EL6	LB/B	-	A0A212CNX5	48	S	Y
Q8WUM4	LB/B	-	A0A0P6ATJ7	730	S	L
Q8WUM4	LB/B	-	A0A0P6ATJ7	309	A	T
Q8WUM4	LB/B	-	A0A0P6ATJ7	378	V	I
Q8WUM4	LB/B	-	A0A0P6ATJ7	550	N	S
Q8WUM4	LB/B	-	A0A0P6ATJ7	638	K	E
Q8WUM4	LB/B	-	A0A0P6ATJ7	7	V	M
Q8WUM4	LB/B	-	A0A0P6ATJ7	429	G	S
Q13371	LB/B	-	H9GIN9	218	K	N
Q9Y233	LB/B	-	F6ZRI6	303	L	P
Q9Y233	LB/B	-	F6ZRI6	706	R	K
Q9Y233	LB/B	-	F6ZRI6	707	D	N
Q9Y233	LP/P	Dyskinesia, limb and orofacial, infantile-onset (IOLOD) [MIM:616921]	F6ZRI6	97	Y	C
Q9Y233	LP/P	Dyskinesia, limb and orofacial, infantile-onset (IOLOD) [MIM:616921]	F6ZRI6	106	A	P
Q9Y233	LP/P	Striatal degeneration, autosomal dominant 2 (ADSD2) [MIM:616922]	F6ZRI6	290	F	L
Q9Y233	LP/P	Striatal degeneration, autosomal dominant 2 (ADSD2) [MIM:616922]	F6ZRI6	324	F	L
Q9HCR9	LB/B	-	E0VPK2	804	R	H
Q9HCR9	LB/B	-	E0VPK2	867	R	G
Q14123	LP/P	Deafness, autosomal dominant, 74 (DFNA74) [MIM:618140]	G1KJ65	260	A	S
O00408	LB/B	-	A0A1V4KFQ1	224	T	I
Q14432	LB/B	-	K7FUU2	12	D	N
Q14432	LP/P	Hypertension and brachydactyly syndrome (HTNB) [MIM:112410]	K7FUU2	445	T	A
Q14432	LP/P	Hypertension and brachydactyly syndrome (HTNB) [MIM:112410]	K7FUU2	445	T	N
Q14432	LP/P	Hypertension and brachydactyly syndrome (HTNB) [MIM:112410]	K7FUU2	445	T	S
Q14432	LP/P	Hypertension and brachydactyly syndrome (HTNB) [MIM:112410]	K7FUU2	447	A	T
Q14432	LP/P	Hypertension and brachydactyly syndrome (HTNB) [MIM:112410]	K7FUU2	447	A	V
Q14432	LP/P	Hypertension and brachydactyly syndrome (HTNB) [MIM:112410]	K7FUU2	449	G	V
Q13370	LB/B	-	K7FUU2	87	A	V
P27815	LB/B	-	T0NQ52	736	A	E
P27815	LB/B	-	T0NQ52	808	H	Y
Q07343	LB/B	-	A0A2I0MC87	703	S	C
Q08493	LB/B	-	P54748	344	R	Q
Q08493	LB/B	-	P54748	131	S	L
Q08493	LB/B	-	P54748	289	R	Q
Q08493	LB/B	-	P54748	344	R	W
Q08499	LP/P	Acrodysostosis 2, with or without hormone resistance (ACRDYS2) [MIM:614613]	Q4RL51	190	S	A
Q08499	LP/P	Acrodysostosis 2, with or without hormone resistance (ACRDYS2) [MIM:614613]	Q4RL51	225	P	T
Q08499	LP/P	Acrodysostosis 2, with or without hormone resistance (ACRDYS2) [MIM:614613]	Q4RL51	226	F	S
Q08499	LP/P	Acrodysostosis 2, with or without hormone resistance (ACRDYS2) [MIM:614613]	Q4RL51	587	T	P
Q08499	LP/P	Acrodysostosis 2, with or without hormone resistance (ACRDYS2) [MIM:614613]	Q4RL51	227	A	S
Q08499	LP/P	Acrodysostosis 2, with or without hormone resistance (ACRDYS2) [MIM:614613]	Q4RL51	228	Q	E
Q08499	LP/P	Acrodysostosis 2, with or without hormone resistance (ACRDYS2) [MIM:614613]	Q4RL51	301	S	T
Q08499	LP/P	Acrodysostosis 2, with or without hormone resistance (ACRDYS2) [MIM:614613]	Q4RL51	304	A	V
Q08499	LP/P	Acrodysostosis 2, with or without hormone resistance (ACRDYS2) [MIM:614613]	Q4RL51	329	V	A
Q08499	LP/P	Acrodysostosis 2, with or without hormone resistance (ACRDYS2) [MIM:614613]	Q4RL51	590	E	A
Q08499	LP/P	Acrodysostosis 2, with or without hormone resistance (ACRDYS2) [MIM:614613]	Q4RL51	673	G	D
Q08499	LP/P	Acrodysostosis 2, with or without hormone resistance (ACRDYS2) [MIM:614613]	Q4RL51	678	I	T
Q5VU43	LB/B	-	A0A1S3FCG7	13	N	S
Q5VU43	LB/B	-	A0A1S3FCG7	25	R	L
Q5VU43	LB/B	-	A0A1S3FCG7	49	I	T
Q5VU43	LB/B	-	A0A1S3FCG7	167	A	T
Q5VU43	LB/B	-	A0A1S3FCG7	171	R	K
Q5VU43	LB/B	-	A0A1S3FCG7	391	E	A
Q5VU43	LB/B	-	A0A1S3FCG7	410	E	V
Q5VU43	LB/B	-	A0A1S3FCG7	482	H	R
Q5VU43	LB/B	-	A0A1S3FCG7	681	R	H
Q5VU43	LB/B	-	A0A1S3FCG7	708	R	C
Q5VU43	LB/B	-	A0A1S3FCG7	1013	F	I
Q5VU43	LB/B	-	A0A1S3FCG7	1066	A	T
Q5VU43	LB/B	-	A0A1S3FCG7	1359	K	E
Q5VU43	LB/B	-	A0A1S3FCG7	1736	V	E
Q5VU43	LB/B	-	A0A1S3FCG7	1742	A	S
Q5VU43	LB/B	-	A0A1S3FCG7	143	K	E
Q5VU43	LB/B	-	A0A1S3FCG7	150	N	S
Q5VU43	LB/B	-	A0A1S3FCG7	1396	R	W
O76074	LB/B	-	A0A1Y1ML52	93	A	V
O76074	LB/B	-	A0A1Y1ML52	181	S	A
P16499	LP/P	Retinitis pigmentosa 43 (RP43) [MIM:613810]	A0A2I2ZH06	344	S	R
P16499	LP/P	Retinitis pigmentosa 43 (RP43) [MIM:613810]	A0A2I2ZH06	102	R	H
P16499	LP/P	Retinitis pigmentosa 43 (RP43) [MIM:613810]	A0A2I2ZH06	102	R	S
P16499	LB/B	-	A0A2I2ZH06	216	N	S
P16499	LB/B	-	A0A2I2ZH06	277	V	A
P16499	LB/B	-	A0A2I2ZH06	293	P	L
P16499	LB/B	-	A0A2I2ZH06	391	V	M
P16499	LP/P	Retinitis pigmentosa 43 (RP43) [MIM:613810]	A0A2I2ZH06	569	Q	K
P16499	LP/P	Retinitis pigmentosa 43 (RP43) [MIM:613810]	A0A2I2ZH06	573	S	P
P16499	LB/B	-	A0A2I2ZH06	827	K	Q
P16499	LB/B	-	A0A2I2ZH06	850	G	V
P16499	LB/B	-	A0A2I2ZH06	145	A	T
P16499	LB/B	-	A0A2I2ZH06	492	Q	H
P35913	LP/P	Retinitis pigmentosa 40 (RP40) [MIM:613801]	S9YQ71	557	H	Y
P35913	LP/P	Retinitis pigmentosa 40 (RP40) [MIM:613801]	S9YQ71	576	G	D
P35913	LP/P	Retinitis pigmentosa 40 (RP40) [MIM:613801]	S9YQ71	699	L	R
P35913	LP/P	Retinitis pigmentosa 40 (RP40) [MIM:613801]	S9YQ71	74	R	C
P35913	LB/B	-	S9YQ71	166	E	K
P35913	LB/B	-	S9YQ71	212	Y	H
P35913	LP/P	Retinitis pigmentosa 40 (RP40) [MIM:613801]	S9YQ71	219	Y	H
P35913	LP/P	Retinitis pigmentosa 40 (RP40) [MIM:613801]	S9YQ71	228	L	H
P35913	LB/B	-	S9YQ71	228	L	I
P35913	LP/P	Night blindness, congenital stationary, autosomal dominant 2 (CSNBAD2) [MIM:163500]	S9YQ71	258	H	N
P35913	LP/P	Retinitis pigmentosa 40 (RP40) [MIM:613801]	S9YQ71	527	L	P
P35913	LP/P	Retinitis pigmentosa 40 (RP40) [MIM:613801]	S9YQ71	535	I	N
P35913	LP/P	Retinitis pigmentosa 40 (RP40) [MIM:613801]	S9YQ71	552	R	Q
P35913	LP/P	Retinitis pigmentosa 40 (RP40) [MIM:613801]	S9YQ71	854	L	R
P35913	LB/B	-	S9YQ71	320	V	I
P35913	LB/B	-	S9YQ71	654	E	D
P35913	LP/P	Retinitis pigmentosa 40 (RP40) [MIM:613801]	S9YQ71	100	R	H
P35913	LP/P	Retinitis pigmentosa 40 (RP40) [MIM:613801]	S9YQ71	776	D	N
Q13946	LB/B	-	A0A0D9RP47	76	G	E
O60658	LB/B	-	A0A0P7VET7	112	E	G
O95263	LP/P	Primary pigmented nodular adrenocortical disease 3 (PPNAD3) [MIM:614190]	A0A2R8N517	305	H	P
Q9HBH1	LB/B	-	H2NRC3	11	W	R
P01127	LB/B	-	A0A1S2ZHH9	88	I	V
P01127	LP/P	Basal ganglia calcification, idiopathic, 5 (IBGC5) [MIM:615483]	A0A1S2ZHH9	9	L	R
P01127	LP/P	Basal ganglia calcification, idiopathic, 5 (IBGC5) [MIM:615483]	A0A1S2ZHH9	119	L	P
Q9GZP0	LB/B	-	G1T961	190	I	V
Q15198	LP/P	Colorectal cancer (CRC) [MIM:114500]	A0A2K5ZU74	23	H	Y
P11177	LB/B	-	S9YAH7	31	L	V
P11177	LP/P	Pyruvate dehydrogenase E1-beta deficiency (PDHBD) [MIM:614111]	S9YAH7	344	P	S
P11177	LP/P	Pyruvate dehydrogenase E1-beta deficiency (PDHBD) [MIM:614111]	S9YAH7	132	Y	C
O00330	LB/B	-	A0A2E2N913	23	R	C
O00330	LB/B	-	A0A2E2N913	101	T	A
O00330	LB/B	-	A0A2E2N913	370	D	V
Q13087	LB/B	-	A0A2K6U893	39	P	S
Q13087	LB/B	-	A0A2K6U893	119	T	R
Q13087	LB/B	-	A0A2K6U893	185	E	K
Q13087	LB/B	-	A0A2K6U893	286	T	M
Q13087	LB/B	-	A0A2K6U893	382	P	A
Q13087	LB/B	-	A0A2K6U893	388	R	Q
Q13087	LB/B	-	A0A2K6U893	502	P	S
P30101	LB/B	-	G1SEV2	415	K	R
Q14554	LB/B	-	A0A1S3WNW4	391	T	M
Q15084	LB/B	-	A0A1U7U4R8	214	K	R
Q8N807	LB/B	-	L8IJI0	26	A	T
Q8N807	LB/B	-	L8IJI0	446	D	N
Q8N807	LB/B	-	L8IJI0	447	V	I
Q8N807	LB/B	-	L8IJI0	475	L	R
Q8N807	LB/B	-	L8IJI0	527	R	K
Q8N807	LB/B	-	L8IJI0	529	G	E
Q15120	LB/B	-	A0A146NHE0	114	K	T
Q15120	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 6 (CMTX6) [MIM:300905]	A0A146NHE0	158	R	H
Q15120	LB/B	-	A0A146NHE0	334	Y	S
Q53GG5	LB/B	-	A0A218UW98	127	V	M
Q96HC4	LB/B	-	A0A287A3D2	136	S	F
Q96HC4	LB/B	-	A0A287A3D2	319	S	L
Q96HC4	LB/B	-	A0A287A3D2	345	A	T
Q96HC4	LB/B	-	A0A287A3D2	381	T	A
Q96HC4	LB/B	-	A0A287A3D2	388	P	S
Q96HC4	LB/B	-	A0A287A3D2	492	S	N
Q86YL7	LB/B	-	A0A2K6TVH0	105	A	G
Q86YL7	LB/B	-	A0A2K6TVH0	147	A	G
Q8NCN5	LB/B	-	C3XU72	109	Y	H
Q5T2R2	LP/P	Coenzyme Q10 deficiency, primary, 2 (COQ10D2) [MIM:614651]	Q33DR2	308	D	E
Q86YH6	LB/B	-	W5PMZ5	3	F	L
Q86YH6	LP/P	Coenzyme Q10 deficiency, primary, 3 (COQ10D3) [MIM:614652]	W5PMZ5	382	S	L
P52945	LB/B	-	L5L5N0	18	C	R
P52945	LB/B	-	L5L5N0	59	Q	L
P52945	LB/B	-	L5L5N0	76	D	N
P52945	LB/B	-	L5L5N0	197	R	H
Q6P996	LB/B	-	A0A1D5PXN7	301	P	L
Q6P474	LB/B	-	Q86XE2	209	M	V
Q6P474	LB/B	-	Q86XE2	429	L	F
Q6P474	LB/B	-	Q86XE2	429	L	R
O00764	LP/P	Neuropathy, hereditary motor and sensory, 6C, with optic atrophy (HMSN6C) [MIM:618511]	A0A1W4YV75	220	R	Q
O00764	LP/P	Neuropathy, hereditary motor and sensory, 6C, with optic atrophy (HMSN6C) [MIM:618511]	A0A1W4YV75	228	A	T
P01213	LP/P	Spinocerebellar ataxia 23 (SCA23) [MIM:610245]	M7BYV4	138	R	S
P01213	LP/P	Spinocerebellar ataxia 23 (SCA23) [MIM:610245]	M7BYV4	211	L	S
P01213	LP/P	Spinocerebellar ataxia 23 (SCA23) [MIM:610245]	M7BYV4	212	R	W
P01213	LP/P	Spinocerebellar ataxia 23 (SCA23) [MIM:610245]	M7BYV4	215	R	C
P01213	LP/P	Spinocerebellar ataxia 23 (SCA23) [MIM:610245]	M7BYV4	22	C	Y
P01213	LB/B	-	M7BYV4	25	R	Q
P01213	LP/P	Spinocerebellar ataxia 23 (SCA23) [MIM:610245]	M7BYV4	206	R	C
P01213	LP/P	Spinocerebellar ataxia 23 (SCA23) [MIM:610245]	M7BYV4	206	R	H
P01213	LP/P	Spinocerebellar ataxia 23 (SCA23) [MIM:610245]	M7BYV4	227	G	D
O15018	LB/B	-	A0A2D0PR72	1258	Q	K
O15018	LB/B	-	A0A2D0PR72	1274	T	A
O15018	LB/B	-	A0A2D0PR72	1343	D	E
O15018	LB/B	-	A0A2D0PR72	1425	T	M
O15018	LB/B	-	A0A2D0PR72	1649	A	V
O15018	LB/B	-	A0A2D0PR72	2247	R	Q
O15018	LB/B	-	A0A2D0PR72	1178	E	G
Q8NEN9	LB/B	-	A0A093PTJ3	806	V	A
Q8NEN9	LB/B	-	A0A093PTJ3	897	R	Q
Q6ZMN7	LB/B	-	A0A087XH79	429	G	S
Q9H792	LB/B	-	A0A1S3EVE0	213	G	R
Q9H792	LB/B	-	A0A1S3EVE0	240	V	I
Q9H792	LB/B	-	A0A1S3EVE0	440	S	P
Q9H792	LB/B	-	A0A1S3EVE0	792	S	I
Q9H792	LB/B	-	A0A1S3EVE0	836	D	E
Q9H792	LB/B	-	A0A1S3EVE0	1071	R	K
Q9H792	LB/B	-	A0A1S3EVE0	1077	T	P
Q9H792	LB/B	-	A0A1S3EVE0	1408	P	Q
Q9H792	LB/B	-	A0A1S3EVE0	1542	S	T
Q9H792	LB/B	-	A0A1S3EVE0	1699	R	G
P30086	LB/B	-	A0A1B6FLK2	9	S	N
Q96S96	LB/B	-	A0A2Y9T8D2	125	K	E
Q96S96	LB/B	-	A0A2Y9T8D2	211	E	G
P16284	LB/B	-	A0A093HVB0	125	V	L
P16284	LB/B	-	A0A093HVB0	304	C	Y
P16284	LB/B	-	A0A093HVB0	563	S	I
P16284	LB/B	-	A0A093HVB0	563	S	N
P16284	LB/B	-	A0A093HVB0	670	R	G
A5PLL7	LB/B	-	G1KRA3	7	W	G
Q9GZU2	LB/B	-	E2J1C2	235	A	T
Q9GZU2	LB/B	-	E2J1C2	839	V	L
Q9GZU2	LB/B	-	E2J1C2	983	D	G
Q9GZU2	LB/B	-	E2J1C2	1576	R	L
Q9GZU2	LB/B	-	E2J1C2	624	E	G
Q9GZU2	LB/B	-	E2J1C2	947	N	S
Q9GZU2	LB/B	-	E2J1C2	1456	A	V
Q9GZU2	LB/B	-	E2J1C2	1576	R	H
Q8N2H9	LB/B	-	A0A147AWU7	287	V	M
Q9BRX2	LB/B	-	A0A2R6XHC6	221	L	M
Q8IZL8	LB/B	-	W5PE21	1126	T	S
Q9UBM1	LB/B	-	D3YTC7	175	V	M
Q9UBM1	LB/B	-	D3YTC7	58	V	I
Q9UBM1	LB/B	-	D3YTC7	3	R	W
Q9UBM1	LB/B	-	D3YTC7	194	G	R
Q9UBM1	LB/B	-	D3YTC7	58	V	L
P01210	LB/B	-	M7BYV4	247	G	D
P01210	LB/B	-	M7BYV4	83	T	N
P12955	LP/P	Prolidase deficiency (PD) [MIM:170100]	A0A1U7THA8	276	D	N
P12955	LP/P	Prolidase deficiency (PD) [MIM:170100]	A0A1U7THA8	448	G	R
P12955	LP/P	Prolidase deficiency (PD) [MIM:170100]	A0A1U7THA8	184	R	Q
P12955	LP/P	Prolidase deficiency (PD) [MIM:170100]	A0A1U7THA8	278	G	D
P12955	LB/B	-	A0A1U7THA8	435	L	F
P12955	LB/B	-	A0A1U7THA8	388	R	H
O15534	LB/B	-	Q8K3T2	962	A	P
O15534	LB/B	-	Q8K3T2	968	R	H
O15055	LB/B	-	Q8K3T2	1244	G	E
O15055	LP/P	Advanced sleep phase syndrome, familial, 1 (FASPS1) [MIM:604348]	Q8K3T2	662	S	G
O15055	LB/B	-	Q8K3T2	5	A	S
O15055	LB/B	-	Q8K3T2	729	V	I
O15055	LB/B	-	Q8K3T2	903	V	I
O15055	LB/B	-	Q8K3T2	949	F	Y
O00541	LB/B	-	W5PEF1	264	T	S
O00541	LB/B	-	W5PEF1	370	D	H
O00541	LB/B	-	W5PEF1	411	A	T
O43933	LP/P	Peroxisome biogenesis disorder 1A (PBD1A) [MIM:214100]	A0A1U7R1A8	664	L	P
O43933	LP/P	Peroxisome biogenesis disorder 1B (PBD1B) [MIM:601539]	A0A1U7R1A8	664	L	P
O43933	LP/P	Peroxisome biogenesis disorder 1A (PBD1A) [MIM:214100]	A0A1U7R1A8	843	G	D
O43933	LP/P	Peroxisome biogenesis disorder 1B (PBD1B) [MIM:601539]	A0A1U7R1A8	843	G	D
O43933	LP/P	Peroxisome biogenesis disorder complementation group 1 (PBD-CG1) [MIM:214100]	A0A1U7R1A8	843	G	D
O43933	LB/B	-	A0A1U7R1A8	696	I	M
O43933	LB/B	-	A0A1U7R1A8	640	I	R
O43933	LP/P	Peroxisome biogenesis disorder complementation group 1 (PBD-CG1) [MIM:214100]	A0A1U7R1A8	590	L	R
O43933	LP/P	Peroxisome biogenesis disorder complementation group 1 (PBD-CG1) [MIM:214100]	A0A1U7R1A8	593	G	R
O43933	LP/P	Peroxisome biogenesis disorder complementation group 1 (PBD-CG1) [MIM:214100]	A0A1U7R1A8	798	R	G
O43933	LB/B	-	A0A1U7R1A8	948	R	Q
O43933	LP/P	Peroxisome biogenesis disorder complementation group 1 (PBD-CG1) [MIM:214100]	A0A1U7R1A8	1237	A	E
O43933	LP/P	Heimler syndrome 1 (HMLR1) [MIM:234580]	A0A1U7R1A8	581	R	P
O43933	LP/P	Heimler syndrome 1 (HMLR1) [MIM:234580]	A0A1U7R1A8	705	L	W
O43933	LP/P	Heimler syndrome 1 (HMLR1) [MIM:234580]	A0A1U7R1A8	989	I	T
O43933	LP/P	Peroxisome biogenesis disorder 1B (PBD1B) [MIM:601539]	A0A1U7R1A8	989	I	T
O43933	LP/P	Peroxisome biogenesis disorder 1B (PBD1B) [MIM:601539]	A0A1U7R1A8	998	R	Q
O43933	LP/P	Peroxisome biogenesis disorder 1A (PBD1A) [MIM:214100]	A0A1U7R1A8	597	L	P
O43933	LP/P	Peroxisome biogenesis disorder 1A (PBD1A) [MIM:214100]	A0A1U7R1A8	949	R	W
O43933	LP/P	Peroxisome biogenesis disorder 1A (PBD1A) [MIM:214100]	A0A1U7R1A8	970	G	A
O60683	LP/P	Peroxisome biogenesis disorder 6B (PBD6B) [MIM:614871]	A0A2K6MU14	290	H	Q
O60683	LB/B	-	A0A2K6MU14	274	T	A
O60683	LP/P	Peroxisome biogenesis disorder 6B (PBD6B) [MIM:614871]	A0A2K6MU14	177	L	R
O60683	LP/P	Peroxisome biogenesis disorder 6B (PBD6B) [MIM:614871]	A0A2K6MU14	276	C	F
O60683	LP/P	Peroxisome biogenesis disorder 6A (PBD6A) [MIM:614870]	A0A2K6MU14	296	C	F
O60683	LP/P	Peroxisome biogenesis disorder 6B (PBD6B) [MIM:614871]	A0A2K6MU14	311	R	Q
Q96HA9	LB/B	-	A0A2R8MV11	91	C	W
Q92968	LP/P	Peroxisome biogenesis disorder 11B (PBD11B) [MIM:614885]	Q6PFQ3	326	I	T
Q92968	LP/P	Peroxisome biogenesis disorder 11B (PBD11B) [MIM:614885]	Q6PFQ3	313	W	G
O75381	LB/B	-	K7FLX6	117	A	S
O75381	LB/B	-	K7FLX6	150	A	S
O75381	LB/B	-	K7FLX6	320	R	K
P28328	LP/P	Peroxisome biogenesis disorder 5B (PBD5B) [MIM:614867]	A0A2B4S4S1	55	E	K
P28328	LB/B	-	A0A2B4S4S1	184	C	R
P28328	LP/P	Peroxisome biogenesis disorder 5A (PBD5A) [MIM:614866]	A0A2B4S4S1	247	C	R
P50542	LP/P	Peroxisome biogenesis disorder 2B (PBD2B) [MIM:202370]	K1RNB9	526	N	K
P50542	LP/P	Peroxisome biogenesis disorder 2B (PBD2B) [MIM:202370]	K1RNB9	600	S	W
P50542	LP/P	-	K1RNB9	218	F	S
Q13608	LP/P	Peroxisome biogenesis disorder 4A (PBD4A) [MIM:614862]	A0A1S3WKM9	812	R	Q
Q13608	LP/P	Peroxisome biogenesis disorder 4A (PBD4A) [MIM:614862]	A0A1S3WKM9	812	R	W
Q13608	LB/B	-	A0A1S3WKM9	809	A	V
Q13608	LB/B	-	A0A1S3WKM9	882	V	I
Q13608	LB/B	-	A0A1S3WKM9	939	P	Q
Q13608	LB/B	-	A0A1S3WKM9	79	A	P
Q13608	LP/P	Heimler syndrome 2 (HMLR2) [MIM:616617]	A0A1S3WKM9	274	P	L
Q13608	LP/P	Peroxisome biogenesis disorder complementation group 4 (PBD-CG4) [MIM:614862]	A0A1S3WKM9	849	N	T
Q13608	LP/P	Peroxisome biogenesis disorder complementation group 4 (PBD-CG4) [MIM:614862]	A0A1S3WKM9	860	R	Q
Q13608	LP/P	Peroxisome biogenesis disorder complementation group 4 (PBD-CG4) [MIM:614862]	A0A1S3WKM9	860	R	W
Q13608	LB/B	-	A0A1S3WKM9	924	A	S
Q13608	LP/P	Heimler syndrome 2 (HMLR2) [MIM:616617]	A0A1S3WKM9	644	R	W
Q13608	LP/P	Peroxisome biogenesis disorder complementation group 4 (PBD-CG4) [MIM:614862]	A0A1S3WKM9	534	L	P
Q13608	LP/P	Peroxisome biogenesis disorder complementation group 4 (PBD-CG4) [MIM:614862]	A0A1S3WKM9	413	G	V
Q13608	LP/P	Heimler syndrome 2 (HMLR2) [MIM:616617]	A0A1S3WKM9	572	T	I
Q13608	LP/P	Heimler syndrome 2 (HMLR2) [MIM:616617]	A0A1S3WKM9	905	C	F
O15067	LB/B	-	A0A0C9QLK2	19	P	S
O15067	LB/B	-	A0A0C9QLK2	367	P	L
O15067	LB/B	-	A0A0C9QLK2	481	F	Y
O15067	LB/B	-	A0A0C9QLK2	621	L	P
P07737	LP/P	Amyotrophic lateral sclerosis 18 (ALS18) [MIM:614808]	A0A2K6FQM5	71	C	G
P07737	LP/P	Amyotrophic lateral sclerosis 18 (ALS18) [MIM:614808]	A0A2K6FQM5	114	M	T
P07737	LP/P	Amyotrophic lateral sclerosis 18 (ALS18) [MIM:614808]	A0A2K6FQM5	118	G	V
P15259	LP/P	Glycogen storage disease 10 (GSD10) [MIM:261670]	K7IU97	89	E	A
P15259	LP/P	Glycogen storage disease 10 (GSD10) [MIM:261670]	K7IU97	90	R	W
P15259	LP/P	Glycogen storage disease 10 (GSD10) [MIM:261670]	K7IU97	97	G	D
Q8N0Y7	LB/B	-	K7IU97	40	R	C
Q8N0Y7	LB/B	-	K7IU97	90	R	Q
Q8N0Y7	LB/B	-	K7IU97	175	I	T
Q9UHJ9	LP/P	Hyperphosphatasia with impaired intellectual development syndrome 3 (HPMRS3) [MIM:614207]	A0A212DHX3	16	R	W
Q9UHJ9	LP/P	Hyperphosphatasia with impaired intellectual development syndrome 3 (HPMRS3) [MIM:614207]	A0A212DHX3	99	Y	C
Q9UHJ9	LP/P	Hyperphosphatasia with impaired intellectual development syndrome 3 (HPMRS3) [MIM:614207]	A0A212DHX3	127	L	S
Q9UHJ9	LP/P	Hyperphosphatasia with impaired intellectual development syndrome 3 (HPMRS3) [MIM:614207]	A0A212DHX3	160	T	I
Q9UHJ9	LP/P	Hyperphosphatasia with impaired intellectual development syndrome 3 (HPMRS3) [MIM:614207]	A0A212DHX3	177	R	P
Q96FM1	LP/P	Hyperphosphatasia with impaired intellectual development syndrome 4 (HPMRS4) [MIM:615716]	A0A2Y9JWQ2	92	G	D
Q96FM1	LP/P	Hyperphosphatasia with impaired intellectual development syndrome 4 (HPMRS4) [MIM:615716]	A0A2Y9JWQ2	105	P	R
Q96FM1	LP/P	Hyperphosphatasia with impaired intellectual development syndrome 4 (HPMRS4) [MIM:615716]	A0A2Y9JWQ2	305	D	G
Q9HCN3	LB/B	-	G1PIW4	136	T	A
Q9HCN3	LB/B	-	G1PIW4	310	I	V
Q9HCN3	LB/B	-	G1PIW4	567	R	W
Q96JS3	LB/B	-	A0A1S3GCY9	244	G	E
Q96JS3	LB/B	-	A0A1S3GCY9	248	Q	E
Q96JS3	LB/B	-	A0A1S3GCY9	256	P	L
Q96JS3	LB/B	-	A0A1S3GCY9	398	N	S
Q96JS3	LB/B	-	A0A1S3GCY9	592	M	I
Q96JS3	LB/B	-	A0A1S3GCY9	678	I	V
Q96JS3	LB/B	-	A0A1S3GCY9	806	H	D
Q96JS3	LB/B	-	A0A1S3GCY9	244	G	R
Q8N328	LB/B	-	A0A2K5QFQ3	382	R	K
Q8N328	LB/B	-	A0A2K5QFQ3	446	Q	E
P52209	LB/B	-	G1T7Z0	268	A	S
P53609	LB/B	-	G5C1J2	103	I	V
Q96PD5	LB/B	-	A0A1U8CG21	46	T	A
Q96PD5	LB/B	-	A0A1U8CG21	99	R	Q
Q96PD5	LB/B	-	A0A1U8CG21	257	T	N
Q96PD5	LB/B	-	A0A1U8CG21	270	M	K
Q96PD5	LB/B	-	A0A1U8CG21	476	R	W
Q96PD5	LB/B	-	A0A1U8CG21	394	R	Q
Q96LB8	LB/B	-	A0A2U3ZVF2	92	Q	R
Q96LB8	LB/B	-	A0A2U3ZVF2	192	G	V
Q96LB8	LB/B	-	A0A2U3ZVF2	213	V	I
Q96LB8	LB/B	-	A0A2U3ZVF2	301	D	N
Q96LB8	LB/B	-	A0A2U3ZVF2	13	I	L
Q96LB8	LB/B	-	A0A2U3ZVF2	3	P	L
P36871	LB/B	-	A0A0K9Q2H9	68	K	M
P36871	LB/B	-	A0A0K9Q2H9	221	R	C
P36871	LB/B	-	A0A0K9Q2H9	420	Y	H
P36871	LB/B	-	A0A0K9Q2H9	501	V	I
P36871	LB/B	-	A0A0K9Q2H9	88	I	V
P36871	LP/P	Congenital disorder of glycosylation 1T (CDG1T) [MIM:614921]	A0A0K9Q2H9	115	T	A
P36871	LP/P	Congenital disorder of glycosylation 1T (CDG1T) [MIM:614921]	A0A0K9Q2H9	121	G	R
P36871	LP/P	Congenital disorder of glycosylation 1T (CDG1T) [MIM:614921]	A0A0K9Q2H9	19	T	A
P36871	LP/P	Congenital disorder of glycosylation 1T (CDG1T) [MIM:614921]	A0A0K9Q2H9	38	N	Y
P36871	LP/P	Congenital disorder of glycosylation 1T (CDG1T) [MIM:614921]	A0A0K9Q2H9	41	Q	R
P36871	LP/P	Congenital disorder of glycosylation 1T (CDG1T) [MIM:614921]	A0A0K9Q2H9	62	D	H
P36871	LP/P	Congenital disorder of glycosylation 1T (CDG1T) [MIM:614921]	A0A0K9Q2H9	263	D	G
P36871	LP/P	Congenital disorder of glycosylation 1T (CDG1T) [MIM:614921]	A0A0K9Q2H9	263	D	Y
P36871	LP/P	Congenital disorder of glycosylation 1T (CDG1T) [MIM:614921]	A0A0K9Q2H9	291	G	R
P36871	LP/P	Congenital disorder of glycosylation 1T (CDG1T) [MIM:614921]	A0A0K9Q2H9	330	G	R
P36871	LP/P	Congenital disorder of glycosylation 1T (CDG1T) [MIM:614921]	A0A0K9Q2H9	377	E	K
P36871	LP/P	Congenital disorder of glycosylation 1T (CDG1T) [MIM:614921]	A0A0K9Q2H9	388	E	K
P36871	LP/P	Congenital disorder of glycosylation 1T (CDG1T) [MIM:614921]	A0A0K9Q2H9	516	L	P
O95394	LB/B	-	A0A0Q3P619	466	D	N
O95394	LP/P	Immunodeficiency 23 (IMD23) [MIM:615816]	A0A0Q3P619	83	L	S
O95394	LP/P	Immunodeficiency 23 (IMD23) [MIM:615816]	A0A0Q3P619	239	D	H
O95394	LP/P	Immunodeficiency 23 (IMD23) [MIM:615816]	A0A0Q3P619	246	N	S
O95394	LP/P	Immunodeficiency 23 (IMD23) [MIM:615816]	A0A0Q3P619	297	D	E
O95394	LP/P	Immunodeficiency 23 (IMD23) [MIM:615816]	A0A0Q3P619	451	Q	R
O95394	LP/P	Immunodeficiency 23 (IMD23) [MIM:615816]	A0A0Q3P619	501	E	Q
O95394	LP/P	Immunodeficiency 23 (IMD23) [MIM:615816]	A0A0Q3P619	502	D	Y
P06401	LB/B	-	F1NYP9	625	R	I
P06401	LB/B	-	F1NYP9	865	S	L
P06401	LB/B	-	F1NYP9	344	S	T
P06401	LB/B	-	F1NYP9	660	V	L
P06401	LB/B	-	F1NYP9	50	A	T
P06401	LB/B	-	F1NYP9	120	A	V
P06401	LB/B	-	F1NYP9	186	P	L
P06401	LB/B	-	F1NYP9	301	M	R
P06401	LB/B	-	F1NYP9	444	A	S
P06401	LB/B	-	F1NYP9	529	V	L
P06401	LB/B	-	F1NYP9	536	Q	P
P06401	LB/B	-	F1NYP9	651	L	V
P06401	LB/B	-	F1NYP9	347	C	S
Q9C0D0	LB/B	-	A0A2U4C4L7	247	I	M
Q9C0D0	LP/P	Developmental and epileptic encephalopathy 70 (DEE70) [MIM:618298]	A0A2U4C4L7	521	R	C
Q9C0D0	LP/P	Developmental and epileptic encephalopathy 70 (DEE70) [MIM:618298]	A0A2U4C4L7	479	N	I
Q9C0D0	LP/P	Developmental and epileptic encephalopathy 70 (DEE70) [MIM:618298]	A0A2U4C4L7	500	L	P
O75167	LB/B	-	A0A2Y9LW70	165	P	S
O75167	LB/B	-	A0A2Y9LW70	449	I	V
Q9H814	LB/B	-	A0A1S3A1D9	82	R	C
O43189	LB/B	-	L5KYZ5	304	R	K
O43189	LB/B	-	L5KYZ5	42	T	S
Q86YI8	LB/B	-	A0A1S3GGK3	20	K	E
O94880	LB/B	-	A0A2U4ARH6	115	K	R
O75151	LB/B	-	G1N1M1	56	T	P
O75151	LB/B	-	G1N1M1	1058	S	L
Q9BVI0	LB/B	-	M4A5R6	605	V	M
Q96BD5	LB/B	-	A2AHG3	347	R	H
Q92576	LB/B	-	A0A0F7Z675	1834	H	Y
Q92576	LB/B	-	A0A0F7Z675	525	V	I
Q8IWS0	LP/P	Boerjeson-Forssman-Lehmann syndrome (BFLS) [MIM:301900]	G3X763	45	C	Y
Q8IWS0	LP/P	Boerjeson-Forssman-Lehmann syndrome (BFLS) [MIM:301900]	G3X763	99	C	F
Q8IWS0	LP/P	Boerjeson-Forssman-Lehmann syndrome (BFLS) [MIM:301900]	G3X763	229	H	R
Q8IWS0	LP/P	Boerjeson-Forssman-Lehmann syndrome (BFLS) [MIM:301900]	G3X763	234	K	E
Q8IWS0	LP/P	Boerjeson-Forssman-Lehmann syndrome (BFLS) [MIM:301900]	G3X763	257	R	G
Q8IWS0	LP/P	Boerjeson-Forssman-Lehmann syndrome (BFLS) [MIM:301900]	G3X763	305	C	F
Q9UPP1	LP/P	Intellectual developmental disorder, X-linked, syndromic, Siderius type (MRXSSD) [MIM:300263]	G5B732	315	F	S
O43175	LP/P	Phosphoglycerate dehydrogenase deficiency (PHGDHD) [MIM:601815]	F7DRK1	425	V	M
O43175	LP/P	Phosphoglycerate dehydrogenase deficiency (PHGDHD) [MIM:601815]	F7DRK1	135	R	W
O43175	LP/P	Phosphoglycerate dehydrogenase deficiency (PHGDHD) [MIM:601815]	F7DRK1	261	V	M
O43175	LP/P	Phosphoglycerate dehydrogenase deficiency (PHGDHD) [MIM:601815]	F7DRK1	373	A	T
O43175	LP/P	Phosphoglycerate dehydrogenase deficiency (PHGDHD) [MIM:601815]	F7DRK1	377	G	S
O43175	LP/P	Phosphoglycerate dehydrogenase deficiency (PHGDHD) [MIM:601815]	F7DRK1	490	V	M
O43175	LP/P	Neu-Laxova syndrome 1 (NLS1) [MIM:256520]	F7DRK1	140	G	R
O43175	LP/P	Neu-Laxova syndrome 1 (NLS1) [MIM:256520]	F7DRK1	163	R	Q
Q93100	LB/B	-	L8I856	770	Y	C
Q93100	LP/P	Glycogen storage disease 9B (GSD9B) [MIM:261750]	L8I856	118	A	P
Q93100	LB/B	-	L8I856	657	Q	K
Q93100	LB/B	-	L8I856	820	E	V
P15735	LP/P	Glycogen storage disease 9C (GSD9C) [MIM:613027]	A0A212CYG6	106	V	E
P15735	LP/P	Glycogen storage disease 9C (GSD9C) [MIM:613027]	A0A212CYG6	189	G	E
P15735	LP/P	Glycogen storage disease 9C (GSD9C) [MIM:613027]	A0A212CYG6	157	E	K
P15735	LP/P	Glycogen storage disease 9C (GSD9C) [MIM:613027]	A0A212CYG6	215	D	N
P15735	LB/B	-	A0A212CYG6	317	A	T
P15735	LB/B	-	A0A212CYG6	247	E	G
Q9Y5J5	LB/B	-	A0A1S3FA22	28	R	Q
Q86SQ0	LB/B	-	M3XMV8	941	P	S
O60346	LB/B	-	A0A2K6N8D6	1118	S	T
Q99453	LB/B	-	A0A2K6KT52	100	R	L
Q99453	LB/B	-	A0A2K6KT52	141	R	G
Q99453	LP/P	Central hypoventilation syndrome, congenital, 1 (CCHS1) [MIM:209880]	A0A2K6KT52	141	R	Q
Q99453	LP/P	Central hypoventilation syndrome, congenital, 1 (CCHS1) [MIM:209880]	A0A2K6KT52	143	Q	R
Q99453	LB/B	-	A0A2K6KT52	197	G	D
O14832	LP/P	Refsum disease (RD) [MIM:266500]	A0A2K5ML30	269	N	H
O14832	LP/P	Refsum disease (RD) [MIM:266500]	A0A2K5ML30	275	R	W
O14832	LB/B	-	A0A2K5ML30	29	P	S
O14832	LP/P	Refsum disease (RD) [MIM:266500]	A0A2K5ML30	173	P	S
O14832	LP/P	Refsum disease (RD) [MIM:266500]	A0A2K5ML30	176	Q	K
O14832	LP/P	Refsum disease (RD) [MIM:266500]	A0A2K5ML30	177	D	G
O14832	LP/P	Refsum disease (RD) [MIM:266500]	A0A2K5ML30	193	W	R
O14832	LP/P	Refsum disease (RD) [MIM:266500]	A0A2K5ML30	197	E	Q
O14832	LP/P	Refsum disease (RD) [MIM:266500]	A0A2K5ML30	199	I	F
O14832	LP/P	Refsum disease (RD) [MIM:266500]	A0A2K5ML30	204	G	S
O14832	LP/P	Refsum disease (RD) [MIM:266500]	A0A2K5ML30	220	H	Y
O14832	LB/B	-	A0A2K5ML30	245	R	Q
O14832	LP/P	Refsum disease (RD) [MIM:266500]	A0A2K5ML30	257	F	S
O14832	LP/P	Refsum disease (RD) [MIM:266500]	A0A2K5ML30	275	R	Q
O14832	LP/P	Refsum disease (RD) [MIM:266500]	A0A2K5ML30	83	N	Y
O14832	LP/P	Refsum disease (RD) [MIM:266500]	A0A2K5ML30	175	H	R
O14832	LB/B	-	A0A2K5ML30	215	G	S
Q96FC7	LB/B	-	S7MUJ3	342	V	L
Q6UXB8	LB/B	-	L5M608	50	T	P
Q6UXB8	LB/B	-	L5M608	416	L	V
Q8TCG2	LB/B	-	M3X9K8	78	S	P
A4QPH2	LB/B	-	B4DQC6	223	E	Q
O75928	LB/B	-	A0A2K5M5T3	207	V	A
Q8WXW3	LB/B	-	F6RPZ8	167	I	V
Q8WXW3	LP/P	Joubert syndrome 33 (JBTS33) [MIM:617767]	F6RPZ8	405	R	Q
Q8WXW3	LB/B	-	F6RPZ8	630	I	V
Q8WXW3	LP/P	-	F6RPZ8	89	E	Q
Q8WXW3	LP/P	Joubert syndrome 33 (JBTS33) [MIM:617767]	F6RPZ8	637	D	A
Q13492	LB/B	-	E1BQV0	158	T	P
Q13492	LB/B	-	E1BQV0	383	S	F
Q13492	LB/B	-	E1BQV0	578	W	C
Q13492	LB/B	-	E1BQV0	579	Q	E
Q13492	LB/B	-	E1BQV0	641	F	L
Q92508	LP/P	Dehydrated hereditary stomatocytosis 1 with or without pseudohyperkalemia and/or perinatal edema (DHS1) [MIM:194380]	A0A0F8AJH8	718	G	S
Q92508	LP/P	Dehydrated hereditary stomatocytosis 1 with or without pseudohyperkalemia and/or perinatal edema (DHS1) [MIM:194380]	A0A0F8AJH8	782	G	S
Q92508	LP/P	Dehydrated hereditary stomatocytosis 1 with or without pseudohyperkalemia and/or perinatal edema (DHS1) [MIM:194380]	A0A0F8AJH8	808	R	Q
Q92508	LP/P	Dehydrated hereditary stomatocytosis 1 with or without pseudohyperkalemia and/or perinatal edema (DHS1) [MIM:194380]	A0A0F8AJH8	1117	S	L
Q92508	LP/P	Dehydrated hereditary stomatocytosis 1 with or without pseudohyperkalemia and/or perinatal edema (DHS1) [MIM:194380]	A0A0F8AJH8	1358	R	P
Q92508	LP/P	Dehydrated hereditary stomatocytosis 1 with or without pseudohyperkalemia and/or perinatal edema (DHS1) [MIM:194380]	A0A0F8AJH8	2003	A	D
Q92508	LP/P	Dehydrated hereditary stomatocytosis 1 with or without pseudohyperkalemia and/or perinatal edema (DHS1) [MIM:194380]	A0A0F8AJH8	2020	A	T
Q92508	LP/P	Dehydrated hereditary stomatocytosis 1 with or without pseudohyperkalemia and/or perinatal edema (DHS1) [MIM:194380]	A0A0F8AJH8	2020	A	V
Q92508	LP/P	Dehydrated hereditary stomatocytosis 1 with or without pseudohyperkalemia and/or perinatal edema (DHS1) [MIM:194380]	A0A0F8AJH8	2127	T	M
Q92508	LP/P	Dehydrated hereditary stomatocytosis 1 with or without pseudohyperkalemia and/or perinatal edema (DHS1) [MIM:194380]	A0A0F8AJH8	2225	M	R
Q92508	LP/P	Dehydrated hereditary stomatocytosis 1 with or without pseudohyperkalemia and/or perinatal edema (DHS1) [MIM:194380]	A0A0F8AJH8	2456	R	H
Q92508	LP/P	Dehydrated hereditary stomatocytosis 1 with or without pseudohyperkalemia and/or perinatal edema (DHS1) [MIM:194380]	A0A0F8AJH8	2488	R	Q
Q9H5I5	LB/B	-	A0A0F8AJH8	2463	V	I
Q9H5I5	LP/P	Arthrogryposis, distal, 5 (DA5) [MIM:108145]	A0A0F8AJH8	802	I	F
Q9H5I5	LB/B	-	A0A0F8AJH8	1354	V	I
Q9H5I5	LP/P	Marden-Walker syndrome (MWKS) [MIM:248700]	A0A0F8AJH8	2686	R	C
Q9H5I5	LP/P	Arthrogryposis, distal, 3 (DA3) [MIM:114300]	A0A0F8AJH8	2686	R	H
Q9H5I5	LP/P	Arthrogryposis, distal, 5 (DA5) [MIM:108145]	A0A0F8AJH8	2718	R	L
Q9H5I5	LP/P	Arthrogryposis, distal, 5 (DA5) [MIM:108145]	A0A0F8AJH8	2718	R	P
Q9H5I5	LP/P	Arthrogryposis, distal, 5 (DA5) [MIM:108145]	A0A0F8AJH8	2739	S	P
Q9H5I5	LP/P	Arthrogryposis, distal, 5 (DA5) [MIM:108145]	A0A0F8AJH8	712	M	V
Q9H5I5	LP/P	Arthrogryposis, distal, with impaired proprioception and touch (DAIPT) [MIM:617146]	A0A0F8AJH8	1685	R	P
Q9H611	LB/B	-	A0A2K5ZH30	640	I	N
P37287	LP/P	Paroxysmal nocturnal hemoglobinuria 1 (PNH1) [MIM:300818]	A0A146MU15	155	S	F
P37287	LP/P	Paroxysmal nocturnal hemoglobinuria 1 (PNH1) [MIM:300818]	A0A146MU15	297	N	D
P37287	LP/P	Paroxysmal nocturnal hemoglobinuria 1 (PNH1) [MIM:300818]	A0A146MU15	40	D	H
P37287	LP/P	Paroxysmal nocturnal hemoglobinuria 1 (PNH1) [MIM:300818]	A0A146MU15	48	G	A
P37287	LP/P	Paroxysmal nocturnal hemoglobinuria 1 (PNH1) [MIM:300818]	A0A146MU15	48	G	D
P37287	LP/P	Paroxysmal nocturnal hemoglobinuria 1 (PNH1) [MIM:300818]	A0A146MU15	48	G	V
P37287	LP/P	Paroxysmal nocturnal hemoglobinuria 1 (PNH1) [MIM:300818]	A0A146MU15	128	H	R
P37287	LP/P	Paroxysmal nocturnal hemoglobinuria 1 (PNH1) [MIM:300818]	A0A146MU15	239	G	R
P37287	LP/P	Paroxysmal nocturnal hemoglobinuria 1 (PNH1) [MIM:300818]	A0A146MU15	19	R	W
P37287	LP/P	Multiple congenital anomalies-hypotonia-seizures syndrome 2 (MCAHS2) [MIM:300868]	A0A146MU15	77	R	L
P37287	LP/P	Multiple congenital anomalies-hypotonia-seizures syndrome 2 (MCAHS2) [MIM:300868]	A0A146MU15	93	P	L
P37287	LP/P	Multiple congenital anomalies-hypotonia-seizures syndrome 2 (MCAHS2) [MIM:300868]	A0A146MU15	119	R	W
P37287	LP/P	Multiple congenital anomalies-hypotonia-seizures syndrome 2 (MCAHS2) [MIM:300868]	A0A146MU15	206	I	F
P37287	LP/P	-	A0A146MU15	135	A	V
P37287	LP/P	Neurodevelopmental disorder with epilepsy and hemochromatosis (NEDEPH) [MIM:301072]	A0A146MU15	77	R	Q
P37287	LP/P	Neurodevelopmental disorder with epilepsy and hemochromatosis (NEDEPH) [MIM:301072]	A0A146MU15	344	L	P
Q92521	LB/B	-	A0A0J9RNZ5	68	I	L
Q92521	LB/B	-	A0A0J9RNZ5	162	M	T
Q92521	LB/B	-	A0A0J9RNZ5	299	W	L
Q92521	LB/B	-	A0A0J9RNZ5	484	L	S
Q92521	LB/B	-	A0A0J9RNZ5	551	K	T
Q92521	LB/B	-	A0A0J9RNZ5	502	S	G
Q92521	LP/P	Developmental and epileptic encephalopathy 80 (DEE80) [MIM:618580]	A0A0J9RNZ5	71	R	Q
Q92521	LP/P	Developmental and epileptic encephalopathy 80 (DEE80) [MIM:618580]	A0A0J9RNZ5	90	S	P
Q92521	LP/P	Developmental and epileptic encephalopathy 80 (DEE80) [MIM:618580]	A0A0J9RNZ5	232	R	H
Q92521	LP/P	Developmental and epileptic encephalopathy 80 (DEE80) [MIM:618580]	A0A0J9RNZ5	286	V	L
Q92521	LP/P	Developmental and epileptic encephalopathy 80 (DEE80) [MIM:618580]	A0A0J9RNZ5	388	A	P
Q92521	LP/P	Developmental and epileptic encephalopathy 80 (DEE80) [MIM:618580]	A0A0J9RNZ5	407	H	R
Q07326	LP/P	Onychodystrophy, osteodystrophy, impaired intellectual development, and seizures syndrome (OORS) [MIM:619356]	M3WMX8	172	P	R
Q5H8A4	LB/B	-	K7GFI5	458	R	H
Q5H8A4	LB/B	-	K7GFI5	610	C	R
Q5H8A4	LB/B	-	K7GFI5	699	V	I
Q5H8A4	LB/B	-	K7GFI5	932	F	S
Q5H8A4	LB/B	-	K7GFI5	55	S	Y
Q5H8A4	LB/B	-	K7GFI5	731	V	I
Q5H8A4	LB/B	-	K7GFI5	881	I	T
Q5H8A4	LP/P	Neurodevelopmental disorder with or without hypotonia, seizures, and cerebellar atrophy (NEDHSCA) [MIM:616917]	K7GFI5	669	R	C
Q5H8A4	LP/P	Neurodevelopmental disorder with or without hypotonia, seizures, and cerebellar atrophy (NEDHSCA) [MIM:616917]	K7GFI5	138	N	S
Q5H8A4	LP/P	Neurodevelopmental disorder with or without hypotonia, seizures, and cerebellar atrophy (NEDHSCA) [MIM:616917]	K7GFI5	214	H	Y
Q5H8A4	LP/P	Neurodevelopmental disorder with or without hypotonia, seizures, and cerebellar atrophy (NEDHSCA) [MIM:616917]	K7GFI5	270	G	D
Q5H8A4	LP/P	Neurodevelopmental disorder with or without hypotonia, seizures, and cerebellar atrophy (NEDHSCA) [MIM:616917]	K7GFI5	271	M	R
Q5H8A4	LP/P	Neurodevelopmental disorder with or without hypotonia, seizures, and cerebellar atrophy (NEDHSCA) [MIM:616917]	K7GFI5	278	G	R
Q5H8A4	LP/P	Neurodevelopmental disorder with or without hypotonia, seizures, and cerebellar atrophy (NEDHSCA) [MIM:616917]	K7GFI5	851	Q	P
Q9Y2B2	LP/P	Coloboma, congenital heart disease, ichthyosiform dermatosis, impaired intellectual development, and ear anomalies syndrome (CHIME) [MIM:280000]	A0A2U3XX50	167	L	P
O95427	LB/B	-	A0A0F7ZDT4	162	K	E
O95427	LB/B	-	A0A0F7ZDT4	229	H	D
O95427	LB/B	-	A0A0F7ZDT4	469	L	F
O95427	LB/B	-	A0A0F7ZDT4	470	I	L
O95427	LB/B	-	A0A0F7ZDT4	904	F	C
O95427	LB/B	-	A0A0F7ZDT4	904	F	L
O95427	LP/P	Multiple congenital anomalies-hypotonia-seizures syndrome 1 (MCAHS1) [MIM:614080]	A0A0F7ZDT4	709	R	Q
Q8TEQ8	LP/P	Hyperphosphatasia with impaired intellectual development syndrome 2 (HPMRS2) [MIM:614749]	A0A0F8D0J3	957	L	F
Q8TEQ8	LP/P	-	A0A0F8D0J3	130	T	N
Q8TEQ8	LP/P	Hyperphosphatasia with impaired intellectual development syndrome 2 (HPMRS2) [MIM:614749]	A0A0F8D0J3	119	R	W
Q8TEQ8	LP/P	Hyperphosphatasia with impaired intellectual development syndrome 2 (HPMRS2) [MIM:614749]	A0A0F8D0J3	370	N	S
Q8TEQ8	LP/P	Hyperphosphatasia with impaired intellectual development syndrome 2 (HPMRS2) [MIM:614749]	A0A0F8D0J3	1047	K	E
Q9BRB3	LB/B	-	A0A2K6R092	14	T	A
Q9BRB3	LB/B	-	A0A2K6R092	592	C	R
Q9BRB3	LB/B	-	A0A2K6R092	668	C	R
Q9BRB3	LB/B	-	A0A2K6R092	668	C	Y
Q969N2	LB/B	-	A0A2R6W2P4	473	A	T
Q969N2	LP/P	Multiple congenital anomalies-hypotonia-seizures syndrome 3 (MCAHS3) [MIM:615398]	A0A2R6W2P4	183	T	P
Q9H490	LP/P	Neurodevelopmental disorder with brain anomalies, seizures, and scoliosis (NEDBSS) [MIM:618590]	A0A1D5R718	70	I	K
Q9H490	LP/P	Neurodevelopmental disorder with brain anomalies, seizures, and scoliosis (NEDBSS) [MIM:618590]	A0A1D5R718	383	N	K
Q9NUD9	LP/P	Hyperphosphatasia with impaired intellectual development syndrome 1 (HPMRS1) [MIM:239300]	A0A1L8H7D7	256	Q	K
Q9NUD9	LP/P	Hyperphosphatasia with impaired intellectual development syndrome 1 (HPMRS1) [MIM:239300]	A0A1L8H7D7	341	A	E
Q9NUD9	LP/P	Hyperphosphatasia with impaired intellectual development syndrome 1 (HPMRS1) [MIM:239300]	A0A1L8H7D7	341	A	V
Q9NUD9	LP/P	Hyperphosphatasia with impaired intellectual development syndrome 1 (HPMRS1) [MIM:239300]	A0A1L8H7D7	385	H	P
Q7Z7B1	LP/P	Glycosylphosphatidylinositol biosynthesis defect 11 (GPIBD11) [MIM:616025]	A0A2K6TNM4	71	T	P
Q7Z7B1	LP/P	Glycosylphosphatidylinositol biosynthesis defect 11 (GPIBD11) [MIM:616025]	A0A2K6TNM4	167	M	V
Q8TBF5	LB/B	-	M3WNE3	155	P	L
Q8TBF5	LB/B	-	M3WNE3	197	E	D
Q3MUY2	LP/P	Hyperphosphatasia with impaired intellectual development syndrome 6 (HPMRS6) [MIM:616809]	G1SAB5	46	L	P
Q86VD9	LB/B	-	A0A1L8G9W0	340	R	Q
Q86VD9	LB/B	-	A0A1L8G9W0	417	V	A
Q86VD9	LB/B	-	A0A1L8G9W0	487	M	I
Q86VD9	LB/B	-	A0A1L8G9W0	266	A	T
Q9NWS0	LB/B	-	A0A1S3HP69	9	M	L
Q9NWS0	LB/B	-	A0A1S3HP69	10	G	E
Q9NWS0	LB/B	-	A0A1S3HP69	224	V	I
Q9NWS0	LB/B	-	A0A1S3HP69	230	D	E
Q9NWS0	LB/B	-	A0A1S3HP69	287	P	L
Q8WWB5	LB/B	-	K9J559	117	A	V
P42336	LP/P	Colorectal cancer (CRC) [MIM:114500]	L7MJU0	38	R	H
P42336	LP/P	Megalencephaly-capillary malformation-polymicrogyria syndrome (MCAP) [MIM:602501]	L7MJU0	88	R	Q
P42336	LP/P	Colorectal cancer (CRC) [MIM:114500]	L7MJU0	106	G	V
P42336	LB/B	-	L7MJU0	391	I	M
P42336	LP/P	Colorectal cancer (CRC) [MIM:114500]	L7MJU0	453	E	Q
P42336	LP/P	Breast cancer (BC) [MIM:114480]	L7MJU0	542	E	K
P42336	LP/P	Cerebral cavernous malformations 4 (CCM4) [MIM:619538]	L7MJU0	542	E	K
P42336	LP/P	CLAPO syndrome (CLAPO) [MIM:613089]	L7MJU0	542	E	K
P42336	LP/P	Colorectal cancer (CRC) [MIM:114500]	L7MJU0	542	E	K
P42336	LP/P	Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi (CLOVE) [MIM:612918]	L7MJU0	542	E	K
P42336	LP/P	Keratosis, seborrheic (KERSEB) [MIM:182000]	L7MJU0	542	E	K
P42336	LP/P	Macrodactyly (MADAC) [MIM:155500]	L7MJU0	542	E	K
P42336	LP/P	Cowden syndrome 5 (CWS5) [MIM:615108]	L7MJU0	545	E	A
P42336	LP/P	Hepatocellular carcinoma (HCC) [MIM:114550]	L7MJU0	545	E	A
P42336	LP/P	Keratosis, seborrheic (KERSEB) [MIM:182000]	L7MJU0	545	E	G
P42336	LP/P	Breast cancer (BC) [MIM:114480]	L7MJU0	545	E	K
P42336	LP/P	Colorectal cancer (CRC) [MIM:114500]	L7MJU0	545	E	K
P42336	LP/P	Keratosis, seborrheic (KERSEB) [MIM:182000]	L7MJU0	545	E	K
P42336	LP/P	Megalencephaly-capillary malformation-polymicrogyria syndrome (MCAP) [MIM:602501]	L7MJU0	545	E	K
P42336	LP/P	Megalencephaly-capillary malformation-polymicrogyria syndrome (MCAP) [MIM:602501]	L7MJU0	1021	Y	C
P42336	LP/P	Megalencephaly-capillary malformation-polymicrogyria syndrome (MCAP) [MIM:602501]	L7MJU0	1035	A	V
P42336	LP/P	Colorectal cancer (CRC) [MIM:114500]	L7MJU0	1043	M	I
P42336	LP/P	Megalencephaly-capillary malformation-polymicrogyria syndrome (MCAP) [MIM:602501]	L7MJU0	1043	M	I
P42336	LP/P	Breast cancer (BC) [MIM:114480]	L7MJU0	1047	H	L
P42336	LP/P	Cerebral cavernous malformations 4 (CCM4) [MIM:619538]	L7MJU0	1047	H	L
P42336	LP/P	CLAPO syndrome (CLAPO) [MIM:613089]	L7MJU0	1047	H	L
P42336	LP/P	Macrodactyly (MADAC) [MIM:155500]	L7MJU0	1047	H	L
P42336	LP/P	Breast cancer (BC) [MIM:114480]	L7MJU0	1047	H	R
P42336	LP/P	Cerebral cavernous malformations 4 (CCM4) [MIM:619538]	L7MJU0	1047	H	R
P42336	LP/P	Colorectal cancer (CRC) [MIM:114500]	L7MJU0	1047	H	R
P42336	LP/P	Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi (CLOVE) [MIM:612918]	L7MJU0	1047	H	R
P42336	LP/P	Keratosis, seborrheic (KERSEB) [MIM:182000]	L7MJU0	1047	H	R
P42336	LP/P	Macrodactyly (MADAC) [MIM:155500]	L7MJU0	1047	H	R
P42336	LP/P	Ovarian cancer (OC) [MIM:167000]	L7MJU0	1047	H	R
P42336	LP/P	Megalencephaly-capillary malformation-polymicrogyria syndrome (MCAP) [MIM:602501]	L7MJU0	1047	H	Y
P42336	LB/B	-	L7MJU0	43	I	V
P42336	LB/B	-	L7MJU0	332	S	R
P42336	LP/P	Megalencephaly-capillary malformation-polymicrogyria syndrome (MCAP) [MIM:602501]	L7MJU0	81	E	K
P42336	LP/P	Megalencephaly-capillary malformation-polymicrogyria syndrome (MCAP) [MIM:602501]	L7MJU0	364	G	R
P42336	LP/P	Megalencephaly-capillary malformation-polymicrogyria syndrome (MCAP) [MIM:602501]	L7MJU0	365	E	K
P42336	LP/P	Megalencephaly-capillary malformation-polymicrogyria syndrome (MCAP) [MIM:602501]	L7MJU0	378	C	Y
P42336	LP/P	Megalencephaly-capillary malformation-polymicrogyria syndrome (MCAP) [MIM:602501]	L7MJU0	726	E	K
P42336	LP/P	Megalencephaly-capillary malformation-polymicrogyria syndrome (MCAP) [MIM:602501]	L7MJU0	914	G	R
P42336	LP/P	Megalencephaly-capillary malformation-polymicrogyria syndrome (MCAP) [MIM:602501]	L7MJU0	1025	T	A
P42336	LP/P	Megalencephaly-capillary malformation-polymicrogyria syndrome (MCAP) [MIM:602501]	L7MJU0	1049	G	S
P42336	LP/P	Cowden syndrome 5 (CWS5) [MIM:615108]	L7MJU0	118	G	D
P42336	LP/P	Cowden syndrome 5 (CWS5) [MIM:615108]	L7MJU0	135	E	K
P42336	LP/P	Cowden syndrome 5 (CWS5) [MIM:615108]	L7MJU0	218	E	K
P42336	LP/P	Cowden syndrome 5 (CWS5) [MIM:615108]	L7MJU0	356	V	I
P42336	LP/P	Cowden syndrome 5 (CWS5) [MIM:615108]	L7MJU0	382	R	K
P42336	LP/P	Megalencephaly-capillary malformation-polymicrogyria syndrome (MCAP) [MIM:602501]	L7MJU0	112	I	N
P42338	LB/B	-	L7MJU0	672	Q	H
O00329	LP/P	Immunodeficiency 14A, autosomal dominant (IMD14A) [MIM:615513]	L7MJU0	1021	E	K
P48736	LP/P	Immunodeficiency 97 with autoinflammation (IMD97) [MIM:619802]	Q4SSV6	49	R	S
P48736	LP/P	Immunodeficiency 97 with autoinflammation (IMD97) [MIM:619802]	Q4SSV6	1021	R	P
P48736	LP/P	Immunodeficiency 97 with autoinflammation (IMD97) [MIM:619802]	Q4SSV6	1085	N	S
Q96FE7	LB/B	-	A0A250YE00	251	T	S
P27986	LB/B	-	W5MWX5	326	M	I
P27986	LB/B	-	W5MWX5	409	R	Q
P27986	LB/B	-	W5MWX5	451	E	K
P27986	LP/P	SHORT syndrome (SHORTS) [MIM:269880]	W5MWX5	489	E	K
P27986	LP/P	SHORT syndrome (SHORTS) [MIM:269880]	W5MWX5	649	R	W
O00459	LB/B	-	W5MWX5	234	S	R
O00459	LB/B	-	W5MWX5	313	S	P
O00459	LP/P	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1 (MPPH1) [MIM:603387]	W5MWX5	373	G	R
O00459	LP/P	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1 (MPPH1) [MIM:603387]	W5MWX5	401	L	P
O00459	LP/P	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1 (MPPH1) [MIM:603387]	W5MWX5	557	D	H
Q92569	LB/B	-	A0A2K5QAG9	283	N	K
Q99570	LB/B	-	Q4TBB7	273	F	L
Q99570	LB/B	-	Q4TBB7	342	R	H
Q99570	LB/B	-	Q4TBB7	347	R	W
Q99570	LB/B	-	Q4TBB7	388	T	I
Q99570	LB/B	-	Q4TBB7	393	D	N
Q99570	LB/B	-	Q4TBB7	699	L	V
Q99570	LB/B	-	Q4TBB7	1043	G	V
Q8WYR1	LP/P	Ataxia-oculomotor apraxia 3 (AOA3) [MIM:615217]	W5NWT6	629	P	S
Q9Y2I7	LP/P	Corneal dystrophy, fleck (CFD) [MIM:121850]	A0A287D3T0	1103	K	R
Q9Y2I7	LB/B	-	A0A287D3T0	617	M	V
Q9Y2I7	LB/B	-	A0A287D3T0	1033	S	A
Q9Y2I7	LB/B	-	A0A287D3T0	1858	R	Q
Q9Y2I7	LB/B	-	A0A287D3T0	696	S	N
Q9Y2I7	LB/B	-	A0A287D3T0	932	L	S
Q9Y2I7	LB/B	-	A0A287D3T0	995	Q	L
Q9Y2I7	LB/B	-	A0A287D3T0	998	T	S
Q9Y2I7	LB/B	-	A0A287D3T0	1183	Q	K
Q9UKJ1	LB/B	-	F1RNP0	279	S	L
Q9UKJ1	LB/B	-	F1RNP0	78	R	G
P11309	LB/B	-	F1PHQ6	124	E	Q
P11309	LB/B	-	F1PHQ6	135	E	K
P11309	LB/B	-	F1PHQ6	142	E	D
Q9BSJ6	LB/B	-	A0A2Y9DK61	199	S	C
P48426	LB/B	-	A0A0N4VN84	251	N	S
P48426	LB/B	-	A0A0N4VN84	7	L	I
Q8TBX8	LB/B	-	S7PXE1	84	V	A
Q8TBX8	LB/B	-	S7PXE1	241	K	R
Q8TBX8	LB/B	-	S7PXE1	300	A	G
O14986	LB/B	-	I3K4S4	415	A	T
O60331	LP/P	Lethal congenital contracture syndrome 3 (LCCS3) [MIM:611369]	A0A2K5F083	253	D	N
O00625	LB/B	-	A0A0K9Q814	228	V	A
Q9BZ72	LB/B	-	H3BDS3	9	P	L
Q9BZ72	LB/B	-	H3BDS3	661	L	M
Q9BZ71	LB/B	-	A0A287BH48	80	A	T
Q9BZ71	LP/P	Cone-rod dystrophy 5 (CORD5) [MIM:600977]	A0A287BH48	626	Q	H
Q9BZ71	LB/B	-	A0A287BH48	17	P	S
P78337	LB/B	-	H9H1T9	299	G	A
P78337	LP/P	Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly (CCF) [MIM:119800]	H9H1T9	130	E	K
Q99697	LP/P	Anterior segment dysgenesis 4 (ASGD4) [MIM:137600]	A0A2K6MVN1	130	R	W
Q99697	LP/P	Axenfeld-Rieger syndrome 1 (RIEG1) [MIM:180500]	A0A2K6MVN1	100	L	Q
Q99697	LP/P	Axenfeld-Rieger syndrome 1 (RIEG1) [MIM:180500]	A0A2K6MVN1	114	T	P
Q99697	LP/P	Anterior segment dysgenesis 4 (ASGD4) [MIM:137600]	A0A2K6MVN1	115	R	H
Q99697	LP/P	Axenfeld-Rieger syndrome 1 (RIEG1) [MIM:180500]	A0A2K6MVN1	137	R	P
Q99697	LP/P	Ring dermoid of cornea (RDC) [MIM:180550]	A0A2K6MVN1	108	R	H
Q99697	LP/P	Axenfeld-Rieger syndrome 1 (RIEG1) [MIM:180500]	A0A2K6MVN1	129	V	L
Q99697	LP/P	Axenfeld-Rieger syndrome 1 (RIEG1) [MIM:180500]	A0A2K6MVN1	110	P	L
Q99697	LP/P	Axenfeld-Rieger syndrome 1 (RIEG1) [MIM:180500]	A0A2K6MVN1	110	P	R
Q99697	LP/P	Axenfeld-Rieger syndrome 1 (RIEG1) [MIM:180500]	A0A2K6MVN1	134	K	E
Q99697	LP/P	Axenfeld-Rieger syndrome 1 (RIEG1) [MIM:180500]	A0A2K6MVN1	136	R	C
Q99697	LP/P	Axenfeld-Rieger syndrome 1 (RIEG1) [MIM:180500]	A0A2K6MVN1	151	L	V
Q99697	LP/P	Axenfeld-Rieger syndrome 1 (RIEG1) [MIM:180500]	A0A2K6MVN1	154	N	T
O75364	LP/P	Cataract 11, multiple types (CTRCT11) [MIM:610623]	H9H1T9	13	S	N
Q96J94	LB/B	-	A0A2U3ZSZ8	491	K	N
Q96J94	LB/B	-	A0A2U3ZSZ8	527	R	K
Q96J94	LB/B	-	A0A2U3ZSZ8	575	L	P
Q96J94	LP/P	-	A0A2U3ZSZ8	217	R	A
Q96J94	LP/P	-	A0A2U3ZSZ8	220	L	A
Q96J94	LP/P	-	A0A2U3ZSZ8	220	L	G
Q96J94	LP/P	-	A0A2U3ZSZ8	220	L	R
Q96J94	LP/P	-	A0A2U3ZSZ8	224	N	H
Q7Z3Z3	LB/B	-	A0A2U3ZSZ8	375	P	S
Q7Z3Z3	LB/B	-	A0A2U3ZSZ8	412	C	R
Q7Z3Z3	LB/B	-	A0A2U3ZSZ8	418	V	M
Q7Z3Z3	LB/B	-	A0A2U3ZSZ8	471	V	I
Q7Z3Z3	LB/B	-	A0A2U3ZSZ8	589	R	C
Q7Z3Z3	LB/B	-	A0A2U3ZSZ8	186	P	L
Q7Z3Z4	LB/B	-	A0A0A7E975	327	Q	L
Q7Z3Z4	LB/B	-	A0A0A7E975	78	Q	R
Q7Z3Z4	LB/B	-	A0A0A7E975	167	K	R
Q7Z3Z4	LB/B	-	A0A0A7E975	370	A	P
Q8NG27	LB/B	-	A0A1S3GE98	432	S	N
Q8NG27	LB/B	-	A0A1S3GE98	606	E	D
O43164	LB/B	-	A0A091SXZ1	297	Q	R
O43164	LB/B	-	A0A091SXZ1	705	A	T
O43164	LB/B	-	A0A091SXZ1	176	E	G
Q8TDX9	LB/B	-	G3TAC4	2410	E	K
Q8TDX9	LB/B	-	G3TAC4	312	V	F
Q8TDX9	LB/B	-	G3TAC4	1053	R	P
Q8TDX9	LB/B	-	G3TAC4	1272	K	E
Q8TDX9	LB/B	-	G3TAC4	812	D	N
Q8TDX9	LB/B	-	G3TAC4	879	T	A
Q8TDX9	LB/B	-	G3TAC4	2685	A	T
Q8TDX9	LB/B	-	G3TAC4	894	V	I
Q8TDX9	LB/B	-	G3TAC4	2057	R	H
Q8TDX9	LB/B	-	G3TAC4	2603	L	F
Q8TDX9	LB/B	-	G3TAC4	906	V	I
Q8TDX9	LP/P	Heterotaxy, visceral, 8, autosomal (HTX8) [MIM:617205]	G3TAC4	1691	C	S
Q9H7B7	LB/B	-	Q9H7B7	32	K	E
Q7Z442	LB/B	-	A0A2Y9G0L6	20	V	A
Q7Z442	LB/B	-	A0A2Y9G0L6	73	W	R
Q7Z442	LB/B	-	A0A2Y9G0L6	77	K	N
Q7Z442	LB/B	-	A0A2Y9G0L6	120	Q	L
Q7Z442	LB/B	-	A0A2Y9G0L6	129	G	D
Q7Z442	LB/B	-	A0A2Y9G0L6	156	V	I
Q7Z442	LB/B	-	A0A2Y9G0L6	162	C	S
Q7Z442	LB/B	-	A0A2Y9G0L6	169	V	M
Q7Z442	LB/B	-	A0A2Y9G0L6	173	L	S
Q7Z442	LB/B	-	A0A2Y9G0L6	183	V	I
Q7Z442	LB/B	-	A0A2Y9G0L6	205	G	R
Q7Z442	LB/B	-	A0A2Y9G0L6	221	E	G
Q7Z442	LB/B	-	A0A2Y9G0L6	252	R	W
Q7Z442	LB/B	-	A0A2Y9G0L6	301	P	A
Q7Z442	LB/B	-	A0A2Y9G0L6	407	N	S
Q7Z442	LB/B	-	A0A2Y9G0L6	416	K	Q
Q7Z442	LB/B	-	A0A2Y9G0L6	462	L	V
Q7Z442	LB/B	-	A0A2Y9G0L6	512	P	L
Q7Z442	LB/B	-	A0A2Y9G0L6	636	R	H
Q7Z442	LB/B	-	A0A2Y9G0L6	711	L	P
Q7Z442	LB/B	-	A0A2Y9G0L6	785	G	C
Q7Z442	LB/B	-	A0A2Y9G0L6	849	R	H
Q7Z442	LB/B	-	A0A2Y9G0L6	863	A	V
Q7Z442	LB/B	-	A0A2Y9G0L6	919	L	M
Q7Z442	LB/B	-	A0A2Y9G0L6	1036	L	P
Q7Z442	LB/B	-	A0A2Y9G0L6	1042	M	V
Q7Z442	LB/B	-	A0A2Y9G0L6	1048	T	A
Q7Z442	LB/B	-	A0A2Y9G0L6	1081	G	V
Q7Z442	LB/B	-	A0A2Y9G0L6	1251	G	W
Q7Z442	LB/B	-	A0A2Y9G0L6	1326	S	P
Q7Z442	LB/B	-	A0A2Y9G0L6	1335	A	D
Q7Z442	LB/B	-	A0A2Y9G0L6	1406	T	M
Q7Z442	LB/B	-	A0A2Y9G0L6	1527	A	V
Q7Z442	LB/B	-	A0A2Y9G0L6	1616	Q	R
Q7Z442	LB/B	-	A0A2Y9G0L6	1645	M	V
Q7Z442	LB/B	-	A0A2Y9G0L6	1665	S	Y
Q7Z442	LB/B	-	A0A2Y9G0L6	1701	Q	H
Q7Z442	LB/B	-	A0A2Y9G0L6	1848	G	R
Q7Z442	LB/B	-	A0A2Y9G0L6	1867	M	V
Q7Z442	LB/B	-	A0A2Y9G0L6	2036	Q	R
Q7Z442	LB/B	-	A0A2Y9G0L6	2046	P	L
Q7Z442	LB/B	-	A0A2Y9G0L6	2055	A	T
Q7Z442	LB/B	-	A0A2Y9G0L6	2119	L	I
Q7Z442	LB/B	-	A0A2Y9G0L6	2139	S	F
Q7Z442	LB/B	-	A0A2Y9G0L6	2315	M	I
Q7Z442	LB/B	-	A0A2Y9G0L6	998	R	C
Q7Z442	LB/B	-	A0A2Y9G0L6	999	Q	H
Q7Z442	LB/B	-	A0A2Y9G0L6	1330	N	D
Q7Z442	LB/B	-	A0A2Y9G0L6	1331	I	V
Q7Z442	LB/B	-	A0A2Y9G0L6	1739	A	V
Q7Z442	LB/B	-	A0A2Y9G0L6	2209	S	R
Q7Z443	LB/B	-	F1PHV2	120	I	F
Q7Z443	LB/B	-	F1PHV2	211	S	P
Q7Z443	LB/B	-	F1PHV2	274	K	E
Q7Z443	LB/B	-	F1PHV2	429	T	S
Q7Z443	LB/B	-	F1PHV2	471	A	D
Q7Z443	LB/B	-	F1PHV2	571	H	Q
Q7Z443	LB/B	-	F1PHV2	593	V	M
Q7Z443	LB/B	-	F1PHV2	903	V	I
Q7Z443	LB/B	-	F1PHV2	1176	S	R
Q7Z443	LB/B	-	F1PHV2	1474	Y	C
Q13563	LP/P	Polycystic kidney disease 2 with or without polycystic liver disease (PKD2) [MIM:613095]	A0A226NES5	414	W	G
Q13563	LB/B	-	A0A226NES5	28	R	P
Q13563	LP/P	Polycystic kidney disease 2 with or without polycystic liver disease (PKD2) [MIM:613095]	A0A226NES5	356	A	P
Q13563	LB/B	-	A0A226NES5	452	I	V
Q13563	LB/B	-	A0A226NES5	24	P	L
Q13563	LB/B	-	A0A226NES5	190	A	T
Q13563	LP/P	Polycystic kidney disease 2 with or without polycystic liver disease (PKD2) [MIM:613095]	A0A226NES5	306	R	Q
Q13563	LP/P	Polycystic kidney disease 2 with or without polycystic liver disease (PKD2) [MIM:613095]	A0A226NES5	322	R	Q
Q13563	LP/P	Polycystic kidney disease 2 with or without polycystic liver disease (PKD2) [MIM:613095]	A0A226NES5	322	R	W
Q13563	LP/P	Polycystic kidney disease 2 with or without polycystic liver disease (PKD2) [MIM:613095]	A0A226NES5	420	R	G
Q13563	LB/B	-	A0A226NES5	482	F	C
Q13563	LP/P	Polycystic kidney disease 2 with or without polycystic liver disease (PKD2) [MIM:613095]	A0A226NES5	511	D	V
Q13563	LP/P	Polycystic kidney disease 2 with or without polycystic liver disease (PKD2) [MIM:613095]	A0A226NES5	632	C	R
Q13563	LB/B	-	A0A226NES5	800	M	L
Q13563	LP/P	Polycystic kidney disease 2 with or without polycystic liver disease (PKD2) [MIM:613095]	A0A226NES5	807	R	Q
Q13563	LP/P	Polycystic kidney disease 2 with or without polycystic liver disease (PKD2) [MIM:613095]	A0A226NES5	384	A	P
Q9NTG1	LB/B	-	G1SX22	1147	I	M
Q9NTG1	LB/B	-	G1SX22	528	R	Q
Q9NTG1	LB/B	-	G1SX22	914	L	P
Q9NTG1	LB/B	-	G1SX22	992	T	P
Q9NTG1	LB/B	-	G1SX22	993	V	A
Q9NTG1	LB/B	-	G1SX22	1091	N	S
Q9NTG1	LB/B	-	G1SX22	1411	N	D
Q9NTG1	LB/B	-	G1SX22	1528	I	M
Q9NTG1	LB/B	-	G1SX22	1729	V	I
Q9NTG1	LB/B	-	G1SX22	26	V	A
Q16512	LB/B	-	G3VV26	901	V	I
Q16512	LB/B	-	G3VV26	197	A	E
Q16512	LB/B	-	G3VV26	436	R	W
Q16512	LB/B	-	G3VV26	520	R	Q
Q16512	LB/B	-	G3VV26	555	L	I
Q16512	LB/B	-	G3VV26	635	R	Q
Q16512	LB/B	-	G3VV26	718	I	V
Q16513	LB/B	-	G3VV26	94	E	D
Q16513	LB/B	-	G3VV26	197	A	E
Q16513	LB/B	-	G3VV26	655	Q	R
Q6P5Z2	LB/B	-	G3VV26	180	A	E
Q6P5Z2	LB/B	-	G3VV26	404	V	L
P55347	LB/B	-	M7B7F9	126	R	H
P55347	LB/B	-	M7B7F9	216	T	A
Q96KN3	LB/B	-	L9LBD9	110	E	K
Q99959	LB/B	-	G7N6P2	140	S	F
Q99959	LP/P	Arrhythmogenic right ventricular dysplasia, familial, 9 (ARVD9) [MIM:609040]	G7N6P2	615	S	F
Q99959	LP/P	Arrhythmogenic right ventricular dysplasia, familial, 9 (ARVD9) [MIM:609040]	G7N6P2	654	K	Q
Q99959	LP/P	Arrhythmogenic right ventricular dysplasia, familial, 9 (ARVD9) [MIM:609040]	G7N6P2	796	C	R
Q99959	LB/B	-	G7N6P2	366	L	P
Q99959	LB/B	-	G7N6P2	26	D	N
Q99959	LB/B	-	G7N6P2	58	E	D
Q99959	LB/B	-	G7N6P2	70	S	I
Q99959	LP/P	Arrhythmogenic right ventricular dysplasia, familial, 9 (ARVD9) [MIM:609040]	G7N6P2	137	E	K
Q99959	LP/P	Arrhythmogenic right ventricular dysplasia, familial, 9 (ARVD9) [MIM:609040]	G7N6P2	169	S	G
Q99959	LB/B	-	G7N6P2	195	A	V
Q99959	LB/B	-	G7N6P2	276	P	S
Q99959	LB/B	-	G7N6P2	338	T	A
Q99959	LB/B	-	G7N6P2	372	A	P
Q99959	LP/P	Arrhythmogenic right ventricular dysplasia, familial, 9 (ARVD9) [MIM:609040]	G7N6P2	424	F	S
Q99959	LB/B	-	G7N6P2	526	T	M
Q99959	LB/B	-	G7N6P2	531	I	S
Q99959	LB/B	-	G7N6P2	587	V	I
Q99959	LP/P	Arrhythmogenic right ventricular dysplasia, familial, 9 (ARVD9) [MIM:609040]	G7N6P2	631	Y	C
Q99959	LP/P	Arrhythmogenic right ventricular dysplasia, familial, 9 (ARVD9) [MIM:609040]	G7N6P2	787	L	F
Q99959	LB/B	-	G7N6P2	490	R	W
Q99959	LB/B	-	G7N6P2	76	N	S
Q99959	LB/B	-	G7N6P2	112	K	N
Q53H76	LB/B	-	P97535	23	S	I
Q53H76	LB/B	-	P97535	110	R	H
Q53H76	LB/B	-	P97535	284	S	N
P04054	LB/B	-	P43434	16	D	A
P04054	LB/B	-	P43434	89	N	T
P04054	LB/B	-	P43434	89	N	K
Q5R387	LB/B	-	A0A226NA12	139	Q	R
Q9UNK4	LB/B	-	A0A226NA12	80	S	G
Q9UNK4	LB/B	-	A0A226NA12	65	Q	H
Q9UNK4	LB/B	-	A0A226NA12	73	H	R
Q9UNK4	LB/B	-	A0A226NA12	96	H	R
Q9UNK4	LB/B	-	A0A226NA12	121	R	C
Q9UNK4	LB/B	-	A0A226NA12	121	R	L
P47712	LB/B	-	A0A2D0Q1U3	651	R	K
P47712	LB/B	-	A0A2D0Q1U3	224	V	I
P47712	LB/B	-	A0A2D0Q1U3	103	G	R
P47712	LB/B	-	A0A2D0Q1U3	637	I	V
P47712	LP/P	Gastrointestinal ulceration, recurrent, with dysfunctional platelets (GURDP) [MIM:618372]	A0A2D0Q1U3	575	D	H
Q9UP65	LB/B	-	A0A1W4Z921	38	A	P
Q9UP65	LB/B	-	A0A1W4Z921	143	I	V
Q9UP65	LB/B	-	A0A1W4Z921	203	S	P
Q9UP65	LB/B	-	A0A1W4Z921	430	R	C
Q9UP65	LB/B	-	A0A1W4Z921	21	E	K
Q9UP65	LB/B	-	A0A1W4Z921	127	A	V
Q9UP65	LB/B	-	A0A1W4Z921	142	V	F
Q9UP65	LB/B	-	A0A1W4Z921	148	R	G
Q9UP65	LB/B	-	A0A1W4Z921	151	P	L
Q9UP65	LB/B	-	A0A1W4Z921	226	T	S
Q9UP65	LB/B	-	A0A1W4Z921	360	T	P
Q9UP65	LB/B	-	A0A1W4Z921	411	D	N
Q3MJ16	LB/B	-	A0A1V4KEY9	400	N	S
Q3MJ16	LB/B	-	A0A1V4KEY9	693	A	T
P39877	LP/P	Fleck retina, familial benign (FRFB) [MIM:228980]	A0A226NA12	45	G	C
P39877	LP/P	Fleck retina, familial benign (FRFB) [MIM:228980]	A0A226NA12	49	G	S
Q13018	LB/B	-	G1KNV4	142	R	Q
Q13018	LB/B	-	G1KNV4	177	P	S
Q13018	LB/B	-	G1KNV4	279	I	V
Q13018	LB/B	-	G1KNV4	292	M	V
Q13018	LB/B	-	G1KNV4	300	H	D
Q13018	LB/B	-	G1KNV4	404	R	H
Q13018	LB/B	-	G1KNV4	1106	G	S
Q13018	LB/B	-	G1KNV4	370	A	E
Q9Y263	LP/P	Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies (NDMSBA) [MIM:617527]	A0A067QX12	23	G	V
Q9Y263	LP/P	Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies (NDMSBA) [MIM:617527]	A0A067QX12	752	L	F
Q96KN8	LB/B	-	H0WQ75	93	A	P
Q96KN8	LB/B	-	H0WQ75	31	S	G
Q96KN8	LB/B	-	H0WQ75	214	Q	R
Q96KN8	LB/B	-	H0WQ75	258	A	V
A1L4L8	LB/B	-	A0A1U7T6M8	11	C	S
Q6DJT9	LB/B	-	W5MDQ4	458	P	T
P00750	LB/B	-	A0A2D0R153	164	R	W
P00750	LB/B	-	A0A2D0R153	34	A	D
P00750	LB/B	-	A0A2D0R153	136	R	S
P00750	LB/B	-	A0A2D0R153	146	A	T
Q03405	LB/B	-	A0A2Y9INB0	317	L	P
Q03405	LB/B	-	A0A2Y9INB0	55	E	G
Q03405	LB/B	-	A0A2Y9INB0	86	T	A
Q03405	LB/B	-	A0A2Y9INB0	105	R	Q
Q03405	LB/B	-	A0A2Y9INB0	220	K	R
Q03405	LB/B	-	A0A2Y9INB0	281	N	K
Q03405	LB/B	-	A0A2Y9INB0	297	D	A
Q6P4A8	LB/B	-	A0A146YFB1	265	V	I
Q6P4A8	LB/B	-	A0A146YFB1	377	V	A
Q6P4A8	LB/B	-	A0A146YFB1	534	P	A
Q9NQ66	LB/B	-	G1KBF0	854	E	K
Q00722	LB/B	-	G3NT25	324	N	I
Q00722	LB/B	-	G3NT25	598	R	H
Q00722	LB/B	-	G3NT25	664	P	L
Q00722	LB/B	-	G3NT25	712	G	R
Q00722	LB/B	-	G3NT25	1095	E	G
Q01970	LB/B	-	G1KBF0	483	R	H
Q01970	LP/P	Spondylometaphyseal dysplasia with corneal dystrophy (SMDCD) [MIM:618961]	G1KBF0	878	A	S
Q15147	LB/B	-	A0A1B6DJU1	21	A	T
Q15147	LB/B	-	A0A1B6DJU1	710	G	S
Q15147	LP/P	Auriculocondylar syndrome 2 (ARCND2) [MIM:614669]	A0A1B6DJU1	329	N	T
Q15147	LP/P	Auriculocondylar syndrome 2 (ARCND2) [MIM:614669]	A0A1B6DJU1	621	R	C
Q15147	LP/P	Auriculocondylar syndrome 2 (ARCND2) [MIM:614669]	A0A1B6DJU1	621	R	H
Q15147	LP/P	Auriculocondylar syndrome 2 (ARCND2) [MIM:614669]	A0A1B6DJU1	623	Y	C
Q15147	LP/P	Auriculocondylar syndrome 2 (ARCND2) [MIM:614669]	A0A1B6DJU1	650	N	H
P51178	LB/B	-	A0A2U4BMN0	257	R	H
P51178	LP/P	Nail disorder, non-syndromic congenital, 3 (NDNC3) [MIM:151600]	A0A2U4BMN0	209	T	R
P51178	LP/P	Nail disorder, non-syndromic congenital, 3 (NDNC3) [MIM:151600]	A0A2U4BMN0	574	I	T
Q8N3E9	LB/B	-	A0A2Y9GEF9	652	P	L
Q9P212	LP/P	Nephrotic syndrome 3 (NPHS3) [MIM:610725]	G3SP36	1484	S	L
Q9P212	LB/B	-	G3SP36	469	S	T
Q9P212	LB/B	-	G3SP36	548	R	L
Q9P212	LB/B	-	G3SP36	1575	R	P
Q9P212	LB/B	-	G3SP36	1777	T	I
Q9P212	LB/B	-	G3SP36	1927	H	R
Q9P212	LB/B	-	G3SP36	2173	K	R
Q13393	LB/B	-	A0A2D0R594	622	A	S
Q13393	LB/B	-	A0A2D0R594	820	V	M
Q13393	LB/B	-	A0A2D0R594	49	P	A
Q13393	LB/B	-	A0A2D0R594	1024	V	I
Q13393	LP/P	Cardiac valvular dysplasia 1 (CVDP1) [MIM:212093]	A0A2D0R594	442	H	P
O14939	LB/B	-	A0A2D0R594	172	R	C
O14939	LB/B	-	A0A2D0R594	577	T	I
O14939	LB/B	-	A0A2D0R594	804	A	T
O14939	LB/B	-	A0A2D0R594	821	G	R
O14939	LB/B	-	A0A2D0R594	821	G	S
O14939	LB/B	-	A0A2D0R594	632	E	G
Q8IV08	LB/B	-	A0A2I2UM88	63	G	S
Q8IV08	LB/B	-	A0A2I2UM88	76	P	A
Q8IV08	LB/B	-	A0A2I2UM88	159	V	M
Q8IV08	LB/B	-	A0A2I2UM88	162	R	C
Q8IV08	LB/B	-	A0A2I2UM88	173	P	S
Q8IV08	LB/B	-	A0A2I2UM88	175	A	G
Q8IV08	LB/B	-	A0A2I2UM88	188	R	C
Q8IV08	LB/B	-	A0A2I2UM88	222	R	H
Q8IV08	LB/B	-	A0A2I2UM88	242	R	Q
Q8IV08	LB/B	-	A0A2I2UM88	249	E	G
Q8IV08	LB/B	-	A0A2I2UM88	272	R	C
Q8IV08	LB/B	-	A0A2I2UM88	284	N	S
Q8IV08	LB/B	-	A0A2I2UM88	293	A	V
Q8IV08	LB/B	-	A0A2I2UM88	297	P	L
Q8IV08	LB/B	-	A0A2I2UM88	300	C	Y
Q8IV08	LB/B	-	A0A2I2UM88	358	V	I
Q8IV08	LB/B	-	A0A2I2UM88	426	T	A
Q8IV08	LB/B	-	A0A2I2UM88	429	G	R
Q96BZ4	LB/B	-	I3N3U4	27	E	Q
Q96BZ4	LB/B	-	I3N3U4	135	V	M
Q96BZ4	LB/B	-	I3N3U4	16	C	R
Q8N2A8	LB/B	-	A0A2R9AEB2	42	L	P
Q8N2A8	LB/B	-	A0A2R9AEB2	108	R	H
Q15149	LP/P	Epidermolysis bullosa simplex 5A, Ogna type (EBS5A) [MIM:131950]	A0A1S3P7B1	2110	R	W
Q15149	LB/B	-	A0A1S3P7B1	641	A	V
Q15149	LB/B	-	A0A1S3P7B1	2150	R	W
Q15149	LB/B	-	A0A1S3P7B1	2194	A	V
Q15149	LB/B	-	A0A1S3P7B1	2791	S	P
Q15149	LB/B	-	A0A1S3P7B1	2821	R	W
Q15149	LB/B	-	A0A1S3P7B1	2969	R	H
Q15149	LB/B	-	A0A1S3P7B1	3162	V	I
Q15149	LB/B	-	A0A1S3P7B1	3171	A	V
Q15149	LB/B	-	A0A1S3P7B1	3486	T	M
Q15149	LB/B	-	A0A1S3P7B1	3490	G	A
Q15149	LB/B	-	A0A1S3P7B1	1321	L	V
Q15149	LB/B	-	A0A1S3P7B1	1386	R	Q
Q15149	LB/B	-	A0A1S3P7B1	1459	H	R
Q15149	LB/B	-	A0A1S3P7B1	102	R	H
Q15149	LB/B	-	A0A1S3P7B1	2005	R	W
Q15149	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 17 (LGMDR17) [MIM:613723]	A0A1S3P7B1	3945	G	S
Q9HB19	LB/B	-	A0A060W6R2	186	I	N
Q9H4M7	LB/B	-	G1SFK2	37	I	V
Q9H4M7	LB/B	-	G1SFK2	597	R	Q
Q9H4M7	LB/B	-	G1SFK2	714	T	A
Q9H4M7	LB/B	-	G1SFK2	742	G	V
Q9Y2H5	LB/B	-	T0MHY4	43	V	I
Q9Y2H5	LB/B	-	T0MHY4	837	R	K
Q9H7P9	LB/B	-	G7PXJ7	540	T	I
Q9H7P9	LB/B	-	G7PXJ7	622	I	V
Q9H7P9	LB/B	-	G7PXJ7	647	R	H
Q9H7P9	LB/B	-	G7PXJ7	992	R	K
Q9H7P9	LB/B	-	G7PXJ7	1302	A	T
Q9H7P9	LB/B	-	G7PXJ7	1329	P	A
Q9H7P9	LP/P	Leukodystrophy and acquired microcephaly with or without dystonia (LDAMD) [MIM:616763]	G7PXJ7	204	R	W
A1L390	LB/B	-	A0A1S3WM19	1036	R	W
A1L390	LB/B	-	A0A1S3WM19	1014	R	H
Q58EX7	LB/B	-	L5LJ02	412	T	I
Q58EX7	LB/B	-	L5LJ02	525	D	G
Q58EX7	LB/B	-	L5LJ02	830	R	H
Q58EX7	LB/B	-	L5LJ02	1090	S	T
Q58EX7	LB/B	-	L5LJ02	1064	R	H
Q96PX9	LB/B	-	A0A2D0PR46	72	A	T
Q96PX9	LB/B	-	A0A2D0PR46	149	G	S
Q96PX9	LB/B	-	A0A2D0PR46	220	R	H
Q96PX9	LB/B	-	A0A2D0PR46	660	A	V
Q96PX9	LB/B	-	A0A2D0PR46	37	V	A
Q96PX9	LB/B	-	A0A2D0PR46	669	T	P
Q96PX9	LB/B	-	A0A2D0PR46	1076	R	Q
Q96PX9	LB/B	-	A0A2D0PR46	1146	R	G
Q3KR16	LB/B	-	G3WM77	35	A	T
Q6ZR37	LB/B	-	A0A151LYU8	411	D	G
Q6ZR37	LB/B	-	A0A151LYU8	524	M	T
Q9ULM0	LB/B	-	H0XE04	75	N	S
Q9ULM0	LB/B	-	H0XE04	113	Q	L
Q9ULM0	LB/B	-	H0XE04	322	R	Q
Q9ULM0	LB/B	-	H0XE04	430	T	A
Q9ULM0	LB/B	-	H0XE04	438	M	V
Q9ULM0	LB/B	-	H0XE04	735	H	R
Q8IVE3	LB/B	-	H0XE04	481	P	T
Q8IVE3	LB/B	-	H0XE04	1069	R	K
Q8IVE3	LB/B	-	H0XE04	1217	N	S
Q8IVE3	LB/B	-	H0XE04	228	M	V
Q9Y4G2	LB/B	-	G1NCH4	377	R	H
Q53GL0	LB/B	-	A0A286ZU67	21	P	A
Q5SXH7	LB/B	-	G5BKD8	323	V	I
Q5SXH7	LB/B	-	G5BKD8	254	S	Y
Q6UQ28	LB/B	-	Q7YQE5	142	S	P
P00747	LP/P	Plasminogen deficiency (PLGD) [MIM:217090]	G3HGQ6	374	V	F
P00747	LP/P	Plasminogen deficiency (PLGD) [MIM:217090]	G3HGQ6	591	S	P
P00747	LP/P	Plasminogen deficiency (PLGD) [MIM:217090]	G3HGQ6	620	A	T
P00747	LP/P	Plasminogen deficiency (PLGD) [MIM:217090]	G3HGQ6	751	G	R
P00747	LB/B	-	G3HGQ6	46	I	R
P00747	LB/B	-	G3HGQ6	453	K	I
P00747	LB/B	-	G3HGQ6	57	E	K
P00747	LB/B	-	G3HGQ6	133	H	Q
P00747	LB/B	-	G3HGQ6	261	R	H
P00747	LB/B	-	G3HGQ6	408	R	W
P00747	LB/B	-	G3HGQ6	472	D	N
P00747	LB/B	-	G3HGQ6	494	A	V
P00747	LB/B	-	G3HGQ6	523	R	W
P00747	LP/P	Plasminogen deficiency (PLGD) [MIM:217090]	G3HGQ6	38	K	E
P00747	LP/P	Plasminogen deficiency (PLGD) [MIM:217090]	G3HGQ6	147	L	P
P00747	LP/P	Plasminogen deficiency (PLGD) [MIM:217090]	G3HGQ6	235	R	H
P00747	LP/P	Plasminogen deficiency (PLGD) [MIM:217090]	G3HGQ6	532	R	H
P00747	LB/B	-	G3HGQ6	676	V	D
P00747	LB/B	-	G3HGQ6	89	R	K
P00747	LP/P	Angioedema, hereditary, 4 (HAE4) [MIM:619360]	G3HGQ6	330	K	E
O60240	LB/B	-	F6XLN0	194	P	A
O60240	LB/B	-	F6XLN0	210	K	E
O60240	LB/B	-	F6XLN0	348	S	L
O60240	LB/B	-	F6XLN0	271	A	V
Q99541	LB/B	-	A0A151P2P1	251	S	P
O60664	LB/B	-	S9YG12	56	I	V
O60664	LB/B	-	S9YG12	275	V	A
Q96Q06	LB/B	-	M3W5M0	1138	A	T
Q96Q06	LB/B	-	M3W5M0	673	S	G
Q96Q06	LB/B	-	M3W5M0	1148	R	C
Q96Q06	LB/B	-	M3W5M0	138	V	A
Q96Q06	LB/B	-	M3W5M0	435	T	A
Q96Q06	LB/B	-	M3W5M0	775	K	N
Q96Q06	LB/B	-	M3W5M0	816	M	T
Q96Q06	LB/B	-	M3W5M0	840	A	E
Q96Q06	LB/B	-	M3W5M0	840	A	G
Q96Q06	LB/B	-	M3W5M0	840	A	V
Q96Q06	LB/B	-	M3W5M0	874	K	N
Q00G26	LB/B	-	A0A2K6RM30	6	A	V
Q00G26	LB/B	-	A0A2K6RM30	255	C	R
Q00G26	LB/B	-	A0A2K6RM30	306	R	W
P53350	LB/B	-	A0A0N5E357	261	L	F
P53350	LB/B	-	A0A0N5E357	332	L	V
P53350	LB/B	-	A0A0N5E357	463	L	H
P53350	LB/B	-	A0A0N5E357	518	R	H
P53350	LB/B	-	A0A0N5E357	297	N	D
P53350	LB/B	-	A0A0N5E357	595	S	L
P53350	LB/B	-	A0A0N5E357	599	R	H
Q9NYY3	LB/B	-	M7BW10	436	E	K
Q9NYY3	LB/B	-	M7BW10	487	P	L
Q9H4B4	LB/B	-	M7BW10	61	T	S
Q9H4B4	LB/B	-	M7BW10	68	L	F
Q9H4B4	LB/B	-	M7BW10	283	L	F
Q9H4B4	LB/B	-	M7BW10	483	R	C
Q9H4B4	LB/B	-	M7BW10	498	S	L
Q9H4B4	LB/B	-	M7BW10	618	S	P
Q9H4B4	LB/B	-	M7BW10	491	D	N
O00444	LB/B	-	A0A212D9V1	232	S	T
O00444	LB/B	-	A0A212D9V1	86	Y	C
O00444	LB/B	-	A0A212D9V1	146	R	H
O00444	LB/B	-	A0A212D9V1	226	A	T
O00444	LB/B	-	A0A212D9V1	317	P	L
O00444	LB/B	-	A0A212D9V1	449	N	D
O00444	LB/B	-	A0A212D9V1	519	W	S
O00444	LB/B	-	A0A212D9V1	830	E	D
P26678	LP/P	Cardiomyopathy, dilated 1P (CMD1P) [MIM:609909]	A0A091NDI3	9	R	C
P26678	LP/P	Cardiomyopathy, dilated 1P (CMD1P) [MIM:609909]	A0A091NDI3	9	R	H
P26678	LP/P	Cardiomyopathy, dilated 1P (CMD1P) [MIM:609909]	A0A091NDI3	9	R	L
Q02809	LP/P	Ehlers-Danlos syndrome, kyphoscoliotic type, 1 (EDSKSCL1) [MIM:225400]	A0A212CYF6	612	W	C
Q02809	LP/P	Ehlers-Danlos syndrome, kyphoscoliotic type, 1 (EDSKSCL1) [MIM:225400]	A0A212CYF6	678	G	R
Q02809	LB/B	-	A0A212CYF6	99	A	T
Q02809	LP/P	Ehlers-Danlos syndrome, kyphoscoliotic type, 1 (EDSKSCL1) [MIM:225400]	A0A212CYF6	446	W	G
Q02809	LP/P	Ehlers-Danlos syndrome, kyphoscoliotic type, 1 (EDSKSCL1) [MIM:225400]	A0A212CYF6	667	A	T
Q02809	LP/P	Ehlers-Danlos syndrome, kyphoscoliotic type, 1 (EDSKSCL1) [MIM:225400]	A0A212CYF6	706	H	R
Q02809	LB/B	-	A0A212CYF6	67	E	D
Q02809	LB/B	-	A0A212CYF6	84	A	T
Q02809	LB/B	-	A0A212CYF6	120	A	S
O00469	LP/P	Bruck syndrome 2 (BRKS2) [MIM:609220]	A0A212CYF6	598	R	H
O00469	LP/P	Bruck syndrome 2 (BRKS2) [MIM:609220]	A0A212CYF6	601	G	V
O00469	LP/P	Bruck syndrome 2 (BRKS2) [MIM:609220]	A0A212CYF6	608	T	I
O00469	LP/P	Bruck syndrome 2 (BRKS2) [MIM:609220]	A0A212CYF6	601	G	C
O60568	LB/B	-	A0A091DYA7	286	R	W
O60568	LB/B	-	A0A091DYA7	151	A	V
O60568	LP/P	Bone fragility with contractures, arterial rupture, and deafness (BCARD) [MIM:612394]	A0A091DYA7	223	N	S
O43688	LB/B	-	U3FC97	180	A	V
Q8IY26	LB/B	-	A0A2I2UXN0	140	S	W
Q8IY26	LB/B	-	A0A2I2UXN0	7	S	G
Q8IY26	LB/B	-	A0A2I2UXN0	8	M	T
Q6T4P5	LB/B	-	M7AWL4	193	I	T
Q6T4P5	LB/B	-	M7AWL4	690	A	V
Q7Z2D5	LB/B	-	M7AWL4	2	Q	K
Q7Z2D5	LB/B	-	M7AWL4	32	A	V
Q7Z2D5	LB/B	-	M7AWL4	345	R	T
Q14651	LB/B	-	A0A0D2WVJ4	146	I	M
Q14651	LB/B	-	A0A0D2WVJ4	216	S	L
Q14651	LP/P	Deafness, autosomal dominant, 76 (DFNA76) [MIM:618787]	A0A0D2WVJ4	128	F	S
Q14651	LP/P	Deafness, autosomal dominant, 76 (DFNA76) [MIM:618787]	A0A0D2WVJ4	238	L	R
Q14651	LP/P	Deafness, autosomal dominant, 76 (DFNA76) [MIM:618787]	A0A0D2WVJ4	269	E	K
Q14651	LP/P	Deafness, autosomal dominant, 76 (DFNA76) [MIM:618787]	A0A0D2WVJ4	363	L	F
O15162	LB/B	-	G7MJK4	262	H	Y
Q9NRQ2	LB/B	-	G3WY42	34	N	S
Q9NRQ2	LB/B	-	G3WY42	155	I	V
A0PG75	LB/B	-	A0A1X7VVQ2	110	R	S
P55058	LB/B	-	L5JYU4	444	F	L
P55058	LB/B	-	L5JYU4	487	T	K
P55058	LB/B	-	L5JYU4	282	R	Q
P55058	LB/B	-	L5JYU4	372	R	H
P55058	LB/B	-	L5JYU4	380	R	W
P55058	LB/B	-	L5JYU4	124	S	Y
P55058	LB/B	-	L5JYU4	425	M	I
Q9BX97	LP/P	Diarrhea 10, protein-losing enteropathy type (DIAR10) [MIM:618183]	A0A2U3W922	34	L	P
Q8IUK5	LB/B	-	S9XHL1	462	R	H
Q6UX71	LB/B	-	A0A061IEZ9	396	V	I
Q6UX71	LB/B	-	A0A061IEZ9	458	I	V
Q9UIW2	LP/P	Dworschak-Punetha neurodevelopmental syndrome (DWOPNED) [MIM:619955]	A0A1S3L9B1	816	C	R
Q9UIW2	LP/P	-	A0A1S3L9B1	1748	R	C
O75051	LB/B	-	A0A1S3L9B1	5	R	Q
O75051	LB/B	-	A0A1S3L9B1	369	E	G
O75051	LB/B	-	A0A1S3L9B1	57	Q	R
O75051	LB/B	-	A0A1S3L9B1	267	A	T
O75051	LB/B	-	A0A1S3L9B1	805	A	G
O75051	LB/B	-	A0A1S3L9B1	1443	A	T
P51805	LB/B	-	A0A1S3L9B1	384	G	S
P51805	LB/B	-	A0A1S3L9B1	413	G	S
P51805	LB/B	-	A0A1S3L9B1	863	E	D
P51805	LB/B	-	A0A1S3L9B1	1238	V	M
O43157	LB/B	-	A0A2D0SGK6	389	R	W
O43157	LB/B	-	A0A2D0SGK6	753	S	L
O15031	LB/B	-	A0A2D0SGK6	318	K	E
O15031	LB/B	-	A0A2D0SGK6	823	I	V
O60486	LB/B	-	A0A1S3WBE8	1499	E	K
Q6GTS8	LB/B	-	R7U0L0	33	H	Y
Q6GTS8	LB/B	-	R7U0L0	149	I	V
Q6GTS8	LB/B	-	R7U0L0	153	R	W
Q6GTS8	LB/B	-	R7U0L0	237	I	T
Q6GTS8	LB/B	-	R7U0L0	258	S	C
Q6GTS8	LB/B	-	R7U0L0	346	G	R
Q6GTS8	LB/B	-	R7U0L0	380	I	T
Q8IYS1	LB/B	-	F1S0E1	333	K	E
P40967	LB/B	-	A0A1L8HHW1	320	P	H
P40967	LB/B	-	A0A1L8HHW1	370	E	D
Q969W9	LB/B	-	A0A2K5CN56	128	E	D
Q6P1K2	LB/B	-	S7MVQ0	75	Q	R
Q6P1K2	LB/B	-	S7MVQ0	137	M	I
P29590	LB/B	-	G1LRJ4	645	F	L
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	44	V	A
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	65	D	Y
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	101	N	K
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	106	Y	C
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	108	A	V
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	113	P	L
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	117	G	R
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	119	F	L
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	123	R	Q
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	129	V	M
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	131	P	A
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	132	I	T
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	141	R	H
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	162	R	W
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	175	G	R
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	188	D	G
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	208	G	A
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	216	N	I
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	223	D	E
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	229	Y	S
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	231	V	M
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	237	T	M
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	238	R	P
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	139	E	K
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	104	L	V
O15305	LB/B	-	A0A2Y9KMM9	37	Q	L
O15305	LB/B	-	A0A2Y9KMM9	212	M	V
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	9	C	Y
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	11	F	C
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	15	G	E
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	20	P	S
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	32	L	R
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	37	Q	H
O15305	LB/B	-	A0A2Y9KMM9	42	G	R
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	64	Y	C
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	67	V	M
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	69	P	S
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	76	Y	C
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	93	E	A
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	103	C	F
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	120	I	T
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	132	I	F
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	132	I	N
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	141	R	C
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	144	F	L
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	148	D	N
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	151	E	G
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	153	I	T
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	157	F	S
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	172	F	V
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	176	G	V
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	177	Q	H
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	183	F	S
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	185	D	G
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	192	C	G
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	195	H	R
O15305	LB/B	-	A0A2Y9KMM9	197	E	A
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	206	F	S
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	214	G	S
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	216	N	S
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	217	D	E
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	218	H	L
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	223	D	N
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	226	T	S
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	228	G	C
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	228	G	R
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	237	T	R
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	238	R	G
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	241	C	S
O15305	LP/P	Congenital disorder of glycosylation 1A (CDG1A) [MIM:212065]	A0A2Y9KMM9	44	V	L
P02689	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1G (CMT1G) [MIM:618279]	A0A087Y865	43	I	N
P02689	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1G (CMT1G) [MIM:618279]	A0A087Y865	51	T	P
P02689	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1G (CMT1G) [MIM:618279]	A0A087Y865	52	I	T
Q01453	LP/P	Dejerine-Sottas syndrome (DSS) [MIM:145900]	E6ZHV5	12	H	Q
Q01453	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1A (CMT1A) [MIM:118220]	E6ZHV5	16	L	P
Q01453	LP/P	Dejerine-Sottas syndrome (DSS) [MIM:145900]	E6ZHV5	16	L	P
Q01453	LP/P	Dejerine-Sottas syndrome (DSS) [MIM:145900]	E6ZHV5	19	L	P
Q01453	LP/P	Dejerine-Sottas syndrome (DSS) [MIM:145900]	E6ZHV5	69	M	K
Q01453	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1A (CMT1A) [MIM:118220]	E6ZHV5	72	S	L
Q01453	LP/P	Dejerine-Sottas syndrome (DSS) [MIM:145900]	E6ZHV5	72	S	L
Q01453	LP/P	Dejerine-Sottas syndrome (DSS) [MIM:145900]	E6ZHV5	72	S	P
Q01453	LP/P	Dejerine-Sottas syndrome (DSS) [MIM:145900]	E6ZHV5	72	S	W
Q01453	LP/P	Dejerine-Sottas syndrome (DSS) [MIM:145900]	E6ZHV5	76	S	I
Q01453	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1A (CMT1A) [MIM:118220]	E6ZHV5	79	S	C
Q01453	LP/P	Dejerine-Sottas syndrome (DSS) [MIM:145900]	E6ZHV5	79	S	P
Q01453	LP/P	Dejerine-Sottas syndrome (DSS) [MIM:145900]	E6ZHV5	80	L	P
Q01453	LP/P	Dejerine-Sottas syndrome (DSS) [MIM:145900]	E6ZHV5	100	G	E
Q01453	LP/P	Dejerine-Sottas syndrome (DSS) [MIM:145900]	E6ZHV5	100	G	R
Q01453	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1A (CMT1A) [MIM:118220]	E6ZHV5	105	L	R
Q01453	LP/P	Dejerine-Sottas syndrome (DSS) [MIM:145900]	E6ZHV5	105	L	R
Q01453	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1A (CMT1A) [MIM:118220]	E6ZHV5	107	G	V
Q01453	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1A (CMT1A) [MIM:118220]	E6ZHV5	118	T	M
Q01453	LB/B	-	E6ZHV5	137	I	V
Q01453	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1A (CMT1A) [MIM:118220]	E6ZHV5	147	L	R
Q01453	LP/P	Dejerine-Sottas syndrome (DSS) [MIM:145900]	E6ZHV5	150	G	C
Q01453	LP/P	Dejerine-Sottas syndrome (DSS) [MIM:145900]	E6ZHV5	150	G	D
Q01453	LP/P	Hereditary neuropathy with liability to pressure palsies (HNPP) [MIM:162500]	E6ZHV5	30	V	M
Q01453	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1A (CMT1A) [MIM:118220]	E6ZHV5	37	D	V
Q01453	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1E (CMT1E) [MIM:118300]	E6ZHV5	67	A	P
Q01453	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1A (CMT1A) [MIM:118220]	E6ZHV5	93	G	R
Q01453	LB/B	-	E6ZHV5	157	R	G
Q01453	LP/P	Dejerine-Sottas syndrome (DSS) [MIM:145900]	E6ZHV5	157	R	W
Q01453	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1A (CMT1A) [MIM:118220]	E6ZHV5	22	S	F
Q01453	LP/P	Hereditary neuropathy with liability to pressure palsies (HNPP) [MIM:162500]	E6ZHV5	22	S	F
Q01453	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1E (CMT1E) [MIM:118300]	E6ZHV5	23	T	R
Q01453	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1E (CMT1E) [MIM:118300]	E6ZHV5	28	W	R
Q01453	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1A (CMT1A) [MIM:118220]	E6ZHV5	65	V	F
Q01453	LP/P	Hereditary neuropathy with liability to pressure palsies (HNPP) [MIM:162500]	E6ZHV5	67	A	T
Q01453	LP/P	Dejerine-Sottas syndrome (DSS) [MIM:145900]	E6ZHV5	71	L	P
Q01453	LP/P	Dejerine-Sottas syndrome (DSS) [MIM:145900]	E6ZHV5	80	L	R
Q01453	LP/P	Dejerine-Sottas syndrome (DSS) [MIM:145900]	E6ZHV5	109	C	R
Q01453	LP/P	Dejerine-Sottas syndrome (DSS) [MIM:145900]	E6ZHV5	149	S	R
Q10713	LP/P	Spinocerebellar ataxia, autosomal recessive, 2 (SCAR2) [MIM:213200]	G5B6B2	96	S	L
Q10713	LP/P	Spinocerebellar ataxia, autosomal recessive, 2 (SCAR2) [MIM:213200]	G5B6B2	256	V	M
Q10713	LP/P	Spinocerebellar ataxia, autosomal recessive, 2 (SCAR2) [MIM:213200]	G5B6B2	377	A	T
Q10713	LP/P	Spinocerebellar ataxia, autosomal recessive, 2 (SCAR2) [MIM:213200]	G5B6B2	515	G	R
O75439	LB/B	-	A0A2D0SFJ9	396	E	D
O75439	LP/P	Multiple mitochondrial dysfunctions syndrome 6 (MMDS6) [MIM:617954]	A0A2D0SFJ9	175	R	C
O75439	LP/P	Multiple mitochondrial dysfunctions syndrome 6 (MMDS6) [MIM:617954]	A0A2D0SFJ9	175	R	H
O75439	LP/P	Multiple mitochondrial dysfunctions syndrome 6 (MMDS6) [MIM:617954]	A0A2D0SFJ9	177	V	G
O75439	LP/P	Multiple mitochondrial dysfunctions syndrome 6 (MMDS6) [MIM:617954]	A0A2D0SFJ9	201	A	P
O75439	LP/P	Multiple mitochondrial dysfunctions syndrome 6 (MMDS6) [MIM:617954]	A0A2D0SFJ9	422	I	T
P54277	LB/B	-	B0S640	394	M	T
P54277	LB/B	-	B0S640	501	G	R
P54277	LB/B	-	B0S640	202	R	K
P54277	LB/B	-	B0S640	632	N	S
P54277	LB/B	-	B0S640	720	E	D
P54277	LB/B	-	B0S640	793	Y	H
P54277	LB/B	-	B0S640	27	E	Q
Q15126	LB/B	-	A0A2S2N4C1	125	V	M
Q8N490	LP/P	Dystonia 8 (DYT8) [MIM:118800]	L8IZG9	7	A	V
Q8N490	LP/P	Dystonia 8 (DYT8) [MIM:118800]	L8IZG9	9	A	V
Q96T60	LB/B	-	A0A067R0U4	20	P	S
Q96T60	LB/B	-	A0A067R0U4	63	A	V
Q96T60	LB/B	-	A0A067R0U4	180	R	S
Q96T60	LB/B	-	A0A067R0U4	196	Y	N
Q96T60	LB/B	-	A0A067R0U4	478	V	G
Q96T60	LP/P	Microcephaly, seizures, and developmental delay (MCSZ) [MIM:613402]	A0A067R0U4	176	L	F
Q96T60	LP/P	Microcephaly, seizures, and developmental delay (MCSZ) [MIM:613402]	A0A067R0U4	326	E	K
Q96T60	LP/P	Ataxia-oculomotor apraxia 4 (AOA4) [MIM:616267]	A0A067R0U4	375	G	W
Q96T60	LP/P	Microcephaly, seizures, and developmental delay (MCSZ) [MIM:613402]	A0A067R0U4	462	R	P
Q8NA58	LP/P	Spermatogenic failure 57 (SPGF57) [MIM:619528]	V8NQY4	84	P	S
Q9UL41	LB/B	-	M3X6D0	382	G	S
Q9UL41	LB/B	-	M3X6D0	386	R	Q
Q96PV4	LB/B	-	M3X6D0	107	N	H
Q96PV4	LB/B	-	M3X6D0	349	R	W
Q86V59	LB/B	-	A0A2U3ZHC8	80	S	T
Q86V59	LB/B	-	A0A2U3ZHC8	97	C	Y
P11086	LB/B	-	F6SN94	276	W	R
P11086	LB/B	-	F6SN94	9	N	S
P11086	LB/B	-	F6SN94	98	T	A
P11086	LB/B	-	F6SN94	112	R	C
P11086	LB/B	-	F6SN94	175	A	T
P11086	LB/B	-	F6SN94	188	S	C
P11086	LB/B	-	F6SN94	211	L	H
P11086	LB/B	-	F6SN94	217	L	Q
P11086	LB/B	-	F6SN94	254	R	H
Q9H307	LB/B	-	P79122	671	S	G
Q9NRX1	LB/B	-	A0A2Y9TEI6	11	R	G
Q9NRX1	LB/B	-	A0A2Y9TEI6	71	G	A
P00491	LB/B	-	A0A1U7T027	51	G	S
P00491	LP/P	Purine nucleoside phosphorylase deficiency (PNPD) [MIM:613179]	A0A1U7T027	89	E	K
P00491	LP/P	Purine nucleoside phosphorylase deficiency (PNPD) [MIM:613179]	A0A1U7T027	128	D	G
P00491	LP/P	Purine nucleoside phosphorylase deficiency (PNPD) [MIM:613179]	A0A1U7T027	174	A	P
P00491	LP/P	Purine nucleoside phosphorylase deficiency (PNPD) [MIM:613179]	A0A1U7T027	234	R	P
P00491	LP/P	Purine nucleoside phosphorylase deficiency (PNPD) [MIM:613179]	A0A1U7T027	192	Y	C
Q8N8W4	LB/B	-	G5BEW0	423	P	H
Q8N8W4	LB/B	-	G5BEW0	490	T	M
Q8N8W4	LB/B	-	G5BEW0	522	S	P
Q8N8W4	LP/P	Ichthyosis, congenital, autosomal recessive 10 (ARCI10) [MIM:615024]	G5BEW0	59	A	V
Q8N8W4	LP/P	Ichthyosis, congenital, autosomal recessive 10 (ARCI10) [MIM:615024]	G5BEW0	34	A	T
Q9NST1	LB/B	-	A0A2K6V701	99	C	G
Q9NST1	LB/B	-	A0A2K6V701	115	G	C
Q9NST1	LB/B	-	A0A2K6V701	434	K	E
Q9NST1	LB/B	-	A0A2K6V701	148	I	M
Q9NST1	LB/B	-	A0A2K6V701	216	T	P
Q9NST1	LB/B	-	A0A2K6V701	453	S	I
P41247	LB/B	-	J9P021	48	V	G
P41247	LB/B	-	J9P021	134	D	G
P41247	LB/B	-	J9P021	187	R	Q
P41247	LB/B	-	J9P021	113	V	I
Q7Z6Z6	LB/B	-	A0A1A6G3A1	140	L	F
Q7Z6Z6	LB/B	-	A0A1A6G3A1	200	T	I
Q7Z6Z6	LB/B	-	A0A1A6G3A1	286	W	R
Q8IY17	LB/B	-	M7ATS3	412	A	P
Q8IY17	LB/B	-	M7ATS3	1033	K	R
Q8IY17	LP/P	Spastic paraplegia 39, autosomal recessive (SPG39) [MIM:612020]	M7ATS3	938	R	H
Q8IY17	LP/P	Spastic paraplegia 39, autosomal recessive (SPG39) [MIM:612020]	M7ATS3	1060	M	V
Q8IY17	LP/P	Spastic paraplegia 39, autosomal recessive (SPG39) [MIM:612020]	M7ATS3	263	V	I
Q8IY17	LP/P	Boucher-Neuhauser syndrome (BNHS) [MIM:215470]	M7ATS3	578	G	W
Q8IY17	LP/P	Spastic paraplegia 39, autosomal recessive (SPG39) [MIM:612020]	M7ATS3	840	G	E
Q8IY17	LP/P	Boucher-Neuhauser syndrome (BNHS) [MIM:215470]	M7ATS3	1045	S	L
Q8IY17	LP/P	Boucher-Neuhauser syndrome (BNHS) [MIM:215470]	M7ATS3	1058	T	I
Q8IY17	LP/P	Boucher-Neuhauser syndrome (BNHS) [MIM:215470]	M7ATS3	1066	F	S
Q8IY17	LP/P	Boucher-Neuhauser syndrome (BNHS) [MIM:215470]	M7ATS3	1110	V	M
Q8IY17	LP/P	Boucher-Neuhauser syndrome (BNHS) [MIM:215470]	M7ATS3	1122	P	L
Q8IY17	LP/P	Laurence-Moon syndrome (LNMS) [MIM:245800]	M7ATS3	726	G	R
Q8IY17	LP/P	Oliver-McFarlane syndrome (OMCS) [MIM:275400]	M7ATS3	1099	R	Q
Q8IY17	LP/P	Oliver-McFarlane syndrome (OMCS) [MIM:275400]	M7ATS3	1129	G	R
Q8IY17	LP/P	Boucher-Neuhauser syndrome (BNHS) [MIM:215470]	M7ATS3	1147	R	C
Q8IY17	LP/P	Boucher-Neuhauser syndrome (BNHS) [MIM:215470]	M7ATS3	1175	S	C
Q8IY17	LP/P	Oliver-McFarlane syndrome (OMCS) [MIM:275400]	M7ATS3	1176	G	S
Q8IY17	LP/P	Oliver-McFarlane syndrome (OMCS) [MIM:275400]	M7ATS3	1215	V	A
Q8IY17	LP/P	Boucher-Neuhauser syndrome (BNHS) [MIM:215470]	M7ATS3	1359	R	W
Q6ZV29	LB/B	-	M7ATS3	323	R	Q
Q6ZV29	LB/B	-	M7ATS3	364	Q	E
Q6ZV29	LB/B	-	M7ATS3	368	E	D
Q6ZV29	LB/B	-	M7ATS3	803	A	V
Q6ZV29	LB/B	-	M7ATS3	824	V	M
Q6ZV29	LB/B	-	M7ATS3	908	P	L
Q6ZV29	LB/B	-	M7ATS3	993	L	M
Q6ZV29	LB/B	-	M7ATS3	286	G	S
Q6ZV29	LB/B	-	M7ATS3	1050	D	N
Q6ZV29	LB/B	-	M7ATS3	387	G	S
Q6ZV29	LB/B	-	M7ATS3	236	R	H
Q9NVS9	LB/B	-	A0A0P7XQP8	50	E	K
Q9NVS9	LB/B	-	A0A0P7XQP8	116	R	Q
Q9NVS9	LP/P	Pyridoxine-5'-phosphate oxidase deficiency (PNPOD) [MIM:610090]	A0A0P7XQP8	229	R	W
Q9NVS9	LP/P	Pyridoxine-5'-phosphate oxidase deficiency (PNPOD) [MIM:610090]	A0A0P7XQP8	225	R	H
Q9NVS9	LP/P	Pyridoxine-5'-phosphate oxidase deficiency (PNPOD) [MIM:610090]	A0A0P7XQP8	229	R	Q
Q8NBT0	LB/B	-	F6XB57	79	G	S
Q8NBT0	LB/B	-	F6XB57	348	Q	H
Q8NBT0	LP/P	Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis (SOFT) [MIM:614813]	F6XB57	171	L	P
Q8TC44	LP/P	Cone-rod dystrophy 20 (CORD20) [MIM:615973]	A0A2I3NH89	106	R	P
Q8NA72	LB/B	-	G1SIN9	36	H	R
Q8NA72	LB/B	-	G1SIN9	85	I	T
Q8NA72	LB/B	-	G1SIN9	446	A	T
Q7Z5L7	LB/B	-	Q6QI48	444	T	M
Q7Z5L7	LB/B	-	Q6QI48	472	V	A
Q6PEZ8	LB/B	-	F1SD62	44	R	W
Q9NZ53	LB/B	-	A0A091SVV3	456	V	A
Q8WVV4	LB/B	-	W5NWH4	207	P	S
Q8WVV4	LB/B	-	W5NWH4	239	C	S
Q8WVV4	LB/B	-	W5NWH4	296	E	A
Q8WVV4	LB/B	-	W5NWH4	323	M	V
Q8WVV4	LP/P	Premature ovarian failure 2B (POF2B) [MIM:300604]	W5NWH4	329	R	Q
Q8WVV4	LB/B	-	W5NWH4	349	M	L
Q8WVV4	LB/B	-	W5NWH4	434	Q	K
Q8WVV4	LB/B	-	W5NWH4	444	C	Y
Q7Z4H8	LB/B	-	V9KSZ0	319	R	L
Q7Z3K3	LB/B	-	A0A1W5AI87	1365	E	D
Q7Z3K3	LP/P	-	A0A1W5AI87	1040	E	K
Q14181	LB/B	-	A0A2B4S8K5	583	G	R
Q14181	LB/B	-	A0A2B4S8K5	588	S	N
P28340	LB/B	-	A0A1V9XNK0	30	R	W
P28340	LB/B	-	A0A1V9XNK0	19	R	H
P28340	LB/B	-	A0A1V9XNK0	119	R	H
P28340	LB/B	-	A0A1V9XNK0	173	S	N
P28340	LB/B	-	A0A1V9XNK0	177	R	H
P28340	LB/B	-	A0A1V9XNK0	849	R	H
P28340	LB/B	-	A0A1V9XNK0	1086	R	Q
P28340	LB/B	-	A0A1V9XNK0	5	R	W
P28340	LB/B	-	A0A1V9XNK0	21	G	C
P28340	LB/B	-	A0A1V9XNK0	347	P	L
P28340	LP/P	Colorectal cancer 10 (CRCS10) [MIM:612591]	A0A1V9XNK0	478	S	N
P28340	LB/B	-	A0A1V9XNK0	787	P	L
P28340	LB/B	-	A0A1V9XNK0	808	R	H
P28340	LB/B	-	A0A1V9XNK0	864	A	T
P28340	LP/P	Colorectal cancer 10 (CRCS10) [MIM:612591]	A0A1V9XNK0	474	L	P
P49005	LB/B	-	W5NDG1	303	N	S
Q9HCU8	LB/B	-	A0A2Y9PMM7	39	R	P
Q9HCU8	LB/B	-	A0A2Y9PMM7	59	G	R
Q9NRF9	LB/B	-	G9KHP2	83	T	A
Q9NRF9	LB/B	-	G9KHP2	135	E	D
Q9NRF9	LB/B	-	G9KHP2	126	D	A
Q9NR33	LB/B	-	E2R060	17	G	V
P54098	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive, 1 (PEOB1) [MIM:258450]	A0A1S3ESF9	3	R	P
P54098	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive, 1 (PEOB1) [MIM:258450]	A0A1S3ESF9	304	L	R
P54098	LP/P	Mitochondrial DNA depletion syndrome 4A (MTDPS4A) [MIM:203700]	A0A1S3ESF9	467	A	T
P54098	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive, 1 (PEOB1) [MIM:258450]	A0A1S3ESF9	467	A	T
P54098	LP/P	Sensory ataxic neuropathy dysarthria and ophthalmoparesis (SANDO) [MIM:607459]	A0A1S3ESF9	467	A	T
P54098	LP/P	Spinocerebellar ataxia with epilepsy (SCAE) [MIM:607459]	A0A1S3ESF9	467	A	T
P54098	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 1 (PEOA1) [MIM:157640]	A0A1S3ESF9	955	Y	C
P54098	LB/B	-	A0A1S3ESF9	18	P	S
P54098	LB/B	-	A0A1S3ESF9	324	P	S
P54098	LB/B	-	A0A1S3ESF9	546	R	C
P54098	LB/B	-	A0A1S3ESF9	662	E	K
P54098	LB/B	-	A0A1S3ESF9	1142	R	W
P54098	LB/B	-	A0A1S3ESF9	1143	E	G
P54098	LB/B	-	A0A1S3ESF9	1236	Q	H
P54098	LB/B	-	A0A1S3ESF9	193	R	Q
P54098	LP/P	Mitochondrial DNA depletion syndrome 4B (MTDPS4B) [MIM:613662]	A0A1S3ESF9	227	R	W
P54098	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive, 1 (PEOB1) [MIM:258450]	A0A1S3ESF9	227	R	W
P54098	LP/P	Mitochondrial DNA depletion syndrome 4A (MTDPS4A) [MIM:203700]	A0A1S3ESF9	251	T	I
P54098	LP/P	Mitochondrial DNA depletion syndrome 4B (MTDPS4B) [MIM:613662]	A0A1S3ESF9	251	T	I
P54098	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive, 1 (PEOB1) [MIM:258450]	A0A1S3ESF9	251	T	I
P54098	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive, 1 (PEOB1) [MIM:258450]	A0A1S3ESF9	309	R	L
P54098	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive, 1 (PEOB1) [MIM:258450]	A0A1S3ESF9	312	W	R
P54098	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive, 1 (PEOB1) [MIM:258450]	A0A1S3ESF9	431	G	V
P54098	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive, 1 (PEOB1) [MIM:258450]	A0A1S3ESF9	468	N	D
P54098	LP/P	Sensory ataxic neuropathy dysarthria and ophthalmoparesis (SANDO) [MIM:607459]	A0A1S3ESF9	497	Q	H
P54098	LP/P	Spinocerebellar ataxia with epilepsy (SCAE) [MIM:607459]	A0A1S3ESF9	497	Q	H
P54098	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive, 1 (PEOB1) [MIM:258450]	A0A1S3ESF9	579	R	W
P54098	LP/P	Mitochondrial DNA depletion syndrome 4A (MTDPS4A) [MIM:203700]	A0A1S3ESF9	587	P	L
P54098	LP/P	Mitochondrial DNA depletion syndrome 4B (MTDPS4B) [MIM:613662]	A0A1S3ESF9	587	P	L
P54098	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive, 1 (PEOB1) [MIM:258450]	A0A1S3ESF9	587	P	L
P54098	LP/P	Sensory ataxic neuropathy dysarthria and ophthalmoparesis (SANDO) [MIM:607459]	A0A1S3ESF9	627	R	W
P54098	LP/P	Leigh syndrome (LS) [MIM:256000]	A0A1S3ESF9	848	G	S
P54098	LP/P	Mitochondrial DNA depletion syndrome 4A (MTDPS4A) [MIM:203700]	A0A1S3ESF9	848	G	S
P54098	LP/P	Mitochondrial DNA depletion syndrome 4B (MTDPS4B) [MIM:613662]	A0A1S3ESF9	848	G	S
P54098	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive, 1 (PEOB1) [MIM:258450]	A0A1S3ESF9	848	G	S
P54098	LP/P	Mitochondrial DNA depletion syndrome 4B (MTDPS4B) [MIM:613662]	A0A1S3ESF9	864	N	S
P54098	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive, 1 (PEOB1) [MIM:258450]	A0A1S3ESF9	889	A	T
P54098	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 1 (PEOA1) [MIM:157640]	A0A1S3ESF9	923	G	D
P54098	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive, 1 (PEOB1) [MIM:258450]	A0A1S3ESF9	932	H	Y
P54098	LP/P	Sensory ataxic neuropathy dysarthria and ophthalmoparesis (SANDO) [MIM:607459]	A0A1S3ESF9	932	H	Y
P54098	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 1 (PEOA1) [MIM:157640]	A0A1S3ESF9	943	R	H
P54098	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 1 (PEOA1) [MIM:157640]	A0A1S3ESF9	953	R	C
P54098	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 1 (PEOA1) [MIM:157640]	A0A1S3ESF9	957	A	S
P54098	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive, 1 (PEOB1) [MIM:258450]	A0A1S3ESF9	1047	R	Q
P54098	LP/P	Sensory ataxic neuropathy dysarthria and ophthalmoparesis (SANDO) [MIM:607459]	A0A1S3ESF9	1051	G	R
P54098	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive, 1 (PEOB1) [MIM:258450]	A0A1S3ESF9	1076	G	V
P54098	LP/P	Mitochondrial DNA depletion syndrome 4A (MTDPS4A) [MIM:203700]	A0A1S3ESF9	1096	R	C
P54098	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive, 1 (PEOB1) [MIM:258450]	A0A1S3ESF9	1096	R	C
P54098	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive, 1 (PEOB1) [MIM:258450]	A0A1S3ESF9	1104	S	C
P54098	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive, 1 (PEOB1) [MIM:258450]	A0A1S3ESF9	1105	A	T
P54098	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive, 1 (PEOB1) [MIM:258450]	A0A1S3ESF9	1106	V	I
P54098	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 1 (PEOA1) [MIM:157640]	A0A1S3ESF9	1176	S	L
P54098	LP/P	Mitochondrial DNA depletion syndrome 4A (MTDPS4A) [MIM:203700]	A0A1S3ESF9	232	R	G
P54098	LP/P	Leigh syndrome (LS) [MIM:256000]	A0A1S3ESF9	232	R	H
P54098	LP/P	Mitochondrial DNA depletion syndrome 4A (MTDPS4A) [MIM:203700]	A0A1S3ESF9	244	L	P
P54098	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive, 1 (PEOB1) [MIM:258450]	A0A1S3ESF9	268	G	A
P54098	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive, 1 (PEOB1) [MIM:258450]	A0A1S3ESF9	308	Q	H
P54098	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive, 1 (PEOB1) [MIM:258450]	A0A1S3ESF9	380	G	D
P54098	LB/B	-	A0A1S3ESF9	463	L	F
P54098	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 1 (PEOA1) [MIM:157640]	A0A1S3ESF9	511	S	N
P54098	LP/P	Sensory ataxic neuropathy dysarthria and ophthalmoparesis (SANDO) [MIM:607459]	A0A1S3ESF9	517	G	V
P54098	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive, 1 (PEOB1) [MIM:258450]	A0A1S3ESF9	562	R	Q
P54098	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive, 1 (PEOB1) [MIM:258450]	A0A1S3ESF9	574	R	W
P54098	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive, 1 (PEOB1) [MIM:258450]	A0A1S3ESF9	603	M	L
P54098	LP/P	Sensory ataxic neuropathy dysarthria and ophthalmoparesis (SANDO) [MIM:607459]	A0A1S3ESF9	627	R	Q
P54098	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive, 1 (PEOB1) [MIM:258450]	A0A1S3ESF9	648	P	R
P54098	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive, 1 (PEOB1) [MIM:258450]	A0A1S3ESF9	737	G	R
P54098	LP/P	Mitochondrial DNA depletion syndrome 4A (MTDPS4A) [MIM:203700]	A0A1S3ESF9	767	A	D
P54098	LP/P	Sensory ataxic neuropathy dysarthria and ophthalmoparesis (SANDO) [MIM:607459]	A0A1S3ESF9	807	R	C
P54098	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive, 1 (PEOB1) [MIM:258450]	A0A1S3ESF9	807	R	P
P54098	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive, 1 (PEOB1) [MIM:258450]	A0A1S3ESF9	853	R	W
P54098	LP/P	Mitochondrial DNA depletion syndrome 4A (MTDPS4A) [MIM:203700]	A0A1S3ESF9	879	Q	H
P54098	LP/P	Mitochondrial DNA depletion syndrome 4A (MTDPS4A) [MIM:203700]	A0A1S3ESF9	885	T	S
P54098	LP/P	Mitochondrial DNA depletion syndrome 4A (MTDPS4A) [MIM:203700]	A0A1S3ESF9	914	T	P
P54098	LP/P	Mitochondrial DNA depletion syndrome 4A (MTDPS4A) [MIM:203700]	A0A1S3ESF9	957	A	P
P54098	LP/P	Mitochondrial DNA depletion syndrome 4A (MTDPS4A) [MIM:203700]	A0A1S3ESF9	1096	R	H
P54098	LP/P	Mitochondrial DNA depletion syndrome 4A (MTDPS4A) [MIM:203700]	A0A1S3ESF9	1110	H	Y
P54098	LP/P	Mitochondrial DNA depletion syndrome 4A (MTDPS4A) [MIM:203700]	A0A1S3ESF9	1134	H	R
P54098	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive, 1 (PEOB1) [MIM:258450]	A0A1S3ESF9	1184	D	N
P54098	LP/P	Mitochondrial DNA depletion syndrome 4A (MTDPS4A) [MIM:203700]	A0A1S3ESF9	1191	K	N
P54098	LP/P	Mitochondrial DNA depletion syndrome 4A (MTDPS4A) [MIM:203700]	A0A1S3ESF9	1136	E	K
P54098	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 1 (PEOA1) [MIM:157640]	A0A1S3ESF9	1186	D	H
Q9UHN1	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 4 (PEOA4) [MIM:610131]	A0A250XZY9	451	G	E
Q9UHN1	LB/B	-	A0A250XZY9	169	A	T
Q9UHN1	LB/B	-	A0A250XZY9	416	G	A
Q9UHN1	LP/P	Mitochondrial DNA depletion syndrome 16, hepatic type (MTDPS16) [MIM:618528]	A0A250XZY9	182	R	W
Q9UHN1	LP/P	Mitochondrial DNA depletion syndrome 16B, neuroophthalmic type (MTDPS16B) [MIM:619425]	A0A250XZY9	433	D	Y
Q9Y253	LP/P	Xeroderma pigmentosum variant type (XPV) [MIM:278750]	M7AHL3	111	R	H
Q9Y253	LP/P	Xeroderma pigmentosum variant type (XPV) [MIM:278750]	M7AHL3	122	T	P
Q9Y253	LB/B	-	M7AHL3	209	G	V
Q9Y253	LP/P	Xeroderma pigmentosum variant type (XPV) [MIM:278750]	M7AHL3	263	G	V
Q9Y253	LB/B	-	M7AHL3	334	R	W
Q9Y253	LP/P	Xeroderma pigmentosum variant type (XPV) [MIM:278750]	M7AHL3	361	R	S
Q9Y253	LB/B	-	M7AHL3	478	T	M
Q9Y253	LP/P	Xeroderma pigmentosum variant type (XPV) [MIM:278750]	M7AHL3	535	K	E
Q9Y253	LB/B	-	M7AHL3	584	L	P
Q9Y253	LP/P	Xeroderma pigmentosum variant type (XPV) [MIM:278750]	M7AHL3	589	K	T
Q9Y253	LB/B	-	M7AHL3	595	M	V
Q9Y253	LB/B	-	M7AHL3	647	M	L
Q9Y253	LP/P	Xeroderma pigmentosum variant type (XPV) [MIM:278750]	M7AHL3	93	R	P
Q9Y253	LP/P	Xeroderma pigmentosum variant type (XPV) [MIM:278750]	M7AHL3	266	V	D
Q9Y253	LP/P	Xeroderma pigmentosum variant type (XPV) [MIM:278750]	M7AHL3	295	G	R
Q9Y253	LP/P	Xeroderma pigmentosum variant type (XPV) [MIM:278750]	M7AHL3	692	T	A
Q9UNA4	LB/B	-	A0A2K5CYJ5	96	R	G
Q9UNA4	LB/B	-	A0A2K5CYJ5	261	I	M
Q9UNA4	LB/B	-	A0A2K5CYJ5	276	E	K
Q9UNA4	LB/B	-	A0A2K5CYJ5	474	H	R
Q9UNA4	LB/B	-	A0A2K5CYJ5	532	F	S
Q9UNA4	LB/B	-	A0A2K5CYJ5	560	C	R
Q9UNA4	LB/B	-	A0A2K5CYJ5	731	A	T
Q9UGP5	LB/B	-	I3KRF4	221	T	P
Q9UGP5	LB/B	-	I3KRF4	438	R	W
Q9NP87	LB/B	-	G5ASQ9	107	E	D
Q9NP87	LB/B	-	G5ASQ9	220	G	A
Q9NP87	LB/B	-	G5ASQ9	246	V	F
Q9NP87	LB/B	-	G5ASQ9	484	L	F
Q7Z5Q5	LB/B	-	G3TDE5	121	Q	H
Q7Z5Q5	LB/B	-	G3TDE5	201	R	G
Q7Z5Q5	LB/B	-	G3TDE5	310	M	L
Q7Z5Q5	LB/B	-	G3TDE5	315	P	S
Q7Z5Q5	LB/B	-	G3TDE5	336	G	S
Q7Z5Q5	LB/B	-	G3TDE5	425	R	C
Q7Z5Q5	LB/B	-	G3TDE5	502	S	G
Q7Z5Q5	LB/B	-	G3TDE5	711	F	L
O75417	LB/B	-	A0A2U9BP56	1056	P	L
O95602	LB/B	-	G3TE69	150	P	A
O95602	LB/B	-	G3TE69	349	Q	E
O95602	LB/B	-	G3TE69	364	K	E
O95602	LB/B	-	G3TE69	396	S	N
O95602	LB/B	-	G3TE69	815	I	V
O95602	LB/B	-	G3TE69	1141	A	T
O95602	LB/B	-	G3TE69	1608	I	M
O95602	LP/P	Acrofacial dysostosis, Cincinnati type (AFDCIN) [MIM:616462]	G3TE69	593	E	Q
O95602	LP/P	Acrofacial dysostosis, Cincinnati type (AFDCIN) [MIM:616462]	G3TE69	1299	V	F
Q9H9Y6	LB/B	-	A0A060W1T4	295	S	L
Q9H9Y6	LB/B	-	A0A060W1T4	887	H	R
Q9H9Y6	LP/P	Treacher Collins syndrome 4 (TCS4) [MIM:618939]	A0A060W1T4	1003	R	C
Q9H9Y6	LP/P	Treacher Collins syndrome 4 (TCS4) [MIM:618939]	A0A060W1T4	1003	R	S
O15160	LP/P	Treacher Collins syndrome 3 (TCS3) [MIM:248390]	A0A2Y9JN77	279	R	Q
O15160	LP/P	Treacher Collins syndrome 3 (TCS3) [MIM:248390]	A0A2Y9JN77	279	R	W
O15160	LP/P	Leukodystrophy, hypomyelinating, 11 (HLD11) [MIM:616494]	A0A2Y9JN77	26	T	I
O15160	LP/P	Leukodystrophy, hypomyelinating, 11 (HLD11) [MIM:616494]	A0A2Y9JN77	32	N	I
O15160	LP/P	Leukodystrophy, hypomyelinating, 11 (HLD11) [MIM:616494]	A0A2Y9JN77	65	M	V
O15160	LP/P	Leukodystrophy, hypomyelinating, 11 (HLD11) [MIM:616494]	A0A2Y9JN77	74	N	S
O15160	LP/P	Leukodystrophy, hypomyelinating, 11 (HLD11) [MIM:616494]	A0A2Y9JN77	94	V	A
O15160	LP/P	Leukodystrophy, hypomyelinating, 11 (HLD11) [MIM:616494]	A0A2Y9JN77	109	R	H
O15160	LP/P	Leukodystrophy, hypomyelinating, 11 (HLD11) [MIM:616494]	A0A2Y9JN77	132	G	D
O15160	LP/P	Leukodystrophy, hypomyelinating, 11 (HLD11) [MIM:616494]	A0A2Y9JN77	146	C	R
O15160	LP/P	Leukodystrophy, hypomyelinating, 11 (HLD11) [MIM:616494]	A0A2Y9JN77	191	R	Q
O15160	LP/P	Leukodystrophy, hypomyelinating, 11 (HLD11) [MIM:616494]	A0A2Y9JN77	262	I	T
O15160	LP/P	Leukodystrophy, hypomyelinating, 11 (HLD11) [MIM:616494]	A0A2Y9JN77	324	E	K
P0DPB6	LP/P	Treacher Collins syndrome 2 (TCS2) [MIM:613717]	G1TA07	47	E	K
P0DPB6	LP/P	Treacher Collins syndrome 2 (TCS2) [MIM:613717]	G1TA07	50	T	I
P0DPB6	LP/P	Treacher Collins syndrome 2 (TCS2) [MIM:613717]	G1TA07	51	L	R
P0DPB6	LP/P	Treacher Collins syndrome 2 (TCS2) [MIM:613717]	G1TA07	52	G	E
P0DPB6	LP/P	Treacher Collins syndrome 2 (TCS2) [MIM:613717]	G1TA07	56	R	C
P0DPB6	LP/P	Treacher Collins syndrome 2 (TCS2) [MIM:613717]	G1TA07	82	L	S
P0DPB6	LP/P	Treacher Collins syndrome 2 (TCS2) [MIM:613717]	G1TA07	99	G	S
Q9GZS1	LB/B	-	U3KES9	192	D	H
Q9GZS1	LB/B	-	U3KES9	356	V	M
Q9GZS1	LB/B	-	U3KES9	383	R	K
O15446	LB/B	-	L9LBJ3	259	K	T
O15446	LB/B	-	L9LBJ3	282	T	A
O15446	LB/B	-	L9LBJ3	373	K	E
O15446	LB/B	-	L9LBJ3	394	D	N
O15446	LB/B	-	L9LBJ3	503	K	Q
O15446	LB/B	-	L9LBJ3	504	Q	K
Q9P1U0	LB/B	-	A0A1I7YDP2	14	Q	H
P24928	LB/B	-	A0A164XR10	292	R	C
P24928	LP/P	Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities (NEDHIB) [MIM:618603]	A0A164XR10	736	T	M
P24928	LP/P	Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities (NEDHIB) [MIM:618603]	A0A164XR10	1124	L	P
P19388	LB/B	-	A0A1S3UP51	44	S	F
Q9GZM3	LB/B	-	A0A2I3MN20	28	K	N
Q6EEV4	LB/B	-	A0A2K6UUK1	127	A	P
Q9NW08	LB/B	-	A0A091E5B2	740	T	A
Q9NW08	LP/P	Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism (HLD8) [MIM:614381]	A0A091E5B2	503	T	K
Q9NW08	LP/P	Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism (HLD8) [MIM:614381]	A0A091E5B2	523	V	E
Q9NW08	LP/P	Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism (HLD8) [MIM:614381]	A0A091E5B2	768	R	H
Q9NW08	LP/P	Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism (HLD8) [MIM:614381]	A0A091E5B2	926	D	E
Q9NW08	LP/P	Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism (HLD8) [MIM:614381]	A0A091E5B2	104	L	F
Q9NW08	LP/P	Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism (HLD8) [MIM:614381]	A0A091E5B2	268	S	G
Q9NW08	LP/P	Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism (HLD8) [MIM:614381]	A0A091E5B2	442	R	C
Q9NW08	LP/P	Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism (HLD8) [MIM:614381]	A0A091E5B2	527	C	R
Q9NW08	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1I (CMT1I) [MIM:619742]	A0A091E5B2	363	E	K
Q9NW08	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1I (CMT1I) [MIM:619742]	A0A091E5B2	365	A	V
Q9NW08	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1I (CMT1I) [MIM:619742]	A0A091E5B2	375	D	V
Q9NW08	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1I (CMT1I) [MIM:619742]	A0A091E5B2	426	L	S
Q9NW08	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1I (CMT1I) [MIM:619742]	A0A091E5B2	462	T	R
Q9NW08	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1I (CMT1I) [MIM:619742]	A0A091E5B2	1046	R	H
Q9BUI4	LB/B	-	L9L2S0	243	H	R
Q9Y2Y1	LB/B	-	A0A0F8B177	24	A	S
Q9Y2Y1	LP/P	Leukodystrophy, hypomyelinating, 21 (HLD21) [MIM:619310]	A0A0F8B177	41	R	W
O00411	LB/B	-	A0A287BLR6	555	E	A
O00411	LP/P	Combined oxidative phosphorylation deficiency 55 (COXPD55) [MIM:619743]	A0A287BLR6	250	H	D
O00411	LP/P	Combined oxidative phosphorylation deficiency 55 (COXPD55) [MIM:619743]	A0A287BLR6	566	P	S
O00411	LP/P	Combined oxidative phosphorylation deficiency 55 (COXPD55) [MIM:619743]	A0A287BLR6	611	S	F
O00411	LP/P	Combined oxidative phosphorylation deficiency 55 (COXPD55) [MIM:619743]	A0A287BLR6	641	F	L
O00411	LP/P	Combined oxidative phosphorylation deficiency 55 (COXPD55) [MIM:619743]	A0A287BLR6	1013	R	C
O00411	LP/P	Combined oxidative phosphorylation deficiency 55 (COXPD55) [MIM:619743]	A0A287BLR6	1193	S	F
Q96HA1	LB/B	-	G3SXZ5	1215	A	G
A8CG34	LB/B	-	G3SXZ5	379	T	A
A8CG34	LB/B	-	G3SXZ5	1165	Q	L
Q8NAT1	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A8 (MDDGA8) [MIM:614830]	R7V8G6	158	R	H
Q8NAT1	LP/P	Muscular dystrophy-dystroglycanopathy limb-girdle C8 (MDDGC8) [MIM:618135]	R7V8G6	165	M	T
Q8NAT1	LP/P	Muscular dystrophy-dystroglycanopathy limb-girdle C8 (MDDGC8) [MIM:618135]	R7V8G6	253	P	L
Q9UKY4	LB/B	-	A0A151M5N0	54	A	E
Q9UKY4	LP/P	Muscular dystrophy-dystroglycanopathy limb-girdle C2 (MDDGC2) [MIM:613158]	A0A151M5N0	184	T	M
Q9UKY4	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A2 (MDDGA2) [MIM:613150]	A0A151M5N0	198	I	N
Q9UKY4	LP/P	Muscular dystrophy-dystroglycanopathy congenital with impaired intellectual development B2 (MDDGB2) [MIM:613156]	A0A151M5N0	246	G	D
Q9UKY4	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A2 (MDDGA2) [MIM:613150]	A0A151M5N0	353	G	S
Q9UKY4	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A2 (MDDGA2) [MIM:613150]	A0A151M5N0	373	V	F
Q9UKY4	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A2 (MDDGA2) [MIM:613150]	A0A151M5N0	413	R	P
Q9UKY4	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A2 (MDDGA2) [MIM:613150]	A0A151M5N0	482	G	V
Q9UKY4	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A2 (MDDGA2) [MIM:613150]	A0A151M5N0	666	Y	C
Q9UKY4	LP/P	Muscular dystrophy-dystroglycanopathy congenital with impaired intellectual development B2 (MDDGB2) [MIM:613156]	A0A151M5N0	666	Y	C
Q9UKY4	LP/P	Muscular dystrophy-dystroglycanopathy congenital with impaired intellectual development B2 (MDDGB2) [MIM:613156]	A0A151M5N0	717	F	S
Q9UKY4	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A2 (MDDGA2) [MIM:613150]	A0A151M5N0	726	G	E
Q9UKY4	LP/P	Muscular dystrophy-dystroglycanopathy congenital with impaired intellectual development B2 (MDDGB2) [MIM:613156]	A0A151M5N0	726	G	E
Q9UKY4	LP/P	Muscular dystrophy-dystroglycanopathy congenital with impaired intellectual development B2 (MDDGB2) [MIM:613156]	A0A151M5N0	748	W	R
Q9UKY4	LP/P	Muscular dystrophy-dystroglycanopathy limb-girdle C2 (MDDGC2) [MIM:613158]	A0A151M5N0	748	W	S
Q9UKY4	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A2 (MDDGA2) [MIM:613150]	A0A151M5N0	478	H	R
P27169	LB/B	-	A0A091DM58	55	L	M
P27169	LB/B	-	A0A091DM58	192	Q	R
P27169	LB/B	-	A0A091DM58	102	I	V
P27169	LB/B	-	A0A091DM58	160	R	G
Q15165	LB/B	-	A0A091DM58	148	A	G
Q15165	LB/B	-	A0A091DM58	311	S	C
Q15165	LB/B	-	A0A091DM58	172	V	L
Q15166	LB/B	-	A0A091DM58	146	E	K
Q15166	LB/B	-	A0A091DM58	179	A	D
Q99575	LB/B	-	A0A1S3EV72	127	S	L
Q99575	LB/B	-	A0A1S3EV72	460	E	A
Q99575	LB/B	-	A0A1S3EV72	522	K	N
Q99575	LB/B	-	A0A1S3EV72	994	L	V
Q99575	LP/P	Anauxetic dysplasia 2 (ANXD2) [MIM:617396]	A0A1S3EV72	583	G	E
Q99575	LP/P	Anauxetic dysplasia 2 (ANXD2) [MIM:617396]	A0A1S3EV72	511	D	Y
Q99575	LP/P	Anauxetic dysplasia 2 (ANXD2) [MIM:617396]	A0A1S3EV72	582	P	S
Q9HBV1	LB/B	-	A0A093F7R5	106	R	Q
Q9HBV1	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 26 (LGMDR26) [MIM:618848]	A0A093F7R5	155	L	H
Q9HBV1	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 26 (LGMDR26) [MIM:618848]	A0A093F7R5	217	L	F
Q9HBV1	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 26 (LGMDR26) [MIM:618848]	A0A093F7R5	261	R	Q
Q9H237	LP/P	Focal dermal hypoplasia (FODH) [MIM:305600]	A0A2D0R3J1	60	G	R
Q9H237	LP/P	Focal dermal hypoplasia (FODH) [MIM:305600]	A0A2D0R3J1	365	R	G
Q9H237	LP/P	Focal dermal hypoplasia (FODH) [MIM:305600]	A0A2D0R3J1	136	S	F
Q9H237	LP/P	Focal dermal hypoplasia (FODH) [MIM:305600]	A0A2D0R3J1	168	G	R
Q9H237	LP/P	Focal dermal hypoplasia (FODH) [MIM:305600]	A0A2D0R3J1	258	V	E
Q9H237	LP/P	Focal dermal hypoplasia (FODH) [MIM:305600]	A0A2D0R3J1	341	H	L
Q9H237	LP/P	Focal dermal hypoplasia (FODH) [MIM:305600]	A0A2D0R3J1	365	R	Q
Q9H237	LP/P	Focal dermal hypoplasia (FODH) [MIM:305600]	A0A2D0R3J1	385	C	R
Q9H237	LP/P	Focal dermal hypoplasia (FODH) [MIM:305600]	A0A2D0R3J1	439	W	R
Q9H237	LP/P	Focal dermal hypoplasia (FODH) [MIM:305600]	A0A2D0R3J1	252	H	Y
Q9H237	LP/P	Focal dermal hypoplasia (FODH) [MIM:305600]	A0A2D0R3J1	297	S	L
Q9H237	LP/P	Focal dermal hypoplasia (FODH) [MIM:305600]	A0A2D0R3J1	331	L	R
Q9H237	LP/P	Focal dermal hypoplasia (FODH) [MIM:305600]	A0A2D0R3J1	361	E	V
Q9H237	LP/P	Focal dermal hypoplasia (FODH) [MIM:305600]	A0A2D0R3J1	385	C	Y
Q9H237	LP/P	Focal dermal hypoplasia (FODH) [MIM:305600]	A0A2D0R3J1	374	A	P
A0A0A6YYL3	LB/B	-	A0A2I3MJF1	249	E	Q
A0A0A6YYL3	LB/B	-	A0A2I3MJF1	492	L	S
A0A0A6YYL3	LB/B	-	A0A2I3MJF1	498	K	M
A0A0A6YYL3	LB/B	-	A0A2I3MJF1	531	T	A
A0JP26	LB/B	-	A0A2I3MJF1	43	M	V
A0JP26	LB/B	-	A0A2I3MJF1	88	N	D
A0JP26	LB/B	-	A0A2I3MJF1	511	K	E
A0JP26	LB/B	-	A0A2I3MJF1	535	M	K
A0JP26	LB/B	-	A0A2I3MJF1	568	A	T
A0JP26	LB/B	-	A0A2I3MJF1	30	H	D
A0JP26	LB/B	-	A0A2I3MJF1	203	D	G
A0JP26	LB/B	-	A0A2I3MJF1	286	Q	E
B2RU33	LB/B	-	A0A2I3MJF1	3	T	A
B2RU33	LB/B	-	A0A2I3MJF1	10	A	T
B2RU33	LB/B	-	A0A2I3MJF1	13	A	T
B2RU33	LB/B	-	A0A2I3MJF1	28	F	C
B2RU33	LB/B	-	A0A2I3MJF1	30	H	P
B2RU33	LB/B	-	A0A2I3MJF1	36	K	R
B2RU33	LB/B	-	A0A2I3MJF1	66	H	R
B2RU33	LB/B	-	A0A2I3MJF1	72	C	Y
B2RU33	LB/B	-	A0A2I3MJF1	86	H	D
B2RU33	LB/B	-	A0A2I3MJF1	166	M	I
B2RU33	LB/B	-	A0A2I3MJF1	221	C	R
Q86YR6	LB/B	-	A0A2I3MJF1	113	G	S
Q86YR6	LB/B	-	A0A2I3MJF1	135	I	V
Q86YR6	LB/B	-	A0A2I3MJF1	172	E	Q
Q16633	LB/B	-	L9KNB1	141	T	A
Q16633	LB/B	-	L9KNB1	194	Q	R
Q9UKI9	LB/B	-	A1L1Z1	152	H	R
Q9UKI9	LB/B	-	A1L1Z1	390	R	K
P20264	LP/P	Snijders Blok-Fisher syndrome (SNIBFIS) [MIM:618604]	W5KQN0	362	R	L
P20264	LP/P	Snijders Blok-Fisher syndrome (SNIBFIS) [MIM:618604]	W5KQN0	407	R	G
P20264	LP/P	Snijders Blok-Fisher syndrome (SNIBFIS) [MIM:618604]	W5KQN0	407	R	L
P20264	LP/P	Snijders Blok-Fisher syndrome (SNIBFIS) [MIM:618604]	W5KQN0	456	N	S
P49335	LP/P	Deafness, X-linked, 2 (DFNX2) [MIM:304400]	P70030	312	A	V
P49335	LP/P	Deafness, X-linked, 2 (DFNX2) [MIM:304400]	P70030	317	L	W
P49335	LP/P	Deafness, X-linked, 2 (DFNX2) [MIM:304400]	P70030	323	R	G
P49335	LP/P	Deafness, X-linked, 2 (DFNX2) [MIM:304400]	P70030	330	R	S
P49335	LP/P	Deafness, X-linked, 2 (DFNX2) [MIM:304400]	P70030	334	K	E
P49335	LB/B	-	P70030	237	G	A
Q01851	LP/P	Ataxia, intention tremor, and hypotonia syndrome, childhood-onset (ATITHS) [MIM:619352]	A0A2U4A722	306	Q	R
Q15319	LP/P	Deafness, autosomal dominant, 15 (DFNA15) [MIM:602459]	A0A2K5WLS1	223	L	P
Q15319	LP/P	Deafness, autosomal dominant, 15 (DFNA15) [MIM:602459]	A0A2K5WLS1	289	L	F
Q15319	LP/P	Deafness, autosomal dominant, 15 (DFNA15) [MIM:602459]	A0A2K5WLS1	64	D	V
Q15319	LP/P	Deafness, autosomal dominant, 15 (DFNA15) [MIM:602459]	A0A2K5WLS1	194	F	Y
Q15319	LP/P	Deafness, autosomal dominant, 15 (DFNA15) [MIM:602459]	A0A2K5WLS1	222	S	L
Q15319	LP/P	Deafness, autosomal dominant, 15 (DFNA15) [MIM:602459]	A0A2K5WLS1	240	N	Y
Q15319	LP/P	Deafness, autosomal dominant, 15 (DFNA15) [MIM:602459]	A0A2K5WLS1	281	I	V
Q15319	LP/P	Deafness, autosomal dominant, 15 (DFNA15) [MIM:602459]	A0A2K5WLS1	299	P	L
Q15319	LP/P	Deafness, autosomal dominant, 15 (DFNA15) [MIM:602459]	A0A2K5WLS1	326	R	K
Q15319	LP/P	Deafness, autosomal dominant, 15 (DFNA15) [MIM:602459]	A0A2K5WLS1	328	K	E
Q01860	LB/B	-	P20263	322	T	A
Q01860	LB/B	-	P20263	357	M	L
Q01860	LB/B	-	P20263	226	L	F
Q01860	LB/B	-	P20263	351	T	I
Q06416	LB/B	-	P20263	33	L	R
Q06416	LB/B	-	P20263	69	L	F
Q06416	LB/B	-	P20263	176	G	E
Q06416	LB/B	-	P20263	182	K	T
Q06416	LB/B	-	P20263	214	N	D
Q06416	LB/B	-	P20263	238	E	Q
Q06416	LB/B	-	P20263	313	P	L
P78424	LP/P	Hereditary susceptibility to Wilms tumor 5 (WT5) [MIM:601583]	A0A2I3S995	192	Q	H
P78424	LB/B	-	A0A2I3S995	199	P	L
P78424	LB/B	-	A0A2I3S995	500	L	M
P78424	LB/B	-	A0A2I3S995	639	E	K
A8MPX8	LB/B	-	K7FM43	37	R	H
A8MPX8	LB/B	-	K7FM43	123	F	L
A8MPX8	LB/B	-	K7FM43	260	A	T
Q9NQ55	LB/B	-	A0A2Y9L9D4	358	G	V
Q9NQ55	LB/B	-	A0A2Y9L9D4	408	Q	R
Q07869	LB/B	-	A0A1S3WME2	127	R	Q
Q07869	LB/B	-	A0A1S3WME2	162	L	V
Q07869	LB/B	-	A0A1S3WME2	227	V	A
Q07869	LB/B	-	A0A1S3WME2	268	A	V
Q07869	LB/B	-	A0A1S3WME2	304	D	N
Q07869	LB/B	-	A0A1S3WME2	409	R	T
Q07869	LB/B	-	A0A1S3WME2	395	G	R
Q9UBK2	LB/B	-	A0A1W4YYJ9	482	G	S
Q9UBK2	LB/B	-	A0A1W4YYJ9	612	T	M
Q86YN6	LB/B	-	A0A226PMK9	203	A	P
Q86YN6	LB/B	-	A0A226PMK9	265	R	Q
Q86YN6	LB/B	-	A0A226PMK9	279	V	I
Q86YN6	LB/B	-	A0A226PMK9	292	R	S
Q96CD2	LB/B	-	R7VXI1	78	I	M
Q9HAB8	LP/P	Cardiomyopathy, dilated 2C (CMD2C) [MIM:618189]	A0A2K6KSB9	180	A	P
Q9HAB8	LP/P	Cardiomyopathy, dilated 2C (CMD2C) [MIM:618189]	A0A2K6KSB9	233	E	V
O14829	LB/B	-	A0A0Q3TP41	367	K	T
O14829	LB/B	-	A0A0Q3TP41	443	G	S
O14830	LB/B	-	L5MES8	120	S	R
O14830	LB/B	-	L5MES8	394	V	L
O14830	LB/B	-	L5MES8	412	E	K
O14830	LB/B	-	L5MES8	553	R	K
O14830	LB/B	-	L5MES8	575	S	C
O14830	LB/B	-	L5MES8	481	M	L
Q13136	LB/B	-	A0A091DCU9	71	V	I
Q13136	LB/B	-	A0A091DCU9	1072	L	F
O75145	LB/B	-	A0A091DCU9	563	A	S
Q86W92	LB/B	-	A0A146VL62	148	V	L
Q8ND30	LB/B	-	A0A2K6GTX7	658	R	G
P23284	LB/B	-	G3NW60	60	V	L
P23284	LP/P	Osteogenesis imperfecta 9 (OI9) [MIM:259440]	G3NW60	9	M	R
P45877	LB/B	-	A0A2R8MMV2	190	N	S
P45877	LB/B	-	A0A2R8MMV2	86	K	R
P45877	LB/B	-	A0A2R8MMV2	160	H	L
Q9H2H8	LB/B	-	B4DN80	146	D	E
Q8IXY8	LB/B	-	A0A087YNR3	110	H	R
O43314	LB/B	-	W5MRW4	944	A	G
O43314	LB/B	-	W5MRW4	985	E	K
O43314	LB/B	-	W5MRW4	1003	R	K
O43314	LB/B	-	W5MRW4	1206	P	Q
O43314	LB/B	-	W5MRW4	1232	T	M
O43314	LP/P	Deafness, autosomal recessive, 100 (DFNB100) [MIM:618422]	W5MRW4	837	R	H
P49593	LB/B	-	L9LFH5	420	L	R
P49593	LB/B	-	L9LFH5	132	R	C
Q5JR12	LB/B	-	A0A0Q3WVG4	213	L	F
Q5JR12	LB/B	-	A0A0Q3WVG4	236	V	I
Q8N3J5	LB/B	-	A0A091CRH9	94	N	K
Q8N3J5	LB/B	-	A0A091CRH9	321	E	K
Q8N3J5	LB/B	-	A0A091CRH9	26	R	H
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	59	R	W
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	152	R	C
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	168	R	C
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	232	G	R
P50336	LB/B	-	A0A0L0HNM1	304	R	H
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	11	G	S
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	11	G	D
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	12	I	T
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	15	L	F
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	20	H	P
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	34	E	V
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	38	R	P
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	40	G	A
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	40	G	E
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	57	G	R
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	73	L	P
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	76	S	F
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	84	V	G
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	85	L	P
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	106	H	P
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	138	R	P
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	139	G	D
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	143	D	V
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	154	L	P
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	158	V	L
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	158	V	M
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	168	R	H
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	169	G	E
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	172	A	V
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	178	L	V
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	205	A	V
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	217	R	C
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	224	W	G
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	224	W	R
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	232	G	S
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	236	L	S
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	282	V	D
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	283	I	N
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	290	V	M
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	295	L	P
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	330	G	R
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	332	G	A
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	335	V	G
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	348	Y	C
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	349	D	A
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	350	S	P
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	358	G	R
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	397	A	D
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	401	L	F
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	420	P	R
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	422	Y	C
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	433	A	P
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	444	L	P
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	448	G	R
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	450	S	P
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	453	G	R
P50336	LP/P	Variegate porphyria (VP) [MIM:176200]	A0A0L0HNM1	453	G	V
P62140	LP/P	Noonan syndrome-like disorder with loose anagen hair 2 (NSLH2) [MIM:617506]	A0A0F8C489	49	P	R
P62140	LP/P	Noonan syndrome-like disorder with loose anagen hair 2 (NSLH2) [MIM:617506]	A0A0F8C489	56	A	P
P62140	LP/P	Noonan syndrome-like disorder with loose anagen hair 2 (NSLH2) [MIM:617506]	A0A0F8C489	183	E	A
P62140	LP/P	Noonan syndrome-like disorder with loose anagen hair 2 (NSLH2) [MIM:617506]	A0A0F8C489	183	E	V
P62140	LP/P	Noonan syndrome-like disorder with loose anagen hair 2 (NSLH2) [MIM:617506]	A0A0F8C489	252	D	Y
P36873	LB/B	-	G3H298	152	F	S
Q96QC0	LB/B	-	A0A087YEV3	173	R	P
O14974	LB/B	-	A0A146VAA8	116	C	W
O14974	LB/B	-	A0A146VAA8	305	T	P
O14974	LB/B	-	A0A146VAA8	734	K	N
O60237	LB/B	-	A0A146VAA8	182	V	I
O60237	LB/B	-	A0A146VAA8	836	R	K
Q9BZL4	LB/B	-	H0WTC3	419	R	C
Q8TAE6	LB/B	-	A0A2U4CPR1	10	T	A
Q5SWA1	LB/B	-	A0A1S3F936	26	P	S
Q5SWA1	LB/B	-	A0A1S3F936	144	E	K
Q5SWA1	LB/B	-	A0A1S3F936	308	N	S
Q5SWA1	LB/B	-	A0A1S3F936	363	E	G
Q5SWA1	LB/B	-	A0A1S3F936	589	K	E
Q5SWA1	LP/P	Microcephaly, short stature, and impaired glucose metabolism 2 (MSSGM2) [MIM:616817]	A0A1S3F936	658	R	C
Q6NYC8	LB/B	-	A0A1U7RHX9	356	P	L
Q6NYC8	LB/B	-	A0A1U7RHX9	222	R	G
Q6NYC8	LB/B	-	A0A1U7RHX9	339	G	R
Q13522	LB/B	-	A0A1S2ZEK6	109	G	E
Q13522	LB/B	-	A0A1S2ZEK6	147	G	D
Q16821	LB/B	-	A0A093H5Y5	883	R	S
Q16821	LB/B	-	A0A093H5Y5	905	D	Y
Q16821	LP/P	Type 2 diabetes mellitus (T2D) [MIM:125853]	A0A093H5Y5	931	A	E
Q16821	LB/B	-	A0A093H5Y5	45	G	S
Q16821	LB/B	-	A0A093H5Y5	231	C	Y
Q16821	LB/B	-	A0A093H5Y5	451	V	M
Q16821	LB/B	-	A0A093H5Y5	476	N	K
Q16821	LB/B	-	A0A093H5Y5	748	E	K
Q16821	LB/B	-	A0A093H5Y5	882	L	H
Q16821	LB/B	-	A0A093H5Y5	627	R	K
Q86XI6	LB/B	-	A0A212CQB3	48	G	E
Q9UQK1	LB/B	-	A0A212CQB3	109	A	S
Q9UQK1	LB/B	-	A0A212CQB3	249	N	S
Q6ZSY5	LB/B	-	W5PKD8	351	F	S
Q6ZSY5	LB/B	-	W5PKD8	441	E	K
B7ZBB8	LB/B	-	Q9CW07	280	P	Q
Q9ULJ8	LB/B	-	H0ZDZ6	331	M	V
Q96SB3	LB/B	-	A0A2D0SX61	201	A	T
P30153	LP/P	Intellectual developmental disorder, autosomal dominant 36 (MRD36) [MIM:616362]	S7NGV3	132	V	L
P30153	LP/P	Intellectual developmental disorder, autosomal dominant 36 (MRD36) [MIM:616362]	S7NGV3	179	P	L
P30153	LP/P	Intellectual developmental disorder, autosomal dominant 36 (MRD36) [MIM:616362]	S7NGV3	182	R	W
P30153	LP/P	Intellectual developmental disorder, autosomal dominant 36 (MRD36) [MIM:616362]	S7NGV3	258	R	H
Q00005	LB/B	-	A0A2R9BTX0	36	G	V
Q00005	LP/P	-	A0A2R9BTX0	138	R	P
Q66LE6	LB/B	-	A0A0P7U2V6	358	G	S
Q06190	LB/B	-	M4A416	745	D	N
Q06190	LB/B	-	M4A416	67	D	G
Q06190	LB/B	-	M4A416	108	N	S
Q06190	LB/B	-	M4A416	171	A	S
Q06190	LB/B	-	M4A416	481	P	A
Q06190	LB/B	-	M4A416	642	S	G
Q06190	LB/B	-	M4A416	695	P	L
Q06190	LB/B	-	M4A416	67	D	N
Q9Y5P8	LB/B	-	A0A2U3YZ52	163	D	E
Q9Y5P8	LB/B	-	A0A2U3YZ52	519	A	V
Q969Q6	LP/P	Myoectodermal gonadal dysgenesis syndrome (MEGD) [MIM:618419]	L9KKA5	103	L	P
Q969Q6	LP/P	Myoectodermal gonadal dysgenesis syndrome (MEGD) [MIM:618419]	L9KKA5	193	L	S
Q969Q6	LP/P	Myoectodermal gonadal dysgenesis syndrome (MEGD) [MIM:618419]	L9KKA5	350	F	S
Q13362	LB/B	-	A0A2H8TVU3	515	A	P
Q14738	LB/B	-	A0A0B4KHB9	53	P	S
Q14738	LP/P	Intellectual developmental disorder, autosomal dominant 35 (MRD35) [MIM:616355]	A0A0B4KHB9	198	E	K
Q14738	LP/P	Intellectual developmental disorder, autosomal dominant 35 (MRD35) [MIM:616355]	A0A0B4KHB9	201	P	R
Q14738	LP/P	Intellectual developmental disorder, autosomal dominant 35 (MRD35) [MIM:616355]	A0A0B4KHB9	200	E	K
Q14738	LP/P	Intellectual developmental disorder, autosomal dominant 35 (MRD35) [MIM:616355]	A0A0B4KHB9	207	W	R
Q08209	LP/P	Epileptic encephalopathy, infantile or early childhood, 1 (IECEE1) [MIM:617711]	A0A2U3XUR5	92	H	R
Q08209	LP/P	Epileptic encephalopathy, infantile or early childhood, 1 (IECEE1) [MIM:617711]	A0A2U3XUR5	281	H	Q
Q08209	LP/P	Epileptic encephalopathy, infantile or early childhood, 1 (IECEE1) [MIM:617711]	A0A2U3XUR5	282	E	K
Q08209	LP/P	Epileptic encephalopathy, infantile or early childhood, 1 (IECEE1) [MIM:617711]	A0A2U3XUR5	150	N	I
Q08209	LP/P	Epileptic encephalopathy, infantile or early childhood, 1 (IECEE1) [MIM:617711]	A0A2U3XUR5	234	D	E
Q08209	LP/P	Arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development (ACCIID) [MIM:618265]	A0A2U3XUR5	470	F	L
Q08209	LP/P	Arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development (ACCIID) [MIM:618265]	A0A2U3XUR5	473	A	T
P48454	LB/B	-	A0A218UP41	501	A	V
Q8TF05	LB/B	-	M3Y5Q1	43	E	K
Q8TF05	LB/B	-	M3Y5Q1	470	I	V
Q8TF05	LB/B	-	M3Y5Q1	595	S	N
Q8TF05	LB/B	-	M3Y5Q1	593	S	N
Q5VV67	LB/B	-	W5Q7V1	536	S	G
Q5VV67	LB/B	-	W5Q7V1	834	P	R
Q5VV67	LB/B	-	W5Q7V1	1288	R	Q
P50897	LP/P	Ceroid lipofuscinosis, neuronal, 1 (CLN1) [MIM:256730]	A0A212CGC3	39	H	Q
P50897	LP/P	Ceroid lipofuscinosis, neuronal, 1 (CLN1) [MIM:256730]	A0A212CGC3	42	G	E
P50897	LP/P	Ceroid lipofuscinosis, neuronal, 1 (CLN1) [MIM:256730]	A0A212CGC3	75	T	P
P50897	LP/P	Ceroid lipofuscinosis, neuronal, 1 (CLN1) [MIM:256730]	A0A212CGC3	79	D	G
P50897	LP/P	Ceroid lipofuscinosis, neuronal, 1 (CLN1) [MIM:256730]	A0A212CGC3	109	Y	D
P50897	LP/P	Ceroid lipofuscinosis, neuronal, 1 (CLN1) [MIM:256730]	A0A212CGC3	122	R	W
P50897	LB/B	-	A0A212CGC3	134	I	T
P50897	LP/P	Ceroid lipofuscinosis, neuronal, 1 (CLN1) [MIM:256730]	A0A212CGC3	177	Q	E
P50897	LP/P	Ceroid lipofuscinosis, neuronal, 1 (CLN1) [MIM:256730]	A0A212CGC3	181	V	L
P50897	LP/P	Ceroid lipofuscinosis, neuronal, 1 (CLN1) [MIM:256730]	A0A212CGC3	181	V	M
P50897	LP/P	Ceroid lipofuscinosis, neuronal, 1 (CLN1) [MIM:256730]	A0A212CGC3	219	L	Q
P50897	LP/P	Ceroid lipofuscinosis, neuronal, 1 (CLN1) [MIM:256730]	A0A212CGC3	247	Y	H
P50897	LP/P	Ceroid lipofuscinosis, neuronal, 1 (CLN1) [MIM:256730]	A0A212CGC3	250	G	V
P50897	LP/P	Ceroid lipofuscinosis, neuronal, 1 (CLN1) [MIM:256730]	A0A212CGC3	108	G	R
P50897	LP/P	Ceroid lipofuscinosis, neuronal, 1 (CLN1) [MIM:256730]	A0A212CGC3	38	W	C
P50897	LP/P	Ceroid lipofuscinosis, neuronal, 1 (CLN1) [MIM:256730]	A0A212CGC3	45	C	Y
P50897	LP/P	Ceroid lipofuscinosis, neuronal, 1 (CLN1) [MIM:256730]	A0A212CGC3	138	S	L
P50897	LP/P	Ceroid lipofuscinosis, neuronal, 1 (CLN1) [MIM:256730]	A0A212CGC3	152	C	Y
P50897	LP/P	Ceroid lipofuscinosis, neuronal, 1 (CLN1) [MIM:256730]	A0A212CGC3	187	H	R
P50897	LP/P	Ceroid lipofuscinosis, neuronal, 1 (CLN1) [MIM:256730]	A0A212CGC3	189	P	R
P50897	LP/P	Ceroid lipofuscinosis, neuronal, 1 (CLN1) [MIM:256730]	A0A212CGC3	222	L	P
P50897	LP/P	Ceroid lipofuscinosis, neuronal, 1 (CLN1) [MIM:256730]	A0A212CGC3	228	V	G
P50897	LP/P	Ceroid lipofuscinosis, neuronal, 1 (CLN1) [MIM:256730]	A0A212CGC3	296	W	R
P50897	LP/P	Ceroid lipofuscinosis, neuronal, 1 (CLN1) [MIM:256730]	A0A212CGC3	305	L	P
P01298	LB/B	-	A0A2Y9MF78	78	E	G
O60828	LP/P	Renpenning syndrome 1 (RENS1) [MIM:309500]	J9P3B0	65	Y	C
O60828	LP/P	-	J9P3B0	244	P	L
Q96KF2	LB/B	-	A0A2K5PL51	4	A	V
O60831	LB/B	-	W5ULW7	56	L	F
Q86YV5	LB/B	-	A0A2U3ZTN7	122	L	I
Q86YV5	LB/B	-	A0A2U3ZTN7	137	R	G
Q86YV5	LB/B	-	A0A2U3ZTN7	139	V	I
Q86YV5	LB/B	-	A0A2U3ZTN7	404	R	Q
Q86YV5	LB/B	-	A0A2U3ZTN7	569	P	L
Q86YV5	LB/B	-	A0A2U3ZTN7	578	S	C
Q86YV5	LB/B	-	A0A2U3ZTN7	595	P	A
Q86YV5	LB/B	-	A0A2U3ZTN7	662	P	T
Q86YV5	LB/B	-	A0A2U3ZTN7	814	P	L
Q86YV5	LB/B	-	A0A2U3ZTN7	851	H	R
Q86YV5	LB/B	-	A0A2U3ZTN7	1003	S	L
Q86YV5	LB/B	-	A0A2U3ZTN7	1041	V	M
Q86YV5	LB/B	-	A0A2U3ZTN7	1113	A	T
Q86YV5	LB/B	-	A0A2U3ZTN7	1315	R	H
Q96QH2	LB/B	-	A0A2Y9L5X2	57	K	Q
Q96QH2	LB/B	-	A0A2Y9L5X2	73	P	Q
Q96QH2	LB/B	-	A0A2Y9L5X2	76	V	F
Q96QH2	LB/B	-	A0A2Y9L5X2	135	G	E
P78395	LB/B	-	G3MYJ9	7	W	R
P78395	LB/B	-	G3MYJ9	218	M	V
O95521	LB/B	-	G3MYJ9	252	E	Q
O95521	LB/B	-	G3MYJ9	302	Y	C
O95521	LB/B	-	G3MYJ9	204	L	M
O95521	LB/B	-	G3MYJ9	386	R	S
O95521	LB/B	-	G3MYJ9	218	P	S
O95521	LB/B	-	G3MYJ9	372	G	A
O95521	LB/B	-	G3MYJ9	213	R	H
O60809	LB/B	-	G3MYJ9	99	K	I
O60809	LB/B	-	G3MYJ9	144	R	H
O60809	LB/B	-	G3MYJ9	306	T	A
O60809	LB/B	-	G3MYJ9	402	R	G
O95522	LB/B	-	G3MYJ9	53	T	K
O95522	LB/B	-	G3MYJ9	157	T	M
O60811	LB/B	-	G3MYJ9	67	V	G
O60811	LB/B	-	G3MYJ9	68	S	W
O60811	LB/B	-	G3MYJ9	72	T	R
O60811	LB/B	-	G3MYJ9	128	A	T
O60811	LB/B	-	G3MYJ9	141	T	M
O60811	LB/B	-	G3MYJ9	225	Y	C
O60811	LB/B	-	G3MYJ9	233	T	N
O60811	LB/B	-	G3MYJ9	301	T	A
O60811	LB/B	-	G3MYJ9	302	C	Y
O60811	LB/B	-	G3MYJ9	304	N	Y
O60811	LB/B	-	G3MYJ9	308	E	G
O60811	LB/B	-	G3MYJ9	310	L	M
O60811	LB/B	-	G3MYJ9	316	F	Y
O60811	LB/B	-	G3MYJ9	375	C	R
O60811	LB/B	-	G3MYJ9	83	E	K
O60811	LB/B	-	G3MYJ9	33	R	S
O60810	LB/B	-	G3MYJ9	85	D	E
Q96NZ9	LB/B	-	A0A2I2U0W5	54	E	G
Q96NZ9	LB/B	-	A0A2I2U0W5	69	K	R
Q96NZ9	LB/B	-	A0A2I2U0W5	81	G	S
Q96NZ9	LB/B	-	A0A2I2U0W5	101	H	R
P04280	LB/B	-	A0A2K6QBJ1	337	S	A
P02812	LB/B	-	A0A2K6QBJ1	274	P	S
P02812	LB/B	-	A0A2K6QBJ1	233	Q	R
Q04118	LB/B	-	A0A0D9R8I2	186	P	Q
P10163	LB/B	-	A0A0D9R8I2	185	R	G
P10163	LB/B	-	A0A0D9R8I2	186	P	R
P10163	LB/B	-	A0A0D9R8I2	200	P	H
P10163	LB/B	-	A0A0D9R8I2	272	A	P
O43663	LB/B	-	A0A146SYR4	187	A	E
O43663	LB/B	-	A0A146SYR4	511	Y	C
Q92733	LB/B	-	A0A091FUZ0	136	P	S
P42785	LB/B	-	G3PEB9	112	E	D
P42785	LB/B	-	G3PEB9	444	T	S
O75626	LB/B	-	W5NIF8	74	G	S
O75626	LB/B	-	W5NIF8	203	D	E
Q9NQV6	LB/B	-	L9KP79	573	T	A
Q9NQV6	LB/B	-	L9KP79	22	A	T
Q9GZV8	LB/B	-	G3TFJ9	244	K	E
P57071	LB/B	-	A0A2K5M5T4	1342	V	I
P57071	LB/B	-	A0A2K5M5T4	1376	T	S
P57071	LB/B	-	A0A2K5M5T4	1481	S	P
Q9HAZ2	LB/B	-	L8IY26	533	S	P
Q9HAZ2	LB/B	-	L8IY26	633	P	L
Q9HAZ2	LP/P	Left ventricular non-compaction 8 (LVNC8) [MIM:615373]	L8IY26	816	N	S
Q9HAZ2	LB/B	-	L8IY26	1101	V	M
Q13029	LB/B	-	I3J7V8	283	D	E
Q13029	LB/B	-	I3J7V8	450	S	N
Q9NQX1	LP/P	Brittle cornea syndrome 2 (BCS2) [MIM:614170]	A0A2K6Q2H6	107	Y	C
Q9NQW5	LB/B	-	A0A2Y9I9R1	90	D	E
Q9NQW5	LB/B	-	A0A2Y9I9R1	131	R	K
Q9NQW5	LB/B	-	A0A2Y9I9R1	435	N	K
Q9NQV8	LP/P	Epilepsy, progressive myoclonic 10 (EPM10) [MIM:616640]	A0A2I3RW29	261	F	L
Q9NQV7	LB/B	-	H0XJF3	681	T	S
Q9NQV7	LB/B	-	H0XJF3	788	K	E
Q9NQV7	LB/B	-	H0XJF3	790	N	H
Q9NQV7	LB/B	-	H0XJF3	814	S	R
P30044	LB/B	-	A0A2K6V2U5	33	Y	C
Q8N945	LB/B	-	A0A2K6MUJ2	99	N	S
P51888	LB/B	-	F7GFP1	348	N	H
P51888	LB/B	-	F7GFP1	157	M	V
P51888	LB/B	-	F7GFP1	334	N	S
P51888	LB/B	-	F7GFP1	33	G	R
Q8TCU6	LB/B	-	G3WEP5	1240	V	I
Q8TCU6	LB/B	-	G3WEP5	1340	K	E
Q8TCU6	LB/B	-	G3WEP5	1559	S	T
Q8TCU6	LB/B	-	G3WEP5	696	R	C
Q8TCU6	LB/B	-	G3WEP5	1118	A	T
Q8TCU6	LB/B	-	G3WEP5	659	V	M
Q8TCU6	LB/B	-	G3WEP5	786	Q	H
Q70Z35	LB/B	-	G3WEP5	312	D	N
P14222	LP/P	Hemophagocytic lymphohistiocytosis, familial, 2 (FHL2) [MIM:603553]	H9GCH7	183	V	G
P14222	LP/P	Hemophagocytic lymphohistiocytosis, familial, 2 (FHL2) [MIM:603553]	H9GCH7	225	R	W
P14222	LP/P	Hemophagocytic lymphohistiocytosis, familial, 2 (FHL2) [MIM:603553]	H9GCH7	252	N	S
P14222	LP/P	Hemophagocytic lymphohistiocytosis, familial, 2 (FHL2) [MIM:603553]	H9GCH7	279	C	Y
P14222	LP/P	Hemophagocytic lymphohistiocytosis, familial, 2 (FHL2) [MIM:603553]	H9GCH7	345	P	L
P14222	LP/P	Hemophagocytic lymphohistiocytosis, familial, 2 (FHL2) [MIM:603553]	H9GCH7	429	G	E
P14222	LP/P	Hemophagocytic lymphohistiocytosis, familial, 2 (FHL2) [MIM:603553]	H9GCH7	50	V	M
P14222	LB/B	-	H9GCH7	123	R	H
P14222	LP/P	Hemophagocytic lymphohistiocytosis, familial, 2 (FHL2) [MIM:603553]	H9GCH7	224	I	N
P14222	LB/B	-	H9GCH7	135	V	M
P14222	LB/B	-	H9GCH7	91	A	V
P14222	LB/B	-	H9GCH7	4	R	H
P13727	LB/B	-	G3STK2	206	H	Y
Q9Y2Y8	LB/B	-	G3STK2	3	C	R
Q9Y2Y8	LB/B	-	G3STK2	109	I	T
Q92954	LB/B	-	H0WIZ1	180	R	W
Q92954	LB/B	-	H0WIZ1	1130	N	S
Q92954	LB/B	-	H0WIZ1	1272	I	T
Q92954	LB/B	-	H0WIZ1	1296	T	M
P02810	LB/B	-	A0A087WZY1	20	D	N
P02810	LB/B	-	A0A087WZY1	66	N	D
P02810	LB/B	-	A0A087WZY1	163	Q	K
P02810	LB/B	-	A0A087WZY1	42	I	L
P02810	LB/B	-	A0A087WZY1	119	R	C
O43900	LB/B	-	H0WDR5	343	R	C
O43900	LP/P	Leber hereditary optic neuropathy, modifier (LOAM) [MIM:308905]	H0WDR5	53	R	W
Q2TBC4	LB/B	-	D3Z6Q6	266	S	R
P49642	LB/B	-	A0A147A6B4	5	D	A
P49642	LP/P	Primordial dwarfism-immunodeficiency-lipodystrophy syndrome (PDIL) [MIM:620005]	A0A147A6B4	301	C	R
Q13131	LB/B	-	A0A091DF85	10	M	L
P17612	LB/B	-	A0A147BUE3	41	L	V
P17612	LB/B	-	A0A147BUE3	46	R	Q
P17612	LB/B	-	A0A147BUE3	264	S	C
P17612	LP/P	Primary pigmented nodular adrenocortical disease 4 (PPNAD4) [MIM:615830]	A0A147BUE3	206	L	R
P17612	LP/P	Cardioacrofacial dysplasia 1 (CAFD1) [MIM:619142]	A0A147BUE3	137	G	R
P22694	LB/B	-	A0A2I0UQN3	106	R	Q
P22694	LP/P	Cardioacrofacial dysplasia 2 (CAFD2) [MIM:619143]	A0A2I0UQN3	54	S	L
P22694	LP/P	Cardioacrofacial dysplasia 2 (CAFD2) [MIM:619143]	A0A2I0UQN3	88	H	N
P22694	LP/P	Cardioacrofacial dysplasia 2 (CAFD2) [MIM:619143]	A0A2I0UQN3	88	H	R
P22694	LP/P	Cardioacrofacial dysplasia 2 (CAFD2) [MIM:619143]	A0A2I0UQN3	235	G	R
P22612	LB/B	-	A0A146NXF8	268	H	D
P22612	LB/B	-	A0A146NXF8	251	I	N
P22612	LP/P	Bleeding disorder, platelet-type, 19 (BDPLT19) [MIM:616176]	A0A146NXF8	74	I	M
P54619	LB/B	-	A0A0G2JVD6	89	T	S
P54619	LB/B	-	A0A0G2JVD6	329	K	N
Q9UGI9	LB/B	-	G1P1P2	71	P	A
Q9UGI9	LB/B	-	G1P1P2	153	L	V
Q9UGI9	LB/B	-	G1P1P2	340	R	W
Q9UGI9	LB/B	-	G1P1P2	76	E	Q
Q9UGI9	LB/B	-	G1P1P2	103	D	G
Q9UGI9	LB/B	-	G1P1P2	113	G	V
Q9UGI9	LB/B	-	G1P1P2	161	L	P
Q9UGI9	LB/B	-	G1P1P2	171	G	S
Q9UGI9	LB/B	-	G1P1P2	180	G	S
Q9UGI9	LB/B	-	G1P1P2	197	M	T
Q9UGI9	LB/B	-	G1P1P2	211	E	Q
Q9UGI9	LB/B	-	G1P1P2	225	R	Q
Q9UGI9	LB/B	-	G1P1P2	225	R	W
Q9UGI9	LB/B	-	G1P1P2	260	Q	R
Q9UGI9	LB/B	-	G1P1P2	269	I	T
Q9UGI9	LB/B	-	G1P1P2	307	R	C
Q9UGI9	LB/B	-	G1P1P2	340	R	Q
Q9UGI9	LB/B	-	G1P1P2	446	R	M
Q9UGI9	LB/B	-	G1P1P2	482	A	V
Q9UGI9	LB/B	-	G1P1P2	485	D	N
P10644	LP/P	Carney complex 1 (CNC1) [MIM:160980]	Q3TYK4	9	S	N
P10644	LP/P	Carney complex 1 (CNC1) [MIM:160980]	Q3TYK4	74	R	C
P10644	LP/P	Carney complex 1 (CNC1) [MIM:160980]	Q3TYK4	146	R	S
P10644	LP/P	Carney complex 1 (CNC1) [MIM:160980]	Q3TYK4	183	D	Y
P10644	LP/P	Carney complex 1 (CNC1) [MIM:160980]	Q3TYK4	213	A	D
P10644	LP/P	Carney complex 1 (CNC1) [MIM:160980]	Q3TYK4	289	G	W
P10644	LP/P	Acrodysostosis 1, with or without hormone resistance (ACRDYS1) [MIM:101800]	Q3TYK4	373	Y	H
P10644	LP/P	Acrodysostosis 1, with or without hormone resistance (ACRDYS1) [MIM:101800]	Q3TYK4	213	A	T
P10644	LB/B	-	Q3TYK4	227	D	N
P10644	LP/P	Acrodysostosis 1, with or without hormone resistance (ACRDYS1) [MIM:101800]	Q3TYK4	239	T	A
P10644	LP/P	Acrodysostosis 1, with or without hormone resistance (ACRDYS1) [MIM:101800]	Q3TYK4	285	Q	R
P10644	LP/P	Acrodysostosis 1, with or without hormone resistance (ACRDYS1) [MIM:101800]	Q3TYK4	289	G	E
P10644	LP/P	Acrodysostosis 1, with or without hormone resistance (ACRDYS1) [MIM:101800]	Q3TYK4	327	I	T
P10644	LP/P	Acrodysostosis 1, with or without hormone resistance (ACRDYS1) [MIM:101800]	Q3TYK4	328	A	V
P10644	LP/P	Acrodysostosis 1, with or without hormone resistance (ACRDYS1) [MIM:101800]	Q3TYK4	335	R	P
P10644	LP/P	Acrodysostosis 1, with or without hormone resistance (ACRDYS1) [MIM:101800]	Q3TYK4	335	R	L
P10644	LP/P	Acrodysostosis 1, with or without hormone resistance (ACRDYS1) [MIM:101800]	Q3TYK4	373	Y	C
P10644	LP/P	Acrodysostosis 1, with or without hormone resistance (ACRDYS1) [MIM:101800]	Q3TYK4	175	Y	C
P31321	LP/P	Marbach-Schaaf neurodevelopmental syndrome (MASNS) [MIM:619680]	F7CWN5	196	E	K
P31321	LP/P	Marbach-Schaaf neurodevelopmental syndrome (MASNS) [MIM:619680]	F7CWN5	335	R	W
P17252	LB/B	-	A0A091HYW3	489	M	V
P17252	LB/B	-	A0A091HYW3	568	V	I
P05771	LB/B	-	A0A091HYW3	588	P	H
Q05655	LB/B	-	H9ZGM5	375	F	S
Q05655	LB/B	-	H9ZGM5	593	V	M
Q05655	LB/B	-	H9ZGM5	494	M	V
Q05655	LB/B	-	H9ZGM5	348	N	S
Q05655	LB/B	-	H9ZGM5	410	L	F
Q05655	LB/B	-	H9ZGM5	483	R	W
P24723	LB/B	-	A0A0P5SYR5	374	V	I
P24723	LB/B	-	A0A0P5SYR5	19	A	V
P24723	LB/B	-	A0A0P5SYR5	65	K	R
P24723	LB/B	-	A0A0P5SYR5	149	R	Q
P24723	LB/B	-	A0A0P5SYR5	359	R	Q
P24723	LB/B	-	A0A0P5SYR5	575	T	A
P24723	LB/B	-	A0A0P5SYR5	612	P	S
P24723	LB/B	-	A0A0P5SYR5	645	D	V
P24723	LB/B	-	A0A0P5SYR5	497	D	Y
P41743	LB/B	-	A0A2U4C879	130	R	C
Q04759	LB/B	-	O61225	330	P	L
Q04759	LB/B	-	O61225	306	D	V
Q04759	LB/B	-	O61225	354	D	N
P14314	LB/B	-	E0VQQ4	74	S	N
P14314	LB/B	-	E0VQQ4	291	A	T
P14314	LB/B	-	E0VQQ4	338	A	G
Q05513	LB/B	-	A0A2Y9K910	84	R	H
Q05513	LB/B	-	A0A2Y9K910	49	R	H
Q9BZL6	LB/B	-	A0A146X5Q7	324	V	M
Q9BZL6	LB/B	-	A0A146X5Q7	496	A	V
Q9BZL6	LB/B	-	A0A146X5Q7	604	S	G
Q9BZL6	LB/B	-	A0A146X5Q7	773	W	R
Q9BZL6	LB/B	-	A0A146X5Q7	835	A	V
O94806	LB/B	-	A0A146X5Q7	42	N	D
O94806	LB/B	-	A0A146X5Q7	128	A	T
O94806	LB/B	-	A0A146X5Q7	546	Q	R
O94806	LB/B	-	A0A146X5Q7	225	P	S
O94806	LB/B	-	A0A146X5Q7	445	L	I
P78527	LB/B	-	B3RQ94	6	A	S
P78527	LB/B	-	B3RQ94	333	M	I
P78527	LB/B	-	B3RQ94	605	T	S
P78527	LB/B	-	B3RQ94	680	I	M
P78527	LB/B	-	B3RQ94	695	P	S
P78527	LB/B	-	B3RQ94	1071	N	S
P78527	LB/B	-	B3RQ94	1314	G	V
P78527	LB/B	-	B3RQ94	1588	D	V
P78527	LB/B	-	B3RQ94	1603	Q	H
P78527	LB/B	-	B3RQ94	2095	A	V
P78527	LB/B	-	B3RQ94	2702	K	E
P78527	LB/B	-	B3RQ94	2899	R	C
P78527	LB/B	-	B3RQ94	3149	G	D
P78527	LB/B	-	B3RQ94	3201	P	S
P78527	LB/B	-	B3RQ94	3404	G	E
P78527	LB/B	-	B3RQ94	3434	I	T
P78527	LB/B	-	B3RQ94	3459	N	S
P78527	LB/B	-	B3RQ94	3562	L	M
P78527	LB/B	-	B3RQ94	3836	P	L
P78527	LB/B	-	B3RQ94	3932	M	V
P78527	LB/B	-	B3RQ94	420	V	I
P78527	LB/B	-	B3RQ94	649	F	L
P78527	LB/B	-	B3RQ94	1190	L	V
P78527	LB/B	-	B3RQ94	1237	A	T
P78527	LB/B	-	B3RQ94	1279	L	F
P78527	LB/B	-	B3RQ94	1619	A	G
P78527	LB/B	-	B3RQ94	2023	S	P
P78527	LB/B	-	B3RQ94	2598	R	Q
P78527	LB/B	-	B3RQ94	3085	E	D
P78527	LB/B	-	B3RQ94	3198	T	S
P78527	LB/B	-	B3RQ94	3584	L	F
P78527	LB/B	-	B3RQ94	3800	L	I
P78527	LB/B	-	B3RQ94	3936	G	S
P78527	LB/B	-	B3RQ94	3937	V	M
P78527	LB/B	-	B3RQ94	3702	P	L
P78527	LP/P	Immunodeficiency 26 with or without neurologic abnormalities (IMD26) [MIM:615966]	B3RQ94	3062	L	R
P78527	LP/P	Immunodeficiency 26 with or without neurologic abnormalities (IMD26) [MIM:615966]	B3RQ94	3574	A	V
O60260	LP/P	Parkinson disease 2 (PARK2) [MIM:600116]	A0A1S3IQ86	15	V	M
O60260	LP/P	Parkinson disease 2 (PARK2) [MIM:600116]	A0A1S3IQ86	33	R	Q
O60260	LP/P	Parkinson disease 2 (PARK2) [MIM:600116]	A0A1S3IQ86	37	P	L
O60260	LP/P	Parkinson disease (PARK) [MIM:168600]	A0A1S3IQ86	42	R	P
O60260	LP/P	Parkinson disease 2 (PARK2) [MIM:600116]	A0A1S3IQ86	42	R	P
O60260	LP/P	Parkinson disease 2 (PARK2) [MIM:600116]	A0A1S3IQ86	46	A	P
O60260	LP/P	Parkinson disease 2 (PARK2) [MIM:600116]	A0A1S3IQ86	82	A	E
O60260	LP/P	Parkinson disease 2 (PARK2) [MIM:600116]	A0A1S3IQ86	92	A	V
O60260	LB/B	-	A0A1S3IQ86	100	Q	H
O60260	LP/P	Parkinson disease 2 (PARK2) [MIM:600116]	A0A1S3IQ86	161	K	N
O60260	LB/B	-	A0A1S3IQ86	167	S	N
O60260	LP/P	Parkinson disease 2 (PARK2) [MIM:600116]	A0A1S3IQ86	211	K	N
O60260	LP/P	Parkinson disease 2 (PARK2) [MIM:600116]	A0A1S3IQ86	212	C	Y
O60260	LP/P	Parkinson disease 2 (PARK2) [MIM:600116]	A0A1S3IQ86	240	T	M
O60260	LP/P	Parkinson disease 2 (PARK2) [MIM:600116]	A0A1S3IQ86	240	T	R
O60260	LP/P	Parkinson disease (PARK) [MIM:168600]	A0A1S3IQ86	253	C	Y
O60260	LP/P	Parkinson disease (PARK) [MIM:168600]	A0A1S3IQ86	256	R	C
O60260	LP/P	Parkinson disease 2 (PARK2) [MIM:600116]	A0A1S3IQ86	256	R	C
O60260	LB/B	-	A0A1S3IQ86	271	R	S
O60260	LP/P	Parkinson disease (PARK) [MIM:168600]	A0A1S3IQ86	275	R	W
O60260	LP/P	Parkinson disease 2 (PARK2) [MIM:600116]	A0A1S3IQ86	275	R	W
O60260	LP/P	Parkinson disease (PARK) [MIM:168600]	A0A1S3IQ86	280	D	N
O60260	LP/P	Parkinson disease 2 (PARK2) [MIM:600116]	A0A1S3IQ86	284	G	R
O60260	LP/P	Parkinson disease 2 (PARK2) [MIM:600116]	A0A1S3IQ86	289	C	G
O60260	LP/P	Parkinson disease 2 (PARK2) [MIM:600116]	A0A1S3IQ86	328	G	E
O60260	LB/B	-	A0A1S3IQ86	334	R	C
O60260	LB/B	-	A0A1S3IQ86	339	A	S
O60260	LP/P	Parkinson disease 2 (PARK2) [MIM:600116]	A0A1S3IQ86	351	T	P
O60260	LB/B	-	A0A1S3IQ86	366	R	W
O60260	LB/B	-	A0A1S3IQ86	380	V	L
O60260	LB/B	-	A0A1S3IQ86	394	D	N
O60260	LP/P	Parkinson disease 2 (PARK2) [MIM:600116]	A0A1S3IQ86	415	T	N
O60260	LP/P	Parkinson disease 2 (PARK2) [MIM:600116]	A0A1S3IQ86	430	G	D
O60260	LP/P	Parkinson disease 2 (PARK2) [MIM:600116]	A0A1S3IQ86	431	C	F
O60260	LP/P	Parkinson disease 2 (PARK2) [MIM:600116]	A0A1S3IQ86	437	P	L
O60260	LP/P	Parkinson disease 2 (PARK2) [MIM:600116]	A0A1S3IQ86	441	C	R
O60260	LP/P	Parkinson disease 2 (PARK2) [MIM:600116]	A0A1S3IQ86	56	V	E
O60260	LP/P	Parkinson disease 2 (PARK2) [MIM:600116]	A0A1S3IQ86	402	R	C
O60260	LP/P	Parkinson disease 2 (PARK2) [MIM:600116]	A0A1S3IQ86	418	C	R
Q9H875	LB/B	-	A0A2I3TS84	7	S	A
Q9H875	LB/B	-	A0A2I3TS84	106	D	Y
P51817	LB/B	-	A0A2I3TVL8	43	V	A
P16471	LB/B	-	G5BQ89	100	I	V
P16471	LP/P	Multiple fibroadenomas of the breast (MFAB) [MIM:615554]	G5BQ89	170	I	L
P16471	LP/P	Hyperprolactinemia (HPRL) [MIM:615555]	G5BQ89	212	H	R
Q9NNZ6	LB/B	-	A0A091CTU1	100	R	Q
Q99873	LB/B	-	A0A2K6SLX0	88	K	M
Q99873	LB/B	-	A0A2K6SLX0	168	L	F
O60678	LB/B	-	A0A087XDH7	440	L	V
O60678	LB/B	-	A0A087XDH7	508	N	S
O60678	LB/B	-	A0A087XDH7	470	S	C
Q96LA8	LB/B	-	A0A2K5SDZ1	194	A	V
Q9NVM4	LP/P	Short stature, brachydactyly, impaired intellectual developmental, and seizures (SBIDDS) [MIM:617157]	A0A0F8BFW5	32	R	T
Q9NVM4	LP/P	Short stature, brachydactyly, impaired intellectual developmental, and seizures (SBIDDS) [MIM:617157]	A0A0F8BFW5	387	R	G
Q9NVM4	LP/P	Short stature, brachydactyly, impaired intellectual developmental, and seizures (SBIDDS) [MIM:617157]	A0A0F8BFW5	494	W	R
Q6P2P2	LB/B	-	A0A2I0MGP0	483	S	G
Q6P2P2	LB/B	-	A0A2I0MGP0	747	C	Y
P04156	LP/P	Gerstmann-Straussler disease (GSD) [MIM:137440]	B2D1U2	102	P	L
P04156	LP/P	Gerstmann-Straussler disease (GSD) [MIM:137440]	B2D1U2	105	P	L
P04156	LB/B	-	B2D1U2	117	A	V
P04156	LB/B	-	B2D1U2	129	M	V
P04156	LB/B	-	B2D1U2	171	N	S
P04156	LP/P	Creutzfeldt-Jakob disease (CJD) [MIM:123400]	B2D1U2	178	D	N
P04156	LP/P	Fatal familial insomnia (FFI) [MIM:600072]	B2D1U2	178	D	N
P04156	LP/P	Creutzfeldt-Jakob disease (CJD) [MIM:123400]	B2D1U2	180	V	I
P04156	LP/P	Spongiform encephalopathy with neuropsychiatric features (SENF) [MIM:606688]	B2D1U2	183	T	A
P04156	LP/P	Gerstmann-Straussler disease (GSD) [MIM:137440]	B2D1U2	198	F	S
P04156	LP/P	Creutzfeldt-Jakob disease (CJD) [MIM:123400]	B2D1U2	200	E	K
P04156	LP/P	Creutzfeldt-Jakob disease (CJD) [MIM:123400]	B2D1U2	208	R	H
P04156	LP/P	Creutzfeldt-Jakob disease (CJD) [MIM:123400]	B2D1U2	210	V	I
P04156	LP/P	Gerstmann-Straussler disease (GSD) [MIM:137440]	B2D1U2	217	Q	R
P04156	LB/B	-	B2D1U2	219	E	K
P04156	LP/P	Creutzfeldt-Jakob disease (CJD) [MIM:123400]	B2D1U2	232	M	R
P04156	LP/P	Gerstmann-Straussler disease (GSD) [MIM:137440]	B2D1U2	187	H	R
P04156	LB/B	-	B2D1U2	188	T	R
P04156	LP/P	Creutzfeldt-Jakob disease (CJD) [MIM:123400]	B2D1U2	196	E	K
P04156	LP/P	Gerstmann-Straussler disease (GSD) [MIM:137440]	B2D1U2	202	D	N
P04156	LP/P	Creutzfeldt-Jakob disease (CJD) [MIM:123400]	B2D1U2	211	E	Q
P04156	LP/P	Gerstmann-Straussler disease (GSD) [MIM:137440]	B2D1U2	212	Q	P
P04156	LB/B	-	B2D1U2	238	P	S
P04156	LP/P	Gerstmann-Straussler disease (GSD) [MIM:137440]	B2D1U2	131	G	V
P04156	LB/B	-	B2D1U2	127	G	V
P04070	LP/P	Thrombophilia due to protein C deficiency, autosomal dominant (THPH3) [MIM:176860]	G1U6I7	32	R	C
P04070	LB/B	-	G1U6I7	38	R	W
P04070	LB/B	-	G1U6I7	42	R	H
P04070	LB/B	-	G1U6I7	42	R	C
P04070	LB/B	-	G1U6I7	43	A	T
P04070	LB/B	-	G1U6I7	51	R	C
P04070	LP/P	Thrombophilia due to protein C deficiency, autosomal dominant (THPH3) [MIM:176860]	G1U6I7	57	R	W
P04070	LB/B	-	G1U6I7	57	R	Q
P04070	LP/P	Thrombophilia due to protein C deficiency, autosomal dominant (THPH3) [MIM:176860]	G1U6I7	62	E	A
P04070	LP/P	Thrombophilia due to protein C deficiency, autosomal dominant (THPH3) [MIM:176860]	G1U6I7	76	V	M
P04070	LB/B	-	G1U6I7	108	H	N
P04070	LP/P	Thrombophilia due to protein C deficiency, autosomal dominant (THPH3) [MIM:176860]	G1U6I7	114	G	R
P04070	LB/B	-	G1U6I7	118	F	L
P04070	LP/P	Thrombophilia due to protein C deficiency, autosomal dominant (THPH3) [MIM:176860]	G1U6I7	145	G	R
P04070	LB/B	-	G1U6I7	147	C	Y
P04070	LB/B	-	G1U6I7	149	H	P
P04070	LB/B	-	G1U6I7	161	S	R
P04070	LP/P	Thrombophilia due to protein C deficiency, autosomal recessive (THPH4) [MIM:612304]	G1U6I7	178	A	P
P04070	LB/B	-	G1U6I7	183	C	R
P04070	LB/B	-	G1U6I7	189	R	W
P04070	LB/B	-	G1U6I7	194	R	C
P04070	LP/P	Thrombophilia due to protein C deficiency, autosomal dominant (THPH3) [MIM:176860]	G1U6I7	210	P	L
P04070	LP/P	Thrombophilia due to protein C deficiency, autosomal dominant (THPH3) [MIM:176860]	G1U6I7	211	R	W
P04070	LB/B	-	G1U6I7	211	R	Q
P04070	LP/P	Thrombophilia due to protein C deficiency, autosomal dominant (THPH3) [MIM:176860]	G1U6I7	220	R	W
P04070	LP/P	Thrombophilia due to protein C deficiency, autosomal dominant (THPH3) [MIM:176860]	G1U6I7	220	R	Q
P04070	LB/B	-	G1U6I7	226	Q	H
P04070	LP/P	Thrombophilia due to protein C deficiency, autosomal dominant (THPH3) [MIM:176860]	G1U6I7	243	I	T
P04070	LB/B	-	G1U6I7	244	H	Y
P04070	LB/B	-	G1U6I7	253	H	Q
P04070	LB/B	-	G1U6I7	265	L	F
P04070	LB/B	-	G1U6I7	271	R	Q
P04070	LB/B	-	G1U6I7	271	R	W
P04070	LP/P	Thrombophilia due to protein C deficiency, autosomal dominant (THPH3) [MIM:176860]	G1U6I7	272	R	C
P04070	LP/P	Thrombophilia due to protein C deficiency, autosomal recessive (THPH4) [MIM:612304]	G1U6I7	289	P	L
P04070	LB/B	-	G1U6I7	294	S	N
P04070	LB/B	-	G1U6I7	301	A	T
P04070	LB/B	-	G1U6I7	301	A	V
P04070	LB/B	-	G1U6I7	309	A	T
P04070	LB/B	-	G1U6I7	312	S	L
P04070	LP/P	Thrombophilia due to protein C deficiency, autosomal dominant (THPH3) [MIM:176860]	G1U6I7	321	P	L
P04070	LP/P	Thrombophilia due to protein C deficiency, autosomal dominant (THPH3) [MIM:176860]	G1U6I7	324	G	R
P04070	LP/P	Thrombophilia due to protein C deficiency, autosomal dominant (THPH3) [MIM:176860]	G1U6I7	328	R	C
P04070	LP/P	Thrombophilia due to protein C deficiency, autosomal recessive (THPH4) [MIM:612304]	G1U6I7	328	R	H
P04070	LP/P	Thrombophilia due to protein C deficiency, autosomal recessive (THPH4) [MIM:612304]	G1U6I7	334	G	S
P04070	LP/P	Thrombophilia due to protein C deficiency, autosomal dominant (THPH3) [MIM:176860]	G1U6I7	340	T	M
P04070	LP/P	Thrombophilia due to protein C deficiency, autosomal recessive (THPH4) [MIM:612304]	G1U6I7	367	V	A
P04070	LP/P	Thrombophilia due to protein C deficiency, autosomal dominant (THPH3) [MIM:176860]	G1U6I7	369	P	L
P04070	LB/B	-	G1U6I7	388	A	V
P04070	LP/P	Thrombophilia due to protein C deficiency, autosomal dominant (THPH3) [MIM:176860]	G1U6I7	392	G	R
P04070	LB/B	-	G1U6I7	394	R	W
P04070	LP/P	Thrombophilia due to protein C deficiency, autosomal dominant (THPH3) [MIM:176860]	G1U6I7	401	D	N
P04070	LP/P	Thrombophilia due to protein C deficiency, autosomal recessive (THPH4) [MIM:612304]	G1U6I7	418	G	D
P04070	LP/P	Thrombophilia due to protein C deficiency, autosomal dominant (THPH3) [MIM:176860]	G1U6I7	423	G	S
P04070	LP/P	Thrombophilia due to protein C deficiency, autosomal dominant (THPH3) [MIM:176860]	G1U6I7	426	C	Y
P04070	LB/B	-	G1U6I7	433	G	S
P04070	LP/P	Thrombophilia due to protein C deficiency, autosomal dominant (THPH3) [MIM:176860]	G1U6I7	436	T	N
P04070	LP/P	Thrombophilia due to protein C deficiency, autosomal dominant (THPH3) [MIM:176860]	G1U6I7	441	Y	H
P04070	LP/P	Thrombophilia due to protein C deficiency, autosomal dominant (THPH3) [MIM:176860]	G1U6I7	444	W	C
P04070	LB/B	-	G1U6I7	445	I	M
P04070	LP/P	Thrombophilia due to protein C deficiency, autosomal dominant (THPH3) [MIM:176860]	G1U6I7	42	R	S
P04070	LP/P	Thrombophilia due to protein C deficiency, autosomal recessive (THPH4) [MIM:612304]	G1U6I7	77	D	G
P04070	LP/P	Thrombophilia due to protein C deficiency, autosomal recessive (THPH4) [MIM:612304]	G1U6I7	163	A	E
P04070	LP/P	Thrombophilia due to protein C deficiency, autosomal dominant (THPH3) [MIM:176860]	G1U6I7	163	A	V
P04070	LB/B	-	G1U6I7	70	K	E
P04070	LB/B	-	G1U6I7	106	C	G
P04070	LB/B	-	G1U6I7	175	C	Y
P04070	LB/B	-	G1U6I7	181	F	V
P04070	LB/B	-	G1U6I7	223	S	R
P04070	LP/P	Thrombophilia due to protein C deficiency, autosomal dominant (THPH3) [MIM:176860]	G1U6I7	297	D	H
P04070	LB/B	-	G1U6I7	327	E	V
P04070	LP/P	Thrombophilia due to protein C deficiency, autosomal dominant (THPH3) [MIM:176860]	G1U6I7	420	V	L
Q8NCQ7	LB/B	-	A0A286XB16	245	D	A
Q8NCQ7	LB/B	-	A0A286XB16	320	E	K
Q9UF12	LB/B	-	A0A2H3WXS8	91	P	R
Q9UF12	LB/B	-	A0A2H3WXS8	525	R	Q
P58294	LB/B	-	F7GW61	67	V	I
Q9HC23	LP/P	Hypogonadotropic hypogonadism 4 with or without anosmia (HH4) [MIM:610628]	F7CNV8	32	G	R
Q9HC23	LP/P	Hypogonadotropic hypogonadism 4 with or without anosmia (HH4) [MIM:610628]	F7CNV8	73	R	C
Q9HC23	LP/P	Hypogonadotropic hypogonadism 4 with or without anosmia (HH4) [MIM:610628]	F7CNV8	24	A	P
Q9HC23	LP/P	Hypogonadotropic hypogonadism 4 with or without anosmia (HH4) [MIM:610628]	F7CNV8	34	C	Y
Q9HC23	LP/P	Hypogonadotropic hypogonadism 4 with or without anosmia (HH4) [MIM:610628]	F7CNV8	50	I	M
Q9HC23	LP/P	Hypogonadotropic hypogonadism 4 with or without anosmia (HH4) [MIM:610628]	F7CNV8	46	C	Y
O43490	LB/B	-	G1PDJ3	31	A	G
O43490	LB/B	-	G1PDJ3	31	A	S
O43490	LP/P	Cone-rod dystrophy 12 (CORD12) [MIM:612657]	G1PDJ3	373	R	C
O43490	LP/P	Macular dystrophy, retinal, 2 (MCDR2) [MIM:608051]	G1PDJ3	373	R	C
O43490	LP/P	Stargardt disease 4 (STGD4) [MIM:603786]	G1PDJ3	373	R	C
Q8N271	LB/B	-	A0A1V4KR42	508	Q	R
O75360	LP/P	Pituitary hormone deficiency, combined, 2 (CPHD2) [MIM:262600]	H0X328	73	R	C
O75360	LP/P	Pituitary hormone deficiency, combined, 2 (CPHD2) [MIM:262600]	H0X328	117	F	I
O75360	LP/P	Pituitary hormone deficiency, combined, 2 (CPHD2) [MIM:262600]	H0X328	120	R	C
O75360	LP/P	Pituitary hormone deficiency, combined, 2 (CPHD2) [MIM:262600]	H0X328	73	R	H
O75360	LB/B	-	H0X328	142	A	T
O75360	LB/B	-	H0X328	20	N	S
O75360	LP/P	Pituitary hormone deficiency, combined, 2 (CPHD2) [MIM:262600]	H0X328	125	R	W
O75360	LP/P	Pituitary hormone deficiency, combined, 2 (CPHD2) [MIM:262600]	H0X328	88	F	S
O75360	LP/P	Pituitary hormone deficiency, combined, 2 (CPHD2) [MIM:262600]	H0X328	99	R	Q
O15091	LB/B	-	A0A287AVI5	437	N	S
O15091	LP/P	Combined oxidative phosphorylation deficiency 54 (COXPD54) [MIM:619737]	A0A287AVI5	412	N	S
O15091	LP/P	Combined oxidative phosphorylation deficiency 54 (COXPD54) [MIM:619737]	A0A287AVI5	445	R	Q
O15091	LP/P	Combined oxidative phosphorylation deficiency 54 (COXPD54) [MIM:619737]	A0A287AVI5	485	A	V
Q86WR7	LB/B	-	A0A212CAN7	412	A	V
O43395	LP/P	Retinitis pigmentosa 18 (RP18) [MIM:601414]	A0A210PQQ4	494	T	M
O43395	LP/P	Retinitis pigmentosa 18 (RP18) [MIM:601414]	A0A210PQQ4	493	P	S
O43395	LB/B	-	A0A210PQQ4	12	K	N
O43172	LP/P	Retinitis pigmentosa 70 (RP70) [MIM:615922]	V5IIJ2	315	P	L
O43172	LP/P	Retinitis pigmentosa 70 (RP70) [MIM:615922]	V5IIJ2	192	R	H
Q13523	LB/B	-	A0A2D0RA03	83	I	V
Q13523	LB/B	-	A0A2D0RA03	584	I	V
O94906	LP/P	Retinitis pigmentosa 60 (RP60) [MIM:613983]	K3Z3C5	729	R	W
O94906	LB/B	-	K3Z3C5	477	N	S
Q6P2Q9	LB/B	-	A3LYV9	68	K	E
Q6P2Q9	LB/B	-	A3LYV9	227	R	H
Q6P2Q9	LB/B	-	A3LYV9	874	P	L
Q6P2Q9	LB/B	-	A3LYV9	1293	N	H
Q6P2Q9	LP/P	Retinitis pigmentosa 13 (RP13) [MIM:600059]	A3LYV9	2301	P	T
Q6P2Q9	LP/P	Retinitis pigmentosa 13 (RP13) [MIM:600059]	A3LYV9	2304	F	L
Q6P2Q9	LP/P	Retinitis pigmentosa 13 (RP13) [MIM:600059]	A3LYV9	2309	H	P
Q6P2Q9	LP/P	Retinitis pigmentosa 13 (RP13) [MIM:600059]	A3LYV9	2309	H	R
Q6P2Q9	LP/P	Retinitis pigmentosa 13 (RP13) [MIM:600059]	A3LYV9	2310	R	G
Q6P2Q9	LP/P	Retinitis pigmentosa 13 (RP13) [MIM:600059]	A3LYV9	2310	R	K
Q6P2Q9	LP/P	Retinitis pigmentosa 13 (RP13) [MIM:600059]	A3LYV9	2314	F	L
Q6P2Q9	LP/P	Retinitis pigmentosa 13 (RP13) [MIM:600059]	A3LYV9	2334	Y	N
P23942	LP/P	Retinitis pigmentosa 7 (RP7) [MIM:608133]	V8NZB1	13	R	W
P23942	LB/B	-	V8NZB1	32	I	V
P23942	LP/P	Macular dystrophy, vitelliform, 3 (VMD3) [MIM:608161]	V8NZB1	45	L	F
P23942	LP/P	Retinitis pigmentosa 7 (RP7) [MIM:608133]	V8NZB1	45	L	F
P23942	LP/P	Macular dystrophy, patterned, 1 (MDPT1) [MIM:169150]	V8NZB1	68	G	R
P23942	LP/P	Retinitis pigmentosa 7 (RP7) [MIM:608133]	V8NZB1	126	L	R
P23942	LP/P	Retinitis pigmentosa 7 (RP7) [MIM:608133]	V8NZB1	142	R	W
P23942	LP/P	Retinitis pigmentosa 7 (RP7) [MIM:608133]	V8NZB1	153	K	R
P23942	LP/P	Macular dystrophy, patterned, 1 (MDPT1) [MIM:169150]	V8NZB1	157	D	N
P23942	LP/P	Retinitis pigmentosa 7 (RP7) [MIM:608133]	V8NZB1	165	C	Y
P23942	LP/P	Macular dystrophy, patterned, 1 (MDPT1) [MIM:169150]	V8NZB1	167	G	D
P23942	LP/P	Macular dystrophy, patterned, 1 (MDPT1) [MIM:169150]	V8NZB1	172	R	G
P23942	LB/B	-	V8NZB1	172	R	Q
P23942	LB/B	-	V8NZB1	172	R	W
P23942	LP/P	Retinitis pigmentosa 7 (RP7) [MIM:608133]	V8NZB1	173	D	V
P23942	LB/B	-	V8NZB1	184	Y	S
P23942	LP/P	Retinitis pigmentosa 7 (RP7) [MIM:608133]	V8NZB1	185	L	P
P23942	LP/P	Retinitis pigmentosa 7 (RP7) [MIM:608133]	V8NZB1	208	G	D
P23942	LP/P	Macular dystrophy, patterned, 1 (MDPT1) [MIM:169150]	V8NZB1	210	P	R
P23942	LP/P	Retinitis pigmentosa 7 (RP7) [MIM:608133]	V8NZB1	210	P	R
P23942	LP/P	Retinitis pigmentosa 7 (RP7) [MIM:608133]	V8NZB1	210	P	S
P23942	LP/P	Retinitis pigmentosa 7 (RP7) [MIM:608133]	V8NZB1	211	F	L
P23942	LP/P	Retinitis pigmentosa 7 (RP7) [MIM:608133]	V8NZB1	212	S	G
P23942	LP/P	Macular dystrophy, vitelliform, 3 (VMD3) [MIM:608161]	V8NZB1	212	S	T
P23942	LP/P	Macular dystrophy, patterned, 1 (MDPT1) [MIM:169150]	V8NZB1	213	C	R
P23942	LP/P	Retinitis pigmentosa 7 (RP7) [MIM:608133]	V8NZB1	214	C	S
P23942	LP/P	Retinitis pigmentosa 7 (RP7) [MIM:608133]	V8NZB1	216	P	L
P23942	LP/P	Retinitis pigmentosa 7 (RP7) [MIM:608133]	V8NZB1	216	P	S
P23942	LB/B	-	V8NZB1	219	P	R
P23942	LP/P	Macular dystrophy, patterned, 1 (MDPT1) [MIM:169150]	V8NZB1	220	R	Q
P23942	LP/P	Macular dystrophy, patterned, 1 (MDPT1) [MIM:169150]	V8NZB1	220	R	W
P23942	LP/P	Retinitis pigmentosa 7 (RP7) [MIM:608133]	V8NZB1	244	N	K
P23942	LB/B	-	V8NZB1	244	N	H
P23942	LP/P	Retinitis pigmentosa 7 (RP7) [MIM:608133]	V8NZB1	266	G	D
P23942	LP/P	Macular dystrophy, vitelliform, 3 (VMD3) [MIM:608161]	V8NZB1	268	V	I
P23942	LB/B	-	V8NZB1	304	E	Q
P23942	LP/P	Macular dystrophy, vitelliform, 3 (VMD3) [MIM:608161]	V8NZB1	305	G	D
P23942	LB/B	-	V8NZB1	310	K	R
P23942	LB/B	-	V8NZB1	313	P	L
P23942	LB/B	-	V8NZB1	338	G	D
P23942	LP/P	Macular dystrophy, patterned, 1 (MDPT1) [MIM:169150]	V8NZB1	167	G	S
P23942	LP/P	Choroidal dystrophy, central areolar 2 (CACD2) [MIM:613105]	V8NZB1	195	R	L
P23942	LP/P	Macular dystrophy, vitelliform, 3 (VMD3) [MIM:608161]	V8NZB1	213	C	F
P23942	LP/P	Choroidal dystrophy, central areolar 2 (CACD2) [MIM:613105]	V8NZB1	123	R	W
P23942	LP/P	Retinitis pigmentosa 7 (RP7) [MIM:608133]	V8NZB1	126	L	P
P23942	LB/B	-	V8NZB1	137	G	S
P23942	LP/P	Macular dystrophy, vitelliform, 3 (VMD3) [MIM:608161]	V8NZB1	141	Y	C
P23942	LP/P	Retinitis pigmentosa 7 (RP7) [MIM:608133]	V8NZB1	141	Y	C
P23942	LP/P	Retinitis pigmentosa 7 (RP7) [MIM:608133]	V8NZB1	198	S	R
P23942	LP/P	Macular dystrophy, vitelliform, 3 (VMD3) [MIM:608161]	V8NZB1	209	V	I
P23942	LP/P	Retinitis pigmentosa 7 (RP7) [MIM:608133]	V8NZB1	210	P	L
P23942	LP/P	Retinitis pigmentosa 7 (RP7) [MIM:608133]	V8NZB1	216	P	A
P23942	LP/P	Retinitis pigmentosa 7 (RP7) [MIM:608133]	V8NZB1	216	P	R
P23942	LP/P	Choroidal dystrophy, central areolar 2 (CACD2) [MIM:613105]	V8NZB1	221	P	L
P23942	LP/P	Retinitis pigmentosa 7 (RP7) [MIM:608133]	V8NZB1	249	G	S
P60891	LP/P	Phosphoribosylpyrophosphate synthetase superactivity (PRPS1 superactivity) [MIM:300661]	A0A1V4JBV3	114	N	S
P60891	LP/P	Phosphoribosylpyrophosphate synthetase superactivity (PRPS1 superactivity) [MIM:300661]	A0A1V4JBV3	183	D	H
P60891	LP/P	Phosphoribosylpyrophosphate synthetase superactivity (PRPS1 superactivity) [MIM:300661]	A0A1V4JBV3	52	D	H
P60891	LP/P	Phosphoribosylpyrophosphate synthetase superactivity (PRPS1 superactivity) [MIM:300661]	A0A1V4JBV3	129	L	I
P60891	LP/P	Phosphoribosylpyrophosphate synthetase superactivity (PRPS1 superactivity) [MIM:300661]	A0A1V4JBV3	190	A	V
P60891	LP/P	Phosphoribosylpyrophosphate synthetase superactivity (PRPS1 superactivity) [MIM:300661]	A0A1V4JBV3	193	H	Q
P60891	LP/P	Charcot-Marie-Tooth disease, X-linked recessive, 5 (CMTX5) [MIM:311070]	A0A1V4JBV3	43	E	D
P60891	LP/P	Charcot-Marie-Tooth disease, X-linked recessive, 5 (CMTX5) [MIM:311070]	A0A1V4JBV3	115	M	T
P60891	LP/P	ARTS syndrome (ARTS) [MIM:301835]	A0A1V4JBV3	133	Q	P
P60891	LP/P	ARTS syndrome (ARTS) [MIM:301835]	A0A1V4JBV3	152	L	P
P60891	LP/P	Deafness, X-linked, 1 (DFNX1) [MIM:304500]	A0A1V4JBV3	65	D	N
P60891	LP/P	Deafness, X-linked, 1 (DFNX1) [MIM:304500]	A0A1V4JBV3	87	A	T
P60891	LP/P	Deafness, X-linked, 1 (DFNX1) [MIM:304500]	A0A1V4JBV3	290	I	T
P60891	LP/P	Deafness, X-linked, 1 (DFNX1) [MIM:304500]	A0A1V4JBV3	306	G	R
P60891	LP/P	-	A0A1V4JBV3	16	S	P
P60891	LP/P	-	A0A1V4JBV3	142	V	L
P21108	LB/B	-	A0A2R8MRN4	279	E	D
Q569H4	LB/B	-	A0A1S3NMK4	110	P	T
Q96S07	LB/B	-	A0A2I3HYM0	92	T	S
Q96S07	LB/B	-	A0A2I3HYM0	249	P	L
Q53SZ7	LB/B	-	L5KSY8	194	R	G
Q53SZ7	LB/B	-	L5KSY8	222	R	C
B1ATL7	LB/B	-	A0A2K5PZB8	193	M	T
B1ATL7	LB/B	-	A0A2K5PZB8	115	L	V
Q9NV39	LB/B	-	A0A2K6MBV1	28	P	L
Q9NV39	LB/B	-	A0A2K6MBV1	137	Q	R
P85299	LB/B	-	H3D3J2	243	V	M
Q8TB68	LB/B	-	G3QC93	127	P	H
Q5JSZ5	LB/B	-	V9K780	1630	S	T
Q5JSZ5	LB/B	-	V9K780	1675	L	P
Q5JSZ5	LB/B	-	V9K780	417	M	V
O14669	LB/B	-	F7GWB4	116	G	C
O14669	LB/B	-	F7GWB4	22	P	S
Q9BZD6	LB/B	-	U3K8B1	33	E	K
Q9BZD6	LB/B	-	U3K8B1	143	C	R
Q9BZD6	LB/B	-	U3K8B1	176	P	Q
Q7Z6L0	LB/B	-	G1Q595	138	P	A
Q7Z6L0	LB/B	-	G1Q595	147	D	H
Q7Z6L0	LB/B	-	G1Q595	214	A	P
Q7Z6L0	LB/B	-	G1Q595	237	G	R
Q7Z6L0	LB/B	-	G1Q595	245	R	H
Q7Z6L0	LB/B	-	G1Q595	215	P	R
Q7Z6L0	LB/B	-	G1Q595	216	P	L
Q7Z6L0	LP/P	Episodic kinesigenic dyskinesia 1 (EKD1) [MIM:128200]	G1Q595	266	R	W
Q7Z6L0	LP/P	Episodic kinesigenic dyskinesia 1 (EKD1) [MIM:128200]	G1Q595	281	W	R
Q7Z6L0	LP/P	Episodic kinesigenic dyskinesia 1 (EKD1) [MIM:128200]	G1Q595	287	A	T
Q7Z6L0	LP/P	Episodic kinesigenic dyskinesia 1 (EKD1) [MIM:128200]	G1Q595	305	G	R
Q7Z6L0	LP/P	Episodic kinesigenic dyskinesia 1 (EKD1) [MIM:128200]	G1Q595	308	R	C
Q7Z6L0	LP/P	Convulsions, familial infantile, with paroxysmal choreoathetosis (ICCA) [MIM:602066]	G1Q595	317	S	N
Q7Z6L0	LP/P	Seizures, benign familial infantile, 2 (BFIS2) [MIM:605751]	G1Q595	323	G	E
P54821	LP/P	Agnathia-otocephaly complex (AGOTC) [MIM:202650]	I3JLY9	113	F	S
P07477	LP/P	Pancreatitis, hereditary (PCTT) [MIM:167800]	Q7T1R8	29	N	I
P07477	LP/P	Pancreatitis, hereditary (PCTT) [MIM:167800]	Q7T1R8	122	R	H
P07477	LP/P	Pancreatitis, hereditary (PCTT) [MIM:167800]	Q7T1R8	22	D	G
P07477	LP/P	Pancreatitis, hereditary (PCTT) [MIM:167800]	Q7T1R8	23	K	R
P07477	LP/P	Pancreatitis, hereditary (PCTT) [MIM:167800]	Q7T1R8	104	L	P
P07477	LP/P	Pancreatitis, hereditary (PCTT) [MIM:167800]	Q7T1R8	116	R	C
P07477	LP/P	Pancreatitis, hereditary (PCTT) [MIM:167800]	Q7T1R8	139	C	F
P07477	LP/P	Pancreatitis, hereditary (PCTT) [MIM:167800]	Q7T1R8	16	A	V
P07477	LP/P	Pancreatitis, hereditary (PCTT) [MIM:167800]	Q7T1R8	29	N	T
P07477	LP/P	Pancreatitis, hereditary (PCTT) [MIM:167800]	Q7T1R8	122	R	C
P07477	LP/P	Pancreatitis, hereditary (PCTT) [MIM:167800]	Q7T1R8	54	N	S
P07477	LP/P	Pancreatitis, hereditary (PCTT) [MIM:167800]	Q7T1R8	79	E	K
P56730	LB/B	-	A0A2U9CFM6	606	A	S
P56730	LB/B	-	A0A2U9CFM6	833	R	Q
Q9NQE7	LB/B	-	A0A2B4RXV5	104	S	I
Q9NQE7	LB/B	-	A0A2B4RXV5	204	A	G
P07478	LB/B	-	Q7T1R8	117	A	V
P07478	LB/B	-	Q7T1R8	153	D	H
Q9Y6M0	LB/B	-	Q80YD8	264	R	Q
P35030	LB/B	-	P35030	188	T	A
P35030	LB/B	-	P35030	232	Y	C
P35030	LB/B	-	P35030	224	T	S
P35030	LB/B	-	P35030	174	A	V
Q8N3Z0	LB/B	-	L9L4K7	224	R	Q
Q7RTY9	LB/B	-	L5KGD4	286	S	G
Q7RTY5	LB/B	-	A0A1S3G8Z7	53	C	Y
Q7RTY5	LB/B	-	A0A1S3G8Z7	118	L	S
Q7RTY5	LB/B	-	A0A1S3G8Z7	290	R	C
Q9UI38	LB/B	-	A0A2Y9GTV3	75	Q	P
Q9UI38	LB/B	-	A0A2Y9GTV3	98	V	I
Q6UWB4	LB/B	-	A0A2K5YXI9	44	P	R
Q6UWB4	LB/B	-	A0A2K5YXI9	212	A	V
P0CW18	LP/P	Microphthalmia, isolated, 6 (MCOP6) [MIM:613517]	A0A212D3H9	176	R	G
P0CW18	LP/P	Microphthalmia, isolated, 6 (MCOP6) [MIM:613517]	A0A212D3H9	309	W	S
P0CW18	LP/P	Microphthalmia, isolated, 6 (MCOP6) [MIM:613517]	A0A212D3H9	237	G	R
P0CW18	LP/P	Microphthalmia, isolated, 6 (MCOP6) [MIM:613517]	A0A212D3H9	302	V	F
P0CW18	LP/P	Microphthalmia, isolated, 6 (MCOP6) [MIM:613517]	A0A212D3H9	320	G	R
P0CW18	LP/P	Microphthalmia, isolated, 6 (MCOP6) [MIM:613517]	A0A212D3H9	395	C	R
P0CW18	LP/P	Microphthalmia, isolated, 6 (MCOP6) [MIM:613517]	A0A212D3H9	599	P	A
Q6UWY2	LB/B	-	S9YJ00	143	P	L
Q2VWP7	LB/B	-	E1BMA1	1062	I	L
Q2VWP7	LB/B	-	E1BMA1	236	T	A
Q2VWP7	LB/B	-	E1BMA1	826	V	L
Q86TP1	LB/B	-	A0A093HF75	397	G	S
Q86TP1	LB/B	-	A0A093HF75	397	G	R
Q86TP1	LP/P	Neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies (NMIHBA) [MIM:617481]	A0A093HF75	30	D	N
Q86TP1	LP/P	Neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies (NMIHBA) [MIM:617481]	A0A093HF75	106	D	N
Q86TP1	LP/P	Neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies (NMIHBA) [MIM:617481]	A0A093HF75	128	R	Q
Q86TP1	LP/P	Neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies (NMIHBA) [MIM:617481]	A0A093HF75	297	R	W
Q8WUY3	LB/B	-	F6Q9V0	806	E	K
P07602	LP/P	Metachromatic leukodystrophy due to saposin B deficiency (MLDSAPB) [MIM:249900]	A0A2Y9EKZ3	217	T	I
P07602	LP/P	Metachromatic leukodystrophy due to saposin B deficiency (MLDSAPB) [MIM:249900]	A0A2Y9EKZ3	241	C	S
P07602	LP/P	Gaucher disease, atypical, due to saposin C deficiency (GDSAPC) [MIM:610539]	A0A2Y9EKZ3	388	C	F
P07602	LP/P	Metachromatic leukodystrophy due to saposin B deficiency (MLDSAPB) [MIM:249900]	A0A2Y9EKZ3	215	N	H
P07602	LP/P	Metachromatic leukodystrophy due to saposin B deficiency (MLDSAPB) [MIM:249900]	A0A2Y9EKZ3	215	N	K
P07602	LP/P	Gaucher disease, atypical, due to saposin C deficiency (GDSAPC) [MIM:610539]	A0A2Y9EKZ3	349	L	P
P07602	LP/P	Parkinson disease 24, autosomal dominant (PARK24) [MIM:619491]	A0A2Y9EKZ3	412	C	Y
P07602	LP/P	Parkinson disease 24, autosomal dominant (PARK24) [MIM:619491]	A0A2Y9EKZ3	453	Q	P
Q6NUJ1	LB/B	-	A0A2Y9EKZ3	268	A	S
Q6NUJ1	LB/B	-	A0A2Y9EKZ3	296	V	M
Q6NUJ1	LB/B	-	A0A2Y9EKZ3	41	A	S
Q6NUJ1	LB/B	-	A0A2Y9EKZ3	44	G	R
Q6NUJ1	LB/B	-	A0A2Y9EKZ3	59	A	T
O43653	LB/B	-	I3MBD7	30	E	K
Q9BQI7	LB/B	-	A0A2K5P3R9	31	R	Q
Q9BQI7	LB/B	-	A0A2K5P3R9	51	R	M
Q9BQI7	LB/B	-	A0A2K5P3R9	363	G	R
Q9NYI0	LB/B	-	A0A151NE61	186	T	M
Q9NYI0	LB/B	-	A0A151NE61	186	T	P
Q9NYI0	LB/B	-	A0A151NE61	293	P	L
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	79	A	V
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	82	V	L
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	96	V	F
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	115	Y	C
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	115	Y	H
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	120	E	D
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	120	E	K
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	139	M	I
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	139	M	T
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	139	M	V
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	143	I	F
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	143	I	T
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	146	M	I
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	146	M	L
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	146	M	V
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	163	H	R
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	163	H	Y
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	169	S	L
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	169	S	P
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	171	L	P
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	209	G	V
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	213	I	T
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	231	A	T
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	231	A	V
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	233	M	T
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	235	L	P
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	246	A	E
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	250	L	S
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	260	A	V
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	262	L	F
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	263	C	R
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	264	P	L
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	267	P	S
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	269	R	G
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	269	R	H
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	278	R	T
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	280	E	A
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	280	E	G
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	285	A	V
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	286	L	V
P49768	LB/B	-	G1T7M0	318	E	G
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	378	G	E
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	384	G	A
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	392	L	V
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	410	C	Y
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	436	P	Q
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	436	P	S
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	105	F	L
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	117	P	L
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	209	G	R
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	233	M	L
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	282	L	R
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	116	T	N
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	135	N	D
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	139	M	K
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	147	T	I
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	165	W	C
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	173	L	W
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	219	L	P
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	289	S	C
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	390	S	I
P49768	LB/B	-	G1T7M0	205	F	L
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	92	C	S
P49768	LP/P	Frontotemporal dementia (FTD) [MIM:600274]	G1T7M0	113	L	P
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	166	L	P
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	174	L	M
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	206	G	A
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	266	G	S
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	271	L	V
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	431	A	E
P49768	LP/P	Cardiomyopathy, dilated 1U (CMD1U) [MIM:613694]	G1T7M0	333	D	G
P49768	LP/P	-	G1T7M0	214	H	Y
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	262	L	V
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	83	I	T
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	177	F	L
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	206	G	S
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	213	I	L
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	261	V	F
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	408	I	T
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	435	L	F
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	85	L	P
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	89	V	L
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	116	T	I
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	117	P	S
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	153	L	V
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	154	Y	N
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	170	S	F
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	184	E	D
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	206	G	D
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	217	G	R
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	229	I	F
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	235	L	R
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	235	L	V
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	263	C	F
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	278	R	I
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	282	L	V
P49768	LP/P	-	G1T7M0	311	K	R
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	378	G	V
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	381	L	F
P49768	LP/P	Alzheimer disease 3 (AD3) [MIM:607822]	G1T7M0	381	L	V
P49810	LB/B	Alzheimer disease 4 (AD4) [MIM:606889]	A0A2D4F8P1	62	R	H
P49810	LP/P	Alzheimer disease 4 (AD4) [MIM:606889]	A0A2D4F8P1	141	N	I
P49810	LP/P	Alzheimer disease 4 (AD4) [MIM:606889]	A0A2D4F8P1	239	M	V
P49810	LP/P	Alzheimer disease 4 (AD4) [MIM:606889]	A0A2D4F8P1	148	V	I
P49810	LP/P	Alzheimer disease 4 (AD4) [MIM:606889]	A0A2D4F8P1	122	T	P
P49810	LP/P	Alzheimer disease 4 (AD4) [MIM:606889]	A0A2D4F8P1	239	M	I
P49810	LP/P	Alzheimer disease 4 (AD4) [MIM:606889]	A0A2D4F8P1	122	T	R
P49810	LP/P	Alzheimer disease 4 (AD4) [MIM:606889]	A0A2D4F8P1	141	N	Y
P11464	LB/B	-	A0A2K5W4J9	41	E	Q
P11464	LB/B	-	A0A2K5W4J9	43	T	P
P11464	LB/B	-	A0A2K5W4J9	47	E	K
P11464	LB/B	-	A0A2K5W4J9	63	T	A
P11464	LB/B	-	A0A2K5W4J9	73	R	K
P11464	LB/B	-	A0A2K5W4J9	87	E	Q
P11464	LB/B	-	A0A2K5W4J9	101	A	V
P11464	LB/B	-	A0A2K5W4J9	134	V	E
P11464	LB/B	-	A0A2K5W4J9	197	E	K
P11464	LB/B	-	A0A2K5W4J9	198	T	N
P11464	LB/B	-	A0A2K5W4J9	125	I	V
Q9UQ72	LB/B	-	A0A2K5PZW6	176	A	T
Q9UQ72	LB/B	-	A0A2K5PZW6	264	N	D
Q9UQ72	LB/B	-	A0A2K5PZW6	83	V	I
Q9UQ72	LB/B	-	A0A2K5PZW6	310	E	K
P11465	LB/B	-	A0A2K5PZW6	20	V	L
P11465	LB/B	-	A0A2K5PZW6	176	T	A
P11465	LB/B	-	A0A2K5PZW6	179	Q	L
P11465	LB/B	-	A0A2K5PZW6	335	T	R
Q16557	LB/B	-	A0A2R9ASF5	30	L	P
Q16557	LB/B	-	A0A2R9ASF5	23	L	S
Q16557	LB/B	-	A0A2R9ASF5	198	N	T
Q16557	LB/B	-	A0A2R9ASF5	199	K	N
Q16557	LB/B	-	A0A2R9ASF5	30	L	S
Q16557	LB/B	-	A0A2R9ASF5	290	I	N
Q00888	LB/B	-	A0A2R9ASF5	75	L	V
Q00888	LB/B	-	A0A2R9ASF5	240	S	P
Q00888	LB/B	-	A0A2R9ASF5	286	V	A
Q00888	LB/B	-	A0A2R9ASF5	11	Q	H
Q00888	LB/B	-	A0A2R9ASF5	177	S	R
Q00888	LB/B	-	A0A2R9ASF5	267	K	E
Q15238	LB/B	-	A0A2K5PZW6	154	N	K
Q15238	LB/B	-	A0A2K5PZW6	18	L	V
Q15238	LB/B	-	A0A2K5PZW6	168	T	I
Q15238	LB/B	-	A0A2K5PZW6	227	R	H
Q00889	LB/B	-	A0A2R9ASF5	155	L	F
Q00889	LB/B	-	A0A2R9ASF5	165	R	L
Q00889	LB/B	-	A0A2R9ASF5	167	I	T
Q00889	LB/B	-	A0A2R9ASF5	180	L	W
Q00889	LB/B	-	A0A2R9ASF5	181	L	M
Q00889	LB/B	-	A0A2R9ASF5	185	N	S
Q00889	LB/B	-	A0A2R9ASF5	191	R	S
Q00889	LB/B	-	A0A2R9ASF5	196	K	E
Q00889	LB/B	-	A0A2R9ASF5	253	K	N
Q00889	LB/B	-	A0A2R9ASF5	257	L	S
Q00889	LB/B	-	A0A2R9ASF5	258	A	T
Q00889	LB/B	-	A0A2R9ASF5	404	I	S
Q00889	LB/B	-	A0A2R9ASF5	85	H	D
Q00889	LB/B	-	A0A2R9ASF5	161	M	T
Q00889	LB/B	-	A0A2R9ASF5	188	M	R
Q13046	LB/B	-	A0A2R9ASF5	65	Y	H
Q9UQ74	LB/B	-	A0A2K5W4J9	349	V	D
Q9UQ74	LB/B	-	A0A2K5W4J9	315	Q	P
Q00887	LB/B	-	A0A2K5PZW6	325	I	T
Q00887	LB/B	-	A0A2K5PZW6	374	Q	L
Q00887	LB/B	-	A0A2K5PZW6	397	H	R
Q00887	LB/B	-	A0A2K5PZW6	176	A	T
Q00887	LB/B	-	A0A2K5PZW6	18	L	V
Q96QS6	LB/B	-	A0A1S3EVE1	72	G	D
Q96QS6	LB/B	-	A0A1S3EVE1	79	R	K
Q96QS6	LB/B	-	A0A1S3EVE1	114	R	Q
Q96QS6	LB/B	-	A0A1S3EVE1	132	Q	R
Q96QS6	LB/B	-	A0A1S3EVE1	148	R	Q
Q96QS6	LB/B	-	A0A1S3EVE1	176	A	S
Q96QS6	LB/B	-	A0A1S3EVE1	211	G	R
Q96QS6	LB/B	-	A0A1S3EVE1	225	T	A
Q96QS6	LB/B	-	A0A1S3EVE1	266	S	R
Q96QS6	LB/B	-	A0A1S3EVE1	336	I	V
P25786	LB/B	-	L9L7Z3	37	G	V
A5LHX3	LB/B	-	A0A1A6H3C3	49	G	S
P49720	LB/B	-	S9YIJ2	34	M	L
P28070	LB/B	-	A0A1D1YES3	95	M	I
P28070	LB/B	-	A0A1D1YES3	234	I	T
P28065	LB/B	-	G1SGW4	60	R	H
P28065	LB/B	-	G1SGW4	9	G	E
P28065	LB/B	-	G1SGW4	32	V	I
P28065	LB/B	-	G1SGW4	173	R	C
P28065	LP/P	Proteasome-associated autoinflammatory syndrome 3 (PRAAS3) [MIM:617591]	G1SGW4	165	G	D
P62195	LB/B	-	A0A2D0SF36	258	R	W
O00232	LB/B	-	A0A2U3X1X6	358	V	A
Q9UNM6	LB/B	-	A0A2K6RKZ0	13	N	S
Q9UNM6	LB/B	-	A0A2K6RKZ0	204	G	E
Q9UNM6	LB/B	-	A0A2K6RKZ0	205	L	F
Q9UNM6	LB/B	-	A0A2K6RKZ0	150	S	L
Q13200	LB/B	-	A0A091DQ91	176	A	T
Q13200	LB/B	-	A0A091DQ91	313	E	D
Q13200	LB/B	-	A0A091DQ91	724	N	Y
Q16401	LB/B	-	V8NM42	21	E	G
Q16401	LB/B	-	V8NM42	72	L	H
O00233	LB/B	-	A0A2J8MDA8	17	V	A
O00233	LB/B	-	A0A2J8MDA8	74	T	I
O00233	LB/B	-	A0A2J8MDA8	134	R	W
O00233	LB/B	-	A0A2J8MDA8	197	E	G
Q06323	LB/B	-	A0A0F8CFA8	55	S	N
Q06323	LB/B	-	A0A0F8CFA8	244	T	K
Q14997	LB/B	-	A0A1W4XWC3	872	I	V
Q14997	LB/B	-	A0A1W4XWC3	1371	S	T
Q14997	LB/B	-	A0A1W4XWC3	1825	T	A
Q92530	LB/B	-	A0A2I3M5D7	174	H	R
Q92530	LB/B	-	A0A2I3M5D7	36	F	C
O95456	LB/B	-	A0A2I2U838	166	I	V
Q9UIG4	LB/B	-	A0A2U4AP49	25	G	D
Q9UIG4	LB/B	-	A0A2U4AP49	84	P	L
Q9UIG4	LB/B	-	A0A2U4AP49	83	L	P
P78330	LP/P	Phosphoserine phosphatase deficiency (PSPHD) [MIM:614023]	A0A2U3WAS8	32	D	N
P78330	LP/P	Phosphoserine phosphatase deficiency (PSPHD) [MIM:614023]	A0A2U3WAS8	52	M	T
P78330	LP/P	Phosphoserine phosphatase deficiency (PSPHD) [MIM:614023]	A0A2U3WAS8	35	A	T
Q6PGN9	LB/B	-	A0A061IKH7	312	R	Q
Q8IV42	LB/B	-	F6ZM75	206	G	R
P25105	LB/B	-	H2MB26	224	A	D
P25105	LB/B	-	H2MB26	338	N	S
O75127	LB/B	-	G5AX92	356	P	L
O75127	LB/B	-	G5AX92	620	V	G
Q13635	LP/P	Basal cell nevus syndrome (BCNS) [MIM:109400]	W5L627	175	L	P
Q13635	LP/P	Basal cell nevus syndrome (BCNS) [MIM:109400]	W5L627	376	F	S
Q13635	LP/P	Basal cell carcinoma (BCC) [MIM:605462]	W5L627	1114	R	W
Q13635	LP/P	Basal cell nevus syndrome (BCNS) [MIM:109400]	W5L627	1114	R	W
Q13635	LP/P	Basal cell nevus syndrome (BCNS) [MIM:109400]	W5L627	509	G	V
Q13635	LP/P	Basal cell nevus syndrome (BCNS) [MIM:109400]	W5L627	513	D	Y
Q13635	LP/P	Basal cell nevus syndrome (BCNS) [MIM:109400]	W5L627	1069	G	R
Q13635	LP/P	Basal cell nevus syndrome (BCNS) [MIM:109400]	W5L627	1132	S	P
Q13635	LP/P	Basal cell nevus syndrome (BCNS) [MIM:109400]	W5L627	1132	S	Y
Q13635	LB/B	-	W5L627	1315	P	L
Q13635	LP/P	Basal cell nevus syndrome (BCNS) [MIM:109400]	W5L627	1438	E	D
Q13635	LB/B	-	W5L627	1195	T	S
Q13635	LP/P	Basal cell nevus syndrome (BCNS) [MIM:109400]	W5L627	230	T	P
Q13635	LB/B	-	W5L627	1282	P	L
Q13635	LP/P	Holoprosencephaly 7 (HPE7) [MIM:610828]	W5L627	393	A	T
Q13635	LP/P	Holoprosencephaly 7 (HPE7) [MIM:610828]	W5L627	443	A	G
Q13635	LP/P	Holoprosencephaly 7 (HPE7) [MIM:610828]	W5L627	728	T	M
Q13635	LP/P	Holoprosencephaly 7 (HPE7) [MIM:610828]	W5L627	751	V	G
Q13635	LP/P	Holoprosencephaly 7 (HPE7) [MIM:610828]	W5L627	827	S	G
Q13635	LP/P	Holoprosencephaly 7 (HPE7) [MIM:610828]	W5L627	908	V	G
Q13635	LP/P	Holoprosencephaly 7 (HPE7) [MIM:610828]	W5L627	1052	T	M
Q96NR3	LB/B	-	A0A146P458	73	L	F
Q96NR3	LB/B	-	A0A146P458	173	I	V
Q96NR3	LB/B	-	A0A146P458	195	V	I
Q96NR3	LB/B	-	A0A146P458	251	P	L
Q96NR3	LB/B	-	A0A146P458	359	H	R
Q96NR3	LB/B	-	A0A146P458	470	A	D
Q96NR3	LB/B	-	A0A146P458	479	E	G
Q96NR3	LB/B	-	A0A146P458	497	N	K
Q96NR3	LB/B	-	A0A146P458	82	R	H
Q96NR3	LB/B	-	A0A146P458	882	V	A
Q3KNS1	LB/B	-	D2I318	126	T	A
Q3KNS1	LB/B	-	D2I318	152	L	P
Q3KNS1	LB/B	-	D2I318	224	A	G
Q3KNS1	LB/B	-	D2I318	372	R	K
Q3KNS1	LB/B	-	D2I318	407	C	G
Q3KNS1	LB/B	-	D2I318	473	D	G
Q3KNS1	LB/B	-	D2I318	521	M	T
Q3KNS1	LB/B	-	D2I318	584	I	M
Q6ISU1	LB/B	-	Q6ZNR1	106	V	I
Q6ISU1	LB/B	-	Q6ZNR1	183	A	T
P48651	LB/B	-	A0A1V4KGX2	423	T	N
P48651	LP/P	Lenz-Majewski hyperostotic dwarfism (LMHD) [MIM:151050]	A0A1V4KGX2	265	L	P
P48651	LP/P	Lenz-Majewski hyperostotic dwarfism (LMHD) [MIM:151050]	A0A1V4KGX2	269	P	S
P48651	LP/P	Lenz-Majewski hyperostotic dwarfism (LMHD) [MIM:151050]	A0A1V4KGX2	353	Q	R
P60484	LP/P	Cowden syndrome 1 (CWS1) [MIM:158350]	A0A024QYR5	67	I	R
P60484	LP/P	Cowden syndrome 1 (CWS1) [MIM:158350]	A0A024QYR5	68	Y	H
P60484	LP/P	Cowden syndrome 1 (CWS1) [MIM:158350]	A0A024QYR5	123	H	R
P60484	LP/P	Cowden syndrome 1 (CWS1) [MIM:158350]	A0A024QYR5	124	C	R
P60484	LP/P	Cowden syndrome 1 (CWS1) [MIM:158350]	A0A024QYR5	129	G	E
P60484	LP/P	Cowden syndrome 1 (CWS1) [MIM:158350]	A0A024QYR5	130	R	L
P60484	LP/P	Cowden syndrome 1 (CWS1) [MIM:158350]	A0A024QYR5	130	R	Q
P60484	LP/P	Prostate cancer (PC) [MIM:176807]	A0A024QYR5	134	M	L
P60484	LP/P	Cowden syndrome 1 (CWS1) [MIM:158350]	A0A024QYR5	170	S	R
P60484	LP/P	Cowden syndrome 1 (CWS1) [MIM:158350]	A0A024QYR5	112	L	P
P60484	LP/P	Lhermitte-Duclos disease (LDD) [MIM:158350]	A0A024QYR5	112	L	P
P60484	LP/P	Cowden syndrome 1 (CWS1) [MIM:158350]	A0A024QYR5	136	C	Y
P60484	LP/P	Cowden syndrome 1 (CWS1) [MIM:158350]	A0A024QYR5	35	M	R
P60484	LP/P	Cowden syndrome 1 (CWS1) [MIM:158350]	A0A024QYR5	34	A	D
P60484	LP/P	Cowden syndrome 1 (CWS1) [MIM:158350]	A0A024QYR5	105	C	Y
P60484	LP/P	Cowden syndrome 1 (CWS1) [MIM:158350]	A0A024QYR5	135	I	V
P60484	LP/P	Cowden syndrome 1 (CWS1) [MIM:158350]	A0A024QYR5	165	G	V
P60484	LP/P	Cowden syndrome 1 (CWS1) [MIM:158350]	A0A024QYR5	165	G	E
P60484	LP/P	Cowden syndrome 1 (CWS1) [MIM:158350]	A0A024QYR5	246	P	L
P60484	LP/P	Cowden syndrome 1 (CWS1) [MIM:158350]	A0A024QYR5	289	K	E
P60484	LP/P	Cowden syndrome 1 (CWS1) [MIM:158350]	A0A024QYR5	343	V	E
P60484	LP/P	Cowden syndrome 1 (CWS1) [MIM:158350]	A0A024QYR5	347	F	L
P60484	LP/P	Cowden syndrome 1 (CWS1) [MIM:158350]	A0A024QYR5	47	R	G
P60484	LP/P	Cowden syndrome 1 (CWS1) [MIM:158350]	A0A024QYR5	70	L	P
P60484	LP/P	Squamous cell carcinoma of the head and neck (HNSCC) [MIM:275355]	A0A024QYR5	121	A	G
P60484	LP/P	Cowden syndrome 1 (CWS1) [MIM:158350]	A0A024QYR5	124	C	S
P60484	LP/P	Glioma 2 (GLM2) [MIM:613028]	A0A024QYR5	234	R	Q
P60484	LB/B	-	A0A024QYR5	290	V	L
P60484	LB/B	-	A0A024QYR5	20	G	E
P60484	LB/B	-	A0A024QYR5	27	Y	S
P60484	LB/B	-	A0A024QYR5	36	G	R
P60484	LB/B	-	A0A024QYR5	61	H	R
P60484	LP/P	Cowden syndrome 1 (CWS1) [MIM:158350]	A0A024QYR5	71	C	Y
P60484	LP/P	Cowden syndrome 1 (CWS1) [MIM:158350]	A0A024QYR5	93	H	Y
P60484	LP/P	Cowden syndrome 1 (CWS1) [MIM:158350]	A0A024QYR5	105	C	F
P60484	LP/P	Cowden syndrome 1 (CWS1) [MIM:158350]	A0A024QYR5	107	D	Y
P60484	LP/P	Endometrial cancer (ENDMC) [MIM:608089]	A0A024QYR5	123	H	Y
P60484	LB/B	-	A0A024QYR5	130	R	G
P60484	LP/P	Cowden syndrome 1 (CWS1) [MIM:158350]	A0A024QYR5	155	Y	C
P60484	LB/B	-	A0A024QYR5	173	R	C
P60484	LB/B	-	A0A024QYR5	173	R	H
P60484	LB/B	-	A0A024QYR5	173	R	P
P60484	LB/B	-	A0A024QYR5	174	Y	N
P60484	LB/B	-	A0A024QYR5	227	S	F
P60484	LP/P	Cowden syndrome 1 (CWS1) [MIM:158350]	A0A024QYR5	331	D	G
P60484	LP/P	Cowden syndrome 1 (CWS1) [MIM:158350]	A0A024QYR5	341	F	V
P60484	LP/P	Cowden syndrome 1 (CWS1) [MIM:158350]	A0A024QYR5	342	K	N
P60484	LP/P	Macrocephaly/autism syndrome (MCEPHAS) [MIM:605309]	A0A024QYR5	93	H	R
P60484	LP/P	Macrocephaly/autism syndrome (MCEPHAS) [MIM:605309]	A0A024QYR5	241	F	S
P60484	LP/P	Macrocephaly/autism syndrome (MCEPHAS) [MIM:605309]	A0A024QYR5	252	D	G
P60484	LP/P	Macrocephaly/autism syndrome (MCEPHAS) [MIM:605309]	A0A024QYR5	131	T	I
P60484	LP/P	Macrocephaly/autism syndrome (MCEPHAS) [MIM:605309]	A0A024QYR5	167	T	N
Q7RTS3	LB/B	-	H2N9Z2	263	S	P
Q9Y5Y4	LB/B	-	A0A2K6F9N6	204	V	A
Q9H7Z7	LB/B	-	G1TJV3	298	R	H
Q9P2B2	LB/B	-	A0A1W5AH42	837	V	I
Q9P2B2	LB/B	-	A0A1W5AH42	277	S	T
P43119	LB/B	-	A0A2Y9DUX1	25	V	M
P43119	LB/B	-	A0A2Y9DUX1	319	S	W
Q16647	LB/B	-	A0A1W5AIV6	38	P	L
Q16647	LB/B	-	A0A1W5AIV6	118	S	R
Q16647	LB/B	-	A0A1W5AIV6	379	R	S
Q16647	LB/B	-	A0A1W5AIV6	154	E	A
Q16647	LB/B	-	A0A1W5AIV6	171	F	L
Q16647	LB/B	-	A0A1W5AIV6	236	R	C
Q16647	LB/B	-	A0A1W5AIV6	500	P	S
Q16647	LB/B	-	A0A1W5AIV6	447	A	T
Q14914	LB/B	-	A0A1U7R3N3	27	A	S
Q8N4Q0	LB/B	-	L5LZX9	323	C	F
P23219	LB/B	-	A0A091CZG8	8	W	R
P23219	LB/B	-	A0A091CZG8	17	P	L
P23219	LB/B	-	A0A091CZG8	359	K	R
P23219	LB/B	-	A0A091CZG8	443	I	V
P23219	LB/B	-	A0A091CZG8	53	R	H
P23219	LB/B	-	A0A091CZG8	149	R	L
P23219	LB/B	-	A0A091CZG8	237	L	M
P23219	LB/B	-	A0A091CZG8	481	V	I
P23219	LB/B	-	A0A091CZG8	185	K	T
P23219	LB/B	-	A0A091CZG8	341	K	R
P01270	LP/P	Hypoparathyroidism, familial isolated, 1 (FIH1) [MIM:146200]	A0A2Y9KUS5	18	C	R
P01270	LP/P	Hypoparathyroidism, familial isolated, 1 (FIH1) [MIM:146200]	A0A2Y9KUS5	23	S	P
Q03431	LP/P	Metaphyseal chondrodysplasia, Jansen type (MCDJ) [MIM:156400]	G5ANQ5	223	H	R
Q03431	LP/P	Metaphyseal chondrodysplasia, Jansen type (MCDJ) [MIM:156400]	G5ANQ5	410	T	P
Q03431	LP/P	Chondrodysplasia Blomstrand type (BOCD) [MIM:215045]	G5ANQ5	132	P	L
Q03431	LB/B	-	G5ANQ5	150	R	C
Q03431	LP/P	Metaphyseal chondrodysplasia, Jansen type (MCDJ) [MIM:156400]	G5ANQ5	458	I	R
Q03431	LP/P	Metaphyseal chondrodysplasia, Jansen type (MCDJ) [MIM:156400]	G5ANQ5	410	T	R
P12272	LP/P	Brachydactyly E2 (BDE2) [MIM:613382]	A0A151P758	44	L	P
P12272	LP/P	Brachydactyly E2 (BDE2) [MIM:613382]	A0A151P758	60	L	P
Q05397	LB/B	-	H2T0L1	292	H	P
Q05397	LB/B	-	H2T0L1	292	H	Q
Q05397	LB/B	-	H2T0L1	1030	D	E
Q14289	LB/B	-	U3IPQ3	838	K	T
Q14289	LB/B	-	U3IPQ3	359	Q	E
Q14289	LB/B	-	U3IPQ3	698	R	H
Q14289	LB/B	-	U3IPQ3	808	L	P
Q14289	LB/B	-	U3IPQ3	970	E	K
Q15257	LB/B	-	H3AZE6	28	K	R
Q15257	LB/B	-	H3AZE6	208	R	Q
Q15257	LB/B	-	H3AZE6	357	S	L
Q06124	LP/P	Noonan syndrome 1 (NS1) [MIM:163950]	L5KVJ5	42	T	A
Q06124	LP/P	Noonan syndrome 1 (NS1) [MIM:163950]	L5KVJ5	60	G	A
Q06124	LP/P	Noonan syndrome 1 (NS1) [MIM:163950]	L5KVJ5	61	D	G
Q06124	LP/P	Noonan syndrome 1 (NS1) [MIM:163950]	L5KVJ5	61	D	N
Q06124	LP/P	Noonan syndrome 1 (NS1) [MIM:163950]	L5KVJ5	62	Y	D
Q06124	LP/P	Noonan syndrome 1 (NS1) [MIM:163950]	L5KVJ5	63	Y	C
Q06124	LP/P	Noonan syndrome 1 (NS1) [MIM:163950]	L5KVJ5	72	A	G
Q06124	LP/P	Noonan syndrome 1 (NS1) [MIM:163950]	L5KVJ5	72	A	S
Q06124	LP/P	Noonan syndrome 1 (NS1) [MIM:163950]	L5KVJ5	73	T	I
Q06124	LP/P	Noonan syndrome 1 (NS1) [MIM:163950]	L5KVJ5	76	E	D
Q06124	LP/P	Noonan syndrome 1 (NS1) [MIM:163950]	L5KVJ5	79	Q	R
Q06124	LP/P	Noonan syndrome 1 (NS1) [MIM:163950]	L5KVJ5	106	D	A
Q06124	LP/P	Noonan syndrome 1 (NS1) [MIM:163950]	L5KVJ5	139	E	D
Q06124	LP/P	LEOPARD syndrome 1 (LPRD1) [MIM:151100]	L5KVJ5	279	Y	C
Q06124	LP/P	Noonan syndrome 1 (NS1) [MIM:163950]	L5KVJ5	279	Y	C
Q06124	LP/P	Noonan syndrome 1 (NS1) [MIM:163950]	L5KVJ5	282	I	V
Q06124	LP/P	Noonan syndrome 1 (NS1) [MIM:163950]	L5KVJ5	285	F	S
Q06124	LP/P	Noonan syndrome 1 (NS1) [MIM:163950]	L5KVJ5	285	F	L
Q06124	LP/P	Noonan syndrome 1 (NS1) [MIM:163950]	L5KVJ5	308	N	S
Q06124	LP/P	Noonan syndrome 1 (NS1) [MIM:163950]	L5KVJ5	308	N	D
Q06124	LP/P	LEOPARD syndrome 1 (LPRD1) [MIM:151100]	L5KVJ5	468	T	M
Q06124	LP/P	Noonan syndrome 1 (NS1) [MIM:163950]	L5KVJ5	501	R	K
Q06124	LP/P	Noonan syndrome 1 (NS1) [MIM:163950]	L5KVJ5	502	S	T
Q06124	LP/P	Noonan syndrome 1 (NS1) [MIM:163950]	L5KVJ5	504	M	V
Q06124	LB/B	-	L5KVJ5	60	G	V
Q06124	LP/P	Leukemia, juvenile myelomonocytic (JMML) [MIM:607785]	L5KVJ5	61	D	V
Q06124	LP/P	Leukemia, juvenile myelomonocytic (JMML) [MIM:607785]	L5KVJ5	61	D	Y
Q06124	LP/P	Leukemia, juvenile myelomonocytic (JMML) [MIM:607785]	L5KVJ5	69	E	K
Q06124	LP/P	Noonan syndrome 1 (NS1) [MIM:163950]	L5KVJ5	71	F	L
Q06124	LP/P	Leukemia, juvenile myelomonocytic (JMML) [MIM:607785]	L5KVJ5	72	A	T
Q06124	LP/P	Leukemia, juvenile myelomonocytic (JMML) [MIM:607785]	L5KVJ5	72	A	V
Q06124	LP/P	Leukemia, juvenile myelomonocytic (JMML) [MIM:607785]	L5KVJ5	76	E	A
Q06124	LP/P	Leukemia, juvenile myelomonocytic (JMML) [MIM:607785]	L5KVJ5	76	E	G
Q06124	LP/P	Leukemia, juvenile myelomonocytic (JMML) [MIM:607785]	L5KVJ5	76	E	K
Q06124	LP/P	Leukemia, juvenile myelomonocytic (JMML) [MIM:607785]	L5KVJ5	76	E	V
Q06124	LP/P	Leukemia, juvenile myelomonocytic (JMML) [MIM:607785]	L5KVJ5	503	G	A
Q06124	LP/P	Leukemia, juvenile myelomonocytic (JMML) [MIM:607785]	L5KVJ5	503	G	R
Q06124	LP/P	Noonan syndrome 1 (NS1) [MIM:163950]	L5KVJ5	503	G	R
Q06124	LP/P	Noonan syndrome 1 (NS1) [MIM:163950]	L5KVJ5	2	T	I
Q06124	LP/P	Noonan syndrome 1 (NS1) [MIM:163950]	L5KVJ5	58	N	K
Q06124	LP/P	Noonan syndrome 1 (NS1) [MIM:163950]	L5KVJ5	69	E	Q
Q06124	LP/P	Noonan syndrome 1 (NS1) [MIM:163950]	L5KVJ5	79	Q	P
Q06124	LP/P	Noonan syndrome 1 (NS1) [MIM:163950]	L5KVJ5	256	Q	R
Q06124	LP/P	LEOPARD syndrome 1 (LPRD1) [MIM:151100]	L5KVJ5	279	Y	S
Q06124	LP/P	Noonan syndrome 1 (NS1) [MIM:163950]	L5KVJ5	411	T	M
Q06124	LP/P	LEOPARD syndrome 1 (LPRD1) [MIM:151100]	L5KVJ5	461	A	T
Q06124	LP/P	LEOPARD syndrome 1 (LPRD1) [MIM:151100]	L5KVJ5	464	G	A
Q06124	LP/P	LEOPARD syndrome 1 (LPRD1) [MIM:151100]	L5KVJ5	498	R	L
Q06124	LP/P	LEOPARD syndrome 1 (LPRD1) [MIM:151100]	L5KVJ5	498	R	W
Q06124	LP/P	LEOPARD syndrome 1 (LPRD1) [MIM:151100]	L5KVJ5	506	Q	P
Q06124	LP/P	Noonan syndrome 1 (NS1) [MIM:163950]	L5KVJ5	506	Q	R
Q06124	LP/P	LEOPARD syndrome 1 (LPRD1) [MIM:151100]	L5KVJ5	510	Q	P
Q06124	LP/P	Noonan syndrome 1 (NS1) [MIM:163950]	L5KVJ5	59	T	A
Q06124	LP/P	Noonan syndrome 1 (NS1) [MIM:163950]	L5KVJ5	491	P	S
Q06124	LP/P	LEOPARD syndrome 1 (LPRD1) [MIM:151100]	L5KVJ5	510	Q	E
Q06124	LP/P	Noonan syndrome 1 (NS1) [MIM:163950]	L5KVJ5	510	Q	E
Q06124	LP/P	Noonan syndrome 1 (NS1) [MIM:163950]	L5KVJ5	261	L	F
Q06124	LP/P	Noonan syndrome 1 (NS1) [MIM:163950]	L5KVJ5	261	L	H
Q06124	LP/P	Noonan syndrome 1 (NS1) [MIM:163950]	L5KVJ5	262	L	F
Q06124	LP/P	Noonan syndrome 1 (NS1) [MIM:163950]	L5KVJ5	262	L	R
Q06124	LP/P	Noonan syndrome 1 (NS1) [MIM:163950]	L5KVJ5	265	R	Q
Q05209	LB/B	-	H2MEM3	322	V	I
Q05209	LB/B	-	H2MEM3	573	T	A
Q05209	LB/B	-	H2MEM3	706	E	K
Q12923	LB/B	-	E1BKT4	1419	L	P
Q12923	LB/B	-	E1BKT4	1522	I	M
Q12923	LB/B	-	E1BKT4	1625	E	K
Q12923	LB/B	-	E1BKT4	2081	Y	D
Q12923	LB/B	-	E1BKT4	1356	F	L
Q12923	LB/B	-	E1BKT4	1744	S	P
Q12923	LB/B	-	E1BKT4	2458	I	V
Q99952	LB/B	-	H0UXC7	193	M	V
P54829	LB/B	-	F7AGY7	170	P	A
P54829	LB/B	-	F7AGY7	561	H	R
P18433	LB/B	-	P18052	109	P	L
P23467	LB/B	-	G3SUY9	395	V	A
P23467	LB/B	-	G3SUY9	415	D	E
P23467	LB/B	-	G3SUY9	939	T	M
P23467	LB/B	-	G3SUY9	1032	T	I
P23467	LB/B	-	G3SUY9	1934	G	A
P23467	LB/B	-	G3SUY9	94	R	K
P23467	LB/B	-	G3SUY9	127	S	G
Q14761	LB/B	-	A0A2U3VGJ1	128	G	E
Q12913	LB/B	-	Q9W6V5	326	R	Q
Q12913	LB/B	-	Q9W6V5	293	A	T
Q12913	LB/B	-	Q9W6V5	372	V	I
Q12913	LB/B	-	Q9W6V5	872	E	D
Q12913	LB/B	-	Q9W6V5	1235	I	T
P28827	LB/B	-	A0A1S3L8I1	39	S	R
Q16849	LB/B	-	A0A0Q3MPP3	419	S	R
Q9UMZ3	LB/B	-	G1KPV1	1040	T	I
Q9UMZ3	LB/B	-	G1KPV1	1098	F	L
Q9UMZ3	LB/B	-	G1KPV1	1120	A	P
Q9UMZ3	LB/B	-	G1KPV1	1244	N	D
Q9UMZ3	LB/B	-	G1KPV1	1734	I	T
Q9UMZ3	LB/B	-	G1KPV1	2121	R	K
Q9UMZ3	LP/P	Deafness, autosomal recessive, 84A (DFNB84A) [MIM:613391]	G1KPV1	281	R	G
Q9UMZ3	LB/B	-	G1KPV1	471	Q	E
Q15256	LB/B	-	Q62132	314	K	R
Q15256	LB/B	-	Q62132	249	Y	H
Q15256	LB/B	-	Q62132	386	V	I
Q15256	LB/B	-	Q62132	439	V	I
O14522	LB/B	-	A0A1S3L8I1	29	A	P
O14522	LB/B	-	A0A1S3L8I1	76	M	V
Q92729	LB/B	-	Q5R4N4	60	T	N
Q92729	LB/B	-	Q5R4N4	471	R	L
Q92729	LB/B	-	Q5R4N4	940	N	S
P23471	LB/B	-	S9Y302	3	I	S
P23471	LB/B	-	S9Y302	6	R	L
P23471	LB/B	-	S9Y302	1433	G	D
Q03393	LP/P	Hyperphenylalaninemia, BH4-deficient, A (HPABH4A) [MIM:261640]	A0A1A9XL25	16	R	C
Q03393	LP/P	Hyperphenylalaninemia, BH4-deficient, A (HPABH4A) [MIM:261640]	A0A1A9XL25	25	R	G
Q03393	LP/P	Hyperphenylalaninemia, BH4-deficient, A (HPABH4A) [MIM:261640]	A0A1A9XL25	25	R	Q
Q03393	LP/P	Hyperphenylalaninemia, BH4-deficient, A (HPABH4A) [MIM:261640]	A0A1A9XL25	35	E	G
Q03393	LP/P	Hyperphenylalaninemia, BH4-deficient, A (HPABH4A) [MIM:261640]	A0A1A9XL25	36	N	K
Q03393	LP/P	Hyperphenylalaninemia, BH4-deficient, A (HPABH4A) [MIM:261640]	A0A1A9XL25	52	N	S
Q03393	LP/P	Hyperphenylalaninemia, BH4-deficient, A (HPABH4A) [MIM:261640]	A0A1A9XL25	56	V	M
Q03393	LP/P	Hyperphenylalaninemia, BH4-deficient, A (HPABH4A) [MIM:261640]	A0A1A9XL25	67	T	M
Q03393	LP/P	Hyperphenylalaninemia, BH4-deficient, A (HPABH4A) [MIM:261640]	A0A1A9XL25	70	V	D
Q03393	LP/P	Hyperphenylalaninemia, BH4-deficient, A (HPABH4A) [MIM:261640]	A0A1A9XL25	87	P	L
Q03393	LP/P	Hyperphenylalaninemia, BH4-deficient, A (HPABH4A) [MIM:261640]	A0A1A9XL25	87	P	S
Q03393	LP/P	Hyperphenylalaninemia, BH4-deficient, A (HPABH4A) [MIM:261640]	A0A1A9XL25	96	D	N
Q03393	LP/P	Hyperphenylalaninemia, BH4-deficient, A (HPABH4A) [MIM:261640]	A0A1A9XL25	100	F	V
Q03393	LP/P	Hyperphenylalaninemia, BH4-deficient, A (HPABH4A) [MIM:261640]	A0A1A9XL25	106	T	M
Q03393	LP/P	Hyperphenylalaninemia, BH4-deficient, A (HPABH4A) [MIM:261640]	A0A1A9XL25	114	I	V
Q03393	LP/P	Hyperphenylalaninemia, BH4-deficient, A (HPABH4A) [MIM:261640]	A0A1A9XL25	129	K	E
Q03393	LP/P	Hyperphenylalaninemia, BH4-deficient, A (HPABH4A) [MIM:261640]	A0A1A9XL25	136	D	V
Q03393	LP/P	Hyperphenylalaninemia, BH4-deficient, A (HPABH4A) [MIM:261640]	A0A1A9XL25	47	N	D
Q03393	LP/P	Hyperphenylalaninemia, BH4-deficient, A (HPABH4A) [MIM:261640]	A0A1A9XL25	116	D	G
Q03393	LP/P	Hyperphenylalaninemia, BH4-deficient, A (HPABH4A) [MIM:261640]	A0A1A9XL25	26	L	F
Q03393	LP/P	Hyperphenylalaninemia, BH4-deficient, A (HPABH4A) [MIM:261640]	A0A1A9XL25	97	V	M
Q03393	LP/P	Hyperphenylalaninemia, BH4-deficient, A (HPABH4A) [MIM:261640]	A0A1A9XL25	99	Y	C
Q03393	LP/P	Hyperphenylalaninemia, BH4-deficient, A (HPABH4A) [MIM:261640]	A0A1A9XL25	124	V	L
Q03393	LP/P	Hyperphenylalaninemia, BH4-deficient, A (HPABH4A) [MIM:261640]	A0A1A9XL25	136	D	G
Q9NZH5	LB/B	-	H0X6L5	44	R	P
P26022	LB/B	-	F7I850	39	H	Q
P26022	LB/B	-	F7I850	48	A	D
P26022	LB/B	-	F7I850	290	A	V
P26022	LB/B	-	F7I850	313	E	K
Q96A99	LB/B	-	A0A2Y9HPJ5	92	R	W
Q96A99	LB/B	-	A0A2Y9HPJ5	220	R	G
Q96A99	LB/B	-	A0A2Y9HPJ5	234	R	Q
Q96A99	LB/B	-	A0A2Y9HPJ5	281	R	K
Q96A99	LB/B	-	A0A2Y9HPJ5	317	A	S
Q96A99	LB/B	-	A0A2Y9HPJ5	2	G	E
Q96A99	LB/B	-	A0A2Y9HPJ5	444	I	V
Q08623	LB/B	-	E2B275	165	P	A
Q08623	LB/B	-	E2B275	88	T	M
Q14671	LP/P	Spinocerebellar ataxia 47 (SCA47) [MIM:617931]	L5JUR1	1033	T	S
Q14671	LP/P	Spinocerebellar ataxia 47 (SCA47) [MIM:617931]	L5JUR1	1137	R	W
Q14671	LP/P	Spinocerebellar ataxia 47 (SCA47) [MIM:617931]	L5JUR1	1145	R	W
Q8TB72	LB/B	-	L5JUR1	367	N	S
Q15397	LB/B	-	A0A2Y9N8L2	289	R	P
Q15397	LB/B	-	A0A2Y9N8L2	297	V	L
Q15397	LB/B	-	A0A2Y9N8L2	13	S	N
Q15397	LB/B	-	A0A2Y9N8L2	264	I	V
Q15397	LB/B	-	A0A2Y9N8L2	414	T	S
Q15397	LB/B	-	A0A2Y9N8L2	480	R	Q
Q00577	LP/P	Neurodevelopmental disorder with neonatal respiratory insufficiency, hypotonia, and feeding difficulties (NEDRIHF) [MIM:616158]	E2R2A4	89	A	P
Q00577	LP/P	Neurodevelopmental disorder with neonatal respiratory insufficiency, hypotonia, and feeding difficulties (NEDRIHF) [MIM:616158]	E2R2A4	97	K	E
Q00577	LP/P	Neurodevelopmental disorder with neonatal respiratory insufficiency, hypotonia, and feeding difficulties (NEDRIHF) [MIM:616158]	E2R2A4	100	L	P
Q00577	LP/P	Neurodevelopmental disorder with neonatal respiratory insufficiency, hypotonia, and feeding difficulties (NEDRIHF) [MIM:616158]	E2R2A4	157	M	K
Q00577	LP/P	Neurodevelopmental disorder with neonatal respiratory insufficiency, hypotonia, and feeding difficulties (NEDRIHF) [MIM:616158]	E2R2A4	199	R	P
Q00577	LP/P	Neurodevelopmental disorder with neonatal respiratory insufficiency, hypotonia, and feeding difficulties (NEDRIHF) [MIM:616158]	E2R2A4	206	I	F
Q9Y606	LP/P	Myopathy with lactic acidosis and sideroblastic anemia 1 (MLASA1) [MIM:600462]	G1RAV7	144	R	W
Q9Y606	LB/B	-	G1RAV7	133	D	N
Q96PZ0	LP/P	Intellectual developmental disorder with abnormal behavior, microcephaly, and short stature (IDDABS) [MIM:618342]	G1SY14	503	D	Y
Q8N0Z8	LB/B	-	A0A2U4BXH8	103	R	Q
Q8N0Z8	LB/B	-	A0A2U4BXH8	197	R	W
P15151	LB/B	-	A0A1D5RK88	67	A	T
P15151	LB/B	-	A0A1D5RK88	340	I	M
P15151	LB/B	-	A0A1D5RK88	295	A	T
Q6DKI7	LB/B	-	L5LTX2	81	N	D
Q13610	LB/B	-	A0A1W4ZT39	288	L	F
Q15269	LB/B	-	V2WYK2	25	D	N
Q15269	LB/B	-	V2WYK2	551	F	I
Q15269	LB/B	-	V2WYK2	174	E	K
Q2TAK8	LB/B	-	W5PPK7	219	G	R
Q2TAK8	LB/B	-	W5PPK7	551	G	A
Q5H9M0	LB/B	-	W5PPK7	95	G	D
P49023	LB/B	-	A0A1U7R9Z3	73	S	G
P32322	LP/P	Cutis laxa, autosomal recessive, 2B (ARCL2B) [MIM:612940]	G1MGB8	119	R	G
P32322	LP/P	Cutis laxa, autosomal recessive, 2B (ARCL2B) [MIM:612940]	G1MGB8	119	R	H
P32322	LP/P	Cutis laxa, autosomal recessive, 2B (ARCL2B) [MIM:612940]	G1MGB8	179	A	T
P32322	LB/B	-	G1MGB8	189	A	V
P32322	LP/P	Cutis laxa, autosomal recessive, 2B (ARCL2B) [MIM:612940]	G1MGB8	206	G	R
P32322	LP/P	Cutis laxa, autosomal recessive, 2B (ARCL2B) [MIM:612940]	G1MGB8	206	G	W
P32322	LP/P	Cutis laxa, autosomal recessive, 3B (ARCL3B) [MIM:614438]	G1MGB8	251	R	H
P32322	LP/P	Cutis laxa, autosomal recessive, 3B (ARCL3B) [MIM:614438]	G1MGB8	257	A	T
P32322	LP/P	Cutis laxa, autosomal recessive, 2B (ARCL2B) [MIM:612940]	G1MGB8	266	R	Q
P32322	LP/P	Cutis laxa, autosomal recessive, 3B (ARCL3B) [MIM:614438]	G1MGB8	248	G	E
P32322	LB/B	-	G1MGB8	297	G	R
Q53H96	LB/B	-	A0A146W3E5	57	R	Q
Q53H96	LB/B	-	A0A146W3E5	105	V	M
Q53H96	LB/B	-	A0A146W3E5	150	K	N
P11216	LB/B	-	F1PSM2	502	D	N
P11216	LB/B	-	F1PSM2	303	A	S
P11217	LP/P	Glycogen storage disease 5 (GSD5) [MIM:232600]	B3RF38	205	G	S
P11217	LP/P	Glycogen storage disease 5 (GSD5) [MIM:232600]	B3RF38	397	L	P
P11217	LP/P	Glycogen storage disease 5 (GSD5) [MIM:232600]	B3RF38	543	K	T
P11217	LP/P	Glycogen storage disease 5 (GSD5) [MIM:232600]	B3RF38	655	E	K
P11217	LP/P	Glycogen storage disease 5 (GSD5) [MIM:232600]	B3RF38	116	L	P
P11217	LP/P	Glycogen storage disease 5 (GSD5) [MIM:232600]	B3RF38	194	R	W
P11217	LP/P	Glycogen storage disease 5 (GSD5) [MIM:232600]	B3RF38	292	L	P
P11217	LP/P	Glycogen storage disease 5 (GSD5) [MIM:232600]	B3RF38	349	E	K
P11217	LP/P	Glycogen storage disease 5 (GSD5) [MIM:232600]	B3RF38	488	T	N
P11217	LP/P	Glycogen storage disease 5 (GSD5) [MIM:232600]	B3RF38	602	R	W
P11217	LP/P	Glycogen storage disease 5 (GSD5) [MIM:232600]	B3RF38	660	A	D
P11217	LP/P	Glycogen storage disease 5 (GSD5) [MIM:232600]	B3RF38	666	Q	E
P11217	LP/P	Glycogen storage disease 5 (GSD5) [MIM:232600]	B3RF38	685	N	Y
P11217	LP/P	Glycogen storage disease 5 (GSD5) [MIM:232600]	B3RF38	686	G	R
P11217	LP/P	Glycogen storage disease 5 (GSD5) [MIM:232600]	B3RF38	687	A	P
P11217	LP/P	Glycogen storage disease 5 (GSD5) [MIM:232600]	B3RF38	704	A	V
P11217	LP/P	Glycogen storage disease 5 (GSD5) [MIM:232600]	B3RF38	798	W	R
P11217	LB/B	-	B3RF38	414	R	G
Q9BRP8	LB/B	-	G3P996	66	E	Q
P10082	LB/B	-	A0A2K6KIW2	72	T	R
P10082	LB/B	-	A0A2K6KIW2	37	R	G
P10082	LB/B	-	A0A2K6KIW2	95	D	H
Q5JQD4	LB/B	-	F7EJQ6	28	T	I
P20742	LB/B	-	A0A091S656	813	V	A
P20742	LB/B	-	A0A091S656	691	V	M
P20742	LB/B	-	A0A091S656	1443	I	N
P20742	LB/B	-	A0A091S656	379	L	V
P20742	LB/B	-	A0A091S656	857	N	S
P20742	LB/B	-	A0A091S656	1205	T	P
P20742	LB/B	-	A0A091S656	1003	T	M
P47897	LP/P	Microcephaly, progressive, with seizures and cerebral and cerebellar atrophy (MSCCA) [MIM:615760]	A0A2K6SGR6	45	G	V
P47897	LP/P	Microcephaly, progressive, with seizures and cerebral and cerebellar atrophy (MSCCA) [MIM:615760]	A0A2K6SGR6	57	Y	H
P47897	LP/P	Microcephaly, progressive, with seizures and cerebral and cerebellar atrophy (MSCCA) [MIM:615760]	A0A2K6SGR6	403	R	W
P47897	LP/P	Microcephaly, progressive, with seizures and cerebral and cerebellar atrophy (MSCCA) [MIM:615760]	A0A2K6SGR6	515	R	W
P09417	LP/P	Hyperphenylalaninemia, BH4-deficient, C (HPABH4C) [MIM:261630]	A0A2K5CQU3	23	G	D
P09417	LP/P	Hyperphenylalaninemia, BH4-deficient, C (HPABH4C) [MIM:261630]	A0A2K5CQU3	36	W	R
P09417	LP/P	Hyperphenylalaninemia, BH4-deficient, C (HPABH4C) [MIM:261630]	A0A2K5CQU3	74	L	P
P09417	LP/P	Hyperphenylalaninemia, BH4-deficient, C (HPABH4C) [MIM:261630]	A0A2K5CQU3	108	W	G
P09417	LP/P	Hyperphenylalaninemia, BH4-deficient, C (HPABH4C) [MIM:261630]	A0A2K5CQU3	145	P	L
P09417	LP/P	Hyperphenylalaninemia, BH4-deficient, C (HPABH4C) [MIM:261630]	A0A2K5CQU3	150	Y	C
P09417	LP/P	Hyperphenylalaninemia, BH4-deficient, C (HPABH4C) [MIM:261630]	A0A2K5CQU3	151	G	S
P09417	LP/P	Hyperphenylalaninemia, BH4-deficient, C (HPABH4C) [MIM:261630]	A0A2K5CQU3	158	H	Y
P09417	LP/P	Hyperphenylalaninemia, BH4-deficient, C (HPABH4C) [MIM:261630]	A0A2K5CQU3	170	G	S
P09417	LP/P	Hyperphenylalaninemia, BH4-deficient, C (HPABH4C) [MIM:261630]	A0A2K5CQU3	212	F	C
P09417	LP/P	Hyperphenylalaninemia, BH4-deficient, C (HPABH4C) [MIM:261630]	A0A2K5CQU3	14	L	P
P09417	LP/P	Hyperphenylalaninemia, BH4-deficient, C (HPABH4C) [MIM:261630]	A0A2K5CQU3	17	G	V
P09417	LB/B	-	A0A2K5CQU3	51	S	T
P09417	LP/P	Hyperphenylalaninemia, BH4-deficient, C (HPABH4C) [MIM:261630]	A0A2K5CQU3	17	G	R
P09417	LP/P	Hyperphenylalaninemia, BH4-deficient, C (HPABH4C) [MIM:261630]	A0A2K5CQU3	18	G	D
P09417	LP/P	Hyperphenylalaninemia, BH4-deficient, C (HPABH4C) [MIM:261630]	A0A2K5CQU3	66	Q	R
P09417	LP/P	Hyperphenylalaninemia, BH4-deficient, C (HPABH4C) [MIM:261630]	A0A2K5CQU3	149	G	R
Q16769	LB/B	-	G1K927	71	Q	R
Q16769	LB/B	-	G1K927	54	R	W
Q16769	LB/B	-	G1K927	360	H	P
Q9NXS2	LB/B	-	A0A212DBP8	214	P	L
Q15274	LB/B	-	A0A0L0TAW4	158	A	V
Q15274	LB/B	-	A0A0L0TAW4	195	T	A
P83859	LB/B	-	A0A087RGY8	68	L	H
Q96P65	LB/B	-	A0A061INJ6	61	F	V
Q96P65	LB/B	-	A0A061INJ6	149	H	Q
Q96P65	LB/B	-	A0A061INJ6	344	L	S
Q9H0J4	LB/B	-	A0A287BCL9	202	L	S
Q9H0J4	LB/B	-	A0A287BCL9	630	I	T
Q9H0J4	LB/B	-	A0A287BCL9	906	H	Y
Q9H0J4	LB/B	-	A0A287BCL9	974	H	R
Q9H0J4	LB/B	-	A0A287BCL9	1036	E	Q
Q9H0J4	LB/B	-	A0A287BCL9	630	I	V
Q9H0J4	LB/B	-	A0A287BCL9	681	V	D
Q9H0R6	LB/B	-	A0A2Y9QVZ2	11	A	V
Q9H0R6	LB/B	-	A0A2Y9QVZ2	263	N	S
Q9H0R6	LP/P	Combined oxidative phosphorylation deficiency 40 (COXPD40) [MIM:618835]	A0A2Y9QVZ2	117	G	E
Q9H0R6	LP/P	Combined oxidative phosphorylation deficiency 40 (COXPD40) [MIM:618835]	A0A2Y9QVZ2	133	G	V
O00391	LB/B	-	G3T3H7	114	N	S
O00391	LB/B	-	G3T3H7	200	G	A
O00391	LB/B	-	G3T3H7	256	R	M
O00391	LB/B	-	G3T3H7	294	A	S
O00391	LB/B	-	G3T3H7	444	H	R
O00391	LB/B	-	G3T3H7	591	N	H
O00391	LB/B	-	G3T3H7	605	R	P
Q6ZRP7	LB/B	-	H2TK30	126	K	E
Q9Y3T6	LB/B	-	F1PVY9	96	A	T
Q9Y3T6	LB/B	-	F1PVY9	145	R	K
Q9Y3T6	LB/B	-	F1PVY9	307	V	M
Q9Y3T6	LB/B	-	F1PVY9	363	L	R
Q7Z5L2	LB/B	-	G3SNJ0	566	H	R
Q7Z5L2	LB/B	-	G3SNJ0	656	H	R
Q7Z5L2	LB/B	-	G3SNJ0	113	S	P
Q7Z5L2	LB/B	-	G3SNJ0	238	K	N
Q7Z5L2	LB/B	-	G3SNJ0	261	S	G
Q7Z5L2	LB/B	-	G3SNJ0	535	D	A
Q7Z5L2	LB/B	-	G3SNJ0	546	P	S
Q9Y2K5	LB/B	-	H2NHT0	35	T	A
Q9H3Y0	LB/B	-	A0A1U7REV8	15	F	C
Q9H3Y0	LB/B	-	A0A1U7REV8	68	D	N
Q7L804	LB/B	-	A0A1A8IMN9	152	F	V
P61106	LB/B	-	A0A2U9CHT4	4	A	T
Q9H0T7	LB/B	-	A0A093QFN7	191	L	P
Q9H0T7	LB/B	-	A0A093QFN7	19	V	A
Q9H0T7	LB/B	-	A0A093QFN7	184	S	G
Q9NX57	LB/B	-	A0A2K5JPE0	134	N	S
Q9ULC3	LB/B	-	T1IX75	207	G	S
Q9ULC3	LB/B	-	T1IX75	40	K	R
Q9ULC3	LP/P	Carpenter syndrome 1 (CRPT1) [MIM:201000]	T1IX75	85	C	R
Q9ULC3	LB/B	-	T1IX75	101	S	A
Q9ULC3	LP/P	Carpenter syndrome 1 (CRPT1) [MIM:201000]	T1IX75	12	M	K
P51159	LP/P	Griscelli syndrome 2 (GS2) [MIM:607624]	A0A146ZKI9	73	W	G
P51159	LP/P	Griscelli syndrome 2 (GS2) [MIM:607624]	A0A146ZKI9	130	L	P
P51159	LP/P	Griscelli syndrome 2 (GS2) [MIM:607624]	A0A146ZKI9	152	A	P
P51159	LB/B	-	A0A146ZKI9	62	T	S
P51159	LB/B	-	A0A146ZKI9	84	L	F
P51159	LB/B	-	A0A146ZKI9	85	T	P
O00194	LB/B	-	A0A1V4JGS5	92	A	T
Q14088	LB/B	-	A0A2I4CSQ6	102	M	T
Q9H082	LP/P	Smith-McCort dysplasia 2 (SMC2) [MIM:615222]	A0A2U3Y343	46	K	Q
Q9H082	LP/P	Smith-McCort dysplasia 2 (SMC2) [MIM:615222]	A0A2U3Y343	148	N	K
Q9BZG1	LB/B	-	Q3TV85	197	V	L
Q96DA2	LP/P	Waisman syndrome (WSMN) [MIM:311510]	A0A2I0MAZ5	168	T	K
Q96DA2	LP/P	Waisman syndrome (WSMN) [MIM:311510]	A0A2I0MAZ5	192	G	R
O95716	LB/B	-	B3W649	64	V	I
Q9H2M9	LB/B	-	M7B276	863	T	A
Q9H2M9	LB/B	-	M7B276	1092	S	T
Q9H2M9	LP/P	Martsolf syndrome 1 (MARTS1) [MIM:212720]	M7B276	1052	G	C
Q9H2M9	LP/P	Martsolf syndrome 1 (MARTS1) [MIM:212720]	M7B276	426	R	C
Q8TBN0	LB/B	-	A0A146VCL7	49	Q	R
Q8TBN0	LB/B	-	A0A146VCL7	323	H	Y
Q15276	LB/B	-	A0A146Z322	640	E	G
P63000	LB/B	-	A0A091D2V2	26	N	D
P63000	LB/B	-	A0A091D2V2	28	F	L
P63000	LB/B	-	A0A091D2V2	59	A	T
P63000	LB/B	-	A0A091D2V2	63	D	G
P63000	LB/B	-	A0A091D2V2	93	V	I
P63000	LB/B	-	A0A091D2V2	93	V	G
P63000	LB/B	-	A0A091D2V2	108	T	I
P63000	LB/B	-	A0A091D2V2	130	K	R
P63000	LB/B	-	A0A091D2V2	133	K	E
P63000	LB/B	-	A0A091D2V2	180	P	S
P63000	LB/B	-	A0A091D2V2	182	V	E
P63000	LB/B	-	A0A091D2V2	135	T	I
P63000	LP/P	Intellectual developmental disorder, autosomal dominant 48 (MRD48) [MIM:617751]	A0A091D2V2	18	C	Y
P63000	LP/P	Intellectual developmental disorder, autosomal dominant 48 (MRD48) [MIM:617751]	A0A091D2V2	39	N	S
P63000	LP/P	Intellectual developmental disorder, autosomal dominant 48 (MRD48) [MIM:617751]	A0A091D2V2	51	V	M
P63000	LP/P	Intellectual developmental disorder, autosomal dominant 48 (MRD48) [MIM:617751]	A0A091D2V2	64	Y	D
P63000	LP/P	Intellectual developmental disorder, autosomal dominant 48 (MRD48) [MIM:617751]	A0A091D2V2	73	P	L
P63000	LP/P	Intellectual developmental disorder, autosomal dominant 48 (MRD48) [MIM:617751]	A0A091D2V2	157	C	Y
P15153	LP/P	Immunodeficiency 73A with defective neutrophil chemotaxis and leukocytosis (IMD73A) [MIM:608203]	A0A2I0USP9	57	D	N
P15153	LP/P	Immunodeficiency 73B with defective neutrophil chemotaxis and lymphopenia (IMD73B) [MIM:618986]	A0A2I0USP9	62	E	K
P60763	LP/P	Neurodevelopmental disorder with structural brain anomalies and dysmorphic facies (NEDBAF) [MIM:618577]	T0M310	29	P	L
P60763	LP/P	Neurodevelopmental disorder with structural brain anomalies and dysmorphic facies (NEDBAF) [MIM:618577]	T0M310	61	Q	L
P60763	LP/P	Neurodevelopmental disorder with structural brain anomalies and dysmorphic facies (NEDBAF) [MIM:618577]	T0M310	62	E	K
P60763	LP/P	Neurodevelopmental disorder with structural brain anomalies and dysmorphic facies (NEDBAF) [MIM:618577]	T0M310	59	A	G
O60671	LB/B	-	A0A2J7Q1I2	33	A	G
O60671	LB/B	-	A0A2J7Q1I2	104	T	S
O60671	LB/B	-	A0A2J7Q1I2	114	G	D
O60671	LB/B	-	A0A2J7Q1I2	281	E	G
O60671	LB/B	-	A0A2J7Q1I2	39	H	Q
Q9NS91	LB/B	-	G3SUP7	6	E	A
Q9NS91	LB/B	-	G3SUP7	302	R	Q
Q9NS91	LB/B	-	G3SUP7	307	I	V
O60216	LB/B	-	A0A091DXQ0	481	G	R
O60216	LP/P	Cornelia de Lange syndrome 4 with or without midline brain defects (CDLS4) [MIM:614701]	A0A091DXQ0	376	P	R
O60216	LP/P	Cornelia de Lange syndrome 4 with or without midline brain defects (CDLS4) [MIM:614701]	A0A091DXQ0	585	C	R
O60216	LP/P	Mungan syndrome (MGS) [MIM:611376]	A0A091DXQ0	622	A	T
P54727	LB/B	-	K9J5C8	249	A	V
Q92878	LB/B	-	A0A1S3IZI9	616	K	E
Q92878	LB/B	-	A0A1S3IZI9	697	V	A
Q92878	LB/B	-	A0A1S3IZI9	964	Y	H
Q92878	LB/B	-	A0A1S3IZI9	973	K	M
Q92878	LB/B	-	A0A1S3IZI9	1038	R	G
Q92878	LB/B	-	A0A1S3IZI9	191	T	I
Q92878	LB/B	-	A0A1S3IZI9	94	I	L
Q92878	LB/B	-	A0A1S3IZI9	224	R	H
Q92878	LB/B	-	A0A1S3IZI9	127	V	I
Q92878	LB/B	-	A0A1S3IZI9	193	R	W
Q92878	LB/B	-	A0A1S3IZI9	842	V	A
Q92878	LB/B	-	A0A1S3IZI9	315	V	L
Q92878	LB/B	-	A0A1S3IZI9	469	G	A
Q06609	LP/P	Breast cancer (BC) [MIM:114480]	L9JC43	150	R	Q
Q06609	LP/P	Fanconi anemia, complementation group R (FANCR) [MIM:617244]	L9JC43	293	A	T
Q06609	LP/P	Fanconi anemia, complementation group R (FANCR) [MIM:617244]	L9JC43	131	T	P
O15315	LB/B	-	O35719	9	V	M
O15315	LB/B	-	O35719	82	F	C
O15315	LB/B	-	O35719	172	L	W
O15315	LB/B	-	O35719	180	Y	C
O15315	LB/B	-	O35719	243	K	R
O15315	LB/B	-	O35719	250	S	A
O15315	LB/B	-	O35719	207	V	L
O15315	LB/B	-	O35719	365	P	R
O43502	LB/B	-	G1SH65	144	I	T
O43502	LB/B	-	G1SH65	249	R	C
O43502	LP/P	Breast-ovarian cancer, familial, 3 (BROVCA3) [MIM:613399]	G1SH65	287	T	A
O43502	LB/B	-	G1SH65	3	G	R
O43502	LP/P	Breast-ovarian cancer, familial, 3 (BROVCA3) [MIM:613399]	G1SH65	125	G	V
O43502	LB/B	-	G1SH65	126	A	T
O43502	LP/P	Breast-ovarian cancer, familial, 3 (BROVCA3) [MIM:613399]	G1SH65	138	L	F
O43502	LB/B	-	G1SH65	169	V	A
O43502	LB/B	-	G1SH65	264	G	S
O43502	LB/B	-	G1SH65	264	G	V
O43502	LB/B	-	G1SH65	366	R	Q
O43502	LP/P	Fanconi anemia complementation group O (FANCO) [MIM:613390]	G1SH65	258	R	H
O43502	LB/B	-	G1SH65	52	I	L
O43502	LB/B	-	G1SH65	114	G	V
O43502	LP/P	Breast-ovarian cancer, familial, 3 (BROVCA3) [MIM:613399]	G1SH65	162	G	E
O43502	LB/B	-	G1SH65	175	A	T
O43502	LP/P	Breast-ovarian cancer, familial, 3 (BROVCA3) [MIM:613399]	G1SH65	178	Q	P
O43502	LB/B	-	G1SH65	262	L	V
O75771	LB/B	-	G1PKN6	24	R	S
O75771	LB/B	-	G1PKN6	165	R	Q
O75771	LB/B	-	G1PKN6	225	A	T
O75771	LB/B	-	G1PKN6	232	R	Q
O75771	LB/B	-	G1PKN6	233	E	G
O75771	LB/B	-	G1PKN6	9	C	S
Q9Y620	LB/B	-	A0A0Q3PJ92	30	L	V
Q9Y620	LB/B	-	A0A0Q3PJ92	97	D	H
Q9Y620	LB/B	-	A0A0Q3PJ92	833	G	E
Q9Y620	LB/B	-	A0A0Q3PJ92	899	I	V
Q9Y4B4	LB/B	-	A0A2U9BYH6	1369	F	L
Q99638	LB/B	-	M7C007	3	C	F
Q99638	LB/B	-	M7C007	100	S	A
Q99638	LB/B	-	M7C007	239	H	R
Q99638	LB/B	-	M7C007	307	M	T
Q99638	LB/B	-	M7C007	71	L	Q
Q96JH8	LB/B	-	A0A2I2UKW4	886	S	G
Q96JH8	LB/B	-	A0A2I2UKW4	239	D	N
Q96JH8	LB/B	-	A0A2I2UKW4	412	H	D
Q96JH8	LB/B	-	A0A2I2UKW4	938	L	P
Q6NSI4	LB/B	-	S7MZE8	593	I	M
Q8TD07	LB/B	-	A0A2J8XAC9	82	Y	N
Q8TD07	LB/B	-	A0A2J8XAC9	12	R	H
Q8TD07	LB/B	-	A0A2J8XAC9	128	R	H
Q8TD07	LB/B	-	A0A2J8XAC9	237	V	L
Q8TD07	LB/B	-	A0A2J8XAC9	141	A	T
Q8TD07	LB/B	-	A0A2J8XAC9	142	T	I
Q8TD07	LB/B	-	A0A2J8XAC9	194	R	G
P04049	LB/B	-	A0A2U9C2H9	308	P	L
P04049	LP/P	Noonan syndrome 5 (NS5) [MIM:611553]	A0A2U9C2H9	256	R	S
P04049	LP/P	LEOPARD syndrome 2 (LPRD2) [MIM:611554]	A0A2U9C2H9	257	S	L
P04049	LP/P	Noonan syndrome 5 (NS5) [MIM:611553]	A0A2U9C2H9	257	S	L
P04049	LP/P	Noonan syndrome 5 (NS5) [MIM:611553]	A0A2U9C2H9	259	S	F
P04049	LP/P	Noonan syndrome 5 (NS5) [MIM:611553]	A0A2U9C2H9	260	T	R
P04049	LP/P	Noonan syndrome 5 (NS5) [MIM:611553]	A0A2U9C2H9	261	P	A
P04049	LP/P	Noonan syndrome 5 (NS5) [MIM:611553]	A0A2U9C2H9	261	P	L
P04049	LP/P	Noonan syndrome 5 (NS5) [MIM:611553]	A0A2U9C2H9	261	P	S
P04049	LP/P	Noonan syndrome 5 (NS5) [MIM:611553]	A0A2U9C2H9	263	V	A
P04049	LP/P	Noonan syndrome 5 (NS5) [MIM:611553]	A0A2U9C2H9	486	D	G
P04049	LP/P	Noonan syndrome 5 (NS5) [MIM:611553]	A0A2U9C2H9	486	D	N
P04049	LP/P	Noonan syndrome 5 (NS5) [MIM:611553]	A0A2U9C2H9	491	T	I
P04049	LP/P	Noonan syndrome 5 (NS5) [MIM:611553]	A0A2U9C2H9	491	T	R
P04049	LP/P	Noonan syndrome 5 (NS5) [MIM:611553]	A0A2U9C2H9	612	S	T
P04049	LP/P	LEOPARD syndrome 2 (LPRD2) [MIM:611554]	A0A2U9C2H9	613	L	V
P04049	LP/P	Noonan syndrome 5 (NS5) [MIM:611553]	A0A2U9C2H9	613	L	V
P04049	LP/P	Cardiomyopathy, dilated 1NN (CMD1NN) [MIM:615916]	A0A2U9C2H9	237	A	T
P04049	LP/P	Cardiomyopathy, dilated 1NN (CMD1NN) [MIM:615916]	A0A2U9C2H9	310	T	A
P04049	LP/P	Cardiomyopathy, dilated 1NN (CMD1NN) [MIM:615916]	A0A2U9C2H9	332	P	A
P04049	LP/P	Cardiomyopathy, dilated 1NN (CMD1NN) [MIM:615916]	A0A2U9C2H9	603	L	P
P04049	LP/P	Cardiomyopathy, dilated 1NN (CMD1NN) [MIM:615916]	A0A2U9C2H9	626	H	R
P04049	LP/P	Cardiomyopathy, dilated 1NN (CMD1NN) [MIM:615916]	A0A2U9C2H9	641	T	M
P15918	LB/B	-	Q5MPF9	156	A	V
P15918	LB/B	-	Q5MPF9	244	R	G
P15918	LB/B	-	Q5MPF9	249	H	R
P15918	LP/P	Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-positive (T(-)B(-)NK(+) SCID) [MIM:601457]	Q5MPF9	624	R	H
P15918	LP/P	Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-positive (T(-)B(-)NK(+) SCID) [MIM:601457]	Q5MPF9	722	E	K
P15918	LP/P	Omenn syndrome (OS) [MIM:603554]	Q5MPF9	396	R	C
P15918	LP/P	Omenn syndrome (OS) [MIM:603554]	Q5MPF9	396	R	H
P15918	LP/P	Omenn syndrome (OS) [MIM:603554]	Q5MPF9	429	D	G
P15918	LP/P	Omenn syndrome (OS) [MIM:603554]	Q5MPF9	561	R	H
P15918	LP/P	Omenn syndrome (OS) [MIM:603554]	Q5MPF9	561	R	C
P15918	LP/P	Combined cellular and humoral immune defects with granulomas (CHIDG) [MIM:233650]	Q5MPF9	737	R	H
P15918	LP/P	Omenn syndrome (OS) [MIM:603554]	Q5MPF9	737	R	H
P15918	LB/B	-	Q5MPF9	820	K	R
P15918	LP/P	Omenn syndrome (OS) [MIM:603554]	Q5MPF9	885	L	R
P15918	LP/P	Omenn syndrome (OS) [MIM:603554]	Q5MPF9	912	Y	C
P15918	LB/B	-	Q5MPF9	302	D	E
P15918	LB/B	-	Q5MPF9	880	E	K
P15918	LP/P	Omenn syndrome (OS) [MIM:603554]	Q5MPF9	328	C	Y
P15918	LP/P	Omenn syndrome (OS) [MIM:603554]	Q5MPF9	396	R	L
P15918	LP/P	Omenn syndrome (OS) [MIM:603554]	Q5MPF9	401	S	P
P15918	LP/P	Omenn syndrome (OS) [MIM:603554]	Q5MPF9	410	R	Q
P15918	LP/P	Omenn syndrome (OS) [MIM:603554]	Q5MPF9	433	V	M
P15918	LP/P	Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-positive (T(-)B(-)NK(+) SCID) [MIM:601457]	Q5MPF9	433	V	M
P15918	LP/P	Omenn syndrome (OS) [MIM:603554]	Q5MPF9	435	M	V
P15918	LP/P	Omenn syndrome (OS) [MIM:603554]	Q5MPF9	444	A	V
P15918	LP/P	Omenn syndrome (OS) [MIM:603554]	Q5MPF9	474	R	H
P15918	LP/P	Combined cellular and humoral immune defects with granulomas (CHIDG) [MIM:233650]	Q5MPF9	507	R	W
P15918	LP/P	Omenn syndrome (OS) [MIM:603554]	Q5MPF9	507	R	W
P15918	LP/P	Omenn syndrome (OS) [MIM:603554]	Q5MPF9	522	W	C
P15918	LP/P	Omenn syndrome (OS) [MIM:603554]	Q5MPF9	559	R	S
P15918	LP/P	Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-positive (T(-)B(-)NK(+) SCID) [MIM:601457]	Q5MPF9	559	R	S
P15918	LP/P	Omenn syndrome (OS) [MIM:603554]	Q5MPF9	624	R	C
P15918	LP/P	Omenn syndrome (OS) [MIM:603554]	Q5MPF9	669	E	G
P15918	LP/P	Omenn syndrome (OS) [MIM:603554]	Q5MPF9	753	H	L
P15918	LP/P	Alpha/beta T-cell lymphopenia, with gamma/delta T-cell expansion, severe cytomegalovirus infection and autoimmunity (T-CMVA) [MIM:609889]	Q5MPF9	841	R	W
P15918	LP/P	-	Q5MPF9	855	N	I
P15918	LP/P	Omenn syndrome (OS) [MIM:603554]	Q5MPF9	975	R	Q
P15918	LP/P	Alpha/beta T-cell lymphopenia, with gamma/delta T-cell expansion, severe cytomegalovirus infection and autoimmunity (T-CMVA) [MIM:609889]	Q5MPF9	981	Q	P
P15918	LB/B	-	Q5MPF9	169	S	L
P15918	LB/B	-	Q5MPF9	247	R	H
P15918	LB/B	-	Q5MPF9	449	R	K
P15918	LB/B	-	Q5MPF9	525	P	S
P15918	LB/B	-	Q5MPF9	887	D	N
P15918	LP/P	Combined cellular and humoral immune defects with granulomas (CHIDG) [MIM:233650]	Q5MPF9	314	R	W
P15918	LP/P	Combined cellular and humoral immune defects with granulomas (CHIDG) [MIM:233650]	Q5MPF9	778	R	Q
P15918	LP/P	Combined cellular and humoral immune defects with granulomas (CHIDG) [MIM:233650]	Q5MPF9	975	R	W
P15918	LP/P	Omenn syndrome (OS) [MIM:603554]	Q5MPF9	454	L	Q
P15918	LP/P	-	Q5MPF9	474	R	C
P15918	LP/P	Omenn syndrome (OS) [MIM:603554]	Q5MPF9	699	R	W
P55895	LP/P	Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-positive (T(-)B(-)NK(+) SCID) [MIM:601457]	Q90XJ3	229	R	Q
P55895	LP/P	Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-positive (T(-)B(-)NK(+) SCID) [MIM:601457]	Q90XJ3	478	C	Y
P55895	LP/P	Omenn syndrome (OS) [MIM:603554]	Q90XJ3	41	C	W
P55895	LP/P	Omenn syndrome (OS) [MIM:603554]	Q90XJ3	285	M	R
P55895	LP/P	Combined cellular and humoral immune defects with granulomas (CHIDG) [MIM:233650]	Q90XJ3	77	T	N
P55895	LB/B	-	Q90XJ3	293	E	G
P55895	LP/P	Combined cellular and humoral immune defects with granulomas (CHIDG) [MIM:233650]	Q90XJ3	451	G	A
Q7Z5J4	LB/B	-	A0A091IYY9	165	P	T
Q7Z5J4	LB/B	-	A0A091IYY9	90	G	A
Q7Z5J4	LB/B	-	A0A091IYY9	939	Q	P
P11233	LP/P	Hiatt-Neu-Cooper neurodevelopmental syndrome (HINCONS) [MIM:619311]	A0A0N8K0I0	25	V	L
P11233	LP/P	Hiatt-Neu-Cooper neurodevelopmental syndrome (HINCONS) [MIM:619311]	A0A0N8K0I0	25	V	M
P11233	LP/P	Hiatt-Neu-Cooper neurodevelopmental syndrome (HINCONS) [MIM:619311]	A0A0N8K0I0	128	K	R
P11233	LP/P	Hiatt-Neu-Cooper neurodevelopmental syndrome (HINCONS) [MIM:619311]	A0A0N8K0I0	130	D	G
P11233	LP/P	Hiatt-Neu-Cooper neurodevelopmental syndrome (HINCONS) [MIM:619311]	A0A0N8K0I0	157	S	A
Q15311	LB/B	-	F1MPV3	617	A	V
Q6GYQ0	LB/B	-	R7U439	931	T	A
Q6GYQ0	LP/P	Neurodevelopmental disorder with hypotonia, neonatal respiratory insufficiency, and thermodysregulation (NEDHRIT) [MIM:618797]	R7U439	1076	N	S
Q2PPJ7	LB/B	-	A0A226MT98	492	S	N
Q5JS13	LB/B	-	V9KE79	290	S	N
Q86X27	LB/B	-	V9KE79	225	N	S
O60896	LB/B	-	A0A2K5ZRE9	56	W	R
O60896	LB/B	-	A0A2K5ZRE9	26	G	D
O60896	LB/B	-	A0A2K5ZRE9	33	M	L
P49792	LB/B	-	F6TKC3	1892	P	A
P49792	LB/B	-	F6TKC3	784	R	K
P49792	LB/B	-	F6TKC3	548	V	L
P49792	LB/B	-	F6TKC3	580	E	K
P49792	LB/B	-	F6TKC3	581	C	Y
P49792	LB/B	-	F6TKC3	1870	P	L
P49792	LB/B	-	F6TKC3	725	S	G
P49792	LB/B	-	F6TKC3	1892	P	R
P49792	LP/P	Encephalopathy, acute, infection-induced, 3 (IIAE3) [MIM:608033]	F6TKC3	585	T	M
P49792	LP/P	Encephalopathy, acute, infection-induced, 3 (IIAE3) [MIM:608033]	F6TKC3	653	T	I
P49792	LP/P	Encephalopathy, acute, infection-induced, 3 (IIAE3) [MIM:608033]	F6TKC3	656	I	V
Q86VV4	LB/B	-	G1M0U1	70	T	R
Q86VV4	LB/B	-	G1M0U1	111	A	D
Q86VV4	LB/B	-	G1M0U1	271	A	V
P46060	LB/B	-	T1IIM9	133	E	Q
P47736	LB/B	-	L9L005	107	A	T
Q684P5	LB/B	-	A0A2Y9SXZ1	202	L	M
P52306	LB/B	-	A0A1W4YYI5	314	K	E
P52306	LB/B	-	A0A1W4YYI5	56	S	T
O95398	LB/B	-	G5BWD0	16	A	P
O95398	LB/B	-	G5BWD0	193	R	G
O95398	LB/B	-	G5BWD0	374	G	S
O95398	LB/B	-	G5BWD0	517	C	Y
P54136	LB/B	-	V3ZJP6	3	V	I
P54136	LB/B	-	V3ZJP6	397	F	Y
P54136	LB/B	-	V3ZJP6	135	R	G
P54136	LP/P	Leukodystrophy, hypomyelinating, 9 (HLD9) [MIM:616140]	V3ZJP6	2	D	G
P54136	LP/P	Leukodystrophy, hypomyelinating, 9 (HLD9) [MIM:616140]	V3ZJP6	512	R	Q
P20936	LP/P	Capillary malformation-arteriovenous malformation 1 (CMAVM1) [MIM:608354]	V9KDN9	540	C	Y
P20936	LP/P	Capillary malformation-arteriovenous malformation 1 (CMAVM1) [MIM:608354]	V9KDN9	530	V	D
P20936	LP/P	Capillary malformation-arteriovenous malformation 1 (CMAVM1) [MIM:608354]	V9KDN9	626	A	E
O95267	LP/P	Immunodeficiency 64 (IMD64) [MIM:618534]	A0A2Y9HP29	214	T	I
Q7LDG7	LB/B	-	F6Z7B1	493	G	A
Q7LDG7	LP/P	Bleeding disorder, platelet-type, 18 (BDPLT18) [MIM:615888]	F6Z7B1	248	G	W
Q7LDG7	LP/P	Bleeding disorder, platelet-type, 18 (BDPLT18) [MIM:615888]	F6Z7B1	296	C	Y
Q7LDG7	LP/P	Bleeding disorder, platelet-type, 18 (BDPLT18) [MIM:615888]	F6Z7B1	305	G	D
Q7LDG7	LP/P	Bleeding disorder, platelet-type, 18 (BDPLT18) [MIM:615888]	F6Z7B1	381	S	F
Q8IV61	LB/B	-	A0A087XGE7	393	T	A
Q8TDF6	LB/B	-	A0A146ZYE9	18	I	T
Q8TDF6	LB/B	-	A0A146ZYE9	120	Q	L
Q8TDF6	LB/B	-	A0A146ZYE9	145	V	A
Q8TDF6	LB/B	-	A0A146ZYE9	261	R	C
Q8TDF6	LB/B	-	A0A146ZYE9	335	R	G
Q8TDF6	LB/B	-	A0A146ZYE9	620	E	K
Q9NS23	LB/B	-	H2S3W4	21	K	Q
Q9NS23	LB/B	-	H2S3W4	53	R	C
Q9NS23	LB/B	-	H2S3W4	133	D	E
Q9NS23	LB/B	-	H2S3W4	135	S	F
Q9NS23	LB/B	-	H2S3W4	137	A	S
Q9NS23	LB/B	-	H2S3W4	329	Y	C
Q9NS23	LB/B	-	H2S3W4	319	H	R
Q02833	LB/B	-	H2NCA3	89	P	A
Q02833	LB/B	-	H2NCA3	156	R	Q
O75901	LB/B	-	A0A0P7V6D6	285	A	T
Q9Y2V3	LB/B	-	O42358	44	D	E
Q9Y2V3	LP/P	Microphthalmia, syndromic 16 (MCOPS16) [MIM:611038]	O42358	192	R	Q
Q96IS3	LP/P	Macular degeneration, age-related, 6 (ARMD6) [MIM:613757]	A0A2U3Z4Y0	87	R	Q
Q96IS3	LP/P	Retinitis pigmentosa 95 (RP95) [MIM:620102]	A0A2U3Z4Y0	52	P	R
Q8TDY2	LB/B	-	A0A091CU67	234	M	T
Q8TDY2	LB/B	-	A0A091CU67	708	P	L
Q8TDY2	LB/B	-	A0A091CU67	1216	R	K
Q8TDY2	LB/B	-	A0A091CU67	1314	N	K
Q8TDY2	LB/B	-	A0A091CU67	1424	S	F
Q9NYW8	LB/B	-	A0A287ATS5	229	G	E
Q7Z6E9	LB/B	-	A0A1L8EYE3	555	V	A
Q7Z6E9	LB/B	-	A0A1L8EYE3	43	D	H
Q7Z6E9	LB/B	-	A0A1L8EYE3	1208	K	I
Q99708	LB/B	-	L5M007	387	H	Y
Q99708	LB/B	-	L5M007	357	K	N
Q99708	LP/P	Seckel syndrome 2 (SCKL2) [MIM:606744]	L5M007	100	R	W
Q9BYM8	LP/P	Polyglucosan body myopathy 1 with or without immunodeficiency (PGBM1) [MIM:615895]	G3VSL8	18	A	P
Q9BYM8	LP/P	Polyglucosan body myopathy 1 with or without immunodeficiency (PGBM1) [MIM:615895]	G3VSL8	387	N	S
P28749	LB/B	-	A0A1D5PSH1	1035	I	M
Q08999	LB/B	-	A0A1D5PSH1	210	Y	C
Q08999	LB/B	-	A0A1D5PSH1	99	V	F
P57052	LB/B	-	W5Q4M0	116	L	V
Q9NTZ6	LB/B	-	V8NHS8	572	N	S
Q9NTZ6	LB/B	-	V8NHS8	921	P	L
Q8IXT5	LB/B	-	F1RY40	250	S	F
Q8IXT5	LB/B	-	F1RY40	605	R	C
Q8IXT5	LB/B	-	F1RY40	864	N	H
Q5T8P6	LB/B	-	T1JCE4	718	V	D
Q9H0Z9	LB/B	-	A0A1S3Q1V7	178	A	V
Q9H0Z9	LB/B	-	A0A1S3Q1V7	200	A	D
Q9H0Z9	LB/B	-	A0A1S3Q1V7	212	P	H
Q9H0Z9	LB/B	-	A0A1S3Q1V7	226	V	L
Q14498	LB/B	-	A0A131XHC5	2	A	V
Q6ZP01	LB/B	-	A0A2K6FU01	52	D	H
Q6ZP01	LB/B	-	A0A2K6FU01	892	N	H
Q6ZP01	LB/B	-	A0A2K6FU01	51	D	H
A0AV96	LB/B	-	L5M4Q5	565	M	V
A0AV96	LB/B	-	L5M4Q5	538	G	R
Q9BQ04	LB/B	-	A0A2U9BA15	93	E	V
P52756	LB/B	-	L5KUL9	163	K	N
Q9Y388	LB/B	-	J9P250	287	R	H
O75526	LB/B	-	G1Q6Z4	15	L	F
O75526	LB/B	-	G1Q6Z4	134	T	A
O75526	LB/B	-	G1Q6Z4	308	Y	C
O75526	LB/B	-	G1Q6Z4	66	A	V
P02753	LP/P	Retinal dystrophy, iris coloboma, and comedogenic acne syndrome (RDCCAS) [MIM:615147]	K7E0U3	59	I	N
P02753	LP/P	Retinal dystrophy, iris coloboma, and comedogenic acne syndrome (RDCCAS) [MIM:615147]	K7E0U3	93	G	D
P02753	LP/P	Microphthalmia, isolated, with coloboma, 10 (MCOPCB10) [MIM:616428]	K7E0U3	73	A	T
P02753	LP/P	Microphthalmia, isolated, with coloboma, 10 (MCOPCB10) [MIM:616428]	K7E0U3	75	A	T
Q06330	LB/B	-	A0A182H557	291	K	E
Q06330	LB/B	-	A0A182H557	334	D	H
Q06330	LB/B	-	A0A182H557	419	R	Q
Q06330	LB/B	-	A0A182H557	425	P	S
Q06330	LB/B	-	A0A182H557	456	A	V
Q06330	LB/B	-	A0A182H557	408	I	V
Q06330	LP/P	Adams-Oliver syndrome 3 (AOS3) [MIM:614814]	A0A182H557	63	E	G
Q06330	LP/P	Adams-Oliver syndrome 3 (AOS3) [MIM:614814]	A0A182H557	169	K	E
Q9UKA8	LB/B	-	E2RFJ5	236	T	N
Q8IZ40	LB/B	-	A0A087X6L8	514	T	A
Q9P2K3	LB/B	-	A0A2K6A0V4	42	K	R
Q6JBY9	LB/B	-	A0A2K6UIG6	384	Q	R
Q7Z3Z2	LB/B	-	G3P658	47	R	C
Q7Z3Z2	LB/B	-	G3P658	6	W	R
Q7Z3Z2	LB/B	-	G3P658	23	E	D
Q7Z3Z2	LB/B	-	G3P658	35	G	R
Q7Z3Z2	LB/B	-	G3P658	57	G	V
Q7Z3Z2	LB/B	-	G3P658	68	R	W
Q7Z3Z2	LB/B	-	G3P658	130	K	M
Q7Z3Z2	LB/B	-	G3P658	167	R	K
Q7Z3Z2	LB/B	-	G3P658	195	D	V
Q96NR8	LP/P	Leber congenital amaurosis 13 (LCA13) [MIM:612712]	V9KU50	49	T	M
Q96NR8	LP/P	Leber congenital amaurosis 13 (LCA13) [MIM:612712]	V9KU50	51	I	N
Q96NR8	LP/P	Leber congenital amaurosis 13 (LCA13) [MIM:612712]	V9KU50	99	L	I
Q96NR8	LP/P	Leber congenital amaurosis 13 (LCA13) [MIM:612712]	V9KU50	151	H	D
Q96NR8	LP/P	Leber congenital amaurosis 13 (LCA13) [MIM:612712]	V9KU50	151	H	N
Q96NR8	LP/P	Leber congenital amaurosis 13 (LCA13) [MIM:612712]	V9KU50	175	S	P
Q96NR8	LP/P	Leber congenital amaurosis 13 (LCA13) [MIM:612712]	V9KU50	226	Y	C
Q96NR8	LP/P	Leber congenital amaurosis 13 (LCA13) [MIM:612712]	V9KU50	230	P	A
Q96NR8	LB/B	-	V9KU50	161	R	Q
Q96NR8	LB/B	-	V9KU50	47	A	T
Q96NR8	LB/B	-	V9KU50	55	T	M
Q96NR8	LB/B	-	V9KU50	65	R	Q
Q96NR8	LP/P	Retinitis pigmentosa 53 (RP53) [MIM:612712]	V9KU50	76	G	R
Q96NR8	LB/B	-	V9KU50	101	D	N
Q96NR8	LP/P	Retinitis pigmentosa 53 (RP53) [MIM:612712]	V9KU50	126	A	V
Q96NR8	LB/B	-	V9KU50	145	G	E
Q96NR8	LB/B	-	V9KU50	155	T	I
Q96NR8	LB/B	-	V9KU50	239	R	W
Q96NR8	LB/B	-	V9KU50	285	C	Y
Q96NR8	LB/B	-	V9KU50	79	A	V
Q92781	LB/B	-	F7FBE8	33	I	V
Q92781	LP/P	Fundus albipunctatus (FALBI) [MIM:136880]	F7FBE8	73	S	F
Q92781	LP/P	Fundus albipunctatus (FALBI) [MIM:136880]	F7FBE8	238	G	W
Q92781	LP/P	Fundus albipunctatus (FALBI) [MIM:136880]	F7FBE8	35	G	S
Q92781	LP/P	Fundus albipunctatus (FALBI) [MIM:136880]	F7FBE8	107	G	R
Q92781	LP/P	Fundus albipunctatus (FALBI) [MIM:136880]	F7FBE8	132	V	M
Q92781	LP/P	Fundus albipunctatus (FALBI) [MIM:136880]	F7FBE8	164	V	F
Q92781	LP/P	Fundus albipunctatus (FALBI) [MIM:136880]	F7FBE8	177	V	G
Q92781	LP/P	Fundus albipunctatus (FALBI) [MIM:136880]	F7FBE8	267	C	W
Q92781	LP/P	Fundus albipunctatus (FALBI) [MIM:136880]	F7FBE8	280	R	H
Q92781	LP/P	Fundus albipunctatus (FALBI) [MIM:136880]	F7FBE8	281	Y	H
Q92781	LP/P	Fundus albipunctatus (FALBI) [MIM:136880]	F7FBE8	294	A	P
Q92781	LB/B	-	F7FBE8	21	R	Q
Q92781	LB/B	-	F7FBE8	70	R	G
Q92781	LP/P	Fundus albipunctatus (FALBI) [MIM:136880]	F7FBE8	105	L	I
Q92781	LP/P	Fundus albipunctatus (FALBI) [MIM:136880]	F7FBE8	128	D	N
Q92781	LP/P	Fundus albipunctatus (FALBI) [MIM:136880]	F7FBE8	157	R	W
Q92781	LP/P	Fundus albipunctatus (FALBI) [MIM:136880]	F7FBE8	264	V	G
Q92781	LP/P	Fundus albipunctatus (FALBI) [MIM:136880]	F7FBE8	175	Y	F
Q92781	LP/P	Fundus albipunctatus (FALBI) [MIM:136880]	F7FBE8	253	M	R
Q92781	LP/P	Fundus albipunctatus (FALBI) [MIM:136880]	F7FBE8	179	K	R
Q9NYR8	LB/B	-	A0A0N8JVZ5	136	H	Q
Q9NYR8	LB/B	-	A0A0N8JVZ5	202	M	T
P35241	LB/B	-	A0A226E532	328	K	E
P35241	LB/B	-	A0A226E532	490	D	N
P35241	LP/P	Deafness, autosomal recessive, 24 (DFNB24) [MIM:611022]	A0A226E532	578	D	N
O95072	LB/B	-	A0A2K6FHF9	31	R	C
O95072	LB/B	-	A0A2K6FHF9	294	P	L
O95072	LB/B	-	A0A2K6FHF9	411	V	F
O95980	LB/B	-	W5MXF5	275	V	I
O94761	LB/B	-	A0A091DK22	267	E	D
O94761	LB/B	-	A0A091DK22	355	R	Q
O94761	LB/B	-	A0A091DK22	441	P	S
O94761	LB/B	-	A0A091DK22	1005	R	Q
O94761	LB/B	-	A0A091DK22	54	Q	R
O94761	LB/B	-	A0A091DK22	71	E	G
O94761	LB/B	-	A0A091DK22	92	S	P
O94761	LB/B	-	A0A091DK22	189	G	S
O94761	LB/B	-	A0A091DK22	273	A	T
O94761	LB/B	-	A0A091DK22	301	E	K
O94761	LB/B	-	A0A091DK22	522	R	C
O94761	LB/B	-	A0A091DK22	522	R	H
O94761	LB/B	-	A0A091DK22	591	P	L
O94761	LB/B	-	A0A091DK22	793	P	S
O94761	LB/B	-	A0A091DK22	799	V	M
O94761	LB/B	-	A0A091DK22	964	P	T
O94761	LB/B	-	A0A091DK22	976	E	K
O94761	LB/B	-	A0A091DK22	1004	R	W
O94761	LB/B	-	A0A091DK22	1021	R	Q
O94761	LB/B	-	A0A091DK22	1045	A	T
O94761	LB/B	-	A0A091DK22	1105	G	D
O94761	LB/B	-	A0A091DK22	1105	G	S
O94761	LB/B	-	A0A091DK22	1106	R	H
O94761	LB/B	-	A0A091DK22	1113	G	R
O94761	LB/B	-	A0A091DK22	1148	S	F
O94761	LB/B	-	A0A091DK22	523	S	T
O94761	LP/P	Baller-Gerold syndrome (BGS) [MIM:218600]	A0A091DK22	1021	R	W
O94761	LB/B	-	A0A091DK22	793	P	L
O94761	LB/B	-	A0A091DK22	103	P	L
O94761	LB/B	-	A0A091DK22	1170	P	L
Q9H902	LP/P	Spastic paraplegia 31, autosomal dominant (SPG31) [MIM:610250]	A0A091DQU5	20	A	E
Q9H902	LP/P	Spastic paraplegia 31, autosomal dominant (SPG31) [MIM:610250]	A0A091DQU5	19	P	L
Q9H902	LP/P	Spastic paraplegia 31, autosomal dominant (SPG31) [MIM:610250]	A0A091DQU5	23	S	F
Q9H902	LP/P	Distal spinal muscular atrophy, autosomal recessive, 6 (DSMA6) [MIM:620011]	A0A091DQU5	42	W	R
Q9H902	LP/P	Spastic paraplegia 31, autosomal dominant (SPG31) [MIM:610250]	A0A091DQU5	42	W	R
Q9H902	LP/P	Spastic paraplegia 31, autosomal dominant (SPG31) [MIM:610250]	A0A091DQU5	19	P	R
Q9H902	LP/P	Spastic paraplegia 31, autosomal dominant (SPG31) [MIM:610250]	A0A091DQU5	107	L	P
Q9BRK0	LP/P	Spastic paraplegia 72 (SPG72) [MIM:615625]	A0A2I4B8I2	36	V	E
Q9BRK0	LP/P	Spastic paraplegia 72 (SPG72) [MIM:615625]	A0A2I4B8I2	72	F	Y
Q6NUK4	LB/B	-	Q5HZP8	171	Q	R
Q96HR9	LB/B	-	G3NG92	150	A	D
Q96HR9	LP/P	Retinitis pigmentosa 77 (RP77) [MIM:617304]	G3NG92	128	P	L
Q96HR9	LP/P	Retinitis pigmentosa 77 (RP77) [MIM:617304]	G3NG92	135	L	P
Q96HR9	LP/P	Retinitis pigmentosa 77 (RP77) [MIM:617304]	G3NG92	75	E	K
P48304	LB/B	-	A0A096MTL0	109	R	H
Q9BYZ8	LB/B	-	A0A2Y9H2S1	135	N	H
Q01201	LB/B	-	G3T150	396	T	M
Q8NC24	LB/B	-	A0A1S3W5U0	128	S	P
Q8NC24	LB/B	-	A0A1S3W5U0	133	L	I
Q8NC24	LB/B	-	A0A1S3W5U0	196	G	R
Q8NC24	LB/B	-	A0A1S3W5U0	283	Q	E
P78509	LB/B	-	S7MMY8	978	T	A
P78509	LB/B	-	S7MMY8	997	L	V
P78509	LB/B	-	S7MMY8	1703	P	R
P78509	LP/P	Epilepsy, familial temporal lobe, 7 (ETL7) [MIM:616436]	S7MMY8	672	P	L
P78509	LP/P	Epilepsy, familial temporal lobe, 7 (ETL7) [MIM:616436]	S7MMY8	723	Y	C
P78509	LP/P	Epilepsy, familial temporal lobe, 7 (ETL7) [MIM:616436]	S7MMY8	763	D	G
P78509	LP/P	Epilepsy, familial temporal lobe, 7 (ETL7) [MIM:616436]	S7MMY8	798	H	N
P78509	LP/P	Epilepsy, familial temporal lobe, 7 (ETL7) [MIM:616436]	S7MMY8	844	P	L
P78509	LP/P	Epilepsy, familial temporal lobe, 7 (ETL7) [MIM:616436]	S7MMY8	2783	G	C
P78509	LP/P	Epilepsy, familial temporal lobe, 7 (ETL7) [MIM:616436]	S7MMY8	3176	E	K
Q969Z4	LB/B	-	W5MGR4	332	A	V
O75628	LB/B	-	A0A2I3NAC9	28	H	R
O75628	LB/B	-	A0A2I3NAC9	59	P	A
O75628	LB/B	-	A0A2I3NAC9	45	R	W
Q8IYK8	LB/B	-	G1SF25	96	G	A
P51606	LB/B	-	B1MTW2	159	Q	R
P51606	LB/B	-	B1MTW2	274	D	G
Q6BDI9	LB/B	-	H2ZS41	101	N	D
Q6BDI9	LB/B	-	H2ZS41	206	E	D
Q9BWE0	LB/B	-	A0A2K6LK78	14	L	P
Q9BWE0	LB/B	-	A0A2K6LK78	88	P	S
Q9BWE0	LB/B	-	A0A2K6LK78	92	R	H
Q9BWE0	LB/B	-	A0A2K6LK78	97	A	V
Q9BWE0	LB/B	-	A0A2K6LK78	49	G	R
Q96D71	LP/P	Neurodegeneration with brain iron accumulation 7 (NBIA7) [MIM:617916]	A0A096M860	78	V	L
Q96D71	LP/P	Neurodegeneration with brain iron accumulation 7 (NBIA7) [MIM:617916]	A0A096M860	113	A	E
Q8NFH8	LB/B	-	A0A1W4ZXA9	321	S	C
Q9H628	LB/B	-	S4RS36	163	M	V
Q9HCM1	LB/B	-	D2H4K2	59	I	V
Q9HCM1	LB/B	-	D2H4K2	106	H	Q
Q9HCM1	LB/B	-	D2H4K2	202	I	V
Q9HCM1	LB/B	-	D2H4K2	250	L	P
Q9HCM1	LB/B	-	D2H4K2	309	R	Q
Q9HCM1	LB/B	-	D2H4K2	346	S	N
Q9HCM1	LB/B	-	D2H4K2	352	S	G
Q9HCM1	LB/B	-	D2H4K2	433	S	T
Q9HCM1	LB/B	-	D2H4K2	518	S	P
Q9HCM1	LB/B	-	D2H4K2	954	F	S
Q9HCM1	LB/B	-	D2H4K2	1010	T	K
Q9HCM1	LB/B	-	D2H4K2	1208	S	C
Q9HCM1	LB/B	-	D2H4K2	1226	V	I
Q9HCM1	LB/B	-	D2H4K2	1338	T	A
Q9HCM1	LB/B	-	D2H4K2	147	P	S
Q9HCM1	LB/B	-	D2H4K2	1479	M	T
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	32	S	L
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	64	P	L
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	142	C	S
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	231	R	H
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	251	E	K
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	287	R	Q
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	330	R	Q
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	393	F	L
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	399	P	L
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	475	R	Q
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	609	C	Y
P07949	LP/P	Medullary thyroid carcinoma (MTC) [MIM:155240]	H2V9H8	609	C	Y
P07949	LP/P	Multiple neoplasia 2A (MEN2A) [MIM:171400]	H2V9H8	609	C	Y
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	609	C	W
P07949	LP/P	Medullary thyroid carcinoma (MTC) [MIM:155240]	H2V9H8	611	C	W
P07949	LP/P	Multiple neoplasia 2A (MEN2A) [MIM:171400]	H2V9H8	611	C	W
P07949	LP/P	Multiple neoplasia 2A (MEN2A) [MIM:171400]	H2V9H8	611	C	Y
P07949	LP/P	Multiple neoplasia 2A (MEN2A) [MIM:171400]	H2V9H8	618	C	G
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	618	C	R
P07949	LP/P	Medullary thyroid carcinoma (MTC) [MIM:155240]	H2V9H8	618	C	R
P07949	LP/P	Multiple neoplasia 2A (MEN2A) [MIM:171400]	H2V9H8	618	C	R
P07949	LP/P	Medullary thyroid carcinoma (MTC) [MIM:155240]	H2V9H8	618	C	F
P07949	LP/P	Multiple neoplasia 2A (MEN2A) [MIM:171400]	H2V9H8	618	C	F
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	618	C	S
P07949	LP/P	Medullary thyroid carcinoma (MTC) [MIM:155240]	H2V9H8	618	C	S
P07949	LP/P	Multiple neoplasia 2A (MEN2A) [MIM:171400]	H2V9H8	618	C	S
P07949	LP/P	Medullary thyroid carcinoma (MTC) [MIM:155240]	H2V9H8	618	C	Y
P07949	LP/P	Multiple neoplasia 2A (MEN2A) [MIM:171400]	H2V9H8	618	C	Y
P07949	LP/P	Medullary thyroid carcinoma (MTC) [MIM:155240]	H2V9H8	620	C	G
P07949	LP/P	Multiple neoplasia 2A (MEN2A) [MIM:171400]	H2V9H8	620	C	G
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	620	C	R
P07949	LP/P	Medullary thyroid carcinoma (MTC) [MIM:155240]	H2V9H8	620	C	R
P07949	LP/P	Multiple neoplasia 2A (MEN2A) [MIM:171400]	H2V9H8	620	C	R
P07949	LP/P	Medullary thyroid carcinoma (MTC) [MIM:155240]	H2V9H8	620	C	S
P07949	LP/P	Multiple neoplasia 2A (MEN2A) [MIM:171400]	H2V9H8	620	C	S
P07949	LP/P	Medullary thyroid carcinoma (MTC) [MIM:155240]	H2V9H8	620	C	F
P07949	LP/P	Multiple neoplasia 2A (MEN2A) [MIM:171400]	H2V9H8	620	C	F
P07949	LP/P	Multiple neoplasia 2A (MEN2A) [MIM:171400]	H2V9H8	620	C	Y
P07949	LP/P	Medullary thyroid carcinoma (MTC) [MIM:155240]	H2V9H8	630	C	F
P07949	LP/P	Multiple neoplasia 2A (MEN2A) [MIM:171400]	H2V9H8	630	C	F
P07949	LP/P	Multiple neoplasia 2A (MEN2A) [MIM:171400]	H2V9H8	634	C	G
P07949	LP/P	Pheochromocytoma (PCC) [MIM:171300]	H2V9H8	634	C	G
P07949	LP/P	Multiple neoplasia 2A (MEN2A) [MIM:171400]	H2V9H8	634	C	F
P07949	LP/P	Pheochromocytoma (PCC) [MIM:171300]	H2V9H8	634	C	F
P07949	LP/P	Medullary thyroid carcinoma (MTC) [MIM:155240]	H2V9H8	634	C	Y
P07949	LP/P	Multiple neoplasia 2A (MEN2A) [MIM:171400]	H2V9H8	634	C	Y
P07949	LP/P	Pheochromocytoma (PCC) [MIM:171300]	H2V9H8	634	C	Y
P07949	LP/P	Medullary thyroid carcinoma (MTC) [MIM:155240]	H2V9H8	634	C	R
P07949	LP/P	Multiple neoplasia 2A (MEN2A) [MIM:171400]	H2V9H8	634	C	R
P07949	LP/P	Pheochromocytoma (PCC) [MIM:171300]	H2V9H8	634	C	R
P07949	LP/P	Medullary thyroid carcinoma (MTC) [MIM:155240]	H2V9H8	634	C	S
P07949	LP/P	Multiple neoplasia 2A (MEN2A) [MIM:171400]	H2V9H8	634	C	S
P07949	LP/P	Pheochromocytoma (PCC) [MIM:171300]	H2V9H8	634	C	S
P07949	LP/P	Medullary thyroid carcinoma (MTC) [MIM:155240]	H2V9H8	634	C	W
P07949	LP/P	Multiple neoplasia 2A (MEN2A) [MIM:171400]	H2V9H8	634	C	W
P07949	LP/P	Pheochromocytoma (PCC) [MIM:171300]	H2V9H8	634	C	W
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	690	S	P
P07949	LB/B	-	H2V9H8	691	G	S
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	767	S	R
P07949	LP/P	Medullary thyroid carcinoma (MTC) [MIM:155240]	H2V9H8	768	E	D
P07949	LP/P	Medullary thyroid carcinoma (MTC) [MIM:155240]	H2V9H8	804	V	L
P07949	LP/P	Medullary thyroid carcinoma (MTC) [MIM:155240]	H2V9H8	804	V	M
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	873	R	Q
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	893	F	L
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	897	R	Q
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	907	K	E
P07949	LP/P	Medullary thyroid carcinoma (MTC) [MIM:155240]	H2V9H8	918	M	T
P07949	LP/P	Multiple neoplasia 2B (MEN2B) [MIM:162300]	H2V9H8	918	M	T
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	921	E	K
P07949	LP/P	Medullary thyroid carcinoma (MTC) [MIM:155240]	H2V9H8	946	T	M
P07949	LP/P	Multiple neoplasia 2B (MEN2B) [MIM:162300]	H2V9H8	946	T	M
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	972	R	G
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	973	P	L
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	980	M	T
P07949	LB/B	-	H2V9H8	982	R	C
P07949	LB/B	-	H2V9H8	600	R	Q
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	20	P	L
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	77	R	C
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	174	F	S
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	180	R	P
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	197	C	Y
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	313	R	Q
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	360	R	W
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	394	N	K
P07949	LP/P	Multiple neoplasia 2A (MEN2A) [MIM:171400]	H2V9H8	609	C	G
P07949	LP/P	Multiple neoplasia 2A (MEN2A) [MIM:171400]	H2V9H8	609	C	R
P07949	LP/P	Medullary thyroid carcinoma (MTC) [MIM:155240]	H2V9H8	611	C	G
P07949	LP/P	Multiple neoplasia 2A (MEN2A) [MIM:171400]	H2V9H8	611	C	R
P07949	LP/P	Multiple neoplasia 2A (MEN2A) [MIM:171400]	H2V9H8	611	C	S
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	620	C	W
P07949	LP/P	Multiple neoplasia 2A (MEN2A) [MIM:171400]	H2V9H8	620	C	W
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	626	Q	K
P07949	LP/P	Medullary thyroid carcinoma (MTC) [MIM:155240]	H2V9H8	630	C	S
P07949	LP/P	Medullary thyroid carcinoma (MTC) [MIM:155240]	H2V9H8	630	C	Y
P07949	LP/P	Multiple neoplasia 2A (MEN2A) [MIM:171400]	H2V9H8	640	A	G
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	762	E	Q
P07949	LP/P	Medullary thyroid carcinoma (MTC) [MIM:155240]	H2V9H8	790	L	F
P07949	LP/P	Multiple neoplasia 2A (MEN2A) [MIM:171400]	H2V9H8	790	L	F
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	791	Y	F
P07949	LP/P	Medullary thyroid carcinoma (MTC) [MIM:155240]	H2V9H8	791	Y	F
P07949	LP/P	Multiple neoplasia 2A (MEN2A) [MIM:171400]	H2V9H8	791	Y	F
P07949	LP/P	Pheochromocytoma (PCC) [MIM:171300]	H2V9H8	791	Y	F
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	813	R	Q
P07949	LP/P	Multiple neoplasia 2B (MEN2B) [MIM:162300]	H2V9H8	883	A	F
P07949	LP/P	Medullary thyroid carcinoma (MTC) [MIM:155240]	H2V9H8	891	S	A
P07949	LB/B	-	H2V9H8	922	S	Y
P07949	LB/B	-	H2V9H8	1039	P	Q
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	1061	L	P
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	1064	M	T
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	40	L	P
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	765	S	P
P07949	LP/P	Medullary thyroid carcinoma (MTC) [MIM:155240]	H2V9H8	844	R	L
P07949	LP/P	Medullary thyroid carcinoma (MTC) [MIM:155240]	H2V9H8	639	A	G
P07949	LP/P	Medullary thyroid carcinoma (MTC) [MIM:155240]	H2V9H8	641	A	G
P07949	LP/P	Medullary thyroid carcinoma (MTC) [MIM:155240]	H2V9H8	922	S	F
P07949	LB/B	-	H2V9H8	67	R	H
P07949	LB/B	-	H2V9H8	114	R	H
P07949	LB/B	-	H2V9H8	489	D	N
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	1039	P	L
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	145	V	G
P07949	LB/B	-	H2V9H8	278	T	N
P07949	LB/B	-	H2V9H8	749	R	T
P07949	LB/B	-	H2V9H8	826	Y	S
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	155	P	L
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	175	R	P
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	278	T	A
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	278	T	P
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	300	D	N
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	316	S	I
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	339	S	L
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	353	D	Y
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	360	R	Q
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	397	V	M
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	412	V	M
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	423	G	R
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	480	E	K
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	595	E	Q
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	679	P	L
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	694	R	Q
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	783	N	S
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	830	G	R
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	907	K	T
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	961	F	L
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	1052	L	V
P07949	LP/P	Hirschsprung disease 1 (HSCR1) [MIM:142623]	H2V9H8	1062	Y	C
Q9BQ08	LB/B	-	F7FTU3	20	P	L
Q8NC44	LB/B	-	G1L6V8	419	P	Q
Q8NC44	LB/B	-	G1L6V8	374	R	H
Q6NUM9	LB/B	-	A0A147B1X3	533	A	V
Q6NUM9	LB/B	-	A0A147B1X3	536	G	R
Q6NUM9	LB/B	-	A0A147B1X3	559	P	T
Q9UBZ9	LB/B	-	W5PV53	138	V	M
Q9UBZ9	LB/B	-	W5PV53	257	F	S
Q9UBZ9	LB/B	-	W5PV53	373	N	S
Q9UBZ9	LB/B	-	W5PV53	1003	A	T
Q9UBZ9	LB/B	-	W5PV53	306	N	D
Q9UBZ9	LB/B	-	W5PV53	656	M	V
Q9UBZ9	LB/B	-	W5PV53	660	L	W
Q9UBZ9	LB/B	-	W5PV53	700	D	N
Q9UBZ9	LB/B	-	W5PV53	704	R	Q
Q9UBZ9	LB/B	-	W5PV53	902	P	S
Q9UBZ9	LB/B	-	W5PV53	902	P	H
Q9UBZ9	LB/B	-	W5PV53	921	S	I
Q9UBZ9	LB/B	-	W5PV53	1060	P	T
Q9UBZ9	LB/B	-	W5PV53	1074	N	K
Q9UBZ9	LB/B	-	W5PV53	1091	N	T
Q9UBZ9	LB/B	-	W5PV53	1102	L	P
O60673	LB/B	-	W5PJA8	231	Q	H
O60673	LB/B	-	W5PJA8	389	S	T
O60673	LB/B	-	W5PJA8	1540	K	E
O60673	LB/B	-	W5PJA8	2607	S	T
O60673	LB/B	-	W5PJA8	3064	V	I
O60673	LB/B	-	W5PJA8	397	Q	P
O60673	LB/B	-	W5PJA8	693	M	T
O60673	LB/B	-	W5PJA8	962	R	Q
O60673	LB/B	-	W5PJA8	1156	Y	C
O60673	LB/B	-	W5PJA8	1224	T	I
O60673	LB/B	-	W5PJA8	1302	S	T
O60673	LB/B	-	W5PJA8	1309	Q	H
O60673	LB/B	-	W5PJA8	1339	P	T
O60673	LB/B	-	W5PJA8	1469	Q	P
O60673	LB/B	-	W5PJA8	1576	S	L
O60673	LB/B	-	W5PJA8	1713	D	N
O60673	LB/B	-	W5PJA8	1724	S	T
O60673	LB/B	-	W5PJA8	1791	P	S
O60673	LB/B	-	W5PJA8	1812	D	H
O60673	LB/B	-	W5PJA8	1923	G	R
O60673	LB/B	-	W5PJA8	1970	R	H
O60673	LB/B	-	W5PJA8	2015	E	V
O60673	LB/B	-	W5PJA8	2075	I	M
O60673	LB/B	-	W5PJA8	2762	R	Q
O60673	LB/B	-	W5PJA8	633	S	G
O60673	LB/B	-	W5PJA8	1220	S	L
O60673	LB/B	-	W5PJA8	1284	T	P
Q8N1G1	LB/B	-	A0A2Y9L4T9	886	S	G
Q8N1G1	LB/B	-	A0A2Y9L4T9	408	V	A
Q8N1G1	LB/B	-	A0A2Y9L4T9	804	I	V
Q8N1G1	LB/B	-	A0A2Y9L4T9	759	S	P
P35251	LB/B	-	G5C3V0	598	I	V
P35251	LB/B	-	G5C3V0	613	R	L
P35251	LB/B	-	G5C3V0	692	E	D
P35251	LB/B	-	G5C3V0	955	Q	K
P35251	LB/B	-	G5C3V0	1146	S	L
P40938	LB/B	-	A0A1S3GDK6	16	L	V
P40937	LB/B	-	A0A0D2WI65	13	A	T
O75677	LB/B	-	A0A2K6M6J4	127	M	T
O75677	LB/B	-	A0A2K6M6J4	94	W	R
O75678	LB/B	-	A0A2J8QP63	119	A	T
O75678	LB/B	-	A0A2J8QP63	141	C	Y
O75678	LB/B	-	A0A2J8QP63	215	Q	H
O75678	LB/B	-	A0A2J8QP63	290	T	S
O75678	LB/B	-	A0A2J8QP63	324	S	G
O75678	LB/B	-	A0A2J8QP63	341	R	C
O75678	LB/B	-	A0A2J8QP63	348	V	I
O75679	LB/B	-	A0A2K6M6J4	83	M	T
O75679	LB/B	-	A0A2K6M6J4	110	L	M
O75679	LB/B	-	A0A2K6M6J4	126	D	N
O75679	LB/B	-	A0A2K6M6J4	181	Y	C
Q6ZWI9	LB/B	-	J3QPR6	234	G	D
Q96AA3	LB/B	-	A0A2Y9QNQ2	185	A	T
Q96AA3	LP/P	Congenital disorder of glycosylation 1N (CDG1N) [MIM:612015]	A0A2Y9QNQ2	67	R	C
Q96AA3	LP/P	Congenital disorder of glycosylation 1N (CDG1N) [MIM:612015]	A0A2Y9QNQ2	152	K	E
Q96AA3	LP/P	Congenital disorder of glycosylation 1N (CDG1N) [MIM:612015]	A0A2Y9QNQ2	298	E	K
Q6PCD5	LB/B	-	G1SWN0	90	T	N
Q6PCD5	LB/B	-	G1SWN0	392	R	K
Q6PCD5	LB/B	-	G1SWN0	564	I	V
Q6PCD5	LB/B	-	G1SWN0	770	I	T
Q6PCD5	LP/P	Fanconi anemia, complementation group W (FANCW) [MIM:617784]	G1SWN0	639	I	K
P22670	LB/B	-	W5PAV5	370	T	A
P48378	LB/B	-	A0A1D5PPB1	86	A	T
P48378	LB/B	-	A0A1D5PPB1	610	R	Q
Q33E94	LB/B	-	A0A2I0UMD9	687	S	N
Q33E94	LB/B	-	A0A2I0UMD9	698	S	A
P48382	LP/P	Bare lymphocyte syndrome 2 (BLS2) [MIM:209920]	F6RLZ3	149	R	Q
P48382	LB/B	-	F6RLZ3	197	R	Q
P48382	LB/B	-	F6RLZ3	409	P	R
P48382	LB/B	-	F6RLZ3	499	P	S
O14593	LP/P	Bare lymphocyte syndrome 2 (BLS2) [MIM:209920]	A0A1S3G597	195	L	P
O14593	LB/B	-	A0A1S3G597	251	Q	E
O14593	LB/B	-	A0A1S3G597	48	E	D
O15211	LB/B	-	K7FR36	598	P	L
O15211	LB/B	-	K7FR36	705	G	E
Q96B86	LB/B	-	L9L746	431	A	V
Q96B86	LB/B	-	L9L746	415	E	D
P47804	LP/P	Retinitis pigmentosa 44 (RP44) [MIM:613769]	W5KA16	66	S	R
P47804	LB/B	-	W5KA16	132	V	L
P47804	LB/B	-	W5KA16	152	H	N
P47804	LB/B	-	W5KA16	241	S	F
P47804	LB/B	-	W5KA16	234	A	T
O43665	LB/B	-	S7PYP3	102	A	V
O14921	LB/B	-	R4GM22	150	L	F
O15492	LB/B	-	L9L715	137	H	R
P41220	LB/B	-	L9KWB7	2	Q	R
P41220	LB/B	-	L9KWB7	3	S	G
P41220	LB/B	-	L9KWB7	4	A	V
P41220	LB/B	-	L9KWB7	5	M	V
P41220	LB/B	-	L9KWB7	18	K	N
P41220	LB/B	-	L9KWB7	23	G	D
P41220	LB/B	-	L9KWB7	50	Q	K
P41220	LB/B	-	L9KWB7	55	P	L
P41220	LB/B	-	L9KWB7	78	Q	H
P41220	LB/B	-	L9KWB7	99	A	G
P41220	LB/B	-	L9KWB7	110	I	V
P41220	LB/B	-	L9KWB7	196	Q	R
Q8NE09	LB/B	-	A0A1U7UDA2	397	R	M
Q8NE09	LB/B	-	A0A1U7UDA2	943	H	Y
P49798	LB/B	-	G1L3M1	195	A	S
Q6MZT1	LB/B	-	A0A2I4CN43	255	I	V
Q6ZS82	LB/B	-	A0A2H5ACH6	96	A	S
A5PLK6	LB/B	-	K7FMJ5	5	E	D
A5PLK6	LB/B	-	K7FMJ5	256	W	C
Q02094	LP/P	Regulator type Rh-null hemolytic anemia (RHN) [MIM:268150]	I3LYK6	79	S	N
Q02094	LB/B	-	I3LYK6	270	V	I
Q02094	LP/P	Regulator type Rh-null hemolytic anemia (RHN) [MIM:268150]	I3LYK6	279	G	E
Q02094	LP/P	Regulator type Rh-null hemolytic anemia (RHN) [MIM:268150]	I3LYK6	280	G	R
Q02094	LP/P	Regulator type Rh-null hemolytic anemia (RHN) [MIM:268150]	I3LYK6	380	G	V
Q02094	LB/B	-	I3LYK6	242	N	D
Q02094	LP/P	Overhydrated hereditary stomatocytosis (OHST) [MIM:185000]	I3LYK6	61	I	R
Q02094	LP/P	Overhydrated hereditary stomatocytosis (OHST) [MIM:185000]	I3LYK6	65	F	S
Q02094	LB/B	-	I3LYK6	106	Q	E
Q02094	LB/B	-	I3LYK6	164	K	Q
Q02094	LB/B	-	I3LYK6	227	S	L
Q8TEB9	LB/B	-	A0A2I4CPE0	110	A	T
Q9Y3P4	LB/B	-	A0A2Y9ICV4	86	T	M
Q9Y3P4	LB/B	-	A0A2Y9ICV4	227	H	R
Q96CC6	LB/B	-	V9KCV8	265	R	W
Q6PJF5	LB/B	-	V9KCV8	208	P	L
Q6PJF5	LB/B	-	V9KCV8	249	A	T
Q6PJF5	LB/B	-	V9KCV8	528	D	Y
Q6PJF5	LP/P	Tylosis with esophageal cancer (TOC) [MIM:148500]	V9KCV8	186	I	T
Q6PJF5	LP/P	Tylosis with esophageal cancer (TOC) [MIM:148500]	V9KCV8	189	P	L
Q9NX52	LB/B	-	H0XBF6	273	L	M
Q9H310	LB/B	-	M3WFS3	76	G	D
Q9H310	LB/B	-	M3WFS3	143	V	D
Q9H310	LB/B	-	M3WFS3	315	G	R
Q9H310	LB/B	-	M3WFS3	339	C	R
Q9UBD6	LB/B	-	F1SK21	202	R	C
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	4	T	K
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	15	N	S
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	17	T	M
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	23	P	H
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	23	P	L
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	28	Q	H
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	40	L	R
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	44	M	T
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	45	F	L
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	46	L	R
P08100	LB/B	-	A0A091DAC6	51	G	A
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	51	G	R
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	51	G	V
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	53	P	R
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	58	T	R
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	87	V	D
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	89	G	D
P08100	LP/P	Night blindness, congenital stationary, autosomal dominant 1 (CSNBAD1) [MIM:610445]	A0A091DAC6	90	G	D
P08100	LP/P	Night blindness, congenital stationary, autosomal dominant 1 (CSNBAD1) [MIM:610445]	A0A091DAC6	94	T	I
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	106	G	R
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	106	G	W
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	109	G	R
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	110	C	F
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	110	C	Y
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	114	G	D
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	125	L	R
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	127	S	F
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	131	L	P
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	135	R	G
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	135	R	L
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	135	R	W
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	140	C	S
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	150	E	K
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	164	A	E
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	164	A	V
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	167	C	R
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	171	P	L
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	171	P	Q
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	171	P	S
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	178	Y	C
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	178	Y	N
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	181	E	K
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	182	G	S
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	186	S	P
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	188	G	E
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	188	G	R
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	190	D	N
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	190	D	G
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	190	D	Y
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	207	M	R
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	211	H	P
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	211	H	R
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	216	M	K
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	220	F	C
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	222	C	R
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	267	P	L
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	267	P	R
P08100	LP/P	Night blindness, congenital stationary, autosomal dominant 1 (CSNBAD1) [MIM:610445]	A0A091DAC6	292	A	E
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	296	K	E
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	297	S	R
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	342	T	M
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	345	V	L
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	345	V	M
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	347	P	A
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	347	P	L
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	347	P	Q
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	347	P	R
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	347	P	S
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	180	P	S
P08100	LP/P	Retinitis pigmentosa 4 (RP4) [MIM:613731]	A0A091DAC6	214	I	N
P61586	LP/P	Ectodermal dysplasia with facial dysmorphism and acral, ocular, and brain anomalies (EDFAOB) [MIM:618727]	M7AMU4	47	E	K
P61586	LP/P	Ectodermal dysplasia with facial dysmorphism and acral, ocular, and brain anomalies (EDFAOB) [MIM:618727]	M7AMU4	71	P	S
Q9BYZ6	LP/P	Developmental and epileptic encephalopathy 64 (DEE64) [MIM:618004]	V9KDN6	488	N	D
Q9BYZ6	LP/P	Developmental and epileptic encephalopathy 64 (DEE64) [MIM:618004]	V9KDN6	452	A	G
Q9BYZ6	LP/P	Developmental and epileptic encephalopathy 64 (DEE64) [MIM:618004]	V9KDN6	461	R	H
Q9BYZ6	LP/P	Developmental and epileptic encephalopathy 64 (DEE64) [MIM:618004]	V9KDN6	485	R	C
Q9BYZ6	LP/P	Developmental and epileptic encephalopathy 64 (DEE64) [MIM:618004]	V9KDN6	489	R	Q
Q9BYZ6	LP/P	Developmental and epileptic encephalopathy 64 (DEE64) [MIM:618004]	V9KDN6	489	R	W
O94955	LB/B	-	G1KN12	21	P	R
O94955	LB/B	-	G1KN12	262	N	D
O94955	LB/B	-	G1KN12	20	R	Q
P08134	LB/B	-	M7AMU4	120	D	H
O00212	LB/B	-	H0X2Z9	134	R	C
Q8IXI1	LB/B	-	A0A197KGZ0	245	R	Q
Q8IXI1	LB/B	-	A0A197KGZ0	425	R	C
Q7L0Q8	LB/B	-	A0A2K6SMG2	121	T	A
Q8NHV9	LB/B	-	F1PP15	177	D	H
Q8IUC4	LB/B	-	L5JQX9	70	R	Q
Q8IUC4	LB/B	-	L5JQX9	342	A	P
Q9H4K1	LB/B	-	A0A2C9JD92	253	R	C
Q9H4K1	LB/B	-	A0A2C9JD92	268	F	L
Q9H4K1	LB/B	-	A0A2C9JD92	335	R	Q
Q7Z5B4	LB/B	-	H3B635	57	P	H
Q7Z5B4	LB/B	-	H3B635	130	C	Y
Q6R327	LB/B	-	A0A1L8I2M9	837	S	F
Q5UIP0	LB/B	-	A0A0Q3USP1	836	G	S
Q5UIP0	LB/B	-	A0A0Q3USP1	1362	V	M
Q5UIP0	LB/B	-	A0A0Q3USP1	1686	R	G
Q5UIP0	LB/B	-	A0A0Q3USP1	1862	V	I
Q5UIP0	LB/B	-	A0A0Q3USP1	2021	N	Y
Q5UIP0	LB/B	-	A0A0Q3USP1	2165	M	R
Q5UIP0	LB/B	-	A0A0Q3USP1	2418	L	V
O95786	LB/B	-	F7E4X4	7	R	C
O95786	LB/B	-	F7E4X4	580	D	E
O95786	LP/P	Singleton-Merten syndrome 2 (SGMRT2) [MIM:616298]	F7E4X4	268	C	F
O95786	LP/P	Singleton-Merten syndrome 2 (SGMRT2) [MIM:616298]	F7E4X4	373	E	A
Q96NA2	LB/B	-	A0A212D8L6	281	R	Q
Q96NA2	LB/B	-	A0A212D8L6	81	A	T
Q9UFD9	LB/B	-	F6YJE9	1513	R	C
A6NDU8	LB/B	-	A0A2K5C132	20	Q	H
Q86UR5	LP/P	Cone-rod dystrophy 7 (CORD7) [MIM:603649]	A0A091UXB2	820	R	H
Q6ZS11	LB/B	-	F6T5H7	402	P	L
Q9H6W3	LB/B	-	W5NQV4	218	F	S
Q9H6W3	LB/B	-	W5NQV4	239	Q	H
Q9H6W3	LB/B	-	W5NQV4	17	K	R
Q9H6W3	LB/B	-	W5NQV4	364	V	A
Q8IUF8	LB/B	-	A0A091E1N3	386	A	T
Q8IUF8	LB/B	-	A0A091E1N3	17	A	P
Q8IUF8	LB/B	-	A0A091E1N3	201	P	L
O43353	LB/B	-	S4RZK5	259	I	T
O43353	LB/B	-	S4RZK5	268	L	V
O43353	LB/B	-	S4RZK5	313	K	N
Q9Y572	LB/B	-	A0A2Y9LC96	300	T	M
Q9Y572	LB/B	-	A0A2Y9LC96	492	P	Q
Q9Y572	LB/B	-	A0A2Y9LC96	260	E	V
Q9Y4F9	LB/B	-	A0A2U3WDE4	145	A	G
Q9Y4F9	LB/B	-	A0A2U3WDE4	320	V	M
Q9Y4F9	LB/B	-	A0A2U3WDE4	424	E	K
Q9Y4F9	LB/B	-	A0A2U3WDE4	452	S	C
Q9Y4F9	LB/B	-	A0A2U3WDE4	495	E	K
Q9Y4F9	LB/B	-	A0A2U3WDE4	520	R	C
Q9Y4F9	LB/B	-	A0A2U3WDE4	868	R	Q
Q92963	LP/P	-	G3MXR6	35	S	T
Q92963	LP/P	Noonan syndrome 8 (NS8) [MIM:615355]	G3MXR6	57	A	G
Q92963	LP/P	Noonan syndrome 8 (NS8) [MIM:615355]	G3MXR6	81	E	G
Q92963	LP/P	Noonan syndrome 8 (NS8) [MIM:615355]	G3MXR6	82	F	L
Q92963	LP/P	-	G3MXR6	82	F	V
Q92963	LP/P	-	G3MXR6	83	T	P
Q92963	LP/P	-	G3MXR6	89	Y	H
Q92963	LP/P	Noonan syndrome 8 (NS8) [MIM:615355]	G3MXR6	90	M	I
Q92963	LP/P	Noonan syndrome 8 (NS8) [MIM:615355]	G3MXR6	95	G	A
P12271	LP/P	Retinitis punctata albescens (RPA) [MIM:136880]	A0A1A6H5G3	151	R	Q
P12271	LP/P	Bothnia retinal dystrophy (BRD) [MIM:607475]	A0A1A6H5G3	234	R	W
P12271	LP/P	Retinitis punctata albescens (RPA) [MIM:136880]	A0A1A6H5G3	226	M	K
Q13129	LB/B	-	K7F5E3	668	R	K
Q13129	LB/B	-	K7F5E3	932	V	A
Q13129	LB/B	-	K7F5E3	957	G	D
Q13129	LB/B	-	K7F5E3	1784	E	D
Q13129	LB/B	-	K7F5E3	1629	P	L
Q13129	LB/B	-	K7F5E3	1685	Q	E
Q9NVW2	LB/B	-	A0A1U8CNB4	590	H	P
Q9NVW2	LP/P	Tonne-Kalscheuer syndrome (TOKAS) [MIM:300978]	A0A1U8CNB4	356	Y	C
Q9NVW2	LP/P	Tonne-Kalscheuer syndrome (TOKAS) [MIM:300978]	A0A1U8CNB4	387	R	C
Q9NVW2	LP/P	Tonne-Kalscheuer syndrome (TOKAS) [MIM:300978]	A0A1U8CNB4	587	P	R
Q9NVW2	LP/P	Tonne-Kalscheuer syndrome (TOKAS) [MIM:300978]	A0A1U8CNB4	599	R	C
Q96TC7	LB/B	-	G7PAX5	33	Q	H
Q9H9A7	LB/B	-	H2TPU1	100	Y	H
Q9H9A7	LB/B	-	H2TPU1	455	N	S
Q5GAN6	LB/B	-	A0A1S3GQP7	131	S	N
Q8TAA1	LB/B	-	Q5GAM9	5	P	S
Q8TAA1	LB/B	-	Q5GAM9	74	T	S
Q5GAN3	LB/B	-	I3LFB2	139	S	A
P10153	LB/B	-	W0UV32	156	H	N
P10153	LB/B	-	W0UV32	100	H	Q
P12724	LB/B	-	W0UV32	124	T	R
P12724	LB/B	-	W0UV32	72	R	C
P12724	LB/B	-	W0UV32	130	G	R
P34096	LB/B	-	A0A1U7TFC5	16	T	S
Q93091	LB/B	-	A0A2Y9FP41	89	R	Q
Q9H1E1	LB/B	-	H2FJU6	103	A	P
Q9H1E1	LB/B	-	H2FJU6	116	H	Y
Q8TDE3	LB/B	-	H2FJU6	10	P	S
O60930	LB/B	-	A0A1A6GLB6	4	L	F
O60930	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 2 (PEOB2) [MIM:616479]	A0A1A6GLB6	142	V	I
O60930	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 2 (PEOB2) [MIM:616479]	A0A1A6GLB6	185	A	V
O75792	LB/B	-	G3HCX0	202	L	S
O75792	LP/P	Aicardi-Goutieres syndrome 4 (AGS4) [MIM:610333]	G3HCX0	37	G	S
O75792	LB/B	-	G3HCX0	258	A	G
O75792	LB/B	-	G3HCX0	99	N	D
O75792	LP/P	Aicardi-Goutieres syndrome 4 (AGS4) [MIM:610333]	G3HCX0	108	R	W
O75792	LP/P	Aicardi-Goutieres syndrome 4 (AGS4) [MIM:610333]	G3HCX0	186	R	W
O75792	LB/B	-	G3HCX0	205	D	E
O75792	LP/P	Aicardi-Goutieres syndrome 4 (AGS4) [MIM:610333]	G3HCX0	230	F	L
O75792	LP/P	Aicardi-Goutieres syndrome 4 (AGS4) [MIM:610333]	G3HCX0	235	R	Q
O75792	LP/P	Aicardi-Goutieres syndrome 4 (AGS4) [MIM:610333]	G3HCX0	240	T	M
O75792	LB/B	-	G3HCX0	260	E	G
O75792	LP/P	Aicardi-Goutieres syndrome 4 (AGS4) [MIM:610333]	G3HCX0	291	R	H
Q5TBB1	LP/P	Aicardi-Goutieres syndrome 2 (AGS2) [MIM:610181]	A0A2K5LNV5	60	L	R
Q5TBB1	LP/P	Aicardi-Goutieres syndrome 2 (AGS2) [MIM:610181]	A0A2K5LNV5	86	H	R
Q5TBB1	LP/P	Aicardi-Goutieres syndrome 2 (AGS2) [MIM:610181]	A0A2K5LNV5	162	K	T
Q5TBB1	LP/P	Aicardi-Goutieres syndrome 2 (AGS2) [MIM:610181]	A0A2K5LNV5	163	T	I
Q5TBB1	LP/P	Aicardi-Goutieres syndrome 2 (AGS2) [MIM:610181]	A0A2K5LNV5	177	A	T
Q5TBB1	LP/P	Aicardi-Goutieres syndrome 2 (AGS2) [MIM:610181]	A0A2K5LNV5	185	V	G
Q5TBB1	LP/P	Aicardi-Goutieres syndrome 2 (AGS2) [MIM:610181]	A0A2K5LNV5	219	Y	H
Q5TBB1	LP/P	Aicardi-Goutieres syndrome 2 (AGS2) [MIM:610181]	A0A2K5LNV5	43	P	H
Q5TBB1	LP/P	Aicardi-Goutieres syndrome 2 (AGS2) [MIM:610181]	A0A2K5LNV5	73	W	L
Q5TBB1	LP/P	Aicardi-Goutieres syndrome 2 (AGS2) [MIM:610181]	A0A2K5LNV5	83	G	S
Q5TBB1	LP/P	Aicardi-Goutieres syndrome 2 (AGS2) [MIM:610181]	A0A2K5LNV5	138	L	F
Q5TBB1	LP/P	Aicardi-Goutieres syndrome 2 (AGS2) [MIM:610181]	A0A2K5LNV5	159	S	I
Q5TBB1	LP/P	Aicardi-Goutieres syndrome 2 (AGS2) [MIM:610181]	A0A2K5LNV5	183	V	M
Q5TBB1	LP/P	Aicardi-Goutieres syndrome 2 (AGS2) [MIM:610181]	A0A2K5LNV5	229	S	P
Q8TDP1	LP/P	Aicardi-Goutieres syndrome 3 (AGS3) [MIM:610329]	H9H442	69	R	W
Q8TDP1	LP/P	Aicardi-Goutieres syndrome 3 (AGS3) [MIM:610329]	H9H442	143	K	I
Q8TDP1	LP/P	Aicardi-Goutieres syndrome 3 (AGS3) [MIM:610329]	H9H442	13	R	H
Q8TDP1	LP/P	Aicardi-Goutieres syndrome 3 (AGS3) [MIM:610329]	H9H442	39	D	Y
Q8TDP1	LP/P	Aicardi-Goutieres syndrome 3 (AGS3) [MIM:610329]	H9H442	76	P	L
Q8TDP1	LP/P	Aicardi-Goutieres syndrome 3 (AGS3) [MIM:610329]	H9H442	138	P	L
Q8TDP1	LP/P	Aicardi-Goutieres syndrome 3 (AGS3) [MIM:610329]	H9H442	151	P	S
O00584	LB/B	-	A0A2K5I9M9	236	R	W
O00584	LP/P	Leukoencephalopathy, cystic, without megalencephaly (LCWM) [MIM:612951]	A0A2K5I9M9	184	C	R
Q92730	LB/B	-	S9X6G6	44	P	R
Q8N5U6	LB/B	-	F7CZB4	332	L	F
Q8N5U6	LB/B	-	F7CZB4	433	E	D
Q9Y3C5	LB/B	-	A0A146VEY4	11	D	E
Q6ZNA4	LB/B	-	F7DBK6	9	N	K
Q6ZNA4	LB/B	-	F7DBK6	718	A	T
Q8IZP6	LB/B	-	G3W479	92	V	M
Q9Y4L5	LB/B	-	A0A0S7HP22	194	G	R
Q5XPI4	LB/B	-	A0A0S7GRI7	51	P	R
Q5XPI4	LB/B	-	A0A0S7GRI7	387	R	Q
Q5XPI4	LB/B	-	A0A0S7GRI7	596	K	E
Q5XPI4	LB/B	-	A0A0S7GRI7	854	R	H
Q96EQ8	LP/P	Tenorio syndrome (TNORS) [MIM:616260]	A0A2D4H083	112	M	I
Q96EQ8	LP/P	Tenorio syndrome (TNORS) [MIM:616260]	A0A2D4H083	163	S	L
Q96EQ8	LP/P	Tenorio syndrome (TNORS) [MIM:616260]	A0A2D4H083	174	R	C
O43567	LP/P	Developmental and epileptic encephalopathy 73 (DEE73) [MIM:618379]	A0A2I3HWN7	311	L	S
O43567	LP/P	Developmental and epileptic encephalopathy 73 (DEE73) [MIM:618379]	A0A2I3HWN7	312	L	P
Q8IUD6	LB/B	-	A0A2K6RFR7	71	H	Q
Q8IUD6	LB/B	-	A0A2K6RFR7	108	S	P
Q8IUD6	LB/B	-	A0A2K6RFR7	115	R	K
Q8IUD6	LB/B	-	A0A2K6RFR7	415	W	C
P50876	LB/B	-	A0A1V4JMV8	4	T	A
Q9NTX7	LB/B	-	A0A060Y7N1	25	C	R
Q8NC42	LB/B	-	A0A250YH94	9	S	G
Q8NC42	LB/B	-	A0A250YH94	344	L	F
Q8NC42	LB/B	-	A0A250YH94	356	D	E
Q9H6Y7	LB/B	-	T0M637	121	N	K
Q8IYW5	LB/B	-	U3J6K4	401	P	Q
Q8IYW5	LB/B	-	U3J6K4	387	K	R
Q8IYW5	LB/B	-	U3J6K4	413	E	K
Q96K19	LP/P	Ataxia, sensory, 1, autosomal dominant (SNAX1) [MIM:608984]	E2RGZ9	199	R	C
Q96K19	LP/P	Spastic paraplegia 85, autosomal recessive (SPG85) [MIM:619686]	E2RGZ9	102	C	R
Q96K19	LP/P	Spastic paraplegia 85, autosomal recessive (SPG85) [MIM:619686]	E2RGZ9	107	C	W
Q8N4F7	LB/B	-	A0A146NP01	159	M	V
Q8N4F7	LB/B	-	A0A146NP01	307	L	F
Q8N4F7	LB/B	-	A0A146NP01	315	I	M
Q8N4F7	LB/B	-	A0A146NP01	322	I	N
Q9P0P0	LB/B	-	L5K7J6	118	Y	H
Q96D59	LB/B	-	F6YT78	82	A	T
Q96D59	LB/B	-	F6YT78	114	Q	R
Q9NXI6	LB/B	-	A0A2Y9FFC1	23	A	T
Q9NXI6	LB/B	-	A0A2Y9FFC1	208	P	T
Q9NV58	LB/B	-	H2LBU7	835	Q	H
Q6ZRF8	LB/B	-	A0A218UM12	421	A	T
Q6ZRF8	LB/B	-	A0A218UM12	573	N	S
Q6ZRF8	LB/B	-	A0A218UM12	603	G	A
Q6ZRF8	LB/B	-	A0A218UM12	539	R	C
Q63HN8	LB/B	-	F6YJA2	2554	D	E
Q63HN8	LB/B	-	F6YJA2	3915	E	G
Q63HN8	LP/P	Moyamoya disease 2 (MYMY2) [MIM:607151]	F6YJA2	4013	D	N
Q63HN8	LP/P	Moyamoya disease 2 (MYMY2) [MIM:607151]	F6YJA2	4399	A	T
Q63HN8	LB/B	-	F6YJA2	4567	V	M
Q63HN8	LP/P	Moyamoya disease 2 (MYMY2) [MIM:607151]	F6YJA2	4810	R	K
Q63HN8	LB/B	-	F6YJA2	5021	A	V
Q9Y6U7	LB/B	-	E2RBV6	322	A	T
Q9NWF9	LP/P	Gordon Holmes syndrome (GDHS) [MIM:212840]	A0A093J6R1	660	R	C
Q9NWF9	LP/P	Gordon Holmes syndrome (GDHS) [MIM:212840]	A0A093J6R1	694	R	C
Q8TC41	LB/B	-	A0A2Y9G2M0	381	V	I
Q5VTB9	LP/P	Leukodystrophy, hypomyelinating, 23, with ataxia, deafness, liver dysfunction, and dilated cardiomyopathy (HLD23) [MIM:619688]	A0A0B6ZYV4	363	R	Q
Q5VTB9	LP/P	Leukodystrophy, hypomyelinating, 23, with ataxia, deafness, liver dysfunction, and dilated cardiomyopathy (HLD23) [MIM:619688]	A0A0B6ZYV4	365	R	Q
Q9H0A6	LB/B	-	B3RQE5	288	R	Q
Q9H0A6	LB/B	-	B3RQE5	291	H	Q
Q9H0A6	LB/B	-	B3RQE5	307	R	C
Q9H2S5	LB/B	-	M3Y816	203	S	P
Q9H2S5	LB/B	-	M3Y816	245	A	T
Q9H2S5	LB/B	-	M3Y816	268	D	N
Q9H2S5	LB/B	-	M3Y816	304	A	E
Q68DV7	LB/B	-	H0V0U6	47	I	V
Q68DV7	LB/B	-	H0V0U6	117	R	H
Q68DV7	LB/B	-	H0V0U6	221	R	Q
Q68DV7	LB/B	-	H0V0U6	231	P	L
Q68DV7	LB/B	-	H0V0U6	418	L	M
Q68DV7	LB/B	-	H0V0U6	686	P	R
Q68DV7	LB/B	-	H0V0U6	343	R	H
Q9Y252	LB/B	-	A0A1A6HGK7	48	N	S
Q9Y252	LB/B	-	A0A1A6HGK7	203	V	E
Q9Y252	LB/B	-	A0A1A6HGK7	623	S	N
Q9Y252	LB/B	-	A0A1A6HGK7	102	R	K
Q9Y252	LB/B	-	A0A1A6HGK7	164	I	T
Q9Y252	LB/B	-	A0A1A6HGK7	242	A	T
Q9Y252	LB/B	-	A0A1A6HGK7	244	G	D
Q9Y252	LB/B	-	A0A1A6HGK7	572	R	Q
O60942	LB/B	-	A0A2D4FHZ4	594	R	H
P13489	LB/B	-	K7G802	170	P	L
Q96LT9	LP/P	Pituitary hormone deficiency, combined or isolated, 7 (CPHD7) [MIM:618160]	A0A2K5MI08	474	P	T
Q9H4A4	LB/B	-	L9JAW4	579	V	I
Q9Y6N7	LB/B	-	S7MVD6	336	V	A
Q9Y6N7	LB/B	-	S7MVD6	1091	S	N
Q13464	LB/B	-	M7B6I5	108	S	N
Q13464	LB/B	-	M7B6I5	773	T	S
Q13464	LB/B	-	M7B6I5	1112	T	P
Q13464	LB/B	-	M7B6I5	1217	Q	E
Q13464	LB/B	-	M7B6I5	1262	R	Q
Q13464	LB/B	-	M7B6I5	1264	C	R
O75116	LB/B	-	A0A287ASJ3	431	T	N
O75116	LB/B	-	A0A287ASJ3	601	D	V
O75116	LB/B	-	A0A287ASJ3	1083	K	M
Q9GZN7	LB/B	-	W5P1F9	59	E	K
Q03395	LB/B	-	V8NZB1	60	P	T
Q03395	LB/B	-	V8NZB1	108	T	M
Q03395	LB/B	-	V8NZB1	229	R	H
Q03395	LB/B	-	V8NZB1	265	A	T
Q03395	LB/B	-	V8NZB1	271	M	T
Q03395	LB/B	-	V8NZB1	16	R	H
Q03395	LB/B	-	V8NZB1	75	G	D
Q03395	LB/B	-	V8NZB1	118	G	A
Q03395	LB/B	-	V8NZB1	242	R	Q
P60602	LB/B	-	A0A1D5R792	28	A	P
Q96C74	LB/B	-	L9L516	103	N	K
Q96C74	LB/B	-	L9L516	156	P	R
Q96C74	LB/B	-	L9L516	113	A	V
Q01974	LP/P	Robinow syndrome, autosomal recessive 1 (RRS1) [MIM:268310]	L8YEE9	184	R	C
Q01974	LP/P	Robinow syndrome, autosomal recessive 1 (RRS1) [MIM:268310]	L8YEE9	189	R	W
Q01974	LP/P	Robinow syndrome, autosomal recessive 1 (RRS1) [MIM:268310]	L8YEE9	366	R	W
Q01974	LP/P	Robinow syndrome, autosomal recessive 1 (RRS1) [MIM:268310]	L8YEE9	620	N	K
Q01974	LP/P	Robinow syndrome, autosomal recessive 1 (RRS1) [MIM:268310]	L8YEE9	182	C	Y
Q01974	LB/B	-	L8YEE9	245	T	A
Q01974	LB/B	-	L8YEE9	819	V	I
Q01974	LB/B	-	L8YEE9	244	R	Q
Q01974	LB/B	-	L8YEE9	349	H	D
Q01974	LB/B	-	L8YEE9	490	G	A
Q01974	LB/B	-	L8YEE9	530	R	Q
Q01974	LB/B	-	L8YEE9	548	P	S
Q01974	LB/B	-	L8YEE9	557	S	L
Q01974	LB/B	-	L8YEE9	644	D	N
Q01974	LB/B	-	L8YEE9	672	D	N
Q01974	LB/B	-	L8YEE9	695	G	R
Q01974	LB/B	-	L8YEE9	738	R	C
Q01974	LB/B	-	L8YEE9	762	S	L
Q01974	LB/B	-	L8YEE9	935	D	E
P08922	LB/B	-	A0A1U7QUL4	145	T	P
P08922	LB/B	-	A0A1U7QUL4	167	R	Q
P08922	LB/B	-	A0A1U7QUL4	1109	S	L
P08922	LB/B	-	A0A1U7QUL4	1439	F	S
P08922	LB/B	-	A0A1U7QUL4	1776	D	H
P08922	LB/B	-	A0A1U7QUL4	1902	E	K
P08922	LB/B	-	A0A1U7QUL4	2039	R	H
P08922	LB/B	-	A0A1U7QUL4	2213	D	N
P08922	LB/B	-	A0A1U7QUL4	2229	S	C
P08922	LB/B	-	A0A1U7QUL4	2240	N	K
P08922	LB/B	-	A0A1U7QUL4	13	N	S
P08922	LB/B	-	A0A1U7QUL4	126	G	V
P08922	LB/B	-	A0A1U7QUL4	224	P	S
P08922	LB/B	-	A0A1U7QUL4	338	Y	C
P08922	LB/B	-	A0A1U7QUL4	370	S	P
P08922	LB/B	-	A0A1U7QUL4	537	I	M
P08922	LB/B	-	A0A1U7QUL4	653	S	F
P08922	LB/B	-	A0A1U7QUL4	1239	Y	F
P08922	LB/B	-	A0A1U7QUL4	1353	Y	S
P08922	LB/B	-	A0A1U7QUL4	1370	C	R
P08922	LB/B	-	A0A1U7QUL4	1506	R	G
P08922	LB/B	-	A0A1U7QUL4	1999	H	N
P08922	LB/B	-	A0A1U7QUL4	2203	D	N
P08922	LB/B	-	A0A1U7QUL4	2213	D	E
P08922	LB/B	-	A0A1U7QUL4	2228	K	Q
P08922	LB/B	-	A0A1U7QUL4	790	N	S
P08922	LB/B	-	A0A1U7QUL4	2328	K	R
P56715	LB/B	-	K7GA53	872	R	H
P56715	LB/B	-	K7GA53	985	N	Y
P56715	LB/B	-	K7GA53	1670	A	T
P56715	LB/B	-	K7GA53	1691	S	P
P56715	LB/B	-	K7GA53	2033	C	Y
P56715	LB/B	-	K7GA53	251	Y	C
P56715	LB/B	-	K7GA53	752	T	M
P56715	LB/B	-	K7GA53	945	V	L
P56715	LB/B	-	K7GA53	1595	R	Q
P56715	LP/P	Retinitis pigmentosa 1 (RP1) [MIM:180100]	K7GA53	202	D	E
P56715	LB/B	-	K7GA53	408	I	L
P56715	LP/P	Retinitis pigmentosa 1 (RP1) [MIM:180100]	K7GA53	669	A	T
P56715	LB/B	-	K7GA53	706	G	R
P56715	LB/B	-	K7GA53	727	C	W
P56715	LP/P	Retinitis pigmentosa 1 (RP1) [MIM:180100]	K7GA53	984	D	G
P56715	LB/B	-	K7GA53	168	R	G
P56715	LB/B	-	K7GA53	218	A	T
P56715	LB/B	-	K7GA53	376	R	L
P56715	LP/P	Retinitis pigmentosa 1 (RP1) [MIM:180100]	K7GA53	900	K	N
P56715	LB/B	-	K7GA53	1072	D	G
P56715	LB/B	-	K7GA53	1356	L	S
P56715	LB/B	-	K7GA53	1417	L	P
P56715	LB/B	-	K7GA53	1425	L	P
P56715	LB/B	-	K7GA53	1793	P	S
P56715	LB/B	-	K7GA53	1935	F	L
P56715	LB/B	-	K7GA53	2066	D	N
P56715	LP/P	Retinitis pigmentosa 1 (RP1) [MIM:180100]	K7GA53	2113	T	N
P56715	LP/P	Retinitis pigmentosa 1 (RP1) [MIM:180100]	K7GA53	172	L	R
Q8IWN7	LB/B	-	A0A2J8Q993	44	P	A
Q8IWN7	LB/B	-	A0A2J8Q993	56	R	C
Q8IWN7	LB/B	-	A0A2J8Q993	112	T	S
Q8IWN7	LB/B	-	A0A2J8Q993	136	R	H
Q8IWN7	LB/B	-	A0A2J8Q993	487	A	V
Q8IWN7	LB/B	-	A0A2J8Q993	624	A	T
Q8IWN7	LB/B	-	A0A2J8Q993	792	L	P
Q8IWN7	LB/B	-	A0A2J8Q993	795	E	K
Q8IWN7	LB/B	-	A0A2J8Q993	860	R	W
Q8IWN7	LB/B	-	A0A2J8Q993	1146	R	W
Q8IWN7	LB/B	-	A0A2J8Q993	1285	A	S
Q8IWN7	LB/B	-	A0A2J8Q993	1324	E	G
Q8IWN7	LB/B	-	A0A2J8Q993	1335	G	R
Q8IWN7	LB/B	-	A0A2J8Q993	1483	A	V
Q8IWN7	LB/B	-	A0A2J8Q993	1495	P	R
Q8IWN7	LB/B	-	A0A2J8Q993	1505	S	L
Q8IWN7	LB/B	-	A0A2J8Q993	1709	A	V
Q8IWN7	LB/B	-	A0A2J8Q993	1816	G	D
Q8IWN7	LB/B	-	A0A2J8Q993	1889	D	V
Q8IWN7	LB/B	-	A0A2J8Q993	1946	A	E
Q8IWN7	LB/B	-	A0A2J8Q993	1954	T	A
Q8IWN7	LB/B	-	A0A2J8Q993	2069	G	V
Q8IWN7	LB/B	-	A0A2J8Q993	2088	Q	H
Q8IWN7	LB/B	-	A0A2J8Q993	2140	E	K
Q8IWN7	LB/B	-	A0A2J8Q993	2171	E	K
Q8IWN7	LB/B	-	A0A2J8Q993	2199	P	L
Q8IWN7	LB/B	-	A0A2J8Q993	2242	E	G
Q8IWN7	LB/B	-	A0A2J8Q993	2285	G	R
Q8IWN7	LB/B	-	A0A2J8Q993	2335	H	R
Q8IWN7	LB/B	-	A0A2J8Q993	1467	R	S
Q8IWN7	LB/B	-	A0A2J8Q993	222	H	P
Q8IWN7	LB/B	-	A0A2J8Q993	2091	E	K
Q8IWN7	LP/P	Occult macular dystrophy (OCMD) [MIM:613587]	A0A2J8Q993	45	R	W
Q8IWN7	LP/P	Occult macular dystrophy (OCMD) [MIM:613587]	A0A2J8Q993	960	W	R
Q8IWN7	LB/B	-	A0A2J8Q993	514	G	S
Q8IWN7	LB/B	-	A0A2J8Q993	1319	A	G
O75695	LP/P	Retinitis pigmentosa 2 (RP2) [MIM:312600]	A0A0G2JUM3	108	C	G
O75695	LP/P	Retinitis pigmentosa 2 (RP2) [MIM:312600]	A0A0G2JUM3	118	R	H
O75695	LP/P	Retinitis pigmentosa 2 (RP2) [MIM:312600]	A0A0G2JUM3	253	L	R
O75695	LB/B	-	A0A0G2JUM3	282	R	W
O75695	LB/B	-	A0A0G2JUM3	338	D	Y
O75695	LP/P	Retinitis pigmentosa 2 (RP2) [MIM:312600]	A0A0G2JUM3	67	C	Y
O75695	LP/P	Retinitis pigmentosa 2 (RP2) [MIM:312600]	A0A0G2JUM3	86	C	Y
O75695	LP/P	Retinitis pigmentosa 2 (RP2) [MIM:312600]	A0A0G2JUM3	118	R	L
O75695	LP/P	Retinitis pigmentosa 2 (RP2) [MIM:312600]	A0A0G2JUM3	138	E	G
O75695	LP/P	Retinitis pigmentosa 2 (RP2) [MIM:312600]	A0A0G2JUM3	188	L	P
O75695	LP/P	Retinitis pigmentosa 2 (RP2) [MIM:312600]	A0A0G2JUM3	118	R	C
O75695	LB/B	-	A0A0G2JUM3	144	K	R
O75695	LP/P	Retinitis pigmentosa 2 (RP2) [MIM:312600]	A0A0G2JUM3	108	C	Y
P27694	LB/B	-	A0A147AYP0	351	T	A
P27694	LP/P	Pulmonary fibrosis, and/or bone marrow failure, telomere-related, 6 (PFBMFT6) [MIM:619767]	A0A147AYP0	240	E	K
P15927	LB/B	-	A0A2Y9LD95	14	Y	S
P15927	LB/B	-	A0A2Y9LD95	15	G	R
P15927	LB/B	-	A0A2Y9LD95	203	N	S
Q13156	LB/B	-	W5M5H7	33	A	T
Q9H6T3	LB/B	-	F1R498	564	D	Y
Q92834	LP/P	Retinitis pigmentosa 3 (RP3) [MIM:300029]	H2U0X0	130	F	C
Q92834	LP/P	Retinitis pigmentosa 3 (RP3) [MIM:300029]	H2U0X0	235	P	S
Q92834	LP/P	Retinitis pigmentosa 3 (RP3) [MIM:300029]	H2U0X0	275	G	S
Q92834	LP/P	Retinitis pigmentosa 3 (RP3) [MIM:300029]	H2U0X0	60	G	V
Q92834	LB/B	Retinitis pigmentosa 3 (RP3) [MIM:300029]	H2U0X0	75	I	V
Q92834	LP/P	Retinitis pigmentosa 3 (RP3) [MIM:300029]	H2U0X0	98	H	Q
Q92834	LP/P	Retinitis pigmentosa 3 (RP3) [MIM:300029]	H2U0X0	215	G	V
Q92834	LP/P	Retinitis pigmentosa 3 (RP3) [MIM:300029]	H2U0X0	250	C	R
Q92834	LB/B	-	H2U0X0	425	R	K
Q92834	LB/B	-	H2U0X0	431	I	V
Q92834	LP/P	Retinitis pigmentosa 3 (RP3) [MIM:300029]	H2U0X0	436	G	D
Q92834	LB/B	-	H2U0X0	566	G	E
Q92834	LP/P	Retinitis pigmentosa 3 (RP3) [MIM:300029]	H2U0X0	302	C	R
Q92834	LB/B	-	H2U0X0	533	T	M
Q92834	LB/B	-	H2U0X0	76	S	I
Q92834	LP/P	Retinitis pigmentosa 3 (RP3) [MIM:300029]	H2U0X0	99	T	N
Q92834	LP/P	Retinitis pigmentosa 3 (RP3) [MIM:300029]	H2U0X0	289	I	V
Q92834	LP/P	Retinitis pigmentosa 3 (RP3) [MIM:300029]	H2U0X0	43	G	E
Q92834	LP/P	Retinitis pigmentosa 3 (RP3) [MIM:300029]	H2U0X0	43	G	R
Q92834	LP/P	Retinitis pigmentosa 3 (RP3) [MIM:300029]	H2U0X0	127	R	G
Q92834	LP/P	Retinitis pigmentosa 3 (RP3) [MIM:300029]	H2U0X0	173	G	R
Q92834	LP/P	Retinitis pigmentosa and sinorespiratory infections with or without deafness (RPDSI) [MIM:300455]	H2U0X0	173	G	R
Q92834	LP/P	Retinitis pigmentosa 3 (RP3) [MIM:300029]	H2U0X0	250	C	Y
Q92834	LP/P	Retinitis pigmentosa 3 (RP3) [MIM:300029]	H2U0X0	267	G	E
Q92834	LP/P	Retinitis pigmentosa 3 (RP3) [MIM:300029]	H2U0X0	302	C	Y
Q92834	LP/P	Retinitis pigmentosa 3 (RP3) [MIM:300029]	H2U0X0	312	D	N
Q92834	LP/P	Retinitis pigmentosa 3 (RP3) [MIM:300029]	H2U0X0	312	D	Y
Q92834	LP/P	Retinitis pigmentosa 3 (RP3) [MIM:300029]	H2U0X0	320	G	R
Q92834	LB/B	-	H2U0X0	345	N	D
Q92834	LP/P	Retinitis pigmentosa 3 (RP3) [MIM:300029]	H2U0X0	152	S	L
Q92834	LP/P	Retinitis pigmentosa 3 (RP3) [MIM:300029]	H2U0X0	267	G	R
Q92834	LP/P	Retinitis pigmentosa 3 (RP3) [MIM:300029]	H2U0X0	285	E	G
Q92834	LB/B	-	H2U0X0	184	Q	H
P49247	LP/P	Ribose 5-phosphate isomerase deficiency (RPIAD) [MIM:608611]	H0VFB7	135	A	V
P27635	LB/B	-	A0A1I8HYW0	202	S	N
P27635	LP/P	Autism, X-linked 5 (AUTSX5) [MIM:300847]	A0A1I8HYW0	206	L	M
P27635	LP/P	Autism, X-linked 5 (AUTSX5) [MIM:300847]	A0A1I8HYW0	213	H	Q
P27635	LP/P	Intellectual developmental disorder, X-linked, syndromic 35 (MRXS35) [MIM:300998]	A0A1I8HYW0	64	A	V
P27635	LP/P	Intellectual developmental disorder, X-linked, syndromic 35 (MRXS35) [MIM:300998]	A0A1I8HYW0	78	K	E
P62906	LB/B	-	A0A061HXQ3	154	T	P
P26373	LB/B	-	A0A151P4L2	112	A	T
P26373	LB/B	-	A0A151P4L2	170	T	P
P26373	LP/P	Spondyloepimetaphyseal dysplasia, Isidor-Toutain type (SEMDIST) [MIM:618728]	A0A151P4L2	183	R	P
P50914	LB/B	-	A0A2K5K3Q3	138	A	S
P46779	LB/B	-	S9Y5H7	66	R	L
P18077	LP/P	Diamond-Blackfan anemia 5 (DBA5) [MIM:612528]	L9KGM3	33	V	I
Q9Y3U8	LB/B	-	A0A1S3AM78	67	K	E
Q969Q0	LB/B	-	A0A2U3ZR68	66	I	V
Q92901	LB/B	-	A0A091DRI9	291	P	L
P46777	LB/B	-	L5K797	210	Y	C
P46777	LP/P	Diamond-Blackfan anemia 6 (DBA6) [MIM:612561]	L5K797	140	G	S
P46777	LP/P	Diamond-Blackfan anemia 6 (DBA6) [MIM:612561]	L5K797	285	A	V
Q02878	LB/B	-	A0A1U7UCS7	227	H	R
Q02878	LB/B	-	A0A1U7UCS7	237	K	E
P62917	LB/B	-	A0A091DJB9	98	I	V
P04844	LB/B	-	A0A2C9K018	597	L	F
Q9H633	LB/B	-	A0A250YAM1	77	Q	H
Q9H633	LB/B	-	A0A250YAM1	149	Q	K
P78346	LB/B	-	A0A147AHY0	12	G	D
P78345	LB/B	-	I3NFY0	88	E	D
P78345	LB/B	-	I3NFY0	114	A	V
P78345	LB/B	-	I3NFY0	181	A	G
P78345	LB/B	-	I3NFY0	212	I	T
P78345	LB/B	-	I3NFY0	86	I	V
P78345	LB/B	-	I3NFY0	202	S	R
P78345	LB/B	-	I3NFY0	250	R	G
Q8N326	LB/B	-	Q8N326	70	R	K
O75818	LB/B	-	A0A2Y9P898	314	V	I
P08708	LB/B	-	A0A0S7KCJ6	36	E	K
P39019	LP/P	Diamond-Blackfan anemia 1 (DBA1) [MIM:105650]	L9L842	62	R	W
P39019	LP/P	Diamond-Blackfan anemia 1 (DBA1) [MIM:105650]	L9L842	56	R	Q
P39019	LP/P	Diamond-Blackfan anemia 1 (DBA1) [MIM:105650]	L9L842	15	V	F
P39019	LP/P	Diamond-Blackfan anemia 1 (DBA1) [MIM:105650]	L9L842	18	L	P
P39019	LP/P	Diamond-Blackfan anemia 1 (DBA1) [MIM:105650]	L9L842	47	P	L
P39019	LP/P	Diamond-Blackfan anemia 1 (DBA1) [MIM:105650]	L9L842	52	W	R
P39019	LP/P	Diamond-Blackfan anemia 1 (DBA1) [MIM:105650]	L9L842	55	T	M
P39019	LP/P	Diamond-Blackfan anemia 1 (DBA1) [MIM:105650]	L9L842	61	A	E
P39019	LP/P	Diamond-Blackfan anemia 1 (DBA1) [MIM:105650]	L9L842	62	R	Q
P39019	LP/P	Diamond-Blackfan anemia 1 (DBA1) [MIM:105650]	L9L842	101	R	H
P39019	LP/P	Diamond-Blackfan anemia 1 (DBA1) [MIM:105650]	L9L842	120	G	R
P39019	LP/P	Diamond-Blackfan anemia 1 (DBA1) [MIM:105650]	L9L842	131	L	P
P39019	LP/P	Diamond-Blackfan anemia 1 (DBA1) [MIM:105650]	L9L842	17	A	P
P39019	LP/P	Diamond-Blackfan anemia 1 (DBA1) [MIM:105650]	L9L842	18	L	R
P39019	LP/P	Diamond-Blackfan anemia 1 (DBA1) [MIM:105650]	L9L842	59	S	F
P39019	LP/P	Diamond-Blackfan anemia 1 (DBA1) [MIM:105650]	L9L842	131	L	R
P39019	LP/P	Diamond-Blackfan anemia 1 (DBA1) [MIM:105650]	L9L842	21	F	S
P39019	LP/P	Diamond-Blackfan anemia 1 (DBA1) [MIM:105650]	L9L842	52	W	C
P39019	LP/P	Diamond-Blackfan anemia 1 (DBA1) [MIM:105650]	L9L842	57	A	P
P39019	LP/P	Diamond-Blackfan anemia 1 (DBA1) [MIM:105650]	L9L842	64	L	P
P39019	LP/P	Diamond-Blackfan anemia 1 (DBA1) [MIM:105650]	L9L842	76	T	P
P39019	LP/P	Diamond-Blackfan anemia 1 (DBA1) [MIM:105650]	L9L842	127	G	E
P39019	LP/P	Diamond-Blackfan anemia 1 (DBA1) [MIM:105650]	L9L842	135	A	T
Q86WX3	LB/B	-	A0A091X650	124	E	A
P62266	LP/P	Brachycephaly, trichomegaly, and developmental delay (BTDD) [MIM:617412]	B3T6H5	67	R	K
P62266	LP/P	Brachycephaly, trichomegaly, and developmental delay (BTDD) [MIM:617412]	B3T6H5	120	F	I
P62854	LP/P	Diamond-Blackfan anemia 10 (DBA10) [MIM:613309]	H0VFT1	33	D	N
P62854	LP/P	Diamond-Blackfan anemia 10 (DBA10) [MIM:613309]	H0VFT1	115	M	T
Q15418	LB/B	-	G1SI78	335	K	T
P51812	LB/B	-	A0A0P7V7B7	38	I	S
P51812	LP/P	Coffin-Lowry syndrome (CLS) [MIM:303600]	A0A0P7V7B7	75	G	V
P51812	LP/P	Coffin-Lowry syndrome (CLS) [MIM:303600]	A0A0P7V7B7	82	V	F
P51812	LP/P	Coffin-Lowry syndrome (CLS) [MIM:303600]	A0A0P7V7B7	114	R	W
P51812	LP/P	Coffin-Lowry syndrome (CLS) [MIM:303600]	A0A0P7V7B7	127	H	Q
P51812	LP/P	Coffin-Lowry syndrome (CLS) [MIM:303600]	A0A0P7V7B7	154	D	Y
P51812	LP/P	Coffin-Lowry syndrome (CLS) [MIM:303600]	A0A0P7V7B7	225	A	V
P51812	LP/P	Coffin-Lowry syndrome (CLS) [MIM:303600]	A0A0P7V7B7	227	S	A
P51812	LP/P	Coffin-Lowry syndrome (CLS) [MIM:303600]	A0A0P7V7B7	431	G	D
P51812	LP/P	Coffin-Lowry syndrome (CLS) [MIM:303600]	A0A0P7V7B7	729	R	Q
P51812	LB/B	-	A0A0P7V7B7	723	R	C
P51812	LP/P	Intellectual developmental disorder, X-linked 19 (XLID19) [MIM:300844]	A0A0P7V7B7	115	T	S
P51812	LP/P	Coffin-Lowry syndrome (CLS) [MIM:303600]	A0A0P7V7B7	189	I	K
P51812	LP/P	Coffin-Lowry syndrome (CLS) [MIM:303600]	A0A0P7V7B7	268	F	S
P51812	LP/P	Intellectual developmental disorder, X-linked 19 (XLID19) [MIM:300844]	A0A0P7V7B7	383	R	W
O75582	LB/B	-	I3LQZ5	554	D	N
O75582	LB/B	-	I3LQZ5	574	P	L
O75582	LB/B	-	I3LQZ5	599	Y	C
O75582	LB/B	-	I3LQZ5	190	H	R
Q9UK32	LB/B	-	A0A091DQ83	692	D	N
Q9UBS0	LB/B	-	A0A2U9BQN6	267	P	L
Q9UBS0	LB/B	-	A0A2U9BQN6	368	V	M
Q9UBS0	LB/B	-	A0A2U9BQN6	420	A	V
Q96S38	LB/B	-	A0A091T486	42	P	T
Q96S38	LB/B	-	A0A091T486	96	E	K
Q96S38	LB/B	-	A0A091T486	319	P	L
Q96S38	LB/B	-	A0A091T486	424	P	L
Q96S38	LB/B	-	A0A091T486	546	A	P
Q96S38	LB/B	-	A0A091T486	575	N	S
Q96S38	LB/B	-	A0A091T486	853	L	F
Q96S38	LB/B	-	A0A091T486	561	P	R
Q9Y6S9	LB/B	-	H2MPZ7	21	R	Q
Q9Y6S9	LB/B	-	H2MPZ7	121	P	L
Q9Y6S9	LB/B	-	H2MPZ7	332	R	W
P62241	LB/B	-	A0A0F8C4K9	110	R	G
Q6XPR3	LB/B	-	A0A2K6BR78	320	S	G
Q9UJJ7	LB/B	-	A0A093G3N1	124	E	Q
Q9UJJ7	LB/B	-	A0A093G3N1	247	L	P
Q96CM3	LB/B	-	A0A146WZX9	44	Q	R
Q96CM3	LB/B	-	A0A146WZX9	58	D	G
Q96CM3	LB/B	-	A0A146WZX9	155	E	D
Q96CM3	LB/B	-	A0A146WZX9	209	A	V
P62070	LP/P	Noonan syndrome 12 (NS12) [MIM:618624]	A0A261XW47	72	Q	L
P62070	LP/P	Noonan syndrome 12 (NS12) [MIM:618624]	A0A261XW47	23	G	V
P62070	LP/P	Noonan syndrome 12 (NS12) [MIM:618624]	A0A261XW47	70	A	T
P62070	LP/P	Noonan syndrome 12 (NS12) [MIM:618624]	A0A261XW47	72	Q	H
P62070	LB/B	-	A0A261XW47	75	F	C
Q92766	LB/B	-	G3N5V1	195	G	R
Q92766	LB/B	-	G3N5V1	783	G	V
Q92766	LB/B	-	G3N5V1	1171	D	N
Q92766	LB/B	-	G3N5V1	1384	G	R
Q92766	LB/B	-	G3N5V1	1467	L	P
Q92766	LB/B	-	G3N5V1	1499	S	Y
P23921	LB/B	-	V4BLJ2	590	K	Q
P23921	LB/B	-	V4BLJ2	778	V	A
Q7LG56	LP/P	Mitochondrial DNA depletion syndrome 8A (MTDPS8A) [MIM:612075]	S9XI31	64	W	R
Q7LG56	LP/P	Mitochondrial DNA depletion syndrome 8A (MTDPS8A) [MIM:612075]	S9XI31	194	E	G
Q7LG56	LP/P	Mitochondrial DNA depletion syndrome 8A (MTDPS8A) [MIM:612075]	S9XI31	194	E	K
Q7LG56	LP/P	Mitochondrial DNA depletion syndrome 8A (MTDPS8A) [MIM:612075]	S9XI31	224	I	S
Q7LG56	LP/P	Mitochondrial DNA depletion syndrome 8A (MTDPS8A) [MIM:612075]	S9XI31	236	C	F
Q7LG56	LP/P	Mitochondrial DNA depletion syndrome 8A (MTDPS8A) [MIM:612075]	S9XI31	282	M	I
Q7LG56	LP/P	Mitochondrial DNA depletion syndrome 8A (MTDPS8A) [MIM:612075]	S9XI31	317	L	V
Q7LG56	LP/P	Mitochondrial DNA depletion syndrome 8B (MTDPS8B) [MIM:612075]	S9XI31	110	R	H
Q7LG56	LP/P	Mitochondrial DNA depletion syndrome 8B (MTDPS8B) [MIM:612075]	S9XI31	121	R	H
Q7LG56	LP/P	Rod-cone dystrophy, sensorineural deafness, and Fanconi-type renal dysfunction (RCDFRD) [MIM:268315]	S9XI31	262	E	D
Q9NYV6	LB/B	-	A0A091VHP8	348	I	M
P56182	LB/B	-	Q5NVP1	194	I	V
P56182	LB/B	-	Q5NVP1	326	K	R
Q5JTH9	LB/B	-	A0A2J7PYA8	1145	G	S
Q5JTH9	LB/B	-	A0A2J7PYA8	1281	R	Q
Q9Y3B9	LB/B	-	H0X243	149	K	N
Q9Y3B9	LB/B	-	H0X243	230	K	R
Q9Y3B9	LB/B	-	H0X243	32	A	V
Q14684	LB/B	-	A0A091X339	436	L	P
Q9Y3A4	LB/B	-	U3KPI8	75	L	M
Q9Y3A4	LB/B	-	U3KPI8	85	V	I
Q9Y3A4	LB/B	-	U3KPI8	88	V	I
Q9Y3A4	LP/P	Microcephaly 28, primary, autosomal recessive (MCPH28) [MIM:619453]	U3KPI8	155	W	C
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	72	E	D
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	72	E	K
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	74	G	V
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	96	W	R
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	102	R	W
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	109	G	R
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	12	L	H
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	13	L	P
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	59	C	S
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	65	Y	C
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	70	G	A
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	70	G	S
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	89	Y	C
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	98	A	E
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	102	R	Q
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	103	L	R
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	108	F	C
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	109	G	E
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	109	G	W
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	110	C	Y
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	112	W	C
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	113	L	F
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	127	L	P
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	135	G	V
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	136	I	T
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	138	T	A
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	140	G	E
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	140	G	R
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	141	R	C
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	141	R	G
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	141	R	H
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	142	C	W
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	143	D	V
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	146	E	D
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	146	E	K
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	155	Y	C
O15537	LB/B	-	A0A2Y9DXA9	158	D	N
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	163	W	C
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	178	G	D
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	182	R	C
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	192	P	R
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	192	P	S
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	193	P	L
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	193	P	S
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	197	R	C
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	197	R	H
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	199	I	T
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	200	R	C
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	200	R	H
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	203	P	L
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	207	H	Q
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	209	R	H
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	213	R	W
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	215	E	K
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	215	E	Q
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	216	L	P
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	219	C	G
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	219	C	R
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	223	C	R
O15537	LB/B	-	A0A2Y9DXA9	222	K	N
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	73	S	P
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	145	D	H
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	156	R	G
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	192	P	L
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	209	R	C
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	213	R	Q
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	72	E	G
O15537	LP/P	Retinoschisis juvenile X-linked 1 (XLRS1) [MIM:312700]	A0A2Y9DXA9	206	W	C
Q9HA92	LB/B	-	A0A2Y9LXM4	119	A	T
Q9HA92	LB/B	-	A0A2Y9LXM4	126	L	S
Q9HA92	LB/B	-	A0A2Y9LXM4	354	E	Q
Q92681	LB/B	-	H0XPH6	62	F	L
Q92681	LB/B	-	H0XPH6	191	C	W
Q92681	LB/B	-	H0XPH6	271	N	S
Q96T23	LB/B	-	Q96T23	475	S	P
Q96T23	LB/B	-	Q96T23	304	E	D
Q8WYR4	LP/P	Ciliary dyskinesia, primary, 24 (CILD24) [MIM:615481]	H0UY56	103	G	D
Q9UHP6	LB/B	-	A0A1W5BJ63	42	T	M
Q6UXX9	LB/B	-	G1SE19	186	L	P
Q6UXX9	LP/P	Humerofemoral hypoplasia with radiotibial ray deficiency (HHRRD) [MIM:618022]	G1SE19	69	R	C
Q2I0M5	LP/P	Nail disorder, non-syndromic congenital, 4 (NDNC4) [MIM:206800]	A0A1S3EQA9	65	Q	R
Q2I0M5	LP/P	Nail disorder, non-syndromic congenital, 4 (NDNC4) [MIM:206800]	A0A1S3EQA9	95	C	F
Q2I0M5	LP/P	Nail disorder, non-syndromic congenital, 4 (NDNC4) [MIM:206800]	A0A1S3EQA9	107	C	R
Q2I0M5	LP/P	Nail disorder, non-syndromic congenital, 4 (NDNC4) [MIM:206800]	A0A1S3EQA9	118	C	Y
Q2I0M5	LB/B	-	A0A1S3EQA9	106	R	Q
Q96DX4	LP/P	Spondyloepimetaphyseal dysplasia, Faden-Alkuraya type (SEMDFA) [MIM:616723]	A0A226P7N7	41	G	C
Q9BUV0	LB/B	-	Q3UC65	147	Y	H
Q9BUV0	LB/B	-	Q3UC65	239	E	G
Q9Y3I0	LB/B	-	L8Y4K2	343	L	F
Q9Y3I0	LB/B	-	L8Y4K2	153	V	A
Q9NZ71	LB/B	-	A0A212CBW5	124	N	S
Q9NZ71	LB/B	-	A0A212CBW5	1042	Q	H
Q9NZ71	LP/P	Dyskeratosis congenita, autosomal recessive, 5 (DKCB5) [MIM:615190]	A0A212CBW5	251	E	K
Q9NZ71	LP/P	Dyskeratosis congenita, autosomal recessive, 5 (DKCB5) [MIM:615190]	A0A212CBW5	492	M	I
Q9NZ71	LP/P	Dyskeratosis congenita, autosomal recessive, 5 (DKCB5) [MIM:615190]	A0A212CBW5	591	E	D
Q9NZ71	LP/P	Dyskeratosis congenita, autosomal dominant, 4 (DKCA4) [MIM:615190]	A0A212CBW5	621	A	T
Q9NZ71	LB/B	-	A0A212CBW5	684	R	Q
Q9NZ71	LP/P	Dyskeratosis congenita, autosomal recessive, 5 (DKCB5) [MIM:615190]	A0A212CBW5	699	I	M
Q9NZ71	LP/P	Dyskeratosis congenita, autosomal recessive, 5 (DKCB5) [MIM:615190]	A0A212CBW5	710	L	R
Q9NZ71	LP/P	Dyskeratosis congenita, autosomal recessive, 5 (DKCB5) [MIM:615190]	A0A212CBW5	739	G	V
Q9NZ71	LP/P	Dyskeratosis congenita, autosomal recessive, 5 (DKCB5) [MIM:615190]	A0A212CBW5	745	V	M
Q9NZ71	LB/B	-	A0A212CBW5	829	Q	P
Q9NZ71	LB/B	-	A0A212CBW5	849	G	D
Q9NZ71	LP/P	Dyskeratosis congenita, autosomal recessive, 5 (DKCB5) [MIM:615190]	A0A212CBW5	897	K	E
Q9NZ71	LB/B	-	A0A212CBW5	929	A	T
Q9NZ71	LP/P	Dyskeratosis congenita, autosomal recessive, 5 (DKCB5) [MIM:615190]	A0A212CBW5	957	R	W
Q9NZ71	LP/P	Dyskeratosis congenita, autosomal recessive, 5 (DKCB5) [MIM:615190]	A0A212CBW5	964	F	L
Q9NZ71	LB/B	-	A0A212CBW5	1034	P	H
Q9NZ71	LB/B	-	A0A212CBW5	1059	A	T
Q9NZ71	LP/P	Pulmonary fibrosis, and/or bone marrow failure, telomere-related, 3 (PFBMFT3) [MIM:616373]	A0A212CBW5	484	P	L
Q9NZ71	LP/P	Pulmonary fibrosis, and/or bone marrow failure, telomere-related, 3 (PFBMFT3) [MIM:616373]	A0A212CBW5	647	P	L
Q9NZ71	LP/P	Pulmonary fibrosis, and/or bone marrow failure, telomere-related, 3 (PFBMFT3) [MIM:616373]	A0A212CBW5	1124	H	P
A6NKG5	LB/B	-	D4YW73	848	E	Q
Q7L3V2	LB/B	-	A0A2U3UYJ9	116	R	H
Q7L3V2	LB/B	-	A0A2U3UYJ9	123	D	Y
Q6ZR62	LB/B	-	S9W890	27	L	P
Q6ZR62	LB/B	-	S9W890	162	D	Y
Q9BWD3	LB/B	-	A0A1U7TWU2	48	S	C
A6ZKI3	LB/B	-	A0A1U7TWU2	60	S	N
O15255	LB/B	-	H2PWU6	152	S	W
Q8NET4	LB/B	-	G3TV41	777	P	S
O75298	LB/B	-	A0A250YIK0	425	R	Q
O75298	LP/P	Spastic paraplegia 12, autosomal dominant (SPG12) [MIM:604805]	A0A250YIK0	367	S	F
O95197	LB/B	-	A0A2K6UQZ0	6	A	E
O95197	LB/B	-	A0A2K6UQZ0	501	D	H
Q8WWV3	LP/P	Optic atrophy 10 with or without ataxia, impaired intellectual development, and seizures (OPA10) [MIM:616732]	A0A1A6HKL0	103	R	H
Q9BZR6	LP/P	Schizophrenia (SCZD) [MIM:181500]	A0A2R8Z8R0	119	R	W
Q9BZR6	LP/P	Schizophrenia (SCZD) [MIM:181500]	A0A2R8Z8R0	196	R	H
Q9BZR6	LB/B	-	A0A2R8Z8R0	53	V	M
Q9BZR6	LB/B	-	A0A2R8Z8R0	68	R	H
Q9BZR6	LB/B	-	A0A2R8Z8R0	141	G	S
Q9BZR6	LB/B	-	A0A2R8Z8R0	227	R	H
Q9BZR6	LB/B	-	A0A2R8Z8R0	259	D	N
Q9BZR6	LB/B	-	A0A2R8Z8R0	263	V	M
Q9BZR6	LP/P	Schizophrenia (SCZD) [MIM:181500]	A0A2R8Z8R0	292	R	H
Q9BZR6	LB/B	-	A0A2R8Z8R0	314	G	S
Q9BZR6	LB/B	-	A0A2R8Z8R0	329	P	L
Q9BZR6	LB/B	-	A0A2R8Z8R0	363	V	M
Q9BZR6	LP/P	Schizophrenia (SCZD) [MIM:181500]	A0A2R8Z8R0	377	R	Q
Q9BZR6	LP/P	Schizophrenia (SCZD) [MIM:181500]	A0A2R8Z8R0	377	R	W
P59025	LB/B	-	F7DH23	212	A	G
P59025	LB/B	-	F7DH23	229	Q	E
Q5QGT7	LB/B	-	F7DH23	82	Q	R
Q96DX8	LB/B	-	A0A2K6FBL8	79	T	I
Q96DX8	LB/B	-	A0A2K6FBL8	168	S	N
Q14D33	LB/B	-	H2P976	101	G	E
Q14D33	LB/B	-	H2P976	412	G	D
Q86VV8	LB/B	-	F1PJJ8	126	S	A
Q86VV8	LB/B	-	F1PJJ8	245	K	R
Q86VV8	LB/B	-	F1PJJ8	1742	H	R
Q86VV8	LB/B	-	F1PJJ8	1761	F	S
Q86VV8	LP/P	Microcephaly, short stature, and polymicrogyria with or without seizures (MSSP) [MIM:614833]	F1PJJ8	27	C	Y
Q86VV8	LP/P	Microcephaly, short stature, and polymicrogyria with or without seizures (MSSP) [MIM:614833]	F1PJJ8	932	L	F
Q9H714	LB/B	-	G1M3U6	152	G	R
Q96T51	LB/B	-	A0A0P7Z4H1	298	H	Q
Q8WXA3	LB/B	-	A0A091E2J3	573	C	S
Q96NL0	LB/B	-	A0A2D0PQ87	47	L	M
Q96NL0	LB/B	-	A0A2D0PQ87	206	E	G
Q96NL0	LB/B	-	A0A2D0PQ87	440	L	P
Q01196	LP/P	Familial platelet disorder with associated myeloid malignancy (FPDMM) [MIM:601399]	F6QMT3	139	R	Q
Q01196	LP/P	Familial platelet disorder with associated myeloid malignancy (FPDMM) [MIM:601399]	F6QMT3	174	R	Q
Q01196	LB/B	-	F6QMT3	431	S	R
Q01196	LB/B	-	F6QMT3	433	S	R
Q13950	LP/P	Cleidocranial dysplasia 1 (CLCD1) [MIM:119600]	G3SVG2	113	L	R
Q13950	LP/P	Cleidocranial dysplasia 1 (CLCD1) [MIM:119600]	G3SVG2	118	S	R
Q13950	LP/P	Cleidocranial dysplasia 1 (CLCD1) [MIM:119600]	G3SVG2	121	F	C
Q13950	LP/P	Cleidocranial dysplasia 1 (CLCD1) [MIM:119600]	G3SVG2	123	C	R
Q13950	LP/P	Cleidocranial dysplasia 1 (CLCD1) [MIM:119600]	G3SVG2	169	R	Q
Q13950	LP/P	Cleidocranial dysplasia 1 (CLCD1) [MIM:119600]	G3SVG2	175	M	R
Q13950	LP/P	Cleidocranial dysplasia 1 (CLCD1) [MIM:119600]	G3SVG2	190	R	Q
Q13950	LP/P	Cleidocranial dysplasia 1 (CLCD1) [MIM:119600]	G3SVG2	190	R	W
Q13950	LP/P	Cleidocranial dysplasia 1 (CLCD1) [MIM:119600]	G3SVG2	191	S	N
Q13950	LP/P	Cleidocranial dysplasia 1 (CLCD1) [MIM:119600]	G3SVG2	193	R	C
Q13950	LP/P	Cleidocranial dysplasia 1 (CLCD1) [MIM:119600]	G3SVG2	197	F	S
Q13950	LP/P	Cleidocranial dysplasia 1 (CLCD1) [MIM:119600]	G3SVG2	199	L	F
Q13950	LP/P	Cleidocranial dysplasia 1 (CLCD1) [MIM:119600]	G3SVG2	200	T	A
Q13950	LP/P	Cleidocranial dysplasia 1 (CLCD1) [MIM:119600]	G3SVG2	205	T	R
Q13950	LP/P	Cleidocranial dysplasia 1 (CLCD1) [MIM:119600]	G3SVG2	209	Q	R
Q13950	LP/P	Cleidocranial dysplasia 1 (CLCD1) [MIM:119600]	G3SVG2	225	R	Q
Q13950	LP/P	Cleidocranial dysplasia 1 (CLCD1) [MIM:119600]	G3SVG2	225	R	W
Q13950	LB/B	-	G3SVG2	511	G	S
Q13950	LP/P	Cleidocranial dysplasia 1 (CLCD1) [MIM:119600]	G3SVG2	53	Q	L
Q13950	LP/P	Cleidocranial dysplasia 1 (CLCD1) [MIM:119600]	G3SVG2	118	S	N
Q13950	LP/P	Cleidocranial dysplasia 1 (CLCD1) [MIM:119600]	G3SVG2	131	R	C
Q13950	LP/P	Cleidocranial dysplasia 1 (CLCD1) [MIM:119600]	G3SVG2	131	R	G
Q13950	LP/P	Cleidocranial dysplasia 1 (CLCD1) [MIM:119600]	G3SVG2	131	R	S
Q13950	LP/P	Cleidocranial dysplasia 1 (CLCD1) [MIM:119600]	G3SVG2	136	L	P
Q13950	LP/P	Cleidocranial dysplasia 1 (CLCD1) [MIM:119600]	G3SVG2	156	V	D
Q13950	LP/P	Cleidocranial dysplasia 1 (CLCD1) [MIM:119600]	G3SVG2	156	V	G
Q13950	LP/P	Cleidocranial dysplasia 1 (CLCD1) [MIM:119600]	G3SVG2	169	R	P
Q13950	LP/P	Cleidocranial dysplasia 1 (CLCD1) [MIM:119600]	G3SVG2	175	M	K
Q13950	LP/P	Cleidocranial dysplasia 1 (CLCD1) [MIM:119600]	G3SVG2	175	M	V
Q13950	LP/P	Cleidocranial dysplasia 1 (CLCD1) [MIM:119600]	G3SVG2	187	F	S
Q13950	LP/P	Cleidocranial dysplasia 1 (CLCD1) [MIM:119600]	G3SVG2	193	R	Q
Q13950	LP/P	Cleidocranial dysplasia 1 (CLCD1) [MIM:119600]	G3SVG2	200	T	I
Q13950	LP/P	Cleidocranial dysplasia 1 (CLCD1) [MIM:119600]	G3SVG2	201	I	K
Q13950	LP/P	Cleidocranial dysplasia 1 (CLCD1) [MIM:119600]	G3SVG2	209	Q	H
Q13950	LP/P	Cleidocranial dysplasia 1 (CLCD1) [MIM:119600]	G3SVG2	211	A	P
Q13950	LP/P	Cleidocranial dysplasia 1 (CLCD1) [MIM:119600]	G3SVG2	218	K	E
Q13950	LP/P	Cleidocranial dysplasia 1 (CLCD1) [MIM:119600]	G3SVG2	218	K	N
Q13950	LP/P	Cleidocranial dysplasia 1 (CLCD1) [MIM:119600]	G3SVG2	218	K	Q
Q13950	LP/P	Cleidocranial dysplasia 1 (CLCD1) [MIM:119600]	G3SVG2	220	T	I
Q13950	LP/P	Cleidocranial dysplasia 1 (CLCD1) [MIM:119600]	G3SVG2	225	R	L
Q13950	LP/P	Cleidocranial dysplasia 1 (CLCD1) [MIM:119600]	G3SVG2	228	R	G
Q13950	LP/P	Cleidocranial dysplasia 1 (CLCD1) [MIM:119600]	G3SVG2	233	K	R
Q13950	LP/P	Cleidocranial dysplasia 1 (CLCD1) [MIM:119600]	G3SVG2	287	D	N
Q13950	LP/P	Cleidocranial dysplasia 1 (CLCD1) [MIM:119600]	G3SVG2	362	A	V
Q13950	LP/P	Cleidocranial dysplasia 1 (CLCD1) [MIM:119600]	G3SVG2	420	T	I
Q13950	LP/P	Cleidocranial dysplasia 1 (CLCD1) [MIM:119600]	G3SVG2	420	T	N
Q13950	LP/P	Cleidocranial dysplasia 1 (CLCD1) [MIM:119600]	G3SVG2	186	R	T
Q13950	LP/P	Cleidocranial dysplasia 1 (CLCD1) [MIM:119600]	G3SVG2	193	R	G
Q9BVN2	LB/B	-	F1RLL8	362	S	F
Q9BVN2	LB/B	-	F1RLL8	493	V	A
Q8N2Y8	LB/B	-	W5MAM7	73	T	A
Q8N2Y8	LB/B	-	W5MAM7	654	P	L
Q8TDU9	LB/B	-	G1RNS4	329	L	S
Q9Y2B1	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A10 (MDDGA10) [MIM:615041]	H0W105	339	Y	C
Q9Y2B1	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A10 (MDDGA10) [MIM:615041]	H0W105	340	R	L
P34925	LB/B	-	A0A2Y9KA78	99	S	N
P34925	LB/B	-	A0A2Y9KA78	227	R	C
P33764	LB/B	-	A0A146RIS7	3	R	K
P33763	LB/B	-	W5MMW1	54	D	G
P31151	LB/B	-	A0A212CGN9	28	E	D
Q86SG5	LB/B	-	A0A212CGN9	84	A	T
Q86SG5	LB/B	-	A0A212CGN9	23	R	H
P06702	LB/B	-	A0A2K6NUC4	20	H	R
P21453	LB/B	-	A0A2U4A3V6	15	S	L
P21453	LB/B	-	A0A2U4A3V6	115	A	T
P21453	LB/B	-	A0A2U4A3V6	332	P	R
Q99500	LB/B	-	A0A1L8GVS0	243	R	Q
O95977	LB/B	-	A0A2I0U4X8	365	R	L
Q9H228	LB/B	-	A0A1L8GVS0	318	L	Q
P35542	LB/B	-	A0A096LPE2	89	C	Y
A6NKF1	LB/B	-	A0A1S3FI86	8	T	P
A6NKF1	LB/B	-	A0A1S3FI86	186	L	P
A6NKF1	LB/B	-	A0A1S3FI86	155	L	R
Q9NTJ5	LB/B	-	A0A087UT65	434	Y	F
Q9NZJ4	LB/B	-	H3A3T5	3369	V	A
Q9NZJ4	LB/B	-	H3A3T5	232	N	K
Q9NZJ4	LB/B	-	H3A3T5	694	A	T
Q9NZJ4	LB/B	-	H3A3T5	2017	K	N
Q9NZJ4	LB/B	-	H3A3T5	2958	K	R
Q9NZJ4	LB/B	-	H3A3T5	3678	P	A
Q9NZJ4	LB/B	-	H3A3T5	4217	N	D
Q9NZJ4	LP/P	Spastic ataxia Charlevoix-Saguenay type (SACS) [MIM:270550]	H3A3T5	168	D	Y
Q9NZJ4	LP/P	Spastic ataxia Charlevoix-Saguenay type (SACS) [MIM:270550]	H3A3T5	201	T	K
Q9NZJ4	LP/P	Spastic ataxia Charlevoix-Saguenay type (SACS) [MIM:270550]	H3A3T5	308	L	F
Q9NZJ4	LP/P	Spastic ataxia Charlevoix-Saguenay type (SACS) [MIM:270550]	H3A3T5	556	L	P
Q9NZJ4	LP/P	Spastic ataxia Charlevoix-Saguenay type (SACS) [MIM:270550]	H3A3T5	802	L	P
Q9NZJ4	LP/P	Spastic ataxia Charlevoix-Saguenay type (SACS) [MIM:270550]	H3A3T5	991	C	R
Q9NZJ4	LP/P	Spastic ataxia Charlevoix-Saguenay type (SACS) [MIM:270550]	H3A3T5	1054	F	S
Q9NZJ4	LP/P	Spastic ataxia Charlevoix-Saguenay type (SACS) [MIM:270550]	H3A3T5	1311	M	K
Q9NZJ4	LP/P	Spastic ataxia Charlevoix-Saguenay type (SACS) [MIM:270550]	H3A3T5	1575	R	P
Q9NZJ4	LP/P	Spastic ataxia Charlevoix-Saguenay type (SACS) [MIM:270550]	H3A3T5	1587	H	R
Q9NZJ4	LP/P	Spastic ataxia Charlevoix-Saguenay type (SACS) [MIM:270550]	H3A3T5	1946	W	R
Q9NZJ4	LP/P	Spastic ataxia Charlevoix-Saguenay type (SACS) [MIM:270550]	H3A3T5	2703	R	C
Q9NZJ4	LP/P	Spastic ataxia Charlevoix-Saguenay type (SACS) [MIM:270550]	H3A3T5	2798	P	Q
Q9NZJ4	LP/P	Spastic ataxia Charlevoix-Saguenay type (SACS) [MIM:270550]	H3A3T5	3248	W	R
Q9NZJ4	LP/P	Spastic ataxia Charlevoix-Saguenay type (SACS) [MIM:270550]	H3A3T5	3481	L	P
Q9NZJ4	LP/P	Spastic ataxia Charlevoix-Saguenay type (SACS) [MIM:270550]	H3A3T5	3636	R	Q
Q9NZJ4	LP/P	Spastic ataxia Charlevoix-Saguenay type (SACS) [MIM:270550]	H3A3T5	3645	L	P
Q9NZJ4	LP/P	Spastic ataxia Charlevoix-Saguenay type (SACS) [MIM:270550]	H3A3T5	3652	P	T
Q9NZJ4	LP/P	Spastic ataxia Charlevoix-Saguenay type (SACS) [MIM:270550]	H3A3T5	3653	F	S
Q9NZJ4	LP/P	Spastic ataxia Charlevoix-Saguenay type (SACS) [MIM:270550]	H3A3T5	4074	A	P
Q9NZJ4	LP/P	Spastic ataxia Charlevoix-Saguenay type (SACS) [MIM:270550]	H3A3T5	4331	R	Q
Q9NZJ4	LP/P	Spastic ataxia Charlevoix-Saguenay type (SACS) [MIM:270550]	H3A3T5	4343	E	K
Q9NZJ4	LP/P	Spastic ataxia Charlevoix-Saguenay type (SACS) [MIM:270550]	H3A3T5	4508	K	T
Q9NZJ4	LP/P	Spastic ataxia Charlevoix-Saguenay type (SACS) [MIM:270550]	H3A3T5	4549	N	D
Q9NZJ4	LP/P	-	H3A3T5	3702	T	A
P10523	LB/B	-	G3NAK9	76	I	V
P10523	LB/B	-	G3NAK9	84	R	C
P10523	LB/B	-	G3NAK9	125	T	M
P10523	LB/B	-	G3NAK9	364	P	L
P10523	LB/B	-	G3NAK9	378	V	I
P10523	LB/B	-	G3NAK9	384	R	C
P10523	LB/B	-	G3NAK9	403	V	I
P10523	LB/B	-	G3NAK9	403	V	A
Q9NXZ1	LB/B	-	G3RSJ3	741	N	K
Q9NXZ1	LB/B	-	G3RSJ3	805	L	S
Q9NSC2	LB/B	-	A0A060YIV0	159	S	G
Q9NSC2	LB/B	-	A0A060YIV0	1265	G	E
Q9BXA9	LB/B	-	A0A060YIV0	593	L	V
Q9BXA9	LB/B	-	A0A060YIV0	533	T	A
Q9UJQ4	LB/B	-	A0A060YIV0	507	L	R
Q9UJQ4	LB/B	-	A0A060YIV0	798	I	L
Q9UJQ4	LP/P	Duane-radial ray syndrome (DRRS) [MIM:607323]	A0A060YIV0	888	H	R
Q9P1V8	LB/B	-	E2RT12	18	L	P
Q9P1V8	LB/B	-	E2RT12	370	K	E
Q9P1V8	LB/B	-	E2RT12	454	K	E
Q9P1V8	LB/B	-	E2RT12	168	M	I
Q8N6K7	LB/B	-	R0KDZ9	94	E	K
Q8N6K7	LB/B	-	R0KDZ9	181	D	N
Q7Z3H4	LB/B	-	F7FYR5	220	E	D
Q5K651	LB/B	-	G3W7T3	143	I	T
Q5K651	LB/B	-	G3W7T3	449	N	S
Q5K651	LB/B	-	G3W7T3	549	V	L
Q5K651	LP/P	Tumoral calcinosis, normophosphatemic, familial (NFTC) [MIM:610455]	G3W7T3	1495	K	E
Q5K651	LP/P	MIRAGE syndrome (MIRAGE) [MIM:617053]	G3W7T3	1293	R	W
Q5K651	LP/P	MIRAGE syndrome (MIRAGE) [MIM:617053]	G3W7T3	459	R	Q
Q5K651	LP/P	MIRAGE syndrome (MIRAGE) [MIM:617053]	G3W7T3	769	D	N
Q5K651	LP/P	MIRAGE syndrome (MIRAGE) [MIM:617053]	G3W7T3	834	N	Y
Q5K651	LP/P	MIRAGE syndrome (MIRAGE) [MIM:617053]	G3W7T3	974	E	K
Q5K651	LP/P	MIRAGE syndrome (MIRAGE) [MIM:617053]	G3W7T3	1195	A	V
Q5K651	LP/P	MIRAGE syndrome (MIRAGE) [MIM:617053]	G3W7T3	1280	P	L
Q5K651	LP/P	MIRAGE syndrome (MIRAGE) [MIM:617053]	G3W7T3	1286	Q	K
Q5K651	LP/P	Monosomy 7 myelodysplasia and leukemia syndrome 2 (M7MLS2) [MIM:619041]	G3W7T3	676	K	E
Q8IVG5	LB/B	-	G3W7T3	266	V	I
Q8IVG5	LB/B	-	G3W7T3	289	F	S
Q8IVG5	LB/B	-	G3W7T3	1137	G	A
Q8IVG5	LB/B	-	G3W7T3	1516	N	T
Q8IVG5	LP/P	Ataxia-pancytopenia syndrome (ATXPC) [MIM:159550]	G3W7T3	880	H	Q
Q8IVG5	LP/P	Monosomy 7 myelodysplasia and leukemia syndrome 1 (M7MLS1) [MIM:252270]	G3W7T3	880	H	Q
Q8IVG5	LP/P	Monosomy 7 myelodysplasia and leukemia syndrome 1 (M7MLS1) [MIM:252270]	G3W7T3	986	R	C
Q8IVG5	LP/P	Monosomy 7 myelodysplasia and leukemia syndrome 1 (M7MLS1) [MIM:252270]	G3W7T3	1281	R	K
Q8IVG5	LP/P	Monosomy 7 myelodysplasia and leukemia syndrome 1 (M7MLS1) [MIM:252270]	G3W7T3	1512	V	A
Q8IVG5	LP/P	Spinocerebellar ataxia 49 (SCA49) [MIM:619806]	G3W7T3	626	S	L
Q9Y3Z3	LP/P	Aicardi-Goutieres syndrome 5 (AGS5) [MIM:612952]	A0A096NSC5	123	H	P
Q9Y3Z3	LP/P	Aicardi-Goutieres syndrome 5 (AGS5) [MIM:612952]	A0A096NSC5	143	R	C
Q9Y3Z3	LP/P	Aicardi-Goutieres syndrome 5 (AGS5) [MIM:612952]	A0A096NSC5	143	R	H
Q9Y3Z3	LP/P	Aicardi-Goutieres syndrome 5 (AGS5) [MIM:612952]	A0A096NSC5	145	R	Q
Q9Y3Z3	LP/P	Aicardi-Goutieres syndrome 5 (AGS5) [MIM:612952]	A0A096NSC5	201	I	N
Q9Y3Z3	LP/P	Chilblain lupus 2 (CHBL2) [MIM:614415]	A0A096NSC5	201	I	N
Q9Y3Z3	LP/P	Aicardi-Goutieres syndrome 5 (AGS5) [MIM:612952]	A0A096NSC5	209	G	S
Q9Y3Z3	LP/P	Aicardi-Goutieres syndrome 5 (AGS5) [MIM:612952]	A0A096NSC5	254	M	V
Q9Y3Z3	LP/P	Aicardi-Goutieres syndrome 5 (AGS5) [MIM:612952]	A0A096NSC5	369	L	S
Q9Y3Z3	LP/P	Aicardi-Goutieres syndrome 5 (AGS5) [MIM:612952]	A0A096NSC5	385	M	V
Q9Y3Z3	LP/P	Aicardi-Goutieres syndrome 5 (AGS5) [MIM:612952]	A0A096NSC5	167	H	Y
Q9Y3Z3	LP/P	Aicardi-Goutieres syndrome 5 (AGS5) [MIM:612952]	A0A096NSC5	290	R	H
Q9Y3Z3	LP/P	Aicardi-Goutieres syndrome 5 (AGS5) [MIM:612952]	A0A096NSC5	448	I	T
Q9NSI8	LB/B	-	A0A2Y9JG27	63	G	A
Q9Y6B6	LP/P	Chylomicron retention disease (CMRD) [MIM:246700]	L9KX28	37	G	R
Q9Y6B6	LP/P	Chylomicron retention disease (CMRD) [MIM:246700]	L9KX28	137	D	N
Q9Y6B6	LP/P	Chylomicron retention disease (CMRD) [MIM:246700]	L9KX28	179	S	R
Q9Y6B6	LP/P	Chylomicron retention disease (CMRD) [MIM:246700]	L9KX28	11	G	D
Q9Y6B6	LP/P	Chylomicron retention disease (CMRD) [MIM:246700]	L9KX28	75	D	G
Q96BY9	LB/B	-	A0A1S3JBE7	78	P	T
Q9BW04	LB/B	-	M3X410	87	P	S
Q9BW04	LB/B	-	M3X410	107	T	A
Q9BW04	LB/B	-	M3X410	157	N	T
Q9BW04	LB/B	-	M3X410	258	R	G
Q9BW04	LB/B	-	M3X410	434	N	S
Q9BW04	LB/B	-	M3X410	444	S	P
Q9BW04	LB/B	-	M3X410	514	F	S
Q6SZW1	LB/B	-	A0A2U3VWE3	23	P	R
Q9NP81	LB/B	-	W5NA24	35	T	A
Q9NP81	LB/B	-	W5NA24	83	S	L
Q9NP81	LP/P	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis syndrome (HUPRAS) [MIM:613845]	W5NA24	390	D	G
Q15020	LB/B	-	E2QXZ2	621	E	D
Q15020	LB/B	-	E2QXZ2	23	D	E
O94885	LB/B	-	A0A286ZVI6	298	P	Q
O94885	LB/B	-	A0A286ZVI6	884	Q	R
O94885	LP/P	Dyschromatosis universalis hereditaria 1 (DUH1) [MIM:127500]	A0A286ZVI6	507	S	A
O94885	LP/P	Dyschromatosis universalis hereditaria 1 (DUH1) [MIM:127500]	A0A286ZVI6	509	E	K
O94885	LP/P	Dyschromatosis universalis hereditaria 1 (DUH1) [MIM:127500]	A0A286ZVI6	515	L	P
O94885	LP/P	Dyschromatosis universalis hereditaria 1 (DUH1) [MIM:127500]	A0A286ZVI6	519	S	N
O94885	LP/P	Dyschromatosis universalis hereditaria 1 (DUH1) [MIM:127500]	A0A286ZVI6	551	Y	D
O94885	LP/P	Dyschromatosis universalis hereditaria 1 (DUH1) [MIM:127500]	A0A286ZVI6	551	Y	H
O94885	LP/P	Cancer, alopecia, pigment dyscrasia, onychodystrophy, and keratoderma (CAPOK) [MIM:618373]	A0A286ZVI6	617	E	K
O75995	LP/P	Immunodeficiency 102 (IMD102) [MIM:301082]	A0A0G2K960	347	R	C
Q6UVJ0	LB/B	-	L5K295	259	A	V
Q6UVJ0	LP/P	Microcephaly 14, primary, autosomal recessive (MCPH14) [MIM:616402]	L5K295	62	I	T
Q96F10	LB/B	-	L8IND4	126	R	C
Q01826	LP/P	Kohlschutter-Tonz syndrome-like (KTZSL) [MIM:619229]	W5Q210	323	M	V
Q01826	LP/P	Kohlschutter-Tonz syndrome-like (KTZSL) [MIM:619229]	W5Q210	402	Q	R
Q01826	LP/P	Kohlschutter-Tonz syndrome-like (KTZSL) [MIM:619229]	W5Q210	407	E	G
Q01826	LP/P	Kohlschutter-Tonz syndrome-like (KTZSL) [MIM:619229]	W5Q210	407	E	Q
Q01826	LP/P	Kohlschutter-Tonz syndrome-like (KTZSL) [MIM:619229]	W5Q210	413	E	K
Q01826	LP/P	Kohlschutter-Tonz syndrome-like (KTZSL) [MIM:619229]	W5Q210	420	Q	R
Q01826	LP/P	Kohlschutter-Tonz syndrome-like (KTZSL) [MIM:619229]	W5Q210	525	Q	R
Q01826	LP/P	Kohlschutter-Tonz syndrome-like (KTZSL) [MIM:619229]	W5Q210	530	E	G
Q01826	LP/P	Kohlschutter-Tonz syndrome-like (KTZSL) [MIM:619229]	W5Q210	530	E	K
Q01826	LP/P	Kohlschutter-Tonz syndrome-like (KTZSL) [MIM:619229]	W5Q210	530	E	Q
Q01826	LP/P	Kohlschutter-Tonz syndrome-like (KTZSL) [MIM:619229]	W5Q210	547	E	K
Q01826	LP/P	Kohlschutter-Tonz syndrome-like (KTZSL) [MIM:619229]	W5Q210	577	H	R
Q9UPW6	LB/B	-	W5Q210	263	S	P
Q8IYX7	LB/B	-	A0A287B999	27	K	E
Q8IYX7	LB/B	-	A0A287B999	63	P	S
Q8IYX7	LB/B	-	A0A287B999	385	N	S
Q658L1	LB/B	-	A0A287B999	8	S	G
Q658L1	LB/B	-	A0A287B999	34	P	L
Q658L1	LB/B	-	A0A287B999	225	W	R
Q9Y3A5	LP/P	Shwachman-Diamond syndrome 1 (SDS1) [MIM:260400]	B5X8W4	126	R	T
Q9Y3A5	LB/B	-	B5X8W4	212	I	T
Q9Y3A5	LP/P	Shwachman-Diamond syndrome 1 (SDS1) [MIM:260400]	B5X8W4	33	K	T
Q52WX2	LB/B	-	G1RL98	250	N	T
Q52WX2	LB/B	-	G1RL98	261	A	S
Q52WX2	LB/B	-	G1RL98	12	R	H
P0C263	LB/B	-	G3HYI4	20	E	K
P0C263	LB/B	-	G3HYI4	41	A	E
P0C263	LB/B	-	G3HYI4	102	G	D
Q6UWP8	LB/B	-	A0A2K5LX46	419	A	G
O75845	LP/P	Lathosterolosis (LATHOS) [MIM:607330]	A0A210PZN1	29	R	Q
O75845	LP/P	Lathosterolosis (LATHOS) [MIM:607330]	A0A210PZN1	211	G	D
O75845	LP/P	Lathosterolosis (LATHOS) [MIM:607330]	A0A210PZN1	46	Y	S
Q99590	LB/B	-	A0A1A6HVD3	657	F	Y
Q99590	LB/B	-	A0A1A6HVD3	1261	V	L
Q9UPN6	LB/B	-	K9IUS5	865	S	N
Q8N9R8	LB/B	-	A0A0P4YPP5	37	A	T
O14828	LB/B	-	A0A2I0TLH1	38	L	R
O14828	LB/B	-	A0A2I0TLH1	235	V	A
O14828	LB/B	-	A0A2I0TLH1	239	I	N
O14828	LB/B	-	A0A2I0TLH1	242	V	D
Q969E2	LB/B	-	A0A1U7QPQ3	49	A	T
Q9GZW5	LB/B	-	A0A024RC51	185	A	T
Q9GZW5	LB/B	-	A0A024RC51	110	P	T
Q6R2W3	LB/B	-	D2I0J4	155	M	V
Q6R2W3	LB/B	-	D2I0J4	465	Q	K
Q12770	LB/B	-	R7UJ94	798	V	I
Q8WTV0	LB/B	-	A0A2U4BYM3	2	G	S
Q8WTV0	LB/B	-	A0A2U4BYM3	135	V	I
Q8WTV0	LB/B	-	A0A2U4BYM3	167	G	S
Q8WTV0	LB/B	-	A0A2U4BYM3	511	C	R
Q8WTV0	LB/B	-	A0A2U4BYM3	229	S	G
Q8WTV0	LB/B	-	A0A2U4BYM3	297	P	S
Q8WTV0	LB/B	-	A0A2U4BYM3	376	P	L
Q14108	LP/P	Epilepsy, progressive myoclonic 4, with or without renal failure (EPM4) [MIM:254900]	A0A1S3FG14	363	H	N
Q14108	LB/B	-	A0A1S3FG14	471	E	G
Q14162	LB/B	-	A0A2Y9JVZ8	425	A	V
Q14162	LB/B	-	A0A2Y9JVZ8	618	R	K
Q14162	LB/B	-	A0A2Y9JVZ8	639	E	D
Q14162	LB/B	-	A0A2Y9JVZ8	662	R	W
Q14162	LB/B	-	A0A2Y9JVZ8	667	G	S
Q14162	LB/B	-	A0A2Y9JVZ8	748	G	V
Q8NBX0	LB/B	-	A0A0D2X0Q6	418	G	R
Q8WVM8	LB/B	-	A0A1Y2FEA4	63	K	R
Q8WU76	LB/B	-	A0A067R6N7	512	L	S
Q8WXD2	LB/B	-	A0A1V4JFM3	125	S	N
Q8WXD2	LB/B	-	A0A1V4JFM3	233	M	V
Q8WXD2	LB/B	-	A0A1V4JFM3	167	V	A
P11684	LB/B	-	Q65C83	56	R	G
P11684	LB/B	-	Q65C83	68	T	A
Q8TD33	LB/B	-	H0WMC1	70	I	R
O95969	LB/B	-	W5PZD0	53	P	L
O95969	LB/B	-	W5PZD0	80	V	A
O76038	LB/B	-	S9X3V9	216	A	V
Q9Y6U3	LB/B	-	F1QQQ5	455	F	L
Q9Y6U3	LB/B	-	F1QQQ5	578	L	F
Q9Y6U3	LB/B	-	F1QQQ5	61	H	R
Q9Y6U3	LB/B	-	F1QQQ5	443	A	P
Q9Y6U3	LB/B	-	F1QQQ5	500	K	R
Q96I15	LB/B	-	T2M6Z4	52	K	E
Q96I15	LB/B	-	T2M6Z4	175	A	T
Q96I15	LB/B	-	T2M6Z4	276	F	S
Q9Y5Y9	LB/B	-	A0A1L8HI81	509	S	P
Q9Y5Y9	LB/B	-	A0A1L8HI81	1073	V	A
Q9Y5Y9	LB/B	-	A0A1L8HI81	1092	L	P
Q9Y5Y9	LB/B	-	A0A1L8HI81	1713	M	V
Q9Y5Y9	LB/B	-	A0A1L8HI81	590	G	R
Q9Y5Y9	LB/B	-	A0A1L8HI81	916	R	W
Q9Y5Y9	LP/P	Episodic pain syndrome, familial, 2 (FEPS2) [MIM:615551]	A0A1L8HI81	554	L	P
Q9Y5Y9	LB/B	-	A0A1L8HI81	939	P	L
Q9Y5Y9	LB/B	-	A0A1L8HI81	940	Q	L
Q9Y5Y9	LB/B	-	A0A1L8HI81	1056	D	N
Q9Y5Y9	LP/P	Episodic pain syndrome, familial, 2 (FEPS2) [MIM:615551]	A0A1L8HI81	1304	A	T
Q9Y5Y9	LB/B	-	A0A1L8HI81	1523	C	Y
Q9Y5Y9	LB/B	-	A0A1L8HI81	1662	G	S
Q9UI33	LB/B	-	A0A091GJD4	481	G	E
Q9UI33	LB/B	-	A0A091GJD4	777	M	R
Q9UI33	LB/B	-	A0A091GJD4	1198	Y	H
Q9UI33	LB/B	-	A0A091GJD4	909	V	I
Q9UI33	LP/P	Episodic pain syndrome, familial, 3 (FEPS3) [MIM:615552]	A0A091GJD4	225	R	C
Q9UI33	LP/P	Episodic pain syndrome, familial, 3 (FEPS3) [MIM:615552]	A0A091GJD4	808	A	G
Q9UI33	LP/P	Neuropathy, hereditary sensory and autonomic, 7 (HSAN7) [MIM:615548]	A0A091GJD4	811	L	P
Q9UI33	LP/P	Neuropathy, hereditary sensory and autonomic, 7 (HSAN7) [MIM:615548]	A0A091GJD4	1184	V	A
Q9UI33	LP/P	Episodic pain syndrome, familial, 3 (FEPS3) [MIM:615552]	A0A091GJD4	222	R	H
Q9UI33	LP/P	Episodic pain syndrome, familial, 3 (FEPS3) [MIM:615552]	A0A091GJD4	222	R	S
Q9UI33	LB/B	-	A0A091GJD4	308	P	L
Q9UI33	LP/P	Episodic pain syndrome, familial, 3 (FEPS3) [MIM:615552]	A0A091GJD4	381	I	T
Q9UI33	LB/B	-	A0A091GJD4	419	K	N
Q9UI33	LB/B	-	A0A091GJD4	582	A	T
Q9UI33	LB/B	-	A0A091GJD4	681	A	D
Q9UI33	LP/P	Episodic pain syndrome, familial, 3 (FEPS3) [MIM:615552]	A0A091GJD4	699	G	R
Q9UI33	LB/B	-	A0A091GJD4	842	A	P
Q9UI33	LP/P	Episodic pain syndrome, familial, 3 (FEPS3) [MIM:615552]	A0A091GJD4	1158	L	P
Q9UI33	LB/B	-	A0A091GJD4	1609	T	I
Q9UI33	LB/B	-	A0A091GJD4	1689	F	L
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	875	T	M
P35498	LP/P	Generalized epilepsy with febrile seizures plus 2 (GEFSP2) [MIM:604403]	A0A1L8HI81	875	T	M
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1648	R	H
P35498	LP/P	Generalized epilepsy with febrile seizures plus 2 (GEFSP2) [MIM:604403]	A0A1L8HI81	1648	R	H
P35498	LP/P	Generalized epilepsy with febrile seizures plus 2 (GEFSP2) [MIM:604403]	A0A1L8HI81	188	D	V
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	986	L	F
P35498	LB/B	-	A0A1L8HI81	1067	A	T
P35498	LP/P	Generalized epilepsy with febrile seizures plus 2 (GEFSP2) [MIM:604403]	A0A1L8HI81	1204	W	R
P35498	LP/P	Generalized epilepsy with febrile seizures plus 2 (GEFSP2) [MIM:604403]	A0A1L8HI81	1270	K	T
P35498	LP/P	Generalized epilepsy with febrile seizures plus 2 (GEFSP2) [MIM:604403]	A0A1L8HI81	1353	V	L
P35498	LP/P	Generalized epilepsy with febrile seizures plus 2 (GEFSP2) [MIM:604403]	A0A1L8HI81	1656	I	M
P35498	LP/P	Migraine, familial hemiplegic, 3 (FHM3) [MIM:609634]	A0A1L8HI81	1489	Q	K
P35498	LP/P	Febrile seizures, familial, 3A (FEB3A) [MIM:604403]	A0A1L8HI81	145	M	T
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	78	E	D
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	101	R	Q
P35498	LP/P	Intractable childhood epilepsy with generalized tonic-clonic seizures (ICEGTC) [MIM:607208]	A0A1L8HI81	101	R	Q
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	103	S	G
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	112	T	I
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	177	G	E
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	190	W	R
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	227	I	S
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	252	I	N
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	265	G	W
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	280	W	R
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	297	T	I
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	343	G	D
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	393	R	H
P35498	LP/P	Intractable childhood epilepsy with generalized tonic-clonic seizures (ICEGTC) [MIM:607208]	A0A1L8HI81	393	R	H
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	426	Y	N
P35498	LP/P	Generalized epilepsy with febrile seizures plus 2 (GEFSP2) [MIM:604403]	A0A1L8HI81	790	Y	C
P35498	LP/P	Intractable childhood epilepsy with generalized tonic-clonic seizures (ICEGTC) [MIM:607208]	A0A1L8HI81	808	T	S
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	902	F	C
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	931	R	C
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	934	M	I
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	939	H	Q
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	944	V	A
P35498	LP/P	Intractable childhood epilepsy with generalized tonic-clonic seizures (ICEGTC) [MIM:607208]	A0A1L8HI81	944	V	A
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	946	R	C
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	946	R	H
P35498	LP/P	Generalized epilepsy with febrile seizures plus 2 (GEFSP2) [MIM:604403]	A0A1L8HI81	946	R	H
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	959	C	R
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	960	M	V
P35498	LP/P	Intractable childhood epilepsy with generalized tonic-clonic seizures (ICEGTC) [MIM:607208]	A0A1L8HI81	979	G	R
P35498	LP/P	Intractable childhood epilepsy with generalized tonic-clonic seizures (ICEGTC) [MIM:607208]	A0A1L8HI81	983	V	A
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	985	N	I
P35498	LP/P	Intractable childhood epilepsy with generalized tonic-clonic seizures (ICEGTC) [MIM:607208]	A0A1L8HI81	1011	N	I
P35498	LB/B	-	A0A1L8HI81	1034	I	T
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1231	S	R
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1233	G	R
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1263	F	L
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1265	L	P
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1355	L	P
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1326	A	P
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1390	V	M
P35498	LP/P	Generalized epilepsy with febrile seizures plus 2 (GEFSP2) [MIM:604403]	A0A1L8HI81	1428	V	A
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1434	W	R
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1450	Q	R
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1461	L	I
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1463	F	S
P35498	LP/P	Intractable childhood epilepsy with generalized tonic-clonic seizures (ICEGTC) [MIM:607208]	A0A1L8HI81	1611	V	F
P35498	LP/P	Intractable childhood epilepsy with generalized tonic-clonic seizures (ICEGTC) [MIM:607208]	A0A1L8HI81	1632	P	S
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1648	R	C
P35498	LP/P	Generalized epilepsy with febrile seizures plus 2 (GEFSP2) [MIM:604403]	A0A1L8HI81	1657	R	C
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1661	F	S
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1668	P	A
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1674	G	R
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1694	Y	C
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1685	A	D
P35498	LP/P	Generalized epilepsy with febrile seizures plus 2 (GEFSP2) [MIM:604403]	A0A1L8HI81	1685	A	V
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1692	F	S
P35498	LP/P	Intractable childhood epilepsy with generalized tonic-clonic seizures (ICEGTC) [MIM:607208]	A0A1L8HI81	1709	T	I
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1749	G	E
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1780	M	T
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1781	Y	C
P35498	LP/P	Intractable childhood epilepsy with generalized tonic-clonic seizures (ICEGTC) [MIM:607208]	A0A1L8HI81	1781	Y	C
P35498	LP/P	Intractable childhood epilepsy with generalized tonic-clonic seizures (ICEGTC) [MIM:607208]	A0A1L8HI81	1808	F	L
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1812	W	G
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1831	F	S
P35498	LP/P	Generalized epilepsy with febrile seizures plus 2 (GEFSP2) [MIM:604403]	A0A1L8HI81	1852	M	T
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1881	E	D
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1909	T	I
P35498	LB/B	-	A0A1L8HI81	1955	I	T
P35498	LB/B	-	A0A1L8HI81	1957	E	G
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	84	Y	C
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	118	R	S
P35498	LP/P	Developmental and epileptic encephalopathy 6B (DEE6B) [MIM:619317]	A0A1L8HI81	226	T	M
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	239	A	T
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	366	D	E
P35498	LP/P	Generalized epilepsy with febrile seizures plus 2 (GEFSP2) [MIM:604403]	A0A1L8HI81	377	R	Q
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	393	R	C
P35498	LP/P	-	A0A1L8HI81	395	A	P
P35498	LP/P	-	A0A1L8HI81	422	V	E
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	626	S	G
P35498	LP/P	Generalized epilepsy with febrile seizures plus 2 (GEFSP2) [MIM:604403]	A0A1L8HI81	973	M	V
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1207	L	P
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1238	E	D
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1335	V	M
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1358	W	S
P35498	LP/P	Generalized epilepsy with febrile seizures plus 2 (GEFSP2) [MIM:604403]	A0A1L8HI81	1366	V	I
P35498	LP/P	Intractable childhood epilepsy with generalized tonic-clonic seizures (ICEGTC) [MIM:607208]	A0A1L8HI81	1366	V	I
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1462	Y	C
P35498	LP/P	-	A0A1L8HI81	1480	G	V
P35498	LB/B	-	A0A1L8HI81	1543	F	S
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1596	R	C
P35498	LP/P	-	A0A1L8HI81	1636	R	Q
P35498	LP/P	-	A0A1L8HI81	1657	R	H
P35498	LB/B	-	A0A1L8HI81	1928	R	G
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	946	R	S
P35498	LP/P	Migraine, familial hemiplegic, 3 (FHM3) [MIM:609634]	A0A1L8HI81	1489	Q	H
P35498	LP/P	Migraine, familial hemiplegic, 3 (FHM3) [MIM:609634]	A0A1L8HI81	1499	F	L
P35498	LP/P	Generalized epilepsy with febrile seizures plus 2 (GEFSP2) [MIM:604403]	A0A1L8HI81	1742	D	G
P35498	LP/P	Generalized epilepsy with febrile seizures plus 2 (GEFSP2) [MIM:604403]	A0A1L8HI81	1857	V	L
P35498	LP/P	Generalized epilepsy with febrile seizures plus 2 (GEFSP2) [MIM:604403]	A0A1L8HI81	1866	D	Y
P35498	LP/P	Generalized epilepsy with febrile seizures plus 2 (GEFSP2) [MIM:604403]	A0A1L8HI81	27	R	T
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	63	F	L
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	90	F	S
P35498	LP/P	Intractable childhood epilepsy with generalized tonic-clonic seizures (ICEGTC) [MIM:607208]	A0A1L8HI81	90	F	S
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	91	I	T
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	101	R	W
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	124	I	N
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	171	I	K
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	175	A	T
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	191	N	Y
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	194	D	N
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	239	A	V
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	259	S	R
P35498	LP/P	Generalized epilepsy with febrile seizures plus 2 (GEFSP2) [MIM:604403]	A0A1L8HI81	388	Y	H
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	406	V	F
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	413	Y	N
P35498	LB/B	-	A0A1L8HI81	604	R	H
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	783	L	P
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	862	R	Q
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	875	T	K
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	939	H	Y
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	944	V	E
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	945	F	L
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	950	G	E
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	952	W	G
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	954	E	K
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1210	T	K
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1260	T	P
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1287	L	P
P35498	LP/P	Generalized epilepsy with febrile seizures plus 2 (GEFSP2) [MIM:604403]	A0A1L8HI81	1309	L	F
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1367	N	K
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1396	C	G
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1433	G	E
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1433	G	R
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1450	Q	K
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1514	L	S
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1545	I	V
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1586	G	E
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1612	V	I
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1637	V	E
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1645	R	Q
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1658	T	M
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1664	M	K
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1726	W	R
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1756	C	G
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1782	I	M
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1783	A	T
P35498	LP/P	Generalized epilepsy with febrile seizures plus 2 (GEFSP2) [MIM:604403]	A0A1L8HI81	1795	E	K
P35498	LP/P	Generalized epilepsy with febrile seizures plus 2 (GEFSP2) [MIM:604403]	A0A1L8HI81	74	S	P
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	162	T	P
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	217	T	K
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	322	R	I
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	356	R	G
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	358	P	T
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	383	F	L
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	393	R	S
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	403	F	L
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	812	T	R
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	846	E	K
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	859	R	C
P35498	LP/P	Generalized epilepsy with febrile seizures plus 2 (GEFSP2) [MIM:604403]	A0A1L8HI81	859	R	C
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	942	L	P
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	957	W	L
P35498	LP/P	Migraine, familial hemiplegic, 3 (FHM3) [MIM:609634]	A0A1L8HI81	1174	T	S
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1231	S	T
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1245	R	Q
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1414	N	Y
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1422	Y	C
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1426	L	R
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1451	P	L
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1470	G	W
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1475	L	S
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1588	C	R
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1608	D	Y
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1630	V	M
P35498	LP/P	Migraine, familial hemiplegic, 3 (FHM3) [MIM:609634]	A0A1L8HI81	1649	L	Q
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1658	T	R
P35498	LP/P	Generalized epilepsy with febrile seizures plus 2 (GEFSP2) [MIM:604403]	A0A1L8HI81	1687	F	S
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1713	S	N
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1714	M	R
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1716	C	R
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1762	G	E
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1773	S	F
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1787	E	K
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1783	A	V
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	79	D	H
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	199	T	R
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1441	A	P
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1707	F	V
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1721	T	R
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1922	I	T
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	289	E	V
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	379	M	R
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	58	G	V
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	61	L	F
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	68	I	T
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	79	D	N
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	98	A	P
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	105	T	I
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	108	L	R
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	127	H	D
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	171	I	R
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	175	A	V
P35498	LP/P	Intractable childhood epilepsy with generalized tonic-clonic seizures (ICEGTC) [MIM:607208]	A0A1L8HI81	178	F	S
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	179	C	R
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	191	N	K
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	194	D	G
P35498	LP/P	Generalized epilepsy with febrile seizures plus 2 (GEFSP2) [MIM:604403]	A0A1L8HI81	218	F	L
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	223	A	E
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	226	T	R
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	227	I	T
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	232	G	S
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	233	L	R
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	243	S	Y
P35498	LP/P	Intractable childhood epilepsy with generalized tonic-clonic seizures (ICEGTC) [MIM:607208]	A0A1L8HI81	252	I	M
P35498	LP/P	Generalized epilepsy with febrile seizures plus 2 (GEFSP2) [MIM:604403]	A0A1L8HI81	254	T	I
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	277	C	R
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	280	W	C
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	281	P	A
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	281	P	L
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	281	P	S
P35498	LP/P	Intractable childhood epilepsy with generalized tonic-clonic seizures (ICEGTC) [MIM:607208]	A0A1L8HI81	290	H	R
P35498	LP/P	Generalized epilepsy with febrile seizures plus 2 (GEFSP2) [MIM:604403]	A0A1L8HI81	291	S	G
P35498	LB/B	-	A0A1L8HI81	333	A	V
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	340	S	F
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	342	A	V
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	345	C	R
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	351	C	W
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	355	G	D
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	357	N	I
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	359	N	S
P35498	LP/P	Intractable childhood epilepsy with generalized tonic-clonic seizures (ICEGTC) [MIM:607208]	A0A1L8HI81	359	N	S
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	363	T	P
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	363	T	R
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	378	L	Q
P35498	LP/P	-	A0A1L8HI81	382	D	N
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	384	W	R
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	400	M	V
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	403	F	V
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	409	L	W
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	426	Y	C
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	525	S	F
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	674	D	G
P35498	LB/B	-	A0A1L8HI81	699	V	I
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	762	N	D
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	785	M	T
P35498	LP/P	-	A0A1L8HI81	790	Y	F
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	812	T	I
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	842	L	R
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	843	S	R
P35498	LP/P	Generalized epilepsy with febrile seizures plus 2 (GEFSP2) [MIM:604403]	A0A1L8HI81	859	R	H
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	865	R	G
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	876	L	I
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	890	L	P
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	896	V	F
P35498	LP/P	Intractable childhood epilepsy with generalized tonic-clonic seizures (ICEGTC) [MIM:607208]	A0A1L8HI81	896	V	I
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	896	V	L
P35498	LP/P	Generalized epilepsy with febrile seizures plus 2 (GEFSP2) [MIM:604403]	A0A1L8HI81	899	I	T
P35498	LB/B	-	A0A1L8HI81	924	A	T
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	927	C	F
P35498	LP/P	-	A0A1L8HI81	931	R	H
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	932	W	C
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	933	H	P
P35498	LP/P	Generalized epilepsy with febrile seizures plus 2 (GEFSP2) [MIM:604403]	A0A1L8HI81	935	N	H
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	940	S	F
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	943	I	N
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	949	C	S
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	949	C	Y
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	950	G	R
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	956	M	K
P35498	LP/P	Generalized epilepsy with febrile seizures plus 2 (GEFSP2) [MIM:604403]	A0A1L8HI81	960	M	T
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	973	M	K
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	976	M	I
P35498	LP/P	Generalized epilepsy with febrile seizures plus 2 (GEFSP2) [MIM:604403]	A0A1L8HI81	976	M	I
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	979	G	V
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	986	L	P
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	987	F	L
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	993	S	R
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	998	D	G
P35498	LP/P	-	A0A1L8HI81	1006	D	E
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1068	E	K
P35498	LB/B	-	A0A1L8HI81	1079	V	I
P35498	LB/B	-	A0A1L8HI81	1109	P	T
P35498	LP/P	Generalized epilepsy with febrile seizures plus 2 (GEFSP2) [MIM:604403]	A0A1L8HI81	1204	W	S
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1208	R	K
P35498	LP/P	Intractable childhood epilepsy with generalized tonic-clonic seizures (ICEGTC) [MIM:607208]	A0A1L8HI81	1213	R	Q
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1221	E	K
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1230	L	F
P35498	LP/P	Generalized epilepsy with febrile seizures plus 2 (GEFSP2) [MIM:604403]	A0A1L8HI81	1230	L	F
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1239	D	G
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1239	D	Y
P35498	LP/P	Generalized epilepsy with febrile seizures plus 2 (GEFSP2) [MIM:604403]	A0A1L8HI81	1249	K	N
P35498	LP/P	Generalized epilepsy with febrile seizures plus 2 (GEFSP2) [MIM:604403]	A0A1L8HI81	1250	T	M
P35498	LP/P	Intractable childhood epilepsy with generalized tonic-clonic seizures (ICEGTC) [MIM:607208]	A0A1L8HI81	1254	Y	C
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1255	A	D
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1266	E	A
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1275	G	V
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1284	W	S
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1288	D	N
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1316	R	G
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1316	R	S
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1320	A	V
P35498	LP/P	Intractable childhood epilepsy with generalized tonic-clonic seizures (ICEGTC) [MIM:607208]	A0A1L8HI81	1325	R	T
P35498	LP/P	-	A0A1L8HI81	1326	A	D
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1328	S	P
P35498	LP/P	Intractable childhood epilepsy with generalized tonic-clonic seizures (ICEGTC) [MIM:607208]	A0A1L8HI81	1328	S	P
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1339	A	V
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1344	I	M
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1350	V	G
P35498	LP/P	Intractable childhood epilepsy with generalized tonic-clonic seizures (ICEGTC) [MIM:607208]	A0A1L8HI81	1357	F	L
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1358	W	R
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1370	A	P
P35498	LP/P	Intractable childhood epilepsy with generalized tonic-clonic seizures (ICEGTC) [MIM:607208]	A0A1L8HI81	1376	C	R
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1378	N	H
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1378	N	T
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1385	F	V
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1391	N	S
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1393	H	P
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1394	T	I
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1396	C	Y
P35498	LP/P	Generalized epilepsy with febrile seizures plus 2 (GEFSP2) [MIM:604403]	A0A1L8HI81	1414	N	D
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1416	D	G
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1417	N	S
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1418	V	G
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1423	L	F
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1427	Q	P
P35498	LP/P	Intractable childhood epilepsy with generalized tonic-clonic seizures (ICEGTC) [MIM:607208]	A0A1L8HI81	1429	A	D
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1431	F	I
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1433	G	V
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1437	I	M
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1451	P	S
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1453	Y	C
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1454	E	K
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1462	Y	H
P35498	LP/P	Intractable childhood epilepsy with generalized tonic-clonic seizures (ICEGTC) [MIM:607208]	A0A1L8HI81	1462	Y	H
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1472	F	S
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1476	N	K
P35498	LP/P	-	A0A1L8HI81	1483	I	M
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1484	D	G
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1485	N	Y
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1503	E	K
P35498	LP/P	Intractable childhood epilepsy with generalized tonic-clonic seizures (ICEGTC) [MIM:607208]	A0A1L8HI81	1511	M	K
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1538	V	I
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1544	D	A
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1544	D	G
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1555	M	R
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1561	E	K
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1579	V	E
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1592	L	H
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1592	L	P
P35498	LP/P	Generalized epilepsy with febrile seizures plus 2 (GEFSP2) [MIM:604403]	A0A1L8HI81	1596	R	H
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1596	R	L
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1605	N	S
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1608	D	G
P35498	LP/P	Intractable childhood epilepsy with generalized tonic-clonic seizures (ICEGTC) [MIM:607208]	A0A1L8HI81	1619	M	V
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1630	V	L
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1638	I	N
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1638	I	T
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1639	R	G
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1642	R	S
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1653	A	E
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1660	L	P
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1662	A	V
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1667	L	P
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1668	P	L
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1672	N	I
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1673	I	T
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1675	L	R
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1677	L	F
P35498	LP/P	-	A0A1L8HI81	1683	I	F
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1683	I	T
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1684	Y	D
P35498	LP/P	Intractable childhood epilepsy with generalized tonic-clonic seizures (ICEGTC) [MIM:607208]	A0A1L8HI81	1684	Y	S
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1688	G	W
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1714	M	K
P35498	LP/P	Intractable childhood epilepsy with generalized tonic-clonic seizures (ICEGTC) [MIM:607208]	A0A1L8HI81	1724	A	P
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1725	G	C
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1727	D	G
P35498	LP/P	Generalized epilepsy with febrile seizures plus 2 (GEFSP2) [MIM:604403]	A0A1L8HI81	1739	P	L
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1741	C	R
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1763	I	N
P35498	LP/P	Generalized epilepsy with febrile seizures plus 2 (GEFSP2) [MIM:604403]	A0A1L8HI81	1765	F	L
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1770	I	F
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1770	I	N
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1770	I	T
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1771	I	F
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1771	I	N
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1781	Y	H
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1782	I	S
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1792	A	T
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1808	F	I
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1812	W	S
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1832	A	P
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1835	L	F
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1852	M	K
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1855	P	L
P35498	LP/P	Intractable childhood epilepsy with generalized tonic-clonic seizures (ICEGTC) [MIM:607208]	A0A1L8HI81	1861	R	W
P35498	LP/P	Generalized epilepsy with febrile seizures plus 2 (GEFSP2) [MIM:604403]	A0A1L8HI81	1867	I	T
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1880	G	E
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	228	S	P
P35498	LP/P	-	A0A1L8HI81	616	E	D
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1605	N	I
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	113	P	T
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1345	P	L
P35498	LP/P	Developmental and epileptic encephalopathy 6B (DEE6B) [MIM:619317]	A0A1L8HI81	422	V	L
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	862	R	G
P35498	LP/P	Developmental and epileptic encephalopathy 6B (DEE6B) [MIM:619317]	A0A1L8HI81	1345	P	S
P35498	LP/P	Dravet syndrome (DRVT) [MIM:607208]	A0A1L8HI81	1669	A	E
Q07699	LP/P	Generalized epilepsy with febrile seizures plus 1 (GEFSP1) [MIM:604233]	G3U3M7	121	C	W
Q07699	LP/P	-	G3U3M7	25	D	N
Q07699	LP/P	-	G3U3M7	87	E	Q
Q07699	LB/B	-	G3U3M7	138	V	I
Q07699	LB/B	-	G3U3M7	208	K	I
Q07699	LB/B	-	G3U3M7	211	C	Y
Q07699	LB/B	-	G3U3M7	213	G	D
Q07699	LP/P	Generalized epilepsy with febrile seizures plus 1 (GEFSP1) [MIM:604233]	G3U3M7	125	R	L
Q07699	LP/P	Atrial fibrillation, familial, 13 (ATFB13) [MIM:615377]	G3U3M7	85	R	H
Q07699	LP/P	Atrial fibrillation, familial, 13 (ATFB13) [MIM:615377]	G3U3M7	153	D	N
Q07699	LP/P	Developmental and epileptic encephalopathy 52 (DEE52) [MIM:617350]	G3U3M7	125	R	C
Q99250	LB/B	-	A0A1L8HI81	19	R	K
Q99250	LP/P	Seizures, benign familial infantile, 3 (BFIS3) [MIM:607745]	A0A1L8HI81	188	R	W
Q99250	LP/P	Seizures, benign familial infantile, 3 (BFIS3) [MIM:607745]	A0A1L8HI81	223	R	Q
Q99250	LB/B	-	A0A1L8HI81	385	F	Y
Q99250	LB/B	-	A0A1L8HI81	524	R	Q
Q99250	LP/P	Seizures, benign familial infantile, 3 (BFIS3) [MIM:607745]	A0A1L8HI81	892	V	I
Q99250	LP/P	Seizures, benign familial infantile, 3 (BFIS3) [MIM:607745]	A0A1L8HI81	1003	L	I
Q99250	LP/P	Seizures, benign familial infantile, 3 (BFIS3) [MIM:607745]	A0A1L8HI81	1319	R	Q
Q99250	LP/P	Seizures, benign familial infantile, 3 (BFIS3) [MIM:607745]	A0A1L8HI81	1330	L	F
Q99250	LP/P	Seizures, benign familial infantile, 3 (BFIS3) [MIM:607745]	A0A1L8HI81	1563	L	V
Q99250	LP/P	Seizures, benign familial infantile, 3 (BFIS3) [MIM:607745]	A0A1L8HI81	252	M	V
Q99250	LP/P	Seizures, benign familial infantile, 3 (BFIS3) [MIM:607745]	A0A1L8HI81	261	V	M
Q99250	LP/P	Developmental and epileptic encephalopathy 11 (DEE11) [MIM:613721]	A0A1L8HI81	263	A	V
Q99250	LP/P	Episodic ataxia 9 (EA9) [MIM:618924]	A0A1L8HI81	263	A	V
Q99250	LB/B	-	A0A1L8HI81	575	A	V
Q99250	LP/P	Developmental and epileptic encephalopathy 11 (DEE11) [MIM:613721]	A0A1L8HI81	1211	E	K
Q99250	LP/P	Developmental and epileptic encephalopathy 11 (DEE11) [MIM:613721]	A0A1L8HI81	1473	I	M
Q99250	LP/P	Developmental and epileptic encephalopathy 11 (DEE11) [MIM:613721]	A0A1L8HI81	169	E	G
Q99250	LP/P	Developmental and epileptic encephalopathy 11 (DEE11) [MIM:613721]	A0A1L8HI81	212	N	D
Q99250	LP/P	Developmental and epileptic encephalopathy 11 (DEE11) [MIM:613721]	A0A1L8HI81	213	V	D
Q99250	LP/P	Developmental and epileptic encephalopathy 11 (DEE11) [MIM:613721]	A0A1L8HI81	236	T	S
Q99250	LP/P	Developmental and epileptic encephalopathy 11 (DEE11) [MIM:613721]	A0A1L8HI81	263	A	T
Q99250	LP/P	Developmental and epileptic encephalopathy 11 (DEE11) [MIM:613721]	A0A1L8HI81	853	R	Q
Q99250	LP/P	Developmental and epileptic encephalopathy 11 (DEE11) [MIM:613721]	A0A1L8HI81	876	N	T
Q99250	LP/P	Developmental and epileptic encephalopathy 11 (DEE11) [MIM:613721]	A0A1L8HI81	999	E	K
Q99250	LP/P	Developmental and epileptic encephalopathy 11 (DEE11) [MIM:613721]	A0A1L8HI81	1323	M	V
Q99250	LP/P	Developmental and epileptic encephalopathy 11 (DEE11) [MIM:613721]	A0A1L8HI81	1326	V	L
Q99250	LP/P	Developmental and epileptic encephalopathy 11 (DEE11) [MIM:613721]	A0A1L8HI81	1336	S	Y
Q99250	LP/P	Developmental and epileptic encephalopathy 11 (DEE11) [MIM:613721]	A0A1L8HI81	1338	M	T
Q99250	LP/P	-	A0A1L8HI81	1422	K	E
Q99250	LP/P	Developmental and epileptic encephalopathy 11 (DEE11) [MIM:613721]	A0A1L8HI81	1623	T	N
Q99250	LP/P	Developmental and epileptic encephalopathy 11 (DEE11) [MIM:613721]	A0A1L8HI81	1629	R	L
Q99250	LP/P	Seizures, benign familial infantile, 3 (BFIS3) [MIM:607745]	A0A1L8HI81	208	V	E
Q99250	LP/P	Developmental and epileptic encephalopathy 11 (DEE11) [MIM:613721]	A0A1L8HI81	1312	R	T
Q99250	LP/P	-	A0A1L8HI81	191	W	G
Q99250	LP/P	Developmental and epileptic encephalopathy 11 (DEE11) [MIM:613721]	A0A1L8HI81	251	V	I
Q99250	LP/P	Developmental and epileptic encephalopathy 11 (DEE11) [MIM:613721]	A0A1L8HI81	896	A	V
Q99250	LP/P	Developmental and epileptic encephalopathy 11 (DEE11) [MIM:613721]	A0A1L8HI81	1316	A	V
Q99250	LP/P	Developmental and epileptic encephalopathy 11 (DEE11) [MIM:613721]	A0A1L8HI81	1344	C	Y
Q99250	LP/P	Developmental and epileptic encephalopathy 11 (DEE11) [MIM:613721]	A0A1L8HI81	1548	M	T
Q99250	LP/P	Developmental and epileptic encephalopathy 11 (DEE11) [MIM:613721]	A0A1L8HI81	1882	R	Q
Q99250	LP/P	-	A0A1L8HI81	12	D	N
Q99250	LP/P	-	A0A1L8HI81	82	D	G
Q99250	LP/P	Developmental and epileptic encephalopathy 11 (DEE11) [MIM:613721]	A0A1L8HI81	132	N	K
Q99250	LP/P	Developmental and epileptic encephalopathy 11 (DEE11) [MIM:613721]	A0A1L8HI81	136	M	I
Q99250	LP/P	Seizures, benign familial infantile, 3 (BFIS3) [MIM:607745]	A0A1L8HI81	240	A	S
Q99250	LP/P	-	A0A1L8HI81	379	R	H
Q99250	LP/P	Developmental and epileptic encephalopathy 11 (DEE11) [MIM:613721]	A0A1L8HI81	430	E	G
Q99250	LP/P	Developmental and epileptic encephalopathy 11 (DEE11) [MIM:613721]	A0A1L8HI81	856	R	L
Q99250	LP/P	Developmental and epileptic encephalopathy 11 (DEE11) [MIM:613721]	A0A1L8HI81	905	K	N
Q99250	LB/B	-	A0A1L8HI81	908	K	R
Q99250	LP/P	Developmental and epileptic encephalopathy 11 (DEE11) [MIM:613721]	A0A1L8HI81	928	F	C
Q99250	LP/P	-	A0A1L8HI81	937	R	C
Q99250	LP/P	-	A0A1L8HI81	937	R	H
Q99250	LP/P	Seizures, benign familial infantile, 3 (BFIS3) [MIM:607745]	A0A1L8HI81	1001	N	K
Q99250	LP/P	Developmental and epileptic encephalopathy 11 (DEE11) [MIM:613721]	A0A1L8HI81	1326	V	D
Q99250	LP/P	Developmental and epileptic encephalopathy 11 (DEE11) [MIM:613721]	A0A1L8HI81	1342	L	P
Q99250	LP/P	-	A0A1L8HI81	1386	C	R
Q99250	LP/P	-	A0A1L8HI81	1420	T	M
Q99250	LP/P	Seizures, benign familial infantile, 3 (BFIS3) [MIM:607745]	A0A1L8HI81	1589	Y	C
Q99250	LP/P	Developmental and epileptic encephalopathy 11 (DEE11) [MIM:613721]	A0A1L8HI81	1593	G	R
Q99250	LP/P	Developmental and epileptic encephalopathy 11 (DEE11) [MIM:613721]	A0A1L8HI81	1634	G	V
Q99250	LP/P	Developmental and epileptic encephalopathy 11 (DEE11) [MIM:613721]	A0A1L8HI81	1660	L	W
Q99250	LP/P	Episodic ataxia 9 (EA9) [MIM:618924]	A0A1L8HI81	1882	R	G
Q99250	LP/P	Developmental and epileptic encephalopathy 11 (DEE11) [MIM:613721]	A0A1L8HI81	1882	R	L
Q99250	LB/B	-	A0A1L8HI81	1918	R	H
Q99250	LP/P	Developmental and epileptic encephalopathy 11 (DEE11) [MIM:613721]	A0A1L8HI81	211	G	D
Q99250	LP/P	Developmental and epileptic encephalopathy 11 (DEE11) [MIM:613721]	A0A1L8HI81	220	R	G
Q99250	LP/P	-	A0A1L8HI81	674	T	K
Q99250	LP/P	Developmental and epileptic encephalopathy 11 (DEE11) [MIM:613721]	A0A1L8HI81	873	I	M
Q99250	LP/P	Developmental and epileptic encephalopathy 11 (DEE11) [MIM:613721]	A0A1L8HI81	987	S	I
Q99250	LP/P	Developmental and epileptic encephalopathy 11 (DEE11) [MIM:613721]	A0A1L8HI81	999	E	V
Q99250	LP/P	Developmental and epileptic encephalopathy 11 (DEE11) [MIM:613721]	A0A1L8HI81	1260	K	E
Q99250	LP/P	Developmental and epileptic encephalopathy 11 (DEE11) [MIM:613721]	A0A1L8HI81	1260	K	Q
Q99250	LP/P	Developmental and epileptic encephalopathy 11 (DEE11) [MIM:613721]	A0A1L8HI81	1479	Q	P
Q99250	LP/P	Developmental and epileptic encephalopathy 11 (DEE11) [MIM:613721]	A0A1L8HI81	1650	L	P
Q99250	LP/P	-	A0A1L8HI81	1744	G	R
Q99250	LP/P	Developmental and epileptic encephalopathy 11 (DEE11) [MIM:613721]	A0A1L8HI81	1829	L	F
Q99250	LP/P	Developmental and epileptic encephalopathy 11 (DEE11) [MIM:613721]	A0A1L8HI81	1853	H	R
Q99250	LP/P	Developmental and epileptic encephalopathy 11 (DEE11) [MIM:613721]	A0A1L8HI81	191	W	C
Q99250	LP/P	-	A0A1L8HI81	424	V	M
Q99250	LP/P	-	A0A1L8HI81	467	A	T
Q99250	LP/P	Developmental and epileptic encephalopathy 11 (DEE11) [MIM:613721]	A0A1L8HI81	773	T	I
Q99250	LP/P	Seizures, benign familial infantile, 3 (BFIS3) [MIM:607745]	A0A1L8HI81	908	K	E
Q99250	LP/P	-	A0A1L8HI81	1460	G	R
O60939	LP/P	Atrial fibrillation, familial, 14 (ATFB14) [MIM:615378]	M0QSJ7	28	R	W
O60939	LB/B	-	M0QSJ7	47	R	H
O60939	LP/P	Atrial fibrillation, familial, 14 (ATFB14) [MIM:615378]	M0QSJ7	28	R	Q
Q9NY46	LB/B	-	A0A1L8HI81	606	S	T
Q9NY46	LB/B	-	A0A1L8HI81	1107	V	A
Q9NY46	LB/B	-	A0A1L8HI81	1813	L	S
Q9NY46	LB/B	-	A0A1L8HI81	1803	D	N
Q9NY46	LB/B	-	A0A1L8HI81	1084	V	I
Q9NY46	LP/P	Epilepsy, familial focal, with variable foci 4 (FFEVF4) [MIM:617935]	A0A1L8HI81	247	L	P
Q9NY46	LP/P	Epilepsy, familial focal, with variable foci 4 (FFEVF4) [MIM:617935]	A0A1L8HI81	357	R	Q
Q9NY46	LP/P	Developmental and epileptic encephalopathy 62 (DEE62) [MIM:617938]	A0A1L8HI81	875	I	T
Q9NY46	LP/P	Epilepsy, familial focal, with variable foci 4 (FFEVF4) [MIM:617935]	A0A1L8HI81	1160	E	K
Q9NY46	LP/P	Developmental and epileptic encephalopathy 62 (DEE62) [MIM:617938]	A0A1L8HI81	1333	P	L
Q9NY46	LP/P	Developmental and epileptic encephalopathy 62 (DEE62) [MIM:617938]	A0A1L8HI81	1769	V	A
Q9NY72	LB/B	-	L5JR61	97	S	N
Q9NY72	LP/P	Atrial fibrillation, familial, 16 (ATFB16) [MIM:613120]	L5JR61	6	R	K
Q9NY72	LP/P	Atrial fibrillation, familial, 16 (ATFB16) [MIM:613120]	L5JR61	130	A	V
Q9NY72	LP/P	Atrial fibrillation, familial, 16 (ATFB16) [MIM:613120]	L5JR61	161	M	T
P35499	LB/B	-	M0QSJ9	135	M	V
P35499	LB/B	-	M0QSJ9	524	S	G
P35499	LP/P	Paramyotonia congenita of von Eulenburg (PMC) [MIM:168300]	M0QSJ9	704	T	M
P35499	LP/P	Periodic paralysis hyperkalemic (HYPP) [MIM:170500]	M0QSJ9	704	T	M
P35499	LP/P	Paramyotonia congenita of von Eulenburg (PMC) [MIM:168300]	M0QSJ9	804	S	F
P35499	LB/B	-	M0QSJ9	861	A	D
P35499	LP/P	Myotonia SCN4A-related (MYOSCN4A) [MIM:608390]	M0QSJ9	1156	A	T
P35499	LP/P	Paramyotonia congenita of von Eulenburg (PMC) [MIM:168300]	M0QSJ9	1156	A	T
P35499	LP/P	Periodic paralysis hyperkalemic (HYPP) [MIM:170500]	M0QSJ9	1156	A	T
P35499	LP/P	Paramyotonia congenita of von Eulenburg (PMC) [MIM:168300]	M0QSJ9	1293	V	I
P35499	LP/P	Paramyotonia congenita of von Eulenburg (PMC) [MIM:168300]	M0QSJ9	1306	G	A
P35499	LP/P	Myotonia SCN4A-related (MYOSCN4A) [MIM:608390]	M0QSJ9	1306	G	E
P35499	LP/P	Paramyotonia congenita of von Eulenburg (PMC) [MIM:168300]	M0QSJ9	1306	G	E
P35499	LP/P	Myotonia SCN4A-related (MYOSCN4A) [MIM:608390]	M0QSJ9	1306	G	V
P35499	LP/P	Paramyotonia congenita of von Eulenburg (PMC) [MIM:168300]	M0QSJ9	1306	G	V
P35499	LP/P	Paramyotonia congenita of von Eulenburg (PMC) [MIM:168300]	M0QSJ9	1313	T	M
P35499	LP/P	Paramyotonia congenita of von Eulenburg (PMC) [MIM:168300]	M0QSJ9	1433	L	R
P35499	LP/P	Periodic paralysis hyperkalemic (HYPP) [MIM:170500]	M0QSJ9	1433	L	R
P35499	LP/P	Paramyotonia congenita of von Eulenburg (PMC) [MIM:168300]	M0QSJ9	1448	R	C
P35499	LP/P	Paramyotonia congenita of von Eulenburg (PMC) [MIM:168300]	M0QSJ9	1448	R	H
P35499	LP/P	Paramyotonia congenita of von Eulenburg (PMC) [MIM:168300]	M0QSJ9	1589	V	M
P35499	LP/P	Periodic paralysis hyperkalemic (HYPP) [MIM:170500]	M0QSJ9	1592	M	V
P35499	LP/P	Periodic paralysis normokalemic (NKPP) [MIM:170500]	M0QSJ9	1592	M	V
P35499	LB/B	-	M0QSJ9	246	S	L
P35499	LP/P	Myotonia SCN4A-related (MYOSCN4A) [MIM:608390]	M0QSJ9	445	V	M
P35499	LB/B	-	M0QSJ9	559	N	D
P35499	LP/P	Periodic paralysis hypokalemic 2 (HOKPP2) [MIM:613345]	M0QSJ9	669	R	H
P35499	LP/P	Periodic paralysis hypokalemic 2 (HOKPP2) [MIM:613345]	M0QSJ9	672	R	G
P35499	LP/P	Periodic paralysis hypokalemic 2 (HOKPP2) [MIM:613345]	M0QSJ9	672	R	H
P35499	LP/P	Periodic paralysis hypokalemic 2 (HOKPP2) [MIM:613345]	M0QSJ9	672	R	S
P35499	LP/P	Periodic paralysis hypokalemic 2 (HOKPP2) [MIM:613345]	M0QSJ9	1158	P	S
P35499	LP/P	Myotonia SCN4A-related (MYOSCN4A) [MIM:608390]	M0QSJ9	1160	I	V
P35499	LB/B	-	M0QSJ9	1376	N	D
P35499	LP/P	Myasthenic syndrome, congenital, 16 (CMS16) [MIM:614198]	M0QSJ9	1442	V	E
P35499	LP/P	Paramyotonia congenita of von Eulenburg (PMC) [MIM:168300]	M0QSJ9	1152	A	D
P35499	LP/P	Periodic paralysis normokalemic (NKPP) [MIM:170500]	M0QSJ9	675	R	G
P35499	LP/P	Periodic paralysis normokalemic (NKPP) [MIM:170500]	M0QSJ9	675	R	Q
P35499	LP/P	Periodic paralysis normokalemic (NKPP) [MIM:170500]	M0QSJ9	675	R	W
P35499	LP/P	Paramyotonia congenita of von Eulenburg (PMC) [MIM:168300]	M0QSJ9	1456	G	E
P35499	LP/P	Myotonia SCN4A-related (MYOSCN4A) [MIM:608390]	M0QSJ9	141	I	V
P35499	LP/P	Periodic paralysis hypokalemic 2 (HOKPP2) [MIM:613345]	M0QSJ9	222	R	W
P35499	LP/P	Paramyotonia congenita of von Eulenburg (PMC) [MIM:168300]	M0QSJ9	270	Q	K
P35499	LP/P	Myotonia SCN4A-related (MYOSCN4A) [MIM:608390]	M0QSJ9	452	E	K
P35499	LP/P	Myotonia SCN4A-related (MYOSCN4A) [MIM:608390]	M0QSJ9	671	F	S
P35499	LP/P	Periodic paralysis hypokalemic 2 (HOKPP2) [MIM:613345]	M0QSJ9	672	R	C
P35499	LP/P	Myotonia SCN4A-related (MYOSCN4A) [MIM:608390]	M0QSJ9	715	A	T
P35499	LB/B	-	M0QSJ9	781	V	I
P35499	LP/P	Myotonia SCN4A-related (MYOSCN4A) [MIM:608390]	M0QSJ9	804	S	N
P35499	LP/P	Periodic paralysis hypokalemic 2 (HOKPP2) [MIM:613345]	M0QSJ9	1132	R	Q
P35499	LP/P	Periodic paralysis hypokalemic 2 (HOKPP2) [MIM:613345]	M0QSJ9	1135	R	H
P35499	LP/P	Myotonia SCN4A-related (MYOSCN4A) [MIM:608390]	M0QSJ9	1297	N	K
P35499	LP/P	Myotonia SCN4A-related (MYOSCN4A) [MIM:608390]	M0QSJ9	1310	I	N
P35499	LP/P	Paramyotonia congenita of von Eulenburg (PMC) [MIM:168300]	M0QSJ9	1436	L	P
P35499	LP/P	Paramyotonia congenita of von Eulenburg (PMC) [MIM:168300]	M0QSJ9	1448	R	L
P35499	LP/P	Paramyotonia congenita of von Eulenburg (PMC) [MIM:168300]	M0QSJ9	1473	F	S
P35499	LP/P	Myotonia SCN4A-related (MYOSCN4A) [MIM:608390]	M0QSJ9	1476	M	I
P35499	LP/P	Myotonia SCN4A-related (MYOSCN4A) [MIM:608390]	M0QSJ9	1481	A	D
P35499	LP/P	Paramyotonia congenita of von Eulenburg (PMC) [MIM:168300]	M0QSJ9	1705	F	I
P35499	LP/P	Periodic paralysis hypokalemic 2 (HOKPP2) [MIM:613345]	M0QSJ9	1129	R	Q
P35499	LP/P	Periodic paralysis normokalemic (NKPP) [MIM:170500]	M0QSJ9	1129	R	Q
P35499	LP/P	Myotonia SCN4A-related (MYOSCN4A) [MIM:608390]	M0QSJ9	225	R	W
P35499	LP/P	Paramyotonia congenita of von Eulenburg (PMC) [MIM:168300]	M0QSJ9	693	I	T
P35499	LP/P	Myotonia SCN4A-related (MYOSCN4A) [MIM:608390]	M0QSJ9	1633	Q	E
P35499	LP/P	-	M0QSJ9	104	R	H
P35499	LP/P	-	M0QSJ9	203	M	K
P35499	LP/P	-	M0QSJ9	382	P	T
P35499	LP/P	-	M0QSJ9	1069	D	N
P35499	LP/P	Periodic paralysis hypokalemic 2 (HOKPP2) [MIM:613345]	M0QSJ9	1135	R	C
P35499	LP/P	-	M0QSJ9	1209	C	F
P35499	LP/P	Myasthenic syndrome, congenital, 16 (CMS16) [MIM:614198]	M0QSJ9	1454	R	W
P35499	LP/P	Myasthenic syndrome, congenital, 16 (CMS16) [MIM:614198]	M0QSJ9	1457	R	H
P35499	LP/P	Myotonia SCN4A-related (MYOSCN4A) [MIM:608390]	M0QSJ9	1290	F	L
Q8IWT1	LP/P	Long QT syndrome 10 (LQT10) [MIM:611819]	A0A1S3EL59	179	L	F
Q8IWT1	LP/P	Atrial fibrillation, familial, 17 (ATFB17) [MIM:611819]	A0A1S3EL59	162	V	G
Q8IWT1	LP/P	Atrial fibrillation, familial, 17 (ATFB17) [MIM:611819]	A0A1S3EL59	166	I	L
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	1325	N	S
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	1623	R	Q
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	1623	R	Q
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	1644	R	H
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	1790	D	G
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	1839	D	G
Q14524	LB/B	-	A0A1L8HI81	558	H	R
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	1304	T	M
Q14524	LB/B	-	A0A1L8HI81	1500	K	N
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	1645	T	M
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	1784	E	K
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	1784	E	K
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	1114	D	N
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	1501	L	V
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	1501	L	V
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	1623	R	L
Q14524	LB/B	-	A0A1L8HI81	1787	S	N
Q14524	LB/B	-	A0A1L8HI81	1090	P	L
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	619	L	F
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	619	L	F
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	220	T	I
Q14524	LP/P	Sick sinus syndrome 1 (SSS1) [MIM:608567]	A0A1L8HI81	220	T	I
Q14524	LP/P	Progressive familial heart block 1A (PFHB1A) [MIM:113900]	A0A1L8HI81	298	G	S
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	367	R	H
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	514	G	C
Q14524	LP/P	Progressive familial heart block 1A (PFHB1A) [MIM:113900]	A0A1L8HI81	514	G	C
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	735	A	V
Q14524	LP/P	Sick sinus syndrome 1 (SSS1) [MIM:608567]	A0A1L8HI81	735	A	V
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	941	S	N
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	997	A	S
Q14524	LB/B	-	A0A1L8HI81	1103	S	Y
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	1193	R	Q
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	1193	R	Q
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	1232	R	W
Q14524	LP/P	Progressive familial heart block 1A (PFHB1A) [MIM:113900]	A0A1L8HI81	1232	R	W
Q14524	LP/P	Sick sinus syndrome 1 (SSS1) [MIM:608567]	A0A1L8HI81	1298	P	L
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	1408	G	R
Q14524	LP/P	Sick sinus syndrome 1 (SSS1) [MIM:608567]	A0A1L8HI81	1408	G	R
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	1512	R	W
Q14524	LP/P	Progressive familial heart block 1A (PFHB1A) [MIM:113900]	A0A1L8HI81	1595	D	N
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	1620	T	M
Q14524	LP/P	Familial paroxysmal ventricular fibrillation 1 (VF1) [MIM:603829]	A0A1L8HI81	1710	S	L
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	1826	R	H
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	1924	A	T
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	1795	Y	C
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	1795	Y	H
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	27	R	H
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	27	R	H
Q14524	LB/B	-	A0A1L8HI81	34	R	C
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	126	K	E
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	161	E	K
Q14524	LP/P	Progressive familial heart block 1A (PFHB1A) [MIM:113900]	A0A1L8HI81	161	E	K
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	187	T	I
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	226	A	V
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	230	I	V
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	282	R	H
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	294	V	M
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	319	G	S
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	351	G	V
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	356	D	N
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	367	R	C
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	367	R	C
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	369	M	K
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	552	G	R
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	567	L	Q
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	615	G	E
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	615	G	E
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	681	H	P
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	735	A	E
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	752	G	R
Q14524	LP/P	Progressive familial heart block 1A (PFHB1A) [MIM:113900]	A0A1L8HI81	752	G	R
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	851	F	L
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	892	F	I
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	896	C	S
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	910	S	L
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	965	R	C
Q14524	LB/B	-	A0A1L8HI81	1027	R	Q
Q14524	LP/P	Atrial fibrillation, familial, 10 (ATFB10) [MIM:614022]	A0A1L8HI81	1053	E	K
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	1053	E	K
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	1053	E	K
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	1225	E	K
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	1225	E	K
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	1236	K	N
Q14524	LB/B	-	A0A1L8HI81	1240	E	Q
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	1250	F	L
Q14524	LP/P	Atrial standstill 1 (ATRST1) [MIM:108770]	A0A1L8HI81	1275	D	N
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	1275	D	N
Q14524	LP/P	Cardiomyopathy, dilated 1E (CMD1E) [MIM:601154]	A0A1L8HI81	1275	D	N
Q14524	LP/P	Progressive familial heart block 1A (PFHB1A) [MIM:113900]	A0A1L8HI81	1275	D	N
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	1319	G	V
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	1344	F	S
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	1382	S	I
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	1405	V	L
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	1406	G	R
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	1502	G	S
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	1714	D	G
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	1740	G	R
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	1743	G	E
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	9	G	V
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	225	R	Q
Q14524	LP/P	Progressive familial heart block 1A (PFHB1A) [MIM:113900]	A0A1L8HI81	512	T	I
Q14524	LB/B	-	A0A1L8HI81	524	S	Y
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	639	G	R
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	1333	S	Y
Q14524	LP/P	Sudden infant death syndrome (SIDS) [MIM:272120]	A0A1L8HI81	1333	S	Y
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	1609	S	W
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	1819	D	N
Q14524	LB/B	-	A0A1L8HI81	618	L	F
Q14524	LB/B	-	A0A1L8HI81	1041	D	N
Q14524	LB/B	-	A0A1L8HI81	1180	A	V
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	43	R	Q
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	95	V	I
Q14524	LP/P	Atrial fibrillation, familial, 10 (ATFB10) [MIM:614022]	A0A1L8HI81	138	M	I
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	212	L	P
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	225	R	W
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	225	R	W
Q14524	LP/P	Progressive familial heart block 1A (PFHB1A) [MIM:113900]	A0A1L8HI81	225	R	W
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	336	P	L
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	353	T	I
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	406	N	K
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	406	N	S
Q14524	LP/P	Atrial fibrillation, familial, 10 (ATFB10) [MIM:614022]	A0A1L8HI81	428	E	K
Q14524	LP/P	Atrial fibrillation, familial, 10 (ATFB10) [MIM:614022]	A0A1L8HI81	445	H	D
Q14524	LB/B	-	A0A1L8HI81	461	L	V
Q14524	LP/P	Atrial fibrillation, familial, 10 (ATFB10) [MIM:614022]	A0A1L8HI81	470	N	K
Q14524	LB/B	-	A0A1L8HI81	481	R	W
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	532	F	C
Q14524	LP/P	Sudden infant death syndrome (SIDS) [MIM:272120]	A0A1L8HI81	532	F	C
Q14524	LB/B	Atrial fibrillation, familial, 10 (ATFB10) [MIM:614022]	A0A1L8HI81	572	A	D
Q14524	LB/B	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	572	A	D
Q14524	LP/P	Atrial fibrillation, familial, 10 (ATFB10) [MIM:614022]	A0A1L8HI81	655	E	K
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	680	R	H
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	814	R	Q
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	878	R	C
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	1023	R	H
Q14524	LP/P	Atrial fibrillation, familial, 10 (ATFB10) [MIM:614022]	A0A1L8HI81	1131	T	I
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	1295	E	K
Q14524	LB/B	-	A0A1L8HI81	1308	L	F
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	1330	A	P
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	1330	A	T
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	1473	F	C
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	1486	F	L
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	1494	Y	N
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	1527	K	R
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	1569	A	P
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	1620	T	K
Q14524	LP/P	Progressive familial heart block 1A (PFHB1A) [MIM:113900]	A0A1L8HI81	1620	T	K
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	1644	R	C
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	1649	A	V
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	1652	M	R
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	1660	I	V
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	1660	I	V
Q14524	LP/P	Sudden infant death syndrome (SIDS) [MIM:272120]	A0A1L8HI81	1705	F	S
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	1743	G	R
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	1763	V	M
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	1766	M	L
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	1768	I	V
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	1777	V	M
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	1825	L	P
Q14524	LP/P	Atrial fibrillation, familial, 10 (ATFB10) [MIM:614022]	A0A1L8HI81	1826	R	C
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	1850	C	S
Q14524	LB/B	-	A0A1L8HI81	1875	M	T
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	1904	S	L
Q14524	LP/P	Atrial fibrillation, familial, 10 (ATFB10) [MIM:614022]	A0A1L8HI81	1951	V	M
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	1968	I	S
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	2004	F	L
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	2004	F	L
Q14524	LP/P	Atrial fibrillation, familial, 10 (ATFB10) [MIM:614022]	A0A1L8HI81	1987	N	K
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	125	V	L
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	245	Q	K
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	404	L	Q
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	411	V	M
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	462	E	K
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	637	P	L
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	648	P	L
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	648	P	L
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	971	R	C
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	1069	T	M
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	1231	E	K
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	1458	S	Y
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	1481	G	E
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	1667	V	I
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	1667	V	I
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	1779	T	M
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	1779	T	M
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	1909	Q	R
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	1949	A	S
Q14524	LP/P	Sick sinus syndrome 1 (SSS1) [MIM:608567]	A0A1L8HI81	1792	D	N
Q14524	LB/B	-	A0A1L8HI81	34	R	H
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	222	R	Q
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	222	R	Q
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	240	V	M
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	240	V	M
Q14524	LB/B	-	A0A1L8HI81	286	A	S
Q14524	LB/B	-	A0A1L8HI81	291	N	S
Q14524	LB/B	-	A0A1L8HI81	299	L	M
Q14524	LB/B	-	A0A1L8HI81	376	R	C
Q14524	LB/B	-	A0A1L8HI81	447	A	G
Q14524	LB/B	-	A0A1L8HI81	449	T	A
Q14524	LB/B	-	A0A1L8HI81	475	R	S
Q14524	LB/B	-	A0A1L8HI81	568	R	H
Q14524	LB/B	-	A0A1L8HI81	592	N	K
Q14524	LB/B	-	A0A1L8HI81	596	D	G
Q14524	LB/B	-	A0A1L8HI81	601	V	A
Q14524	LB/B	-	A0A1L8HI81	638	G	D
Q14524	LB/B	-	A0A1L8HI81	656	P	L
Q14524	LB/B	-	A0A1L8HI81	672	A	T
Q14524	LB/B	-	A0A1L8HI81	692	Q	K
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	701	P	L
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	701	P	L
Q14524	LB/B	-	A0A1L8HI81	705	S	F
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	772	D	N
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	772	D	N
Q14524	LB/B	-	A0A1L8HI81	924	V	I
Q14524	LB/B	-	A0A1L8HI81	986	R	Q
Q14524	LB/B	-	A0A1L8HI81	1016	T	M
Q14524	LB/B	-	A0A1L8HI81	1040	G	R
Q14524	LB/B	-	A0A1L8HI81	1082	V	A
Q14524	LB/B	-	A0A1L8HI81	1098	V	L
Q14524	LB/B	-	A0A1L8HI81	1107	E	K
Q14524	LB/B	-	A0A1L8HI81	1116	R	W
Q14524	LB/B	-	A0A1L8HI81	1251	V	M
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	1432	R	S
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	1432	R	S
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	1629	R	Q
Q14524	LB/B	-	A0A1L8HI81	1836	I	T
Q14524	LB/B	-	A0A1L8HI81	1901	E	K
Q14524	LB/B	-	A0A1L8HI81	1919	R	C
Q14524	LB/B	-	A0A1L8HI81	1962	P	L
Q14524	LB/B	-	A0A1L8HI81	1968	I	M
Q14524	LB/B	-	A0A1L8HI81	1991	R	Q
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	2004	F	V
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	2004	F	V
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	812	L	Q
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	817	K	E
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	1690	D	N
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	1748	G	D
Q14524	LP/P	Long QT syndrome 3 (LQT3) [MIM:603830]	A0A1L8HI81	1849	H	R
Q14524	LP/P	Brugada syndrome 1 (BRGDA1) [MIM:601144]	A0A1L8HI81	1571	F	L
Q01118	LB/B	-	A0A1L8HI81	407	I	V
Q01118	LB/B	-	A0A1L8HI81	600	M	L
Q01118	LB/B	-	A0A1L8HI81	1313	A	V
Q01118	LB/B	-	A0A1L8HI81	1516	R	K
Q01118	LB/B	-	A0A1L8HI81	1596	V	L
Q01118	LB/B	-	A0A1L8HI81	1657	D	G
Q01118	LB/B	-	A0A1L8HI81	41	T	N
Q01118	LB/B	-	A0A1L8HI81	958	M	I
Q9UQD0	LP/P	Developmental and epileptic encephalopathy 13 (DEE13) [MIM:614558]	A0A1L8HI81	1768	N	D
Q9UQD0	LP/P	Developmental and epileptic encephalopathy 13 (DEE13) [MIM:614558]	A0A1L8HI81	216	V	D
Q9UQD0	LP/P	Developmental and epileptic encephalopathy 13 (DEE13) [MIM:614558]	A0A1L8HI81	846	F	S
Q9UQD0	LP/P	Developmental and epileptic encephalopathy 13 (DEE13) [MIM:614558]	A0A1L8HI81	1327	I	V
Q9UQD0	LP/P	Developmental and epileptic encephalopathy 13 (DEE13) [MIM:614558]	A0A1L8HI81	1466	N	K
Q9UQD0	LP/P	Developmental and epileptic encephalopathy 13 (DEE13) [MIM:614558]	A0A1L8HI81	1466	N	T
Q9UQD0	LP/P	Developmental and epileptic encephalopathy 13 (DEE13) [MIM:614558]	A0A1L8HI81	1617	R	Q
Q9UQD0	LP/P	Developmental and epileptic encephalopathy 13 (DEE13) [MIM:614558]	A0A1L8HI81	1650	A	T
Q9UQD0	LP/P	Developmental and epileptic encephalopathy 13 (DEE13) [MIM:614558]	A0A1L8HI81	1872	R	W
Q9UQD0	LP/P	Developmental and epileptic encephalopathy 13 (DEE13) [MIM:614558]	A0A1L8HI81	223	R	G
Q9UQD0	LP/P	Developmental and epileptic encephalopathy 13 (DEE13) [MIM:614558]	A0A1L8HI81	767	T	I
Q9UQD0	LP/P	Developmental and epileptic encephalopathy 13 (DEE13) [MIM:614558]	A0A1L8HI81	890	A	T
Q9UQD0	LP/P	Developmental and epileptic encephalopathy 13 (DEE13) [MIM:614558]	A0A1L8HI81	984	N	K
Q9UQD0	LP/P	Developmental and epileptic encephalopathy 13 (DEE13) [MIM:614558]	A0A1L8HI81	1451	G	S
Q9UQD0	LP/P	Developmental and epileptic encephalopathy 13 (DEE13) [MIM:614558]	A0A1L8HI81	1872	R	L
Q9UQD0	LP/P	Developmental and epileptic encephalopathy 13 (DEE13) [MIM:614558]	A0A1L8HI81	1872	R	Q
Q9UQD0	LP/P	Developmental and epileptic encephalopathy 13 (DEE13) [MIM:614558]	A0A1L8HI81	1877	N	S
Q9UQD0	LP/P	Seizures, benign familial infantile, 5 (BFIS5) [MIM:617080]	A0A1L8HI81	1877	N	S
Q9UQD0	LP/P	Seizures, benign familial infantile, 5 (BFIS5) [MIM:617080]	A0A1L8HI81	1483	E	K
Q9UQD0	LP/P	Developmental and epileptic encephalopathy 13 (DEE13) [MIM:614558]	A0A1L8HI81	978	S	G
Q9UQD0	LP/P	Developmental and epileptic encephalopathy 13 (DEE13) [MIM:614558]	A0A1L8HI81	1475	G	R
Q9UQD0	LP/P	Developmental and epileptic encephalopathy 13 (DEE13) [MIM:614558]	A0A1L8HI81	1279	L	V
Q9UQD0	LP/P	Developmental and epileptic encephalopathy 13 (DEE13) [MIM:614558]	A0A1L8HI81	210	F	L
Q9UQD0	LP/P	Developmental and epileptic encephalopathy 13 (DEE13) [MIM:614558]	A0A1L8HI81	232	S	P
Q9UQD0	LP/P	Developmental and epileptic encephalopathy 13 (DEE13) [MIM:614558]	A0A1L8HI81	850	R	E
Q9UQD0	LP/P	Developmental and epileptic encephalopathy 13 (DEE13) [MIM:614558]	A0A1L8HI81	891	V	M
Q9UQD0	LP/P	Developmental and epileptic encephalopathy 13 (DEE13) [MIM:614558]	A0A1L8HI81	1598	V	A
Q9UQD0	LP/P	Myoclonus, familial, 2 (MYOCL2) [MIM:618364]	A0A1L8HI81	1719	P	R
Q15858	LP/P	Primary erythermalgia (PERYTHM) [MIM:133020]	A0A1L8HI81	859	I	T
Q15858	LP/P	Primary erythermalgia (PERYTHM) [MIM:133020]	A0A1L8HI81	869	L	H
Q15858	LB/B	-	A0A1L8HI81	1161	W	R
Q15858	LB/B	-	A0A1L8HI81	1919	D	G
Q15858	LB/B	-	A0A1L8HI81	932	M	L
Q15858	LP/P	Primary erythermalgia (PERYTHM) [MIM:133020]	A0A1L8HI81	241	S	T
Q15858	LP/P	Paroxysmal extreme pain disorder (PEXPD) [MIM:167400]	A0A1L8HI81	1007	R	C
Q15858	LP/P	Paroxysmal extreme pain disorder (PEXPD) [MIM:167400]	A0A1L8HI81	1309	V	D
Q15858	LP/P	Paroxysmal extreme pain disorder (PEXPD) [MIM:167400]	A0A1L8HI81	1309	V	F
Q15858	LP/P	Paroxysmal extreme pain disorder (PEXPD) [MIM:167400]	A0A1L8HI81	1310	V	F
Q15858	LP/P	Primary erythermalgia (PERYTHM) [MIM:133020]	A0A1L8HI81	1460	F	V
Q15858	LP/P	Paroxysmal extreme pain disorder (PEXPD) [MIM:167400]	A0A1L8HI81	1472	I	T
Q15858	LP/P	Paroxysmal extreme pain disorder (PEXPD) [MIM:167400]	A0A1L8HI81	1473	F	V
Q15858	LP/P	Paroxysmal extreme pain disorder (PEXPD) [MIM:167400]	A0A1L8HI81	1475	T	I
Q15858	LP/P	Paroxysmal extreme pain disorder (PEXPD) [MIM:167400]	A0A1L8HI81	1638	M	K
Q15858	LB/B	-	A0A1L8HI81	943	M	L
Q15858	LP/P	Primary erythermalgia (PERYTHM) [MIM:133020]	A0A1L8HI81	10	Q	R
Q15858	LP/P	Primary erythermalgia (PERYTHM) [MIM:133020]	A0A1L8HI81	216	F	S
Q15858	LB/B	-	A0A1L8HI81	228	I	M
Q15858	LP/P	Primary erythermalgia (PERYTHM) [MIM:133020]	A0A1L8HI81	395	N	K
Q15858	LB/B	-	A0A1L8HI81	490	S	N
Q15858	LB/B	-	A0A1L8HI81	519	E	K
Q15858	LB/B	-	A0A1L8HI81	666	K	R
Q15858	LB/B	-	A0A1L8HI81	695	I	M
Q15858	LB/B	-	A0A1L8HI81	750	I	V
Q15858	LP/P	Primary erythermalgia (PERYTHM) [MIM:133020]	A0A1L8HI81	869	L	F
Q15858	LP/P	Indifference to pain, congenital, autosomal recessive (CIP) [MIM:243000]	A0A1L8HI81	907	R	Q
Q15858	LB/B	-	A0A1L8HI81	1134	L	F
Q15858	LB/B	-	A0A1L8HI81	1278	L	V
Q15858	LP/P	Paroxysmal extreme pain disorder (PEXPD) [MIM:167400]	A0A1L8HI81	1623	L	P
Q15858	LP/P	Paroxysmal extreme pain disorder (PEXPD) [MIM:167400]	A0A1L8HI81	1643	A	E
Q15858	LP/P	Primary erythermalgia (PERYTHM) [MIM:133020]	A0A1L8HI81	1643	A	E
Q15858	LP/P	Primary erythermalgia (PERYTHM) [MIM:133020]	A0A1L8HI81	1643	A	T
P37088	LB/B	-	J9PB48	493	W	R
P37088	LP/P	Pseudohypoaldosteronism 1B1, autosomal recessive (PHA1B1) [MIM:264350]	J9PB48	562	S	L
P37088	LB/B	-	J9PB48	663	T	A
P37088	LB/B	-	J9PB48	618	C	F
P37088	LP/P	Pseudohypoaldosteronism 1B1, autosomal recessive (PHA1B1) [MIM:264350]	J9PB48	327	G	C
P37088	LB/B	-	J9PB48	402	P	H
P37088	LP/P	Bronchiectasis with or without elevated sweat chloride 2 (BESC2) [MIM:613021]	J9PB48	61	F	L
P37088	LP/P	Bronchiectasis with or without elevated sweat chloride 2 (BESC2) [MIM:613021]	J9PB48	114	V	I
P37088	LB/B	-	J9PB48	181	R	W
P37088	LB/B	-	J9PB48	334	A	T
P37088	LB/B	-	J9PB48	573	V	I
P37088	LP/P	Liddle syndrome 3 (LIDLS3) [MIM:618126]	J9PB48	479	C	R
P51172	LB/B	-	A0A2K5RGP1	344	R	P
P51172	LB/B	-	A0A2K5RGP1	544	E	Q
P51172	LB/B	-	A0A2K5RGP1	636	A	T
P51172	LB/B	-	A0A2K5RGP1	696	C	Y
P51172	LB/B	-	A0A2K5RGP1	726	G	S
P51172	LB/B	-	A0A2K5RGP1	770	G	R
P51170	LB/B	-	G1TDL6	49	G	C
P51170	LB/B	-	G1TDL6	183	G	S
P51170	LB/B	-	G1TDL6	178	R	W
P51170	LB/B	-	G1TDL6	502	A	P
P51170	LB/B	-	G1TDL6	614	A	S
P51170	LB/B	-	G1TDL6	197	E	K
O75880	LP/P	Mitochondrial complex IV deficiency, nuclear type 4 (MC4DN4) [MIM:619048]	A0A287ACH8	174	P	L
O75880	LB/B	-	A0A287ACH8	58	P	S
O43819	LP/P	Mitochondrial complex IV deficiency, nuclear type 2 (MC4DN2) [MIM:604377]	A0A1U7UNY0	140	E	K
O43819	LP/P	Myopia 6 (MYP6) [MIM:608908]	A0A1U7UNY0	140	E	K
O43819	LP/P	Mitochondrial complex IV deficiency, nuclear type 2 (MC4DN2) [MIM:604377]	A0A1U7UNY0	225	S	F
O43819	LB/B	-	A0A1U7UNY0	20	R	P
O43819	LP/P	Mitochondrial complex IV deficiency, nuclear type 2 (MC4DN2) [MIM:604377]	A0A1U7UNY0	171	R	W
O43819	LB/B	Myopia 6 (MYP6) [MIM:608908]	A0A1U7UNY0	259	A	V
O43819	LP/P	Myopia 6 (MYP6) [MIM:608908]	A0A1U7UNY0	114	R	H
O43819	LP/P	Mitochondrial complex IV deficiency, nuclear type 2 (MC4DN2) [MIM:604377]	A0A1U7UNY0	133	C	Y
O43819	LP/P	Mitochondrial complex IV deficiency, nuclear type 2 (MC4DN2) [MIM:604377]	A0A1U7UNY0	193	G	S
O43819	LP/P	Mitochondrial complex IV deficiency, nuclear type 2 (MC4DN2) [MIM:604377]	A0A1U7UNY0	258	M	T
Q9UJQ7	LB/B	-	F7DU90	99	P	S
Q9HB40	LB/B	-	D6W8Z8	3	L	V
Q9HB40	LB/B	-	D6W8Z8	241	V	I
Q14160	LB/B	-	A0A2K6PBT9	422	P	L
Q14160	LP/P	Neural tube defects (NTD) [MIM:182940]	A0A2K6PBT9	454	P	S
Q14160	LP/P	Neural tube defects (NTD) [MIM:182940]	A0A2K6PBT9	1535	R	Q
Q9BWW7	LB/B	-	I3LD82	133	A	S
P47872	LB/B	-	A0A1A6GWP0	122	A	P
P47872	LB/B	-	A0A1A6GWP0	110	D	N
Q8IWY4	LB/B	-	G1SPU4	398	G	R
Q8IWY4	LB/B	-	G1SPU4	648	S	P
Q9NQ36	LB/B	-	G1SPU4	591	T	M
Q9NQ36	LB/B	-	G1SPU4	712	Q	H
Q9NQ36	LB/B	-	G1SPU4	752	V	G
Q9NQ36	LB/B	-	G1SPU4	791	T	S
Q9NQ36	LB/B	-	G1SPU4	843	P	R
Q96KG9	LB/B	-	A0A224Z2U3	479	P	L
Q96KG9	LB/B	-	A0A224Z2U3	663	Q	H
Q96KG9	LB/B	-	A0A224Z2U3	755	W	S
Q6P3W7	LB/B	-	B7ZVJ2	357	P	L
Q6P3W7	LB/B	-	B7ZVJ2	720	T	S
Q8IZE3	LB/B	-	A0A212CRA7	597	G	A
Q8IZE3	LB/B	-	A0A212CRA7	621	Q	R
Q9NVU7	LB/B	-	A0A2I3RRR5	258	K	Q
Q9NVU7	LB/B	-	A0A2I3RRR5	490	A	D
Q9NVU7	LB/B	-	A0A2I3RRR5	575	S	C
Q9NVU7	LB/B	-	A0A2I3RRR5	660	V	I
P18827	LB/B	-	G1TUQ1	76	T	M
P18827	LB/B	-	G1TUQ1	136	L	Q
P34741	LB/B	-	H3BXQ4	59	A	T
P34741	LB/B	-	H3BXQ4	71	S	T
P31431	LB/B	-	F8QYW9	12	F	L
O00560	LB/B	-	G3WHP2	69	N	S
Q9H190	LB/B	-	G3WHP2	182	V	M
Q9H190	LB/B	-	G3WHP2	223	R	C
Q9H190	LB/B	-	G3WHP2	242	G	R
Q86SQ7	LB/B	-	A0A1S3F7V7	378	E	D
Q6IQ49	LB/B	-	A0A1U7REM5	312	M	I
P31040	LP/P	Leigh syndrome (LS) [MIM:256000]	A0A2K6D385	554	R	W
P31040	LP/P	Leigh syndrome (LS) [MIM:256000]	A0A2K6D385	524	A	V
P31040	LP/P	Cardiomyopathy, dilated 1GG (CMD1GG) [MIM:613642]	A0A2K6D385	555	G	E
P31040	LP/P	Mitochondrial complex II deficiency, nuclear type 1 (MC2DN1) [MIM:252011]	A0A2K6D385	555	G	E
P31040	LB/B	-	A0A2K6D385	33	F	V
P31040	LB/B	-	A0A2K6D385	38	D	V
P31040	LB/B	-	A0A2K6D385	240	E	Q
P31040	LB/B	-	A0A2K6D385	657	V	I
P31040	LB/B	-	A0A2K6D385	333	V	I
P31040	LP/P	Paragangliomas 5 (PGL5) [MIM:614165]	A0A2K6D385	589	R	W
P31040	LB/B	-	A0A2K6D385	629	Y	F
P31040	LP/P	Leigh syndrome (LS) [MIM:256000]	A0A2K6D385	189	C	G
P31040	LB/B	-	A0A2K6D385	508	T	I
P31040	LP/P	Neurodegeneration with ataxia and late-onset optic atrophy (NDAXOA) [MIM:619259]	A0A2K6D385	451	R	C
A6NFY7	LP/P	Mitochondrial complex II deficiency, nuclear type 2 (MC2DN2) [MIM:619166]	L8HW57	55	R	P
A6NFY7	LP/P	Mitochondrial complex II deficiency, nuclear type 2 (MC2DN2) [MIM:619166]	L8HW57	57	G	R
A6NFY7	LP/P	Mitochondrial complex II deficiency, nuclear type 2 (MC2DN2) [MIM:619166]	L8HW57	57	G	E
Q9NX18	LP/P	Paragangliomas 2 (PGL2) [MIM:601650]	A0A2Y9ENU0	78	G	R
Q5VUM1	LB/B	-	A0A250XUU9	46	Q	R
Q5VUM1	LB/B	-	A0A250XUU9	57	R	C
P21912	LP/P	Paragangliomas 4 (PGL4) [MIM:115310]	A0A0X8HT74	197	P	R
P21912	LP/P	Paragangliomas 4 (PGL4) [MIM:115310]	A0A0X8HT74	242	R	H
P21912	LP/P	Pheochromocytoma (PCC) [MIM:171300]	A0A0X8HT74	242	R	H
P21912	LP/P	Pheochromocytoma (PCC) [MIM:171300]	A0A0X8HT74	87	L	S
P21912	LP/P	Paragangliomas 4 (PGL4) [MIM:115310]	A0A0X8HT74	131	P	R
P21912	LP/P	Pheochromocytoma (PCC) [MIM:171300]	A0A0X8HT74	46	R	G
P21912	LP/P	Pheochromocytoma (PCC) [MIM:171300]	A0A0X8HT74	101	C	Y
P21912	LP/P	Pheochromocytoma (PCC) [MIM:171300]	A0A0X8HT74	192	C	R
P21912	LP/P	Pheochromocytoma (PCC) [MIM:171300]	A0A0X8HT74	196	C	Y
P21912	LP/P	Pheochromocytoma (PCC) [MIM:171300]	A0A0X8HT74	100	S	F
P21912	LP/P	Paragangliomas 4 (PGL4) [MIM:115310]	A0A0X8HT74	132	H	P
P21912	LB/B	-	A0A0X8HT74	40	K	E
P21912	LP/P	Pheochromocytoma (PCC) [MIM:171300]	A0A0X8HT74	43	A	P
P21912	LP/P	Paragangliomas 4 (PGL4) [MIM:115310]	A0A0X8HT74	46	R	Q
P21912	LP/P	Pheochromocytoma (PCC) [MIM:171300]	A0A0X8HT74	46	R	Q
P21912	LP/P	Pheochromocytoma (PCC) [MIM:171300]	A0A0X8HT74	53	G	R
P21912	LP/P	Pheochromocytoma (PCC) [MIM:171300]	A0A0X8HT74	65	L	H
P21912	LP/P	Pheochromocytoma (PCC) [MIM:171300]	A0A0X8HT74	65	L	P
P21912	LP/P	Pheochromocytoma (PCC) [MIM:171300]	A0A0X8HT74	127	I	N
P21912	LP/P	Pheochromocytoma (PCC) [MIM:171300]	A0A0X8HT74	230	R	C
P21912	LP/P	Mitochondrial complex II deficiency, nuclear type 4 (MC2DN4) [MIM:619224]	A0A0X8HT74	48	D	V
P21912	LP/P	Mitochondrial complex II deficiency, nuclear type 4 (MC2DN4) [MIM:619224]	A0A0X8HT74	103	M	T
P21912	LP/P	Mitochondrial complex II deficiency, nuclear type 4 (MC2DN4) [MIM:619224]	A0A0X8HT74	230	R	H
P21912	LP/P	Mitochondrial complex II deficiency, nuclear type 4 (MC2DN4) [MIM:619224]	A0A0X8HT74	257	L	V
Q7Z5N4	LB/B	-	U3IN82	1016	D	N
Q7Z5N4	LB/B	-	U3IN82	1641	H	R
Q8N3Y7	LB/B	-	A0A2Y9SZP2	62	R	W
Q8WUS8	LB/B	-	V8NW49	10	S	T
Q8WUS8	LB/B	-	V8NW49	96	K	E
Q8WUS8	LB/B	-	V8NW49	320	G	D
Q8NEX9	LP/P	Ichthyosis, congenital, autosomal recessive 13 (ARCI13) [MIM:617574]	G5E8H9	72	R	W
Q8NEX9	LP/P	Ichthyosis, congenital, autosomal recessive 13 (ARCI13) [MIM:617574]	G5E8H9	200	I	T
P55735	LB/B	-	L5KAV7	172	S	L
O15027	LB/B	-	G1PD21	1039	R	C
Q96JE7	LB/B	-	L5KYG9	292	H	R
Q96JE7	LB/B	-	L5KYG9	730	G	R
Q96JE7	LB/B	-	L5KYG9	845	Q	H
Q96JE7	LB/B	-	L5KYG9	864	P	A
Q96JE7	LB/B	-	L5KYG9	873	S	N
Q15436	LB/B	-	A0A261Y1I8	211	L	V
Q15436	LP/P	Craniolenticulosutural dysplasia (CLSD) [MIM:607812]	A0A261Y1I8	382	F	L
Q15437	LB/B	-	A0A261Y1I8	489	H	Q
Q15437	LB/B	-	A0A261Y1I8	433	P	L
Q15437	LP/P	Anemia, congenital dyserythropoietic, 2 (CDAN2) [MIM:224100]	A0A261Y1I8	14	R	W
Q15437	LB/B	-	A0A261Y1I8	18	R	H
Q15437	LP/P	Anemia, congenital dyserythropoietic, 2 (CDAN2) [MIM:224100]	A0A261Y1I8	109	E	K
Q15437	LB/B	-	A0A261Y1I8	313	R	H
Q15437	LB/B	-	A0A261Y1I8	318	I	T
Q15437	LP/P	Anemia, congenital dyserythropoietic, 2 (CDAN2) [MIM:224100]	A0A261Y1I8	348	D	A
Q15437	LB/B	-	A0A261Y1I8	373	M	V
Q15437	LB/B	-	A0A261Y1I8	386	Q	R
Q15437	LB/B	-	A0A261Y1I8	426	V	I
Q15437	LB/B	-	A0A261Y1I8	462	Y	C
Q15437	LB/B	-	A0A261Y1I8	524	A	V
Q15437	LP/P	Anemia, congenital dyserythropoietic, 2 (CDAN2) [MIM:224100]	A0A261Y1I8	530	R	W
Q15437	LP/P	Anemia, congenital dyserythropoietic, 2 (CDAN2) [MIM:224100]	A0A261Y1I8	603	S	L
Q15437	LP/P	Anemia, congenital dyserythropoietic, 2 (CDAN2) [MIM:224100]	A0A261Y1I8	701	R	C
Q15437	LP/P	Cowden syndrome 7 (CWS7) [MIM:616858]	A0A261Y1I8	594	V	G
Q9Y6Y8	LB/B	-	H3AFN6	644	K	E
O95486	LB/B	-	F6ZKT1	261	S	G
O95486	LB/B	-	F6ZKT1	302	T	I
O95486	LB/B	-	F6ZKT1	396	T	M
O95487	LB/B	-	F7FF75	456	A	G
P53992	LB/B	-	G3Q7G4	934	L	P
P53992	LB/B	-	G3Q7G4	109	P	S
O94855	LB/B	-	G3Q7G4	42	M	T
O94855	LB/B	-	G3Q7G4	193	P	L
O94855	LB/B	-	G3Q7G4	496	F	I
O94855	LP/P	Cole-Carpenter syndrome 2 (CLCRP2) [MIM:616294]	G3Q7G4	978	Q	P
O94855	LP/P	Cole-Carpenter syndrome 2 (CLCRP2) [MIM:616294]	G3Q7G4	1015	S	F
Q9UGP8	LB/B	-	A0A1E1XBE7	556	V	I
Q9UBV2	LB/B	-	A0A1A8IZ51	162	D	G
Q9UBV2	LB/B	-	A0A1A8IZ51	714	V	I
Q5TEA6	LB/B	-	A0A2Y9INY6	687	H	Q
Q5TEA6	LB/B	-	A0A2Y9INY6	477	G	S
P16581	LB/B	-	U3JZP0	149	S	R
P16581	LB/B	-	U3JZP0	130	C	W
P16581	LB/B	-	U3JZP0	295	E	K
P16581	LB/B	-	U3JZP0	421	E	Q
P16581	LB/B	-	U3JZP0	468	H	Y
P16581	LB/B	-	U3JZP0	575	L	F
P16581	LB/B	-	U3JZP0	21	A	S
P16581	LB/B	-	U3JZP0	31	M	I
P16581	LB/B	-	U3JZP0	257	Q	P
P16581	LB/B	-	U3JZP0	550	P	S
P16581	LB/B	-	U3JZP0	545	P	L
Q13228	LP/P	Extraoral halitosis due to methanethiol oxidase deficiency (EHMTO) [MIM:618148]	A0A2A8CUU2	225	G	W
Q13228	LP/P	Extraoral halitosis due to methanethiol oxidase deficiency (EHMTO) [MIM:618148]	A0A2A8CUU2	329	H	Y
Q9C0D9	LP/P	Spastic paraplegia 81, autosomal recessive (SPG81) [MIM:618768]	W5UEW6	112	R	P
Q9NZV5	LP/P	Rigid spine muscular dystrophy 1 (RSMD1) [MIM:602771]	K7FNJ2	273	G	E
Q9NZV5	LP/P	Rigid spine muscular dystrophy 1 (RSMD1) [MIM:602771]	K7FNJ2	293	H	R
Q9NZV5	LP/P	Myopathy, congenital, with fiber-type disproportion (CFTD) [MIM:255310]	K7FNJ2	315	G	S
Q9NZV5	LP/P	Rigid spine muscular dystrophy 1 (RSMD1) [MIM:602771]	K7FNJ2	315	G	S
Q9NZV5	LP/P	Rigid spine muscular dystrophy 1 (RSMD1) [MIM:602771]	K7FNJ2	340	N	I
Q9NZV5	LP/P	Rigid spine muscular dystrophy 1 (RSMD1) [MIM:602771]	K7FNJ2	453	W	S
Q9NZV5	LP/P	Rigid spine muscular dystrophy 1 (RSMD1) [MIM:602771]	K7FNJ2	462	U	G
Q9NZV5	LP/P	Rigid spine muscular dystrophy 1 (RSMD1) [MIM:602771]	K7FNJ2	466	R	Q
Q9NZV5	LB/B	-	K7FNJ2	137	T	A
Q9NZV5	LB/B	-	K7FNJ2	142	C	Y
Q9NZV5	LB/B	-	K7FNJ2	502	N	K
Q9NZV5	LP/P	Rigid spine muscular dystrophy 1 (RSMD1) [MIM:602771]	K7FNJ2	463	G	V
Q9NZV5	LP/P	Rigid spine muscular dystrophy 1 (RSMD1) [MIM:602771]	K7FNJ2	469	R	Q
Q9NZV5	LP/P	Rigid spine muscular dystrophy 1 (RSMD1) [MIM:602771]	K7FNJ2	469	R	W
P49908	LB/B	-	A0A2Y9IKP6	112	P	S
P49908	LB/B	-	A0A2Y9IKP6	234	A	T
P49908	LB/B	-	A0A2Y9IKP6	278	R	Q
P49908	LB/B	-	A0A2Y9IKP6	314	S	P
P49908	LB/B	-	A0A2Y9IKP6	368	R	C
P59797	LB/B	-	A0A1D5QD10	284	K	R
P14151	LB/B	-	L5LTU1	193	F	L
P14151	LB/B	-	L5LTU1	201	E	Q
P14151	LB/B	-	L5LTU1	213	P	S
P14151	LB/B	-	L5LTU1	369	N	D
P16109	LB/B	-	A0A2K6T4T1	331	S	N
P16109	LB/B	-	A0A2K6T4T1	603	D	N
P16109	LB/B	-	A0A2K6T4T1	640	L	V
P16109	LB/B	-	A0A2K6T4T1	756	T	P
P16109	LB/B	-	A0A2K6T4T1	209	V	M
P16109	LB/B	-	A0A2K6T4T1	301	P	L
P16109	LB/B	-	A0A2K6T4T1	365	M	V
P16109	LB/B	-	A0A2K6T4T1	500	S	F
P16109	LB/B	-	A0A2K6T4T1	179	G	R
P16109	LB/B	-	A0A2K6T4T1	230	C	F
P16109	LB/B	-	A0A2K6T4T1	274	T	I
P16109	LB/B	-	A0A2K6T4T1	385	S	L
P16109	LB/B	-	A0A2K6T4T1	542	E	K
P16109	LB/B	-	A0A2K6T4T1	619	S	A
P16109	LB/B	-	A0A2K6T4T1	631	G	V
P16109	LB/B	-	A0A2K6T4T1	661	T	N
P16109	LB/B	-	A0A2K6T4T1	673	N	S
Q14242	LB/B	-	A0A091DLT4	62	M	I
Q14242	LB/B	-	A0A091DLT4	246	P	S
Q14242	LB/B	-	A0A091DLT4	249	T	M
P60896	LB/B	-	A0A2K5KTI2	17	D	G
Q14563	LB/B	-	H2UFS0	396	P	S
Q14563	LP/P	Hypogonadotropic hypogonadism 16 with or without anosmia (HH16) [MIM:614897]	H2UFS0	66	R	W
Q14563	LP/P	Hypogonadotropic hypogonadism 16 with or without anosmia (HH16) [MIM:614897]	H2UFS0	153	N	S
Q14563	LP/P	Hypogonadotropic hypogonadism 16 with or without anosmia (HH16) [MIM:614897]	H2UFS0	400	I	V
Q14563	LP/P	Hypogonadotropic hypogonadism 16 with or without anosmia (HH16) [MIM:614897]	H2UFS0	435	V	I
Q14563	LP/P	Hypogonadotropic hypogonadism 16 with or without anosmia (HH16) [MIM:614897]	H2UFS0	688	T	A
Q14563	LP/P	Hypogonadotropic hypogonadism 16 with or without anosmia (HH16) [MIM:614897]	H2UFS0	730	R	Q
Q14563	LP/P	Hypogonadotropic hypogonadism 16 with or without anosmia (HH16) [MIM:614897]	H2UFS0	733	R	H
Q14563	LP/P	Hypogonadotropic hypogonadism 16 with or without anosmia (HH16) [MIM:614897]	H2UFS0	342	M	T
Q14563	LP/P	Hypogonadotropic hypogonadism 16 with or without anosmia (HH16) [MIM:614897]	H2UFS0	447	D	G
Q14563	LP/P	Hypogonadotropic hypogonadism 16 with or without anosmia (HH16) [MIM:614897]	H2UFS0	657	I	M
O95025	LB/B	-	H2UFS0	701	K	Q
O15041	LB/B	-	H2PAJ7	208	R	P
O15041	LB/B	-	H2PAJ7	619	R	C
O15041	LB/B	-	H2PAJ7	717	I	V
Q13275	LB/B	-	H2UFS0	503	L	M
Q13275	LB/B	-	H2UFS0	474	A	G
Q9NS98	LB/B	-	H2PAJ7	232	I	T
Q9NS98	LB/B	-	H2PAJ7	180	S	N
Q9NS98	LB/B	-	H2PAJ7	332	V	I
Q9NPR2	LB/B	-	J3SD69	797	S	A
Q92854	LB/B	-	D3ZYR4	72	A	T
Q92854	LB/B	-	D3ZYR4	327	A	T
Q13591	LB/B	-	A0A147AMA7	246	V	L
Q13591	LB/B	-	A0A147AMA7	792	S	L
Q9P283	LB/B	-	G1QHK5	220	I	T
Q9P283	LB/B	-	G1QHK5	742	M	T
Q9P283	LB/B	-	G1QHK5	840	V	D
Q9P283	LB/B	-	G1QHK5	996	S	P
Q9P283	LB/B	-	G1QHK5	1028	D	G
Q9H2E6	LB/B	-	H3BX77	518	H	Y
Q9H2E6	LB/B	-	H3BX77	559	R	H
Q9H2E6	LB/B	-	H3BX77	567	D	E
Q9H3T2	LB/B	-	A0A287D9A9	455	T	P
Q8NFY4	LB/B	-	H3BX77	307	N	S
Q8NFY4	LB/B	-	H3BX77	478	S	N
Q8NFY4	LB/B	-	H3BX77	969	S	T
O75326	LB/B	-	G5BRG5	115	S	T
O75326	LB/B	-	G5BRG5	207	R	Q
O75326	LB/B	-	G5BRG5	207	R	W
O75326	LB/B	-	G5BRG5	460	R	H
O75326	LB/B	-	G5BRG5	461	R	C
O75326	LB/B	-	G5BRG5	347	R	L
O75326	LP/P	Cholestasis, progressive familial intrahepatic, 11 (PFIC11) [MIM:619874]	G5BRG5	148	R	W
P04279	LB/B	-	A4K2T5	79	S	T
P04279	LB/B	-	A4K2T5	372	R	L
P04279	LB/B	-	A4K2T5	58	E	G
P04279	LB/B	-	A4K2T5	108	H	R
Q02383	LB/B	-	A4K2Q1	274	S	N
Q02383	LB/B	-	A4K2Q1	368	G	R
Q02383	LB/B	-	A4K2Q1	43	Q	K
Q02383	LB/B	-	A4K2Q1	57	T	A
Q02383	LB/B	-	A4K2Q1	279	H	Y
Q9P0U3	LB/B	-	A0A093GNV7	193	I	V
Q9P0U3	LB/B	-	A0A093GNV7	350	D	G
Q9P0U3	LB/B	-	A0A093GNV7	280	A	T
Q9HC62	LB/B	-	A0A212CID7	301	T	K
Q9H4L4	LB/B	-	A0A091CLW9	515	W	R
Q96HI0	LB/B	-	G1NAP6	83	N	S
Q96HI0	LB/B	-	G1NAP6	340	L	F
Q9GZR1	LB/B	-	A0A2K5JCX4	1106	Y	C
Q9GZR1	LB/B	-	A0A2K5JCX4	121	T	M
Q9GZR1	LB/B	-	A0A2K5JCX4	637	E	K
Q9GZR1	LB/B	-	A0A2K5JCX4	717	R	P
Q9GZR1	LB/B	-	A0A2K5JCX4	820	A	V
Q9BQF6	LB/B	-	K7F8B0	79	K	Q
Q9BQF6	LB/B	-	K7F8B0	612	Q	H
Q96LD8	LB/B	-	A0A1S3WUB5	207	T	A
Q9HD40	LP/P	Pontocerebellar hypoplasia 2D (PCH2D) [MIM:613811]	A0A2K5NHZ3	239	A	T
Q9HD40	LP/P	Pontocerebellar hypoplasia 2D (PCH2D) [MIM:613811]	A0A2K5NHZ3	334	Y	C
Q9HD40	LP/P	Pontocerebellar hypoplasia 2D (PCH2D) [MIM:613811]	A0A2K5NHZ3	325	T	S
Q9P0V9	LB/B	-	L5KH61	189	L	P
O43236	LB/B	-	F7EQ08	311	E	V
Q96JX3	LB/B	-	A0A0P6GZ08	543	S	T
Q96JX3	LP/P	3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome (MEGDEL) [MIM:614739]	A0A0P6GZ08	401	G	D
Q96JX3	LP/P	3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome (MEGDEL) [MIM:614739]	A0A0P6GZ08	404	G	E
Q96JX3	LP/P	3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome (MEGDEL) [MIM:614739]	A0A0P6GZ08	498	S	T
P84101	LB/B	-	A0A2K5ESN2	40	D	Y
Q9UGK8	LB/B	-	A0A2Y9JR15	429	K	E
Q9UGK8	LB/B	-	A0A2Y9JR15	457	G	E
Q9H4I8	LB/B	-	A0A1L8GND3	46	S	N
Q9H4I8	LB/B	-	A0A1L8GND3	3	E	K
Q9H4I8	LB/B	-	A0A1L8GND3	306	C	R
Q96SA4	LB/B	-	A0A2B4RDD2	303	G	S
P01009	LB/B	-	A0A2I3MVI3	26	D	A
P01009	LB/B	-	A0A2I3MVI3	58	A	T
P01009	LB/B	-	A0A2I3MVI3	63	R	C
P01009	LB/B	-	A0A2I3MVI3	65	L	P
P01009	LB/B	-	A0A2I3MVI3	69	S	F
P01009	LB/B	-	A0A2I3MVI3	77	S	F
P01009	LB/B	-	A0A2I3MVI3	84	A	T
P01009	LB/B	-	A0A2I3MVI3	91	G	E
P01009	LB/B	-	A0A2I3MVI3	92	T	I
P01009	LB/B	-	A0A2I3MVI3	112	P	T
P01009	LB/B	-	A0A2I3MVI3	116	I	N
P01009	LB/B	-	A0A2I3MVI3	125	R	H
P01009	LB/B	-	A0A2I3MVI3	139	G	S
P01009	LB/B	-	A0A2I3MVI3	172	G	R
P01009	LB/B	-	A0A2I3MVI3	172	G	W
P01009	LB/B	-	A0A2I3MVI3	180	Q	E
P01009	LB/B	-	A0A2I3MVI3	228	E	K
P01009	LB/B	-	A0A2I3MVI3	237	V	A
P01009	LB/B	-	A0A2I3MVI3	247	R	C
P01009	LB/B	-	A0A2I3MVI3	280	D	V
P01009	LB/B	-	A0A2I3MVI3	288	E	V
P01009	LB/B	-	A0A2I3MVI3	354	S	F
P01009	LB/B	-	A0A2I3MVI3	360	A	T
P01009	LB/B	-	A0A2I3MVI3	365	D	N
P01009	LB/B	-	A0A2I3MVI3	366	E	K
P01009	LB/B	-	A0A2I3MVI3	382	M	R
P01009	LB/B	-	A0A2I3MVI3	386	P	H
P01009	LB/B	-	A0A2I3MVI3	386	P	T
P01009	LB/B	-	A0A2I3MVI3	387	E	K
P01009	LB/B	-	A0A2I3MVI3	393	P	L
P01009	LB/B	-	A0A2I3MVI3	400	E	D
P01009	LB/B	-	A0A2I3MVI3	109	T	M
P01009	LB/B	-	A0A2I3MVI3	37	T	A
Q9UK55	LB/B	-	A0A1A6GNW9	46	K	R
Q9UK55	LB/B	-	A0A1A6GNW9	61	S	G
Q9UK55	LB/B	-	A0A1A6GNW9	161	T	S
Q9UK55	LB/B	-	A0A1A6GNW9	139	G	R
Q9UK55	LB/B	-	A0A1A6GNW9	271	G	S
Q9UK55	LB/B	-	A0A1A6GNW9	384	Q	P
Q9UK55	LB/B	-	A0A1A6GNW9	158	L	Q
Q9UK55	LB/B	-	A0A1A6GNW9	196	R	H
Q9UK55	LB/B	-	A0A1A6GNW9	384	Q	R
Q9UK55	LB/B	-	A0A1A6GNW9	420	F	L
Q86U17	LB/B	-	F1SCC9	406	T	S
Q86U17	LB/B	-	F1SCC9	230	E	A
Q8IW75	LB/B	-	F1SCC9	142	Q	K
Q8IW75	LB/B	-	F1SCC9	394	I	V
Q8IW75	LB/B	-	F1SCC9	219	D	G
P01011	LB/B	-	F1SCC9	9	A	T
P01011	LB/B	-	F1SCC9	78	L	P
P01011	LB/B	-	F1SCC9	167	A	G
P01011	LB/B	-	F1SCC9	252	P	A
P01011	LB/B	-	F1SCC9	401	M	V
P01011	LB/B	-	F1SCC9	407	D	G
P01011	LB/B	-	F1SCC9	267	K	R
P05154	LB/B	-	A0A2I4AS29	55	A	V
P05154	LB/B	-	A0A2I4AS29	105	K	E
P05154	LB/B	-	A0A2I4AS29	44	S	G
P05154	LB/B	-	A0A2I4AS29	64	S	N
P05154	LB/B	-	A0A2I4AS29	94	G	V
P05154	LB/B	-	A0A2I4AS29	115	L	P
P05154	LB/B	-	A0A2I4AS29	217	G	R
P05154	LB/B	-	A0A2I4AS29	121	P	A
P08185	LP/P	Corticosteroid-binding globulin deficiency (CBG deficiency) [MIM:611489]	F1SCC9	115	L	H
P08185	LP/P	Corticosteroid-binding globulin deficiency (CBG deficiency) [MIM:611489]	F1SCC9	389	D	N
P08185	LB/B	-	F1SCC9	246	S	A
P05543	LB/B	-	F1SCC9	43	S	T
P05543	LB/B	-	F1SCC9	116	I	N
P05543	LB/B	-	F1SCC9	133	A	P
P05543	LB/B	-	F1SCC9	191	D	N
P05543	LB/B	-	F1SCC9	211	A	T
P05543	LB/B	-	F1SCC9	247	L	P
P05543	LB/B	-	F1SCC9	303	L	F
P05543	LB/B	-	F1SCC9	351	H	Y
P05543	LB/B	-	F1SCC9	383	P	L
Q86WD7	LB/B	-	F1SCC9	24	A	V
Q86WD7	LB/B	-	F1SCC9	218	P	L
Q86WD7	LB/B	-	F1SCC9	236	H	Q
Q86WD7	LB/B	-	F1SCC9	292	R	I
Q86WD7	LB/B	-	F1SCC9	330	V	A
P30740	LB/B	-	U3KF17	82	A	V
P48595	LB/B	-	U3KF17	246	R	C
P48595	LB/B	-	U3KF17	41	I	M
P48595	LB/B	-	U3KF17	99	I	T
P48595	LB/B	-	U3KF17	140	P	S
P48595	LB/B	-	U3KF17	3	S	A
P48595	LB/B	-	U3KF17	135	G	D
P48595	LB/B	-	U3KF17	360	D	N
Q96P15	LB/B	-	U3KF17	148	M	T
Q96P15	LB/B	-	U3KF17	181	I	T
Q96P15	LB/B	-	U3KF17	354	I	T
Q96P15	LB/B	-	U3KF17	51	A	E
Q96P15	LB/B	-	U3KF17	188	R	W
Q96P15	LB/B	-	U3KF17	293	I	T
Q96P15	LB/B	-	U3KF17	303	P	S
Q96P15	LB/B	-	U3KF17	181	I	A
Q96P63	LB/B	-	U3KF17	227	K	E
Q96P63	LB/B	-	U3KF17	289	N	T
Q96P63	LB/B	-	U3KF17	338	N	S
Q9UIV8	LB/B	-	U3KF17	293	G	S
P05120	LB/B	-	U3KF17	120	N	D
P05120	LB/B	-	U3KF17	404	N	K
P05120	LB/B	-	U3KF17	413	S	C
P05120	LB/B	-	U3KF17	229	R	H
P05120	LB/B	-	U3KF17	374	G	A
P29508	LB/B	-	M3W9H3	351	G	A
P29508	LB/B	-	M3W9H3	357	T	A
P36952	LB/B	-	U3KF17	319	I	V
P36952	LB/B	-	U3KF17	176	S	P
P36952	LB/B	-	U3KF17	187	V	L
P35237	LB/B	-	U3KF17	90	M	V
P35237	LB/B	-	U3KF17	153	G	S
O75635	LB/B	-	A0A091EEE9	266	R	Q
P50452	LB/B	-	U3KF17	68	R	Q
P50452	LB/B	-	U3KF17	158	K	N
P50452	LB/B	-	U3KF17	304	T	A
P50452	LB/B	-	U3KF17	359	H	R
P01008	LB/B	-	A0A091DDY3	30	V	E
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	39	I	N
P01008	LB/B	-	A0A091DDY3	52	M	T
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	56	R	C
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	73	P	L
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	79	R	C
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	79	R	H
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	79	R	S
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	89	R	C
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	90	F	L
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	112	P	T
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	131	L	F
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	131	L	V
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	133	Q	K
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	148	S	P
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	150	Q	P
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	152	H	Y
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	158	L	P
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	161	R	Q
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	198	Y	C
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	214	S	Y
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	219	N	K
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	219	N	D
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	269	E	K
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	283	M	I
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	302	L	P
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	316	I	N
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	334	E	K
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	381	S	P
P01008	LB/B	-	A0A091DDY3	391	R	Q
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	414	A	T
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	416	A	P
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	416	A	S
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	419	A	V
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	424	G	D
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	425	R	H
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	425	R	C
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	425	R	P
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	426	S	L
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	434	F	C
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	434	F	S
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	434	F	L
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	436	A	T
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	437	N	K
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	438	R	M
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	439	P	L
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	439	P	T
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	453	I	T
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	456	G	R
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	457	R	T
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	459	A	D
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	461	P	L
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	462	C	F
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	438	R	G
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	95	Y	S
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	23	L	P
P01008	LB/B	-	A0A091DDY3	167	N	T
P01008	LB/B	-	A0A091DDY3	147	T	A
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	17	Y	S
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	32	C	R
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	95	Y	C
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	98	L	P
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	121	M	K
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	127	C	R
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	146	K	E
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	160	C	Y
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	178	L	H
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	179	F	L
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	198	Y	H
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	214	S	F
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	223	S	P
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	243	T	I
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	251	I	T
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	257	W	R
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	261	F	L
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	283	M	V
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	323	S	P
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	397	S	P
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	398	D	H
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	412	S	R
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	441	L	P
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	53	C	F
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	125	G	D
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	170	S	P
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	218	I	N
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	248	V	G
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	293	R	P
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	401	H	R
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	439	P	A
P01008	LP/P	Antithrombin III deficiency (AT3D) [MIM:613118]	A0A091DDY3	112	P	S
P05546	LP/P	Thrombophilia due to heparin cofactor 2 deficiency (THPH10) [MIM:612356]	F6SP26	208	R	H
P05546	LB/B	-	F6SP26	7	A	T
P05546	LB/B	-	F6SP26	60	H	P
P05546	LB/B	-	F6SP26	237	K	R
P05546	LB/B	-	F6SP26	442	T	M
P05546	LB/B	-	F6SP26	87	S	N
P05546	LB/B	-	F6SP26	129	L	V
P05546	LP/P	Thrombophilia due to heparin cofactor 2 deficiency (THPH10) [MIM:612356]	F6SP26	447	E	K
P05546	LP/P	Thrombophilia due to heparin cofactor 2 deficiency (THPH10) [MIM:612356]	F6SP26	462	P	L
P05121	LB/B	-	L5K8V6	15	A	T
P05121	LB/B	-	L5K8V6	17	V	I
P05121	LB/B	-	L5K8V6	25	H	P
P05121	LB/B	-	L5K8V6	209	R	H
P05121	LB/B	-	L5K8V6	255	T	N
P07093	LB/B	-	A0A1S3AA54	51	I	M
A8MV23	LB/B	-	A0A2Y9DL23	143	D	N
P36955	LB/B	-	A0A2I4BIP3	72	T	M
P36955	LB/B	-	A0A2I4BIP3	132	P	R
P05155	LP/P	Angioedema, hereditary, 1 (HAE1) [MIM:106100]	I3ME21	429	G	R
P05155	LP/P	Angioedema, hereditary, 1 (HAE1) [MIM:106100]	I3ME21	454	V	E
P05155	LP/P	Angioedema, hereditary, 1 (HAE1) [MIM:106100]	I3ME21	456	A	E
P05155	LP/P	Angioedema, hereditary, 1 (HAE1) [MIM:106100]	I3ME21	458	A	T
P05155	LP/P	Angioedema, hereditary, 1 (HAE1) [MIM:106100]	I3ME21	458	A	V
P05155	LP/P	Angioedema, hereditary, 1 (HAE1) [MIM:106100]	I3ME21	465	A	V
P05155	LP/P	Angioedema, hereditary, 1 (HAE1) [MIM:106100]	I3ME21	466	R	C
P05155	LP/P	Angioedema, hereditary, 1 (HAE1) [MIM:106100]	I3ME21	466	R	H
P05155	LP/P	Angioedema, hereditary, 1 (HAE1) [MIM:106100]	I3ME21	466	R	L
P05155	LP/P	Angioedema, hereditary, 1 (HAE1) [MIM:106100]	I3ME21	466	R	S
P05155	LP/P	Angioedema, hereditary, 1 (HAE1) [MIM:106100]	I3ME21	467	T	P
P05155	LP/P	Angioedema, hereditary, 1 (HAE1) [MIM:106100]	I3ME21	473	V	M
P05155	LB/B	-	I3ME21	474	Q	E
P05155	LP/P	Angioedema, hereditary, 1 (HAE1) [MIM:106100]	I3ME21	477	F	S
P05155	LB/B	-	I3ME21	480	V	M
P05155	LP/P	Angioedema, hereditary, 1 (HAE1) [MIM:106100]	I3ME21	481	L	P
P05155	LP/P	Angioedema, hereditary, 1 (HAE1) [MIM:106100]	I3ME21	481	L	R
P05155	LP/P	Angioedema, hereditary, 1 (HAE1) [MIM:106100]	I3ME21	489	P	R
P05155	LP/P	Angioedema, hereditary, 1 (HAE1) [MIM:106100]	I3ME21	498	P	S
P05155	LB/B	-	I3ME21	308	T	S
P05155	LB/B	-	I3ME21	39	D	E
P05155	LB/B	-	I3ME21	56	V	A
P05155	LP/P	Angioedema, hereditary, 1 (HAE1) [MIM:106100]	I3ME21	345	G	R
P05155	LP/P	Angioedema, hereditary, 1 (HAE1) [MIM:106100]	I3ME21	130	C	Y
P05155	LP/P	Angioedema, hereditary, 1 (HAE1) [MIM:106100]	I3ME21	394	T	P
P05155	LP/P	Angioedema, hereditary, 1 (HAE1) [MIM:106100]	I3ME21	408	D	V
P05155	LP/P	Angioedema, hereditary, 1 (HAE1) [MIM:106100]	I3ME21	473	V	E
P05155	LP/P	Angioedema, hereditary, 1 (HAE1) [MIM:106100]	I3ME21	493	G	E
P05155	LP/P	Angioedema, hereditary, 1 (HAE1) [MIM:106100]	I3ME21	498	P	R
P05155	LP/P	Angioedema, hereditary, 1 (HAE1) [MIM:106100]	I3ME21	118	T	A
P05155	LP/P	Angioedema, hereditary, 1 (HAE1) [MIM:106100]	I3ME21	154	Y	C
P05155	LP/P	Angioedema, hereditary, 1 (HAE1) [MIM:106100]	I3ME21	170	S	F
P05155	LP/P	Angioedema, hereditary, 1 (HAE1) [MIM:106100]	I3ME21	184	G	R
P05155	LP/P	Angioedema, hereditary, 1 (HAE1) [MIM:106100]	I3ME21	230	L	P
P05155	LP/P	Angioedema, hereditary, 1 (HAE1) [MIM:106100]	I3ME21	232	I	K
P05155	LP/P	Angioedema, hereditary, 1 (HAE1) [MIM:106100]	I3ME21	299	W	R
P05155	LP/P	Angioedema, hereditary, 1 (HAE1) [MIM:106100]	I3ME21	430	L	Q
P05155	LP/P	Angioedema, hereditary, 1 (HAE1) [MIM:106100]	I3ME21	441	M	T
P05155	LP/P	Angioedema, hereditary, 1 (HAE1) [MIM:106100]	I3ME21	447	L	P
P05155	LP/P	Angioedema, hereditary, 1 (HAE1) [MIM:106100]	I3ME21	473	V	G
P05155	LP/P	Angioedema, hereditary, 1 (HAE1) [MIM:106100]	I3ME21	497	D	G
P05155	LP/P	Angioedema, hereditary, 1 (HAE1) [MIM:106100]	I3ME21	11	L	R
P05155	LP/P	Angioedema, hereditary, 1 (HAE1) [MIM:106100]	I3ME21	265	W	R
P05155	LP/P	Angioedema, hereditary, 1 (HAE1) [MIM:106100]	I3ME21	274	I	V
P05155	LP/P	Angioedema, hereditary, 1 (HAE1) [MIM:106100]	I3ME21	493	G	R
P50454	LB/B	-	H2RTV3	41	A	P
P50454	LP/P	Osteogenesis imperfecta 10 (OI10) [MIM:613848]	H2RTV3	78	L	P
Q99574	LP/P	Encephalopathy, familial, with neuroserpin inclusion bodies (FENIB) [MIM:604218]	A0A1S3AA54	49	S	P
Q99574	LP/P	Encephalopathy, familial, with neuroserpin inclusion bodies (FENIB) [MIM:604218]	A0A1S3AA54	52	S	R
O75830	LB/B	-	A0A0N8JXX7	148	E	G
O75830	LB/B	-	A0A0N8JXX7	6	L	V
Q9UHV2	LB/B	-	F7IN23	31	T	A
Q9Y6P5	LB/B	-	L5JMI5	44	L	I
P58004	LB/B	-	C3XTE9	320	T	A
Q86VW0	LB/B	-	W5MH68	49	Y	F
Q86VW0	LB/B	-	W5MH68	563	V	A
Q01105	LP/P	Intellectual developmental disorder, autosomal dominant 58 (MRD58) [MIM:618106]	B0BMV1	95	W	G
Q01105	LP/P	Intellectual developmental disorder, autosomal dominant 58 (MRD58) [MIM:618106]	B0BMV1	118	H	Y
Q9Y6X0	LB/B	-	W5KM97	1130	P	T
Q9Y6X0	LB/B	-	W5KM97	231	V	L
Q9Y6X0	LB/B	-	W5KM97	1101	V	I
Q9Y6X0	LP/P	Schinzel-Giedion midface retraction syndrome (SGMFS) [MIM:269150]	W5KM97	868	D	A
Q9Y6X0	LP/P	Leukemia, chronic myeloid, atypical (ACML) [MIM:608232]	W5KM97	868	D	N
Q9Y6X0	LP/P	Leukemia, juvenile myelomonocytic (JMML) [MIM:607785]	W5KM97	868	D	N
Q9Y6X0	LP/P	Myelodysplastic syndrome (MDS) [MIM:614286]	W5KM97	868	D	N
Q9Y6X0	LP/P	Schinzel-Giedion midface retraction syndrome (SGMFS) [MIM:269150]	W5KM97	868	D	N
Q9Y6X0	LP/P	Schinzel-Giedion midface retraction syndrome (SGMFS) [MIM:269150]	W5KM97	870	G	D
Q9Y6X0	LP/P	Leukemia, acute myelogenous (AML) [MIM:601626]	W5KM97	870	G	S
Q9Y6X0	LP/P	Leukemia, chronic myeloid, atypical (ACML) [MIM:608232]	W5KM97	870	G	S
Q9Y6X0	LP/P	Myelodysplastic syndrome (MDS) [MIM:614286]	W5KM97	870	G	S
Q9Y6X0	LP/P	Schinzel-Giedion midface retraction syndrome (SGMFS) [MIM:269150]	W5KM97	870	G	S
Q9Y6X0	LP/P	Leukemia, chronic myeloid, atypical (ACML) [MIM:608232]	W5KM97	871	I	T
Q9Y6X0	LP/P	Schinzel-Giedion midface retraction syndrome (SGMFS) [MIM:269150]	W5KM97	871	I	T
Q9Y6X0	LP/P	Leukemia, acute myelogenous (AML) [MIM:601626]	W5KM97	854	S	A
Q9Y6X0	LP/P	Leukemia, chronic myeloid, atypical (ACML) [MIM:608232]	W5KM97	858	E	K
Q9Y6X0	LP/P	Myelodysplastic syndrome (MDS) [MIM:614286]	W5KM97	869	S	N
Q9Y6X0	LP/P	Leukemia, acute myelogenous (AML) [MIM:601626]	W5KM97	870	G	R
Q9Y6X0	LP/P	Leukemia, acute myelogenous (AML) [MIM:601626]	W5KM97	871	I	S
Q9Y6X0	LP/P	Myelodysplastic syndrome (MDS) [MIM:614286]	W5KM97	873	T	R
Q9Y6X0	LB/B	-	W5KM97	908	D	N
Q9Y6X0	LB/B	-	W5KM97	1321	R	H
Q9Y6X0	LB/B	-	W5KM97	1377	V	L
O15047	LB/B	-	A0A2U3Y2V4	639	D	N
O15047	LP/P	Epilepsy, early-onset, with or without developmental delay (EPEDD) [MIM:618832]	A0A2U3Y2V4	269	Q	R
O15047	LP/P	Epilepsy, early-onset, with or without developmental delay (EPEDD) [MIM:618832]	A0A2U3Y2V4	913	R	C
O15047	LP/P	Epilepsy, early-onset, with or without developmental delay (EPEDD) [MIM:618832]	A0A2U3Y2V4	1369	G	R
O15047	LP/P	Epilepsy, early-onset, with or without developmental delay (EPEDD) [MIM:618832]	A0A2U3Y2V4	1392	R	H
O15047	LP/P	Neurodevelopmental disorder with speech impairment and dysmorphic facies (NEDSID) [MIM:619056]	A0A2U3Y2V4	1499	Y	D
Q9UPS6	LP/P	Intellectual developmental disorder with seizures and language delay (IDDSELD) [MIM:619000]	G3QV10	129	V	G
Q9UPS6	LP/P	Intellectual developmental disorder with seizures and language delay (IDDSELD) [MIM:619000]	G3QV10	1885	R	W
Q9UPS6	LP/P	Intellectual developmental disorder with seizures and language delay (IDDSELD) [MIM:619000]	G3QV10	1902	R	C
Q9UPS6	LP/P	Intellectual developmental disorder with seizures and language delay (IDDSELD) [MIM:619000]	G3QV10	1945	F	L
Q86TU7	LB/B	-	M7BFX0	278	N	D
Q9C0A6	LB/B	-	K9IUS4	77	R	H
Q9C0A6	LB/B	-	K9IUS4	119	R	I
Q9C0A6	LB/B	-	K9IUS4	1137	M	V
Q9C0A6	LB/B	-	K9IUS4	1308	T	I
Q9C0A6	LP/P	Intellectual developmental disorder, autosomal dominant 23 (MRD23) [MIM:615761]	K9IUS4	175	S	G
Q8TBK2	LB/B	-	A0A2Y9LX37	185	R	S
Q8TBK2	LB/B	-	A0A2Y9LX37	206	R	G
Q8TBK2	LB/B	-	A0A2Y9LX37	340	D	N
Q8TBK2	LB/B	-	A0A2Y9LX37	426	T	A
Q8TBK2	LB/B	-	A0A2Y9LX37	445	A	V
Q8NE22	LB/B	-	A0A1S3KL33	76	S	T
Q8NE22	LB/B	-	A0A1S3KL33	209	K	E
Q15047	LB/B	-	G1MQP3	236	N	S
Q15047	LB/B	-	G1MQP3	824	A	P
Q15047	LB/B	-	G1MQP3	824	A	G
Q15047	LB/B	-	G1MQP3	506	P	S
Q7Z333	LP/P	Amyotrophic lateral sclerosis 4 (ALS4) [MIM:602433]	F6ZZC8	3	T	I
Q7Z333	LP/P	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 (SCAN2) [MIM:606002]	F6ZZC8	305	W	C
Q7Z333	LP/P	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 (SCAN2) [MIM:606002]	F6ZZC8	332	R	W
Q7Z333	LP/P	Amyotrophic lateral sclerosis 4 (ALS4) [MIM:602433]	F6ZZC8	389	L	S
Q7Z333	LP/P	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 (SCAN2) [MIM:606002]	F6ZZC8	413	P	L
Q7Z333	LB/B	-	F6ZZC8	660	A	G
Q7Z333	LB/B	-	F6ZZC8	1061	P	L
Q7Z333	LB/B	-	F6ZZC8	1152	F	C
Q7Z333	LB/B	-	F6ZZC8	1192	D	E
Q7Z333	LB/B	-	F6ZZC8	1252	G	R
Q7Z333	LB/B	-	F6ZZC8	1331	P	L
Q7Z333	LB/B	-	F6ZZC8	1386	I	V
Q7Z333	LP/P	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 (SCAN2) [MIM:606002]	F6ZZC8	1756	F	S
Q7Z333	LB/B	-	F6ZZC8	1855	T	A
Q7Z333	LP/P	Amyotrophic lateral sclerosis 4 (ALS4) [MIM:602433]	F6ZZC8	2136	R	H
Q7Z333	LP/P	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 (SCAN2) [MIM:606002]	F6ZZC8	2213	P	L
Q7Z333	LB/B	-	F6ZZC8	2587	I	V
Q7Z333	LB/B	-	F6ZZC8	2612	S	G
Q7Z333	LP/P	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 (SCAN2) [MIM:606002]	F6ZZC8	274	M	I
Q7Z333	LP/P	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 (SCAN2) [MIM:606002]	F6ZZC8	603	N	D
Q7Z333	LP/P	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 (SCAN2) [MIM:606002]	F6ZZC8	653	Q	K
Q7Z333	LP/P	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 (SCAN2) [MIM:606002]	F6ZZC8	1294	R	C
Q7Z333	LP/P	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 (SCAN2) [MIM:606002]	F6ZZC8	2368	P	R
Q7Z333	LB/B	-	F6ZZC8	1221	K	N
Q7Z333	LB/B	-	F6ZZC8	1855	T	P
Q7Z333	LP/P	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 (SCAN2) [MIM:606002]	F6ZZC8	331	I	K
Q7Z333	LP/P	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 (SCAN2) [MIM:606002]	F6ZZC8	496	P	L
Q7Z333	LB/B	-	F6ZZC8	992	K	R
Q7Z333	LB/B	Amyotrophic lateral sclerosis 4 (ALS4) [MIM:602433]	F6ZZC8	1554	C	G
Q7Z333	LP/P	Amyotrophic lateral sclerosis 4 (ALS4) [MIM:602433]	F6ZZC8	2029	K	E
Q7Z333	LP/P	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 (SCAN2) [MIM:606002]	F6ZZC8	2229	M	T
Q7Z333	LP/P	Amyotrophic lateral sclerosis 4 (ALS4) [MIM:602433]	F6ZZC8	2547	I	T
Q7Z333	LP/P	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 (SCAN2) [MIM:606002]	F6ZZC8	274	M	V
Q7Z333	LP/P	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 (SCAN2) [MIM:606002]	F6ZZC8	1976	L	R
Q53EL9	LB/B	-	L5JU91	300	V	M
Q53EL9	LB/B	-	L5JU91	330	A	V
Q53EL9	LB/B	-	L5JU91	546	T	A
Q53EL9	LB/B	-	L5JU91	592	V	A
Q53EL9	LB/B	-	L5JU91	736	Y	N
Q53EL9	LB/B	-	L5JU91	756	L	V
Q53EL9	LB/B	-	L5JU91	806	M	T
Q6UXD5	LB/B	-	V8NZJ7	74	R	P
Q15637	LB/B	-	G3N6Z3	357	S	T
Q15393	LB/B	-	A0A1Y1XUW3	908	G	R
A8K8P3	LB/B	-	F6SF99	13	H	L
A8K8P3	LB/B	-	F6SF99	72	R	H
A8K8P3	LB/B	-	F6SF99	167	Q	H
A8K8P3	LB/B	-	F6SF99	322	Y	H
A8K8P3	LB/B	-	F6SF99	330	W	R
A8K8P3	LB/B	-	F6SF99	549	R	Q
A8K8P3	LB/B	-	F6SF99	1087	L	P
A8K8P3	LB/B	-	F6SF99	760	R	H
Q5VUG0	LB/B	-	A0A1V4K8S2	675	P	R
Q12872	LB/B	-	A0A2K5U1J9	421	L	P
Q12872	LB/B	-	A0A2K5U1J9	52	L	Q
Q12872	LB/B	-	A0A2K5U1J9	122	L	F
Q12872	LB/B	-	A0A2K5U1J9	136	L	F
Q12872	LB/B	-	A0A2K5U1J9	512	G	S
Q12872	LB/B	-	A0A2K5U1J9	538	E	G
Q12872	LB/B	-	A0A2K5U1J9	887	A	E
Q8WV19	LB/B	-	R7V2F7	109	I	V
Q587I9	LB/B	-	A0A2K5C5N4	38	R	G
Q6UW10	LB/B	-	H2PIG8	37	N	S
P07988	LB/B	-	A0A286Y294	131	T	I
P07988	LB/B	-	A0A286Y294	176	L	F
P07988	LB/B	-	A0A286Y294	272	R	H
P07988	LP/P	Pulmonary surfactant metabolism dysfunction 1 (SMDP1) [MIM:265120]	A0A286Y294	236	R	C
P11686	LB/B	-	A0A2J8X4H5	138	N	T
P11686	LB/B	-	A0A2J8X4H5	186	N	S
P11686	LP/P	Pulmonary surfactant metabolism dysfunction 2 (SMDP2) [MIM:610913]	A0A2J8X4H5	73	I	T
P11686	LP/P	Pulmonary surfactant metabolism dysfunction 2 (SMDP2) [MIM:610913]	A0A2J8X4H5	116	A	D
P11686	LP/P	Pulmonary surfactant metabolism dysfunction 2 (SMDP2) [MIM:610913]	A0A2J8X4H5	167	R	Q
P11686	LP/P	Pulmonary surfactant metabolism dysfunction 2 (SMDP2) [MIM:610913]	A0A2J8X4H5	188	L	Q
P11686	LP/P	Pulmonary surfactant metabolism dysfunction 2 (SMDP2) [MIM:610913]	A0A2J8X4H5	66	E	K
P35247	LB/B	-	L7N1D0	31	M	T
P35247	LB/B	-	L7N1D0	123	L	V
P35247	LB/B	-	L7N1D0	180	T	A
P35247	LB/B	-	L7N1D0	290	S	T
P35247	LB/B	-	L7N1D0	309	E	K
Q9H9B4	LB/B	-	A0A061IGB8	26	N	S
Q9H9B4	LB/B	-	A0A061IGB8	266	P	S
Q16586	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 3 (LGMDR3) [MIM:608099]	A0A226ML05	77	R	C
Q16586	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 3 (LGMDR3) [MIM:608099]	A0A226ML05	98	R	H
Q16586	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 3 (LGMDR3) [MIM:608099]	A0A226ML05	175	V	A
Q16586	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 3 (LGMDR3) [MIM:608099]	A0A226ML05	284	R	C
Q16586	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 3 (LGMDR3) [MIM:608099]	A0A226ML05	30	P	L
Q16586	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 3 (LGMDR3) [MIM:608099]	A0A226ML05	31	L	P
Q16586	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 3 (LGMDR3) [MIM:608099]	A0A226ML05	34	R	C
Q16586	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 3 (LGMDR3) [MIM:608099]	A0A226ML05	34	R	H
Q16586	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 3 (LGMDR3) [MIM:608099]	A0A226ML05	62	Y	H
Q16586	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 3 (LGMDR3) [MIM:608099]	A0A226ML05	68	G	E
Q16586	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 3 (LGMDR3) [MIM:608099]	A0A226ML05	74	R	W
Q16586	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 3 (LGMDR3) [MIM:608099]	A0A226ML05	89	L	P
Q16586	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 3 (LGMDR3) [MIM:608099]	A0A226ML05	91	G	R
Q16586	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 3 (LGMDR3) [MIM:608099]	A0A226ML05	93	A	V
Q16586	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 3 (LGMDR3) [MIM:608099]	A0A226ML05	97	D	G
Q16586	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 3 (LGMDR3) [MIM:608099]	A0A226ML05	98	R	C
Q16586	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 3 (LGMDR3) [MIM:608099]	A0A226ML05	103	I	T
Q16586	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 3 (LGMDR3) [MIM:608099]	A0A226ML05	124	I	T
Q16586	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 3 (LGMDR3) [MIM:608099]	A0A226ML05	137	E	K
Q16586	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 3 (LGMDR3) [MIM:608099]	A0A226ML05	158	L	F
Q16586	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 3 (LGMDR3) [MIM:608099]	A0A226ML05	196	V	I
Q16586	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 3 (LGMDR3) [MIM:608099]	A0A226ML05	205	P	H
Q16586	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 3 (LGMDR3) [MIM:608099]	A0A226ML05	242	V	A
Q16586	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 3 (LGMDR3) [MIM:608099]	A0A226ML05	173	L	P
Q16586	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 3 (LGMDR3) [MIM:608099]	A0A226ML05	228	P	Q
Q16586	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 3 (LGMDR3) [MIM:608099]	A0A226ML05	247	V	M
Q16586	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 3 (LGMDR3) [MIM:608099]	A0A226ML05	137	E	G
Q16586	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 3 (LGMDR3) [MIM:608099]	A0A226ML05	76	L	F
Q16586	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 3 (LGMDR3) [MIM:608099]	A0A226ML05	81	R	C
Q92629	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 6 (LGMDR6) [MIM:601287]	V9KR50	261	E	K
Q92629	LB/B	-	V9KR50	96	R	Q
Q92629	LP/P	Cardiomyopathy, dilated 1L (CMD1L) [MIM:606685]	V9KR50	150	S	A
Q13326	LB/B	-	V9KR50	116	R	H
Q13326	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 5 (LGMDR5) [MIM:253700]	V9KR50	283	C	Y
Q13326	LB/B	-	V9KR50	287	N	S
Q13326	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 5 (LGMDR5) [MIM:253700]	V9KR50	69	G	D
Q13326	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 5 (LGMDR5) [MIM:253700]	V9KR50	69	G	R
Q13326	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 5 (LGMDR5) [MIM:253700]	V9KR50	71	L	S
Q9BQI5	LB/B	-	F1NDK3	112	E	Q
Q9BQI5	LB/B	-	F1NDK3	131	K	R
Q9BQI5	LB/B	-	F1NDK3	161	P	Q
Q9BQI5	LB/B	-	F1NDK3	575	K	E
Q9HBY8	LB/B	-	A0A286ZR47	289	H	Y
Q8NHU3	LB/B	-	M7BSC6	21	T	M
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	40	Y	N
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	44	A	T
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	66	S	W
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	74	R	C
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	74	R	H
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	79	T	P
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	85	Q	R
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	90	G	R
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	122	G	R
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	128	P	L
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	131	V	M
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	139	T	M
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	146	L	P
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	150	R	Q
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	179	D	N
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	182	R	C
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	193	F	L
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	206	R	P
P51688	LB/B	-	A0A1S3WWI5	226	V	A
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	227	P	R
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	234	A	G
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	235	D	V
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	245	R	H
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	298	S	P
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	321	T	A
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	354	A	P
P51688	LB/B	-	A0A1S3WWI5	361	V	I
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	364	S	R
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	369	E	K
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	377	R	C
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	377	R	H
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	380	Q	R
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	386	L	R
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	389	N	K
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	447	E	K
P51688	LB/B	-	A0A1S3WWI5	456	R	H
P51688	LB/B	-	A0A1S3WWI5	394	M	I
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	32	D	E
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	32	D	G
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	42	N	K
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	84	H	Y
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	88	M	T
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	106	S	R
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	150	R	W
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	163	L	P
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	191	G	R
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	235	D	N
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	251	G	A
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	273	D	N
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	288	P	S
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	293	P	S
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	293	P	T
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	300	E	V
P51688	LB/B	-	A0A1S3WWI5	304	R	L
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	307	Q	P
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	322	I	S
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	355	E	K
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	374	Y	H
P51688	LB/B	-	A0A1S3WWI5	387	V	M
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	433	R	Q
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	433	R	W
P51688	LP/P	Mucopolysaccharidosis 3A (MPS3A) [MIM:252900]	A0A1S3WWI5	486	V	F
P51688	LB/B	-	A0A1S3WWI5	372	M	I
Q2NKQ1	LB/B	-	A0A1S3PIY8	802	T	P
Q2NKQ1	LB/B	-	A0A1S3PIY8	873	R	K
O43147	LB/B	-	H2U6C9	63	L	M
O43147	LB/B	-	H2U6C9	238	R	K
O43147	LB/B	-	H2U6C9	244	R	S
O43147	LB/B	-	H2U6C9	329	H	R
O43147	LB/B	-	H2U6C9	374	R	Q
O43147	LB/B	-	H2U6C9	968	D	V
Q96HU1	LB/B	-	A0A2K6Q898	20	W	R
Q96HU1	LB/B	-	A0A2K6Q898	279	H	Q
Q9NRF2	LB/B	-	A0A2K5TVT4	484	T	A
Q9NRF2	LB/B	-	A0A2K5TVT4	541	V	A
Q9UQQ2	LB/B	-	A0A0Q3LYS7	262	W	R
Q9UQQ2	LB/B	-	A0A0Q3LYS7	182	F	L
O60880	LP/P	Lymphoproliferative syndrome, X-linked, 1 (XLP1) [MIM:308240]	A0A091KZT2	32	R	T
O60880	LP/P	Lymphoproliferative syndrome, X-linked, 1 (XLP1) [MIM:308240]	A0A091KZT2	68	T	I
O60880	LP/P	Lymphoproliferative syndrome, X-linked, 1 (XLP1) [MIM:308240]	A0A091KZT2	101	P	L
O60880	LP/P	Lymphoproliferative syndrome, X-linked, 1 (XLP1) [MIM:308240]	A0A091KZT2	55	R	L
O60880	LP/P	Lymphoproliferative syndrome, X-linked, 1 (XLP1) [MIM:308240]	A0A091KZT2	7	Y	C
O60880	LP/P	Lymphoproliferative syndrome, X-linked, 1 (XLP1) [MIM:308240]	A0A091KZT2	8	H	D
O60880	LP/P	Lymphoproliferative syndrome, X-linked, 1 (XLP1) [MIM:308240]	A0A091KZT2	16	G	D
O60880	LP/P	Lymphoproliferative syndrome, X-linked, 1 (XLP1) [MIM:308240]	A0A091KZT2	27	G	S
O60880	LP/P	Lymphoproliferative syndrome, X-linked, 1 (XLP1) [MIM:308240]	A0A091KZT2	28	S	R
O60880	LP/P	Lymphoproliferative syndrome, X-linked, 1 (XLP1) [MIM:308240]	A0A091KZT2	31	L	P
O60880	LP/P	Lymphoproliferative syndrome, X-linked, 1 (XLP1) [MIM:308240]	A0A091KZT2	33	D	Y
O60880	LP/P	Lymphoproliferative syndrome, X-linked, 1 (XLP1) [MIM:308240]	A0A091KZT2	42	C	W
O60880	LP/P	Lymphoproliferative syndrome, X-linked, 1 (XLP1) [MIM:308240]	A0A091KZT2	49	G	V
O60880	LP/P	Lymphoproliferative syndrome, X-linked, 1 (XLP1) [MIM:308240]	A0A091KZT2	53	T	I
O60880	LP/P	Lymphoproliferative syndrome, X-linked, 1 (XLP1) [MIM:308240]	A0A091KZT2	54	Y	C
O60880	LP/P	Lymphoproliferative syndrome, X-linked, 1 (XLP1) [MIM:308240]	A0A091KZT2	84	I	T
O60880	LP/P	Lymphoproliferative syndrome, X-linked, 1 (XLP1) [MIM:308240]	A0A091KZT2	87	F	S
O60880	LP/P	Lymphoproliferative syndrome, X-linked, 1 (XLP1) [MIM:308240]	A0A091KZT2	99	Q	P
O60880	LP/P	Lymphoproliferative syndrome, X-linked, 1 (XLP1) [MIM:308240]	A0A091KZT2	102	V	G
O14796	LB/B	-	U3JV36	36	I	T
O14796	LB/B	-	U3JV36	122	N	K
Q9NP31	LB/B	-	A0A1U7T2A1	52	N	S
Q9NP31	LB/B	-	A0A1U7T2A1	272	R	C
Q9BRG2	LB/B	-	S9YFY3	32	N	D
Q9BRG2	LB/B	-	S9YFY3	223	D	G
Q8N5H7	LB/B	-	A0A2Y9NNE1	23	L	F
A6NKC9	LB/B	-	A0A2K5EVA0	137	M	T
A6NKC9	LB/B	-	A0A2K5EVA0	206	R	W
Q9Y3L3	LB/B	-	A0A091HLI6	511	P	L
Q9Y3L3	LB/B	-	A0A091HLI6	656	S	F
P78314	LP/P	Cherubism (CRBM) [MIM:118400]	F6YA05	415	R	P
P78314	LP/P	Cherubism (CRBM) [MIM:118400]	F6YA05	415	R	Q
P78314	LP/P	Cherubism (CRBM) [MIM:118400]	F6YA05	418	P	H
P78314	LP/P	Cherubism (CRBM) [MIM:118400]	F6YA05	418	P	L
P78314	LP/P	Cherubism (CRBM) [MIM:118400]	F6YA05	418	P	R
P78314	LP/P	Cherubism (CRBM) [MIM:118400]	F6YA05	420	G	E
P78314	LP/P	Cherubism (CRBM) [MIM:118400]	F6YA05	420	G	R
Q9P0V3	LB/B	-	H2L355	155	M	T
Q9P0V3	LB/B	-	H2L355	197	A	T
A4FU49	LB/B	-	W5QEJ4	217	S	A
A4FU49	LB/B	-	W5QEJ4	455	A	S
Q9NR46	LB/B	-	A0A147ATX3	305	A	V
Q9NR46	LB/B	-	A0A147ATX3	319	P	L
Q5TCZ1	LB/B	-	A0A1S3L619	659	K	Q
Q5TCZ1	LB/B	-	A0A1S3L619	1035	R	Q
Q5TCZ1	LB/B	-	A0A1S3L619	1073	L	P
A1X283	LB/B	-	I3LPF8	101	Y	F
A1X283	LP/P	Frank-Ter Haar syndrome (FTHS) [MIM:249420]	I3LPF8	43	R	W
Q7Z6J0	LB/B	-	A0A2R5LEX2	663	P	S
Q8TEC5	LB/B	-	F7CI92	267	R	C
Q8TEC5	LB/B	-	F7CI92	592	W	R
Q8TEC5	LB/B	-	F7CI92	687	V	I
Q8TEC5	LB/B	-	F7CI92	710	G	A
Q8TEC5	LB/B	-	F7CI92	16	F	S
Q8TEC5	LB/B	-	F7CI92	174	F	V
Q8TEC5	LB/B	-	F7CI92	477	R	Q
Q8TE82	LB/B	-	A0A093JJV8	785	R	C
Q8TE82	LB/B	-	A0A093JJV8	291	D	N
Q8TE82	LB/B	-	A0A093JJV8	437	L	P
Q8TF17	LB/B	-	A0A093JJV8	468	A	S
Q8TF17	LP/P	Charcot-Marie-Tooth disease 4C (CMT4C) [MIM:601596]	A0A093JJV8	529	R	Q
Q8TF17	LP/P	Charcot-Marie-Tooth disease 4C (CMT4C) [MIM:601596]	A0A093JJV8	657	E	K
Q8TF17	LP/P	Charcot-Marie-Tooth disease 4C (CMT4C) [MIM:601596]	A0A093JJV8	658	R	C
Q8TF17	LB/B	-	A0A093JJV8	171	G	E
Q8TF17	LB/B	-	A0A093JJV8	696	H	R
Q8TF17	LP/P	Mononeuropathy of the median nerve mild (MNMN) [MIM:613353]	A0A093JJV8	169	Y	H
Q9Y566	LB/B	-	H3DBR7	1504	V	A
Q9Y566	LB/B	-	H3DBR7	6	A	V
Q9BYB0	LB/B	-	H3DBR7	198	A	G
Q9BYB0	LB/B	-	H3DBR7	224	A	T
Q9BYB0	LB/B	-	H3DBR7	245	I	T
Q9BYB0	LB/B	-	H3DBR7	493	H	Q
Q9BYB0	LP/P	Schizophrenia 15 (SCZD15) [MIM:613950]	H3DBR7	536	R	W
Q9BYB0	LB/B	-	H3DBR7	720	A	T
Q9BYB0	LB/B	-	H3DBR7	952	S	T
Q9BYB0	LB/B	-	H3DBR7	1010	G	V
Q9BYB0	LB/B	-	H3DBR7	1134	P	H
Q9BYB0	LB/B	-	H3DBR7	1298	R	K
Q9BYB0	LB/B	-	H3DBR7	1333	V	G
Q9BYB0	LB/B	-	H3DBR7	1546	I	V
Q9BYB0	LB/B	-	H3DBR7	1645	P	T
Q9BYB0	LP/P	Phelan-McDermid syndrome (PHMDS) [MIM:606232]	H3DBR7	141	P	A
Q9BYB0	LB/B	-	H3DBR7	963	A	G
Q9BYB0	LB/B	-	H3DBR7	1011	G	V
Q9BYB0	LB/B	-	H3DBR7	1231	R	H
Q9BYB0	LP/P	Phelan-McDermid syndrome (PHMDS) [MIM:606232]	H3DBR7	1452	A	S
Q9BYB0	LB/B	-	H3DBR7	1566	S	G
Q9H0F6	LB/B	-	K7DSJ3	282	S	T
Q9H0F6	LB/B	-	K7DSJ3	294	P	S
Q9H0F6	LB/B	-	K7DSJ3	311	P	R
P04278	LB/B	-	Q4R6W8	356	D	N
P04278	LB/B	-	Q4R6W8	25	R	H
P04278	LB/B	-	Q4R6W8	185	P	L
P04278	LB/B	-	Q4R6W8	22	R	H
Q6S5L8	LB/B	-	A0A1U8BW27	52	N	D
Q6S5L8	LB/B	-	A0A1U8BW27	244	K	E
Q6S5L8	LB/B	-	A0A1U8BW27	400	Q	H
Q6S5L8	LB/B	-	A0A1U8BW27	447	D	G
Q8NEM2	LB/B	-	A0A218UXU0	21	M	T
Q8NEM2	LB/B	-	A0A218UXU0	60	M	R
Q9BZQ2	LB/B	-	Q3TTP0	491	V	M
Q96IW2	LB/B	-	A0A2K6G9Y7	138	G	S
Q96IW2	LB/B	-	A0A2K6G9Y7	270	N	S
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	31	G	R
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	117	W	G
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	117	W	R
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	88	D	V
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	100	Q	H
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	115	N	K
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	188	E	Q
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	222	D	N
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	224	V	E
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	226	A	T
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	236	S	R
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	290	G	D
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	383	A	T
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	424	P	A
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	436	S	L
Q15465	LP/P	Solitary median maxillary central incisor (SMMCI) [MIM:147250]	A0A2I0MRN6	111	I	F
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	6	R	T
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	110	A	D
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	150	T	R
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	271	L	P
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	332	V	A
Q15465	LP/P	Solitary median maxillary central incisor (SMMCI) [MIM:147250]	A0A2I0MRN6	332	V	A
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	347	P	Q
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	354	I	T
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	381	R	P
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	27	G	A
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	111	I	N
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	140	H	P
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	140	H	Q
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	183	C	F
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	267	T	I
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	373	A	T
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	17	L	P
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	26	P	L
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	39	L	P
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	53	E	K
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	83	D	V
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	84	I	F
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	102	C	R
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	102	C	Y
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	109	L	F
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	110	A	T
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	124	V	M
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	136	E	K
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	143	G	D
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	144	R	P
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	147	D	N
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	150	T	K
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	156	S	R
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	170	F	C
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	171	D	H
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	183	C	R
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	183	C	Y
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	184	S	L
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	196	G	E
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	197	G	V
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	198	C	F
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	198	C	S
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	218	L	P
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	231	G	V
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	232	R	G
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	234	L	P
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	236	S	N
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	241	F	L
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	241	F	V
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	255	I	N
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	275	A	E
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	280	S	W
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	310	R	C
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	321	R	S
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	346	A	V
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	347	P	L
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	347	P	R
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	362	S	L
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	363	C	Y
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	364	Y	C
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	374	H	R
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	376	A	D
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	377	F	S
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	382	L	P
Q15465	LP/P	Holoprosencephaly 3 (HPE3) [MIM:142945]	A0A2I0MRN6	435	Y	N
A0PJX4	LB/B	-	W5PXN7	13	W	C
A6NKW6	LB/B	-	G3VPV5	5	S	R
A6NKW6	LB/B	-	G3VPV5	111	A	P
Q8IYI0	LB/B	-	A0A2Y9DXB6	23	A	V
P34897	LP/P	Neurodevelopmental disorder with cardiomyopathy, spasticity, and brain abnormalities (NEDCASB) [MIM:619121]	A0A2F0AX16	499	P	A
Q9UQ13	LP/P	Noonan syndrome-like disorder with loose anagen hair 1 (NSLH1) [MIM:607721]	A0A146NQ26	2	S	G
Q9UQ13	LP/P	Noonan syndrome-like disorder with loose anagen hair 1 (NSLH1) [MIM:607721]	A0A146NQ26	173	M	I
O15266	LP/P	Leri-Weill dyschondrosteosis (LWD) [MIM:127300]	A0A2K6PH02	173	R	C
O15266	LP/P	Leri-Weill dyschondrosteosis (LWD) [MIM:127300]	A0A2K6PH02	132	L	V
O15266	LP/P	Leri-Weill dyschondrosteosis (LWD) [MIM:127300]	A0A2K6PH02	153	R	L
O15266	LP/P	Langer mesomelic dysplasia (LMD) [MIM:249700]	A0A2K6PH02	168	R	W
Q9UHJ6	LB/B	-	A0A2B4SG39	215	E	K
Q9UHJ6	LB/B	-	A0A2B4SG39	421	E	D
Q9UHJ6	LB/B	-	A0A2B4SG39	434	L	M
Q6PI26	LB/B	-	L5K7Q3	140	S	I
Q6PI26	LB/B	-	L5K7Q3	489	S	N
Q6PI26	LP/P	Dystonia 35, childhood-onset (DYT35) [MIM:619921]	L5K7Q3	175	D	Y
Q6PI26	LP/P	Neurodevelopmental disorder with dystonia and seizures (NEDDS) [MIM:619922]	L5K7Q3	292	E	K
Q2M3G4	LB/B	-	A0A2K6D3Q2	180	P	L
Q13796	LB/B	-	J9NXX4	1607	L	F
Q13796	LB/B	-	J9NXX4	942	D	E
Q13796	LB/B	-	J9NXX4	1475	I	V
Q8TF72	LB/B	-	W5M858	147	L	H
Q8TF72	LB/B	-	W5M858	279	G	A
Q8TF72	LB/B	-	W5M858	469	P	A
Q8TF72	LB/B	-	W5M858	1290	P	L
Q9ULL8	LB/B	-	W5NAI8	970	D	G
Q9ULL8	LB/B	-	W5NAI8	722	R	H
Q9ULL8	LB/B	-	W5NAI8	807	I	T
Q9ULL8	LB/B	-	W5NAI8	1367	L	F
Q9ULL8	LB/B	-	W5NAI8	627	P	S
P14410	LP/P	Congenital sucrase-isomaltase deficiency (CSID) [MIM:222900]	A0A091GJ02	1098	Q	P
P14410	LB/B	-	A0A091GJ02	15	V	F
P14410	LP/P	Congenital sucrase-isomaltase deficiency (CSID) [MIM:222900]	A0A091GJ02	117	Q	R
P14410	LB/B	-	A0A091GJ02	231	T	A
P14410	LP/P	Congenital sucrase-isomaltase deficiency (CSID) [MIM:222900]	A0A091GJ02	341	L	P
P14410	LP/P	Congenital sucrase-isomaltase deficiency (CSID) [MIM:222900]	A0A091GJ02	577	V	G
P14410	LP/P	Congenital sucrase-isomaltase deficiency (CSID) [MIM:222900]	A0A091GJ02	594	S	P
P14410	LP/P	Congenital sucrase-isomaltase deficiency (CSID) [MIM:222900]	A0A091GJ02	620	L	P
P14410	LP/P	Congenital sucrase-isomaltase deficiency (CSID) [MIM:222900]	A0A091GJ02	694	T	P
P14410	LP/P	Congenital sucrase-isomaltase deficiency (CSID) [MIM:222900]	A0A091GJ02	1073	G	D
P14410	LP/P	Congenital sucrase-isomaltase deficiency (CSID) [MIM:222900]	A0A091GJ02	1229	C	Y
P14410	LP/P	Congenital sucrase-isomaltase deficiency (CSID) [MIM:222900]	A0A091GJ02	1367	R	G
P14410	LB/B	-	A0A091GJ02	1523	M	I
P14410	LP/P	Congenital sucrase-isomaltase deficiency (CSID) [MIM:222900]	A0A091GJ02	1745	F	C
P14410	LB/B	-	A0A091GJ02	1802	T	S
Q9HAT2	LB/B	-	F1PXN3	71	K	R
Q9HAT2	LB/B	-	F1PXN3	467	A	V
Q9HAT2	LB/B	-	F1PXN3	3	A	G
Q9HAT2	LB/B	-	F1PXN3	33	N	S
Q9HAT2	LB/B	-	F1PXN3	62	R	H
Q9HAT2	LB/B	-	F1PXN3	64	G	S
Q9HAT2	LB/B	-	F1PXN3	89	M	V
Q9HAT2	LB/B	-	F1PXN3	161	Q	K
Q9HAT2	LP/P	Autoimmune disease 6 (AIS6) [MIM:613551]	F1PXN3	196	C	F
Q9HAT2	LP/P	Autoimmune disease 6 (AIS6) [MIM:613551]	F1PXN3	212	G	R
Q9HAT2	LP/P	Autoimmune disease 6 (AIS6) [MIM:613551]	F1PXN3	230	R	W
Q9HAT2	LP/P	Autoimmune disease 6 (AIS6) [MIM:613551]	F1PXN3	266	C	G
Q9HAT2	LP/P	Autoimmune disease 6 (AIS6) [MIM:613551]	F1PXN3	309	Q	P
Q9HAT2	LB/B	-	F1PXN3	312	T	M
Q9HAT2	LB/B	-	F1PXN3	314	R	H
Q9HAT2	LP/P	Autoimmune disease 6 (AIS6) [MIM:613551]	F1PXN3	349	Y	C
Q9HAT2	LP/P	Autoimmune disease 6 (AIS6) [MIM:613551]	F1PXN3	393	R	H
Q9HAT2	LB/B	-	F1PXN3	400	K	N
Q9HAT2	LP/P	Autoimmune disease 6 (AIS6) [MIM:613551]	F1PXN3	404	F	S
Q9HAT2	LB/B	-	F1PXN3	447	H	R
Q9HAT2	LB/B	-	F1PXN3	462	Q	R
Q9HAT2	LP/P	Autoimmune disease 6 (AIS6) [MIM:613551]	F1PXN3	479	R	C
Q8IUQ4	LP/P	Buratti-Harel syndrome (BURHAS) [MIM:619314]	A0A1A6GZK6	41	C	G
Q8IUQ4	LP/P	Buratti-Harel syndrome (BURHAS) [MIM:619314]	A0A1A6GZK6	50	P	L
Q8IUQ4	LP/P	Buratti-Harel syndrome (BURHAS) [MIM:619314]	A0A1A6GZK6	128	C	F
Q8IUQ4	LP/P	Buratti-Harel syndrome (BURHAS) [MIM:619314]	A0A1A6GZK6	168	T	A
Q8IUQ4	LP/P	Buratti-Harel syndrome (BURHAS) [MIM:619314]	A0A1A6GZK6	174	G	R
Q9NXL6	LB/B	-	F7AAY2	78	V	M
Q9NXL6	LB/B	-	F7AAY2	363	T	I
Q9NXL6	LB/B	-	F7AAY2	3	G	S
Q8NBJ9	LB/B	-	F7AAY2	631	T	M
Q8NBJ9	LB/B	-	F7AAY2	636	V	I
Q9BZZ2	LB/B	-	M7BIM5	239	K	R
Q9BZZ2	LB/B	-	M7BIM5	919	H	P
Q9BZZ2	LB/B	-	M7BIM5	1519	A	P
Q9BZZ2	LB/B	-	M7BIM5	974	A	V
Q9BZZ2	LB/B	-	M7BIM5	1335	S	Y
Q9BZZ2	LB/B	-	M7BIM5	221	V	M
Q9BZZ2	LB/B	-	M7BIM5	141	V	L
Q9BZZ2	LB/B	-	M7BIM5	464	R	H
Q9BZZ2	LB/B	-	M7BIM5	1487	R	W
Q96LC7	LB/B	-	L8HPX9	226	A	V
Q96LC7	LB/B	-	L8HPX9	520	R	S
Q96PQ1	LB/B	-	A0A2K5VR22	81	P	T
Q96PQ1	LB/B	-	A0A2K5VR22	478	T	M
Q96PQ1	LB/B	-	A0A2K5VR22	494	Y	S
Q96PQ1	LB/B	-	A0A2K5VR22	217	H	Q
Q96PQ1	LB/B	-	A0A2K5VR22	81	P	H
Q96PQ1	LB/B	-	A0A2K5VR22	82	A	V
Q96PQ1	LB/B	-	A0A2K5VR22	218	G	R
Q96PQ1	LB/B	-	A0A2K5VR22	398	H	Y
Q96PQ1	LB/B	-	A0A2K5VR22	586	Y	C
Q96PQ1	LB/B	-	A0A2K5VR22	546	P	Q
Q6ZMC9	LB/B	-	G3WW17	273	F	L
O43699	LB/B	-	A0A2K5KC68	57	L	V
O43699	LB/B	-	A0A2K5KC68	262	L	F
Q9NYZ4	LB/B	-	A0A2K6M826	170	S	P
Q9NYZ4	LB/B	-	A0A2K6M826	388	R	G
Q9Y336	LB/B	-	A0A2K5KC68	100	K	E
Q9Y336	LB/B	-	A0A2K5KC68	125	S	N
Q9Y336	LB/B	-	A0A2K5KC68	147	N	K
Q9Y336	LB/B	-	A0A2K5KC68	315	A	E
Q9Y336	LB/B	-	A0A2K5KC68	316	A	D
Q9Y336	LB/B	-	A0A2K5KC68	131	K	Q
Q9Y336	LB/B	-	A0A2K5KC68	349	V	A
P57059	LB/B	-	A0A1U7QMJ7	615	A	V
P57059	LB/B	-	A0A1U7QMJ7	430	R	W
P57059	LB/B	-	A0A1U7QMJ7	15	G	S
P57059	LB/B	-	A0A1U7QMJ7	142	D	N
P57059	LB/B	-	A0A1U7QMJ7	696	P	L
P57059	LB/B	-	A0A1U7QMJ7	725	A	V
P57059	LP/P	Developmental and epileptic encephalopathy 30 (DEE30) [MIM:616341]	A0A1U7QMJ7	287	P	T
P57059	LP/P	Developmental and epileptic encephalopathy 30 (DEE30) [MIM:616341]	A0A1U7QMJ7	411	S	C
P57059	LP/P	Developmental and epileptic encephalopathy 30 (DEE30) [MIM:616341]	A0A1U7QMJ7	636	G	S
Q9Y2K2	LB/B	-	A0A1W4ZU69	1098	D	E
Q9Y2K2	LB/B	-	A0A1W4ZU69	1136	P	R
Q9Y2K2	LP/P	Spondyloepimetaphyseal dysplasia, Krakow type (SEMDK) [MIM:618162]	A0A1W4ZU69	187	R	C
Q14190	LB/B	-	G1T4B4	483	L	M
Q8NDZ2	LB/B	-	F7G0D9	221	S	F
Q8NDZ2	LB/B	-	F7G0D9	463	K	R
Q8NDZ2	LB/B	-	F7G0D9	772	H	R
Q8NDZ2	LB/B	-	F7G0D9	636	S	F
Q9NP50	LB/B	-	A0A2U3ZP25	117	R	H
O43166	LB/B	-	H2M5H4	56	P	T
Q9P2F8	LB/B	-	F6VGX4	49	T	A
Q9P2F8	LB/B	-	F6VGX4	1322	T	A
Q9P2F8	LB/B	-	F6VGX4	1403	S	L
Q9P2F8	LB/B	-	F6VGX4	1639	G	S
Q9P2F8	LB/B	-	F6VGX4	1424	M	L
O60292	LB/B	-	H2M5H4	1371	G	S
O60292	LB/B	-	H2M5H4	1450	P	A
O00241	LB/B	-	I3MA97	23	R	G
O00241	LB/B	-	I3MA97	53	R	H
O00241	LB/B	-	I3MA97	229	I	M
O00241	LB/B	-	I3MA97	363	A	P
Q5TFQ8	LB/B	-	I3MA97	23	R	G
Q5TFQ8	LB/B	-	I3MA97	51	T	I
Q9H106	LB/B	-	A0A2K6C286	55	N	D
Q9P1W8	LB/B	-	I3MA97	263	V	A
Q9P1W8	LB/B	-	I3MA97	286	S	L
Q96EB6	LB/B	-	A0A151P0R7	3	D	E
Q96EB6	LB/B	-	A0A151P0R7	484	V	D
Q9NTG7	LB/B	-	A0A2K6FCU9	80	R	W
Q9NTG7	LB/B	-	A0A2K6FCU9	208	V	I
Q9NTG7	LB/B	-	A0A2K6FCU9	369	G	S
Q9NXA8	LB/B	-	A0A1S3WWN1	285	F	L
Q9NXA8	LB/B	-	A0A1S3WWN1	305	E	G
Q8N6T7	LB/B	-	A0A093S046	46	S	N
Q8N6T7	LB/B	-	A0A093S046	25	D	N
Q8N6T7	LB/B	-	A0A093S046	63	D	H
Q8N6T7	LB/B	-	A0A093S046	116	D	N
Q8N6T7	LB/B	-	A0A093S046	263	T	P
Q15475	LP/P	Branchiootic syndrome 3 (BOS3) [MIM:608389]	G1NXL5	110	R	W
Q15475	LP/P	Branchiootic syndrome 3 (BOS3) [MIM:608389]	G1NXL5	129	Y	C
Q15475	LP/P	Branchiootic syndrome 3 (BOS3) [MIM:608389]	G1NXL5	17	V	E
Q15475	LP/P	Branchiootic syndrome 3 (BOS3) [MIM:608389]	G1NXL5	73	H	P
Q15475	LP/P	Branchiootic syndrome 3 (BOS3) [MIM:608389]	G1NXL5	106	V	G
Q15475	LP/P	Branchiootic syndrome 3 (BOS3) [MIM:608389]	G1NXL5	110	R	Q
Q15475	LP/P	Branchiootic syndrome 3 (BOS3) [MIM:608389]	G1NXL5	112	R	C
Q15475	LP/P	Branchiootic syndrome 3 (BOS3) [MIM:608389]	G1NXL5	122	W	R
Q15475	LB/B	-	G1NXL5	99	R	C
Q9NPC8	LB/B	-	H9GNL3	43	L	F
Q9NPC8	LB/B	-	H9GNL3	241	P	L
Q9NPC8	LB/B	-	H9GNL3	276	D	N
O95343	LP/P	Holoprosencephaly 2 (HPE2) [MIM:157170]	A0A2K6E1B0	226	L	V
O95343	LP/P	Holoprosencephaly 2 (HPE2) [MIM:157170]	A0A2K6E1B0	250	V	A
O95343	LP/P	Holoprosencephaly 2 (HPE2) [MIM:157170]	A0A2K6E1B0	257	R	P
O95343	LP/P	Holoprosencephaly 2 (HPE2) [MIM:157170]	A0A2K6E1B0	92	V	G
O95343	LP/P	Holoprosencephaly 2 (HPE2) [MIM:157170]	A0A2K6E1B0	105	I	V
O95343	LP/P	Holoprosencephaly 2 (HPE2) [MIM:157170]	A0A2K6E1B0	173	H	P
O95343	LP/P	Holoprosencephaly 2 (HPE2) [MIM:157170]	A0A2K6E1B0	202	T	I
O95343	LP/P	Holoprosencephaly 2 (HPE2) [MIM:157170]	A0A2K6E1B0	231	P	R
O95343	LP/P	Holoprosencephaly 2 (HPE2) [MIM:157170]	A0A2K6E1B0	257	R	W
O95343	LP/P	Holoprosencephaly 2 (HPE2) [MIM:157170]	A0A2K6E1B0	69	G	D
O95343	LP/P	Holoprosencephaly 2 (HPE2) [MIM:157170]	A0A2K6E1B0	37	G	C
O95343	LP/P	Schizencephaly (SCHZC) [MIM:269160]	A0A2K6E1B0	37	G	C
O95343	LP/P	Holoprosencephaly 2 (HPE2) [MIM:157170]	A0A2K6E1B0	79	M	V
O95343	LP/P	Holoprosencephaly 2 (HPE2) [MIM:157170]	A0A2K6E1B0	93	A	D
O95343	LP/P	Holoprosencephaly 2 (HPE2) [MIM:157170]	A0A2K6E1B0	113	W	C
O95343	LP/P	Holoprosencephaly 2 (HPE2) [MIM:157170]	A0A2K6E1B0	114	S	L
O95343	LP/P	Holoprosencephaly 2 (HPE2) [MIM:157170]	A0A2K6E1B0	138	V	D
O95343	LP/P	Holoprosencephaly 2 (HPE2) [MIM:157170]	A0A2K6E1B0	157	F	I
O95343	LP/P	Schizencephaly (SCHZC) [MIM:269160]	A0A2K6E1B0	167	A	S
O95343	LP/P	Holoprosencephaly 2 (HPE2) [MIM:157170]	A0A2K6E1B0	172	A	V
O95343	LP/P	Holoprosencephaly 2 (HPE2) [MIM:157170]	A0A2K6E1B0	174	Y	H
O95343	LP/P	Holoprosencephaly 2 (HPE2) [MIM:157170]	A0A2K6E1B0	213	F	V
O95343	LP/P	Holoprosencephaly 2 (HPE2) [MIM:157170]	A0A2K6E1B0	218	R	P
O95343	LP/P	Holoprosencephaly 2 (HPE2) [MIM:157170]	A0A2K6E1B0	218	R	W
O95343	LP/P	Holoprosencephaly 2 (HPE2) [MIM:157170]	A0A2K6E1B0	227	Q	P
O95343	LP/P	Holoprosencephaly 2 (HPE2) [MIM:157170]	A0A2K6E1B0	244	G	C
O95343	LP/P	Holoprosencephaly 2 (HPE2) [MIM:157170]	A0A2K6E1B0	254	F	L
O95343	LP/P	Holoprosencephaly 2 (HPE2) [MIM:157170]	A0A2K6E1B0	257	R	G
O95343	LP/P	Holoprosencephaly 2 (HPE2) [MIM:157170]	A0A2K6E1B0	258	R	L
O95343	LP/P	Holoprosencephaly 2 (HPE2) [MIM:157170]	A0A2K6E1B0	262	R	H
O95343	LP/P	Holoprosencephaly 2 (HPE2) [MIM:157170]	A0A2K6E1B0	269	R	M
O95343	LP/P	Holoprosencephaly 2 (HPE2) [MIM:157170]	A0A2K6E1B0	269	R	S
O95343	LP/P	Holoprosencephaly 2 (HPE2) [MIM:157170]	A0A2K6E1B0	269	R	T
O95343	LP/P	Holoprosencephaly 2 (HPE2) [MIM:157170]	A0A2K6E1B0	297	P	L
Q9UIU6	LB/B	-	G5C5H9	605	H	P
Q8IX90	LB/B	-	L5MLK6	254	T	A
Q8IX90	LB/B	-	L5MLK6	58	V	I
Q8IX90	LB/B	-	L5MLK6	335	D	E
P12755	LP/P	Shprintzen-Goldberg craniosynostosis syndrome (SGS) [MIM:182212]	A0A1S3LDX5	21	L	R
P12755	LP/P	Shprintzen-Goldberg craniosynostosis syndrome (SGS) [MIM:182212]	A0A1S3LDX5	31	S	L
P12755	LP/P	Shprintzen-Goldberg craniosynostosis syndrome (SGS) [MIM:182212]	A0A1S3LDX5	32	L	P
P12755	LP/P	Shprintzen-Goldberg craniosynostosis syndrome (SGS) [MIM:182212]	A0A1S3LDX5	32	L	V
P12755	LP/P	Shprintzen-Goldberg craniosynostosis syndrome (SGS) [MIM:182212]	A0A1S3LDX5	34	G	C
P12755	LP/P	Shprintzen-Goldberg craniosynostosis syndrome (SGS) [MIM:182212]	A0A1S3LDX5	34	G	D
P12755	LP/P	Shprintzen-Goldberg craniosynostosis syndrome (SGS) [MIM:182212]	A0A1S3LDX5	34	G	S
P12755	LP/P	Shprintzen-Goldberg craniosynostosis syndrome (SGS) [MIM:182212]	A0A1S3LDX5	34	G	V
P12755	LP/P	Shprintzen-Goldberg craniosynostosis syndrome (SGS) [MIM:182212]	A0A1S3LDX5	35	P	Q
P12755	LP/P	Shprintzen-Goldberg craniosynostosis syndrome (SGS) [MIM:182212]	A0A1S3LDX5	35	P	S
P12755	LP/P	Shprintzen-Goldberg craniosynostosis syndrome (SGS) [MIM:182212]	A0A1S3LDX5	116	G	E
P12755	LP/P	Shprintzen-Goldberg craniosynostosis syndrome (SGS) [MIM:182212]	A0A1S3LDX5	117	G	R
P12755	LP/P	Shprintzen-Goldberg craniosynostosis syndrome (SGS) [MIM:182212]	A0A1S3LDX5	28	S	T
P12755	LP/P	Shprintzen-Goldberg craniosynostosis syndrome (SGS) [MIM:182212]	A0A1S3LDX5	34	G	A
P12757	LB/B	-	F6ZDC3	38	A	V
P84550	LB/B	-	G3PXH4	73	K	Q
Q2VWA4	LB/B	-	A0A1U8CD05	947	F	C
Q13309	LB/B	-	Q9Z0Z3	85	P	L
Q13309	LB/B	-	Q9Z0Z3	87	L	I
Q14973	LP/P	Hypercholanemia, familial, 2 (FHCA2) [MIM:619256]	G1SWX0	267	S	F
Q14973	LB/B	-	G1SWX0	21	R	C
Q14973	LB/B	-	G1SWX0	39	M	T
Q14973	LB/B	-	G1SWX0	41	S	L
Q14973	LB/B	-	G1SWX0	64	A	T
Q14973	LB/B	-	G1SWX0	73	P	T
Q14973	LP/P	Hypercholanemia, familial, 2 (FHCA2) [MIM:619256]	G1SWX0	88	I	T
Q14973	LB/B	-	G1SWX0	138	L	P
Q14973	LB/B	-	G1SWX0	159	I	M
Q14973	LB/B	-	G1SWX0	180	R	Q
Q14973	LB/B	-	G1SWX0	190	G	E
Q14973	LP/P	Hypercholanemia, familial, 2 (FHCA2) [MIM:619256]	G1SWX0	199	S	R
Q14973	LB/B	-	G1SWX0	223	I	T
Q14973	LB/B	-	G1SWX0	232	I	T
Q14973	LB/B	-	G1SWX0	234	F	L
Q14973	LB/B	-	G1SWX0	241	S	F
Q14973	LB/B	-	G1SWX0	249	R	W
Q14973	LB/B	-	G1SWX0	252	R	C
Q14973	LP/P	Hypercholanemia, familial, 2 (FHCA2) [MIM:619256]	G1SWX0	252	R	H
Q14973	LB/B	-	G1SWX0	252	R	S
Q14973	LB/B	-	G1SWX0	258	T	S
Q14973	LB/B	-	G1SWX0	279	I	T
Q14973	LB/B	-	G1SWX0	293	Q	E
Q14973	LB/B	-	G1SWX0	314	K	E
Q12908	LB/B	-	A0A2I4CR74	171	S	A
Q12908	LP/P	Bile acid malabsorption, primary, 1 (PBAM1) [MIM:613291]	A0A2I4CR74	243	L	P
Q12908	LP/P	Bile acid malabsorption, primary, 1 (PBAM1) [MIM:613291]	A0A2I4CR74	262	T	M
Q12908	LB/B	-	A0A2I4CR74	290	P	S
Q12908	LB/B	-	A0A2I4CR74	98	V	I
Q12908	LB/B	-	A0A2I4CR74	159	V	I
P09131	LB/B	-	B2KIK4	354	V	I
Q0GE19	LP/P	Short stature, amelogenesis imperfecta, and skeletal dysplasia with scoliosis (SSASKS) [MIM:618363]	A0A2R7WHY6	74	L	P
Q0GE19	LP/P	Short stature, amelogenesis imperfecta, and skeletal dysplasia with scoliosis (SSASKS) [MIM:618363]	A0A2R7WHY6	112	G	D
Q0GE19	LP/P	Short stature, amelogenesis imperfecta, and skeletal dysplasia with scoliosis (SSASKS) [MIM:618363]	A0A2R7WHY6	303	P	L
P49279	LB/B	-	A0A1S3IMJ2	30	Q	R
P49279	LB/B	-	A0A1S3IMJ2	318	A	V
P49279	LB/B	-	A0A1S3IMJ2	543	D	N
P49281	LB/B	-	A0A1S3IMJ2	435	L	I
P49281	LP/P	Anemia, hypochromic microcytic, with iron overload 1 (AHMIO1) [MIM:206100]	A0A1S3IMJ2	212	G	V
P49281	LP/P	Anemia, hypochromic microcytic, with iron overload 1 (AHMIO1) [MIM:206100]	A0A1S3IMJ2	399	E	D
P49281	LP/P	Anemia, hypochromic microcytic, with iron overload 1 (AHMIO1) [MIM:206100]	A0A1S3IMJ2	416	R	C
P55011	LP/P	Delpire-McNeill syndrome (DELMNES) [MIM:619083]	V9XMC5	327	A	V
P55011	LP/P	Delpire-McNeill syndrome (DELMNES) [MIM:619083]	V9XMC5	376	N	I
P55011	LP/P	Delpire-McNeill syndrome (DELMNES) [MIM:619083]	V9XMC5	379	A	L
P55011	LP/P	Delpire-McNeill syndrome (DELMNES) [MIM:619083]	V9XMC5	410	R	Q
P55011	LP/P	Deafness, autosomal dominant, 78 (DFNA78) [MIM:619081]	V9XMC5	979	E	K
P55011	LP/P	Delpire-McNeill syndrome (DELMNES) [MIM:619083]	V9XMC5	980	E	K
P55011	LP/P	Deafness, autosomal dominant, 78 (DFNA78) [MIM:619081]	V9XMC5	981	D	Y
P55011	LP/P	Deafness, autosomal dominant, 78 (DFNA78) [MIM:619081]	V9XMC5	988	P	T
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	209	R	W
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	349	P	L
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	421	C	R
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	486	D	N
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	496	G	C
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	588	A	V
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	630	G	V
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	655	R	H
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	655	R	L
P55017	LB/B	-	A0A2H6N7H6	728	A	T
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	741	G	R
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	850	L	P
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	955	R	Q
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	60	T	M
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	62	D	N
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	68	E	K
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	69	H	N
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	90	H	Y
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	145	R	H
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	153	V	M
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	154	I	F
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	158	R	Q
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	163	T	M
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	172	W	R
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	178	S	L
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	180	T	K
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	186	G	D
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	209	R	Q
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	215	L	P
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	226	A	T
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	230	G	D
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	261	R	H
P55017	LB/B	-	A0A2H6N7H6	264	A	G
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	283	S	Y
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	284	K	R
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	304	T	P
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	313	A	V
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	316	G	V
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	321	R	W
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	334	R	W
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	342	G	A
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	374	G	V
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	399	R	C
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	439	G	S
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	463	G	E
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	464	A	T
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	478	K	E
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	542	L	P
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	555	S	L
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	560	P	H
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	569	A	E
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	569	A	V
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	578	V	M
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	613	G	S
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	615	S	L
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	615	S	W
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	623	L	P
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	642	R	C
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	642	R	G
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	642	R	H
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	643	P	L
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	649	T	R
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	655	R	C
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	672	M	I
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	677	V	L
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	677	V	M
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	729	G	V
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	731	G	R
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	738	L	R
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	849	L	H
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	852	R	C
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	852	R	H
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	852	R	S
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	867	G	S
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	871	R	H
P55017	LB/B	-	A0A2H6N7H6	904	R	Q
P55017	LB/B	-	A0A2H6N7H6	919	R	C
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	958	R	G
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	985	C	Y
P55017	LB/B	-	A0A2H6N7H6	854	R	K
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	62	D	H
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	83	R	Q
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	83	R	W
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	121	E	D
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	135	R	C
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	145	R	C
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	150	I	M
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	157	L	P
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	158	R	L
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	166	A	V
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	192	I	T
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	194	T	I
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	235	T	R
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	259	D	N
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	272	L	P
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	304	T	M
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	374	G	E
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	382	T	M
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	392	T	I
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	442	N	S
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	463	G	R
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	475	S	C
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	489	Y	H
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	507	R	C
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	523	A	T
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	534	N	S
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	536	F	L
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	546	S	G
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	560	P	R
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	647	V	M
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	735	P	R
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	751	P	L
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	824	S	T
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	839	D	N
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	849	L	F
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	862	R	C
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	872	M	T
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	887	R	Q
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	934	R	W
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	980	G	R
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	1009	R	Q
P55017	LP/P	Gitelman syndrome (GTLMNS) [MIM:263800]	A0A2H6N7H6	1021	Q	R
Q9Y666	LB/B	-	L5KCE5	408	A	T
Q13183	LB/B	-	G3HSA6	385	P	S
Q13183	LB/B	-	G3HSA6	550	I	V
Q13183	LB/B	-	G3HSA6	44	L	F
Q13183	LB/B	-	G3HSA6	254	F	L
Q13183	LB/B	-	G3HSA6	310	A	P
Q13183	LB/B	-	G3HSA6	477	V	M
Q13183	LB/B	-	G3HSA6	45	M	L
Q86YT5	LP/P	Developmental and epileptic encephalopathy 25, with amelogenesis imperfecta (DEE25) [MIM:615905]	G3HSA6	142	T	M
Q86YT5	LP/P	Developmental and epileptic encephalopathy 25, with amelogenesis imperfecta (DEE25) [MIM:615905]	G3HSA6	219	G	R
Q86YT5	LP/P	Developmental and epileptic encephalopathy 25, with amelogenesis imperfecta (DEE25) [MIM:615905]	G3HSA6	227	T	M
Q86YT5	LP/P	Developmental and epileptic encephalopathy 25, with amelogenesis imperfecta (DEE25) [MIM:615905]	G3HSA6	427	S	L
Q86YT5	LP/P	Developmental and epileptic encephalopathy 25, with amelogenesis imperfecta (DEE25) [MIM:615905]	G3HSA6	488	L	P
Q86YT5	LP/P	Developmental and epileptic encephalopathy 25, with amelogenesis imperfecta (DEE25) [MIM:615905]	G3HSA6	524	D	H
Q86YT5	LB/B	-	G3HSA6	219	G	E
Q86YT5	LB/B	-	G3HSA6	243	D	N
Q86YT5	LB/B	-	G3HSA6	420	L	P
Q86YT5	LB/B	-	G3HSA6	485	L	R
P46059	LB/B	-	A0A139WKW8	122	V	M
P46059	LB/B	-	A0A139WKW8	419	G	A
P46059	LB/B	-	A0A139WKW8	451	T	N
P46059	LB/B	-	A0A139WKW8	117	S	N
P46059	LB/B	-	A0A139WKW8	450	V	I
P46059	LB/B	-	A0A139WKW8	459	R	C
P46059	LB/B	-	A0A139WKW8	21	V	I
P46059	LB/B	-	A0A139WKW8	28	F	Y
P46059	LB/B	-	A0A139WKW8	117	S	R
P46059	LB/B	-	A0A139WKW8	537	P	S
Q16348	LB/B	-	A0A139WKW8	57	R	H
Q16348	LB/B	-	A0A139WKW8	73	Y	C
Q16348	LB/B	-	A0A139WKW8	350	L	F
Q16348	LB/B	-	A0A139WKW8	409	P	S
Q16348	LB/B	-	A0A139WKW8	509	R	K
Q16348	LB/B	-	A0A139WKW8	609	A	G
Q16348	LB/B	-	A0A139WKW8	704	M	L
Q8N697	LB/B	-	A0A1S3ART7	239	V	A
A6NIM6	LB/B	-	H0W4U7	141	H	Q
A6NIM6	LB/B	-	H0W4U7	271	P	L
A6NIM6	LB/B	-	H0W4U7	494	D	E
A6NIM6	LB/B	-	H0W4U7	508	E	K
P53985	LP/P	Symptomatic deficiency in lactate transport (SDLT) [MIM:245340]	A0A146NHU9	204	K	E
P53985	LP/P	Symptomatic deficiency in lactate transport (SDLT) [MIM:245340]	A0A146NHU9	472	G	R
P53985	LB/B	-	A0A146NHU9	490	D	E
P53985	LB/B	-	A0A146NHU9	85	S	G
P53985	LP/P	Monocarboxylate transporter 1 deficiency (MCT1D) [MIM:616095]	A0A146NHU9	313	R	Q
O15403	LB/B	-	H9G5W1	121	I	T
O15403	LB/B	-	H9G5W1	204	F	I
O15403	LB/B	-	H9G5W1	217	E	D
O15403	LB/B	-	H9G5W1	221	E	V
O60669	LB/B	-	A0A087XKJ9	445	T	S
O95907	LB/B	-	G1LV32	405	V	A
O95907	LB/B	-	G1LV32	235	R	W
Q7RTY1	LB/B	-	F7CAV5	258	T	K
Q7RTY1	LB/B	-	F7CAV5	461	D	E
Q7RTY1	LB/B	-	F7CAV5	203	A	V
Q9NRA2	LP/P	Salla disease (SD) [MIM:604369]	M3XYS2	39	R	C
Q9NRA2	LP/P	Salla disease (SD) [MIM:604369]	M3XYS2	136	K	E
Q9NRA2	LP/P	Infantile sialic acid storage disorder (ISSD) [MIM:269920]	M3XYS2	183	H	R
Q9NRA2	LP/P	Infantile sialic acid storage disorder (ISSD) [MIM:269920]	M3XYS2	334	P	R
Q9NRA2	LP/P	Infantile sialic acid storage disorder (ISSD) [MIM:269920]	M3XYS2	371	G	V
Q9NRA2	LB/B	-	M3XYS2	296	V	I
Q9NRA2	LP/P	Infantile sialic acid storage disorder (ISSD) [MIM:269920]	M3XYS2	328	G	E
Q9P2U7	LB/B	-	L9J983	431	P	R
Q9BYT1	LB/B	-	X1Z7B5	228	N	S
Q9BYT1	LB/B	-	X1Z7B5	397	T	M
Q9BYT1	LP/P	Porokeratosis 8, disseminated superficial actinic type (POROK8) [MIM:616063]	X1Z7B5	9	R	C
Q9BYT1	LP/P	Porokeratosis 8, disseminated superficial actinic type (POROK8) [MIM:616063]	X1Z7B5	311	R	Q
P54219	LB/B	-	A0A2D4FY49	136	I	T
P54219	LB/B	-	A0A2D4FY49	98	S	T
P54219	LB/B	-	A0A2D4FY49	4	T	P
P54219	LB/B	-	A0A2D4FY49	74	A	V
P54219	LB/B	-	A0A2D4FY49	84	F	S
P54219	LB/B	-	A0A2D4FY49	101	A	P
P54219	LB/B	-	A0A2D4FY49	164	I	M
P54219	LB/B	-	A0A2D4FY49	249	V	I
P54219	LB/B	-	A0A2D4FY49	392	L	V
P54219	LB/B	-	A0A2D4FY49	82	F	C
P54219	LB/B	-	A0A2D4FY49	140	G	R
P54219	LB/B	-	A0A2D4FY49	202	I	T
P54219	LB/B	-	A0A2D4FY49	11	R	Q
P54219	LB/B	-	A0A2D4FY49	10	Q	R
P54219	LB/B	-	A0A2D4FY49	138	R	L
Q16572	LB/B	-	A0A2R8QBK8	13	A	P
Q16572	LB/B	-	A0A2R8QBK8	29	R	W
Q16572	LB/B	-	A0A2R8QBK8	520	A	E
Q16572	LB/B	-	A0A2R8QBK8	11	R	Q
Q16572	LP/P	Myasthenic syndrome, congenital, 21, presynaptic (CMS21) [MIM:617239]	A0A2R8QBK8	186	G	A
Q16572	LP/P	Myasthenic syndrome, congenital, 21, presynaptic (CMS21) [MIM:617239]	A0A2R8QBK8	398	D	H
Q6NT16	LB/B	-	A0A2K5X171	204	V	I
Q6NT16	LB/B	-	A0A2K5X171	11	R	L
Q6NT16	LB/B	-	A0A2K5X171	30	S	P
P41440	LB/B	-	A0A1U7U393	27	H	R
P41440	LB/B	-	A0A1U7U393	558	A	V
O60779	LP/P	Thiamine-responsive megaloblastic anemia syndrome (TRMA) [MIM:249270]	A0A1L8GBG9	172	G	D
O60779	LP/P	Thiamine-responsive megaloblastic anemia syndrome (TRMA) [MIM:249270]	A0A1L8GBG9	93	D	H
O60779	LP/P	Thiamine-responsive megaloblastic anemia syndrome (TRMA) [MIM:249270]	A0A1L8GBG9	143	S	F
Q9BZV2	LP/P	Thiamine metabolism dysfunction syndrome 2, biotin- or thiamine-responsive type (THMD2) [MIM:607483]	A0A2K6UPQ7	23	G	V
Q9BZV2	LP/P	Thiamine metabolism dysfunction syndrome 2, biotin- or thiamine-responsive type (THMD2) [MIM:607483]	A0A2K6UPQ7	422	T	A
Q9BZV2	LB/B	-	A0A2K6UPQ7	350	V	A
Q9BZV2	LB/B	-	A0A2K6UPQ7	174	V	I
P43005	LB/B	-	A0A2M3ZE48	50	F	Y
P43005	LB/B	-	A0A2M3ZE48	27	A	G
P43005	LP/P	Dicarboxylic aminoaciduria (DCBXA) [MIM:222730]	A0A2M3ZE48	445	R	W
P43004	LP/P	Developmental and epileptic encephalopathy 41 (DEE41) [MIM:617105]	T0MIX6	82	G	R
P43004	LP/P	Developmental and epileptic encephalopathy 41 (DEE41) [MIM:617105]	T0MIX6	85	L	P
P43004	LP/P	Developmental and epileptic encephalopathy 41 (DEE41) [MIM:617105]	T0MIX6	289	P	R
P43003	LB/B	-	A0A0P7WDB7	219	E	D
P43003	LP/P	Episodic ataxia 6 (EA6) [MIM:612656]	A0A0P7WDB7	290	P	R
O15245	LB/B	-	A0A182LW08	14	S	F
O15245	LB/B	-	A0A182LW08	41	F	L
O15245	LB/B	-	A0A182LW08	61	R	C
O15245	LB/B	-	A0A182LW08	85	L	F
O15245	LB/B	-	A0A182LW08	88	C	R
O15245	LB/B	-	A0A182LW08	160	L	F
O15245	LB/B	-	A0A182LW08	189	S	L
O15245	LB/B	-	A0A182LW08	220	G	V
O15245	LB/B	-	A0A182LW08	283	P	L
O15245	LB/B	-	A0A182LW08	287	R	G
O15245	LB/B	-	A0A182LW08	341	P	L
O15245	LB/B	-	A0A182LW08	342	R	H
O15245	LB/B	-	A0A182LW08	401	G	S
O15245	LB/B	-	A0A182LW08	408	M	V
O15245	LB/B	-	A0A182LW08	440	M	I
O15245	LB/B	-	A0A182LW08	461	V	I
O15245	LB/B	-	A0A182LW08	465	G	R
O15245	LB/B	-	A0A182LW08	488	R	M
Q9Y226	LB/B	-	A0A1S2ZC86	43	V	I
Q9Y226	LB/B	-	A0A1S2ZC86	443	L	F
Q9Y226	LB/B	-	A0A1S2ZC86	377	R	C
Q8IZD6	LB/B	-	H3AAD1	349	P	Q
Q86VW1	LB/B	-	G1T2K9	49	H	R
Q86VW1	LB/B	-	G1T2K9	252	V	A
Q86VW1	LB/B	-	G1T2K9	409	M	T
Q86VW1	LB/B	-	G1T2K9	431	V	I
Q96BI1	LP/P	Lung cancer (LNCR) [MIM:211980]	U3J4M2	233	S	F
Q96BI1	LB/B	-	U3J4M2	309	R	Q
Q96BI1	LB/B	-	U3J4M2	6	A	T
Q96BI1	LB/B	-	U3J4M2	12	R	Q
Q96BI1	LB/B	-	U3J4M2	324	W	C
A6NK97	LB/B	-	A0A151MTJ4	58	A	D
A6NK97	LB/B	-	A0A151MTJ4	139	A	V
Q6T423	LB/B	-	S9Y7H7	250	S	G
Q6T423	LB/B	-	S9Y7H7	300	R	T
Q6T423	LB/B	-	S9Y7H7	89	R	C
Q6T423	LB/B	-	S9Y7H7	448	G	A
Q6T423	LB/B	-	S9Y7H7	486	M	V
O75751	LB/B	-	L8I999	44	T	M
O75751	LB/B	-	L8I999	116	A	S
Q9H015	LB/B	-	A0A2K6MNT9	306	I	T
Q9H015	LB/B	-	A0A2K6MNT9	462	G	E
Q9H015	LB/B	-	A0A2K6MNT9	503	L	F
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	169	R	Q
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	211	Y	C
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	283	W	R
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	446	V	F
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	452	E	K
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	478	P	L
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	17	F	L
O76082	LB/B	-	S9YCA5	144	L	F
O76082	LB/B	-	S9YCA5	481	V	F
O76082	LB/B	-	S9YCA5	549	P	S
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	283	W	C
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	467	S	C
O76082	LB/B	-	S9YCA5	508	F	L
O76082	LB/B	-	S9YCA5	530	M	V
O76082	LB/B	-	S9YCA5	481	V	I
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	15	G	W
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	19	R	P
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	32	N	S
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	46	P	S
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	66	T	P
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	75	R	P
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	83	R	L
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	96	G	A
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	122	D	Y
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	123	V	G
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	143	P	L
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	169	R	W
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	177	M	V
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	186	L	P
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	227	R	H
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	230	F	L
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	232	T	M
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	234	G	R
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	240	A	T
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	242	G	V
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	257	R	W
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	264	T	R
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	282	R	Q
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	301	A	D
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	351	W	R
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	355	S	L
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	358	Y	N
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	362	S	L
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	398	P	L
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	399	R	Q
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	399	R	W
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	440	T	M
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	442	A	I
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	443	F	V
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	447	Y	C
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	455	P	R
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	468	T	R
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	471	R	C
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	488	R	C
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	507	L	S
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	26	S	N
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	280	S	F
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	471	R	P
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	16	P	L
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	28	S	I
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	44	A	V
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	46	P	L
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	50	C	Y
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	93	S	W
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	115	D	G
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	169	R	P
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	175	V	M
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	205	M	R
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	210	N	S
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	225	S	L
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	231	S	F
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	247	P	R
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	363	L	P
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	439	V	G
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	448	V	L
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	462	G	V
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	470	S	F
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	471	R	H
O76082	LP/P	Systemic primary carnitine deficiency (CDSP) [MIM:212140]	S9YCA5	476	L	R
Q4U2R8	LB/B	-	S9Y7H7	7	L	P
Q4U2R8	LB/B	-	S9Y7H7	50	R	H
Q4U2R8	LB/B	-	S9Y7H7	293	R	W
Q4U2R8	LB/B	-	S9Y7H7	104	P	L
Q9Y694	LB/B	-	A0A146YSS9	303	R	K
Q9Y694	LB/B	-	A0A146YSS9	327	R	W
Q9Y694	LB/B	-	A0A146YSS9	507	G	V
Q8TCC7	LB/B	-	A0A151MTJ4	129	F	L
Q8TCC7	LB/B	-	A0A151MTJ4	149	R	S
Q8TCC7	LB/B	-	A0A151MTJ4	260	I	R
Q8TCC7	LB/B	-	A0A151MTJ4	277	R	W
Q8TCC7	LB/B	-	A0A151MTJ4	281	V	A
Q8TCC7	LB/B	-	A0A151MTJ4	305	I	F
Q8TCC7	LB/B	-	A0A151MTJ4	389	A	V
Q8TCC7	LB/B	-	A0A151MTJ4	448	V	I
Q9UHI7	LB/B	-	S9YKC8	218	I	V
Q9UHI7	LB/B	-	S9YKC8	258	M	V
Q9UHI7	LB/B	-	S9YKC8	264	V	M
Q9UHI7	LB/B	-	S9YKC8	421	A	S
O60721	LB/B	-	E2RRL5	37	T	S
O60721	LB/B	-	E2RRL5	311	V	L
O60721	LB/B	-	E2RRL5	313	L	V
Q8NFF2	LB/B	-	A0A2U3ZZZ8	613	V	I
Q8NFF2	LP/P	Amelogenesis imperfecta, hypomaturation type, 2A5 (AI2A5) [MIM:615887]	A0A2U3ZZZ8	499	S	C
Q8NFF2	LP/P	Amelogenesis imperfecta, hypomaturation type, 2A5 (AI2A5) [MIM:615887]	A0A2U3ZZZ8	146	A	V
Q71RS6	LB/B	-	H2UL39	111	T	A
P53007	LP/P	Combined D-2- and L-2-hydroxyglutaric aciduria (D2L2AD) [MIM:615182]	A0A2I0UA42	45	P	L
P53007	LP/P	Combined D-2- and L-2-hydroxyglutaric aciduria (D2L2AD) [MIM:615182]	A0A2I0UA42	144	E	Q
P53007	LP/P	Combined D-2- and L-2-hydroxyglutaric aciduria (D2L2AD) [MIM:615182]	A0A2I0UA42	167	G	R
P53007	LP/P	Combined D-2- and L-2-hydroxyglutaric aciduria (D2L2AD) [MIM:615182]	A0A2I0UA42	193	S	W
P53007	LP/P	Combined D-2- and L-2-hydroxyglutaric aciduria (D2L2AD) [MIM:615182]	A0A2I0UA42	202	M	T
P53007	LP/P	Combined D-2- and L-2-hydroxyglutaric aciduria (D2L2AD) [MIM:615182]	A0A2I0UA42	282	R	C
P53007	LP/P	Combined D-2- and L-2-hydroxyglutaric aciduria (D2L2AD) [MIM:615182]	A0A2I0UA42	282	R	G
P53007	LP/P	Combined D-2- and L-2-hydroxyglutaric aciduria (D2L2AD) [MIM:615182]	A0A2I0UA42	297	Y	C
P53007	LP/P	Combined D-2- and L-2-hydroxyglutaric aciduria (D2L2AD) [MIM:615182]	A0A2I0UA42	198	R	H
P53007	LP/P	Combined D-2- and L-2-hydroxyglutaric aciduria (D2L2AD) [MIM:615182]	A0A2I0UA42	40	I	N
P53007	LP/P	Combined D-2- and L-2-hydroxyglutaric aciduria (D2L2AD) [MIM:615182]	A0A2I0UA42	47	E	K
P53007	LP/P	Combined D-2- and L-2-hydroxyglutaric aciduria (D2L2AD) [MIM:615182]	A0A2I0UA42	93	G	D
P53007	LP/P	Combined D-2- and L-2-hydroxyglutaric aciduria (D2L2AD) [MIM:615182]	A0A2I0UA42	130	G	D
P53007	LP/P	Combined D-2- and L-2-hydroxyglutaric aciduria (D2L2AD) [MIM:615182]	A0A2I0UA42	238	N	S
P53007	LP/P	Myasthenic syndrome, congenital, 23, presynaptic (CMS23) [MIM:618197]	A0A2I0UA42	247	R	Q
P53007	LP/P	Combined D-2- and L-2-hydroxyglutaric aciduria (D2L2AD) [MIM:615182]	A0A2I0UA42	262	C	R
P53007	LP/P	Combined D-2- and L-2-hydroxyglutaric aciduria (D2L2AD) [MIM:615182]	A0A2I0UA42	282	R	H
O75746	LB/B	-	A0A0M9A7S9	473	R	Q
O75746	LP/P	Developmental and epileptic encephalopathy 39 with leukodystrophy (DEE39) [MIM:612949]	A0A0M9A7S9	590	Q	R
O75746	LP/P	Developmental and epileptic encephalopathy 39 with leukodystrophy (DEE39) [MIM:612949]	A0A0M9A7S9	353	R	Q
Q9UJS0	LP/P	Cholestasis, neonatal intrahepatic, caused by citrin deficiency (NICCD) [MIM:605814]	A0A0M9A7S9	601	E	K
Q9UJS0	LB/B	-	A0A0M9A7S9	141	E	K
Q9UJS0	LB/B	-	A0A0M9A7S9	232	L	I
O43808	LB/B	-	A0A2Y9KMA7	98	H	R
Q9HC21	LP/P	Microcephaly, Amish type (MCPHA) [MIM:607196]	A0A2Y9ED84	177	G	A
Q9HC21	LP/P	Thiamine metabolism dysfunction syndrome 4, bilateral striatal degeneration and progressive polyneuropathy type (THMD4) [MIM:613710]	A0A2Y9ED84	125	G	S
Q9HC21	LP/P	Thiamine metabolism dysfunction syndrome 4, bilateral striatal degeneration and progressive polyneuropathy type (THMD4) [MIM:613710]	A0A2Y9ED84	192	Q	H
Q9BXI2	LB/B	-	S4RN05	159	G	C
Q9BXI2	LB/B	-	S4RN05	181	V	G
Q9BXI2	LB/B	-	S4RN05	226	V	I
O43772	LP/P	Carnitine-acylcarnitine translocase deficiency (CACTD) [MIM:212138]	A0A1Y1WU54	133	R	W
O43772	LP/P	Carnitine-acylcarnitine translocase deficiency (CACTD) [MIM:212138]	A0A1Y1WU54	231	D	H
O43772	LP/P	Carnitine-acylcarnitine translocase deficiency (CACTD) [MIM:212138]	A0A1Y1WU54	238	Q	R
Q9BQT8	LB/B	-	I3MXM0	299	W	C
Q9BQT8	LP/P	Mitochondrial DNA depletion syndrome 18 (MTDPS18) [MIM:618811]	I3MXM0	232	K	R
Q9H936	LP/P	Developmental and epileptic encephalopathy 3 (DEE3) [MIM:609304]	V9L2Z8	206	P	L
Q6NUK1	LP/P	Fontaine progeroid syndrome (FPS) [MIM:612289]	A0A2U9C1Z4	217	R	C
Q6NUK1	LP/P	Fontaine progeroid syndrome (FPS) [MIM:612289]	A0A2U9C1Z4	217	R	H
Q70HW3	LB/B	-	G1ST76	208	T	M
Q70HW3	LP/P	Combined oxidative phosphorylation deficiency 28 (COXPD28) [MIM:616794]	G1ST76	102	A	V
Q70HW3	LP/P	Combined oxidative phosphorylation deficiency 28 (COXPD28) [MIM:616794]	G1ST76	148	V	G
Q70HW3	LP/P	Combined oxidative phosphorylation deficiency 28 (COXPD28) [MIM:616794]	G1ST76	199	P	L
Q70HW3	LB/B	-	G1ST76	41	S	N
O95847	LB/B	-	Q9EPH5	197	I	T
O95847	LB/B	-	Q9EPH5	145	A	V
Q9NYZ2	LB/B	-	H2PPT9	87	I	V
Q9NYZ2	LB/B	-	H2PPT9	96	R	Q
P12235	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 2 (PEOA2) [MIM:609283]	M3XR42	114	A	P
P12235	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 2 (PEOA2) [MIM:609283]	M3XR42	289	V	M
P12235	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 2 (PEOA2) [MIM:609283]	M3XR42	98	L	P
P12235	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 2 (PEOA2) [MIM:609283]	M3XR42	104	D	G
P12235	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 2 (PEOA2) [MIM:609283]	M3XR42	90	A	D
P12235	LP/P	Mitochondrial DNA depletion syndrome 12B, cardiomyopathic type (MTDPS12B) [MIM:615418]	M3XR42	123	A	D
P12235	LP/P	Mitochondrial DNA depletion syndrome 12A, cardiomyopathic type (MTDPS12A) [MIM:617184]	M3XR42	80	R	H
P12235	LP/P	Mitochondrial DNA depletion syndrome 12A, cardiomyopathic type (MTDPS12A) [MIM:617184]	M3XR42	235	R	G
P12235	LP/P	Mitochondrial DNA depletion syndrome 12B, cardiomyopathic type (MTDPS12B) [MIM:615418]	M3XR42	236	R	P
Q8N5S1	LB/B	-	F1PUP3	144	G	S
Q8N5S1	LB/B	-	F1PUP3	258	T	S
Q86VD7	LB/B	-	M3YVK6	39	S	P
Q86VD7	LB/B	-	M3YVK6	312	L	M
Q86VD7	LP/P	Metabolic crises, recurrent, with variable encephalomyopathic features and neurologic regression (MECREN) [MIM:618416]	M3YVK6	291	N	D
Q8WUT9	LB/B	-	E1BX35	334	P	L
Q96H78	LB/B	-	A0A2Y9GF53	52	S	I
Q8N413	LB/B	-	A0A060W8U5	224	M	V
Q8N413	LB/B	-	A0A060W8U5	251	R	Q
Q3SY17	LB/B	-	L5KNU3	239	L	I
Q86WA9	LB/B	-	G1STR8	122	Y	C
P50443	LP/P	Atelosteogenesis 2 (AO2) [MIM:256050]	H3CKV8	255	G	E
P50443	LP/P	Atelosteogenesis 2 (AO2) [MIM:256050]	H3CKV8	279	R	W
P50443	LP/P	Multiple epiphyseal dysplasia 4 (EDM4) [MIM:226900]	H3CKV8	279	R	W
P50443	LP/P	Achondrogenesis 1B (ACG1B) [MIM:600972]	H3CKV8	425	N	D
P50443	LP/P	Achondrogenesis 1B (ACG1B) [MIM:600972]	H3CKV8	678	G	V
P50443	LP/P	Atelosteogenesis 2 (AO2) [MIM:256050]	H3CKV8	715	A	V
P50443	LP/P	Multiple epiphyseal dysplasia 4 (EDM4) [MIM:226900]	H3CKV8	715	A	V
P50443	LB/B	-	H3CKV8	454	Q	P
P50443	LP/P	Multiple epiphyseal dysplasia 4 (EDM4) [MIM:226900]	H3CKV8	653	C	S
P50443	LB/B	-	H3CKV8	689	T	S
P50443	LB/B	-	H3CKV8	574	I	T
P50443	LP/P	Multiple epiphyseal dysplasia 4 (EDM4) [MIM:226900]	H3CKV8	256	F	S
P40879	LP/P	Diarrhea 1, secretory chloride, congenital (DIAR1) [MIM:214700]	F6WBF8	120	G	S
P40879	LP/P	Diarrhea 1, secretory chloride, congenital (DIAR1) [MIM:214700]	F6WBF8	124	H	L
P40879	LP/P	Diarrhea 1, secretory chloride, congenital (DIAR1) [MIM:214700]	F6WBF8	131	P	R
P40879	LB/B	-	F6WBF8	307	C	W
P40879	LP/P	Diarrhea 1, secretory chloride, congenital (DIAR1) [MIM:214700]	F6WBF8	206	S	P
P40879	LP/P	Diarrhea 1, secretory chloride, congenital (DIAR1) [MIM:214700]	F6WBF8	468	D	V
P40879	LB/B	-	F6WBF8	68	R	Q
P40879	LB/B	-	F6WBF8	554	R	Q
P40879	LB/B	-	F6WBF8	753	N	S
P40879	LP/P	Diarrhea 1, secretory chloride, congenital (DIAR1) [MIM:214700]	F6WBF8	129	P	L
P40879	LP/P	Diarrhea 1, secretory chloride, congenital (DIAR1) [MIM:214700]	F6WBF8	131	P	L
P40879	LP/P	Diarrhea 1, secretory chloride, congenital (DIAR1) [MIM:214700]	F6WBF8	136	M	I
P40879	LP/P	Diarrhea 1, secretory chloride, congenital (DIAR1) [MIM:214700]	F6WBF8	204	Y	D
P40879	LP/P	Diarrhea 1, secretory chloride, congenital (DIAR1) [MIM:214700]	F6WBF8	220	H	P
P40879	LP/P	Diarrhea 1, secretory chloride, congenital (DIAR1) [MIM:214700]	F6WBF8	343	C	Y
P40879	LP/P	Diarrhea 1, secretory chloride, congenital (DIAR1) [MIM:214700]	F6WBF8	379	G	A
P40879	LP/P	Diarrhea 1, secretory chloride, congenital (DIAR1) [MIM:214700]	F6WBF8	398	S	F
P40879	LP/P	Diarrhea 1, secretory chloride, congenital (DIAR1) [MIM:214700]	F6WBF8	496	L	R
P40879	LP/P	Diarrhea 1, secretory chloride, congenital (DIAR1) [MIM:214700]	F6WBF8	520	Y	C
P40879	LP/P	Diarrhea 1, secretory chloride, congenital (DIAR1) [MIM:214700]	F6WBF8	521	K	N
P40879	LP/P	Diarrhea 1, secretory chloride, congenital (DIAR1) [MIM:214700]	F6WBF8	544	I	N
P40879	LP/P	Diarrhea 1, secretory chloride, congenital (DIAR1) [MIM:214700]	F6WBF8	652	D	N
P40879	LP/P	Diarrhea 1, secretory chloride, congenital (DIAR1) [MIM:214700]	F6WBF8	134	S	N
P40879	LP/P	Diarrhea 1, secretory chloride, congenital (DIAR1) [MIM:214700]	F6WBF8	175	R	S
P40879	LP/P	Diarrhea 1, secretory chloride, congenital (DIAR1) [MIM:214700]	F6WBF8	394	S	I
P40879	LP/P	Diarrhea 1, secretory chloride, congenital (DIAR1) [MIM:214700]	F6WBF8	438	S	P
P40879	LP/P	Diarrhea 1, secretory chloride, congenital (DIAR1) [MIM:214700]	F6WBF8	495	Q	P
P40879	LP/P	Diarrhea 1, secretory chloride, congenital (DIAR1) [MIM:214700]	F6WBF8	508	C	R
P40879	LP/P	Diarrhea 1, secretory chloride, congenital (DIAR1) [MIM:214700]	F6WBF8	547	A	E
P40879	LP/P	Diarrhea 1, secretory chloride, congenital (DIAR1) [MIM:214700]	F6WBF8	654	S	P
O43511	LP/P	Deafness, autosomal recessive, 4 (DFNB4) [MIM:600791]	L5JRB0	209	G	V
O43511	LP/P	Pendred syndrome (PDS) [MIM:274600]	L5JRB0	209	G	V
O43511	LP/P	Deafness, autosomal recessive, 4 (DFNB4) [MIM:600791]	L5JRB0	236	L	P
O43511	LP/P	Pendred syndrome (PDS) [MIM:274600]	L5JRB0	236	L	P
O43511	LP/P	Deafness, autosomal recessive, 4 (DFNB4) [MIM:600791]	L5JRB0	369	K	E
O43511	LP/P	Deafness, autosomal recessive, 4 (DFNB4) [MIM:600791]	L5JRB0	372	A	V
O43511	LP/P	Deafness, autosomal recessive, 4 (DFNB4) [MIM:600791]	L5JRB0	416	T	P
O43511	LP/P	Pendred syndrome (PDS) [MIM:274600]	L5JRB0	416	T	P
O43511	LP/P	Deafness, autosomal recessive, 4 (DFNB4) [MIM:600791]	L5JRB0	497	G	S
O43511	LP/P	Pendred syndrome (PDS) [MIM:274600]	L5JRB0	667	F	C
O43511	LP/P	Deafness, autosomal recessive, 4 (DFNB4) [MIM:600791]	L5JRB0	721	T	M
O43511	LP/P	Pendred syndrome (PDS) [MIM:274600]	L5JRB0	721	T	M
O43511	LP/P	Deafness, autosomal recessive, 4 (DFNB4) [MIM:600791]	L5JRB0	723	H	R
O43511	LP/P	Pendred syndrome (PDS) [MIM:274600]	L5JRB0	723	H	R
O43511	LP/P	Pendred syndrome (PDS) [MIM:274600]	L5JRB0	193	T	I
O43511	LB/B	-	L5JRB0	24	R	G
O43511	LP/P	Deafness, autosomal recessive, 4 (DFNB4) [MIM:600791]	L5JRB0	28	S	R
O43511	LP/P	Pendred syndrome (PDS) [MIM:274600]	L5JRB0	28	S	R
O43511	LP/P	Pendred syndrome (PDS) [MIM:274600]	L5JRB0	29	E	Q
O43511	LP/P	Pendred syndrome (PDS) [MIM:274600]	L5JRB0	78	Y	C
O43511	LP/P	Deafness, autosomal recessive, 4 (DFNB4) [MIM:600791]	L5JRB0	90	S	L
O43511	LP/P	Pendred syndrome (PDS) [MIM:274600]	L5JRB0	102	G	R
O43511	LB/B	-	L5JRB0	104	A	V
O43511	LP/P	Pendred syndrome (PDS) [MIM:274600]	L5JRB0	105	Y	C
O43511	LP/P	Pendred syndrome (PDS) [MIM:274600]	L5JRB0	106	A	D
O43511	LP/P	Deafness, autosomal recessive, 4 (DFNB4) [MIM:600791]	L5JRB0	117	L	F
O43511	LP/P	Pendred syndrome (PDS) [MIM:274600]	L5JRB0	117	L	F
O43511	LP/P	Deafness, autosomal recessive, 4 (DFNB4) [MIM:600791]	L5JRB0	132	T	I
O43511	LP/P	Pendred syndrome (PDS) [MIM:274600]	L5JRB0	133	S	T
O43511	LP/P	Pendred syndrome (PDS) [MIM:274600]	L5JRB0	137	S	P
O43511	LP/P	Pendred syndrome (PDS) [MIM:274600]	L5JRB0	138	V	F
O43511	LP/P	Pendred syndrome (PDS) [MIM:274600]	L5JRB0	139	G	A
O43511	LP/P	Deafness, autosomal recessive, 4 (DFNB4) [MIM:600791]	L5JRB0	239	V	D
O43511	LP/P	Pendred syndrome (PDS) [MIM:274600]	L5JRB0	239	V	D
O43511	LP/P	Deafness, autosomal recessive, 4 (DFNB4) [MIM:600791]	L5JRB0	252	S	P
O43511	LP/P	Pendred syndrome (PDS) [MIM:274600]	L5JRB0	271	D	H
O43511	LP/P	Deafness, autosomal recessive, 4 (DFNB4) [MIM:600791]	L5JRB0	335	F	L
O43511	LP/P	Pendred syndrome (PDS) [MIM:274600]	L5JRB0	335	F	L
O43511	LP/P	Pendred syndrome (PDS) [MIM:274600]	L5JRB0	391	S	N
O43511	LP/P	Deafness, autosomal recessive, 4 (DFNB4) [MIM:600791]	L5JRB0	392	N	Y
O43511	LP/P	Pendred syndrome (PDS) [MIM:274600]	L5JRB0	409	R	H
O43511	LP/P	Deafness, autosomal recessive, 4 (DFNB4) [MIM:600791]	L5JRB0	409	R	P
O43511	LP/P	Deafness, autosomal recessive, 4 (DFNB4) [MIM:600791]	L5JRB0	410	T	M
O43511	LP/P	Pendred syndrome (PDS) [MIM:274600]	L5JRB0	410	T	M
O43511	LP/P	Pendred syndrome (PDS) [MIM:274600]	L5JRB0	411	A	P
O43511	LB/B	-	L5JRB0	421	Q	R
O43511	LP/P	Deafness, autosomal recessive, 4 (DFNB4) [MIM:600791]	L5JRB0	446	Q	R
O43511	LP/P	Pendred syndrome (PDS) [MIM:274600]	L5JRB0	446	Q	R
O43511	LB/B	-	L5JRB0	455	I	F
O43511	LP/P	Deafness, autosomal recessive, 4 (DFNB4) [MIM:600791]	L5JRB0	457	N	K
O43511	LP/P	Pendred syndrome (PDS) [MIM:274600]	L5JRB0	480	V	D
O43511	LP/P	Deafness, autosomal recessive, 4 (DFNB4) [MIM:600791]	L5JRB0	490	I	L
O43511	LP/P	Pendred syndrome (PDS) [MIM:274600]	L5JRB0	530	Y	H
O43511	LP/P	Pendred syndrome (PDS) [MIM:274600]	L5JRB0	552	S	I
O43511	LP/P	Deafness, autosomal recessive, 4 (DFNB4) [MIM:600791]	L5JRB0	556	Y	C
O43511	LP/P	Pendred syndrome (PDS) [MIM:274600]	L5JRB0	556	Y	C
O43511	LP/P	Pendred syndrome (PDS) [MIM:274600]	L5JRB0	556	Y	H
O43511	LP/P	Pendred syndrome (PDS) [MIM:274600]	L5JRB0	565	C	Y
O43511	LP/P	Pendred syndrome (PDS) [MIM:274600]	L5JRB0	653	V	A
O43511	LP/P	Pendred syndrome (PDS) [MIM:274600]	L5JRB0	672	G	E
O43511	LP/P	Deafness, autosomal recessive, 4 (DFNB4) [MIM:600791]	L5JRB0	676	L	Q
O43511	LB/B	-	L5JRB0	683	F	S
O43511	LP/P	Pendred syndrome (PDS) [MIM:274600]	L5JRB0	694	S	P
O43511	LP/P	Pendred syndrome (PDS) [MIM:274600]	L5JRB0	724	D	N
O43511	LP/P	Deafness, autosomal recessive, 4 (DFNB4) [MIM:600791]	L5JRB0	123	P	S
O43511	LP/P	Deafness, autosomal recessive, 4 (DFNB4) [MIM:600791]	L5JRB0	147	M	V
O43511	LP/P	Pendred syndrome (PDS) [MIM:274600]	L5JRB0	508	T	N
O43511	LP/P	Pendred syndrome (PDS) [MIM:274600]	L5JRB0	514	Q	R
O43511	LP/P	Deafness, autosomal recessive, 4 (DFNB4) [MIM:600791]	L5JRB0	530	Y	S
O43511	LP/P	Pendred syndrome (PDS) [MIM:274600]	L5JRB0	530	Y	S
O43511	LB/B	-	L5JRB0	609	V	G
O43511	LP/P	Deafness, autosomal recessive, 4 (DFNB4) [MIM:600791]	L5JRB0	666	S	F
O43511	LB/B	-	L5JRB0	740	G	S
O43511	LB/B	-	L5JRB0	301	P	L
O43511	LB/B	-	L5JRB0	324	N	Y
O43511	LB/B	-	L5JRB0	687	D	Y
O43511	LP/P	Deafness, autosomal recessive, 4 (DFNB4) [MIM:600791]	L5JRB0	402	V	M
O43511	LP/P	Pendred syndrome (PDS) [MIM:274600]	L5JRB0	402	V	M
O43511	LP/P	Deafness, autosomal recessive, 4 (DFNB4) [MIM:600791]	L5JRB0	775	M	T
O43511	LP/P	Pendred syndrome (PDS) [MIM:274600]	L5JRB0	775	M	T
O43511	LB/B	-	L5JRB0	6	G	V
O43511	LB/B	-	L5JRB0	99	T	M
O43511	LP/P	Deafness, autosomal recessive, 4 (DFNB4) [MIM:600791]	L5JRB0	281	V	I
O43511	LP/P	Deafness, autosomal recessive, 4 (DFNB4) [MIM:600791]	L5JRB0	558	N	K
O43511	LP/P	Deafness, autosomal recessive, 4 (DFNB4) [MIM:600791]	L5JRB0	227	A	P
Q9BXS9	LB/B	-	A0A2Y9N7D6	206	V	M
Q8TE54	LB/B	-	D3Z8P6	215	I	V
Q8TE54	LB/B	-	D3Z8P6	381	V	G
Q96RN1	LB/B	-	A0A2Y9KB22	73	V	M
Q96RN1	LB/B	-	A0A2Y9KB22	148	I	V
Q96RN1	LB/B	-	A0A2Y9KB22	230	S	N
Q96RN1	LB/B	-	A0A2Y9KB22	639	I	V
Q96RN1	LP/P	Spermatogenic failure 3 (SPGF3) [MIM:606766]	A0A2Y9KB22	87	R	Q
Q96RN1	LP/P	Spermatogenic failure 3 (SPGF3) [MIM:606766]	A0A2Y9KB22	812	E	K
Q96RN1	LP/P	Spermatogenic failure 3 (SPGF3) [MIM:606766]	A0A2Y9KB22	954	R	C
Q7LBE3	LB/B	-	F7GB82	744	V	M
Q7LBE3	LB/B	-	F7GB82	748	H	R
Q7LBE3	LB/B	-	F7GB82	70	Y	N
Q7LBE3	LB/B	-	F7GB82	127	T	N
Q7LBE3	LB/B	-	F7GB82	384	I	T
Q7LBE3	LB/B	-	F7GB82	575	R	W
Q7LBE3	LB/B	-	F7GB82	606	P	L
Q7LBE3	LB/B	-	F7GB82	622	V	L
O14975	LB/B	-	A0A2K6S9K3	48	K	Q
Q5K4L6	LB/B	-	A0A2K6E8F5	63	G	A
Q5K4L6	LB/B	-	A0A2K6E8F5	392	R	H
Q6P1M0	LB/B	-	A0A2U9CEV3	209	G	S
Q6P1M0	LP/P	Ichthyosis prematurity syndrome (IPS) [MIM:608649]	A0A2U9CEV3	92	A	T
Q6P1M0	LP/P	Ichthyosis prematurity syndrome (IPS) [MIM:608649]	A0A2U9CEV3	247	S	P
Q6P1M0	LP/P	Ichthyosis prematurity syndrome (IPS) [MIM:608649]	A0A2U9CEV3	300	Q	R
Q6P1M0	LP/P	Ichthyosis prematurity syndrome (IPS) [MIM:608649]	A0A2U9CEV3	583	R	H
Q6P1M0	LP/P	Ichthyosis prematurity syndrome (IPS) [MIM:608649]	A0A2U9CEV3	374	R	C
Q9Y2P4	LB/B	-	A0A146V4R7	19	L	V
Q9HAS3	LB/B	-	A0A1S3A2R8	4	R	K
Q9HAS3	LB/B	-	A0A1S3A2R8	5	S	N
Q9HAS3	LB/B	-	A0A1S3A2R8	62	D	H
Q9HAS3	LB/B	-	A0A1S3A2R8	67	R	K
Q9HAS3	LB/B	-	A0A1S3A2R8	113	Y	C
Q9HAS3	LB/B	-	A0A1S3A2R8	131	L	F
Q9HAS3	LB/B	-	A0A1S3A2R8	221	P	Q
Q9HAS3	LB/B	-	A0A1S3A2R8	328	I	V
Q9HAS3	LB/B	-	A0A1S3A2R8	349	R	Q
Q9HAS3	LB/B	-	A0A1S3A2R8	367	G	R
Q9HAS3	LB/B	-	A0A1S3A2R8	418	L	I
Q9HAS3	LB/B	-	A0A1S3A2R8	513	Y	F
Q9HAS3	LB/B	-	A0A1S3A2R8	585	R	H
Q9HAS3	LB/B	-	A0A1S3A2R8	366	A	T
Q99808	LB/B	-	W5PHS7	216	I	T
Q99808	LB/B	-	W5PHS7	391	E	K
Q14542	LB/B	-	W5PHS7	5	D	Y
Q14542	LB/B	-	W5PHS7	68	N	K
Q14542	LB/B	-	W5PHS7	94	P	L
Q9BZD2	LB/B	-	W5PHS7	18	R	G
Q9BZD2	LB/B	-	W5PHS7	158	S	F
Q9BZD2	LB/B	-	W5PHS7	239	V	I
Q9BZD2	LB/B	-	W5PHS7	326	I	V
Q9BZD2	LB/B	-	W5PHS7	452	V	E
Q9BZD2	LP/P	Histiocytosis-lymphadenopathy plus syndrome (HLAS) [MIM:602782]	W5PHS7	427	G	S
Q9BZD2	LP/P	Histiocytosis-lymphadenopathy plus syndrome (HLAS) [MIM:602782]	W5PHS7	437	G	R
Q9BZD2	LP/P	Histiocytosis-lymphadenopathy plus syndrome (HLAS) [MIM:602782]	W5PHS7	116	M	R
Q9BZD2	LP/P	Histiocytosis-lymphadenopathy plus syndrome (HLAS) [MIM:602782]	W5PHS7	134	R	C
Q9BZD2	LB/B	-	W5PHS7	163	G	V
Q9BZD2	LP/P	Histiocytosis-lymphadenopathy plus syndrome (HLAS) [MIM:602782]	W5PHS7	184	S	R
Q9BZD2	LB/B	-	W5PHS7	281	L	P
Q9BZD2	LP/P	Histiocytosis-lymphadenopathy plus syndrome (HLAS) [MIM:602782]	W5PHS7	363	R	Q
Q9BZD2	LP/P	Histiocytosis-lymphadenopathy plus syndrome (HLAS) [MIM:602782]	W5PHS7	363	R	W
Q9BZD2	LB/B	-	W5PHS7	407	V	M
Q9BZD2	LP/P	Histiocytosis-lymphadenopathy plus syndrome (HLAS) [MIM:602782]	W5PHS7	449	T	R
P11166	LP/P	GLUT1 deficiency syndrome 1 (GLUT1DS1) [MIM:606777]	M7B6D5	91	G	D
P11166	LP/P	GLUT1 deficiency syndrome 1 (GLUT1DS1) [MIM:606777]	M7B6D5	126	R	H
P11166	LP/P	GLUT1 deficiency syndrome 1 (GLUT1DS1) [MIM:606777]	M7B6D5	126	R	L
P11166	LP/P	GLUT1 deficiency syndrome 1 (GLUT1DS1) [MIM:606777]	M7B6D5	256	K	E
P11166	LP/P	GLUT1 deficiency syndrome 1 (GLUT1DS1) [MIM:606777]	M7B6D5	66	S	F
P11166	LP/P	GLUT1 deficiency syndrome 1 (GLUT1DS1) [MIM:606777]	M7B6D5	146	E	K
P11166	LP/P	GLUT1 deficiency syndrome 1 (GLUT1DS1) [MIM:606777]	M7B6D5	310	T	I
P11166	LP/P	GLUT1 deficiency syndrome 1 (GLUT1DS1) [MIM:606777]	M7B6D5	333	R	W
P11166	LP/P	GLUT1 deficiency syndrome 2 (GLUT1DS2) [MIM:612126]	M7B6D5	34	N	I
P11166	LP/P	GLUT1 deficiency syndrome 1 (GLUT1DS1) [MIM:606777]	M7B6D5	34	N	S
P11166	LP/P	Dystonia 9 (DYT9) [MIM:601042]	M7B6D5	126	R	C
P11166	LP/P	GLUT1 deficiency syndrome 1 (GLUT1DS1) [MIM:606777]	M7B6D5	126	R	C
P11166	LP/P	GLUT1 deficiency syndrome 2 (GLUT1DS2) [MIM:612126]	M7B6D5	126	R	C
P11166	LP/P	GLUT1 deficiency syndrome 1 (GLUT1DS1) [MIM:606777]	M7B6D5	130	G	S
P11166	LP/P	GLUT1 deficiency syndrome 1 (GLUT1DS1) [MIM:606777]	M7B6D5	153	R	C
P11166	LP/P	GLUT1 deficiency syndrome 2 (GLUT1DS2) [MIM:612126]	M7B6D5	275	A	T
P11166	LP/P	GLUT1 deficiency syndrome 1 (GLUT1DS1) [MIM:606777]	M7B6D5	295	T	M
P11166	LP/P	GLUT1 deficiency syndrome 2 (GLUT1DS2) [MIM:612126]	M7B6D5	314	G	S
P11166	LP/P	GLUT1 deficiency syndrome 1 (GLUT1DS1) [MIM:606777]	M7B6D5	34	N	Y
P11166	LP/P	GLUT1 deficiency syndrome 2 (GLUT1DS2) [MIM:612126]	M7B6D5	93	R	W
P11166	LP/P	GLUT1 deficiency syndrome 2 (GLUT1DS2) [MIM:612126]	M7B6D5	95	S	I
P11166	LP/P	GLUT1 deficiency syndrome 1 (GLUT1DS1) [MIM:606777]	M7B6D5	96	M	V
P11166	LP/P	GLUT1 deficiency syndrome 2 (GLUT1DS2) [MIM:612126]	M7B6D5	153	R	H
P11166	LP/P	GLUT1 deficiency syndrome 1 (GLUT1DS1) [MIM:606777]	M7B6D5	155	A	V
P11166	LP/P	GLUT1 deficiency syndrome 2 (GLUT1DS2) [MIM:612126]	M7B6D5	165	V	I
P11166	LP/P	Dystonia 9 (DYT9) [MIM:601042]	M7B6D5	212	R	C
P11166	LP/P	GLUT1 deficiency syndrome 1 (GLUT1DS1) [MIM:606777]	M7B6D5	212	R	C
P11166	LP/P	GLUT1 deficiency syndrome 1 (GLUT1DS1) [MIM:606777]	M7B6D5	212	R	H
P11166	LP/P	Epilepsy, idiopathic generalized 12 (EIG12) [MIM:614847]	M7B6D5	223	R	P
P11166	LP/P	GLUT1 deficiency syndrome 1 (GLUT1DS1) [MIM:606777]	M7B6D5	223	R	W
P11166	LB/B	-	M7B6D5	303	V	L
P11166	LP/P	GLUT1 deficiency syndrome 2 (GLUT1DS2) [MIM:612126]	M7B6D5	317	N	T
P11166	LP/P	GLUT1 deficiency syndrome 2 (GLUT1DS2) [MIM:612126]	M7B6D5	324	S	L
P11166	LP/P	GLUT1 deficiency syndrome 1 (GLUT1DS1) [MIM:606777]	M7B6D5	329	E	Q
P11166	LP/P	GLUT1 deficiency syndrome 1 (GLUT1DS1) [MIM:606777]	M7B6D5	333	R	Q
P11166	LP/P	GLUT1 deficiency syndrome 2 (GLUT1DS2) [MIM:612126]	M7B6D5	333	R	Q
P11166	LP/P	GLUT1 deficiency syndrome 1 (GLUT1DS1) [MIM:606777]	M7B6D5	382	G	D
P11166	LP/P	GLUT1 deficiency syndrome 1 (GLUT1DS1) [MIM:606777]	M7B6D5	405	A	D
P11166	LP/P	GLUT1 deficiency syndrome 1 (GLUT1DS1) [MIM:606777]	M7B6D5	485	P	L
P11166	LP/P	GLUT1 deficiency syndrome 2 (GLUT1DS2) [MIM:612126]	M7B6D5	294	S	P
P11166	LP/P	GLUT1 deficiency syndrome 2 (GLUT1DS2) [MIM:612126]	M7B6D5	92	R	W
P11166	LP/P	Epilepsy, idiopathic generalized 12 (EIG12) [MIM:614847]	M7B6D5	232	R	C
P11166	LP/P	GLUT1 deficiency syndrome 1 (GLUT1DS1) [MIM:606777]	M7B6D5	468	R	W
P11166	LP/P	Epilepsy, idiopathic generalized 12 (EIG12) [MIM:614847]	M7B6D5	77	M	T
P11166	LP/P	Epilepsy, idiopathic generalized 12 (EIG12) [MIM:614847]	M7B6D5	218	R	S
P11166	LP/P	Epilepsy, idiopathic generalized 12 (EIG12) [MIM:614847]	M7B6D5	243	E	V
P11166	LP/P	Stomatin-deficient cryohydrocytosis with neurologic defects (SDCHCN) [MIM:608885]	M7B6D5	286	G	D
P11166	LP/P	Epilepsy, idiopathic generalized 12 (EIG12) [MIM:614847]	M7B6D5	411	N	S
P11166	LP/P	Epilepsy, idiopathic generalized 12 (EIG12) [MIM:614847]	M7B6D5	458	R	W
O95528	LB/B	-	A0A2D0SKE2	518	T	A
O95528	LB/B	-	A0A2D0SKE2	206	A	T
O95528	LP/P	Arterial tortuosity syndrome (ATORS) [MIM:208050]	A0A2D0SKE2	81	S	R
O95528	LB/B	-	A0A2D0SKE2	106	A	S
O95528	LB/B	-	A0A2D0SKE2	537	I	V
O95528	LP/P	Arterial tortuosity syndrome (ATORS) [MIM:208050]	A0A2D0SKE2	132	R	W
O95528	LP/P	Arterial tortuosity syndrome (ATORS) [MIM:208050]	A0A2D0SKE2	142	G	V
O95528	LB/B	-	A0A2D0SKE2	225	R	H
O95528	LP/P	Arterial tortuosity syndrome (ATORS) [MIM:208050]	A0A2D0SKE2	231	R	Q
O95528	LP/P	Arterial tortuosity syndrome (ATORS) [MIM:208050]	A0A2D0SKE2	246	G	E
O95528	LP/P	Arterial tortuosity syndrome (ATORS) [MIM:208050]	A0A2D0SKE2	426	G	W
O95528	LP/P	Arterial tortuosity syndrome (ATORS) [MIM:208050]	A0A2D0SKE2	437	E	K
O95528	LP/P	Arterial tortuosity syndrome (ATORS) [MIM:208050]	A0A2D0SKE2	445	G	E
P11168	LB/B	-	S7NU55	68	P	L
P11168	LB/B	-	S7NU55	101	V	I
P11168	LB/B	-	S7NU55	110	T	I
P11168	LB/B	-	S7NU55	478	L	V
P11168	LB/B	-	S7NU55	197	V	I
P11168	LP/P	Fanconi-Bickel syndrome (FBS) [MIM:227810]	S7NU55	389	L	P
P11168	LP/P	Fanconi-Bickel syndrome (FBS) [MIM:227810]	S7NU55	417	P	L
P11168	LP/P	Fanconi-Bickel syndrome (FBS) [MIM:227810]	S7NU55	423	V	E
P11168	LB/B	-	S7NU55	404	I	T
P14672	LP/P	Type 2 diabetes mellitus (T2D) [MIM:125853]	M7B6D5	383	V	I
P14672	LB/B	-	M7B6D5	385	I	T
P14672	LB/B	-	M7B6D5	78	T	S
P14672	LB/B	-	M7B6D5	358	A	V
P14672	LB/B	-	M7B6D5	55	S	R
Q9NR83	LB/B	-	F1ML80	233	E	D
Q6XR72	LP/P	Hypermanganesemia with dystonia 1 (HMNDYT1) [MIM:613280]	A0A2D0QM81	89	L	P
Q6XR72	LB/B	-	A0A2D0QM81	167	F	S
Q6XR72	LP/P	Hypermanganesemia with dystonia 1 (HMNDYT1) [MIM:613280]	A0A2D0QM81	349	L	P
Q9BRI3	LP/P	Zinc deficiency, transient neonatal (TNZD) [MIM:608118]	T1JWH5	54	H	R
Q9BRI3	LP/P	Zinc deficiency, transient neonatal (TNZD) [MIM:608118]	T1JWH5	87	G	R
Q8IWU4	LB/B	-	T1JWH5	325	R	Q
Q8IWU4	LB/B	-	T1JWH5	325	R	W
Q6PML9	LB/B	-	H3A254	50	M	V
Q6PML9	LB/B	-	H3A254	97	T	A
Q6PML9	LB/B	-	H3A254	353	L	S
O15431	LB/B	-	A0A2K6F9M9	25	P	A
Q9H598	LB/B	-	G3WUN5	423	S	G
O95436	LP/P	Pulmonary alveolar microlithiasis (PULAM) [MIM:265100]	M1V485	106	G	R
O95436	LB/B	-	M1V485	634	D	G
O95436	LB/B	-	M1V485	45	V	A
Q8N130	LB/B	-	H0WT46	67	R	H
Q8N130	LP/P	Hereditary hypophosphatemic rickets with hypercalciuria (HHRH) [MIM:241530]	H0WT46	138	S	F
Q8N130	LB/B	-	H0WT46	180	G	A
Q8N130	LP/P	Hereditary hypophosphatemic rickets with hypercalciuria (HHRH) [MIM:241530]	H0WT46	192	S	L
Q8N130	LP/P	Hereditary hypophosphatemic rickets with hypercalciuria (HHRH) [MIM:241530]	H0WT46	196	G	R
Q8N130	LB/B	-	H0WT46	237	D	N
Q8N130	LB/B	-	H0WT46	337	G	S
Q8N130	LP/P	Hereditary hypophosphatemic rickets with hypercalciuria (HHRH) [MIM:241530]	H0WT46	353	R	L
Q8N130	LP/P	Hereditary hypophosphatemic rickets with hypercalciuria (HHRH) [MIM:241530]	H0WT46	413	A	E
Q8N130	LP/P	Hereditary hypophosphatemic rickets with hypercalciuria (HHRH) [MIM:241530]	H0WT46	468	R	W
Q8N130	LB/B	-	H0WT46	513	E	V
P78383	LB/B	-	A0A2R8NA48	81	R	H
Q8TB61	LB/B	-	S9WE71	342	L	V
Q96A29	LP/P	Congenital disorder of glycosylation 2C (CDG2C) [MIM:266265]	S9WSG2	147	R	C
Q96A29	LP/P	Congenital disorder of glycosylation 2C (CDG2C) [MIM:266265]	S9WSG2	308	T	R
Q96A29	LB/B	-	S9WSG2	49	W	S
Q96A29	LB/B	-	S9WSG2	240	I	V
Q8IY50	LB/B	-	M4A581	231	S	C
P0C7Q5	LB/B	-	A0A2I2UH70	104	T	A
Q96KT7	LB/B	-	A0A2I2UH70	46	G	D
Q96KT7	LB/B	-	A0A2I2UH70	307	L	P
P0C7Q6	LB/B	-	A0A2I2UH70	51	A	T
P0C7Q6	LB/B	-	A0A2I2UH70	251	P	L
P0C7Q6	LB/B	-	A0A2I2UH70	263	A	T
Q7Z2H8	LB/B	-	A0A2K6BEF8	362	F	L
Q495M3	LB/B	-	F6ZUD7	445	A	V
Q495M3	LP/P	Hyperglycinuria (HG) [MIM:138500]	F6ZUD7	87	G	V
Q495M3	LP/P	Iminoglycinuria (IG) [MIM:242600]	F6ZUD7	87	G	V
Q495N2	LB/B	-	M3XK98	167	K	E
Q495N2	LB/B	-	M3XK98	185	P	S
Q495N2	LB/B	-	M3XK98	190	R	H
Q495N2	LB/B	-	M3XK98	415	E	D
Q495N2	LB/B	-	M3XK98	421	S	F
Q96QD8	LB/B	-	A0A146YJK2	48	N	K
Q99624	LP/P	Developmental and epileptic encephalopathy 102 (DEE102) [MIM:619881]	A0A2J8R8R5	375	T	P
Q969I6	LB/B	-	A0A146YJK2	29	G	R
Q969I6	LB/B	-	A0A146YJK2	366	T	M
Q8WUX1	LB/B	-	A0A2J8R8R5	451	M	T
Q8IZM9	LB/B	-	A0A2J8R8R5	70	L	M
Q8IZM9	LB/B	-	A0A2J8R8R5	419	S	T
Q9NVC3	LB/B	-	A0A2D0RR49	46	L	P
Q9NVC3	LB/B	-	A0A2D0RR49	78	T	I
A6NNN8	LB/B	-	A0A2D0RR49	220	S	T
A6NNN8	LP/P	Foveal hypoplasia 2 (FVH2) [MIM:609218]	A0A2D0RR49	32	I	S
A6NNN8	LP/P	Foveal hypoplasia 2 (FVH2) [MIM:609218]	A0A2D0RR49	34	M	R
A6NNN8	LP/P	Foveal hypoplasia 2 (FVH2) [MIM:609218]	A0A2D0RR49	233	E	K
A6NNN8	LP/P	Foveal hypoplasia 2 (FVH2) [MIM:609218]	A0A2D0RR49	236	V	D
A6NNN8	LP/P	Foveal hypoplasia 2 (FVH2) [MIM:609218]	A0A2D0RR49	412	G	R
Q9ULF5	LB/B	-	A0A091DHK1	87	T	S
Q96H72	LB/B	-	K7F906	28	E	G
Q96H72	LB/B	-	K7F906	346	P	L
Q9BRY0	LB/B	-	A0A151NRY3	100	F	L
Q9BRY0	LB/B	-	A0A151NRY3	257	P	L
Q6P5W5	LB/B	-	A0A1L8FUA7	58	A	T
Q6P5W5	LB/B	-	A0A1L8FUA7	84	P	L
Q6P5W5	LP/P	Acrodermatitis enteropathica, zinc-deficiency type (AEZ) [MIM:201100]	A0A1L8FUA7	95	R	C
Q6P5W5	LP/P	Acrodermatitis enteropathica, zinc-deficiency type (AEZ) [MIM:201100]	A0A1L8FUA7	106	N	K
Q6P5W5	LB/B	-	A0A1L8FUA7	114	A	T
Q6P5W5	LP/P	Acrodermatitis enteropathica, zinc-deficiency type (AEZ) [MIM:201100]	A0A1L8FUA7	200	P	L
Q6P5W5	LP/P	Acrodermatitis enteropathica, zinc-deficiency type (AEZ) [MIM:201100]	A0A1L8FUA7	303	Q	H
Q6P5W5	LP/P	Acrodermatitis enteropathica, zinc-deficiency type (AEZ) [MIM:201100]	A0A1L8FUA7	330	G	D
Q6P5W5	LB/B	-	A0A1L8FUA7	357	T	A
Q6P5W5	LP/P	Acrodermatitis enteropathica, zinc-deficiency type (AEZ) [MIM:201100]	A0A1L8FUA7	372	V	P
Q6P5W5	LP/P	Acrodermatitis enteropathica, zinc-deficiency type (AEZ) [MIM:201100]	A0A1L8FUA7	374	G	R
Q6P5W5	LP/P	Acrodermatitis enteropathica, zinc-deficiency type (AEZ) [MIM:201100]	A0A1L8FUA7	526	G	R
Q6P5W5	LP/P	Acrodermatitis enteropathica, zinc-deficiency type (AEZ) [MIM:201100]	A0A1L8FUA7	630	G	R
Q6P5W5	LB/B	-	A0A1L8FUA7	158	M	T
Q6P5W5	LB/B	-	A0A1L8FUA7	284	E	K
Q6P5W5	LB/B	-	A0A1L8FUA7	372	V	L
Q6P5W5	LB/B	-	A0A1L8FUA7	22	A	E
Q6ZMH5	LP/P	Myopia 24, autosomal dominant (MYP24) [MIM:615946]	W5PIW8	304	M	T
Q13433	LB/B	-	G3TDV4	119	E	D
Q92504	LB/B	-	A0A146MGR5	87	D	N
Q92504	LB/B	-	A0A146MGR5	124	G	R
Q92504	LB/B	-	A0A146MGR5	280	E	G
Q92504	LP/P	Agammaglobulinemia 9, autosomal recessive (AGM9) [MIM:619693]	A0A146MGR5	190	P	A
Q92504	LP/P	Agammaglobulinemia 9, autosomal recessive (AGM9) [MIM:619693]	A0A146MGR5	217	L	P
Q92504	LP/P	Agammaglobulinemia 9, autosomal recessive (AGM9) [MIM:619693]	A0A146MGR5	363	E	K
Q07837	LP/P	Cystinuria (CSNU) [MIM:220100]	H2E958	128	P	Q
Q07837	LP/P	Cystinuria (CSNU) [MIM:220100]	H2E958	181	R	Q
Q07837	LP/P	Cystinuria (CSNU) [MIM:220100]	H2E958	268	E	K
Q07837	LP/P	Cystinuria (CSNU) [MIM:220100]	H2E958	341	T	A
Q07837	LP/P	Cystinuria (CSNU) [MIM:220100]	H2E958	365	R	W
Q07837	LP/P	Cystinuria (CSNU) [MIM:220100]	H2E958	452	R	W
Q07837	LP/P	Cystinuria (CSNU) [MIM:220100]	H2E958	461	Y	H
Q07837	LP/P	Cystinuria (CSNU) [MIM:220100]	H2E958	467	M	T
Q07837	LP/P	Cystinuria (CSNU) [MIM:220100]	H2E958	467	M	K
Q07837	LP/P	Cystinuria (CSNU) [MIM:220100]	H2E958	582	Y	H
Q07837	LP/P	Cystinuria (CSNU) [MIM:220100]	H2E958	615	P	T
Q07837	LB/B	-	H2E958	618	M	I
Q07837	LP/P	Cystinuria (CSNU) [MIM:220100]	H2E958	648	F	S
Q07837	LP/P	Cystinuria (CSNU) [MIM:220100]	H2E958	652	T	R
Q07837	LP/P	Cystinuria (CSNU) [MIM:220100]	H2E958	678	L	P
Q07837	LP/P	Cystinuria (CSNU) [MIM:220100]	H2E958	216	T	M
Q07837	LP/P	Cystinuria (CSNU) [MIM:220100]	H2E958	362	R	C
Q07837	LP/P	Cystinuria (CSNU) [MIM:220100]	H2E958	508	P	A
Q07837	LP/P	Cystinuria (CSNU) [MIM:220100]	H2E958	151	Y	C
Q07837	LP/P	Cystinuria (CSNU) [MIM:220100]	H2E958	253	N	K
Q07837	LP/P	Cystinuria (CSNU) [MIM:220100]	H2E958	362	R	H
Q07837	LP/P	Cystinuria (CSNU) [MIM:220100]	H2E958	398	G	R
Q07837	LP/P	Cystinuria (CSNU) [MIM:220100]	H2E958	481	G	V
Q07837	LP/P	Cystinuria (CSNU) [MIM:220100]	H2E958	482	E	K
Q07837	LP/P	Cystinuria (CSNU) [MIM:220100]	H2E958	510	Q	R
Q07837	LP/P	Cystinuria (CSNU) [MIM:220100]	H2E958	584	R	T
Q07837	LP/P	Cystinuria (CSNU) [MIM:220100]	H2E958	599	F	S
Q07837	LP/P	Cystinuria (CSNU) [MIM:220100]	H2E958	600	G	E
Q07837	LP/P	Cystinuria (CSNU) [MIM:220100]	H2E958	122	P	S
Q07837	LP/P	Cystinuria (CSNU) [MIM:220100]	H2E958	89	L	P
Q07837	LP/P	Cystinuria (CSNU) [MIM:220100]	H2E958	123	M	R
Q07837	LP/P	Cystinuria (CSNU) [MIM:220100]	H2E958	124	Y	C
Q07837	LP/P	Cystinuria (CSNU) [MIM:220100]	H2E958	130	S	P
Q07837	LP/P	Cystinuria (CSNU) [MIM:220100]	H2E958	137	D	G
Q07837	LP/P	Cystinuria (CSNU) [MIM:220100]	H2E958	140	G	R
Q07837	LP/P	Cystinuria (CSNU) [MIM:220100]	H2E958	149	L	Q
Q07837	LP/P	Cystinuria (CSNU) [MIM:220100]	H2E958	179	D	Y
Q07837	LP/P	Cystinuria (CSNU) [MIM:220100]	H2E958	189	T	M
Q07837	LP/P	Cystinuria (CSNU) [MIM:220100]	H2E958	348	H	P
Q07837	LP/P	Cystinuria (CSNU) [MIM:220100]	H2E958	365	R	P
Q07837	LP/P	Cystinuria (CSNU) [MIM:220100]	H2E958	410	N	K
Q07837	LP/P	Cystinuria (CSNU) [MIM:220100]	H2E958	441	P	R
Q07837	LP/P	Cystinuria (CSNU) [MIM:220100]	H2E958	452	R	Q
Q07837	LP/P	Cystinuria (CSNU) [MIM:220100]	H2E958	455	S	L
Q07837	LP/P	Cystinuria (CSNU) [MIM:220100]	H2E958	456	R	C
Q07837	LP/P	Cystinuria (CSNU) [MIM:220100]	H2E958	456	R	H
Q07837	LP/P	Cystinuria (CSNU) [MIM:220100]	H2E958	507	S	L
Q07837	LP/P	Cystinuria (CSNU) [MIM:220100]	H2E958	547	S	W
Q07837	LP/P	Cystinuria (CSNU) [MIM:220100]	H2E958	568	G	S
Q07837	LP/P	Cystinuria (CSNU) [MIM:220100]	H2E958	666	C	W
Q9NP59	LB/B	-	F6YA92	561	R	G
Q9NP59	LB/B	-	F6YA92	248	Q	H
Q9NP59	LB/B	-	F6YA92	432	M	V
Q9NP59	LP/P	Hemochromatosis 4 (HFE4) [MIM:606069]	F6YA92	77	A	D
Q9NP59	LP/P	Hemochromatosis 4 (HFE4) [MIM:606069]	F6YA92	144	N	H
Q9NP59	LP/P	Hemochromatosis 4 (HFE4) [MIM:606069]	F6YA92	157	D	G
Q9NP59	LP/P	Hemochromatosis 4 (HFE4) [MIM:606069]	F6YA92	182	Q	H
Q9NP59	LP/P	Hemochromatosis 4 (HFE4) [MIM:606069]	F6YA92	323	G	V
Q9NP59	LB/B	-	F6YA92	443	P	L
Q9NP59	LP/P	Hemochromatosis 4 (HFE4) [MIM:606069]	F6YA92	64	Y	N
Q9NP59	LP/P	Hemochromatosis 4 (HFE4) [MIM:606069]	F6YA92	80	G	S
Q9NP59	LP/P	Hemochromatosis 4 (HFE4) [MIM:606069]	F6YA92	80	G	V
Q9NP59	LP/P	Hemochromatosis 4 (HFE4) [MIM:606069]	F6YA92	144	N	D
Q9NP59	LP/P	Hemochromatosis 4 (HFE4) [MIM:606069]	F6YA92	144	N	T
Q9NP59	LB/B	-	F6YA92	174	N	I
Q9NP59	LP/P	Hemochromatosis 4 (HFE4) [MIM:606069]	F6YA92	181	D	V
Q9NP59	LP/P	Hemochromatosis 4 (HFE4) [MIM:606069]	F6YA92	267	G	D
Q9NP59	LP/P	Hemochromatosis 4 (HFE4) [MIM:606069]	F6YA92	270	D	V
Q9NP59	LP/P	Hemochromatosis 4 (HFE4) [MIM:606069]	F6YA92	490	G	D
Q8IVJ1	LP/P	Nephronophthisis-like nephropathy 2 (NPHPL2) [MIM:619468]	A0A147ALQ7	233	G	V
Q8IVJ1	LB/B	-	A0A147ALQ7	350	A	V
Q96GZ6	LB/B	-	L5LW03	62	T	A
Q96GZ6	LB/B	-	L5LW03	71	V	M
O75387	LB/B	-	F7FT44	238	G	V
O75387	LB/B	-	F7FT44	443	H	Y
Q8NBI5	LB/B	-	Q29RA6	53	P	L
Q8WWI5	LB/B	-	L5L300	644	S	A
Q8IWA5	LB/B	-	Q4S7S2	154	Q	R
Q8N4M1	LB/B	-	A0A1S3IJI3	438	V	I
Q53GD3	LB/B	-	Q4S7S2	6	R	L
Q53GD3	LB/B	-	Q4S7S2	187	V	I
Q53GD3	LB/B	-	Q4S7S2	326	M	V
Q53GD3	LB/B	-	Q4S7S2	493	R	C
Q53GD3	LB/B	-	Q4S7S2	123	D	V
Q53GD3	LB/B	-	Q4S7S2	128	G	E
Q53GD3	LP/P	Deafness, autosomal dominant, 72 (DFNA72) [MIM:617606]	Q4S7S2	156	M	V
Q53GD3	LB/B	-	Q4S7S2	397	P	S
Q9Y2W3	LP/P	Intellectual developmental disorder with neuropsychiatric features (IDDNPF) [MIM:617532]	A0A2K5JXQ3	90	I	T
Q9Y2W3	LP/P	Intellectual developmental disorder with neuropsychiatric features (IDDNPF) [MIM:617532]	A0A2K5JXQ3	210	R	W
Q9Y2W3	LP/P	Intellectual developmental disorder with neuropsychiatric features (IDDNPF) [MIM:617532]	A0A2K5JXQ3	244	A	V
Q9UMX9	LB/B	-	H2UMN9	374	L	F
Q9UMX9	LP/P	Albinism, oculocutaneous, 4 (OCA4) [MIM:606574]	H2UMN9	58	P	A
Q9UMX9	LP/P	Albinism, oculocutaneous, 4 (OCA4) [MIM:606574]	H2UMN9	58	P	S
Q9UMX9	LP/P	Albinism, oculocutaneous, 4 (OCA4) [MIM:606574]	H2UMN9	157	D	N
Q9UMX9	LP/P	Albinism, oculocutaneous, 4 (OCA4) [MIM:606574]	H2UMN9	188	G	V
Q9UMX9	LP/P	Albinism, oculocutaneous, 4 (OCA4) [MIM:606574]	H2UMN9	202	W	C
Q9UMX9	LB/B	-	H2UMN9	272	E	K
Q9UMX9	LP/P	Albinism, oculocutaneous, 4 (OCA4) [MIM:606574]	H2UMN9	317	Y	C
Q9UMX9	LP/P	Albinism, oculocutaneous, 4 (OCA4) [MIM:606574]	H2UMN9	361	L	P
Q9UMX9	LP/P	Albinism, oculocutaneous, 4 (OCA4) [MIM:606574]	H2UMN9	477	A	T
Q9UMX9	LP/P	Albinism, oculocutaneous, 4 (OCA4) [MIM:606574]	H2UMN9	486	A	V
Q9UMX9	LB/B	-	H2UMN9	500	T	P
Q9UMX9	LB/B	-	H2UMN9	507	V	L
Q9UMX9	LP/P	Albinism, oculocutaneous, 4 (OCA4) [MIM:606574]	H2UMN9	42	M	I
Q9UMX9	LP/P	Albinism, oculocutaneous, 4 (OCA4) [MIM:606574]	H2UMN9	64	G	S
Q9UMX9	LP/P	Albinism, oculocutaneous, 4 (OCA4) [MIM:606574]	H2UMN9	302	T	S
Q9UMX9	LP/P	Albinism, oculocutaneous, 4 (OCA4) [MIM:606574]	H2UMN9	348	R	C
Q9UMX9	LP/P	Albinism, oculocutaneous, 4 (OCA4) [MIM:606574]	H2UMN9	60	L	R
Q9UMX9	LP/P	Albinism, oculocutaneous, 4 (OCA4) [MIM:606574]	H2UMN9	110	G	R
Q9UMX9	LP/P	Albinism, oculocutaneous, 4 (OCA4) [MIM:606574]	H2UMN9	151	L	P
Q9UMX9	LP/P	Albinism, oculocutaneous, 4 (OCA4) [MIM:606574]	H2UMN9	160	D	H
Q9UMX9	LP/P	Albinism, oculocutaneous, 4 (OCA4) [MIM:606574]	H2UMN9	233	H	Q
Q9UMX9	LP/P	Albinism, oculocutaneous, 4 (OCA4) [MIM:606574]	H2UMN9	349	G	R
Q9UMX9	LP/P	Albinism, oculocutaneous, 4 (OCA4) [MIM:606574]	H2UMN9	368	E	K
Q9UMX9	LP/P	Albinism, oculocutaneous, 4 (OCA4) [MIM:606574]	H2UMN9	418	F	L
Q5BKX6	LB/B	-	A0A091D6W0	277	P	L
Q5BKX6	LB/B	-	A0A091D6W0	718	N	D
Q96NT5	LP/P	Hereditary folate malabsorption (HFM) [MIM:229050]	A0A2K5M1D4	113	R	S
Q96NT5	LP/P	Hereditary folate malabsorption (HFM) [MIM:229050]	A0A2K5M1D4	147	G	R
Q96NT5	LP/P	Hereditary folate malabsorption (HFM) [MIM:229050]	A0A2K5M1D4	318	S	R
Q96NT5	LP/P	Hereditary folate malabsorption (HFM) [MIM:229050]	A0A2K5M1D4	376	R	W
Q96NT5	LP/P	Hereditary folate malabsorption (HFM) [MIM:229050]	A0A2K5M1D4	425	P	R
Q96NT5	LB/B	-	A0A2K5M1D4	295	T	A
Q96NT5	LP/P	Hereditary folate malabsorption (HFM) [MIM:229050]	A0A2K5M1D4	113	R	C
Q96NT5	LP/P	Hereditary folate malabsorption (HFM) [MIM:229050]	A0A2K5M1D4	156	D	Y
Q96NT5	LP/P	Hereditary folate malabsorption (HFM) [MIM:229050]	A0A2K5M1D4	335	A	D
Q96NT5	LP/P	Hereditary folate malabsorption (HFM) [MIM:229050]	A0A2K5M1D4	338	G	R
Q96NT5	LP/P	Hereditary folate malabsorption (HFM) [MIM:229050]	A0A2K5M1D4	376	R	Q
Q96NT5	LP/P	Hereditary folate malabsorption (HFM) [MIM:229050]	A0A2K5M1D4	189	G	V
Q96NT5	LP/P	Hereditary folate malabsorption (HFM) [MIM:229050]	A0A2K5M1D4	392	F	V
Q96NT5	LP/P	Hereditary folate malabsorption (HFM) [MIM:229050]	A0A2K5M1D4	411	N	K
Q9BY10	LB/B	-	A0A287ANG2	366	A	V
Q6UXD7	LB/B	-	A0A2J8K721	170	S	P
Q8NBS3	LB/B	-	A0A2U9CJX4	392	Q	H
Q8NBS3	LB/B	-	A0A2U9CJX4	393	K	N
Q8NBS3	LB/B	-	A0A2U9CJX4	467	M	T
Q8NBS3	LB/B	-	A0A2U9CJX4	692	T	A
Q8NBS3	LP/P	Corneal endothelial dystrophy (CHED) [MIM:217700]	A0A2U9CJX4	448	G	D
Q8NBS3	LP/P	Corneal endothelial dystrophy (CHED) [MIM:217700]	A0A2U9CJX4	473	S	L
Q8NBS3	LP/P	Corneal endothelial dystrophy (CHED) [MIM:217700]	A0A2U9CJX4	739	R	Q
Q8NBS3	LP/P	Corneal endothelial dystrophy (CHED) [MIM:217700]	A0A2U9CJX4	853	R	C
Q8NBS3	LB/B	-	A0A2U9CJX4	134	N	S
Q8NBS3	LP/P	Corneal endothelial dystrophy (CHED) [MIM:217700]	A0A2U9CJX4	144	A	T
Q8NBS3	LP/P	Corneal dystrophy and perceptive deafness (CDPD) [MIM:217400]	A0A2U9CJX4	197	S	P
Q8NBS3	LP/P	Corneal dystrophy and perceptive deafness (CDPD) [MIM:217400]	A0A2U9CJX4	472	R	K
Q8NBS3	LP/P	Corneal endothelial dystrophy (CHED) [MIM:217700]	A0A2U9CJX4	788	R	H
Q8NBS3	LP/P	Corneal endothelial dystrophy (CHED) [MIM:217700]	A0A2U9CJX4	808	V	M
Q8NBS3	LP/P	Corneal endothelial dystrophy (CHED) [MIM:217700]	A0A2U9CJX4	817	T	M
Q8NBS3	LP/P	Corneal dystrophy and perceptive deafness (CDPD) [MIM:217400]	A0A2U9CJX4	827	L	P
Q8NBS3	LB/B	-	A0A2U9CJX4	832	M	I
Q8NBS3	LP/P	Corneal dystrophy and perceptive deafness (CDPD) [MIM:217400]	A0A2U9CJX4	840	M	V
Q8NBS3	LP/P	Corneal endothelial dystrophy (CHED) [MIM:217700]	A0A2U9CJX4	853	R	H
Q8NBS3	LB/B	-	A0A2U9CJX4	56	N	T
Q8NBS3	LB/B	-	A0A2U9CJX4	75	M	V
Q8NBS3	LB/B	-	A0A2U9CJX4	311	A	V
Q8NBS3	LP/P	Corneal dystrophy, Fuchs endothelial, 4 (FECD4) [MIM:613268]	A0A2U9CJX4	383	E	K
Q8NBS3	LB/B	-	A0A2U9CJX4	545	T	M
Q8NBS3	LB/B	-	A0A2U9CJX4	549	S	L
Q8NBS3	LP/P	Corneal dystrophy, Fuchs endothelial, 4 (FECD4) [MIM:613268]	A0A2U9CJX4	693	G	E
Q8NBS3	LP/P	Corneal dystrophy, Fuchs endothelial, 4 (FECD4) [MIM:613268]	A0A2U9CJX4	738	T	M
Q8NBS3	LP/P	Corneal endothelial dystrophy (CHED) [MIM:217700]	A0A2U9CJX4	109	R	H
Q8NBS3	LP/P	Corneal endothelial dystrophy (CHED) [MIM:217700]	A0A2U9CJX4	253	A	V
Q8NBS3	LP/P	Corneal endothelial dystrophy (CHED) [MIM:217700]	A0A2U9CJX4	370	C	R
Q8NBS3	LP/P	Corneal endothelial dystrophy (CHED) [MIM:217700]	A0A2U9CJX4	739	R	W
Q8NBS3	LP/P	Corneal endothelial dystrophy (CHED) [MIM:217700]	A0A2U9CJX4	757	P	L
Q8NBS3	LP/P	Corneal endothelial dystrophy (CHED) [MIM:217700]	A0A2U9CJX4	857	L	P
Q8NBS3	LP/P	Corneal dystrophy, Fuchs endothelial, 4 (FECD4) [MIM:613268]	A0A2U9CJX4	151	E	D
Q8NBS3	LP/P	Corneal dystrophy, Fuchs endothelial, 4 (FECD4) [MIM:613268]	A0A2U9CJX4	266	R	P
Q8NBS3	LP/P	Corneal dystrophy, Fuchs endothelial, 4 (FECD4) [MIM:613268]	A0A2U9CJX4	510	Y	C
Q8NBS3	LP/P	Corneal dystrophy, Fuchs endothelial, 4 (FECD4) [MIM:613268]	A0A2U9CJX4	559	V	M
Q8NBS3	LP/P	Corneal dystrophy, Fuchs endothelial, 4 (FECD4) [MIM:613268]	A0A2U9CJX4	567	G	D
Q8NBS3	LP/P	Corneal dystrophy, Fuchs endothelial, 4 (FECD4) [MIM:613268]	A0A2U9CJX4	726	G	R
Q8NBS3	LP/P	Corneal dystrophy, Fuchs endothelial, 4 (FECD4) [MIM:613268]	A0A2U9CJX4	818	G	S
Q8NBS3	LP/P	Corneal endothelial dystrophy (CHED) [MIM:217700]	A0A2U9CJX4	193	R	W
Q8NBS3	LP/P	Corneal endothelial dystrophy (CHED) [MIM:217700]	A0A2U9CJX4	197	S	L
Q8NBS3	LP/P	Corneal endothelial dystrophy (CHED) [MIM:217700]	A0A2U9CJX4	217	R	C
Q8NBS3	LP/P	Corneal endothelial dystrophy (CHED) [MIM:217700]	A0A2U9CJX4	378	G	R
Q8NBS3	LP/P	Corneal endothelial dystrophy (CHED) [MIM:217700]	A0A2U9CJX4	385	T	K
Q8NBS3	LP/P	Corneal endothelial dystrophy (CHED) [MIM:217700]	A0A2U9CJX4	402	G	D
Q8NBS3	LP/P	Corneal endothelial dystrophy (CHED) [MIM:217700]	A0A2U9CJX4	457	L	R
Q8NBS3	LP/P	Corneal endothelial dystrophy (CHED) [MIM:217700]	A0A2U9CJX4	568	T	K
Q8NBS3	LP/P	Corneal endothelial dystrophy (CHED) [MIM:217700]	A0A2U9CJX4	127	E	K
Q8NBS3	LP/P	Corneal endothelial dystrophy (CHED) [MIM:217700]	A0A2U9CJX4	659	E	A
Q8NBS3	LP/P	Corneal dystrophy, Fuchs endothelial, 4 (FECD4) [MIM:613268]	A0A2U9CJX4	224	W	S
Q8NBS3	LP/P	Corneal dystrophy, Fuchs endothelial, 4 (FECD4) [MIM:613268]	A0A2U9CJX4	418	T	I
Q8NBS3	LP/P	Corneal dystrophy, Fuchs endothelial, 4 (FECD4) [MIM:613268]	A0A2U9CJX4	491	V	I
P04920	LB/B	-	G3UD22	26	G	E
P04920	LB/B	-	G3UD22	202	E	V
P04920	LB/B	-	G3UD22	311	R	W
P04920	LB/B	-	G3UD22	1204	L	F
Q9BY07	LB/B	-	L5M336	251	S	N
Q9BY07	LB/B	-	L5M336	253	H	Y
Q9Y6M7	LB/B	-	H2TX43	326	E	K
Q2Y0W8	LB/B	-	H2TX43	312	D	A
Q2Y0W8	LB/B	-	H2TX43	898	I	V
Q86UW1	LB/B	-	A0A2J8RG83	202	V	I
Q9NWF4	LB/B	-	E2RP36	70	Q	R
Q9NWF4	LB/B	-	E2RP36	271	A	V
Q9NWF4	LB/B	-	E2RP36	296	V	M
Q9NWF4	LB/B	-	E2RP36	386	L	V
Q9HAB3	LP/P	Brown-Vialetto-Van Laere syndrome 2 (BVVLS2) [MIM:614707]	E2RP36	306	G	R
Q9HAB3	LP/P	Brown-Vialetto-Van Laere syndrome 2 (BVVLS2) [MIM:614707]	E2RP36	31	W	S
Q9HAB3	LP/P	Brown-Vialetto-Van Laere syndrome 2 (BVVLS2) [MIM:614707]	E2RP36	52	S	F
Q9HAB3	LP/P	Brown-Vialetto-Van Laere syndrome 2 (BVVLS2) [MIM:614707]	E2RP36	123	L	P
Q9HAB3	LP/P	Brown-Vialetto-Van Laere syndrome 2 (BVVLS2) [MIM:614707]	E2RP36	141	P	T
Q9HAB3	LP/P	Brown-Vialetto-Van Laere syndrome 2 (BVVLS2) [MIM:614707]	E2RP36	284	A	D
Q9HAB3	LP/P	Brown-Vialetto-Van Laere syndrome 2 (BVVLS2) [MIM:614707]	E2RP36	305	Y	C
Q9HAB3	LP/P	Brown-Vialetto-Van Laere syndrome 2 (BVVLS2) [MIM:614707]	E2RP36	312	L	P
Q9HAB3	LP/P	Brown-Vialetto-Van Laere syndrome 2 (BVVLS2) [MIM:614707]	E2RP36	339	L	P
Q9HAB3	LP/P	Brown-Vialetto-Van Laere syndrome 2 (BVVLS2) [MIM:614707]	E2RP36	419	G	S
P13866	LP/P	Congenital glucose/galactose malabsorption (GGM) [MIM:606824]	A0A2Y9RC35	28	D	N
P13866	LP/P	Congenital glucose/galactose malabsorption (GGM) [MIM:606824]	A0A2Y9RC35	28	D	G
P13866	LP/P	Congenital glucose/galactose malabsorption (GGM) [MIM:606824]	A0A2Y9RC35	135	R	W
P13866	LP/P	Congenital glucose/galactose malabsorption (GGM) [MIM:606824]	A0A2Y9RC35	318	G	R
P13866	LP/P	Congenital glucose/galactose malabsorption (GGM) [MIM:606824]	A0A2Y9RC35	468	A	V
P13866	LP/P	Congenital glucose/galactose malabsorption (GGM) [MIM:606824]	A0A2Y9RC35	51	N	S
P13866	LP/P	Congenital glucose/galactose malabsorption (GGM) [MIM:606824]	A0A2Y9RC35	411	A	T
P13866	LP/P	Congenital glucose/galactose malabsorption (GGM) [MIM:606824]	A0A2Y9RC35	159	S	P
P13866	LP/P	Congenital glucose/galactose malabsorption (GGM) [MIM:606824]	A0A2Y9RC35	166	A	T
P13866	LP/P	Congenital glucose/galactose malabsorption (GGM) [MIM:606824]	A0A2Y9RC35	276	W	L
P13866	LP/P	Congenital glucose/galactose malabsorption (GGM) [MIM:606824]	A0A2Y9RC35	292	C	Y
P13866	LP/P	Congenital glucose/galactose malabsorption (GGM) [MIM:606824]	A0A2Y9RC35	295	Q	R
P13866	LP/P	Congenital glucose/galactose malabsorption (GGM) [MIM:606824]	A0A2Y9RC35	300	R	S
P13866	LP/P	Congenital glucose/galactose malabsorption (GGM) [MIM:606824]	A0A2Y9RC35	304	A	V
P13866	LP/P	Congenital glucose/galactose malabsorption (GGM) [MIM:606824]	A0A2Y9RC35	369	L	S
P13866	LP/P	Congenital glucose/galactose malabsorption (GGM) [MIM:606824]	A0A2Y9RC35	379	R	Q
P13866	LP/P	Congenital glucose/galactose malabsorption (GGM) [MIM:606824]	A0A2Y9RC35	388	A	V
P13866	LP/P	Congenital glucose/galactose malabsorption (GGM) [MIM:606824]	A0A2Y9RC35	405	F	S
P13866	LP/P	Congenital glucose/galactose malabsorption (GGM) [MIM:606824]	A0A2Y9RC35	426	G	R
P13866	LP/P	Congenital glucose/galactose malabsorption (GGM) [MIM:606824]	A0A2Y9RC35	470	V	N
P13866	LP/P	Congenital glucose/galactose malabsorption (GGM) [MIM:606824]	A0A2Y9RC35	499	R	H
P13866	LP/P	Congenital glucose/galactose malabsorption (GGM) [MIM:606824]	A0A2Y9RC35	615	H	Q
A0PJK1	LB/B	-	H3C6F1	522	A	V
Q8WWX8	LB/B	-	A0A2Y9RC35	182	V	A
Q8WWX8	LB/B	-	A0A2Y9RC35	258	F	L
Q8WWX8	LB/B	-	A0A2Y9RC35	452	Q	R
Q8WWX8	LB/B	-	A0A2Y9RC35	526	M	I
Q8WWX8	LB/B	-	A0A2Y9RC35	47	T	P
Q8WWX8	LB/B	-	A0A2Y9RC35	539	V	M
P31639	LP/P	Renal glucosuria (GLYS) [MIM:233100]	A0A2Y9RC35	654	N	S
Q9NY91	LB/B	-	A0A2Y9RC35	46	A	T
Q9NY91	LB/B	-	A0A2Y9RC35	4	T	M
Q9Y289	LB/B	-	H3C281	481	S	F
Q9Y289	LB/B	-	H3C281	492	S	N
Q9Y289	LP/P	Sodium-dependent multivitamin transporter deficiency (SMVTD) [MIM:618973]	H3C281	123	R	L
Q9Y289	LP/P	Sodium-dependent multivitamin transporter deficiency (SMVTD) [MIM:618973]	H3C281	400	R	T
Q9Y289	LP/P	Peripheral motor neuropathy, childhood-onset, biotin-responsive (COMNB) [MIM:619903]	H3C281	162	Y	C
Q9Y289	LP/P	Peripheral motor neuropathy, childhood-onset, biotin-responsive (COMNB) [MIM:619903]	H3C281	429	S	G
Q9GZV3	LB/B	-	A7RWE4	89	I	V
Q9GZV3	LP/P	Myasthenic syndrome, congenital, 20, presynaptic (CMS20) [MIM:617143]	A7RWE4	48	D	G
Q9GZV3	LP/P	Myasthenic syndrome, congenital, 20, presynaptic (CMS20) [MIM:617143]	A7RWE4	65	G	E
Q9GZV3	LP/P	Myasthenic syndrome, congenital, 20, presynaptic (CMS20) [MIM:617143]	A7RWE4	105	P	S
Q9GZV3	LP/P	Myasthenic syndrome, congenital, 20, presynaptic (CMS20) [MIM:617143]	A7RWE4	111	Y	H
Q9GZV3	LP/P	Myasthenic syndrome, congenital, 20, presynaptic (CMS20) [MIM:617143]	A7RWE4	361	R	Q
Q9GZV3	LP/P	Myasthenic syndrome, congenital, 20, presynaptic (CMS20) [MIM:617143]	A7RWE4	446	R	G
Q2M3M2	LB/B	-	H3C6F1	152	V	M
Q2M3M2	LB/B	-	H3C6F1	207	M	T
Q2M3M2	LB/B	-	H3C6F1	269	I	M
Q2M3M2	LB/B	-	H3C6F1	124	V	I
Q6ZP29	LB/B	-	S7QAR6	16	S	N
P48065	LB/B	-	M7AJU4	10	C	R
Q9NSD5	LB/B	-	A0A1I8HK84	426	V	I
Q9GZN6	LB/B	-	A0A2K6C1P7	108	S	R
Q96N87	LB/B	-	F6WBL5	12	C	S
Q96N87	LB/B	-	F6WBL5	32	T	I
Q96N87	LB/B	-	F6WBL5	478	P	L
Q96N87	LB/B	-	F6WBL5	4	A	D
Q96N87	LB/B	-	F6WBL5	79	G	S
Q96N87	LB/B	-	F6WBL5	496	G	R
Q695T7	LP/P	Hartnup disorder (HND) [MIM:234500]	A0A060YIZ7	57	R	C
Q695T7	LP/P	Hartnup disorder (HND) [MIM:234500]	A0A060YIZ7	173	D	N
Q695T7	LP/P	Hartnup disorder (HND) [MIM:234500]	A0A060YIZ7	240	R	Q
Q695T7	LP/P	Hartnup disorder (HND) [MIM:234500]	A0A060YIZ7	242	L	P
Q695T7	LB/B	-	A0A060YIZ7	252	V	I
Q695T7	LP/P	Hartnup disorder (HND) [MIM:234500]	A0A060YIZ7	501	E	K
Q695T7	LP/P	Hartnup disorder (HND) [MIM:234500]	A0A060YIZ7	66	G	R
Q695T7	LP/P	Hartnup disorder (HND) [MIM:234500]	A0A060YIZ7	69	A	T
Q695T7	LP/P	Hartnup disorder (HND) [MIM:234500]	A0A060YIZ7	93	G	R
Q695T7	LP/P	Hartnup disorder (HND) [MIM:234500]	A0A060YIZ7	265	P	L
Q695T7	LP/P	Hartnup disorder (HND) [MIM:234500]	A0A060YIZ7	284	G	R
Q695T7	LP/P	Hartnup disorder (HND) [MIM:234500]	A0A060YIZ7	328	R	C
Q695T7	LP/P	Hartnup disorder (HND) [MIM:234500]	A0A060YIZ7	405	E	K
Q695T7	LP/P	Hartnup disorder (HND) [MIM:234500]	A0A060YIZ7	517	D	G
Q695T7	LP/P	Hartnup disorder (HND) [MIM:234500]	A0A060YIZ7	579	P	L
P31645	LB/B	-	G1SK44	56	G	A
P31645	LB/B	-	G1SK44	605	K	N
P31645	LB/B	-	G1SK44	425	I	V
P31645	LB/B	-	G1SK44	201	K	N
P31645	LB/B	-	G1SK44	425	I	L
P31645	LB/B	-	G1SK44	465	F	L
P31645	LB/B	-	G1SK44	550	L	V
Q9Y345	LB/B	-	G5AR25	463	D	N
Q9Y345	LB/B	-	G5AR25	89	A	E
Q9Y345	LB/B	-	G5AR25	102	G	S
Q9Y345	LB/B	-	G5AR25	124	F	S
Q9Y345	LB/B	-	G5AR25	132	A	G
Q9Y345	LB/B	-	G5AR25	162	A	G
Q9Y345	LP/P	Hyperekplexia 3 (HKPX3) [MIM:614618]	G5AR25	306	L	V
Q9Y345	LP/P	Hyperekplexia 3 (HKPX3) [MIM:614618]	G5AR25	425	T	M
Q9Y345	LB/B	-	G5AR25	457	K	N
Q9Y345	LP/P	Hyperekplexia 3 (HKPX3) [MIM:614618]	G5AR25	482	W	C
Q9Y345	LP/P	Hyperekplexia 3 (HKPX3) [MIM:614618]	G5AR25	491	Y	C
Q9Y345	LB/B	-	G5AR25	499	Y	F
Q9Y345	LP/P	Hyperekplexia 3 (HKPX3) [MIM:614618]	G5AR25	509	N	S
Q9Y345	LP/P	Hyperekplexia 3 (HKPX3) [MIM:614618]	G5AR25	510	S	R
Q9Y345	LB/B	-	G5AR25	767	G	R
Q9Y345	LP/P	Hyperekplexia 3 (HKPX3) [MIM:614618]	G5AR25	429	P	L
Q9Y345	LB/B	-	G5AR25	705	Y	C
Q99884	LB/B	-	A0A0P0LE73	345	L	V
Q9NS82	LB/B	-	A0A091DG23	112	E	D
Q9NS82	LB/B	-	A0A091DG23	413	R	Q
Q8TCU3	LB/B	-	I3LIX2	249	V	M
Q8TCU3	LB/B	-	I3LIX2	380	R	K
Q8TCU3	LB/B	-	I3LIX2	452	M	T
Q8TCU3	LB/B	-	I3LIX2	470	E	K
Q8TBB6	LP/P	Retinitis pigmentosa 68 (RP68) [MIM:615725]	A0A1V4K3L6	330	G	R
Q8TBB6	LP/P	Retinitis pigmentosa 68 (RP68) [MIM:615725]	A0A1V4K3L6	132	A	V
Q8TBB6	LP/P	Retinitis pigmentosa 68 (RP68) [MIM:615725]	A0A1V4K3L6	464	C	F
Q8TBB6	LP/P	Retinitis pigmentosa 68 (RP68) [MIM:615725]	A0A1V4K3L6	708	F	V
P52569	LB/B	-	A0A218VG33	20	V	M
P52569	LB/B	-	A0A218VG33	376	C	F
P52569	LB/B	-	A0A218VG33	531	A	T
P52569	LB/B	-	A0A218VG33	547	Q	L
Q8WY07	LB/B	-	A0A218VG33	508	L	V
O43246	LB/B	-	A0A146Y3H2	28	T	I
O43246	LB/B	-	A0A146Y3H2	349	A	T
O43246	LB/B	-	A0A146Y3H2	608	F	Y
Q01650	LB/B	-	A0A2D0RK95	230	N	K
Q01650	LB/B	-	A0A2D0RK95	223	D	V
Q96CW6	LB/B	-	H3A346	24	V	M
Q96CW6	LB/B	-	H3A346	45	G	D
Q96CW6	LB/B	-	H3A346	116	S	A
Q96CW6	LB/B	-	H3A346	220	Y	C
Q96CW6	LP/P	Epilepsy, progressive myoclonic 12 (EPM12) [MIM:619191]	H3A346	64	Q	R
Q9UM01	LP/P	Lysinuric protein intolerance (LPI) [MIM:222700]	S9XB09	54	G	V
Q9UM01	LP/P	Lysinuric protein intolerance (LPI) [MIM:222700]	S9XB09	334	L	R
Q9UM01	LP/P	Lysinuric protein intolerance (LPI) [MIM:222700]	S9XB09	338	G	D
Q9UM01	LP/P	Lysinuric protein intolerance (LPI) [MIM:222700]	S9XB09	386	S	R
Q9UM01	LP/P	Lysinuric protein intolerance (LPI) [MIM:222700]	S9XB09	50	M	K
Q9UM01	LP/P	Lysinuric protein intolerance (LPI) [MIM:222700]	S9XB09	188	T	I
Q9UM01	LP/P	Lysinuric protein intolerance (LPI) [MIM:222700]	S9XB09	238	S	F
Q9UM01	LP/P	Lysinuric protein intolerance (LPI) [MIM:222700]	S9XB09	333	R	M
Q9UM01	LP/P	Lysinuric protein intolerance (LPI) [MIM:222700]	S9XB09	489	S	P
Q9UM01	LP/P	Lysinuric protein intolerance (LPI) [MIM:222700]	S9XB09	5	T	I
Q9UM01	LP/P	Lysinuric protein intolerance (LPI) [MIM:222700]	S9XB09	53	S	L
Q9UM01	LB/B	-	S9XB09	91	A	V
Q9UM01	LP/P	Lysinuric protein intolerance (LPI) [MIM:222700]	S9XB09	124	L	P
Q9UM01	LP/P	Lysinuric protein intolerance (LPI) [MIM:222700]	S9XB09	140	A	P
Q9UM01	LP/P	Lysinuric protein intolerance (LPI) [MIM:222700]	S9XB09	152	F	L
Q9UM01	LB/B	-	S9XB09	159	R	C
Q9UM01	LP/P	Lysinuric protein intolerance (LPI) [MIM:222700]	S9XB09	191	K	E
Q9UM01	LP/P	Lysinuric protein intolerance (LPI) [MIM:222700]	S9XB09	251	E	D
Q9UM01	LP/P	Lysinuric protein intolerance (LPI) [MIM:222700]	S9XB09	261	L	P
Q9UM01	LP/P	Lysinuric protein intolerance (LPI) [MIM:222700]	S9XB09	365	N	Y
P82251	LP/P	Cystinuria (CSNU) [MIM:220100]	A0A212F3Y6	105	G	R
P82251	LP/P	Cystinuria (CSNU) [MIM:220100]	A0A212F3Y6	170	V	M
P82251	LP/P	Cystinuria (CSNU) [MIM:220100]	A0A212F3Y6	182	A	T
P82251	LP/P	Cystinuria (CSNU) [MIM:220100]	A0A212F3Y6	195	G	R
P82251	LP/P	Cystinuria (CSNU) [MIM:220100]	A0A212F3Y6	259	G	R
P82251	LP/P	Cystinuria (CSNU) [MIM:220100]	A0A212F3Y6	44	I	T
P82251	LP/P	Cystinuria (CSNU) [MIM:220100]	A0A212F3Y6	261	P	L
P82251	LP/P	Cystinuria (CSNU) [MIM:220100]	A0A212F3Y6	354	A	T
P82251	LP/P	Cystinuria (CSNU) [MIM:220100]	A0A212F3Y6	330	V	M
P82251	LP/P	Cystinuria (CSNU) [MIM:220100]	A0A212F3Y6	52	P	L
P82251	LP/P	Cystinuria (CSNU) [MIM:220100]	A0A212F3Y6	63	G	R
P82251	LP/P	Cystinuria (CSNU) [MIM:220100]	A0A212F3Y6	69	W	L
P82251	LP/P	Cystinuria (CSNU) [MIM:220100]	A0A212F3Y6	70	A	V
P82251	LP/P	Cystinuria (CSNU) [MIM:220100]	A0A212F3Y6	123	T	M
P82251	LP/P	Cystinuria (CSNU) [MIM:220100]	A0A212F3Y6	126	A	T
P82251	LP/P	Cystinuria (CSNU) [MIM:220100]	A0A212F3Y6	187	I	F
P82251	LB/B	-	A0A212F3Y6	223	L	M
P82251	LP/P	Cystinuria (CSNU) [MIM:220100]	A0A212F3Y6	230	W	R
P82251	LP/P	Cystinuria (CSNU) [MIM:220100]	A0A212F3Y6	241	I	T
P82251	LP/P	Cystinuria (CSNU) [MIM:220100]	A0A212F3Y6	333	R	W
P82251	LP/P	Cystinuria (CSNU) [MIM:220100]	A0A212F3Y6	379	S	R
P82251	LP/P	Cystinuria (CSNU) [MIM:220100]	A0A212F3Y6	382	A	T
P82251	LP/P	Cystinuria (CSNU) [MIM:220100]	A0A212F3Y6	224	A	V
P82251	LP/P	Cystinuria (CSNU) [MIM:220100]	A0A212F3Y6	331	A	V
P82251	LB/B	-	A0A212F3Y6	142	V	A
P82251	LP/P	Cystinuria (CSNU) [MIM:220100]	A0A212F3Y6	62	V	M
P82251	LP/P	Cystinuria (CSNU) [MIM:220100]	A0A212F3Y6	105	G	E
P82251	LP/P	Cystinuria (CSNU) [MIM:220100]	A0A212F3Y6	188	V	M
P82251	LP/P	Cystinuria (CSNU) [MIM:220100]	A0A212F3Y6	227	N	D
P82251	LP/P	Cystinuria (CSNU) [MIM:220100]	A0A212F3Y6	232	Y	C
P82251	LP/P	Cystinuria (CSNU) [MIM:220100]	A0A212F3Y6	250	R	K
P82251	LP/P	Cystinuria (CSNU) [MIM:220100]	A0A212F3Y6	283	L	F
P82251	LP/P	Cystinuria (CSNU) [MIM:220100]	A0A212F3Y6	316	A	V
P82251	LP/P	Cystinuria (CSNU) [MIM:220100]	A0A212F3Y6	319	G	R
P82251	LP/P	Cystinuria (CSNU) [MIM:220100]	A0A212F3Y6	333	R	Q
P82251	LP/P	Cystinuria (CSNU) [MIM:220100]	A0A212F3Y6	482	P	L
P32418	LB/B	-	O02196	692	E	V
Q9UPR5	LB/B	-	O02196	429	V	L
Q6J4K2	LB/B	-	A0A2U4CK72	222	R	C
Q6J4K2	LB/B	-	A0A2U4CK72	358	L	F
Q6AI14	LB/B	-	F7F984	116	G	S
Q6AI14	LB/B	-	F7F984	581	I	V
Q92581	LP/P	Intellectual developmental disorder, X-linked, syndromic, Christianson type (MRXSCH) [MIM:300243]	A0A1S3FAC5	218	G	R
Q92581	LP/P	Intellectual developmental disorder, X-linked, syndromic, Christianson type (MRXSCH) [MIM:300243]	A0A1S3FAC5	188	L	P
Q92581	LP/P	Intellectual developmental disorder, X-linked, syndromic, Christianson type (MRXSCH) [MIM:300243]	A0A1S3FAC5	383	G	D
Q96T83	LP/P	Intellectual developmental disorder, X-linked 108 (MRX108) [MIM:301024]	A0A1S3FAC5	515	L	F
Q8IVB4	LB/B	-	A0A1S3FAC5	589	I	V
Q8IVB4	LB/B	-	A0A1S3FAC5	540	I	V
Q4ZJI4	LB/B	-	G3RZ79	33	Q	H
Q86UD5	LB/B	-	A0A151NMD8	159	I	T
Q86UD5	LB/B	-	A0A151NMD8	161	V	A
Q86UD5	LB/B	-	A0A151NMD8	357	F	C
Q5TAH2	LB/B	-	L9JGX7	481	T	M
Q5TAH2	LB/B	-	L9JGX7	505	A	G
Q5TAH2	LB/B	-	L9JGX7	934	R	S
P46721	LB/B	-	W5KDI0	128	N	Y
P46721	LB/B	-	W5KDI0	135	N	I
P46721	LB/B	-	W5KDI0	172	E	D
P46721	LB/B	-	W5KDI0	355	I	V
P46721	LB/B	-	W5KDI0	668	T	S
P46721	LB/B	-	W5KDI0	13	I	T
P46721	LB/B	-	W5KDI0	187	A	T
Q9Y6L6	LB/B	-	L9KCK1	73	F	L
Q9Y6L6	LB/B	-	L9KCK1	82	V	A
Q9Y6L6	LB/B	-	L9KCK1	130	N	D
Q9Y6L6	LB/B	-	L9KCK1	152	R	K
Q9Y6L6	LB/B	-	L9KCK1	155	P	T
Q9Y6L6	LB/B	-	L9KCK1	156	E	G
Q9Y6L6	LB/B	-	L9KCK1	174	V	A
Q9Y6L6	LB/B	-	L9KCK1	193	L	R
Q9Y6L6	LB/B	-	L9KCK1	241	D	N
Q9Y6L6	LB/B	-	L9KCK1	353	I	T
Q9Y6L6	LB/B	-	L9KCK1	432	N	D
Q9Y6L6	LB/B	-	L9KCK1	462	D	G
Q9Y6L6	LB/B	-	L9KCK1	488	G	A
Q9Y6L6	LB/B	-	L9KCK1	655	D	G
Q9Y6L6	LB/B	-	L9KCK1	667	E	G
Q9Y6L6	LB/B	-	L9KCK1	151	N	S
Q9Y6L6	LB/B	-	L9KCK1	643	L	F
Q9Y6L6	LB/B	-	L9KCK1	245	I	V
Q9NPD5	LB/B	-	L9KCK1	112	S	A
Q9NPD5	LB/B	-	L9KCK1	233	M	I
Q9NPD5	LB/B	-	L9KCK1	560	V	A
Q9NPD5	LB/B	-	L9KCK1	256	G	A
Q92959	LB/B	-	A0A2I0TN35	396	A	T
Q92959	LP/P	Hypertrophic osteoarthropathy, primary, autosomal dominant (PHOAD) [MIM:167100]	A0A2I0TN35	222	G	R
Q92959	LP/P	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 (PHOAR2) [MIM:614441]	A0A2I0TN35	222	G	R
Q92959	LP/P	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 (PHOAR2) [MIM:614441]	A0A2I0TN35	255	G	E
Q92959	LP/P	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 (PHOAR2) [MIM:614441]	A0A2I0TN35	557	F	S
Q92959	LP/P	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 (PHOAR2) [MIM:614441]	A0A2I0TN35	85	I	F
Q92959	LP/P	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 (PHOAR2) [MIM:614441]	A0A2I0TN35	97	R	H
Q92959	LP/P	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 (PHOAR2) [MIM:614441]	A0A2I0TN35	181	G	A
Q92959	LP/P	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 (PHOAR2) [MIM:614441]	A0A2I0TN35	181	G	D
Q92959	LP/P	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 (PHOAR2) [MIM:614441]	A0A2I0TN35	204	S	L
Q92959	LP/P	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 (PHOAR2) [MIM:614441]	A0A2I0TN35	255	G	R
Q92959	LP/P	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 (PHOAR2) [MIM:614441]	A0A2I0TN35	420	C	F
Q92959	LB/B	-	A0A2I0TN35	445	R	C
Q92959	LP/P	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 (PHOAR2) [MIM:614441]	A0A2I0TN35	556	Q	H
Q92959	LP/P	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 (PHOAR2) [MIM:614441]	A0A2I0TN35	565	W	G
Q92959	LP/P	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 (PHOAR2) [MIM:614441]	A0A2I0TN35	181	G	R
O94956	LB/B	-	H2UZP3	486	S	F
O94956	LB/B	-	H2UZP3	201	V	M
O94956	LB/B	-	H2UZP3	312	R	Q
O94956	LB/B	-	H2UZP3	392	I	T
Q9UIG8	LB/B	-	R7UW06	294	E	D
Q8IX21	LB/B	-	F1N9I2	541	S	Y
Q7Z7L1	LB/B	-	A0A1G5SJR4	121	V	F
Q7Z7L1	LB/B	-	A0A1G5SJR4	301	N	D
Q7Z7L1	LB/B	-	A0A1G5SJR4	822	Y	C
Q7Z7L1	LB/B	-	A0A1G5SJR4	489	R	L
Q8IYM2	LB/B	-	A0A2Y9RJV2	43	S	R
Q8IYM2	LB/B	-	A0A2Y9RJV2	168	C	R
Q8IYM2	LB/B	-	A0A2Y9RJV2	448	S	P
Q6IEE8	LB/B	-	A0A2Y9RJV2	275	L	S
Q6IEE8	LB/B	-	A0A2Y9RJV2	373	A	G
Q6IEE8	LB/B	-	A0A2Y9RJV2	430	C	Y
Q6IEE8	LB/B	-	A0A2Y9RJV2	518	Y	S
Q68D06	LB/B	-	A0A1G5SJR4	4	N	S
Q68D06	LB/B	-	A0A1G5SJR4	50	A	T
Q68D06	LB/B	-	A0A1G5SJR4	652	E	K
Q68D06	LB/B	-	A0A1G5SJR4	433	P	L
Q68D06	LB/B	-	A0A1G5SJR4	642	D	V
P0C7P3	LB/B	-	A0A1G5SJR4	93	Q	R
P0C7P3	LB/B	-	A0A1G5SJR4	385	K	E
P0C7P3	LB/B	-	A0A1G5SJR4	870	G	S
P0C7P3	LB/B	-	A0A1G5SJR4	880	S	I
P0C7P3	LB/B	-	A0A1G5SJR4	905	L	F
P0C7P3	LB/B	-	A0A1G5SJR4	912	Y	F
P0C7P3	LP/P	Bleeding disorder, platelet-type, 20 (BDPLT20) [MIM:616913]	A0A1G5SJR4	218	K	E
P0C7P3	LP/P	Bleeding disorder, platelet-type, 20 (BDPLT20) [MIM:616913]	A0A1G5SJR4	219	K	N
P0C7P3	LP/P	Bleeding disorder, platelet-type, 20 (BDPLT20) [MIM:616913]	A0A1G5SJR4	220	V	D
P0C7P3	LP/P	Bleeding disorder, platelet-type, 20 (BDPLT20) [MIM:616913]	A0A1G5SJR4	223	R	W
Q08AF3	LB/B	-	A0A1G5SJR4	787	P	L
Q08AF3	LB/B	-	A0A1G5SJR4	797	A	V
Q08AF3	LB/B	-	A0A1G5SJR4	754	V	L
Q499Z3	LB/B	-	H9GNR9	30	A	T
Q499Z3	LB/B	-	H9GNR9	128	R	S
Q499Z3	LB/B	-	H9GNR9	144	R	T
O75093	LB/B	-	A0A0Q3ME83	824	P	L
O94813	LB/B	-	A0A0Q3ME83	636	S	P
O94813	LB/B	-	A0A0Q3ME83	1277	S	F
Q96PX8	LB/B	-	W5NMM3	552	L	M
Q96PX8	LP/P	-	W5NMM3	400	N	I
Q96PX8	LP/P	-	W5NMM3	418	T	S
Q9H156	LB/B	-	G1KU71	601	S	P
O94933	LB/B	-	G1KU71	605	I	V
Q9H5Y7	LB/B	-	G1KU71	25	L	F
Q9H5Y7	LB/B	-	G1KU71	315	P	R
Q9H5Y7	LB/B	-	G1KU71	414	Q	R
Q9H2G2	LB/B	-	A0A1S3L661	552	C	Y
Q9H2G2	LB/B	-	A0A1S3L661	658	A	G
Q9H2G2	LB/B	-	A0A1S3L661	679	I	T
Q9H2G2	LB/B	-	A0A1S3L661	683	K	N
Q9H2G2	LB/B	-	A0A1S3L661	697	T	I
Q9H2G2	LB/B	-	A0A1S3L661	666	G	E
Q8IY92	LB/B	-	A0A2U4AR22	1122	P	L
Q8IY92	LB/B	-	A0A2U4AR22	1271	S	F
Q8IY92	LB/B	-	A0A2U4AR22	1221	A	V
Q8IY92	LB/B	-	A0A2U4AR22	1367	A	T
Q8IY92	LB/B	-	A0A2U4AR22	1677	P	S
Q8IY92	LB/B	-	A0A2U4AR22	38	L	F
Q8IY92	LB/B	-	A0A2U4AR22	141	G	W
Q8IY92	LB/B	-	A0A2U4AR22	197	V	A
Q8IY92	LB/B	-	A0A2U4AR22	204	R	C
Q8IY92	LB/B	-	A0A2U4AR22	237	R	Q
Q8IY92	LB/B	-	A0A2U4AR22	284	H	R
Q8IY92	LB/B	-	A0A2U4AR22	378	P	T
Q8IY92	LB/B	-	A0A2U4AR22	385	P	T
Q8IY92	LB/B	-	A0A2U4AR22	386	M	V
Q8IY92	LB/B	-	A0A2U4AR22	424	A	V
Q8IY92	LB/B	-	A0A2U4AR22	457	N	K
Q8IY92	LB/B	-	A0A2U4AR22	458	K	E
Q8IY92	LB/B	-	A0A2U4AR22	505	A	T
Q8IY92	LB/B	-	A0A2U4AR22	506	S	N
Q8IY92	LB/B	-	A0A2U4AR22	568	V	M
Q8IY92	LB/B	-	A0A2U4AR22	579	L	P
Q8IY92	LB/B	-	A0A2U4AR22	671	L	S
Q8IY92	LB/B	-	A0A2U4AR22	787	E	K
Q8IY92	LB/B	-	A0A2U4AR22	870	A	V
Q8IY92	LB/B	-	A0A2U4AR22	894	V	G
Q8IY92	LB/B	-	A0A2U4AR22	929	P	L
Q8IY92	LB/B	-	A0A2U4AR22	942	E	Q
Q8IY92	LB/B	-	A0A2U4AR22	952	A	M
Q8IY92	LB/B	-	A0A2U4AR22	975	P	L
Q8IY92	LB/B	-	A0A2U4AR22	1007	Q	K
Q8IY92	LB/B	-	A0A2U4AR22	1060	R	W
Q8IY92	LB/B	-	A0A2U4AR22	1123	S	Y
Q8IY92	LB/B	-	A0A2U4AR22	1286	A	V
Q8IY92	LB/B	-	A0A2U4AR22	1287	V	G
Q8IY92	LB/B	-	A0A2U4AR22	1342	S	G
Q8IY92	LB/B	-	A0A2U4AR22	1421	I	F
Q8IY92	LB/B	-	A0A2U4AR22	1476	T	S
Q8IY92	LB/B	-	A0A2U4AR22	1550	R	W
Q8IY92	LB/B	-	A0A2U4AR22	1694	A	V
Q8IY92	LB/B	-	A0A2U4AR22	1814	R	C
Q8IY92	LB/B	-	A0A2U4AR22	1834	N	S
Q15796	LP/P	Congenital heart defects, multiple types, 8, with or without heterotaxy (CHTD8) [MIM:619657]	L5KEQ5	274	W	C
Q15796	LP/P	Congenital heart defects, multiple types, 8, with or without heterotaxy (CHTD8) [MIM:619657]	L5KEQ5	312	C	S
Q15796	LP/P	Loeys-Dietz syndrome 6 (LDS6) [MIM:619656]	L5KEQ5	457	G	R
P84022	LB/B	-	F7I1B6	170	I	V
P84022	LP/P	Loeys-Dietz syndrome 3 (LDS3) [MIM:613795]	F7I1B6	261	T	I
P84022	LP/P	Loeys-Dietz syndrome 3 (LDS3) [MIM:613795]	F7I1B6	287	R	W
P84022	LP/P	Loeys-Dietz syndrome 3 (LDS3) [MIM:613795]	F7I1B6	239	E	K
P84022	LP/P	Loeys-Dietz syndrome 3 (LDS3) [MIM:613795]	F7I1B6	279	R	K
P84022	LP/P	Loeys-Dietz syndrome 3 (LDS3) [MIM:613795]	F7I1B6	112	A	V
Q13485	LP/P	Juvenile polyposis syndrome (JPS) [MIM:174900]	A0A1Y1M8L8	352	G	R
Q13485	LP/P	Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome (JP/HHT) [MIM:175050]	A0A1Y1M8L8	352	G	R
Q13485	LP/P	Juvenile polyposis syndrome (JPS) [MIM:174900]	A0A1Y1M8L8	361	R	C
Q13485	LP/P	Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome (JP/HHT) [MIM:175050]	A0A1Y1M8L8	386	G	D
Q13485	LP/P	Juvenile polyposis syndrome (JPS) [MIM:174900]	A0A1Y1M8L8	330	E	G
Q13485	LP/P	Myhre syndrome (MYHRS) [MIM:139210]	A0A1Y1M8L8	500	I	M
Q13485	LP/P	Myhre syndrome (MYHRS) [MIM:139210]	A0A1Y1M8L8	500	I	T
Q13485	LP/P	Myhre syndrome (MYHRS) [MIM:139210]	A0A1Y1M8L8	500	I	V
Q9Y6J3	LB/B	-	A0A2K5JTB3	85	K	N
O43541	LB/B	-	W5K5U3	325	A	T
O43541	LP/P	Aortic valve disease 2 (AOVD2) [MIM:614823]	W5K5U3	415	P	L
O43541	LP/P	Aortic valve disease 2 (AOVD2) [MIM:614823]	W5K5U3	484	C	F
O43541	LP/P	Craniosynostosis 7 (CRS7) [MIM:617439]	W5K5U3	306	T	A
O43541	LP/P	Craniosynostosis 7 (CRS7) [MIM:617439]	W5K5U3	323	P	L
O43541	LP/P	Craniosynostosis 7 (CRS7) [MIM:617439]	W5K5U3	390	G	C
O43541	LP/P	Craniosynostosis 7 (CRS7) [MIM:617439]	W5K5U3	465	R	C
O43541	LP/P	Craniosynostosis 7 (CRS7) [MIM:617439]	W5K5U3	490	I	T
O15198	LP/P	Pulmonary hypertension, primary, 2 (PPH2) [MIM:615342]	L5KEQ5	43	K	E
Q8WU79	LB/B	-	L8Y7Z6	289	A	T
P28370	LB/B	-	A2RUY6	656	Q	R
P51531	LB/B	-	A0A1S3R976	1416	G	A
P51531	LB/B	-	A0A1S3R976	1546	D	E
P51531	LP/P	Nicolaides-Baraitser syndrome (NCBRS) [MIM:601358]	A0A1S3R976	752	G	A
P51531	LP/P	Nicolaides-Baraitser syndrome (NCBRS) [MIM:601358]	A0A1S3R976	755	K	R
P51531	LP/P	Nicolaides-Baraitser syndrome (NCBRS) [MIM:601358]	A0A1S3R976	756	T	I
P51531	LP/P	Nicolaides-Baraitser syndrome (NCBRS) [MIM:601358]	A0A1S3R976	851	D	H
P51531	LP/P	Nicolaides-Baraitser syndrome (NCBRS) [MIM:601358]	A0A1S3R976	852	E	D
P51531	LP/P	Nicolaides-Baraitser syndrome (NCBRS) [MIM:601358]	A0A1S3R976	852	E	K
P51531	LP/P	Nicolaides-Baraitser syndrome (NCBRS) [MIM:601358]	A0A1S3R976	854	H	N
P51531	LP/P	Nicolaides-Baraitser syndrome (NCBRS) [MIM:601358]	A0A1S3R976	854	H	R
P51531	LP/P	Nicolaides-Baraitser syndrome (NCBRS) [MIM:601358]	A0A1S3R976	855	R	G
P51531	LP/P	Nicolaides-Baraitser syndrome (NCBRS) [MIM:601358]	A0A1S3R976	881	G	R
P51531	LP/P	Nicolaides-Baraitser syndrome (NCBRS) [MIM:601358]	A0A1S3R976	881	G	V
P51531	LP/P	Nicolaides-Baraitser syndrome (NCBRS) [MIM:601358]	A0A1S3R976	883	P	L
P51531	LP/P	Nicolaides-Baraitser syndrome (NCBRS) [MIM:601358]	A0A1S3R976	939	H	Y
P51531	LP/P	Nicolaides-Baraitser syndrome (NCBRS) [MIM:601358]	A0A1S3R976	946	L	F
P51531	LP/P	Nicolaides-Baraitser syndrome (NCBRS) [MIM:601358]	A0A1S3R976	946	L	S
P51531	LP/P	Nicolaides-Baraitser syndrome (NCBRS) [MIM:601358]	A0A1S3R976	1105	R	C
P51531	LP/P	Nicolaides-Baraitser syndrome (NCBRS) [MIM:601358]	A0A1S3R976	1105	R	P
P51531	LP/P	Nicolaides-Baraitser syndrome (NCBRS) [MIM:601358]	A0A1S3R976	1135	L	P
P51531	LP/P	Nicolaides-Baraitser syndrome (NCBRS) [MIM:601358]	A0A1S3R976	1146	S	R
P51531	LP/P	Nicolaides-Baraitser syndrome (NCBRS) [MIM:601358]	A0A1S3R976	1158	D	V
P51531	LP/P	Nicolaides-Baraitser syndrome (NCBRS) [MIM:601358]	A0A1S3R976	1159	R	G
P51531	LP/P	Nicolaides-Baraitser syndrome (NCBRS) [MIM:601358]	A0A1S3R976	1159	R	L
P51531	LP/P	Nicolaides-Baraitser syndrome (NCBRS) [MIM:601358]	A0A1S3R976	1159	R	Q
P51531	LP/P	Nicolaides-Baraitser syndrome (NCBRS) [MIM:601358]	A0A1S3R976	1162	R	H
P51531	LP/P	Nicolaides-Baraitser syndrome (NCBRS) [MIM:601358]	A0A1S3R976	1188	A	P
P51531	LP/P	Nicolaides-Baraitser syndrome (NCBRS) [MIM:601358]	A0A1S3R976	1201	A	V
P51531	LP/P	Nicolaides-Baraitser syndrome (NCBRS) [MIM:601358]	A0A1S3R976	1202	G	C
P51531	LP/P	Nicolaides-Baraitser syndrome (NCBRS) [MIM:601358]	A0A1S3R976	1205	D	G
P51531	LP/P	Nicolaides-Baraitser syndrome (NCBRS) [MIM:601358]	A0A1S3R976	1213	R	W
P51531	LP/P	Nicolaides-Baraitser syndrome (NCBRS) [MIM:601358]	A0A1S3R976	855	R	Q
P51531	LP/P	Nicolaides-Baraitser syndrome (NCBRS) [MIM:601358]	A0A1S3R976	880	T	I
P51531	LP/P	Nicolaides-Baraitser syndrome (NCBRS) [MIM:601358]	A0A1S3R976	1241	Q	E
P51531	LP/P	-	A0A1S3R976	484	H	N
P51531	LP/P	-	A0A1S3R976	486	N	K
P51531	LP/P	Blepharophimosis-impaired intellectual development syndrome (BIS) [MIM:619293]	A0A1S3R976	505	R	Q
P51531	LP/P	Blepharophimosis-impaired intellectual development syndrome (BIS) [MIM:619293]	A0A1S3R976	513	G	V
P51531	LP/P	Blepharophimosis-impaired intellectual development syndrome (BIS) [MIM:619293]	A0A1S3R976	525	R	C
P51531	LP/P	Blepharophimosis-impaired intellectual development syndrome (BIS) [MIM:619293]	A0A1S3R976	525	R	H
P51531	LP/P	Blepharophimosis-impaired intellectual development syndrome (BIS) [MIM:619293]	A0A1S3R976	529	L	V
P51531	LP/P	Blepharophimosis-impaired intellectual development syndrome (BIS) [MIM:619293]	A0A1S3R976	534	D	N
P51531	LP/P	-	A0A1S3R976	719	L	P
P51531	LP/P	Blepharophimosis-impaired intellectual development syndrome (BIS) [MIM:619293]	A0A1S3R976	929	E	V
P51531	LP/P	-	A0A1S3R976	932	I	T
P51531	LP/P	Blepharophimosis-impaired intellectual development syndrome (BIS) [MIM:619293]	A0A1S3R976	937	R	C
P51531	LP/P	Blepharophimosis-impaired intellectual development syndrome (BIS) [MIM:619293]	A0A1S3R976	937	R	H
P51531	LP/P	Blepharophimosis-impaired intellectual development syndrome (BIS) [MIM:619293]	A0A1S3R976	937	R	L
P51531	LP/P	-	A0A1S3R976	1014	K	E
P51532	LB/B	-	A0A1S3R976	561	V	E
P51532	LB/B	-	A0A1S3R976	1036	M	I
P51532	LP/P	Coffin-Siris syndrome 4 (CSS4) [MIM:614609]	A0A1S3R976	859	T	M
P51532	LP/P	Coffin-Siris syndrome 4 (CSS4) [MIM:614609]	A0A1S3R976	885	R	C
P51532	LP/P	Coffin-Siris syndrome 4 (CSS4) [MIM:614609]	A0A1S3R976	921	L	F
P51532	LP/P	Coffin-Siris syndrome 4 (CSS4) [MIM:614609]	A0A1S3R976	1011	M	T
P51532	LP/P	Coffin-Siris syndrome 4 (CSS4) [MIM:614609]	A0A1S3R976	1157	R	G
Q9H4L7	LB/B	-	L5LY36	66	S	F
Q9H4L7	LB/B	-	L5LY36	135	L	F
Q9H4L7	LB/B	-	L5LY36	140	R	C
Q9H4L7	LB/B	-	L5LY36	245	S	Y
Q9H4L7	LB/B	-	L5LY36	247	S	N
Q9H4L7	LB/B	-	L5LY36	301	V	A
Q9H4L7	LB/B	-	L5LY36	351	P	Q
Q9H4L7	LB/B	-	L5LY36	972	V	A
Q9NZC9	LB/B	-	G3H3Z4	43	A	T
Q9NZC9	LB/B	-	G3H3Z4	114	R	H
Q9NZC9	LB/B	-	G3H3Z4	207	I	F
Q9NZC9	LB/B	-	G3H3Z4	315	S	R
Q9NZC9	LB/B	-	G3H3Z4	377	E	Q
Q9NZC9	LB/B	-	G3H3Z4	424	D	V
Q9NZC9	LP/P	Schimke immuno-osseous dysplasia (SIOD) [MIM:242900]	G3H3Z4	468	A	P
Q9NZC9	LP/P	Schimke immuno-osseous dysplasia (SIOD) [MIM:242900]	G3H3Z4	548	I	N
Q9NZC9	LP/P	Schimke immuno-osseous dysplasia (SIOD) [MIM:242900]	G3H3Z4	579	S	L
Q9NZC9	LP/P	Schimke immuno-osseous dysplasia (SIOD) [MIM:242900]	G3H3Z4	586	R	W
Q9NZC9	LP/P	Schimke immuno-osseous dysplasia (SIOD) [MIM:242900]	G3H3Z4	644	R	W
Q9NZC9	LP/P	Schimke immuno-osseous dysplasia (SIOD) [MIM:242900]	G3H3Z4	645	R	C
Q9NZC9	LP/P	Schimke immuno-osseous dysplasia (SIOD) [MIM:242900]	G3H3Z4	647	K	Q
Q9NZC9	LP/P	Schimke immuno-osseous dysplasia (SIOD) [MIM:242900]	G3H3Z4	647	K	T
Q9NZC9	LB/B	-	G3H3Z4	649	D	N
Q9NZC9	LP/P	Schimke immuno-osseous dysplasia (SIOD) [MIM:242900]	G3H3Z4	705	T	I
Q9NZC9	LB/B	-	G3H3Z4	742	T	M
Q9NZC9	LP/P	Schimke immuno-osseous dysplasia (SIOD) [MIM:242900]	G3H3Z4	764	R	Q
Q9NZC9	LP/P	Schimke immuno-osseous dysplasia (SIOD) [MIM:242900]	G3H3Z4	820	R	H
Q9NZC9	LB/B	-	G3H3Z4	22	A	G
Q12824	LP/P	Coffin-Siris syndrome 3 (CSS3) [MIM:614608]	L8I7P0	377	R	H
Q12824	LP/P	Coffin-Siris syndrome 3 (CSS3) [MIM:614608]	L8I7P0	366	R	C
Q12824	LP/P	Coffin-Siris syndrome 3 (CSS3) [MIM:614608]	L8I7P0	374	R	Q
Q92922	LB/B	-	H2PAW2	1075	P	H
Q92922	LP/P	-	H2PAW2	526	H	P
Q96GM5	LP/P	Coffin-Siris syndrome 11 (CSS11) [MIM:618779]	A0A287B0X1	446	R	G
Q96GM5	LP/P	Coffin-Siris syndrome 11 (CSS11) [MIM:618779]	A0A287B0X1	495	F	L
Q6STE5	LB/B	-	A0A287CZB3	170	P	S
Q969G3	LP/P	Coffin-Siris syndrome 5 (CSS5) [MIM:616938]	A0A0Q3PDW9	73	Y	C
Q969G3	LP/P	Coffin-Siris syndrome 5 (CSS5) [MIM:616938]	A0A0Q3PDW9	73	Y	S
Q14683	LP/P	Cornelia de Lange syndrome 2 (CDLS2) [MIM:300590]	A0A1S3JMQ0	493	E	A
Q14683	LB/B	-	A0A1S3JMQ0	28	T	P
Q14683	LP/P	Cornelia de Lange syndrome 2 (CDLS2) [MIM:300590]	A0A1S3JMQ0	133	F	V
Q14683	LP/P	Cornelia de Lange syndrome 2 (CDLS2) [MIM:300590]	A0A1S3JMQ0	141	E	K
Q14683	LP/P	Cornelia de Lange syndrome 2 (CDLS2) [MIM:300590]	A0A1S3JMQ0	196	R	H
Q14683	LP/P	Cornelia de Lange syndrome 2 (CDLS2) [MIM:300590]	A0A1S3JMQ0	398	R	Q
Q14683	LP/P	Cornelia de Lange syndrome 2 (CDLS2) [MIM:300590]	A0A1S3JMQ0	496	R	C
Q14683	LP/P	Cornelia de Lange syndrome 2 (CDLS2) [MIM:300590]	A0A1S3JMQ0	496	R	H
Q14683	LP/P	Cornelia de Lange syndrome 2 (CDLS2) [MIM:300590]	A0A1S3JMQ0	693	R	G
Q14683	LP/P	Cornelia de Lange syndrome 2 (CDLS2) [MIM:300590]	A0A1S3JMQ0	711	R	W
Q14683	LP/P	Cornelia de Lange syndrome 2 (CDLS2) [MIM:300590]	A0A1S3JMQ0	781	C	F
Q14683	LP/P	Cornelia de Lange syndrome 2 (CDLS2) [MIM:300590]	A0A1S3JMQ0	790	R	Q
Q14683	LP/P	Cornelia de Lange syndrome 2 (CDLS2) [MIM:300590]	A0A1S3JMQ0	816	R	G
Q14683	LP/P	Cornelia de Lange syndrome 2 (CDLS2) [MIM:300590]	A0A1S3JMQ0	1049	R	Q
Q14683	LP/P	Cornelia de Lange syndrome 2 (CDLS2) [MIM:300590]	A0A1S3JMQ0	1085	Y	C
Q14683	LP/P	Cornelia de Lange syndrome 2 (CDLS2) [MIM:300590]	A0A1S3JMQ0	1122	F	L
Q14683	LP/P	Cornelia de Lange syndrome 2 (CDLS2) [MIM:300590]	A0A1S3JMQ0	1123	R	W
Q14683	LP/P	Cornelia de Lange syndrome 2 (CDLS2) [MIM:300590]	A0A1S3JMQ0	711	R	Q
Q14683	LP/P	Cornelia de Lange syndrome 2 (CDLS2) [MIM:300590]	A0A1S3JMQ0	784	I	T
Q14683	LP/P	Cornelia de Lange syndrome 2 (CDLS2) [MIM:300590]	A0A1S3JMQ0	398	R	G
Q14683	LP/P	Cornelia de Lange syndrome 2 (CDLS2) [MIM:300590]	A0A1S3JMQ0	693	R	Q
Q14683	LP/P	Developmental and epileptic encephalopathy 85 with or without midline brain defects (DEE85) [MIM:301044]	A0A1S3JMQ0	895	R	G
Q8NDV3	LB/B	-	A0A1S3JMQ0	473	F	V
Q8NDV3	LB/B	-	A0A1S3JMQ0	1050	L	M
Q8NDV3	LB/B	-	A0A1S3JMQ0	758	R	Q
Q8NDV3	LB/B	-	A0A1S3JMQ0	1008	S	A
O95347	LB/B	-	M4B1T2	1009	E	K
Q8IY18	LB/B	-	A0A226MHX6	306	V	I
Q8IY18	LB/B	-	A0A226MHX6	308	C	R
Q8IY18	LB/B	-	A0A226MHX6	682	H	R
Q96SB8	LB/B	-	W5NL09	691	A	T
Q96SB8	LB/B	-	W5NL09	1046	I	M
Q96SB8	LB/B	-	W5NL09	464	R	G
Q96SB8	LB/B	-	W5NL09	928	K	Q
A6NHR9	LB/B	-	A0A1W5BFL1	708	V	I
A6NHR9	LB/B	-	A0A1W5BFL1	879	K	N
A6NHR9	LB/B	-	A0A1W5BFL1	960	I	V
A6NHR9	LP/P	Facioscapulohumeral muscular dystrophy 2, digenic (FSHD2) [MIM:158901]	A0A1W5BFL1	353	Y	C
A6NHR9	LP/P	Facioscapulohumeral muscular dystrophy 2, digenic (FSHD2) [MIM:158901]	A0A1W5BFL1	479	R	P
A6NHR9	LP/P	Facioscapulohumeral muscular dystrophy 2, digenic (FSHD2) [MIM:158901]	A0A1W5BFL1	492	C	R
A6NHR9	LP/P	Facioscapulohumeral muscular dystrophy 2, digenic (FSHD2) [MIM:158901]	A0A1W5BFL1	690	P	S
A6NHR9	LP/P	Facioscapulohumeral muscular dystrophy 2, digenic (FSHD2) [MIM:158901]	A0A1W5BFL1	868	S	N
A6NHR9	LP/P	Facioscapulohumeral muscular dystrophy 2, digenic (FSHD2) [MIM:158901]	A0A1W5BFL1	1554	F	S
A6NHR9	LP/P	Bosma arhinia microphthalmia syndrome (BAMS) [MIM:603457]	A0A1W5BFL1	107	L	P
A6NHR9	LP/P	Bosma arhinia microphthalmia syndrome (BAMS) [MIM:603457]	A0A1W5BFL1	129	M	K
A6NHR9	LP/P	Bosma arhinia microphthalmia syndrome (BAMS) [MIM:603457]	A0A1W5BFL1	134	A	S
A6NHR9	LP/P	Bosma arhinia microphthalmia syndrome (BAMS) [MIM:603457]	A0A1W5BFL1	135	S	C
A6NHR9	LP/P	Bosma arhinia microphthalmia syndrome (BAMS) [MIM:603457]	A0A1W5BFL1	135	S	I
A6NHR9	LP/P	Bosma arhinia microphthalmia syndrome (BAMS) [MIM:603457]	A0A1W5BFL1	135	S	N
A6NHR9	LP/P	Bosma arhinia microphthalmia syndrome (BAMS) [MIM:603457]	A0A1W5BFL1	136	E	D
A6NHR9	LP/P	Bosma arhinia microphthalmia syndrome (BAMS) [MIM:603457]	A0A1W5BFL1	136	E	G
A6NHR9	LP/P	Bosma arhinia microphthalmia syndrome (BAMS) [MIM:603457]	A0A1W5BFL1	137	G	E
A6NHR9	LP/P	Facioscapulohumeral muscular dystrophy 2, digenic (FSHD2) [MIM:158901]	A0A1W5BFL1	137	G	E
A6NHR9	LP/P	Bosma arhinia microphthalmia syndrome (BAMS) [MIM:603457]	A0A1W5BFL1	139	N	H
A6NHR9	LP/P	Bosma arhinia microphthalmia syndrome (BAMS) [MIM:603457]	A0A1W5BFL1	141	L	F
A6NHR9	LP/P	Bosma arhinia microphthalmia syndrome (BAMS) [MIM:603457]	A0A1W5BFL1	171	F	V
A6NHR9	LP/P	Facioscapulohumeral muscular dystrophy 2, digenic (FSHD2) [MIM:158901]	A0A1W5BFL1	194	L	F
A6NHR9	LP/P	Bosma arhinia microphthalmia syndrome (BAMS) [MIM:603457]	A0A1W5BFL1	242	A	G
A6NHR9	LP/P	Facioscapulohumeral muscular dystrophy 2, digenic (FSHD2) [MIM:158901]	A0A1W5BFL1	263	H	D
A6NHR9	LP/P	Bosma arhinia microphthalmia syndrome (BAMS) [MIM:603457]	A0A1W5BFL1	342	W	S
A6NHR9	LP/P	Bosma arhinia microphthalmia syndrome (BAMS) [MIM:603457]	A0A1W5BFL1	345	Q	R
A6NHR9	LP/P	Bosma arhinia microphthalmia syndrome (BAMS) [MIM:603457]	A0A1W5BFL1	348	H	R
A6NHR9	LP/P	Bosma arhinia microphthalmia syndrome (BAMS) [MIM:603457]	A0A1W5BFL1	400	Q	L
A6NHR9	LP/P	Bosma arhinia microphthalmia syndrome (BAMS) [MIM:603457]	A0A1W5BFL1	420	D	V
A6NHR9	LP/P	Facioscapulohumeral muscular dystrophy 2, digenic (FSHD2) [MIM:158901]	A0A1W5BFL1	425	G	R
A6NHR9	LP/P	Bosma arhinia microphthalmia syndrome (BAMS) [MIM:603457]	A0A1W5BFL1	473	E	Q
A6NHR9	LP/P	Bosma arhinia microphthalmia syndrome (BAMS) [MIM:603457]	A0A1W5BFL1	518	K	E
A6NHR9	LP/P	Bosma arhinia microphthalmia syndrome (BAMS) [MIM:603457]	A0A1W5BFL1	523	T	K
A6NHR9	LP/P	Bosma arhinia microphthalmia syndrome (BAMS) [MIM:603457]	A0A1W5BFL1	524	N	S
A6NHR9	LP/P	Facioscapulohumeral muscular dystrophy 2, digenic (FSHD2) [MIM:158901]	A0A1W5BFL1	527	T	M
A6NHR9	LP/P	Bosma arhinia microphthalmia syndrome (BAMS) [MIM:603457]	A0A1W5BFL1	552	R	Q
A6NHR9	LP/P	Facioscapulohumeral muscular dystrophy 2, digenic (FSHD2) [MIM:158901]	A0A1W5BFL1	716	G	S
A6NHR9	LP/P	Facioscapulohumeral muscular dystrophy 2, digenic (FSHD2) [MIM:158901]	A0A1W5BFL1	748	L	P
A6NHR9	LP/P	Facioscapulohumeral muscular dystrophy 2, digenic (FSHD2) [MIM:158901]	A0A1W5BFL1	849	D	N
A6NHR9	LP/P	Facioscapulohumeral muscular dystrophy 2, digenic (FSHD2) [MIM:158901]	A0A1W5BFL1	1468	M	I
A6NHR9	LP/P	Facioscapulohumeral muscular dystrophy 2, digenic (FSHD2) [MIM:158901]	A0A1W5BFL1	110	A	T
A6NHR9	LP/P	Facioscapulohumeral muscular dystrophy 2, digenic (FSHD2) [MIM:158901]	A0A1W5BFL1	283	Y	C
A6NHR9	LP/P	Facioscapulohumeral muscular dystrophy 2, digenic (FSHD2) [MIM:158901]	A0A1W5BFL1	478	G	E
A6NHR9	LP/P	Facioscapulohumeral muscular dystrophy 2, digenic (FSHD2) [MIM:158901]	A0A1W5BFL1	615	V	D
A6NHR9	LP/P	Facioscapulohumeral muscular dystrophy 2, digenic (FSHD2) [MIM:158901]	A0A1W5BFL1	1449	R	K
A6NHR9	LP/P	Facioscapulohumeral muscular dystrophy 2, digenic (FSHD2) [MIM:158901]	A0A1W5BFL1	1463	Q	P
A6NHR9	LP/P	Facioscapulohumeral muscular dystrophy 2, digenic (FSHD2) [MIM:158901]	A0A1W5BFL1	1485	P	L
Q147U7	LB/B	-	A0A2Y9DFD4	20	H	Y
Q147U7	LB/B	-	A0A2Y9DFD4	64	R	W
A2RU48	LB/B	-	A0A091LEM9	49	C	R
A2RU48	LB/B	-	A0A091LEM9	75	K	R
Q8TEV9	LB/B	-	A0A1A8AUQ7	524	P	L
Q8TEV9	LB/B	-	A0A1A8AUQ7	556	R	H
Q8TEV9	LB/B	-	A0A1A8AUQ7	636	N	S
Q9UPR3	LB/B	-	A0A2Y9GF42	1004	N	D
Q86US8	LB/B	-	M4A799	291	R	P
Q86US8	LB/B	-	M4A799	294	K	Q
Q86US8	LB/B	-	M4A799	341	N	T
Q86US8	LB/B	-	M4A799	972	A	T
Q86US8	LB/B	-	M4A799	1233	H	R
Q86US8	LB/B	-	M4A799	575	N	S
Q86US8	LB/B	-	M4A799	984	R	C
Q86US8	LB/B	-	M4A799	1189	E	K
Q92540	LB/B	-	Q4TB26	627	S	F
Q92540	LB/B	-	Q4TB26	900	V	I
Q8ND04	LB/B	-	S9Y801	280	P	L
Q8ND04	LP/P	Alzahrani-Kuwahara syndrome (ALKUS) [MIM:619268]	S9Y801	208	H	R
P58511	LB/B	-	A0A2Y9RRC0	51	K	R
Q7Z3B0	LB/B	-	A0A0Q3TC75	23	L	F
Q8N5G0	LB/B	-	A0A2J8RG21	8	A	T
A6NLE4	LB/B	-	A0A1U7UF14	36	T	M
Q16637	LP/P	Spinal muscular atrophy 2 (SMA2) [MIM:253550]	L5LYN8	2	A	G
Q16637	LP/P	Spinal muscular atrophy 3 (SMA3) [MIM:253400]	L5LYN8	2	A	G
Q16637	LP/P	Spinal muscular atrophy 3 (SMA3) [MIM:253400]	L5LYN8	262	S	I
Q16637	LP/P	Spinal muscular atrophy 1 (SMA1) [MIM:253300]	L5LYN8	272	Y	C
Q16637	LP/P	Spinal muscular atrophy 2 (SMA2) [MIM:253550]	L5LYN8	274	T	I
Q16637	LP/P	Spinal muscular atrophy 3 (SMA3) [MIM:253400]	L5LYN8	274	T	I
Q16637	LP/P	Spinal muscular atrophy 3 (SMA3) [MIM:253400]	L5LYN8	275	G	S
Q16637	LP/P	Spinal muscular atrophy 1 (SMA1) [MIM:253300]	L5LYN8	279	G	V
Q16637	LP/P	Spinal muscular atrophy 2 (SMA2) [MIM:253550]	L5LYN8	279	G	C
Q16637	LP/P	Spinal muscular atrophy 3 (SMA3) [MIM:253400]	L5LYN8	279	G	C
Q16637	LP/P	Spinal muscular atrophy 3 (SMA3) [MIM:253400]	L5LYN8	245	P	L
Q16637	LP/P	Spinal muscular atrophy 2 (SMA2) [MIM:253550]	L5LYN8	30	D	N
Q16637	LP/P	Spinal muscular atrophy 3 (SMA3) [MIM:253400]	L5LYN8	44	D	V
Q16637	LP/P	Spinal muscular atrophy 3 (SMA3) [MIM:253400]	L5LYN8	95	G	R
Q16637	LP/P	Spinal muscular atrophy 2 (SMA2) [MIM:253550]	L5LYN8	111	A	G
Q16637	LP/P	Spinal muscular atrophy 1 (SMA1) [MIM:253300]	L5LYN8	116	I	F
Q16637	LP/P	Spinal muscular atrophy 1 (SMA1) [MIM:253300]	L5LYN8	136	Q	E
Q16637	LP/P	Spinal muscular atrophy 3 (SMA3) [MIM:253400]	L5LYN8	262	S	G
Q99835	LB/B	-	S7PG13	473	D	H
Q99835	LP/P	Curry-Jones syndrome (CRJS) [MIM:601707]	S7PG13	412	L	F
Q9H4F8	LB/B	-	S7PVK1	82	V	M
Q9H4F8	LP/P	Ophthalmoacromelic syndrome (OAS) [MIM:206920]	S7PVK1	278	R	C
Q9H4F8	LP/P	Ophthalmoacromelic syndrome (OAS) [MIM:206920]	S7PVK1	283	T	N
Q9H4F8	LP/P	Ophthalmoacromelic syndrome (OAS) [MIM:206920]	S7PVK1	286	R	H
Q9NWM0	LB/B	-	W5KBM0	522	H	Y
Q9NWM0	LB/B	-	W5KBM0	301	R	P
O60906	LB/B	-	H2PK06	265	R	S
O60906	LB/B	-	H2PK06	3	P	L
O60906	LB/B	-	H2PK06	223	V	I
Q9NXE4	LP/P	Neurodevelopmental disorder with microcephaly, arthrogryposis, and structural brain anomalies (NEDMABA) [MIM:618622]	G1T0C2	231	L	P
Q92484	LB/B	-	H2MH70	16	H	Y
Q92484	LB/B	-	H2MH70	161	P	S
Q92485	LB/B	-	H2MH70	381	R	H
P52788	LB/B	-	A0A1U7T4C0	60	N	S
P52788	LP/P	Intellectual developmental disorder, X-linked, syndromic, Snyder-Robinson type (MRXSSR) [MIM:309583]	A0A1U7T4C0	58	F	L
P52788	LP/P	Intellectual developmental disorder, X-linked, syndromic, Snyder-Robinson type (MRXSSR) [MIM:309583]	A0A1U7T4C0	56	G	S
P52788	LP/P	Intellectual developmental disorder, X-linked, syndromic, Snyder-Robinson type (MRXSSR) [MIM:309583]	A0A1U7T4C0	67	G	E
P52788	LP/P	Intellectual developmental disorder, X-linked, syndromic, Snyder-Robinson type (MRXSSR) [MIM:309583]	A0A1U7T4C0	132	V	G
P52788	LP/P	Intellectual developmental disorder, X-linked, syndromic, Snyder-Robinson type (MRXSSR) [MIM:309583]	A0A1U7T4C0	328	Y	C
P53814	LB/B	-	A0A212D6Y4	455	G	D
P53814	LB/B	-	A0A212D6Y4	547	A	P
P53814	LB/B	-	A0A212D6Y4	559	A	V
P53814	LB/B	-	A0A212D6Y4	580	A	T
P53814	LB/B	-	A0A212D6Y4	642	R	C
Q2TAL5	LB/B	-	W5KNG5	162	A	T
Q2TAL5	LB/B	-	W5KNG5	251	W	R
Q53HV7	LB/B	-	A0A091DET1	15	G	V
Q53HV7	LB/B	-	A0A091DET1	105	R	W
Q9HCE7	LB/B	-	J9K682	466	S	Y
Q8NB12	LB/B	-	M3YD35	164	Q	P
Q9NRG4	LB/B	-	G3TCN8	165	G	E
Q9NRG4	LB/B	-	G3TCN8	430	I	M
Q8IYR2	LB/B	-	U3IX66	131	R	I
Q8IYR2	LB/B	-	U3IX66	727	Y	C
Q8IYR2	LB/B	-	U3IX66	562	R	W
Q8IYR2	LB/B	-	U3IX66	101	N	D
Q8IYR2	LB/B	-	U3IX66	236	G	S
Q8IYR2	LB/B	-	U3IX66	374	I	M
Q8IYR2	LB/B	-	U3IX66	382	P	R
Q8IYR2	LP/P	-	U3IX66	345	G	D
Q8IYR2	LB/B	-	U3IX66	579	R	Q
O95863	LB/B	-	Q91367	118	V	A
O95863	LB/B	-	Q91367	66	A	V
P60880	LP/P	Myasthenic syndrome, congenital, 18 (CMS18) [MIM:616330]	C3XS03	67	I	N
Q92966	LB/B	-	G1SWZ4	398	E	A
Q5SXM2	LB/B	-	A0A2K5H7P0	799	H	Q
Q5SXM2	LB/B	-	A0A2K5H7P0	1448	P	S
Q5SXM2	LB/B	-	A0A2K5H7P0	44	D	N
P37840	LP/P	Parkinson disease 1, autosomal dominant (PARK1) [MIM:168601]	R4GAF5	53	A	T
P37840	LP/P	Parkinson disease 1, autosomal dominant (PARK1) [MIM:168601]	R4GAF5	30	A	P
P37840	LP/P	Dementia, Lewy body (DLB) [MIM:127750]	R4GAF5	46	E	K
P37840	LP/P	Parkinson disease 1, autosomal dominant (PARK1) [MIM:168601]	R4GAF5	46	E	K
P37840	LP/P	Parkinson disease 1, autosomal dominant (PARK1) [MIM:168601]	R4GAF5	50	H	Q
Q9Y6H5	LB/B	-	A0A1S3PT40	235	E	G
Q9Y6H5	LB/B	-	A0A1S3PT40	44	V	A
Q9Y6H5	LB/B	-	A0A1S3PT40	706	E	Q
O76070	LB/B	-	G1T542	110	E	V
Q8TER0	LB/B	-	E7F2S5	1228	L	P
Q8TER0	LB/B	-	E7F2S5	1289	R	Q
Q8TER0	LB/B	-	E7F2S5	1299	H	R
Q8TER0	LB/B	-	E7F2S5	1362	A	S
Q8TAD8	LP/P	Neurodevelopmental disorder with hypotonia, craniofacial abnormalities, and seizures (NEDHCS) [MIM:614501]	A0A093H035	366	E	G
O75324	LB/B	-	A0A060W9U3	17	V	I
O75324	LB/B	-	A0A060W9U3	88	G	S
Q9NRH2	LB/B	-	A0A287A2M0	260	L	S
Q9NRH2	LB/B	-	A0A287A2M0	391	P	S
Q8WVK2	LB/B	-	A0A158NMY0	81	T	I
Q8WVK2	LB/B	-	A0A158NMY0	114	S	F
Q6IEG0	LB/B	-	A0A146XXB5	45	P	L
Q6IEG0	LB/B	-	A0A146XXB5	281	R	Q
P14678	LB/B	-	A0A2K5S1R8	79	S	P
P14678	LP/P	Cerebrocostomandibular syndrome (CCMS) [MIM:117650]	A0A2K5S1R8	55	N	S
P14678	LP/P	Cerebrocostomandibular syndrome (CCMS) [MIM:117650]	A0A2K5S1R8	55	N	T
P14678	LP/P	Cerebrocostomandibular syndrome (CCMS) [MIM:117650]	A0A2K5S1R8	56	S	R
P14678	LP/P	Cerebrocostomandibular syndrome (CCMS) [MIM:117650]	A0A2K5S1R8	56	S	W
Q13424	LB/B	-	A0A2I4B8M3	364	L	F
Q13424	LP/P	Long QT syndrome 12 (LQT12) [MIM:612955]	A0A2I4B8M3	257	A	G
Q13424	LP/P	Long QT syndrome 12 (LQT12) [MIM:612955]	A0A2I4B8M3	390	A	V
Q13425	LB/B	-	A0A2K6S646	424	D	E
Q13425	LB/B	-	A0A2K6S646	376	S	R
Q9NY99	LB/B	-	Q4SLM0	168	S	Y
Q9NY99	LB/B	-	Q4SLM0	200	S	L
Q9NY99	LB/B	-	Q4SLM0	391	I	V
P55769	LB/B	-	A0A2I0MJI5	19	T	N
Q13596	LB/B	-	A0A0P7UP85	466	D	N
Q13596	LB/B	-	A0A0P7UP85	115	S	Y
Q9Y5X0	LB/B	-	S7MND8	187	S	I
Q9Y5X0	LP/P	Osteopetrosis, autosomal recessive 8 (OPTB8) [MIM:615085]	S7MND8	16	R	L
Q9Y5X0	LP/P	Osteopetrosis, autosomal recessive 8 (OPTB8) [MIM:615085]	S7MND8	32	Y	S
Q9Y5X0	LP/P	Osteopetrosis, autosomal recessive 8 (OPTB8) [MIM:615085]	S7MND8	51	R	P
Q9Y5X0	LP/P	Osteopetrosis, autosomal recessive 8 (OPTB8) [MIM:615085]	S7MND8	51	R	Q
Q9Y5W8	LB/B	-	A0A1B6DXD3	472	L	S
Q9NRS6	LB/B	-	A0A2J8TYY3	334	R	C
P57768	LB/B	-	A0A151PGX0	98	P	L
Q96RF0	LB/B	-	A0A146WSX3	571	E	D
Q96RF0	LB/B	-	A0A146WSX3	593	K	T
Q92543	LB/B	-	A0A2U4BWN1	407	S	G
Q92543	LB/B	-	A0A2U4BWN1	361	V	L
Q92543	LB/B	-	A0A2U4BWN1	396	D	E
Q92543	LB/B	-	A0A2U4BWN1	618	L	F
Q92543	LB/B	-	A0A2U4BWN1	753	N	S
Q92543	LB/B	-	A0A2U4BWN1	878	L	R
Q7Z614	LB/B	-	K7FPP4	35	P	L
Q969T3	LB/B	-	G1T2S2	154	A	T
Q9H3E2	LB/B	-	H0VG67	318	E	K
Q9H3E2	LB/B	-	H0VG67	586	I	V
Q9H3E2	LB/B	-	H0VG67	725	T	I
Q96L92	LB/B	-	T1KRR3	459	E	K
Q5VWJ9	LB/B	-	K7DSF5	83	D	H
Q5VWJ9	LB/B	-	K7DSF5	125	P	A
Q86XE0	LB/B	-	A0A0N4V4R1	155	H	N
Q86XE0	LB/B	-	A0A0N4V4R1	282	A	V
Q86XE0	LB/B	-	A0A0N4V4R1	354	S	Y
Q9UNH6	LB/B	-	M3WT56	186	F	L
Q9UNH6	LB/B	-	M3WT56	278	S	N
P35610	LB/B	-	G3HW11	526	Q	R
O75908	LB/B	-	A0A212DEU1	14	E	G
O75908	LB/B	-	A0A212DEU1	254	T	I
A7XYQ1	LB/B	-	G3TBR3	683	S	G
O15524	LB/B	-	A0A2R8PBQ0	210	Q	H
O15524	LP/P	Autoinflammatory syndrome, familial, with or without immunodeficiency (AISIMD) [MIM:619375]	A0A2R8PBQ0	22	R	W
O15524	LP/P	Autoinflammatory syndrome, familial, with or without immunodeficiency (AISIMD) [MIM:619375]	A0A2R8PBQ0	123	P	R
O14543	LB/B	-	A0A2F0B2F4	125	H	Y
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	5	A	T
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	5	A	V
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	8	V	E
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	15	V	M
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	17	G	S
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	22	E	K
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	38	G	R
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	39	L	V
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	42	G	S
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	42	G	D
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	44	H	R
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	47	H	R
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	49	H	Q
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	85	L	V
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	86	G	R
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	91	D	A
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	94	G	A
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	94	G	C
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	94	G	D
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	94	G	R
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	101	E	G
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	102	D	G
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	102	D	N
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	107	L	V
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	113	I	T
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	114	I	T
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	116	R	G
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	126	D	H
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	135	S	N
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	140	N	K
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	145	L	F
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	149	V	G
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	149	V	I
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	150	I	T
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	152	I	T
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	7	C	F
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	73	G	S
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	94	G	V
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	105	I	F
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	125	D	V
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	145	L	S
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	146	A	T
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	5	A	S
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	9	L	Q
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	9	L	V
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	13	G	R
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	15	V	G
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	22	E	G
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	39	L	R
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	46	F	C
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	50	E	K
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	66	N	S
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	68	L	R
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	77	D	Y
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	85	L	F
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	87	N	S
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	90	A	V
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	91	D	V
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	101	E	K
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	106	S	L
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	109	G	V
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	113	I	M
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	115	G	A
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	127	L	S
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	147	C	R
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	81	H	A
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	21	F	C
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	23	Q	L
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	49	H	R
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	55	T	R
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	88	V	A
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	90	A	T
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	98	V	M
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	119	V	L
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	125	D	G
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	148	G	R
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	96	A	G
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	68	L	P
P00441	LP/P	Amyotrophic lateral sclerosis 1 (ALS1) [MIM:105400]	A0A1D1UKR0	112	C	Y
P04179	LB/B	-	A0A2B4RVE0	82	I	T
P04179	LB/B	-	A0A2B4RVE0	16	V	A
P04179	LB/B	-	A0A2B4RVE0	10	S	I
P04179	LB/B	-	A0A2B4RVE0	66	E	V
P04179	LB/B	-	A0A2B4RVE0	156	R	W
P04179	LB/B	-	A0A2B4RVE0	76	G	R
P08294	LB/B	-	G1PZI4	231	R	G
P08294	LB/B	-	G1PZI4	58	A	T
P08294	LB/B	-	G1PZI4	91	A	T
O94964	LB/B	-	G3GXW7	993	Q	H
O94875	LB/B	-	A0A1S2ZDI5	1048	A	V
O60504	LB/B	-	A0A1U8DC03	556	I	T
O60504	LB/B	-	A0A1U8DC03	573	T	A
O60504	LB/B	-	A0A1U8DC03	255	P	L
Q96PQ0	LB/B	-	A0A091D3Z8	345	G	R
Q96PQ0	LB/B	-	A0A091D3Z8	695	T	M
Q96PQ0	LB/B	-	A0A091D3Z8	745	T	I
Q00796	LB/B	-	A0A2M4CZL8	239	Q	L
Q00796	LB/B	-	A0A2M4CZL8	269	N	T
Q00796	LP/P	Sorbitol dehydrogenase deficiency with peripheral neuropathy (SORDD) [MIM:618912]	A0A2M4CZL8	10	L	F
Q00796	LP/P	Sorbitol dehydrogenase deficiency with peripheral neuropathy (SORDD) [MIM:618912]	A0A2M4CZL8	110	R	P
Q00796	LP/P	Sorbitol dehydrogenase deficiency with peripheral neuropathy (SORDD) [MIM:618912]	A0A2M4CZL8	135	H	R
Q92673	LB/B	-	W5LG26	528	A	T
Q92673	LB/B	-	W5LG26	1074	Q	E
Q92673	LB/B	-	W5LG26	1967	V	I
Q99523	LB/B	-	B0R052	358	D	Y
Q07890	LB/B	-	M4AJM7	672	L	I
Q07890	LB/B	-	M4AJM7	483	S	N
Q07890	LB/B	-	M4AJM7	508	H	Y
Q07890	LP/P	Noonan syndrome 9 (NS9) [MIM:616559]	M4AJM7	267	M	K
Q07890	LP/P	Noonan syndrome 9 (NS9) [MIM:616559]	M4AJM7	376	T	S
Q07890	LB/B	-	M4AJM7	449	T	A
Q07890	LB/B	-	M4AJM7	952	D	N
Q9BQB4	LP/P	Sclerosteosis 1 (SOST1) [MIM:269500]	A0A1V4JR39	167	C	R
Q9BQB4	LP/P	Craniodiaphyseal dysplasia autosomal dominant (CDD) [MIM:122860]	A0A1V4JR39	21	V	L
Q9BQB4	LP/P	Craniodiaphyseal dysplasia autosomal dominant (CDD) [MIM:122860]	A0A1V4JR39	21	V	M
Q6X4U4	LB/B	-	U3K5U4	189	Q	H
Q2M3V2	LB/B	-	V8NVP8	124	R	P
Q2M3V2	LB/B	-	V8NVP8	545	L	F
P35716	LP/P	Coffin-Siris syndrome 9 (CSS9) [MIM:615866]	H3A415	60	S	P
P35716	LP/P	Coffin-Siris syndrome 9 (CSS9) [MIM:615866]	H3A415	116	Y	C
Q9UN79	LB/B	-	U3IYX7	532	P	S
Q9H6I2	LP/P	Vesicoureteral reflux 3 (VUR3) [MIM:613674]	A0A147AU71	178	G	C
Q9H6I2	LP/P	Vesicoureteral reflux 3 (VUR3) [MIM:613674]	A0A147AU71	259	Y	N
Q9H6I2	LB/B	-	A0A147AU71	33	A	D
P35713	LP/P	Hypotrichosis-lymphedema-telangiectasia syndrome (HLTS) [MIM:607823]	A0A0D9RW20	95	W	R
P35713	LP/P	Hypotrichosis-lymphedema-telangiectasia syndrome (HLTS) [MIM:607823]	A0A0D9RW20	104	A	P
Q9Y651	LB/B	-	H0ZLS6	230	G	R
P41225	LB/B	-	E2R420	43	A	T
Q06945	LP/P	Intellectual developmental disorder with speech delay and dysmorphic facies (IDDSDF) [MIM:618506]	F6WHW4	59	I	S
Q06945	LP/P	Intellectual developmental disorder with speech delay and dysmorphic facies (IDDSDF) [MIM:618506]	F6WHW4	66	F	L
Q06945	LP/P	Intellectual developmental disorder with speech delay and dysmorphic facies (IDDSDF) [MIM:618506]	F6WHW4	105	K	N
Q06945	LP/P	Intellectual developmental disorder with speech delay and dysmorphic facies (IDDSDF) [MIM:618506]	F6WHW4	112	A	P
P35711	LB/B	-	G1KMW4	362	Q	P
P48436	LP/P	Campomelic dysplasia (CMD1) [MIM:114290]	A0A146MJL5	108	P	L
P48436	LP/P	Campomelic dysplasia (CMD1) [MIM:114290]	A0A146MJL5	112	F	L
P48436	LP/P	Campomelic dysplasia (CMD1) [MIM:114290]	A0A146MJL5	112	F	S
P48436	LP/P	Campomelic dysplasia (CMD1) [MIM:114290]	A0A146MJL5	119	A	V
P48436	LP/P	Campomelic dysplasia (CMD1) [MIM:114290]	A0A146MJL5	143	W	R
P48436	LP/P	Campomelic dysplasia (CMD1) [MIM:114290]	A0A146MJL5	152	R	P
P48436	LP/P	Campomelic dysplasia (CMD1) [MIM:114290]	A0A146MJL5	170	P	R
P48436	LP/P	Campomelic dysplasia (CMD1) [MIM:114290]	A0A146MJL5	154	F	L
P48436	LP/P	Campomelic dysplasia (CMD1) [MIM:114290]	A0A146MJL5	158	A	T
P48436	LP/P	Campomelic dysplasia (CMD1) [MIM:114290]	A0A146MJL5	165	H	Y
P48436	LP/P	Campomelic dysplasia (CMD1) [MIM:114290]	A0A146MJL5	76	A	E
P48436	LP/P	Campomelic dysplasia (CMD1) [MIM:114290]	A0A146MJL5	113	M	T
P48436	LP/P	Campomelic dysplasia (CMD1) [MIM:114290]	A0A146MJL5	113	M	V
P48436	LP/P	Campomelic dysplasia (CMD1) [MIM:114290]	A0A146MJL5	165	H	Q
P48436	LP/P	Campomelic dysplasia (CMD1) [MIM:114290]	A0A146MJL5	170	P	L
P48436	LP/P	Campomelic dysplasia (CMD1) [MIM:114290]	A0A146MJL5	173	K	E
P48436	LP/P	Campomelic dysplasia (CMD1) [MIM:114290]	A0A146MJL5	169	H	P
P48436	LP/P	Campomelic dysplasia (CMD1) [MIM:114290]	A0A146MJL5	169	H	Q
P08047	LB/B	-	A0A2Y9QN16	737	T	A
Q9HB58	LB/B	-	A0A2U3ZBF1	112	W	R
Q9HB58	LB/B	-	A0A2U3ZBF1	128	A	V
Q9HB58	LB/B	-	A0A2U3ZBF1	206	A	V
Q9HB58	LB/B	-	A0A2U3ZBF1	207	E	K
Q9HB58	LB/B	-	A0A2U3ZBF1	212	E	G
Q9HB58	LB/B	-	A0A2U3ZBF1	249	M	V
Q9HB58	LB/B	-	A0A2U3ZBF1	267	E	G
Q9HB58	LB/B	-	A0A2U3ZBF1	299	G	R
Q9HB58	LB/B	-	A0A2U3ZBF1	367	T	M
Q9HB58	LB/B	-	A0A2U3ZBF1	425	L	S
Q9HB58	LB/B	-	A0A2U3ZBF1	523	M	T
Q9HB58	LB/B	-	A0A2U3ZBF1	579	M	I
Q9HB58	LB/B	-	A0A2U3ZBF1	173	S	L
Q9HB58	LB/B	-	A0A2U3ZBF1	210	S	A
Q9H930	LB/B	-	A0A2Y9QFE5	88	M	T
Q9H930	LB/B	-	A0A2Y9QFE5	225	T	M
Q9H930	LB/B	-	A0A2Y9QFE5	377	P	S
Q02446	LB/B	-	A0A287ADD7	197	Q	K
Q6BEB4	LB/B	-	W5NWQ1	75	A	T
Q3SY56	LB/B	-	A0A218UBJ2	156	V	I
Q3SY56	LP/P	Amelogenesis imperfecta 1K (AI1K) [MIM:620104]	A0A218UBJ2	273	A	K
Q3SY56	LP/P	Amelogenesis imperfecta 1K (AI1K) [MIM:620104]	A0A218UBJ2	273	A	M
Q8IXA5	LB/B	-	B4DYD1	80	C	Y
Q8IXA5	LB/B	-	B4DYD1	100	H	R
Q8IXA5	LB/B	-	B4DYD1	128	A	T
Q96KW9	LB/B	-	A0A2K5UIQ3	111	V	D
Q96E40	LB/B	-	A0A1U7T450	104	V	I
Q07617	LB/B	-	H9GN66	331	E	K
Q07617	LB/B	-	H9GN66	777	M	T
Q07617	LB/B	-	H9GN66	827	H	Y
Q08648	LB/B	-	Q6PDA7	77	R	Q
Q08648	LB/B	-	Q6PDA7	89	D	G
Q8N0X2	LB/B	-	A7SR29	361	Q	H
Q8N0X2	LB/B	-	A7SR29	425	K	T
Q8N0X2	LB/B	-	A7SR29	324	P	T
Q6Q759	LB/B	-	A0A061IPH7	143	R	Q
Q6Q759	LB/B	-	A0A061IPH7	158	E	V
Q6Q759	LB/B	-	A0A061IPH7	1253	T	P
Q6Q759	LB/B	-	A0A061IPH7	1348	P	L
O75602	LB/B	-	A0A1I8IZL8	216	Q	R
P38567	LB/B	-	A0A1S3AA20	47	V	A
Q5MJ10	LB/B	-	A0A2K5IDX2	8	T	I
Q5MJ09	LB/B	-	A0A2K5IDX2	43	K	N
Q5MJ09	LB/B	-	A0A2K5IDX2	89	V	I
P09486	LB/B	-	W5PGY0	19	P	S
P09486	LB/B	-	W5PGY0	70	N	S
P09486	LP/P	Osteogenesis imperfecta 17 (OI17) [MIM:616507]	W5PGY0	166	R	H
P09486	LP/P	Osteogenesis imperfecta 17 (OI17) [MIM:616507]	W5PGY0	263	E	K
Q14515	LB/B	-	H0X100	49	A	D
Q14515	LB/B	-	H0X100	419	T	A
Q14515	LB/B	-	H0X100	106	H	D
Q8N0X7	LP/P	Spastic paraplegia 20, autosomal recessive (SPG20) [MIM:275900]	E9PT90	330	M	V
Q9UBP0	LB/B	-	T1J5Z5	44	S	L
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	362	S	C
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	424	R	G
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	448	C	Y
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	499	R	C
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	584	D	H
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	378	L	Q
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	386	N	S
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	390	M	V
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	503	R	L
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	534	L	P
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	614	T	I
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	344	I	K
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	407	S	R
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	551	A	Y
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	615	T	I
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	195	L	V
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	406	I	V
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	493	D	G
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	499	R	H
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	503	R	W
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	607	W	C
Q9UBP0	LB/B	-	T1J5Z5	45	P	Q
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	347	Q	K
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	361	P	L
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	370	G	R
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	381	F	C
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	386	N	K
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	388	K	R
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	399	S	L
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	426	L	V
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	435	P	L
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	436	S	F
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	441	D	G
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	459	R	G
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	460	R	C
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	460	R	L
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	470	D	V
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	485	A	V
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	489	P	L
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	512	E	D
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	555	D	N
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	556	A	V
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	559	G	D
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	562	R	G
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	562	R	Q
Q9UBP0	LB/B	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	162	V	I
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	413	S	L
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	454	E	K
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	460	R	S
Q9UBP0	LB/B	-	T1J5Z5	229	S	G
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	293	P	L
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	364	R	T
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	378	L	R
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	380	L	H
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	391	L	P
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	409	A	T
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	410	S	R
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	426	L	F
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	436	S	P
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	441	D	N
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	463	T	A
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	492	L	F
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	498	R	G
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	514	R	G
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	580	I	T
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	95	A	T
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	309	R	H
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	363	L	P
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	364	R	M
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	368	F	L
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	372	R	G
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	377	G	E
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	406	I	R
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	441	D	V
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	450	R	S
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	458	S	R
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	461	L	P
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	555	D	G
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	559	G	R
Q9UBP0	LP/P	Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]	T1J5Z5	595	S	R
Q5VX52	LB/B	-	M3WXW0	175	V	L
Q96N96	LB/B	-	A0A218UQ71	20	R	W
Q9BXB7	LB/B	-	A0A2Y9JXN8	50	N	S
Q9BXB7	LB/B	-	A0A2Y9JXN8	78	E	K
Q9BXB7	LB/B	-	A0A2Y9JXN8	90	E	G
Q9BXB7	LB/B	-	A0A2Y9JXN8	133	M	V
Q9BXB7	LB/B	-	A0A2Y9JXN8	147	G	E
Q9BXB7	LP/P	Spermatogenic failure 6 (SPGF6) [MIM:102530]	A0A2Y9JXN8	283	R	Q
Q9BXB7	LB/B	-	A0A2Y9JXN8	286	M	V
Q9BXB7	LB/B	-	A0A2Y9JXN8	423	V	M
Q9BXB7	LB/B	-	A0A2Y9JXN8	509	A	V
Q9BXB7	LB/B	-	A0A2Y9JXN8	526	M	T
Q9BXB7	LB/B	-	A0A2Y9JXN8	564	Q	R
Q96L03	LB/B	-	B6VAM9	16	N	S
Q7Z5L4	LB/B	-	I3N3E4	50	A	V
Q8TB22	LB/B	-	W4YTT1	88	Q	E
Q8TB22	LB/B	-	W4YTT1	483	S	T
Q8TB22	LB/B	-	W4YTT1	609	K	R
Q7Z572	LB/B	-	A0A2K6DJE9	53	I	L
Q7Z572	LB/B	-	A0A2K6DJE9	184	Q	R
Q7Z572	LB/B	-	A0A2K6DJE9	255	V	L
Q7Z572	LB/B	-	A0A2K6DJE9	390	N	K
Q9BR10	LB/B	-	A0A2K6DN65	94	P	L
Q6ZUB1	LB/B	-	M3W9N5	335	T	P
Q6ZUB1	LB/B	-	M3W9N5	682	D	E
Q6ZUB1	LB/B	-	M3W9N5	704	D	E
Q6ZUB1	LB/B	-	M3W9N5	1202	D	G
Q6ZUB1	LB/B	-	M3W9N5	1350	R	H
Q6ZUB1	LB/B	-	M3W9N5	409	V	M
Q6ZUB1	LB/B	-	M3W9N5	586	K	E
Q6ZUB1	LB/B	-	M3W9N5	671	T	M
Q6ZUB1	LB/B	-	M3W9N5	700	G	R
Q6ZUB1	LB/B	-	M3W9N5	736	A	V
Q6ZUB1	LB/B	-	M3W9N5	924	P	L
Q6ZUB1	LB/B	-	M3W9N5	1019	V	E
Q6ZUB1	LB/B	-	M3W9N5	208	T	S
Q96LK8	LB/B	-	A0A2U3ZMQ4	142	V	M
Q8NEY3	LB/B	-	D5K8A0	149	Y	C
Q537H7	LB/B	-	A0A1S3AG35	8	I	T
Q5T0L3	LB/B	-	G1TJI0	69	A	V
Q5T0L3	LB/B	-	G1TJI0	217	R	H
Q8NB90	LB/B	-	G1QCX9	27	C	S
Q8NB90	LB/B	-	G1QCX9	673	S	Y
Q8NB90	LP/P	Neurodevelopmental disorder with hearing loss, seizures, and brain abnormalities (NEDHSB) [MIM:616577]	G1QCX9	84	R	Q
Q8NB90	LP/P	Neurodevelopmental disorder with hearing loss, seizures, and brain abnormalities (NEDHSB) [MIM:616577]	G1QCX9	90	S	I
Q8NB90	LP/P	Neurodevelopmental disorder with hearing loss, seizures, and brain abnormalities (NEDHSB) [MIM:616577]	G1QCX9	100	A	T
Q8NB90	LP/P	Neurodevelopmental disorder with hearing loss, seizures, and brain abnormalities (NEDHSB) [MIM:616577]	G1QCX9	448	S	L
Q8NB90	LP/P	Neurodevelopmental disorder with hearing loss, seizures, and brain abnormalities (NEDHSB) [MIM:616577]	G1QCX9	488	V	L
Q8NB90	LP/P	Neurodevelopmental disorder with hearing loss, seizures, and brain abnormalities (NEDHSB) [MIM:616577]	G1QCX9	529	R	Q
Q8NB90	LP/P	Neurodevelopmental disorder with hearing loss, seizures, and brain abnormalities (NEDHSB) [MIM:616577]	G1QCX9	626	W	C
Q8NB90	LP/P	Neurodevelopmental disorder with hearing loss, seizures, and brain abnormalities (NEDHSB) [MIM:616577]	G1QCX9	628	D	G
Q8NB90	LP/P	Neurodevelopmental disorder with hearing loss, seizures, and brain abnormalities (NEDHSB) [MIM:616577]	G1QCX9	784	R	Q
Q8NB90	LP/P	Neurodevelopmental disorder with hearing loss, seizures, and brain abnormalities (NEDHSB) [MIM:616577]	G1QCX9	844	A	V
Q9BVQ7	LB/B	-	A0A1Q9P2B6	119	R	P
Q9BVQ7	LB/B	-	A0A1Q9P2B6	592	N	D
Q9BVQ7	LB/B	-	A0A1Q9P2B6	252	R	Q
Q9BVQ7	LP/P	Neurodevelopmental disorder with hearing loss and spasticity (NEDHLS) [MIM:619616]	A0A1Q9P2B6	26	T	A
Q9BVQ7	LP/P	Neurodevelopmental disorder with hearing loss and spasticity (NEDHLS) [MIM:619616]	A0A1Q9P2B6	29	C	G
Q9BVQ7	LP/P	Neurodevelopmental disorder with hearing loss and spasticity (NEDHLS) [MIM:619616]	A0A1Q9P2B6	41	A	P
Q9BVQ7	LP/P	Neurodevelopmental disorder with hearing loss and spasticity (NEDHLS) [MIM:619616]	A0A1Q9P2B6	64	R	W
Q9BVQ7	LP/P	Neurodevelopmental disorder with hearing loss and spasticity (NEDHLS) [MIM:619616]	A0A1Q9P2B6	66	D	Y
Q9BVQ7	LP/P	Neurodevelopmental disorder with hearing loss and spasticity (NEDHLS) [MIM:619616]	A0A1Q9P2B6	71	F	L
Q9BVQ7	LP/P	Neurodevelopmental disorder with hearing loss and spasticity (NEDHLS) [MIM:619616]	A0A1Q9P2B6	172	P	H
Q9BVQ7	LP/P	Deafness, autosomal recessive, 119 (DFNB119) [MIM:619615]	A0A1Q9P2B6	176	G	V
Q9BVQ7	LP/P	Neurodevelopmental disorder with hearing loss and spasticity (NEDHLS) [MIM:619616]	A0A1Q9P2B6	245	V	E
Q9BVQ7	LP/P	Neurodevelopmental disorder with hearing loss and spasticity (NEDHLS) [MIM:619616]	A0A1Q9P2B6	360	F	S
Q9BVQ7	LP/P	Neurodevelopmental disorder with hearing loss and spasticity (NEDHLS) [MIM:619616]	A0A1Q9P2B6	364	V	E
Q9BVQ7	LP/P	Neurodevelopmental disorder with hearing loss and spasticity (NEDHLS) [MIM:619616]	A0A1Q9P2B6	400	T	I
Q9BVQ7	LP/P	Neurodevelopmental disorder with hearing loss and spasticity (NEDHLS) [MIM:619616]	A0A1Q9P2B6	438	L	P
Q9BVQ7	LP/P	Deafness, autosomal recessive, 119 (DFNB119) [MIM:619615]	A0A1Q9P2B6	466	I	M
Q9BVQ7	LP/P	Neurodevelopmental disorder with hearing loss and spasticity (NEDHLS) [MIM:619616]	A0A1Q9P2B6	519	A	D
Q9BVQ7	LP/P	Neurodevelopmental disorder with hearing loss and spasticity (NEDHLS) [MIM:619616]	A0A1Q9P2B6	561	L	S
Q9BVQ7	LP/P	Neurodevelopmental disorder with hearing loss and spasticity (NEDHLS) [MIM:619616]	A0A1Q9P2B6	658	R	K
Q9BVQ7	LP/P	Neurodevelopmental disorder with hearing loss and spasticity (NEDHLS) [MIM:619616]	A0A1Q9P2B6	669	M	R
Q9BVQ7	LP/P	Neurodevelopmental disorder with hearing loss and spasticity (NEDHLS) [MIM:619616]	A0A1Q9P2B6	689	G	V
Q9NWH7	LB/B	-	V8PIG3	333	R	W
Q9NWH7	LB/B	-	V8PIG3	478	C	Y
Q9NWH7	LB/B	-	V8PIG3	478	C	F
Q9NWH7	LB/B	-	V8PIG3	478	C	S
Q8N4H0	LB/B	-	I3LVU4	243	R	G
Q8N4H0	LB/B	-	I3LVU4	310	A	T
Q9P0W8	LB/B	-	D5K898	74	V	M
Q9P0W8	LB/B	-	D5K898	2	D	N
Q9P0W8	LB/B	-	D5K898	119	F	L
Q9P0W8	LB/B	-	D5K898	165	S	N
Q9P0W8	LB/B	-	D5K898	324	G	E
Q9P0W8	LB/B	-	D5K898	534	R	Q
Q9P0W8	LB/B	-	D5K898	332	I	T
Q9BWV2	LB/B	-	G3RIN7	209	K	E
Q9H0A9	LB/B	-	K7GEY6	113	P	L
Q9H0A9	LB/B	-	K7GEY6	298	S	N
Q496A3	LB/B	-	F6T8X0	8	G	R
O95238	LB/B	-	A0A2I2U5Z6	57	A	T
Q96EA4	LB/B	-	G1SP23	508	Y	H
Q96EA4	LB/B	-	G1SP23	586	L	S
Q5M775	LB/B	-	L9KIQ6	293	M	L
Q5M775	LB/B	-	L9KIQ6	274	S	R
Q5M775	LB/B	-	L9KIQ6	769	D	N
Q69YQ0	LB/B	-	A0A0P7UPY4	301	G	D
Q69YQ0	LB/B	-	A0A0P7UPY4	712	S	F
Q69YQ0	LB/B	-	A0A0P7UPY4	717	T	A
Q69YQ0	LB/B	-	A0A0P7UPY4	943	V	A
Q69YQ0	LB/B	-	A0A0P7UPY4	951	V	M
Q69YQ0	LB/B	-	A0A0P7UPY4	190	T	M
Q69YQ0	LP/P	Facial clefting, oblique, 1 (OBLFC1) [MIM:600251]	A0A0P7UPY4	415	Q	P
Q69YQ0	LP/P	Teebi hypertelorism syndrome 1 (TBHS1) [MIM:145420]	A0A0P7UPY4	397	T	P
Q69YQ0	LP/P	Teebi hypertelorism syndrome 1 (TBHS1) [MIM:145420]	A0A0P7UPY4	1083	G	S
Q9C093	LB/B	-	F7E308	71	N	H
Q9C093	LB/B	-	F7E308	74	G	S
Q9C093	LB/B	-	F7E308	366	R	K
Q9C093	LB/B	-	F7E308	447	R	Q
Q9C093	LB/B	-	F7E308	500	D	N
Q9C093	LB/B	-	F7E308	616	N	K
Q9C093	LB/B	-	F7E308	655	E	G
Q9C093	LB/B	-	F7E308	1482	K	N
Q9C093	LB/B	-	F7E308	904	A	V
Q9C093	LB/B	-	F7E308	934	A	P
Q15772	LB/B	-	G1RE96	206	R	H
Q15772	LB/B	-	G1RE96	934	R	C
Q15772	LB/B	-	G1RE96	966	R	Q
Q15772	LB/B	-	G1RE96	1103	P	L
Q15772	LB/B	-	G1RE96	1135	A	V
Q15772	LB/B	-	G1RE96	1234	R	W
Q15772	LB/B	-	G1RE96	1340	R	Q
Q15772	LB/B	-	G1RE96	1621	R	C
Q15772	LB/B	-	G1RE96	2687	P	T
Q15772	LB/B	-	G1RE96	3079	H	R
Q15772	LB/B	-	G1RE96	2189	P	L
Q15772	LP/P	Myopathy, centronuclear, 5 (CNM5) [MIM:615959]	G1RE96	2757	G	V
Q96T58	LB/B	-	U3JLP9	970	A	V
Q96T58	LB/B	-	U3JLP9	1091	L	P
Q96T58	LB/B	-	U3JLP9	2360	N	D
Q96T58	LB/B	-	U3JLP9	1363	D	E
Q6UW49	LB/B	-	A0A2K6FH28	191	G	E
Q6UW49	LB/B	-	A0A2K6FH28	133	L	F
Q6UW49	LB/B	-	A0A2K6FH28	134	H	Q
Q96JI7	LB/B	-	A0A091DPJ6	396	Y	C
Q96JI7	LB/B	-	A0A091DPJ6	463	F	S
Q96JI7	LP/P	Spastic paraplegia 11, autosomal recessive (SPG11) [MIM:604360]	A0A091DPJ6	1349	F	I
Q9UQ90	LB/B	-	A0A2Y9IFX0	503	T	A
Q9UQ90	LB/B	-	A0A2Y9IFX0	688	R	Q
Q9UQ90	LP/P	Spastic paraplegia 7, autosomal recessive (SPG7) [MIM:607259]	A0A2Y9IFX0	692	S	T
Q9UQ90	LB/B	-	A0A2Y9IFX0	623	F	C
Q9UQ90	LB/B	-	A0A2Y9IFX0	730	N	D
Q9UQ90	LB/B	-	A0A2Y9IFX0	645	S	T
Q9UQ90	LB/B	-	A0A2Y9IFX0	2	A	T
Q9UQ90	LB/B	-	A0A2Y9IFX0	294	R	H
Q9UQ90	LP/P	Spastic paraplegia 7, autosomal recessive (SPG7) [MIM:607259]	A0A2Y9IFX0	349	G	S
Q9UQ90	LB/B	-	A0A2Y9IFX0	486	R	Q
Q9UQ90	LP/P	Spastic paraplegia 7, autosomal recessive (SPG7) [MIM:607259]	A0A2Y9IFX0	510	A	V
Q9UQ90	LB/B	-	A0A2Y9IFX0	545	F	L
Q9UQ90	LP/P	Spastic paraplegia 7, autosomal recessive (SPG7) [MIM:607259]	A0A2Y9IFX0	583	W	C
Q9UQ90	LB/B	-	A0A2Y9IFX0	603	A	T
Q9UQ90	LB/B	-	A0A2Y9IFX0	635	S	L
Q9NRA0	LB/B	-	G1P6Q7	652	R	Q
P17947	LP/P	Agammaglobulinemia 10, autosomal dominant (AGM10) [MIM:619707]	L9JE22	211	H	P
P17947	LP/P	Agammaglobulinemia 10, autosomal dominant (AGM10) [MIM:619707]	L9JE22	241	V	G
P00995	LP/P	Pancreatitis, hereditary (PCTT) [MIM:167800]	A0A2K5PC02	14	L	P
P00995	LP/P	Pancreatitis, hereditary (PCTT) [MIM:167800]	A0A2K5PC02	34	N	S
P00995	LP/P	Tropical calcific pancreatitis (TCP) [MIM:608189]	A0A2K5PC02	34	N	S
P00995	LB/B	-	A0A2K5PC02	55	P	S
P00995	LB/B	Pancreatitis, hereditary (PCTT) [MIM:167800]	A0A2K5PC02	12	L	F
P00995	LB/B	-	A0A2K5PC02	67	R	H
O60575	LB/B	-	A0A2Y9TJ91	7	V	I
Q9NQ38	LB/B	-	W5P1K5	420	K	E
Q9NQ38	LB/B	-	W5P1K5	267	Q	R
Q9NQ38	LB/B	-	W5P1K5	368	S	N
Q9NQ38	LB/B	-	W5P1K5	386	D	N
Q9NQ38	LB/B	-	W5P1K5	395	V	M
Q9NQ38	LB/B	-	W5P1K5	441	R	H
Q9NQ38	LB/B	-	W5P1K5	588	I	M
Q9NQ38	LB/B	-	W5P1K5	711	R	Q
Q9NQ38	LB/B	-	W5P1K5	825	E	D
Q9NQ38	LB/B	-	W5P1K5	887	S	R
Q9NQ38	LB/B	-	W5P1K5	969	K	E
Q9NQ38	LB/B	-	W5P1K5	972	H	R
Q9NQ38	LB/B	-	W5P1K5	335	A	V
Q6UWN8	LB/B	-	A0A1U7RVR7	36	P	T
P0C7L1	LB/B	-	G1L3H0	78	K	N
O43278	LB/B	-	G3WU07	123	Y	C
O43278	LB/B	-	G3WU07	142	T	R
O43278	LB/B	-	G3WU07	337	P	L
O43291	LB/B	-	A0A2K5BW18	200	V	L
O43291	LP/P	Diarrhea 3, secretory sodium, congenital, with or without other congenital anomalies (DIAR3) [MIM:270420]	A0A2K5BW18	163	Y	C
P49223	LB/B	-	F7HCK1	77	L	S
P16150	LB/B	-	A0A2U4A8K5	22	T	I
P16150	LB/B	-	A0A2U4A8K5	93	T	A
Q6ZMD2	LB/B	-	A0A226PGP4	293	G	R
Q6ZMD2	LB/B	-	A0A226PGP4	330	A	S
Q9Y5K1	LB/B	-	Q6P0S6	36	T	A
Q9Y5K1	LB/B	-	Q6P0S6	211	R	W
Q9Y5K1	LB/B	-	Q6P0S6	91	M	V
Q9Y5K1	LB/B	-	Q6P0S6	202	A	V
Q6ZMY3	LB/B	-	H2N866	109	T	A
Q6ZMY3	LB/B	-	H2N866	436	R	W
O43791	LP/P	Nabais Sa-de Vries syndrome 2 (NSDVS2) [MIM:618829]	A0A1S3I9S6	25	T	A
O43791	LP/P	Nabais Sa-de Vries syndrome 2 (NSDVS2) [MIM:618829]	A0A1S3I9S6	83	Y	C
O43791	LP/P	Nabais Sa-de Vries syndrome 1 (NSDVS1) [MIM:618828]	A0A1S3I9S6	121	R	Q
O43791	LP/P	Nabais Sa-de Vries syndrome 2 (NSDVS2) [MIM:618829]	A0A1S3I9S6	132	G	V
O43791	LP/P	Nabais Sa-de Vries syndrome 2 (NSDVS2) [MIM:618829]	A0A1S3I9S6	138	R	C
O43791	LP/P	Nabais Sa-de Vries syndrome 1 (NSDVS1) [MIM:618828]	A0A1S3I9S6	144	D	N
Q6IQ16	LB/B	-	A0A1S3I9S6	45	R	Q
Q13103	LB/B	-	F7GVY9	38	S	F
Q7Z699	LP/P	Legius syndrome (LGSS) [MIM:611431]	A0A1W4Z4D3	31	W	C
Q7Z699	LP/P	Legius syndrome (LGSS) [MIM:611431]	A0A1W4Z4D3	44	V	D
Q7Z698	LP/P	Noonan syndrome 14 (NS14) [MIM:619745]	A0A2P6LAN3	100	L	P
Q5BIV9	LB/B	-	A0A2R8PMR5	7	T	M
P35325	LB/B	-	G3TW52	39	P	S
P22532	LB/B	-	G3TW52	20	T	A
Q9UBC9	LB/B	-	A0A0D9SAQ6	149	L	V
Q9UBC9	LB/B	-	A0A0D9SAQ6	156	T	M
Q96PI1	LB/B	-	A0A1U7V225	45	P	S
Q9H040	LB/B	-	G1L772	296	P	L
Q9H040	LP/P	Ruijs-Aalfs syndrome (RJALS) [MIM:616200]	G1L772	117	Y	C
O43597	LB/B	-	G3VYZ1	106	P	S
O43597	LP/P	IgA nephropathy 3 (IGAN3) [MIM:616818]	G3VYZ1	119	R	W
Q9C004	LP/P	Hypogonadotropic hypogonadism 17 with or without anosmia (HH17) [MIM:615266]	A0A091CP76	77	T	M
Q9C004	LP/P	Hypogonadotropic hypogonadism 17 with or without anosmia (HH17) [MIM:615266]	A0A091CP76	82	D	N
Q9C004	LP/P	Hypogonadotropic hypogonadism 17 with or without anosmia (HH17) [MIM:615266]	A0A091CP76	154	K	R
Q9C004	LP/P	Hypogonadotropic hypogonadism 17 with or without anosmia (HH17) [MIM:615266]	A0A091CP76	186	C	Y
Q9C004	LP/P	Hypogonadotropic hypogonadism 17 with or without anosmia (HH17) [MIM:615266]	A0A091CP76	218	S	Y
Q9C004	LP/P	Hypogonadotropic hypogonadism 17 with or without anosmia (HH17) [MIM:615266]	A0A091CP76	258	V	M
Q9C004	LP/P	Hypogonadotropic hypogonadism 17 with or without anosmia (HH17) [MIM:615266]	A0A091CP76	281	V	I
P02549	LP/P	Elliptocytosis 2 (EL2) [MIM:130600]	F1KPR0	24	I	S
P02549	LP/P	Elliptocytosis 2 (EL2) [MIM:130600]	F1KPR0	28	R	H
P02549	LP/P	Elliptocytosis 2 (EL2) [MIM:130600]	F1KPR0	28	R	L
P02549	LP/P	Elliptocytosis 2 (EL2) [MIM:130600]	F1KPR0	28	R	S
P02549	LP/P	Elliptocytosis 2 (EL2) [MIM:130600]	F1KPR0	28	R	C
P02549	LP/P	Elliptocytosis 2 (EL2) [MIM:130600]	F1KPR0	31	V	A
P02549	LP/P	Elliptocytosis 2 (EL2) [MIM:130600]	F1KPR0	34	R	W
P02549	LP/P	Elliptocytosis 2 (EL2) [MIM:130600]	F1KPR0	41	R	W
P02549	LP/P	Elliptocytosis 2 (EL2) [MIM:130600]	F1KPR0	45	R	S
P02549	LP/P	Elliptocytosis 2 (EL2) [MIM:130600]	F1KPR0	45	R	T
P02549	LP/P	Elliptocytosis 2 (EL2) [MIM:130600]	F1KPR0	46	G	V
P02549	LP/P	Hereditary pyropoikilocytosis (HPP) [MIM:266140]	F1KPR0	48	K	R
P02549	LP/P	Elliptocytosis 2 (EL2) [MIM:130600]	F1KPR0	49	L	F
P02549	LP/P	Elliptocytosis 2 (EL2) [MIM:130600]	F1KPR0	151	G	D
P02549	LP/P	Elliptocytosis 2 (EL2) [MIM:130600]	F1KPR0	207	L	P
P02549	LP/P	Hereditary pyropoikilocytosis (HPP) [MIM:266140]	F1KPR0	207	L	P
P02549	LP/P	Elliptocytosis 2 (EL2) [MIM:130600]	F1KPR0	260	L	P
P02549	LP/P	Elliptocytosis 2 (EL2) [MIM:130600]	F1KPR0	261	S	P
P02549	LP/P	Elliptocytosis 2 (EL2) [MIM:130600]	F1KPR0	469	H	P
P02549	LP/P	Elliptocytosis 2 (EL2) [MIM:130600]	F1KPR0	471	Q	P
P02549	LB/B	-	F1KPR0	701	R	H
P02549	LP/P	Elliptocytosis 2 (EL2) [MIM:130600]	F1KPR0	791	D	E
P02549	LB/B	-	F1KPR0	809	I	V
P02549	LB/B	-	F1KPR0	853	T	R
P02549	LB/B	-	F1KPR0	970	A	D
P02549	LB/B	-	F1KPR0	1858	L	V
P02549	LB/B	-	F1KPR0	109	S	F
P02549	LB/B	-	F1KPR0	152	D	N
P02549	LB/B	-	F1KPR0	766	A	T
P02549	LB/B	-	F1KPR0	957	A	V
P02549	LB/B	-	F1KPR0	1163	S	A
P02549	LB/B	-	F1KPR0	1330	R	I
P02549	LB/B	-	F1KPR0	1568	C	R
P02549	LB/B	-	F1KPR0	1693	K	Q
P02549	LB/B	-	F1KPR0	1836	N	S
P02549	LB/B	-	F1KPR0	2265	I	T
Q13813	LB/B	-	A0A0Q3X5U1	1300	I	T
Q13813	LB/B	-	A0A0Q3X5U1	385	N	S
Q01082	LB/B	-	V8PFR6	1411	D	H
Q01082	LP/P	Developmental delay, impaired speech, and behavioral abnormalities (DDISBA) [MIM:619475]	V8PFR6	59	T	I
Q01082	LP/P	Developmental delay, impaired speech, and behavioral abnormalities (DDISBA) [MIM:619475]	V8PFR6	205	G	D
Q01082	LP/P	Developmental delay, impaired speech, and behavioral abnormalities (DDISBA) [MIM:619475]	V8PFR6	205	G	S
Q01082	LP/P	Developmental delay, impaired speech, and behavioral abnormalities (DDISBA) [MIM:619475]	V8PFR6	247	L	H
Q01082	LP/P	Developmental delay, impaired speech, and behavioral abnormalities (DDISBA) [MIM:619475]	V8PFR6	250	L	R
Q01082	LP/P	Developmental delay, impaired speech, and behavioral abnormalities (DDISBA) [MIM:619475]	V8PFR6	255	D	E
Q01082	LP/P	Developmental delay, impaired speech, and behavioral abnormalities (DDISBA) [MIM:619475]	V8PFR6	268	T	A
Q01082	LP/P	Developmental delay, impaired speech, and behavioral abnormalities (DDISBA) [MIM:619475]	V8PFR6	268	T	N
Q01082	LP/P	Developmental delay, impaired speech, and behavioral abnormalities (DDISBA) [MIM:619475]	V8PFR6	268	T	S
Q01082	LP/P	Developmental delay, impaired speech, and behavioral abnormalities (DDISBA) [MIM:619475]	V8PFR6	271	V	M
Q01082	LP/P	Developmental delay, impaired speech, and behavioral abnormalities (DDISBA) [MIM:619475]	V8PFR6	275	H	R
Q01082	LP/P	Developmental delay, impaired speech, and behavioral abnormalities (DDISBA) [MIM:619475]	V8PFR6	411	R	Q
Q01082	LP/P	Developmental delay, impaired speech, and behavioral abnormalities (DDISBA) [MIM:619475]	V8PFR6	411	R	W
Q01082	LP/P	Developmental delay, impaired speech, and behavioral abnormalities (DDISBA) [MIM:619475]	V8PFR6	491	E	Q
Q01082	LP/P	Developmental delay, impaired speech, and behavioral abnormalities (DDISBA) [MIM:619475]	V8PFR6	850	A	G
Q01082	LP/P	Developmental delay, impaired speech, and behavioral abnormalities (DDISBA) [MIM:619475]	V8PFR6	1003	R	W
Q01082	LP/P	Developmental delay, impaired speech, and behavioral abnormalities (DDISBA) [MIM:619475]	V8PFR6	1086	A	T
Q01082	LP/P	Developmental delay, impaired speech, and behavioral abnormalities (DDISBA) [MIM:619475]	V8PFR6	1110	E	D
Q01082	LP/P	Developmental delay, impaired speech, and behavioral abnormalities (DDISBA) [MIM:619475]	V8PFR6	1674	S	P
Q01082	LP/P	Developmental delay, impaired speech, and behavioral abnormalities (DDISBA) [MIM:619475]	V8PFR6	1886	E	Q
Q9NRC6	LB/B	-	A0A091THL9	1345	R	H
Q9NRC6	LB/B	-	A0A091THL9	1367	R	T
Q9NRC6	LB/B	-	A0A091THL9	2862	Q	R
Q9NRC6	LB/B	-	A0A091THL9	3275	A	G
O15269	LP/P	Neuropathy, hereditary sensory and autonomic, 1A (HSAN1A) [MIM:162400]	A7SJP9	133	C	W
O15269	LP/P	Neuropathy, hereditary sensory and autonomic, 1A (HSAN1A) [MIM:162400]	A7SJP9	133	C	Y
O15269	LP/P	Neuropathy, hereditary sensory and autonomic, 1A (HSAN1A) [MIM:162400]	A7SJP9	144	V	D
O15269	LB/B	-	A7SJP9	151	R	L
O15269	LB/B	-	A7SJP9	387	G	A
O15269	LP/P	Neuropathy, hereditary sensory and autonomic, 1A (HSAN1A) [MIM:162400]	A7SJP9	331	S	F
O15269	LP/P	Neuropathy, hereditary sensory and autonomic, 1A (HSAN1A) [MIM:162400]	A7SJP9	352	A	V
O15269	LP/P	-	A7SJP9	331	S	Y
O15270	LP/P	Neuropathy, hereditary sensory and autonomic, 1C (HSAN1C) [MIM:613640]	G5ALV7	359	V	M
O15270	LP/P	Neuropathy, hereditary sensory and autonomic, 1C (HSAN1C) [MIM:613640]	G5ALV7	382	G	V
O15270	LP/P	Neuropathy, hereditary sensory and autonomic, 1C (HSAN1C) [MIM:613640]	G5ALV7	504	I	F
O15270	LP/P	Neuropathy, hereditary sensory and autonomic, 1C (HSAN1C) [MIM:613640]	G5ALV7	182	A	P
O15270	LP/P	Neuropathy, hereditary sensory and autonomic, 1C (HSAN1C) [MIM:613640]	G5ALV7	183	R	W
Q9NUV7	LB/B	-	A0A146ZIX8	140	L	V
Q68D10	LB/B	-	H0VKH1	317	S	F
Q68D10	LB/B	-	H0VKH1	447	R	Q
Q68D10	LB/B	-	H0VKH1	617	K	R
Q9HD15	LB/B	-	F7CNG7	20	Q	E
Q8NEQ6	LB/B	-	F7H4J0	112	L	F
P12931	LB/B	-	A0A1A8HQL5	237	A	T
P12931	LB/B	-	A0A1A8HQL5	176	L	F
P12931	LP/P	Thrombocytopenia 6 (THC6) [MIM:616937]	A0A1A8HQL5	527	E	K
P31213	LP/P	Pseudovaginal perineoscrotal hypospadias (PPSH) [MIM:264600]	R4GCD2	246	R	W
P31213	LB/B	-	R4GCD2	49	A	T
P31213	LP/P	Pseudovaginal perineoscrotal hypospadias (PPSH) [MIM:264600]	R4GCD2	55	L	Q
P31213	LP/P	Pseudovaginal perineoscrotal hypospadias (PPSH) [MIM:264600]	R4GCD2	115	G	D
P31213	LP/P	Pseudovaginal perineoscrotal hypospadias (PPSH) [MIM:264600]	R4GCD2	183	G	S
P31213	LP/P	Pseudovaginal perineoscrotal hypospadias (PPSH) [MIM:264600]	R4GCD2	196	G	S
P31213	LP/P	Pseudovaginal perineoscrotal hypospadias (PPSH) [MIM:264600]	R4GCD2	197	E	D
P31213	LP/P	Pseudovaginal perineoscrotal hypospadias (PPSH) [MIM:264600]	R4GCD2	212	P	R
P31213	LP/P	Pseudovaginal perineoscrotal hypospadias (PPSH) [MIM:264600]	R4GCD2	228	A	T
P31213	LP/P	Pseudovaginal perineoscrotal hypospadias (PPSH) [MIM:264600]	R4GCD2	231	H	R
P31213	LP/P	Pseudovaginal perineoscrotal hypospadias (PPSH) [MIM:264600]	R4GCD2	85	G	D
P31213	LB/B	-	R4GCD2	89	V	L
P31213	LP/P	Pseudovaginal perineoscrotal hypospadias (PPSH) [MIM:264600]	R4GCD2	200	E	K
P31213	LP/P	Pseudovaginal perineoscrotal hypospadias (PPSH) [MIM:264600]	R4GCD2	245	S	Y
P31213	LP/P	Pseudovaginal perineoscrotal hypospadias (PPSH) [MIM:264600]	R4GCD2	246	R	Q
P31213	LB/B	-	R4GCD2	113	L	V
P31213	LP/P	Pseudovaginal perineoscrotal hypospadias (PPSH) [MIM:264600]	R4GCD2	145	R	W
P31213	LP/P	Pseudovaginal perineoscrotal hypospadias (PPSH) [MIM:264600]	R4GCD2	181	P	L
P31213	LP/P	Pseudovaginal perineoscrotal hypospadias (PPSH) [MIM:264600]	R4GCD2	235	Y	F
P31213	LP/P	Pseudovaginal perineoscrotal hypospadias (PPSH) [MIM:264600]	R4GCD2	123	G	R
P31213	LP/P	Pseudovaginal perineoscrotal hypospadias (PPSH) [MIM:264600]	R4GCD2	126	Q	R
P31213	LP/P	Pseudovaginal perineoscrotal hypospadias (PPSH) [MIM:264600]	R4GCD2	158	G	R
P31213	LP/P	Pseudovaginal perineoscrotal hypospadias (PPSH) [MIM:264600]	R4GCD2	207	A	D
P31213	LB/B	-	R4GCD2	224	L	M
P31213	LP/P	Pseudovaginal perineoscrotal hypospadias (PPSH) [MIM:264600]	R4GCD2	227	R	Q
P31213	LB/B	-	R4GCD2	203	G	S
P31213	LB/B	-	R4GCD2	224	L	H
P31213	LB/B	-	R4GCD2	5	C	R
P31213	LB/B	-	R4GCD2	48	P	R
P31213	LB/B	-	R4GCD2	51	A	T
P31213	LB/B	-	R4GCD2	187	T	M
P31213	LB/B	-	R4GCD2	194	F	L
P31213	LB/B	-	R4GCD2	234	F	L
P36956	LB/B	-	A0A1U8DEF4	306	N	S
P36956	LB/B	-	A0A1U8DEF4	309	A	T
P36956	LB/B	-	A0A1U8DEF4	417	V	M
P36956	LB/B	-	A0A1U8DEF4	580	V	M
P36956	LB/B	-	A0A1U8DEF4	746	R	H
P36956	LB/B	-	A0A1U8DEF4	834	S	L
P36956	LB/B	-	A0A1U8DEF4	1000	T	A
P36956	LB/B	-	A0A1U8DEF4	1008	A	P
P36956	LP/P	IFAP syndrome 2 (IFAP2) [MIM:619016]	A0A1U8DEF4	527	R	C
P36956	LP/P	Mucoepithelial dysplasia, hereditary (HMD) [MIM:158310]	A0A1U8DEF4	527	R	C
P36956	LP/P	Mucoepithelial dysplasia, hereditary (HMD) [MIM:158310]	A0A1U8DEF4	527	R	H
P36956	LP/P	IFAP syndrome 2 (IFAP2) [MIM:619016]	A0A1U8DEF4	530	L	P
Q7Z6B7	LP/P	Thyroid cancer, non-medullary, 2 (NMTC2) [MIM:188470]	I3J8M0	149	Q	H
Q7Z6B7	LP/P	Thyroid cancer, non-medullary, 2 (NMTC2) [MIM:188470]	I3J8M0	275	A	T
Q7Z6B7	LB/B	-	I3J8M0	512	V	I
Q7Z6B7	LP/P	Thyroid cancer, non-medullary, 2 (NMTC2) [MIM:188470]	I3J8M0	617	R	C
Q7Z6B7	LP/P	Thyroid cancer, non-medullary, 2 (NMTC2) [MIM:188470]	I3J8M0	875	H	R
O75044	LB/B	-	A0A1S3LCM8	874	R	G
O43295	LB/B	-	I3J8M0	628	I	V
P10124	LB/B	-	G1TRF0	31	R	Q
Q9H3Y6	LB/B	-	A0A2Y9T6E9	73	R	C
Q9H3Y6	LB/B	-	A0A2Y9T6E9	75	G	R
Q9H3Y6	LB/B	-	A0A2Y9T6E9	88	I	V
Q9H3Y6	LB/B	-	A0A2Y9T6E9	301	V	L
Q9H3Y6	LB/B	-	A0A2Y9T6E9	377	D	E
Q9H3Y6	LB/B	-	A0A2Y9T6E9	397	A	V
Q9H3Y6	LB/B	-	A0A2Y9T6E9	452	P	L
Q9H3Y6	LB/B	-	A0A2Y9T6E9	453	A	T
Q9H3Y6	LB/B	-	A0A2Y9T6E9	457	V	L
Q9H3Y6	LB/B	-	A0A2Y9T6E9	465	S	T
Q9H3Y6	LB/B	-	A0A2Y9T6E9	218	P	L
Q9H3Y6	LB/B	-	A0A2Y9T6E9	255	V	M
Q9H3Y6	LB/B	-	A0A2Y9T6E9	325	P	L
P09132	LB/B	-	A0A2K5ND67	4	A	T
P61011	LP/P	Neutropenia, severe congenital 8, autosomal dominant (SCN8) [MIM:618752]	A0A0F8AE77	113	G	R
P61011	LP/P	Neutropenia, severe congenital 8, autosomal dominant (SCN8) [MIM:618752]	A0A0F8AE77	115	T	A
P61011	LP/P	Neutropenia, severe congenital 8, autosomal dominant (SCN8) [MIM:618752]	A0A0F8AE77	118	C	Y
P61011	LP/P	Neutropenia, severe congenital 8, autosomal dominant (SCN8) [MIM:618752]	A0A0F8AE77	136	C	Y
P61011	LP/P	Neutropenia, severe congenital 8, autosomal dominant (SCN8) [MIM:618752]	A0A0F8AE77	223	A	D
P61011	LP/P	Neutropenia, severe congenital 8, autosomal dominant (SCN8) [MIM:618752]	A0A0F8AE77	226	G	E
P61011	LP/P	Neutropenia, severe congenital 8, autosomal dominant (SCN8) [MIM:618752]	A0A0F8AE77	274	G	D
O76094	LP/P	Bone marrow failure syndrome 1 (BMFS1) [MIM:614675]	H2PDC6	207	R	H
Q96SB4	LB/B	-	E2RL63	72	I	T
P78362	LB/B	-	A0A091DEZ5	43	P	L
P78362	LB/B	-	A0A091DEZ5	426	T	P
P78362	LB/B	-	A0A091DEZ5	486	S	F
P78362	LB/B	-	A0A091DEZ5	515	P	T
P78362	LB/B	-	A0A091DEZ5	615	L	I
P78362	LB/B	-	A0A091DEZ5	608	S	N
Q9UPE1	LB/B	-	A0A1S3GN98	101	R	C
Q9UPE1	LB/B	-	A0A1S3GN98	114	G	E
Q9UPE1	LB/B	-	A0A1S3GN98	233	E	K
P78539	LB/B	-	H3B8Z2	225	P	S
P78539	LB/B	-	H3B8Z2	413	S	F
O60687	LB/B	-	H3B8Z2	287	T	S
Q9UH36	LB/B	-	S7N1N3	99	A	T
A7MD48	LB/B	-	G7PIT2	243	S	N
A7MD48	LB/B	-	G7PIT2	406	R	Q
A7MD48	LB/B	-	G7PIT2	547	R	S
Q08170	LB/B	-	A0A2K5F1Z2	253	E	D
Q08170	LB/B	-	A0A2K5F1Z2	338	G	A
Q08170	LB/B	-	A0A2K5F1Z2	356	G	S
Q08170	LB/B	-	A0A2K5F1Z2	438	Q	E
Q13243	LB/B	-	V8PEZ8	160	A	S
Q05066	LP/P	46,XY sex reversal 1 (SRXY1) [MIM:400044]	A0A0S1U3N3	18	S	N
Q05066	LP/P	46,XY sex reversal 1 (SRXY1) [MIM:400044]	A0A0S1U3N3	60	V	A
Q05066	LP/P	46,XY sex reversal 1 (SRXY1) [MIM:400044]	A0A0S1U3N3	60	V	L
Q05066	LP/P	46,XY sex reversal 1 (SRXY1) [MIM:400044]	A0A0S1U3N3	62	R	G
Q05066	LP/P	46,XY sex reversal 1 (SRXY1) [MIM:400044]	A0A0S1U3N3	64	M	I
Q05066	LP/P	46,XY sex reversal 1 (SRXY1) [MIM:400044]	A0A0S1U3N3	68	I	T
Q05066	LP/P	46,XY sex reversal 1 (SRXY1) [MIM:400044]	A0A0S1U3N3	78	M	T
Q05066	LP/P	46,XY sex reversal 1 (SRXY1) [MIM:400044]	A0A0S1U3N3	90	I	M
Q05066	LP/P	46,XY sex reversal 1 (SRXY1) [MIM:400044]	A0A0S1U3N3	91	S	G
Q05066	LP/P	46,XY sex reversal 1 (SRXY1) [MIM:400044]	A0A0S1U3N3	95	G	R
Q05066	LP/P	46,XY sex reversal 1 (SRXY1) [MIM:400044]	A0A0S1U3N3	101	L	H
Q05066	LP/P	46,XY sex reversal 1 (SRXY1) [MIM:400044]	A0A0S1U3N3	106	K	I
Q05066	LP/P	46,XY sex reversal 1 (SRXY1) [MIM:400044]	A0A0S1U3N3	108	P	R
Q05066	LP/P	46,XY sex reversal 1 (SRXY1) [MIM:400044]	A0A0S1U3N3	109	F	S
Q05066	LP/P	46,XY sex reversal 1 (SRXY1) [MIM:400044]	A0A0S1U3N3	113	A	T
Q05066	LP/P	46,XY sex reversal 1 (SRXY1) [MIM:400044]	A0A0S1U3N3	125	P	L
Q05066	LP/P	46,XY sex reversal 1 (SRXY1) [MIM:400044]	A0A0S1U3N3	127	Y	C
Q05066	LP/P	46,XY sex reversal 1 (SRXY1) [MIM:400044]	A0A0S1U3N3	133	R	W
Q05066	LP/P	46,XY sex reversal 1 (SRXY1) [MIM:400044]	A0A0S1U3N3	64	M	R
Q05066	LP/P	46,XY sex reversal 1 (SRXY1) [MIM:400044]	A0A0S1U3N3	67	F	V
Q05066	LP/P	46,XY sex reversal 1 (SRXY1) [MIM:400044]	A0A0S1U3N3	76	R	S
Q05066	LP/P	46,XY sex reversal 1 (SRXY1) [MIM:400044]	A0A0S1U3N3	87	N	Y
Q05066	LP/P	46,XY sex reversal 1 (SRXY1) [MIM:400044]	A0A0S1U3N3	95	G	E
Q05066	LP/P	46,XY sex reversal 1 (SRXY1) [MIM:400044]	A0A0S1U3N3	127	Y	F
Q05066	LP/P	46,XY sex reversal 1 (SRXY1) [MIM:400044]	A0A0S1U3N3	131	P	R
Q05066	LP/P	46,XY sex reversal 1 (SRXY1) [MIM:400044]	A0A0S1U3N3	3	S	L
Q05066	LP/P	46,XY sex reversal 1 (SRXY1) [MIM:400044]	A0A0S1U3N3	75	R	M
O75177	LB/B	-	S9YTZ1	321	A	T
O75177	LB/B	-	S9YTZ1	189	M	I
Q04837	LP/P	Optic atrophy 13 with retinal and foveal abnormalities (OPA13) [MIM:165510]	A0A287D4B8	38	R	Q
Q04837	LP/P	Optic atrophy 13 with retinal and foveal abnormalities (OPA13) [MIM:165510]	A0A287D4B8	40	G	V
Q04837	LP/P	Optic atrophy 13 with retinal and foveal abnormalities (OPA13) [MIM:165510]	A0A287D4B8	62	N	D
Q04837	LP/P	Optic atrophy 13 with retinal and foveal abnormalities (OPA13) [MIM:165510]	A0A287D4B8	107	R	Q
Q04837	LP/P	Optic atrophy 13 with retinal and foveal abnormalities (OPA13) [MIM:165510]	A0A287D4B8	111	E	Q
Q04837	LP/P	Optic atrophy 13 with retinal and foveal abnormalities (OPA13) [MIM:165510]	A0A287D4B8	141	S	N
Q8WTU2	LB/B	-	A0A1S3GEB8	128	R	H
Q76I76	LB/B	-	A0A099Z5U9	743	S	L
Q76I76	LB/B	-	A0A099Z5U9	763	V	A
Q76I76	LB/B	-	A0A099Z5U9	1300	H	Q
Q8TE77	LB/B	-	G1KHA2	239	E	V
Q8TE77	LB/B	-	G1KHA2	600	R	H
Q8WWF3	LB/B	-	A0A151NQ01	88	R	W
A2VEC9	LB/B	-	H2LGR4	146	Q	R
A2VEC9	LB/B	-	H2LGR4	298	V	M
A2VEC9	LB/B	-	H2LGR4	1274	L	P
A2VEC9	LB/B	-	H2LGR4	540	V	M
A2VEC9	LB/B	-	H2LGR4	1273	S	P
A2VEC9	LB/B	-	H2LGR4	1425	S	G
A2VEC9	LB/B	-	H2LGR4	1449	P	Q
A2VEC9	LB/B	-	H2LGR4	1454	P	R
A2VEC9	LB/B	-	H2LGR4	1779	S	P
A2VEC9	LB/B	-	H2LGR4	1794	L	P
A2VEC9	LB/B	-	H2LGR4	1883	R	C
A2VEC9	LB/B	-	H2LGR4	2018	T	M
A2VEC9	LB/B	-	H2LGR4	2892	L	V
A2VEC9	LB/B	-	H2LGR4	3274	R	W
A2VEC9	LB/B	-	H2LGR4	3513	N	S
A2VEC9	LB/B	-	H2LGR4	3894	C	W
A2VEC9	LB/B	-	H2LGR4	3911	R	C
A2VEC9	LB/B	-	H2LGR4	4030	S	I
A2VEC9	LB/B	-	H2LGR4	4166	H	R
A2VEC9	LB/B	-	H2LGR4	4332	R	C
A2VEC9	LB/B	-	H2LGR4	4790	H	R
A2VEC9	LB/B	-	H2LGR4	4944	E	K
A2VEC9	LB/B	-	H2LGR4	2453	M	T
A2VEC9	LB/B	-	H2LGR4	2542	R	Q
A2VEC9	LB/B	-	H2LGR4	4109	Q	H
P43307	LB/B	-	A0A1U7TI21	28	L	S
Q08945	LB/B	-	L5L2R7	225	L	V
Q08945	LB/B	-	L5L2R7	458	E	Q
P61278	LB/B	-	B2D1T8	11	A	V
P61278	LB/B	-	B2D1T8	61	N	T
P31391	LB/B	-	H3AEP3	83	N	T
P31391	LB/B	-	H3AEP3	284	F	V
P31391	LB/B	-	H3AEP3	321	F	S
P31391	LB/B	-	H3AEP3	236	G	D
Q9Y2M2	LB/B	-	H2M2D3	50	P	L
Q9Y2M2	LP/P	-	H2M2D3	140	P	Q
Q9Y2D8	LB/B	-	F6QME7	578	C	R
O60225	LB/B	-	G3SGQ0	19	E	Q
Q7RTT6	LB/B	-	H2PVH8	90	R	C
Q7RTT6	LB/B	-	H2PVH8	138	K	Q
Q7RTT5	LB/B	-	H2PVH8	43	L	S
Q7RTT3	LB/B	-	H2PVH8	72	C	R
Q7RTT3	LB/B	-	H2PVH8	97	S	P
P50502	LB/B	-	A0A2R5LAW2	297	M	I
O60284	LB/B	-	W5MFD8	515	R	C
Q9HBF5	LB/B	-	A0A2J8SKI3	57	P	L
Q8NBB2	LB/B	-	Q8NBB2	62	V	A
Q11203	LP/P	Intellectual developmental disorder, autosomal recessive 12 (MRT12) [MIM:611090]	A0A2R8Y7Z2	13	A	D
Q11203	LP/P	Intellectual developmental disorder, autosomal recessive 12 (MRT12) [MIM:611090]	A0A2R8Y7Z2	370	D	Y
Q11203	LP/P	Developmental and epileptic encephalopathy 15 (DEE15) [MIM:615006]	A0A2R8Y7Z2	320	A	P
Q9Y274	LB/B	-	A0A2D4I5X4	311	A	T
Q96JF0	LB/B	-	H0VTS1	154	G	R
Q96JF0	LB/B	-	H0VTS1	341	I	V
Q9NSC7	LB/B	-	M3YPR9	80	V	A
Q9NSC7	LB/B	-	M3YPR9	424	I	V
Q9NSC7	LP/P	-	M3YPR9	391	R	Q
Q8NDV1	LB/B	-	A0A1S3A299	223	L	I
Q9NRC1	LB/B	-	R0KCF3	186	A	T
Q9NRC1	LB/B	-	R0KCF3	361	I	V
O43173	LB/B	-	A0A2Y9DSA6	91	K	T
Q9NY15	LB/B	-	A0A091L6B9	2506	M	T
Q9NY15	LB/B	-	A0A091L6B9	1127	G	R
Q9NY15	LB/B	-	A0A091L6B9	2282	I	V
Q9NY15	LB/B	-	A0A091L6B9	672	L	M
Q9NY15	LB/B	-	A0A091L6B9	912	M	V
Q9NY15	LB/B	-	A0A091L6B9	1833	A	P
Q8WWQ8	LB/B	-	A0A091L6B9	510	P	H
Q8WWQ8	LB/B	-	A0A091L6B9	110	I	V
Q8WWQ8	LB/B	-	A0A091L6B9	306	E	K
Q8WWQ8	LB/B	-	A0A091L6B9	787	R	Q
Q8WWQ8	LB/B	-	A0A091L6B9	881	R	H
Q8WWQ8	LB/B	-	A0A091L6B9	1736	N	T
Q8WWQ8	LB/B	-	A0A091L6B9	2039	P	T
Q8WWQ8	LB/B	-	A0A091L6B9	2401	L	V
Q8WWQ8	LB/B	-	A0A091L6B9	2519	Y	S
Q96MF2	LP/P	Myopathy, congenital, Bailey-Bloch (MYPBB) [MIM:255995]	H2NHT0	284	W	S
Q8WVM7	LB/B	-	H3BW53	1132	Q	H
Q8WVM7	LP/P	Intellectual developmental disorder, autosomal dominant 47 (MRD47) [MIM:617635]	H3BW53	214	Q	R
Q8WVM7	LP/P	Intellectual developmental disorder, autosomal dominant 47 (MRD47) [MIM:617635]	H3BW53	216	R	G
Q8WVM7	LP/P	Intellectual developmental disorder, autosomal dominant 47 (MRD47) [MIM:617635]	H3BW53	220	H	R
Q8WVM7	LP/P	Intellectual developmental disorder, autosomal dominant 47 (MRD47) [MIM:617635]	H3BW53	333	K	Q
Q8WVM7	LP/P	Intellectual developmental disorder, autosomal dominant 47 (MRD47) [MIM:617635]	H3BW53	351	L	W
Q8WVM7	LP/P	Intellectual developmental disorder, autosomal dominant 47 (MRD47) [MIM:617635]	H3BW53	373	R	Q
Q8WVM7	LP/P	Intellectual developmental disorder, autosomal dominant 47 (MRD47) [MIM:617635]	H3BW53	478	H	P
Q8WVM7	LP/P	Intellectual developmental disorder, autosomal dominant 47 (MRD47) [MIM:617635]	H3BW53	979	K	R
Q8WVM7	LB/B	-	H3BW53	377	R	C
Q8N3U4	LB/B	-	H3BW53	699	N	K
Q8N3U4	LP/P	Mullegama-Klein-Martinez syndrome (MKMS) [MIM:301022]	H3BW53	159	Y	C
Q8N3U4	LP/P	Mullegama-Klein-Martinez syndrome (MKMS) [MIM:301022]	H3BW53	327	S	N
Q8N3U4	LP/P	Mullegama-Klein-Martinez syndrome (MKMS) [MIM:301022]	H3BW53	1009	K	N
Q9UJ98	LP/P	Premature ovarian failure 8 (POF8) [MIM:615723]	K7FX04	321	R	H
Q9UJ98	LP/P	Spermatogenic failure 61 (SPGF61) [MIM:619672]	K7FX04	321	R	H
Q9UJ98	LP/P	Spermatogenic failure 61 (SPGF61) [MIM:619672]	K7FX04	421	L	R
O95630	LP/P	Microcephaly-capillary malformation syndrome (MICCAP) [MIM:614261]	A0A182KBF1	14	R	P
O95630	LP/P	Microcephaly-capillary malformation syndrome (MICCAP) [MIM:614261]	A0A182KBF1	38	R	C
O95630	LP/P	Microcephaly-capillary malformation syndrome (MICCAP) [MIM:614261]	A0A182KBF1	42	E	G
O95630	LP/P	Microcephaly-capillary malformation syndrome (MICCAP) [MIM:614261]	A0A182KBF1	63	Y	C
O95630	LP/P	Microcephaly-capillary malformation syndrome (MICCAP) [MIM:614261]	A0A182KBF1	100	F	Y
O95630	LP/P	Microcephaly-capillary malformation syndrome (MICCAP) [MIM:614261]	A0A182KBF1	313	T	I
Q96FJ0	LB/B	-	A0A0D9R393	196	S	N
Q96FJ0	LB/B	-	A0A0D9R393	204	E	K
Q96FJ0	LB/B	-	A0A0D9R393	210	A	T
P49675	LP/P	Adrenal hyperplasia 1 (AH1) [MIM:201710]	H2SGS8	182	R	L
P49675	LB/B	-	H2SGS8	203	A	D
P49675	LP/P	Adrenal hyperplasia 1 (AH1) [MIM:201710]	H2SGS8	169	E	G
P49675	LP/P	Adrenal hyperplasia 1 (AH1) [MIM:201710]	H2SGS8	169	E	K
P49675	LP/P	Adrenal hyperplasia 1 (AH1) [MIM:201710]	H2SGS8	217	R	T
P49675	LP/P	Adrenal hyperplasia 1 (AH1) [MIM:201710]	H2SGS8	218	A	V
P49675	LP/P	Adrenal hyperplasia 1 (AH1) [MIM:201710]	H2SGS8	225	M	T
P49675	LP/P	Adrenal hyperplasia 1 (AH1) [MIM:201710]	H2SGS8	275	L	P
P49675	LB/B	-	H2SGS8	121	R	W
Q9NSY2	LB/B	-	W5LKQ3	74	G	S
P59095	LB/B	-	A0A2K6MCS3	159	E	K
Q9NQZ5	LB/B	-	H2TKU9	140	R	P
P42224	LP/P	Immunodeficiency 31B (IMD31B) [MIM:613796]	H3ADH2	600	L	P
P42224	LP/P	Immunodeficiency 31A (IMD31A) [MIM:614892]	H3ADH2	706	L	S
P42224	LB/B	-	H3ADH2	30	I	T
P42224	LP/P	Immunodeficiency 31B (IMD31B) [MIM:613796]	H3ADH2	201	K	N
P42224	LP/P	Immunodeficiency 31A (IMD31A) [MIM:614892]	H3ADH2	320	E	Q
P42224	LP/P	Immunodeficiency 31A (IMD31A) [MIM:614892]	H3ADH2	463	Q	H
P42224	LP/P	Immunodeficiency 31C (IMD31C) [MIM:614162]	H3ADH2	165	D	G
P42224	LP/P	Immunodeficiency 31C (IMD31C) [MIM:614162]	H3ADH2	165	D	H
P42224	LP/P	Immunodeficiency 31C (IMD31C) [MIM:614162]	H3ADH2	170	Y	N
P42224	LP/P	Immunodeficiency 31C (IMD31C) [MIM:614162]	H3ADH2	174	C	R
P42224	LP/P	Immunodeficiency 31C (IMD31C) [MIM:614162]	H3ADH2	202	M	I
P42224	LP/P	Immunodeficiency 31C (IMD31C) [MIM:614162]	H3ADH2	202	M	V
P42224	LP/P	Immunodeficiency 31C (IMD31C) [MIM:614162]	H3ADH2	267	A	V
P42224	LP/P	Immunodeficiency 31C (IMD31C) [MIM:614162]	H3ADH2	271	Q	P
P42224	LP/P	Immunodeficiency 31C (IMD31C) [MIM:614162]	H3ADH2	274	R	Q
P42224	LP/P	Immunodeficiency 31C (IMD31C) [MIM:614162]	H3ADH2	274	R	W
P42224	LP/P	Immunodeficiency 31C (IMD31C) [MIM:614162]	H3ADH2	286	K	I
P42224	LP/P	Immunodeficiency 31C (IMD31C) [MIM:614162]	H3ADH2	288	T	A
P42224	LP/P	Immunodeficiency 31A (IMD31A) [MIM:614892]	H3ADH2	637	K	E
P42224	LP/P	Immunodeficiency 31A (IMD31A) [MIM:614892]	H3ADH2	673	K	R
P42224	LP/P	Immunodeficiency 31C (IMD31C) [MIM:614162]	H3ADH2	179	N	K
P42224	LP/P	Immunodeficiency 31C (IMD31C) [MIM:614162]	H3ADH2	278	K	E
P42224	LP/P	Immunodeficiency 31C (IMD31C) [MIM:614162]	H3ADH2	285	Q	R
P42224	LP/P	Immunodeficiency 31C (IMD31C) [MIM:614162]	H3ADH2	298	K	N
P42224	LP/P	Immunodeficiency 31C (IMD31C) [MIM:614162]	H3ADH2	384	G	D
P42224	LP/P	Immunodeficiency 31C (IMD31C) [MIM:614162]	H3ADH2	385	T	M
P42224	LP/P	Immunodeficiency 31B (IMD31B) [MIM:613796]	H3ADH2	701	Y	C
P52630	LB/B	-	A0A2Y9MYK6	66	Q	H
P52630	LB/B	-	A0A2Y9MYK6	220	L	P
P52630	LB/B	-	A0A2Y9MYK6	448	T	M
P52630	LB/B	-	A0A2Y9MYK6	464	I	V
P52630	LB/B	-	A0A2Y9MYK6	501	S	I
P52630	LB/B	-	A0A2Y9MYK6	594	M	I
P52630	LB/B	-	A0A2Y9MYK6	826	Q	H
P52630	LB/B	-	A0A2Y9MYK6	246	C	S
P52630	LP/P	Pseudo-TORCH syndrome 3 (PTORCH3) [MIM:618886]	A0A2Y9MYK6	148	R	Q
P52630	LP/P	Pseudo-TORCH syndrome 3 (PTORCH3) [MIM:618886]	A0A2Y9MYK6	148	R	W
Q14765	LB/B	-	H3ADH2	115	I	V
Q14765	LB/B	-	H3ADH2	584	R	W
P42229	LB/B	-	H2MH80	389	R	H
P42226	LB/B	-	A0A1S3FJS3	181	M	R
P42226	LB/B	-	A0A1S3FJS3	419	D	N
Q9NUL3	LB/B	-	H2MXL0	198	V	M
Q9UHE8	LB/B	-	A4D1F3	47	H	Q
Q9UHE8	LB/B	-	A4D1F3	169	F	L
Q6NZ63	LB/B	-	G3QHK2	7	I	V
Q6NZ63	LB/B	-	G3QHK2	29	Q	R
Q6NZ63	LB/B	-	G3QHK2	166	R	M
Q6NZ63	LB/B	-	G3QHK2	210	I	T
Q8NFT2	LB/B	-	A0A060X979	214	G	E
Q8NFT2	LB/B	-	A0A060X979	456	R	Q
Q8NFT2	LB/B	-	A0A060X979	17	F	C
Q8NFT2	LB/B	-	A0A060X979	40	D	Y
Q8NFT2	LB/B	-	A0A060X979	475	M	I
Q658P3	LB/B	-	A0A1S3PPD7	184	A	T
Q687X5	LB/B	-	A0A091N5N5	75	G	D
Q687X5	LB/B	-	A0A091N5N5	122	A	T
Q8IWL8	LB/B	-	A0A0U1SNL1	7	Q	R
Q15468	LB/B	-	S7NNP0	86	A	V
Q15468	LB/B	-	S7NNP0	984	H	R
Q15468	LB/B	-	S7NNP0	1012	P	R
Q15468	LB/B	-	S7NNP0	1145	A	V
Q15468	LP/P	Microcephaly 7, primary, autosomal recessive (MCPH7) [MIM:612703]	S7NNP0	798	L	W
Q13586	LB/B	-	A0A1S3RFX3	538	P	S
Q13586	LP/P	Myopathy, tubular aggregate, 1 (TAM1) [MIM:160565]	A0A1S3RFX3	72	H	Q
Q13586	LP/P	Myopathy, tubular aggregate, 1 (TAM1) [MIM:160565]	A0A1S3RFX3	84	D	G
Q13586	LP/P	Myopathy, tubular aggregate, 1 (TAM1) [MIM:160565]	A0A1S3RFX3	109	H	N
Q13586	LP/P	Myopathy, tubular aggregate, 1 (TAM1) [MIM:160565]	A0A1S3RFX3	109	H	R
Q13586	LP/P	Immunodeficiency 10 (IMD10) [MIM:612783]	A0A1S3RFX3	429	R	C
Q13586	LP/P	Stormorken syndrome (STRMK) [MIM:185070]	A0A1S3RFX3	304	R	W
Q13586	LP/P	-	A0A1S3RFX3	426	R	C
Q13586	LP/P	Myopathy, tubular aggregate, 1 (TAM1) [MIM:160565]	A0A1S3RFX3	115	I	F
Q13586	LP/P	Stormorken syndrome (STRMK) [MIM:185070]	A0A1S3RFX3	115	I	F
Q13586	LP/P	Myopathy, tubular aggregate, 1 (TAM1) [MIM:160565]	A0A1S3RFX3	80	N	T
Q13586	LP/P	Myopathy, tubular aggregate, 1 (TAM1) [MIM:160565]	A0A1S3RFX3	81	G	D
Q13586	LP/P	Myopathy, tubular aggregate, 1 (TAM1) [MIM:160565]	A0A1S3RFX3	96	L	V
Q13586	LP/P	Myopathy, tubular aggregate, 1 (TAM1) [MIM:160565]	A0A1S3RFX3	108	F	I
Q13586	LP/P	Myopathy, tubular aggregate, 1 (TAM1) [MIM:160565]	A0A1S3RFX3	108	F	L
Q86WV6	LB/B	-	A0A1A6FWE1	71	R	H
Q86WV6	LB/B	-	A0A1A6FWE1	232	H	R
Q86WV6	LB/B	-	A0A1A6FWE1	293	R	Q
Q86WV6	LP/P	STING-associated vasculopathy, infantile-onset (SAVI) [MIM:615934]	A0A1A6FWE1	147	V	L
Q86WV6	LP/P	STING-associated vasculopathy, infantile-onset (SAVI) [MIM:615934]	A0A1A6FWE1	154	N	S
Q86WV6	LP/P	STING-associated vasculopathy, infantile-onset (SAVI) [MIM:615934]	A0A1A6FWE1	155	V	M
Q86WV6	LP/P	-	A0A1A6FWE1	284	R	S
O94804	LP/P	Testicular germ cell tumor (TGCT) [MIM:273300]	A0A1S3L661	277	K	E
O94804	LB/B	-	A0A1S3L661	268	R	C
O94804	LB/B	-	A0A1S3L661	322	R	W
O94804	LB/B	-	A0A1S3L661	336	T	I
O94804	LB/B	-	A0A1S3L661	467	N	S
O94804	LB/B	-	A0A1S3L661	710	M	T
O94804	LB/B	-	A0A1S3L661	853	S	L
O94804	LB/B	-	A0A1S3L661	905	S	T
O94804	LB/B	-	A0A1S3L661	947	C	Y
O94804	LB/B	-	A0A1S3L661	480	P	L
O94804	LB/B	-	A0A1S3L661	520	P	L
O94804	LB/B	-	A0A1S3L661	942	S	N
Q15831	LP/P	Peutz-Jeghers syndrome (PJS) [MIM:175200]	F6ZGN9	67	L	P
Q15831	LP/P	Peutz-Jeghers syndrome (PJS) [MIM:175200]	F6ZGN9	194	D	N
Q15831	LP/P	Peutz-Jeghers syndrome (PJS) [MIM:175200]	F6ZGN9	297	R	K
Q15831	LP/P	Testicular germ cell tumor (TGCT) [MIM:273300]	F6ZGN9	163	G	D
Q15831	LP/P	Peutz-Jeghers syndrome (PJS) [MIM:175200]	F6ZGN9	239	W	C
Q15831	LP/P	Peutz-Jeghers syndrome (PJS) [MIM:175200]	F6ZGN9	315	P	S
Q15831	LP/P	Peutz-Jeghers syndrome (PJS) [MIM:175200]	F6ZGN9	16	E	G
Q15831	LP/P	Peutz-Jeghers syndrome (PJS) [MIM:175200]	F6ZGN9	176	D	N
Q15831	LP/P	Peutz-Jeghers syndrome (PJS) [MIM:175200]	F6ZGN9	308	W	C
Q8N1F8	LB/B	-	A0A2K6EQQ3	382	R	H
Q8N1F8	LB/B	-	A0A2K6EQQ3	399	R	G
Q8N1F8	LB/B	-	A0A2K6EQQ3	552	V	I
Q8N1F8	LB/B	-	A0A2K6EQQ3	741	S	F
Q8N1F8	LB/B	-	A0A2K6EQQ3	1074	I	V
O75716	LB/B	-	A0A2J8NG48	41	H	R
O75716	LB/B	-	A0A2J8NG48	55	E	K
O75716	LB/B	-	A0A2J8NG48	77	I	V
O75716	LB/B	-	A0A2J8NG48	266	R	W
O75716	LB/B	-	A0A2J8NG48	277	P	L
Q9UEE5	LB/B	-	A0A2K5VDB9	362	K	E
Q9UEE5	LB/B	-	A0A2K5VDB9	286	E	Q
Q9UEE5	LB/B	-	A0A2K5VDB9	126	E	D
Q9UEE5	LB/B	-	A0A2K5VDB9	167	M	T
O94768	LB/B	-	A0A1S3AID0	320	S	F
P49842	LB/B	-	F1N2Q3	89	D	N
P49842	LB/B	-	F1N2Q3	311	S	G
P49842	LB/B	-	F1N2Q3	331	A	V
P49842	LB/B	-	F1N2Q3	39	A	D
Q9Y6E0	LB/B	-	A0A146Z090	414	A	V
Q9Y6E0	LB/B	-	A0A146Z090	426	L	I
Q9P289	LB/B	-	M3XSP8	9	Q	R
Q9P289	LB/B	-	M3XSP8	45	R	C
Q13188	LB/B	-	K1PMC6	418	F	C
Q8WU08	LB/B	-	A0A147ABW2	58	K	M
Q9NY57	LB/B	-	A0A147ABW2	198	R	G
Q9NY57	LB/B	-	A0A147ABW2	244	R	H
Q9NY57	LB/B	-	A0A147ABW2	310	D	V
Q9NY57	LB/B	-	A0A147ABW2	342	K	T
Q86UX6	LB/B	-	A0A147ABW2	334	T	A
Q86UX6	LB/B	-	A0A147ABW2	454	A	T
Q86UX6	LB/B	-	A0A147ABW2	467	E	K
Q9BYT3	LB/B	-	G1PNZ3	98	E	D
Q9BYT3	LB/B	-	G1PNZ3	436	D	E
Q9BYT3	LB/B	-	G1PNZ3	437	A	T
Q9BYT3	LB/B	-	G1PNZ3	458	A	E
Q9BYT3	LB/B	-	G1PNZ3	60	K	E
Q9NRP7	LB/B	-	A0A1L8EYT7	463	K	N
Q9NRP7	LB/B	-	A0A1L8EYT7	767	S	T
Q9NRP7	LB/B	-	A0A1L8EYT7	1003	G	D
Q9NRP7	LB/B	-	A0A1L8EYT7	90	I	M
Q9NRP7	LB/B	-	A0A1L8EYT7	240	R	W
Q9NRP7	LB/B	-	A0A1L8EYT7	295	K	R
Q9NRP7	LB/B	-	A0A1L8EYT7	329	D	N
Q9NRP7	LB/B	-	A0A1L8EYT7	462	L	V
Q9NRP7	LB/B	-	A0A1L8EYT7	476	F	S
Q9NRP7	LB/B	-	A0A1L8EYT7	477	R	W
Q9NRP7	LB/B	-	A0A1L8EYT7	583	R	Q
Q9NRP7	LB/B	-	A0A1L8EYT7	672	L	P
Q9NRP7	LB/B	-	A0A1L8EYT7	816	T	A
Q9NRP7	LB/B	-	A0A1L8EYT7	839	R	Q
Q9NRP7	LB/B	-	A0A1L8EYT7	840	L	V
Q9NRP7	LB/B	-	A0A1L8EYT7	1111	Y	C
Q9NRP7	LB/B	-	A0A1L8EYT7	1112	R	Q
Q9NRP7	LB/B	-	A0A1L8EYT7	1313	H	P
Q9NRP7	LB/B	-	A0A1L8EYT7	638	Q	P
Q9NRP7	LB/B	-	A0A1L8EYT7	1004	V	I
Q13043	LB/B	-	K1PMC6	312	V	M
Q13043	LB/B	-	K1PMC6	162	H	N
Q13043	LB/B	-	K1PMC6	310	R	Q
Q13043	LB/B	-	K1PMC6	355	I	T
Q13043	LB/B	-	K1PMC6	416	P	L
Q8NE28	LB/B	-	A0A2I0M3H1	473	E	K
Q8NE28	LB/B	-	A0A2I0M3H1	568	R	Q
Q8WXE9	LB/B	-	Q4V9G6	307	S	P
Q8WXE9	LB/B	-	Q4V9G6	851	S	A
Q8WXE9	LB/B	-	Q4V9G6	646	R	H
Q8WXE9	LB/B	-	Q4V9G6	694	T	A
Q6ZVD7	LP/P	Pre-eclampsia/eclampsia 4 (PEE4) [MIM:609404]	A0A2Y9PKY9	18	R	P
Q6ZVD7	LB/B	-	A0A2Y9PKY9	153	Y	H
Q6ZVD7	LB/B	-	A0A2Y9PKY9	608	E	D
Q6ZVD7	LP/P	Pre-eclampsia/eclampsia 4 (PEE4) [MIM:609404]	A0A2Y9PKY9	825	N	I
Q6ZVD7	LB/B	-	A0A2Y9PKY9	863	A	T
Q8N412	LB/B	-	A0A1S3ACC7	111	C	W
Q8N412	LB/B	-	A0A1S3ACC7	112	F	V
Q8N412	LB/B	-	A0A1S3ACC7	125	Y	H
Q8N412	LB/B	-	A0A1S3ACC7	178	I	V
Q8N412	LB/B	-	A0A1S3ACC7	279	K	R
Q8N412	LB/B	-	A0A1S3ACC7	420	V	A
Q8N7X2	LB/B	-	A0A0D9RVP4	126	S	G
Q8N801	LB/B	-	H0W9T0	17	L	M
Q8N801	LB/B	-	H0W9T0	31	Q	R
Q9BX79	LP/P	Microphthalmia, syndromic, 9 (MCOPS9) [MIM:601186]	A0A093D4S5	90	P	L
Q9BX79	LP/P	Microphthalmia, syndromic, 9 (MCOPS9) [MIM:601186]	A0A093D4S5	293	P	L
Q9BX79	LP/P	Microphthalmia, syndromic, 9 (MCOPS9) [MIM:601186]	A0A093D4S5	321	T	P
Q9BX79	LB/B	-	A0A093D4S5	339	G	S
Q9BX79	LB/B	-	A0A093D4S5	517	L	F
Q9BX79	LB/B	-	A0A093D4S5	527	M	I
Q9BX79	LP/P	Microphthalmia, syndromic, 9 (MCOPS9) [MIM:601186]	A0A093D4S5	644	T	M
Q9BX79	LP/P	Microphthalmia, syndromic, 9 (MCOPS9) [MIM:601186]	A0A093D4S5	655	R	C
Q9BX79	LB/B	-	A0A093D4S5	217	G	E
Q9BX79	LB/B	-	A0A093D4S5	438	Q	R
Q9BX79	LB/B	-	A0A093D4S5	638	R	P
Q9BX79	LP/P	Microphthalmia, syndromic, 9 (MCOPS9) [MIM:601186]	A0A093D4S5	304	G	K
Q7RTU9	LB/B	-	A0A2Y9P7B0	1640	L	F
Q5VSL9	LB/B	-	L5LZ76	628	K	N
Q9ULQ0	LB/B	-	L5LZ76	383	R	Q
Q13033	LB/B	-	A0A2C9K792	471	N	S
Q9NRL3	LB/B	-	A0A2C9K792	568	V	I
P46977	LP/P	Congenital disorder of glycosylation 1W, autosomal recessive (CDG1WAR) [MIM:615596]	L5KDL5	626	V	A
P46977	LP/P	Congenital disorder of glycosylation 1W, autosomal dominant (CDG1WAD) [MIM:619714]	L5KDL5	46	H	R
P46977	LP/P	Congenital disorder of glycosylation 1W, autosomal dominant (CDG1WAD) [MIM:619714]	L5KDL5	160	R	Q
P46977	LP/P	Congenital disorder of glycosylation 1W, autosomal dominant (CDG1WAD) [MIM:619714]	L5KDL5	405	R	C
P46977	LP/P	Congenital disorder of glycosylation 1W, autosomal dominant (CDG1WAD) [MIM:619714]	L5KDL5	405	R	H
Q9UNE7	LP/P	Spinocerebellar ataxia, autosomal recessive, 16 (SCAR16) [MIM:615768]	A0A2Y9HUR9	79	A	D
Q9UNE7	LP/P	Spinocerebellar ataxia, autosomal recessive, 16 (SCAR16) [MIM:615768]	A0A2Y9HUR9	79	A	T
Q9UNE7	LP/P	Spinocerebellar ataxia, autosomal recessive, 16 (SCAR16) [MIM:615768]	A0A2Y9HUR9	123	L	V
Q9UNE7	LP/P	Spinocerebellar ataxia, autosomal recessive, 16 (SCAR16) [MIM:615768]	A0A2Y9HUR9	130	N	I
Q9UNE7	LP/P	Spinocerebellar ataxia, autosomal recessive, 16 (SCAR16) [MIM:615768]	A0A2Y9HUR9	147	W	C
Q9UNE7	LP/P	Spinocerebellar ataxia, autosomal recessive, 16 (SCAR16) [MIM:615768]	A0A2Y9HUR9	165	L	F
Q9UNE7	LP/P	Spinocerebellar ataxia, autosomal recessive, 16 (SCAR16) [MIM:615768]	A0A2Y9HUR9	236	S	T
Q9UNE7	LP/P	Spinocerebellar ataxia, autosomal recessive, 16 (SCAR16) [MIM:615768]	A0A2Y9HUR9	240	M	T
Q9UNE7	LP/P	Spinocerebellar ataxia, autosomal recessive, 16 (SCAR16) [MIM:615768]	A0A2Y9HUR9	246	T	M
Q9UNE7	LP/P	Spinocerebellar ataxia, autosomal recessive, 16 (SCAR16) [MIM:615768]	A0A2Y9HUR9	28	E	K
Q9UNE7	LP/P	Spinocerebellar ataxia, autosomal recessive, 16 (SCAR16) [MIM:615768]	A0A2Y9HUR9	65	N	S
Q9UNE7	LP/P	Spinocerebellar ataxia, autosomal recessive, 16 (SCAR16) [MIM:615768]	A0A2Y9HUR9	145	K	Q
Q9P2W9	LB/B	-	E6ZG47	32	D	Y
Q9P2W9	LB/B	-	E6ZG47	51	S	G
Q9P2W9	LB/B	-	E6ZG47	228	S	T
P61266	LP/P	Generalized epilepsy with febrile seizures plus 9 (GEFSP9) [MIM:616172]	H2NQR3	216	V	E
P61266	LP/P	Generalized epilepsy with febrile seizures plus 9 (GEFSP9) [MIM:616172]	H2NQR3	226	G	R
P32856	LB/B	-	A0A2U3YA68	42	S	T
P32856	LB/B	-	A0A2U3YA68	54	K	R
Q13277	LB/B	-	A0A1L8HDF1	83	E	D
Q13277	LB/B	-	A0A1L8HDF1	276	G	S
Q13277	LB/B	-	A0A1L8HDF1	285	S	P
Q13190	LB/B	-	A0A1S2ZY90	51	P	L
Q13190	LB/B	-	A0A1S2ZY90	72	Q	H
P61764	LP/P	Developmental and epileptic encephalopathy 4 (DEE4) [MIM:612164]	A0A1I8BDU0	84	V	D
P61764	LP/P	Developmental and epileptic encephalopathy 4 (DEE4) [MIM:612164]	A0A1I8BDU0	180	C	Y
P61764	LP/P	Developmental and epileptic encephalopathy 4 (DEE4) [MIM:612164]	A0A1I8BDU0	443	M	R
P61764	LP/P	Developmental and epileptic encephalopathy 4 (DEE4) [MIM:612164]	A0A1I8BDU0	544	G	D
P61764	LP/P	Developmental and epileptic encephalopathy 4 (DEE4) [MIM:612164]	A0A1I8BDU0	283	E	K
P61764	LP/P	Developmental and epileptic encephalopathy 4 (DEE4) [MIM:612164]	A0A1I8BDU0	285	D	Y
P61764	LP/P	Developmental and epileptic encephalopathy 4 (DEE4) [MIM:612164]	A0A1I8BDU0	445	H	P
P61764	LB/B	-	A0A1I8BDU0	84	V	I
P61764	LP/P	Developmental and epileptic encephalopathy 4 (DEE4) [MIM:612164]	A0A1I8BDU0	183	L	R
P61764	LP/P	Developmental and epileptic encephalopathy 4 (DEE4) [MIM:612164]	A0A1I8BDU0	251	A	T
P61764	LP/P	Developmental and epileptic encephalopathy 4 (DEE4) [MIM:612164]	A0A1I8BDU0	406	R	H
P61764	LP/P	Developmental and epileptic encephalopathy 4 (DEE4) [MIM:612164]	A0A1I8BDU0	480	P	L
P61764	LP/P	Developmental and epileptic encephalopathy 4 (DEE4) [MIM:612164]	A0A1I8BDU0	574	T	P
P61764	LP/P	Developmental and epileptic encephalopathy 4 (DEE4) [MIM:612164]	A0A1I8BDU0	406	R	C
P61764	LP/P	Developmental and epileptic encephalopathy 4 (DEE4) [MIM:612164]	A0A1I8BDU0	42	S	F
P61764	LP/P	-	A0A1I8BDU0	80	S	P
P61764	LP/P	Developmental and epileptic encephalopathy 4 (DEE4) [MIM:612164]	A0A1I8BDU0	190	R	W
P61764	LP/P	Developmental and epileptic encephalopathy 4 (DEE4) [MIM:612164]	A0A1I8BDU0	354	C	R
P61764	LP/P	-	A0A1I8BDU0	570	T	A
P61764	LP/P	Developmental and epileptic encephalopathy 4 (DEE4) [MIM:612164]	A0A1I8BDU0	281	L	P
P61764	LP/P	Developmental and epileptic encephalopathy 4 (DEE4) [MIM:612164]	A0A1I8BDU0	292	R	H
Q15833	LB/B	-	A0A1I8BDU0	526	I	V
Q15833	LP/P	Hemophagocytic lymphohistiocytosis, familial, 5, with or without microvillus inclusion disease (FHL5) [MIM:613101]	A0A1I8BDU0	209	L	P
Q15833	LP/P	Hemophagocytic lymphohistiocytosis, familial, 5, with or without microvillus inclusion disease (FHL5) [MIM:613101]	A0A1I8BDU0	292	R	H
Q15833	LP/P	Hemophagocytic lymphohistiocytosis, familial, 5, with or without microvillus inclusion disease (FHL5) [MIM:613101]	A0A1I8BDU0	405	R	Q
Q15833	LP/P	Hemophagocytic lymphohistiocytosis, familial, 5, with or without microvillus inclusion disease (FHL5) [MIM:613101]	A0A1I8BDU0	405	R	W
Q15833	LP/P	Hemophagocytic lymphohistiocytosis, familial, 5, with or without microvillus inclusion disease (FHL5) [MIM:613101]	A0A1I8BDU0	477	P	L
O00186	LB/B	-	A0A1I8BDU0	433	E	G
O00186	LB/B	-	A0A1I8BDU0	546	C	G
O00186	LB/B	-	A0A1I8BDU0	295	R	Q
Q6ZWJ1	LB/B	-	G1P945	120	C	R
Q6ZWJ1	LB/B	-	G1P945	92	G	R
Q6J9G0	LB/B	-	A0A091IZA1	204	S	G
Q6J9G0	LB/B	-	A0A091IZA1	71	R	G
Q6J9G0	LB/B	-	A0A091IZA1	210	R	W
Q6J9G0	LB/B	-	A0A091IZA1	237	L	S
Q6J9G0	LB/B	-	A0A091IZA1	379	R	H
Q6J9G0	LB/B	-	A0A091IZA1	400	V	L
Q5VZP5	LB/B	-	A0A093QJ83	265	E	D
Q5VZP5	LB/B	-	A0A093QJ83	466	R	H
Q5VZP5	LB/B	-	A0A093QJ83	505	A	T
Q5VZP5	LB/B	-	A0A093QJ83	855	K	Q
Q5VZP5	LB/B	-	A0A093QJ83	1124	T	N
P53999	LB/B	-	G1SQM7	11	S	G
Q96I99	LB/B	-	A0A197JV50	347	K	R
Q96I99	LB/B	-	A0A197JV50	381	R	W
Q9UMX1	LB/B	-	A0A1V4KIK6	15	P	L
Q9UMX1	LB/B	-	A0A1V4KIK6	340	A	S
Q9UMX1	LB/B	-	A0A1V4KIK6	19	G	V
Q9UMX1	LB/B	-	A0A1V4KIK6	37	I	V
Q9UMX1	LB/B	-	A0A1V4KIK6	77	V	M
Q9UMX1	LP/P	Joubert syndrome 32 (JBTS32) [MIM:617757]	A0A1V4KIK6	176	H	R
Q9UMX1	LB/B	-	A0A1V4KIK6	289	R	Q
Q9UMX1	LB/B	-	A0A1V4KIK6	293	I	V
Q9UMX1	LB/B	-	A0A1V4KIK6	382	P	L
Q9UMX1	LP/P	Joubert syndrome 32 (JBTS32) [MIM:617757]	A0A1V4KIK6	406	I	T
Q9UMX1	LB/B	-	A0A1V4KIK6	442	K	R
Q9UMX1	LB/B	-	A0A1V4KIK6	481	S	N
P50225	LB/B	-	S7P6Z4	213	R	H
P50225	LB/B	-	S7P6Z4	37	R	Q
P50225	LB/B	-	S7P6Z4	223	V	M
P50225	LB/B	-	S7P6Z4	235	N	T
P50225	LB/B	-	S7P6Z4	151	E	D
P50225	LB/B	-	S7P6Z4	151	E	Q
P50225	LB/B	-	S7P6Z4	282	E	K
P50226	LB/B	-	S7P6Z4	7	I	T
P50226	LB/B	-	S7P6Z4	235	N	T
P50226	LB/B	-	S7P6Z4	19	P	L
P50226	LB/B	-	S7P6Z4	62	Y	F
P50226	LB/B	-	S7P6Z4	239	N	S
P50226	LB/B	-	S7P6Z4	282	K	E
P0DMM9	LB/B	-	S7P6Z4	101	P	H
P0DMM9	LB/B	-	S7P6Z4	101	P	L
P0DMM9	LB/B	-	S7P6Z4	144	R	C
P0DMM9	LB/B	-	S7P6Z4	234	K	N
P0DMN0	LB/B	-	S7P6Z4	101	P	H
P0DMN0	LB/B	-	S7P6Z4	101	P	L
O43704	LB/B	-	P52847	145	L	V
O00338	LB/B	-	P52847	128	Y	H
O00338	LB/B	-	P52847	255	S	A
O00338	LB/B	-	P52847	282	R	T
Q6IMI6	LB/B	-	P52847	148	Y	C
Q6IMI6	LB/B	-	P52847	179	G	R
Q6IMI6	LB/B	-	P52847	194	M	T
Q6IMI6	LB/B	-	P52847	88	A	T
O75897	LB/B	-	P52847	5	D	E
O75897	LB/B	-	P52847	68	I	M
P49888	LB/B	-	P52847	22	D	Y
Q06520	LB/B	-	G1QJP3	63	A	P
Q06520	LB/B	-	G1QJP3	261	A	T
Q06520	LB/B	-	G1QJP3	44	K	E
Q06520	LB/B	-	G1QJP3	76	P	T
Q06520	LB/B	-	G1QJP3	147	E	K
Q06520	LB/B	-	G1QJP3	148	E	K
Q06520	LB/B	-	G1QJP3	246	L	P
Q06520	LB/B	-	G1QJP3	258	F	L
Q06520	LB/B	-	G1QJP3	262	Q	E
O00204	LB/B	-	A0A2Y9F1X1	51	L	S
O00204	LB/B	-	A0A2Y9F1X1	345	P	L
O00204	LB/B	-	A0A2Y9F1X1	240	V	I
Q6IMI4	LB/B	-	A0A087X549	61	A	T
Q6IMI4	LB/B	-	A0A087X549	75	V	D
Q6IMI4	LB/B	-	A0A087X549	88	K	E
Q6IMI4	LB/B	-	A0A087X549	167	E	V
Q6IMI4	LB/B	-	A0A087X549	181	R	S
Q6IMI4	LB/B	-	A0A087X549	296	K	R
Q6IMI4	LB/B	-	A0A087X549	150	L	F
Q8NBK3	LB/B	-	A0A2Y9J224	63	S	N
Q8NBK3	LP/P	Multiple sulfatase deficiency (MSD) [MIM:272200]	A0A2Y9J224	155	S	P
Q8NBK3	LP/P	Multiple sulfatase deficiency (MSD) [MIM:272200]	A0A2Y9J224	218	C	Y
Q8NBK3	LP/P	Multiple sulfatase deficiency (MSD) [MIM:272200]	A0A2Y9J224	279	A	V
Q8NBK3	LP/P	Multiple sulfatase deficiency (MSD) [MIM:272200]	A0A2Y9J224	336	C	R
Q8NBK3	LP/P	Multiple sulfatase deficiency (MSD) [MIM:272200]	A0A2Y9J224	345	R	C
Q8NBK3	LP/P	Multiple sulfatase deficiency (MSD) [MIM:272200]	A0A2Y9J224	348	A	P
Q8NBK3	LP/P	Multiple sulfatase deficiency (MSD) [MIM:272200]	A0A2Y9J224	349	R	Q
Q8NBK3	LP/P	Multiple sulfatase deficiency (MSD) [MIM:272200]	A0A2Y9J224	349	R	W
Q8NBK3	LP/P	Multiple sulfatase deficiency (MSD) [MIM:272200]	A0A2Y9J224	20	L	F
Q8NBK3	LP/P	Multiple sulfatase deficiency (MSD) [MIM:272200]	A0A2Y9J224	177	A	P
Q8NBK3	LP/P	Multiple sulfatase deficiency (MSD) [MIM:272200]	A0A2Y9J224	224	R	W
Q8NBK3	LP/P	Multiple sulfatase deficiency (MSD) [MIM:272200]	A0A2Y9J224	259	N	I
Q8NBK3	LP/P	Multiple sulfatase deficiency (MSD) [MIM:272200]	A0A2Y9J224	266	P	L
Q8NBK3	LP/P	Multiple sulfatase deficiency (MSD) [MIM:272200]	A0A2Y9J224	179	W	S
Q8NBK3	LP/P	Multiple sulfatase deficiency (MSD) [MIM:272200]	A0A2Y9J224	247	G	R
Q8NBK3	LP/P	Multiple sulfatase deficiency (MSD) [MIM:272200]	A0A2Y9J224	263	G	V
Q8NBJ7	LB/B	-	A0A2K5Q844	51	D	E
P55854	LB/B	-	A0A2K6A2N5	38	P	S
Q6EEV6	LB/B	-	A0A166EVJ7	55	V	M
O94901	LB/B	-	A0A2Y9GAD1	118	H	Y
O94901	LB/B	-	A0A2Y9GAD1	203	A	V
O94901	LB/B	-	A0A2Y9GAD1	587	A	V
Q9UH99	LB/B	-	A0A091W5W8	671	G	S
Q9UH99	LB/B	-	A0A091W5W8	33	T	A
Q9UH99	LB/B	-	A0A091W5W8	89	L	R
Q9UH99	LB/B	-	A0A091W5W8	348	R	C
Q8TC36	LB/B	-	G5E798	16	E	K
Q8TC36	LB/B	-	G5E798	39	E	D
Q8TC36	LB/B	-	G5E798	174	A	T
Q8TC36	LB/B	-	G5E798	120	I	V
Q8TC36	LP/P	Spermatogenic failure 16 (SPGF16) [MIM:617187]	G5E798	114	G	R
Q8TC36	LP/P	Spermatogenic failure 16 (SPGF16) [MIM:617187]	G5E798	275	T	M
Q8TC36	LP/P	Spermatogenic failure 16 (SPGF16) [MIM:617187]	G5E798	348	N	I
P51687	LP/P	Sulfite oxidase deficiency, isolated (ISOD) [MIM:272300]	A0A091DP44	217	R	Q
P51687	LP/P	Sulfite oxidase deficiency, isolated (ISOD) [MIM:272300]	A0A091DP44	265	A	D
P51687	LP/P	Sulfite oxidase deficiency, isolated (ISOD) [MIM:272300]	A0A091DP44	427	S	Y
P51687	LP/P	Sulfite oxidase deficiency, isolated (ISOD) [MIM:272300]	A0A091DP44	530	G	D
P51687	LP/P	Sulfite oxidase deficiency, isolated (ISOD) [MIM:272300]	A0A091DP44	258	I	L
P51687	LP/P	Sulfite oxidase deficiency, isolated (ISOD) [MIM:272300]	A0A091DP44	268	R	Q
P51687	LP/P	Sulfite oxidase deficiency, isolated (ISOD) [MIM:272300]	A0A091DP44	362	G	S
P51687	LP/P	Sulfite oxidase deficiency, isolated (ISOD) [MIM:272300]	A0A091DP44	366	R	H
P51687	LP/P	Sulfite oxidase deficiency, isolated (ISOD) [MIM:272300]	A0A091DP44	379	K	R
P51687	LP/P	Sulfite oxidase deficiency, isolated (ISOD) [MIM:272300]	A0A091DP44	396	Q	R
P51687	LP/P	Sulfite oxidase deficiency, isolated (ISOD) [MIM:272300]	A0A091DP44	450	W	R
Q15527	LB/B	-	K7G9V5	213	G	S
Q15527	LB/B	-	K7G9V5	221	R	Q
Q6UWL2	LB/B	-	F1SNB0	524	H	Q
Q6UWL2	LB/B	-	F1SNB0	201	Q	E
Q9UGT4	LB/B	-	M3ZKE1	59	R	Q
Q9UGT4	LB/B	-	M3ZKE1	110	S	T
Q9UGT4	LB/B	-	M3ZKE1	466	N	S
O60279	LB/B	-	A0A2Y9LJ14	52	L	F
O60279	LB/B	-	A0A2Y9LJ14	228	R	K
O60279	LB/B	-	A0A2Y9LJ14	40	F	L
O60279	LB/B	-	A0A2Y9LJ14	216	R	K
O60279	LB/B	-	A0A2Y9LJ14	378	E	D
Q15022	LB/B	-	H9GFC2	216	N	I
Q15022	LP/P	Imagawa-Matsumoto syndrome (IMMAS) [MIM:618786]	H9GFC2	610	E	V
Q15022	LP/P	Imagawa-Matsumoto syndrome (IMMAS) [MIM:618786]	H9GFC2	599	Q	H
Q15022	LP/P	Imagawa-Matsumoto syndrome (IMMAS) [MIM:618786]	H9GFC2	603	F	L
Q496J9	LB/B	-	L8Y486	482	T	S
Q496J9	LB/B	-	L8Y486	543	D	N
Q4LDE5	LB/B	-	A0A146NVA9	332	G	A
Q4LDE5	LB/B	-	A0A146NVA9	428	G	S
Q4LDE5	LB/B	-	A0A146NVA9	507	V	I
Q4LDE5	LB/B	-	A0A146NVA9	581	Q	H
Q4LDE5	LB/B	-	A0A146NVA9	637	I	V
Q4LDE5	LB/B	-	A0A146NVA9	899	K	R
Q4LDE5	LB/B	-	A0A146NVA9	1157	I	V
Q4LDE5	LB/B	-	A0A146NVA9	1330	L	M
Q4LDE5	LB/B	-	A0A146NVA9	1416	K	Q
Q4LDE5	LB/B	-	A0A146NVA9	1444	M	L
Q4LDE5	LB/B	-	A0A146NVA9	1648	L	V
Q4LDE5	LB/B	-	A0A146NVA9	1810	E	A
Q4LDE5	LB/B	-	A0A146NVA9	1953	R	K
Q4LDE5	LB/B	-	A0A146NVA9	2607	T	A
Q4LDE5	LB/B	-	A0A146NVA9	2750	A	V
Q4LDE5	LB/B	-	A0A146NVA9	2922	I	V
Q4LDE5	LB/B	-	A0A146NVA9	3161	F	I
Q4LDE5	LB/B	-	A0A146NVA9	3230	P	T
Q4LDE5	LB/B	-	A0A146NVA9	3559	T	M
Q9UH65	LB/B	-	A0A2I3M7H1	505	Q	E
Q9UH65	LB/B	-	A0A2I3M7H1	230	R	G
Q6NVH7	LB/B	-	A0A2K5XLP7	171	D	G
Q5T5J6	LB/B	-	G3W5L0	148	I	V
Q5T5J6	LB/B	-	G3W5L0	536	H	R
Q5T5J6	LB/B	-	G3W5L0	638	L	F
Q5T5J6	LB/B	-	G3W5L0	821	N	D
Q8N0S2	LB/B	-	I3M9X9	132	E	D
Q8N0S2	LB/B	-	I3M9X9	183	K	R
Q8N0S2	LB/B	-	I3M9X9	317	P	A
A1L190	LB/B	-	A0A091W3T1	88	L	P
Q0VAF6	LB/B	-	W5PNW4	111	L	M
Q15431	LB/B	-	A0A1U8DJ08	78	E	D
Q15431	LB/B	-	A0A1U8DJ08	805	E	D
Q9H7V2	LB/B	-	W5P8D5	54	G	R
O95473	LB/B	-	F6RFA6	27	R	W
O43426	LB/B	-	A0A146Z829	295	K	R
O43426	LB/B	-	A0A146Z829	1366	V	A
O43426	LB/B	-	A0A146Z829	1547	P	L
O43426	LP/P	Parkinson disease 20, early-onset (PARK20) [MIM:615530]	A0A146Z829	219	R	Q
O43426	LP/P	Parkinson disease 20, early-onset (PARK20) [MIM:615530]	A0A146Z829	420	R	P
O43426	LP/P	Developmental and epileptic encephalopathy 53 (DEE53) [MIM:617389]	A0A146Z829	849	Y	C
O43426	LB/B	-	A0A146Z829	981	M	I
O43426	LB/B	-	A0A146Z829	1018	Y	S
O15056	LB/B	-	A0A091RQL8	1468	E	G
O15061	LB/B	-	A0A093G7M8	272	V	A
O15061	LB/B	-	A0A093G7M8	330	V	I
O15061	LB/B	-	A0A093G7M8	338	R	W
O15061	LB/B	-	A0A093G7M8	567	P	L
O15061	LB/B	-	A0A093G7M8	612	E	A
O15061	LB/B	-	A0A093G7M8	761	P	L
O15061	LB/B	-	A0A093G7M8	946	R	W
O15061	LB/B	-	A0A093G7M8	976	Q	R
O15061	LB/B	-	A0A093G7M8	1059	P	L
O15061	LB/B	-	A0A093G7M8	1067	R	P
O15061	LB/B	-	A0A093G7M8	1077	S	L
O15061	LB/B	-	A0A093G7M8	1386	E	G
O15061	LB/B	-	A0A093G7M8	1462	F	C
O15061	LB/B	-	A0A093G7M8	355	R	W
O15061	LB/B	-	A0A093G7M8	462	G	S
O15061	LB/B	-	A0A093G7M8	1130	G	S
O15061	LB/B	-	A0A093G7M8	1345	G	A
Q9UMS6	LB/B	-	A0A087X9G6	573	T	A
Q9UMS6	LB/B	-	A0A087X9G6	154	G	A
Q9UMS6	LB/B	-	A0A087X9G6	174	Q	H
Q9UMS6	LB/B	-	A0A087X9G6	179	A	T
P21579	LP/P	Baker-Gordon syndrome (BAGOS) [MIM:618218]	A0A2K5D4S2	368	I	T
P21579	LP/P	Baker-Gordon syndrome (BAGOS) [MIM:618218]	A0A2K5D4S2	303	M	K
P21579	LP/P	Baker-Gordon syndrome (BAGOS) [MIM:618218]	A0A2K5D4S2	304	D	G
P21579	LP/P	Baker-Gordon syndrome (BAGOS) [MIM:618218]	A0A2K5D4S2	366	D	E
P21579	LP/P	Baker-Gordon syndrome (BAGOS) [MIM:618218]	A0A2K5D4S2	371	N	K
Q6XYQ8	LB/B	-	A0A1L8GIZ8	420	T	S
Q6XYQ8	LB/B	-	A0A1L8GIZ8	488	H	P
Q6XYQ8	LB/B	-	A0A1L8GIZ8	505	A	V
Q6XYQ8	LB/B	-	A0A1L8GIZ8	172	S	I
Q8IV01	LB/B	-	A0A087RJ42	170	N	H
Q8NB59	LB/B	-	H3D3W0	138	G	E
Q8NB59	LP/P	Spinocerebellar ataxia, autosomal recessive, 11 (SCAR11) [MIM:614229]	H3D3W0	439	G	D
Q17RD7	LB/B	-	U3JL59	10	V	A
Q17RD7	LB/B	-	U3JL59	131	R	L
Q8N9I0	LP/P	Myasthenic syndrome, congenital, 7A, presynaptic, and distal motor neuropathy, autosomal dominant (CMS7A) [MIM:616040]	L9JBE6	307	D	A
Q8N9I0	LP/P	Myasthenic syndrome, congenital, 7A, presynaptic, and distal motor neuropathy, autosomal dominant (CMS7A) [MIM:616040]	L9JBE6	308	P	L
Q8N9I0	LP/P	Myasthenic syndrome, congenital, 7A, presynaptic, and distal motor neuropathy, autosomal dominant (CMS7A) [MIM:616040]	L9JBE6	365	L	P
Q9H2B2	LB/B	-	S9WAE2	142	S	N
O00445	LB/B	-	A0A2K5D4S2	111	R	Q
O00445	LB/B	-	A0A2K5D4S2	4	E	D
Q8NBV8	LB/B	-	L5KPG4	120	C	R
Q8NBV8	LB/B	-	L5KPG4	129	F	I
Q8NBV8	LB/B	-	L5KPG4	17	H	Q
Q86SS6	LB/B	-	A0A1L8GIZ8	154	V	M
Q86SS6	LB/B	-	A0A1L8GIZ8	238	I	V
Q86SS6	LB/B	-	A0A1L8GIZ8	353	L	V
Q4VX76	LB/B	-	F1QFP0	414	P	S
Q4VX76	LB/B	-	F1QFP0	540	V	I
Q4VX76	LB/B	-	F1QFP0	587	L	Q
Q96C24	LB/B	-	A0A226PIG0	420	I	V
Q8TDW5	LB/B	-	A0A226PIG0	275	I	V
Q8TDW5	LB/B	-	A0A226PIG0	302	R	C
Q5T011	LP/P	Developmental and epileptic encephalopathy 18 (DEE18) [MIM:615476]	V8NXL0	499	S	I
O14804	LB/B	-	W5LUU2	272	T	M
O14804	LB/B	-	W5LUU2	330	R	C
Q969N4	LB/B	-	W5LUU2	153	S	N
Q969N4	LB/B	-	W5LUU2	328	D	A
Q969N4	LB/B	-	W5LUU2	211	V	D
Q15750	LB/B	-	A0A091E018	224	D	E
Q9UHF0	LP/P	Hypogonadotropic hypogonadism 10 with or without anosmia (HH10) [MIM:614839]	G3V6J3	90	M	T
Q9UHF0	LP/P	Hypogonadotropic hypogonadism 10 with or without anosmia (HH10) [MIM:614839]	G3V6J3	80	R	S
O75410	LB/B	-	A0A0G2K9K2	187	P	L
O75410	LB/B	-	A0A0G2K9K2	243	I	T
O75410	LB/B	-	A0A0G2K9K2	255	E	G
O95359	LB/B	-	A0A2Y9I6R6	2102	N	S
O95359	LB/B	-	A0A2Y9I6R6	2197	V	A
O95359	LB/B	-	A0A2Y9I6R6	2261	L	H
O95359	LB/B	-	A0A2Y9I6R6	2718	V	I
O95359	LB/B	-	A0A2Y9I6R6	2732	A	T
O95359	LB/B	-	A0A2Y9I6R6	2078	I	T
O95359	LB/B	-	A0A2Y9I6R6	2210	A	V
O95359	LB/B	-	A0A2Y9I6R6	2900	Q	K
O95359	LB/B	-	A0A2Y9I6R6	170	V	I
O95359	LB/B	-	A0A2Y9I6R6	830	L	F
O95359	LB/B	-	A0A2Y9I6R6	1103	W	R
O95359	LB/B	-	A0A2Y9I6R6	1425	A	T
O95359	LB/B	-	A0A2Y9I6R6	1492	P	L
O95359	LB/B	-	A0A2Y9I6R6	1916	E	K
O95359	LB/B	-	A0A2Y9I6R6	2216	P	L
O95359	LB/B	-	A0A2Y9I6R6	2271	E	D
Q9Y6A5	LB/B	-	A0A0A0ACP7	143	E	K
Q9Y6A5	LB/B	-	A0A0A0ACP7	275	C	Y
Q9Y6A5	LB/B	-	A0A0A0ACP7	287	G	S
Q9Y6A5	LB/B	-	A0A0A0ACP7	514	G	E
P25103	LB/B	-	A0A093HV01	192	Y	H
P21452	LB/B	-	A0A2U9B9H7	375	R	H
P21452	LB/B	-	A0A2U9B9H7	23	I	T
P21452	LB/B	-	A0A2U9B9H7	47	A	T
P21452	LB/B	-	A0A2U9B9H7	245	M	K
P21452	LB/B	-	A0A2U9B9H7	363	T	A
P21452	LB/B	-	A0A2U9B9H7	395	H	R
P29371	LB/B	-	A0A093HV01	286	K	R
P29371	LB/B	-	A0A093HV01	449	A	T
P29371	LP/P	Hypogonadotropic hypogonadism 11 with or without anosmia (HH11) [MIM:614840]	A0A093HV01	93	G	D
P29371	LP/P	Hypogonadotropic hypogonadism 11 with or without anosmia (HH11) [MIM:614840]	A0A093HV01	353	P	S
P29371	LP/P	Hypogonadotropic hypogonadism 11 with or without anosmia (HH11) [MIM:614840]	A0A093HV01	364	R	Q
P29371	LP/P	Hypogonadotropic hypogonadism 11 with or without anosmia (HH11) [MIM:614840]	A0A093HV01	137	F	V
P29371	LP/P	Hypogonadotropic hypogonadism 11 with or without anosmia (HH11) [MIM:614840]	A0A093HV01	346	M	V
Q96BN2	LB/B	-	L5KZT9	198	R	Q
O75478	LB/B	-	A0A151N5V1	6	P	S
O75478	LB/B	-	A0A151N5V1	115	M	V
O75478	LB/B	-	A0A151N5V1	351	I	M
Q12962	LB/B	-	A0A1U8CQC7	92	I	T
Q15573	LB/B	-	S7MUE2	98	I	M
Q53T94	LB/B	-	A0A1S3EZW5	6	A	S
Q53T94	LB/B	-	A0A1S3EZW5	282	V	I
Q53T94	LB/B	-	A0A1S3EZW5	351	T	A
Q53T94	LB/B	-	A0A1S3EZW5	462	E	D
Q53T94	LB/B	-	A0A1S3EZW5	487	T	M
Q53T94	LB/B	-	A0A1S3EZW5	292	R	H
Q6P1X5	LB/B	-	A0A1A8A1T5	8	P	L
Q6P1X5	LB/B	-	A0A1A8A1T5	447	S	T
Q6P1X5	LB/B	-	A0A1A8A1T5	1122	S	N
Q6P1X5	LB/B	-	A0A1A8A1T5	1139	T	A
Q6P1X5	LB/B	-	A0A1A8A1T5	686	E	K
Q6P1X5	LP/P	Neurodevelopmental disorder with feeding difficulties, thin corpus callosum, and foot deformity (NEDFCF) [MIM:615599]	A0A1A8A1T5	649	W	R
Q5VWG9	LB/B	-	F7I4L2	349	S	T
Q5VWG9	LB/B	-	F7I4L2	442	N	S
Q5VWG9	LB/B	-	F7I4L2	696	V	A
Q5VWG9	LB/B	-	F7I4L2	696	V	L
O00268	LB/B	-	A0A2Y9INQ0	651	P	L
Q15542	LB/B	-	H0V546	130	S	A
P49848	LB/B	-	A0A2K6DJI8	36	C	S
P49848	LP/P	Alazami-Yuan syndrome (ALYUS) [MIM:617126]	A0A2K6DJI8	46	R	C
P49848	LP/P	Alazami-Yuan syndrome (ALYUS) [MIM:617126]	A0A2K6DJI8	71	I	T
Q15545	LB/B	-	F7DGK1	178	S	R
Q5H9L4	LB/B	-	G3N1E6	34	L	P
Q5H9L4	LB/B	-	G3N1E6	61	E	K
Q5H9L4	LB/B	-	G3N1E6	308	S	G
Q5H9L4	LB/B	-	G3N1E6	458	R	H
Q16635	LP/P	Barth syndrome (BTHS) [MIM:302060]	A0A151NC97	94	R	S
Q16635	LP/P	Barth syndrome (BTHS) [MIM:302060]	A0A151NC97	118	C	R
Q16635	LP/P	Barth syndrome (BTHS) [MIM:302060]	A0A151NC97	167	G	R
Q16635	LP/P	Barth syndrome (BTHS) [MIM:302060]	A0A151NC97	210	G	R
Q16635	LP/P	Barth syndrome (BTHS) [MIM:302060]	A0A151NC97	57	R	L
Q16635	LP/P	Barth syndrome (BTHS) [MIM:302060]	A0A151NC97	69	H	Q
Q16635	LP/P	Barth syndrome (BTHS) [MIM:302060]	A0A151NC97	179	I	N
Q16635	LP/P	Barth syndrome (BTHS) [MIM:302060]	A0A151NC97	180	L	R
Q16635	LP/P	Barth syndrome (BTHS) [MIM:302060]	A0A151NC97	182	L	P
Q16635	LP/P	Barth syndrome (BTHS) [MIM:302060]	A0A151NC97	184	H	R
Q8N103	LB/B	-	A0A151M2F4	346	G	D
Q01995	LB/B	-	L8YC96	182	N	S
P37802	LB/B	-	L5JYR9	69	L	Q
P37837	LP/P	Transaldolase deficiency (TALDOD) [MIM:606003]	A0A0N0BBQ9	192	R	C
Q96BW9	LB/B	-	G1LWW4	116	N	S
Q96BW9	LB/B	-	G1LWW4	179	I	V
Q9C0D5	LB/B	-	G3H8L1	251	N	S
Q9C0D5	LB/B	-	G3H8L1	1511	G	S
Q9C0D5	LB/B	-	G3H8L1	1573	T	A
Q9C0D5	LB/B	-	G3H8L1	30	P	S
Q9HCD6	LP/P	Intellectual developmental disorder with autistic features and language delay, with or without seizures (IDDALDS) [MIM:618906]	A0A1U7SNC1	760	R	C
Q6ICL3	LB/B	-	E2RCR6	125	D	N
Q6ICL3	LB/B	-	E2RCR6	200	E	K
Q6ICL3	LB/B	-	E2RCR6	245	D	E
Q6ICL3	LP/P	Metabolic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration (MECRCN) [MIM:616878]	E2RCR6	154	G	R
Q6ICL3	LP/P	Metabolic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration (MECRCN) [MIM:616878]	E2RCR6	20	L	P
Q6ICL3	LP/P	Metabolic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration (MECRCN) [MIM:616878]	E2RCR6	20	L	R
Q7L7X3	LB/B	-	V5HL98	855	A	T
Q7L7X3	LP/P	Developmental delay with or without intellectual impairment or behavioral abnormalities (DDIB) [MIM:619575]	V5HL98	17	E	G
Q7L7X3	LP/P	Developmental delay with or without intellectual impairment or behavioral abnormalities (DDIB) [MIM:619575]	V5HL98	111	S	F
Q7L7X3	LP/P	Developmental delay with or without intellectual impairment or behavioral abnormalities (DDIB) [MIM:619575]	V5HL98	150	R	I
Q7L7X3	LP/P	Developmental delay with or without intellectual impairment or behavioral abnormalities (DDIB) [MIM:619575]	V5HL98	167	L	R
Q7L7X3	LP/P	Developmental delay with or without intellectual impairment or behavioral abnormalities (DDIB) [MIM:619575]	V5HL98	298	K	E
Q7L7X3	LP/P	Developmental delay with or without intellectual impairment or behavioral abnormalities (DDIB) [MIM:619575]	V5HL98	305	D	A
Q7L7X3	LP/P	Developmental delay with or without intellectual impairment or behavioral abnormalities (DDIB) [MIM:619575]	V5HL98	548	L	P
Q9H2K8	LB/B	-	V5HL98	47	S	N
Q9H2K8	LB/B	-	V5HL98	727	C	Y
Q03519	LB/B	-	A0A061IH93	379	V	I
Q03519	LB/B	-	A0A061IH93	565	A	T
Q03519	LB/B	-	A0A061IH93	651	R	C
Q03519	LB/B	-	A0A061IH93	665	T	A
Q03519	LB/B	-	A0A061IH93	374	A	T
Q03519	LB/B	-	A0A061IH93	467	V	I
Q03519	LB/B	-	A0A061IH93	577	M	V
Q03519	LB/B	-	A0A061IH93	56	R	K
O15533	LB/B	-	A0A2Y9E9X7	260	T	R
Q9BX59	LB/B	-	A0A2K6TAM0	151	G	R
Q9BX59	LB/B	-	A0A2K6TAM0	334	T	M
Q9BX59	LB/B	-	A0A2K6TAM0	42	A	V
Q9BX59	LB/B	-	A0A2K6TAM0	146	M	V
Q9BX59	LB/B	-	A0A2K6TAM0	165	T	A
Q9BX59	LB/B	-	A0A2K6TAM0	169	A	V
Q6NXT6	LB/B	-	A0A0D9RV92	465	E	K
Q6NXT6	LB/B	-	A0A0D9RV92	522	N	S
Q6NXT6	LP/P	Osteochondrodysplasia, complex lethal, Symoens-Barnes-Gistelinck type (OCLSBG) [MIM:616897]	A0A0D9RV92	353	D	V
Q15633	LB/B	-	A0A1S2ZEN6	251	S	F
Q13148	LB/B	-	D6WYQ8	90	A	V
Q13148	LP/P	Amyotrophic lateral sclerosis 10 (ALS10) [MIM:612069]	D6WYQ8	169	D	G
Q13148	LP/P	Amyotrophic lateral sclerosis 10 (ALS10) [MIM:612069]	D6WYQ8	287	G	S
Q13148	LP/P	Amyotrophic lateral sclerosis 10 (ALS10) [MIM:612069]	D6WYQ8	290	G	A
Q13148	LP/P	Amyotrophic lateral sclerosis 10 (ALS10) [MIM:612069]	D6WYQ8	294	G	A
Q13148	LP/P	Amyotrophic lateral sclerosis 10 (ALS10) [MIM:612069]	D6WYQ8	298	G	S
Q13148	LP/P	Amyotrophic lateral sclerosis 10 (ALS10) [MIM:612069]	D6WYQ8	315	A	T
Q13148	LP/P	Amyotrophic lateral sclerosis 10 (ALS10) [MIM:612069]	D6WYQ8	331	Q	K
Q13148	LP/P	Amyotrophic lateral sclerosis 10 (ALS10) [MIM:612069]	D6WYQ8	337	M	V
Q13148	LP/P	Amyotrophic lateral sclerosis 10 (ALS10) [MIM:612069]	D6WYQ8	348	G	C
Q13148	LP/P	Amyotrophic lateral sclerosis 10 (ALS10) [MIM:612069]	D6WYQ8	361	R	S
Q13148	LP/P	Amyotrophic lateral sclerosis 10 (ALS10) [MIM:612069]	D6WYQ8	382	A	T
Q13148	LP/P	Amyotrophic lateral sclerosis 10 (ALS10) [MIM:612069]	D6WYQ8	390	N	D
Q13148	LP/P	Amyotrophic lateral sclerosis 10 (ALS10) [MIM:612069]	D6WYQ8	390	N	S
Q13148	LP/P	Amyotrophic lateral sclerosis 10 (ALS10) [MIM:612069]	D6WYQ8	267	N	S
Q13148	LP/P	Amyotrophic lateral sclerosis 10 (ALS10) [MIM:612069]	D6WYQ8	294	G	V
Q13148	LP/P	Amyotrophic lateral sclerosis 10 (ALS10) [MIM:612069]	D6WYQ8	295	G	R
Q13148	LP/P	Amyotrophic lateral sclerosis 10 (ALS10) [MIM:612069]	D6WYQ8	295	G	S
Q13148	LP/P	Amyotrophic lateral sclerosis 10 (ALS10) [MIM:612069]	D6WYQ8	332	S	N
Q13148	LP/P	Amyotrophic lateral sclerosis 10 (ALS10) [MIM:612069]	D6WYQ8	335	G	D
Q13148	LP/P	Amyotrophic lateral sclerosis 10 (ALS10) [MIM:612069]	D6WYQ8	379	S	C
Q13148	LP/P	Amyotrophic lateral sclerosis 10 (ALS10) [MIM:612069]	D6WYQ8	379	S	P
Q13148	LP/P	Amyotrophic lateral sclerosis 10 (ALS10) [MIM:612069]	D6WYQ8	393	S	L
Q13148	LP/P	Amyotrophic lateral sclerosis 10 (ALS10) [MIM:612069]	D6WYQ8	343	Q	R
Q13148	LP/P	Amyotrophic lateral sclerosis 10 (ALS10) [MIM:612069]	D6WYQ8	357	G	R
Q13148	LP/P	Amyotrophic lateral sclerosis 10 (ALS10) [MIM:612069]	D6WYQ8	361	R	T
Q13148	LP/P	Amyotrophic lateral sclerosis 10 (ALS10) [MIM:612069]	D6WYQ8	321	A	V
Q13148	LP/P	Amyotrophic lateral sclerosis 10 (ALS10) [MIM:612069]	D6WYQ8	348	G	V
B6A8C7	LB/B	-	H9H678	37	S	P
B6A8C7	LB/B	-	H9H678	111	R	H
B6A8C7	LB/B	-	H9H678	258	R	W
P26639	LB/B	-	N6T335	21	G	D
P26639	LP/P	Trichothiodystrophy 7, non-photosensitive (TTD7) [MIM:618546]	N6T335	227	L	P
P26639	LP/P	Trichothiodystrophy 7, non-photosensitive (TTD7) [MIM:618546]	N6T335	276	K	E
Q9BW92	LP/P	Combined oxidative phosphorylation deficiency 21 (COXPD21) [MIM:615918]	A0A212CGF3	282	P	L
Q7RTX1	LB/B	-	W5MD11	347	K	E
Q7RTX1	LB/B	-	W5MD11	372	A	T
Q7RTX1	LB/B	-	W5MD11	507	R	Q
Q7RTX0	LB/B	-	G7NWS4	757	C	R
Q9NYW7	LB/B	-	I3MQD4	111	R	H
Q9NYW7	LB/B	-	I3MQD4	206	R	W
Q9NYW7	LB/B	-	I3MQD4	141	C	Y
Q9NYV7	LB/B	-	G3TYK3	222	R	H
Q9NYV7	LB/B	-	G3TYK3	172	N	K
Q9NYV7	LB/B	-	G3TYK3	101	V	M
Q9NYV7	LB/B	-	G3TYK3	114	I	V
Q9NYV7	LB/B	-	G3TYK3	116	L	P
Q9NYV7	LB/B	-	G3TYK3	161	P	S
Q9NYV7	LB/B	-	G3TYK3	177	Q	P
Q9NYV7	LB/B	-	G3TYK3	216	N	D
Q9NYV7	LB/B	-	G3TYK3	221	A	V
Q9NYV7	LB/B	-	G3TYK3	235	V	M
Q9NYV7	LB/B	-	G3TYK3	240	F	V
P59534	LB/B	-	I3LCT3	193	S	F
P59534	LB/B	-	I3LCT3	197	K	E
P59535	LB/B	-	F1SRV3	23	V	L
P59535	LB/B	-	F1SRV3	187	S	Y
P59536	LB/B	-	G3TYK3	127	P	L
Q7RTR8	LB/B	-	Q2ABB1	196	F	S
Q7RTR8	LB/B	-	Q2ABB1	265	Y	C
Q7RTR8	LB/B	-	Q2ABB1	175	Y	F
Q7RTR8	LB/B	-	Q2ABB1	255	G	W
Q7RTR8	LB/B	-	Q2ABB1	292	R	Q
Q7RTR8	LB/B	-	Q2ABB1	311	A	P
Q9NYW4	LB/B	-	A0A2I2V4G7	26	S	I
Q9NYW4	LB/B	-	A0A2I2V4G7	213	R	Q
Q9NYW4	LB/B	-	A0A2I2V4G7	113	P	L
Q9NYW4	LB/B	-	A0A2I2V4G7	167	Y	C
Q9NYW4	LB/B	-	A0A2I2V4G7	20	G	S
Q9NYW4	LB/B	-	A0A2I2V4G7	294	R	L
Q9NYW1	LB/B	-	A0A2Y9HA09	187	V	A
Q9NYW1	LB/B	-	A0A2Y9HA09	170	K	Q
Q9NYW1	LB/B	-	A0A2Y9HA09	238	L	V
Q9UK61	LB/B	-	A0A091CQ52	831	A	G
Q9UK61	LB/B	-	A0A091CQ52	1046	T	R
Q9UK61	LB/B	-	A0A091CQ52	1435	I	V
Q9UK61	LB/B	-	A0A091CQ52	998	V	I
Q9UK61	LB/B	-	A0A091CQ52	38	Q	P
Q5VWN6	LB/B	-	F7B3T1	1075	R	P
Q5VWN6	LB/B	-	F7B3T1	1679	V	A
Q5VWN6	LB/B	-	F7B3T1	2404	S	N
Q5VWN6	LB/B	-	F7B3T1	499	C	G
Q5VWN6	LB/B	-	F7B3T1	630	A	D
Q5VWN6	LB/B	-	F7B3T1	1206	V	M
Q5VWN6	LB/B	-	F7B3T1	1578	P	S
Q5VWN6	LB/B	-	F7B3T1	1782	T	I
Q5VWN6	LB/B	-	F7B3T1	2288	K	R
Q5VWN6	LB/B	-	F7B3T1	724	S	Y
Q5VWN6	LB/B	-	F7B3T1	807	I	V
P17735	LP/P	Tyrosinemia 2 (TYRSN2) [MIM:276600]	A0A1X2GKX8	362	G	V
P17735	LB/B	-	A0A1X2GKX8	70	N	D
Q86TI0	LB/B	-	S7Q4J4	14	S	P
Q86TI0	LB/B	-	S7Q4J4	55	T	I
Q86TI0	LB/B	-	S7Q4J4	228	V	G
Q86TI0	LB/B	-	S7Q4J4	685	Y	S
Q86TI0	LB/B	-	S7Q4J4	1136	R	Q
Q86TI0	LB/B	-	S7Q4J4	125	R	W
Q9BXI6	LB/B	-	A0A2U3VX62	411	R	H
Q9NVG8	LB/B	-	A0A0D2X4N5	190	V	A
Q8TBP0	LB/B	-	L9L497	476	E	K
Q8N5T2	LB/B	-	C3XZG3	241	S	G
Q8N5T2	LB/B	-	C3XZG3	509	S	F
Q9BYX2	LB/B	-	A0A2R5LA93	241	P	T
Q9BYX2	LB/B	-	A0A2R5LA93	253	L	S
Q9BYX2	LB/B	-	A0A2R5LA93	261	G	V
Q8IYX1	LB/B	-	G5BRF6	113	R	Q
Q9ULP9	LP/P	Familial infantile myoclonic epilepsy (FIME) [MIM:605021]	H3ADB4	147	D	H
Q9ULP9	LP/P	Familial infantile myoclonic epilepsy (FIME) [MIM:605021]	H3ADB4	251	F	L
Q9ULP9	LP/P	Familial infantile myoclonic epilepsy (FIME) [MIM:605021]	H3ADB4	515	A	V
Q9ULP9	LP/P	Developmental and epileptic encephalopathy 16 (DEE16) [MIM:615338]	H3ADB4	229	F	S
Q9ULP9	LB/B	-	H3ADB4	295	F	L
Q9ULP9	LP/P	Deafness, onychodystrophy, osteodystrophy, impaired intellectual development, and seizures syndrome (DOORS) [MIM:220500]	H3ADB4	20	Q	E
Q9ULP9	LP/P	Deafness, onychodystrophy, osteodystrophy, impaired intellectual development, and seizures syndrome (DOORS) [MIM:220500]	H3ADB4	40	R	C
Q9ULP9	LP/P	Deafness, onychodystrophy, osteodystrophy, impaired intellectual development, and seizures syndrome (DOORS) [MIM:220500]	H3ADB4	242	R	C
Q9ULP9	LP/P	Deafness, onychodystrophy, osteodystrophy, impaired intellectual development, and seizures syndrome (DOORS) [MIM:220500]	H3ADB4	333	L	F
Q9ULP9	LP/P	Deafness, autosomal recessive, 86 (DFNB86) [MIM:614617]	H3ADB4	70	D	Y
Q9ULP9	LP/P	Deafness, autosomal recessive, 86 (DFNB86) [MIM:614617]	H3ADB4	293	R	P
Q9ULP9	LP/P	Deafness, autosomal dominant, 65 (DFNA65) [MIM:616044]	H3ADB4	178	S	L
Q9ULP9	LP/P	Developmental and epileptic encephalopathy 16 (DEE16) [MIM:615338]	H3ADB4	113	A	D
Q9ULP9	LP/P	Developmental and epileptic encephalopathy 16 (DEE16) [MIM:615338]	H3ADB4	159	L	P
Q9ULP9	LP/P	Epilepsy, rolandic, with proxysmal exercise-induce dystonia and writer's cramp (EPRPDC) [MIM:608105]	H3ADB4	360	R	H
Q9ULP9	LP/P	Epilepsy, rolandic, with proxysmal exercise-induce dystonia and writer's cramp (EPRPDC) [MIM:608105]	H3ADB4	500	A	V
Q9ULP9	LP/P	Epilepsy, rolandic, with proxysmal exercise-induce dystonia and writer's cramp (EPRPDC) [MIM:608105]	H3ADB4	501	G	R
Q3MII6	LB/B	-	T1IEE6	277	N	S
Q8IZP1	LB/B	-	A0A2K5Z8K8	526	Q	P
Q9Y2I9	LB/B	-	G7N7J8	296	Q	H
Q9Y2I9	LB/B	-	G7N7J8	752	V	I
Q9Y2I9	LB/B	-	G7N7J8	596	N	D
Q9Y2I9	LB/B	-	G7N7J8	759	N	D
Q96DN5	LB/B	-	H0ZQA1	414	R	H
Q96DN5	LB/B	-	H0ZQA1	709	V	F
Q96DN5	LB/B	-	H0ZQA1	1065	A	T
O95759	LB/B	-	Q4S8R1	1079	R	G
O95759	LB/B	-	Q4S8R1	1108	M	V
O95759	LB/B	-	Q4S8R1	954	G	R
O95759	LB/B	-	Q4S8R1	317	T	A
O95759	LB/B	-	Q4S8R1	1073	F	L
Q0IIM8	LP/P	Nephrotic syndrome 20 (NPHS20) [MIM:301028]	Q4S8R1	246	Q	H
Q0IIM8	LP/P	Nephrotic syndrome 20 (NPHS20) [MIM:301028]	Q4S8R1	291	F	S
Q15814	LB/B	-	A0A2Y9FFH1	169	P	S
Q15814	LB/B	-	A0A2Y9FFH1	180	P	S
Q15814	LB/B	-	A0A2Y9FFH1	65	V	A
Q15814	LB/B	-	A0A2Y9FFH1	157	G	D
Q15814	LB/B	-	A0A2Y9FFH1	279	A	T
Q15814	LB/B	-	A0A2Y9FFH1	86	E	D
Q9BTW9	LB/B	-	A0A1Y1X769	617	M	T
Q9BTW9	LB/B	-	A0A1Y1X769	923	S	N
Q9BTW9	LB/B	-	A0A1Y1X769	943	G	V
Q9BTW9	LB/B	-	A0A1Y1X769	1185	L	P
Q9BTW9	LP/P	Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum (PEBAT) [MIM:617193]	A0A1Y1X769	229	L	R
Q9BTW9	LP/P	Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum (PEBAT) [MIM:617193]	A0A1Y1X769	374	T	M
Q9BTW9	LP/P	Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum (PEBAT) [MIM:617193]	A0A1Y1X769	377	R	Q
Q9BTW9	LP/P	Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum (PEBAT) [MIM:617193]	A0A1Y1X769	387	M	R
Q9BTW9	LP/P	Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum (PEBAT) [MIM:617193]	A0A1Y1X769	475	A	T
Q9BTW9	LP/P	Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum (PEBAT) [MIM:617193]	A0A1Y1X769	586	A	V
Q9BTW9	LP/P	Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum (PEBAT) [MIM:617193]	A0A1Y1X769	626	A	T
Q9BTW9	LP/P	Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum (PEBAT) [MIM:617193]	A0A1Y1X769	772	R	C
Q9BTW9	LP/P	Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum (PEBAT) [MIM:617193]	A0A1Y1X769	921	A	T
Q9BTW9	LP/P	Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum (PEBAT) [MIM:617193]	A0A1Y1X769	937	P	R
Q9BTW9	LP/P	Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum (PEBAT) [MIM:617193]	A0A1Y1X769	1122	P	L
Q15813	LB/B	-	W5NG15	205	V	A
Q15813	LB/B	-	W5NG15	333	S	T
Q15813	LB/B	-	W5NG15	409	E	G
Q15813	LP/P	Encephalopathy, progressive, with amyotrophy and optic atrophy (PEAMO) [MIM:617207]	W5NG15	155	I	N
Q8TEA7	LB/B	-	A0A1Y1JR89	266	Q	E
Q8TEA7	LB/B	-	A0A1Y1JR89	489	K	N
Q8TEA7	LB/B	-	A0A1Y1JR89	66	R	L
Q8TEA7	LB/B	-	A0A1Y1JR89	151	I	M
Q8TEA7	LB/B	-	A0A1Y1JR89	265	D	N
Q8TEA7	LB/B	-	A0A1Y1JR89	425	T	M
Q8TEA7	LB/B	-	A0A1Y1JR89	471	M	I
Q8TEA7	LB/B	-	A0A1Y1JR89	692	R	C
Q8TEA7	LP/P	Hypotonia, infantile, with psychomotor retardation and characteristic facies 3 (IHPRF3) [MIM:616900]	A0A1Y1JR89	511	R	H
Q8TEA7	LP/P	Hypotonia, infantile, with psychomotor retardation and characteristic facies 3 (IHPRF3) [MIM:616900]	A0A1Y1JR89	551	L	P
Q9UHD2	LB/B	-	H3ARH4	388	N	D
Q9UHD2	LB/B	-	H3ARH4	570	K	Q
Q9UHD2	LB/B	-	H3ARH4	271	R	Q
Q9UHD2	LB/B	-	H3ARH4	291	K	E
Q9UHD2	LB/B	-	H3ARH4	464	V	A
Q9UHD2	LB/B	-	H3ARH4	151	S	F
Q9UHD2	LP/P	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4 (FTDALS4) [MIM:616439]	H3ARH4	47	R	H
Q9UHD2	LP/P	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4 (FTDALS4) [MIM:616439]	H3ARH4	105	Y	C
Q9UHD2	LP/P	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4 (FTDALS4) [MIM:616439]	H3ARH4	305	I	T
Q9UHD2	LP/P	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4 (FTDALS4) [MIM:616439]	H3ARH4	308	R	Q
Q9UHD2	LP/P	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4 (FTDALS4) [MIM:616439]	H3ARH4	357	R	Q
Q9UHD2	LP/P	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4 (FTDALS4) [MIM:616439]	H3ARH4	401	K	E
Q9UHD2	LP/P	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4 (FTDALS4) [MIM:616439]	H3ARH4	559	M	R
Q9UHD2	LP/P	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4 (FTDALS4) [MIM:616439]	H3ARH4	571	A	V
Q9UHD2	LP/P	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4 (FTDALS4) [MIM:616439]	H3ARH4	598	M	V
Q9UHD2	LP/P	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4 (FTDALS4) [MIM:616439]	H3ARH4	696	E	K
Q9UHD2	LP/P	Encephalopathy, acute, infection-induced, 8, herpes-specific (IIAE8) [MIM:617900]	H3ARH4	50	D	A
Q9UHD2	LP/P	Encephalopathy, acute, infection-induced, 8, herpes-specific (IIAE8) [MIM:617900]	H3ARH4	159	G	A
Q9BZK7	LP/P	Intellectual developmental disorder, autosomal dominant 41 (MRD41) [MIM:616944]	L5KRN7	70	G	D
Q9BZK7	LB/B	-	L5KRN7	116	A	S
Q9BZK7	LP/P	Intellectual developmental disorder, autosomal dominant 41 (MRD41) [MIM:616944]	L5KRN7	245	Y	C
Q9BZK7	LP/P	Intellectual developmental disorder, autosomal dominant 41 (MRD41) [MIM:616944]	L5KRN7	282	L	P
Q9BZK7	LP/P	Pierpont syndrome (PRPTS) [MIM:602342]	L5KRN7	446	Y	C
Q12788	LB/B	-	A0A168KNR7	457	S	P
Q12788	LB/B	-	A0A168KNR7	293	Q	R
Q12788	LB/B	-	A0A168KNR7	294	E	Q
Q6SJ96	LB/B	-	A0A2Y9N507	31	R	P
Q16650	LB/B	-	A0A146ZVA7	289	H	Q
Q16650	LP/P	Intellectual developmental disorder with autism and speech delay (IDDAS) [MIM:606053]	A0A146ZVA7	271	W	R
Q16650	LP/P	Intellectual developmental disorder with autism and speech delay (IDDAS) [MIM:606053]	A0A146ZVA7	228	K	E
Q16650	LP/P	Intellectual developmental disorder with autism and speech delay (IDDAS) [MIM:606053]	A0A146ZVA7	271	W	C
Q16650	LP/P	Intellectual developmental disorder with autism and speech delay (IDDAS) [MIM:606053]	A0A146ZVA7	374	N	H
Q16650	LP/P	Intellectual developmental disorder with autism and speech delay (IDDAS) [MIM:606053]	A0A146ZVA7	389	K	E
Q969Z0	LB/B	-	G3VWZ0	22	A	S
Q969Z0	LB/B	-	G3VWZ0	57	P	L
O43435	LB/B	-	A0A2K5YJZ7	350	T	M
O43435	LP/P	DiGeorge syndrome (DGS) [MIM:188400]	A0A2K5YJZ7	310	G	S
O43435	LP/P	Conotruncal heart malformations (CTHM) [MIM:217095]	A0A2K5YJZ7	148	F	Y
O43435	LP/P	Velocardiofacial syndrome (VCFS) [MIM:192430]	A0A2K5YJZ7	148	F	Y
O43435	LP/P	Velocardiofacial syndrome (VCFS) [MIM:192430]	A0A2K5YJZ7	194	H	Q
O60806	LP/P	ACTH deficiency, isolated (IAD) [MIM:201400]	F7DUM9	128	S	F
Q13207	LP/P	Vertebral anomalies and variable endocrine and T-cell dysfunction (VETD) [MIM:618223]	A0A2D0QFN0	305	R	H
Q9UMR3	LP/P	Atrial septal defect 4 (ASD4) [MIM:611363]	L9L5V2	152	I	M
Q9UMR3	LP/P	Atrial septal defect 4 (ASD4) [MIM:611363]	L9L5V2	121	I	M
Q9Y458	LP/P	Cleft palate with or without ankyloglossia, X-linked (CPX) [MIM:303400]	G3WW38	118	G	C
Q9Y458	LP/P	Cleft palate with or without ankyloglossia, X-linked (CPX) [MIM:303400]	G3WW38	260	T	M
Q9Y458	LP/P	Cleft palate with or without ankyloglossia, X-linked (CPX) [MIM:303400]	G3WW38	214	L	P
Q9Y458	LP/P	Cleft palate with or without ankyloglossia, X-linked (CPX) [MIM:303400]	G3WW38	264	N	Y
Q9Y458	LP/P	Cleft palate with or without ankyloglossia, X-linked (CPX) [MIM:303400]	G3WW38	121	M	V
Q9Y458	LP/P	Cleft palate with or without ankyloglossia, X-linked (CPX) [MIM:303400]	G3WW38	183	P	L
Q9Y458	LB/B	-	G3WW38	187	E	K
Q9Y458	LB/B	-	G3WW38	249	F	Y
O15119	LP/P	Ulnar-mammary syndrome (UMS) [MIM:181450]	A0A2D0QFN0	143	L	P
O15119	LP/P	Ulnar-mammary syndrome (UMS) [MIM:181450]	A0A2D0QFN0	149	Y	S
P21731	LP/P	Bleeding disorder, platelet-type, 13 (BDPLT13) [MIM:614009]	A0A2K5TYV1	60	R	L
P21731	LB/B	-	A0A2K5TYV1	68	C	S
P21731	LB/B	-	A0A2K5TYV1	80	V	E
P21731	LB/B	-	A0A2K5TYV1	94	E	V
P21731	LB/B	-	A0A2K5TYV1	160	A	T
P21731	LB/B	-	A0A2K5TYV1	176	V	E
P21731	LB/B	-	A0A2K5TYV1	217	V	I
O15178	LB/B	-	F7DUM9	369	N	S
O15178	LB/B	-	F7DUM9	177	G	D
O15178	LB/B	-	F7DUM9	356	G	S
O15178	LB/B	-	F7DUM9	367	V	M
O15178	LB/B	-	F7DUM9	402	E	K
O15178	LB/B	-	F7DUM9	358	V	I
O15178	LP/P	Sacral agenesis with vertebral anomalies (SAVA) [MIM:615709]	F7DUM9	171	H	R
Q8N9U0	LB/B	-	A0A287D428	151	K	T
Q8N9U0	LB/B	-	A0A287D428	172	S	N
O15273	LP/P	Cardiomyopathy, familial hypertrophic 25 (CMH25) [MIM:607487]	V8PE91	70	R	W
O15273	LB/B	-	V8PE91	74	L	H
O15273	LP/P	-	V8PE91	132	E	Q
O15273	LP/P	Cardiomyopathy, familial hypertrophic 25 (CMH25) [MIM:607487]	V8PE91	137	T	I
O15273	LP/P	Cardiomyopathy, familial hypertrophic 25 (CMH25) [MIM:607487]	V8PE91	153	R	H
O15273	LB/B	-	V8PE91	106	R	C
Q9H3H9	LB/B	-	H0XPB3	19	D	G
Q9H3H9	LB/B	-	H0XPB3	68	G	A
Q969E4	LB/B	-	H0XPB3	87	Q	E
Q8N8B7	LB/B	-	A0A2D0Q7B8	163	S	L
Q5VWI1	LB/B	-	F1NNN3	339	P	Q
Q5VWI1	LB/B	-	F1NNN3	529	E	K
Q5VWI1	LB/B	-	F1NNN3	566	Q	K
Q9UGU0	LB/B	-	G3WIE0	485	T	N
Q9UGU0	LB/B	-	G3WIE0	722	S	G
Q9UGU0	LB/B	-	G3WIE0	1165	M	I
Q9UGU0	LB/B	-	G3WIE0	1325	S	N
Q9UGU0	LB/B	-	G3WIE0	405	M	V
Q9UGU0	LB/B	-	G3WIE0	1910	Y	C
Q9UGU0	LB/B	-	G3WIE0	16	S	T
Q9UGU0	LP/P	Developmental delay with variable intellectual impairment and behavioral abnormalities (DDVIBA) [MIM:618430]	G3WIE0	1909	H	Y
Q7RTU1	LB/B	-	G3WGP3	25	R	Q
Q7RTU1	LB/B	-	G3WGP3	40	T	S
Q9HCS4	LB/B	-	A0A2K6NWJ8	533	G	R
Q9NQB0	LB/B	-	A0A2K6NWJ8	346	K	N
Q9BT92	LB/B	-	K7GGQ8	127	K	R
Q9BT92	LB/B	-	K7GGQ8	417	E	K
Q9NR00	LB/B	-	E2R282	10	V	I
O95988	LB/B	-	A0A2Y9NF68	93	G	R
P20062	LB/B	-	S9X006	198	M	T
P20062	LB/B	-	S9X006	219	I	L
P20062	LB/B	-	S9X006	259	R	P
P20062	LB/B	-	S9X006	376	L	S
P20062	LB/B	-	S9X006	23	I	V
P20062	LB/B	-	S9X006	89	F	L
P20062	LB/B	-	S9X006	215	R	W
P20062	LB/B	-	S9X006	227	R	Q
P20062	LB/B	-	S9X006	348	S	F
P20062	LB/B	-	S9X006	399	R	Q
Q13428	LP/P	Treacher Collins syndrome 1 (TCS1) [MIM:154500]	A0A2U3W460	53	W	R
Q13428	LB/B	-	A0A2U3W460	516	P	L
Q13428	LB/B	-	A0A2U3W460	887	V	A
Q13428	LB/B	-	A0A2U3W460	1390	A	V
Q13428	LB/B	-	A0A2U3W460	1432	D	G
Q13428	LB/B	-	A0A2U3W460	665	A	P
Q13428	LB/B	-	A0A2U3W460	221	A	P
Q13428	LB/B	-	A0A2U3W460	1176	P	R
Q13428	LB/B	-	A0A2U3W460	1280	G	R
Q13428	LB/B	-	A0A2U3W460	1431	G	A
Q8WWU5	LB/B	-	S9X0R1	253	G	A
Q8WWU5	LB/B	-	S9X0R1	429	R	Q
Q8N4U5	LB/B	-	U3KLW4	41	A	T
Q8N4U5	LB/B	-	U3KLW4	82	A	S
Q8N4U5	LB/B	-	U3KLW4	261	D	N
Q5JU00	LB/B	-	G3WYW9	35	P	L
Q5JU00	LB/B	-	G3WYW9	53	H	R
Q5JU00	LB/B	-	G3WYW9	261	F	S
Q13569	LB/B	-	A0A2K5F2H6	199	G	S
Q13569	LB/B	-	A0A2K5F2H6	367	V	M
Q13569	LB/B	-	A0A2K5F2H6	381	G	E
Q13569	LB/B	-	A0A2K5F2H6	367	V	L
P13385	LB/B	-	P51865	43	Y	D
P13385	LB/B	-	P51865	22	V	A
P13385	LB/B	-	P51865	111	R	G
P48775	LP/P	Hypertryptophanemia (HYPTRP) [MIM:600627]	A0A0Q3PEX2	108	M	I
Q9NUW8	LP/P	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 1 (SCAN1) [MIM:607250]	F7FXC6	493	H	R
Q9NUW8	LB/B	-	F7FXC6	566	P	L
Q9NUW8	LB/B	-	F7FXC6	95	E	D
Q9NUW8	LB/B	-	F7FXC6	101	P	L
Q9NUW8	LB/B	-	F7FXC6	134	A	T
Q9NUW8	LB/B	-	F7FXC6	187	D	G
Q9NUW8	LB/B	-	F7FXC6	304	R	Q
Q9NUW8	LB/B	-	F7FXC6	569	T	A
O95551	LB/B	-	A0A0P4WWI8	249	Q	E
O95551	LB/B	-	A0A0P4WWI8	268	R	Q
O95551	LB/B	-	A0A0P4WWI8	166	S	G
O95551	LB/B	-	A0A0P4WWI8	307	I	V
Q5VZ19	LB/B	-	F4MHU6	181	R	Q
Q5VZ19	LB/B	-	F4MHU6	215	V	I
Q8NHU6	LB/B	-	A6NAF9	150	V	A
Q8NHU6	LB/B	-	A6NAF9	456	P	L
Q9Y2W6	LB/B	-	J9P0T0	257	G	A
P28347	LP/P	Sveinsson chorioretinal atrophy (SCRA) [MIM:108985]	A0A1U8CJW9	421	Y	H
Q99594	LB/B	-	A0A2Y9G553	254	T	M
Q15561	LB/B	-	A0A2Y9NIM0	323	P	S
P42680	LB/B	-	A0A2U9C741	44	R	Q
Q7Z6L1	LB/B	-	H3AXP5	733	S	Y
Q7Z6L1	LB/B	-	H3AXP5	944	P	L
Q9NZ01	LP/P	Intellectual developmental disorder, autosomal recessive 14 (MRT14) [MIM:614020]	I3JB62	182	P	L
Q5HYJ1	LB/B	-	K7F4S5	169	Y	H
O75443	LB/B	-	A0A1L8FG04	371	R	G
O75443	LB/B	-	A0A1L8FG04	932	V	A
O75443	LP/P	Deafness, autosomal dominant, 12 (DFNA12) [MIM:601543]	A0A1L8FG04	1057	C	S
O75443	LP/P	Deafness, autosomal dominant, 12 (DFNA12) [MIM:601543]	A0A1L8FG04	1619	C	S
O75443	LB/B	-	A0A1L8FG04	1724	S	N
O75443	LP/P	Deafness, autosomal dominant, 12 (DFNA12) [MIM:601543]	A0A1L8FG04	1820	L	F
O75443	LP/P	Deafness, autosomal dominant, 12 (DFNA12) [MIM:601543]	A0A1L8FG04	1824	G	D
O75443	LP/P	Deafness, autosomal dominant, 12 (DFNA12) [MIM:601543]	A0A1L8FG04	1837	C	G
O75443	LP/P	Deafness, autosomal dominant, 12 (DFNA12) [MIM:601543]	A0A1L8FG04	1870	Y	C
O75443	LP/P	Deafness, autosomal dominant, 12 (DFNA12) [MIM:601543]	A0A1L8FG04	2021	R	H
O75443	LB/B	-	A0A1L8FG04	2100	S	T
O75443	LB/B	-	A0A1L8FG04	19	Q	R
O75443	LB/B	-	A0A1L8FG04	1584	S	T
O75443	LB/B	-	A0A1L8FG04	1878	S	R
O75443	LP/P	Deafness, autosomal dominant, 12 (DFNA12) [MIM:601543]	A0A1L8FG04	197	D	N
O75443	LP/P	Deafness, autosomal dominant, 12 (DFNA12) [MIM:601543]	A0A1L8FG04	211	F	S
O75443	LP/P	Deafness, autosomal dominant, 12 (DFNA12) [MIM:601543]	A0A1L8FG04	317	V	E
O75443	LP/P	Deafness, autosomal dominant, 12 (DFNA12) [MIM:601543]	A0A1L8FG04	362	S	C
O75443	LP/P	Deafness, autosomal dominant, 12 (DFNA12) [MIM:601543]	A0A1L8FG04	465	N	K
O75443	LP/P	Deafness, autosomal dominant, 12 (DFNA12) [MIM:601543]	A0A1L8FG04	562	T	M
O75443	LP/P	Deafness, autosomal dominant, 12 (DFNA12) [MIM:601543]	A0A1L8FG04	815	T	M
O75443	LP/P	Deafness, autosomal dominant, 12 (DFNA12) [MIM:601543]	A0A1L8FG04	886	N	S
O75443	LP/P	Deafness, autosomal dominant, 12 (DFNA12) [MIM:601543]	A0A1L8FG04	1036	C	Y
O75443	LP/P	Deafness, autosomal dominant, 12 (DFNA12) [MIM:601543]	A0A1L8FG04	1098	A	V
O75443	LP/P	Deafness, autosomal dominant, 12 (DFNA12) [MIM:601543]	A0A1L8FG04	1136	D	H
O75443	LP/P	Deafness, autosomal dominant, 12 (DFNA12) [MIM:601543]	A0A1L8FG04	1248	P	L
O75443	LP/P	Deafness, autosomal dominant, 12 (DFNA12) [MIM:601543]	A0A1L8FG04	1509	C	G
O75443	LP/P	Deafness, autosomal dominant, 12 (DFNA12) [MIM:601543]	A0A1L8FG04	1517	C	R
O75443	LP/P	Deafness, autosomal dominant, 12 (DFNA12) [MIM:601543]	A0A1L8FG04	1791	P	R
O75443	LP/P	Deafness, autosomal dominant, 12 (DFNA12) [MIM:601543]	A0A1L8FG04	1837	C	R
O75443	LP/P	Deafness, autosomal dominant, 12 (DFNA12) [MIM:601543]	A0A1L8FG04	1866	T	M
O75443	LP/P	Deafness, autosomal dominant, 12 (DFNA12) [MIM:601543]	A0A1L8FG04	1867	H	R
O75443	LP/P	Deafness, autosomal dominant, 12 (DFNA12) [MIM:601543]	A0A1L8FG04	1890	R	C
O75443	LP/P	Deafness, autosomal dominant, 12 (DFNA12) [MIM:601543]	A0A1L8FG04	1898	C	R
O75443	LP/P	Deafness, autosomal dominant, 12 (DFNA12) [MIM:601543]	A0A1L8FG04	1947	R	C
O75443	LP/P	Deafness, autosomal dominant, 12 (DFNA12) [MIM:601543]	A0A1L8FG04	2009	I	T
Q7L2K0	LB/B	-	A0A2K5DEA4	346	R	K
Q5T9Z0	LB/B	-	L8HR72	130	Y	H
Q02763	LP/P	Dominantly inherited venous malformations (VMCM) [MIM:600195]	L5KWH1	849	R	W
Q02763	LP/P	Dominantly inherited venous malformations (VMCM) [MIM:600195]	L5KWH1	897	Y	S
Q02763	LB/B	-	L5KWH1	486	V	I
Q02763	LB/B	-	L5KWH1	148	I	T
Q02763	LB/B	-	L5KWH1	226	A	V
Q02763	LB/B	-	L5KWH1	600	V	L
Q02763	LB/B	-	L5KWH1	634	L	F
Q02763	LB/B	-	L5KWH1	676	V	I
Q02763	LB/B	-	L5KWH1	724	A	T
Q02763	LB/B	-	L5KWH1	346	Q	P
Q02763	LB/B	-	L5KWH1	391	T	I
Q02763	LP/P	Dominantly inherited venous malformations (VMCM) [MIM:600195]	L5KWH1	897	Y	C
Q02763	LP/P	Dominantly inherited venous malformations (VMCM) [MIM:600195]	L5KWH1	915	R	H
Q02763	LP/P	Dominantly inherited venous malformations (VMCM) [MIM:600195]	L5KWH1	918	R	C
Q02763	LP/P	Dominantly inherited venous malformations (VMCM) [MIM:600195]	L5KWH1	919	V	L
Q02763	LP/P	Dominantly inherited venous malformations (VMCM) [MIM:600195]	L5KWH1	925	A	S
Q02763	LP/P	Dominantly inherited venous malformations (VMCM) [MIM:600195]	L5KWH1	1100	K	N
Q02763	LP/P	Glaucoma 3, primary congenital, E (GLC3E) [MIM:617272]	L5KWH1	233	C	Y
Q02763	LP/P	Glaucoma 3, primary congenital, E (GLC3E) [MIM:617272]	L5KWH1	611	Y	C
Q02763	LB/B	-	L5KWH1	914	L	F
Q02763	LB/B	-	L5KWH1	915	R	C
Q969V4	LB/B	-	I3M7W7	254	R	C
Q969V4	LB/B	-	I3M7W7	332	V	I
Q969V4	LB/B	-	I3M7W7	146	I	V
Q9UIF3	LB/B	-	A0A1V4JJ24	46	R	C
Q9UIF3	LB/B	-	A0A1V4JJ24	114	I	T
Q9BXF9	LB/B	-	A0A1I8GB64	282	G	A
Q9BXF9	LB/B	-	A0A1I8GB64	296	V	A
Q9BXF9	LB/B	-	A0A1I8GB64	410	E	D
Q9BXF9	LB/B	-	A0A1I8GB64	3	R	H
Q8WW24	LB/B	-	H3AHP5	83	T	M
Q8WW24	LB/B	-	H3AHP5	102	K	N
Q8WW24	LB/B	-	H3AHP5	409	N	K
Q8WW24	LB/B	-	H3AHP5	100	S	G
Q96M29	LB/B	-	A0A1I8GB64	59	A	T
Q96M29	LB/B	-	A0A1I8GB64	196	H	R
Q96M29	LB/B	-	A0A1I8GB64	239	M	T
Q96M29	LB/B	-	A0A1I8GB64	315	Q	R
A6NCJ1	LB/B	-	A0A1S2ZUZ4	83	P	L
A6NCJ1	LB/B	-	A0A1S2ZUZ4	137	A	V
Q9Y4R8	LB/B	-	L5KGJ7	7	E	G
Q9Y4R8	LB/B	-	L5KGJ7	146	Q	R
Q9Y4R8	LB/B	-	L5KGJ7	674	Q	R
Q9Y4R8	LB/B	-	L5KGJ7	7	E	Q
Q9Y4R8	LB/B	-	L5KGJ7	511	A	V
Q9Y4R8	LP/P	You-Hoover-Fong syndrome (YHFS) [MIM:616954]	L5KGJ7	260	P	L
Q9Y4R8	LP/P	You-Hoover-Fong syndrome (YHFS) [MIM:616954]	L5KGJ7	367	C	F
Q9Y4R8	LP/P	You-Hoover-Fong syndrome (YHFS) [MIM:616954]	L5KGJ7	609	R	H
Q9Y4R8	LP/P	You-Hoover-Fong syndrome (YHFS) [MIM:616954]	L5KGJ7	720	D	V
Q9Y4R8	LP/P	You-Hoover-Fong syndrome (YHFS) [MIM:616954]	L5KGJ7	766	V	M
Q6N022	LB/B	-	G3I6B7	396	V	I
Q6N022	LB/B	-	G3I6B7	506	E	Q
Q6N022	LB/B	-	G3I6B7	14	R	Q
Q6N022	LP/P	Tremor, hereditary essential 5 (ETM5) [MIM:616736]	G3I6B7	1138	V	M
Q6N022	LP/P	Tremor, hereditary essential 5 (ETM5) [MIM:616736]	G3I6B7	1367	T	N
Q6N022	LP/P	Tremor, hereditary essential 5 (ETM5) [MIM:616736]	G3I6B7	1442	A	T
Q5VWP2	LB/B	-	W5L249	67	H	Q
Q8NEK8	LB/B	-	W5L249	185	D	E
Q99973	LB/B	-	A0A1U7U3M8	116	S	P
Q99973	LB/B	-	A0A1U7U3M8	307	N	K
Q99973	LB/B	-	A0A1U7U3M8	1055	R	C
Q99973	LB/B	-	A0A1U7U3M8	1195	S	P
Q99973	LB/B	-	A0A1U7U3M8	1447	S	T
Q99973	LB/B	-	A0A1U7U3M8	1468	C	Y
Q99973	LB/B	-	A0A1U7U3M8	2214	V	I
Q99973	LB/B	-	A0A1U7U3M8	2486	I	M
Q99973	LB/B	-	A0A1U7U3M8	2562	H	R
Q99973	LB/B	-	A0A1U7U3M8	137	T	M
Q99973	LB/B	-	A0A1U7U3M8	368	K	R
Q99973	LB/B	-	A0A1U7U3M8	434	K	N
Q99973	LB/B	-	A0A1U7U3M8	510	S	L
Q99973	LB/B	-	A0A1U7U3M8	553	A	G
Q99973	LB/B	-	A0A1U7U3M8	933	R	H
Q99973	LB/B	-	A0A1U7U3M8	1155	R	Q
Q99973	LB/B	-	A0A1U7U3M8	1351	R	Q
Q99973	LB/B	-	A0A1U7U3M8	1408	G	R
Q99973	LB/B	-	A0A1U7U3M8	1661	R	Q
Q99973	LB/B	-	A0A1U7U3M8	1772	R	Q
Q99973	LB/B	-	A0A1U7U3M8	2310	A	S
Q8NHR7	LB/B	-	A0A1L8GT75	31	P	R
Q8NHR7	LB/B	-	A0A1L8GT75	103	S	R
Q8NHR7	LB/B	-	A0A1L8GT75	190	H	N
Q9NYB0	LB/B	-	A0A091CQ38	324	K	E
O14746	LP/P	Aplastic anemia (AA) [MIM:609135]	Q27ID4	412	H	Y
O14746	LP/P	Dyskeratosis congenita, autosomal recessive, 4 (DKCB4) [MIM:613989]	Q27ID4	412	H	Y
O14746	LP/P	Pulmonary fibrosis, and/or bone marrow failure, telomere-related, 1 (PFBMFT1) [MIM:614742]	Q27ID4	412	H	Y
O14746	LB/B	-	Q27ID4	1062	A	T
O14746	LP/P	Aplastic anemia (AA) [MIM:609135]	Q27ID4	202	A	T
O14746	LP/P	Pulmonary fibrosis, and/or bone marrow failure, telomere-related, 1 (PFBMFT1) [MIM:614742]	Q27ID4	202	A	T
O14746	LB/B	-	Q27ID4	279	A	T
O14746	LP/P	Aplastic anemia (AA) [MIM:609135]	Q27ID4	694	V	M
O14746	LP/P	Pulmonary fibrosis, and/or bone marrow failure, telomere-related, 1 (PFBMFT1) [MIM:614742]	Q27ID4	694	V	M
O14746	LP/P	Pulmonary fibrosis, and/or bone marrow failure, telomere-related, 1 (PFBMFT1) [MIM:614742]	Q27ID4	772	Y	C
O14746	LP/P	Pulmonary fibrosis, and/or bone marrow failure, telomere-related, 1 (PFBMFT1) [MIM:614742]	Q27ID4	865	R	H
O14746	LP/P	Dyskeratosis congenita, autosomal dominant, 2 (DKCA2) [MIM:613989]	Q27ID4	902	K	N
O14746	LP/P	Pulmonary fibrosis, and/or bone marrow failure, telomere-related, 1 (PFBMFT1) [MIM:614742]	Q27ID4	1090	V	M
O14746	LB/B	-	Q27ID4	948	S	R
O14746	LP/P	Pulmonary fibrosis, and/or bone marrow failure, telomere-related, 1 (PFBMFT1) [MIM:614742]	Q27ID4	55	L	Q
O14746	LP/P	Aplastic anemia (AA) [MIM:609135]	Q27ID4	570	K	N
O14746	LP/P	Aplastic anemia (AA) [MIM:609135]	Q27ID4	682	G	D
O14746	LP/P	Dyskeratosis congenita, autosomal recessive, 4 (DKCB4) [MIM:613989]	Q27ID4	721	P	R
O14746	LP/P	Aplastic anemia (AA) [MIM:609135]	Q27ID4	726	T	M
O14746	LP/P	Dyskeratosis congenita, autosomal recessive, 4 (DKCB4) [MIM:613989]	Q27ID4	811	R	C
O14746	LP/P	Dyskeratosis congenita, autosomal recessive, 4 (DKCB4) [MIM:613989]	Q27ID4	901	R	W
O14746	LP/P	Dyskeratosis congenita, autosomal dominant, 2 (DKCA2) [MIM:613989]	Q27ID4	979	R	W
O14746	LP/P	Dyskeratosis congenita, autosomal dominant, 2 (DKCA2) [MIM:613989]	Q27ID4	1127	F	L
O14746	LB/B	-	Q27ID4	65	P	A
O14746	LB/B	-	Q27ID4	299	V	M
O14746	LB/B	-	Q27ID4	522	R	K
O14746	LP/P	Aplastic anemia (AA) [MIM:609135]	Q27ID4	631	R	Q
O14746	LP/P	Aplastic anemia (AA) [MIM:609135]	Q27ID4	785	P	L
O14746	LP/P	Pulmonary fibrosis, and/or bone marrow failure, telomere-related, 1 (PFBMFT1) [MIM:614742]	Q27ID4	170	V	M
O14746	LP/P	Dyskeratosis congenita, autosomal recessive, 4 (DKCB4) [MIM:613989]	Q27ID4	704	P	S
O14746	LP/P	Pulmonary fibrosis, and/or bone marrow failure, telomere-related, 1 (PFBMFT1) [MIM:614742]	Q27ID4	716	A	T
O14746	LP/P	Pulmonary fibrosis, and/or bone marrow failure, telomere-related, 1 (PFBMFT1) [MIM:614742]	Q27ID4	791	V	I
O14746	LP/P	Pulmonary fibrosis, and/or bone marrow failure, telomere-related, 1 (PFBMFT1) [MIM:614742]	Q27ID4	841	L	F
O14746	LP/P	Pulmonary fibrosis, and/or bone marrow failure, telomere-related, 1 (PFBMFT1) [MIM:614742]	Q27ID4	867	V	M
O14746	LP/P	Pulmonary fibrosis, and/or bone marrow failure, telomere-related, 1 (PFBMFT1) [MIM:614742]	Q27ID4	902	K	R
O14746	LP/P	Pulmonary fibrosis, and/or bone marrow failure, telomere-related, 1 (PFBMFT1) [MIM:614742]	Q27ID4	923	P	L
O14746	LP/P	Pulmonary fibrosis, and/or bone marrow failure, telomere-related, 1 (PFBMFT1) [MIM:614742]	Q27ID4	1025	V	F
O14746	LB/B	-	Q27ID4	381	R	P
Q9UGI8	LB/B	-	G5ARD3	221	A	V
Q15569	LB/B	-	I3JXY6	574	G	S
Q9Y4I5	LB/B	-	A0A1D5Q220	223	C	R
Q9Y4I5	LB/B	-	A0A1D5Q220	260	V	A
Q6N021	LB/B	-	A0A2I0TQF2	29	P	R
Q6N021	LB/B	-	A0A2I0TQF2	218	V	M
Q6N021	LB/B	-	A0A2I0TQF2	363	P	L
Q6N021	LB/B	-	A0A2I0TQF2	912	A	G
Q6N021	LB/B	-	A0A2I0TQF2	123	R	H
Q6N021	LB/B	-	A0A2I0TQF2	355	G	D
Q6N021	LB/B	-	A0A2I0TQF2	429	G	R
Q6N021	LB/B	-	A0A2I0TQF2	817	S	T
Q6N021	LB/B	-	A0A2I0TQF2	924	H	R
Q6N021	LB/B	-	A0A2I0TQF2	949	H	R
Q6N021	LB/B	-	A0A2I0TQF2	1869	G	W
Q6N021	LB/B	-	A0A2I0TQF2	1881	H	R
Q6N021	LB/B	-	A0A2I0TQF2	1900	V	A
Q6N021	LB/B	-	A0A2I0TQF2	1919	A	V
Q6N021	LB/B	-	A0A2I0TQF2	1962	P	L
Q6N021	LB/B	-	A0A2I0TQF2	2000	R	K
Q6N021	LB/B	-	A0A2I0TQF2	34	L	F
Q6N021	LB/B	-	A0A2I0TQF2	174	P	H
Q6N021	LB/B	-	A0A2I0TQF2	867	Y	H
Q6N021	LB/B	-	A0A2I0TQF2	1073	E	V
Q6N021	LB/B	-	A0A2I0TQF2	1084	Q	P
Q6N021	LB/B	-	A0A2I0TQF2	1135	C	Y
Q6N021	LB/B	-	A0A2I0TQF2	1214	R	W
Q6N021	LB/B	-	A0A2I0TQF2	1261	R	C
Q6N021	LB/B	-	A0A2I0TQF2	1701	M	I
Q6N021	LB/B	-	A0A2I0TQF2	1718	V	L
Q6N021	LB/B	-	A0A2I0TQF2	1721	L	W
Q6N021	LB/B	-	A0A2I0TQF2	1723	P	S
Q6N021	LB/B	-	A0A2I0TQF2	1762	I	V
Q6N021	LB/B	-	A0A2I0TQF2	1778	H	R
Q6N021	LP/P	Immunodeficiency 75 (IMD75) [MIM:619126]	A0A2I0TQF2	1382	H	R
Q9BY14	LB/B	-	A0A2K6MRH9	99	G	V
Q8IWB6	LB/B	-	G1SXW7	88	D	G
Q8IWB6	LB/B	-	G1SXW7	443	S	C
Q8IWB6	LB/B	-	G1SXW7	559	I	M
Q8IWB9	LB/B	-	J9P462	158	T	I
Q8N6G2	LB/B	-	F1RST3	231	K	N
Q9Y6I9	LB/B	-	G1R5W2	292	G	E
Q5T0J7	LB/B	-	M3Y198	55	E	G
Q5T0J7	LB/B	-	M3Y198	146	A	G
Q5T0J7	LB/B	-	M3Y198	171	L	R
Q5T0J7	LB/B	-	M3Y198	171	L	P
Q5VZQ5	LB/B	-	A0A2U3V8H1	38	E	Q
Q6PEX7	LB/B	-	A0A1S2ZM11	104	D	E
Q6PEX7	LB/B	-	A0A1S2ZM11	199	A	V
Q53QW1	LB/B	-	A0A2J8TQC4	11	V	L
Q53QW1	LB/B	-	A0A2J8TQC4	79	Q	R
Q53QW1	LB/B	-	A0A2J8TQC4	168	E	K
Q53QW1	LB/B	-	A0A2J8TQC4	261	S	P
Q8NA69	LB/B	-	A0A2R9AWX2	256	D	G
Q8NA69	LB/B	-	A0A2R9AWX2	396	Y	N
Q8NA69	LB/B	-	A0A2R9AWX2	434	Y	N
Q8NA69	LB/B	-	A0A2R9AWX2	497	P	S
Q8NA69	LB/B	-	A0A2R9AWX2	500	L	P
Q8TBZ9	LB/B	-	F6T3J0	48	D	H
Q8TBZ9	LB/B	-	F6T3J0	126	I	V
Q8TBZ9	LB/B	-	F6T3J0	186	C	S
Q8TBZ9	LB/B	-	F6T3J0	221	E	K
Q8TBZ9	LB/B	-	F6T3J0	221	E	A
Q96M34	LB/B	-	F7HPA8	45	N	T
Q96M34	LB/B	-	F7HPA8	99	D	G
Q96M34	LB/B	-	F7HPA8	193	Q	H
Q96M34	LB/B	-	F7HPA8	312	G	S
Q96M34	LB/B	-	F7HPA8	473	D	E
Q96M34	LB/B	-	F7HPA8	447	S	L
Q00059	LB/B	-	Q5REW5	12	S	T
Q00059	LP/P	Mitochondrial DNA depletion syndrome 15, hepatocerebral type (MTDPS15) [MIM:617156]	Q5REW5	178	P	L
Q92481	LP/P	Char syndrome (CHAR) [MIM:169100]	M4AEL7	275	A	D
Q92481	LP/P	Char syndrome (CHAR) [MIM:169100]	M4AEL7	300	R	C
Q92481	LP/P	Char syndrome (CHAR) [MIM:169100]	M4AEL7	73	P	R
Q92481	LP/P	Char syndrome (CHAR) [MIM:169100]	M4AEL7	236	R	C
Q92481	LP/P	Char syndrome (CHAR) [MIM:169100]	M4AEL7	236	R	S
Q92481	LP/P	Char syndrome (CHAR) [MIM:169100]	M4AEL7	285	R	Q
Q9H5Q4	LB/B	-	G3TEE6	156	P	L
Q9H5Q4	LB/B	-	G3TEE6	264	H	Y
Q9H5Q4	LB/B	-	G3TEE6	48	S	F
Q9H5Q4	LB/B	-	G3TEE6	64	A	T
Q14186	LB/B	-	L9JAY5	401	D	N
Q14188	LB/B	-	Q66KI2	64	I	T
Q14188	LB/B	-	Q66KI2	81	P	S
P19532	LB/B	-	G1Q720	96	S	C
P19532	LB/B	-	G1Q720	313	T	A
P19532	LP/P	Intellectual developmental disorder, X-linked, syndromic, with pigmentary mosaicism and coarse facies (MRXSPF) [MIM:301066]	G1Q720	117	R	Q
P19532	LP/P	Intellectual developmental disorder, X-linked, syndromic, with pigmentary mosaicism and coarse facies (MRXSPF) [MIM:301066]	G1Q720	119	Q	P
P19532	LP/P	Intellectual developmental disorder, X-linked, syndromic, with pigmentary mosaicism and coarse facies (MRXSPF) [MIM:301066]	G1Q720	184	E	G
P19532	LP/P	Intellectual developmental disorder, X-linked, syndromic, with pigmentary mosaicism and coarse facies (MRXSPF) [MIM:301066]	G1Q720	186	P	L
P19532	LP/P	Intellectual developmental disorder, X-linked, syndromic, with pigmentary mosaicism and coarse facies (MRXSPF) [MIM:301066]	G1Q720	187	T	K
P19532	LP/P	Intellectual developmental disorder, X-linked, syndromic, with pigmentary mosaicism and coarse facies (MRXSPF) [MIM:301066]	G1Q720	187	T	M
P19532	LP/P	Intellectual developmental disorder, X-linked, syndromic, with pigmentary mosaicism and coarse facies (MRXSPF) [MIM:301066]	G1Q720	187	T	P
P19532	LP/P	Intellectual developmental disorder, X-linked, syndromic, with pigmentary mosaicism and coarse facies (MRXSPF) [MIM:301066]	G1Q720	187	T	R
P19532	LP/P	Intellectual developmental disorder, X-linked, syndromic, with pigmentary mosaicism and coarse facies (MRXSPF) [MIM:301066]	G1Q720	189	Y	C
P19532	LP/P	Intellectual developmental disorder, X-linked, syndromic, with pigmentary mosaicism and coarse facies (MRXSPF) [MIM:301066]	G1Q720	190	H	Q
P19532	LP/P	Intellectual developmental disorder, X-linked, syndromic, with pigmentary mosaicism and coarse facies (MRXSPF) [MIM:301066]	G1Q720	191	L	P
P19532	LP/P	Intellectual developmental disorder, X-linked, syndromic, with pigmentary mosaicism and coarse facies (MRXSPF) [MIM:301066]	G1Q720	201	Q	P
O14948	LB/B	-	H2ME84	6	Q	H
O14948	LB/B	-	H2ME84	100	G	S
Q03403	LB/B	-	F7F8F0	3	R	W
Q92734	LB/B	-	K4FU35	211	A	V
Q92734	LB/B	-	K4FU35	364	T	P
Q92734	LP/P	Neuropathy, hereditary motor and sensory, Okinawa type (HMSNO) [MIM:604484]	K4FU35	285	P	L
Q92734	LP/P	Spastic paraplegia 57, autosomal recessive (SPG57) [MIM:615658]	K4FU35	106	R	C
Q92734	LP/P	Spastic paraplegia 57, autosomal recessive (SPG57) [MIM:615658]	K4FU35	106	R	H
P10646	LB/B	-	A0A2Y9EW96	292	V	M
P48307	LB/B	-	A0A1U8CFC1	102	V	A
P48307	LB/B	-	A0A1U8CFC1	231	R	Q
Q9UP52	LP/P	Hemochromatosis 3 (HFE3) [MIM:604250]	K7FKB8	172	M	K
Q9UP52	LB/B	-	K7FKB8	230	D	E
Q9UP52	LB/B	-	K7FKB8	238	I	M
Q9UP52	LB/B	-	K7FKB8	752	R	H
Q9UP52	LP/P	Hemochromatosis 3 (HFE3) [MIM:604250]	K7FKB8	22	V	I
Q9UP52	LB/B	-	K7FKB8	455	R	Q
Q9UP52	LP/P	Hemochromatosis 3 (HFE3) [MIM:604250]	K7FKB8	690	Q	P
P02786	LB/B	-	K7FKB8	142	G	S
P02786	LB/B	-	K7FKB8	212	L	V
P02786	LB/B	-	K7FKB8	420	G	S
P02786	LB/B	-	K7FKB8	677	R	H
P02786	LP/P	Immunodeficiency 46 (IMD46) [MIM:616740]	K7FKB8	20	Y	H
P01266	LB/B	-	H2MQZ5	870	Q	H
P01266	LB/B	-	H2MQZ5	135	Q	H
P01266	LB/B	-	H2MQZ5	734	S	A
P01266	LB/B	-	H2MQZ5	830	Q	E
P01266	LP/P	Thyroid dyshormonogenesis 3 (TDH3) [MIM:274700]	H2MQZ5	1264	C	R
P01266	LB/B	-	H2MQZ5	1312	D	G
P01266	LB/B	-	H2MQZ5	1838	D	N
P01266	LP/P	Thyroid dyshormonogenesis 3 (TDH3) [MIM:274700]	H2MQZ5	1996	C	S
P01266	LB/B	-	H2MQZ5	1999	R	W
P01266	LB/B	-	H2MQZ5	2501	W	R
P01266	LB/B	-	H2MQZ5	2530	R	Q
P01266	LB/B	-	H2MQZ5	515	Q	E
P01266	LB/B	-	H2MQZ5	604	S	D
P01266	LB/B	-	H2MQZ5	653	G	D
P01266	LB/B	-	H2MQZ5	1043	H	Y
P01266	LB/B	-	H2MQZ5	1059	I	T
P01266	LB/B	-	H2MQZ5	1437	W	R
P01266	LB/B	-	H2MQZ5	1463	P	H
P01266	LB/B	-	H2MQZ5	1936	A	T
P01266	LB/B	-	H2MQZ5	2091	D	E
P01266	LB/B	-	H2MQZ5	2149	P	L
P01266	LB/B	-	H2MQZ5	2170	Q	R
P01266	LB/B	-	H2MQZ5	2242	R	H
P01266	LB/B	-	H2MQZ5	777	P	L
P01266	LB/B	-	H2MQZ5	815	G	R
P01266	LB/B	-	H2MQZ5	988	R	P
P01266	LB/B	-	H2MQZ5	1063	L	M
P01266	LB/B	-	H2MQZ5	1222	S	L
P01266	LB/B	-	H2MQZ5	1740	T	K
P01266	LB/B	-	H2MQZ5	2455	R	H
P01266	LB/B	-	H2MQZ5	2469	L	P
P01266	LB/B	-	H2MQZ5	2526	F	L
P01266	LB/B	-	H2MQZ5	2616	N	S
P01266	LB/B	-	H2MQZ5	1974	M	T
P01266	LP/P	Thyroid dyshormonogenesis 3 (TDH3) [MIM:274700]	H2MQZ5	183	C	Y
P01266	LP/P	Thyroid dyshormonogenesis 3 (TDH3) [MIM:274700]	H2MQZ5	1897	C	Y
P01266	LP/P	Thyroid dyshormonogenesis 3 (TDH3) [MIM:274700]	H2MQZ5	2234	A	D
P01266	LP/P	Thyroid dyshormonogenesis 3 (TDH3) [MIM:274700]	H2MQZ5	2336	R	Q
P01266	LP/P	Thyroid dyshormonogenesis 3 (TDH3) [MIM:274700]	H2MQZ5	2375	G	R
P01135	LB/B	-	A0A2I2ZCX9	109	V	M
P01137	LB/B	-	A0A2K5RED7	10	L	P
P01137	LB/B	-	A0A2K5RED7	25	R	P
P01137	LB/B	-	A0A2K5RED7	263	T	I
P01137	LP/P	Camurati-Engelmann disease (CAEND) [MIM:131300]	A0A2K5RED7	81	Y	H
P01137	LP/P	Camurati-Engelmann disease (CAEND) [MIM:131300]	A0A2K5RED7	218	R	C
P01137	LP/P	Camurati-Engelmann disease (CAEND) [MIM:131300]	A0A2K5RED7	218	R	H
P01137	LP/P	Camurati-Engelmann disease (CAEND) [MIM:131300]	A0A2K5RED7	222	H	D
P01137	LP/P	Camurati-Engelmann disease (CAEND) [MIM:131300]	A0A2K5RED7	225	C	R
P01137	LP/P	Camurati-Engelmann disease (CAEND) [MIM:131300]	A0A2K5RED7	223	C	G
P01137	LP/P	Camurati-Engelmann disease (CAEND) [MIM:131300]	A0A2K5RED7	223	C	R
P01137	LP/P	Inflammatory bowel disease, immunodeficiency, and encephalopathy (IBDIMDE) [MIM:618213]	A0A2K5RED7	45	R	C
P01137	LP/P	Inflammatory bowel disease, immunodeficiency, and encephalopathy (IBDIMDE) [MIM:618213]	A0A2K5RED7	110	R	C
P01137	LP/P	Inflammatory bowel disease, immunodeficiency, and encephalopathy (IBDIMDE) [MIM:618213]	A0A2K5RED7	387	C	R
O43294	LB/B	-	L5M9C1	129	Q	H
P10600	LB/B	-	A0A1W4ZD14	60	T	M
P10600	LP/P	Loeys-Dietz syndrome 5 (LDS5) [MIM:615582]	A0A1W4ZD14	409	C	Y
P37173	LP/P	Hereditary non-polyposis colorectal cancer 6 (HNPCC6) [MIM:614331]	F6YQ99	315	T	M
P37173	LP/P	Esophageal cancer (ESCR) [MIM:133239]	F6YQ99	526	E	Q
P37173	LB/B	-	F6YQ99	191	V	I
P37173	LB/B	-	F6YQ99	36	M	V
P37173	LP/P	Loeys-Dietz syndrome 2 (LDS2) [MIM:610168]	F6YQ99	308	L	P
P37173	LP/P	Loeys-Dietz syndrome 2 (LDS2) [MIM:610168]	F6YQ99	336	Y	N
P37173	LP/P	Loeys-Dietz syndrome 2 (LDS2) [MIM:610168]	F6YQ99	355	A	P
P37173	LP/P	Loeys-Dietz syndrome 2 (LDS2) [MIM:610168]	F6YQ99	357	G	W
P37173	LP/P	Loeys-Dietz syndrome 2 (LDS2) [MIM:610168]	F6YQ99	449	S	F
P37173	LP/P	Loeys-Dietz syndrome 2 (LDS2) [MIM:610168]	F6YQ99	528	R	C
P37173	LP/P	Loeys-Dietz syndrome 2 (LDS2) [MIM:610168]	F6YQ99	528	R	H
P37173	LP/P	Loeys-Dietz syndrome 2 (LDS2) [MIM:610168]	F6YQ99	537	R	C
P37173	LB/B	-	F6YQ99	439	V	A
P37173	LP/P	Loeys-Dietz syndrome 2 (LDS2) [MIM:610168]	F6YQ99	460	R	C
P37173	LP/P	Loeys-Dietz syndrome 2 (LDS2) [MIM:610168]	F6YQ99	460	R	H
P37173	LB/B	-	F6YQ99	373	M	I
P37173	LP/P	Loeys-Dietz syndrome 2 (LDS2) [MIM:610168]	F6YQ99	377	H	R
P37173	LP/P	Loeys-Dietz syndrome 2 (LDS2) [MIM:610168]	F6YQ99	446	D	N
P37173	LP/P	Loeys-Dietz syndrome 2 (LDS2) [MIM:610168]	F6YQ99	457	M	K
P37173	LP/P	Loeys-Dietz syndrome 2 (LDS2) [MIM:610168]	F6YQ99	509	G	V
P37173	LP/P	Loeys-Dietz syndrome 2 (LDS2) [MIM:610168]	F6YQ99	510	I	F
P37173	LP/P	Loeys-Dietz syndrome 2 (LDS2) [MIM:610168]	F6YQ99	510	I	S
P37173	LP/P	Loeys-Dietz syndrome 2 (LDS2) [MIM:610168]	F6YQ99	514	C	R
P37173	LP/P	Loeys-Dietz syndrome 2 (LDS2) [MIM:610168]	F6YQ99	521	W	R
P37173	LP/P	Loeys-Dietz syndrome 2 (LDS2) [MIM:610168]	F6YQ99	190	R	H
P37173	LP/P	Loeys-Dietz syndrome 2 (LDS2) [MIM:610168]	F6YQ99	247	D	V
P37173	LP/P	Loeys-Dietz syndrome 2 (LDS2) [MIM:610168]	F6YQ99	325	T	P
P37173	LP/P	Loeys-Dietz syndrome 2 (LDS2) [MIM:610168]	F6YQ99	357	G	R
P37173	LP/P	Loeys-Dietz syndrome 2 (LDS2) [MIM:610168]	F6YQ99	530	T	I
Q03167	LB/B	-	A0A1S3FAW2	15	S	F
Q03167	LB/B	-	A0A1S3FAW2	14	S	N
Q03167	LB/B	-	A0A1S3FAW2	163	W	L
Q03167	LB/B	-	A0A1S3FAW2	635	A	T
Q03167	LB/B	-	A0A1S3FAW2	765	G	R
Q03167	LB/B	-	A0A1S3FAW2	351	F	I
Q03167	LB/B	-	A0A1S3FAW2	777	P	S
Q8WUH2	LB/B	-	C3XVZ5	725	H	R
Q8IUE1	LB/B	-	Q6ED44	197	V	I
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	142	R	H
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	143	R	C
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	143	R	H
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	218	G	S
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	379	V	L
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	396	R	L
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	42	S	Y
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	323	R	Q
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	389	R	H
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	102	D	V
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	289	N	T
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	307	R	W
P22735	LB/B	-	A0A2Y9L2I9	802	D	V
P22735	LB/B	-	A0A2Y9L2I9	132	D	N
P22735	LB/B	-	A0A2Y9L2I9	518	V	M
P22735	LB/B	-	A0A2Y9L2I9	607	R	C
P22735	LB/B	-	A0A2Y9L2I9	755	S	L
P22735	LB/B	-	A0A2Y9L2I9	372	V	I
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	53	C	S
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	94	G	D
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	126	R	C
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	126	R	H
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	134	Y	C
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	142	R	C
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	142	R	P
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	144	G	E
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	144	G	R
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	160	S	C
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	205	L	Q
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	209	V	F
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	225	R	H
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	225	R	P
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	243	I	S
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	249	P	L
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	264	R	Q
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	264	R	W
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	272	S	P
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	276	Y	N
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	278	G	R
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	285	E	K
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	286	R	Q
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	293	F	V
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	304	I	F
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	307	R	G
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	315	R	C
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	315	R	H
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	315	R	L
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	323	R	W
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	330	N	H
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	331	S	P
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	342	W	R
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	358	S	R
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	359	V	M
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	365	Y	D
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	366	L	P
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	382	G	R
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	383	V	M
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	389	R	P
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	392	G	D
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	396	R	H
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	396	R	S
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	401	F	V
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	430	D	V
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	473	G	S
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	490	D	G
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	520	E	G
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	544	Y	C
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	687	R	C
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	687	R	H
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	764	R	C
P22735	LP/P	Ichthyosis, congenital, autosomal recessive 1 (ARCI1) [MIM:242300]	A0A2Y9L2I9	212	S	F
P21980	LB/B	-	L8IQL6	76	R	H
P21980	LB/B	-	L8IQL6	536	P	S
P21980	LB/B	-	L8IQL6	214	R	H
P21980	LB/B	-	L8IQL6	324	Q	R
P21980	LB/B	-	L8IQL6	436	R	W
Q08188	LB/B	-	L8IQL6	13	T	K
Q08188	LB/B	-	L8IQL6	163	I	L
Q08188	LB/B	-	L8IQL6	249	S	N
Q08188	LB/B	-	L8IQL6	562	K	R
Q08188	LB/B	-	L8IQL6	654	G	R
Q08188	LB/B	-	L8IQL6	687	L	M
O43548	LB/B	-	L8IQL6	67	P	S
O43548	LB/B	-	L8IQL6	352	A	G
O43548	LB/B	-	L8IQL6	109	T	M
O43548	LP/P	Peeling skin syndrome 2 (PSS2) [MIM:609796]	L8IQL6	113	G	C
O43548	LB/B	-	L8IQL6	504	V	M
O43548	LB/B	-	L8IQL6	521	Q	R
O95932	LB/B	-	L8IQL6	58	M	V
O95932	LP/P	Spinocerebellar ataxia 35 (SCA35) [MIM:613908]	L8IQL6	327	D	G
O95932	LP/P	Spinocerebellar ataxia 35 (SCA35) [MIM:613908]	L8IQL6	517	L	W
O95932	LP/P	Spinocerebellar ataxia 35 (SCA35) [MIM:613908]	L8IQL6	111	R	C
O95932	LP/P	Spinocerebellar ataxia 35 (SCA35) [MIM:613908]	L8IQL6	510	D	H
O95932	LP/P	Spinocerebellar ataxia 35 (SCA35) [MIM:613908]	L8IQL6	426	T	N
O43493	LB/B	-	A0A2R9AP06	10	L	V
O43493	LB/B	-	A0A2R9AP06	86	A	G
O43493	LB/B	-	A0A2R9AP06	91	Q	L
O43493	LB/B	-	A0A2R9AP06	103	K	Q
O43493	LB/B	-	A0A2R9AP06	105	Q	P
O43493	LB/B	-	A0A2R9AP06	259	R	W
O43493	LB/B	-	A0A2R9AP06	322	E	G
Q96RS0	LB/B	-	A0A2I0MX86	16	I	T
Q96RS0	LB/B	-	A0A2I0MX86	160	I	V
Q96RS0	LB/B	-	A0A2I0MX86	511	I	T
Q96RS0	LB/B	-	A0A2I0MX86	576	V	I
Q96RS0	LB/B	-	A0A2I0MX86	754	F	C
Q96RS0	LB/B	-	A0A2I0MX86	299	P	S
Q96RS0	LB/B	-	A0A2I0MX86	595	T	A
P07101	LB/B	-	L8I2M6	112	V	M
P07101	LP/P	Segawa syndrome autosomal recessive (ARSEGS) [MIM:605407]	L8I2M6	233	R	H
P07101	LP/P	Segawa syndrome autosomal recessive (ARSEGS) [MIM:605407]	L8I2M6	236	L	P
P07101	LP/P	Segawa syndrome autosomal recessive (ARSEGS) [MIM:605407]	L8I2M6	276	T	P
P07101	LP/P	Segawa syndrome autosomal recessive (ARSEGS) [MIM:605407]	L8I2M6	314	T	M
P07101	LP/P	Segawa syndrome autosomal recessive (ARSEGS) [MIM:605407]	L8I2M6	337	R	H
P07101	LP/P	Segawa syndrome autosomal recessive (ARSEGS) [MIM:605407]	L8I2M6	412	Q	K
P07101	LP/P	Segawa syndrome autosomal recessive (ARSEGS) [MIM:605407]	L8I2M6	494	T	M
P07101	LB/B	-	L8I2M6	499	V	M
P07101	LP/P	Segawa syndrome autosomal recessive (ARSEGS) [MIM:605407]	L8I2M6	251	P	L
P07101	LP/P	Segawa syndrome autosomal recessive (ARSEGS) [MIM:605407]	L8I2M6	279	C	F
P07101	LP/P	Segawa syndrome autosomal recessive (ARSEGS) [MIM:605407]	L8I2M6	296	R	Q
P07101	LP/P	Segawa syndrome autosomal recessive (ARSEGS) [MIM:605407]	L8I2M6	315	G	S
P07101	LP/P	Segawa syndrome autosomal recessive (ARSEGS) [MIM:605407]	L8I2M6	382	I	T
P07101	LP/P	Segawa syndrome autosomal recessive (ARSEGS) [MIM:605407]	L8I2M6	428	G	R
P07101	LP/P	Segawa syndrome autosomal recessive (ARSEGS) [MIM:605407]	L8I2M6	207	C	Y
P07101	LP/P	Segawa syndrome autosomal recessive (ARSEGS) [MIM:605407]	L8I2M6	227	D	G
P07101	LP/P	Segawa syndrome autosomal recessive (ARSEGS) [MIM:605407]	L8I2M6	241	A	T
P07101	LP/P	Segawa syndrome autosomal recessive (ARSEGS) [MIM:605407]	L8I2M6	246	H	Y
P07101	LP/P	Segawa syndrome autosomal recessive (ARSEGS) [MIM:605407]	L8I2M6	247	G	S
P07101	LP/P	Segawa syndrome autosomal recessive (ARSEGS) [MIM:605407]	L8I2M6	259	E	G
P07101	LP/P	Segawa syndrome autosomal recessive (ARSEGS) [MIM:605407]	L8I2M6	294	G	R
P07101	LP/P	Segawa syndrome autosomal recessive (ARSEGS) [MIM:605407]	L8I2M6	301	P	A
P07101	LP/P	Segawa syndrome autosomal recessive (ARSEGS) [MIM:605407]	L8I2M6	309	F	S
P07101	LP/P	Segawa syndrome autosomal recessive (ARSEGS) [MIM:605407]	L8I2M6	319	R	P
P07101	LP/P	Segawa syndrome autosomal recessive (ARSEGS) [MIM:605407]	L8I2M6	328	R	W
P07101	LP/P	Segawa syndrome autosomal recessive (ARSEGS) [MIM:605407]	L8I2M6	359	C	F
P07101	LP/P	Segawa syndrome autosomal recessive (ARSEGS) [MIM:605407]	L8I2M6	375	F	L
P07101	LP/P	Segawa syndrome autosomal recessive (ARSEGS) [MIM:605407]	L8I2M6	376	A	V
P07101	LP/P	Segawa syndrome autosomal recessive (ARSEGS) [MIM:605407]	L8I2M6	385	A	V
P07101	LP/P	Segawa syndrome autosomal recessive (ARSEGS) [MIM:605407]	L8I2M6	387	L	M
P07101	LP/P	Segawa syndrome autosomal recessive (ARSEGS) [MIM:605407]	L8I2M6	394	I	T
P07101	LP/P	Segawa syndrome autosomal recessive (ARSEGS) [MIM:605407]	L8I2M6	399	T	M
P07101	LP/P	Segawa syndrome autosomal recessive (ARSEGS) [MIM:605407]	L8I2M6	408	G	R
P07101	LP/P	Segawa syndrome autosomal recessive (ARSEGS) [MIM:605407]	L8I2M6	414	G	R
P07101	LP/P	Segawa syndrome autosomal recessive (ARSEGS) [MIM:605407]	L8I2M6	441	R	P
P07101	LP/P	Segawa syndrome autosomal recessive (ARSEGS) [MIM:605407]	L8I2M6	467	S	G
P07101	LP/P	Segawa syndrome autosomal recessive (ARSEGS) [MIM:605407]	L8I2M6	492	P	L
P07101	LP/P	Segawa syndrome autosomal recessive (ARSEGS) [MIM:605407]	L8I2M6	498	D	G
P07101	LP/P	Segawa syndrome autosomal recessive (ARSEGS) [MIM:605407]	L8I2M6	510	L	Q
Q6YHU6	LB/B	-	A0A1W4XLS7	63	E	G
Q6YHU6	LB/B	-	A0A1W4XLS7	699	V	I
Q6YHU6	LB/B	-	A0A1W4XLS7	1187	T	A
Q6YHU6	LB/B	-	A0A1W4XLS7	1385	T	S
Q6YHU6	LB/B	-	A0A1W4XLS7	1451	P	S
Q6YHU6	LB/B	-	A0A1W4XLS7	1605	C	Y
Q6YHU6	LB/B	-	A0A1W4XLS7	1668	C	R
Q9NVV9	LP/P	Dystonia 6, torsion (DYT6) [MIM:602629]	A0A2K5EZ56	81	F	L
Q9NVV9	LP/P	Dystonia 6, torsion (DYT6) [MIM:602629]	A0A2K5EZ56	12	N	K
Q9NVV9	LP/P	Dystonia 6, torsion (DYT6) [MIM:602629]	A0A2K5EZ56	21	S	T
Q9NVV9	LP/P	Dystonia 6, torsion (DYT6) [MIM:602629]	A0A2K5EZ56	29	R	P
Q9NVV9	LP/P	Dystonia 6, torsion (DYT6) [MIM:602629]	A0A2K5EZ56	39	A	T
Q9NVV9	LP/P	Dystonia 6, torsion (DYT6) [MIM:602629]	A0A2K5EZ56	59	T	I
Q9NVV9	LP/P	Dystonia 6, torsion (DYT6) [MIM:602629]	A0A2K5EZ56	89	K	R
Q9NVV9	LP/P	Dystonia 6, torsion (DYT6) [MIM:602629]	A0A2K5EZ56	136	N	K
Q9NVV9	LP/P	Dystonia 6, torsion (DYT6) [MIM:602629]	A0A2K5EZ56	170	C	R
Q9NVV9	LP/P	Dystonia 6, torsion (DYT6) [MIM:602629]	A0A2K5EZ56	6	S	F
Q9NVV9	LP/P	Dystonia 6, torsion (DYT6) [MIM:602629]	A0A2K5EZ56	6	S	P
Q9NVV9	LP/P	Dystonia 6, torsion (DYT6) [MIM:602629]	A0A2K5EZ56	8	Y	C
Q9NVV9	LP/P	Dystonia 6, torsion (DYT6) [MIM:602629]	A0A2K5EZ56	9	G	C
Q9NVV9	LP/P	Dystonia 6, torsion (DYT6) [MIM:602629]	A0A2K5EZ56	13	R	H
Q9NVV9	LP/P	Dystonia 6, torsion (DYT6) [MIM:602629]	A0A2K5EZ56	16	K	E
Q9NVV9	LP/P	Dystonia 6, torsion (DYT6) [MIM:602629]	A0A2K5EZ56	17	D	G
Q9NVV9	LP/P	Dystonia 6, torsion (DYT6) [MIM:602629]	A0A2K5EZ56	23	H	P
Q9NVV9	LP/P	Dystonia 6, torsion (DYT6) [MIM:602629]	A0A2K5EZ56	24	K	E
Q9NVV9	LP/P	Dystonia 6, torsion (DYT6) [MIM:602629]	A0A2K5EZ56	26	P	L
Q9NVV9	LP/P	Dystonia 6, torsion (DYT6) [MIM:602629]	A0A2K5EZ56	26	P	R
Q9NVV9	LP/P	Dystonia 6, torsion (DYT6) [MIM:602629]	A0A2K5EZ56	29	R	Q
Q9NVV9	LP/P	Dystonia 6, torsion (DYT6) [MIM:602629]	A0A2K5EZ56	30	P	R
Q9NVV9	LP/P	Dystonia 6, torsion (DYT6) [MIM:602629]	A0A2K5EZ56	32	L	H
Q9NVV9	LP/P	Dystonia 6, torsion (DYT6) [MIM:602629]	A0A2K5EZ56	54	C	F
Q9NVV9	LP/P	Dystonia 6, torsion (DYT6) [MIM:602629]	A0A2K5EZ56	57	H	N
Q9NVV9	LP/P	Dystonia 6, torsion (DYT6) [MIM:602629]	A0A2K5EZ56	72	L	R
Q9NVV9	LP/P	Dystonia 6, torsion (DYT6) [MIM:602629]	A0A2K5EZ56	75	N	I
Q9NVV9	LP/P	Dystonia 6, torsion (DYT6) [MIM:602629]	A0A2K5EZ56	80	I	V
Q9NVV9	LP/P	Dystonia 6, torsion (DYT6) [MIM:602629]	A0A2K5EZ56	83	C	R
Q9NVV9	LP/P	Dystonia 6, torsion (DYT6) [MIM:602629]	A0A2K5EZ56	132	F	S
Q9NVV9	LP/P	Dystonia 6, torsion (DYT6) [MIM:602629]	A0A2K5EZ56	136	N	S
Q9NVV9	LP/P	Dystonia 6, torsion (DYT6) [MIM:602629]	A0A2K5EZ56	137	Y	C
Q9NVV9	LP/P	Dystonia 6, torsion (DYT6) [MIM:602629]	A0A2K5EZ56	143	M	V
Q9NVV9	LP/P	Dystonia 6, torsion (DYT6) [MIM:602629]	A0A2K5EZ56	149	I	T
Q9NVV9	LP/P	Dystonia 6, torsion (DYT6) [MIM:602629]	A0A2K5EZ56	150	H	P
Q9NVV9	LP/P	Dystonia 6, torsion (DYT6) [MIM:602629]	A0A2K5EZ56	166	A	T
Q9NVV9	LP/P	Dystonia 6, torsion (DYT6) [MIM:602629]	A0A2K5EZ56	169	R	Q
Q9NVV9	LP/P	Dystonia 6, torsion (DYT6) [MIM:602629]	A0A2K5EZ56	174	E	G
Q9NVV9	LP/P	Dystonia 6, torsion (DYT6) [MIM:602629]	A0A2K5EZ56	180	L	S
Q9NVV9	LP/P	Dystonia 6, torsion (DYT6) [MIM:602629]	A0A2K5EZ56	187	Q	K
Q9NVV9	LP/P	Dystonia 6, torsion (DYT6) [MIM:602629]	A0A2K5EZ56	192	D	N
Q9NVV9	LP/P	Dystonia 6, torsion (DYT6) [MIM:602629]	A0A2K5EZ56	7	A	D
Q9NVV9	LP/P	Dystonia 6, torsion (DYT6) [MIM:602629]	A0A2K5EZ56	21	S	C
Q9NVV9	LP/P	Dystonia 6, torsion (DYT6) [MIM:602629]	A0A2K5EZ56	56	E	G
Q9NVV9	LP/P	Dystonia 6, torsion (DYT6) [MIM:602629]	A0A2K5EZ56	177	L	P
Q9H0W7	LB/B	-	K7G2G8	170	T	M
Q9BT49	LB/B	-	A0A2Y9E396	115	A	P
Q8NA92	LB/B	-	A0A2Y9TFH8	112	K	R
Q8NA92	LB/B	-	A0A2Y9TFH8	70	R	H
Q8NA92	LB/B	-	A0A2Y9TFH8	157	P	S
Q8NA92	LB/B	-	A0A2Y9TFH8	185	R	Q
Q8NA92	LB/B	-	A0A2Y9TFH8	189	R	W
P07204	LP/P	Hemolytic uremic syndrome atypical 6 (AHUS6) [MIM:612926]	B3KVV1	43	A	T
P07204	LB/B	-	B3KVV1	79	G	A
P07204	LB/B	-	B3KVV1	473	A	V
P07204	LP/P	Hemolytic uremic syndrome atypical 6 (AHUS6) [MIM:612926]	B3KVV1	486	D	Y
P07204	LP/P	Thrombophilia due to thrombomodulin defect (THPH12) [MIM:614486]	B3KVV1	486	D	Y
P07204	LP/P	Hemolytic uremic syndrome atypical 6 (AHUS6) [MIM:612926]	B3KVV1	495	P	S
P07204	LP/P	Hemolytic uremic syndrome atypical 6 (AHUS6) [MIM:612926]	B3KVV1	501	P	L
P07204	LB/B	-	B3KVV1	162	A	P
P07204	LP/P	Hemolytic uremic syndrome atypical 6 (AHUS6) [MIM:612926]	B3KVV1	53	D	G
P07204	LP/P	Hemolytic uremic syndrome atypical 6 (AHUS6) [MIM:612926]	B3KVV1	81	V	L
P07204	LP/P	Hemolytic uremic syndrome atypical 6 (AHUS6) [MIM:612926]	B3KVV1	34	D	E
P07204	LP/P	Hemolytic uremic syndrome atypical 6 (AHUS6) [MIM:612926]	B3KVV1	236	A	G
P07996	LB/B	-	A0A1U7T972	523	T	A
P07996	LB/B	-	A0A1U7T972	700	N	S
P07996	LB/B	-	A0A1U7T972	24	S	A
P35442	LB/B	-	A0A1U7T972	133	T	S
P35442	LB/B	-	A0A1U7T972	375	L	F
P49746	LB/B	-	H2ZQX6	279	S	G
Q5T1C6	LB/B	-	A0A2K6NWH7	17	L	R
Q5T1C6	LB/B	-	A0A2K6NWH7	38	S	C
Q8N1Q8	LB/B	-	H0UVC1	55	Y	S
Q8N1Q8	LB/B	-	H0UVC1	197	D	G
Q8N1Q8	LB/B	-	H0UVC1	206	L	V
Q5TEJ8	LB/B	-	A0A1U7TZS2	431	V	L
Q5TEJ8	LB/B	-	A0A1U7TZS2	511	K	E
Q8IYQ7	LB/B	-	E6ZJC6	154	L	P
Q8IYQ7	LB/B	-	E6ZJC6	248	A	E
Q8IYQ7	LB/B	-	E6ZJC6	399	Q	R
Q8IYQ7	LB/B	-	E6ZJC6	239	P	R
Q8NI27	LP/P	Intellectual developmental disorder, X-linked 12 (XLID12) [MIM:300957]	W5L428	313	L	F
Q8NI27	LP/P	Intellectual developmental disorder, X-linked 12 (XLID12) [MIM:300957]	W5L428	438	L	P
Q8NI27	LP/P	Intellectual developmental disorder, X-linked 12 (XLID12) [MIM:300957]	W5L428	800	I	T
Q8NI27	LP/P	Intellectual developmental disorder, X-linked 12 (XLID12) [MIM:300957]	W5L428	1012	S	P
Q96J01	LB/B	-	A0A0P6JTF4	326	C	F
Q13769	LB/B	-	Q4RSS1	579	V	I
Q13769	LB/B	-	Q4RSS1	475	T	S
Q13769	LB/B	-	Q4RSS1	525	V	I
Q86W42	LP/P	Beaulieu-Boycott-Innes syndrome (BBIS) [MIM:613680]	A0A2B4SRY0	46	G	R
P40225	LB/B	-	H2PC72	14	L	P
P40225	LB/B	-	H2PC72	116	G	E
P10827	LP/P	Hypothyroidism, congenital, non-goitrous, 6 (CHNG6) [MIM:614450]	A0A2K6GS02	263	A	V
P10827	LP/P	Hypothyroidism, congenital, non-goitrous, 6 (CHNG6) [MIM:614450]	A0A2K6GS02	359	N	Y
Q9Y2W1	LB/B	-	W5M529	201	A	V
Q9NS62	LB/B	-	A0A2U3VVP7	125	V	G
Q9NS62	LB/B	-	A0A2U3VVP7	224	R	G
Q9NS62	LB/B	-	A0A2U3VVP7	768	K	R
Q9NS62	LB/B	-	A0A2U3VVP7	491	D	H
Q9NS62	LP/P	Aneurysm, intracranial berry, 12 (ANIB12) [MIM:618734]	A0A2U3VVP7	5	L	F
Q9NS62	LP/P	Aneurysm, intracranial berry, 12 (ANIB12) [MIM:618734]	A0A2U3VVP7	639	P	L
Q9UPZ6	LB/B	-	A0A1W5AAU9	238	F	L
Q9UPZ6	LB/B	-	A0A1W5AAU9	771	D	E
Q9UPZ6	LB/B	-	A0A1W5AAU9	583	N	H
Q9UPZ6	LB/B	-	A0A1W5AAU9	906	D	E
Q9UPZ6	LB/B	-	A0A1W5AAU9	1652	D	E
Q9BU02	LB/B	-	A0A1S3HYD9	176	H	R
Q9NXG2	LB/B	-	G5BVA0	311	E	D
Q9NXG2	LP/P	Neurodevelopmental disorder with speech delay and variable ocular anomalies (NEDSOA) [MIM:619989]	G5BVA0	164	P	S
Q9BV44	LB/B	-	A0A091E6E4	459	R	Q
P31483	LP/P	Welander distal myopathy (WDM) [MIM:604454]	A0A060W678	384	E	K
P31483	LP/P	Amyotrophic lateral sclerosis 26, with or without frontotemporal dementia (ALS26) [MIM:619133]	A0A060W678	362	P	L
Q13009	LB/B	-	W5K366	247	G	R
Q13009	LB/B	-	W5K366	247	G	V
Q13009	LB/B	-	W5K366	844	Q	H
Q13009	LB/B	-	W5K366	1007	R	H
Q13009	LB/B	-	W5K366	1023	D	V
Q8IVF5	LB/B	-	G1T2P8	1101	R	C
Q8IVF5	LB/B	-	G1T2P8	1572	D	E
Q8IVF5	LB/B	-	G1T2P8	332	R	H
Q8IVF5	LB/B	-	G1T2P8	913	R	H
Q8IVF5	LB/B	-	G1T2P8	1089	S	P
Q8IUC6	LB/B	-	L5MI62	75	R	C
Q8IUC6	LB/B	-	L5MI62	275	L	V
Q8IUC6	LB/B	-	L5MI62	666	A	T
Q8IUC6	LP/P	Encephalopathy, acute, infection-induced, 6, herpes-specific (IIAE6) [MIM:614850]	L5MI62	186	S	L
Q8IUC6	LB/B	-	L5MI62	4	T	I
Q8IUC6	LB/B	-	L5MI62	60	S	C
Q8IUC6	LB/B	-	L5MI62	71	R	Q
Q8IUC6	LB/B	-	L5MI62	80	V	M
Q8IUC6	LB/B	-	L5MI62	111	A	T
Q8IUC6	LB/B	-	L5MI62	157	T	M
Q8IUC6	LB/B	-	L5MI62	377	T	I
Q8IUC6	LB/B	-	L5MI62	557	D	N
Q8IUC6	LB/B	-	L5MI62	595	M	L
Q8IUC6	LB/B	-	L5MI62	598	G	W
P35590	LB/B	-	A0A0A0AFW9	448	V	M
P35590	LB/B	-	A0A0A0AFW9	1104	A	V
Q96CG3	LB/B	-	I3NE14	19	T	M
Q8IY51	LB/B	-	A0A091MWL6	439	I	V
Q8IY51	LB/B	-	A0A091MWL6	432	A	T
Q8IY51	LB/B	-	A0A091MWL6	489	Q	R
Q53EQ6	LB/B	-	A0A226PFU7	568	M	I
Q17RP2	LB/B	-	A0A1U7TGS4	59	R	W
Q17RP2	LB/B	-	A0A1U7TGS4	327	Q	R
Q495A1	LB/B	-	A0A2K5R7F7	33	I	V
Q96H15	LB/B	-	A0A2J8X6P6	240	V	A
Q96H15	LB/B	-	A0A2J8X6P6	365	V	M
Q9UNS1	LB/B	-	H3DLL5	455	I	L
Q9UNS1	LB/B	-	H3DLL5	831	R	Q
Q9UNS1	LB/B	-	H3DLL5	1018	P	L
Q9UNS1	LB/B	-	H3DLL5	129	A	S
Q9UNS1	LB/B	-	H3DLL5	471	N	S
Q9UNS1	LB/B	-	H3DLL5	870	M	V
Q9UNS1	LB/B	-	H3DLL5	922	R	H
Q9UNS1	LB/B	-	H3DLL5	924	R	W
Q9UNS1	LB/B	-	H3DLL5	1017	I	T
Q9Y5J6	LB/B	-	F1LTU8	90	G	S
Q9Y5J6	LB/B	-	F1LTU8	66	A	S
Q99595	LB/B	-	A0A1W7R9F2	113	V	I
Q9BVV7	LB/B	-	L5LZ28	79	G	S
Q9Y584	LP/P	Combined oxidative phosphorylation deficiency 43 (COXPD43) [MIM:618851]	A0A0Q3M7G9	33	V	L
Q9NPL8	LB/B	-	A0A2Y9DFZ9	76	N	D
Q9NPL8	LB/B	-	A0A2Y9DFZ9	217	V	I
P35625	LP/P	Sorsby fundus dystrophy (SFD) [MIM:136900]	A0A2U9CSN1	179	S	C
P35625	LP/P	Sorsby fundus dystrophy (SFD) [MIM:136900]	A0A2U9CSN1	191	Y	C
P35625	LP/P	Sorsby fundus dystrophy (SFD) [MIM:136900]	A0A2U9CSN1	204	S	C
P35625	LP/P	Sorsby fundus dystrophy (SFD) [MIM:136900]	A0A2U9CSN1	189	G	C
P35625	LP/P	Sorsby fundus dystrophy (SFD) [MIM:136900]	A0A2U9CSN1	190	G	C
Q9UJW2	LB/B	-	A0A210QBT7	3	T	A
Q9UJW2	LB/B	-	A0A210QBT7	22	Q	R
Q9UJW2	LB/B	-	A0A210QBT7	158	S	P
Q9UJW2	LB/B	-	A0A210QBT7	413	V	I
Q9UJW2	LB/B	-	A0A210QBT7	433	I	L
Q9BSI4	LP/P	Dyskeratosis congenita, autosomal dominant, 3 (DKCA3) [MIM:613990]	G3TC22	280	K	E
Q9BSI4	LP/P	Dyskeratosis congenita, autosomal dominant, 3 (DKCA3) [MIM:613990]	G3TC22	282	R	H
Q9BSI4	LP/P	Dyskeratosis congenita, autosomal dominant, 5 (DKCA5) [MIM:268130]	G3TC22	282	R	H
Q9BSI4	LP/P	Dyskeratosis congenita, autosomal dominant, 3 (DKCA3) [MIM:613990]	G3TC22	282	R	S
Q9BSI4	LB/B	-	G3TC22	43	A	T
Q9BSI4	LB/B	-	G3TC22	237	G	D
Q9BSI4	LB/B	-	G3TC22	241	P	S
Q7Z3E1	LB/B	-	F6PPH2	406	R	S
P58753	LB/B	-	H0W128	9	A	P
P58753	LB/B	-	H0W128	13	R	W
P58753	LB/B	-	H0W128	96	D	N
P58753	LB/B	-	H0W128	180	S	L
P58753	LB/B	-	H0W128	55	S	N
P58753	LB/B	-	H0W128	197	V	I
Q07157	LB/B	-	F6RJQ3	471	N	S
Q07157	LB/B	-	F6RJQ3	790	I	V
Q07157	LB/B	-	F6RJQ3	930	P	L
Q07157	LB/B	-	F6RJQ3	1110	H	R
Q07157	LB/B	-	F6RJQ3	1347	D	A
Q07157	LB/B	-	F6RJQ3	1605	N	S
O95049	LB/B	-	F6WF73	898	M	T
O00142	LP/P	Mitochondrial DNA depletion syndrome 2 (MTDPS2) [MIM:609560]	A0A2K5W2D4	53	I	M
O00142	LP/P	Mitochondrial DNA depletion syndrome 2 (MTDPS2) [MIM:609560]	A0A2K5W2D4	108	T	M
O00142	LP/P	Mitochondrial DNA depletion syndrome 2 (MTDPS2) [MIM:609560]	A0A2K5W2D4	121	H	N
O00142	LP/P	Mitochondrial DNA depletion syndrome 2 (MTDPS2) [MIM:609560]	A0A2K5W2D4	212	I	N
O00142	LP/P	Mitochondrial DNA depletion syndrome 2 (MTDPS2) [MIM:609560]	A0A2K5W2D4	64	T	M
O00142	LP/P	Mitochondrial DNA depletion syndrome 2 (MTDPS2) [MIM:609560]	A0A2K5W2D4	183	R	W
O00142	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 3 (PEOB3) [MIM:617069]	A0A2K5W2D4	183	R	W
O00142	LP/P	Mitochondrial DNA depletion syndrome 2 (MTDPS2) [MIM:609560]	A0A2K5W2D4	192	R	K
O00142	LP/P	Mitochondrial DNA depletion syndrome 2 (MTDPS2) [MIM:609560]	A0A2K5W2D4	117	M	V
O00142	LP/P	Mitochondrial DNA depletion syndrome 2 (MTDPS2) [MIM:609560]	A0A2K5W2D4	139	A	V
O00142	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 3 (PEOB3) [MIM:617069]	A0A2K5W2D4	188	T	A
Q3LXA3	LB/B	-	I3IV90	185	A	T
Q3LXA3	LB/B	-	I3IV90	334	A	G
Q3LXA3	LP/P	Triokinase and FMN cyclase deficiency syndrome (TKFCD) [MIM:618805]	I3IV90	445	G	S
Q3LXA3	LP/P	Triokinase and FMN cyclase deficiency syndrome (TKFCD) [MIM:618805]	I3IV90	543	R	I
P51854	LB/B	-	H3AYY5	24	L	F
P51854	LB/B	-	H3AYY5	152	I	T
P51854	LB/B	-	H3AYY5	317	R	K
Q9H0I9	LB/B	-	E5S1D6	442	R	Q
Q9H0I9	LB/B	-	E5S1D6	590	Q	H
Q04725	LB/B	-	A0A139WM63	381	S	G
Q04726	LB/B	-	M7B069	229	A	V
Q08117	LB/B	-	A0A139WM63	168	A	E
Q9H808	LP/P	Preimplantation embryonic lethality 1 (PREMBL1) [MIM:616814]	M3XW37	510	S	Y
Q9UKI8	LB/B	-	A0A146WHQ7	121	R	C
Q86UE8	LB/B	-	A0A146WHQ7	6	H	R
Q86UE8	LB/B	-	A0A146WHQ7	54	E	D
Q86UE8	LB/B	-	A0A146WHQ7	95	A	G
Q86UE8	LB/B	-	A0A146WHQ7	108	A	G
Q86UE8	LB/B	-	A0A146WHQ7	109	R	L
Q86UE8	LB/B	-	A0A146WHQ7	262	R	Q
Q86UE8	LP/P	Intellectual developmental disorder, autosomal dominant 57 (MRD57) [MIM:618050]	A0A146WHQ7	493	H	R
Q86UE8	LP/P	Intellectual developmental disorder, autosomal dominant 57 (MRD57) [MIM:618050]	A0A146WHQ7	518	H	R
Q86UE8	LP/P	Intellectual developmental disorder, autosomal dominant 57 (MRD57) [MIM:618050]	A0A146WHQ7	568	R	W
Q86UE8	LP/P	Intellectual developmental disorder, autosomal dominant 57 (MRD57) [MIM:618050]	A0A146WHQ7	629	D	N
Q86UE8	LP/P	Intellectual developmental disorder, autosomal dominant 57 (MRD57) [MIM:618050]	A0A146WHQ7	680	P	R
Q86UE8	LP/P	Intellectual developmental disorder, autosomal dominant 57 (MRD57) [MIM:618050]	A0A146WHQ7	617	S	L
O43897	LB/B	-	A0A2U3VDN4	958	T	A
O43897	LP/P	Atrial septal defect 6 (ASD6) [MIM:613087]	A0A2U3VDN4	182	M	L
O43897	LP/P	Atrial septal defect 6 (ASD6) [MIM:613087]	A0A2U3VDN4	238	V	A
O43897	LP/P	Atrial septal defect 6 (ASD6) [MIM:613087]	A0A2U3VDN4	629	I	V
Q15399	LB/B	-	A0A1A6HSB8	118	H	Y
Q15399	LB/B	-	A0A1A6HSB8	80	R	T
Q15399	LB/B	-	A0A1A6HSB8	248	N	S
Q15399	LB/B	-	A0A1A6HSB8	305	H	L
Q15399	LB/B	-	A0A1A6HSB8	315	P	L
Q15399	LB/B	-	A0A1A6HSB8	587	V	G
Q15399	LB/B	-	A0A1A6HSB8	602	S	I
Q15399	LB/B	-	A0A1A6HSB8	631	L	R
Q15399	LB/B	-	A0A1A6HSB8	733	P	L
Q15399	LB/B	-	A0A1A6HSB8	44	S	P
Q15399	LB/B	-	A0A1A6HSB8	75	I	T
Q15399	LB/B	-	A0A1A6HSB8	352	H	N
Q15399	LB/B	-	A0A1A6HSB8	460	I	V
Q15399	LB/B	-	A0A1A6HSB8	542	V	A
Q15399	LB/B	-	A0A1A6HSB8	554	Y	C
Q15399	LB/B	-	A0A1A6HSB8	651	V	A
Q15399	LB/B	-	A0A1A6HSB8	674	V	A
Q15399	LB/B	-	A0A1A6HSB8	720	H	P
Q9BXR5	LB/B	-	A0A1A6HSB8	163	A	S
Q9BXR5	LB/B	-	A0A1A6HSB8	241	N	H
Q9BXR5	LB/B	-	A0A1A6HSB8	326	M	T
Q9BXR5	LB/B	-	A0A1A6HSB8	369	I	L
Q9BXR5	LB/B	-	A0A1A6HSB8	381	G	D
Q9BXR5	LB/B	-	A0A1A6HSB8	525	R	W
Q9BXR5	LB/B	-	A0A1A6HSB8	167	L	P
Q9BXR5	LB/B	-	A0A1A6HSB8	298	V	I
Q9BXR5	LB/B	-	A0A1A6HSB8	469	R	G
Q9BXR5	LB/B	-	A0A1A6HSB8	473	I	T
Q9BXR5	LB/B	-	A0A1A6HSB8	736	Y	C
Q9BXR5	LB/B	-	A0A1A6HSB8	775	I	L
Q9BXR5	LB/B	-	A0A1A6HSB8	799	R	Q
Q9BXR5	LB/B	-	A0A1A6HSB8	775	I	F
Q9BXR5	LB/B	-	A0A1A6HSB8	775	I	V
Q9BXR5	LB/B	-	A0A1A6HSB8	799	R	L
Q9BXR5	LB/B	-	A0A1A6HSB8	799	R	P
O60603	LB/B	-	L9KUB2	631	P	H
O60603	LB/B	-	L9KUB2	411	T	I
O60603	LB/B	-	L9KUB2	579	R	H
O60603	LB/B	-	L9KUB2	677	R	W
O60603	LB/B	-	L9KUB2	753	R	Q
O60603	LB/B	-	L9KUB2	715	Y	N
O60603	LB/B	-	L9KUB2	89	N	D
O60603	LB/B	-	L9KUB2	571	R	H
O60603	LB/B	-	L9KUB2	636	S	R
O15455	LB/B	-	U3LT59	412	L	F
O15455	LB/B	-	U3LT59	737	S	T
O15455	LB/B	-	U3LT59	284	N	I
O15455	LB/B	-	U3LT59	307	Y	D
O15455	LP/P	Immunodeficiency 83, susceptibility to viral infections (IMD83) [MIM:613002]	U3LT59	554	P	S
O15455	LB/B	-	U3LT59	251	R	G
O15455	LB/B	-	U3LT59	732	F	L
O15455	LB/B	-	U3LT59	867	R	Q
O00206	LB/B	-	U5LL01	299	D	G
O00206	LB/B	-	U5LL01	399	T	I
O00206	LB/B	-	U5LL01	188	Q	R
O00206	LB/B	-	U5LL01	246	C	S
O00206	LB/B	-	U5LL01	329	N	S
O00206	LB/B	-	U5LL01	443	F	L
O00206	LB/B	-	U5LL01	474	E	K
O00206	LB/B	-	U5LL01	510	Q	H
O00206	LB/B	-	U5LL01	694	K	R
O00206	LB/B	-	U5LL01	763	R	H
O00206	LB/B	-	U5LL01	834	Q	H
O00206	LB/B	-	U5LL01	342	F	Y
O00206	LB/B	-	U5LL01	400	S	N
O00206	LB/B	-	U5LL01	175	T	A
O00206	LB/B	-	U5LL01	385	L	F
O00206	LB/B	-	U5LL01	306	C	W
O00206	LB/B	-	U5LL01	310	V	G
O00206	LB/B	-	U5LL01	287	E	D
O60602	LB/B	-	A0A2Y9G7V9	592	N	S
O60602	LB/B	-	A0A2Y9G7V9	616	F	L
O60602	LB/B	-	A0A2Y9G7V9	82	T	I
O60602	LB/B	-	A0A2Y9G7V9	112	P	A
O60602	LB/B	-	A0A2Y9G7V9	822	F	L
O60602	LB/B	-	A0A2Y9G7V9	143	N	T
O60602	LB/B	-	A0A2Y9G7V9	181	Q	K
O60602	LB/B	-	A0A2Y9G7V9	769	L	F
O60602	LB/B	-	A0A2Y9G7V9	644	I	F
Q9Y2C9	LB/B	-	A0A1A6HSB8	120	I	T
Q9Y2C9	LB/B	-	A0A1A6HSB8	194	L	P
Q9Y2C9	LB/B	-	A0A1A6HSB8	247	R	K
Q9Y2C9	LB/B	-	A0A1A6HSB8	327	V	M
Q9Y2C9	LB/B	-	A0A1A6HSB8	345	H	Y
Q9Y2C9	LB/B	-	A0A1A6HSB8	427	V	A
Q9Y2C9	LB/B	-	A0A1A6HSB8	465	V	I
Q9Y2C9	LB/B	-	A0A1A6HSB8	474	A	T
Q9Y2C9	LB/B	-	A0A1A6HSB8	783	M	V
Q9Y2C9	LB/B	-	A0A1A6HSB8	249	S	P
Q9Y2C9	LB/B	-	A0A1A6HSB8	128	L	V
Q9Y2C9	LB/B	-	A0A1A6HSB8	210	A	G
Q9Y2C9	LB/B	-	A0A1A6HSB8	210	A	T
Q9Y2C9	LB/B	-	A0A1A6HSB8	283	I	V
Q9Y2C9	LB/B	-	A0A1A6HSB8	442	D	A
Q9Y2C9	LB/B	-	A0A1A6HSB8	474	A	V
Q9Y2C9	LB/B	-	A0A1A6HSB8	592	G	V
Q9Y2C9	LB/B	-	A0A1A6HSB8	690	N	T
Q9Y2C9	LB/B	-	A0A1A6HSB8	708	Q	H
Q9NYK1	LB/B	-	A0A1L8HGJ7	448	A	V
Q9NYK1	LB/B	-	A0A1L8HGJ7	11	Q	L
Q9NYK1	LP/P	Immunodeficiency 74, COVID19-related, X-linked (IMD74) [MIM:301051]	A0A1L8HGJ7	795	V	F
Q9NYK1	LP/P	Systemic lupus erythematosus 17 (SLEB17) [MIM:301080]	A0A1L8HGJ7	28	R	G
Q9NYK1	LP/P	Systemic lupus erythematosus 17 (SLEB17) [MIM:301080]	A0A1L8HGJ7	264	Y	H
Q9NYK1	LP/P	Systemic lupus erythematosus 17 (SLEB17) [MIM:301080]	A0A1L8HGJ7	507	F	L
Q9NR97	LB/B	-	A0A1L8HGJ7	10	M	V
Q9NR97	LB/B	-	A0A1L8HGJ7	715	R	Q
Q9NR97	LP/P	Immunodeficiency 98 with autoinflammation, X-linked (IMD98) [MIM:301078]	A0A1L8HGJ7	432	P	L
Q9NR97	LP/P	Immunodeficiency 98 with autoinflammation, X-linked (IMD98) [MIM:301078]	A0A1L8HGJ7	494	F	L
Q9NR97	LP/P	Immunodeficiency 98 with autoinflammation, X-linked (IMD98) [MIM:301078]	A0A1L8HGJ7	572	G	D
Q9NR97	LP/P	Immunodeficiency 98 with autoinflammation, X-linked (IMD98) [MIM:301078]	A0A1L8HGJ7	572	G	V
Q96DZ7	LB/B	-	G1SNX4	162	V	I
Q96DZ7	LB/B	-	G1SNX4	8	Q	P
Q53R12	LB/B	-	A0A2Y9E2E4	27	A	V
Q9BZW4	LB/B	-	A0A2K6LIX0	167	E	K
O76062	LB/B	-	A0A1X0RY76	299	T	I
O76062	LB/B	-	A0A1X0RY76	119	A	V
Q96EY4	LB/B	-	A0A286XZ25	65	Q	P
Q96EY4	LB/B	-	A0A286XZ25	176	I	T
Q96EY4	LB/B	-	A0A286XZ25	12	R	Q
Q969X1	LB/B	-	A0A087XXQ6	21	P	L
Q9HC24	LB/B	-	A0A087WXH1	88	I	T
Q9HC24	LB/B	-	A0A087WXH1	2	A	V
Q8TDI8	LP/P	Deafness, autosomal dominant, 36 (DFNA36) [MIM:606705]	L5LRJ7	572	D	N
Q8TDI8	LP/P	Deafness, autosomal recessive, 7 (DFNB7) [MIM:600974]	L5LRJ7	654	M	V
Q8TDI8	LB/B	-	L5LRJ7	81	E	K
Q8TDI8	LB/B	-	L5LRJ7	141	R	W
Q8TDI8	LB/B	-	L5LRJ7	486	M	T
Q7Z5M5	LB/B	-	G3ID89	196	V	I
Q7Z5M5	LB/B	-	G3ID89	893	C	Y
Q7Z5M5	LB/B	-	G3ID89	1012	R	K
Q7Z5M5	LB/B	-	G3ID89	1099	D	N
Q7Z404	LB/B	-	A0A2K5PB99	17	G	E
Q7Z404	LB/B	-	A0A2K5PB99	689	Q	E
Q7Z403	LB/B	-	M7BA50	125	W	R
Q7Z403	LB/B	-	M7BA50	153	L	F
Q7Z403	LB/B	-	M7BA50	191	G	D
Q8IU68	LB/B	-	A0A1A6H6X5	306	N	I
Q8IU68	LB/B	-	A0A1A6H6X5	501	V	I
Q9ULS5	LB/B	-	A0A226PBF2	16	Y	D
Q9ULS5	LB/B	-	A0A226PBF2	232	P	Q
Q5TGY1	LB/B	-	L5LN72	72	Q	K
Q5TGY1	LB/B	-	L5LN72	478	R	H
P49755	LB/B	-	S7NM46	64	S	Y
P49755	LB/B	-	S7NM46	152	R	G
Q9Y3Q3	LB/B	-	F7FL73	86	D	N
Q6PL24	LB/B	-	M3YBR2	5	Q	K
Q9BVK6	LB/B	-	H0WKP6	16	T	S
Q8IYR6	LB/B	-	H3CM12	189	V	I
Q8N8V8	LB/B	-	A0A2K6SWC4	122	R	W
Q9NUM4	LB/B	-	A0A1S3Q0K4	185	T	S
Q9NUM4	LP/P	Leukodystrophy, hypomyelinating, 16 (HLD16) [MIM:617964]	A0A1S3Q0K4	252	D	N
Q9BVX2	LB/B	-	A0A1S3Q0K4	175	S	F
Q9BVX2	LB/B	-	A0A1S3Q0K4	103	V	F
Q6UX40	LP/P	Orofaciodigital syndrome 16 (OFD16) [MIM:617563]	A0A2I4CRE6	45	E	G
Q6UXF1	LB/B	-	L5M4B0	84	P	L
B3SHH9	LB/B	-	A0A1S3ABQ1	35	I	T
B3SHH9	LB/B	-	A0A1S3ABQ1	147	A	V
B3SHH9	LB/B	-	A0A1S3ABQ1	206	F	L
Q8NCL8	LB/B	-	H9GF39	22	C	G
Q9H0C3	LB/B	-	G3NIW3	90	R	H
Q4V9L6	LB/B	-	W5Q9C0	72	I	T
Q96AQ2	LB/B	-	I3JQJ0	112	A	D
Q9H061	LB/B	-	A0A2I2U3D7	64	R	H
Q8IUX1	LB/B	-	A0A2R9BNV7	198	A	V
Q8IUX1	LP/P	Mitochondrial complex I deficiency, nuclear type 29 (MC1DN29) [MIM:618250]	A0A2R9BNV7	212	G	V
O75204	LP/P	Pheochromocytoma (PCC) [MIM:171300]	L5KUC5	90	V	M
O75204	LP/P	Pheochromocytoma (PCC) [MIM:171300]	L5KUC5	53	W	S
O75204	LP/P	Pheochromocytoma (PCC) [MIM:171300]	L5KUC5	70	D	N
O75204	LP/P	Pheochromocytoma (PCC) [MIM:171300]	L5KUC5	73	G	R
O75204	LP/P	Pheochromocytoma (PCC) [MIM:171300]	L5KUC5	94	R	W
O75204	LP/P	Pheochromocytoma (PCC) [MIM:171300]	L5KUC5	140	C	R
O75204	LP/P	Pheochromocytoma (PCC) [MIM:171300]	L5KUC5	140	C	Y
Q5BJH2	LB/B	-	A0A2K5I173	16	L	I
A0AVI4	LB/B	-	J3SDI7	83	L	I
A2VDJ0	LB/B	-	A0A1U7UN07	604	I	V
A2VDJ0	LB/B	-	A0A1U7UN07	645	M	T
A2VDJ0	LB/B	-	A0A1U7UN07	1110	S	Y
A2VDJ0	LB/B	-	A0A1U7UN07	1254	N	S
A2VDJ0	LB/B	-	A0A1U7UN07	1392	A	P
Q24JP5	LB/B	-	F6ZBX9	699	R	H
Q24JP5	LB/B	-	F6ZBX9	969	A	V
Q14DG7	LB/B	-	L9KWF2	658	A	V
Q8N3T6	LB/B	-	L9KWF2	161	H	R
Q8N3T6	LB/B	-	L9KWF2	232	V	M
Q8N3T6	LB/B	-	L9KWF2	272	V	I
Q8N3T6	LB/B	-	L9KWF2	444	V	I
Q8N3T6	LB/B	-	L9KWF2	730	T	S
Q8N3T6	LB/B	-	L9KWF2	799	F	I
Q8N3T6	LB/B	-	L9KWF2	810	G	R
Q14C87	LB/B	-	L9KWF2	878	L	F
Q14C87	LB/B	-	L9KWF2	436	E	Q
Q14C87	LB/B	-	L9KWF2	460	D	H
Q6IEE7	LP/P	Deafness, autosomal recessive, 99 (DFNB99) [MIM:618481]	G1NUQ6	510	R	Q
A2RUQ5	LB/B	-	A2RUQ5	98	G	R
A2RUQ5	LB/B	-	A2RUQ5	155	R	K
Q9NPI0	LP/P	Joubert syndrome 16 (JBTS16) [MIM:614465]	A0A0K2UPC7	96	H	R
Q9NPI0	LP/P	Joubert syndrome 16 (JBTS16) [MIM:614465]	A0A0K2UPC7	126	A	T
Q9NPI0	LP/P	Joubert syndrome 16 (JBTS16) [MIM:614465]	A0A0K2UPC7	127	A	V
Q9NPI0	LP/P	Joubert syndrome 16 (JBTS16) [MIM:614465]	A0A0K2UPC7	130	Y	C
Q9NV12	LB/B	-	A0A1U8CE69	6	P	S
Q9NV12	LB/B	-	A0A1U8CE69	7	R	Q
Q9NV12	LB/B	-	A0A1U8CE69	11	Q	E
Q9NV12	LB/B	-	A0A1U8CE69	29	F	L
Q96AN5	LB/B	-	A0A1S3G3P3	143	D	N
Q8NBT3	LB/B	-	A0A2Y9P7P6	256	L	M
Q9BVK8	LB/B	-	A7SY17	132	Y	H
Q9BVK8	LP/P	Neurodevelopmental disorder with facial dysmorphism, absent language, and pseudo-Pelger-Huet anomaly (NEDFLPH) [MIM:620075]	A7SY17	7	G	R
Q9BVK8	LP/P	Neurodevelopmental disorder with facial dysmorphism, absent language, and pseudo-Pelger-Huet anomaly (NEDFLPH) [MIM:620075]	A7SY17	133	I	N
Q9BVK8	LP/P	Neurodevelopmental disorder with facial dysmorphism, absent language, and pseudo-Pelger-Huet anomaly (NEDFLPH) [MIM:620075]	A7SY17	166	R	W
Q9Y6G1	LB/B	-	C3Y1B6	37	C	R
Q9P0S9	LB/B	-	A0A1U8CMR3	106	S	R
Q9P0S9	LB/B	-	A0A1U8CMR3	108	F	L
Q9P0S9	LB/B	-	A0A1U8CMR3	109	N	I
Q9P0S9	LB/B	-	A0A1U8CMR3	112	H	D
A8MWL7	LB/B	-	A0A1U8CMR3	108	R	C
Q6UXP3	LB/B	-	Q6UXP3	82	L	P
A6NC51	LB/B	-	A0A2F0B8X3	199	L	F
Q6P9G4	LB/B	-	V9KDN0	93	S	F
Q9NX00	LB/B	-	F1RM05	120	G	S
Q5U3C3	LB/B	-	L5KC20	204	S	N
Q9HC07	LP/P	Congenital disorder of glycosylation 2K (CDG2K) [MIM:614727]	A0A1V4JG33	126	R	C
Q9HC07	LP/P	Congenital disorder of glycosylation 2K (CDG2K) [MIM:614727]	A0A1V4JG33	126	R	H
Q9HC07	LP/P	Congenital disorder of glycosylation 2K (CDG2K) [MIM:614727]	A0A1V4JG33	304	G	R
Q86X19	LB/B	-	A0A2Y9EQ02	26	G	S
Q9BSA9	LB/B	-	A0A2I0M6D6	65	Q	P
Q9BSA9	LB/B	-	A0A2I0M6D6	393	M	T
Q96HP8	LB/B	-	G3UD86	122	T	A
Q96HP8	LB/B	-	G3UD86	187	L	F
Q96HP8	LB/B	-	G3UD86	208	T	A
Q8NBL3	LB/B	-	A0A1S3N5V2	107	L	V
Q6ZP80	LB/B	-	H3ASC1	223	W	R
Q8IXX5	LB/B	-	A0A2I3HBM2	10	R	M
Q8IXX5	LB/B	-	A0A2I3HBM2	80	A	T
Q1AE95	LB/B	-	A0A2I3HBM2	193	M	V
Q6ZMB5	LB/B	-	A0A2K6DXG2	390	S	G
Q6ZMB5	LB/B	-	A0A2K6DXG2	18	A	V
Q8N511	LB/B	-	A0A1S3SYW5	158	V	I
Q8N511	LB/B	-	A0A1S3SYW5	166	L	V
Q8N511	LP/P	Congenital disorder of glycosylation 2P (CDG2P) [MIM:616829]	A0A1S3SYW5	7	A	G
Q8N511	LP/P	Congenital disorder of glycosylation 2P (CDG2P) [MIM:616829]	A0A1S3SYW5	14	A	P
Q8N511	LP/P	Congenital disorder of glycosylation 2P (CDG2P) [MIM:616829]	A0A1S3SYW5	31	R	P
A6NGA9	LB/B	-	A0A2K6V4U8	204	M	L
Q6UWW9	LB/B	-	I3LQ19	57	L	V
Q9BTX3	LB/B	-	Q6NYP0	82	D	Y
Q9BTX3	LB/B	-	Q6NYP0	102	L	P
Q96SK2	LB/B	-	A0A2K5R315	469	P	R
Q96SK2	LB/B	-	A0A2K5R315	505	H	R
Q96A57	LB/B	-	E9G6B5	108	R	C
Q9H6L2	LB/B	-	F7B645	6	L	V
Q9H6L2	LP/P	Joubert syndrome 20 (JBTS20) [MIM:614970]	F7B645	209	D	N
Q9H6L2	LP/P	Meckel syndrome 11 (MKS11) [MIM:615397]	F7B645	272	Q	P
Q24JQ0	LB/B	-	S7PY01	131	L	F
Q5VVB8	LB/B	-	A0A2Y9JF69	80	F	L
Q5VVB8	LB/B	-	A0A2Y9JF69	86	E	G
Q5VVB8	LB/B	-	A0A2Y9JF69	111	F	V
Q5VVB8	LB/B	-	A0A2Y9JF69	60	N	I
Q9H330	LB/B	-	H0V6N6	314	A	T
Q9H330	LB/B	-	H0V6N6	787	T	A
Q9H330	LB/B	-	H0V6N6	9	D	E
Q5JRV8	LB/B	-	A0A1U7UEX4	345	P	Q
Q9NX78	LB/B	-	H2VB26	245	A	S
Q9NX78	LB/B	-	H2VB26	565	S	N
Q2M3C6	LB/B	-	K7GH59	391	R	H
Q2M3C6	LB/B	-	K7GH59	427	P	L
Q6UE05	LB/B	-	G1QCZ7	14	I	N
Q6UE05	LB/B	-	G1QCZ7	70	A	D
Q6UE05	LB/B	-	G1QCZ7	78	W	R
Q6UE05	LB/B	-	G1QCZ7	67	G	V
Q5T292	LB/B	-	A0A2K5J516	83	P	L
Q9NVV0	LB/B	-	A0A2K6REJ5	254	C	S
Q9NV64	LB/B	-	A0A226NMD0	487	A	T
Q9BTV4	LB/B	-	G3VWU5	168	K	N
Q9BTV4	LB/B	-	G3VWU5	179	M	T
Q9BTV4	LB/B	-	G3VWU5	233	Y	C
Q9BTV4	LB/B	-	G3VWU5	318	A	V
Q9BTV4	LP/P	Arrhythmogenic right ventricular dysplasia, familial, 5 (ARVD5) [MIM:604400]	G3VWU5	358	S	L
Q9BTV4	LP/P	Emery-Dreifuss muscular dystrophy 7, autosomal dominant (EDMD7) [MIM:614302]	G3VWU5	85	E	K
Q9BTV4	LP/P	Emery-Dreifuss muscular dystrophy 7, autosomal dominant (EDMD7) [MIM:614302]	G3VWU5	91	I	V
Q2T9K0	LB/B	-	A5PKD4	24	H	N
Q2T9K0	LB/B	-	A5PKD4	232	R	H
Q2T9K0	LB/B	-	A5PKD4	284	Q	R
Q96B21	LB/B	-	F7FBF9	59	T	I
O95807	LB/B	-	V8P1X2	141	F	L
O95807	LB/B	-	V8P1X2	58	A	V
Q969K7	LB/B	-	A0A2K6EIX0	110	L	F
Q9BXS4	LB/B	-	G1SUJ2	46	A	V
Q9H2L4	LB/B	-	A0A1A6G121	42	V	G
Q8N0U2	LB/B	-	G3UMY1	40	E	K
Q5T3F8	LB/B	-	A0A0P7WHD9	307	V	M
Q6PI78	LB/B	-	G3NTY0	97	I	V
Q5HYA8	LP/P	Meckel syndrome 3 (MKS3) [MIM:607361]	K7F332	376	Q	P
Q5HYA8	LB/B	-	K7F332	604	I	V
Q5HYA8	LP/P	COACH syndrome 1 (COACH1) [MIM:216360]	K7F332	513	Y	C
Q5HYA8	LP/P	Joubert syndrome 6 (JBTS6) [MIM:610688]	K7F332	513	Y	C
Q5HYA8	LP/P	Meckel syndrome 3 (MKS3) [MIM:607361]	K7F332	513	Y	C
Q5HYA8	LP/P	Joubert syndrome 6 (JBTS6) [MIM:610688]	K7F332	545	G	E
Q5HYA8	LB/B	-	K7F332	218	G	A
Q5HYA8	LP/P	COACH syndrome 1 (COACH1) [MIM:216360]	K7F332	252	M	T
Q5HYA8	LP/P	Joubert syndrome 6 (JBTS6) [MIM:610688]	K7F332	252	M	T
Q5HYA8	LP/P	Meckel syndrome 3 (MKS3) [MIM:607361]	K7F332	252	M	T
Q5HYA8	LB/B	-	K7F332	261	D	N
Q5HYA8	LB/B	-	K7F332	320	S	C
Q5HYA8	LB/B	-	K7F332	437	L	V
Q5HYA8	LP/P	COACH syndrome 1 (COACH1) [MIM:216360]	K7F332	440	R	Q
Q5HYA8	LP/P	Meckel syndrome 3 (MKS3) [MIM:607361]	K7F332	440	R	Q
Q5HYA8	LP/P	COACH syndrome 1 (COACH1) [MIM:216360]	K7F332	615	C	R
Q5HYA8	LP/P	Meckel syndrome 3 (MKS3) [MIM:607361]	K7F332	615	C	R
Q5HYA8	LP/P	Nephronophthisis 11 (NPHP11) [MIM:613550]	K7F332	615	C	R
Q5HYA8	LP/P	Meckel syndrome 3 (MKS3) [MIM:607361]	K7F332	966	L	P
Q5HYA8	LP/P	COACH syndrome 1 (COACH1) [MIM:216360]	K7F332	130	P	R
Q5HYA8	LP/P	COACH syndrome 1 (COACH1) [MIM:216360]	K7F332	242	N	S
Q5HYA8	LP/P	Joubert syndrome 6 (JBTS6) [MIM:610688]	K7F332	242	N	S
Q5HYA8	LP/P	COACH syndrome 1 (COACH1) [MIM:216360]	K7F332	349	L	S
Q5HYA8	LP/P	Meckel syndrome 3 (MKS3) [MIM:607361]	K7F332	349	L	S
Q5HYA8	LP/P	COACH syndrome 1 (COACH1) [MIM:216360]	K7F332	358	P	L
Q5HYA8	LP/P	Joubert syndrome 6 (JBTS6) [MIM:610688]	K7F332	358	P	L
Q5HYA8	LP/P	COACH syndrome 1 (COACH1) [MIM:216360]	K7F332	372	T	K
Q5HYA8	LP/P	COACH syndrome 1 (COACH1) [MIM:216360]	K7F332	376	Q	E
Q5HYA8	LP/P	COACH syndrome 1 (COACH1) [MIM:216360]	K7F332	590	F	S
Q5HYA8	LP/P	COACH syndrome 1 (COACH1) [MIM:216360]	K7F332	728	S	G
Q5HYA8	LP/P	COACH syndrome 1 (COACH1) [MIM:216360]	K7F332	782	H	R
Q5HYA8	LP/P	COACH syndrome 1 (COACH1) [MIM:216360]	K7F332	820	R	S
Q5HYA8	LP/P	COACH syndrome 1 (COACH1) [MIM:216360]	K7F332	833	I	T
Q5HYA8	LP/P	Joubert syndrome 6 (JBTS6) [MIM:610688]	K7F332	833	I	T
Q5HYA8	LP/P	Nephronophthisis 11 (NPHP11) [MIM:613550]	K7F332	290	W	L
Q5HYA8	LP/P	Nephronophthisis 11 (NPHP11) [MIM:613550]	K7F332	821	G	R
Q5HYA8	LP/P	Nephronophthisis 11 (NPHP11) [MIM:613550]	K7F332	821	G	S
Q5HYA8	LP/P	Joubert syndrome 6 (JBTS6) [MIM:610688]	K7F332	711	D	A
Q5HYA8	LP/P	-	K7F332	90	N	K
Q5HYA8	LP/P	-	K7F332	124	E	K
Q5HYA8	LP/P	-	K7F332	301	D	E
Q5HYA8	LP/P	Meckel syndrome 3 (MKS3) [MIM:607361]	K7F332	441	R	L
Q5HYA8	LP/P	-	K7F332	569	G	D
Q5HYA8	LP/P	-	K7F332	616	A	V
Q5HYA8	LP/P	Meckel syndrome 3 (MKS3) [MIM:607361]	K7F332	668	W	R
Q5HYA8	LP/P	-	K7F332	739	L	R
Q5HYA8	LP/P	Meckel syndrome 3 (MKS3) [MIM:607361]	K7F332	786	G	E
Q5HYA8	LP/P	Meckel syndrome 3 (MKS3) [MIM:607361]	K7F332	843	Y	C
Q5HYA8	LP/P	COACH syndrome 1 (COACH1) [MIM:216360]	K7F332	132	G	A
Q5HYA8	LP/P	RHYNS syndrome (RHYNS) [MIM:602152]	K7F332	430	D	G
Q5HYA8	LP/P	Meckel syndrome 3 (MKS3) [MIM:607361]	K7F332	549	R	C
Q5HYA8	LP/P	Meckel syndrome 3 (MKS3) [MIM:607361]	K7F332	786	G	A
Q9NUR3	LB/B	-	A0A2R8NEC9	33	L	M
Q9BSE2	LB/B	-	G3WN02	147	V	M
Q6P7N7	LB/B	-	G3WI96	77	R	Q
Q6P7N7	LB/B	-	G3WI96	100	F	S
A0PJX8	LB/B	-	F7GCD0	284	R	H
Q8N2M4	LB/B	-	A0A2U3X0Z2	215	V	A
Q8N661	LB/B	-	Q9D8N3	176	A	T
Q8N661	LB/B	-	Q9D8N3	199	H	R
Q6PEY1	LB/B	-	F7EDW6	44	L	F
Q12767	LB/B	-	L9KZU2	1040	I	T
Q9Y2Y6	LB/B	-	R7U8L5	83	W	R
Q9Y2Y6	LP/P	Nanophthalmos 4 (NNO4) [MIM:615972]	R7U8L5	193	A	P
Q9Y2Y6	LP/P	Nanophthalmos 4 (NNO4) [MIM:615972]	R7U8L5	196	H	P
P82094	LB/B	-	L9J9X3	798	D	H
P82094	LB/B	-	L9J9X3	430	Q	E
P82094	LB/B	-	L9J9X3	448	C	Y
P82094	LB/B	-	L9J9X3	682	Q	R
Q8NEW7	LP/P	Deafness, autosomal recessive, 6 (DFNB6) [MIM:600971]	A0A2K5NEG5	81	R	C
Q8NEW7	LP/P	Deafness, autosomal recessive, 6 (DFNB6) [MIM:600971]	A0A2K5NEG5	84	R	W
Q8NEW7	LP/P	Deafness, autosomal recessive, 6 (DFNB6) [MIM:600971]	A0A2K5NEG5	92	R	W
Q96BF3	LB/B	-	A0A0A0MUV1	202	A	P
Q96BF3	LB/B	-	A0A0A0MUV1	168	W	L
Q9NVH6	LP/P	Autism, X-linked 6 (AUTSX6) [MIM:300872]	A0A1V4KZM7	244	D	H
Q9NZQ9	LB/B	-	T1DHS5	336	N	S
P42166	LB/B	-	A0A250YKK1	599	Q	E
P42166	LB/B	-	A0A250YKK1	238	L	R
P42166	LB/B	-	A0A250YKK1	293	S	A
P42166	LB/B	-	A0A250YKK1	317	T	S
P42166	LB/B	-	A0A250YKK1	416	K	E
P42166	LB/B	-	A0A250YKK1	478	K	N
P42166	LB/B	-	A0A250YKK1	690	R	C
P42167	LB/B	-	Q5ZMN6	427	L	F
P42167	LB/B	-	Q5ZMN6	287	A	P
Q6ZMR5	LB/B	-	F6R3B3	290	R	Q
Q86T26	LB/B	-	F6R3B3	242	I	V
Q86T26	LB/B	-	F6R3B3	348	T	S
Q86T26	LB/B	-	F6R3B3	325	D	A
Q9UL52	LB/B	-	A0A091CND9	303	Y	C
Q6ZWK6	LB/B	-	F6R3B3	4	A	T
Q6ZWK6	LB/B	-	F6R3B3	124	D	N
P98073	LB/B	-	H2RVR1	641	E	K
P98073	LB/B	-	H2RVR1	77	K	R
P98073	LB/B	-	H2RVR1	660	N	H
P98073	LB/B	-	H2RVR1	65	T	I
P98073	LB/B	-	H2RVR1	134	E	Q
P98073	LB/B	-	H2RVR1	545	S	C
P98073	LB/B	-	H2RVR1	732	P	S
P98073	LB/B	-	H2RVR1	828	Y	C
O15393	LB/B	-	A0A2K5HDE0	449	K	N
O15393	LB/B	-	A0A2K5HDE0	160	V	M
O15393	LB/B	-	A0A2K5HDE0	254	S	C
O15393	LB/B	-	A0A2K5HDE0	329	E	Q
O15393	LB/B	-	A0A2K5HDE0	491	D	N
O15393	LB/B	-	A0A2K5HDE0	28	A	T
O15393	LB/B	-	A0A2K5HDE0	74	G	R
P57727	LB/B	-	S9XEK5	53	V	I
P57727	LP/P	Deafness, autosomal recessive, 8 (DFNB8) [MIM:601072]	S9XEK5	251	W	C
P57727	LP/P	Deafness, autosomal recessive, 8 (DFNB8) [MIM:601072]	S9XEK5	404	P	L
P57727	LB/B	-	S9XEK5	253	I	V
P57727	LP/P	Deafness, autosomal recessive, 8 (DFNB8) [MIM:601072]	S9XEK5	103	D	G
P57727	LP/P	Deafness, autosomal recessive, 8 (DFNB8) [MIM:601072]	S9XEK5	109	R	W
P57727	LB/B	-	S9XEK5	111	G	S
P57727	LB/B	-	S9XEK5	173	D	N
P57727	LP/P	Deafness, autosomal recessive, 8 (DFNB8) [MIM:601072]	S9XEK5	194	C	F
P57727	LP/P	Deafness, autosomal recessive, 8 (DFNB8) [MIM:601072]	S9XEK5	407	C	R
P57727	LP/P	Deafness, autosomal recessive, 8 (DFNB8) [MIM:601072]	S9XEK5	426	A	T
P57727	LP/P	Deafness, autosomal recessive, 8 (DFNB8) [MIM:601072]	S9XEK5	216	R	L
Q9NRS4	LB/B	-	S7MDL4	177	R	Q
Q9NRS4	LB/B	-	S7MDL4	198	K	E
Q9NRS4	LB/B	-	S7MDL4	208	V	G
Q9H3S3	LB/B	-	L9KMT3	46	R	Q
Q9H3S3	LB/B	-	L9KMT3	125	V	M
Q9H3S3	LB/B	-	L9KMT3	249	A	V
Q9H3S3	LB/B	-	L9KMT3	337	P	S
Q9H3S3	LB/B	-	L9KMT3	369	F	L
Q8IU80	LB/B	-	A0A151NHU0	262	E	K
Q8IU80	LP/P	Iron-refractory iron deficiency anemia (IRIDA) [MIM:206200]	A0A151NHU0	442	G	R
Q8IU80	LP/P	Iron-refractory iron deficiency anemia (IRIDA) [MIM:206200]	A0A151NHU0	521	D	N
Q8IU80	LP/P	Iron-refractory iron deficiency anemia (IRIDA) [MIM:206200]	A0A151NHU0	774	R	C
Q8IU80	LB/B	-	A0A151NHU0	253	K	E
Q8IU80	LB/B	-	A0A151NHU0	288	S	L
Q8IU80	LB/B	-	A0A151NHU0	736	V	A
Q8IU80	LB/B	-	A0A151NHU0	763	G	D
Q8IU80	LP/P	Iron-refractory iron deficiency anemia (IRIDA) [MIM:206200]	A0A151NHU0	141	Y	C
Q8IU80	LP/P	Iron-refractory iron deficiency anemia (IRIDA) [MIM:206200]	A0A151NHU0	212	I	T
Q8IU80	LP/P	Iron-refractory iron deficiency anemia (IRIDA) [MIM:206200]	A0A151NHU0	271	R	Q
Q8IU80	LP/P	Iron-refractory iron deficiency anemia (IRIDA) [MIM:206200]	A0A151NHU0	304	S	L
Q8IU80	LP/P	Iron-refractory iron deficiency anemia (IRIDA) [MIM:206200]	A0A151NHU0	510	C	S
Q8IU80	LP/P	Iron-refractory iron deficiency anemia (IRIDA) [MIM:206200]	A0A151NHU0	114	E	K
Q8IU80	LP/P	Iron-refractory iron deficiency anemia (IRIDA) [MIM:206200]	A0A151NHU0	118	A	D
Q8IU80	LB/B	-	A0A151NHU0	228	G	D
Q8IU80	LP/P	Iron-refractory iron deficiency anemia (IRIDA) [MIM:206200]	A0A151NHU0	235	L	P
Q8IU80	LP/P	Iron-refractory iron deficiency anemia (IRIDA) [MIM:206200]	A0A151NHU0	418	Y	C
Q8IU80	LB/B	-	A0A151NHU0	446	R	W
Q8IU80	LP/P	Iron-refractory iron deficiency anemia (IRIDA) [MIM:206200]	A0A151NHU0	522	E	K
Q8IU80	LP/P	Iron-refractory iron deficiency anemia (IRIDA) [MIM:206200]	A0A151NHU0	603	G	R
Q8IU80	LB/B	-	A0A151NHU0	674	L	F
Q8IU80	LP/P	Iron-refractory iron deficiency anemia (IRIDA) [MIM:206200]	A0A151NHU0	765	P	A
Q8IU80	LB/B	-	A0A151NHU0	795	V	I
Q8IU80	LP/P	Iron-refractory iron deficiency anemia (IRIDA) [MIM:206200]	A0A151NHU0	247	W	C
Q8IU80	LP/P	Iron-refractory iron deficiency anemia (IRIDA) [MIM:206200]	A0A151NHU0	287	T	N
Q8IU80	LP/P	Iron-refractory iron deficiency anemia (IRIDA) [MIM:206200]	A0A151NHU0	335	C	F
Q8IU80	LP/P	Iron-refractory iron deficiency anemia (IRIDA) [MIM:206200]	A0A151NHU0	510	C	R
Q8IU80	LP/P	Iron-refractory iron deficiency anemia (IRIDA) [MIM:206200]	A0A151NHU0	521	D	G
Q8IU80	LP/P	Iron-refractory iron deficiency anemia (IRIDA) [MIM:206200]	A0A151NHU0	590	W	R
Q8IU80	LP/P	Iron-refractory iron deficiency anemia (IRIDA) [MIM:206200]	A0A151NHU0	597	R	W
Q8IU80	LP/P	Iron-refractory iron deficiency anemia (IRIDA) [MIM:206200]	A0A151NHU0	605	A	G
Q8IU80	LP/P	Iron-refractory iron deficiency anemia (IRIDA) [MIM:206200]	A0A151NHU0	606	L	R
Q8IU80	LP/P	Iron-refractory iron deficiency anemia (IRIDA) [MIM:206200]	A0A151NHU0	623	S	T
Q7Z410	LB/B	-	U3IVG7	30	S	T
Q7Z410	LB/B	-	U3IVG7	793	S	N
Q7Z410	LB/B	-	U3IVG7	938	E	K
Q7Z410	LB/B	-	U3IVG7	73	R	W
Q7Z410	LB/B	-	U3IVG7	4	T	A
Q7Z410	LB/B	-	U3IVG7	456	A	T
Q7Z410	LB/B	-	U3IVG7	659	S	T
P63313	LB/B	-	A0A0D9RU42	7	M	R
Q9H8H3	LB/B	-	A0A286XN59	134	A	T
Q8IUR5	LB/B	-	A0A2I3LC95	814	V	L
Q8N394	LB/B	-	A0A1W5AZS9	315	A	T
Q8N394	LB/B	-	A0A1W5AZS9	443	Y	S
Q8N394	LB/B	-	A0A1W5AZS9	741	D	Y
Q5T4D3	LB/B	-	L9L9E6	286	V	M
Q5T4D3	LB/B	-	L9L9E6	419	V	I
Q71RG4	LB/B	-	G8JL73	228	R	H
Q9Y320	LP/P	Neurodevelopmental disorder with microcephaly, cortical malformations, and spasticity (NEDMCMS) [MIM:618730]	M7BHD8	53	R	C
Q9Y320	LP/P	Neurodevelopmental disorder with microcephaly, cortical malformations, and spasticity (NEDMCMS) [MIM:618730]	M7BHD8	205	R	Q
Q9Y320	LP/P	Neurodevelopmental disorder with microcephaly, cortical malformations, and spasticity (NEDMCMS) [MIM:618730]	M7BHD8	231	R	W
Q96JJ7	LB/B	-	L5KIF9	61	P	S
Q9H1E5	LB/B	-	G1TLL7	215	Y	C
Q9H1E5	LB/B	-	G1TLL7	303	G	R
P21580	LB/B	-	H3B3Q6	125	A	V
P21580	LB/B	-	H3B3Q6	127	F	C
P21580	LB/B	-	H3B3Q6	766	A	P
P21580	LP/P	Autoinflammatory syndrome, familial, Behcet-like 1 (AIFBL1) [MIM:616744]	H3B3Q6	243	C	Y
O95379	LB/B	-	G3HHY6	151	S	C
Q8WVP5	LB/B	-	C3YNR0	118	A	V
Q5GJ75	LB/B	-	A0A2K6F210	38	A	T
O00220	LB/B	-	F6VG37	33	T	I
O00220	LB/B	-	F6VG37	141	H	R
O00220	LB/B	-	F6VG37	209	R	T
O00220	LB/B	-	F6VG37	228	E	A
O00220	LB/B	-	F6VG37	11	G	V
O00220	LB/B	-	F6VG37	105	P	R
O00220	LB/B	-	F6VG37	297	N	H
O00220	LB/B	-	F6VG37	441	R	K
O14763	LB/B	-	A0A2K5E643	32	P	L
O14763	LB/B	-	A0A2K5E643	67	A	V
O14763	LB/B	-	A0A2K5E643	191	V	A
O14798	LB/B	-	H2QVV9	199	T	N
O14798	LB/B	-	H2QVV9	229	I	T
Q9UBN6	LB/B	-	A0A2K5CUG8	35	P	S
Q9UBN6	LB/B	-	A0A2K5CUG8	310	L	S
Q9UBN6	LB/B	-	A0A2K5CUG8	345	T	P
Q9UBN6	LB/B	-	A0A2K5CUG8	276	R	H
Q9Y6Q6	LB/B	-	G1SNN2	192	A	V
Q9Y6Q6	LP/P	Osteopetrosis, autosomal recessive 7 (OPTB7) [MIM:612301]	G1SNN2	53	G	R
Q9Y6Q6	LP/P	Osteopetrosis, autosomal recessive 7 (OPTB7) [MIM:612301]	G1SNN2	129	R	C
Q9Y6Q6	LB/B	-	G1SNN2	141	H	Y
Q9Y6Q6	LP/P	Osteopetrosis, autosomal recessive 7 (OPTB7) [MIM:612301]	G1SNN2	170	R	G
Q9Y6Q6	LP/P	Osteopetrosis, autosomal recessive 7 (OPTB7) [MIM:612301]	G1SNN2	175	C	R
Q9Y6Q6	LP/P	Osteopetrosis, autosomal recessive 7 (OPTB7) [MIM:612301]	G1SNN2	244	A	S
O00300	LB/B	-	A0A1U7S9Z5	3	N	K
O00300	LB/B	-	A0A1U7S9Z5	104	V	M
Q92956	LB/B	-	M3WBL5	17	K	R
Q92956	LB/B	-	M3WBL5	241	V	I
Q92956	LB/B	-	M3WBL5	117	A	T
Q92956	LB/B	-	M3WBL5	174	G	E
Q9Y5U5	LB/B	-	A0A2K6F375	43	T	R
Q9Y5U5	LB/B	-	A0A2K6F375	64	E	K
Q9Y5U5	LB/B	-	A0A2K6F375	83	D	N
Q9Y5U5	LB/B	-	A0A2K6F375	173	V	M
Q9NS68	LB/B	-	H0VKK7	31	S	T
Q9NS68	LB/B	-	H0VKK7	405	V	I
Q9NS68	LB/B	-	H0VKK7	159	A	V
P19438	LB/B	-	M3YZQ0	305	P	T
P19438	LP/P	Periodic fever, familial, autosomal dominant (FPF) [MIM:142680]	M3YZQ0	59	C	R
P19438	LP/P	Periodic fever, familial, autosomal dominant (FPF) [MIM:142680]	M3YZQ0	62	C	Y
P19438	LP/P	Periodic fever, familial, autosomal dominant (FPF) [MIM:142680]	M3YZQ0	79	T	M
P19438	LP/P	Periodic fever, familial, autosomal dominant (FPF) [MIM:142680]	M3YZQ0	81	C	F
P19438	LP/P	Periodic fever, familial, autosomal dominant (FPF) [MIM:142680]	M3YZQ0	117	C	R
P19438	LP/P	Periodic fever, familial, autosomal dominant (FPF) [MIM:142680]	M3YZQ0	117	C	Y
P19438	LP/P	Periodic fever, familial, autosomal dominant (FPF) [MIM:142680]	M3YZQ0	59	C	S
P19438	LP/P	Periodic fever, familial, autosomal dominant (FPF) [MIM:142680]	M3YZQ0	62	C	G
P19438	LP/P	Periodic fever, familial, autosomal dominant (FPF) [MIM:142680]	M3YZQ0	99	C	S
P19438	LP/P	Periodic fever, familial, autosomal dominant (FPF) [MIM:142680]	M3YZQ0	121	R	P
P19438	LP/P	Periodic fever, familial, autosomal dominant (FPF) [MIM:142680]	M3YZQ0	51	H	Q
P19438	LB/B	Periodic fever, familial, autosomal dominant (FPF) [MIM:142680]	M3YZQ0	75	P	L
P19438	LP/P	Periodic fever, familial, autosomal dominant (FPF) [MIM:142680]	M3YZQ0	115	S	G
P20333	LB/B	-	A0A1S3AD59	196	M	R
P20333	LB/B	-	A0A1S3AD59	232	E	K
P20333	LB/B	-	A0A1S3AD59	187	V	M
P20333	LB/B	-	A0A1S3AD59	236	A	T
P20333	LB/B	-	A0A1S3AD59	264	L	P
P20333	LB/B	-	A0A1S3AD59	269	T	P
P20333	LB/B	-	A0A1S3AD59	295	Q	R
P20333	LB/B	-	A0A1S3AD59	301	P	R
Q93038	LB/B	-	A0A151MNZ6	370	R	L
Q93038	LB/B	-	A0A151MNZ6	381	R	H
Q93038	LB/B	-	A0A151MNZ6	23	R	Q
Q93038	LB/B	-	A0A151MNZ6	159	D	G
Q93038	LB/B	-	A0A151MNZ6	254	P	R
P43489	LB/B	-	G7NWR7	10	R	C
P43489	LP/P	Immunodeficiency 16 (IMD16) [MIM:615593]	G7NWR7	65	R	C
P50591	LB/B	-	A0A2K5DVZ8	33	V	I
P50591	LB/B	-	A0A2K5DVZ8	47	D	E
O75888	LB/B	-	G3U2R8	67	G	R
O75888	LB/B	-	G3U2R8	96	N	S
Q9Y275	LB/B	-	A0A096MJG3	105	A	T
O43557	LB/B	-	H3BBD0	32	S	L
O43557	LB/B	-	H3BBD0	120	L	V
O43557	LB/B	-	H3BBD0	214	K	E
O95150	LB/B	-	G3TAV2	110	F	L
P41273	LB/B	-	A0A2Y9L5P1	17	P	A
Q96KP6	LB/B	-	A0A2K6E9X1	99	K	E
Q13470	LB/B	-	H2RU66	278	V	I
Q13470	LB/B	-	H2RU66	514	T	K
Q13470	LB/B	-	H2RU66	539	R	C
Q13470	LB/B	-	H2RU66	546	S	C
Q13470	LB/B	-	H2RU66	598	V	M
Q9C0C2	LB/B	-	E2R6L1	322	T	S
Q9C0C2	LB/B	-	E2R6L1	714	S	N
P63316	LP/P	Cardiomyopathy, familial hypertrophic 13 (CMH13) [MIM:613243]	A0A1J9PLU9	29	L	Q
P63316	LP/P	Cardiomyopathy, dilated 1Z (CMD1Z) [MIM:611879]	A0A1J9PLU9	159	G	D
P63316	LP/P	Cardiomyopathy, familial hypertrophic 13 (CMH13) [MIM:613243]	A0A1J9PLU9	8	A	V
P63316	LP/P	Cardiomyopathy, familial hypertrophic 13 (CMH13) [MIM:613243]	A0A1J9PLU9	84	C	Y
P63316	LP/P	Cardiomyopathy, familial hypertrophic 13 (CMH13) [MIM:613243]	A0A1J9PLU9	134	E	D
P63316	LP/P	Cardiomyopathy, familial hypertrophic 13 (CMH13) [MIM:613243]	A0A1J9PLU9	145	D	E
P19237	LB/B	-	A0A2Y9FQN1	67	R	W
P48788	LP/P	Arthrogryposis, distal, 2B1 (DA2B1) [MIM:601680]	L9LB62	174	R	Q
P45378	LP/P	Arthrogryposis, distal, 2B2 (DA2B2) [MIM:618435]	Q9DE11	74	R	H
P45378	LP/P	Arthrogryposis, distal, 2B2 (DA2B2) [MIM:618435]	Q9DE11	74	R	C
Q05952	LB/B	-	P11378	131	R	W
O14787	LP/P	Intellectual developmental disorder with hypotonia, impaired speech, and dysmorphic facies (IDDHISD) [MIM:619556]	A0A1D1UI22	370	W	C
O14787	LP/P	Intellectual developmental disorder with hypotonia, impaired speech, and dysmorphic facies (IDDHISD) [MIM:619556]	A0A1D1UI22	28	Q	R
O14787	LP/P	Intellectual developmental disorder with hypotonia, impaired speech, and dysmorphic facies (IDDHISD) [MIM:619556]	A0A1D1UI22	32	Q	R
O14787	LP/P	Intellectual developmental disorder with hypotonia, impaired speech, and dysmorphic facies (IDDHISD) [MIM:619556]	A0A1D1UI22	61	P	R
O14787	LP/P	Intellectual developmental disorder with hypotonia, impaired speech, and dysmorphic facies (IDDHISD) [MIM:619556]	A0A1D1UI22	118	K	N
O14787	LP/P	Intellectual developmental disorder with hypotonia, impaired speech, and dysmorphic facies (IDDHISD) [MIM:619556]	A0A1D1UI22	156	D	N
O14787	LP/P	Intellectual developmental disorder with hypotonia, impaired speech, and dysmorphic facies (IDDHISD) [MIM:619556]	A0A1D1UI22	370	W	R
O14787	LP/P	Intellectual developmental disorder with hypotonia, impaired speech, and dysmorphic facies (IDDHISD) [MIM:619556]	A0A1D1UI22	514	P	L
O14787	LP/P	Intellectual developmental disorder with hypotonia, impaired speech, and dysmorphic facies (IDDHISD) [MIM:619556]	A0A1D1UI22	546	A	V
O14787	LP/P	Intellectual developmental disorder with hypotonia, impaired speech, and dysmorphic facies (IDDHISD) [MIM:619556]	A0A1D1UI22	548	S	F
O14787	LP/P	Intellectual developmental disorder with hypotonia, impaired speech, and dysmorphic facies (IDDHISD) [MIM:619556]	A0A1D1UI22	727	W	C
Q9Y5L0	LP/P	Muscular dystrophy, limb-girdle, autosomal dominant 2 (LGMDD2) [MIM:608423]	A0A091DGD8	818	R	P
Q92752	LB/B	-	A0A0P7VHZ2	17	I	V
Q92752	LB/B	-	A0A0P7VHZ2	128	A	S
Q92752	LB/B	-	A0A0P7VHZ2	293	G	S
Q92752	LB/B	-	A0A0P7VHZ2	643	R	K
Q92752	LB/B	-	A0A0P7VHZ2	302	S	N
Q92752	LP/P	Neurodevelopmental disorder, non-progressive, with spasticity and transient opisthotonus (NEDSTO) [MIM:619653]	A0A0P7VHZ2	1192	R	W
O15417	LB/B	-	A0A2U4CBV3	1193	A	G
Q8NDV7	LB/B	-	A0A1D5PXV4	185	N	K
Q8NDV7	LB/B	-	A0A1D5PXV4	592	A	T
Q8NDV7	LB/B	-	A0A1D5PXV4	788	P	S
Q8NDV7	LB/B	-	A0A1D5PXV4	1268	E	K
Q9UPQ9	LB/B	-	A0A1D5PXV4	517	S	C
Q9HCJ0	LB/B	-	A0A1D5PXV4	820	P	R
Q9HBL0	LB/B	-	A0A1S3NWX0	436	I	M
Q9HBL0	LB/B	-	A0A1S3NWX0	591	R	C
Q9HBL0	LB/B	-	A0A1S3NWX0	653	T	I
Q9HBL0	LB/B	-	A0A1S3NWX0	1301	W	R
Q9HBL0	LB/B	-	A0A1S3NWX0	1708	V	I
Q63HR2	LB/B	-	H2UF61	353	S	T
Q63HR2	LB/B	-	H2UF61	670	A	T
Q68CZ2	LB/B	-	H2UF61	600	Q	H
Q68CZ2	LB/B	-	H2UF61	679	G	S
Q68CZ2	LB/B	-	H2UF61	1034	E	K
Q8IZW8	LB/B	-	U3IK11	179	L	P
Q8IZW8	LB/B	-	U3IK11	498	S	N
Q8IZW8	LB/B	-	U3IK11	327	T	K
P22105	LB/B	-	G1KPP3	2301	P	H
P22105	LB/B	-	G1KPP3	2495	G	S
P22105	LB/B	-	G1KPP3	2518	G	E
P22105	LB/B	-	G1KPP3	511	R	H
P22105	LB/B	-	G1KPP3	1161	H	R
P22105	LB/B	-	G1KPP3	302	T	A
P22105	LP/P	Ehlers-Danlos syndrome, classic-like (EDSCLL) [MIM:606408]	G1KPP3	29	R	W
P22105	LP/P	Ehlers-Danlos syndrome, classic-like (EDSCLL) [MIM:606408]	G1KPP3	1108	V	M
P22105	LB/B	-	G1KPP3	3988	L	I
P22105	LB/B	-	G1KPP3	641	G	C
P22105	LB/B	-	G1KPP3	650	R	H
P22105	LB/B	-	G1KPP3	873	S	A
P22105	LB/B	-	G1KPP3	2363	P	H
P22105	LB/B	-	G1KPP3	1905	E	K
P22105	LB/B	-	G1KPP3	2412	P	L
P22105	LP/P	Vesicoureteral reflux 8 (VUR8) [MIM:615963]	G1KPP3	1244	T	R
P22105	LP/P	Vesicoureteral reflux 8 (VUR8) [MIM:615963]	G1KPP3	3212	V	I
P22105	LP/P	Ehlers-Danlos syndrome, classic-like (EDSCLL) [MIM:606408]	G1KPP3	4074	R	C
P50616	LB/B	-	F6V783	319	K	R
Q96GM8	LB/B	-	A0A146RCH4	341	R	H
Q96GM8	LB/B	-	A0A146RCH4	381	E	K
Q96GM8	LP/P	Pontocerebellar hypoplasia 7 (PCH7) [MIM:614969]	A0A146RCH4	220	E	K
Q96GM8	LP/P	Pontocerebellar hypoplasia 7 (PCH7) [MIM:614969]	A0A146RCH4	73	R	S
Q96GM8	LP/P	Pontocerebellar hypoplasia 7 (PCH7) [MIM:614969]	A0A146RCH4	103	A	T
Q96GM8	LP/P	Pontocerebellar hypoplasia 7 (PCH7) [MIM:614969]	A0A146RCH4	148	F	Y
Q96GM8	LP/P	Pontocerebellar hypoplasia 7 (PCH7) [MIM:614969]	A0A146RCH4	173	V	G
Q96GM8	LP/P	Pontocerebellar hypoplasia 7 (PCH7) [MIM:614969]	A0A146RCH4	239	F	S
Q96GM8	LP/P	Pontocerebellar hypoplasia 7 (PCH7) [MIM:614969]	A0A146RCH4	253	R	W
Q96GM8	LP/P	Pontocerebellar hypoplasia 7 (PCH7) [MIM:614969]	A0A146RCH4	319	H	Q
Q96GM8	LP/P	Pontocerebellar hypoplasia 7 (PCH7) [MIM:614969]	A0A146RCH4	319	H	Y
Q96GM8	LP/P	Pontocerebellar hypoplasia 7 (PCH7) [MIM:614969]	A0A146RCH4	496	S	F
Q9Y4F4	LB/B	-	W5PHF7	416	E	Q
Q9Y4F4	LB/B	-	W5PHF7	511	L	V
Q9Y4F4	LP/P	Joubert syndrome 37 (JBTS37) [MIM:619185]	W5PHF7	368	R	W
Q9Y4F4	LP/P	Joubert syndrome 37 (JBTS37) [MIM:619185]	W5PHF7	375	L	P
Q9Y4F4	LP/P	Joubert syndrome 37 (JBTS37) [MIM:619185]	W5PHF7	1311	R	C
Q6ZUX3	LB/B	-	A0A1A6FUM5	55	A	T
Q6ZUX3	LB/B	-	A0A1A6FUM5	265	Q	R
Q6ZUX3	LB/B	-	A0A1A6FUM5	362	Q	R
Q6ZUX3	LB/B	-	A0A1A6FUM5	441	I	V
Q6ZUX3	LB/B	-	A0A1A6FUM5	535	V	A
Q6ZUX3	LB/B	-	A0A1A6FUM5	941	T	A
Q6ZUX3	LB/B	-	A0A1A6FUM5	944	G	V
Q6ZUX3	LB/B	-	A0A1A6FUM5	724	R	C
Q9H0E2	LB/B	-	A0A2R9A6V6	222	A	S
Q9H0E2	LB/B	-	A0A2R9A6V6	161	D	N
O75674	LB/B	-	A0A2Y9DQ60	108	R	S
Q15785	LB/B	-	F7FY89	293	R	K
Q96HA7	LB/B	-	S9WR27	488	V	M
Q96HA7	LB/B	-	S9WR27	493	G	S
Q96HA7	LB/B	-	S9WR27	714	A	V
Q96HA7	LB/B	-	S9WR27	1276	P	L
Q96HA7	LP/P	Spondyloepimetaphyseal dysplasia, sponastrime type (SEMDSP) [MIM:271510]	S9WR27	174	S	N
Q96HA7	LP/P	Spondyloepimetaphyseal dysplasia, sponastrime type (SEMDSP) [MIM:271510]	S9WR27	199	E	K
Q96HA7	LP/P	Spondyloepimetaphyseal dysplasia, sponastrime type (SEMDSP) [MIM:271510]	S9WR27	539	E	K
Q96HA7	LP/P	Spondyloepimetaphyseal dysplasia, sponastrime type (SEMDSP) [MIM:271510]	S9WR27	558	R	Q
Q96HA7	LP/P	Spondyloepimetaphyseal dysplasia, sponastrime type (SEMDSP) [MIM:271510]	S9WR27	653	T	M
Q96HA7	LP/P	Spondyloepimetaphyseal dysplasia, sponastrime type (SEMDSP) [MIM:271510]	S9WR27	934	R	W
Q96HA7	LP/P	Spondyloepimetaphyseal dysplasia, sponastrime type (SEMDSP) [MIM:271510]	S9WR27	973	G	R
Q96HA7	LP/P	Spondyloepimetaphyseal dysplasia, sponastrime type (SEMDSP) [MIM:271510]	S9WR27	1197	S	P
P11388	LB/B	-	A0A146V9E8	450	R	Q
P11388	LB/B	-	A0A146V9E8	487	R	K
P11388	LB/B	-	A0A146V9E8	1324	T	K
P11388	LB/B	-	A0A146V9E8	1386	G	D
P11388	LB/B	-	A0A146V9E8	1515	A	S
Q02880	LP/P	-	A0A146V9E8	63	H	Y
Q02880	LP/P	B-cell immunodeficiency, distal limb anomalies, and urogenital malformations (BILU) [MIM:609296]	A0A146V9E8	488	S	L
Q02880	LP/P	B-cell immunodeficiency, distal limb anomalies, and urogenital malformations (BILU) [MIM:609296]	A0A146V9E8	490	A	P
Q02880	LP/P	B-cell immunodeficiency, distal limb anomalies, and urogenital malformations (BILU) [MIM:609296]	A0A146V9E8	638	G	S
Q13472	LB/B	-	H9GF12	596	C	Y
Q13472	LB/B	-	H9GF12	459	D	N
Q13472	LB/B	-	H9GF12	742	D	N
Q13472	LB/B	-	H9GF12	773	N	D
Q13472	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 5 (PEOB5) [MIM:618098]	H9GF12	100	M	V
Q13472	LP/P	Microcephaly, growth restriction, and increased sister chromatid exchange 2 (MGRISCE2) [MIM:618097]	H9GF12	176	A	V
Q8N9V7	LB/B	-	A0A2I0MQM6	43	C	R
Q8N9V7	LB/B	-	A0A2I0MQM6	88	P	Q
Q8N9V7	LB/B	-	A0A2I0MQM6	196	V	I
Q8N9V7	LB/B	-	A0A2I0MQM6	483	Q	R
Q8N9V7	LB/B	-	A0A2I0MQM6	673	P	A
Q8N9V7	LB/B	-	A0A2I0MQM6	796	K	E
Q8N9V7	LB/B	-	A0A2I0MQM6	1352	Q	R
Q92547	LB/B	-	U3KD35	955	N	S
Q92547	LB/B	-	U3KD35	817	S	L
Q92547	LB/B	-	U3KD35	1042	N	S
Q9NS56	LB/B	-	A0A1S3FZX8	154	A	T
Q9NS56	LB/B	-	A0A1S3FZX8	517	E	K
Q9NS56	LB/B	-	A0A1S3FZX8	749	N	D
Q9NS56	LB/B	-	A0A1S3FZX8	812	P	R
O14656	LB/B	-	K7D0C8	264	D	H
O14656	LB/B	-	K7D0C8	216	D	H
O14656	LP/P	Dystonia 1, torsion, autosomal dominant (DYT1) [MIM:128100]	K7D0C8	205	F	I
O14656	LP/P	Dystonia 1, torsion, autosomal dominant (DYT1) [MIM:128100]	K7D0C8	288	R	Q
O14656	LP/P	Arthrogryposis multiplex congenita 5 (AMC5) [MIM:618947]	K7D0C8	318	G	S
Q5JTV8	LB/B	-	A0A2K5Z1X2	146	M	T
Q5JTV8	LB/B	-	A0A2K5Z1X2	276	P	R
Q5JTV8	LB/B	-	A0A2K5Z1X2	293	Q	H
O14657	LB/B	-	V9KZY7	54	A	T
Q5JU69	LB/B	-	V9KZY7	203	K	E
Q9H497	LB/B	-	A0A2J8N6X0	13	F	L
Q96NM4	LB/B	-	A0A151MNG9	223	V	A
O15405	LB/B	-	G1MZN1	128	V	M
O15405	LB/B	-	G1MZN1	572	Q	P
P04637	LB/B	-	L5JZ91	72	P	R
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	133	M	T
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	138	A	P
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	141	C	Y
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	151	P	S
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	151	P	T
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	152	P	L
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	158	R	G
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	158	R	H
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	173	V	M
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	175	R	G
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	175	R	L
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	175	R	H
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	193	H	R
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	213	R	Q
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	220	Y	C
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	234	Y	C
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	237	M	I
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	241	S	F
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	245	G	C
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	245	G	D
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	245	G	S
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	245	G	V
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	246	M	V
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	248	R	Q
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	248	R	W
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	252	L	P
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	258	E	K
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	272	V	L
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	273	R	C
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	273	R	G
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	273	R	H
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	275	C	Y
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	278	P	L
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	278	P	S
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	278	P	T
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	282	R	W
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	283	R	C
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	285	E	Q
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	286	E	A
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	309	P	S
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	325	G	V
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	337	R	C
P04637	LB/B	-	L5JZ91	47	P	S
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	292	K	I
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	163	Y	C
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	337	R	H
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	213	R	P
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	273	R	L
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	82	P	L
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	105	G	C
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	132	K	E
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	133	M	R
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	138	A	S
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	144	Q	L
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	155	T	N
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	156	R	H
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	167	Q	K
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	172	V	F
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	174	R	G
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	179	H	Y
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	180	E	K
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	181	R	C
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	181	R	H
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	196	R	P
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	197	V	M
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	227	S	T
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	233	H	D
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	235	N	S
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	236	Y	C
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	238	C	G
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	238	C	S
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	244	G	D
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	244	G	V
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	251	I	M
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	257	L	Q
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	265	L	P
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	267	R	Q
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	282	R	G
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	290	R	H
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	290	R	L
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	306	R	P
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	344	L	P
P04637	LB/B	-	L5JZ91	360	G	A
P04637	LB/B	-	L5JZ91	217	V	M
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	241	S	T
P04637	LP/P	Li-Fraumeni syndrome (LFS) [MIM:151623]	L5JZ91	281	D	N
Q12888	LB/B	-	W5NA29	353	D	E
Q12888	LB/B	-	W5NA29	412	G	S
Q12888	LB/B	-	W5NA29	648	M	V
Q12888	LB/B	-	W5NA29	699	Q	R
Q12888	LB/B	-	W5NA29	1014	E	G
Q12888	LB/B	-	W5NA29	1026	V	A
Q12888	LB/B	-	W5NA29	1136	K	Q
Q12888	LB/B	-	W5NA29	1170	A	G
Q12888	LB/B	-	W5NA29	1174	I	V
Q12888	LB/B	-	W5NA29	841	D	G
Q12888	LB/B	-	W5NA29	1137	E	K
Q12888	LB/B	-	W5NA29	1442	R	Q
Q12888	LB/B	-	W5NA29	1488	G	W
Q53FA7	LB/B	-	A0A2K5E6F6	223	E	K
Q96A56	LB/B	-	A0A1A6FWA7	75	C	R
Q96S44	LB/B	-	J9NUH9	25	A	T
Q96S44	LB/B	-	J9NUH9	129	T	A
Q96S44	LB/B	-	J9NUH9	123	R	Q
Q96S44	LB/B	-	J9NUH9	145	T	A
Q96S44	LP/P	Galloway-Mowat syndrome 4 (GAMOS4) [MIM:617730]	J9NUH9	42	G	D
Q96S44	LP/P	Galloway-Mowat syndrome 4 (GAMOS4) [MIM:617730]	J9NUH9	81	T	R
Q96S44	LP/P	Galloway-Mowat syndrome 4 (GAMOS4) [MIM:617730]	J9NUH9	243	R	L
Q9H3D4	LP/P	Split-hand/foot malformation 4 (SHFM4) [MIM:605289]	G9J1L9	233	K	E
Q9H3D4	LP/P	Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3 (EEC3) [MIM:604292]	G9J1L9	243	R	Q
Q9H3D4	LP/P	Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3 (EEC3) [MIM:604292]	G9J1L9	243	R	W
Q9H3D4	LP/P	Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3 (EEC3) [MIM:604292]	G9J1L9	318	R	H
Q9H3D4	LP/P	Rapp-Hodgkin syndrome (RHS) [MIM:129400]	G9J1L9	318	R	H
Q9H3D4	LP/P	Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3 (EEC3) [MIM:604292]	G9J1L9	319	R	C
Q9H3D4	LP/P	Acro-dermato-ungual-lacrimal-tooth syndrome (ADULT syndrome) [MIM:103285]	G9J1L9	337	R	Q
Q9H3D4	LP/P	Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3 (EEC3) [MIM:604292]	G9J1L9	343	R	Q
Q9H3D4	LP/P	Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3 (EEC3) [MIM:604292]	G9J1L9	345	C	R
Q9H3D4	LP/P	Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3 (EEC3) [MIM:604292]	G9J1L9	351	D	G
Q9H3D4	LP/P	Ankyloblepharon-ectodermal defects-cleft lip/palate (AEC) [MIM:106260]	G9J1L9	553	L	F
Q9H3D4	LP/P	Ankyloblepharon-ectodermal defects-cleft lip/palate (AEC) [MIM:106260]	G9J1L9	561	C	G
Q9H3D4	LP/P	Split-hand/foot malformation 4 (SHFM4) [MIM:605289]	G9J1L9	232	K	E
Q9H3D4	LP/P	Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3 (EEC3) [MIM:604292]	G9J1L9	266	R	Q
Q9H3D4	LP/P	Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3 (EEC3) [MIM:604292]	G9J1L9	308	C	Y
Q9H3D4	LP/P	Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3 (EEC3) [MIM:604292]	G9J1L9	311	S	N
Q9H3D4	LP/P	Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3 (EEC3) [MIM:604292]	G9J1L9	318	R	C
Q9H3D4	LP/P	Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3 (EEC3) [MIM:604292]	G9J1L9	318	R	Q
Q9H3D4	LP/P	Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3 (EEC3) [MIM:604292]	G9J1L9	319	R	H
Q9H3D4	LP/P	Split-hand/foot malformation 4 (SHFM4) [MIM:605289]	G9J1L9	319	R	H
Q9H3D4	LP/P	Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3 (EEC3) [MIM:604292]	G9J1L9	319	R	S
Q9H3D4	LP/P	Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3 (EEC3) [MIM:604292]	G9J1L9	343	R	W
Q9H3D4	LP/P	Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3 (EEC3) [MIM:604292]	G9J1L9	347	C	S
Q9H3D4	LP/P	Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3 (EEC3) [MIM:604292]	G9J1L9	348	P	S
Q9H3D4	LP/P	Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3 (EEC3) [MIM:604292]	G9J1L9	351	D	H
Q9H3D4	LB/B	-	G9J1L9	129	S	L
Q9H3D4	LP/P	Orofacial cleft 8 (OFC8) [MIM:618149]	G9J1L9	352	R	G
Q9H3D4	LP/P	Rapp-Hodgkin syndrome (RHS) [MIM:129400]	G9J1L9	549	I	T
Q9H3D4	LP/P	Rapp-Hodgkin syndrome (RHS) [MIM:129400]	G9J1L9	580	S	P
Q9H3D4	LB/B	-	G9J1L9	603	D	H
Q8NHX9	LB/B	-	A0A2I3MPX4	376	K	R
Q8NHX9	LB/B	-	A0A2I3MPX4	564	L	P
Q8NHX9	LB/B	-	A0A2I3MPX4	734	G	E
Q8NHX9	LB/B	-	A0A2I3MPX4	484	M	L
Q16890	LB/B	-	W5PDM7	62	R	K
Q96J77	LB/B	-	A0A2K6FYA0	118	F	L
Q68CL5	LB/B	-	A0A2K6KRL5	47	R	C
Q8IWU9	LB/B	-	A0A146V521	441	R	H
Q8IWU9	LB/B	-	A0A146V521	206	P	S
Q8IWU9	LB/B	-	A0A146V521	36	L	P
Q8IWU9	LB/B	-	A0A146V521	36	L	V
Q8IWU9	LB/B	-	A0A146V521	41	S	Y
Q8IWU9	LB/B	-	A0A146V521	55	R	C
Q8IWU9	LP/P	Attention deficit-hyperactivity disorder 7 (ADHD7) [MIM:613003]	A0A146V521	303	R	W
Q8IWU9	LB/B	-	A0A146V521	328	A	V
Q8IWU9	LB/B	-	A0A146V521	479	D	E
Q8IWU9	LB/B	-	A0A146V521	468	Q	R
P60174	LP/P	Triosephosphate isomerase deficiency (TPID) [MIM:615512]	A0A0G4N4T0	42	C	Y
P60174	LP/P	Triosephosphate isomerase deficiency (TPID) [MIM:615512]	A0A0G4N4T0	73	G	A
P60174	LP/P	Triosephosphate isomerase deficiency (TPID) [MIM:615512]	A0A0G4N4T0	105	E	D
P60174	LB/B	-	A0A0G4N4T0	123	G	R
P60174	LP/P	Triosephosphate isomerase deficiency (TPID) [MIM:615512]	A0A0G4N4T0	155	V	M
P60174	LP/P	Triosephosphate isomerase deficiency (TPID) [MIM:615512]	A0A0G4N4T0	171	I	V
P60174	LP/P	Triosephosphate isomerase deficiency (TPID) [MIM:615512]	A0A0G4N4T0	232	V	M
P60174	LP/P	Triosephosphate isomerase deficiency (TPID) [MIM:615512]	A0A0G4N4T0	241	F	L
P09493	LP/P	Cardiomyopathy, familial hypertrophic 3 (CMH3) [MIM:115196]	A0A146ZH60	175	D	N
P09493	LP/P	Cardiomyopathy, familial hypertrophic 3 (CMH3) [MIM:115196]	A0A146ZH60	180	E	G
P09493	LP/P	Cardiomyopathy, familial hypertrophic 3 (CMH3) [MIM:115196]	A0A146ZH60	63	A	V
P09493	LP/P	Cardiomyopathy, familial hypertrophic 3 (CMH3) [MIM:115196]	A0A146ZH60	180	E	V
P09493	LP/P	Cardiomyopathy, dilated 1Y (CMD1Y) [MIM:611878]	A0A146ZH60	40	E	K
P09493	LP/P	Cardiomyopathy, dilated 1Y (CMD1Y) [MIM:611878]	A0A146ZH60	54	E	K
P09493	LP/P	Left ventricular non-compaction 9 (LVNC9) [MIM:611878]	A0A146ZH60	192	E	K
P09493	LP/P	Left ventricular non-compaction 9 (LVNC9) [MIM:611878]	A0A146ZH60	248	K	E
P07951	LP/P	Nemaline myopathy 4 (NEM4) [MIM:609285]	F7GSX8	117	E	A
P07951	LP/P	Nemaline myopathy 4 (NEM4) [MIM:609285]	F7GSX8	147	Q	P
P07951	LP/P	Arthrogryposis, distal, 1A (DA1A) [MIM:108120]	F7GSX8	91	R	G
P07951	LB/B	-	F7GSX8	273	E	K
P07951	LP/P	Nemaline myopathy 4 (NEM4) [MIM:609285]	F7GSX8	41	E	K
P07951	LP/P	Arthrogryposis, distal, 1A (DA1A) [MIM:108120]	F7GSX8	133	R	W
P07951	LP/P	Arthrogryposis, distal, 2B4 (DA2B4) [MIM:108120]	F7GSX8	133	R	W
P07951	LP/P	Nemaline myopathy 4 (NEM4) [MIM:609285]	F7GSX8	133	R	W
P07951	LP/P	Cap myopathy 2 (CAPM2) [MIM:609285]	F7GSX8	202	N	K
P07951	LP/P	-	F7GSX8	2	D	V
P07951	LP/P	Nemaline myopathy 4 (NEM4) [MIM:609285]	F7GSX8	3	A	G
P07951	LP/P	Nemaline myopathy 4 (NEM4) [MIM:609285]	F7GSX8	14	D	V
P07951	LP/P	-	F7GSX8	93	Q	H
P07951	LP/P	Arthrogryposis, distal, 1A (DA1A) [MIM:108120]	F7GSX8	93	Q	R
P07951	LP/P	Arthrogryposis, distal, 1A (DA1A) [MIM:108120]	F7GSX8	117	E	K
P07951	LP/P	-	F7GSX8	128	K	E
P07951	LP/P	-	F7GSX8	133	R	P
P07951	LP/P	Nemaline myopathy 4 (NEM4) [MIM:609285]	F7GSX8	143	L	P
P07951	LP/P	Nemaline myopathy 4 (NEM4) [MIM:609285]	F7GSX8	148	L	P
P07951	LP/P	-	F7GSX8	155	A	T
P07951	LP/P	Arthrogryposis, distal, 1A (DA1A) [MIM:108120]	F7GSX8	261	Y	C
P51580	LB/B	-	A0A151MNX0	49	L	S
P51580	LB/B	-	A0A151MNX0	80	A	P
P51580	LB/B	-	A0A151MNX0	154	A	T
P51580	LB/B	-	A0A151MNX0	180	Y	F
P51580	LB/B	-	A0A151MNX0	227	H	Q
P51580	LB/B	-	A0A151MNX0	240	Y	C
P51580	LB/B	-	A0A151MNX0	215	R	H
P51580	LB/B	-	A0A151MNX0	179	Q	H
P07202	LB/B	-	A0A2K6UMR9	257	A	S
P07202	LB/B	-	A0A2K6UMR9	373	A	S
P07202	LB/B	-	A0A2K6UMR9	398	S	T
P07202	LP/P	Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500]	A0A2K6UMR9	453	Y	D
P07202	LB/B	-	A0A2K6UMR9	725	T	P
P07202	LP/P	Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500]	A0A2K6UMR9	799	E	K
P07202	LP/P	Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500]	A0A2K6UMR9	648	R	Q
P07202	LP/P	Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500]	A0A2K6UMR9	447	I	F
P07202	LP/P	Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500]	A0A2K6UMR9	53	A	P
P07202	LP/P	Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500]	A0A2K6UMR9	240	D	N
P07202	LP/P	Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500]	A0A2K6UMR9	307	N	T
P07202	LP/P	Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500]	A0A2K6UMR9	326	A	T
P07202	LP/P	Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500]	A0A2K6UMR9	433	V	M
P07202	LP/P	Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500]	A0A2K6UMR9	458	L	P
P07202	LP/P	Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500]	A0A2K6UMR9	491	R	H
P07202	LP/P	Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500]	A0A2K6UMR9	493	G	S
P07202	LP/P	Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500]	A0A2K6UMR9	499	P	L
P07202	LP/P	Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500]	A0A2K6UMR9	527	W	C
P07202	LP/P	Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500]	A0A2K6UMR9	660	Q	E
P07202	LP/P	Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500]	A0A2K6UMR9	665	R	W
P07202	LP/P	Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500]	A0A2K6UMR9	693	R	W
P07202	LP/P	Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500]	A0A2K6UMR9	771	G	R
P07202	LP/P	Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500]	A0A2K6UMR9	796	D	Y
P07202	LP/P	Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500]	A0A2K6UMR9	808	C	R
P07202	LP/P	Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500]	A0A2K6UMR9	378	E	K
P07202	LP/P	Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500]	A0A2K6UMR9	533	G	C
P07202	LP/P	Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500]	A0A2K6UMR9	590	G	S
P07202	LB/B	-	A0A2K6UMR9	618	V	M
P07202	LB/B	-	A0A2K6UMR9	706	M	V
P07202	LB/B	-	A0A2K6UMR9	793	L	P
P07202	LP/P	Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500]	A0A2K6UMR9	839	V	I
P07202	LB/B	-	A0A2K6UMR9	846	R	W
P07202	LB/B	-	A0A2K6UMR9	847	V	A
O14773	LB/B	-	B4E0C7	175	R	H
O14773	LP/P	Ceroid lipofuscinosis, neuronal, 2 (CLN2) [MIM:204500]	B4E0C7	365	C	R
O14773	LP/P	Ceroid lipofuscinosis, neuronal, 2 (CLN2) [MIM:204500]	B4E0C7	365	C	Y
O14773	LP/P	Ceroid lipofuscinosis, neuronal, 2 (CLN2) [MIM:204500]	B4E0C7	447	R	H
O14773	LP/P	Ceroid lipofuscinosis, neuronal, 2 (CLN2) [MIM:204500]	B4E0C7	77	G	R
O14773	LB/B	-	B4E0C7	100	Q	R
O14773	LP/P	Ceroid lipofuscinosis, neuronal, 2 (CLN2) [MIM:204500]	B4E0C7	206	R	C
O14773	LP/P	Ceroid lipofuscinosis, neuronal, 2 (CLN2) [MIM:204500]	B4E0C7	287	I	N
O14773	LP/P	Ceroid lipofuscinosis, neuronal, 2 (CLN2) [MIM:204500]	B4E0C7	343	E	K
O14773	LP/P	Ceroid lipofuscinosis, neuronal, 2 (CLN2) [MIM:204500]	B4E0C7	385	V	D
O14773	LP/P	Ceroid lipofuscinosis, neuronal, 2 (CLN2) [MIM:204500]	B4E0C7	389	G	E
O14773	LP/P	Ceroid lipofuscinosis, neuronal, 2 (CLN2) [MIM:204500]	B4E0C7	422	Q	H
O14773	LP/P	Ceroid lipofuscinosis, neuronal, 2 (CLN2) [MIM:204500]	B4E0C7	454	A	E
O14773	LP/P	Ceroid lipofuscinosis, neuronal, 2 (CLN2) [MIM:204500]	B4E0C7	475	S	L
O14773	LP/P	Ceroid lipofuscinosis, neuronal, 2 (CLN2) [MIM:204500]	B4E0C7	127	R	Q
O14773	LP/P	Ceroid lipofuscinosis, neuronal, 2 (CLN2) [MIM:204500]	B4E0C7	153	S	P
O14773	LP/P	Ceroid lipofuscinosis, neuronal, 2 (CLN2) [MIM:204500]	B4E0C7	206	R	H
O14773	LP/P	Ceroid lipofuscinosis, neuronal, 2 (CLN2) [MIM:204500]	B4E0C7	277	V	M
O14773	LP/P	Ceroid lipofuscinosis, neuronal, 2 (CLN2) [MIM:204500]	B4E0C7	278	Q	P
O14773	LP/P	Ceroid lipofuscinosis, neuronal, 2 (CLN2) [MIM:204500]	B4E0C7	284	G	V
O14773	LP/P	Ceroid lipofuscinosis, neuronal, 2 (CLN2) [MIM:204500]	B4E0C7	286	N	S
O14773	LP/P	Ceroid lipofuscinosis, neuronal, 2 (CLN2) [MIM:204500]	B4E0C7	353	T	P
O14773	LP/P	Ceroid lipofuscinosis, neuronal, 2 (CLN2) [MIM:204500]	B4E0C7	428	K	N
O14773	LP/P	Ceroid lipofuscinosis, neuronal, 2 (CLN2) [MIM:204500]	B4E0C7	473	G	R
O14773	LP/P	Ceroid lipofuscinosis, neuronal, 2 (CLN2) [MIM:204500]	B4E0C7	481	F	C
O14773	LB/B	-	B4E0C7	62	S	L
O14773	LB/B	-	B4E0C7	185	R	C
O14773	LP/P	Ceroid lipofuscinosis, neuronal, 2 (CLN2) [MIM:204500]	B4E0C7	482	G	R
O14773	LP/P	Ceroid lipofuscinosis, neuronal, 2 (CLN2) [MIM:204500]	B4E0C7	202	P	L
O14773	LP/P	Ceroid lipofuscinosis, neuronal, 2 (CLN2) [MIM:204500]	B4E0C7	544	P	S
O14773	LP/P	Ceroid lipofuscinosis, neuronal, 2 (CLN2) [MIM:204500]	B4E0C7	62	S	T
O14773	LP/P	Ceroid lipofuscinosis, neuronal, 2 (CLN2) [MIM:204500]	B4E0C7	209	Y	H
O14773	LP/P	Ceroid lipofuscinosis, neuronal, 2 (CLN2) [MIM:204500]	B4E0C7	266	R	Q
O14773	LP/P	Ceroid lipofuscinosis, neuronal, 2 (CLN2) [MIM:204500]	B4E0C7	339	R	Q
O14773	LP/P	Ceroid lipofuscinosis, neuronal, 2 (CLN2) [MIM:204500]	B4E0C7	382	S	R
O14773	LP/P	Ceroid lipofuscinosis, neuronal, 2 (CLN2) [MIM:204500]	B4E0C7	448	A	V
O14773	LP/P	Ceroid lipofuscinosis, neuronal, 2 (CLN2) [MIM:204500]	B4E0C7	501	G	C
O14773	LP/P	Ceroid lipofuscinosis, neuronal, 2 (CLN2) [MIM:204500]	B4E0C7	504	N	Y
O14773	LP/P	Ceroid lipofuscinosis, neuronal, 2 (CLN2) [MIM:204500]	B4E0C7	548	W	R
O14773	LP/P	Spinocerebellar ataxia, autosomal recessive, 7 (SCAR7) [MIM:609270]	B4E0C7	466	V	G
O14773	LP/P	Ceroid lipofuscinosis, neuronal, 2 (CLN2) [MIM:204500]	B4E0C7	278	Q	R
P29144	LP/P	Immunodeficiency 78 with autoimmunity and developmental delay (IMD78) [MIM:619220]	A0A287BD60	500	G	D
P59282	LB/B	-	A4IIY2	133	R	L
P12270	LB/B	-	A0A1S3HYA9	960	S	N
P12270	LB/B	-	A0A1S3HYA9	1428	V	G
P12270	LB/B	-	A0A1S3HYA9	1707	T	A
Q9Y3C4	LP/P	Galloway-Mowat syndrome 5 (GAMOS5) [MIM:617731]	C1BYK7	136	L	P
Q9Y3C4	LP/P	Galloway-Mowat syndrome 5 (GAMOS5) [MIM:617731]	C1BYK7	149	Y	C
Q9NRR2	LB/B	-	A0A1S3G8Z7	60	V	M
Q9NRR2	LB/B	-	A0A1S3G8Z7	126	I	M
Q9NRR2	LB/B	-	A0A1S3G8Z7	132	S	T
Q9NRR2	LB/B	-	A0A1S3G8Z7	204	L	I
Q9NRR2	LB/B	-	A0A1S3G8Z7	288	F	L
Q9NRR2	LB/B	-	A0A1S3G8Z7	160	W	S
Q9NRR2	LB/B	-	A0A1S3G8Z7	239	T	I
P13693	LB/B	-	S7P5V3	146	V	F
Q6XPS3	LB/B	-	A0A2Y9N6U2	367	V	I
Q6XPS3	LB/B	-	A0A2Y9N6U2	444	I	V
Q8TDR0	LB/B	-	W5MRQ8	228	N	S
Q8TDR0	LB/B	-	W5MRQ8	239	R	W
Q8TDR0	LB/B	-	W5MRQ8	620	M	L
Q8TDR0	LB/B	-	W5MRQ8	295	K	N
Q8TDR0	LB/B	-	W5MRQ8	416	T	S
Q8TDR0	LP/P	Senior-Loken syndrome 9 (SLSN9) [MIM:616629]	W5MRQ8	17	I	S
Q8TDR0	LP/P	Senior-Loken syndrome 9 (SLSN9) [MIM:616629]	W5MRQ8	125	V	A
Q8TDR0	LP/P	Senior-Loken syndrome 9 (SLSN9) [MIM:616629]	W5MRQ8	125	V	M
Q8TDR0	LP/P	Senior-Loken syndrome 9 (SLSN9) [MIM:616629]	W5MRQ8	520	M	R
Q9BUZ4	LB/B	-	A0A0P7UEV6	173	A	T
Q9BUZ4	LB/B	-	A0A0P7UEV6	178	R	G
O00463	LB/B	-	A0A2Y9EC52	186	N	H
O00463	LB/B	-	A0A2Y9EC52	120	V	G
O00463	LB/B	-	A0A2Y9EC52	358	L	V
O00463	LB/B	-	A0A2Y9EC52	268	H	Y
Q9BWF2	LP/P	Seckel syndrome 9 (SCKL9) [MIM:616777]	A0A1A7XES4	18	R	C
O60296	LB/B	-	H9G5C4	142	V	I
O60296	LB/B	-	H9G5C4	528	T	I
O60296	LB/B	-	H9G5C4	863	I	N
Q12931	LB/B	-	A0A1S2ZNF3	307	R	G
Q12931	LB/B	-	A0A1S2ZNF3	395	D	E
Q12931	LB/B	-	A0A1S2ZNF3	692	R	H
Q12931	LB/B	-	A0A1S2ZNF3	572	E	K
P48553	LB/B	-	C3YX42	257	V	E
P48553	LB/B	-	C3YX42	633	I	M
P48553	LB/B	-	C3YX42	726	V	M
P48553	LP/P	Neurodevelopmental disorder with microcephaly, short stature, and speech delay (NEDMISS) [MIM:620027]	C3YX42	929	P	L
Q7Z392	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 18 (LGMDR18) [MIM:615356]	A0A067RLD5	980	G	R
Q8WVT3	LB/B	-	Q4RGN1	301	S	G
Q8WVR3	LB/B	-	H2MET6	295	R	H
P0DI81	LP/P	Spondyloepiphyseal dysplasia tarda (SEDT) [MIM:313400]	A0A2R8M592	47	D	Y
P0DI81	LP/P	Spondyloepiphyseal dysplasia tarda (SEDT) [MIM:313400]	A0A2R8M592	73	S	L
P0DI81	LP/P	Spondyloepiphyseal dysplasia tarda (SEDT) [MIM:313400]	A0A2R8M592	130	V	D
P0DI81	LP/P	Spondyloepiphyseal dysplasia tarda (SEDT) [MIM:313400]	A0A2R8M592	83	F	S
Q9UL33	LP/P	Encephalopathy, progressive, early-onset, with episodic rhabdomyolysis (PEERB) [MIM:618331]	A0A2I2YA48	37	D	Y
Q9Y296	LB/B	-	Q3B8F1	78	D	A
Q8IUR0	LB/B	-	I7GAW8	52	S	A
Q9Y2L5	LB/B	-	A0A0N0BHF5	74	N	S
Q9Y2L5	LB/B	-	A0A0N0BHF5	708	Q	E
Q9Y2L5	LB/B	-	A0A0N0BHF5	1189	I	V
Q9Y2L5	LB/B	-	A0A0N0BHF5	137	L	S
Q9Y2L5	LB/B	-	A0A0N0BHF5	517	S	G
Q9Y2L5	LB/B	-	A0A0N0BHF5	954	R	H
Q9Y2L5	LB/B	-	A0A0N0BHF5	1146	T	A
Q9Y2L5	LB/B	-	A0A0N0BHF5	1298	S	P
O14717	LB/B	-	A0A2G5BJZ8	101	H	Y
Q9NP99	LB/B	-	G1M3H0	25	T	S
Q9NP99	LB/B	-	G1M3H0	214	F	L
Q9NP99	LB/B	-	G1M3H0	135	K	T
Q9NZC2	LB/B	-	A0A286ZYX9	157	H	Y
Q9NZC2	LB/B	-	A0A286ZYX9	211	L	P
Q9NZC2	LB/B	-	A0A286ZYX9	96	T	K
Q9NZC2	LB/B	-	A0A286ZYX9	96	T	R
Q9NZC2	LB/B	-	A0A286ZYX9	192	A	T
Q9NZC2	LP/P	Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2 (PLOSL2) [MIM:618193]	A0A286ZYX9	126	V	G
Q9NZC2	LB/B	-	A0A286ZYX9	38	Y	C
Q9NZC2	LB/B	-	A0A286ZYX9	62	R	H
Q9NZC2	LB/B	-	A0A286ZYX9	66	T	M
Q9NZC2	LB/B	-	A0A286ZYX9	87	D	N
Q9NZC2	LB/B	-	A0A286ZYX9	130	A	S
Q9NZC2	LB/B	-	A0A286ZYX9	162	S	R
Q9NZC2	LB/B	-	A0A286ZYX9	223	T	I
Q5T2D2	LB/B	-	A0A1U7U344	50	V	M
Q5T2D2	LB/B	-	A0A1U7U344	144	S	G
Q5T2D2	LB/B	-	A0A1U7U344	285	V	I
Q5T2D2	LB/B	-	A0A1U7U344	19	G	C
Q6UXN2	LB/B	-	A0A2K5KW44	73	W	R
Q6UXN2	LB/B	-	A0A2K5KW44	146	T	K
Q6UXN2	LB/B	-	A0A2K5KW44	168	T	I
Q96PN7	LB/B	-	A0A2I0MAH9	431	T	A
Q96PN7	LB/B	-	A0A2I0MAH9	834	C	S
Q96PN7	LB/B	-	A0A2I0MAH9	1019	N	T
Q96PN7	LB/B	-	A0A2I0MAH9	1187	D	N
Q96PN7	LB/B	-	A0A2I0MAH9	766	V	I
Q9NSU2	LP/P	Aicardi-Goutieres syndrome 1 (AGS1) [MIM:225750]	F7E304	114	R	H
Q9NSU2	LP/P	Systemic lupus erythematosus (SLE) [MIM:152700]	F7E304	114	R	H
Q9NSU2	LP/P	Aicardi-Goutieres syndrome 1 (AGS1) [MIM:225750]	F7E304	201	V	D
Q9NSU2	LP/P	Aicardi-Goutieres syndrome 1 (AGS1) [MIM:225750]	F7E304	200	D	N
Q9NSU2	LP/P	Aicardi-Goutieres syndrome 1 (AGS1) [MIM:225750]	F7E304	18	D	N
Q9NSU2	LP/P	Chilblain lupus 1 (CHBL1) [MIM:610448]	F7E304	18	D	N
Q9NSU2	LP/P	Systemic lupus erythematosus (SLE) [MIM:152700]	F7E304	158	A	V
Q9NSU2	LP/P	Systemic lupus erythematosus (SLE) [MIM:152700]	F7E304	227	G	S
Q9NSU2	LP/P	Systemic lupus erythematosus (SLE) [MIM:152700]	F7E304	240	R	S
Q9NSU2	LP/P	Systemic lupus erythematosus (SLE) [MIM:152700]	F7E304	247	A	P
Q9NSU2	LB/B	-	F7E304	266	E	G
Q9NSU2	LP/P	Systemic lupus erythematosus (SLE) [MIM:152700]	F7E304	290	P	L
Q9NSU2	LP/P	Systemic lupus erythematosus (SLE) [MIM:152700]	F7E304	305	Y	C
Q9NSU2	LP/P	Systemic lupus erythematosus (SLE) [MIM:152700]	F7E304	306	G	A
Q9NSU2	LP/P	Aicardi-Goutieres syndrome 1 (AGS1) [MIM:225750]	F7E304	122	V	A
Q9NSU2	LP/P	Aicardi-Goutieres syndrome 1 (AGS1) [MIM:225750]	F7E304	198	E	K
Q9NSU2	LP/P	Aicardi-Goutieres syndrome 1 (AGS1) [MIM:225750]	F7E304	200	D	H
Q9NSU2	LP/P	Systemic lupus erythematosus (SLE) [MIM:152700]	F7E304	200	D	H
Q9NSU2	LP/P	Aicardi-Goutieres syndrome 1 (AGS1) [MIM:225750]	F7E304	303	T	P
P20396	LB/B	-	Q62361	8	L	V
P34981	LB/B	-	L5KDM9	10	N	K
P34981	LB/B	-	L5KDM9	168	I	M
P34981	LP/P	Hypothyroidism, congenital, non-goitrous, 7 (CHNG7) [MIM:618573]	L5KDM9	81	P	R
P34981	LP/P	Hypothyroidism, congenital, non-goitrous, 7 (CHNG7) [MIM:618573]	L5KDM9	131	I	T
Q9UDY6	LB/B	-	K7G875	65	R	H
Q9UDY6	LB/B	-	K7G875	119	V	M
O60858	LB/B	-	A0A1L8HIQ6	355	S	T
Q14142	LB/B	-	G1LDD6	219	V	M
O95361	LB/B	-	M7AHD6	121	E	D
O95361	LB/B	-	M7AHD6	561	G	V
O95361	LB/B	-	M7AHD6	493	R	W
Q9C040	LP/P	Charcot-Marie-Tooth disease, axonal, 2R (CMT2R) [MIM:615490]	M7AKI4	227	E	V
P19474	LB/B	-	S9X519	52	P	A
P19474	LB/B	-	S9X519	96	G	R
P19474	LB/B	-	S9X519	231	E	K
P19474	LB/B	-	S9X519	88	Q	K
Q8IYM9	LB/B	-	S9X519	155	D	N
Q8IYM9	LB/B	-	S9X519	232	T	A
Q8IYM9	LB/B	-	S9X519	242	R	T
Q8IYM9	LB/B	-	S9X519	321	R	K
O15164	LB/B	-	G3HQH5	762	S	N
O15164	LB/B	-	G3HQH5	1009	R	S
O15164	LB/B	-	G3HQH5	796	N	S
Q12899	LB/B	-	A0A2K6E716	197	Q	H
Q13263	LB/B	-	G5B3G4	794	T	M
Q9BZY9	LB/B	-	A0A2I3HUU4	421	E	K
Q9BZY9	LB/B	-	A0A2I3HUU4	118	R	C
Q9BZY9	LB/B	-	A0A2I3HUU4	232	V	I
Q9BZY9	LB/B	-	A0A2I3HUU4	17	P	R
Q9BZY9	LB/B	-	A0A2I3HUU4	235	L	P
Q13049	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 8 (LGMDR8) [MIM:254110]	A8WGA9	487	D	N
Q13049	LP/P	Bardet-Biedl syndrome 11 (BBS11) [MIM:615988]	A8WGA9	130	P	S
Q13049	LB/B	-	A8WGA9	257	T	R
Q13049	LB/B	-	A8WGA9	408	R	C
Q13049	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 8 (LGMDR8) [MIM:254110]	A8WGA9	394	R	H
Q9UPN9	LB/B	-	A0A2I4D825	840	I	T
Q9UPN9	LB/B	-	A0A2I4D825	67	V	A
Q9UPN9	LB/B	-	A0A2I4D825	696	L	S
Q9UPN9	LB/B	-	A0A2I4D825	961	V	M
Q9UPN9	LB/B	-	A0A2I4D825	1090	P	T
Q9BYJ4	LB/B	-	H2NEC4	276	T	S
Q9BYJ4	LB/B	-	H2NEC4	282	D	H
Q9BYJ4	LB/B	-	H2NEC4	404	N	K
Q9NQ86	LB/B	-	A0A091SLF3	678	D	N
Q9NQ86	LB/B	-	A0A091SLF3	428	K	R
Q9NQ86	LB/B	-	A0A091SLF3	456	N	S
Q9NQ86	LB/B	-	A0A091SLF3	725	Q	E
Q9NQ86	LP/P	Anencephaly 1 (ANPH1) [MIM:206500]	A0A091SLF3	518	D	N
O94972	LB/B	-	W5LZG5	838	V	I
O94972	LP/P	Mulibrey nanism (MUL) [MIM:253250]	W5LZG5	76	L	P
O94972	LB/B	-	W5LZG5	108	T	A
O94972	LP/P	Mulibrey nanism (MUL) [MIM:253250]	W5LZG5	109	C	S
O94972	LP/P	Mulibrey nanism (MUL) [MIM:253250]	W5LZG5	322	G	V
O94972	LB/B	-	W5LZG5	432	Q	R
O00635	LB/B	-	S9X519	421	G	R
Q9C037	LB/B	-	K7G875	367	P	S
Q9C037	LB/B	-	K7G875	474	S	C
Q6P9F5	LB/B	-	H0XX79	142	K	Q
Q6P9F5	LB/B	-	H0XX79	215	E	K
Q6P9F5	LB/B	-	H0XX79	244	E	K
Q8WV44	LB/B	-	B1N1C1	78	A	T
Q8WV44	LB/B	-	B1N1C1	438	D	G
Q8IWZ5	LB/B	-	A0A091VUS0	475	V	M
Q8IWZ5	LB/B	-	A0A091VUS0	579	A	E
Q8IWZ5	LB/B	-	A0A091VUS0	244	K	R
Q96DX7	LB/B	-	A0A2Y9RKP0	64	S	Y
Q96DX7	LP/P	Aniridia 3 (AN3) [MIM:617142]	A0A2Y9RKP0	155	G	R
Q9H8W5	LB/B	-	A0A212CHA0	375	C	Y
Q9H8W5	LB/B	-	A0A212CHA0	413	R	Q
Q9H8W5	LB/B	-	A0A212CHA0	496	M	T
Q9H8W5	LB/B	-	A0A212CHA0	353	R	Q
P0CI25	LB/B	-	A0A2K5HBD7	373	G	R
A6NDI0	LB/B	-	A0A2K5HBD7	398	L	M
Q9C035	LB/B	-	A0A1U8CPZ3	43	H	Y
Q9C035	LB/B	-	A0A1U8CPZ3	136	R	Q
Q9C035	LB/B	-	A0A1U8CPZ3	112	V	F
Q9C035	LB/B	-	A0A1U8CPZ3	249	G	D
Q9C035	LB/B	-	A0A1U8CPZ3	419	H	Y
Q9C035	LB/B	-	A0A1U8CPZ3	479	P	L
Q9C035	LB/B	-	A0A1U8CPZ3	31	G	S
Q9C035	LB/B	-	A0A1U8CPZ3	58	C	Y
Q9C035	LB/B	-	A0A1U8CPZ3	110	G	E
Q9C035	LB/B	-	A0A1U8CPZ3	467	C	S
Q86XT4	LB/B	-	A0A1D5PEX9	8	P	L
Q86XT4	LB/B	-	A0A1D5PEX9	13	R	W
Q8NG06	LB/B	-	S9X519	3	W	S
Q8NG06	LB/B	-	S9X519	322	V	I
Q8NG06	LB/B	-	S9X519	374	T	M
Q9C030	LB/B	-	K7G875	154	E	K
Q969Q1	LB/B	-	S9XQS5	237	K	E
Q969Q1	LB/B	-	S9XQS5	61	S	R
Q969Q1	LB/B	-	S9XQS5	126	E	D
Q969Q1	LB/B	-	S9XQS5	254	D	N
Q969Q1	LB/B	-	S9XQS5	305	M	I
Q969Q1	LB/B	-	S9XQS5	321	A	D
Q969Q1	LB/B	-	S9XQS5	351	G	R
Q6PJ69	LB/B	-	U3JE51	364	G	R
Q6PJ69	LB/B	-	U3JE51	366	G	S
Q6PJ69	LB/B	-	U3JE51	222	V	G
Q6PJ69	LB/B	-	U3JE51	509	L	P
Q6AZZ1	LB/B	-	L9LA82	442	C	Y
Q6AZZ1	LB/B	-	L9LA82	457	R	H
Q6AZZ1	LB/B	-	L9LA82	466	Y	S
Q86WT6	LB/B	-	A0A151M795	31	V	A
Q86WT6	LB/B	-	A0A151M795	12	D	N
Q86WT6	LB/B	-	A0A151M795	15	D	N
Q86WT6	LB/B	-	A0A151M795	104	K	R
Q86WT6	LB/B	-	A0A151M795	161	T	M
Q86WT6	LB/B	-	A0A151M795	190	A	V
Q9C029	LB/B	-	K7G875	18	A	S
Q9C029	LB/B	-	K7G875	73	P	S
Q9C029	LB/B	-	K7G875	95	Q	E
Q9C029	LB/B	-	K7G875	258	V	A
Q9C029	LB/B	-	K7G875	363	G	S
Q2Q1W2	LP/P	Hydrocephalus, congenital communicating, 1 (HYDCC1) [MIM:618667]	A0A0P5QB53	608	R	H
Q2Q1W2	LP/P	Hydrocephalus, congenital communicating, 1 (HYDCC1) [MIM:618667]	A0A0P5QB53	796	R	H
Q86UV6	LB/B	-	A0A1D5PEX9	13	W	R
Q9C026	LB/B	-	A0A1L8F9X1	653	L	F
Q8N9V2	LB/B	-	S9X519	132	E	K
O75962	LB/B	-	A0A2K6RUH1	291	S	T
O75962	LB/B	-	A0A2K6RUH1	1644	T	M
O75962	LB/B	-	A0A2K6RUH1	1690	H	R
O75962	LB/B	-	A0A2K6RUH1	2242	T	M
O75962	LB/B	-	A0A2K6RUH1	348	D	E
O75962	LB/B	-	A0A2K6RUH1	1613	A	T
O75962	LP/P	Intellectual developmental disorder, autosomal dominant 63, with macrocephaly (MRD63) [MIM:618825]	A0A2K6RUH1	1080	N	I
O75962	LP/P	Intellectual developmental disorder, autosomal dominant 44, with microcephaly (MRD44) [MIM:617061]	A0A2K6RUH1	1428	R	Q
O75962	LP/P	Intellectual developmental disorder, autosomal dominant 44, with microcephaly (MRD44) [MIM:617061]	A0A2K6RUH1	1461	P	T
O75962	LP/P	Intellectual developmental disorder, autosomal dominant 63, with macrocephaly (MRD63) [MIM:618825]	A0A2K6RUH1	1075	T	I
O75962	LP/P	Intellectual developmental disorder, autosomal dominant 63, with macrocephaly (MRD63) [MIM:618825]	A0A2K6RUH1	1078	R	G
O75962	LP/P	Intellectual developmental disorder, autosomal dominant 63, with macrocephaly (MRD63) [MIM:618825]	A0A2K6RUH1	1078	R	Q
O75962	LP/P	Intellectual developmental disorder, autosomal dominant 63, with macrocephaly (MRD63) [MIM:618825]	A0A2K6RUH1	1078	R	W
O75962	LP/P	Intellectual developmental disorder, autosomal dominant 44, with microcephaly (MRD44) [MIM:617061]	A0A2K6RUH1	1299	E	K
O75962	LP/P	Intellectual developmental disorder, autosomal dominant 63, with macrocephaly (MRD63) [MIM:618825]	A0A2K6RUH1	1461	P	L
O75962	LP/P	Intellectual developmental disorder, autosomal dominant 44, with microcephaly (MRD44) [MIM:617061]	A0A2K6RUH1	1469	H	R
Q9H2D6	LP/P	Deafness, autosomal recessive, 28 (DFNB28) [MIM:609823]	G1SJ87	1019	G	R
Q9H2D6	LB/B	-	G1SJ87	863	N	K
Q9H2D6	LB/B	-	G1SJ87	1372	E	D
Q9H2D6	LB/B	-	G1SJ87	1377	W	R
Q9H2D6	LB/B	-	G1SJ87	217	S	N
Q9H2D6	LB/B	-	G1SJ87	493	S	N
Q9H2D6	LB/B	-	G1SJ87	1187	F	L
Q9H2D6	LB/B	-	G1SJ87	1300	H	R
Q9H2D6	LB/B	-	G1SJ87	817	T	S
Q15643	LB/B	-	A0A1A8IYN1	1846	T	I
Q15643	LB/B	-	A0A1A8IYN1	39	M	L
Q15643	LB/B	-	A0A1A8IYN1	506	E	A
Q15643	LB/B	-	A0A1A8IYN1	795	V	L
Q15643	LB/B	-	A0A1A8IYN1	884	D	G
Q15643	LB/B	-	A0A1A8IYN1	1040	I	V
Q15643	LB/B	-	A0A1A8IYN1	1503	M	V
Q15643	LB/B	-	A0A1A8IYN1	1576	R	H
Q15643	LB/B	-	A0A1A8IYN1	1749	E	A
Q15643	LB/B	-	A0A1A8IYN1	1752	R	K
Q15643	LB/B	-	A0A1A8IYN1	1107	E	D
Q15643	LB/B	-	A0A1A8IYN1	1413	D	A
Q15643	LB/B	-	A0A1A8IYN1	1827	G	S
Q15643	LB/B	-	A0A1A8IYN1	559	V	A
Q15643	LP/P	Odontochondrodysplasia 1 (ODCD1) [MIM:184260]	A0A1A8IYN1	410	D	Y
Q15643	LP/P	Odontochondrodysplasia 1 (ODCD1) [MIM:184260]	A0A1A8IYN1	1806	M	V
Q14669	LP/P	Clark-Baraitser syndrome (CLABARS) [MIM:617752]	A0A146XG02	761	A	V
Q14669	LP/P	Clark-Baraitser syndrome (CLABARS) [MIM:617752]	A0A146XG02	1557	D	H
Q14669	LP/P	Clark-Baraitser syndrome (CLABARS) [MIM:617752]	A0A146XG02	1595	R	Q
Q14669	LP/P	Clark-Baraitser syndrome (CLABARS) [MIM:617752]	A0A146XG02	1840	S	L
Q15645	LP/P	Oocyte maturation defect 9 (OOMD9) [MIM:619011]	Q6PH52	26	H	R
Q15654	LB/B	-	A0A1W4YC95	296	L	F
Q15654	LB/B	-	A0A1W4YC95	230	V	I
Q15654	LB/B	-	A0A1W4YC95	111	R	Q
Q9H3H1	LB/B	-	S7PFK8	202	F	L
Q9H3H1	LP/P	Combined oxidative phosphorylation deficiency 35 (COXPD35) [MIM:617873]	S7PFK8	323	R	Q
Q9BU70	LB/B	-	G5AZ27	7	S	P
Q9BU70	LB/B	-	G5AZ27	252	V	A
Q9BU70	LB/B	-	G5AZ27	324	V	M
Q7L0Y3	LB/B	-	K7F8E4	56	P	R
Q7L0Y3	LB/B	-	K7F8E4	164	K	N
Q7L0Y3	LP/P	Combined oxidative phosphorylation deficiency 30 (COXPD30) [MIM:616974]	K7F8E4	181	R	L
Q7L0Y3	LP/P	Combined oxidative phosphorylation deficiency 30 (COXPD30) [MIM:616974]	K7F8E4	272	T	A
Q9NUP7	LB/B	-	A0A2I4BGR2	48	A	V
Q8IZ69	LB/B	-	M3W1P7	602	S	R
Q32P41	LB/B	-	Q9D0C4	217	S	P
Q32P41	LB/B	-	Q9D0C4	255	L	P
Q32P41	LB/B	-	Q9D0C4	294	E	A
Q32P41	LP/P	Peripheral neuropathy with variable spasticity, exercise intolerance, and developmental delay (PNSED) [MIM:616539]	Q9D0C4	291	R	H
Q32P41	LP/P	Peripheral neuropathy with variable spasticity, exercise intolerance, and developmental delay (PNSED) [MIM:616539]	Q9D0C4	386	M	V
Q9UJA5	LB/B	-	F1SBM2	293	E	K
Q9UJA5	LB/B	-	F1SBM2	299	E	G
Q9UJA5	LB/B	-	F1SBM2	333	P	L
Q96FX7	LB/B	-	H2NMC2	66	V	A
Q9P272	LB/B	-	G1KI75	219	P	T
Q9P272	LB/B	-	G1KI75	265	I	T
Q9P272	LB/B	-	G1KI75	337	H	L
Q9P272	LB/B	-	G1KI75	150	H	R
Q9P272	LB/B	-	G1KI75	207	C	G
Q9P272	LB/B	-	G1KI75	304	G	E
Q9P272	LB/B	-	G1KI75	451	R	G
O75648	LB/B	-	A0A2I3MY51	10	A	S
O75648	LB/B	-	A0A2I3MY51	25	R	S
O75648	LB/B	-	A0A2I3MY51	148	E	K
O75648	LB/B	-	A0A2I3MY51	398	R	C
O75648	LB/B	-	A0A2I3MY51	14	G	S
O75648	LP/P	Liver failure, infantile, transient (LFIT) [MIM:613070]	A0A2I3MY51	77	Y	H
O75648	LP/P	Liver failure, infantile, transient (LFIT) [MIM:613070]	A0A2I3MY51	272	G	D
O75648	LB/B	-	A0A2I3MY51	279	V	M
Q6NT89	LB/B	-	U3DJA7	27	W	R
Q12816	LB/B	-	A0A2U3XF00	738	S	G
Q12816	LB/B	-	A0A2U3XF00	65	R	W
Q12816	LB/B	-	A0A2U3XF00	951	G	S
Q13507	LP/P	Spinocerebellar ataxia 41 (SCA41) [MIM:616410]	A0A2Y9IKE5	847	R	H
Q9UL62	LB/B	-	W5NAE7	702	R	H
Q9Y210	LP/P	Focal segmental glomerulosclerosis 2 (FSGS2) [MIM:603965]	A0A2Y9IKE5	112	P	Q
Q9Y210	LP/P	Focal segmental glomerulosclerosis 2 (FSGS2) [MIM:603965]	A0A2Y9IKE5	143	N	S
Q9Y210	LP/P	Focal segmental glomerulosclerosis 2 (FSGS2) [MIM:603965]	A0A2Y9IKE5	270	S	T
Q9Y210	LP/P	Focal segmental glomerulosclerosis 2 (FSGS2) [MIM:603965]	A0A2Y9IKE5	895	R	C
Q9Y210	LP/P	Focal segmental glomerulosclerosis 2 (FSGS2) [MIM:603965]	A0A2Y9IKE5	897	E	K
Q9Y210	LB/B	-	A0A2Y9IKE5	157	N	T
Q9Y210	LB/B	-	A0A2Y9IKE5	404	A	V
Q9Y210	LP/P	Focal segmental glomerulosclerosis 2 (FSGS2) [MIM:603965]	A0A2Y9IKE5	218	H	L
Q9Y210	LP/P	Focal segmental glomerulosclerosis 2 (FSGS2) [MIM:603965]	A0A2Y9IKE5	895	R	L
Q9Y210	LB/B	-	A0A2Y9IKE5	15	P	S
Q9Y210	LP/P	Focal segmental glomerulosclerosis 2 (FSGS2) [MIM:603965]	A0A2Y9IKE5	109	G	S
Q9Y210	LP/P	Focal segmental glomerulosclerosis 2 (FSGS2) [MIM:603965]	A0A2Y9IKE5	175	R	Q
Q9Y210	LP/P	Focal segmental glomerulosclerosis 2 (FSGS2) [MIM:603965]	A0A2Y9IKE5	757	G	D
Q7Z4N2	LB/B	-	G1U1T5	32	S	N
Q7Z4N2	LB/B	-	G1U1T5	605	V	M
Q7Z4N2	LB/B	-	G1U1T5	1229	N	T
Q7Z4N2	LB/B	-	G1U1T5	1305	R	H
Q7Z4N2	LB/B	-	G1U1T5	1395	V	I
Q7Z4N2	LB/B	-	G1U1T5	1422	R	G
Q7Z4N2	LB/B	-	G1U1T5	1498	H	Q
Q7Z4N2	LB/B	-	G1U1T5	6	R	W
Q7Z4N2	LP/P	Night blindness, congenital stationary, 1C (CSNB1C) [MIM:613216]	G1U1T5	56	Y	C
Q7Z4N2	LP/P	Night blindness, congenital stationary, 1C (CSNB1C) [MIM:613216]	G1U1T5	72	Y	C
Q7Z4N2	LP/P	Night blindness, congenital stationary, 1C (CSNB1C) [MIM:613216]	G1U1T5	74	R	C
Q7Z4N2	LP/P	Night blindness, congenital stationary, 1C (CSNB1C) [MIM:613216]	G1U1T5	99	L	P
Q7Z4N2	LP/P	Night blindness, congenital stationary, 1C (CSNB1C) [MIM:613216]	G1U1T5	364	L	R
Q7Z4N2	LB/B	-	G1U1T5	399	P	T
Q7Z4N2	LP/P	Night blindness, congenital stationary, 1C (CSNB1C) [MIM:613216]	G1U1T5	473	R	P
Q7Z4N2	LP/P	Night blindness, congenital stationary, 1C (CSNB1C) [MIM:613216]	G1U1T5	534	G	R
Q7Z4N2	LP/P	Night blindness, congenital stationary, 1C (CSNB1C) [MIM:613216]	G1U1T5	541	M	K
Q7Z4N2	LP/P	Night blindness, congenital stationary, 1C (CSNB1C) [MIM:613216]	G1U1T5	611	P	H
Q7Z4N2	LP/P	Night blindness, congenital stationary, 1C (CSNB1C) [MIM:613216]	G1U1T5	721	R	Q
Q7Z4N2	LP/P	Night blindness, congenital stationary, 1C (CSNB1C) [MIM:613216]	G1U1T5	883	E	G
Q7Z4N2	LP/P	Night blindness, congenital stationary, 1C (CSNB1C) [MIM:613216]	G1U1T5	1002	I	F
Q7Z4N2	LB/B	-	G1U1T5	1161	Q	H
Q7Z4N2	LB/B	-	G1U1T5	1379	P	T
Q7Z4N2	LB/B	-	G1U1T5	1422	R	W
O94759	LB/B	-	A0A091P3B6	543	D	E
O94759	LB/B	-	A0A091P3B6	52	N	K
O94759	LB/B	-	A0A091P3B6	166	V	I
O94759	LB/B	-	A0A091P3B6	385	V	M
O94759	LB/B	-	A0A091P3B6	780	D	E
O94759	LB/B	-	A0A091P3B6	1189	Q	R
O94759	LB/B	-	A0A091P3B6	1199	R	W
O94759	LB/B	-	A0A091P3B6	1201	S	G
O94759	LB/B	-	A0A091P3B6	1249	N	S
O94759	LB/B	-	A0A091P3B6	1347	T	M
O94759	LB/B	-	A0A091P3B6	1359	E	K
O94759	LB/B	-	A0A091P3B6	1368	I	M
O94759	LB/B	-	A0A091P3B6	1438	A	S
Q9HCF6	LB/B	-	A0A1W5AR71	1695	R	Q
Q9HCF6	LB/B	-	A0A1W5AR71	1653	T	I
Q9HCF6	LB/B	-	A0A1W5AR71	1732	N	T
Q9HCF6	LB/B	-	A0A1W5AR71	1717	R	K
Q8TD43	LP/P	Progressive familial heart block 1B (PFHB1B) [MIM:604559]	A0A091P3B6	7	E	K
Q8TD43	LB/B	-	A0A091P3B6	101	A	T
Q8TD43	LB/B	-	A0A091P3B6	103	Y	C
Q8TD43	LP/P	Progressive familial heart block 1B (PFHB1B) [MIM:604559]	A0A091P3B6	131	Q	H
Q8TD43	LP/P	Progressive familial heart block 1B (PFHB1B) [MIM:604559]	A0A091P3B6	164	R	W
Q8TD43	LB/B	-	A0A091P3B6	252	R	H
Q8TD43	LP/P	Progressive familial heart block 1B (PFHB1B) [MIM:604559]	A0A091P3B6	293	Q	R
Q8TD43	LP/P	Progressive familial heart block 1B (PFHB1B) [MIM:604559]	A0A091P3B6	432	A	T
Q8TD43	LB/B	-	A0A091P3B6	561	D	A
Q8TD43	LP/P	Progressive familial heart block 1B (PFHB1B) [MIM:604559]	A0A091P3B6	582	G	S
Q8TD43	LP/P	Progressive familial heart block 1B (PFHB1B) [MIM:604559]	A0A091P3B6	790	Y	H
Q8TD43	LP/P	Progressive familial heart block 1B (PFHB1B) [MIM:604559]	A0A091P3B6	844	G	D
Q8TD43	LB/B	-	A0A091P3B6	854	Q	R
Q8TD43	LP/P	Progressive familial heart block 1B (PFHB1B) [MIM:604559]	A0A091P3B6	914	K	R
Q8TD43	LP/P	Progressive familial heart block 1B (PFHB1B) [MIM:604559]	A0A091P3B6	970	P	S
Q8TD43	LB/B	-	A0A091P3B6	1204	P	L
Q8TD43	LP/P	Erythrokeratodermia variabilis et progressiva 6 (EKVP6) [MIM:618531]	A0A091P3B6	1033	I	M
Q8TD43	LP/P	Erythrokeratodermia variabilis et progressiva 6 (EKVP6) [MIM:618531]	A0A091P3B6	1040	I	T
Q9NZQ8	LB/B	-	A0A2K6MRI5	254	V	A
Q9NZQ8	LB/B	-	A0A2K6MRI5	235	N	S
Q9NZQ8	LB/B	-	A0A2K6MRI5	335	V	L
Q9NZQ8	LB/B	-	A0A2K6MRI5	456	A	T
Q9NZQ8	LB/B	-	A0A2K6MRI5	578	R	Q
Q9BX84	LP/P	Hypomagnesemia 1 (HOMG1) [MIM:602014]	M7BQL9	141	S	L
Q9BX84	LB/B	-	M7BQL9	1071	N	D
Q9BX84	LB/B	-	M7BQL9	1393	V	I
Q9BX84	LB/B	-	M7BQL9	1584	K	E
Q9BX84	LB/B	-	M7BQL9	338	M	I
Q9BX84	LB/B	-	M7BQL9	1243	H	R
Q9BX84	LB/B	-	M7BQL9	1274	Q	R
Q9BX84	LB/B	-	M7BQL9	1663	Q	R
Q9BX84	LB/B	-	M7BQL9	1673	L	S
Q9BX84	LB/B	-	M7BQL9	1724	T	I
Q9BX84	LB/B	-	M7BQL9	948	F	L
Q9BX84	LP/P	Hypomagnesemia 1 (HOMG1) [MIM:602014]	M7BQL9	708	L	P
Q9BX84	LP/P	Hypomagnesemia 1 (HOMG1) [MIM:602014]	M7BQL9	872	E	G
Q9BX84	LP/P	Hypomagnesemia 1 (HOMG1) [MIM:602014]	M7BQL9	1053	Y	C
Q9BX84	LP/P	Hypomagnesemia 1 (HOMG1) [MIM:602014]	M7BQL9	1143	L	P
Q9BX84	LP/P	Hypomagnesemia 1 (HOMG1) [MIM:602014]	M7BQL9	1754	S	N
Q96QT4	LB/B	-	M7BQL9	1482	T	I
Q96QT4	LB/B	-	M7BQL9	68	G	V
Q96QT4	LB/B	-	M7BQL9	459	I	T
Q96QT4	LB/B	-	M7BQL9	574	K	N
Q96QT4	LB/B	-	M7BQL9	949	F	Y
Q96QT4	LB/B	-	M7BQL9	1064	Q	R
Q96QT4	LB/B	-	M7BQL9	1211	I	T
Q96QT4	LB/B	-	M7BQL9	1254	A	V
Q96QT4	LB/B	-	M7BQL9	1306	D	E
Q96QT4	LB/B	-	M7BQL9	1444	R	K
Q96QT4	LB/B	-	M7BQL9	1033	A	G
Q96QT4	LB/B	-	M7BQL9	1145	I	V
Q96QT4	LP/P	-	M7BQL9	1046	G	D
Q7Z2W7	LB/B	-	A0A091P3B6	247	R	T
Q7Z2W7	LB/B	-	A0A091P3B6	251	Y	C
Q7Z2W7	LB/B	-	A0A091P3B6	462	M	T
Q7Z2W7	LB/B	-	A0A091P3B6	732	T	I
Q7Z2W7	LB/B	-	A0A091P3B6	821	N	S
Q7Z2W7	LB/B	-	A0A091P3B6	419	S	N
Q8NER1	LB/B	-	A0A2P4T7R6	585	I	V
Q8NER1	LB/B	-	A0A2P4T7R6	91	P	S
Q8NER1	LB/B	-	A0A2P4T7R6	469	T	I
Q8NER1	LB/B	-	A0A2P4T7R6	505	T	A
Q8NER1	LB/B	-	A0A2P4T7R6	315	M	I
Q9Y5S1	LB/B	-	A0A146Y2C4	17	G	A
Q9Y5S1	LB/B	-	A0A146Y2C4	764	N	S
Q9HBA0	LB/B	-	A0A093SKZ0	19	P	S
Q9HBA0	LP/P	Brachyolmia 3 (BCYM3) [MIM:113500]	A0A093SKZ0	616	R	Q
Q9HBA0	LP/P	Brachyolmia 3 (BCYM3) [MIM:113500]	A0A093SKZ0	620	V	I
Q9HBA0	LP/P	Metatropic dysplasia (MTD) [MIM:156530]	A0A093SKZ0	331	I	F
Q9HBA0	LP/P	Spondylometaphyseal dysplasia Kozlowski type (SMDK) [MIM:184252]	A0A093SKZ0	333	D	G
Q9HBA0	LP/P	Parastremmatic dwarfism (PSTD) [MIM:168400]	A0A093SKZ0	594	R	H
Q9HBA0	LP/P	Spondylometaphyseal dysplasia Kozlowski type (SMDK) [MIM:184252]	A0A093SKZ0	594	R	H
Q9HBA0	LP/P	Spondylometaphyseal dysplasia Kozlowski type (SMDK) [MIM:184252]	A0A093SKZ0	716	A	S
Q9HBA0	LP/P	Metatropic dysplasia (MTD) [MIM:156530]	A0A093SKZ0	799	P	L
Q9HBA0	LP/P	Charcot-Marie-Tooth disease, axonal, 2C (CMT2C) [MIM:606071]	A0A093SKZ0	269	R	C
Q9HBA0	LP/P	Charcot-Marie-Tooth disease, axonal, 2C (CMT2C) [MIM:606071]	A0A093SKZ0	269	R	H
Q9HBA0	LP/P	Neuronopathy, distal hereditary motor, 8 (HMN8) [MIM:600175]	A0A093SKZ0	269	R	H
Q9HBA0	LP/P	Charcot-Marie-Tooth disease, axonal, 2C (CMT2C) [MIM:606071]	A0A093SKZ0	316	R	C
Q9HBA0	LP/P	Scapuloperoneal spinal muscular atrophy (SPSMA) [MIM:181405]	A0A093SKZ0	316	R	C
Q9HBA0	LP/P	Charcot-Marie-Tooth disease, axonal, 2C (CMT2C) [MIM:606071]	A0A093SKZ0	315	R	W
Q9HBA0	LP/P	Metatropic dysplasia (MTD) [MIM:156530]	A0A093SKZ0	89	T	I
Q9HBA0	LB/B	-	A0A093SKZ0	183	E	K
Q9HBA0	LP/P	Metatropic dysplasia (MTD) [MIM:156530]	A0A093SKZ0	197	K	R
Q9HBA0	LP/P	Metatropic dysplasia (MTD) [MIM:156530]	A0A093SKZ0	199	L	F
Q9HBA0	LP/P	Spondylometaphyseal dysplasia Kozlowski type (SMDK) [MIM:184252]	A0A093SKZ0	278	E	K
Q9HBA0	LP/P	Metatropic dysplasia (MTD) [MIM:156530]	A0A093SKZ0	295	T	A
Q9HBA0	LP/P	Metatropic dysplasia (MTD) [MIM:156530]	A0A093SKZ0	331	I	T
Q9HBA0	LP/P	Metatropic dysplasia (MTD) [MIM:156530]	A0A093SKZ0	342	V	F
Q9HBA0	LP/P	Metatropic dysplasia (MTD) [MIM:156530]	A0A093SKZ0	592	F	L
Q9HBA0	LP/P	Spondylometaphyseal dysplasia Kozlowski type (SMDK) [MIM:184252]	A0A093SKZ0	596	L	P
Q9HBA0	LP/P	Spondylometaphyseal dysplasia Kozlowski type (SMDK) [MIM:184252]	A0A093SKZ0	600	G	W
Q9HBA0	LB/B	-	A0A093SKZ0	602	Y	C
Q9HBA0	LP/P	Metatropic dysplasia (MTD) [MIM:156530]	A0A093SKZ0	604	I	M
Q9HBA0	LP/P	Metatropic dysplasia (MTD) [MIM:156530]	A0A093SKZ0	617	F	L
Q9HBA0	LP/P	Metatropic dysplasia (MTD) [MIM:156530]	A0A093SKZ0	618	L	P
Q9HBA0	LP/P	Spondylometaphyseal dysplasia Kozlowski type (SMDK) [MIM:184252]	A0A093SKZ0	625	M	I
Q9HBA0	LP/P	Spondylometaphyseal dysplasia Kozlowski type (SMDK) [MIM:184252]	A0A093SKZ0	709	L	M
Q9HBA0	LP/P	Metatropic dysplasia (MTD) [MIM:156530]	A0A093SKZ0	775	R	K
Q9HBA0	LP/P	Spondylometaphyseal dysplasia Kozlowski type (SMDK) [MIM:184252]	A0A093SKZ0	777	C	Y
Q9HBA0	LP/P	Metatropic dysplasia (MTD) [MIM:156530]	A0A093SKZ0	797	E	K
Q9HBA0	LP/P	Spondylometaphyseal dysplasia Kozlowski type (SMDK) [MIM:184252]	A0A093SKZ0	797	E	K
Q9HBA0	LP/P	Metatropic dysplasia (MTD) [MIM:156530]	A0A093SKZ0	799	P	A
Q9HBA0	LP/P	Metatropic dysplasia (MTD) [MIM:156530]	A0A093SKZ0	799	P	R
Q9HBA0	LP/P	Metatropic dysplasia (MTD) [MIM:156530]	A0A093SKZ0	799	P	S
Q9HBA0	LP/P	Neuronopathy, distal hereditary motor, 8 (HMN8) [MIM:600175]	A0A093SKZ0	97	P	R
Q9HBA0	LP/P	Charcot-Marie-Tooth disease, axonal, 2C (CMT2C) [MIM:606071]	A0A093SKZ0	232	R	C
Q9HBA0	LP/P	Neuronopathy, distal hereditary motor, 8 (HMN8) [MIM:600175]	A0A093SKZ0	232	R	C
Q9HBA0	LP/P	Charcot-Marie-Tooth disease, axonal, 2C (CMT2C) [MIM:606071]	A0A093SKZ0	316	R	H
Q9HBA0	LP/P	Charcot-Marie-Tooth disease, axonal, 2C (CMT2C) [MIM:606071]	A0A093SKZ0	542	S	Y
Q9HBA0	LP/P	Digital arthropathy-brachydactyly, familial (FDAB) [MIM:606835]	A0A093SKZ0	270	G	V
Q9HBA0	LP/P	Digital arthropathy-brachydactyly, familial (FDAB) [MIM:606835]	A0A093SKZ0	271	R	P
Q9HBA0	LP/P	Digital arthropathy-brachydactyly, familial (FDAB) [MIM:606835]	A0A093SKZ0	273	F	L
Q9Y4A5	LB/B	-	E2BLG5	878	R	L
Q9Y4A5	LB/B	-	E2BLG5	1070	S	G
Q9Y4A5	LB/B	-	E2BLG5	1925	A	V
Q9Y4A5	LB/B	-	E2BLG5	2139	W	G
Q9Y4A5	LB/B	-	E2BLG5	2433	S	G
Q9Y4A5	LB/B	-	E2BLG5	2750	E	D
Q9Y4A5	LB/B	-	E2BLG5	2801	K	E
Q9Y4A5	LB/B	-	E2BLG5	722	S	F
Q9Y4A5	LP/P	Developmental delay with or without dysmorphic facies and autism (DEDDFA) [MIM:618454]	E2BLG5	1031	I	M
Q9Y4A5	LP/P	Developmental delay with or without dysmorphic facies and autism (DEDDFA) [MIM:618454]	E2BLG5	1043	A	T
Q9Y4A5	LP/P	Developmental delay with or without dysmorphic facies and autism (DEDDFA) [MIM:618454]	E2BLG5	1104	E	G
Q9Y4A5	LP/P	Developmental delay with or without dysmorphic facies and autism (DEDDFA) [MIM:618454]	E2BLG5	1106	E	K
Q9Y4A5	LP/P	Developmental delay with or without dysmorphic facies and autism (DEDDFA) [MIM:618454]	E2BLG5	1159	G	R
Q9Y4A5	LP/P	Developmental delay with or without dysmorphic facies and autism (DEDDFA) [MIM:618454]	E2BLG5	1859	R	C
Q9Y4A5	LP/P	Developmental delay with or without dysmorphic facies and autism (DEDDFA) [MIM:618454]	E2BLG5	1866	W	R
Q9Y4A5	LP/P	Developmental delay with or without dysmorphic facies and autism (DEDDFA) [MIM:618454]	E2BLG5	1883	G	R
Q8WWH5	LB/B	-	G1PXG1	167	R	K
Q8WWH5	LB/B	-	G1PXG1	103	E	A
Q5SRN2	LB/B	-	A0A2K6KPD7	30	C	R
Q5SRN2	LB/B	-	A0A2K6KPD7	36	Y	H
Q5SRN2	LB/B	-	A0A2K6KPD7	69	Y	C
Q5SRN2	LB/B	-	A0A2K6KPD7	128	P	L
Q5SRN2	LB/B	-	A0A2K6KPD7	150	I	F
Q5SRN2	LB/B	-	A0A2K6KPD7	170	S	P
Q5SRN2	LB/B	-	A0A2K6KPD7	227	S	P
Q5SRN2	LB/B	-	A0A2K6KPD7	315	I	V
Q5SRN2	LB/B	-	A0A2K6KPD7	400	K	Q
Q5SRN2	LB/B	-	A0A2K6KPD7	161	P	L
Q5SRN2	LB/B	-	A0A2K6KPD7	266	L	W
Q5SRN2	LB/B	-	A0A2K6KPD7	274	P	S
Q5SRN2	LB/B	-	A0A2K6KPD7	433	A	T
Q5SRN2	LB/B	-	A0A2K6KPD7	479	G	V
Q92574	LB/B	-	A0A1U7SDG4	190	R	S
Q92574	LP/P	Tuberous sclerosis 1 (TSC1) [MIM:191100]	A0A1U7SDG4	191	L	H
Q92574	LP/P	Tuberous sclerosis 1 (TSC1) [MIM:191100]	A0A1U7SDG4	224	M	R
Q92574	LB/B	-	A0A1U7SDG4	322	M	T
Q92574	LB/B	-	A0A1U7SDG4	577	E	D
Q92574	LB/B	-	A0A1U7SDG4	587	K	R
Q92574	LP/P	Tuberous sclerosis 1 (TSC1) [MIM:191100]	A0A1U7SDG4	654	Q	E
Q92574	LP/P	Tuberous sclerosis 1 (TSC1) [MIM:191100]	A0A1U7SDG4	726	A	E
Q92574	LB/B	-	A0A1U7SDG4	732	H	Y
Q92574	LB/B	-	A0A1U7SDG4	809	E	Q
Q92574	LB/B	-	A0A1U7SDG4	829	S	R
Q92574	LP/P	Tuberous sclerosis 1 (TSC1) [MIM:191100]	A0A1U7SDG4	899	T	S
Q92574	LB/B	-	A0A1U7SDG4	1035	G	S
Q92574	LB/B	-	A0A1U7SDG4	1108	G	S
Q92574	LP/P	Tuberous sclerosis 1 (TSC1) [MIM:191100]	A0A1U7SDG4	72	L	P
Q92574	LP/P	Tuberous sclerosis 1 (TSC1) [MIM:191100]	A0A1U7SDG4	500	R	Q
Q92574	LP/P	Tuberous sclerosis 1 (TSC1) [MIM:191100]	A0A1U7SDG4	117	L	P
Q92574	LP/P	Tuberous sclerosis 1 (TSC1) [MIM:191100]	A0A1U7SDG4	180	L	P
Q92574	LB/B	-	A0A1U7SDG4	204	R	P
Q92574	LB/B	-	A0A1U7SDG4	448	P	S
Q92574	LB/B	-	A0A1U7SDG4	509	R	Q
Q92574	LB/B	-	A0A1U7SDG4	567	A	V
Q92574	LB/B	-	A0A1U7SDG4	1097	R	H
Q92574	LP/P	Focal cortical dysplasia 2 (FCORD2) [MIM:607341]	A0A1U7SDG4	22	R	W
Q92574	LP/P	Focal cortical dysplasia 2 (FCORD2) [MIM:607341]	A0A1U7SDG4	204	R	C
P49815	LP/P	Tuberous sclerosis 2 (TSC2) [MIM:613254]	E0VSQ1	292	L	P
P49815	LP/P	Tuberous sclerosis 2 (TSC2) [MIM:613254]	E0VSQ1	407	Y	D
P49815	LP/P	Tuberous sclerosis 2 (TSC2) [MIM:613254]	E0VSQ1	449	M	I
P49815	LB/B	-	E0VSQ1	607	A	T
P49815	LP/P	Lymphangioleiomyomatosis (LAM) [MIM:606690]	E0VSQ1	611	R	Q
P49815	LP/P	Tuberous sclerosis 2 (TSC2) [MIM:613254]	E0VSQ1	611	R	Q
P49815	LP/P	Tuberous sclerosis 2 (TSC2) [MIM:613254]	E0VSQ1	611	R	W
P49815	LP/P	Tuberous sclerosis 2 (TSC2) [MIM:613254]	E0VSQ1	826	L	M
P49815	LP/P	Tuberous sclerosis 2 (TSC2) [MIM:613254]	E0VSQ1	905	R	Q
P49815	LP/P	Tuberous sclerosis 2 (TSC2) [MIM:613254]	E0VSQ1	905	R	W
P49815	LP/P	Tuberous sclerosis 2 (TSC2) [MIM:613254]	E0VSQ1	1084	D	E
P49815	LP/P	Tuberous sclerosis 2 (TSC2) [MIM:613254]	E0VSQ1	1200	R	W
P49815	LP/P	Tuberous sclerosis 2 (TSC2) [MIM:613254]	E0VSQ1	1227	P	L
P49815	LP/P	Tuberous sclerosis 2 (TSC2) [MIM:613254]	E0VSQ1	1240	R	W
P49815	LP/P	Tuberous sclerosis 2 (TSC2) [MIM:613254]	E0VSQ1	1295	D	V
P49815	LP/P	Tuberous sclerosis 2 (TSC2) [MIM:613254]	E0VSQ1	1549	Y	C
P49815	LP/P	Tuberous sclerosis 2 (TSC2) [MIM:613254]	E0VSQ1	1643	N	I
P49815	LP/P	Tuberous sclerosis 2 (TSC2) [MIM:613254]	E0VSQ1	1650	Y	C
P49815	LP/P	Tuberous sclerosis 2 (TSC2) [MIM:613254]	E0VSQ1	1690	D	Y
P49815	LP/P	Tuberous sclerosis 2 (TSC2) [MIM:613254]	E0VSQ1	1712	A	E
P49815	LP/P	Tuberous sclerosis 2 (TSC2) [MIM:613254]	E0VSQ1	1750	L	F
P49815	LB/B	-	E0VSQ1	94	P	T
P49815	LP/P	Tuberous sclerosis 2 (TSC2) [MIM:613254]	E0VSQ1	227	C	Y
P49815	LP/P	Tuberous sclerosis 2 (TSC2) [MIM:613254]	E0VSQ1	331	N	K
P49815	LP/P	Tuberous sclerosis 2 (TSC2) [MIM:613254]	E0VSQ1	486	N	I
P49815	LB/B	-	E0VSQ1	490	I	V
P49815	LB/B	-	E0VSQ1	536	A	V
P49815	LB/B	-	E0VSQ1	615	F	S
P49815	LP/P	Tuberous sclerosis 2 (TSC2) [MIM:613254]	E0VSQ1	816	P	L
P49815	LP/P	Tuberous sclerosis 2 (TSC2) [MIM:613254]	E0VSQ1	1144	V	M
P49815	LP/P	Tuberous sclerosis 2 (TSC2) [MIM:613254]	E0VSQ1	1315	P	S
P49815	LB/B	-	E0VSQ1	1329	R	H
P49815	LP/P	Tuberous sclerosis 2 (TSC2) [MIM:613254]	E0VSQ1	1709	P	L
P49815	LP/P	Tuberous sclerosis 2 (TSC2) [MIM:613254]	E0VSQ1	1743	R	Q
P49815	LP/P	Tuberous sclerosis 2 (TSC2) [MIM:613254]	E0VSQ1	1773	H	P
P49815	LP/P	Tuberous sclerosis 2 (TSC2) [MIM:613254]	E0VSQ1	1783	E	Q
P49815	LB/B	-	E0VSQ1	160	L	V
P49815	LP/P	Tuberous sclerosis 2 (TSC2) [MIM:613254]	E0VSQ1	258	K	N
P49815	LP/P	Tuberous sclerosis 2 (TSC2) [MIM:613254]	E0VSQ1	261	R	P
P49815	LB/B	-	E0VSQ1	261	R	W
P49815	LB/B	-	E0VSQ1	286	M	T
P49815	LB/B	-	E0VSQ1	286	M	V
P49815	LP/P	Tuberous sclerosis 2 (TSC2) [MIM:613254]	E0VSQ1	294	G	E
P49815	LB/B	-	E0VSQ1	309	L	Q
P49815	LB/B	-	E0VSQ1	320	L	F
P49815	LP/P	Tuberous sclerosis 2 (TSC2) [MIM:613254]	E0VSQ1	361	L	P
P49815	LB/B	-	E0VSQ1	367	R	Q
P49815	LB/B	-	E0VSQ1	378	P	L
P49815	LB/B	-	E0VSQ1	440	G	S
P49815	LB/B	-	E0VSQ1	463	I	V
P49815	LP/P	Tuberous sclerosis 2 (TSC2) [MIM:613254]	E0VSQ1	525	N	S
P49815	LB/B	-	E0VSQ1	583	A	T
P49815	LB/B	-	E0VSQ1	593	H	R
P49815	LP/P	Tuberous sclerosis 2 (TSC2) [MIM:613254]	E0VSQ1	599	K	M
P49815	LP/P	Tuberous sclerosis 2 (TSC2) [MIM:613254]	E0VSQ1	614	A	D
P49815	LP/P	Tuberous sclerosis 2 (TSC2) [MIM:613254]	E0VSQ1	696	C	Y
P49815	LP/P	Tuberous sclerosis 2 (TSC2) [MIM:613254]	E0VSQ1	717	L	R
P49815	LP/P	Tuberous sclerosis 2 (TSC2) [MIM:613254]	E0VSQ1	895	M	V
P49815	LB/B	-	E0VSQ1	1282	S	G
P49815	LP/P	Tuberous sclerosis 2 (TSC2) [MIM:613254]	E0VSQ1	1497	P	R
P49815	LP/P	Tuberous sclerosis 2 (TSC2) [MIM:613254]	E0VSQ1	1498	S	N
P49815	LP/P	Tuberous sclerosis 2 (TSC2) [MIM:613254]	E0VSQ1	1620	H	Y
P49815	LP/P	Tuberous sclerosis 2 (TSC2) [MIM:613254]	E0VSQ1	1643	N	K
P49815	LP/P	Tuberous sclerosis 2 (TSC2) [MIM:613254]	E0VSQ1	1651	N	S
P49815	LP/P	Tuberous sclerosis 2 (TSC2) [MIM:613254]	E0VSQ1	1675	P	L
P49815	LP/P	Tuberous sclerosis 2 (TSC2) [MIM:613254]	E0VSQ1	1681	N	K
P49815	LP/P	Tuberous sclerosis 2 (TSC2) [MIM:613254]	E0VSQ1	1704	S	T
P49815	LP/P	Tuberous sclerosis 2 (TSC2) [MIM:613254]	E0VSQ1	1743	R	P
P49815	LP/P	Tuberous sclerosis 2 (TSC2) [MIM:613254]	E0VSQ1	1744	L	P
P49815	LB/B	-	E0VSQ1	1787	G	S
P49815	LB/B	-	E0VSQ1	1791	G	S
P49815	LB/B	-	E0VSQ1	862	A	V
P49815	LB/B	-	E0VSQ1	1429	A	S
P49815	LB/B	-	E0VSQ1	1450	P	R
P49815	LP/P	Tuberous sclerosis 2 (TSC2) [MIM:613254]	E0VSQ1	1653	S	F
P49815	LP/P	Tuberous sclerosis 2 (TSC2) [MIM:613254]	E0VSQ1	1027	L	P
P49815	LB/B	-	E0VSQ1	1341	S	R
P49815	LB/B	-	E0VSQ1	1636	D	N
P49815	LB/B	-	E0VSQ1	1673	V	L
P49815	LB/B	-	E0VSQ1	1141	A	V
P49815	LB/B	-	E0VSQ1	1774	S	T
P49815	LB/B	-	E0VSQ1	619	L	F
P49815	LB/B	-	E0VSQ1	802	S	R
P49815	LP/P	Focal cortical dysplasia 2 (FCORD2) [MIM:607341]	E0VSQ1	1547	V	I
Q15714	LB/B	-	F1PJA5	652	P	S
Q8WW01	LB/B	-	A0A287CUY3	19	G	D
Q8WW01	LB/B	-	A0A287CUY3	59	Q	H
Q8WW01	LP/P	Pontocerebellar hypoplasia 2F (PCH2F) [MIM:617026]	A0A287CUY3	76	W	G
Q8WW01	LP/P	Pontocerebellar hypoplasia 2F (PCH2F) [MIM:617026]	A0A287CUY3	116	H	Y
Q8WW01	LP/P	Pontocerebellar hypoplasia 2F (PCH2F) [MIM:617026]	A0A287CUY3	152	Y	C
Q8NCE0	LB/B	-	A0A2U3VLH8	41	R	H
Q8NCE0	LB/B	-	A0A2U3VLH8	126	R	H
Q8NCE0	LP/P	Pontocerebellar hypoplasia 2B (PCH2B) [MIM:612389]	A0A2U3VLH8	309	Y	C
Q9BSV6	LP/P	Pontocerebellar hypoplasia 2C (PCH2C) [MIM:612390]	A0A1A8J4U6	58	R	W
Q9BSV6	LB/B	-	A0A1A8J4U6	112	L	V
Q7Z6J9	LB/B	-	F6ST55	4	E	D
Q7Z6J9	LB/B	-	F6ST55	38	H	Q
Q7Z6J9	LB/B	-	F6ST55	347	K	N
Q7Z6J9	LB/B	-	F6ST55	437	A	V
Q7Z6J9	LP/P	Pontocerebellar hypoplasia 4 (PCH4) [MIM:225753]	F6ST55	93	S	P
Q7Z6J9	LP/P	Pontocerebellar hypoplasia 2A (PCH2A) [MIM:277470]	F6ST55	307	A	S
Q7Z6J9	LP/P	Pontocerebellar hypoplasia 4 (PCH4) [MIM:225753]	F6ST55	307	A	S
Q7Z6J9	LB/B	-	F6ST55	137	I	L
Q7Z6J9	LB/B	-	F6ST55	525	G	R
Q7Z6J9	LP/P	Pontocerebellar hypoplasia 2A (PCH2A) [MIM:277470]	F6ST55	119	Y	D
P43897	LP/P	Combined oxidative phosphorylation deficiency 3 (COXPD3) [MIM:610505]	A0A287AVW2	312	R	W
P43897	LP/P	Combined oxidative phosphorylation deficiency 3 (COXPD3) [MIM:610505]	A0A287AVW2	240	C	S
Q3SY00	LB/B	-	A0A091DBD3	210	A	V
Q3SY00	LB/B	-	A0A091DBD3	237	R	S
Q3SY00	LB/B	-	A0A091DBD3	292	S	N
Q3SY00	LB/B	-	A0A091DBD3	305	R	P
Q3SY00	LB/B	-	A0A091DBD3	521	M	V
Q6ZSZ6	LB/B	-	H9GVM3	666	L	P
Q9NRE2	LB/B	-	H9GVM3	113	R	S
Q9NRE2	LB/B	-	H9GVM3	681	A	T
Q63HK5	LB/B	-	H9GVM3	687	P	L
Q63HK5	LB/B	-	H9GVM3	469	E	G
Q9UJT2	LB/B	-	I3ME59	167	E	K
Q9UJT2	LB/B	-	I3ME59	382	D	G
Q8WUA8	LB/B	-	A0A2K6PHE1	344	D	E
Q8WUA8	LB/B	-	A0A2K6PHE1	208	R	C
Q8WUA8	LB/B	-	A0A2K6PHE1	248	S	N
Q8WUA8	LB/B	-	A0A2K6PHE1	308	V	I
Q96NA8	LB/B	-	H0WTV4	55	R	P
Q96NA8	LB/B	-	H0WTV4	118	T	A
Q96NA8	LB/B	-	H0WTV4	268	V	I
Q96NA8	LB/B	-	H0WTV4	18	F	L
Q9H1Z9	LB/B	-	S9XPQ6	187	R	H
Q9H1Z9	LB/B	-	S9XPQ6	218	Y	H
A1L157	LB/B	-	L5JTD4	190	V	A
O95859	LB/B	-	V8P0W0	57	L	S
O95859	LP/P	Vitreoretinopathy, exudative 5 (EVR5) [MIM:613310]	V8P0W0	101	L	H
O95859	LP/P	Vitreoretinopathy, exudative 5 (EVR5) [MIM:613310]	V8P0W0	188	G	R
O95859	LP/P	Vitreoretinopathy, exudative 5 (EVR5) [MIM:613310]	V8P0W0	210	M	R
O95859	LP/P	Vitreoretinopathy, exudative 5 (EVR5) [MIM:613310]	V8P0W0	237	A	P
O95859	LP/P	Vitreoretinopathy, exudative 5 (EVR5) [MIM:613310]	V8P0W0	49	T	M
O95859	LP/P	Vitreoretinopathy, exudative 5 (EVR5) [MIM:613310]	V8P0W0	138	Y	C
O95859	LP/P	Vitreoretinopathy, exudative 5 (EVR5) [MIM:613310]	V8P0W0	223	L	P
Q9UKR8	LB/B	-	A0A2Y9DPN7	53	Y	D
Q9UKR8	LB/B	-	A0A2Y9DPN7	55	L	P
Q9UKR8	LB/B	-	A0A2Y9DPN7	233	S	C
Q96SJ8	LB/B	-	A0A147A3D7	133	V	I
O60636	LB/B	-	H2UQZ6	118	R	L
B1AH88	LB/B	-	B1AH88	53	H	R
P30536	LB/B	-	A0A067TXB7	147	T	A
P30536	LB/B	-	A0A067TXB7	162	R	H
P30536	LB/B	-	A0A067TXB7	169	E	Q
O95153	LB/B	-	V8PCA3	514	Q	R
O95153	LB/B	-	V8PCA3	586	A	T
O95153	LB/B	-	V8PCA3	1118	H	L
O95153	LB/B	-	V8PCA3	1140	A	P
O95153	LB/B	-	V8PCA3	1253	R	C
O95153	LB/B	-	V8PCA3	1830	G	E
O95153	LB/B	-	V8PCA3	817	Q	R
O95153	LB/B	-	V8PCA3	851	W	R
O95153	LB/B	-	V8PCA3	1728	H	R
O95153	LB/B	-	V8PCA3	652	G	R
Q01534	LB/B	-	A0A1D5QBQ8	195	P	R
Q01534	LB/B	-	A0A1D5QBQ8	216	I	F
Q9H489	LB/B	-	A0A1S3EQ95	246	P	H
Q9H0U9	LB/B	-	A0A2K6LC87	62	P	S
Q9H0U9	LB/B	-	A0A2K6LC87	74	A	P
Q9H0U9	LB/B	-	A0A2K6LC87	181	A	T
Q9UJ04	LB/B	-	A0A2K6LC87	30	R	L
Q86VY4	LB/B	-	G5B8X8	120	T	S
Q86VY4	LB/B	-	G5B8X8	365	I	V
Q8N831	LB/B	-	H0XWM8	60	A	V
Q8N831	LB/B	-	H0XWM8	109	G	S
Q8N831	LB/B	-	H0XWM8	116	P	L
Q8N831	LB/B	-	H0XWM8	246	R	C
Q2NL82	LB/B	-	A7SGF5	386	S	G
Q2NL82	LB/B	-	A7SGF5	719	N	S
Q2NL82	LB/B	-	A7SGF5	727	K	Q
Q2NL82	LB/B	-	A7SGF5	750	H	Q
Q9Y5U2	LB/B	-	A0A091EBY2	17	H	P
Q9Y5U2	LB/B	-	A0A091EBY2	230	R	S
Q9Y5U2	LB/B	-	A0A091EBY2	262	G	R
Q9Y5U2	LB/B	-	A0A091EBY2	124	R	Q
Q9Y5U2	LB/B	-	A0A091EBY2	274	H	P
Q9BXA7	LB/B	-	A0A1S2ZKR1	50	A	T
Q9BXA7	LB/B	-	A0A1S2ZKR1	83	H	Y
Q9BXA7	LB/B	-	A0A1S2ZKR1	233	V	L
Q9BXA7	LB/B	-	A0A1S2ZKR1	237	R	C
Q9BXA7	LB/B	-	A0A1S2ZKR1	288	G	W
Q9BXA7	LB/B	-	A0A1S2ZKR1	293	G	E
Q96PN8	LB/B	-	H3B9R4	140	A	T
Q96PN8	LB/B	-	H3B9R4	235	S	L
Q96PN8	LB/B	-	H3B9R4	71	I	V
Q6SA08	LB/B	-	D6WSN9	33	H	Y
Q6SA08	LB/B	-	D6WSN9	89	Y	C
Q6SA08	LB/B	-	D6WSN9	145	V	M
Q6SA08	LB/B	-	D6WSN9	196	Q	R
Q6SA08	LB/B	-	D6WSN9	327	T	M
Q16762	LB/B	-	A0A2K6JUR9	102	E	D
Q16762	LB/B	-	A0A2K6JUR9	228	E	G
Q5T7W7	LB/B	-	G7PRW2	83	R	Q
Q5T7W7	LB/B	-	G7PRW2	109	A	D
Q5TCY1	LB/B	-	A0A1S3PFL5	613	P	L
Q5TCY1	LB/B	-	A0A1S3PFL5	623	G	A
Q5TCY1	LB/B	-	A0A1S3PFL5	649	P	R
Q5TCY1	LB/B	-	A0A1S3PFL5	741	D	E
Q5TCY1	LB/B	-	A0A1S3PFL5	744	E	D
Q5TCY1	LB/B	-	A0A1S3PFL5	1145	K	R
Q5TCY1	LB/B	-	A0A1S3PFL5	1184	L	S
Q6IQ55	LB/B	-	S7MKK1	8	L	P
Q6IQ55	LB/B	-	S7MKK1	120	R	Q
Q6IQ55	LB/B	-	S7MKK1	313	T	A
Q6IQ55	LB/B	-	S7MKK1	440	V	M
Q6IQ55	LB/B	-	S7MKK1	500	R	P
Q6IQ55	LB/B	-	S7MKK1	1062	T	I
Q6IQ55	LB/B	-	S7MKK1	1084	T	M
Q6IQ55	LB/B	-	S7MKK1	1097	V	A
Q6IQ55	LB/B	-	S7MKK1	1122	P	R
Q6IQ55	LB/B	-	S7MKK1	1241	K	T
Q6IQ55	LB/B	-	S7MKK1	367	K	I
Q6IQ55	LB/B	-	S7MKK1	724	G	E
Q9H892	LB/B	-	A0A2K6TZJ1	73	M	L
Q9H892	LB/B	-	A0A2K6TZJ1	468	M	L
Q9H892	LB/B	-	A0A2K6TZJ1	563	V	A
Q9H892	LP/P	Ciliary dyskinesia, primary, 45 (CILD45) [MIM:618801]	A0A2K6TZJ1	567	M	R
Q96AE7	LB/B	-	C3Y677	145	I	L
Q96AE7	LB/B	-	C3Y677	270	N	H
Q8NDW8	LB/B	-	K7FZF7	91	R	Q
Q8NDW8	LB/B	-	K7FZF7	108	V	L
Q8NDW8	LB/B	-	K7FZF7	290	R	K
Q8NDW8	LB/B	-	K7FZF7	293	E	K
Q8NDW8	LB/B	-	K7FZF7	622	R	W
Q8NDW8	LB/B	-	K7FZF7	719	R	Q
Q8NDW8	LB/B	-	K7FZF7	1055	R	L
Q8NDW8	LB/B	-	K7FZF7	1160	S	R
Q8NDW8	LB/B	-	K7FZF7	1316	R	K
Q8NDW8	LB/B	-	K7FZF7	719	R	H
Q8NDW8	LP/P	Spermatogenic failure 37 (SPGF37) [MIM:618429]	K7FZF7	114	Y	C
Q7Z4L5	LB/B	-	K7FZF7	201	V	M
Q7Z4L5	LB/B	-	K7FZF7	276	T	A
Q7Z4L5	LB/B	-	K7FZF7	463	P	S
Q7Z4L5	LB/B	-	K7FZF7	473	L	F
Q7Z4L5	LB/B	-	K7FZF7	846	K	R
Q7Z4L5	LB/B	-	K7FZF7	66	K	R
Q7Z4L5	LP/P	Nephronophthisis 12 (NPHP12) [MIM:613820]	K7FZF7	150	W	R
Q7Z4L5	LP/P	Nephronophthisis 12 (NPHP12) [MIM:613820]	K7FZF7	209	P	L
Q7Z4L5	LP/P	Nephronophthisis 12 (NPHP12) [MIM:613820]	K7FZF7	231	T	S
Q7Z4L5	LP/P	Short-rib thoracic dysplasia 4 with or without polydactyly (SRTD4) [MIM:613819]	K7FZF7	231	T	S
Q7Z4L5	LB/B	-	K7FZF7	242	D	N
Q7Z4L5	LB/B	-	K7FZF7	255	Y	C
Q7Z4L5	LB/B	-	K7FZF7	411	R	G
Q7Z4L5	LB/B	-	K7FZF7	412	Q	R
Q7Z4L5	LB/B	-	K7FZF7	424	D	E
Q7Z4L5	LP/P	Joubert syndrome 11 (JBTS11) [MIM:613820]	K7FZF7	591	S	N
Q7Z4L5	LB/B	-	K7FZF7	616	R	C
Q7Z4L5	LB/B	-	K7FZF7	624	I	V
Q7Z4L5	LB/B	-	K7FZF7	645	H	R
Q7Z4L5	LB/B	-	K7FZF7	724	S	T
Q7Z4L5	LP/P	Short-rib thoracic dysplasia 4 with or without polydactyly (SRTD4) [MIM:613819]	K7FZF7	755	D	Y
Q7Z4L5	LP/P	Short-rib thoracic dysplasia 4 with or without polydactyly (SRTD4) [MIM:613819]	K7FZF7	795	L	P
Q7Z4L5	LP/P	Joubert syndrome 11 (JBTS11) [MIM:613820]	K7FZF7	867	R	C
Q7Z4L5	LB/B	-	K7FZF7	867	R	H
Q7Z4L5	LB/B	-	K7FZF7	939	R	Q
Q7Z4L5	LB/B	-	K7FZF7	939	R	W
Q7Z4L5	LB/B	-	K7FZF7	1011	M	V
Q7Z4L5	LB/B	-	K7FZF7	1035	Y	C
Q7Z4L5	LB/B	-	K7FZF7	1103	T	R
Q7Z4L5	LP/P	Nephronophthisis 12 (NPHP12) [MIM:613820]	K7FZF7	1167	Y	C
Q7Z4L5	LP/P	Joubert syndrome 11 (JBTS11) [MIM:613820]	K7FZF7	1186	M	V
Q7Z4L5	LB/B	-	K7FZF7	1208	I	S
Q7Z4L5	LB/B	-	K7FZF7	1284	D	H
Q7Z4L5	LB/B	-	K7FZF7	1311	R	G
Q7Z4L5	LP/P	Joubert syndrome 11 (JBTS11) [MIM:613820]	K7FZF7	1011	M	T
Q5TAA0	LB/B	-	A0A2U9C4L7	14	L	V
Q6PF05	LB/B	-	A0A2Y9T1X7	22	H	R
Q6PF05	LB/B	-	A0A2Y9T1X7	67	K	E
Q6PF05	LB/B	-	A0A2Y9T1X7	150	T	M
Q6PF05	LB/B	-	A0A2Y9T1X7	153	N	D
Q6PF05	LB/B	-	A0A2Y9T1X7	247	K	N
Q6PF05	LB/B	-	A0A2Y9T1X7	325	R	K
A0AVF1	LB/B	-	A0A1Y1HXI3	310	D	N
A0AVF1	LP/P	Biliary, renal, neurologic, and skeletal syndrome (BRENS) [MIM:619534]	A0A1Y1HXI3	263	N	S
Q8NA56	LB/B	-	A0A1U8D594	94	L	P
Q8NA56	LB/B	-	A0A1U8D594	140	H	Y
Q8NA56	LB/B	-	A0A1U8D594	276	A	T
P53804	LB/B	-	L9KYV3	840	M	T
P53804	LB/B	-	L9KYV3	1751	D	H
P53804	LB/B	-	L9KYV3	1154	P	S
P53804	LB/B	-	L9KYV3	1038	S	C
Q86WT1	LB/B	-	A0A2G8L1E2	577	K	R
Q86WT1	LB/B	-	A0A2G8L1E2	446	V	I
Q8N4P2	LB/B	-	A0A2G8L1E2	117	R	H
Q8N4P2	LB/B	-	A0A2G8L1E2	446	I	V
Q49AM3	LB/B	-	I3LXU5	28	A	V
Q49AM3	LB/B	-	I3LXU5	205	T	P
Q6PID6	LB/B	-	A0A091DF85	69	L	M
A6NLP5	LB/B	-	A0A1S3NVC8	78	I	M
Q5R3I4	LB/B	-	A0A2U4B610	243	F	L
Q5VTQ0	LB/B	-	A0A2Y9GG62	420	I	V
Q5VTQ0	LB/B	-	A0A2Y9GG62	128	T	P
O95801	LB/B	-	A0A1S3JGY2	47	S	T
Q86TZ1	LB/B	-	G1NYL4	140	T	I
Q86TZ1	LB/B	-	G1NYL4	87	I	S
Q86TZ1	LB/B	-	G1NYL4	98	A	T
Q86TZ1	LB/B	-	G1NYL4	376	T	S
Q9ULT0	LB/B	-	A0A1S3H7R7	538	V	L
Q9ULT0	LB/B	-	A0A1S3H7R7	545	V	I
Q9ULT0	LP/P	Gastrointestinal defects and immunodeficiency syndrome 1 (GIDID1) [MIM:243150]	A0A1S3H7R7	823	L	P
Q9ULT0	LP/P	Gastrointestinal defects and immunodeficiency syndrome 1 (GIDID1) [MIM:243150]	A0A1S3H7R7	71	E	K
Q9ULT0	LP/P	Gastrointestinal defects and immunodeficiency syndrome 1 (GIDID1) [MIM:243150]	A0A1S3H7R7	346	L	P
Q9ULT0	LP/P	Gastrointestinal defects and immunodeficiency syndrome 1 (GIDID1) [MIM:243150]	A0A1S3H7R7	399	L	P
Q9ULT0	LP/P	Gastrointestinal defects and immunodeficiency syndrome 1 (GIDID1) [MIM:243150]	A0A1S3H7R7	539	S	L
Q9ULT0	LP/P	Gastrointestinal defects and immunodeficiency syndrome 1 (GIDID1) [MIM:243150]	A0A1S3H7R7	551	A	D
Q9ULT0	LP/P	Gastrointestinal defects and immunodeficiency syndrome 1 (GIDID1) [MIM:243150]	A0A1S3H7R7	606	K	R
Q9ULT0	LP/P	Gastrointestinal defects and immunodeficiency syndrome 1 (GIDID1) [MIM:243150]	A0A1S3H7R7	672	S	P
Q9ULT0	LP/P	Gastrointestinal defects and immunodeficiency syndrome 1 (GIDID1) [MIM:243150]	A0A1S3H7R7	832	A	T
Q92623	LB/B	-	A0A2U3X2N6	103	P	A
Q9UNY4	LB/B	-	A0A2U4A1M9	167	K	E
Q9UNY4	LB/B	-	A0A2U4A1M9	213	K	R
Q9UNY4	LB/B	-	A0A2U4A1M9	256	E	G
Q9UNY4	LB/B	-	A0A2U4A1M9	1134	K	R
Q9UNY4	LB/B	-	A0A2U4A1M9	1155	D	H
O43156	LB/B	-	A0A1S3H4E5	671	A	V
O43156	LB/B	-	A0A1S3H4E5	979	A	T
O43156	LB/B	-	A0A1S3H4E5	450	R	H
O43156	LB/B	-	A0A1S3H4E5	1028	R	K
O43156	LB/B	-	A0A1S3H4E5	751	K	E
Q6NXR4	LB/B	-	M7BN88	63	E	G
Q6NXR4	LB/B	-	M7BN88	425	L	R
Q6NXR4	LP/P	Intellectual developmental disorder, autosomal recessive 39 (MRT39) [MIM:615541]	M7BN88	436	I	N
P33981	LB/B	-	Q98T92	97	A	V
P33981	LB/B	-	Q98T92	758	D	N
O95922	LB/B	-	A9VDM9	168	S	L
Q6ZVT0	LB/B	-	A0A2K5YYV5	249	V	A
Q6ZVT0	LB/B	-	A0A2K5YYV5	448	S	N
Q6ZVT0	LB/B	-	A0A2K5YYV5	578	G	D
Q14166	LB/B	-	F6PH47	84	R	W
Q14166	LB/B	-	F6PH47	95	N	S
Q14166	LB/B	-	F6PH47	297	V	M
Q14166	LB/B	-	F6PH47	464	V	M
A6NNM8	LB/B	-	H0V4X7	126	A	T
A6NNM8	LB/B	-	H0V4X7	262	T	I
Q9BWV7	LB/B	-	A0A0P7XZX5	3	G	R
Q9BWV7	LB/B	-	A0A0P7XZX5	127	T	A
Q9BWV7	LB/B	-	A0A0P7XZX5	202	L	P
Q9BWV7	LB/B	-	A0A0P7XZX5	425	R	G
Q9BWV7	LB/B	-	A0A0P7XZX5	445	G	S
Q9BWV7	LB/B	-	A0A0P7XZX5	529	Q	H
Q9BWV7	LB/B	-	A0A0P7XZX5	63	P	S
Q9BWV7	LB/B	-	A0A0P7XZX5	356	I	V
Q9BWV7	LB/B	-	A0A0P7XZX5	559	V	I
Q9BWV7	LB/B	-	A0A0P7XZX5	441	K	T
Q9Y4R7	LB/B	-	G5BX86	502	M	R
Q9Y4R7	LB/B	-	G5BX86	174	E	K
Q9Y4R7	LB/B	-	G5BX86	418	N	H
Q9Y4R7	LB/B	-	G5BX86	689	A	T
Q8N841	LB/B	-	G3SS89	664	E	D
A6PVC2	LB/B	-	A0A2Y9H227	191	R	H
A6PVC2	LB/B	-	A0A2Y9H227	294	E	K
A6PVC2	LB/B	-	A0A2Y9H227	127	L	W
Q3SXZ7	LB/B	-	A0A1U7S7K9	76	Y	C
Q5BVD1	LB/B	-	M3W4K1	111	I	V
Q5BVD1	LB/B	-	M3W4K1	144	G	S
Q5BVD1	LB/B	-	M3W4K1	66	L	P
Q9BTX7	LB/B	-	A0A1L8EL65	278	A	G
P02766	LB/B	-	A0A1S3F262	26	G	S
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	30	C	R
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	38	D	E
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	38	D	G
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	40	V	I
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	44	P	S
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	50	V	A
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	50	V	L
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	50	V	M
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	53	F	I
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	53	F	L
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	56	A	P
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	62	E	G
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	65	A	D
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	65	A	T
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	67	G	A
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	67	G	R
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	67	G	V
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	69	T	A
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	70	S	I
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	70	S	R
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	72	S	P
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	74	E	G
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	75	L	P
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	78	L	H
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	78	L	R
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	79	T	K
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	80	T	A
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	81	E	K
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	84	F	L
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	88	I	L
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	89	Y	H
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	90	K	N
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	91	V	A
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	93	I	V
P02766	LB/B	-	A0A1S3F262	94	D	H
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	97	S	Y
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	104	I	N
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	104	I	S
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	109	E	Q
P02766	LB/B	-	A0A1S3F262	110	H	N
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	111	A	S
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	117	A	G
P02766	LB/B	-	A0A1S3F262	121	G	S
P02766	LB/B	-	A0A1S3F262	122	P	R
P02766	LB/B	-	A0A1S3F262	124	R	C
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	127	I	V
P02766	LP/P	Hyperthyroxinemia, dystransthyretinemic (DTTRH) [MIM:145680]	A0A1S3F262	129	A	T
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	131	L	M
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	134	Y	C
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	136	Y	S
P02766	LP/P	Carpal tunnel syndrome 1 (CTS1) [MIM:115430]	A0A1S3F262	134	Y	H
P02766	LB/B	-	A0A1S3F262	139	T	M
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	142	V	I
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	48	V	M
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	109	E	K
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	32	L	P
P02766	LB/B	-	A0A1S3F262	33	M	I
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	43	S	N
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	50	V	G
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	53	F	V
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	54	R	T
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	55	K	N
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	58	D	A
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	58	D	V
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	61	W	L
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	62	E	D
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	64	F	S
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	65	A	S
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	67	G	E
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	69	T	I
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	73	G	E
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	74	E	K
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	75	L	Q
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	81	E	G
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	98	Y	F
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	104	I	T
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	117	A	S
P02766	LB/B	-	A0A1S3F262	124	R	H
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	126	T	N
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	127	I	M
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	140	A	S
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	142	V	A
P02766	LP/P	Amyloidosis, transthyretin-related (AMYL-TTR) [MIM:105210]	A0A1S3F262	144	N	S
Q9BSA4	LB/B	-	L8IW32	11	P	H
Q9BSA4	LB/B	-	L8IW32	85	H	D
Q9BSA4	LB/B	-	L8IW32	262	A	T
Q9BSA4	LB/B	-	L8IW32	265	S	A
Q9BSA4	LB/B	-	L8IW32	419	T	I
Q9BSA4	LB/B	-	L8IW32	423	D	E
Q9BSA4	LB/B	-	L8IW32	409	A	E
A6NHL2	LB/B	-	A0A1X2H4N5	135	Q	H
A6NHL2	LB/B	-	A0A1X2H4N5	250	R	W
Q3ZCM7	LB/B	-	A0A146NTL8	345	L	F
Q3ZCM7	LP/P	Oocyte maturation defect 2 (OOMD2) [MIM:616780]	A0A146NTL8	2	R	K
Q3ZCM7	LP/P	Oocyte maturation defect 2 (OOMD2) [MIM:616780]	A0A146NTL8	176	S	L
Q3ZCM7	LP/P	Oocyte maturation defect 2 (OOMD2) [MIM:616780]	A0A146NTL8	210	I	V
Q3ZCM7	LP/P	Oocyte maturation defect 2 (OOMD2) [MIM:616780]	A0A146NTL8	229	V	A
Q3ZCM7	LP/P	Oocyte maturation defect 2 (OOMD2) [MIM:616780]	A0A146NTL8	238	T	M
Q3ZCM7	LP/P	Oocyte maturation defect 2 (OOMD2) [MIM:616780]	A0A146NTL8	255	V	M
Q3ZCM7	LP/P	Oocyte maturation defect 2 (OOMD2) [MIM:616780]	A0A146NTL8	262	R	Q
Q3ZCM7	LP/P	Oocyte maturation defect 2 (OOMD2) [MIM:616780]	A0A146NTL8	262	R	W
Q3ZCM7	LP/P	Oocyte maturation defect 2 (OOMD2) [MIM:616780]	A0A146NTL8	285	T	P
Q3ZCM7	LP/P	Oocyte maturation defect 2 (OOMD2) [MIM:616780]	A0A146NTL8	300	M	I
Q3ZCM7	LP/P	Oocyte maturation defect 2 (OOMD2) [MIM:616780]	A0A146NTL8	348	N	S
Q3ZCM7	LP/P	Oocyte maturation defect 2 (OOMD2) [MIM:616780]	A0A146NTL8	363	M	T
Q3ZCM7	LP/P	Oocyte maturation defect 2 (OOMD2) [MIM:616780]	A0A146NTL8	417	D	N
Q3ZCM7	LP/P	Oocyte maturation defect 2 (OOMD2) [MIM:616780]	A0A146NTL8	54	A	V
Q3ZCM7	LP/P	Oocyte maturation defect 2 (OOMD2) [MIM:616780]	A0A146NTL8	320	R	H
P23258	LB/B	-	A0A179IVQ9	413	M	V
P23258	LP/P	Cortical dysplasia, complex, with other brain malformations 4 (CDCBM4) [MIM:615412]	A0A179IVQ9	92	Y	C
P23258	LP/P	Cortical dysplasia, complex, with other brain malformations 4 (CDCBM4) [MIM:615412]	A0A179IVQ9	331	T	P
P23258	LP/P	Cortical dysplasia, complex, with other brain malformations 4 (CDCBM4) [MIM:615412]	A0A179IVQ9	387	L	P
Q9NRH3	LB/B	-	A0A179IVQ9	413	M	V
Q9BSJ2	LB/B	-	A0A1U7TD27	111	A	T
Q9BSJ2	LB/B	-	A0A1U7TD27	193	I	T
Q9BSJ2	LB/B	-	A0A1U7TD27	809	A	T
Q96RT8	LB/B	-	A0A091CNZ1	662	E	D
P49411	LP/P	Combined oxidative phosphorylation deficiency 4 (COXPD4) [MIM:610678]	G3RE26	339	R	Q
O00295	LB/B	-	A0A1U8CUI9	245	E	K
O00295	LB/B	-	A0A1U8CUI9	251	D	N
O00295	LB/B	-	A0A1U8CUI9	18	A	T
O00295	LB/B	-	A0A1U8CUI9	122	G	S
O75386	LP/P	Hepatorenocardiac degenerative fibrosis (HRCDF) [MIM:619902]	A0A1U8CUI9	408	R	H
Q9NRJ4	LB/B	-	A0A091WAT0	214	G	S
Q9NRJ4	LB/B	-	A0A091WAT0	522	S	N
Q9NRJ4	LB/B	-	A0A091WAT0	979	D	N
Q9NRJ4	LB/B	-	A0A091WAT0	1084	V	I
Q9NRJ4	LB/B	-	A0A091WAT0	1281	P	T
Q9NRJ4	LB/B	-	A0A091WAT0	199	R	S
Q2TAM9	LB/B	-	F1SP79	123	N	D
Q13454	LB/B	-	H3AUW9	65	I	V
Q13454	LB/B	-	H3AUW9	247	M	V
Q9H6E5	LB/B	-	A0A1S3NGA6	442	L	F
Q5TAX3	LB/B	-	A0A0P6K4X1	796	D	Y
Q5VYS8	LB/B	-	L9LDA0	40	A	V
Q96ET8	LB/B	-	A0A2K6SG02	12	D	A
Q96ET8	LB/B	-	A0A2K6SG02	271	L	Q
Q15672	LP/P	Saethre-Chotzen syndrome (SCS) [MIM:101400]	W5PJ37	119	Q	P
Q15672	LP/P	Saethre-Chotzen syndrome (SCS) [MIM:101400]	W5PJ37	131	L	P
Q15672	LP/P	Saethre-Chotzen syndrome (SCS) [MIM:101400]	W5PJ37	156	I	V
Q15672	LP/P	Craniosynostosis 1 (CRS1) [MIM:123100]	W5PJ37	186	A	T
Q15672	LP/P	Craniosynostosis 1 (CRS1) [MIM:123100]	W5PJ37	188	S	L
Q15672	LB/B	-	W5PJ37	95	S	G
Q15672	LP/P	Sweeney-Cox syndrome (SWCOS) [MIM:617746]	W5PJ37	117	E	G
Q15672	LP/P	Sweeney-Cox syndrome (SWCOS) [MIM:617746]	W5PJ37	117	E	V
Q8WVJ9	LP/P	Focal facial dermal dysplasia 3, Setleis type (FFDD3) [MIM:227260]	Q9PTE3	109	L	P
Q8WVJ9	LP/P	Barber-Say syndrome (BBRSAY) [MIM:209885]	Q9PTE3	75	E	A
Q8WVJ9	LP/P	Ablepharon-macrostomia syndrome (AMS) [MIM:200110]	Q9PTE3	75	E	K
Q8WVJ9	LP/P	Barber-Say syndrome (BBRSAY) [MIM:209885]	Q9PTE3	75	E	Q
Q96RR1	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 3 (PEOA3) [MIM:609286]	A0A2I4D6X5	303	R	W
Q96RR1	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 3 (PEOA3) [MIM:609286]	A0A2I4D6X5	315	W	L
Q96RR1	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 3 (PEOA3) [MIM:609286]	A0A2I4D6X5	319	K	E
Q96RR1	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 3 (PEOA3) [MIM:609286]	A0A2I4D6X5	319	K	T
Q96RR1	LB/B	-	A0A2I4D6X5	334	R	Q
Q96RR1	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 3 (PEOA3) [MIM:609286]	A0A2I4D6X5	335	P	L
Q96RR1	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 3 (PEOA3) [MIM:609286]	A0A2I4D6X5	354	R	P
Q96RR1	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 3 (PEOA3) [MIM:609286]	A0A2I4D6X5	359	A	T
Q96RR1	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 3 (PEOA3) [MIM:609286]	A0A2I4D6X5	367	I	T
Q96RR1	LB/B	-	A0A2I4D6X5	368	V	I
Q96RR1	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 3 (PEOA3) [MIM:609286]	A0A2I4D6X5	369	S	P
Q96RR1	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 3 (PEOA3) [MIM:609286]	A0A2I4D6X5	369	S	Y
Q96RR1	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 3 (PEOA3) [MIM:609286]	A0A2I4D6X5	374	R	Q
Q96RR1	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 3 (PEOA3) [MIM:609286]	A0A2I4D6X5	381	L	P
Q96RR1	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 3 (PEOA3) [MIM:609286]	A0A2I4D6X5	474	W	C
Q96RR1	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 3 (PEOA3) [MIM:609286]	A0A2I4D6X5	475	A	P
Q96RR1	LP/P	Mitochondrial DNA depletion syndrome 7 (MTDPS7) [MIM:271245]	A0A2I4D6X5	457	T	I
Q96RR1	LP/P	Mitochondrial DNA depletion syndrome 7 (MTDPS7) [MIM:271245]	A0A2I4D6X5	508	Y	C
Q96RR1	LB/B	-	A0A2I4D6X5	427	E	G
Q96RR1	LB/B	-	A0A2I4D6X5	348	G	R
Q96RR1	LB/B	-	A0A2I4D6X5	634	N	K
Q96RR1	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 3 (PEOA3) [MIM:609286]	A0A2I4D6X5	303	R	Q
Q96RR1	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 3 (PEOA3) [MIM:609286]	A0A2I4D6X5	315	W	S
Q96RR1	LP/P	Mitochondrial DNA depletion syndrome 7 (MTDPS7) [MIM:271245]	A0A2I4D6X5	318	A	T
Q96RR1	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 3 (PEOA3) [MIM:609286]	A0A2I4D6X5	334	R	P
Q96RR1	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 3 (PEOA3) [MIM:609286]	A0A2I4D6X5	357	R	P
Q96RR1	LP/P	Mitochondrial DNA depletion syndrome 7 (MTDPS7) [MIM:271245]	A0A2I4D6X5	360	L	G
Q96RR1	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 3 (PEOA3) [MIM:609286]	A0A2I4D6X5	362	A	P
Q96RR1	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 3 (PEOA3) [MIM:609286]	A0A2I4D6X5	363	W	L
Q96RR1	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 3 (PEOA3) [MIM:609286]	A0A2I4D6X5	370	F	C
Q96RR1	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 3 (PEOA3) [MIM:609286]	A0A2I4D6X5	370	F	L
Q96RR1	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 3 (PEOA3) [MIM:609286]	A0A2I4D6X5	426	S	N
Q96RR1	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 3 (PEOA3) [MIM:609286]	A0A2I4D6X5	458	Q	H
Q96RR1	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 3 (PEOA3) [MIM:609286]	A0A2I4D6X5	460	A	P
Q96RR1	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 3 (PEOA3) [MIM:609286]	A0A2I4D6X5	474	W	S
Q96RR1	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 3 (PEOA3) [MIM:609286]	A0A2I4D6X5	475	A	D
Q96RR1	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 3 (PEOA3) [MIM:609286]	A0A2I4D6X5	478	F	I
Q96RR1	LP/P	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 3 (PEOA3) [MIM:609286]	A0A2I4D6X5	479	E	K
Q96RR1	LP/P	Mitochondrial DNA depletion syndrome 7 (MTDPS7) [MIM:271245]	A0A2I4D6X5	456	L	V
Q96RR1	LP/P	Perrault syndrome 5 (PRLTS5) [MIM:616138]	A0A2I4D6X5	391	R	H
Q96RR1	LP/P	Perrault syndrome 5 (PRLTS5) [MIM:616138]	A0A2I4D6X5	441	W	G
Q96RR1	LP/P	Perrault syndrome 5 (PRLTS5) [MIM:616138]	A0A2I4D6X5	507	V	I
Q96RR1	LP/P	Perrault syndrome 5 (PRLTS5) [MIM:616138]	A0A2I4D6X5	585	N	S
P42681	LB/B	-	A0A091D5V0	45	R	H
P42681	LB/B	-	A0A091D5V0	336	R	Q
P42681	LB/B	-	A0A091D5V0	63	R	C
Q8N3L3	LB/B	-	G1P9L4	11	A	T
Q8N3L3	LB/B	-	G1P9L4	348	V	M
Q8N3L3	LB/B	-	G1P9L4	527	I	T
Q8N3L3	LB/B	-	G1P9L4	602	A	P
Q9NUQ3	LB/B	-	A0A1U7RNI9	246	I	V
Q86VQ3	LB/B	-	A0A2J8J0H5	341	E	K
Q86VQ3	LB/B	-	A0A2J8J0H5	357	G	D
Q86VQ3	LB/B	-	A0A2J8J0H5	461	A	T
Q86VQ3	LB/B	-	A0A2J8J0H5	487	R	T
Q86VQ3	LB/B	-	A0A2J8J0H5	225	A	P
Q86VQ3	LB/B	-	A0A2J8J0H5	314	I	L
Q6A555	LB/B	-	J9P7G7	60	N	H
O14530	LB/B	-	A0A226MUG9	14	L	Q
O14530	LB/B	-	A0A226MUG9	38	Q	R
Q9H3M7	LB/B	-	X1WCU4	177	R	Q
Q9NNW7	LB/B	-	A0A2U4CBR5	14	R	L
Q9NNW7	LB/B	-	A0A2U4CBR5	66	A	S
Q9NNW7	LB/B	-	A0A2U4CBR5	299	S	R
Q9NNW7	LB/B	-	A0A2U4CBR5	370	I	T
P29597	LB/B	-	V9KBV7	684	I	S
P29597	LB/B	-	V9KBV7	4	R	H
P29597	LB/B	-	V9KBV7	197	R	H
P29597	LB/B	-	V9KBV7	362	V	F
P29597	LB/B	-	V9KBV7	363	G	S
P29597	LB/B	-	V9KBV7	81	A	V
P29597	LB/B	-	V9KBV7	442	R	Q
P29597	LB/B	-	V9KBV7	820	P	H
P29597	LB/B	-	V9KBV7	386	V	M
P29597	LB/B	-	V9KBV7	703	R	W
P29597	LB/B	-	V9KBV7	928	A	V
P29597	LB/B	-	V9KBV7	1104	P	A
P29597	LB/B	-	V9KBV7	1163	E	G
Q06418	LB/B	-	A0A1A6H3Y8	831	A	T
Q06418	LB/B	-	A0A1A6H3Y8	21	P	L
Q06418	LB/B	-	A0A1A6H3Y8	346	I	N
Q06418	LB/B	-	A0A1A6H3Y8	542	G	S
Q06418	LB/B	-	A0A1A6H3Y8	815	A	V
Q06418	LB/B	-	A0A1A6H3Y8	819	L	M
Q06418	LB/B	-	A0A1A6H3Y8	824	R	G
O43914	LB/B	-	A0A2K6V3H6	111	Y	H
Q6IPR3	LB/B	-	A0A2K6G7N9	110	R	Q
Q6IPR3	LB/B	-	A0A2K6G7N9	121	M	V
A2RUC4	LB/B	-	A0A2J7R3B4	50	S	G
Q9BZF9	LB/B	-	A0A2U3YBF0	814	I	T
Q3KQV9	LB/B	-	A0A197JEI1	319	A	V
Q3KQV9	LB/B	-	A0A197JEI1	373	P	S
Q9UBT2	LB/B	-	A0A1U8LJ33	307	L	R
Q9UBT2	LP/P	ACCES syndrome (ACCES) [MIM:619959]	A0A1U8LJ33	24	G	V
Q9UBT2	LP/P	ACCES syndrome (ACCES) [MIM:619959]	A0A1U8LJ33	56	N	T
Q9UBT2	LP/P	ACCES syndrome (ACCES) [MIM:619959]	A0A1U8LJ33	122	R	G
Q9UBT2	LP/P	ACCES syndrome (ACCES) [MIM:619959]	A0A1U8LJ33	483	E	K
Q8TBC4	LB/B	-	A0A0P6IND7	9	K	R
A0AVT1	LB/B	-	L5KBF8	224	A	T
Q9NZ09	LB/B	-	H3CZA1	357	N	K
Q5T6F2	LB/B	-	G3TFN1	606	N	S
Q5T6F2	LB/B	-	G3TFN1	756	A	V
Q5T6F2	LB/B	-	G3TFN1	14	R	Q
Q5T6F2	LB/B	-	G3TFN1	429	P	L
Q5T6F2	LB/B	-	G3TFN1	762	M	I
Q14157	LB/B	-	G3TFN1	482	Q	H
P57075	LB/B	-	A0A091U553	18	S	G
P57075	LB/B	-	A0A091U553	28	L	F
P57075	LB/B	-	A0A091U553	286	Q	R
P57075	LB/B	-	A0A091U553	466	D	E
P57075	LB/B	-	A0A091U553	324	R	L
P57075	LB/B	-	A0A091U553	324	R	Q
Q8TF42	LB/B	-	A0A091U553	68	A	T
Q8TF42	LB/B	-	A0A091U553	569	N	S
O15205	LB/B	-	A0A2K6SGS7	51	L	S
O15205	LB/B	-	A0A2K6SGS7	68	I	T
O15205	LB/B	-	A0A2K6SGS7	95	S	P
O15205	LB/B	-	A0A2K6SGS7	162	C	F
O15205	LB/B	-	A0A2K6SGS7	99	A	G
O15205	LB/B	-	A0A2K6SGS7	160	C	S
O15205	LB/B	-	A0A2K6SGS7	120	E	K
P49459	LP/P	Intellectual developmental disorder, X-linked, syndromic, Nascimento-type (MRXSN) [MIM:300860]	A0A286XDM4	11	R	Q
P49459	LP/P	Intellectual developmental disorder, X-linked, syndromic, Nascimento-type (MRXSN) [MIM:300860]	A0A286XDM4	23	G	R
O00762	LB/B	-	M7AUA7	25	G	D
P51965	LB/B	-	Q6AY98	25	E	D
Q969T4	LB/B	-	W5MHI2	201	W	R
Q9Y385	LB/B	-	F1S0C9	55	G	V
Q9Y385	LB/B	-	F1S0C9	229	L	V
Q9C0C9	LB/B	-	A0A224Z9G1	1207	G	S
Q9NPD8	LP/P	Fanconi anemia complementation group T (FANCT) [MIM:616435]	A0A024R9A9	2	Q	E
Q5VVX9	LB/B	-	W5MID8	90	I	T
Q05086	LB/B	-	A0A0P5N822	44	C	Y
Q05086	LB/B	-	A0A0P5N822	201	A	T
Q05086	LB/B	-	A0A0P5N822	62	R	H
Q05086	LB/B	-	A0A0P5N822	372	S	P
Q05086	LB/B	-	A0A0P5N822	290	V	G
Q05086	LB/B	-	A0A0P5N822	140	C	R
Q05086	LB/B	-	A0A0P5N822	156	V	G
Q05086	LB/B	-	A0A0P5N822	293	N	T
Q05086	LB/B	-	A0A0P5N822	358	S	T
Q05086	LB/B	-	A0A0P5N822	501	M	I
Q05086	LB/B	-	A0A0P5N822	611	Q	E
Q05086	LB/B	-	A0A0P5N822	611	Q	P
Q05086	LB/B	-	A0A0P5N822	696	L	R
Q05086	LB/B	-	A0A0P5N822	785	V	I
Q7Z6J8	LB/B	-	H3AB66	174	T	P
Q7Z6J8	LB/B	-	H3AB66	379	V	M
O95155	LB/B	-	A0A226MNC8	605	V	I
Q9Y5Z9	LB/B	-	A0A2D4IT28	75	S	F
Q9Y5Z9	LP/P	Corneal dystrophy, Schnyder type (SCCD) [MIM:121800]	A0A2D4IT28	102	N	S
Q9Y5Z9	LP/P	Corneal dystrophy, Schnyder type (SCCD) [MIM:121800]	A0A2D4IT28	112	D	G
Q9Y5Z9	LP/P	Corneal dystrophy, Schnyder type (SCCD) [MIM:121800]	A0A2D4IT28	118	D	G
Q9Y5Z9	LP/P	Corneal dystrophy, Schnyder type (SCCD) [MIM:121800]	A0A2D4IT28	119	R	G
Q9Y5Z9	LP/P	Corneal dystrophy, Schnyder type (SCCD) [MIM:121800]	A0A2D4IT28	121	L	F
Q9Y5Z9	LP/P	Corneal dystrophy, Schnyder type (SCCD) [MIM:121800]	A0A2D4IT28	171	S	P
Q9Y5Z9	LP/P	Corneal dystrophy, Schnyder type (SCCD) [MIM:121800]	A0A2D4IT28	175	T	I
Q9Y5Z9	LP/P	Corneal dystrophy, Schnyder type (SCCD) [MIM:121800]	A0A2D4IT28	177	G	R
Q9Y5Z9	LP/P	Corneal dystrophy, Schnyder type (SCCD) [MIM:121800]	A0A2D4IT28	186	G	R
Q9Y5Z9	LP/P	Corneal dystrophy, Schnyder type (SCCD) [MIM:121800]	A0A2D4IT28	232	N	S
Q9Y5Z9	LP/P	Corneal dystrophy, Schnyder type (SCCD) [MIM:121800]	A0A2D4IT28	236	D	E
Q9Y5Z9	LP/P	Corneal dystrophy, Schnyder type (SCCD) [MIM:121800]	A0A2D4IT28	97	A	T
Q9Y5Z9	LP/P	Corneal dystrophy, Schnyder type (SCCD) [MIM:121800]	A0A2D4IT28	98	G	S
Q9Y5Z9	LP/P	Corneal dystrophy, Schnyder type (SCCD) [MIM:121800]	A0A2D4IT28	112	D	N
Q9Y5Z9	LP/P	Corneal dystrophy, Schnyder type (SCCD) [MIM:121800]	A0A2D4IT28	122	V	E
Q9Y5Z9	LP/P	Corneal dystrophy, Schnyder type (SCCD) [MIM:121800]	A0A2D4IT28	122	V	G
Q9Y5Z9	LP/P	Corneal dystrophy, Schnyder type (SCCD) [MIM:121800]	A0A2D4IT28	188	L	H
Q9Y5Z9	LP/P	Corneal dystrophy, Schnyder type (SCCD) [MIM:121800]	A0A2D4IT28	240	D	N
Q9Y5Z9	LP/P	Corneal dystrophy, Schnyder type (SCCD) [MIM:121800]	A0A2D4IT28	177	G	E
O94941	LB/B	-	H0ZL46	96	T	M
O94941	LB/B	-	H0ZL46	479	L	P
Q9NZI7	LB/B	-	A0A151P5L9	212	T	A
Q9NZI7	LB/B	-	A0A151P5L9	109	N	S
Q9H347	LB/B	-	A0A2Y9MP69	624	R	Q
Q9H347	LB/B	-	A0A2Y9MP69	546	M	T
Q9H347	LB/B	-	A0A2Y9MP69	255	C	R
Q9H347	LB/B	-	A0A2Y9MP69	285	N	D
Q9H347	LB/B	-	A0A2Y9MP69	287	T	A
Q9H347	LB/B	-	A0A2Y9MP69	290	T	S
Q9NRR5	LB/B	-	A0A2K6CHQ6	495	I	M
Q9NRR5	LP/P	Amyotrophic lateral sclerosis (ALS) [MIM:105400]	A0A2K6CHQ6	90	D	A
Q8IWV7	LP/P	Johanson-Blizzard syndrome (JBS) [MIM:243800]	T1JGA7	136	H	R
Q8IWV7	LP/P	Johanson-Blizzard syndrome (JBS) [MIM:243800]	T1JGA7	1279	G	S
Q8IWV7	LB/B	-	T1JGA7	596	K	M
Q8IWV7	LB/B	-	T1JGA7	899	I	V
Q8IWV7	LB/B	-	T1JGA7	1548	T	A
Q8IWV7	LP/P	Johanson-Blizzard syndrome (JBS) [MIM:243800]	T1JGA7	122	V	L
Q8IWV7	LP/P	Johanson-Blizzard syndrome (JBS) [MIM:243800]	T1JGA7	127	C	F
Q8IWV7	LP/P	Johanson-Blizzard syndrome (JBS) [MIM:243800]	T1JGA7	166	H	R
Q8IWV7	LP/P	Johanson-Blizzard syndrome (JBS) [MIM:243800]	T1JGA7	217	L	R
Q8IWV7	LP/P	Johanson-Blizzard syndrome (JBS) [MIM:243800]	T1JGA7	286	I	R
Q8IWV7	LP/P	Johanson-Blizzard syndrome (JBS) [MIM:243800]	T1JGA7	317	L	P
Q8IWV7	LP/P	Johanson-Blizzard syndrome (JBS) [MIM:243800]	T1JGA7	563	A	D
Q8IWV7	LP/P	Johanson-Blizzard syndrome (JBS) [MIM:243800]	T1JGA7	700	S	P
Q8IWV7	LP/P	Johanson-Blizzard syndrome (JBS) [MIM:243800]	T1JGA7	754	R	C
Q8IWV7	LP/P	Johanson-Blizzard syndrome (JBS) [MIM:243800]	T1JGA7	754	R	H
Q8IWV7	LP/P	Johanson-Blizzard syndrome (JBS) [MIM:243800]	T1JGA7	1102	Q	E
Q8IWV7	LP/P	Johanson-Blizzard syndrome (JBS) [MIM:243800]	T1JGA7	1242	R	G
Q8IWV7	LP/P	Johanson-Blizzard syndrome (JBS) [MIM:243800]	T1JGA7	1426	P	L
Q8IWV7	LP/P	Johanson-Blizzard syndrome (JBS) [MIM:243800]	T1JGA7	1427	S	F
Q8IWV7	LP/P	Johanson-Blizzard syndrome (JBS) [MIM:243800]	T1JGA7	1431	S	P
Q8IWV7	LP/P	Johanson-Blizzard syndrome (JBS) [MIM:243800]	T1JGA7	1661	G	R
Q8IWV8	LB/B	-	T1JGA7	1095	A	T
Q8IWV8	LB/B	-	T1JGA7	172	E	D
Q8IWV8	LB/B	-	T1JGA7	1095	A	P
Q8IWV8	LB/B	-	T1JGA7	1095	A	S
Q5T4S7	LB/B	-	A0A1S3WVQ0	1107	T	A
Q5T4S7	LB/B	-	A0A1S3WVQ0	4867	M	L
Q5T4S7	LB/B	-	A0A1S3WVQ0	5084	V	M
Q8WUN7	LB/B	-	F7AG15	129	M	I
P17480	LP/P	Neurodegeneration, childhood-onset, with brain atrophy (CONDBA) [MIM:617672]	A0A2K5DJQ0	210	E	K
Q04323	LB/B	-	A0A2K5DEW6	56	L	F
Q5T124	LB/B	-	A0A2R9ARU5	165	E	G
Q5T124	LB/B	-	A0A2R9ARU5	312	L	R
Q5T124	LB/B	-	A0A2R9ARU5	474	A	V
Q5T124	LB/B	-	A0A2R9ARU5	509	P	S
P09936	LB/B	-	A0A2K5UVM3	18	S	Y
P09936	LP/P	Parkinson disease 5 (PARK5) [MIM:613643]	A0A2K5UVM3	93	I	M
P09936	LP/P	Spastic paraplegia 79B, autosomal recessive (SPG79B) [MIM:615491]	A0A2K5UVM3	7	E	A
P09936	LP/P	Spastic paraplegia 79B, autosomal recessive (SPG79B) [MIM:615491]	A0A2K5UVM3	178	R	Q
P09936	LP/P	Spastic paraplegia 79B, autosomal recessive (SPG79B) [MIM:615491]	A0A2K5UVM3	216	A	D
P25874	LB/B	-	A0A093GLU8	64	A	T
P25874	LB/B	-	A0A093GLU8	229	M	L
P55851	LB/B	-	A0A2F0B6D5	55	A	V
P55851	LB/B	-	A0A2F0B6D5	76	R	Q
P55851	LB/B	-	A0A2F0B6D5	154	R	Q
P55851	LB/B	-	A0A2F0B6D5	268	A	G
P55851	LB/B	-	A0A2F0B6D5	282	S	C
P55916	LB/B	-	A0A2F0B6D5	70	R	W
P55916	LP/P	Obesity (OBESITY) [MIM:601665]	A0A2F0B6D5	102	V	I
P55916	LB/B	-	A0A2F0B6D5	9	V	M
Q9Y3C8	LB/B	-	G5E2X6	90	Y	C
Q9Y3C8	LP/P	Neurodevelopmental disorder with spasticity and poor growth (NEDSG) [MIM:618076]	G5E2X6	23	R	Q
Q9Y3C8	LP/P	Neurodevelopmental disorder with spasticity and poor growth (NEDSG) [MIM:618076]	G5E2X6	106	T	I
Q92890	LB/B	-	A0A091DWL1	130	P	A
P61960	LP/P	Leukodystrophy, hypomyelinating, 14 (HLD14) [MIM:617899]	W4XDD8	81	R	C
Q6NVU6	LB/B	-	S4RUK9	47	L	V
Q9NUQ7	LB/B	-	A0A2D4K9N6	83	N	T
Q9NUQ7	LP/P	Beukes familial hip dysplasia (BFHD) [MIM:142669]	A0A2D4K9N6	290	Y	H
Q9NUQ7	LP/P	Spondyloepimetaphyseal dysplasia, Di Rocco type (SEMDDR) [MIM:617974]	A0A2D4K9N6	426	D	A
Q9NUQ7	LP/P	Developmental and epileptic encephalopathy 106 (DEE106) [MIM:620028]	A0A2D4K9N6	115	V	E
Q9NUQ7	LP/P	Spondyloepimetaphyseal dysplasia, Di Rocco type (SEMDDR) [MIM:617974]	A0A2D4K9N6	428	H	R
Q9NYU1	LB/B	-	W4XSK4	323	A	T
Q9NYU1	LB/B	-	W4XSK4	328	S	A
Q9NYU1	LB/B	-	W4XSK4	994	M	L
Q9NYU1	LB/B	-	W4XSK4	821	A	T
Q9NYU1	LB/B	-	W4XSK4	924	F	I
Q9NYU1	LB/B	-	W4XSK4	1274	F	L
Q9NYU1	LB/B	-	W4XSK4	865	K	R
Q9NYU1	LB/B	-	W4XSK4	1285	Y	F
Q9BY64	LB/B	-	G1QFJ6	365	L	H
Q9BY64	LB/B	-	G1QFJ6	447	I	R
Q9BY64	LB/B	-	G1QFJ6	458	H	D
P06133	LB/B	-	G1QFJ6	458	D	E
P06133	LB/B	-	G1QFJ6	109	F	L
P06133	LB/B	-	G1QFJ6	396	F	L
P06133	LB/B	-	G1QFJ6	40	K	N
P06133	LB/B	-	G1QFJ6	78	P	T
P06133	LB/B	-	G1QFJ6	80	S	P
P06133	LB/B	-	G1QFJ6	277	V	I
P06133	LB/B	-	G1QFJ6	511	C	R
P16662	LB/B	-	G1QFJ6	268	Y	H
P16662	LB/B	-	G1QFJ6	71	A	S
P16662	LB/B	-	G1QFJ6	378	N	S
Q6NUS8	LB/B	-	A0A1S3FD50	121	C	G
Q3SY77	LB/B	-	A0A1S3FD50	74	Y	N
Q8TAS1	LB/B	-	H2MH83	159	L	V
Q8TAS1	LB/B	-	H2MH83	197	Y	D
Q96T88	LB/B	-	Q4SJH5	240	D	H
Q96T88	LB/B	-	Q4SJH5	379	E	K
Q96T88	LB/B	-	Q4SJH5	638	A	T
Q96T88	LB/B	-	Q4SJH5	642	T	M
Q96T88	LB/B	-	Q4SJH5	713	L	F
Q96RL1	LB/B	-	D2HHU8	15	R	W
Q96RL1	LB/B	-	D2HHU8	435	P	L
Q96RL1	LB/B	-	D2HHU8	511	C	R
Q96RL1	LB/B	-	D2HHU8	596	G	E
Q96RL1	LB/B	-	D2HHU8	353	M	T
O75385	LB/B	-	A0A212D6Z2	298	S	L
O75385	LB/B	-	A0A212D6Z2	478	P	L
O75385	LB/B	-	A0A212D6Z2	503	T	M
O75385	LB/B	-	A0A212D6Z2	665	S	L
O75385	LB/B	-	A0A212D6Z2	714	P	L
O75385	LB/B	-	A0A212D6Z2	816	T	A
Q8IYT8	LB/B	-	A0A212D6Z2	242	P	S
Q8IYT8	LB/B	-	A0A212D6Z2	752	G	R
Q8IYT8	LB/B	-	A0A212D6Z2	842	D	E
Q8IYT8	LB/B	-	A0A212D6Z2	370	V	M
Q8IYT8	LB/B	-	A0A212D6Z2	533	T	I
Q6PHR2	LB/B	-	L8YAN1	101	R	H
Q6PHR2	LB/B	-	L8YAN1	445	K	R
Q5DID0	LB/B	-	H0Z545	173	V	I
Q5DID0	LB/B	-	H0Z545	274	N	D
Q5DID0	LB/B	-	H0Z545	274	N	H
Q5DID0	LB/B	-	H0Z545	447	R	Q
Q5DID0	LB/B	-	H0Z545	559	M	T
Q5DID0	LB/B	-	H0Z545	639	I	T
Q5DID0	LB/B	-	H0Z545	698	T	P
Q5DID0	LB/B	-	H0Z545	850	V	I
Q5DID0	LB/B	-	H0Z545	1027	S	N
Q5DID0	LB/B	-	H0Z545	1068	G	S
Q5DID0	LB/B	-	H0Z545	1115	E	K
Q5DID0	LB/B	-	H0Z545	1208	D	N
Q5DID0	LB/B	-	H0Z545	1309	N	H
Q8N2C9	LB/B	-	A0A0D9SA29	98	V	F
P11172	LP/P	Orotic aciduria 1 (ORAC1) [MIM:258900]	A0A1U8BAN3	96	R	G
P11172	LP/P	Orotic aciduria 1 (ORAC1) [MIM:258900]	A0A1U8BAN3	109	V	G
P11172	LB/B	-	A0A1U8BAN3	213	G	A
P11172	LP/P	Orotic aciduria 1 (ORAC1) [MIM:258900]	A0A1U8BAN3	429	G	R
P11172	LB/B	-	A0A1U8BAN3	30	S	G
P11172	LB/B	-	A0A1U8BAN3	446	I	V
Q13432	LP/P	Immunodeficiency 13 (IMD13) [MIM:615518]	A0A1U7UHY4	22	G	V
Q70J99	LB/B	-	U3J6G6	858	H	Q
Q70J99	LB/B	-	U3J6G6	867	K	E
Q70J99	LB/B	-	U3J6G6	59	A	T
Q9H3U1	LB/B	-	A0A1A6G3D3	796	T	M
Q8IWX7	LB/B	-	V4AXD0	60	V	I
Q8IWX7	LB/B	-	V4AXD0	852	I	N
Q8IWX7	LB/B	-	V4AXD0	199	A	V
Q8IWX7	LB/B	-	V4AXD0	377	K	R
Q8IWX7	LP/P	Cataract 43 (CTRCT43) [MIM:616279]	V4AXD0	805	R	W
Q8IWX7	LP/P	Myopathy, myofibrillar, 11 (MFM11) [MIM:619178]	V4AXD0	403	S	P
Q8IWX7	LP/P	Myopathy, myofibrillar, 11 (MFM11) [MIM:619178]	V4AXD0	754	R	Q
Q8IZJ1	LB/B	-	A0A0F8B195	516	A	T
Q8IZJ1	LB/B	-	A0A0F8B195	242	I	V
O95185	LB/B	-	T1IHT4	37	G	V
O95185	LB/B	-	T1IHT4	721	M	T
O95185	LB/B	-	T1IHT4	841	A	T
O95185	LP/P	Alzheimer disease (AD) [MIM:104300]	T1IHT4	835	T	M
Q8IV45	LB/B	-	A0A091DIS9	432	R	G
Q6UXZ4	LB/B	-	T1IHT4	728	R	K
Q9P2D8	LB/B	-	A0A0Q3NFV3	1597	V	A
Q9P2D8	LB/B	-	A0A0Q3NFV3	1670	V	I
Q9P2D8	LB/B	-	A0A0Q3NFV3	2183	K	R
Q9P2D8	LB/B	-	A0A0Q3NFV3	2444	G	S
Q8N2C7	LB/B	-	A0A1A8CPY5	131	R	W
Q8N2C7	LB/B	-	A0A1A8CPY5	1505	D	G
Q8N2C7	LP/P	Hypotonia, infantile, with psychomotor retardation and characteristic facies 2 (IHPRF2) [MIM:616801]	A0A1A8CPY5	189	V	M
Q8N2C7	LP/P	Hypotonia, infantile, with psychomotor retardation and characteristic facies 2 (IHPRF2) [MIM:616801]	A0A1A8CPY5	1700	P	S
Q86WB7	LB/B	-	T0MHC8	292	V	I
Q86WB7	LB/B	-	T0MHC8	387	Y	H
Q86WB7	LB/B	-	T0MHC8	403	M	T
Q86WB7	LB/B	-	T0MHC8	409	V	I
Q86WB7	LB/B	-	T0MHC8	445	V	A
Q86WB7	LB/B	-	T0MHC8	6	R	K
Q86WB7	LB/B	-	T0MHC8	128	K	Q
Q86WB7	LB/B	-	T0MHC8	295	V	M
Q86WB7	LB/B	-	T0MHC8	403	M	I
Q86WB7	LB/B	-	T0MHC8	308	V	M
Q9H1C4	LB/B	-	H2PUK1	436	Y	C
Q92900	LB/B	-	U5D2Y9	69	A	S
Q9HAU5	LB/B	-	U3IS29	496	N	S
O00322	LB/B	-	L8Y4Q9	257	M	T
O00322	LB/B	-	L8Y4Q9	33	S	A
O00526	LB/B	-	A0A1U7QAC9	47	A	S
O00526	LB/B	-	A0A1U7QAC9	160	T	M
O75631	LB/B	-	A0A2Y9FTI8	154	A	P
O75631	LB/B	-	A0A2Y9FTI8	91	Q	L
Q9NVA1	LB/B	-	L9L3S0	51	R	Q
Q9NVA1	LB/B	-	L9L3S0	85	P	L
Q6UW78	LP/P	Mitochondrial complex III deficiency, nuclear type 9 (MC3DN9) [MIM:616111]	A0A212DG39	20	V	E
Q69YU5	LB/B	-	A0A2K5HW21	45	R	C
Q9UDW1	LB/B	-	Q1HRI1	47	I	V
P14927	LB/B	-	R4WPG7	30	L	P
P31930	LB/B	-	A0A2D0SFJ9	301	N	S
P31930	LB/B	-	A0A2D0SFJ9	215	D	H
P31930	LP/P	Parkinsonism with polyneuropathy (PKNPY) [MIM:619279]	A0A2D0SFJ9	311	I	L
P31930	LP/P	Parkinsonism with polyneuropathy (PKNPY) [MIM:619279]	A0A2D0SFJ9	314	Y	S
P22695	LB/B	-	A0A2K6V357	148	R	S
P22695	LB/B	-	A0A2K6V357	183	R	Q
P22695	LB/B	-	A0A2K6V357	254	R	H
P22695	LP/P	Mitochondrial complex III deficiency, nuclear type 5 (MC3DN5) [MIM:615160]	A0A2K6V357	183	R	W
P07919	LB/B	-	A0A2K5N9M8	51	E	Q
O14949	LP/P	Mitochondrial complex III deficiency, nuclear type 4 (MC3DN4) [MIM:615159]	A0A224ZB31	45	S	F
A6NGE7	LB/B	-	S9WEA6	57	Q	P
O60287	LB/B	-	A0A091HA09	2071	P	R
O60287	LB/B	-	A0A091HA09	1791	V	L
Q14146	LB/B	-	T1DK86	778	V	G
Q14146	LB/B	-	T1DK86	1400	V	M
Q8TCY9	LB/B	-	L8Y7J6	779	M	L
Q8TCY9	LB/B	-	L8Y7J6	697	T	A
Q8TCY9	LB/B	-	L8Y7J6	756	L	F
O94763	LB/B	-	J9NXQ7	22	L	P
Q96N76	LB/B	-	G3GRZ9	188	R	W
Q96N76	LB/B	-	G3GRZ9	311	S	T
Q96N76	LB/B	-	G3GRZ9	429	R	C
Q96N76	LP/P	Urocanase deficiency (UROCD) [MIM:276880]	G3GRZ9	450	R	C
Q96N76	LP/P	Urocanase deficiency (UROCD) [MIM:276880]	G3GRZ9	70	L	P
P10746	LP/P	Congenital erythropoietic porphyria (CEP) [MIM:263700]	A0A2K6KP03	4	L	F
P10746	LP/P	Congenital erythropoietic porphyria (CEP) [MIM:263700]	A0A2K6KP03	19	Y	C
P10746	LP/P	Congenital erythropoietic porphyria (CEP) [MIM:263700]	A0A2K6KP03	53	P	L
P10746	LP/P	Congenital erythropoietic porphyria (CEP) [MIM:263700]	A0A2K6KP03	62	T	A
P10746	LP/P	Congenital erythropoietic porphyria (CEP) [MIM:263700]	A0A2K6KP03	66	A	V
P10746	LP/P	Congenital erythropoietic porphyria (CEP) [MIM:263700]	A0A2K6KP03	73	C	R
P10746	LP/P	Congenital erythropoietic porphyria (CEP) [MIM:263700]	A0A2K6KP03	82	V	F
P10746	LP/P	Congenital erythropoietic porphyria (CEP) [MIM:263700]	A0A2K6KP03	99	V	A
P10746	LP/P	Congenital erythropoietic porphyria (CEP) [MIM:263700]	A0A2K6KP03	104	A	V
P10746	LP/P	Congenital erythropoietic porphyria (CEP) [MIM:263700]	A0A2K6KP03	212	S	P
P10746	LP/P	Congenital erythropoietic porphyria (CEP) [MIM:263700]	A0A2K6KP03	225	G	S
P10746	LP/P	Congenital erythropoietic porphyria (CEP) [MIM:263700]	A0A2K6KP03	228	T	M
P10746	LP/P	Congenital erythropoietic porphyria (CEP) [MIM:263700]	A0A2K6KP03	188	G	R
P10746	LP/P	Congenital erythropoietic porphyria (CEP) [MIM:263700]	A0A2K6KP03	3	V	F
P10746	LP/P	Congenital erythropoietic porphyria (CEP) [MIM:263700]	A0A2K6KP03	47	S	P
P10746	LP/P	Congenital erythropoietic porphyria (CEP) [MIM:263700]	A0A2K6KP03	69	A	T
P10746	LP/P	Congenital erythropoietic porphyria (CEP) [MIM:263700]	A0A2K6KP03	129	I	T
P10746	LP/P	Congenital erythropoietic porphyria (CEP) [MIM:263700]	A0A2K6KP03	188	G	W
P10746	LP/P	Congenital erythropoietic porphyria (CEP) [MIM:263700]	A0A2K6KP03	219	I	S
P10746	LB/B	-	A0A2K6KP03	124	K	R
P10746	LB/B	-	A0A2K6KP03	171	V	G
P10746	LP/P	Congenital erythropoietic porphyria (CEP) [MIM:263700]	A0A2K6KP03	248	P	Q
P10746	LP/P	Congenital erythropoietic porphyria (CEP) [MIM:263700]	A0A2K6KP03	237	L	P
Q9BQ65	LB/B	-	A0A1L8GLI6	250	Q	E
Q9BQ65	LB/B	-	A0A1L8GLI6	115	R	K
Q9NZ43	LB/B	-	A0A0N8JZ38	154	L	S
Q68DE3	LB/B	-	A0A060XI00	222	P	A
Q68DE3	LB/B	-	A0A060XI00	1966	A	V
Q68DE3	LB/B	-	A0A060XI00	907	A	E
Q68DE3	LB/B	-	A0A060XI00	943	V	G
Q68DE3	LB/B	-	A0A060XI00	2200	A	V
O75445	LB/B	-	K1QPM1	125	A	T
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	163	C	Y
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	218	V	E
O75445	LB/B	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	230	V	M
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	319	C	Y
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	334	R	W
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	346	N	H
O75445	LP/P	Retinitis pigmentosa 39 (RP39) [MIM:613809]	K1QPM1	419	C	F
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	419	C	F
O75445	LB/B	Retinitis pigmentosa 39 (RP39) [MIM:613809]	K1QPM1	478	E	D
O75445	LB/B	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	478	E	D
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	536	C	R
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	555	L	V
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	610	H	P
O75445	LB/B	-	K1QPM1	644	D	V
O75445	LB/B	-	K1QPM1	703	D	E
O75445	LB/B	-	K1QPM1	713	G	R
O75445	LP/P	Retinitis pigmentosa 39 (RP39) [MIM:613809]	K1QPM1	759	C	F
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	759	C	F
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	761	P	R
O75445	LB/B	-	K1QPM1	841	S	Y
O75445	LB/B	-	K1QPM1	1486	R	K
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	1515	T	M
O75445	LP/P	Retinitis pigmentosa 39 (RP39) [MIM:613809]	K1QPM1	4115	R	C
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	4115	R	C
O75445	LP/P	Retinitis pigmentosa 39 (RP39) [MIM:613809]	K1QPM1	4425	T	M
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	4425	T	M
O75445	LB/B	-	K1QPM1	3199	N	D
O75445	LB/B	-	K1QPM1	1665	I	T
O75445	LB/B	-	K1QPM1	2106	I	T
O75445	LB/B	-	K1QPM1	2169	I	T
O75445	LB/B	-	K1QPM1	2875	R	Q
O75445	LB/B	-	K1QPM1	3099	N	S
O75445	LB/B	-	K1QPM1	3144	D	N
O75445	LB/B	-	K1QPM1	3335	I	M
O75445	LP/P	Retinitis pigmentosa 39 (RP39) [MIM:613809]	K1QPM1	4674	R	G
O75445	LB/B	-	K1QPM1	3411	E	A
O75445	LB/B	-	K1QPM1	3835	T	I
O75445	LB/B	-	K1QPM1	4739	R	K
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	280	L	F
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	284	E	K
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	303	R	C
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	303	R	S
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	334	R	Q
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	352	T	I
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	357	N	T
O75445	LB/B	-	K1QPM1	365	L	F
O75445	LB/B	-	K1QPM1	479	F	S
O75445	LB/B	-	K1QPM1	595	F	S
O75445	LB/B	-	K1QPM1	1047	L	V
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	1212	P	L
O75445	LB/B	-	K1QPM1	1349	S	P
O75445	LB/B	-	K1QPM1	1572	L	F
O75445	LB/B	-	K1QPM1	1757	Y	C
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	1833	V	E
O75445	LB/B	-	K1QPM1	2086	T	N
O75445	LB/B	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	2238	E	A
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	2249	A	D
O75445	LB/B	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	2292	R	H
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	2354	R	H
O75445	LB/B	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	2562	V	A
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	2795	A	S
O75445	LB/B	-	K1QPM1	2886	L	F
O75445	LB/B	-	K1QPM1	3088	E	K
O75445	LB/B	-	K1QPM1	3115	T	A
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	3251	C	R
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	3267	C	R
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	3282	C	R
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	3504	P	T
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	3521	W	R
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	3571	T	M
O75445	LB/B	-	K1QPM1	3590	P	L
O75445	LB/B	-	K1QPM1	3868	M	V
O75445	LB/B	-	K1QPM1	3893	P	T
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	3895	G	E
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	3976	T	M
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	4054	S	I
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	4232	P	R
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	4337	T	M
O75445	LB/B	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	4433	V	L
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	4439	T	I
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	4487	Y	C
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	4592	Q	H
O75445	LB/B	-	K1QPM1	4624	F	V
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	4795	L	R
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	4818	P	L
O75445	LB/B	-	K1QPM1	5031	R	W
O75445	LB/B	-	K1QPM1	2820	V	I
O75445	LB/B	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	4692	G	R
O75445	LB/B	-	K1QPM1	4838	G	E
O75445	LB/B	-	K1QPM1	4203	Q	R
O75445	LP/P	Retinitis pigmentosa 39 (RP39) [MIM:613809]	K1QPM1	1859	F	C
O75445	LP/P	Retinitis pigmentosa 39 (RP39) [MIM:613809]	K1QPM1	2460	R	H
O75445	LP/P	Retinitis pigmentosa 39 (RP39) [MIM:613809]	K1QPM1	3358	C	Y
O75445	LP/P	Retinitis pigmentosa 39 (RP39) [MIM:613809]	K1QPM1	3669	S	R
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	44	G	R
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	180	S	P
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	382	V	M
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	691	C	Y
O75445	LP/P	Retinitis pigmentosa 39 (RP39) [MIM:613809]	K1QPM1	934	C	W
O75445	LP/P	Retinitis pigmentosa 39 (RP39) [MIM:613809]	K1QPM1	1442	F	S
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	1734	G	R
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	1777	R	W
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	1840	G	V
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	1843	P	L
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	1861	G	S
O75445	LB/B	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	2196	S	T
O75445	LB/B	-	K1QPM1	2377	N	S
O75445	LB/B	-	K1QPM1	2394	N	K
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	2738	D	N
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	2744	W	C
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	2752	G	R
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	3515	D	G
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	3546	G	R
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	3747	Y	C
O75445	LP/P	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	3894	N	D
O75445	LB/B	-	K1QPM1	4493	R	H
O75445	LB/B	-	K1QPM1	4611	A	V
O75445	LB/B	-	K1QPM1	4616	G	V
O75445	LB/B	-	K1QPM1	4778	A	D
O75445	LB/B	-	K1QPM1	4848	R	Q
O75445	LB/B	-	K1QPM1	4881	S	T
O75445	LB/B	-	K1QPM1	4921	E	K
O75445	LB/B	-	K1QPM1	5026	K	E
O75445	LP/P	Retinitis pigmentosa 39 (RP39) [MIM:613809]	K1QPM1	5063	L	R
O75445	LB/B	Usher syndrome 2A (USH2A) [MIM:276901]	K1QPM1	5143	R	C
O75445	LB/B	Retinitis pigmentosa 39 (RP39) [MIM:613809]	K1QPM1	5143	R	H
O75445	LB/B	Retinitis pigmentosa 39 (RP39) [MIM:613809]	K1QPM1	5188	S	G
Q8N6Y0	LB/B	-	A0A212D2A0	439	M	V
Q8N6Y0	LB/B	-	A0A212D2A0	525	V	M
Q8N6Y0	LB/B	-	A0A212D2A0	677	A	V
Q9Y5T5	LB/B	-	A0A2K5INF0	141	Q	H
Q6R6M4	LB/B	-	G1U0E1	438	K	R
P0C7H9	LB/B	-	G1U0E1	161	A	G
P0C7H9	LB/B	-	G1U0E1	494	P	L
Q9UMW8	LB/B	-	Q6AYC7	169	T	M
O75604	LB/B	-	A0A1V4J7L5	174	R	Q
O75604	LB/B	-	A0A1V4J7L5	383	N	S
Q9Y2K6	LB/B	-	A0A210QTF4	103	S	Y
Q9Y2K6	LB/B	-	A0A210QTF4	444	V	I
Q9UK80	LB/B	-	L5KY52	91	P	S
Q9UK80	LB/B	-	L5KY52	321	G	D
Q9UK80	LB/B	-	L5KY52	336	P	T
Q9BXU7	LB/B	-	A0A2K6G5X2	165	L	S
Q9BXU7	LB/B	-	A0A2K6G5X2	364	L	F
Q9BXU7	LB/B	-	A0A2K6G5X2	475	H	Y
Q9BXU7	LB/B	-	A0A2K6G5X2	517	L	F
Q9BXU7	LB/B	-	A0A2K6G5X2	579	M	I
A6NNY8	LP/P	Intellectual developmental disorder, X-linked 105 (XLID105) [MIM:300984]	A0A1U8CN06	381	Y	H
Q9HBJ7	LB/B	-	A0A2K6G5X2	586	E	K
Q9HBJ7	LB/B	-	A0A2K6G5X2	368	N	S
Q9Y6I4	LB/B	-	A7SFT1	360	P	T
Q70CQ4	LB/B	-	A0A226NMX0	445	D	Y
Q70CQ4	LB/B	-	A0A226NMX0	532	Q	H
Q70CQ4	LB/B	-	A0A226NMX0	538	I	T
Q70CQ4	LB/B	-	A0A226NMX0	552	A	T
Q70CQ4	LB/B	-	A0A226NMX0	931	R	L
Q70CQ4	LB/B	-	A0A226NMX0	1269	D	N
Q70CQ4	LB/B	-	A0A226NMX0	1309	R	C
Q70CQ2	LB/B	-	A0A0G2JTF5	661	M	T
Q70CQ2	LB/B	-	A0A0G2JTF5	1663	L	R
Q70CQ2	LB/B	-	A0A0G2JTF5	2348	D	N
Q9P2H5	LB/B	-	G1MWM9	236	V	M
Q9P275	LB/B	-	A0A1U8DW05	271	V	I
Q9P275	LB/B	-	A0A1U8DW05	489	I	M
Q9P275	LB/B	-	A0A1U8DW05	775	R	Q
Q9P275	LB/B	-	A0A1U8DW05	806	Q	R
Q9P275	LB/B	-	A0A1U8DW05	814	K	N
Q9P275	LB/B	-	A0A1U8DW05	828	R	C
Q9P275	LB/B	-	A0A1U8DW05	887	R	P
Q86T82	LB/B	-	H2SH63	979	L	S
Q13107	LB/B	-	A0A1V4K8S0	620	Y	C
Q9NVE5	LB/B	-	L5L225	666	V	A
Q9NVE5	LB/B	-	L5L225	1111	R	C
Q9NVE5	LB/B	-	L5L225	1025	T	M
Q3LFD5	LB/B	-	Q6AYC7	130	Y	C
Q3LFD5	LB/B	-	Q6AYC7	325	N	S
Q9H9J4	LB/B	-	A0A091D2V2	1030	L	P
P62068	LB/B	-	A0A195CML2	81	A	V
Q96K76	LB/B	-	A0A1B6CWW5	163	G	V
Q70EL1	LB/B	-	H0WK75	976	K	E
Q70EL1	LB/B	-	H0WK75	1231	D	N
Q70EL1	LB/B	-	H0WK75	1367	G	D
P35125	LB/B	-	G3REQ0	475	W	R
P35125	LB/B	-	G3REQ0	912	R	Q
P35125	LB/B	-	G3REQ0	525	V	I
Q93009	LP/P	Hao-Fountain syndrome (HAFOUS) [MIM:616863]	G5BSC6	225	M	I
Q93009	LP/P	Hao-Fountain syndrome (HAFOUS) [MIM:616863]	G5BSC6	345	E	K
Q93009	LP/P	Hao-Fountain syndrome (HAFOUS) [MIM:616863]	G5BSC6	373	L	F
Q93009	LP/P	Hao-Fountain syndrome (HAFOUS) [MIM:616863]	G5BSC6	392	G	D
Q93009	LP/P	Hao-Fountain syndrome (HAFOUS) [MIM:616863]	G5BSC6	485	V	G
Q93009	LP/P	Hao-Fountain syndrome (HAFOUS) [MIM:616863]	G5BSC6	766	I	T
Q93009	LP/P	Hao-Fountain syndrome (HAFOUS) [MIM:616863]	G5BSC6	1080	D	N
P40818	LB/B	-	A0A1S3ILW4	443	D	G
P40818	LB/B	-	A0A1S3ILW4	827	A	G
P40818	LB/B	-	A0A1S3ILW4	739	T	A
Q9Y2C2	LB/B	-	A0A2Y9HAY5	21	M	L
Q5T230	LB/B	-	H0XHY7	73	G	R
Q9BVJ6	LB/B	-	Q6NTY7	487	V	A
Q9BVJ6	LB/B	-	Q6NTY7	771	D	G
Q5TAP6	LB/B	-	Q6NTY7	85	G	V
Q5TAP6	LB/B	-	Q6NTY7	101	T	A
Q5TAP6	LB/B	-	Q6NTY7	319	R	H
Q8TED0	LB/B	-	A0A1X2GWQ2	228	Y	H
Q8TED0	LB/B	-	A0A1X2GWQ2	332	R	S
Q8TED0	LB/B	-	A0A1X2GWQ2	483	T	P
Q68CQ4	LB/B	-	F1SF51	67	Q	E
Q68CQ4	LB/B	-	F1SF51	111	G	D
Q9NQZ2	LB/B	-	A0A2Y9FB68	23	T	M
Q969X6	LB/B	-	A0A2J7RKP9	438	R	H
Q9NYH9	LB/B	-	A0A2K5VWR2	69	Q	R
Q9NYH9	LB/B	-	A0A2K5VWR2	35	K	R
Q9NYH9	LB/B	-	A0A2K5VWR2	134	L	V
P46939	LB/B	-	T1IRG4	1880	L	I
P46939	LB/B	-	T1IRG4	1974	A	T
P46939	LB/B	-	T1IRG4	2060	G	D
P46939	LB/B	-	T1IRG4	2202	N	S
O95399	LB/B	-	A0A2K6KUJ1	74	S	N
O95399	LB/B	-	A0A2K6KUJ1	12	I	T
Q765I0	LB/B	-	A0A2Y9NCY6	21	S	I
Q9UKP6	LB/B	-	A0A2Y9GBR0	70	A	P
Q9P2Y5	LB/B	-	W5MBD8	10	P	H
Q2YD98	LB/B	-	G3HK84	391	R	H
Q2YD98	LB/B	-	G3HK84	620	P	L
Q2YD98	LP/P	UV-sensitive syndrome 3 (UVSS3) [MIM:614640]	G3HK84	32	C	R
Q08AM6	LP/P	Striatonigral degeneration, childhood-onset (SNDC) [MIM:617054]	A0A1B6I0P4	424	W	L
Q08AM6	LP/P	Striatonigral degeneration, childhood-onset (SNDC) [MIM:617054]	A0A1B6I0P4	582	A	S
Q08AM6	LP/P	Striatonigral degeneration, childhood-onset (SNDC) [MIM:617054]	A0A1B6I0P4	583	S	L
Q9P0L0	LB/B	-	W5M365	8	M	T
Q9P0L0	LB/B	-	W5M365	104	P	L
O95292	LP/P	Amyotrophic lateral sclerosis 8 (ALS8) [MIM:608627]	W5M365	56	P	S
O95292	LP/P	Spinal muscular atrophy, proximal, adult, autosomal dominant (SMAPAD) [MIM:182980]	W5M365	56	P	S
O95292	LP/P	Amyotrophic lateral sclerosis 8 (ALS8) [MIM:608627]	W5M365	46	T	I
P26640	LB/B	-	A0A1A6G1Q6	51	P	R
P26640	LB/B	-	A0A1A6G1Q6	181	R	C
P26640	LB/B	-	A0A1A6G1Q6	626	P	S
P26640	LB/B	-	A0A1A6G1Q6	1008	P	L
P26640	LB/B	-	A0A1A6G1Q6	51	P	T
Q5ST30	LB/B	-	A0A1Q3F4M7	64	G	R
Q5ST30	LB/B	-	A0A1Q3F4M7	449	W	R
Q5ST30	LB/B	-	A0A1Q3F4M7	680	V	L
Q5ST30	LB/B	-	A0A1Q3F4M7	917	R	Q
Q5ST30	LB/B	-	A0A1Q3F4M7	965	A	T
Q5ST30	LB/B	-	A0A1Q3F4M7	1049	R	Q
Q5ST30	LB/B	-	A0A1Q3F4M7	26	H	Y
Q5ST30	LB/B	-	A0A1Q3F4M7	765	V	M
Q5ST30	LP/P	Combined oxidative phosphorylation deficiency 20 (COXPD20) [MIM:615917]	A0A1Q3F4M7	337	T	I
Q5ST30	LP/P	Combined oxidative phosphorylation deficiency 20 (COXPD20) [MIM:615917]	A0A1Q3F4M7	349	A	T
Q5ST30	LP/P	Combined oxidative phosphorylation deficiency 20 (COXPD20) [MIM:615917]	A0A1Q3F4M7	596	A	D
Q6EMK4	LB/B	-	H2LW70	384	E	A
P50552	LB/B	-	J9P328	104	A	T
P50552	LB/B	-	J9P328	140	Q	H
P15498	LB/B	-	A0A212D1T9	739	T	M
P52735	LB/B	-	H2PTV8	594	M	V
P61758	LB/B	-	A0A0D9R2G2	123	V	M
P19320	LB/B	-	F1PCD0	318	S	F
P19320	LB/B	-	F1PCD0	384	T	A
P19320	LB/B	-	F1PCD0	413	G	A
P19320	LB/B	-	F1PCD0	716	I	L
P19320	LB/B	-	F1PCD0	18	M	I
P19320	LB/B	-	F1PCD0	421	V	I
P19320	LB/B	-	F1PCD0	488	H	R
P13611	LB/B	-	D4A8Y6	428	G	D
P13611	LB/B	-	D4A8Y6	2301	F	Y
P13611	LB/B	-	D4A8Y6	2315	V	L
P13611	LB/B	-	D4A8Y6	300	S	L
P13611	LB/B	-	D4A8Y6	1516	K	R
P13611	LB/B	-	D4A8Y6	2937	D	Y
P13611	LB/B	-	D4A8Y6	1826	R	H
P13611	LB/B	-	D4A8Y6	3011	N	K
P55072	LP/P	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1 (IBMPFD1) [MIM:167320]	L9L6K9	95	R	G
P55072	LP/P	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1 (IBMPFD1) [MIM:167320]	L9L6K9	155	R	C
P55072	LP/P	Frontotemporal dementia and/or amyotrophic lateral sclerosis 6 (FTDALS6) [MIM:613954]	L9L6K9	155	R	H
P55072	LP/P	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1 (IBMPFD1) [MIM:167320]	L9L6K9	155	R	H
P55072	LP/P	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1 (IBMPFD1) [MIM:167320]	L9L6K9	155	R	P
P55072	LP/P	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1 (IBMPFD1) [MIM:167320]	L9L6K9	159	R	H
P55072	LP/P	Frontotemporal dementia and/or amyotrophic lateral sclerosis 6 (FTDALS6) [MIM:613954]	L9L6K9	191	R	Q
P55072	LP/P	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1 (IBMPFD1) [MIM:167320]	L9L6K9	191	R	Q
P55072	LP/P	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1 (IBMPFD1) [MIM:167320]	L9L6K9	232	A	E
P55072	LP/P	Frontotemporal dementia and/or amyotrophic lateral sclerosis 6 (FTDALS6) [MIM:613954]	L9L6K9	159	R	G
P55072	LP/P	Frontotemporal dementia and/or amyotrophic lateral sclerosis 6 (FTDALS6) [MIM:613954]	L9L6K9	592	D	N
P55072	LP/P	Charcot-Marie-Tooth disease, axonal, 2Y (CMT2Y) [MIM:616687]	L9L6K9	97	G	E
P55072	LP/P	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1 (IBMPFD1) [MIM:167320]	L9L6K9	155	R	S
P55072	LP/P	Charcot-Marie-Tooth disease, axonal, 2Y (CMT2Y) [MIM:616687]	L9L6K9	185	E	K
P55072	LP/P	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1 (IBMPFD1) [MIM:167320]	L9L6K9	198	L	W
P55072	LP/P	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1 (IBMPFD1) [MIM:167320]	L9L6K9	155	R	L
Q9H867	LB/B	-	A0A091DFB7	63	A	D
Q9H322	LB/B	-	A0A2I3MR06	70	A	G
Q9H322	LB/B	-	A0A2I3MR06	104	L	P
Q9H322	LB/B	-	A0A2I3MR06	110	V	L
Q9H322	LB/B	-	A0A2I3MR06	138	T	S
P45880	LB/B	-	A0A2I4C1K6	24	A	V
P11473	LP/P	Rickets vitamin D-dependent 2A (VDDR2A) [MIM:277440]	B3FNS0	33	G	D
P11473	LP/P	Rickets vitamin D-dependent 2A (VDDR2A) [MIM:277440]	B3FNS0	35	H	Q
P11473	LP/P	Rickets vitamin D-dependent 2A (VDDR2A) [MIM:277440]	B3FNS0	45	K	E
P11473	LP/P	Rickets vitamin D-dependent 2A (VDDR2A) [MIM:277440]	B3FNS0	46	G	D
P11473	LP/P	Rickets vitamin D-dependent 2A (VDDR2A) [MIM:277440]	B3FNS0	47	F	I
P11473	LP/P	Rickets vitamin D-dependent 2A (VDDR2A) [MIM:277440]	B3FNS0	50	R	Q
P11473	LP/P	Rickets vitamin D-dependent 2A (VDDR2A) [MIM:277440]	B3FNS0	73	R	Q
P11473	LP/P	Rickets vitamin D-dependent 2A (VDDR2A) [MIM:277440]	B3FNS0	80	R	Q
P11473	LP/P	Rickets vitamin D-dependent 2A (VDDR2A) [MIM:277440]	B3FNS0	274	R	L
P11473	LP/P	Rickets vitamin D-dependent 2A (VDDR2A) [MIM:277440]	B3FNS0	305	H	Q
P11473	LP/P	Rickets vitamin D-dependent 2A (VDDR2A) [MIM:277440]	B3FNS0	314	I	S
P11473	LP/P	Rickets vitamin D-dependent 2A (VDDR2A) [MIM:277440]	B3FNS0	391	R	C
P11473	LB/B	-	B3FNS0	230	L	V
P11473	LB/B	-	B3FNS0	362	T	I
P11473	LP/P	Rickets vitamin D-dependent 2A (VDDR2A) [MIM:277440]	B3FNS0	346	V	M
P11473	LP/P	Rickets vitamin D-dependent 2A (VDDR2A) [MIM:277440]	B3FNS0	360	S	P
O95231	LB/B	-	G7N1G0	42	L	P
O95231	LB/B	-	G7N1G0	79	M	V
O95231	LB/B	-	G7N1G0	101	E	K
O95231	LB/B	-	G7N1G0	191	G	R
O95231	LB/B	-	G7N1G0	247	G	D
Q14D04	LB/B	-	C3XQ29	208	S	C
Q14D04	LB/B	-	C3XQ29	263	V	G
Q14D04	LB/B	-	C3XQ29	271	S	C
Q14D04	LB/B	-	C3XQ29	319	M	V
Q14D04	LB/B	-	C3XQ29	329	L	V
Q14D04	LB/B	-	C3XQ29	365	R	Q
Q14D04	LB/B	-	C3XQ29	522	S	P
Q14D04	LB/B	-	C3XQ29	501	S	L
Q99990	LB/B	-	I3LPB1	59	T	I
Q14135	LB/B	-	Q80V24	32	M	I
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	38	S	P
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	52	E	K
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	65	S	L
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	65	S	W
P40337	LP/P	Pheochromocytoma (PCC) [MIM:171300]	A0A2K5RHS4	68	S	W
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	68	S	W
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	70	E	K
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	74	V	G
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	76	F	I
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	76	F	L
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	76	F	S
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	78	N	H
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	78	N	S
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	78	N	T
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	79	R	P
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	80	S	I
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	80	S	R
P40337	LP/P	Pheochromocytoma (PCC) [MIM:171300]	A0A2K5RHS4	80	S	N
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	80	S	N
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	81	P	S
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	82	R	P
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	84	V	L
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	86	P	A
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	86	P	L
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	86	P	R
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	86	P	S
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	88	W	R
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	88	W	S
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	89	L	P
P40337	LB/B	-	A0A2K5RHS4	91	F	L
P40337	LP/P	Pheochromocytoma (PCC) [MIM:171300]	A0A2K5RHS4	93	G	C
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	93	G	C
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	93	G	D
P40337	LP/P	Pheochromocytoma (PCC) [MIM:171300]	A0A2K5RHS4	93	G	S
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	93	G	S
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	96	Q	P
P40337	LP/P	Pheochromocytoma (PCC) [MIM:171300]	A0A2K5RHS4	98	Y	H
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	98	Y	H
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	101	L	G
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	101	L	R
P40337	LB/B	-	A0A2K5RHS4	104	G	A
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	105	T	P
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	107	R	P
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	111	S	C
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	111	S	N
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	111	S	R
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	112	Y	H
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	114	G	C
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	114	G	R
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	114	G	S
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	115	H	Y
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	115	H	Q
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	116	L	V
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	117	W	C
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	118	L	P
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	118	L	R
P40337	LP/P	Pheochromocytoma (PCC) [MIM:171300]	A0A2K5RHS4	119	F	L
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	119	F	L
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	119	F	S
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	121	D	G
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	128	L	F
P40337	LP/P	Erythrocytosis, familial, 2 (ECYT2) [MIM:263400]	A0A2K5RHS4	130	V	L
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	130	V	L
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	131	N	K
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	131	N	T
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	136	F	S
P40337	LP/P	Pheochromocytoma (PCC) [MIM:171300]	A0A2K5RHS4	136	F	C
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	136	F	C
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	143	D	E
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	149	A	T
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	154	P	L
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	155	V	G
P40337	LP/P	Pheochromocytoma (PCC) [MIM:171300]	A0A2K5RHS4	156	Y	C
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	156	Y	C
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	156	Y	D
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	157	T	I
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	158	L	P
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	158	L	V
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	159	K	E
P40337	LP/P	Pheochromocytoma (PCC) [MIM:171300]	A0A2K5RHS4	161	R	Q
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	161	R	Q
P40337	LP/P	Pheochromocytoma (PCC) [MIM:171300]	A0A2K5RHS4	161	R	P
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	161	R	P
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	161	R	G
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	162	C	F
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	162	C	R
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	162	C	W
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	162	C	Y
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	164	Q	R
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	166	V	F
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	167	R	G
P40337	LP/P	Pheochromocytoma (PCC) [MIM:171300]	A0A2K5RHS4	167	R	Q
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	167	R	Q
P40337	LP/P	Pheochromocytoma (PCC) [MIM:171300]	A0A2K5RHS4	167	R	W
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	167	R	W
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	170	V	D
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	170	V	F
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	170	V	G
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	175	Y	D
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	178	L	P
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	178	L	Q
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	180	I	V
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	184	L	R
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	184	L	P
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	186	E	K
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	188	L	P
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	188	L	Q
P40337	LP/P	Erythrocytosis, familial, 2 (ECYT2) [MIM:263400]	A0A2K5RHS4	188	L	V
P40337	LP/P	Pheochromocytoma (PCC) [MIM:171300]	A0A2K5RHS4	188	L	V
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	188	L	V
P40337	LP/P	Erythrocytosis, familial, 2 (ECYT2) [MIM:263400]	A0A2K5RHS4	198	L	R
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	198	L	R
P40337	LP/P	Erythrocytosis, familial, 2 (ECYT2) [MIM:263400]	A0A2K5RHS4	200	R	W
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	200	R	W
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	86	P	H
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	115	H	R
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	136	F	Y
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	145	Q	H
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	155	V	M
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	164	Q	H
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	166	V	D
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	176	R	W
P40337	LB/B	Pheochromocytoma (PCC) [MIM:171300]	A0A2K5RHS4	25	P	L
P40337	LP/P	Pheochromocytoma (PCC) [MIM:171300]	A0A2K5RHS4	63	L	P
P40337	LP/P	Pheochromocytoma (PCC) [MIM:171300]	A0A2K5RHS4	64	R	P
P40337	LP/P	Pheochromocytoma (PCC) [MIM:171300]	A0A2K5RHS4	65	S	A
P40337	LP/P	Pheochromocytoma (PCC) [MIM:171300]	A0A2K5RHS4	107	R	G
P40337	LP/P	Von Hippel-Lindau disease (VHLD) [MIM:193300]	A0A2K5RHS4	112	Y	N
P40337	LP/P	Pheochromocytoma (PCC) [MIM:171300]	A0A2K5RHS4	122	A	I
P40337	LP/P	Erythrocytosis, familial, 2 (ECYT2) [MIM:263400]	A0A2K5RHS4	126	D	Y
P40337	LB/B	-	A0A2K5RHS4	135	L	F
P40337	LP/P	Pheochromocytoma (PCC) [MIM:171300]	A0A2K5RHS4	147	I	T
P40337	LP/P	Pheochromocytoma (PCC) [MIM:171300]	A0A2K5RHS4	156	Y	N
P40337	LP/P	Renal cell carcinoma (RCC) [MIM:144700]	A0A2K5RHS4	163	L	P
P40337	LP/P	Erythrocytosis, familial, 2 (ECYT2) [MIM:263400]	A0A2K5RHS4	191	H	D
P40337	LP/P	Erythrocytosis, familial, 2 (ECYT2) [MIM:263400]	A0A2K5RHS4	192	P	S
P40337	LP/P	Pheochromocytoma (PCC) [MIM:171300]	A0A2K5RHS4	198	L	Q
P40337	LB/B	-	A0A2K5RHS4	110	H	Y
P09327	LB/B	-	F1QQQ5	254	K	R
P08670	LP/P	Cataract 30, multiple types (CTRCT30) [MIM:116300]	L9JAU6	151	E	K
P32241	LB/B	-	K7GGM6	445	R	L
P32241	LB/B	-	K7GGM6	341	R	M
P41587	LB/B	-	A0A2I3N0J8	39	A	T
P41587	LB/B	-	A0A2I3N0J8	412	R	H
P98155	LB/B	-	H3K2Y7	59	V	I
P98155	LB/B	-	H3K2Y7	379	E	K
P98155	LB/B	-	H3K2Y7	262	P	H
P98155	LB/B	-	H3K2Y7	464	L	I
P98155	LB/B	-	H3K2Y7	561	I	V
P98155	LB/B	-	H3K2Y7	613	R	H
P98155	LB/B	-	H3K2Y7	791	V	I
Q7Z5L0	LB/B	-	A0A1V4J9H7	77	T	S
Q7Z5L0	LB/B	-	A0A1V4J9H7	26	T	A
Q9GZP7	LB/B	-	A0A0A0Y845	139	I	T
Q9GZP7	LB/B	-	A0A0A0Y845	241	S	F
Q9GZP7	LB/B	-	A0A0A0Y845	269	A	D
Q9GZP7	LB/B	-	A0A0A0Y845	103	I	M
Q8NFZ6	LB/B	-	A0A2I3HWF8	38	C	R
Q7Z5H5	LB/B	-	A0A0A0Y845	52	A	V
Q7Z5H5	LB/B	-	A0A0A0Y845	58	R	L
Q7Z5H5	LB/B	-	A0A0A0Y845	220	D	N
O95497	LB/B	-	L9L6Y2	26	T	I
O95497	LB/B	-	L9L6Y2	63	A	T
O95497	LB/B	-	L9L6Y2	131	N	S
O95497	LB/B	-	L9L6Y2	136	V	L
O95497	LB/B	-	L9L6Y2	146	D	N
O95497	LB/B	-	L9L6Y2	296	E	D
O95497	LB/B	-	L9L6Y2	325	A	E
O95497	LB/B	-	L9L6Y2	336	T	A
O95497	LB/B	-	L9L6Y2	373	I	T
O95498	LB/B	-	L9L6Y2	404	L	M
O95498	LB/B	-	L9L6Y2	17	T	N
O95498	LB/B	-	L9L6Y2	112	D	E
O95498	LB/B	-	L9L6Y2	241	V	I
O95498	LB/B	-	L9L6Y2	349	T	S
O95498	LB/B	-	L9L6Y2	30	V	A
P12018	LB/B	-	A0A2Y9ISG2	76	D	N
P12018	LB/B	-	A0A2Y9ISG2	122	S	L
P12018	LB/B	-	A0A2Y9ISG2	132	E	K
Q9UKI3	LB/B	-	S7N8C0	4	R	W
Q7Z7G8	LP/P	Cohen syndrome (COH1) [MIM:216550]	A0A096LTP0	2341	Y	C
Q7Z7G8	LP/P	Cohen syndrome (COH1) [MIM:216550]	A0A096LTP0	2645	G	D
Q7Z7G8	LP/P	Cohen syndrome (COH1) [MIM:216550]	A0A096LTP0	2993	N	S
Q7Z7G8	LB/B	-	A0A096LTP0	1138	P	L
Q7Z7G8	LB/B	-	A0A096LTP0	2584	V	A
Q7Z7G8	LB/B	-	A0A096LTP0	3432	G	R
Q7Z7G8	LB/B	-	A0A096LTP0	829	A	T
Q7Z7G8	LB/B	-	A0A096LTP0	866	V	I
Q7Z7G8	LB/B	-	A0A096LTP0	1994	I	V
Q7Z7G8	LP/P	Cohen syndrome (COH1) [MIM:216550]	A0A096LTP0	2773	S	L
Q7Z7G8	LP/P	Cohen syndrome (COH1) [MIM:216550]	A0A096LTP0	2820	I	T
Q7Z7G8	LB/B	-	A0A096LTP0	2822	Y	C
Q7Z7G8	LB/B	-	A0A096LTP0	3142	S	R
Q7Z7G8	LB/B	-	A0A096LTP0	2481	V	I
Q9H269	LB/B	-	K7FQH3	637	S	I
Q9H269	LP/P	Dystonia 30 (DYT30) [MIM:619291]	K7FQH3	52	N	K
Q9BRG1	LB/B	-	A0A091DE45	76	I	V
Q96AX1	LB/B	-	A0A1Y1XUL5	256	I	L
Q96AX1	LP/P	Mucopolysaccharidosis-plus syndrome (MPSPS) [MIM:617303]	A0A1Y1XUL5	498	R	W
Q96QK1	LB/B	-	L5LV74	602	V	D
Q96QK1	LB/B	-	L5LV74	51	G	S
Q96QK1	LB/B	-	L5LV74	57	M	I
Q96QK1	LB/B	-	L5LV74	82	T	R
Q96QK1	LB/B	-	L5LV74	241	I	M
Q96QK1	LB/B	-	L5LV74	316	P	S
Q96QK1	LB/B	-	L5LV74	524	R	W
Q96QK1	LP/P	Parkinson disease 17 (PARK17) [MIM:614203]	L5LV74	620	D	N
Q96QK1	LB/B	-	L5LV74	737	A	V
Q96QK1	LB/B	-	L5LV74	774	L	M
Q7Z3J2	LB/B	-	A0A224YT66	32	Y	C
Q7Z3J2	LB/B	-	A0A224YT66	186	N	I
Q7Z3J2	LB/B	-	A0A224YT66	506	A	V
Q7Z3J2	LP/P	Ritscher-Schinzel syndrome 3 (RTSC3) [MIM:619135]	A0A224YT66	830	A	T
Q8NEZ2	LB/B	-	V8PG02	206	I	F
Q8NEZ2	LB/B	-	V8PG02	213	I	V
Q8NEZ2	LP/P	Spastic paraplegia 53, autosomal recessive (SPG53) [MIM:614898]	V8PG02	382	K	N
Q9NRW7	LP/P	Neutropenia, severe congenital 5, autosomal recessive (SCN5) [MIM:615285]	S9WM13	224	T	N
Q9NRW7	LP/P	Neutropenia, severe congenital 5, autosomal recessive (SCN5) [MIM:615285]	S9WM13	238	E	K
Q9UN37	LP/P	CIMDAG syndrome (CIMDAG) [MIM:619273]	S9X0H6	203	G	E
Q9UN37	LP/P	CIMDAG syndrome (CIMDAG) [MIM:619273]	S9X0H6	206	E	K
Q9UN37	LP/P	CIMDAG syndrome (CIMDAG) [MIM:619273]	S9X0H6	284	R	G
Q9UN37	LP/P	CIMDAG syndrome (CIMDAG) [MIM:619273]	S9X0H6	284	R	W
Q9UID3	LP/P	Pontocerebellar hypoplasia 13 (PCH13) [MIM:618606]	A0A1A6HUX7	490	R	C
Q5VIR6	LB/B	-	W4YQ68	328	L	I
Q5VIR6	LB/B	-	W4YQ68	375	L	R
Q5VIR6	LP/P	Pontocerebellar hypoplasia 2E (PCH2E) [MIM:615851]	W4YQ68	695	Q	R
Q8N3P4	LB/B	-	K1R9K0	83	I	V
Q8N3P4	LB/B	-	K1R9K0	1165	H	Y
Q8N3P4	LB/B	-	K1R9K0	1364	I	T
Q8N3P4	LB/B	-	K1R9K0	1372	R	H
Q8IV63	LB/B	-	G5B8R8	59	S	F
Q8IV63	LB/B	-	G5B8R8	105	P	T
Q8IV63	LB/B	-	G5B8R8	171	F	L
Q8IV63	LB/B	-	G5B8R8	268	S	L
Q8IV63	LB/B	-	G5B8R8	288	C	Y
Q8IV63	LB/B	-	G5B8R8	370	R	C
Q8IV63	LB/B	-	G5B8R8	371	S	G
Q8IV63	LB/B	-	G5B8R8	170	S	P
Q8IV63	LB/B	-	G5B8R8	188	T	A
Q8IV63	LB/B	-	G5B8R8	304	H	L
Q86XK7	LB/B	-	G1PQ80	147	V	I
Q8N0Z9	LB/B	-	G3WME4	333	V	M
Q8N0Z9	LB/B	-	G3WME4	435	H	Y
Q86VR7	LB/B	-	A0A1S3G2N7	3	N	T
Q86VR7	LB/B	-	A0A1S3G2N7	356	M	I
Q86VR7	LB/B	-	A0A1S3G2N7	592	R	Q
Q86VR7	LB/B	-	A0A1S3G2N7	627	R	H
Q9Y279	LB/B	-	A0A2K6TYU4	108	R	W
Q9Y279	LB/B	-	A0A2K6TYU4	272	G	E
Q9Y279	LB/B	-	A0A2K6TYU4	279	G	E
Q9Y279	LB/B	-	A0A2K6TYU4	397	S	I
P62760	LB/B	-	Q4REH7	65	A	G
P62760	LB/B	-	Q4REH7	172	K	R
Q6UX27	LB/B	-	A0A2K5C3W0	163	S	G
Q8IW00	LB/B	-	A0A2K6U9L6	68	F	S
Q8IW00	LB/B	-	A0A2K6U9L6	243	K	R
Q9NZR4	LB/B	-	A0A2G9P2P9	144	D	E
Q9NZR4	LP/P	Keratoconus 1 (KTCN1) [MIM:148300]	A0A2G9P2P9	166	R	W
Q9NZR4	LP/P	Keratoconus 1 (KTCN1) [MIM:148300]	A0A2G9P2P9	175	Q	H
Q9NZR4	LP/P	Keratoconus 1 (KTCN1) [MIM:148300]	A0A2G9P2P9	17	L	P
Q9NZR4	LB/B	-	A0A2G9P2P9	131	R	S
Q9NZR4	LP/P	Craniofacial anomalies and anterior segment dysgenesis syndrome (CAASDS) [MIM:614195]	A0A2G9P2P9	256	A	S
P58304	LP/P	Microphthalmia with cataracts and iris abnormalities (MCOPCTI) [MIM:610092]	G1KSG9	200	R	P
P58304	LP/P	Microphthalmia with cataracts and iris abnormalities (MCOPCTI) [MIM:610092]	G1KSG9	200	R	Q
P58304	LP/P	Microphthalmia, isolated, 2 (MCOP2) [MIM:610093]	G1KSG9	227	R	W
P58304	LB/B	-	G1KSG9	100	P	Q
P58304	LP/P	Microphthalmia, isolated, 2 (MCOP2) [MIM:610093]	G1KSG9	223	G	A
P58304	LP/P	Microphthalmia, isolated, with coloboma, 3 (MCOPCB3) [MIM:610092]	G1KSG9	223	G	R
Q9NP79	LB/B	-	A0A2K5J7L2	239	I	M
P04004	LB/B	-	G7PTW8	122	A	S
P04004	LB/B	-	G7PTW8	268	R	Q
P04004	LB/B	-	G7PTW8	400	T	M
Q5GFL6	LB/B	-	F6TFA3	9	A	T
Q5GFL6	LB/B	-	F6TFA3	131	E	G
A6NCI4	LB/B	-	S9WDU6	657	T	I
A6NCI4	LB/B	-	S9WDU6	1165	Q	P
A6NCI4	LB/B	-	S9WDU6	464	T	I
Q502W6	LB/B	-	L8YB21	181	R	W
Q502W6	LB/B	-	L8YB21	677	L	V
Q502W6	LB/B	-	L8YB21	885	V	M
Q502W6	LB/B	-	L8YB21	1223	D	E
Q502W6	LB/B	-	L8YB21	1245	R	K
Q502W6	LB/B	-	L8YB21	1277	T	I
Q502W6	LB/B	-	L8YB21	1103	I	M
Q502W6	LP/P	Spinocerebellar ataxia, autosomal recessive, 22 (SCAR22) [MIM:616948]	L8YB21	622	K	T
Q502W6	LB/B	-	L8YB21	42	L	M
Q5TIE3	LB/B	-	U3K002	319	A	S
Q5TIE3	LB/B	-	U3K002	469	N	S
Q5TIE3	LB/B	-	U3K002	506	S	N
Q5TIE3	LB/B	-	U3K002	634	K	R
Q8N398	LB/B	-	U3K002	200	P	S
Q2TAL6	LB/B	-	W5MCB8	120	A	G
Q96DN2	LB/B	-	W5PSF1	842	P	R
Q8N2E2	LB/B	-	G7MLS7	964	K	N
Q8N2E2	LB/B	-	G7MLS7	1032	T	M
Q8N2E2	LB/B	-	G7MLS7	1256	Q	K
Q8N2E2	LB/B	-	G7MLS7	1485	F	C
Q8N2E2	LB/B	-	G7MLS7	607	S	F
P04275	LP/P	Von Willebrand disease 3 (VWD3) [MIM:277480]	G1NM99	377	W	C
P04275	LP/P	Von Willebrand disease 2 (VWD2) [MIM:613554]	G1NM99	528	N	S
P04275	LP/P	Von Willebrand disease 2 (VWD2) [MIM:613554]	G1NM99	550	G	R
P04275	LB/B	-	G1NM99	789	T	A
P04275	LP/P	Von Willebrand disease 2 (VWD2) [MIM:613554]	G1NM99	791	T	M
P04275	LP/P	Von Willebrand disease 2 (VWD2) [MIM:613554]	G1NM99	816	R	W
P04275	LB/B	-	G1NM99	852	Q	R
P04275	LP/P	Von Willebrand disease 2 (VWD2) [MIM:613554]	G1NM99	854	R	Q
P04275	LB/B	-	G1NM99	857	N	D
P04275	LP/P	Von Willebrand disease 2 (VWD2) [MIM:613554]	G1NM99	1266	P	L
P04275	LP/P	Von Willebrand disease 2 (VWD2) [MIM:613554]	G1NM99	1268	H	D
P04275	LP/P	Von Willebrand disease 2 (VWD2) [MIM:613554]	G1NM99	1272	C	R
P04275	LP/P	Von Willebrand disease 2 (VWD2) [MIM:613554]	G1NM99	1306	R	W
P04275	LP/P	Von Willebrand disease 2 (VWD2) [MIM:613554]	G1NM99	1308	R	C
P04275	LP/P	Von Willebrand disease 2 (VWD2) [MIM:613554]	G1NM99	1313	W	C
P04275	LP/P	Von Willebrand disease 2 (VWD2) [MIM:613554]	G1NM99	1314	V	L
P04275	LP/P	Von Willebrand disease 2 (VWD2) [MIM:613554]	G1NM99	1316	V	M
P04275	LP/P	Von Willebrand disease 2 (VWD2) [MIM:613554]	G1NM99	1318	V	L
P04275	LP/P	Von Willebrand disease 2 (VWD2) [MIM:613554]	G1NM99	1324	G	S
P04275	LP/P	Von Willebrand disease 2 (VWD2) [MIM:613554]	G1NM99	1341	R	Q
P04275	LP/P	Von Willebrand disease 2 (VWD2) [MIM:613554]	G1NM99	1374	R	C
P04275	LP/P	Von Willebrand disease 2 (VWD2) [MIM:613554]	G1NM99	1374	R	H
P04275	LB/B	-	G1NM99	1381	T	A
P04275	LB/B	-	G1NM99	1399	R	H
P04275	LP/P	Von Willebrand disease 2 (VWD2) [MIM:613554]	G1NM99	1460	L	V
P04275	LP/P	Von Willebrand disease 2 (VWD2) [MIM:613554]	G1NM99	1461	A	V
P04275	LP/P	Von Willebrand disease 2 (VWD2) [MIM:613554]	G1NM99	1514	F	C
P04275	LP/P	Von Willebrand disease 2 (VWD2) [MIM:613554]	G1NM99	1540	L	P
P04275	LB/B	-	G1NM99	1584	Y	C
P04275	LP/P	Von Willebrand disease 2 (VWD2) [MIM:613554]	G1NM99	1597	R	G
P04275	LP/P	Von Willebrand disease 2 (VWD2) [MIM:613554]	G1NM99	1597	R	Q
P04275	LP/P	Von Willebrand disease 2 (VWD2) [MIM:613554]	G1NM99	1597	R	W
P04275	LP/P	Von Willebrand disease 2 (VWD2) [MIM:613554]	G1NM99	1607	V	D
P04275	LP/P	Von Willebrand disease 2 (VWD2) [MIM:613554]	G1NM99	1609	G	R
P04275	LP/P	Von Willebrand disease 2 (VWD2) [MIM:613554]	G1NM99	1613	S	P
P04275	LP/P	Von Willebrand disease 2 (VWD2) [MIM:613554]	G1NM99	1628	I	T
P04275	LP/P	Von Willebrand disease 2 (VWD2) [MIM:613554]	G1NM99	1638	E	K
P04275	LP/P	Von Willebrand disease 2 (VWD2) [MIM:613554]	G1NM99	1648	P	S
P04275	LP/P	Von Willebrand disease 2 (VWD2) [MIM:613554]	G1NM99	1665	V	E
P04275	LP/P	Von Willebrand disease 3 (VWD3) [MIM:277480]	G1NM99	2739	C	Y
P04275	LP/P	Von Willebrand disease 2 (VWD2) [MIM:613554]	G1NM99	2773	C	R
P04275	LP/P	Von Willebrand disease 2 (VWD2) [MIM:613554]	G1NM99	788	C	Y
P04275	LB/B	Von Willebrand disease 3 (VWD3) [MIM:277480]	G1NM99	2063	P	S
P04275	LP/P	Von Willebrand disease 3 (VWD3) [MIM:277480]	G1NM99	2362	C	F
P04275	LP/P	Von Willebrand disease 3 (VWD3) [MIM:277480]	G1NM99	2546	N	Y
P04275	LP/P	Von Willebrand disease 1 (VWD1) [MIM:193400]	G1NM99	273	R	W
P04275	LP/P	Von Willebrand disease 3 (VWD3) [MIM:277480]	G1NM99	273	R	W
P04275	LB/B	-	G1NM99	1565	V	L
P04275	LB/B	-	G1NM99	484	H	R
P04275	LP/P	Von Willebrand disease 2 (VWD2) [MIM:613554]	G1NM99	1060	C	R
P04275	LB/B	-	G1NM99	1472	D	H
P04275	LB/B	-	G1NM99	318	N	K
P04275	LB/B	-	G1NM99	740	M	I
P04275	LB/B	-	G1NM99	885	F	S
P04275	LB/B	-	G1NM99	2178	A	S
P04275	LB/B	-	G1NM99	2185	R	Q
P04275	LB/B	-	G1NM99	2705	G	R
P04275	LB/B	-	G1NM99	471	V	I
P04275	LP/P	Von Willebrand disease 1 (VWD1) [MIM:193400]	G1NM99	1149	C	R
P04275	LP/P	Von Willebrand disease 2 (VWD2) [MIM:613554]	G1NM99	1272	C	F
Q9BTA9	LB/B	-	A0A2Y9P2P6	242	S	R
Q9BTA9	LB/B	-	A0A2Y9P2P6	531	T	S
Q9BTA9	LB/B	-	A0A2Y9P2P6	309	T	A
Q7Z5K2	LB/B	-	F1QU33	124	V	I
Q9UGM6	LB/B	-	A0A2Y9P8J0	267	A	P
Q9UGM6	LB/B	-	A0A2Y9P8J0	50	G	S
Q9UGM6	LB/B	-	A0A2Y9P8J0	360	L	P
Q9UGM6	LP/P	Neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures (NEMMLAS) [MIM:617710]	A0A2Y9P8J0	13	W	G
Q9UGM6	LP/P	Parkinsonism-dystonia 3, childhood-onset (PKDYS3) [MIM:619738]	A0A2Y9P8J0	13	W	G
Q9UGM6	LP/P	Neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures (NEMMLAS) [MIM:617710]	A0A2Y9P8J0	45	G	V
Q9UGM6	LP/P	Neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures (NEMMLAS) [MIM:617710]	A0A2Y9P8J0	178	V	L
Q9UGM6	LP/P	Neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures (NEMMLAS) [MIM:617710]	A0A2Y9P8J0	313	K	M
Q9UGM6	LP/P	Neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures (NEMMLAS) [MIM:617710]	A0A2Y9P8J0	349	V	L
Q9UGM6	LP/P	Parkinsonism-dystonia 3, childhood-onset (PKDYS3) [MIM:619738]	A0A2Y9P8J0	50	G	D
Q9UGM6	LP/P	Parkinsonism-dystonia 3, childhood-onset (PKDYS3) [MIM:619738]	A0A2Y9P8J0	228	S	W
Q9UGM6	LP/P	Neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures (NEMMLAS) [MIM:617710]	A0A2Y9P8J0	278	V	G
Q2M389	LB/B	-	A0A067QYP0	323	V	L
Q2M389	LB/B	-	A0A067QYP0	901	V	I
Q2M389	LB/B	-	A0A067QYP0	599	T	S
Q2M389	LP/P	Intellectual developmental disorder, autosomal recessive 43 (MRT43) [MIM:615817]	A0A067QYP0	1019	P	R
Q9NX94	LB/B	-	A0A091DJM8	302	S	P
Q9NX94	LB/B	-	A0A091DJM8	320	A	S
Q6ICG8	LB/B	-	L5KBU6	5	Q	E
Q6ICG8	LB/B	-	L5KBU6	121	D	G
Q6ICG8	LB/B	-	L5KBU6	170	C	F
Q6ICG8	LB/B	-	L5KBU6	285	Q	H
Q9H6R7	LB/B	-	A0A2K5D1L8	102	T	M
Q8IZQ1	LB/B	-	A0A1W5AG64	3032	I	V
Q8IZQ1	LP/P	Microcephaly 18, primary, autosomal dominant (MCPH18) [MIM:617520]	A0A1W5AG64	2637	R	W
O75717	LB/B	-	K7FYF0	338	F	L
O75717	LB/B	-	K7FYF0	411	L	P
O75717	LB/B	-	K7FYF0	1102	E	K
O95876	LB/B	-	S7Q6Z2	268	G	S
O95876	LB/B	-	S7Q6Z2	55	R	K
O95876	LB/B	-	S7Q6Z2	708	S	F
O95876	LP/P	Congenital heart defects, hamartomas of tongue, and polysyndactyly (CHDTHP) [MIM:217085]	S7Q6Z2	54	D	N
O75083	LB/B	-	A0A0L0HLV8	185	I	V
O75083	LP/P	Periodic fever, immunodeficiency, and thrombocytopenia syndrome (PFITS) [MIM:150550]	A0A0L0HLV8	293	L	F
O75083	LP/P	Periodic fever, immunodeficiency, and thrombocytopenia syndrome (PFITS) [MIM:150550]	A0A0L0HLV8	572	D	V
Q9BZH6	LP/P	Hypogonadotropic hypogonadism 14 with or without anosmia (HH14) [MIM:614858]	L5MA68	395	R	W
Q9BZH6	LP/P	Hypogonadotropic hypogonadism 14 with or without anosmia (HH14) [MIM:614858]	L5MA68	435	A	T
Q9BZH6	LP/P	Hypogonadotropic hypogonadism 14 with or without anosmia (HH14) [MIM:614858]	L5MA68	448	R	Q
Q9BZH6	LP/P	Hypogonadotropic hypogonadism 14 with or without anosmia (HH14) [MIM:614858]	L5MA68	690	H	Q
Q9BZH6	LB/B	-	L5MA68	978	K	Q
Q9BZH6	LP/P	Hypogonadotropic hypogonadism 14 with or without anosmia (HH14) [MIM:614858]	L5MA68	1150	F	L
Q9BZH6	LP/P	Hypogonadotropic hypogonadism 14 with or without anosmia (HH14) [MIM:614858]	L5MA68	537	P	L
Q9GZL7	LB/B	-	A0A1Y2GSN6	72	M	V
Q9GZL7	LB/B	-	A0A1Y2GSN6	89	Y	C
Q9GZL7	LB/B	-	A0A1Y2GSN6	286	E	G
Q9GZL7	LB/B	-	A0A1Y2GSN6	75	I	V
Q9H1Z4	LB/B	-	I3LPL0	325	R	H
Q8IZU2	LB/B	-	A0A0P7TZN4	814	A	T
Q8IZU2	LB/B	-	A0A0P7TZN4	913	C	S
Q8IZU2	LB/B	-	A0A0P7TZN4	952	E	K
Q8IZU2	LB/B	-	A0A0P7TZN4	1215	A	T
Q8IZU2	LB/B	-	A0A0P7TZN4	1295	A	T
Q8IZU2	LB/B	-	A0A0P7TZN4	418	I	V
Q8NEZ3	LB/B	-	C3Z0T8	1084	G	S
Q8NEZ3	LP/P	Short-rib thoracic dysplasia 5 with or without polydactyly (SRTD5) [MIM:614376]	C3Z0T8	7	L	P
Q8NEZ3	LP/P	Nephronophthisis 13 (NPHP13) [MIM:614377]	C3Z0T8	345	V	G
Q8NEZ3	LP/P	Cranioectodermal dysplasia 4 (CED4) [MIM:614378]	C3Z0T8	710	L	S
Q8NEZ3	LP/P	Senior-Loken syndrome 8 (SLSN8) [MIM:616307]	C3Z0T8	710	L	S
Q8NEZ3	LP/P	Senior-Loken syndrome 8 (SLSN8) [MIM:616307]	C3Z0T8	30	A	P
Q8NEZ3	LP/P	Senior-Loken syndrome 8 (SLSN8) [MIM:616307]	C3Z0T8	68	V	D
Q8NEZ3	LP/P	Senior-Loken syndrome 8 (SLSN8) [MIM:616307]	C3Z0T8	109	G	E
Q8NEZ3	LP/P	Senior-Loken syndrome 8 (SLSN8) [MIM:616307]	C3Z0T8	272	R	C
Q8NEZ3	LP/P	Senior-Loken syndrome 8 (SLSN8) [MIM:616307]	C3Z0T8	493	D	H
Q8NEZ3	LP/P	Senior-Loken syndrome 8 (SLSN8) [MIM:616307]	C3Z0T8	1178	R	Q
Q8NEZ3	LP/P	Senior-Loken syndrome 8 (SLSN8) [MIM:616307]	C3Z0T8	1235	E	K
Q8TBZ3	LB/B	-	G3PIK2	159	P	H
Q8TBZ3	LB/B	-	G3PIK2	444	G	C
A2RRH5	LB/B	-	A0A2Y9SI00	133	L	P
A2RRH5	LB/B	-	A0A2Y9SI00	393	V	L
A2RRH5	LB/B	-	A0A2Y9SI00	437	R	H
A2RRH5	LB/B	-	A0A2Y9SI00	470	P	L
A2RRH5	LB/B	-	A0A2Y9SI00	697	A	V
Q9UNX4	LB/B	-	X2BAP9	234	P	A
Q9P2L0	LB/B	-	A0A0P4W8W7	18	Q	R
Q9P2L0	LB/B	-	A0A0P4W8W7	983	E	G
Q9P2L0	LB/B	-	A0A0P4W8W7	878	A	P
Q9P2L0	LB/B	-	A0A0P4W8W7	878	A	T
Q9P2L0	LP/P	Cranioectodermal dysplasia 2 (CED2) [MIM:613610]	A0A0P4W8W7	626	E	G
Q9P2L0	LP/P	Cranioectodermal dysplasia 2 (CED2) [MIM:613610]	A0A0P4W8W7	875	A	T
Q9P2L0	LP/P	Short-rib thoracic dysplasia 7 with or without polydactyly (SRTD7) [MIM:614091]	A0A0P4W8W7	261	W	R
Q9P2L0	LP/P	Short-rib thoracic dysplasia 7 with or without polydactyly (SRTD7) [MIM:614091]	A0A0P4W8W7	311	W	L
Q9P2L0	LP/P	Short-rib thoracic dysplasia 7/20 with polydactyly, digenic (SRTD7/20) [MIM:614091]	A0A0P4W8W7	311	W	L
Q9P2L0	LP/P	Short-rib thoracic dysplasia 7 with or without polydactyly (SRTD7) [MIM:614091]	A0A0P4W8W7	478	R	K
Q9Y2I8	LB/B	-	A0A146WVA0	225	I	V
Q9Y2I8	LB/B	-	A0A146WVA0	11	A	T
Q9Y2I8	LB/B	-	A0A146WVA0	221	Q	K
Q9Y2I8	LP/P	Neurooculocardiogenitourinary syndrome (NOCGUS) [MIM:618652]	A0A146WVA0	119	S	F
Q9Y2I8	LP/P	Neurooculocardiogenitourinary syndrome (NOCGUS) [MIM:618652]	A0A146WVA0	125	T	I
Q9Y2I8	LP/P	Neurooculocardiogenitourinary syndrome (NOCGUS) [MIM:618652]	A0A146WVA0	129	S	C
Q9Y2I8	LP/P	Neurooculocardiogenitourinary syndrome (NOCGUS) [MIM:618652]	A0A146WVA0	130	T	I
Q9Y2I8	LP/P	Neurooculocardiogenitourinary syndrome (NOCGUS) [MIM:618652]	A0A146WVA0	115	T	I
Q9Y2I8	LP/P	Neurooculocardiogenitourinary syndrome (NOCGUS) [MIM:618652]	A0A146WVA0	119	S	Y
Q9Y2I8	LP/P	Neurooculocardiogenitourinary syndrome (NOCGUS) [MIM:618652]	A0A146WVA0	220	D	G
Q9Y2I8	LP/P	Neurooculocardiogenitourinary syndrome (NOCGUS) [MIM:618652]	A0A146WVA0	260	D	N
Q5JTN6	LB/B	-	A0A2Y9NLC8	172	H	R
Q5JTN6	LB/B	-	A0A2Y9NLC8	193	A	G
P57081	LB/B	-	A0A2U4AAT9	71	K	N
P57081	LB/B	-	A0A2U4AAT9	266	P	S
P57081	LB/B	-	A0A2U4AAT9	390	R	Q
P57081	LP/P	Microcephaly, growth deficiency, seizures, and brain malformations (MIGSB) [MIM:618346]	A0A2U4AAT9	170	R	L
P57081	LP/P	Galloway-Mowat syndrome 6 (GAMOS6) [MIM:618347]	A0A2U4AAT9	170	R	Q
Q9HAD4	LB/B	-	F1Q4U0	329	V	I
Q9HAD4	LB/B	-	F1Q4U0	61	G	D
Q9HAD4	LB/B	-	F1Q4U0	260	R	C
Q5JSH3	LB/B	-	I3JCN2	289	A	T
Q5JSH3	LB/B	-	I3JCN2	296	T	A
O15213	LB/B	-	A0A287BMA8	341	V	A
O15213	LB/B	-	A0A287BMA8	94	T	A
O15213	LB/B	-	A0A287BMA8	124	S	Y
Q8IV35	LB/B	-	L8HXZ5	651	L	P
Q7Z5U6	LB/B	-	W5KB01	338	H	P
Q9H6Y2	LB/B	-	U3J1P2	50	R	C
Q9H6Y2	LB/B	-	U3J1P2	151	C	R
Q9H6Y2	LB/B	-	U3J1P2	210	S	F
Q9H6Y2	LB/B	-	U3J1P2	235	Y	C
Q6PJI9	LB/B	-	A0A131YP78	201	P	T
O43379	LB/B	-	L9JCQ8	850	L	S
O43379	LB/B	-	L9JCQ8	1370	G	S
O43379	LB/B	-	L9JCQ8	1385	L	F
O43379	LB/B	-	L9JCQ8	289	K	R
O43379	LB/B	-	L9JCQ8	1305	Q	L
O43379	LB/B	-	L9JCQ8	1311	Q	E
O43379	LP/P	Microcephaly 2, primary, autosomal recessive, with or without cortical malformations (MCPH2) [MIM:604317]	L9JCQ8	224	W	S
O43379	LP/P	Microcephaly 2, primary, autosomal recessive, with or without cortical malformations (MCPH2) [MIM:604317]	L9JCQ8	526	E	K
O43379	LP/P	Microcephaly 2, primary, autosomal recessive, with or without cortical malformations (MCPH2) [MIM:604317]	L9JCQ8	65	V	M
O43379	LP/P	Microcephaly 2, primary, autosomal recessive, with or without cortical malformations (MCPH2) [MIM:604317]	L9JCQ8	438	R	H
O43379	LP/P	Microcephaly 2, primary, autosomal recessive, with or without cortical malformations (MCPH2) [MIM:604317]	L9JCQ8	511	D	N
Q3MJ13	LB/B	-	A0A2I2UWN0	819	L	F
Q3MJ13	LB/B	-	A0A2I2UWN0	833	S	A
Q3MJ13	LB/B	-	A0A2I2UWN0	399	K	Q
Q3MJ13	LB/B	-	A0A2I2UWN0	479	Q	H
Q3MJ13	LB/B	-	A0A2I2UWN0	100	M	V
Q3MJ13	LB/B	-	A0A2I2UWN0	781	K	E
Q6P4I2	LB/B	-	H9GMS3	249	R	H
Q9BRX9	LB/B	-	L8YCZ6	278	G	S
Q9BRX9	LB/B	-	L8YCZ6	304	R	Q
Q9Y284	LB/B	-	F1QTT0	104	P	A
Q86TI4	LB/B	-	F7GZ51	355	M	T
Q6ZQQ6	LB/B	-	L8HSL9	496	H	Y
Q6ZQQ6	LB/B	-	L8HSL9	1583	R	Q
Q6ZQQ6	LB/B	-	L8HSL9	1885	N	K
Q6ZQQ6	LB/B	-	L8HSL9	2570	H	L
Q6ZMY6	LB/B	-	A0A2Y9DBY9	310	C	R
Q96KV7	LB/B	-	A0A091WLJ8	165	S	T
Q96KV7	LB/B	-	A0A091WLJ8	250	P	L
Q96KV7	LB/B	-	A0A091WLJ8	537	V	A
Q96KV7	LB/B	-	A0A091WLJ8	1001	P	T
Q96KV7	LB/B	-	A0A091WLJ8	1492	R	H
Q96KV7	LB/B	-	A0A091WLJ8	1555	C	R
Q8N9V3	LB/B	-	A0A2K6SWP4	215	K	T
Q8N9V3	LB/B	-	A0A2K6SWP4	223	H	D
Q8N9V3	LB/B	-	A0A2K6SWP4	320	R	S
P0C1S8	LB/B	-	H0XWX5	8	K	T
P0C1S8	LB/B	-	H0XWX5	470	D	E
P0C1S8	LB/B	-	H0XWX5	526	Y	D
P0C1S8	LP/P	Oocyte maturation defect 5 (OOMD5) [MIM:617996]	H0XWX5	234	D	H
Q8IUB3	LB/B	-	G1M1D8	8	L	P
Q8IUB2	LB/B	-	A0A250XWP2	36	H	D
Q8IUB2	LB/B	-	A0A250XWP2	198	G	S
Q8IUA0	LB/B	-	F6WMJ9	96	M	T
Q8IUA0	LB/B	-	F6WMJ9	137	N	S
Q8NEX5	LB/B	-	G1SFP4	27	N	T
Q8TEU8	LB/B	-	A0A2Y9DF56	96	V	M
Q8TEU8	LB/B	-	A0A2Y9DF56	31	R	Q
O76024	LB/B	-	A0A2K5EBD4	333	V	I
O76024	LB/B	-	A0A2K5EBD4	456	R	H
O76024	LP/P	Wolfram syndrome 1 (WFS1) [MIM:222300]	A0A2K5EBD4	504	P	L
O76024	LB/B	-	A0A2K5EBD4	611	R	H
O76024	LP/P	Wolfram syndrome 1 (WFS1) [MIM:222300]	A0A2K5EBD4	695	G	V
O76024	LP/P	Wolfram syndrome 1 (WFS1) [MIM:222300]	A0A2K5EBD4	724	P	L
O76024	LP/P	Wolfram syndrome 1 (WFS1) [MIM:222300]	A0A2K5EBD4	169	E	K
O76024	LP/P	Wolfram syndrome 1 (WFS1) [MIM:222300]	A0A2K5EBD4	292	P	S
O76024	LP/P	Wolfram syndrome 1 (WFS1) [MIM:222300]	A0A2K5EBD4	296	I	S
O76024	LP/P	Wolfram syndrome 1 (WFS1) [MIM:222300]	A0A2K5EBD4	437	G	R
O76024	LP/P	Wolfram syndrome 1 (WFS1) [MIM:222300]	A0A2K5EBD4	690	C	R
O76024	LP/P	Wolfram syndrome 1 (WFS1) [MIM:222300]	A0A2K5EBD4	700	W	C
O76024	LP/P	Wolfram syndrome 1 (WFS1) [MIM:222300]	A0A2K5EBD4	736	G	S
O76024	LP/P	Wolfram syndrome 1 (WFS1) [MIM:222300]	A0A2K5EBD4	885	P	L
O76024	LB/B	-	A0A2K5EBD4	559	A	T
O76024	LB/B	-	A0A2K5EBD4	576	G	S
O76024	LB/B	-	A0A2K5EBD4	720	I	V
O76024	LP/P	Wolfram syndrome 1 (WFS1) [MIM:222300]	A0A2K5EBD4	58	A	V
O76024	LP/P	Wolfram syndrome 1 (WFS1) [MIM:222300]	A0A2K5EBD4	126	A	T
O76024	LP/P	Wolfram syndrome 1 (WFS1) [MIM:222300]	A0A2K5EBD4	443	S	I
O76024	LB/B	-	A0A2K5EBD4	674	G	R
O76024	LP/P	Wolfram-like syndrome autosomal dominant (WFSL) [MIM:614296]	A0A2K5EBD4	684	A	V
O76024	LB/B	-	A0A2K5EBD4	708	R	C
O76024	LB/B	-	A0A2K5EBD4	737	E	K
O76024	LP/P	Wolfram syndrome 1 (WFS1) [MIM:222300]	A0A2K5EBD4	780	G	R
O76024	LP/P	Wolfram syndrome 1 (WFS1) [MIM:222300]	A0A2K5EBD4	818	R	C
O76024	LP/P	Wolfram syndrome 1 (WFS1) [MIM:222300]	A0A2K5EBD4	133	A	T
O76024	LP/P	Wolfram syndrome 1 (WFS1) [MIM:222300]	A0A2K5EBD4	669	Y	C
O76024	LB/B	-	A0A2K5EBD4	193	K	Q
O76024	LB/B	-	A0A2K5EBD4	871	V	M
O76024	LB/B	-	A0A2K5EBD4	602	A	V
O76024	LP/P	Wolfram syndrome 1 (WFS1) [MIM:222300]	A0A2K5EBD4	110	Y	N
O76024	LB/B	-	A0A2K5EBD4	326	A	V
O76024	LP/P	Wolfram syndrome 1 (WFS1) [MIM:222300]	A0A2K5EBD4	457	R	S
O76024	LP/P	Wolfram syndrome 1 (WFS1) [MIM:222300]	A0A2K5EBD4	629	R	W
O76024	LB/B	-	A0A2K5EBD4	802	I	V
O76024	LB/B	-	A0A2K5EBD4	16	P	L
O76024	LB/B	-	A0A2K5EBD4	107	G	R
O76024	LP/P	Deafness, autosomal dominant, 6 (DFNA6) [MIM:600965]	A0A2K5EBD4	634	K	T
O76024	LP/P	Deafness, autosomal dominant, 6 (DFNA6) [MIM:600965]	A0A2K5EBD4	699	T	M
O76024	LP/P	Deafness, autosomal dominant, 6 (DFNA6) [MIM:600965]	A0A2K5EBD4	716	A	T
O76024	LB/B	Deafness, autosomal dominant, 6 (DFNA6) [MIM:600965]	A0A2K5EBD4	779	V	M
O76024	LP/P	Deafness, autosomal dominant, 6 (DFNA6) [MIM:600965]	A0A2K5EBD4	829	L	P
O76024	LP/P	Deafness, autosomal dominant, 6 (DFNA6) [MIM:600965]	A0A2K5EBD4	831	G	D
O76024	LP/P	Wolfram-like syndrome autosomal dominant (WFSL) [MIM:614296]	A0A2K5EBD4	864	E	K
O76024	LP/P	Wolfram syndrome 1 (WFS1) [MIM:222300]	A0A2K5EBD4	558	R	C
O76024	LP/P	Wolfram-like syndrome autosomal dominant (WFSL) [MIM:614296]	A0A2K5EBD4	780	G	S
O76024	LP/P	Wolfram-like syndrome autosomal dominant (WFSL) [MIM:614296]	A0A2K5EBD4	797	D	Y
O76024	LP/P	Wolfram-like syndrome autosomal dominant (WFSL) [MIM:614296]	A0A2K5EBD4	836	K	N
O76024	LP/P	Deafness, autosomal dominant, 6 (DFNA6) [MIM:600965]	A0A2K5EBD4	859	R	Q
O76024	LP/P	Cataract 41 (CTRCT41) [MIM:116400]	A0A2K5EBD4	462	E	G
O76024	LP/P	Deafness, autosomal dominant, 6 (DFNA6) [MIM:600965]	A0A2K5EBD4	171	D	N
O76024	LP/P	Deafness, autosomal dominant, 6 (DFNA6) [MIM:600965]	A0A2K5EBD4	669	Y	H
O76024	LP/P	Deafness, autosomal dominant, 6 (DFNA6) [MIM:600965]	A0A2K5EBD4	685	R	P
O76024	LP/P	Deafness, autosomal dominant, 6 (DFNA6) [MIM:600965]	A0A2K5EBD4	696	H	Y
O76024	LP/P	Deafness, autosomal dominant, 6 (DFNA6) [MIM:600965]	A0A2K5EBD4	703	R	H
Q8TF30	LB/B	-	A0A2R9BWP3	340	Q	K
Q8TF30	LB/B	-	A0A2R9BWP3	345	R	Q
Q8TF30	LB/B	-	A0A2R9BWP3	686	R	H
Q8TF30	LB/B	-	A0A2R9BWP3	736	H	P
Q8TF30	LB/B	-	A0A2R9BWP3	736	H	Q
Q8TF30	LB/B	-	A0A2R9BWP3	212	N	S
O43516	LB/B	-	A0A2B4SNR8	495	A	G
O43516	LB/B	-	A0A2B4SNR8	198	P	L
A6NGB9	LB/B	-	A0A2Y9JD61	321	E	G
Q5T9L3	LB/B	-	Q4SSK0	465	V	I
Q5T9L3	LP/P	Zaki syndrome (ZKS) [MIM:619648]	Q4SSK0	392	Y	C
Q5T9L3	LP/P	Zaki syndrome (ZKS) [MIM:619648]	Q4SSK0	478	Y	C
Q5T9L3	LP/P	Zaki syndrome (ZKS) [MIM:619648]	Q4SSK0	531	I	T
Q5T9L3	LP/P	Zaki syndrome (ZKS) [MIM:619648]	Q4SSK0	536	R	C
Q9H4A3	LB/B	-	A0A1S3WF00	665	T	I
Q9H4A3	LB/B	-	A0A1S3WF00	141	A	T
Q9H4A3	LB/B	-	A0A1S3WF00	149	A	V
Q9H4A3	LB/B	-	A0A1S3WF00	509	I	T
Q9H4A3	LB/B	-	A0A1S3WF00	527	D	G
Q9H4A3	LB/B	-	A0A1S3WF00	674	T	A
Q9H4A3	LB/B	-	A0A1S3WF00	823	H	R
Q9H4A3	LB/B	-	A0A1S3WF00	1546	A	V
Q9H4A3	LB/B	-	A0A1S3WF00	1808	M	I
Q9H4A3	LB/B	-	A0A1S3WF00	1823	P	L
Q9H4A3	LB/B	-	A0A1S3WF00	1957	R	H
Q9H4A3	LB/B	-	A0A1S3WF00	2380	R	W
Q9H4A3	LB/B	-	A0A1S3WF00	1056	T	P
Q9H4A3	LB/B	-	A0A1S3WF00	1506	C	S
Q96J92	LP/P	Pseudohypoaldosteronism 2B (PHA2B) [MIM:614491]	L9JWV9	562	E	K
Q96J92	LP/P	Pseudohypoaldosteronism 2B (PHA2B) [MIM:614491]	L9JWV9	564	D	A
Q96J92	LP/P	Pseudohypoaldosteronism 2B (PHA2B) [MIM:614491]	L9JWV9	565	Q	E
Q96J92	LP/P	Pseudohypoaldosteronism 2B (PHA2B) [MIM:614491]	L9JWV9	1185	R	C
Q96J92	LB/B	-	L9JWV9	813	P	L
Q96J92	LB/B	-	L9JWV9	1013	L	P
Q96J92	LB/B	-	L9JWV9	677	R	W
Q96J92	LB/B	-	L9JWV9	961	P	S
Q96J92	LB/B	-	L9JWV9	601	A	S
O00744	LB/B	-	L5KA64	77	H	Y
O00744	LB/B	-	L5KA64	285	I	T
O00744	LB/B	-	L5KA64	301	P	S
O00744	LP/P	Split-hand/foot malformation 6 (SHFM6) [MIM:225300]	L5KA64	332	R	W
O00744	LP/P	Tooth agenesis, selective, 8 (STHAG8) [MIM:617073]	L5KA64	211	R	Q
Q9UBV4	LB/B	-	Q75PH5	82	G	R
Q9UBV4	LB/B	-	Q75PH5	263	T	I
P09544	LB/B	-	A0A0V1ITM9	5	L	R
P09544	LB/B	-	A0A0V1ITM9	299	R	W
P09544	LB/B	-	A0A0V1ITM9	294	C	F
P56705	LP/P	Mullerian aplasia and hyperandrogenism (MULLAPL) [MIM:158330]	A0A2Y9GQE1	216	E	G
P56705	LP/P	Mullerian aplasia and hyperandrogenism (MULLAPL) [MIM:158330]	A0A2Y9GQE1	12	L	P
P56705	LP/P	Mullerian aplasia and hyperandrogenism (MULLAPL) [MIM:158330]	A0A2Y9GQE1	83	R	C
P56705	LP/P	46,XX sex reversal with dysgenesis of kidneys, adrenals, and lungs (SERKAL) [MIM:611812]	A0A2Y9GQE1	114	A	V
P56705	LB/B	-	A0A2Y9GQE1	277	P	L
Q93098	LB/B	-	A0A2I0TM25	11	C	S
O14904	LB/B	-	B4LS45	260	A	T
O14905	LB/B	-	B4LS45	106	M	T
Q9BUR4	LB/B	-	Q60525	11	P	S
Q9BUR4	LB/B	-	Q60525	68	R	G
Q9BUR4	LB/B	-	Q60525	522	A	G
Q9BUR4	LB/B	-	Q60525	136	P	R
Q9BUR4	LB/B	-	Q60525	187	N	T
Q9BUR4	LB/B	-	Q60525	494	E	Q
Q9BUR4	LP/P	Dyskeratosis congenita, autosomal recessive, 3 (DKCB3) [MIM:613988]	Q60525	164	F	L
Q9BUR4	LP/P	Dyskeratosis congenita, autosomal recessive, 3 (DKCB3) [MIM:613988]	Q60525	376	H	Y
Q9BUR4	LP/P	Dyskeratosis congenita, autosomal recessive, 3 (DKCB3) [MIM:613988]	Q60525	398	R	W
Q9BUR4	LP/P	Dyskeratosis congenita, autosomal recessive, 3 (DKCB3) [MIM:613988]	Q60525	435	G	R
Q9P2S5	LB/B	-	A0A1S3WGU3	331	I	M
Q9P2S5	LB/B	-	A0A1S3WGU3	358	V	I
Q14191	LB/B	-	G3H625	324	T	A
Q14191	LB/B	-	G3H625	387	M	I
Q14191	LB/B	-	G3H625	1367	C	R
Q14191	LB/B	-	G3H625	1074	L	F
Q14191	LB/B	-	G3H625	834	R	C
Q14191	LB/B	-	G3H625	1079	S	L
Q14191	LB/B	-	G3H625	32	K	R
Q14191	LB/B	-	G3H625	114	V	I
Q14191	LB/B	-	G3H625	172	T	P
Q14191	LB/B	-	G3H625	240	N	K
Q14191	LB/B	-	G3H625	383	L	W
Q14191	LB/B	-	G3H625	724	Q	L
Q14191	LB/B	-	G3H625	1269	K	E
Q14191	LB/B	-	G3H625	343	E	K
Q14191	LB/B	-	G3H625	533	N	S
Q14191	LB/B	-	G3H625	612	S	C
Q14191	LB/B	-	G3H625	708	S	F
Q14191	LB/B	-	G3H625	912	I	S
Q14191	LB/B	-	G3H625	1133	S	A
Q14191	LB/B	-	G3H625	1339	V	I
Q14191	LB/B	-	G3H625	329	Q	R
Q14191	LB/B	-	G3H625	383	L	F
Q14191	LP/P	Werner syndrome (WRN) [MIM:277700]	G3H625	125	K	N
Q14191	LP/P	Werner syndrome (WRN) [MIM:277700]	G3H625	135	K	E
Q14191	LB/B	-	G3H625	1141	S	L
Q14191	LB/B	-	G3H625	711	R	W
Q9Y6I7	LB/B	-	Q6P1V3	16	L	S
Q658N2	LB/B	-	V9KUJ4	212	H	Y
P19544	LP/P	Wilms tumor 1 (WT1) [MIM:194070]	F6QTA6	181	P	S
P19544	LP/P	Wilms tumor 1 (WT1) [MIM:194070]	F6QTA6	223	S	N
P19544	LP/P	Wilms tumor 1 (WT1) [MIM:194070]	F6QTA6	253	G	A
P19544	LB/B	-	F6QTA6	273	S	G
P19544	LP/P	Denys-Drash syndrome (DDS) [MIM:194080]	F6QTA6	330	C	Y
P19544	LP/P	Denys-Drash syndrome (DDS) [MIM:194080]	F6QTA6	360	C	G
P19544	LP/P	Denys-Drash syndrome (DDS) [MIM:194080]	F6QTA6	366	R	C
P19544	LP/P	Meacham syndrome (MEACHS) [MIM:608978]	F6QTA6	366	R	C
P19544	LP/P	Wilms tumor 1 (WT1) [MIM:194070]	F6QTA6	366	R	C
P19544	LP/P	Denys-Drash syndrome (DDS) [MIM:194080]	F6QTA6	366	R	H
P19544	LP/P	Wilms tumor 1 (WT1) [MIM:194070]	F6QTA6	366	R	H
P19544	LP/P	Denys-Drash syndrome (DDS) [MIM:194080]	F6QTA6	373	H	Q
P19544	LP/P	Wilms tumor 1 (WT1) [MIM:194070]	F6QTA6	373	H	Q
P19544	LP/P	Nephrotic syndrome 4 (NPHS4) [MIM:256370]	F6QTA6	377	H	Y
P19544	LP/P	Nephrotic syndrome 4 (NPHS4) [MIM:256370]	F6QTA6	383	F	L
P19544	LP/P	Denys-Drash syndrome (DDS) [MIM:194080]	F6QTA6	394	R	W
P19544	LP/P	Meacham syndrome (MEACHS) [MIM:608978]	F6QTA6	394	R	W
P19544	LP/P	Nephrotic syndrome 4 (NPHS4) [MIM:256370]	F6QTA6	394	R	W
P19544	LP/P	Wilms tumor 1 (WT1) [MIM:194070]	F6QTA6	394	R	W
P19544	LP/P	Denys-Drash syndrome (DDS) [MIM:194080]	F6QTA6	396	D	N
P19544	LP/P	Nephrotic syndrome 4 (NPHS4) [MIM:256370]	F6QTA6	396	D	N
P19544	LP/P	Denys-Drash syndrome (DDS) [MIM:194080]	F6QTA6	396	D	G
P19544	LP/P	Nephrotic syndrome 4 (NPHS4) [MIM:256370]	F6QTA6	312	R	Q
P19544	LP/P	Denys-Drash syndrome (DDS) [MIM:194080]	F6QTA6	342	M	R
P19544	LP/P	Denys-Drash syndrome (DDS) [MIM:194080]	F6QTA6	355	C	Y
P19544	LP/P	Denys-Drash syndrome (DDS) [MIM:194080]	F6QTA6	373	H	Y
P19544	LP/P	Denys-Drash syndrome (DDS) [MIM:194080]	F6QTA6	377	H	R
P19544	LP/P	Denys-Drash syndrome (DDS) [MIM:194080]	F6QTA6	385	C	R
P19544	LP/P	Denys-Drash syndrome (DDS) [MIM:194080]	F6QTA6	388	C	F
P19544	LP/P	Frasier syndrome (FS) [MIM:136680]	F6QTA6	392	F	L
P19544	LP/P	Denys-Drash syndrome (DDS) [MIM:194080]	F6QTA6	394	R	Q
P19544	LP/P	Nephrotic syndrome 4 (NPHS4) [MIM:256370]	F6QTA6	394	R	Q
P19544	LP/P	Denys-Drash syndrome (DDS) [MIM:194080]	F6QTA6	398	L	P
P19544	LP/P	Wilms tumor 1 (WT1) [MIM:194070]	F6QTA6	355	C	G
P19544	LP/P	Denys-Drash syndrome (DDS) [MIM:194080]	F6QTA6	360	C	Y
P19544	LP/P	Nephrotic syndrome 4 (NPHS4) [MIM:256370]	F6QTA6	364	F	L
P19544	LP/P	Denys-Drash syndrome (DDS) [MIM:194080]	F6QTA6	366	R	L
P19544	LP/P	Denys-Drash syndrome (DDS) [MIM:194080]	F6QTA6	369	Q	P
P19544	LP/P	Nephrotic syndrome 4 (NPHS4) [MIM:256370]	F6QTA6	379	G	C
P19544	LP/P	Nephrotic syndrome 4 (NPHS4) [MIM:256370]	F6QTA6	388	C	R
P19544	LP/P	Denys-Drash syndrome (DDS) [MIM:194080]	F6QTA6	388	C	Y
P19544	LP/P	Wilms tumor 1 (WT1) [MIM:194070]	F6QTA6	394	R	L
P19544	LP/P	Denys-Drash syndrome (DDS) [MIM:194080]	F6QTA6	394	R	P
P19544	LP/P	Denys-Drash syndrome (DDS) [MIM:194080]	F6QTA6	396	D	Y
P19544	LP/P	Nephrotic syndrome 4 (NPHS4) [MIM:256370]	F6QTA6	397	H	P
P19544	LP/P	Denys-Drash syndrome (DDS) [MIM:194080]	F6QTA6	401	H	Y
P19544	LP/P	Denys-Drash syndrome (DDS) [MIM:194080]	F6QTA6	405	H	R
Q06250	LB/B	-	H2NDS5	13	A	T
Q06250	LB/B	-	H2NDS5	66	G	A
Q15007	LB/B	-	A0A091DIP9	84	E	D
Q8IX03	LB/B	-	A0A2K6FBW7	250	R	C
Q8IX03	LB/B	-	A0A2K6FBW7	734	M	I
Q8IX03	LB/B	-	A0A2K6FBW7	735	S	A
Q6AWC2	LB/B	-	A0A2K6FBW7	773	A	S
Q6AWC2	LB/B	-	A0A2K6FBW7	816	V	F
Q6AWC2	LB/B	-	A0A2K6FBW7	904	D	H
Q6AWC2	LB/B	-	A0A2K6FBW7	1189	A	T
Q6AWC2	LB/B	-	A0A2K6FBW7	979	R	C
Q9ULE0	LB/B	-	A0A2K6FBW7	495	A	T
Q9ULE0	LB/B	-	A0A2K6FBW7	593	Y	C
Q9ULE0	LB/B	-	A0A2K6FBW7	831	P	L
Q9NZC7	LB/B	-	A0A2Y9NV04	98	P	L
Q9NZC7	LB/B	-	A0A2Y9NV04	179	A	T
Q9NZC7	LB/B	-	A0A2Y9NV04	272	L	F
Q9NZC7	LB/B	-	A0A2Y9NV04	282	P	A
Q9NZC7	LB/B	-	A0A2Y9NV04	291	L	P
Q9NZC7	LB/B	-	A0A2Y9NV04	314	R	H
Q9NZC7	LB/B	-	A0A2Y9NV04	216	L	V
Q9NZC7	LP/P	Spinocerebellar ataxia, autosomal recessive, 12 (SCAR12) [MIM:614322]	A0A2Y9NV04	47	P	T
Q9NZC7	LP/P	Spinocerebellar ataxia, autosomal recessive, 12 (SCAR12) [MIM:614322]	A0A2Y9NV04	372	G	R
Q9NZC7	LP/P	Developmental and epileptic encephalopathy 28 (DEE28) [MIM:616211]	A0A2Y9NV04	47	P	R
Q9HCS7	LB/B	-	A0A2K5LMZ5	126	V	I
Q9HCS7	LB/B	-	A0A2K5LMZ5	454	R	Q
Q9HCS7	LB/B	-	A0A2K5LMZ5	702	A	T
Q6GPH4	LB/B	-	L9KET4	85	E	G
Q6GPH4	LB/B	-	L9KET4	132	R	H
Q6GPH4	LB/B	-	L9KET4	188	E	K
Q6GPH4	LB/B	-	L9KET4	219	R	I
P55808	LB/B	-	A0A2R8M8P1	60	D	N
P98170	LB/B	-	S7N3Y5	107	N	S
P98170	LB/B	-	S7N3Y5	133	S	F
P98170	LB/B	-	S7N3Y5	242	D	E
P98170	LB/B	-	S7N3Y5	423	Q	P
Q702N8	LB/B	-	F6ULB0	3	D	N
Q702N8	LB/B	-	F6ULB0	346	Q	R
Q702N8	LB/B	-	F6ULB0	551	R	Q
Q702N8	LB/B	-	F6ULB0	965	H	P
Q702N8	LB/B	-	F6ULB0	1046	P	A
Q702N8	LB/B	-	F6ULB0	1604	G	R
Q702N8	LB/B	-	F6ULB0	1608	A	V
Q702N8	LB/B	-	F6ULB0	1724	I	V
Q702N8	LB/B	-	F6ULB0	695	R	C
Q702N8	LB/B	-	F6ULB0	776	R	W
Q702N8	LB/B	-	F6ULB0	1061	A	V
Q702N8	LB/B	-	F6ULB0	1707	Q	H
A4UGR9	LB/B	-	W5MNV5	450	P	A
A4UGR9	LB/B	-	W5MNV5	457	Y	H
A4UGR9	LB/B	-	W5MNV5	1397	I	T
A4UGR9	LB/B	-	W5MNV5	1488	I	T
A4UGR9	LB/B	-	W5MNV5	1626	R	H
A4UGR9	LB/B	-	W5MNV5	1833	N	S
A4UGR9	LB/B	-	W5MNV5	2423	L	R
A4UGR9	LB/B	-	W5MNV5	2553	S	N
A4UGR9	LB/B	-	W5MNV5	2595	H	Y
A4UGR9	LB/B	-	W5MNV5	2607	V	I
A4UGR9	LB/B	-	W5MNV5	2728	G	D
A4UGR9	LB/B	-	W5MNV5	2910	A	T
A4UGR9	LB/B	-	W5MNV5	2975	Y	C
A4UGR9	LB/B	-	W5MNV5	3022	I	V
A4UGR9	LB/B	-	W5MNV5	3202	G	E
A4UGR9	LB/B	-	W5MNV5	2769	I	V
P51811	LP/P	McLeod syndrome (MLS) [MIM:300842]	L5LFR8	222	R	G
P51811	LP/P	McLeod syndrome (MLS) [MIM:300842]	L5LFR8	294	C	R
P51811	LP/P	McLeod syndrome (MLS) [MIM:300842]	L5LFR8	327	E	K
Q5T750	LB/B	-	G1T8X6	26	S	T
Q5T750	LB/B	-	G1T8X6	159	T	P
Q5T750	LB/B	-	G1T8X6	173	L	V
P23025	LP/P	Xeroderma pigmentosum complementation group A (XP-A) [MIM:278700]	A0A1J1IXI0	94	P	L
P23025	LP/P	Xeroderma pigmentosum complementation group A (XP-A) [MIM:278700]	A0A1J1IXI0	108	C	F
P23025	LP/P	Xeroderma pigmentosum complementation group A (XP-A) [MIM:278700]	A0A1J1IXI0	130	R	K
P23025	LP/P	Xeroderma pigmentosum complementation group A (XP-A) [MIM:278700]	A0A1J1IXI0	185	Q	H
P23025	LP/P	Xeroderma pigmentosum complementation group A (XP-A) [MIM:278700]	A0A1J1IXI0	244	H	R
P23025	LB/B	-	A0A1J1IXI0	228	R	Q
P23025	LB/B	-	A0A1J1IXI0	252	L	V
P23025	LB/B	-	A0A1J1IXI0	234	V	L
P23025	LB/B	-	A0A1J1IXI0	97	V	I
P23025	LB/B	-	A0A1J1IXI0	256	M	V
Q01831	LP/P	Xeroderma pigmentosum complementation group C (XP-C) [MIM:278720]	A0A287ABD7	334	P	H
Q01831	LB/B	-	A0A287ABD7	939	Q	K
Q01831	LB/B	-	A0A287ABD7	16	L	V
Q01831	LB/B	-	A0A287ABD7	48	L	F
Q01831	LB/B	-	A0A287ABD7	86	K	R
Q01831	LB/B	-	A0A287ABD7	314	R	Q
Q01831	LB/B	-	A0A287ABD7	492	R	H
Q01831	LB/B	-	A0A287ABD7	499	A	V
Q01831	LB/B	-	A0A287ABD7	513	M	I
Q01831	LB/B	-	A0A287ABD7	632	Q	E
Q01831	LB/B	-	A0A287ABD7	671	R	H
Q01831	LB/B	-	A0A287ABD7	689	T	M
Q01831	LB/B	-	A0A287ABD7	928	K	Q
Q01831	LB/B	-	A0A287ABD7	287	F	C
Q01831	LB/B	-	A0A287ABD7	514	C	S
Q01831	LB/B	-	A0A287ABD7	511	K	Q
Q01831	LP/P	Xeroderma pigmentosum complementation group C (XP-C) [MIM:278720]	A0A287ABD7	690	W	S
O43895	LB/B	-	L5MH26	215	T	I
O43895	LB/B	-	L5MH26	223	V	I
O43895	LB/B	-	L5MH26	232	K	N
Q9NQH7	LB/B	-	A0A293M5D4	450	I	L
Q9NQH7	LP/P	Nephronophthisis-like nephropathy 1 (NPHPL1) [MIM:613159]	A0A293M5D4	453	G	C
Q96QU8	LB/B	-	A0A0Q3PS82	1029	V	L
Q9UIA9	LB/B	-	S4REY2	398	E	D
Q9UIA9	LB/B	-	S4REY2	835	C	Y
Q9UBH6	LB/B	-	W5LJ34	491	T	A
Q9UBH6	LP/P	Basal ganglia calcification, idiopathic, 6 (IBGC6) [MIM:616413]	W5LJ34	136	S	N
Q9UBH6	LP/P	Basal ganglia calcification, idiopathic, 6 (IBGC6) [MIM:616413]	W5LJ34	140	L	P
Q9UBH6	LP/P	Basal ganglia calcification, idiopathic, 6 (IBGC6) [MIM:616413]	W5LJ34	145	L	P
Q9UBH6	LP/P	Basal ganglia calcification, idiopathic, 6 (IBGC6) [MIM:616413]	W5LJ34	218	L	S
O43543	LB/B	-	A0A099YRH1	16	A	S
O43543	LB/B	-	A0A099YRH1	188	R	H
O43543	LB/B	-	A0A099YRH1	221	I	T
O43543	LB/B	-	A0A099YRH1	47	H	R
O43543	LB/B	-	A0A099YRH1	61	L	I
O43543	LB/B	-	A0A099YRH1	75	E	Q
O43543	LB/B	-	A0A099YRH1	95	I	V
O43543	LB/B	-	A0A099YRH1	118	V	A
O43543	LB/B	-	A0A099YRH1	164	E	Q
O43543	LB/B	-	A0A099YRH1	170	E	A
O43543	LB/B	-	A0A099YRH1	188	R	C
O43543	LB/B	-	A0A099YRH1	194	T	M
O43543	LB/B	-	A0A099YRH1	199	M	L
O43543	LB/B	-	A0A099YRH1	207	E	G
O43543	LB/B	-	A0A099YRH1	220	D	V
O43543	LB/B	-	A0A099YRH1	231	W	C
O43543	LB/B	-	A0A099YRH1	238	R	S
O43543	LB/B	-	A0A099YRH1	248	Q	E
O43543	LB/B	-	A0A099YRH1	258	R	C
O43543	LB/B	-	A0A099YRH1	270	F	V
O43543	LP/P	Premature ovarian failure 17 (POF17) [MIM:619146]	A0A099YRH1	14	L	P
O43543	LP/P	Spermatogenic failure 50 (SPGF50) [MIM:619145]	A0A099YRH1	14	L	P
P13010	LB/B	-	A0A0D2X4F7	463	L	F
P13010	LB/B	-	A0A0D2X4F7	508	I	V
Q8IZH2	LB/B	-	A0A087Y8E7	674	S	G
Q8IZH2	LB/B	-	A0A087Y8E7	1259	V	A
O75191	LB/B	-	A0A2U3YTG8	85	D	E
O75191	LB/B	-	A0A2U3YTG8	133	D	N
O75191	LB/B	-	A0A2U3YTG8	139	D	E
O75191	LB/B	-	A0A2U3YTG8	262	Y	N
O75191	LB/B	-	A0A2U3YTG8	348	N	D
Q9H1B5	LB/B	-	S4RXJ0	305	R	T
Q9H1B5	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	S4RXJ0	801	T	R
Q9H1B5	LB/B	-	S4RXJ0	60	G	R
Q9H1B5	LB/B	-	S4RXJ0	56	D	N
Q9H1B5	LB/B	-	S4RXJ0	115	P	L
Q9H1B5	LB/B	-	S4RXJ0	418	P	L
P54577	LP/P	Charcot-Marie-Tooth disease, dominant intermediate C (CMTDIC) [MIM:608323]	A0A1Y2FT17	41	G	R
P54577	LB/B	-	A0A1Y2FT17	170	Q	H
P54577	LP/P	Charcot-Marie-Tooth disease, dominant intermediate C (CMTDIC) [MIM:608323]	A0A1Y2FT17	196	E	K
P54577	LP/P	Neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset 2 (IMNEPD2) [MIM:619418]	A0A1Y2FT17	167	P	T
P54577	LP/P	-	A0A1Y2FT17	308	D	Y
Q9Y2Z4	LB/B	-	A0A2K6P4D8	191	G	V
Q9Y2Z4	LP/P	Myopathy with lactic acidosis and sideroblastic anemia 2 (MLASA2) [MIM:613561]	A0A2K6P4D8	52	F	L
Q9Y2Z4	LP/P	Myopathy with lactic acidosis and sideroblastic anemia 2 (MLASA2) [MIM:613561]	A0A2K6P4D8	46	G	D
P16989	LB/B	-	K7BBH4	75	T	A
A8MPS7	LB/B	-	A0A1S3GFH3	263	A	T
Q9ULM3	LB/B	-	A0A0F7Z303	184	I	V
Q9ULM3	LB/B	-	A0A0F7Z303	530	V	I
Q9ULM3	LB/B	-	A0A0F7Z303	993	Q	H
Q5BJH7	LB/B	-	W5KLH2	56	P	S
Q5BJH7	LP/P	Kaya-Barakat-Masson syndrome (KABAMAS) [MIM:619125]	W5KLH2	123	K	Q
Q969M3	LP/P	Microcephaly, epilepsy, and diabetes syndrome 2 (MEDS2) [MIM:619278]	L5JYP4	98	I	S
Q96EC8	LB/B	-	G1T7J9	202	F	L
Q8N8F6	LB/B	-	A0A151PB15	54	A	T
A6XGL0	LB/B	-	A0A2K6GY50	213	A	T
P13994	LB/B	-	G3WDP9	22	S	C
P13994	LB/B	-	G3WDP9	336	C	S
Q9H6S0	LB/B	-	H9GD25	652	S	N
Q9H6S0	LB/B	-	H9GD25	1409	L	Q
Q9Y5A9	LB/B	-	A0A091E4L4	217	T	S
Q9Y5A9	LB/B	-	A0A091E4L4	454	P	S
P25490	LP/P	Gabriele-de Vries syndrome (GADEVS) [MIM:617557]	A0A2I0MPS6	380	D	Y
P25490	LB/B	-	A0A2I0MPS6	372	T	R
P25490	LP/P	Gabriele-de Vries syndrome (GADEVS) [MIM:617557]	A0A2I0MPS6	366	L	P
Q9H869	LB/B	-	A0A2K5CIY6	412	G	S
Q9H869	LB/B	-	A0A2K5CIY6	786	E	Q
Q401N2	LB/B	-	F6ZYC6	152	A	T
Q9Y493	LB/B	-	A0A2K6EWE0	412	G	S
Q9Y493	LB/B	-	A0A2K6EWE0	690	S	T
Q9Y493	LB/B	-	A0A2K6EWE0	1012	L	R
Q9Y493	LB/B	-	A0A2K6EWE0	1096	F	C
Q9Y493	LB/B	-	A0A2K6EWE0	1375	A	T
Q9Y493	LB/B	-	A0A2K6EWE0	1674	G	C
Q9Y493	LB/B	-	A0A2K6EWE0	1698	L	P
Q9Y493	LB/B	-	A0A2K6EWE0	1742	C	R
Q9Y493	LB/B	-	A0A2K6EWE0	1878	P	S
Q9Y493	LB/B	-	A0A2K6EWE0	1903	C	Y
Q9Y493	LB/B	-	A0A2K6EWE0	1995	I	M
Q9Y493	LB/B	-	A0A2K6EWE0	2073	N	S
Q9Y493	LB/B	-	A0A2K6EWE0	2527	T	M
Q9Y493	LB/B	-	A0A2K6EWE0	2643	W	R
Q9Y493	LB/B	-	A0A2K6EWE0	113	G	A
Q9Y493	LB/B	-	A0A2K6EWE0	2334	Y	S
Q9Y493	LB/B	-	A0A2K6EWE0	2349	L	F
Q9Y493	LB/B	-	A0A2K6EWE0	16	L	F
Q9Y493	LB/B	-	A0A2K6EWE0	430	Q	H
Q9Y493	LB/B	-	A0A2K6EWE0	1922	H	C
Q9Y493	LB/B	-	A0A2K6EWE0	1969	F	L
Q9Y493	LB/B	-	A0A2K6EWE0	2035	S	T
Q9Y493	LB/B	-	A0A2K6EWE0	2111	L	P
A8MT70	LB/B	-	A0A1U7REX9	636	A	G
A8MT70	LB/B	-	A0A1U7REX9	14	P	T
A8MT70	LB/B	-	A0A1U7REX9	160	K	N
A8MT70	LB/B	-	A0A1U7REX9	178	K	R
A8MT70	LB/B	-	A0A1U7REX9	473	A	G
A8MT70	LB/B	-	A0A1U7REX9	511	I	T
A8MT70	LB/B	-	A0A1U7REX9	555	E	K
A8MT70	LB/B	-	A0A1U7REX9	346	H	R
Q96DT7	LB/B	-	A0A2I0TMM3	50	P	T
Q96DT7	LB/B	-	A0A2I0TMM3	174	M	I
O95625	LB/B	-	A0A1S3FSL1	44	G	S
O95625	LB/B	-	A0A1S3FSL1	350	T	N
O95625	LP/P	Intellectual developmental disorder, autosomal recessive 69 (MRT69) [MIM:618383]	A0A1S3FSL1	880	H	Q
O95625	LP/P	Intellectual developmental disorder, autosomal recessive 69 (MRT69) [MIM:618383]	A0A1S3FSL1	729	H	Y
O43829	LB/B	-	A0A0F8BFJ1	77	E	G
O43829	LB/B	-	A0A0F8BFJ1	139	Q	R
Q9HC78	LP/P	Primrose syndrome (PRIMS) [MIM:259050]	H3AAE4	590	K	Q
Q9HC78	LP/P	Primrose syndrome (PRIMS) [MIM:259050]	H3AAE4	596	H	R
Q9HC78	LP/P	Primrose syndrome (PRIMS) [MIM:259050]	H3AAE4	602	G	A
Q9HC78	LP/P	Primrose syndrome (PRIMS) [MIM:259050]	H3AAE4	621	L	F
Q9ULJ3	LB/B	-	A0A060WKN5	185	N	S
Q9ULJ3	LB/B	-	A0A060WKN5	218	K	Q
Q9HCK0	LB/B	-	A0A091CPC3	236	H	R
Q9H5J0	LB/B	-	L5LAV5	574	I	M
Q9Y2Y4	LB/B	-	A0A1S3FYR8	174	R	S
Q8NAP3	LB/B	-	A0A2I4C0W2	319	S	A
Q8NAP3	LB/B	-	A0A2I4C0W2	615	T	M
Q8NAP3	LB/B	-	A0A2I4C0W2	809	A	T
O15060	LB/B	-	A0A151LZ72	689	P	A
Q9P1Z0	LB/B	-	H9GR07	550	M	I
Q9P1Z0	LB/B	-	H9GR07	539	A	V
Q9P1Z0	LB/B	-	H9GR07	561	N	S
Q9NUA8	LB/B	-	A0A2D0PJ10	225	A	T
Q9NUA8	LB/B	-	A0A2D0PJ10	267	M	I
Q9NUA8	LB/B	-	A0A2D0PJ10	595	Y	C
Q9NUA8	LB/B	-	A0A2D0PJ10	997	V	M
B2RXF5	LP/P	Lethal congenital contracture syndrome 6 (LCCS6) [MIM:616248]	H2NME6	397	R	H
Q8NCP5	LB/B	-	A0A2I0TM34	185	K	E
Q96K62	LB/B	-	A0A2K5IHH8	293	D	E
Q86UZ6	LB/B	-	U3IAL7	11	T	A
Q9UFB7	LB/B	-	B8JL75	385	A	T
P10074	LB/B	-	F6VV18	675	S	A
Q6ZSB9	LB/B	-	I3LWW2	320	Y	S
Q6ZSB9	LB/B	-	I3LWW2	348	A	T
Q6ZSB9	LB/B	-	I3LWW2	642	A	V
Q6ZSB9	LB/B	-	I3LWW2	556	T	A
O15062	LB/B	-	A0A060YTB4	300	D	G
O95365	LP/P	Macrocephaly, neurodevelopmental delay, lymphoid hyperplasia, and persistent fetal hemoglobin (MNDLFH) [MIM:619769]	A0A1U7RAV2	384	C	W
O95365	LP/P	Macrocephaly, neurodevelopmental delay, lymphoid hyperplasia, and persistent fetal hemoglobin (MNDLFH) [MIM:619769]	A0A1U7RAV2	405	T	K
Q96BR9	LB/B	-	A0A2P4SHJ3	418	A	G
Q96C00	LB/B	-	A0A1U7RFD0	274	A	G
Q96GY0	LB/B	-	A0A1V4KGK7	156	T	A
Q5TFG8	LB/B	-	A0A2K6LNS0	6	P	S
O75152	LB/B	-	A0A1V4KX55	640	T	N
Q5D1E8	LB/B	-	F7CZ99	547	G	D
Q5D1E8	LB/B	-	F7CZ99	240	V	M
A2A288	LB/B	-	A0A2Y9M0Q0	53	P	L
Q5T200	LB/B	-	G1TV15	1429	E	D
Q8WU90	LB/B	-	A0A2K6FW07	342	V	E
Q8WU90	LB/B	-	A0A2K6FW07	408	T	P
Q86VM9	LB/B	-	G3VM41	368	A	T
Q86VM9	LB/B	-	G3VM41	440	R	H
Q8IXZ2	LB/B	-	F1PNB5	6	I	M
Q8IXZ2	LB/B	-	F1PNB5	149	F	Y
Q8IXZ2	LB/B	-	F1PNB5	151	E	D
Q8IXZ2	LB/B	-	F1PNB5	399	S	G
Q8IXZ2	LB/B	-	F1PNB5	452	S	G
Q8IXZ2	LB/B	-	F1PNB5	168	R	W
Q8IXZ2	LB/B	-	F1PNB5	228	A	S
Q8IXZ2	LB/B	-	F1PNB5	351	P	L
Q8IXZ2	LB/B	-	F1PNB5	415	P	L
Q8IXZ2	LB/B	-	F1PNB5	503	T	K
Q8IXZ2	LB/B	-	F1PNB5	102	Q	R
Q8IXZ2	LB/B	-	F1PNB5	165	E	K
Q8IXZ2	LB/B	-	F1PNB5	231	P	A
Q8IXZ2	LB/B	-	F1PNB5	578	R	H
Q8IXZ2	LB/B	-	F1PNB5	636	R	W
Q8IXZ2	LB/B	-	F1PNB5	727	P	R
Q9UPT8	LB/B	-	L5LDC6	287	E	K
Q9UPT8	LB/B	-	L5LDC6	464	M	V
Q9UPT8	LB/B	-	L5LDC6	1228	A	G
Q8IWR0	LB/B	-	I3KUJ3	3	N	S
Q8IWR0	LB/B	-	I3KUJ3	57	H	R
Q9UGR2	LB/B	-	G3UF08	363	D	N
Q8N5P1	LB/B	-	G1P3F9	240	C	W
Q7Z2W4	LB/B	-	A0A2K6FVP6	485	R	K
Q7Z2W4	LB/B	-	A0A2K6FVP6	565	H	Q
Q7Z2W4	LB/B	-	A0A2K6FVP6	851	T	I
Q7Z2W4	LB/B	-	A0A2K6FVP6	701	Q	E
Q86WB0	LB/B	-	S7MXU1	271	T	A
Q86WB0	LB/B	-	S7MXU1	363	R	H
Q6PEW1	LB/B	-	S9W5H6	7	R	C
Q6PEW1	LB/B	-	S9W5H6	179	L	I
Q6PEW1	LB/B	-	S9W5H6	214	R	G
Q6PEW1	LB/B	-	S9W5H6	241	R	T
Q8WYQ9	LB/B	-	E2QSI9	693	V	M
Q8WYQ9	LB/B	-	E2QSI9	54	I	V
Q8WYQ9	LB/B	-	E2QSI9	244	G	A
Q9H5U6	LB/B	-	H2PD20	396	L	H
Q9H5U6	LB/B	-	H2PD20	382	P	L
Q8N3Z6	LB/B	-	A0A1S2ZT76	118	G	D
Q8N3Z6	LB/B	-	A0A1S2ZT76	539	R	K
Q8N567	LB/B	-	A0A2K5R8K1	15	P	A
Q8TBF4	LB/B	-	A0A0K9QW68	131	P	Q
Q9H0M4	LB/B	-	G1PE65	153	T	A
Q9H0M4	LB/B	-	G1PE65	365	E	K
Q504Y3	LB/B	-	A0A1S3G6N7	202	L	Q
Q9HCK1	LB/B	-	A0A2U3ZMW5	160	R	K
Q8WTX9	LB/B	-	A0A2K6T8Z7	124	R	Q
Q96GR4	LB/B	-	L9KLK1	69	P	S
Q96GR4	LB/B	-	L9KLK1	172	Q	L
Q8IUH4	LB/B	-	A0A061I683	99	K	R
Q8IUH4	LB/B	-	A0A061I683	392	Y	C
Q8IZN3	LB/B	-	A0A1S3M987	334	T	M
Q8IUH5	LB/B	-	A0A061I683	383	N	S
Q9NPG8	LB/B	-	G3P3E7	53	V	M
Q9H6R6	LB/B	-	A0A0A9Z6P4	41	D	N
O60315	LP/P	Mowat-Wilson syndrome (MOWS) [MIM:235730]	A0A1S3MR58	953	R	G
O60315	LP/P	Mowat-Wilson syndrome (MOWS) [MIM:235730]	A0A1S3MR58	1119	Q	R
Q7Z7L7	LB/B	-	A0A067R7W4	539	T	I
Q86XD8	LB/B	-	A0A146V3X0	118	K	T
Q86XD8	LB/B	-	A0A146V3X0	358	H	Y
Q86XD8	LB/B	-	A0A146V3X0	523	T	A
Q9P243	LB/B	-	F7EBZ2	64	G	R
Q9P243	LB/B	-	F7EBZ2	102	P	S
Q9P243	LB/B	-	F7EBZ2	672	R	K
O60293	LB/B	-	L9L3J3	1006	E	K
O60293	LB/B	-	L9L3J3	1807	K	R
Q9C0A1	LP/P	Marsili syndrome (MARSIS) [MIM:147430]	W5QDC8	1913	R	K
Q15911	LB/B	-	A0A091WCN6	3374	A	V
Q15911	LB/B	-	A0A091WCN6	460	E	Q
Q15911	LB/B	-	A0A091WCN6	72	S	A
Q15911	LB/B	-	A0A091WCN6	428	T	P
Q15911	LB/B	-	A0A091WCN6	777	V	A
Q15911	LB/B	-	A0A091WCN6	3421	P	A
Q15911	LB/B	-	A0A091WCN6	997	A	S
Q15911	LB/B	-	A0A091WCN6	146	S	G
Q86UP3	LB/B	-	A0A091WCN6	2036	I	V
Q86UP3	LB/B	-	A0A091WCN6	3033	V	G
Q6ZN57	LB/B	-	A0A287B1N6	113	Q	H
Q6ZN57	LB/B	-	A0A287B1N6	142	R	G
Q8NHY6	LB/B	-	A0A1U8CPC9	620	A	V
Q8NHY6	LB/B	-	A0A1U8CPC9	141	S	W
Q9Y6Q3	LB/B	-	A0A061IGK1	7	V	D
Q9NU63	LB/B	-	A0A2K6A8F8	114	N	S
Q9NU63	LB/B	-	A0A2K6A8F8	284	D	V
Q9NU63	LP/P	Diabetes mellitus, transient neonatal, 1 (TNDM1) [MIM:601410]	A0A2K6A8F8	166	R	H
Q9NU63	LP/P	Diabetes mellitus, transient neonatal, 1 (TNDM1) [MIM:601410]	A0A2K6A8F8	193	H	N
Q9NU63	LP/P	Diabetes mellitus, transient neonatal, 1 (TNDM1) [MIM:601410]	A0A2K6A8F8	374	H	D
Q8NB50	LB/B	-	A0A2I2UUE7	34	M	I
Q8NB50	LB/B	-	A0A2I2UUE7	698	R	K
Q9NTW7	LB/B	-	A0A2K5RUZ6	68	Q	P
Q9NTW7	LB/B	-	A0A2K5RUZ6	139	P	L
Q49AA0	LB/B	-	I3NCX0	113	V	L
Q9UJL9	LB/B	-	I3NCX0	115	C	Y
Q9UJL9	LB/B	-	I3NCX0	359	G	R
Q96JP5	LB/B	-	A0A061IDQ8	207	S	G
Q96JP5	LB/B	-	A0A061IDQ8	37	V	I
O95159	LB/B	-	R7UXH8	218	R	Q
Q8IX07	LB/B	-	H3BGB1	70	G	A
Q8WW38	LP/P	Conotruncal heart malformations (CTHM) [MIM:217095]	A0A146VZ07	30	E	G
Q8WW38	LP/P	Tetralogy of Fallot (TOF) [MIM:187500]	A0A146VZ07	30	E	G
Q8WW38	LP/P	Tetralogy of Fallot (TOF) [MIM:187500]	A0A146VZ07	657	S	G
Q8WW38	LB/B	-	A0A146VZ07	782	E	D
Q8WW38	LB/B	-	A0A146VZ07	403	A	G
Q8WW38	LB/B	-	A0A146VZ07	1055	A	V
Q8WW38	LP/P	46,XY sex reversal 9 (SRXY9) [MIM:616067]	A0A146VZ07	260	R	Q
Q8WW38	LP/P	46,XY sex reversal 9 (SRXY9) [MIM:616067]	A0A146VZ07	402	S	R
Q8WW38	LP/P	Conotruncal heart malformations (CTHM) [MIM:217095]	A0A146VZ07	227	I	V
Q8WW38	LP/P	46,XY sex reversal 9 (SRXY9) [MIM:616067]	A0A146VZ07	544	M	I
Q8WW38	LP/P	Tetralogy of Fallot (TOF) [MIM:187500]	A0A146VZ07	544	M	I
Q96KR1	LB/B	-	F7IMC1	461	V	I
Q96KR1	LB/B	-	F7IMC1	520	I	T
Q9UPR6	LB/B	-	F7CHA4	164	S	L
Q9UPR6	LB/B	-	F7CHA4	183	V	M
Q9UPR6	LB/B	-	F7CHA4	210	V	L
Q9UPR6	LB/B	-	F7CHA4	235	P	L
Q9UPR6	LB/B	-	F7CHA4	577	A	T
Q9UPR6	LB/B	-	F7CHA4	589	D	N
Q9UPR6	LB/B	-	F7CHA4	718	I	M
Q7Z3T8	LB/B	-	H3AKU1	192	I	T
Q7Z3T8	LB/B	-	H3AKU1	598	I	T
Q7Z3T8	LB/B	-	H3AKU1	1055	S	G
Q7Z3T8	LB/B	-	H3AKU1	35	A	E
Q7Z3T8	LB/B	-	H3AKU1	1519	T	N
Q7Z3T8	LB/B	-	H3AKU1	380	A	V
Q68DK2	LB/B	-	A0A2I0MPS7	429	K	E
Q68DK2	LB/B	-	A0A2I0MPS7	898	T	S
Q68DK2	LB/B	-	A0A2I0MPS7	951	T	M
Q68DK2	LB/B	-	A0A2I0MPS7	1071	S	N
Q68DK2	LB/B	-	A0A2I0MPS7	1103	P	L
Q68DK2	LB/B	-	A0A2I0MPS7	1122	A	V
Q68DK2	LB/B	-	A0A2I0MPS7	1457	C	Y
Q68DK2	LB/B	-	A0A2I0MPS7	1891	S	N
Q68DK2	LB/B	-	A0A2I0MPS7	2411	R	H
Q9HCC9	LB/B	-	A0A1S3I6J5	603	S	N
Q9HCC9	LB/B	-	A0A1S3I6J5	672	S	P
O95405	LB/B	-	A0A226PRN0	287	Y	C
O95405	LB/B	-	A0A226PRN0	414	Q	P
O95405	LB/B	-	A0A226PRN0	639	I	V
Q96DA0	LB/B	-	F7FT45	133	M	V
Q8N5A5	LB/B	-	A0A1W2WFM6	61	S	R
Q9Y6X8	LB/B	-	A0A1U7RSJ7	357	V	M
Q9Y6X8	LB/B	-	A0A1U7RSJ7	649	R	K
Q9Y6X8	LB/B	-	A0A1U7RSJ7	779	G	S
Q9H4I2	LB/B	-	W5LMQ9	310	N	S
Q15915	LP/P	Craniosynostosis 6 (CRS6) [MIM:616602]	H3B7J9	400	G	R
Q15915	LB/B	-	H3B7J9	414	T	A
O95409	LP/P	Holoprosencephaly 5 (HPE5) [MIM:609637]	A0A2Y9SJV5	36	Q	P
O95409	LP/P	Holoprosencephaly 5 (HPE5) [MIM:609637]	A0A2Y9SJV5	152	D	F
O95409	LP/P	Holoprosencephaly 5 (HPE5) [MIM:609637]	A0A2Y9SJV5	37	D	N
O95409	LP/P	Holoprosencephaly 5 (HPE5) [MIM:609637]	A0A2Y9SJV5	128	D	N
O95409	LP/P	Holoprosencephaly 5 (HPE5) [MIM:609637]	A0A2Y9SJV5	272	S	N
O95409	LP/P	Holoprosencephaly 5 (HPE5) [MIM:609637]	A0A2Y9SJV5	286	H	L
O95409	LP/P	Holoprosencephaly 5 (HPE5) [MIM:609637]	A0A2Y9SJV5	286	H	Q
O95409	LP/P	Holoprosencephaly 5 (HPE5) [MIM:609637]	A0A2Y9SJV5	286	H	Y
O95409	LP/P	Holoprosencephaly 5 (HPE5) [MIM:609637]	A0A2Y9SJV5	291	H	Y
O95409	LP/P	Holoprosencephaly 5 (HPE5) [MIM:609637]	A0A2Y9SJV5	304	W	R
O95409	LP/P	Holoprosencephaly 5 (HPE5) [MIM:609637]	A0A2Y9SJV5	314	F	C
O95409	LP/P	Holoprosencephaly 5 (HPE5) [MIM:609637]	A0A2Y9SJV5	325	R	L
O95409	LP/P	Holoprosencephaly 5 (HPE5) [MIM:609637]	A0A2Y9SJV5	325	R	S
O95409	LP/P	Holoprosencephaly 5 (HPE5) [MIM:609637]	A0A2Y9SJV5	327	H	Y
O95409	LP/P	Holoprosencephaly 5 (HPE5) [MIM:609637]	A0A2Y9SJV5	335	C	F
O95409	LP/P	Holoprosencephaly 5 (HPE5) [MIM:609637]	A0A2Y9SJV5	373	R	P
O95409	LP/P	Holoprosencephaly 5 (HPE5) [MIM:609637]	A0A2Y9SJV5	402	Y	N
O95409	LP/P	Holoprosencephaly 5 (HPE5) [MIM:609637]	A0A2Y9SJV5	403	T	K
O95409	LP/P	Holoprosencephaly 5 (HPE5) [MIM:609637]	A0A2Y9SJV5	404	H	R
O95409	LP/P	Holoprosencephaly 5 (HPE5) [MIM:609637]	A0A2Y9SJV5	409	R	W
O95409	LP/P	Holoprosencephaly 5 (HPE5) [MIM:609637]	A0A2Y9SJV5	415	H	Q
O60481	LP/P	Heterotaxy, visceral, 1, X-linked (HTX1) [MIM:306955]	H3B7J9	323	T	M
O60481	LP/P	Congenital heart defects, multiple types, 1, X-linked (CHTD1) [MIM:306955]	H3B7J9	217	P	A
O60481	LP/P	Heterotaxy, visceral, 1, X-linked (HTX1) [MIM:306955]	H3B7J9	217	P	A
O60481	LP/P	Heterotaxy, visceral, 1, X-linked (HTX1) [MIM:306955]	H3B7J9	253	C	S
O60481	LP/P	Heterotaxy, visceral, 1, X-linked (HTX1) [MIM:306955]	H3B7J9	286	H	R
O60481	LP/P	Heterotaxy, visceral, 1, X-linked (HTX1) [MIM:306955]	H3B7J9	405	K	E
O60481	LP/P	Heterotaxy, visceral, 1, X-linked (HTX1) [MIM:306955]	H3B7J9	255	W	G
O60481	LP/P	Congenital heart defects, multiple types, 1, X-linked (CHTD1) [MIM:306955]	H3B7J9	109	S	C
O60481	LP/P	VACTERL association X-linked with or without hydrocephalus (VACTERLX) [MIM:314390]	H3B7J9	318	H	N
O60481	LP/P	Congenital heart defects, multiple types, 1, X-linked (CHTD1) [MIM:306955]	H3B7J9	447	A	G
Q96T25	LB/B	-	H0XLY3	610	S	F
Q9NZV7	LB/B	-	A0A2K5PS82	110	A	T
Q9NZV7	LB/B	-	A0A2K5PS82	408	Q	R
Q9NZV7	LB/B	-	A0A2K5PS82	473	R	K
Q96PE6	LB/B	-	G3WER6	7	R	K
Q96PE6	LB/B	-	G3WER6	28	E	K
Q96PE6	LB/B	-	G3WER6	157	N	D
Q96PE6	LB/B	-	G3WER6	379	I	V
Q96PE6	LB/B	-	G3WER6	69	L	M
Q96PE6	LB/B	-	G3WER6	205	G	R
P17029	LB/B	-	A0A2Y9SJY7	26	V	A
Q9BRR0	LB/B	-	Q07231	3	R	T
Q9BRR0	LB/B	-	Q07231	33	G	V
Q9BRR0	LB/B	-	Q07231	34	F	L
Q9BRR0	LB/B	-	Q07231	189	V	M
Q9BRR0	LB/B	-	Q07231	200	K	E
Q9BRR0	LB/B	-	Q07231	200	K	T
Q9BRR0	LB/B	-	Q07231	246	H	Q
Q9BRR0	LB/B	-	Q07231	200	K	A
Q969J2	LB/B	-	G3VZJ1	33	S	F
Q9P0L1	LB/B	-	F6XAK9	24	R	C
Q9P0L1	LB/B	-	F6XAK9	153	F	S
Q9P0L1	LB/B	-	F6XAK9	342	T	I
Q9P0L1	LB/B	-	F6XAK9	359	E	K
Q9P0L1	LB/B	-	F6XAK9	432	T	A
Q9P0L1	LB/B	-	F6XAK9	483	T	I
Q9P0L1	LB/B	-	F6XAK9	746	S	F
Q15776	LB/B	-	F6XAK9	163	P	L
Q5H9K5	LB/B	-	D3ZGI1	214	R	K
Q5H9K5	LB/B	-	D3ZGI1	536	Q	R
Q9H898	LB/B	-	M3Y383	201	T	A
Q9ULJ6	LP/P	Neurodevelopmental disorder with dysmorphic facies and distal skeletal anomalies (NEDDFSA) [MIM:618659]	F6V623	91	K	R
Q9ULJ6	LP/P	Neurodevelopmental disorder with dysmorphic facies and distal skeletal anomalies (NEDDFSA) [MIM:618659]	F6V623	296	T	I
Q9ULJ6	LP/P	Neurodevelopmental disorder with dysmorphic facies and distal skeletal anomalies (NEDDFSA) [MIM:618659]	F6V623	296	T	K
Q9ULJ6	LP/P	Neurodevelopmental disorder with dysmorphic facies and distal skeletal anomalies (NEDDFSA) [MIM:618659]	F6V623	298	T	I
Q9ULJ6	LP/P	Neurodevelopmental disorder with dysmorphic facies and distal skeletal anomalies (NEDDFSA) [MIM:618659]	F6V623	300	T	M
Q8NF64	LB/B	-	A0A1U7TDD2	408	L	F
O75844	LP/P	Mandibuloacral dysplasia with type B lipodystrophy (MADB) [MIM:608612]	A0A232F8H0	340	W	R
O75844	LB/B	-	A0A232F8H0	137	T	A
O75844	LP/P	Mandibuloacral dysplasia with type B lipodystrophy (MADB) [MIM:608612]	A0A232F8H0	248	P	L
O75844	LP/P	Mandibuloacral dysplasia with type B lipodystrophy (MADB) [MIM:608612]	A0A232F8H0	265	N	S
Q5SVZ6	LB/B	-	I3M018	73	V	M
Q5SVZ6	LB/B	-	I3M018	454	R	Q
Q5SVZ6	LB/B	-	I3M018	493	E	G
Q9UBW7	LB/B	-	A0A1A8KDU8	126	E	A
Q9UBW7	LB/B	-	A0A1A8KDU8	387	I	V
Q9UBW7	LB/B	-	A0A1A8KDU8	649	K	R
Q9UBW7	LB/B	-	A0A1A8KDU8	763	Y	H
Q9UBW7	LB/B	-	A0A1A8KDU8	763	Y	L
Q9UBW7	LB/B	-	A0A1A8KDU8	775	G	E
Q9UBW7	LB/B	-	A0A1A8KDU8	1031	E	K
Q5VZL5	LB/B	-	M7BH05	452	V	I
Q9UJ78	LB/B	-	Q9UJ78	125	I	V
Q9UJ78	LB/B	-	Q9UJ78	137	C	F
Q9UJ78	LB/B	-	Q9UJ78	231	T	A
O75800	LP/P	Ciliary dyskinesia, primary, 22 (CILD22) [MIM:615444]	A0A1W2WQN0	16	V	G
O75800	LP/P	Ciliary dyskinesia, primary, 22 (CILD22) [MIM:615444]	A0A1W2WQN0	29	S	P
O75800	LP/P	Ciliary dyskinesia, primary, 22 (CILD22) [MIM:615444]	A0A1W2WQN0	39	L	P
O75800	LP/P	Ciliary dyskinesia, primary, 22 (CILD22) [MIM:615444]	A0A1W2WQN0	266	L	P
O75800	LB/B	-	A0A1W2WQN0	369	R	W
O75800	LP/P	Ciliary dyskinesia, primary, 22 (CILD22) [MIM:615444]	A0A1W2WQN0	379	Y	C
Q9H0C1	LB/B	-	K1PK64	316	F	L
P21506	LB/B	-	U3KMR9	227	Q	R
Q8IYN0	LB/B	-	A0A2K6KB75	8	M	V
Q8IYN0	LB/B	-	A0A2K6KB75	389	T	I
Q8IZC7	LB/B	-	A0A2I3M8J5	121	M	L
Q9UJU3	LB/B	-	A0A287B1Q1	159	F	L
Q9UJU3	LB/B	-	A0A287B1Q1	163	G	E
Q9UJU3	LB/B	-	A0A287B1Q1	287	T	K
Q9UJU3	LB/B	-	A0A287B1Q1	780	E	A
Q9UJU3	LB/B	-	A0A287B1Q1	54	P	S
Q9UJU3	LB/B	-	A0A287B1Q1	446	E	Q
Q9UJU3	LB/B	-	A0A287B1Q1	485	Y	H
Q03924	LB/B	-	A0A2K6KB75	83	C	Y
Q03924	LB/B	-	A0A2K6KB75	112	K	N
P52740	LB/B	-	A0A2Y9MFH9	252	P	L
P52740	LB/B	-	A0A2Y9MFH9	203	G	D
P52736	LB/B	-	A0A2I3G9S0	193	S	T
P52736	LB/B	-	A0A2I3G9S0	194	G	E
P52741	LB/B	-	A0A2R8MFN8	30	I	T
P52741	LB/B	-	A0A2R8MFN8	46	A	T
P52741	LB/B	-	A0A2R8MFN8	207	S	R
P52737	LB/B	-	A0A2F0BMP4	107	Y	C
P52743	LB/B	-	A0A091MES2	181	Q	H
P52743	LB/B	-	A0A091MES2	112	R	Q
P52744	LB/B	-	A0A2K6JWS3	62	G	E
P17017	LB/B	-	L5MLC9	274	T	S
P17017	LB/B	-	L5MLC9	379	R	Q
P52738	LB/B	-	G3WER6	386	A	V
Q15928	LB/B	-	A0A2J8J7G9	349	R	K
Q15928	LB/B	-	A0A2J8J7G9	358	K	N
Q15928	LB/B	-	A0A2J8J7G9	124	K	E
Q15928	LP/P	Polydactyly, postaxial A6 (PAPA6) [MIM:615226]	A0A2J8J7G9	474	T	I
P52747	LB/B	-	A0A091CNP3	561	E	Q
P52747	LB/B	-	A0A091CNP3	461	G	D
Q12901	LB/B	-	K7ENM7	379	K	R
Q12901	LB/B	-	K7ENM7	157	I	F
Q12901	LB/B	-	K7ENM7	251	R	H
Q12901	LB/B	-	K7ENM7	231	P	L
Q9HCG1	LB/B	-	A0A287ATS5	7	R	Q
Q9HCG1	LB/B	-	A0A287ATS5	82	P	R
Q14929	LB/B	-	A0A2Y9K5W5	72	P	L
Q14929	LB/B	-	A0A2Y9K5W5	381	R	C
Q14929	LB/B	-	A0A2Y9K5W5	78	E	K
Q14929	LB/B	-	A0A2Y9K5W5	152	S	L
Q14929	LB/B	-	A0A2Y9K5W5	596	Q	H
P17021	LB/B	-	A0A2K5ZR08	148	T	K
Q9Y473	LB/B	-	G1U9P6	505	C	R
Q9Y473	LB/B	-	G1U9P6	363	Y	N
Q9Y473	LB/B	-	G1U9P6	622	K	R
Q13360	LB/B	-	A0A287CXJ3	94	D	G
Q13360	LB/B	-	A0A287CXJ3	112	T	M
Q13360	LB/B	-	A0A287CXJ3	455	I	F
P17022	LB/B	-	G1SYK1	210	Q	R
P17022	LB/B	-	G1SYK1	240	M	I
Q9UJW8	LB/B	-	A0A287D493	41	A	V
Q9UJW8	LB/B	-	A0A287D493	89	W	C
Q9UJW8	LB/B	-	A0A287D493	272	C	S
O75820	LB/B	-	A0A2Y9R9X1	221	R	K
P17023	LB/B	-	G3WER6	218	Q	H
P17023	LB/B	-	G3WER6	224	R	Q
P98182	LB/B	-	A0A2K5Q6L1	140	T	M
O95125	LB/B	-	F6XAK9	154	V	A
O95125	LB/B	-	F6XAK9	533	G	A
O95201	LB/B	-	F6YU45	43	T	A
O95201	LB/B	-	F6YU45	255	A	D
O43670	LB/B	-	W5N8H1	224	A	S
O43345	LB/B	-	H0XUE0	282	E	K
O43345	LB/B	-	H0XUE0	298	S	L
O43345	LB/B	-	H0XUE0	456	E	Q
O43345	LB/B	-	H0XUE0	640	K	E
O43345	LB/B	-	H0XUE0	1035	D	G
Q13398	LB/B	-	A0A2Y9MFH9	110	D	N
Q13398	LB/B	-	A0A2Y9MFH9	314	A	V
Q9UDV6	LB/B	-	A0A2Y9NNC2	293	H	Y
Q9UL59	LB/B	-	A0A2Y9MT77	128	L	H
Q9UL59	LB/B	-	A0A2Y9MT77	185	I	R
Q9UL59	LB/B	-	A0A2Y9MT77	66	Y	C
Q9UL59	LB/B	-	A0A2Y9MT77	160	H	R
Q9UL58	LB/B	-	H0XJX0	376	M	V
Q9UL58	LB/B	-	H0XJX0	119	M	V
Q9UL58	LB/B	-	H0XJX0	36	N	S
Q9UL58	LB/B	-	H0XJX0	38	V	I
Q9UL58	LB/B	-	H0XJX0	263	S	F
Q9UL58	LB/B	-	H0XJX0	323	V	L
O75362	LB/B	-	M7BCX1	739	V	I
O75362	LB/B	-	M7BCX1	889	D	G
Q9P2Y4	LB/B	-	F7GEQ7	260	P	T
P17026	LB/B	-	G3IEA2	65	S	G
Q9UK12	LB/B	-	K7ENM7	50	K	E
Q9UK12	LB/B	-	K7ENM7	58	V	F
Q9UK12	LB/B	-	K7ENM7	263	G	D
Q9UK12	LB/B	-	K7ENM7	82	R	G
Q9UK11	LB/B	-	K7ENM7	60	L	I
Q9UK11	LB/B	-	K7ENM7	138	L	I
Q9NZL3	LB/B	-	A0A2Y9RUA5	640	K	E
Q9NZL3	LB/B	-	A0A2Y9RUA5	162	H	L
Q9NZL3	LB/B	-	A0A2Y9RUA5	118	M	V
Q9NZL3	LB/B	-	A0A2Y9RUA5	438	K	N
Q9NZL3	LB/B	-	A0A2Y9RUA5	506	H	D
Q9NZL3	LB/B	-	A0A2Y9RUA5	447	Q	H
Q9UK10	LB/B	-	A0A2Y9RUA5	50	Q	R
Q9UK10	LB/B	-	A0A2Y9RUA5	679	T	S
Q9UJW7	LB/B	-	A0A287B1Q1	156	F	S
Q9UJW7	LB/B	-	A0A287B1Q1	337	R	C
Q9UJW7	LB/B	-	A0A287B1Q1	662	G	R
Q9UJW7	LB/B	-	A0A287B1Q1	804	G	R
Q9UJW7	LB/B	-	A0A287B1Q1	417	S	N
A6NK53	LB/B	-	A0A287B1Q1	247	S	P
A6NK53	LB/B	-	A0A287B1Q1	531	K	T
Q14588	LB/B	-	A0A2Y9RUA5	16	V	I
Q14588	LB/B	-	A0A2Y9RUA5	208	V	M
Q14590	LB/B	-	A0A287B1Q1	296	H	P
Q9UL36	LB/B	-	G3WIU0	166	S	L
Q9UL36	LB/B	-	G3WIU0	614	P	S
Q9UL36	LB/B	-	G3WIU0	643	S	G
Q9UL36	LB/B	-	G3WIU0	818	A	T
Q9UL36	LB/B	-	G3WIU0	613	I	V
Q16600	LB/B	-	A0A2Y9MT77	172	A	G
Q16600	LB/B	-	A0A2Y9MT77	209	C	G
Q16600	LB/B	-	A0A2Y9MT77	266	D	E
P17028	LB/B	-	A0A2K5URW7	220	N	S
P17028	LB/B	-	A0A2K5URW7	331	G	W
Q8NDW4	LB/B	-	A0A096N193	218	K	E
P17030	LB/B	-	A0A2K5N1B4	453	N	K
O75437	LB/B	-	A0A2K5DWU8	93	D	G
O75437	LB/B	-	A0A2K5DWU8	386	A	T
O75437	LB/B	-	A0A2K5DWU8	457	T	A
O75437	LB/B	-	A0A2K5DWU8	594	V	I
O75437	LB/B	-	A0A2K5DWU8	537	K	N
Q9Y2P7	LB/B	-	A0A2Y9MFH9	304	F	I
O14978	LB/B	-	F6XAK9	310	C	S
O14978	LB/B	-	F6XAK9	534	V	I
O14978	LB/B	-	F6XAK9	646	R	Q
O43296	LB/B	-	H0XXW7	181	R	T
O43296	LB/B	-	H0XXW7	183	R	H
Q14584	LB/B	-	A0A2I3MU03	519	P	L
Q14586	LB/B	-	A0A1U7SS69	257	M	V
Q14586	LB/B	-	A0A1U7SS69	350	C	Y
Q14593	LB/B	-	A0A1U8CPC9	454	G	E
Q14593	LB/B	-	A0A1U8CPC9	461	E	D
Q8N554	LB/B	-	A0A2P4TEP8	605	E	D
Q8N554	LB/B	-	A0A2P4TEP8	263	W	R
Q8N554	LB/B	-	A0A2P4TEP8	351	R	W
Q9NRM2	LB/B	-	A0A093CSX0	364	V	M
Q9NRM2	LB/B	-	A0A093CSX0	174	V	I
P17035	LB/B	-	A0A0D9S5F9	179	R	G
P17035	LB/B	-	A0A0D9S5F9	465	K	Q
P17035	LB/B	-	A0A0D9S5F9	524	M	T
P59817	LB/B	-	A0A1S3GLQ4	71	N	K
P59817	LB/B	-	A0A1S3GLQ4	136	S	N
P59817	LB/B	-	A0A1S3GLQ4	137	S	Y
P59817	LB/B	-	A0A1S3GLQ4	246	S	N
P59817	LB/B	-	A0A1S3GLQ4	249	A	G
P59817	LB/B	-	A0A1S3GLQ4	276	L	F
P59817	LB/B	-	A0A1S3GLQ4	278	D	N
P59817	LB/B	-	A0A1S3GLQ4	486	L	F
P59817	LB/B	-	A0A1S3GLQ4	488	S	R
Q86YH2	LB/B	-	A0A1S3GLQ4	256	E	A
Q86YH2	LB/B	-	A0A1S3GLQ4	522	V	G
Q6N043	LB/B	-	A0A024R5W1	568	V	I
Q6N043	LB/B	-	A0A024R5W1	778	A	V
Q6N043	LB/B	-	A0A024R5W1	781	K	I
Q6N043	LB/B	-	A0A024R5W1	785	G	A
Q9UDV7	LB/B	-	F7HG04	273	M	V
Q8N7M2	LB/B	-	A0A1U7SS69	629	R	H
Q8N7M2	LB/B	-	A0A1U7SS69	646	R	I
Q8N7M2	LB/B	-	A0A1U7SS69	314	T	I
Q8N7M2	LB/B	-	A0A1U7SS69	638	C	R
Q8N7M2	LB/B	-	A0A1U7SS69	638	C	Y
Q96NJ3	LB/B	-	A0A2I3RWS6	208	S	N
Q96NJ3	LB/B	-	A0A2I3RWS6	536	G	R
Q9HBT7	LB/B	-	F6XAK9	281	K	T
P17036	LB/B	-	A0A2Y9SJY7	102	I	T
P17039	LB/B	-	F6WQ97	123	Q	R
P17039	LB/B	-	F6WQ97	190	A	T
P17039	LB/B	-	F6WQ97	379	R	K
P17039	LB/B	-	F6WQ97	400	Y	C
Q96RE9	LB/B	-	A0A096N193	336	Q	H
Q9HCX3	LB/B	-	A0A2Y9MFH9	121	L	P
Q9HCX3	LB/B	-	A0A2Y9MFH9	367	K	E
Q5JNZ3	LB/B	-	A0A1S3GCS3	486	R	C
Q5JNZ3	LB/B	-	A0A1S3GCS3	511	K	Q
Q5VUA4	LB/B	-	K9J4E0	407	S	I
Q5VUA4	LB/B	-	K9J4E0	870	L	V
Q5VUA4	LB/B	-	K9J4E0	1292	T	I
Q5VUA4	LB/B	-	K9J4E0	1580	A	T
Q5VUA4	LB/B	-	K9J4E0	1583	T	I
Q5VUA4	LB/B	-	K9J4E0	1797	V	A
Q6AW86	LB/B	-	G5B3G0	63	S	G
Q86UD4	LB/B	-	A0A1U8CRL1	182	N	D
Q86UD4	LB/B	-	A0A1U8CRL1	99	S	N
Q9Y3S2	LB/B	-	A0A061IEV4	28	T	A
Q9Y3S2	LB/B	-	A0A061IEV4	298	L	M
Q96JL9	LB/B	-	A0A1U7TMQ1	251	A	E
Q96JL9	LB/B	-	A0A1U7TMQ1	537	A	V
Q9HCZ1	LB/B	-	A0A2U3V4K8	547	N	S
Q9H4Z2	LB/B	-	A0A250Y7I6	294	S	T
Q9H4Z2	LB/B	-	A0A250Y7I6	65	R	C
Q9H4Z2	LB/B	-	A0A250Y7I6	101	G	S
Q9H4Z2	LB/B	-	A0A250Y7I6	603	Y	H
Q9H4Z2	LP/P	Microcephaly 10, primary, autosomal recessive (MCPH10) [MIM:615095]	A0A250Y7I6	1111	R	H
Q9Y3M9	LB/B	-	A0A287ATS5	17	V	I
Q9Y3M9	LB/B	-	A0A287ATS5	467	R	G
Q06730	LB/B	-	A0A287ATS5	549	Q	E
Q06730	LB/B	-	A0A287ATS5	614	G	R
Q06730	LB/B	-	A0A287ATS5	804	D	H
Q06732	LB/B	-	A0A2U4BE60	145	R	C
Q06732	LB/B	-	A0A2U4BE60	356	H	R
Q6P1L6	LB/B	-	A0A2K5QZU5	520	P	L
Q96SE7	LB/B	-	A0A0D9S5F9	117	M	V
Q96SE7	LB/B	-	A0A0D9S5F9	264	N	D
Q9GZX5	LB/B	-	A0A287D4F5	66	L	P
Q9GZX5	LB/B	-	A0A287D4F5	472	S	P
Q9GZX5	LB/B	-	A0A287D4F5	501	R	S
Q9GZX5	LB/B	-	A0A287D4F5	524	V	I
Q9GZX5	LB/B	-	A0A287D4F5	37	M	I
Q9GZX5	LB/B	-	A0A287D4F5	69	I	T
Q9GZX5	LB/B	-	A0A287D4F5	132	R	C
Q9GZX5	LB/B	-	A0A287D4F5	406	E	K
Q86Y25	LB/B	-	A0A091DT10	250	E	K
Q86Y25	LB/B	-	A0A091DT10	546	F	L
Q86Y25	LB/B	-	A0A091DT10	553	E	K
Q70YC4	LB/B	-	A0A1D5QXY5	62	T	A
Q70YC5	LB/B	-	G5C602	337	A	S
P17032	LB/B	-	A0A096N193	105	D	N
Q96SR6	LB/B	-	J9P0W5	168	E	G
Q9UJN7	LB/B	-	H0XU87	51	K	R
Q9UJN7	LB/B	-	H0XU87	59	G	C
Q53GI3	LB/B	-	G3VZJ1	325	T	M
Q96N95	LB/B	-	A0A1S3AIC6	211	H	L
Q8TD17	LB/B	-	A0A287AU96	87	E	D
Q8TD17	LB/B	-	A0A287AU96	294	S	L
Q494X3	LB/B	-	F6WQ97	233	H	Y
Q494X3	LB/B	-	F6WQ97	337	G	S
Q9C0G0	LB/B	-	A0A2U3X273	972	N	T
Q9C0G0	LB/B	-	A0A2U3X273	69	N	S
Q9C0G0	LB/B	-	A0A2U3X273	512	G	R
Q9C0G0	LB/B	-	A0A2U3X273	1913	A	T
Q9C0G0	LB/B	-	A0A2U3X273	1259	S	L
Q9C0G0	LP/P	Short stature, impaired intellectual development, microcephaly, hypotonia, and ocular anomalies (SIMHA) [MIM:619557]	A0A2U3X273	1685	S	W
Q9H9D4	LB/B	-	A0A1U7UE47	337	R	P
Q9H9D4	LP/P	Vitreoretinopathy, exudative 6 (EVR6) [MIM:616468]	A0A1U7UE47	455	H	Y
Q9H9D4	LB/B	-	A0A1U7UE47	492	G	R
Q9H9D4	LP/P	Retinitis pigmentosa 72 (RP72) [MIM:616469]	A0A1U7UE47	541	R	C
Q9H9D4	LB/B	-	A0A1U7UE47	583	Q	K
P51814	LB/B	-	A0A287ATS5	167	I	R
P51814	LB/B	-	A0A287ATS5	357	D	E
Q96IQ9	LB/B	-	G1LEG3	65	Q	R
Q96IQ9	LB/B	-	G1LEG3	77	P	S
Q8TAU3	LB/B	-	A0A2Y9MFH9	495	N	S
Q96HQ0	LB/B	-	A0A287A8U1	141	E	Q
Q96HQ0	LB/B	-	A0A287A8U1	336	I	V
Q6IV72	LB/B	-	A0A2U4B8D4	166	D	V
Q9BUY5	LB/B	-	G3H6F5	4	A	V
Q9BUY5	LB/B	-	G3H6F5	219	T	A
Q86V71	LB/B	-	A0A2K5DWU8	650	H	Y
P17038	LB/B	-	A0A2K5DWU8	718	S	P
Q8TF32	LB/B	-	A0A2K6KB75	3	D	G
Q7Z4V0	LB/B	-	A0A091GXD9	173	P	S
Q7Z4V0	LB/B	-	A0A091GXD9	693	L	V
P15621	LB/B	-	G5C799	92	G	A
P15621	LB/B	-	G5C799	212	T	A
Q8IYI8	LB/B	-	A0A2I3M8J5	88	P	R
Q8IYI8	LB/B	-	A0A2I3M8J5	569	S	N
Q8IYI8	LB/B	-	A0A2I3M8J5	43	L	I
Q8IYI8	LB/B	-	A0A2I3M8J5	124	N	S
Q9H7R0	LB/B	-	A0A2I3M8J5	110	P	T
Q9H7R0	LB/B	-	A0A2I3M8J5	443	R	C
Q9H7R0	LB/B	-	A0A2I3M8J5	93	I	V
Q9H7R0	LB/B	-	A0A2I3M8J5	422	G	R
Q9Y2A4	LB/B	-	A0A2I3M8J5	591	P	Q
Q9Y2A4	LB/B	-	A0A2I3M8J5	111	K	N
Q9Y2A4	LB/B	-	A0A2I3M8J5	485	C	F
Q9Y2A4	LB/B	-	A0A2I3M8J5	111	K	I
Q9Y2A4	LB/B	-	A0A2I3M8J5	397	Q	H
P59923	LB/B	-	K9IUE7	428	Y	C
Q9NWS9	LB/B	-	J9NX09	192	N	H
Q9NWS9	LB/B	-	J9NX09	300	P	S
Q9NWS9	LB/B	-	J9NX09	387	R	H
Q02386	LB/B	-	A0A287B1Q1	187	A	T
Q02386	LB/B	-	A0A287B1Q1	255	R	K
Q02386	LB/B	-	A0A287B1Q1	299	T	A
Q02386	LB/B	-	A0A287B1Q1	303	P	R
Q02386	LB/B	-	A0A287B1Q1	504	R	K
Q8N9F8	LB/B	-	G5BCG6	166	D	A
Q8N9F8	LB/B	-	G5BCG6	152	C	Y
Q8TAF7	LB/B	-	F6WQ97	87	N	S
Q96JM2	LB/B	-	A0A2I4BAR9	404	M	V
Q96JM2	LB/B	-	A0A2I4BAR9	1187	P	S
Q96JM2	LB/B	-	A0A2I4BAR9	1828	N	S
Q96JM2	LB/B	-	A0A2I4BAR9	2052	K	R
Q96JM2	LB/B	-	A0A2I4BAR9	2452	H	L
Q7Z7K2	LB/B	-	M3WF37	324	T	A
Q5VIY5	LB/B	-	H9KXD2	374	H	R
Q5VIY5	LB/B	-	H9KXD2	477	G	R
Q96JG9	LB/B	-	G3WGA3	366	R	S
Q96JG9	LB/B	-	G3WGA3	1162	K	E
Q96JG9	LB/B	-	G3WGA3	1420	P	L
Q96JG9	LB/B	-	G3WGA3	2129	R	K
Q96JG9	LB/B	-	G3WGA3	2358	G	R
Q96JG9	LB/B	-	G3WGA3	2670	L	Q
Q96JG9	LB/B	-	G3WGA3	2710	A	T
Q96JG9	LB/B	-	G3WGA3	2749	D	V
Q96JG9	LB/B	-	G3WGA3	2848	H	R
Q96JG9	LB/B	-	G3WGA3	3630	E	Q
Q96JG9	LB/B	-	G3WGA3	3636	T	A
Q96JG9	LB/B	-	G3WGA3	357	S	P
Q6ECI4	LB/B	-	A0A1U8CPC9	23	V	L
Q6ECI4	LB/B	-	A0A1U8CPC9	254	K	R
Q6ECI4	LB/B	-	A0A1U8CPC9	418	T	I
Q6ECI4	LB/B	-	A0A1U8CPC9	642	I	T
Q9BX82	LB/B	-	A0A1S3FZD9	192	M	I
Q9BX82	LB/B	-	A0A1S3FZD9	406	G	D
Q9BX82	LB/B	-	A0A1S3FZD9	556	S	C
Q9BX82	LB/B	-	A0A1S3FZD9	309	Q	R
Q8WTR7	LB/B	-	Q8BI67	59	S	G
Q8WTR7	LB/B	-	Q8BI67	74	S	G
Q8WTR7	LB/B	-	Q8BI67	164	T	M
Q8WTR7	LB/B	-	Q8BI67	309	E	G
Q8WTR7	LB/B	-	Q8BI67	654	T	I
Q8WTR7	LB/B	-	Q8BI67	662	S	A
Q6S9Z5	LB/B	-	D2HAR4	173	R	H
Q8WV37	LB/B	-	A0A2R8MXV4	177	P	S
Q5JVG2	LB/B	-	A0A287ATS5	502	G	D
Q8NCK3	LB/B	-	A0A2Y9N1K4	252	A	T
B1APH4	LB/B	-	A0A2Y9TEM2	61	P	R
B1APH4	LB/B	-	A0A2Y9TEM2	120	R	S
Q96MN9	LB/B	-	F6UEU6	72	A	V
Q96MN9	LB/B	-	F6UEU6	106	P	L
Q96MN9	LB/B	-	F6UEU6	249	P	S
Q9P255	LB/B	-	A0A2K6KB75	106	T	K
Q6ZR52	LB/B	-	A0A2K5DWU8	195	C	F
Q6ZR52	LB/B	-	A0A2K5DWU8	292	L	V
Q6ZNH5	LB/B	-	A0A2J8RQH2	174	H	Q
Q96CX3	LB/B	-	A0A2P2IBI4	17	M	V
Q96CX3	LB/B	-	A0A2P2IBI4	147	I	V
Q8TBZ5	LB/B	-	G3WMQ5	243	E	A
Q8TBZ5	LB/B	-	G3WMQ5	28	L	P
Q8TBZ5	LB/B	-	G3WMQ5	174	Q	R
Q96F45	LB/B	-	A0A2G9RLZ7	509	N	K
Q5JVG8	LB/B	-	A0A2K6KB75	189	T	P
Q9Y2H8	LB/B	-	A0A096N193	43	Q	R
Q9Y2H8	LB/B	-	A0A096N193	89	C	R
Q9Y2H8	LB/B	-	A0A096N193	273	N	K
Q9Y2H8	LB/B	-	A0A096N193	398	H	D
Q9Y2H8	LB/B	-	A0A096N193	401	M	I
Q9Y2H8	LB/B	-	A0A096N193	634	G	E
Q96KM6	LB/B	-	A0A151N025	372	M	V
Q96KM6	LB/B	-	A0A151N025	453	A	T
Q96KM6	LB/B	-	A0A151N025	288	V	M
Q8N8E2	LP/P	Retinitis pigmentosa 58 (RP58) [MIM:613617]	W5NJ78	339	C	R
Q92618	LB/B	-	A0A2K6JY59	4	N	S
Q92618	LB/B	-	A0A2K6JY59	239	G	S
Q6ZMY9	LB/B	-	A0A0G2K279	6	P	L
Q9C0D4	LB/B	-	F7EAK5	105	S	P
Q9C0D4	LB/B	-	F7EAK5	523	S	N
Q9C0D4	LB/B	-	F7EAK5	92	G	S
Q8TB69	LB/B	-	F6WQ97	18	W	R
Q8TB69	LB/B	-	F6WQ97	89	G	S
Q8TB69	LB/B	-	F6WQ97	206	K	E
Q8TB69	LB/B	-	F6WQ97	229	R	I
Q8TF50	LB/B	-	F6XP31	94	V	A
Q8TF50	LB/B	-	F6XP31	511	S	F
Q6P280	LB/B	-	L8YFZ4	131	L	V
Q6P9A1	LB/B	-	A0A2K5QG08	64	T	A
Q6P9A1	LB/B	-	A0A2K5QG08	110	H	Q
Q6P9A1	LB/B	-	A0A2K5QG08	124	S	P
Q6P9A1	LB/B	-	A0A2K5QG08	169	T	M
Q6P9A1	LB/B	-	A0A2K5QG08	262	G	S
Q8NDQ6	LB/B	-	A0A1U7SS69	53	D	V
Q8NDQ6	LB/B	-	A0A1U7SS69	340	G	R
Q9H0D2	LB/B	-	A0A2K6K6C1	486	P	S
Q9H0D2	LB/B	-	A0A2K6K6C1	791	K	E
Q9H0D2	LB/B	-	A0A2K6K6C1	795	T	S
Q08ER8	LB/B	-	S7PB44	55	P	A
Q08ER8	LB/B	-	S7PB44	107	Q	R
Q08ER8	LB/B	-	S7PB44	246	L	H
Q08ER8	LB/B	-	S7PB44	287	E	V
Q08ER8	LB/B	-	S7PB44	439	V	D
Q08ER8	LB/B	-	S7PB44	573	M	V
Q86UE3	LB/B	-	A0A1S3FZD9	201	Q	R
Q86UE3	LB/B	-	A0A1S3FZD9	243	R	T
Q86UE3	LB/B	-	A0A1S3FZD9	253	A	V
Q86UE3	LB/B	-	A0A1S3FZD9	298	V	E
Q86UE3	LB/B	-	A0A1S3FZD9	427	E	G
Q86UE3	LB/B	-	A0A1S3FZD9	452	L	F
Q86UE3	LB/B	-	A0A1S3FZD9	652	L	F
Q8NEK5	LB/B	-	A0A2K5QG08	58	A	S
Q8NEK5	LB/B	-	A0A2K5QG08	73	A	T
Q6P9A3	LB/B	-	A0A2Y9MFH9	8	I	N
Q7Z340	LB/B	-	A0A2Y9MFH9	218	N	S
Q7Z340	LB/B	-	A0A2Y9MFH9	550	R	W
Q9H707	LB/B	-	H2PB98	242	W	C
Q86TJ5	LB/B	-	A0A2U3ZM65	190	E	G
Q86TJ5	LB/B	-	A0A2U3ZM65	211	V	I
Q9HAH1	LB/B	-	A0A2U3ZE69	137	R	C
Q9HAH1	LB/B	-	A0A2U3ZE69	146	R	L
Q9HAH1	LB/B	-	A0A2U3ZE69	353	A	T
Q9HAH1	LB/B	-	A0A2U3ZE69	428	E	K
Q9BR84	LB/B	-	G3H6F5	251	T	N
Q96MR9	LB/B	-	A0A2J8RVB8	630	Y	C
Q8N9K5	LB/B	-	A0A096N193	228	I	T
Q3ZCX4	LB/B	-	A0A096N193	437	M	T
Q3ZCX4	LB/B	-	A0A096N193	642	Q	R
Q68EA5	LB/B	-	A0A2U4AL73	223	T	N
Q68EA5	LB/B	-	A0A2U4AL73	230	R	W
Q68EA5	LB/B	-	A0A2U4AL73	357	T	M
Q7Z3V5	LB/B	-	F6WQ97	189	Q	H
Q7Z3V5	LB/B	-	F6WQ97	252	E	D
Q7Z3V5	LB/B	-	F6WQ97	573	L	H
Q7Z3V5	LB/B	-	F6WQ97	593	K	E
Q7Z3V5	LB/B	-	F6WQ97	170	K	M
Q7Z3I7	LB/B	-	F1RRR4	317	K	T
Q7Z3I7	LB/B	-	F1RRR4	380	G	E
Q7Z3I7	LB/B	-	F1RRR4	448	S	C
Q7Z3I7	LB/B	-	F1RRR4	500	V	I
Q86YE8	LB/B	-	A0A1U7SS69	186	G	A
Q86YE8	LB/B	-	A0A1U7SS69	224	G	A
Q9H609	LB/B	-	A0A1S3GGT3	81	P	L
Q9BSK1	LB/B	-	A0A2Y9RA39	357	R	S
Q9BSK1	LB/B	-	A0A2Y9RA39	84	A	V
Q9BSK1	LB/B	-	A0A2Y9RA39	123	R	C
Q9BSK1	LB/B	-	A0A2Y9RA39	234	R	K
Q9BSK1	LB/B	-	A0A2Y9RA39	246	K	E
Q9BSK1	LB/B	-	A0A2Y9RA39	346	R	C
Q9BSK1	LB/B	-	A0A2Y9RA39	373	E	K
Q9BSK1	LB/B	-	A0A2Y9RA39	375	T	I
Q96N58	LB/B	-	A0A2Y9R9X1	238	E	K
Q8NAF0	LB/B	-	A0A0D9SE63	353	E	D
Q96NG8	LB/B	-	G3WER6	69	R	T
Q8IVC4	LB/B	-	A0A2J8JM69	142	P	S
Q8IVC4	LB/B	-	A0A2J8JM69	301	T	A
Q52M93	LB/B	-	A0A096N193	467	V	I
Q86UQ0	LB/B	-	A0A2I3G9S0	216	T	R
Q86UQ0	LB/B	-	A0A2I3G9S0	12	T	A
Q92610	LB/B	-	A0A2K6M1Z7	926	S	N
O00488	LB/B	-	A0A1C7MVP9	6	R	Q
Q96JF6	LB/B	-	A0A2G9SKR6	171	I	T
Q96JF6	LB/B	-	A0A2G9SKR6	199	V	G
Q96JF6	LB/B	-	A0A2G9SKR6	166	Q	H
Q8IYB9	LB/B	-	A0A2J8J7G9	628	A	G
Q8TC21	LB/B	-	A0A096N193	136	T	K
Q8TC21	LB/B	-	A0A096N193	476	V	G
Q96LX8	LB/B	-	A0A2Y9Q4R4	30	T	S
Q96NL3	LB/B	-	S7PB44	178	L	F
Q6ZNG1	LB/B	-	A0A0D9S5F9	2	M	V
Q6ZNG1	LB/B	-	A0A0D9S5F9	13	T	R
Q6ZNG1	LB/B	-	A0A0D9S5F9	209	C	R
Q8WXB4	LB/B	-	L5L2B7	141	S	G
Q96SK3	LB/B	-	A0A1U8CR70	2	S	A
Q96SK3	LB/B	-	A0A1U8CR70	70	R	H
Q96SK3	LB/B	-	A0A1U8CR70	123	F	L
Q96SK3	LB/B	-	A0A1U8CR70	375	S	T
Q96SK3	LB/B	-	A0A1U8CR70	653	A	P
Q96SK3	LB/B	-	A0A1U8CR70	433	R	H
Q96SK3	LB/B	-	A0A1U8CR70	531	K	R
Q9ULD9	LB/B	-	H0V9J3	721	T	N
Q8N9Z0	LB/B	-	A0A2R8MXV4	216	R	P
Q8N9Z0	LB/B	-	A0A2R8MXV4	104	V	M
Q8N9Z0	LB/B	-	A0A2R8MXV4	131	A	S
Q8N9Z0	LB/B	-	A0A2R8MXV4	298	R	I
Q8N823	LB/B	-	A0A0D9S5F9	252	P	L
Q8N823	LB/B	-	A0A0D9S5F9	340	E	G
Q8N823	LB/B	-	A0A0D9S5F9	252	P	T
Q8N823	LB/B	-	A0A0D9S5F9	234	N	I
Q8N823	LB/B	-	A0A0D9S5F9	252	P	I
Q6PF04	LB/B	-	A0A287D4F5	84	D	N
Q6PF04	LB/B	-	A0A287D4F5	93	K	E
Q6PF04	LB/B	-	A0A287D4F5	135	I	R
Q6PF04	LB/B	-	A0A287D4F5	163	S	F
Q6PF04	LB/B	-	A0A287D4F5	611	D	V
Q8N8J6	LB/B	-	L5L4A7	129	T	M
Q8N8J6	LB/B	-	L5L4A7	360	T	I
Q8N8J6	LB/B	-	L5L4A7	727	R	K
Q08AN1	LB/B	-	A0A2Y9R9X1	451	H	R
Q08AN1	LB/B	-	A0A2Y9R9X1	50	P	S
Q9P2J8	LB/B	-	A0A1U7SS69	135	K	N
Q96I27	LB/B	-	A0A2U3ZE69	41	V	M
Q68DY1	LB/B	-	A0A2K6KB75	68	N	H
Q68DY1	LB/B	-	A0A2K6KB75	65	M	T
Q68DY1	LB/B	-	A0A2K6KB75	89	Q	E
Q68DY1	LB/B	-	A0A2K6KB75	90	S	N
Q68DY1	LB/B	-	A0A2K6KB75	464	C	Y
Q68DY1	LB/B	-	A0A2K6KB75	500	E	K
Q9UEG4	LB/B	-	F6SQ37	707	P	A
Q96N77	LB/B	-	Q8BZ34	231	S	C
Q96N77	LB/B	-	Q8BZ34	363	Q	P
Q9H582	LB/B	-	W5MC42	556	M	V
Q9H582	LB/B	-	W5MC42	794	A	V
Q9H582	LP/P	Myopia 21, autosomal dominant (MYP21) [MIM:614167]	W5MC42	587	I	V
Q9H582	LP/P	Myopia 21, autosomal dominant (MYP21) [MIM:614167]	W5MC42	672	S	G
Q9H582	LP/P	Myopia 21, autosomal dominant (MYP21) [MIM:614167]	W5MC42	680	R	G
Q9H582	LP/P	Myopia 21, autosomal dominant (MYP21) [MIM:614167]	W5MC42	699	C	Y
Q9H582	LB/B	-	W5MC42	550	A	T
Q9H582	LB/B	-	W5MC42	706	H	Y
Q9H582	LB/B	-	W5MC42	707	K	E
Q9H582	LB/B	-	W5MC42	1100	R	H
O15015	LB/B	-	V8P455	98	A	V
O15015	LB/B	-	V8P455	327	E	G
O15015	LB/B	-	V8P455	774	I	M
O15015	LB/B	-	V8P455	921	G	A
O15015	LB/B	-	V8P455	1249	R	W
O15015	LB/B	-	V8P455	1318	R	Q
O15015	LB/B	-	V8P455	1477	G	D
O15015	LB/B	-	V8P455	1788	T	M
Q5T619	LB/B	-	L8HYU3	111	N	K
Q5T619	LB/B	-	L8HYU3	42	E	K
Q9BS31	LB/B	-	A0A2Y9TEM2	352	G	D
Q9BS31	LB/B	-	A0A2Y9TEM2	469	A	T
Q96CK0	LB/B	-	A0A1D5PXX1	54	K	R
Q96CK0	LB/B	-	A0A1D5PXX1	329	A	T
Q8N720	LB/B	-	A0A1S3WST5	52	E	D
Q6ZS27	LB/B	-	G3WER6	176	N	S
Q9H7R5	LB/B	-	A0A2Y9R9X1	84	V	A
Q9H7R5	LB/B	-	A0A2Y9R9X1	157	H	R
Q9H7R5	LB/B	-	A0A2Y9R9X1	647	V	I
Q5HYK9	LB/B	-	A0A2K6FWA0	260	K	R
Q5HYK9	LB/B	-	A0A2K6FWA0	540	T	A
Q5HYK9	LB/B	-	A0A2K6FWA0	134	P	L
Q8TAW3	LB/B	-	A0A2R8MFN8	149	A	V
Q8TAW3	LB/B	-	A0A2R8MFN8	237	P	S
Q8TD23	LB/B	-	A0A2K6KB75	197	V	A
Q8TD23	LB/B	-	A0A2K6KB75	124	L	V
Q8TD23	LB/B	-	A0A2K6KB75	410	A	T
Q8N7Q3	LB/B	-	A0A2K6KB75	27	G	E
Q8N7Q3	LB/B	-	A0A2K6KB75	96	E	K
Q8N7Q3	LB/B	-	A0A2K6KB75	292	S	W
Q86XU0	LB/B	-	A6QNZ9	56	D	N
Q86XU0	LB/B	-	A6QNZ9	254	G	E
Q5SXM1	LB/B	-	A0A2K6KB75	144	K	E
Q5SXM1	LB/B	-	A0A2K6KB75	197	T	I
Q5SXM1	LB/B	-	A0A2K6KB75	152	P	T
Q8IYX0	LB/B	-	A0A2K6JWS3	69	E	G
Q8IYX0	LB/B	-	A0A2K6JWS3	120	H	R
Q8IYX0	LB/B	-	A0A2K6JWS3	212	Y	H
Q8IYX0	LB/B	-	A0A2K6JWS3	223	C	S
Q8NEM1	LB/B	-	A0A2K6KB75	132	S	F
Q8NEM1	LB/B	-	A0A2K6KB75	330	D	G
Q8NEM1	LB/B	-	A0A2K6KB75	525	N	D
Q96N22	LB/B	-	A0A2K5DWU8	84	D	H
Q96N22	LB/B	-	A0A2K5DWU8	295	L	S
Q96N22	LB/B	-	A0A2K5DWU8	367	R	K
Q96N22	LB/B	-	A0A2K5DWU8	548	H	Q
O95780	LB/B	-	A0A2K6KB75	65	V	M
O95780	LB/B	-	A0A2K6KB75	209	T	I
O95780	LB/B	-	A0A2K6KB75	450	V	I
Q8IZ20	LB/B	-	A0A2Y9LQT5	204	H	N
Q8IZ20	LB/B	-	A0A2Y9LQT5	22	G	V
Q8IZ20	LB/B	-	A0A2Y9LQT5	48	D	G
Q8IZ20	LB/B	-	A0A2Y9LQT5	53	H	R
Q8IZ20	LB/B	-	A0A2Y9LQT5	288	R	L
Q8N1G0	LB/B	-	H2M0P7	259	G	E
Q8N1G0	LB/B	-	H2M0P7	344	R	T
Q8N1G0	LP/P	Paget disease of bone 6 (PDB6) [MIM:616833]	H2M0P7	937	P	R
P0C7X2	LB/B	-	A0A2Y9PNI2	131	S	I
Q9BU19	LB/B	-	S9WN59	230	P	R
Q8IW36	LB/B	-	A0A2J8J7G9	84	R	K
Q8IW36	LB/B	-	A0A2J8J7G9	87	V	A
Q8IW36	LB/B	-	A0A2J8J7G9	110	M	I
Q9H0M5	LB/B	-	G5C799	321	L	V
Q9H0M5	LB/B	-	G5C799	269	E	G
Q9NV72	LB/B	-	A0A2R8MXV4	70	L	P
Q9NV72	LB/B	-	A0A2R8MXV4	182	T	I
Q9NV72	LB/B	-	A0A2R8MXV4	521	R	C
Q9NV72	LB/B	-	A0A2R8MXV4	337	T	K
Q9NV72	LB/B	-	A0A2R8MXV4	185	L	V
Q9NV72	LB/B	-	A0A2R8MXV4	495	R	H
Q9NV72	LB/B	-	A0A2R8MXV4	306	D	E
Q6ZNC4	LB/B	-	A0A1D5PK21	35	A	S
Q6ZN79	LB/B	-	A0A2I3GB01	142	K	Q
Q6ZN79	LB/B	-	A0A2I3GB01	126	T	A
Q6ZN79	LB/B	-	A0A2I3GB01	134	R	C
Q6ZN79	LB/B	-	A0A2I3GB01	186	R	H
Q96C28	LB/B	-	G3WER6	96	P	H
P17019	LB/B	-	A0A2K6KB75	71	A	V
P17019	LB/B	-	A0A2K6KB75	113	K	E
P17019	LB/B	-	A0A2K6KB75	122	K	T
P17019	LB/B	-	A0A2K6KB75	130	R	Q
Q9NQZ8	LB/B	-	A0A096N193	105	V	I
Q9NQZ8	LB/B	-	A0A096N193	27	R	G
Q9NQZ8	LB/B	-	A0A096N193	121	P	L
Q9Y462	LB/B	-	A0A2D0RGN1	221	T	A
Q9Y462	LB/B	-	A0A2D0RGN1	524	M	T
Q9Y462	LP/P	Intellectual developmental disorder, X-linked 97 (XLID97) [MIM:300803]	A0A2D0RGN1	244	I	T
Q96N38	LB/B	-	A0A2K6KB75	331	K	R
Q96N38	LB/B	-	A0A2K6KB75	473	I	V
Q96N38	LB/B	-	A0A2K6KB75	472	I	V
Q3SXZ3	LB/B	-	A0A2J8J7G9	140	K	N
Q3SXZ3	LB/B	-	A0A2J8J7G9	140	K	R
Q3SXZ3	LB/B	-	A0A2J8J7G9	297	S	Y
Q3SXZ3	LB/B	-	A0A2J8J7G9	413	H	R
Q6ZMV8	LB/B	-	A0A2K6KB75	365	G	E
O75373	LB/B	-	A0A2K6KB75	78	C	S
O75373	LB/B	-	A0A2K6KB75	125	V	L
O75373	LB/B	-	A0A2K6KB75	492	R	C
O75373	LB/B	-	A0A2K6KB75	516	K	E
Q16587	LB/B	-	A0A2I3GG67	117	E	K
O43361	LB/B	-	A0A2K5ZR08	243	Q	R
O43361	LB/B	-	A0A2K5ZR08	405	A	T
O43361	LB/B	-	A0A2K5ZR08	771	I	R
Q32MQ0	LB/B	-	W5N9F9	235	M	V
Q32MQ0	LB/B	-	W5N9F9	288	P	L
Q32MQ0	LB/B	-	W5N9F9	392	Q	R
Q96N20	LB/B	-	A0A2Y9PU14	84	V	A
P36508	LB/B	-	A0A2K6CS41	48	T	M
P36508	LB/B	-	A0A2K6CS41	272	R	C
P36508	LB/B	-	A0A2K6CS41	403	R	Q
Q86XN6	LB/B	-	A0A0D9S5F9	122	I	S
Q86XN6	LB/B	-	A0A0D9S5F9	168	V	I
Q86XN6	LB/B	-	A0A0D9S5F9	528	G	S
Q86XN6	LB/B	-	A0A0D9S5F9	603	E	Q
Q86XN6	LB/B	-	A0A0D9S5F9	678	I	V
Q0D2J5	LB/B	-	A0A2R9ATA1	327	Y	H
Q0D2J5	LB/B	-	A0A2R9ATA1	324	Y	H
Q96H86	LB/B	-	A0A2K5E576	332	A	V
Q7L2R6	LB/B	-	H9KXD2	389	S	G
Q5HY98	LB/B	-	A0A2R8MXV4	95	C	Y
Q75MW2	LB/B	-	H2PNZ6	31	H	R
Q75MW2	LB/B	-	H2PNZ6	38	Q	R
Q75MW2	LB/B	-	H2PNZ6	131	A	T
Q75MW2	LB/B	-	H2PNZ6	134	T	A
Q9H5H4	LB/B	-	G1U9E7	181	E	D
Q9H5H4	LB/B	-	G1U9E7	488	A	S
Q15935	LB/B	-	A0A2U4AL73	20	L	W
Q15935	LB/B	-	A0A2U4AL73	179	P	S
Q15935	LB/B	-	A0A2U4AL73	460	G	R
Q15935	LB/B	-	A0A2U4AL73	3	C	S
Q15935	LB/B	-	A0A2U4AL73	5	I	V
Q68DY9	LB/B	-	G5B7M9	182	C	W
Q68DY9	LB/B	-	G5B7M9	218	M	L
Q96BV0	LB/B	-	A0A2Y9RB96	428	T	A
Q9ULD5	LB/B	-	G3VD42	70	R	W
Q9ULD5	LB/B	-	G3VD42	115	V	A
Q9ULD5	LB/B	-	G3VD42	512	A	T
Q96MU6	LB/B	-	A0A2J8RVB8	683	N	D
Q6ZMW2	LB/B	-	G5ALJ8	130	R	P
Q6ZMW2	LB/B	-	G5ALJ8	165	R	H
Q6ZMW2	LB/B	-	G5ALJ8	246	N	S
Q6ZMW2	LB/B	-	G5ALJ8	289	T	A
Q6ZMS7	LB/B	-	A0A2Y9NNC2	63	R	C
Q5FWF6	LB/B	-	G3WER6	77	T	A
Q15937	LB/B	-	G3WER6	31	T	I
Q15937	LB/B	-	G3WER6	51	R	G
Q15937	LB/B	-	G3WER6	401	S	N
Q6PG37	LB/B	-	L8YFZ4	486	T	S
Q6PG37	LB/B	-	L8YFZ4	301	Q	R
Q3KQV3	LB/B	-	A0A2K5QG08	177	R	Q
Q3KQV3	LB/B	-	A0A2K5QG08	525	R	W
Q6ZN11	LB/B	-	G3WER6	68	I	M
Q6ZN11	LB/B	-	G3WER6	133	I	V
Q96GE5	LB/B	-	A0A2I3M8J5	44	G	V
Q96GE5	LB/B	-	A0A2I3M8J5	593	C	R
Q2TB10	LB/B	-	A0A096M6R5	102	L	V
Q7Z570	LB/B	-	H9G7Y9	261	Q	L
Q7Z570	LB/B	-	H9G7Y9	542	E	K
Q7Z570	LB/B	-	H9G7Y9	707	T	K
Q7Z570	LB/B	-	H9G7Y9	747	H	R
Q7Z570	LB/B	-	H9G7Y9	1081	L	V
Q7Z570	LB/B	-	H9G7Y9	479	D	G
Q7Z570	LB/B	-	H9G7Y9	600	K	R
Q7Z570	LB/B	-	H9G7Y9	1152	G	R
Q5CZA5	LB/B	-	H0XXW7	68	G	E
Q8N4W9	LB/B	-	A0A0D9S5F9	134	K	N
Q8N4W9	LB/B	-	A0A0D9S5F9	262	D	N
P51508	LB/B	-	G1U9P6	3	A	V
P51508	LB/B	-	G1U9P6	157	N	S
P51508	LB/B	-	G1U9P6	185	S	L
P51508	LB/B	-	G1U9P6	499	I	V
P51508	LB/B	-	G1U9P6	117	G	V
P51508	LB/B	-	G1U9P6	213	A	E
Q6ZN06	LB/B	-	A0A0D9S5F9	231	R	K
Q6ZN06	LB/B	-	A0A0D9S5F9	439	Y	F
Q6ZN06	LB/B	-	A0A0D9S5F9	62	A	T
Q6ZN06	LB/B	-	A0A0D9S5F9	93	D	V
Q6ZN06	LB/B	-	A0A0D9S5F9	168	I	F
Q6ZN06	LB/B	-	A0A0D9S5F9	192	Y	C
Q0VGE8	LB/B	-	A0A0D9S5F9	80	I	N
Q0VGE8	LB/B	-	A0A0D9S5F9	162	S	L
Q6ZRF7	LB/B	-	G7NN39	14	E	K
Q6ZT77	LB/B	-	F7FUR3	148	C	Y
Q96NB3	LB/B	-	A0A2R8ZG32	99	H	Q
Q96NB3	LB/B	-	A0A2R8ZG32	154	S	T
Q96NB3	LB/B	-	A0A2R8ZG32	16	I	V
Q96NB3	LB/B	-	A0A2R8ZG32	93	S	P
Q96NB3	LB/B	-	A0A2R8ZG32	135	F	L
Q9Y2P0	LB/B	-	A0A2U3W9Y6	29	E	K
Q9Y2P0	LB/B	-	A0A2U3W9Y6	88	E	A
Q6ZNA1	LB/B	-	L5L2B7	219	M	I
Q6ZNA1	LB/B	-	L5L2B7	809	N	S
A6NDX5	LB/B	-	A0A1U7SS69	181	Y	C
Q08AG5	LB/B	-	F6XKD1	113	V	M
Q08AG5	LB/B	-	F6XKD1	146	R	H
Q08AG5	LB/B	-	F6XKD1	226	K	E
Q08AG5	LB/B	-	F6XKD1	276	T	A
Q08AG5	LB/B	-	F6XKD1	308	A	P
Q08AG5	LB/B	-	F6XKD1	329	V	A
Q08AG5	LB/B	-	F6XKD1	584	M	L
Q08AG5	LB/B	-	F6XKD1	642	I	M
Q08AG5	LB/B	-	F6XKD1	658	V	I
Q147U1	LB/B	-	F6WQ97	450	C	Y
Q147U1	LB/B	-	F6WQ97	492	Y	C
Q03923	LB/B	-	A0A2K6KB75	60	K	T
Q03923	LB/B	-	A0A2K6KB75	184	G	R
Q03923	LB/B	-	A0A2K6KB75	270	F	S
Q03923	LB/B	-	A0A2K6KB75	266	T	A
Q03923	LB/B	-	A0A2K6KB75	84	Q	R
Q03923	LB/B	-	A0A2K6KB75	115	R	I
Q03923	LB/B	-	A0A2K6KB75	177	T	R
P10072	LB/B	-	A0A096N193	448	R	H
P10072	LB/B	-	A0A096N193	513	S	I
P10072	LB/B	-	A0A096N193	628	T	I
Q05481	LB/B	-	H0XUE0	112	Y	H
Q05481	LB/B	-	H0XUE0	896	T	A
Q05481	LB/B	-	H0XUE0	455	F	I
Q05481	LB/B	-	H0XUE0	1164	L	P
Q05481	LB/B	-	H0XUE0	1164	L	V
Q05481	LB/B	-	H0XUE0	336	T	A
Q05481	LB/B	-	H0XUE0	386	A	T
Q05481	LB/B	-	H0XUE0	521	E	K
Q05481	LB/B	-	H0XUE0	1011	R	I
Q05481	LB/B	-	H0XUE0	1033	R	Q
Q03936	LB/B	-	A0A2K6KB75	492	Q	R
Q03936	LB/B	-	A0A2K6KB75	122	A	V
Q03936	LB/B	-	A0A2K6KB75	527	R	H
P35789	LB/B	-	A0A2K6KB75	93	D	Y
A8MXY4	LB/B	-	A0A2K5DWU8	129	A	G
A8MXY4	LB/B	-	A0A2K5DWU8	7	W	R
Q9P2E3	LB/B	-	F6XSV9	864	L	V
Q9P2E3	LB/B	-	F6XSV9	910	T	A
Q9P2E3	LB/B	-	F6XSV9	924	Q	H
Q9P2E3	LB/B	-	F6XSV9	1351	T	I
Q9P2E3	LB/B	-	F6XSV9	1259	M	I
Q9P2E3	LB/B	-	F6XSV9	1297	G	S
Q9UHR6	LB/B	-	L8IMH0	155	E	K
Q9UHR6	LB/B	-	L8IMH0	176	A	V
Q9NWK9	LB/B	-	A0A2K6EZN6	9	G	R
P21754	LB/B	-	A0A1S3GER7	31	G	R
P21754	LB/B	-	A0A1S3GER7	315	S	P
P21754	LB/B	-	A0A1S3GER7	340	M	V
P21754	LP/P	Oocyte maturation defect 3 (OOMD3) [MIM:617712]	A0A1S3GER7	134	A	T
Q12836	LB/B	-	K7G6A6	114	A	V
Q12836	LB/B	-	K7G6A6	295	P	S
Q6X784	LB/B	-	A0A151P1K4	68	P	A
Q6X784	LB/B	-	A0A151P1K4	118	A	T
Q6X784	LB/B	-	A0A151P1K4	173	S	I
Q6X784	LB/B	-	A0A151P1K4	335	Q	E
Q6X784	LB/B	-	A0A151P1K4	69	T	I
O75312	LB/B	-	A0A1V4J819	264	A	V
O95218	LB/B	-	A0A2K5JBK6	207	R	G
Q5FWF4	LB/B	-	A0A1A8V380	541	E	K
Q5FWF4	LB/B	-	A0A1A8V380	546	R	Q
Q5FWF4	LB/B	-	A0A1A8V380	637	E	V
Q8TBC5	LB/B	-	A0A2K6CA57	379	G	E
Q7Z7L9	LB/B	-	A0A1S3ARZ7	191	S	T
Q16670	LB/B	-	K9IKD4	220	R	S
Q16670	LB/B	-	K9IKD4	59	Y	C
Q16670	LB/B	-	K9IKD4	73	R	Q
Q16670	LB/B	-	K9IKD4	83	E	K
Q86W11	LB/B	-	Q07231	238	Q	P
Q96LW9	LB/B	-	U3KMS0	50	T	S
Q96LW9	LB/B	-	U3KMS0	205	K	R
Q96LW9	LB/B	-	U3KMS0	128	A	P
Q96LW9	LB/B	-	U3KMS0	222	R	Q
Q96LW9	LB/B	-	U3KMS0	365	G	E
Q8NAM6	LB/B	-	A0A212DD64	387	E	K
Q9BUG6	LB/B	-	A0A2Y9PBK1	337	G	V
A6NJL1	LB/B	-	A0A2Y9PBK1	187	P	S
A6NJL1	LB/B	-	A0A2Y9PBK1	208	V	I
A6NJL1	LB/B	-	A0A2Y9PBK1	236	S	T
A6NJL1	LB/B	-	A0A2Y9PBK1	304	S	T
A6NJL1	LB/B	-	A0A2Y9PBK1	412	M	L
A6NGD5	LB/B	-	A0A2Y9PBK1	181	Q	R
A6NGD5	LB/B	-	A0A2Y9PBK1	197	E	D
A6NGD5	LB/B	-	A0A2Y9PBK1	24	Q	R
A6NGD5	LB/B	-	A0A2Y9PBK1	259	Q	K
O15535	LB/B	-	U3KMS0	254	H	R
Q9BR11	LB/B	-	A0A091VNM3	101	R	Q
Q96MP5	LB/B	-	A0A2K6LS13	259	V	A
Q96MP5	LB/B	-	A0A2K6LS13	291	R	W
Q9P217	LB/B	-	J9JYZ1	368	V	G
Q9HCJ5	LP/P	Acromelic frontonasal dysostosis (AFND) [MIM:603671]	J9JYZ1	1163	R	W
Q9HCJ5	LB/B	-	J9JYZ1	763	S	R
Q96AP4	LB/B	-	F1NTN4	379	N	D
Q9H900	LB/B	-	A0A093GSC0	344	S	G
Q2QGD7	LB/B	-	F6Z495	562	P	L
Q15942	LB/B	-	H2RUI5	223	H	L
O43149	LB/B	-	A0A2I0M1U5	30	V	A
O43149	LB/B	-	A0A2I0M1U5	1021	I	V
O43149	LB/B	-	A0A2I0M1U5	1437	S	A
O43149	LB/B	-	A0A2I0M1U5	1972	L	P
O43149	LB/B	-	A0A2I0M1U5	2014	I	V
O43149	LB/B	-	A0A2I0M1U5	2051	P	S
O43149	LB/B	-	A0A2I0M1U5	2301	Y	H
O43149	LB/B	-	A0A2I0M1U5	2303	L	P
O43149	LB/B	-	A0A2I0M1U5	2369	E	Q
O43149	LB/B	-	A0A2I0M1U5	2421	A	T
Q0VG73	LB/B	-	Q0VG73	19	S	R
Q0VG73	LB/B	-	Q0VG73	63	I	M
Q6ZRM9	LB/B	-	A0A2I3SPG8	149	A	V
Q6ZRM9	LB/B	-	A0A2I3SPG8	158	V	M
Q6ZRM9	LB/B	-	A0A2I3SPG8	205	F	L
Q6ZRN7	LB/B	-	G7NP63	108	A	G
Q6ZVL8	LB/B	-	Q6ZVL8	30	T	A
Q6ZVL8	LB/B	-	Q6ZVL8	75	G	R
Q6ZVL8	LB/B	-	Q6ZVL8	82	K	R
Q6ZVL8	LB/B	-	Q6ZVL8	105	P	S
Q6ZVL8	LB/B	-	Q6ZVL8	136	C	S
Q8N402	LB/B	-	G3QPU9	97	P	L
Q8N402	LB/B	-	G3QPU9	114	T	S
Q8N402	LB/B	-	G3QPU9	131	T	P
